586	chr1	229375	229407	3500122478	29		229375	229407	8421504	3	18,6,5	0,19,27	g	350012247800000000	0-29						Compositions and methods for the treatment of immune related diseases	Grewal	2009	0		
587	chr1	331305	331330	3500381082	25		331305	331330	8421504	1	25	0	c	350038108200000005	0-25						Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway. - ResearchGate	.researchgate.net	0	0		
590	chr1	723184	723207	3500152160	23		723184	723207	8421504	1	23	0	c	350015216000000117	21-44						Short Communication A 4 Mb high resolution BAC contig on bovine chromosome 1q12 and comparative analysis with human chromosome 21q22	loads.hindawi.com	0	0		
593	chr1	1058257	1058283	3500185318	23		1058257	1058283	8421504	3	11,7,5	0,12,21	c	350018531800000093	15-38						Canine coronavirus s gene and uses therefor	Jones	1993	0		
593	chr1	1058257	1058283	3500102026	23		1058257	1058283	8421504	3	11,7,5	0,12,21	c	350010202600000586	15-38						Compositions and methods for vaccination against coronaviruses	Jones	1993	0		
593	chr1	1067573	1067597	3500370232	23		1067573	1067597	8421504	2	9,14	0,10	c	350037023200000111	14-37						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
593	chr1	1067573	1067597	3500187760	23		1067573	1067597	8421504	2	9,14	0,10	c	350018776000000093	14-37					Patent	Enzyme capable of degrading cellulose or hemicellulose (Patent US:5686593)	Hagen	1997	0		
593	chr1	1090443	1090534	3500152160	42		1090443	1090534	8421504	2	21,21	0,70	c	350015216000000113,350015216000000064	21-42,0-21						Short Communication A 4 Mb high resolution BAC contig on bovine chromosome 1q12 and comparative analysis with human chromosome 21q22	loads.hindawi.com	0	0		
594	chr1	1270190	1271555	3500211153	138		1270190	1271555	8421504	2	75,63	0,1302	p	350021115300015005,350021115300015007	0-138,0-138						Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor	Fuchs	2010	0		
594	chr1	1270190	1271555	3500002271	138		1270190	1271555	8421504	2	75,63	0,1302	p	350000227100015004,350000227100015006	0-138,0-138						Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor - Patent application	www.faqs.org	0	0		
595	chr1	1364121	1392682	3500258129	1790		1364121	1392682	8421504	8	750,197,158,148,167,158,124,88	0,760,6932,14521,19691,21354,25990,28473	c	350025812900000078,350025812900000077,350025812900000090,350025812900000092	0-750,0-1040,0-1040,0-1040						Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases - Patent application	www.faqs.org	0	0		
595	chr1	1383974	1385505	3500048026	35		1383974	1385505	8421504	2	5,30	0,1501	c	350004802600000215	13-48						ANTI-IL-20, ANTI-IL-22 AND ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION - Patent application	www.faqs.org	0	0		
595	chr1	1394573	1394600	3500165384	24		1394573	1394600	8421504	2	15,9	0,18	c	350016538400000164	1-25						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
595	chr1	1406938	1410629	3500319127	40		1406938	1410629	8421504	3	11,9,20	0,1408,3671	c,g	350031912700000009,350031912700000008,350031912700000008	0-20,0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
597	chr1	1689432	1689458	3500051756	24		1689432	1689458	8421504	2	11,13	0,13	g	350005175600000105	22-46						Food Science and Technology New Research	www.scribd.com	0	0		
599	chr1	1904852	1904882	3500051838	25		1904852	1904882	8421504	2	18,7	0,23	g	350005183800000002	9-34					Patent	Use of bacterial polysaccharides for biofilm inhibition (Patent EP:2046378)	Da	2010	0		
599	chr1	1946626	1947385	3500279355	25		1946626	1947385	8421504	3	19,4,2	0,22,757	c	350027935500000019	17-42						US Patent # 5,516,674. Insecticide resistance associated cytochrome 450 - Patents.com	www.patents.com	0	0		
599	chr1	1946626	1947385	3500150096	25		1946626	1947385	8421504	3	19,4,2	0,22,757	c	350015009600000019	17-42						Insecticide resistance associated cytochrome 450	Roe	1994	0		
607	chr1	2903064	2911254	3500046035	327		2903064	2911254	8421504	7	81,60,45,32,64,24,21	0,1682,1745,2665,4479,4546,8169	p	350004603500015209,350004603500015245,350004603500015068,350004603500015219,350004603500015206,350004603500015218,350004603500015205,350004603500015204,350004603500015215,350004603500015199,350004603500015240,350004603500015214,350004603500015197,350004603500015196	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Method of identifying compounds useful to treat neuronal degenerative diseases - Patent application	www.faqs.org	0	0		
607	chr1	2903078	2905695	3500047878	40		2903078	2905695	8421504	3	20,16,4	0,1770,2613	c	350004787800000049,350004787800000048	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
607	chr1	2903086	2905754	3500075634	40		2903086	2905754	8421504	2	20,20	0,2648	c	350007563400000001,350007563400000000	0-20,0-20						Quercetin Induces Oxidative Stress and Potentiates the Apoptotic Action of 2-Methoxyestradiol in Human Hepatoma Cells	embers.linode.com	0	0		SOD1
607	chr1	2903099	2903123	3500411693	24		2903099	2903123	8421504	1	24	0	c	350041169300000007	0-24						The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. - ResearchGate	.researchgate.net	0	0		SOD1
607	chr1	2903101	2905700	3500130062	40		2903101	2905700	8421504	3	20,11,9	0,1752,2590	c	350013006200000002,350013006200000001	0-20,0-20		16478720	10.1074/jbc.M513387200	0021-9258	Journal of Biological Chemistry	Dysfunctions of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1 and NDUFS4 Genes of Complex I	Iuso	2006	5		
607	chr1	2903115	2904787	3500455327	50		2903115	2904787	8421504	2	22,28	0,1644	c,g	350045532700000002,350045532700000002,350045532700000000	0-22,0-22,0-28						Influence of Growth Factors on Bovine Embryo Development	cholar.lib.vt.edu	0	0		
607	chr1	2903118	2904750	3500005363	31		2903118	2904750	8421504	2	27,4	0,1628	c	350000536300000001	7-38						E-Print Network 3.0 - g94a a4v mutant Sample Search Results	www.osti.gov	0	0		SOD1
607	chr1	2903126	2904751	3500437899	24		2903126	2904751	8421504	2	19,5	0,1620	c	350043789900000002,350043789900000001	11-35,0-20		19216795	10.1186/1471-2407-9-54	1471-2407	BMC Cancer	Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors	Rieske	2009	3		SOD1
607	chr1	2903135	2911381	3500326548	44		2903135	2911381	8421504	3	10,12,22	0,1611,8224	c,g	350032654800000009,350032654800000008,350032654800000008	0-22,0-22,0-22		12040026	10.1210/me.16.6.1417	0888-8809	Molecular Endocrinology	Identification of Two Novel ACTH-Responsive Genes Encoding Manganese-Dependent Superoxide Dismutase (SOD2) and the Zinc Finger Protein TIS11b [Tetradecanoyl Phorbol Acetate (TPA)-Inducible Sequence 11b]	Chinn	2002	5		
607	chr1	2904767	2904812	3500253779	45		2904767	2904812	8421504	1	45	0	p	350025377900015067	0-45						Mice having a mutant SOD-1-encoding transgene	Brown	1994	0		
607	chr1	2904841	2907545	3500205152	49		2904841	2907545	8421504	4	23,4,20,2	0,850,900,2702	c	350020515200000013,350020515200000012	0-27,5-27						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		
607	chr1	2904846	2905696	3500172455	23		2904846	2905696	8421504	2	18,5	0,845	c	350017245500000019	19-42						Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation	hives-ouvertes.fr	0	0		
607	chr1	2904848	2911296	3500364935	40		2904848	2911296	8421504	3	16,4,20	0,843,6428	c,g	350036493500000001,350036493500000000,350036493500000000	0-20,0-20,0-20		23101731	10.1186/1477-7827-10-87	1477-7827	Reproductive Biology and Endocrinology	Roles of prostaglandin F2alpha and hydrogen peroxide in the regulation of Copper/Zinc superoxide dismutase in bovine corpus luteum and luteal endothelial cells	Vu	2012	2		
607	chr1	2904848	2905698	3500395598	23		2904848	2905698	8421504	2	16,7	0,843	c	350039559800000009	0-23						Consequences of physiological heat shock beginning at the zygote stage on embryonic development and expression of stress response genes in cattle	imal.ifas.ufl.edu	0	0		
607	chr1	2904848	2905698	3500280109	23		2904848	2905698	8421504	2	16,7	0,843	c	350028010900000009	0-23						Consequences of physiological heat shock beginning at the zygote stage on embryonic development and expression of stress response genes in cattle	imal.ifas.ufl.edu	0	0		
607	chr1	2905711	2905756	3500132173	45		2905711	2905756	8421504	1	45	0	p	350013217300015018	0-45						Tesis Alberto Garc&#xed;a Redondo	www.fundela.info	0	0		
607	chr1	2905722	2905745	3500235636	23		2905722	2905745	8421504	1	23	0	c	350023563600000003	0-23						Effects of oxygen concentration on in vitro maturation of canine oocytes in a chemically defined serum-free medium	uction-online.org	0	0		
607	chr1	2907547	2907604	3500065502	57		2907547	2907604	8421504	1	57	0	p	350006550200015007	6-63						THROMBUS-SPECIFIC ANTIBODY DERIVATIVES - CORVAS INTERNATIONAL N	www.sumobrain.com	0	0		
607	chr1	2907623	2911267	3500156475	42		2907623	2911267	8421504	3	11,11,20	0,3610,3624	c	350015647500000037,350015647500000038	0-22,0-20						REPRODUCTION	uction-online.org	0	0		
607	chr1	2911278	2911306	3500455319	28		2911278	2911306	8421504	1	28	0	c	350045531900000000,350045531900000009,350045531900000001	5-33,6-32,0-21						Method for screening of modulators of calcineurin activity	Voelkel	2000	0		SOD1
608	chr1	3073531	3073783	3500259232	240		3073531	3073783	8421504	3	121,104,15	0,131,237	g	350025923200000011,350025923200000012	0-122,0-120						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
608	chr1	3073553	3073783	3500000589	218		3073553	3073783	8421504	3	99,104,15	0,109,215	g	350000058900000027,350000058900000028	0-100,0-120						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
617	chr1	4279781	4279808	3500022801	24		4279781	4279808	8421504	2	9,15	0,12	g	350002280100000005	1-25						CHROMOSOMAL LOCALIZATION OF A PROINSULIN TRANSGENE INSERTED WITH A TRANSPOSON-BASED VECTOR INTO JAPANESE QUAIL, COTURNIX COTURNIX	etd.lsu.edu	0	0		
620	chr1	4620595	4620622	3500119363	23		4620595	4620622	8421504	2	12,11	0,16	g	350011936300000000	0-23		19727868	10.1007/s10096-009-0804-7	0934-9723	European Journal of Clinical Microbiology Infectious Diseases	Development of a real-time PCR for the specific detection of Waddlia chondrophila in clinical samples | DeepDyve	G.	2009	3		
620	chr1	4648263	4648286	3500311161	23		4648263	4648286	8421504	1	23	0	g	350031116100000189	10-48						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
623	chr1	4987560	4987588	3500378445	27		4987560	4987588	8421504	2	7,20	0,8	g	350037844500000968,350037844500001468	1-25,1-21						Multitargeting Interfering RNAs And Methods Of Their Use And Design - Patent application	www.faqs.org	0	0		
626	chr1	5460888	5460912	3500150594	23		5460888	5460912	8421504	2	10,13	0,11	g	350015059400000014	1-24		19581408	10.1084/jem.20082815	0022-1007	The Journal of Experimental Medicine	NF-&#x03ba;B activity marks cells engaged in receptor editing	Cadera	2009	14		
627	chr1	5585989	5586030	3500338459	41		5585989	5586030	8421504	1	41	0	c	350033845900000098	0-41						Glutamate receptor (or EAA receptor) polynucleotides and their uses	Kamboj	1996	0		
628	chr1	5651045	5717206	3500338459	328		5651045	5717206	8421504	11	6,41,24,24,48,48,48,7,41,11,30	0,7806,7896,11401,12625,18610,23251,40064,47527,47767,66131	c	350033845900000104,350033845900000106,350033845900000112,350033845900000116,350033845900000118,350033845900000127,350033845900000132	0-47,0-48,0-48,0-48,0-48,0-48,7-48						Glutamate receptor (or EAA receptor) polynucleotides and their uses	Kamboj	1996	0		
635	chr1	6650003	6650032	3500308897	25		6650003	6650032	8421504	3	4,15,6	0,5,23	g	350030889700000280	18-43						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
641	chr1	7435282	7435310	3500022146	24		7435282	7435310	8421504	2	16,8	0,20	g	350002214600000002	0-30						TYPE III T. BRUCEI ARGININE METHYLTRANSFERASE	Read	2009	0		
645	chr1	7973990	7974017	3500053431	23		7973990	7974017	8421504	2	8,15	0,12	g	350005343100000303	0-25					Patent	Binding agents which inhibit myostatin (Patent US:7928075)	Han	2011	0		
651	chr1	8707223	8707247	3500035308	24		8707223	8707247	8421504	1	24	0	c	350003530800000008	0-24		20568084	10.1002/term.275		Journal of tissue engineering and regenerative medicine	Lentiviral shRNA knockdown of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture	Teresa	2010	0		
651	chr1	8720045	8720090	3500402466	45		8720045	8720090	8421504	1	45	0	p	350040246600015004	9-54			10.1046/j.1432-1033.2003.03607.x	1432-1033	European Journal of Biochemistry	Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters - Vankemmelbeke - 2003 - European Journal of Biochemistry - Wiley Online Library	Vankemmelbeke	2003	0		ADAMTS5
651	chr1	8722408	8722432	3500058146	24		8722408	8722432	8421504	1	24	0	c	350005814600000002	0-24						Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes	itis-research.com	0	0		
651	chr1	8722435	8730108	3500083194	40		8722435	8730108	8421504	2	20,20	0,7653	c,g	350008319400000011,350008319400000011,350008319400000012,350008319400000012	0-20,0-20,0-20,0-20						Role of infrapatellar fat pad in knee osteoarthritis	www.tipharma.com	0	0		
652	chr1	8903199	8903226	3500347910	23		8903199	8903226	8421504	3	5,5,13	0,7,14	c	350034791000000034	0-23						Plant ubiquitin promoter system	Quail	1996	0		
652	chr1	8905128	8905157	3500320331	26		8905128	8905157	8421504	3	12,8,6	0,14,23	c	350032033100000013	11-37						Polypeptides Having Endoglucanase Activity and Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
652	chr1	8905307	8905331	3500055849	24		8905307	8905331	8421504	1	24	0	c,g	350005584900000010,350005584900000010	18-42,18-42						Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells	s.ulb.uni-bonn.de	0	0		
652	chr1	8905621	8905678	3500059087	57		8905621	8905678	8421504	1	57	0	p	350005908700015030	0-57						Novel Integrin Ligand Itgl-tsp 	.freshpatents.com	0	0		
652	chr1	8905979	8906030	3500362697	50		8905979	8906030	8421504	2	21,29	0,22	c	350036269700000000	0-50		19180493	10.1002/art.24291	1529-0131	Arthritis & Rheumatism	Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration - Pockert - 2009 - Arthritis & Rheumatism - Wiley Online Library	Pockert	2009	0		ADAMTS1
652	chr1	8906001	8906029	3500331821	28		8906001	8906029	8421504	1	28	0	c	350033182100000003	21-49						Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma	.aacrjournals.org	0	0		
652	chr1	8907065	8907419	3500151235	40		8907065	8907419	8421504	2	20,20	0,334	c,g	350015123500000000,350015123500000000,350015123500000001	0-20,0-20,0-20		19514085	10.1002/cncr.24417	1097-0142	Cancer	Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures - Braconi - 2009 - Cancer - Wiley Online Library	Braconi	2009	0		ADAMTS1
652	chr1	8907933	8907960	3500105905	24		8907933	8907960	8421504	2	7,17	0,10	c	350010590500000025	23-47						Method for Expression and Accumulation of Peptide in Plant - Patent application	www.faqs.org	0	0		
82	chr1	9540677	9908629	3500325483	351		9540677	9908629	8421504	4	54,51,147,99	0,295873,299130,367853	p	350032548300015002	0-351						Transgenic C. elegans as a model organism for investigations on Alzheimer's disease	Peraus	1999	0		APP
82	chr1	9540677	9908629	3500115195	2085		9540677	9908629	8421504	16	57,168,130,113,194,203,134,75,159,129,100,222,54,101,147,99	0,68470,94875,128296,130818,168666,202854,212569,214034,237236,241456,280252,289074,295823,299130,367853	p	350011519500015004	0-2085						Method For Analyzing Cell Free Notch Cleavage And Method For Drug Screening 	.freshpatents.com	0	0		
82	chr1	9540677	9908629	3500089561	2085		9540677	9908629	8421504	16	57,168,130,113,194,203,134,75,159,129,100,222,54,101,147,99	0,68470,94875,128296,130818,168666,202854,212569,214034,237236,241456,280252,289074,295823,299130,367853	p	350008956100015006	0-2085						Method for analyzing cell free notch cleavage and method for drug screening	Okochi	2006	0		
82	chr1	9540677	9908629	3500012355	2085		9540677	9908629	8421504	16	57,168,130,113,194,203,134,75,159,129,100,222,54,101,147,99	0,68470,94875,128296,130818,168666,202854,212569,214034,237236,241456,280252,289074,295823,299130,367853	p	350001235500015003,350001235500015006	0-2085,3-63						&#x7279;&#x958b;WO2005-045028&#x53f7; &#x30bb;&#x30eb;&#x30fb;&#x30d5;&#x30ea;&#x30fc;&#x30fb;&#xff2e;&#xff4f;&#xff54;&#xff43;&#xff48;&#x5207;&#x65ad;&#x5206;&#x6790;&#x65b9;&#x6cd5;&#x53ca;&#x3073;&#x85ac;&#x5264;&#x30b9;&#x30af;&#x30ea;&#x30fc;&#x30cb;&	astamuse.com	0	0		
82	chr1	9540677	9671639	3500363494	612		9540677	9671639	8421504	5	57,168,130,113,144	0,68470,94875,128296,130818	p	350036349400015010	0-612						DR6 ANTAGONISTS AND USES THEREOF IN TREATING NEUROLOGICAL DISORDERS	Nikolaev	2007	0		
82	chr1	9540677	9671639	3500201238	612		9540677	9671639	8421504	5	57,168,130,113,144	0,68470,94875,128296,130818	p	350020123800015007	0-612						Dr6 Antagonists And Uses Thereof In Treating Neurological Disorders 	.freshpatents.com	0	0		APP
82	chr1	9540677	9671639	3500123104	612		9540677	9671639	8421504	5	57,168,130,113,144	0,68470,94875,128296,130818	p	350012310400015008	0-612						Method for inhibiting neurodegeneration	Nikolaev	2012	0		APP
82	chr1	9540677	9671639	3500098346	612		9540677	9671639	8421504	5	57,168,130,113,144	0,68470,94875,128296,130818	p	350009834600015006	0-612						Method for inhibiting neurodegeneration	Nikolaev	2011	0		
82	chr1	9540677	9671639	3500089957	612		9540677	9671639	8421504	5	57,168,130,113,144	0,68470,94875,128296,130818	p	350008995700015006	0-612						Method for inhibiting neurodegeneration	Nikolaev	2010	0		
657	chr1	9540689	9540719	3500396179	30		9540689	9540719	8421504	1	30	0	c	350039617900000008	0-30						Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease	Cordell	1995	0		APP
657	chr1	9540689	9540719	3500280558	30		9540689	9540719	8421504	1	30	0	c	350028055800000006	0-30					Patent	Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease (Patent US:5387742)	Cordell	1995	0		APP
82	chr1	9540725	9609183	3500322740	45		9540725	9609183	8421504	2	9,36	0,68422	p	350032274000015101	0-45						Cell-free notch cleavage analysis method and drug screening method	Da He Nei Zheng Kang 	2006	0		APP
82	chr1	9635567	9839912	3500242595	479		9635567	9839912	8421504	13	48,1,46,15,33,9,38,22,19,62,87,33,66	0,73978,107964,108083,117679,119294,142346,146644,185362,185445,200947,204240,204279	c	350024259500000007,350024259500000020,350024259500000070,350024259500000075,350024259500000032,350024259500000128,350024259500000034,350024259500000082,350024259500000086,350024259500000039,350024259500000040,350024259500000041,350024259500000089	0-48,0-47,0-48,0-47,0-41,0-26,9-48,0-47,0-48,0-48,0-48,6-48,0-48						Method for identifying alzheimer's disease therapeutics using transgenic animal models	Mcconlogue	1996	0		
658	chr1	9635589	9635613	3500094008	24		9635589	9635613	8421504	1	24	0	c	350009400800000000	9-33						Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis 10.1016/j.febslet.2006.10.072 : FEBS Letters | ScienceDirect.com	sciencedirect.com	0	0		APP
658	chr1	9671606	9671651	3500322740	45		9671606	9671651	8421504	1	45	0	p	350032274000015123	0-45						Cell-free notch cleavage analysis method and drug screening method	Da He Nei Zheng Kang 	2006	0		APP
659	chr1	9709521	9743556	3500378165	94		9709521	9743556	8421504	4	25,24,20,25	0,17805,17858,34010	c,g	350037816500000006,350037816500000007,350037816500000004,350037816500000005	0-25,1-25,0-20,0-25					Patent	A novel senile amyloid precursor protein and an antibody specific for the same (Patent EP:0304013)	Itoh	1996	0		APP
82	chr1	9709545	9839840	3500072819	143		9709545	9839840	8421504	4	1,46,63,33	0,33986,126993,130262	c	350007281900000020,350007281900000039,350007281900000040	0-47,0-48,0-48						Method for identifying alzheimer's disease therapeutics using transgenic animal models	Mcconlogue	1998	0		
659	chr1	9743620	9753273	3500370146	72		9743620	9753273	8421504	2	45,27	0,9626	p,c	350037014600015005,350037014600000000	3-54,15-37						Substances having the growth-promoting effect of amyloid precursor protein	Saitoh	1994	0		
659	chr1	9753291	9754831	3500056556	150		9753291	9754831	8421504	2	30,120	0,1420	p	350005655600015032	0-150						protein Identification IB protein amyloid Alzheimer	www.pnas.org	0	0		APP
659	chr1	9777945	9777970	3500173139	25		9777945	9777970	8421504	1	25	0	c	350017313900000009	0-25		21325636	10.1152/ajpcell.00451.2010		American Journal of Physiology - Cell Physiolog	A disintegrin and metalloprotease 10 activity sheds the ectodomain of the amyloid precursor-like protein 2 and regulates protein expression in proximal tubule cells	Cong	2011	0		
659	chr1	9777945	9777970	3500043261	25		9777945	9777970	8421504	1	25	0	c	350004326100000009	0-25		21325636	10.1152/ajpcell.00451.2010		American Journal of Physiology - Cell Physiology	A disintegrin and metalloprotease 10 activity sheds the ectodomain of the amyloid precursor-like protein 2 and regulates protein expression in proximal tubule cells	Rong	June	0		
82	chr1	9829787	9836506	3500463535	24		9829787	9836506	8421504	2	18,6	0,6713	c	350046353500000002	0-24		20624932	10.1096/fj.09-148825	0892-6638	The FASEB Journal	Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain	Kim	2010	6		APP
82	chr1	9829787	9836506	3500394536	24		9829787	9836506	8421504	2	18,6	0,6713	c	350039453600000000	0-24		21179415	10.1371/journal.pone.0015349		PLoS ONE	Zinc Overload Enhances APP Cleavage and A&#x03b2; Deposition in the Alzheimer Mouse Brain	Chun-Yan	2010	0		APP
82	chr1	9829787	9836506	3500354838	24		9829787	9836506	8421504	2	18,6	0,6713	c	350035483800000011,350035483800000004	0-24,0-24						PHARMACEUTICAL COMPOSITION TO PREVENT AND TREAT ALZHEIMER'S DISEASE COMPRISING GCP II MUTANT - Patent application	www.faqs.org	0	0		APP
82	chr1	9829787	9836506	3500348389	24		9829787	9836506	8421504	2	18,6	0,6713	c	350034838900000002	0-24		19200347	10.1111/j.1471-4159.2009.05959.x	1471-4159	Journal of Neurochemistry	Role of caspase-3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies - Zhang - 2009 - Journal of Neurochemistry - Wiley Online Library	Zhang	2009	0		APP
82	chr1	9829787	9836506	3500272588	24		9829787	9836506	8421504	2	18,6	0,6713	c	350027258800000000	0-24		21179415	10.1371/journal.pone.0015349	1932-6203	PLOS ONE	PLOS ONE: Zinc Overload Enhances APP Cleavage and A&#x03b2; Deposition in the Alzheimer Mouse Brain	Wang	2010	4		APP
82	chr1	9829787	9836506	3500252146	24		9829787	9836506	8421504	2	18,6	0,6713	c	350025214600000000	0-24						Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model	odegeneration.com	0	0		APP
82	chr1	9829787	9836506	3500085956	24		9829787	9836506	8421504	2	18,6	0,6713	c	350008595600000000	0-24						Huperzine A Activates Wnt&sol;&#x03b2;-Catenin Signaling and Enhances the Nonamyloidogenic Pathway in an Alzheimer Transgenic Mouse Model	library.ibp.ac.cn	0	0		APP
82	chr1	9829787	9836506	3500029385	24		9829787	9836506	8421504	2	18,6	0,6713	c	350002938500000000	0-24		21044348	10.1186/1750-1326-5-46	1750-1326	Molecular Neurodegeneration	Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model	Wang	2010	4		APP
82	chr1	9829787	9836506	3500002582	24		9829787	9836506	8421504	2	18,6	0,6713	c	350000258200000000	0-24		21044348	10.1186/1750-1326-5-46	1750-1326	Molecular Neurodegeneration	Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model	Wang	2010	4		APP
82	chr1	9829804	9839954	3500364899	246		9829804	9839954	8421504	4	1,101,105,39	0,6696,10003,10111	p	350036489900015057	0-246					Patent	Vaccine compositions containing amyloid beta1-6 antigen arrays (Patent CA:2492930)	Bachmann	2013	0		APP
660	chr1	9836526	9839813	3500399520	81		9836526	9839813	8421504	2	75,6	0,3281	p	350039952000015015	0-81						 Lysine 	www.docstoc.com	0	0		APP
660	chr1	9836529	9839903	3500450758	168		9836529	9839903	8421504	2	72,96	0,3278	p	350045075800015004	0-168						Method Of Producing Catalytically Active Bace2 Enzymes 	.freshpatents.com	0	0		APP
660	chr1	9836529	9839903	3500331462	168		9836529	9839903	8421504	2	72,96	0,3278	p	350033146200015010	0-168						Method of producing catalytically active BACE2 enzymes	Tomasselli	2008	0		APP
660	chr1	9836532	9839915	3500221122	177		9836532	9839915	8421504	2	69,108	0,3275	p	350022112200015071	0-177						&#x0395;&#x0398;&#x039d;&#x0399;&#x039a;&#x039f; &#x039c;&#x0395;&#x03a4;&#x03a3;&#x039f;&#x0392;&#x0399;&#x039f; &#x03a0;&#x039f;&#x039b;&#x03a5;&#x03a4;&#x0395;&#x03a7;&#x039d;&#x0395;&#x0399;&#x039f;	dbnet.ece.ntua.gr	0	0		APP
660	chr1	9836532	9839882	3500346949	144		9836532	9839882	8421504	2	69,75	0,3275	p	350034694900015045,350034694900015021,350034694900015042,350034694900015025,350034694900015046,350034694900015043	0-48,0-126,0-48,0-111,0-48,0-48						Antibodies Against Amyloid Beta 4 With Glycosylated in the Variable Region - Patent application	www.faqs.org	0	0		APP
660	chr1	9836538	9839921	3500256894	120		9836538	9839921	8421504	3	63,6,51	0,3269,3332	p	350025689400015020,350025689400015021	0-69,0-51						TESI DOCTORAL	www.tdx.cat	0	0		APP
660	chr1	9836538	9839888	3500379942	144		9836538	9839888	8421504	2	63,81	0,3269	p	350037994200015101,350037994200015008,350037994200015080,350037994200015006,350037994200015102,350037994200015083,350037994200015089,350037994200015090,350037994200015091,350037994200015092,350037994200015093,350037994200015094,350037994200015095,350037994200015096,350037994200015097,350037994200015104,350037994200015103	0-48,0-129,0-48,0-108,0-48,0-48,0-45,0-45,0-45,0-48,0-48,0-45,0-45,0-45,0-45,0-45,0-48						Antibodies Directed Against Amyloid-beta Peptide And Methods Using Same 	.freshpatents.com	0	0		APP
660	chr1	9836538	9839840	3500220663	96		9836538	9839840	8421504	2	63,33	0,3269	p	350022066300015006,350022066300015005	0-96,0-60		18753367	10.1523/JNEUROSCI.2094-08.2008	0270-6474	The Journal of Neuroscience	BRI2 Inhibits Amyloid &#x03b2;-Peptide Precursor Protein Processing by Interfering with the Docking of Secretases to the Substrate	Matsuda	2008	7		APP
660	chr1	9836546	9836595	3500143153	49		9836546	9836595	8421504	1	49	0	p,c	350014315300000000,350014315300015013,350014315300015000	118-167,6-54,0-45					Patent	&#x6297;&#x6dc0;&#x7c89;&#x6837;&#x86cb;&#x767d;&#x514d;&#x75ab;&#x539f;&#x6027;&#x7ec4;&#x5408;&#x7269;&#x3001;&#x65b9;&#x6cd5;&#x548c;&#x7528;&#x9014; Anti-amyloid immunogenic compositions, methods and uses (Patent CN:101384279)	B*P*Ai Mu Bi Mu Bo 	2012	0		APP
660	chr1	9836547	9836576	3500321372	29		9836547	9836576	8421504	1	29	0	c	350032137200000000	13-42						Compositions and methods of treating neurological diseases	Bowers	2005	0		APP
660	chr1	9836547	9836576	3500141924	29		9836547	9836576	8421504	1	29	0	c	350014192400000000	13-42						Compositions and methods of treating neurological diseases	Bowers	2006	0		APP
660	chr1	9836550	9839921	3500422706	165		9836550	9839921	8421504	2	51,114	0,3257	p	350042270600015001,350042270600015000	0-165,0-150						&#x30a2;&#x30df;&#x30ed;&#x30a4;&#x30c9;&#x03b2;&#x95a2;&#x9023;&#x306e;&#x75be;&#x60a3;&#x7528;&#x533b;&#x85ac;&#x53ca;&#x3073;&#x305d;&#x306e;&#x30b9;&#x30af;&#x30ea;&#x30fc;&#x30cb;&#x30f3;&#x30b0;	Yuyama	2013	0		APP
660	chr1	9836550	9839888	3500420805	132		9836550	9839888	8421504	2	51,81	0,3257	p	350042080500015010,350042080500015008,350042080500015103,350042080500015084,350042080500015104	0-129,0-102,0-48,0-48,0-48						ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAME - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839885	3500442707	129		9836550	9839885	8421504	2	51,78	0,3257	p	350044270700015008	0-129						YEAST CELLS EXPRESSING AMYLOID BETA AND USES THEREFOR	Treusch	2012	0		APP
660	chr1	9836550	9839885	3500420827	129		9836550	9839885	8421504	2	51,78	0,3257	p	350042082700015009,350042082700015014,350042082700015015,350042082700015016,350042082700015012	0-120,0-57,0-51,0-45,0-48						Methods of treating ophthalmic diseases	Lin	2009	0		APP
660	chr1	9836550	9839885	3500384310	129		9836550	9839885	8421504	2	51,78	0,3257	p	350038431000015026,350038431000015027	0-66,0-63						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		APP
660	chr1	9836550	9839885	3500342390	129		9836550	9839885	8421504	2	51,78	0,3257	p	350034239000015012,350034239000015021,350034239000015020,350034239000015022,350034239000015018,350034239000015017	0-78,0-51,0-57,0-45,0-48,0-51						Antibodies directed against amyloid-beta peptide and methods using same	Grimm	2006	0		APP
660	chr1	9836550	9839885	3500325346	129		9836550	9839885	8421504	2	51,78	0,3257	p	350032534600015009,350032534600015011	0-102,0-129						ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAME	Rosenthal	2013	0		APP
660	chr1	9836550	9839885	3500260757	129		9836550	9839885	8421504	2	51,78	0,3257	p	350026075700015008,350026075700015006	0-129,0-102						Antibodies directed against amyloid-beta peptide and methods using same	Ho	2011	0		APP
660	chr1	9836550	9839885	3500247008	129		9836550	9839885	8421504	2	51,78	0,3257	p	350024700800015006,350024700800015008	0-102,0-129					Patent	Antibodies directed against amyloid-beta peptide and methods using same (Patent US:8398978)	Rosenthal	2013	0		APP
660	chr1	9836550	9839885	3500230923	129		9836550	9839885	8421504	2	51,78	0,3257	p	350023092300015000	0-129						Differenzielle Effekte von Presenilin-Mutationen auf die Generierung des Amyloid-&#xdf;-Peptids (A&#xdf;) und die Endoproteolyse des Notch-Rezeptors	b.uni-muenchen.de	0	0		APP
660	chr1	9836550	9839885	3500225362	129		9836550	9839885	8421504	2	51,78	0,3257	p	350022536200015006,350022536200015008	0-108,0-129					Patent	Antibodies directed against amyloid-beta peptide and nucleic acids encoding same (Patent US:7763250)	Ho	2010	0		APP
660	chr1	9836550	9839885	3500218988	129		9836550	9839885	8421504	2	51,78	0,3257	p	350021898800015006,350021898800015008	0-108,0-129						Antibodies directed against amyloid-beta peptide and methods using same	Ho	2006	0		APP
660	chr1	9836550	9839885	3500206227	129		9836550	9839885	8421504	2	51,78	0,3257	p	350020622700015010,350020622700015016,350020622700015020,350020622700015018,350020622700015019,350020622700015015	0-78,0-48,0-45,0-57,0-51,0-51					Patent	Antibodies directed against amyloid-beta peptide (Patent US:7927594)	Grimm	2011	0		APP
660	chr1	9836550	9839885	3500191571	129		9836550	9839885	8421504	2	51,78	0,3257	p	350019157100015015	0-129						POLYNUCLEOTIDES ENCODING ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE	Rosenthal	2010	0		APP
660	chr1	9836550	9839885	3500148822	129		9836550	9839885	8421504	2	51,78	0,3257	p	350014882200015011	0-129					Patent	Antibodies directed against amyloid-beta peptide and methods using same (Patent US:8425905)	Rosenthal	2013	0		APP
660	chr1	9836550	9839885	3500129065	129		9836550	9839885	8421504	2	51,78	0,3257	p	350012906500015010,350012906500015108,350012906500015164,350012906500015020,350012906500015026,350012906500015018,350012906500015019,350012906500015016,350012906500015015	0-78,0-45,0-45,0-45,0-45,0-57,0-51,0-48,0-51						Antibodies directed against amyloid-beta peptide and methods using same - US Patent 7807165 Description	ww.patentstorm.us	0	0		APP
660	chr1	9836550	9839885	3500122023	129		9836550	9839885	8421504	2	51,78	0,3257	p	350012202300015002,350012202300015004	0-129,0-45						Therapeutic Agent For Alzheimer's Disease - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839885	3500043107	129		9836550	9839885	8421504	2	51,78	0,3257	p	350004310700015010,350004310700015100,350004310700015152,350004310700015153,350004310700015018,350004310700015019,350004310700015026,350004310700015020,350004310700015016,350004310700015015	0-78,0-45,0-45,0-45,0-57,0-51,0-45,0-45,0-48,0-51						 Antibodies Directed Against Amyloid 	www.docstoc.com	0	0		APP
660	chr1	9836550	9839885	3500020769	129		9836550	9839885	8421504	2	51,78	0,3257	p	350002076900015003	0-129						YEAST CELLS EXPRESSING AMYLOID BETA AND USES THEREFOR	Matlack	2011	0		APP
660	chr1	9836550	9839885	3500018203	129		9836550	9839885	8421504	2	51,78	0,3257	p	350001820300015006,350001820300015008	0-102,0-129						Antibodies directed against amyloid-beta peptide and methods using same	Ho	2011	0		APP
660	chr1	9836550	9839885	3500010389	129		9836550	9839885	8421504	2	51,78	0,3257	p	350001038900015011	0-129						Polynucleotides encoding antibodies directed against amyloid-beta peptide	Grimm	2011	0		APP
660	chr1	9836550	9839882	3500390692	126		9836550	9839882	8421504	2	51,75	0,3257	p	350039069200015009,350039069200015010	15-90,0-51						Soluble complexes of amylod &#x03b2; peptide and peptidyl prolyl isomerase chaperone and methods of making and using them	Scholz	2003	0		APP
660	chr1	9836550	9839882	3500201309	126		9836550	9839882	8421504	2	51,75	0,3257	p	350020130900015005,350020130900015004,350020130900015007,350020130900015006,350020130900015012,350020130900015017	0-120,0-126,0-114,0-120,3-114,0-96						 Inhibitors Of Glutaminyl Cyclase For Treating Neurodegenerative Diseases 	www.docstoc.com	0	0		APP
660	chr1	9836550	9839882	3500138954	126		9836550	9839882	8421504	2	51,75	0,3257	p	350013895400015035,350013895400015005	0-126,0-114					Patent	&#x6297;&#x4f53;&#x53ef;&#x53d8;&#x533a;&#x7684;&#x7cd6;&#x57fa;&#x5316; (Patent CN:101351476)	H*Luo Ci Xi Er 	2013	0		APP
660	chr1	9836550	9839879	3500283312	123		9836550	9839879	8421504	2	51,72	0,3257	p	350028331200015002,350028331200015027	0-114,0-111						&#x6297;&#x4f53;&#x53ef;&#x53d8;&#x533a;&#x7684;&#x7cd6;&#x57fa;&#x5316;	A*Shao Bu Ma 	2009	0		APP
660	chr1	9836550	9839879	3500128132	123		9836550	9839879	8421504	2	51,72	0,3257	p	350012813200015005,350012813200015001,350012813200015063	0-114,0-78,0-111						Antibodies with glycosylated in the variable region	A*Shao Bu Ma 	2009	0		APP
660	chr1	9836550	9839876	3500461845	120		9836550	9839876	8421504	2	51,69	0,3257	p	350046184500015006	0-120						Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fiber formation and modulating cross-beta structure-mediated toxicity	Kroon-Batenburg	2008	0		APP
660	chr1	9836550	9839876	3500448175	120		9836550	9839876	8421504	2	51,69	0,3257	p	350044817500015013,350044817500015015	0-120,0-45						Filamentous bacteriophage displaying an &#x03b2;-amyloid epitope	Solomon	1999	0		APP
660	chr1	9836550	9839876	3500423701	120		9836550	9839876	8421504	2	51,69	0,3257	p	350042370100015005	0-120						Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity	Kroon-Batenburg	2006	0		APP
660	chr1	9836550	9839876	3500423664	120		9836550	9839876	8421504	2	51,69	0,3257	p	350042366400015000	0-120						Transgenic knockouts of BACE-1	Gurney	2002	0		APP
660	chr1	9836550	9839876	3500417545	120		9836550	9839876	8421504	2	51,69	0,3257	p	350041754500015006	0-120					Patent	Cross-&#x03b2; structure comprising amyloid-binding proteins and methods for detection of the cross-&#x03b2; structure, for modulating cross-&#x03b2; structures fiber formation and modulating cross-&#x03b2; structure-mediated toxicity (Patent US:8158585)	Bouma	2012	0		APP
660	chr1	9836550	9839876	3500414434	120		9836550	9839876	8421504	2	51,69	0,3257	p	350041443400015006	0-120						CROSS-&#xdf; STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-&#xdf; STRUCTURE, FOR MODULATING CROSS-&#xdf; STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-&#xdf; STRUCTURE-MEDIATED TOXICITY	Bouma	2012	0		APP
660	chr1	9836550	9839876	3500411770	120		9836550	9839876	8421504	2	51,69	0,3257	p	350041177000015017	0-120						Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500407212	120		9836550	9839876	8421504	2	51,69	0,3257	p	350040721200015041	0-120						Science.Magazine.5707.2005-01-14	www.scribd.com	0	0		APP
660	chr1	9836550	9839876	3500390904	120		9836550	9839876	8421504	2	51,69	0,3257	p	350039090400015004	0-120						Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming	Frenkel	2003	0		APP
660	chr1	9836550	9839876	3500381063	120		9836550	9839876	8421504	2	51,69	0,3257	p	350038106300015000	0-120						Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity	Gebbink	2008	0		APP
660	chr1	9836550	9839876	3500373661	120		9836550	9839876	8421504	2	51,69	0,3257	p	350037366100015006	0-120						Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fiber formation and modulating cross-beta structure-mediated toxicity - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500369662	120		9836550	9839876	8421504	2	51,69	0,3257	p	350036966200015000	0-120						LDP-341 | Online Peptides Guide	tein-fragment.com	0	0		APP
660	chr1	9836550	9839876	3500353830	120		9836550	9839876	8421504	2	51,69	0,3257	p	350035383000015002	0-120						UNIVERSIDAD DE EXTREMADURA Departamento de Bioqu&#xed;mica y Biolog&#xed;a Molecular	alnet.unirioja.es	0	0		APP
660	chr1	9836550	9839876	3500345829	120		9836550	9839876	8421504	2	51,69	0,3257	p	350034582900015017	0-120						Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof	Hillen	2008	0		APP
660	chr1	9836550	9839876	3500343991	120		9836550	9839876	8421504	2	51,69	0,3257	p	350034399100015043,350034399100015045,350034399100015050	0-120,0-114,3-114						Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases	Hoffman	2007	0		APP
660	chr1	9836550	9839876	3500331858	120		9836550	9839876	8421504	2	51,69	0,3257	p	350033185800015001,350033185800015006	0-120,0-45						METHODS OF PREPARATION OF RECOMBINANT FORMS OF HUMAN BETA-AMYLOID PROTEIN AND USES OF THESE PROTEINS - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500293903	120		9836550	9839876	8421504	2	51,69	0,3257	p	350029390300015000	0-120					Patent	Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity (Patent EP:1536778)	Gebbink	2008	0		APP
660	chr1	9836550	9839876	3500289825	120		9836550	9839876	8421504	2	51,69	0,3257	p	350028982500015009	0-120						Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases	Solomon	2005	0		APP
660	chr1	9836550	9839876	3500288552	120		9836550	9839876	8421504	2	51,69	0,3257	p	350028855200015000	0-120						A method for inhibiting tumor invasion or spreading in a subject	Schmidt	1999	0		APP
660	chr1	9836550	9839876	3500278173	120		9836550	9839876	8421504	2	51,69	0,3257	p	350027817300015000	0-120						Method For Detecting Peptides Comprising A Cross-b Structure 	.freshpatents.com	0	0		APP
660	chr1	9836550	9839876	3500266877	120		9836550	9839876	8421504	2	51,69	0,3257	p	350026687700015041,350026687700015045	0-120,0-45						ANTIBODY AND USE THEREOF - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500265599	120		9836550	9839876	8421504	2	51,69	0,3257	p	350026559900015001,350026559900015005	0-120,0-48						Method For Detecting And/or Removing Protein And/or Peptide Comprising A Cross-beta Structure From An Aqueous Solution Comprising A Protein 	.freshpatents.com	0	0		APP
660	chr1	9836550	9839876	3500260613	120		9836550	9839876	8421504	2	51,69	0,3257	p	350026061300015001	0-120						Method for detecting and/or removing protein and/or peptide comprising a cross-beta structure from an aqueous solution comprising a protein	Gerard	2007	0		APP
660	chr1	9836550	9839876	3500260462	120		9836550	9839876	8421504	2	51,69	0,3257	p	350026046200015017	0-120						Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof	Hillen	2009	0		APP
660	chr1	9836550	9839876	3500260191	120		9836550	9839876	8421504	2	51,69	0,3257	p	350026019100015000	0-120						Method for Detecting and/or Removing Protein and/or Peptide Comprising a Cross-Beta Structure From an Aqueous Solution Comprising a Protein	Bouma	2008	0		APP
660	chr1	9836550	9839876	3500257267	120		9836550	9839876	8421504	2	51,69	0,3257	p	350025726700015001	0-120						Method For Detecting And/or Removing Protien Comprising A Cross-beta Structure From A Pharmaceutical Composition 	.freshpatents.com	0	0		APP
660	chr1	9836550	9839876	3500197869	120		9836550	9839876	8421504	2	51,69	0,3257	p	350019786900015001	0-120						Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With	Gebbink	2006	0		APP
660	chr1	9836550	9839876	3500191522	120		9836550	9839876	8421504	2	51,69	0,3257	p	350019152200015011	0-120						Humanized Antibodies Which Bind To Ab (1-42) Globulomer And Uses Thereof 	.freshpatents.com	0	0		APP
660	chr1	9836550	9839876	3500181952	120		9836550	9839876	8421504	2	51,69	0,3257	p	350018195200015004,350018195200015002,350018195200015006,350018195200015007,350018195200015033,350018195200015040	0-114,0-120,0-114,0-108,0-45,0-45						DIAGNOSTIC ANTIBODY ASSAY - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500162571	120		9836550	9839876	8421504	2	51,69	0,3257	p	350016257100015003,350016257100015007,350016257100015009	0-114,0-120,0-111						&#x5316;&#x5b78;&#x5de5;&#x7a0b;&#x8207;&#x6750;&#xf9be;&#x5de5;&#x7a0b;&#x5b78;&#x7cfb; &#x535a; &#x58eb; &#xf941; &#x6587; &#xf9d0;&#x6fb1;&#x7c89;&#x80dc;&#x80bd;&#x8207;&#x7d30;&#x80de;&#x819c;&#x4ea4;&#x4e92;&#x4f5c;&#x7528;&#x6a5f;&#x8f49;&#x4e4b; &	is.lib.ncu.edu.tw	0	0		APP
660	chr1	9836550	9839876	3500146253	120		9836550	9839876	8421504	2	51,69	0,3257	p	350014625300015006,350014625300015004,350014625300015009,350014625300015008	0-114,0-120,0-108,0-114						Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides	Demuth	2009	0		APP
660	chr1	9836550	9839876	3500144205	120		9836550	9839876	8421504	2	51,69	0,3257	p	350014420500015001,350014420500015002,350014420500015003,350014420500015007,350014420500015010,350014420500015009	0-120,0-114,0-87,0-108,0-84,0-90						Diagnostic antibody assay	Demuth	2012	0		APP
660	chr1	9836550	9839876	3500137705	120		9836550	9839876	8421504	2	51,69	0,3257	p	350013770500015001	0-120					Patent	Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition (Patent US:8114832)	Bouma	2012	0		APP
660	chr1	9836550	9839876	3500133928	120		9836550	9839876	8421504	2	51,69	0,3257	p	350013392800015002,350013392800015003,350013392800015006,350013392800015005,350013392800015008,350013392800015009	0-120,0-114,0-108,0-114,0-90,0-84						Diagnostic antibody assay	Kleinschmidt	2012	0		APP
660	chr1	9836550	9839876	3500121082	120		9836550	9839876	8421504	2	51,69	0,3257	p	350012108200015006,350012108200015008,350012108200015013	0-120,0-114,3-114						USE OF EFFECTORS OF GLUTAMINYL AND GLUTAMATE CYCLASES	Hoffmann	2007	0		APP
660	chr1	9836550	9839876	3500119310	120		9836550	9839876	8421504	2	51,69	0,3257	p	350011931000015006,350011931000015060	0-120,0-45						CROSS- STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS- STRUCTURE, FOR MODULATING CROSS- STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS- STRUCTURE-MEDIATED TOXICITY - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500091449	120		9836550	9839876	8421504	2	51,69	0,3257	p	350009144900015001	0-120						Transgenic knockouts of bace-1	Gurney	2005	0		APP
660	chr1	9836550	9839876	3500090542	120		9836550	9839876	8421504	2	51,69	0,3257	p	350009054200015012,350009054200015014,350009054200015019	0-120,0-114,3-114						USE OF INHIBITORS OF GLUTAMINYL CYCLASE AND GLUTAMATE CYCLASE FOR TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES	Hoffmann	2009	0		APP
660	chr1	9836550	9839876	3500044014	120		9836550	9839876	8421504	2	51,69	0,3257	p	350004401400015001,350004401400015016	0-120,0-45						Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500038898	120		9836550	9839876	8421504	2	51,69	0,3257	p	350003889800015000	0-120						Method for Detecting Peptides Comprising a Cross-B Structure - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500029192	120		9836550	9839876	8421504	2	51,69	0,3257	p	350002919200015000	0-120						Method For Detecting And/or Removing Protein And/or Peptide Comprising A Cross-beta Structure From An Aqueous Solution Comprising A Protein 	.freshpatents.com	0	0		APP
660	chr1	9836550	9839876	3500027539	120		9836550	9839876	8421504	2	51,69	0,3257	p	350002753900015042	0-120						Science.Magazine.5707.2005-01-14	www.scribd.com	0	0		APP
660	chr1	9836550	9839876	3500011009	120		9836550	9839876	8421504	2	51,69	0,3257	p	350001100900015001	0-120						US Patent # 7,309,811. Transgenic mice knockouts of BACE-1 - Patents.com	www.patents.com	0	0		APP
660	chr1	9836550	9839876	3500007602	120		9836550	9839876	8421504	2	51,69	0,3257	p	350000760200015002,350000760200015004,350000760200015006,350000760200015007,350000760200015033,350000760200015040	0-120,0-114,0-114,0-108,0-45,0-45						DIAGNOSTIC ANTIBODY ASSAY - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839876	3500002488	120		9836550	9839876	8421504	2	51,69	0,3257	p	350000248800015000	0-120						Adjuvation Through Cross -beta Structure 	.freshpatents.com	0	0		APP
660	chr1	9836550	9839876	3500001809	120		9836550	9839876	8421504	2	51,69	0,3257	p	350000180900015006,350000180900015004,350000180900015008,350000180900015009	0-114,0-120,0-114,0-108						DIAGNOSTIC ANTIBODY ASSAY	Demuth	2009	0		APP
660	chr1	9836550	9839870	3500319699	114		9836550	9839870	8421504	2	51,63	0,3257	p	350031969900015000	0-114						ADJUVATION THROUGH CROSS-&#x03b2; STRUCTURE	Bouma	2007	0		APP
660	chr1	9836550	9839870	3500239837	114		9836550	9839870	8421504	2	51,63	0,3257	p	350023983700015001	0-114						A method for detecting peptides comprising a cross-beta structure	Bouma	2008	0		APP
660	chr1	9836550	9839870	3500231097	114		9836550	9839870	8421504	2	51,63	0,3257	p	350023109700015004,350023109700015106	0-114,0-48						IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS - ELAN PHARMA INTERNATIONAL LIMITED	www.sumobrain.com	0	0		APP
660	chr1	9836550	9839870	3500174235	114		9836550	9839870	8421504	2	51,63	0,3257	p	350017423500015006	0-114						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		APP
660	chr1	9836550	9839867	3500306406	111		9836550	9839867	8421504	2	51,60	0,3257	p	350030640600015012	0-111						Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases	Solomon	2005	0		APP
660	chr1	9836550	9839867	3500239896	111		9836550	9839867	8421504	2	51,60	0,3257	p	350023989600015013	0-111						Bacteriophage displaying a&#x03b2; epitopes and method of use	Solomon	2000	0		APP
660	chr1	9836550	9839867	3500199279	111		9836550	9839867	8421504	2	51,60	0,3257	p	350019927900015013	0-111						Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases	Solomon	2005	0		APP
660	chr1	9836550	9839867	3500195098	111		9836550	9839867	8421504	2	51,60	0,3257	p	350019509800015011,350019509800015013	0-111,0-45						IMMUNIZATION AGAINST AMYLOID PLAQUES USING DISPLAY TECHNOLOGY - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839867	3500147545	111		9836550	9839867	8421504	2	51,60	0,3257	p	350014754500015006	0-111						Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases	Frenkel	2002	0		APP
660	chr1	9836550	9839867	3500139209	111		9836550	9839867	8421504	2	51,60	0,3257	p	350013920900015013	0-111					Patent	Bacteriophage displaying a&#x03b2; epitopes and method of use (Patent US:6919075)	Solomon	2005	0		APP
660	chr1	9836550	9839867	3500022405	111		9836550	9839867	8421504	2	51,60	0,3257	p	350002240500015026,350002240500015025	0-48,0-111						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		APP
660	chr1	9836550	9839852	3500352639	96		9836550	9839852	8421504	2	51,45	0,3257	p	350035263900015096,350035263900015007,350035263900015100,350035263900015006,350035263900015098	0-48,0-87,0-45,0-45,0-48						Molecular Antigen Arrays 	.freshpatents.com	0	0		APP
660	chr1	9836550	9839852	3500203729	96		9836550	9839852	8421504	2	51,45	0,3257	p	350020372900015006,350020372900015005,350020372900015077,350020372900015074	0-87,0-45,0-84,0-72						US Patent # 7,138,252. Molecular antigen arrays - Patents.com	www.patents.com	0	0		APP
660	chr1	9836550	9839852	3500165202	96		9836550	9839852	8421504	2	51,45	0,3257	p	350016520200015002,350016520200015000,350016520200015044	0-84,0-81,0-45						MUTANT FORMS OF CHOLERA HOLOTOXIN AS AN ADJUVANT - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839852	3500079017	96		9836550	9839852	8421504	2	51,45	0,3257	p	350007901700015001,350007901700015043	0-84,0-45						MUTANT FORMS OF CHOLERA HOLOTOXIN AS AN ADJUVANT - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839843	3500456576	87		9836550	9839843	8421504	2	51,36	0,3257	p	350045657600015007,350045657600015008	0-45,0-87						Molecular antigen arrays	Bachmann	2003	0		APP
660	chr1	9836550	9839843	3500383796	87		9836550	9839843	8421504	2	51,36	0,3257	p	350038379600015082,350038379600015079	0-87,0-45						Molecular Antigen Array	Renner	2011	0		APP
660	chr1	9836550	9839843	3500380208	87		9836550	9839843	8421504	2	51,36	0,3257	p	350038020800015007,350038020800015006	0-87,0-45					Patent	Molecular antigen arrays using a virus like particle derived from the ap205 coat protein (Patent EP:1532167)	Bachmann	2012	0		APP
660	chr1	9836550	9839843	3500374171	87		9836550	9839843	8421504	2	51,36	0,3257	p	350037417100015060,350037417100015058	0-87,0-45						Molecular antigen array	Renner	2011	0		APP
660	chr1	9836550	9839843	3500373345	87		9836550	9839843	8421504	2	51,36	0,3257	p	350037334500015007,350037334500015006	0-87,0-45						Molecular antigen arrays using a virus like particle derived from the ap205 coat protein	Bachmann	2005	0		APP
660	chr1	9836550	9839843	3500370744	87		9836550	9839843	8421504	2	51,36	0,3257	p	350037074400015007,350037074400015006	0-87,0-45						Molecular antigen arrays using a virus like particle derived from the ap205 coat protein	Bachmann	2011	0		APP
660	chr1	9836550	9839843	3500370493	87		9836550	9839843	8421504	2	51,36	0,3257	p	350037049300015090,350037049300015093	0-45,0-87						Molecular antigen array	Renner	2002	0		APP
660	chr1	9836550	9839843	3500363578	87		9836550	9839843	8421504	2	51,36	0,3257	p	350036357800015017,350036357800015018	0-45,0-87						Molecular antigen arrays	Bachmann	2006	0		APP
660	chr1	9836550	9839843	3500287603	87		9836550	9839843	8421504	2	51,36	0,3257	p	350028760300015000,350028760300015005	0-45,0-87					Patent	Molecular antigen array (Patent US:7320793)	Renner	2008	0		APP
660	chr1	9836550	9839843	3500284318	87		9836550	9839843	8421504	2	51,36	0,3257	p	350028431800015014,350028431800015012	0-87,0-45						Molecular antigen arrays using a virus like particle derived from the AP205 coat protein	A*Di Suo 	2011	0		APP
660	chr1	9836550	9839843	3500279893	87		9836550	9839843	8421504	2	51,36	0,3257	p	350027989300015000,350027989300015006	0-45,0-87					Patent	Molecular antigen array presenting amyloid beta (Patent EP:1353691)	Renner	2009	0		APP
660	chr1	9836550	9839843	3500271723	87		9836550	9839843	8421504	2	51,36	0,3257	p	350027172300015004,350027172300015000	0-87,0-45						Molecular antigen array	Wo Er Fu Gang *A*Lun Na 	2004	0		APP
660	chr1	9836550	9839843	3500261692	87		9836550	9839843	8421504	2	51,36	0,3257	p	350026169200015006,350026169200015007	0-45,0-87					Patent	Molecular antigen arrays (Patent US:7138252)	Bachmann	2006	0		APP
660	chr1	9836550	9839843	3500260645	87		9836550	9839843	8421504	2	51,36	0,3257	p	350026064500015000,350026064500015007	0-45,0-87						Molecular antigen arrary	Renner	2008	0		APP
660	chr1	9836550	9839843	3500259268	87		9836550	9839843	8421504	2	51,36	0,3257	p	350025926800015071,350025926800015068	0-87,0-45						Molecular antigen array	Bachmann	2003	0		APP
660	chr1	9836550	9839843	3500256065	87		9836550	9839843	8421504	2	51,36	0,3257	p	350025606500015006,350025606500015007	0-45,0-87						Molecular Antigen Arrays	Bachmann	2010	0		APP
660	chr1	9836550	9839843	3500255293	87		9836550	9839843	8421504	2	51,36	0,3257	p	350025529300015006,350025529300015007	0-45,0-87						Molecular antigen arrays	Bachmann	2007	0		APP
660	chr1	9836550	9839843	3500241654	87		9836550	9839843	8421504	2	51,36	0,3257	p	350024165400015016,350024165400015014	0-87,0-45					Patent	Molecular antigen arrays using a virus like particle derived from the AP205 coat protein (Patent CN:1668637)	A*Di Suo 	2010	0		APP
660	chr1	9836550	9839843	3500227774	87		9836550	9839843	8421504	2	51,36	0,3257	p	350022777400015006,350022777400015008	0-45,0-87						Molecular antigen arrays	Bachmann	2004	0		APP
660	chr1	9836550	9839843	3500225500	87		9836550	9839843	8421504	2	51,36	0,3257	p	350022550000015006,350022550000015007	0-45,0-87					Patent	Molecular antigen arrays (Patent US:7494656)	Bachmann	2009	0		APP
660	chr1	9836550	9839843	3500206521	87		9836550	9839843	8421504	2	51,36	0,3257	p	350020652100015006,350020652100015007	0-45,0-87						&#x041c;&#x043e;&#x043b;&#x0435;&#x043a;&#x0443;&#x043b;&#x044f;&#x0440;&#x043d;&#x044b;&#x0435; &#x043c;&#x0430;&#x0441;&#x0441;&#x0438;&#x0432;&#x044b; &#x0430;&#x043d;&#x0442;&#x0438;&#x0433;&#x0435;&#x043d;&#x043e;&#x0432;. &#x041f;&#x0430;&#x0442;&#x	www.findpatent.ru	0	0		APP
660	chr1	9836550	9839843	3500180006	87		9836550	9839843	8421504	2	51,36	0,3257	p	350018000600015007,350018000600015006	0-87,0-45						Molecular antigen arrays	Bachmann	2004	0		APP
660	chr1	9836550	9839843	3500154312	87		9836550	9839843	8421504	2	51,36	0,3257	p	350015431200015069,350015431200015066	0-87,0-45						Molecular antigen array	Bachmann	2003	0		APP
660	chr1	9836550	9839843	3500143718	87		9836550	9839843	8421504	2	51,36	0,3257	p	350014371800015063,350014371800015066,350014371800015107	0-45,0-87,0-72						Molecular antigen array presenting amyloid beta	Bachmann	2003	0		APP
660	chr1	9836550	9839843	3500096921	87		9836550	9839843	8421504	2	51,36	0,3257	p	350009692100015000,350009692100015007	0-45,0-87						Molecular antigen array	Bachmann	2003	0		APP
660	chr1	9836550	9839843	3500095833	87		9836550	9839843	8421504	2	51,36	0,3257	p	350009583300015080,350009583300015077	0-87,0-45					Patent	Molecular antigen array (Patent US:7264810)	Renner	2007	0		APP
660	chr1	9836550	9839843	3500089496	87		9836550	9839843	8421504	2	51,36	0,3257	p	350008949600015063,350008949600015066,350008949600015107	0-45,0-87,0-72						Molecular antigen array presenting amyloid beta	Renner	2002	0		APP
660	chr1	9836550	9839843	3500075936	87		9836550	9839843	8421504	2	51,36	0,3257	p	350007593600015007,350007593600015008	0-45,0-87					Patent	&#x4f7f;&#x7528;&#x884d;&#x751f;&#x81ea;ap205&#x5916;&#x58f3;&#x86cb;&#x767d;&#x7684;&#x75c5;&#x6bd2;&#x6837;&#x9897;&#x7c92;&#x7684;&#x5206;&#x5b50;&#x6297;&#x539f;&#x9635;&#x5217; (Patent CN:1668637)	A*Di Suo 	2010	0		APP
660	chr1	9836550	9839843	3500069495	87		9836550	9839843	8421504	2	51,36	0,3257	p	350006949500015007,350006949500015006	0-87,0-45						&#x4f7f;&#x7528;&#x884d;&#x751f;&#x81ea;ap205&#x5916;&#x58f3;&#x86cb;&#x767d;&#x7684;&#x75c5;&#x6bd2;&#x6837;&#x9897;&#x7c92;&#x7684;&#x5206;&#x5b50;&#x6297;&#x539f;&#x9635;&#x5217;	M*F*Ba He Man 	2005	0		APP
660	chr1	9836550	9839843	3500020039	87		9836550	9839843	8421504	2	51,36	0,3257	p	350002003900015005,350002003900015012	0-45,0-87						Molecular antigen array	Renner	2002	0		APP
660	chr1	9836550	9839840	3500431657	84		9836550	9839840	8421504	2	51,33	0,3257	p	350043165700015001	0-84						Mutant Forms Of Cholera Holotoxin As An Adjuvant 	.freshpatents.com	0	0		APP
660	chr1	9836550	9839840	3500347181	84		9836550	9839840	8421504	2	51,33	0,3257	p	350034718100015005	0-84						ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPS)	Galarza	2001	0		APP
660	chr1	9836550	9839840	3500294965	84		9836550	9839840	8421504	2	51,33	0,3257	p	350029496500015001	0-84						ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs)	Galarza	2009	0		APP
660	chr1	9836550	9839840	3500290811	84		9836550	9839840	8421504	2	51,33	0,3257	p	350029081100015001	0-84					Patent	Assembly of wild-type and chimeric influenza virus-like particles (VLPs) (Patent US:7556940)	Galarza	2009	0		APP
660	chr1	9836550	9839840	3500260696	84		9836550	9839840	8421504	2	51,33	0,3257	p	350026069600015001	0-84					Patent	Mutant forms of cholera holotoxin as an adjuvant (Patent US:7332174)	Green	2008	0		APP
660	chr1	9836550	9839840	3500240521	84		9836550	9839840	8421504	2	51,33	0,3257	p	350024052100015001	0-84						ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9839840	3500221765	84		9836550	9839840	8421504	2	51,33	0,3257	p	350022176500015001	0-84					Patent	Mutant forms of cholera holotoxin as an adjuvant (Patent US:7285281)	Green	2007	0		APP
660	chr1	9836550	9839840	3500216968	84		9836550	9839840	8421504	2	51,33	0,3257	p	350021696800015002	0-84					Patent	Mutant forms of cholera holotoxin as an adjuvant (Patent EP:1404368)	Green	2009	0		APP
660	chr1	9836550	9839840	3500214218	84		9836550	9839840	8421504	2	51,33	0,3257	p	350021421800015001	0-84					Patent	Mutant forms of cholera holotoxin as an adjuvant (Patent US:7361355)	Green	2008	0		APP
660	chr1	9836550	9839840	3500194448	84		9836550	9839840	8421504	2	51,33	0,3257	p	350019444800015002	0-84						Assembly of wild-type and chimeric influenza virus-like particles (VLPs)	Galarza	2005	0		APP
660	chr1	9836550	9839840	3500193456	84		9836550	9839840	8421504	2	51,33	0,3257	p	350019345600015003	0-84						Rescue of mumps virus from cDNA	Clarke	2000	0		APP
660	chr1	9836550	9839840	3500172361	84		9836550	9839840	8421504	2	51,33	0,3257	p	350017236100015002	0-84					Patent	Mutant forms of cholera holotoxin as an adjuvant (Patent EP:1404368)	Green	2009	0		APP
660	chr1	9836550	9839840	3500115340	84		9836550	9839840	8421504	2	51,33	0,3257	p	350011534000015003	0-84						Mutant forms of cholera holotoxin as an adjuvant	Green	2002	0		APP
660	chr1	9836550	9839840	3500043133	84		9836550	9839840	8421504	2	51,33	0,3257	p	350004313300015001	0-84					Patent	Assembly of wild-type and chimeric influenza virus-like particles (vlps) (Patent EP:1294892)	Galarza	2007	0		APP
660	chr1	9836550	9839840	3500015098	84		9836550	9839840	8421504	2	51,33	0,3257	p	350001509800015003	0-84						Rescue of mumps virus from cDNA	Clarke	2007	0		APP
660	chr1	9836550	9839837	3500224880	81		9836550	9839837	8421504	2	51,30	0,3257	p	350022488000015000	0-81			10.1186/1750-1326-2-17		Molecular Neurodegeneration	Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau	IsmaSanta-Maria	2007	0		APP
660	chr1	9836550	9839837	3500004985	81		9836550	9839837	8421504	2	51,30	0,3257	p	350000498500015000	0-81			10.1186/1750-1326-2-17	1750-1326	Molecular Neurodegeneration	Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau	Santa-Maria	2007	4		APP
660	chr1	9836550	9839816	3500305185	60		9836550	9839816	8421504	2	51,9	0,3257	p	350030518500015003	0-60						ANTIBODIES SPECIFIC FOR THE PROTOFIBRIL FORM OF BETA-AMYLOID PROTEIN	Ravetch	2008	0		APP
660	chr1	9836550	9836598	3500101330	48		9836550	9836598	8421504	1	48	0	p	350010133000015001	0-48						Catalytic Immunoglobulins BBK32 and Uses Therefor - Patent application	www.faqs.org	0	0		APP
660	chr1	9836550	9836595	3500079733	45		9836550	9836595	8421504	1	45	0	p	350007973300015000	0-45					Patent	Assembly of wild-type and chimeric influenza virus-like particles (VLPS) (Patent CN:1196788)	J*M*Jia La Er Sa 	2005	0		APP
660	chr1	9836550	9836595	3500062088	45		9836550	9836595	8421504	1	45	0	p	350006208800015000	0-45					Patent	&#x91ce;&#x751f;&#x578b;&#x548c;&#x5d4c;&#x5408;&#x6d41;&#x611f;&#x75c5;&#x6bd2;&#x6837;&#x9897;&#x7c92;(vlp)&#x7684;&#x88c5;&#x914d; (Patent CN:1196788)	J*M*Jia La Er Sa 	2005	0		APP
660	chr1	9836550	9836595	3500015291	45		9836550	9836595	8421504	1	45	0	p	350001529100015039	6-51						Spore Associated Display 	.freshpatents.com	0	0		APP
660	chr1	9836552	9836576	3500341106	24		9836552	9836576	8421504	1	24	0	c	350034110600000006	16-40		18987338	10.1091/mbc.E08-06-0635	1059-1524	Molecular Biology of the Cell	Specific Biarsenical Labeling of Cell Surface Proteins Allows Fluorescent- and Biotin-tagging of Amyloid Precursor Protein and Prion Proteins	Taguchi	2009	5		
660	chr1	9836552	9836576	3500215469	24		9836552	9836576	8421504	1	24	0	c	350021546900000006	16-40						Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin- tagging of APP and prion proteins	w.molbiolcell.org	0	0		
660	chr1	9836552	9836576	3500044940	24		9836552	9836576	8421504	1	24	0	c	350004494000000006	16-40		18987338	10.1091/mbc.E08-06-0635		Molecular Biology of the Cell	Specific Biarsenical Labeling of Cell Surface Proteins Allows Fluorescent- and Biotin-tagging of Amyloid Precursor Protein and Prion Proteins	Yuzuru	2009	0		APP
660	chr1	9836553	9839879	3500085264	120		9836553	9839879	8421504	2	48,72	0,3254	p	350008526400015000,350008526400015062	0-69,0-111						 <HTML> <HEAD><TITLE>aei1/4!I2aea1/2a"aa(r)a(c)c"ae3 - c1ei1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4	www.j-tokkyo.com	0	0		APP
660	chr1	9836553	9839870	3500422276	111		9836553	9839870	8421504	2	48,63	0,3254	p	350042227600015003,350042227600015004,350042227600015009,350042227600015013	0-45,0-48,0-48,0-45						AMYLOID BETA-DERIVED DIFFUSIBLE LIGANDS (ADDLs), ADDL-SURROGATES, ADDL-BINDING MOLECULES, AND USES THEREOF - Patent application	www.faqs.org	0	0		APP
660	chr1	9836562	9839879	3500267142	111		9836562	9839879	8421504	2	39,72	0,3245	p	350026714200015007	0-111						Antibody glycosylation in the variable region	Bohrmann	2011	0		APP
660	chr1	9836565	9839840	3500246673	69		9836565	9839840	8421504	2	36,33	0,3242	p	350024667300015001,350024667300015005	0-57,0-57						Mutant forms of cholera holotoxin as an adjuvant	B*A*Ge Lin 	2007	0		APP
660	chr1	9836565	9839840	3500239993	69		9836565	9839840	8421504	2	36,33	0,3242	p	350023999300015001,350023999300015003	0-57,0-57						&#x4f5c;&#x4e3a;&#x4f50;&#x5242;&#x7684;&#x970d;&#x4e71;&#x5168;&#x6bd2;&#x7d20;&#x7684;&#x7a81;&#x53d8;&#x4f53;&#x5f62;&#x5f0f;	B*A*Ge Lin 	2007	0		APP
660	chr1	9836568	9839840	3500292806	66		9836568	9839840	8421504	2	33,33	0,3239	p	350029280600015001,350029280600015004	0-57,0-54						&#x4f5c;&#x4e3a;&#x4f50;&#x5242;&#x7684;&#x970d;&#x4e71;&#x5168;&#x6bd2;&#x7d20;&#x7684;&#x7a81;&#x53d8;&#x4f53;&#x5f62;&#x5f0f;	B*A*Ge Lin 	2004	0		APP
660	chr1	9836568	9839840	3500283886	66		9836568	9839840	8421504	2	33,33	0,3239	p	350028388600015001,350028388600015004	0-57,0-54					Patent	&#x4f5c;&#x4e3a;&#x4f50;&#x5242;&#x7684;&#x970d;&#x4e71;&#x5168;&#x6bd2;&#x7d20;&#x7684;&#x7a81;&#x53d8;&#x4f53;&#x5f62;&#x5f0f; (Patent CN:1297316)	B*A*Ge Lin 	2007	0		APP
660	chr1	9836568	9839840	3500275483	66		9836568	9839840	8421504	2	33,33	0,3239	p	350027548300015001,350027548300015007	0-57,0-54						Mutant forms of cholera holotoxin as adjuvant	B*A*Ge Lin 	2004	0		APP
660	chr1	9836568	9839840	3500262203	66		9836568	9839840	8421504	2	33,33	0,3239	p	350026220300015001,350026220300015007	0-57,0-54					Patent	Mutant forms of cholera holotoxin as adjuvant (Patent CN:1297316)	B*A*Ge Lin 	2007	0		APP
660	chr1	9836574	9839879	3500277188	99		9836574	9839879	8421504	2	27,72	0,3233	p	350027718800015031	0-99						ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF	Demattos	2012	0		APP
660	chr1	9836574	9839828	3500232685	48		9836574	9839828	8421504	2	27,21	0,3233	p	350023268500015001	0-48						Mutant forms of cholera holotoxin as adjuvant	B*A*Ge Lin 	2004	0		APP
660	chr1	9836574	9839828	3500033083	48		9836574	9839828	8421504	2	27,21	0,3233	p	350003308300015001	0-48						&#x4f5c;&#x4e3a;&#x4f50;&#x5242;&#x7684;&#x970d;&#x4e71;&#x5168;&#x6bd2;&#x7d20;&#x7684;&#x7a81;&#x53d8;&#x5f62;&#x5f0f;	B*A*Ge Lin 	2004	0		APP
660	chr1	9836576	9836599	3500396921	23		9836576	9836599	8421504	1	23	0	c	350039692100000001	12-35		21646356	10.1074/jbc.M111.252718		The Journal of Biological Chemistry	Metalloprotease Meprin &#x03b2; Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo	Tamara	2011	0		
660	chr1	9836576	9836599	3500255607	23		9836576	9836599	8421504	1	23	0	c	350025560700000001	12-35		21646356	10.1074/jbc.M111.252718	0021-9258	Journal of Biological Chemistry	Metalloprotease Meprin &#x03b2; Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo	Jefferson	2011	5		APP
660	chr1	9836576	9836599	3500079109	23		9836576	9836599	8421504	1	23	0	c	350007910900000019	12-35						Metalloproteinase Research	www.jbc.org	0	0		
660	chr1	9836577	9839852	3500208243	66		9836577	9839852	8421504	2	21,45	0,3230	p	350020824300015226	0-66						US Patent # 7,279,165. Amyloid .beta.1-6 antigen arrays - Patents.com	www.patents.com	0	0		
660	chr1	9836577	9839840	3500326606	57		9836577	9839840	8421504	2	24,33	0,3230	p	350032660600015003	0-57						Assembly of wild-type and chimeric influenza virus-like particles (VLPs)	Galarza	2005	0		APP
660	chr1	9836577	9839831	3500409071	48		9836577	9839831	8421504	2	24,24	0,3230	p	350040907100015068	0-48						IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS	Black	2011	0		APP
660	chr1	9836577	9839831	3500298994	48		9836577	9839831	8421504	2	24,24	0,3230	p	350029899400015069	0-48						Immunotherapy Regimes Dependent On APOE Status	Black	2008	0		APP
660	chr1	9836583	9839837	3500166675	48		9836583	9839837	8421504	2	18,30	0,3224	p	350016667500015123	0-48						US Patent # 7,501,484. Methods and DNA constructs for high yield production of polypeptides - Patents.com	www.patents.com	0	0		APP
660	chr1	9836586	9839840	3500024437	48		9836586	9839840	8421504	2	15,33	0,3221	p	350002443700015007	0-48						Stable Macroscopic Membranes Formed By Self-assembly Of Amphiphilic Peptides And Uses Therefor 	.freshpatents.com	0	0		APP
660	chr1	9839807	9839852	3500042740	45		9839807	9839852	8421504	1	45	0	p	350004274000015132	0-45						Compound And Method For Treatment Of Alzheimer's Disease - Patent application	www.faqs.org	0	0		APP
660	chr1	9839807	9839852	3500007381	45		9839807	9839852	8421504	1	45	0	p	350000738100015042	0-45						Mutant Pneumolysin Proteins 	.freshpatents.com	0	0		APP
660	chr1	9839819	9839870	3500299558	51		9839819	9839870	8421504	1	51	0	p	350029955800015016	12-63						ANTIGEN BINDING PROTEINS - Patent application	www.faqs.org	0	0		APP
660	chr1	9839849	9908614	3500325483	180		9839849	9908614	8421504	5	45,45,9,36,45	0,48,96,68681,68720	p	350032548300015007,350032548300015008,350032548300015009,350032548300015010	0-45,0-45,0-45,0-45						Transgenic C. elegans as a model organism for investigations on Alzheimer's disease	Peraus	1999	0		APP
660	chr1	9839910	9839933	3500442544	23		9839910	9839933	8421504	1	23	0	c	350044254400000000	0-23						Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease	Cordell	1991	0		APP
660	chr1	9839910	9839933	3500396179	23		9839910	9839933	8421504	1	23	0	c	350039617900000005	0-23						Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease	Cordell	1995	0		APP
660	chr1	9839910	9839933	3500280558	23		9839910	9839933	8421504	1	23	0	c	350028055800000000	0-23					Patent	Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease (Patent US:5387742)	Cordell	1995	0		APP
660	chr1	9908545	9908617	3500367901	72		9908545	9908617	8421504	1	72	0	p	350036790100015003	0-72						Human brain carboxypeptidase B	Matsumoto	2000	0		APP
660	chr1	9908545	9908617	3500107368	72		9908545	9908617	8421504	1	72	0	p	350010736800015001	0-72						Human brain carboxypeptidase b	Matsumoto	2002	0		APP
660	chr1	9908545	9908617	3500081144	72		9908545	9908617	8421504	1	72	0	p	350008114400015003	0-72						Human Brain Carboxypeptidase B - Patent application	www.faqs.org	0	0		APP
660	chr1	9908560	9908629	3500134249	69		9908560	9908629	8421504	1	69	0	p	350013424900015004	0-69						METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta	Kim	2012	0		APP
660	chr1	9908560	9908629	3500102018	69		9908560	9908629	8421504	1	69	0	p	350010201800015004	0-69						METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPB - Patent application	www.faqs.org	0	0		APP
660	chr1	9908560	9908629	3500045495	69		9908560	9908629	8421504	1	69	0	p	350004549500015004	0-69						METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta - Patent application	www.faqs.org	0	0		APP
660	chr1	9908569	9908629	3500459880	60		9908569	9908629	8421504	1	60	0	p	350045988000015006,350045988000015000	0-60,0-48		20809979	10.1186/1471-2202-11-109	1471-2202	BMC Neuroscience	Characterization of the beta amyloid precursor protein-like gene in the central nervous system of the crab Chasmagnathus. Expression during memory consolidation	FustiA+-ana	2010	3		APP
660	chr1	9908569	9908629	3500304653	60		9908569	9908629	8421504	1	60	0	p	350030465300015002	0-60						RESEARCH ARTICLE Open Access Characterization of the beta amyloid precursor	biomedcentral.com	0	0		APP
660	chr1	9908569	9908629	3500056481	60		9908569	9908629	8421504	1	60	0	p	350005648100015001	0-60						79-94-7 | Sigma-Aldrich	.sigmaaldrich.com	0	0		APP
660	chr1	9908575	9908629	3500242595	54		9908575	9908629	8421504	1	54	0	c	350024259500000140,350024259500000092	0-48,0-45						Method for identifying alzheimer's disease therapeutics using transgenic animal models	Mcconlogue	1996	0		
660	chr1	9908581	9908629	3500156315	48		9908581	9908629	8421504	1	48	0	p	350015631500015001	3-51						Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells	jcb.rupress.org	0	0		APP
660	chr1	9908604	9908632	3500426560	28		9908604	9908632	8421504	1	28	0	c	350042656000000011	0-28						Sphingolipid-modulatedExosomeSecretionPromotes ClearanceofAmyloid- byMicroglia	www.jbc.org	0	0		APP
660	chr1	9908604	9908632	3500203953	28		9908604	9908632	8421504	1	28	0	c	350020395300000011	0-28						The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M111.324616	www.jbc.org	0	0		APP
660	chr1	9908604	9908632	3500018514	28		9908604	9908632	8421504	1	28	0	c	350001851400000011	0-28		22303002	10.1074/jbc.M111.324616	0021-9258	Journal of Biological Chemistry	Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-&#x03b2; by Microglia	Yuyama	2012	5		APP
660	chr1	9908615	9908643	3500071899	25		9908615	9908643	8421504	2	17,8	0,20	c,g	350007189900000001,350007189900000001	1-30,1-30			10.1111/j.1365-2443.2006.00968.x	1365-2443	Genes to Cells	Role of APP phosphorylation in FE65-dependent gene transactivation mediated by AICD - Nakaya - 2006 - Genes to Cells - Wiley Online Library	Nakaya	2006	0		
660	chr1	9908866	9908889	3500014192	23		9908866	9908889	8421504	1	23	0	c	350001419200000019	0-23						UNIVERSIT&#xc0; DEGLI STUDI DI ROMA TOR VERGATA	space.uniroma2.it	0	0		APP
660	chr1	9937651	9937675	3500378054	23		9937651	9937675	8421504	2	19,4	0,20	g	350037805400000174	0-24					Patent	17Q-linked breast and ovarian cancer susceptibility gene (Patent US:5747282)	Futreal	1998	0		
661	chr1	9970108	9970246	3500186119	138		9970108	9970246	8421504	1	138	0	p	350018611900015102	0-138						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		GABPA
661	chr1	9970108	9970246	3500095373	138		9970108	9970246	8421504	1	138	0	p	350009537300015102	0-138						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		GABPA
662	chr1	10158072	10158095	3500463538	23		10158072	10158095	8421504	1	23	0	c,g	350046353800000001,350046353800000001	0-23,0-23						&#x064a;&#xfe8e;&#xfed4;&#xfedf;&#x0622; &#x0647;&#xfeae;&#xfef4;&#xfea0;&#xfee7;&#x0632; &#x0646;&#xfe8e;&#xfef4;&#xfe91; mir-150 &#x0631;&#xfe8e;&#xfeec;&#xfee3; &#xfeae;&#xfef4;&#xfe9b;&#xfe8e;&#xfe97; &#xfef2;&#xfeb3;&#x0631;&#xfeae;&#xfe91;	urnals.tums.ac.ir	0	0		MIR155HG
662	chr1	10158072	10158095	3500437947	23		10158072	10158095	8421504	1	23	0	c,g	350043794700000000,350043794700000000	0-23,0-23						Oncogenic microRNA-155 downregulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: Implications for cancer therapeutics	www.jbc.org	0	0		MIR155HG
662	chr1	10158072	10158095	3500305977	23		10158072	10158095	8421504	1	23	0	c,g	350030597700000084,350030597700000084	0-23,0-23						Method for Quantification of Small RNA Species	Busk	2012	0		MIR155HG
662	chr1	10158072	10158095	3500190354	23		10158072	10158095	8421504	1	23	0	c,g	350019035400000001,350019035400000001	0-23,0-23						&#x064a;&#xfe8e;&#xfed4;&#xfedf;&#x0622; &#x0647;&#xfeae;&#xfef4;&#xfea0;&#xfee7;&#x0632; &#x0646;&#xfe8e;&#xfef4;&#xfe91; mir-150 &#x0631;&#xfe8e;&#xfeec;&#xfee3; &#xfeae;&#xfef4;&#xfe9b;&#xfe8e;&#xfe97; &#xfef2;&#xfeb3;&#x0631;&#xfeae;&#xfe91;	urnals.tums.ac.ir	0	0		MIR155HG
662	chr1	10158072	10158095	3500106400	23		10158072	10158095	8421504	1	23	0	c,g	350010640000000178,350010640000000178,350010640000000013,350010640000000100	0-23,0-23,2-21,2-21						Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor - Patent application	www.faqs.org	0	0		MIR155HG
662	chr1	10158072	10158095	3500090446	23		10158072	10158095	8421504	1	23	0	c,g	350009044600000030,350009044600000030	0-23,0-23						Kaposi sarcoma herpesvirus microRNA function in lymphatic endothelial cells	scovery.ucl.ac.uk	0	0		MIR155HG
662	chr1	10158073	10158096	3500352593	23		10158073	10158096	8421504	1	23	0	c,g	350035259300000001,350035259300000001	0-23,0-23						A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. - ResearchGate	.researchgate.net	0	0		MIR155HG
662	chr1	10169840	10169871	3500384244	29		10169840	10169871	8421504	2	24,5	0,26	g	350038424400000009	0-30		18940871	10.1093/nar/gkn666		Nucleic Acids Research	Epstein&#x2013;Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-&#x03ba;B pathway	Graziana	2008	0		
698	chr1	14930134	14930159	3500382093	23		14930134	14930159	8421504	2	13,10	0,15	g	350038209300000089	15-38						US8236311B2	www.scribd.com	0	0		
701	chr1	15218251	15218277	3500426411	24		15218251	15218277	8421504	2	5,19	0,7	g	350042641100000052	9-33						Final Report # &#xab;09080412&#xbb; RFCID/HHSRF/HSRF/HCPF	rants.netsoft.net	0	0		
701	chr1	15288920	15306846	3500445405	44		15288920	15306846	8421504	4	9,13,13,9	0,10,17903,17917	g	350044540500000221,350044540500000170	3-25,0-22						Haemophilus outer membrane protein	Chong	1998	0		
701	chr1	15288920	15306846	3500226498	44		15288920	15306846	8421504	4	9,13,13,9	0,10,17903,17917	g	350022649800000221,350022649800000170	3-25,0-22					Patent	Haemophilus outer membrane protein (Patent US:6013514)	Chong	2000	0		
701	chr1	15288920	15306846	3500093232	44		15288920	15306846	8421504	4	9,13,13,9	0,10,17903,17917	g	350009323200000221,350009323200000170	3-25,0-22					Patent	Haemophilus outer membrane protein (Patent US:6083743)	Chong	2000	0		
713	chr1	16907118	16907144	3500364133	24		16907118	16907144	8421504	2	9,15	0,11	g	350036413300000004	4-28						US Patent # 7,304,032. CD-10 activated prodrug compounds - Patents.com	www.patents.com	0	0		
714	chr1	16917925	16917948	3500308662	23		16917925	16917948	8421504	1	23	0	g	350030866200000007	0-23						DNA	.lib.kobe-u.ac.jp	0	0		
715	chr1	17064512	17064633	3500259232	121		17064512	17064633	8421504	1	121	0	g	350025923200000018	0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
719	chr1	17621465	17621490	3500055721	23		17621465	17621490	8421504	2	7,16	0,9	g	350005572100000039	12-35						US Patent # 5,770,368. Cryptosporidium detection method - Patents.com	www.patents.com	0	0		
90	chr1	18220359	18370775	3500449405	2492		18220359	18370775	8421504	33	145,131,24,20,30,18,109,77,23,107,141,150,106,25,96,84,22,90,126,141,101,1,133,96,50,11,60,59,118,78,51,9,60	0,3726,4357,11709,11739,11779,28125,36076,36165,48270,56659,57497,64817,65232,65287,67794,67908,75093,80227,82578,91736,91846,93394,107317,111984,112192,112227,112308,137197,145607,145694,150272,150356	p,c,g	350044940500015003,350044940500000003,350044940500015005,350044940500015046,350044940500000002,350044940500015006,350044940500015064,350044940500015007,350044940500015008,350044940500015069,350044940500015072,350044940500015010,350044940500015011,350044940500015074,350044940500015092,350044940500015012,350044940500015081,350044940500015013,350044940500015048,350044940500015086,350044940500015015,350044940500015101,350044940500015016,350044940500015017,350044940500015021,350044940500015022,350044940500015033,350044940500015039,350044940500015041	0-300,12-80,0-288,0-84,0-71,0-300,0-210,15-147,0-60,0-60,0-96,0-54,0-207,0-135,0-45,0-120,0-90,0-120,0-66,0-90,0-60,0-150,0-87,0-60,0-60,0-180,0-144,0-60,0-60						Enterokinase,	www.pnas.org	0	0		
724	chr1	18224743	18232010	3500337360	48		18224743	18232010	8421504	2	41,7	0,7260	c	350033736000000401	0-48						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
90	chr1	18256439	18370930	3500445496	2537		18256439	18370930	8421504	20	108,107,141,150,106,151,136,90,126,141,111,133,96,50,175,182,96,140,288,10	0,12190,20579,21417,28737,29152,31714,39013,44147,46498,55656,57314,71237,75904,76112,101117,102987,109525,114192,114481	c	350044549600000011	3-2540						Cloning of enterokinase and method of use	Lavallie	1997	0		
90	chr1	18256439	18370930	3500380477	2257		18256439	18370930	8421504	46	108,107,141,150,106,151,123,3,49,31,17,51,38,12,50,50,50,50,50,50,3,47,39,11,29,21,50,50,24,26,50,50,26,24,50,2,48,50,22,28,50,50,50,52,8,10	0,12190,20579,21417,28737,29152,31714,31847,39013,39072,44147,44174,44235,46498,46520,46580,55657,55717,57324,57384,57444,71237,71294,75904,75925,76112,76143,76203,76263,101117,101153,101213,101273,102987,103021,103081,109525,109583,109643,114192,114230,114290,114350,114410,114472,114481	c	350038047700000011	3-2260						Cloning of enterokinase and method of use	Lavallie	1994	0		
90	chr1	18256440	18370724	3500380477	723		18256440	18370724	8421504	17	93,48,60,37,11,23,17,8,13,35,25,23,14,82,134,49,51	0,28756,29230,31812,39012,39039,39085,44146,44259,46497,55741,57313,57432,71236,76152,101116,114233	p,c,g	350038047700015014,350038047700015015,350038047700015022,350038047700015013,350038047700015027,350038047700000010,350038047700000009,350038047700015029,350038047700015034,350038047700015036,350038047700015037,350038047700015002,350038047700015051,350038047700015003,350038047700000005,350038047700000005,350038047700000018,350038047700000018,350038047700015041,350038047700015042,350038047700015007	3-48,0-48,0-48,0-60,0-48,10-33,0-25,0-48,0-48,0-48,0-48,0-90,0-45,0-72,8-28,8-28,9-28,9-28,0-48,0-48,0-51						Cloning of enterokinase and method of use	Lavallie	1994	0		
90	chr1	18256488	18370742	3500445496	1793		18256488	18370742	8421504	51	45,11,34,45,45,45,19,26,45,25,20,45,35,10,45,72,3,45,34,11,23,28,17,45,45,10,35,45,7,38,45,22,23,45,11,34,45,11,34,140,1,45,45,34,11,82,29,45,30,15,93	0,48,12141,12178,20556,20604,20652,21368,21397,21493,28688,28711,28759,29103,29116,29182,31665,31671,31767,38964,38991,39026,44098,44118,44166,44214,46449,46535,46583,55607,55648,55696,57265,57339,57387,71188,71225,71273,75855,76098,101068,101072,101168,101216,102938,102952,109476,109538,109586,114143,114161	p,c,g	350044549600015014,350044549600015015,350044549600015016,350044549600015018,350044549600015019,350044549600015020,350044549600015021,350044549600015023,350044549600015024,350044549600015025,350044549600015026,350044549600015012,350044549600015028,350044549600015029,350044549600015031,350044549600000010,350044549600000010,350044549600015033,350044549600000009,350044549600015034,350044549600015035,350044549600015036,350044549600015038,350044549600015039,350044549600015040,350044549600015041,350044549600015043,350044549600015044,350044549600015045,350044549600015046,350044549600015048,350044549600015002,350044549600015003,350044549600000005,350044549600000005,350044549600000018,350044549600000018,350044549600015049,350044549600015050,350044549600015051,350044549600015053,350044549600015054,350044549600015055,350044549600015006,350044549600015056,350044549600015058,350044549600015059,350044549600015060,350044549600015007,350044549600015061	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-60,0-45,0-45,0-45,10-33,10-33,0-45,0-25,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-90,0-72,8-28,8-28,9-28,9-28,0-45,0-45,0-45,0-45,0-45,0-45,0-69,0-45,0-45,0-45,0-45,0-51,0-45						Cloning of enterokinase and method of use	Lavallie	1997	0		
724	chr1	18285268	18285615	3500337360	38		18285268	18285615	8421504	2	14,24	0,323	c	350033736000000421	0-38						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
90	chr1	18285670	18370724	3500038956	324		18285670	18370724	8421504	8	60,23,17,8,96,40,29,51	0,9809,9855,14916,46922,73812,80294,85003	p,c,g	350003895600015012,350003895600000010,350003895600000009,350003895600015002,350003895600015003,350003895600000005,350003895600000005,350003895600015006,350003895600015007	0-60,10-33,0-25,0-90,0-72,8-28,8-28,0-69,0-51					Patent	Cloning of enterokinase and method of use (Patent US:6746859)	LaVallie	2004	0		
725	chr1	18379754	18385554	3500094124	108		18379754	18385554	8421504	4	45,29,16,18	0,48,5763,5782	p	350009412400015062	0-108						US Patent # 7,087,718. C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof - Patents.com	www.patents.com	0	0		
727	chr1	18725041	18725065	3500126483	24		18725041	18725065	8421504	1	24	0	g	350012648300000125	1-30						MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - Patent application	www.faqs.org	0	0		
728	chr1	18832142	18832169	3500115116	24		18832142	18832169	8421504	2	19,5	0,22	g	350011511600000628	1-28						Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use	J*M*Wei Er Sen 	2005	0		
730	chr1	19077919	19077944	3500093009	23		19077919	19077944	8421504	2	8,15	0,10	g	350009300900000009	0-23						Mechanisms and enzymes involved in SARS coronavirus genome expression	r.sgmjournals.org	0	0		
730	chr1	19086499	19086527	3500284394	23		19086499	19086527	8421504	2	10,13	0,15	g	350028439400000466	0-37						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2011	0		
730	chr1	19086499	19086527	3500068199	23		19086499	19086527	8421504	2	10,13	0,15	g	350006819900000466	0-37						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
738	chr1	20054324	20104192	3500322980	44		20054324	20104192	8421504	2	22,22	0,49846	c,g	350032298000000029,350032298000000029,350032298000000017	0-22,0-22,0-22						AD (Leave blank)	handle.dtic.mil	0	0		
738	chr1	20054324	20104192	3500114594	44		20054324	20104192	8421504	2	22,22	0,49846	c,g	350011459400000411,350011459400000838,350011459400000828,350011459400000401	0-22,0-22,0-22,0-22						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		
738	chr1	20054324	20103471	3500131966	44		20054324	20103471	8421504	2	22,22	0,49125	c,g	350013196600000017,350013196600000001,350013196600000001	0-22,0-22,0-22						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
738	chr1	20103397	20103481	3500408810	84		20103397	20103481	8421504	1	84	0	c,g	350040881000000015,350040881000000015	0-84,0-84						Compositions And Methods For Modulation Of Pdx-1 	freshpatents.com	0	0		MIRLET7C
738	chr1	20103397	20103481	3500185291	84		20103397	20103481	8421504	1	84	0	c,g	350018529100000007,350018529100000007,350018529100000006	0-84,0-84,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		
738	chr1	20103449	20104192	3500439152	44		20103449	20104192	8421504	2	22,22	0,721	c,g	350043915200000137,350043915200000257,350043915200000286,350043915200000286	0-22,0-22,0-22,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		
738	chr1	20103449	20104192	3500125321	44		20103449	20104192	8421504	2	22,22	0,721	c,g	350012532100000035,350012532100000035,350012532100000064	0-22,0-22,0-22						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIRLET7C
738	chr1	20103909	20104204	3500139175	87		20103909	20104204	8421504	2	6,81	0,214	g	350013917500000010	6-93						Functional characterisation of microRNA-containing Argonaute Protein complexes	b.uni-muenchen.de	0	0		MIRLET7C
738	chr1	20104123	20104204	3500465622	81		20104123	20104204	8421504	1	81	0	c,g	350046562200000020,350046562200000020	0-81,0-81						ISSN 1684 - 5315 Volume 10 Number 18 2 May, 2011	demicjournals.org	0	0		MIRLET7C
743	chr1	20742849	20742876	3500059804	23		20742849	20742876	8421504	2	14,9	0,18	g	350005980400000222	0-32						Isolation and characterisation of two chitinase and one novel glucanase genes for engineering plant defence against fungal pathogens	ry.murdoch.edu.au	0	0		
748	chr1	21466250	21466274	3500290366	23		21466250	21466274	8421504	2	11,12	0,12	g	350029036600000175	2-25						FUNGUS RESISTANT PLANTS AND THEIR USES - Patent application	www.faqs.org	0	0		
755	chr1	22369388	22369415	3500282252	23		22369388	22369415	8421504	2	16,7	0,20	g	350028225200000250	16-39						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
772	chr1	24604117	24604142	3500290016	23		24604117	24604142	8421504	2	18,5	0,20	g	350029001600000012	0-23						MUTANT $i(AEQUOREA VICTORIA) FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE	Gaitanaris	1999	0		
776	chr1	25163967	25163992	3500068547	23		25163967	25163992	8421504	3	6,13,4	0,7,21	g	350006854700000167,350006854700000470	11-37,11-37						HUMAN ERYTHROVIRUS - Patent application	www.faqs.org	0	0		
777	chr1	25173073	25173107	3500371752	25		25173073	25173107	8421504	3	6,6,13	0,11,21	g	350037175200000020	12-37						METHODS AND KITS FOR DIAGNOSING OR MONITORING AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES - Patent application	www.faqs.org	0	0		
780	chr1	25587355	25587383	3500115843	23		25587355	25587383	8421504	3	13,4,6	0,14,22	g	350011584300000724,350011584300001674	0-23,0-23						Methods And Compositions For Detecting Sars Virus And Other Infectious Agents 	.freshpatents.com	0	0		
783	chr1	25994182	25994208	3500425181	23		25994182	25994208	8421504	2	11,12	0,14	c	350042518100000002	8-32			10.1111/j.1365-2567.2004.01946.x	1365-2567	Immunology	Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components - Talreja - 2004 - Immunology - Wiley Online Library	Talreja	2004	0		
783	chr1	26066203	26066346	3500068421	47		26066203	26066346	8421504	2	26,21	0,122	g	350006842100000004	1-48						Human Placental Expression of SLIT/ROBO Signaling Cues: Effects of Preeclampsia and Hypoxia Authors 1, 2 1,	ww.biolreprod.org	0	0		ROBO1
784	chr1	26114958	26115003	3500195537	45		26114958	26115003	8421504	1	45	0	p	350019553700015000	0-45		18753371	10.1523/JNEUROSCI.1479-08.2008		The Journal of neuroscience : the official journal of the Society for Neuroscience	Manipulating Robo Expression In Vivo Perturbs Commissural Axon Pathfinding in the Chick Spinal Cord	Stacey	2008	0		ROBO1
784	chr1	26114958	26115003	3500190525	45		26114958	26115003	8421504	1	45	0	p	350019052500015000	0-45		18753371	10.1523/JNEUROSCI.1479-08.2008	0270-6474	The Journal of Neuroscience	Manipulating Robo Expression In Vivo Perturbs Commissural Axon Pathfinding in the Chick Spinal Cord	Reeber	2008	7		ROBO1
786	chr1	26424961	26425242	3500389826	44		26424961	26425242	8421504	3	4,18,22	0,5,259	c	350038982600000005,350038982600000004	4-26,7-29		16740745	10.1158/1078-0432.CCR-05-2787	1078-0432	Clinical Cancer Research	Identification of ROBO1 as a Novel Hepatocellular Carcinoma Antigen and a Potential Therapeutic and Diagnostic Target	Ito	2006	8		
786	chr1	26424961	26425242	3500313745	44		26424961	26425242	8421504	3	4,18,22	0,5,259	c	350031374500000009,350031374500000008	4-26,7-29					Patent	Cancer diagnosis and treatment using anti-robo1 antibody (Patent EP:1744162)	Aburatani	2010	0		
786	chr1	26424961	26425242	3500298397	44		26424961	26425242	8421504	3	4,18,22	0,5,259	c	350029839700000009,350029839700000008	4-26,7-29					Patent	Cancer diagnosis and treatment using anti-robo1 antibody (Patent EP:2226636)	Aburatani	2012	0		
790	chr1	26976025	26976053	3500232262	23		26976025	26976053	8421504	2	8,15	0,13	g	350023226200000143	8-43					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
101	chr1	29398240	29514511	3500324801	180		29398240	29514511	8421504	5	45,45,45,43,2	0,60365,64752,111723,116269	p	350032480100015031,350032480100015018,350032480100015016,350032480100015011	0-45,0-45,0-45,0-45						US Patent # 7,129,049. Method of detecting equine glycogen storage disease IV - Patents.com	www.patents.com	0	0		
809	chr1	29398366	29440939	3500410280	60		29398366	29440939	8421504	2	41,19	0,42554	p	350041028000015012	0-60						Plant starch composition	Cooke	1997	0		GBE1
809	chr1	29398366	29440939	3500277673	60		29398366	29440939	8421504	2	41,19	0,42554	p	350027767300015013	0-60						Plant Starch Composition	Cooke	2002	0		GBE1
809	chr1	29398366	29440939	3500252968	60		29398366	29440939	8421504	2	41,19	0,42554	p	350025296800015000	0-60					Patent	Plant starch composition (Patent US:6825342)	Cooke	2004	0		GBE1
809	chr1	29398366	29440939	3500220629	60		29398366	29440939	8421504	2	41,19	0,42554	p	350022062900015002	0-60					Patent	Plant Starch Composition (Patent US:6974894)	Cooke	2005	0		GBE1
812	chr1	29864298	29864326	3500396610	23		29864298	29864326	8421504	3	5,13,5	0,7,23	g	350039661000000041	0-23						Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations 	.freshpatents.com	0	0		
819	chr1	30697888	30697916	3500074339	23		30697888	30697916	8421504	2	14,9	0,19	g	350007433900000020	16-48						NOVEL VARIANTS OF PQQ-DEPENDENT GLUCOSE DEHYDROGENASE HAVING IMPROVED SUBSTRATE SPECIFICITY - Patent application	www.faqs.org	0	0		
832	chr1	32491108	32491134	3500025873	24		32491108	32491134	8421504	2	19,5	0,21	g	350002587300000381	0-27						US Patent # 6,593,293. Lepidopteran-active Bacillus thuringiensis .delta.-endotoxin compositions and methods of use - Patents.com	www.patents.com	0	0		
833	chr1	32550204	32550233	3500188603	29		32550204	32550233	8421504	1	29	0	g	350018860300000000	25-54						Parentage verification and identity test of Ghezel sheep using microsatillate markers	www.ajol.info	0	0		
833	chr1	32550204	32550233	3500012335	29		32550204	32550233	8421504	1	29	0	g	350001233500000000	25-54						ISSN 1684 - 5315	demicjournals.org	0	0		
835	chr1	32895403	32895434	3500031829	31		32895403	32895434	8421504	1	31	0	g	350003182900000002,350003182900000019	9-40,0-20		21062931	10.1158/1078-0432.CCR-10-1461		Clinical cancer research : an official journal of the American Association for Cancer Research	Hypoexpression and Epigenetic Regulation of Candidate Tumor Suppressor Gene CADM-2 in Human Prostate Cancer	Guimin	2010	0		CADM2
835	chr1	32896785	32896812	3500116606	23		32896785	32896812	8421504	2	5,18	0,9	g	350011660600000170	5-28						MOUSE ARTIFICIAL CHROMOSOME VECTOR - Patent application	www.faqs.org	0	0		
857	chr1	35722935	35726013	3500142339	1960		35722935	35726013	8421504	8	871,17,79,789,153,4,7,40	0,873,891,2078,2870,3024,3030,3038	c,g	350014233900000017,350014233900000009,350014233900000004,350014233900000010,350014233900000016,350014233900000005	0-968,0-21,0-21,0-21,5-1001,0-20						Genetic marker for improved milk production traits in cattle	Tuggle	1994	0		
857	chr1	35722960	35738912	3500060799	15952		35722960	35738912	8421504	1	15952	0	p,c,g	350006079900000006,350006079900000005,350006079900015020,350006079900015019,350006079900000003,350006079900015018	0-15952,0-25,0-45,0-45,0-20,0-45						Methods and Compositions for Improved Cattle Longevity and Milk Production - Patent application	www.faqs.org	0	0		
857	chr1	35723032	35723752	3500463722	720		35723032	35723752	8421504	1	720	0	c,g	350046372200000003,350046372200000004,350046372200000002	0-660,23-46,0-60						Polymorphism Identification of Pit1 Gene in Indonesian Buffaloes (Bubalus bubalis) and Holstein-Friesian Cows - ResearchGate	.researchgate.net	0	0		
857	chr1	35723032	35723322	3500029392	93		35723032	35723322	8421504	3	22,28,43	0,203,247	c,g	350002939200000007,350002939200000014,350002939200000009,350002939200000008,350002939200000015,350002939200000015	0-22,0-28,0-27,0-27,0-24,0-24						Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes	Gengler	2003	0		
857	chr1	35723235	35723322	3500326870	71		35723235	35723322	8421504	2	28,43	0,44	c	350032687000000014,350032687000000008,350032687000000009,350032687000000015	0-28,0-27,0-27,0-24					Patent	Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes (Patent EP:1485506)	Gengler	2009	0		
857	chr1	35723279	35723306	3500361718	27		35723279	35723306	8421504	1	27	0	c	350036171800000024,350036171800000004,350036171800000023,350036171800000002	0-27,0-25,0-27,0-25						PIT-1 GENE POLYMORPHISM AND TRAIT SELECTION IN ANIMALS	Renaville	1999	0		
857	chr1	35723411	35724504	3500350371	54		35723411	35724504	8421504	2	28,26	0,1067	p	350035037100015011	0-54						Supporting Information	www.pnas.org	0	0		POU1F1
857	chr1	35727925	35735469	3500148347	65		35727925	35735469	8421504	3	25,20,20	0,6773,7524	c,g	350014834700000005,350014834700000003,350014834700000002	0-25,0-20,0-20						Methods and Compositions for Improved Cattle Longevity and Milk Production	Khatib	2008	0		
857	chr1	35727925	35727950	3500331418	25		35727925	35727950	8421504	1	25	0	c	350033141800000003	0-25						m k Z j m d g Z b yf	csl.bas-net.by	0	0		POU1F1
859	chr1	35988456	35988488	3500096515	27		35988456	35988488	8421504	3	9,4,14	0,13,18	g	350009651500000122	14-47						Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins	M*Le Na Er 	2007	0		
862	chr1	36347977	36348025	3500249258	48		36347977	36348025	8421504	1	48	0	c	350024925800000013	0-48					Patent	DNA encoding a human 5-HT.sub.1F receptor and uses thereof (Patent US:5639652)	Branchek	1997	0		
862	chr1	36347977	36348025	3500038515	48		36347977	36348025	8421504	1	48	0	c	350003851500000013	0-48						Dna encoding a human 5-ht 1f? receptor and uses thereof	Branchek	1993	0		
862	chr1	36348025	36348073	3500276253	48		36348025	36348073	8421504	1	48	0	c	350027625300000010	0-48					Patent	DNA encoding a human 5-HT.sub.1F receptor, vectors, and host cells (Patent US:5360735)	Branchek	1994	0		
863	chr1	36447073	36447101	3500205714	26		36447073	36447101	8421504	3	8,5,13	0,9,15	c	350020571400000448	0-26						Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants - Patent application	www.faqs.org	0	0		
866	chr1	36927548	36927577	3500108244	25		36927548	36927577	8421504	3	7,3,15	0,10,14	g	350010824400000082	3-28						Materials and methods relating to proteins that interact with casein kinase i	Demaggio	1996	0		
871	chr1	37540792	37540815	3500259529	23		37540792	37540815	8421504	1	23	0	c	350025952900000008	0-23						Methods for production of receptor and ligand isoforms	Jin	2006	0		EPHA3
13	chr1	37540802	37950983	3500286800	2940		37540802	37950983	8421504	18	88,65,661,156,336,125,163,103,13,52,126,186,62,210,150,194,156,94	0,23590,122398,271501,272340,330036,332974,344461,345263,345279,351782,358222,367652,369511,386713,388393,403620,410087	p	350028680000015000	0-2940						Methods for Identifying Risk of Type II Diabetes and Treatments Thereof - Patent application	www.faqs.org	0	0		
108	chr1	37540883	37663659	3500376096	528		37540883	37663659	8421504	4	7,65,69,387	0,23509,122317,122389	p	350037609600015007,350037609600015016,350037609600015025,350037609600015034	0-141,0-141,0-141,0-105						Eph receptor ligands and methods of use	Pasquale	2010	0		EPHA3
13	chr1	37540886	37812338	3500330320	654		37540886	37812338	8421504	5	4,65,447,103,35	0,23506,122314,122872,271417	p	350033032000015002,350033032000015054,350033032000015003,350033032000015027,350033032000015056,350033032000015057,350033032000015004,350033032000015006,350033032000015036	0-147,0-180,0-147,0-153,0-177,0-180,0-135,0-87,0-138						Structure, Function & Control of the EphA3 Receptor Tyrosine Kinase	.swinburne.edu.au	0	0		EPHA3
872	chr1	37703901	37703924	3500447831	23		37703901	37703924	8421504	1	23	0	g	350044783100000003	3-26					Antimicrobial Agents and Chemotherapy	Streptococcus pneumoniae DNA Gyrase and Topoisomerase IV: Overexpression, Purification, and Differential Inhibition by Fluoroquinolones	Xiao-Su	1999	0		
874	chr1	37885271	37885303	3500368298	28		37885271	37885303	8421504	2	21,7	0,25	c	350036829800000001	9-37						Ligands for eph-like receptors	Bartley	1997	0		
874	chr1	37885271	37885303	3500175083	28		37885271	37885303	8421504	2	21,7	0,25	c	350017508300000001	9-37						Ligands for eph-like receptors	Bartley	1996	0		
874	chr1	37885271	37885303	3500173271	28		37885271	37885303	8421504	2	21,7	0,25	c	350017327100000001	9-37						Ligands for eph-like receptors	Bartley	1996	0		
874	chr1	37892703	37929248	3500438553	43		37892703	37929248	8421504	3	7,13,23	0,6321,36522	c	350043855300000569,350043855300000277	15-35,0-23						Eph-related tyrosine kinases, nucleotide sequences and methods of use	Pasquale	1993	0		
874	chr1	37910364	37927536	3500219244	180		37910364	37927536	8421504	2	159,21	0,17151	p	350021924400015132	0-180						Polypeptides and nucleic acids encoding same	Gangolli	2005	0		
874	chr1	37929216	37929279	3500356256	63		37929216	37929279	8421504	1	63	0	p	350035625600015005	0-63						A novel receptor-type tyrosine kinase and use thereof	Boyd	1993	0		EPHA3
880	chr1	38764696	38776430	3500461455	44		38764696	38776430	8421504	2	20,24	0,11710	c	350046145500000018,350046145500000022	10-30,0-24					Patent	Host cell protein knock-out cells for production of therapeutic proteins (Patent EP:1904528)	Steenstrup	2012	0		
880	chr1	38764696	38776430	3500215233	44		38764696	38776430	8421504	2	20,24	0,11710	c	350021523300000020,350021523300000024	10-30,0-24						Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins	Steenstrup	2012	0		
880	chr1	38764696	38776430	3500212598	44		38764696	38776430	8421504	2	20,24	0,11710	c	350021259800000021,350021259800000025	10-30,0-24					Patent	Host cell protein knock-out cells for production of therapeutic proteins (Patent US:7696318)	Steenstrup	2010	0		
880	chr1	38764696	38776430	3500175632	44		38764696	38776430	8421504	2	20,24	0,11710	c	350017563200000021,350017563200000025	10-30,0-24						Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins	Steenstrup	2008	0		
880	chr1	38764696	38776430	3500102129	44		38764696	38776430	8421504	2	20,24	0,11710	c	350010212900000021,350010212900000025	10-30,0-24						Host cell protein knock-out cells for production of therapeutic proteins	Steenstrup	2010	0		
880	chr1	38764696	38776430	3500065053	44		38764696	38776430	8421504	2	20,24	0,11710	c	350006505300000021,350006505300000066,350006505300000025	10-30,0-24,0-24						HOST CELL PROTEIN KNOCK-OUT CELLS FOR PRODUCTION OF THERAPEUTIC PROTEINS - Patent application	www.faqs.org	0	0		
880	chr1	38776406	38776430	3500363643	24		38776406	38776430	8421504	1	24	0	c	350036364300000060,350036364300000024	0-24,0-24						Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins - Patent application	www.faqs.org	0	0		
880	chr1	38776406	38776430	3500182115	24		38776406	38776430	8421504	1	24	0	c	350018211500000025	0-24					Patent	Host cell protein knock-out cells for production of therapeutic proteins (Patent US:8158771)	Steenstrup	2012	0		
881	chr1	38822389	38822415	3500240894	24		38822389	38822415	8421504	2	14,10	0,16	c	350024089400000091	0-27						Regulatory nucleic acid elements	Ke Si Ting *Suo Te 	2009	0		
900	chr1	41299643	41299670	3500291423	23		41299643	41299670	8421504	3	5,11,7	0,7,20	g	350029142300000001	5-29						Isolation, cloning and expression of the melitensis Omp31 gene	www.shirazu.ac.ir	0	0		
903	chr1	41688314	41688340	3500072776	26		41688314	41688340	8421504	1	26	0	g	350007277600000054	26-52						Methods for detecting target nucleic acids using coupled ligation and amplification	Wenz	2006	0		TUBA1A,CHORDC1
907	chr1	42232307	42232336	3500172416	24		42232307	42232336	8421504	3	5,5,14	0,8,15	g	350017241600000005,350017241600000015	1-25,1-25						NEISSERIA MENINGITIDIS SEROGROUP A CAPSULAR POLYSACCHARIDE ACETYLTRANSFERASE, METHODS AND COMPOSITIONS - Patent application	www.faqs.org	0	0		
907	chr1	42298049	42298078	3500006708	24		42298049	42298078	8421504	2	15,9	0,20	g	350000670800000010	18-48						Self-inactivating Retroviral Vector 	.freshpatents.com	0	0		
912	chr1	42930897	42934454	3500086341	60		42930897	42934454	8421504	2	35,25	0,3532	c	350008634100000022,350008634100000023,350008634100000025	0-35,0-35,0-25						Elucidating a role for BBS3 in syndromic and non-syndromic retinal disease	ir.uiowa.edu	0	0		
913	chr1	43062961	43062986	3500385390	23		43062961	43062986	8421504	3	4,8,11	0,5,14	g	350038539000000031	8-31						US Patent # 6,632,924. Method of measuring plasma membrane targeting of GLUT4 - Patents.com	www.patents.com	0	0		
914	chr1	43174586	43174611	3500400238	24		43174586	43174611	8421504	2	6,18	0,7	c	350040023800000069	7-31						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
921	chr1	44056474	44056498	3500215583	24		44056474	44056498	8421504	1	24	0	c	350021558300000005	0-24		18985860	10.1038/onc.2008.263	0950-9232	Oncogene	Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B	Koyama	2008	6		
921	chr1	44079773	44081194	3500145189	24		44079773	44081194	8421504	2	1,23	0,1398	c	350014518900000046,350014518900000009	12-36,12-36						ANTI-HUMAN CLCP1 ANTIBODY AND USE THEREOF - Patent application	www.faqs.org	0	0		
921	chr1	44079773	44081194	3500110425	24		44079773	44081194	8421504	2	1,23	0,1398	c	350011042500000017	12-36						Anti-human clcp1 antibody and use thereof	Ono	2010	0		
932	chr1	45503470	45515010	3500227860	61		45503470	45515010	8421504	3	43,5,13	0,439,11527	p	350022786000015012	135-235						Human TMEM30a Promotes Uptake of Antitumor and Bioactive Choline Phospholipids into Mammalian Cells	www.jimmunol.org	0	0		
933	chr1	45679455	45679485	3500262569	24		45679455	45679485	8421504	3	13,6,5	0,17,25	g	350026256900000027	3-28						Carbohydrate binding modules with reduced binding to lignin	Tomashek	2011	0		
933	chr1	45696155	45732740	3500231766	1503		45696155	45732740	8421504	12	151,123,98,117,108,135,208,149,110,127,174,3	0,5939,6665,11641,12616,13900,16516,19671,20671,22399,24963,36582	p	350023176600015042	0-1503						29 human secreted proteins	Birse	2001	0		TOMM70A,LNP1
933	chr1	45696155	45715966	3500386968	64		45696155	45715966	8421504	2	45,19	0,19792	p,c,g	350038696800015001,350038696800000008,350038696800000008	0-45,0-19,0-19			10.1091/mbc.E06-04-0319		Molecular Biology of the Cell	An Internal EELD Domain Facilitates Mitochondrial Targeting of Mcl-1 via a Tom70-dependent Pathway	Chiang-Hung	2006	0		TOMM70A
933	chr1	45696155	45715966	3500182569	64		45696155	45715966	8421504	2	45,19	0,19792	p,c	350018256900015000,350018256900000008	0-45,0-19		16822835	10.1091/mbc.E06-04-0319	1059-1524	Molecular Biology of the Cell	An Internal EELD Domain Facilitates Mitochondrial Targeting of Mcl-1 via a Tom70-dependent Pathway	Chou	2006	5		TOMM70A
937	chr1	46240585	46253071	3500252558	39		46240585	46253071	8421504	2	20,19	0,12467	c	350025255800000004,350025255800000006	0-20,0-19						The DNA Rearrangement That Generates theTRK-T3Oncogene Involves a Novel Gene on Chromosome 3 Whose Product Has a Potential Coiled-Coil Domain | Claudia Miranda - Academia.edu	www.academia.edu	0	0		TFG
937	chr1	46244625	46249049	3500456378	24		46244625	46249049	8421504	2	4,20	0,4404	c	350045637800000009	0-24					Patent	Gene defects and mutant ALK kinase in human solid tumors (Patent US:8288102)	Rikova	2012	0		TFG
937	chr1	46244625	46249049	3500454288	24		46244625	46249049	8421504	2	4,20	0,4404	c	350045428800000009	0-24						Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase	Rikova	2012	0		TFG
937	chr1	46244625	46249049	3500340157	24		46244625	46249049	8421504	2	4,20	0,4404	c	350034015700000009	0-24						Gene defects and mutant ALK kinase in human solid tumors	Rikova	2009	0		TFG
937	chr1	46244625	46249049	3500337440	24		46244625	46249049	8421504	2	4,20	0,4404	c	350033744000000009	0-24						Gene defects and mutant alk kinase in human solid tumors	Gu	2008	0		TFG
937	chr1	46244625	46249049	3500300944	24		46244625	46249049	8421504	2	4,20	0,4404	c	350030094400000009	0-24						Gene defects and mutant ALK kinase in human solid tumors	Rikova	2011	0		
937	chr1	46244625	46249049	3500294731	24		46244625	46249049	8421504	2	4,20	0,4404	c	350029473100000009	0-24						Gene defects and mutant ALK kinase in human solid tumors	Rikova	2009	0		TFG
937	chr1	46244625	46249049	3500293307	24		46244625	46249049	8421504	2	4,20	0,4404	c	350029330700000009	0-24						Gene Defects And Mutant ALK Kinase In Human Solid Tumors	Rikova	2010	0		TFG
937	chr1	46244625	46249049	3500283017	24		46244625	46249049	8421504	2	4,20	0,4404	c	350028301700000009	0-24					Patent	Gene defects and mutant ALK kinase in human solid tumors (Patent US:8377642)	Rikova	2013	0		TFG
937	chr1	46244625	46249049	3500258575	24		46244625	46249049	8421504	2	4,20	0,4404	c	350025857500000009	0-24						Gene defects and mutant ALK kinase in human solid tumors	Rikova	2012	0		TFG
937	chr1	46244625	46249049	3500238045	24		46244625	46249049	8421504	2	4,20	0,4404	c	350023804500000009	0-24						Gene Defects and Mutant ALK Kinase in Human Solid Tumors	Rikova	2010	0		TFG
937	chr1	46244625	46249049	3500182027	24		46244625	46249049	8421504	2	4,20	0,4404	c	350018202700000009	0-24						Gene defects and mutant ALK kinase in human solid tumors	Rikova	2007	0		
937	chr1	46244625	46249049	3500175489	24		46244625	46249049	8421504	2	4,20	0,4404	c	350017548900000009	0-24						Gene defects and mutant alk kinase in human solid tumors	Rikova	2012	0		
937	chr1	46244625	46249049	3500161373	24		46244625	46249049	8421504	2	4,20	0,4404	c	350016137300000009	0-24						Gene defects and mutant ALK kinase in human solid tumors	Rikova	2007	0		
937	chr1	46244625	46249049	3500135729	24		46244625	46249049	8421504	2	4,20	0,4404	c	350013572900000009	0-24					Patent	Gene defects and mutant ALK kinase in human solid tumors (Patent US:8288102)	Rikova	2012	0		
937	chr1	46244625	46249049	3500133511	24		46244625	46249049	8421504	2	4,20	0,4404	c	350013351100000009	0-24					Patent	Gene defects and mutant ALK kinase in human solid tumors (Patent US:7700339)	Rikova	2010	0		
937	chr1	46244625	46249049	3500068038	24		46244625	46249049	8421504	2	4,20	0,4404	c	350006803800000018	0-24						Gene defect and mutant ALK kinase in human entity tumour	Jian 	2009	0		TFG
937	chr1	46244625	46249049	3500025044	24		46244625	46249049	8421504	2	4,20	0,4404	c	350002504400000009	0-24						Gene Defects And Mutant ALK Kinase In Human Solid Tumors	Rikova	2011	0		TFG
937	chr1	46244625	46249049	3500019248	24		46244625	46249049	8421504	2	4,20	0,4404	c	350001924800000009	0-24					Patent	Gene defects and mutant ALK kinase in human solid tumors (Patent US:8232060)	Rikova	2012	0		
937	chr1	46244625	46249049	3500017865	24		46244625	46249049	8421504	2	4,20	0,4404	c	350001786500000009	0-24						Gene Defects And Mutant Alk Kinase In Human Solid Tumors 	.freshpatents.com	0	0		TFG
944	chr1	47091136	47091161	3500240894	23		47091136	47091161	8421504	2	10,13	0,12	c	350024089400000075	2-25						Regulatory nucleic acid elements	Ke Si Ting *Suo Te 	2009	0		
944	chr1	47091886	47091913	3500288139	24		47091886	47091913	8421504	2	19,5	0,22	c	350028813900000097	20-45						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
944	chr1	47091886	47091913	3500219109	24		47091886	47091913	8421504	2	19,5	0,22	c	350021910900000097	20-45						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
944	chr1	47136676	47138525	3500409160	39		47136676	47138525	8421504	2	19,20	0,1829	c,g	350040916000000041,350040916000000041,350040916000000040,350040916000000040	0-19,0-19,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
944	chr1	47137413	47141291	3500139016	42		47137413	47141291	8421504	3	21,8,13	0,1219,3865	c	350013901600000005,350013901600000004	0-21,0-21		19273598	10.1128/MCB.01588-08		Molecular and Cellular Biology	The p53 Tumor Suppressor Causes Congenital Malformations in Rpl24-Deficient Mice and Promotes Their Survival 	Martina	2009	0		RPL24
945	chr1	47273218	47275118	3500120476	37		47273218	47275118	8421504	2	3,34	0,1866	c	350012047600000007	3-40						Letter	biologia.uniba.it	0	0		NFKBIZ
951	chr1	47982220	47982247	3500034609	24		47982220	47982247	8421504	3	8,3,13	0,9,14	g	350003460900000014	0-24						Small Interfering RNAs Targeting Feline Herpes Virus - Patent application	www.faqs.org	0	0		
955	chr1	48540242	48540267	3500021081	23		48540242	48540267	8421504	3	6,5,12	0,7,13	g	350002108100000174	8-36						US Patent # 6,312,903. Simulataneous detection, identification and differentiation of eubacterial taxa using a hybridization assay - Patents.com	www.patents.com	0	0		
962	chr1	49470759	49470786	3500051709	24		49470759	49470786	8421504	3	4,8,12	0,5,15	g	350005170900000037	6-35						 Membrane Scaffold Proteins 	www.docstoc.com	0	0		
963	chr1	49593609	49593636	3500068199	24		49593609	49593636	8421504	3	8,12,4	0,10,23	g	350006819900000414	13-37						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
969	chr1	50417944	50417967	3500017696	23		50417944	50417967	8421504	1	23	0	c	350001769600000012	0-23						Equine Veterinary Journal ISSN 0425-1644 DOI: 10.1111/j.2042-3306.2010.00353.x Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells	library.hverf.org	0	0		
969	chr1	50445357	50445543	3500418301	186		50445357	50445543	8421504	1	186	0	g	350041830100000008,350041830100000011	55-241,0-20					Patent	Sexing method of bovine embyros (Patent US:5461145)	Itagaki	1995	0		
969	chr1	50445357	50445543	3500160638	186		50445357	50445543	8421504	1	186	0	g	350016063800000008,350016063800000012,350016063800000011	55-241,0-20,0-20						Sexing method of bovine embyros	Kudo	1992	0		
969	chr1	50445407	50445509	3500024096	40		50445407	50445509	8421504	2	20,20	0,82	g	350002409600000003,350002409600000002	0-20,0-20						Polimeraz Zincir Reaksiyonu (PZR) ile S&#x0131;&#x011f;&#x0131;rlardaki Freemartinismus Sendromunun Tan&#x0131;s&#x0131;	rgi.kafkas.edu.tr	0	0		
970	chr1	50581570	50581593	3500331099	23		50581570	50581593	8421504	1	23	0	c	350033109900000001,350033109900000000	0-23,0-23						 <HTML> <HEAD> <TITLE> Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166	.aacrjournals.org	0	0		ALCAM
970	chr1	50588774	50588799	3500370985	25		50588774	50588799	8421504	1	25	0	c	350037098500000063,350037098500000292	0-25,0-25						Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same - Patent application	www.faqs.org	0	0		ALCAM
970	chr1	50588774	50588799	3500003368	25		50588774	50588799	8421504	1	25	0	c	350000336800000059	0-25						Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same	Sugioka	2009	0		ALCAM
971	chr1	50598076	50619873	3500153648	40		50598076	50619873	8421504	2	20,20	0,21777	c,g	350015364800000006,350015364800000006,350015364800000007,350015364800000007	0-20,0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
971	chr1	50623273	50623297	3500431819	24		50623273	50623297	8421504	1	24	0	c	350043181900000000	0-24						Ligands that modulate differentiation of mesenchymal stem cells	Bruder	1998	0		
121	chr1	50745474	50966258	3500446296	2946		50745474	50966258	8421504	19	257,120,141,132,40,55,147,95,366,186,204,132,88,138,122,157,147,251,168	0,12667,19805,22622,22867,22910,27036,41123,50924,53038,72756,89266,92240,95708,98804,104691,127449,207510,220616	p	350044629600015000	0-2946						KEGG T01001: 868	www.genome.jp	0	0		CBLB
121	chr1	50745480	50966258	3500024074	2940		50745480	50966258	8421504	19	251,120,141,132,40,55,147,95,366,186,204,132,88,138,122,157,147,251,168	0,12661,19799,22616,22861,22904,27030,41117,50918,53032,72750,89260,92234,95702,98798,104685,127443,207504,220610	p	350002407400015019	0-2940						Cbl-b polypeptides, complexes and related methods	Reiss	2004	0		CBLB
972	chr1	50850227	50850257	3500284394	25		50850227	50850257	8421504	3	6,5,14	0,10,16	g	350028439400000648	9-35						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2011	0		
973	chr1	50900995	50901021	3500051779	23		50900995	50901021	8421504	3	5,14,4	0,7,22	g	350005177900000023	14-37						Synthetic Bacillus thuringiensis cryic gene encoding insect toxin	Strizhov	1996	0		
973	chr1	50953067	50966147	3500187783	225		50953067	50966147	8421504	2	168,57	0,13023	p	350018778300015041	3-228						Oxford_SGC_Clones_web	www.docstoc.com	0	0		CBLB
975	chr1	51118541	51118565	3500373791	24		51118541	51118565	8421504	1	24	0	c	350037379100000005	6-30						Compositions and methods for fusion protein separation	Kim	2008	0		TMSB4X
975	chr1	51118591	51118988	3500375699	395		51118591	51118988	8421504	3	309,41,45	0,310,352	c	350037569900000021	0-396						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
975	chr1	51118779	51118803	3500190719	24		51118779	51118803	8421504	1	24	0	c	350019071900000000	0-24						Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. - ResearchGate	.researchgate.net	0	0		TMSB4X
988	chr1	52902620	52902649	3500421125	23		52902620	52902649	8421504	3	12,6,5	0,16,24	g	350042112500000038	0-23						Emerging Infectious Diseases | Neurologic Dissorders	www.docstoc.com	0	0		
994	chr1	53708677	53709278	3500382374	600		53708677	53709278	8421504	2	147,453	0,148	g	350038237400000003	28-688						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
994	chr1	53708677	53709278	3500221817	600		53708677	53709278	8421504	2	147,453	0,148	g	350022181700000003	28-688					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
994	chr1	53708677	53709250	3500101798	573		53708677	53709250	8421504	1	573	0	g	350010179800000003	28-660						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
1006	chr1	55216618	55219092	3500310579	702		55216618	55219092	8421504	5	34,41,41,270,316	0,239,803,904,2158	g	350031057900000007	0-702						Methods of modulating immune function	Chen	2011	0		
1018	chr1	56850289	56850314	3500042383	23		56850289	56850314	8421504	3	5,6,12	0,6,13	g	350004238300000081	22-45						NUCLEOTIDE TRANSIENT BINDING FOR SEQUENCING METHODS - Patent application	www.faqs.org	0	0		
1019	chr1	56989442	56989471	3500188073	26		56989442	56989471	8421504	2	6,20	0,9	g	350018807300000014	0-27						High titer recombinant influenza viruses for vaccines and gene therapy	Kawaoka	2004	0		
1019	chr1	57012218	57012248	3500452287	25		57012218	57012248	8421504	3	14,5,6	0,16,24	g	350045228700000002,350045228700000003	0-29,1-30						GLYCOSYLATED HUMAN ALPHA INTERFERON MUTEINS, METHOD FOR OBTAINING THEM AND USE - Patent application	www.faqs.org	0	0		
1022	chr1	57336946	57336972	3500240436	25		57336946	57336972	8421504	2	20,5	0,21	g	350024043600000009,350024043600000008	17-42,0-25						Subunit vaccine against respiratory syncytial virus infection	Anderson	2005	0		
1028	chr1	58112931	58112960	3500271175	24		58112931	58112960	8421504	2	13,11	0,18	c	350027117500000060	25-49						G-protein coupled recptors	Casman	2002	0		
1032	chr1	58632199	58632226	3500467157	23		58632199	58632226	8421504	2	11,12	0,15	g	350046715700000014	0-23		22096574	10.1371/journal.pone.0027450		PLoS ONE	The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines	Andrea	2011	0		DLGAP1
1032	chr1	58638330	58638356	3500042281	23		58638330	58638356	8421504	3	6,13,4	0,8,22	g	350004228100000113	3-26					Patent	Single chain multivalent binding proteins with effector function (Patent US:8409577)	Thompson	2013	0		
1032	chr1	58649723	58649749	3500414565	25		58649723	58649749	8421504	2	9,16	0,10	g	350041456500000032	0-25						Analyzing Comparative Sequence Data to Understand Genome Function and Evolution	gradworks.umi.com	0	0		
1033	chr1	58725033	58725057	3500242111	23		58725033	58725057	8421504	2	17,6	0,18	g	350024211100000006	0-23						Peptides and related molecules that modulate nerve growth factor activity	Boone	2012	0		
1033	chr1	58731479	58731503	3500435354	23		58731479	58731503	8421504	2	8,15	0,9	c	350043535400000015	25-48						Novel Wheat Allergens - Patent application	www.faqs.org	0	0		
1034	chr1	58968127	58968153	3500445397	23		58968127	58968153	8421504	2	15,8	0,18	c	350044539700000028	0-23						Vector - Patent application	www.faqs.org	0	0		
1036	chr1	59212927	59213075	3500275422	54		59212927	59213075	8421504	2	16,38	0,110	p	350027542200015000	0-54		23924428	10.1186/1742-9994-10-46		Frontiers in Zoology	Compensatory regulation of Na+ absorption by Na+/H+ exchanger and Na+-Cl- cotransporter in zebrafish (Danio rerio)	Wei-Jen	2013	0		ATP6V1A
1036	chr1	59212927	59213069	3500464363	48		59212927	59213069	8421504	2	16,32	0,110	p	350046436300015055	0-48						African lungfish, Protopterus annectens, possess an arginine vasotocin receptor homologous to the tetrapod V2-type receptor	eb.biologists.org	0	0		ATP6V1A
1036	chr1	59212927	59213069	3500083082	48		59212927	59213069	8421504	2	16,32	0,110	p	350008308200015001	0-48						CathepsinEDeficiencyInducesaNovelFormofLysosomal StorageDisorderShowingtheAccumulationofLysosomal MembraneSialoglycoproteinsandtheElevationof LysosomalpHinMacrophages	www.jbc.org	0	0		ATP6V1A
1036	chr1	59226984	59227029	3500177690	45		59226984	59227029	8421504	1	45	0	p	350017769000015002	3-48		18657050	10.1042/BJ20081073		The Biochemical journal	Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts	Shengmei	2009	0		ATP6V1A
1040	chr1	59709163	59709188	3500145861	23		59709163	59709188	8421504	2	16,7	0,18	g	350014586100000054	10-42						PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME FROM THERMOSIPHO AFRICANUS - Cetus	www.sumobrain.com	0	0		
1041	chr1	59817447	59817471	3500458003	24		59817447	59817471	8421504	1	24	0	g	350045800300000012	0-24			10.1111/j.1752-4571.2010.00142.x		Evolutionary Applications	Broad and fine-scale genetic analysis of white-tailed deer populations: estimating the relative risk of chronic wasting disease spread	Catherine	2011	0		
1045	chr1	60331390	60331417	3500173591	25		60331390	60331417	8421504	3	15,5,5	0,16,22	g	350017359100000061	16-41						 Methods Of Using The OB Receptor Antibodies To Treat Bodyweight Disorders 	www.docstoc.com	0	0		
1047	chr1	60591703	60591727	3500334096	23		60591703	60591727	8421504	2	11,12	0,12	g	350033409600000010	0-34					Patent	Thermophilic polymerase III holoenzyme (Patent US:6677146)	Janjic	2004	0		
1048	chr1	60757591	60757684	3500119257	82		60757591	60757684	8421504	2	30,52	0,41	g	350011925700000034,350011925700000008	0-91,9-100						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
1048	chr1	60763739	60763766	3500408630	25		60763739	60763766	8421504	3	4,12,9	0,5,18	g	350040863000000000	5-30						DIFFERENTIALLY FLUORESCENT YEAST BIOSENSORS FOR THE DETECTION AND BIODEGRADATION OF CHEMICAL AGENTS - Patent application	www.faqs.org	0	0		
1048	chr1	60763739	60763766	3500106955	25		60763739	60763766	8421504	3	4,12,9	0,5,18	g	350010695500000000	5-30						SureChem - Document - WO/PCT - Patent No. 2009082525 - "DIFFERENTIALLY FLUORESCENT YEAST BIOSENSORS FOR THE DETECTION AND BIODEGRADATION OF CHEMICAL AGENTS" - Description	www.surechem.org	0	0		
131	chr1	61175935	61237553	3500134622	60		61175935	61237553	8421504	2	30,30	0,61588	p	350013462200015000	0-60		23185580	10.1371/journal.pone.0050218		PLoS ONE	In Vivo Imaging of Hierarchical Spatiotemporal Activation of Caspase-8 during Apoptosis	Katsuya	2012	0		GAP43
131	chr1	61175935	61237552	3500347618	59		61175935	61237552	8421504	2	30,29	0,61588	c	350034761800000001	6-65						A MOLECULAR SENSOR DETECTS SIGNAL TRANSDUCTION FROM CAVEOLAE IN LIVING CELLS	www.jbc.org	0	0		GAP43
131	chr1	61175935	61237552	3500347618	59		61175935	61237552	8421504	2	30,29	0,61588	c	350034761800000000	5-64						A MOLECULAR SENSOR DETECTS SIGNAL TRANSDUCTION FROM CAVEOLAE IN LIVING CELLS	www.jbc.org	0	0		GAP43
1052	chr1	61237539	61237625	3500324287	44		61237539	61237625	8421504	2	24,20	0,66	c,g	350032428700000011,350032428700000012,350032428700000012	0-24,0-20,0-20						Neuroblastoma	www.scribd.com	0	0		GAP43
1052	chr1	61237580	61237661	3500389626	81		61237580	61237661	8421504	1	81	0	p	350038962600015015	0-81						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		GAP43
1052	chr1	61237580	61237661	3500061337	81		61237580	61237661	8421504	1	81	0	p	350006133700015149,350006133700015025	0-48,0-81						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		GAP43
1052	chr1	61276639	61276665	3500246474	26		61276639	61276665	8421504	1	26	0	c	350024647400000033	0-26						BMC Molecular Biology BioMed Central	air.unimi.it	0	0		
1052	chr1	61276785	61276810	3500353377	23		61276785	61276810	8421504	3	13,5,5	0,14,20	c	350035337700000112	21-44						Compositions and methods for producing bioactive fusion proteins - Patent application	www.faqs.org	0	0		
1053	chr1	61351844	61351871	3500451941	24		61351844	61351871	8421504	2	8,16	0,11	c	350045194100000007	7-31		18673458	10.1111/j.1365-2958.2008.06377.x	1365-2958	Molecular Microbiology	Hierarchal type III secretion of translocators and effectors from Escherichia coli O157:H7 requires the carboxy terminus of SepL that binds to Tir - Wang - 2008 - Molecular Microbiology - Wiley Online Library	Wang	2008	0		
16	chr1	61389056	62195181	3500054122	843		61389056	62195181	8421504	6	148,121,135,126,233,80	0,612,10506,194082,312950,806045	p	350005412200015070	0-843						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		LSAMP
16	chr1	61389056	62195181	3500054122	843		61389056	62195181	8421504	6	148,121,135,126,233,80	0,612,10506,194082,312950,806045	p	350005412200015069	0-843						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		LSAMP
131	chr1	61389056	61583214	3500251406	480		61389056	61583214	8421504	4	148,121,135,76	0,612,10506,194082	p	350025140600015073	0-480					Patent	Human cDNAs and proteins and uses thereof (Patent US:7285631)	Bejanin	2007	0		LSAMP
1053	chr1	61389685	61389730	3500328917	45		61389685	61389730	8421504	1	45	0	c	350032891700000378	0-45						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
1054	chr1	61583139	61583232	3500328917	90		61583139	61583232	8421504	2	45,45	0,48	c	350032891700000373,350032891700000372	0-45,0-45						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
16	chr1	61583259	62195103	3500346464	240		61583259	62195103	8421504	3	5,233,2	0,118747,611842	p	350034646400015033,350034646400015013,350034646400015032,350034646400015012,350034646400015031,350034646400015011,350034646400015030,350034646400015010,350034646400015029	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Lsamp Gene Associated With Cardiovascular Disease 	.freshpatents.com	0	0		LSAMP
16	chr1	61702139	62195181	3500251406	180		61702139	62195181	8421504	2	100,80	0,492962	p	350025140600015072	0-180					Patent	Human cDNAs and proteins and uses thereof (Patent US:7285631)	Bejanin	2007	0		LSAMP
1058	chr1	62092252	62092278	3500093009	24		62092252	62092278	8421504	3	6,5,13	0,7,13	g	350009300900000026	0-24						Mechanisms and enzymes involved in SARS coronavirus genome expression	r.sgmjournals.org	0	0		
1062	chr1	62616213	62616239	3500438028	24		62616213	62616239	8421504	3	4,5,15	0,5,11	g	350043802800000377	5-31						 Personal Care Compositions Comprising Modified Variant Bowman Birk Protease Inhibitors 	www.docstoc.com	0	0		
1062	chr1	62616213	62616239	3500246658	24		62616213	62616239	8421504	3	4,5,15	0,5,11	g	350024665800000376	5-31						PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS - Patent application	www.faqs.org	0	0		
1063	chr1	62672093	62672122	3500193635	24		62672093	62672122	8421504	2	7,17	0,12	g	350019363500000291	1-26						Materials and methods for immunocontraception	Harris	1993	0		
1063	chr1	62757976	62758001	3500290366	23		62757976	62758001	8421504	2	6,17	0,8	g	350029036600000300	5-30						FUNGUS RESISTANT PLANTS AND THEIR USES - Patent application	www.faqs.org	0	0		
1064	chr1	62813399	62813439	3500328253	33		62813399	62813439	8421504	2	22,11	0,29	g	350032825300000063,350032825300000062	10-46,15-51						Expression and regulation of the porin gene mspA of Mycobacterium smegmatis	b.uni-erlangen.de	0	0		
1068	chr1	63346269	63347053	3500166204	719		63346269	63347053	8421504	7	217,66,7,28,57,126,218	0,219,291,301,335,438,566	g	350016620400000040	0-766						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1071	chr1	63710016	63710040	3500378054	23		63710016	63710040	8421504	2	7,16	0,8	g	350037805400000082	0-31					Patent	17Q-linked breast and ovarian cancer susceptibility gene (Patent US:5747282)	Futreal	1998	0		
1071	chr1	63710016	63710040	3500039576	23		63710016	63710040	8421504	2	7,16	0,8	g	350003957600000051	0-31						METHOD FOR DIAGNOSING A PREDISPOSITION FOR BREAST AND OVARIAN CANCER - MYRIAD GENETICS, INC	www.sumobrain.com	0	0		
1072	chr1	63909513	63909539	3500316254	23		63909513	63909539	8421504	3	4,14,5	0,5,21	g	350031625400000138,350031625400000278	9-32,9-32						Gene Synthesis Kit 	.freshpatents.com	0	0		
134	chr1	64875425	64889257	3500000328	40		64875425	64889257	8421504	2	20,20	0,13812	c	350000032800000002,350000032800000003	0-20,0-20					The American Journal of Pathology	Uroplakin Gene Expression by Normal and Neoplastic Human Urothelium	E.	1998	0		UPK1B
1081	chr1	65047530	65047557	3500212290	24		65047530	65047557	8421504	2	17,7	0,20	c	350021229000000005	4-28						Anti-proliferative effect of ginseng saponins on human prostate cancer cell line	le218.uf.daum.net	0	0		
1082	chr1	65181797	65203746	3500411953	891		65181797	65203746	8421504	5	71,111,282,327,100	0,1266,7601,12777,21849	p,c,g	350041195300000148,350041195300000216,350041195300000150,350041195300000220,350041195300000208,350041195300000226,350041195300000014,350041195300000212,350041195300015099,350041195300015087,350041195300000198,350041195300000176,350041195300000188,350041195300000044,350041195300000026,350041195300000038,350041195300000182,350041195300000028,350041195300000048,350041195300000162,350041195300000194,350041195300000158,350041195300000140,350041195300000224,350041195300000142,350041195300000202,350041195300000168,350041195300000200,350041195300000138,350041195300000164,350041195300000036,350041195300000030,350041195300000032,350041195300000034,350041195300000054,350041195300000196,350041195300000056,350041195300000136,350041195300000214,350041195300000170,350041195300000172,350041195300000146,350041195300000178,350041195300000132,350041195300000218,350041195300000156,350041195300000134,350041195300000154,350041195300015083,350041195300000023,350041195300015098,350041195300015079,350041195300015023,350041195300000184,350041195300000186,350041195300000160,350041195300000144,350041195300000174,350041195300015108,350041195300015097,350041195300015057,350041195300015075,350041195300015015,350041195300015089,350041195300015122,350041195300015117,350041195300000013,350041195300000013,350041195300015096,350041195300000022,350041195300015011,350041195300015073,350041195300015055,350041195300000012,350041195300015071,350041195300000043,350041195300000133,350041195300000223,350041195300000143,350041195300000011,350041195300000037,350041195300000139,350041195300000177	0-830,0-828,0-828,0-828,0-828,0-819,0-705,0-828,0-339,0-168,0-626,0-567,0-576,0-576,0-515,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-570,0-576,0-576,0-576,0-575,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-575,0-576,0-576,0-576,0-576,0-54,0-446,0-183,0-141,0-45,0-366,0-366,0-366,0-348,0-348,0-183,0-183,0-168,0-162,0-93,0-78,0-183,0-183,0-61,0-61,0-183,0-122,0-81,0-57,0-147,0-61,0-75,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61						Co-stimulatory polypeptides	Punnonen	2006	0		
1082	chr1	65181797	65203746	3500119027	893		65181797	65203746	8421504	5	71,111,284,327,100	0,1266,7601,12777,21849	c,g	350011902700000148,350011902700000331,350011902700000325,350011902700000340,350011902700000150,350011902700000014,350011902700000220,350011902700000226,350011902700000334,350011902700000208,350011902700000328,350011902700000322,350011902700000212,350011902700000216,350011902700000343,350011902700000345,350011902700000354,350011902700000140,350011902700000054,350011902700000198,350011902700000162,350011902700000164,350011902700000168,350011902700000154,350011902700000156,350011902700000158,350011902700000026,350011902700000028,350011902700000224,350011902700000142,350011902700000146,350011902700000036,350011902700000034,350011902700000032,350011902700000030,350011902700000038,350011902700000138,350011902700000136,350011902700000134,350011902700000132,350011902700000200,350011902700000202,350011902700000042,350011902700000044,350011902700000048,350011902700000214,350011902700000218,350011902700000194,350011902700000196,350011902700000056,350011902700000188,350011902700000182,350011902700000172,350011902700000170,350011902700000176,350011902700000178,350011902700000023,350011902700000160,350011902700000186,350011902700000184,350011902700000144,350011902700000210,350011902700000174,350011902700000013,350011902700000013,350011902700000022,350011902700000012,350011902700000025,350011902700000327,350011902700000353,350011902700000342,350011902700000324,350011902700000157,350011902700000024,350011902700000027,350011902700000223,350011902700000221,350011902700000143,350011902700000338,350011902700000335,350011902700000011,350011902700000139,350011902700000133,350011902700000326,350011902700000041,350011902700000352,350011902700000215,350011902700000344,350011902700000187,350011902700000185,350011902700000171,350011902700000177	0-829,0-766,0-769,0-766,0-828,0-706,0-828,0-818,0-767,0-827,0-764,291-694,0-826,0-828,0-764,0-830,0-766,0-700,0-700,0-626,0-576,0-574,0-570,0-576,0-577,0-575,0-515,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-575,0-574,0-576,0-575,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-576,0-574,0-576,0-575,0-567,0-576,0-446,0-366,0-366,0-366,0-348,0-348,0-348,0-61,0-61,0-122,0-61,0-61,0-61,0-60,0-61,0-57,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-61,0-60,0-61,0-61						US Patent # 7,094,875. Co-stimulatory polypeptides - Patents.com	www.patents.com	0	0		
1082	chr1	65189534	65189577	3500262703	43		65189534	65189577	8421504	1	43	0	c	350026270300000101	5-48					Patent	CTLA4/CD28 ligands and uses therefor (Patent US:6084067)	Freeman	2000	0		
1082	chr1	65189534	65189577	3500116212	43		65189534	65189577	8421504	1	43	0	c	350011621200000121	5-48						US Patent # 6,824,779. Methods for inhibiting the interaction of B7-2 with its natural ligand - Patents.com	www.patents.com	0	0		
1082	chr1	65194833	65203746	3500318143	168		65194833	65203746	8421504	2	68,100	0,8813	p	350031814300015036	0-168						Novel tumor-associated antigens	Apt	2004	0		
1082	chr1	65218401	65218430	3500181609	25		65218401	65218430	8421504	3	12,7,6	0,13,23	c	350018160900000967	11-39						METHODS AND COMPOSITIONS FOR MODULATING T CELL AND/OR B CELL ACTIVATION - Patent application	www.faqs.org	0	0		
1084	chr1	65425215	65425241	3500378345	24		65425215	65425241	8421504	3	4,7,13	0,5,13	g	350037834500000009	14-44						Human insulin receptor endocytic code binding protein - US Patent 5504192 Description	ww.patentstorm.us	0	0		
1084	chr1	65510528	65513210	3500434074	43		65510528	65513210	8421504	3	24,9,10	0,45,2672	c	350043407400000001,350043407400000000	0-24,0-19		9770465	10.1073/pnas.95.21.12208	0027-8424	Proceedings of the National Academy of Sciences	Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction	Bertilsson	1998	10		NR1I2
1084	chr1	65510541	65513207	3500254727	48		65510541	65513207	8421504	2	41,7	0,2659	c	350025472700000045	0-48						Xenobiotic compound modulated expression systems and uses therefor - US Patent 6911537 Description	ww.patentstorm.us	0	0		
1084	chr1	65519411	65520613	3500077888	44		65519411	65520613	8421504	2	23,21	0,1181	c,g	350007788800000052,350007788800000052,350007788800000053,350007788800000053	0-23,0-23,0-21,0-21						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
135	chr1	65528908	65746845	3500412513	1296		65528908	65746845	8421504	12	62,99,187,39,96,98,107,131,111,84,194,88	0,16506,30715,33573,42627,65101,68780,73420,76788,101854,145459,217849	p	350041251300015001	0-1296						Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders	Haggarty	2011	0		
135	chr1	65528908	65746845	3500371866	1296		65528908	65746845	8421504	12	62,99,187,39,96,98,107,131,111,84,194,88	0,16506,30715,33573,42627,65101,68780,73420,76788,101854,145459,217849	p	350037186600015002	0-1296						Uses of chemicals to modulate gsk-3 signaling for treatment of bipolar disorder and other brain disorders	Haggarty	2010	0		
135	chr1	65528908	65746845	3500284067	1296		65528908	65746845	8421504	12	62,99,187,39,96,98,107,131,111,84,194,88	0,16506,30715,33573,42627,65101,68780,73420,76788,101854,145459,217849	p	350028406700015004	0-1296						USES OF CHEMICALS TO MODULATE GSK-3 SIGNALING FOR TREATMENT OF BIPOLAR DISORDER AND OTHER BRAIN DISORDERS - MASSACHUSETTS INSTITUTE OF TECHNOLOGY	www.sumobrain.com	0	0		
135	chr1	65528908	65746845	3500187135	1296		65528908	65746845	8421504	12	62,99,187,39,96,98,107,131,111,84,194,88	0,16506,30715,33573,42627,65101,68780,73420,76788,101854,145459,217849	p	350018713500015003	0-1296						Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders	Haggarty	2010	0		
135	chr1	65528908	65746791	3500220796	366		65528908	65746791	8421504	13	48,1,34,57,8,33,11,37,12,36,48,7,34	0,16604,30715,30788,42715,65101,65188,68780,101926,145459,145591,145646,217849	c	350022079600000157,350022079600000156,350022079600000130,350022079600000070,350022079600000098,350022079600000065,350022079600000063,350022079600000054,350022079600000051,350022079600000050	0-48,0-35,0-25,0-48,0-48,6-47,0-48,0-48,0-48,0-41						Detecting disease association with aberrant glycogen synthase kinase 3beta expression - Patent application	www.faqs.org	0	0		
1085	chr1	65545511	65630765	3500448099	738		65545511	65630765	8421504	9	2,187,3,96,98,107,131,111,3	0,14112,16970,26024,48498,52177,56817,60185,85251	p	350044809900015005	57-897						<HTML> <PRE> GENSCAN 1.0 Date run: 16-Jan-104 Time: 05:29:21 Sequence GSK3B_1 : 269380 bp : 37.17% 	ne.univ-paris5.fr	0	0		
1085	chr1	65559623	65562520	3500408772	38		65559623	65562520	8421504	2	19,19	0,2878	c,g	350040877200000003,350040877200000003,350040877200000002,350040877200000002	0-19,0-19,0-19,0-19						Glycogen synthase kinase-3 acts upstream of ADP-ribosylation factor 6 and Rac1 to regulate epithelial cell migration	ww.biochemweb.org	0	0		GSK3B
1085	chr1	65559624	65571540	3500294258	42		65559624	65571540	8421504	3	21,16,5	0,2880,11911	c	350029425800000006,350029425800000005	0-21,0-21		20356412	10.1186/1471-2334-10-86		BMC Infectious Diseases	Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases	Gui-Rong	2010	0		GSK3B
1085	chr1	65571535	65571595	3500197517	60		65571535	65571595	8421504	1	60	0	p	350019751700015037,350019751700015035,350019751700015034,350019751700015038	3-63,3-63,3-63,3-63						Isolation and characterization of TaGSK1 involved in wheat salt tolerance - ResearchGate	.researchgate.net	0	0		GSK3B
1085	chr1	65571607	65594036	3500182376	51		65571607	65594036	8421504	2	24,27	0,22402	p	350018237600015008,350018237600015010	9-60,9-60						MEANS AND METHODS FOR MEDIATING PROTEIN INTERFERENCE	Schymkowitz	2011	0		GSK3B
1085	chr1	65571607	65594036	3500098756	51		65571607	65594036	8421504	2	24,27	0,22402	p	350009875600015011,350009875600015009	9-60,9-60						MEANS AND METHODS FOR MEDIATING PROTEIN INTERFERENCE - Patent application	www.faqs.org	0	0		GSK3B
1085	chr1	65594023	65602418	3500324368	40		65594023	65602418	8421504	2	20,20	0,8375	c	350032436800000009,350032436800000008	0-20,0-20		22802352	10.1084/jem.20120225	0022-1007	The Journal of Experimental Medicine	Hematopoietic stem cell development requires transient Wnt/&#x03b2;-catenin activity	Ruiz-Herguido	2012	14		
1085	chr1	65594023	65602418	3500058456	40		65594023	65602418	8421504	2	20,20	0,8375	c	350005845600000009,350005845600000008	0-20,0-20						Hematopoietic stem cell development requires transient Wnt/&#x03b2;-catenin activity. - ResearchGate	.researchgate.net	0	0		
1085	chr1	65594071	65602418	3500152152	40		65594071	65602418	8421504	2	20,20	0,8327	c	350015215200000011,350015215200000010	0-20,0-20						Functional effect of mir-27b on myostatin expression: a relationship in piedmontese cattle with double-muscled phenotype	biomedcentral.com	0	0		GSK3B
1085	chr1	65602418	65605799	3500333278	47		65602418	65605799	8421504	2	24,23	0,3358	c,g	350033327800000005,350033327800000005,350033327800000004	0-24,0-24,0-23		23166798	10.1371/journal.pone.0049930		PLoS ONE	Sidestream Smoke Exposure Increases the Susceptibility of Airway Epithelia to Adenoviral Infection	Priyanka	2012	0		GSK3B
1085	chr1	65630815	65630838	3500279259	23		65630815	65630838	8421504	1	23	0	c,g	350027925900000001,350027925900000001,350027925900000006,350027925900000006	7-27,7-27,0-20,0-20						Mechanismen des rezeptorvermittelten Myokardschutzes nach akutem Herzinfarkt: Beteiligung von Adenosin-, &#x03b4;&#x03b4;&#x03b4;&#x03b4;-Opioidrezeptoren und GSK-3&#x03b2;&#x03b2;&#x03b2;&#x03b2; I n a u g u r a l d i s s e r t a t i o n	uni-greifswald.de	0	0		GSK3B
135	chr1	65630824	65674382	3500458797	37		65630824	65674382	8421504	2	22,15	0,43543	c	350045879700000002,350045879700000004	3-29,0-35						Expression characterization kinase-3 activity intact	www.pnas.org	0	0		
1086	chr1	65674469	65674541	3500369149	72		65674469	65674541	8421504	1	72	0	p	350036914900015001	0-72						Methods And Products Relating To Gsk3ss Regulation 	.freshpatents.com	0	0		GSK3B
1086	chr1	65746804	65746846	3500049054	42		65746804	65746846	8421504	1	42	0	c	350004905400000014,350004905400000013,350004905400000011	0-31,0-29,14-34						GSK3 Activity Modifies the Localization and Function of Presenilin 1--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
1086	chr1	65746819	65746845	3500331355	26		65746819	65746845	8421504	1	26	0	c	350033135500000005	0-26						Methods and compositions for the treatment of inflammatory diseases	Cahoon	2003	0		
1086	chr1	65746821	65746846	3500133590	25		65746821	65746846	8421504	1	25	0	c	350013359000000004	11-36						FACULTAD DE FARMACIA DEPARTAMENTO BIOQUAMICA Y BIOLOGAA MOLECULAR PROGRAMA DE DOCTORADO DE BIOQUA	www.tdx.cat	0	0		GPR156
1087	chr1	65848308	65848334	3500429779	23		65848308	65848334	8421504	2	10,13	0,13	c	350042977900000007	10-33						FGF21 MUTANTS AND USES THEREOF	Belouski	2012	0		
1087	chr1	65848308	65848334	3500383699	23		65848308	65848334	8421504	2	10,13	0,13	c	350038369900000007	10-33					Patent	FGF21 polypeptides comprising two or more mutations (Patent US:8034770)	Belouski	2011	0		
1087	chr1	65848308	65848334	3500362631	23		65848308	65848334	8421504	2	10,13	0,13	c	350036263100000007	10-33						FGF21 mutants and uses thereof	Belouski	2011	0		
1087	chr1	65848308	65848334	3500258757	23		65848308	65848334	8421504	2	10,13	0,13	c	350025875700000007	10-33						Fgf21 mutants and uses thereof	Belouski	2012	0		
1087	chr1	65848308	65848334	3500222185	23		65848308	65848334	8421504	2	10,13	0,13	c	350022218500000007	10-33					Patent	FGF21 mutants and uses thereof (Patent US:8410051)	Belouski	2013	0		
1087	chr1	65848308	65848334	3500218535	23		65848308	65848334	8421504	2	10,13	0,13	c	350021853500000007	10-33					Patent	Uses of FGF21 polypeptides comprising two or more mutations (Patent US:8361963)	Belouski	2013	0		
1087	chr1	65848308	65848334	3500218175	23		65848308	65848334	8421504	2	10,13	0,13	c	350021817500000007	10-33					Patent	FGF21 polypeptides comprising two or more mutations (Patent US:8034770)	Belouski	2011	0		
1087	chr1	65848308	65848334	3500193445	23		65848308	65848334	8421504	2	10,13	0,13	c	350019344500000007	10-33						FGF21 Mutants and uses thereof	Belouski	2009	0		
1087	chr1	65848308	65848334	3500111471	23		65848308	65848334	8421504	2	10,13	0,13	c	350011147100000008	10-33						Fgf21 mutants and uses thereof	Belouski	2012	0		
1087	chr1	65848308	65848334	3500110771	23		65848308	65848334	8421504	2	10,13	0,13	c	350011077100000007,350011077100000025	10-33,10-33						FGF21 Mutants and uses thereof - Patent application	www.faqs.org	0	0		
1087	chr1	65848308	65848334	3500086394	23		65848308	65848334	8421504	2	10,13	0,13	c	350008639400000007	10-33						Fgf21 mutants and uses thereof	Belouski	2012	0		
1087	chr1	65848308	65848334	3500085167	23		65848308	65848334	8421504	2	10,13	0,13	c	350008516700000007	10-33						FGF21 Mutants and uses thereof	Belouski	2009	0		
1087	chr1	65848308	65848334	3500017844	23		65848308	65848334	8421504	2	10,13	0,13	c	350001784400000025,350001784400000007	10-33,10-33						FGF21 MUTANTS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1087	chr1	65848308	65848334	3500010326	23		65848308	65848334	8421504	2	10,13	0,13	c	350001032600000007,350001032600000025	10-33,10-33						FGF21 MUTANTS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1087	chr1	65903965	65903994	3500425870	24		65903965	65903994	8421504	2	7,17	0,12	c	350042587000000083	0-24							w.bhdsyndrome.org	0	0		
1088	chr1	65981164	65981300	3500193635	129		65981164	65981300	8421504	4	107,6,7,9	0,108,115,127	g	350019363500000366	0-138						Materials and methods for immunocontraception	Harris	1993	0		
1093	chr1	66600318	66604141	3500239410	24		66600318	66604141	8421504	3	1,15,8	0,3799,3815	c	350023941000000000	20-44		19237543	10.1074/jbc.M808747200	0021-9258	Journal of Biological Chemistry	FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action	Shin	2009	5		
1097	chr1	67165914	67166779	3500085562	24		67165914	67166779	8421504	3	4,13,7	0,843,858	c	350008556200000331	15-39						Methods and compositions for assaying analytes	Yuan	1999	0		
137	chr1	67574168	67663305	3500458273	3543		67574168	67663305	8421504	22	278,350,26,22,48,96,48,96,96,48,48,144,9,39,37,203,48,167,48,48,48,1596	0,56321,56719,59182,59395,63773,63965,64061,64205,64349,64445,77980,78172,83796,83883,86138,86773,86869,87157,87349,87445,87541	c,g	350045827300000004,350045827300000005,350045827300000006,350045827300000008,350045827300000013,350045827300000018,350045827300000019,350045827300000022,350045827300000024,350045827300000025,350045827300000027,350045827300000028,350045827300000030,350045827300000032,350045827300000034,350045827300000035,350045827300000036,350045827300000038,350045827300000040,350045827300000041,350045827300000042,350045827300000043,350045827300000044,350045827300000054,350045827300000056,350045827300000057,350045827300000058,350045827300000129,350045827300000062,350045827300000066,350045827300000068,350045827300000070,350045827300000071,350045827300000072,350045827300000072,350045827300000073	0-532,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-32,0-48,0-48,0-48,0-48,0-48,0-51,0-51,0-1449						US Patent # 6,031,003. Calcium receptor-active molecules - Patents.com	www.patents.com	0	0		
137	chr1	67574168	67663305	3500340200	3678		67574168	67663305	8421504	23	278,350,26,22,48,93,3,96,48,96,96,48,48,144,9,78,37,203,167,96,48,48,1596	0,56321,56719,59182,59299,59395,63626,63773,63965,64061,64205,64349,64445,77980,78172,83796,83883,86138,86869,87157,87349,87445,87541	c,g	350034020000000004,350034020000000005,350034020000000006,350034020000000008,350034020000000011,350034020000000013,350034020000000014,350034020000000018,350034020000000019,350034020000000022,350034020000000024,350034020000000025,350034020000000027,350034020000000028,350034020000000030,350034020000000032,350034020000000034,350034020000000035,350034020000000036,350034020000000038,350034020000000178,350034020000000109,350034020000000040,350034020000000041,350034020000000042,350034020000000043,350034020000000044,350034020000000044,350034020000000056,350034020000000057,350034020000000058,350034020000000129,350034020000000062,350034020000000063,350034020000000066,350034020000000068,350034020000000070,350034020000000071,350034020000000072,350034020000000072,350034020000000073	0-532,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-32,0-48,0-48,0-48,0-48,0-48,0-48,0-51,0-51,0-1449					Patent	Calcium receptor-active molecules (Patent US:6031003)	Balandrin	2000	0		
137	chr1	67574168	67663305	3500202061	4032		67574168	67663305	8421504	23	278,350,26,22,48,48,48,96,96,96,192,48,233,39,37,203,48,96,192,96,96,48,1596	0,56321,56719,59182,59299,59395,63677,63773,63917,64061,64205,64445,77948,83796,83883,86138,86437,86629,86869,87157,87301,87445,87541	c,g	350020206100000004,350020206100000005,350020206100000006,350020206100000006,350020206100000008,350020206100000011,350020206100000013,350020206100000013,350020206100000016,350020206100000018,350020206100000018,350020206100000019,350020206100000019,350020206100000021,350020206100000022,350020206100000022,350020206100000024,350020206100000025,350020206100000027,350020206100000027,350020206100000028,350020206100000029,350020206100000030,350020206100000030,350020206100000032,350020206100000032,350020206100000033,350020206100000034,350020206100000034,350020206100000035,350020206100000035,350020206100000036,350020206100000037,350020206100000038,350020206100000040,350020206100000041,350020206100000041,350020206100000042,350020206100000042,350020206100000043,350020206100000043,350020206100000044,350020206100000044,350020206100000047,350020206100000051,350020206100000052,350020206100000056,350020206100000056,350020206100000057,350020206100000057,350020206100000058,350020206100000058,350020206100000267,350020206100000059,350020206100000062,350020206100000062,350020206100000063,350020206100000065,350020206100000066,350020206100000066,350020206100000068,350020206100000068,350020206100000070,350020206100000070,350020206100000071,350020206100000071,350020206100000072,350020206100000072,350020206100000073	0-532,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,16-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-51,0-51,0-1449						Calcium receptor-active molecules	Wagenen	1995	0		
137	chr1	67574168	67663305	3500024484	3702		67574168	67663305	8421504	24	278,350,26,22,48,93,3,96,48,96,96,48,48,144,9,78,37,203,47,144,96,48,48,1596	0,56321,56719,59182,59299,59395,63626,63773,63965,64061,64205,64349,64445,77980,78172,83796,83883,86138,86506,86869,87157,87349,87445,87541	c,g	350002448400000004,350002448400000005,350002448400000006,350002448400000008,350002448400000011,350002448400000013,350002448400000014,350002448400000018,350002448400000019,350002448400000022,350002448400000024,350002448400000025,350002448400000027,350002448400000028,350002448400000030,350002448400000032,350002448400000034,350002448400000035,350002448400000036,350002448400000038,350002448400000178,350002448400000109,350002448400000040,350002448400000041,350002448400000042,350002448400000043,350002448400000044,350002448400000188,350002448400000056,350002448400000057,350002448400000058,350002448400000062,350002448400000063,350002448400000066,350002448400000068,350002448400000070,350002448400000071,350002448400000072,350002448400000072,350002448400000073	0-532,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-51,0-51,0-1449						US Patent # 6,313,146. Calcium receptor-active molecules - Patents.com	www.patents.com	0	0		
137	chr1	67574168	67663295	3500225844	4536		67574168	67663295	8421504	20	278,367,26,22,189,243,69,240,144,201,124,338,102,22,48,345,96,48,48,1586	0,56321,56719,59182,59299,63626,63965,64061,64349,77980,83796,86138,86485,86602,86629,86764,87157,87349,87445,87541	c,g	350022584400000004,350022584400000005,350022584400000006,350022584400000076,350022584400000008,350022584400000011,350022584400000012,350022584400000013,350022584400000014,350022584400000084,350022584400000015,350022584400000016,350022584400000017,350022584400000226,350022584400000018,350022584400000019,350022584400000022,350022584400000092,350022584400000024,350022584400000025,350022584400000026,350022584400000027,350022584400000028,350022584400000030,350022584400000031,350022584400000032,350022584400000034,350022584400000035,350022584400000036,350022584400000037,350022584400000038,350022584400000178,350022584400000109,350022584400000039,350022584400000040,350022584400000041,350022584400000181,350022584400000042,350022584400000043,350022584400000044,350022584400000044,350022584400000045,350022584400000046,350022584400000255,350022584400000186,350022584400000117,350022584400000048,350022584400000119,350022584400000049,350022584400000258,350022584400000190,350022584400000051,350022584400000124,350022584400000054,350022584400000125,350022584400000055,350022584400000056,350022584400000057,350022584400000058,350022584400000059,350022584400000060,350022584400000062,350022584400000063,350022584400000066,350022584400000068,350022584400000070,350022584400000071,350022584400000072,350022584400000072,350022584400000073	0-532,0-48,0-48,0-44,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-22,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-51,0-51,0-1439						US Patent # 6,011,068. Calcium receptor-active molecules - Patents.com	www.patents.com	0	0		
137	chr1	67574168	67663295	3500186968	4656		67574168	67663295	8421504	18	278,424,70,189,24,309,96,96,162,231,124,203,96,336,144,144,48,1682	0,56321,59182,59299,63626,63725,64061,64205,64349,77950,83796,86138,86389,86506,86869,87157,87349,87445	c,g	350018696800000004,350018696800000005,350018696800000006,350018696800000076,350018696800000007,350018696800000008,350018696800000009,350018696800000011,350018696800000012,350018696800000013,350018696800000014,350018696800000084,350018696800000017,350018696800000018,350018696800000018,350018696800000019,350018696800000020,350018696800000021,350018696800000022,350018696800000092,350018696800000024,350018696800000025,350018696800000027,350018696800000028,350018696800000030,350018696800000031,350018696800000032,350018696800000033,350018696800000034,350018696800000035,350018696800000105,350018696800000036,350018696800000037,350018696800000038,350018696800000178,350018696800000109,350018696800000039,350018696800000040,350018696800000041,350018696800000042,350018696800000043,350018696800000044,350018696800000044,350018696800000046,350018696800000255,350018696800000117,350018696800000047,350018696800000188,350018696800000049,350018696800000120,350018696800000050,350018696800000051,350018696800000052,350018696800000053,350018696800000124,350018696800000054,350018696800000194,350018696800000056,350018696800000057,350018696800000058,350018696800000062,350018696800000063,350018696800000064,350018696800000066,350018696800000068,350018696800000069,350018696800000070,350018696800000071,350018696800000072,350018696800000072,350018696800000073	0-532,0-48,0-48,0-44,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-51,0-51,0-1439						Calcium receptor-active molecules	Nemeth	1994	0		
137	chr1	67630795	67638342	3500331841	89		67630795	67638342	8421504	4	21,23,24,21	0,2598,7116,7526	c	350033184100000000,350033184100000002,350033184100000001,350033184100000003	0-21,0-23,0-24,0-21						EXTRACELLULAR Ca2+ IN SKELETAL MYOGENIC CELLS	ll.physiology.org	0	0		CASR
137	chr1	67630795	67638342	3500173295	89		67630795	67638342	8421504	4	21,23,24,21	0,2598,7116,7526	c	350017329500000000,350017329500000002,350017329500000001,350017329500000003	0-21,0-23,0-24,0-21		12490436	10.1152/ajpcell.00237.2002		American Journal of Physiology - Cell Physiolog	Increase in cytosolic Ca2+ induced by elevation of extracellular Ca2+ in skeletal myogenic cells	Naro	2003	0		
137	chr1	67630815	67661599	3500292541	250		67630815	67661599	8421504	6	41,35,42,44,48,40	0,7451,7780,21405,29766,30744	c	350029254100000004,350029254100000022,350029254100000029,350029254100000033,350029254100000044,350029254100000064	0-41,13-48,6-48,0-44,0-48,0-40						CASR AGONISTS - Patent application	www.faqs.org	0	0		
137	chr1	67630824	67661310	3500326993	223		67630824	67661310	8421504	5	32,48,48,48,47	0,27164,29766,29862,30439	c	350032699300000010,350032699300000042,350032699300000269,350032699300000271,350032699300000283	0-32,0-48,0-48,0-48,1-48						Nucleic Acid, Polypeptide and Its Use - Patent application	www.faqs.org	0	0		
1101	chr1	67637851	67638181	3500227328	330		67637851	67638181	8421504	1	330	0	p	350022732800015006,350022732800015007	0-180,0-150						Musings of a Biologist and Dog Lover: Cats don't Prefer Sweets 	over.blogspot.com	0	0		CASR
1101	chr1	67637885	67637932	3500426745	47		67637885	67637932	8421504	1	47	0	c,g	350042674500000001,350042674500000001	50-97,50-97						Calcium receptor: Molecular cloning rat to	www.pnas.org	0	0		
1101	chr1	67637941	67661016	3500060331	309		67637941	67661016	8421504	4	72,45,48,144	0,22529,22865,22931	p,c,g	350006033100015002,350006033100015003,350006033100015005,350006033100015048,350006033100015049,350006033100015033,350006033100015044,350006033100000011,350006033100000007	0-69,0-66,48-93,90-138,3-141,0-102,3-105,85-114,5-34						Methods for raising pre-adult anadromous fish - US Patent 7121227 Description	ww.patentstorm.us	0	0		CASR
1101	chr1	67637941	67660869	3500412202	159		67637941	67660869	8421504	3	69,45,45	0,390,22883	p	350041220200015001,350041220200015003,350041220200015006	0-69,3-48,0-45						Calcium Receptor-active Molecules 	.freshpatents.com	0	0		
1101	chr1	67637941	67660869	3500355814	213		67637941	67660869	8421504	3	123,45,45	0,390,22883	p	350035581400015005,350035581400015006,350035581400015007,350035581400015010	0-69,0-57,3-48,0-45						Calcium receptor-active molecules	Brown	1995	0		
1101	chr1	67637941	67660869	3500342911	159		67637941	67660869	8421504	3	69,45,45	0,390,22883	p	350034291100015002,350034291100015004,350034291100015007	0-69,3-48,0-45						Calcium receptor-active molecules	Wagenen	2005	0		
1101	chr1	67637941	67638010	3500082725	69		67637941	67638010	8421504	1	69	0	p	350008272500015000	0-69		21969374	10.1074/jbc.M111.265454		The Journal of Biological Chemistry	Calcium-sensing Receptor Modulates Cell Adhesion and Migration via Integrins	Sujeenthar	2011	0		CASR
1101	chr1	67637941	67638007	3500294901	66		67637941	67638007	8421504	1	66	0	p	350029490100015000	0-66		9403564	10.1161/01.HYP.30.6.1431	0194-911X	Hypertension	Perivascular Sensory Nerve Ca2+ Receptor and Ca2+-Induced Relaxation of Isolated Arteries	Bukoski	1997	6		CASR
1101	chr1	67637941	67637998	3500256561	57		67637941	67637998	8421504	1	57	0	p	350025656100015000	0-57						THE CALCIUM-SENSING RECEPTOR MODULATES CELL ADHESION AND MIGRATION VIA INTEGRINS	www.jbc.org	0	0		CASR
1101	chr1	67637980	67638021	3500407806	41		67637980	67638021	8421504	1	41	0	c	350040780600000153	6-47						METHOD RELATING TO SWEETNESS ENHANCEMENT - Patent application	www.faqs.org	0	0		
1101	chr1	67658038	67661016	3500085792	40		67658038	67661016	8421504	2	20,20	0,2958	c	350008579200000000,350008579200000001	0-20,0-20		12039977	10.1097/01.ASN.0000015623.73739.B8	1046-6673	Journal of the American Society of Nephrology	Aminoglycosides Increase Intracellular Calcium Levels and ERK Activity in Proximal Tubular OK Cells Expressing the Extracellular Calcium-Sensing Receptor	Ward	2002	10		CASR
1101	chr1	67658041	67658065	3500079650	24		67658041	67658065	8421504	1	24	0	c	350007965000000001	0-24		23864702	10.1210/jc.2013-1834	0021-972X	Journal of Clinical Endocrinology & Metabolism	Decreased Transcriptional Activity of Calcium-sensing receptor Gene Promoter 1 Is Associated With Calcium Nephrolithiasis	Vezzoli	2013	6		
1101	chr1	67660500	67660524	3500185049	24		67660500	67660524	8421504	1	24	0	c	350018504900000001	4-28						Substituted pyrazolo[1,5-a]pyrimidines as calcium receptor modulating agents	Yasuma	2009	0		CASR
1101	chr1	67660692	67661310	3500385544	175		67660692	67661310	8421504	4	48,48,32,47	0,240,480,571	c	350038554400000069,350038554400000074,350038554400000079,350038554400000151	0-48,0-48,0-32,1-48						Chimeric metabotropic glutamate receptors and uses thereof	Gupta	2005	0		
1101	chr1	67661118	67661146	3500331692	28		67661118	67661146	8421504	1	28	0	c	350033169200000009	0-28						The Corpuscles of Stannius, Calcium-Sensing Receptor, and Stanniocalcin: Responses to Calcimimetics and Physiological Challenges	.endojournals.org	0	0		
1101	chr1	67661753	67661777	3500284747	24		67661753	67661777	8421504	1	24	0	c,g	350028474700000001,350028474700000001	0-24,0-24						 Free web based email address extractor from text 	www.skymem.com	0	0		
1101	chr1	67711594	67711619	3500467352	23		67711594	67711619	8421504	3	13,4,6	0,14,19	g	350046735200000153	16-39					Patent	Recombinant fowlpox virus S-FPV-043 and uses thereof (Patent US:6123949)	Cochran	2000	0		
1103	chr1	67945887	67946026	3500121860	42		67945887	67946026	8421504	2	21,21	0,118	c,g	350012186000000005,350012186000000005,350012186000000023,350012186000000023,350012186000000006	0-21,0-21,0-21,0-21,0-21		16207835	10.1095/biolreprod.105.046748	0006-3363	Biology of Reproduction	Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	Klein	2006	4		
1103	chr1	67945887	67946026	3500049790	42		67945887	67946026	8421504	2	21,21	0,118	c,g	350004979000000005,350004979000000005,350004979000000023,350004979000000023,350004979000000006	0-21,0-21,0-21,0-21,0-21						Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	ww.biolreprod.org	0	0		
1103	chr1	68000958	68007350	3500104392	24		68000958	68007350	8421504	2	18,6	0,6386	c	350010439200000050	6-30						&#x30b9;&#x30da;&#x30eb;&#x30df;&#x30b8;&#x30f3;&#x8f38;&#x9001;&#x7cfb;&#x306e;&#x89e3;&#x660e;&#x3068;&#x30b4;&#x30eb;&#x30b8;&#x4f53;&#x306b;&#x5bfe;&#x3059;&#x308b;&#x30dd;&#x30ea;&#x30a2;&#x30df;&#x30f3;&#x306e;&#x5f79;&#x5272;	ane.ll.chiba-u.jp	0	0		
1103	chr1	68014273	68014300	3500392358	23		68014273	68014300	8421504	2	13,10	0,17	c	350039235800000347	7-30						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
1103	chr1	68014273	68014300	3500004392	23		68014273	68014300	8421504	2	13,10	0,17	c	350000439200000347	7-30						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
1105	chr1	68258147	68258178	3500452209	24		68258147	68258178	8421504	3	7,12,5	0,12,26	g	350045220900000013	4-28						Anwendung der RNA-Interferenz zur Untersuchung von DPC4 und seinen Zielgenen	uhr-uni-bochum.de	0	0		
1107	chr1	68451481	68451504	3500243043	23		68451481	68451504	8421504	1	23	0	c	350024304300000129	17-40					Patent	Genomic screen for epigenetically silenced genes associated with cancer (Patent US:7794929)	Baylin	2010	0		PDIA5
1107	chr1	68451481	68451504	3500057503	23		68451481	68451504	8421504	1	23	0	c	350005750300000128	17-40						Genomic Screen for Epigenetically Silenced Genes Associated With Cancer	Baylin	2009	0		
1108	chr1	68618353	68618377	3500444540	23		68618353	68618377	8421504	2	8,15	0,9	c	350044454000000105	14-37						IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF	Reed	2008	0		
1108	chr1	68618353	68618377	3500007784	23		68618353	68618377	8421504	2	8,15	0,9	c	350000778400000276,350000778400000105	14-37,14-37						IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF - Patent application	www.faqs.org	0	0		
138	chr1	68618717	68684511	3500253777	2649		68618717	68684511	8421504	20	126,125,205,264,133,30,176,165,117,88,98,145,23,141,142,159,128,112,122,150	0,1861,5214,6454,11872,13038,15132,18498,19086,28964,32430,33781,35334,40261,42337,43306,45474,47131,61842,65644	p	350025377700015000	84-2733						KEGG T01001: 111	www.genome.jp	0	0		ADCY5
138	chr1	68618717	68684511	3500167164	2649		68618717	68684511	8421504	20	126,125,205,264,133,30,176,165,117,88,98,145,23,141,142,159,128,112,122,150	0,1861,5214,6454,11872,13038,15132,18498,19086,28964,32430,33781,35334,40261,42337,43306,45474,47131,61842,65644	p	350016716400015003	84-2733						KEGG T01001: 107	www.genome.jp	0	0		ADCY5
1108	chr1	68620587	68620647	3500463808	60		68620587	68620647	8421504	1	60	0	p	350046380800015029	0-60						Molecular Cloning and Characterization of a Ca2+/Calmodulin- Insensitive Adenylyl Cyclase from Rat Brain	www.jstor.org	0	0		
1108	chr1	68661072	68680579	3500142413	543		68661072	68680579	8421504	5	124,159,128,112,20	0,951,3119,4776,19487	p	350014241300015067,350014241300015062,350014241300015057,350014241300015052	0-45,0-186,0-144,0-168						Die Adenylatcyclase CyaB1 aus Anabaena sp. PCC 7120 ist ein cAMP-sensitives Protein	.uni-tuebingen.de	0	0		
1111	chr1	68948439	68954282	3500389626	60		68948439	68954282	8421504	2	42,18	0,5825	p	350038962600015001	0-60						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		MYLK
1111	chr1	68948472	68954321	3500439903	66		68948472	68954321	8421504	2	9,57	0,5792	p	350043990300015000	0-66		19541925	10.1152/ajpgi.00112.2009		American Journal of Physiology - Gastrointestinal and Liver Physiology	Ca2+-independent contraction of longitudinal ileal smooth muscle is potentiated by a zipper-interacting protein kinase pseudosubstrate peptide	Ihara	2009	0		MYLK
1111	chr1	68948472	68954321	3500077231	66		68948472	68954321	8421504	2	9,57	0,5792	p	350007723100015002	0-66		11278951	10.1074/jbc.M011634200	0021-9258	Journal of Biological Chemistry	Ca2+-independent Smooth Muscle Contraction	Deng	2001	5		MYLK
1111	chr1	68948472	68954321	3500042171	66		68948472	68954321	8421504	2	9,57	0,5792	p	350004217100015000	0-66		17215325	10.1152/ajpcell.00434.2006		American Journal of Physiology - Cell Physiolog	Inhibition of zipper-interacting protein kinase function in smooth muscle by a myosin light chain kinase pseudosubstrate peptide	Ihara	2007	0		MYLK
1111	chr1	68948472	68954321	3500022427	66		68948472	68954321	8421504	2	9,57	0,5792	p	350002242700015000	0-66		17215325	10.1152/ajpcell.00434.2006		American Journal of Physiology - Cell Physiolog	Inhibition of zipper-interacting protein kinase function in smooth muscle by a myosin light chain kinase pseudosubstrate peptide	Ihara	2007	0		MYLK
1111	chr1	68948472	68954321	3500000905	66		68948472	68954321	8421504	2	9,57	0,5792	p	350000090500015000	0-66		19541925	10.1152/ajpgi.00112.2009		American Journal of Physiology - Gastrointestinal and Liver Physiology	Ca2+-independent contraction of longitudinal ileal smooth muscle is potentiated by a zipper-interacting protein kinase pseudosubstrate peptide	Ihara	2009	0		MYLK
1111	chr1	68948478	68954306	3500130111	45		68948478	68954306	8421504	2	3,42	0,5786	p	350013011100015085	0-45						DAP-kinase related protein - Patent # 7026148 - PatentGenius	.patentgenius.com	0	0		MYLK
1111	chr1	68966962	68967129	3500347133	44		68966962	68967129	8421504	2	22,22	0,145	c,g	350034713300000017,350034713300000016,350034713300000016	0-22,0-22,0-22						Rho-Rho kinase pathway in the actomyosin contraction and cell- matrix adhesion in immortalized human trabecular meshwork cells	www.molvis.org	0	0		
1116	chr1	69667910	69667937	3500293073	23		69667910	69667937	8421504	2	13,10	0,17	g	350029307300000019,350029307300000018	9-32,4-27						Coagulation Factor VII polypeptides	Ostergaard	2006	0		
1116	chr1	69687582	69687611	3500361492	25		69687582	69687611	8421504	3	14,3,8	0,17,21	c	350036149200000068	0-25						Hcv Neutralizing Epitopes 	.freshpatents.com	0	0		
1116	chr1	69687582	69687611	3500144057	25		69687582	69687611	8421504	3	14,3,8	0,17,21	c	350014405700000052,350014405700000155	0-25,0-25						HCV neutralizing epitopes - Patent application	www.faqs.org	0	0		
1118	chr1	69901544	69933546	3500141481	765		69901544	69933546	8421504	11	63,110,40,27,90,93,112,59,9,102,60	0,626,15161,15204,17834,22306,27851,29781,29963,30401,31942	p	350014148100015004,350014148100015012,350014148100015021,350014148100015038	0-213,0-159,0-222,0-171						A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2	dlab.stanford.edu	0	0		KALRN
1119	chr1	70086426	70086452	3500145517	23		70086426	70086452	8421504	2	10,13	0,13	g	350014551700000013	3-26						Proteins and nucleic acids encoding same	Pena	2002	0		
1120	chr1	70173009	70173032	3500348821	23		70173009	70173032	8421504	1	23	0	c	350034882100000002	0-23						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa h&#x1ecd;c: "Screening for bovine leukocyte adhesion deficiency, deficiency of uridine monophosphate synthase, complex vertebral malformation, bovine citrullinaemia, and factor XI deficiency in Holstein cows reared in Tu	tailieu.vn/doc/ba	0	0		
1120	chr1	70173009	70173032	3500314956	23		70173009	70173032	8421504	1	23	0	c	350031495600000015	0-23						Jeld 1 Shomareh 1 Mojaleh-4	.joagribiotech.ir	0	0		
1120	chr1	70173009	70173032	3500287230	23		70173009	70173032	8421504	1	23	0	c	350028723000000000	0-23						No incidence of DUMPS carriers in Polish dairy cattle	www.docstoc.com	0	0		
1120	chr1	70173009	70173032	3500019942	23		70173009	70173032	8421504	1	23	0	c	350001994200000002	0-23						Identification of A lleles for Factor XI (FXID) and Uridine Monophosphate Synthase (DUMPS) Deficiencies in Holstein Cows Reared in Antalya [1]	rgi.kafkas.edu.tr	0	0		
1120	chr1	70218419	70219219	3500275013	171		70218419	70219219	8421504	2	93,78	0,722	p	350027501300015001	0-171					The Journal of Cell Biology	Enhancement of Endothelial Cell Migration and in Vitro Tube Formation by Tap20, a Novel &#x03b2;5 Integrin&#x2013;Modulating, Pkc&#x03b8;-Dependent Protein	Shaoqing	1999	0		ITGB5
1120	chr1	70218419	70219201	3500197411	144		70218419	70219201	8421504	3	30,54,60	0,39,722	p	350019741100015104	0-144						HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLAY	Arap	2011	0		ITGB5
1120	chr1	70218419	70219201	3500117014	126		70218419	70219201	8421504	4	30,21,15,60	0,39,78,722	p	350011701400015102,350011701400015101	12-63,0-75					Patent	Peptide compositions for targeting adipose tissue (Patent US:8067377)	Arap	2011	0		ITGB5
1120	chr1	70218419	70219201	3500056865	153		70218419	70219201	8421504	2	93,60	0,722	p	350005686500015004	0-153						Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin &#x03b2;1A	cs.biologists.org	0	0		ITGB5
1120	chr1	70226968	70248531	3500319127	40		70226968	70248531	8421504	2	20,20	0,21543	c,g	350031912700000039,350031912700000038,350031912700000038	0-20,0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
1122	chr1	70414168	70414195	3500309840	23		70414168	70414195	8421504	2	8,15	0,12	g	350030984000000799	15-38						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1123	chr1	70589651	70589678	3500074339	23		70589651	70589678	8421504	2	10,13	0,14	g	350007433900000027	16-45						NOVEL VARIANTS OF PQQ-DEPENDENT GLUCOSE DEHYDROGENASE HAVING IMPROVED SUBSTRATE SPECIFICITY - Patent application	www.faqs.org	0	0		
1124	chr1	70710080	70711337	3500430220	1257		70710080	70711337	8421504	1	1257	0	p	350043022000015261,350043022000015258,350043022000015255,350043022000015254,350043022000015253,350043022000015249,350043022000015247,350043022000015248,350043022000015246,350043022000015243	0-177,0-180,0-180,0-180,0-156,0-180,0-174,0-180,0-180,0-180						49 human secreted proteins	A	2000	0		ZNF148
140	chr1	70763573	70790289	3500204516	345		70763573	70790289	8421504	2	12,333	0,26383	p	350020451600015001,350020451600015000	0-345,0-306						Perl Bioinf 0411 PDF	www.scribd.com	0	0		ZNF148
1125	chr1	70790052	70790157	3500463168	105		70790052	70790157	8421504	1	105	0	p	350046316800015002	0-105						Mastering Perl for Bioinformatics	www.scribd.com	0	0		ZNF148
1125	chr1	70790173	70790200	3500106940	25		70790173	70790200	8421504	3	12,9,4	0,13,23	c	350010694000000018	5-30						Detection Of Target Molecules With Labeled Nucleic Acid Detection Molecules 	.freshpatents.com	0	0		
1125	chr1	70790263	70790290	3500253701	27		70790263	70790290	8421504	1	27	0	c	350025370100000002	8-35						Sumoylation-dependent Control of Homotypic and Heterotypic Synergy by the Kr&#xfc;ppel-type Zinc Finger Protein ZBP-89--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x	journal.9med.net	0	0		ZNF148
1125	chr1	70812476	70812501	3500437190	24		70812476	70812501	8421504	2	5,19	0,6	g	350043719000000009	6-30					Patent	Modified hemoglobin-like compounds and methods of purifying same (Patent US:6150506)	Anderson	2000	0		
1125	chr1	70812476	70812501	3500029219	24		70812476	70812501	8421504	2	5,19	0,6	g	350002921900000009	6-30						 Modified Hemoglobin 	www.docstoc.com	0	0		
1126	chr1	70988168	70988195	3500108605	24		70988168	70988195	8421504	2	18,6	0,21	c	350010860500000187,350010860500000236	11-35,14-38						Production of apomictic seed	De	1999	0		
1126	chr1	71001400	71001431	3500355951	24		71001400	71001431	8421504	3	13,6,5	0,17,26	g	350035595100000024	10-37						Novel Bacterial Proteins with Pesticidal Activity - Patent application	www.faqs.org	0	0		
1128	chr1	71223377	71224427	3500375699	193		71223377	71224427	8421504	3	142,45,6	0,363,1044	c	350037569900000024	0-193						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1130	chr1	71533546	71535335	3500188956	44		71533546	71535335	8421504	2	19,25	0,1764	g	350018895600000008,350018895600000006	0-19,36-61						Mucin biosynthesis in the bovine goblet cell induced by Cooperia oncophora infection. - ResearchGate	.researchgate.net	0	0		
1131	chr1	71653835	71653862	3500440545	27		71653835	71653862	8421504	1	27	0	g	350044054500000065	1-28						Constructs for gene expression analysis	Daly	2003	0		TFRC
1131	chr1	71655069	71655095	3500139708	26		71655069	71655095	8421504	1	26	0	c	350013970800000024	0-26						METHODS AND COMPOSITIONS FOR THE TREATMENT OF ERYTHROCYTE DISEASES - Patent application	www.faqs.org	0	0		
1131	chr1	71661200	71661446	3500198595	24		71661200	71661446	8421504	2	11,13	0,233	c	350019859500000027	16-40						Human Blood-Brain Barrier Endothelial Cells Derived From Pluripotent Stem Cells and Blood-Brain Barrier Model Thereof	Shusta	2011	0		TFRC
1131	chr1	71672875	71674269	3500447030	40		71672875	71674269	8421504	2	20,20	0,1374	c,g	350044703000000015,350044703000000014,350044703000000014	0-20,0-20,0-20						Evaluation of Internal Reference Genes for Quantitative Expression Analysis by Real-Time PCR in Ovine Whole Blood	www.mdpi.com	0	0		
1131	chr1	71675100	71675686	3500048635	48		71675100	71675686	8421504	2	12,36	0,550	p	350004863500015008	0-48						trans-Golgl	jcb.rupress.org	0	0		TFRC
1133	chr1	71834091	71834139	3500206555	48		71834091	71834139	8421504	1	48	0	p	350020655500015003	0-48						14-3-3 escorts CCT for calcium-activated nuclear import in lung epithelia	www.fasebj.org	0	0		PCYT1A
1133	chr1	71835216	71835242	3500431821	26		71835216	71835242	8421504	1	26	0	c	350043182100000018	0-26		17804406	10.1074/jbc.M706472200	0021-9258	Journal of Biological Chemistry	Calmodulin Binds and Stabilizes the Regulatory Enzyme, CTP:Phosphocholine Cytidylyltransferase	Chen	2007	5		
1135	chr1	72164068	72169090	3500376368	534		72164068	72169090	8421504	2	351,183	0,4839	p	350037636800015177	6-540						148 human secreted proteins	Brewer	1999	0		FBXO45
1135	chr1	72169062	72169094	3500287255	32		72169062	72169094	8421504	1	32	0	c	350028725500000001	8-40						PhD program in Biology Applied to Human Health &#x201c;BASU&#x201d;	e-roma3.caspur.it	0	0		
1137	chr1	72418063	72418643	3500250474	47		72418063	72418643	8421504	3	4,7,36	0,5,544	c	350025047400000027	0-47						USE OF p97 AND IRON BINDING PROTEINS AS DIAGNOSTIC AND THERAPEUTIC AGENTS	Food	1995	0		
1137	chr1	72418063	72418643	3500125123	48		72418063	72418643	8421504	2	12,36	0,544	c	350012512300000027	0-48					Patent	Use of p97 and iron binding proteins as diagnostic and therapeutic agents (Patent US:5981194)	Food	1999	0		
1137	chr1	72446624	72446651	3500267418	23		72446624	72446651	8421504	3	5,12,6	0,6,21	g	350026741800000003	8-33					Patent	Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen Chlamydia antigens, and respective DNA fragments and their uses (Patent DE:60037900)	DUNN	2009	0		
1141	chr1	72922620	72951223	3500299541	1032		72922620	72951223	8421504	6	470,153,142,111,73,83	0,1834,9141,21987,22777,28520	p	350029954100015001	0-1032						BMDB: Showing (R)-3-Hydroxybutyric acid (BMDB00011)	www.cowmetdb.ca	0	0		
1142	chr1	73027569	73027593	3500081530	24		73027569	73027593	8421504	1	24	0	c	350008153000000003	0-24						CAROLA TRINIDAD MELO ROJAS Dpto de Ciencia Animal y de los Alimentos UNIVERSIDAD AUT&#xd3;NOMA DE BARCELONA 2009	riunet.upv.es	0	0		
1142	chr1	73032810	73032837	3500195242	27		73032810	73032837	8421504	1	27	0	c	350019524200000002	0-29						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: "SOX9 transduction of a human chondrocytic cell line identifies novel genes regulated in primary human chondrocytes and in osteoarthritis" 	tailieu.vn/doc/ba	0	0		
1142	chr1	73050407	73050431	3500279401	24		73050407	73050431	8421504	1	24	0	g	350027940100000117	9-37						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1992	0		
142	chr1	73108217	73170449	3500391891	54		73108217	73170449	8421504	2	53,1	0,62231	p	350039189100015008	0-54						Crosstalk and Integration of Membrane Trafficking Pathways	www.scribd.com	0	0		MIR5692C1,ACAP2
1151	chr1	74287133	74289736	3500240006	123		74287133	74289736	8421504	2	66,57	0,2546	p	350024000600015095	0-123						Novel human proteins, polynucleotides encoding them and methods of using the same	Edinger	2002	0		
1153	chr1	74531360	74531386	3500249229	23		74531360	74531386	8421504	3	5,4,14	0,7,12	g	350024922900000006	10-33						Associations of platelet-activating factor acetylhydrolase with plasma Takeshi Kujiraoka*, Tadao Iwasaki*, Mitsuaki Ishihara*, Mayumi Ito*, Makoto	www.jlr.org	0	0		
1153	chr1	74560553	74560583	3500040785	30		74560553	74560583	8421504	1	30	0	c	350004078500000013,350004078500000133	12-42,12-42						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		
1153	chr1	74561274	74561401	3500054159	43		74561274	74561401	8421504	2	23,20	0,107	c,g	350005415900000001,350005415900000015,350005415900000015,350005415900000010,350005415900000010,350005415900000007,350005415900000007,350005415900000014,350005415900000014	18-41,0-21,0-21,0-19,0-19,0-19,0-19,0-20,0-20						METHOD FOR GENERATING ISLET BETA CELLS FROM DEDIFFERENTIATED EXOCRINE PANCREATIC CELLS - Patent application	www.faqs.org	0	0		
1153	chr1	74561290	74562694	3500428850	116		74561290	74562694	8421504	4	30,45,23,18	0,847,1223,1386	c	350042885000000012,350042885000000010,350042885000000002	15-45,0-45,0-41						Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split	enesdev.cshlp.org	0	0		
1153	chr1	74561375	74562724	3500361796	40		74561375	74562724	8421504	2	20,20	0,1329	c,g	350036179600000003,350036179600000003,350036179600000002,350036179600000002	0-20,0-20,0-20,0-20						OverexpressionoftheNOTCHligandJAG2inmalignantplasmacellsfrom multiplemyelomapatientsandcelllines	tologylibrary.org	0	0		HES1
1153	chr1	74561375	74562715	3500245483	40		74561375	74562715	8421504	2	20,20	0,1320	c,g	350024548300000006,350024548300000006,350024548300000005	0-20,0-20,0-20						Ubiquitin interacting motif peptides as cancer therapeutics	Dong	2012	0		
1153	chr1	74561376	74562730	3500208957	42		74561376	74562730	8421504	2	20,22	0,1332	c,g	350020895700000005,350020895700000005,350020895700000004,350020895700000004	0-20,0-20,0-22,0-22						TESIS DOCTORAL &#x201c;Papel de la Prote&#xed;na Adaptadora Numb en la Modulaci&#xf3;n de la Se&#xf1;al izaci&#xf3;n por TCR&#x201d;	hera.ugr.es	0	0		HES1
1153	chr1	74561381	74562732	3500423065	42		74561381	74562732	8421504	2	21,21	0,1330	c,g	350042306500000003,350042306500000003,350042306500000002,350042306500000002	0-21,0-21,0-21,0-21						Retinal ganglion cell-derived sonic hedgehog locally controls proliferation and the timing of RGC development in the embryonic mouse retina	ev.biologists.org	0	0		HES1
1153	chr1	74561381	74562732	3500354442	41		74561381	74562732	8421504	2	20,21	0,1330	c,g	350035444200000004,350035444200000004,350035444200000003,350035444200000003	0-20,0-20,0-21,0-21		20740684	10.1002/jbmr.227	1523-4681	Journal of Bone and Mineral Research	Inhibition of Notch1 signaling by Runx2 during osteoblast differentiation - Ann - 2011 - Journal of Bone and Mineral Research - Wiley Online Library	Ann	2011	0		HES1
1153	chr1	74561381	74562732	3500041773	41		74561381	74562732	8421504	2	20,21	0,1330	c,g	350004177300000004,350004177300000004,350004177300000003,350004177300000003	0-20,0-20,0-21,0-21						Tip60 Histone Acetyltransferase Acts as a Negative Regulator of Notch1 Signaling by Means of Acetylation	mcb.asm.org	0	0		
1153	chr1	74561383	74562686	3500431616	40		74561383	74562686	8421504	3	19,11,10	0,1142,1293	c	350043161600000005,350043161600000004	0-19,0-21						The Notch signaling inhibitor DAPT down-regulates cdk5 activity and modulates the distribution of neuronal cytoskeletal proteins. - ResearchGate	.researchgate.net	0	0		HES1
1153	chr1	74561383	74562168	3500263196	45		74561383	74562168	8421504	2	21,24	0,761	c	350026319600000011,350026319600000010	0-21,0-24		17234707	10.1210/en.2006-1553	0013-7227	Endocrinology	Characterization of Side Population in Thyroid Cancer Cell Lines: Cancer Stem-Like Cells Are Enriched Partly But Not Exclusively	Mitsutake	2007	4		
1153	chr1	74562150	74562174	3500238804	24		74562150	74562174	8421504	1	24	0	c	350023880400000002	0-24		19243219	10.1371/journal.pbio.1000039		PLoS Biology	Atonal homolog 1 Is a Tumor Suppressor Gene	WouBossuyt	2009	0		
1153	chr1	74562161	74562491	3500353322	90		74562161	74562491	8421504	3	42,3,45	0,279,285	p	350035332200015006,350035332200015005	0-45,0-45						Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor - Patent application	www.faqs.org	0	0		HES1
1153	chr1	74562472	74562717	3500367820	45		74562472	74562717	8421504	2	20,25	0,220	c	350036782000000017,350036782000000018	0-20,0-25						Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway	Condie	2004	0		
1153	chr1	74562472	74562711	3500460831	40		74562472	74562711	8421504	2	20,20	0,219	c	350046083100000003,350046083100000002	0-20,0-20						Plasmids. Mouse Dll4-Fc (Dll4-Fc), comprising the extracellular domain of murine	tologylibrary.org	0	0		HES1
1153	chr1	74562511	74562722	3500366020	44		74562511	74562722	8421504	2	24,20	0,191	c	350036602000000001,350036602000000000	0-24,0-20			10.1634/stemcells.2006-0170	1549-4918	STEM CELLS	Bone Marrow Transplantation Attenuates the Myopathic Phenotype of a Muscular Mouse Model of Spinal Muscular Atrophy - Salah-Mohellibi - 2006 - STEM CELLS - Wiley Online Library	Salah-Mohellibi	2006	0		
1153	chr1	74562519	74562688	3500339717	28		74562519	74562688	8421504	3	4,12,12	0,5,157	c	350033971700000010	0-28						Online Methods	s.ahajournals.org	0	0		
1153	chr1	74562521	74562715	3500136757	54		74562521	74562715	8421504	2	15,39	0,155	p	350013675700015001	0-54		19343206	10.1371/journal.pgen.1000443		PLoS Genetics	Combined In Silico and In Vivo Analyses Reveal Role of Hes1 in Taste Cell Differentiation	Masato	2009	0		HES1
1153	chr1	74562743	74562778	3500171669	35		74562743	74562778	8421504	1	35	0	c	350017166900000002	0-35						Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells	Levesque	2000	0		HES1
1155	chr1	74820602	74820630	3500232838	24		74820602	74820630	8421504	3	4,15,5	0,5,23	g	350023283800000001	5-29			10.1128/JVI.78.21.11841-11852.2004		Journal of Virology	Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging	Kun	2004	0		
1157	chr1	75024426	75024957	3500022279	54		75024426	75024957	8421504	2	17,37	0,494	p	350002227900015000	0-54						Antibody Review - Find the Best Antibodies	ntibodyreview.com	0	0		OPA1
1157	chr1	75052636	75052659	3500195594	23		75052636	75052659	8421504	1	23	0	c	350019559400000000	0-23						Accelerated Publication THE J B C	www.jbc.org	0	0		OPA1
1157	chr1	75055639	75055665	3500237380	23		75055639	75055665	8421504	2	8,15	0,11	g	350023738000000001	5-33						Biofuel production	Van	2011	0		
1157	chr1	75072023	75080881	3500330391	96		75072023	75080881	8421504	2	90,6	0,8852	p	350033039100015006	0-96		18419770	10.1111/j.1471-4159.2008.05401.x	1471-4159	Journal of Neurochemistry	Characterization of OPA1 isoforms isolated from mouse tissues - Akepati - 2008 - Journal of Neurochemistry - Wiley Online Library	Akepati	2008	0		OPA1
1162	chr1	75688230	75688256	3500378054	23		75688230	75688256	8421504	3	13,6,4	0,15,22	g	350037805400000129	22-45					Patent	17Q-linked breast and ovarian cancer susceptibility gene (Patent US:5747282)	Futreal	1998	0		
1163	chr1	75847208	75847250	3500419411	40		75847208	75847250	8421504	2	30,10	0,32	g	350041941100000027	7-47						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		
1165	chr1	76035193	76035216	3500227126	23		76035193	76035216	8421504	1	23	0	g	350022712600000028	8-41						Novel expressed sequence tag- simple sequence repeats (EST-SSR) markers characterized by new bioinformatic criteria reveal high genetic similarity in sugarcane ( Saccharum spp.) breeding lines	demicjournals.org	0	0		
18	chr1	76051791	76656915	3500321720	540		76051791	76656915	8421504	5	13,111,104,199,113	0,375391,411618,582030,605011	p	350032172000015012	0-540						KEGG T01001: 2246	www.genome.jp	0	0		
1166	chr1	76281468	76281497	3500115843	24		76281468	76281497	8421504	2	8,16	0,13	g	350011584300001715,350011584300000765	10-34,10-34						Methods And Compositions For Detecting Sars Virus And Other Infectious Agents 	.freshpatents.com	0	0		
1167	chr1	76394285	76394313	3500264869	23		76394285	76394313	8421504	2	6,17	0,11	g	350026486900000013	7-30						Jia Chang, Zhuo Wang, Eric Tang, Zhipeng Fan,Laurie McCauley, Renny Franceschi, Kunliang Guan, Paul H. Krebsbach, and Cun-Yu Wang	europepmc.org	0	0		
1168	chr1	76427241	76463498	3500213723	135		76427241	76463498	8421504	4	45,4,41,45	0,48,36168,36212	p	350021372300015036,350021372300015037,350021372300015039	0-45,0-45,0-45						Methods of Diagnosing Hypophosphatemic Disorders - Patent application	www.faqs.org	0	0		
1169	chr1	76633857	76633983	3500142509	120		76633857	76633983	8421504	3	45,45,30	0,48,96	p	350014250900015033,350014250900015034	0-45,0-75						Fibroblast growth factor (FGF23) polypeptides - US Patent 7745406 Description	ww.patentstorm.us	0	0		FGF12
1169	chr1	76633920	76656894	3500445910	192		76633920	76656894	8421504	2	100,92	0,22882	p	350044591000015091,350044591000015092,350044591000015093,350044591000015094	0-48,0-48,0-48,0-48						Human Fgf-23 Gene And Gene Expression Products 	.freshpatents.com	0	0		FGF12
1176	chr1	77512558	77512582	3500091413	24		77512558	77512582	8421504	1	24	0	c	350009141300000007	9-33						Osteocrin Is a Specific Ligand of the Natriuretic Peptide Clearance Receptor That Modulates Bone Growth--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#	journal.9med.net	0	0		
1182	chr1	78295231	78295271	3500435328	24		78295231	78295271	8421504	2	12,12	0,28	c	350043532800000057	1-25						Transgenic fungal resistant plants expressing chitinase and glucanase, process for obtaining, and recombinant polynucleotides for uses therein	Cornelissen	1997	0		RB1CC1
1182	chr1	78295480	78315606	3500288224	318		78295480	78315606	8421504	3	15,156,147	0,828,19979	p	350028822400015001	150-1092						&#xff08;&#x30d1;&#x30e9;&#x30bb;&#x30ea;&#x30f3;&#xff0d;&#xff11;&#x306e;&#x767a;&#x73fe;&#x306b;&#x5bfe;&#x3059;&#x308b;&#x98df;&#x5869;&#x6442;&#x53d6;&#x306e;&#x5f71;&#x97ff;&#x3068;&#x30d1;&#x30e9;&#x30bb;&#x30ea;&#x30f3;&#xff0d;&#xff11;&#x767a;&#x73fe	saltscience.or.jp	0	0		
1183	chr1	78420376	78420399	3500225200	23		78420376	78420399	8421504	1	23	0	c	350022520000000008	0-23						Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same	Bourner	2003	0		CLDN1
1183	chr1	78430324	78435043	3500095669	40		78430324	78435043	8421504	2	20,20	0,4699	c,g	350009566900000004,350009566900000004,350009566900000005	0-20,0-20,0-20		22234052	10.1186/1743-422X-9-11		Virology Journal	Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell	Sultan	2012	0		CLDN1
1183	chr1	78430324	78435043	3500088854	40		78430324	78435043	8421504	2	20,20	0,4699	c,g	350008885400000005,350008885400000005,350008885400000006	0-20,0-20,0-20						Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell. - ResearchGate	.researchgate.net	0	0		CLDN1
1183	chr1	78430324	78435043	3500040660	40		78430324	78435043	8421504	2	20,20	0,4699	c,g	350004066000000004,350004066000000004,350004066000000005	0-20,0-20,0-20						Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell	www.virologyj.com	0	0		CLDN1
1183	chr1	78435318	78435438	3500281920	44		78435318	78435438	8421504	2	23,21	0,99	c	350028192000000012,350028192000000013	0-23,0-21						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
1186	chr1	78836056	78836119	3500338637	63		78836056	78836119	8421504	1	63	0	p	350033863700015001	0-63		17562792	10.1083/jcb.200703003	0021-9525	The Journal of Cell Biology	C/EBP&#x03b4; regulates cell cycle and self-renewal of human limbal stem cells	Barbaro	2007	10		TP63
1186	chr1	78836056	78836119	3500313507	63		78836056	78836119	8421504	1	63	0	p	350031350700015000	0-63						CEBP Delta	www.scribd.com	0	0		TP63
1186	chr1	78836056	78836119	3500061009	63		78836056	78836119	8421504	1	63	0	p	350006100900015000	0-63						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		TP63
148	chr1	78836086	78934837	3500070460	362		78836086	78934837	8421504	9	42,48,48,30,18,38,47,47,44	0,3246,4954,20855,23329,25316,29965,98656,98707	c	350007046000000352,350007046000000050,350007046000000144,350007046000000137,350007046000000134,350007046000000125,350007046000000122,350007046000000121	6-48,0-48,0-48,0-48,0-38,0-47,0-47,0-44						CELL REGULATORY GENES, ENCODED PRODUCTS, AND USES RELATED THERETO - Patent application	www.faqs.org	0	0		
148	chr1	78836086	78934693	3500170460	166		78836086	78934693	8421504	7	42,22,26,24,5,38,9	0,3273,4880,7508,20748,30013,98598	c	350017046000000363,350017046000000157,350017046000000248,350017046000000334	6-48,0-48,0-29,0-47						US Patent # 6,946,256. Cell regulatory genes, encoded products, and uses related thereto - Patents.com	www.patents.com	0	0		
1186	chr1	78836136	78839372	3500265784	40		78836136	78839372	8421504	2	20,20	0,3216	c,g	350026578400000007,350026578400000006,350026578400000006	0-20,0-20,0-20						Proteomic analysis of epithelium-denuded human amniotic membrane as a limbal stem cell niche	www.molvis.org	0	0		TP63
1186	chr1	78843514	78843559	3500220725	45		78843514	78843559	8421504	1	45	0	c	350022072500000000,350022072500000001	0-44,0-45					Cell cycle (Georgetown, Tex.)	Homeodomain protein Dlx3 induces phosphorylation-dependent p63 degradation	Antonella	2009	0		
1186	chr1	78843606	78863458	3500007278	40		78843606	78863458	8421504	4	12,8,2,18	0,13228,18635,19834	c	350000727800000001,350000727800000000	0-20,0-20						Stony Brook University	yconnect.suny.edu	0	0		
1186	chr1	78856834	78861440	3500278591	47		78856834	78861440	8421504	2	24,23	0,4583	c	350027859100000003,350027859100000002	0-24,0-23		17114587	10.1101/gad.1463206	0890-9369	Genes & Development	p63 regulates proliferation and differentiation of developmentally mature keratinocytes	Truong	2006	12		TP63
1186	chr1	78856834	78861440	3500209459	47		78856834	78861440	8421504	2	24,23	0,4583	c	350020945900000003,350020945900000002	0-24,0-23			10.1101/gad.1463206		Genes & Development	p63 regulates proliferation and differentiation of developmentally mature keratinocytes	Amy	2006	0		TP63
1186	chr1	78861467	78863479	3500079966	180		78861467	78863479	8421504	3	31,110,39	0,666,1973	p	350007996600015006	0-180						What is Bioinformatics? Why Bioinformatics?	www.cis.fiu.edu	0	0		TP63
1186	chr1	78866006	78866045	3500060834	39		78866006	78866045	8421504	1	39	0	c	350006083400000190,350006083400000076	0-29,23-48						PURIFIED SR-P70 PROTEIN - Patent application	www.faqs.org	0	0		
1187	chr1	78907564	78907589	3500274896	23		78907564	78907589	8421504	3	4,4,15	0,5,10	g	350027489600000012	0-23						METHODS FOR PRODUCING ANTIBODY LIBRARIES USING UNIVERSAL OR RANDOMIZED IMMUNOGLOBULIN LIGHT CHAINS	Barbas	1995	0		
1187	chr1	78934874	78934898	3500306174	24		78934874	78934898	8421504	1	24	0	c	350030617400000016	18-42						EMT-INDUCING TRANSCRIPTION FACTORS COOPERATE WITH SOX9 - WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH	www.sumobrain.com	0	0		MIR944
1187	chr1	78934903	79006278	3500020627	102		78934903	79006278	8421504	2	36,66	0,71309	p	350002062700015004	78-180						DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation. - ResearchGate	.researchgate.net	0	0		
1187	chr1	78953759	78953785	3500114643	26		78953759	78953785	8421504	1	26	0	g	350011464300000007	0-26		17079275	10.1242/dev.02621	0950-1991	Development	&#x0394;Np63 plays an anti-apoptotic role in ventral bladder development	Cheng	2006	7		
1187	chr1	78954618	78954642	3500129820	24		78954618	78954642	8421504	1	24	0	g	350012982000000012	6-30		18198175	10.1074/jbc.M800183200	0021-9258	Journal of Biological Chemistry	Transcriptional Activity of the &#x0394;Np63 Promoter Is Regulated by STAT3	Chu	2008	5		
1187	chr1	79007867	79007892	3500056281	24		79007867	79007892	8421504	2	19,5	0,20	g	350005628100000003	2-26		16254338	10.1128/JVI.79.22.14031-14043.2005	0022-538X	Journal of Virology	The Vaccinia Virus F1L Protein Interacts with the Proapoptotic Protein Bak and Inhibits Bak Activation	Wasilenko	2005	5		
1188	chr1	79131908	79132463	3500119257	56		79131908	79132463	8421504	3	6,23,27	0,492,528	g	350011925700000007,350011925700000033	31-100,31-100						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
1194	chr1	79927739	79927767	3500055850	23		79927739	79927767	8421504	3	8,3,12	0,10,16	g	350005585000000027	5-28			10.1111/j.1365-2958.2006.05198.x	1365-2958	Molecular Microbiology	Bacillus subtilis Fnr senses oxygen via a [4Fe-4S] cluster coordinated by three cysteine residues without change in the oligomeric state - Reents - 2006 - Molecular Microbiology - Wiley Online Library	Reents	2006	0		
1195	chr1	79996192	79996215	3500343734	23		79996192	79996215	8421504	1	23	0	g	350034373400000607	4-27					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
1196	chr1	80186389	80186416	3500465825	24		80186389	80186416	8421504	2	11,13	0,14	g	350046582500000056	7-32						US Patent # 5,447,862. Pectin lyase genes of aspergillus niger - Patents.com	www.patents.com	0	0		
1199	chr1	80480583	80480640	3500377730	57		80480583	80480640	8421504	1	57	0	p	350037773000015001	6-63						Impact Journals presents	w.impactaging.com	0	0		LPP
1199	chr1	80480583	80480640	3500276077	57		80480583	80480640	8421504	1	57	0	p	350027607700015001	6-63						Impact Journals presents	w.impactaging.com	0	0		LPP
1199	chr1	80577028	80577056	3500127679	23		80577028	80577056	8421504	2	9,14	0,14	g	350012767900000210	5-28						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
1199	chr1	80603175	80603201	3500438028	23		80603175	80603201	8421504	2	17,6	0,20	g	350043802800000336	4-28						 Personal Care Compositions Comprising Modified Variant Bowman Birk Protease Inhibitors 	www.docstoc.com	0	0		
1201	chr1	80852496	80852531	3500351366	26		80852496	80852531	8421504	4	6,5,4,11	0,11,19,24	g	350035136600000120	18-44						Calcium-binding photoprotein, gene encoding the same, and use thereof - Patent application	www.faqs.org	0	0		
1203	chr1	81065425	81112956	3500224210	54		81065425	81112956	8421504	3	12,8,34	0,14,47497	g	350022421000000074,350022421000000036,350022421000000073	0-21,0-21,0-34						DNA MICROARRAY BASED IDENTIFICATION AND MAPPING OF BALANCED TRANSLOCATION BREAKPOINTS - Patent application	www.faqs.org	0	0		
1203	chr1	81120728	81120754	3500284936	23		81120728	81120754	8421504	2	6,17	0,9	g	350028493600000011,350028493600000010	0-23,16-39		10805736	10.1128/MCB.20.11.3928-3941.2000	0270-7306	Molecular and Cellular Biology	Neoplastic Transformation by Notch Requires Nuclear Localization	Jeffries	2000	6		
1203	chr1	81128755	81128778	3500126763	23		81128755	81128778	8421504	1	23	0	c	350012676300000000	0-23						BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia	.218.239.101:8082	0	0		
150	chr1	81132511	81136150	3500464707	40		81132511	81136150	8421504	2	20,20	0,3619	c	350046470700000002,350046470700000003	0-20,0-20		22766978	10.3892/ijo.2012.1545		International Journal of Oncology	Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide	YAWARA	2012	0		BCL6
150	chr1	81132511	81136150	3500386958	40		81132511	81136150	8421504	2	20,20	0,3619	c,g	350038695800000002,350038695800000003,350038695800000003	0-20,0-20,0-20						Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide	-publications.com	0	0		BCL6
150	chr1	81132523	81136161	3500282008	42		81132523	81136161	8421504	2	22,20	0,3618	c	350028200800000021,350028200800000022	0-22,0-20						Hypoxia-induced IL-18 Increases Hypoxia-inducible Factor-1 Expression through a Rac1-dependent NF- B Pathway	w.molbiolcell.org	0	0		BCL6
150	chr1	81132606	81136079	3500293636	25		81132606	81136079	8421504	2	4,21	0,3452	c	350029363600000000	0-25		23911289	10.1016/j.celrep.2013.06.016	2211-1247	Cell Reports	Cell Reports - A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters	Hatzi	2013	0		BCL6
150	chr1	81132606	81136079	3500228055	25		81132606	81136079	8421504	2	4,21	0,3452	c	350022805500000000	0-25		23911289	10.1016/j.celrep.2013.06.016	2211-1247	Cell Reports	Cell Reports - A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters	Hatzi	2013	0		BCL6
150	chr1	81132606	81136079	3500022814	25		81132606	81136079	8421504	2	4,21	0,3452	c	350002281400000000	0-25		23911289	10.1016/j.celrep.2013.06.016	2211-1247	Cell Reports	Cell Reports - A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters	Hatzi	2013	0		BCL6
1204	chr1	81183211	81186141	3500286339	2498		81183211	81186141	8421504	10	446,120,719,452,27,20,292,102,300,20	0,480,660,1439,1892,1955,2140,2470,2590,2910	c,g	350028633900000066,350028633900000068,350028633900000070,350028633900000017,350028633900000034,350028633900000033,350028633900000071,350028633900000073,350028633900000074,350028633900000036,350028633900000036,350028633900000035,350028633900000076,350028633900000077,350028633900000078,350028633900000080,350028633900000082,350028633900000037	0-446,0-120,0-600,0-20,0-20,0-20,0-120,0-452,0-27,0-20,0-20,0-20,0-22,0-246,0-21,0-102,0-300,0-20						QUANTITATIVE TRAIT LOCI MAPPING AND CANDIDATE GENE ANALYSIS	nces.missouri.edu	0	0		
1204	chr1	81184019	81185463	3500253152	595		81184019	81185463	8421504	4	66,170,350,9	0,74,1084,1435	c	350025315200000021	1-596						AN INTRODUCTION TO COMPUTATIONAL BIOCHEMISTRY - C Stan Tsai	www.docstoc.com	0	0		
1204	chr1	81184019	81185463	3500212806	595		81184019	81185463	8421504	4	66,170,350,9	0,74,1084,1435	c	350021280600000010	1-596						George Mason : BIOCHEMIST 1 : An Introduction to Computational Biochemistry Jeremy J. Ramsden	ww.coursehero.com	0	0		
1204	chr1	81184161	81185219	3500303959	42		81184161	81185219	8421504	2	21,21	0,1037	c	350030395900000004,350030395900000005	0-21,0-21						Diminished -cell mass in fetal sheep with intrauterine growth restriction	gu.physiology.org	0	0		
1204	chr1	81184161	81185219	3500212325	42		81184161	81185219	8421504	2	21,21	0,1037	c	350021232500000004,350021232500000005	0-21,0-21		15650129	10.1152/ajpregu.00494.2004		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Diminished &#x03b2;-cell replication contributes to reduced &#x03b2;-cell mass in fetal sheep with intrauterine growth restriction	Limesand	2005	0		
1204	chr1	81184217	81184244	3500194863	27		81184217	81184244	8421504	1	27	0	c	350019486300000044	0-27						Insulin-producing bone marrow derived cells and methods of generating and using same	Efrat	2004	0		
1204	chr1	81184262	81185127	3500412246	25		81184262	81185127	8421504	2	1,24	0,841	c	350041224600000000	17-42						Combined Expression of Pancreatic Duodenal Homeobox 1 and Islet Factor 1 Induces Immature Enterocytes to Produce Insulin	betesjournals.org	0	0		
1204	chr1	81184262	81185127	3500246273	25		81184262	81185127	8421504	2	1,24	0,841	c	350024627300000057	18-43						Methods and compositions for treatment of diabetes and related disorders	Newgard	2007	0		
1204	chr1	81184262	81185125	3500433861	23		81184262	81185125	8421504	2	1,22	0,841	c	350043386100000017	0-23						Ef&#xfb01;cientDifferentiationofMouseEmbryonic StemCellsintoInsulin-ProducingCells	loads.hindawi.com	0	0		
1204	chr1	81184262	81185125	3500420461	23		81184262	81185125	8421504	2	1,22	0,841	c	350042046100000009	0-23			10.1634/stemcells.22-6-1070	1549-4918	STEM CELLS	Adult Pancreas Generates Multipotent Stem Cells and Pancreatic and Nonpancreatic Progeny - Choi - 2004 - STEM CELLS - Wiley Online Library	Choi	2004	0		
1204	chr1	81184262	81185125	3500002250	23		81184262	81185125	8421504	2	1,22	0,841	c	350000225000000017	0-23						Efficient differentiation of mouse embryonic stem cells into insulin-producing cells. - ResearchGate	.researchgate.net	0	0		
1204	chr1	81185113	81185293	3500013804	44		81185113	81185293	8421504	2	22,22	0,158	c	350001380400000027,350001380400000028	0-22,0-22						DIFFERENTIATING INDUCED PLURIPOTENT STEM CELLS INTO GLUCOSE-RESPONSIVE, INSULIN-SECRETING PROGENY	Thatava	2012	0		
1204	chr1	81185127	81185289	3500181256	41		81185127	81185289	8421504	2	20,21	0,141	c,g	350018125600000018,350018125600000018,350018125600000019	0-20,0-20,0-21						PANCREATIC ISLET-LIKE CELLS	Winnier	2012	0		SST
1204	chr1	81185127	81185289	3500104220	41		81185127	81185289	8421504	2	20,21	0,141	c,g	350010422000000046,350010422000000046,350010422000000018,350010422000000018,350010422000000047,350010422000000047,350010422000000019,350010422000000019	0-20,0-20,0-20,0-20,0-21,0-21,0-21,0-21						PANCREATIC ISLET-LIKE CELLS - Patent application	www.faqs.org	0	0		SST
1204	chr1	81185127	81185288	3500303388	40		81185127	81185288	8421504	2	20,20	0,141	c	350030338800000002,350030338800000003	0-20,0-20						World J Gastroenterol	www.wjgnet.com	0	0		SST
1204	chr1	81185127	81185288	3500223194	40		81185127	81185288	8421504	2	20,20	0,141	c,g	350022319400000002,350022319400000002,350022319400000003	0-20,0-20,0-20						World J Gastroenterol	www.wjgnet.com	0	0		SST
1204	chr1	81185166	81185288	3500315071	40		81185166	81185288	8421504	2	20,20	0,102	c	350031507100000008,350031507100000009	0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1204	chr1	81185213	81185270	3500342863	57		81185213	81185270	8421504	1	57	0	p	350034286300015016	0-57							library.wiley.com	0	0		SST
1204	chr1	81185228	81185312	3500415613	84		81185228	81185312	8421504	1	84	0	p,c	350041561300015005,350041561300000007,350041561300000003	0-84,0-21,0-20						Somatostatins and methods	Sheridan	2000	0		
1204	chr1	81185228	81185312	3500369266	84		81185228	81185312	8421504	1	84	0	p	350036926600015003	0-84						&#x4f9b;&#x5e94;&#x5546;&#x5927;&#x5168;&#xff1a;79299-77-7&#x81f3;66735-62-4_&#x4f9b;&#x5e94;&#x5546;&#x76ee;&#x5f55; &#xff0d;&#x4e2d;&#x56fd;&#x5316;&#x5de5;&#x4f01;&#x4e1a;&#x8054;&#x76df;&#x4e13;&#x6ce8;&#x4e8e;&#x5316;&#x5de5;&#x4f01;&#x4e1a;&#x7f51;&	www.chem960.com	0	0		SST
1204	chr1	81185228	81185312	3500245815	84		81185228	81185312	8421504	1	84	0	p	350024581500015005	0-84						CAS&#x53f7;&#xff1a;79952-42-4&#x81f3;66895-33-8_&#x5316;&#x5de5;&#x5b57;&#x5178;,&#x5316;&#x5de5;&#x8bcd;&#x5178;,&#x5316;&#x5de5;&#x8f9e;&#x5178; &#xff0d;&#x4e2d;&#x56fd;&#x5316;&#x5de5;&#x4f01;&#x4e1a;&#x8054;&#x76df;&#x4e13;&#x6ce8;&#x4e8e;&#x5316;&#x5	www.chem960.com	0	0		SST
1204	chr1	81185228	81185312	3500082184	84		81185228	81185312	8421504	1	84	0	p	350008218400015014	0-84					Patent	Vector for expression and secretion of polypeptide microorganism transformed by the vector and production of polypeptide with the same microorganism (Patent US:5545564)	Kajifusa	1996	0		SST
1204	chr1	81185270	81185312	3500376822	42		81185270	81185312	8421504	1	42	0	c	350037682200000000	0-42						Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof	Mendelsohn	2009	0		
1204	chr1	81185270	81185312	3500007608	42		81185270	81185312	8421504	1	42	0	c	350000760800000000	0-42						CHLORAMPHENICOL ACETYL TRANSFERASE (CAT)-DEFECTIVE SOMATOSTATIN FUSION PROTEIN AND USES THEREOF	Mendelsohn	2008	0		
1207	chr1	81542186	81566479	3500343897	384		81542186	81566479	8421504	3	90,178,116	0,22373,24177	p	350034389700015005	0-384						CHIMERIC INHIBITOR MOLECULES OF COMPLEMENT ACTIVATION	Garred	2011	0		
1208	chr1	81733805	81733964	3500369966	70		81733805	81733964	8421504	2	27,43	0,116	c	350036996600000064,350036996600000110	21-48,0-43						Proteins having glycosyltransferase activity	Berger	1997	0		
1208	chr1	81733865	81769732	3500376668	588		81733865	81769732	8421504	5	149,175,99,98,67	0,2497,3887,25362,35800	p	350037666800015026,350037666800015003	0-276,0-312						comprehensive Analysis of sialyltransferases in Vertebrate Genomes	www.la-press.com	0	0		
1208	chr1	81736441	81736471	3500465560	30		81736441	81736471	8421504	1	30	0	c	350046556000000118	15-45						Sugar-chain synthetase and process for producing the same	Tsuji	1996	0		
1210	chr1	81952699	81967830	3500286339	7312		81952699	81967830	8421504	21	622,1309,897,625,573,118,106,8,78,1154,13,42,7,160,194,75,20,384,280,638,9	0,628,1940,2872,3524,4113,4278,4385,4394,4473,5628,5644,5690,13110,13316,13569,13741,13786,14190,14483,15122	g	350028633900000065,350028633900000064,350028633900000063,350028633900000025,350028633900000061,350028633900000059,350028633900000024,350028633900000057,350028633900000054,350028633900000053,350028633900000021,350028633900000051,350028633900000048,350028633900000019,350028633900000000,350028633900000042,350028633900000006,350028633900000040,350028633900000038	0-622,0-1309,0-897,0-20,0-625,0-573,0-20,0-118,0-1437,0-160,0-20,0-194,0-61,0-20,0-20,0-384,0-19,0-280,0-647						QUANTITATIVE TRAIT LOCI MAPPING AND CANDIDATE GENE ANALYSIS	nces.missouri.edu	0	0		
1210	chr1	81999511	81999534	3500427186	23		81999511	81999534	8421504	1	23	0	c	350042718600000085	19-42						PREDICTOR SETS FOR TYROSINE KINASE PATHWAYS - BRISTOL-MYERS SQUIBB COMPANY	www.sumobrain.com	0	0		RFC4
1210	chr1	82005501	82005528	3500256218	27		82005501	82005528	8421504	1	27	0	c	350025621800000114	0-27						REPRODUCTION	uction-online.org	0	0		
151	chr1	82050792	82071026	3500378421	198		82050792	82071026	8421504	4	45,57,48,48	0,3763,8230,20186	p	350037842100015211,350037842100015170,350037842100015217,350037842100015220	0-45,3-60,0-48,6-54						University of Southampton Research Repository ePrints Soton	rints.soton.ac.uk	0	0		
1211	chr1	82054490	82054590	3500058101	41		82054490	82054590	8421504	2	20,21	0,79	c	350005810100000000,350005810100000001	0-20,0-21						CARACTERIZA&#xc7;&#xc3;O DO SISTEMA CALICRE&#xcd;NA- CININA DURANTE O PROCESSO OVULAT&#xd3;RIO DE BOVINOS	cavel.cpd.ufsm.br	0	0		
1211	chr1	82072671	82072696	3500428283	25		82072671	82072696	8421504	1	25	0	c	350042828300000044	6-31						HIGHLY EFFECTIVE ANTI-CADHERIN ANTIBODY FOR INDUCTION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN VIVO - Patent application	www.faqs.org	0	0		
1211	chr1	82072671	82072696	3500305210	25		82072671	82072696	8421504	1	25	0	c	350030521000000040	9-34						METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-CDH3 ANTIBODIES - Patent application	www.faqs.org	0	0		
1211	chr1	82072671	82072696	3500154332	25		82072671	82072696	8421504	1	25	0	c	350015433200000044	6-31						HIGHLY EFFECTIVE ANTI-CADHERIN ANTIBODY FOR INDUCTION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN VIVO - Patent application	www.faqs.org	0	0		
1211	chr1	82072679	82072748	3500240162	69		82072679	82072748	8421504	1	69	0	p	350024016200015009,350024016200015050	36-105,0-45						SOLUBILITY TAGS FOR THE EXPRESSION AND PURIFICATION OF BIOACTIVE PEPTIDES - Patent application	www.faqs.org	0	0		
1211	chr1	82072679	82072748	3500197065	69		82072679	82072748	8421504	1	69	0	p	350019706500015010	24-93						Solubility tags for the expression and purification of bioactive peptides	Cheng	2010	0		
1211	chr1	82072679	82072748	3500066992	69		82072679	82072748	8421504	1	69	0	p	350006699200015009,350006699200015050	36-105,0-45						SOLUBILITY TAGS FOR THE EXPRESSION AND PURIFICATION OF BIOACTIVE PEPTIDES - Patent application	www.faqs.org	0	0		
1211	chr1	82072694	82072748	3500108962	54		82072694	82072748	8421504	1	54	0	p	350010896200015180,350010896200015168	0-45,0-45						PEPTIDES HAVING AFFINITY FOR BODY SURFACES - Patent application	www.faqs.org	0	0		
1211	chr1	82153409	82160365	3500378421	1497		82153409	82160365	8421504	7	686,87,102,164,85,111,262	0,1315,2260,3545,4075,4479,6694	p,c,g	350037842100000062,350037842100000051,350037842100000051,350037842100000026,350037842100000010,350037842100015029,350037842100000050,350037842100000050,350037842100015064,350037842100015015,350037842100015122,350037842100000049,350037842100015028,350037842100015062,350037842100000048,350037842100000048,350037842100015027,350037842100015043,350037842100000023,350037842100015014,350037842100000047,350037842100000047,350037842100015026,350037842100015013,350037842100000022,350037842100000005,350037842100000059,350037842100015042,350037842100000045,350037842100015024,350037842100015057,350037842100015144,350037842100000044,350037842100000044,350037842100015023,350037842100015011,350037842100000020,350037842100000057,350037842100015055,350037842100000006,350037842100000046,350037842100000046,350037842100000056,350037842100015025,350037842100000019,350037842100015040,350037842100015137,350037842100015135,350037842100000043,350037842100015010,350037842100000055,350037842100000018,350037842100015038,350037842100015074,350037842100015136,350037842100000042,350037842100000017,350037842100000054,350037842100015035,350037842100000016	0-436,0-357,0-357,0-120,0-29,0-120,0-120,0-120,0-48,0-120,126-186,0-120,0-120,0-114,0-120,0-120,0-111,6-126,0-67,0-63,0-120,0-120,0-108,0-120,0-121,0-65,0-120,0-108,0-121,366-477,0-126,0-57,0-120,0-120,0-105,0-105,0-104,0-120,126-561,17-40,0-114,0-114,0-120,0-75,0-114,360-468,0-81,12-81,0-120,0-120,0-120,0-120,3-72,57-123,0-63,1-99,13-118,13-120,0-45,0-26						University of Southampton Research Repository ePrints Soton	rints.soton.ac.uk	0	0		
1211	chr1	82153409	82160316	3500175287	1016		82153409	82160316	8421504	10	545,36,12,42,102,14,82,18,30,135	0,1366,2260,2320,3545,3695,4075,4572,6694,6772	c,g	350017528700000028,350017528700000028,350017528700000027,350017528700000027,350017528700000026,350017528700000025,350017528700000024,350017528700000019,350017528700000017,350017528700000016,350017528700000015,350017528700000013,350017528700000012,350017528700000009,350017528700000007,350017528700000006,350017528700000005	0-348,0-348,0-53,0-53,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-39					Patent	Methods and constructs for protein expression (Patent US:6051401)	Chan	2000	0		
1211	chr1	82153793	82153930	3500248474	40		82153793	82153930	8421504	2	20,20	0,117	c,g	350024847400000041,350024847400000041,350024847400000040,350024847400000040	0-20,0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
1212	chr1	82185676	82199382	3500277012	927		82185676	82199382	8421504	9	62,160,112,58,83,143,133,98,78	0,518,901,1990,2905,3740,5552,7993,13628	p	350027701200015069	0-927						Vectors and yeast strains for protein production	Bobrowicz	2010	0		DNAJB11
1212	chr1	82185676	82199382	3500221916	927		82185676	82199382	8421504	9	62,160,112,58,83,143,133,98,78	0,518,901,1990,2905,3740,5552,7993,13628	p	350022191600015071	0-927						VECTORS AND YEAST STRAINS FOR PROTEIN PRODUCTION	Choi	2009	0		DNAJB11
1212	chr1	82189508	82189553	3500419636	45		82189508	82189553	8421504	1	45	0	p	350041963600015001	0-45					Patent	Methods and means for inducing apoptosis by interfering with Bip-like proteins (Patent US:6472142)	Noteborn	2002	0		DNAJB11
1212	chr1	82234470	82234494	3500364659	23		82234470	82234494	8421504	2	13,10	0,14	g	350036465900000000,350036465900000036	1-32,1-32						Recombinant vector for deleting specific regions of chromosome and method for deleting specific chromosomal regions of chromosome in the microorganism using the same - Patent application	www.faqs.org	0	0		
1213	chr1	82397409	82397434	3500341139	23		82397409	82397434	8421504	3	4,14,5	0,5,20	g	350034113900000213	7-30						Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 - Patent application	www.faqs.org	0	0		
1215	chr1	82680486	82680509	3500049915	23		82680486	82680509	8421504	1	23	0	c	350004991500000025	20-43						Trehalose transporter gene and method of introducing trehalose into cells - Patent application	www.faqs.org	0	0		
1216	chr1	82830297	82830330	3500130191	33		82830297	82830330	8421504	1	33	0	c	350013019100000157	0-33						Function of Splicing factor Tra2-beta1 in Alternative Splicing and Translation	b.uni-erlangen.de	0	0		
18	chr1	82830302	82849458	3500016511	45		82830302	82849458	8421504	3	24,10,11	0,18657,19145	c,g	350001651100000034,350001651100000034,350001651100000035	0-24,0-24,0-21						Spinal Muscular Atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences	Singh	2005	0		TRA2B
18	chr1	82830303	82849457	3500306201	830		82830303	82849457	8421504	11	36,90,26,109,39,189,116,84,58,73,10	0,11318,11426,12506,12630,13991,16049,16471,17763,18593,19144	p,c	350030620100015031,350030620100015032,350030620100015033,350030620100015008,350030620100000065	0-126,0-135,0-561,0-60,28-49						Signal dependency of Tra2-beta1 alternative splicing	b.uni-erlangen.de	0	0		
1217	chr1	82943916	82943943	3500323428	27		82943916	82943943	8421504	1	27	0	c	350032342800000006	10-37						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		
152	chr1	83080174	83113627	3500323428	46		83080174	83113627	8421504	2	21,25	0,33428	c	350032342800000032,350032342800000007	0-21,15-40						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		IGF2BP2
1219	chr1	83101337	83105924	3500404324	60		83101337	83105924	8421504	2	3,57	0,4530	p	350040432400015045	0-60						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER - Patent application	www.faqs.org	0	0		IGF2BP2
1219	chr1	83101337	83105924	3500247743	60		83101337	83105924	8421504	2	3,57	0,4530	p	350024774300015019	0-60						Compositions and methods for the therapy and diagnosis of lung cancer	Foy	2003	0		IGF2BP2
1219	chr1	83101337	83105924	3500196583	60		83101337	83105924	8421504	2	3,57	0,4530	p	350019658300015059	0-60						Compositions and methods for the therapy and diagnosis of lung cancer	Wang	2006	0		IGF2BP2
1219	chr1	83101337	83105924	3500087105	60		83101337	83105924	8421504	2	3,57	0,4530	p	350008710500015057	0-60						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER - Patent application	www.faqs.org	0	0		IGF2BP2
1219	chr1	83101337	83105924	3500024144	60		83101337	83105924	8421504	2	3,57	0,4530	p	350002414400015048	0-60						 Methods For The Detection Of Cervical Cancer 	www.docstoc.com	0	0		IGF2BP2
1219	chr1	83129373	83141008	3500313215	234		83129373	83141008	8421504	5	36,57,10,80,51	0,1658,8104,10442,11584	p	350031321500015056	0-234						A TALE OF THREE PHYTOPATHOGENS: IMPACT OF TRANSPOSABLE ELEMENTS ON GENOME EVOLUTION by KOMAL VADNAGARA Presented to the Faculty of the Graduate School of The University of Texas at Arlington in Partial Fulfillment of the Requirements for the Degree of MAS	dspace.uta.edu	0	0		SENP2
1219	chr1	83141157	83142386	3500132606	32		83141157	83142386	8421504	4	4,10,11,7	0,1194,1209,1222	c	350013260600000101	13-48						 Ostertagia Vaccine 	www.docstoc.com	0	0		
1220	chr1	83261681	83277640	3500245468	41		83261681	83277640	8421504	2	20,21	0,15938	c	350024546800000352,350024546800000389	25-45,19-40						Inhibition Of Cancer Metastasis 	.freshpatents.com	0	0		
1225	chr1	83973335	83973364	3500266812	29		83973335	83973364	8421504	1	29	0	g	350026681200000102	10-39					Patent	Production of odd chain fatty acid derivatives in recombinant microbial cells (Patent US:8372610)	Lee	2013	0		
1226	chr1	84102770	84102798	3500340855	23		84102770	84102798	8421504	2	16,7	0,21	g	350034085500000001	1-32		17167031	10.1124/mol.106.030254	1521-0111 (Online)	Molecular Pharmacology	Amino-Pyrrolidine Tricarboxylic Acids Give New Insight into Group III Metabotropic Glutamate Receptor Activation Mechanism	Frauli	2007	0		
1227	chr1	84155955	84156069	3500295373	23		84155955	84156069	8421504	3	16,6,1	0,17,113	c	350029537300000113	14-37					Patent	Polypeptides having kinase activity, their preparation and use (Patent US:5824492)	Dhand	1998	0		
1227	chr1	84155955	84156069	3500193936	23		84155955	84156069	8421504	3	16,6,1	0,17,113	c	350019393600000113	14-37						Polypeptides having kinase activity, their preparation and use	Hiles	1994	0		EPHB3
1227	chr1	84155955	84156069	3500152577	23		84155955	84156069	8421504	3	16,6,1	0,17,113	c	350015257700000103	8-31						US Patent # 7,422,849. Method for determining expression of a PI3 kinase gene - Patents.com	www.patents.com	0	0		EPHB3
1227	chr1	84156181	84164688	3500438553	137		84156181	84164688	8421504	5	42,2,29,45,19	0,320,433,8279,8488	c	350043855300000405,350043855300000043,350043855300000235,350043855300000003	6-48,16-47,0-45,24-43						Eph-related tyrosine kinases, nucleotide sequences and methods of use	Pasquale	1993	0		
1227	chr1	84156677	84156700	3500032480	23		84156677	84156700	8421504	1	23	0	g	350003248000000339	0-23						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments - US Patent 7964349 Description	ww.patentstorm.us	0	0		
1227	chr1	84156689	84156731	3500036421	42		84156689	84156731	8421504	1	42	0	c,g	350003642100000076,350003642100000076	6-48,6-48						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
1227	chr1	84164391	84175117	3500376096	516		84164391	84175117	8421504	3	444,65,7	0,1538,10719	p	350037609600015060,350037609600015054,350037609600015048,350037609600015042	0-111,0-123,0-141,0-141						Eph receptor ligands and methods of use	Pasquale	2010	0		EPHB3
1228	chr1	84361849	84366006	3500428366	84		84361849	84366006	8421504	5	11,11,27,14,21	0,249,350,666,4136	c	350042836600000096,350042836600000064,350042836600000075	0-22,0-41,27-48						Mpl ligand analogs	Elliott	1997	0		
1228	chr1	84361849	84362111	3500158942	24		84361849	84362111	8421504	2	11,13	0,249	c	350015894200000011,350015894200000002	0-24,0-24						CATTLE BETA-CASEIN GENE TARGETING VECTOR USING HOMOLOGOUS RECOMBINATION - Patent application	www.faqs.org	0	0		
1228	chr1	84362148	84362208	3500300794	60		84362148	84362208	8421504	1	60	0	p,c,g	350030079400015004,350030079400015006,350030079400000001,350030079400000009,350030079400000003,350030079400000003,350030079400000005,350030079400000005,350030079400000008,350030079400000008,350030079400000010,350030079400000010	0-60,0-60,12-50,12-50,15-50,15-50,15-51,15-51,15-51,15-51,15-51,15-51						Porcine mpl ligand - Patent # 6660256 - PatentGenius	.patentgenius.com	0	0		
1228	chr1	84362148	84362208	3500083848	60		84362148	84362208	8421504	1	60	0	p,c,g	350008384800015004,350008384800015007,350008384800000009,350008384800000001,350008384800000008,350008384800000008,350008384800000010,350008384800000010,350008384800000003,350008384800000003,350008384800000005,350008384800000005	0-60,0-60,12-50,12-50,15-51,15-51,15-51,15-51,15-50,15-50,15-51,15-51						Porcine mpl ligand	Eaton	1994	0		
1228	chr1	84362148	84362208	3500026625	60		84362148	84362208	8421504	1	60	0	p,c,g	350002662500015001,350002662500000004,350002662500000006,350002662500000006	0-60,12-50,15-51,15-51						Monoclonal antibody to human thrombopoietin	Eaton	1995	0		
1228	chr1	84362186	84366033	3500436843	198		84362186	84366033	8421504	5	40,14,27,69,48	0,329,3283,3526,3799	c	350043684300000060,350043684300000039,350043684300000066,350043684300000044,350043684300000067,350043684300000049,350043684300000070	20-48,0-41,0-48,0-48,0-48,27-48,0-40						US Patent # 5,766,581. Method for treating mammals with monopegylated proteins that stimulates megakaryocyte growth and differentiation - Patents.com	www.patents.com	0	0		
1228	chr1	84362186	84366033	3500397827	211		84362186	84366033	8421504	5	28,27,69,39,48	0,3283,3526,3697,3799	c	350039782700000103,350039782700000067,350039782700000109,350039782700000074,350039782700000110,350039782700000077,350039782700000100,350039782700000079,350039782700000113	20-48,23-48,0-48,0-47,0-48,9-48,12-51,15-48,0-40						Composition for stimulating megacaryocyte growth and differentiation and process thereof	T*D*Ba Li 	2001	0		
1228	chr1	84362186	84366033	3500164756	240		84362186	84366033	8421504	7	25,27,69,27,5,39,48	0,3283,3526,3651,3681,3697,3799	c	350016475600000034,350016475600000076,350016475600000041,350016475600000077,350016475600000043,350016475600000044,350016475600000046,350016475600000080	23-48,0-48,0-47,0-48,11-43,9-48,15-48,0-40						Compositions and methods for stimulating megakaryocyte growth and differentiation	Bartley	1997	0		
1228	chr1	84362186	84365796	3500048499	91		84362186	84365796	8421504	3	40,3,48	0,329,3562	c	350004849900000078,350004849900000037,350004849900000085	5-48,20-49,0-48						Protein having TPO activity	Akahori	1995	0		
1228	chr1	84365466	84365730	3500396213	48		84365466	84365730	8421504	2	30,18	0,246	c	350039621300000059	0-48					Patent	Composition for stimulating megacaryocyte growth and differentiation and process thereof (Patent CN:1229385)	T*D*Ba Li 	2005	0		
1228	chr1	84365489	84365742	3500386819	37		84365489	84365742	8421504	2	7,30	0,223	c	350038681900000054,350038681900000053	11-30,8-27						Multi-functional chimeric hematopoietic receptor agonists	Feng	1998	0		
1228	chr1	84365733	84365781	3500385036	48		84365733	84365781	8421504	1	48	0	c	350038503600000110	0-48						Compositions and methods for stimulating megakaryocyte growth and differentiation	T*D*Ba Li 	1996	0		
1228	chr1	84375385	84389715	3500286627	2700		84375385	84389715	8421504	24	72,157,132,129,134,78,79,126,85,102,85,156,70,111,214,134,173,115,74,60,39,105,87,183	0,2294,3275,3750,3970,4210,4378,4554,4782,4956,5846,6067,6611,6915,7251,7777,8151,8453,8742,9045,9250,9457,13925,14147	p	350028662700015000	0-2700						KEGG T01008: 505569	www.genome.jp	0	0		
1228	chr1	84379486	84389356	3500015872	69		84379486	84389356	8421504	4	3,18,24,24	0,109,5372,9846	c	350001587200000015,350001587200000014,350001587200000000,350001587200000007	0-21,0-19,0-24,0-24		17873007	10.1152/ajplung.00121.2007		American Journal of Physiology - Lung Cellular and Molecular Physiology	Involvement of chloride channels in TGF-&#x03b2;1-induced apoptosis of human bronchial epithelial cells	Cheng	2007	0		
1228	chr1	84380385	84382010	3500316180	39		84380385	84382010	8421504	3	19,6,14	0,1217,1611	c	350031618000000002,350031618000000003	0-19,0-20		12604647	10.1095/biolreprod.102.007088	0006-3363	Biology of Reproduction	Amino Acid-Permeable Anion Channels in Early Mouse Embryos and Their Possible Effects on Cleavage	Sonoda	2003	4		CLCN2
1228	chr1	84393557	84394015	3500053081	70		84393557	84394015	8421504	3	22,25,23	0,101,435	c	350005308100000055,350005308100000052,350005308100000053	0-22,0-25,0-23						GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO - Patent 2050335	data.epo.org	0	0		FAM131A
1229	chr1	84441947	84471757	3500237513	363		84441947	84471757	8421504	5	69,99,48,128,19	0,24890,24995,25046,29791	p	350023751300015124,350023751300015122,350023751300015118,350023751300015116	0-69,0-150,0-174,0-99						50 human secreted proteins	Komatsoulis	2000	0		
1229	chr1	84447540	84467002	3500123865	142		84447540	84467002	8421504	10	12,12,8,16,16,6,21,4,22,25	0,3950,4008,4165,4296,4427,5196,5427,6286,19437	c	350012386500000000,350012386500000001,350012386500000002,350012386500000005,350012386500000004,350012386500000003	0-24,0-24,0-22,0-25,0-22,0-25						Molecular isolation and characterization of novel four subisoforms of ECE-2. - ResearchGate	.researchgate.net	0	0		
1229	chr1	84463195	84464292	3500333485	40		84463195	84464292	8421504	2	20,20	0,1077	c,g	350033348500000002,350033348500000002,350033348500000003,350033348500000003	0-20,0-20,0-20,0-20						Genome wide array analysis indicates that an amyotrophic lateral sclerosis mutation of FUS causes an early increase of CAMK2N2 in vitro. - ResearchGate	.researchgate.net	0	0		CAMK2N2
1231	chr1	84748614	84758563	3500254537	40		84748614	84758563	8421504	2	20,20	0,9929	c,g	350025453700000018,350025453700000018,350025453700000036	20-40,20-40,24-44						Nuclear Factor (Erythroid 2-like) Factor 2 (Nrf2) as Cellular Protector in Bile Acid and Retinoid Toxicities	brary.utoronto.ca	0	0		
1231	chr1	84751869	84751894	3500230241	25		84751869	84751894	8421504	1	25	0	c	350023024100000012	0-25						In Vitro Models of the Blood-Brain Barrier: Applications and Evaluation of a New Human Immortalized Brain Capillary Endothelial Cell Line	edoc.unibas.ch	0	0		
1232	chr1	84887130	84911757	3500362636	492		84887130	84911757	8421504	5	64,150,71,98,109	0,632,8207,22180,24518	p	350036263600015042	0-495						Isolated human vCOL16A1 polypeptide and fragments thereof	Bejanin	2001	0		
1233	chr1	85062865	85062894	3500055591	24		85062865	85062894	8421504	2	7,17	0,12	g	350005559100000000	0-24			10.1128/AEM.71.2.930-939.2005		Applied and Environmental Microbiology	Genomic and Phylogenetic Characterization of Luminous Bacteria Symbiotic with the Deep-Sea Fish Chlorophthalmus albatrossis (Aulopiformes: Chlorophthalmidae)	Paul	2005	0		
1237	chr1	85471264	85471291	3500318788	24		85471264	85471291	8421504	2	14,10	0,17	c	350031878800000130	0-24						Nematode Control 	.freshpatents.com	0	0		
1237	chr1	85471264	85471291	3500259202	24		85471264	85471291	8421504	2	14,10	0,17	c	350025920200000158	0-24						Nematode Control	Craen	2010	0		
1238	chr1	85644351	85644396	3500433857	45		85644351	85644396	8421504	1	45	0	p	350043385700015026	0-45						US Patent # 6,268,550. Methods and a maize acetyl CoA carboxylase gene for altering the oil content of plants - Patents.com	www.patents.com	0	0		MCCC1
1238	chr1	85644351	85644396	3500174459	45		85644351	85644396	8421504	1	45	0	p	350017445900015032	0-45						Methods for expressing a maize acetyl CoA carboxylase gene in host cells and encoded protein produced thereby	Gengenbach	1996	0		MCCC1
1238	chr1	85700920	85700945	3500392738	24		85700920	85700945	8421504	2	18,6	0,19	g	350039273800000067	13-37						Immunodeficiency virus recombinant poxvirus vaccine	Cox	1992	0		
1238	chr1	85700920	85700945	3500383486	24		85700920	85700945	8421504	2	18,6	0,19	g	350038348600000111	13-37						 NYVAC Vaccinia Virus Recombinants Comprising Heterologous Inserts 	www.docstoc.com	0	0		
1238	chr1	85700920	85700945	3500215539	24		85700920	85700945	8421504	2	18,6	0,19	g	350021553900000111	13-37					Patent	NYVAC vaccinia virus recombinants comprising heterologous inserts (Patent US:5494807)	Audonnet	1996	0		
1240	chr1	85931156	85931181	3500202328	24		85931156	85931181	8421504	2	10,14	0,11	g	350020232800000010	6-30			10.1046/j.1365-313x.1998.00305.x	1365-313X	The Plant Journal	Molecular characterization of higher plant NAD-dependent isocitrate dehydrogenase: evidence for a heteromeric structure by the complementation of yeast mutants - Lancien - 2008 - The Plant Journal - Wiley Online Library	Lancien	1998	0		
1248	chr1	86955689	86959127	3500120757	76		86955689	86959127	8421504	3	30,25,21	0,2885,3417	c,g	350012075700000051,350012075700000001,350012075700000011,350012075700000011	0-30,0-25,0-21,0-21						Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor	Ikushima	2012	0		
1248	chr1	86956590	86972201	3500418632	39		86956590	86972201	8421504	2	19,20	0,15591	g	350041863200000005,350041863200000004	0-19,0-20			10.1038/onc.2013.67	0950-9232	Oncogene	Snail depletes the tumorigenic potential of glioblastoma	Savary	2013	6		SOX2
1248	chr1	86957802	86958162	3500219497	40		86957802	86958162	8421504	2	20,20	0,340	g	350021949700000005,350021949700000004	0-20,0-20						Oct4 expression in in vitro-produced sheep blastocysts and embryonic-stem-like cells	w.cellbiolint.org	0	0		
1248	chr1	86957802	86958162	3500081681	40		86957802	86958162	8421504	2	20,20	0,340	g	350008168100000005,350008168100000004	0-20,0-20						Oct4 expression in in vitro-produced sheep blastocysts and embryonic-stem-like cells	.all-portland.net	0	0		
1248	chr1	86957817	86957931	3500280137	40		86957817	86957931	8421504	2	20,20	0,94	g	350028013700000023,350028013700000022	0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
1248	chr1	86958322	86958346	3500277529	24		86958322	86958346	8421504	1	24	0	g	350027752900000097	0-24						CELLS AND METHODS FOR OBTAINING THEM	Liu	2010	0		
1248	chr1	86958512	86959480	3500175345	43		86958512	86959480	8421504	2	21,22	0,946	c,g	350017534500000013,350017534500000013,350017534500000012	10-31,10-31,10-32						Genetically Intact Induced Pluripotent Cells Or Transdifferentiated Cells And Methods For The Production Thereof	Klimanskaya	2010	0		
1248	chr1	86958512	86959480	3500043198	43		86958512	86959480	8421504	2	21,22	0,946	c	350004319800000013,350004319800000031,350004319800000012,350004319800000030	10-31,10-31,10-32,10-32						Genetically Intact Induced Pluripotent Cells Or Transdifferentiated Cells And Methods For The Production Thereof - Patent application	www.faqs.org	0	0		
1248	chr1	86958512	86959479	3500127346	91		86958512	86959479	8421504	4	25,21,21,24	0,301,477,943	c,g	350012734600000005,350012734600000015,350012734600000015,350012734600000014,350012734600000004	8-33,0-21,0-21,0-21,9-33						Generation of an HVS-based Episomally Maintained Gene Delivery System for Reprogramming Adult Somatic Cells	s.whiterose.ac.uk	0	0		SOX2
1248	chr1	86958513	86959543	3500432740	123		86958513	86959543	8421504	4	40,27,29,27	0,484,941,1003	c	350043274000000012,350043274000000010,350043274000000112,350043274000000114,350043274000000032,350043274000000130,350043274000000009,350043274000000111,350043274000000113,350043274000000011,350043274000000007,350043274000000109	45-85,1-24,1-24,45-85,0-27,0-27,1-26,1-26,7-32,7-32,0-27,0-27						METHOD FOR PRODUCTION OF REPROGRAMMED CELL USING CHROMOSOMALLY UNINTEGRATED VIRUS VECTOR - Patent application	www.faqs.org	0	0		SOX2
1248	chr1	86958513	86959480	3500115142	54		86958513	86959480	8421504	2	26,28	0,939	c	350011514200000003,350011514200000002	0-26,3-31						Efficient Production And Use Of Highly Cardiogenic Progenitors And Cardiomyocytes From Embryonic And Induced Pluripotent Stem Cells 	.freshpatents.com	0	0		SOX2
1248	chr1	86958513	86959479	3500463766	954		86958513	86959479	8421504	3	885,11,58	0,888,908	c	350046376600000012	0-954						SOMATIC CELL REPROGRAMMING - Patent application	www.faqs.org	0	0		SOX2
1248	chr1	86958513	86959479	3500301886	954		86958513	86959479	8421504	3	885,11,58	0,888,908	c	350030188600000006	0-954						METHOD FOR INDUCING PLURIPOTENCY IN CELLS - Patent application	www.faqs.org	0	0		SOX2
1248	chr1	86958513	86959479	3500282811	48		86958513	86959479	8421504	2	24,24	0,942	c,g	350028281100000005,350028281100000005,350028281100000004	0-24,0-24,0-24						Canine iPS cells and method of producing same	Nakamura	2011	0		SOX2
1248	chr1	86958513	86959479	3500157275	46		86958513	86959479	8421504	2	24,22	0,944	c,g	350015727500000005,350015727500000005,350015727500000004,350015727500000004	0-24,0-24,0-22,0-22						CANINE iPS CELLS AND METHOD OF PRODUCING SAME	Nakamura	2010	0		SOX2
1248	chr1	86958513	86959024	3500179831	67		86958513	86959024	8421504	2	40,27	0,484	c	350017983100000026,350017983100000050	45-85,0-27						Composition for inducing pluripotent stem cell, and use thereof	Ban	2012	0		SOX2
1248	chr1	86958513	86958593	3500060159	50		86958513	86958593	8421504	2	26,24	0,56	c	350006015900000043,350006015900000152,350006015900000042	0-26,0-26,0-24						METHOD OF EFFICIENTLY ESTABLISHING INDUCED PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		
1248	chr1	86958516	86959480	3500032096	71		86958516	86959480	8421504	3	25,20,26	0,737,938	c	350003209600000001,350003209600000022,350003209600000000	0-25,0-20,2-28						A Dominant-negative Form of Mouse SOX2 Induces Trophectoderm Differentiation and Progressive Polyploidy in Mouse Embryonic Stem Cells--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x905	journal.9med.net	0	0		
1248	chr1	86958516	86959479	3500385366	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p	350038536600015017,350038536600015029,350038536600015026	0-951,0-549,0-204						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		SOX2
1248	chr1	86958516	86959479	3500330278	921		86958516	86959479	8421504	9	69,51,72,267,162,150,81,15,54	0,72,129,213,483,648,801,885,909	p,c	350033027800015005,350033027800015004,350033027800015003,350033027800000014	0-120,0-72,0-729,0-22						METHOD FOR INDUCING PLURIPOTENCY IN HUMAN SOMATIC CELLS WITH PRDM14 OR NFRKB - AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH	www.sumobrain.com	0	0		SOX2
1248	chr1	86958516	86959479	3500321901	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p,c	350032190100015017,350032190100000022,350032190100015024,350032190100015025	0-951,0-20,0-204,0-549						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		SOX2
1248	chr1	86958516	86959479	3500312550	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p	350031255000015001	0-951						Recombinant Human Sox2-11R Protein	w.ldbiopharma.com	0	0		SOX2
1248	chr1	86958516	86959479	3500295400	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p,c	350029540000015017,350029540000000022,350029540000015024,350029540000015025	0-948,0-20,0-204,0-549						Multipotent/pluripotent cells and methods	Sakurada	2010	0		SOX2
1248	chr1	86958516	86959479	3500283192	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p,c	350028319200015017,350028319200000022,350028319200015025,350028319200015024	0-951,0-20,0-549,0-204						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		SOX2
1248	chr1	86958516	86959479	3500282644	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p,c	350028264400015017,350028264400000022,350028264400015024,350028264400015023	0-951,0-20,0-549,0-204					Patent	Induced pluripotent stem cells produced using reprogramming factors and a rho kinase inhibitor or a histone deacetylase inhibitor (Patent US:8211697)	Ishikawa	2012	0		SOX2
1248	chr1	86958516	86959479	3500273416	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p	350027341600015017,350027341600015029,350027341600015026	0-951,0-549,0-204						Multipotent/pluripotent cells and methods	Ishikawa	2009	0		SOX2
1248	chr1	86958516	86959479	3500230063	870		86958516	86959479	8421504	5	675,57,69,15,54	0,681,813,885,909	p	350023006300015007,350023006300015006,350023006300015004	0-675,0-57,0-138						Method for rejuvenating cells	LAPASSET	2012	0		SOX2
1248	chr1	86958516	86959479	3500128563	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p	350012856300015017,350012856300015029,350012856300015026	0-951,0-549,0-204						MULTIPOTENT/PLURIPOTENT CELLS AND METHODS - IZUMI BIO, INC	www.sumobrain.com	0	0		SOX2
1248	chr1	86958516	86959479	3500127647	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p,c	350012764700015017,350012764700000022,350012764700015023,350012764700015024	0-951,0-20,0-204,0-549						Multipotent/pluripotent cells and methods	Ishikawa	2009	0		SOX2
1248	chr1	86958516	86959479	3500071780	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p	350007178000015030,350007178000015029,350007178000015028,350007178000015061,350007178000015053,350007178000015026,350007178000015060,350007178000015025,350007178000015031,350007178000015023	0-126,0-171,0-162,0-57,0-174,0-162,0-171,0-168,0-165,0-162						&#x591a;&#x80fd;&#x7ec6;&#x80de;/&#x591a;&#x6f5c;&#x80fd;&#x7ec6;&#x80de;&#x53ca;&#x65b9;&#x6cd5;	Ying Tian [?] Yang 	2012	0		SOX2
1248	chr1	86958516	86959479	3500025784	951		86958516	86959479	8421504	3	882,15,54	0,885,909	p,c	350002578400015017,350002578400000022,350002578400015024,350002578400015025	0-951,0-20,0-204,0-549						Multipotent/Pluripotent Cells and Methods	Ishikawa	2009	0		SOX2
1248	chr1	86958516	86958551	3500439109	35		86958516	86958551	8421504	1	35	0	c	350043910900000008,350043910900000059	55-90,55-90						SINGLE LENTIVIRAL VECTOR SYSTEM FOR INDUCED PLURIPOTENT (IPS) STEM CELLS DERIVATION - Patent application	www.faqs.org	0	0		
1248	chr1	86958528	86958552	3500383465	24		86958528	86958552	8421504	1	24	0	c	350038346500000001	0-24							olecularbrain.com	0	0		SOX2
1248	chr1	86958529	86958598	3500308493	39		86958529	86958598	8421504	2	19,20	0,49	c,g	350030849300000007,350030849300000007,350030849300000006,350030849300000006	0-19,0-19,0-20,0-20		21717460	10.1002/ijc.26271	1097-0215	International Journal of Cancer	Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer - Arima - 2011 - International Journal of Cancer - Wiley Online Library	Arima	2012	0		SOX2
1248	chr1	86958529	86958598	3500226878	39		86958529	86958598	8421504	2	19,20	0,49	c,g	350022687800000007,350022687800000007,350022687800000006	0-19,0-19,0-20						Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer. - ResearchGate	.researchgate.net	0	0		SOX2
1248	chr1	86958567	86958963	3500007804	43		86958567	86958963	8421504	2	22,21	0,375	c	350000780400000015,350000780400000014	0-22,0-21						RETINAL PIGMENT EPITHELIAL STEM CELLS	Temple	2009	0		TMEM65
1248	chr1	86958568	86958603	3500166168	35		86958568	86958603	8421504	1	35	0	c	350016616800000015,350016616800000007	0-20,0-19						VITRO HEPATIC DIFFERENTIATION	Vallier	2011	0		SOX2
1248	chr1	86958570	86959386	3500432629	282		86958570	86959386	8421504	5	45,93,48,48,48	0,288,528,624,768	p,c,g	350043262900015076,350043262900000050,350043262900015062,350043262900000045,350043262900000045,350043262900000043,350043262900000040,350043262900015044	0-45,0-48,0-45,0-48,0-48,0-48,0-48,0-45						CANINE iPS CELLS AND METHOD OF PRODUCING SAME - Patent application	www.faqs.org	0	0		
1248	chr1	86958570	86959287	3500382422	306		86958570	86959287	8421504	3	132,87,87	0,315,630	p	350038242200015093,350038242200015088,350038242200015082	0-132,0-87,0-87						 Integration 	www.docstoc.com	0	0		SOX2
1248	chr1	86958576	86959334	3500276182	41		86958576	86959334	8421504	2	21,20	0,738	c	350027618200000003,350027618200000015	0-21,0-20						METHODS OF ISOLATING AND USING STEM CELLS	Huang	2009	0		SOX2
1248	chr1	86958588	86958639	3500342863	51		86958588	86958639	8421504	1	51	0	p	350034286300015103	0-51							library.wiley.com	0	0		SOX2
1248	chr1	86958683	86959479	3500248431	54		86958683	86959479	8421504	2	23,31	0,765	c	350024843100000000,350024843100000013	0-23,0-31		19376775	10.1074/jbc.M109.008938	0021-9258	Journal of Biological Chemistry	Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig	Esteban	2009	5		
1248	chr1	86958683	86959479	3500057234	54		86958683	86959479	8421504	2	23,31	0,765	c	350005723400000000,350005723400000013	0-23,0-31						GenerationofInducedPluripotentStemCellLinesfrom TibetanMiniaturePig	www.jbc.org	0	0		
1248	chr1	86958683	86959479	3500001753	54		86958683	86959479	8421504	2	23,31	0,765	c	350000175300000000,350000175300000013	0-23,0-31		19376775	10.1074/jbc.M109.008938		The Journal of Biological Chemistry	Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig	MiguA.	June	0		
1248	chr1	86958690	86958842	3500328799	38		86958690	86958842	8421504	2	19,19	0,133	c,g	350032879900000005,350032879900000036,350032879900000036	0-19,0-19,0-19						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
1248	chr1	86958693	86959377	3500184951	40		86958693	86959377	8421504	2	20,20	0,664	c,g	350018495100000005,350018495100000005,350018495100000004	0-20,0-20,0-20		21325692	10.1095/biolreprod.109.082792	0006-3363	Biology of Reproduction	Rat Blastocyst-Derived Stem Cells Are Precursors of Embryonic and Extraembryonic Lineages	Demers	2011	4		
1248	chr1	86958693	86959377	3500177996	40		86958693	86959377	8421504	2	20,20	0,664	c,g	350017799600000005,350017799600000005,350017799600000004,350017799600000004	0-20,0-20,0-20,0-20		21209071	10.1530/REP-09-0536	1470-1626	Reproduction	Trophoblast stem cell marker gene expression in inner cell mass-derived cells from parthenogenetic equine embryos	Desmarais	2011	3		
1248	chr1	86958751	86958777	3500357319	26		86958751	86958777	8421504	1	26	0	c	350035731900000052	0-26						INDUCED PLURIPOTENT STEM CELLS DERIVED FROM HUMAN PANCREATIC BETA CELLS - Patent application	www.faqs.org	0	0		
1248	chr1	86958751	86958777	3500103242	26		86958751	86958777	8421504	1	26	0	c	350010324200000093	0-26						LARGE-SCALE PROPAGATION AND MAINTENANCE METHOD OF EMBRYOID BODIES GENERATED FROM STEM CELLS - Patent application	www.faqs.org	0	0		
1248	chr1	86958751	86958777	3500026197	26		86958751	86958777	8421504	1	26	0	c	350002619700000006	0-26						Pluripotent cell lines and methods of use thereof	Reijo	2009	0		
1248	chr1	86958751	86958777	3500019479	26		86958751	86958777	8421504	1	26	0	c	350001947900000030	0-26		19997091	10.1038/mt.2009.274	1525-0016	Molecular Therapy	Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy	Kazuki	2009	7		SOX2
1248	chr1	86958751	86958777	3500011021	26		86958751	86958777	8421504	1	26	0	c	350001102100000030	0-26		19997091	10.1038/mt.2009.274	1525-0016	Molecular Therapy	Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy	Kazuki	2009	7		SOX2
1248	chr1	86958813	86959267	3500354445	40		86958813	86959267	8421504	2	20,20	0,434	c,g	350035444500000005,350035444500000005,350035444500000004,350035444500000004	0-20,0-20,0-20,0-20						Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)	B	2007	0		
1248	chr1	86958832	86958963	3500420461	49		86958832	86958963	8421504	2	24,25	0,106	c	350042046100000027,350042046100000026	0-24,0-25			10.1634/stemcells.22-6-1070	1549-4918	STEM CELLS	Adult Pancreas Generates Multipotent Stem Cells and Pancreatic and Nonpancreatic Progeny - Choi - 2004 - STEM CELLS - Wiley Online Library	Choi	2004	0		SOX2
1248	chr1	86958938	86958963	3500322504	25		86958938	86958963	8421504	1	25	0	c	350032250400000000	0-25						Amelioration of Murine Schistosoma mansoni Induced Liver Fibrosis by Mesenchymal Stem Cells	w.pubstemcell.com	0	0		SOX2
1248	chr1	86958938	86958963	3500223486	25		86958938	86958963	8421504	1	25	0	c	350022348600000003	23-48						Differentiation of human osteosarcoma 3AB-OS stem-like cells in derivatives of the three primary germ layers as a useful in vitro model to develop several purposes	www.scirp.org	0	0		
1248	chr1	86958938	86958963	3500207032	25		86958938	86958963	8421504	1	25	0	c	350020703200000014	0-25						MYOMETRIAL-DERIVED MESENCHYMAL STEM CELLS AND USES THEREOF - PROJECH SCIENCE TO TECHNOLOGY, S.L.	www.sumobrain.com	0	0		SOX2
1248	chr1	86958938	86958963	3500183762	25		86958938	86958963	8421504	1	25	0	c	350018376200000026	0-25						Mechanism of PKA-Dependent and Lipid-Raft Independent Stimulation of Connexin43 Expression by Oxytoxin in Mouse Embryonic Stem Cells	.endojournals.org	0	0		SOX2
1248	chr1	86958962	86963710	3500371297	45		86958962	86963710	8421504	3	23,16,6	0,4725,4742	c,g	350037129700000020,350037129700000020,350037129700000061	0-23,0-23,0-22		15988017	10.1128/MCB.25.14.6031-6046.2005	0270-7306	Molecular and Cellular Biology	Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells	Chew	2005	6		SOX2
1248	chr1	86959093	86959116	3500339446	23		86959093	86959116	8421504	1	23	0	g	350033944600000017	0-23						Embryonic Stem Cell-Like Cells	Lim	2006	0		
1248	chr1	86959106	86959370	3500151744	42		86959106	86959370	8421504	2	22,20	0,244	c,g	350015174400000003,350015174400000003,350015174400000002,350015174400000002	0-22,0-22,0-20,0-20		21880014	10.1042/CBI20100720	1095-8355	Cell Biology International	Stemness characteristics and osteogenic potential of sheep amniotic epithelial cells	M	2012	0		
1248	chr1	86959142	86959269	3500251976	40		86959142	86959269	8421504	2	20,20	0,107	c	350025197600000119,350025197600000118	0-20,0-20						DIFFERENTIATION OF NON-EMBRYONIC STEM CELLS TO CELLS HAVING A PANCREATIC PHENOTYPE - Patent application	www.faqs.org	0	0		
1248	chr1	86959248	86959467	3500449206	40		86959248	86959467	8421504	2	21,19	0,200	c,g	350044920600000005,350044920600000043,350044920600000001,350044920600000036,350044920600000036	0-21,0-20,20-39,0-19,0-19						EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS - Patent application	www.faqs.org	0	0		
1248	chr1	86959448	86959480	3500456648	32		86959448	86959480	8421504	1	32	0	c,g	350045664800000017,350045664800000025	0-28,0-25						SUSTAINED POLYPEPTIDE EXPRESSION FROM SYNTHETIC, MODIFIED RNAS AND USES THEREOF - Patent application	www.faqs.org	0	0		SOX2
1248	chr1	86959448	86959480	3500251610	32		86959448	86959480	8421504	1	32	0	c,g	350025161000000017,350025161000000025	0-28,0-25						SUSTAINED POLYPEPTIDE EXPRESSION FROM SYNTHETIC, MODIFIED RNAS AND USES THEREOF - Patent application	www.faqs.org	0	0		SOX2
1248	chr1	86959448	86959480	3500139083	32		86959448	86959480	8421504	1	32	0	c,g	350013908300000017,350013908300000025	0-28,0-25						SUSTAINED POLYPEPTIDE EXPRESSION FROM SYNTHETIC, MODIFIED RNAS AND USES THEREOF - Patent application	www.faqs.org	0	0		SOX2
1248	chr1	86959453	86959480	3500212518	27		86959453	86959480	8421504	1	27	0	c	350021251800000000	13-40						Title: SOX2 Modulates Reprogramming of Gene Expression in Two-Cell Mouse Embryos	ww.biolreprod.org	0	0		SOX2
1248	chr1	86959453	86959479	3500404444	26		86959453	86959479	8421504	1	26	0	c	350040444400000028	0-26			10.1111/j.1471-4159.2007.04910.x	1471-4159	Journal of Neurochemistry	Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains - Ngamukote - 2007 - Journal of Neurochemistry - Wiley Online Library	Ngamukote	2007	0		
1248	chr1	86959454	86959479	3500385363	25		86959454	86959479	8421504	1	25	0	c	350038536300000018	1-26						Method for production of reprogrammed cell using chromosomally unintegrated virus vector	Fusaki	2010	0		
1248	chr1	86959456	86959480	3500273909	24		86959456	86959480	8421504	1	24	0	c	350027390900000031,350027390900000030	0-24,6-30						Record for a UF thesis. Title & abstract won't display until thesis is accessible after 2014-05-31.	ufdc.ufl.edu	0	0		
1248	chr1	86959457	86959480	3500290370	23		86959457	86959480	8421504	1	23	0	c	350029037000000002	15-38						Goat can be induced pluripotent stem cell preparation method... - IP.com	ip.com/patfam/en/	0	0		
1248	chr1	86959462	86959674	3500260149	40		86959462	86959674	8421504	2	20,20	0,192	c,g	350026014900000009,350026014900000009,350026014900000008	0-20,0-20,0-20						Differentiation Therapy in Chordoma	www.ukessays.com	0	0		SOX2
1248	chr1	86959742	86959772	3500068995	30		86959742	86959772	8421504	1	30	0	c	350006899500000172	28-58						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
1248	chr1	86959756	86959831	3500452433	43		86959756	86959831	8421504	2	20,23	0,52	c	350045243300000005,350045243300000004	0-20,0-23		23326490	10.1371/journal.pone.0053710	1932-6203	PLOS ONE	PLOS ONE: The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels	Koyama-Nasu	2013	4		SOX2
1248	chr1	86959756	86959831	3500219336	43		86959756	86959831	8421504	2	20,23	0,52	c	350021933600000017,350021933600000016	0-20,0-23						CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. - ResearchGate	.researchgate.net	0	0		SOX2
1248	chr1	86959756	86959831	3500036050	43		86959756	86959831	8421504	2	20,23	0,52	c	350003605000000017,350003605000000016	0-20,0-23						CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy	link.springer.com	0	0		SOX2
1254	chr1	87688450	87690578	3500021577	40		87688450	87690578	8421504	2	19,21	0,2107	c	350002157700000012,350002157700000013	0-19,0-21						O-12	www.scribd.com	0	0		DNAJC19
1257	chr1	88085085	88085112	3500327324	23		88085085	88085112	8421504	2	14,9	0,18	g	350032732400000085	17-41						Method for producing influenza hemagglutinin multivalent vaccines	G*E*Shi Mi Si 	1998	0		
1264	chr1	89003070	89003101	3500343734	25		89003070	89003101	8421504	3	7,4,14	0,12,17	g	350034373400000603	0-29					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
1265	chr1	89138686	89138726	3500120476	40		89138686	89138726	8421504	1	40	0	g	350012047600000012	0-40						Letter	biologia.uniba.it	0	0		
1265	chr1	89180105	89180130	3500092252	25		89180105	89180130	8421504	1	25	0	g	350009225200000000	5-30		21659512	10.1074/jbc.M111.218214		The Journal of Biological Chemistry	USP13 Enzyme Regulates Siah2 Ligase Stability and Activity via Noncatalytic Ubiquitin-binding Domains	Marzia	2011	0		
1266	chr1	89337303	89337328	3500341139	24		89337303	89337328	8421504	2	11,13	0,12	g	350034113900000132	11-35						Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 - Patent application	www.faqs.org	0	0		
1266	chr1	89337303	89337328	3500307446	24		89337303	89337328	8421504	2	11,13	0,12	g	350030744600000040	11-35						Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties - Patent application	www.faqs.org	0	0		
1267	chr1	89454908	89455143	3500455139	216		89454908	89455143	8421504	2	184,32	0,203	c	350045513900000050	15-238						lacto_sin	www.scribd.com	0	0		
1268	chr1	89598354	89627357	3500264907	2597		89598354	89627357	8421504	24	272,136,104,42,48,22,26,37,47,144,42,48,64,125,135,153,106,86,246,251,60,150,16,237	0,414,1340,1450,1597,1693,2302,2436,5439,8828,10044,10350,11253,12195,19261,19492,20110,23224,23967,26188,27993,28054,28699,28766	p,c,g	350026490700000078,350026490700000074,350026490700000073,350026490700000072,350026490700000071,350026490700000070,350026490700000069,350026490700000068,350026490700000066,350026490700000063,350026490700000062,350026490700000055,350026490700015071,350026490700000054,350026490700000053,350026490700000051,350026490700015063,350026490700000046,350026490700000045,350026490700000044,350026490700015051,350026490700000043,350026490700000042,350026490700015049,350026490700000041,350026490700000040,350026490700015045,350026490700000039,350026490700000038,350026490700015041,350026490700000037,350026490700000036,350026490700000035,350026490700000034,350026490700000033,350026490700000032,350026490700000031,350026490700000030,350026490700000030,350026490700000029,350026490700000028,350026490700000027,350026490700000026,350026490700000025,350026490700000024,350026490700000023,350026490700000022,350026490700015017,350026490700015015,350026490700000019,350026490700000018,350026490700000005,350026490700015009,350026490700000015,350026490700000014,350026490700000013,350026490700000013,350026490700000007,350026490700000012	0-272,0-48,0-48,0-48,0-48,0-48,0-42,0-48,0-48,0-36,0-48,0-48,0-48,0-48,0-48,0-42,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-23,0-45,0-48,0-48,0-48,0-48,9-35,0-48						Eucaryotic cells transformed with a mammalian phospholipid kinase or protein kinase and assays using them	Goode	1994	0		
1268	chr1	89598515	89627321	3500165774	153		89598515	89627321	8421504	6	20,45,20,19,23,26	0,121,195,23987,28012,28780	p,c,g	350016577400000011,350016577400015010,350016577400000012,350016577400000014,350016577400000014,350016577400000005,350016577400000007	0-20,3-48,0-20,0-19,0-19,0-23,9-35						Polypeptides having kinase activity, their preparation and use	Dhand	1993	0		PIK3CA
1268	chr1	89598633	89627418	3500295373	3220		89598633	89627418	8421504	21	271,152,118,171,79,122,107,172,104,165,82,125,135,153,106,86,246,251,60,150,365	0,1061,1318,2023,5160,6070,6718,8522,9712,10032,10956,11916,18982,19213,19831,22945,23688,25909,27714,27775,28420	p,c,g	350029537300000101,350029537300000101,350029537300015010,350029537300000096,350029537300000012,350029537300000095,350029537300000093,350029537300000092,350029537300000089,350029537300000082,350029537300000081,350029537300000080,350029537300000079,350029537300000076,350029537300000073,350029537300000069,350029537300000066,350029537300000060,350029537300000059,350029537300000058,350029537300000057,350029537300000056,350029537300000054,350029537300000052,350029537300000050,350029537300000015,350029537300000049,350029537300000048,350029537300000047,350029537300000045,350029537300000044,350029537300000043,350029537300000041,350029537300000040,350029537300000005,350029537300000038,350029537300000037,350029537300000036,350029537300000035,350029537300000007,350029537300000033,350029537300000032,350029537300000014	0-3207,0-3207,3-48,0-48,0-20,0-48,0-48,0-47,0-42,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-19,0-40,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-23,0-48,0-48,0-48,0-48,9-35,0-48,0-48,0-19					Patent	Polypeptides having kinase activity, their preparation and use (Patent US:5824492)	Dhand	1998	0		
1268	chr1	89598633	89627405	3500152577	3000		89598633	89627405	8421504	64	23,53,60,55,64,50,52,38,18,54,35,20,55,53,25,79,11,54,46,8,54,33,23,56,85,32,57,9,50,55,57,57,16,41,57,21,36,58,35,21,129,48,57,58,20,36,54,115,26,87,54,55,38,16,38,16,53,53,10,47,54,117,53,60	0,27,84,148,207,1061,1117,1175,1318,1342,1401,2023,2049,2110,2169,5160,6070,6086,6146,6718,6732,6792,8522,8549,8609,9712,9747,9807,10032,10085,10143,10962,11022,11916,11960,12020,18982,19021,19082,19213,19237,19831,19882,22950,23011,23688,23727,23787,23908,25909,26002,26062,26122,27714,27736,27775,27797,27856,27915,28420,28472,28532,28653,28712	c,g	350015257700000093,350015257700000085,350015257700000084,350015257700000075,350015257700000073,350015257700000066,350015257700000059,350015257700000054,350015257700000051,350015257700000050,350015257700000042,350015257700000040,350015257700000039,350015257700000038,350015257700000028,350015257700000027	0-2963,0-44,0-42,0-42,0-42,0-42,0-42,0-42,0-42,0-42,0-45,0-45,0-42,0-36,0-48,0-45						US Patent # 7,422,849. Method for determining expression of a PI3 kinase gene - Patents.com	www.patents.com	0	0		
1268	chr1	89598636	89627418	3500389361	152		89598636	89627418	8421504	6	45,20,19,23,26,19	0,74,23866,27891,28659,28763	p,c,g	350038936100015010,350038936100000012,350038936100000015,350038936100000005,350038936100000007,350038936100000014	3-48,0-20,0-19,0-23,9-35,0-19					Patent	Polypeptides having kinase activity, their preparation and use (Patent EP:0590126)	Dhand	2007	0		PIK3CA
1268	chr1	89598636	89627418	3500326001	152		89598636	89627418	8421504	6	45,20,19,23,26,19	0,74,23866,27891,28659,28763	p,c,g	350032600100015010,350032600100000012,350032600100000015,350032600100000005,350032600100000005,350032600100000007,350032600100000014	3-48,0-20,0-19,0-23,0-23,9-35,0-19						Method for determining expression of a PI3 kinase gene	Hiles	1999	0		
1268	chr1	89598636	89627418	3500229155	152		89598636	89627418	8421504	6	45,20,19,23,26,19	0,74,23866,27891,28659,28763	p,c,g	350022915500015005,350022915500000024,350022915500000029,350022915500000010,350022915500000010,350022915500000014,350022915500000028	3-48,0-20,0-19,0-23,0-23,9-35,0-19					Patent	Polypeptide mit kinaseaktivit&#xe4;t, ihre herstellung und verwendung Polypeptides having kinase activity, their production and use (Patent DE:69334113)	Dhand	2007	0		PIK3CA
1268	chr1	89598636	89627345	3500457922	3144		89598636	89627345	8421504	21	268,152,118,171,79,122,107,172,104,165,82,125,135,153,106,86,246,251,60,150,292	0,1058,1315,2020,5157,6067,6715,8519,9709,10029,10953,11913,18979,19210,19828,22942,23685,25906,27711,27772,28417	p	350045792200015020,350045792200015019,350045792200015018,350045792200015017,350045792200015016,350045792200015015,350045792200015014,350045792200015013,350045792200015012,350045792200015011,350045792200015010,350045792200015009,350045792200015008,350045792200015007,350045792200015006,350045792200015005,350045792200015004,350045792200015003	0-87,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,3-180						Organic Compounds	Fairhurst	2010	0		PIK3CA
1268	chr1	89598636	89627345	3500339431	3144		89598636	89627345	8421504	21	268,152,118,171,79,122,107,172,104,165,82,125,135,153,106,86,246,251,60,150,292	0,1058,1315,2020,5157,6067,6715,8519,9709,10029,10953,11913,18979,19210,19828,22942,23685,25906,27711,27772,28417	p	350033943100015022,350033943100015021,350033943100015020,350033943100015019,350033943100015018,350033943100015017,350033943100015016,350033943100015015,350033943100015014,350033943100015013,350033943100015012,350033943100015011,350033943100015010,350033943100015009,350033943100015008,350033943100015007,350033943100015006,350033943100015005	0-87,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,3-180						Organic Compounds	Caravatti	2008	0		PIK3CA
1268	chr1	89598636	89627345	3500287341	3144		89598636	89627345	8421504	21	268,152,118,171,79,122,107,172,104,165,82,125,135,153,106,86,246,251,60,150,292	0,1058,1315,2020,5157,6067,6715,8519,9709,10029,10953,11913,18979,19210,19828,22942,23685,25906,27711,27772,28417	p	350028734100015021,350028734100015020,350028734100015019,350028734100015018,350028734100015017,350028734100015016,350028734100015015,350028734100015014,350028734100015013,350028734100015012,350028734100015011,350028734100015010,350028734100015009,350028734100015008,350028734100015007,350028734100015006,350028734100015005,350028734100015004	0-87,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,3-180						Substituted 2-Carboxamide Cycloamino Ureas	Fairhurst	2010	0		PIK3CA
1268	chr1	89598636	89627345	3500260002	3078		89598636	89627345	8421504	24	268,152,118,171,79,122,107,172,104,165,82,125,135,153,24,76,86,246,216,5,60,150,115,147	0,1058,1315,2020,5157,6067,6715,8519,9709,10029,10953,11913,18979,19210,19828,19858,22942,23685,25906,26152,27711,27772,28417,28562	p	350026000200015021,350026000200015020,350026000200015019,350026000200015018,350026000200015017,350026000200015016,350026000200015015,350026000200015014,350026000200015013,350026000200015012,350026000200015011,350026000200015010,350026000200015009,350026000200015008,350026000200015007,350026000200015006,350026000200015004,350026000200015003,350026000200015002	0-87,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-90,0-84,0-180,0-180,0-180,0-150,0-180,3-150						Bis-thiazole derivatives, process for their preparation and their use as medicaments	Fairhurst	2010	0		PIK3CA
1268	chr1	89598636	89627345	3500160801	3144		89598636	89627345	8421504	21	268,152,118,171,79,122,107,172,104,165,82,125,135,153,106,86,246,251,60,150,292	0,1058,1315,2020,5157,6067,6715,8519,9709,10029,10953,11913,18979,19210,19828,22942,23685,25906,27711,27772,28417	p	350016080100015019,350016080100015018,350016080100015017,350016080100015016,350016080100015083,350016080100015082,350016080100015081,350016080100015015,350016080100015079,350016080100015078,350016080100015077,350016080100015014,350016080100015076,350016080100015074,350016080100015073,350016080100015013,350016080100015072,350016080100015071,350016080100015069,350016080100015012,350016080100015068,350016080100015067,350016080100015066,350016080100015011,350016080100015064,350016080100015063,350016080100015062,350016080100015010,350016080100015061,350016080100015059,350016080100015058,350016080100015009,350016080100015057,350016080100015056,350016080100015054,350016080100015008,350016080100015053,350016080100015052,350016080100015051,350016080100015007,350016080100015049,350016080100015048,350016080100015047,350016080100015006,350016080100015046,350016080100015044,350016080100015043,350016080100015005,350016080100015042,350016080100015041,350016080100015039,350016080100015004,350016080100015038,350016080100015037,350016080100015036,350016080100015003,350016080100015034,350016080100015033,350016080100015032,350016080100015002,350016080100015031,350016080100015029	0-87,0-180,0-180,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,0-180,0-45,0-45,0-45,3-180,0-45,0-45						Novel Heterocyclic Derivatives - Patent application	www.faqs.org	0	0		PIK3CA
1268	chr1	89598636	89627321	3500293469	133		89598636	89627321	8421504	5	45,20,19,23,26	0,74,23866,27891,28659	p,c	350029346900015010,350029346900000012,350029346900000015,350029346900000005,350029346900000007	3-48,0-20,0-19,0-23,9-35					Patent	Method for determining expression of a PI3 kinase gene (Patent US:7422849)	Hiles	2008	0		PIK3CA
1268	chr1	89598636	89598681	3500378751	45		89598636	89598681	8421504	1	45	0	p	350037875100015002	0-45					Patent	Lipid kinase (Patent EP:0914448)	VANHASEBROECK	2006	0		PIK3CA
1268	chr1	89598636	89598681	3500374256	45		89598636	89598681	8421504	1	45	0	p	350037425600015003	0-45						Lipid kinase	VANHASEBROECK	1999	0		PIK3CA
1268	chr1	89598636	89598681	3500291818	45		89598636	89598681	8421504	1	45	0	p	350029181800015000	0-45						Lipid kinase	Ba Te *Mo Yi Si Bu Luo Ke 	1999	0		PIK3CA
1268	chr1	89598636	89598681	3500237376	45		89598636	89598681	8421504	1	45	0	p	350023737600015000	0-45					Patent	Lipid kinase (Patent CN:1260360)	Ba Te *Mo Yi Si Bu Luo Ke 	2006	0		PIK3CA
1268	chr1	89598636	89598681	3500232941	45		89598636	89598681	8421504	1	45	0	p	350023294100015004	0-45					Patent	Lipid kinase Lipid kinase (Patent DE:69736807)	Vanhasebroeck	2007	0		PIK3CA
1268	chr1	89598636	89598681	3500215861	45		89598636	89598681	8421504	1	45	0	p	350021586100015002	0-45					Patent	Method for determining modulation of P110&#x0394; activity (Patent US:7422886)	Vanhasebroeck	2008	0		PIK3CA
1268	chr1	89598636	89598681	3500175281	45		89598636	89598681	8421504	1	45	0	p	350017528100015004	3-48						Differential mRNA expression and subcellular locations of PI3-kinase isoforms in sympathetic and sensory neurons. - ResearchGate	.researchgate.net	0	0		PIK3CA
1268	chr1	89598636	89598681	3500173071	45		89598636	89598681	8421504	1	45	0	p	350017307100015002	0-45						Method for determining modulation of p110delta activity	Vanhaesebroeck	2003	0		PIK3CA
1268	chr1	89598636	89598681	3500099693	45		89598636	89598681	8421504	1	45	0	p	350009969300015002	0-45					Patent	Lipid kinase (Patent US:6482623)	Vanhaesebroeck	2002	0		PIK3CA
1268	chr1	89598636	89598681	3500085118	45		89598636	89598681	8421504	1	45	0	p	350008511800015002	0-45					Patent	Method for determining modulation of p110&#x03b4; activity (Patent US:6849420)	Vanhasebroeck	2005	0		PIK3CA
1268	chr1	89598636	89598681	3500081884	45		89598636	89598681	8421504	1	45	0	p	350008188400015000	0-45					Patent	&#x8102;&#x6fc0;&#x9176; (Patent CN:1260360)	Ba Te *Mo Yi Si Bu Luo Ke 	2006	0		PIK3CA
1268	chr1	89598636	89598681	3500076119	45		89598636	89598681	8421504	1	45	0	p	350007611900015002	0-45					Patent	Lipid kinase (Patent DE:69736807)	Vanhasebroeck	2007	0		PIK3CA
1268	chr1	89598663	89627345	3500335292	2892		89598663	89627345	8421504	28	241,152,27,55,89,52,38,103,107,172,104,165,82,125,87,42,153,106,86,12,60,114,216,11,60,76,65,292	0,1031,1288,1351,1993,2112,5130,6059,6688,8492,9682,10002,10926,11886,18952,19045,19183,19801,22915,23658,23700,23790,25879,26119,27684,27745,27830,28390	p	350033529200015022,350033529200015021,350033529200015020,350033529200015018,350033529200015017,350033529200015015,350033529200015014,350033529200015013,350033529200015012,350033529200015011,350033529200015010,350033529200015009,350033529200015008,350033529200015007,350033529200015006,350033529200015005,350033529200015004,350033529200015003,350033529200015002	0-60,0-180,0-180,0-144,0-90,0-180,0-180,0-180,0-180,0-180,0-177,0-180,0-90,0-60,0-150,0-180,0-147,0-180,3-180						NOVEL HETEROCYCLIC DERIVATIVES - NOVARTIS AG	www.sumobrain.com	0	0		
1268	chr1	89598723	89627345	3500267181	2694		89598723	89627345	8421504	27	181,152,18,91,171,8,41,122,107,150,66,165,9,108,102,3,87,6,84,78,72,144,216,11,60,150,292	0,971,1228,1255,1933,5070,5108,5980,6628,8432,9660,9942,10866,11843,18892,19024,19123,19270,19741,22863,23598,23700,25819,26059,27624,27685,28330	p	350026718100015047,350026718100015045,350026718100015043,350026718100015041,350026718100015039,350026718100015037,350026718100015035,350026718100015031,350026718100015029,350026718100015025,350026718100015023,350026718100015021,350026718100015017,350026718100015015,350026718100015013,350026718100015011,350026718100015009,350026718100015007,350026718100015005	0-180,0-171,0-180,0-90,0-60,0-180,0-180,0-120,0-120,0-150,0-60,0-90,0-90,0-150,0-180,0-180,0-156,0-180,3-180						Bis-thiazole derivatives, process for their preparation and their use as medicaments	P*Yin Ba He 	2011	0		
1268	chr1	89598723	89627345	3500136124	2634		89598723	89627345	8421504	26	181,152,18,91,171,8,103,107,150,66,165,9,108,102,3,87,6,84,78,72,144,216,11,60,150,292	0,971,1228,1255,1933,5070,5999,6628,8432,9660,9942,10866,11843,18892,19024,19123,19270,19741,22863,23598,23700,25819,26059,27624,27685,28330	p	350013612400015024,350013612400015023,350013612400015022,350013612400015021,350013612400015019,350013612400015018,350013612400015016,350013612400015015,350013612400015013,350013612400015012,350013612400015011,350013612400015009,350013612400015008,350013612400015007,350013612400015006,350013612400015005,350013612400015004,350013612400015003	0-180,0-171,0-180,0-90,0-180,0-180,0-120,0-120,0-150,0-60,0-90,0-90,0-150,0-180,0-180,0-156,0-180,3-180						&#x8054;&#x567b;&#x5511;&#x884d;&#x751f;&#x7269;&#x3001;&#x5b83;&#x4eec;&#x7684;&#x5236;&#x5907;&#x65b9;&#x6cd5;&#x4ee5;&#x53ca;&#x5b83;&#x4eec;&#x4f5c;&#x4e3a;&#x836f;&#x7269;&#x7684;&#x7528;&#x9014;	P*Yin Ba He 	2011	0		
1268	chr1	89598747	89607248	3500048817	984		89598747	89607248	8421504	10	157,152,118,95,64,79,13,106,107,93	0,947,1204,1909,2016,5046,5956,5972,6604,8408	p	350004881700015064,350004881700015059,350004881700015055,350004881700015049,350004881700015044	0-159,0-237,0-126,0-225,0-237						homolog Tor, interacts FKBP12/rapamycin	www.pnas.org	0	0		PIK3CA
1268	chr1	89598761	89598842	3500455118	45		89598761	89598842	8421504	2	21,24	0,57	c	350045511800000001,350045511800000000	0-21,0-24		18372911	10.1038/onc.2008.91	0950-9232	Oncogene	Phosphoinositide 3-OH kinase p85&#x03b1; and p110&#x03b2; are essential for androgen receptor transactivation and tumor progression in prostate cancers	Zhu	2008	6		PIK3CA
1268	chr1	89598772	89610664	3500436244	69		89598772	89610664	8421504	3	22,20,27	0,43,11865	c	350043624400000005,350043624400000003,350043624400000002	0-22,0-20,0-27						Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture	Markby	2012	0		PIK3CA
1268	chr1	89598863	89599728	3500337725	48		89598863	89599728	8421504	2	25,23	0,842	c,g	350033772500000012,350033772500000012,350033772500000011	0-25,0-25,0-23						Felipe Camargo Braga TESE	www.teses.usp.br	0	0		
1268	chr1	89598863	89598888	3500074470	25		89598863	89598888	8421504	1	25	0	c	350007447000000002	23-48						L&#xcd;GIA GARCIA MESQUITA	www.teses.usp.br	0	0		
1268	chr1	89598879	89599698	3500329604	29		89598879	89599698	8421504	2	25,4	0,815	c	350032960400000000	0-29						Effects of small interfering RNA inhibit Class &#x2160; phosphoinositide 3-kinase on human gastric cancer cells	www.wjgnet.com	0	0		PIK3CA
1268	chr1	89599798	89621583	3500131281	120		89599798	89621583	8421504	6	24,24,24,24,19,5	0,4993,9819,10779,18753,21780	c,g	350013128100000046,350013128100000044,350013128100000042,350013128100000042,350013128100000008,350013128100000068,350013128100000039	0-24,0-24,0-24,0-24,0-23,0-24,0-24						Rna Antagonist Compounds For The Modulation Of Pik3ca Expression 	.freshpatents.com	0	0		
1268	chr1	89599831	89617912	3500323647	40		89599831	89617912	8421504	3	15,5,20	0,120,18061	c	350032364700000002,350032364700000001	0-20,0-20		19401449	10.1158/0008-5472.CAN-08-4765	0008-5472	Cancer Research	PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers	Wee	2009	8		PIK3CA
1268	chr1	89599831	89617912	3500042848	40		89599831	89617912	8421504	3	15,5,20	0,120,18061	c	350004284800000002,350004284800000001	0-20,0-20		19401449	10.1158/0008-5472.CAN-08-4765	0008-5472	Cancer Research	PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers	Wee	2009	8		PIK3CA
1268	chr1	89600775	89604722	3500278619	150		89600775	89604722	8421504	3	52,79,19	0,3018,3928	p	350027861900015037	0-150						ORGANIC COMPOUNDS - NOVARTIS AG	www.sumobrain.com	0	0		
1268	chr1	89604719	89627418	3500193936	944		89604719	89627418	8421504	18	96,48,33,48,48,48,43,48,43,93,48,14,34,48,47,96,48,61	0,3985,4081,4888,13187,13748,16857,17653,17805,19823,19964,20060,21628,21711,21760,22350,22494,22638	c,g	350019393600000080,350019393600000079,350019393600000069,350019393600000067,350019393600000066,350019393600000059,350019393600000057,350019393600000055,350019393600000052,350019393600000049,350019393600000048,350019393600000047,350019393600000045,350019393600000045,350019393600000043,350019393600000041,350019393600000040,350019393600000038,350019393600000037,350019393600000035,350019393600000032,350019393600000014	0-48,0-48,0-48,15-48,0-48,0-48,0-48,0-43,0-48,0-40,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-19						Polypeptides having kinase activity, their preparation and use	Hiles	1994	0		
1268	chr1	89604749	89627378	3500171682	42		89604749	89627378	8421504	2	23,19	0,22610	c	350017168200000001,350017168200000004	0-23,0-19		18285463	10.1128/MCB.01786-07	0270-7306	Molecular and Cellular Biology	Phosphoinositide 3-Kinases p110&#x03b1; and p110&#x03b2; Regulate Cell Cycle Entry, Exhibiting Distinct Activation Kinetics in G1 Phase	Marques	2008	6		PIK3CA
1268	chr1	89604749	89627378	3500033723	42		89604749	89627378	8421504	2	23,19	0,22610	c,g	350003372300000001,350003372300000004,350003372300000004	0-23,0-19,0-19		18285463	10.1128/MCB.01786-07	0270-7306	Molecular and Cellular Biology	Phosphoinositide 3-Kinases p110&#x03b1; and p110&#x03b2; Regulate Cell Cycle Entry, Exhibiting Distinct Activation Kinetics in G1 Phase	Marques	2008	6		PIK3CA
1268	chr1	89610577	89621583	3500377194	47		89610577	89621583	8421504	4	12,11,19,5	0,13,7974,11001	c	350037719400000000,350037719400000068,350037719400000026	0-23,0-24,0-24						RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF PIK3CA EXPRESSION - Patent application	www.faqs.org	0	0		
1268	chr1	89617855	89617880	3500068739	25		89617855	89617880	8421504	1	25	0	c,g	350006873900000002,350006873900000002	0-28,0-28		22815900	10.1371/journal.pone.0041017		PLoS ONE	Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells	Keisuke	2012	0		
1268	chr1	89618517	89627398	3500029320	56		89618517	89627398	8421504	2	28,28	0,8853	c	350002932000000000,350002932000000001	0-28,0-28		14672955	10.1074/jbc.M310638200	0021-9258	Journal of Biological Chemistry	Stable Gene Silencing in Human Monocytic Cell Lines Using Lentiviral-delivered Small Interference RNA	Lee	2004	5		PIK3CA
1268	chr1	89624641	89626473	3500386985	48		89624641	89626473	8421504	2	25,23	0,1809	c,g	350038698500000010,350038698500000010,350038698500000009	0-25,0-25,0-23						Specific role for p85/p110&#x03b2; in GTP-binding-protein-mediated activation of Akt - Keeping the Faith	pthefaith1296.com	0	0		PIK3CA
1268	chr1	89624778	89627404	3500453368	44		89624778	89627404	8421504	3	15,9,20	0,1569,2606	c,g	350045336800000001,350045336800000000,350045336800000000	0-24,0-20,0-20		10913001			American Journal of Physiology - Cell Physiolog	Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle	Yamboliev	2000	0		
1268	chr1	89624778	89627404	3500242712	44		89624778	89627404	8421504	3	15,9,20	0,1569,2606	c	350024271200000001,350024271200000000	0-24,0-20		10913001			American Journal of Physiology - Cell Physiolog	Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle	Yamboliev	2000	0		
1268	chr1	89624778	89627404	3500007112	44		89624778	89627404	8421504	3	15,9,20	0,1569,2606	c	350000711200000001,350000711200000000	0-24,0-20		10913001			American Journal of Physiology - Cell Physiology	Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle	Yamboliev	2000	0		
1268	chr1	89627326	89627363	3500328202	37		89627326	89627363	8421504	1	37	0	c,g	350032820200000079,350032820200000079	0-37,0-37						Methods of generating gene specific libraries	C*K*Lei Meng De 	2011	0		PIK3CA
1269	chr1	89777374	89777534	3500124863	40		89777374	89777534	8421504	2	20,20	0,140	c,g	350012486300000019,350012486300000020,350012486300000020	0-20,0-20,0-20						[tel-00604466, v1] Identification et caract&#xe9;risation d'un nouveau marqueur de la s&#xe9;nescence cellulaire : la prot&#xe9;ine WNT16B	hives-ouvertes.fr	0	0		ZMAT3
1273	chr1	90180314	90180341	3500160249	23		90180314	90180341	8421504	2	6,17	0,10	g	350016024900000469	24-47						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN - Patent application	www.faqs.org	0	0		
1273	chr1	90180314	90180341	3500104979	23		90180314	90180341	8421504	2	6,17	0,10	g	350010497900000469	24-47						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
1274	chr1	90398453	90398478	3500120071	24		90398453	90398478	8421504	2	11,13	0,12	g	350012007100000024	0-24						Barcoding generalist predators by polymerase chain reaction: carabids and spiders	www.ars.usda.gov	0	0		
1275	chr1	90523155	90523183	3500416176	23		90523155	90523183	8421504	2	15,8	0,20	g	350041617600000005	1-25					Journal of Bacteriology	Multiple Roles for TnpI Recombinase in Regulation of Tn5401 Transposition in Bacillus thuringiensis	James	1999	0		
1275	chr1	90532050	90532079	3500448882	24		90532050	90532079	8421504	2	13,11	0,18	g	350044888200000013	8-32						Peer-Reviewed Journal Tracking and Analyzing Disease Trends pages 701&#x2013;874	wwwnc.cdc.gov	0	0		
1275	chr1	90532050	90532079	3500080604	24		90532050	90532079	8421504	2	13,11	0,18	g	350008060400000021	8-32						IDENTIFICA&#xc7;&#xc3;O, RESIST&#xca;NCIA A ANTIMICROBIANOS E CARACTERIZA&#xc7;&#xc3;O MOLECULAR DE ENTEROCOCCUS ISOLADOS DE ALIMENTOS	.icict.fiocruz.br	0	0		
1275	chr1	90532050	90532079	3500013367	24		90532050	90532079	8421504	2	13,11	0,18	g	350001336700000023	8-32						Epidemiological characterization, antimicrobial resistance and virulence mechanisms of human and animal streptococci	run.unl.pt/bitstr	0	0		
1277	chr1	90758904	90759193	3500373947	42		90758904	90759193	8421504	2	20,22	0,267	g	350037394700000004,350037394700000005	0-20,0-22						Udder Health Characteristics	Lund	2007	0		
1277	chr1	90758904	90759193	3500024826	42		90758904	90759193	8421504	2	20,22	0,267	g	350002482600000013,350002482600000014	0-20,0-22						Udder Health Characteristics 	.freshpatents.com	0	0		
1284	chr1	91629615	91629638	3500020590	23		91629615	91629638	8421504	1	23	0	g	350002059000000017	0-32						Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression. - ResearchGate	.researchgate.net	0	0		
1284	chr1	91710162	91710187	3500227650	24		91710162	91710187	8421504	2	19,5	0,20	g	350022765000000054	5-29						Detection of acid-resistant micro-organisms in a stool	Cullmann	2000	0		
1284	chr1	91710162	91710187	3500091340	24		91710162	91710187	8421504	2	19,5	0,20	g	350009134000000001	6-30						DESACYL GHRELIN ANTIBODIES AND THERAPEUTIC USES THEREOF - Patent application	www.faqs.org	0	0		
1286	chr1	91900534	91900561	3500296391	23		91900534	91900561	8421504	2	6,17	0,10	g	350029639100000011	9-33		18657071	10.1111/j.1600-0854.2008.00785.x	1600-0854	Traffic	Ubiquitylation is Required for Degradation of Transmembrane Surface Proteins in Trypanosomes - Chung - 2008 - Traffic - Wiley Online Library	Chung	2008	0		
1289	chr1	92337719	92337750	3500413325	25		92337719	92337750	8421504	3	7,12,6	0,10,25	g	350041332500000278	8-38						Fusion Proteins Useful For Detecting Analytes 	.freshpatents.com	0	0		
1299	chr1	93654275	93654306	3500102801	23		93654275	93654306	8421504	3	5,8,10	0,8,21	g	350010280100000007	11-34						Microsatellite characterization of Cimarron Uruguayo dogs	www.scielo.br	0	0		
1300	chr1	93835940	93835964	3500334528	23		93835940	93835964	8421504	2	13,10	0,14	g	350033452800000025,350033452800000014	0-40,0-40					Patent	&#x5e7d;&#x95e8;&#x87ba;&#x6746;&#x83cc;&#x6d3b;&#x75ab;&#x82d7; Helicobacter pylori vaccine (Patent CN:1215167)	T*F*Mai Ye 	2005	0		
1302	chr1	94027154	94027178	3500134343	23		94027154	94027178	8421504	2	6,17	0,7	g	350013434300000166	0-23						Assessing the complex nature of behavior: Sequence-based and transcriptomic analyses in a mouse model of extremes in trait anxiety	b.uni-muenchen.de	0	0		
1303	chr1	94230940	94230965	3500352806	25		94230940	94230965	8421504	1	25	0	g	350035280600000014	0-25		19461874	10.1371/journal.pgen.1000487		PLoS Genetics	CA8 Mutations Cause a Novel Syndrome Characterized by Ataxia and Mild Mental Retardation with Predisposition to Quadrupedal Gait	SevTurkmen	2009	0		NXPH1,GAPDH
1303	chr1	94230940	94230965	3500307025	25		94230940	94230965	8421504	1	25	0	g	350030702500000014	0-25		19461874	10.1371/journal.pgen.1000487	1553-7404	PLOS Genetics	PLOS Genetics: CA8 Mutations Cause a Novel Syndrome Characterized by Ataxia and Mild Mental Retardation with Predisposition to Quadrupedal Gait	Turkmen	2009	0		GAPDH,CALCRL
1303	chr1	94230940	94230963	3500289717	23		94230940	94230963	8421504	1	23	0	g	350028971700000010	23-46						Identification of novel molecular mechanisms of tumor suppressor effect induced by soy isoflavones: Studies on EMP2 and ITM1 genes	u.lib.ncku.edu.tw	0	0		GAPDH
1308	chr1	94886012	94886041	3500448112	24		94886012	94886041	8421504	2	12,12	0,17	g	350044811200000001	0-24		12368310	10.1128/JVI.76.21.10685-10691.2002	0022-538X	Journal of Virology	Simian Virus 40 Small Tumor Antigen Activates AKT and Telomerase and Induces Anchorage-Independent Growth of Human Epithelial Cells	Yuan	2002	5		
1308	chr1	94886012	94886041	3500425166	24		94886012	94886041	8421504	2	12,12	0,17	g	350042516600000046	0-24						US Patent # 6,428,955. DNA diagnostics based on mass spectrometry - Patents.com	www.patents.com	0	0		
1308	chr1	94886012	94886041	3500349864	24		94886012	94886041	8421504	2	12,12	0,17	g	350034986400000000	0-24					The Journal of molecular diagnostics : JMD	Analytical Validation of Telomerase Activity for Cancer Early Detection : TRAP/PCR-CE and hTERT mRNA Quantification Assay for High-Throughput Screening of Tumor Cells	John	2004	0		
1308	chr1	94886012	94886041	3500348251	24		94886012	94886041	8421504	2	12,12	0,17	g	350034825100000050	0-24						DNA DIAGNOSTICS BASED ON MASS SPECTROMETRY	Koster	1999	0		
1308	chr1	94886012	94886041	3500257161	24		94886012	94886041	8421504	2	12,12	0,17	g	350025716100000001	0-24			10.1186/1471-2407-1-10	1471-2407	BMC Cancer	Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study	Kuranaga	2001	3		
1308	chr1	94886012	94886041	3500131235	24		94886012	94886041	8421504	2	12,12	0,17	g	350013123500000021,350013123500000023	0-24,0-24						Molecular Studies of an Alternative Lengthening of Telomeres (ALT) Mechanism	brary.usyd.edu.au	0	0		
1308	chr1	94886012	94886041	3500118887	24		94886012	94886041	8421504	2	12,12	0,17	g	350011888700000161,350011888700000049	0-24,0-24						DNA diagnostics based on mass spectrometry - US Patent 7198893 Description	ww.patentstorm.us	0	0		
1308	chr1	94886012	94886041	3500078293	24		94886012	94886041	8421504	2	12,12	0,17	g	350007829300000001	0-24						Hair follicle pharmacodynamic assay for telomerase activity	Bassett	2009	0		
1308	chr1	94886012	94886041	3500074534	24		94886012	94886041	8421504	2	12,12	0,17	g	350007453400000002	0-24						Assay for telomerase activity	Pirot	2011	0		
1311	chr1	95252371	95252650	3500120855	40		95252371	95252650	8421504	2	20,20	0,259	g	350012085500000002,350012085500000003	0-20,0-20		18162520	10.1210/en.2007-1425	0013-7227	Endocrinology	Kisspeptin Is Present in Ovine Hypophysial Portal Blood But Does Not Increase during the Preovulatory Luteinizing Hormone Surge: Evidence that Gonadotropes Are Not Direct Targets of Kisspeptin in Vivo	Smith	2008	4		PPIA
1312	chr1	95335144	95335171	3500160136	23		95335144	95335171	8421504	2	11,12	0,15	g	350016013600000012	3-33						Use of WNT inhibitor to inhibit angiogenesis in the CNS - Patent application	www.faqs.org	0	0		
1312	chr1	95335987	95336033	3500165929	34		95335987	95336033	8421504	3	4,23,7	0,5,39	g	350016592900000065	109-144						METHOD FOR PREDICTING THE ATHLETIC PERFORMANCE POTENTIAL OF A SUBJECT - Patent application	www.faqs.org	0	0		
1319	chr1	96242145	96292729	3500399153	682		96242145	96292729	8421504	24	45,15,27,45,27,15,38,4,32,13,18,42,35,15,27,39,3,30,6,42,42,11,78,33	0,48,1092,1125,1173,9694,9811,11160,11183,16879,18720,19500,20747,20785,31707,31788,38454,42830,43175,43193,44272,44324,45244,50551	c	350039915300000143,350039915300000142,350039915300000141,350039915300000140,350039915300000137,350039915300000136,350039915300000128,350039915300000125,350039915300000123,350039915300000122,350039915300000120,350039915300000111,350039915300000110,350039915300000105,350039915300000104,350039915300000103,350039915300000093	0-45,0-42,0-45,0-42,0-42,0-32,1-32,0-42,0-35,0-42,0-42,9-45,0-42,0-42,0-44,0-45,12-45						 Method Of Diagnosing Esophageal Cancer 	www.docstoc.com	0	0		
1319	chr1	96242193	96291967	3500288139	450		96242193	96291967	8421504	13	15,81,38,10,48,13,18,48,15,63,18,48,35	0,1044,9763,11112,13384,16831,18672,40935,41127,42749,43127,45229,49739	c	350028813900000146,350028813900000145,350028813900000141,350028813900000137,350028813900000132,350028813900000120,350028813900000116,350028813900000115,350028813900000107,350028813900000100	0-48,0-48,0-48,0-48,4-35,0-48,0-48,0-48,0-48,1-36						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
1319	chr1	96242193	96287470	3500219109	546		96242193	96287470	8421504	16	15,81,38,10,35,48,13,18,15,33,39,9,15,63,66,48	0,1044,9763,11112,11135,13384,16831,18672,20737,31659,31740,38406,41127,42749,43127,45229	c	350021910900000146,350021910900000145,350021910900000141,350021910900000140,350021910900000137,350021910900000132,350021910900000126,350021910900000124,350021910900000116,350021910900000115,350021910900000114,350021910900000107	0-48,0-48,0-48,0-35,0-48,4-35,0-48,0-48,0-48,0-48,0-48,0-48						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
1319	chr1	96291980	96292005	3500165494	25		96291980	96292005	8421504	1	25	0	c	350016549400000001	0-25						Centralspindlin regulates ECT2 and RhoA accumulation at the equatorial cortex during cytokinesis	cs.biologists.org	0	0		ECT2
1320	chr1	96408062	96408088	3500439477	26		96408062	96408088	8421504	1	26	0	c	350043947700000001	0-26		19592704	10.1194/jlr.M900201-JLR200		Journal of Lipid Research	Targeting of neutral cholesterol ester hydrolase to the endoplasmic reticulum via its N-terminal sequence	Masaki	2010	0		
1320	chr1	96408062	96408088	3500356826	26		96408062	96408088	8421504	1	26	0	c	350035682600000001	0-26		19592704	10.1194/jlr.M900201-JLR200	0022-2275	Journal of Lipid Research	Targeting of neutral cholesterol ester hydrolase to the endoplasmic reticulum via its N-terminal sequence	Igarashi	2010	6		
1320	chr1	96408062	96408088	3500162264	26		96408062	96408088	8421504	1	26	0	c	350016226400000001	0-26		19592704	10.1194/jlr.M900201-JLR200	0022-2275	Journal of Lipid Research	Targeting of neutral cholesterol ester hydrolase to the endoplasmic reticulum via its N-terminal sequence	Igarashi	2010	6		
1320	chr1	96408958	96408988	3500346263	25		96408958	96408988	8421504	3	14,5,6	0,17,24	c	350034626300000009	0-29						Insecticidal plectoxins from Plectreurys tristis	Leisy	1994	0		
1321	chr1	96557459	96557772	3500291842	313		96557459	96557772	8421504	1	313	0	g	350029184200000003	0-709						&#x8fb2;&#x696d;&#x751f;&#x7269;&#x8cc7;&#x6e90;&#x30b8;&#x30fc;&#x30f3;&#x30d0;&#x30f3;&#x30af;&#x4e8b;&#x696d; &#x52d5;&#x7269;&#x907a;&#x4f1d;&#x8cc7;&#x6e90;&#x90e8;&#x9580; &#x5e73;&#x6210;21&#x5e74;&#x5ea6;&#x5b8c;&#x4e86;&#x59d4;&#x8a17;&#x8ab2;&#x	.gene.affrc.go.jp	0	0		
1321	chr1	96558190	96558214	3500444587	24		96558190	96558214	8421504	1	24	0	c	350044458700000022,350044458700000006	0-24,0-24						METHODS FOR SYNTHESIS AND USES OF INHIBITORS OF GHRELIN O-ACYLTRANSFERASE AS POTENTIAL THERAPEUTIC AGENTS FOR OBESITY AND DIABETES - Patent application	www.faqs.org	0	0		
1321	chr1	96560970	96560993	3500204674	23		96560970	96560993	8421504	1	23	0	c,g	350020467400000006,350020467400000006	0-23,0-23			10.1152/ajpendo.00377.2006		American Journal of Physiology - Endocrinology and Metabolism	Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway	Delhanty	2007	0		
1321	chr1	96560987	96561011	3500452131	24		96560987	96561011	8421504	1	24	0	c	350045213100000000	0-24		21804576	10.1038/aps.2011.79	1671-4083	Acta Pharmacologica Sinica	Ghrelin promotes differentiation of human embryonic stem cells into cardiomyocytes	Yang	2011	2		GHSR
1321	chr1	96560987	96561011	3500435114	24		96560987	96561011	8421504	1	24	0	c	350043511400000000	0-24		21804576	10.1038/aps.2011.79	1671-4083	Acta Pharmacologica Sinica	Ghrelin promotes differentiation of human embryonic stem cells into cardiomyocytes	Yang	2011	2		GHSR
1321	chr1	96561069	96561097	3500274642	28		96561069	96561097	8421504	1	28	0	g	350027464200000005	26-54						Growth hormone releasing peptides	Dong Zheng Xin 	2008	0		
1323	chr1	96806220	96806246	3500027618	24		96806220	96806246	8421504	2	16,8	0,18	g	350002761800000008	0-24						Proteome changes in sugar beet in response to Beet necrotic yellow vein virus - ResearchGate	.researchgate.net	0	0		
1328	chr1	97446593	97446617	3500054912	24		97446593	97446617	8421504	1	24	0	c	350005491200000007	0-24		17065600	10.1095/biolreprod.106.056226	0006-3363	Biology of Reproduction	Phospholipase D1 as a Key Enzyme for Decidualization in Human Endometrial Stromal Cells	Yoon	2007	4		PLD1
1328	chr1	97481184	97481209	3500215999	23		97481184	97481209	8421504	2	18,5	0,20	g	350021599900000025	3-28						Methods and reagents related to foxo	Goldberg	2004	0		
1329	chr1	97530951	97556749	3500064797	42		97530951	97556749	8421504	3	9,12,21	0,3147,25777	c	350006479700000001,350006479700000002	0-21,0-21		20554760	10.1091/mbc.E10-02-0167	1059-1524	Molecular Biology of the Cell	Phosphatidic Acid Induces Ligand-independent Epidermal Growth Factor Receptor Endocytic Traffic through PDE4 Activation	Norambuena	2010	5		PLD1
1330	chr1	97684183	97684211	3500239371	24		97684183	97684211	8421504	2	18,6	0,22	g	350023937100000031	22-48						Transglutaminase gene of Streptoverticillium ladakanum and the transglutaminase encoded therefrom - US Patent 6660510 Description	ww.patentstorm.us	0	0		
1330	chr1	97748971	97748994	3500287500	23		97748971	97748994	8421504	1	23	0	g	350028750000000068	9-33						Reconstituted human anti-hm1.24 antibody	Xiao Ye Hao [?] Lang 	2006	0		
1332	chr1	97910850	97910876	3500343774	23		97910850	97910876	8421504	2	11,12	0,14	g	350034377400000019	14-37						US Patent # 7,227,003. Anti-TNF antibody fragments - Patents.com	www.patents.com	0	0		
1332	chr1	97910850	97910876	3500012852	23		97910850	97910876	8421504	2	11,12	0,14	g	350001285200000019	14-37						Anti-TNF antibodies and peptides of human necrosis factor	Le	2001	0		
1333	chr1	98130587	98130612	3500282252	23		98130587	98130612	8421504	2	9,14	0,11	c	350028225200000448	0-23						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
1333	chr1	98130611	98139789	3500163467	426		98130611	98139789	8421504	5	1,188,105,102,30	0,475,4362,7991,9148	p,c,g	350016346700015000,350016346700015001,350016346700000006,350016346700000006,350016346700015002	0-180,0-180,0-20,0-20,0-66						Entwicklungsspezifische Expression und m&#xf6;gliche funktionelle Bedeutung der Glukosetransporterisoformen in Pr&#xe4;implantationsembryonen des Rindes	ebdoc.sub.gwdg.de	0	0		
1333	chr1	98131187	98139761	3500119526	38		98131187	98139761	8421504	3	19,17,2	0,7500,8572	c,g	350011952600000002,350011952600000002,350011952600000003	0-19,0-19,0-19						Authors: Chu Yan CHAN1,2, Jeremy A. GUGGENHEIM1, Chi Ho TO2	ll.physiology.org	0	0		
1333	chr1	98131206	98140142	3500161292	40		98131206	98140142	8421504	2	20,20	0,8916	c,g	350016129200000026,350016129200000026,350016129200000064,350016129200000064,350016129200000007,350016129200000045	0-20,0-20,0-20,0-20,0-20,0-20						Method of Inducing Embryonic Stem Cells Into Pancreatic Cells - Patent application	www.faqs.org	0	0		SLC2A2
1333	chr1	98138651	98138675	3500355847	24		98138651	98138675	8421504	1	24	0	c	350035584700000020	21-45						Untersuchungen zu genomweiten Ver&#xe4;nderungen der Genexpression in der Leber von Sauen w&#xe4;hrend der Laktation	eb.uni-giessen.de	0	0		SLC2A2
1334	chr1	98208059	98208107	3500352951	48		98208059	98208107	8421504	1	48	0	p	350035295100015004	0-48						Plants Resistant To Cytoplasm-feeding Parasites 	.freshpatents.com	0	0		EIF5A2
1334	chr1	98223918	98223943	3500184026	23		98223918	98223943	8421504	2	9,14	0,11	c	350018402600000014	0-23			10.1002/ijc.22875	1097-0215	International Journal of Cancer	Id1 expression is transcriptionally regulated in radial growth phase melanomas - Ryu - 2007 - International Journal of Cancer - Wiley Online Library	Ryu	2007	0		
1334	chr1	98238660	98240550	3500434170	40		98238660	98240550	8421504	3	12,7,21	0,1801,1869	c,g	350043417000000024,350043417000000025,350043417000000025	0-19,0-21,0-21						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
1336	chr1	98505588	98505621	3500017833	33		98505588	98505621	8421504	1	33	0	g	350001783300000014	8-41						The Human SETMAR Protein Preserves Most of the Activities of the Ancestral Hsmar1 Transposase	www.irisa.fr	0	0		
1336	chr1	98549824	98549849	3500066857	24		98549824	98549849	8421504	2	8,16	0,9	g	350006685700000062	12-39						Anti-IGF-I receptor antibody	R*Xin Ge 	2005	0		
1337	chr1	98665833	98679248	3500019989	40		98665833	98679248	8421504	2	20,20	0,13395	c,g	350001998900000258,350001998900000258,350001998900000257	0-20,0-20,0-20						Genexpressions-Profil einer dysmyelinisierenden Doppel knock out-Mausmutante (mbp-/- plp-/-) und Rescue-Versuch des normalen Ph&#xe4;notyps	www.uni-koeln.de	0	0		CLDN11
1337	chr1	98679170	98679215	3500104165	45		98679170	98679215	8421504	1	45	0	p	350010416500015143	0-45						The detection and role of human endogenous retroviruses in multiple sclerosis and other neurological diseases	penrepository.com	0	0		CLDN11
1339	chr1	98846246	98914291	3500165258	1788		98846246	98914291	8421504	18	85,116,90,80,126,88,136,87,98,177,59,55,141,86,51,90,122,101	0,4065,4921,6683,8137,9391,14901,16967,17970,18505,21696,22897,26895,28404,32438,33995,53701,67944	p	350016525800015019	0-1788						T3DB: Showing Lead subacetate (T3D1331)	classic.t3db.org	0	0		PRKCI
1339	chr1	98846279	98914213	3500104834	1196		98846279	98914213	8421504	36	45,47,24,69,18,27,2,43,32,13,45,45,45,16,29,45,21,45,9,36,45,45,45,5,40,45,9,36,45,45,2,43,45,45,22,23	0,4076,4124,4888,4960,6650,6728,8104,8198,9358,9374,14892,14940,14988,16934,16966,17947,17978,18026,18472,18511,18559,21669,21717,22864,26898,26994,28371,28410,32406,32454,33962,53672,53720,53768,67911	p,c,g	350010483400015068,350010483400015064,350010483400000020,350010483400015062,350010483400000007,350010483400000019,350010483400015060,350010483400015058,350010483400015054,350010483400015050,350010483400015048,350010483400015044,350010483400015042,350010483400015040,350010483400015038,350010483400000004,350010483400000004,350010483400000016,350010483400000016,350010483400015034,350010483400015033,350010483400015031,350010483400015029,350010483400015025,350010483400015023,350010483400015019,350010483400015015,350010483400015072,350010483400015012,350010483400015010,350010483400015006,350010483400015004,350010483400015002	0-45,0-45,0-25,0-45,0-22,0-22,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-21,0-21,0-21,0-21,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						PROTEIN KINASE C IOTA - Patent application	www.faqs.org	0	0		
1339	chr1	98855662	98855725	3500393400	63		98855662	98855725	8421504	1	63	0	p	350039340000015007	0-63						METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS - Patent application	www.faqs.org	0	0		PRKCZ
1339	chr1	98855662	98855725	3500321498	63		98855662	98855725	8421504	1	63	0	p	350032149800015007	0-63						Methods and compositions related to wrapping of dehydrons	Bornmann	2008	0		PRKCZ
1339	chr1	98864286	98874668	3500273790	40		98864286	98874668	8421504	3	20,2,18	0,8994,10364	c	350027379000000011,350027379000000017	0-20,0-20		22664730		1791-2997	Molecular Medicine Reports	Role of protein kinase C&#xb5; isoform expression in dimethylhydrazine-induced vascular endothelial proliferation	Nam	2012	0		PRKCZ
1339	chr1	98864286	98874668	3500273660	40		98864286	98874668	8421504	3	20,2,18	0,8994,10364	c	350027366000000013,350027366000000019	0-20,0-20						Role of protein kinase C&#xb5; isoform expression in dimethylhydrazine-induced vascular endothelial proliferation	-publications.com	0	0		PRKCZ
1339	chr1	98873179	98873209	3500441689	24		98873179	98873209	8421504	3	6,12,6	0,11,24	c	350044168900000086	2-28						Patent Search: US Patent Number 8168602 - Compositions, kits and methods for identification, assessment, prevention and therapy of cancer	ww.archpatent.com	0	0		
1339	chr1	98880322	98914216	3500192260	41		98880322	98914216	8421504	3	9,11,21	0,19625,33873	c,g	350019226000000003,350019226000000002,350019226000000002	0-20,0-21,0-21						Coordination of glioblastoma cell motility by PKC&#x03b9;	ww.slideshare.net	0	0		PRKCI
1339	chr1	98880322	98914216	3500025756	41		98880322	98914216	8421504	3	9,11,21	0,19625,33873	c,g	350002575600000003,350002575600000002,350002575600000002	0-20,0-21,0-21		20815904	10.1186/1476-4598-9-233	1476-4598	Molecular Cancer	Coordination of glioblastoma cell motility by PKC&#xce;&#xb9;	Baldwin	2010	4		PRKCI
1339	chr1	98914541	98914564	3500207695	23		98914541	98914564	8421504	1	23	0	g	350020769500000022	15-38		14670960	10.1074/jbc.M312840200	0021-9258	Journal of Biological Chemistry	Bcr-Abl Regulates Protein Kinase C&#x03b9; (PKC&#x03b9;) Transcription via an Elk1 Site in the PKC&#x03b9; Promoter	Gustafson	2004	5		
1340	chr1	99027097	99027221	3500042521	52		99027097	99027221	8421504	3	23,6,23	0,27,101	c	350004252100000013,350004252100000136,350004252100000137	0-29,0-23,0-23						TUMOR ANGIOGENESIS ASSOCIATED GENES AND A METHOD FOR THEIR IDENTIFICATION - Patent application	www.faqs.org	0	0		PHC3
1341	chr1	99096733	99096760	3500465838	23		99096733	99096760	8421504	2	13,10	0,17	g	350046583800000010	5-28						Plant myo-inositol kinase polynucleotides and methods of use	Shi	2008	0		
1341	chr1	99160158	99160186	3500408792	25		99160158	99160186	8421504	2	20,5	0,23	c	350040879200000065	16-41						Engulfment gene and uses thereof	Liu	1998	0		
1343	chr1	99375864	99375916	3500401025	52		99375864	99375916	8421504	1	52	0	c	350040102500000001	4-56						Identification of Short Interspersed Elements (SINEs) in Iranian River Buffalo	www.eaap.org	0	0		
1343	chr1	99423076	99423411	3500250987	41		99423076	99423411	8421504	2	21,20	0,315	c,g	350025098700000001,350025098700000002,350025098700000002	8-29,0-20,0-20					Neoplasia (New York, N.Y.)	Activation of Telomerase RNA Gene Promoter Activity by NF-Y, Sp1, and the Retinoblastoma Protein and Repression by Sp3	Jiang-Qin	2000	0		
1343	chr1	99423668	99423694	3500307235	26		99423668	99423694	8421504	1	26	0	c	350030723500000100	0-26						US Patent # 6,025,194. Nucleic acid sequence of senescence asssociated gene - Patents.com	www.patents.com	0	0		
1344	chr1	99509384	99509408	3500414160	23		99509384	99509408	8421504	2	13,10	0,14	g	350041416000000084	5-28						 Removal Of Phthalyl Groups From Amides And Esters Using An Amidase Isolated From Xanthobacter Agilis 	www.docstoc.com	0	0		
1348	chr1	100063355	100063380	3500193652	24		100063355	100063380	8421504	2	15,9	0,16	g	350019365200000021,350019365200000025,350019365200000026	0-20,0-22,0-21						SUPERCHARGED PROTEINS FOR CELL PENETRATION - Patent application	www.faqs.org	0	0		
1349	chr1	100268324	100268352	3500427280	27		100268324	100268352	8421504	2	13,14	0,14	g	350042728000000021	0-34						US Patent # 6,265,149. In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies - Patents.com	www.patents.com	0	0		
1355	chr1	101016289	101016316	3500334664	24		101016289	101016316	8421504	3	14,4,6	0,15,21	g	350033466400000097	10-39						Expression Cassettes for Seed-Preferential Expression in Plants - Patent application	www.faqs.org	0	0		
1356	chr1	101150745	101150771	3500193005	24		101150745	101150771	8421504	2	12,12	0,14	g	350019300500000024	0-24						PREPARATION OF ISOLATED AGONIST ANTI-EDAR MONOCLONAL ANTIBODIES	Schneider	2010	0		
1358	chr1	101448830	101448853	3500392816	23		101448830	101448853	8421504	1	23	0	g	350039281600000004	0-23						Sulfonylureas and Glinides Exhibit Peroxisome Proliferator- Activated Receptor Activity: A Combined Virtual Screening and Biological Assay Approach	aspetjournals.org	0	0		HNRNPH2
1358	chr1	101448830	101448853	3500240211	23		101448830	101448853	8421504	1	23	0	g	350024021100000004	0-23						Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor Activity: A Combined Virtual Screening and Biological Assay Approach 2007&#x5e74;&#x7b2c;69&#x5377;&#x7b2c;2&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x75	www.39kf.com	0	0		ZNF217,HNRNPH2
1359	chr1	101525047	101526547	3500456763	60		101525047	101526547	8421504	2	35,25	0,1475	p	350045676300015020	0-60						Use Of Serine Protease Inhibitors In The Treatment Of Neutropenia	Fontana	2012	0		SERPINI1
1360	chr1	101623592	101654078	3500160135	45		101623592	101654078	8421504	2	24,21	0,30465	c,g	350016013500000000,350016013500000000,350016013500000001	0-24,0-24,0-21			10.1091/mbc.E06-07-0608		Molecular Biology of the Cell	PDCD10 Interacts with Ste20-related Kinase MST4 to Promote Cell Growth and Transformation via Modulation of the ERK Pathway	Xi	June	0		PDCD10
1360	chr1	101623596	101636451	3500441097	46		101623596	101636451	8421504	3	23,3,20	0,89,12835	c	350044109700000004,350044109700000005	0-23,0-23		21561862	10.1074/jbc.M110.214486		The Journal of Biological Chemistry	Structure-Function Analysis of Core STRIPAK Proteins: A SIGNALING COMPLEX IMPLICATED IN GOLGI POLARIZATION*	Michelle	July	0		PDCD10
1360	chr1	101623596	101636451	3500307414	46		101623596	101636451	8421504	3	23,3,20	0,89,12835	c,g	350030741400000004,350030741400000004,350030741400000005	0-23,0-23,0-23		21561862	10.1074/jbc.M110.214486	0021-9258	Journal of Biological Chemistry	Structure-Function Analysis of Core STRIPAK Proteins	Kean	2011	5		
1360	chr1	101654396	101684348	3500019989	40		101654396	101684348	8421504	2	20,20	0,29932	c,g	350001998900000274,350001998900000273	0-20,0-20						Genexpressions-Profil einer dysmyelinisierenden Doppel knock out-Mausmutante (mbp-/- plp-/-) und Rescue-Versuch des normalen Ph&#xe4;notyps	www.uni-koeln.de	0	0		PDCD10
1360	chr1	101673429	101684466	3500355881	232		101673429	101684466	8421504	9	30,25,18,20,16,5,16,32,70	0,1714,1746,1803,7130,7594,10801,10818,10967	c	350035588100000004,350035588100000003	0-250,0-190						Inhibitory polynucleotide compositions and methods for treating cancer	Liu	2011	0		
1361	chr1	101713868	101713897	3500307028	24		101713868	101713897	8421504	2	14,10	0,19	g	350030702800000006	0-36					Patent	Verfahren zur verkn&#xfc;pfung interessierender sequenzen Method of linkage sequences of interest (Patent DE:602004012299)	Andersen	2009	0		
1361	chr1	101776102	101776133	3500245535	27		101776102	101776133	8421504	3	14,8,5	0,17,26	g	350024553500000003	4-31						Selective Sphingosine 1-Phosphate 1 (S1P ) Receptor Activation Reduces Ischemia-Reperfusion Injury in Mouse Kidney	al.physiology.org	0	0		
1370	chr1	103001967	103001996	3500249562	24		103001967	103001996	8421504	2	11,13	0,16	g	350024956200000001	8-36						B-cell reduction using CD37-specific and CD20-specific binding molecules	Grosmaire	2007	0		
1374	chr1	103425932	103426678	3500116874	122		103425932	103426678	8421504	3	48,48,26	0,192,720	c,g	350011687400000022,350011687400000026,350011687400000037	0-48,0-48,0-26						ENZYME CONJUGATES FOR USE AS DETOXIFYING AGENTS - Patent application	www.faqs.org	0	0		
1374	chr1	103426136	103426196	3500278687	60		103426136	103426196	8421504	1	60	0	p	350027868700015012	0-60						Molecular Cloning and Characterization of Esterase-6, a Serine Hydrolase of Drosophila	www.jstor.org	0	0		BCHE
1374	chr1	103522073	103522097	3500101289	23		103522073	103522097	8421504	2	19,4	0,20	g	350010128900000311	8-31						NOVEL SURFACE ANTIGEN - Patent application	www.faqs.org	0	0		
1374	chr1	103522073	103522097	3500057001	23		103522073	103522097	8421504	2	19,4	0,20	g	350005700100000311	8-31						Surface antigen	www.devileye.net	0	0		
171	chr1	103542989	103555617	3500116874	66		103542989	103555617	8421504	2	30,36	0,12592	c	350011687400000046,350011687400000048	18-48,12-48						ENZYME CONJUGATES FOR USE AS DETOXIFYING AGENTS - Patent application	www.faqs.org	0	0		
1380	chr1	104232039	104232063	3500319613	24		104232039	104232063	8421504	1	24	0	c,g	350031961300000003,350031961300000003,350031961300000002,350031961300000002	18-42,18-42,0-24,0-24		10692463	10.1074/jbc.275.9.6566	0021-9258	Journal of Biological Chemistry	Structural Determinants Required for Apical Sorting of an Intestinal Brush-border Membrane Protein	Jacob	2000	5		
1380	chr1	104317470	104318424	3500090833	23		104317470	104318424	8421504	3	5,8,10	0,8,944	c	350009083300000049	14-38						Les transporteurs de peptides de	hives-ouvertes.fr	0	0		
1381	chr1	104435067	104435092	3500120201	23		104435067	104435092	8421504	2	6,17	0,8	g	350012020100000019	19-42						INDUCIBLE EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
1387	chr1	105179039	105179157	3500024826	42		105179039	105179157	8421504	2	20,22	0,96	g	350002482600000022,350002482600000021	0-20,0-22						Udder Health Characteristics 	.freshpatents.com	0	0		
1394	chr1	106088272	106088301	3500345824	25		106088272	106088301	8421504	3	7,5,13	0,8,16	g	350034582400000013	11-36						Method of producing secreted CMV glycoprotein H	Spaete	1992	0		
1397	chr1	106450054	106450081	3500343677	25		106450054	106450081	8421504	2	12,13	0,14	g	350034367700000001	0-28		18495761	10.1128/JVI.02414-07	0022-538X	Journal of Virology	Cross Talk between Expression of the Human T-Cell Leukemia Virus Type 1 Tax Transactivator and the Oncogenic bHLH Transcription Factor TAL1	Terme	2008	5		
1400	chr1	106836553	106836579	3500203604	23		106836553	106836579	8421504	2	8,15	0,11	g	350020360400000057	0-23						Methods in Molecular Biology Vol. 057 in Vitro Mutagenesis Protocols	www.scribd.com	0	0		
1410	chr1	108152950	108152979	3500003762	29		108152950	108152979	8421504	1	29	0	c	350000376200000008	18-47						Novel Regulators of Pancreatic Cancer Cell Growth and Mobility	tampub.uta.fi	0	0		
1410	chr1	108242523	108242709	3500185291	120		108242523	108242709	8421504	2	22,98	0,88	c,g	350018529100000038,350018529100000037,350018529100000036,350018529100000036	0-22,0-98,0-22,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		SMC4
1410	chr1	108242523	108242690	3500439152	66		108242523	108242690	8421504	3	22,22,22	0,107,145	c,g	350043915200000184,350043915200000184,350043915200000221,350043915200000221,350043915200000192,350043915200000192	0-22,0-22,0-22,0-22,0-22,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		SMC4
1410	chr1	108242523	108242690	3500363476	44		108242523	108242690	8421504	2	22,22	0,145	c,g	350036347600000024,350036347600000023,350036347600000023	0-22,0-22,0-22						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - Patent application	www.faqs.org	0	0		SMC4
1410	chr1	108242523	108242690	3500323428	44		108242523	108242690	8421504	2	22,22	0,145	c,g	350032342800000038,350032342800000040,350032342800000040	0-22,0-22,0-22						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		DLEU2,SMC4
1410	chr1	108242523	108242690	3500307429	44		108242523	108242690	8421504	2	22,22	0,145	c,g	350030742900000024,350030742900000024,350030742900000023,350030742900000023	0-22,0-22,0-22,0-22						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - YEDA RESEARCH AND DEVELOPMENT CO. LTD.	www.sumobrain.com	0	0		
1410	chr1	108242523	108242690	3500277393	44		108242523	108242690	8421504	2	22,22	0,145	c,g	350027739300000035,350027739300000035,350027739300000027,350027739300000027	0-22,0-22,0-22,0-22						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		SMC4
1410	chr1	108242523	108242690	3500244257	44		108242523	108242690	8421504	2	22,22	0,145	c,g	350024425700000040,350024425700000039,350024425700000039	0-22,0-22,0-22						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		DLEU2
1410	chr1	108242523	108242690	3500131966	44		108242523	108242690	8421504	2	22,22	0,145	c,g	350013196600000040,350013196600000039,350013196600000039	0-22,0-22,0-22						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		SMC4
1410	chr1	108242523	108242652	3500114594	44		108242523	108242652	8421504	2	22,22	0,107	c,g	350011459400000810,350011459400000810,350011459400000383,350011459400000383,350011459400000382,350011459400000382,350011459400000809,350011459400000809	0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-22						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		SMC4
1410	chr1	108242523	108242652	3500031979	44		108242523	108242652	8421504	2	22,22	0,107	c	350003197900000298,350003197900000297	0-22,0-22						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		SMC4
1410	chr1	108242523	108242546	3500180001	23		108242523	108242546	8421504	1	23	0	c,g	350018000100000009,350018000100000009	0-23,0-23						Glucocorticoid-Mediated Repression of the Oncogenic microRNA Cluster miR-17 92 Contributes to the Induction of Bim and Initiation of Apoptosis	.endojournals.org	0	0		
1410	chr1	108242630	108242690	3500306016	44		108242630	108242690	8421504	2	22,22	0,38	c,g	350030601600000003,350030601600000002,350030601600000002	0-22,0-22,0-22						Upregulating of miR-15b for preventing cellular senescence and tissue aging	Krutmann	2013	0		SMC4
1413	chr1	108584853	108584876	3500375146	23		108584853	108584876	8421504	1	23	0	c	350037514600000058	20-43						A radiation hybrid map of river buffalo (Bubalus bubalis) chromosome 1 (BBU1)	ticabovina.com.br	0	0		
1413	chr1	108584874	108591551	3500131600	499		108584874	108591551	8421504	9	42,99,119,24,24,11,84,80,16	0,57,1882,2002,2126,2275,2638,5959,6661	p,c	350013160000000007,350013160000000054,350013160000000040,350013160000000039,350013160000000052,350013160000000038,350013160000000051,350013160000000050,350013160000000036,350013160000015042,350013160000015035,350013160000000033,350013160000000046,350013160000000032,350013160000015057,350013160000015047,350013160000015056,350013160000000006	9-30,0-42,0-27,0-48,0-48,0-48,0-48,0-48,1-48,0-45,0-48,0-47,0-48,0-48,0-48,0-45,0-48,9-30						Immune response modulators and uses therefor	Seow	1997	0		
1413	chr1	108584880	108591551	3500203975	587		108584880	108591551	8421504	16	54,13,36,31,24,48,44,36,6,26,34,58,13,44,104,16	0,64,78,119,1876,1913,1976,2126,2238,2254,2632,2672,2734,5881,5929,6655	c,g	350020397500000066,350020397500000067,350020397500000025,350020397500000025,350020397500000027,350020397500000024	0-601,11-596,0-58,0-58,9-58,0-58						US Patent # 7,115,712. Cytokine polypeptides - Patents.com	www.patents.com	0	0		
1413	chr1	108584977	108590810	3500355031	43		108584977	108590810	8421504	2	22,21	0,5812	c,g	350035503100000007,350035503100000006,350035503100000006	0-22,0-21,0-21						OKAMATSU-OGURA, Yuko; SOLIMAN, Mohamed; ABD Citation Journal of Veterinary Medical Science, 69(5): 509-514 Issue Date 2007-05	lib.hokudai.ac.jp	0	0		
1413	chr1	108584998	108590805	3500201044	100		108584998	108590805	8421504	3	29,38,33	0,1795,5774	c	350020104400000046,350020104400000044,350020104400000036	0-29,0-38,1-34						Natural killer stimulatory factor	Trinchieri	1990	0		
1413	chr1	108585029	108587005	3500457411	40		108585029	108587005	8421504	4	1,19,15,5	0,1727,1856,1971	c	350045741100000005,350045741100000004	0-20,0-20		19515866	10.1128/CVI.00424-08	1556-6811	Clinical and Vaccine Immunology	T-Cell mRNA Expression in Response to Mycobacterium bovis BCG Vaccination and Mycobacterium bovis Infection of White-Tailed Deer	Thacker	2009	3		
1413	chr1	108586848	108590770	3500423964	40		108586848	108590770	8421504	3	20,11,9	0,767,3913	c,g	350042396400000000,350042396400000000,350042396400000001	0-20,0-20,0-20						gd T cells present antigen to CD4 ab T cells	www.jleukbio.org	0	0		
1413	chr1	108586852	108586876	3500148728	24		108586852	108586876	8421504	1	24	0	c	350014872800000017	0-24		15047817	10.1128/JVI.78.8.4011-4019.2004	0022-538X	Journal of Virology	Gamma Interferon/Interleukin 10 Balance in Tissue Lymphocytes Correlates with Down Modulation of Mucosal Feline Immunodeficiency Virus Infection	Avery	2004	5		IL12A
1413	chr1	108586873	108587542	3500399883	44		108586873	108587542	8421504	2	24,20	0,649	c,g	350039988300000011,350039988300000010,350039988300000010	0-24,0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	bdtd.ufscar.br	0	0		
1413	chr1	108586873	108587542	3500177864	44		108586873	108587542	8421504	2	24,20	0,649	c,g	350017786400000012,350017786400000012,350017786400000011,350017786400000011	0-24,0-24,0-20,0-20						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
1413	chr1	108586873	108587542	3500164845	44		108586873	108587542	8421504	2	24,20	0,649	c,g	350016484500000011,350016484500000010,350016484500000010	0-24,0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	ww.bdtd.ufscar.br	0	0		
1413	chr1	108586873	108587542	3500136902	44		108586873	108587542	8421504	2	24,20	0,649	c,g	350013690200000007,350013690200000007,350013690200000006,350013690200000006	0-24,0-24,0-20,0-20						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
1413	chr1	108587528	108587553	3500149326	25		108587528	108587553	8421504	1	25	0	c	350014932600000002	0-25		9616161		0006-4971	Blood	Interferon-&#x03b3;&#x2013;Dependent Inducible Expression of the Human Interleukin-12 p35 Gene in Monocytes Initiates From a TATA-Containing Promoter Distinct From the CpG-Rich Promoter Active in Epstein-Barr Virus-Transformed Lymphoblastoid Cells	Hayes	1998	10		
1413	chr1	108587538	108587561	3500140535	23		108587538	108587561	8421504	1	23	0	c	350014053500000015	0-23		21084468	10.1128/JVI.01635-10	0022-538X	Journal of Virology	RIG-I-Mediated Antiviral Signaling Is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I	Solis	2011	5		
1413	chr1	108587557	108587626	3500179003	69		108587557	108587626	8421504	1	69	0	p	350017900300015056,350017900300015068	0-48,0-48						US Patent # 6,472,509. Feline cytokine protein - Patents.com	www.patents.com	0	0		
1413	chr1	108587596	108587622	3500261631	26		108587596	108587622	8421504	1	26	0	c	350026163100000013	0-26						Innate immune markers that distinguish red deer (Cervus elaphus) selected for resistant or susceptible genotypes for Johne&#xfffd;s disease	inaryresearch.org	0	0		
1414	chr1	108714392	108714483	3500378226	87		108714392	108714483	8421504	2	19,68	0,23	g	350037822600000029	77-165						Diagnostic detection of nucleic acids	Schuetz	2004	0		
1414	chr1	108714392	108714483	3500134371	87		108714392	108714483	8421504	2	19,68	0,23	g	350013437100000029	77-165						Diagnostic detection of nucleic acids	Schuetz	2002	0		
1415	chr1	108860517	108860543	3500327411	25		108860517	108860543	8421504	2	19,6	0,20	g	350032741100000012	13-38						Genetic diversity and bottleneck studies in the Marwari horse breed	www.ias.ac.in	0	0		
1423	chr1	109842870	109842899	3500158783	25		109842870	109842899	8421504	2	19,6	0,23	g	350015878300000019	2-29						Clostridium beijerinckii and Clostridium dif&#xfb01;cile Methylglyoxal by a Novel Mechanism Involving Glycerol Dehydrogenase	aem.asm.org	0	0		
1423	chr1	109920415	109920446	3500207808	25		109920415	109920446	8421504	3	5,12,8	0,8,23	c	350020780800000024	16-41						Polypeptides Recognized by Anti-Trichinella Antibodies, and Uses Thereof - Patent application	www.faqs.org	0	0		
1423	chr1	109929790	109940059	3500348941	513		109929790	109940059	8421504	6	91,57,112,99,103,51	0,426,1821,2463,4829,10218	p	350034894100015012	9-522						 Secreted Protein HT5GJ57 	www.docstoc.com	0	0		MFSD1
1424	chr1	110058141	110068732	3500047878	40		110058141	110068732	8421504	3	17,3,20	0,10352,10571	c	350004787800000052,350004787800000053	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1425	chr1	110140923	110140951	3500080185	25		110140923	110140951	8421504	3	5,15,5	0,7,23	g	350008018500000081	6-31						Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers	Parr	2011	0		
1429	chr1	110690199	110690229	3500307193	25		110690199	110690229	8421504	2	17,8	0,22	g	350030719300000040	8-36						Banana streak badnavirus (BSV) in South Africa: incidence, transmission and the development of an antibody based detection system	upetd.up.ac.za	0	0		
1430	chr1	110855460	110855492	3500112358	26		110855460	110855492	8421504	4	11,4,4,7	0,12,17,25	g	350011235800000001	1-29						Cell density-dependent regulation of tumor necrosis factor &#x03b1; gene expression in a human hepatoma cell line	-publications.com	0	0		
1431	chr1	110911740	110911763	3500408875	23		110911740	110911763	8421504	1	23	0	g	350040887500000015	9-32						US Patent # 7,141,408. Plasmid maintenance system for antigen delivery - Patents.com	www.patents.com	0	0		
1431	chr1	110944345	110944372	3500005314	25		110944345	110944372	8421504	2	6,19	0,8	g	350000531400000868	1-26						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
1432	chr1	111146168	111146191	3500344185	23		111146168	111146191	8421504	1	23	0	g	350034418500000001	4-27						Collagen Producing Plants And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
1434	chr1	111377449	111377482	3500414160	25		111377449	111377482	8421504	3	13,3,9	0,18,24	g	350041416000000008	14-39						 Removal Of Phthalyl Groups From Amides And Esters Using An Amidase Isolated From Xanthobacter Agilis 	www.docstoc.com	0	0		
1435	chr1	111508977	111514695	3500288419	53		111508977	111514695	8421504	2	22,31	0,5687	c,g	350028841900000010,350028841900000011,350028841900000011,350028841900000012,350028841900000012	19-41,8-37,8-37,7-38,7-38						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
1435	chr1	111509032	111509205	3500172791	41		111509032	111509205	8421504	2	21,20	0,153	c,g	350017279100000005,350017279100000004,350017279100000004	0-21,0-20,0-20		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
1435	chr1	111509032	111509205	3500120290	41		111509032	111509205	8421504	2	21,20	0,153	c,g	350012029000000005,350012029000000005,350012029000000004,350012029000000004	0-21,0-21,0-20,0-20						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
1435	chr1	111509032	111509205	3500048191	41		111509032	111509205	8421504	2	21,20	0,153	c	350004819100000005,350004819100000004	0-21,0-20		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
1435	chr1	111509186	111509529	3500145630	48		111509186	111509529	8421504	2	24,24	0,319	c,g	350014563000000027,350014563000000026,350014563000000026	0-24,0-24,0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1435	chr1	111509211	111509243	3500155690	32		111509211	111509243	8421504	1	32	0	c,g	350015569000000000,350015569000000000	0-32,0-32						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		
1435	chr1	111514190	111514645	3500204539	45		111514190	111514645	8421504	2	14,31	0,424	p	350020453900015002	0-45						Methods And Kits For Early Detection Of Cancer Or Predisposition Thereto 	.freshpatents.com	0	0		
1435	chr1	111514625	111514650	3500003989	25		111514625	111514650	8421504	1	25	0	c	350000398900000005,350000398900000000	0-24,0-25						Evolution of the Pentraxin Family: The New Entry PTX4	www.jimmunol.org	0	0		PTX3
1439	chr1	111990190	112000245	3500366168	492		111990190	112000245	8421504	6	147,75,110,103,51,6	0,431,1191,6903,9878,10049	p	350036616800015001,350036616800015002	0-435,0-57						POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-KB PATHWAY - BRISTOL-MYERS SQUIBB COMPANY	www.sumobrain.com	0	0		CCNL1
1439	chr1	111990328	111991417	3500081248	120		111990328	111991417	8421504	3	9,75,36	0,293,1053	p	350008124800015019	0-120						NPG.nature.vol.409.Issue.6822.Feb	www.scribd.com	0	0		CCNL1
1441	chr1	112323374	112323401	3500387182	24		112323374	112323401	8421504	2	6,18	0,9	g	350038718200000014	8-32						A Novel Screening Tool using Microarray and PCR to Detect Pathogens in Agriculturally Impacted Waters. - ResearchGate	.researchgate.net	0	0		
1443	chr1	112473313	112474551	3500296333	540		112473313	112474551	8421504	4	78,114,211,137	0,90,213,1101	p	350029633300015128,350029633300015119,350029633300015110,350029633300015101,350029633300015102	0-78,0-114,0-177,0-171,0-171						Molekulare Klonierung und Charakterisierung neuer ADP-Ribosyltransferasen bei Homo sapiens und Salmonella typhimurium	ub.uni-hamburg.de	0	0		TIPARP
1445	chr1	112732989	112780560	3500467027	55		112732989	112780560	8421504	4	20,8,8,19	0,4947,4977,47552	c	350046702700000007,350046702700000017	0-28,0-27			10.1113/jphysiol.2001.018333		The Journal of Physiology	Potassium channels Kv1.1, Kv1.2 and Kv1.6 influence excitability of rat visceral sensory neurons	Patricia	June	0		KCNAB1
1445	chr1	112732989	112780560	3500200716	55		112732989	112780560	8421504	4	20,8,8,19	0,4947,4977,47552	c	350020071600000007,350020071600000017	0-28,0-27			10.1113/jphysiol.2001.018333	0022-3751	The Journal of Physiology	Potassium channels Kv1.1, Kv1.2 and Kv1.6 influence excitability of rat visceral sensory neurons	Glazebrook	2002	5		KCNAB1
1445	chr1	112732989	112780560	3500154739	55		112732989	112780560	8421504	4	20,8,8,19	0,4947,4977,47552	c	350015473900000007,350015473900000017	0-28,0-27			10.1113/jphysiol.2001.018333	0022-3751	The Journal of Physiology	Potassium channels Kv1.1, Kv1.2 and Kv1.6 influence excitability of rat visceral sensory neurons	Glazebrook	2002	5		KCNAB1
1450	chr1	113456108	113456134	3500187053	24		113456108	113456134	8421504	2	12,12	0,14	c	350018705300000016	21-45						Production of Bacillus entomotoxins in methylotrophic yeast	Sreekrishna	1994	0		
1452	chr1	113643678	113643707	3500465169	25		113643678	113643707	8421504	2	13,12	0,17	g	350046516900000029	10-44						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
1452	chr1	113722664	113722690	3500136429	23		113722664	113722690	8421504	3	13,6,4	0,15,22	g	350013642900000012,350013642900000013	0-26,3-29						METHOD FOR PRODUCING MONATIN	Takakura	2011	0		
1453	chr1	113841607	113841635	3500066729	23		113841607	113841635	8421504	2	14,9	0,19	g	350006672900000008	0-35		10762614			American Journal of Physiology - Gastrointestinal and Liver Physiology	Regulation of the human Na+-glucose cotransporter gene, SGLT1, by HNF-1 and Sp1	Martin	2000	0		
1457	chr1	114376134	114376160	3500325015	24		114376134	114376160	8421504	2	18,6	0,20	g	350032501500000006	0-25						METHOD AND SYSTEM FOR PURIFYING AND QUANTITATING PROTEINS USING HEME FUSION TAGS	Bren	2011	0		
1458	chr1	114532886	114532917	3500017833	31		114532886	114532917	8421504	1	31	0	g	350001783300000022,350001783300000021	14-45,14-45						The Human SETMAR Protein Preserves Most of the Activities of the Ancestral Hsmar1 Transposase	www.irisa.fr	0	0		
1458	chr1	114550399	114550423	3500440195	23		114550399	114550423	8421504	2	7,16	0,8	g	350044019500000712,350044019500000736,350044019500000743	4-27,4-27,4-27						METHODS AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENE EXPRESSION ASSOCIATED WITH THE PROGNOSIS OF PROSTATE CELL PROLIFERATIVE DISORDERS - Patent application	www.faqs.org	0	0		
1459	chr1	114624149	114624174	3500160499	23		114624149	114624174	8421504	2	7,16	0,9	g	350016049900000049	7-33						Sam-6 variants, target and methods of use	Ilag	2010	0		
1462	chr1	115079674	115079698	3500438386	23		115079674	115079698	8421504	2	14,9	0,15	c	350043838600000025	0-23						US Patent # 6,316,225. Human Prt1-like subunit protein (hPrt1) polynucleotides - Patents.com	www.patents.com	0	0		
1470	chr1	116106753	116106779	3500105958	24		116106753	116106779	8421504	2	10,14	0,12	g	350010595800000018	21-45						Hepatitis c assay utilizing recombinant antigens from ns5 region	Dailey	1994	0		
1473	chr1	116466864	116466888	3500243043	24		116466864	116466888	8421504	1	24	0	g	350024304300000127	0-24					Patent	Genomic screen for epigenetically silenced genes associated with cancer (Patent US:7794929)	Baylin	2010	0		MBNL1
1473	chr1	116470718	116470744	3500010487	26		116470718	116470744	8421504	1	26	0	c	350001048700000019,350001048700000014	19-45,0-25					Patent	Method of obtaining small conformationally rigid conopeptides (Patent US:5885780)	Hillyard	1999	0		
1473	chr1	116470719	116470744	3500242013	25		116470719	116470744	8421504	1	25	0	c	350024201300000014	0-25					Patent	Method of obtaining small conformationally rigid conopeptides (Patent US:5885780)	Hillyard	1999	0		
1473	chr1	116473191	116473222	3500071688	31		116473191	116473222	8421504	1	31	0	c,g	350007168800000003,350007168800000003	8-39,8-39			10.1093/emboj/19.17.4439		The EMBO Journal	Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy	Jill	2000	0		MBNL1
1473	chr1	116473191	116473217	3500424726	26		116473191	116473217	8421504	1	26	0	c	350042472600000023	0-26		24010014	10.7717/peerj.134	2167-8359	PeerJ	The emerin-binding transcription factor Lmo7 is regulated by association with p130Cas at focal adhesions [PeerJ]	Wozniak	2013	0		MBNL1
1473	chr1	116473191	116473217	3500350580	26		116473191	116473217	8421504	1	26	0	c	350035058000000023	0-26						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal P	peerj.com/article	0	0		MBNL1
1473	chr1	116473191	116473217	3500283136	26		116473191	116473217	8421504	1	26	0	c,g	350028313600000023,350028313600000023	0-26,0-26		24010014	10.7717/peerj.134		PeerJ	The emerin-binding transcription factor Lmo7 is regulated by association with p130Cas at focal adhesions	Michele	2013	0		MBNL1
1473	chr1	116473219	116497180	3500354615	44		116473219	116497180	8421504	3	25,5,14	0,13725,23947	c	350035461500000001,350035461500000005	6-31,0-19		19095965	10.2353/ajpath.2009.080520		The American Journal of Pathology	Muscleblind-Like Proteins : Similarities and Differences in Normal and Myotonic Dystrophy Muscle	Ian	2009	0		MBNL1
1473	chr1	116473219	116473244	3500216530	25		116473219	116473244	8421504	1	25	0	c,g	350021653000000001,350021653000000001	6-31,6-31			10.1111/j.1365-2443.2007.01112.x	1365-2443	Genes to Cells	Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles - Holt - 2007 - Genes to Cells - Wiley Online Library	Holt	2007	0		MBNL1
1473	chr1	116484422	116486754	3500456400	43		116484422	116486754	8421504	2	22,21	0,2311	c,g	350045640000000009,350045640000000008,350045640000000008	0-22,0-21,0-21		19680539	10.1371/journal.pgen.1000600	1553-7404	PLOS Genetics	PLOS Genetics: RNA Gain-of-Function in Spinocerebellar Ataxia Type 8	Daughters	2009	0		MBNL1
1473	chr1	116484422	116486754	3500319560	43		116484422	116486754	8421504	2	22,21	0,2311	c,g	350031956000000009,350031956000000008,350031956000000008	0-22,0-21,0-21		19680539	10.1371/journal.pgen.1000600	1553-7404	PLOS Genetics	PLOS Genetics: RNA Gain-of-Function in Spinocerebellar Ataxia Type 8	Daughters	2009	0		MBNL1
1473	chr1	116508795	116508818	3500134343	23		116508795	116508818	8421504	1	23	0	c	350013434300000047	0-23						Assessing the complex nature of behavior: Sequence-based and transcriptomic analyses in a mouse model of extremes in trait anxiety	b.uni-muenchen.de	0	0		
1475	chr1	116689689	116689717	3500440211	23		116689689	116689717	8421504	2	8,15	0,13	g	350044021100000013	4-27						Use of alpha-toxin for treating and preventing staphylococcus infections	Taylor	2007	0		
1477	chr1	116995559	116996363	3500386499	40		116995559	116996363	8421504	2	20,20	0,784	c,g	350038649900000000,350038649900000000,350038649900000001,350038649900000001	0-20,0-20,0-20,0-20		15722352	10.1074/jbc.M410764200	0021-9258	Journal of Biological Chemistry	P2Y6 Nucleotide Receptors Activate NF-&#x03ba;B and Increase Survival of Osteoclasts	Korcok	2005	5		
1477	chr1	116996009	116996033	3500431119	24		116996009	116996033	8421504	1	24	0	c	350043111900000000	0-24			10.1124/jpet.107.131169	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Involvement of P2Y1 and P2Y11 Purinoceptors in Parasympathetic Inhibition of Colonic Smooth Muscle	King	2008	0		
1477	chr1	116996047	116996366	3500062901	42		116996047	116996366	8421504	2	21,21	0,298	c,g	350006290100000000,350006290100000000,350006290100000001	0-21,0-21,0-21						ATP Induces Synaptic Gene Expressions in Cortical Neurons: Transduction and Transcription Control via P2Y Receptors	aspetjournals.org	0	0		P2RY1
1477	chr1	116996109	116996133	3500404200	24		116996109	116996133	8421504	1	24	0	c	350040420000000003	0-24						Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. - ResearchGate	.researchgate.net	0	0		
1477	chr1	116996109	116996133	3500156080	24		116996109	116996133	8421504	1	24	0	c	350015608000000003	0-24						Immortalized human microglia cell line - Patent # 6780641 - PatentGenius	.patentgenius.com	0	0		
1485	chr1	118079862	118079888	3500452586	26		118079862	118079888	8421504	1	26	0	g	350045258600000004	0-26						Use of Spectral Analysis to Test Hypotheses on the Origin of Pinnipeds	brary.arizona.edu	0	0		MTRNR2L10
1485	chr1	118079862	118079888	3500379924	26		118079862	118079888	8421504	1	26	0	g	350037992400000002	9-35						ScienceDirect.com - Virology - Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon	sciencedirect.com	0	0		
1485	chr1	118079862	118079888	3500120123	26		118079862	118079888	8421504	1	26	0	g	350012012300000002	9-35						Phylogenetic Relationships and Biogeography of Xantusiid Lizards, Inferred from Mitochondria1 DNA Sequences	www.hedgeslab.org	0	0		
1485	chr1	118079865	118079892	3500085480	27		118079865	118079892	8421504	1	27	0	g	350008548000000002	0-27		17337445	10.1074/jbc.M700461200	0021-9258	Journal of Biological Chemistry	Human Mitochondrial Ribosomal Protein MRPL12 Interacts Directly with Mitochondrial RNA Polymerase to Modulate Mitochondrial Gene Expression	Wang	2007	5		
1485	chr1	118084961	118084987	3500164180	26		118084961	118084987	8421504	1	26	0	g	350016418000000000	0-26						Looking for the Iberian lynx in central Spain: a needle in a haystack?	w.priorimancha.es	0	0		
1486	chr1	118214493	118214528	3500200211	35		118214493	118214528	8421504	1	35	0	c	350020021100000308	0-35						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1487	chr1	118311069	118311097	3500060062	28		118311069	118311097	8421504	1	28	0	c	350006006200000002	0-28			10.1124/mol.104.000224	1521-0111 (Online)	Molecular Pharmacology	Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells	Ennion	2004	0		
1489	chr1	118570155	118570183	3500263756	23		118570155	118570183	8421504	3	11,8,4	0,15,24	g	350026375600000024	6-29						GAMMA SATELLITE INSULATOR SEQUENCES AND THEIR USE IN PREVENTING GENE SILENCING - Patent application	www.faqs.org	0	0		
1491	chr1	118860538	118860566	3500068547	24		118860538	118860566	8421504	2	16,8	0,20	g	350006854700000163,350006854700000466	11-35,11-35						HUMAN ERYTHROVIRUS - Patent application	www.faqs.org	0	0		
1492	chr1	118980129	118997515	3500227478	43		118980129	118997515	8421504	2	20,23	0,17363	c	350022747800000020,350022747800000010,350022747800000021,350022747800000011	6-26,6-26,8-31,8-31						Methods Of Regulating Growth And Death Of Cancer Cells 	.freshpatents.com	0	0		
1492	chr1	118997014	118997038	3500156344	24		118997014	118997038	8421504	1	24	0	c	350015634400000003	18-42			10.1111/j.1471-4159.2006.03962.x	1471-4159	Journal of Neurochemistry	Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation - Ravni - 2006 - Journal of Neurochemistry - Wiley Online Library	Ravni	2006	0		SIAH2
1496	chr1	119454850	119486022	3500135939	312		119454850	119486022	8421504	3	258,52,2	0,1198,31170	p	350013593900015002	0-312						Oreochromis_mossambicus-Contig_7-v1 | MarineGenomics.org	arinegenomics.org	0	0		TSC22D2
1496	chr1	119496591	119496616	3500454832	24		119496591	119496616	8421504	2	13,11	0,14	c	350045483200000444,350045483200000295,350045483200000358,350045483200000361,350045483200000401,350045483200000406,350045483200000368	0-24,0-25,0-20,0-20,0-19,0-19,0-19						Systematic evolution of ligands by exponential enrichment: tissue selex	Heilig	2002	0		
1496	chr1	119496591	119496616	3500406595	24		119496591	119496616	8421504	2	13,11	0,14	c	350040659500000444,350040659500000295,350040659500000361,350040659500000421,350040659500000358,350040659500000368,350040659500000406,350040659500000401	0-24,0-25,0-20,0-20,0-20,0-19,0-19,0-19						 Systematic Evolution Of Ligands By Exponential Enrichment: Tissue SELEX 	www.docstoc.com	0	0		
1498	chr1	119747532	119747558	3500224153	23		119747532	119747558	8421504	2	8,15	0,11	g	350022415300000027	14-43						Baculovirus-Based Vaccines - Patent application	www.faqs.org	0	0		
1500	chr1	120000208	120005615	3500244093	88		120000208	120005615	8421504	5	22,16,4,25,21	0,2433,4989,5066,5386	c,g	350024409300000006,350024409300000006,350024409300000002,350024409300000003,350024409300000007	8-30,8-30,4-24,0-25,0-21						Decreased expression of profilin 2 in oral squamous cell carcinoma and its clinicopathological implications	-publications.com	0	0		
1500	chr1	120002578	120005889	3500257433	43		120002578	120005889	8421504	2	20,23	0,3288	c,g	350025743300000018,350025743300000018,350025743300000009,350025743300000009,350025743300000008	0-20,0-20,0-21,0-21,0-21						Investigation of the molecular mechanisms regulating growth and recombinant protein productivity in suspension-adapted CHO-K1 cells	doras.dcu.ie	0	0		PFN2
1500	chr1	120005346	120005806	3500442637	235		120005346	120005806	8421504	4	14,50,139,32	0,68,121,428	c	350044263700000006	0-241						Functionally different mouse profilin II isoforms	cs.biologists.org	0	0		
1500	chr1	120011103	120011498	3500407657	153		120011103	120011498	8421504	2	77,76	0,319	p	350040765700015015	0-153						RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex	nlab.med.ucla.edu	0	0		RNF13
1502	chr1	120217430	120217458	3500113837	23		120217430	120217458	8421504	2	10,13	0,15	g	350011383700000046,350011383700000006	1-24,1-24						MARIA CRISTINA OW	aeum.libs.uga.edu	0	0		
1502	chr1	120234074	120234101	3500193635	26		120234074	120234101	8421504	2	22,4	0,23	g	350019363500000231	9-35						Materials and methods for immunocontraception	Harris	1993	0		
1504	chr1	120544480	120544503	3500024826	23		120544480	120544503	8421504	1	23	0	g	350002482600000023	0-23						Udder Health Characteristics 	.freshpatents.com	0	0		
1507	chr1	120935636	120935684	3500203985	48		120935636	120935684	8421504	1	48	0	p	350020398500015000	0-48						La Asociaci&#xf3;n de s&#xed;ndrome de Hermansky-Pudlak tipo de prote&#xed;na-3 con clathrin	viaclinica.com	0	0		HPS3
1508	chr1	121005645	121005685	3500120476	40		121005645	121005685	8421504	1	40	0	c	350012047600000010	0-40						Letter	biologia.uniba.it	0	0		HLTF
1508	chr1	121069273	121109348	3500448744	49		121069273	121109348	8421504	3	22,23,4	0,37348,40071	c	350044874400000001,350044874400000000	8-30,3-30						ScienceDirect.com - FEBS Letters - Glycogenin, the primer of glycogen synthesis, binds to actin	sciencedirect.com	0	0		
1509	chr1	121230400	121230424	3500382910	23		121230400	121230424	8421504	2	9,14	0,10	g	350038291000000092	23-48					Patent	DNA expression systems based on alphaviruses (Patent US:5739026)	Garoff	1998	0		
1510	chr1	121271497	121271532	3500343734	29		121271497	121271532	8421504	4	5,6,14,4	0,6,16,31	g	350034373400000555	7-36					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
1510	chr1	121282317	121282341	3500073470	23		121282317	121282341	8421504	2	9,14	0,10	g	350007347000000166	0-25						COMBINATION METHODS OF INHIBITING TUMOR GROWTH WITH A VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTAGONIST - Patent application	www.faqs.org	0	0		
1511	chr1	121398559	121398904	3500408683	337		121398559	121398904	8421504	4	92,14,16,215	0,93,108,130	c	350040868300000031	15-360						Ungulates with genetically modified immune systems	Wells	2006	0		
1511	chr1	121399646	121400429	3500189570	117		121399646	121400429	8421504	2	60,57	0,726	p	350018957000015036,350018957000015015	27-87,0-57						Expression cloning of an ATP receptor from mouse neuroblastoma cells. - ResearchGate	.researchgate.net	0	0		
1511	chr1	121399895	121399959	3500256977	44		121399895	121399959	8421504	2	21,23	0,41	c,g	350025697700000006,350025697700000006,350025697700000005,350025697700000005	0-21,0-21,0-23,0-23						REPRODUCTION	uction-online.org	0	0		
1511	chr1	121400000	121400237	3500185511	49		121400000	121400237	8421504	2	22,27	0,210	c	350018551100000001,350018551100000000	0-22,0-27						USE OF AT-1 RECEPTOR ANTAGONIST OR AT-2 RECEPTOR MODULATOR FOR TREATING DISEASES ASSOCIATED WITH AN INCREASE OF AT-1 OR AT-2 RECEPTORS	Bullock	1999	0		AGTR1
1511	chr1	121400000	121400237	3500112288	49		121400000	121400237	8421504	2	22,27	0,210	c,g	350011228800000001,350011228800000000,350011228800000000	0-22,0-27,0-27						Additional therapeutic use	Bullock	1999	0		AGTR1
1511	chr1	121400002	121400071	3500028051	44		121400002	121400071	8421504	2	22,22	0,47	c,g	350002805100000019,350002805100000018,350002805100000018	0-22,0-22,0-22						Research Paper Interaction of RAS Activation and Lipid Disorders Ac- celerates the Progression of Glomerulosclerosis	www.medsci.org	0	0		AGTR1
1511	chr1	121400105	121400255	3500311961	150		121400105	121400255	8421504	1	150	0	p	350031196100015001,350031196100015004	0-150,0-150						Sequence Analysis of the Angiotensin II Type 1 Receptor (AGTR1) Gene for Mutations Contributing to Pulmonary Hypertension in the Chicken (Gallus gallus)	inquiry.uark.edu	0	0		AGTR1
1511	chr1	121456209	121456235	3500142932	24		121456209	121456235	8421504	2	18,6	0,20	c	350014293200000018	23-47						AND THE IN	tionscanada.gc.ca	0	0		
1514	chr1	121798159	121798184	3500343734	23		121798159	121798184	8421504	2	18,5	0,20	g	350034373400000007	7-31					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
1521	chr1	122686003	122717546	3500344185	39		122686003	122717546	8421504	4	14,5,16,4	0,15,31522,31539	g	350034418500000178,350034418500000187	8-27,9-29						Collagen Producing Plants And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
1521	chr1	122743774	122743799	3500307457	23		122743774	122743799	8421504	3	12,6,5	0,13,20	g	350030745700000055	5-34						Protein c production in transgenic animals	Cottingham	1997	0		
1522	chr1	122930538	122930566	3500312616	24		122930538	122930566	8421504	3	5,7,12	0,8,16	g	350031261600000213	14-38						METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Patent application	www.faqs.org	0	0		
1532	chr1	124200467	124205681	3500370403	44		124200467	124205681	8421504	2	21,23	0,5191	c,g	350037040300000001,350037040300000000,350037040300000000	0-21,0-23,0-23		23426682	10.1523/JNEUROSCI.3654-12.2013	0270-6474	The Journal of Neuroscience	Phospholipid Scramblase-1-Induced Lipid Reorganization Regulates Compensatory Endocytosis in Neuroendocrine Cells	Ory	2013	7		
1532	chr1	124200467	124205681	3500088308	44		124200467	124205681	8421504	2	21,23	0,5191	c,g	350008830800000001,350008830800000000	0-21,0-23		23426682	10.1523/JNEUROSCI.3654-12.2013	0270-6474	The Journal of Neuroscience	Phospholipid Scramblase-1-Induced Lipid Reorganization Regulates Compensatory Endocytosis in Neuroendocrine Cells	Ory	2013	7		
1535	chr1	124555516	124555542	3500072483	23		124555516	124555542	8421504	2	13,10	0,16	c	350007248300000363	3-26						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
1536	chr1	124675372	124688756	3500412680	40		124675372	124688756	8421504	2	20,20	0,13364	c,g	350041268000000006,350041268000000006,350041268000000007,350041268000000007	0-20,0-20,0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		
1536	chr1	124675372	124688756	3500105107	40		124675372	124688756	8421504	2	20,20	0,13364	c,g	350010510700000006,350010510700000006,350010510700000007,350010510700000007	0-20,0-20,0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		
1536	chr1	124675372	124688756	3500035761	40		124675372	124688756	8421504	2	20,20	0,13364	c,g	350003576100000006,350003576100000006,350003576100000007,350003576100000007	0-20,0-20,0-20,0-20						Enhanced transforming growth factor- signaling and &#xfb01;brogenesis in ovine fetal skeletal muscle of obese dams at late gestation	do.physiology.org	0	0		
1536	chr1	124717543	124717568	3500037398	25		124717543	124717568	8421504	1	25	0	c	350003739800000011	0-25		22008206	10.1074/mcp.M111.010496	1535-9476	Molecular & Cellular Proteomics	Proteome Analysis During Chondrocyte Differentiation in a New Chondrogenesis Model Using Human Umbilical Cord Stroma Mesenchymal Stem Cells	Fuente	2012	7		
1536	chr1	124723123	124726074	3500466715	45		124723123	124726074	8421504	2	38,7	0,2944	p	350046671500015015	0-45						Novel lysyl hydroxylase isoforms	herkules.oulu.fi	0	0		PLOD2
1536	chr1	124729476	124729506	3500023687	30		124729476	124729506	8421504	1	30	0	c	350002368700000079,350002368700000031	6-36,6-36						Modification of collagenous materials and medical treatment, diagnosis and monitoring of fibrotic conditions	Te	2002	0		
1543	chr1	125675293	125675316	3500443773	23		125675293	125675316	8421504	1	23	0	g	350044377300000003	2-25		12221122	10.1091/mbc.01-11-0540	1059-1524	Molecular Biology of the Cell	The Major Sites of Cellular Phospholipid Synthesis and Molecular Determinants of Fatty Acid and Lipid Head Group Specificity	Henneberry	2002	5		
1545	chr1	125933640	125933668	3500066394	23		125933640	125933668	8421504	2	13,10	0,18	g	350006639400000333	4-27					Patent	Hybrid winter oilseed rape and methods for producing same (Patent CN:1690211)	G*De Bo Te 	2010	0		
1552	chr1	126769848	126769873	3500438192	23		126769848	126769873	8421504	2	14,9	0,16	g	350043819200000179	4-27						Porphorymonas gingivalis polypeptides and nucleotides	Ross	2006	0		
1552	chr1	126805310	126805336	3500434928	23		126805310	126805336	8421504	2	7,16	0,10	g	350043492800000713	0-23						Compositions, methods and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals - Patent application	www.faqs.org	0	0		
1556	chr1	127290789	127290816	3500296154	23		127290789	127290816	8421504	3	5,7,11	0,8,16	g	350029615400000002	0-23		17468215	10.1104/pp.107.099473	0032-0889	Plant Physiology	Down-Regulation of a SILENT INFORMATION REGULATOR2-Related Histone Deacetylase Gene, OsSRT1, Induces DNA Fragmentation and Cell Death in Rice	Huang	2007	7		
1561	chr1	127931530	127931557	3500300059	25		127931530	127931557	8421504	2	13,12	0,15	g	350030005900000068	0-26						Physcomitrella patens (Hedw.) B.S.G. als Bioreaktor: Proteinzielsteuerung und Produktion von rekombinantem humanem Blutgerinnungsfaktor IX	k.uni-freiburg.de	0	0		
1561	chr1	127970460	127970490	3500085280	26		127970460	127970490	8421504	2	12,14	0,16	g	350008528000000077	3-48						Recombinant Production of Serum Albumin - Patent application	www.faqs.org	0	0		
1561	chr1	127973189	127973861	3500375693	96		127973189	127973861	8421504	2	48,48	0,624	c	350037569300000068,350037569300000055	0-48,0-48						Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same	Uchimura	1999	0		
1561	chr1	127973916	127973957	3500276416	41		127973916	127973957	8421504	1	41	0	c	350027641600000053	0-41						POLYPEPTIDE OF N-ACETYLGLUCOSAMINE-6-O-SULFOTRANSFERASE AND DNA ENCODING THE SAME - Patent application	www.faqs.org	0	0		
1562	chr1	128141576	128142344	3500307883	179		128141576	128142344	8421504	3	48,35,96	0,445,672	c	350030788300000212,350030788300000221,350030788300000226,350030788300000227,350030788300000017	0-48,13-48,0-48,0-48,0-20						Methods and materials relating to PAQR polypeptides and polynucleotides - Patent application	www.faqs.org	0	0		
1564	chr1	128364541	128369794	3500460618	43		128364541	128369794	8421504	3	15,6,22	0,314,5231	c,g	350046061800000001,350046061800000000,350046061800000000	0-21,0-22,0-22		12060571	10.1152/ajplung.00412.2001		American Journal of Physiology - Lung Cellular and Molecular Physiology	Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation	Sweeney	2002	0		TRPC1
1564	chr1	128364541	128369794	3500442148	43		128364541	128369794	8421504	3	15,6,22	0,314,5231	c	350044214800000001,350044214800000000	0-21,0-22		20003325	10.1186/1465-9921-10-123	1465-9921	Respiratory Research	Inhibition of SOC/Ca2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells	Wang	2009	0		TRPC1
1564	chr1	128364541	128369794	3500399015	43		128364541	128369794	8421504	3	15,6,22	0,314,5231	c	350039901500000001,350039901500000000	0-21,0-22						Sildenafil Inhibits Human Pulmonary Artery Smooth Muscle Cell Proliferation by Decreasing Capacitative Ca	sbms.ccmu.edu.cn	0	0		TRPC1
1564	chr1	128364541	128369794	3500394576	43		128364541	128369794	8421504	3	15,6,22	0,314,5231	c	350039457600000001,350039457600000000	0-21,0-22		11158974			American Journal of Physiology - Heart and Circulatory Physiology	Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation	Golovina	2001	0		TRPC1
1564	chr1	128364541	128369794	3500336882	43		128364541	128369794	8421504	3	15,6,22	0,314,5231	c	350033688200000001,350033688200000000	0-21,0-22						Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation	rt.physiology.org	0	0		TRPC1
1564	chr1	128364541	128369794	3500212465	43		128364541	128369794	8421504	3	15,6,22	0,314,5231	c	350021246500000001,350021246500000000	0-21,0-22		12060571	10.1152/ajplung.00412.2001		American Journal of Physiology - Lung Cellular and Molecular Physiology	Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation	Sweeney	2002	0		TRPC1
1564	chr1	128364541	128369794	3500025846	43		128364541	128369794	8421504	3	15,6,22	0,314,5231	c	350002584600000001,350002584600000000	0-21,0-22		20003325	10.1186/1465-9921-10-123		Respiratory Research	Inhibition of SOC/Ca2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells	Cong	2009	0		TRPC1
1564	chr1	128364541	128369791	3500420907	48		128364541	128369791	8421504	3	15,8,25	0,314,5225	c	350042090700000001,350042090700000000	0-23,0-25		15347566	10.1152/ajplung.00240.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Tumor necrosis factor-&#x03b1;-induced TRPC1 expression amplifies store-operated Ca2+ influx and endothelial permeability	Paria	2004	0		TRPC1
1564	chr1	128364541	128364863	3500169580	23		128364541	128364863	8421504	2	15,8	0,314	c	350016958000000000	25-48		18506892	10.1002/hep.22263	1527-3350	Hepatology	Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation - El Boustany - 2008 - Hepatology - Wiley Online Library	Boustany	2008	0		
1564	chr1	128365029	128380423	3500253245	46		128365029	128380423	8421504	2	21,25	0,15369	c	350025324500000003,350025324500000002	0-21,0-25		20219951	10.1152/ajpcell.00518.2009		American Journal of Physiology - Cell Physiolog	Amino acid sensing by enteroendocrine STC-1 cells: role of the Na+-coupled neutral amino acid transporter 2	Young	2010	0		TRPC1
1564	chr1	128365029	128380423	3500224214	46		128365029	128380423	8421504	2	21,25	0,15369	c,g	350022421400000003,350022421400000002,350022421400000002	0-21,0-25,0-25		20219951	10.1152/ajpcell.00518.2009		American Journal of Physiology - Cell Physiolog	Amino acid sensing by enteroendocrine STC-1 cells: role of the Na+-coupled neutral amino acid transporter 2	Young	2010	0		TRPC1
1564	chr1	128365029	128380423	3500000816	46		128365029	128380423	8421504	2	21,25	0,15369	c	350000081600000003,350000081600000002	0-21,0-25		20219951	10.1152/ajpcell.00518.2009		American Journal of Physiology - Cell Physiology	Amino acid sensing by enteroendocrine STC-1 cells: role of the Na+-coupled neutral amino acid transporter 2	Young	2010	0		TRPC1
1564	chr1	128365053	128369658	3500437773	23		128365053	128369658	8421504	2	4,19	0,4586	c	350043777300000003	0-23						Gastroenterology	wjgnet.com/1007-9	0	0		
1564	chr1	128365053	128369658	3500278351	23		128365053	128369658	8421504	2	4,19	0,4586	c	350027835100000000	0-23						M4:07384- Revised TRPC1-Mediated Inhibition of MPP Neurotoxicity in Human SH-SY5Y Neuroblastoma Cells	www.jbc.org	0	0		
1564	chr1	128365053	128369658	3500210535	23		128365053	128369658	8421504	2	4,19	0,4586	c	350021053500000003	0-23						Gastroenterology	wjgnet.com/1007-9	0	0		
1564	chr1	128369648	128380422	3500228930	44		128369648	128380422	8421504	2	22,22	0,10752	c	350022893000000005,350022893000000004	0-22,0-22		17189322	10.1152/ajplung.00214.2006		American Journal of Physiology - Lung Cellular and Molecular Physiology	Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry	Zhang	2007	0		
1564	chr1	128369648	128380422	3500052324	44		128369648	128380422	8421504	2	22,22	0,10752	c	350005232400000005,350005232400000004	0-22,0-22		17189322	10.1152/ajplung.00214.2006		American Journal of Physiology - Lung Cellular and Molecular Physiology	Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry	Zhang	2007	0		
1564	chr1	128391024	128401859	3500428056	40		128391024	128401859	8421504	2	20,20	0,10815	c	350042805600000106,350042805600000105	0-20,0-20						USE OF NOVEL HNF4ALPHA TARGET GENES AND THEIR GENE PRODUCTS	Niehof	2006	0		TRPC1
1564	chr1	128391024	128401859	3500149508	40		128391024	128401859	8421504	2	20,20	0,10815	c,g	350014950800000106,350014950800000105,350014950800000105	0-20,0-20,0-20						Use of Novel HNF4a Target Genes and Their Gene Products	Borlak	2006	0		TRPC1
1567	chr1	128757070	128776294	3500118659	42		128757070	128776294	8421504	2	21,21	0,19203	c,g	350011865900000023,350011865900000023,350011865900000059,350011865900000059,350011865900000031,350011865900000067	0-19,0-19,0-21,0-21,16-37,16-37						Nonsense-mediated mrna decay - US Patent Application 20060154883 Description	ww.patentstorm.us	0	0		XRN1
1568	chr1	128847795	128847821	3500340909	23		128847795	128847821	8421504	2	11,12	0,14	g	350034090900000030	10-33						Therapies For Renal Failure Using Interferon-beta 	.freshpatents.com	0	0		
1571	chr1	129354095	129354118	3500375146	23		129354095	129354118	8421504	1	23	0	c	350037514600000060	21-44						A radiation hybrid map of river buffalo (Bubalus bubalis) chromosome 1 (BBU1)	ticabovina.com.br	0	0		
1571	chr1	129360752	129360778	3500178849	25		129360752	129360778	8421504	2	6,19	0,7	c	350017884900000021	13-38					Patent	Human bikunin (Patent US:7452859)	Tamburini	2008	0		RNF7
1571	chr1	129360752	129360778	3500110587	25		129360752	129360778	8421504	2	6,19	0,7	c	350011058700000032	13-38					Patent	Human bikunin (Patent US:6583108)	Tamburini	2003	0		RNF7
1573	chr1	129521153	129521178	3500052253	24		129521153	129521178	8421504	2	10,14	0,11	g	350005225300000036	4-32						Uncoupling cis-Acting RNA Elements from Coding Sequences Revealed a Requirement of the N-Terminal Region of Dengue Virus Capsid Protein in Virus Particle Formation	jvi.asm.org	0	0		
1573	chr1	129564958	129564982	3500233276	23		129564958	129564982	8421504	2	14,9	0,15	g	350023327600000043	1-24						LA FAMILIA DE GENES DE LA QUERATINA 6: CARACTERIZACION Y REGULACION	emigracion.ucm.es	0	0		
1574	chr1	129729075	129729102	3500275967	23		129729075	129729102	8421504	2	12,11	0,16	g	350027596700000019	8-33						Fungal Peroxygenases and Methods of Application	Pecyna	2010	0		
1575	chr1	129788837	129788862	3500386203	23		129788837	129788862	8421504	2	6,17	0,8	g	350038620300000095	23-46						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
1578	chr1	130158724	130158755	3500066984	23		130158724	130158755	8421504	3	12,6,5	0,17,26	g	350006698400000063	0-23						Proteases - Patent application	www.faqs.org	0	0		GRM4
1578	chr1	130200426	130200456	3500343734	24		130200426	130200456	8421504	3	5,6,13	0,8,17	g	350034373400000506	24-48					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
1586	chr1	131258520	131258549	3500130366	24		131258520	131258549	8421504	2	12,12	0,17	g	350013036600000022,350013036600000021,350013036600000020	0-31,18-49,17-49						Fsp27/CIDEC is a CREB target gene induced during fasting and regulated by fatty acid oxidation rate	run.unl.pt/bitstr	0	0		
1588	chr1	131484318	131484346	3500116920	24		131484318	131484346	8421504	3	5,5,14	0,8,14	g	350011692000000006	10-36						Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP	Rupar	2000	0		
1590	chr1	131782975	131783005	3500257081	25		131782975	131783005	8421504	3	11,8,6	0,15,24	g	350025708100000002	0-28						Mycobacterium tuberculosis(Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated controls from TB patients	www.cdfd.org.in	0	0		
1591	chr1	131943740	131943763	3500262979	23		131943740	131943763	8421504	1	23	0	c	350026297900000007	0-23		12016134	10.1152/ajpgi.00041.2001		American Journal of Physiology - Gastrointestinal and Liver Physiology	Analysis of human cellular retinol-binding protein II promoter during enterocyte differentiation	Zhang	2002	0		
1592	chr1	132039099	132039125	3500068827	25		132039099	132039125	8421504	2	13,12	0,14	c	350006882700000036	8-33					Patent	High bone mass gene of 1.1q13.3 (Patent US:6780609)	Carulli	2004	0		
1592	chr1	132085552	132085600	3500464980	48		132085552	132085600	8421504	1	48	0	p	350046498000015002	0-48		19753101	10.1371/journal.pbio.1000196		PLoS Biology	Loss of Mitogen-Activated Protein Kinase Kinase Kinase 4 (MAP3K4) Reveals a Requirement for MAPK Signalling in Mouse Sex Determination	Debora	2009	0		PRR23A
1592	chr1	132085552	132085600	3500455785	48		132085552	132085600	8421504	1	48	0	p	350045578500015000	0-48			10.1002/dvdy.20189	1097-0177	Developmental Dynamics	Isolation of chicken homolog of the FOXL2 gene and comparison of its expression patterns with those of aromatase during ovarian development - Govoroun - 2004 - Developmental Dynamics - Wiley Online Library	Govoroun	2004	0		PRR23A
1592	chr1	132085782	132085808	3500380516	23		132085782	132085808	8421504	2	14,9	0,17	c	350038051600000007,350038051600000056	9-32,9-32						Human Cystathionine beta-Synthase Variants and Methods of Production Thereof - Patent application	www.faqs.org	0	0		
1592	chr1	132085782	132085808	3500125664	23		132085782	132085808	8421504	2	14,9	0,17	c	350012566400000007	9-32						Human cystathionine &#x03b2;-synthase variants and methods of production thereof	Kraus	2003	0		
1592	chr1	132085914	132085938	3500309908	24		132085914	132085938	8421504	1	24	0	c	350030990800000035	22-46						Ryegrass pollen allergen - Patent # 5965455 - PatentGenius	.patentgenius.com	0	0		
1592	chr1	132085914	132085938	3500084037	24		132085914	132085938	8421504	1	24	0	c	350008403700000031	22-46						Ryegrass pollen allergen	www.devileye.net	0	0		
1592	chr1	132086060	132086105	3500120381	45		132086060	132086105	8421504	1	45	0	p	350012038100015079	93-138						<Html><Title> Complet list of 1mpf hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
1592	chr1	132086329	132086464	3500293908	135		132086329	132086464	8421504	1	135	0	c,g	350029390800000015,350029390800000221,350029390800000220,350029390800000220,350029390800000222,350029390800000217,350029390800000214,350029390800000014	0-19,0-26,0-26,0-26,0-26,0-35,0-35,0-20						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	hera.ugr.es	0	0		
1592	chr1	132086329	132086464	3500192823	135		132086329	132086464	8421504	1	135	0	c,g	350019282300000015,350019282300000222,350019282300000221,350019282300000220,350019282300000220,350019282300000217,350019282300000214,350019282300000014	0-19,0-26,0-26,0-26,0-26,0-35,0-35,0-20						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	digibug.ugr.es	0	0		
1592	chr1	132086365	132086536	3500464114	40		132086365	132086536	8421504	2	20,20	0,151	c,g	350046411400000003,350046411400000002,350046411400000002	0-20,0-20,0-20			10.1002/dvdy.1194	1097-0177	Developmental Dynamics	Time course of female-to-male sex reversal in 38,XX fetal and postnatal pigs - Pailhoux - 2001 - Developmental Dynamics - Wiley Online Library	Pailhoux	2001	0		
1594	chr1	132284008	132284037	3500265756	25		132284008	132284037	8421504	3	7,5,13	0,8,16	g	350026575600000028	3-42						Tissue-specific transcription of dna sequence encoding a heterologous enzyme for use in prodrug therapy to lung cancer	Dev	1997	0		
199	chr1	132334451	132400160	3500354667	1746		132334451	132400160	8421504	13	117,189,122,144,100,179,110,79,168,124,146,133,135	0,18810,25443,28424,30713,40883,41885,42743,55624,56962,63993,65086,65574	p	350035466700015000	0-1746						KEGG T01001: 5291	www.genome.jp	0	0		PIK3CB
199	chr1	132334451	132400160	3500149165	1746		132334451	132400160	8421504	13	117,189,122,144,100,179,110,79,168,124,146,133,135	0,18810,25443,28424,30713,40883,41885,42743,55624,56962,63993,65086,65574	p	350014916500015002	0-1746						KEGG T01001: 23533	www.genome.jp	0	0		PIK3CB
1595	chr1	132390105	132390225	3500333199	48		132390105	132390225	8421504	2	24,24	0,96	c,g	350033319900000015,350033319900000016,350033319900000016	0-24,0-24,0-24		18676771	10.1158/1078-0432.CCR-07-4604	1078-0432	Clinical Cancer Research	Silencing of Transforming Growth Factor-&#x03b2;1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo	Moore	2008	8		PIK3CB
1595	chr1	132400133	132400163	3500311185	30		132400133	132400163	8421504	1	30	0	c	350031118500000001,350031118500000072	12-42,12-42						Quinazolinones as Inhibitors of Human Phosphatidylinositol 3-Kinase Delta - Patent application	www.faqs.org	0	0		PIK3CB
1595	chr1	132400133	132400163	3500307977	30		132400133	132400163	8421504	1	30	0	c	350030797700000001	12-42						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	Fowler	2013	0		PIK3CB
1595	chr1	132400133	132400163	3500299796	30		132400133	132400163	8421504	1	30	0	c	350029979600000001	12-42						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	Fowler	2010	0		PIK3CB
1595	chr1	132400133	132400163	3500241531	30		132400133	132400163	8421504	1	30	0	c	350024153100000001	12-42						Inhibitors of human phosphatidyl-inositol 3-kinase delta	C*Sa Du 	2005	0		PIK3CB
1595	chr1	132400133	132400163	3500186175	30		132400133	132400163	8421504	1	30	0	c	350018617500000001	12-42						Inhibitors of human phosphatidylinositol 3-kinase delta	Sadhu	2010	0		PIK3CB
1595	chr1	132400133	132400163	3500173904	30		132400133	132400163	8421504	1	30	0	c	350017390400000001	12-42						Inhibitors of human phosphatidylinositol 3-kinase delta	Sadhu	2010	0		PIK3CB
1595	chr1	132400133	132400163	3500166986	30		132400133	132400163	8421504	1	30	0	c	350016698600000000	12-42						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	Fowler	2013	0		PIK3CB
1595	chr1	132400133	132400163	3500166550	30		132400133	132400163	8421504	1	30	0	c	350016655000000001	12-42						Inhibitors of human phosphatidyl-inositol 3-kinase delta	Farouz	2010	0		PIK3CB
1595	chr1	132400133	132400163	3500127478	30		132400133	132400163	8421504	1	30	0	c	350012747800000001	12-42					Patent	Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (Patent US:8207153)	Fowler	2012	0		PIK3CB
1595	chr1	132400133	132400163	3500120979	30		132400133	132400163	8421504	1	30	0	c	350012097900000001	12-42					Patent	Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (Patent US:7932260)	Fowler	2011	0		PIK3CB
1595	chr1	132400133	132400163	3500083335	30		132400133	132400163	8421504	1	30	0	c	350008333500000002,350008333500000073	12-42,12-42					Patent	Inhibitors of human phosphatidylinositol 3-kinase delta (Patent US:6667300)	Sadhu	2003	0		PIK3CB
1595	chr1	132400133	132400163	3500079890	30		132400133	132400163	8421504	1	30	0	c	350007989000000001,350007989000000072	12-42,12-42						INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA - Patent application	www.faqs.org	0	0		PIK3CB
1595	chr1	132400133	132400163	3500018554	30		132400133	132400163	8421504	1	30	0	c	350001855400000001	12-42						Quinazolinones as Inhibitors of Human Phosphatidylinositol 3-Kinase Delta	Fowler	2005	0		PIK3CB
1595	chr1	132497781	132497806	3500066984	24		132497781	132497806	8421504	2	8,16	0,9	g	350006698400000039	0-24						Proteases - Patent application	www.faqs.org	0	0		
1595	chr1	132511002	132511027	3500454832	23		132511002	132511027	8421504	2	9,14	0,11	g	350045483200000141	9-32						Systematic evolution of ligands by exponential enrichment: tissue selex	Heilig	2002	0		
1597	chr1	132659886	132659940	3500147403	54		132659886	132659940	8421504	1	54	0	p	350014740300015000	3-57						Asthma associated factors as targets for treating atopic allergies including asthma and related disorders	Grasso	1999	0		MRAS
1597	chr1	132659964	132734091	3500281526	534		132659964	132734091	8421504	5	7,80,100,154,193	0,1618,7061,8681,73934	p	350028152600015001,350028152600015003	0-534,0-51						&#x5909;&#x7570;&#x578b;&#xff32;&#xff41;&#xff53;&#x30dd;&#x30ea;&#x30da;&#x30d7;&#x30c1;&#x30c9;&#x306e;&#x7d50;&#x6676; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; WO2011007773&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamu	astamuse.com	0	0		MRAS
1599	chr1	132942967	132942995	3500348593	23		132942967	132942995	8421504	2	7,16	0,12	c	350034859300000025	7-33						UNIVERSITAT AUTONAMA DE BARCELONA Development of gut microbiota in the pig: modulation of bacteria	www.tdx.cat	0	0		
1600	chr1	133129238	133129302	3500462160	48		133129238	133129302	8421504	2	23,25	0,39	c	350046216000000007,350046216000000008	0-23,0-25						Compositions and methods relating to lung specific genes	Chen	2002	0		CLDN18
1601	chr1	133230054	133230079	3500068788	23		133230054	133230079	8421504	3	5,4,14	0,6,11	g	350006878800000067	2-25						Truncated St6galnaci Polypeptides and Nucleic Acids - Patent application	www.faqs.org	0	0		
1602	chr1	133401522	133402242	3500324137	720		133401522	133402242	8421504	1	720	0	p	350032413700015004	783-3198						Int. J. Dev. Biol. 52 THE INTERNATIONAL JOURNAL OFDEVELOPMENTAL doi: 10.1387/ijdb.082586dc BIOLOGY	w9.georgetown.edu	0	0		SOX14
1602	chr1	133402035	133402188	3500329759	153		133402035	133402188	8421504	1	153	0	p	350032975900015003	0-153						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa hoc:"SRY-related genes in the genome of the rice &#xfb01;eld eel (Monopterus albus)" 	tailieu.vn/doc/ba	0	0		SOX14
1602	chr1	133402113	133402185	3500388252	72		133402113	133402185	8421504	1	72	0	p	350038825200015169,350038825200015149	0-45,0-45						Fusion Protein and Use Thereof - Patent application	www.faqs.org	0	0		
1602	chr1	133402149	133402194	3500313691	45		133402149	133402194	8421504	1	45	0	p	350031369100015064	0-45						COMPOSITIONS AND METHODS FOR THE TREATMENT OF A NEOPLASIA - Patent application	www.faqs.org	0	0		SPACA7
1607	chr1	134068411	134068436	3500119454	24		134068411	134068436	8421504	2	11,13	0,12	g	350011945400000273	0-24						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1609	chr1	134219965	134219993	3500444911	24		134219965	134219993	8421504	3	12,6,6	0,13,22	g	350044491100000003	0-26		10874033	10.1074/jbc.M003314200	0021-9258	Journal of Biological Chemistry	Neelaredoxin, an Iron-binding Protein from the Syphilis Spirochete, Treponema pallidum, Is a Superoxide Reductase	Jovanovic	2000	5		
1609	chr1	134255058	134255083	3500307051	23		134255058	134255083	8421504	3	14,4,5	0,15,20	g	350030705100000004	1-24						Clinical & Cellular Immunology	w.omicsonline.org	0	0		
1609	chr1	134265001	134265318	3500222351	40		134265001	134265318	8421504	2	20,20	0,297	c	350022235100000001,350022235100000000	0-20,0-20		21992144	10.1186/1471-2407-11-443		BMC Cancer	Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo	Melissa	2011	0		NCK1
1609	chr1	134265001	134265318	3500131598	40		134265001	134265318	8421504	2	20,20	0,297	c	350013159800000001,350013159800000000	0-20,0-20						Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo	biomedcentral.com	0	0		NCK1
1618	chr1	135456217	135456243	3500434901	23		135456217	135456243	8421504	2	9,14	0,12	g	350043490100000041	3-26						HCV GENE	Mori	2008	0		
1625	chr1	136406437	136406476	3500332703	39		136406437	136406476	8421504	1	39	0	c	350033270300000002,350033270300000003	0-39,0-31						Article	jcb.rupress.org	0	0		EPHB1
1625	chr1	136418606	136432995	3500168474	24		136418606	136432995	8421504	2	8,16	0,14373	c	350016847400000011	0-24		19918883	10.1002/dvdy.22163	1097-0177	Developmental Dynamics	A migratory role for EphrinB ligands in avian epicardial mesothelial cells - Wengerhoff - 2009 - Developmental Dynamics - Wiley Online Library	Wengerhoff	2010	0		
1625	chr1	136418606	136432994	3500036421	23		136418606	136432994	8421504	2	8,15	0,14373	c	350003642100000068	25-48						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
203	chr1	136508069	136695584	3500330320	135		136508069	136695584	8421504	2	35,100	0,187415	p	350033032000015040	0-135						Structure, Function & Control of the EphA3 Receptor Tyrosine Kinase	.swinburne.edu.au	0	0		EPHB1
203	chr1	136695710	136858577	3500376096	528		136695710	136858577	8421504	3	456,65,7	0,24797,162860	p	350037609600015058,350037609600015052,350037609600015046,350037609600015040	0-114,0-132,0-141,0-141						Eph receptor ligands and methods of use	Pasquale	2010	0		EPHB1
1629	chr1	136858826	136858855	3500363733	27		136858826	136858855	8421504	2	10,17	0,12	c	350036373300000002	8-35						TaiLieu.VN: Clinical Pancreatology for Practising Gastroenterologists and Surgeons - part 5 	tailieu.vn/doc/cl	0	0		
1629	chr1	136911485	136911511	3500463327	23		136911485	136911511	8421504	2	18,5	0,21	g	350046332700000000,350046332700000024	1-25,1-25					Patent	Vaccins adn ameliores pour herpesvirus-1 bovin (Patent EP:1248650)	Audonnet	2006	0		
1629	chr1	136911485	136911511	3500409044	23		136911485	136911511	8421504	2	18,5	0,21	g	350040904400000015	1-25						Recombinant vaccine against West Nile Virus	Audonnet	2005	0		
1629	chr1	136911485	136911511	3500407857	23		136911485	136911511	8421504	2	18,5	0,21	g	350040785700000015	1-25						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS	Loosmore	2010	0		
1629	chr1	136911485	136911511	3500378178	23		136911485	136911511	8421504	2	18,5	0,21	g	350037817800000000	1-25					Patent	Improved dna vaccines for bovine herpesvirus-1 (Patent EP:1248650)	Audonnet	2006	0		
1629	chr1	136911485	136911511	3500326542	23		136911485	136911511	8421504	2	18,5	0,21	g	350032654200000015	1-25						Recombinant vaccine against West Nile Virus	Loosmore	2003	0		
1629	chr1	136911485	136911511	3500325423	23		136911485	136911511	8421504	2	18,5	0,21	g	350032542300000000	1-25						Dna vaccines for pets and sport animals	Audonnet	2002	0		
1629	chr1	136911485	136911511	3500320240	23		136911485	136911511	8421504	2	18,5	0,21	g	350032024000000000	1-25					Patent	Dna vaccines for dogs (Patent EP:1185662)	Audonnet	2011	0		
1629	chr1	136911485	136911511	3500303979	23		136911485	136911511	8421504	2	18,5	0,21	g	350030397900000000	1-25						 DNA Vaccines For Farm Animals, In Particular Bovines And Porcines 	www.docstoc.com	0	0		
1629	chr1	136911485	136911511	3500276508	23		136911485	136911511	8421504	2	18,5	0,21	g	350027650800000000,350027650800000024	1-25,1-25					Patent	Vaccins adn ameliores pour herpesvirus-1 bovin (Patent EP:1248650)	Audonnet	2006	0		
1629	chr1	136911485	136911511	3500271240	23		136911485	136911511	8421504	2	18,5	0,21	g	350027124000000000	1-25					Patent	Improved dna vaccines for bovine herpesvirus-1 (Patent EP:1248650)	Audonnet	2006	0		
1629	chr1	136911485	136911511	3500232418	23		136911485	136911511	8421504	2	18,5	0,21	g	350023241800000000	1-25						Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3	Audonnet	2005	0		
1629	chr1	136911485	136911511	3500172045	23		136911485	136911511	8421504	2	18,5	0,21	g	350017204500000000	1-25						Vaccins adn pour animaux de compagnie et de sport	Audonnet	2000	0		
1629	chr1	136911485	136911511	3500163096	23		136911485	136911511	8421504	2	18,5	0,21	g	350016309600000000	1-25						Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3	Audonnet	2004	0		
1629	chr1	136911485	136911511	3500143098	23		136911485	136911511	8421504	2	18,5	0,21	g	350014309800000015,350014309800000052	1-25,1-25						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS - Patent application	www.faqs.org	0	0		
1629	chr1	136911485	136911511	3500069346	23		136911485	136911511	8421504	2	18,5	0,21	g	350006934600000077,350006934600000000	1-25,1-25					Patent	Dna vaccines for pets or for animals used in sports (Patent CA:2375320)	Fischer	2013	0		
1629	chr1	136911485	136911511	3500012787	23		136911485	136911511	8421504	2	18,5	0,21	g	350001278700000000	1-25						Improved DNA vaccines for production-type animals	J-C*F*Ao Duo Nai Te 	2003	0		
1629	chr1	136911485	136911511	3500009339	23		136911485	136911511	8421504	2	18,5	0,21	g	350000933900000015	1-25						Recombinant vaccine against West Nile Virus	Loosmore	2010	0		
1629	chr1	136911485	136911511	3500009333	23		136911485	136911511	8421504	2	18,5	0,21	g	350000933300000000	1-25						DNA vaccines for farm animals, in particular bovines and porcines - Patent # 6852705 - PatentGenius	.patentgenius.com	0	0		
1633	chr1	137458572	137458596	3500054041	24		137458572	137458596	8421504	1	24	0	g	350005404100000390	0-24						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2012	0		RYK
204	chr1	137738350	137758538	3500325264	63		137738350	137758538	8421504	4	20,21,20,2	0,17445,17490,20186	c,g	350032526400000004,350032526400000004,350032526400000000,350032526400000000,350032526400000003	0-20,0-20,0-21,0-21,0-22		17901226	10.1210/en.2007-1087	0013-7227	Endocrinology	Molecular Cloning and Characterization of Prostaglandin (PG) Transporter in Ovine Endometrium: Role for Multiple Cell Signaling Pathways in Transport of PGF2&#x03b1;	Banu	2008	4		
204	chr1	137868582	137934164	3500037042	119		137868582	137934164	8421504	5	21,29,26,41,2	0,17665,19547,58920,65580	c	350003704200000127,350003704200000104,350003704200000165,350003704200000120,350003704200000169	12-33,18-47,0-24,25-48,0-43						Mutant Paramyxovirus and Method for Production Thereof - Patent application	www.faqs.org	0	0		
1636	chr1	137868582	137886276	3500432660	48		137868582	137886276	8421504	2	21,27	0,17667	c	350043266000000078,350043266000000055	12-33,18-45						Oral delivery of modified transferrin fusion proteins - US Patent 8129504 Description	ww.patentstorm.us	0	0		
1636	chr1	137868582	137886276	3500343032	48		137868582	137886276	8421504	2	21,27	0,17667	c	350034303200000070,350034303200000047	15-36,21-48						Modified Transferin-antibody Fusion Proteins 	.freshpatents.com	0	0		
204	chr1	137873325	137888190	3500428753	43		137873325	137888190	8421504	2	22,21	0,14844	c	350042875300000038,350042875300000035	26-48,26-47						 Cloning, Expression, And Uses Of Human Lactoferrin 	www.docstoc.com	0	0		
1636	chr1	137884803	137884828	3500239690	25		137884803	137884828	8421504	1	25	0	c,g	350023969000000038,350023969000000038	33-58,33-58						Transferrin fusion protein libraries	Turner	2008	0		
1636	chr1	137886249	137886276	3500445500	27		137886249	137886276	8421504	1	27	0	c	350044550000000049	21-48						MODIFIED TRANSFERIN-ANTIBODY FUSION PROTEINS - Patent application	www.faqs.org	0	0		
1636	chr1	137886249	137886276	3500030627	27		137886249	137886276	8421504	1	27	0	c	350003062700000055	21-48						ORAL DELIVERY OF MODIFIED TRANSFERRIN FUSION PROTEINS - Patent application	www.faqs.org	0	0		
204	chr1	137886287	137896648	3500337770	44		137886287	137896648	8421504	4	5,19,2,18	0,775,2823,10343	c	350033777000000021,350033777000000020	0-24,0-20						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
1637	chr1	137934268	137934297	3500197130	29		137934268	137934297	8421504	1	29	0	c	350019713000000031	3-32						Production of recombinant human lactoferrin	Conneely	1994	0		
1638	chr1	138023081	138023924	3500445500	42		138023081	138023924	8421504	2	11,31	0,812	c	350044550000000042	0-42						MODIFIED TRANSFERIN-ANTIBODY FUSION PROTEINS - Patent application	www.faqs.org	0	0		
1638	chr1	138023897	138026969	3500234350	44		138023897	138026969	8421504	2	22,22	0,3050	c	350023435000000011,350023435000000041,350023435000000040	22-44,0-22,0-22						Biomatrix Scaffolds - Patent application	www.faqs.org	0	0		TF
1638	chr1	138027097	138037464	3500262818	34		138027097	138037464	8421504	3	13,8,13	0,10343,10354	c	350026281800000057	10-47						Combination therapy using transferrin fusion proteins comprising GLP-1	Huo Ma Yang *Sa De Ji 	2007	0		
1638	chr1	138132469	138138201	3500124682	40		138132469	138138201	8421504	2	20,20	0,5712	c,g	350012468200000034,350012468200000035,350012468200000035	0-20,0-20,0-20		19289498	10.1128/MCB.01140-08	0270-7306	Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer	Liu	2009	6		TOPBP1
1638	chr1	138132469	138138201	3500115594	40		138132469	138138201	8421504	2	20,20	0,5712	c,g	350011559400000034,350011559400000035,350011559400000035	0-20,0-20,0-20		19289498	10.1128/MCB.01140-08		Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer 	Kang	2009	0		TOPBP1
1639	chr1	138175500	138175527	3500364288	27		138175500	138175527	8421504	1	27	0	g	350036428800000027	25-52						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
1647	chr1	139278208	139278234	3500242028	23		139278208	139278234	8421504	2	13,10	0,16	c	350024202800000741	1-24						Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases	Silverman	2011	0		
1648	chr1	139383902	139383925	3500325157	23		139383902	139383925	8421504	1	23	0	c	350032515700000034	0-23						Identifikation und Charakterisierung von im Thymus exprimierten Chemokinrezeptoren	k.uni-freiburg.de	0	0		
1650	chr1	139668918	139679035	3500040982	114		139668918	139679035	8421504	3	24,42,48	0,5884,10069	c	350004098200000118,350004098200000116,350004098200000111	0-24,6-48,0-48					Patent	Biomarkers and targets for diagnosis, prognosis and management of prostate disease (Patent US:5882864)	An	1999	0		
1650	chr1	139674802	139674844	3500334614	42		139674802	139674844	8421504	1	42	0	c	350033461400000119	6-48						US Patent # 5,882,864. Biomarkers and targets for diagnosis, prognosis and management of prostate disease - Patents.com	www.patents.com	0	0		
1653	chr1	139986293	139986317	3500369845	23		139986293	139986317	8421504	2	9,14	0,10	g	350036984500000085	9-33						LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof - Patent application	www.faqs.org	0	0		
1658	chr1	140681914	140681938	3500009936	23		140681914	140681938	8421504	2	9,14	0,10	g	350000993600000002	11-35		10523649		0270-7306	Molecular and Cellular Biology	A Human TATA Binding Protein-Related Protein with Altered DNA Binding Specificity Inhibits Transcription from Multiple Promoters and Activators	Moore	1999	6		
1659	chr1	140814106	140814132	3500343774	23		140814106	140814132	8421504	3	4,6,13	0,5,13	g	350034377400000024	20-43						US Patent # 7,227,003. Anti-TNF antibody fragments - Patents.com	www.patents.com	0	0		
1659	chr1	140814106	140814132	3500012852	23		140814106	140814132	8421504	3	4,6,13	0,5,13	g	350001285200000024	20-43						Anti-TNF antibodies and peptides of human necrosis factor	Le	2001	0		
1661	chr1	141056269	141056332	3500225389	63		141056269	141056332	8421504	1	63	0	g	350022538900000048	0-63						Pegasoferae? - Genomewiki	nomewiki.ucsc.edu	0	0		
1663	chr1	141329725	141329757	3500343961	25		141329725	141329757	8421504	3	11,5,9	0,13,23	g	350034396100000023	0-26			10.1111/j.1567-1364.2007.00329.x	1567-1364	FEMS Yeast Research	The SSK2 MAPKKK of Candida albicans is required for oxidant adaptation in vitro - Walia - 2007 - FEMS Yeast Research - Wiley Online Library	Walia	2008	0		
1663	chr1	141360440	141360465	3500124182	24		141360440	141360465	8421504	2	16,8	0,17	c	350012418200000004	14-38						How to escape from a tense situation: Bacterial mechanosensitive channels	tations.ub.rug.nl	0	0		
1667	chr1	141834705	141842471	3500211210	357		141834705	141842471	8421504	3	93,153,111	0,6572,7655	p	350021121000015000	0-357						SGC | Structure Details	www.thesgc.org	0	0		BRWD1
1667	chr1	141892575	141892600	3500335263	24		141892575	141892600	8421504	2	4,20	0,5	c	350033526300000170	4-28						Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof	Chandrashekar	1999	0		
1667	chr1	141892575	141892600	3500008109	24		141892575	141892600	8421504	2	4,20	0,5	c	350000810900000171	4-28						Parasitic nematode transglutaminase proteins and uses thereof	Chandrashekar	1997	0		BRWD1
1668	chr1	141974640	141974663	3500369913	23		141974640	141974663	8421504	1	23	0	g	350036991300000055	24-47						IDENTIFICATION AND MOLECULAR CHARACTERISATION OF PROTEINS, EXPRESSED IN THE IXODES RICINUS SALIVARY GLANDS - Patent application	www.faqs.org	0	0		
1668	chr1	141979067	141979097	3500011724	25		141979067	141979097	8421504	2	18,7	0,23	c	350001172400000040	0-25						Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer	www.neoplasia.com	0	0		HMGN1
1668	chr1	141979864	141984876	3500376180	252		141979864	141984876	8421504	5	45,129,42,6,30	0,1752,4849,4894,4982	p	350037618000015012	0-252						Lung Cancer Diagnostic Assay - Patent application	www.faqs.org	0	0		HMGN1
1668	chr1	141979864	141984876	3500209076	252		141979864	141984876	8421504	5	45,129,42,6,30	0,1752,4849,4894,4982	p	350020907600015013	0-252						Lung Cancer Diagnostic Assay	Hirschowitz	2006	0		HMGN1
1668	chr1	141995549	141996587	3500361851	455		141995549	141996587	8421504	4	237,30,44,144	0,450,658,894	p,c	350036185100000080,350036185100000077,350036185100000078,350036185100000009,350036185100000090,350036185100000075,350036185100000053,350036185100000082,350036185100000001,350036185100000052,350036185100000051,350036185100000027,350036185100000108,350036185100015054,350036185100000045,350036185100000040,350036185100000035,350036185100000028,350036185100000109,350036185100000034,350036185100015003,350036185100000033	0-72,5-30,0-25,0-50,0-50,0-51,0-24,0-24,0-24,0-48,0-48,0-33,0-33,0-45,0-30,0-44,0-48,0-41,0-41,0-48,0-45,0-48						Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates - Patent application	www.faqs.org	0	0		
1668	chr1	141995701	141995734	3500007758	33		141995701	141995734	8421504	1	33	0	c	350000775800000027	0-33						Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates	Miskey	2006	0		
1668	chr1	141995704	141995741	3500052099	37		141995704	141995741	8421504	1	37	0	c	350005209900000405	11-48						Card Domain Containing Polypeptides, Encoding Nucleic Acids, And Methods Of Use 	.freshpatents.com	0	0		
1676	chr1	142999619	142999647	3500340967	23		142999619	142999647	8421504	2	7,16	0,12	g	350034096700000199	2-28						FULL BIBLIOGRAPHIC DETAILS: File ID 41134 Type Dissertation Pages 197 http://dare.uva.nl/record/209312	dare.uva.nl	0	0		
1684	chr1	144123734	144123762	3500269834	24		144123734	144123762	8421504	2	18,6	0,22	g	350026983400000004,350026983400000062	0-24,0-24						FLOWERING INDUCER - Patent application	www.faqs.org	0	0		
210	chr1	144439958	144484177	3500090514	45		144439958	144484177	8421504	2	21,24	0,44195	p	350009051400015052	0-45						Method of producing catalytically active BACE2 enzymes - Patent application	www.faqs.org	0	0		BACE2,MIR3197,PLAC4
1687	chr1	144545081	144545144	3500118517	63		144545081	144545144	8421504	1	63	0	p	350011851700015003	9-72						 <HTML> <HEAD><TITLE>aC/a<<aaa$?aa1/4ca>>a-a!a?a1/4a1/4 - c1ei1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4	www.j-tokkyo.com	0	0		
1687	chr1	144564313	144564336	3500299455	23		144564313	144564336	8421504	1	23	0	g	350029945500000000	0-23						>	earningcenter.org	0	0		ACTG1
1687	chr1	144564313	144564336	3500266718	23		144564313	144564336	8421504	1	23	0	g	350026671800000006	0-23		17158758	10.1677/erc.1.01257	1351-0088	Endocrine-Related Cancer	Endocrine therapy resistance can be associated with high estrogen receptor &#x03b1; (ER&#x03b1;) expression and reduced ER&#x03b1; phosphorylation in breast cancer models	Kuske	2006	4		MURC
1687	chr1	144564614	144564637	3500165789	23		144564614	144564637	8421504	1	23	0	g	350016578900000006	0-23		18042303	10.1186/1471-2164-8-436	1471-2164	BMC Genomics	Characterization of Smoc-1 uncovers two transcript variants showing differential tissue and age specific expression in Bubalus bubalis	Srivastava	2007	4		CCDC74A
1687	chr1	144564641	144564668	3500333566	26		144564641	144564668	8421504	2	20,6	0,21	g	350033356600000002	1-27		20233216	10.1111/j.1476-5381.2009.00627.x	1476-5381	British Journal of Pharmacology	Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cells - Tan - 2010 - British Journal of Pharmacology - Wiley Online Library	Tan	2010	0		
1687	chr1	144564940	144564966	3500398863	25		144564940	144564966	8421504	2	19,6	0,20	g	350039886300000008	0-25		22471389	10.1186/1472-6882-12-31		BMC Complementary and Alternative Medicine	Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells	Gon-Sup	2012	0		ACTG1
1687	chr1	144564940	144564966	3500055680	25		144564940	144564966	8421504	2	19,6	0,20	g	350005568000000008	0-25		22471389	10.1186/1472-6882-12-31		BMC Complementary and Alternative Medicine	Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells	GS	2012	0		ACTG1
1687	chr1	144564941	144564965	3500260673	23		144564941	144564965	8421504	2	18,5	0,19	g	350026067300000005	0-23		15143161	10.1128/MCB.24.11.4651-4663.2004	0270-7306	Molecular and Cellular Biology	Temporal Recruitment of Transcription Factors and SWI/SNF Chromatin-Remodeling Enzymes during Adipogenic Induction of the Peroxisome Proliferator-Activated Receptor &#x03b3; Nuclear Hormone Receptor	Salma	2004	6		ACTG1
1687	chr1	144564941	144564965	3500259414	23		144564941	144564965	8421504	2	18,5	0,19	g	350025941400000003	0-23		20100864	10.1128/MCB.00952-09	0270-7306	Molecular and Cellular Biology	Regulation of RB Transcription In Vivo by RB Family Members	Burkhart	2010	6		ACTG1
1688	chr1	144656945	144656972	3500343421	23		144656945	144656972	8421504	2	8,15	0,12	g	350034342100000201	15-43						NOVEL NUCLEIC ACID SEQUENCES AND THEIR USE IN METHODS FOR ACHIEVING PATHOGEN RESISTANCE IN PLANTS - Patent application	www.faqs.org	0	0		
1688	chr1	144690049	144693550	3500443994	43		144690049	144693550	8421504	2	23,20	0,3481	c,g	350044399400000003,350044399400000003,350044399400000004,350044399400000004	0-23,0-23,0-20,0-20						 SpringerImages - Oligonucleotide primers and probes used for real-time RT-PCR analysis 	pringerimages.com	0	0		
1688	chr1	144690049	144693550	3500030650	43		144690049	144693550	8421504	2	23,20	0,3481	c,g	350003065000000003,350003065000000003,350003065000000004	0-23,0-23,0-20						Relationship between quantity of IFNT estimated by IFN-stimulated gene expression in peripheral blood mononuclear cells and bovine embryonic mortality after AI or ET	www.rbej.com	0	0		
1689	chr1	144713347	144756113	3500362403	80		144713347	144756113	8421504	4	20,20,20,20	0,1848,39217,42746	c,g	350036240300000074,350036240300000074,350036240300000075,350036240300000072,350036240300000072,350036240300000073	0-20,0-20,0-20,0-20,0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
1689	chr1	144732517	144752047	3500437571	75		144732517	144752047	8421504	3	25,30,20	0,2578,19510	c,g	350043757100000009,350043757100000002,350043757100000000	0-25,0-30,0-20						Cloning and characterizing of the ovine MX1 gene promoter/enhancer region. - ResearchGate	.researchgate.net	0	0		
1689	chr1	144773934	144774018	3500108068	81		144773934	144774018	8421504	2	63,18	0,66	p	350010806800015019	33-114						Protein amf-1 to amf-10 and nucleic acids encoding the same	Burgess	2001	0		
1689	chr1	144774040	144774265	3500403156	32		144774040	144774265	8421504	2	26,6	0,219	c	350040315600000057	12-44						TMPRSS2 is a tumor suppressor	www.devileye.net	0	0		
1689	chr1	144774043	144774265	3500395462	29		144774043	144774265	8421504	2	23,6	0,216	c	350039546200000075	12-41					Patent	Activatable fibrinolytic and anti-thrombotic proteins (Patent US:5637492)	Dawson	1997	0		
1689	chr1	144774043	144774265	3500248450	29		144774043	144774265	8421504	2	23,6	0,216	c	350024845000000075	12-41						Activatable fibrinolytic and anti-thrombotic proteins - US Patent 5637492 Description	ww.patentstorm.us	0	0		
1689	chr1	144774043	144774262	3500463784	26		144774043	144774262	8421504	2	23,3	0,216	c	350046378400000019	0-26					Patent	Modified plasmin precursors with resistance to inhibitors of plasmin (Patent US:5932213)	Dawson	1999	0		
1689	chr1	144778189	144791711	3500156631	65		144778189	144791711	8421504	2	25,40	0,13482	c	350015663100000048,350015663100000081,350015663100000035	17-42,23-45,0-40						US Patent # 7,037,667. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer - Patents.com	www.patents.com	0	0		
1689	chr1	144802335	144802362	3500240436	24		144802335	144802362	8421504	3	6,14,4	0,8,23	g	350024043600000010	16-40						Subunit vaccine against respiratory syncytial virus infection	Anderson	2005	0		
1693	chr1	145269121	145269148	3500122563	23		145269121	145269148	8421504	3	6,4,13	0,9,14	g	350012256300000014	1-24			10.1016/j.femsle.2005.02.029	1574-6968	FEMS Microbiology Letters	CTX-M and SHV-12 &#x03b2;-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea - Kim - 2006 - FEMS Microbiology Letters - Wiley Onlin	Kim	2005	0		
1693	chr1	145271146	145271172	3500327411	25		145271146	145271172	8421504	2	10,15	0,11	g	350032741100000002	20-45						Genetic diversity and bottleneck studies in the Marwari horse breed	www.ias.ac.in	0	0		
1694	chr1	145489313	145489340	3500193635	23		145489313	145489340	8421504	3	4,14,5	0,5,22	g	350019363500000140	9-32						Materials and methods for immunocontraception	Harris	1993	0		
1696	chr1	145699528	145699556	3500137367	28		145699528	145699556	8421504	1	28	0	c	350013736700000005	0-28						ANovelPrincipleforPartialAgonismofLiverX ReceptorLigands	www.dkfz.de	0	0		ABCG1
1696	chr1	145718036	145719352	3500390669	23		145718036	145719352	8421504	2	10,13	0,1303	c	350039066900000050	0-23						Trefoil Factors and Methods of Treating Proliferation Disorders Using Same - Patent application	www.faqs.org	0	0		
1696	chr1	145718038	145719355	3500066812	24		145718038	145719355	8421504	2	8,16	0,1301	c	350006681200000012	19-43						Effects of Low Progesterone on the Endometrial Transcriptome in Cattle1	ww.biolreprod.org	0	0		TFF3
1696	chr1	145719344	145719367	3500270746	23		145719344	145719367	8421504	1	23	0	c	350027074600000026	0-23						SPINK1 AS A PROSTATE CANCER MARKER AND USES THEREOF - Patent application	www.faqs.org	0	0		TFF3
1696	chr1	145719346	145719391	3500411390	45		145719346	145719391	8421504	1	45	0	p	350041139000015060	0-45						Yeast Expression Vectors For Production Of Itf 	.freshpatents.com	0	0		
1698	chr1	146009291	146009318	3500451407	23		146009291	146009318	8421504	2	10,13	0,14	g	350045140700000046	1-24						Dye compositions containing purified polyporus laccases and nucleic acids encoding same	Yaver	1995	0		
1700	chr1	146209815	146209841	3500446349	23		146209815	146209841	8421504	3	4,5,14	0,5,12	g	350044634900000183,350044634900000227	3-26,4-27						Glial mitogenic factors	www.devileye.net	0	0		
1701	chr1	146374044	146374070	3500212432	26		146374044	146374070	8421504	1	26	0	c	350021243200000003	9-35		19365557	10.1371/journal.pone.0005213	1932-6203	PLOS ONE	PLOS ONE: Cytoplasmic Prep1 Interacts with 4EHP Inhibiting Hoxb4 Translation	Villaescusa	2009	4		
1702	chr1	146410373	146416062	3500196806	45		146410373	146416062	8421504	3	23,15,7	0,46,5682	c	350019680600000027,350019680600000028	0-23,0-22						Polynucleotides and polypeptides associated with the NF-kappaB pathway	Nadler	2004	0		WDR4
1702	chr1	146444887	146446848	3500122110	30		146444887	146446848	8421504	2	3,27	0,1934	c	350012211000000032	0-30						 DNA Sequence Encoding Human Cystathionine .beta. 	www.docstoc.com	0	0		
1702	chr1	146444887	146446848	3500085562	30		146444887	146446848	8421504	2	3,27	0,1934	c	350008556200000215	0-30						Methods and compositions for assaying analytes	Yuan	1999	0		
1702	chr1	146444887	146446848	3500044517	30		146444887	146446848	8421504	2	3,27	0,1934	c	350004451700000032	0-30						US Patent # 5,523,225. DNA sequence encoding human cystathionine .beta.-synthase - Patents.com	www.patents.com	0	0		
1702	chr1	146454533	146457641	3500380516	72		146454533	146457641	8421504	2	47,25	0,3083	c,g	350038051600000021,350038051600000059	0-47,15-40						Human Cystathionine beta-Synthase Variants and Methods of Production Thereof - Patent application	www.faqs.org	0	0		
1702	chr1	146454809	146454832	3500080816	23		146454809	146454832	8421504	1	23	0	g	350008081600000016	6-29						Conditionally replicating viral vectors and their use	Dropulic	1997	0		
1703	chr1	146540651	146540694	3500082435	43		146540651	146540694	8421504	1	43	0	c	350008243500000002	0-43						Trimethylamine N-oxide alleviates the severe aggregation and ER stress caused by G98R &#x03b1;A-crystallin	www.molvis.org	0	0		
1703	chr1	146541877	146541934	3500366563	57		146541877	146541934	8421504	1	57	0	p	350036656300015000	0-57		11598124	10.1074/jbc.M107737200	0021-9258	Journal of Biological Chemistry	Phe71 Is Essential for Chaperone-like Function in &#x03b1;A-crystallin	Santhoshkumar	2001	5		CRYAA
1703	chr1	146541880	146541934	3500083054	54		146541880	146541934	8421504	1	54	0	p	350008305400015002	3-57							stractsonline.com	0	0		CRYAA
213	chr1	147052745	147069340	3500171178	1812		147052745	147069340	8421504	14	19,89,181,86,27,96,90,141,188,245,220,203,167,60	0,355,5241,6403,7925,8900,10708,11503,13106,13375,13796,14199,16182,16535	p	350017117800015129,350017117800015131,350017117800015162,350017117800015163,350017117800015164,350017117800015166,350017117800015178,350017117800015177,350017117800015176,350017117800015193,350017117800015191,350017117800015194,350017117800015195,350017117800015210,350017117800015205	0-375,0-375,0-441,0-441,0-441,0-441,0-444,0-444,0-444,0-447,0-444,0-447,3-447,0-108,0-108						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
1706	chr1	147058369	147061916	3500213480	178		147058369	147061916	8421504	8	20,20,20,20,38,20,20,20	0,327,451,1186,1572,2284,2964,3527	c,g	350021348000000007,350021348000000006,350021348000000009,350021348000000011,350021348000000010,350021348000000012,350021348000000017,350021348000000015,350021348000000015,350021348000000021,350021348000000022	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						&#x201e;GEN ETI KA A &#x0160;LECHT&#x011a;N&#xcd; ZV&#xcd;&#x0158;AT&#x201c; &#x201e;GENETICS AND ANIMAL BREEDING&#x201c;	user.mendelu.cz	0	0		
1706	chr1	147059162	147060616	3500272653	165		147059162	147060616	8421504	3	81,9,75	0,552,1379	c,g	350027265300000002,350027265300000000,350027265300000000,350027265300000001,350027265300000003	0-81,0-19,0-19,0-30,0-84						 Diagnostic Assays For Genetic Mutations Associated With Bovine Leukocyte Adhesion Deficiency 	www.docstoc.com	0	0		
1706	chr1	147059167	147059226	3500073544	59		147059167	147059226	8421504	1	59	0	c,g	350007354400000006,350007354400000008,350007354400000007,350007354400000007,350007354400000005,350007354400000004,350007354400000004	57-116,58-116,0-58,0-58,0-27,0-27,0-27						Lesson Module II &#x2013; Marker Assisted Selection II	otech.iastate.edu	0	0		
1706	chr1	147059492	147060649	3500089941	62		147059492	147060649	8421504	3	21,22,19	0,1049,1138	c,g	350008994100000001,350008994100000001,350008994100000002,350008994100000002,350008994100000003,350008994100000003	0-21,0-21,0-22,0-22,0-19,0-19						Study of an association between SNP 775C>T within the bovine ITBG2 gene and milk performance traits in Black and White cows	ulturejournals.cz	0	0		
213	chr1	147059563	147069375	3500238511	81		147059563	147069375	8421504	2	31,50	0,9762	c	350023851100000006,350023851100000004,350023851100000001,350023851100000002,350023851100000003	31-62,30-79,45-94,36-85,36-86		16041046	10.1128/IAI.73.8.5233-5237.2005		Infection and Immunity	Mapping of the binding site for Mannheimia haemolytica leukotoxin within bovine CD18.	Dileepan	2005	0		
1707	chr1	147066274	147066319	3500077786	45		147066274	147066319	8421504	1	45	0	p	350007778600015042	0-45						US Patent # 6,670,328. Proteins and peptides derived from protein ESM-1 and their uses in the treatment and diagnosis of diseases linked to leukocyte migration - Patents.com	www.patents.com	0	0		
1707	chr1	147069034	147069340	3500197411	120		147069034	147069340	8421504	2	60,60	0,246	p	350019741100015102	0-120						HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLAY	Arap	2011	0		ITGB2
1707	chr1	147069034	147069340	3500117014	120		147069034	147069340	8421504	2	60,60	0,246	p	350011701400015097,350011701400015098	0-69,0-51					Patent	Peptide compositions for targeting adipose tissue (Patent US:8067377)	Arap	2011	0		ITGB2
1707	chr1	147069034	147069340	3500056865	120		147069034	147069340	8421504	2	60,60	0,246	p	350005686500015002	0-120						Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin &#x03b2;1A	cs.biologists.org	0	0		ITGB2
1707	chr1	147069034	147069312	3500003718	42		147069034	147069312	8421504	2	21,21	0,257	c,g	350000371800000002,350000371800000002,350000371800000003	0-21,0-21,0-21		12117943	10.1128/IAI.70.8.4336-4343.2002	0019-9567	Infection and Immunity	Inflammatory Cytokines Enhance the Interaction of Mannheimia haemolytica Leukotoxin with Bovine Peripheral Blood Neutrophils In Vitro	Leite	2002	4		
1707	chr1	147069037	147069340	3500078577	111		147069037	147069340	8421504	3	57,6,48	0,243,255	p	350007857700015100	0-111						Human And Mouse Targeting Peptides Identified By Phage Display 	.freshpatents.com	0	0		ITGB2
1707	chr1	147069280	147069340	3500385690	60		147069280	147069340	8421504	1	60	0	p	350038569000015001	0-60					The Journal of Cell Biology	ICAP-1, a Novel &#x03b2;1 Integrin Cytoplasmic Domain&#x2013;associated Protein, Binds to a Conserved and Functionally Important NPXY Sequence Motif of &#x03b2;1 Integrin 	David	1997	0		ITGB2
1707	chr1	147111758	147111791	3500394592	33		147111758	147111791	8421504	1	33	0	c	350039459200000023	11-53					Patent	Vector for the expression of fusion proteins and protein immunogens (Patent US:4973551)	Condra	1990	0		
1707	chr1	147132716	147140922	3500421009	276		147132716	147140922	8421504	4	21,129,72,54	0,4536,6768,8152	p	350042100900015004	0-276						Compositions and uses for a novel cell-death-protecting protein	Yeh	2000	0		
1707	chr1	147140895	147140918	3500324111	23		147140895	147140918	8421504	1	23	0	c	350032411100000005	19-42						MUTATED SUMO ISOFORMS AND USES THEREOF - UNIVERSIT&#xc9; DE MONTR&#xc9;AL	www.sumobrain.com	0	0		
1707	chr1	147145035	147169661	3500137987	495		147145035	147169661	8421504	6	43,36,46,119,141,110	0,8369,8499,18945,21210,24516	p	350013798700015012	0-495						Express&#xe3;o Heter&#xf3;loga, Purifica&#xe7;&#xe3;o e Caracteriza&#xe7;&#xe3;o Estrutural do Pept&#xed;deo (171-194) da p24 do HIV-1&#x201d;	ww.bdtd.ufscar.br	0	0		
1708	chr1	147254785	147254810	3500337360	23		147254785	147254810	8421504	3	4,4,15	0,5,10	c	350033736000000372	4-27						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
1709	chr1	147365290	147368834	3500160249	39		147365290	147368834	8421504	3	14,5,20	0,15,3524	g	350016024900000027,350016024900000310	29-48,23-46						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN - Patent application	www.faqs.org	0	0		
1709	chr1	147365290	147368834	3500104979	39		147365290	147368834	8421504	3	14,5,20	0,15,3524	g	350010497900000027,350010497900000310	29-48,23-46						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
1710	chr1	147492299	147492327	3500167742	24		147492299	147492327	8421504	2	10,14	0,14	g	350016774200000057	1-25						By Jonathan Seaman	www.rhizobium.net	0	0		
1710	chr1	147494563	147494620	3500247257	57		147494563	147494620	8421504	1	57	0	p	350024725700015000	0-57						Supplementary Materials for	grtc.ucsd.edu	0	0		PFKL
1710	chr1	147496134	147496163	3500245468	25		147496134	147496163	8421504	3	15,6,4	0,18,25	c	350024546800000218	5-34						Inhibition Of Cancer Metastasis 	.freshpatents.com	0	0		
1710	chr1	147517225	147517249	3500400238	24		147517225	147517249	8421504	1	24	0	c	350040023800000353,350040023800000331	3-22,12-37						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1711	chr1	147595830	147595854	3500419250	24		147595830	147595854	8421504	1	24	0	g	350041925000000007	8-34						JULIO CESAR CARRANZA MARTINEZ	www.teses.usp.br	0	0		
1712	chr1	147728895	147728922	3500239356	24		147728895	147728922	8421504	2	9,15	0,12	g	350023935600000009	1-26						NEUREGULIN ANTAGONISTS AND USE THEREOF IN TREATING CANCER - GENENTECH, INC.	www.sumobrain.com	0	0		
1712	chr1	147797461	147805995	3500028471	180		147797461	147805995	8421504	5	21,30,44,48,37	0,3297,6037,7749,8497	c	350002847100000096,350002847100000074,350002847100000072,350002847100000065,350002847100000084	0-48,0-48,0-44,0-48,11-48						Method of screening compounds that inhibit lysophosphatidic acid acyltransferase	Leung	2001	0		
1712	chr1	147828273	147828301	3500376275	24		147828273	147828301	8421504	2	9,15	0,13	g	350037627500000004,350037627500000003	9-33,0-24						HEPATITIS C VIRUS NON-STRUCTURAL NS3/4A FUSION GENE - Patent application	www.faqs.org	0	0		
1712	chr1	147828273	147828301	3500361131	24		147828273	147828301	8421504	2	9,15	0,13	g	350036113100000003,350036113100000010,350036113100000011,350036113100000004	0-24,0-24,9-33,9-33						VACCINES CONTAINING RIBAVIRIN	Sallberg	2001	0		
1712	chr1	147828273	147828301	3500340881	24		147828273	147828301	8421504	2	9,15	0,13	g	350034088100000003,350034088100000004	0-24,9-33						Hepatitis C Virus Codon Optimized Non-structural Ns3/4a Fusion Gene 	.freshpatents.com	0	0		
1712	chr1	147828273	147828301	3500305544	24		147828273	147828301	8421504	2	9,15	0,13	g	350030554400000006	0-24					Patent	A hepatitis C virus codon optimized non-structural NS3/4A fusion gene (Patent CN:100566753)	Ma Di *Sa Er Bei Li 	2009	0		
1712	chr1	147828273	147828301	3500289116	24		147828273	147828301	8421504	2	9,15	0,13	g	350028911600000002,350028911600000001	9-33,0-24					Patent	Hepatitis C virus codon optimized non-structural NS3/4A fusion gene (Patent US:7022830)	Sallberg	2006	0		
1712	chr1	147828273	147828301	3500287883	24		147828273	147828301	8421504	2	9,15	0,13	g	350028788300000003,350028788300000004	0-24,9-33					Patent	Hepatitis C virus codon optimized non-structural NS3/4A fusion gene (Patent US:7638499)	Sallberg	2009	0		
1712	chr1	147828273	147828301	3500137328	24		147828273	147828301	8421504	2	9,15	0,13	g	350013732800000003	0-24					Patent	Hepatitis C virus codon optimized non-structural NS3/4A fusion gene (Patent US:7307066)	Sallberg	2007	0		
1712	chr1	147828273	147828301	3500099237	24		147828273	147828301	8421504	2	9,15	0,13	g	350009923700000004,350009923700000003	9-33,0-24						IMMUNOGEN PLATFORM - Patent application	www.faqs.org	0	0		
1712	chr1	147828273	147828301	3500090297	24		147828273	147828301	8421504	2	9,15	0,13	g	350009029700000003,350009029700000004	0-24,9-33						IMMUNOGEN PLATFORM - Patent application	www.faqs.org	0	0		
1712	chr1	147828273	147828301	3500072684	24		147828273	147828301	8421504	2	9,15	0,13	g	350007268400000023,350007268400000025,350007268400000007,350007268400000006	0-24,9-33,9-33,0-24						A hepatitis c virus codon optimized non-structural NS3/4A fusion gene	Ma Di *Sa Er Bei Li 	2006	0		
1713	chr1	147891289	147891313	3500014982	23		147891289	147891313	8421504	2	4,19	0,5	g	350001498200000139	10-33						&#x201e;Das AUACCC-bindende Protein Khd4 kontrolliert Morphogenese und Pathogenit&#xe4;t in Ustilago maydis&#x201c;	ub.uni-marburg.de	0	0		
1713	chr1	147970391	147970417	3500440314	24		147970391	147970417	8421504	3	14,4,6	0,15,20	c	350044031400000003	12-36			10.1110/ps.11901	1469-896X	Protein Science	Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases - Pol - 2008 - Protein Science - Wiley Online Library	Pol	2001	0		
1714	chr1	148064548	148064575	3500165695	23		148064548	148064575	8421504	2	14,9	0,18	g	350016569500000502	0-33						BIOLOGICAL METHODS FOR PREPARING ADIPIC ACID - Patent application	www.faqs.org	0	0		
1717	chr1	148438222	148438250	3500209798	23		148438222	148438250	8421504	2	15,8	0,20	g	350020979800000002	5-40						Enzymatic Degradation of Chitosans	u.diva-portal.org	0	0		
1717	chr1	148454076	148454331	3500204244	24		148454076	148454331	8421504	2	13,11	0,244	c	350020424400000091	17-41						US Patent # 5,643,783. Collagen and uses therefor - Patents.com	www.patents.com	0	0		
1717	chr1	148454076	148454331	3500058951	24		148454076	148454331	8421504	2	13,11	0,244	c	350005895100000091	17-41						Collagen and uses therefor	Olsen	1993	0		
1717	chr1	148462361	148462386	3500329425	25		148462361	148462386	8421504	1	25	0	c	350032942500000009	3-28		15901832	10.1091/mbc.E04-11-1029	1059-1524	Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Im	2005	5		
1717	chr1	148462361	148462386	3500228083	25		148462361	148462386	8421504	1	25	0	c,g	350022808300000009,350022808300000009	3-28,3-28			10.1091/mbc.E04-11-1029		Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Eunok	2005	0		
1717	chr1	148462361	148462386	3500078966	25		148462361	148462386	8421504	1	25	0	c	350007896600000009	3-28						Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells	w.molbiolcell.org	0	0		
1717	chr1	148464403	148465078	3500436314	144		148464403	148465078	8421504	2	51,93	0,582	p	350043631400015020,350043631400015009,350043631400015026,350043631400015012,350043631400015027	0-45,0-45,0-45,0-45,0-45						Methods and compositions for diagnosing and treating disorders involving angiogenesis	Tong	2001	0		
1717	chr1	148466332	148466367	3500327978	35		148466332	148466367	8421504	1	35	0	c	350032797800000001	0-35						Methods and compositions for diagnosing and treating disorders involving angiogenesis	Sheppard	2002	0		
1718	chr1	148565531	148565578	3500205377	47		148565531	148565578	8421504	1	47	0	c	350020537700000011	70-117						US Patent # 5,763,216. Gene encoding a human reduced folate carrier (RFC) - Patents.com	www.patents.com	0	0		
1723	chr1	149219729	149221305	3500233903	24		149219729	149221305	8421504	3	7,7,10	0,1556,1566	c	350023390300000316	1-25						VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS - Patent application	www.faqs.org	0	0		
1723	chr1	149219729	149221305	3500135823	24		149219729	149221305	8421504	3	7,7,10	0,1556,1566	c	350013582300000316	1-25						VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS - Patent application	www.faqs.org	0	0		
1723	chr1	149242229	149281168	3500449380	214		149242229	149281168	8421504	9	21,10,11,38,7,28,35,38,26	0,1165,3010,5411,5918,21205,25616,30034,38913	c	350044938000000258,350044938000000122,350044938000000245,350044938000000206,350044938000000062,350044938000000050,350044938000000159	23-44,24-45,0-45,17-45,0-35,0-38,0-26						Anti-hiv Antibody 	freshpatents.com	0	0		
1723	chr1	149249617	149249643	3500203681	25		149249617	149249643	8421504	2	11,14	0,12	g	350020368100000010	9-34		21597459	10.1038/cdd.2011.57	1350-9047	Cell Death & Differentiation	E3 ubiquitin ligase Hades negatively regulates the exonuclear function of p53	Jung	2011	9		
1723	chr1	149284349	149288552	3500430517	354		149284349	149288552	8421504	3	210,69,75	0,3043,4128	p	350043051700015093	0-483						Nuclease compositions and methods	Davies	2009	0		
1729	chr1	149963185	149963211	3500193635	24		149963185	149963211	8421504	2	6,18	0,8	g	350019363500000188	23-47						Materials and methods for immunocontraception	Harris	1993	0		
1730	chr1	150096104	150096132	3500229887	23		150096104	150096132	8421504	2	16,7	0,21	g	350022988700000056	24-47						US Patent # 5,589,367. Recombinant plant viral nucleic acids - Patents.com	www.patents.com	0	0		
1732	chr1	150340876	150340904	3500465310	28		150340876	150340904	8421504	1	28	0	g	350046531000000003	15-43		20875108	10.1186/1741-7007-8-128		BMC Biology	Direct targets of Klf5 transcription factor contribute to the maintenance of mouse embryonic stem cell undifferentiated state	Silvia	2010	0		RUNX3
1732	chr1	150340880	150441923	3500392765	1344		150340880	150441923	8421504	7	473,162,192,105,157,254,1	0,6708,40965,68366,88245,94892,101042	p	350039276500015000	15-1359						KEGG T01001: 861	www.genome.jp	0	0		
1732	chr1	150381853	150429168	3500441191	45		150381853	150429168	8421504	2	20,25	0,47290	c	350044119100000004,350044119100000000	0-20,0-25		19342459	10.1210/en.2008-1527	0013-7227	Endocrinology	Runt-Related Transcription Factor 1 Regulates Luteinized Hormone-Induced Prostaglandin-Endoperoxide Synthase 2 Expression in Rat Periovulatory Granulosa Cells	Liu	2009	4		
1732	chr1	150381865	150382021	3500227396	40		150381865	150382021	8421504	2	20,20	0,136	c,g	350022739600000000,350022739600000000,350022739600000001	0-20,0-20,0-20			10.1242/jcs.01332	0021-9533	Journal of Cell Science	Breakpoint cluster regions of the AML-1 and ETO genes contain MAR elements and are preferentially associated with the nuclear matrix in proliferating HEL cells	Iarovaia	2004	6		RUNX1
1732	chr1	150409247	150409347	3500446911	100		150409247	150409347	8421504	1	100	0	c	350044691100000009	0-100						Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene	Heidenreich	2007	0		RUNX1
1732	chr1	150409338	150436044	3500288227	45		150409338	150436044	8421504	3	13,7,25	0,19787,26681	c,g	350028822700000000,350028822700000002	0-20,0-25						AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression	ev.biologists.org	0	0		RUNX1
1732	chr1	150409338	150436044	3500209282	45		150409338	150436044	8421504	3	13,7,25	0,19787,26681	c,g	350020928200000000,350020928200000002	0-20,0-25						Zebrafish models of acute myelogenous leukemia	Peterson	2006	0		RUNX1
1732	chr1	150409338	150436044	3500205979	45		150409338	150436044	8421504	3	13,7,25	0,19787,26681	c,g	350020597900000000,350020597900000002	0-20,0-25		18156164	10.1242/dev.008904	0950-1991	Development	AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression	Yeh	2008	7		RUNX1
1732	chr1	150429207	150435839	3500208042	44		150429207	150435839	8421504	2	23,21	0,6611	c	350020804200000082,350020804200000083	0-23,0-21						Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Translocations and Chromosomal Aberrations in Acute Leukemia	tologylibrary.org	0	0		RUNX1
1732	chr1	150429231	150429259	3500398179	23		150429231	150429259	8421504	2	17,6	0,22	c	350039817900000000,350039817900000005	0-24,0-23						Species Having C Single-Cell-Type Photosynthesis in the Chenopodiaceae Family Evolved a Photosynthetic enol Kranz-Type C Species	.plantphysiol.org	0	0		
1732	chr1	150429231	150429259	3500176399	23		150429231	150429259	8421504	2	17,6	0,22	c	350017639900000000	0-24			10.1104/pp.106.085829		Plant Physiology	Species Having C4 Single-Cell-Type Photosynthesis in the Chenopodiaceae Family Evolved a Photosynthetic Phosphoenolpyruvate Carboxylase Like That of Kranz-Type C4 Species	Maria	2006	0		
1732	chr1	150429231	150429259	3500041246	23		150429231	150429259	8421504	2	17,6	0,22	c	350004124600000000,350004124600000005	0-24,0-23		16920871	10.1104/pp.106.085829	0032-0889	Plant Physiology	Species Having C4 Single-Cell-Type Photosynthesis in the Chenopodiaceae Family Evolved a Photosynthetic Phosphoenolpyruvate Carboxylase Like That of Kranz-Type C4 Species	Lara	2006	7		
1732	chr1	150436049	150436080	3500194485	31		150436049	150436080	8421504	1	31	0	g	350019448500000003,350019448500000000	0-23,0-20		12393679	10.1182/blood-2002-04-1010	0006-4971	Blood	Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia	Harada	2003	10		
1732	chr1	150440474	150440501	3500012719	24		150440474	150440501	8421504	2	10,14	0,13	g	350001271900000006	5-29						ECOLOGY OF TOXIGENIC BACILLUS SPECIES	works.unsw.edu.au	0	0		
1732	chr1	150443703	150443731	3500289629	25		150443703	150443731	8421504	3	6,5,14	0,7,14	g	350028962900000024,350028962900000120,350028962900000121,350028962900000023	10-35,9-34,10-35,9-34						METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - Patent application	www.faqs.org	0	0		
1736	chr1	150924324	150924349	3500392569	23		150924324	150924349	8421504	3	13,5,5	0,14,20	g	350039256900000002	7-30					Patent	Soybeans with reduced isoflavones (Patent US:8329995)	Facciotti	2012	0		
1736	chr1	150924324	150924349	3500199117	23		150924324	150924349	8421504	3	13,5,5	0,14,20	g	350019911700000002	7-30						SOYBEANS WITH REDUCED ISOFLAVONES	Facciotti	2008	0		
1737	chr1	151011309	151011333	3500254523	23		151011309	151011333	8421504	2	10,13	0,11	g	350025452300000000	7-32					Patent	Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins (Patent US:6042832)	Hooper	2000	0		
1741	chr1	151567419	151567444	3500408660	23		151567419	151567444	8421504	2	13,10	0,15	g	350040866000000075	8-31						Detection of a respiratory coronavirus from tissues archived during a pneumonia epizootic in free-ranging Pacific harbor seals Phoca vitulina richardsii	www.int-res.com	0	0		
1741	chr1	151567419	151567444	3500130000	23		151567419	151567444	8421504	2	13,10	0,15	g	350013000000000075	8-31						Detection of a respiratory coronavirus from tissues archived during a pneumonia epizootic in free-ranging Pacific harbor seals Phoca vitulina richardsii. - ResearchGate	.researchgate.net	0	0		
1744	chr1	151936513	151936537	3500063691	24		151936513	151936537	8421504	1	24	0	c	350006369100000000	0-24		22962580	10.1371/journal.pone.0042198		PLoS ONE	RNA-Seq Approach for Genetic Improvement of Meat Quality in Pig and Evolutionary Insight into the Substrate Specificity of Animal Carbonyl Reductases	Won	2012	0		CBR1
1746	chr1	152247839	152247867	3500137915	24		152247839	152247867	8421504	2	8,16	0,12	c	350013791500000592	11-46						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1746	chr1	152249809	152249836	3500076824	23		152249809	152249836	8421504	2	7,16	0,11	c	350007682400000011	11-35						Traduuuuuu1	ww.slideshare.net	0	0		
1748	chr1	152504550	152504573	3500440489	23		152504550	152504573	8421504	1	23	0	g	350044048900000051	7-30						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
219	chr1	153313311	153404666	3500106625	42		153313311	153404666	8421504	3	12,8,22	0,50455,91333	c,g	350010662500000008,350010662500000009,350010662500000009	13-33,12-34,12-34		14593110	10.1074/jbc.M301769200	0021-9258	Journal of Biological Chemistry	Phosphorylation of Ser640 in Muscle Glycogen Synthase by DYRK Family Protein Kinases	Skurat	2004	5		DYRK1A
1755	chr1	153370904	153404426	3500018156	113		153370904	153404426	8421504	3	63,25,25	0,3450,33497	c	350001815600000007,350001815600000006,350001815600000003,350001815600000002,350001815600000000	20-83,10-73,0-25,0-25,0-25		12964950	10.1186/1471-2121-4-12	1471-2121	BMC Cell Biology	Overexpression of the human MNB/DYRK1A gene induces formation of multinucleate cells through overduplication of the centrosome	Funakoshi	2003	3		DYRK1A
1755	chr1	153383143	153390703	3500412095	48		153383143	153390703	8421504	2	24,24	0,7536	c	350041209500000000,350041209500000001	0-24,0-24						Regulators of NFAT	Rao	2007	0		DYRK1A
1755	chr1	153394711	153394756	3500201296	45		153394711	153394756	8421504	1	45	0	p	350020129600015000	0-45		17229891	10.1091/mbc.E06-08-0668	1059-1524	Molecular Biology of the Cell	DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding	Alvarez	2007	5		DYRK1A
1755	chr1	153404183	153404234	3500377779	51		153404183	153404234	8421504	1	51	0	p	350037777900015022	42-93						Complementation of snf1, a Mutation Affecting Global Regulation of Carbon Metabolism in Yeast, by a Plant Protein Kinase cDNA	www.jstor.org	0	0		DYRK1A
1761	chr1	154174835	154174861	3500395029	23		154174835	154174861	8421504	2	13,10	0,16	g	350039502900000494	20-43						 Recombinant Infectious Laryngotracheitis Virus And Uses Thereof 	www.docstoc.com	0	0		
1762	chr1	154344623	154344648	3500460789	24		154344623	154344648	8421504	2	11,13	0,12	g	350046078900000001	0-24		16227263	10.1128/JVI.79.21.13421-13433.2005	0022-538X	Journal of Virology	VP24 of Marburg Virus Influences Formation of Infectious Particles	Bamberg	2005	5		
1763	chr1	154424405	154424428	3500374842	23		154424405	154424428	8421504	1	23	0	c	350037484200000001	0-23						Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer	Petrovics	2011	0		
1763	chr1	154425381	154425406	3500253033	25		154425381	154425406	8421504	1	25	0	c	350025303300000003	0-25		18212050	10.1128/MCB.00740-07	0270-7306	Molecular and Cellular Biology	Inducible Expression of Chimeric EWS/ETS Proteins Confers Ewing's Family Tumor-Like Phenotypes to Human Mesenchymal Progenitor Cells	Miyagawa	2008	6		ERG
1763	chr1	154425753	154425891	3500186119	138		154425753	154425891	8421504	1	138	0	p	350018611900015103	0-138						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		ERG
1763	chr1	154436806	154448014	3500436952	28		154436806	154448014	8421504	2	9,19	0,11189	c	350043695200000028	0-28						Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations	Srivastava	2008	0		
1763	chr1	154436806	154448014	3500213922	28		154436806	154448014	8421504	2	9,19	0,11189	c	350021392200000028	0-28						Prostate Cancer-specific Alterations In Erg Gene Expression And Detection And Treatment Methods Based On Those Alterations 	.freshpatents.com	0	0		
1763	chr1	154436806	154448014	3500103269	28		154436806	154448014	8421504	2	9,19	0,11189	c	350010326900000041	0-28						Prostate cancer-specific alterations in erg gene expression and detection and treatment methods based on those alterations	Srivastava	2009	0		
1763	chr1	154436806	154448014	3500069476	28		154436806	154448014	8421504	2	9,19	0,11189	c	350006947600000075,350006947600000029	0-28,0-28						Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations - Patent application	www.faqs.org	0	0		
1763	chr1	154436806	154448014	3500023397	28		154436806	154448014	8421504	2	9,19	0,11189	c	350002339700000028	0-28						Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations	Srivastava	2008	0		
220	chr1	154499508	154559114	3500078892	24		154499508	154559114	8421504	2	5,19	0,59587	c	350007889200000000	11-35		20713528	10.1158/0008-5472.CAN-10-0244	0008-5472	Cancer Research	FZD4 as a Mediator of ERG Oncogene&#x2013;Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells	Gupta	2010	8		ERG
220	chr1	154499509	154559118	3500365820	27		154499509	154559118	8421504	2	4,23	0,59586	c	350036582000000008	0-27						Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis. - ResearchGate	.researchgate.net	0	0		
1770	chr1	155351024	155351052	3500048166	23		155351024	155351052	8421504	3	8,11,4	0,12,24	c	350004816600000003	14-37		18498090	10.1002/dvdy.21578	1097-0177	Developmental Dynamics	Differential expression pattern of the four mitochondrial adenine nucleotide transporter ant genes and their roles during the development of Caenorhabditis elegans - Farina - 2008 - Developmental Dynamics - Wiley Online Library	Farina	2008	0		
1775	chr1	156050115	156050142	3500460081	27		156050115	156050142	8421504	1	27	0	c	350046008100000008	0-27						Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor	Kapeller-libermann	2006	0		
1776	chr1	156159889	156159913	3500353418	24		156159889	156159913	8421504	1	24	0	c	350035341800000006	3-27						Regulation of Myt1	cs.biologists.org	0	0		
1778	chr1	156391768	156391791	3500116568	23		156391768	156391791	8421504	1	23	0	g	350011656800000077	0-23						SYSTEMS, METHODS AND MICRORGANISMS FOR ANTIBODY PRODUCTION WITH TYPE III SECRETION SYSTEM - Patent application	www.faqs.org	0	0		
1778	chr1	156425278	156425305	3500440049	24		156425278	156425305	8421504	3	13,5,6	0,15,21	g	350044004900000038	0-24						Humanized antibodies that bind to the antigen bound by antibody NR-LU-13	Graves	1997	0		
1779	chr1	156583312	156583335	3500443438	23		156583312	156583335	8421504	1	23	0	g	350044343800000028	0-23						US Patent # 6,319,493. Treatment of neoplastic disease with interleukin-10 - Patents.com	www.patents.com	0	0		
1783	chr1	157093484	157093509	3500439741	23		157093484	157093509	8421504	2	16,7	0,18	g	350043974100000040	0-23						MATERIALS AND METHOD FOR ASSAYING FOR METHYLATION OF CpG ISLANDS ASSOCIATED WITH GENES IN THE EVALUATION OF CANCER	Freije	2011	0		
1783	chr1	157093484	157093509	3500325928	23		157093484	157093509	8421504	2	16,7	0,18	g	350032592800000040	0-23						Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer	Freije	2008	0		
1783	chr1	157093484	157093509	3500286420	23		157093484	157093509	8421504	2	16,7	0,18	g	350028642000000040	0-23						Materials And Methods For Assaying For Methylation Of Cpg Islands Associated With Genes In The Evaluation Of Cancer 	.freshpatents.com	0	0		
1783	chr1	157093484	157093509	3500115772	23		157093484	157093509	8421504	2	16,7	0,18	g	350011577200000040	0-23						MATERIALS AND METHOD FOR ASSAYING FOR METHYLATION OF CpG ISLANDS ASSOCIATED WITH GENES IN THE EVALUATION OF CANCER	Freije	2011	0		
1783	chr1	157093484	157093509	3500039093	23		157093484	157093509	8421504	2	16,7	0,18	g	350003909300000040,350003909300000195	0-23,0-23						MATERIALS AND METHOD FOR ASSAYING FOR METHYLATION OF CpG ISLANDS ASSOCIATED WITH GENES IN THE EVALUATION OF CANCER - Patent application	www.faqs.org	0	0		
1786	chr1	157446093	157463650	3500381467	179		157446093	157463650	8421504	8	22,25,21,22,24,23,22,20	0,1181,6390,7556,8444,15572,17500,17537	c,g	350038146700000005,350038146700000009,350038146700000003,350038146700000003,350038146700000004,350038146700000004,350038146700000007,350038146700000006,350038146700000001,350038146700000002,350038146700000002	0-22,0-25,0-21,0-21,0-22,0-22,0-24,0-23,0-22,0-20,0-20						ScienceDirect.com - Progress in Natural Science - b-DAZL: A novel gene in bovine spermatogenesis	sciencedirect.com	0	0		
1786	chr1	157462397	157463572	3500310981	40		157462397	157463572	8421504	2	20,20	0,1155	c,g	350031098100000001,350031098100000001,350031098100000000	0-20,0-20,0-20						Co-Culture of Spermatogonial Stem Cells with Sertoli Cells in the Presence of Testosterone and FSH Improved Differentiation via Up-Regulation of Post Meiotic Genes	acta.tums.ac.ir	0	0		DAZL
1786	chr1	157462397	157463572	3500134460	40		157462397	157463572	8421504	2	20,20	0,1155	c,g	350013446000000001,350013446000000001,350013446000000000,350013446000000000	0-20,0-20,0-20,0-20						Co-Culture of Spermatogonial Stem Cells with Sertoli Cells in the Presence of Testosterone and FSH Improved Differentiation via Up-Regulation of Post Meiotic Genes	urnals.tums.ac.ir	0	0		DAZL
1786	chr1	157462397	157463572	3500086922	40		157462397	157463572	8421504	2	20,20	0,1155	c,g	350008692200000001,350008692200000001,350008692200000000,350008692200000000	0-20,0-20,0-20,0-20						Co-Culture of Spermatogonial Stem Cells with Sertoli Cells in the Presence of Testosterone and FSH Improved Differentiation via Up-Regulation of Post Meiotic Genes	urnals.tums.ac.ir	0	0		
1786	chr1	157463055	157463105	3500314401	50		157463055	157463105	8421504	1	50	0	c	350031440100000020	0-50						SI appendix for	www.pnas.org	0	0		
1787	chr1	157560715	157560742	3500454678	23		157560715	157560742	8421504	2	11,12	0,15	g	350045467800000044	0-23						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2004	0		
1791	chr1	158184089	158184115	3500371882	24		158184089	158184115	8421504	2	16,8	0,18	g	350037188200000005	21-45						One-step purification process for organophosphorus hydrolase enzyme	Rastogi	2000	0		
1794	chr1	158579784	158579812	3500386203	26		158579784	158579812	8421504	2	19,7	0,21	g	350038620300000074	20-47						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
1794	chr1	158587628	158587651	3500170847	23		158587628	158587651	8421504	1	23	0	g	350017084700000021	10-38						Protein and gene involved in myocyte differentiation	Wadhwa	2000	0		
1799	chr1	159184202	159184226	3500399046	24		159184202	159184226	8421504	1	24	0	g	350039904600000007	0-32						Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same	Iverson	2001	0		
1799	chr1	159184202	159184226	3500280243	24		159184202	159184226	8421504	1	24	0	g	350028024300000007	0-32					Patent	Therapeutic and diagnostic domain 1 &#x03b2;2GPI polypeptides and methods of using same (Patent US:6858210)	Marquis	2005	0		
1800	chr1	159283975	159350619	3500187127	107		159283975	159350619	8421504	3	20,39,48	0,47766,66596	c	350018712700000080,350018712700000059,350018712700000055	0-20,9-48,0-48						Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof	Smith	1995	0		
1800	chr1	159284019	159355495	3500080296	228		159284019	159355495	8421504	5	51,27,18,57,75	0,28499,67466,67487,71401	p,c	350008029600015020,350008029600015003,350008029600000011	0-78,0-75,0-81						US Patent # 6,333,407. Matrix-associating DNA-binding protein, nucleic acids encoding the same and methods for detecting the nucleic acids - Patents.com	www.patents.com	0	0		
1800	chr1	159351540	159355495	3500261101	80		159351540	159355495	8421504	2	5,75	0,3880	c	350026110100000006	0-80						US Patent # 5,652,340. Matrix-associating DNA-binding protein, nucleic acids encoding the same and methods for detecting the nucleic acids - Patents.com	www.patents.com	0	0		
1803	chr1	159735468	159735497	3500374909	24		159735468	159735497	8421504	2	14,10	0,19	g	350037490900000760	15-39						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
1804	chr1	159853462	159853489	3500134391	24		159853462	159853489	8421504	2	17,7	0,20	g	350013439100000197	6-31						Anti-Prominin-1 Antibody having ADCC Activity or CDC Activity - Patent application	www.faqs.org	0	0		
1809	chr1	160472136	160472166	3500453674	25		160472136	160472166	8421504	2	9,16	0,14	g	350045367400000006	0-25		9573115		0019-9567	Infection and Immunity	Identification and Characterization of Heparin Binding Regions of the Fim2 Subunit of Bordetella pertussis	Geuijen	1998	4		
1813	chr1	160979773	160979802	3500112083	24		160979773	160979802	8421504	2	6,18	0,11	g	350011208300000280	3-34						 Mycobacterial Sulfation Pathway Proteins And Methods Of Use Thereof 	www.docstoc.com	0	0		
1813	chr1	161011330	161011356	3500386074	23		161011330	161011356	8421504	3	12,6,5	0,13,21	g	350038607400000001	0-23			10.1124/mol.52.3.515	1521-0111 (Online)	Molecular Pharmacology	Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor	Boess	1997	0		
1813	chr1	161042051	161070853	3500113579	645		161042051	161070853	8421504	5	163,152,123,94,113	0,22296,22755,24841,28689	p	350011357900015000	0-645						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"> <HTML> <HEAD> <META http-equiv="Cont	e.dna.affrc.go.jp	0	0		RAB5A
1815	chr1	161232898	161232924	3500467426	26		161232898	161232924	8421504	1	26	0	c	350046742600000004	1-27		11553537	10.1128/IAI.69.10.6004-6011.2001	0019-9567	Infection and Immunity	Characterization of the Enzymatic Component of the ADP-Ribosyltransferase Toxin CDTa from Clostridium difficile	Gulke	2001	4		
1815	chr1	161245139	161252714	3500421693	67		161245139	161252714	8421504	3	22,25,20	0,1682,7555	c	350042169300000005,350042169300000004,350042169300000000	0-22,0-25,0-20		24019931	10.1371/journal.pone.0073636		PLoS ONE	SGO1 Maintains Bovine Meiotic and Mitotic Centromeric Cohesions of Sister Chromatids and Directly Affects Embryo Development	Feng-Xia	2013	0		
1815	chr1	161246821	161252714	3500233221	67		161246821	161252714	8421504	4	25,19,3,20	0,4428,5850,5873	c	350023322100000004,350023322100000002,350023322100000000	0-25,0-22,0-20		24019931	10.1371/journal.pone.0073636	1932-6203	PLOS ONE	PLOS ONE: SGO1 Maintains Bovine Meiotic and Mitotic Centromeric Cohesions of Sister Chromatids and Directly Affects Embryo Development	Yin	2013	4		
589	chr10	550803	550830	3500126207	25		550803	550830	8421504	2	13,12	0,15	g	350012620700000128	1-26					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
589	chr10	624772	624799	3500289926	23		624772	624799	8421504	3	14,4,5	0,15,22	c	350028992600000002,350028992600000083	13-36,13-36					Patent	Nucleic acid sequence detection by triple helix formation at primer site in amplification reactions (Patent US:5800984)	Vary	1998	0		
589	chr10	640612	640672	3500276786	60		640612	640672	8421504	1	60	0	p	350027678600015001	0-60		10987267		0008-5472	Cancer Research	Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels	Wyder	2000	8		APC
589	chr10	641750	641773	3500113683	23		641750	641773	8421504	1	23	0	c	350011368300000071	0-23						GENTIC POLYMORPHISMS ASSOCIATED WITH STROKE, METHODS OF DETECTION AND USES THEREOF - Patent application	www.faqs.org	0	0		APC
589	chr10	645362	645389	3500456727	25		645362	645389	8421504	2	13,12	0,15	c	350045672700000071	6-47					Patent	Recombinant plant expressing non-competitively binding insecticidal crystal proteins (Patent US:5866784)	Botterman	1999	0		
589	chr10	645362	645389	3500376795	25		645362	645389	8421504	2	13,12	0,15	c	350037679500000144,350037679500000071	7-47,6-47						Recombinant plant expressing non-competitively binding insecticidal crystal proteins	Mellaert	1995	0		
589	chr10	645884	645911	3500234385	24		645884	645911	8421504	2	19,5	0,22	c	350023438500000031	10-34						 Cloning And Expression Of Phytase From Aspergillus 	www.docstoc.com	0	0		
589	chr10	645884	645911	3500019879	24		645884	645911	8421504	2	19,5	0,22	c	350001987900000031	10-34						Cloning and expression of phytase from aspergillus	Gorcom	1993	0		
589	chr10	646659	646682	3500444601	23		646659	646682	8421504	1	23	0	c	350044460100000002	0-23		23530816	10.1186/1471-2407-13-157	1471-2407	BMC Cancer	Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc &#xe2; /+ mice	Karim	2013	3		
589	chr10	646659	646682	3500291065	23		646659	646682	8421504	1	23	0	c	350029106500000002	0-23		23530816	10.1186/1471-2407-13-157		BMC Cancer	Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc&#x2212;/+ mice	Baktiar	2013	0		
589	chr10	646659	646682	3500122176	23		646659	646682	8421504	1	23	0	c	350012217600000002	0-23							biomedcentral.com	0	0		
590	chr10	656154	661191	3500321939	48		656154	661191	8421504	2	24,24	0,5013	c,g	350032193900000001,350032193900000001,350032193900000000,350032193900000000	0-24,0-24,0-24,0-24		21078161	10.1186/1476-4598-9-294	1476-4598	Molecular Cancer	Aberrant WNT/&#xce;&#xb2;-catenin signaling in parathyroid carcinoma	Svedlund	2010	4		APC
590	chr10	705017	713707	3500462351	147		705017	713707	8421504	2	27,120	0,8570	p	350046235100015019	0-147						3335532 Protein Engineering Protocols	www.scribd.com	0	0		APC
590	chr10	713695	713728	3500384185	33		713695	713728	8421504	1	33	0	c	350038418500000000	10-43						Interactions between EB1, microtubules and APC	cs.biologists.org	0	0		
590	chr10	713698	713722	3500295049	24		713698	713722	8421504	1	24	0	c	350029504900000000	25-49						The APC Tumor Suppressor Promotes Transcription- Independent Apoptosis In vitro	.aacrjournals.org	0	0		APC
590	chr10	713698	713722	3500172550	24		713698	713722	8421504	1	24	0	c	350017255000000000	25-49		15755874	10.1158/1541-7786.MCR-03-0189	1541-7786	Molecular Cancer Research	The APC Tumor Suppressor Promotes Transcription-Independent Apoptosis In vitro11NIH CA 63517 (J. Groden) and CA 53683 (M.C. Barton) and Albert J. Ryan Foundation (K. Steigerwald).	Steigerwald	2005	4		APC
605	chr10	2677637	2677666	3500400848	24		2677637	2677666	8421504	2	8,16	0,13	g	350040084800000112	3-27						Characterisation of the Salmonella Pathogenicity Island 4-encoded proteins SiiE, SiiA and SiiB: a new mechanism of bacterial adhesion	b.uni-erlangen.de	0	0		
606	chr10	2774228	2817348	3500220331	174		2774228	2817348	8421504	2	24,150	0,42970	p,c	350022033100000010,350022033100015037	0-24,0-150					Patent	Small and intermediate conductance, calcium-activated potassium channels and uses thereof (Patent US:7026451)	Adelman	2006	0		
606	chr10	2774228	2817120	3500370024	189		2774228	2817120	8421504	5	48,6,42,48,45	0,195,547,637,42847	p	350037002400015056,350037002400015059,350037002400015060,350037002400015067	0-48,0-48,0-48,0-45						Human leukocyte calcium activated potassium channel polypeptide	Aiyar	1999	0		
75	chr10	2774417	2899933	3500399874	50		2774417	2899933	8421504	3	6,20,24	0,1318,125492	c	350039987400000009	0-50		18624921	10.1111/j.1471-4159.2008.05557.x	1471-4159	Journal of Neurochemistry	Identification and characterization of a novel, shorter isoform of the small conductance Ca2+-activated K+ channel SK2 - Murthy - 2008 - Journal of Neurochemistry - Wiley Online Library	Murthy	2008	0		
606	chr10	2774841	2774867	3500406109	24		2774841	2774867	8421504	3	8,4,12	0,9,14	c	350040610900000007	8-41						Compositions and methods for the therapy and diagnosis of prostate cancer	Xu	2002	0		
75	chr10	2774931	2930452	3500375774	921		2774931	2930452	8421504	9	99,30,96,363,29,142,21,75,66	0,105,729,42006,42396,124978,146922,146958,155455	p	350037577400015002	0-954						52906, 33408, and 12189, potassium channel family members and uses thereof	Curtis	2001	0		
606	chr10	2774943	2774991	3500180522	48		2774943	2774991	8421504	1	48	0	p	350018052200015003	0-48						&#x4f4e;&#x53ca;&#x3073;&#x4e2d;&#x9593;&#x30b3;&#x30f3;&#x30c0;&#x30af;&#x30bf;&#x30f3;&#x30b9;&#x306e;&#x30ab;&#x30eb;&#x30b7;&#x30a6;&#x30e0;&#x6d3b;&#x6027;&#x5316;&#x3055;&#x308c;&#x305f;&#x30ab;&#x30ea;&#x30a6;&#x30e0;&#x30c1;&#x30e3;&#x30cd;&#x30eb	astamuse.com	0	0		KCNN2
75	chr10	2775730	2899933	3500399874	49		2775730	2899933	8421504	2	25,24	0,124179	c	350039987400000008	0-49		18624921	10.1111/j.1471-4159.2008.05557.x	1471-4159	Journal of Neurochemistry	Identification and characterization of a novel, shorter isoform of the small conductance Ca2+-activated K+ channel SK2 - Murthy - 2008 - Journal of Neurochemistry - Wiley Online Library	Murthy	2008	0		
75	chr10	2817192	2936770	3500167053	414		2817192	2936770	8421504	9	75,24,21,14,46,93,78,32,31	0,78,105,150,82717,82766,104661,113290,119547	p	350016705300015006,350016705300015007,350016705300015010	0-120,0-231,0-63						Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders	Chen	2004	0		
75	chr10	2817342	2921931	3500434600	231		2817342	2921931	8421504	4	14,46,93,78	0,82567,82616,104511	p	350043460000015007	0-231						Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders	Chen	2003	0		
607	chr10	2899955	2921907	3500154352	150		2899955	2921907	8421504	2	96,54	0,21898	p	350015435200015011	0-150						NPG.nature.vol.417.Issue.6888.May	www.scribd.com	0	0		KCNN3
607	chr10	2921916	2921945	3500040440	29		2921916	2921945	8421504	1	29	0	c	350004044000000022	0-29						COMPOSITIONS AND METHODS FOR MODULATING CELL-CELL FUSION VIA INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS - Patent application	www.faqs.org	0	0		
607	chr10	2921921	2921945	3500417122	24		2921921	2921945	8421504	1	24	0	c	350041712200000052	0-24						Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat	jp.physoc.org	0	0		KCNN1
607	chr10	2930425	2936791	3500226279	141		2930425	2936791	8421504	3	89,1,51	0,3624,6315	p	350022627900015050	0-141					Patent	Small conductance, calcium-activated potassium channels (SKI) (Patent US:6828420)	Adelman	2004	0		
607	chr10	2930425	2936791	3500205116	141		2930425	2936791	8421504	3	89,1,51	0,3624,6315	p	350020511600015051	0-141						Small and intermediate conductance, calcium-activated potassium channels and uses thereof	Adelman	2005	0		
607	chr10	2930482	2936770	3500087477	63		2930482	2936770	8421504	3	32,1,30	0,3567,6258	p	350008747700015010	0-63						Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders	Chen	2003	0		
607	chr10	2940692	2940716	3500220152	24		2940692	2940716	8421504	1	24	0	c	350022015200000007,350022015200000013	0-24,0-23						Small and intermediate conductance, calcium-activated potassium channels and uses thereof	Adelman	2003	0		KCNN2
607	chr10	2940692	2940716	3500216552	24		2940692	2940716	8421504	1	24	0	c	350021655200000011	0-24						Small and intermediate conductance, calcium-activated potassium channels and uses thereof	Adelman	2002	0		KCNN2
607	chr10	2940692	2940716	3500213920	24		2940692	2940716	8421504	1	24	0	c,g	350021392000000007,350021392000000013,350021392000000013	0-24,0-23,0-23						Small and intermediate conductance, calcium-activated potassium channels and uses thereof	Adelman	2002	0		KCNN2
607	chr10	2940692	2940716	3500179861	24		2940692	2940716	8421504	1	24	0	c	350017986100000007	0-24						Small and intermediate conductance, calcium-activated potassium channels and uses thereof	Adelman	2003	0		KCNN2
607	chr10	2940692	2940716	3500057828	24		2940692	2940716	8421504	1	24	0	c	350005782800000003	0-24						Patent 7,534,869	www.pharmcast.com	0	0		KCNN2
607	chr10	2940693	2940716	3500376124	23		2940693	2940716	8421504	1	23	0	c	350037612400000009	0-23					Patent	Small and intermediate conductance, calcium-activated potassium channels and uses thereof (Patent EP:0948542)	Adelman	2007	0		KCNN2
607	chr10	2940693	2940716	3500241632	23		2940693	2940716	8421504	1	23	0	c	350024163200000001	0-23		15797870	10.1074/jbc.M413125200	0021-9258	Journal of Biological Chemistry	A Novel Isoform of SK2 Assembles with Other SK Subunits in Mouse Brain	Strassmaier	2005	5		KCNN2
607	chr10	2940693	2940716	3500220331	23		2940693	2940716	8421504	1	23	0	c	350022033100000017	0-23					Patent	Small and intermediate conductance, calcium-activated potassium channels and uses thereof (Patent US:7026451)	Adelman	2006	0		KCNN2
612	chr10	3589634	3589666	3500189823	27		3589634	3589666	8421504	3	11,8,8	0,15,24	g	350018982300000193	21-48						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
612	chr10	3621722	3621748	3500090675	23		3621722	3621748	8421504	2	15,8	0,18	c	350009067500000027	1-24						Cloning Nucleotide Sequences oflux Genes Characterization Luciferase Xenorhabdus	jb.asm.org/conten	0	0		
613	chr10	3761857	3761883	3500271571	23		3761857	3761883	8421504	2	6,17	0,9	g	350027157100000693	12-35						Cellular permissivity factor for viruses and uses thereof	Calvert	2005	0		
615	chr10	3942259	3942285	3500465169	23		3942259	3942285	8421504	2	8,15	0,11	c	350046516900000096	16-40						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
615	chr10	3942659	3943298	3500022796	62		3942659	3943298	8421504	3	22,20,20	0,260,619	c,g	350002279600000004,350002279600000019,350002279600000019,350002279600000018	20-42,0-20,0-20,0-20						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
616	chr10	4177353	4177378	3500445622	25		4177353	4177378	8421504	1	25	0	c	350044562200000068	0-25						Utilization of Genome-wide DNA Methylation Changes in Breast Cancer for Identification of Biomarkers for Prognosis and Mechanisms of Tumorigenesis	d-nb.info/1033029	0	0		
618	chr10	4383505	4383530	3500336416	23		4383505	4383530	8421504	2	16,7	0,18	c	350033641600000015	5-28		21391224	10.1002/hep.24290	1527-3350	Hepatology	Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in heparg cells - Anth&#xe9;rieu - 2011 - Hepatology - Wiley Online Library	Antherieu	2011	0		
619	chr10	4569998	4570024	3500376903	24		4569998	4570024	8421504	3	8,3,13	0,9,13	c	350037690300000041	9-33						Antibody libray display by yeast cell plasma membrane	Gao	2008	0		
619	chr10	4569998	4570024	3500202615	24		4569998	4570024	8421504	3	8,3,13	0,9,13	c	350020261500000041	9-33						Antibody libray display by yeast cell plasma membrane	Wu	2009	0		
619	chr10	4569998	4570024	3500181405	24		4569998	4570024	8421504	3	8,3,13	0,9,13	c	350018140500000041	9-33						Antibody library display by yeast cell plasma membrane	Gao	2009	0		
619	chr10	4583754	4583815	3500255716	60		4583754	4583815	8421504	2	46,14	0,47	g	350025571600000001	0-60						ScienceDirect.com - Molecular Cell - tRNA Binds to Cytochrome c and Inhibits Caspase Activation	sciencedirect.com	0	0		
619	chr10	4583754	4583815	3500252356	60		4583754	4583815	8421504	2	46,14	0,47	g	350025235600000001	0-60		20227371	10.1016/j.molcel.2010.01.023		Molecular cell	tRNA binds to cytochrome c and inhibits caspase activation	YiMei	2010	0		
619	chr10	4584632	4584655	3500419349	23		4584632	4584655	8421504	1	23	0	g	350041934900000001	20-43						Population-speci&#xfb01;c incidence of testicular ovarian follicles in Xenopus laevis from South Africa: A potential issue in endocrine testing	www.usask.ca	0	0		
619	chr10	4585395	4585657	3500379917	48		4585395	4585657	8421504	2	36,12	0,250	g	350037991700000053	0-97						Complete Sequence a Sea Lamprey (Petromyzon marinus) Mitochondrial Genome: Early Establishment of the Vertebrate Genome Organization	cichlid.umd.edu	0	0		
624	chr10	5235876	5235903	3500390314	23		5235876	5235903	8421504	2	17,6	0,21	g	350039031400000007	4-28		20810730	10.1128/JVI.01296-10		Journal of Virology	Resolving the Assembly State of Herpes Simplex Virus during Axon Transport by Live-Cell Imaging 	Sarah	2010	0		
625	chr10	5261187	5262701	3500462667	51		5261187	5262701	8421504	2	24,27	0,1487	p	350046266700015023	0-51						17 human secreted proteins	Baker	2003	0		
625	chr10	5261187	5262701	3500370116	51		5261187	5262701	8421504	2	24,27	0,1487	p	350037011600015023	0-51						17 human secreted proteins	Baker	2002	0		
625	chr10	5345447	5346785	3500009560	1338		5345447	5346785	8421504	1	1338	0	p	350000956000015000	0-1338						KEGG T01007: 489110	www.genome.jp	0	0		DRD1
625	chr10	5345554	5345583	3500413480	29		5345554	5345583	8421504	1	29	0	c	350041348000000057	0-29						and BLASTN AGAAACCAAAACGAAAGGTGCAGAA AACGAAAGGTGCAGAAGGGGAA GAAGGGGAA	arlandscience.com	0	0		DRD1
625	chr10	5345747	5346100	3500181748	40		5345747	5346100	8421504	2	20,20	0,333	c,g	350018174800000000,350018174800000000,350018174800000001	0-20,0-20,0-20						TREATMENT OF PARKINSON'S DISEASE AND ENHANCEMENT OF DOPAMINE SIGNAL USING PDE 10 INHIBITOR - Patent application	www.faqs.org	0	0		DRD1
625	chr10	5346134	5346178	3500060904	44		5346134	5346178	8421504	1	44	0	c	350006090400000002	0-44						Homeostatic Plasticity of Striatal Neurons Intrinsic Excitability following Dopamine Depletion | Marcelo Chavez - Academia.edu	www.academia.edu	0	0		
625	chr10	5346506	5346529	3500021182	23		5346506	5346529	8421504	1	23	0	c	350002118200000001	21-44		20590577	10.1111/j.1476-5381.2010.00773.x		British Journal of Pharmacology	Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease	EL	June	0		DRD1
630	chr10	6021844	6021870	3500399321	24		6021844	6021870	8421504	3	5,4,15	0,6,11	g	350039932100000016	0-24						Microorganism expressing aldose-1-epimerase	Sibbesen	2010	0		
631	chr10	6074385	6074413	3500189237	25		6074385	6074413	8421504	3	11,5,9	0,13,19	g	350018923700000020	11-36						BIO-INFORMATIQUE POUR LA G&#xc9;NOMIQUE	fr.scribd.com	0	0		
633	chr10	6311981	6312011	3500077341	25		6311981	6312011	8421504	2	14,11	0,19	g	350007734100000003	17-42		14557661	10.1128/JVI.77.21.11767-11780.2003	0022-538X	Journal of Virology	Metaphase Chromosome Tethering Is Necessary for the DNA Synthesis and Maintenance of oriP Plasmids but Is Insufficient for Transcription Activation by Epstein-Barr Nuclear Antigen 1	Sears	2003	5		
633	chr10	6312021	6326245	3500113516	2664		6312021	6326245	8421504	19	165,112,88,85,106,107,117,161,248,179,195,159,158,106,171,141,159,155,52	0,579,970,2530,3515,6324,6541,7082,7353,7714,8887,9427,9725,10677,12604,13016,13244,13883,14172	p	350011351600015000	0-2664						KEGG T01001: 3156	www.genome.jp	0	0		
633	chr10	6315631	6319115	3500461150	42		6315631	6319115	8421504	4	11,9,10,12	0,2714,3038,3472	c	350046115000000001,350046115000000000	0-20,0-22						LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions	www.ufrgs.br	0	0		HMGCR
633	chr10	6315631	6319115	3500311226	42		6315631	6319115	8421504	4	11,9,10,12	0,2714,3038,3472	c	350031122600000004,350031122600000005	0-20,0-22						Effects of Reduced Maternal Lipoprotein-Cholesterol Availability on Placental Progesterone Biosynthesis in the Baboon*	.endojournals.org	0	0		HMGCR
633	chr10	6315631	6319115	3500306305	42		6315631	6319115	8421504	4	11,9,10,12	0,2714,3038,3472	c	350030630500000041,350030630500000042	0-20,0-22						METHODS FOR THE DIAGNOSIS OF PROLIFERATIVE AND/OR CONFORMATIONAL DISEASES - Patent application	www.faqs.org	0	0		HMGCR
633	chr10	6315631	6319115	3500293283	42		6315631	6319115	8421504	4	11,9,10,12	0,2714,3038,3472	c	350029328300000009,350029328300000010	9-29,0-22			10.1073/pnas.0409834102		Proceedings of the National Academy of Sciences of the United States of America	Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids	Sharookh	2005	0		HMGCR
633	chr10	6315631	6319115	3500288606	42		6315631	6319115	8421504	4	11,9,10,12	0,2714,3038,3472	c	350028860600000000,350028860600000001	0-20,0-22						Polyunsaturated fatty acids reduce Fatty Acid Synthase and Hydroxy-Methyl-Glutaryl CoA-Reductase gene expression and promote apoptosis in HepG2 cell line	ww.lipidworld.com	0	0		HMGCR
633	chr10	6315631	6319115	3500128684	42		6315631	6319115	8421504	4	11,9,10,12	0,2714,3038,3472	c	350012868400000022,350012868400000023	0-20,0-22						Ubiquitin-proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase	cs.biologists.org	0	0		HMGCR
633	chr10	6315631	6319115	3500124075	42		6315631	6319115	8421504	4	11,9,10,12	0,2714,3038,3472	c	350012407500000002,350012407500000003	0-20,0-22		18032389	10.1074/jbc.M703583200	0021-9258	Journal of Biological Chemistry	Quercetin 3-Glucoside Protects Neuroblastoma (SH-SY5Y) Cells in Vitro against Oxidative Damage by Inducing Sterol Regulatory Element-binding Protein-2-mediated Cholesterol Biosynthesis	Soundararajan	2008	5		HMGCR
633	chr10	6318365	6318390	3500444872	25		6318365	6318390	8421504	1	25	0	c	350044487200000000	22-47		18083912	10.1124/jpet.107.132217	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Inhibition of Geranylgeranyl Diphosphate Synthase Induces Apoptosis through Multiple Mechanisms and Displays Synergy with Inhibition of Other Isoprenoid Biosynthetic Enzymes	Dudakovic	2008	0		
633	chr10	6318669	6319116	3500461096	23		6318669	6319116	8421504	2	10,13	0,434	c	350046109600000025	19-42						2 Eigene Originalarbeiten (A1-A15)	thek.uni-halle.de	0	0		HMGCR
633	chr10	6318669	6319116	3500066560	23		6318669	6319116	8421504	2	10,13	0,434	c	350006656000000006	19-42						Quantitation ofmRNA bythe polymerasechain reaction	www.pnas.org	0	0		HMGCR
633	chr10	6321500	6321760	3500261436	40		6321500	6321760	8421504	3	20,6,14	0,101,246	c,g	350026143600000051,350026143600000051,350026143600000052	0-20,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
79	chr10	6340267	6468729	3500380174	1867		6340267	6468729	8421504	25	38,57,77,19,63,129,18,38,133,96,66,87,9,30,66,137,4,48,66,48,48,48,30,330,182	0,2299,2359,3671,3738,4779,7824,7857,8710,11082,17451,18052,23380,23437,47969,53111,57763,57770,64964,65438,86792,122750,122816,127745,128280	c,g	350038017400000135,350038017400000251,350038017400000251,350038017400000434,350038017400000133,350038017400000248,350038017400000132,350038017400000130,350038017400000129,350038017400000128,350038017400000127,350038017400000242,350038017400000305,350038017400000425,350038017400000240,350038017400000201,350038017400000124,350038017400000239,350038017400000042,350038017400000423,350038017400000123,350038017400000381,350038017400000238,350038017400000122,350038017400000121,350038017400000236,350038017400000340,350038017400000300,350038017400000449,350038017400000420,350038017400000378,350038017400000339,350038017400000118,350038017400000117,350038017400000115,350038017400000334,350038017400000033,350038017400000114,350038017400000112,350038017400000111,350038017400000269,350038017400000109,350038017400000106,350038017400000065,350038017400000104,350038017400000260,350038017400000099,350038017400000057,350038017400000097,350038017400000096	0-50,0-20,0-20,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,4-48,0-47,0-48,18-41,0-48,0-48,0-41,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-32,0-48,0-48,0-48,0-48,0-43,1-468						Goodpasture Antigen Binding Protein 	.freshpatents.com	0	0		
79	chr10	6342578	6468108	3500360109	1794		6342578	6468108	8421504	16	125,130,129,71,133,96,93,87,93,158,84,139,108,117,135,96	0,1360,2468,5513,6399,8771,15735,21069,45658,50779,55452,62586,63103,84424,120400,125434	p	350036010900015010	0-1794						PROTEIN PRODUCTION	Kaufmann	2008	0		COL4A3BP
633	chr10	6351421	6405770	3500359981	168		6351421	6405770	8421504	6	24,78,16,9,22,19	0,6297,6969,12226,12249,54330	p,c,g	350035998100000009,350035998100000010,350035998100000021,350035998100015005,350035998100000020,350035998100000007,350035998100000022,350035998100000018,350035998100000018	0-24,18-39,0-21,0-78,0-21,0-25,0-22,0-19,0-19						Methods and reagents for treating autoimmune disorders	Saus	2002	0		COL4A3BP
633	chr10	6351421	6363695	3500465572	49		6351421	6363695	8421504	2	23,26	0,12248	c	350046557200000031,350046557200000000,350046557200000029	0-23,0-26,0-22						Supplementary Materials	www.jbc.org	0	0		
633	chr10	6351421	6363656	3500223549	127		6351421	6363656	8421504	4	24,78,16,9	0,6297,6969,12226	p,c	350022354900000010,350022354900015005,350022354900000008	0-24,0-78,0-25						Goodpasture antigen binding protein	Saus	2002	0		COL4A3BP
633	chr10	6351444	6393432	3500338859	107		6351444	6393432	8421504	6	1,20,18,1,22,45	0,6274,6334,6869,12226,41943	p,c	350033885900000004,350033885900000000,350033885900000003,350033885900015005	0-21,0-19,0-22,0-45						Methods for treating and diagnosing disease	Saus	2012	0		
633	chr10	6351444	6363692	3500182167	43		6351444	6363692	8421504	3	1,20,22	0,6274,12226	c	350018216700000002,350018216700000001	0-21,0-22						Increased Goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basement membrane. - ResearchGate	.researchgate.net	0	0		COL4A3BP
633	chr10	6351444	6363692	3500041796	43		6351444	6363692	8421504	3	1,20,22	0,6274,12226	c	350004179600000003,350004179600000002	0-21,0-22						&#x4e3b;&#x9898;&#xff1a;iv | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
641	chr10	7405954	7406081	3500360000	40		7405954	7406081	8421504	2	20,20	0,107	c,g	350036000000000009,350036000000000009,350036000000000008,350036000000000008	0-20,0-20,0-20,0-20						Detection of Blood Thrombin Enzyme in Surimi-Based Products by Using Polymerase Chain Reaction (PCR) Method	idosi.org/wasj/wa	0	0		
641	chr10	7405954	7406081	3500252379	40		7405954	7406081	8421504	2	20,20	0,107	c,g	350025237900000009,350025237900000009,350025237900000008	0-20,0-20,0-20						Detection of Blood Thrombin Enzyme in Surimi-Based Products by Using Polymerase Chain Reaction (PCR) Method | Alina Rahim - Academia.edu	www.academia.edu	0	0		
641	chr10	7406522	7406588	3500026406	66		7406522	7406588	8421504	1	66	0	p	350002640600015006	69-135						Journal of Laboratory and Clinical Medicine	lib.ajaums.ac.ir	0	0		
641	chr10	7460993	7461017	3500212630	23		7460993	7461017	8421504	2	6,17	0,7	g	350021263000000022	15-38						Protective helicobacter antigens	Doidge	1998	0		
642	chr10	7587426	7587604	3500360000	40		7587426	7587604	8421504	2	20,20	0,158	c	350036000000000006,350036000000000007	0-20,0-20						Detection of Blood Thrombin Enzyme in Surimi-Based Products by Using Polymerase Chain Reaction (PCR) Method	idosi.org/wasj/wa	0	0		
644	chr10	7762901	7768850	3500271107	90		7762901	7768850	8421504	3	18,27,45	0,4535,5904	p	350027110700015065,350027110700015073	0-45,0-45						Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis - Patent application	www.faqs.org	0	0		
648	chr10	8319928	8319954	3500449315	23		8319928	8319954	8421504	2	5,18	0,8	c	350044931500000373	11-34						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
652	chr10	8830381	8830404	3500399152	23		8830381	8830404	8421504	1	23	0	g	350039915200000133	12-36						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease - US Patent 6790612 Description	ww.patentstorm.us	0	0		
81	chr10	9007491	9128792	3500399228	288		9007491	9128792	8421504	8	45,45,42,57,38,13,6,42	0,30733,75581,79626,84577,94957,97787,121259	p	350039922800015001,350039922800015009,350039922800015005,350039922800015007,350039922800015003	0-45,0-45,0-99,0-51,0-48					Molecular Biology of the Cell	The Secretory Carrier Membrane Protein Family: Structure and Membrane Topology	Charles	2000	0		LHFPL2,SCAMP1
81	chr10	9007491	9128792	3500130276	288		9007491	9128792	8421504	8	45,45,42,57,38,13,6,42	0,30733,75581,79626,84577,94957,97787,121259	p	350013027600015000,350013027600015008,350013027600015004,350013027600015006,350013027600015002	0-45,0-45,0-99,0-51,0-48		10982391	10.1091/mbc.11.9.2933	1059-1524	Molecular Biology of the Cell	The Secretory Carrier Membrane Protein Family: Structure and Membrane Topology	Hubbard	2000	5		LHFPL2,SCAMP1
653	chr10	9007491	9007536	3500458938	45		9007491	9007536	8421504	1	45	0	p	350045893800015000	0-45		9658162	10.1091/mbc.9.7.1661	1059-1524	Molecular Biology of the Cell	Tyrosine Phosphorylation of Selected Secretory Carrier Membrane Proteins, SCAMP1 and SCAMP3, and Association with the EGF Receptor	Wu	1998	5		SCAMP1
654	chr10	9105278	9128792	3500458938	48		9105278	9128792	8421504	2	6,42	0,23472	p	350045893800015001	0-48		9658162	10.1091/mbc.9.7.1661	1059-1524	Molecular Biology of the Cell	Tyrosine Phosphorylation of Selected Secretory Carrier Membrane Proteins, SCAMP1 and SCAMP3, and Association with the EGF Receptor	Wu	1998	5		LHFPL2,SCAMP1
659	chr10	9779697	9780407	3500258851	72		9779697	9780407	8421504	2	24,48	0,662	p	350025885100015007	0-72						20-July-2006 Betaine Homocysteine Methyltransferase, Disease and Diet The Use of Proton N	.canterbury.ac.nz	0	0		BHMT2
661	chr10	9971803	9971831	3500063903	28		9971803	9971831	8421504	1	28	0	c	350006390300000003	8-36		17584991	10.1124/mol.107.037796	1521-0111 (Online)	Molecular Pharmacology	A Key Role for Diacylglycerol Lipase-&#x03b1; in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization	Jung	2007	0		HOMER1
661	chr10	9971803	9971831	3500040112	28		9971803	9971831	8421504	1	28	0	c	350004011200000003	8-36						A Key Role for Diacylglycerol Lipase- in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization	aspetjournals.org	0	0		HOMER1
82	chr10	10087919	10135134	3500063903	23		10087919	10135134	8421504	2	21,2	0,47213	c	350006390300000002	11-34		17584991	10.1124/mol.107.037796	1521-0111 (Online)	Molecular Pharmacology	A Key Role for Diacylglycerol Lipase-&#x03b1; in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization	Jung	2007	0		HOMER1
82	chr10	10087919	10135134	3500040112	23		10087919	10135134	8421504	2	21,2	0,47213	c	350004011200000002	11-34						A Key Role for Diacylglycerol Lipase- in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization	aspetjournals.org	0	0		HOMER1
667	chr10	10772916	10772945	3500035992	26		10772916	10772945	8421504	2	21,5	0,24	c	350003599200000023	0-26						Fusion Proteins Between Plant Cell-Wall Degrading Enzymes, and Their Uses - Patent application	www.faqs.org	0	0		
667	chr10	10776677	10779551	3500230259	132		10776677	10779551	8421504	3	35,40,57	0,2765,2817	p	350023025900015045	42-183						Therapeutic polypeptides, nucleic acids encoding same, and methods of use	Alsobrook	2003	0		THBS4
669	chr10	11049065	11072296	3500177982	38		11049065	11072296	8421504	3	7,12,19	0,10,23212	g	350017798200000425,350017798200000849	15-34,17-36						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		
669	chr10	11121694	11121719	3500177683	25		11121694	11121719	8421504	1	25	0	c,g	350017768300000040,350017768300000040	0-25,0-25		23045395	10.1128/MCB.00822-12	0270-7306	Molecular and Cellular Biology	SIRT3 Functions in the Nucleus in the Control of Stress-Related Gene Expression	Iwahara	2012	6		
670	chr10	11187421	11192850	3500009450	25		11187421	11192850	8421504	2	20,5	0,5424	c	350000945000000024	0-25						Supplementary Figures Suppl. Figure 1: Thapsigargin and Tunicamycin dose response in WT rat hippocampal neurons A.	www.jneurosci.org	0	0		ERO1L
670	chr10	11192911	11211858	3500409318	44		11192911	11211858	8421504	4	11,11,9,13	0,102,18806,18934	c	350040931800000012,350040931800000013	0-22,0-22		20647473	10.1158/1078-0432.CCR-10-0529	1078-0432	Clinical Cancer Research	Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-Mediated Potentiation of Bortezomib-Induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma Cells	Rao	2010	8		ERO1L
670	chr10	11192911	11211858	3500154327	44		11192911	11211858	8421504	4	11,11,9,13	0,102,18806,18934	c	350015432700000012,350015432700000013	0-22,0-22		20647473	10.1158/1078-0432.CCR-10-0529	1078-0432	Clinical Cancer Research	Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-Mediated Potentiation of Bortezomib-Induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma Cells	Rao	2010	8		ERO1L
670	chr10	11214419	11214446	3500126207	23		11214419	11214446	8421504	2	11,12	0,15	g	350012620700000326	25-48					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
670	chr10	11236220	11237961	3500350882	162		11236220	11237961	8421504	5	12,39,63,4,44	0,1433,1478,1550,1697	p	350035088200015003,350035088200015008,350035088200015009	0-51,0-63,0-48						HUMAN GENE	Fujiwara	2009	0		PSMC6
670	chr10	11236220	11237961	3500196150	162		11236220	11237961	8421504	5	12,39,63,4,44	0,1433,1478,1550,1697	p	350019615000015002,350019615000015007,350019615000015008	0-51,0-63,0-48						GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins	Fujiwara	1997	0		PSMC6
670	chr10	11236220	11237961	3500098563	162		11236220	11237961	8421504	5	12,39,63,4,44	0,1433,1478,1550,1697	p	350009856300015002,350009856300015007,350009856300015008	0-51,0-63,0-48						Human gene	Fujiwara	2001	0		PSMC6
671	chr10	11306106	11306131	3500340698	25		11306106	11306131	8421504	1	25	0	g	350034069800000016	25-50						METHODS OF TREATMENT USING SIRT MODULATORS AND COMPOSITIONS CONTAINING SIRT1 MODULATORS	Farmer	2008	0		
671	chr10	11306179	11307496	3500020435	96		11306179	11307496	8421504	3	21,23,52	0,27,1265	p	350002043500015008	18-117						IMPROVED VECTORS AND YEAST STRAINS FOR PROTEIN PRODUCTION: CA2+ ATPASE OVEREXPRESSION - GLYCOFI, INC.	www.sumobrain.com	0	0		
671	chr10	11307473	11307505	3500438785	32		11307473	11307505	8421504	1	32	0	c	350043878500000033	9-41						Chaperone expression genomes	Belyaev	2007	0		
671	chr10	11307473	11307505	3500008269	32		11307473	11307505	8421504	1	32	0	c	350000826900000033,350000826900000082	9-41,9-41						Chaperone Expression Genomes 	.freshpatents.com	0	0		
671	chr10	11380114	11380158	3500041679	44		11380114	11380158	8421504	1	44	0	c	350004167900000019	53-97						The Amino Acid Sequence of a Glutamic Acid-Rich Protein from Bovine Retina as Deduced from the cDNA Sequence	www.jstor.org	0	0		
673	chr10	11535306	11535330	3500410183	23		11535306	11535330	8421504	2	4,19	0,5	g	350041018300000111	14-37						Brassica polymorphisms	Lemieux	1999	0		
673	chr10	11599900	11610394	3500104791	72		11599900	11610394	8421504	3	24,24,24	0,10134,10470	c	350010479100000001,350010479100000006,350010479100000002	0-24,0-24,0-24		12810564	10.1210/en.2002-0088	0013-7227	Endocrinology	Molecular Cloning and Characterization of Bovine Prostaglandin E2 Receptors EP2 and EP4: Expression and Regulation in Endometrium and Myometrium during the Estrous Cycle and Early Pregnancy	Arosh	2003	4		
673	chr10	11599959	11610496	3500351074	48		11599959	11610496	8421504	2	24,24	0,10513	c,g	350035107400000003,350035107400000002,350035107400000002	0-24,0-24,0-24		16024629	10.1158/0008-5472.CAN-05-0216	0008-5472	Cancer Research	Prostaglandin E2 Activates Mitogen-Activated Protein Kinase/Erk Pathway Signaling and Cell Proliferation in Non&#x2013;Small Cell Lung Cancer Cells in an Epidermal Growth Factor Receptor&#x2013;Independent Manner	Krysan	2005	8		PTGER2
673	chr10	11599959	11610496	3500332518	48		11599959	11610496	8421504	2	24,24	0,10513	c	350033251800000003,350033251800000002	0-24,0-24						Therapeutics Proanthocyanidins Inhibit In vitro In vivo Growth of Human Non Small Cell Lung Cancer Cells by Inhibiting Receptors	.aacrjournals.org	0	0		PTGER2
673	chr10	11599959	11610496	3500057867	48		11599959	11610496	8421504	2	24,24	0,10513	c	350005786700000007,350005786700000006	0-24,0-24		14744769	10.1158/0008-5472.CAN-03-1301	0008-5472	Cancer Research	Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-Regulation	Su	2004	8		PTGER2
673	chr10	11600057	11610100	3500433790	93		11600057	11610100	8421504	2	45,48	0,9995	c	350043379000000045,350043379000000043	1-47,0-48						Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression - Patent # 6020155 - PatentGenius	.patentgenius.com	0	0		
673	chr10	11600071	11610077	3500102451	48		11600071	11610077	8421504	2	24,24	0,9982	c	350010245100000015,350010245100000014	0-24,0-24		19180509	10.1002/art.24258	1529-0131	Arthritis & Rheumatism	Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis - Li - 2009 - Arthritis & Rheumatism - Wiley Online Library	Li	2009	0		
673	chr10	11610052	11610514	3500187127	96		11610052	11610514	8421504	2	48,48	0,414	c,g	350018712700000038,350018712700000029	0-48,0-48						Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof	Smith	1995	0		
673	chr10	11610416	11610662	3500349767	40		11610416	11610662	8421504	2	20,20	0,226	c	350034976700000027,350034976700000026	0-20,0-20						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
677	chr10	12156270	12156306	3500161108	36		12156270	12156306	8421504	1	36	0	c	350016110800000001	15-51						Dpp inhibitors and uses thereof	Cole	2007	0		DPP8
678	chr10	12201950	12201975	3500327297	25		12201950	12201975	8421504	1	25	0	c	350032729700000000	18-43						Methods and compositions relating to immunostimulation	Jesson	2007	0		
678	chr10	12291263	12291287	3500277907	23		12291263	12291287	8421504	2	10,13	0,11	g	350027790700000002	1-24			10.1073/pnas.0605302103		Proceedings of the National Academy of Sciences of the United States of America	Pathogen escape from host immunity by a genome program for antigenic variation	Alan	2006	0		
678	chr10	12307166	12307211	3500063444	45		12307166	12307211	8421504	1	45	0	p	350006344400015057	0-45						SCREENING METHODS - Patent application	www.faqs.org	0	0		SLC24A1
679	chr10	12328346	12332235	3500400761	75		12328346	12332235	8421504	3	51,8,16	0,3864,3873	p,c,g	350040076100015002,350040076100000001,350040076100000001	0-51,8-32,8-32		10751314			American Journal of Physiology - Cell Physiolog	Alternatively spliced isoforms of the rat eye sodium/calcium+potassium exchanger NCKX1	Poon	2000	0		
679	chr10	12328346	12332235	3500133812	75		12328346	12332235	8421504	3	51,8,16	0,3864,3873	p,c	350013381200015002,350013381200000001	0-51,8-32		10751314			American Journal of Physiology - Cell Physiolog	Alternatively spliced isoforms of the rat eye sodium/calcium+potassium exchanger NCKX1	Poon	2000	0		
679	chr10	12328346	12332235	3500015981	75		12328346	12332235	8421504	3	51,8,16	0,3864,3873	p,c	350001598100015002,350001598100000001	0-51,8-32		10751314			American Journal of Physiology - Cell Physiolog	Alternatively spliced isoforms of the rat eye sodium/calcium+potassium exchanger NCKX1	Poon	2000	0		
679	chr10	12346950	12346974	3500034199	23		12346950	12346974	8421504	2	13,10	0,14	c	350003419900000336	2-25						MODULATION OF APOLIPOPROTEIN (a) EXPRESSION - Patent application	www.faqs.org	0	0		
679	chr10	12392572	12392603	3500441298	25		12392572	12392603	8421504	3	6,14,5	0,10,26	c	350044129800000029	16-42					Patent	Compounds and methods for development of Ret modulators (Patent US:8067434)	Artis	2011	0		
679	chr10	12392572	12392603	3500360215	25		12392572	12392603	8421504	3	6,14,5	0,10,26	c	350036021500000029	16-42					Patent	Compounds and methods for development of Ret modulators (Patent US:8067434)	Artis	2011	0		
679	chr10	12392572	12392603	3500325527	25		12392572	12392603	8421504	3	6,14,5	0,10,26	c	350032552700000029	16-42						Compounds and methods for development of RET modulators	Ibrahim	2006	0		
679	chr10	12392572	12392603	3500052438	25		12392572	12392603	8421504	3	6,14,5	0,10,26	g	350005243800000029	16-42					Patent	Compounds and methods for development of Ret modulators (Patent US:8067434)	Artis	2011	0		
680	chr10	12525302	12544273	3500192023	56		12525302	12544273	8421504	2	27,29	0,18942	c,g	350019202300000009,350019202300000009,350019202300000010	11-38,11-38,7-36		22241992	10.1371/journal.ppat.1002466		PLoS Pathogens	Molecular Determinants and Dynamics of Hepatitis C Virus Secretion	Kelly	2012	0		RAB11A
680	chr10	12525302	12544271	3500450026	44		12525302	12544271	8421504	2	19,25	0,18944	c,g	350045002600000000,350045002600000000,350045002600000001	0-19,0-19,0-25		19335615	10.1111/j.1365-2443.2009.01285.x	1365-2443	Genes to Cells	Rab11 and its effector Rip11 participate in regulation of insulin granule exocytosis - Sugawara - 2009 - Genes to Cells - Wiley Online Library	Sugawara	2009	0		RAB11A
680	chr10	12525302	12544271	3500353937	43		12525302	12544271	8421504	2	21,22	0,18947	c,g	350035393700000000,350035393700000000,350035393700000001	0-21,0-21,0-22		14500507	10.1128/IAI.71.10.5855-5870.2003	0019-9567	Infection and Immunity	Rab GTPases Are Recruited to Chlamydial Inclusions in Both a Species-Dependent and Species-Independent Manner	Rzomp	2003	4		
680	chr10	12525311	12532423	3500315427	40		12525311	12532423	8421504	2	20,20	0,7092	c,g	350031542700000004,350031542700000004,350031542700000005,350031542700000005	0-20,0-20,0-20,0-20						ScienceDirect.com - Cell Calcium - Insulin-mediated upregulation of T-type Ca2+ currents in GH3 cells is mediated by increased endosomal recycling and incorporation of surface membrane Cav3.1 channels	sciencedirect.com	0	0		RAB11A
680	chr10	12531761	12544215	3500278518	44		12531761	12544215	8421504	2	23,21	0,12433	c	350027851800000003,350027851800000005	0-23,0-21			10.1038/sj.emboj.7601606		The EMBO Journal	MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway	Jose	2007	0		RAB11A
680	chr10	12531798	12531870	3500279089	42		12531798	12531870	8421504	2	21,21	0,51	c,g	350027908900000006,350027908900000004,350027908900000004	0-21,0-21,0-21						The JNK/AP-1 pathway upregulates expression of the recycling endosome rab11a gene in B cells transformed by Theileria	theileria.org	0	0		
680	chr10	12532347	12532372	3500462129	25		12532347	12532372	8421504	1	25	0	c	350046212900000003	0-25						Protrudin serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation	w.molbiolcell.org	0	0		RAB11A
680	chr10	12532347	12532372	3500361336	25		12532347	12532372	8421504	1	25	0	c	350036133600000003	0-25		21976701	10.1091/mbc.E11-01-0068	1059-1524	Molecular Biology of the Cell	Protrudin serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation	Matsuzaki	2011	5		
681	chr10	12676027	12676052	3500286446	23		12676027	12676052	8421504	2	6,17	0,8	g	350028644600000005	0-23		19622613	10.1158/1940-6207.CAPR-09-0082	1940-6207	Cancer Prevention Research	Pitavastatin Fails to Lower Serum Lipid Levels or Inhibit Gastric Carcinogenesis in Helicobacter pylori&#x2013;Infected Rodent Models	Toyoda	2009	5		
684	chr10	13058729	13058792	3500078565	63		13058729	13058792	8421504	1	63	0	p	350007856500015004	0-63						Autoantigen discovery with a synthetic human peptidome	p.med.harvard.edu	0	0		TIPIN
684	chr10	13097702	13097725	3500324928	23		13097702	13097725	8421504	1	23	0	c	350032492800000000	0-23		17332336	10.1158/0008-5472.CAN-06-2969	0008-5472	Cancer Research	Serine-Arginine Protein Kinase 1 Overexpression Is Associated with Tumorigenic Imbalance in Mitogen-Activated Protein Kinase Pathways in Breast, Colonic, and Pancreatic Carcinomas	Hayes	2007	8		TIPIN
85	chr10	13097707	13171254	3500297728	1179		13097707	13171254	8421504	11	80,211,147,78,52,125,202,65,62,46,111	0,36310,37928,45294,45927,66335,69271,70477,72290,72751,73436	p	350029772800015000	0-1179						KEGG T01001: 5604	www.genome.jp	0	0		MAP2K1,SNAPC5,TIPIN
85	chr10	13097707	13171254	3500052417	1179		13097707	13171254	8421504	11	80,211,147,78,52,125,202,65,62,46,111	0,36310,37928,45294,45927,66335,69271,70477,72290,72751,73436	p	350005241700015000	0-1179						KEGG T01001: 5604	www.genome.jp	0	0		MAP2K1,SNAPC5,TIPIN
85	chr10	13097707	13171254	3500012903	1179		13097707	13171254	8421504	11	80,211,147,78,52,125,202,65,62,46,111	0,36310,37928,45294,45927,66335,69271,70477,72290,72751,73436	p	350001290300015000	0-1179						KEGG T01001: 5604	www.genome.jp	0	0		MAP2K1,SNAPC5,TIPIN
85	chr10	13097707	13171251	3500370433	1176		13097707	13171251	8421504	11	80,211,147,78,52,125,202,65,62,46,108	0,36310,37928,45294,45927,66335,69271,70477,72290,72751,73436	p	350037043300015006	0-1176						Braf biomarkers	Hosted	2011	0		MAP2K1,SNAPC5,TIPIN
85	chr10	13097707	13171251	3500259816	1161		13097707	13171251	8421504	13	80,160,45,147,42,27,52,125,202,65,62,46,108	0,36310,36476,37928,45294,45345,45927,66335,69271,70477,72290,72751,73436	p	350025981600015006,350025981600015007	0-477,0-687						Braf biomarkers	Hosted	2010	0		
85	chr10	13097707	13171251	3500167730	1176		13097707	13171251	8421504	11	80,211,147,78,52,125,202,65,62,46,108	0,36310,37928,45294,45927,66335,69271,70477,72290,72751,73436	p	350016773000015006	0-1176						BRAF BIOMARKERS - Patent application	www.faqs.org	0	0		MAP2K1,SNAPC5,TIPIN
85	chr10	13097707	13134048	3500259953	111		13097707	13134048	8421504	2	80,31	0,36310	p	350025995300015007	0-111						The DDBJ/EMBL/GenBank Feature Table: Definition	ww.ddbj.nig.ac.jp	0	0		MAP2K1,TIPIN
684	chr10	13097707	13097735	3500252950	28		13097707	13097735	8421504	1	28	0	c,g	350025295000000008,350025295000000008	10-38,10-38						Heterocyclic compound and use thereof	Okaniwa	2011	0		TIPIN
684	chr10	13097707	13097735	3500127255	28		13097707	13097735	8421504	1	28	0	c	350012725500000008	10-38						Heterocyclic compound and use thereof	Okaniwa	2010	0		TIPIN
684	chr10	13097707	13097735	3500126349	28		13097707	13097735	8421504	1	28	0	c	350012634900000008	10-38						Heterocyclic compound and use thereof	Hirose	2012	0		TIPIN
684	chr10	13097707	13097735	3500098592	28		13097707	13097735	8421504	1	28	0	c,g	350009859200000008,350009859200000008	10-38,10-38						Benzothiazole derivatives as anticancer agents	Hirose	2011	0		TIPIN
684	chr10	13097707	13097732	3500457933	25		13097707	13097732	8421504	1	25	0	c,g	350045793300000000,350045793300000000	0-25,0-25		19266047	10.1371/journal.pone.0004734		PLoS ONE	Mechanisms of KGF Mediated Signaling in Pancreatic Duct Cell Proliferation and Differentiation	Benjamin	2009	0		TIPIN
85	chr10	13097758	13171227	3500167730	879		13097758	13171227	8421504	21	29,16,45,45,45,141,33,12,37,104,57,45,45,28,17,45,11,34,9,36,45	0,36259,36278,36326,36422,37877,45288,45876,45891,66284,69238,69298,69346,69394,70426,72242,72290,72700,72737,73385,73424	p	350016773000015193,350016773000015194,350016773000015195,350016773000015197,350016773000015198,350016773000015223,350016773000015199,350016773000015224,350016773000015200,350016773000015202,350016773000015203,350016773000015228,350016773000015204,350016773000015229,350016773000015205,350016773000015231,350016773000015207,350016773000015208,350016773000015209,350016773000015210,350016773000015212,350016773000015213,350016773000015214,350016773000015215	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						BRAF BIOMARKERS - Patent application	www.faqs.org	0	0		
685	chr10	13134128	13143058	3500133527	42		13134128	13143058	8421504	2	21,21	0,8909	c	350013352700000004,350013352700000005	0-21,0-21		22606284	10.1371/journal.pone.0036739		PLoS ONE	Radiation-Induced c-Jun Activation Depends on MEK1-ERK1/2 Signaling Pathway in Microglial Cells	Zhiyong	2012	0		
685	chr10	13134138	13170054	3500059375	480		13134138	13170054	8421504	7	48,141,3,7,125,108,48	0,1503,8863,9541,29904,32840,35868	p	350005937500015137,350005937500015139,350005937500015140,350005937500015141,350005937500015143,350005937500015144,350005937500015145,350005937500015146,350005937500015147,350005937500015150	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Plant-derived map kinase kinase - US Patent 6376747 Description	ww.patentstorm.us	0	0		
685	chr10	13135689	13143043	3500383675	120		13135689	13143043	8421504	3	63,15,42	0,78,7312	p	350038367500015048,350038367500015015	0-63,0-57						Arabl'dopsl'sthall'ana	.lib.kobe-u.ac.jp	0	0		MAP2K1
685	chr10	13135748	13135773	3500153271	25		13135748	13135773	8421504	1	25	0	g	350015327100000016,350015327100000017	109-134,0-24						Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference--&#x300a;&#x6838;&#x9178;&#x7814;&#x7a76;&#x533b;&#x5b66;&#x671f;&#x520a;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x	journal.9med.net	0	0		
685	chr10	13143021	13143046	3500058518	25		13143021	13143046	8421504	1	25	0	c	350005851800000002	0-25			10.1128/JVI.80.9.4422-4430.2006		Journal of Virology	Negative Regulation of the Alpha Interferon-Induced Antiviral Response by the Ras/Raf/MEK Pathway	Sarah	2006	0		MAP2K1
685	chr10	13164089	13164155	3500327386	66		13164089	13164155	8421504	1	66	0	p	350032738600015029	0-66						Site-Specific Incorporation of Phosphoserine Into Proteins in Escherichia Coli	Park	2011	0		MAP2K2
685	chr10	13164107	13164158	3500430551	51		13164107	13164158	8421504	1	51	0	p	350043055100015001	0-51						Novel murine and human kinases	Anderson	2000	0		MAP2K2
685	chr10	13164107	13164158	3500349597	51		13164107	13164158	8421504	1	51	0	p	350034959700015019,350034959700015243	0-51,0-48						 Methods For Identifying Compounds That Alter Kinase Activity 	www.docstoc.com	0	0		TSPAN33
685	chr10	13164107	13164158	3500220810	51		13164107	13164158	8421504	1	51	0	p	350022081000015001	0-51						Novel murine and human kinases	Anderson	2002	0		MAP2K2
685	chr10	13164107	13164158	3500157094	51		13164107	13164158	8421504	1	51	0	p	350015709400015011	0-51					Patent	Methods for identifying compounds that alter kinase activity (Patent US:6514719)	Bird	2003	0		TSPAN33
685	chr10	13164107	13164158	3500156707	51		13164107	13164158	8421504	1	51	0	p	350015670700015015	0-51					Patent	Calcium/calmodulin-dependent kinase (Patent US:6759223)	Bird	2004	0		MAP2K2
685	chr10	13164107	13164158	3500156219	51		13164107	13164158	8421504	1	51	0	p	350015621900015011	0-51						Antibodies to novel murine and human kinases	Anderson	2006	0		MAP2K2
685	chr10	13164107	13164158	3500089714	51		13164107	13164158	8421504	1	51	0	p	350008971400015011	0-51						Methods for identifying compounds that alter kinase activity	Bird	2000	0		MAP2K2
685	chr10	13164107	13164158	3500026875	51		13164107	13164158	8421504	1	51	0	p	350002687500015011	0-51						Novel murine and human kinases	Anderson	2008	0		MAP2K2
685	chr10	13167005	13167053	3500286722	48		13167005	13167053	8421504	1	48	0	p	350028672200015029	0-48						METHOD OF TREATMENT WITH BRAF INHIBITOR - Patent application	www.faqs.org	0	0		
685	chr10	13167010	13171457	3500250244	44		13167010	13171457	8421504	3	20,7,17	0,4420,4430	c,g	350025024400000004,350025024400000004,350025024400000002	0-20,0-20,0-24						MEK1 and MEK2 isoforms regulate distinct functions in pancreatic cancer cells	-publications.com	0	0		MAP2K2,MAP2K1,SNAPC5
685	chr10	13171394	13171418	3500442677	24		13171394	13171418	8421504	1	24	0	c	350044267700000052	0-29						RNA polymerase II holoenzyme from Saccharomyces cerevisiae	Young	1994	0		
685	chr10	13171710	13171827	3500464357	43		13171710	13171827	8421504	2	22,21	0,96	c	350046435700000010,350046435700000011	0-22,0-21		20945381	10.1002/jcp.22449		Journal of cellular physiology	Oncoprotein Cot1 Represses Kinase Suppressors of Ras1/2 and 1,25-Dihydroxyvitamin D3-Induced Differentiation of Human Acute Myeloid Leukemia Cells	XUENING	2011	0		
685	chr10	13171710	13171827	3500317153	43		13171710	13171827	8421504	2	22,21	0,96	c,g	350031715300000052,350031715300000052,350031715300000024,350031715300000024,350031715300000053,350031715300000053,350031715300000025,350031715300000025	0-22,0-22,0-22,0-22,0-21,0-21,0-21,0-21						Markers for Viral Infections and Other Inflammatory Responses - Patent application	www.faqs.org	0	0		
685	chr10	13178828	13179114	3500400505	47		13178828	13179114	8421504	3	6,15,26	0,11,260	c,g	350040050500000011,350040050500000011,350040050500000010,350040050500000010	0-21,0-21,0-26,0-26						Selection of reference genes for quantitative RT-PCR studies in striped dolphin (Stenella coeruleoalba) skin biopsies.	.biomedsearch.com	0	0		RPL4
685	chr10	13179498	13179930	3500164379	177		13179498	13179930	8421504	2	116,61	0,371	p	350016437900015012	177-354						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPL4
685	chr10	13180317	13180345	3500131269	23		13180317	13180345	8421504	3	6,4,13	0,10,15	c	350013126900000010	1-24						Identi&#xfb01;cation and molecular characterization of a complement C3 molecule in a lophotrochozoan, the Hawaiian bobtail squid Euprymna scolopes	medmicro.wisc.edu	0	0		RPL4
685	chr10	13180732	13181210	3500224487	44		13180732	13181210	8421504	3	22,11,11	0,128,467	c	350022448700000005,350022448700000004	0-22,0-22		16052228	10.1038/sj.cgt.7700880	0929-1903	Cancer Gene Therapy	Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene	Yang	2005	3		RPL4
685	chr10	13180778	13181207	3500434170	40		13180778	13181207	8421504	3	20,12,8	0,81,421	c,g	350043417000000029,350043417000000029,350043417000000028	0-20,0-20,0-20						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
686	chr10	13326211	13326237	3500189823	24		13326211	13326237	8421504	2	16,8	0,18	g	350018982300000550	3-27						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
686	chr10	13367272	13367301	3500085287	29		13367272	13367301	8421504	1	29	0	c,g	350008528700000023,350008528700000023	3-32,3-32						Methods and compositions for the diagnosis, prognosis, and treatment of cancer	Neuman	2003	0		SMAD6
686	chr10	13367275	13367863	3500176788	105		13367275	13367863	8421504	4	21,33,24,27	0,24,534,561	p	350017678800015014,350017678800015023	0-54,0-51						XenopusSmad8 acts downstream of BMP-4 to modulate its activity during vertebrate embryonic patterning	ev.biologists.org	0	0		
686	chr10	13367878	13367902	3500213737	24		13367878	13367902	8421504	1	24	0	c	350021373700000012	0-24			10.1128/MCB.23.13.4627-4636.2003		Molecular and Cellular Biology	Bone Morphogenetic Protein 4 Mediates Apoptosis of Capillary Endothelial Cells during Rat Pupillary Membrane Regression	Mari	July	0		SMAD6
687	chr10	13375838	13442202	3500241494	96		13375838	13442202	8421504	3	48,34,14	0,3836,66350	c	350024149400000145,350024149400000147	0-48,0-48						US Patent # 6,534,641. Compositions and methods for the treatment and diagnosis of cardiovascular disease - Patents.com	www.patents.com	0	0		
687	chr10	13379674	13442202	3500021769	48		13379674	13442202	8421504	2	34,14	0,62514	c	350002176900000150	0-48						Compositions and methods for the treatment and diagnosis of cardiovascular disease	Falb	1997	0		
687	chr10	13429345	13429371	3500373979	23		13429345	13429371	8421504	2	6,17	0,9	g	350037397900000012	4-30						Herpes simplex type 1 protease mutants and vectors	Register	1996	0		
687	chr10	13429345	13429371	3500354881	23		13429345	13429371	8421504	2	6,17	0,9	g	350035488100000012	4-30						Herpes simplex type 1 protease mutants and vectors	Register	1998	0		
687	chr10	13429345	13429371	3500200529	23		13429345	13429371	8421504	2	6,17	0,9	g	350020052900000012	4-30						Method of making herpes simplex type 1 mutants and mutants so produced	Register	1995	0		
687	chr10	13442298	13442685	3500241494	144		13442298	13442685	8421504	3	48,48,48	0,96,339	c	350024149400000150,350024149400000152,350024149400000157	0-48,0-48,0-48						US Patent # 6,534,641. Compositions and methods for the treatment and diagnosis of cardiovascular disease - Patents.com	www.patents.com	0	0		
687	chr10	13442529	13442559	3500054692	30		13442529	13442559	8421504	1	30	0	c	350005469200000000	0-30		16491121	10.1038/sj.onc.1209436	0950-9232	Oncogene	Smad6 is a protein kinase X phosphorylation substrate and is required for HL-60 cell differentiation	Glesne	2006	6		SMAD6
687	chr10	13442661	13442709	3500176788	48		13442661	13442709	8421504	1	48	0	p	350017678800015054	0-48						XenopusSmad8 acts downstream of BMP-4 to modulate its activity during vertebrate embryonic patterning	ev.biologists.org	0	0		SMAD6
687	chr10	13442771	13442794	3500414007	23		13442771	13442794	8421504	1	23	0	c	350041400700000001	0-23		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		SMAD6
687	chr10	13442771	13442794	3500213699	23		13442771	13442794	8421504	1	23	0	c	350021369900000001	0-23		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		SMAD6
687	chr10	13442771	13442794	3500207867	23		13442771	13442794	8421504	1	23	0	c	350020786700000001	0-23		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		SMAD6
687	chr10	13442771	13442794	3500179866	23		13442771	13442794	8421504	1	23	0	c	350017986600000001	0-23		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		SMAD6
688	chr10	13577664	13577687	3500146159	23		13577664	13577687	8421504	1	23	0	g	350014615900000003	10-33						Murine and humanizer 23F2G antibodies and cell lines expressing said antibodies	Rose	1997	0		
689	chr10	13717715	13717739	3500410121	24		13717715	13717739	8421504	1	24	0	c	350041012100000000	1-25		12244043	10.1074/jbc.M204291200	0021-9258	Journal of Biological Chemistry	Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression	Langley	2002	5		
690	chr10	13779583	13779610	3500147998	24		13779583	13779610	8421504	2	13,11	0,16	g	350014799800000060	23-47						Regulation Of Endogenous Gene Expression In Cells Using Zinc Finger Proteins 	.freshpatents.com	0	0		
690	chr10	13817787	13839776	3500332365	960		13817787	13839776	8421504	8	85,132,75,51,213,138,145,121	0,273,1661,5052,14336,16751,19294,21868	p	350033236500015001	0-960						KEGG T01001: 4087	www.genome.jp	0	0		
690	chr10	13817797	13817820	3500391143	23		13817797	13817820	8421504	1	23	0	c	350039114300000005	21-44		12639945	10.1210/en.2002-220978	0013-7227	Endocrinology	Activin Signaling through Type IB Activin Receptor Stimulates Aromatase Activity in the Ovarian Granulosa Cell-Like Human Granulosa (KGN) Cells	Mukasa	2003	4		
690	chr10	13818169	13819512	3500331515	43		13818169	13819512	8421504	2	20,23	0,1320	c,g	350033151500000012,350033151500000012,350033151500000013	0-20,0-20,0-23						R&#xf4;le de l&#x2019;endoth&#xe9;lium dans les dommages radio-induits aux tissus sains	www.irsn.fr	0	0		SMAD3
690	chr10	13818169	13819512	3500035734	43		13818169	13819512	8421504	2	20,23	0,1320	c,g	350003573400000011,350003573400000011,350003573400000012	0-20,0-20,0-23						&#x4e3b;&#x9898;&#xff1a;Vascular | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		SMAD3
690	chr10	13839710	13839734	3500181709	24		13839710	13839734	8421504	1	24	0	c	350018170900000002	0-24		16495553	10.1128/IAI.74.3.1795-1799.2006	0019-9567	Infection and Immunity	Interaction of Chlamydia trachomatis with Mammalian Cells Is Independent of Host Cell Surface Heparan Sulfate Glycosaminoglycans	Stephens	2006	4		SMAD3
691	chr10	13998290	13998319	3500271665	26		13998290	13998319	8421504	2	14,12	0,17	g	350027166500000015	9-36					Patent	Oil-body proteins as carriers of high-value peptides in plants (Patent US:5650554)	Moloney	1997	0		
86	chr10	14264698	14290140	3500270113	25		14264698	14290140	8421504	3	15,6,4	0,19,25438	c	350027011300000174	11-36						USE OF A ROCK INHIBITOR TO SUSTAIN PRIMARY HUMAN KERATINOCYTES IN A PROLIFERATIVE STATE - Patent application	www.faqs.org	0	0		
694	chr10	14354465	14365743	3500366238	102		14354465	14365743	8421504	3	3,51,48	0,965,11230	p	350036623800015022,350036623800015021	15-117,0-93						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		MAP2K5
695	chr10	14433782	14473647	3500189823	39		14433782	14473647	8421504	4	4,15,13,7	0,5,39843,39858	g	350018982300000461,350018982300000639,350018982300000668,350018982300000158	6-25,3-22,3-22,7-27						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
10	chr10	14673205	14788171	3500051474	912		14673205	14788171	8421504	12	21,147,292,85,40,24,57,72,39,45,35,55	0,36720,36873,77974,78318,83099,91270,101827,113036,113096,113162,114911	p	350005147400015015,350005147400015022,350005147400015023,350005147400015034,350005147400015032,350005147400015046,350005147400015045,350005147400015049,350005147400015054,350005147400015055,350005147400015056	3-201,0-180,0-180,0-198,0-153,0-81,0-81,0-78,0-168,0-102,0-66						Structural and functional characterisation of the protein inhibitor of activated STAT3 (PIAS3)	eprints.ru.ac.za	0	0		
697	chr10	14710072	14797291	3500303696	909		14710072	14797291	8421504	14	66,39,4,74,48,110,4,121,77,74,115,25,32,120	0,237,54505,64958,76169,76220,78044,78054,78880,78987,84147,84265,86269,87099	p	350030369600015122	234-1521						p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME	Bischoff	1995	0		
697	chr10	14710097	14797168	3500303696	1610		14710097	14797168	8421504	15	273,85,48,91,105,24,106,74,161,43,64,181,143,38,174	0,41082,41426,45352,46096,46207,54378,64933,76144,78019,78086,78855,84122,86244,86897	p,c,g	350030369600000014,350030369600000015,350030369600015019,350030369600000016,350030369600015124,350030369600015020,350030369600015000,350030369600015093,350030369600000018,350030369600000018,350030369600015016,350030369600000019,350030369600000019,350030369600015001,350030369600000020,350030369600015024,350030369600015002,350030369600000021,350030369600015076,350030369600015028,350030369600015004,350030369600015061,350030369600015032,350030369600015006,350030369600015094,350030369600015064,350030369600015007,350030369600015095,350030369600015035,350030369600015101,350030369600015036,350030369600015096,350030369600015102,350030369600015081,350030369600015097,350030369600015009,350030369600015125,350030369600015126,350030369600015010,350030369600015083,350030369600015069,350030369600015012,350030369600015048,350030369600015072,350030369600015013,350030369600015098,350030369600015086,350030369600015050,350030369600015014,350030369600015099	0-50,0-79,0-75,0-100,0-57,0-150,0-90,0-150,0-100,0-100,0-438,0-100,0-100,0-45,0-99,0-150,0-150,0-99,0-54,0-150,0-150,0-147,0-111,15-141,15-147,0-150,0-147,0-150,0-51,0-51,0-150,0-120,0-90,0-60,0-111,0-147,0-303,0-306,0-90,0-60,0-90,0-48,0-105,0-150,0-150,0-147,0-57,0-150,0-147,0-150						p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME	Bischoff	1995	0		
697	chr10	14775089	14788135	3500290590	195		14775089	14788135	8421504	3	15,161,19	0,11152,13027	p	350029059000015037	0-195						The Drosophila trithorax group gene tonalli(tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING &#xfb01;nger protein	ev.biologists.org	0	0		PIAS1
87	chr10	14807983	14812456	3500228810	40		14807983	14812456	8421504	3	19,3,18	0,132,4455	c	350022881000000003,350022881000000002	0-19,0-21						Expression analysis of regulatory MicroRNA in bovine cumulus oocyte complex and preimplantation embryos	s.ulb.uni-bonn.de	0	0		
698	chr10	14885210	14885273	3500391427	63		14885210	14885273	8421504	1	63	0	p	350039142700015002	0-63						Assays - Patent application	www.faqs.org	0	0		ITGA11
698	chr10	14885210	14885255	3500208501	45		14885210	14885255	8421504	1	45	0	p	350020850100015004	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		ITGA11
698	chr10	14885210	14885255	3500189065	45		14885210	14885255	8421504	1	45	0	p	350018906500015006	0-45						Assays	Schofield	2005	0		ITGA11
698	chr10	14907615	14907644	3500186547	24		14907615	14907644	8421504	2	15,9	0,20	g	350018654700000284	4-37						Polycystic kidney disease gene and protein	Klinger	1996	0		
700	chr10	15185137	15185164	3500254292	25		15185137	15185164	8421504	2	18,7	0,20	g	350025429200000087	11-36					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent US:7579446)	Bakker	2009	0		
700	chr10	15185137	15185162	3500398534	23		15185137	15185162	8421504	2	18,5	0,20	g	350039853400000026	0-23						US Patent # 7,338,660. Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 - Patents.com	www.patents.com	0	0		
700	chr10	15185137	15185162	3500270923	23		15185137	15185162	8421504	2	18,5	0,20	g	350027092300000016,350027092300000010	0-23,0-23						Transgenic ungulates capable of human antibody production	Collas	2003	0		
705	chr10	15753003	15760259	3500055621	445		15753003	15760259	8421504	10	99,25,18,98,13,27,69,6,42,48	0,299,345,2502,3982,4154,6763,6880,7118,7208	c	350005562100000014,350005562100000010,350005562100000009,350005562100000007,350005562100000005	15-407,0-48,0-48,0-48,0-48						US Patent # 5,734,022. Antibodies to a novel mammalian protein associated with uncontrolled cell division - Patents.com	www.patents.com	0	0		MIR3942
705	chr10	15753003	15760259	3500004010	397		15753003	15760259	8421504	9	99,25,18,98,13,48,6,42,48	0,299,345,2502,3982,6784,6880,7118,7208	c	350000401000000014,350000401000000009,350000401000000007,350000401000000005	15-407,0-48,0-48,0-48						US Patent # 5,874,234. Assay for a novel mammalian protein associated with uncontrolled cell division - Patents.com	www.patents.com	0	0		
705	chr10	15753003	15760163	3500220627	301		15753003	15760163	8421504	7	99,25,18,98,13,6,42	0,299,345,2502,3982,6880,7118	c	350022062700000014,350022062700000007	15-407,0-48						US Patent # 5,726,018. Nucleic acid based assays to detect a novel mammalian protein associated with uncontrolled cell division - Patents.com	www.patents.com	0	0		
705	chr10	15753003	15756998	3500224734	253		15753003	15756998	8421504	5	99,25,18,98,13	0,299,345,2502,3982	c	350022473400000014	15-407						US Patent # 5,756,676. Mammalian protein associated with uncontrolled cell division - Patents.com	www.patents.com	0	0		
705	chr10	15753006	15753041	3500458527	35		15753006	15753041	8421504	1	35	0	c,g	350045852700000005,350045852700000007,350045852700000007	3-24,3-23,3-23		21317927	10.1038/onc.2011.15	0950-9232	Oncogene	MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4	Schramedei	2011	6		ANP32A
705	chr10	15753006	15753041	3500009279	35		15753006	15753041	8421504	1	35	0	c	350000927900000005,350000927900000007	3-24,3-23		21317927	10.1038/onc.2011.15	0950-9232	Oncogene	MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4	Schramedei	2011	6		ANP32A
705	chr10	15771848	15771876	3500066097	23		15771848	15771876	8421504	2	13,10	0,18	g	350006609700000019	1-30			10.1128/JVI.77.7.4113-4126.2003		Journal of Virology	Mapping and Functional Analysis of Interaction Sites within the Cytoplasmic Domains of the Vaccinia Virus A33R and A36R Envelope Proteins	Brian	2003	0		
707	chr10	15992672	15992707	3500391814	35		15992672	15992707	8421504	1	35	0	c	350039181400000006,350039181400000005	11-45,11-40		17923694	10.1128/MCB.01304-07	0270-7306	Molecular and Cellular Biology	Drosophila Blimp-1 Is a Transient Transcriptional Repressor That Controls Timing of the Ecdysone-Induced Developmental Pathway	Agawa	2007	6		
707	chr10	15992674	15992698	3500044049	24		15992674	15992698	8421504	1	24	0	c	350004404900000030	24-48						Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation	Journot	1998	0		
707	chr10	15992678	15992707	3500101941	29		15992678	15992707	8421504	1	29	0	c	350010194100000005	11-40		17923694	10.1128/MCB.01304-07	0270-7306	Molecular and Cellular Biology	Drosophila Blimp-1 Is a Transient Transcriptional Repressor That Controls Timing of the Ecdysone-Induced Developmental Pathway	Agawa	2007	6		
707	chr10	16068234	16070086	3500251779	40		16068234	16070086	8421504	2	20,20	0,1832	c	350025177900000004,350025177900000005	0-20,0-20			10.1152/ajpcell.00135.2005		American Journal of Physiology - Cell Physiolog	Interferon-&#x03b3; activates transcription of NADPH oxidase 1 gene and upregulates production of superoxide anion by human large intestinal epithelial cells	Kuwano	2006	0		NOX5
707	chr10	16068234	16070086	3500015675	40		16068234	16070086	8421504	2	20,20	0,1832	c,g	350001567500000004,350001567500000004,350001567500000005,350001567500000005	0-20,0-20,0-20,0-20			10.1152/ajpcell.00135.2005		American Journal of Physiology - Cell Physiology	Interferon-&#x03b3; activates transcription of NADPH oxidase 1 gene and upregulates production of superoxide anion by human large intestinal epithelial cells	Kuwano	2006	0		NOX5
707	chr10	16088339	16088365	3500427647	26		16088339	16088365	8421504	1	26	0	c	350042764700000001	1-27		17660236	10.1530/REP-06-0120	1470-1626	Reproduction	Characterization of NADPH oxidase 5 in equine testis and spermatozoa	Sabeur	2007	3		
709	chr10	16330091	16330117	3500141241	24		16330091	16330117	8421504	2	5,19	0,7	c	350014124100000001	16-40		9346972	10.1074/jbc.272.44.28158	0021-9258	Journal of Biological Chemistry	Biosynthesis of Heparin/Heparan Sulfate	Li	1997	5		
709	chr10	16337297	16337324	3500382628	27		16337297	16337324	8421504	1	27	0	c	350038262800000013	0-27			10.1186/1471-213X-5-19		BMC Developmental Biology	D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish	Giancarlo	2005	0		GLCE
709	chr10	16337297	16337324	3500340117	27		16337297	16337324	8421504	1	27	0	c	350034011700000013	0-27			10.1186/1471-213X-5-19	1471-213X	BMC Developmental Biology	D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish	Ghiselli	2005	3		GLCE
709	chr10	16337297	16337324	3500298095	27		16337297	16337324	8421504	1	27	0	c	350029809500000013	0-27						D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish.	.biomedsearch.com	0	0		GLCE
711	chr10	16527634	16527958	3500437830	135		16527634	16527958	8421504	3	69,2,64	0,72,260	p	350043783000015026	0-141						Microtubule Interactions and Regulation of the Mitotic-Kinesin Like Protein-1 and Kinesin-Like Calmodulin-Binding Protein	cholar.lib.vt.edu	0	0		
712	chr10	16714629	16714658	3500394874	23		16714629	16714658	8421504	3	5,12,6	0,6,23	g	350039487400000138	17-40						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2002	0		
715	chr10	17122640	17122678	3500253226	33		17122640	17122678	8421504	2	14,19	0,19	c	350025322600000049	11-49						The Human Histone H2A.Z Gene	www.jbc.org	0	0		
717	chr10	17308804	17308832	3500010585	23		17308804	17308832	8421504	3	4,6,13	0,5,15	g	350001058500000002	21-45			10.1111/j.1365-2958.2007.06033.x	1365-2958	Molecular Microbiology	Experimental analysis of Helicobacter pylori transcriptional terminators suggests this microbe uses both intrinsic and factor-dependent termination - Castillo - 2007 - Molecular Microbiology - Wiley Online Library	Castillo	2008	0		
718	chr10	17456627	17456655	3500028004	23		17456627	17456655	8421504	2	7,16	0,12	g	350002800400000000	7-30		20686666	10.1371/journal.ppat.1001029		PLoS Pathogens	Biogenesis of the Inner Membrane Complex Is Dependent on Vesicular Transport by the Alveolate Specific GTPase Rab11B	Carolina	July	0		
718	chr10	17491697	17491720	3500038119	23		17491697	17491720	8421504	1	23	0	g	350003811900000010	14-37						Methods in Molecular Biology Vol. 077 Protein Synthesis	www.scribd.com	0	0		
720	chr10	17761355	17761379	3500048806	23		17761355	17761379	8421504	2	7,16	0,8	g	350004880600000034	16-39						Polynucleotides encoding novel adiponectin receptor variants - Patent application	www.faqs.org	0	0		
721	chr10	17937549	17945612	3500373648	194		17937549	17945612	8421504	5	24,44,30,48,48	0,580,864,912,8015	c	350037364800000034,350037364800000022,350037364800000016,350037364800000015,350037364800000010	21-45,0-44,18-48,0-48,0-48						REGULATION OF ACHERON EXPRESSION - Patent application	www.faqs.org	0	0		
726	chr10	18533069	18533096	3500140430	24		18533069	18533096	8421504	2	7,17	0,10	g	350014043000000051	23-47						DNA sequence encoding N-acetyl-galactosamine-transferase	Lowe	1994	0		
727	chr10	18675854	18675931	3500443370	48		18675854	18675931	8421504	3	18,4,26	0,19,51	c,g	350044337000000006,350044337000000006,350044337000000016	0-22,0-22,15-41		19940141	10.1074/jbc.M109.076919		The Journal of Biological Chemistry	ADAMTSL-6 Is a Novel Extracellular Matrix Protein That Binds to Fibrillin-1 and Promotes Fibrillin-1 Fibril Formation	Ko	2010	0		
728	chr10	18835560	18835586	3500140405	24		18835560	18835586	8421504	2	5,19	0,7	g	350014040500000056	8-32						METHOD FOR TREATING CANCER USING ANTI-WNT2 MONOCLONAL ANTIBODIES AND siRNA - Patent application	www.faqs.org	0	0		
729	chr10	18874885	18874908	3500443370	23		18874885	18874908	8421504	1	23	0	c	350044337000000008	7-30		19940141	10.1074/jbc.M109.076919		The Journal of Biological Chemistry	ADAMTSL-6 Is a Novel Extracellular Matrix Protein That Binds to Fibrillin-1 and Promotes Fibrillin-1 Fibril Formation	Ko	2010	0		
729	chr10	18933064	18933112	3500052842	48		18933064	18933112	8421504	1	48	0	p	350005284200015017	0-48						DMD #24695 A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor	aspetjournals.org	0	0		NR2E3
730	chr10	19074635	19074661	3500445144	24		19074635	19074661	8421504	2	5,19	0,7	g	350044514400000001	16-40						Pestivirus mutant for use in a vaccine - Patent application	www.faqs.org	0	0		
732	chr10	19278365	19278389	3500355496	23		19278365	19278389	8421504	2	13,10	0,14	g	350035549600000006	17-40						High resolution typing of Chlamydophila psittaci by multilocus VNTR analysis (MLVA)	tal.umaryland.edu	0	0		
732	chr10	19292234	19306431	3500199211	1455		19292234	19306431	8421504	11	76,92,132,187,218,47,151,153,167,182,50	0,648,3510,4041,5054,5278,7047,7422,11076,13025,14147	p	350019921100015218,350019921100015225,350019921100015232,350019921100015241,350019921100015242,350019921100015250,350019921100015249,350019921100015255,350019921100015261	0-210,0-210,0-204,0-81,0-120,0-210,0-210,0-210,0-210						Etude des voies metaboliques des sucres chez l'huitre creuse crassostrea gigas. Implication dans les mortalites estivales.	chimer.ifremer.fr	0	0		PKM
732	chr10	19297301	19297325	3500373336	23		19297301	19297325	8421504	2	18,5	0,19	c	350037333600000104	3-26						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins - US Patent 7378506 Description	ww.patentstorm.us	0	0		
733	chr10	19438895	19438923	3500245486	23		19438895	19438923	8421504	3	12,4,7	0,13,21	g	350024548600000200	0-24						Antagonists of IL-6 to raise Albumin and/or lower CRP - Patent application	www.faqs.org	0	0		
734	chr10	19531821	19531852	3500093092	26		19531821	19531852	8421504	2	19,7	0,24	c	350009309200000024	4-31						Gene regulation by targeting putative intramolecular triple helix	Lu	1994	0		
734	chr10	19621642	19621696	3500306083	54		19621642	19621696	8421504	1	54	0	p	350030608300015021	0-54						Nature June 2 ,2011	www.calameo.com	0	0		ARIH1
739	chr10	20233162	20233188	3500305030	23		20233162	20233188	8421504	2	18,5	0,21	g	350030503000000207	18-41						Biological methods for preparing a fatty dicarboxylic acid	Beardslee	2013	0		
741	chr10	20567358	20570655	3500416605	40		20567358	20570655	8421504	2	23,17	0,3280	c	350041660500000001	0-40						Distribution of Transcript and Protein Isoforms of the Synaptic Glycoprotein Neuroplastin in Rat Retina	brainience.com	0	0		NPTN
742	chr10	20665152	20665176	3500308897	23		20665152	20665176	8421504	2	9,14	0,10	g	350030889700000317,350030889700000944	13-36,10-33						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
742	chr10	20681552	20687772	3500091308	58		20681552	20687772	8421504	2	29,29	0,6191	g	350009130800000000,350009130800000001	0-29,0-29		21518725	10.1158/1535-7163.MCT-11-0072	1535-7163	Molecular Cancer Therapeutics	B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation	Liu	2011	5		CD276
742	chr10	20687715	20687744	3500106372	24		20687715	20687744	8421504	2	16,8	0,21	g	350010637200000038	0-24						HYDROCARBON-PRODUCING GENES AND METHODS OF THEIR USE - Patent application	www.faqs.org	0	0		
743	chr10	20733446	20758779	3500398923	40		20733446	20758779	8421504	3	20,13,7	0,25308,25326	g	350039892300000182,350039892300000122,350039892300000110	16-36,16-36,21-41						PHAGE-DISPLAYING SINGLE-CHAIN ANTIBODY CAPABLE OF RECOGNIZING NON-REDUCED MANNOSE RESIDUE - Patent application	www.faqs.org	0	0		
744	chr10	20915385	20916281	3500050330	207		20915385	20916281	8421504	3	66,84,57	0,347,839	p	350005033000015018,350005033000015047	0-150,0-57						MgC1q, a novel C1q-domain-containing protein involved in the immune response of Mytilus galloprovincialis	digital.csic.es	0	0		CBLN3
744	chr10	20929407	20929432	3500374916	25		20929407	20929432	8421504	1	25	0	c	350037491600000016,350037491600000119	0-25,0-25						Autism Genes And Regulated Secretion 	.freshpatents.com	0	0		
11	chr10	20970573	20974475	3500153655	135		20970573	20974475	8421504	3	48,39,48	0,1986,3854	c	350015365500000161,350015365500000146,350015365500000135	0-48,9-48,0-48						Nuclear factors and binding assay	Hoey	1995	0		
745	chr10	20973194	20973248	3500114930	54		20973194	20973248	8421504	1	54	0	p	350011493000015000	0-54		8631809	10.1074/jbc.271.13.7700	0021-9258	Journal of Biological Chemistry	Activation of Nuclear Factor of Activated T Cells in a Cyclosporin A-resistant Pathway	Ghosh	1996	5		NFATC3
745	chr10	20973197	20973245	3500196824	48		20973197	20973245	8421504	1	48	0	p	350019682400015108	0-48						 Methods Of Determining SAM 	www.docstoc.com	0	0		NFATC3
745	chr10	20976350	20976443	3500411148	93		20976350	20976443	8421504	1	93	0	p	350041114800015006	27-120						transcription with calcineurin Interaction NFAT1	www.pnas.org	0	0		NFATC4
745	chr10	21028173	21028202	3500344705	25		21028173	21028202	8421504	2	11,14	0,15	c	350034470500000040	0-32						APJ ligand polypeptides	Hinuma	1999	0		LTB4R2
745	chr10	21036785	21037501	3500385029	24		21036785	21037501	8421504	3	2,7,15	0,692,701	c	350038502900000020,350038502900000028	0-24,0-24						RAGE protein derivatives	O'keefe	2005	0		
745	chr10	21036785	21037501	3500221685	24		21036785	21037501	8421504	3	2,7,15	0,692,701	c	350022168500000055,350022168500000020,350022168500000028	0-24,0-24,0-24						Rage protein derivatives - Patent application	www.faqs.org	0	0		
745	chr10	21036785	21037501	3500218259	24		21036785	21037501	8421504	3	2,7,15	0,692,701	c	350021825900000020,350021825900000028	0-24,0-24						Rage Protein Derivatives 	.freshpatents.com	0	0		
745	chr10	21036785	21037501	3500193705	24		21036785	21037501	8421504	3	2,7,15	0,692,701	c	350019370500000046	0-24						Novel polyadenylation signal for use in expression vectors	O'keefe	2005	0		
745	chr10	21074596	21079054	3500333575	40		21074596	21079054	8421504	3	20,14,6	0,4331,4452	c	350033357500000000,350033357500000001	0-20,0-20					The British Journal of Ophthalmology	Enhanced expression of transglutaminase 2 in anterior polar cataracts and its induction by TGF-&#x03b2; in vitro	X	2002	0		TGM1
745	chr10	21074596	21079054	3500206519	40		21074596	21079054	8421504	3	20,14,6	0,4331,4452	c	350020651900000000,350020651900000001	0-20,0-20		12386092	10.1136/bjo.86.11.1293	1468-2079	British Journal of Ophthalmology	Enhanced expression of transglutaminase 2 in anterior polar cataracts and its induction by TGF-&#x03b2; in vitro	Wan	2002	0		TGM1
746	chr10	21105328	21113239	3500083444	105		21105328	21113239	8421504	3	18,48,39	0,7656,7872	p	350008344400015002	0-105						NMT : CS 221 : test_MP1_s	ww.coursehero.com	0	0		GMPR2,TM9SF1
746	chr10	21113206	21113269	3500052832	63		21113206	21113269	8421504	1	63	0	p	350005283200015165	57-120						NOTES ON SELECTED SOFTBERRY PRODUCTS	ux1.softberry.com	0	0		TM9SF1
746	chr10	21130294	21130319	3500120692	23		21130294	21130319	8421504	2	18,5	0,20	g	350012069200000007	0-23						Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases S	aspetjournals.org	0	0		
746	chr10	21130347	21176558	3500059586	41		21130347	21176558	8421504	5	9,12,6,7,7	0,13,46096,46107,46204	c,g	350005958600000045,350005958600000036	13-34,2-22						Human alanyl-tRNA synthetase proteins, nucleic acids and tester strains comprising same	Shiba	1995	0		
746	chr10	21157521	21157548	3500156499	23		21157521	21157548	8421504	2	7,16	0,11	c	350015649900000005	8-31						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
746	chr10	21157536	21158553	3500319127	40		21157536	21158553	8421504	2	20,20	0,997	c	350031912700000021,350031912700000020	0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
746	chr10	21158706	21158757	3500042649	48		21158706	21158757	8421504	2	20,28	0,23	c	350004264900000003	16-64						SPORE SURFACE DISPLAYS OF BIOACTIVE MOLECULES - Patent application	www.faqs.org	0	0		
746	chr10	21158714	21158744	3500466562	30		21158714	21158744	8421504	1	30	0	c	350046656200000004	12-45						BIOLOGICAL ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY	Skerra	2008	0		
746	chr10	21158714	21158744	3500260823	30		21158714	21158744	8421504	1	30	0	c	350026082300000004	12-45						Biological active proteins having increased in vivo and/or vitro stability	Schlapschy	2010	0		
746	chr10	21158714	21158744	3500258999	30		21158714	21158744	8421504	1	30	0	c	350025899900000008	12-45					Patent	Biological active proteins having increased in vivo and/or vitro stability (Patent EP:2173890)	Schlapschy	2011	0		
746	chr10	21158714	21158744	3500229410	30		21158714	21158744	8421504	1	30	0	c	350022941000000008	12-45						Biological active proteins having increased in vivo and/or vitro stability	Yi Na *Xi Ao Bo De 	2011	0		
746	chr10	21158714	21158744	3500211516	30		21158714	21158744	8421504	1	30	0	c	350021151600000004	12-45						Biological active proteins having increased in vivo and/or in vitro stability	Skerra	2010	0		
746	chr10	21158729	21158755	3500041433	25		21158729	21158755	8421504	2	5,20	0,6	c	350004143300000046	22-47						US Patent # 5,260,200. Isolated DNA encoding an insulin receptor substrate - Patents.com	www.patents.com	0	0		
746	chr10	21160347	21160371	3500113379	23		21160347	21160371	8421504	2	12,11	0,13	c	350011337900000290	15-45						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
746	chr10	21182367	21184134	3500274037	59		21182367	21184134	8421504	5	6,14,19,12,8	0,91,801,1204,1759	c	350027403700000113,350027403700000115,350027403700000114	0-20,0-19,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
746	chr10	21206423	21208422	3500364507	45		21206423	21208422	8421504	3	20,12,13	0,117,1986	c	350036450700000009,350036450700000010	0-20,0-25						Maternal diabetes impairs gastrulation and insulin and IGF-I receptor expression in rabbit blastocysts. - ResearchGate	.researchgate.net	0	0		PCK2
747	chr10	21291132	21291156	3500422293	23		21291132	21291156	8421504	2	19,4	0,20	g	350042229300000053	11-37						Recombinant production of human and bovine receptors for modified low-density lipoprotein	Sawamura	1997	0		
747	chr10	21310584	21310608	3500124631	23		21310584	21310608	8421504	2	5,18	0,6	c	350012463100000001	13-36						2006 12:21 PM	www.unclaw.com	0	0		
748	chr10	21434037	21434065	3500211134	23		21434037	21434065	8421504	2	15,8	0,20	g	350021113400000007,350021113400000005	0-23,0-23						Monoclonal antibody against platelet membrane glycoprotein VI	Takayama	2004	0		
749	chr10	21565964	21566159	3500323961	24		21565964	21566159	8421504	2	11,13	0,182	c	350032396100000007	9-33		22114351	10.1091/mbc.E11-08-0699		Molecular Biology of the Cell	AMPK directly inhibits NDPK through a phosphoserine switch to maintain cellular homeostasis	Rob	2012	0		
749	chr10	21565964	21566159	3500316289	24		21565964	21566159	8421504	2	11,13	0,182	c	350031628900000007	9-33		22114351	10.1091/mbc.E11-08-0699	1059-1524	Molecular Biology of the Cell	AMPK directly inhibits NDPK through a phosphoserine switch to maintain cellular homeostasis	Onyenwoke	2012	5		
750	chr10	21644602	21645752	3500237513	261		21644602	21645752	8421504	4	118,101,8,34	0,859,1020,1116	p	350023751300015109,350023751300015106	0-141,0-180						50 human secreted proteins	Komatsoulis	2000	0		NGDN
750	chr10	21644665	21645757	3500235713	44		21644665	21645757	8421504	2	22,22	0,1070	c,g	350023571300000001,350023571300000000,350023571300000000	0-22,0-22,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
750	chr10	21644669	21646143	3500308562	41		21644669	21646143	8421504	2	20,21	0,1453	c,g	350030856200000019,350030856200000019,350030856200000018	0-20,0-20,0-21						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
750	chr10	21672677	21672842	3500423761	165		21672677	21672842	8421504	1	165	0	p	350042376100015042	0-165						Bases de detection en reconnaissance des formes pour la bioInformatique	fesseurs.esiea.fr	0	0		
750	chr10	21672677	21672842	3500377403	165		21672677	21672842	8421504	1	165	0	p	350037740300015046	0-165						Introduction &#xe0; la bioinformatique PLU4199 Support de cours blog : http://professeurs.esiea.fr/wassner/	fesseurs.esiea.fr	0	0		
750	chr10	21676143	21677181	3500246254	40		21676143	21677181	8421504	2	20,20	0,1018	c,g	350024625400000018,350024625400000006,350024625400000007,350024625400000007,350024625400000019,350024625400000019	0-20,0-20,0-20,0-20,0-20,0-20						Calcium/Calmodulin-Dependent Protein Kinase Kinase as a Control Point for Cardiac Hypertrophy - Patent application	www.faqs.org	0	0		
750	chr10	21677774	21679090	3500296667	40		21677774	21679090	8421504	2	20,20	0,1296	c	350029666700000035,350029666700000036	0-20,0-20						7 Materials and methods	thek.uni-halle.de	0	0		
750	chr10	21678626	21678708	3500243216	72		21678626	21678708	8421504	3	23,27,22	0,24,60	c,g	350024321600000009,350024321600000011,350024321600000011,350024321600000010	0-23,0-27,0-27,0-22						EFFECT OF ZILPATEROL HYDROCHLORIDE AND STEROID IMPLANTATION ON YEARLING STEER FEEDLOT PERFORMANCE, CARCASS CHARACTERISTICS, AND SKELETAL MUSCLE GENE EXPRESSION TIMOTHY JOHN BAXA B.S., Kansas State University, 2004 A THESIS	krex.k-state.edu	0	0		
750	chr10	21678650	21678708	3500345859	49		21678650	21678708	8421504	2	27,22	0,36	c,g	350034585900000010,350034585900000010,350034585900000009	0-27,0-27,0-22						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
750	chr10	21678650	21678708	3500093083	49		21678650	21678708	8421504	2	27,22	0,36	c,g	350009308300000008,350009308300000008,350009308300000007	0-27,0-27,0-22						messenger ribonucleic acid abundance in finishing steers1	animalscience.org	0	0		
750	chr10	21681296	21696683	3500133203	61		21681296	21696683	8421504	3	21,20,20	0,14701,15367	c,g	350013320300000210,350013320300000212,350013320300000211	0-21,0-20,0-20						[tel-00521428, v1] &#xc9;tude des voies de conduction cardiaque : identification des g&#xe8;nes sp&#xe9;cifiquement exprim&#xe9;s et impliqu&#xe9;s dans des troubles de conduction	hives-ouvertes.fr	0	0		
750	chr10	21695975	21722190	3500032348	40		21695975	21722190	8421504	2	20,20	0,26195	c	350003234800000005,350003234800000004	0-20,0-20			10.1186/1471-2164-8-63		BMC Genomics	Target genes of myostatin loss-of-function in muscles of late bovine fetuses	Isabelle	2007	0		
750	chr10	21700850	21715277	3500353647	45		21700850	21715277	8421504	2	22,23	0,14404	c	350035364700000076,350035364700000075	0-22,0-23						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		
750	chr10	21700850	21715277	3500351139	45		21700850	21715277	8421504	2	22,23	0,14404	c,g	350035113900000076,350035113900000204,350035113900000204,350035113900000203,350035113900000203,350035113900000075,350035113900000201,350035113900000201,350035113900000202,350035113900000202	0-22,1-22,1-22,0-22,0-22,0-23,0-22,0-22,1-22,1-22						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		MIR208A,MIR208B,MYH6,MYH7
750	chr10	21717927	21718050	3500136884	123		21717927	21718050	8421504	1	123	0	p	350013688400015000	0-123						 <HTML> <HEAD> <meta name="GENERATOR" content="Microsoft Internet Assistant for PowerPoint 97	ww.toxicology.org	0	0		MYH7
750	chr10	21717927	21718050	3500033053	123		21717927	21718050	8421504	1	123	0	p	350003305300015000	0-123						Types of Algorithms 	ww.toxicology.org	0	0		MYH7
750	chr10	21720268	21722190	3500005911	49		21720268	21722190	8421504	2	24,25	0,1897	c	350000591100000032,350000591100000033	22-46,24-49						Stem Cell Assays	.researchgate.net	0	0		MYH7
750	chr10	21720268	21720292	3500021306	24		21720268	21720292	8421504	1	24	0	c	350002130600000001	0-24			10.1634/stemcells.2005-0128	1549-4918	STEM CELLS	Bone Marrow Cells Transdifferentiate to Cardiomyocytes When Introduced into the Embryonic Heart - Eisenberg - 2006 - STEM CELLS - Wiley Online Library	Eisenberg	2006	0		
750	chr10	21722165	21722194	3500464117	29		21722165	21722194	8421504	1	29	0	c	350046411700000005	0-29			10.1634/stemcells.2004-0176	1549-4918	STEM CELLS	Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells: Proliferation, Migration, and Differentiation - Forte - 2005 - STEM CELLS - Wiley Online Library	Forte	2006	0		
750	chr10	21722165	21722189	3500004287	24		21722165	21722189	8421504	1	24	0	c	350000428700000003	0-24						Reprogramming of gene expression in cultured cardiomyocytes and in explanted hearts by the myosin ATPase inhibitor butanedione monoxime. - ResearchGate	.researchgate.net	0	0		
750	chr10	21722165	21722188	3500360727	23		21722165	21722188	8421504	1	23	0	c	350036072700000010	0-23		19625611	10.1152/ajpcell.00049.2009		American Journal of Physiology - Cell Physiolog	Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor	Wang	2009	0		MYH6
750	chr10	21722174	21722198	3500090022	24		21722174	21722198	8421504	1	24	0	c	350009002200000004	0-24						Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Calcineurin/Nfatc3 Pathway	www.ijbs.com	0	0		MYH6
750	chr10	21725440	21725740	3500081673	89		21725440	21725740	8421504	2	50,39	0,261	c	350008167300000494	1-108						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
750	chr10	21731461	21731485	3500325934	24		21731461	21731485	8421504	1	24	0	g	350032593400000003	3-27						IL-17 and IL-17R homologous polypeptides and therapeutic uses thereof	Chen	2010	0		
750	chr10	21747876	21749112	3500006756	24		21747876	21749112	8421504	2	10,14	0,1222	c	350000675600000010	0-24						Extracellular segments of human &#x03b5; immunoglobulin anchoring peptides and antibodies specific therefor	Chang	1993	0		
750	chr10	21757431	21757742	3500256218	47		21757431	21757742	8421504	2	23,24	0,287	c,g	350025621800000129,350025621800000129,350025621800000130,350025621800000130	0-23,0-23,0-24,0-24						REPRODUCTION	uction-online.org	0	0		
751	chr10	21758780	21758933	3500328917	23		21758780	21758933	8421504	3	5,5,13	0,6,140	c	350032891700000100	21-44						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
751	chr10	21772346	21774154	3500378194	45		21772346	21774154	8421504	2	25,20	0,1788	c	350037819400000001,350037819400000015	16-41,0-20						MCB Accepts, published online ahead of print on 20 August 2012 Mol. Cell. Biol. doi:10.1128/MCB.06785-11 Copyright &#xa9; 2012, American Society for Microbiology. All Rights Reserved.	mcb.asm.org	0	0		SLC22A17,PPP1R3E
751	chr10	21783066	21783089	3500438220	23		21783066	21783089	8421504	1	23	0	c	350043822000000015,350043822000000016	0-23,0-22						Universal Target Sequences For Sirna Gene Silencing 	.freshpatents.com	0	0		PPP1R3E
751	chr10	21783875	21783934	3500346026	53		21783875	21783934	8421504	2	18,35	0,24	c	350034602600000005,350034602600000004	5-58,5-58						Dysregulation of miR-15a and miR-214 in human pancreatic cancer	biomedcentral.com	0	0		PPP1R3E
751	chr10	21783875	21783934	3500114623	53		21783875	21783934	8421504	2	18,35	0,24	c	350011462300000005,350011462300000004	5-58,5-58						Dysregulation of miR-15a and miR-214 in human pancreatic cancer	www.jhoonline.org	0	0		PPP1R3E
751	chr10	21785829	21785856	3500447109	27		21785829	21785856	8421504	1	27	0	c	350044710900000005	9-36		22194685	10.1371/journal.ppat.1002430	1553-7374	PLOS Pathogens	PLOS Pathogens: Inhibition of Apoptosis and NF-&#x03ba;B Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence	Motes	2011	0		
752	chr10	21915138	21915164	3500061221	26		21915138	21915164	8421504	1	26	0	c	350006122100000002	0-26						LAT1 transporters expressed in cancer cells	Zerangue	2006	0		SLC7A10
752	chr10	21924450	21924473	3500053931	23		21924450	21924473	8421504	1	23	0	c,g	350005393100000007,350005393100000007	0-23,0-23		18765732	10.1128/IAI.00851-08	0019-9567	Infection and Immunity	Anaplasma phagocytophilum Increases Cathepsin L Activity, Thereby Globally Influencing Neutrophil Function	Thomas	2008	4		CEBPE
752	chr10	21924451	21924562	3500423935	40		21924451	21924562	8421504	2	20,20	0,91	c,g	350042393500000002,350042393500000002,350042393500000003,350042393500000003	0-20,0-20,0-20,0-20		19507250	10.1002/ijc.24472	1097-0215	International Journal of Cancer	Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells - Nishioka - 2009 - International Journal of Cancer - Wiley Onli	Nishioka	2009	0		CEBPE
752	chr10	21925554	21925797	3500191222	243		21925554	21925797	8421504	1	243	0	p	350019122200015013	0-243						Basic leucine zipper transcription factor Hac1 binds DNA in two distinct modes as revealed by microfluidic analyses	alterlab.ucsf.edu	0	0		CEBPE
752	chr10	21925832	21925863	3500355861	31		21925832	21925863	8421504	1	31	0	c	350035586100000021	6-37			10.1042/BJ20070245		The Biochemical Journal	Identification of a responsible promoter region and a key transcription factor, CCAAT/enhancer-binding protein &#x03f5;, for up-regulation of PHGPx in HL60 cells stimulated with TNF&#x03b1;	Hiroyuki	2007	0		
752	chr10	21982362	21982389	3500010512	26		21982362	21982389	8421504	2	15,11	0,16	g	350001051200000010	11-37					Proceedings of the National Academy of Sciences of the United States of America	Identification of thyroid hormone response elements in the human fatty acid synthase promoter	Shunbin	1998	0		
752	chr10	22007551	22007575	3500212475	23		22007551	22007575	8421504	2	10,13	0,11	c	350021247500000242	19-42						CELLS AND METHODOLOGY TO GENERATE NON-SEGMENTED NEGATIVE-STRAND RNA VIRUSES - Patent application	www.faqs.org	0	0		
753	chr10	22070531	22070558	3500438180	23		22070531	22070558	8421504	2	15,8	0,19	c	350043818000000016	11-39						Identification of novel keloid biomarkers through Profiling of Tissue Biopsies versus Cell Cultures in Keloid Margin specimens Compared to adjacent Normal Skin	www.eplasty.com	0	0		
753	chr10	22070531	22070558	3500278147	23		22070531	22070558	8421504	2	15,8	0,19	c	350027814700000016	11-39						Identification of novel keloid biomarkers through Profiling of Tissue Biopsies versus Cell Cultures in Keloid Margin specimens Compared to adjacent Normal Skin	www.eplasty.com	0	0		
753	chr10	22070531	22070558	3500188755	23		22070531	22070558	8421504	2	15,8	0,19	c	350018875500000016	11-39						Identification of novel keloid biomarkers through Profiling of Tissue Biopsies versus Cell Cultures in Keloid Margin specimens Compared to adjacent Normal Skin	eplasty.com	0	0		
753	chr10	22099696	22100370	3500055027	38		22099696	22100370	8421504	3	19,14,5	0,449,669	c,g	350005502700000004,350005502700000004,350005502700000005	0-19,0-19,0-19						METHOD OF TREATMENT AND PROPHYLAXIS - MELBOURNE HEALTH	www.sumobrain.com	0	0		PRMT5
753	chr10	22099696	22100370	3500015038	38		22099696	22100370	8421504	3	19,14,5	0,449,669	c	350001503800000004,350001503800000005	0-19,0-19						METHOD OF TREATMENT AND PROPHYLAXIS	Jane	2007	0		PRMT5
753	chr10	22101840	22101864	3500143098	23		22101840	22101864	8421504	2	11,12	0,12	c	350014309800000478	11-34						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS - Patent application	www.faqs.org	0	0		
753	chr10	22134774	22134797	3500014352	23		22134774	22134797	8421504	1	23	0	c,g	350001435200000001,350001435200000001	0-23,0-23						RESEARCH ARTICLE Open Access LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimers disease	odegeneration.com	0	0		
753	chr10	22143502	22143533	3500198677	24		22143502	22143533	8421504	3	5,12,7	0,7,24	g	350019867700000058	18-42						NOVEL CANCER-ASSOCIATED GENES - Patent application	www.faqs.org	0	0		
94	chr10	22151002	22159426	3500034114	73		22151002	22159426	8421504	3	24,25,24	0,3336,8400	c	350003411400000023,350003411400000003,350003411400000002,350003411400000024	8-32,0-25,0-25,11-35		19934222	10.1242/jcs.050724	0021-9533	Journal of Cell Science	MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices	Fisher	2009	6		MMP14,MRPL52
94	chr10	22151002	22159426	3500003722	73		22151002	22159426	8421504	3	24,25,24	0,3336,8400	c	350000372200000023,350000372200000002,350000372200000003,350000372200000024	8-32,0-25,0-25,11-35		19934222	10.1242/jcs.050724		Journal of Cell Science	MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices	Kevin	2009	0		MMP14,MRPL52
754	chr10	22152282	22152305	3500426979	23		22152282	22152305	8421504	1	23	0	c	350042697900000009	0-23		22064657	10.1158/1541-7786.MCR-11-0180	1541-7786	Molecular Cancer Research	Regulation of CXCL8/IL-8 Expression by Zonula Occludens-1 in Human Breast Cancer Cells	Brysse	2012	4		
754	chr10	22152591	22152614	3500395674	23		22152591	22152614	8421504	1	23	0	c	350039567400000004	0-23						Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A activity	www.molvis.org	0	0		
754	chr10	22153077	22154919	3500302580	41		22153077	22154919	8421504	2	20,21	0,1821	c,g	350030258000000016,350030258000000015,350030258000000015	0-20,0-21,0-21			10.1002/art.20596	1529-0131	Arthritis & Rheumatism	Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes - Martin - 2004 - Arthritis & Rheumatism - Wiley Online Library	Martin	2004	0		MMP14
754	chr10	22153581	22154221	3500134803	41		22153581	22154221	8421504	2	19,22	0,618	c,g	350013480300000021,350013480300000021,350013480300000020,350013480300000020	0-19,0-19,0-22,0-22						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
754	chr10	22154206	22154231	3500202371	25		22154206	22154231	8421504	1	25	0	c	350020237100000001	19-44		22310287	10.1038/onc.2012.25	0950-9232	Oncogene	Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion	Ferguson	2012	6		
754	chr10	22154210	22154234	3500011839	24		22154210	22154234	8421504	1	24	0	c	350001183900000007	0-24						Matrix interaction, locomotion and regulation of matrix metalloproteinases (MMPs) by IL-2 and chemokines	gupea.ub.gu.se	0	0		MMP14
754	chr10	22159405	22159429	3500225022	24		22159405	22159429	8421504	1	24	0	c	350022502200000000	9-33		21849471	10.1158/1541-7786.MCR-11-0033	1541-7786	Molecular Cancer Research	Oxidative Stress and Prostate Cancer Progression Are Elicited by Membrane-Type 1 Matrix Metalloproteinase	Nguyen	2011	4		MRPL52
754	chr10	22210200	22210224	3500329263	24		22210200	22210224	8421504	1	24	0	c	350032926300000006	0-24		14578430	10.1167/iovs.03-0403	1552-5783	Investigative Ophthalmology & Visual Science	Prevention of Ornithine Cytotoxicity by Nonpolar Side Chain Amino Acids in Retinal Pigment Epithelial Cells	Nakauchi	2003	0		
754	chr10	22214849	22214875	3500161257	26		22214849	22214875	8421504	1	26	0	c	350016125700000024	0-26						LAT1 TRANSPORTERS EXPRESSED IN BLOOD BRAIN BARRIER CELLS - Patent application	www.faqs.org	0	0		
755	chr10	22387541	22387565	3500403028	24		22387541	22387565	8421504	1	24	0	g	350040302800000002	6-30						Transduced PEP-1-Grb7 fusion protein suppressed LPS-induced COX-2 expression. - ResearchGate	.researchgate.net	0	0		PPIAP30
755	chr10	22387542	22387566	3500264880	24		22387542	22387566	8421504	1	24	0	g	350026488000000006	0-24						BMC Neuroscience BioMed Central	biomedcentral.com	0	0		PPIA
755	chr10	22387548	22387848	3500390379	40		22387548	22387848	8421504	2	20,20	0,280	g	350039037900000004,350039037900000005	0-20,0-20						Methods of treating neurological conditions with hematopoeitic growth factors	Gassler	2005	0		
755	chr10	22387548	22387848	3500258255	40		22387548	22387848	8421504	2	20,20	0,280	g	350025825500000006,350025825500000007	0-20,0-20						Method of identifying a modulator of a voltage-gated sodium channel using cells expressing Nav1.8 and p11	Okuse	2002	0		
755	chr10	22387548	22387848	3500182671	40		22387548	22387848	8421504	2	20,20	0,280	g	350018267100000006,350018267100000007	0-20,0-20					Patent	Method of identifying a modulator of a voltage-gated sodium channel using cells expressing Nav1.8 and p11 (Patent US:7563586)	Baker	2009	0		
755	chr10	22387613	22387637	3500292648	24		22387613	22387637	8421504	1	24	0	g	350029264800000004	0-24						NeurobiologyofDisease Presenilin-1RegulatesNeuralProgenitorCellDifferentiation intheAdultBrain	w.anatomy.uic.edu	0	0		HNRNPH2
755	chr10	22387614	22387637	3500052436	23		22387614	22387637	8421504	1	23	0	g	350005243600000008	0-23						Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. 4 Nicole de Wit , Muriel Derrien , Hanneke Bosch-Vermeulen , Els Oosterink , Shohreh 5 Keshtkar ,	gi.physiology.org	0	0		
755	chr10	22387657	22387682	3500215545	25		22387657	22387682	8421504	1	25	0	g	350021554500000001	0-25						Nuclear GSK-3&#x03b2; segregation in desmoid-type fibromatosis. - ResearchGate	.researchgate.net	0	0		LINC00623
755	chr10	22387814	22387847	3500423401	33		22387814	22387847	8421504	1	33	0	g	350042340100000007	0-33						Thecal Cell-Granulosa Cell Interactions Involve a Positive Feedback Loop among Keratinocyte Growth Factor, Hepatocyte Growth Factor, and Kit Ligand during Ovarian Follicular Development*	.endojournals.org	0	0		PPIAL4G
755	chr10	22388012	22388037	3500189555	25		22388012	22388037	8421504	1	25	0	g	350018955500000008	10-35		19193229	10.1186/1742-4690-6-11		Retrovirology	HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome	Lyubov	2009	0		LINC00623
755	chr10	22388012	22388037	3500189225	25		22388012	22388037	8421504	1	25	0	g	350018922500000008	10-35		19193229	10.1186/1742-4690-6-11	1742-4690	Retrovirology	HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome	Zaitseva	2009	6		LINC00623,VAT1L
756	chr10	22422969	22458719	3500049946	55		22422969	22458719	8421504	3	24,16,15	0,28,35735	c	350004994600000009,350004994600000010,350004994600000008	0-24,0-26,0-31						Method for regulating immune function in primates using the Foxp3 protein	Brunkow	2003	0		
756	chr10	22476840	22476863	3500070815	23		22476840	22476863	8421504	1	23	0	g	350007081500000019	0-23					Patent	Method for promoting angiogenesis with a nucleic acid construct comprising an SM22&#x03b1;0 promoter (Patent US:6297221)	Parmacek	2001	0		
756	chr10	22481902	22485500	3500332706	40		22481902	22485500	8421504	2	20,20	0,3578	g	350033270600000010,350033270600000011	0-20,0-20						T cell immunodominant Anaplasma marginale	www.jleukbio.org	0	0		
756	chr10	22481935	22525078	3500259306	66		22481935	22525078	8421504	3	22,21,23	0,3686,43120	g	350025930600000020,350025930600000019,350025930600000017	0-22,0-21,0-23		10377186	10.1084/jem.189.12.1907	0022-1007	The Journal of Experimental Medicine	An Invariant T Cell Receptor &#x03b1; Chain Defines a Novel TAP-independent Major Histocompatibility Complex Class Ib&#x2013;restricted &#x03b1;/&#x03b2; T Cell Subpopulation in Mammals	Tilloy	1999	14		
756	chr10	22507939	22507966	3500378050	25		22507939	22507966	8421504	3	5,6,14	0,6,13	g	350037805000000028	5-34						Gonococcal Proteins and Nucleic Acids - Patent application	www.faqs.org	0	0		
756	chr10	22507939	22507966	3500255217	25		22507939	22507966	8421504	3	5,6,14	0,6,13	g	350025521700000028	5-34						Gonococcal Proteins and Nucleic Acids	Fontana	2009	0		
756	chr10	22507939	22507966	3500178861	25		22507939	22507966	8421504	3	5,6,14	0,6,13	g	350017886100000028	5-34					Patent	Gonococcal proteins and nucleic acids (Patent US:7504111)	Fontana	2009	0		
757	chr10	22575313	22575392	3500143254	41		22575313	22575392	8421504	2	20,21	0,58	g	350014325400000023,350014325400000022	0-20,0-21						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
760	chr10	23032101	23032127	3500143229	23		23032101	23032127	8421504	2	10,13	0,13	g	350014322900000054	12-35						Regulation of the molecular control of ovarian function by gene targeting	.era.lib.ed.ac.uk	0	0		
760	chr10	23056288	23056315	3500150260	23		23056288	23056315	8421504	2	13,10	0,17	g	350015026000000002	2-32						Method for identifying validated target and assay combinations	Gene	1999	0		
761	chr10	23165582	23165638	3500353503	47		23165582	23165638	8421504	2	23,24	0,32	g	350035350300000003	20-75						The cloning and nucleotide sequence of cDNA for an amplified glutamine synthetase gene from the Chinese hamster. - ResearchGate	.researchgate.net	0	0		
763	chr10	23342059	23342089	3500414794	25		23342059	23342089	8421504	2	16,9	0,21	g	350041479400000007	6-31		18385252	10.1128/JVI.00124-08	0022-538X	Journal of Virology	Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1	Keele	2008	5		
774	chr10	24832660	24832713	3500259306	46		24832660	24832713	8421504	2	21,25	0,28	g	350025930600000018,350025930600000016	0-21,0-25		10377186	10.1084/jem.189.12.1907	0022-1007	The Journal of Experimental Medicine	An Invariant T Cell Receptor &#x03b1; Chain Defines a Novel TAP-independent Major Histocompatibility Complex Class Ib&#x2013;restricted &#x03b1;/&#x03b2; T Cell Subpopulation in Mammals	Tilloy	1999	14		
774	chr10	24832688	24832713	3500114656	25		24832688	24832713	8421504	1	25	0	g	350011465600000016	0-25						An Invariant T Cell Receptor a Chain De&#xfb01;nes a Novel TAP-independent Major Histocompatibility Complex Class Ib&#x2013;restricted a b T Cell Subpopulation in Mammals	jem.rupress.org	0	0		
775	chr10	25025689	25025721	3500153707	26		25025689	25025721	8421504	3	5,8,13	0,6,19	g	350015370700000002	9-35		20538758	10.1189/jlb.0909648	0741-5400	Journal of Leukocyte Biology	IL-15 has innate anti-tumor activity independent of NK and CD8 T cells	Davies	2010	5		
776	chr10	25065622	25068782	3500342848	366		25065622	25068782	8421504	7	73,11,59,10,57,55,101	0,1258,1329,2304,2323,2838,3059	p	350034284800015024,350034284800015026,350034284800015036	129-213,0-69,0-213						The DNA-binding domain of the Chd1 chromatin-remodelling enzyme contains SANT and SLIDE domains. - ResearchGate	.researchgate.net	0	0		CHD8,SNORD8
777	chr10	25212273	25214766	3500139220	276		25212273	25214766	8421504	3	174,61,41	0,177,2452	p	350013922000015015,350013922000015017	0-132,0-144						The embryonic lethality of homozygous lethal yellow mice (AY/A y) with the disruption of a novel RNA-binding protein	enesdev.cshlp.org	0	0		
777	chr10	25212489	25214751	3500194466	48		25212489	25214751	8421504	2	22,26	0,2236	p	350019446600015006	0-48						Proteomic Analysis of Phosphorylated Nuclear Proteins Underscores Novel Roles for Rapid Actions of Retinoic Acid in the Regulation of mRNA Splicing and Translation	digital.csic.es	0	0		HNRNPC
777	chr10	25214762	25230827	3500118087	77		25214762	25230827	8421504	4	23,21,12,21	0,25,878,16044	c,g	350011808700000006,350011808700000008,350011808700000014,350011808700000007	0-23,0-21,0-25,0-21						Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. - ResearchGate	.researchgate.net	0	0		
778	chr10	25358140	25358164	3500016524	23		25358140	25358164	8421504	2	17,6	0,18	c	350001652400000105	0-23						Modified Annexin Proteins And Methods For Their Use In Platelet Storage And Transfusion 	.freshpatents.com	0	0		
779	chr10	25541128	25541440	3500161219	312		25541128	25541440	8421504	1	312	0	p,c,g	350016121900015008,350016121900000008,350016121900000008,350016121900000004,350016121900000003,350016121900015017,350016121900000019,350016121900000019,350016121900000016,350016121900000015,350016121900015016,350016121900000018,350016121900000018,350016121900000020,350016121900000020,350016121900000014,350016121900015027,350016121900000028,350016121900000029,350016121900000030,350016121900000030	0-102,0-101,0-101,22-90,0-49,0-105,0-20,0-20,0-81,0-83,0-78,0-77,0-77,0-60,0-60,0-30,0-105,0-90,0-96,9-80,9-80						Pseudogenes in ribonuclease evolution a source of new biomacromolecular function?	tectingdesign.com	0	0		
779	chr10	25541636	25541660	3500134916	24		25541636	25541660	8421504	1	24	0	c	350013491600000040	24-48						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
780	chr10	25572495	25573384	3500205057	42		25572495	25573384	8421504	2	22,20	0,869	c	350020505700000004,350020505700000005	0-22,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
780	chr10	25572495	25573384	3500137197	42		25572495	25573384	8421504	2	22,20	0,869	c,g	350013719700000004,350013719700000005,350013719700000005	0-22,0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
780	chr10	25573549	25573785	3500369862	84		25573549	25573785	8421504	3	20,32,32	0,136,204	c	350036986200000019,350036986200000026,350036986200000010,350036986200000011	14-34,15-47,1-33,0-32						Ribonuclease zymogen design	Raines	2003	0		
780	chr10	25673071	25673125	3500392554	54		25673071	25673125	8421504	1	54	0	p	350039255400015054,350039255400015047	39-90,36-90						Biological applications of steroid binding domains	Hovens	2010	0		
780	chr10	25673071	25673125	3500162071	54		25673071	25673125	8421504	1	54	0	p	350016207100015047,350016207100015054	36-90,39-90						Biological applications of steroid binding domains	Corcoran	2011	0		
780	chr10	25673074	25673446	3500363464	372		25673074	25673446	8421504	1	372	0	p	350036346400015044,350036346400015049,350036346400015002,350036346400015045,350036346400015050,350036346400015046,350036346400015051	72-147,0-90,0-357,0-150,0-150,0-147,0-120						Anticancer fusion protein	Pieczykolan	2013	0		
780	chr10	25673074	25673446	3500181216	372		25673074	25673446	8421504	1	372	0	p	350018121600015045,350018121600015050,350018121600015003,350018121600015046,350018121600015051,350018121600015047,350018121600015052	72-147,0-90,0-357,0-150,0-150,0-147,0-120						ANTICANCER FUSION PROTEIN - ADAMED SP. Z O.O.	www.sumobrain.com	0	0		
780	chr10	25673074	25673407	3500369862	196		25673074	25673407	8421504	5	34,63,19,40,40	0,60,179,209,293	c,g	350036986200000008,350036986200000009,350036986200000014,350036986200000017,350036986200000017,350036986200000016,350036986200000020,350036986200000025,350036986200000022,350036986200000024,350036986200000029,350036986200000029,350036986200000028	0-34,0-34,15-45,15-34,15-34,9-30,8-27,14-34,9-30,9-30,15-34,15-34,9-30						Ribonuclease zymogen design	Raines	2003	0		
780	chr10	25673074	25673164	3500307736	83		25673074	25673164	8421504	2	44,39	0,51	c	350030773600000022,350030773600000024,350030773600000163,350030773600000165,350030773600000021,350030773600000162,350030773600000129,350030773600000114	0-31,0-21,0-31,0-21,0-32,0-26,0-39,0-31						 Cysteine 	www.docstoc.com	0	0		
780	chr10	25673074	25673164	3500165664	89		25673074	25673164	8421504	2	44,45	0,45	c	350016566400000165,350016566400000022,350016566400000163,350016566400000024,350016566400000162,350016566400000021,350016566400000129,350016566400000114	0-21,0-31,0-31,0-21,0-32,0-32,0-45,0-30						Cysteine-containing peptide tag for site-specific conjugation of proteins - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673134	3500169224	60		25673074	25673134	8421504	1	60	0	p	350016922400015001	0-60						ScienceDirect.com - Neuron - Uncoating of Clathrin-Coated Vesicles in Presynaptic Terminals: Roles for Hsc70 and Auxilin	sciencedirect.com	0	0		
780	chr10	25673074	25673128	3500359116	54		25673074	25673128	8421504	1	54	0	p	350035911600015004	3-57						Gentamicin inhibits HSP70-assisted protein folding by interfering with substrate recognition. - ResearchGate	.researchgate.net	0	0		
780	chr10	25673074	25673122	3500277837	48		25673074	25673122	8421504	1	48	0	p	350027783700015024,350027783700015029	0-45,0-48						Tear lipocalin in muteins binding Il-4 R alpha	A*Huo Er Bao Mu 	2013	0		
780	chr10	25673074	25673119	3500450966	45		25673074	25673119	8421504	1	45	0	p	350045096600015049	54-99						Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials	Kaplan	2011	0		
780	chr10	25673074	25673119	3500448437	45		25673074	25673119	8421504	1	45	0	p	350044843700015002	99-144						 Kh&#xf3;a lu&#x1ead;n Thi&#x1ebf;t k&#x1ebf; vector bi&#x1ec3;u hi&#x1ec7;n gen m&#xe3; h&#xf3;a legumain - T&#xe0;i li&#x1ec7;u, tai lieu 	tai-lieu.com	0	0		
780	chr10	25673074	25673119	3500447941	45		25673074	25673119	8421504	1	45	0	p	350044794100015004	0-45						AUTO-DEVELOPING AND REGULARLY-WEIGHTED PROTEIN MOLECULAR WEIGHT MARKER KIT AND METHOD FOR PREPARING THE SAME	Cheng	2012	0		
780	chr10	25673074	25673119	3500413489	45		25673074	25673119	8421504	1	45	0	p	350041348900015006	0-45						METHOD FOR ENHANCING THE CLEAVAGE ACTIVITY OF I-CREI DERIVED MEGANUCLEASES - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500409908	45		25673074	25673119	8421504	1	45	0	p	350040990800015002	0-45		19243080	10.1002/yea.1658	1097-0061	Yeast	Small epitope-linker modules for PCR-based C-terminal tagging in Saccharomyces cerevisiae - Funakoshi - 2009 - Yeast - Wiley Online Library	Funakoshi	2009	0		
780	chr10	25673074	25673119	3500395136	45		25673074	25673119	8421504	1	45	0	p	350039513600015019	0-45						Methods and Systems for Cell State Quantification - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500366704	45		25673074	25673119	8421504	1	45	0	p	350036670400015129,350036670400015109	0-45,12-57						Molekulare Grundlagen der Erdnussallergie	b.uni-bayreuth.de	0	0		
780	chr10	25673074	25673119	3500362642	45		25673074	25673119	8421504	1	45	0	p	350036264200015000	3-48		18408216	10.1074/jbc.M802246200		The Journal of Biological Chemistry	Mitotic Phosphorylation Stimulates DNA Relaxation Activity of Human Topoisomerase I	Jennifer	June	0		
780	chr10	25673074	25673119	3500356646	45		25673074	25673119	8421504	1	45	0	p	350035664600015001	0-45		19584299	10.1093/nar/gkp548		Nucleic Acids Research	Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease	Sylvestre	2009	0		
780	chr10	25673074	25673119	3500354488	45		25673074	25673119	8421504	1	45	0	p	350035448800015020	0-45						NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 162P1E6 USEFUL IN TREATMENT AND DETECTION OF CANCER	Challita-eid	2011	0		
780	chr10	25673074	25673119	3500353266	45		25673074	25673119	8421504	1	45	0	p	350035326600015000	0-45						Insulin-Like Growth Factor II (IGF-II) Binding Factors - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500346535	45		25673074	25673119	8421504	1	45	0	p	350034653500015013	0-45						Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders	Stritzker	2007	0		
780	chr10	25673074	25673119	3500345423	45		25673074	25673119	8421504	1	45	0	p	350034542300015004	0-45						BACTERIAL EXPRESSION OF AN ARTIFICIAL GENE FOR THE PRODUCTION OF CRM197 AND ITS DERIVATIVES	Baglioni	2010	0		
780	chr10	25673074	25673119	3500338721	45		25673074	25673119	8421504	1	45	0	p	350033872100015067	0-45						IMMUNODOMINANT MHC DR52B RESTRICTED NY-ESO-1 EPITOPES, MHC CLASS II MONOMERS AND MULTIMERS, AND USES THEREOF	Valmori	2010	0		
780	chr10	25673074	25673119	3500330918	45		25673074	25673119	8421504	1	45	0	p	350033091800015005	0-45					Patent	Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof (Patent EP:2167656)	GOUBLE	2011	0		
780	chr10	25673074	25673119	3500325488	45		25673074	25673119	8421504	1	45	0	p	350032548800015010	0-45						Methods And Compositions For Detection Of Microorganisms And Cells And Treatment Of Diseases And Disorders 	.freshpatents.com	0	0		
780	chr10	25673074	25673119	3500322499	45		25673074	25673119	8421504	1	45	0	p	350032249900015006	0-45						 Methods And Compositions For Detection Of Microorganisms And Cells And Treatment Of Diseases And Disorders 	www.docstoc.com	0	0		
780	chr10	25673074	25673119	3500322388	45		25673074	25673119	8421504	1	45	0	p	350032238800015019	0-45						Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides	Ault-riche	2006	0		
780	chr10	25673074	25673119	3500298688	45		25673074	25673119	8421504	1	45	0	p	350029868800015003	0-45						BACTERIAL EXPRESSION OF AN ARTIFICIAL GENE FOR THE PRODUCTION OF CRM197 AND ITS DERIVATIVES - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500295693	45		25673074	25673119	8421504	1	45	0	p	350029569300015022	0-45						Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders	Stritzker	2007	0		
780	chr10	25673074	25673119	3500294302	45		25673074	25673119	8421504	1	45	0	p	350029430200015006	0-45						Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders - US Patent 7763420 Description	ww.patentstorm.us	0	0		
780	chr10	25673074	25673119	3500287607	45		25673074	25673119	8421504	1	45	0	p	350028760700015014	0-45						Synthetic repetitive proteins, the production and use thereof	B*Li Bu Man 	2010	0		
780	chr10	25673074	25673119	3500282628	45		25673074	25673119	8421504	1	45	0	p	350028262800015015	0-45						Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer	Challita-Eid	2011	0		
780	chr10	25673074	25673119	3500266705	45		25673074	25673119	8421504	1	45	0	p	350026670500015001	0-45						RECOMBINANT PRODUCTION OF PEPTIDES - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500263399	45		25673074	25673119	8421504	1	45	0	p	350026339900015010	0-45						Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500259529	45		25673074	25673119	8421504	1	45	0	p	350025952900015059	0-45						Methods for production of receptor and ligand isoforms	Jin	2006	0		
780	chr10	25673074	25673119	3500257606	45		25673074	25673119	8421504	1	45	0	p	350025760600015007	0-45					Patent	Synthetic repetitive proteins, the production and use thereof (Patent US:8367803)	Liebmann	2013	0		
780	chr10	25673074	25673119	3500255004	45		25673074	25673119	8421504	1	45	0	p	350025500400015001	0-45						Recombinant production of peptides	Bruser	2012	0		
780	chr10	25673074	25673119	3500254037	45		25673074	25673119	8421504	1	45	0	p	350025403700015005	0-45						Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof	Gouble	2010	0		
780	chr10	25673074	25673119	3500241095	45		25673074	25673119	8421504	1	45	0	p	350024109500015004	0-45					Patent	Meganuclease variants cleaving a DNA target sequence from the mouse ROSA26 locus and uses thereof (Patent US:8426177)	Gouble	2013	0		
780	chr10	25673074	25673119	3500240308	45		25673074	25673119	8421504	1	45	0	p	350024030800015006	0-45						&#x5207;&#x5272;&#x6765;&#x81ea;&#x5c0f;&#x9f20;rosa26&#x57fa;&#x56e0;&#x5ea7;&#x4e4b;dna&#x9776;&#x5e8f;&#x5217;&#x7684;&#x5927;&#x8303;&#x56f4;&#x6838;&#x9178;&#x9176;&#x53d8;&#x4f53;&#x53ca;&#x5176;&#x7528;&#x9014;	A Ge Nei Si *Gu Bu Le 	2010	0		
780	chr10	25673074	25673119	3500214719	45		25673074	25673119	8421504	1	45	0	p	350021471900015004	0-45						Bacterial expression of an artificial gene for the production of crm197 and its derivatives	Baglioni	2010	0		
780	chr10	25673074	25673119	3500213423	45		25673074	25673119	8421504	1	45	0	p	350021342300015056	0-45						SEQUENCE ENABLED REASSEMBLY (SEER) - A NOVEL METHOD FOR VISUALIZING SPECIFIC DNA SEQUENCES - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500206203	45		25673074	25673119	8421504	1	45	0	p	350020620300015004	0-45					Patent	Meganuclease variants cleaving a DNA target sequence from the mouse ROSA26 locus and uses thereof (Patent US:8426177)	Gouble	2013	0		
780	chr10	25673074	25673119	3500201635	45		25673074	25673119	8421504	1	45	0	p	350020163500015020	0-45						Neoplasia-Specific tNOX Isoforms and Methods - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500178006	45		25673074	25673119	8421504	1	45	0	p	350017800600015009	0-45						B Master	-egpr.ups-tlse.fr	0	0		
780	chr10	25673074	25673119	3500172478	45		25673074	25673119	8421504	1	45	0	p	350017247800015003	0-45						MMB 241 Cell Cycle Checkpoint Control Protocols	www.scribd.com	0	0		
780	chr10	25673074	25673119	3500165058	45		25673074	25673119	8421504	1	45	0	p	350016505800015006	0-45						Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof	Gouble	2009	0		
780	chr10	25673074	25673119	3500135443	45		25673074	25673119	8421504	1	45	0	p	350013544300015000	0-45		17369258	10.1074/jbc.M609193200	0021-9258	Journal of Biological Chemistry	Systematic Analysis of Proteoglycan Modification Sites in Caenorhabditis elegans by Scanning Mutagenesis	Wang	2007	5		
780	chr10	25673074	25673119	3500113245	45		25673074	25673119	8421504	1	45	0	p	350011324500015009	0-45						G-Genetique Partie 2	fr.scribd.com	0	0		
780	chr10	25673074	25673119	3500110797	45		25673074	25673119	8421504	1	45	0	p	350011079700015011	0-45						ATTENUATED RNA VIRUS AND APPLICATIONS THEREOF - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500109718	45		25673074	25673119	8421504	1	45	0	p	350010971800015004	0-45						Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders - US Patent 7820184 Description	ww.patentstorm.us	0	0		
780	chr10	25673074	25673119	3500107459	45		25673074	25673119	8421504	1	45	0	p	350010745900015003	0-45						Method for enhancing the cleavage activity of i-crei derived meganucleases	GOUBLE	2010	0		
780	chr10	25673074	25673119	3500104790	45		25673074	25673119	8421504	1	45	0	p	350010479000015013,350010479000015014	54-99,54-99						FUNCTIONALIZED MOLECULES COMPRISING AN AUTOSILIFICATION MOIETY AND METHODS OF MAKING AND USING SAME - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500102459	45		25673074	25673119	8421504	1	45	0	p	350010245900015017	0-45						Synthetic repetitive proteins, the production and use thereof	Fehr	2010	0		
780	chr10	25673074	25673119	3500095518	45		25673074	25673119	8421504	1	45	0	p	350009551800015002	0-45						Method for enhancing the cleavage activity of i-crei derived meganucleases	Gouble	2010	0		
780	chr10	25673074	25673119	3500094835	45		25673074	25673119	8421504	1	45	0	p	350009483500015003	0-45						Prevention and Treatment of HCV Infection Employing Antibodies Directed Against Conformational and Linear Epitopes - Patent application	www.faqs.org	0	0		
780	chr10	25673074	25673119	3500091513	45		25673074	25673119	8421504	1	45	0	p	350009151300015007	0-45						Synthetic repetitive proteins, the production and use thereof	Liebmann	2010	0		
780	chr10	25673074	25673119	3500079685	45		25673074	25673119	8421504	1	45	0	p	350007968500015111,350007968500015119,350007968500015097,350007968500015122,350007968500015104	54-99,54-99,54-99,54-99,54-99						Rozprawa doktorska pt. Antygeny rekombinantowe Toxoplasma gondii jako narz dzie w diagnostyce toksoplazmozy	pbc.gda.pl/Conten	0	0		
780	chr10	25673074	25673119	3500068716	45		25673074	25673119	8421504	1	45	0	p	350006871600015011	0-45						Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders	Stritzker	2008	0		
780	chr10	25673074	25673119	3500062852	45		25673074	25673119	8421504	1	45	0	p	350006285200015018	0-45						Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides	Atkinson	2007	0		
780	chr10	25673074	25673119	3500046760	45		25673074	25673119	8421504	1	45	0	p	350004676000015006	0-45						Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof	GOUBLE	2010	0		
780	chr10	25673074	25673119	3500038537	45		25673074	25673119	8421504	1	45	0	p	350003853700015051	54-99						Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials	George	2006	0		
780	chr10	25673074	25673119	3500024986	45		25673074	25673119	8421504	1	45	0	p	350002498600015010	0-45						Regulated Stop Codon Readthrough	Bouquin	2005	0		
780	chr10	25673074	25673119	3500023426	45		25673074	25673119	8421504	1	45	0	p	350002342600015022	0-45						Use of collections of binding sites for sample profiling and other applications	Ault-riche	2003	0		
780	chr10	25673074	25673119	3500023023	45		25673074	25673119	8421504	1	45	0	p	350002302300015022	0-45						Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides	Ault-riche	2003	0		
780	chr10	25673074	25673119	3500021713	45		25673074	25673119	8421504	1	45	0	p	350002171300015006	0-45						Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof	Gouble	2008	0		
780	chr10	25673074	25673119	3500017368	45		25673074	25673119	8421504	1	45	0	p	350001736800015024	0-45						Human Monoclonal Antibodies to Human Nucleolin	Sutkowski	2010	0		
780	chr10	25673074	25673119	3500007800	45		25673074	25673119	8421504	1	45	0	p	350000780000015006	0-45						Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof	Gouble	2009	0		
780	chr10	25673074	25673118	3500169190	44		25673074	25673118	8421504	1	44	0	c	350016919000000022,350016919000000024,350016919000000021	0-31,0-21,0-32					Patent	Cysteine-containing peptide tag for site-specific conjugation of proteins (Patent US:7807778)	Backer	2010	0		
780	chr10	25673074	25673118	3500008291	44		25673074	25673118	8421504	1	44	0	c	350000829100000024,350000829100000022,350000829100000021	0-21,0-31,0-32						Cysteine-containing peptide tag for site-specific conjugation of proteins	Backer	2008	0		
780	chr10	25673086	25673446	3500063625	348		25673086	25673446	8421504	2	237,111	0,249	p	350006362500015059,350006362500015060	0-237,0-111						Comparaison de s&#xe9;quences deux &#xe0; deux	www.lifl.fr	0	0		
780	chr10	25673116	25673428	3500161219	312		25673116	25673428	8421504	1	312	0	p,c,g	350016121900015000,350016121900000000,350016121900000000,350016121900000001,350016121900000007,350016121900015009,350016121900000009,350016121900000009,350016121900000010,350016121900015018,350016121900000021,350016121900000021,350016121900000022,350016121900000022	0-102,0-86,0-86,0-82,74-101,0-105,0-104,0-104,12-76,0-105,0-30,0-30,6-35,6-35						Pseudogenes in ribonuclease evolution a source of new biomacromolecular function?	tectingdesign.com	0	0		
780	chr10	25673125	25673350	3500082476	225		25673125	25673350	8421504	1	225	0	p	350008247600015003,350008247600015005	0-105,0-120						Sequence Similarity & Sequence Searching	staff.aub.edu.lb	0	0		
780	chr10	25673194	25673257	3500388417	63		25673194	25673257	8421504	1	63	0	p	350038841700015001,350038841700015000,350038841700015007	0-63,0-60,0-57						Transgenic arthritic mice	Benoist	1995	0		
780	chr10	25673197	25673242	3500003827	45		25673197	25673242	8421504	1	45	0	p	350000382700015000	0-45		11238647		0022-1767	The Journal of Immunology	Two MHC Surface Amino Acid Differences Distinguish Foreign Peptide Recognition from Autoantigen Specificity	Basu	2001	6		
780	chr10	25673245	25673446	3500186750	201		25673245	25673446	8421504	1	201	0	p	350018675000015205	0-234						Brian Golding and Dick Morton	www.cs.ukzn.ac.za	0	0		
780	chr10	25673356	25673446	3500395661	90		25673356	25673446	8421504	1	90	0	p	350039566100015002,350039566100015001	0-90,0-90						Intein mediated peptide ligation	Evans	2000	0		
780	chr10	25673356	25673446	3500395389	90		25673356	25673446	8421504	1	90	0	p	350039538900015001,350039538900015002	0-90,0-90						Intein mediated peptide ligation	Evans	2003	0		
780	chr10	25673356	25673446	3500237612	90		25673356	25673446	8421504	1	90	0	p	350023761200015001,350023761200015000	0-90,0-90					Patent	Intein mediated peptide ligation (Patent EP:1117693)	Evans	2006	0		
780	chr10	25673356	25673446	3500236617	90		25673356	25673446	8421504	1	90	0	p	350023661700015001,350023661700015002	0-90,0-90						Intein mediated peptide ligation	Evans	2001	0		
780	chr10	25673356	25673446	3500235543	90		25673356	25673446	8421504	1	90	0	p	350023554300015000,350023554300015002	0-90,0-90					Patent	Intein vermittelte peptidligation Intein-mediated peptide ligation (Patent DE:69931382)	EVANS	2007	0		
780	chr10	25673356	25673446	3500160480	90		25673356	25673446	8421504	1	90	0	p	350016048000015001,350016048000015002	0-90,0-90						Intein mediated peptide ligation	Evans	2000	0		
780	chr10	25673356	25673446	3500097992	90		25673356	25673446	8421504	1	90	0	p	350009799200015002,350009799200015003	0-90,0-90						INTEIN VERMITTELTE PEPTIDLIGATION - Dokument DE69931382T2	patent-de.com	0	0		
780	chr10	25673356	25673446	3500062396	90		25673356	25673446	8421504	1	90	0	p	350006239600015000,350006239600015001	0-90,0-90					Patent	Intein vermittelte peptidligation (Patent DE:69931382)	EVANS	2007	0		
780	chr10	25673356	25673446	3500025742	90		25673356	25673446	8421504	1	90	0	p	350002574200015000	0-90						Intein mediated peptide ligation - Patent # 7001745 - PatentGenius	.patentgenius.com	0	0		
780	chr10	25673386	25673458	3500186119	72		25673386	25673458	8421504	1	72	0	p	350018611900015004	12-84						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		
780	chr10	25673386	25673458	3500095373	72		25673386	25673458	8421504	1	72	0	p	350009537300015004	12-84						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		
780	chr10	25673389	25673437	3500430581	48		25673389	25673437	8421504	1	48	0	p	350043058100015000	0-48						BIOTEC: bachelor1	tec.tu-dresden.de	0	0		
780	chr10	25673646	25673673	3500017029	23		25673646	25673673	8421504	2	11,12	0,15	c	350001702900000048	0-23						Vertebrate telomerase genes and proteins and uses thereof	Kilian	2000	0		
781	chr10	25713508	25713531	3500171116	23		25713508	25713531	8421504	1	23	0	c	350017111600000015	0-23						Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells	www.iovs.org	0	0		
97	chr10	25810300	25844209	3500177982	41		25810300	25844209	8421504	3	14,7,20	0,17,33889	g	350017798200000202,350017798200000599	15-36,25-45						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		
782	chr10	25950540	25950569	3500137240	29		25950540	25950569	8421504	1	29	0	c	350013724000000003,350013724000000002	0-29,0-29						Remote Mutations and Active Site Dynamics Correlate with Catalytic Properties of Purine Nucleoside Phosphorylase	www.blnz.com	0	0		PNP
782	chr10	25950540	25950569	3500046660	29		25950540	25950569	8421504	1	29	0	c	350004666000000002,350004666000000003	0-29,0-29						ScienceDirect.com - Biophysical Journal - Remote Mutations and Active Site Dynamics Correlate with Catalytic Properties of Purine Nucleoside Phosphorylase	sciencedirect.com	0	0		PNP
783	chr10	25972795	25972819	3500130848	23		25972795	25972819	8421504	2	13,10	0,14	c	350013084800000721	15-38						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		TMEM55B
783	chr10	25972795	25972819	3500008756	23		25972795	25972819	8421504	2	13,10	0,14	c	350000875600000721	15-38						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		TMEM55B
783	chr10	25975022	25975045	3500218688	23		25975022	25975045	8421504	1	23	0	c	350021868800000157	4-30						US Patent # 6,388,169. Maize orthologues of bacterial RecA proteins - Patents.com	www.patents.com	0	0		
783	chr10	25975520	25975544	3500067686	24		25975520	25975544	8421504	1	24	0	c	350006768600000015	0-24						AssociationbetweenPolymorphismsintheDNARepairGenes, XRCC1, APE1 ,andXPD andAcuteSideEffectsof RadiotherapyinBreastCancerPatients	.aacrjournals.org	0	0		APEX1
784	chr10	26101214	26101238	3500185629	24		26101214	26101238	8421504	1	24	0	c,g	350018562900000005,350018562900000005	2-28,2-28		19019161	10.1111/j.1365-2958.2008.06490.x	1365-2958	Molecular Microbiology	Functional analysis of the large periplasmic loop of the Escherichia coli K-12 WaaL O-antigen ligase - P&#xe9;rez - 2008 - Molecular Microbiology - Wiley Online Library	Perez	2008	0		
784	chr10	26125604	26125633	3500197351	23		26125604	26125633	8421504	3	6,4,13	0,11,16	g	350019735100000041	0-25						STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS	Birkett	2003	0		
789	chr10	26833850	26833876	3500270660	23		26833850	26833876	8421504	2	10,13	0,13	g	350027066000000011	0-23		18448538	10.1128/JVI.00554-08		Journal of Virology	Comparison of G-to-A Mutation Frequencies Induced by APOBEC3 Proteins in H9 Cells and Peripheral Blood Mononuclear Cells in the Context of Impaired Processivities of Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Variants 	Stefanie	July	0		
789	chr10	26833850	26833876	3500151397	23		26833850	26833876	8421504	2	10,13	0,13	g	350015139700000011	0-23		18448538	10.1128/JVI.00554-08	0022-538X	Journal of Virology	Comparison of G-to-A Mutation Frequencies Induced by APOBEC3 Proteins in H9 Cells and Peripheral Blood Mononuclear Cells in the Context of Impaired Processivities of Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Variants	Knoepfel	2008	5		
789	chr10	26833851	26833877	3500391560	23		26833851	26833877	8421504	2	9,14	0,12	g	350039156000000001	1-24		11991995	10.1128/JVI.76.11.5667-5677.2002	0022-538X	Journal of Virology	Formation of a Human Immunodeficiency Virus Type 1 Core of Optimal Stability Is Crucial for Viral Replication	Forshey	2002	5		
789	chr10	26833851	26833877	3500353162	23		26833851	26833877	8421504	2	9,14	0,12	g	350035316200000003	1-24		16409631	10.1186/1742-4690-3-4	1742-4690	Retrovirology	Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin	Iordanskiy	2006	6		
789	chr10	26833851	26833877	3500230007	23		26833851	26833877	8421504	2	9,14	0,12	g	350023000700000001	1-24						19S-19-Acetoxychavicol acetate isolated from Alpinia galanga inhibits human immunode&#xfb01;ciency virus type 1 replication by blocking Rev transport	r.sgmjournals.org	0	0		
789	chr10	26833851	26833877	3500036736	23		26833851	26833877	8421504	2	9,14	0,12	g	350003673600000001	1-24						The use of hiv-1 integrase in screening hiv-1 drug candidates	Kappes	1999	0		
791	chr10	27063189	27063213	3500466483	24		27063189	27063213	8421504	1	24	0	g	350046648300000006	0-31						Characterization of multiple ion channels in cultured human cardiac fibroblasts. - ResearchGate	.researchgate.net	0	0		
796	chr10	27691651	27691681	3500434101	30		27691651	27691681	8421504	1	30	0	g	350043410100000005	7-37		11074001	10.1128/MCB.20.23.9028-9040.2000	0270-7306	Molecular and Cellular Biology	Human H/ACA Small Nucleolar RNPs and Telomerase Share Evolutionarily Conserved Proteins NHP2 and NOP10	Pogacic	2000	6		
99	chr10	27775442	27798036	3500227974	243		27775442	27798036	8421504	9	51,24,27,43,8,35,4,25,26	0,16414,17954,18107,18937,21063,21487,21596,22568	p	350022797400015007,350022797400015014	0-153,0-90						Phospho-dependent modulation of potassium chloride co-transporter KCC2	eprints.ucl.ac.uk	0	0		SLC12A6
797	chr10	27797056	27798026	3500289584	23		27797056	27798026	8421504	2	7,16	0,954	c	350028958400000314	0-23					Patent	CNS chloride modulation and uses thereof (Patent CN:100581621)	J*A*M*Ku Er 	2010	0		
798	chr10	27932131	27932157	3500349145	24		27932131	27932157	8421504	2	5,19	0,7	c	350034914500000333	0-28						Novel Human Beta-2 Integrin Alpha Subunit 	.freshpatents.com	0	0		
798	chr10	27932200	27932225	3500274997	25		27932200	27932225	8421504	1	25	0	c	350027499700000004	0-25						Parathyroid Ca2+-conducting currents are modulated by muscarinic receptor agonists and antagonists	g.library.pcc.edu	0	0		
798	chr10	27932210	27932258	3500230939	48		27932210	27932258	8421504	1	48	0	p	350023093900015005	0-48						Identification Of Ligands By Selective Amplification Of Cells Transfected With Receptors 	.freshpatents.com	0	0		CHRM5
798	chr10	27932210	27932255	3500188848	45		27932210	27932255	8421504	1	45	0	p	350018884800015008	0-45						IDENTIFICATION OF LIGANDS BY SELECTIVE AMPLIFICATION OF CELLS TRANSFECTED WITH RECEPTORS - Patent application	www.faqs.org	0	0		CHRM5
798	chr10	27932453	27932513	3500378152	60		27932453	27932513	8421504	1	60	0	p	350037815200015003	0-60				0798-0469	Revista de la Facultad de Medicina	Revista de la Facultad de Medicina - Clonamiento Molecular de las Asas Intracelulares de los receptores Muscar&#xed;nicos M2 y M3 implicadas en la interacci&#xf3;n con Prote&#xed;nas G en el M&#xfa;sculo Liso Traqueal de Bovino	Bruges	2002	0		CHRM3
800	chr10	28201735	28201759	3500049193	23		28201735	28201759	8421504	2	4,19	0,5	g	350004919300000008	3-26		22701599	10.1371/journal.pone.0038054		PLoS ONE	Role of Sphingomyelinase in Infectious Diseases Caused by Bacillus cereus	Masataka	2012	0		
800	chr10	28247526	28247557	3500143098	26		28247526	28247557	8421504	2	8,18	0,13	g	350014309800000358	2-28						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS - Patent application	www.faqs.org	0	0		
801	chr10	28432585	28432612	3500445486	24		28432585	28432612	8421504	2	16,8	0,19	g	350044548600000092	0-24						Novel methods for production of di-chain botulinum toxin	Li	2004	0		
809	chr10	29421323	29421622	3500401111	43		29421323	29421622	8421504	2	22,21	0,278	c,g	350040111100000000,350040111100000001,350040111100000001	21-43,21-42,21-42		17077323	10.1182/blood-2006-06-032276	0006-4971	Blood	Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor	Stabile	2007	10		
809	chr10	29421323	29421622	3500320365	43		29421323	29421622	8421504	2	22,21	0,278	c	350032036500000000,350032036500000001	21-43,21-42						Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor--&#x300a;&#x8840;&#x6db2;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
809	chr10	29421347	29421872	3500439970	405		29421347	29421872	8421504	9	45,45,45,45,45,45,45,45,45	0,96,144,192,240,336,384,432,480	p	350043997000015105,350043997000015103,350043997000015102,350043997000015101,350043997000015100,350043997000015098,350043997000015097,350043997000015096,350043997000015095	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Compositions and Methods for Increasing Bone Mineralization - Patent application	www.faqs.org	0	0		GREM1
809	chr10	29421395	29421551	3500145630	43		29421395	29421551	8421504	2	22,21	0,135	c,g	350014563000000005,350014563000000004,350014563000000004	0-22,0-21,0-21						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
809	chr10	29421546	29421779	3500031651	136		29421546	29421779	8421504	2	47,89	0,144	c	350003165100000125,350003165100000122,350003165100000121	0-47,0-47,6-48						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2003	0		
809	chr10	29421690	29421779	3500394874	89		29421690	29421779	8421504	1	89	0	c	350039487400000122,350039487400000121	0-47,6-48						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2002	0		
809	chr10	29421746	29421776	3500280145	30		29421746	29421776	8421504	1	30	0	c	350028014500000110	0-30						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2003	0		
810	chr10	29515253	29515277	3500393283	24		29515253	29515277	8421504	1	24	0	c	350039328300000012	17-41		18239671	10.1038/cdd.2008.8	1350-9047	Cell Death & Differentiation	Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells	Li	2008	9		
811	chr10	29709704	29709761	3500422615	57		29709704	29709761	8421504	1	57	0	p	350042261500015037	0-57						TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES - FIRSTSTRING RESEARCH, INC.	www.sumobrain.com	0	0		GJD2
811	chr10	29709704	29709761	3500414025	57		29709704	29709761	8421504	1	57	0	p	350041402500015103	0-57						Compositions and methods for promoting wound healing and tissue regeneration	Ghatnekar	2011	0		GJD2
811	chr10	29709704	29709761	3500408014	57		29709704	29709761	8421504	1	57	0	p	350040801400015115,350040801400015165	0-57,0-48						Composition And Methods For Promoting Wound Healing And Tissue Regeneration 	.freshpatents.com	0	0		GJD2
811	chr10	29709704	29709761	3500374795	57		29709704	29709761	8421504	1	57	0	p	350037479500015091	0-57						COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION	Gourdie	2007	0		GJD2
811	chr10	29709704	29709761	3500332070	57		29709704	29709761	8421504	1	57	0	p	350033207000015096	0-57						 Composition And Methods For Promoting Wound Healing And Tissue Regeneration 	www.docstoc.com	0	0		GJD2
811	chr10	29709704	29709761	3500257959	57		29709704	29709761	8421504	1	57	0	p	350025795900015094	0-57						Composition and Methods for Promoting Wound Healing and tissue Regeneration	Ghatnekar	2008	0		GJD2
811	chr10	29709704	29709761	3500254081	57		29709704	29709761	8421504	1	57	0	p	350025408100015088	0-57						Compositions and methods for promoting wound healing and tissue regeneration	Gourdie	2009	0		GJD2
811	chr10	29709704	29709761	3500248458	57		29709704	29709761	8421504	1	57	0	p	350024845800015088	0-57					Patent	Compositions and methods for promoting wound healing and tissue regeneration (Patent US:7888319)	Ghatnekar	2011	0		GJD2
811	chr10	29709704	29709761	3500226091	57		29709704	29709761	8421504	1	57	0	p	350022609100015105	0-57						Compositions and methods for promoting wound healing and tissue regeneration	Gourdie	2011	0		GJD2
811	chr10	29709704	29709761	3500103084	57		29709704	29709761	8421504	1	57	0	p	350010308400015105	0-57						ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION - Patent application	www.faqs.org	0	0		GJD2
811	chr10	29709704	29709761	3500096913	57		29709704	29709761	8421504	1	57	0	p	350009691300015094	0-57					Patent	Composition and methods for promoting wound healing and tissue regeneration (Patent US:7786074)	Ghatnekar	2010	0		GJD2
811	chr10	29709704	29709761	3500079904	57		29709704	29709761	8421504	1	57	0	p	350007990400015089	0-57						COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION - Patent application	www.faqs.org	0	0		GJD2
811	chr10	29710082	29710350	3500026061	47		29710082	29710350	8421504	2	24,23	0,245	c	350002606100000005,350002606100000004	0-24,0-23						Human pancreatic pluripotential stem cell line	Tsao	2002	0		GJD2
811	chr10	29743189	29743963	3500226244	75		29743189	29743963	8421504	4	19,6,27,23	0,20,58,751	c	350022624400000051,350022624400000034	101-323,101-323						Method for creating broad-spectrum resistance to fungi in transgenic plants	Gay	2011	0		
811	chr10	29743189	29743274	3500249740	52		29743189	29743274	8421504	3	19,6,27	0,20,58	c	350024974000000022	67-150						Method for creating broad-spectrum resistance to fungi in transgenic plants	Schweizer	2011	0		
811	chr10	29743191	29743220	3500273470	28		29743191	29743220	8421504	2	8,20	0,9	c	350027347000000003	1-29			10.1046/j.1365-2249.1999.00999.x		Clinical and Experimental Immunology	An African green monkey lacking peripheral CD4 lymphocytes that retains helper T cell activity and coexists with SIVagm	Y	1999	0		ACTG1
811	chr10	29743191	29743220	3500143135	28		29743191	29743220	8421504	2	8,20	0,9	c,g	350014313500000004,350014313500000004	1-29,1-29						Primary cultured hepatocytes of the bony &#xfb01;sh, Oreochromis mossambicus, the tilapia: a valid tool for physiological studies on IGF-I expression in liver	logy-journals.org	0	0		ACTG1
811	chr10	29743191	29743218	3500211088	27		29743191	29743218	8421504	1	27	0	c	350021108800000014	3-30						Methods and Compositions Related to Inhibition of Ceramide Synthesis	Summers	2007	0		
811	chr10	29743191	29743218	3500136791	27		29743191	29743218	8421504	1	27	0	c	350013679100000001	1-28			10.1128/AEM.01325-06		Applied and Environmental Microbiology	Use of Native Lactococci as Vehicles for Delivery of DNA into Mammalian Epithelial Cells 	Valeria	2006	0		
811	chr10	29743191	29743218	3500107017	27		29743191	29743218	8421504	1	27	0	c	350010701700000001	1-28		16963550	10.1128/AEM.01325-06	0099-2240	Applied and Environmental Microbiology	Use of Native Lactococci as Vehicles for Delivery of DNA into Mammalian Epithelial Cells	Guimaraes	2006	4		
811	chr10	29743192	29743216	3500405538	24		29743192	29743216	8421504	1	24	0	c	350040553800000019	0-24						<?xml version="1.0" encoding="US-ASCII"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing	ke.sciencemag.org	0	0		
811	chr10	29743192	29743215	3500291333	23		29743192	29743215	8421504	1	23	0	c	350029133300000254	0-23						Method for amplifying nucleic acid sequence - Patent # 6951722 - PatentGenius	.patentgenius.com	0	0		
811	chr10	29743193	29747624	3500083692	1131		29743193	29747624	8421504	6	141,182,192,162,325,129	0,689,1652,1972,2847,4302	p	350008369200015000	0-1131						KEGG T01058: 100057678	www.genome.jp	0	0		ACTA2
811	chr10	29743193	29743220	3500156448	26		29743193	29743220	8421504	2	6,20	0,7	c	350015644800000003	2-28		9734473	10.1161/01.RES.83.5.508	0009-7330	Circulation Research	Lysophosphatidylcholine Enhances Cytokine-Induced Interferon Gamma Expression in Human T Lymphocytes	Nishi	1998	9		AMY2B,SPZ1
811	chr10	29743193	29743218	3500314584	24		29743193	29743218	8421504	2	6,18	0,7	c	350031458400000023	0-24		20849415	10.1111/j.1742-4658.2010.07819.x	1742-4658	FEBS Journal	MBP-1 is efficiently encoded by an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover - Lung - 2010 - FEBS Journal - Wiley Online Library	Lung	2010	0		ACTG1
811	chr10	29743230	29743257	3500235602	27		29743230	29743257	8421504	1	27	0	c	350023560200000006	8-35						Method of suppressing replication of hepatitis c virus, inhibitor of replication of the virus and method of screening for the same	Matsuura	2007	0		
811	chr10	29743233	29743292	3500409951	59		29743233	29743292	8421504	1	59	0	c	350040995100000300,350040995100000257	6-65,6-65						SOMATIC HYPERMUTATION SYSTEMS - Patent application	www.faqs.org	0	0		
811	chr10	29743233	29743292	3500068686	59		29743233	29743292	8421504	1	59	0	c	350006868600000021	6-65						Methods of generating libraries and uses thereof	Bowers	2009	0		
811	chr10	29743233	29743292	3500014331	59		29743233	29743292	8421504	1	59	0	c	350001433100000257	6-65						SOMATIC HYPERMUTATION SYSTEMS	Horlick	2010	0		
811	chr10	29743239	29743273	3500000158	34		29743239	29743273	8421504	1	34	0	c	350000015800000005,350000015800000037	0-25,0-25		17504977	10.1096/fj.06-7440com	0892-6638	The FASEB Journal	Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1&#x03b1;- and basic FGF-dependent pathway in muscle cells	Egger	2007	6		
811	chr10	29743242	29743266	3500334858	24		29743242	29743266	8421504	1	24	0	c	350033485800000004	0-24						Novel anti-aging agents and methods to identify them	Qi	2010	0		POTEG
811	chr10	29743247	29743270	3500209090	23		29743247	29743270	8421504	1	23	0	c	350020909000000010	24-47		20920359	10.1186/1743-422X-7-259	1743-422X	Virology Journal	Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein	Candia	2010	2		
811	chr10	29743248	29743272	3500177682	24		29743248	29743272	8421504	1	24	0	g	350017768200000011	0-24		20615257	10.1186/1471-2407-10-364		BMC Cancer	Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion	Deshui	2010	0		
811	chr10	29743249	29743274	3500238840	25		29743249	29743274	8421504	1	25	0	c	350023884000000008	5-31						GH overexpression causes muscle hypertrophy independent from local IGF-I in a zebra&#xfb01;sh transgenic model	orio.furg.br:8080	0	0		ACTG1
811	chr10	29743258	29743285	3500349534	27		29743258	29743285	8421504	1	27	0	g	350034953400000002	24-51			10.1046/j.1365-3083.2001.00994.x	1365-3083	Scandinavian Journal of Immunology	Morphologic and Functional Changes in Bovine Monocytes Infected In vitro with the Bovine Leukaemia Virus - Altreuther - 2002 - Scandinavian Journal of Immunology - Wiley Online Library	Altreuther	2001	0		
811	chr10	29743277	29743884	3500436500	59		29743277	29743884	8421504	2	57,2	0,605	c	350043650000000015	13-72						Molecular Structure and Evolutionary Origin of Human Cardiac Muscle Actin Gene	www.jstor.org	0	0		
811	chr10	29743974	29743998	3500149423	24		29743974	29743998	8421504	1	24	0	c	350014942300000002	0-24						71989-31-6 | Online Peptides Guide	tor-1-alpha-1.com	0	0		
811	chr10	29744886	29745214	3500011215	42		29744886	29745214	8421504	2	23,19	0,309	c,g	350001121500000034,350001121500000011	0-23,0-19						Volume 12 Number 19 May 21, 2006	www.wjgnet.com	0	0		
811	chr10	29744886	29744909	3500290833	23		29744886	29744909	8421504	1	23	0	c	350029083300000024	1-24		18353861	10.1093/nar/gkn032		Nucleic Acids Research	Transforming growth factor-&#x03b2;-regulated miR-24 promotes skeletal muscle differentiation	Qiang	2008	0		ACTC1
811	chr10	29744886	29744909	3500157469	23		29744886	29744909	8421504	1	23	0	c	350015746900000006	0-23						An efficient method of sorting liver stem cells by using immuno-magnetic microbeads	www.wjgnet.com	0	0		ACTC1
811	chr10	29744886	29744909	3500117320	23		29744886	29744909	8421504	1	23	0	c	350011732000000001	0-23		19773800	10.1038/jcbfm.2009.196	0271-678X	Journal of Cerebral Blood Flow & Metabolism	The role of bradykinin B1 and B2 receptors for secondary brain damage after traumatic brain injury in mice	Trabold	2009	5		ACTC1
811	chr10	29744889	29744914	3500383214	25		29744889	29744914	8421504	1	25	0	c	350038321400000001	0-25						Helminth Infection Protects Mice from Anaphylaxis via	www.jimmunol.org	0	0		ACTC1
811	chr10	29744889	29744914	3500355427	25		29744889	29744914	8421504	1	25	0	c,g	350035542700000003,350035542700000009,350035542700000009	0-25,0-20,0-20						TH17 cells contribute to uveitis and scleritis and are inhibited by IL-27/STAT1 in the retina (1) Detection of TH17 cells in human blood | MolMeth	www.molmeth.org	0	0		
811	chr10	29744889	29744914	3500152627	25		29744889	29744914	8421504	1	25	0	c	350015262700000001	0-25		15528374		0022-1767	The Journal of Immunology	Helminth Infection Protects Mice from Anaphylaxis via IL-10-Producing B Cells	Mangan	2004	6		ACTC1
811	chr10	29744889	29744914	3500133489	25		29744889	29744914	8421504	1	25	0	c	350013348900000003	0-25						Immunotolerance against a Foreign Antigen Transgenically Expressed in the Lens	www.iovs.org	0	0		ACTC1
811	chr10	29744889	29744914	3500081711	25		29744889	29744914	8421504	1	25	0	c	350008171100000001	0-25		21294722	10.1111/j.1365-2567.2010.03379.x		Immunology	Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10	Yun	2011	0		ACTC1
811	chr10	29744889	29744912	3500208324	23		29744889	29744912	8421504	1	23	0	c	350020832400000006	0-23			10.1111/j.1365-2958.2005.05042.x	1365-2958	Molecular Microbiology	Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi - Seshu - 2006 - Molecular Microbiology - Wiley Online Library	Seshu	2006	0		ACTC1
811	chr10	29744917	29746349	3500401047	42		29744917	29746349	8421504	2	21,21	0,1411	c	350040104700000009,350040104700000008	0-21,0-21						Cellular Mechanisms in the Induction and Regulation of Experimental Allergic Encephalomyelitis | Rana Zeine - Academia.edu	www.academia.edu	0	0		
811	chr10	29744917	29746349	3500367159	42		29744917	29746349	8421504	2	21,21	0,1411	c	350036715900000013,350036715900000014	0-21,0-21						Journal of Ethnopharmacology	.researchgate.net	0	0		
811	chr10	29744917	29746349	3500285188	42		29744917	29746349	8421504	2	21,21	0,1411	c	350028518800000003,350028518800000002	0-21,0-21						Mutation Research	005.pasteur.ac.ir	0	0		
811	chr10	29744917	29746349	3500044081	42		29744917	29746349	8421504	2	21,21	0,1411	c	350004408100000003,350004408100000002	0-21,0-21			10.1128/JVI.77.24.13257-13266.2003		Journal of Virology	A Recombinant Influenza A Virus Expressing an RNA-Binding-Defective NS1 Protein Induces High Levels of Beta Interferon and Is Attenuated in Mice	Nicola	2003	0		
811	chr10	29744917	29744941	3500347331	24		29744917	29744941	8421504	1	24	0	c	350034733100000008	0-24		23531147	10.1186/1476-511X-12-42	1476-511X	Lipids in Health and Disease	C-reactive protein/oxidised low-density lipoprotein/&#xce;&#xb2;2-glycoprotein I complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway	Zhang	2013	2		AMY2B
811	chr10	29744988	29745012	3500367416	24		29744988	29745012	8421504	1	24	0	c	350036741600000006	0-24						BASIC RESEARCH Adult islets cultured in collagen gel transdifferentiate into duct-like cells	www.wjgnet.com	0	0		
811	chr10	29744991	29745019	3500279725	28		29744991	29745019	8421504	1	28	0	c	350027972500000006	0-28		17875714	10.1158/0008-5472.CAN-07-1617	0008-5472	Cancer Research	Repression of Vascular Endothelial Growth Factor Expression by the Zinc Finger Transcription Factor ZNF24	Harper	2007	8		ACTC1
811	chr10	29744991	29745016	3500388718	25		29744991	29745016	8421504	1	25	0	c	350038871800000020	0-25			10.1038/sj.bjp.0703688	1476-5381	British Journal of Pharmacology	The human prostanoid DP receptor stimulates mucin secretion in LS174T cells - Wright - 2009 - British Journal of Pharmacology - Wiley Online Library	Wright	2000	0		
811	chr10	29744994	29745018	3500456297	24		29744994	29745018	8421504	1	24	0	c	350045629700000014	0-24			10.1093/nar/gkl624		Nucleic Acids Research	Inducible microRNA expression by an all-in-one episomal vector system	Alexey	2006	0		SYT8,ACTG1
811	chr10	29744994	29745018	3500011490	24		29744994	29745018	8421504	1	24	0	c	350001149000000000	0-24		19726508	10.1128/JVI.00569-09	0022-538X	Journal of Virology	Simian Immunodeficiency Virus SIVagm from African Green Monkeys Does Not Antagonize Endogenous Levels of African Green Monkey Tetherin/BST-2	Lim	2009	5		
811	chr10	29744996	29745020	3500438307	24		29744996	29745020	8421504	1	24	0	c	350043830700000002	0-24		18275596	10.1186/bcr1862	1465-5411	Breast Cancer Research	1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE) disrupts the estrogen-androgen balance regulating the growth of hormone-dependent breast cancer cells	AubA(c)	2008	0		
811	chr10	29744996	29745020	3500388350	24		29744996	29745020	8421504	1	24	0	c	350038835000000029	0-24						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
811	chr10	29744996	29745020	3500318615	24		29744996	29745020	8421504	1	24	0	c	350031861500000004	0-24						&#xc9;tude des effets endocriniens produits par les organochlor&#xe9;s en lien avec la carcinogen&#xe8;se mammaire	de.bibl.ulaval.ca	0	0		
811	chr10	29744996	29745020	3500147802	24		29744996	29745020	8421504	1	24	0	c	350014780200000002	0-24						Le r&#xf4;le des phosphodiest&#xe9;rases dans le follicule ovarien	theses.ulaval.ca	0	0		
811	chr10	29744996	29745020	3500027904	24		29744996	29745020	8421504	1	24	0	c	350002790400000004	0-24						 SpringerImages - primers sequences 	pringerimages.com	0	0		
811	chr10	29744996	29745019	3500219537	23		29744996	29745019	8421504	1	23	0	c	350021953700000007	0-23		18332133	10.1074/jbc.M800501200		The Journal of Biological Chemistry	Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response	Andrea	2008	0		
811	chr10	29744997	29745020	3500399536	23		29744997	29745020	8421504	1	23	0	c	350039953600000005	0-23		17848962	10.1038/sj.mt.6300300	1525-0016	Molecular Therapy	Oncolytic Adenoviruses Kill Breast Cancer Initiating CD44&plus;CD24&#x2013;/Low Cells	Eriksson	2007	7		
811	chr10	29744999	29745022	3500233835	23		29744999	29745022	8421504	1	23	0	c	350023383500000001	0-23						Steroid Receptor Coactivator-1 Splice Variants Differentially Affect Corticosteroid Receptor Signaling(&#x671f;&#x520a;&#x8bba;&#x6587;)	www.100md.com	0	0		ACTB
811	chr10	29745167	29745214	3500417171	47		29745167	29745214	8421504	1	47	0	c	350041717100000055,350041717100000054	0-47,0-33						UNIVERSIDAD COMPLUTENSE DE MADRID	www.elfoiegras.es	0	0		
811	chr10	29745190	29745216	3500230365	26		29745190	29745216	8421504	1	26	0	c	350023036500000015	0-26						Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes	ural.nimh.nih.gov	0	0		
811	chr10	29745191	29745214	3500282316	23		29745191	29745214	8421504	1	23	0	c	350028231600000003	0-23						MitochondriaAreanEssentialMediatorofNitric Oxide/CyclicGuanosine3 ,5 -Monophosphate BlockingofGlucoseDepletion&#x2013;Induced CytotoxicityinHumanHepG2Cells	.aacrjournals.org	0	0		
811	chr10	29745320	29746056	3500368844	23		29745320	29746056	8421504	2	7,16	0,720	c	350036884400000001	0-23		16707565	10.1681/ASN.2005101136	1046-6673	Journal of the American Society of Nephrology	Parathyroid Hormone 7-84 Induces Hypocalcemia and Inhibits the Parathyroid Hormone 1-84 Secretory Response to Hypocalcemia in Rats with Intact Parathyroid Glands	Huan	2006	10		
811	chr10	29745320	29746056	3500128144	23		29745320	29746056	8421504	2	7,16	0,720	c	350012814400000001	0-23		16707565	10.1681/ASN.2005101136	1046-6673	Journal of the American Society of Nephrology	Parathyroid Hormone 7-84 Induces Hypocalcemia and Inhibits the Parathyroid Hormone 1-84 Secretory Response to Hypocalcemia in Rats with Intact Parathyroid Glands	Huan	2006	10		
811	chr10	29745320	29746056	3500121792	23		29745320	29746056	8421504	2	7,16	0,720	c	350012179200000001	0-23						Parathyroid Hormone 7-84 Induces Hypocalcemia and Inhibits the Parathyroid Hormone 1-84 Secretory Response to Hypocalcemia in Rats with Intact Parathyroid Glands	n.asnjournals.org	0	0		
811	chr10	29745320	29746056	3500088122	23		29745320	29746056	8421504	2	7,16	0,720	c	350008812200000001	0-23						Parathyroid Hormone 7-84 Induces Hypocalcemia and Inhibits the Parathyroid Hormone 1-84 Secretory Response to Hypocalcemia in Rats with Intact Parathyroid Glands	n.asnjournals.org	0	0		
811	chr10	29745320	29746056	3500059775	23		29745320	29746056	8421504	2	7,16	0,720	c	350005977500000003	0-23		17989650	10.1038/sj.ki.5002646	0085-2538	Kidney International	Metabolic acidosis inhibits soft tissue calcification in uremic rats	Mendoza	2007	7		
811	chr10	29745322	29746286	3500032980	41		29745322	29746286	8421504	3	5,16,20	0,718,944	c	350003298000000014,350003298000000013	0-21,0-20		19356234	10.1186/1471-2199-10-30		BMC Molecular Biology	A novel liver specific isoform of the rat LAR transcript is expressed as a truncated isoform encoded from a 5'UTR located within intron 11	Simon	2009	0		
811	chr10	29746043	29746066	3500242176	23		29746043	29746066	8421504	1	23	0	c	350024217600000013	0-23						Prostaglandin E -EP4 signaling suppresses adipocyte differentiation in mouse embryonic &#xfb01; broblasts via an autocrine mechanism	www.jlr.org	0	0		
811	chr10	29746043	29746066	3500037384	23		29746043	29746066	8421504	1	23	0	c	350003738400000000	19-42						Vol.23 No.1 2003 Original Article	www.jsir.gr.jp	0	0		
811	chr10	29746105	29747566	3500451594	43		29746105	29747566	8421504	2	23,20	0,1441	c,g	350045159400000004,350045159400000007,350045159400000007	10-33,0-20,0-20		11568008	10.1182/blood.V98.7.2200	0006-4971	Blood	Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia	Sperr	2001	10		
811	chr10	29746129	29746154	3500387919	25		29746129	29746154	8421504	1	25	0	c	350038791900000004	0-25		22230953	10.1590/S0100-879X2012007500001	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - BC047440 antisense eukaryotic expression vectors inhibited HepG2 cell proliferation and suppressed xenograft tumorigenicity	Zheng	2012	1		ACTA1
811	chr10	29746129	29746154	3500282361	25		29746129	29746154	8421504	1	25	0	c	350028236100000004	0-25			10.1046/j.1365-2567.2004.01905.x	1365-2567	Immunology	Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis - Roy - 2004 - Immunology - Wiley Online Library	Roy	2004	0		POTEF
811	chr10	29746129	29746154	3500212883	25		29746129	29746154	8421504	1	25	0	c	350021288300000014	0-25						&#x4e3b;&#x9898;&#xff1a;transporter | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		POTEI
811	chr10	29746129	29746154	3500199325	25		29746129	29746154	8421504	1	25	0	c	350019932500000004	0-25		16804107	10.1152/ajprenal.00014.2006		American Journal of Physiology - Renal Physiology	Molecular cloning and functional characterization of novel zinc transporter rZip10 (Slc39a10) involved in zinc uptake across rat renal brush-border membrane	Kaler	2007	0		ACTC1,ACTB
811	chr10	29746129	29746154	3500141774	25		29746129	29746154	8421504	1	25	0	c	350014177400000012	0-25		22870326	10.1371/journal.pone.0042406		PLoS ONE	The Effect of Gonadotropin on Glucose Transport and Apoptosis in Rat Ovary	Cheng	2012	0		ACTC1
811	chr10	29746129	29746152	3500283215	23		29746129	29746152	8421504	1	23	0	c	350028321500000007	0-23		21917957	10.1128/JVI.05766-11		Journal of Virology	Baculovirus Infection Induces a DNA Damage Response That Is Required for Efficient Viral Replication	Ning	2011	0		POTEM
811	chr10	29746130	29746154	3500147701	24		29746130	29746154	8421504	1	24	0	c	350014770100000006	0-24						Isolation of human and mouse genes based on homology to REC2, a recombinational repair gene from the fungus Ustilago maydis	www.pnas.org	0	0		POTEF,ACTA1
811	chr10	29746199	29746241	3500195965	41		29746199	29746241	8421504	2	22,19	0,23	c	350019596500000015,350019596500000016	0-22,0-19						The Pathogenic Fungus Cryptococcus neoformans Expresses Two Functional GDP-Mannose Transporters with Distinct Expression Patterns and Roles in Capsule Synthesis	.crypto.wustl.edu	0	0		
811	chr10	29746208	29746231	3500170614	23		29746208	29746231	8421504	1	23	0	c	350017061400000004	0-23						Koz&#x0142;owska Anna, 2009, Analiza ekspresji gen&#xf3;w FYN, CD70 i PRF1 w limfocytach T CD4+ u os&#xf3;b z toczniem rumieniowatym uk&#x0142;adowym oraz w liniach kom&#xf3;rkowych limfocyt&#xf3;w T	www.wbc.poznan.pl	0	0		POTEF
811	chr10	29746209	29746236	3500409133	27		29746209	29746236	8421504	1	27	0	c	350040913300000005	0-27		18688877	10.1002/hep.22464	1527-3350	Hepatology	Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response - Sir - 2008 - Hepatology - Wiley Online Library	Sir	2008	0		ACTC1,RAPGEF6
811	chr10	29746209	29746236	3500096136	27		29746209	29746236	8421504	1	27	0	c	350009613600000006	0-27		12855567	10.1182/blood-2003-05-1585	0006-4971	Blood	Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone	Albesiano	2003	10		ZP4
811	chr10	29746209	29746233	3500287133	24		29746209	29746233	8421504	1	24	0	c	350028713300000005	0-24		10827006			American Journal of Physiology - Endocrinology and Metabolism	The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner	Masuda	2000	0		RAPGEF6,ACTG1
811	chr10	29746209	29746233	3500015567	24		29746209	29746233	8421504	1	24	0	c	350001556700000030	0-24						On Identifying Signatures of Positive Selection in Human Populations: A Dissertation	ship.umassmed.edu	0	0		
811	chr10	29746211	29746315	3500441406	47		29746211	29746315	8421504	2	23,24	0,80	c	350044140600000003,350044140600000002	0-23,0-24		15735026	10.1158/0008-5472.CAN-04-3263	0008-5472	Cancer Research	Development of Skin Tumors in Mice Transgenic for Early Genes of Human Papillomavirus Type 8	Schaper	2005	8		POTEE
811	chr10	29746211	29746234	3500441266	23		29746211	29746234	8421504	1	23	0	c	350044126600000002	0-23		14645601	10.1128/JVI.77.24.13433-13438.2003	0022-538X	Journal of Virology	Folate Receptor Alpha and Caveolae Are Not Required for Ebola Virus Glycoprotein-Mediated Viral Infection	Simmons	2003	5		
811	chr10	29746211	29746234	3500121194	23		29746211	29746234	8421504	1	23	0	c	350012119400000016	0-23						available journal homepage:http://www.elsevier.com/locate/aob	cellbiosignal.jp	0	0		ACTC1,CCDC74A
811	chr10	29746327	29746350	3500430202	23		29746327	29746350	8421504	1	23	0	c	350043020200000013	0-23		18332108	10.1128/MCB.02078-07		Molecular and Cellular Biology	Transcription Regulation of the rRNA Gene by a Multifunctional Nucleolar Protein, B23/Nucleophosmin, through Its Histone Chaperone Activity 	Kensaku	2008	0		ACTB
811	chr10	29746327	29746350	3500355279	23		29746327	29746350	8421504	1	23	0	c	350035527900000004	0-23		15837745	10.1158/1078-0432.CCR-04-1470	1078-0432	Clinical Cancer Research	Expression of CXCR4 and Its Down-Regulation by IFN-&#x03b3; in Head and Neck Squamous Cell Carcinoma	Katayama	2005	8		ACTB
811	chr10	29746327	29746350	3500259926	23		29746327	29746350	8421504	1	23	0	c	350025992600000013	0-23		18332108	10.1128/MCB.02078-07	0270-7306	Molecular and Cellular Biology	Transcription Regulation of the rRNA Gene by a Multifunctional Nucleolar Protein, B23/Nucleophosmin, through Its Histone Chaperone Activity	Murano	2008	6		ACTB
811	chr10	29746327	29746350	3500249299	23		29746327	29746350	8421504	1	23	0	c	350024929900000002	0-23						Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis	-publications.com	0	0		ACTB
811	chr10	29746335	29746358	3500304223	23		29746335	29746358	8421504	1	23	0	c	350030422300000004	0-23		21149478	10.2967/jnumed.110.079004	0161-5505	Journal of Nuclear Medicine	Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with 68Ga-DOTATOC	Zhang	2011	6		
811	chr10	29746335	29746358	3500152410	23		29746335	29746358	8421504	1	23	0	c	350015241000000004	0-23		21149478	10.2967/jnumed.110.079004	0161-5505	Journal of Nuclear Medicine	Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with 68Ga-DOTATOC	Zhang	2011	6		
812	chr10	29822992	29836503	3500447618	426		29822992	29836503	8421504	10	40,14,66,24,72,30,36,27,33,84	0,4836,4856,6760,9644,9752,9791,10830,10869,13427	p	350044761800015043,350044761800015042,350044761800015044	0-147,0-72,0-219					Patent	Antibodies to HASAV70 polypeptide (Patent US:7169565)	Ruben	2007	0		AQR
812	chr10	29822992	29836503	3500439093	777		29822992	29836503	8421504	8	40,86,171,172,77,75,72,84	0,4836,6760,8774,9639,9752,10830,13427	p	350043909300015041,350043909300015042	0-546,0-231						Secreted protein HFEAF41	Brewer	2003	0		AQR
812	chr10	29822992	29836503	3500080223	777		29822992	29836503	8421504	8	40,86,171,172,77,75,72,84	0,4836,6760,8774,9639,9752,10830,13427	p	350008022300015046,350008022300015047	0-546,0-231						87 Human Secreted Proteins	Young	2007	0		AQR
812	chr10	29822992	29836503	3500064227	777		29822992	29836503	8421504	8	40,86,171,172,77,75,72,84	0,4836,6760,8774,9639,9752,10830,13427	p	350006422700015041,350006422700015042	0-546,0-231						Secreted protein HFEAF41	Brewer	2003	0		AQR
812	chr10	29822992	29836503	3500048645	774		29822992	29836503	8421504	9	40,74,9,171,172,77,75,72,84	0,4836,4913,6760,8774,9639,9752,10830,13427	p	350004864500015042,350004864500015043	0-543,0-231						Secreted protein HFEAF41	Brewer	2002	0		AQR
812	chr10	29822992	29836503	3500032881	756		29822992	29836503	8421504	9	40,86,171,172,35,21,75,72,84	0,4836,6760,8774,9639,9677,9752,10830,13427	p	350003288100015041,350003288100015042	15-540,0-231						87 human secreted proteins	Brewer	2003	0		
812	chr10	29822992	29836503	3500029713	426		29822992	29836503	8421504	10	40,14,66,24,72,30,36,27,33,84	0,4836,4856,6760,9644,9752,9791,10830,10869,13427	p	350002971300015043,350002971300015042,350002971300015044	0-147,0-72,0-219						87 human secreted proteins	Young	2005	0		AQR
815	chr10	30265273	30265301	3500445130	23		30265273	30265301	8421504	2	12,11	0,17	g	350044513000000037	3-26						Full text of "Expression of the TPI gene of Saccharomyces cerevisiae is controlled by a single complex upstream activating sequence containing binding sites for three trans-acting factors: REB1, RAP1, and GCR1"	archive.org	0	0		
821	chr10	30948261	30948287	3500392358	24		30948261	30948287	8421504	2	9,15	0,11	g	350039235800000266	24-48						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
821	chr10	30948261	30948287	3500004392	24		30948261	30948287	8421504	2	9,15	0,11	g	350000439200000266	24-48						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
825	chr10	31534588	31534616	3500271912	27		31534588	31534616	8421504	2	11,16	0,12	g	350027191200000055	17-45						Response regulator	www.devileye.net	0	0		
827	chr10	31728130	31728157	3500058448	23		31728130	31728157	8421504	2	14,9	0,18	g	350005844800000003,350005844800000021,350005844800000005	0-21,0-24,20-44						Variable antibodies	Jacquemin	2010	0		
828	chr10	31870662	31908872	3500022325	23		31870662	31908872	8421504	3	13,2,8	0,15,38202	c	350002232500000003	20-43		20483784	10.4049/jimmunol.1000231	0022-1767	The Journal of Immunology	V&#x03b3;2V&#x03b4;2 T Cell Receptor Recognition of Prenyl Pyrophosphates Is Dependent on All CDRs	Wang	2010	6		
830	chr10	32148357	32148385	3500441995	28		32148357	32148385	8421504	1	28	0	c	350044199500000035,350044199500000034,350044199500000001	4-32,4-32,0-28		22383888	10.1371/journal.pgen.1002481	1553-7404	PLOS Genetics	PLOS Genetics: A Pathogenic Mechanism in Huntington's Disease Involves Small CAG-Repeated RNAs with Neurotoxic Activity	Banez-Coronel	2012	0		MEIS2
830	chr10	32149317	32149340	3500223437	23		32149317	32149340	8421504	1	23	0	c	350022343700000059	0-23			10.1128/MCB.01429-06		Molecular and Cellular Biology	Regulation of EphA8 Gene Expression by TALE Homeobox Transcription Factors during Development of the Mesencephalon 	Sungbo	2007	0		MEIS2
830	chr10	32149326	32149446	3500431628	120		32149326	32149446	8421504	1	120	0	p	350043162800015130,350043162800015131,350043162800015132	3-120,0-114,0-120						49 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		MEIS2
831	chr10	32369937	32371244	3500260233	48		32369937	32371244	8421504	2	36,12	0,1295	p	350026023300015000	0-48		15294870	10.1242/dev.01308	0950-1991	Development	Retinoic acid signalling specifies intermediate character in the developing telencephalon	Marklund	2004	7		MEIS2
831	chr10	32369937	32371244	3500010049	48		32369937	32371244	8421504	2	36,12	0,1295	p	350001004900015000	0-48		15294870	10.1242/dev.01308	0950-1991	Development	Retinoic acid signalling specifies intermediate character in the developing telencephalon	Marklund	2004	7		MEIS2
832	chr10	32382147	32382170	3500440946	23		32382147	32382170	8421504	1	23	0	g	350044094600000006	3-26					Patent	Heterodimer complex of RXR and NURR1 or NGFI-B (Patent US:6458926)	Evans	2002	0		
839	chr10	33350195	33350220	3500428861	23		33350195	33350220	8421504	2	15,8	0,17	g	350042886100000051	2-25						Family of high affinity, modified antibodies for cancer treatment	Mezes	1995	0		
839	chr10	33350195	33350220	3500185560	23		33350195	33350220	8421504	2	15,8	0,17	g	350018556000000051	2-25						Family of high affinity, modified antibodies for cancer treatment	Mezes	1993	0		
839	chr10	33413752	33413781	3500244026	24		33413752	33413781	8421504	2	8,16	0,13	g	350024402600000032	0-34						OLIGONUCLEOTIDE BASED ANALYTE DETECTION METHOD - LOXBRIDGE RESEARCH LLP	www.sumobrain.com	0	0		
840	chr10	33490250	33490276	3500391943	23		33490250	33490276	8421504	2	17,6	0,20	c	350039194300000077	18-41						Osteoinductive compositions	Celeste	1991	0		
841	chr10	33580989	33581017	3500445486	23		33580989	33581017	8421504	2	9,14	0,14	g	350044548600000336	2-25						Novel methods for production of di-chain botulinum toxin	Li	2004	0		
841	chr10	33606221	33606714	3500054844	94		33606221	33606714	8421504	4	28,21,23,22	0,239,287,471	c	350005484400000000,350005484400000010,350005484400000011,350005484400000001	0-28,0-21,0-23,6-28		16652141	10.1038/sj.onc.1209635	0950-9232	Oncogene	Spreds, inhibitors of the Ras&sol;ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors	Yoshida	2006	6		SPRED1
842	chr10	33757738	33762029	3500327519	40		33757738	33762029	8421504	2	20,20	0,4271	c	350032751900000003,350032751900000002	0-20,0-20						Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer	www.systembio.com	0	0		RASGRP1
844	chr10	34011605	34011631	3500312864	23		34011605	34011631	8421504	2	10,13	0,13	g	350031286400000020	0-23			10.1111/j.1365-2958.2004.04368.x	1365-2958	Molecular Microbiology	Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus - Frees - 2004 - Molecular Microbiology - Wiley Online Library	Frees	2004	0		
846	chr10	34308724	34308752	3500153276	23		34308724	34308752	8421504	2	15,8	0,20	g	350015327600000725	13-37						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
849	chr10	34681430	34681455	3500002984	23		34681430	34681455	8421504	3	12,4,7	0,13,18	g	350000298400000009	0-23						 <HTML> <HEAD> <TITLE> Binding of 14-3-3{beta} to the Carboxyl Terminus of Wee	.aacrjournals.org	0	0		
851	chr10	34866349	34866375	3500035055	23		34866349	34866375	8421504	2	6,17	0,9	g	350003505500000053	13-36						ANTIBODIES - CELLTECH LIMITED MORGAN	www.sumobrain.com	0	0		
852	chr10	35004000	35004023	3500362678	23		35004000	35004023	8421504	1	23	0	c	350036267800000005	19-42						Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth	www.molvis.org	0	0		
852	chr10	35005535	35008478	3500145630	40		35005535	35008478	8421504	2	20,20	0,2923	c,g	350014563000000030,350014563000000031,350014563000000031	0-20,0-20,0-20						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
852	chr10	35005535	35008478	3500046604	40		35005535	35008478	8421504	2	20,20	0,2923	c,g	350004660400000012,350004660400000013,350004660400000013	0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
852	chr10	35005614	35005811	3500404999	84		35005614	35005811	8421504	2	54,30	0,167	p	350040499900015030	0-84						COMBINATORIAL LIBRARIES BASED ON C-TYPE LECTIN DOMAIN - ANPHORE, INC	www.sumobrain.com	0	0		THBS1
852	chr10	35005614	35005811	3500256587	84		35005614	35005811	8421504	2	54,30	0,167	p	350025658700015040	0-84						Polypeptides that bind Trail-R1 and Trail-R2	Bowdish	2010	0		THBS1
852	chr10	35005614	35005808	3500198756	81		35005614	35005808	8421504	2	54,27	0,167	p	350019875600015046	0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Le	2010	0		THBS1
852	chr10	35005614	35005808	3500117727	81		35005614	35005808	8421504	2	54,27	0,167	p	350011772700015044	0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Holtet	2011	0		THBS1
852	chr10	35008591	35008960	3500257029	54		35008591	35008960	8421504	2	7,47	0,322	p	350025702900015015	0-54						Application # 2002/0177551. Compositions and methods for treatment of neoplastic disease - Patents.com	www.patents.com	0	0		THBS1
852	chr10	35008591	35008960	3500140682	54		35008591	35008960	8421504	2	7,47	0,322	p	350014068200015016	0-54						Compositions and methods for treatment of neoplastic disease	Terman	2000	0		THBS1
852	chr10	35008591	35008960	3500031257	54		35008591	35008960	8421504	2	7,47	0,322	p	350003125700015007	0-54						Compositions and methods for treatment of neoplastic disease	Terman	2003	0		THBS1
852	chr10	35011389	35011948	3500155690	24		35011389	35011948	8421504	2	22,2	0,557	c	350015569000000042	0-24						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		THBS1
852	chr10	35014494	35014586	3500036127	48		35014494	35014586	8421504	2	24,24	0,68	c,g	350003612700000006,350003612700000007,350003612700000007	0-24,0-24,0-24						Modulating levels of RNA-binding proteins for the treatment of breast cancer - Patent application	www.faqs.org	0	0		THBS1
852	chr10	35014570	35014919	3500003770	40		35014570	35014919	8421504	2	20,20	0,329	c,g	350000377000000000,350000377000000000,350000377000000001	0-20,0-20,0-20		20456314	10.1111/j.1398-9995.2010.02376.x	1398-9995	Allergy	Regulation of epithelial cell proliferation by bronchial fibroblasts obtained from mild asthmatic subjects - Semlali - 2010 - Allergy - Wiley Online Library	Semlali	2010	0		THBS1
852	chr10	35015527	35015697	3500326912	66		35015527	35015697	8421504	2	47,19	0,151	p	350032691200015006	0-66						Compositions and methods for tumor-targeted delivery of effector molecules	Bermudes	2005	0		THBS1
852	chr10	35015527	35015697	3500268320	66		35015527	35015697	8421504	2	47,19	0,151	p	350026832000015019	0-66						Compositions and methods for tumor-targeted delivery of effector molecules	Bermudes	2005	0		THBS1
852	chr10	35015527	35015697	3500002509	66		35015527	35015697	8421504	2	47,19	0,151	p	350000250900015009	0-66						Compositions and methods for tumor-targeted delivery of effector molecules	D*G*Bei Er Mu De Si 	2003	0		THBS1
852	chr10	35015703	35016288	3500091455	38		35015703	35016288	8421504	3	19,16,3	0,565,582	c,g	350009145500000012,350009145500000012,350009145500000013	0-19,0-19,0-19		22174022	10.1095/biolreprod.111.095067	0006-3363	Biology of Reproduction	Regulation of Angiogenesis-Related Prostaglandin F2alpha-Induced Genes in the Bovine Corpus Luteum	Zalman	2012	4		
852	chr10	35017618	35017817	3500220647	43		35017618	35017817	8421504	2	20,23	0,176	c	350022064700000000,350022064700000001	0-20,0-23			10.1113/jphysiol.2007.138735		The Journal of Physiology	Thrombospondin-1 expression and localization in the developing ovine lung	Foula	2007	0		
853	chr10	35131978	35132002	3500153276	23		35131978	35132002	8421504	2	9,14	0,10	g	350015327600000673	25-48						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
853	chr10	35180280	35180306	3500311219	23		35180280	35180306	8421504	2	7,16	0,10	c	350031121900000225	5-28						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
106	chr10	35249562	35371724	3500300648	541		35249562	35371724	8421504	12	106,78,33,21,27,47,38,34,14,47,48,48	0,107,395,434,743,780,866,1067,5850,5865,6035,122114	c	350030064800000272,350030064800000306,350030064800000238,350030064800000237,350030064800000236,350030064800000269,350030064800000230,350030064800000263,350030064800000257,350030064800000222,350030064800000254,350030064800000216,350030064800000215,350030064800000279,350030064800000210	4-47,9-41,0-48,1-48,0-48,6-47,15-48,27-48,0-27,0-47,10-48,0-48,0-47,0-48,0-48						Methods and targets for identifying compounds for regulating angiogenesis - Patent application	www.faqs.org	0	0		
854	chr10	35373790	35373814	3500106372	23		35373790	35373814	8421504	2	14,9	0,15	g	350010637200000063	0-23						HYDROCARBON-PRODUCING GENES AND METHODS OF THEIR USE - Patent application	www.faqs.org	0	0		
856	chr10	35600652	35602321	3500226956	50		35600652	35602321	8421504	2	25,25	0,1644	c	350022695600000002,350022695600000003	0-25,0-25		14576821	10.1038/sj.onc.1206880	0950-9232	Oncogene	Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1	Gupta	2003	6		
857	chr10	35688659	35697265	3500272696	522		35688659	35697265	8421504	10	48,36,40,44,45,27,141,24,48,69	0,1028,1163,1208,7224,7299,7539,7787,8358,8537	p,c	350027269600000041,350027269600000044,350027269600000047,350027269600000048,350027269600000058,350027269600000016,350027269600000021,350027269600000065,350027269600000066,350027269600015034,350027269600015093,350027269600015055,350027269600000072,350027269600000012,350027269600015042,350027269600015024,350027269600015062,350027269600015138	0-48,12-48,3-43,0-44,3-48,0-27,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						US Patent # 6,861,239. Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof - Patents.com	www.patents.com	0	0		
857	chr10	35699426	35699602	3500441703	76		35699426	35699602	8421504	2	48,28	0,148	p,c	350044170300015012,350044170300000080	0-48,0-28						STE20-RELATED PROTEIN KINASES	Plowman	1999	0		
857	chr10	35699426	35699597	3500028732	71		35699426	35699597	8421504	2	48,23	0,148	p,c	350002873200015012,350002873200000087	0-48,0-23					Patent	Polypeptide fragments of human PAK5 protein kinase (Patent US:6656716)	Plowman	2003	0		PAK6
857	chr10	35714097	35714122	3500144838	24		35714097	35714122	8421504	2	18,6	0,19	c	350014483800000062	12-37						Method of Providing Disease-Specific Binding Molecules and Targets - Patent application	www.faqs.org	0	0		
857	chr10	35736004	35736031	3500440739	24		35736004	35736031	8421504	2	13,11	0,16	g	350044073900000200	10-38						5' to 3' exonuclease mutations of thermostable DNA polymerases	Abramson	1993	0		
857	chr10	35762770	35762796	3500424344	23		35762770	35762796	8421504	2	8,15	0,11	g	350042434400000033	1-24						38307288 Molecular Diagnosis of Genetic Diseases	www.scribd.com	0	0		
858	chr10	35785819	35790818	3500198677	675		35785819	35790818	8421504	18	28,16,32,52,47,39,47,43,24,47,29,23,43,48,21,47,48,41	0,870,1255,2025,2079,2135,2504,2658,2792,2942,3086,3272,3465,4088,4265,4382,4724,4958	c,g	350019867700000104,350019867700000110,350019867700000117,350019867700000022,350019867700000023,350019867700000118,350019867700000024,350019867700000127,350019867700000035,350019867700000133,350019867700000041,350019867700000044,350019867700000143,350019867700000147,350019867700000160,350019867700000068,350019867700000071,350019867700000078,350019867700000178	0-28,0-48,1-47,1-47,1-48,7-48,9-48,0-47,4-47,0-24,0-47,0-29,0-23,1-44,0-48,27-48,0-47,0-48,0-41						NOVEL CANCER-ASSOCIATED GENES - Patent application	www.faqs.org	0	0		
858	chr10	35838532	35838557	3500308897	24		35838532	35838557	8421504	2	6,18	0,7	c	350030889700000706	11-36						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
858	chr10	35863035	35863062	3500429822	24		35863035	35863062	8421504	2	11,13	0,14	g	350042982200000001	8-32						Protease Variants Active Over A Broad Temperature Range	Augustinus	2010	0		
858	chr10	35879818	35879853	3500379744	35		35879818	35879853	8421504	1	35	0	c	350037974400000026	0-35						Methods and compositions for inhibiting neoplastic cell growth	Baker	2008	0		
858	chr10	35879818	35879853	3500326424	35		35879818	35879853	8421504	1	35	0	c	350032642400000007	0-35					Patent	Methods and compositions for inhibiting neoplastic cell growth (Patent EP:1185648)	Baker	2007	0		
858	chr10	35879818	35879853	3500271772	34		35879818	35879853	8421504	2	7,27	0,8	g	350027177200000026	0-34						Methods and compositions for inhibiting neoplastic cell growth	Baker	2007	0		
858	chr10	35879818	35879853	3500243679	35		35879818	35879853	8421504	1	35	0	c	350024367900000026	0-35						Methods and compositions for inhibiting neoplastic cell growth	Baker	2007	0		
858	chr10	35879818	35879853	3500176649	35		35879818	35879853	8421504	1	35	0	c	350017664900000028	0-35						Methods and compositions for inhibiting neoplastic cell growth	Baker	2000	0		
858	chr10	35881601	35881627	3500200683	25		35881601	35881627	8421504	2	14,11	0,15	c	350020068300000087	0-25						Impact Journals presents	impactaging.com	0	0		
860	chr10	36060842	36060867	3500003884	25		36060842	36060867	8421504	1	25	0	c	350000388400000007	12-37		21858113	10.1371/journal.pone.0023427		PLoS ONE	Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51	Qiao	2011	0		
860	chr10	36071398	36091790	3500009038	350		36071398	36091790	8421504	8	22,38,92,28,38,114,12,6	0,23,1242,10988,11045,18796,19257,20386	c	350000903800000012,350000903800000014	0-180,0-170						Tissues or organs for use in xenotransplantation	Aspland	2002	0		
860	chr10	36082401	36091048	3500373623	140		36082401	36091048	8421504	4	20,60,9,51	0,8276,8375,8596	p,c	350037362300000063,350037362300015013,350037362300015077,350037362300015032,350037362300015054	15-35,0-60,0-48,0-60,0-48						US Patent # 6,905,857. RAD51 polypeptides - Patents.com	www.patents.com	0	0		
860	chr10	36091649	36091698	3500052878	49		36091649	36091698	8421504	1	49	0	c	350005287800000000	0-51		15897881	10.1038/sj.onc.1208723	0950-9232	Oncogene	DNA damage induce &#x03b3;-tubulin&#x2013;RAD51 nuclear complexes in mammalian cells	Lesca	2005	6		RAD51
860	chr10	36126259	36126288	3500064240	24		36126259	36126288	8421504	2	11,13	0,16	c	350006424000000166	9-33						Ubiquitin ligases, and uses related thereto	Beach	1997	0		
861	chr10	36240894	36240920	3500112083	23		36240894	36240920	8421504	2	13,10	0,16	c,g	350011208300000271,350011208300000271	22-45,22-45						 Mycobacterial Sulfation Pathway Proteins And Methods Of Use Thereof 	www.docstoc.com	0	0		
861	chr10	36268024	36268061	3500411288	37		36268024	36268061	8421504	1	37	0	g	350041128800000000,350041128800000001	0-37,76-113						ETS Factors Regulate Vegf-Dependent Arterial Specification. - ResearchGate	.researchgate.net	0	0		
861	chr10	36268721	36271394	3500266913	40		36268721	36271394	8421504	3	20,8,12	0,2470,2661	c,g	350026691300000006,350026691300000006,350026691300000007	0-20,0-20,0-20						Jagged1 contributes to the drug resistance of Jurkat cells in contact with human umbilical cord&#x2011;derived mesenchymal stem cells	-publications.com	0	0		DLL4
107	chr10	36271398	36307944	3500225737	43		36271398	36307944	8421504	3	21,16,6	0,36522,36540	c	350022573700000010,350022573700000023	16-37,13-35					Patent	Methods and compositions for multiple gene transfer into bone cells (Patent US:5942496)	Bonadio	1999	0		
861	chr10	36274031	36274590	3500316676	25		36274031	36274590	8421504	2	17,8	0,551	c	350031667600000001	6-31		23901223	10.3748/wjg.v19.i28.4486		World Journal of Gastroenterology : WJG	Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells	Guo-Gang	July	0		DLL4
861	chr10	36288017	36288970	3500292152	40		36288017	36288970	8421504	3	20,13,7	0,492,946	c,g	350029215200000004,350029215200000004,350029215200000005	0-20,0-20,0-20						Use Of Mgc4504 	.freshpatents.com	0	0		CHAC1
861	chr10	36288968	36288992	3500137275	24		36288968	36288992	8421504	1	24	0	c	350013727500000011	1-25		23805861	10.1186/1471-2164-14-429	1471-2164	BMC Genomics	The duration of gastrin treatment affects global gene expression and molecular responses involved in ER stress and anti-apoptosis	Selvik	2013	4		
863	chr10	36457801	36457828	3500155828	23		36457801	36457828	8421504	2	9,14	0,13	g	350015582800000008	3-26						US Patent # 5,714,385. Media for culturing schwann cells - Patents.com	www.patents.com	0	0		
865	chr10	36701470	36701494	3500389953	24		36701470	36701494	8421504	1	24	0	c	350038995300000003	0-24		11350808			American Journal of Physiology - Lung Cellular and Molecular Physiology	Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells	Healy	2001	0		TYRO3
865	chr10	36701470	36701494	3500333403	24		36701470	36701494	8421504	1	24	0	c	350033340300000005	0-24		12364394	10.1161/01.RES.0000036753.50601.E9	0009-7330	Circulation Research	Acidification Prevents Endothelial Cell Apoptosis by Axl Activation	D'Arcangelo	2002	9		TYRO3
865	chr10	36701470	36701494	3500022729	24		36701470	36701494	8421504	1	24	0	c	350002272900000003	0-24		11350808			American Journal of Physiology - Lung Cellular and Molecular Physiology	Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells	Healy	2001	0		
865	chr10	36715204	36715229	3500277759	25		36715204	36715229	8421504	1	25	0	c	350027775900000012	8-33						Axl antibodies	Hettmann	2010	0		TYRO3
865	chr10	36715204	36715229	3500270263	25		36715204	36715229	8421504	1	25	0	c	350027026300000012,350027026300000074	8-33,8-33						AXL ANTIBODIES - Patent application	www.faqs.org	0	0		TYRO3
865	chr10	36755359	36755385	3500345689	23		36755359	36755385	8421504	3	12,6,5	0,13,21	g	350034568900000097	4-28						Procaryotic xylose isomerase muteins	Drummond	1987	0		
866	chr10	36870937	36875141	3500288953	522		36870937	36875141	8421504	3	1,518,3	0,1320,4201	p	350028895300015006	21-543						101 human secreted proteins	Carter	1999	0		MGA
866	chr10	36870937	36875141	3500277995	522		36870937	36875141	8421504	3	1,518,3	0,1320,4201	p	350027799500015006	21-543						101 human secreted proteins	Carter	2000	0		MGA
866	chr10	36954190	36954220	3500125541	24		36954190	36954220	8421504	3	12,6,6	0,16,24	g	350012554100000011	0-25						TGR3-Like Protein Receptor - Patent application	www.faqs.org	0	0		
868	chr10	37122998	37123024	3500193093	25		37122998	37123024	8421504	2	13,12	0,14	g	350019309300000098,350019309300000000	9-34,0-23						 Recombinant Vesiculoviruses And Their Uses 	www.docstoc.com	0	0		
868	chr10	37123000	37123024	3500399634	23		37123000	37123024	8421504	2	11,12	0,12	g	350039963400000000	0-23						Recombinant vesiculoviruses and their uses	Rose	1998	0		
868	chr10	37123000	37123024	3500391882	23		37123000	37123024	8421504	2	11,12	0,12	g	350039188200000000	0-23					Patent	Methods for making modified recombinant vesiculoviruses (Patent US:6168943)	Rose	2001	0		
868	chr10	37123000	37123024	3500332745	23		37123000	37123024	8421504	2	11,12	0,12	g	350033274500000000	0-23					Patent	Recombinant vesiculoviruses and their uses (Patent EP:0871482)	Rose	2008	0		
868	chr10	37123000	37123024	3500278645	23		37123000	37123024	8421504	2	11,12	0,12	g	350027864500000000	0-23						Recombinant vesiculoviruses and their uses		1997	0		
868	chr10	37123000	37123024	3500123973	23		37123000	37123024	8421504	2	11,12	0,12	g	350012397300000000	0-23					Patent	Recombinant vesiculoviruses and their uses (Patent US:7153510)	Rose	2006	0		
868	chr10	37123000	37123024	3500033789	23		37123000	37123024	8421504	2	11,12	0,12	g	350003378900000000	0-23						US Patent # 6,168,943. Methods for making modified recombinant vesiculoviruses - Patents.com	www.patents.com	0	0		
108	chr10	37450241	37507362	3500009791	3057		37450241	37507362	8421504	24	513,70,119,134,169,147,84,86,78,161,170,12,209,37,18,114,78,58,65,69,79,117,59,411	0,30862,32636,34204,35047,36007,38097,39114,41366,44273,45803,46313,46982,47948,49937,53217,54294,54740,54893,55443,55601,55888,56318,56710	g	350000979100000032	6-3064						Dna Marker For Meat Tenderness In Cattle 	.freshpatents.com	0	0		
108	chr10	37450445	37507288	3500009791	2170		37450445	37507288	8421504	4	309,1165,673,23	0,45725,56142,56820	c,g	350000979100000017,350000979100000017,350000979100000018,350000979100000027,350000979100000010,350000979100000019,350000979100000012,350000979100000015,350000979100000016,350000979100000011	1-311,1-311,23-1189,0-21,0-23,14-680,12-677,0-22,0-23,0-23						Dna Marker For Meat Tenderness In Cattle 	.freshpatents.com	0	0		
871	chr10	37498199	37503473	3500156963	57		37498199	37503473	8421504	3	27,15,15	0,1982,5259	p	350015696300015002	0-57						0946.Calpain Methods and Protocols	www.scribd.com	0	0		
871	chr10	37498199	37503473	3500013656	57		37498199	37503473	8421504	3	27,15,15	0,1982,5259	p	350001365600015001	0-57						144-Calpain Methods and Protocols	www.scribd.com	0	0		
871	chr10	37546174	37548405	3500353647	23		37546174	37548405	8421504	3	13,4,6	0,2218,2225	c	350035364700000006	4-27						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		
871	chr10	37546174	37548405	3500351139	23		37546174	37548405	8421504	3	13,4,6	0,2218,2225	c	350035113900000006,350035113900000123	4-27,4-27						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
872	chr10	37706642	37706665	3500197418	23		37706642	37706665	8421504	1	23	0	g	350019741800000080	9-32					Patent	Reagents and methods useful for controlling the translation of hepatitis GBV proteins (Patent US:5955318)	Desai	1999	0		
873	chr10	37821263	37821294	3500242595	24		37821263	37821294	8421504	3	11,8,5	0,16,26	c	350024259500000016	15-39						Method for identifying alzheimer's disease therapeutics using transgenic animal models	Mcconlogue	1996	0		
873	chr10	37821263	37821294	3500072819	24		37821263	37821294	8421504	3	11,8,5	0,16,26	c	350007281900000016	15-39						Method for identifying alzheimer's disease therapeutics using transgenic animal models	Mcconlogue	1998	0		
873	chr10	37869269	37869372	3500271950	48		37869269	37869372	8421504	2	24,24	0,79	c	350027195000000040,350027195000000039	0-24,0-24						Novel human protein kinases and protein kinase-like enzymes	Clary	2001	0		TTBK2
109	chr10	37963583	38091175	3500074260	346		37963583	38091175	8421504	11	1,32,33,47,34,14,41,41,7,48,48	0,2468,3922,66401,76253,77358,80266,86782,89306,105768,127544	c	350007426000000120,350007426000000116,350007426000000073,350007426000000062,350007426000000059,350007426000000050,350007426000000035,350007426000000019	12-45,12-45,0-47,0-48,0-41,0-48,0-48,0-48						 Human E3.alpha. Ubiquitin Ligase Family 	www.docstoc.com	0	0		
109	chr10	37966095	38052896	3500096506	125		37966095	38052896	8421504	4	44,33,41,7	0,1410,84270,86794	c	350009650600000119,350009650600000116,350009650600000050	1-45,12-45,0-48						HUMAN E3ALPHA UBIQUITIN LIGASE FAMILY - Patent application	www.faqs.org	0	0		
109	chr10	37967505	38052896	3500043928	81		37967505	38052896	8421504	3	33,41,7	0,82860,85384	c	350004392800000116,350004392800000050	12-45,0-48						HUMAN E3ALPHA UBIQUITIN LIGASE FAMILY - Patent application	www.faqs.org	0	0		
109	chr10	37967505	38029082	3500123068	77		37967505	38029082	8421504	2	33,44	0,61533	c	350012306800000116,350012306800000075	12-45,0-44						Human E3&#x03b1; ubiquitin ligase family	Han	2000	0		
879	chr10	38587087	38587114	3500423257	24		38587087	38587114	8421504	3	6,13,5	0,7,22	g	350042325700000584	8-37						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
882	chr10	38947770	38947797	3500144006	25		38947770	38947797	8421504	2	5,20	0,7	g	350014400600000449,350014400600000452	0-25,0-25						MULTIDOMAIN BIOTAGS FOR CANCER DETECTION, DIAGNOSIS AND THERAPY AND METHODS OF THEIR USE - Patent application	www.faqs.org	0	0		
882	chr10	38947770	38947797	3500046289	25		38947770	38947797	8421504	2	5,20	0,7	g	350004628900000449,350004628900000452	0-25,0-25						METHODS FOR IN VIVO CANCER DETECTION, DIAGNOSIS AND THERAPY USING MULTIDOMAIN BIOTAGS - Patent application	www.faqs.org	0	0		
882	chr10	38947770	38947797	3500006313	25		38947770	38947797	8421504	2	5,20	0,7	g	350000631300000434,350000631300000431	0-25,0-25						METHODS FOR SELECTIVE ERADICATION OF METASTASIZING CANCER CELLS EX VIVO USING MULTIDOMAIN BIOTAGS - Patent application	www.faqs.org	0	0		
886	chr10	39484199	39484226	3500139764	27		39484199	39484226	8421504	1	27	0	c	350013976400000004	0-27					The Journal of Cell Biology	Regulation and Localization of the Bloom Syndrome Protein in Response to DNA Damage	Oliver	2001	0		LINC00871
887	chr10	39687088	39687117	3500318788	24		39687088	39687117	8421504	2	11,13	0,16	g	350031878800000116	23-47						Nematode Control 	.freshpatents.com	0	0		
889	chr10	39971210	39971242	3500024422	23		39971210	39971242	8421504	3	6,11,6	0,10,26	g	350002442200000003,350002442200000004	4-27,4-27						IN VIVO PHOSPHORYLATION OF BACTERIAL&#x2013;TYPE PHOSPHOENOLPYRUVATE CARBOXYLASE FROM DEVELOPING CASTOR OIL SEEDS AT THREONINE-4 AND SERINE-451	ibrary.queensu.ca	0	0		
890	chr10	39977169	39977196	3500253796	23		39977169	39977196	8421504	3	12,6,5	0,15,22	g	350025379600000477	1-26					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
890	chr10	39977169	39977196	3500241875	23		39977169	39977196	8421504	3	12,6,5	0,15,22	g	350024187500000477	1-26					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
890	chr10	39977169	39977196	3500070088	23		39977169	39977196	8421504	3	12,6,5	0,15,22	g	350007008800000477	1-26						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
890	chr10	39977169	39977196	3500068199	23		39977169	39977196	8421504	3	12,6,5	0,15,22	g	350006819900000477	1-26						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
893	chr10	40441804	40441832	3500126523	25		40441804	40441832	8421504	3	5,15,5	0,6,23	g	350012652300000153	3-28						PLANTS WITH INCREASED HYALURONAN PRODUCTION - Patent application	www.faqs.org	0	0		
900	chr10	41305194	41305222	3500155608	24		41305194	41305222	8421504	2	16,8	0,20	g	350015560800000070	22-46						Borrelia burdorferi Osp A and B proteins and immunogenic peptides	Barbour	1995	0		
904	chr10	41872525	41872550	3500189712	24		41872525	41872550	8421504	2	8,16	0,9	g	350018971200000001	12-36		14671118	10.1128/JVI.78.1.367-377.2004	0022-538X	Journal of Virology	EBNA3C Coactivation with EBNA2 Requires a SUMO Homology Domain	Rosendorff	2004	5		
907	chr10	42250819	42264880	3500424316	41		42250819	42264880	8421504	4	12,7,16,6	0,14,14038,14055	g	350042431600000168,350042431600000067	19-38,3-25						Vaccine and antitoxin for treatment and prevention of c. difficile disease	Firca	1997	0		
908	chr10	42412064	42413787	3500020619	45		42412064	42413787	8421504	3	6,19,20	0,1329,1703	c	350002061900000014,350002061900000013	0-25,0-20			10.1074/jbc.M112.383430		The Journal of Biological Chemistry	Identification of UV-protective Activators of Nuclear Factor Erythroid-derived 2-Related Factor 2 (Nrf2) by Combining a Chemical Library Screen with Computer-based Virtual Screening	Franziska	2012	0		
908	chr10	42413485	42413793	3500188989	44		42413485	42413793	8421504	3	8,12,24	0,243,284	c	350018898900000007,350018898900000006	0-20,0-24		16277686	10.1186/ar1830	1478-6354	Arthritis Research & Therapy	Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)&#xce;&#xb3; agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1&#xce;&#xb2;-stimulated rat chondrocytes: evidence for PPAR&#xce;&#xb3;-independent inhibition by 15-de	Bianchi	2005	4		
908	chr10	42413485	42413793	3500118026	46		42413485	42413793	8421504	3	8,12,26	0,243,282	c	350011802600000001,350011802600000000	0-20,0-26						SCD T 2010 0057 FRANCIN2	.scd.uhp-nancy.fr	0	0		
908	chr10	42413485	42413793	3500021956	44		42413485	42413793	8421504	3	8,12,24	0,243,284	c	350002195600000007,350002195600000006	0-20,0-24						Arnaud Bianchi*, David Moulin*, Sylvie Sebillaud, Meriem Koufany, Marie-Madeleine Galteau, Patrick Netter, Bernard Terlain and Jean-Yves Jouzeau	biomedcentral.com	0	0		
908	chr10	42413767	42413793	3500324079	26		42413767	42413793	8421504	1	26	0	c	350032407900000000	0-26						1-Page de Garde	.scd.uhp-nancy.fr	0	0		RPS29
908	chr10	42450220	42450249	3500357772	27		42450220	42450249	8421504	2	5,22	0,7	c	350035777200000059	0-27						Functional Polymorphisms: Bovine Calpastatin Gene and Meat Tenderness	.nottingham.ac.uk	0	0		
913	chr10	43047565	43051608	3500261496	89		43047565	43051608	8421504	4	26,5,31,27	0,85,1058,4016	c,g	350026149600000002,350026149600000003,350026149600000000,350026149600000001,350026149600000001	27-58,0-31,7-38,0-27,0-27						The proximal N-terminal amino acid residues are required for the coupling activity of the bovine heart mitochondrial factor B. - ResearchGate	.researchgate.net	0	0		
915	chr10	43334843	43342322	3500325589	96		43334843	43342322	8421504	4	48,6,15,27	0,1553,5629,7452	c	350032558900000080,350032558900000090	0-48,0-48						ATLASTIN - Patent application	www.faqs.org	0	0		
915	chr10	43376738	43376994	3500060769	54		43376738	43376994	8421504	2	33,21	0,235	p	350006076900015014	159-213						Computational Comparison of Complete Genomes	www.ebi.ac.uk	0	0		
917	chr10	43589695	43619391	3500311503	900		43589695	43619391	8421504	8	45,83,112,132,104,79,102,243	0,4602,5205,9948,18463,20582,23616,29453	p	350031150300015016	0-900						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose	erummetabolome.ca	0	0		
917	chr10	43610278	43610302	3500130848	24		43610278	43610302	8421504	1	24	0	c	350013084800000734	9-33						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
917	chr10	43610278	43610302	3500008756	24		43610278	43610302	8421504	1	24	0	c	350000875600000734	9-33						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
917	chr10	43610347	43619217	3500199211	180		43610347	43619217	8421504	3	9,102,69	0,2964,8801	p	350019921100015006	0-180						Etude des voies metaboliques des sucres chez l'huitre creuse crassostrea gigas. Implication dans les mortalites estivales.	chimer.ifremer.fr	0	0		
919	chr10	43809708	43811879	3500020470	156		43809708	43811879	8421504	3	32,46,78	0,1945,2093	p	350002047000015009	624-780						peer-00479227, version 1 - 30 Apr 2010 Accepted Manuscript	peer.ccsd.cnrs.fr	0	0		
919	chr10	43814962	43814990	3500175236	25		43814962	43814990	8421504	2	18,7	0,21	c	350017523600000000	10-35		21525343	10.1128/JVI.00379-11	0022-538X	Journal of Virology	Sulfolobus Turreted Icosahedral Virus c92 Protein Responsible for the Formation of Pyramid-Like Cellular Lysis Structures	Snyder	2011	5		
919	chr10	43831250	43839443	3500153276	40		43831250	43839443	8421504	4	13,6,4,17	0,15,8171,8176	g	350015327600000379,350015327600000094	5-24,24-45						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
921	chr10	44066060	44066086	3500276568	24		44066060	44066086	8421504	2	10,14	0,12	g	350027656800000016	1-42						Cellulose binding domain proteins - US Patent 5837814 Description	ww.patentstorm.us	0	0		
923	chr10	44344418	44344448	3500318648	27		44344418	44344448	8421504	2	10,17	0,13	g	350031864800000070	4-31						US Patent # 6,060,594. Nucleic acid segments encoding modified bacillus thuringiensis coleopteran-toxic crystal proteins - Patents.com	www.patents.com	0	0		
924	chr10	44552887	44552910	3500055721	23		44552887	44552910	8421504	1	23	0	c	350005572100000037	22-46						US Patent # 5,770,368. Cryptosporidium detection method - Patents.com	www.patents.com	0	0		
924	chr10	44552887	44552910	3500025064	23		44552887	44552910	8421504	1	23	0	c	350002506400000037	22-46						Cryptosporidium detection method	Leon	1996	0		
115	chr10	44675928	44806862	3500434299	425		44675928	44806862	8421504	4	18,41,114,252	0,18514,109490,130682	p,c	350043429900000044,350043429900000046,350043429900015019,350043429900015022,350043429900015025	31-456,0-216,0-48,0-48,0-48						Zebrafish Heterotrimer G-protein Gamma 2 Subunit (gng2) 	.freshpatents.com	0	0		
926	chr10	44785445	44806739	3500033112	216		44785445	44806739	8421504	2	87,129	0,21165	p,c	350003311200000036,350003311200015025,350003311200000035,350003311200015024	0-214,0-213,33-246,33-243						Fluorescent Assay Technologies for G-protein Interactions	y.adelaide.edu.au	0	0		
926	chr10	44785445	44806736	3500347034	213		44785445	44806736	8421504	2	87,126	0,21165	p	350034703400015032,350034703400015029,350034703400015031	0-213,0-138,0-129						Binding domains directed against gpcr:g protein complexes and uses derived thereof	Steyaert	2012	0		GNG2
926	chr10	44806664	44806736	3500383952	72		44806664	44806736	8421504	1	72	0	p	350038395200015053,350038395200015018,350038395200015025	0-72,0-63,6-54						Yeast cells expressing modified g proteins and methods of use therefor	Benegal	2000	0		
926	chr10	44806664	44806736	3500049768	72		44806664	44806736	8421504	1	72	0	p	350004976800015013,350004976800015034,350004976800015017	0-72,0-45,6-54						YEAST CELLS EXPRESSING MODIFIED G PROTEINS AND METHODS OF USE THEREFOR - Patent application	www.faqs.org	0	0		
927	chr10	44864637	44866529	3500279766	45		44864637	44866529	8421504	3	25,11,9	0,27,1883	c,g	350027976600000001,350027976600000001,350027976600000000	0-25,0-25,0-20						Identi&#xfb01;cation of Differentially Expressed Genes in Individual Bovine Preimplantation Embryos Produced by Nuclear Transfer: Improper Reprogramming of Genes Required for Development	ww.biolreprod.org	0	0		
927	chr10	44867401	44867476	3500017175	75		44867401	44867476	8421504	1	75	0	p	350001717500015046	0-75						IZRA&#x017d;ANJE IN BIOKEMIJSKA KARAKTERIZACIJA TIROGLOBULINSKIH DOMEN TIPA 1 TESTIKANA IN NIDOGENOV	bio.ijs.si/~brigi	0	0		
927	chr10	44912461	44912505	3500066194	43		44912461	44912505	8421504	2	9,34	0,10	g	350006619400000039	11-55						The application of a PCR based species identification method to African wildlife	upetd.up.ac.za	0	0		
927	chr10	44913119	44913161	3500303644	42		44913119	44913161	8421504	1	42	0	g	350030364400000006	13-55						ENTRE CHIEN ET LOUP : DE LA CROTTE A L&#x2019;ADN	.univ-toulouse.fr	0	0		
929	chr10	45182439	45182468	3500055218	25		45182439	45182468	8421504	2	10,15	0,14	g	350005521800000007	3-28		20733040	10.1128/AAC.00716-10		Antimicrobial Agents and Chemotherapy	Mechanisms Involved in the Selection of HIV-1 Reverse Transcriptase Thumb Subdomain Polymorphisms Associated with Nucleoside Analogue Therapy Failure 	Gilberto	2010	0		
930	chr10	45273521	45273546	3500310997	24		45273521	45273546	8421504	2	17,7	0,18	c	350031099700000118	13-37						ISOLATION AND CHARACTERIZATION OF A NOVEL PYTHIUM OMEGA 3 DESATURASE WITH SPECIFICITY TO ALL OMEGA 6 FATTY ACIDS LONGER THAN 18 CARBON CHAINS - Patent application	www.faqs.org	0	0		
930	chr10	45311014	45311132	3500312616	52		45311014	45311132	8421504	2	23,29	0,89	c	350031261600000253,350031261600000255	19-42,12-41						METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Patent application	www.faqs.org	0	0		
930	chr10	45311103	45311132	3500047977	29		45311103	45311132	8421504	1	29	0	c	350004797700000255	12-41						METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Patent application	www.faqs.org	0	0		
931	chr10	45354639	45354666	3500428877	24		45354639	45354666	8421504	3	6,5,13	0,8,14	g	350042887700000108	3-27						Recombinant fowlpox viruses and uses thereof	Cochran	1994	0		
931	chr10	45354639	45354666	3500177869	24		45354639	45354666	8421504	3	6,5,13	0,8,14	g	350017786900000105	3-27						US Patent # 6,123,949. Recombinant fowlpox virus S-FPV-043 and uses thereof - Patents.com	www.patents.com	0	0		
931	chr10	45414906	45414977	3500078673	50		45414906	45414977	8421504	3	22,15,13	0,42,58	c	350007867300000010,350007867300000030,350007867300000031	0-22,0-28,0-28						UNIVERSIDAD DE MURCIA FACULTAD DE MEDICINA Departamento de Bioqu&#xed;mica y Biolog&#xed;a Molecular B e Inmunolog&#xed;a	digitum.um.es	0	0		
933	chr10	45663124	45663148	3500466773	24		45663124	45663148	8421504	1	24	0	g	350046677300000013	0-43						PROTEASES AND VARIANTS THEREOF - Patent application	www.faqs.org	0	0		
933	chr10	45684596	45684623	3500171141	27		45684596	45684623	8421504	1	27	0	c	350017114100000001,350017114100000003	12-39,15-42						Target specific screening andits use for identifying target binders	Blume	2003	0		
933	chr10	45684596	45684623	3500047898	27		45684596	45684623	8421504	1	27	0	c	350004789800000001,350004789800000003	12-39,15-42					Patent	Target specific screening and its use for identifying target binders (Patent US:7056679)	Blume	2006	0		
934	chr10	45847337	45854443	3500321005	251		45847337	45854443	8421504	7	21,45,36,84,6,39,20	0,2423,2471,3189,3297,3952,7086	p,c,g	350032100500000052,350032100500015028,350032100500015019,350032100500000055,350032100500000055,350032100500000028,350032100500000028,350032100500015010,350032100500015050,350032100500015056,350032100500000056,350032100500000029,350032100500015014,350032100500000059,350032100500000032	0-21,0-45,0-45,0-22,0-22,0-22,0-22,0-45,0-45,0-45,0-24,0-24,0-45,0-20,0-20						Methods for detecting a Cyclophilin B SNP associated with Herda - Patent application	www.faqs.org	0	0		
934	chr10	45849719	45855626	3500247721	850		45849719	45855626	8421504	6	125,114,94,185,258,74	0,807,1570,4642,5574,5833	c,g	350024772100000019,350024772100000020,350024772100000020,350024772100000021	0-850,0-20,0-20,0-20						Genomic marker for tenderness meat - Patent application	www.faqs.org	0	0		
934	chr10	45850586	45854482	3500441913	39		45850586	45854482	8421504	2	19,20	0,3876	c	350044191300000016,350044191300000000	0-19,0-20						Amino acid lipids and uses thereof	Quay	2011	0		SNX22,PPIB
934	chr10	45850586	45854482	3500234479	39		45850586	45854482	8421504	2	19,20	0,3876	c	350023447900000016,350023447900000000	0-19,0-20						Amino acid lipids and uses thereof	Quay	2008	0		SNX22,PPIB
934	chr10	45850586	45854482	3500140733	39		45850586	45854482	8421504	2	19,20	0,3876	c	350014073300000016,350014073300000000	0-19,0-20						Amino acid lipids and uses thereof	Quay	2012	0		SNX22,PPIB
934	chr10	45850607	45851349	3500341196	38		45850607	45851349	8421504	2	19,19	0,723	c	350034119600000012,350034119600000049	0-19,0-19					Patent	siRNA targeting cyclin-dependent kinase 4 (CDK4) (Patent US:8030474)	Khvorova	2011	0		
934	chr10	45850607	45851349	3500086655	38		45850607	45851349	8421504	2	19,19	0,723	c,g	350008665500000012,350008665500000012,350008665500000049,350008665500000049	0-19,0-19,0-19,0-19						siRNA targeting DNA-damage-inducible transcript 4 (DDIT4)	Khvorova	2008	0		
934	chr10	45850607	45851297	3500430146	38		45850607	45851297	8421504	3	19,11,8	0,22,682	c,g	350043014600000012,350043014600000012,350043014600000023	0-19,0-19,0-19					Patent	siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) (Patent US:7985854)	Khvorova	2011	0		
934	chr10	45850632	45851355	3500090572	45		45850632	45851355	8421504	3	8,16,21	0,657,702	c,g	350009057200000012,350009057200000013,350009057200000013	0-24,0-21,0-21		16682454	10.1124/jpet.106.102459	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	A Selective Peroxisome Proliferator-Activated Receptor &#x03b3; Modulator with Distinct Fat Cell Regulation Properties	Fujimura	2006	0		PPIB
934	chr10	45850632	45851355	3500043260	45		45850632	45851355	8421504	3	8,16,21	0,657,702	c	350004326000000002,350004326000000003	0-24,0-21						Method of screening for antidiabetic agents	Aramori	2004	0		PPIB
934	chr10	45850632	45851355	3500005467	45		45850632	45851355	8421504	3	8,16,21	0,657,702	c,g	350000546700000012,350000546700000013,350000546700000013	0-24,0-21,0-21		16682454	10.1124/jpet.106.102459	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	A Selective Peroxisome Proliferator-Activated Receptor &#x03b3; Modulator with Distinct Fat Cell Regulation Properties	Fujimura	2006	0		
934	chr10	45851297	45851320	3500261631	23		45851297	45851320	8421504	1	23	0	c	350026163100000002	0-23						Innate immune markers that distinguish red deer (Cervus elaphus) selected for resistant or susceptible genotypes for Johne&#xfffd;s disease	inaryresearch.org	0	0		
934	chr10	45851311	45851334	3500452206	23		45851311	45851334	8421504	1	23	0	c	350045220600000014	0-23		22509368	10.1371/journal.pone.0034921	1932-6203	PLOS ONE	PLOS ONE: Regulation of p53 Stability and Apoptosis by a ROR Agonist	Wang	2012	4		PPIB
934	chr10	45851311	45851334	3500072369	23		45851311	45851334	8421504	1	23	0	c	350007236900000014	0-23		22509368	10.1371/journal.pone.0034921		PLoS ONE	Regulation of p53 Stability and Apoptosis by a ROR Agonist	Yongjun	2012	0		PPIB
934	chr10	45851314	45854493	3500411173	49		45851314	45854493	8421504	2	25,24	0,3155	c	350041117300000000,350041117300000001	0-25,0-24		21748762	10.1002/hep.24539	1527-3350	Hepatology	Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans - Kim - 2011 - Hepatology - Wiley Online Library	Kim	2011	0		SNX22,PPIB
934	chr10	45854387	45854467	3500212912	44		45854387	45854467	8421504	2	25,19	0,61	c,g	350021291200000006,350021291200000006,350021291200000007,350021291200000007	0-25,0-25,0-19,0-19		20089928	10.1152/ajpcell.00406.2009		American Journal of Physiology - Cell Physiolog	Regulation of gap junction coupling in bovine ciliary epithelium	Wang	2010	0		
934	chr10	45854405	45854465	3500198305	60		45854405	45854465	8421504	1	60	0	p	350019830500015003	0-60						RECENT ADVANCES IN THE DOMESTICATION AND BREEDING OF Farfantepenaeus paulensis	www.was.org	0	0		PPIB
934	chr10	45855602	45855625	3500269873	23		45855602	45855625	8421504	1	23	0	c	350026987300000041	0-36						Methods and Nucleic Acids for Analyses of Cellular Proliferative Disorders	Distler	2011	0		
936	chr10	46078785	46078808	3500282491	23		46078785	46078808	8421504	1	23	0	g	350028249100000050	0-23						Development of novel RNA- and protein-based cancer therapeutics by either silencing of potential oncogenes or active restoration of a tumor suppressor gene	th.rwth-aachen.de	0	0		
936	chr10	46100945	46100971	3500189823	25		46100945	46100971	8421504	2	17,8	0,18	g	350018982300000101,350018982300000609,350018982300000732	20-45,8-33,11-36						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
937	chr10	46157790	46157815	3500292931	23		46157790	46157815	8421504	2	8,15	0,10	g	350029293100000078	9-32					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent EP:2135950)	NATT	2012	0		
937	chr10	46266568	46266686	3500388065	85		46266568	46266686	8421504	2	25,60	0,58	c	350038806500000015,350038806500000012,350038806500000011	33-58,0-60,0-60						A 1.3 kb Satellite DNA from Bubalus bubalis not Conserved Evolutionarily is Transcribed	.znaturforsch.com	0	0		
938	chr10	46325465	46341594	3500259213	42		46325465	46341594	8421504	3	6,13,23	0,10,16106	g	350025921300000016,350025921300000119	26-45,13-38					Patent	Purified coprinus laccases and nucleic acids encoding the same (Patent US:6008029)	Brown	1999	0		
939	chr10	46459245	46459292	3500321684	45		46459245	46459292	8421504	2	25,20	0,27	c	350032168400000008	4-50						EVALUATION OF SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH FERTILITY AND PRODUCTION TRAITS IN HOLSTEIN AND MULTI-GENERATIONAL ANGUS FEMALES	etd.lsu.edu	0	0		
941	chr10	46662165	46662197	3500445013	32		46662165	46662197	8421504	1	32	0	g	350044501300000052	6-38						Lung cancer marker	www.devileye.net	0	0		
942	chr10	46802997	46817579	3500460491	46		46802997	46817579	8421504	2	19,27	0,14555	c	350046049100000008,350046049100000023	18-57,0-27		24035388	10.1016/j.celrep.2013.08.008	2211-1247	Cell Reports	Cell Reports - RAB8B Is Required for Activity and Caveolar Endocytosis of LRP6	Demir	2013	0		
942	chr10	46802997	46817579	3500435155	46		46802997	46817579	8421504	2	19,27	0,14555	c	350043515500000008,350043515500000023	18-57,0-27		24035388	10.1016/j.celrep.2013.08.008	2211-1247	Cell Reports	Cell Reports - RAB8B Is Required for Activity and Caveolar Endocytosis of LRP6	Demir	2013	0		
942	chr10	46904052	46905199	3500035193	51		46904052	46905199	8421504	2	46,5	0,1142	p	350003519300015023	0-51						Conserved Ribosomal Protein Sequences S5, S18, S27, S30 in the Pacific Oyster Crassostrea gigas and Crassostrea virginica	clib.kindai.ac.jp	0	0		RPS27
942	chr10	46918616	46918644	3500001971	24		46918616	46918644	8421504	2	9,15	0,13	c	350000197100000066	2-26						US Patent # 7,037,492. Gene transfer for studying and treating a connective tissue of a mammalian host - Patents.com	www.patents.com	0	0		
943	chr10	47013220	47014804	3500169773	26		47013220	47014804	8421504	2	4,22	0,1562	c	350016977300000001	9-35						Tropomyosin Dynamics in Cardiac Thin Filaments: A Multisite Fo&#xa8;rster Resonance Energy Transfer and Anisotropy Study	ysiology.wisc.edu	0	0		
943	chr10	47017234	47017259	3500227287	25		47017234	47017259	8421504	1	25	0	c	350022728700000004,350022728700000005	17-42,23-47						US Patent # 7,285,630. Tropomyosin isoforms, and diagnostic and therapeutic uses therefor - Patents.com	www.patents.com	0	0		
943	chr10	47017235	47017259	3500422513	24		47017235	47017259	8421504	1	24	0	c	350042251300000005	23-47						TROPOMYOSIN ISOFORMS, AND DIAGNOSTIC AND THERAPEUTIC USES THEREFOR	Das	2002	0		
943	chr10	47021371	47021491	3500245546	120		47021371	47021491	8421504	1	120	0	p	350024554600015005,350024554600015004	0-60,0-60						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/	www.dmd.nl/nmdb/r	0	0		TPM3
943	chr10	47021431	47034966	3500319008	90		47021431	47034966	8421504	2	60,30	0,13505	p	350031900800015027	0-90						Cell surface tropomyosin as a target of angiogenesis inhibition	Donate	2005	0		
943	chr10	47021461	47034957	3500335102	51		47021461	47034957	8421504	2	30,21	0,13475	p	350033510200015116	0-51						BiochemicalCharacterizationandN-terminomicsAnalysisof Leukolysin,theMembrane-type6MatrixMetalloprotease (MMP25)	www.jbc.org	0	0		TPM1
943	chr10	47036210	47036234	3500296667	24		47036210	47036234	8421504	1	24	0	c	350029666700000041	0-24						7 Materials and methods	thek.uni-halle.de	0	0		TPM2
945	chr10	47249661	47249687	3500279951	23		47249661	47249687	8421504	3	5,4,14	0,7,12	g	350027995100000036	4-28						Recombinant hexose oxidase - Patent application	www.faqs.org	0	0		
950	chr10	47881026	47881060	3500052099	25		47881026	47881060	8421504	3	15,3,7	0,20,27	g	350005209900000255	0-25						Card Domain Containing Polypeptides, Encoding Nucleic Acids, And Methods Of Use 	.freshpatents.com	0	0		
950	chr10	47950474	47950498	3500434184	23		47950474	47950498	8421504	2	18,5	0,19	g	350043418400000155	5-28						US Patent # 6,902,922. Subtilisin variants - Patents.com	www.patents.com	0	0		
952	chr10	48114212	48114236	3500410183	23		48114212	48114236	8421504	2	9,14	0,10	g	350041018300000097	1-24						Brassica polymorphisms	Lemieux	1999	0		
964	chr10	49706134	49741427	3500438684	141		49706134	49741427	8421504	5	48,10,38,43,2	0,20506,23697,32776,35291	p	350043868400015070,350043868400015084,350043868400015027	0-48,0-48,0-45						Compositions And Methods For Modulation Of Rorgammat Functions 	.freshpatents.com	0	0		RORA
964	chr10	49771246	49771271	3500299093	23		49771246	49771271	8421504	2	12,11	0,14	c	350029909300000030	8-35						An STR Forensic Typing System for Genetic Individualization of Domestic Cat (Felis catus) Samples	www.cstl.nist.gov	0	0		
965	chr10	49899417	49932597	3500066181	573		49899417	49932597	8421504	8	48,36,60,94,96,59,123,57	0,3247,27754,29480,30155,30694,31991,33123	p	350006618100015002,350006618100015008,350006618100015012	0-84,0-249,0-240						Structure of the humanannexin gene	www.pnas.org	0	0		ANXA2
965	chr10	49899420	49932597	3500015056	1014		49899420	49932597	8421504	12	45,100,95,114,91,80,60,94,96,59,123,57	0,3244,18528,22104,25331,26343,27751,29477,30152,30691,31988,33120	p,c	350001505600015009,350001505600015010,350001505600015011,350001505600000006	0-1014,0-969,0-939,9-32						Therapeutic compositions and methods for treating diseases that involve angiogenesis	Semov	2005	0		
965	chr10	49899445	49902727	3500256218	45		49899445	49902727	8421504	3	20,2,23	0,3219,3259	c,g	350025621800000115,350025621800000116,350025621800000116	0-22,0-23,0-23						REPRODUCTION	uction-online.org	0	0		
965	chr10	49902742	49918027	3500202457	42		49902742	49918027	8421504	2	22,20	0,15265	c,g	350020245700000004,350020245700000005,350020245700000005	0-22,0-20,0-20						Fluids and Barriers of the CNS	dsbarrierscns.com	0	0		ANXA2
965	chr10	49902748	49921543	3500404944	40		49902748	49921543	8421504	4	16,4,1,19	0,15200,15294,18776	c	350040494400000008,350040494400000009	0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		ANXA2
965	chr10	49902760	49921593	3500048481	93		49902760	49921593	8421504	3	4,41,48	0,15188,18785	p	350004848100015024,350004848100015021	3-48,0-48						PROTEIN IMPORT, CHOLESTEROL TRANSPORT AND	ry.georgetown.edu	0	0		ANXA2
965	chr10	49921527	49932582	3500082476	237		49921527	49932582	8421504	5	60,60,57,18,42	0,4250,8083,9986,11013	p	350008247600015014,350008247600015015,350008247600015016,350008247600015017	0-60,0-60,0-57,0-60						Sequence Similarity & Sequence Searching	staff.aub.edu.lb	0	0		
965	chr10	49924751	49927231	3500404015	102		49924751	49927231	8421504	2	48,54	0,2426	p	350040401500015010,350040401500015012,350040401500015011	0-48,0-54,0-51			10.1111/j.1432-1033.2004.04004.x	1432-1033	European Journal of Biochemistry	Functional analyses of placental protein&#xa0;13/galectin-13 - Than - 2004 - European Journal of Biochemistry - Wiley Online Library	Than	2004	0		ANXA2
965	chr10	49927183	49932564	3500378861	44		49927183	49932564	8421504	2	22,22	0,5359	c	350037886100000001,350037886100000002	0-22,0-22		23950866	10.1371/journal.pone.0067268	1932-6203	PLOS ONE	PLOS ONE: Annexin A2 Promotes the Migration and Invasion of Human Hepatocellular Carcinoma Cells In Vitro by Regulating the Shedding of CD147-Harboring Microvesicles from Tumor Cells	Zhang	2013	4		PTENP1
965	chr10	49927183	49932564	3500151467	44		49927183	49932564	8421504	2	22,22	0,5359	c,g	350015146700000001,350015146700000001,350015146700000002	0-22,0-22,0-22		23950866	10.1371/journal.pone.0067268		PLoS ONE	Annexin A2 Promotes the Migration and Invasion of Human Hepatocellular Carcinoma Cells In Vitro by Regulating the Shedding of CD147-Harboring Microvesicles from Tumor Cells	Wei	2013	0		ANXA2
965	chr10	49932383	49932411	3500212220	24		49932383	49932411	8421504	2	11,13	0,15	g	350021222000000010	3-27						THE J B C &#xa9; 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Activation of the Murine Dihydrofolate Reductase Promoter by E2F1	enter.ucdavis.edu	0	0		
969	chr10	50358350	50358376	3500058103	23		50358350	50358376	8421504	2	9,14	0,12	g	350005810300000091	0-23						MITOCHONDRIAL MUTATIONS AND REARRANGEMENTS AS A DIAGNOSTIC TOOL FOR THE DETECTION OF SUN EXPOSURE, PROSTATE CANCER AND OTHER CANCERS - Patent application	www.faqs.org	0	0		
971	chr10	50650307	50650333	3500185639	25		50650307	50650333	8421504	2	9,16	0,10	g	350018563900000003	10-35						Further Evidence for Inclusion of the New Zealand Short-Tailed Bat (Mystacina tuberculata) within Noctilionoidea	www.jstor.org	0	0		
971	chr10	50697138	50700678	3500100720	210		50697138	50700678	8421504	6	21,42,39,42,48,18	0,910,3384,3426,3471,3522	p	350010072000015166,350010072000015209	0-63,0-147						Methods for the detection of variant cayman ataxia nucleic acids - US Patent 7267954 Description	ww.patentstorm.us	0	0		
972	chr10	50766576	50768013	3500378787	84		50766576	50768013	8421504	4	21,21,20,22	0,67,1390,1415	c,g	350037878700000004,350037878700000006,350037878700000006,350037878700000003,350037878700000005	0-21,0-21,0-21,0-20,0-22			10.1128/JVI.77.3.1784-1792.2003		Journal of Virology	The Core 2 &#x03b2;-1,6-N-Acetylglucosaminyltransferase-Mucin Encoded by Bovine Herpesvirus 4 Was Acquired from an Ancestor of the African Buffalo	N.	2003	0		
972	chr10	50767307	50767330	3500356580	23		50767307	50767330	8421504	1	23	0	c	350035658000000007	1-24		20841351	10.1074/jbc.M110.162735	0021-9258	Journal of Biological Chemistry	Core2 O-Glycan Structure Is Essential for the Cell Surface Expression of Sucrase Isomaltase and Dipeptidyl Peptidase-IV during Intestinal Cell Differentiation	Lee	2010	5		
972	chr10	50767307	50767330	3500301736	23		50767307	50767330	8421504	1	23	0	c	350030173600000007	1-24		20841351	10.1074/jbc.M110.162735		The Journal of Biological Chemistry	Core2 O-Glycan Structure Is Essential for the Cell Surface Expression of Sucrase Isomaltase and Dipeptidyl Peptidase-IV during Intestinal Cell Differentiation	Seung	2010	0		
972	chr10	50768815	50768867	3500401025	52		50768815	50768867	8421504	1	52	0	c	350040102500000002	18-70						Identification of Short Interspersed Elements (SINEs) in Iranian River Buffalo	www.eaap.org	0	0		
973	chr10	50963249	50963272	3500370305	23		50963249	50963272	8421504	1	23	0	g	350037030500000431	18-41						 3 	www.docstoc.com	0	0		
973	chr10	50963249	50963272	3500166501	23		50963249	50963272	8421504	1	23	0	g	350016650100000442	18-41						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
975	chr10	51190369	51190397	3500245061	23		51190369	51190397	8421504	3	12,5,6	0,13,22	g	350024506100000037,350024506100000114	0-26,0-26						The Rice Bentazon and Sulfonylurea Herbicide Resistant Gene Cyp81a6 - Patent application	www.faqs.org	0	0		
975	chr10	51242588	51242612	3500264907	24		51242588	51242612	8421504	1	24	0	g	350026490700000067	23-48						Eucaryotic cells transformed with a mammalian phospholipid kinase or protein kinase and assays using them	Goode	1994	0		
978	chr10	51533770	51535709	3500076526	153		51533770	51535709	8421504	2	47,106	0,1833	p	350007652600015086	0-153						41 human secreted proteins	Komatsoulis	2001	0		RNF111
978	chr10	51621865	51621891	3500126207	23		51621865	51621891	8421504	2	16,7	0,19	g	350012620700000250	21-48					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
979	chr10	51677884	51677910	3500399152	23		51677884	51677910	8421504	2	9,14	0,12	c	350039915200000057	0-23						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease - US Patent 6790612 Description	ww.patentstorm.us	0	0		
979	chr10	51677884	51677910	3500377977	23		51677884	51677910	8421504	2	9,14	0,12	c	350037797700000751	0-23						Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide	Malcolm	2000	0		
979	chr10	51677884	51677910	3500316820	23		51677884	51677910	8421504	2	9,14	0,12	c	350031682000000057	0-23						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease	Potts	2002	0		
979	chr10	51677884	51677910	3500261697	23		51677884	51677910	8421504	2	9,14	0,12	c	350026169700000057	0-23						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease	Potts	2001	0		
980	chr10	51773754	51773780	3500043964	26		51773754	51773780	8421504	1	26	0	c	350004396400000004,350004396400000005	0-26,0-25						Self-Control of HGF Regulation on Human Trophoblast Cell Invasion via Enhancing c-Met Receptor Shedding by ADAM10 and ADAM17	.endojournals.org	0	0		FAM63B
980	chr10	51773797	51812863	3500190573	42		51773797	51812863	8421504	3	12,8,22	0,38975,39044	c	350019057300000012,350019057300000013	0-20,0-22						Use of the CYP46A1 Gene for the Treatment of Alzheimer's Disease - Patent application	www.faqs.org	0	0		
980	chr10	51773804	51812818	3500199537	51		51773804	51812818	8421504	2	5,46	0,38968	c	350019953700000000	9-60		22940918	10.1007/s00018-012-1106-2		Cellular and Molecular Life Sciences	The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin&#xa0;&#x03b2; and ADAM10	Tamara	2013	0		ADAM10,FAM63B
980	chr10	51862577	51862602	3500006238	25		51862577	51862602	8421504	1	25	0	c	350000623800000000	0-25						Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases	tologylibrary.org	0	0		ADAM10
980	chr10	51887709	51891278	3500008335	42		51887709	51891278	8421504	3	20,15,7	0,46,3562	c	350000833500000022,350000833500000023	0-20,0-22						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
980	chr10	51887743	51887766	3500229192	23		51887743	51887766	8421504	1	23	0	c,g	350022919200000000,350022919200000000	0-23,0-23						Cell, Vol. 90, 271&#x2013;280, July 25, 1997, Copyright 1997 by Cell Press Kuzbanian Controls Proteolytic Processing of Notch and Mediates Lateral Inhibition during Drosophila and Vertebrate Neurogenesis	mcdb.colorado.edu	0	0		ADAM10
980	chr10	51891298	51901819	3500388209	341		51891298	51901819	8421504	9	20,4,11,60,23,11,19,175,18	0,41,46,58,122,146,7446,9645,10503	c	350038820900000000,350038820900000008,350038820900000010,350038820900000005	0-20,0-129,3-196,0-20						Estudio de la composici&#xf3;n de los gr&#xe1;nulos corticales y del oolema de ovocitos porcinos y bovinos madurados y fecundados in vitro	tdx.cat/bitstream	0	0		
980	chr10	51898747	51900948	3500177649	43		51898747	51900948	8421504	3	21,8,14	0,140,2187	c,g	350017764900000002,350017764900000002,350017764900000003	0-21,0-21,0-22			10.1111/j.1742-4658.2005.04976.x	1742-4658	FEBS Journal	Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases - Endres - 2005 - FEBS Journal - Wiley Online Library	Endres	2005	0		ADAM10
980	chr10	51898779	51902494	3500085847	38		51898779	51902494	8421504	2	19,19	0,3696	c,g	350008584700000001,350008584700000001,350008584700000000,350008584700000000	0-19,0-19,0-19,0-19						Constitutive and regulated a-secretase cleavage of Alzheimer&#x2019;s amyloid precursor protein by a disintegrin metalloprotease	www.pnas.org	0	0		ADAM10
980	chr10	51898797	51902448	3500147796	363		51898797	51902448	8421504	9	45,45,2,43,45,42,51,45,45	0,48,96,2137,2231,2279,3004,3058,3606	p,c	350014779600015006,350014779600015007,350014779600015008,350014779600015010,350014779600015011,350014779600000023,350014779600000012,350014779600015012,350014779600000015,350014779600000000,350014779600015013,350014779600015015	0-45,0-45,0-45,0-45,0-45,0-21,0-21,0-45,0-21,0-21,0-45,0-45						Regulation of Metalloprotease Cleavage of Cell Surface Proteins - Patent application	www.faqs.org	0	0		
980	chr10	51901114	51901843	3500145930	42		51901114	51901843	8421504	3	4,17,21	0,687,708	c	350014593000000012,350014593000000000	0-21,0-21					Patent	Antibody against a human ADAM protease (Patent US:7960513)	Janes	2011	0		ADAM10
980	chr10	51902501	51902526	3500198208	25		51902501	51902526	8421504	1	25	0	c	350019820800000001	0-25						ADAM10 in Cancer Diagnosis, Detection and Treatment	Lai	2006	0		
981	chr10	51930368	51930398	3500048879	26		51930368	51930398	8421504	3	17,4,5	0,18,25	g	350004887900000009	0-27						Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host	Della-Cioppa	2000	0		
981	chr10	51935564	51935593	3500183022	24		51935564	51935593	8421504	2	17,7	0,22	g	350018302200000000	0-27						Pan-African Genetic Structure in the African Buffalo (Syncerus caffer): Investigating Intraspecific Divergence. - ResearchGate	.researchgate.net	0	0		
981	chr10	51954848	51954886	3500370232	32		51954848	51954886	8421504	4	11,3,9,9	0,12,19,29	c	350037023200000093	1-33						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
981	chr10	51954848	51954886	3500187760	32		51954848	51954886	8421504	4	11,3,9,9	0,12,19,29	c	350018776000000075	1-33					Patent	Enzyme capable of degrading cellulose or hemicellulose (Patent US:5686593)	Hagen	1997	0		
983	chr10	52202872	52202895	3500381169	23		52202872	52202895	8421504	1	23	0	g	350038116900000003	9-32						Forensic DNA Fingerprinting Kit Instruction Manual	les.wordpress.com	0	0		
983	chr10	52268048	52268074	3500189823	23		52268048	52268074	8421504	3	13,4,6	0,14,20	g	350018982300000718	15-38						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
984	chr10	52382114	52382143	3500067200	24		52382114	52382143	8421504	3	6,13,5	0,8,24	c	350006720000000073	16-40						Recombinant hexose oxidase, a method of producing same and use of such enzyme - Patent application	www.faqs.org	0	0		
986	chr10	52670099	52670127	3500359363	26		52670099	52670127	8421504	3	13,6,7	0,14,21	g	350035936300000338	4-32						Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments 	.freshpatents.com	0	0		
988	chr10	52847008	52847068	3500361819	60		52847008	52847068	8421504	1	60	0	p	350036181900015003	0-60						Tfiis and gdown1 as targets for cancer therapy	Gnatt	2007	0		
990	chr10	53160280	53160309	3500198391	24		53160280	53160309	8421504	4	11,4,5,4	0,12,19,25	g	350019839100000002	0-24		19833766	10.1101/gad.1840109	0890-9369	Genes & Development	Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A	Yamaji	2009	12		
991	chr10	53282013	53282039	3500277668	26		53282013	53282039	8421504	1	26	0	c	350027766800000035	0-26						320-022125 FOCUS 25	ww.invitrogen.com	0	0		TCF12
991	chr10	53294128	53294154	3500324896	26		53294128	53294154	8421504	1	26	0	c	350032489600000021	0-26			10.1634/stemcells.2004-0366	1549-4918	STEM CELLS	Establishment of Novel Embryonic Stem Cell Lines Derived from the Common Marmoset (Callithrix jacchus) - Sasaki - 2005 - STEM CELLS - Wiley Online Library	Sasaki	2005	0		
991	chr10	53309542	53309566	3500423257	23		53309542	53309566	8421504	2	6,17	0,7	c	350042325700000153	0-23						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
992	chr10	53400546	53400569	3500271180	23		53400546	53400569	8421504	1	23	0	c	350027118000000013	0-23		17452521	10.1084/jem.20061959	0022-1007	The Journal of Experimental Medicine	Mature natural killer cell and lymphoid tissue&#x2013;inducing cell development requires Id2-mediated suppression of E protein activity	Boos	2007	14		TCF12
994	chr10	53736626	53736651	3500422390	23		53736626	53736651	8421504	2	10,13	0,12	g	350042239000000002	0-23						Preliminary study of the changes in rumen bacterial populations from cattle intoxicated with young oak (Quercus pyrenaica) leaves	digital.csic.es	0	0		
995	chr10	53869626	53869652	3500440739	23		53869626	53869652	8421504	2	5,18	0,8	g	350044073900000317	8-31						5' to 3' exonuclease mutations of thermostable DNA polymerases	Abramson	1993	0		
996	chr10	53925269	53925293	3500056119	24		53925269	53925293	8421504	1	24	0	c	350005611900000000	0-24		16847330	10.1128/MCB.02404-05	0270-7306	Molecular and Cellular Biology	MyoD Synergizes with the E-Protein HEB&#x03b2; To Induce Myogenic Differentiation	Parker	2006	6		
1004	chr10	54951338	54951368	3500279650	30		54951338	54951368	8421504	1	30	0	g	350027965000000000	10-40		20177066	10.1074/jbc.M109.072280	0021-9258	Journal of Biological Chemistry	Ubiquitination of PTEN (Phosphatase and Tensin Homolog) Inhibits Phosphatase Activity and Is Enhanced by Membrane Targeting and Hyperosmotic Stress	Maccario	2010	5		NEDD4
1004	chr10	54967353	54967380	3500077263	26		54967353	54967380	8421504	2	21,5	0,22	g	350007726300000003	0-26		18948188	10.1016/j.freeradbiomed.2008.09.022		Free radical biology & medicine	P21Cip1 Protects against Oxidative Stress by Suppressing ER Dependent Activation of Mitochondrial Death Pathways	PeF.	2009	0		
1005	chr10	55053300	55053330	3500420576	30		55053300	55053330	8421504	1	30	0	g	350042057600000012	0-30						The distal convoluted tubule of rabbit kidney does not express a functional sodium channel	al.physiology.org	0	0		
1007	chr10	55425796	55425828	3500048879	26		55425796	55425828	8421504	3	6,13,7	0,9,25	g	350004887900000067	3-33						Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host	Della-Cioppa	2000	0		
1008	chr10	55484162	55484186	3500264644	24		55484162	55484186	8421504	1	24	0	c	350026464400000039	10-34						Y Strain differentiation of Citrus tristeza virus isolates from South Africa by PCR and microarray.	upetd.up.ac.za	0	0		
1009	chr10	55648557	55669628	3500173515	209		55648557	55669628	8421504	10	21,20,21,21,21,21,21,22,20,21	0,77,1429,2096,3248,6979,7279,7724,20050,21050	c,g	350017351500000002,350017351500000017,350017351500000008,350017351500000003,350017351500000019,350017351500000010,350017351500000021,350017351500000011,350017351500000013,350017351500000025	0-21,0-20,0-21,0-21,0-21,0-21,0-21,0-22,0-20,0-21						Single nucleotide polymorphism (SNP) identification and characterization of goat RAB27A gene in different populations	demicjournals.org	0	0		
1009	chr10	55668723	55668751	3500205076	24		55668723	55668751	8421504	3	5,4,15	0,8,13	c	350020507600000002	2-26					Journal of Virology	Autographa californica Nuclear Polyhedrosis Virus DNA Polymerase: Measurements of Processivity and Strand Displacement	Vivien	June	0		
1012	chr10	56055223	56055248	3500423257	24		56055223	56055248	8421504	2	10,14	0,11	g	350042325700000216	3-34						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
1017	chr10	56675785	56675813	3500423257	25		56675785	56675813	8421504	2	18,7	0,21	g	350042325700000208	0-25						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
1020	chr10	57017884	57017912	3500352528	27		57017884	57017912	8421504	2	4,23	0,5	c	350035252800000525,350035252800000250	9-36,0-27						Compositions And Methods Comprising Variant Microbial Proteases - Patent application	www.faqs.org	0	0		
1022	chr10	57329520	57329547	3500128132	23		57329520	57329547	8421504	2	15,8	0,19	g	350012813200000027	11-34						Antibodies with glycosylated in the variable region	A*Shao Bu Ma 	2009	0		
1024	chr10	57593634	57593659	3500333669	23		57593634	57593659	8421504	3	13,6,4	0,14,21	g	350033366900000714	12-35						Transgenic Animal With Enhanced Immune Response And Method For The Preparation Thereof 	.freshpatents.com	0	0		
1031	chr10	58466390	58466421	3500266204	31		58466390	58466421	8421504	1	31	0	c	350026620400000128,350026620400000038	17-48,17-48						Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography	Ai Li Ke *Fei De Le 	2007	0		
1031	chr10	58466390	58466421	3500158657	31		58466390	58466421	8421504	1	31	0	c	350015865700000049,350015865700000048	17-48,17-39						Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography	Ebersbach	2006	0		
1031	chr10	58466410	58466435	3500333462	25		58466410	58466435	8421504	1	25	0	c	350033346200000017	16-41		22105709	10.1007/s00018-011-0882-4		Cellular and Molecular Life Sciences	APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms	Simone	2012	0		
1031	chr10	58466447	58498456	3500099362	69		58466447	58498456	8421504	3	22,23,24	0,426,31985	c	350009936200000031,350009936200000032,350009936200000034	20-42,21-44,22-46						Method for identifying genetic markers for secondary tumors and means for the identification, labelling and targeting of secondary tumors	filed	2007	0		
1031	chr10	58466940	58466963	3500391930	23		58466940	58466963	8421504	1	23	0	c	350039193000000036	1-24						Hepatoblast-Like Progenitor Cells Derived From Embryonic Stem Cells Can Repopulate Livers of Mice	library.ibp.ac.cn	0	0		ONECUT1
1031	chr10	58467024	58498207	3500327864	40		58467024	58498207	8421504	2	20,20	0,31163	c	350032786400000076,350032786400000077	0-20,0-20						ENDODERMAL PROGENITOR CELLS - Patent application	www.faqs.org	0	0		
1031	chr10	58498151	58498238	3500451013	39		58498151	58498238	8421504	2	20,19	0,68	c,g	350045101300000059,350045101300000059,350045101300000057	0-20,0-20,0-19						DIFFERENTIATED HUMAN LIVER CELL CULTURES AND THEIR USE IN BIOARTIFICIAL LIVER SYSTEMS	Chamuleau	2010	0		
1031	chr10	58567922	58567952	3500259074	25		58567922	58567952	8421504	2	7,18	0,12	g	350025907400000031	10-35						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
1032	chr10	58688593	58694086	3500075307	352		58688593	58694086	8421504	4	120,172,30,30	0,4201,5376,5463	p,c,g	350007530700000010,350007530700000012,350007530700015005,350007530700000016,350007530700000054,350007530700000042,350007530700000053,350007530700000045,350007530700015009,350007530700000046,350007530700000047,350007530700015011,350007530700000017,350007530700000039,350007530700000013,350007530700000043,350007530700000019,350007530700000021	12-39,12-39,0-48,29-56,0-289,29-56,0-291,0-41,0-48,0-48,0-48,0-48,27-57,11-42,11-42,27-57,0-30,0-30						NUCLEOTIDE AND AMINO ACID SEQUENCES OF C4-2, A TUMOR SUPPRESSOR GENE, AND METHODS OF USE THEREOF - NORTHWEST BIOTHERAPEUTICS LLC	www.sumobrain.com	0	0		
1035	chr10	59078202	59078225	3500158630	23		59078202	59078225	8421504	1	23	0	g	350015863000000006	0-23		18559914	10.1210/jc.2008-0248		The Journal of Clinical Endocrinology and Metabolism	Androstenedione Up-Regulation of Endometrial Aromatase Expression via Local Conversion to Estrogen: Potential Relevance to the Pathogenesis of Endometriosis	Orhan	2008	0		
1036	chr10	59152613	59152814	3500207343	49		59152613	59152814	8421504	2	26,23	0,178	c	350020734300000001,350020734300000000	0-26,0-23		18296508	10.1530/REP-07-0556	1470-1626	Reproduction	Dietary unsaturated fatty acids influence preovulatory follicle characteristics in dairy cows	Zachut	2008	3		
1036	chr10	59153444	59214615	3500403025	399		59153444	59214615	8421504	16	23,20,22,20,25,22,19,20,22,39,26,50,25,20,24,22	0,505,2079,4679,5414,8307,10898,11012,23345,23446,36725,36788,40044,40477,45057,61149	c,g	350040302500000021,350040302500000027,350040302500000018,350040302500000018,350040302500000017,350040302500000017,350040302500000014,350040302500000012,350040302500000012,350040302500000010,350040302500000010,350040302500000011,350040302500000026,350040302500000026,350040302500000008,350040302500000009,350040302500000009,350040302500000024,350040302500000006,350040302500000025,350040302500000007,350040302500000005,350040302500000023,350040302500000001,350040302500000001	0-23,0-20,0-22,0-22,0-20,0-20,0-25,0-22,0-22,0-19,0-19,0-20,0-22,0-22,0-23,0-22,0-22,0-26,0-23,0-22,0-20,0-25,96-160,0-22,0-22			10.1046/j.1432-1327.1999.00734.x	1432-1033	European Journal of Biochemistry	Placenta-specific transcripts of the aromatase encoding gene include different untranslated first exons in sheep and cattle - Vanselow - 2001 - European Journal of Biochemistry - Wiley Online Library	Vanselow	1999	0		
1036	chr10	59153605	59154036	3500175106	44		59153605	59154036	8421504	2	23,21	0,410	c	350017510600000001,350017510600000000	0-23,0-21						2,3,, George W Smith 1,3,4 Laboratory of Mammalian Reproductive Biology and Genomics	.endojournals.org	0	0		
1036	chr10	59153816	59153894	3500435393	46		59153816	59153894	8421504	2	24,22	0,56	c	350043539300000005,350043539300000004	0-24,0-22						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
1036	chr10	59153913	59153937	3500245482	23		59153913	59153937	8421504	2	8,15	0,9	c	350024548200000146	21-47						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
1036	chr10	59154158	59155376	3500127481	45		59154158	59155376	8421504	3	20,15,10	0,27,1208	c	350012748100000001,350012748100000000	0-20,0-25						Insulin-Like Growth Factor (IGF) 2 Stimulates Steroidogenesis and Mitosis of Bovine Granulosa Cells Through the IGF1 Receptor: Role of Follicle-Stimulating Hormone and IGF2 Receptor	ww.biolreprod.org	0	0		
1036	chr10	59154170	59154193	3500401331	23		59154170	59154193	8421504	1	23	0	c	350040133100000009	21-44						Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesis	.researchgate.net	0	0		CYP19A1
1036	chr10	59154170	59154193	3500221075	23		59154170	59154193	8421504	1	23	0	c	350022107500000006	21-44						Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesis. - ResearchGate	.researchgate.net	0	0		CYP19A1
1036	chr10	59155464	59155509	3500054995	45		59155464	59155509	8421504	1	45	0	c	350005499500000000	0-45						REPRODUCTION	uction-online.org	0	0		
1036	chr10	59155465	59166115	3500419191	52		59155465	59166115	8421504	2	28,24	0,10626	c,g	350041919100000005,350041919100000007	0-28,1-25						Characterization of a cetacean aromatase (CYP19) and the phylogeny and functional conservation of vertebrate aromatase	www.whoi.edu	0	0		
1036	chr10	59158141	59158883	3500256218	81		59158141	59158883	8421504	4	23,26,8,24	0,26,708,718	c,g	350025621800000097,350025621800000097,350025621800000098,350025621800000096	0-23,0-23,0-34,0-24						REPRODUCTION	uction-online.org	0	0		
1036	chr10	59161769	59176851	3500151420	47		59161769	59176851	8421504	2	21,26	0,15056	c	350015142000000091,350015142000000093,350015142000000090	0-21,0-26,0-22						&#x30a6;&#x30de;&#x598a;&#x5a20;&#x671f;&#x306e;&#x80ce;&#x5b50;&#x80ce;&#x76e4;&#x7cfb;&#x306b;&#x304a;&#x3051;&#x308b;&#x30b9;&#x30c6;&#x30ed;&#x30a4;&#x30c9;&#x4ee3;&#x8b1d;&#x306b;&#x95a2;&#x3059;&#x308b;&#x7814;&#x7a76;	itc.u-tokyo.ac.jp	0	0		CYP19A1
1036	chr10	59164338	59164361	3500452931	23		59164338	59164361	8421504	1	23	0	c	350045293100000000	0-23		12604651	10.1095/biolreprod.102.008037	0006-3363	Biology of Reproduction	Three Different Promoters Control Expression of the Aromatase Cytochrome P450 Gene (Cyp19) in Mouse Gonads and Brain	Golovine	2003	4		CYP19A1
1036	chr10	59190142	59190282	3500193658	41		59190142	59190282	8421504	2	21,20	0,120	c,g	350019365800000003,350019365800000003,350019365800000002	0-21,0-21,0-20						disserta..o de mestrado original	cnptia.embrapa.br	0	0		
1036	chr10	59190142	59190282	3500160276	41		59190142	59190282	8421504	2	21,20	0,120	c,g	350016027600000003,350016027600000003,350016027600000002	0-21,0-21,0-20						disserta..o de mestrado original	torio.ufc.br:8080	0	0		
1036	chr10	59190234	59193571	3500126808	42		59190234	59193571	8421504	2	21,21	0,3316	c,g	350012680800000003,350012680800000003,350012680800000002,350012680800000002	0-21,0-21,0-21,0-21						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
1036	chr10	59193544	59193569	3500048010	25		59193544	59193569	8421504	1	25	0	c,g	350004801000000008,350004801000000008	0-25,0-25		14568916	10.1095/biolreprod.103.021709	0006-3363	Biology of Reproduction	Gene Expression Profiling of Differentially Expressed Genes in Granulosa Cells of Bovine Dominant Follicles Using Suppression Subtractive Hybridization	Fayad	2004	4		
1036	chr10	59215359	59215764	3500318873	40		59215359	59215764	8421504	2	20,20	0,385	g	350031887300000001,350031887300000000	0-20,0-20						Evaluation of associations of the polymorphism in the placentaspecific promoter 1.1 of the CYP19 gene in Black-and-White and Jersey cattle with milk production traits (short communication)	bn-dummerstorf.de	0	0		
1036	chr10	59215359	59215764	3500307262	40		59215359	59215764	8421504	2	20,20	0,385	g	350030726200000001,350030726200000000	0-20,0-20						Association between polymorphisms of CYP19 CYP21, and genes and milk production traits in Black-and-White cattle	ls.tubitak.gov.tr	0	0		
1037	chr10	59261433	59261520	3500259232	87		59261433	59261520	8421504	1	87	0	g	350025923200000058	0-89						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
1040	chr10	59738324	59738369	3500099329	45		59738324	59738369	8421504	1	45	0	p	350009932900015004	0-45						N-tropomodulin: a novel isoform of tropomodulin identi&#xfb01;ed as the major binding protein to brain tropomyosin	cs.biologists.org	0	0		TMOD2
1041	chr10	59892157	59894217	3500235713	44		59892157	59894217	8421504	2	22,22	0,2038	c	350023571300000017,350023571300000016	0-22,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
1043	chr10	60081058	60112811	3500328743	1059		60081058	60112811	8421504	11	9,167,97,49,92,144,133,77,42,137,112	0,1335,2387,4091,6416,8303,11622,15359,18218,22144,31641	p	350032874300015000	0-1059						KEGG T01001: 10681	www.genome.jp	0	0		GNB5
1048	chr10	60760340	60788200	3500243526	41		60760340	60788200	8421504	3	17,2,22	0,19673,27838	c	350024352600000006,350024352600000007	0-19,0-22						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		SPPL2A,TRPM7
1048	chr10	60760340	60788200	3500083138	41		60760340	60788200	8421504	3	17,2,22	0,19673,27838	c	350008313800000006,350008313800000007	0-19,0-22						OPEN ACCESS pharmaceuticals	www.mdpi.com	0	0		SPPL2A,TRPM7
1048	chr10	60760351	60780030	3500418065	23		60760351	60780030	8421504	2	6,17	0,19662	c	350041806500000006	0-23						Ion channel-kinase TRPM7 is required for maintaining cardiac automaticity. - ResearchGate	.researchgate.net	0	0		
1048	chr10	60771771	60771797	3500259202	24		60771771	60771797	8421504	2	6,18	0,8	g	350025920200000329	8-32						Nematode Control	Craen	2010	0		
16	chr10	60780028	60841866	3500228413	1503		60780028	60841866	8421504	22	65,39,109,18,66,24,54,102,25,29,72,33,37,47,77,19,18,142,133,262,66,66	0,4222,8108,8220,8241,10528,10555,10612,10717,13364,54716,54791,54827,58327,58377,59519,59541,59562,60587,61423,61700,61772	p	350022841300015057,350022841300015064	15-546,12-996						Proteins and nucleic acids encoding the same	Alsobrook	2002	0		
1048	chr10	60794387	60797230	3500265186	40		60794387	60797230	8421504	2	20,20	0,2823	c	350026518600000001,350026518600000000	0-20,0-20		19780400	10.1684/mrh.2009.0176	0953-1424	Magnesium Research	John Libbey Eurotext : &#xc9;ditions m&#xe9;dicales et scientifiques France : revues, m&#xe9;dicales, scientifiques, m&#xe9;decine, sant&#xe9;, livres - Texte int&#xe9;gral de l'article	Schweigel	2009	2		
16	chr10	60817343	60869244	3500320034	109		60817343	60869244	8421504	7	21,19,5,20,20,9,15	0,39033,39204,39222,42024,42102,51886	c,g	350032003400000004,350032003400000004,350032003400000000,350032003400000002,350032003400000002,350032003400000003,350032003400000003,350032003400000001	0-21,0-21,0-24,0-20,0-20,0-20,0-20,0-24		19032368	10.1111/j.1349-7006.2008.00982.x	1349-7006	Cancer Science	Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer - Kim - 2008 - Cancer Science - Wiley Online Library	Kim	2008	0		TRPM7
1049	chr10	60838405	60869249	3500400752	387		60838405	60869249	8421504	9	77,13,24,33,48,91,35,46,20	0,1142,17760,17907,18206,18257,20789,21003,30824	p	350040075200015229,350040075200015018,350040075200015223,350040075200015206,350040075200015207,350040075200015222,350040075200015209,350040075200015224,350040075200015211	3-93,0-60,15-72,0-57,0-48,0-102,0-102,0-60,0-66						Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants	Lee	2007	0		TRPM7
1049	chr10	60855077	60856611	3500256575	49		60855077	60856611	8421504	2	26,23	0,1511	c,g	350025657500000012,350025657500000013,350025657500000013	0-26,0-23,0-23						Thrombin Activates Ca&#xc6cc;&#xc6b8;-permeating Nonselective Cation Channels through Protein Kinase C in Human Umbilical Vein Endothelial Cells	s-igaku.umin.jp	0	0		TRPM7
1049	chr10	60856376	60869244	3500246246	48		60856376	60869244	8421504	4	19,5,9,15	0,171,3069,12853	c	350024624600000000,350024624600000001	0-24,0-24		18006838	10.1158/0008-5472.CAN-07-1121	0008-5472	Cancer Research	Transient Receptor Potential Melastatin 7&#x2013;like Current in Human Head and Neck Carcinoma Cells: Role in Cell Proliferation	Jiang	2007	8		
1049	chr10	60856602	60859223	3500039441	180		60856602	60859223	8421504	2	151,29	0,2592	p	350003944100015112,350003944100015106	0-180,0-150						PROTEINS AND NUCLEIC ACIDS ENCODING THE SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
1050	chr10	61042854	61042899	3500098952	45		61042854	61042899	8421504	1	45	0	p	350009895200015006	0-45						PROCESS FOR THE PRODUCTION OF A PEPTIDE - Patent application	www.faqs.org	0	0		GABPB1
1050	chr10	61048065	61049780	3500391427	60		61048065	61049780	8421504	2	30,30	0,1685	p	350039142700015006	0-60						Assays - Patent application	www.faqs.org	0	0		GABPB1
1050	chr10	61048065	61049765	3500208501	45		61048065	61049765	8421504	2	30,15	0,1685	p	350020850100015008	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		GABPB1
1050	chr10	61048065	61049765	3500189065	45		61048065	61049765	8421504	2	30,15	0,1685	p	350018906500015010	0-45						Assays	Schofield	2005	0		GABPB1
1050	chr10	61049830	61078747	3500358810	43		61049830	61078747	8421504	2	20,23	0,28894	c	350035881000000001,350035881000000005	0-20,8-31		19951946	10.1074/jbc.M109.044305	0021-9258	Journal of Biological Chemistry	Nuclear Respiratory Factor 2 Induces the Expression of Many but Not All Human Proteins Acting in Mitochondrial DNA Transcription and Replication	Bruni	2010	5		GABPB1
1050	chr10	61049876	61049945	3500400817	69		61049876	61049945	8421504	1	69	0	p	350040081700015001	3-72						Designing Repeat Proteins: Well-expressed, Soluble and Stable Proteins from Combinatorial Libraries of Consensus Ankyrin Repeat Proteins	www.bioc.uzh.ch	0	0		GABPB1
1050	chr10	61071307	61078692	3500409160	41		61071307	61078692	8421504	2	20,21	0,7364	c	350040916000000032,350040916000000033	0-20,0-21			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
1050	chr10	61078650	61078701	3500308993	51		61078650	61078701	8421504	1	51	0	p	350030899300015001	0-51						PU.1 and a TTTAAA Element in the Myeloid Defensin-1 Promoter Create an Operational TATA Box That Can Impose	www.jimmunol.org	0	0		GABPB1
1050	chr10	61078650	61078701	3500205588	51		61078650	61078701	8421504	1	51	0	p	350020558800015001	0-51		16709851		0022-1767	The Journal of Immunology	PU.1 and a TTTAAA Element in the Myeloid Defensin-1 Promoter Create an Operational TATA Box That Can Impose Cell Specificity onto TFIID Function	Yaneva	2006	6		GABPB1
1051	chr10	61079844	61079869	3500189016	25		61079844	61079869	8421504	1	25	0	c	350018901600000464	7-32						Methods of inhibiting locomotor damage following spinal cord injury with &#x03b1; D-specific antibodies	Gallatin	2000	0		
1051	chr10	61106024	61106047	3500265684	23		61106024	61106047	8421504	1	23	0	c	350026568400000025	17-46						Szent Istv&#xe1;n Egyetem &#x0150;SHONOS MAGYAR TY&#xda;K&#xc1;LLOM&#xc1;NYOK GENETIKAI DIVERZIT&#xc1;S&#xc1;NAK VIZSG&#xc1;LATA K&#xdc;L&#xd6;NB&#xd6;Z&#x0150; MOLEKUL&#xc1;RIS GENETIKAI MARKEREK SEG&#xcd;TS&#xc9;G&#xc9;VEL	www.szie.hu	0	0		
1051	chr10	61112630	61112654	3500315740	24		61112630	61112654	8421504	1	24	0	c	350031574000000001	6-30		10711350	10.1038/sj.bjp.0703085	1476-5381	British Journal of Pharmacology	Participation of mitogen-activated protein kinase in thapsigargin- and TPA-induced histamine production in murine macrophage RAW 264.7 cells - Shiraishi - 2009 - British Journal of Pharmacology - Wiley Online Library	Shiraishi	2000	0		
1051	chr10	61128881	61128905	3500342144	23		61128881	61128905	8421504	2	5,18	0,6	c	350034214400000046	13-38						Use of multiple recombination sites with unique specificity in recombinational cloning	Cheo	2000	0		
1051	chr10	61128881	61128905	3500311609	23		61128881	61128905	8421504	2	7,16	0,8	c	350031160900000048	13-38						Use of multiple recombination sites with unique specificity in recombinational cloning	Brasch	2001	0		
1051	chr10	61128881	61128905	3500292898	24		61128881	61128905	8421504	1	24	0	c	350029289800000048,350029289800000046,350029289800000056	13-38,13-38,14-38					Patent	Use of multiple recombination sites with unique specificity in recombinational cloning (Patent US:7393632)	Cheo	2008	0		
1051	chr10	61128881	61128905	3500102953	23		61128881	61128905	8421504	2	5,18	0,6	c	350010295300000046	13-38						Use of multiple recombination sites with unique specificity in recombinational cloning	Brasch	2001	0		
1051	chr10	61128881	61128905	3500014789	24		61128881	61128905	8421504	1	24	0	c	350001478900000052,350001478900000050,350001478900000058	13-38,13-38,13-38						Use of multiple recombination sites with unique specificity in recombinational cloning	Cheo	2000	0		
1053	chr10	61379633	61379658	3500183198	24		61379633	61379658	8421504	2	4,20	0,5	g	350018319800000008,350018319800000009	15-39,1-25			10.1046/j.1462-5822.2003.00348.x	1462-5822	Cellular Microbiology	Evidence implicating the 5&#x2032; untranslated region of Listeria monocytogenes actA in the regulation of bacterial actin-based motility - Wong - 2003 - Cellular Microbiology - Wiley Online Library	Wong	2004	0		
1054	chr10	61596669	61596698	3500177982	26		61596669	61596698	8421504	2	15,11	0,18	g	350017798200000452	0-26						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		
1055	chr10	61691062	61691087	3500451372	23		61691062	61691087	8421504	3	12,5,6	0,13,19	c	350045137200000004,350045137200000016	5-34,5-34						Preparation of soluble N-protein/truncated P-protein complexes or N-proteinssoluble in a virus of the paramyxoviridae family and use thereof in vaccines - Patent application	www.faqs.org	0	0		
1055	chr10	61691062	61691087	3500396976	23		61691062	61691087	8421504	3	12,5,6	0,13,19	c	350039697600000022,350039697600000004	5-34,5-34						N PROTEIN OF A VIRUS OF THE PARAMYXOVIRIDAE FAMILY-PROTEIN OF INTEREST FUSION PROTEINS - Patent application	www.faqs.org	0	0		
1055	chr10	61691062	61691087	3500320580	23		61691062	61691087	8421504	3	12,5,6	0,13,19	c	350032058000000004	5-34						Proteines de fusion proteine n d'un virus de la famille des paramyxoviridae-proteine d'interet	Eleouet	2007	0		
1055	chr10	61691062	61691087	3500233523	23		61691062	61691087	8421504	3	12,5,6	0,13,19	c	350023352300000004	5-34						N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family	Eleouet	2007	0		
1056	chr10	61779165	61779215	3500346026	50		61779165	61779215	8421504	1	50	0	c	350034602600000012,350034602600000013	5-55,8-58						Dysregulation of miR-15a and miR-214 in human pancreatic cancer	biomedcentral.com	0	0		ANKRD20A3
1056	chr10	61779165	61779215	3500114623	50		61779165	61779215	8421504	1	50	0	c	350011462300000012,350011462300000013	5-55,8-58						Dysregulation of miR-15a and miR-214 in human pancreatic cancer	www.jhoonline.org	0	0		ANKRD20A3
1056	chr10	61779558	61840302	3500367790	588		61779558	61840302	8421504	3	198,104,286	0,1444,60458	p	350036779000015006	18-606						ELASTIN BASED GROWTH FACTOR DELIVERY PLATFORM FOR WOUND HEALING AND REGENERATION - Patent application	www.faqs.org	0	0		
1056	chr10	61779564	61840302	3500321720	582		61779564	61840302	8421504	3	192,104,286	0,1438,60452	p	350032172000015007	0-582						KEGG T01001: 2246	www.genome.jp	0	0		FGF7
1056	chr10	61779569	61779593	3500234187	24		61779569	61779593	8421504	1	24	0	c	350023418700000014	0-24						Clinical Efficacy and Mechanism of Bilayered Living Human Skin Equivalent (HSE) in Treatment of Diabetic Foot Ulcers	xwoundhealing.org	0	0		FGF7
1056	chr10	61779570	61840302	3500280081	342		61779570	61840302	8421504	10	45,42,3,45,2,43,45,45,45,27	0,144,1432,1486,1534,60446,60540,60588,60636,60705	p,c	350028008100015262,350028008100015259,350028008100015257,350028008100015256,350028008100015254,350028008100015253,350028008100015252,350028008100000031	0-45,0-45,0-45,0-45,0-45,0-45,0-45,19-46						Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance - Patent application	www.faqs.org	0	0		
1056	chr10	61779570	61840302	3500241753	342		61779570	61840302	8421504	10	45,42,3,45,2,43,45,45,45,27	0,144,1432,1486,1534,60446,60540,60588,60636,60705	p,c	350024175300015272,350024175300015269,350024175300015267,350024175300015266,350024175300015264,350024175300015263,350024175300015262,350024175300000029	0-45,0-45,0-45,0-45,0-45,0-45,0-45,19-46						COMPOSITIONS AND METHODS FOR GENETIC MODIFICATION OF CELLS HAVING COSMETIC FUNCTION TO ENHANCE COSMETIC APPEARANCE - Patent application	www.faqs.org	0	0		
1056	chr10	61779570	61840251	3500021819	315		61779570	61840251	8421504	9	45,42,3,45,2,43,45,45,45	0,144,1432,1486,1534,60446,60540,60588,60636	p	350002181900015223,350002181900015220,350002181900015218,350002181900015217,350002181900015215,350002181900015214,350002181900015213	0-45,0-45,0-45,0-45,0-45,0-45,0-45						Fibroblast growth factor homologous factor-4	Nathans	2000	0		
1056	chr10	61779573	61840209	3500420465	144		61779573	61840209	8421504	4	48,17,31,48	0,1516,60443,60588	c	350042046500000057,350042046500000060,350042046500000048	0-48,0-48,0-48						KGF polypeptide compositions - Patent application	www.faqs.org	0	0		
1056	chr10	61779576	61840302	3500100959	570		61779576	61840302	8421504	3	180,104,286	0,1426,60440	p,c	350010095900015003,350010095900015002,350010095900015001,350010095900000003,350010095900000002,350010095900015000,350010095900000001,350010095900000000	0-120,0-150,0-150,0-50,0-50,0-150,0-50,0-50						Sequence of Keratinocyte Growth Factor and Keratinocyte Growth Factor Receptor Orthologs [Monkey, Pig, Rabbit]	www.jstor.org	0	0		
1056	chr10	61779684	61840029	3500142509	90		61779684	61840029	8421504	3	45,32,13	0,1390,60332	p	350014250900015081,350014250900015078	0-45,0-45						Fibroblast growth factor (FGF23) polypeptides - US Patent 7745406 Description	ww.patentstorm.us	0	0		FGF7
1056	chr10	61779732	61840221	3500367790	225		61779732	61840221	8421504	7	24,21,32,13,45,45,45	0,1270,1342,60284,60300,60396,60444	p	350036779000015016,350036779000015014,350036779000015013,350036779000015011,350036779000015010	0-45,0-45,0-45,0-45,0-45						ELASTIN BASED GROWTH FACTOR DELIVERY PLATFORM FOR WOUND HEALING AND REGENERATION - Patent application	www.faqs.org	0	0		FGF7
1056	chr10	61779742	61781013	3500354530	25		61779742	61781013	8421504	2	14,11	0,1260	c	350035453000000003	0-25						LOW INTENSITY PULSED ULTRASOUND STIMULATES CELL PROLIFERATION	www.docstoc.com	0	0		FGF7
1056	chr10	61781069	61781098	3500325052	29		61781069	61781098	8421504	1	29	0	c	350032505200000019	0-29						MECHANISM OF HIC-5/ARA55 ACTION, A NOVEL STROMAL-SPECIFIC NUCLEAR RECEPTOR COACTIVATOR	olarship.pitt.edu	0	0		FGF7
1056	chr10	61781085	61840020	3500436134	25		61781085	61840020	8421504	2	21,4	0,58931	c	350043613400000029	4-29						Regulation of thymic epithelium by keratinocyte growth factor	tologylibrary.org	0	0		
1056	chr10	61840075	61840155	3500211808	80		61840075	61840155	8421504	1	80	0	c,g	350021180800000017,350021180800000031,350021180800000028,350021180800000004,350021180800000018,350021180800000006	0-40,2-32,7-32,0-35,0-33,0-45						KGF polypeptide compositions	Gospodarowicz	2002	0		
1056	chr10	61840083	61840293	3500057425	210		61840083	61840293	8421504	1	210	0	p	350005742500015015,350005742500015011	0-150,0-60						A novel &#xfb01;broblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1	ev.biologists.org	0	0		FGF7
1056	chr10	61840156	61840328	3500274037	40		61840156	61840328	8421504	2	20,20	0,152	c,g	350027403700000153,350027403700000152	0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1056	chr10	61840156	61840285	3500200683	40		61840156	61840285	8421504	2	20,20	0,109	c	350020068300000013,350020068300000012	0-20,0-20						Impact Journals presents	impactaging.com	0	0		FGF7
1056	chr10	61840186	61840269	3500304250	45		61840186	61840269	8421504	2	22,23	0,60	c	350030425000000001,350030425000000000	0-22,0-23						Progesterone Regulates FGF10, MET, IGFBP1, and IGFBP3 in the Endometrium of the Ovine Uterus	ww.biolreprod.org	0	0		
1056	chr10	61840245	61840290	3500423401	45		61840245	61840290	8421504	1	45	0	g	350042340100000000	0-45						Thecal Cell-Granulosa Cell Interactions Involve a Positive Feedback Loop among Keratinocyte Growth Factor, Hepatocyte Growth Factor, and Kit Ligand during Ovarian Follicular Development*	.endojournals.org	0	0		
1056	chr10	61840278	61840302	3500043049	24		61840278	61840302	8421504	1	24	0	c	350004304900000000	8-32						A Role for Skin &#x03b3;&#x03b4; T Cells in Wound Repair &#x2014; Supplemental Data 	ww.sciencemag.org	0	0		
1056	chr10	61840279	61840302	3500180897	23		61840279	61840302	8421504	1	23	0	c	350018089700000002	4-27		15470477	10.1038/sj.gt.3302383	0969-7128	Gene Therapy	Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model	Marti	2004	4		FGF7
1059	chr10	62188212	62188235	3500377423	23		62188212	62188235	8421504	1	23	0	c	350037742300000009	3-26						YeiL, the third member of the CRP&#x2013;FNR family in Escherichia coli	c.sgmjournals.org	0	0		
1059	chr10	62188212	62188235	3500188515	23		62188212	62188235	8421504	1	23	0	c	350018851500000008	3-26				1350-0872	Microbiology	YeiL, the third member of the CRP&#x2013;FNR family in Escherichia coli	Anjum	2000	3		
1059	chr10	62239955	62239981	3500194299	23		62239955	62239981	8421504	2	5,18	0,8	c	350019429900000015	10-33						Methods And Oligonucleotides For Detection Of Mastitis Causing Bacteria 	.freshpatents.com	0	0		
1062	chr10	62606889	62606913	3500197497	23		62606889	62606913	8421504	2	18,5	0,19	g	350019749700000004	9-32		11568184	10.1074/jbc.M106861200	0021-9258	Journal of Biological Chemistry	Biochemical Activities Associated with Mouse Mcm2 Protein	Ishimi	2001	5		
1063	chr10	62722905	62722928	3500411406	23		62722905	62722928	8421504	1	23	0	g	350041140600000005	0-23		14638678	10.1074/jbc.M312062200	0021-9258	Journal of Biological Chemistry	Fatty Aldehyde Dehydrogenase	Demozay	2004	5		HPRT1
133	chr10	63055395	63314515	3500460137	1020		63055395	63314515	8421504	19	44,83,99,96,96,2,136,44,60,40,20,28,32,16,44,16,44,60,60	0,33123,35870,48379,51819,120744,120806,124235,151460,154750,155848,171857,172004,197872,197983,229563,231310,249013,259060	p	350046013700015002,350046013700015003,350046013700015004,350046013700015005,350046013700015006,350046013700015007,350046013700015008,350046013700015010,350046013700015011,350046013700015012,350046013700015029,350046013700015032,350046013700015053,350046013700015080,350046013700015110,350046013700015125,350046013700015133	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						Homo sapiens fibrillin 1 (Marfan syndrome) (FBN1), mRNA. , NM_000138.2 - GenScript	www.genscript.com	0	0		
1067	chr10	63235757	63244548	3500079109	48		63235757	63244548	8421504	2	25,23	0,8768	c,g	350007910900000000,350007910900000001,350007910900000001	0-25,0-23,0-23						Metalloproteinase Research	www.jbc.org	0	0		
1067	chr10	63254808	63254831	3500304117	23		63254808	63254831	8421504	1	23	0	c	350030411700000000	0-23		17943183	10.1038/sj.jid.5701101	0022-202X	Journal of Investigative Dermatology	Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis	Bayle	2007	6		FBN1
1070	chr10	63644327	63664296	3500063444	90		63644327	63664296	8421504	4	44,1,41,4	0,1921,8380,19965	p	350006344400015098,350006344400015138	0-45,0-45						SCREENING METHODS - Patent application	www.faqs.org	0	0		
1070	chr10	63646265	63652734	3500269673	50		63646265	63652734	8421504	2	25,25	0,6444	c,g	350026967300000079,350026967300000033,350026967300000080,350026967300000045,350026967300000001,350026967300000002	0-25,0-25,0-25,0-25,0-25,0-25						Method of Screening for Compounds That Alter Skin and/or Hair Pigmentation - Patent application	www.faqs.org	0	0		
1070	chr10	63652709	63652734	3500064454	25		63652709	63652734	8421504	1	25	0	c	350006445400000002,350006445400000001	0-25,0-25						Method of screening for compounds that alter skin and/or hair pigmentation	Filsell	2007	0		
134	chr10	64041856	64099238	3500181609	4337		64041856	64099238	8421504	35	2456,78,48,96,96,45,23,48,48,48,48,45,96,20,76,47,20,57,19,96,48,37,59,48,37,3,74,22,2,46,48,18,30,67,288	0,2465,2591,2687,2831,2957,3054,3167,3242,3311,3407,3497,3551,3698,5452,5529,5600,7096,7513,8245,9565,9661,9789,9896,10382,10518,11471,12216,12334,13228,13555,13807,13935,15162,57094	c,g	350018160900000979,350018160900000978,350018160900000978,350018160900000165,350018160900000362,350018160900000976,350018160900000974,350018160900000972,350018160900000971,350018160900000969,350018160900000968,350018160900000905,350018160900000903,350018160900000962,350018160900000277,350018160900000959,350018160900000895,350018160900000957,350018160900000893,350018160900000954,350018160900000953,350018160900000336,350018160900000602,350018160900000335,350018160900000334,350018160900000885,350018160900000599,350018160900000884,350018160900000946,350018160900000945,350018160900000943,350018160900000941,350018160900000940,350018160900000938,350018160900000935,350018160900000933,350018160900000932,350018160900000929,350018160900000927,350018160900000924,350018160900000918,350018160900000918	0-2392,0-55,0-55,0-40,0-42,0-48,0-48,0-48,0-48,0-48,0-48,0-45,15-38,0-48,0-48,0-48,18-45,0-48,0-45,0-48,0-48,0-48,0-39,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,8-48,0-48,0-48,0-48,0-48,0-48,0-355,0-355						METHODS AND COMPOSITIONS FOR MODULATING T CELL AND/OR B CELL ACTIVATION - Patent application	www.faqs.org	0	0		
1073	chr10	64043487	64043510	3500457925	23		64043487	64043510	8421504	1	23	0	c	350045792500000001	5-34			10.1128/CDLI.12.2.249-253.2005		Clinical and Diagnostic Laboratory Immunology	Development and Validation of an Enzyme-Linked Immunosorbent Assay for Human Metapneumovirus Serology Based on a Recombinant Viral Protein	Marie-Eve	2005	0		
1073	chr10	64043487	64043510	3500144969	23		64043487	64043510	8421504	1	23	0	c	350014496900000001	5-34			10.1128/CDLI.12.2.249-253.2005	1556-6811	Clinical and Diagnostic Laboratory Immunology	Development and Validation of an Enzyme-Linked Immunosorbent Assay for Human Metapneumovirus Serology Based on a Recombinant Viral Protein	Hamelin	2005	3		
1073	chr10	64045208	64045232	3500406269	24		64045208	64045232	8421504	1	24	0	c,g	350040626900000301,350040626900000301	8-34,8-34					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
1083	chr10	65280497	65280521	3500422079	24		65280497	65280521	8421504	1	24	0	g	350042207900000007	0-24						Mitochondrial DNA and Y-Chromosome Variation of Eastern Aleut Populations: Implications for the Genetic Structure and Peopling of the Aleutian Archipelago	holarworks.ku.edu	0	0		MIMT1
1090	chr10	66228077	66228109	3500262078	25		66228077	66228109	8421504	3	8,5,12	0,11,20	c	350026207800000019	22-47						SURVEY OF THE GENOME OF	northumbria.ac.uk	0	0		
1091	chr10	66452354	66452754	3500308562	39		66452354	66452754	8421504	2	20,19	0,381	c,g	350030856200000028,350030856200000029,350030856200000029	0-20,0-19,0-19						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		GATM
1093	chr10	66630194	66630219	3500300004	23		66630194	66630219	8421504	2	7,16	0,9	c	350030000400000005	0-23		15642994	10.1128/CDLI.12.1.114-121.2005	1556-6811	Clinical and Diagnostic Laboratory Immunology	Antigenic and Immunogenic Investigation of B-Cell Epitopes in the Nucleocapsid Protein of Peste des Petits Ruminants Virus	Choi	2005	3		
1093	chr10	66633517	66635162	3500181036	26		66633517	66635162	8421504	2	20,6	0,1639	c	350018103600000000,350018103600000002	0-26,0-26						Conserved Cysteine Residues Provide a Protein-Protein Interaction Surface in Dual Oxidase (DUOX) Proteins	www.jbc.org	0	0		
1093	chr10	66637441	66637478	3500058951	29		66637441	66637478	8421504	3	16,4,9	0,21,28	c	350005895100000108	12-41						Collagen and uses therefor	Olsen	1993	0		
1093	chr10	66692550	66692595	3500119438	45		66692550	66692595	8421504	1	45	0	c	350011943800000017	5-50						Sex Differences in Gene Expression in Dog Cortex	www.ibg.uu.se	0	0		
1095	chr10	66905180	66917244	3500079754	45		66905180	66917244	8421504	2	29,16	0,12048	p	350007975400015087	0-45						Heparanase Specific Molecular Probes And Their Use In Research And Medical Applications 	.freshpatents.com	0	0		FERMT2
1096	chr10	67014955	67014980	3500091006	23		67014955	67014980	8421504	2	13,10	0,15	g	350009100600000001	8-31						Method for selecting and producing vaccine components and vaccines based thereon	Ke Nei Li Si *Yue Han Ni Si *Li En Huo Te Si 	2006	0		
1096	chr10	67091448	67091474	3500097096	23		67091448	67091474	8421504	2	15,8	0,18	g	350009709600000005	0-23						Elements for improved expression of bovine somatotropin	Bogosian	2008	0		
1097	chr10	67169858	67169886	3500439692	24		67169858	67169886	8421504	2	12,12	0,16	g	350043969200000233	0-24						HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof	Hasel	1993	0		
1102	chr10	67869630	67869660	3500210020	30		67869630	67869660	8421504	1	30	0	c	350021002000000011	0-30		20585586	10.1371/journal.pone.0011303		PLoS ONE	Hypoxia Regulates BMP4 Expression in the Murine Spleen during the Recovery from Acute Anemia	Dai-Chen	2010	0		MIR5580
1102	chr10	67869850	67871703	3500260926	122		67869850	67871703	8421504	4	26,48,14,34	0,412,844,1819	c	350026092600000013,350026092600000056,350026092600000047	12-38,0-48,0-48						Osteogenic factor	Grinna	1993	0		
1102	chr10	67869853	67870204	3500079459	351		67869853	67870204	8421504	1	351	0	p,c	350007945900000005,350007945900000044,350007945900000023,350007945900000001,350007945900015010,350007945900000042,350007945900000043,350007945900015067,350007945900015057,350007945900015111,350007945900015120,350007945900015100,350007945900015055,350007945900015110,350007945900015119,350007945900015099,350007945900015109,350007945900015118,350007945900015064,350007945900015108,350007945900015097,350007945900015008,350007945900015009,350007945900015018,350007945900015015,350007945900015013,350007945900015019,350007945900015051,350007945900015116,350007945900015096,350007945900015062,350007945900015060,350007945900015105,350007945900000000,350007945900000028,350007945900000030,350007945900000004	7-32,52-403,0-21,6-30,0-168,9-357,93-441,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-180,0-180,0-174,0-174,0-174,0-174,0-45,0-45,0-45,0-45,0-45,0-45,7-31,7-31,5-31,5-31						Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		
1102	chr10	67869854	67872042	3500002402	1224		67869854	67872042	8421504	3	854,94,276	0,1815,1912	p	350000240200015005	0-1224						Bone Morphogenetic Proteins for Appetite Control	Tseng	2010	0		BMP4,MIR5580
1102	chr10	67869854	67872036	3500229660	1209		67869854	67872036	8421504	4	854,94,186,75	0,1815,1912,2107	p	350022966000015016,350022966000015015,350022966000015014,350022966000015013,350022966000015012,350022966000015011,350022966000015010,350022966000015009	0-144,0-180,0-180,0-180,0-180,0-180,0-90,0-75						Methods and compositions for inducing brown adipogenesis	Tseng	2009	0		BMP4,MIR5580
1102	chr10	67869854	67870157	3500362819	264		67869854	67870157	8421504	2	120,144	0,159	p	350036281900015047,350036281900015027	0-120,0-144						Characterization of a gonad-specific transforming growth factor-&#x03b2; superfamily member differentially expressed during the reproductive cycle of the oyster Crassostrea gigas	chimer.ifremer.fr	0	0		BMP4,MIR5580
1102	chr10	67869857	67870157	3500063913	276		67869857	67870157	8421504	2	111,165	0,135	p	350006391300015020,350006391300015019	0-111,0-165						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		BMP4,MIR5580
1102	chr10	67869866	67870103	3500168337	180		67869866	67870103	8421504	4	45,45,45,45	0,48,144,192	p	350016833700015085,350016833700015084,350016833700015082,350016833700015081	0-45,0-45,0-45,0-45						Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		BMP4,MIR5580
1102	chr10	67869878	67870157	3500467295	240		67869878	67870157	8421504	2	105,135	0,144	p	350046729500015027,350046729500015013	0-105,0-135						Anti-Dorsalizing Morphogenetic Protein is a novel TGF- homolog expressed in the Spemann organizer	ev.biologists.org	0	0		BMP4,MIR5580
1102	chr10	67869904	67872031	3500434282	40		67869904	67872031	8421504	2	20,20	0,2107	c,g	350043428200000005,350043428200000005,350043428200000004,350043428200000004	0-20,0-20,0-20,0-20		16514193	10.1530/rep.1.00958	1470-1626	Reproduction	The role of bone morphogenetic proteins 2, 4, 6 and 7 during ovarian follicular development in sheep: contrast to rat	Juengel	2006	3		BMP4,MIR5580
1102	chr10	67869904	67872031	3500425131	40		67869904	67872031	8421504	2	20,20	0,2107	c,g	350042513100000005,350042513100000004,350042513100000004	0-20,0-20,0-20		16514193	10.1530/rep.1.00958	1470-1626	Reproduction	The role of bone morphogenetic proteins 2, 4, 6 and 7 during ovarian follicular development in sheep: contrast to rat	Juengel	2006	3		BMP4,MIR5580
1102	chr10	67869911	67870346	3500422167	126		67869911	67870346	8421504	2	30,96	0,339	c,g	350042216700000209,350042216700000079,350042216700000073,350042216700000072	18-48,21-48,0-48,0-48					Patent	Osteogenic proteins (Patent US:5266683)	Kuberasampath	1993	0		
1102	chr10	67869914	67870538	3500008143	219		67869914	67870538	8421504	4	27,48,96,48	0,48,336,576	c	350000814300000172,350000814300000171,350000814300000165,350000814300000164,350000814300000160	21-48,0-48,0-48,0-48,0-48						 Prosthetic Devices Having Enhanced Osteogenic Properties 	www.docstoc.com	0	0		
1102	chr10	67869914	67869959	3500303480	45		67869914	67869959	8421504	1	45	0	p	350030348000015039	0-45					Patent	Mutations of the C-terminal portion of TGF-&#x03b2; superfamily proteins (Patent US:6677432)	Oppermann	2004	0		BMP2
1102	chr10	67869917	67870031	3500145334	99		67869917	67870031	8421504	2	54,45	0,69	p	350014533400015141,350014533400015163,350014533400015116	0-45,0-45,0-45						Tendon Stem Cells - Patent application	www.faqs.org	0	0		MIR5580
1102	chr10	67869962	67871982	3500092036	336		67869962	67871982	8421504	5	48,96,48,48,96	0,288,432,528,1924	c	350009203600000067,350009203600000062,350009203600000061,350009203600000059,350009203600000057,350009203600000048,350009203600000047	0-48,0-48,0-48,0-48,0-48,0-48,0-48					Patent	Recombinant bone morphogenetic protein heterodimers (Patent US:5866364)	Israel	1999	0		
1102	chr10	67869986	67870031	3500106454	45		67869986	67870031	8421504	1	45	0	p	350010645400015021	0-45						Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof - Patent application	www.faqs.org	0	0		MIR5580
1102	chr10	67870010	67870310	3500400218	40		67870010	67870310	8421504	2	20,20	0,280	c,g	350040021800000009,350040021800000008,350040021800000008	0-20,0-20,0-20						Human parthenogenetic stem cells - Patent application	www.faqs.org	0	0		BMP4,MIR5580
1102	chr10	67870010	67870310	3500015504	40		67870010	67870310	8421504	2	20,20	0,280	c,g	350001550400000009,350001550400000008,350001550400000008	0-20,0-20,0-20						Human parthenogenetic stem cells	Brevini	2007	0		BMP4,MIR5580
1102	chr10	67870011	67870035	3500202732	24		67870011	67870035	8421504	1	24	0	c	350020273200000022	24-48						FGF2 Signaling in Mouse Embryonic Fibroblasts Is Crucial for Self-Renewal of Embryonic Stem Cells	mdc.helmholtz.de	0	0		MIR5580
1102	chr10	67870013	67870346	3500342586	93		67870013	67870346	8421504	2	45,48	0,285	p,c	350034258600015053,350034258600000039	0-45,0-48						Bmp-9 compositions	Celeste	1993	0		
1102	chr10	67870058	67871691	3500203533	96		67870058	67871691	8421504	3	48,26,22	0,624,1611	c	350020353300000082,350020353300000070	0-48,0-48						US Patent # 5,468,845. Antibodies to osteogenic proteins - Patents.com	www.patents.com	0	0		
1102	chr10	67870147	67872034	3500450464	40		67870147	67872034	8421504	2	20,20	0,1867	c,g	350045046400000005,350045046400000004,350045046400000004	0-20,0-20,0-20		19369394	10.1242/dev.034082		Development (Cambridge, England)	FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate	Jie	2009	0		BMP4
1102	chr10	67870147	67872034	3500084753	40		67870147	67872034	8421504	2	20,20	0,1867	c,g	350008475300000005,350008475300000004,350008475300000004	0-20,0-20,0-20		19369394	10.1242/dev.034082	0950-1991	Development	FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate	Huang	2009	7		BMP4
1102	chr10	67870181	67870205	3500244732	24		67870181	67870205	8421504	1	24	0	c	350024473200000000	16-40		21862694	10.1530/REP-11-0275	1470-1626	Reproduction	Bone morphogenetic protein 4 accelerates the establishment of bovine trophoblastic cell lines	Suzuki	2011	3		
1102	chr10	67870247	67870538	3500418018	99		67870247	67870538	8421504	2	51,48	0,243	c	350041801800000203,350041801800000073,350041801800000068	0-48,0-48,0-48						US Patent # 5,266,683. Osteogenic proteins - Patents.com	www.patents.com	0	0		
1102	chr10	67870250	67871982	3500018954	144		67870250	67871982	8421504	3	48,48,48	0,144,1684	c	350001895400000063,350001895400000060,350001895400000048	0-48,0-48,0-48						Novel Bmp Products 	.freshpatents.com	0	0		
1102	chr10	67870250	67870442	3500262519	96		67870250	67870442	8421504	2	48,48	0,144	c	350026251900000063,350026251900000060	0-48,0-48						BMP-9 compositions	www.devileye.net	0	0		
1102	chr10	67870250	67870298	3500320185	48		67870250	67870298	8421504	1	48	0	c	350032018500000063	0-48						Recombinant bone morphogenetic protein heterodimers	Israel	1992	0		
1102	chr10	67870298	67870447	3500334789	67		67870298	67870447	8421504	2	48,19	0,130	c	350033478900000066,350033478900000036	0-48,28-47						Recombinant bone morphogenetic protein heterodimers, compositions and methods of use	Israel	1994	0		
1102	chr10	67870298	67870340	3500149263	42		67870298	67870340	8421504	1	42	0	c	350014926300000063	0-42						 Methods Of Treatment Of Periodontal Disease 	www.docstoc.com	0	0		
1102	chr10	67870310	67870358	3500300553	48		67870310	67870358	8421504	1	48	0	c	350030055300000055	0-48						Osteogenic factor	Grinna	1993	0		
1102	chr10	67870313	67870339	3500012335	23		67870313	67870339	8421504	2	18,5	0,21	c	350001233500000024	0-23						ISSN 1684 - 5315	demicjournals.org	0	0		
1102	chr10	67870519	67872038	3500218903	39		67870519	67872038	8421504	2	20,19	0,1500	c,g	350021890300000005,350021890300000004,350021890300000004	0-20,0-19,0-19					Patent	Spondyloarthropathies (Patent US:7371725)	Luyten	2008	0		BMP4
1102	chr10	67870519	67872038	3500111962	39		67870519	67872038	8421504	2	20,19	0,1500	c,g	350011196200000005,350011196200000004,350011196200000004	0-20,0-19,0-19						Bmp inhibitors for the treatment of spondyloarthropathies	Lories	2004	0		BMP4
1102	chr10	67870633	67872027	3500122201	39		67870633	67872027	8421504	2	20,19	0,1375	c,g	350012220100000012,350012220100000011,350012220100000011	0-20,0-19,0-19						Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis-an in vitro efficacy study. - ResearchGate	.researchgate.net	0	0		BMP4
1102	chr10	67870636	67870660	3500031349	24		67870636	67870660	8421504	1	24	0	c	350003134900000020	0-24		18795143	10.1371/journal.pone.0002814		PLoS ONE	Role of the Transcriptional Corepressor Bcor in Embryonic Stem Cell Differentiation and Early Embryonic Development	Joseph	2008	0		BMP4
1102	chr10	67870644	67871976	3500007804	49		67870644	67871976	8421504	2	25,24	0,1308	c	350000780400000055,350000780400000054	0-25,0-24						RETINAL PIGMENT EPITHELIAL STEM CELLS	Temple	2009	0		BMP4
1102	chr10	67870650	67871962	3500242713	41		67870650	67871962	8421504	2	21,20	0,1292	c	350024271300000007,350024271300000006	0-21,0-20						BONE MORPHOGENETIC PROTEIN-4: A NOVEL MODULATOR OF MELANOGENESIS	www.jbc.org	0	0		BMP4
1102	chr10	67870650	67871962	3500219600	42		67870650	67871962	8421504	2	21,21	0,1291	c	350021960000000037,350021960000000036	0-21,0-21						MULTIPLE MESODERMAL LINEAGE DIFFERENTIATION POTENTIALS FOR ADIPOSE TISSUE-DERIVED STROMAL CELLS AND USES THEREOF - Patent application	www.faqs.org	0	0		BMP4
1102	chr10	67870650	67871962	3500107504	42		67870650	67871962	8421504	2	21,21	0,1291	c	350010750400000037,350010750400000036	0-21,0-21						MULTIPLE MESODERMAL LINEAGE DIFFERENTIATION POTENTIALS FOR ADIPOSE TISSUE-DERIVED STROMAL CELLS AND USES THEREOF - Patent application	www.faqs.org	0	0		BMP4
1102	chr10	67870650	67871962	3500072682	41		67870650	67871962	8421504	2	21,20	0,1292	c,g	350007268200000007,350007268200000006,350007268200000006	0-21,0-20,0-20		16837459	10.1074/jbc.M600580200	0021-9258	Journal of Biological Chemistry	Bone Morphogenetic Protein-4, a Novel Modulator of Melanogenesis	Yaar	2006	5		BMP4
1102	chr10	67870650	67871962	3500058826	42		67870650	67871962	8421504	2	21,21	0,1291	c	350005882600000007,350005882600000006	0-21,0-21						BoneMorphogeneticProtein-4,aNovelModulator ofMelanogenesis	www.jbc.org	0	0		BMP4
1102	chr10	67870694	67871997	3500417024	39		67870694	67871997	8421504	3	14,5,20	0,975,1283	c,g	350041702400000013,350041702400000012,350041702400000012	0-19,0-20,0-20						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - STEMPEUTICS RESEARCH PRIVATE LIMITED	www.sumobrain.com	0	0		BMP4
1102	chr10	67870694	67871997	3500401984	39		67870694	67871997	8421504	3	14,5,20	0,975,1283	c,g	350040198400000013,350040198400000012,350040198400000012	0-19,0-20,0-20						XENO-FREE CULTURE CONDITIONS FOR HUMAN EMBRYONIC STEM CELLS AND METHODS THEREOF	Totey	2009	0		BMP4
1102	chr10	67870694	67871997	3500032816	39		67870694	67871997	8421504	3	14,5,20	0,975,1283	c,g	350003281600000053,350003281600000013,350003281600000052,350003281600000052,350003281600000012,350003281600000012	0-19,0-19,0-20,0-20,0-20,0-20						XENO-FREE CULTURE CONDITIONS FOR HUMAN EMBRYONIC STEM CELLS AND METHODS THEREOF - Patent application	www.faqs.org	0	0		BMP4
1102	chr10	67870694	67871997	3500008009	39		67870694	67871997	8421504	3	14,5,20	0,975,1283	c,g	350000800900000013,350000800900000053,350000800900000012,350000800900000012,350000800900000052,350000800900000052	0-19,0-19,0-20,0-20,0-20,0-20						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - Patent application	www.faqs.org	0	0		BMP4
1102	chr10	67870703	67871966	3500155007	40		67870703	67871966	8421504	3	5,15,20	0,966,1243	c,g	350015500700000005,350015500700000004,350015500700000004	0-20,0-20,0-20		19692649	10.1096/fj.08-127795	0892-6638	The FASEB Journal	In vitro and In vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cells	Kang	2009	6		BMP4
1102	chr10	67871854	67872003	3500170203	73		67871854	67872003	8421504	3	21,30,22	0,96,127	c	350017020300000006,350017020300000007	26-77,0-22						9-Methyl- -carboline has restorative effects in an animal model of Parkinson&#x2019;s disease	.if-pan.krakow.pl	0	0		BMP4
1102	chr10	67871923	67872038	3500143726	42		67871923	67872038	8421504	2	21,21	0,94	c,g	350014372600000001,350014372600000001,350014372600000000,350014372600000000	0-21,0-21,0-21,0-21						COMPOSITIONS AND METHODS FOR CARDIOVASCULAR DISEASE - THE GENERAL HOSPITAL CORPORATION	www.sumobrain.com	0	0		BMP4
1102	chr10	67871943	67873188	3500042708	43		67871943	67873188	8421504	2	23,20	0,1225	c,g	350004270800000015,350004270800000005,350004270800000005,350004270800000004	17-40,0-20,0-20,0-20						METHODS AND COMPOSITIONS FOR GROWTH OF CELLS AND EMBRYONIC TISSUE ON A SYNTHETIC POLYMER MATRIX - Patent application	www.faqs.org	0	0		BMP4
1102	chr10	67871946	67873188	3500419399	40		67871946	67873188	8421504	2	20,20	0,1222	c,g	350041939900000007,350041939900000007,350041939900000006,350041939900000006	0-20,0-20,0-20,0-20						Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or &#x03b1;1 type IV collagen	Doi	2004	0		BMP4
1102	chr10	67871946	67873188	3500396763	40		67871946	67873188	8421504	2	20,20	0,1222	c	350039676300000019,350039676300000018	0-20,0-20		19737815	10.1242/jcs.051904	0021-9533	Journal of Cell Science	Axin2 controls bone remodeling through the &#x03b2;-catenin&#x2013;BMP signaling pathway in adult mice	Yan	2009	6		BMP4
1102	chr10	67871946	67873188	3500026211	40		67871946	67873188	8421504	2	20,20	0,1222	c,g	350002621100000006,350002621100000006,350002621100000016,350002621100000005	0-20,0-20,0-20,0-20						METHODS AND COMPOSITIONS FOR GROWTH OF EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		BMP4
1102	chr10	67872001	67872026	3500450459	25		67872001	67872026	8421504	1	25	0	c	350045045900000003	0-41						Bone Morphogenic Proteins (bmp), Bmp Receptors And Bmp Binding Proteins And Their Use In The Diagnosis And Treatment Of Glaucoma 	.freshpatents.com	0	0		BMP4
1102	chr10	67872001	67872026	3500312664	25		67872001	67872026	8421504	1	25	0	c	350031266400000003	0-41					Patent	Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin (Patent US:7744873)	Clark	2010	0		
1102	chr10	67872001	67872026	3500282153	25		67872001	67872026	8421504	1	25	0	c	350028215300000003	0-41						Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2008	0		
1102	chr10	67872001	67872026	3500211075	25		67872001	67872026	8421504	1	25	0	c,g	350021107500000003,350021107500000003	0-41,0-41						BONE MORPHOGENIC PROTEINS (BMP), BMP RECEPTORS AND BMP BINDING PROTEINS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF GLAUCOMA	Clark	2008	0		BMP4
1102	chr10	67872003	67872026	3500090229	23		67872003	67872026	8421504	1	23	0	c,g	350009022900000048,350009022900000048,350009022900000011,350009022900000011	0-23,0-23,0-23,0-23						REISHI-MEDIATED ENHANCEMENT OF HUMAN TISSUE PROGENITOR CELL ADHESION AND DIFFERENTIATION - Patent application	www.faqs.org	0	0		
1102	chr10	67872013	67872042	3500346710	29		67872013	67872042	8421504	1	29	0	c	350034671000000000	0-29			10.1002/dvdy.21245	1097-0177	Developmental Dynamics	Phenotypic analysis of a novel chordin mutant in medaka - Takashima - 2007 - Developmental Dynamics - Wiley Online Library	Takashima	2007	0		BMP4
1102	chr10	67872019	67872046	3500396444	27		67872019	67872046	8421504	1	27	0	c	350039644400000003	4-31						RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE - Patent application	www.faqs.org	0	0		BMP4
1102	chr10	67872019	67872046	3500231518	27		67872019	67872046	8421504	1	27	0	c,g	350023151800000003,350023151800000003	4-31,4-31					Patent	Recombinant bone morphogenetic protein heterodimers, compositions and methods of use (Patent US:7678885)	Israel	2010	0		BMP4
1102	chr10	67872019	67872046	3500218613	27		67872019	67872046	8421504	1	27	0	c	350021861300000003	4-31					Patent	Recombinant bone morphogenetic protein heterodimers, compositions and methods of use (Patent US:6190880)	Israel	2001	0		BMP4
1102	chr10	67872019	67872046	3500180209	27		67872019	67872046	8421504	1	27	0	c	350018020900000003	4-31					Patent	Recombinant bone morphogenetic protein heterodimers, compositions and methods of use (Patent US:7678885)	Israel	2010	0		BMP4
1102	chr10	67872019	67872046	3500176407	27		67872019	67872046	8421504	1	27	0	c	350017640700000003	4-31					Patent	Recombinant bone morphogenetic protein heterodimers, compositions and methods of use (Patent US:6593109)	Israel	2003	0		BMP4
1102	chr10	67872019	67872045	3500007402	26		67872019	67872045	8421504	1	26	0	c	350000740200000000	2-28						Pharmacology Pharmacy and African Journal of	demicjournals.org	0	0		BMP4
1102	chr10	67872028	67873114	3500147619	24		67872028	67873114	8421504	2	21,3	0,1083	c	350014761900000022	0-24						Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth	Tsuji	2009	0		BMP4
1102	chr10	67872028	67873114	3500133138	24		67872028	67873114	8421504	2	21,3	0,1083	c	350013313800000022	0-24						Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth	Tsuji	2010	0		BMP4
1104	chr10	68118785	68118810	3500394860	23		68118785	68118810	8421504	2	12,11	0,14	g	350039486000000098	20-47						METHODS AND COMPOSITIONS FOR TREATING TULAREMIA - Patent application	www.faqs.org	0	0		
1105	chr10	68272850	68282814	3500337656	176		68272850	68282814	8421504	7	48,34,45,1,14,32,2	0,1338,1826,4353,4427,8291,9962	c	350033765600000006,350033765600000008,350033765600000009,350033765600000014	0-48,0-48,0-32,0-48					Patent	Interaction trap system for isolating novel proteins (Patent US:5580736)	Brent	1996	0		
1105	chr10	68272850	68277204	3500035830	128		68272850	68277204	8421504	4	48,34,45,1	0,1338,1826,4353	c	350003583000000006,350003583000000008,350003583000000009	0-48,0-48,0-32					Patent	Interaction trap system for isolating novel proteins (Patent US:5580736)	Brent	1996	0		
1105	chr10	68277277	68282814	3500310260	48		68277277	68282814	8421504	3	14,32,2	0,3864,5535	c	350031026000000014	0-48						Interaction trap system for isolating novel proteins	Brent	1994	0		
1106	chr10	68292480	68292718	3500019989	40		68292480	68292718	8421504	2	20,20	0,218	c	350001998900000224,350001998900000223	0-20,0-20						Genexpressions-Profil einer dysmyelinisierenden Doppel knock out-Mausmutante (mbp-/- plp-/-) und Rescue-Versuch des normalen Ph&#xe4;notyps	www.uni-koeln.de	0	0		CNIH
1106	chr10	68300515	68300560	3500202314	45		68300515	68300560	8421504	1	45	0	p	350020231400015000	0-45			10.1242/jcs.004200	0021-9533	Journal of Cell Science	Cornichon regulates transport and secretion of TGF&#x03b1;-related proteins in metazoan cells	Castro	2007	6		CNIH
1106	chr10	68330366	68336403	3500360141	180		68330366	68336403	8421504	6	27,18,45,44,1,45	0,1942,1963,4520,5988,5992	p	350036014100015016,350036014100015015,350036014100015012,350036014100015011	0-45,0-45,0-45,0-45						Antibodies that bind human haemopoietic maturation factor	Kirkness	1999	0		GMFB
1108	chr10	68676936	68676961	3500152838	24		68676936	68676961	8421504	2	20,4	0,21	g	350015283800000116	8-32						US Patent # 5,876,951. Yeast cells engineered to produce pheromone system protein surrogates and uses therefor - Patents.com	www.patents.com	0	0		
1109	chr10	68700487	68700515	3500173273	28		68700487	68700515	8421504	1	28	0	c	350017327300000169	0-28						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT	Murphy	2009	0		CARNS1
1109	chr10	68701137	68701164	3500027937	27		68701137	68701164	8421504	1	27	0	c	350002793700000057	32-59						Gpcr-like Retinoic Acid-induced Gene 1 Protein And Nucleic Acid 	.freshpatents.com	0	0		
1110	chr10	68815560	68815584	3500002244	23		68815560	68815584	8421504	2	19,4	0,20	g	350000224400000154,350000224400000070	0-23,0-23						GENE EXPRESSION AND PAIN - Patent application	www.faqs.org	0	0		
1110	chr10	68934217	68934240	3500336865	23		68934217	68934240	8421504	1	23	0	c	350033686500000164	21-44						Stem cell inhibiting proteins	Craig	1993	0		
1111	chr10	69051799	69051827	3500155690	28		69051799	69051827	8421504	1	28	0	c	350015569000000035	0-28						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		
1111	chr10	69051831	69051855	3500415939	24		69051831	69051855	8421504	1	24	0	c,g	350041593900000001,350041593900000001	0-24,0-24		12556378	10.1167/iovs.02-0268	1552-5783	Investigative Ophthalmology & Visual Science	Expression and Function of Receptors for Advanced Glycation End Products in Bovine Corneal Endothelial Cells	Kaji	2003	0		LGALS3
1112	chr10	69118324	69118349	3500359000	23		69118324	69118349	8421504	2	15,8	0,17	g	350035900000000006	0-27						Chimeric Viral Envelopes	Pedersen	2007	0		
1114	chr10	69349915	69349942	3500394860	25		69349915	69349942	8421504	3	6,5,14	0,7,13	g	350039486000000119	13-41						METHODS AND COMPOSITIONS FOR TREATING TULAREMIA - Patent application	www.faqs.org	0	0		
1117	chr10	69766959	69766984	3500223047	23		69766959	69766984	8421504	2	14,9	0,16	g	350022304700000009	5-28			10.1111/j.1365-313X.2005.02412.x	1365-313X	The Plant Journal	The maize low-phytic acid 3 encodes a myo-inositol kinase that plays a role in phytic acid biosynthesis in developing seeds - Shi - 2005 - The Plant Journal - Wiley Online Library	Shi	2005	0		
1118	chr10	69977393	69977417	3500240600	23		69977393	69977417	8421504	2	9,14	0,10	g	350024060000000021	13-38						CD30 ligand conjugates	Goodwin	1995	0		
1119	chr10	70047575	70047603	3500437918	23		70047575	70047603	8421504	2	9,14	0,14	g	350043791800000083	0-23						Detecting Bacillus anthracis	Radnedge	2005	0		
1123	chr10	70625962	70625987	3500107865	24		70625962	70625987	8421504	2	10,14	0,11	c	350010786500000490	9-47						Anti-Cd14 Antibody Fusion Protein - Patent application	www.faqs.org	0	0		
1125	chr10	70872157	70880783	3500445486	41		70872157	70880783	8421504	5	6,13,4,4,14	0,11,8602,8607,8612	g	350044548600000413,350044548600000083	0-19,3-25						Novel methods for production of di-chain botulinum toxin	Li	2004	0		
1125	chr10	70896334	70896545	3500413820	51		70896334	70896545	8421504	2	26,25	0,186	c	350041382000000040,350041382000000026,350041382000000039	0-26,25-51,0-25						CELL CULTURE	Choo	2003	0		OTX2
1125	chr10	70896334	70896545	3500372742	51		70896334	70896545	8421504	2	26,25	0,186	c	350037274200000017,350037274200000016	0-26,0-25						Derivation of midbrain dopaminergic neurons from embryonic stem cells	Lee	2001	0		
1125	chr10	70896334	70896545	3500276823	51		70896334	70896545	8421504	2	26,25	0,186	c,g	350027682300000034,350027682300000034,350027682300000033,350027682300000033	0-26,0-26,0-25,0-25						GENERATION OF INNER EAR CELLS - Patent application	www.faqs.org	0	0		OTX2
1125	chr10	70896334	70896545	3500007804	51		70896334	70896545	8421504	2	26,25	0,186	c	350000780400000019,350000780400000018	0-26,0-25						RETINAL PIGMENT EPITHELIAL STEM CELLS	Temple	2009	0		
1125	chr10	70896334	70896360	3500386021	26		70896334	70896360	8421504	1	26	0	c	350038602100000026	25-51						Cell culture	Choo	2008	0		OTX2
1125	chr10	70896334	70896360	3500005911	26		70896334	70896360	8421504	1	26	0	c	350000591100000024	25-51						Stem Cell Assays	.researchgate.net	0	0		OTX2
1125	chr10	70896520	70896546	3500220080	26		70896520	70896546	8421504	1	26	0	c	350022008000000019,350022008000000020	21-47,0-25						Method for inducing differentiation of embryonic stem cells	Inoue	2003	0		OTX2
1127	chr10	71149912	71149941	3500271912	25		71149912	71149941	8421504	3	5,15,5	0,7,24	g	350027191200000039	23-48						Response regulator	www.devileye.net	0	0		
1128	chr10	71289789	71289815	3500197082	23		71289789	71289815	8421504	3	14,5,4	0,16,22	g	350019708200000001	11-34						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: " The pp24 phosphoprotein of Mason-Pfizer monkey virus contributes to viral genome packaging" 	tailieu.vn/doc/ba	0	0		
1129	chr10	71321368	71321394	3500401653	23		71321368	71321394	8421504	2	14,9	0,17	c	350040165300000081,350040165300000080	0-24,2-26					Patent	Amplification of target nucleic acids using gap filling ligase chain reaction (Patent US:5427930)	Birkenmeyer	1995	0		
1129	chr10	71322763	71322808	3500453437	45		71322763	71322808	8421504	1	45	0	p	350045343700015001	3-48		19297529	10.1091/mbc.E08-07-0772		Molecular Biology of the Cell	An InCytes from MBC Selection: The Exocyst Protein Sec10 Is Necessary for Primary Ciliogenesis and Cystogenesis In Vitro	Xiaofeng	2009	0		EXOC5
1130	chr10	71488852	71488876	3500386203	24		71488852	71488876	8421504	1	24	0	c	350038620300000238	5-36						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
1130	chr10	71488852	71488876	3500160528	24		71488852	71488876	8421504	1	24	0	c	350016052800000243	5-36						Anthrax toxin fusion proteins and uses thereof	Arora	1994	0		
1130	chr10	71540991	71541018	3500263908	24		71540991	71541018	8421504	2	16,8	0,19	g	350026390800000198	5-47						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
1136	chr10	72321780	72322105	3500375699	325		72321780	72322105	8421504	1	325	0	g	350037569900000037	10-338						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
17	chr10	72349752	72352519	3500061911	234		72349752	72352519	8421504	4	132,30,42,30	0,2299,2353,2737	p	350006191100015024,350006191100015018,350006191100015012	0-111,0-51,0-72						Molekulare Ursachen des Mohr-Tranebjaerg-Syndroms	b.uni-muenchen.de	0	0		TIMM9
1144	chr10	73352185	73352212	3500115748	23		73352185	73352212	8421504	2	10,13	0,14	c	350011574800000004	1-24		22133879	10.1172/JCI59251		The Journal of Clinical Investigation	Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms	Kiyoshi	2012	0		
1145	chr10	73495834	73514544	3500449321	38		73495834	73514544	8421504	3	19,7,12	0,17736,18698	c,g	350044932100000000,350044932100000001	0-19,0-19						JAMP Optimizes ERAD to Protect Cells from Unfolded Proteins	w.molbiolcell.org	0	0		JKAMP,CCDC175
1145	chr10	73495834	73514544	3500284305	38		73495834	73514544	8421504	3	19,7,12	0,17736,18698	c,g	350028430500000000,350028430500000001	0-19,0-19		18784250	10.1091/mbc.E08-08-0839		Molecular Biology of the Cell	JAMP Optimizes ERAD to Protect Cells from Unfolded Proteins	Marianna	2008	0		JKAMP,CCDC175
1145	chr10	73495834	73514544	3500129815	38		73495834	73514544	8421504	3	19,7,12	0,17736,18698	c,g	350012981500000000,350012981500000001	0-19,0-19		18784250	10.1091/mbc.E08-08-0839	1059-1524	Molecular Biology of the Cell	JAMP Optimizes ERAD to Protect Cells from Unfolded Proteins	Tcherpakov	2008	5		JKAMP,CCDC175
1150	chr10	74183398	74184004	3500323393	237		74183398	74184004	8421504	5	45,45,72,45,30	0,48,453,528,576	p	350032339300015037,350032339300015043	0-90,0-147						US Patent # 7,320,785. Compositions and methods for modulation of DARPP-32 phosphorylation - Patents.com	www.patents.com	0	0		
1150	chr10	74183449	74183903	3500361312	40		74183449	74183903	8421504	2	20,20	0,434	c,g	350036131200000023,350036131200000023,350036131200000024	0-20,0-20,0-20						Tumour associated antigens	Banham	2004	0		PPM1A
1150	chr10	74183449	74183903	3500288773	40		74183449	74183903	8421504	2	20,20	0,434	c,g	350028877300000023,350028877300000023,350028877300000024	0-20,0-20,0-20						Tumour associated antigens	Banham	2003	0		PPM1A
1150	chr10	74184228	74186629	3500198186	28		74184228	74186629	8421504	2	1,27	0,2374	c	350019818600000007	20-48						Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone	do.physiology.org	0	0		
1151	chr10	74194334	74194535	3500367934	183		74194334	74194535	8421504	2	69,114	0,87	c	350036793400000282,350036793400000283	0-69,0-114						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
1158	chr10	75128146	75128194	3500023334	48		75128146	75128194	8421504	1	48	0	c	350002333400000386	0-48						Proteins, Polynucleotides Encoding Them And Methods Of Using The Same 	.freshpatents.com	0	0		
1158	chr10	75128176	75128200	3500391930	24		75128176	75128200	8421504	1	24	0	g	350039193000000004	20-44						Hepatoblast-Like Progenitor Cells Derived From Embryonic Stem Cells Can Repopulate Livers of Mice	library.ibp.ac.cn	0	0		
1158	chr10	75128307	75128331	3500361047	24		75128307	75128331	8421504	1	24	0	c	350036104700000006,350036104700000026	0-24,0-22						Development of a 3D culture system to study the skeletal metastasis of prostate cancer	prints.qut.edu.au	0	0		KRT8
1158	chr10	75128307	75128331	3500094094	24		75128307	75128331	8421504	1	24	0	c	350009409400000002	0-24						Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo	-publications.com	0	0		KRT8
1158	chr10	75128880	75129117	3500398906	41		75128880	75129117	8421504	2	20,21	0,216	c,g	350039890600000013,350039890600000013,350039890600000012,350039890600000012	0-20,0-20,0-21,0-21						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
1158	chr10	75129223	75129286	3500065419	63		75129223	75129286	8421504	1	63	0	p	350006541900015020	0-63						The Genetic Basis of Weber-Cockayne Epidermolysis Bullosa Simplex	www.jstor.org	0	0		
1158	chr10	75129524	75129549	3500129719	25		75129524	75129549	8421504	1	25	0	c	350012971900000001	0-25						Down-Regulated CK8 Expression in Human Intervertebral Disc Degeneration. - ResearchGate	.researchgate.net	0	0		
1158	chr10	75216638	75216664	3500015533	23		75216638	75216664	8421504	3	14,5,4	0,16,22	g	350001553300000099,350001553300000072	26-49,14-36						 Method Of Diagnosing Lung Cancer Using BGS42 	www.docstoc.com	0	0		
1158	chr10	75217794	75217848	3500106421	54		75217794	75217848	8421504	1	54	0	p	350010642100015062	0-54						ISOZYME-SPECIFIC ANTAGONISTS OF PROTEIN KINASE C - Patent application	www.faqs.org	0	0		PRKCH
1158	chr10	75217794	75217848	3500042770	54		75217794	75217848	8421504	1	54	0	p	350004277000015056	0-54						Isozyme-specific antagonists of protein kinase C - Patent application	www.faqs.org	0	0		PRKCH
1159	chr10	75352063	75352086	3500232777	23		75352063	75352086	8421504	1	23	0	c	350023277700000024	0-23						1 abstract title	tory.lib.ncsu.edu	0	0		PRKCH
1160	chr10	75437400	75437426	3500333519	24		75437400	75437426	8421504	2	6,18	0,8	g	350033351900000107,350033351900000043	4-24,8-33						Methods of treating inflammatory skin diseases	Xia	2001	0		
145	chr10	75621383	75648741	3500272405	744		75621383	75648741	8421504	8	35,191,146,85,92,18,132,45	0,20667,21226,21459,26229,26324,27178,27313	p	350027240500015001	0-744						METHODS AND COMPOSITIONS RELATED TO HIF-1&#x03b1;	Huang	2008	0		
145	chr10	75621383	75642123	3500064672	108		75621383	75642123	8421504	2	35,73	0,20667	p	350006467200015000	0-108						Calpain Mediates a von Hippel-Lindau Protein&#x2013; independent Destruction of Hypoxia-inducible Factor-1	w.molbiolcell.org	0	0		
1162	chr10	75642131	75642686	3500363258	41		75642131	75642686	8421504	2	20,21	0,534	c,g	350036325800000000,350036325800000000,350036325800000001	0-20,0-20,0-21		20953377	10.1155/2010/537531		Clinical and Developmental Immunology	Clinicopathologic Significance of HIF-1&#x03b1;, CXCR4, and VEGF Expression in Colon Cancer	Yugang	2010	0		HIF1A
1162	chr10	75642134	75642226	3500400330	40		75642134	75642226	8421504	2	20,20	0,72	c,g	350040033000000004,350040033000000005,350040033000000005	0-20,0-20,0-20		20861464	10.1152/ajpcell.00068.2010		American Journal of Physiology - Cell Physiolog	Hypoxic upregulation of arginase II in human lung endothelial cells	Krotova	2010	0		HIF1A
1162	chr10	75642134	75642226	3500234077	40		75642134	75642226	8421504	2	20,20	0,72	c,g	350023407700000004,350023407700000005,350023407700000005	0-20,0-20,0-20		20861464	10.1152/ajpcell.00068.2010		American Journal of Physiology - Cell Physiolog	Hypoxic upregulation of arginase II in human lung endothelial cells	Krotova	2010	0		HIF1A
1162	chr10	75642169	75660529	3500124685	42		75642169	75660529	8421504	2	21,21	0,18339	c	350012468500000011,350012468500000031	19-40,20-41						Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide	www.jleukbio.org	0	0		
1162	chr10	75642182	75648736	3500329425	58		75642182	75648736	8421504	2	28,30	0,6524	c	350032942500000006,350032942500000007	0-28,0-30		15901832	10.1091/mbc.E04-11-1029	1059-1524	Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Im	2005	5		
1162	chr10	75642182	75648736	3500228083	58		75642182	75648736	8421504	2	28,30	0,6524	c	350022808300000006,350022808300000007	0-28,0-30			10.1091/mbc.E04-11-1029		Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Eunok	2005	0		
1162	chr10	75642182	75648736	3500078966	58		75642182	75648736	8421504	2	28,30	0,6524	c,g	350007896600000006,350007896600000007,350007896600000007	0-28,0-30,0-30						Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells	w.molbiolcell.org	0	0		
1162	chr10	75642183	75642207	3500248687	24		75642183	75642207	8421504	1	24	0	c	350024868700000007	0-24		22028336	10.1093/cvr/cvr282		Cardiovascular Research	Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells	Kakali	2012	0		
1162	chr10	75642231	75659952	3500266239	234		75642231	75659952	8421504	7	10,38,48,42,48,24,24	0,378,5428,16024,16168,16264,17697	c	350026623900000059,350026623900000065,350026623900000081,350026623900000084,350026623900000086	0-48,0-48,0-42,0-48,0-48						Methods to diagnose a required regulation of trophoblast invasion - US Patent 6376199 Description	ww.patentstorm.us	0	0		
1162	chr10	75642616	75642640	3500257901	24		75642616	75642640	8421504	1	24	0	c	350025790100000031	0-24						NF-kappaB Activity Induced by Inflammatory Cytokines	eb.uni-giessen.de	0	0		
1162	chr10	75642742	75642900	3500275124	45		75642742	75642900	8421504	3	13,12,20	0,100,138	c	350027512400000009,350027512400000008,350027512400000000	0-25,0-25,0-20		17085645	10.1158/1078-0432.CCR-06-1252	1078-0432	Clinical Cancer Research	Activation of Hypoxia-Inducible Factor-1&#x03b1; Is Necessary for Lysophosphatidic Acid&#x2013;Induced Vascular Endothelial Growth Factor Expression	Lee	2006	8		HIF1A
1162	chr10	75642845	75648674	3500365167	42		75642845	75648674	8421504	2	21,21	0,5808	c	350036516700000016,350036516700000017	0-21,0-21		23942196	10.1038/srep01763	xxxx-xxxx	Scientific Reports	Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats	Sugimoto	2013	0		HIF1A
1162	chr10	75642845	75648674	3500178390	42		75642845	75648674	8421504	2	21,21	0,5808	c,g	350017839000000016,350017839000000017,350017839000000017	0-21,0-21,0-21		23942196	10.1038/srep01763	xxxx-xxxx	Scientific Reports	Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats	Sugimoto	2013	0		HIF1A
1162	chr10	75642889	75655832	3500194807	45		75642889	75655832	8421504	2	25,20	0,12923	c	350019480700000000,350019480700000008	0-25,0-20		20015878	10.3324/haematol.2009.015628	0390-6078	Haematologica	Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells	Martin	2010	6		HIF1A
1162	chr10	75642889	75642914	3500431302	25		75642889	75642914	8421504	1	25	0	c	350043130200000010	0-25						Hypoxia-inducible Factor 1 (HIF-1)-mediated Hypoxia Increases BACE1 Expression and -Amyloid Generation--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x	journal.9med.net	0	0		
1162	chr10	75642889	75642914	3500405199	25		75642889	75642914	8421504	1	25	0	c	350040519900000022	0-25		20002786	10.1111/j.1365-2567.2009.03203.x	1365-2567	Immunology	Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor - Kim - 2009 - Immunology - Wiley Online Library	Kim	2010	0		
1162	chr10	75642889	75642914	3500116918	25		75642889	75642914	8421504	1	25	0	c	350011691800000022	0-25		20002786	10.1111/j.1365-2567.2009.03203.x		Immunology	Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor	So	2010	0		HIF1A
1162	chr10	75642903	75654616	3500466231	44		75642903	75654616	8421504	3	22,14,8	0,5847,11705	c	350046623100000000,350046623100000001	0-22,0-22						HIF-1a is required for solid tumor formation and embryonic vascularization	www.mhhe.com	0	0		HIF1A
1162	chr10	75647701	75647724	3500290730	23		75647701	75647724	8421504	1	23	0	g	350029073000000000	0-23						PROLYL HYDROXYLASE INHIBITORS AS RADIATION MITIGATORS AND RADIATION PROTECTORS - DANA-FARBER CANCER INSTITUTE, INC.	www.sumobrain.com	0	0		
1162	chr10	75648595	75657468	3500382403	59		75648595	75657468	8421504	4	20,19,8,12	0,7255,7346,8861	c,g	350038240300000006,350038240300000000,350038240300000000,350038240300000001,350038240300000007	0-20,0-19,0-19,0-19,0-20						Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1 expression	-publications.com	0	0		HIF1A
1162	chr10	75650065	75650091	3500084378	26		75650065	75650091	8421504	1	26	0	g	350008437800000094	86-112						Novel polypeptides and nucleic acids encoding same	Shimkets	2000	0		
1162	chr10	75654634	75660237	3500404753	60		75654634	75660237	8421504	3	20,21,19	0,2973,5584	c	350040475300000006,350040475300000007,350040475300000000	0-20,25-46,2-21						ScienceDirect.com - Experimental Eye Research - Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells	sciencedirect.com	0	0		HIF1A
1162	chr10	75657504	75657527	3500074976	23		75657504	75657527	8421504	1	23	0	c,g	350007497600000208,350007497600000088,350007497600000086,350007497600000086,350007497600000206,350007497600000206	0-21,0-21,0-21,0-21,0-21,0-21						Interfering RNAs Targeting the Morbillivirus Nucleoprotein Gene - Patent application	www.faqs.org	0	0		
1162	chr10	75657540	75657660	3500112772	40		75657540	75657660	8421504	2	20,20	0,100	c	350011277200000022,350011277200000023	0-20,0-20						DEVICE FOR DECELERATING THE ROTATION OF A HINGE IN PARTICULAR FOR FURNITURE AND A HINGE PARTICULARLY FOR FURNITURE HAVING SAID DECELERATION DEVICE - Patent application	www.faqs.org	0	0		HIF1A
1162	chr10	75657553	75657579	3500178049	26		75657553	75657579	8421504	1	26	0	c	350017804900000003	6-32		18551145	10.1038/cgt.2008.39	0929-1903	Cancer Gene Therapy	Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model	Winnard	2008	3		
1162	chr10	75657601	75660223	3500362262	96		75657601	75660223	8421504	2	48,48	0,2574	p	350036226200015003,350036226200015004	0-48,0-48						Prolyl Hydroxylase-1 Negatively Regulates I&#xce;&#xba;B Kinase-&#xce;&#xb2;, Giving Insight into Hypoxia-Induced NF&#xce;&#xba;B Activity	www.jstor.org	0	0		HIF1A
1162	chr10	75657602	75657629	3500262013	27		75657602	75657629	8421504	1	27	0	c	350026201300000008	0-27		21224490	10.1074/jbc.M110.150557		The Journal of Biological Chemistry	Hypoxia-inducible Factor-1&#x03b1; Enhances Haptoglobin Gene Expression by Improving Binding of STAT3 to the Promoter	Mi-Kyung	2011	0		
1162	chr10	75657604	75664121	3500370506	144		75657604	75664121	8421504	3	48,48,48	0,795,6469	c	350037050600000057,350037050600000062,350037050600000080	0-48,0-48,0-48						Hypoxia inducible factor-1 and method of use	Semenza	1996	0		
1162	chr10	75657624	75658393	3500453420	40		75657624	75658393	8421504	2	20,20	0,749	c,g	350045342000000000,350045342000000001,350045342000000001	0-20,0-20,0-20		16951224	10.1158/1078-0432.CCR-05-2794	1078-0432	Clinical Cancer Research	Rac Activation Is Associated with Hepatocellular Carcinoma Metastasis by Up-regulation of Vascular Endothelial Growth Factor Expression	Lee	2006	8		HIF1A
1162	chr10	75657624	75658393	3500369248	40		75657624	75658393	8421504	2	20,20	0,749	c	350036924800000004,350036924800000005	0-20,0-20						Oxygen-regulatedexpressionoftheerythropoietingeneinthehumanrenalcell lineREPC	tologylibrary.org	0	0		HIF1A
1162	chr10	75657624	75658393	3500062993	40		75657624	75658393	8421504	2	20,20	0,749	c	350006299300000004,350006299300000005	0-20,0-20						Oxygen-regulated expression of the erythropoietin gene in a human renal cell line REPC	tologylibrary.org	0	0		HIF1A
1162	chr10	75657657	75659993	3500463087	43		75657657	75659993	8421504	3	20,1,22	0,575,2314	c	350046308700000001,350046308700000002	0-21,0-22		19021771	10.1111/j.1742-4658.2008.06725.x	1742-4658	FEBS Journal	DNA-dependent protein kinase is involved in heat shock protein-mediated accumulation of hypoxia-inducible factor-1&#x03b1; in hypoxic preconditioned HepG2 cells - Kang - 2008 - FEBS Journal - Wiley Online Library	Kang	2008	0		HIF1A
1162	chr10	75657657	75659993	3500282582	43		75657657	75659993	8421504	3	20,1,22	0,575,2314	c	350028258200000000,350028258200000001	0-21,0-22						Involvement of SIRT1 in hypoxic down-regulation of c-Myc and &#x03b2;-catenin and hypoxic preconditioning effect of polyphenols	ww.snupharm.ac.kr	0	0		HIF1A
1162	chr10	75658373	75660238	3500451410	77		75658373	75660238	8421504	2	20,57	0,1808	p,c	350045141000000000,350045141000015001	20-40,0-57		18332861	10.1038/bjp.2008.70	1476-5381	British Journal of Pharmacology	Rapid degradation of hypoxia-inducible factor-1&#x03b1; by KRH102053, a new activator of prolyl hydroxylase 2 - Choi - 2009 - British Journal of Pharmacology - Wiley Online Library	Choi	2008	0		HIF1A
1162	chr10	75658508	75659941	3500444491	24		75658508	75659941	8421504	2	11,13	0,1420	c	350044449100000004	0-24		17311997	10.1182/blood-2006-08-040006	0006-4971	Blood	Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle	Robach	2007	10		
1162	chr10	75658510	75659967	3500280660	48		75658510	75659967	8421504	2	9,39	0,1418	p	350028066000015266	0-48						Endothelial pas domain protein	Mcknight	1998	0		
1162	chr10	75660036	75660262	3500447533	102		75660036	75660262	8421504	2	15,87	0,139	p	350044753300015015,350044753300015013	0-102,0-57						&#x7279;&#x958b;2010-246542&#x53f7; &#xff36;&#xff28;&#xff2c;&#x816b;&#x760d;&#x30b5;&#x30d7;&#x30ec;&#x30c3;&#x30b5;&#x30fc;&#x3068;&#x4f4e;&#x9178;&#x7d20;&#x8a98;&#x5c0e;&#x56e0;&#x5b50;&#x3068;&#x306e;&#x76f8;&#x4e92;&#x4f5c;&#x7528;&#x3001;&#x304a;&#x	astamuse.com	0	0		HIF1A
1162	chr10	75660036	75660262	3500301456	102		75660036	75660262	8421504	2	15,87	0,139	p	350030145600015011,350030145600015004	0-102,0-57						Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase	Maxwell	2002	0		HIF1A
1162	chr10	75660036	75660262	3500295114	102		75660036	75660262	8421504	2	15,87	0,139	p	350029511400015014,350029511400015000	0-102,0-57					Patent	Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase (Patent EP:1379630)	MAXWELL	2012	0		HIF1A
1162	chr10	75660036	75660262	3500250777	102		75660036	75660262	8421504	2	15,87	0,139	p	350025077700015011,350025077700015000	0-102,0-57						Assays, methods and means	Maxwell	2010	0		HIF1A
1162	chr10	75660036	75660262	3500199680	102		75660036	75660262	8421504	2	15,87	0,139	p	350019968000015011,350019968000015004	0-102,0-57						Assay for identifying a modulator of HIF hydroxylase	Maxwell	2010	0		HIF1A
1162	chr10	75660036	75660262	3500180627	102		75660036	75660262	8421504	2	15,87	0,139	p	350018062700015009,350018062700015008	0-102,0-57						&#xff36;&#xff28;&#xff2c;&#x816b;&#x760d;&#x30b5;&#x30d7;&#x30ec;&#x30c3;&#x30b5;&#x30fc;&#x3068;&#x4f4e;&#x9178;&#x7d20;&#x8a98;&#x5c0e;&#x56e0;&#x5b50;&#x3068;&#x306e;&#x76f8;&#x4e92;&#x4f5c;&#x7528;&#x3001;&#x304a;&#x3088;&#x3073;&#x305d;&#x308c;&#x306b	astamuse.com	0	0		HIF1A
1162	chr10	75660036	75660262	3500099088	102		75660036	75660262	8421504	2	15,87	0,139	p	350009908800015012,350009908800015001	0-102,0-57						Assays, methods and means	Maxwell	2004	0		HIF1A
1162	chr10	75660036	75660262	3500061397	102		75660036	75660262	8421504	2	15,87	0,139	p	350006139700015016,350006139700015014	0-102,0-57						Interaction between the vhl tumour suppressor and hypoxia inducible factor, and assay methods relating thereto	Maxwell	2000	0		HIF1A
1162	chr10	75660181	75664786	3500109773	174		75660181	75664786	8421504	2	57,117	0,4488	p	350010977300015007,350010977300015008	0-57,0-117						Selective Inhibition and Mechanistic Studies of the Human O2 Sensor, Prolyl Hydroxylase Domain 2 (PHD2)	arworks.umass.edu	0	0		HIF1A
1162	chr10	75660181	75664786	3500056360	177		75660181	75664786	8421504	2	60,117	0,4488	p	350005636000015002,350005636000015003,350005636000015005	0-60,0-105,3-81		18426857	10.1124/mol.108.045278	1521-0111 (Online)	Molecular Pharmacology	Nitric Oxide Donor, (&#xb1;)-S-Nitroso-N-acetylpenicillamine, Stabilizes Transactive Hypoxia-Inducible Factor-1&#x03b1; by Inhibiting von Hippel-Lindau Recruitment and Asparagine Hydroxylation	Park	2008	0		HIF1A
1162	chr10	75660181	75664786	3500019337	177		75660181	75664786	8421504	2	60,117	0,4488	p	350001933700015002,350001933700015003,350001933700015005	0-60,0-105,3-81		18426857	10.1124/mol.108.045278	1521-0111 (Online)	Molecular Pharmacology	Nitric Oxide Donor, (&#xb1;)-S-Nitroso-N-acetylpenicillamine, Stabilizes Transactive Hypoxia-Inducible Factor-1&#x03b1; by Inhibiting von Hippel-Lindau Recruitment and Asparagine Hydroxylation	Park	2008	0		HIF1A
1162	chr10	75660181	75660241	3500295020	60		75660181	75660241	8421504	1	60	0	p	350029502000015010,350029502000015001	0-57,0-60		16155211	10.1124/mol.105.015271	1521-0111 (Online)	Molecular Pharmacology	Inhibition of the Catalytic Activity of Hypoxia-Inducible Factor-1&#x03b1;-Prolyl-Hydroxylase 2 by a MYND-Type Zinc Finger	Choi	2005	0		HIF1A
1162	chr10	75660181	75660241	3500195679	60		75660181	75660241	8421504	1	60	0	p	350019567900015000	0-60		12351678	10.1073/pnas.192342099	0027-8424	Proceedings of the National Academy of Sciences	Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor	Ivan	2002	10		HIF1A
1162	chr10	75660181	75660241	3500083176	60		75660181	75660241	8421504	1	60	0	p	350008317600015000	0-60						Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor	www.pnas.org	0	0		HIF1A
1162	chr10	75660181	75660238	3500362968	57		75660181	75660238	8421504	1	57	0	p	350036296800015000	0-57						Treatment of diabetes	Guenzler-pukall	2003	0		HIF1A
1162	chr10	75660181	75660238	3500293830	57		75660181	75660238	8421504	1	57	0	p	350029383000015001	0-57						Treatment of diabetes	Guenzler-pukall	2003	0		HIF1A
1162	chr10	75660181	75660238	3500155073	57		75660181	75660238	8421504	1	57	0	p	350015507300015000	0-57						&#x30a2;&#x30c3;&#x30bb;&#x30a4;&#x3001;&#x65b9;&#x6cd5;&#x304a;&#x3088;&#x3073;&#x624b;&#x6bb5; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; 2009050260&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		HIF1A
1162	chr10	75660184	75660238	3500263450	54		75660184	75660238	8421504	1	54	0	c	350026345000000001,350026345000000002,350026345000000003	0-20,0-40,11-34						The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma	-publications.com	0	0		HIF1A
1162	chr10	75660184	75660238	3500041136	54		75660184	75660238	8421504	1	54	0	c	350004113600000001,350004113600000002,350004113600000003	0-20,0-40,11-34		23292657	10.3892/or.2012.2217		Oncology Reports	The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma	JIANG	2013	0		HIF1A
1162	chr10	75660193	75660220	3500396345	27		75660193	75660220	8421504	1	27	0	c	350039634500000002,350039634500000001	0-27,0-27						Muteins of hypoxia inducible factor alpha and methods of use thereof	William	2002	0		
1162	chr10	75660497	75664786	3500317921	49		75660497	75664786	8421504	2	25,24	0,4265	c	350031792100000000,350031792100000001	0-25,0-24						Noscapine inhibits hypoxia-mediated HIF-1 expression and angiogenesis in vitro: A novel function for an old drug	-publications.com	0	0		HIF1A
1162	chr10	75660497	75664786	3500168583	49		75660497	75664786	8421504	2	25,24	0,4265	c	350016858300000004,350016858300000005	0-25,0-24		19179443	10.1210/en.2008-1333	0013-7227	Endocrinology	Stathmin, a Microtubule Regulatory Protein, Is Associated with Hypoxia-Inducible Factor-1&#x03b1; Levels in Human Endometrial and Endothelial Cells	Yoshie	2009	4		HIF1A
1162	chr10	75660554	75663394	3500407152	50		75660554	75663394	8421504	2	25,25	0,2815	c,g	350040715200000003,350040715200000004,350040715200000004	0-25,0-25,0-25					Patent	Oligomeric compounds for the modulation HIF-1&#x03b1; expression (Patent US:7737264)	Thrue	2010	0		HIF1A
1162	chr10	75660554	75663394	3500172764	50		75660554	75663394	8421504	2	25,25	0,2815	c	350017276400000003,350017276400000004	0-25,0-25						Oligomeric compounds for the modulation of HIF-1alpha expression	Thrue	2010	0		HIF1A
1162	chr10	75660554	75663394	3500154493	50		75660554	75663394	8421504	2	25,25	0,2815	c	350015449300000000,350015449300000001	0-25,0-25						Oligomeric compounds for the modulation HIF-1alpha expression	Hog	2004	0		HIF1A
1162	chr10	75660554	75660579	3500412166	25		75660554	75660579	8421504	1	25	0	c	350041216600000000	0-25					Patent	Potent LNA oligonucleotides for the inhibition of HIF-1A expression (Patent US:7589190)	Hansen	2009	0		
1162	chr10	75660554	75660579	3500364928	25		75660554	75660579	8421504	1	25	0	c	350036492800000000,350036492800000027	0-25,0-25						POTENT LNA OLIGONUCLEOTIDES FOR THE INHIBITION OF HIF-1a EXPRESSION - Patent application	www.faqs.org	0	0		
1162	chr10	75660554	75660579	3500049058	25		75660554	75660579	8421504	1	25	0	g	350004905800000000	0-25		18974394	10.1158/1535-7163.MCT-08-0510	1535-7163	Molecular Cancer Therapeutics	A RNA antagonist of hypoxia-inducible factor-1&#x03b1;, EZN-2968, inhibits tumor cell growth	Greenberger	2008	5		
1162	chr10	75663418	75663998	3500178103	23		75663418	75663998	8421504	2	20,3	0,577	c	350017810300000004	0-23		23457597	10.1371/journal.pone.0056631	1932-6203	PLOS ONE	PLOS ONE: Bioactivity-Guided Identification and Cell Signaling Technology to Delineate the Lactate Dehydrogenase A Inhibition Effects of Spatholobus suberectus on Breast Cancer	Wang	2013	4		
1162	chr10	75664082	75665586	3500016107	76		75664082	75665586	8421504	4	24,22,11,19	0,564,1472,1485	c	350001610700000016,350001610700000017,350001610700000014	0-24,0-22,0-30		16126907	10.1096/fj.05-3788com	0892-6638	The FASEB Journal	Human HIF-3&#x03b1;4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma	Maynard	2005	6		HIF1A
1162	chr10	75664082	75664106	3500200226	24		75664082	75664106	8421504	1	24	0	c	350020022600000016	0-24						Faseb Journal	005.pasteur.ac.ir	0	0		
1162	chr10	75664121	75664789	3500428705	42		75664121	75664789	8421504	3	1,20,21	0,516,647	c,g	350042870500000000,350042870500000001,350042870500000001	0-21,0-21,0-21		18339855	10.1158/0008-5472.CAN-07-2766	0008-5472	Cancer Research	Kaposi's Sarcoma&#x2013;Associated Herpesvirus Viral IFN Regulatory Factor 3 Stabilizes Hypoxia-Inducible Factor-1&#x03b1; to Induce Vascular Endothelial Growth Factor Expression	Shin	2008	8		
1162	chr10	75664669	75664774	3500119250	105		75664669	75664774	8421504	1	105	0	p	350011925000015003	0-105						HIF-1 ALPHA ACTIVATING AGENT - Patent application	www.faqs.org	0	0		HIF1A
1162	chr10	75664669	75664774	3500096163	105		75664669	75664774	8421504	1	105	0	p	350009616300015001	0-105						Hif-1 Alpha Activating Agent 	.freshpatents.com	0	0		HIF1A
1162	chr10	75664669	75664774	3500018653	102		75664669	75664774	8421504	2	45,57	0,48	p	350001865300015000,350001865300015001	0-45,0-57		16973622	10.1074/jbc.M603913200	0021-9258	Journal of Biological Chemistry	Clioquinol, a Cu(II)/Zn(II) Chelator, Inhibits Both Ubiquitination and Asparagine Hydroxylation of Hypoxia-inducible Factor-1&#x03b1;, Leading to Expression of Vascular Endothelial Growth Factor and Erythropoietin in Normoxic Cells	Choi	2006	5		HIF1A
1162	chr10	75664669	75664756	3500194660	87		75664669	75664756	8421504	1	87	0	p	350019466000015002,350019466000015009	0-81,0-45						Use of Baicalein As Prolyl Hydroxylase 2 Inhibitor - Patent application	www.faqs.org	0	0		HIF1A
1162	chr10	75664669	75664726	3500391427	57		75664669	75664726	8421504	1	57	0	p	350039142700015003	0-57						Assays - Patent application	www.faqs.org	0	0		HIF1A
1162	chr10	75664669	75664714	3500289333	45		75664669	75664714	8421504	1	45	0	p	350028933300015000	24-69						Assays 	.freshpatents.com	0	0		HIF1A
1162	chr10	75664669	75664714	3500208501	45		75664669	75664714	8421504	1	45	0	p	350020850100015005	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		HIF1A
1162	chr10	75664669	75664714	3500189065	45		75664669	75664714	8421504	1	45	0	p	350018906500015007	0-45						Assays	Schofield	2005	0		HIF1A
1162	chr10	75664732	75664755	3500346452	23		75664732	75664755	8421504	1	23	0	c	350034645200000000	17-40		12925778	10.1091/mbc.E02-12-0791	1059-1524	Molecular Biology of the Cell	Nitric Oxide Impairs Normoxic Degradation of HIF-1&#x03b1; by Inhibition of Prolyl Hydroxylases	Metzen	2003	5		
1162	chr10	75664732	75664755	3500224310	23		75664732	75664755	8421504	1	23	0	c	350022431000000000	17-40		12586627	10.1182/blood-2002-09-2711	0006-4971	Blood	Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1&#x03b1; (HIF-1&#x03b1;) accumulation via redox-dependent mechanisms	Shatrov	2003	10		
1162	chr10	75664732	75664755	3500186711	23		75664732	75664755	8421504	1	23	0	c	350018671100000000	17-40						Brief report Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1 (HIF-1 ) accumulation via redox-dependent mechanisms	tologylibrary.org	0	0		HIF1A
1162	chr10	75664732	75664755	3500007529	23		75664732	75664755	8421504	1	23	0	c	350000752900000000	17-40		12586627	10.1182/blood-2002-09-2711	0006-4971	Blood	Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1&#x03b1; (HIF-1&#x03b1;) accumulation via redox-dependent mechanisms	Shatrov	2003	10		HIF1A
1162	chr10	75664762	75664789	3500464340	27		75664762	75664789	8421504	1	27	0	c	350046434000000005	12-39						Differential expression screening method	Kingsman	2001	0		HIF1A
1162	chr10	75703183	75703207	3500418252	24		75703183	75703207	8421504	1	24	0	c	350041825200000207	13-37						US Patent # 7,157,262. Lipolytic enzymes - Patents.com	www.patents.com	0	0		
1164	chr10	75897656	75897681	3500258078	24		75897656	75897681	8421504	2	15,9	0,16	g	350025807800000034	22-48						Nematode PAN and ZP Receptor-Like Sequences - Patent application	www.faqs.org	0	0		
1171	chr10	76843052	76865265	3500375774	303		76843052	76865265	8421504	3	146,49,108	0,22032,22105	p	350037577400015008,350037577400015007	3-198,0-108						52906, 33408, and 12189, potassium channel family members and uses thereof	Curtis	2001	0		KCNH5
1171	chr10	76916128	76916153	3500306471	25		76916128	76916153	8421504	1	25	0	c	350030647100000057,350030647100000140	0-25,0-20						RESISTANCE TO BACTERIAL INFECTION - Patent application	www.faqs.org	0	0		KCNH5
146	chr10	77048382	77072975	3500005513	423		77048382	77072975	8421504	2	138,285	0,24308	p	350000551300015002	0-423		9714851	10.1111/j.1469-7793.1998.675bg.x	0022-3751	The Journal of Physiology	Cloning of a mammalian elk potassium channel gene and EAG mRNA distribution in rat sympathetic ganglia	Shi	1998	5		KCNH5
1173	chr10	77072749	77116499	3500212850	54		77072749	77116499	8421504	2	27,27	0,43723	c,g	350021285000000007,350021285000000005,350021285000000005	0-27,0-27,0-27						EAG gene	Stuhmer	2002	0		
1175	chr10	77375365	77377583	3500063394	25		77375365	77377583	8421504	2	8,17	0,2201	c	350006339400000008,350006339400000007	0-25,0-25		23439680	10.1083/jcb.201208150		The Journal of Cell Biology	The WD40 protein Morg1 facilitates Par6&#x2013;aPKC binding to Crb3 for apical identity in epithelial cells	Junya	2013	0		
1175	chr10	77377599	77377625	3500152562	24		77377599	77377625	8421504	3	5,5,14	0,6,12	c	350015256200000007	0-24			10.1046/j.1365-2958.2003.03516.x	1365-2958	Molecular Microbiology	Haemophore-mediated signal transduction across the bacterial cell envelope in Serratia marcescens: the inducer and the transported substrate are different molecules - Rossi - 2003 - Molecular Microbiology - Wiley Online Library	Rossi	2003	0		
1175	chr10	77380286	77380886	3500382374	600		77380286	77380886	8421504	1	600	0	g	350038237400000001	29-693						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
1175	chr10	77380286	77380886	3500221817	600		77380286	77380886	8421504	1	600	0	g	350022181700000001	29-693					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
1175	chr10	77380286	77380886	3500101798	600		77380286	77380886	8421504	1	600	0	g	350010179800000001	29-693						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
1182	chr10	78254252	78303695	3500352841	132		78254252	78303695	8421504	5	27,20,30,30,25	0,20247,47384,49134,49418	c	350035284100000003,350035284100000007,350035284100000001,350035284100000002,350035284100000000	0-27,0-20,0-30,0-30,0-25						Cloning and Characterization of Porcine Ovarian: MATERIALS AND METHODS | Medicine Active	dicine-active.com	0	0		
1182	chr10	78254252	78303695	3500347931	132		78254252	78303695	8421504	5	27,20,30,30,25	0,20247,47384,49134,49418	c	350034793100000003,350034793100000007,350034793100000001,350034793100000002,350034793100000000	0-27,0-20,0-30,0-30,0-25		11870066	10.1095/biolreprod66.3.616	0006-3363	Biology of Reproduction	Cloning and Characterization of Porcine Ovarian Estrogen Receptor &#x03b2; Isoforms	LaVoie	2002	4		
1182	chr10	78254423	78257041	3500096517	84		78254423	78257041	8421504	2	16,68	0,2550	p	350009651700015043	3-87						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
1182	chr10	78256983	78257102	3500134803	40		78256983	78257102	8421504	2	20,20	0,99	c,g	350013480300000003,350013480300000003,350013480300000002,350013480300000002	0-20,0-20,0-20,0-20						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
1182	chr10	78257046	78284326	3500426220	41		78257046	78284326	8421504	2	21,20	0,27260	c,g	350042622000000003,350042622000000002,350042622000000002	0-21,0-20,0-20		12700204	10.1095/biolreprod.102.010355	0006-3363	Biology of Reproduction	Toxic Effects of In Vitro Exposure to p-tert-Octylphenol on Bovine Oocyte Maturation and Developmental Competence	Pocar	2003	4		
1182	chr10	78274484	78274511	3500181936	27		78274484	78274511	8421504	1	27	0	c	350018193600000116	16-43						ESTROGEN RECEPTOR GENES AND UTILIZATION THEREOF - Patent application	www.faqs.org	0	0		
1182	chr10	78274495	78281057	3500465087	42		78274495	78281057	8421504	2	22,20	0,6542	c	350046508700000005,350046508700000004	0-22,0-20						REPRODUCTION	uction-online.org	0	0		
1182	chr10	78274495	78281057	3500333063	42		78274495	78281057	8421504	2	22,20	0,6542	c,g	350033306300000005,350033306300000005,350033306300000004,350033306300000004	0-22,0-22,0-20,0-20						Characterisation of gene expression patterns in 22RV1 cells for determination of environmental androgenic/antiandrogenic compounds	quantification.de	0	0		
1182	chr10	78274515	78281056	3500024081	44		78274515	78281056	8421504	2	24,20	0,6521	c	350002408100000035,350002408100000034	0-24,0-20						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
1182	chr10	78274515	78274539	3500248474	24		78274515	78274539	8421504	1	24	0	c,g	350024847400000031,350024847400000031	0-24,0-24						REPRODUCTION	uction-online.org	0	0		ESR2
1182	chr10	78284116	78284139	3500180208	23		78284116	78284139	8421504	1	23	0	c	350018020800000296,350018020800000177,350018020800000714,350018020800000362,350018020800000146,350018020800000716,350018020800000081,350018020800000368,350018020800000097,350018020800000339,350018020800000312,350018020800000140,350018020800000052,350018020800000216,350018020800000233,350018020800000234,350018020800000009,350018020800000184	0-23,0-23,0-22,0-22,0-22,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		
1182	chr10	78284116	78284139	3500164893	23		78284116	78284139	8421504	1	23	0	c,g	350016489300000177,350016489300000296,350016489300000714,350016489300000362,350016489300000146,350016489300000076,350016489300000261,350016489300000104,350016489300000293,350016489300000337,350016489300000189,350016489300000118,350016489300000206,350016489300000289,350016489300000352,350016489300000357,350016489300000436,350016489300000320,350016489300000222,350016489300000220,350016489300000227,350016489300000225,350016489300000131,350016489300000383,350016489300000384,350016489300000388,350016489300000308,350016489300000148,350016489300000649,350016489300000394,350016489300000392,350016489300000390,350016489300000245,350016489300000155,350016489300000406,350016489300000157,350016489300000001,350016489300000275,350016489300000278,350016489300000161,350016489300000766,350016489300000767,350016489300000764,350016489300000765,350016489300000083,350016489300000085,350016489300001495,350016489300000372,350016489300000077,350016489300000074,350016489300000072,350016489300000173,350016489300000302,350016489300000269,350016489300000079,350016489300001392,350016489300001393,350016489300000306,350016489300001494,350016489300000108,350016489300000031,350016489300000518,350016489300000214,350016489300000102,350016489300000421,350016489300000218,350016489300000106,350016489300000064,350016489300000299,350016489300000060,350016489300000062,350016489300000291,350016489300000297,350016489300000295,350016489300000182,350016489300000181,350016489300000186,350016489300000184,350016489300000263,350016489300000201,350016489300000203,350016489300000694,350016489300000070,350016489300000110,350016489300000112,350016489300000116,350016489300000350,350016489300000356,350016489300000355,350016489300000355,350016489300000722,350016489300000052,350016489300000284,350016489300000286,350016489300000034,350016489300000034,350016489300000210,350016489300000191,350016489300000197,350016489300000234,350016489300000236,350016489300000129,350016489300000233,350016489300000125,350016489300000126,350016489300000238,350016489300000239,350016489300000326,350016489300000044,350016489300000042,350016489300000271,350016489300000006,350016489300000038,350016489300000037,350016489300000035,350016489300000035,350016489300000335,350016489300000132,350016489300000136,350016489300000019,350016489300000381,350016489300000386,350016489300000259,350016489300000020,350016489300000023,350016489300000022,350016489300000025,350016489300000024,350016489300000411,350016489300000413,350016489300000142,350016489300000140,350016489300000417,350016489300000300,350016489300000179,350016489300001501,350016489300001500,350016489300000018,350016489300000016,350016489300000017,350016489300000011,350016489300000243,350016489300000318,350016489300000316,350016489300000312,350016489300000716,350016489300000254,350016489300000094,350016489300000021,350016489300000096,350016489300000097,350016489300000091,350016489300000099,350016489300000255,350016489300000252,350016489300000002,350016489300000000,350016489300000000,350016489300000005,350016489300000004,350016489300000009,350016489300000167,350016489300000081	0-23,0-23,0-22,0-22,0-22,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						Methods for quantitating small rna molecules	Raymond	2007	0		
1182	chr10	78284152	78303415	3500412988	38		78284152	78303415	8421504	2	19,19	0,19244	c,g	350041298800000004,350041298800000004,350041298800000003,350041298800000003	0-19,0-19,0-19,0-19		14724136	10.1095/biolreprod.103.025684	0006-3363	Biology of Reproduction	Estradiol and Its Membrane-Impermeable Conjugate (Estradiol-Bovine Serum Albumin) During In Vitro Maturation of Bovine Oocytes: Effects on Nuclear and Cytoplasmic Maturation, Cytoskeleton, and Embryo Quality	Woudenberg	2004	4		
1182	chr10	78284213	78284258	3500286280	45		78284213	78284258	8421504	1	45	0	p	350028628000015020	0-45						BMC Evolutionary Biology BioMed Central	biomedcentral.com	0	0		ESR2
1182	chr10	78294193	78301644	3500370623	114		78294193	78301644	8421504	2	57,57	0,7394	p	350037062300015032,350037062300015058,350037062300015030,350037062300015056	0-48,0-48,0-48,0-48						ESTROGEN RECEPTORS AND METHODS OF USE - Patent application	www.faqs.org	0	0		ESR2
1182	chr10	78294193	78301635	3500449211	105		78294193	78301635	8421504	2	48,57	0,7385	p	350044921100015028,350044921100015087,350044921100015024	0-48,0-48,0-48						Genetic polymorphisms of estrogen receptor alpha associated with favorable response to hormone replacement therapy	Herrington	2002	0		ESR2
1182	chr10	78294193	78294238	3500136456	45		78294193	78294238	8421504	1	45	0	p	350013645600015113	0-45						US Patent # 7,429,650. Methods and compositions in breast cancer diagnosis and therapeutics - Patents.com	www.patents.com	0	0		ESR2
1182	chr10	78294268	78301611	3500021751	45		78294268	78301611	8421504	2	2,43	0,7300	p	350002175100015008	0-45						Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same	Dedhar	1995	0		ESR2
1182	chr10	78301587	78301632	3500304398	45		78301587	78301632	8421504	1	45	0	p	350030439800015053	0-45						METHODS AND COMPOSITIONS IN BREAST CANCER THERAPY RESISTANCE - Patent application	www.faqs.org	0	0		ESR2
1182	chr10	78303440	78303533	3500302954	45		78303440	78303533	8421504	2	26,19	0,74	c	350030295400000005,350030295400000000	0-26,26-45						Human estrogen receptor-beta	Bhat	1999	0		
1183	chr10	78442390	78443055	3500035109	48		78442390	78443055	8421504	2	12,36	0,629	c	350003510900000038	0-48						METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE - Patent application	www.faqs.org	0	0		
1183	chr10	78474972	78475047	3500446950	75		78474972	78475047	8421504	1	75	0	p	350044695000015061,350044695000015157,350044695000015123	0-75,0-45,0-45						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells - Patent application	www.faqs.org	0	0		AKAP5
1183	chr10	78474972	78475047	3500430125	75		78474972	78475047	8421504	1	75	0	p	350043012500015056	0-75						Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer	Gold	2012	0		AKAP5
1183	chr10	78474972	78475047	3500427070	75		78474972	78475047	8421504	1	75	0	p	350042707000015120	0-75						Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases	Chang	2011	0		AKAP5
1183	chr10	78474972	78475047	3500382936	75		78474972	78475047	8421504	1	75	0	p	350038293600015060	0-75						Detection of Early-Stage Pancreatic Adenocarcinoma - Patent application	www.faqs.org	0	0		AKAP5
1183	chr10	78474972	78475047	3500377644	75		78474972	78475047	8421504	1	75	0	p	350037764400015078	0-75						Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma	Burton	2012	0		AKAP5
1183	chr10	78474972	78475047	3500304681	75		78474972	78475047	8421504	1	75	0	p	350030468100015061	0-75						Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer - Patent application	www.faqs.org	0	0		AKAP5
1183	chr10	78474972	78475047	3500289124	75		78474972	78475047	8421504	1	75	0	p	350028912400015048	0-75						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells	Chang	2011	0		AKAP5
1183	chr10	78474972	78475047	3500249189	75		78474972	78475047	8421504	1	75	0	p	350024918900015056	0-75						Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity - Patent application	www.faqs.org	0	0		AKAP5
1183	chr10	78474972	78475047	3500221336	75		78474972	78475047	8421504	1	75	0	p	350022133600015112	0-75						COMBINATION THERAPY WITH ANTI-CD74 ANTIBODIES PROVIDES ENHANCED TOXICITY TO MALIGNANCIES, AUTOIMMUNE DISEASE AND OTHER DISEASES - IMMUNOMEDICS, INC.	www.sumobrain.com	0	0		AKAP5
1183	chr10	78474972	78475047	3500196739	75		78474972	78475047	8421504	1	75	0	p	350019673900015056	0-75						Anti-HLA-DR Antibodies Suppress Allogeneic and Xenogeneic Immune Responses to Organ Transplants	Sawada	2012	0		AKAP5
1183	chr10	78474972	78475047	3500165028	75		78474972	78475047	8421504	1	75	0	p	350016502800015042	0-75						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting	Mcbride	2012	0		AKAP5
1183	chr10	78474972	78475047	3500147691	75		78474972	78475047	8421504	1	75	0	p	350014769100015111	0-75						Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases	Chang	2011	0		AKAP5
1183	chr10	78474972	78475047	3500111111	75		78474972	78475047	8421504	1	75	0	p	350011111100015061	0-75						Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity	Chang	2012	0		AKAP5
1183	chr10	78474972	78475047	3500100255	75		78474972	78475047	8421504	1	75	0	p	350010025500015048	0-75						Dock-and-lock (dnl) complexes for delivery of interference rna	Chang	2012	0		AKAP5
1183	chr10	78474972	78475047	3500096413	75		78474972	78475047	8421504	1	75	0	p	350009641300015050,350009641300015190	0-75,0-48						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting - Patent application	www.faqs.org	0	0		AKAP5
1183	chr10	78474972	78475047	3500089169	75		78474972	78475047	8421504	1	75	0	p	350008916900015061	0-75						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells - Patent application	www.faqs.org	0	0		AKAP5
1183	chr10	78474972	78475047	3500080236	75		78474972	78475047	8421504	1	75	0	p	350008023600015111	0-75						Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases	Chang	2011	0		AKAP5
1183	chr10	78474972	78475047	3500036974	75		78474972	78475047	8421504	1	75	0	p	350003697400015048	0-75						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting - Patent application	www.faqs.org	0	0		AKAP5
1184	chr10	78523996	78524032	3500027388	29		78523996	78524032	8421504	3	12,11,6	0,15,30	c	350002738800000086,350002738800000113	0-35,0-35						US Patent # 5,773,691. Chimeric genes and methods for increasing the lysine and threonine content of the seeds of plants - Patents.com	www.patents.com	0	0		
1184	chr10	78525344	78525372	3500106719	25		78525344	78525372	8421504	3	14,4,7	0,15,21	c	350010671900000152	23-48						Optimizing Expression of Active Botulinum Toxin Type E - Patent application	www.faqs.org	0	0		
1184	chr10	78538640	78538676	3500445200	36		78538640	78538676	8421504	1	36	0	c	350044520000000047	24-60						BMC Genomics BioMed Central	biomedcentral.com	0	0		HSPA2
1184	chr10	78538649	78538709	3500260954	60		78538649	78538709	8421504	1	60	0	p	350026095400015007	0-60						ABREVIA&#xc7;&#xd5;ES	www.teses.usp.br	0	0		HSPA2
1184	chr10	78539287	78539310	3500166888	23		78539287	78539310	8421504	1	23	0	c	350016688800000078	9-34						Nucleic acid sequences encoding capsaicin receptor and uses thereof	Julius	1999	0		
1184	chr10	78539537	78539588	3500284316	51		78539537	78539588	8421504	1	51	0	p	350028431600015026	0-51						Expression Patterns of Three Heat Shock Protein 70 Genes Among Developmental Stages of the Red Flour Beetle, Tribolium castaneum (Coleoptera: Tenebrionidae)	alremediation.com	0	0		HSPA2
1186	chr10	78850857	78850884	3500333545	23		78850857	78850884	8421504	2	8,15	0,12	g	350033354500000029	2-25						Coniothyrium minitans xylanase gene Cxy1 - US Patent 6121034 Description	ww.patentstorm.us	0	0		
1187	chr10	78967916	78970844	3500433860	363		78967916	78970844	8421504	2	348,15	0,2913	p	350043386000015018	0-363						Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa	Campochiaro	2011	0		GPX2
1187	chr10	78968089	78970873	3500440387	40		78968089	78970873	8421504	2	20,20	0,2764	c,g	350044038700000003,350044038700000003,350044038700000002	0-20,0-20,0-20		20042006	10.1111/j.1365-3024.2009.01156.x	1365-3024	Parasite Immunology	Nematode challenge induces differential expression of oxidant, antioxidant and mucous genes down the longitudinal axis of the sheep gut - MENZIES - 2009 - Parasite Immunology - Wiley Online Library	MENZIES	2010	0		
1187	chr10	78975384	78975410	3500407090	24		78975384	78975410	8421504	2	5,19	0,7	c	350040709000000536	0-29						HIV envelope polypeptides and vaccine	Berman	1997	0		
148	chr10	79007600	79088487	3500201370	1314		79007600	79088487	8421504	12	144,65,73,92,147,84,87,130,133,112,115,132	0,36376,42345,44832,53780,54013,59472,67144,69858,75194,76537,80755	g	350020137000000006	0-1314					Patent	Genes for the subunits of human farnesyl-protein transferase (Patent US:5821118)	Diehl	1998	0		
148	chr10	79007600	79088487	3500201370	1314		79007600	79088487	8421504	12	144,65,73,92,147,84,87,130,133,112,115,132	0,36376,42345,44832,53780,54013,59472,67144,69858,75194,76537,80755	c	350020137000000006	0-1314					Patent	Genes for the subunits of human farnesyl-protein transferase (Patent US:5821118)	Diehl	1998	0		
148	chr10	79007600	79088487	3500106688	1314		79007600	79088487	8421504	12	144,65,73,92,147,84,87,130,133,112,115,132	0,36376,42345,44832,53780,54013,59472,67144,69858,75194,76537,80755	g	350010668800000016	0-1314						Assay for inhibitors of farnesyl-protein transferase	Diehl	1995	0		
148	chr10	79007600	79088487	3500106688	1314		79007600	79088487	8421504	12	144,65,73,92,147,84,87,130,133,112,115,132	0,36376,42345,44832,53780,54013,59472,67144,69858,75194,76537,80755	c	350010668800000016	0-1314						Assay for inhibitors of farnesyl-protein transferase	Diehl	1995	0		
1187	chr10	79007600	79007648	3500106688	48		79007600	79007648	8421504	1	48	0	p	350010668800015003	0-48						Assay for inhibitors of farnesyl-protein transferase	Diehl	1995	0		
1188	chr10	79061668	79088469	3500106688	93		79061668	79088469	8421504	3	29,19,45	0,5404,26756	p	350010668800015027,350010668800015049	0-48,0-45						Assay for inhibitors of farnesyl-protein transferase	Diehl	1995	0		
1188	chr10	79103388	79130889	3500139513	40		79103388	79130889	8421504	2	20,20	0,27481	c,g	350013951300000007,350013951300000006,350013951300000006	0-20,0-20,0-20						Cell-Restricted Immortalization by Human Papillomavirus Correlates with Telomerase Activation and Engagement of the hTERT Promoter by Myc	jvi.asm.org	0	0		MAX
1188	chr10	79103388	79130889	3500108843	40		79103388	79130889	8421504	2	20,20	0,27481	c,g	350010884300000007,350010884300000006,350010884300000006	0-20,0-20,0-20		18818322	10.1128/JVI.01318-08	0022-538X	Journal of Virology	Cell-Restricted Immortalization by Human Papillomavirus Correlates with Telomerase Activation and Engagement of the hTERT Promoter by Myc	Liu	2008	5		MAX
1188	chr10	79103452	79104743	3500106542	48		79103452	79104743	8421504	2	47,1	0,1290	c	350010654200000015	0-48						Vectors Containing the Max Gene - Patent application	www.faqs.org	0	0		
1188	chr10	79103488	79122782	3500219475	243		79103488	79122782	8421504	3	11,124,108	0,1254,19186	p	350021947500015012,350021947500015002	0-87,0-243						Targeting the c-Myc coiled coil with interfering peptides	h.uni-freiburg.de	0	0		
1188	chr10	79104824	79130875	3500409387	198		79104824	79130875	8421504	4	42,108,27,21	0,17850,25272,26030	p	350040938700015000	12-210						Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers	enesdev.cshlp.org	0	0		MAX
18	chr10	79537822	79711987	3500368539	1422		79537822	79711987	8421504	9	203,116,163,115,238,247,177,151,12	0,59990,60222,74349,109230,149312,154358,162166,174153	p	350036853900015020,350036853900015010,350036853900015018	0-189,0-528,0-1038						Production of glycoproteins with modified fucosylation	Hamilton	2009	0		
1192	chr10	79598049	79598103	3500282719	54		79598049	79598103	8421504	1	54	0	p	350028271900015009	0-54						RESEARCH ARTICLE Open Access Molecular cloning, characterization, genomic	biomedcentral.com	0	0		FUT8
1192	chr10	79612205	79647268	3500386041	135		79612205	79647268	8421504	3	57,21,57	0,34922,35006	p,c,g	350038604100015022,350038604100015070,350038604100000014,350038604100000014,350038604100015028,350038604100015080	0-48,0-45,0-21,0-21,0-48,0-45						Plant cell having animal-type sugar chain adding function	Guan Da Zhi 	2010	0		FUT8
18	chr10	79647174	79712263	3500460111	96		79647174	79712263	8421504	4	25,24,23,24	0,40079,64959,65065	c,g	350046011100000006,350046011100000013,350046011100000014,350046011100000001,350046011100000007,350046011100000007	0-25,0-24,0-23,0-23,0-24,0-24						METHOD OF MODULATING THE ACTIVITY OF FUNCTIONAL IMMUNE MOLECULES - Patent application	www.faqs.org	0	0		
18	chr10	79647174	79712263	3500430640	96		79647174	79712263	8421504	4	25,24,23,24	0,40079,64959,65065	c	350043064000000006,350043064000000013,350043064000000014,350043064000000001,350043064000000007	0-25,0-24,0-23,0-23,0-24						Method Of Modulating The Activity Of Functional Immune Molecules 	.freshpatents.com	0	0		
18	chr10	79647174	79712263	3500416136	96		79647174	79712263	8421504	4	25,24,23,24	0,40079,64959,65065	c,g	350041613600000006,350041613600000013,350041613600000014,350041613600000001,350041613600000007,350041613600000007	0-25,0-24,0-23,0-23,0-24,0-24						Method Of Modulating The Activity Of Functional Immune Molecules 	.freshpatents.com	0	0		
18	chr10	79647174	79712263	3500328562	96		79647174	79712263	8421504	4	25,24,23,24	0,40079,64959,65065	c	350032856200000006,350032856200000011,350032856200000001,350032856200000012,350032856200000007	0-25,0-24,0-23,0-23,0-24					Patent	Method for controlling the activity of immunologically functional molecule (Patent EP:1176195)	HANAI	2013	0		
18	chr10	79687253	79692346	3500446081	69		79687253	79692346	8421504	2	24,45	0,5048	p,c	350044608100000018,350044608100015049	0-24,0-45						Antibody Composition-Producing Cell - Patent application	www.faqs.org	0	0		FUT8
1193	chr10	79692238	79700013	3500382891	96		79692238	79700013	8421504	3	48,23,25	0,96,7750	c	350038289100000049,350038289100000062	0-48,0-48						Plant cell having animal-type sugar chain adding function	Teng Shan He Ren 	2004	0		
1193	chr10	79712133	79712156	3500460477	23		79712133	79712156	8421504	1	23	0	c	350046047700000001	0-23						Method of modulating the activity of functional immune molecules to CD52	Hanai	2007	0		
1193	chr10	79712133	79712156	3500337108	23		79712133	79712156	8421504	1	23	0	c	350033710800000001	0-23					Patent	Method of modulating the activity of functional immune molecules (Patent US:7708997)	Hanai	2010	0		FUT8
1193	chr10	79712133	79712156	3500332612	23		79712133	79712156	8421504	1	23	0	c	350033261200000001	0-23					Patent	Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor (Patent US:7763246)	Hanai	2010	0		FUT8
1193	chr10	79712133	79712156	3500331435	23		79712133	79712156	8421504	1	23	0	c	350033143500000001	0-23						Method for controlling the activity of immunologically functional molecule	Anazawa	2011	0		FUT8
1193	chr10	79712133	79712156	3500327438	23		79712133	79712156	8421504	1	23	0	c	350032743800000001	0-23					Patent	Method of modulating the activity of functional immune molecules to CXCR4 protein (Patent US:7682611)	Hanai	2010	0		FUT8
1193	chr10	79712133	79712156	3500323030	23		79712133	79712156	8421504	1	23	0	c	350032303000000001	0-23						Method for controlling the activity of immunologically functional molecule	Hanai	2011	0		FUT8
1193	chr10	79712133	79712156	3500321175	23		79712133	79712156	8421504	1	23	0	c	350032117500000001	0-23					Patent	Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein (Patent US:7718175)	Hanai	2010	0		FUT8
1193	chr10	79712133	79712156	3500290232	23		79712133	79712156	8421504	1	23	0	c	350029023200000001	0-23					Patent	Method of enhancing of binding activity of antibody composition to Fc&#x03b3; receptor IIIa (Patent US:8313913)	Nakamura	2012	0		FUT8
1193	chr10	79712133	79712156	3500264278	23		79712133	79712156	8421504	1	23	0	c	350026427800000001	0-23					Patent	Cells with altered fucosylation and producing antibodies therefrom (Patent US:8367407)	Kanda	2013	0		FUT8
1193	chr10	79712133	79712156	3500198866	23		79712133	79712156	8421504	1	23	0	c	350019886600000001	0-23					Patent	Method of modulating the activity of functional immune molecules to GM2 (Patent US:7655228)	Hanai	2010	0		FUT8
1193	chr10	79712133	79712156	3500196894	23		79712133	79712156	8421504	1	23	0	c	350019689400000001	0-23					Patent	Method of modulating the activity of functional immune molecules (Patent US:7682610)	Hanai	2010	0		
1193	chr10	79712133	79712156	3500189949	23		79712133	79712156	8421504	1	23	0	c	350018994900000001	0-23						Method of modulating the activity of functional immune molecules	Hanai	2005	0		FUT8
1193	chr10	79712133	79712156	3500154350	23		79712133	79712156	8421504	1	23	0	c	350015435000000001	0-23						Methods for producing antibody compositions with increased ADCC	Hanai	2005	0		FUT8
1193	chr10	79712133	79712156	3500119330	23		79712133	79712156	8421504	1	23	0	c	350011933000000001	0-23					Patent	Method of modulating the activity of functional immune molecules to Her-2 (Patent US:7687061)	Hanai	2010	0		FUT8
1193	chr10	79712133	79712156	3500054883	23		79712133	79712156	8421504	1	23	0	c	350005488300000001	0-23					Patent	Method of modulating the activity of functional immune molecules to CD52 (Patent US:7651688)	Hanai	2010	0		FUT8
1193	chr10	79712133	79712156	3500032745	23		79712133	79712156	8421504	1	23	0	c	350003274500000001	0-23						Method of modulating the activity of functional immune molecules	Hanai	2008	0		
1193	chr10	79712133	79712156	3500004863	23		79712133	79712156	8421504	1	23	0	c	350000486300000001	0-23						Method of modulating the activity of functional immune molecules	Hanai	2005	0		FUT8
1196	chr10	80139560	80139732	3500073718	165		80139560	80139732	8421504	4	6,4,105,50	0,11,16,122	g	350007371800000000	0-195						 Tophat can't find Bowtie index files - Page 2 - SEQanswers	seqanswers.com	0	0		
1196	chr10	80139560	80139732	3500029296	165		80139560	80139732	8421504	4	6,4,105,50	0,11,16,122	g	350002929600000000	0-195						 Tophat can't find Bowtie index files - Page 2 - SEQanswers	seqanswers.com	0	0		
1198	chr10	80407484	80407510	3500153946	23		80407484	80407510	8421504	2	14,9	0,17	g	350015394600000028	0-31			10.1111/j.1365-2958.2007.05849.x	1365-2958	Molecular Microbiology	The novel transcriptional regulator SczA mediates protection against Zn2+ stress by activation of the Zn2+-resistance gene czcD in Streptococcus pneumoniae - Kloosterman - 2007 - Molecular Microbiology - Wiley Online Library	Kloosterman	2007	0		
1204	chr10	81136562	81178214	3500273481	49		81136562	81178214	8421504	2	24,25	0,41627	c	350027348100000017,350027348100000005,350027348100000014	22-46,10-34,20-42						MPP5 Recruits MPP4 to the CRB1 Complex in Photoreceptors	www.iovs.org	0	0		
1204	chr10	81158738	81158762	3500176992	24		81158738	81158762	8421504	1	24	0	c	350017699200000000	0-24						Quantifying the lateral mobility of the &#xf067;-aminobutyric acid transporter GAT1	brary.caltech.edu	0	0		
1204	chr10	81204271	81219569	3500176949	45		81204271	81219569	8421504	2	26,19	0,15279	c	350017694900000000,350017694900000001	8-34,0-19		11809833	10.1091/mbc.01-05-0221	1059-1524	Molecular Biology of the Cell	Evidence That Ternary Complex (eIF2-GTP-tRNAi Met)&#x2013;Deficient Preinitiation Complexes Are Core Constituents of Mammalian Stress Granules	Kedersha	2002	5		EIF2S1
1204	chr10	81204271	81219566	3500389640	918		81204271	81219566	8421504	9	241,80,152,107,17,72,30,96,123	0,5641,7354,11500,13230,13256,14095,14143,15172	p	350038964000015017,350038964000015019,350038964000015018,350038964000015020,350038964000015021,350038964000015056,350038964000015057,350038964000015075,350038964000015074	0-357,0-207,0-357,0-81,0-63,0-240,0-102,0-219,0-219						Characterization of a ranavirus inhibitor of the antiviral protein kinase PKR	biomedcentral.com	0	0		
1204	chr10	81204430	81209977	3500353221	147		81204430	81209977	8421504	2	82,65	0,5482	p	350035322100015002	0-147						TH&#xc8;SE / UNIVERSIT&#xc9; DE RENNES 1 sous le seau de lUniversit&#xe9; Europ&#xe9;enne de Bretagne	m.univ-rennes1.fr	0	0		EIF2S1
1204	chr10	81204430	81209977	3500011552	147		81204430	81209977	8421504	2	82,65	0,5482	p	350001155200015002	0-147						TH&#xc8;SE / UNIVERSIT&#xc9; DE RENNES 1 sous le seau de lUniversit&#xe9; Europ&#xe9;enne de Bretagne	m.univ-rennes1.fr	0	0		EIF2S1
1204	chr10	81219669	81219696	3500130369	23		81219669	81219696	8421504	2	14,9	0,18	c	350013036900000042	5-28						BETA-GLUCOSIDASE CODING SEQUENCES AND PROTEIN FROM ORPINOMYCES PC-2 - UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	www.sumobrain.com	0	0		
1206	chr10	81415032	81415059	3500336748	25		81415032	81415059	8421504	3	14,7,4	0,15,23	g	350033674800000008	1-40						October - December 2003	rdi.ku.ac.th	0	0		
1206	chr10	81488142	81488169	3500156792	27		81488142	81488169	8421504	1	27	0	c	350015679200000005	0-27			10.1186/1479-5876-1-5	1479-5876	Journal of Translational Medicine	rIFN-&#xce;&#xb3;-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition	Melichar	2003	3		ARG2
1206	chr10	81490400	81490427	3500041280	27		81490400	81490427	8421504	1	27	0	c	350004128000000011	0-27						Comparative Study of the L-arginine-NO Pathway Gene Expressions between Human and Porcine Pulmonary Artery Endothelial Cells in Response to Lipopolysaccharide	ufdc.ufl.edu	0	0		
1207	chr10	81548426	81548458	3500052099	27		81548426	81548458	8421504	3	7,15,5	0,11,27	c	350005209900000304	10-42						Card Domain Containing Polypeptides, Encoding Nucleic Acids, And Methods Of Use 	.freshpatents.com	0	0		
1207	chr10	81563968	81564933	3500271050	43		81563968	81564933	8421504	4	13,6,5,19	0,17,938,946	c	350027105000000221,350027105000000245	3-22,1-27						Cloning by complementation and related processes	Colicelli	1991	0		
1207	chr10	81583514	81583539	3500048321	23		81583514	81583539	8421504	3	6,13,4	0,7,21	c	350004832100000136	0-23						Hbm variants that modulate bone mass and lipid levels	Allen	2002	0		
1207	chr10	81605311	81605431	3500330329	23		81605311	81605431	8421504	3	14,8,1	0,17,119	c	350033032900000011	25-48						Direct Control of Cell Cycle Gene Expression by Proto-Oncogene Product ACTR, and Its Autoregulation Underlies Its Transforming Activity	mcb.asm.org	0	0		
1207	chr10	81607856	81607887	3500363820	25		81607856	81607887	8421504	3	4,10,11	0,5,20	c	350036382000000016	0-25						Genome-wide differential gene expression in immortalized DF-1 chicken embryo fibroblast cell line	biomedcentral.com	0	0		ZFYVE26
1207	chr10	81607856	81607887	3500168417	25		81607856	81607887	8421504	3	4,10,11	0,5,20	c	350016841700000014	0-25						Genome-wide host responses against infectious laryngotracheitis virus vaccine infection in chicken embryo lung cells	biomedcentral.com	0	0		ZFYVE26
1207	chr10	81619423	81619733	3500378226	76		81619423	81619733	8421504	4	5,25,23,23	0,7,242,287	g	350037822600000030	214-345						Diagnostic detection of nucleic acids	Schuetz	2004	0		
1207	chr10	81619423	81619733	3500134371	76		81619423	81619733	8421504	4	5,25,23,23	0,7,242,287	g	350013437100000030	214-345						Diagnostic detection of nucleic acids	Schuetz	2002	0		
1207	chr10	81620612	81620637	3500403930	23		81620612	81620637	8421504	3	15,4,4	0,16,21	c	350040393000000129	10-33						Human ubiquitin conjugating enzyme	Draetta	1994	0		
1207	chr10	81637413	81637439	3500085287	26		81637413	81637439	8421504	1	26	0	c	350008528700000015	3-29						Methods and compositions for the diagnosis, prognosis, and treatment of cancer	Neuman	2003	0		
1207	chr10	81637419	81637472	3500283642	53		81637419	81637472	8421504	1	53	0	c	350028364200000001,350028364200000000	0-26,0-27					Patent	Mammalian and human REC2 (Patent US:6410226)	Kmiec	2002	0		RAD51B
1207	chr10	81637419	81637472	3500161792	53		81637419	81637472	8421504	1	53	0	c	350016179200000001,350016179200000000	0-26,0-27						Mammalian and human REC2	Kmiec	1997	0		RAD51B
1210	chr10	81942615	81942639	3500160528	23		81942615	81942639	8421504	2	14,9	0,15	g	350016052800000075	20-43						Anthrax toxin fusion proteins and uses thereof	Arora	1994	0		
1212	chr10	82198041	82198066	3500444502	24		82198041	82198066	8421504	2	13,11	0,14	g	350044450200000005	3-27						USES OF HUMAN MONOCLONAL ANTIBODIES AGAINST OXIDIZED LDL RECEPTOR - Patent application	www.faqs.org	0	0		WNK1
1213	chr10	82363966	82387507	3500012452	43		82363966	82387507	8421504	5	5,4,12,17,5	0,8,13,23518,23536	g	350001245200000180,350001245200000191	24-45,21-45						Rabies Virus Vector Systems and Compositions and Methods Thereof - Patent application	www.faqs.org	0	0		
1213	chr10	82377794	82377821	3500360991	23		82377794	82377821	8421504	2	10,13	0,14	g	350036099100000031	1-24						NOVEL INDUCER OF CHONDROCYTE PROLIFERATION AND DIFFERENTIATION - Patent application	www.faqs.org	0	0		
1215	chr10	82579380	82579408	3500205867	24		82579380	82579408	8421504	2	11,13	0,15	c	350020586700000014	0-24						Kupplung der DNA-Methyltransferase M.SssI mit Triplehelix-bildenden Oligodesoxynucleotiden	th.rwth-aachen.de	0	0		
1215	chr10	82580307	82580877	3500433612	136		82580307	82580877	8421504	2	90,46	0,524	c	350043361200000261,350043361200000260,350043361200000250	0-45,0-45,0-46						US Patent # 7,132,399. Mammalian cell surface DNA receptor - Patents.com	www.patents.com	0	0		
1215	chr10	82581261	82583751	3500354530	25		82581261	82583751	8421504	2	6,19	0,2471	c	350035453000000004	0-25						LOW INTENSITY PULSED ULTRASOUND STIMULATES CELL PROLIFERATION	www.docstoc.com	0	0		ZFP36L1
151	chr10	82644845	82742082	3500445406	2676		82644845	82742082	8421504	21	156,159,81,147,180,135,183,141,109,151,148,231,93,86,82,79,88,87,120,115,105	0,1624,3505,4533,5432,6605,7009,7943,8580,9134,12493,14364,15844,22769,24077,27702,28293,30211,38419,42797,97132	p	350044540600015000	0-2676						KEGG T01001: 87	www.genome.jp	0	0		ACTN1
151	chr10	82644845	82742082	3500033422	2676		82644845	82742082	8421504	21	156,159,81,147,180,135,183,141,109,151,148,231,93,86,82,79,88,87,120,115,105	0,1624,3505,4533,5432,6605,7009,7943,8580,9134,12493,14364,15844,22769,24077,27702,28293,30211,38419,42797,97132	p	350003342200015001	0-2676						KEGG T01001: 81	www.genome.jp	0	0		ACTN1
1215	chr10	82650287	82657387	3500268016	39		82650287	82657387	8421504	2	20,19	0,7081	c,g	350026801600000011,350026801600000011,350026801600000010,350026801600000010	0-20,0-20,0-19,0-19		20473295	10.1038/ncb2062		Nature cell biology	A distinctive role for focal adhesion proteins in three-dimensional cell motility	Stephanie	June	0		ACTN1
1215	chr10	82688206	82688233	3500391456	25		82688206	82688233	8421504	2	7,18	0,9	g	350039145600000023	4-31						Analyte detection assays	Belyaev	2009	0		
1215	chr10	82688206	82688233	3500362805	25		82688206	82688233	8421504	2	7,18	0,9	g	350036280500000014	4-31						Polymorphisms In Genes Affecting Cns Disorders And Uses Thereof 	.freshpatents.com	0	0		
1216	chr10	82742025	82742082	3500039057	57		82742025	82742082	8421504	1	57	0	p	350003905700015051	0-57						Human Endothelial Actin-binding Protein (ABP-280, Nonmuscle Filamin): A Molecular Leaf Spring	jcb.rupress.org	0	0		ACTN1
1216	chr10	82742097	82742120	3500425506	23		82742097	82742120	8421504	1	23	0	c	350042550600000026	0-23						Snail and Slug Promote Epithelial-Mesenchymal Transition through -Catenin&#x2013;T-Cell Factor-4-dependent Expression of Transforming Growth Factor- 3	w.molbiolcell.org	0	0		ACTN1
1216	chr10	82742097	82742120	3500006489	23		82742097	82742120	8421504	1	23	0	c	350000648900000026	0-23		18799618	10.1091/mbc.E08-05-0506		Molecular Biology of the Cell	Snail and Slug Promote Epithelial-Mesenchymal Transition through &#x03b2;-Catenin&#x2013;T-Cell Factor-4-dependent Expression of Transforming Growth Factor-&#x03b2;3	Damian	2008	0		ACTN1
1217	chr10	82876538	82876564	3500125371	23		82876538	82876564	8421504	3	6,12,5	0,7,21	g	350012537100000006	11-34						IB- Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b	journal.9med.net	0	0		
1218	chr10	82975524	82975548	3500399667	24		82975524	82975548	8421504	1	24	0	c	350039966700000034	9-33						ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES	Clausen	2007	0		EXD2
1218	chr10	82975524	82975548	3500265908	24		82975524	82975548	8421504	1	24	0	c	350026590800000034,350026590800000120	9-33,9-33						Isolated Lectin Polypeptides Consisting Of Truncated Mammalian Udp-galnac:polypeptide N- Acetylgalactosaminyltransferases 	.freshpatents.com	0	0		EXD2
1220	chr10	83324450	83324477	3500445885	23		83324450	83324477	8421504	3	5,6,12	0,6,15	g	350044588500000009,350044588500000003	6-29,6-29						Prostate Cancer Diagnosis And Treatment 	.freshpatents.com	0	0		
1220	chr10	83324450	83324477	3500386289	23		83324450	83324477	8421504	3	5,6,12	0,6,15	g	350038628900000003	6-29						Prostate cancer diagnosis and treatment	Bernard	2011	0		
1220	chr10	83324450	83324477	3500341347	23		83324450	83324477	8421504	3	5,6,12	0,6,15	g	350034134700000003	6-29						PROSTATE CANCER DIAGNOSIS AND TREATMENT	Cuello	2011	0		
1220	chr10	83324450	83324477	3500282791	23		83324450	83324477	8421504	3	5,6,12	0,6,15	g	350028279100000003	6-29					Patent	Prostate cancer diagnosis and treatment (Patent US:7811564)	Cuello	2010	0		
1220	chr10	83324450	83324477	3500252426	23		83324450	83324477	8421504	3	5,6,12	0,6,15	g	350025242600000003,350025242600000009	6-29,6-29						PROSTATE CANCER DIAGNOSIS AND TREATMENT - Patent application	www.faqs.org	0	0		
1221	chr10	83425706	83426019	3500440514	24		83425706	83426019	8421504	2	15,9	0,304	c	350044051400000021	0-24		15735005	10.1158/0008-5472.CAN-04-4249	0008-5472	Cancer Research	A Germline DNA Polymorphism Enhances Alternative Splicing of the KLF6 Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk	Narla	2005	8		SRSF5
1221	chr10	83425706	83426019	3500277251	24		83425706	83426019	8421504	2	15,9	0,304	c	350027725100000021	0-24						KLF6 ALTERNATIVE SPLICE FORMS AND A GERMLINE KLF6 DNA POLYMORPHISM ASSOCIATED WITH INCREASED CANCER RISK	Martignetti	2005	0		SRSF5
1222	chr10	83521720	83589217	3500165789	24		83521720	83589217	8421504	2	2,22	0,67475	c	350016578900000009	0-24		18042303	10.1186/1471-2164-8-436	1471-2164	BMC Genomics	Characterization of Smoc-1 uncovers two transcript variants showing differential tissue and age specific expression in Bubalus bubalis	Srivastava	2007	4		SMOC1
1223	chr10	83660921	83660945	3500165789	24		83660921	83660945	8421504	1	24	0	c	350016578900000010	0-24		18042303	10.1186/1471-2164-8-436	1471-2164	BMC Genomics	Characterization of Smoc-1 uncovers two transcript variants showing differential tissue and age specific expression in Bubalus bubalis	Srivastava	2007	4		
1223	chr10	83692342	83692365	3500326695	23		83692342	83692365	8421504	1	23	0	c	350032669500000218,350032669500000205	11-34,11-34						 Directed Evolution Of Disulfide 	www.docstoc.com	0	0		
1224	chr10	83833029	83833254	3500132803	222		83833029	83833254	8421504	2	120,102	0,123	p	350013280300015005	0-222						METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER	Carroll	2004	0		
1224	chr10	83845684	83845711	3500068199	24		83845684	83845711	8421504	3	12,6,6	0,13,21	g	350006819900000627	16-40						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
1228	chr10	84295524	84295549	3500300591	23		84295524	84295549	8421504	2	16,7	0,18	g	350030059100000228	22-45						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
1231	chr10	84712548	84712575	3500394305	23		84712548	84712575	8421504	2	13,10	0,17	g	350039430500000005	0-23						Pretreatment with Mycobacterium avium-derived lipids attenuates the response of murine macrophages to components of Mycobacterium tuberculosis	-publications.com	0	0		
1235	chr10	85317451	85317477	3500430879	23		85317451	85317477	8421504	2	11,12	0,14	g	350043087900000171	2-26						Unnatural Reactive Amino Acid Genetic Code Additions - Patent application	www.faqs.org	0	0		
1235	chr10	85317451	85317477	3500310209	23		85317451	85317477	8421504	2	11,12	0,14	g	350031020900000144	2-26						Site Specific Incorporation of Non-Natural Amino Acids by Vertebrate Cells - Patent application	www.faqs.org	0	0		
1236	chr10	85435036	85435061	3500205215	23		85435036	85435061	8421504	2	5,18	0,7	g	350020521500000078	2-25						Control of ostrinia	www.devileye.net	0	0		
1241	chr10	86075041	86075064	3500283532	23		86075041	86075064	8421504	1	23	0	g	350028353200000066	6-44						Chimeric genes and methods for increasing lysine content of seeds of plants	S*C*Fa Er Ke 	2000	0		
1246	chr10	86641335	86641358	3500406521	23		86641335	86641358	8421504	1	23	0	c	350040652100000124	0-23						High molecular weight major outer membrane protein of moraxella	Sasaki	1998	0		
1246	chr10	86641335	86641358	3500023267	23		86641335	86641358	8421504	1	23	0	c	350002326700000124	0-23						High molecular weight major outer membrane protein of moraxella	Sasaki	1996	0		
1246	chr10	86740200	86740224	3500450622	24		86740200	86740224	8421504	1	24	0	c	350045062200000006	6-30		21298055	10.1371/journal.pone.0014602		PLoS ONE	Familial CJD Associated PrP Mutants within Transmembrane Region Induced Ctm-PrP Retention in ER and Triggered Apoptosis by ER Stress in SH-SY5Y Cells	Xin	2011	0		PSEN1
1246	chr10	86740206	86740278	3500435240	72		86740206	86740278	8421504	1	72	0	p	350043524000015018	0-72						Transgenic mice expressing human presenilin proteins	George-hyslop	1998	0		
1246	chr10	86740209	86740278	3500294933	69		86740209	86740278	8421504	1	69	0	p	350029493300015016	3-72					Patent	Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene (Patent US:6194153)	George-Hyslop	2001	0		
155	chr10	86740242	86778714	3500413475	72		86740242	86778714	8421504	4	45,3,7,17	0,19403,34294,38455	c	350041347500000003,350041347500000050	0-48,0-24						Genetic alterations related to familial alzheimer's disease	Tanzi	1996	0		
1246	chr10	86740259	86759800	3500282274	41		86740259	86759800	8421504	2	21,20	0,19521	c	350028227400000006,350028227400000007	11-32,16-36		9045726		0270-6474	The Journal of Neuroscience	Light and Electron Microscopic Localization of Presenilin-1 in Primate Brain	Lah	1997	7		
1247	chr10	86859855	86859878	3500021888	23		86859855	86859878	8421504	1	23	0	c	350002188800000005	0-23		19097049	10.1002/dvdy.21833		Developmental dynamics : an official publication of the American Association of Anatomists	Analysis of human muscle stem cells reveals a differentiation-resistant progenitor cell population expressing Pax7 capable of self-renewal	Bradley	2009	0		
1248	chr10	86909936	86909985	3500068995	49		86909936	86909985	8421504	1	49	0	c,g	350006899500000227,350006899500000832	67-116,0-27						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
1252	chr10	87453829	87453857	3500091692	23		87453829	87453857	8421504	2	10,13	0,15	g	350009169200000005	0-23						Differences in Early Lineage Segregation Between Mammals	www.uu.nl/faculty	0	0		
1254	chr10	87707275	87707303	3500119347	23		87707275	87707303	8421504	3	5,5,13	0,8,15	g	350011934700000006	2-26		21119622	10.1038/mt.2010.269	1525-0016	Molecular Therapy	Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell&#x2013;derived Induced Pluripotent Stem Cells	Kambal	2010	7		
1254	chr10	87708295	87708350	3500119546	40		87708295	87708350	8421504	2	20,20	0,35	g	350011954600000034,350011954600000069,350011954600000036,350011954600000071	4-24,4-24,4-24,4-24						REGULATORY ELEMENTS THAT MEDIATE RETINAL CELL-SPECIFIC GENE EXPRESSION - Patent application	www.faqs.org	0	0		
1254	chr10	87722919	87739883	3500185397	38		87722919	87739883	8421504	3	18,1,19	0,3816,16945	c,g	350018539700000008,350018539700000009,350018539700000009	0-19,0-19,0-19						Chx10repression of Mitfis required for the maintenance of mammalian neuroretinal identity	ev.biologists.org	0	0		VSX2
1254	chr10	87722919	87739883	3500098403	38		87722919	87739883	8421504	3	18,1,19	0,3816,16945	c,g	350009840300000008,350009840300000009,350009840300000009	0-19,0-19,0-19		15576400	10.1242/dev.01571	0950-1991	Development	Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity	Horsford	2005	7		VSX2
1254	chr10	87722919	87739883	3500047666	38		87722919	87739883	8421504	3	18,1,19	0,3816,16945	c,g	350004766600000008,350004766600000009,350004766600000009	0-19,0-19,0-19		15576400	10.1242/dev.01571	0950-1991	Development	Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity	Horsford	2005	7		VSX2
1254	chr10	87753185	87753209	3500432414	24		87753185	87753209	8421504	1	24	0	c	350043241400000030	3-27						OVINE IDENTIFICATION METHOD	Mcewan	2008	0		
1255	chr10	87918904	87918961	3500335102	57		87918904	87918961	8421504	1	57	0	p	350033510200015094	0-57						BiochemicalCharacterizationandN-terminomicsAnalysisof Leukolysin,theMembrane-type6MatrixMetalloprotease (MMP25)	www.jbc.org	0	0		LTBP2
1255	chr10	87927050	87928148	3500204907	25		87927050	87928148	8421504	3	5,16,4	0,6,1094	c	350020490700000007	22-47						Cell Stem Cell	fhs.mcmaster.ca	0	0		
1255	chr10	87935281	87935305	3500097443	24		87935281	87935305	8421504	1	24	0	c	350009744300000000	0-24						Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. - ResearchGate	.researchgate.net	0	0		LTBP2
1255	chr10	87941247	87943816	3500413545	23		87941247	87943816	8421504	3	14,8,1	0,15,2568	c	350041354500000001	2-25						Citation Infection Genetics And Evolution, 16: 137-143 Issue Date 2013-06	lib.hokudai.ac.jp	0	0		
1255	chr10	87941247	87943816	3500220918	23		87941247	87943816	8421504	3	14,8,1	0,15,2568	c	350022091800000017	2-25						Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek&#x2019;s disease virus	www.virologyj.com	0	0		
1255	chr10	87941247	87943816	3500125134	23		87941247	87943816	8421504	3	14,8,1	0,15,2568	c	350012513400000001	2-25		22612856	10.1186/1743-422X-9-94	1743-422X	Virology Journal	Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek&#xe2; s disease virus	Matsuyama-Kato	2012	2		
1256	chr10	88001570	88023942	3500088918	150		88001570	88023942	8421504	3	74,71,5	0,15601,22367	p	350008891800015096	0-150						and the Immune System of Drosophila melanogaster.	edoc.hu-berlin.de	0	0		LTBP2
1257	chr10	88093426	88093457	3500060191	28		88093426	88093457	8421504	2	12,16	0,15	g	350006019100000148	0-33						Multiplex-Genotypisierung forensisch relevanter SNPs unter&#x2026;	m.opus.hbz-nrw.de	0	0		
1258	chr10	88325354	88325431	3500388552	47		88325354	88325431	8421504	2	25,22	0,55	c,g	350038855200000017,350038855200000017,350038855200000016,350038855200000016	0-25,0-25,0-22,0-22						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
1258	chr10	88325354	88325431	3500143254	47		88325354	88325431	8421504	2	25,22	0,55	c,g	350014325400000017,350014325400000016,350014325400000016	0-25,0-22,0-22						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
1259	chr10	88348425	88348450	3500157945	24		88348425	88348450	8421504	2	14,10	0,15	g	350015794500000037	0-24						 Endoglucanases 	www.docstoc.com	0	0		
1259	chr10	88348425	88348450	3500084765	24		88348425	88348450	8421504	2	14,10	0,15	g	350008476500000038	0-24						Endoglucanases	www.devileye.net	0	0		
157	chr10	88472820	88477710	3500341913	135		88472820	88477710	8421504	5	9,36,45,22,23	0,1224,2353,4383,4867	p	350034191300015045,350034191300015046,350034191300015044	0-45,0-45,0-45						Protein Kinases 	.freshpatents.com	0	0		NEK9
1260	chr10	88496523	88496551	3500444502	23		88496523	88496551	8421504	2	17,6	0,22	c	350044450200000057	12-35						USES OF HUMAN MONOCLONAL ANTIBODIES AGAINST OXIDIZED LDL RECEPTOR - Patent application	www.faqs.org	0	0		
1261	chr10	88613753	88613843	3500404466	87		88613753	88613843	8421504	3	6,30,51	0,7,39	g	350040446600000010	10-98		9584171		0270-7306	Molecular and Cellular Biology	TFII-I Enhances Activation of the c-fosPromoter through Interactions with Upstream Elements	Kim	1998	6		
1261	chr10	88613761	88613785	3500226355	24		88613761	88613785	8421504	1	24	0	g	350022635500000008	0-24						cAMP-responseElement-bindingProtein(CREB)Controls MSK1-mediatedPhosphorylationofHistoneH3atthec-fos Promoter inVitro S	www.jbc.org	0	0		
1261	chr10	88613764	88613788	3500362035	24		88613764	88613788	8421504	1	24	0	g	350036203500000003	0-24						Differential Binding Activity of the Transcription Factor LIL-Stat in Immature and Differentiated Normal and Leukemic Myeloid Cells	tologylibrary.org	0	0		
1261	chr10	88613795	88613820	3500111302	25		88613795	88613820	8421504	1	25	0	g	350011130200000008	0-25						Net, a transcription factor of the TCF family, as regulator of angiogenic factor expression	Wasylyk	2001	0		
1261	chr10	88614288	88614311	3500309652	23		88614288	88614311	8421504	1	23	0	g	350030965200000016	0-23			10.1093/emboj/cdf302		The EMBO Journal	Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth	Sheng	June	0		
1261	chr10	88614905	88615024	3500467173	114		88614905	88615024	8421504	2	55,59	0,60	g	350046717300000018,350046717300000020	0-55,0-59						Vincent COULON	hives-ouvertes.fr	0	0		
1261	chr10	88614905	88615024	3500222725	114		88614905	88615024	8421504	2	55,59	0,60	g	350022272500000018,350022272500000020	0-55,0-59						Vincent COULON	hives-ouvertes.fr	0	0		
1261	chr10	88615405	88616202	3500191222	252		88615405	88616202	8421504	3	66,108,78	0,488,719	p	350019122200015021	0-252						Basic leucine zipper transcription factor Hac1 binds DNA in two distinct modes as revealed by microfluidic analyses	alterlab.ucsf.edu	0	0		FOS
1261	chr10	88615908	88616253	3500173293	219		88615908	88616253	8421504	3	93,96,30	0,216,315	p	350017329300015045	36-261						Team:Freiburg bioware/cloning - 2009.igem.org	2009.igem.org	0	0		FOS
1261	chr10	88615914	88615992	3500382888	78		88615914	88615992	8421504	1	78	0	p	350038288800015026	0-78						Phenotypic Reversion Of Pancreatic Carcinoma Cells 	.freshpatents.com	0	0		FOS
1261	chr10	88615914	88615992	3500345251	78		88615914	88615992	8421504	1	78	0	p	350034525100015035	0-78						MEMBRANE RESIDENT PEPTIDE IN ANTI-CANCER PEPTIDES CAUSES TUMOR CELL NECROSIS RATHER THAN APOPTOSIS OF CANCER CELLS	Pincus	2009	0		FOS
1261	chr10	88615914	88615992	3500108161	78		88615914	88615992	8421504	1	78	0	p	350010816100015016	0-78						PHENOTYPIC REVERSION OF PANCREATIC CARCINOMA CELLS - Patent application	www.faqs.org	0	0		FOS
1261	chr10	88615916	88615950	3500146183	34		88615916	88615950	8421504	1	34	0	c	350014618300000008	0-34						The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M113.469973	www.jbc.org	0	0		
1261	chr10	88615921	88615944	3500215215	23		88615921	88615944	8421504	1	23	0	c	350021521500000189	0-23						Arrays and Methods for Reverse Genetic Functional Analysis - Patent application	www.faqs.org	0	0		
1261	chr10	88615926	88615977	3500254665	51		88615926	88615977	8421504	1	51	0	p	350025466500015061	0-51						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		FOS
1261	chr10	88615937	88615967	3500074637	30		88615937	88615967	8421504	1	30	0	g	350007463700000012,350007463700000002	0-30,0-30						Combination Treatment of Cancer With Cetuximab and Tetrac - Patent application	www.faqs.org	0	0		
1261	chr10	88615962	88615985	3500458955	23		88615962	88615985	8421504	1	23	0	c	350045895500000004	0-23						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		
1261	chr10	88615980	88616223	3500383796	120		88615980	88616223	8421504	2	21,99	0,144	p	350038379600015001	9-129						Molecular Antigen Array	Renner	2011	0		FOS
1261	chr10	88615980	88616223	3500381508	120		88615980	88616223	8421504	2	21,99	0,144	p	350038150800015001	9-129					Patent	Ordered molecular presentation of allergens, method of preparation and use (Patent EP:1135162)	Bachmann	2008	0		FOS
1261	chr10	88615980	88616223	3500374171	120		88615980	88616223	8421504	2	21,99	0,144	p	350037417100015001	9-129						Molecular antigen array	Renner	2011	0		FOS
1261	chr10	88615980	88616223	3500370493	120		88615980	88616223	8421504	2	21,99	0,144	p	350037049300015029	9-129						Molecular antigen array	Renner	2002	0		FOS
1261	chr10	88615980	88616223	3500287603	120		88615980	88616223	8421504	2	21,99	0,144	p	350028760300015009	9-129					Patent	Molecular antigen array (Patent US:7320793)	Renner	2008	0		FOS
1261	chr10	88615980	88616223	3500279893	114		88615980	88616223	8421504	3	21,60,33	0,144,210	p	350027989300015010	9-123					Patent	Molecular antigen array presenting amyloid beta (Patent EP:1353691)	Renner	2009	0		FOS
1261	chr10	88615980	88616223	3500276554	120		88615980	88616223	8421504	2	21,99	0,144	p	350027655400015012	0-120						ISOLATED HIGH AFFINITY ENTITIES WITH T-CELL RECEPTOR LIKE SPECIFICITY TOWARDS NATIVE COMPLEXES OF MHC CLASS II AND GLUTAMIC ACID DECARBOXYLASE (GAD) AUTOANTIGENIC PEPTIDES	Reiter	2011	0		FOS
1261	chr10	88615980	88616223	3500271723	120		88615980	88616223	8421504	2	21,99	0,144	p	350027172300015008	9-129						Molecular antigen array	Wo Er Fu Gang *A*Lun Na 	2004	0		FOS
1261	chr10	88615980	88616223	3500260645	120		88615980	88616223	8421504	2	21,99	0,144	p	350026064500015011	9-129						Molecular antigen arrary	Renner	2008	0		FOS
1261	chr10	88615980	88616223	3500244984	120		88615980	88616223	8421504	2	21,99	0,144	p	350024498400015004,350024498400015039,350024498400015047,350024498400015018	9-129,9-123,0-54,0-54						Ordered molecular presentation of antigens, method of preparation and use	W*A*Lun Na 	2005	0		FOS
1261	chr10	88615980	88616223	3500219378	120		88615980	88616223	8421504	2	21,99	0,144	p	350021937800015001,350021937800015025,350021937800015022,350021937800015010	9-129,0-60,0-60,0-54					Patent	Ordered molecular presentation of antigens, method of preparation and use (Patent US:7229624)	Renner	2007	0		FOS
1261	chr10	88615980	88616223	3500212737	120		88615980	88616223	8421504	2	21,99	0,144	p	350021273700015001	9-129						Ordered molecular presetation of antigens, method of preparation and use	Bachmann	2004	0		FOS
1261	chr10	88615980	88616223	3500175602	120		88615980	88616223	8421504	2	21,99	0,144	p	350017560200015003,350017560200015029,350017560200015008	510-630,0-45,0-45						METHODS OF INDUCING IL-10 PRODUCTION - Patent application	www.faqs.org	0	0		FOS
1261	chr10	88615980	88616223	3500154312	120		88615980	88616223	8421504	2	21,99	0,144	p	350015431200015036	9-129						Molecular antigen array	Bachmann	2003	0		FOS
1261	chr10	88615980	88616223	3500143718	120		88615980	88616223	8421504	2	21,99	0,144	p	350014371800015006	9-129						Molecular antigen array presenting amyloid beta	Bachmann	2003	0		FOS
1261	chr10	88615980	88616223	3500096921	120		88615980	88616223	8421504	2	21,99	0,144	p	350009692100015011	9-129						Molecular antigen array	Bachmann	2003	0		FOS
1261	chr10	88615980	88616223	3500095833	120		88615980	88616223	8421504	2	21,99	0,144	p	350009583300015016	9-129					Patent	Molecular antigen array (Patent US:7264810)	Renner	2007	0		FOS
1261	chr10	88615980	88616223	3500089496	120		88615980	88616223	8421504	2	21,99	0,144	p	350008949600015006	9-129						Molecular antigen array presenting amyloid beta	Renner	2002	0		FOS
1261	chr10	88615980	88616223	3500079495	120		88615980	88616223	8421504	2	21,99	0,144	p	350007949500015002,350007949500015019,350007949500015023,350007949500015009	9-129,9-123,0-54,0-54						&#x6297;&#x539f;&#x7684;&#x6709;&#x5e8f;&#x5206;&#x5b50;&#x5448;&#x9012;&#xff0c;&#x5236;&#x5907;&#x53ca;&#x4f7f;&#x7528;&#x7684;&#x65b9;&#x6cd5;	W*A*Lun Na 	2005	0		FOS
1261	chr10	88615980	88616223	3500032428	120		88615980	88616223	8421504	2	21,99	0,144	p	350003242800015011	0-120						Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides	Dahan	2012	0		FOS
1261	chr10	88615980	88616223	3500020039	120		88615980	88616223	8421504	2	21,99	0,144	p	350002003900015016	9-129						Molecular antigen array	Renner	2002	0		FOS
1261	chr10	88615980	88616220	3500070627	117		88615980	88616220	8421504	2	21,96	0,144	p	350007062700015001	0-117						Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem Cells	w.molbiolcell.org	0	0		FOS
1261	chr10	88615980	88616220	3500051366	117		88615980	88616220	8421504	2	21,96	0,144	p	350005136600015001	0-117		16624864	10.1091/mbc.E05-12-1129	1059-1524	Molecular Biology of the Cell	Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem Cells	Stuhlmann-Laeisz	2006	5		FOS
1261	chr10	88615980	88616220	3500015291	117		88615980	88616220	8421504	2	21,96	0,144	p	350001529100015038	0-117						Spore Associated Display 	.freshpatents.com	0	0		FOS
1261	chr10	88615980	88616217	3500438749	114		88615980	88616217	8421504	2	21,93	0,144	p	350043874900015005,350043874900015000	21-135,0-114						Tethering Small Molecules to a Phage Display Library: Discovery of a Selective Bivalent Inhibitor of Protein Kinase A Supporting Information	cbc.arizona.edu	0	0		FOS
1261	chr10	88615980	88616217	3500275153	114		88615980	88616217	8421504	2	21,93	0,144	p	350027515300015000,350027515300015005	0-114,21-135						Tethering Small Molecules to a Phage Display Library: Discovery of a Selective Bivalent Inhibitor of Protein Kinase A Supporting Information	.chem.arizona.edu	0	0		FOS
1261	chr10	88615980	88616217	3500074119	114		88615980	88616217	8421504	2	21,93	0,144	p	350007411900015002,350007411900015000	0-114,0-87						Surface display of recombinant proteins in lower eukaryotes	Zha	2009	0		FOS
1261	chr10	88615980	88616208	3500259268	105		88615980	88616208	8421504	2	21,84	0,144	p	350025926800015016	9-114						Molecular antigen array	Bachmann	2003	0		FOS
1261	chr10	88615983	88616202	3500362031	96		88615983	88616202	8421504	2	18,78	0,141	p	350036203100015013	0-96						Totally synthetic affinity reagents	Fowlkes	1996	0		FOS
1261	chr10	88615983	88616202	3500307462	96		88615983	88616202	8421504	2	18,78	0,141	p	350030746200015012	0-96						Totally synthetic affinity reagents	Fowlkes	1994	0		FOS
1261	chr10	88615983	88616190	3500462351	84		88615983	88616190	8421504	2	18,66	0,141	p	350046235100015012	0-84						3335532 Protein Engineering Protocols	www.scribd.com	0	0		FOS
1261	chr10	88615992	88616165	3500433474	50		88615992	88616165	8421504	2	9,41	0,132	c	350043347400000003,350043347400000004	0-24,0-44		16326707	10.1074/jbc.M509818200	0021-9258	Journal of Biological Chemistry	Use of Synthetic Peptides to Locate Novel Integrin &#x03b1;2&#x03b2;1-binding Motifs in Human Collagen III	Raynal	2006	5		
1261	chr10	88615998	88616161	3500226199	40		88615998	88616161	8421504	2	3,37	0,126	c	350022619900000018,350022619900000023,350022619900000025	0-20,0-40,0-40						US Patent # 6,228,592. Nucleic acid detection in cytoplasm - Patents.com	www.patents.com	0	0		
1261	chr10	88616130	88616217	3500369777	87		88616130	88616217	8421504	1	87	0	p	350036977700015031,350036977700015028	0-60,0-60						Ordered molecular presentation of antigens, method of preparation and use	Bachmann	2001	0		FOS
1261	chr10	88616160	88616220	3500289431	60		88616160	88616220	8421504	1	60	0	p	350028943100015042,350028943100015014	0-54,0-54						ordered molecualr presentation of antigens, method of preparation and use	W*A*Lun Na 	2002	0		FOS
1261	chr10	88616166	88616211	3500023901	45		88616166	88616211	8421504	1	45	0	p	350002390100015078	0-45						US Patent # 7,141,417. Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene - Patents.com	www.patents.com	0	0		FOS
1261	chr10	88616173	88616197	3500391398	24		88616173	88616197	8421504	1	24	0	c	350039139800000009	0-24		20814972	10.1002/jbmr.242	1523-4681	Journal of Bone and Mineral Research	Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-&#x03ba;B and MAPK signaling pathways - Li - 2011 - Journal of Bone and Mineral Research - Wiley Online Library	Li	2011	0		
1261	chr10	88616265	88616293	3500038784	28		88616265	88616293	8421504	1	28	0	c	350003878400000007	2-30		17550983	10.1124/mol.107.036541	1521-0111 (Online)	Molecular Pharmacology	Stromal Cell-Derived Factor-1 Induces Matrix Metalloprotease-13 Expression in Human Chondrocytes	Chiu	2007	0		
1261	chr10	88616353	88616423	3500320087	41		88616353	88616423	8421504	2	21,20	0,50	c	350032008700000005,350032008700000006	0-21,0-20		16439548	10.1128/JVI.80.4.1922-1938.2006	0022-538X	Journal of Virology	Insights into Gene Expression Changes Impacting B-Cell Transformation: Cross-Species Microarray Analysis of Bovine Leukemia Virus Tax-Responsive Genes in Ovine B Cells	Klener	2006	5		
1261	chr10	88616478	88616522	3500177145	44		88616478	88616522	8421504	1	44	0	c	350017714500000002	45-89			10.1046/j.1471-4159.2001.00389.x	1471-4159	Journal of Neurochemistry	Functional striatal hypodopaminergic activity in mice lacking adenosine A2A receptors - Dassesse - 2001 - Journal of Neurochemistry - Wiley Online Library	Dassesse	2001	0		FOS
1261	chr10	88616593	88616617	3500412427	24		88616593	88616617	8421504	1	24	0	c	350041242700000005	0-24		11504688			American Journal of Physiology - Lung Cellular and Molecular Physiology	AP-1-dependent induction of plasminogen activator inhibitor-1 by nickel does not require reactive oxygen	Andrew	2001	0		FOS
1261	chr10	88616593	88616617	3500172871	24		88616593	88616617	8421504	1	24	0	c	350017287100000005	0-24		11504688			American Journal of Physiology - Lung Cellular and Molecular Physiology	AP-1-dependent induction of plasminogen activator inhibitor-1 by nickel does not require reactive oxygen	Andrew	2001	0		FOS
1261	chr10	88616619	88616706	3500333830	87		88616619	88616706	8421504	1	87	0	p	350033383000015018	0-87						&#x6700;&#x65b0;&#x5206;&#x5b50;&#x751f;&#x7269;&#x5b66;&#x5373;&#x5e2d;&#x5165;&#x9580;	chianti.ucsd.edu	0	0		
1261	chr10	88616641	88616965	3500021622	41		88616641	88616965	8421504	2	19,22	0,302	c,g	350002162200000002,350002162200000003,350002162200000003	0-19,0-22,0-22						JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection	Mohapatra	2004	0		FOS
1261	chr10	88616729	88616762	3500020224	33		88616729	88616762	8421504	1	33	0	c	350002022400000001	0-33					Molecular and Cellular Biology	Increased c-fos mRNA Expression By Human Fibroblasts Contracting Stressed Collagen Matrices	Hans	1998	0		
1261	chr10	88617054	88617078	3500274445	24		88617054	88617078	8421504	1	24	0	c	350027444500000013	1-25		19846754	10.1152/ajpcell.00417.2008		American Journal of Physiology - Cell Physiology	TGF-&#x03b2; suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB	George	2010	0		
1261	chr10	88617314	88617348	3500399808	32		88617314	88617348	8421504	2	16,16	0,18	c	350039980800000016	0-33						Vectors with modified protease-dependent tropism	Kinoh	2003	0		
1261	chr10	88617314	88617348	3500313675	32		88617314	88617348	8421504	2	16,16	0,18	c	350031367500000062,350031367500000118,350031367500000057,350031367500000115	0-33,0-33,0-33,0-33						 Envelope Gene 	www.docstoc.com	0	0		
1261	chr10	88617314	88617348	3500160072	32		88617314	88617348	8421504	2	16,16	0,18	c	350016007200000016	0-33						VECTORS WITH MODIFIED PROTEASE-DEPENDENT TROPISM - Patent application	www.faqs.org	0	0		
1261	chr10	88617314	88617348	3500055224	32		88617314	88617348	8421504	2	16,16	0,18	c	350005522400000001	0-33		12743299	10.1128/JVI.77.11.6419-6429.2003	0022-538X	Journal of Virology	A New Sendai Virus Vector Deficient in the Matrix Gene Does Not Form Virus Particles and Shows Extensive Cell-to-Cell Spreading	Inoue	2003	5		
1261	chr10	88617340	88617541	3500211987	43		88617340	88617541	8421504	2	20,23	0,178	c	350021198700000018,350021198700000019	0-20,0-23						Tristetraprolin Regulates the Expression of the Human Inducible Nitric-Oxide Synthase Gene 2005&#x5e74;&#x7b2c;67&#x5377;&#x7b2c;6&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		FOS
1261	chr10	88617340	88617541	3500117526	43		88617340	88617541	8421504	2	20,23	0,178	c,g	350011752600000018,350011752600000018,350011752600000019	0-20,0-20,0-23		15778452	10.1124/mol.104.008763	1521-0111 (Online)	Molecular Pharmacology	Tristetraprolin Regulates the Expression of the Human Inducible Nitric-Oxide Synthase Gene	Fechir	2005	0		FOS
1261	chr10	88617396	88617465	3500416974	69		88617396	88617465	8421504	1	69	0	c	350041697400000002,350041697400000017	0-69,0-46						Curriculum Vitae Beth E. Zucconi Education	hsl.umaryland.edu	0	0		
1261	chr10	88617405	88617435	3500314698	30		88617405	88617435	8421504	1	30	0	c	350031469800000006	0-30			10.1093/emboj/cdf639		The EMBO Journal	Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs	Simon	2002	0		
1261	chr10	88617405	88617435	3500018217	30		88617405	88617435	8421504	1	30	0	c	350001821700000005	0-30		12456657	10.1093/emboj/cdf639	ERROR! NO ISSN	The EMBO Journal	Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs	Rousseau	2002	0		
1262	chr10	88780531	88780591	3500040245	60		88780531	88780591	8421504	1	60	0	p	350004024500015004	0-60						Development of an optimized backbone of FRET biosensors for kinases and GTPases	w.molbiolcell.org	0	0		JDP2
1262	chr10	88840638	88842970	3500448316	25		88840638	88842970	8421504	2	9,16	0,2316	c	350044831600000004	0-25						Transcriptional regulation of follicular T-helper (Tfh) cells. - ResearchGate	.researchgate.net	0	0		BATF
1267	chr10	89482980	89487087	3500112035	336		89482980	89487087	8421504	3	156,154,26	0,1330,4081	p	350011203500015060,350011203500015054,350011203500015061,350011203500015059,350011203500015053,350011203500015058,350011203500015052,350011203500015057,350011203500015051,350011203500015056,350011203500015050	0-69,0-60,0-123,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent	Schlingensiepen	2010	0		TGFB3
1267	chr10	89482983	89484448	3500063913	282		89482983	89484448	8421504	3	153,81,48	0,1327,1417	p	350006391300015011,350006391300015010	0-234,0-48						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		TGFB3
1267	chr10	89483004	89487087	3500396205	312		89483004	89487087	8421504	3	132,154,26	0,1306,4057	p	350039620500015010,350039620500015007	0-132,0-180						HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS	Gold	2002	0		TGFB3
1267	chr10	89484355	89484400	3500392138	45		89484355	89484400	8421504	1	45	0	c	350039213800000464	0-45						Designer ligands of tgf-beta superfamily	Choe	2010	0		
1267	chr10	89489874	89495863	3500274037	40		89489874	89495863	8421504	2	20,20	0,5969	c,g	350027403700000161,350027403700000161,350027403700000160,350027403700000160	0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1267	chr10	89496484	89505477	3500134803	40		89496484	89505477	8421504	3	20,11,9	0,58,8984	c	350013480300000031,350013480300000030	0-20,0-20						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
1273	chr10	90260341	90271335	3500279839	40		90260341	90271335	8421504	3	2,18,20	0,7847,10974	c	350027983900000002,350027983900000003	0-20,0-20		16528006	10.1161/01.ATV.0000216747.66660.26	1079-5642	Arteriosclerosis, Thrombosis, and Vascular Biology	Isolation and Characterization of Vasohibin-2 as a Homologue of VEGF-Inducible Endothelium-Derived Angiogenesis Inhibitor Vasohibin	Shibuya	2006	6		VASH1
1273	chr10	90269677	90276350	3500076571	135		90269677	90276350	8421504	3	44,52,39	0,1620,6634	c	350007657100000013,350007657100000014,350007657100000025	0-48,0-48,0-39						POLYPEPTIDE AND DNA THEREOF USEFUL AS A NEOVASCULAR MARKER - Patent application	www.faqs.org	0	0		
1273	chr10	90278782	90278809	3500326397	23		90278782	90278809	8421504	2	13,10	0,17	c	350032639700000007	0-23		16123161	10.1210/en.2005-0759	0013-7227	Endocrinology	Expression and Regulation of Progestin Membrane Receptors in the Rat Corpus Luteum	Cai	2005	4		
1274	chr10	90367575	90367603	3500440316	23		90367575	90367603	8421504	2	12,11	0,17	g	350044031600000022	11-34						Covalent tethering of functional groups to proteins and substrates therefor	Darzins	2008	0		
1274	chr10	90367575	90367603	3500340836	23		90367575	90367603	8421504	2	12,11	0,17	g	350034083600000085	11-34						Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule - Patent application	www.faqs.org	0	0		
1274	chr10	90367575	90367603	3500338674	23		90367575	90367603	8421504	2	12,11	0,17	g	350033867400000087	11-34						COVALENT TETHERING OF FUNCTIONAL GROUPS TO PROTEINS AND SUBSTRATES THEREFOR - Patent application	www.faqs.org	0	0		
1274	chr10	90435554	90435577	3500394447	23		90435554	90435577	8421504	1	23	0	g	350039444700000002	0-28		20195546	10.1371/journal.pone.0009429	1932-6203	PLOS ONE	PLOS ONE: miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells	Qin	2010	4		
1277	chr10	90747416	90748985	3500020680	23		90747416	90748985	8421504	3	16,2,5	0,18,1564	c	350002068000000022,350002068000000023	10-33,7-30			10.1042/BJ20060781		Biochemical Journal	A protein extension to shorten RNA: elongated elongation factor-Tu recognizes the D-arm of T-armless tRNAs in nematode mitochondria	Masayuki	2006	0		
1277	chr10	90762141	90764431	3500026517	312		90762141	90764431	8421504	3	132,120,60	0,1504,2230	p	350002651700015124,350002651700015157,350002651700015140,350002651700015127,350002651700015171,350002651700015135,350002651700015164	288-429,294-435,0-171,330-501,207-375,0-159,216-372						0470085851	www.scribd.com	0	0		
1277	chr10	90762153	90764461	3500016254	330		90762153	90764461	8421504	3	120,120,90	0,1492,2218	p	350001625400015051,350001625400015046,350001625400015041	0-45,0-144,0-141						Eniko - Blogger.hu	aeniko.blogger.hu	0	0		NGB
1277	chr10	90764440	90765896	3500187175	48		90764440	90765896	8421504	2	43,5	0,1451	c	350018717500000011	0-48						FIVE-COORDINATE NEUROGLOBIN AND USE THEREOF AS A BLOOD SUBSTITUTE - Patent application	www.faqs.org	0	0		
1278	chr10	90849697	90849721	3500445631	24		90849697	90849721	8421504	1	24	0	c	350044563100000045	9-33						Igm Production By Transformed Cells And Methods Of Quantifying Said Igm Production 	.freshpatents.com	0	0		
1278	chr10	90849697	90849721	3500228494	24		90849697	90849721	8421504	1	24	0	c	350022849400000044	9-33						IgM Production by Transformed Cell and Method of Quantifying the Same - Patent application	www.faqs.org	0	0		
1279	chr10	90983606	91029331	3500424108	189		90983606	91029331	8421504	4	15,33,9,132	0,7420,42140,45593	p	350042410800015070,350042410800015048,350042410800015047,350042410800015046	0-48,0-48,0-48,0-45						MUTATIONS IN SPTLC2 GENE ASSOCIATED WITH SENSORY NEUROPATHY - Patent application	www.faqs.org	0	0		
1279	chr10	91025654	91025677	3500298491	23		91025654	91025677	8421504	1	23	0	c	350029849100000030	15-44						Methods For The Preparation of Lysine By Fermentation Of Corynebacterium Glutamicum - Patent application	www.faqs.org	0	0		
1279	chr10	91025654	91025677	3500155089	23		91025654	91025677	8421504	1	23	0	g	350015508900000030	9-38						 Methods For The Preparation Of Lysine By Fermentation Of Corynebacterium Glutamicum 	www.docstoc.com	0	0		
1280	chr10	91135598	91135623	3500379885	24		91135598	91135623	8421504	2	16,8	0,17	c	350037988500000102	13-45						HUMANIZED ANTI-CD20 ANTIBODIES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1280	chr10	91159870	91159895	3500300579	23		91159870	91159895	8421504	2	11,12	0,13	g	350030057900000005	19-43						Genomic and Transcriptomic Features of Chlamydia trachomatis: Tracking the Basis for the Ecological Success	run.unl.pt/bitstr	0	0		
1280	chr10	91160074	91160097	3500282491	23		91160074	91160097	8421504	1	23	0	c	350028249100000031	0-23						Development of novel RNA- and protein-based cancer therapeutics by either silencing of potential oncogenes or active restoration of a tumor suppressor gene	th.rwth-aachen.de	0	0		
1280	chr10	91179396	91183477	3500463357	24		91179396	91183477	8421504	2	1,23	0,4058	c	350046335700000045	9-33						Genes And Polypeptides Relating To Hepatocellular Or Colorectal Carcinoma 	.freshpatents.com	0	0		
1280	chr10	91179396	91183477	3500229865	24		91179396	91183477	8421504	2	1,23	0,4058	c	350022986500000045,350022986500000242	9-33,0-24						GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA - Patent application	www.faqs.org	0	0		
1280	chr10	91179396	91183477	3500164243	24		91179396	91183477	8421504	2	1,23	0,4058	c	350016424300000045	9-33						Genes and polypeptides relating to hepatocellular or colorectal carcinoma - Patent #08124341	w.strutpatent.com	0	0		SNW1
1281	chr10	91248223	91248252	3500462164	24		91248223	91248252	8421504	2	9,15	0,14	g	350046216400000002	1-26			10.1111/j.1462-5822.2005.00543.x	1462-5822	Cellular Microbiology	A quorum-sensing regulator controls expression of both the type IV secretion system and the flagellar apparatus of Brucella melitensis - Delrue - 2005 - Cellular Microbiology - Wiley Online Library	Delrue	2005	0		
1281	chr10	91259538	91259566	3500150528	23		91259538	91259566	8421504	3	13,6,4	0,17,24	g	350015052800000234	25-48						Anti-igf-1r Antibodies And Uses Thereof 	.freshpatents.com	0	0		
1282	chr10	91416735	91416762	3500309930	23		91416735	91416762	8421504	3	12,6,5	0,14,22	g	350030993000000041	3-26						CHARACTERIZATION OF THE REGULATORY MECHANISM CONTROLLING PHYTOTOXIN PRODUCTION BY	pository.tamu.edu	0	0		
1283	chr10	91489646	91489679	3500129001	25		91489646	91489679	8421504	3	6,12,7	0,9,26	g	350012900100000019	4-36						Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	.biomedsearch.com	0	0		
1283	chr10	91599178	91599205	3500338627	23		91599178	91599205	8421504	2	7,16	0,11	g	350033862700000027	13-36						Human Cyclooxygenase-3 Enzyme And Uses Thereof 	freshpatents.com	0	0		
1286	chr10	91997690	91997721	3500352178	25		91997690	91997721	8421504	3	4,14,7	0,5,24	g	350035217800000158	2-27						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1292	chr10	92711697	92711724	3500329339	26		92711697	92711724	8421504	2	15,11	0,16	c	350032933900000161	0-36						US Patent # 8,389,207. Methods for identifying candidate fat-mobilizing agents - Patents.com	patents.com	0	0		
1294	chr10	92988779	92988808	3500053228	24		92988779	92988808	8421504	2	17,7	0,22	g	350005322800000014	6-30						The human G Protein-Coupled Receptor GPR30: interaction partners and expression analysis in endothelial cells	edoc.hu-berlin.de	0	0		
1294	chr10	93050828	93050852	3500365320	24		93050828	93050852	8421504	1	24	0	c	350036532000000011	0-24		17035546	10.1523/JNEUROSCI.1913-06.2006	0270-6474	The Journal of Neuroscience	Important Contribution of &#x03b1;-Neurexins to Ca2+-Triggered Exocytosis of Secretory Granules	Dudanova	2006	7		NRXN3
1296	chr10	93194152	93194177	3500394172	23		93194152	93194177	8421504	2	17,6	0,19	g	350039417200000000	7-30						MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells	-publications.com	0	0		
1296	chr10	93204366	93204390	3500414317	23		93204366	93204390	8421504	2	8,15	0,9	g	350041431700000208	5-35						US Patent # 7,408,100. Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene - Patents.com	www.patents.com	0	0		
1300	chr10	93824293	93824323	3500460452	26		93824293	93824323	8421504	3	15,6,5	0,17,25	g	350046045200000131	21-47						Nucleic Acid - Patent application	www.faqs.org	0	0		
1301	chr10	93859829	93859934	3500223658	47		93859829	93859934	8421504	2	23,24	0,81	c	350022365800000001,350022365800000000	0-23,0-24						Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans 2005&#x5e74;&#x7b2c;115&#x5377;&#x7b2c;9&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		DIO2
1301	chr10	93859931	93860031	3500464199	38		93859931	93860031	8421504	2	19,19	0,81	c,g	350046419900000025,350046419900000025,350046419900000024,350046419900000024	0-19,0-19,0-19,0-19				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		
1301	chr10	93869265	93869311	3500165927	46		93869265	93869311	8421504	1	46	0	g	350016592700000001,350016592700000000	3-49,5-50			10.1210/en.2007-0779		Endocrinology	Activation of Thyroid Hormone Is Transcriptionally Regulated by Epidermal Growth Factor in Human Placenta-Derived JEG3 Cells	Gianluca	2008	0		DIO2
1302	chr10	94028187	94028216	3500228046	24		94028187	94028216	8421504	2	10,14	0,15	g	350022804600000005	0-24		18287333	10.1152/ajpcell.00411.2007		American Journal of Physiology - Cell Physiolog	A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin	Zhu	2008	0		
1304	chr10	94345426	94345450	3500361666	23		94345426	94345450	8421504	2	15,8	0,16	g	350036166600000050,350036166600000240	0-23,0-23						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
1305	chr10	94457460	94457487	3500148414	23		94457460	94457487	8421504	2	14,9	0,18	g	350014841400000628	0-25						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
1308	chr10	94845153	94845176	3500238883	23		94845153	94845176	8421504	1	23	0	c	350023888300000007	0-23		18180327	10.1677/JOE-07-0452		The Journal of endocrinology	TSH stimulates adipogenesis in mouse embryonic stem cells	Min	2008	0		
1308	chr10	94845153	94845176	3500209415	23		94845153	94845176	8421504	1	23	0	c	350020941500000008	0-23						TSH stimulates adipogenesis in mouse embryonic stem cells	ww.slideshare.net	0	0		
1308	chr10	94845153	94845176	3500001411	23		94845153	94845176	8421504	1	23	0	c	350000141100000007	0-23		18180327	10.1677/JOE-07-0452	0022-0795	Journal of Endocrinology	TSH stimulates adipogenesis in mouse embryonic stem cells	Lu	2008	4		
163	chr10	94876688	94904749	3500242878	123		94876688	94904749	8421504	3	2,76,45	0,27931,28016	p	350024287800015080	3-126						Encyclopedia of Biological Chemistry - Vol_4	www.scribd.com	0	0		
1309	chr10	94906234	94906311	3500103201	51		94906234	94906311	8421504	3	24,7,20	0,43,57	g	350010320100000120	14-91						DEPARTAMENT DE GENATICA CARACTERIZACIAN MOLECULAR DE LOS RECEPTORES DE GONADOTROFINAS DE LUBINA (	www.tdx.cat	0	0		
1309	chr10	94906384	94906407	3500385214	23		94906384	94906407	8421504	1	23	0	c	350038521400000000	0-23						Overexpression of thyroid hormone receptor 1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line	logy-journals.org	0	0		
1309	chr10	94906456	94906528	3500007844	72		94906456	94906528	8421504	1	72	0	p	350000784400015012	0-72						A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease	P	1998	0		TSHR
1309	chr10	94906465	94906510	3500440179	45		94906465	94906510	8421504	1	45	0	p	350044017900015070	0-45						HUMAN MONOCLONAL ANTIBODIES TO THE THYROTROPIN RECEPTOR WHICH ACT AS ANTAGONISTS - Patent application	www.faqs.org	0	0		FSHR
1309	chr10	94906679	94907101	3500350011	43		94906679	94907101	8421504	2	22,21	0,401	c,g	350035001100000083,350035001100000084,350035001100000084	0-22,0-21,0-21						Wirkungen einer PPAR&#x03b1;-Aktivierung auf Parameter des Stoffwechsels von Lipiden, Schilddr&#xfc;senhormonen und Carnitin bei Schwein und Ratte als Modelltieren Dissertation	thek.uni-halle.de	0	0		TSHR
1309	chr10	94906679	94907101	3500256209	43		94906679	94907101	8421504	2	22,21	0,401	c,g	350025620900000082,350025620900000083,350025620900000083	0-22,0-21,0-21						Clo&#xfb01;brate causes an upregulation of PPAR- target genes but does not alter AQ:1 expression of S REBP target genes in liver and adipose tissue of pigs	thek.uni-halle.de	0	0		TSHR
1309	chr10	94944244	94944269	3500427097	23		94944244	94944269	8421504	3	4,15,4	0,5,21	g	350042709700000060	25-48						Probing method for identifying antibodies specific for selected antigens	Mezes	2000	0		
1309	chr10	94954289	94954313	3500324797	24		94954289	94954313	8421504	1	24	0	c	350032479700000004	22-46						Identification of candidate epigenetic biomarkers for ovarian cancer detection	-publications.com	0	0		
1309	chr10	94964558	94964584	3500228069	26		94964558	94964584	8421504	1	26	0	c	350022806900000033	10-39						Production of recombinant blood clotting factors in human cell lines	C*Hao Ze Er 	2003	0		GTF2A1
1311	chr10	95244670	95271976	3500393339	450		95244670	95271976	8421504	10	27,117,30,63,39,42,21,6,54,51	0,4056,8598,9929,11365,15468,18181,21159,21255,27255	p	350039333900015005,350039333900015012,350039333900015007	0-144,0-132,0-285						Novel gene and protein expressed in neural and pancreatic tissues	Bernstein	1999	0		
1317	chr10	96022014	96022040	3500378770	23		96022014	96022040	8421504	2	15,8	0,18	g	350037877000000055	19-42						Fermentive Production Of Four Carbon Alcohols 	.freshpatents.com	0	0		
1326	chr10	97145000	97145032	3500205047	25		97145000	97145032	8421504	3	7,6,12	0,11,20	g	350020504700000012	1-31						CONDITIONAL EXPRESSION OF TRANSGENES IN VIVO	Schebelle	2010	0		
1332	chr10	98028344	98028369	3500006313	24		98028344	98028369	8421504	2	9,15	0,10	g	350000631300000062	3-38						METHODS FOR SELECTIVE ERADICATION OF METASTASIZING CANCER CELLS EX VIVO USING MULTIDOMAIN BIOTAGS - Patent application	www.faqs.org	0	0		
1336	chr10	98476502	98476533	3500385809	28		98476502	98476533	8421504	3	16,7,5	0,17,26	g	350038580900000338	2-37						Novel family of pheromone receptors	Buck	1999	0		
1339	chr10	98869952	98869977	3500352178	23		98869952	98869977	8421504	2	11,12	0,13	g	350035217800000127	0-23						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1341	chr10	99124345	99124379	3500179670	28		99124345	99124379	8421504	4	12,4,7,5	0,13,21,29	g	350017967000000093	5-38						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
1344	chr10	99571819	99575371	3500440223	40		99571819	99575371	8421504	2	20,20	0,3532	g	350044022300000010,350044022300000005	0-20,0-20		19019083	10.1111/j.1742-4658.2008.06762.x	1742-4658	FEBS Journal	A &#x03d5;C31 integrase-mediated integration hotspot in favor of transgene expression exists in the bovine genome - Ou - 2008 - FEBS Journal - Wiley Online Library	Ou	2009	0		
1345	chr10	99615208	99615235	3500205215	24		99615208	99615235	8421504	2	17,7	0,20	g	350020521500000188	1-27						Control of ostrinia	www.devileye.net	0	0		
1348	chr10	100047971	100047996	3500245243	23		100047971	100047996	8421504	2	8,15	0,10	g	350024524300000135	13-36						Broad-spectrum delta-endotoxins	Gilmer	1999	0		
1348	chr10	100047971	100047996	3500073664	23		100047971	100047996	8421504	2	8,15	0,10	g	350007366400000238	13-36						Lepidopteran-active bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use - Patent application	www.faqs.org	0	0		
1352	chr10	100550796	100557642	3500100734	39		100550796	100557642	8421504	3	15,5,19	0,17,6827	g	350010073400000064,350010073400000315,350010073400000298	6-26,22-41,13-32						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
1352	chr10	100567554	100567579	3500160782	23		100567554	100567579	8421504	3	12,4,7	0,13,18	g	350016078200000000	0-23		16260608	10.1128/MCB.25.22.9936-9948.2005	0270-7306	Molecular and Cellular Biology	The DnaJ-Related Factor Mrj Interacts with Nuclear Factor of Activated T Cells c3 and Mediates Transcriptional Repression through Class II Histone Deacetylase Recruitment	Dai	2005	6		
1356	chr10	101178271	101178301	3500344641	23		101178271	101178301	8421504	3	5,6,12	0,8,18	g	350034464100000031	10-34						RECOMBINANT TRYPANOSOMA THEILERI PARASITE	Matthews	2011	0		
1360	chr10	101606932	101606962	3500412153	25		101606932	101606962	8421504	2	7,18	0,12	g	350041215300000026	7-32						Methods and/or Use of Oligonucleotide Conjugates for Assays and Flow Cytometry Detections	Schwartz	2011	0		
1363	chr10	102100049	102100073	3500395029	23		102100049	102100073	8421504	2	10,13	0,11	g	350039502900000443	11-34						 Recombinant Infectious Laryngotracheitis Virus And Uses Thereof 	www.docstoc.com	0	0		
1364	chr10	102201849	102201878	3500247539	24		102201849	102201878	8421504	3	12,6,6	0,15,23	g	350024753900000447	0-24						Promoters from Brassica Napus for Seed Specific Gene Expression	Bauer	2009	0		
1364	chr10	102201849	102201878	3500100892	24		102201849	102201878	8421504	3	12,6,6	0,15,23	g	350010089200000447	0-24						Promoters from Brassica Napus for Seed Specific Gene Expression	Bauer	2011	0		
1371	chr10	103025832	103025857	3500401980	23		103025832	103025857	8421504	2	6,17	0,8	c	350040198000000132	9-32						Modifying insect cell gylcosylation pathways with baculovirus expression vectors	Jarvis	1999	0		
1374	chr10	103474895	103474921	3500155809	24		103474895	103474921	8421504	2	14,10	0,16	c	350015580900000201	7-31						NUCLEIC ACID CONSTRUCT AND COMPLEX FORMATION METHOD AND SCREENING METHOD USING THE SAME - Patent application	www.faqs.org	0	0		
1374	chr10	103544384	103544410	3500406269	23		103544384	103544410	8421504	2	16,7	0,19	g	350040626900000028	0-31					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
1375	chr10	103599922	103599946	3500274649	24		103599922	103599946	8421504	1	24	0	c	350027464900000004	0-24						The Utilization of Mouse Models to Study Gene Functions: The Role of Foxn3 and Chd2 in Murine Development and Cancer	ace.tennessee.edu	0	0		
1376	chr10	103726726	103726777	3500443049	51		103726726	103726777	8421504	1	51	0	p	350044304900015021	0-51						Bestimmung der Kopienzahl von FoxN1/ FoxN4-Homologen in Lampetra fluviatilis	k.uni-freiburg.de	0	0		
1379	chr10	104146910	104146935	3500348581	23		104146910	104146935	8421504	2	14,9	0,16	g	350034858100000160	0-38						Use of Proteins as Demulsifying Agents - Patent application	www.faqs.org	0	0		
172	chr10	104277639	104339928	3500349107	238		104277639	104339928	8421504	9	31,14,6,42,40,2,26,47,30	0,3527,3565,4754,17381,25833,26465,50387,62259	c	350034910700000023,350034910700000064,350034910700000029,350034910700000039,350034910700000045,350034910700000113,350034910700000046	0-45,0-48,0-40,19-47,0-47,24-47,18-48						Methods for determining tyrosine-DNA phosphodiesterase activity	Kan	2002	0		
1382	chr10	104513071	104513097	3500208516	25		104513071	104513097	8421504	2	13,12	0,14	c	350020851600000009,350020851600000007	0-23,0-23						Genome Structure of Mycobacteriophage D29: Implications for Phage Evolut ion	www.pitt.edu	0	0		
1383	chr10	104600767	104600793	3500205215	25		104600767	104600793	8421504	2	15,10	0,16	g	350020521500000184	2-27						Control of ostrinia	www.devileye.net	0	0		
1383	chr10	104636639	104640796	3500414985	441		104636639	104640796	8421504	5	31,144,107,136,23	0,1073,3351,3837,4134	p	350041498500015002,350041498500015011,350041498500015012,350041498500015015,350041498500015018	0-180,3-177,0-168,0-180,0-81						Bioinformatics Tools - PowerPoint - PowerPoint	www.docstoc.com	0	0		CALM2
1383	chr10	104636648	104639995	3500390472	171		104636648	104639995	8421504	3	22,144,5	0,1064,3342	p	350039047200015140	15-186						Characterizing components of the Dictyostelium centrosome	b.uni-muenchen.de	0	0		CALM2
1383	chr10	104636669	104640799	3500446820	348		104636669	104640799	8421504	8	1,86,37,50,33,54,61,26	0,1043,1150,3321,3395,3807,3882,4104	p	350044682000015035,350044682000015036,350044682000015037,350044682000015038	0-87,0-87,0-87,0-87						Identifizierung einer Proteinkinase mit Calmodulin-&#xe4;hnlicher Dom&#xe4;ne bei Eimeria bovis und Studien zu ihrer Lokalisation im Parasiten	eb.uni-giessen.de	0	0		CALM2
1383	chr10	104640004	104640048	3500249051	44		104640004	104640048	8421504	1	44	0	c	350024905100000023	0-44						Bone/joint disease sensitivity gene and use thereof - Patent application	www.faqs.org	0	0		
1383	chr10	104640037	104640491	3500340749	75		104640037	104640491	8421504	2	60,15	0,439	p	350034074900015004	0-75						during Down-regulation	www.pnas.org	0	0		CALM1
1383	chr10	104640578	104640784	3500400779	45		104640578	104640784	8421504	2	34,11	0,195	p	350040077900015002	0-45		18039973	10.1242/dev.008979	0950-1991	Development	Neuronal calcium sensor-1 modulation of optimal calcium level for neurite outgrowth	Hui	2007	7		CALM2
1383	chr10	104641130	104641154	3500396759	24		104641130	104641154	8421504	1	24	0	c	350039675900000020	24-48						Mechanisms of Chlamydia trachomatis Entry into Nonphagocytic Cells	ww.hybiskelab.org	0	0		CALM1
1384	chr10	104806011	104806036	3500043721	25		104806011	104806036	8421504	1	25	0	g	350004372100000315,350004372100000237,350004372100000233	0-24,0-23,0-24						NUCLEIC ACIDS CODING FOR ADHESION FACTOR OF GROUP B STREPTOCOCCUS, ADHESION FACTORS OF GROUP B STREPTOCOCCUS AND FURTHER USES THEREOF - Patent application	www.faqs.org	0	0		
1386	chr10	105105963	105106638	3500022779	24		105105963	105106638	8421504	4	7,1,5,11	0,8,657,664	c	350002277900000083	11-40						Attenuated Viruses Useful For Vaccines 	.freshpatents.com	0	0		
1388	chr10	105289043	105289077	3500414499	29		105289043	105289077	8421504	2	22,7	0,27	g	350041449900000280	3-48						Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies - Patent application	www.faqs.org	0	0		
1390	chr10	105605350	105605375	3500277022	23		105605350	105605375	8421504	2	13,10	0,15	g	350027702200000087	0-23						Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS	Fu	2002	0		
1391	chr10	105705640	105711446	3500077888	40		105705640	105711446	8421504	3	19,7,14	0,50,5792	c,g	350007788800000044,350007788800000044,350007788800000045	0-19,0-19,0-21						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1391	chr10	105705666	105711487	3500447030	39		105705666	105711487	8421504	2	19,20	0,5801	c,g	350044703000000020,350044703000000020,350044703000000021	0-19,0-19,0-20						Evaluation of Internal Reference Genes for Quantitative Expression Analysis by Real-Time PCR in Ovine Whole Blood	www.mdpi.com	0	0		
1391	chr10	105711487	105711659	3500055740	46		105711487	105711659	8421504	2	24,22	0,150	c	350005574000000001,350005574000000002	0-24,0-22						Heat shock protein 70 vaccination induced immune responses in bovine paratuberculosis	ive.library.uu.nl	0	0		
1391	chr10	105711584	105711607	3500395659	23		105711584	105711607	8421504	1	23	0	c	350039565900000004	0-23						A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine in&#xfb02;uenza virus	w.vet.k-state.edu	0	0		B2M
1391	chr10	105711693	105712233	3500121183	29		105711693	105712233	8421504	2	14,15	0,525	c	350012118300000009,350012118300000017	0-21,5-30						Cystatin c, beta2 microglobulin, alpha1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy	Hoshi	2012	0		B2M
1391	chr10	105711693	105712230	3500257031	26		105711693	105712230	8421504	2	14,12	0,525	c	350025703100000006	0-26						REPRODUCTION	uction-online.org	0	0		
1391	chr10	105711694	105712234	3500396054	29		105711694	105712234	8421504	2	13,16	0,524	c	350039605400000001	7-36					Patent	Methods of inhibiting the binding of a cd8+ t cell to a class i mhc employing a modified beta 2 microglobulin (Patent EP:1244704)	Jakobsen	2008	0		
1391	chr10	105711694	105712234	3500086038	29		105711694	105712234	8421504	2	13,16	0,524	c	350008603800000001	7-36						Methods of inhibiting the binding of a cd8+ t cell to a class i mhc employing a modified beta 2 microglobulin	Jakobsen	2002	0		
1391	chr10	105711697	105712233	3500158710	25		105711697	105712233	8421504	2	10,15	0,521	c	350015871000000003,350015871000000011	5-30,5-30						Method Of Selecting Wt1 Vaccine Adaptive Patient 	.freshpatents.com	0	0		B2M
1391	chr10	105711698	105712234	3500405660	25		105711698	105712234	8421504	2	9,16	0,520	c	350040566000000011	0-25		17702698	10.1158/0008-5472.CAN-06-4666	0008-5472	Cancer Research	Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment	Giuliani	2007	8		B2M
1391	chr10	105711698	105712234	3500252859	25		105711698	105712234	8421504	2	9,16	0,520	c	350025285900000075,350025285900000025	0-25,0-25						HUMAN TROPHOBLAST STEM CELLS AND USE THEREOF - Patent application	www.faqs.org	0	0		B2M
1391	chr10	105711698	105712234	3500133658	25		105711698	105712234	8421504	2	9,16	0,520	c	350013365800000005	0-25		12393684	10.1182/blood-2002-04-1121	0006-4971	Blood	Human myeloma cells stimulate the receptor activator of nuclear factor-&#x03ba;B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease	Giuliani	2002	10		B2M
1391	chr10	105711698	105712234	3500031606	25		105711698	105712234	8421504	2	9,16	0,520	c	350003160600000029,350003160600000081	0-25,0-25						Generation of Neural Stem Cells from Human Trophoblast Stem Cells - Patent application	www.faqs.org	0	0		B2M
1391	chr10	105711698	105712234	3500013625	25		105711698	105712234	8421504	2	9,16	0,520	c	350001362500000025	0-25						Human trophoblast stem cells and use thereof	Lee	2010	0		B2M
586	chr11	157609	157632	3500168805	23		157609	157632	8421504	1	23	0	g	350016880500000003	0-23		16352839	10.1128/JB.188.1.231-239.2006	0021-9193	Journal of Bacteriology	Assembly of CS1 Pili: the Role of Specific Residues of the Major Pilin, CooA	Starks	2006	4		
73	chr11	392335	393324	3500366238	99		392335	393324	8421504	3	3,36,60	0,887,929	p	350036623800015009	0-102						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		MERTK
588	chr11	393304	393327	3500258634	23		393304	393327	8421504	1	23	0	c	350025863400000001	18-41		22043818	10.1111/j.1365-2567.2011.03511.x	1365-2567	Immunology	Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages - Deng - 2011 - Immunology - Wiley Online Library	Deng	2012	0		
591	chr11	829738	829763	3500128024	24		829738	829763	8421504	2	7,17	0,8	g	350012802400000035	6-30						Methods and compositions for polypeptide engineering	Patten	2006	0		
593	chr11	1070633	1070657	3500423725	23		1070633	1070657	8421504	2	16,7	0,17	g	350042372500000134	4-27					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
593	chr11	1070633	1070657	3500184607	23		1070633	1070657	8421504	2	16,7	0,17	g	350018460700000126	4-27						US Patent # 6,028,173. Human chromosome 16 genes, compositions, methods of making and using same - Patents.com	www.patents.com	0	0		
594	chr11	1282228	1282273	3500251491	45		1282228	1282273	8421504	1	45	0	p	350025149100015035	0-45						Biochemische und molekularbiologische Charakterisierung von Spike, einem neuen BH3-Dom&#xe4;nen Protein	b.uni-muenchen.de	0	0		BCL2L11
594	chr11	1309871	1309896	3500213569	25		1309871	1309896	8421504	1	25	0	c	350021356900000002	24-49		19109422	10.1091/mbc.E08-08-0829	1059-1524	Molecular Biology of the Cell	Autophagy Provides Nutrients but Can Lead to Chop-dependent Induction of Bim to Sensitize Growth Factor&#x2013;deprived Cells to Apoptosis	Altman	2009	5		
594	chr11	1310220	1310246	3500232295	26		1310220	1310246	8421504	1	26	0	c	350023229500000001	7-33		11997495	10.1128/MCB.22.11.3577-3589.2002	0270-7306	Molecular and Cellular Biology	Identification of Novel Isoforms of the BH3 Domain Protein Bim Which Directly Activate Bax To Trigger Apoptosis	Marani	2002	6		BCL2L11
597	chr11	1680870	1703216	3500195024	175		1680870	1703216	8421504	7	47,7,21,11,16,41,32	0,4643,6097,9005,11968,15112,22314	c	350019502400000131,350019502400000140,350019502400000152,350019502400000160,350019502400000176	0-47,0-28,20-47,7-48,0-32						NOVEL TUMOR ANTIGEN PEPTIDES - Patent application	www.faqs.org	0	0		
598	chr11	1731871	1731896	3500422816	23		1731871	1731896	8421504	2	16,7	0,18	c	350042281600000024	1-24					Patent	Polynucleotides encoding novel PCSK9 variants (Patent US:8354264)	Mintier	2013	0		
598	chr11	1731871	1731896	3500122523	23		1731871	1731896	8421504	2	16,7	0,18	c	350012252300000024	1-24						POLYNUCLEOTIDES ENCODING NOVEL PCSK9 VARIANTS - Patent application	www.faqs.org	0	0		
598	chr11	1759773	1759802	3500043078	24		1759773	1759802	8421504	3	14,5,5	0,17,24	g	350004307800000004	1-25						A read-ahead function in archaeal DNA polymerases detects promutagenic template-strand uracil	www.pnas.org	0	0		
600	chr11	1987934	1987969	3500334416	34		1987934	1987969	8421504	2	17,17	0,18	c	350033441600000001	0-35		19553470	10.1091/mbc.E09-02-0142		Molecular Biology of the Cell	Clustering and Lateral Concentration of Raft Lipids by the MAL Protein	Lee	2009	0		
600	chr11	2007703	2007729	3500431462	23		2007703	2007729	8421504	2	7,16	0,10	c	350043146200000001	11-34						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
600	chr11	2007703	2007729	3500110550	23		2007703	2007729	8421504	2	7,16	0,10	c	350011055000000001	11-34						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
600	chr11	2007703	2007729	3500031022	23		2007703	2007729	8421504	2	7,16	0,10	c	350003102200000001	11-34						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
602	chr11	2319047	2319074	3500461946	23		2319047	2319074	8421504	2	15,8	0,19	g	350046194600000032	12-35						TRANSGENIC COVER PLANTS CONTAINING HEMICELLULASE AND CELLULASE WHICH DEGRADE LIGNIN AND CELLULOSE TO FERMENTABLE SUGARS - Patent application	www.faqs.org	0	0		
603	chr11	2421101	2421146	3500209724	45		2421101	2421146	8421504	1	45	0	p	350020972400015025	0-45						UNIVERSIDAD COMPLUTENSE DE MADRID	emigracion.ucm.es	0	0		KCNIP3
603	chr11	2425663	2425689	3500115572	25		2425663	2425689	8421504	2	15,10	0,16	g	350011557200000162	13-38						METHOD FOR PRODUCING SCYLLO-INOSITOL - Patent application	www.faqs.org	0	0		
603	chr11	2432710	2432754	3500242494	44		2432710	2432754	8421504	1	44	0	c	350024249400000020	0-44						Taiwan Banded Krait -Bungarotoxins: Novel Isotoxins, Targeting and Gene Organization	.lib.nsysu.edu.tw	0	0		
604	chr11	2552086	2552110	3500108665	24		2552086	2552110	8421504	1	24	0	c	350010866500000019	24-48						US Patent # 5,516,683. Human D4 dopamine receptor and its uses - Patents.com	www.patents.com	0	0		
604	chr11	2552157	2552182	3500438825	25		2552157	2552182	8421504	1	25	0	c	350043882500000004	0-41						Nuclear DNA Sequences from Late Pleistocene Megafauna	email.eva.mpg.de	0	0		
604	chr11	2603388	2603415	3500092036	23		2603388	2603415	8421504	2	15,8	0,19	g	350009203600000087	5-28					Patent	Recombinant bone morphogenetic protein heterodimers (Patent US:5866364)	Israel	1999	0		
605	chr11	2631344	2631372	3500049566	26		2631344	2631372	8421504	2	15,11	0,17	g	350004956600000183	8-39					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
605	chr11	2721293	2721508	3500400334	40		2721293	2721508	8421504	2	20,20	0,195	g	350040033400000002,350040033400000003	0-20,0-20		20881009	10.1158/1541-7786.MCR-10-0334	1541-7786	Molecular Cancer Research	TROY (TNFRSF19) Is Overexpressed in Advanced Glial Tumors and Promotes Glioblastoma Cell Invasion via Pyk2-Rac1 Signaling	Paulino	2010	4		H3F3A
605	chr11	2744250	2744277	3500234773	23		2744250	2744277	8421504	3	12,5,6	0,14,21	g	350023477300000160	13-37						UNC-45A SPLICE VARIANTS BASED CANCER DIAGNOSTICS AND THERAPEUTICS - Patent application	www.faqs.org	0	0		
606	chr11	2756526	2756553	3500448395	23		2756526	2756553	8421504	2	17,6	0,21	c	350044839500000063	3-26						Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them and their use	Piepersberg	1996	0		
606	chr11	2780345	2780372	3500177876	23		2780345	2780372	8421504	3	6,4,13	0,9,14	g	350017787600000007	0-23						Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism	Belgore	2004	0		
606	chr11	2780345	2780372	3500121984	23		2780345	2780372	8421504	3	6,4,13	0,9,14	g	350012198400000007	0-23						Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM	Belgore	2012	0		
607	chr11	2984630	3001591	3500447618	624		2984630	3001591	8421504	9	65,103,9,60,99,33,99,119,37	0,3008,3114,3215,3278,11766,12650,15628,16924	p	350044761800015045,350044761800015046	0-369,0-255					Patent	Antibodies to HASAV70 polypeptide (Patent US:7169565)	Ruben	2007	0		LMAN2L
607	chr11	2984630	3001591	3500439093	630		2984630	3001591	8421504	7	65,115,162,33,99,119,37	0,3008,3215,11766,12650,15628,16924	p	350043909300015043,350043909300015044	0-375,0-255						Secreted protein HFEAF41	Brewer	2003	0		LMAN2L
607	chr11	2984630	3001591	3500080223	630		2984630	3001591	8421504	7	65,115,162,33,99,119,37	0,3008,3215,11766,12650,15628,16924	p	350008022300015048,350008022300015049	0-375,0-255						87 Human Secreted Proteins	Young	2007	0		LMAN2L
607	chr11	2984630	3001591	3500064227	630		2984630	3001591	8421504	7	65,115,162,33,99,119,37	0,3008,3215,11766,12650,15628,16924	p	350006422700015043,350006422700015044	0-375,0-255						Secreted protein HFEAF41	Brewer	2003	0		LMAN2L
607	chr11	2984630	3001591	3500048645	627		2984630	3001591	8421504	8	65,115,120,39,33,99,119,37	0,3008,3215,3338,11766,12650,15628,16924	p	350004864500015044,350004864500015045	0-372,0-255						Secreted protein HFEAF41	Brewer	2002	0		LMAN2L
607	chr11	2984630	3001591	3500032881	621		2984630	3001591	8421504	8	65,103,3,162,33,99,119,37	0,3008,3120,3215,11766,12650,15628,16924	p	350003288100015043,350003288100015044	0-366,0-255						87 human secreted proteins	Brewer	2003	0		LMAN2L
607	chr11	2984630	3001591	3500029713	624		2984630	3001591	8421504	9	65,103,9,60,99,33,99,119,37	0,3008,3114,3215,3278,11766,12650,15628,16924	p	350002971300015045,350002971300015046	0-369,0-255						87 human secreted proteins	Young	2005	0		LMAN2L
608	chr11	3055558	3055584	3500241434	23		3055558	3055584	8421504	3	6,5,12	0,7,14	c	350024143400000662	0-23						GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME	Schellenberger	2010	0		
610	chr11	3367923	3368004	3500310887	81		3367923	3368004	8421504	1	81	0	c	350031088700000028	79-160						T7 promoter-based expression system	Bundell	2000	0		
610	chr11	3368921	3375768	3500211925	162		3368921	3375768	8421504	2	77,85	0,6762	p	350021192500015010	0-162						 Phylogeography Ppt Presentation 	.authorstream.com	0	0		ZAP70
610	chr11	3380113	3380173	3500247109	60		3380113	3380173	8421504	1	60	0	p	350024710900015025	0-60						Spleen tyrosine kinase catalytic domain:crystal structure and binding pockets thereof	Cherry	2007	0		ZAP70
610	chr11	3380428	3380694	3500361666	42		3380428	3380694	8421504	2	21,21	0,245	c,g	350036166600000309,350036166600000309,350036166600000119,350036166600000119,350036166600000310,350036166600000310,350036166600000120,350036166600000120	0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
610	chr11	3380428	3380694	3500156510	42		3380428	3380694	8421504	2	21,21	0,245	c,g	350015651000000120,350015651000000120,350015651000000121,350015651000000121	0-21,0-21,0-21,0-21						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
610	chr11	3385960	3385998	3500001762	38		3385960	3385998	8421504	1	38	0	c	350000176200000153	103-141						DNA profiling of captive Roseate Spoonbill (Ajaia ajaja) populations as a mechanism of determining lineage in colonial nesting birds.	l.library.unt.edu	0	0		
610	chr11	3386845	3386941	3500317153	39		3386845	3386941	8421504	2	19,20	0,76	c	350031715300000016,350031715300000044,350031715300000017,350031715300000045	0-19,0-19,0-20,0-20						Markers for Viral Infections and Other Inflammatory Responses - Patent application	www.faqs.org	0	0		
611	chr11	3477274	3477301	3500149274	26		3477274	3477301	8421504	2	8,18	0,9	g	350014927400000002	2-28						Cancer-associated mar binding protein	Kohwi-shigematsu	1995	0		
612	chr11	3646569	3646596	3500164821	23		3646569	3646596	8421504	2	10,13	0,14	g	350016482100000000	0-23						An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase	Chen	2000	0		
614	chr11	3901090	3901117	3500214186	23		3901090	3901117	8421504	2	8,15	0,12	g	350021418600001331	6-30						Highly conserved genes and their use to generate probes and primers for detection of microorganisms - Patent application	www.faqs.org	0	0		
614	chr11	3917508	3917559	3500029772	51		3917508	3917559	8421504	1	51	0	p	350002977200015006	0-51						SECTION EDITOR: JANEY L. WIGGS, MD, PhD Identification of Variants in CNGA3 as Cause for Achromatopsia by Exome Sequencing of a Single Patient	t.jamanetwork.com	0	0		
614	chr11	3918341	3918416	3500282031	75		3918341	3918416	8421504	1	75	0	p	350028203100015006	0-75						Untersuchungen zur Heteromerisierung, Funktion und genetischen Struktur von HCN Schrittmacherkan&#xe4;len	b.uni-muenchen.de	0	0		CNGA3
615	chr11	3963749	3963781	3500258554	26		3963749	3963781	8421504	3	8,5,13	0,13,19	g	350025855400000907,350025855400001047	19-45,19-45						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
615	chr11	4056229	4056277	3500372641	48		4056229	4056277	8421504	1	48	0	p	350037264100015008	0-48						Isolated Ptpmt1 Protein Which Mediates Insulin Production And Uses Thereof 	.freshpatents.com	0	0		INPP4A
616	chr11	4066997	4067025	3500201864	25		4066997	4067025	8421504	2	12,13	0,15	c	350020186400000258	1-26						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
616	chr11	4066997	4067025	3500005314	25		4066997	4067025	8421504	2	12,13	0,15	c	350000531400000262	1-26						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
618	chr11	4338224	4338251	3500253092	23		4338224	4338251	8421504	2	9,14	0,13	g	350025309200000000	2-25						Changes in BiP availability reveal hypersensitivity to acute endoplasmic reticulum stress in cells expressing mutant huntingtin	cs.biologists.org	0	0		
618	chr11	4338224	4338251	3500177670	23		4338224	4338251	8421504	2	9,14	0,13	g	350017767000000000	2-25		21896647	10.1242/jcs.087510		Journal of Cell Science	Changes in BiP availability reveal hypersensitivity to acute endoplasmic reticulum stress in cells expressing mutant huntingtin	Patrick	2011	0		
621	chr11	4768467	4768492	3500058643	24		4768467	4768492	8421504	2	15,9	0,16	g	350005864300000024	24-48						 Method Of Promoting Stem Cell Proliferation Or Survival By Contacting A Cell With A Stem Cell Factor 	www.docstoc.com	0	0		
627	chr11	5553442	5553481	3500429819	30		5553442	5553481	8421504	4	5,11,6,8	0,8,21,31	g	350042981900000275	0-31						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
628	chr11	5739829	5739855	3500423725	23		5739829	5739855	8421504	2	13,10	0,16	g	350042372500000295,350042372500000149	10-33,22-45					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
631	chr11	6082141	6111821	3500394423	150		6082141	6111821	8421504	2	2,148	0,29532	p	350039442300015002	0-150						NPAS2: An Analog of Clock Operative in the Mammalian Forebrain	mcknightlab.com	0	0		NPAS2
632	chr11	6189844	6191167	3500315247	25		6189844	6191167	8421504	2	5,20	0,1303	c	350031524700000002	0-25		18819933	10.1158/1541-7786.MCR-07-2094	1541-7786	Molecular Cancer Research	The Circadian Gene NPAS2, a Putative Tumor Suppressor, Is Involved in DNA Damage Response	Hoffman	2008	4		
634	chr11	6462358	6462389	3500395280	27		6462358	6462389	8421504	3	14,5,8	0,17,23	g	350039528000000218,350039528000000137	10-44,19-38						Method of providing a hybrid polypeptide exhibiting an activity of interest - Patent # 6270968 - PatentGenius	.patentgenius.com	0	0		
634	chr11	6552236	6552262	3500429620	23		6552236	6552262	8421504	3	5,4,14	0,7,12	g	350042962000000084	3-26						Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof	Luke	2006	0		
636	chr11	6768164	6768191	3500182925	24		6768164	6768191	8421504	2	14,10	0,17	g	350018292500000007	0-24		16514146	10.1099/mic.0.28692-0	1350-0872	Microbiology	Phosphoethanolamine substitution in the lipid A of Escherichia coli O157&#x200a;:&#x200a;H7 and its association with PmrC	Kim	2006	3		
638	chr11	7015269	7018795	3500261436	50		7015269	7018795	8421504	2	25,25	0,3501	c,g	350026143600000063,350026143600000063,350026143600000064,350026143600000064	0-25,0-25,0-25,0-25						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
638	chr11	7025197	7026922	3500349767	44		7025197	7026922	8421504	2	22,22	0,1703	c	350034976700000012,350034976700000013	0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		IL1R2
640	chr11	7209620	7218417	3500246951	62		7209620	7218417	8421504	3	6,26,30	0,896,8767	c	350024695100000010,350024695100000019	0-32,9-39					Patent	Method of using soluble human interleukin-1 receptors to suppress immune responses (Patent US:5492888)	Dower	1996	0		
640	chr11	7210516	7225423	3500001971	98		7210516	7225423	8421504	3	26,30,42	0,7871,14865	c	350000197100000015,350000197100000024,350000197100000030	0-26,6-36,3-45						US Patent # 7,037,492. Gene transfer for studying and treating a connective tissue of a mammalian host - Patents.com	www.patents.com	0	0		
640	chr11	7218387	7225323	3500106407	51		7218387	7225323	8421504	3	30,5,16	0,5682,6920	c	350010640700000022,350010640700000063	6-36,26-47						IRAP gene as treatment for arthritis	Glorioso	1995	0		
640	chr11	7224069	7225423	3500178917	63		7224069	7225423	8421504	3	5,16,42	0,1238,1312	c	350017891700000063,350017891700000028	26-47,6-48						 IRAP Gene As Treatment For Arthritis 	www.docstoc.com	0	0		
640	chr11	7275078	7275102	3500441307	23		7275078	7275102	8421504	2	19,4	0,20	g	350044130700000012	3-26						P. Gingivalis Antigenic Composition 	.freshpatents.com	0	0		
644	chr11	7805245	7805269	3500429690	24		7805245	7805269	8421504	1	24	0	c	350042969000000131	0-24						IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND USES THEREOF - Patent application	www.faqs.org	0	0		
644	chr11	7805245	7805269	3500030259	24		7805245	7805269	8421504	1	24	0	c	350003025900000145	0-24						IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND USES THEREOF - Patent application	www.faqs.org	0	0		
644	chr11	7805245	7805269	3500011638	24		7805245	7805269	8421504	1	24	0	c	350001163800000025	0-24						Immunostimulatory oligonucleotides and uses thereof	Lopez	2002	0		
649	chr11	8504809	8504836	3500427792	23		8504809	8504836	8421504	2	12,11	0,16	g	350042779200000573	10-43						Highly conserved genes and their use to generate probes and primers for detection of microorganisms	Bergeron	2005	0		
652	chr11	8788495	8788522	3500087579	25		8788495	8788522	8421504	3	14,6,5	0,15,22	g	350008757900000045	23-48					Patent	Nucleotide sequences of soybean acyl-ACP thioesterase genes (Patent US:5530186)	Hitz	1996	0		
653	chr11	8945730	8945759	3500370457	26		8945730	8945759	8421504	3	14,7,5	0,16,24	g	350037045700000008	8-37						Leaf Development in the Single-Cell C&#x2084; System in Bienertia sinuspersici: Expression of Genes and Peptide Levels for C&#x2084; Metabolism in Relation to Chlorenchyma Structure under Different Light Conditions	www.jstor.org	0	0		
658	chr11	9592676	9599267	3500366104	23		9592676	9599267	8421504	3	5,17,1	0,7,6590	c	350036610400000002	4-27						Transmissible Familial Creutzfeldt-Jakob Disease Associated with Five, Seven, and Eight Extra Octapeptide Coding Repeats in the PRNP Gene	www.jstor.org	0	0		
658	chr11	9597884	9597910	3500116480	23		9597884	9597910	8421504	2	17,6	0,20	g	350011648000000005	1-25						Supporting Information 	www.pnas.org	0	0		
658	chr11	9614437	9614465	3500081673	23		9614437	9614465	8421504	2	14,9	0,19	c	350008167300000047	10-33						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
665	chr11	10511473	10511498	3500335075	24		10511473	10511498	8421504	2	20,4	0,21	c	350033507500000018	13-37						US Patent # 5,990,390. Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof - Patents.com	www.patents.com	0	0		
665	chr11	10511473	10511498	3500032466	24		10511473	10511498	8421504	2	20,4	0,21	c	350003246600000016	13-37						US Patent # 6,777,589. Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof - Patents.com	www.patents.com	0	0		
665	chr11	10548424	10548451	3500096621	23		10548424	10548451	8421504	3	12,5,6	0,13,21	g	350009662100000004	5-30		12481089	10.1104/pp.011049	0032-0889	Plant Physiology	Cloning and Expression of the Gene for Soybean Hydroxyisourate Hydrolase. Localization and Implications for Function and Mechanism	Raychaudhuri	2002	7		
665	chr11	10573384	10574695	3500391575	237		10573384	10574695	8421504	3	131,103,3	0,250,1308	p	350039157500015022,350039157500015020	0-57,0-180						32 human secreted proteins	Baker	2001	0		
666	chr11	10673686	10673709	3500067855	23		10673686	10673709	8421504	1	23	0	c,g	350006785500000003,350006785500000003,350006785500000002,350006785500000002	0-21,0-21,0-21,0-21		19758999	10.1074/jbc.M109.012625	0021-9258	Journal of Biological Chemistry	Dynein Dysfunction Induces Endocytic Pathology Accompanied by an Increase in Rab GTPases	Kimura	2009	5		DCTN1
666	chr11	10714552	10714589	3500153410	37		10714552	10714589	8421504	1	37	0	g	350015341000000017	81-118						US Patent # 5,646,008. Vertebrate apoptosis gene: compositions and methods - Patents.com	www.patents.com	0	0		
667	chr11	10831628	10831651	3500318059	23		10831628	10831651	8421504	1	23	0	c	350031805900000061	3-26						Devices from Prion-Like Proteins - Patent application	www.faqs.org	0	0		
667	chr11	10831628	10831651	3500135243	23		10831628	10831651	8421504	1	23	0	c	350013524300000040	3-26						Electrical Conductors and Devices from Prion-Like Proteins - Patent application	www.faqs.org	0	0		
669	chr11	11031612	11031636	3500021913	24		11031612	11031636	8421504	1	24	0	g	350002191300000000	0-24		21209961	10.1371/journal.pone.0015884	1932-6203	PLOS ONE	PLOS ONE: Phosphatidylserine Increases IKBKAP Levels in Familial Dysautonomia Cells	Keren	2010	4		
670	chr11	11237571	11237595	3500031195	24		11237571	11237595	8421504	1	24	0	c	350003119500000007	0-24						Expression of Actin Isoforms in Human Auricular Cartilage	fb.cuni.cz/Data/f	0	0		ACTG2
670	chr11	11237657	11237711	3500164379	54		11237657	11237711	8421504	1	54	0	p	350016437900015059	54-108						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		ACTG2
670	chr11	11237704	11245255	3500257592	66		11237704	11245255	8421504	3	22,23,21	0,2560,7530	c	350025759200000003,350025759200000002,350025759200000006	0-22,0-23,0-21							ingtechnology.com	0	0		ACTG1
670	chr11	11237704	11240287	3500414007	45		11237704	11240287	8421504	2	22,23	0,2560	c	350041400700000009,350041400700000008	0-22,0-23		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		
670	chr11	11237704	11240287	3500207867	45		11237704	11240287	8421504	2	22,23	0,2560	c	350020786700000009,350020786700000008	0-22,0-23		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		
670	chr11	11237706	11237730	3500377886	24		11237706	11237730	8421504	1	24	0	c	350037788600000004	0-24						NOVEL ANTI AGING AGENTS AND METHODS TO IDENTIFY THEM - Patent application	www.faqs.org	0	0		ACTG2
670	chr11	11237708	11240203	3500448384	44		11237708	11240203	8421504	2	21,23	0,2472	c	350044838400000001,350044838400000000	0-21,0-23		15102943	10.1124/mol.65.5.1148	1521-0111 (Online)	Molecular Pharmacology	Cloning, Expression, and Characterization of Three New Mouse Cytochrome P450 Enzymes and Partial Characterization of Their Fatty Acid Oxidation Activities	Wang	2004	0		
670	chr11	11237708	11240203	3500304455	44		11237708	11240203	8421504	2	21,23	0,2472	c	350030445500000010,350030445500000009	0-21,0-23						Estrogen Stimulates Estrogen-Related Receptor Gene Expression through Conserved Hormone Response Elements	.endojournals.org	0	0		ACTG1
670	chr11	11237708	11240195	3500418061	42		11237708	11240195	8421504	2	21,21	0,2466	c,g	350041806100000007,350041806100000006,350041806100000006	0-21,0-21,0-21		21798065	10.1186/1756-9966-30-71	1756-9966	Journal of Experimental & Clinical Cancer Research	Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK	Luo	2011	2		
670	chr11	11237709	11237734	3500418064	25		11237709	11237734	8421504	1	25	0	c	350041806400000005	0-25			10.2353/ajpath.2006.051136		The American Journal of Pathology	Inhibition of Intrahepatic Bile Duct Dilation of the Polycystic Kidney Rat with a Novel Tyrosine Kinase Inhibitor Gefitinib	Yasunori	2006	0		TBCA
670	chr11	11237710	11240203	3500023385	45		11237710	11240203	8421504	2	22,23	0,2470	c	350002338500000014,350002338500000013	0-22,0-23		21898343	10.1002/art.30637	1529-0131	Arthritis & Rheumatism	Origin and functional activity of the membrane-bound glucocorticoid receptor - Strehl - 2011 - Arthritis & Rheumatism - Wiley Online Library	Strehl	2011	0		
670	chr11	11237711	11242070	3500190311	41		11237711	11242070	8421504	2	20,21	0,4338	c	350019031100000009,350019031100000019,350019031100000008,350019031100000018	0-20,0-20,0-21,0-21						Lymph Nodes as a Site for Regeneration - Patent application	www.faqs.org	0	0		
670	chr11	11237714	11242981	3500449523	40		11237714	11242981	8421504	2	20,20	0,5247	c	350044952300000005,350044952300000004	0-20,0-20		19277051	10.1038/jcbfm.2009.19	0271-678X	Journal of Cerebral Blood Flow & Metabolism	Heme&#x2013;hemopexin complex attenuates neuronal cell death and stroke damage	Li	2009	5		ACTG2
670	chr11	11237714	11242981	3500434765	40		11237714	11242981	8421504	2	20,20	0,5247	c,g	350043476500000013,350043476500000013,350043476500000012	0-20,0-20,0-20		14871847	10.1158/0008-5472.CAN-03-0609	0008-5472	Cancer Research	Soluble Decoy Receptor 3 Induces Angiogenesis by Neutralization of TL1A, a Cytokine Belonging to Tumor Necrosis Factor Superfamily and Exhibiting Angiostatic Action	Yang	2004	8		
670	chr11	11237714	11242981	3500184081	40		11237714	11242981	8421504	2	20,20	0,5247	c,g	350018408100000006,350018408100000006,350018408100000005	0-20,0-20,0-20		19405983	10.1186/1423-0127-16-43	1423-0127	Journal of Biomedical Science	Apoptosis signal-regulating kinase 1 mediates denbinobin-induced apoptosis in human lung adenocarcinoma cells	Kuo	2009	0		ACTG1
670	chr11	11237714	11242981	3500167143	40		11237714	11242981	8421504	2	20,20	0,5247	c	350016714300000003,350016714300000002	0-20,0-20		14602578	10.1152/ajpcell.00283.2003		American Journal of Physiology - Cell Physiolog	ATP-dependent regulation of SK4/IK1-like currents in rat submandibular acinar cells: possible role of cAMP-dependent protein kinase	Hayashi	2004	0		POTEH
670	chr11	11237714	11242981	3500161159	40		11237714	11242981	8421504	2	20,20	0,5247	c,g	350016115900000013,350016115900000013,350016115900000012,350016115900000012	0-20,0-20,0-20,0-20		14871847	10.1158/0008-5472.CAN-03-0609	0008-5472	Cancer Research	Soluble Decoy Receptor 3 Induces Angiogenesis by Neutralization of TL1A, a Cytokine Belonging to Tumor Necrosis Factor Superfamily and Exhibiting Angiostatic Action	Yang	2004	8		POTEM
670	chr11	11237714	11242981	3500118501	40		11237714	11242981	8421504	2	20,20	0,5247	g	350011850100000004,350011850100000003	0-20,0-20						ScienceDirect.com - Experimental Cell Research - HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBP&#x03b2;	sciencedirect.com	0	0		ACTA2,ACTG1
670	chr11	11237787	11240162	3500116922	24		11237787	11240162	8421504	2	11,13	0,2362	c	350011692200000003	0-24		12618753	10.1038/sj.onc.1206261	0950-9232	Oncogene	Activation of ERK1&sol;2 by &#x0394;Raf-1&#x2009;:&#x2009;ER&ast; represses Bim expression independently of the JNK or PI3K pathways	Weston	2003	6		
670	chr11	11240173	11240213	3500075252	40		11240173	11240213	8421504	1	40	0	c	350007525200000181	0-40						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
670	chr11	11240180	11240203	3500041331	23		11240180	11240203	8421504	1	23	0	c	350004133100000033	0-23						Juvenile Parkinson disease caused by parkin mutations: large deletions and pathogenic mechanisms	run.unl.pt/bitstr	0	0		ACTG2
670	chr11	11240185	11240210	3500427251	25		11240185	11240210	8421504	1	25	0	c	350042725100000015	0-25		20805357	10.1128/MCB.00396-10	0270-7306	Molecular and Cellular Biology	The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression	Yu	2010	6		ACTG1
670	chr11	11240189	11240213	3500424562	24		11240189	11240213	8421504	1	24	0	c	350042456200000004	0-24		17363579	10.1158/0008-5472.CAN-06-3436	0008-5472	Cancer Research	p53-Independent Abrogation of a Postmitotic Checkpoint Contributes to Human Papillomavirus E6-Induced Polyploidy	Liu	2007	8		
670	chr11	11240189	11240213	3500411841	24		11240189	11240213	8421504	1	24	0	c	350041184100000002	0-24		22771636	10.4103/0377-4929.97849		Indian Journal of Pathology and Microbiology	Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration	Liu	2012	0		
670	chr11	11240191	11240214	3500439987	23		11240191	11240214	8421504	1	23	0	c	350043998700000009	0-23		19232089	10.1186/1756-9966-28-24	1756-9966	Journal of Experimental & Clinical Cancer Research	Expression and biological significance of c-FLIP in human hepatocellular carcinomas	Du	2009	2		ACTB,ACTG1
670	chr11	11240193	11240219	3500164202	26		11240193	11240219	8421504	1	26	0	c	350016420200000005	0-26		16462771	10.1038/sj.onc.1209363	0950-9232	Oncogene	The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter	Li	2006	6		POTEM
670	chr11	11240197	11240260	3500137241	63		11240197	11240260	8421504	1	63	0	p	350013724100015106	0-63						Improved cancer therapeutics	Lewensohn	2009	0		ACTG1
670	chr11	11240203	11240227	3500112246	24		11240203	11240227	8421504	1	24	0	c	350011224600000005	1-25		21637535	10.1590/S1415-47572010005000109	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Transcriptional activity of the 5'-flanking region of the thyroid transcription factor-1 gene in human thyroid cell lines	Yamada	2011	1		
670	chr11	11240263	11240288	3500102726	25		11240263	11240288	8421504	1	25	0	c	350010272600000006	0-25		19797053	10.1074/jbc.M109.033910		The Journal of Biological Chemistry	Myocardin-dependent Activation of the CArG Box-rich Smooth Muscle &#x03b3;-Actin Gene: PREFERENTIAL UTILIZATION OF A SINGLE CArG ELEMENT THROUGH FUNCTIONAL ASSOCIATION WITH THE NKX3.1 HOMEODOMAIN PROTEIN*	Qiang	2009	0		
670	chr11	11240264	11240289	3500282519	25		11240264	11240289	8421504	1	25	0	c	350028251900000004	0-25						CELL-BASED SYSTEMS FOR PRODUCING INFLUENZA VACCINES	Bilsel	2009	0		ACTG1
670	chr11	11240264	11240289	3500203298	25		11240264	11240289	8421504	1	25	0	c	350020329800000029	0-25		18057259	10.1128/JVI.01650-07	0022-538X	Journal of Virology	Negative Feedback Regulation of RIG-I-Mediated Antiviral Signaling by Interferon-Induced ISG15 Conjugation	Kim	2008	5		ACTG1
670	chr11	11240264	11240289	3500198848	25		11240264	11240289	8421504	1	25	0	c	350019884800000029	0-25			10.1128/JVI.01650-07		Journal of Virology	Negative Feedback Regulation of RIG-I-Mediated Antiviral Signaling by Interferon-Induced ISG15 Conjugation 	Min-Jung	2008	0		ACTG1
670	chr11	11240265	11240289	3500098010	24		11240265	11240289	8421504	1	24	0	c	350009801000000027	0-24						Aus der Klinik f&#xfc;r Gastroenterologie mit Sektionen Infektiologie und Tropenmedizin	ub.uni-hamburg.de	0	0		
670	chr11	11242005	11242030	3500062149	25		11242005	11242030	8421504	1	25	0	c	350006214900000004	23-48						Media composition for adipocyte differentiation	Cho	2010	0		ACTB
670	chr11	11242006	11242031	3500462572	25		11242006	11242031	8421504	1	25	0	c	350046257200000046	0-25						COMPOSITIONS AND METHODS FOR INCREASING CHOLESTEROL EFFLUX AND RAISING HDL USING ATP BINDING CASSETTE TRANSPORTER PROTEIN ABC1	Lawn	2008	0		ACTG1
670	chr11	11242006	11242031	3500441742	25		11242006	11242031	8421504	1	25	0	c	350044174200000003	0-25		21092172	10.1186/1476-4598-9-296	1476-4598	Molecular Cancer	Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma	Cao	2010	4		ACTG2
670	chr11	11242006	11242031	3500440133	25		11242006	11242031	8421504	1	25	0	c	350044013300000002	0-25						PII: B978-0-12-164730-8.50053-8	gitus.itk.ppke.hu	0	0		ACTB,ACTG2
670	chr11	11242006	11242031	3500421849	25		11242006	11242031	8421504	1	25	0	c	350042184900000007	0-25		21193388	10.1289/ehp.1002733		Environmental Health Perspectives	Involvement of N-6 Adenine-Specific DNA Methyltransferase 1 (N6AMT1) in Arsenic Biomethylation and Its Role in Arsenic-Induced Toxicity	Xuefeng	June	0		ACTG2
670	chr11	11242006	11242031	3500402816	25		11242006	11242031	8421504	1	25	0	c	350040281600000003	0-25						ABCA-1 Elevating compounds	Ibrahim	2002	0		ACTG1
670	chr11	11242006	11242031	3500401864	25		11242006	11242031	8421504	1	25	0	c	350040186400000046,350040186400000116	0-25,0-25						COMPOSITIONS AND METHODS FOR INCREASING CHOLESTEROL EFFLUX AND RAISING HDL USING ATP BINDING CASSETTE TRANSPORTER PROTEIN ABC1 - Patent application	www.faqs.org	0	0		ACTG1
670	chr11	11242006	11242031	3500398044	23		11242006	11242031	8421504	2	7,16	0,9	g	350039804400000003	0-24						Prognostic value of matrix Gla protein in breast cancer	-publications.com	0	0		ACTG2
670	chr11	11242006	11242031	3500397893	25		11242006	11242031	8421504	1	25	0	c	350039789300000001	0-25					Patent	Method for detecting the presence of a single target nucleic acid in a sample (Patent US:8278071)	Brown	2012	0		ACTG2
670	chr11	11242006	11242031	3500394407	25		11242006	11242031	8421504	1	25	0	c	350039440700000001	0-25						Device having regions of differing affinities to fluid, methods of making such devices, and methods of using such devices	Brown	2008	0		ACTG1
670	chr11	11242006	11242031	3500346127	25		11242006	11242031	8421504	1	25	0	c	350034612700000001	0-25						Nanoliter scale PCR with TaqMan detection	quantification.de	0	0		ACTG1
670	chr11	11242006	11242031	3500335138	25		11242006	11242031	8421504	1	25	0	c	350033513800000046	0-25						Atp binding cassette transporter protein abc1 polypeptides	Garvin	2002	0		ACTG1
670	chr11	11242006	11242031	3500329055	25		11242006	11242031	8421504	1	25	0	c	350032905500000091,350032905500000188	0-25,0-25						Regulation effect of conjugated frame transport protein ABC1	Li Cha De *M*Luo En 	2003	0		ACTB,ACTG1
670	chr11	11242006	11242031	3500328762	25		11242006	11242031	8421504	1	25	0	c	350032876200000005	0-25						A novel approach to rescue immune escape in oral squamous cell carcinoma: Combined use of interferon-&#xc1;	-publications.com	0	0		ACTB,ACTG2
670	chr11	11242006	11242031	3500317342	25		11242006	11242031	8421504	1	25	0	c	350031734200000003	0-25					Patent	ABCA-1 elevating compounds (Patent US:6548548)	Campbell	2003	0		ACTG1
670	chr11	11242006	11242031	3500293183	25		11242006	11242031	8421504	1	25	0	c	350029318300000001	0-25						Microfluidic assembly with reagent	Brown	2008	0		ACTG2
670	chr11	11242006	11242031	3500262844	25		11242006	11242031	8421504	1	25	0	c	350026284400000005,350026284400000011	0-25,0-25						METHODS AND COMPOSITIONS FOR MODULATING PROSTASIN - Patent application	www.faqs.org	0	0		ACTG1
670	chr11	11242006	11242031	3500262560	25		11242006	11242031	8421504	1	25	0	c	350026256000000009	0-25					PLoS ONE	Prostate Cancer-Specific and Potent Antitumor Effect of a DD3-Controlled Oncolytic Virus Harboring the PTEN Gene - Scolaris	Ding	2012	0		ACTG1
670	chr11	11242006	11242031	3500255992	25		11242006	11242031	8421504	1	25	0	c	350025599200000003	0-25						Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma	-publications.com	0	0		ACTG2
670	chr11	11242006	11242031	3500251011	25		11242006	11242031	8421504	1	25	0	c	350025101100000003	0-25		22580838		1791-2997	Molecular Medicine Reports	Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma	Wu	2012	0		ACTG2
670	chr11	11242006	11242031	3500243546	25		11242006	11242031	8421504	1	25	0	c	350024354600000011	0-25		19228727	10.1158/1078-0432.CCR-08-1270	1078-0432	Clinical Cancer Research	Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias	Mitsiades	2009	8		ACTB
670	chr11	11242006	11242031	3500226697	25		11242006	11242031	8421504	1	25	0	c	350022669700000003	0-25		23704824	10.3748/wjg.v19.i19.2913		World Journal of Gastroenterology : WJG	Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma	Wei	2013	0		ACTG1
670	chr11	11242006	11242031	3500215301	25		11242006	11242031	8421504	1	25	0	c	350021530100000003	0-25					Patent	ABCA-1 elevating compounds (Patent US:6713650)	Ibrahim	2004	0		ACTG2
670	chr11	11242006	11242031	3500212514	25		11242006	11242031	8421504	1	25	0	c	350021251400000011,350021251400000005	0-25,0-25						Methods And Compositions For Modulating Prostasin 	.freshpatents.com	0	0		ACTG2
670	chr11	11242006	11242031	3500206723	25		11242006	11242031	8421504	1	25	0	c	350020672300000004	0-25						MMB 292 DNA Viruses Methods and Protocols	www.scribd.com	0	0		ACTG2
670	chr11	11242006	11242031	3500202409	25		11242006	11242031	8421504	1	25	0	c	350020240900000011	0-25		18059336	10.1038/sj.onc.1210964	0950-9232	Oncogene	Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer	Al-azawi	2007	6		ACTG1
670	chr11	11242006	11242031	3500176893	25		11242006	11242031	8421504	1	25	0	c	350017689300000003	0-25					The American Journal of Pathology	Trypsin-2 Degrades Human Type II Collagen and Is Expressed and Activated in Mesenchymally Transformed Rheumatoid Arthritis Synovitis Tissue	Mathias	2005	0		ACTG2
670	chr11	11242006	11242031	3500173789	25		11242006	11242031	8421504	1	25	0	c	350017378900000003	0-25						DEVELOPMENT OF A CANINE COCCIDIOSIS MODEL AND THE ANTICOCCIDIAL EFFECTS OF A NEW CHEMOTHERAPEUTIC AGENT	cholar.lib.vt.edu	0	0		ACTG1
670	chr11	11242006	11242031	3500150774	25		11242006	11242031	8421504	1	25	0	c	350015077400000007	0-25		20406991	10.1158/0008-5472.CAN-09-2942	0008-5472	Cancer Research	Hypoxia Induces Trimethylated H3 Lysine 4 by Inhibition of JARID1A Demethylase	Zhou	2010	8		ACTG2
670	chr11	11242006	11242031	3500149845	25		11242006	11242031	8421504	1	25	0	c	350014984500000001,350014984500000007	0-25,1-25						Method for conducting PCR protected from evaporation - Patent # 6664044 - PatentGenius	.patentgenius.com	0	0		ACTG2
670	chr11	11242006	11242031	3500134586	25		11242006	11242031	8421504	1	25	0	c	350013458600000001	0-25						Method and device for detecting the presence of a single target nucleic acid in samples	Brown	2008	0		ACTG2
670	chr11	11242006	11242031	3500118192	25		11242006	11242031	8421504	1	25	0	c	350011819200000001	0-25		20406200	10.1111/j.1742-7843.2010.00572.x	1742-7843	Basic & Clinical Pharmacology & Toxicology	Inhibition of Pulmonary Surfactants Synthesis during N-Methyl-d-Aspartate-Induced Lung Injury - Shen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library	Shen	2010	0		ACTB,ACTG1
670	chr11	11242006	11242031	3500117959	25		11242006	11242031	8421504	1	25	0	c	350011795900000091	0-25						Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1	Li Cha De *M*Luo En 	2002	0		ACTB,ACTG1
670	chr11	11242006	11242031	3500095424	25		11242006	11242031	8421504	1	25	0	c	350009542400000001	0-25						Microfluidic devices and methods of using same	Mcbride	2004	0		ACTG2
670	chr11	11242006	11242031	3500095379	25		11242006	11242031	8421504	1	25	0	c	350009537900000003	0-25					Patent	ABCA-1 elevating compounds (Patent US:6995285)	Ibrahim	2006	0		ACTG2
670	chr11	11242006	11242031	3500094500	25		11242006	11242031	8421504	1	25	0	c	350009450000000003	0-25						Downregulation of Hepatoma-Derived Growth Factor Contributes to Retarded Lung Metastasis via Inhibition of Epithelial Mesenchymal Transition by Systemic POMC Gene Delivery in Melanoma	.aacrjournals.org	0	0		ACTG1
670	chr11	11242006	11242031	3500079596	25		11242006	11242031	8421504	1	25	0	c	350007959600000003	0-25						Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis	Ibrahim	2004	0		ACTB,ACTG2
670	chr11	11242006	11242031	3500074159	25		11242006	11242031	8421504	1	25	0	c	350007415900000007,350007415900000031	0-25,0-25						Tetracycline-Regulated Adeno-Associated Viral (AAV) Vectors for Gene Delivery to the Nervous System - Patent application	www.faqs.org	0	0		ACTG1
670	chr11	11242006	11242031	3500069296	25		11242006	11242031	8421504	1	25	0	c	350006929600000001,350006929600000005	0-25,0-25						US Patent # 8,257,925. Method for detecting the presence of a single target nucleic acid in a sample - Patents.com	patents.com	0	0		ACTG2
670	chr11	11242006	11242031	3500068033	25		11242006	11242031	8421504	1	25	0	c	350006803300000001	0-25						Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly	www.cytonix.com	0	0		ACTG2
670	chr11	11242006	11242031	3500066974	25		11242006	11242031	8421504	1	25	0	c	350006697400000003	0-25					Patent	ABCA-1 elevating compounds (Patent US:6900219)	Ibrahim	2005	0		ACTG1
670	chr11	11242006	11242031	3500062993	25		11242006	11242031	8421504	1	25	0	c	350006299300000003	0-25						Oxygen-regulated expression of the erythropoietin gene in a human renal cell line REPC	tologylibrary.org	0	0		ACTG1
670	chr11	11242006	11242031	3500062395	25		11242006	11242031	8421504	1	25	0	c	350006239500000003	0-25						ABCA-1 elevating compounds	Campbell	2003	0		ACTG1
670	chr11	11242006	11242031	3500051541	25		11242006	11242031	8421504	1	25	0	c	350005154100000001	0-25						&#x570b;&#x7acb;&#x4e2d;&#x5c71;&#x5927;&#x5b78; &#x751f;&#x7269;&#x79d1;&#x5b78;&#x5b78;&#x5728;&#x8077;&#x78a9;&#x5c08;&#x73ed; &#x78a9;&#x58eb;&#x8ad6;&#x6587;	.lib.nsysu.edu.tw	0	0		ACTG2
670	chr11	11242006	11242031	3500018884	25		11242006	11242031	8421504	1	25	0	c	350001888400000007	0-25		14514642	10.2337/diabetes.52.10.2570	0012-1797	Diabetes	Reactive Oxygen Species from Mitochondria Induce Cyclooxygenase-2 Gene Expression in Human Mesangial Cells	Kiritoshi	2003	8		ACTG1
670	chr11	11242006	11242031	3500010522	25		11242006	11242031	8421504	1	25	0	c	350001052200000003	0-25						ABCA-1 elevating compounds	Ibrahim	2003	0		ACTG2
670	chr11	11242006	11242031	3500007947	25		11242006	11242031	8421504	1	25	0	c	350000794700000091	0-25					Patent	Regulation effect of conjugated frame transport protein ABC1 (Patent CN:100513570)	Da Wei *Wei De 	2009	0		ACTG1
670	chr11	11242006	11242030	3500325572	24		11242006	11242030	8421504	1	24	0	c	350032557200000003	0-24		18923445	10.1038/jid.2008.320	0022-202X	Journal of Investigative Dermatology	Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37	Park	2008	6		ACTG2
670	chr11	11242006	11242030	3500191757	24		11242006	11242030	8421504	1	24	0	c	350019175700000003	0-24		21835792	10.1128/JVI.00173-11	0022-538X	Journal of Virology	Rab5 and Class III Phosphoinositide 3-Kinase Vps34 Are Involved in Hepatitis C Virus NS4B-Induced Autophagy	Su	2011	5		ACTG2
670	chr11	11242015	11242041	3500031735	26		11242015	11242041	8421504	1	26	0	c,g	350003173500000000,350003173500000000	0-26,0-26		21292685	10.1093/neuonc/noq195		Neuro-Oncology	Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation	In	2011	0		
670	chr11	11242015	11242040	3500258844	25		11242015	11242040	8421504	1	25	0	c,g	350025884400000081,350025884400000035,350025884400000035	0-25,0-24,0-24						Nucleic acid amplification method: ramification-extension amplification method (RAM)	Zhang	1999	0		
670	chr11	11242015	11242040	3500245771	25		11242015	11242040	8421504	1	25	0	c	350024577100000034	0-25						Nucleic acid amplification method: ramification-extension amplification method (ram)	Brandwein	1998	0		ACTG1
670	chr11	11242015	11242040	3500141386	24		11242015	11242040	8421504	2	6,18	0,7	c	350014138600000035	0-24					Patent	Nucleic acid amplification method: ramification-extension amplification method (RAM) (Patent US:6569647)	Zhang	2003	0		ACTG1
670	chr11	11242015	11242040	3500071383	25		11242015	11242040	8421504	1	25	0	c,g	350007138300000034,350007138300000034	0-25,0-25						Nucieic acid amplification methods	Yi	2006	0		ACTG1
670	chr11	11242051	11242074	3500104260	23		11242051	11242074	8421504	1	23	0	c	350010426000000003	0-23						RESEARCH Open Access Induction of microRNA-214-5p in human and rodent liver fibrosis	biomedcentral.com	0	0		
670	chr11	11242108	11242131	3500371036	23		11242108	11242131	8421504	1	23	0	c	350037103600000007	1-24						Inhibition of infectious pancreatic necrosis virus replication by atlantic salmon Mx1 protein. - ResearchGate	.researchgate.net	0	0		
670	chr11	11242108	11242131	3500025312	23		11242108	11242131	8421504	1	23	0	c	350002531200000034	1-24						TaiLieu.VN: B&#xe1;o c&#xe1;o Y h&#x1ecd;c: Atlantic salmon possess three mitogen activated protein kinase kinase 6 paralogs responding differently to stress 	tailieu.vn/doc/ba	0	0		
670	chr11	11242958	11245155	3500061888	42		11242958	11245155	8421504	3	22,14,6	0,1923,2191	c	350006188800000049,350006188800000013,350006188800000012,350006188800000048	0-22,0-22,0-20,0-20						METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS - Patent application	www.faqs.org	0	0		
670	chr11	11242958	11242981	3500324994	23		11242958	11242981	8421504	1	23	0	c	350032499400000025	0-23		17569822	10.1124/jpet.107.124461	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Bcr-Abl-Independent Imatinib-Resistant K562 Cells Show Aberrant Protein Acetylation and Increased Sensitivity to Histone Deacetylase Inhibitors	Lee	2007	0		ACTA2
670	chr11	11242958	11242981	3500126722	23		11242958	11242981	8421504	1	23	0	g	350012672200000007	0-23		16609006	10.1158/1078-0432.CCR-05-2797	1078-0432	Clinical Cancer Research	Glycoprotein Nonmetastatic Melanoma Protein B, a Potential Molecular Therapeutic Target in Patients with Glioblastoma Multiforme	Kuan	2006	8		ACTG2
670	chr11	11244874	11245156	3500388577	28		11244874	11245156	8421504	2	21,7	0,275	c	350038857700000002	0-28						Neutrophil elastase induces mucus cell metaplasia in mouse lung	ng.physiology.org	0	0		
670	chr11	11244874	11245156	3500285802	28		11244874	11245156	8421504	2	21,7	0,275	c	350028580200000002	0-28		15273079	10.1152/ajplung.00140.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Neutrophil elastase induces mucus cell metaplasia in mouse lung	Voynow	2004	0		
670	chr11	11244874	11245153	3500265103	25		11244874	11245153	8421504	2	21,4	0,275	c	350026510300000006	0-25		23297341	10.1128/MCB.01567-12		Molecular and Cellular Biology	RVBs Are Required for Assembling a Functional TIP60 Complex	Sudhakar	2013	0		
670	chr11	11244874	11245153	3500222675	25		11244874	11245153	8421504	2	21,4	0,275	c	350022267500000008	0-25		18724390	10.1038/onc.2008.264	0950-9232	Oncogene	Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration	Wu	2008	6		
670	chr11	11244874	11245153	3500055860	25		11244874	11245153	8421504	2	21,4	0,275	c	350005586000000002	0-25						Inhibition of Methyltransferases Results in Induction of G /M Checkpoint and Programmed Cell Death in Human T-Lymphotropic Virus Type 1-Transformed Cells	jvi.asm.org	0	0		
670	chr11	11244874	11245152	3500435579	24		11244874	11245152	8421504	2	21,3	0,275	c	350043557900000009	0-24		20819092	10.1111/j.1365-2249.2010.04243.x	1365-2249	Clinical & Experimental Immunology	The inhibitory effects of intravenous administration of rabbit immunoglobulin G on airway inflammation are dependent upon Fc&#x03b3; receptor IIb on CD11c+ dendritic cells in a murine model - Yamamoto - 2010 - Clinical & Experimental Immunology - Wiley On	Yamamoto	2010	0		
670	chr11	11244874	11245152	3500378600	24		11244874	11245152	8421504	2	21,3	0,275	c	350037860000000008	0-24			10.1186/1471-2199-8-33		BMC Molecular Biology	Transcriptional analysis of an immune-responsive serine protease from Indian malarial vector, Anopheles culicifacies	Janneth	2007	0		
670	chr11	11244874	11245152	3500162114	24		11244874	11245152	8421504	2	21,3	0,275	c	350016211400000003	0-24		8621536	10.1074/jbc.271.15.8925	0021-9258	Journal of Biological Chemistry	Characterization of a Major Peritrophic Membrane Protein, Peritrophin-44, from the Larvae of Lucilia cuprina	Elvin	1996	5		
670	chr11	11244874	11245152	3500016716	24		11244874	11245152	8421504	2	21,3	0,275	c	350001671600000002	0-24		20036271	10.1016/j.taap.2009.12.014		Toxicology and applied pharmacology	Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure	Elena	2010	0		
670	chr11	11244876	11245153	3500344256	23		11244876	11245153	8421504	2	19,4	0,273	c	350034425600000001	0-23		17667996	10.1038/sj.jcbfm.9600538	0271-678X	Journal of Cerebral Blood Flow & Metabolism	Blood&#x2013;brain barrier genomics and cloning of a novel organic anion transporter	Chu	2007	5		
670	chr11	11244877	11245156	3500334488	25		11244877	11245156	8421504	2	18,7	0,272	c	350033448800000006	0-25						ScienceDirect.com - Vascular Pharmacology - Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia	sciencedirect.com	0	0		
670	chr11	11244877	11245156	3500276303	25		11244877	11245156	8421504	2	18,7	0,272	c	350027630300000025	0-25		17569794	10.1124/mol.107.035550	1521-0111 (Online)	Molecular Pharmacology	Functional Characterization of the Promoter of Human Carbonyl Reductase 1 (CBR1). Role of XRE Elements in Mediating the Induction of CBR1 by Ligands of the Aryl Hydrocarbon Receptor	Lakhman	2007	0		ACTG2
670	chr11	11244877	11245156	3500118086	25		11244877	11245156	8421504	2	18,7	0,272	c	350011808600000025	0-25			10.1124/mol.107.035550		Molecular pharmacology	Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating induction of CBR1 by ligands of the aryl hydrocarbon receptor	Sukhwinder	2007	0		
670	chr11	11244877	11245156	3500025563	25		11244877	11245156	8421504	2	18,7	0,272	c	350002556300000006	0-25		23573157	10.1155/2013/916590		Evidence-based Complementary and Alternative Medicine : eCAM	Therapeutic Effect of C-Phycocyanin Extracted from Blue Green Algae in a Rat Model of Acute Lung Injury Induced by Lipopolysaccharide	Pak-on	2013	0		
670	chr11	11244877	11245155	3500434456	24		11244877	11245155	8421504	2	18,6	0,272	c	350043445600000011	0-24		18344492	10.1158/1541-7786.MCR-07-0277	1541-7786	Molecular Cancer Research	CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro	Lu	2008	4		ACTG2
670	chr11	11244877	11245155	3500285792	24		11244877	11245155	8421504	2	18,6	0,272	c	350028579200000022	0-24		14988089	10.1161/01.ATV.0000124102.11472.36	1079-5642	Arteriosclerosis, Thrombosis, and Vascular Biology	CXCL16/SR-PSOX Is an Interferon-&#x03b3;&#x2013;Regulated Chemokine and Scavenger Receptor Expressed in Atherosclerotic Lesions	Wuttge	2004	6		
670	chr11	11244877	11245155	3500046122	24		11244877	11245155	8421504	2	18,6	0,272	c	350004612200000003	0-24		16873375	10.1074/jbc.M602237200	0021-9258	Journal of Biological Chemistry	Androgen Induction of Prostate Cancer Cell Invasion Is Mediated by Ezrin	Chuan	2006	5		
670	chr11	11244878	11245156	3500232228	24		11244878	11245156	8421504	2	17,7	0,271	c	350023222800000006	0-24						Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. - ResearchGate	.researchgate.net	0	0		ACTG2
670	chr11	11244880	11245161	3500147763	27		11244880	11245161	8421504	2	15,12	0,269	c	350014776300000002,350014776300000019	0-27,0-27						HYPOXIA-INDUCED MITOGENIC FACTOR - Patent application	www.faqs.org	0	0		
670	chr11	11244880	11245158	3500425493	24		11244880	11245158	8421504	2	15,9	0,269	c	350042549300000005	0-24			10.1186/2213-0802-1-2	2213-0802	Translational Respiratory Medicine	A linear polyethylenimine mediated siRNA-based therapy targeting human epidermal growth factor receptor in SPC-A1 xenograft mice	Zhang	2013	0		
670	chr11	11244880	11245157	3500225983	23		11244880	11245157	8421504	2	15,8	0,269	c	350022598300000013	0-23		18508966	10.1681/ASN.2007111245		Journal of the American Society of Nephrology : JASN	Characterization of the Sodium/Hydrogen Exchanger NHA2	DaniG.	2008	0		
670	chr11	11244880	11245157	3500074393	23		11244880	11245157	8421504	2	15,8	0,269	c	350007439300000013	0-23		18508966	10.1681/ASN.2007111245	1046-6673	Journal of the American Society of Nephrology	Characterization of the Sodium/Hydrogen Exchanger NHA2	Fuster	2008	10		
670	chr11	11244881	11245161	3500226739	26		11244881	11245161	8421504	2	14,12	0,268	c	350022673900000000	0-26					The American Journal of Pathology	Infectious Angiogenesis: Bartonella bacilliformis Infection Results in Endothelial Production of Angiopoetin-2 and Epidermal Production of Vascular Endothelial Growth Factor	Francesca	2003	0		
670	chr11	11244881	11245161	3500044536	26		11244881	11245161	8421504	2	14,12	0,268	c	350004453600000002	0-26			10.1124/jpet.106.116921	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells	Salim	2007	0		
670	chr11	11244881	11245159	3500451352	24		11244881	11245159	8421504	2	14,10	0,268	c	350045135200000002	0-24						Hedgehog	Lamb	2003	0		
670	chr11	11244881	11245159	3500092839	24		11244881	11245159	8421504	2	14,10	0,268	c	350009283900000002	0-24						Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways	Lamb	2002	0		
670	chr11	11244884	11245164	3500342293	26		11244884	11245164	8421504	2	11,15	0,265	c	350034229300000009	0-26		21931504	10.2147/CMR.S11678		Cancer Management and Research	Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver	Fatemeh	2011	0		
670	chr11	11244884	11245162	3500023477	24		11244884	11245162	8421504	2	11,13	0,265	c	350002347700000003	0-24						Effect of dietary n-6 to n-3 polyunsaturated fatty acid ratio on prostaglandin plasma levels and genes expression peroxisome proliferator-activated receptor (PPAR) in pregnant Sprague Dawley rats	demicjournals.org	0	0		
670	chr11	11244884	11245161	3500331692	23		11244884	11245161	8421504	2	11,12	0,265	c	350033169200000013	0-23						The Corpuscles of Stannius, Calcium-Sensing Receptor, and Stanniocalcin: Responses to Calcimimetics and Physiological Challenges	.endojournals.org	0	0		
670	chr11	11244884	11245161	3500222796	23		11244884	11245161	8421504	2	11,12	0,265	c	350022279600000000	0-23		18219662	10.1002/cncr.23285	1097-0142	Cancer	Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells - Nakano - 2008 - Cancer - Wiley Online Library	Nakano	2008	0		
670	chr11	11244884	11245161	3500174220	23		11244884	11245161	8421504	2	11,12	0,265	c	350017422000000004	0-23						NuclearOrphanReceptorTLXInducesOct-3/4forthe SurvivalandMaintenanceofAdultHippocampalProgenitors uponHypoxia S	www.jbc.org	0	0		
670	chr11	11244885	11245257	3500411828	44		11244885	11245257	8421504	3	10,10,24	0,264,348	c	350041182800000004,350041182800000005	0-20,0-24		10827006			American Journal of Physiology - Endocrinology and Metabolism	The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner	Masuda	2000	0		
670	chr11	11244885	11245164	3500466430	25		11244885	11245164	8421504	2	10,15	0,264	c	350046643000000015	0-25		18199654	10.1128/JVI.02126-07	0022-538X	Journal of Virology	Targets of Small Interfering RNA Restriction during Human Immunodeficiency Virus Type 1 Replication	Gao	2008	5		
670	chr11	11244885	11245164	3500448062	25		11244885	11245164	8421504	2	10,15	0,264	c	350044806200000007	0-25						FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells	tologylibrary.org	0	0		
670	chr11	11244885	11245164	3500421673	25		11244885	11245164	8421504	2	10,15	0,264	c	350042167300000008	0-25		17409144	10.1128/JVI.00053-07	0022-538X	Journal of Virology	The ATM/ATR Signaling Effector Chk2 Is Targeted by Epstein-Barr Virus Nuclear Antigen 3C To Release the G2/M Cell Cycle Block	Choudhuri	2007	5		ACTG2
670	chr11	11244885	11245164	3500413051	25		11244885	11245164	8421504	2	10,15	0,264	c	350041305100000005	0-25						ISSUU - CLINICS January 2012 by Clinics	issuu.com/clinics	0	0		
670	chr11	11244885	11245164	3500403018	25		11244885	11245164	8421504	2	10,15	0,264	c	350040301800000007	0-25					Patent	Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof (Patent US:7307093)	Dalton	2007	0		
670	chr11	11244885	11245164	3500401984	25		11244885	11245164	8421504	2	10,15	0,264	c	350040198400000021	0-25						XENO-FREE CULTURE CONDITIONS FOR HUMAN EMBRYONIC STEM CELLS AND METHODS THEREOF	Totey	2009	0		
670	chr11	11244885	11245164	3500350546	25		11244885	11245164	8421504	2	10,15	0,264	c	350035054600000015	0-25						Volume 17 Number 22 June 14, 2011	www.wjgnet.com	0	0		
670	chr11	11244885	11245164	3500232984	25		11244885	11245164	8421504	2	10,15	0,264	c	350023298400000009	0-25		16611985	10.1128/MCB.26.9.3414-3431.2006	0270-7306	Molecular and Cellular Biology	Protein Kinase C &#x03b4; Activates Topoisomerase II&#x03b1; To Induce Apoptotic Cell Death in Response to DNA Damage	Yoshida	2006	6		
670	chr11	11244885	11245164	3500190682	25		11244885	11245164	8421504	2	10,15	0,264	c	350019068200000005	0-25						&#xb2c4;&#xa440;&#xb3b9; &#xab65;&#xa8a5;	ir.cmu.edu.tw	0	0		
670	chr11	11244885	11245164	3500188099	25		11244885	11245164	8421504	2	10,15	0,264	c	350018809900000011	0-25						THESE DE DOCTORAT DE L'UNIVERSITE PARIS 6	hives-ouvertes.fr	0	0		ACTG2
670	chr11	11244885	11245164	3500168389	25		11244885	11245164	8421504	2	10,15	0,264	c	350016838900000005	0-25						Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay. - ResearchGate	.researchgate.net	0	0		
670	chr11	11244885	11245164	3500166292	25		11244885	11245164	8421504	2	10,15	0,264	c	350016629200000007	0-25						Ellagic Acid Induced p53/p21 Expression, G1 Arrest and Apoptosis in Human Bladder Cancer T24 Cells	.iiarjournals.org	0	0		
670	chr11	11244885	11245164	3500161002	25		11244885	11245164	8421504	2	10,15	0,264	c	350016100200000008	0-25			10.1104/pp.102.018309		Plant Physiology	Heat Sensitivity in a Bentgrass Variant. Failure to Accumulate a Chloroplast Heat Shock Protein Isoform Implicated in Heat Tolerance	Dongfang	2003	0		
670	chr11	11244885	11245164	3500160459	25		11244885	11245164	8421504	2	10,15	0,264	c	350016045900000007	0-25						Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study	ww.eurjmedres.com	0	0		
670	chr11	11244885	11245164	3500158877	25		11244885	11245164	8421504	2	10,15	0,264	c	350015887700000005	0-25						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
670	chr11	11244885	11245164	3500150912	25		11244885	11245164	8421504	2	10,15	0,264	c	350015091200000007	0-25						Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof	Miller	2004	0		ACTG2
670	chr11	11244885	11245164	3500129408	25		11244885	11245164	8421504	2	10,15	0,264	c	350012940800000008	0-25						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
670	chr11	11244885	11245164	3500116820	25		11244885	11245164	8421504	2	10,15	0,264	c	350011682000000003	21-46						Gene Expression Profiling Identified High- mobility Group AT-hook 2 (HMGA2) as Being Frequently Upregulated in Esophageal Squamous Cell Carcinoma	sciencedomain.org	0	0		
670	chr11	11244885	11245164	3500093231	25		11244885	11245164	8421504	2	10,15	0,264	c	350009323100000005	0-25		17938203	10.1128/MCB.01126-07	0270-7306	Molecular and Cellular Biology	Protein Kinase C &#x03b4; Induces Transcription of the TP53 Tumor Suppressor Gene by Controlling Death-Promoting Factor Btf in the Apoptotic Response to DNA Damage	Liu	2007	6		
670	chr11	11244885	11245164	3500078241	25		11244885	11245164	8421504	2	10,15	0,264	c	350007824100000005	0-25						Protection by Quercetin Against Cooking Oil Fumes-Induced DNA Damage in Human Lung Adenocarcinoma CL-3 Cells: Role of COX-2	embers.linode.com	0	0		
670	chr11	11244885	11245164	3500023082	25		11244885	11245164	8421504	2	10,15	0,264	c	350002308200000027,350002308200000013	0-25,0-25						Human Mesenchymal stem cells and preparation thereof - Patent application	www.faqs.org	0	0		
670	chr11	11244885	11245164	3500020495	25		11244885	11245164	8421504	2	10,15	0,264	c	350002049500000009	0-25			10.1002/ar.a.20010	1552-4892	The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology	Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture - Charles Huang - 2004 - The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology - Wiley Online Library	Charles	2004	0		
670	chr11	11244885	11245164	3500019638	25		11244885	11245164	8421504	2	10,15	0,264	c	350001963800000007	0-25						Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof	Dalton	2006	0		
670	chr11	11244885	11245164	3500012446	25		11244885	11245164	8421504	2	10,15	0,264	c	350001244600000005	0-25						Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells	Z	2006	0		
670	chr11	11244885	11245163	3500157080	24		11244885	11245163	8421504	2	10,14	0,264	c	350015708000000018	0-24						MOLECULAR MECHANISMS IN MYOGENESIS AND IN RHABDOMYOSARCOMA	krex.k-state.edu	0	0		ACTG2
670	chr11	11244886	11245164	3500430480	24		11244886	11245164	8421504	2	9,15	0,263	c	350043048000000008	6-30			10.1113/jphysiol.2002.027185	0022-3751	The Journal of Physiology	Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion	McManaman	2002	5		
670	chr11	11244886	11245164	3500415346	24		11244886	11245164	8421504	2	9,15	0,263	c	350041534600000026	0-24						Methods And Compositions For The Diagnosis And Treatment Of Schizophrenia 	.freshpatents.com	0	0		ACTG2
670	chr11	11244886	11245164	3500352782	24		11244886	11245164	8421504	2	9,15	0,263	c	350035278200000002	6-30						Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. - ResearchGate	.researchgate.net	0	0		
670	chr11	11244887	11245166	3500071008	25		11244887	11245166	8421504	2	8,17	0,262	c	350007100800000008	0-25		22648170	10.1091/mbc.E11-12-1007		Molecular Biology of the Cell	The clathrin adaptor Dab2 recruits EH domain scaffold proteins to regulate integrin &#x03b2;1 endocytosis	Anjali	2012	0		
670	chr11	11244887	11245164	3500025602	23		11244887	11245164	8421504	2	8,15	0,262	c	350002560200000008	1-24		19332548	10.1074/jbc.M808810200		The Journal of Biological Chemistry	Ionizing Radiation Induces ATM-independent Degradation of p21Cip1 in Transformed Cells	Scott	2009	0		
670	chr11	11245203	11245260	3500408015	57		11245203	11245260	8421504	1	57	0	p	350040801500015005	0-57			10.1124/mol.61.5.1174	1521-0111 (Online)	Molecular Pharmacology	Identification of Albumin Precursor Protein, Phi AP3, and &#x03b1;-Smooth Muscle Actin as Novel Components of Redox Sensing Machinery in Vascular Smooth Muscle Cells	Holderman	2002	0		ACTG2
670	chr11	11245228	11245260	3500464942	32		11245228	11245260	8421504	1	32	0	c	350046494200000008	0-32		19657391	10.1371/journal.pone.0006535	1932-6203	PLOS ONE	PLOS ONE: Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice	Yadav	2009	4		ACTG2
670	chr11	11245228	11245260	3500464557	32		11245228	11245260	8421504	1	32	0	c	350046455700000000	0-32						World J Gastroenterol	www.wjgnet.com	0	0		ACTG2
670	chr11	11245228	11245260	3500463514	32		11245228	11245260	8421504	1	32	0	c	350046351400000008	0-32			10.3748/wjg.14.2308		World Journal of Gastroenterology : WJG	Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro	Ji-Kun	2008	0		ACTB,POTEE
670	chr11	11245228	11245260	3500461897	32		11245228	11245260	8421504	1	32	0	c	350046189700000010,350046189700000040	0-32,0-32						CULTURE MEDIA, CELL CULTURES AND METHODS OF CULTURING PLURIPOTENT STEM CELLS IN AN UNDIFFERENTIATED STATE - Patent application	www.faqs.org	0	0		ACTG2
670	chr11	11245228	11245260	3500455283	32		11245228	11245260	8421504	1	32	0	c	350045528300000002	0-32						Respiratory Syncytial Virus Induces Selective Production of the Chemokine RANTES by Upper Airway Epithelial Cells	www.jstor.org	0	0		ACTB
670	chr11	11245228	11245260	3500439728	32		11245228	11245260	8421504	1	32	0	c	350043972800000004	0-32						The Cell Adhesion Molecules N-Cadherin and Neural Cell Adhesion Molecule Regulate Human Growth Hormone: A Novel Mechanism for Regulating Pituitary Hormone Secretion	.endojournals.org	0	0		POTEE
670	chr11	11245228	11245260	3500435139	32		11245228	11245260	8421504	1	32	0	c	350043513900000006	0-32						Tamoxifen-induced Apoptosis in Breast Cancer Cells Relates to Down-Regulation of bcl-2, but not bax and bcl-X, without	.aacrjournals.org	0	0		ACTB
670	chr11	11245228	11245260	3500434352	32		11245228	11245260	8421504	1	32	0	c	350043435200000000	0-32						PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. - ResearchGate	.researchgate.net	0	0		POTEM
670	chr11	11245228	11245260	3500427926	32		11245228	11245260	8421504	1	32	0	c	350042792600000000	0-32						LIV ERCAN g pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells	www.wjgnet.com	0	0		CCDC74A
670	chr11	11245228	11245260	3500426691	32		11245228	11245260	8421504	1	32	0	c	350042669100000002	0-32		16983343	10.1038/sj.onc.1209961	0950-9232	Oncogene	Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells	Neesse	2006	6		CCDC74A
670	chr11	11245228	11245260	3500425565	32		11245228	11245260	8421504	1	32	0	c	350042556500000008	0-32		11535826	10.1073/pnas.191362598	0027-8424	Proceedings of the National Academy of Sciences	Hematopoietic colony-forming cells derived from human embryonic stem cells	Kaufman	2001	10		ACTG2,POTEH
670	chr11	11245228	11245260	3500404069	32		11245228	11245260	8421504	1	32	0	c	350040406900000002	0-32			10.3748/wjg.15.3874		World Journal of Gastroenterology : WJG	Peroxisome proliferator-activated receptor-&#x03b3; is essential in the pathogenesis of gastric carcinoma	Xiu-Mei	2009	0		CCDC74A
670	chr11	11245228	11245260	3500398321	32		11245228	11245260	8421504	1	32	0	c	350039832100000002	0-32						Hyperglycemia regulates mdr drug uptake and ros levels	www.ukessays.com	0	0		ACTC1,CCDC74A
670	chr11	11245228	11245260	3500390960	32		11245228	11245260	8421504	1	32	0	c	350039096000000008,350039096000000028	0-32,0-32						METHODS INVOLVING ALDOSE REDUCTASE INHIBITORS - Patent application	www.faqs.org	0	0		
670	chr11	11245228	11245260	3500381639	32		11245228	11245260	8421504	1	32	0	c	350038163900000000	0-32						World J Gastroenterol	www.wjgnet.com	0	0		ACTG2
670	chr11	11245228	11245260	3500380670	32		11245228	11245260	8421504	1	32	0	c	350038067000000008	0-32						Compositions and Methods for Treating Pigmentary Conditions and Melanoma	Hearing	2008	0		ACTC1
670	chr11	11245228	11245260	3500361492	32		11245228	11245260	8421504	1	32	0	c	350036149200000010	0-32						Hcv Neutralizing Epitopes 	.freshpatents.com	0	0		ACTG2
670	chr11	11245228	11245260	3500361312	32		11245228	11245260	8421504	1	32	0	c	350036131200000061	0-32						Tumour associated antigens	Banham	2004	0		ACTG2
670	chr11	11245228	11245260	3500356848	32		11245228	11245260	8421504	1	32	0	c	350035684800000017,350035684800000200	0-32,0-32						P450rai-2 (p450 Cytochrome 26b), Encoding Nucleic Acid Molecules And Methods And Uses Thereof 	.freshpatents.com	0	0		ACTC1
670	chr11	11245228	11245260	3500352147	32		11245228	11245260	8421504	1	32	0	c	350035214700000002,350035214700000013	0-32,0-32						MAP-2 as a determinant of metastatic potential	Setaluri	2001	0		
670	chr11	11245228	11245260	3500339428	32		11245228	11245260	8421504	1	32	0	c	350033942800000011	0-32						T-cell receptor&#x03b3; alternate reading frame protein, (TARP) and uses thereof	Pastan	2000	0		ACTC1
670	chr11	11245228	11245260	3500338718	32		11245228	11245260	8421504	1	32	0	c	350033871800000004,350033871800000099	0-32,0-32						US Patent # 6,824,781. Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist - Patents.com	www.patents.com	0	0		ACTG2
670	chr11	11245228	11245260	3500321867	32		11245228	11245260	8421504	1	32	0	c	350032186700000002	0-32						World J Gastroenterol	www.wjgnet.com	0	0		POTEM
670	chr11	11245228	11245260	3500308568	32		11245228	11245260	8421504	1	32	0	c	350030856800000000	0-32		22550507	10.1155/2012/417865	1687-966X	Stem Cells International	Derivation of Neural Progenitors and Retinal Pigment Epithelium from Common Marmoset and Human Pluripotent Stem Cells	Torrez	2012	0		POTEM
670	chr11	11245228	11245260	3500308129	32		11245228	11245260	8421504	1	32	0	c	350030812900000004	0-32						Characterization of mesenchymal stem cells isolated from the human umbilical cord	S	2008	0		ACTG2
670	chr11	11245228	11245260	3500308041	32		11245228	11245260	8421504	1	32	0	c	350030804100000004	0-32		20180806	10.1111/j.1349-7006.2010.01516.x	1349-7006	Cancer Science	Hyperthermia-associated carboplatin resistance: Differential role of p53, HSF1 and Hsp70 in hepatoma cells - Sharma - 2010 - Cancer Science - Wiley Online Library	Sharma	2010	0		ACTG2
670	chr11	11245228	11245260	3500291793	32		11245228	11245260	8421504	1	32	0	c	350029179300000004	0-32						Characterization of mesenchymal stem cells isolated from the human umbilical cord	w.cellbiolint.org	0	0		ACTG1,POTEH
670	chr11	11245228	11245260	3500288814	32		11245228	11245260	8421504	1	32	0	c	350028881400000010,350028881400000040	0-32,0-32						METHODS OF EXPANDING EMBRYONIC STEM CEELS IN A SUSPENSION CULTURE - Patent application	www.faqs.org	0	0		CCDC74A,ACTB
670	chr11	11245228	11245260	3500288773	32		11245228	11245260	8421504	1	32	0	c	350028877300000061	0-32						Tumour associated antigens	Banham	2003	0		CCDC74A,ACTB
670	chr11	11245228	11245260	3500287369	32		11245228	11245260	8421504	1	32	0	c	350028736900000000	0-32						Measurement of Single-Cell Gene Expression Using Capillary Electrophoresis	lib3.dss.go.th	0	0		POTEF
670	chr11	11245228	11245260	3500286780	32		11245228	11245260	8421504	1	32	0	c	350028678000000009	0-32						Agents for retarding change of hormone-dependent cancer into hormone-independent cancer	Song Gu Yue Zai 	2001	0		POTEM,ACTB
670	chr11	11245228	11245260	3500274728	32		11245228	11245260	8421504	1	32	0	c	350027472800000008	0-32						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		POTEF
670	chr11	11245228	11245260	3500252258	32		11245228	11245260	8421504	1	32	0	c	350025225800000008	0-32						Methods Involving Aldose Reductase Inhibitors	Srivastava	2013	0		ACTC1,POTEH
670	chr11	11245228	11245260	3500249642	32		11245228	11245260	8421504	1	32	0	c	350024964200000008	0-32						Methods involving aldose reductase inhibitors	Srivastava	2010	0		ACTG2
670	chr11	11245228	11245260	3500218382	32		11245228	11245260	8421504	1	32	0	c	350021838200000012	0-32					Patent	Tissue culture medium comprising transforming growth factor beta 1 and basic fibroblast growth factor (Patent US:8222034)	Amit	2012	0		ACTB,ACTG1
670	chr11	11245228	11245260	3500214911	32		11245228	11245260	8421504	1	32	0	c	350021491100000003	0-32						NOVEL TUMOR ANTIGENS ELICIT ANTI-TUMOR HUMORAL IMMUNE REACTIONS IN A SUBSET OF PATIENTS WITH POLYCYTHEMIA VERA	Yang	2007	0		POTEM
670	chr11	11245228	11245260	3500208389	32		11245228	11245260	8421504	1	32	0	c	350020838900000016	0-32		21160040	10.4049/jimmunol.1001954	0022-1767	The Journal of Immunology	Autophagy Negatively Regulates Keratinocyte Inflammatory Responses via Scaffolding Protein p62/SQSTM1	Lee	2011	6		ACTC1
670	chr11	11245228	11245260	3500207003	32		11245228	11245260	8421504	1	32	0	c	350020700300000004	0-32						Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy	www.jeccr.com	0	0		CCDC74A
670	chr11	11245228	11245260	3500203697	32		11245228	11245260	8421504	1	32	0	c	350020369700000008	0-32						Methods involving aldose reductase inhibitors	Srivastava	2008	0		ACTG1
670	chr11	11245228	11245260	3500203544	32		11245228	11245260	8421504	1	32	0	c	350020354400000008	0-32						Volume 17 Number 25 July 7, 2011	www.wjgnet.com	0	0		ACTG1
670	chr11	11245228	11245260	3500189250	32		11245228	11245260	8421504	1	32	0	c	350018925000000200,350018925000000017	0-32,0-32						P450RAI-2 (P450 CYTOCHROME 26B), ENCODING NUCLEIC ACID MOLECULES AND METHODS AND USES THEREOF - Patent application	www.faqs.org	0	0		POTEE
670	chr11	11245228	11245260	3500188830	32		11245228	11245260	8421504	1	32	0	c	350018883000000027	0-32						FRIEDRICH-SCHILLER-UNIVERSITAT JENA BIOLOGISCH-PHARMAZEUTISCHE FAKULTAT Experimentelle Unter	.db-thueringen.de	0	0		ACTC1,POTEH
670	chr11	11245228	11245260	3500187949	32		11245228	11245260	8421504	1	32	0	c	350018794900000010	0-32		12186908	10.1128/JVI.76.18.9242-9252.2002	0022-538X	Journal of Virology	Upregulation of Surface Feline CXCR4 Expression following Ectopic Expression of CCR5: Implications for Studies of the Cell Tropism of Feline Immunodeficiency Virus	Willett	2002	5		CCDC74A
670	chr11	11245228	11245260	3500186343	32		11245228	11245260	8421504	1	32	0	c	350018634300000010	0-32						CULTURE MEDIA, CELL CULTURES AND METHODS OF CULTURING PLURIPOTENT STEM CELLS IN AN UNDIFFERENTIATED STATE	Amit	2010	0		
670	chr11	11245228	11245260	3500185226	32		11245228	11245260	8421504	1	32	0	c	350018522600000010	0-32						Media for culturing stem cells	Amit	2006	0		ACTG1
670	chr11	11245228	11245260	3500182696	32		11245228	11245260	8421504	1	32	0	c	350018269600000012	0-32						Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same	Amit	2010	0		
670	chr11	11245228	11245260	3500175030	32		11245228	11245260	8421504	1	32	0	c	350017503000000008	0-32					Patent	Methods involving aldose reductase inhibitors (Patent US:8273746)	Srivastava	2012	0		ACTG2
670	chr11	11245228	11245260	3500171169	32		11245228	11245260	8421504	1	32	0	c	350017116900000002	0-32		10103198		0066-4804	Antimicrobial Agents and Chemotherapy	Fourteen-Member Macrolides Inhibit Interleukin-8 Release by Human Eosinophils from Atopic Donors	Kohyama	1999	5		ACTC1
670	chr11	11245228	11245260	3500156992	32		11245228	11245260	8421504	1	32	0	c	350015699200000002	0-32		15385510	10.1128/IAI.72.10.6061-6067.2004	0019-9567	Infection and Immunity	Cryptosporidium parvum at Different Developmental Stages Modulates Host Cell Apoptosis In Vitro	Mele	2004	4		ACTG1
670	chr11	11245228	11245260	3500154545	32		11245228	11245260	8421504	1	32	0	c	350015454500000008	0-32						Hematopoietic colony-forming cells derived from human embryonic stem cells. - ResearchGate	.researchgate.net	0	0		ACTC1
670	chr11	11245228	11245260	3500149810	32		11245228	11245260	8421504	1	32	0	c	350014981000000004	0-32		15117948	10.1074/jbc.M403793200	0021-9258	Journal of Biological Chemistry	The SANT Domain of Human MI-ER1 Interacts with Sp1 to Interfere with GC Box Recognition and Repress Transcription from Its Own Promoter	Ding	2004	5		
670	chr11	11245228	11245260	3500148871	32		11245228	11245260	8421504	1	32	0	c	350014887100000004	0-32		10781420			American Journal of Physiology - Lung Cellular and Molecular Physiology	Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers	Takizawa	2000	0		
670	chr11	11245228	11245260	3500132876	32		11245228	11245260	8421504	1	32	0	c	350013287600000018	0-32		19147749	10.1158/1078-0432.CCR-08-1631	1078-0432	Clinical Cancer Research	Targeted Knockdown of Notch1 Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen Activator	Hafeez	2009	8		
670	chr11	11245228	11245260	3500125919	32		11245228	11245260	8421504	1	32	0	c	350012591900000016	0-32						Translational Dysfunction Based Therapeutics - Patent application	www.faqs.org	0	0		ACTC1,POTEH
670	chr11	11245228	11245260	3500124924	32		11245228	11245260	8421504	1	32	0	c	350012492400000006	0-32		19752229	10.4049/jimmunol.0901177	0022-1767	The Journal of Immunology	Aldose Reductase Inhibition Suppresses the Expression of Th2 Cytokines and Airway Inflammation in Ovalbumin-Induced Asthma in Mice	Yadav	2009	6		ACTC1,CCDC74A
670	chr11	11245228	11245260	3500123549	32		11245228	11245260	8421504	1	32	0	c	350012354900000006	0-32		14574334	10.1038/sj.leu.2403183	0887-6924	Leukemia	Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells	Morales	2003	10		
670	chr11	11245228	11245260	3500109278	32		11245228	11245260	8421504	1	32	0	c	350010927800000002	0-32						ScienceDirect.com - FEBS Letters - Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect	sciencedirect.com	0	0		ACTG2
670	chr11	11245228	11245260	3500078740	32		11245228	11245260	8421504	1	32	0	c	350007874000000008	0-32		19359429	10.1152/ajpgi.90223.2008		American Journal of Physiology - Gastrointestinal and Liver Physiology	Inflammasome-mediated regulation of hepatic stellate cells	Watanabe	2009	0		CCDC74A
670	chr11	11245228	11245260	3500078465	32		11245228	11245260	8421504	1	32	0	c	350007846500000004	0-32						Antibody and Uses Thereof	Burden	2009	0		POTEF
670	chr11	11245228	11245260	3500073560	32		11245228	11245260	8421504	1	32	0	c	350007356000000040	0-32						MODULATION OF &#xdf;-CATENIN/TCF ACTIVATED TRANSCRIPTION	Ha	2006	0		ACTB
670	chr11	11245228	11245260	3500069781	32		11245228	11245260	8421504	1	32	0	c	350006978100000004	0-32						Antibody and uses thereof	Burden	2009	0		ACTB,ACTG1
670	chr11	11245228	11245260	3500048969	32		11245228	11245260	8421504	1	32	0	c	350004896900000004	0-32					Patent	Antibody and uses thereof (Patent US:7939642)	Burden	2011	0		ACTC1
670	chr11	11245228	11245260	3500045743	32		11245228	11245260	8421504	1	32	0	c	350004574300000012	0-32						Methods of culturing cells in a medium comprising transforming growth factor beta 1 and basic fibroblast growth factor	Amit	2012	0		ACTG1
670	chr11	11245228	11245260	3500043389	32		11245228	11245260	8421504	1	32	0	c	350004338900000008	0-32						Methods Involving Aldose Reductase Inhibitors	Srivastava	2013	0		ACTG1
670	chr11	11245228	11245260	3500042309	32		11245228	11245260	8421504	1	32	0	c	350004230900000004	0-32						Original article Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication	w.intmedpress.com	0	0		
670	chr11	11245228	11245260	3500030970	31		11245228	11245260	8421504	2	13,18	0,14	c	350003097000000004	0-31		23887626	10.1038/cddis.2013.241	false	Cell Death & Disease	Role of fucosyltransferase IV in epithelial&#x2013;mesenchymal transition in breast cancer cells	Yang	2013	0		CCDC74A
670	chr11	11245228	11245260	3500026211	32		11245228	11245260	8421504	1	32	0	c	350002621100000009	0-32						METHODS AND COMPOSITIONS FOR GROWTH OF EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		CCDC74A
670	chr11	11245228	11245260	3500020623	32		11245228	11245260	8421504	1	32	0	c	350002062300000006	0-32		12218071	10.1097/01.LAB.0000027838.69455.39	0023-6837	Laboratory Investigation	Functional Expression of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Human Colonic Adenocarcinoma Cells	Inoue	2002	4		POTEM,CCDC74A
670	chr11	11245228	11245260	3500020349	32		11245228	11245260	8421504	1	32	0	c	350002034900000008	0-32		21799645	10.3748/wjg.v17.i25.2992		World Journal of Gastroenterology : WJG	Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth	Chen	July	0		ACTG1
670	chr11	11245228	11245260	3500014816	32		11245228	11245260	8421504	1	32	0	c	350001481600000004	0-32						NPG.nature.vol.413.Issue.6854.Sep	www.scribd.com	0	0		POTEE
670	chr11	11245228	11245260	3500007841	32		11245228	11245260	8421504	1	32	0	c	350000784100000002	0-32			10.1128/IAI.72.10.6061-6067.2004		Infection and Immunity	Cryptosporidium parvum at Different Developmental Stages Modulates Host Cell Apoptosis In Vitro 	Raffaella	2004	0		ACTC1
670	chr11	11245228	11245260	3500002798	32		11245228	11245260	8421504	1	32	0	c	350000279800000008	0-32						Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice	www.plosone.org	0	0		CCDC74A
670	chr11	11245228	11245251	3500056215	23		11245228	11245251	8421504	1	23	0	c	350005621500000006	0-23						Research report Molecular analysis of nicotinic receptor expression in autism	www.utdallas.edu	0	0		ZP4
670	chr11	11245229	11245260	3500211760	31		11245229	11245260	8421504	1	31	0	c	350021176000000010	0-31						Characterization of HuH6, Hep3B, HepG2 and HLE liver cancer cell lines by WNT/&#x03b2; - catenin pathway, microRNA expression and protein expression profile. - ResearchGate	.researchgate.net	0	0		POTEF
670	chr11	11245229	11245260	3500133584	31		11245229	11245260	8421504	1	31	0	c	350013358400000004	0-31						BMC Cancer BioMed Central	biomedcentral.com	0	0		
670	chr11	11245230	11245260	3500076605	30		11245230	11245260	8421504	1	30	0	c	350007660500000002	0-30						BBRC	nri.bjmu.edu.cn	0	0		ZP4
670	chr11	11245230	11245258	3500089988	28		11245230	11245258	8421504	1	28	0	c	350008998800000000,350008998800000046	0-28,0-28						PKHDL1, a homolog of the autosomal recessive kidney disease gene - Patent application	www.faqs.org	0	0		ACTG2
670	chr11	11245232	11245259	3500318226	27		11245232	11245259	8421504	1	27	0	c	350031822600000005	0-27		20107176	10.1167/iovs.09-3789	1552-5783	Investigative Ophthalmology & Visual Science	The Expression of Intercellular Adhesion Molecule-1 Induced by CD40-CD40L Ligand Signaling in Orbital Fibroblasts in Patients with Graves' Ophthalmopathy	Zhao	2010	0		POTEF,RAPGEF6
670	chr11	11245232	11245258	3500382403	26		11245232	11245258	8421504	1	26	0	c	350038240300000008	0-26						Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1 expression	-publications.com	0	0		POTEM,POTEH
670	chr11	11245232	11245257	3500449843	25		11245232	11245257	8421504	1	25	0	c	350044984300000008	0-25						Multi-layered polymerizing hydrogels for tissue regeneration	Williams	2003	0		
670	chr11	11245232	11245257	3500345015	25		11245232	11245257	8421504	1	25	0	c	350034501500000008	0-25						Isolation and in vitro characterisation of dental pulp stem cells from natal teeth	el.kocaeli.edu.tr	0	0		ACTC1
670	chr11	11245232	11245257	3500341621	25		11245232	11245257	8421504	1	25	0	c	350034162100000000	0-25						Method of forming multicellular spheroids from the cultured cells	Yang	2005	0		ZP4
670	chr11	11245232	11245257	3500282735	25		11245232	11245257	8421504	1	25	0	c	350028273500000000	0-25						Metabolic Changes in Mesenchymal Stem Cells in Osteogenic Medium Measured by Autofluorescence Spectroscopy--&#x300a;&#x5e72;&#x7ec6;&#x80de;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66	journal.9med.net	0	0		
670	chr11	11245232	11245257	3500198742	25		11245232	11245257	8421504	1	25	0	c	350019874200000010	0-25		16585162	10.1158/0008-5472.CAN-05-1608	0008-5472	Cancer Research	N-Methyl-d-Aspartate Receptor Type 2B Is Epigenetically Inactivated and Exhibits Tumor-Suppressive Activity in Human Esophageal Cancer	Kim	2006	8		
670	chr11	11245232	11245257	3500189255	25		11245232	11245257	8421504	1	25	0	c	350018925500000002	0-25						Isolation and Differentiation of Human Mesenchymal Stem Cells Obtained from Second Trimester Amniotic Fluid; Experiments at Chang Gung Memorial Hospital	memo.cgu.edu.tw	0	0		ZP4
670	chr11	11245232	11245257	3500144790	25		11245232	11245257	8421504	1	25	0	c	350014479000000004	0-25						Chinese Medical Journal: a peer reviewed, open access journal, published semimonthly by the Chinese Medical Association	www.cmj.org	0	0		POTEH
670	chr11	11245232	11245257	3500087067	25		11245232	11245257	8421504	1	25	0	c	350008706700000000	0-25		15703277	10.1242/dev.01706	0950-1991	Development	TGF&#x03b2;/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells	James	2005	7		POTEF
670	chr11	11245232	11245257	3500051794	25		11245232	11245257	8421504	1	25	0	c	350005179400000000	0-25			10.1634/stemcells.21-6-624	1549-4918	STEM CELLS	Epithelial Colonies Cultured from Human Explanted Liver in Subacute Hepatic Failure Exhibit Hepatocyte, Biliary Epithelial, and Stem Cell Phenotypic Markers - Selden - 2003 - STEM CELLS - Wiley Online Library	Selden	2003	0		POTEM
670	chr11	11245232	11245257	3500002924	25		11245232	11245257	8421504	1	25	0	c	350000292400000000	0-25						Method Of Forming Multicellular Spheroids From The Cultured Cells 	.freshpatents.com	0	0		
670	chr11	11245232	11245256	3500205637	24		11245232	11245256	8421504	1	24	0	c	350020563700000018	0-24		16452631	10.1091/mbc.E05-10-0951	1059-1524	Molecular Biology of the Cell	Versican Mediates Mesenchymal-Epithelial Transition	Sheng	2006	5		
670	chr11	11245232	11245255	3500409693	23		11245232	11245255	8421504	1	23	0	c	350040969300000006	0-23		16333316	10.1038/sj.ejhg.5201536	1018-4813	European Journal of Human Genetics	A novel mutation in PAX9 causes familial form of molar oligodontia	Mostowska	2005	4		ZP4
670	chr11	11245232	11245255	3500397377	23		11245232	11245255	8421504	1	23	0	c	350039737700000002	0-23		19605357	10.1074/jbc.M109.034629	0021-9258	Journal of Biological Chemistry	Nuclear Degradation of Wilms Tumor 1-associating Protein and Survivin Splice Variant Switching Underlie IGF-1-mediated Survival	Small	2009	5		
670	chr11	11245232	11245255	3500394720	23		11245232	11245255	8421504	1	23	0	c	350039472000000004	0-23						Enhanced Expression of Keratinocyte Growth Factor and Its Receptor Correlates with Venous Invasion in Pancreatic Cancer 2007&#x5e74;&#x7b2c;169&#x5377;&#x7b2c;6&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		POTEM,ACTG2
670	chr11	11245232	11245255	3500364121	23		11245232	11245255	8421504	1	23	0	c	350036412100000002	0-23		19605357	10.1074/jbc.M109.034629		The Journal of Biological Chemistry	Nuclear Degradation of Wilms Tumor 1-associating Protein and Survivin Splice Variant Switching Underlie IGF-1-mediated Survival	Theodore	2009	0		POTEM,KIAA1279
670	chr11	11245232	11245255	3500166780	23		11245232	11245255	8421504	1	23	0	c	350016678000000027	0-23						UNIVERSIDADE DE LISBOA	repositorio.ul.pt	0	0		
670	chr11	11245233	11245260	3500188498	27		11245233	11245260	8421504	1	27	0	c	350018849800000006	0-27		17438107	10.1158/1078-0432.CCR-06-2353	1078-0432	Clinical Cancer Research	The Human T-Box Mesodermal Transcription Factor Brachyury Is a Candidate Target for T-Cell&#x2013;Mediated Cancer Immunotherapy	Palena	2007	8		POTEE
670	chr11	11245233	11245257	3500188980	24		11245233	11245257	8421504	1	24	0	c	350018898000000005	0-24		10827006			American Journal of Physiology - Endocrinology and Metabolism	The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner	Masuda	2000	0		ACTC1,POTEH
670	chr11	11245233	11245256	3500434137	23		11245233	11245256	8421504	1	23	0	c	350043413700000005	0-23		21079779	10.1371/journal.pone.0013828	1932-6203	PLOS ONE	PLOS ONE: Versican G3 Promotes Mouse Mammary Tumor Cell Growth, Migration, and Metastasis by Influencing EGF Receptor Signaling	Du	2010	4		POTEG
670	chr11	11245233	11245256	3500175582	23		11245233	11245256	8421504	1	23	0	c	350017558200000002	0-23		18573902	10.1128/IAI.00109-08	0019-9567	Infection and Immunity	CD46 Contributes to the Severity of Group A Streptococcal Infection	Lovkvist	2008	4		RAPGEF6
670	chr11	11245234	11245258	3500302150	24		11245234	11245258	8421504	1	24	0	c	350030215000000002	0-24		21714934	10.1186/1479-5876-9-99	1479-5876	Journal of Translational Medicine	Periostin: a promising target of therapeutical intervention for prostate cancer	Sun	2011	3		POTEM
670	chr11	11245234	11245258	3500195684	24		11245234	11245258	8421504	1	24	0	c	350019568400000016	0-24						Establishment of immortalized human periodontal ligament cells derived from deciduous teeth. - ResearchGate	.researchgate.net	0	0		
670	chr11	11245234	11245258	3500156222	24		11245234	11245258	8421504	1	24	0	c	350015622200000002	0-24						Periostin: a promising target of therapeutical intervention for prostate cancer	onal-medicine.com	0	0		
670	chr11	11245234	11245258	3500102969	24		11245234	11245258	8421504	1	24	0	c	350010296900000018	0-24		21652629	10.1242/jcs.079327	0021-9533	Journal of Cell Science	Differential altered stability and transcriptional activity of &#x0394;Np63 mutants in distinct ectodermal dysplasias	Browne	2011	6		ACTC1
670	chr11	11245235	11245261	3500225393	26		11245235	11245261	8421504	1	26	0	c	350022539300000007	0-26		16014577	10.1124/mol.105.014712	1521-0111 (Online)	Molecular Pharmacology	Environmental Chemical-Induced Bone Marrow B Cell Apoptosis: Death Receptor-Independent Activation of a Caspase-3 to Caspase-8 Pathway	Ryu	2005	0		POTEM,CCDC74A
670	chr11	11245235	11245261	3500215260	26		11245235	11245261	8421504	1	26	0	c	350021526000000000	0-26		20513800	10.1074/mcp.M110.000281	1535-9476	Molecular & Cellular Proteomics	Quantitative Proteome Analysis of Pluripotent Cells by iTRAQ Mass Tagging Reveals Post-transcriptional Regulation of Proteins Required for ES Cell Self-renewal	O'Brien	2010	7		ZP4
670	chr11	11245235	11245260	3500091192	25		11245235	11245260	8421504	1	25	0	c	350009119200000013	0-25		10022976	10.1101/gr.9.2.121	1088-9051	Genome Research	Isolation of Zebrafish gdf7 and Comparative Genetic Mapping of Genes Belonging to the Growth/Differentiation Factor 5, 6, 7 Subgroup of the TGF-&#x03b2; Superfamily	Davidson	1999	14		POTEF
670	chr11	11245235	11245260	3500069479	25		11245235	11245260	8421504	1	25	0	c	350006947900000008	0-25						Sodium/Glucose Co-transporter 1 Expression Increases in Human Diseased Prostate	w.omicsonline.org	0	0		ZP4
670	chr11	11245235	11245260	3500016053	25		11245235	11245260	8421504	1	25	0	c	350001605300000000	0-25		11592940	10.1152/ajprenal.0083.2001		American Journal of Physiology - Renal Physiology	Adenosine A2A and A2B receptor activation of erythropoietin production	Fisher	2001	0		ACTG2
670	chr11	11245235	11245258	3500353333	23		11245235	11245258	8421504	1	23	0	c	350035333300000025	0-23						Establishment of immortalized human periodontal ligament cells derived from deciduous teeth	cellbiosignal.jp	0	0		CCDC74A,KIAA1279
670	chr11	11245235	11245258	3500029452	23		11245235	11245258	8421504	1	23	0	c	350002945200000006	0-23						Implication de la m&#xe9;lanotransferrine dans la progression tumorale : identification d'une nouvelle cible th&#xe9;rapeutique	.archipel.uqam.ca	0	0		CCDC74A
671	chr11	11378507	11378532	3500356218	25		11378507	11378532	8421504	1	25	0	c,g	350035621800000033,350035621800000033	9-34,9-34						Human calcium binding protein and a polynucleotide encoding the same	Mao	2002	0		TPRKB
674	chr11	11718520	11718592	3500422420	72		11718520	11718592	8421504	1	72	0	p	350042242000015017	0-72						Clone pAT 133 Identifies a Gene that Encodes Another Human Member of a Class of Growth Factor-Induced Genes with Almost Identical Zinc-Finger Domains	www.jstor.org	0	0		
674	chr11	11773889	11777594	3500024754	633		11773889	11777594	8421504	5	136,101,110,168,118	0,2164,2814,3194,3587	p	350002475400015039	60-693						52 human secreted proteins	Baker	2002	0		
674	chr11	11773958	11777594	3500245940	564		11773958	11777594	8421504	5	67,101,110,168,118	0,2095,2745,3125,3518	p	350024594000015140,350024594000015141	0-564,0-210						Secreted protein HCEJQ69	Brewer	2003	0		CCT7,PRADC1
677	chr11	12107249	12114725	3500460246	103		12107249	12114725	8421504	4	22,31,24,26	0,6490,7134,7450	c,g	350046024600000002,350046024600000002,350046024600000010,350046024600000010,350046024600000005,350046024600000004,350046024600000003	0-22,0-22,0-21,0-21,0-24,0-24,9-35						Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability	rt.physiology.org	0	0		
677	chr11	12107249	12114725	3500000254	103		12107249	12114725	8421504	4	22,31,24,26	0,6490,7134,7450	c,g	350000025400000002,350000025400000002,350000025400000010,350000025400000005,350000025400000004,350000025400000003	0-22,0-22,0-21,0-24,0-24,9-35		19429835	10.1152/ajpheart.00007.2009		American Journal of Physiology - Heart and Circulatory Physiology	Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability	Gao	2009	0		
677	chr11	12157313	12157343	3500401651	25		12157313	12157343	8421504	3	14,4,7	0,15,23	g	350040165100000325	1-37					Patent	Tissue plasminogen activator (Patent US:5840533)	Hayashi	1998	0		
683	chr11	12932688	12932716	3500021514	23		12932688	12932716	8421504	2	16,7	0,21	g	350002151400000032	8-33						Production of oligosaccharides in transgenic plants	Smeekens	1998	0		
85	chr11	12962504	12978309	3500139758	1440		12962504	12978309	8421504	9	204,225,102,168,156,132,114,81,258	0,3618,12723,12831,13268,14780,14951,15418,15547	p,g	350013975800015007,350013975800015003,350013975800000002,350013975800015013,350013975800015010,350013975800015015,350013975800015025,350013975800015021,350013975800015031,350013975800015037,350013975800015039,350013975800015043,350013975800015048,350013975800015052,350013975800015059	0-180,0-180,51-78,0-180,0-180,0-171,0-168,0-168,0-168,0-120,0-150,0-150,0-45,0-78,0-180						Cytochromes P450: Inhibition of CYP2A Enzymes Involved in Xenobiotic Metabolism and	holarworks.ku.edu	0	0		
85	chr11	12962504	12977523	3500356848	194		12962504	12977523	8421504	6	48,12,36,22,32,44	0,192,3618,13331,14914,14975	c	350035684800000149,350035684800000153,350035684800000165,350035684800000004,350035684800000186,350035684800000171	0-48,0-48,0-22,0-32,0-32,0-44						P450rai-2 (p450 Cytochrome 26b), Encoding Nucleic Acid Molecules And Methods And Uses Thereof 	.freshpatents.com	0	0		
85	chr11	12962696	12978114	3500189250	223		12962696	12978114	8421504	8	12,36,22,45,2,32,44,30	0,3426,13139,13187,14588,14722,14783,15388	c	350018925000000153,350018925000000165,350018925000000166,350018925000000004,350018925000000186,350018925000000171,350018925000000019	0-48,0-22,0-47,0-32,0-32,0-44,0-30						P450RAI-2 (P450 CYTOCHROME 26B), ENCODING NUCLEIC ACID MOLECULES AND METHODS AND USES THEREOF - Patent application	www.faqs.org	0	0		
684	chr11	12978293	12978316	3500013017	23		12978293	12978316	8421504	1	23	0	c	350001301700000003	6-29		19884280	10.1124/mol.109.059071	1521-0111 (Online)	Molecular Pharmacology	A Comparison of the Roles of Peroxisome Proliferator-Activated Receptor and Retinoic Acid Receptor on CYP26 Regulation	Tay	2010	0		
684	chr11	13075719	13075746	3500379751	24		13075719	13075746	8421504	2	12,12	0,15	g	350037975100000063	3-27						ANTI-IGF-I RECEPTOR ANTIBODY - Patent application	www.faqs.org	0	0		
687	chr11	13496496	13496527	3500464832	26		13496496	13496527	8421504	3	6,5,15	0,10,16	g	350046483200000002	14-40						Handbook of RNA Biochemistry (Wiley, 2005)	www.scribd.com	0	0		
688	chr11	13564124	13567728	3500456201	26		13564124	13567728	8421504	3	14,5,7	0,16,3597	c	350045620100000093	5-34						Lxr ligand testing method - Patent application	www.faqs.org	0	0		DYSF
688	chr11	13586487	13589379	3500391274	54		13586487	13589379	8421504	2	19,35	0,2857	p	350039127400015002	0-54						Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells	cs.biologists.org	0	0		DYSF
688	chr11	13586487	13589379	3500293775	54		13586487	13589379	8421504	2	19,35	0,2857	p	350029377500015002	0-54		22349696	10.1242/jcs.094565	0021-9533	Journal of Cell Science	Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells	Han	2012	6		DYSF
689	chr11	13760092	13760117	3500144428	24		13760092	13760117	8421504	2	20,4	0,21	g	350014442800000005	6-30						Gene regulation	Girdlestone	2004	0		
689	chr11	13760092	13760117	3500096847	24		13760092	13760117	8421504	2	20,4	0,21	g	350009684700000009	6-30						Nucleic acid binding polypeptides	Choo	2004	0		
690	chr11	13825264	13825289	3500342905	25		13825264	13825289	8421504	1	25	0	c,g	350034290500000000,350034290500000000	5-30,5-30		11959863	10.1074/jbc.M201858200	0021-9258	Journal of Biological Chemistry	Calcium-sensitive Phospholipid Binding Properties of Normal and Mutant Ferlin C2 Domains	Davis	2002	5		
690	chr11	13869075	13869104	3500210720	25		13869075	13869104	8421504	2	16,9	0,20	c	350021072000000108	0-25						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
693	chr11	14206146	14206206	3500362806	57		14206146	14206206	8421504	2	18,39	0,21	p	350036280600015015	0-57						V-ATPASE EXPRESSION AND FUNCTION IN THE BRINE SHRIMP, ARTEMIA FRANCISCANA ROLE OF PROTON GRADIENTS IN ANOXIA-INDUCED QUIESCENCE	etd.lsu.edu	0	0		
694	chr11	14327815	14327842	3500132030	24		14327815	14327842	8421504	2	11,13	0,14	g	350013203000000043	22-46						 Pfu Replication Accessory Factors And Methods Of Use 	www.docstoc.com	0	0		
694	chr11	14386503	14386530	3500436977	23		14386503	14386530	8421504	3	14,4,5	0,15,22	g	350043697700000029	1-24						Highly conserved genes and their use to generate probes and primers for detection of microorganisms	Bergeron	2006	0		
694	chr11	14386503	14386530	3500394873	23		14386503	14386530	8421504	3	14,4,5	0,15,22	g	350039487300000028	1-24						Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitica	Bergeron	2001	0		
694	chr11	14386503	14386530	3500300874	23		14386503	14386530	8421504	3	14,4,5	0,15,22	g	350030087400000039	1-24						HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE PROBES AND PRIMERS FOR DETECTION OF MICROORGANISMS	Bergeron	2011	0		
694	chr11	14386503	14386530	3500214186	23		14386503	14386530	8421504	3	14,4,5	0,15,22	g	350021418600000029	1-24						Highly conserved genes and their use to generate probes and primers for detection of microorganisms - Patent application	www.faqs.org	0	0		
694	chr11	14386503	14386530	3500205565	23		14386503	14386530	8421504	3	14,4,5	0,15,22	g	350020556500000039	1-24						HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE PROBES AND PRIMERS FOR DETECTION OF MICROORGANISMS - Patent application	www.faqs.org	0	0		
695	chr11	14450420	14450444	3500363548	23		14450420	14450444	8421504	2	9,14	0,10	g	350036354800000003	1-24				1556-6811	Clinical and Diagnostic Laboratory Immunology	Antigenic Structure of the Nucleocapsid Protein of Porcine Reproductive and Respiratory Syndrome Virus	Wootton	1998	3		
695	chr11	14450420	14450444	3500244169	23		14450420	14450444	8421504	2	9,14	0,10	g	350024416900000003	1-24					Clinical and Diagnostic Laboratory Immunology	Antigenic Structure of the Nucleocapsid Protein of Porcine Reproductive and Respiratory Syndrome Virus	Sarah	1998	0		
695	chr11	14463250	14463343	3500389626	93		14463250	14463343	8421504	1	93	0	p	350038962600015018	0-93						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		ADD2
695	chr11	14478783	14478876	3500360396	93		14478783	14478876	8421504	1	93	0	p	350036039600015000	0-93		10516168			American Journal of Physiology - Heart and Circulatory Physiology	Evidence for an interaction between adducin and Na+-K+-ATPase: relation to genetic hypertension	Ferrandi	1999	0		
695	chr11	14478783	14478876	3500236366	93		14478783	14478876	8421504	1	93	0	p	350023636600015000	0-93		10516168			American Journal of Physiology - Heart and Circulatory Physiology	Evidence for an interaction between adducin and Na+-K+-ATPase: relation to genetic hypertension	Ferrandi	1999	0		
695	chr11	14478783	14478876	3500132724	93		14478783	14478876	8421504	1	93	0	p	350013272400015000	0-93		10516168			American Journal of Physiology - Heart and Circulatory Physiology	Evidence for an interaction between adducin and Na+-K+-ATPase: relation to genetic hypertension	Ferrandi	1999	0		
697	chr11	14694509	14694532	3500107470	23		14694509	14694532	8421504	1	23	0	g	350010747000000759	24-47						Transmembrane protein amigo and uses thereof - Patent application	www.faqs.org	0	0		
697	chr11	14698400	14698426	3500443188	23		14698400	14698426	8421504	2	18,5	0,21	g	350044318800000034	13-36						Family GH-61 polypeptides - Patent # 7273738 - PatentGenius	.patentgenius.com	0	0		
697	chr11	14708902	14708925	3500129722	23		14708902	14708925	8421504	1	23	0	g	350012972200000008	0-23			10.1128/MCB.25.6.2419-2430.2005		Molecular and Cellular Biology	p21WAF1/CIP1 Selectively Controls the Transcriptional Activity of Estrogen Receptor &#x03b1;	Asmaa	2005	0		
697	chr11	14794895	14794923	3500154516	26		14794895	14794923	8421504	2	5,21	0,7	g	350015451600000004	5-31						Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor	al.physiology.org	0	0		
698	chr11	14817294	14817317	3500464835	23		14817294	14817317	8421504	1	23	0	g	350046483500000002	6-29		18362890	10.1038/onc.2008.66	0950-9232	Oncogene	Threonine 74 of MOB1 is a putative key phosphorylation site by MST2 to form the scaffold to activate nuclear Dbf2-related kinase 1	Hirabayashi	2008	6		
87	chr11	14904885	14955702	3500085562	326		14904885	14955702	8421504	8	48,47,47,47,48,41,17,31	0,9747,11339,16401,22704,31901,47926,50786	c	350008556200000415,350008556200000400,350008556200000393,350008556200000387,350008556200000375,350008556200000360,350008556200000339	0-48,0-47,0-47,0-47,0-48,0-41,0-48						Methods and compositions for assaying analytes	Yuan	1999	0		
87	chr11	14938197	14959303	3500072483	40		14938197	14959303	8421504	2	20,20	0,21086	c,g	350007248300000203,350007248300000506	12-35,9-29						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
87	chr11	15067615	15106217	3500054944	70		15067615	15106217	8421504	3	11,29,30	0,8534,38572	c,g	350005494400000067,350005494400000061	8-48,18-48						Steroid 5A-reductases	Andersson	1995	0		
701	chr11	15253865	15253892	3500367106	27		15253865	15253892	8421504	1	27	0	g	350036710600000005	0-27						Quantitative Transcription Factor Binding Kinetics at the Single-Molecule Level	www.princeton.edu	0	0		
701	chr11	15253899	15253923	3500103434	24		15253899	15253923	8421504	1	24	0	g	350010343400000030,350010343400000241	0-24,0-24						PRODUCTION OF ODD CHAIN FATTY ACID DERIVATIVES IN RECOMBINANT MICROBIAL CELLS - Patent application	www.faqs.org	0	0		
701	chr11	15253904	15253929	3500330844	25		15253904	15253929	8421504	1	25	0	g	350033084400000010,350033084400000003	8-33,7-32						Production and use of multimeric hemoglobins	Anderson	1993	0		
703	chr11	15579705	15579753	3500052099	48		15579705	15579753	8421504	1	48	0	c	350005209900000136	0-48						Card Domain Containing Polypeptides, Encoding Nucleic Acids, And Methods Of Use 	.freshpatents.com	0	0		
703	chr11	15579987	15580015	3500033254	24		15579987	15580015	8421504	2	14,10	0,18	c	350003325400000174	7-31						METHODS AND COMPOSITIONS FOR THE RESPONSE PREDICTION OF MALIG-NANT NEOPLASIA TO TREATMENT - BAYER HEALTHCARE AG	www.sumobrain.com	0	0		
705	chr11	15768200	15768233	3500459021	29		15768200	15768233	8421504	2	9,20	0,13	g	350045902100000652	11-42						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
705	chr11	15786934	15787975	3500404944	40		15786934	15787975	8421504	2	20,20	0,1021	c,g	350040494400000028,350040494400000028,350040494400000029	0-20,0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
705	chr11	15847315	15847339	3500313649	24		15847315	15847339	8421504	1	24	0	c	350031364900000005	0-24		18239605	10.1038/gt.2008.6	0969-7128	Gene Therapy	Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil	Chu	2008	4		
706	chr11	15939379	15939405	3500461096	25		15939379	15939405	8421504	2	8,17	0,9	g	350046109600000077,350046109600000039	0-24,0-25						2 Eigene Originalarbeiten (A1-A15)	thek.uni-halle.de	0	0		
709	chr11	16256998	16257022	3500199741	23		16256998	16257022	8421504	2	5,18	0,6	g	350019974100000021	4-27						a1 subunit of nicotinic acetylcholine receptors in the inner ear: transcriptional regulation by ATOH1 and co-expression with the c subunit in hair cells	y.med.harvard.edu	0	0		
709	chr11	16377986	16378014	3500202148	27		16377986	16378014	8421504	2	5,22	0,6	g	350020214800000000	4-31		11160716	10.1128/JVI.75.5.2119-2129.2001	0022-538X	Journal of Virology	Self-Assembly of Nucleocapsid-Like Particles from Recombinant Hepatitis C Virus Core Protein	Kunkel	2001	5		
710	chr11	16395368	16395449	3500398670	49		16395368	16395449	8421504	2	27,22	0,59	c	350039867000000008,350039867000000030	9-36,10-32						Article	jcb.rupress.org	0	0		LTBP1
711	chr11	16565859	16574045	3500398670	29		16565859	16574045	8421504	2	16,13	0,8173	c	350039867000000043	9-38						Article	jcb.rupress.org	0	0		
711	chr11	16644879	16644903	3500300543	23		16644879	16644903	8421504	2	15,8	0,16	g	350030054300000042	3-27						UNIVERSITE HENRI POINCARE, NANCY 1	.scd.uhp-nancy.fr	0	0		
713	chr11	16878120	16878153	3500398670	33		16878120	16878153	8421504	1	33	0	c	350039867000000017	12-45						Article	jcb.rupress.org	0	0		
719	chr11	17638165	17638189	3500370698	23		17638165	17638189	8421504	2	7,16	0,8	g	350037069800000007	2-25						Identification and molecular characterisation of salivary metalloproteases expressed in the tick salivary glands	Decrem	2009	0		
724	chr11	18339209	18339232	3500049740	23		18339209	18339232	8421504	1	23	0	g	350004974000000000	3-26						MONITORAMENTO SOROL&#xd3;GICO E DA PRESEN&#xc7;A DO DNA PR&#xd3;-VIRAL DO LENTIV&#xcd;RUS CAPRINO (CAEV) NO SANGUE E S&#xca;MEN DE REPRODUTORES INFECTADOS	cnptia.embrapa.br	0	0		
730	chr11	19120086	19120114	3500197600	24		19120086	19120114	8421504	3	6,13,5	0,7,23	g	350019760000000009	0-29		19723873	10.1158/1541-7786.MCR-09-0082	1541-7786	Molecular Cancer Research	CCAAT Enhancer Binding Protein-&#x03b2; Regulates Matrix Metalloproteinase-1 Expression in Interleukin-1&#x03b2;&#x2013;Stimulated A549 Lung Carcinoma Cells	Armstrong	2009	4		
735	chr11	19703382	19703414	3500300591	26		19703382	19703414	8421504	3	8,14,4	0,13,28	g	350030059100000670	3-29						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
735	chr11	19749455	19749482	3500461857	24		19749455	19749482	8421504	2	18,6	0,21	g	350046185700000004	0-24						Targeted expression of Cre recombinase provokes placental-specific DNA recombination in transgenic mice. - ResearchGate	.researchgate.net	0	0		
735	chr11	19749455	19749482	3500127570	24		19749455	19749482	8421504	2	18,6	0,21	g	350012757000000004	0-24		22363401	10.1371/journal.pone.0029236	1932-6203	PLOS ONE	PLOS ONE: Targeted Expression of Cre Recombinase Provokes Placental-Specific DNA Recombination in Transgenic Mice	Zhou	2012	4		
737	chr11	19929310	19970402	3500407720	23		19929310	19970402	8421504	3	4,6,13	0,41071,41079	c	350040772000000062	25-48						US Patent # 5,935,824. Protein expression system - Patents.com	www.patents.com	0	0		
92	chr11	20046203	20055667	3500068155	25		20046203	20055667	8421504	3	12,7,6	0,9449,9458	c	350006815500000169	9-39						AMPLIFICATION DYNAMICS OF PRIMATE RETROTRANSPOSONS	etd.lsu.edu	0	0		
739	chr11	20207125	20207149	3500429620	24		20207125	20207149	8421504	1	24	0	g	350042962000000055	0-24						Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof	Luke	2006	0		HEATR5B
740	chr11	20342013	20346301	3500125041	64		20342013	20346301	8421504	3	25,19,20	0,35,4268	c,g	350012504100000003,350012504100000003,350012504100000002,350012504100000002,350012504100000010,350012504100000009,350012504100000009	0-25,0-25,0-25,0-25,0-19,0-20,0-20			10.1099/vir.0.81820-0	0022-1317	Journal of General Virology	The double-stranded RNA-induced apoptosis pathway is involved in the cytopathogenicity of cytopathogenic Bovine viral diarrhea virus	Yamane	2006	3		
741	chr11	20449050	20451841	3500341913	45		20449050	20451841	8421504	2	20,25	0,2766	p	350034191300015022	0-45						Protein Kinases 	.freshpatents.com	0	0		PRKD3
745	chr11	21022389	21022421	3500247350	26		21022389	21022421	8421504	3	5,15,6	0,8,26	g	350024735000000098	18-44						Modified factor VIII	J*S*Luo La 	2003	0		
748	chr11	21385617	21385646	3500022166	28		21385617	21385646	8421504	2	7,21	0,8	g	350002216600000167	16-45						Identification of polycystic kidney disease gene, diagnostics and treatment	Reeders	1995	0		
748	chr11	21396154	21396177	3500408194	23		21396154	21396177	8421504	1	23	0	g	350040819400000064	2-28						ENHANCEMENT OF BACILLUS THURINGIENSIS CRY PROTEIN TOXICITIES TO COLEOPTERANS, AND NOVEL INSECT CADHERIN FRAGMENTS - Patent application	www.faqs.org	0	0		
750	chr11	21715604	21715676	3500249582	41		21715604	21715676	8421504	2	21,20	0,52	c	350024958200000027,350024958200000026	0-21,0-20		12134042	10.1128/JVI.76.16.8383-8399.2002	0022-538X	Journal of Virology	Kaposi's Sarcoma-Associated Herpesvirus-Induced Upregulation of the c-kit Proto-Oncogene, as Identified by Gene Expression Profiling, Is Essential for the Transformation of Endothelial Cells	Moses	2002	5		
751	chr11	21775125	21775155	3500376849	26		21775125	21775155	8421504	3	12,8,6	0,14,24	g	350037684900000483,350037684900000256	0-30,1-31						Methods for enhancing antibody-induced cell lysis and treating cancer	Weiner	2001	0		
751	chr11	21775125	21775155	3500361339	26		21775125	21775155	8421504	3	12,8,6	0,14,24	g	350036133900000728,350036133900000188,350036133900000189	0-30,0-30,1-31						US Patent # 7,271,156. Immunostimulatory nucleic acids - Patents.com	www.patents.com	0	0		
751	chr11	21775125	21775155	3500237781	26		21775125	21775155	8421504	3	12,8,6	0,14,24	g	350023778100000256,350023778100000483	1-31,0-30					Patent	Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. (Patent EP:1296714)	Hartmann	2009	0		
751	chr11	21775125	21775155	3500237369	26		21775125	21775155	8421504	3	12,8,6	0,14,24	g	350023736900000487,350023736900000260	0-30,1-31						Methods for enhancing antibody-induced cell lysis and treating cancer	Weiner	2001	0		
751	chr11	21775125	21775155	3500111091	26		21775125	21775155	8421504	3	12,8,6	0,14,24	g	350011109100000736,350011109100000854,350011109100000855	0-30,0-30,1-31						IMMUNOSTIMULATORY NUCLEIC ACIDS - Patent application	www.faqs.org	0	0		
751	chr11	21775125	21775155	3500091043	26		21775125	21775155	8421504	3	12,8,6	0,14,24	g	350009104300000483,350009104300000256	0-30,1-31					Patent	Methods for enhancing antibody-induced cell lysis and treating cancer (Patent US:7534772)	Weiner	2009	0		
752	chr11	21981069	21981096	3500003440	26		21981069	21981096	8421504	2	15,11	0,16	c	350000344000000050	1-28						Ornithobacterium Rhinotracheale Subunit Vaccines 	.freshpatents.com	0	0		
754	chr11	22231940	22231967	3500463282	24		22231940	22231967	8421504	3	12,3,9	0,13,18	g	350046328200000005	10-34						CUSTOM MICROARRAY ANALYSIS PIPELINE Perl scripts and file formats	theileria.org	0	0		
755	chr11	22328733	22328757	3500465579	23		22328733	22328757	8421504	2	14,9	0,15	g	350046557900000006	0-23		7538129	10.1074/jbc.270.20.11977	0021-9258	Journal of Biological Chemistry	Identification of a Second Region Upstream of the Mouse Heme Oxygenase-1 Gene That Functions as a Basal Level and Inducer-dependent Transcription Enhancer	Alam	1995	5		
756	chr11	22434936	22437635	3500071364	50		22434936	22437635	8421504	2	25,25	0,2674	c	350007136400000020,350007136400000021	0-25,0-25			10.1128/JVI.02471-05		Journal of Virology	Identification of a Novel Human Immunodeficiency Virus Type 1 Integrase Interactor, Gemin2, That Facilitates Efficient Viral cDNA Synthesis In Vivo	Seiji	June	0		GEMIN6
756	chr11	22511425	22511450	3500319134	23		22511425	22511450	8421504	2	17,6	0,19	c	350031913400000009	0-23		12748124	10.1095/biolreprod.103.017103	0006-3363	Biology of Reproduction	Class II Transactivator (CIITA) Promoter Methylation Does Not Correlate with Silencing of CIITA Transcription in Trophoblasts	Holtz	2003	4		
757	chr11	22606055	22606082	3500232864	25		22606055	22606082	8421504	3	12,4,9	0,13,18	g	350023286400000001	0-25						Acquisition of selective antitumoral effects of recombinant adeno-associated virus by genetically inserting tumor-targeting peptides into capsid proteins	-publications.com	0	0		
759	chr11	22877889	22928182	3500441703	106		22877889	22928182	8421504	4	21,21,32,32	0,46837,47503,50261	p,c,g	350044170300000053,350044170300000051,350044170300000051,350044170300000052,350044170300015021	0-21,0-21,0-21,0-23,0-45						STE20-RELATED PROTEIN KINASES	Plowman	1999	0		
759	chr11	22877889	22928182	3500028732	106		22877889	22928182	8421504	4	21,21,32,32	0,46837,47503,50261	p,c,g	350002873200000053,350002873200000051,350002873200000051,350002873200000052,350002873200015019	0-21,0-21,0-21,0-23,0-45					Patent	Polypeptide fragments of human PAK5 protein kinase (Patent US:6656716)	Plowman	2003	0		MAP4K3
759	chr11	22877889	22925415	3500055432	65		22877889	22925415	8421504	3	21,21,23	0,46837,47503	c,g	350005543200000053,350005543200000137,350005543200000051,350005543200000051,350005543200000135,350005543200000135,350005543200000052,350005543200000136	0-21,0-21,0-21,0-21,0-21,0-21,0-23,0-23						Polynucleotides encoding STE20-related protein kinases and methods of use	Plowman	1999	0		MAP4K3
759	chr11	22877889	22925415	3500018915	65		22877889	22925415	8421504	3	21,21,23	0,46837,47503	c,g	350001891500000048,350001891500000046,350001891500000046,350001891500000047	0-21,0-21,0-21,0-23						Ste20-related protein kinases	Martinez	2003	0		
759	chr11	22924726	22925415	3500236894	44		22924726	22925415	8421504	2	21,23	0,666	c,g	350023689400000051,350023689400000051,350023689400000135,350023689400000135,350023689400000052,350023689400000136	0-21,0-21,0-21,0-21,0-23,0-23						US Patent # 6,656,716. Polypeptide fragments of human PAK5 protein kinase - Patents.com	www.patents.com	0	0		MAP4K3
759	chr11	22924726	22925415	3500058132	44		22924726	22925415	8421504	2	21,23	0,666	c,g	350005813200000135,350005813200000135,350005813200000051,350005813200000051,350005813200000136,350005813200000052	0-21,0-21,0-21,0-21,0-23,0-23						Polypeptide fragments of human PAK5 protein kinase	Plowman	2000	0		MAP4K3
760	chr11	22947642	22947667	3500005476	24		22947642	22947667	8421504	2	18,6	0,19	g	350000547600000002	4-28				0798-2259	Revista Cient&#xed;fica	Revista Cient&#xed;fica - Importance of parentage verification-assignment in extensive multiple-sired breeding herds	Arellano-Vera	2010	0		
95	chr11	23723801	24078147	3500156280	1689		23723801	24078147	8421504	29	36,51,30,54,20,16,36,21,47,52,42,131,10,33,37,24,20,100,29,10,173,66,39,387,36,54,63,27,45	0,87,201,297,354,42478,42551,42626,42707,70553,70611,74826,80030,84410,84478,87745,87777,87805,87906,87936,352646,353182,353260,353308,353944,354046,354103,354238,354301	p,g	350015628000015010,350015628000000004,350015628000000001,350015628000015009,350015628000015007,350015628000015006,350015628000015005	0-672,10-81,0-89,3-180,0-492,0-180,90-135						Mutually exclusive and cassette exons underlie alternatively spliced isoforms of the Na/Ca exchanger. - ResearchGate	.researchgate.net	0	0		SLC8A1
766	chr11	23724167	23766294	3500096175	23		23724167	23766294	8421504	2	8,15	0,42112	c	350009617500000045	0-23						ECOLE DOCTORALE DES SCIENCES DE LA VIE ET DE LA SANTE	hives-ouvertes.fr	0	0		
767	chr11	23976545	23976570	3500049566	23		23976545	23976570	8421504	3	4,13,6	0,5,19	g	350004956600000146	13-42					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
767	chr11	23983484	23983507	3500361666	23		23983484	23983507	8421504	1	23	0	g	350036166600000339,350036166600000150	0-23,0-23						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
767	chr11	23983484	23983507	3500156510	23		23983484	23983507	8421504	1	23	0	g	350015651000000150	0-23						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
768	chr11	24007789	24007815	3500452101	24		24007789	24007815	8421504	2	12,12	0,14	g	350045210100000011	0-24		15466486	10.1101/gad.1234304	0890-9369	Genes & Development	A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation	Penn	2004	12		
768	chr11	24077436	24077496	3500227830	60		24077436	24077496	8421504	1	60	0	p	350022783000015000	0-60						Differences in Expression and Function in the Atrium versus Ventricle of the Sodium-Calcium Exchanger in the Embryonic Chicken Heart	loads.hindawi.com	0	0		SLC8A1
768	chr11	24078151	24078186	3500064667	35		24078151	24078186	8421504	1	35	0	c	350006466700000001,350006466700000000	0-41,0-41		21187336	10.1085/jgp.201010468		The Journal of General Physiology	Massive calcium&#x2013;activated endocytosis without involvement of classical endocytic proteins	Vincenzo	2011	0		
768	chr11	24078154	24078180	3500392495	26		24078154	24078180	8421504	1	26	0	c	350039249500000012	0-26		21486818	10.1113/jphysiol.2010.201400	0022-3751	The Journal of Physiology	Ca2+&#x2013;calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel &#x03b1;1C-subunit gene (Cacna1c) by DREAM translocation	Ronkainen	2011	5		
768	chr11	24078154	24078180	3500198536	26		24078154	24078180	8421504	1	26	0	c	350019853600000012	0-26		21486818	10.1113/jphysiol.2010.201400		The Journal of Physiology	Ca2+&#x2013;calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel &#x03b1;1C-subunit gene (Cacna1c) by DREAM translocation	Jarkko	June	0		
768	chr11	24078154	24078180	3500118285	26		24078154	24078180	8421504	1	26	0	c	350011828500000012	0-26		21486818	10.1113/jphysiol.2010.201400	0022-3751	The Journal of Physiology	Ca2+&#x2013;calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel &#x03b1;1C-subunit gene (Cacna1c) by DREAM translocation	Ronkainen	2011	5		
770	chr11	24337046	24337073	3500338349	23		24337046	24337073	8421504	2	7,16	0,11	g	350033834900000012	4-29						Emm and Emm-like Pharyngeal Streptococcal Isolates: Results	www.medscape.com	0	0		
772	chr11	24614559	24614584	3500400238	23		24614559	24614584	8421504	2	14,9	0,16	g	350040023800000532	7-30						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
775	chr11	24910414	24910438	3500420363	24		24910414	24910438	8421504	1	24	0	g	350042036300000007,350042036300000000	13-37,13-37						Jennifer Bohls thesis Final edits July 8	hsl.umaryland.edu	0	0		
775	chr11	24910414	24910438	3500241652	24		24910414	24910438	8421504	1	24	0	g	350024165200000000	11-35						Modified antibody with enhanced bioactivity	MASUHO	2009	0		
775	chr11	24910414	24910438	3500049159	24		24910414	24910438	8421504	1	24	0	g	350004915900000022	4-28						Bee venom protein and gene encoding same - US Patent 6395306 Description	ww.patentstorm.us	0	0		
777	chr11	25225764	25225791	3500463282	25		25225764	25225791	8421504	2	12,13	0,14	g	350046328200000003	0-27						CUSTOM MICROARRAY ANALYSIS PIPELINE Perl scripts and file formats	theileria.org	0	0		
784	chr11	26091162	26093157	3500070832	93		26091162	26093157	8421504	3	45,32,16	0,93,1979	c	350007083200000008,350007083200000010	0-45,0-48						EML4-ALK fusion gene - Patent # 7605131 - PatentGenius	.patentgenius.com	0	0		
784	chr11	26109272	26109299	3500021662	23		26109272	26109299	8421504	2	8,15	0,12	g	350002166200000380	8-34						FLAVIVIRUS IMMUNOGENS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
785	chr11	26326705	26329486	3500264245	43		26326705	26329486	8421504	2	22,21	0,2760	c,g	350026424500000014,350026424500000015,350026424500000015	0-22,0-21,0-21		18089822	10.1158/0008-5472.CAN-07-1868	0008-5472	Cancer Research	Induction of Apoptosis in Plasma Cells by B Lymphocyte&#x2013;Induced Maturation Protein-1 Knockdown	Lin	2007	8		MTA3
786	chr11	26355964	26355988	3500155898	23		26355964	26355988	8421504	2	7,16	0,8	c	350015589800000291	17-40						Heparin-binding growth factors for gene therapy and anterior eye disorders	Sosnowski	1995	0		
788	chr11	26635965	26635993	3500303084	24		26635965	26635993	8421504	2	11,13	0,15	g	350030308400000082	9-33						Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof	Alvaro	1994	0		
791	chr11	27056587	27056611	3500234586	24		27056587	27056611	8421504	1	24	0	g	350023458600000068	0-25						Compounds and methods for development of Ret modulators	Artis	2007	0		
792	chr11	27147190	27147213	3500288204	23		27147190	27147213	8421504	1	23	0	g	350028820400000039	14-37						Molecular mechanisms of the human pathogen	uni-goettingen.de	0	0		CNTNAP2
792	chr11	27209473	27209498	3500308409	24		27209473	27209498	8421504	2	16,8	0,17	g	350030840900000000	0-24		20527045	10.1002/jgm.1463		The journal of gene medicine	Optimization of Enzyme-Substrate Pairing for Bioluminescence Imaging of Gene Transfer Using Renilla and Gaussia Luciferases	Takahiro	June	0		
794	chr11	27459173	27459199	3500432568	23		27459173	27459199	8421504	2	16,7	0,19	c	350043256800000028	19-42						 VMP 	www.docstoc.com	0	0		
794	chr11	27459173	27459199	3500396369	23		27459173	27459199	8421504	2	16,7	0,19	c	350039636900000040	19-42						 VMP 	www.docstoc.com	0	0		
794	chr11	27460173	27510058	3500243191	331		27460173	27510058	8421504	11	34,2,47,1,29,48,18,29,47,32,44	0,5725,13070,14840,19657,30038,43150,43628,43990,49565,49841	c	350024319100000120,350024319100000099,350024319100000093,350024319100000090,350024319100000140,350024319100000146,350024319100000166,350024319100000170	6-42,0-48,19-48,0-48,0-47,1-48,0-32,0-44						ABCG8 vectors, host cells, and method of making	Hobbs	2001	0		
794	chr11	27490233	27490259	3500265379	26		27490233	27490259	8421504	1	26	0	c	350026537900000000	0-26						>	ww.leeshulman.net	0	0		ABCG5
794	chr11	27490235	27490259	3500334700	24		27490235	27490259	8421504	1	24	0	c	350033470000000153	24-48						'cause 'cause IN 257 'd 'd MD 11481 'd 'd NNP 2166 'em 'em NNP 15 'em 'em PRP 586 'll 'll MD 13	cs.cmu.edu/afs/cs	0	0		
794	chr11	27490235	27490259	3500227847	24		27490235	27490259	8421504	1	24	0	c	350022784700000000	0-24						'pokemon heard gold dowloat : pokemon heartgold dns celebi' 'pokemon heartgold map sprites'	rabian-center.org	0	0		ABCG5
795	chr11	27604232	27604258	3500179502	23		27604232	27604258	8421504	3	4,14,5	0,5,21	g	350017950200000027	19-42						PREVENTIVE AND THERAPEUTIC VACCINE FOR STORKE AND NEUROLOGICAL DISORDERS - Patent application	www.faqs.org	0	0		
796	chr11	27681370	27681398	3500123819	23		27681370	27681398	8421504	3	13,5,5	0,16,23	g	350012381900000012	1-24						Use of a Serotype-Specific DNA Microarray for Identification of Group B Streptococcus Streptococcus agalactiae	jcm.asm.org	0	0		
797	chr11	27811115	27811163	3500346242	48		27811115	27811163	8421504	1	48	0	p	350034624200015014	0-48						Alkenyl Substituted Cycloaliphatic Compounds as Chemical Inducers of Proximity - Patent application	www.faqs.org	0	0		PPM1B
797	chr11	27825253	27835874	3500245940	78		27825253	27835874	8421504	2	57,21	0,10600	p	350024594000015130	0-78						Secreted protein HCEJQ69	Brewer	2003	0		
797	chr11	27868921	27901761	3500102291	112		27868921	27901761	8421504	4	20,48,21,23	0,7587,27250,32817	c	350010229100000300,350010229100000317,350010229100000333	0-20,0-48,0-44						Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods	Alvarez	2000	0		
797	chr11	27907985	27908008	3500234906	23		27907985	27908008	8421504	1	23	0	g	350023490600000015	3-26						Adenovirus particles with mutagenized fiber proteins	Hallenbeck	2001	0		
801	chr11	28397860	28397884	3500284039	23		28397860	28397884	8421504	2	8,15	0,9	g	350028403900000077	8-31						Rapid Evolution of Diversity in the Root Nodule Bacteria of Biserrula pelecinus L.	ry.murdoch.edu.au	0	0		
802	chr11	28547389	28547433	3500070224	32		28547389	28547433	8421504	2	10,22	0,22	c	350007022400000000	19-51						GenerationofInducedPluripotentStemCellsfromHuman RenalProximalTubularCellswithOnlyTwoTranscription Factors, and Sox2 S	www.salk.edu	0	0		
802	chr11	28547878	28548058	3500331473	180		28547878	28548058	8421504	1	180	0	p	350033147300015009,350033147300015010,350033147300015011	0-60,0-60,0-60						Six3, a murine homologue of the sine oculisgene, demarcates the most anterior border of the developing neural plate and is expressed during eye development	ev.biologists.org	0	0		
802	chr11	28547944	28550059	3500439018	40		28547944	28550059	8421504	2	20,20	0,2095	c,g	350043901800000002,350043901800000003,350043901800000003	0-20,0-20,0-20						COMPOSITIONS FOR INDUCING DIFFERENTIATION INTO RETINAL CELLS FROM RETINAL PROGENITOR CELLS OR INDUCING PROLIFERATION OF RETINAL CELLS COMPRISING WNT SIGNALING PATHWAY ACTIVATORS	Park	2010	0		SIX3
802	chr11	28548022	28550083	3500155991	58		28548022	28550083	8421504	2	29,29	0,2032	c	350015599100000007,350015599100000006	0-29,0-29		23977152	10.1371/journal.pone.0071816	1932-6203	PLOS ONE	PLOS ONE: Down-Regulation of SIX3 is Associated with Clinical Outcome in Lung Adenocarcinoma	Mo	2013	4		
802	chr11	28548085	28549950	3500180675	57		28548085	28549950	8421504	2	2,55	0,1810	p	350018067500015003	0-57		20534668	10.1242/dev.045294	0950-1991	Development	Proper differentiation of photoreceptors and amacrine cells depends on a regulatory loop between NeuroD and Six6	Conte	2010	7		SIX3
802	chr11	28550067	28550090	3500466793	23		28550067	28550090	8421504	1	23	0	c,g	350046679300000011,350046679300000011	0-23,0-23		19570849	10.1242/dev.031344		Development (Cambridge, England)	Morphogenesis and cytodifferentiation of the avian retinal pigmented epithelium require downregulation of Group B1 Sox genes	Yasuo	2009	0		SIX3
802	chr11	28550067	28550090	3500383629	23		28550067	28550090	8421504	1	23	0	c,g	350038362900000011,350038362900000011	0-23,0-23		19570849	10.1242/dev.031344	0950-1991	Development	Morphogenesis and cytodifferentiation of the avian retinal pigmented epithelium require downregulation of Group B1 Sox genes	Ishii	2009	7		SIX3
802	chr11	28550067	28550090	3500132940	23		28550067	28550090	8421504	1	23	0	c	350013294000000012	0-23						Development 136, 2579-2589 (2009) doi:10.1242/dev.031344 Morphogenesis and cytodifferentiation of the avian retinal pigmented epithelium require downregulation of Group B1 Sox genes	ev.biologists.org	0	0		SIX3
803	chr11	28602952	28602979	3500107506	23		28602952	28602979	8421504	2	7,16	0,11	g	350010750600000150	1-25						METHOD FOR PRODUCING L-BETA-LYSINE - Patent application	www.faqs.org	0	0		
803	chr11	28607159	28607225	3500331473	66		28607159	28607225	8421504	1	66	0	p	350033147300015026	0-66						Six3, a murine homologue of the sine oculisgene, demarcates the most anterior border of the developing neural plate and is expressed during eye development	ev.biologists.org	0	0		SIX2
804	chr11	28820296	28820320	3500173273	23		28820296	28820320	8421504	2	15,8	0,16	g	350017327300000069	4-27						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT	Murphy	2009	0		
806	chr11	29063304	29063330	3500226292	26		29063304	29063330	8421504	1	26	0	c	350022629200000007	6-32						MolecularConsequencesoftheACVR1R206H Mutationof FibrodysplasiaOssificansProgressiva S	www.jbc.org	0	0		FKBP1A
12	chr11	29242467	29778088	3500165258	2211		29242467	29778088	8421504	15	348,64,160,35,86,130,143,97,200,174,155,139,189,147,144	0,210116,343146,345371,346761,349930,363828,367585,370316,373111,450006,500373,506602,510284,535477	p	350016525800015016	0-2211						T3DB: Showing Lead subacetate (T3D1331)	classic.t3db.org	0	0		PRKCE
12	chr11	29242467	29452616	3500088069	264		29242467	29452616	8421504	3	183,48,33	0,300,210116	p	350008806900015017,350008806900015031	33-216,0-81						UNIVERSIDAD DE MURCIA DEPARTAMENTO DE BIOQUAMICA Y BIOLOGAA MOLECULAR (A) ESTUDIO DE LA ESTRUCTUR	www.tdx.cat	0	0		PRKCE
808	chr11	29242467	29242490	3500408321	23		29242467	29242490	8421504	1	23	0	c,g	350040832100000000,350040832100000000	0-23,0-23						RESEARCH Open Access The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma	www.jeccr.com	0	0		PRKCE
808	chr11	29242467	29242490	3500405090	23		29242467	29242490	8421504	1	23	0	c	350040509000000000	0-23						The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma	.researchgate.net	0	0		PRKCE
808	chr11	29242467	29242490	3500181595	23		29242467	29242490	8421504	1	23	0	c	350018159500000000	0-23		21955404	10.1186/1756-9966-30-88	1756-9966	Journal of Experimental & Clinical Cancer Research	The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma	Huang	2011	2		PRKCE
808	chr11	29242477	29242501	3500453649	24		29242477	29242501	8421504	1	24	0	c	350045364900000004	0-24		15755899	10.1182/blood-2004-12-4794	0006-4971	Blood	NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia	Lin	2005	10		PRKCE
808	chr11	29313546	29313571	3500144411	23		29313546	29313571	8421504	2	10,13	0,12	g	350014441100000066	4-30						Tumor-Targeting Monoclonal Antibodies to FZD10 and Uses Thereof - Patent application	www.faqs.org	0	0		
808	chr11	29333558	29333586	3500058951	23		29333558	29333586	8421504	2	9,14	0,14	g	350005895100000105	15-38						Collagen and uses therefor	Olsen	1993	0		
810	chr11	29615638	29615686	3500184860	48		29615638	29615686	8421504	1	48	0	p	350018486000015000	0-48		16288040	10.1158/0008-5472.CAN-05-1989	0008-5472	Cancer Research	Identification of an Inactivating Cysteine Switch in Protein Kinase C&#x03b5;, a Rational Target for the Design of Protein Kinase C&#x03b5;&#x2013;Inhibitory Cancer Therapeutics	Chu	2005	8		PRKCE
811	chr11	29633319	29633343	3500165538	23		29633319	29633343	8421504	2	19,4	0,20	g	350016553800000022	0-26						Detection of proteins based on amino acid sequences by multiple aptamers against tripeptides	iotechnology.info	0	0		
811	chr11	29742892	29742916	3500303084	24		29742892	29742916	8421504	1	24	0	c	350030308400000077	21-45						Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof	Alvaro	1994	0		
101	chr11	29752769	29778196	3500264907	160		29752769	29778196	8421504	8	35,26,7,7,3,23,41,18	0,60,89,104,126,25175,25282,25409	c	350026490700000080	304-580						Eucaryotic cells transformed with a mammalian phospholipid kinase or protein kinase and assays using them	Goode	1994	0		
812	chr11	29778037	29778088	3500381344	51		29778037	29778088	8421504	1	51	0	p	350038134400015000	0-51		12427847		0270-6474	The Journal of Neuroscience	Conditional Rescue of Protein Kinase C &#x03b5; Regulates Ethanol Preference and Hypnotic Sensitivity in Adult Mice	Choi	2002	7		PRKCE
813	chr11	29941927	29941957	3500212475	25		29941927	29941957	8421504	2	12,13	0,17	g	350021247500000225	2-31						CELLS AND METHODOLOGY TO GENERATE NON-SEGMENTED NEGATIVE-STRAND RNA VIRUSES - Patent application	www.faqs.org	0	0		
813	chr11	29944007	29944030	3500273651	23		29944007	29944030	8421504	1	23	0	c	350027365100000002	0-23						The Role of Hypoxia-Inducible Factor-1 and -2 in Androgen Insensitive Prostate Cancer Cells	logiconcology.org	0	0		EPAS1
813	chr11	29966756	29967310	3500273077	27		29966756	29967310	8421504	2	17,10	0,544	c	350027307700000001	10-37					BMC Cancer	HIF2&#x03b1; reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma - Scolaris	Favier	2007	0		
813	chr11	29966756	29967310	3500074726	27		29966756	29967310	8421504	2	17,10	0,544	c	350007472600000001	10-37					BMC Cancer	 HIF2[alpha] reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma.(Research article)(Clinical report) - BMC Cancer | HighBeam Research 	Favier	2007	0		
815	chr11	30166367	30203066	3500285465	45		30166367	30203066	8421504	3	19,3,23	0,629,36676	c	350028546500000000,350028546500000001	0-22,0-23		12456725	10.1242/jcs.00208	0021-9533	Journal of Cell Science	Small GTPase Tc10 and its homologue RhoT induce N-WASP-mediated long process formation and neurite outgrowth	Abe	2003	6		RHOQ
815	chr11	30198168	30198193	3500185560	23		30198168	30198193	8421504	3	5,4,14	0,6,11	g	350018556000000134	13-36						Family of high affinity, modified antibodies for cancer treatment	Mezes	1993	0		
815	chr11	30198922	30198973	3500378198	51		30198922	30198973	8421504	1	51	0	p	350037819800015002	0-51						TC10 Is Required for Insulin-Stimulated Glucose Uptake in Adipocytes	.endojournals.org	0	0		RHOQ
815	chr11	30203116	30203145	3500450126	29		30203116	30203145	8421504	1	29	0	c	350045012600000002	5-34		20573066	10.1111/j.1600-0854.2010.01091.x	1600-0854	Traffic	Structural Determinants Allowing Endolysosomal Sorting and Degradation of Endosomal GTPases - Valero - 2010 - Traffic - Wiley Online Library	Valero	2010	0		RHOQ
817	chr11	30428600	30429510	3500011698	109		30428600	30429510	8421504	4	16,18,37,38	0,19,384,872	c	350001169800000120,350001169800000112,350001169800000102	0-35,9-46,0-38						Therapeutic and diagnostic agents - US Patent 7279557 Description	ww.patentstorm.us	0	0		
817	chr11	30428984	30429021	3500241928	37		30428984	30429021	8421504	1	37	0	c	350024192800000110	11-48						THERAPEUTIC AND DIAGNOSTIC AGENTS CAPABLE OF MODULATING CELLULAR RESPONSIVENESS TO CYTOKINES - THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH	www.sumobrain.com	0	0		
817	chr11	30429804	30430005	3500376180	201		30429804	30430005	8421504	1	201	0	p	350037618000015002	0-201						Lung Cancer Diagnostic Assay - Patent application	www.faqs.org	0	0		SOCS5
817	chr11	30429804	30430005	3500209076	201		30429804	30430005	8421504	1	201	0	p	350020907600015003	0-201						Lung Cancer Diagnostic Assay	Hirschowitz	2006	0		SOCS5
818	chr11	30563812	30563839	3500175973	25		30563812	30563839	8421504	3	5,16,4	0,6,23	c	350017597300000262	10-35					Patent	DNA encoding the Canine coronavirus spike protein (Patent US:5661006)	Brown	1997	0		
818	chr11	30564434	30564461	3500103754	24		30564434	30564461	8421504	2	8,16	0,11	c,g	350010375400000045,350010375400000045	0-29,0-29						Application # 2006/0150271. Artificial chromosomes, uses thereof and method for preparing artificial chromosomes - Patents.com	www.patents.com	0	0		
818	chr11	30576328	30576353	3500255057	23		30576328	30576353	8421504	2	13,10	0,15	g	350025505700000048	11-35						Virus-like particles and methods of use	Akahata	2012	0		
818	chr11	30622420	30622446	3500464999	23		30622420	30622446	8421504	3	7,5,11	0,8,15	g	350046499900000010	7-33						INTEIN-MODIFIED ENZYMES, THEIR PRODUCTION AND INDUSTRIAL APPLICATIONS - AGRIVIDA, INC.	www.sumobrain.com	0	0		
819	chr11	30688058	30690704	3500446682	23		30688058	30690704	8421504	3	2,7,14	0,2622,2632	c	350044668200000034,350044668200000302	2-25,2-25						Metabolically Engineered Cells For The Production Of Polyunsaturated Fatty Acids 	.freshpatents.com	0	0		
819	chr11	30789809	30790387	3500461725	41		30789809	30790387	8421504	2	21,20	0,558	c	350046172500000012,350046172500000011	0-21,0-20						Peroxisome proliferator-activated receptor-g suppresses CYP11B2 expression and aldosterone production	logy-journals.org	0	0		CALM2
819	chr11	30789814	30790343	3500386988	42		30789814	30790343	8421504	3	4,27,11	0,5,518	c	350038698800000020,350038698800000032,350038698800000004,350038698800000006	7-33,8-34,64-97,22-55						Supporting Online Material for	ww.sciencemag.org	0	0		
102	chr11	30789820	30802059	3500431821	64		30789820	30802059	8421504	5	8,14,22,17,3	0,11,584,6621,12236	c,g	350043182100000031,350043182100000031,350043182100000024,350043182100000025,350043182100000030	0-22,0-22,0-21,0-20,0-20		17804406	10.1074/jbc.M706472200	0021-9258	Journal of Biological Chemistry	Calmodulin Binds and Stabilizes the Regulatory Enzyme, CTP:Phosphocholine Cytidylyltransferase	Chen	2007	5		
819	chr11	30790364	30790445	3500256218	42		30790364	30790445	8421504	2	23,19	0,62	c,g	350025621800000118,350025621800000117,350025621800000117	0-23,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
819	chr11	30790405	30790960	3500145809	93		30790405	30790960	8421504	2	45,48	0,507	p	350014580900015030,350014580900015028	0-45,0-48						Calcium-integrin binding protein	Naik	1998	0		CALM3
819	chr11	30790414	30790918	3500239256	93		30790414	30790918	8421504	2	54,39	0,465	p	350023925600015013	0-93						ANALYTE SENSORS, METHODS FOR PREPARING AND USING SUCH SENSORS, AND METHODS OF DETECTING ANALYTE ACTIVITY - GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.	www.sumobrain.com	0	0		CALM3
819	chr11	30796434	30796458	3500222925	24		30796434	30796458	8421504	1	24	0	c	350022292500000008	18-42						VOLUME 205 E. coli Gene Expression Protocols	jpkc.yzu.edu.cn	0	0		
821	chr11	30986419	30991112	3500381121	119		30986419	30991112	8421504	4	23,48,24,24	0,483,3796,4669	p,c	350038112100000005,350038112100015020,350038112100000016	25-48,0-48,0-48						Soluble variants of type i membrane proteins, and methods of using them	Herlyn	1994	0		
821	chr11	30986758	30986788	3500415882	30		30986758	30986788	8421504	1	30	0	c	350041588200000026	0-30						Identification of markers in lung and breast cancer	Godfrey	2005	0		
821	chr11	30990177	30990201	3500100565	24		30990177	30990201	8421504	1	24	0	c	350010056500000003	0-24						Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets	Kim	2003	0		EPCAM
821	chr11	30993151	30993873	3500318143	33		30993151	30993873	8421504	2	3,30	0,692	c	350031814300000036	0-33						Novel tumor-associated antigens	Apt	2004	0		
821	chr11	30993858	30993882	3500391583	24		30993858	30993882	8421504	1	24	0	c	350039158300000013	0-24						MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE - IMMUNIVEST CORPORATION	www.sumobrain.com	0	0		
821	chr11	30993858	30993882	3500386225	24		30993858	30993882	8421504	1	24	0	c	350038622500000022	0-24						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	S*M*Ao Ha La 	2005	0		
821	chr11	30993858	30993882	3500171619	24		30993858	30993882	8421504	1	24	0	c	350017161900000013	0-24						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2003	0		
821	chr11	30993858	30993882	3500106806	24		30993858	30993882	8421504	1	24	0	c	350010680600000013	0-24						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2004	0		
821	chr11	30993858	30993882	3500100860	24		30993858	30993882	8421504	1	24	0	c	350010086000000013	0-24						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2004	0		
821	chr11	31020627	31020651	3500402055	24		31020627	31020651	8421504	1	24	0	c,g	350040205500000202,350040205500000202,350040205500000462,350040205500000462	0-24,0-24,0-24,0-24						Methods And Kits For Detecting Mutations 	.freshpatents.com	0	0		MSH2
821	chr11	31021375	31021492	3500425671	117		31021375	31021492	8421504	1	117	0	p	350042567100015002	0-117						PowerPoint Presentation	cs.technion.ac.il	0	0		MSH2
821	chr11	31021405	31021486	3500254357	81		31021405	31021486	8421504	1	81	0	p	350025435700015015	0-81						Algoritmo otimizado para compara&#xe7;&#xe3;o de sequ&#xea;ncias e busca em base de dados	pt.scribd.com	0	0		MSH2
821	chr11	31021408	31021489	3500154595	81		31021408	31021489	8421504	1	81	0	p	350015459500015003	0-81						Dynamic Programming and Applications Michael Schatz	chatzlab.cshl.edu	0	0		MSH2
821	chr11	31022693	31022728	3500461116	29		31022693	31022728	8421504	3	5,16,8	0,8,27	g	350046111600000000	3-33						Chimeric Antibody-Binding Vitreoscilla Hemoglobin (VHb) Mediates Redox- Catalysis Reaction: New Insight into the Functional Role of VHb	www.ijbs.com	0	0		
821	chr11	31031684	31050444	3500081021	187		31031684	31050444	8421504	2	186,1	0,18759	c	350008102100000066	13-200						A method for detection of alterations in the dna mismatch repair pathway	Fishel	1995	0		
102	chr11	31050479	31070750	3500409650	81		31050479	31070750	8421504	2	75,6	0,20265	p	350040965000015064	225-306						NPG.nature.vol.407.Issue.6805.Oct	www.scribd.com	0	0		
822	chr11	31078525	31081711	3500224879	39		31078525	31081711	8421504	2	19,20	0,3166	c	350022487900000000,350022487900000001	0-19,0-20						MSH2 disrupted mice develop lymphomas	Mak	1996	0		MSH2
822	chr11	31078635	31079990	3500082872	81		31078635	31079990	8421504	2	52,29	0,1326	p	350008287200015001	0-81						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"> <HTML> <HEAD> <TITLE>npre20093257-1.	edings.nature.com	0	0		MSH2
822	chr11	31078635	31079990	3500073764	81		31078635	31079990	8421504	2	52,29	0,1326	p	350007376400015000	0-81						OICR PL BFFO 080212b	oicr.on.ca/files/	0	0		MSH2
822	chr11	31079999	31081582	3500213328	180		31079999	31081582	8421504	2	167,13	0,1570	p	350021332800015011	0-180						PPT &#x2013; An Example PowerPoint presentation | free to download 	www.powershow.com	0	0		MSH2
822	chr11	31080030	31083449	3500428541	40		31080030	31083449	8421504	2	20,20	0,3399	c	350042854100000030,350042854100000031	0-20,0-20						Developmental Regulation and In Vitro Culture Effects on Expression of DNA Repair and Cell Cycle Checkpoint Control Genes in Rhesus Monkey Oocytes and Embryos1	ww.biolreprod.org	0	0		
822	chr11	31188121	31188144	3500225920	23		31188121	31188144	8421504	1	23	0	g	350022592000000020,350022592000000065	14-37,14-37						METHODS AND MATERIALS FOR GASTROINTESTINAL DELIVERY OF PATHOGEN/TOXIN BINDING AGENTS - Patent application	www.faqs.org	0	0		
823	chr11	31267288	31267316	3500122110	24		31267288	31267316	8421504	2	11,13	0,15	g	350012211000000020	24-48						 DNA Sequence Encoding Human Cystathionine .beta. 	www.docstoc.com	0	0		
824	chr11	31337144	31337169	3500190233	25		31337144	31337169	8421504	1	25	0	c	350019023300000012	0-25		15713769	10.1001/jama.293.7.799	0098-7484	JAMA	 JAMA Network | JAMA | Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer 	Casey	2005	30		
824	chr11	31342253	31342834	3500162179	46		31342253	31342834	8421504	2	26,20	0,561	c,g	350016217900000040,350016217900000043,350016217900000043	18-44,18-38,18-38						Pseudoxanthoma elasticum: evidence for the existence of a pseudogene highly homologous to the ABCC6 gene	jmg.bmj.com	0	0		
824	chr11	31342739	31342767	3500416133	28		31342739	31342767	8421504	1	28	0	c	350041613300000034	2-30						Herstellung und Evaluierung eines Modellsystems zur in vivo Untersuchung der humanen DNA Fehlpaarungsreparatur (mismatch repair - MMR)	etc.tu-bs.de:8080	0	0		
824	chr11	31366462	31455256	3500275596	580		31366462	31455256	8421504	8	48,2,141,55,27,128,157,22	0,3903,3907,4459,4517,4677,88612,88772	c	350027559600000021	0-591						Methods to identify compounds useful for the treatment of proliferative and differentiative disorders - Patent application	www.faqs.org	0	0		
824	chr11	31370411	31370439	3500035109	26		31370411	31370439	8421504	2	16,10	0,18	c	350003510900000154	16-42						METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE - Patent application	www.faqs.org	0	0		FBXO11
829	chr11	32028720	32028753	3500161043	26		32028720	32028753	8421504	3	12,6,8	0,14,25	g	350016104300000391	0-26						PRODUCTION OF SIALYLATED N-GLYCANS IN LOWER EUKARYOTES - Patent application	www.faqs.org	0	0		
829	chr11	32090392	32090415	3500196470	23		32090392	32090415	8421504	1	23	0	c	350019647000000134	0-35						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
830	chr11	32153188	32153404	3500031998	39		32153188	32153404	8421504	2	20,19	0,197	c,g	350003199800000015,350003199800000015,350003199800000016,350003199800000016	0-20,0-20,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
831	chr11	32255649	32255740	3500435393	50		32255649	32255740	8421504	2	30,20	0,71	c,g	350043539300000001,350043539300000000,350043539300000000	0-30,0-20,0-20						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
831	chr11	32255649	32255740	3500256218	50		32255649	32255740	8421504	2	30,20	0,71	c,g	350025621800000103,350025621800000102,350025621800000102	0-30,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
831	chr11	32255649	32255740	3500180860	50		32255649	32255740	8421504	2	30,20	0,71	c,g	350018086000000007,350018086000000006,350018086000000006	0-30,0-20,0-20						Evidence That High Variation in Ovarian Reserves of Healthy Young Adults Has a Negative Impact on the Corpus Luteum and Endometrium During Estrous Cycles in Cattle	ww.biolreprod.org	0	0		
831	chr11	32255725	32256503	3500256281	41		32255725	32256503	8421504	2	21,20	0,758	c	350025628100000003,350025628100000002	0-21,0-20						Increase in mitochondrial DNA quantity and impairment of oxidative phosphorylation in bovine fibroblast cells treated with ethidium bromide for 15 passages in culture	w.funpecrp.com.br	0	0		
831	chr11	32255725	32256503	3500196603	41		32255725	32256503	8421504	2	21,20	0,758	c	350019660300000003,350019660300000002	0-21,0-20						Increase in mitochondrial DNA quantity and impairment of oxidative phosphorylation in bovine fibroblast cells treated with ethidium bromide for 15 passages in culture	w.funpecrp.com.br	0	0		
831	chr11	32256077	32256100	3500339402	23		32256077	32256100	8421504	1	23	0	c	350033940200000001	0-23		12606491	10.1095/biolreprod.102.010082	0006-3363	Biology of Reproduction	Luteinizing Hormone Receptor Formation in Cumulus Cells Surrounding Porcine Oocytes and Its Role During Meiotic Maturation of Porcine Oocytes	Shimada	2003	4		
831	chr11	32256078	32256630	3500137167	40		32256078	32256630	8421504	2	20,20	0,532	c,g	350013716700000001,350013716700000000,350013716700000000	0-20,0-20,0-20						Expression of Functional Luteinizing Hormone (LH) Receptor and Its Messenger Ribonucleic Acid in Bovine Uterine Veins: LH Induction of Cyclooxygenase and Augmentation of Prostaglandin Production in Bovine Uterine Veins*	.endojournals.org	0	0		
831	chr11	32256216	32256241	3500442431	25		32256216	32256241	8421504	1	25	0	c	350044243100000006	27-52						THE FLUSHING EFFECT AND EXPRESSION OF FOLLICLE STIMULATING HORMONE RECEPTOR VARIANTS IN SHEEP JACQELYN M. HAND B.S., Kansas State University, 2008 A THESIS	krex.k-state.edu	0	0		
831	chr11	32256434	32256459	3500316577	25		32256434	32256459	8421504	1	25	0	c,g	350031657700000003,350031657700000003	8-33,8-33		9716555	10.1095/biolreprod59.3.571	0006-3363	Biology of Reproduction	Luteotropic Hormone Receptors in the Ovary of the Mink (Mustela vison) during Delayed Implantation and Early-Postimplantation Gestation	Douglas	1998	4		
831	chr11	32256434	32256459	3500204456	25		32256434	32256459	8421504	1	25	0	c	350020445600000003	8-33						Luteotropic Hormone Receptors in the Ovary of the Mink (Mustela vison) during Delayed Implantation and Early-Postimplantation Gestation	ww.biolreprod.org	0	0		
831	chr11	32256524	32256828	3500257009	304		32256524	32256828	8421504	1	304	0	c,g	350025700900000001,350025700900000017,350025700900000027,350025700900000026,350025700900000026,350025700900000024,350025700900000024,350025700900000022,350025700900000021,350025700900000021,350025700900000020,350025700900000018,350025700900000019,350025700900000019	21-45,0-303,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,1-60,0-60,0-59,0-59						JABS (2013) 7(2), 94-101 - ResearchGate	.researchgate.net	0	0		
831	chr11	32256525	32257047	3500353920	46		32256525	32257047	8421504	2	23,23	0,499	c,g	350035392000000001,350035392000000001,350035392000000000	0-23,0-23,0-23						DESENVOLVIMENTO DE NOVAS METODOLOGIAS PARA A IDENTIFICA&#xc7;&#xc3;O E CARACTERIZA&#xc7;&#xc3;O GEN&#xc9;TICA DE HERPESV&#xcd;RUS BOVINO TIPO 1 (BHV-1)	www.ibb.unesp.br	0	0		
831	chr11	32256525	32256828	3500338416	45		32256525	32256828	8421504	2	23,22	0,281	c,g	350033841600000001,350033841600000000,350033841600000000	0-23,0-22,0-22						Genetic characterization of European-Zebu composite bovine using RFLP markers. - ResearchGate	.researchgate.net	0	0		
831	chr11	32256525	32256828	3500265603	45		32256525	32256828	8421504	2	23,22	0,281	c,g	350026560300000001,350026560300000001,350026560300000000,350026560300000000	0-23,0-23,0-22,0-22						Effects of polymorphisms of LHR and FSHR genes on sexual precocity in a Bos taurus x indicus beef composite population	w.funpecrp.com.br	0	0		
831	chr11	32256737	32256848	3500255740	40		32256737	32256848	8421504	2	20,20	0,91	c,g	350025574000000004,350025574000000004,350025574000000005	0-20,0-20,0-20						Intra-follicular interactions affecting mammalian oocyte maturation	ive.library.uu.nl	0	0		
831	chr11	32256741	32256766	3500312086	25		32256741	32256766	8421504	1	25	0	c	350031208600000032	10-35						Human gonadotropin receptor (fsh receptor)		1994	0		
831	chr11	32256743	32263190	3500424047	43		32256743	32263190	8421504	2	23,20	0,6427	c	350042404700000001,350042404700000000	0-23,0-20			10.1042/BJ20120172		Biochemical Journal	Dedifferentiated follicular granulosa cells derived from pig ovary can transdifferentiate into osteoblasts	Yoshinao	2012	0		
831	chr11	32256776	32256920	3500242878	132		32256776	32256920	8421504	3	21,57,54	0,27,90	p	350024287800015091	0-132						Encyclopedia of Biological Chemistry - Vol_4	www.scribd.com	0	0		
831	chr11	32256978	32263187	3500126808	46		32256978	32263187	8421504	2	24,22	0,6187	c,g	350012680800000007,350012680800000007,350012680800000006,350012680800000006	0-24,0-24,0-22,0-22						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
831	chr11	32257007	32257031	3500400144	24		32257007	32257031	8421504	1	24	0	c,g	350040014400000005,350040014400000005	0-27,0-27						Endocrine Characterization of the Reproductive Axis in Highly Prolific Lacaune	ww.biolreprod.org	0	0		LHCGR
831	chr11	32257012	32257036	3500427330	24		32257012	32257036	8421504	1	24	0	c	350042733000000000	0-24						Effect of the Reproductive Cycle on Morphology and Activity of the Ovarian Surface Epithelium in Mammals	.era.lib.ed.ac.uk	0	0		
831	chr11	32263183	32276843	3500453109	48		32263183	32276843	8421504	2	24,24	0,13636	c	350045310900000031,350045310900000030	0-24,0-24						Expression von lokalen Regulationsfaktoren im Ovar des Schweins	b.uni-muenchen.de	0	0		
831	chr11	32267047	32271102	3500276119	39		32267047	32271102	8421504	2	19,20	0,4035	c	350027611900000009,350027611900000008	0-19,0-20						Cystic ovarian follicles in the high yielding dairy cow	www.docstoc.com	0	0		
831	chr11	32321313	32321338	3500403336	24		32321313	32321338	8421504	2	15,9	0,16	g	350040333600000154	20-44					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
833	chr11	32553661	32553967	3500458111	49		32553661	32553967	8421504	2	26,23	0,283	c,g	350045811100000000,350045811100000002,350045811100000002,350045811100000001,350045811100000001	0-26,0-23,0-23,0-22,0-22						&#xcd;NDICE GENERAL	cdigital.uv.mx	0	0		
833	chr11	32553661	32553967	3500399094	49		32553661	32553967	8421504	2	26,23	0,283	c	350039909400000015,350039909400000014	0-26,0-23						Paulo Ricardo Loss Aguiar	ticabovina.com.br	0	0		
833	chr11	32553661	32553967	3500338416	49		32553661	32553967	8421504	2	26,23	0,283	c	350033841600000003,350033841600000002	0-26,0-23						Genetic characterization of European-Zebu composite bovine using RFLP markers. - ResearchGate	.researchgate.net	0	0		
833	chr11	32553661	32553967	3500265603	49		32553661	32553967	8421504	2	26,23	0,283	c	350026560300000003,350026560300000002	0-26,0-23						Effects of polymorphisms of LHR and FSHR genes on sexual precocity in a Bos taurus x indicus beef composite population	w.funpecrp.com.br	0	0		
833	chr11	32553661	32553967	3500257009	306		32553661	32553967	8421504	1	306	0	c,g	350025700900000000,350025700900000003,350025700900000012,350025700900000010,350025700900000008,350025700900000008,350025700900000006,350025700900000006,350025700900000005,350025700900000004,350025700900000004	23-49,0-306,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						JABS (2013) 7(2), 94-101 - ResearchGate	.researchgate.net	0	0		
833	chr11	32553690	32573745	3500442431	71		32553690	32573745	8421504	3	23,21,27	0,147,20028	c	350044243100000003,350044243100000004,350044243100000005	26-49,0-21,0-27						THE FLUSHING EFFECT AND EXPRESSION OF FOLLICLE STIMULATING HORMONE RECEPTOR VARIANTS IN SHEEP JACQELYN M. HAND B.S., Kansas State University, 2008 A THESIS	krex.k-state.edu	0	0		
833	chr11	32553745	32553856	3500320137	48		32553745	32553856	8421504	2	24,24	0,87	c	350032013700000001,350032013700000000	0-24,0-24						Revista Brasileira de Zootecnia	www.scielo.br	0	0		
833	chr11	32553833	32553916	3500435393	42		32553833	32553916	8421504	2	21,21	0,62	c,g	350043539300000003,350043539300000003,350043539300000036,350043539300000002	0-21,0-21,0-20,0-21						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
833	chr11	32553835	32554234	3500467553	40		32553835	32554234	8421504	2	20,20	0,379	c,g	350046755300000003,350046755300000003,350046755300000002	0-20,0-20,0-20			10.1186/1477-7827-2-44	1477-7827	Reproductive Biology and Endocrinology	Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis	Dell'Aquila	2004	2		
833	chr11	32553866	32553889	3500072982	23		32553866	32553889	8421504	1	23	0	c	350007298200000003	0-23		18199880	10.1095/biolreprod.107.063925	0006-3363	Biology of Reproduction	Functional and Structural Roles of Conserved Cysteine Residues in the Carboxyl-Terminal Domain of the Follicle-Stimulating Hormone Receptor in Human Embryonic Kidney 293 Cells	Uribe	2008	4		FSHR
833	chr11	32554073	32554178	3500126808	47		32554073	32554178	8421504	2	23,24	0,81	c,g	350012680800000017,350012680800000017,350012680800000016,350012680800000016	0-23,0-23,0-24,0-24						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
833	chr11	32554435	32554512	3500340475	44		32554435	32554512	8421504	2	20,24	0,53	c	350034047500000013,350034047500000012	0-20,0-24		21401961	10.1186/1477-7827-9-33	1477-7827	Reproductive Biology and Endocrinology	Quantitative analysis of bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) gene expression in calf and adult bovine ovaries	Hosoe	2011	2		
833	chr11	32554475	32554613	3500224441	138		32554475	32554613	8421504	1	138	0	p	350022444100015044	0-138						This page intentionally left blank	les.wordpress.com	0	0		
833	chr11	32554707	32554844	3500255740	40		32554707	32554844	8421504	2	20,20	0,117	c	350025574000000001,350025574000000002	0-20,0-20						Intra-follicular interactions affecting mammalian oocyte maturation	ive.library.uu.nl	0	0		
833	chr11	32554851	32554893	3500235435	42		32554851	32554893	8421504	1	42	0	c	350023543500000003,350023543500000004	0-30,0-30						Non-endogenous, Constitutively Activated Versions Of Human G Protein Coupled Receptor: Fshr 	.freshpatents.com	0	0		FSHR
833	chr11	32559447	32559478	3500103201	31		32559447	32559478	8421504	1	31	0	c	350010320100000115	52-83						DEPARTAMENT DE GENATICA CARACTERIZACIAN MOLECULAR DE LOS RECEPTORES DE GONADOTROFINAS DE LUBINA (	www.tdx.cat	0	0		
104	chr11	32559595	32669329	3500243815	143		32559595	32669329	8421504	5	13,35,47,25,23	0,14090,14285,62358,109711	c	350024381500000017,350024381500000015,350024381500000008	0-48,0-47,0-48						A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors	Buckler	1996	0		
833	chr11	32619500	32619524	3500423043	24		32619500	32619524	8421504	1	24	0	c	350042304300000013	0-24						Activin-A reduces follicular growth stimulated by FSH in bovine preantral follicles	www.uece.br	0	0		
833	chr11	32619500	32619524	3500411508	24		32619500	32619524	8421504	1	24	0	c	350041150800000003	0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Fol&#xed;culos ovarianos caprinos expressam diferentes n&#xed;veis de RNAm para subunidade &#xdf;A da inibina e ativina-A promove o crescimento de fol&#xed;culos secund&#xe1;rios in vitro	Leitao	2013	0		
833	chr11	32619500	32619524	3500053285	24		32619500	32619524	8421504	1	24	0	c	350005328500000003	0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Goat ovarian follicles express different levels of mRNA for inhibin-&#xdf;A subunit and activin-A stimulates secondary follicle growth in vitro	Leitao	2013	0		
833	chr11	32619500	32619524	3500053265	24		32619500	32619524	8421504	1	24	0	c	350005326500000013	0-24						Levels of mRNA for BMP-7 in goat ovarian follicles and in vitro effects of BMP-7 on secondary follicle development	www.cbra.org.br	0	0		
104	chr11	32621907	32669329	3500030805	40		32621907	32669329	8421504	2	20,20	0,47402	c	350003080500000003,350003080500000002	0-20,0-20						Bone morphogenetic proteins (BMP) 2, 4, 6 and 7 affect ovarian follicular development through regulation of follicle-stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) expression in goat granulosa cells	demicjournals.org	0	0		
104	chr11	32621953	32669307	3500318283	26		32621953	32669307	8421504	2	25,1	0,47353	c	350031828300000003	0-26						Bone marrow transplantation restores follicular maturation and steroid hormones production in a mouse model for primary ovarian failure. - ResearchGate	.researchgate.net	0	0		FSHR
104	chr11	32621953	32669307	3500071150	26		32621953	32669307	8421504	2	25,1	0,47353	c	350007115000000003	0-26		20086006	10.1093/molehr/gaq003		Molecular Human Reproduction	Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(&#x2212;/&#x2212;) FORKO mice	M.	2010	0		FSHR
834	chr11	32669344	32669368	3500069763	24		32669344	32669368	8421504	1	24	0	c	350006976300000000	0-24		20171950	10.1016/j.bbrc.2010.02.112		Biochemical and biophysical research communications	FSH-Receptor Isoforms and FSH-dependent Gene Transcription in Human Monocytes and Osteoclasts	Lisa	2010	0		FSHR
834	chr11	32758505	32758528	3500126509	23		32758505	32758528	8421504	1	23	0	c,g	350012650900000000,350012650900000000	0-23,0-23		11559549		0008-5472	Cancer Research	Expression of Gonadotropin Receptor and Growth Responses to Key Reproductive Hormones in Normal and Malignant Human Ovarian Surface Epithelial Cells	Syed	2001	8		FSHR
834	chr11	32758505	32758528	3500113695	23		32758505	32758528	8421504	1	23	0	c	350011369500000000	0-23		12606356	10.1095/biolreprod.102.011494	0006-3363	Biology of Reproduction	Developmental Regulation of Follicle-Stimulating Hormone Receptor Messenger RNA Expression in the Baboon Fetal Ovary	Zachos	2003	4		FSHR
834	chr11	32758624	32758649	3500233686	25		32758624	32758649	8421504	1	25	0	c	350023368600000001	0-25						Molecular cloning and functional analysis of the follicle-stimulating hormone (FSH) receptor gene promoter from the Jintang black goat	demicjournals.org	0	0		
835	chr11	32881918	32881942	3500130848	23		32881918	32881942	8421504	2	14,9	0,15	g	350013084800000143	25-48						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
105	chr11	33746076	34070279	3500380957	156		33746076	34070279	8421504	3	111,11,34	0,212230,324169	p	350038095700015005,350038095700015030	0-111,0-45						beta-Neurexin 1 ( -NRXN1 &#x0e17;&#x0e35;&#x0e48;&#x0e40;&#x0e1b;&#xf712;&#x0e19;&#x0e2d;&#x0e2d;&#x0e17; &#x0e34;&#x0e0b;&#x0e36;&#x0e21;&#x0e2a;&#x0e40;&#x0e1b;&#x0e04;&#x0e15;&#x0e23; &#x0e31;&#x0e21; Mutation Screening of the beta-Neurexin 1 (&#x03b2;	kb.psu.ac.th	0	0		
844	chr11	34070294	34070408	3500365320	43		34070294	34070408	8421504	2	19,24	0,90	c,g	350036532000000020,350036532000000020,350036532000000006	0-19,0-19,0-24		17035546	10.1523/JNEUROSCI.1913-06.2006	0270-6474	The Journal of Neuroscience	Important Contribution of &#x03b1;-Neurexins to Ca2+-Triggered Exocytosis of Secretory Granules	Dudanova	2006	7		
845	chr11	34145835	34145861	3500423473	24		34145835	34145861	8421504	2	10,14	0,12	g	350042347300000016	1-36						POLYPEPTIDES HAVING LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME - Patent application	www.faqs.org	0	0		
847	chr11	34350254	34353702	3500251406	321		34350254	34353702	8421504	2	120,201	0,3247	p	350025140600015056	0-321					Patent	Human cDNAs and proteins and uses thereof (Patent US:7285631)	Bejanin	2007	0		NRXN3
847	chr11	34350254	34353702	3500054122	321		34350254	34353702	8421504	2	120,201	0,3247	p	350005412200015054	0-321						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		NRXN1
847	chr11	34350260	34353627	3500328917	96		34350260	34353627	8421504	2	48,48	0,3319	c	350032891700000277,350032891700000273	0-48,0-48						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
847	chr11	34350322	34350346	3500365320	24		34350322	34350346	8421504	1	24	0	c,g	350036532000000000,350036532000000000	0-24,0-24		17035546	10.1523/JNEUROSCI.1913-06.2006	0270-6474	The Journal of Neuroscience	Important Contribution of &#x03b1;-Neurexins to Ca2+-Triggered Exocytosis of Secretory Granules	Dudanova	2006	7		NRXN1
850	chr11	34859624	34859649	3500370305	23		34859624	34859649	8421504	3	14,4,5	0,15,20	g	350037030500000484	14-37						 3 	www.docstoc.com	0	0		
855	chr11	35508777	35508806	3500029950	29		35508777	35508806	8421504	1	29	0	g	350002995000000151	7-37						ESCUELA SUPERIOR POLITECNICA DEL LITORAL Facultad de Ingenier&#xed;a Mec&#xe1;nica y Ciencias de la Producci&#xf3;n. Programa de Maestr&#xed;a en Biotecnolog&#xed;a Agr&#xed;cola	pace.espol.edu.ec	0	0		
862	chr11	36347613	36347638	3500422855	23		36347613	36347638	8421504	2	11,12	0,13	g	350042285500000044	4-27						&#x5c0f;&#x9f20;&#x809d;&#x518d;&#x751f;&#x4e2d;&#x5370;&#x75d5;&#x57fa;&#x56e0;&#x7684;&#x8868;&#x73fe;&#x4ee5;&#x53ca;&#x57fa;&#x56e0; &#x7532;&#x57fa;&#x5316;&#x4e4b;&#x63a2;&#x8a0e;	ir.ym.edu.tw	0	0		
863	chr11	36439640	36439667	3500163533	25		36439640	36439667	8421504	2	5,20	0,7	g	350016353300000023	20-45						NPG.nature.vol.409.Issue.6816.Jan	www.scribd.com	0	0		
866	chr11	36861629	36861654	3500303861	24		36861629	36861654	8421504	2	4,20	0,5	g	350030386100000000	10-37		21633709	10.1371/journal.pone.0020519	1932-6203	PLOS ONE	PLOS ONE: Sequencing and Comparative Genome Analysis of Two Pathogenic Streptococcus gallolyticus Subspecies: Genome Plasticity, Adaptation and Virulence	Lin	2011	4		
871	chr11	37508895	37508923	3500151718	23		37508895	37508923	8421504	2	15,8	0,20	g	350015171800000025,350015171800000005,350015171800000003,350015171800000023	9-39,9-39,0-30,0-30						Cardiac Glycoside Resistant Non-immunogenic Selection Marker 	.freshpatents.com	0	0		
874	chr11	37903471	37903495	3500311171	23		37903471	37903495	8421504	2	11,12	0,12	c	350031117100000103	0-23						HUMAN ANTIGEN BINDING PROTEINS THAT BIND BETA-KLOTHO, FGF RECEPTORS AND COMPLEXES THEREOF - Patent application	www.faqs.org	0	0		
874	chr11	37903471	37903495	3500145013	23		37903471	37903495	8421504	2	11,12	0,12	c	350014501300000103	0-23						HUMAN ANTIGEN BINDING PROTEINS THAT BIND BETA-KLOTHO, FGF RECEPTORS AND COMPLEXES THEREOF	Hu	2010	0		
874	chr11	37932837	37932860	3500346255	23		37932837	37932860	8421504	1	23	0	c	350034625500000012	23-46						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		
874	chr11	37953036	37953064	3500119167	23		37953036	37953064	8421504	3	6,12,5	0,8,23	c	350011916700000056	5-28						Human jagged polypeptide, encoding nucleic acids and methods of use	Li	1997	0		
874	chr11	37962448	37962475	3500340026	25		37962448	37962475	8421504	2	7,18	0,9	c	350034002600000017	13-38						Flea serine protease inhibitor proteins	Silver	1996	0		
874	chr11	37962448	37962475	3500194063	25		37962448	37962475	8421504	2	7,18	0,9	c	350019406300000017	13-38						 Flea Serine Protease Inhibitor Proteins 	www.docstoc.com	0	0		
880	chr11	38675604	38675627	3500284590	23		38675604	38675627	8421504	1	23	0	g	350028459000000010	1-24		21915330	10.1371/journal.pone.0024451	1932-6203	PLOS ONE	PLOS ONE: Differential Methylation of the HPV 16 Upstream Regulatory Region during Epithelial Differentiation and Neoplastic Transformation	Vinokurova	2011	4		
880	chr11	38698113	38698139	3500207362	23		38698113	38698139	8421504	2	13,10	0,16	g	350020736200000010	0-23						Irf-5 Haplotypes In Systemic Lupus Erythematosus 	.freshpatents.com	0	0		
13	chr11	38770769	38816436	3500115394	1392		38770769	38816436	8421504	29	36,42,21,36,21,69,20,13,48,14,25,88,44,33,27,51,45,30,60,90,63,15,138,30,51,3,81,111,87	0,11202,11247,11298,11355,15131,15203,16656,16672,16723,17094,17122,20400,20450,20486,21640,21694,21742,42708,42771,42864,42930,44383,44524,44557,45224,45233,45466,45580	p	350011539400015061,350011539400015062,350011539400015074	0-156,0-531,0-729						Method for identification of genes involved in specific diseases	Harris	2002	0		
880	chr11	38785945	38791216	3500201465	291		38785945	38791216	8421504	4	47,81,116,47	0,1480,1918,5224	p	350020146500015018,350020146500015020	0-180,0-111						UNIVERSITA&#x2019; DEGLI STUDI DI NAPOLI	.xoom.virgilio.it	0	0		SPTBN1
881	chr11	38797757	38798681	3500008154	59		38797757	38798681	8421504	3	20,20,19	0,33,905	c,g	350000815400000015,350000815400000015,350000815400000017,350000815400000017,350000815400000016	0-20,0-20,0-20,0-20,0-19						Mining the Mammalian Genome for Artiodactyl Systematics	www.jstor.org	0	0		
881	chr11	38839560	38839585	3500160136	23		38839560	38839585	8421504	2	15,8	0,17	c	350016013600000039	17-40						Use of WNT inhibitor to inhibit angiogenesis in the CNS - Patent application	www.faqs.org	0	0		
884	chr11	39214376	39214401	3500197547	24		39214376	39214401	8421504	2	20,4	0,21	g	350019754700000086	20-44						Recombinant fowlpox virus s-fpv-043 and uses thereof		1994	0		
884	chr11	39231491	39247130	3500379861	468		39231491	39247130	8421504	7	31,59,47,43,60,64,164	0,413,663,1336,12106,12178,15475	p	350037986100015010,350037986100015009,350037986100015008,350037986100015007,350037986100015006	0-60,0-120,0-60,0-78,0-150						Method for identifying modulators of bace	Blackstock	2002	0		RTN4
884	chr11	39231518	39304121	3500104155	136		39231518	39304121	8421504	5	4,44,36,12,40	0,386,1343,12076,72563	c	350010415500000152,350010415500000149,350010415500000090	0-48,0-48,0-40						Nogo receptor-mediated blockade of axonal growth - Patent application	www.faqs.org	0	0		
884	chr11	39243594	39247025	3500290593	198		39243594	39247025	8421504	2	139,59	0,3372	p	350029059300015012	0-198						Nogo receptor homologs that decrease inhibition of axonal elongation - Patent #07456255	w.strutpatent.com	0	0		RTN4
884	chr11	39243600	39247025	3500057976	192		39243600	39247025	8421504	2	133,59	0,3366	p	350005797600015142,350005797600015020,350005797600015015,350005797600015141,350005797600015019,350005797600015013,350005797600015010,350005797600015004,350005797600015018,350005797600015008,350005797600015000,350005797600015017	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Method for Treating Neurological Disorders - Patent application	www.faqs.org	0	0		RTN4
884	chr11	39243606	39247001	3500035951	162		39243606	39247001	8421504	2	127,35	0,3360	p	350003595100015025	0-162						Nogo receptor homologs	Cate	2002	0		RTN4
884	chr11	39243624	39247025	3500170812	168		39243624	39247025	8421504	2	109,59	0,3342	p	350017081200015000,350017081200015001	0-75,0-114						Supporting Information 	www.pnas.org	0	0		RTN4
884	chr11	39243633	39243678	3500194091	45		39243633	39243678	8421504	1	45	0	p	350019409100015128	0-45						NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF - Patent application	www.faqs.org	0	0		RTN4
884	chr11	39243633	39243678	3500099137	45		39243633	39243678	8421504	1	45	0	p	350009913700015128	0-45						NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF - Patent application	www.faqs.org	0	0		RTN4
884	chr11	39243672	39247025	3500154352	120		39243672	39247025	8421504	2	61,59	0,3294	p	350015435200015018	0-120						NPG.nature.vol.417.Issue.6888.May	www.scribd.com	0	0		RTN4
884	chr11	39304604	39304655	3500396915	48		39304604	39304655	8421504	2	19,29	0,22	c	350039691500000002	0-48						NOGO-A BINDING MOLECULES AND PHARMACEUTICAL USE THEREOF - Patent application	www.faqs.org	0	0		
886	chr11	39479001	39479495	3500071382	44		39479001	39479495	8421504	2	22,22	0,472	c	350007138200000016,350007138200000017	0-22,0-22						REPRODUCTION	uction-online.org	0	0		RPS27A
886	chr11	39479003	39480344	3500086724	225		39479003	39480344	8421504	4	45,55,86,39	0,438,842,1302	p	350008672400015011,350008672400015013,350008672400015015,350008672400015016,350008672400015017,350008672400015018,350008672400015019,350008672400015021,350008672400015020,350008672400015022	222-447,33-258,222-447,222-447,222-447,222-447,201-426,222-447,183-408,222-447						Cleavage of fusion proteins using granzyme b protease	Lorentsen	2004	0		
886	chr11	39479003	39480332	3500287310	210		39479003	39480332	8421504	4	45,52,86,27	0,441,842,1302	p	350028731000015176,350028731000015185,350028731000015181,350028731000015177,350028731000015186,350028731000015182,350028731000015178,350028731000015187,350028731000015183	0-90,0-48,0-48,0-48,0-45,0-45,0-45,0-48,0-48						 Assays For Identifying Ubiquitin Agents And For Identifying Agents That Modify The Activity Of Ubiquitin Agents 	www.docstoc.com	0	0		
886	chr11	39479009	39480983	3500222026	66		39479009	39480983	8421504	3	24,20,22	0,1830,1952	c	350022202600000007,350022202600000003,350022202600000006,350022202600000008	28-47,9-30,9-29,0-22		9765411		0022-538X	Journal of Virology	Ribosomal S27a Coding Sequences Upstream of Ubiquitin Coding Sequences in the Genome of a Pestivirus	Becher	1998	5		
886	chr11	39479018	39480338	3500277093	168		39479018	39480338	8421504	5	30,55,23,27,33	0,423,827,886,1287	p	350027709300015006,350027709300015011,350027709300015039,350027709300015040	0-63,0-48,0-45,0-60						Charakterisierung von Herc2 und seiner Interaktion mit der Ubiquitin-Protein-Ligase E6-AP	www.uni-koeln.de	0	0		
886	chr11	39479030	39479447	3500003004	24		39479030	39479447	8421504	2	18,6	0,411	c	350000300400000046	0-24						Compositions and methods for the modification of gene expression - Patent # 7211711 - PatentGenius	.patentgenius.com	0	0		
886	chr11	39479033	39479474	3500327071	48		39479033	39479474	8421504	2	15,33	0,408	p	350032707100015004	0-48						&#x201e;Identification and Characterization of Interferon &#xf067; Induced Ubiquitinated Newly Synthesized Proteins&#x201c;	edoc.hu-berlin.de	0	0		
886	chr11	39479033	39479474	3500244023	48		39479033	39479474	8421504	2	15,33	0,408	p	350024402300015001	0-48		18519587	10.1128/MCB.01784-07	0270-7306	Molecular and Cellular Biology	c-Cbl-Dependent Monoubiquitination and Lysosomal Degradation of gp130	Tanaka	2008	6		
886	chr11	39479444	39480341	3500140069	174		39479444	39480341	8421504	3	52,86,36	0,401,861	p	350014006900015009,350014006900015002,350014006900015010,350014006900015011,350014006900015003	0-45,0-78,0-45,0-45,0-69						DNA Vaccine for Cancer Therapy - Patent application	www.faqs.org	0	0		
886	chr11	39479444	39480308	3500151389	135		39479444	39480308	8421504	5	45,4,41,42,3	0,48,401,445,861	p	350015138900015009,350015138900015010,350015138900015011	0-45,0-45,0-45						METHODS OF IDENTIFYING MODULATORS OF UBIQUITIN LIGASES - Patent application	www.faqs.org	0	0		
886	chr11	39479483	39480344	3500097418	75		39479483	39480344	8421504	4	13,14,30,18	0,362,379,843	p	350009741800015007	0-75						Hemendra-Thesis Corected (1)	www.scribd.com	0	0		
886	chr11	39479892	39480344	3500146679	78		39479892	39480344	8421504	2	39,39	0,413	p	350014667900015002	0-78						&#x591a;&#x805a;&#x4f53;&#x7f00;&#x5408;&#x7269;	Wu Er Li Ke *Fei De Le 	2009	0		
886	chr11	39479925	39480344	3500227699	45		39479925	39480344	8421504	2	6,39	0,380	p	350022769900015035	0-45						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		
886	chr11	39480308	39480944	3500004187	240		39480308	39480944	8421504	2	129,111	0,525	p	350000418700015025,350000418700015026,350000418700015027,350000418700015028,350000418700015029	0-48,0-48,0-48,0-48,0-48						Substrates And Methods For Assaying Deubiquitinating Enzymes 	.freshpatents.com	0	0		RPS27A
886	chr11	39480320	39480345	3500417646	25		39480320	39480345	8421504	1	25	0	c	350041764600000003	8-33						Biomedical and Environmental Sciences	ww.besjournal.com	0	0		
886	chr11	39480320	39480345	3500360927	25		39480320	39480345	8421504	1	25	0	c	350036092700000003	8-33						Biomedical and Environmental Sciences	ww.besjournal.com	0	0		
886	chr11	39536131	39542485	3500116021	38		39536131	39542485	8421504	3	15,4,19	0,143,6335	c,g	350011602100000001,350011602100000000,350011602100000000	0-19,0-19,0-19						Involvement of Girdin in the determination of cell polarity during cell migration.	.biomedsearch.com	0	0		CCDC88A
886	chr11	39536131	39542485	3500004011	38		39536131	39542485	8421504	3	15,4,19	0,143,6335	c,g	350000401100000001,350000401100000000,350000401100000000	0-19,0-19,0-19		22574214	10.1371/journal.pone.0036681	1932-6203	PLOS ONE	PLOS ONE: Involvement of Girdin in the Determination of Cell Polarity during Cell Migration	Ohara	2012	4		CCDC88A
888	chr11	39815720	39815771	3500126351	51		39815720	39815771	8421504	1	51	0	p	350012635100015001	3-54			10.1128/MCB.01002-06		Molecular and Cellular Biology	Mammalian Polynucleotide Phosphorylase Is an Intermembrane Space RNase That Maintains Mitochondrial Homeostasis 	Hsiao-Wen	2006	0		PNPT1
888	chr11	39841190	39841224	3500237963	28		39841190	39841224	8421504	3	6,16,6	0,9,28	c	350023796300000160	5-33						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
890	chr11	39994633	40063851	3500284840	1591		39994633	40063851	8421504	18	9,6,7,11,17,117,200,196,51,32,113,47,113,123,402,49,88,10	0,10,17,27,39,57,175,6607,6882,6969,11334,12671,13738,17808,63125,63690,67863,69208	c,g	350028484000000061,350028484000000060,350028484000000292,350028484000000059,350028484000000059,350028484000000058,350028484000000291,350028484000000057,350028484000000057,350028484000000056,350028484000000056,350028484000000055,350028484000000055,350028484000000206,350028484000000290,350028484000000286,350028484000000205,350028484000000205,350028484000000053,350028484000000053,350028484000000052,350028484000000052,350028484000000287,350028484000000050,350028484000000050,350028484000000049,350028484000000049,350028484000000048,350028484000000284,350028484000000047,350028484000000047,350028484000000046,350028484000000046,350028484000000045,350028484000000045,350028484000000044,350028484000000044,350028484000000043,350028484000000042,350028484000000042,350028484000000282,350028484000000041,350028484000000283,350028484000000283	0-135,0-80,10-30,0-80,0-80,0-80,0-32,0-80,0-80,0-80,0-80,0-80,0-80,0-22,0-32,0-20,0-22,0-22,0-80,0-80,0-80,0-80,0-20,0-80,0-80,0-80,0-80,0-80,0-20,0-80,0-80,0-80,0-80,0-80,0-80,0-80,0-80,0-80,0-80,0-80,0-20,15-80,0-21,0-21						Die Positionsklonierung als Strategie zur Isolierung und Charakterisierung retinaler Gene	.uni-wuerzburg.de	0	0		
890	chr11	40007813	40007953	3500383918	139		40007813	40007953	8421504	2	25,114	0,26	g	350038391800000093	0-146						Macular degeneration diagnostics and therapeutics	Stone	1999	0		
890	chr11	40034535	40034562	3500466907	25		40034535	40034562	8421504	2	11,14	0,13	g	350046690700000069	0-28						Multifunctional M-CSF proteins and genes encoding therefor - US Patent 5567611 Description	ww.patentstorm.us	0	0		
890	chr11	40062543	40062581	3500171634	38		40062543	40062581	8421504	1	38	0	c	350017163400000000	0-38						EFEMP1 ExpressionPromotes In vivo TumorGrowth inHumanPancreaticAdenocarcinoma	.aacrjournals.org	0	0		
891	chr11	40120096	40120125	3500108998	29		40120096	40120125	8421504	1	29	0	g	350010899800000005	18-47		12517964		0022-1767	The Journal of Immunology	A Complex Containing Polypyrimidine Tract-Binding Protein Is Involved in Regulating the Stability of CD40 Ligand (CD154) mRNA	Kosinski	2003	6		
891	chr11	40136695	40136721	3500144541	23		40136695	40136721	8421504	3	8,4,11	0,10,15	g	350014454100000001	0-23		11973356		0021-9533	Journal of Cell Science	Sequential activation of individual PKC isozymes in integrin-mediated muscle cell spreading: a role for MARCKS in an integrin signaling pathway	Disatnik	2002	6		
891	chr11	40138033	40150310	3500125321	45		40138033	40150310	8421504	2	24,21	0,12256	c,g	350012532100000003,350012532100000054,350012532100000054	0-24,0-21,0-21						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
891	chr11	40138033	40138057	3500371873	24		40138033	40138057	8421504	1	24	0	c	350037187300000099	0-24						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		MIR217
891	chr11	40138033	40138057	3500304886	24		40138033	40138057	8421504	1	24	0	c	350030488600000075	0-24						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		
891	chr11	40138033	40138057	3500131061	24		40138033	40138057	8421504	1	24	0	c	350013106100000029,350013106100000069	0-24,0-23						MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES - Patent application	www.faqs.org	0	0		MIR217
893	chr11	40483457	40483539	3500302965	50		40483457	40483539	8421504	3	13,16,21	0,14,61	g	350030296500000007,350030296500000006	0-29,0-21			10.1002/hep.21367	1527-3350	Hepatology	Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis - Zindy - 2006 - Hepatology - Wiley Online Library	Zindy	2006	0		PTMA
896	chr11	40785645	40785671	3500395029	23		40785645	40785671	8421504	2	5,18	0,8	g	350039502900000530	0-23						 Recombinant Infectious Laryngotracheitis Virus And Uses Thereof 	www.docstoc.com	0	0		
898	chr11	41074666	41074692	3500187962	23		41074666	41074692	8421504	2	11,12	0,14	g	350018796200000025	11-48						 Starchless Variety Of Pisum Sativum Having Elevated Levels Of Sucrose 	www.docstoc.com	0	0		
903	chr11	41721632	41721657	3500442231	23		41721632	41721657	8421504	2	11,12	0,13	g	350044223100000132,350044223100000125	4-27,4-26						High Affinity Nucleic Acid Ligands To Lectins - Patent application	www.faqs.org	0	0		
907	chr11	42282986	42283012	3500054944	25		42282986	42283012	8421504	2	9,16	0,10	c	350005494400000008	0-25						Steroid 5A-reductases	Andersson	1995	0		
910	chr11	42604684	42604710	3500129958	23		42604684	42604710	8421504	2	12,11	0,15	g	350012995800000118	0-23						Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains - Patent # 6495137 - PatentGenius	.patentgenius.com	0	0		
911	chr11	42746963	42791045	3500161485	39		42746963	42791045	8421504	3	20,13,6	0,44060,44076	g	350016148500000110,350016148500000090	6-28,19-38						Hepadnavirus receptor	Li	1997	0		
911	chr11	42789594	42789620	3500449315	23		42789594	42789620	8421504	2	15,8	0,18	g	350044931500000320	1-25						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
911	chr11	42789594	42789620	3500080694	23		42789594	42789620	8421504	2	15,8	0,18	g	350008069400000297	4-28						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
915	chr11	43319792	43319820	3500351388	23		43319792	43319820	8421504	2	16,7	0,21	g	350035138800000017	3-32						&#x9632;&#x75ab;&#x5b78;&#x82d1;&#x7cfb;&#xf99c; 035-1 &#x50b3;&#x67d3;&#x75c5; &#x6a19;&#x6e96;&#x6aa2;&#x9a57;&#x65b9;&#x6cd5;&#x624b;&#x518a;(&#x4e0a;)	www.cdc.gov.tw	0	0		
917	chr11	43584844	43584869	3500138953	23		43584844	43584869	8421504	2	13,10	0,15	g	350013895300000015	0-23						Endogenous and non-endogenous versions of human g protein-coupled receptors	Chen	2003	0		
921	chr11	44081034	44081062	3500212475	24		44081034	44081062	8421504	2	8,16	0,12	g	350021247500000326	0-24						CELLS AND METHODOLOGY TO GENERATE NON-SEGMENTED NEGATIVE-STRAND RNA VIRUSES - Patent application	www.faqs.org	0	0		
922	chr11	44245756	44245782	3500424541	23		44245756	44245782	8421504	2	15,8	0,18	g	350042454100000003	0-23		23894411	10.1371/journal.pone.0069090	1932-6203	PLOS ONE	PLOS ONE: miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling	Collins	2013	4		
923	chr11	44350542	44350570	3500215098	23		44350542	44350570	8421504	2	6,17	0,11	g	350021509800000026	4-28		18194158	10.1111/j.1365-2958.2007.06089.x	1365-2958	Molecular Microbiology	Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium - Crouch - 2007 - Molecular Microbiology - Wiley Online Library	Crouch	2008	0		
923	chr11	44363643	44363666	3500358098	23		44363643	44363666	8421504	1	23	0	g	350035809800000009	15-43						The Hemagglutinin Protein of Highly Pathogenic H5N1 In&#xfb02;uenza Viruses Overcomes an Early Block in the Replication Cycle To Promote Productive Replication in Macrophages	jvi.asm.org	0	0		
924	chr11	44528431	44528455	3500373322	23		44528431	44528455	8421504	2	6,17	0,7	g	350037332200000009	5-33					Patent	Antagonistic selective binding agents of osteoprotegerin binding protein (Patent EP:1257648)	Boyle	2008	0		
924	chr11	44528431	44528455	3500276908	23		44528431	44528455	8421504	2	6,17	0,7	g	350027690800000014	5-33						Antagonistic selective binding agents of osteoprotegerin binding protein	Deshpande	2011	0		
927	chr11	44947380	44954505	3500058791	48		44947380	44954505	8421504	2	24,24	0,7101	c,g	350005879100000001,350005879100000000,350005879100000000	0-24,0-24,0-24						METHOD - KING'S COLLEGE LONDON	www.sumobrain.com	0	0		BCL11A
927	chr11	44947380	44954505	3500035614	48		44947380	44954505	8421504	2	24,24	0,7101	c	350003561400000013,350003561400000001,350003561400000012,350003561400000000	0-24,0-24,0-24,0-24						Method - Patent application	www.faqs.org	0	0		BCL11A
928	chr11	45078826	45078851	3500126523	24		45078826	45078851	8421504	2	15,9	0,16	g	350012652300000118	18-42						PLANTS WITH INCREASED HYALURONAN PRODUCTION - Patent application	www.faqs.org	0	0		
930	chr11	45284924	45303942	3500401846	48		45284924	45303942	8421504	2	24,24	0,18994	c	350040184600000000,350040184600000001	0-24,0-24						ScienceDirect.com - Experimental Cell Research - Unraveling androgen receptor interactomes by an array-based method: Discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor	sciencedirect.com	0	0		
930	chr11	45284924	45303942	3500205423	48		45284924	45303942	8421504	2	24,24	0,18994	c	350020542300000002,350020542300000003	0-24,0-24		14744759	10.1158/0008-5472.CAN-03-0005	0008-5472	Cancer Research	Involvement of Rel/Nuclear Factor-&#x03ba;B Transcription Factors in Keratinocyte Senescence	Bernard	2004	8		REL
930	chr11	45284924	45284948	3500362022	24		45284924	45284948	8421504	1	24	0	c	350036202200000002	0-24						&#x4e3b;&#x9898;&#xff1a;TRAIL | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		REL
930	chr11	45284924	45284948	3500312872	24		45284924	45284948	8421504	1	24	0	c	350031287200000002	0-24		17673570	10.1124/mol.107.038042	1521-0111 (Online)	Molecular Pharmacology	Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-&#x0394;12,14-Prostaglandin J2 in T Lymphocytes	Fionda	2007	0		REL
930	chr11	45284924	45284948	3500061002	24		45284924	45284948	8421504	1	24	0	c	350006100200000002	0-24						&#x4e3b;&#x9898;&#xff1a;TRAIL | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		REL
932	chr11	45591003	45591028	3500303229	25		45591003	45591028	8421504	1	25	0	g	350030322900000006	7-32						US Patent # 6,884,879. Anti-VEGF antibodies - Patents.com	www.patents.com	0	0		
933	chr11	45731927	45731950	3500177166	23		45731927	45731950	8421504	1	23	0	g	350017716600000009	0-23					Neoplasia (New York, N.Y.)	SPARC Inhibits LPA-Mediated Mesothelial-Ovarian Cancer Cell Crosstalk	Neveen	2007	0		TASP1
933	chr11	45731932	45732170	3500151883	40		45731932	45732170	8421504	2	20,20	0,218	g	350015188300000006,350015188300000007	0-20,0-20		18253123	10.1038/sj.bjc.6604227		British Journal of Cancer	20(S)-25-methoxyl-dammarane-3&#x03b2;, 12&#x03b2;, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action	W	2008	0		GAPDH
933	chr11	45731933	45731957	3500143827	24		45731933	45731957	8421504	1	24	0	g	350014382700000003	0-24						Angiogenesis and Tumor Proliferation/Metastasis of Human Colorectal Cancer Cell Line SW620 Transfected with Endocrine Glands-Derived-Vascular Endothelial Growth Factor, As a New Angiogenic Factor	.aacrjournals.org	0	0		
933	chr11	45731934	45732138	3500303355	40		45731934	45732138	8421504	2	20,20	0,184	g	350030335500000007,350030335500000008	0-20,0-20		22696253	10.1002/stem.1154	1549-4918	STEM CELLS	microRNA-124 Regulates Cardiomyocyte Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Via Targeting STAT3 Signaling - Cai - 2012 - STEM CELLS - Wiley Online Library	Cai	2012	0		GAPDH
933	chr11	45731934	45732138	3500198678	40		45731934	45732138	8421504	2	20,20	0,184	g	350019867800000004,350019867800000005	0-20,0-20			10.1124/mol.105.017483	1521-0111 (Online)	Molecular Pharmacology	Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-&#x03b2;1-Induced Extracellular Matrix Expression	Jinnin	2006	0		GAPDH
937	chr11	46167522	46167547	3500005314	24		46167522	46167547	8421504	2	11,13	0,12	g	350000531400000283	13-40						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
938	chr11	46323695	46323726	3500188099	26		46323695	46323726	8421504	3	8,5,13	0,11,18	g	350018809900000008	19-46						THESE DE DOCTORAT DE L'UNIVERSITE PARIS 6	hives-ouvertes.fr	0	0		
938	chr11	46347123	46347153	3500303208	24		46347123	46347153	8421504	3	7,12,5	0,12,25	g	350030320800000014	8-39						Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening - US Patent 7279279 Description	ww.patentstorm.us	0	0		
940	chr11	46609784	46609816	3500358221	23		46609784	46609816	8421504	3	6,11,6	0,11,26	g	350035822100000099	4-28						Stabilized polypeptide compositions	Glaser	2007	0		
940	chr11	46619800	46619826	3500418252	24		46619800	46619826	8421504	2	12,12	0,14	g	350041825200000100	21-45						US Patent # 7,157,262. Lipolytic enzymes - Patents.com	www.patents.com	0	0		
945	chr11	47281108	47306979	3500376668	573		47281108	47306979	8421504	6	67,98,102,30,127,149	0,6579,8283,12744,12792,25722	p	350037666800015019,350037666800015043	0-297,0-276						comprehensive Analysis of sialyltransferases in Vertebrate Genomes	www.la-press.com	0	0		
947	chr11	47484381	47484406	3500014515	25		47484381	47484406	8421504	1	25	0	g	350001451500000019,350001451500000010	0-25,0-25						Primers, probes and reference plasmid for detection of meat adulteration	Chiueh	2005	0		
947	chr11	47514051	47514077	3500087743	26		47514051	47514077	8421504	1	26	0	g	350008774300000062	0-26						Molecular Biological and Immunological Techniques and Applications for Food Chemists	www.scribd.com	0	0		
947	chr11	47555399	47555426	3500146321	23		47555399	47555426	8421504	3	4,8,11	0,5,16	g	350014632100000035	21-44						Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use - US Patent 7056714 Description	ww.patentstorm.us	0	0		
948	chr11	47643325	47643353	3500288475	25		47643325	47643353	8421504	3	11,7,7	0,13,21	g	350028847500000008	5-30					Patent	170-linked breast and ovarian cancer susceptibility gene (Patent US:5753441)	Futreal	1998	0		
948	chr11	47643325	47643353	3500198696	25		47643325	47643353	8421504	3	11,7,7	0,13,21	g	350019869600000184	5-30						Linked breast and ovarian cancer susceptibility gene	Shattuck-eidens	1995	0		
948	chr11	47643325	47643353	3500006742	25		47643325	47643353	8421504	3	11,7,7	0,13,21	g	350000674200000183	5-30						17q-linked breast and ovarian cancer susceptibility gene	Skolnick	1995	0		
948	chr11	47681955	47681981	3500064236	23		47681955	47681981	8421504	2	10,13	0,13	g	350006423600000017	5-28						Synthesis of branched nucleic acids	Gryaznov	1996	0		
950	chr11	47854354	47854377	3500288124	23		47854354	47854377	8421504	1	23	0	g	350028812400000033	0-23						Method for diagnosing testicular seminomas	Nakamura	2006	0		CHORDC1
950	chr11	47854354	47854377	3500247076	23		47854354	47854377	8421504	1	23	0	g	350024707600000003	0-23						Genes and polypeptides relating to human pancreatic cancers	Katagiri	2005	0		
950	chr11	47854354	47854377	3500211421	23		47854354	47854377	8421504	1	23	0	g	350021142100000003	0-23					Patent	Genes and polypeptides relating to human pancreatic cancers (Patent US:7601826)	Nakamura	2009	0		TUBA1A
950	chr11	47854354	47854377	3500167856	23		47854354	47854377	8421504	1	23	0	g	350016785600000003	0-23						Genes and polypeptides relating to human pancreatic cancers	Nakamura	2012	0		TUBA1A
950	chr11	47854354	47854377	3500086559	23		47854354	47854377	8421504	1	23	0	g	350008655900000027,350008655900000003	0-23,0-23					Patent	Genes and polypeptides relating to human pancreatic cancers (Patent EP:1556518)	Nakamura	2008	0		TUBA1A
951	chr11	47981971	47982000	3500261567	25		47981971	47982000	8421504	3	7,13,5	0,8,24	c	350026156700000026	0-25						Asthma Susceptibility Locus	Kere	2008	0		
951	chr11	47981971	47982000	3500099272	25		47981971	47982000	8421504	3	7,13,5	0,8,24	c	350009927200000025	0-25					Patent	Asthma susceptibility locus (Patent EP:1572739)	Kere	2008	0		
952	chr11	48183853	48183881	3500467548	28		48183853	48183881	8421504	1	28	0	c	350046754800000004	22-50						Effects of Lipopolysaccharide and Mannheimia haemolytica Leukotoxin on Bovine Lung Microvascular Endothelial Cells and Alveolar Epithelial Cells	cvi.asm.org	0	0		
952	chr11	48183864	48189799	3500056646	42		48183864	48189799	8421504	2	22,20	0,5915	c	350005664600000013,350005664600000011	20-42,0-20						Genetic susceptibility to S. aureus mastitis in sheep: differential expression of mammary epithelial cells in response to live bacteria or supernatant	cs.physiology.org	0	0		
952	chr11	48183864	48183936	3500265224	41		48183864	48183936	8421504	2	22,19	0,53	c	350026522400000001,350026522400000000	0-22,0-19						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
952	chr11	48183935	48186348	3500349767	44		48183935	48186348	8421504	2	22,22	0,2391	c	350034976700000009,350034976700000008	0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
952	chr11	48186306	48192998	3500285599	43		48186306	48192998	8421504	2	19,24	0,6668	c	350028559900000003,350028559900000002	0-19,0-24					Infection and Immunity	Borrelia burgdorferi Induces the Production and Release of Proinflammatory Cytokines in Canine Synovial Explant Cultures	Reinhard	1998	0		
952	chr11	48186306	48192998	3500180956	43		48186306	48192998	8421504	2	19,24	0,6668	c,g	350018095600000003,350018095600000002,350018095600000002	0-19,0-24,0-24		9423865		0019-9567	Infection and Immunity	Borrelia burgdorferi Induces the Production and Release of Proinflammatory Cytokines in Canine Synovial Explant Cultures	Straubinger	1998	4		
952	chr11	48186338	48186365	3500261631	27		48186338	48186365	8421504	1	27	0	c	350026163100000007	0-27						Innate immune markers that distinguish red deer (Cervus elaphus) selected for resistant or susceptible genotypes for Johne&#xfffd;s disease	inaryresearch.org	0	0		
952	chr11	48188192	48189971	3500275310	40		48188192	48189971	8421504	2	20,20	0,1759	c,g	350027531000000001,350027531000000000,350027531000000000	0-20,0-20,0-20						The Bovine Mammary Glands Cytokines at the Periparturient Period	apps.kfu.edu.sa	0	0		
952	chr11	48188211	48189771	3500106681	42		48188211	48189771	8421504	3	20,13,9	0,51,1551	c	350010668100000039,350010668100000038	27-47,22-44						Inhibitors of leaderless protein export	Baird	1998	0		
953	chr11	48245169	48251957	3500355031	41		48245169	48251957	8421504	2	19,22	0,6766	c,g	350035503100000003,350035503100000002,350035503100000002	1-20,0-22,0-22						OKAMATSU-OGURA, Yuko; SOLIMAN, Mohamed; ABD Citation Journal of Veterinary Medical Science, 69(5): 509-514 Issue Date 2007-05	lib.hokudai.ac.jp	0	0		
953	chr11	48245207	48245233	3500449915	26		48245207	48245233	8421504	1	26	0	c	350044991500000020	0-26						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
953	chr11	48245294	48245319	3500288419	25		48245294	48245319	8421504	1	25	0	g	350028841900000001	20-45						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
953	chr11	48245311	48246396	3500090395	138		48245311	48246396	8421504	2	24,114	0,971	p	350009039500015005,350009039500015006	0-138,0-138						INTERLEUKIN-1&#x03b2; DELETION MUTANT	Bartfai	1994	0		
953	chr11	48246285	48248243	3500379004	45		48246285	48248243	8421504	3	20,13,12	0,115,1946	c	350037900400000011,350037900400000010	0-20,0-25						Adaptation to High Grain Diets Proceeds Through Minimal Immune System Stimulation and Differences in Extracellular Matrix Protein Expression in A Model of Subacute Ruminal Acidosis in Non-lactating Dairy Cows	thescipub.com	0	0		
953	chr11	48246285	48248243	3500249098	45		48246285	48248243	8421504	3	20,13,12	0,115,1946	c	350024909800000009,350024909800000008	0-20,0-25						A CHARACTERIZATION OF INFLAMMATORY AND STRUCTURAL MARKERS WITHIN THE RUMEN EPITHELIUM DURING GRAIN-INDUCED RUMINAL ACIDOSIS IN	thescipub.com	0	0		
953	chr11	48246319	48246345	3500400639	25		48246319	48246345	8421504	2	20,5	0,21	c	350040063900000003	0-25						Compositions And Methods For Altering Alpha- And Beta-tocotrienol Content Using Multiple Transgenes 	.freshpatents.com	0	0		
953	chr11	48246319	48246345	3500223603	25		48246319	48246345	8421504	2	20,5	0,21	c	350022360300000005	0-25						Molecular Characteristics and Biological Activities of Anionic Macromolecules from Codium fragile | Mehdi Tabarsa - Academia.edu	www.academia.edu	0	0		
953	chr11	48246381	48248238	3500409280	39		48246381	48248238	8421504	2	32,7	0,1850	c	350040928000000001	85-124						Changes in glucose transporter expression in monocytes of periparturient dairy cows. - ResearchGate	.researchgate.net	0	0		
953	chr11	48246392	48251128	3500373489	48		48246392	48251128	8421504	4	21,3,12,12	0,1839,2968,4724	c	350037348900000011,350037348900000010	0-24,0-24			10.1186/ar1991		Arthritis Research & Therapy	Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary	Ilse-GerlinSunk	2006	0		
953	chr11	48246392	48251128	3500001250	48		48246392	48251128	8421504	4	21,3,12,12	0,1839,2968,4724	c	350000125000000011,350000125000000010	0-24,0-24		16831232	10.1186/ar1991	1478-6354	Arthritis Research & Therapy	Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary	Sunk	2006	4		
953	chr11	48246400	48251120	3500261509	40		48246400	48251120	8421504	4	13,7,16,4	0,1831,2956,4716	c	350026150900000003,350026150900000002	0-20,0-20		10679109		0022-1767	The Journal of Immunology	Functional Genomic Analysis in Arthritis-Affected Cartilage: Yin-Yang Regulation of Inflammatory Mediators by &#x03b1;5&#x03b2;1 and &#x03b1;V&#x03b2;3 Integrins	Attur	2000	6		
953	chr11	48248294	48249241	3500383646	40		48248294	48249241	8421504	2	20,20	0,927	c,g	350038364600000001,350038364600000001,350038364600000000,350038364600000000	0-20,0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
953	chr11	48248329	48249341	3500275310	40		48248329	48249341	8421504	2	20,20	0,992	c,g	350027531000000003,350027531000000003,350027531000000002	0-20,0-20,0-20						The Bovine Mammary Glands Cytokines at the Periparturient Period	apps.kfu.edu.sa	0	0		
953	chr11	48248365	48248391	3500296484	26		48248365	48248391	8421504	1	26	0	c,g	350029648400000001,350029648400000001	0-26,0-26						Evaluation of cytokine expression by blood monocytes of lactating Holstein cows with or without postpartum uterine disease. - ResearchGate	.researchgate.net	0	0		
953	chr11	48249308	48249331	3500056646	23		48249308	48249331	8421504	1	23	0	c	350005664600000012	20-43						Genetic susceptibility to S. aureus mastitis in sheep: differential expression of mammary epithelial cells in response to live bacteria or supernatant	cs.physiology.org	0	0		
953	chr11	48251158	48251929	3500467548	26		48251158	48251929	8421504	2	7,19	0,752	c	350046754800000005	21-47						Effects of Lipopolysaccharide and Mannheimia haemolytica Leukotoxin on Bovine Lung Microvascular Endothelial Cells and Alveolar Epithelial Cells	cvi.asm.org	0	0		
954	chr11	48455818	48456019	3500408928	30		48455818	48456019	8421504	2	7,23	0,178	c	350040892800000014	11-41						Interleukin-1 receptor antagonist and recombinant production thereof	Ford	1999	0		
954	chr11	48455818	48456019	3500394357	30		48455818	48456019	8421504	2	7,23	0,178	c	350039435700000025	5-35						Anti-interleukin-1 receptor antagonist antibodies and uses thereof	Ford	1999	0		
954	chr11	48455818	48456019	3500388019	30		48455818	48456019	8421504	2	7,23	0,178	c	350038801900000020	11-41						US Patent # 6,541,623. Interleukin--1 receptor antagonist and uses thereof - Patents.com	www.patents.com	0	0		
955	chr11	48531494	48537132	3500450960	522		48531494	48537132	8421504	4	110,89,113,210	0,2551,4208,5428	p	350045096000015011	0-522						METHODS FOR TREATING ARTICULAR DISEASE OR DYSFUNCTION USING SELF-COMPLIMENTARY ADENO-ASSOCIATED VIRAL VECTORS	Ghivizzani	2007	0		
955	chr11	48531494	48537132	3500352864	522		48531494	48537132	8421504	4	110,89,113,210	0,2551,4208,5428	p	350035286400015008	0-522						Methods For Treating Articular Disease Or Dysfunction Using Self-complimentary Adeno-associated Viral Vectors 	.freshpatents.com	0	0		
955	chr11	48618337	48619932	3500288519	40		48618337	48619932	8421504	2	20,20	0,1575	g	350028851900000006,350028851900000005	0-20,0-20						Dedifferentiation of Human Primary Thyrocytes into Multilineage Progenitor Cells without Gene Introduction	www.plosone.org	0	0		PAX8
957	chr11	48812808	48863542	3500282840	86		48812808	48863542	8421504	3	24,23,39	0,50369,50695	g	350028284000000099,350028284000000201,350028284000000071,350028284000000489	0-246,33-276,0-246,33-276						ANTIBODIES TO IL-6 AND USE THEREOF - Patent application	www.faqs.org	0	0		
957	chr11	48812808	48863542	3500249437	77		48812808	48863542	8421504	3	24,23,30	0,50369,50704	g	350024943700000100,350024943700000072	0-246,0-246					Patent	Antagonists of IL-6 to raise albumin and/or lower CRP (Patent US:8404235)	Smith	2013	0		
957	chr11	48812808	48863542	3500245486	86		48812808	48863542	8421504	3	24,23,39	0,50369,50695	g	350024548600000100,350024548600000230,350024548600000072	0-246,33-276,0-246						Antagonists of IL-6 to raise Albumin and/or lower CRP - Patent application	www.faqs.org	0	0		
957	chr11	48812953	48813020	3500284573	67		48812953	48813020	8421504	1	67	0	g	350028457300000078	53-120						Hepatocyte growth factor (hgf) binding proteins	Breault	2008	0		
957	chr11	48812953	48813020	3500114582	67		48812953	48813020	8421504	1	67	0	g	350011458200000078	53-120					Patent	Hepatocyte growth factor (HGF) binding antibody (Patent US:7659378)	Breault	2010	0		
957	chr11	48812963	48812986	3500370944	23		48812963	48812986	8421504	1	23	0	g	350037094400000014	14-37						Carrier immunoglobulins and uses thereof	Walker	2012	0		
957	chr11	48812963	48812986	3500370067	23		48812963	48812986	8421504	1	23	0	g	350037006700000091	14-37						SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 - Patent application	www.faqs.org	0	0		
957	chr11	48812963	48812986	3500199604	23		48812963	48812986	8421504	1	23	0	g	350019960400000089	14-37						Selective and potent peptide inhibitors of kv1.3	Sullivan	2010	0		
957	chr11	48812963	48812986	3500145475	23		48812963	48812986	8421504	1	23	0	g	350014547500000089	14-37						Selective and potent peptide inhibitors of kv1.3	Arora	2012	0		
957	chr11	48812966	48812992	3500461106	26		48812966	48812992	8421504	1	26	0	g	350046110600000080	0-26						Neutralizing anti-ccl20 antibodies	Imai	2012	0		
957	chr11	48812966	48812989	3500397639	23		48812966	48812989	8421504	1	23	0	g	350039763900000031	0-23						Chemokine beta-1 fusion proteins	Bell	2004	0		
957	chr11	48812966	48812989	3500225617	23		48812966	48812989	8421504	1	23	0	g	350022561700000037	0-23						Vascular endothelial growth factor 2	Rosen	2002	0		
957	chr11	48812966	48812989	3500208662	23		48812966	48812989	8421504	1	23	0	g	350020866200000075	0-23					Patent	Methods for producing members of specific binding pairs (Patent US:7635666)	McCafferty	2009	0		
957	chr11	48812966	48812989	3500079998	23		48812966	48812989	8421504	1	23	0	g	350007999800000011	0-23						Antibodies that immunospecifically bind to trail receptors	Albert	2005	0		
957	chr11	48812966	48812989	3500046229	23		48812966	48812989	8421504	1	23	0	g	350004622900000001	0-23						Soluble polypeptides	Beasley	2013	0		
957	chr11	48812966	48812989	3500026089	23		48812966	48812989	8421504	1	23	0	g	350002608900000010	0-23						Recombinant Anti-cd4 Antibodies For Human Therapy 	.freshpatents.com	0	0		
957	chr11	48812970	48813008	3500211654	38		48812970	48813008	8421504	1	38	0	g	350021165400000064	19-57						Polypeptides	Basran	2004	0		
957	chr11	48812970	48813008	3500199754	38		48812970	48813008	8421504	1	38	0	g	350019975400000224	16-54						Tie1-binding Ligands 	.freshpatents.com	0	0		
957	chr11	48812971	48813040	3500038999	59		48812971	48813040	8421504	2	49,10	0,59	g	350003899900000080	0-64						Antibodies against carbonic anhydrase IX (CA IX) tumor antigen - US Patent 7378091 Description	ww.patentstorm.us	0	0		
957	chr11	48812971	48812997	3500119980	26		48812971	48812997	8421504	1	26	0	g	350011998000000082	30-56						Binding Molecules Capable Of Neutralizing Rabies Virus And Uses Thereof 	.freshpatents.com	0	0		
957	chr11	48812972	48813008	3500341570	36		48812972	48813008	8421504	1	36	0	g	350034157000000004	21-57						Ligand	Grant	2007	0		
957	chr11	48813058	48813090	3500072233	32		48813058	48813090	8421504	1	32	0	g	350007223300000021,350007223300000020	1-33,0-32						CD44 ANTIBODIES - MEDAREX, INC.	www.sumobrain.com	0	0		
957	chr11	48813059	48813084	3500042099	25		48813059	48813084	8421504	1	25	0	g	350004209900000154	1-26						CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY - Patent application	www.faqs.org	0	0		
957	chr11	48816921	48816960	3500037714	39		48816921	48816960	8421504	1	39	0	g	350003771400000052	32-71					Patent	Anti-TRAIL-R antibodies (Patent CN:100475848)	Sen Ying Zhi 	2009	0		
957	chr11	48816921	48816952	3500153094	31		48816921	48816952	8421504	1	31	0	g	350015309400000126	8-39						Humanized anti-EGF receptor monoclonal antibody - Patent # 7060808 - PatentGenius	.patentgenius.com	0	0		
957	chr11	48816921	48816952	3500020761	31		48816921	48816952	8421504	1	31	0	g	350002076100000126	8-39						US Patent # 7,060,808. Humanized anti-EGF receptor monoclonal antibody - Patents.com	www.patents.com	0	0		
957	chr11	48817717	48817891	3500037020	69		48817717	48817891	8421504	3	16,33,20	0,40,154	g	350003702000000036,350003702000000037	61-233,63-233						NOVEL ANTIGEN BINDING PROTEINS - GLAXO GROUP LIMITED	www.sumobrain.com	0	0		
957	chr11	48838282	48838305	3500429779	23		48838282	48838305	8421504	1	23	0	g	350042977900000005	8-34						FGF21 MUTANTS AND USES THEREOF	Belouski	2012	0		
957	chr11	48857713	48857740	3500145013	27		48857713	48857740	8421504	1	27	0	g	350014501300000107	6-33						HUMAN ANTIGEN BINDING PROTEINS THAT BIND BETA-KLOTHO, FGF RECEPTORS AND COMPLEXES THEREOF	Hu	2010	0		
957	chr11	48863177	48863544	3500264236	55		48863177	48863544	8421504	2	23,32	0,335	g	350026423600000071	33-280						ANTAGONISTS OF IL-6 TO PREVENT OR TREAT CACHEXIA, WEAKNESS, FATIGUE, AND/OR FEVER - Patent application	www.faqs.org	0	0		
957	chr11	48863177	48863542	3500166438	56		48863177	48863542	8421504	3	23,9,24	0,326,341	g	350016643800000147	33-276						Antibodies to IL-6 and use thereof - Patent application	www.faqs.org	0	0		
957	chr11	48863177	48863542	3500037866	56		48863177	48863542	8421504	3	23,9,24	0,326,341	g	350003786600000340	33-276						ANTIBODIES TO IL-6 AND USE THEREOF	Garcia-martinez	2010	0		
957	chr11	48863177	48863542	3500037261	56		48863177	48863542	8421504	3	23,9,24	0,326,341	g	350003726100000293	33-276						ANTIBODIES TO IL-6 AND USE THEREOF - Patent application	www.faqs.org	0	0		
957	chr11	48863177	48863542	3500013197	56		48863177	48863542	8421504	3	23,9,24	0,326,341	g	350001319700000293	33-276						ANTIBODIES TO IL-6 AND USE THEREOF - Patent application	www.faqs.org	0	0		
957	chr11	48863501	48863546	3500377179	40		48863501	48863546	8421504	2	7,33	0,12	g	350037717900000003	13-58						Single chain antigen-binding polypeptides for polymer conjugation	Basu	2004	0		
957	chr11	48863501	48863546	3500319169	40		48863501	48863546	8421504	2	7,33	0,12	g	350031916900000003	13-58						Single chain antigen-binding polypeptides for polymer conjugation	Basu	2005	0		
957	chr11	48863512	48863597	3500402349	60		48863512	48863597	8421504	2	34,26	0,59	g	350040234900000099	168-260						Antibodies and methods for making and using them	Anderson	2009	0		
957	chr11	48863518	48863546	3500399740	28		48863518	48863546	8421504	1	28	0	g	350039974000000053	18-46						Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same	Lee	2009	0		
957	chr11	48863518	48863546	3500347156	28		48863518	48863546	8421504	1	28	0	g	350034715600000053	18-46						Antibodies Recognizing A Carbohydrate Containing Epitope On Cd-43 And Cea Expressed On Cancer Cells And Methods Using Same 	.freshpatents.com	0	0		
957	chr11	48863518	48863546	3500181311	28		48863518	48863546	8421504	1	28	0	g	350018131100000053	18-46					Patent	Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (Patent US:7674605)	Lee	2010	0		
957	chr11	48863518	48863546	3500092588	28		48863518	48863546	8421504	1	28	0	g	350009258800000053	18-46						Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same	Lin	2007	0		
957	chr11	48863518	48863546	3500058290	28		48863518	48863546	8421504	1	28	0	g	350005829000000053	18-46					Patent	Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same (Patent US:7674605)	Lee	2010	0		
957	chr11	48863518	48863546	3500023713	28		48863518	48863546	8421504	1	28	0	g	350002371300000068	2-30						Fusion proteins and polynucleotides encoding gelonin sequences	Better	2000	0		
957	chr11	48863518	48863546	3500019935	28		48863518	48863546	8421504	1	28	0	g	350001993500000053	18-46						Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same	Lee	2008	0		
957	chr11	48872309	48872333	3500197658	24		48872309	48872333	8421504	1	24	0	g	350019765800000036	1-25						Methods of treating cancer and enhancing immune responses with antibodies that bind CD40	Bedian	2005	0		
958	chr11	48902863	48902888	3500045837	23		48902863	48902888	8421504	2	13,10	0,15	g	350004583700000164	0-23						Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same - US Patent 7105345 Description	ww.patentstorm.us	0	0		
958	chr11	48947382	48947411	3500315782	29		48947382	48947411	8421504	1	29	0	g	350031578200000006	16-45					Molecular and Cellular Biology	Detection of RAG Protein-V(D)J Recombination Signal Interactions Near the Site of DNA Cleavage by UV Cross-Linking	Quinn	1999	0		
958	chr11	48947382	48947411	3500272449	29		48947382	48947411	8421504	1	29	0	g	350027244900000005	16-45		10207102		0270-7306	Molecular and Cellular Biology	Detection of RAG Protein-V(D)J Recombination Signal Interactions Near the Site of DNA Cleavage by UV Cross-Linking	Eastman	1999	6		
958	chr11	48970924	48971439	3500013789	81		48970924	48971439	8421504	4	9,16,43,13	0,16,458,502	g	350001378900000297	0-126						Methods for using canine immunoglobulin variable domains and caninized antibodies	Krah	2002	0		
119	chr11	48982290	49080061	3500435035	708		48982290	49080061	8421504	4	50,294,38,326	0,466,92945,97445	g	350043503500000055	0-723						Tissue Specific Expression Of Exogenous Proteins In Transgenic Chickens 	.freshpatents.com	0	0		
119	chr11	48982290	49080061	3500297579	708		48982290	49080061	8421504	4	50,294,38,326	0,466,92945,97445	g	350029757900000112	0-723						Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates - Patent application	www.faqs.org	0	0		
119	chr11	48982290	49080061	3500111880	708		48982290	49080061	8421504	4	50,294,38,326	0,466,92945,97445	g	350011188000000142	0-723						Transgenic ungulates having reduced prion protein activity and uses thereof - Patent application	www.faqs.org	0	0		
958	chr11	48993503	48993535	3500429641	26		48993503	48993535	8421504	3	6,5,15	0,10,17	g	350042964100000045	18-44						Activity dependent neurotrophic factor III (ADNF III)	Gozes	1998	0		
958	chr11	49015302	49015330	3500390345	28		49015302	49015330	8421504	1	28	0	g	350039034500000064,350039034500000065,350039034500000029,350039034500000030,350039034500000068,350039034500000031	0-28,2-30,0-28,2-30,0-22,0-22					Patent	ANTIBODIES TO MAdCAM (Patent EP:1709080)	Green	2011	0		
958	chr11	49015302	49015330	3500273025	28		49015302	49015330	8421504	1	28	0	g	350027302500000024,350027302500000023,350027302500000027,350027302500000028	2-30,0-28,0-22,2-24						ANTIBODIES TO MAdCAM	Green	2005	0		
958	chr11	49015302	49015330	3500143658	28		49015302	49015330	8421504	1	28	0	g	350014365800000074,350014365800000073,350014365800000036,350014365800000037	2-30,0-28,0-28,2-30					Patent	Antibodies to MAdCAM (Patent EP:2177537)	Green	2011	0		
958	chr11	49015302	49015330	3500054352	28		49015302	49015330	8421504	1	28	0	g	350005435200000038,350005435200000037,350005435200000041,350005435200000042	2-30,0-28,0-22,2-24						Antibodies to MAdCAM	Pullen	2007	0		
958	chr11	49015306	49015330	3500272920	24		49015306	49015330	8421504	1	24	0	g	350027292000000030	0-24						Antibodies to CD40 - Patent application	www.faqs.org	0	0		
958	chr11	49019506	49019532	3500302637	26		49019506	49019532	8421504	1	26	0	g	350030263700000032,350030263700000088	7-38,0-20						Ig genes specific oligonucleotides and uses thereof	Devinder	2009	0		
958	chr11	49019509	49019533	3500461106	24		49019509	49019533	8421504	1	24	0	g	350046110600000007	0-24						Neutralizing anti-ccl20 antibodies	Imai	2012	0		
958	chr11	49019748	49019771	3500087534	23		49019748	49019771	8421504	1	23	0	g	350008753400000015	0-23						Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof	King	1993	0		
959	chr11	49030653	49030678	3500370067	25		49030653	49030678	8421504	1	25	0	g	350037006700000035,350037006700000036	0-25,0-25						SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 - Patent application	www.faqs.org	0	0		
959	chr11	49030653	49030678	3500199604	25		49030653	49030678	8421504	1	25	0	g	350019960400000034,350019960400000035	0-25,0-25						Selective and potent peptide inhibitors of kv1.3	Sullivan	2010	0		
959	chr11	49030665	49075919	3500258554	50		49030665	49075919	8421504	2	23,27	0,45227	g	350025855400001339,350025855400001463,350025855400001482	0-23,0-23,21-48						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
959	chr11	49030848	49030898	3500010160	50		49030848	49030898	8421504	1	50	0	g	350001016000000003	7-57						Expression vector for secreting antibody fragment using signal sequence and method for mass-producing antibody fragment - US Patent 7718399 Description	ww.patentstorm.us	0	0		
959	chr11	49030849	49030936	3500395134	59		49030849	49030936	8421504	2	46,13	0,74	g	350039513400000005	170-251						 Domain Antibody Construct 	www.docstoc.com	0	0		
959	chr11	49065797	49066087	3500282840	57		49065797	49066087	8421504	3	23,26,8	0,255,282	g	350028284000000075	0-179						ANTIBODIES TO IL-6 AND USE THEREOF - Patent application	www.faqs.org	0	0		
959	chr11	49065797	49066087	3500249437	54		49065797	49066087	8421504	3	23,23,8	0,258,282	g	350024943700000176	0-179					Patent	Antagonists of IL-6 to raise albumin and/or lower CRP (Patent US:8404235)	Smith	2013	0		
959	chr11	49065797	49066087	3500245486	54		49065797	49066087	8421504	3	23,23,8	0,258,282	g	350024548600000176	0-179						Antagonists of IL-6 to raise Albumin and/or lower CRP - Patent application	www.faqs.org	0	0		
959	chr11	49075901	49075926	3500226354	24		49075901	49075926	8421504	2	15,9	0,16	g	350022635400000032	7-31						Rapid Expression Cloning of Human Monoclonal Antibodies from Memory B Cells - Patent application	www.faqs.org	0	0		
959	chr11	49075901	49075926	3500023664	25		49075901	49075926	8421504	1	25	0	g	350002366400000016	5-30					Patent	Antibodies against PDGFRa (Patent US:8128929)	Huber	2012	0		
959	chr11	49075901	49075925	3500441209	24		49075901	49075925	8421504	1	24	0	g	350044120900000035,350044120900000473	0-24,0-24						Antibodies Against Lesion Tissue 	.freshpatents.com	0	0		
959	chr11	49075901	49075925	3500414903	24		49075901	49075925	8421504	1	24	0	g	350041490300000039,350041490300000158	0-24,0-24						Novel Human Leucine-rich Repeat Domain Containing Protein Hllrcr-1 	.freshpatents.com	0	0		
959	chr11	49075901	49075925	3500400313	24		49075901	49075925	8421504	1	24	0	g	350040031300000073	0-24					Patent	Polynucleotides encoding BSL2vcvc-lg (Patent US:8354513)	Mikesell	2013	0		
959	chr11	49075901	49075925	3500387786	24		49075901	49075925	8421504	1	24	0	g	350038778600000025	0-24						Antibodies that immunospecifically bind to trail receptors	Salcedo	2004	0		
959	chr11	49075901	49075925	3500365957	24		49075901	49075925	8421504	1	24	0	g	350036595700000081,350036595700000044,350036595700000086	0-24,22-42,28-48						Methods for producing members of specific binding pairs	McCafferty	2010	0		
959	chr11	49075901	49075925	3500342885	24		49075901	49075925	8421504	1	24	0	g	350034288500000049,350034288500000086,350034288500000091	22-42,0-24,28-48					Patent	Methods for producing members of specific binding pairs (Patent US:5969108)	Bonnert	1999	0		
959	chr11	49075901	49075925	3500340807	24		49075901	49075925	8421504	1	24	0	g	350034080700000054	0-24						Polynucleotide encoding a novel immunoglobulin superfamily member, APEX4, and variants and splice variants thereof	Finger	2002	0		
959	chr11	49075901	49075925	3500303285	24		49075901	49075925	8421504	1	24	0	g	350030328500000024	0-24						Antibodies that specifically bind to reg iv	Rosen	2004	0		
959	chr11	49075901	49075925	3500225617	24		49075901	49075925	8421504	1	24	0	g	350022561700000051	0-24						Vascular endothelial growth factor 2	Rosen	2002	0		
959	chr11	49075901	49075925	3500216632	24		49075901	49075925	8421504	1	24	0	g	350021663200000037,350021663200000104	0-24,0-24						Polynucleotides encoding a human G-protein coupled receptor, HGPRBMY39 - Patent # 7198912 - PatentGenius	.patentgenius.com	0	0		
959	chr11	49075901	49075925	3500208662	24		49075901	49075925	8421504	1	24	0	g	350020866200000086,350020866200000044,350020866200000081	28-48,22-42,0-24					Patent	Methods for producing members of specific binding pairs (Patent US:7635666)	McCafferty	2009	0		
959	chr11	49075901	49075925	3500190029	24		49075901	49075925	8421504	1	24	0	g	350019002900000042	0-24						Polynucleotides encoding a novel human neuronal cell adhesion protein, BGS-28, and variants thereof	Wu	2004	0		
959	chr11	49075901	49075925	3500177118	24		49075901	49075925	8421504	1	24	0	g	350017711800000051	0-24						Vascular endothelial growth factor 2	Rosen	2008	0		
959	chr11	49075901	49075925	3500083834	24		49075901	49075925	8421504	1	24	0	g	350008383400000045	0-24						Chemokine beta-1 fusion proteins	Bell	2002	0		
959	chr11	49075901	49075925	3500026089	24		49075901	49075925	8421504	1	24	0	g	350002608900000024	0-24						Recombinant Anti-cd4 Antibodies For Human Therapy 	.freshpatents.com	0	0		
959	chr11	49079827	49079859	3500144411	32		49079827	49079859	8421504	1	32	0	g	350014441100000134	3-35						Tumor-Targeting Monoclonal Antibodies to FZD10 and Uses Thereof - Patent application	www.faqs.org	0	0		
959	chr11	49126443	49126470	3500367934	27		49126443	49126470	8421504	1	27	0	c	350036793400000446	0-27						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
963	chr11	49561197	49561223	3500366733	25		49561197	49561223	8421504	2	11,14	0,12	g	350036673300000292	20-45						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
963	chr11	49598324	49598349	3500401025	25		49598324	49598349	8421504	1	25	0	c	350040102500000014	5-30						Identification of Short Interspersed Elements (SINEs) in Iranian River Buffalo	www.eaap.org	0	0		
963	chr11	49611719	49611744	3500154075	23		49611719	49611744	8421504	2	6,17	0,8	c	350015407500000330,350015407500000699,350015407500000080,350015407500000700,350015407500000329,350015407500000581	0-22,0-21,7-28,0-22,0-21,7-30						US Patent # 6,730,479. Detection of nucleic acid hybrids - Patents.com	www.patents.com	0	0		
963	chr11	49651997	49654384	3500210802	40		49651997	49654384	8421504	2	20,20	0,2367	c,g	350021080200000014,350021080200000014,350021080200000015	0-20,0-20,0-20			10.1002/ejlt.201100343	1438-9312	European Journal of Lipid Science and Technology	Fish-meal diet enriched with omega-3 PUFA and treatment of canine chronic enteropathies - Ontsouka - 2012 - European Journal of Lipid Science and Technology - Wiley Online Library	Ontsouka	2012	0		
963	chr11	49652036	49655221	3500317426	39		49652036	49655221	8421504	3	19,4,16	0,2368,3169	c	350031742600000002,350031742600000003	0-19,0-20		23302080	10.1111/j.1740-0929.2012.01038.x	1740-0929	Animal Science Journal	Fatty acid-binding protein expression in the gastrointestinal tract of calves and cows - HAYASHI - 2012 - Animal Science Journal - Wiley Online Library	HAYASHI	2013	0		
963	chr11	49652091	49655219	3500281920	40		49652091	49655219	8421504	3	20,6,14	0,2311,3114	c	350028192000000036,350028192000000037	0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
963	chr11	49665174	49665202	3500317072	24		49665174	49665202	8421504	2	12,12	0,16	c	350031707200000244,350031707200000245,350031707200000249,350031707200000242,350031707200000196,350031707200000240,350031707200000241,350031707200000246,350031707200000247,350031707200000208,350031707200000209,350031707200000206,350031707200000207,350031707200000204,350031707200000205,350031707200000202,350031707200000203,350031707200000200,350031707200000201,350031707200000237,350031707200000236,350031707200000235,350031707200000216,350031707200000233,350031707200000232,350031707200000231,350031707200000230,350031707200000239,350031707200000238,350031707200000256,350031707200000257,350031707200000197,350031707200000217,350031707200000251,350031707200000250,350031707200000253,350031707200000234,350031707200000219,350031707200000218,350031707200000198,350031707200000199,350031707200000215,350031707200000214,350031707200000194,350031707200000195,350031707200000211,350031707200000210,350031707200000213,350031707200000212,350031707200000220,350031707200000221,350031707200000222,350031707200000223,350031707200000224,350031707200000225,350031707200000226,350031707200000227,350031707200000228,350031707200000229,350031707200000243,350031707200000252,350031707200000255,350031707200000248,350031707200000254	6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30,6-30						STRUCTURE AND USE OF 5'PHOSPHATE OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		
964	chr11	49780671	49780735	3500361666	44		49780671	49780735	8421504	2	24,20	0,44	c	350036166600000165,350036166600000354,350036166600000166,350036166600000355	0-24,0-24,0-20,0-20						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
964	chr11	49780671	49780735	3500156510	44		49780671	49780735	8421504	2	24,20	0,44	c,g	350015651000000165,350015651000000165,350015651000000166	0-24,0-24,0-20						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
965	chr11	49852748	49852775	3500174638	23		49852748	49852775	8421504	2	15,8	0,19	c	350017463800000327	22-45						US Patent # 8,318,908. Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof - Patents.com	patents.com	0	0		
965	chr11	49852748	49852775	3500043721	23		49852748	49852775	8421504	2	15,8	0,19	c	350004372100000332	25-48						NUCLEIC ACIDS CODING FOR ADHESION FACTOR OF GROUP B STREPTOCOCCUS, ADHESION FACTORS OF GROUP B STREPTOCOCCUS AND FURTHER USES THEREOF - Patent application	www.faqs.org	0	0		
965	chr11	49869061	49924600	3500349361	1173		49869061	49924600	8421504	9	61,155,103,166,167,101,135,143,142	0,906,3555,6146,7129,18969,22189,36916,55397	p	350034936100015000	0-1173						KEGG T01001: 64795	www.genome.jp	0	0		RMND5A
965	chr11	49869061	49876257	3500447618	534		49869061	49876257	8421504	7	61,155,60,40,47,104,67	0,906,3555,3618,6146,6208,7129	p	350044761800015039	3-543					Patent	Antibodies to HASAV70 polypeptide (Patent US:7169565)	Ruben	2007	0		RMND5A
965	chr11	49869061	49876257	3500439093	552		49869061	49876257	8421504	5	61,155,103,166,67	0,906,3555,6146,7129	p	350043909300015038	3-555						Secreted protein HFEAF41	Brewer	2003	0		RMND5A
965	chr11	49869061	49876257	3500080223	552		49869061	49876257	8421504	5	61,155,103,166,67	0,906,3555,6146,7129	p	350008022300015041,350008022300015040	0-453,3-102						87 Human Secreted Proteins	Young	2007	0		RMND5A
965	chr11	49869061	49876257	3500064227	552		49869061	49876257	8421504	5	61,155,103,166,67	0,906,3555,6146,7129	p	350006422700015038	3-555						Secreted protein HFEAF41	Brewer	2003	0		RMND5A
965	chr11	49869061	49876257	3500048645	390		49869061	49876257	8421504	6	39,19,29,70,166,67	0,42,906,3588,6146,7129	p	350004864500015039,350004864500015038	0-87,3-306						Secreted protein HFEAF41	Brewer	2002	0		RMND5A
965	chr11	49869061	49876257	3500032881	540		49869061	49876257	8421504	8	61,98,54,63,34,53,110,67	0,906,1007,3555,3624,6146,6202,7129	p	350003288100015038	3-546						87 human secreted proteins	Brewer	2003	0		RMND5A
965	chr11	49869061	49876257	3500029713	534		49869061	49876257	8421504	7	61,155,60,40,47,104,67	0,906,3555,3618,6146,6208,7129	p	350002971300015039	3-543						87 human secreted proteins	Young	2005	0		RMND5A
967	chr11	50076914	50092188	3500384752	276		50076914	50092188	8421504	4	114,7,122,33	0,117,11661,15241	p	350038475200015002,350038475200015005	0-177,0-99						48 human secreted proteins	Komatsoulis	2002	0		KDM3A
967	chr11	50076914	50092188	3500375425	276		50076914	50092188	8421504	4	114,7,122,33	0,117,11661,15241	p	350037542500015002,350037542500015005	0-177,0-99						48 human secreted proteins	Komatsoulis	2000	0		KDM3A
967	chr11	50130991	50131129	3500177411	45		50130991	50131129	8421504	2	22,23	0,115	c,g	350017741100000005,350017741100000005,350017741100000004,350017741100000004	0-22,0-22,0-23,0-23		18535151	10.1634/stemcells.2008-0388	1549-4918	STEM CELLS	G9a and Jhdm2a Regulate Embryonic Stem Cell Fusion-Induced Reprogramming of Adult Neural Stem Cells - Ma - 2008 - STEM CELLS - Wiley Online Library	Ma	2008	0		KDM3A
969	chr11	50400994	50415818	3500028989	23		50400994	50415818	8421504	2	12,11	0,14813	c	350002898900000005,350002898900000009	13-36,9-31						UNIVERSITY OF NOVA GORICA GRADUATE SCHOOL	www.ung.si/~libra	0	0		REEP1,MRPL35
970	chr11	50469169	50469743	3500156067	23		50469169	50469743	8421504	3	11,3,9	0,16,565	c	350015606700000021	22-46						SULFOTRANSFERASE 1E1 SEQUENCE VARIANTS	Adjei	2011	0		
970	chr11	50535900	50535924	3500164528	23		50535900	50535924	8421504	2	13,10	0,14	c	350016452800000077	10-33						JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS - Patent application	www.faqs.org	0	0		
972	chr11	50802676	50802701	3500431731	23		50802676	50802701	8421504	3	8,4,11	0,9,14	g	350043173100000014	15-38						Integrin-linked kinase and its uses	Dedhar	2000	0		
973	chr11	50954275	50955734	3500399012	147		50954275	50955734	8421504	4	19,90,18,20	0,560,1363,1439	p,c	350039901200000002,350039901200015004,350039901200015005,350039901200015001,350039901200000001	0-19,0-60,12-90,0-60,0-20		15294977		0022-1767	The Journal of Immunology	Characterization of Bovine Homologues of Granulysin and NK-lysin	Endsley	2004	6		
974	chr11	51060542	51060570	3500144006	25		51060542	51060570	8421504	3	6,12,7	0,8,21	g	350014400600000036	5-32						MULTIDOMAIN BIOTAGS FOR CANCER DETECTION, DIAGNOSIS AND THERAPY AND METHODS OF THEIR USE - Patent application	www.faqs.org	0	0		
974	chr11	51091917	51092851	3500193113	40		51091917	51092851	8421504	3	20,16,4	0,105,930	c	350019311300000004,350019311300000005	0-20,0-20		24086682	10.1371/journal.pone.0076036	1932-6203	PLOS ONE	PLOS ONE: Establishment and Evaluation of a Stable Cattle Type II Alveolar Epithelial Cell Line	Su	2013	4		
975	chr11	51148805	51148831	3500369652	23		51148805	51148831	8421504	2	9,14	0,12	c	350036965200000268	16-39						<HTML> <HEAD> <TITLE>U.S. Patent: 5635617 - Methods and compositions comprising the agfA gene for	w.everypatent.com	0	0		
975	chr11	51148805	51148831	3500187612	23		51148805	51148831	8421504	2	9,14	0,12	c	350018761200000268	16-39						US Patent # 5,635,617. Methods and compositions comprising the agfA gene for detection of Salmonella - Patents.com	www.patents.com	0	0		
975	chr11	51172265	51172294	3500202865	28		51172265	51172294	8421504	2	23,5	0,24	c	350020286500000112	11-42						Nucleic acids encoding PTH functional domain conjugate peptides - Patent # 7244834 - PatentGenius	.patentgenius.com	0	0		
975	chr11	51216189	51216216	3500346862	27		51216189	51216216	8421504	1	27	0	c	350034686200000025,350034686200000006	0-27,0-27						Host Cell Comprising a Vector for Production of Proteins Requiring Gamma-Carboxylation - Patent application	www.faqs.org	0	0		
975	chr11	51216189	51216216	3500339216	27		51216189	51216216	8421504	1	27	0	c	350033921600000007	0-27						Host Cell Comprising A Vector For Production Of Proteins Requiring Gamma-carboxylation 	.freshpatents.com	0	0		
975	chr11	51216189	51216216	3500279705	27		51216189	51216216	8421504	1	27	0	c	350027970500000006	0-27					Patent	Compositions and methods relating to proteins requiring gamma-carboxylation (Patent US:8304224)	Lovgren	2012	0		
975	chr11	51216189	51216216	3500130881	27		51216189	51216216	8421504	1	27	0	c	350013088100000006,350013088100000023	0-27,0-27						COMPOSITIONS AND METHODS FOR PRODUCING GAMMA-CARBOXYLATED PROTEINS - Patent application	www.faqs.org	0	0		
975	chr11	51216737	51216764	3500299368	23		51216737	51216764	8421504	2	15,8	0,19	c	350029936800000022	9-32						PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI - Patent application	www.faqs.org	0	0		
975	chr11	51222539	51227458	3500200468	42		51222539	51227458	8421504	2	21,21	0,4898	c,g	350020046800000000,350020046800000000,350020046800000001,350020046800000001	0-21,0-21,0-21,0-21						Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development	digital.csic.es	0	0		
975	chr11	51223724	51224001	3500356816	45		51223724	51224001	8421504	2	24,21	0,256	p	350035681600015128	0-45						Biomarkers And Detection Methods For Gastric Diseases 	.freshpatents.com	0	0		MAT2A
976	chr11	51340418	51340444	3500062911	24		51340418	51340444	8421504	2	16,8	0,18	g	350006291100000001	7-31		18820299	10.1093/nar/gkn605		Nucleic Acids Research	Evolutionary conservation supports ancient origin for Nudt16, a nuclear-localized, RNA-binding, RNA-decapping enzyme	Melissa	2008	0		
976	chr11	51356985	51357921	3500009551	25		51356985	51357921	8421504	2	20,5	0,931	c	350000955100000017	0-25						METHODS AND GENE EXPRESSION SIGNATURE FOR WNT/B-CATENIN SIGNALING PATHWAY - Patent application	www.faqs.org	0	0		CAPG
976	chr11	51360858	51361962	3500117251	45		51360858	51361962	8421504	2	18,27	0,1077	p	350011725100015080	0-45						Diagnostic composition and kit for renal cell carcinoma - Patent # 8278058 - PatentGenius	.patentgenius.com	0	0		
977	chr11	51398613	51398638	3500231208	23		51398613	51398638	8421504	2	7,16	0,9	g	350023120800000009	9-36					Patent	C1 Inhibitor produced in the milk of transgenic non-human mammals (Patent US:7067713)	Heus	2006	0		
977	chr11	51398613	51398638	3500012382	23		51398613	51398638	8421504	2	7,16	0,9	g	350001238200000009	9-36						C1 Inhibitor produced in the milk of transgenic non-human mammals	Nuijens	2001	0		
979	chr11	51702609	51723230	3500121800	249		51702609	51723230	8421504	5	8,28,42,102,69	0,1996,2129,5439,20552	p	350012180000015036,350012180000015033	0-174,0-180						49 human secreted proteins	Komatsoulis	2000	0		KCMF1
980	chr11	51850621	51851011	3500404944	40		51850621	51851011	8421504	2	20,20	0,370	c,g	350040494400000047,350040494400000047,350040494400000046	0-20,0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
980	chr11	51850670	51851055	3500239275	102		51850670	51851055	8421504	2	20,82	0,303	p	350023927500015020,350023927500015016,350023927500015015	3-75,18-102,0-102						Planaria EST Database	an.bio.keio.ac.jp	0	0		
980	chr11	51850687	51851012	3500157797	42		51850687	51851012	8421504	2	3,39	0,286	c	350015779700000005	0-42						 Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	www.docstoc.com	0	0		
986	chr11	52567465	52591444	3500187625	41		52567465	52591444	8421504	4	8,12,7,14	0,9,23955,23965	g	350018762500000113,350018762500000121	3-23,6-27						Anti-IGF-1R Antibodies and Uses Thereof	Demarest	2008	0		
1006	chr11	55273499	55273527	3500320517	23		55273499	55273527	8421504	2	7,16	0,12	g	350032051700000030	22-45						Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides	Boehling	2005	0		
1007	chr11	55333260	55333286	3500019915	23		55333260	55333286	8421504	2	16,7	0,19	g	350001991500000199	8-31						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
1014	chr11	56324242	56324305	3500309903	63		56324242	56324305	8421504	1	63	0	p	350030990300015000	0-63						Antagonism of Cell Adhesion by an a -Catenin Mutant, and of the Wnt-signaling Pathway by a -Catenin in Xenopus	userwww.sfsu.edu	0	0		CTNNA2
1014	chr11	56324242	56324305	3500210172	63		56324242	56324305	8421504	1	63	0	p	350021017200015004	0-63						Antagonism of cell adhesion by an alpha-catenin mutant, and of the Wnt-signaling pathway by alpha-catenin in Xenopus embryos. - ResearchGate	.researchgate.net	0	0		CTNNA2
1015	chr11	56421282	56421305	3500461467	23		56421282	56421305	8421504	1	23	0	g	350046146700000003	4-30		19179414	10.1128/IAI.01456-08	0019-9567	Infection and Immunity	Helicobacter pylori-Induced Interleukin-12 p40 Expression	Takeshima	2009	4		
1017	chr11	56685799	56685828	3500156379	23		56685799	56685828	8421504	3	12,4,7	0,13,22	g	350015637900000000	0-24						Heterologous expression in Pichia pastoris and characterization of an endogenous thermostable and high-glucose-tolerant &#x03b2;-glucosidase from the termite Nasutitermes takasagoensis. - ResearchGate	.researchgate.net	0	0		
1017	chr11	56740388	56740433	3500454482	45		56740388	56740433	8421504	1	45	0	p	350045448200015114	0-45						LRRTM1 Compositions and Methods of Their Use for the Diagnosis and Treatment of Cancer - Patent application	www.faqs.org	0	0		
1023	chr11	57421940	57421968	3500456727	26		57421940	57421968	8421504	3	13,5,8	0,14,20	g	350045672700000100	22-48					Patent	Recombinant plant expressing non-competitively binding insecticidal crystal proteins (Patent US:5866784)	Botterman	1999	0		
1024	chr11	57585027	57585051	3500442923	24		57585027	57585051	8421504	1	24	0	c	350044292300000008	10-34						Charakterisierung der Interaktion von Nesprin-2 und &#x03b1;-Catenin an der Plasma- und Zellkernmembran	www.uni-koeln.de	0	0		CTNNA2
1026	chr11	57804922	57804950	3500302030	27		57804922	57804950	8421504	2	19,8	0,20	g	350030203000000002	4-31						Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates	Ferguson	2002	0		
1026	chr11	57804953	57805215	3500451179	242		57804953	57805215	8421504	5	53,54,57,54,24	0,58,117,179,238	g	350045117900000137	233-475						 Transgenic Animals And Uses Thereof 	www.docstoc.com	0	0		
1026	chr11	57804953	57805215	3500123062	262		57804953	57805215	8421504	1	262	0	g	350012306200000149	308-570						TRANSGENIC ANIMALS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1026	chr11	57805007	57805044	3500319187	37		57805007	57805044	8421504	1	37	0	g	350031918700000028,350031918700000002	0-20,0-25						Transgenic animals and uses thereof	Robl	2005	0		
1027	chr11	58029378	58029404	3500062852	24		58029378	58029404	8421504	2	7,17	0,9	g	350006285200000025	8-36						Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides	Atkinson	2007	0		
1029	chr11	58217401	58217425	3500024354	24		58217401	58217425	8421504	1	24	0	c	350002435400000001	0-24						High level of expression of ingap	Barlow	2000	0		
1040	chr11	59726259	59726284	3500130057	25		59726259	59726284	8421504	1	25	0	g	350013005700000307	17-42						ABSTRACT BIRKENHEUER, ADAM JOSEPH. Canine Babesiosis: Epidemiological, Molecular and	tory.lib.ncsu.edu	0	0		
1042	chr11	59993637	59994187	3500302241	39		59993637	59994187	8421504	2	20,19	0,531	g	350030224100000195,350030224100000169,350030224100000192	24-44,12-31,21-40						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
1042	chr11	60018755	60018778	3500087615	23		60018755	60018778	8421504	1	23	0	g	350008761500000043	24-47						Crossless retroviral vectors	Bodner	1999	0		
1048	chr11	60755567	60755593	3500375146	24		60755567	60755593	8421504	2	5,19	0,7	g	350037514600000024	13-37						A radiation hybrid map of river buffalo (Bubalus bubalis) chromosome 1 (BBU1)	ticabovina.com.br	0	0		
1058	chr11	62098220	62098447	3500215496	51		62098220	62098447	8421504	2	25,26	0,201	c	350021549600000013,350021549600000012	0-25,0-26						Extensive promoter hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia Supplementary Methods	.aacrjournals.org	0	0		
1060	chr11	62288744	62288767	3500172748	23		62288744	62288767	8421504	1	23	0	g	350017274800000005	8-31						Studies on the antimicrobial defence of human hair follicle epithelium	diss.fu-berlin.de	0	0		
1061	chr11	62405332	62405378	3500313498	36		62405332	62405378	8421504	3	22,9,5	0,31,41	g	350031349800000051	44-83						Recombinantly produced spider silk	www.devileye.net	0	0		
1062	chr11	62523876	62523988	3500343582	47		62523876	62523988	8421504	2	22,25	0,87	c	350034358200000014,350034358200000015	0-22,0-25						ABSTRACT	tory.lib.ncsu.edu	0	0		
1064	chr11	62910392	62910418	3500007163	23		62910392	62910418	8421504	2	9,14	0,12	g	350000716300000001	2-26		23533592	10.1371/journal.pone.0058796	1932-6203	PLOS ONE	PLOS ONE: OstemiR: A Novel Panel of MicroRNA Biomarkers in Osteoblastic and Osteocytic Differentiation from Mesencymal Stem Cells	Eguchi	2013	4		
1067	chr11	63205250	63205286	3500097271	26		63205250	63205286	8421504	3	9,3,14	0,14,22	g	350009727100000000	4-30						Analysis of CCL5 expression in classical Hodgkin's lymphoma L428 cell line	-publications.com	0	0		
1067	chr11	63267781	63267808	3500307135	23		63267781	63267808	8421504	2	8,15	0,12	c	350030713500000186	7-30						NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1067	chr11	63268502	63268556	3500078283	54		63268502	63268556	8421504	1	54	0	p	350007828300015017	0-54						Annelid regeneration and fission	rm.biology.uh.edu	0	0		OTX1
1067	chr11	63271107	63271133	3500062030	23		63271107	63271133	8421504	2	10,13	0,13	g	350006203000000012	1-24					Patent	Streptavidin expressed gene fusions and methods of use thereof (Patent US:7144991)	Goshorn	2006	0		
1070	chr11	63661254	63662846	3500370584	23		63661254	63662846	8421504	3	6,10,7	0,1574,1585	c	350037058400000112	19-42						Protease inhibition - Patent application	www.faqs.org	0	0		
1070	chr11	63661254	63662846	3500248879	23		63661254	63662846	8421504	3	6,10,7	0,1574,1585	c	350024887900000096	19-42						Protease Inhibition 	.freshpatents.com	0	0		
1070	chr11	63661254	63662846	3500127909	23		63661254	63662846	8421504	3	6,10,7	0,1574,1585	c	350012790900000096	19-42						Protease inhibition	Ladner	2008	0		
1071	chr11	63793448	63795396	3500409234	38		63793448	63795396	8421504	2	19,19	0,1929	c,g	350040923400000008,350040923400000009	0-19,0-19						A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress	www.ejcho.info	0	0		MDH1
1077	chr11	64602010	64606995	3500464481	513		64602010	64606995	8421504	5	33,72,89,178,141	0,777,994,2302,4844	p	350046448100015007,350046448100015008	75-156,0-432						Antibodies to HBIMF63 polypeptide - US Patent 7381800 Description	ww.patentstorm.us	0	0		LGALSL
1077	chr11	64602010	64606995	3500235475	513		64602010	64606995	8421504	5	33,72,89,178,141	0,777,994,2302,4844	p	350023547500015009	75-588						18 human secreted proteins	Ebner	2001	0		LGALSL
1078	chr11	64629499	64629524	3500400115	23		64629499	64629524	8421504	2	9,14	0,11	g	350040011500000075,350040011500000081	3-24,3-22						Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation	Witte	2001	0		
1078	chr11	64728018	64728041	3500161237	23		64728018	64728041	8421504	1	23	0	g	350016123700000007	10-33						US Patent # 6,683,165. Human gene relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
1082	chr11	65219104	65220592	3500321930	38		65219104	65220592	8421504	2	19,19	0,1469	c,g	350032193000000001,350032193000000001,350032193000000000	0-19,0-19,0-19						Proteomic analysis of endocytic vesicles: Rab1a regulates motility of early endocytic vesicles	cs.biologists.org	0	0		RAB1A
1082	chr11	65219193	65220538	3500451669	24		65219193	65220538	8421504	2	13,11	0,1334	c	350045166900000006	16-40						Diagnostic for lung disorders using class prediction - Patent application	www.faqs.org	0	0		RAB1A
1082	chr11	65219193	65220538	3500429764	24		65219193	65220538	8421504	2	13,11	0,1334	c	350042976400000006	16-40						Diagnostic for lung disorders using class prediction	Beane	2012	0		
1082	chr11	65219193	65220538	3500182576	24		65219193	65220538	8421504	2	13,11	0,1334	c	350018257600000006	16-40						Diagnostic for lung disorders using class prediction	Brody	2010	0		RAB1A
1082	chr11	65219193	65220538	3500156300	24		65219193	65220538	8421504	2	13,11	0,1334	c	350015630000000006	16-40						Diagnostic for lung disorders using class prediction	Brody	2013	0		RAB1A
1083	chr11	65368499	65368524	3500060061	25		65368499	65368524	8421504	1	25	0	c	350006006100000008	0-25			10.1242/jcs.03311	0021-9533	Journal of Cell Science	Rac-WAVE-mediated actin reorganization is required for organization and maintenance of cell-cell adhesion	Yamazaki	2007	6		
1083	chr11	65380097	65380142	3500284706	45		65380097	65380142	8421504	1	45	0	p	350028470600015000	3-48						The Embo Journal	005.pasteur.ac.ir	0	0		ACTR2
1084	chr11	65489062	65489224	3500156510	43		65489062	65489224	8421504	2	22,21	0,141	g	350015651000000175,350015651000000176	0-22,0-21						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
1085	chr11	65600334	65600361	3500328855	24		65600334	65600361	8421504	2	16,8	0,19	g	350032885500000088	0-24						Polynucleotide encoding cytokine receptor zcytor17 multimer - US Patent 7494804 Description	ww.patentstorm.us	0	0		
1086	chr11	65687089	65687116	3500288444	26		65687089	65687116	8421504	2	10,16	0,11	g	350028844400000022,350028844400000011	8-35,8-34						Tissue factor compositions and ligands for the specific coagulation of vasculature	Thorpe	1995	0		
1089	chr11	66176072	66176101	3500004520	24		66176072	66176101	8421504	2	14,10	0,19	g	350000452000000027	19-43					Patent	GnRH-leukotoxin chimeras (Patent US:6022960)	Manns	2000	0		
1090	chr11	66193393	66222374	3500072483	39		66193393	66222374	8421504	4	14,5,4,16	0,17,28960,28965	g	350007248300000697,350007248300000247	9-28,4-24						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
1090	chr11	66235970	66236002	3500261192	26		66235970	66236002	8421504	3	9,4,13	0,14,19	g	350026119200000009	0-26						Production of antibodies in plants with plus-sense single-stranded viral rna vectors	Giritch	2007	0		
1090	chr11	66235970	66236002	3500096793	26		66235970	66236002	8421504	3	9,4,13	0,14,19	g	350009679300000009	0-26						Production of antibodies in plants with plus -sense single -stranded viral rna vectors	Giritch	2006	0		
1090	chr11	66245089	66245118	3500180586	24		66245089	66245118	8421504	2	17,7	0,22	g	350018058600000015	2-26						EXPRESSION OF TRIPLE-HELICAL COLLAGEN-LIKE PRODUCTS IN E.COLI - Patent application	www.faqs.org	0	0		DUSP7
1091	chr11	66411868	66411895	3500273486	23		66411868	66411895	8421504	3	5,12,6	0,6,21	g	350027348600000030,350027348600000156,350027348600000157	5-29,5-29,7-31						Single-Point Genome Signature Tags - Patent application	www.faqs.org	0	0		
1092	chr11	66519694	66519717	3500448014	23		66519694	66519717	8421504	1	23	0	c	350044801400000016	0-23						Characterization of the putative CALM AF10 collaborator Meis1 in leukemia development	b.uni-muenchen.de	0	0		MEIS1
136	chr11	66547874	66635280	3500189468	40		66547874	66635280	8421504	3	3,17,20	0,49970,87386	c,g	350018946800000003,350018946800000004,350018946800000004	0-20,0-20,0-20						The trithorax protein partner menin acts in tandem with EZH2 to suppress C/EBPa and differentiation in MLL-AF9 leukemi	haematologica.org	0	0		MEIS1
1093	chr11	66657228	66659575	3500448014	75		66657228	66659575	8421504	3	31,24,20	0,32,2327	c	350044801400000020,350044801400000017,350044801400000009,350044801400000023	0-20,0-24,7-31,0-20						Characterization of the putative CALM AF10 collaborator Meis1 in leukemia development	b.uni-muenchen.de	0	0		
1093	chr11	66657258	66657283	3500172558	25		66657258	66657283	8421504	1	25	0	c	350017255800000017	0-25		12609849	10.1182/blood-2002-02-0380	0006-4971	Blood	Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 gene	Okada	2003	10		MEIS1
1093	chr11	66660174	66660197	3500424254	23		66660174	66660197	8421504	1	23	0	c	350042425400000014	1-24						Ca2+/calmodulin-dependent protein kinase IV	Means	2002	0		
1093	chr11	66660189	66660216	3500242494	27		66660189	66660216	8421504	1	27	0	c	350024249400000196,350024249400000193	0-25,0-25						Taiwan Banded Krait -Bungarotoxins: Novel Isotoxins, Targeting and Gene Organization	.lib.nsysu.edu.tw	0	0		
1093	chr11	66660225	66660314	3500321118	40		66660225	66660314	8421504	2	20,20	0,69	c	350032111800000012,350032111800000013	0-20,0-20						G&#xfb01;1integratesprogenitorversusgranulocytictranscriptionalprogramming	tologylibrary.org	0	0		
1093	chr11	66660225	66660314	3500145457	40		66660225	66660314	8421504	2	20,20	0,69	c,g	350014545700000012,350014545700000012,350014545700000013,350014545700000013	0-20,0-20,0-20,0-20		19346496	10.1182/blood-2008-09-179747		Blood	Gfi1 integrates progenitor versus granulocytic transcriptional programming	Shane	2009	0		MEIS1
1101	chr11	67732220	67732247	3500190153	23		67732220	67732247	8421504	2	10,13	0,14	g	350019015300000030	14-43						Glyphosate tolerant plants	Barry	1995	0		
1107	chr11	68474024	68533281	3500114396	54		68474024	68533281	8421504	3	27,24,3	0,23773,59254	c,g	350011439600000014,350011439600000013	6-33,6-33						Studies on Bovine Eye Retinal Calcineurin	ecommons.usask.ca	0	0		
1107	chr11	68474027	68533281	3500351863	510		68474027	68533281	8421504	6	45,185,60,177,40,3	0,4688,6227,7341,23754,59251	p	350035186300015004	0-510						KEGG T01001: 11261	www.genome.jp	0	0		PPP3R1
1107	chr11	68474027	68497821	3500025621	507		68474027	68497821	8421504	5	45,185,60,177,40	0,4688,6227,7341,23754	p	350002562100015004,350002562100015003,350002562100015002,350002562100015001	0-57,0-150,0-150,0-153						Pharmaceutical composition containing calcineurin B subunit	Wei	1999	0		PPP3R1
1107	chr11	68474054	68497821	3500392830	432		68474054	68497821	8421504	6	18,78,59,60,177,40	0,4661,4787,6200,7314,23727	p	350039283000015034,350039283000015033,350039283000015031,350039283000015030,350039283000015029,350039283000015028,350039283000015027,350039283000015026,350039283000015025	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						DNA molecules encoding a calcium-integrin binding protein	Naik	1996	0		
1107	chr11	68481444	68533281	3500128493	96		68481444	68533281	8421504	4	48,5,40,3	0,96,16337,51834	p	350012849300015019,350012849300015017	0-48,0-48						Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons	Abramovitch	2000	0		PPP3R1
1109	chr11	68700754	68700777	3500403401	23		68700754	68700777	8421504	1	23	0	g	350040340100000000	15-38					Patent	Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity (Patent US:5529926)	Maat	1996	0		
1109	chr11	68729376	68729404	3500375638	23		68729376	68729404	8421504	2	9,14	0,14	c	350037563800000003	16-39						Treating syndrome x with substituted tetralins and indanes	Chen	2004	0		
1110	chr11	68874056	68878424	3500391741	168		68874056	68878424	8421504	7	23,25,24,22,23,28,23	0,3944,3971,3997,4166,4303,4345	c,g	350039174100000007,350039174100000020,350039174100000022,350039174100000021,350039174100000019,350039174100000019,350039174100000003,350039174100000002	0-23,0-25,0-24,0-22,0-23,0-23,0-28,0-23						Angiogenesis inhibitors	Masuda	2005	0		
1110	chr11	68912431	68912454	3500452021	23		68912431	68912454	8421504	1	23	0	c	350045202100000001	0-23						EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). - ResearchGate	.researchgate.net	0	0		PROKR1
1110	chr11	68912809	68912844	3500173525	35		68912809	68912844	8421504	1	35	0	c	350017352500000024	0-35						UNIVERSITA&#x2019; DEGLI STUDI DI MILANO	air.unimi.it	0	0		
1112	chr11	69101296	69108114	3500248301	1536		69101296	69108114	8421504	4	111,22,1309,94	0,113,136,6724	p,c,g	350024830100000028,350024830100000027,350024830100015081,350024830100000026,350024830100015020,350024830100015046,350024830100000001,350024830100000001,350024830100000032,350024830100015080,350024830100015019,350024830100015044,350024830100015052,350024830100015079,350024830100015054,350024830100000024,350024830100015018,350024830100015042,350024830100000030,350024830100015051,350024830100000060,350024830100015078,350024830100015053,350024830100000023,350024830100015017,350024830100015040,350024830100000029,350024830100000029,350024830100015077,350024830100000000,350024830100000000,350024830100000022,350024830100015016,350024830100015038,350024830100000058,350024830100015076,350024830100000021,350024830100015015,350024830100015036,350024830100015075,350024830100000020,350024830100015014,350024830100015034,350024830100015074,350024830100015013,350024830100015033,350024830100015012,350024830100015032,350024830100015011,350024830100015031,350024830100015010,350024830100000016,350024830100000016,350024830100015030,350024830100000015,350024830100015009,350024830100015029,350024830100015008,350024830100015028,350024830100000013,350024830100015007,350024830100015026,350024830100015067,350024830100015006,350024830100000012,350024830100015025,350024830100015005,350024830100000011,350024830100015024,350024830100015004,350024830100000010,350024830100015023,350024830100000009,350024830100015003,350024830100015022,350024830100015002,350024830100000008,350024830100015021,350024830100015062,350024830100000007,350024830100015088,350024830100015061,350024830100015087	0-300,0-55,0-48,0-48,0-48,0-48,9-33,9-33,0-42,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,6-53,6-53,0-48,9-32,9-32,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-175,0-48,0-48,0-48						Bmp-10 compositions	Celeste	1994	0		
1112	chr11	69101681	69101866	3500278701	48		69101681	69101866	8421504	2	24,24	0,161	c,g	350027870100000002,350027870100000002,350027870100000000,350027870100000001	9-33,9-33,9-33,9-32					Patent	Bmp-10 zusammensetzungen BMP-10 compositions (Patent DE:69433742)	CELESTE	2005	0		
1112	chr11	69101681	69101866	3500138794	47		69101681	69101866	8421504	2	24,23	0,162	c,g	350013879400000001,350013879400000001,350013879400000000,350013879400000000	9-33,9-33,9-32,9-32					Patent	Bmp-10 zusammensetzungen (Patent DE:69433742)	CELESTE	2005	0		
1112	chr11	69101713	69101740	3500448510	24		69101713	69101740	8421504	2	17,7	0,20	c	350044851000000046	10-34					Patent	Chimeric adenoviral coat protein and methods of using same (Patent US:6127525)	Crystal	2000	0		
1112	chr11	69101713	69101740	3500199435	24		69101713	69101740	8421504	2	17,7	0,20	c	350019943500000046	10-34					Patent	Nucleic acid that encodes a chimeric adenoviral coat protein (Patent US:6153435)	Crystal	2000	0		
1112	chr11	69101787	69101831	3500392138	44		69101787	69101831	8421504	1	44	0	c	350039213800000314	0-44						Designer ligands of tgf-beta superfamily	Choe	2010	0		
139	chr11	69249541	69403313	3500238673	954		69249541	69403313	8421504	13	152,72,72,82,34,80,69,81,61,99,70,79,3	0,28038,32888,57335,57964,59637,62284,63819,80200,95380,122413,123978,153769	p	350023867300015002	0-954						VIOLIN: Vaccine Investigation and Online Information Network	www.violinet.org	0	0		ANTXR1
1114	chr11	69434079	69434670	3500265923	63		69434079	69434670	8421504	2	51,12	0,579	p	350026592300015000	0-63		20221438	10.1371/journal.ppat.1000792		PLoS Pathogens	Endocytosis of the Anthrax Toxin Is Mediated by Clathrin, Actin and Unconventional Adaptors	Laurence	2010	0		ANTXR2
1116	chr11	69603626	69623799	3500126523	69		69603626	69623799	8421504	3	48,3,18	0,18232,20155	c	350012652300000071,350012652300000101	0-48,8-29						PLANTS WITH INCREASED HYALURONAN PRODUCTION - Patent application	www.faqs.org	0	0		
1116	chr11	69676359	69699018	3500307946	567		69676359	69699018	8421504	7	30,175,61,115,39,19,128	0,5380,10220,14907,16653,16701,22531	p	350030794600015030,350030794600015024,350030794600015018	0-225,0-195,60-207						BMC Evolutionary Biology BioMed Central	web.onetel.com	0	0		
1119	chr11	70036361	70068785	3500425727	361		70036361	70068785	8421504	14	40,4,28,6,17,40,3,48,1,44,46,39,39,6	0,5462,8700,8753,9589,9622,13264,21191,21284,27049,27099,27733,28830,32418	c	350042572700000123,350042572700000078,350042572700000144,350042572700000082,350042572700000021,350042572700000084,350042572700000088,350042572700000154,350042572700000090,350042572700000091,350042572700000157,350042572700000092,350042572700000158,350042572700000095	6-44,3-41,0-41,7-35,0-23,0-40,0-45,0-45,0-45,0-41,0-42,0-37,0-34,0-45						US Patent # 7,635,678. Modified annexin compositions and methods of using same - Patents.com	www.patents.com	0	0		
1119	chr11	70045061	70045089	3500016524	28		70045061	70045089	8421504	1	28	0	c	350001652400000079	7-35						Modified Annexin Proteins And Methods For Their Use In Platelet Storage And Transfusion 	.freshpatents.com	0	0		
1119	chr11	70045114	70045967	3500307736	23		70045114	70045967	8421504	2	6,17	0,836	c	350030773600000077	0-23						 Cysteine 	www.docstoc.com	0	0		
1119	chr11	70049609	70057562	3500297499	27		70049609	70057562	8421504	4	4,9,4,10	0,5,15,7943	c	350029749900000003	6-33						Growth and Differentiation Factor-9 Stimulates Progression of Early Primary but Not Primordial Rat Ovarian Follicle Development1	ww.biolreprod.org	0	0		
1119	chr11	70049622	70068790	3500068107	197		70049622	70068790	8421504	6	6,42,94,2,42,11	0,7930,13790,14472,15566,19157	c	350006810700000084,350006810700000151,350006810700000087,350006810700000152,350006810700000091,350006810700000156	0-48,0-48,0-47,0-48,0-48,0-47						Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia - Patent application	www.faqs.org	0	0		
1119	chr11	70049625	70068785	3500452256	127		70049625	70068785	8421504	5	3,42,37,39,6	0,7927,14471,15566,19154	c	350045225600000085,350045225600000089,350045225600000092	0-45,0-37,0-45						 Modified Annexin Proteins And Methods For Their Use In Organ Transplantation 	www.docstoc.com	0	0		
1119	chr11	70069012	70069035	3500082615	23		70069012	70069035	8421504	1	23	0	c	350008261500000013	0-23		24212609	10.3390/cancers3010106		Cancers	Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma	Wolfgang	2011	0		GMCL1
1120	chr11	70158233	70159086	3500317306	108		70158233	70159086	8421504	2	73,35	0,818	p	350031730600015002	0-108					Patent	DNA binding compound-mediated molecular switch system (Patent US:7189506)	Bruice	2007	0		MXD1
1120	chr11	70158239	70159074	3500066566	90		70158239	70159074	8421504	2	67,23	0,812	p	350006656600015019,350006656600015021	0-90,0-48						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		MXD1
1120	chr11	70158244	70159107	3500195416	42		70158244	70159107	8421504	2	19,23	0,840	c,g	350019541600000006,350019541600000006,350019541600000007	0-19,0-19,0-23		20682043	10.1186/1476-4598-9-205	1476-4598	Molecular Cancer	Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription Factor	Courapied	2010	4		MXD1
1120	chr11	70158251	70159083	3500299792	87		70158251	70159083	8421504	2	55,32	0,800	p	350029979200015014,350029979200015004	39-123,9-96						Control of gene expression using a complex of an oligonucleotide and a regulatory peptide	Ali	2003	0		MXD1
1120	chr11	70158251	70159083	3500259681	87		70158251	70159083	8421504	2	55,32	0,800	p	350025968100015002,350025968100015012	9-96,39-123						Control of gene expression using a complex of an oligonucleotide and a regulatory peptide - Patent application	www.faqs.org	0	0		MXD1
1120	chr11	70158251	70159083	3500178179	87		70158251	70159083	8421504	2	55,32	0,800	p	350017817900015012,350017817900015002	39-126,9-96						Control Of Gene Expression Using A Complex Of An Oligonucleotide And A Regulatory Peptide 	.freshpatents.com	0	0		MXD1
1120	chr11	70158251	70159083	3500101924	87		70158251	70159083	8421504	2	55,32	0,800	p	350010192400015010,350010192400015005	39-123,9-96						Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide	Jenkinson	2004	0		MXD1
1120	chr11	70158251	70158294	3500310489	43		70158251	70158294	8421504	1	43	0	c	350031048900000001,350031048900000000,350031048900000025,350031048900000024	41-84,15-58,41-84,15-58						COMPOSITIONS AND METHODS FOR DISRUPTING THE FUNCTION OF THE TRANSCRIPTIONAL REPRESSOR COMPONENT Sin3A-PAH2 DOMAIN TO INDUCE DIFFERENTIATION AND GROWTH INHIBITION IN BREAST CANCER - Patent application	www.faqs.org	0	0		MXD1
1120	chr11	70179805	70179829	3500244928	24		70179805	70179829	8421504	1	24	0	c	350024492800000009	1-26						167	www.aaabg.org	0	0		
1120	chr11	70180217	70180242	3500385077	23		70180217	70180242	8421504	2	5,18	0,7	c	350038507700000099,350038507700000097	0-24,1-25						Nucleic acid based detection methods	Arora	2009	0		
1121	chr11	70309085	70309439	3500448129	58		70309085	70309439	8421504	2	37,21	0,333	c,g	350044812900000019,350044812900000015,350044812900000020,350044812900000020	0-21,0-21,0-21,0-21		15933215	10.1124/mol.105.012245	1521-0111 (Online)	Molecular Pharmacology	Poly(C) Binding Protein Family Is a Transcription Factor in &#x03bc;-Opioid Receptor Gene Expression	Kim	2005	0		TIA1
1121	chr11	70309087	70310151	3500424633	40		70309087	70310151	8421504	2	19,21	0,1043	c	350042463300000000,350042463300000001	0-19,27-48		19702650	10.1111/j.1462-5822.2009.01375.x	1462-5822	Cellular Microbiology	Secretory protein with RING finger domain (SPRING) specific to Trypanosoma cruzi is directed, as a ubiquitin ligase related protein, to the nucleus of host cells - Hashimoto - 2009 - Cellular Microbiology - Wiley Online Library	Hashimoto	2010	0		
1121	chr11	70309428	70310213	3500191076	61		70309428	70310213	8421504	3	20,20,21	0,334,764	c,g	350019107600000009,350019107600000009,350019107600000010,350019107600000001	0-20,0-20,0-20,0-21						Poly (C)-Binding Protein 1 Regulates p63 Expression through mRNA Stability. - ResearchGate	.researchgate.net	0	0		TIA1
1121	chr11	70309584	70309620	3500002129	36		70309584	70309620	8421504	1	36	0	c,g	350000212900000021,350000212900000021,350000212900000022,350000212900000022	0-36,0-36,0-33,0-33		17178840	10.1128/MCB.02014-06	0270-7306	Molecular and Cellular Biology	Deciphering the Cross Talk between hnRNP K and c-Src: the c-Src Activation Domain in hnRNP K Is Distinct from a Second Interaction Site	Adolph	2007	6		TIA1
1121	chr11	70309641	70310148	3500145130	129		70309641	70310148	8421504	2	72,57	0,450	p	350014513000015003,350014513000015000	0-72,0-57		11527973	10.1074/jbc.M106824200	0021-9258	Journal of Biological Chemistry	Isolation and Characterization of a Folate Receptor mRNA-binding trans-Factor from Human Placenta	Xiao	2001	5		TIA1
1121	chr11	70309881	70310437	3500137208	38		70309881	70310437	8421504	2	19,19	0,537	c,g	350013720800000007,350013720800000008,350013720800000008	0-19,0-19,0-19						Global analysis of alternative polyadenylation regulation using high-throughput sequencing	ir.uiowa.edu	0	0		TIA1
1121	chr11	70336756	70336781	3500457990	23		70336756	70336781	8421504	2	7,16	0,9	g	350045799000000041	19-42						US Patent # 7,217,554. Proteases and variants thereof - Patents.com	www.patents.com	0	0		
1122	chr11	70421301	70421326	3500240561	23		70421301	70421326	8421504	2	5,18	0,7	c	350024056100000102	0-25						MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR - Patent application	www.faqs.org	0	0		
1122	chr11	70422184	70431461	3500338735	96		70422184	70431461	8421504	3	7,41,48	0,933,9229	c	350033873500000020,350033873500000008	0-48,0-48						DNA encoding a protein active in lymphocyte-mediated cytotoxicity	Anderson	1991	0		
1122	chr11	70423183	70423210	3500116103	26		70423183	70423210	8421504	2	22,4	0,23	c	350011610300000001	18-44		16227602	10.1128/MCB.25.21.9520-9531.2005	0270-7306	Molecular and Cellular Biology	Identification and Functional Outcome of mRNAs Associated with RNA-Binding Protein TIA-1	Silanes	2005	6		
1122	chr11	70424210	70424614	3500116798	23		70424210	70424614	8421504	2	19,4	0,400	c	350011679800000003	19-42						Distance-Dependent Processing of Adeno-Associated Virus Type 5 RNA Is Controlled by 5 Exon De&#xfb01;nition	jvi.asm.org	0	0		
1122	chr11	70425351	70431456	3500070011	43		70425351	70431456	8421504	2	20,23	0,6082	c,g	350007001100000010,350007001100000010,350007001100000011	0-20,0-20,0-23		21347286	10.1371/journal.pone.0016958	1932-6203	PLOS ONE	PLOS ONE: RNA Binding Protein CUGBP2/CELF2 Mediates Curcumin-Induced Mitotic Catastrophe of Pancreatic Cancer Cells	Subramaniam	2011	4		TIA1
1122	chr11	70452925	70452996	3500386452	71		70452925	70452996	8421504	1	71	0	g	350038645200000386,350038645200000142,350038645200000040	0-71,0-31,4-27						NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES	Anderson	2011	0		
1122	chr11	70452925	70452996	3500235647	71		70452925	70452996	8421504	1	71	0	g	350023564700000386,350023564700001179	0-71,0-71						NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES - Patent application	www.faqs.org	0	0		FAM195A
1123	chr11	70559229	70559424	3500262495	195		70559229	70559424	8421504	1	195	0	p	350026249500015006,350026249500015020	0-195,0-195						est_a_palmata1012 | MarineGenomics.org	arinegenomics.org	0	0		EHD3
1123	chr11	70563612	70563663	3500056210	51		70563612	70563663	8421504	1	51	0	p	350005621000015039	0-51						ScienceDirect.com - Journal of Proteomics - A comparative proteome analysis links tyrosine kinase 2 (Tyk2) to the regulation of cellular glucose and lipid metabolism in response to poly(I:C)	sciencedirect.com	0	0		EHD1
1123	chr11	70586357	70586380	3500137915	23		70586357	70586380	8421504	1	23	0	c	350013791500000722	2-25						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1124	chr11	70728528	70728556	3500408124	23		70728528	70728556	8421504	2	7,16	0,12	g	350040812400000011	11-34						Binding molecules	Grosveld	2010	0		
1124	chr11	70728529	70728558	3500161347	24		70728529	70728558	8421504	2	6,18	0,11	g	350016134700000016	0-24						Multivalent antigen-binding proteins	Frenken	1999	0		
1125	chr11	70810036	70867477	3500032868	138		70810036	70867477	8421504	3	48,46,44	0,22320,57397	c	350003286800000076,350003286800000080,350003286800000093	0-48,1-47,0-44						ASSAYS AND METHODS USING BIOMARKERS - Patent application	www.faqs.org	0	0		
1130	chr11	71454917	71454942	3500329624	23		71454917	71454942	8421504	2	17,6	0,19	g	350032962400000000	11-34		16282982	10.1038/sj.cdd.4401794	1350-9047	Cell Death & Differentiation	Stress response in mesoangioblast stem cells	Geraci	2005	9		
1130	chr11	71528471	71528497	3500019863	26		71528471	71528497	8421504	1	26	0	c	350001986300000005	10-36						MOUSE MODELS OF CYSTIC FIBROSIS	repub.eur.nl	0	0		SMARCD3
1130	chr11	71550884	71550909	3500097234	23		71550884	71550909	8421504	2	14,9	0,16	g	350009723400000030	0-24						MICROSATELLITE VARIABILITY IN FOUR CONTEMPORARY RHINOCEROS SPECIES: IMPLICATIONS FOR CONSERVATION	esourcecenter.com	0	0		
1134	chr11	72048832	72048855	3500441104	23		72048832	72048855	8421504	1	23	0	g	350044110400000023	1-24						Methods and reagents that generate a CD8 T cell immune response	Mcmichael	2004	0		
1134	chr11	72078858	72078884	3500375186	23		72078858	72078884	8421504	3	5,12,6	0,6,20	g	350037518600000013	18-41						Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities - Patent application	www.faqs.org	0	0		
1137	chr11	72438046	72438076	3500005314	25		72438046	72438076	8421504	2	12,13	0,17	g	350000531400000127	8-33						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
1138	chr11	72576617	72576642	3500076607	23		72576617	72576642	8421504	2	8,15	0,10	g	350007660700000034	0-23						Internalizing Anti-CD74 Antibodies and Methods of Use - Patent application	www.faqs.org	0	0		
1141	chr11	72905772	72907682	3500373113	23		72905772	72907682	8421504	2	11,12	0,1898	c	350037311300000003	9-32		19360125	10.1371/journal.ppat.1000383	1553-7374	PLOS Pathogens	PLOS Pathogens: Identification of Proteins Targeted by the Thioredoxin Superfamily in Plasmodium falciparum	Sturm	2009	0		
1141	chr11	72937614	72937800	3500271478	38		72937614	72937800	8421504	2	19,19	0,167	c	350027147800000003,350027147800000002	0-19,0-19						Role of Vimentin in the Inhibitory Effects of Low-Molecular- Weight Heparin on PC-3M Cell Adhesion to, and Migration through, Endothelium	aspetjournals.org	0	0		PPP1CB
1141	chr11	72937614	72937800	3500216362	38		72937614	72937800	8421504	2	19,19	0,167	c,g	350021636200000003,350021636200000003,350021636200000002	0-19,0-19,0-19		21733881	10.1124/jpet.111.182055	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Role of Vimentin in the Inhibitory Effects of Low-Molecular-Weight Heparin on PC-3M Cell Adhesion to, and Migration through, Endothelium	Pan	2011	0		PPP1CB
1141	chr11	72937655	72937688	3500395798	33		72937655	72937688	8421504	1	33	0	c	350039579800000031	0-33						Differential Expression of Protein Phosphatase 1 Isoforms in Mammalian Brain	www.jneurosci.org	0	0		PPP1CB
1141	chr11	72937764	72948305	3500105210	86		72937764	72948305	8421504	5	20,25,21,10,10	0,4955,5064,9121,10531	c,g	350010521000000003,350010521000000003,350010521000000023,350010521000000023,350010521000000022,350010521000000002	0-20,0-20,0-25,0-25,0-21,0-20						Differential expression of the catalytic subunits for PP-1 and PP-2A and the regulatory subunits for PP&#x2013;2A in mouse eye	www.molvis.org	0	0		
1141	chr11	72952519	72952549	3500463958	26		72952519	72952549	8421504	3	6,7,13	0,8,17	c	350046395800000010	11-37						N-terminally chemically modified protein compositions and methods - Patent # 8258262 - PatentGenius	.patentgenius.com	0	0		
1143	chr11	73195388	73195418	3500144438	24		73195388	73195418	8421504	3	13,4,7	0,14,23	g	350014443800000029	3-27						Allergenic proteins and peptides from japanese cedar pollen	Bond	1993	0		
1144	chr11	73370476	73370501	3500364697	25		73370476	73370501	8421504	1	25	0	c	350036469700000008	0-25						Expression of AP-1 family transcription factors in the amygdala during conditioned taste aversion learning: Role for Fra-2	houptlab.org	0	0		FOSL2
1144	chr11	73373329	73373353	3500284895	24		73373329	73373353	8421504	1	24	0	c	350028489500000002	12-36			10.1128/MCB.22.2.587-598.2002		Molecular and Cellular Biology	Transactivation of Fra-1 and Consequent Activation of AP-1 Occur Extracellular Signal-Regulated Kinase Dependently	Matthew	2002	0		
1144	chr11	73373329	73373353	3500041480	24		73373329	73373353	8421504	1	24	0	c	350004148000000002	12-36		11756554	10.1128/MCB.22.2.587-598.2002	0270-7306	Molecular and Cellular Biology	Transactivation of Fra-1 and Consequent Activation of AP-1 Occur Extracellular Signal-Regulated Kinase Dependently	Young	2002	6		
1145	chr11	73449150	73449179	3500422690	24		73449150	73449179	8421504	2	11,13	0,16	g	350042269000000003	8-32		21752914	10.1128/JVI.00273-11	0022-538X	Journal of Virology	APOBEC3G Complexes Decrease Human Immunodeficiency Virus Type 1 Production	Martin	2011	5		
1145	chr11	73479437	73479463	3500419411	26		73479437	73479463	8421504	1	26	0	g	350041941100000042	28-54						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		
1147	chr11	73761178	73761208	3500118752	28		73761178	73761208	8421504	2	9,19	0,11	g	350011875200000001	4-33						Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407. - ResearchGate	.researchgate.net	0	0		
1148	chr11	73802529	73802557	3500190760	23		73802529	73802557	8421504	2	8,15	0,13	g	350019076000000397	2-36						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
1149	chr11	73933580	73933615	3500311219	35		73933580	73933615	8421504	1	35	0	c	350031121900000259	0-35						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
1149	chr11	74017745	74017775	3500459484	23		74017745	74017775	8421504	3	12,6,5	0,17,25	g	350045948400000030	6-29						Structural Variants of Antibodies for Improved Therapeutic Characteristics - Patent application	www.faqs.org	0	0		
1150	chr11	74071526	74071574	3500237513	48		74071526	74071574	8421504	1	48	0	p	350023751300015168	0-48						50 human secreted proteins	Komatsoulis	2000	0		
1150	chr11	74076933	74080027	3500046413	64		74076933	74080027	8421504	2	19,45	0,3049	p,c,g	350004641300000000,350004641300000000,350004641300015001	0-19,0-19,0-45			10.1128/MCB.01402-07		Molecular and Cellular Biology	STAGA Recruits Mediator to the MYC Oncoprotein To Stimulate Transcription and Cell Proliferation 	Xiaohui	2008	0		SUPT7L
1150	chr11	74080770	74080795	3500359474	24		74080770	74080795	8421504	2	15,9	0,16	c	350035947400000259,350035947400000223	19-43,19-43						US Patent # 7,501,131. Haemophilus influenzae type IV pili - Patents.com	www.patents.com	0	0		
1150	chr11	74080770	74080795	3500246549	24		74080770	74080795	8421504	2	15,9	0,16	c	350024654900000013	10-34						Haemophilus influenzae type IV pili - Patent application	www.faqs.org	0	0		
1151	chr11	74231652	74231677	3500103146	23		74231652	74231677	8421504	3	13,4,6	0,14,19	c	350010314600000049	0-23						Methods and compounds for curing diseases caused by mutations	Cole-Strauss	1997	0		
1151	chr11	74231652	74231677	3500090625	23		74231652	74231677	8421504	3	13,4,6	0,14,19	c	350009062500000116,350009062500000039,350009062500000031	0-23,0-23,0-23					Patent	Methods and compounds for curing diseases caused by mutations (Patent US:5760012)	Cole-Strauss	1998	0		
143	chr11	74301255	74319423	3500323393	423		74301255	74319423	8421504	10	48,69,24,48,45,45,22,20,57,45	0,51,14787,15325,15795,15843,15891,16605,16628,18123	p,c	350032339300000004,350032339300000016,350032339300015073,350032339300015074,350032339300015076,350032339300015078,350032339300015087	12-35,8-31,0-84,0-48,0-48,0-189,0-45						US Patent # 7,320,785. Compositions and methods for modulation of DARPP-32 phosphorylation - Patents.com	www.patents.com	0	0		
1152	chr11	74317892	74317924	3500334532	32		74317892	74317924	8421504	1	32	0	c	350033453200000005,350033453200000006	2-34,12-42						Growth factor inducible serine/threonine phosphatase fin13	Basilico	1997	0		PPM1G
1152	chr11	74334029	74334252	3500459386	24		74334029	74334252	8421504	3	13,6,5	0,210,218	c	350045938600000001	9-33						Frizzled 2 and frizzled 7 function redundantly in convergent extension and closure of the ventricular septum and palate: evidence for a network of interacting genes	ev.biologists.org	0	0		
1152	chr11	74375202	74375247	3500072195	45		74375202	74375247	8421504	1	45	0	p	350007219500015000	0-45		11238533	10.1210/jc.86.3.1362	0021-972X	Journal of Clinical Endocrinology & Metabolism	Urocortin and Corticotropin-Releasing Factor Receptor Expression in Normal Cycling Human Ovaries	Muramatsu	2001	6		UCN
1152	chr11	74396495	74396555	3500306837	60		74396495	74396555	8421504	1	60	0	p	350030683700015000	0-60						IDENTIFICATION OF A cDNA ASSOCIATED WITH VENTRICULAR FUNCTION IN HUMAN MYOCARDIAL TISSUE	Bednarik	2001	0		TRIM54
1152	chr11	74396711	74396739	3500276642	23		74396711	74396739	8421504	2	13,10	0,18	c	350027664200000027	1-24						HUMAN ARTIFICIAL CHROMOSOME VECTOR - Patent application	www.faqs.org	0	0		
1152	chr11	74418226	74418251	3500419864	25		74418226	74418251	8421504	1	25	0	c	350041986400000002	0-25						Effects of high-fat diet feeding on Znt8-null mice: differences between &#x03b2;-cell and global knockout of Znt8	do.physiology.org	0	0		SLC30A3
1153	chr11	74454448	74455367	3500412442	50		74454448	74455367	8421504	2	42,8	0,911	c	350041244200000010	0-50						Novel PRO1199 gene disruptions, and methods relating thereto	Anderson	2012	0		ATRAID
1153	chr11	74454448	74455367	3500060578	50		74454448	74455367	8421504	2	42,8	0,911	c	350006057800000010	0-50						Novel Gene Disruptions, Compositions and Methods Relating Thereto	Anderson	2004	0		ATRAID
1153	chr11	74454448	74455367	3500031136	50		74454448	74455367	8421504	2	42,8	0,911	c	350003113600000009	0-50						Compositions and methods for the treatment of immune related diseases	Ashkenazi	2001	0		ATRAID
1153	chr11	74455594	74455617	3500121372	23		74455594	74455617	8421504	1	23	0	c	350012137200000010	0-23						cDNA Microarray Analysis of Host-Pathogen Interactions in a Porcine In Vitro Model for Toxoplasma gondii Infection&#x2020;	iai.asm.org	0	0		ATRAID
1153	chr11	74544659	74546255	3500408877	237		74544659	74546255	8421504	7	81,10,11,45,5,43,42	0,132,329,751,1040,1231,1554	c	350040887700000085,350040887700000086,350040887700000023,350040887700000093,350040887700000029,350040887700000097,350040887700000101	15-48,0-48,27-48,3-48,0-20,0-48,6-48						Prolactin regulatory element binding protein and uses thereof	Bancroft	2000	0		
1153	chr11	74548407	74548433	3500449315	23		74548407	74548433	8421504	3	4,14,5	0,5,21	c	350044931500000644	5-29						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
1153	chr11	74548407	74548433	3500080694	23		74548407	74548433	8421504	3	4,14,5	0,5,21	c	350008069400000614	5-29						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
1153	chr11	74577946	74577976	3500245482	27		74577946	74577976	8421504	3	13,5,9	0,15,21	c	350024548200000196	18-45						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
1154	chr11	74591546	74591569	3500344185	23		74591546	74591569	8421504	1	23	0	c	350034418500000108	12-35						Collagen Producing Plants And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
1154	chr11	74622472	74622503	3500048321	26		74622472	74622503	8421504	2	9,17	0,14	c	350004832100000256	10-39						Hbm variants that modulate bone mass and lipid levels	Allen	2002	0		
1154	chr11	74649975	74650041	3500117760	66		74649975	74650041	8421504	1	66	0	p	350011776000015030	0-66						Identifikation und Charakterisierung molekularer Komponenten des Verbindungsciliums der Photorezeptoren von Vertebraten	m.opus.hbz-nrw.de	0	0		MAPRE3
1155	chr11	74727276	74727336	3500059323	60		74727276	74727336	8421504	1	60	0	p	350005932300015000	0-60		11549731		0270-6474	The Journal of Neuroscience	Isolation and Expression Pattern of Human Unc-33-Like Phosphoprotein 6/Collapsin Response Mediator Protein 5 (Ulip6/CRMP5): Coexistence with Ulip2/CRMP2 in Sema3A- Sensitive Oligodendrocytes	Ricard	2001	7		DPYSL5
1155	chr11	74733910	74735342	3500277424	40		74733910	74735342	8421504	3	20,4,16	0,41,1416	c,g	350027742400000035,350027742400000035,350027742400000014,350027742400000012	0-20,0-20,0-20,0-20					Patent	Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire (Patent EP:1435993)	Antoine	2011	0		DPYSL5
1155	chr11	74834949	74835009	3500326725	60		74834949	74835009	8421504	1	60	0	p	350032672500015004	3-63						Universitat AutA2noma de Barcelona Facultat de CiA"ncies Departament de Bi	ddd.uab.cat	0	0		CENPA
1156	chr11	74886384	74886672	3500288579	59		74886384	74886672	8421504	3	20,19,20	0,105,268	g	350028857900000021,350028857900000008,350028857900000020	0-20,0-19,0-20						REPRODUCTION	uction-online.org	0	0		
1157	chr11	74975459	75026598	3500365533	504		74975459	75026598	8421504	7	3,35,97,142,110,89,28	0,429,9806,42040,48646,49621,51111	p	350036553300015107	99-603						Serine carboxypeptidase hx (SCPhx) and compositions thereof	Bejanin	2001	0		
1157	chr11	74975459	75026598	3500362636	504		74975459	75026598	8421504	7	3,35,97,142,110,89,28	0,429,9806,42040,48646,49621,51111	p	350036263600015059	99-603						Isolated human vCOL16A1 polypeptide and fragments thereof	Bejanin	2001	0		
1157	chr11	74975459	75026598	3500222007	504		74975459	75026598	8421504	7	3,35,97,142,110,89,28	0,429,9806,42040,48646,49621,51111	p	350022200700015061	99-603						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		
1157	chr11	74975459	75026598	3500203017	504		74975459	75026598	8421504	7	3,35,97,142,110,89,28	0,429,9806,42040,48646,49621,51111	p	350020301700015059	99-603						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		
1157	chr11	74975459	75026598	3500185026	504		74975459	75026598	8421504	7	3,35,97,142,110,89,28	0,429,9806,42040,48646,49621,51111	p	350018502600015109	99-603						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		
1157	chr11	75049604	75049631	3500408244	23		75049604	75049631	8421504	2	7,16	0,11	g	350040824400000039	22-45						Cerebellum-derived growth factors	Chang	1995	0		
1158	chr11	75223734	75223764	3500114730	25		75223734	75223764	8421504	3	14,5,6	0,17,24	g	350011473000000014	0-30						Isolation and use of ryanodine receptors	Caspar	2011	0		
1158	chr11	75223734	75223764	3500011753	25		75223734	75223764	8421504	3	14,5,6	0,17,24	g	350001175300000014	0-30						Isolation and use of ryanodine receptors	Casper	2007	0		
1159	chr11	75299972	75342654	3500401861	2658		75299972	75342654	8421504	25	71,40,71,134,139,120,103,123,119,57,110,135,172,87,141,29,36,126,68,115,146,65,367,4,80	0,5434,5567,6920,12207,13303,14758,17787,18375,20469,25954,30290,32484,35792,38619,39401,39434,40245,40373,41133,41922,42155,42229,42597,42602	p,c,g	350040186100000007,350040186100000008,350040186100000009,350040186100015000,350040186100015001,350040186100000010,350040186100000010,350040186100000005,350040186100000005,350040186100000011,350040186100000012,350040186100015002,350040186100000004,350040186100000004,350040186100000013,350040186100015003,350040186100000014,350040186100000014,350040186100000015,350040186100015005,350040186100000016,350040186100015006,350040186100000017,350040186100015007,350040186100015008,350040186100000018,350040186100000019,350040186100000020,350040186100015010,350040186100015011,350040186100000021,350040186100000022,350040186100015012,350040186100000023,350040186100015013,350040186100000024,350040186100000025,350040186100015015,350040186100000026,350040186100000026,350040186100015016,350040186100000027,350040186100000028,350040186100015018,350040186100015019,350040186100000029,350040186100000030,350040186100015021,350040186100000031,350040186100000032,350040186100015022,350040186100000033,350040186100000034,350040186100015023,350040186100000035,350040186100000036	10-81,30-81,0-81,0-81,0-81,0-81,0-81,0-25,0-25,0-81,0-81,0-84,0-25,0-25,0-80,0-81,0-81,0-81,0-78,0-78,0-81,0-87,0-81,0-81,0-81,0-80,0-81,0-81,0-81,0-81,10-81,0-78,0-78,0-81,0-81,0-81,0-81,0-81,0-81,0-81,0-81,0-82,0-81,0-84,0-81,0-81,2-81,0-81,0-81,0-81,0-81,0-81,0-72,0-72,0-82,0-370						A novel HADHA gene differentially expressed in muscle and other tissues from black-boned vs. ordinary sheep	www.ighz.edu.pl	0	0		
1159	chr11	75305406	75342270	3500311752	2220		75305406	75342270	8421504	19	40,71,134,139,120,103,123,119,57,110,135,172,87,141,69,196,115,146,143	0,133,1486,6773,7869,9324,12353,12941,15035,20520,24856,27050,30358,33185,33967,34811,35699,36488,36721	p	350031175200015000	99-2319						KEGG T01008: 281810	www.genome.jp	0	0		
1159	chr11	75313294	75313320	3500189183	24		75313294	75313320	8421504	2	17,7	0,19	g	350018918300000365	6-30						Modulation of survivin expression	Bhat	2004	0		
1159	chr11	75313294	75313320	3500000180	24		75313294	75313320	8421504	2	17,7	0,19	c	350000018000000365	6-30						Modulation Of Survivin Expression 	.freshpatents.com	0	0		
1159	chr11	75325992	75326016	3500146204	23		75325992	75326016	8421504	2	14,9	0,15	c	350014620400000039	0-23						[tel-00612631, v1] L'ilot g&#xe9;nomique pks chez Escherichia coli : structure-fonction de la prot&#xe9;ine ClbP et &#xe9;tudes &#xe9;pid&#xe9;miologiques	hives-ouvertes.fr	0	0		
1160	chr11	75388420	75388444	3500442591	24		75388420	75388444	8421504	1	24	0	c	350044259100000010	10-34		18779367	10.1083/jcb.200802176	0021-9525	The Journal of Cell Biology	Rab13 regulates membrane trafficking between TGN and recycling endosomes in polarized epithelial cells	Nokes	2008	10		RAB10
1160	chr11	75388420	75388444	3500206561	24		75388420	75388444	8421504	1	24	0	c	350020656100000010	10-34		18779367	10.1083/jcb.200802176		The Journal of Cell Biology	Rab13 regulates membrane trafficking between TGN and recycling endosomes in polarized epithelial cells	Rita	2008	0		
1160	chr11	75388468	75395465	3500436663	105		75388468	75395465	8421504	4	36,18,24,27	0,2109,2579,6970	p	350043666300015000,350043666300015001	0-54,0-51		20576682	10.1152/ajprenal.00198.2010		American Journal of Physiology - Renal Physiology	Rab10 associates with primary cilia and the exocyst complex in renal epithelial cells	Babbey	2010	0		RAB10
1160	chr11	75388468	75395465	3500120971	105		75388468	75395465	8421504	4	36,18,24,27	0,2109,2579,6970	p	350012097100015000,350012097100015001	0-54,0-51		20576682	10.1152/ajprenal.00198.2010		American Journal of Physiology - Renal Physiology	Rab10 associates with primary cilia and the exocyst complex in renal epithelial cells	Babbey	2010	0		RAB10
1161	chr11	75510170	75510194	3500161204	23		75510170	75510194	8421504	2	14,9	0,15	g	350016120400000014	0-23						15	jeremydewaard.com	0	0		
1161	chr11	75537912	75537939	3500369975	23		75537912	75537939	8421504	2	9,14	0,13	c	350036997500000008	15-47						Defective interfering hiv particles with chimeric cd4-env	Banerjea	1993	0		
1162	chr11	75710704	75710727	3500155974	23		75710704	75710727	8421504	1	23	0	g	350015597400000008	12-37						' '	ir.obihiro.ac.jp	0	0		
1164	chr11	76004459	76004484	3500173278	24		76004459	76004484	8421504	2	17,7	0,18	g	350017327800000005	4-28		19692484	10.1152/ajprenal.00360.2009		American Journal of Physiology - Renal Physiology	Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology	Meir	2009	0		
1164	chr11	76004459	76004484	3500099492	24		76004459	76004484	8421504	2	17,7	0,18	g	350009949200000005	4-28		19692484	10.1152/ajprenal.00360.2009		American Journal of Physiology - Renal Physiology	Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology	Meir	2009	0		
1165	chr11	76085403	76085428	3500316820	23		76085403	76085428	8421504	2	8,15	0,10	g	350031682000000069	22-45						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease	Potts	2002	0		
1165	chr11	76142029	76142053	3500352177	23		76142029	76142053	8421504	2	15,8	0,16	c	350035217700000167	15-38						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
1165	chr11	76148342	76149644	3500181711	41		76148342	76149644	8421504	2	21,20	0,1282	c,g	350018171100000004,350018171100000005,350018171100000005	0-21,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
1165	chr11	76148342	76149644	3500162809	41		76148342	76149644	8421504	2	21,20	0,1282	c,g	350016280900000006,350016280900000007,350016280900000007	0-21,0-20,0-20						Epigenetic differences between male and female bovine blastocysts produced in vitro	cs.physiology.org	0	0		
145	chr11	76148464	76153711	3500284169	46		76148464	76153711	8421504	4	19,4,5,18	0,826,4562,5229	c	350028416900000011,350028416900000012	0-23,0-23		15632075	10.1128/MCB.25.2.751-766.2005	0270-7306	Molecular and Cellular Biology	DNA Methyltransferase 3b Regulates Nerve Growth Factor-Induced Differentiation of PC12 Cells by Recruiting Histone Deacetylase 2	Bai	2005	6		DNMT3A
145	chr11	76148464	76153711	3500265959	46		76148464	76153711	8421504	4	19,4,5,18	0,826,4562,5229	c	350026595900000011,350026595900000012	0-23,0-23			10.1128/MCB.25.2.751-766.2005		Molecular and Cellular Biology	DNA Methyltransferase 3b Regulates Nerve Growth Factor-Induced Differentiation of PC12 Cells by Recruiting Histone Deacetylase 2	Shoumei	2005	0		DNMT3A
145	chr11	76149305	76154947	3500456772	405		76149305	76154947	8421504	5	76,149,9,35,136	0,254,1414,4472,5506	p	350045677200015008,350045677200015010	0-234,0-171						Epigenomics	www.scribd.com	0	0		DNMT3A
145	chr11	76149641	76153706	3500308562	45		76149641	76153706	8421504	3	22,10,13	0,3380,4052	c	350030856200000002,350030856200000003	0-22,0-23						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
1165	chr11	76149674	76149697	3500407969	23		76149674	76149697	8421504	1	23	0	c	350040796900000005	21-44		20398055	10.1111/j.1349-7006.2010.01565.x	1349-7006	Cancer Science	DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8 - Kurita - 2010 - Cancer Science - Wiley Online Library	Kurita	2010	0		DNMT3A
1166	chr11	76154927	76154950	3500140863	23		76154927	76154950	8421504	1	23	0	c	350014086300000003	10-33						Cellular/Molecular EpigeneticRegulationofMotorNeuronCellDeaththrough DNAMethylation	www.jneurosci.org	0	0		
1166	chr11	76193467	76195301	3500374872	265		76193467	76195301	8421504	2	134,131	0,1703	g	350037487200000002,350037487200000011	4-140,1-132						ASSESSMENT OF NEURONS IN THE ARCUATE NUCLEUS TO SCREEN FOR AGENTS THAT MODIFY FEEDING BEHAVIOR - Patent application	www.faqs.org	0	0		
1166	chr11	76193467	76195301	3500302326	247		76193467	76195301	8421504	5	56,52,16,114,9	0,62,118,1707,1825	g	350030232600000007,350030232600000016,350030232600000020	4-130,0-117,0-28						US Patent # 7,125,979. Upstream control elements of the proopiomelanocortin gene and their use - Patents.com	www.patents.com	0	0		
1166	chr11	76209161	76212338	3500092612	798		76209161	76212338	8421504	2	132,666	0,2511	c	350009261200000022,350009261200000038	0-798,0-798						RAAV VECTOR-BASED PRO-OPIOMELANOCORTIN COMPOSITIONS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1166	chr11	76211933	76212050	3500448411	114		76211933	76212050	8421504	2	66,48	0,69	p	350044841100015020,350044841100015021	0-66,0-48						UNIVERSIDAD COMPLUTENSE DE MADRID	eprints.ucm.es	0	0		
1166	chr11	76211978	76212023	3500369904	45		76211978	76212023	8421504	1	45	0	p	350036990400015002	0-45						Recombinant plasmids for producing human adrenocorticotropic hormone (acth)	Boidol	1989	0		POMC
1166	chr11	76211978	76212023	3500337071	45		76211978	76212023	8421504	1	45	0	p	350033707100015002	0-45						Recombinant plasmids for producing human adrenocorticotropic hormone (acth)	Boidol	1990	0		POMC
1166	chr11	76211978	76212023	3500092016	45		76211978	76212023	8421504	1	45	0	p	350009201600015001	0-45						Rekombinante plasmide zur produktion von humanem adrenocorticotropen hormon (acth)	Boidol	1990	0		POMC
1166	chr11	76212242	76212320	3500376680	78		76212242	76212320	8421504	1	78	0	p	350037668000015028	0-78						Opioid receptor agonist fusion proteins	Bell	2008	0		
1166	chr11	76212242	76212320	3500072826	78		76212242	76212320	8421504	1	78	0	p	350007282600015028	0-78						Opioid receptor agonist fusion proteins	Bell	2008	0		
1166	chr11	76212242	76212299	3500436734	57		76212242	76212299	8421504	1	57	0	p	350043673400015001,350043673400015000	39-93,24-93						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd	ww.learnnext.info	0	0		POMC
1166	chr11	76212242	76212293	3500000057	51		76212242	76212293	8421504	1	51	0	p	350000005700015008	0-51						TREATMENT OF PAIN THROUGH EXPRESSION OF OPIOID RECEPTORS	Kyrkanides	2007	0		POMC
1166	chr11	76212280	76212389	3500315071	40		76212280	76212389	8421504	2	20,20	0,89	c	350031507100000026,350031507100000027	0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1166	chr11	76212329	76212379	3500463464	50		76212329	76212379	8421504	1	50	0	c,g	350046346400000016,350046346400000007,350046346400000007	16-64,21-42,21-42						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
1167	chr11	76396562	76396595	3500343734	24		76396562	76396595	8421504	3	11,7,6	0,16,27	c	350034373400000377	21-48					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
1167	chr11	76396562	76396595	3500190760	24		76396562	76396595	8421504	3	11,7,6	0,16,27	c	350019076000000377	21-48						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
1168	chr11	76417949	76417973	3500163652	23		76417949	76417973	8421504	2	14,9	0,15	g	350016365200000005	7-34						DE-TTK	ib.unideb.hu:8080	0	0		
1168	chr11	76457685	76457709	3500187962	23		76457685	76457709	8421504	2	8,15	0,9	g	350018796200000113	3-47						 Starchless Variety Of Pisum Sativum Having Elevated Levels Of Sucrose 	www.docstoc.com	0	0		
1168	chr11	76487484	76503265	3500239881	115		76487484	76503265	8421504	3	48,47,20	0,7967,15761	c	350023988100000007,350023988100000008,350023988100000010	0-48,1-48,16-36						Method for diagnosis and treatment of disorders of carbohydrate metabolism	Efendic	1999	0		
1168	chr11	76537236	76537263	3500455730	23		76537236	76537263	8421504	2	10,13	0,14	c	350045573000000015	7-30						Accelerated Publication THE J B C	www.jbc.org	0	0		
1168	chr11	76537236	76537263	3500282320	23		76537236	76537263	8421504	2	10,13	0,14	c	350028232000000058	7-30						INDUCED PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		NCOA1
1168	chr11	76539381	76539408	3500190826	27		76539381	76539408	8421504	1	27	0	c,g	350019082600000003,350019082600000003	0-27,0-27		22660634	10.1038/nm.2826		Nature medicine	A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis	Sang	July	0		NCOA1
18	chr11	76539384	76592970	3500397526	54		76539384	76592970	8421504	2	24,30	0,53556	p	350039752600015175	0-54						Method of prediciting receptor modulating activity	Barnett	2001	0		NCOA1
1168	chr11	76539384	76539441	3500002742	57		76539384	76539441	8421504	1	57	0	p	350000274200015004	0-57			10.1073/pnas.0705517104		Proceedings of the National Academy of Sciences of the United States of America	Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein&#x2013;protein interaction profile	Jeffrey	2007	0		NCOA1
1168	chr11	76543369	76543396	3500181478	27		76543369	76543396	8421504	1	27	0	c	350018147800000033	17-44					Patent	Targeted modification of chromatin structure (Patent US:7001768)	Wolffe	2006	0		
1168	chr11	76543369	76543396	3500157707	27		76543369	76543396	8421504	1	27	0	c	350015770700000058,350015770700000033	17-44,17-44						Targeted modification of chromatin structure - Patent # 7001768 - PatentGenius	.patentgenius.com	0	0		
1168	chr11	76543369	76543396	3500104188	27		76543369	76543396	8421504	1	27	0	c	350010418800000016,350010418800000036	17-44,17-44					Patent	Targeted modification of chromatin structure (Patent EP:1276859)	Collingwood	2007	0		NCOA1
1169	chr11	76565140	76565165	3500058966	23		76565140	76565165	8421504	2	7,16	0,9	g	350005896600000488	12-35						Application # 2006/0127915. Gene mutation associated with age-related macular degeneration - Patents.com	patents.com	0	0		
1169	chr11	76566320	76566346	3500380439	24		76566320	76566346	8421504	2	17,7	0,19	c	350038043900000224	3-27						Understanding Aging | Free Medical Textbook	ree.wordpress.com	0	0		
1169	chr11	76592940	76593336	3500128180	96		76592940	76593336	8421504	2	48,48	0,348	p	350012818000015010,350012818000015008	0-48,0-48						PEPTIDES AND PROTEINS INTERACTING WITH THE ANDROGEN RECEPTOR	repub.eur.nl	0	0		NCOA1
1169	chr11	76593114	76593189	3500436926	75		76593114	76593189	8421504	1	75	0	p	350043692600015000	0-75						The neurobiology of operant learning: biophysical and molecular mechanisms in a hierarchical organization of multiple memory systems	uni-regensburg.de	0	0		NCOA1
1169	chr11	76593114	76593189	3500422053	75		76593114	76593189	8421504	1	75	0	p	350042205300015000	0-75						Substituted aminopropoxyaryl derivatives useful as agonists for LXR	Collins	2005	0		NCOA1
1169	chr11	76593114	76593189	3500371658	75		76593114	76593189	8421504	1	75	0	p	350037165800015007	0-75						NPG.nature.vol.415.Issue.6873.Feb	www.scribd.com	0	0		NCOA1
1169	chr11	76593114	76593189	3500354410	75		76593114	76593189	8421504	1	75	0	p	350035441000015004	0-75		22700697	10.1124/mol.112.078667	1521-0111 (Online)	Molecular Pharmacology	Increasing Human Th17 Differentiation through Activation of Orphan Nuclear Receptor Retinoid Acid-Related Orphan Receptor &#x03b3; (ROR&#x03b3;) by a Class of Aryl Amide Compounds	Zhang	2012	0		NCOA1
1169	chr11	76593114	76593189	3500294770	75		76593114	76593189	8421504	1	75	0	p	350029477000015000	0-75						Compounds and compositions as lxr modulators	Anaclerio	2012	0		NCOA1
1169	chr11	76593114	76593189	3500294608	75		76593114	76593189	8421504	1	75	0	p	350029460800015000	0-75						Compounds and compositions as lxr modulators	Molteni	2009	0		NCOA1
1169	chr11	76593114	76593189	3500291729	75		76593114	76593189	8421504	1	75	0	p	350029172900015001	0-75					Patent	Purine derivatives as liver X receptor agonists (Patent US:7495004)	Boggs	2009	0		NCOA1
1169	chr11	76593114	76593189	3500287226	75		76593114	76593189	8421504	1	75	0	p	350028722600015000	0-75						Novel fxr (nr1h4) binding and activity modulating compounds	Kremoser	2012	0		NCOA1
1169	chr11	76593114	76593189	3500283299	75		76593114	76593189	8421504	1	75	0	p	350028329900015001	0-75						Purine derivatives as liver x receptor agonists	Boggs	2006	0		NCOA1
1169	chr11	76593114	76593189	3500282347	75		76593114	76593189	8421504	1	75	0	p	350028234700015000	0-75					Patent	Compounds and compositions as LXR modulators (Patent US:8158662)	Anaclerio	2012	0		NCOA1
1169	chr11	76593114	76593189	3500255872	75		76593114	76593189	8421504	1	75	0	p	350025587200015000	0-75						Substitued aminopropoxyaryl derivatives useful as agonists for lxr	Collins	2004	0		NCOA1
1169	chr11	76593114	76593189	3500236564	75		76593114	76593189	8421504	1	75	0	p	350023656400015000	0-75					Patent	Substituierte aminopropoxyarylderivate als lxr agonisten Substituted aminopropoxyarylderivate as lxr agonists (Patent DE:60107449)	Collins	2005	0		NCOA1
1169	chr11	76593114	76593189	3500183416	75		76593114	76593189	8421504	1	75	0	p	350018341600015002	0-75						NOVEL COMPOUNDS - GLAXO GROUP LIMITED	www.sumobrain.com	0	0		NCOA1
1169	chr11	76593114	76593189	3500139684	75		76593114	76593189	8421504	1	75	0	p	350013968400015000	0-75						Heterocyclic cyclopropyl-substituted fxr binding compounds	Abel	2009	0		NCOA1
1169	chr11	76593114	76593189	3500091522	75		76593114	76593189	8421504	1	75	0	p	350009152200015000	0-75						COMPOUNDS AND COMPOSITIONS AS LXR MODULATORS - Patent application	www.faqs.org	0	0		NCOA1
1169	chr11	76593114	76593189	3500048120	75		76593114	76593189	8421504	1	75	0	p	350004812000015000	0-75						Novel fxr (nr1h4 ) binding and activity modulating compounds	Abel	2012	0		NCOA1
1169	chr11	76593114	76593186	3500081400	72		76593114	76593186	8421504	1	72	0	p	350008140000015000	0-72					Patent	&#x4f5c;&#x4e3a;lxr&#x8c03;&#x8282;&#x5242;&#x7684;&#x5316;&#x5408;&#x7269;&#x548c;&#x7ec4;&#x5408;&#x7269; (Patent CN:1918155)	V*Mo Er Tai Ni 	2010	0		NCOA1
1169	chr11	76593114	76593186	3500074423	72		76593114	76593186	8421504	1	72	0	p	350007442300015000	0-72					Patent	Compounds and compositions as LXR modulators (Patent CN:1918155)	V*Mo Er Tai Ni 	2010	0		NCOA1
1169	chr11	76593114	76593171	3500255323	57		76593114	76593171	8421504	1	57	0	p	350025532300015000	27-84						Nuclear hormone receptor	Allen	2004	0		NCOA1
1172	chr11	76971833	76971861	3500212475	23		76971833	76971861	8421504	2	10,13	0,15	g	350021247500000322	11-35						CELLS AND METHODOLOGY TO GENERATE NON-SEGMENTED NEGATIVE-STRAND RNA VIRUSES - Patent application	www.faqs.org	0	0		
1173	chr11	77097631	77097860	3500424225	42		77097631	77097860	8421504	2	21,21	0,208	c	350042422500000004,350042422500000005	0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
1173	chr11	77111580	77117785	3500333174	180		77111580	77117785	8421504	3	60,92,28	0,1135,6177	p,c	350033317400015013,350033317400000000,350033317400015023,350033317400015007,350033317400015029	0-60,0-120,0-63,0-54,0-48						Fk-506 cytosolic binding protein	Sewell	1995	0		FKBP1B
1173	chr11	77112700	77112745	3500373846	45		77112700	77112745	8421504	1	45	0	p	350037384600015064	0-45						Conditional-Stop Dimerizable Caspase Transgenic Animals - Patent application	www.faqs.org	0	0		FKBP1B
1175	chr11	77389722	77403768	3500340994	405		77389722	77403768	8421504	4	120,160,123,2	0,3910,11155,14044	p	350034099400015000	3-408						SGC | Structure Details	www.thesgc.org	0	0		
1175	chr11	77416700	77416726	3500294513	23		77416700	77416726	8421504	2	14,9	0,17	c	350029451300000019	0-23						NOVEL DEATH DOMAIN PROTEINS - Patent application	www.faqs.org	0	0		
1176	chr11	77515611	77515634	3500008258	23		77515611	77515634	8421504	1	23	0	c	350000825800000178	23-48						Polypeptides having L-asparaginase activity	Ario	1997	0		
1177	chr11	77673785	77673813	3500237510	25		77673785	77673813	8421504	2	20,5	0,23	g	350023751000000009	1-26						NEUTRALIZATION OF CLOSTRIDIUM DIFFICILE TOXIN A WITH SINGLE-DOMAIN ANTIBODIES TARGETING THE CELL-RECEPTOR BINDING DOMAIN &#xa7;,# &#xa7;,&#xb6; , Roger MacKenzie	www.jbc.org	0	0		
1177	chr11	77673785	77673813	3500146091	25		77673785	77673813	8421504	2	20,5	0,23	g	350014609100000009,350014609100000032	1-26,1-26						CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF - Patent application	www.faqs.org	0	0		
1178	chr11	77748747	77748776	3500083716	28		77748747	77748776	8421504	2	17,11	0,18	g	350008371600000242	4-32					Patent	Streptococcus pneumoniae antigens and vaccines (Patent US:6573082)	Choi	2003	0		
1179	chr11	77926474	77926498	3500466559	24		77926474	77926498	8421504	1	24	0	g	350046655900000025	10-34						ROLE OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS NON-STRUCTURAL PROTEIN 1 IN VIRAL REPLICATION AND PATHOGENESIS	alcommons.unl.edu	0	0		
1182	chr11	78330010	78330035	3500186313	24		78330010	78330035	8421504	2	13,11	0,14	g	350018631300000047	2-32						2&#xaa;lamacroestafadelsida	es.scribd.com	0	0		
1188	chr11	79045564	79045590	3500117791	24		79045564	79045590	8421504	2	12,12	0,14	g	350011779100000004	2-28						Characterization of the Ubiquitin/Nedd8 E3 Ligase Activity of the Mdm2/MdmX complex	www.uni-koeln.de	0	0		
1192	chr11	79683584	79683607	3500116045	23		79683584	79683607	8421504	1	23	0	g	350011604500000172	8-31						Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease	Progulske-fox	1994	0		
1199	chr11	80482199	80482226	3500230031	27		80482199	80482226	8421504	1	27	0	g	350023003100000065,350023003100000283	15-42,15-42						METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCER - Patent application	www.faqs.org	0	0		
1199	chr11	80482199	80482226	3500229865	27		80482199	80482226	8421504	1	27	0	g	350022986500000013,350022986500000223	15-42,15-42						GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA - Patent application	www.faqs.org	0	0		
1199	chr11	80499603	80499632	3500091192	29		80499603	80499632	8421504	1	29	0	c	350009119200000002,350009119200000006	0-22,0-21		10022976	10.1101/gr.9.2.121	1088-9051	Genome Research	Isolation of Zebrafish gdf7 and Comparative Genetic Mapping of Genes Belonging to the Growth/Differentiation Factor 5, 6, 7 Subgroup of the TGF-&#x03b2; Superfamily	Davidson	1999	14		GDF7
1199	chr11	80499738	80499786	3500335228	48		80499738	80499786	8421504	1	48	0	c	350033522800000045	0-48						Composition and Method for the Treatment or Prevention of Spinal Disorders III - Patent application	www.faqs.org	0	0		
1199	chr11	80499826	80499857	3500392138	31		80499826	80499857	8421504	1	31	0	c	350039213800000342	6-37						Designer ligands of tgf-beta superfamily	Choe	2010	0		
1199	chr11	80499968	80499995	3500360991	24		80499968	80499995	8421504	3	5,15,4	0,7,23	c	350036099100000010	1-25						NOVEL INDUCER OF CHONDROCYTE PROLIFERATION AND DIFFERENTIATION - Patent application	www.faqs.org	0	0		
1199	chr11	80527247	80528800	3500432629	23		80527247	80528800	8421504	2	16,7	0,1546	c	350043262900000007,350043262900000123	3-26,3-26						CANINE iPS CELLS AND METHOD OF PRODUCING SAME - Patent application	www.faqs.org	0	0		
1199	chr11	80527247	80528800	3500157275	23		80527247	80528800	8421504	2	16,7	0,1546	c	350015727500000007	3-26						CANINE iPS CELLS AND METHOD OF PRODUCING SAME	Nakamura	2010	0		
1200	chr11	80654623	80654648	3500277898	24		80654623	80654648	8421504	2	10,14	0,11	g	350027789800000002	2-26						Life Science Journal, 2011;8(2)	fesciencesite.com	0	0		
1200	chr11	80693270	80695173	3500191364	44		80693270	80695173	8421504	2	25,19	0,1884	c,g	350019136400000005,350019136400000000,350019136400000000	0-25,0-19,0-19						 miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells 	sciencedirect.com	0	0		RHOB
1200	chr11	80694583	80694615	3500412838	25		80694583	80694615	8421504	3	5,9,11	0,8,21	c	350041283800000008	22-47						RESEARCH Open Access The 0.3-kb fragment containing the R-U5-5 leader sequence of Friend murine leukemia virus influences the level of protein expression from	biomedcentral.com	0	0		
1200	chr11	80694583	80694615	3500184029	25		80694583	80694615	8421504	3	5,9,11	0,8,21	c	350018402900000007	22-47		23602143	10.1186/1743-422X-10-124	1743-422X	Virology Journal	The 0.3-kb fragment containing the R-U5-5&#xe2; leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA	Choo	2013	2		
1200	chr11	80694690	80695222	3500015495	138		80694690	80695222	8421504	4	68,23,22,25	0,134,215,507	c	350001549500000028,350001549500000021,350001549500000020,350001549500000016,350001549500000019,350001549500000015,350001549500000014,350001549500000007,350001549500000003	30-55,23-46,19-43,0-25,18-39,25-48,24-47,27-49,23-48						RhoB variants and methods of use	Sebti	2005	0		RHOB
1200	chr11	80694690	80694761	3500450126	71		80694690	80694761	8421504	1	71	0	c	350045012600000010	0-80		20573066	10.1111/j.1600-0854.2010.01091.x	1600-0854	Traffic	Structural Determinants Allowing Endolysosomal Sorting and Degradation of Endosomal GTPases - Valero - 2010 - Traffic - Wiley Online Library	Valero	2010	0		RHOB
1200	chr11	80694690	80694748	3500193782	56		80694690	80694748	8421504	2	48,8	0,50	c,g	350019378200000007,350019378200000007,350019378200000001,350019378200000001	7-63,7-63,7-63,7-63						CHIMERIC PEPTIDES FOR THE REGULATION OF GTPASES - Patent application	www.faqs.org	0	0		RHOB
1200	chr11	80694690	80694748	3500120777	58		80694690	80694748	8421504	1	58	0	p,c,g	350012077700000001,350012077700000001,350012077700015017	7-63,7-63,0-54					Patent	Chimeric peptides for the regulation of GTPases (Patent US:8242246)	Zheng	2012	0		RHOB
1200	chr11	80694690	80694748	3500115295	58		80694690	80694748	8421504	1	58	0	p,c,g	350011529500000001,350011529500000001,350011529500015017	7-63,7-63,0-54						Chimeric Peptides for the Regulation of GTPases	Zheng	2012	0		RHOB
1200	chr11	80694690	80694748	3500113429	58		80694690	80694748	8421504	1	58	0	p,c,g	350011342900000001,350011342900000001,350011342900015017	7-63,7-63,0-54						Chimeric peptides for the regulation of GTPases	Zheng	2005	0		RHOB
1200	chr11	80694690	80694748	3500061717	58		80694690	80694748	8421504	1	58	0	p,c,g	350006171700000001,350006171700000001,350006171700015017	7-63,7-63,0-54						Chimeric peptides for the regulation of gtpases	Williams	2005	0		RHOB
1200	chr11	80694691	80695240	3500263867	42		80694691	80695240	8421504	2	21,21	0,528	c,g	350026386700000008,350026386700000007,350026386700000007	0-21,0-21,0-21		21586513	10.1093/carcin/bgr092		Carcinogenesis	Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate	Chuanyu	2011	0		
1200	chr11	80694691	80695223	3500401573	42		80694691	80695223	8421504	2	21,21	0,511	c,g	350040157300000003,350040157300000002,350040157300000002	0-21,0-21,0-21			10.1186/1476-4598-4-34	1476-4598	Molecular Cancer	Global gene expression profiling of cells overexpressing SMC3	Ghiselli	2005	4		RHOB
1200	chr11	80694691	80695223	3500202065	42		80694691	80695223	8421504	2	21,21	0,511	c,g	350020206500000003,350020206500000002,350020206500000002	0-21,0-21,0-21			10.1186/1476-4598-4-34	1476-4598	Molecular Cancer	Global gene expression profiling of cells overexpressing SMC3	Ghiselli	2005	4		RHOB
1200	chr11	80694691	80695223	3500001470	42		80694691	80695223	8421504	2	21,21	0,511	c,g	350000147000000003,350000147000000002,350000147000000002	0-21,0-21,0-21						Global gene expression profiling of cells overexpressing SMC3.	.biomedsearch.com	0	0		RHOB
1200	chr11	80694693	80695726	3500005693	85		80694693	80695726	8421504	4	20,19,23,23	0,461,608,1010	c,g	350000569300000009,350000569300000009,350000569300000019,350000569300000019,350000569300000026,350000569300000028	0-20,0-20,0-19,0-19,10-33,8-31						Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618	ww.snupharm.ac.kr	0	0		RHOB
1200	chr11	80694704	80695282	3500407529	63		80694704	80695282	8421504	3	21,21,21	0,206,557	c,g	350040752900000003,350040752900000003,350040752900000005,350040752900000000,350040752900000000	1-22,1-22,0-21,0-21,0-21			10.1124/jpet.104.065318	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Botulinum Toxin Type A Targets RhoB to Inhibit Lysophosphatidic Acid-Stimulated Actin Reorganization and Acetylcholine Release in Nerve Growth Factor-Treated PC12 Cells	Ishida	2004	0		RHOB
1200	chr11	80694718	80695199	3500019454	187		80694718	80695199	8421504	6	21,20,40,41,42,23	0,241,281,341,399,458	c	350001945400000011,350001945400000010,350001945400000009,350001945400000008	3-24,0-20,0-40,0-106						Introduction to Computational Molecular Biology - Carlos Setubal, Joao Meidanis	www.scribd.com	0	0		RHOB
1202	chr11	80926178	80948647	3500223687	52		80926178	80948647	8421504	2	30,22	0,22447	c	350022368700000004,350022368700000009	0-30,2-24		22238310	10.1128/JVI.05783-11	0022-538X	Journal of Virology	Entry of Human T-Cell Leukemia Virus Type 1 Is Augmented by Heparin Sulfate Proteoglycans Bearing Short Heparin-Like Structures	Tanaka	2012	5		
1202	chr11	80946161	80947160	3500337770	44		80946161	80947160	8421504	2	23,21	0,978	c,g	350033777000000022,350033777000000023,350033777000000023	0-23,0-21,0-21						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
1202	chr11	80947454	80948651	3500049177	148		80947454	80948651	8421504	7	23,19,11,33,7,32,23	0,126,744,836,882,1025,1174	c,g	350004917700000037,350004917700000017,350004917700000018,350004917700000019,350004917700000049	14-37,5-35,79-112,9-48,0-23						US Patent # 5,851,993. Suppression of tumor cell growth by syndecan-1 ectodomain - Patents.com	www.patents.com	0	0		
1202	chr11	80948532	80948651	3500102487	71		80948532	80948651	8421504	2	48,23	0,96	c	350010248700000102,350010248700000104	0-48,0-23						Syndecan enhancer element and syndecan stimulation of cellular differentiation	Jalkanen	1996	0		
1202	chr11	80948574	80948634	3500092539	60		80948574	80948634	8421504	1	60	0	p	350009253900015023	0-60						vol 13 1 2009	.irevues.inist.fr	0	0		SDC1
1202	chr11	80958038	80958061	3500107253	23		80958038	80958061	8421504	1	23	0	g	350010725300000000	9-32						Receptor family profiling	Landsman	2010	0		
1203	chr11	81110527	81110777	3500141583	40		81110527	81110777	8421504	2	20,20	0,230	c,g	350014158300000078,350014158300000079,350014158300000079	0-20,0-20,0-20						Annealing control primer system for improving specificity of PCR amplification	www.seegene.com	0	0		LAPTM4A
1203	chr11	81110655	81110960	3500463719	46		81110655	81110960	8421504	2	25,21	0,284	c	350046371900000004,350046371900000005	0-25,0-21			10.1111/j.1574-695X.2005.00035.x	1574-695X	FEMS Immunology & Medical Microbiology	Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and nontuberculous European wild boars naturally exposed to Mycobacterium bovis - Naranjo - 2006 - FEMS Immunology & Medical Microbiology - Wiley Online Libr	Naranjo	2006	0		
1203	chr11	81110655	81110960	3500322660	46		81110655	81110960	8421504	2	25,21	0,284	c	350032266000000004,350032266000000005	0-25,0-21						Caracterizaci&#xf3;n gen&#xf3;mica y prote&#xf3;mica de la expresi&#xf3;n g&#xe9;nica diferencial en jabal&#xed;es infectados de forma natural con Mycobacterium bovis Identificaci&#xf3;n de biomarcadores asociados con la infecci&#xf3;n y la respuesta inmu	digital.csic.es	0	0		
150	chr11	81253206	81306020	3500008756	60		81253206	81306020	8421504	6	6,15,13,6,5,15	0,10,48627,48643,52792,52799	g	350000875600000212,350000875600000726,350000875600000663	21-45,9-28,15-35						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
1205	chr11	81384871	81384897	3500445013	24		81384871	81384897	8421504	3	4,7,13	0,5,13	g	350044501300000017	14-45						Lung cancer marker	www.devileye.net	0	0		
1206	chr11	81496555	81496582	3500143658	24		81496555	81496582	8421504	2	19,5	0,22	g	350014365800000038,350014365800000039,350014365800000076,350014365800000075	11-36,11-36,11-36,11-36					Patent	Antibodies to MAdCAM (Patent EP:2177537)	Green	2011	0		
1214	chr11	82489251	82489277	3500287953	23		82489251	82489277	8421504	3	6,5,12	0,8,14	g	350028795300000175	11-34						Method For Increasing Pathogen Resistance In Transgenic Plants - Patent application	www.faqs.org	0	0		
1217	chr11	82949283	82949306	3500292953	23		82949283	82949306	8421504	1	23	0	g	350029295300000024	0-40						CYCLODIPEPTIDE SYNTHETASE AND ITS USE FOR SYNTHESIS OF CYCLO(Tyr-Xaa) CYCLODIPEPTIDES - Patent application	www.faqs.org	0	0		
1218	chr11	83039076	83039170	3500017050	38		83039076	83039170	8421504	2	19,19	0,75	c,g	350001705000000005,350001705000000005,350001705000000004,350001705000000004,350001705000000003,350001705000000003,350001705000000002,350001705000000002	0-19,0-19,0-19,0-19,0-19,0-19,0-19,0-19						Regulation der Expression des Tumorinvasionssuppressors Visinin-like Protein 1 (VILIP-1) und seine Bedeutung f&#xfc;r das Metastasierungspotential von Plattenepithelkarzinomzellen	diss.fu-berlin.de	0	0		
1218	chr11	83039246	83042402	3500269671	57		83039246	83042402	8421504	4	20,6,11,20	0,22,3123,3136	c,g	350026967100000014,350026967100000014,350026967100000013	0-20,0-20,0-37						Microarray analysis in caudal medulla of cattle orally challenged with bovine spongiform encephalopathy	w.funpecrp.com.br	0	0		
1218	chr11	83042504	83042532	3500359671	24		83042504	83042532	8421504	2	7,17	0,11	c	350035967100000019	4-33						METABOLIC ENGINEERING OF Escherichia coli TO EFFICIENTLY PRODUCE SUCCINATE IN MINERAL SALTS MEDIA	ges.uflib.ufl.edu	0	0		
1219	chr11	83108675	83108703	3500266153	28		83108675	83108703	8421504	1	28	0	c	350026615300000004	6-34						&#xb0ea;&#xa5df;&#xa4a4;&#xa473;&#xa46a;&#xbec7; &#xa5cd;&#xaaab;&#xc2e5;&#xbec7;&#xace3;&#xa873;&#xa9d2; &#xbad3;&#xa468;&#xbdd7;&#xa4e5;	.lib.nsysu.edu.tw	0	0		VSNL1
152	chr11	83619302	83667169	3500104098	40		83619302	83667169	8421504	4	5,14,7,14	0,8,47843,47853	g	350010409800000605,350010409800000702	9-28,0-21						METHOD OF DETECTING HUMAN PAPILLOMA VIRUS BY USING NUCLEIC ACID AMPLIFICATION METHOD AND NUCLEIC ACID CHAIN-IMMOBILIZED CARRIER - Patent application	www.faqs.org	0	0		
1225	chr11	83902995	83903022	3500209040	24		83902995	83903022	8421504	2	14,10	0,17	g	350020904000000045	7-31						Novel mutagenesis methods and compositions	Andrews	1993	0		
1225	chr11	83922538	83922569	3500028061	26		83922538	83922569	8421504	2	7,19	0,12	g	350002806100000367	9-35						Surface proteins of leptospira	www.devileye.net	0	0		
1227	chr11	84177153	84177177	3500104098	23		84177153	84177177	8421504	2	19,4	0,20	g	350010409800000594	9-35						METHOD OF DETECTING HUMAN PAPILLOMA VIRUS BY USING NUCLEIC ACID AMPLIFICATION METHOD AND NUCLEIC ACID CHAIN-IMMOBILIZED CARRIER - Patent application	www.faqs.org	0	0		
1229	chr11	84444566	84444592	3500189823	24		84444566	84444592	8421504	2	10,14	0,12	g	350018982300000626	22-46						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
1229	chr11	84459547	84459571	3500028061	24		84459547	84459571	8421504	1	24	0	g	350002806100000063	1-25						Surface proteins of leptospira	www.devileye.net	0	0		
1230	chr11	84553337	84559437	3500061531	39		84553337	84559437	8421504	2	20,19	0,6081	g	350006153100000001,350006153100000020	0-20,0-19		22815527	10.1158/0008-5472.CAN-12-0943	0008-5472	Cancer Research	NLRR1 Enhances EGF-Mediated MYCN Induction in Neuroblastoma and Accelerates Tumor Growth In Vivo	Hossain	2012	8		MYCN
1233	chr11	84973609	84973632	3500399379	23		84973609	84973632	8421504	1	23	0	g	350039937900000003,350039937900000006,350039937900000014	0-23,0-23,0-23						Fibronectin type iii domain-based multimeric scaffolds	Baca	2013	0		
1233	chr11	84973609	84973632	3500108333	23		84973609	84973632	8421504	1	23	0	g	350010833300000010	0-23						Trail r2-specific multimeric scaffolds	Baca	2013	0		
1237	chr11	85513500	85513528	3500007099	25		85513500	85513528	8421504	2	10,15	0,13	g	350000709900000375	11-36						Uses Of Myostatin Antagonists 	.freshpatents.com	0	0		
1238	chr11	85600339	85600365	3500362791	23		85600339	85600365	8421504	2	5,18	0,8	c	350036279100000005	0-23		23254128	10.1128/JCM.02750-12	0095-1137	Journal of Clinical Microbiology	Phylogenetic and Pathotypic Characterization of Newcastle Disease Viruses Circulating in West Africa and Efficacy of a Current Vaccine	Samuel	2013	4		
1238	chr11	85600339	85600365	3500265345	23		85600339	85600365	8421504	2	5,18	0,8	c	350026534500000005	0-23		23254128	10.1128/JCM.02750-12		Journal of Clinical Microbiology	Phylogenetic and Pathotypic Characterization of Newcastle Disease Viruses Circulating in West Africa and Efficacy of a Current Vaccine	Arthur	2013	0		
1246	chr11	86659171	86659322	3500024826	44		86659171	86659322	8421504	2	22,22	0,129	g	350002482600000195,350002482600000196	0-22,0-22						Udder Health Characteristics 	.freshpatents.com	0	0		
1251	chr11	87348293	87348317	3500432327	23		87348293	87348317	8421504	2	17,6	0,18	g	350043232700000003	0-23		23594879	10.1098/rsob.130017	2046-2441	Open Biology	MHJ_0125 is an M42 glutamyl aminopeptidase that moonlights as a multifunctional adhesin on the surface of Mycoplasma hyopneumoniae	Robinson	2013	0		
1251	chr11	87373049	87373073	3500182929	23		87373049	87373073	8421504	2	12,11	0,13	g	350018292900000094	7-30						Free Medical Textbook | every people has explanation!!!!!!!! | Page 31	ree.wordpress.com	0	0		
1252	chr11	87486018	87486044	3500305636	23		87486018	87486044	8421504	2	5,18	0,8	g	350030563600000038	0-23						Epidemiology of peste des petits ruminants virus in Ethiopia and molecular studies on virulence	s.inp-toulouse.fr	0	0		
1253	chr11	87588594	87588618	3500171265	24		87588594	87588618	8421504	1	24	0	g	350017126500000052	11-35						Gc Tag-modified Bisulfite Genomic Dna Sequencing For Continuous Methylation Spectra 	.freshpatents.com	0	0		
1255	chr11	87834575	87834759	3500046604	48		87834575	87834759	8421504	2	24,24	0,160	c,g	350004660400000003,350004660400000002,350004660400000002	0-24,0-24,0-24						REPRODUCTION	uction-online.org	0	0		
1255	chr11	87834965	87834994	3500019007	24		87834965	87834994	8421504	3	11,7,6	0,13,23	g	350001900700000002	14-38						Kiwifruit's Key Roll in Cancer Prevention & DNA Repair	ww.calharvest.com	0	0		APEX1
1258	chr11	88307524	88321324	3500008756	42		88307524	88321324	8421504	4	13,4,5,20	0,14,19,13780	g	350000875600000921,350000875600000719	4-28,16-36						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
1261	chr11	88612922	88612947	3500241839	23		88612922	88612947	8421504	2	5,18	0,7	g	350024183900000022	22-45						 Compositions And Methods For Delivery Of Genetic Material 	www.docstoc.com	0	0		
1261	chr11	88660429	88666228	3500301078	40		88660429	88666228	8421504	3	19,11,10	0,80,5789	c,g	350030107800000050,350030107800000050,350030107800000049	0-19,0-19,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
1261	chr11	88660429	88666228	3500261436	40		88660429	88666228	8421504	3	19,11,10	0,80,5789	c	350026143600000068,350026143600000067	0-19,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1261	chr11	88724262	88724288	3500249786	23		88724262	88724288	8421504	2	11,12	0,14	c	350024978600000512	0-23						Promoters from brassica napus for seed specific gene expression	BAUER	2011	0		
1262	chr11	88838234	88838257	3500445239	23		88838234	88838257	8421504	1	23	0	g	350044523900000015	0-23						Robert W. Li, Matthew J. Meyer, Curtis. P. Van Tassell, Tad S. Sonstegard, Erin E. Connor, Michael E. Van Amburgh, Yves R. Boisclair and Anthony V. Capuco Physiol Genomics 27:42-53, 2006. First published Jun 20, 2006; This article cites 42 articles, 25 of	ddr.nal.usda.gov	0	0		
1262	chr11	88846607	88846640	3500442868	29		88846607	88846640	8421504	2	6,23	0,10	g	350044286800000097	13-43						US Patent # 5,378,822. Nucleic acids encoding murine and human Ah receptors - Patents.com	www.patents.com	0	0		
1262	chr11	88865914	88865937	3500174943	23		88865914	88865937	8421504	1	23	0	g	350017494300000014	5-28		15155653	10.1128/IAI.72.6.3461-3470.2004	0019-9567	Infection and Immunity	Role of Transferrin Receptor from a Neisseria meningitidis tbpB Isotype II Strain in Human Transferrin Binding and Virulence	Renauld-Mongenie	2004	4		
1263	chr11	88892210	88892235	3500265669	24		88892210	88892235	8421504	2	15,9	0,16	g	350026566900000020	14-39						VARIABLE ANTIBODIES - Patent application	www.faqs.org	0	0		
157	chr11	88991255	89005633	3500309883	96		88991255	89005633	8421504	3	15,55,26	0,11839,14352	p	350030988300015189	0-96						THAP1, UN REGULATEUR CLE DE LA PROLIFERATION DES CELLULES ENDOTHELIALES : RELATIONS STRUCTURE/FONCTION ET GENES CIBLES	esups.ups-tlse.fr	0	0		
1264	chr11	89005663	89005810	3500352503	129		89005663	89005810	8421504	2	78,51	0,96	p	350035250300015018,350035250300015019	0-78,0-51						E2F AS A TARGET OF HORMONE REFRACTORY PROSTATE CANCER	Bertino	2011	0		E2F6
1264	chr11	89080748	89080783	3500183250	28		89080748	89080783	8421504	3	12,3,13	0,15,22	g	350018325000000182	18-46						US Patent # 7,057,086. Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors - Patents.com	www.patents.com	0	0		
19	chr11	89127017	89253661	3500313188	4983		89127017	89253661	8421504	38	93,82,101,138,261,145,139,92,160,61,12,6,68,49,136,92,247,107,160,161,185,70,104,187,94,95,180,169,71,89,79,262,214,301,64,429,57,23	0,43649,45703,57565,68241,75368,78130,80342,81277,82935,83595,87747,87759,87986,88610,88840,89157,89777,92391,94318,94836,101637,102410,105819,108233,108422,109253,109943,112566,113675,114435,115728,116075,125700,126002,126117,126548,126621	c,g	350031318800000009,350031318800000010,350031318800000098,350031318800000011,350031318800000012,350031318800000013,350031318800000014,350031318800000103,350031318800000015,350031318800000016,350031318800000017,350031318800000106,350031318800000018,350031318800000107,350031318800000019,350031318800000020,350031318800000021,350031318800000022,350031318800000110,350031318800000006,350031318800000023,350031318800000111,350031318800000024,350031318800000025,350031318800000026,350031318800000114,350031318800000027,350031318800000028,350031318800000029,350031318800000030,350031318800000031,350031318800000119,350031318800000032,350031318800000033,350031318800000034,350031318800000000,350031318800000035,350031318800000036,350031318800000037,350031318800000038,350031318800000039,350031318800000188,350031318800000040,350031318800000041,350031318800000130,350031318800000042,350031318800000131,350031318800000043,350031318800000132,350031318800000044,350031318800000045,350031318800000046,350031318800000047,350031318800000048,350031318800000049,350031318800000138,350031318800000050,350031318800000051,350031318800000052,350031318800000053,350031318800000054,350031318800000055,350031318800000144,350031318800000056,350031318800000057,350031318800000058,350031318800000147,350031318800000059,350031318800000187,350031318800000004,350031318800000004,350031318800000060,350031318800000061,350031318800000062,350031318800000063,350031318800000064,350031318800000065,350031318800000066,350031318800000154,350031318800000189,350031318800000067,350031318800000155,350031318800000068,350031318800000069,350031318800000070,350031318800000071,350031318800000159,350031318800000072,350031318800000160,350031318800000073,350031318800000161,350031318800000074,350031318800000162,350031318800000075,350031318800000076,350031318800000164,350031318800000077,350031318800000078,350031318800000185,350031318800000185,350031318800000001,350031318800000079,350031318800000080,350031318800000081,350031318800000169,350031318800000170,350031318800000082,350031318800000083,350031318800000084,350031318800000173,350031318800000085,350031318800000086,350031318800000087,350031318800000088,350031318800000089,350031318800000090,350031318800000091,350031318800000092,350031318800000093,350031318800000094,350031318800000095	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-30,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,10-33,0-42,0-48,0-48,0-48,0-48,0-24,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-41,0-48,0-24,0-40,0-40,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-20,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-19,0-19,13-35,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-46,0-863						US Patent # 5,906,819. Rho target protein Rho-kinase - Patents.com	www.patents.com	0	0		
19	chr11	89127062	89243178	3500270113	715		89127062	89243178	8421504	20	20,48,41,48,29,33,40,8,41,48,6,42,41,45,24,21,23,79,33,45	0,57556,78105,81261,87753,88854,89319,89732,94357,94803,105955,108188,109289,109334,112568,113630,113696,114390,115683,116071	c,g	350027011300000094,350027011300000100,350027011300000111,350027011300000116,350027011300000121,350027011300000127,350027011300000132,350027011300000140,350027011300000142,350027011300000153,350027011300000159,350027011300000160,350027011300000166,350027011300000168,350027011300000169,350027011300000170,350027011300000177	21-41,0-48,0-41,0-48,15-44,0-33,0-48,7-48,0-48,0-48,0-41,0-45,0-45,0-45,0-45,0-45,0-45						USE OF A ROCK INHIBITOR TO SUSTAIN PRIMARY HUMAN KERATINOCYTES IN A PROLIFERATIVE STATE - Patent application	www.faqs.org	0	0		
1265	chr11	89195312	89195399	3500247920	48		89195312	89195399	8421504	2	23,25	0,62	c	350024792000000533,350024792000000534	0-23,0-25						Methods for Inducing Differentiation of Undifferentiated Mammalian Cells Into Osteoblasts	Brown	2010	0		
1265	chr11	89195312	89195399	3500186558	48		89195312	89195399	8421504	2	23,25	0,62	c	350018655800000536,350018655800000537	0-23,0-25						Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts	Rompaey	2006	0		
1265	chr11	89195312	89195399	3500037128	48		89195312	89195399	8421504	2	23,25	0,62	c	350003712800000533,350003712800000534	0-23,0-25					Patent	Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts (Patent US:8338124)	Rompaey	2012	0		
1265	chr11	89216369	89232994	3500335347	45		89216369	89232994	8421504	2	21,24	0,16601	c,g	350033534700000002,350033534700000002,350033534700000003	0-21,0-21,0-24				1552-5783	Investigative Ophthalmology & Visual Science	Role of the Small GTP-Binding Protein Rho in Epithelial Cell Migration in the Rabbit Cornea	Nakamura	2001	0		ROCK2
1265	chr11	89237461	89242807	3500418466	41		89237461	89242807	8421504	2	20,21	0,5325	c,g	350041846600000005,350041846600000007	1-21,0-21		17606625	10.1128/MCB.01735-06	0270-7306	Molecular and Cellular Biology	ROCK2 and Its Alternatively Spliced Isoform ROCK2m Positively Control the Maturation of the Myogenic Program	Pelosi	2007	6		
1265	chr11	89253215	89253256	3500401872	39		89253215	89253256	8421504	2	16,23	0,18	c	350040187200000017	57-96						Methods And Compositions For Treating And Preventing Peripheral Nerve Damage 	.freshpatents.com	0	0		
1266	chr11	89270869	89270899	3500245111	24		89270869	89270899	8421504	3	14,4,6	0,15,24	g	350024511100000006	19-45						Production of chimeric antibodies - a combinatorial approach	Baier	1993	0		
1267	chr11	89424942	89425065	3500276041	40		89424942	89425065	8421504	2	21,19	0,104	c,g	350027604100000015,350027604100000015,350027604100000014,350027604100000014	0-21,0-21,0-19,0-19		21813710	10.1152/ajpcell.00455.2010		American Journal of Physiology - Cell Physiolog	Contribution of Kv2.1 channels to the delayed rectifier current in freshly dispersed smooth muscle cells from rabbit urethra	Kyle	2011	0		
1267	chr11	89425181	89425244	3500226062	57		89425181	89425244	8421504	2	21,36	0,27	p	350022606200015018	3-63						Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases	Brys	2007	0		
1267	chr11	89425181	89425244	3500108932	57		89425181	89425244	8421504	2	21,36	0,27	p	350010893200015018	3-63						Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases	Brys	2006	0		
1267	chr11	89504614	89504668	3500335102	54		89504614	89504668	8421504	1	54	0	p	350033510200015131	0-54						BiochemicalCharacterizationandN-terminomicsAnalysisof Leukolysin,theMembrane-type6MatrixMetalloprotease (MMP25)	www.jbc.org	0	0		PDIA6
1267	chr11	89504701	89508299	3500335263	30		89504701	89508299	8421504	2	17,13	0,3585	c	350033526300000138,350033526300000152	9-32,9-39						Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof	Chandrashekar	1999	0		PDIA6
1269	chr11	89742743	89742771	3500300648	23		89742743	89742771	8421504	2	15,8	0,20	g	350030064800000184	20-43						Methods and targets for identifying compounds for regulating angiogenesis - Patent application	www.faqs.org	0	0		
1271	chr11	89931943	89931988	3500422640	41		89931943	89931988	8421504	2	21,20	0,25	c	350042264000000020,350042264000000019	0-21,19-39						ScienceDirect.com - The Journal of Steroid Biochemistry and Molecular Biology - Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast ca	sciencedirect.com	0	0		HPCA
1271	chr11	89947731	89947754	3500096622	23		89947731	89947754	8421504	1	23	0	c	350009662200000023	7-30						Method for carrying out the parallel sequencing of a nucleic acid mixture on a surface	Fischer	2001	0		
1271	chr11	89948176	89949238	3500359784	48		89948176	89949238	8421504	2	24,24	0,1038	c	350035978400000026,350035978400000025	0-24,0-24						THE CELLULAR NUCLEIC ACID BINDING PROTEIN REGULATES THE ALZHEIMER&#xe2; S DISEASE &#xce;&#xb2;-SECRETASE PROTEIN BACE1	knowledge.uky.edu	0	0		ODC1
1271	chr11	89949468	89950015	3500071382	41		89949468	89950015	8421504	3	20,11,10	0,302,537	c	350007138200000013,350007138200000012	0-20,0-21						REPRODUCTION	uction-online.org	0	0		
1271	chr11	89950033	89950062	3500148324	29		89950033	89950062	8421504	1	29	0	c	350014832400000002	0-29		18045478	10.1186/1475-2867-7-18	1475-2867	Cancer Cell International	Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids	Miller	2007	2		
1272	chr11	90159448	90159476	3500447624	24		90159448	90159476	8421504	2	8,16	0,12	c	350044762400000199	15-39						USE OF R-GENES AS A SELECTION MARKER IN PLANT TRANSFORMATION AND USE OF CISGENES IN PLANT TRANSFORMATION - Patent application	www.faqs.org	0	0		
1272	chr11	90164022	90164046	3500335414	24		90164022	90164046	8421504	1	24	0	c	350033541400000000	0-24		19250552	10.1186/1476-4598-8-11	1476-4598	Molecular Cancer	Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis	Zhang	2009	4		RRM2
1272	chr11	90167044	90167072	3500314320	23		90167044	90167072	8421504	2	14,9	0,19	g	350031432000000051	1-27						Journal of Virological Methods	005.pasteur.ac.ir	0	0		
1273	chr11	90258836	90258859	3500029159	23		90258836	90258859	8421504	1	23	0	c	350002915900000290,350002915900000227	9-32,21-44						Compositions for the prevention and treatment of verotoxin-induced disease	Williams	1997	0		
1273	chr11	90258836	90258859	3500014455	23		90258836	90258859	8421504	1	23	0	c	350001445500000243,350001445500000314	21-44,9-32						Methods for producing avian verotoxin antitoxin	Williams	1999	0		
1273	chr11	90298530	90298557	3500425496	24		90298530	90298557	8421504	2	7,17	0,10	c	350042549600000064	9-33						GenerationandCharacterizationofanscFvDirectedagainst SiteIIofRabiesGlycoprotein	dcentralcanada.ca	0	0		
1274	chr11	90333478	90333501	3500376609	23		90333478	90333501	8421504	1	23	0	c	350037660900000008	0-23		20139417	10.1093/nar/gkq044		Nucleic Acids Research	Efficient conditional and promoter-specific in vivo expression of cDNAs of choice by taking advantage of recombinase-mediated cassette exchange using FlEx gene traps	Laura	2010	0		
1274	chr11	90333478	90333501	3500205047	23		90333478	90333501	8421504	1	23	0	c	350020504700000009	0-23						CONDITIONAL EXPRESSION OF TRANSGENES IN VIVO	Schebelle	2010	0		
1274	chr11	90333478	90333501	3500173404	23		90333478	90333501	8421504	1	23	0	c	350017340400000008	0-23		20139417	10.1093/nar/gkq044		Nucleic Acids Research	Efficient conditional and promoter-specific in vivo expression of cDNAs of choice by taking advantage of recombinase-mediated cassette exchange using FlEx gene traps	Laura	2010	0		
1274	chr11	90333478	90333501	3500042548	23		90333478	90333501	8421504	1	23	0	c	350004254800000009,350004254800000045	0-23,0-22						CONDITIONAL EXPRESSION OF TRANSGENES IN VIVO - Patent application	www.faqs.org	0	0		
1274	chr11	90421282	90421306	3500201864	23		90421282	90421306	8421504	2	11,12	0,12	g	350020186400000807	11-34						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1275	chr11	90523951	90523978	3500444890	23		90523951	90523978	8421504	3	6,11,6	0,9,21	g	350044489000000035	5-28						ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION	Iversen	2012	0		
1275	chr11	90523951	90523978	3500190042	23		90523951	90523978	8421504	3	6,11,6	0,9,21	g	350019004200000214,350019004200000509	5-28,5-28						Oligonucleotide analogs having cationic intersubunit linkages - Patent application	www.faqs.org	0	0		
1275	chr11	90523951	90523978	3500179145	23		90523951	90523978	8421504	3	6,11,6	0,9,21	g	350017914500000180,350017914500000035	5-28,5-28						ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION - Patent application	www.faqs.org	0	0		
1275	chr11	90523951	90523978	3500057157	23		90523951	90523978	8421504	3	6,11,6	0,9,21	g	350005715700000032	5-28						Antisense antiviral compound and method for treating ssRNA viral infection	Iversen	2005	0		
1275	chr11	90523951	90523978	3500013799	23		90523951	90523978	8421504	3	6,11,6	0,9,21	g	350001379900000032	5-28					Patent	Antisense antiviral compound and method for treating ssRNA viral infection (Patent US:8129352)	Iversen	2012	0		
1275	chr11	90533235	90562713	3500322286	696		90533235	90562713	8421504	6	294,42,76,164,96,24	0,25722,25770,27615,28416,29454	p	350032228600015004,350032228600015011,350032228600015018,350032228600015025	0-174,0-162,0-180,0-180						Lysine acetylation targets protein complexes and co-regulates major cellular functions	ww.sciencemag.org	0	0		YWHAQ
1275	chr11	90533262	90533379	3500132981	72		90533262	90533379	8421504	2	30,42	0,75	p	350013298100015047	42-165						14-3-3 isoform specificity in barley	dare.ubvu.vu.nl	0	0		YWHAQ
1275	chr11	90533286	90562704	3500072427	432		90533286	90562704	8421504	11	45,45,45,3,90,31,14,45,3,96,15	0,96,192,240,25671,25764,27564,27677,27725,28365,29403	p	350007242700015138,350007242700015139,350007242700015141,350007242700015142,350007242700015111,350007242700015143,350007242700015144,350007242700015146,350007242700015147,350007242700015052	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-108						14-3-3 ETA Antibodies and Uses Thereof for the Diagnosis and Treatment of Arthritis - Patent application	www.faqs.org	0	0		
1275	chr11	90533405	90533477	3500205284	68		90533405	90533477	8421504	3	20,24,24	0,23,48	c	350020528400000015,350020528400000017,350020528400000016	0-20,0-24,0-24		19047086	10.1158/1078-0432.CCR-08-1366	1078-0432	Clinical Cancer Research	14-3-3&#x03c3; Modulates Pancreatic Cancer Cell Survival and Invasiveness	Neupane	2008	8		YWHAQ
1276	chr11	90626634	90626916	3500388209	145		90626634	90626916	8421504	4	14,18,33,80	0,17,41,202	g	350038820900000011,350038820900000009	0-146,0-56						Estudio de la composici&#xf3;n de los gr&#xe1;nulos corticales y del oolema de ovocitos porcinos y bovinos madurados y fecundados in vitro	tdx.cat/bitstream	0	0		
1276	chr11	90651223	90654402	3500047878	40		90651223	90654402	8421504	2	20,20	0,3159	c,g	350004787800000005,350004787800000004,350004787800000004	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1278	chr11	90880965	90880991	3500104401	23		90880965	90880991	8421504	3	14,5,4	0,16,22	g	350010440100000146	5-28						3-HYDROXYPROPIONIC ACID AND OTHER ORGANIC COMPOUNDS - Patent application	www.faqs.org	0	0		
1280	chr11	91160369	91160399	3500320735	25		91160369	91160399	8421504	2	12,13	0,17	g	350032073500000016	0-25						Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes	Simons	1991	0		
1280	chr11	91178253	91178277	3500394182	24		91178253	91178277	8421504	1	24	0	g	350039418200000008	0-24		19855901	10.1590/S0100-879X2009001100004	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Dengue virus-induced regulation of the host cell translational machinery	Villas-Boas	2009	1		
1281	chr11	91273436	91275327	3500207250	64		91273436	91275327	8421504	3	20,20,24	0,153,1867	c,g	350020725000000002,350020725000000002,350020725000000003,350020725000000003,350020725000000005	0-20,0-20,0-20,0-20,0-24		22848373	10.1371/journal.pone.0040269		PLoS ONE	A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and -103, Target the Differentiation Inhibitor ID2	Daniela	2012	0		
1281	chr11	91275288	91275399	3500360598	41		91275288	91275399	8421504	2	20,21	0,90	c	350036059800000003,350036059800000002	1-21,0-21		19366699	10.1074/jbc.M109.002881		The Journal of Biological Chemistry	Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells	Paul	June	0		ID2
1281	chr11	91275383	91275478	3500388350	41		91275383	91275478	8421504	2	19,22	0,73	c,g	350038835000000069,350038835000000069,350038835000000068,350038835000000068	0-19,0-19,0-22,0-22						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
1281	chr11	91275383	91275478	3500027904	41		91275383	91275478	8421504	2	19,22	0,73	c,g	350002790400000044,350002790400000044,350002790400000043	0-19,0-19,0-22						 SpringerImages - primers sequences 	pringerimages.com	0	0		
1282	chr11	91481145	91481175	3500240462	24		91481145	91481175	8421504	3	13,4,7	0,18,23	g	350024046200000015	11-35						Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell lines	biomedcentral.com	0	0		
1283	chr11	91529860	91572165	3500383915	39		91529860	91572165	8421504	3	13,6,20	0,14,42285	g	350038391500000505,350038391500001228	0-19,3-24						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
1294	chr11	93002425	93002453	3500432515	24		93002425	93002453	8421504	2	11,13	0,15	g	350043251500000003	0-31						In vitro and in vivo characterization of disulfide bond use in myocilin complex formation	www.molvis.org	0	0		
1295	chr11	93078860	93131830	3500432414	85		93078860	93131830	8421504	4	20,20,23,22	0,16534,16699,52948	g	350043241400000049,350043241400000048,350043241400000047,350043241400000039	18-38,7-27,17-40,18-40						OVINE IDENTIFICATION METHOD	Mcewan	2008	0		
1297	chr11	93426173	93426201	3500417160	23		93426173	93426201	8421504	2	15,8	0,20	g	350041716000000015	0-24			10.1128/MCB.22.10.3345-3357.2002		Molecular and Cellular Biology	mRTVP-1, a Novel p53 Target Gene with Proapoptotic Activities	Chengzhen	2002	0		
1297	chr11	93426173	93426201	3500302071	23		93426173	93426201	8421504	2	15,8	0,20	g	350030207100000015,350030207100000021	0-24,2-26						mRTVP-1, a Novel p53 Target Gene with Proapoptotic Activities	mcb.asm.org	0	0		
1298	chr11	93532124	93532152	3500417160	23		93532124	93532152	8421504	2	8,15	0,13	g	350041716000000016	8-32			10.1128/MCB.22.10.3345-3357.2002		Molecular and Cellular Biology	mRTVP-1, a Novel p53 Target Gene with Proapoptotic Activities	Chengzhen	2002	0		
1298	chr11	93532124	93532152	3500302071	23		93532124	93532152	8421504	2	8,15	0,13	g	350030207100000016	8-32						mRTVP-1, a Novel p53 Target Gene with Proapoptotic Activities	mcb.asm.org	0	0		
1300	chr11	93727133	93727156	3500160528	23		93727133	93727156	8421504	1	23	0	g	350016052800000277	11-40						Anthrax toxin fusion proteins and uses thereof	Arora	1994	0		
1304	chr11	94362280	94362312	3500008756	28		94362280	94362312	8421504	3	17,4,7	0,20,25	g	350000875600000152	10-40						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
1305	chr11	94425820	94425845	3500285858	23		94425820	94425845	8421504	2	14,9	0,16	g	350028585800000097,350028585800000015	0-23,0-23						LIVE, ATTENUATED RESPIRATORY SYNCYTIAL VIRUS - Patent application	www.faqs.org	0	0		
1305	chr11	94425820	94425845	3500195851	23		94425820	94425845	8421504	2	14,9	0,16	g	350019585100000015	0-23						LIVE, ATTENUATED RESPIRATORY SYNCYTIAL VIRUS	Yagodich	2009	0		
1305	chr11	94463609	94463718	3500024337	49		94463609	94463718	8421504	2	24,25	0,84	g	350002433700000002,350002433700000003	0-24,0-25						Genetic Diversity Analysis of the Gohilwari Breed of Indian Goat Capra hircus ) Using Microsatellite Markers	thescipub.com	0	0		
1308	chr11	94790140	94790165	3500084437	23		94790140	94790165	8421504	2	18,5	0,20	g	350008443700000001	0-23		23190684	10.1186/1471-2164-13-678	1471-2164	BMC Genomics	Structure of the type IV secretion system in different strains of Anaplasma phagocytophilum	Al-Khedery	2012	4		
1309	chr11	94951010	94951038	3500408979	23		94951010	94951038	8421504	2	7,16	0,12	g	350040897900000002	3-26						Compositions and Methods for Binding Lysophosphatidic Acid - US Patent Application 20120195901 Description	ww.patentstorm.us	0	0		
1309	chr11	94951010	94951038	3500382810	23		94951010	94951038	8421504	2	7,16	0,12	g	350038281000000014	3-26						Polypeptide having enhanced effector function	Tsuji	2010	0		
1309	chr11	94951010	94951038	3500348054	23		94951010	94951038	8421504	2	7,16	0,12	g	350034805400000014	3-26						Mutant polypeptide having effector function	Tsuji	2009	0		
1309	chr11	94951010	94951038	3500024779	23		94951010	94951038	8421504	2	7,16	0,12	g	350002477900000002	3-26						Compositions And Methods For Binding Lysophosphatidic Acid 	.freshpatents.com	0	0		
1311	chr11	95225397	95225422	3500031175	23		95225397	95225422	8421504	2	12,11	0,14	c	350003117500000185	3-26						Prf protein and nucleic acid sequences: compositions and methods for plant pathogen resistance - Patent # 6245510 - PatentGenius	.patentgenius.com	0	0		
163	chr11	95226053	95338272	3500074276	1293		95226053	95338272	8421504	12	23,676,138,93,66,36,89,3,55,52,1,61	0,35378,40383,48309,48961,50659,57196,67974,67980,68038,102119,112158	p,c,g	350007427600000050,350007427600000058,350007427600000032,350007427600015025,350007427600015040,350007427600000057,350007427600015024,350007427600000080,350007427600000080,350007427600000005,350007427600000005,350007427600015039,350007427600015023,350007427600015022,350007427600015037,350007427600015021,350007427600000053,350007427600015020,350007427600000051,350007427600015018,350007427600015014,350007427600000047,350007427600000044,350007427600000043,350007427600015030,350007427600000041,350007427600000039,350007427600015005,350007427600000038,350007427600000079,350007427600000079,350007427600000004,350007427600000004,350007427600015026,350007427600015004,350007427600000036	0-23,0-45,0-1092,0-45,0-45,0-42,0-45,0-20,0-20,0-20,0-20,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-48,0-48,0-45,0-45,0-41,3-48,0-45,0-48,0-45,0-44,0-22,0-22,0-22,0-22,0-93,0-48,0-218						 Telomerizing Nuclear Donor Cells And Improving The Efficiency On Nuclear Transfer 	www.docstoc.com	0	0		
163	chr11	95261160	95338454	3500442428	1396		95261160	95338454	8421504	14	343,336,48,22,26,19,66,11,66,116,95,107,25,116	0,439,823,5392,13202,13276,13854,15552,22112,32867,67012,77044,77152,77178	c,g	350044242800000078,350044242800000078,350044242800000003,350044242800000077,350044242800000077,350044242800000076,350044242800000073,350044242800000072,350044242800000071,350044242800000070,350044242800000002,350044242800000069,350044242800000068,350044242800000067,350044242800000065,350044242800000060,350044242800000058,350044242800000057,350044242800000055	0-245,0-245,0-20,0-50,0-50,0-48,0-48,0-48,0-48,0-48,0-20,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-528					Patent	Mice homozygous for an inactivated &#x03b1; 1,3-galactosyl transferase gene (Patent US:5849991)	Crawford	1998	0		
163	chr11	95261212	95294112	3500305411	60		95261212	95294112	8421504	3	20,20,20	0,543,32880	c,g	350030541100000003,350030541100000003,350030541100000002,350030541100000002,350030541100000000	0-20,0-20,0-20,0-20,0-20						Materials and methods for management of hyperacute rejection in human xenotransplantation	Crawford	1995	0		
163	chr11	95261212	95294112	3500235758	60		95261212	95294112	8421504	3	20,20,20	0,543,32880	c	350023575800000003,350023575800000002,350023575800000000	0-20,0-20,0-20						Materials and methods for management of hyperacute rejection in human xenotransplantation	D'apice	2004	0		
163	chr11	95261230	95294087	3500453842	47		95261230	95294087	8421504	2	23,24	0,32833	c	350045384200000002,350045384200000001	0-23,0-24						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
163	chr11	95261371	95338454	3500100718	1613		95261371	95338454	8421504	13	49,40,643,138,93,66,36,89,116,95,107,25,116	0,51,93,5065,12991,13643,15341,21878,32656,66801,76833,76941,76967	c	350010071800000033	0-1613						Animal tissue with carbohydrate antigens compatible for human transplantation	Clark	2002	0		
163	chr11	95261371	95338394	3500206302	1556		95261371	95338394	8421504	12	44,691,138,93,66,36,89,116,95,107,25,56	0,45,5065,12991,13643,15341,21878,32656,66801,76833,76941,76967	c	350020630200000038	0-1556						Animal tissue with carbohydrate antigens compatible for human transplantation	Denning	2002	0		
1311	chr11	95261413	95274400	3500435464	44		95261413	95274400	8421504	2	24,20	0,12967	c	350043546400000007,350043546400000006	6-30,3-23						METABOLIC ENGINEERING AND OMICS ANALYSIS OF	artech.gatech.edu	0	0		
1311	chr11	95261413	95274400	3500266908	44		95261413	95274400	8421504	2	24,20	0,12967	c	350026690800000007,350026690800000006	6-30,3-23						METABOLIC ENGINEERING AND OMICS ANALYSIS OF	artech.gatech.edu	0	0		
1311	chr11	95261413	95274400	3500218847	44		95261413	95274400	8421504	2	24,20	0,12967	c	350021884700000001,350021884700000000	6-30,3-23		20067629	10.1186/1475-2859-9-1	1475-2859	Microbial Cell Factories	Metabolic engineering of Agrobacterium sp. strain ATCC 31749 for production of an &#xce;&#xb1;-Gal epitope	Ruffing	2010	4		
1311	chr11	95261413	95274400	3500030556	44		95261413	95274400	8421504	2	24,20	0,12967	c	350003055600000001,350003055600000000	8-32,11-31						Metabolic engineering of Agrobacterium sp. strain ATCC 31749 for production of an a-Gal epitope	biomedcentral.com	0	0		
1311	chr11	95261413	95274391	3500295740	48		95261413	95274391	8421504	2	21,27	0,12951	c	350029574000000001,350029574000000000	15-36,9-39			10.1128/AEM.69.9.5238-5242.2003		Applied and Environmental Microbiology	Enhanced Production of &#x03b1;-Galactosyl Epitopes by Metabolically Engineered Pichia pastoris	Jun	2003	0		
1311	chr11	95261413	95274391	3500030367	48		95261413	95274391	8421504	2	21,27	0,12951	c	350003036700000001,350003036700000000	15-36,9-39		12957908	10.1128/AEM.69.9.5238-5242.2003	0099-2240	Applied and Environmental Microbiology	Enhanced Production of &#x03b1;-Galactosyl Epitopes by Metabolically Engineered Pichia pastoris	Shao	2003	4		
163	chr11	95261416	95338454	3500206302	1350		95261416	95338454	8421504	10	691,138,93,66,36,89,116,1,60,60	0,5020,12946,13598,15296,21833,32611,66756,76796,76978	p,c	350020630200015017,350020630200000036,350020630200000005,350020630200015016,350020630200015014,350020630200015012,350020630200000004,350020630200000035,350020630200000003,350020630200000034,350020630200000037	0-477,0-1092,0-20,0-450,3-180,0-141,0-22,7-133,0-19,0-60,0-60						Animal tissue with carbohydrate antigens compatible for human transplantation	Denning	2002	0		
163	chr11	95261431	95338272	3500230782	1282		95261431	95338272	8421504	9	676,138,93,66,36,89,116,1,67	0,5005,12931,13583,15281,21818,32596,66741,76774	p,c	350023078200000031,350023078200015005,350023078200000004,350023078200000003,350023078200000030	0-1092,0-117,0-20,0-22,0-193						Use of telomerase reverse transcriptase to create homozygous knockout animals	Clark	2002	0		
163	chr11	95261431	95338272	3500100718	1174		95261431	95338272	8421504	14	342,174,154,86,13,93,23,4,36,20,45,116,1,67	0,345,522,5005,5130,12931,13583,13645,15281,21818,21862,32596,66741,76774	p,c,g	350010071800000032,350010071800015015,350010071800015010,350010071800000005,350010071800000005,350010071800015014,350010071800015009,350010071800015013,350010071800015012,350010071800015011,350010071800000004,350010071800015005,350010071800000010,350010071800000030,350010071800000003,350010071800000003	0-240,0-117,0-141,0-20,0-20,0-255,0-315,0-357,0-129,0-114,0-22,0-84,18-47,0-193,0-19,0-19						Animal tissue with carbohydrate antigens compatible for human transplantation	Clark	2002	0		
1311	chr11	95261464	95262019	3500435035	41		95261464	95262019	8421504	2	21,20	0,535	c	350043503500000057,350043503500000056	0-21,0-20						Tissue Specific Expression Of Exogenous Proteins In Transgenic Chickens 	.freshpatents.com	0	0		
1311	chr11	95261464	95262019	3500426402	41		95261464	95262019	8421504	2	21,20	0,535	c,g	350042640200000081,350042640200000081,350042640200000080	0-21,0-21,0-20					Patent	Transgenic bovines having reduced prion protein production (Patent US:7429690)	Ishida	2008	0		
1311	chr11	95261464	95262019	3500401473	41		95261464	95262019	8421504	2	21,20	0,535	c	350040147300000051,350040147300000050	0-21,0-20						Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin	Robl	2001	0		
1311	chr11	95261464	95262019	3500302030	41		95261464	95262019	8421504	2	21,20	0,535	c	350030203000000051,350030203000000050	0-21,0-20						Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates	Ferguson	2002	0		
1311	chr11	95261464	95262019	3500297848	41		95261464	95262019	8421504	2	21,20	0,535	c	350029784800000051,350029784800000050	0-21,0-20						Expression of xenogenous (human) imunoglobulins in cloned, transgenic ungulates	Robl	2005	0		
1311	chr11	95261464	95262019	3500297579	41		95261464	95262019	8421504	2	21,20	0,535	c	350029757900000050,350029757900000049	0-21,0-20						Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates - Patent application	www.faqs.org	0	0		
1311	chr11	95261464	95262019	3500270923	41		95261464	95262019	8421504	2	21,20	0,535	c,g	350027092300000057,350027092300000057,350027092300000056	0-21,0-21,0-20						Transgenic ungulates capable of human antibody production	Collas	2003	0		
1311	chr11	95261464	95262019	3500111880	41		95261464	95262019	8421504	2	21,20	0,535	c,g	350011188000000080,350011188000000079,350011188000000079	0-21,0-20,0-20						Transgenic ungulates having reduced prion protein activity and uses thereof - Patent application	www.faqs.org	0	0		
163	chr11	95261755	95294112	3500326124	40		95261755	95294112	8421504	2	20,20	0,32337	c	350032612400000002,350032612400000000	0-20,0-20						Materials and methods for management of hyperacute rejection in human xenotransplantation	D'apice	2004	0		
163	chr11	95261755	95294112	3500190873	40		95261755	95294112	8421504	2	20,20	0,32337	c	350019087300000002,350019087300000000	0-20,0-20						Pigs and pig cells having an inactivated &#x03b1; 1,3-galactosyl transferase gene	D'apice	1997	0		
163	chr11	95261755	95294112	3500162254	40		95261755	95294112	8421504	2	20,20	0,32337	c	350016225400000002,350016225400000000	0-20,0-20					Patent	Pigs and pig cells having an inactivated &#x03b1; 1,3-galactosyl transferase gene (Patent US:6849448)	Crawford	2005	0		
1311	chr11	95261908	95262159	3500314401	118		95261908	95262159	8421504	2	94,24	0,227	c,g	350031440100000049,350031440100000025,350031440100000025,350031440100000075	0-90,0-51,0-51,0-24						SI appendix for	www.pnas.org	0	0		
1311	chr11	95274379	95274403	3500360470	24		95274379	95274403	8421504	1	24	0	c,g	350036047000000007,350036047000000007,350036047000000001	12-36,12-36,13-34						THE J B C &#xa9; 2000 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Changing the Donor Cofactor of Bovine a1,3-Galactosyltransferase by Fusion with UDP-galactose 4-Epimerase	roups.ucdavis.edu	0	0		
163	chr11	95283309	95294029	3500083196	31		95283309	95294029	8421504	2	29,2	0,10718	c	350008319600000004	0-31			10.1073/pnas.0610012104		Proceedings of the National Academy of Sciences of the United States of America	Functionally important glycosyltransferase gain and loss during catarrhine primate emergence	Chihiro	2007	0		
163	chr11	95283329	95338272	3500074276	193		95283329	95338272	8421504	4	9,116,1,67	0,10698,44843,54876	c	350007427600000031	0-193						 Telomerizing Nuclear Donor Cells And Improving The Efficiency On Nuclear Transfer 	www.docstoc.com	0	0		
1312	chr11	95418076	95418099	3500061987	23		95418076	95418099	8421504	1	23	0	g	350006198700000032	0-25						N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor - Patent application	www.faqs.org	0	0		
164	chr11	95543813	95620770	3500057903	53		95543813	95620770	8421504	2	17,36	0,76921	p	350005790300015145	61-114						<HTML lang="en"> <HEAD> <TITLE>[KDRI]Chlamydomonas reinhardtii EST index</TITLE> <LINK REL ="parent	est.kazusa.or.jp	0	0		
164	chr11	95543813	95620770	3500057903	44		95543813	95620770	8421504	2	8,36	0,76921	p	350005790300015091	52-96						<HTML lang="en"> <HEAD> <TITLE>[KDRI]Chlamydomonas reinhardtii EST index</TITLE> <LINK REL ="parent	est.kazusa.or.jp	0	0		
1314	chr11	95607038	95607061	3500352313	23		95607038	95607061	8421504	1	23	0	c,g	350035231300000011,350035231300000011	0-23,0-23		20410161	10.1677/ERC-09-0269	1351-0088	Endocrine-Related Cancer	Suppression of MG132-mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells	Du	2010	4		DAB2IP
1314	chr11	95629921	95629946	3500179094	24		95629921	95629946	8421504	2	9,15	0,10	c	350017909400000025	1-25						Glaucoma therapeutics and diagnostics	www.devileye.net	0	0		
164	chr11	95961982	96089828	3500447721	34		95961982	96089828	8421504	2	6,28	0,127818	c	350044772100000631	10-44						Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications - Patent application	www.faqs.org	0	0		
164	chr11	95961982	96089828	3500447721	34		95961982	96089828	8421504	2	6,28	0,127818	c	350044772100000630	6-40						Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications - Patent application	www.faqs.org	0	0		
1317	chr11	96043550	96043780	3500236087	24		96043550	96043780	8421504	2	18,6	0,224	c	350023608700000028	12-39						Melanocortin receptor polypeptides MC-3, MC-4, and MC-5	Yamada	1996	0		LHX6
1317	chr11	96056777	96058008	3500240572	81		96056777	96058008	8421504	2	57,24	0,1207	p	350024057200015001	33-114						Expression and regulation of Lhx6and Lhx7, a novel subfamily of LIM homeodomain encoding genes, suggests a role in mammalian head development	ev.biologists.org	0	0		LHX6
1318	chr11	96146820	96146971	3500432414	40		96146820	96146971	8421504	2	20,20	0,131	g	350043241400000016,350043241400000015	7-27,18-38						OVINE IDENTIFICATION METHOD	Mcewan	2008	0		
1318	chr11	96162190	96162216	3500160528	24		96162190	96162216	8421504	2	9,15	0,11	g	350016052800000136	12-37						Anthrax toxin fusion proteins and uses thereof	Arora	1994	0		
1319	chr11	96237027	96254600	3500279900	186		96237027	96254600	8421504	4	63,57,38,28	0,9655,17155,17545	p	350027990000015102,350027990000015100,350027990000015098	0-63,0-57,0-66						-Dioxygenase aus Erbsen	.uni-wuerzburg.de	0	0		
1319	chr11	96238851	96249277	3500326589	50		96238851	96249277	8421504	2	25,25	0,10401	c,g	350032658900000001,350032658900000000	0-25,0-25		8977409	10.1210/en.138.1.237	0013-7227	Endocrinology	Cloning of Guinea Pig Cyclooxygenase-2 and 15-Hydroxyprostaglandin Dehydrogenase Complementary Deoxyribonucleic Acids: Steroid-Modulated Gene Expression Correlates to Prostaglandin F2&#x03b1; Secretion in Cultured Endometrial Cells	Bracken	1997	4		PTGS1
1319	chr11	96238851	96249277	3500213083	50		96238851	96249277	8421504	2	25,25	0,10401	c	350021308300000001,350021308300000000	0-25,0-25		9916000	10.1095/biolreprod60.2.341	0006-3363	Biology of Reproduction	Accumulation of Cyclooxygenase-2 Gene Transcripts in Uterine Tissues of Pregnant and Parturient Cows: Stimulation by Oxytocin	Fuchs	1999	4		
1319	chr11	96246620	96246645	3500322601	25		96246620	96246645	8421504	1	25	0	c	350032260100000002	5-30		16239265	10.1113/jphysiol.2005.099309	0022-3751	The Journal of Physiology	Interaction between spontaneous and neurally mediated regulation of smooth muscle tone in the rabbit corpus cavernosum	Hashitani	2005	5		
1319	chr11	96246679	96246739	3500145306	60		96246679	96246739	8421504	1	60	0	p	350014530600015000	0-60						Inducible Nitric Oxide Synthase Mediates Prostaglandin H Synthase Nitration and Suppresses Eicosanoid Production--&#x300a;&#x7f8e;&#x56fd;&#x75c5;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&	journal.9med.net	0	0		
1319	chr11	96249336	96249360	3500339822	24		96249336	96249360	8421504	1	24	0	c	350033982200000003	0-24		21042289	10.1038/aps.2010.152	1671-4083	Acta Pharmacologica Sinica	Isochaihulactone protects PC12 cell against H2O2 induced oxidative stress and exerts the potent anti-aging effects in D-galactose aging mouse model	Yu	2010	2		
1319	chr11	96249336	96249360	3500011906	24		96249336	96249360	8421504	1	24	0	c	350001190600000003	0-24		21042289	10.1038/aps.2010.152	1671-4083	Acta Pharmacologica Sinica	Isochaihulactone protects PC12 cell against H2O2 induced oxidative stress and exerts the potent anti-aging effects in D-galactose aging mouse model	Yu	2010	2		
1319	chr11	96251416	96251626	3500059806	78		96251416	96251626	8421504	3	24,30,24	0,151,186	c,g	350005980600000001,350005980600000001,350005980600000002,350005980600000002,350005980600000000	0-24,0-24,0-30,0-30,0-24						ANALYSIS OF ENDOMETRIAL GENE AND PROTEIN ALTERATIONS FOLLOWING ENDOCRINE DISRUPTION IN THE PREGNANT GILT	brary.okstate.edu	0	0		
1319	chr11	96251718	96254581	3500353746	40		96251718	96254581	8421504	4	15,5,11,9	0,2358,2491,2854	c	350035374600000003,350035374600000002	0-20,0-20		20110403	10.1677/JME-09-0112	0952-5041	Journal of Molecular Endocrinology	Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-&#x03b1;	Sobrino	2010	3		PTGS1
1319	chr11	96251718	96254581	3500002660	40		96251718	96254581	8421504	4	15,5,11,9	0,2358,2491,2854	c	350000266000000003,350000266000000002	0-20,0-20		16046614	10.1124/jpet.105.090456	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Effects of Phytoestrogens Genistein and Daidzein on Prostacyclin Production by Human Endothelial Cells	Hermenegildo	2005	0		
1323	chr11	96818657	96818681	3500104098	23		96818657	96818681	8421504	2	11,12	0,12	g	350010409800000639,350010409800000638	11-34,8-29						METHOD OF DETECTING HUMAN PAPILLOMA VIRUS BY USING NUCLEIC ACID AMPLIFICATION METHOD AND NUCLEIC ACID CHAIN-IMMOBILIZED CARRIER - Patent application	www.faqs.org	0	0		
1325	chr11	97030861	97030887	3500384820	23		97030861	97030887	8421504	2	17,6	0,20	c	350038482000000047	10-35						Genetic engineering of Staphylococcus gallinarum	on.ethbib.ethz.ch	0	0		
1325	chr11	97030861	97030887	3500135883	23		97030861	97030887	8421504	2	17,6	0,20	c	350013588300000047	10-35						Genetic engineering of Staphylococcus gallinarum	n.library.ethz.ch	0	0		
1325	chr11	97031373	97031418	3500298686	45		97031373	97031418	8421504	1	45	0	p	350029868600015005	0-45						Compositions and Methods Which Modulate G-Protein Signaling for the Treatment of Inflammatory Disorders such as Asthma and Allergic Conjunctivitis - Patent application	www.faqs.org	0	0		
1326	chr11	97166632	97166663	3500145608	31		97166632	97166663	8421504	1	31	0	c,g	350014560800000016,350014560800000016	8-39,8-39						Regulation of endocytosis and secretion by Rab GTPase activating proteins	b.uni-muenchen.de	0	0		
1326	chr11	97166753	97166784	3500301274	31		97166753	97166784	8421504	1	31	0	c,g	350030127400000001,350030127400000002	17-48,8-35		10202141	10.1093/emboj/18.7.1772	ERROR! NO ISSN	The EMBO Journal	Characterization of GAPCenA, a GTPase activating protein for Rab6, part of which associates with the centrosome	Cuif	1999	0		
1326	chr11	97187908	97187934	3500376754	23		97187908	97187934	8421504	2	13,10	0,16	g	350037675400000004	1-24		19201889	10.4049/jimmunol.0713637		Journal of immunology (Baltimore, Md. : 1950)	CREB Mediates Prostaglandin F2&#x03b1;-Induced MUC5AC Overexpression	Wen-Cheng	2009	0		
1326	chr11	97197230	97197259	3500055303	24		97197230	97197259	8421504	2	13,11	0,18	g	350005530300000062	7-31						Enzymatic DNA molecules that contain modified nucleotides	Barbas	1999	0		
1326	chr11	97233344	97233368	3500397484	24		97233344	97233368	8421504	1	24	0	c	350039748400000032	6-30					Patent	Non-endogenous, constitutively activated human G protein-coupled receptors (Patent CN:1329511)	Duo Mi Ni Ke *P*Bi Yi 	2007	0		
1326	chr11	97233344	97233368	3500242697	24		97233344	97233368	8421504	1	24	0	c	350024269700000033	6-30						Non-endogenous, constitutively activated human G protein-coupled receptors	Duo Mi Ni Ke *P*Bi Yi 	2003	0		
1326	chr11	97233344	97233368	3500239403	24		97233344	97233368	8421504	1	24	0	c	350023940300000087	6-30						Endogenous constitutively activated G protein-coupled orphan receptors	Duo Mi Ni Ke *P*Bi Yi 	2001	0		
1326	chr11	97233344	97233368	3500228439	24		97233344	97233368	8421504	1	24	0	c	350022843900000088	6-30					Patent	Method for directly identifying candidate compound (Patent CN:1231762)	Duo Mi Ni Ke *P*Bi Yi 	2005	0		
1326	chr11	97233463	97234278	3500157763	285		97233463	97234278	8421504	5	95,47,48,48,47	0,240,384,528,768	c	350015776300000009,350015776300000010,350015776300000014,350015776300000017,350015776300000020,350015776300000025	0-48,0-47,0-47,0-48,0-48,0-47						Human g-protein receptor hibef51	Adams	1996	0		
1330	chr11	97663524	97663550	3500406269	25		97663524	97663550	8421504	2	7,18	0,8	g	350040626900000397	10-35					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
1330	chr11	97688773	97688800	3500153501	25		97688773	97688800	8421504	2	20,5	0,22	g	350015350100000070	23-48						HUMAN INTERLEUKIN-13 - SCHERING CORPORATION.	www.sumobrain.com	0	0		
1330	chr11	97775668	97775697	3500058897	25		97775668	97775697	8421504	2	8,17	0,12	c	350005889700000053	17-42						Methods of screening for compounds that regulate the level of Nramp	Gros	2000	0		
1334	chr11	98223379	98242426	3500460691	1218		98223379	98242426	8421504	5	120,203,404,206,285	0,1624,2739,8779,18762	p	350046069100015013	0-1218						Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph	Cotsarelis	2011	0		LHX2
1334	chr11	98225031	98225056	3500443601	25		98225031	98225056	8421504	1	25	0	c	350044360100000015	19-44						Method of making a protein polymer and uses of the polymer	Short	2001	0		
1334	chr11	98226270	98226295	3500289220	25		98226270	98226295	8421504	1	25	0	c	350028922000000009	0-25						Neural differentiation from human embryonic stem cells in a defined adherent culture condition	www.ijdb.ehu.es	0	0		
1334	chr11	98232308	98242370	3500439018	40		98232308	98242370	8421504	2	20,20	0,10042	c,g	350043901800000006,350043901800000006,350043901800000007	0-20,0-20,0-20						COMPOSITIONS FOR INDUCING DIFFERENTIATION INTO RETINAL CELLS FROM RETINAL PROGENITOR CELLS OR INDUCING PROLIFERATION OF RETINAL CELLS COMPRISING WNT SIGNALING PATHWAY ACTIVATORS	Park	2010	0		LHX2
1334	chr11	98242316	98242371	3500131526	47		98242316	98242371	8421504	2	25,22	0,33	c	350013152600000002,350013152600000003	0-25,0-22						ClearCellSarcomaoftheKidney:Up-regulationofNeuralMarkers withActivationoftheSonicHedgehogandAktPathways	.aacrjournals.org	0	0		LHX2
1334	chr11	98255558	98255582	3500438426	23		98255558	98255582	8421504	2	6,17	0,7	g	350043842600000044,350043842600000129	12-35,12-35						COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR - Patent application	www.faqs.org	0	0		
1334	chr11	98255558	98255582	3500229956	23		98255558	98255582	8421504	2	6,17	0,7	g	350022995600000126,350022995600000044	12-35,12-35						Compounds Modulating C-kit And C-fms Activity And Uses Therefor 	.freshpatents.com	0	0		
1338	chr11	98807905	98808023	3500228131	49		98807905	98808023	8421504	2	21,28	0,90	c	350022813100000001,350022813100000007	10-31,0-28		20650879	10.1095/biolreprod.110.085621	0006-3363	Biology of Reproduction	Synergistic Activation of the Mc2r Promoter by FOXL2 and NR5A1 in Mice	Yang	2010	4		
1338	chr11	98807908	98827795	3500358531	42		98807908	98827795	8421504	2	22,20	0,19867	c,g	350035853100000011,350035853100000010,350035853100000010	8-30,2-22,2-22						Di(n-butyl) phthalate impairs cholesterol transport and steroidogenesis in the fetal rat testis through a rapid and reversible mechanism.	.endojournals.org	0	0		
1338	chr11	98807908	98827795	3500164742	42		98807908	98827795	8421504	2	22,20	0,19867	c,g	350016474200000011,350016474200000010,350016474200000010	8-30,2-22,2-22		14617579	10.1210/en.2003-1475	0013-7227	Endocrinology	Di(n-Butyl) Phthalate Impairs Cholesterol Transport and Steroidogenesis in the Fetal Rat Testis through a Rapid and Reversible Mechanism	Thompson	2004	4		
1338	chr11	98808065	98824641	3500319611	39		98808065	98824641	8421504	2	20,19	0,16557	c,g	350031961100000003,350031961100000003,350031961100000002,350031961100000002	0-20,0-20,0-19,0-19						Medicine Chest - About your prescription and over-the-counter medicines, herbs and supplements - Part 6	medicinechest.com	0	0		NR5A1
1338	chr11	98824620	98827783	3500193660	90		98824620	98827783	8421504	4	22,24,23,21	0,498,528,3142	c	350019366000000012,350019366000000019,350019366000000026,350019366000000018	0-22,0-24,0-23,0-21		12606467	10.1095/biolreprod.102.010884	0006-3363	Biology of Reproduction	Porcine SRY Promoter Is a Target for Steroidogenic Factor 1	Pilon	2003	4		
1338	chr11	98824652	98824676	3500338834	24		98824652	98824676	8421504	1	24	0	c	350033883400000006	0-24						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		NR5A1
1338	chr11	98824709	98824732	3500404936	23		98824709	98824732	8421504	1	23	0	c	350040493600000005	6-29						Role of nonstructural protein NS2A in flavivirus assembly. - ResearchGate	.researchgate.net	0	0		
1338	chr11	98825122	98827743	3500342796	43		98825122	98827743	8421504	2	22,21	0,2600	c,g	350034279600000006,350034279600000006,350034279600000005,350034279600000005	0-22,0-22,0-21,0-21			10.1124/mol.107.040089	1521-0111 (Online)	Molecular Pharmacology	Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes	Tredici	2008	0		NR5A1
1338	chr11	98825122	98827743	3500027789	43		98825122	98827743	8421504	2	22,21	0,2600	c,g	350002778900000006,350002778900000005,350002778900000005	0-22,0-21,0-21						Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes 2008&#x5e74;&#x7b2c;70&#x5377;&#x7b2c;3&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		NR5A1
1338	chr11	98827769	98827794	3500355947	25		98827769	98827794	8421504	1	25	0	c,g	350035594700000000,350035594700000000	0-25,0-25						Ontogeny of Steroidogenesis in the Fetal Sheep Gonad: MATERIALS AND METHODS(2) | Canadian Health&Care Mall	chcm-drug.com	0	0		NR5A1
1339	chr11	98856722	98856747	3500201864	23		98856722	98856747	8421504	3	15,4,4	0,16,21	g	350020186400000450	8-31						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1339	chr11	98863144	98879840	3500142526	40		98863144	98879840	8421504	2	20,20	0,16676	g	350014252600000009,350014252600000008	0-20,0-20			10.1128/MCB.25.19.8507-8519.2005		Molecular and Cellular Biology	Orphan Nuclear Receptor GCNF Is Required for the Repression of Pluripotency Genes during Retinoic Acid-Induced Embryonic Stem Cell Differentiation	Peili	2005	0		
1340	chr11	98999506	98999577	3500460589	71		98999506	98999577	8421504	1	71	0	c	350046058900000001,350046058900000002,350046058900000000	0-22,0-71,0-21						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Soreq	2010	0		MIR181B2
1340	chr11	98999506	98999577	3500256738	71		98999506	98999577	8421504	1	71	0	c	350025673800000001,350025673800000002,350025673800000000	0-22,0-71,0-21						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2007	0		MIR181B2
1340	chr11	98999506	98999577	3500246068	71		98999506	98999577	8421504	1	71	0	c	350024606800000001,350024606800000002,350024606800000000	0-22,0-71,0-21						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2008	0		MIR181B2
1340	chr11	98999506	98999577	3500208886	71		98999506	98999577	8421504	1	71	0	c	350020888600000002,350020888600000001,350020888600000000	0-71,0-22,0-21						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL	Soreq	2008	0		MIR181B2
1340	chr11	98999517	99000733	3500103477	48		98999517	99000733	8421504	2	24,24	0,1192	c	350010347700000002,350010347700000000,350010347700000004,350010347700000009,350010347700000001,350010347700000010	0-22,0-24,0-23,4-23,0-24,4-23		23152505	10.1128/JVI.02386-12	0022-538X	Journal of Virology	Increasing Expression of MicroRNA 181 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication and Has Implications for Controlling Virus Infection	Guo	2013	5		
1340	chr11	98999517	98999577	3500125321	45		98999517	98999577	8421504	2	23,22	0,38	c	350012532100000073,350012532100000091	0-23,0-22						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
1340	chr11	98999517	98999577	3500032016	43		98999517	98999577	8421504	2	23,20	0,40	c,g	350003201600000007,350003201600000013,350003201600000040,350003201600000039,350003201600000012,350003201600000008,350003201600000008	0-23,0-23,0-23,0-21,0-21,0-20,0-20						SMALL INTERFERING RNA (SIRNA) TARGET SITE BLOCKING OLIGOS AND USES THEREOF - Patent application	www.faqs.org	0	0		MIR181B2
1340	chr11	98999517	98999540	3500357539	23		98999517	98999540	8421504	1	23	0	c	350035753900000188	0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		MIR181A1
1340	chr11	98999517	98999540	3500244257	23		98999517	98999540	8421504	1	23	0	c	350024425700000043	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR181A1,MIR181B2
1340	chr11	98999517	98999540	3500210973	23		98999517	98999540	8421504	1	23	0	c	350021097300000188	0-23						Microrna molecules	Tuschl	2002	0		MIR181A1
1340	chr11	98999517	98999540	3500139708	23		98999517	98999540	8421504	1	23	0	g	350013970800000030,350013970800000014	0-23,0-23						METHODS AND COMPOSITIONS FOR THE TREATMENT OF ERYTHROCYTE DISEASES - Patent application	www.faqs.org	0	0		MIR181B2
1340	chr11	98999555	99000731	3500185291	44		98999555	99000731	8421504	2	22,22	0,1154	c	350018529100000003,350018529100000040	0-22,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR181B2
1340	chr11	99000709	99000733	3500180208	24		99000709	99000733	8421504	1	24	0	c	350018020800001515	0-24					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		MIR181A1,MIR181C
1340	chr11	99000709	99000733	3500166534	24		99000709	99000733	8421504	1	24	0	c	350016653400001515	0-24						METHODS FOR QUANTITATING SMALL RNA MOLECULES	Raymond	2007	0		MIR181A1,MIR181C
1341	chr11	99200387	99200428	3500183734	40		99200387	99200428	8421504	2	28,12	0,29	c	350018373400000000	9-49		12972563	10.1091/mbc.E03-01-0864	1059-1524	Molecular Biology of the Cell	Interaction of Arl1-GTP with GRIP Domains Recruits Autoantigens Golgin-97 and Golgin-245/p230 onto the Golgi	Lu	2003	5		
1342	chr11	99335040	99335075	3500424588	33		99335040	99335075	8421504	2	14,19	0,16	c	350042458800000047	0-33						Molecular cloning of a protein serine/threonine phosphatase containing a putative regulatory tetratricopeptide repeat domain. - ResearchGate	.researchgate.net	0	0		
1342	chr11	99337119	99340019	3500105210	25		99337119	99340019	8421504	2	9,16	0,2884	c	350010521000000027	0-25						Differential expression of the catalytic subunits for PP-1 and PP-2A and the regulatory subunits for PP&#x2013;2A in mouse eye	www.molvis.org	0	0		
1343	chr11	99406006	99406033	3500450253	27		99406006	99406033	8421504	1	27	0	c	350045025300000028	0-27						Methods For Synthesizing Polynucleotides Using A Single Primer 	.freshpatents.com	0	0		
1343	chr11	99406312	99406584	3500300246	52		99406312	99406584	8421504	2	27,25	0,247	c	350030024600000001,350030024600000000	0-27,0-25		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		
1343	chr11	99406312	99406584	3500168730	52		99406312	99406584	8421504	2	27,25	0,247	c	350016873000000001,350016873000000000	0-27,0-25		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		
1343	chr11	99406322	99406646	3500332326	44		99406322	99406646	8421504	2	24,20	0,304	c	350033232600000006,350033232600000005	0-24,0-20						Transcriptional and post-translational regulation of mouse cation transport regulator homolog 1. - ResearchGate	.researchgate.net	0	0		
1343	chr11	99406574	99406684	3500185298	48		99406574	99406684	8421504	2	24,24	0,86	c	350018529800000005,350018529800000004	0-24,0-24						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Fluoride Induces Endoplasmic Reticulum Stress in Ameloblasts Responsible for Dental Enamel Formation*	www.jbc.org	0	0		
1343	chr11	99406638	99407289	3500440875	52		99406638	99407289	8421504	2	26,26	0,625	c	350044087500000009,350044087500000008	0-26,0-26						Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	ecular-cancer.com	0	0		HSPA5
1343	chr11	99406638	99407289	3500190261	52		99406638	99407289	8421504	2	26,26	0,625	c	350019026100000009,350019026100000008	0-26,0-26		22913813	10.1186/1476-4598-11-59	1476-4598	Molecular Cancer	Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	Horibe	2012	4		HSPA5
1343	chr11	99406638	99407289	3500068922	52		99406638	99407289	8421504	2	26,26	0,625	c	350006892200000009,350006892200000008	0-26,0-26		22913813	10.1186/1476-4598-11-59		Molecular Cancer	Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	Tomohisa	2012	0		HSPA5
1343	chr11	99406755	99409378	3500228611	60		99406755	99409378	8421504	3	20,20,20	0,590,2603	c,g	350022861100000007,350022861100000006,350022861100000006,350022861100000000	0-20,0-20,0-20,0-20			10.1152/ajpendo.00265.2006		American Journal of Physiology - Endocrinology and Metabolism	Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic &#x03b2;-cells	Rozance	2007	0		
1343	chr11	99406755	99409378	3500172774	60		99406755	99409378	8421504	3	20,20,20	0,590,2603	c,g	350017277400000007,350017277400000006,350017277400000006,350017277400000000	0-20,0-20,0-20,0-20			10.1152/ajpendo.00265.2006		American Journal of Physiology - Endocrinology and Metabolism	Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic &#x03b2;-cells	Rozance	2007	0		
1343	chr11	99406755	99409378	3500058040	60		99406755	99409378	8421504	3	20,20,20	0,590,2603	c,g	350005804000000007,350005804000000006,350005804000000006,350005804000000000,350005804000000000	0-20,0-20,0-20,0-20,0-20			10.1152/ajpendo.00265.2006		American Journal of Physiology - Endocrinology and Metabolism	Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic &#x03b2;-cells	Rozance	2007	0		
1343	chr11	99407829	99407874	3500169473	45		99407829	99407874	8421504	1	45	0	p	350016947300015022	0-45						 <HTML> <HEAD><TITLE>aaa1/2aa(c)aoaa>>a'a3aaPSaeaae(c)2aeaa<<a-3/4aaaea1/2aa	www.j-tokkyo.com	0	0		HSPA5
1343	chr11	99409438	99409461	3500309908	23		99409438	99409461	8421504	1	23	0	c	350030990800000042	2-25						Ryegrass pollen allergen - Patent # 5965455 - PatentGenius	.patentgenius.com	0	0		
1343	chr11	99409438	99409461	3500084037	23		99409438	99409461	8421504	1	23	0	c	350008403700000038	2-25						Ryegrass pollen allergen	www.devileye.net	0	0		
1343	chr11	99409440	99409571	3500293064	82		99409440	99409571	8421504	2	41,41	0,90	c,g	350029306400000008,350029306400000006	0-41,6-47						Methods and Compositions for Modulating Apoptosis - Patent application	www.faqs.org	0	0		
1343	chr11	99409455	99409484	3500238762	29		99409455	99409484	8421504	1	29	0	c	350023876200000019	9-38						A DISSERTATION SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERSITY OFHAWAII INPARTIAL FULFILLMENT OFTHE REQUIREMENTS FOR THE DEGREE OF DOCTOR OFPHILOSOPHY IN BIOMEDICAL SCIENCES MAY 1995	.manoa.hawaii.edu	0	0		
1344	chr11	99572916	99577552	3500271050	48		99572916	99577552	8421504	2	21,27	0,4609	c	350027105000000084	0-48						Cloning by complementation and related processes	Colicelli	1991	0		
1345	chr11	99616885	99632506	3500185291	42		99616885	99632506	8421504	3	11,10,21	0,15514,15600	c	350018529100000135,350018529100000136	0-21,0-21						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MAPKAP1
1345	chr11	99616885	99632506	3500054575	42		99616885	99632506	8421504	3	11,10,21	0,15514,15600	c	350005457500000000,350005457500000001	0-21,0-21						Compositions and Methods for Modulating mTOR Signaling - Patent application	www.faqs.org	0	0		MAPKAP1
1345	chr11	99620066	99620092	3500008756	23		99620066	99620092	8421504	2	17,6	0,20	g	350000875600000697	4-28						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
1345	chr11	99666130	99680781	3500271050	48		99666130	99680781	8421504	2	40,8	0,14643	c	350027105000000072	0-48						Cloning by complementation and related processes	Colicelli	1991	0		
1345	chr11	99667945	99667971	3500408735	23		99667945	99667971	8421504	3	11,4,8	0,12,18	g	350040873500000048	0-23						METHODS AND MEANS FOR REGULATING GENE EXPRESSION	Den	2004	0		
1346	chr11	99767277	99767308	3500160732	25		99767277	99767308	8421504	3	14,6,5	0,18,26	g	350016073200000143	13-40						Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions - Patent application	www.faqs.org	0	0		
1346	chr11	99776492	99776519	3500427271	27		99776492	99776519	8421504	1	27	0	c	350042727100000000	19-46						mSIN1 mediates SGK1 interaction with mTORC2 and is required for selective activation of the epithelial sodium channel	www.jbc.org	0	0		MAPKAP1
1346	chr11	99802917	99802943	3500011103	23		99802917	99802943	8421504	2	7,16	0,10	g	350001110300000051	0-23						A Thesis Submitted for the Degree of PhD at the University of Warwick	rap.warwick.ac.uk	0	0		
1346	chr11	99825616	99825643	3500264085	23		99825616	99825643	8421504	2	10,13	0,14	g	350026408500000001	1-24						JANAINA FERNANDES DE ARA&#xda;JO	www.bdtd.ucb.br	0	0		
1348	chr11	100060079	100060108	3500028050	27		100060079	100060108	8421504	2	22,5	0,24	g	350002805000000449	5-39						Stress response and virulence in Salmonella Typhimurium: a genomics approach	edepot.wur.nl	0	0		PBX3
1350	chr11	100356011	100356041	3500394172	23		100356011	100356041	8421504	3	5,6,12	0,7,18	g	350039417200000001	7-30						MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells	-publications.com	0	0		
1351	chr11	100499892	100499919	3500189823	25		100499892	100499919	8421504	2	10,15	0,12	g	350018982300000712,350018982300000114	5-31,26-47						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
1353	chr11	100764551	100764577	3500380236	24		100764551	100764577	8421504	2	9,15	0,11	g	350038023600000013	0-24						Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase	Foehr	2011	0		
1356	chr11	101151400	101151427	3500285379	27		101151400	101151427	8421504	1	27	0	c	350028537900000004	0-27						Secreted and transmembrane polypeptides and nucleic acids encoding the same - Patent #07390879	w.strutpatent.com	0	0		
1356	chr11	101151528	101151559	3500399951	31		101151528	101151559	8421504	1	31	0	c	350039995100000028,350039995100000002	0-31,0-31						NL4 tie ligand homologue	Godowski	1998	0		
1356	chr11	101151528	101151559	3500272586	31		101151528	101151559	8421504	1	31	0	c	350027258600000002	0-31						US Patent # 6,057,435. Tie ligand homologues - Patents.com	www.patents.com	0	0		
1356	chr11	101151528	101151559	3500236207	31		101151528	101151559	8421504	1	31	0	c	350023620700000005	0-31						Novel gene disruptions, compositions and methods relating thereto	Brennan	2007	0		
1356	chr11	101151528	101151559	3500176302	31		101151528	101151559	8421504	1	31	0	c	350017630200000002	0-31						US Patent # 6,413,770. NL4 tie ligand homologue nucleic acid - Patents.com	www.patents.com	0	0		
1356	chr11	101151528	101151559	3500050284	31		101151528	101151559	8421504	1	31	0	c	350005028400000003	0-31						Novel Gene Disruptions, Compositions And Methods Relating Thereto 	.freshpatents.com	0	0		
1356	chr11	101151528	101151559	3500032360	31		101151528	101151559	8421504	1	31	0	c	350003236000000005	0-31						Novel gene disruptions, compositions and methods relating thereto	Brennan	2006	0		
1356	chr11	101156237	101156262	3500442503	23		101156237	101156262	8421504	2	11,12	0,13	g	350044250300000074	1-24						CISTATINAS DE CEBADA: PROTE&#xcd;NAS DE DEFENSA CONTRA ARTR&#xd3;PODOS	oa.upm.es/3003/1/	0	0		
1358	chr11	101442934	101448495	3500363972	23		101442934	101448495	8421504	2	16,7	0,5554	c	350036397200000017	7-34						Flagella-less borrelia	Barbour	1993	0		
1358	chr11	101442934	101448495	3500052824	23		101442934	101448495	8421504	2	16,7	0,5554	c	350005282400000018	7-34						Flagella-less borrelia	www.devileye.net	0	0		
1359	chr11	101463577	101469436	3500163467	1002		101463577	101469436	8421504	7	94,200,144,109,174,146,135	0,1525,2442,2684,3522,4044,5724	p,c,g	350016346700015018,350016346700015019,350016346700000021,350016346700000021,350016346700015020,350016346700015021,350016346700015023,350016346700015024	0-180,0-180,0-20,0-20,0-180,0-180,0-180,0-102						Entwicklungsspezifische Expression und m&#xf6;gliche funktionelle Bedeutung der Glukosetransporterisoformen in Pr&#xe4;implantationsembryonen des Rindes	ebdoc.sub.gwdg.de	0	0		
1359	chr11	101469347	101469428	3500071105	42		101469347	101469428	8421504	2	21,21	0,60	c,g	350007110500000012,350007110500000012,350007110500000013,350007110500000013	0-21,0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
1359	chr11	101469454	101469587	3500230702	40		101469454	101469587	8421504	2	20,20	0,113	c,g	350023070200000002,350023070200000002,350023070200000003	0-20,0-20,0-20						Effect of glucose availability on glucose transport in bovine mammary epithelial cells	cience.zju.edu.cn	0	0		
1359	chr11	101492488	101492847	3500391361	48		101492488	101492847	8421504	2	39,9	0,350	p	350039136100015169	0-48						Transcriptomic and Proteomic Approaches to the Discovery of New Markers of Pathology	n.library.ethz.ch	0	0		RPL12
1359	chr11	101492494	101492888	3500269671	60		101492494	101492888	8421504	3	21,16,23	0,352,371	c	350026967100000018,350026967100000017	0-21,0-39						Microarray analysis in caudal medulla of cattle orally challenged with bovine spongiform encephalopathy	w.funpecrp.com.br	0	0		
1359	chr11	101492895	101519769	3500141583	41		101492895	101519769	8421504	2	21,20	0,26854	c,g	350014158300000081,350014158300000080,350014158300000080	0-21,0-20,0-20						Annealing control primer system for improving specificity of PCR amplification	www.seegene.com	0	0		
1361	chr11	101745686	101745715	3500047637	24		101745686	101745715	8421504	2	13,11	0,18	c	350004763700000681	21-45						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
1361	chr11	101760274	101764235	3500110574	231		101760274	101764235	8421504	4	9,81,139,2	0,986,2954,3959	p	350011057400015017,350011057400015016,350011057400015020	0-180,0-84,0-51						UNDERSTANDING TICK SALIVARY SECRETIONS VIJAY GANESH RAMAKRISHNAN 1998	brary.okstate.edu	0	0		STXBP1
1361	chr11	101801066	101801091	3500351507	23		101801066	101801091	8421504	2	5,18	0,7	c	350035150700000007	2-25						Journal of Virological Methods	005.pasteur.ac.ir	0	0		
1361	chr11	101801066	101801091	3500005206	23		101801066	101801091	8421504	2	5,18	0,7	c	350000520600000030	2-25						X Congresso Nazionale S.I.Di.L.V.	www.sidilv.org	0	0		
1361	chr11	101805454	101805484	3500235753	24		101805454	101805484	8421504	3	13,5,6	0,16,24	c	350023575300000092	4-28						Protein Fragment Complementation Assays For High-throughput And High-content Screening 	.freshpatents.com	0	0		
1361	chr11	101805454	101805484	3500207420	24		101805454	101805484	8421504	3	13,5,6	0,16,24	c	350020742000000092	1-25						 Protein Fragment Complementation Assays For High 	www.docstoc.com	0	0		
1361	chr11	101823263	101823314	3500393090	51		101823263	101823314	8421504	1	51	0	p	350039309000015001	0-51		19544412	10.1002/stem.138	1549-4918	STEM CELLS	Implanted Adult Human Dental Pulp Stem Cells Induce Endogenous Axon Guidance - Arthur - 2009 - STEM CELLS - Wiley Online Library	Arthur	2009	0		SH2D3C
1362	chr11	101860263	101864044	3500441970	211		101860263	101864044	8421504	6	44,35,45,25,20,42	0,2040,2297,2345,2533,3739	c,g	350044197000000077,350044197000000077,350044197000000085,350044197000000088,350044197000000089,350044197000000099	0-44,0-44,0-35,0-45,0-45,0-42						US Patent # 7,018,836. P-TEFb compositions, methods and screening assays - Patents.com	www.patents.com	0	0		
1362	chr11	101860263	101862816	3500314350	92		101860263	101862816	8421504	3	44,28,20	0,2342,2533	c,g	350031435000000078,350031435000000078,350031435000000090	0-44,0-44,0-48						P-TEFb compositions, methods and screening assays - US Patent 7018836 Description	ww.patentstorm.us	0	0		
1362	chr11	101860263	101860287	3500332935	24		101860263	101860287	8421504	1	24	0	c,g	350033293500000012,350033293500000012	3-27,3-27						Chiquimato Desidrogenase de Mycobacterium tuberculosis: mecanismos cin&#xe9;tico e qu&#xed;mico da enzima recombinante	www.lume.ufrgs.br	0	0		CDK9
1362	chr11	101860266	101864056	3500268189	42		101860266	101864056	8421504	2	21,21	0,3769	c,g	350026818900000002,350026818900000002,350026818900000003,350026818900000003	10-31,10-31,10-31,10-31		20106982	10.1074/jbc.M109.091496		The Journal of Biological Chemistry	CDKN1C Negatively Regulates RNA Polymerase II C-terminal Domain Phosphorylation in an E2F1-dependent Manner	Yihong	2010	0		CDK9
1362	chr11	101860323	101862599	3500200973	102		101860323	101862599	8421504	3	32,13,57	0,518,2219	p	350020097300015000,350020097300015002	0-45,0-57		23140174	10.1186/1742-4690-9-94		Retrovirology	CDK2 Regulates HIV-1 Transcription by Phosphorylation of CDK9 on Serine 90	Denitra	2012	0		CDK9
1362	chr11	101860323	101862599	3500177278	102		101860323	101862599	8421504	3	32,13,57	0,518,2219	p	350017727800015000,350017727800015002	0-45,0-57		23140174	10.1186/1742-4690-9-94	1742-4690	Retrovirology	CDK2 Regulates HIV-1 Transcription by Phosphorylation of CDK9 on Serine 90	Breuer	2012	6		CDK9
1362	chr11	101861755	101862909	3500084329	232		101861755	101862909	8421504	6	48,41,47,31,17,48	0,542,799,847,1041,1106	c	350008432900000027,350008432900000031,350008432900000034,350008432900000035,350008432900000037	0-48,0-41,0-47,0-48,0-48						Novel human cyclin-dependent kinase-like proteins and methods of using the same	Giordano	1996	0		
1362	chr11	101864545	101864569	3500416808	24		101864545	101864569	8421504	1	24	0	c	350041680800000067	1-47					Patent	Recombinant herpesvirus of turkeys and uses thereof (Patent US:5853733)	Cochran	1998	0		
1362	chr11	101864545	101864569	3500280721	24		101864545	101864569	8421504	1	24	0	c	350028072100000074	1-47						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1362	chr11	101894036	101894064	3500457194	23		101894036	101894064	8421504	2	8,15	0,13	c	350045719400000125	23-46						 Guanosine Triphosphate (GTP) Binding Protein 	www.docstoc.com	0	0		
1362	chr11	101905051	101908152	3500153648	40		101905051	101908152	8421504	2	20,20	0,3081	c,g	350015364800000001,350015364800000001,350015364800000000,350015364800000000	0-20,0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
1362	chr11	101927047	101927071	3500305281	24		101927047	101927071	8421504	1	24	0	g	350030528100000004,350030528100000005	5-29,5-24		9845534		0006-4971	Blood	Cloning of the Promoter Region of Human Endoglin, the Target Gene for Hereditary Hemorrhagic Telangiectasia Type 1	Rius	1998	10		
1362	chr11	101937976	101938030	3500450263	54		101937976	101938030	8421504	1	54	0	p	350045026300015051	0-54						Structure-function studies of human cytosolic thymidine kinase	rudar.ruc.dk	0	0		
1362	chr11	101937976	101938030	3500149900	54		101937976	101938030	8421504	1	54	0	p	350014990000015051	0-54						Structure-function studies of human cytosolic thymidine kinase Ph.D. Thesis Dvora Berenstein Departm	diggy.ruc.dk:8080	0	0		
1363	chr11	101990297	101990326	3500207917	26		101990297	101990326	8421504	2	7,19	0,10	g	350020791700000024	19-45						US Patent # 7,208,310. Proteases - Patents.com	www.patents.com	0	0		
1364	chr11	102215208	102215234	3500427057	23		102215208	102215234	8421504	2	15,8	0,18	c	350042705700000015	21-44						Tracheal antimicrobial peptides, DNA sequences and methods for the production and use thereof	Zasloff	1990	0		
1364	chr11	102215208	102215234	3500266706	23		102215208	102215234	8421504	2	15,8	0,18	c	350026670600000021	21-44						Novel tracheal antimicrobial peptides	Bevins	1994	0		
1364	chr11	102215208	102215234	3500265948	23		102215208	102215234	8421504	2	15,8	0,18	c	350026594800000007	21-44						Production and use of tracheal antimicrobial peptides	Bevins	1993	0		
170	chr11	102221037	102236620	3500452922	46		102221037	102236620	8421504	2	24,22	0,15561	c,g	350045292200000001,350045292200000003,350045292200000003	0-24,0-22,0-22		23940613	10.1371/journal.pone.0070638		PLoS ONE	Dynamin-2 Regulates Fusion Pore Expansion and Quantal Release through a Mechanism that Involves Actin Dynamics in Neuroendocrine Chromaffin Cells	Arlek	2013	0		
1364	chr11	102228592	102231548	3500252730	90		102228592	102231548	8421504	5	2,43,6,12,27	0,183,229,440,2929	p	350025273000015065,350025273000015067	0-45,0-45						METHOD OF DETECTING CANINE EXERCISE-INDUCED COLLAPSE - Patent application	www.faqs.org	0	0		
170	chr11	102231521	102236599	3500182420	180		102231521	102236599	8421504	3	81,11,88	0,4073,4990	p	350018242000015001,350018242000015026	0-81,0-99						Ein Protein f&#xfc;r neue Aufgaben: die cytosolische PH-Dom&#xe4;ne des Cytohesin-1 als Paratop und als Substrat f&#xfc;r Translokationen	b.uni-muenchen.de	0	0		MIR3154,DNM1
170	chr11	102231578	102236581	3500195495	180		102231578	102236581	8421504	5	45,9,36,45,45	0,48,3917,3956,4958	p	350019549500015146,350019549500015147,350019549500015148,350019549500015150	0-45,0-45,0-45,0-45						3-phosphoinositide-dependent protein kinase	Alessi	1997	0		MIR3154,DNM1
1364	chr11	102233842	102233865	3500455022	23		102233842	102233865	8421504	1	23	0	g	350045502200000017	0-23		23598416	10.1038/cddis.2013.134	false	Cell Death & Disease	microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress	Dai	2013	0		MIR3154,MIR199A1
1364	chr11	102233845	102233906	3500439152	45		102233845	102233906	8421504	2	22,23	0,38	c	350043915200000310,350043915200000248,350043915200000127	0-22,0-23,0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		DNM3OS
1364	chr11	102233845	102233906	3500232262	44		102233845	102233906	8421504	2	22,22	0,39	c,g	350023226200000035,350023226200000035,350023226200000037,350023226200000037,350023226200000091	0-22,0-22,0-22,0-22,22-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		MIR199A1
1364	chr11	102233883	102233906	3500423784	23		102233883	102233906	8421504	1	23	0	c	350042378400000076	0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR3154
1364	chr11	102233883	102233906	3500244257	23		102233883	102233906	8421504	1	23	0	c,g	350024425700000062,350024425700000062	0-23,0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR3154
1364	chr11	102233883	102233906	3500175527	23		102233883	102233906	8421504	1	23	0	c	350017552700000003	0-23						Compositions and methods of treating neoplasia	Mendell	2011	0		MIR3154
1364	chr11	102233883	102233906	3500131966	23		102233883	102233906	8421504	1	23	0	c	350013196600000062	0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR3154
1364	chr11	102233883	102233906	3500114594	23		102233883	102233906	8421504	1	23	0	c	350011459400000436,350011459400000863	0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR3154
1364	chr11	102233883	102233906	3500031979	23		102233883	102233906	8421504	1	23	0	c	350003197900000351	0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR3154
1364	chr11	102233883	102233906	3500017451	23		102233883	102233906	8421504	1	23	0	c,g	350001745100000003,350001745100000003	0-23,0-23						COMPOSITIONS AND METHODS OF TREATING NEOPLASIA	Mendell	2008	0		MIR3154
1365	chr11	102330528	102334141	3500464472	417		102330528	102334141	8421504	5	85,70,55,144,63	0,1485,1660,3231,3550	p,c	350046447200015050,350046447200000065,350046447200015052	0-210,0-20,3-210						CARACTERIZACI&#xd3;N DE GENES CANDIDATOS PARA CARACTERES LIP&#xcd;DICOS E IDENTIFICACI&#xd3;N DE COPY NUMBER VARIATION EN UNA POBLACI&#xd3;N PORCINA DUROC	www.tdx.cat	0	0		SLC27A4
1365	chr11	102330528	102332243	3500274639	210		102330528	102332243	8421504	3	85,70,55	0,1485,1660	p	350027463900015049	0-210						CARACTERIZACIAN DE GENES CANDIDATOS PARA CARACTERES LIPADICOS E IDENTIFICACIAN DE COPY NUMBER VAR	www.tdx.cat	0	0		
1365	chr11	102334827	102334860	3500390047	33		102334827	102334860	8421504	1	33	0	c	350039004700000096	5-38						Fatty acid transport proteins	Stahl	1999	0		
1365	chr11	102334850	102335094	3500006584	38		102334850	102335094	8421504	3	15,4,19	0,158,225	c	350000658400000030,350000658400000031	0-19,0-19						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
1365	chr11	102354159	102354188	3500106189	24		102354159	102354188	8421504	3	6,13,5	0,10,24	g	350010618900000018	18-42						Product and process for t cell regulation	Kappler	1995	0		
1365	chr11	102364520	102364543	3500177892	23		102364520	102364543	8421504	1	23	0	c	350017789200000005	0-23						Supporting Information	www.pnas.org	0	0		URM1
1366	chr11	102419364	102419388	3500166501	23		102419364	102419388	8421504	2	9,14	0,10	g	350016650100000496	4-42						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
1366	chr11	102432175	102432200	3500437416	24		102432175	102432200	8421504	2	13,11	0,14	g	350043741600000069,350043741600000009	21-45,21-45						FAP&#x03b1;-specific antibody with improved producibility	Park	1999	0		
1367	chr11	102594711	102595919	3500466707	135		102594711	102595919	8421504	2	84,51	0,1157	p	350046670700015044,350046670700015045,350046670700015046	0-45,0-45,0-45						US Patent # 6,887,705. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPs) - Patents.com	www.patents.com	0	0		SPTAN1
1367	chr11	102594780	102595922	3500323180	69		102594780	102595922	8421504	2	15,54	0,1088	p	350032318000015011	0-69						Bioinformatics	www.koshika.co.in	0	0		SPTAN1
1367	chr11	102597093	102598260	3500180005	60		102597093	102598260	8421504	2	59,1	0,1166	p	350018000500015000	0-60		23937664	10.1186/1478-811X-11-56	1478-811X	Cell Communication and Signaling	Mena/VASP and &#xce;&#xb1;II-Spectrin complexes regulate cytoplasmic actin networks in cardiomyocytes and protect from conduction abnormalities and dilated cardiomyopathy	Benz	2013	6		SPTAN1
1367	chr11	102597093	102598260	3500148354	60		102597093	102598260	8421504	2	59,1	0,1166	p	350014835400015000	0-60							.biosignaling.com	0	0		SPTAN1
1367	chr11	102600925	102603791	3500061337	72		102600925	102603791	8421504	3	21,48,3	0,2092,2863	p	350006133700015151,350006133700015026	0-48,0-72						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		SPTAN1
1367	chr11	102624766	102625098	3500396986	25		102624766	102625098	8421504	3	12,5,8	0,13,324	c	350039698600000010	1-33						Compositions and Methods for Identifying Autism Spectrum Disorders - Patent application	www.faqs.org	0	0		SPTAN1
1367	chr11	102625188	102625213	3500384085	25		102625188	102625213	8421504	1	25	0	c	350038408500000013	15-40		22389408	10.1242/jcs.093104	0021-9533	Journal of Cell Science	Orientation-based FRET sensor for real-time imaging of cellular forces	Meng	2012	6		SPTAN1
1367	chr11	102625622	102625646	3500240613	23		102625622	102625646	8421504	2	11,12	0,12	c	350024061300000042	11-34						AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY - Patent application	www.faqs.org	0	0		
1368	chr11	102701445	102701468	3500029108	23		102701445	102701468	8421504	1	23	0	c	350002910800000000	0-37						The A-T, G-C ratios in cattle and rats are very similar. Are the RNA'S of the 2 species similar? ? - Yahoo! Answers	answers.yahoo.com	0	0		
1368	chr11	102758964	102758988	3500028061	23		102758964	102758988	8421504	2	12,11	0,13	g	350002806100000340	4-27						Surface proteins of leptospira	www.devileye.net	0	0		
1369	chr11	102761122	102762340	3500224517	40		102761122	102762340	8421504	2	19,21	0,1197	c,g	350022451700000004,350022451700000004,350022451700000001,350022451700000005,350022451700000000	0-19,0-19,0-21,0-20,0-19		21460199	10.1152/ajpheart.01311.2010		American Journal of Physiology - Heart and Circulatory Physiology	Endonuclease G mediates endothelial cell death induced by carbamylated LDL	Apostolov	2011	0		
1369	chr11	102761122	102762340	3500172287	40		102761122	102762340	8421504	2	19,21	0,1197	c,g	350017228700000004,350017228700000004,350017228700000001,350017228700000005,350017228700000005,350017228700000000	0-19,0-19,0-21,0-20,0-20,0-19		21460199	10.1152/ajpheart.01311.2010		American Journal of Physiology - Heart and Circulatory Physiology	Endonuclease G mediates endothelial cell death induced by carbamylated LDL	Apostolov	2011	0		
1369	chr11	102763873	102763898	3500069851	25		102763873	102763898	8421504	1	25	0	c	350006985100000001	0-25						Endonuclease G: A role for the enzyme in recombination and cellular proliferation	hman.stanford.edu	0	0		
1369	chr11	102824093	102824120	3500018954	24		102824093	102824120	8421504	3	15,5,4	0,17,23	g	350001895400000053	20-44						Novel Bmp Products 	.freshpatents.com	0	0		
1369	chr11	102827656	102827681	3500018444	23		102827656	102827681	8421504	2	9,14	0,11	g	350001844400000003	0-23						Human virus causing respiratory tract infection and uses thereof	Yuen	2005	0		
1370	chr11	102912461	102912489	3500189676	25		102912461	102912489	8421504	2	7,18	0,10	g	350018967600000170	0-25						 Transgenic Plants Containing Ligninase And Cellulase Which Degrade Lignin And Cellulose To Fermentab 	www.docstoc.com	0	0		
1370	chr11	102912461	102912487	3500202468	23		102912461	102912487	8421504	2	7,16	0,10	g	350020246800000178	8-31						Production Of Beta-glucosidase, Hemicellulase And Ligninase In E1 And Flc-cellulase-transgenic Plants 	.freshpatents.com	0	0		
1370	chr11	102943247	102985980	3500160490	5214		102943247	102985980	8421504	46	2,55,74,58,24,81,45,93,120,212,115,201,90,66,120,127,153,127,88,77,115,121,67,129,140,107,207,170,70,68,196,78,86,146,182,201,93,159,138,75,78,150,132,74,130,174	0,5978,7363,10176,10237,10828,11393,15317,15549,17601,18851,19819,20876,22366,23346,24253,26423,26769,27105,27288,28085,29553,29785,30510,30940,32164,33271,33608,34284,34744,35242,37105,37461,37731,38104,39220,39569,40043,40470,41239,41408,41492,41748,42109,42314,42559	p	350016049000015001,350016049000015013,350016049000015029,350016049000015027,350016049000015033,350016049000015015,350016049000015007,350016049000015017,350016049000015005,350016049000015011,350016049000015003,350016049000015000,350016049000015021,350016049000015023,350016049000015019,350016049000015025,350016049000015009	42-231,0-1665,0-4110,0-3744,0-4881,0-2010,0-828,0-2277,0-564,0-1422,0-357,0-5025,0-3015,0-3219,0-2637,0-3504,0-1101						Composition and method for treating lupus nephritis	O'toole	2003	0		NUP188
1370	chr11	102951986	102952009	3500122716	23		102951986	102952009	8421504	1	23	0	g	350012271600000015	0-25						Technologies for Protein Analysis and Tissue Engineering, with Applications in Cancer	brary.caltech.edu	0	0		
1371	chr11	103108545	103108573	3500171075	23		103108545	103108573	8421504	2	9,14	0,14	g	350017107500000253	10-33						$i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES	Choi	1999	0		
1371	chr11	103125957	103125984	3500313823	24		103125957	103125984	8421504	2	18,6	0,21	c	350031382300000143	0-25						Selection of Human TNFAlpha Specific Antibodies - Patent application	www.faqs.org	0	0		
1371	chr11	103126102	103126146	3500102637	35		103126102	103126146	8421504	2	14,21	0,23	c	350010263700000102	0-35						Identification and expression of insect steroid receptor dna sequences	Hogness	1991	0		
1371	chr11	103136865	103136892	3500442796	23		103136865	103136892	8421504	2	16,7	0,20	g	350044279600000227	6-31						Pharmacokinetic Modulation And Compositions For Modified Fn3 Polypeptides 	.freshpatents.com	0	0		
1375	chr11	103617555	103628942	3500287186	134		103617555	103628942	8421504	6	24,23,21,23,23,20	0,127,388,474,7679,11367	c,g	350028718600000003,350028718600000004,350028718600000004,350028718600000013,350028718600000005,350028718600000005,350028718600000012,350028718600000008,350028718600000008	0-24,0-23,0-23,9-30,0-23,0-23,7-30,0-20,0-20		11448962	10.1074/jbc.M103709200	0021-9258	Journal of Biological Chemistry	Molecular Cloning and Induction of Bovine Prostaglandin E Synthase by Gonadotropins in Ovarian Follicles Prior to Ovulationin Vivo	Filion	2001	5		
1375	chr11	103617682	103618160	3500375223	47		103617682	103618160	8421504	2	23,24	0,454	c,g	350037522300000001,350037522300000001,350037522300000000	0-23,0-23,0-24						Printed in U.S.A. Copyright &#xa9; 2002 by The Endocrine Society	.endojournals.org	0	0		
1375	chr11	103617986	103628903	3500298653	40		103617986	103628903	8421504	2	20,20	0,10897	c,g	350029865300000005,350029865300000004,350029865300000004	0-20,0-20,0-20						Pregnancy and Bovine Somatotropin in Nonlactating Dairy Cows: II. Endometrial Gene Expression Related to Maintenance of Pregnancy	ww.animal.ufl.edu	0	0		
1375	chr11	103618028	103625253	3500181178	41		103618028	103625253	8421504	2	21,20	0,7205	c,g	350018117800000003,350018117800000003,350018117800000002,350018117800000008	0-21,0-21,0-20,0-20						INHIBITOR OF INFLAMMATORY CONDITIONS - Patent application	www.faqs.org	0	0		
1375	chr11	103618135	103618159	3500093419	24		103618135	103618159	8421504	1	24	0	c	350009341900000024	17-41						Compositions and methods of treatment	Best	2005	0		
1376	chr11	103721380	103721410	3500279932	25		103721380	103721410	8421504	3	11,9,5	0,14,25	g	350027993200000010	0-26						Alternative Pre-mRNA Splicing Governs Expression of a Conserved Acidic Transactivation Domain in Myocyte Enhancer Factor 2 Factors of Striated Muscle and Brain--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x6	journal.9med.net	0	0		
1376	chr11	103753689	103753714	3500312985	23		103753689	103753714	8421504	2	8,15	0,10	g	350031298500000259	2-25					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
1377	chr11	103812613	103818570	3500301607	189		103812613	103818570	8421504	2	6,183	0,5774	p	350030160700015014	0-189						31 human secreted proteins	Ferrie	1999	0		FNBP1
1378	chr11	103977975	103978002	3500007099	24		103977975	103978002	8421504	3	12,7,5	0,13,22	g	350000709900000510	0-24						Uses Of Myostatin Antagonists 	.freshpatents.com	0	0		
1378	chr11	103980025	103980053	3500041283	25		103980025	103980053	8421504	3	4,8,13	0,5,15	g	350004128300000004	6-32						Reticulon3Bindsthe2CProteinofEnterovirus71and IsRequiredforViralReplication	www.jbc.org	0	0		
1380	chr11	104295188	104295213	3500388825	23		104295188	104295213	8421504	2	13,10	0,15	g	350038882500000002	0-23			10.1016/j.gene.2005.11.001		Gene	Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter	Shanmugarajan	2006	0		
172	chr11	104306249	104358199	3500036562	1399		104306249	104358199	8421504	16	10,110,69,189,57,75,71,31,91,85,65,132,157,66,120,71	0,7687,9954,11374,17743,19751,23006,23289,28325,31074,31667,40751,45998,50516,51756,51879	p,c,g	350003656200000006,350003656200015001,350003656200000007,350003656200000007,350003656200015002,350003656200000008,350003656200015004,350003656200000009,350003656200000009,350003656200015005,350003656200000010,350003656200015006,350003656200000011,350003656200000012,350003656200015009,350003656200000013,350003656200015010,350003656200000014,350003656200015011,350003656200015012,350003656200000015,350003656200000016,350003656200000017,350003656200000017,350003656200015014,350003656200000018,350003656200000018,350003656200000019,350003656200000020,350003656200000020,350003656200000021,350003656200000021,350003656200000022,350003656200000022	0-90,0-60,0-90,0-90,0-54,0-84,0-87,0-90,0-90,0-90,0-90,0-90,0-90,0-90,0-57,0-90,0-90,0-90,0-90,0-72,0-72,0-90,0-21,0-21,0-90,0-66,0-66,0-90,0-90,0-90,0-69,0-69,0-84,0-84						Molecular definition ofbovine argininosuccinate synthetase deficiency	www.pnas.org	0	0		
1380	chr11	104316221	104317626	3500431828	54		104316221	104317626	8421504	2	51,3	0,1402	p	350043182800015000	6-60		19818875	10.1016/j.vph.2009.09.005		Vascular pharmacology	Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow	Shruti	2009	0		ASS1
1380	chr11	104317647	104317707	3500246522	60		104317647	104317707	8421504	1	60	0	p	350024652200015032	0-60						K&#xc1;TIA LUCIANO PEREIRA MORAIS	bdtd.unifesp.br	0	0		ASS1
1380	chr11	104317677	104317728	3500425895	41		104317677	104317728	8421504	2	21,20	0,31	c,g	350042589500000000,350042589500000000,350042589500000001	0-21,0-21,0-20		17496212	10.1152/ajpheart.01100.2006		American Journal of Physiology - Heart and Circulatory Physiology	Tumor necrosis factor-&#x03b1; reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells	Goodwin	2007	0		
1381	chr11	104334577	104337329	3500127170	65		104334577	104337329	8421504	4	20,23,16,6	0,25,72,2746	c	350012717000000000,350012717000000002,350012717000000001	0-20,0-23,0-22		17145837	10.1158/1078-0432.CCR-06-1101	1078-0432	Clinical Cancer Research	In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion	Szlosarek	2006	8		
1381	chr11	104337947	104347014	3500418973	48		104337947	104347014	8421504	2	34,14	0,9053	p	350041897300015038	0-48						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		ASS1
1382	chr11	104541308	104541341	3500433740	33		104541308	104541341	8421504	1	33	0	c	350043374000000008	0-33		11158327	10.1128/MCB.21.4.1429-1439.2001	0270-7306	Molecular and Cellular Biology	Human L1 Retrotransposition: cisPreference versus trans Complementation	Wei	2001	6		ABL1
1382	chr11	104541308	104541341	3500397035	33		104541308	104541341	8421504	1	33	0	c	350039703500000004	0-33		9075693	10.1210/en.138.4.1392	0013-7227	Endocrinology	Isolation of a New Mouse 3&#x03b2;-Hydroxysteroid Dehydrogenase Isoform, 3&#x03b2;-HSD VI, Expressed During Early Pregnancy	Abbaszade	1997	4		ABL1
172	chr11	104541311	104676453	3500025991	1599		104541311	104676453	8421504	10	136,174,296,273,85,178,185,153,90,29	0,109590,110318,118286,127752,128479,130470,132963,134676,135113	p	350002599100015006	0-4470						imatinib drug resistance	www.scribd.com	0	0		
172	chr11	104541311	104659609	3500025991	618		104541311	104659609	8421504	4	136,174,296,12	0,109590,110318,118286	p	350002599100015003	0-618						imatinib drug resistance	www.scribd.com	0	0		
172	chr11	104541446	104650954	3500417407	54		104541446	104650954	8421504	2	1,53	0,109455	p	350041740700015001	195-249						&#xfffd;&#xfffd;DNA-Vakzinierung zur Behandlung von minimal residual disease bei Ph+ akuter lymphoblastischer Leuk&#xfffd;mie im syngenen Mausmodell	ik.uni-luebeck.de	0	0		ABL1
172	chr11	104541446	104650932	3500313592	32		104541446	104650932	8421504	2	1,31	0,109455	c	350031359200000050	15-47						Compounds and methods for the treatment of leukemias	Coney	1994	0		
1383	chr11	104650901	104650932	3500167953	31		104650901	104650932	8421504	1	31	0	c	350016795300000033,350016795300000108	5-36,5-36					Patent	Splice-region antisense composition and method (Patent US:6784291)	Iversen	2004	0		
1383	chr11	104650901	104650932	3500051887	31		104650901	104650932	8421504	1	31	0	c	350005188700000031	5-36						Splice-region Antisense Composition And Method 	.freshpatents.com	0	0		
1383	chr11	104650901	104650932	3500003434	31		104650901	104650932	8421504	1	31	0	c	350000343400000023	5-36						Splice-region antisense composition and method	Hudziak	2001	0		
1383	chr11	104650907	104651662	3500050322	50		104650907	104651662	8421504	2	25,25	0,730	c	350005032200000006,350005032200000001	0-25,0-25		9160683		0006-4971	Blood	Cellular Expression of Antiapoptotic BCL-2 Oncoprotein in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Children's Cancer Group Study	Uckun	1997	10		
1383	chr11	104650907	104651662	3500025638	55		104650907	104651662	8421504	2	25,30	0,725	c	350002563800000000,350002563800000001	0-25,0-30		19685493	10.1002/ijc.24832	1097-0215	International Journal of Cancer	Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation - Ro&#x017e;kov&#xe1; - 2009 - International Journal of Cancer - Wiley Online Library	Rozkova	2010	0		ABL1
1383	chr11	104650995	104651018	3500386453	23		104650995	104651018	8421504	1	23	0	c	350038645300000000	0-23						Modulation of growth factors and cell cycle regulatory molecules in experimental cardiomyopathy	theses.ulb.ac.be	0	0		
1383	chr11	104650999	104651730	3500251659	177		104650999	104651730	8421504	2	76,101	0,630	p	350025165900015027	3-180						UNIVERSIDAD DE GRANADA	hera.ugr.es	0	0		ABL1
1383	chr11	104651011	104651739	3500214246	174		104651011	104651739	8421504	2	64,110	0,618	p	350021424600015089	0-174						Alignement multiple ClustalW	polytech.unice.fr	0	0		ABL1
1383	chr11	104651637	104651696	3500425137	55		104651637	104651696	8421504	2	25,30	0,29	c	350042513700000002,350042513700000000	0-25,0-30						Efficient silencing of bcr/abl oncogene by single- and double-stranded siRNAs targeted against b2a2 transcripts. - ResearchGate	.researchgate.net	0	0		ABL1
1383	chr11	104651637	104651662	3500232376	25		104651637	104651662	8421504	1	25	0	c	350023237600000010	0-25		16891454	10.1158/1535-7163.MCT-06-0006	1535-7163	Molecular Cancer Therapeutics	Antisense locked nucleic acids efficiently suppress BCR/ABL and induce cell growth decline and apoptosis in leukemic cells	Rapozzi	2006	5		ABL1
1383	chr11	104651666	104651696	3500416133	30		104651666	104651696	8421504	1	30	0	c	350041613300000022	0-30						Herstellung und Evaluierung eines Modellsystems zur in vivo Untersuchung der humanen DNA Fehlpaarungsreparatur (mismatch repair - MMR)	etc.tu-bs.de:8080	0	0		
1383	chr11	104651668	104651724	3500454405	49		104651668	104651724	8421504	2	28,21	0,35	c	350045440500000009,350045440500000008	0-28,0-21						Disulfide-linked Liposomes: Effective Delivery Vehicle for Bcl-2 Antisense Oligodeoxyribonucleotide G3139	.iiarjournals.org	0	0		ABL1
1383	chr11	104651733	104659702	3500004002	297		104651733	104659702	8421504	2	192,105	0,7864	p	350000400200015017	0-297						COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS	Walker	2013	0		ABL1
1383	chr11	104651733	104659696	3500263315	291		104651733	104659696	8421504	2	192,99	0,7864	p	350026331500015015	0-291						Compositions and methods for producing bioactive fusion proteins	Walker	2008	0		ABL1
1383	chr11	104651883	104659702	3500236543	147		104651883	104659702	8421504	2	42,105	0,7714	p	350023654300015031	0-147					Patent	Compositions and methods for producing bioactive fusion proteins (Patent US:8420779)	Walker	2013	0		ABL1
1383	chr11	104651883	104659702	3500227699	147		104651883	104659702	8421504	2	42,105	0,7714	p	350022769900015031	0-147						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		ABL1
1383	chr11	104651908	104659615	3500152373	35		104651908	104659615	8421504	2	17,18	0,7689	c	350015237300000191,350015237300000192	8-42,3-38						AGENT FOR SUPPRESSING EXPRESSION OF DOMINANT MUTANT GENE	Hohjoh	2011	0		
1383	chr11	104659849	104674330	3500312040	225		104659849	104674330	8421504	7	21,24,45,44,1,45,45	0,9214,9241,10075,11932,12032,14436	p	350031204000015009,350031204000015013,350031204000015029,350031204000015041,350031204000015049	0-45,0-45,0-45,0-45,0-45						METHODS OF TREATING CHEMORESISTANCE AND RELAPSE IN CANCER CELLS - Patent application	www.faqs.org	0	0		ABL2
1383	chr11	104669108	104669795	3500284426	45		104669108	104669795	8421504	2	40,5	0,682	p	350028442600015019	0-45						 Pyrrolo 	www.docstoc.com	0	0		ABL2
1383	chr11	104669120	104669879	3500378011	117		104669120	104669879	8421504	2	28,89	0,670	p	350037801100015002	0-117						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	mcb.berkeley.edu	0	0		ABL1
1383	chr11	104669120	104669879	3500145445	117		104669120	104669879	8421504	2	28,89	0,670	p	350014544500015002	0-117						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	physio.ucsf.edu	0	0		ABL1
1383	chr11	104669120	104669858	3500244206	96		104669120	104669858	8421504	2	28,68	0,670	p	350024420600015024,350024420600015025	0-48,0-48						High affinity protein kinase inhibitors - US Patent 6383790 Description	ww.patentstorm.us	0	0		ABL1
1383	chr11	104669120	104669858	3500109878	96		104669120	104669858	8421504	2	28,68	0,670	p	350010987800015024,350010987800015025	0-48,0-48						US Patent # 6,383,790. High affinity protein kinase inhibitors - Patents.com	www.patents.com	0	0		ABL1
1383	chr11	104669924	104671832	3500381850	90		104669924	104671832	8421504	3	24,15,51	0,27,1857	p	350038185000015002	0-90						Bcr-abl truncation mutations	Albitar	2011	0		
1383	chr11	104671860	104671956	3500366238	96		104671860	104671956	8421504	1	96	0	p	350036623800015014	0-96						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		ABL1
1383	chr11	104671890	104674369	3500100763	171		104671890	104674369	8421504	2	76,95	0,2384	p	350010076300015002	9-180						5 Multiple Sequence Alignment 5.1 Introduction	.inf.fu-berlin.de	0	0		ABL1
1383	chr11	104674292	104674317	3500324994	25		104674292	104674317	8421504	1	25	0	c,g	350032499400000000,350032499400000000	0-25,0-25		17569822	10.1124/jpet.107.124461	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Bcr-Abl-Independent Imatinib-Resistant K562 Cells Show Aberrant Protein Acetylation and Increased Sensitivity to Histone Deacetylase Inhibitors	Lee	2007	0		ABL2
1384	chr11	104733078	104733102	3500359214	23		104733078	104733102	8421504	2	18,5	0,19	g	350035921400000003	9-32						Bioenergetics: Trypanosome Letm1 Protein Is Essential for Mitochondrial Potassium Homeostasis Hassan Hashimi, Lindsay McDonald, Eva Str&#xed;brn&#xe1; and Julius Lukes	www.paru.cas.cz	0	0		
1384	chr11	104800904	104800930	3500432660	25		104800904	104800930	8421504	2	14,11	0,15	g	350043266000000105	20-48						Oral delivery of modified transferrin fusion proteins - US Patent 8129504 Description	ww.patentstorm.us	0	0		
1385	chr11	104907167	104907191	3500193540	24		104907167	104907191	8421504	1	24	0	c	350019354000000001	0-24						Expansion of Early Hematopoietic Progenitors and Hyperproliferation of Stomach Mucosa in Transgenic Mice 2007&#x5e74;&#x7b2c;169&#x5377;&#x7b2c;8&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		NUP214
1386	chr11	105018490	105018518	3500382837	23		105018490	105018518	8421504	2	17,6	0,22	g	350038283700000013	0-24		16148034	10.1152/ajpcell.00160.2005		American Journal of Physiology - Cell Physiolog	Induction of cellular prion protein gene expression by copper in neurons	Varela-Nallar	2006	0		
1386	chr11	105032908	105032932	3500230331	23		105032908	105032932	8421504	2	7,16	0,8	g	350023033100000130	2-27						Cross-species-specific single domain bispecific single chain antibody	Kufer	2011	0		
1387	chr11	105209697	105209726	3500348183	24		105209697	105209726	8421504	2	11,13	0,16	g	350034818300000018	3-27						US Patent # 5,723,581. Murine and human box-dependent myc-interacting protein (Bin1) - Patents.com	www.patents.com	0	0		
1388	chr11	105278066	105282259	3500173556	582		105278066	105282259	8421504	10	45,10,35,58,98,15,81,79,95,66	0,102,276,347,1413,2382,2403,2563,3890,4127	p	350017355600015041,350017355600015038,350017355600015035,350017355600015033,350017355600015031	0-45,0-45,0-171,0-168,0-153						EpacisaRap1guanine- nucleotide-exchangefactor directlyactivatedby cyclicAMP	mcr.umcutrecht.nl	0	0		RAPGEF1
1388	chr11	105290365	105290390	3500002474	25		105290365	105290390	8421504	1	25	0	g	350000247400000000	3-28						Modified l49-sfv exhibiting increased stability and methods of use thereof	Mcdonagh	2002	0		
1389	chr11	105466382	105466407	3500201864	23		105466382	105466407	8421504	2	12,11	0,14	g	350020186400000321	3-26						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1390	chr11	105545312	105545336	3500438426	23		105545312	105545336	8421504	2	11,12	0,12	g	350043842600000136,350043842600000051	9-32,9-32						COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR - Patent application	www.faqs.org	0	0		
1390	chr11	105545312	105545336	3500229956	23		105545312	105545336	8421504	2	11,12	0,12	g	350022995600000133,350022995600000051	9-32,9-32						Compounds Modulating C-kit And C-fms Activity And Uses Therefor 	.freshpatents.com	0	0		
1391	chr11	105715037	105715062	3500189837	23		105715037	105715062	8421504	2	7,16	0,9	g	350018983700000017	1-24						Anti-pathogen system and methods of use thereof	Dowdy	2001	0		
1392	chr11	105856540	105856564	3500230394	23		105856540	105856564	8421504	2	12,11	0,13	g	350023039400000042	0-23						COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES - Patent application	www.faqs.org	0	0		
1392	chr11	105878686	105878714	3500120660	23		105878686	105878714	8421504	2	9,14	0,14	c	350012066000000316,350012066000000315	12-35,14-37						MUTATED PARVOVIRUS STRUCTURAL PROTEINS AS VACCINES - Patent application	www.faqs.org	0	0		
1395	chr11	106221916	106221941	3500203632	25		106221916	106221941	8421504	1	25	0	c	350020363200000008	1-26			10.1111/j.1365-2672.2007.03386.x	1365-2672	Journal of Applied Microbiology	Characterization of OmpK, GAPDH and their fusion OmpK&#x2013;GAPDH derived from Vibrio harveyi outer membrane proteins: their immunoprotective ability against vibriosis in large yellow croaker (Pseudosciaena crocea) - Zhang - 2007 - Journal of Applied Mic	Zhang	2007	0		
1397	chr11	106488917	106488941	3500269550	24		106488917	106488941	8421504	1	24	0	c	350026955000000325,350026955000000326	9-29,8-29						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
1397	chr11	106503509	106503539	3500445108	25		106503509	106503539	8421504	3	15,3,7	0,18,23	g	350044510800000034	8-33						Modified factor VII polypeptides and uses thereof	Madison	2008	0		
1398	chr11	106574355	106578575	3500200274	42		106574355	106578575	8421504	2	20,22	0,4198	c	350020027400000000,350020027400000004,350020027400000001,350020027400000013,350020027400000003,350020027400000011	0-20,0-20,0-21,0-21,5-26,4-25						Yang independent growth factor 1b of the polyclonal antibody a method... - IP.com	ip.com/patfam/en/	0	0		
1398	chr11	106620039	106620066	3500287939	24		106620039	106620066	8421504	2	11,13	0,14	g	350028793900000001,350028793900000002	8-32,4-28						Fusion Proteins Between Plant Cell-Wall Degrading Enzymes, and Their Uses	Levasseur	2009	0		
1398	chr11	106626150	106634997	3500085562	1879		106626150	106634997	8421504	13	66,151,123,198,131,108,118,187,204,198,321,37,37	0,2182,2410,2733,3504,3790,3998,5862,6547,7957,8449,8772,8810	c	350008556200000525,350008556200000487	21-1903,0-26						Methods and compositions for assaying analytes	Yuan	1999	0		
1401	chr11	106969093	106986770	3500370967	171		106969093	106986770	8421504	4	51,46,37,37	0,13433,15331,17640	c,g	350037096700000025,350037096700000023,350037096700000009,350037096700000014,350037096700000020	4-55,4-55,9-55,0-37,0-37						Allele mining in &#x03b2;-lactoglobulin gene of Capra hircus	demicjournals.org	0	0		
1401	chr11	106979850	106989282	3500435005	1667		106979850	106989282	8421504	8	180,230,910,95,7,105,8,132	0,3538,3769,5767,5871,6553,6880,9300	p,c,g	350043500500000011,350043500500015013,350043500500015014,350043500500015015,350043500500000010,350043500500015016,350043500500015017,350043500500015018,350043500500015019	0-1452,0-60,0-60,9-57,0-25,0-60,0-51,0-60,0-60						ANKARA &#xdc;N&#x0130;VERS&#x0130;TES&#x0130; FEN B&#x0130;L&#x0130;MLER&#x0130; ENST&#x0130;T&#xdc;S&#xdc; Y&#xdc;KSEK L&#x0130;SANS TEZ&#x0130;	siv.ankara.edu.tr	0	0		
1401	chr11	106981484	106982478	3500183343	60		106981484	106982478	8421504	3	20,19,21	0,783,973	g	350018334300000000,350018334300000004,350018334300000006	0-20,0-19,0-21						Obtaining calves after transfer of embryos microin- jected with the human interferon alpha (IFN&#x03b1;) gene, pbLGIFN-GFPBsd	www.au.poznan.pl	0	0		
1401	chr11	106981484	106982286	3500385731	39		106981484	106982286	8421504	2	20,19	0,783	g	350038573100000000,350038573100000004	0-20,0-19						Obtaining transgenic bovine skin fibroblasts containing human interferon alpha gene	www.ighz.edu.pl	0	0		
1401	chr11	106981902	106982720	3500345230	792		106981902	106982720	8421504	9	9,5,14,39,216,81,156,107,165	0,12,18,42,82,299,381,539,653	g	350034523000000138	0-807						Transgenic bovines and milk from transgenic bovines	Deboer	1995	0		
1401	chr11	106981902	106982720	3500151266	792		106981902	106982720	8421504	9	9,5,14,39,216,81,156,107,165	0,12,18,42,82,299,381,539,653	g	350015126600000137	0-807						Transgenic bovine	Deboer	1995	0		
1401	chr11	106982446	106982471	3500213847	25		106982446	106982471	8421504	1	25	0	g	350021384700000001	0-25						&#x0421;&#x043f;&#x043e;&#x0441;&#x043e;&#x0431; &#x0432;&#x044b;&#x044f;&#x0432;&#x043b;&#x0435;&#x043d;&#x0438;&#x044f; &#x0432;&#x0430;&#x0440;&#x0438;&#x0430;&#x043d;&#x0442;&#x0430; &#x0432;* &#x0431;&#x0435;&#x0442;&#x0430;-&#x043b;&#x0430;&#x043a;&	www.freepatent.ru	0	0		
1401	chr11	106982620	106985703	3500455139	43		106982620	106985703	8421504	2	21,22	0,3061	c	350045513900000043,350045513900000005	0-21,0-22						lacto_sin	www.scribd.com	0	0		
1401	chr11	106982660	106986438	3500359063	450		106982660	106986438	8421504	5	90,140,74,111,35	0,759,1763,2957,3743	p	350035906300015066,350035906300015046,350035906300015152,350035906300015163,350035906300015067,350035906300015149,350035906300015147,350035906300015068	0-150,0-60,0-72,0-168,0-150,3-105,0-63,0-150						Bioinformatics and Functional Genomics	www.scribd.com	0	0		
1401	chr11	106982660	106984493	3500460516	300		106982660	106984493	8421504	3	90,140,70	0,759,1763	p	350046051600015004,350046051600015025,350046051600015008,350046051600015027	0-132,0-177,0-147,0-63						&#x53cc;&#x5e8f;&#x5217;&#x6bd4;&#x5bf9; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
1401	chr11	106982660	106984493	3500355377	300		106982660	106984493	8421504	3	90,140,70	0,759,1763	p	350035537700015011,350035537700015004,350035537700015019,350035537700015006	0-132,0-177,0-147,0-63						COMP 571 Bioinformatics: Sequence Analysis	edick.rutgers.edu	0	0		
1401	chr11	106982660	106984493	3500304308	300		106982660	106984493	8421504	3	90,140,70	0,759,1763	p	350030430800015008,350030430800015092,350030430800015018,350030430800015094	0-132,0-177,0-147,0-63						Bilkent University : MBG 326 : Bioinformatics_Lecture2_Alignment	ww.coursehero.com	0	0		
1401	chr11	106982660	106984493	3500211485	300		106982660	106984493	8421504	3	90,140,70	0,759,1763	p	350021148500015013,350021148500015006,350021148500015021,350021148500015008	0-132,0-177,0-147,0-63						No Slide Title	www.cs.uml.edu	0	0		
1401	chr11	106982660	106984493	3500168195	300		106982660	106984493	8421504	3	90,140,70	0,759,1763	p	350016819500015075,350016819500015006,350016819500015085,350016819500015008	0-132,0-177,0-147,0-63						No Slide Title	ennedykrieger.org	0	0		
1401	chr11	106982660	106984472	3500407729	279		106982660	106984472	8421504	3	90,140,49	0,759,1763	p	350040772900015005,350040772900015015	0-132,0-147						No Slide Title	bioinfbook.org	0	0		
1401	chr11	106982660	106984472	3500375077	279		106982660	106984472	8421504	3	90,140,49	0,759,1763	p	350037507700015013,350037507700015015	0-132,0-147						Pairwise Alignments Part 1	www.csus.edu	0	0		
1401	chr11	106982660	106984472	3500324612	279		106982660	106984472	8421504	3	90,140,49	0,759,1763	p	350032461200015005,350032461200015006,350032461200015009	0-60,0-132,0-147						&#x7b2c;&#x516d;&#x7ae0;&#x7b2c;&#x516d;&#x7ae0;&#x7b2c;&#x516d;&#x7ae0;&#x7b2c;&#x516d;&#x7ae0; &#x5206;&#x5b50;&#x8fdb;&#x5316;&#x4e0e;&#x57fa;&#x56e0;&#x7ec4;&#x6f14;&#x5316;&#x7684; &#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x7814;&#x7a76; &#xff08;&#xf	ww.coe.pku.edu.cn	0	0		
1401	chr11	106982660	106984472	3500188478	279		106982660	106984472	8421504	3	90,140,49	0,759,1763	p	350018847800015008,350018847800015010	0-132,0-147						Pairwise Alignments	www.csus.edu	0	0		
1401	chr11	106982660	106984472	3500043918	279		106982660	106984472	8421504	3	90,140,49	0,759,1763	p	350004391800015007,350004391800015006,350004391800015010	0-132,0-60,0-147						&#x7b2c;&#x4e94;&#x7ae0;&#x7b2c;&#x4e94;&#x7ae0;&#x7b2c;&#x4e94;&#x7ae0;&#x7b2c;&#x4e94;&#x7ae0; &#x57fa;&#x5b66;&#x7684;&#x57fa;&#x56e0;&#x7ec4;&#x5b66;&#x7684; &#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x7814;&#x7a76; &#xff08;&#xff08;Part IIPart II	ww.coe.pku.edu.cn	0	0		
1401	chr11	106982660	106983509	3500099054	180		106982660	106983509	8421504	2	90,90	0,759	p	350009905400015002	567-747						Air Force Academy : PDM 276 : french	ww.coursehero.com	0	0		
1401	chr11	106982722	106985647	3500030431	359		106982722	106985647	8421504	3	28,2,329	0,697,2596	c,g	350003043100000019,350003043100000007,350003043100000031,350003043100000032,350003043100000009,350003043100000021	0-30,0-30,0-68,0-329,0-22,0-22						Methods - Patent application	www.faqs.org	0	0		
1401	chr11	106982726	106983461	3500455073	66		106982726	106983461	8421504	2	24,42	0,693	p	350045507300015005	0-66						TaiLieu.VN: SO S&#xc1;NH C&#xc1;C TR&#xcc;NH T&#x1ef0; SINH H&#x1ecc;C B&#x1eb0;NG BLAST V&#xc0; CLUTALX 	tailieu.vn/doc/so	0	0		
1401	chr11	106982726	106983461	3500374430	66		106982726	106983461	8421504	2	24,42	0,693	p	350037443000015004	0-66						BLAST	www.csus.edu	0	0		
1401	chr11	106982726	106983461	3500217555	66		106982726	106983461	8421504	2	24,42	0,693	p	350021755500015002	0-66						Biology 4900	www.docstoc.com	0	0		
1401	chr11	106982726	106983461	3500138377	66		106982726	106983461	8421504	2	24,42	0,693	p	350013837700015004	0-66						&#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x7b2c;4&#x8bb2;-&#x5e8f;&#x5217;&#x76f8;&#x4f3c;&#x6027;&#x641c;&#x7d22; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
1401	chr11	106982744	106984424	3500135112	147		106982744	106984424	8421504	3	6,140,1	0,675,1679	p	350013511200015243	0-147						&#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x57f9;&#x8bad;&#x6559;&#x6750;	ibi.cqupt.edu.cn	0	0		
1401	chr11	106982745	106986448	3500398906	41		106982745	106986448	8421504	3	5,15,21	0,674,3682	c,g	350039890600000010,350039890600000011,350039890600000011	0-20,0-21,0-21						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
1401	chr11	106983428	106986468	3500150647	315		106983428	106986468	8421504	10	45,45,35,10,13,32,45,28,17,45	0,48,96,995,1056,2189,2224,2272,2975,2995	p	350015064700015004,350015064700015008,350015064700015012,350015064700015020,350015064700015024,350015064700015028,350015064700015032	0-45,0-45,0-45,0-45,0-45,0-45,0-45						MODIFIED BETA-LACTOGLOBULINS FOR IMMUNOTHERAPY OF MILK ALLERGY - Patent application	www.faqs.org	0	0		
1401	chr11	106983437	106986738	3500418941	468		106983437	106986738	8421504	5	122,74,111,153,8	0,986,2180,2918,3293	p,c,g	350041894100015065,350041894100015066,350041894100015067,350041894100015068,350041894100015069,350041894100015070,350041894100000003,350041894100000008,350041894100000008,350041894100000004,350041894100000005,350041894100015017,350041894100015071	0-60,0-60,0-60,0-60,0-60,0-60,0-56,0-21,0-21,0-45,0-45,0-45,0-60						TEJFEH&#xc9;RJE GENETIKAI VIZSG&#xc1;LATOK HAZAI SZARVASMARHA FAJT&#xc1;KBAN	www.szie.hu	0	0		
1401	chr11	106983497	106986738	3500337518	330		106983497	106986738	8421504	6	62,28,16,111,105,8	0,926,984,2120,2906,3233	p	350033751800015013,350033751800015018,350033751800015021	0-90,0-120,0-120						Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens	Jylhae	2008	0		
1401	chr11	106983540	106985620	3500123623	40		106983540	106985620	8421504	4	19,1,17,3	0,883,940,2077	c	350012362300000002,350012362300000003	0-20,0-20						Targeted microRNA expression in dairy cattle directs production of &#x03b2;-lactoglobulin-free, high-casein milk. - ResearchGate	.researchgate.net	0	0		
1401	chr11	106984484	106985667	3500067316	63		106984484	106985667	8421504	2	13,50	0,1133	p	350006731600015002	3-66						Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions	Corthesy	2004	0		
1401	chr11	106985560	106986007	3500022485	447		106985560	106986007	8421504	1	447	0	c,g	350002248500000002,350002248500000000,350002248500000000,350002248500000001	0-447,0-25,0-25,0-25						BOVINE BETA LACTOGLOBULIN: PCR-RFLP PROTOCOL FOR ALLELES A AND B	ience.ucdavis.edu	0	0		
1401	chr11	106985634	106986450	3500303856	69		106985634	106986450	8421504	2	27,42	0,774	p	350030385600015003	0-102						Posteraustellung	www.sge-ssn.ch	0	0		
1401	chr11	106985634	106985896	3500267865	50		106985634	106985896	8421504	2	25,25	0,237	c,g	350026786500000019,350026786500000019,350026786500000020	0-25,0-25,0-25						DIVERSIDAD GEN&#xc9;TICA DEL GANADO HART&#xd3;N DEL VALLE Y SUS RELACIONES CON HOLSTEIN Y BRAHMAN, MEDIANTE EL USO DE MARCADORES MOLECULARES	www.uco.es/conbia	0	0		
1401	chr11	106985634	106985896	3500239914	50		106985634	106985896	8421504	2	25,25	0,237	c,g	350023991400000000,350023991400000000,350023991400000001	0-25,0-25,0-25						Introducci&#xf3;n a la Investigaci&#xf3;n	cdigital.uv.mx	0	0		
1401	chr11	106985634	106985896	3500127284	50		106985634	106985896	8421504	2	25,25	0,237	c,g	350012728400000000,350012728400000000,350012728400000001	0-25,0-25,0-25				0798-2259	Revista Cient&#xed;fica	Revista Cient&#xed;fica - Frecuencias Al&#xe9;licas de Beta-lactoglobulina en ganado criollo Limonero	Rojas	2010	0		
1401	chr11	106985634	106985896	3500093653	50		106985634	106985896	8421504	2	25,25	0,237	c,g	350009365300000000,350009365300000000,350009365300000001	0-25,0-25,0-25						&#x0e1b;&#xf701;&#x0e22;&#x0e30;&#x0e1e;&#x0e23; &#x0e1b;&#xf706;&#x0e2d;&#x0e21;&#x0e04;&#x0e4d;&#x0e32;1 2	ence.kps.ku.ac.th	0	0		
1401	chr11	106985634	106985659	3500174182	24		106985634	106985659	8421504	2	12,12	0,13	c,g	350017418200000000,350017418200000000	0-24,0-24						&#xc720;&#xc804; &#xbc0f; &#xc721;&#xc885; ; PCR - RFLP &#xae30;&#xbc95;&#xc744; &#xc774;&#xc6a9;&#xd55c; &#xc816;&#xc18c; &#xc720;&#xc804;&#xc801; &#xac1c;&#xb7c9;&#xc744; &#xc704;&#xd55c; &#xc120;&#xbc1c;&#xb3c4;&#xad6c;&#xb85c;&#xc11c; &#x03b2;- lactog	blog.naver.com	0	0		
1401	chr11	106985639	106985886	3500415721	48		106985639	106985886	8421504	2	24,24	0,223	c,g	350041572100000000,350041572100000000,350041572100000001	0-24,0-24,0-24						Polymorphism of the &#x03b2;-lactoglobulin gene and its associ- ation with milk production traits in Iranian Najdi cattle	ijb.nigeb.ac.ir	0	0		
1401	chr11	106985639	106985886	3500310383	49		106985639	106985886	8421504	2	25,24	0,223	c,g	350031038300000002,350031038300000002,350031038300000003	0-25,0-25,0-24						&#x0412;&#x0415;&#x0421;&#x0422;&#x041d;&#x0418;&#x041a; &#x2116;10 15	www.rgazu.ru	0	0		
1401	chr11	106985639	106985886	3500296031	49		106985639	106985886	8421504	2	25,24	0,223	c,g	350029603100000002,350029603100000003	0-25,0-24			10.1590/S1415-47572005000200015	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Effects of CSN3 and LGB gene polymorphisms on production traits in beef cattle	Curi	2005	1		
1401	chr11	106985639	106985886	3500294754	49		106985639	106985886	8421504	2	25,24	0,223	c,g	350029475400000002,350029475400000003	0-25,0-24			10.1590/S1415-47572005000200015	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Effects of CSN3 and LGB gene polymorphisms on production traits in beef cattle	Curi	2005	1		
1401	chr11	106985639	106985886	3500035207	49		106985639	106985886	8421504	2	25,24	0,223	c,g	350003520700000002,350003520700000003	0-25,0-24			10.1590/S1415-47572005000200015	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Effects of CSN3 and LGB gene polymorphisms on production traits in beef cattle	Curi	2005	1		
1401	chr11	106985639	106985664	3500407801	25		106985639	106985664	8421504	1	25	0	c,g	350040780100000000,350040780100000000	0-25,0-25						&#x0422;&#x0415;&#x0425;&#x041d;&#x041e;&#x041b;&#x041e;&#x0413;&#x0406;&#x042f; &#x0412;&#x0418;&#x0420;&#x041e;&#x0411;&#x041d;&#x0418;&#x0426;&#x0422;&#x0412;&#x0410; &#x0406; &#x041f;&#x0415;&#x0420;&#x0415;&#x0420;&#x041e;&#x0411;&#x041a;&#x0418; &#x	btsau.net.ua	0	0		
1401	chr11	106985727	106988423	3500307457	1030		106985727	106988423	8421504	36	1,38,38,24,21,5,128,26,50,7,19,26,6,11,29,69,15,22,19,44,11,38,8,18,66,38,37,6,23,12,27,12,39,49,31,17	0,676,716,757,950,974,986,1115,1145,1204,1212,1235,1306,1313,1327,1361,1431,1452,1484,1519,1564,1581,1621,1641,1670,1737,1791,1830,1838,2466,2481,2524,2538,2586,2637,2679	c,g	350030745700000057,350030745700000058,350030745700000077,350030745700000059,350030745700000079	223-325,16-802,0-164,0-66,0-213						Protein c production in transgenic animals	Cottingham	1997	0		
1401	chr11	106986423	106986483	3500286152	60		106986423	106986483	8421504	1	60	0	p	350028615200015007	0-60		20023075	10.1128/AEM.00151-09	0099-2240	Applied and Environmental Microbiology	Milk Protein Fragments Induce the Biosynthesis of Macedocin, the Lantibiotic Produced by Streptococcus macedonicus ACA-DC 198	Georgalaki	2010	4		
1401	chr11	106986423	106986483	3500164001	60		106986423	106986483	8421504	1	60	0	p	350016400100015002	0-60		20023075	10.1128/AEM.00151-09		Applied and Environmental Microbiology	Milk Protein Fragments Induce the Biosynthesis of Macedocin, the Lantibiotic Produced by Streptococcus macedonicus ACA-DC 198 	Marina	2010	0		
1402	chr11	107160340	107160363	3500307235	23		107160340	107160363	8421504	1	23	0	g	350030723500000193	11-35						US Patent # 6,025,194. Nucleic acid sequence of senescence asssociated gene - Patents.com	www.patents.com	0	0		
1403	chr11	107338830	107338853	3500270675	23		107338830	107338853	8421504	1	23	0	g	350027067500000121	12-37						Nested oligonucleotides containing a hairpin for nucleic acid amplification	Bowdish	2001	0		
1404	chr11	107407632	107407659	3500339122	23		107407632	107407659	8421504	2	6,17	0,10	g	350033912200000019	6-29		18463165	10.1091/mbc.E07-11-1156	1059-1524	Molecular Biology of the Cell	High-Resolution Crystal Structure and In Vivo Function of a Kinesin-2 Homologue in Giardia intestinalis	Hoeng	2008	5		
1404	chr11	107407632	107407659	3500300831	23		107407632	107407659	8421504	2	6,17	0,10	g	350030083100000006	0-23						Development and Characterization of Lifeact - a versatile marker for the visualization of F-actin	b.uni-muenchen.de	0	0		
1404	chr11	107407632	107407659	3500183252	23		107407632	107407659	8421504	2	6,17	0,10	g	350018325200000004	0-23		18268009	10.1128/MCB.02102-07		Molecular and Cellular Biology	The Protein Dendrite Arborization and Synapse Maturation 1 (Dasm-1) Is Dispensable for Dendrite Arborization 	Archana	2008	0		
1404	chr11	107407632	107407659	3500139675	23		107407632	107407659	8421504	2	6,17	0,10	g	350013967500000004	0-23		18268009	10.1128/MCB.02102-07	0270-7306	Molecular and Cellular Biology	The Protein Dendrite Arborization and Synapse Maturation 1 (Dasm-1) Is Dispensable for Dendrite Arborization	Mishra	2008	6		
1404	chr11	107460514	107460541	3500213123	26		107460514	107460541	8421504	2	22,4	0,23	g	350021312300000080,350021312300000058	2-29,2-29						PPAR active compounds - Patent application	www.faqs.org	0	0		
1405	chr11	107555024	107584108	3500406269	40		107555024	107584108	8421504	3	21,5,14	0,29062,29070	g	350040626900000209,350040626900000393	18-39,16-35					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
1405	chr11	107589164	107589189	3500251744	24		107589164	107589189	8421504	2	9,15	0,10	c	350025174400000003	1-25						DNA methylation patterns in tissues from mid-gestation bovine foetuses produced by somatic cell nuclear transfer show subtle abnormalities in nuclear reprogramming	biomedcentral.com	0	0		
1405	chr11	107589164	107589189	3500020615	24		107589164	107589189	8421504	2	9,15	0,10	c	350002061500000003	1-25					BMC Developmental Biology	DNA methylation patterns in tissues from mid-gestation bovine foetuses produced by somatic cell nuclear transfer show subtle abnormalities in nuclear reprogramming - Scolaris	Couldrey	2010	0		
1406	chr11	107620255	107620286	3500230031	24		107620255	107620286	8421504	3	12,6,6	0,14,25	g	350023003100000221	11-35						METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCER - Patent application	www.faqs.org	0	0		
1406	chr11	107678825	107678923	3500465380	98		107678825	107678923	8421504	1	98	0	g	350046538000000018	0-98						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	quantification.de	0	0		
1406	chr11	107678825	107678923	3500011924	98		107678825	107678923	8421504	1	98	0	g	350001192400000018	0-98						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	qpcrupdate.net	0	0		
1407	chr11	107821258	107826384	3500013267	39		107821258	107826384	8421504	3	20,6,13	0,5104,5113	c	350001326700000088,350001326700000109	4-24,1-20						Diagnostic for metastatic prostate cancer	Wu	2000	0		
1407	chr11	107826414	107826951	3500299398	72		107826414	107826951	8421504	2	6,66	0,471	c,g	350029939800000000,350029939800000002,350029939800000001,350029939800000001	0-66,0-21,0-22,0-22						vol 15 12 2011	.irevues.inist.fr	0	0		
1407	chr11	107826889	107826957	3500353647	57		107826889	107826957	8421504	2	27,30	0,38	c	350035364700000033,350035364700000034	9-36,5-35						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		
1407	chr11	107826889	107826957	3500351139	57		107826889	107826957	8421504	2	27,30	0,38	c	350035113900000033,350035113900000150,350035113900000151,350035113900000034	9-36,9-36,5-35,5-35						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
1407	chr11	107826928	107826951	3500107408	23		107826928	107826951	8421504	1	23	0	c,g	350010740800000013,350010740800000013,350010740800000012,350010740800000012	12-35,12-35,11-34,11-34						Compositions and methods relating to mir-31	Weinberg	2011	0		EGFL7
1408	chr11	107993747	107993770	3500107470	23		107993747	107993770	8421504	1	23	0	c	350010747000000487,350010747000000410	13-36,22-45						Transmembrane protein amigo and uses thereof - Patent application	www.faqs.org	0	0		
1409	chr11	108013520	108022636	3500080223	597		108013520	108022636	8421504	9	21,144,36,77,1,180,72,27,39	0,588,1147,1686,2308,2315,8961,9040,9077	p	350008022300015083,350008022300015082,350008022300015089,350008022300015084	0-165,0-114,945-1263,0-177						87 Human Secreted Proteins	Young	2007	0		SURF4
1409	chr11	108013520	108015239	3500439093	285		108013520	108015239	8421504	4	21,187,44,33	0,588,1139,1686	p	350043909300015087	0-285						Secreted protein HFEAF41	Brewer	2003	0		
1410	chr11	108151701	108151725	3500267336	23		108151701	108151725	8421504	2	12,11	0,13	c	350026733600000020	9-32						Protein Glycosylation Modification In Methylotrophic Yeast 	.freshpatents.com	0	0		
1410	chr11	108214475	108214502	3500174088	23		108214475	108214502	8421504	2	13,10	0,17	g	350017408800000002	23-46						PDGF RECEPTOR BETA BINDING POLYPEPTIDES	Chen	2012	0		
1410	chr11	108214903	108214931	3500146321	24		108214903	108214931	8421504	3	5,12,7	0,7,21	g	350014632100000066	0-24						Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use - US Patent 7056714 Description	ww.patentstorm.us	0	0		
1411	chr11	108394554	108394579	3500160780	24		108394554	108394579	8421504	2	6,18	0,7	g	350016078000000004	6-30						Method for the production of erythropoietin	Fritsch	1991	0		
1412	chr11	108504805	108505472	3500166204	110		108504805	108505472	8421504	10	7,11,15,7,9,18,10,8,9,16	0,21,49,89,109,457,502,520,532,651	g	350016620400000089	52-174						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1413	chr11	108644428	108644455	3500085390	26		108644428	108644455	8421504	2	20,6	0,21	g	350008539000000000	9-35						Proteinaceous pharmaceuticals and uses thereof	Bader	2007	0		
1416	chr11	108921220	108938997	3500077888	41		108921220	108938997	8421504	2	19,22	0,17755	g	350007788800000008,350007788800000055	0-19,0-22						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1417	chr11	109165855	109165888	3500068063	31		109165855	109165888	8421504	3	12,6,13	0,13,20	c	350006806300000097	5-36						MICROBIAL SYNTHESIS OF D-1,2,4-BUTANETRIOL - Patent application	www.faqs.org	0	0		
1418	chr11	109210409	109210433	3500011328	23		109210409	109210433	8421504	2	13,10	0,14	c	350001132800000271	21-44						US Patent # 7,119,183. Rapid immunoselection cloning method - Patents.com	www.patents.com	0	0		
1418	chr11	109215995	109216055	3500126022	60		109215995	109216055	8421504	1	60	0	p	350012602200015010,350012602200015045	0-60,0-45						Histidine protein-phosphatase	Klumpp	2001	0		
1418	chr11	109215995	109216055	3500029582	60		109215995	109216055	8421504	1	60	0	p	350002958200015008,350002958200015042	0-60,0-48						Histidine protein-phosphatase	www.devileye.net	0	0		
1418	chr11	109226427	109226453	3500269841	23		109226427	109226453	8421504	2	15,8	0,18	c	350026984100000104	2-25						Therapeutic compositions and methods - Patent application	www.faqs.org	0	0		
1418	chr11	109226427	109226453	3500096608	23		109226427	109226453	8421504	2	15,8	0,18	c	350009660800000107	2-25						Erbb2 binding proteins and use thereof	Algate	2008	0		
1421	chr11	109589707	109589733	3500406269	23		109589707	109589733	8421504	2	7,16	0,10	g	350040626900000500	23-46					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
1421	chr11	109665761	109665789	3500088017	23		109665761	109665789	8421504	2	9,14	0,14	g	350008801700000010	0-23						US Patent # 5,451,522. Genes encoding and method of expressing an enzyme: phthalyl amidase - Patents.com	www.patents.com	0	0		
1422	chr11	109713647	109713775	3500435393	44		109713647	109713775	8421504	2	22,22	0,106	c	350043539300000013,350043539300000012	0-22,0-22						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
1422	chr11	109765652	109765918	3500006584	66		109765652	109765918	8421504	3	20,35,11	0,56,255	c,g	350000658400000006,350000658400000006,350000658400000032,350000658400000007	0-20,0-20,78-113,0-21						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
1422	chr11	109799909	109799932	3500464289	23		109799909	109799932	8421504	1	23	0	g	350046428900000342	20-43						High bone mass gene of 11q13.3	Carulli	2000	0		
1423	chr11	109875805	109875833	3500365497	23		109875805	109875833	8421504	2	15,8	0,20	g	350036549700000038	0-23					Patent	Recombinant antibodies for human therapy (Patent US:5750105)	Hanna	1998	0		
1423	chr11	109875805	109875833	3500308014	23		109875805	109875833	8421504	2	15,8	0,20	g	350030801400000135	0-23						Recombinant anti-cd4 antibodies for human therapy	Hanna	1997	0		
1423	chr11	109875805	109875833	3500191035	23		109875805	109875833	8421504	2	15,8	0,20	g	350019103500000092	0-23						MMB 248 Antibody Engineering, Methods and Protocols	www.scribd.com	0	0		
586	chr12	209237	209261	3500205428	23		209237	209261	8421504	2	16,7	0,17	g	350020542800000039,350020542800000008	3-26,3-26						Bacterial pheromones and uses thereof - Patent application	www.faqs.org	0	0		
588	chr12	505277	505325	3500080418	48		505277	505325	8421504	1	48	0	p	350008041800015116	9-57						Methods and compositions for predicting response to eribulin	AGOULNIK	2012	0		AFF2
597	chr12	1636750	1636775	3500062244	23		1636750	1636775	8421504	2	15,8	0,17	g	350006224400000001	0-24		19109449	10.1128/CVI.00371-08	1556-6811	Clinical and Vaccine Immunology	Streptococcus suis Bacterin and Subunit Vaccine Immunogenicities and Protective Efficacies against Serotypes 2 and 9	Baums	2009	3		
598	chr12	1736256	1736279	3500188455	23		1736256	1736279	8421504	1	23	0	g	350018845500000296	11-42						 Polypeptide For A TRP Channel Family Member, TRP 	www.docstoc.com	0	0		
610	chr12	3334167	3334197	3500190760	23		3334167	3334197	8421504	3	5,6,12	0,8,18	g	350019076000000098	24-47						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
612	chr12	3642874	3642901	3500062329	23		3642874	3642901	8421504	2	8,15	0,12	g	350006232900000625,350006232900000077	0-23,0-23						ISOLATION OF UNKNOWN REARRANGED T-CELL RECEPTORS FROM SINGLE CELLS - Patent application	www.faqs.org	0	0		
622	chr12	4913585	4913612	3500437423	23		4913585	4913612	8421504	3	11,6,6	0,12,21	g	350043742300000113	21-44						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
625	chr12	5271147	5271171	3500252168	23		5271147	5271171	8421504	2	9,14	0,10	g	350025216800000033	1-24						PLANT OVEREXPRESSING ABSCISIC ACID TRANSPORTER PROTEIN AND METHOD FOR PRODUCING THE SAME - Patent application	www.faqs.org	0	0		
626	chr12	5411304	5411333	3500148818	23		5411304	5411333	8421504	3	13,6,4	0,18,25	g	350014881800000040	0-25						Infectious Clone Of Human Parvovirus B19 And Methods 	.freshpatents.com	0	0		
636	chr12	6779978	6780004	3500253796	23		6779978	6780004	8421504	2	8,15	0,11	g	350025379600000702	6-33					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
642	chr12	7484521	7484547	3500263494	23		7484521	7484547	8421504	2	10,13	0,13	g	350026349400000001	4-29						Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions	INC	1995	0		
648	chr12	8322803	8346741	3500444851	44		8322803	8346741	8421504	5	5,14,4,8,13	0,6,21,23915,23925	g	350044485100000144,350044485100000294	17-40,0-21						Methods For Rapid Identification Of Pathogens In Humans And Animals - Patent application	www.faqs.org	0	0		
649	chr12	8467405	8467429	3500326034	24		8467405	8467429	8421504	1	24	0	g	350032603400000267	3-29						 Selection Method 	www.docstoc.com	0	0		
652	chr12	8793598	8793629	3500155303	26		8793598	8793629	8421504	2	20,6	0,25	g	350015530300000022	1-27						Expanding the eukaryotic genetic code	Chin	2010	0		
654	chr12	9173878	9173911	3500231685	27		9173878	9173911	8421504	3	17,3,7	0,18,26	g	350023168500000459,350023168500000622,350023168500000457	9-36,9-35,10-36						Stress tolerance and delayed senescence in plants	Mccourt	2004	0		
657	chr12	9547295	9547321	3500160446	23		9547295	9547321	8421504	2	7,16	0,10	c	350016044600000157	1-24						COMPOSITIONS THAT BIND MULTIPLE EPITOPES OF IGF-1R	Glaser	2008	0		
657	chr12	9547347	9547372	3500057503	25		9547347	9547372	8421504	1	25	0	c	350005750300000083	0-25						Genomic Screen for Epigenetically Silenced Genes Associated With Cancer	Baylin	2009	0		
659	chr12	9706026	9711715	3500463792	362		9706026	9711715	8421504	3	18,131,213	0,19,5476	c,g	350046379200000005,350046379200000005,350046379200000003,350046379200000008,350046379200000006	0-117,0-117,0-357,19-290,0-222						Chondromodulin-I protein	Suzuki	1993	0		
662	chr12	10168054	10168079	3500126483	24		10168054	10168079	8421504	2	16,8	0,17	g	350012648300000665	0-24						MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - Patent application	www.faqs.org	0	0		
669	chr12	11015335	11015362	3500428877	23		11015335	11015362	8421504	3	11,7,5	0,14,22	g	350042887700000024	3-26						Recombinant fowlpox viruses and uses thereof	Cochran	1994	0		
672	chr12	11427985	11428008	3500443697	23		11427985	11428008	8421504	1	23	0	g	350044369700000002	4-28						Delta-5 Desaturase And Uses Thereof 	.freshpatents.com	0	0		
672	chr12	11466720	11473936	3500206937	42		11466720	11473936	8421504	3	1,21,20	0,81,7196	c,g	350020693700000016,350020693700000017,350020693700000017	0-22,0-20,0-20						terms and conditions of use	.era.lib.ed.ac.uk	0	0		
674	chr12	11683606	11686069	3500408375	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350040837500000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5437951)	Kirnbauer	1995	0		
674	chr12	11683606	11686069	3500330774	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350033077400000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5871998)	Kirnbauer	1999	0		
674	chr12	11683606	11686069	3500322850	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350032285000000011	7-33						 <HTML> <HEAD><TITLE>eaa*+-cuc<<a|cuaeaaaaa1/4aa|a$?a<<a1aaPSaa*aaec1/2e3	www.j-tokkyo.com	0	0		
674	chr12	11683606	11686069	3500259796	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350025979600000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5744142)	Kirnbauer	1998	0		
674	chr12	11683606	11686069	3500254998	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350025499800000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5985610)	Kirnbauer	1999	0		
674	chr12	11683606	11686069	3500225258	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350022525800000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5716620)	Kirnbauer	1998	0		
674	chr12	11683606	11686069	3500225015	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350022501500000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5437951)	Kirnbauer	1995	0		
674	chr12	11683606	11686069	3500092529	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350009252900000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5756284)	Kirnbauer	1998	0		
674	chr12	11683606	11686069	3500091312	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350009131200000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5871998)	Kirnbauer	1999	0		
674	chr12	11683606	11686069	3500083348	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350008334800000008	7-33					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5709996)	Kirnbauer	1998	0		
674	chr12	11683606	11686069	3500055245	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350005524500000027	7-33						Papilloma virus capsomere vaccine formulations and methods of use	Gissmann	1999	0		
674	chr12	11683606	11686069	3500003098	23		11683606	11686069	8421504	3	16,1,6	0,2455,2457	c	350000309800000008	7-33						Self-assembling recombinant papillomavirus capsid proteins	Lowy	1993	0		
676	chr12	11988935	11988961	3500337447	23		11988935	11988961	8421504	2	18,5	0,21	g	350033744700000002	14-37						Lipases preduodenales recombinantes et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations	Baudino	1996	0		
678	chr12	12272421	12272446	3500062015	24		12272421	12272446	8421504	2	10,14	0,11	g	350006201500000078	9-33						Human fgf receptor and beta-klotho binding proteins	Fachini	2013	0		
678	chr12	12272421	12272446	3500059779	24		12272421	12272446	8421504	2	10,14	0,11	g	350005977900000028	10-34						CE7-specific chimeric T cell receptor - Patent # 7265209 - PatentGenius	.patentgenius.com	0	0		
684	chr12	12998713	12998741	3500404568	24		12998713	12998741	8421504	3	5,5,14	0,6,14	c	350040456800000379	20-44						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - US Patent 7700341 Description	ww.patentstorm.us	0	0		
688	chr12	13517874	13517903	3500354416	25		13517874	13517903	8421504	3	5,5,15	0,8,14	g	350035441600000028	1-26						Studie van het celdoodproces in Candida albicans	lib.ugent.be	0	0		
689	chr12	13651347	13653194	3500135939	276		13651347	13653194	8421504	3	222,52,2	0,1387,1845	p	350013593900015014,350013593900015020	0-276,0-249						Oreochromis_mossambicus-Contig_7-v1 | MarineGenomics.org	arinegenomics.org	0	0		
691	chr12	14009461	14009491	3500230360	24		14009461	14009491	8421504	3	7,6,11	0,9,19	g	350023036000000008	0-24						METHOD FOR GENERATING PRIMATE CARDIOVASCULAR PROGENITOR CELLS FOR CLINICAL USE FROM PRIMATE EMBRYONIC STEM CELLS OR EMBRYONIC-LIKE STATE CELLS, AND THEIR APPLICATIONS - Patent application	www.faqs.org	0	0		
695	chr12	14455376	14456226	3500128937	48		14455376	14456226	8421504	3	20,3,25	0,39,825	c	350012893700000029,350012893700000028	0-20,0-28						The impact of reference gene selection in quantification of gene expression levels in guinea pig cervical tissues and cells	genomebiology.com	0	0		TPT1
695	chr12	14455391	14456725	3500055005	192		14455391	14456725	8421504	3	27,106,59	0,810,1275	p	350005500500015000	0-192						Histamine-releasing factor (hrf), hrf-receptor and methods of modulating inflammation	Kawakami	2013	0		TPT1
695	chr12	14456252	14456300	3500149195	48		14456252	14456300	8421504	1	48	0	p	350014919500015003	0-48						Method of diagnosing diseases relating to endometriosis	Kosugi	2004	0		TPT1
695	chr12	14456797	14456845	3500094716	48		14456797	14456845	8421504	1	48	0	p	350009471600015002	0-48						Materials and methods for detection of breast cancer	Keesee	1997	0		TPT1
695	chr12	14456840	14457485	3500353933	46		14456840	14457485	8421504	3	17,5,24	0,580,621	c	350035393300000001,350035393300000000	1-23,0-24						Effet d'extraits de plantes m&#xe9;dicinales sur la diff&#xe9;renciation cellulaire et le transport du calcium par les cellules syncytiotrophoblaste-like humaines	.archipel.uqam.ca	0	0		TPT1
699	chr12	15058593	15058620	3500224614	23		15058593	15058620	8421504	2	16,7	0,20	g	350022461400000015	20-43						Process for the preparation of non-toxic anthrax vaccine	Bhatnagar	2002	0		
700	chr12	15151892	15181469	3500443255	53		15151892	15181469	8421504	2	23,30	0,29547	c	350044325500000036,350044325500000018	8-31,0-30						US Patent # 5,206,161. Human plasma carboxypeptidase B - Patents.com	www.patents.com	0	0		
700	chr12	15151892	15181469	3500348547	53		15151892	15181469	8421504	2	23,30	0,29547	c	350034854700000036,350034854700000018	8-31,0-30						US Patent # 5,474,901. Antibodies to human carboxypeptidase B and methods of use thereof - Patents.com	www.patents.com	0	0		
700	chr12	15158232	15158262	3500088275	24		15158232	15158262	8421504	3	8,11,5	0,13,25	g	350008827500000030	20-48					Patent	Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides (Patent US:6051217)	Abrams	2000	0		
700	chr12	15159796	15159841	3500065768	45		15159796	15159841	8421504	1	45	0	c	350006576800000022	0-45						Baboon TAFI polypeptides - US Patent 7189829 Description	ww.patentstorm.us	0	0		
700	chr12	15181439	15181469	3500224783	30		15181439	15181469	8421504	1	30	0	c	350022478300000018	0-30					Patent	Human plasma carboxypeptidase B (Patent US:5206161)	Drayna	1993	0		
702	chr12	15390181	15390205	3500407097	24		15390181	15390205	8421504	1	24	0	c	350040709700000002	0-24						Detection of Germ line and Somatic Copy Number Variations in Cattle	ddr.nal.usda.gov	0	0		
702	chr12	15390295	15390762	3500388065	55		15390295	15390762	8421504	2	6,49	0,418	c	350038806500000014	0-58						A 1.3 kb Satellite DNA from Bubalus bubalis not Conserved Evolutionarily is Transcribed	.znaturforsch.com	0	0		
702	chr12	15390332	15390357	3500367859	25		15390332	15390357	8421504	1	25	0	c	350036785900000005	0-25						Biological markers and uses therefor	Spelman	2011	0		
702	chr12	15390623	15390647	3500308662	24		15390623	15390647	8421504	1	24	0	c	350030866200000085	0-24						DNA	.lib.kobe-u.ac.jp	0	0		
704	chr12	15678379	15678403	3500230330	23		15678379	15678403	8421504	2	16,7	0,17	g	350023033000000275	25-48						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
705	chr12	15794899	15795683	3500037451	48		15794899	15795683	8421504	2	24,24	0,760	c,g	350003745100000019,350003745100000019,350003745100000018	0-24,0-24,0-24						Comparative genomic imprinting a	www.docstoc.com	0	0		
705	chr12	15796460	15796907	3500411135	65		15796460	15796907	8421504	3	20,20,25	0,130,422	c,g	350041113500000007,350041113500000006,350041113500000006,350041113500000001	0-20,0-20,0-20,5-30						Canine 5-hydroxytryptamine 2a and 2b receptor materials and thier use	Bonaventure	2006	0		
705	chr12	15796460	15796907	3500038386	65		15796460	15796907	8421504	3	20,20,25	0,130,422	c,g	350003838600000007,350003838600000006,350003838600000006,350003838600000001	0-20,0-20,0-20,5-30						European Journal of Pharmacology	005.pasteur.ac.ir	0	0		
705	chr12	15796460	15796907	3500022156	65		15796460	15796907	8421504	3	20,20,25	0,130,422	c,g	350002215600000007,350002215600000006,350002215600000006,350002215600000001	0-20,0-20,0-20,5-30						Canine 5-hydroxytryptamine 2a And 2b Receptor Materials And Their Use 	.freshpatents.com	0	0		
705	chr12	15796484	15796724	3500365441	94		15796484	15796724	8421504	2	47,47	0,193	c	350036544100000064,350036544100000060	1-48,0-47						Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path - Patent # 5854004 - PatentGenius	.patentgenius.com	0	0		
705	chr12	15796556	15796604	3500045595	48		15796556	15796604	8421504	1	48	0	p	350004559500015120	0-48						Dna encoding a human 5-ht 1e? receptor and uses thereof	Branchek	1994	0		HTR2A
705	chr12	15797057	15855411	3500282007	48		15797057	15855411	8421504	2	35,13	0,58341	p	350028200700015013	0-48						Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabh&#xe4;ngigen zellul&#xe4;ren signal&#xfc;bertragungsweg	Czernilofsky	1993	0		HTR2A
705	chr12	15797057	15855411	3500077273	48		15797057	15855411	8421504	2	35,13	0,58341	p	350007727300015013	0-48						Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabh&#xe4;ngigen zellul&#xe4;ren signal&#xfc;bertragungsweg	Czernilofsky	1993	0		HTR2A
705	chr12	15855483	15855555	3500282007	72		15855483	15855555	8421504	1	72	0	p	350028200700015040,350028200700015010	0-48,0-48						Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabh&#xe4;ngigen zellul&#xe4;ren signal&#xfc;bertragungsweg	Czernilofsky	1993	0		
88	chr12	15859223	15859867	3500185530	46		15859223	15859867	8421504	2	23,23	0,621	c	350018553000000003,350018553000000002	0-23,0-23		19654143	10.1677/JOE-09-0187	0022-0795	Journal of Endocrinology	The bovine mammary gland expresses multiple functional isoforms of serotonin receptors	Hernandez	2009	4		
705	chr12	15859548	15859574	3500179336	26		15859548	15859574	8421504	1	26	0	c	350017933600000013	17-43						Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex | Ryan Smith - Academia.edu	www.academia.edu	0	0		
712	chr12	16732359	16732388	3500044638	24		16732359	16732388	8421504	2	15,9	0,20	g	350004463800000050	11-35						Recombinant n-propanol and isopropanol production	Grotkjaer	2012	0		
713	chr12	16822624	16822651	3500101373	24		16822624	16822651	8421504	2	19,5	0,22	g	350010137300000025	0-26						NOVEL SHIGELLA PROTEIN ANTIGENS AND METHODS - Patent application	www.faqs.org	0	0		
715	chr12	17145933	17153562	3500042549	2148		17145933	17153562	8421504	8	78,67,164,162,110,196,115,1256	0,125,1445,2285,2920,4439,5376,6373	g	350004254900000055	0-2148						ISOLATION OF THE T-COMPLEX DISTORTERS AND APPLICATIONS THEREOF - Patent application	www.faqs.org	0	0		
717	chr12	17351008	17375698	3500296749	46		17351008	17375698	8421504	2	23,23	0,24667	c	350029674900000004,350029674900000005	0-23,0-23						Method of examining allergic diseases	MATSUI	2002	0		ITM2B
717	chr12	17351008	17375698	3500214159	46		17351008	17375698	8421504	2	23,23	0,24667	c	350021415900000004,350021415900000005	0-23,0-23						Method of examining allergic diseases	Matsui	2003	0		ITM2B
717	chr12	17372544	17373512	3500337725	49		17372544	17373512	8421504	2	23,26	0,942	c,g	350033772500000009,350033772500000009,350033772500000010	0-23,0-23,0-26						Felipe Camargo Braga TESE	www.teses.usp.br	0	0		ITM2B
717	chr12	17372566	17373538	3500404944	40		17372566	17373538	8421504	2	20,20	0,952	c,g	350040494400000016,350040494400000016,350040494400000017,350040494400000017	0-20,0-20,0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
717	chr12	17372583	17373514	3500074470	48		17372583	17373514	8421504	3	15,5,28	0,879,903	c	350007447000000011,350007447000000010	0-20,21-49						L&#xcd;GIA GARCIA MESQUITA	www.teses.usp.br	0	0		
718	chr12	17432918	17432942	3500272744	24		17432918	17432942	8421504	1	24	0	c,g	350027274400000000,350027274400000000	6-30,6-30		19555499	10.1186/1471-2121-10-50		BMC Cell Biology	Evidence for a mitochondrial localization of the retinoblastoma protein	Ioana	2009	0		RB1
718	chr12	17435854	17546145	3500456121	421		17435854	17546145	8421504	11	87,9,29,19,27,18,41,9,39,48,95	0,23082,23139,23169,58190,98698,102048,103703,104340,105231,110196	p,c	350045612100000040,350045612100000041,350045612100000043,350045612100015094,350045612100000076,350045612100000080,350045612100000087,350045612100000089,350045612100000090	0-48,0-48,0-48,0-45,0-41,0-48,0-48,0-48,0-47						METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
718	chr12	17476486	17476546	3500098146	60		17476486	17476546	8421504	1	60	0	p	350009814600015000	3-63						Gene therapy for cell proliferative diseases	Fung	1991	0		RB1
718	chr12	17494035	17494058	3500002351	23		17494035	17494058	8421504	1	23	0	c	350000235100000110	0-23						POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF	Dongxu	2008	0		RB1
718	chr12	17539560	17540245	3500071086	57		17539560	17540245	8421504	2	6,51	0,634	p	350007108600015008	0-57						MATERIALS AND METHODS RELATING TO THE INTERACTION OF P53 AND MDM2 - WALLACE, Maura	www.sumobrain.com	0	0		RB1
718	chr12	17541095	17541119	3500117444	24		17541095	17541119	8421504	1	24	0	c	350011744400000004	0-24						J. Cell. Mol. Med. Vol 12, No	www.scribd.com	0	0		RB1
718	chr12	17546041	17546738	3500343021	168		17546041	17546738	8421504	3	90,41,37	0,102,660	p	350034302100015052,350034302100015053	0-90,0-78						AGENTS PROVIDING CONTROLS AND STANDARDS FOR IMMUNO-PRECIPITATION ASSAYS	Bernstein	2013	0		RB1
718	chr12	17546098	17546149	3500366951	51		17546098	17546149	8421504	1	51	0	p	350036695100015007	0-51						METHOD FOR DETECTING INTERACTIONS BETWEEN TWO AND MORE BIOLOGICAL MACROMOLECULES	Lee	2009	0		RB1
718	chr12	17546098	17546149	3500100434	51		17546098	17546149	8421504	1	51	0	p	350010043400015004	0-51						METHOD FOR DETECTING INTERACTIONS BETWEEN TWO AND MORE BIOLOGICAL MACROMOLECULES - Patent application	www.faqs.org	0	0		RB1
718	chr12	17546113	17550208	3500029729	40		17546113	17550208	8421504	2	20,20	0,4075	c,g	350002972900000008,350002972900000008,350002972900000009	0-20,0-20,0-20						Biallelicmutationof SOCS-1 impairsJAK2degradationandsustains phospho-JAK2actionintheMedB-1mediastinallymphomaline	tologylibrary.org	0	0		RB1
718	chr12	17546113	17550208	3500006015	40		17546113	17550208	8421504	2	20,20	0,4075	c,g	350000601500000040,350000601500000040,350000601500000041,350000601500000041	0-20,0-20,0-20,0-20						PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1. - ResearchGate	.researchgate.net	0	0		RB1
718	chr12	17546116	17546161	3500040408	45		17546116	17546161	8421504	1	45	0	p	350004040800015001	0-45		21233209	10.1074/jbc.M110.173872		The Journal of Biological Chemistry	Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition	Maria	2011	0		RB1
718	chr12	17546131	17546711	3500199633	63		17546131	17546711	8421504	2	53,10	0,570	p	350019963300015007,350019963300015015	0-60,0-57						Mutants of the Rb and p53 genes and uses thereof	Fung	1997	0		RB1
718	chr12	17546131	17546708	3500436137	60		17546131	17546708	8421504	2	53,7	0,570	p	350043613700015025,350043613700015013	0-45,0-60						Mutants of the Rb and p53 genes and uses thereof	Fung	1995	0		RB1
718	chr12	17552206	17552230	3500088539	24		17552206	17552230	8421504	1	24	0	c	350008853900000000	0-24						Original article Development and assignment of bovine-speci&#x02dd;c PCR systems for the Texas nomenclature marker genes and isolation of homologous BAC probes	w.gse-journal.org	0	0		RB1
719	chr12	17690810	17690837	3500300397	26		17690810	17690837	8421504	2	13,13	0,14	g	350030039700000028	0-40						Methods and compositions for polypeptide engineering	Patten	2005	0		
719	chr12	17690810	17690837	3500129817	26		17690810	17690837	8421504	2	13,13	0,14	g	350012981700000028	0-40						Methods and compositions for polypeptide engineering	Patten	2006	0		
719	chr12	17690810	17690837	3500030062	26		17690810	17690837	8421504	2	13,13	0,14	g	350003006200000028	0-40						Methods and compositions for polypeptide engineering	Patten	2006	0		
723	chr12	18133996	18136576	3500291981	40		18133996	18136576	8421504	2	20,20	0,2560	c,g	350029198100000016,350029198100000016,350029198100000017	0-20,0-20,0-20						MIR-182 IN THE DIAGNOSIS AND TREATMENT OF CANCER	Chowdhury	2011	0		
726	chr12	18525938	18525963	3500005314	24		18525938	18525963	8421504	2	5,19	0,6	g	350000531400000495	19-44						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
726	chr12	18559008	18559032	3500441689	24		18559008	18559032	8421504	1	24	0	c	350044168900000155	22-46						Patent Search: US Patent Number 8168602 - Compositions, kits and methods for identification, assessment, prevention and therapy of cancer	ww.archpatent.com	0	0		
728	chr12	18813077	18813284	3500168448	82		18813077	18813284	8421504	3	23,32,27	0,146,180	c,g	350016844800000042,350016844800000042,350016844800000040,350016844800000073,350016844800000073,350016844800000074,350016844800000074,350016844800000067,350016844800000067,350016844800000037,350016844800000037	0-23,0-23,0-22,0-19,0-19,0-27,0-27,0-22,0-22,0-22,0-22						Oligomeric compounds and compositions for use in modulation of small non-coding rnas	Baker	2005	0		DLEU2
728	chr12	18813095	18813276	3500131869	55		18813095	18813276	8421504	2	21,34	0,147	c,g	350013186900000008,350013186900000010,350013186900000010,350013186900000005,350013186900000005	0-21,0-19,0-19,0-22,0-22						THE J BIOLOGICAL C &#xa9; 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Depletion of Human Micro-RNA miR-125b Reveals That It Is Critical for the Proliferation of Differentiated Cells but Not for the Down- reg	www.jbc.org	0	0		DLEU2
728	chr12	18813258	18813281	3500025704	23		18813258	18813281	8421504	1	23	0	c	350002570400000002	0-23						METHODS FOR QUANTIFYING MICRORNA PRECURSORS	Schmittigen	2006	0		DLEU2
728	chr12	18813265	18813293	3500070906	28		18813265	18813293	8421504	1	28	0	c,g	350007090600000014,350007090600000014	0-28,0-28		15372072	10.1038/sj.emboj.7600385	ERROR! NO ISSN	The EMBO Journal	MicroRNA genes are transcribed by RNA polymerase II	Lee	2004	0		
729	chr12	18931757	18931781	3500155579	23		18931757	18931781	8421504	2	18,5	0,19	g	350015557900000000	0-24		10026225	10.1074/jbc.274.9.5987	0021-9258	Journal of Biological Chemistry	Properties of Filament-bound Myosin Light Chain Kinase	Lin	1999	5		
731	chr12	19155112	19155137	3500283078	24		19155112	19155137	8421504	2	12,12	0,13	g	350028307800000002	21-45						Clonal multidrug-resistant Corynebacterium striatum within a nosocomial environment, Rio de Janeiro, Brazil	as.ioc.fiocruz.br	0	0		
731	chr12	19249253	19249277	3500303658	23		19249253	19249277	8421504	2	19,4	0,20	g	350030365800000005	20-43		15163704	10.1128/JVI.78.12.6112-6121.2004	0022-538X	Journal of Virology	Characterization of the Polymerase and RNase H Activities of Human Foamy Virus Reverse Transcriptase	Boyer	2004	5		
739	chr12	20226355	20226384	3500393957	24		20226355	20226384	8421504	2	16,8	0,21	c	350039395700000017	16-40			10.1128/MCB.22.24.8539-8551.2002		Molecular and Cellular Biology	Early B-Cell Factor, E2A, and Pax-5 Cooperate To Activate the Early B Cell-Specific mb-1 Promoter	MikaSigvardsson	2002	0		
743	chr12	20720960	20720986	3500098010	23		20720960	20720986	8421504	2	8,15	0,11	c	350009801000000003	3-26						Aus der Klinik f&#xfc;r Gastroenterologie mit Sektionen Infektiologie und Tropenmedizin	ub.uni-hamburg.de	0	0		
743	chr12	20721101	20721224	3500311219	59		20721101	20721224	8421504	2	22,37	0,86	c	350031121900000294,350031121900000296	21-43,11-48						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
743	chr12	20740020	20740046	3500048995	24		20740020	20740046	8421504	2	17,7	0,19	g	350004899500000001	0-24			10.1172/JCI24030	0021-9738	The Journal of Clinical Investigation	Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities	Lay	2005	13		
744	chr12	20966173	20966198	3500165384	23		20966173	20966198	8421504	2	17,6	0,19	c	350016538400000916	13-36						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
745	chr12	20979904	20979930	3500199445	25		20979904	20979930	8421504	2	19,6	0,20	c	350019944500000021	14-39						Desaturase genes and uses thereof	Mukerji	2002	0		
746	chr12	21105164	21105193	3500195441	23		21105164	21105193	8421504	3	6,4,13	0,11,16	g	350019544100000130	3-27						PUUMALA VIRUS FULL-LENGTH M SEGMENT-BASED DNA VACCINES	Hooper	2008	0		
746	chr12	21228216	21228242	3500408649	23		21228216	21228242	8421504	2	10,13	0,13	c	350040864900000155	2-25						HBM variants that modulate bone mass and lipid levels	Allen	2008	0		MRPS31
759	chr12	22919241	22919273	3500153276	27		22919241	22919273	8421504	3	15,5,7	0,16,25	g	350015327600000513	0-28						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
762	chr12	23213546	23219092	3500346732	63		23213546	23219092	8421504	2	34,29	0,5517	p	350034673200015037	27-90						ANNUAL REPORT 2009-2010	instpath.gov.in	0	0		UFM1
765	chr12	23701171	23701200	3500417867	24		23701171	23701200	8421504	2	18,6	0,23	g	350041786700000070	1-26						Methods for degrading or converting plant cell wall polysaccharides - US Patent 7413882 Description	ww.patentstorm.us	0	0		
766	chr12	23734419	23742072	3500450003	45		23734419	23742072	8421504	2	22,23	0,7630	c,g	350045000300000004,350045000300000004,350045000300000005,350045000300000005	0-22,0-22,0-23,0-23		20668213	10.1152/ajpcell.00036.2010		American Journal of Physiology - Cell Physiology	Somatic ATP release from guinea pig sympathetic neurons does not require calcium-induced calcium release from internal stores	Laura	2010	0		TRPC4
766	chr12	23734419	23742072	3500002946	45		23734419	23742072	8421504	2	22,23	0,7630	c,g	350000294600000004,350000294600000004,350000294600000005	0-22,0-22,0-23		20668213	10.1152/ajpcell.00036.2010		American Journal of Physiology - Cell Physiology	Somatic ATP release from guinea pig sympathetic neurons does not require calcium-induced calcium release from internal stores	Merriam	2010	0		TRPC4
766	chr12	23756673	23757267	3500193255	40		23756673	23757267	8421504	2	20,20	0,574	c	350019325500000002,350019325500000003	0-20,0-20		15044151	10.1152/ajpcell.00068.2004		American Journal of Physiology - Cell Physiology	TRPC4 forms store-operated Ca2+ channels in mouse mesangial cells	Wang	2004	0		
766	chr12	23807056	23838373	3500438841	392		23807056	23838373	8421504	12	5,65,1,27,11,45,57,36,6,44,84,11	0,3128,5196,7558,8447,11802,16678,17131,18160,26323,26751,31306	c	350043884100000105,350043884100000008,350043884100000015,350043884100000125,350043884100000038,350043884100000136,350043884100000043,350043884100000290,350043884100000051,350043884100000100,350043884100000241,350043884100000052,350043884100000194,350043884100000242	3-44,0-44,0-38,0-45,0-41,0-42,0-42,11-45,0-45,0-25,0-42,0-42,0-45,0-45						 Periostin 	www.docstoc.com	0	0		
766	chr12	23812272	23823793	3500182305	269		23812272	23823793	8421504	6	32,50,47,48,7,85	0,2213,3315,6586,10915,11436	c	350018230500000016,350018230500000071,350018230500000122,350018230500000076,350018230500000127,350018230500000086,350018230500000147,350018230500000097	0-35,0-48,0-47,0-47,0-44,0-48,0-48,0-47						Protein with bone formation ability and process for its production	Amann	1995	0		
766	chr12	23818814	23818879	3500022437	41		23818814	23818879	8421504	2	20,21	0,44	c,g	350002243700000020,350002243700000020,350002243700000021,350002243700000021	0-20,0-20,0-21,0-21						ONLINE MATERIALS AND METHODS	b.ahajournals.org	0	0		
766	chr12	23820149	23823091	3500156222	48		23820149	23823091	8421504	2	24,24	0,2918	c	350015622200000000,350015622200000001	0-24,0-24						Periostin: a promising target of therapeutical intervention for prostate cancer	onal-medicine.com	0	0		POSTN
766	chr12	23832570	23838371	3500225836	40		23832570	23838371	8421504	4	19,1,11,9	0,775,1310,5792	c	350022583600000004,350022583600000005	0-20,0-20		19248097	10.1002/art.24330	1529-0131	Arthritis & Rheumatism	Stromal cell&#x2013;derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model - Kitaori - 2009 - Arthritis & Rheumatism - Wiley Online Library	Kitaori	2009	0		POSTN
770	chr12	24341874	24341901	3500083716	23		24341874	24341901	8421504	2	7,16	0,11	g	350008371600000243	14-37					Patent	Streptococcus pneumoniae antigens and vaccines (Patent US:6573082)	Choi	2003	0		
770	chr12	24376302	24378770	3500442253	48		24376302	24378770	8421504	2	30,18	0,2450	p	350044225300015023	0-48						Inhibition Of Smad3 To Prevent Fibrosis And Improve Wound Healing 	.freshpatents.com	0	0		SMAD5
770	chr12	24378821	24378884	3500254584	63		24378821	24378884	8421504	1	63	0	p	350025458400015015	3-66						Methods, reagents, kits and apparatus for protein function analysis	Biebuyck	2004	0		SMAD5
770	chr12	24378821	24378884	3500041602	63		24378821	24378884	8421504	1	63	0	p	350004160200015028	3-66					Patent	Methods, reagents, kits and apparatus for protein function analysis (Patent US:7063946)	Kenten	2006	0		SMAD5
770	chr12	24378821	24378884	3500041347	63		24378821	24378884	8421504	1	63	0	p	350004134700015031	3-66						METHODS, REAGENTS, KITS AND APPARATUS FOR PROTEIN FUNCTION ANALYSIS - MESO SCALE TECHNOLOGIES, LLC	www.sumobrain.com	0	0		SMAD5
771	chr12	24379477	24379503	3500259202	23		24379477	24379503	8421504	2	6,17	0,9	c	350025920200000324	12-36						Nematode Control	Craen	2010	0		
775	chr12	24930430	24953430	3500110272	450		24930430	24953430	8421504	10	45,45,45,45,45,45,45,45,45,45	0,48,96,192,240,22715,22811,22859,22907,22955	p,c,g	350011027200015007,350011027200015008,350011027200015009,350011027200015011,350011027200015012,350011027200000016,350011027200000016,350011027200000037,350011027200000081,350011027200000081,350011027200015014,350011027200015016,350011027200015017,350011027200015018,350011027200015019	0-45,0-45,0-45,0-45,0-45,0-19,0-19,0-19,0-19,0-19,0-45,0-45,0-45,0-45,0-45						COMPOSITIONS USEFUL FOR CANCER DETECTION AND TREATMENT, A CANCER STEM CELL MODEL, AND METHODS OF PRODUCTION AND USE THEREOF - Patent application	www.faqs.org	0	0		
775	chr12	24930430	24953430	3500107199	405		24930430	24953430	8421504	9	45,45,45,45,45,45,45,45,45	0,96,192,240,22715,22811,22859,22907,22955	p,c	350010719900015003,350010719900015005,350010719900015007,350010719900015008,350010719900000014,350010719900000000,350010719900015010,350010719900015012,350010719900015013,350010719900015014,350010719900015015	0-45,0-45,0-45,0-45,0-19,0-19,0-45,0-45,0-45,0-45,0-45						Identification of gastrointestinal, pancreatic and cancer stem cell markers and methods of use thereof - Patent application	www.faqs.org	0	0		
775	chr12	24930475	24953382	3500294229	144		24930475	24953382	8421504	3	48,48,48	0,192,22859	p	350029422900015005,350029422900015013,350029422900015024	0-48,0-48,0-48						Novel mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapy	Kuik-Romeijn	2006	0		
775	chr12	24930667	24953382	3500351654	96		24930667	24953382	8421504	2	48,48	0,22667	p	350035165400015015,350035165400015026	0-48,0-48						mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapy	Vreugdenhil	2005	0		DCLK2
775	chr12	24930667	24953382	3500140068	96		24930667	24953382	8421504	2	48,48	0,22667	p	350014006800015015,350014006800015026	0-48,0-48						NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN	Platenburg	2011	0		DCLK2
777	chr12	25250028	25250052	3500070923	23		25250028	25250052	8421504	2	9,14	0,10	g	350007092300000012	10-36		19734146	10.1074/jbc.M109.014506	0021-9258	Journal of Biological Chemistry	Speckled-like Pattern in the Germinal Center (SLIP-GC), a Nuclear GTPase Expressed in Activation-induced Deaminase-expressing Lymphomas and Germinal Center B Cells	Richter	2009	5		
777	chr12	25250028	25250052	3500034211	23		25250028	25250052	8421504	2	9,14	0,10	g	350003421100000012	10-36						1&#xb6; , Laurent Verkoczy , and Marilyn Diaz Both authors contributed equally	www.jbc.org	0	0		
780	chr12	25582927	25582951	3500130848	23		25582927	25582951	8421504	2	6,17	0,7	c	350013084800000701	1-24						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
783	chr12	26003157	26003183	3500005314	23		26003157	26003183	8421504	2	10,13	0,13	g	350000531400000177	8-33						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
788	chr12	26661750	26661778	3500429819	24		26661750	26661778	8421504	2	12,12	0,16	g	350042981900000150	16-40						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
788	chr12	26703893	26703917	3500102026	23		26703893	26703917	8421504	2	13,10	0,14	g	350010202600000110,350010202600000394	15-39,15-39						Compositions and methods for vaccination against coronaviruses	Jones	1993	0		
791	chr12	27086096	27086122	3500137915	23		27086096	27086122	8421504	3	12,7,4	0,14,22	c	350013791500000290	8-32						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
796	chr12	27745332	27745357	3500323086	25		27745332	27745357	8421504	1	25	0	c	350032308600000000,350032308600000001	0-25,0-25		23364520	10.1038/ki.2012.482	0085-2538	Kidney International	Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release	Dai	2013	7		
796	chr12	27745332	27745357	3500056536	25		27745332	27745357	8421504	1	25	0	c	350005653600000001,350005653600000000	0-25,0-25						Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. - ResearchGate	.researchgate.net	0	0		
796	chr12	27745332	27745357	3500033778	25		27745332	27745357	8421504	1	25	0	c,g	350003377800000000,350003377800000000,350003377800000001,350003377800000001	0-25,0-25,0-25,0-25		23364520	10.1038/ki.2012.482	0085-2538	Kidney International	Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release	Dai	2013	7		
796	chr12	27753879	27753908	3500464718	29		27753879	27753908	8421504	1	29	0	c	350046471800000001	0-29		20642846	10.1186/1756-9966-29-99		Journal of Experimental & Clinical Cancer Research : CR	Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549	Bo	2010	0		
796	chr12	27753879	27753908	3500458764	29		27753879	27753908	8421504	1	29	0	c	350045876400000001	0-29		23437382	10.1371/journal.pone.0057391	1932-6203	PLOS ONE	PLOS ONE: Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway	Wang	2013	4		
796	chr12	27753879	27753908	3500376691	29		27753879	27753908	8421504	1	29	0	c	350037669100000001	0-29						Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549	www.jeccr.com	0	0		
796	chr12	27780589	27780618	3500186547	24		27780589	27780618	8421504	2	14,10	0,19	c	350018654700000259	13-37						Polycystic kidney disease gene and protein	Klinger	1996	0		
797	chr12	27840168	27840292	3500190572	42		27840168	27840292	8421504	2	19,23	0,101	g	350019057200000027,350019057200000026	0-19,0-23						Conservation of Microsatellite Loci across Species of Artiodactyls: Implications for Population Studies	www.jstor.org	0	0		
800	chr12	28228093	28228116	3500200895	23		28228093	28228116	8421504	1	23	0	g	350020089500000198	0-42						 Chemoreceptors In Plant Parasitic Nematodes 	www.docstoc.com	0	0		
12	chr12	28309718	28325557	3500095165	55		28309718	28325557	8421504	2	19,36	0,15803	g	350009516500000238,350009516500000199	0-19,12-48						Chromosome 13-linked breast cancer susceptibility gene		1997	0		
12	chr12	28309718	28324608	3500339718	90		28309718	28324608	8421504	3	19,23,48	0,6226,14842	g	350033971800000228,350033971800000224,350033971800000194	0-19,25-48,0-48						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1998	0		
811	chr12	29673236	29673262	3500267336	25		29673236	29673262	8421504	2	21,4	0,22	g	350026733600000041	0-25						Protein Glycosylation Modification In Methylotrophic Yeast 	.freshpatents.com	0	0		
814	chr12	30027797	30029719	3500436580	42		30027797	30029719	8421504	2	4,38	0,1884	c	350043658000000000,350043658000000001	0-42,11-30						Methods of diagnosing sepsis by measuring HMG1	Tracey	2005	0		
814	chr12	30027797	30029719	3500316309	42		30027797	30029719	8421504	2	4,38	0,1884	c	350031630900000000	0-42						Antagonists of HMG1 for treating inflammatory conditions	Tracey	2003	0		
814	chr12	30027797	30029719	3500195198	42		30027797	30029719	8421504	2	4,38	0,1884	c	350019519800000000	0-42						Methods for diagnosing sepsis	www.devileye.net	0	0		HMGB1
814	chr12	30027797	30029719	3500155274	42		30027797	30029719	8421504	2	4,38	0,1884	c	350015527400000000	0-42						Methods for diagnosing sepsis	Tracey	1999	0		HMGB1
814	chr12	30028538	30028564	3500000430	25		30028538	30028564	8421504	2	8,17	0,9	g	350000043000000326	1-30						Nucleic acid sequence and methods for selectively expressing a protein in a target cell or tissue	Frazer	2000	0		
814	chr12	30029694	30031990	3500225280	142		30029694	30031990	8421504	4	19,21,24,78	0,1101,1146,2218	p,c	350022528000000000,350022528000000003,350022528000015000	8-27,8-30,0-102		12183440		0008-5472	Cancer Research	Receptor for Advanced Glycation End Products-binding COOH-terminal Motif of Amphoterin Inhibits Invasive Migration and Metastasis	Huttunen	2002	8		
814	chr12	30029694	30029720	3500106951	26		30029694	30029720	8421504	1	26	0	c	350010695100000000	31-57						Metaphase Chromosome Tethering Is Necessary for the DNA Synthesis and Maintenance of oriP Plasmids but Is Insuf&#xfb01;cient for Transcription Activation by Epstein-Barr Nuclear Antigen 1	jvi.asm.org	0	0		DMRTA2,HMGB1
814	chr12	30029694	30029720	3500077341	26		30029694	30029720	8421504	1	26	0	c	350007734100000000	31-57		14557661	10.1128/JVI.77.21.11767-11780.2003	0022-538X	Journal of Virology	Metaphase Chromosome Tethering Is Necessary for the DNA Synthesis and Maintenance of oriP Plasmids but Is Insufficient for Transcription Activation by Epstein-Barr Nuclear Antigen 1	Sears	2003	5		HMGB1,ACACA
814	chr12	30029695	30032086	3500208810	638		30029695	30032086	8421504	5	150,146,175,146,21	0,376,994,2217,2370	p,c	350020881000015100,350020881000000000,350020881000015114,350020881000000010,350020881000000018,350020881000015021,350020881000015023,350020881000015027,350020881000015012,350020881000015088,350020881000015030,350020881000015028,350020881000015062,350020881000015133,350020881000015000,350020881000015172,350020881000015024,350020881000015047,350020881000015173,350020881000015090,350020881000015008,350020881000015063,350020881000015033,350020881000015120,350020881000015038,350020881000015073,350020881000000006,350020881000015015,350020881000015013,350020881000015016,350020881000015019,350020881000015159,350020881000015025,350020881000015076,350020881000015053,350020881000015070,350020881000015074,350020881000015094,350020881000015077,350020881000015065,350020881000015054,350020881000015026,350020881000015075,350020881000015078,350020881000000003,350020881000000013,350020881000000014	0-93,1-22,0-45,1-22,0-604,0-123,0-105,0-90,0-240,0-93,0-198,0-156,0-78,0-93,0-150,0-48,0-441,0-45,0-45,0-45,0-60,0-48,0-48,0-48,0-48,0-45,0-21,0-210,0-210,0-210,0-270,0-72,0-132,0-87,0-90,3-183,3-90,0-147,0-45,0-48,0-129,0-90,0-117,0-45,11-32,11-32,7-28						US Patent # 7,304,034. Use of HMGB fragments as anti-inflammatory agents - Patents.com	www.patents.com	0	0		
814	chr12	30029695	30032041	3500446558	600		30029695	30032041	8421504	4	150,146,175,129	0,376,994,2217	p	350044655800015000,350044655800015001,350044655800015007,350044655800015003,350044655800015004,350044655800015008	0-597,0-600,0-165,0-231,0-222,0-207						Antagonists Of Hmgb1 And/or Rage And Methods Of Use Thereof 	.freshpatents.com	0	0		HMGB1
814	chr12	30029695	30032041	3500440473	600		30029695	30032041	8421504	4	150,146,175,129	0,376,994,2217	p,c	350044047300015000,350044047300015004,350044047300015003,350044047300015008,350044047300000000,350044047300015002,350044047300015007,350044047300015001,350044047300015005	0-600,0-231,0-150,3-54,0-21,0-222,0-54,0-150,0-54						Immunogenic Compositions Comprising Hmgb 1 Polypeptides 	.freshpatents.com	0	0		
814	chr12	30029695	30032041	3500421157	600		30029695	30032041	8421504	4	150,146,175,129	0,376,994,2217	p	350042115700015000,350042115700015002,350042115700015004,350042115700015014,350042115700015001,350042115700015005,350042115700015015	0-237,0-600,0-231,0-231,0-360,0-222,0-207						JP 2009-517404 A 2009.4	biosciencedbc.jp	0	0		HMGB1
814	chr12	30029695	30032041	3500339917	600		30029695	30032041	8421504	4	150,146,175,129	0,376,994,2217	p,c	350033991700015007,350033991700015010,350033991700015008,350033991700000000,350033991700015011,350033991700000006,350033991700015006,350033991700015000,350033991700015002,350033991700015003,350033991700015009,350033991700000003	0-600,0-255,0-546,1-22,0-231,0-21,0-270,0-210,0-210,0-210,0-222,11-32						Use of hmgb polypetides for increasing immune responses	Tracey	2003	0		
814	chr12	30029695	30032041	3500156107	600		30029695	30032041	8421504	4	150,146,175,129	0,376,994,2217	p	350015610700015002,350015610700015000,350015610700015009,350015610700015010,350015610700015005,350015610700015006,350015610700015011,350015610700015003,350015610700015001	0-294,0-450,0-153,0-66,0-63,0-222,0-207,0-147,0-141						HIGH AFFINITY ANTIBODIES AGAINST HMGB1 AND METHODS OF USE THEREOF - MEDIMMUNE, INC.	www.sumobrain.com	0	0		
814	chr12	30029695	30032041	3500091901	600		30029695	30032041	8421504	4	150,146,175,129	0,376,994,2217	p,c	350009190100000010,350009190100015020,350009190100015140,350009190100015021,350009190100015023,350009190100015025,350009190100000000,350009190100015011,350009190100015197,350009190100015024,350009190100015111,350009190100015198,350009190100015107,350009190100015061,350009190100015000,350009190100015199,350009190100015108,350009190100015064,350009190100015200,350009190100015109,350009190100015067,350009190100015148,350009190100000016,350009190100000006,350009190100015018,350009190100015015,350009190100015014,350009190100015179,350009190100015012,350009190100015022,350009190100015069,350009190100015029,350009190100015087,350009190100015071,350009190100015092,350009190100015072,350009190100015115,350009190100015031,350009190100015097,350009190100015073,350009190100015202,350009190100015036,350009190100015125,350009190100000013,350009190100000003,350009190100015041	1-22,0-600,0-45,0-546,0-255,0-48,1-22,0-240,0-48,0-231,0-45,0-48,0-48,0-48,0-150,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-21,0-21,0-270,0-210,0-210,0-48,0-210,0-222,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,3-48,11-32,11-32,0-48						Use of HMGB fragments as anti-inflammatory agents - Patent application	www.faqs.org	0	0		HMGB1
814	chr12	30029695	30032017	3500221685	576		30029695	30032017	8421504	4	150,146,175,105	0,376,994,2217	p	350022168500015126,350022168500015128,350022168500015150,350022168500015130,350022168500015151,350022168500015132,350022168500015152,350022168500015134,350022168500015136,350022168500015153,350022168500015138,350022168500015154,350022168500015140,350022168500015155,350022168500015142,350022168500015156,350022168500015144,350022168500015146,350022168500015148	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Rage protein derivatives - Patent application	www.faqs.org	0	0		
814	chr12	30029695	30031987	3500249093	540		30029695	30031987	8421504	5	126,18,146,175,75	0,132,376,994,2217	p,c	350024909300015011,350024909300015014,350024909300000000,350024909300015012,350024909300015015,350024909300015018,350024909300015020,350024909300000006,350024909300015009,350024909300015016,350024909300015004,350024909300015013,350024909300015002,350024909300015005,350024909300000003	0-120,0-126,1-22,3-144,0-405,0-87,0-51,0-21,0-240,0-219,0-210,3-156,0-120,0-120,11-32						Use of hmgb polypeptides for increasing immune responses	Tracey	2005	0		
814	chr12	30029695	30031987	3500180393	546		30029695	30031987	8421504	4	150,146,175,75	0,376,994,2217	p,c	350018039300000000,350018039300015022,350018039300015026,350018039300015024,350018039300015013,350018039300015027,350018039300015002,350018039300000006,350018039300015020,350018039300015025,350018039300015017,350018039300015014,350018039300015016,350018039300000003	1-22,0-156,0-246,0-546,0-240,0-231,0-150,0-21,0-270,0-222,0-210,0-210,0-210,11-32						HMGB1 combination therapies	Newman	2003	0		
814	chr12	30029719	30030107	3500324960	162		30029719	30030107	8421504	2	126,36	0,352	p	350032496000015004	156-318						Edwin Kamau- DNA Supercoiling with a Twist	www.scribd.com	0	0		HMGB1
814	chr12	30029737	30029762	3500048899	25		30029737	30029762	8421504	1	25	0	c	350004889900000001	0-25			10.1371/journal.pone.0066527		PLoS ONE	Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice	Roberta	2013	0		HMGB1
814	chr12	30029746	30030107	3500332150	105		30029746	30030107	8421504	3	60,9,36	0,90,325	p	350033215000015009,350033215000015011	0-60,0-45						DNA SUPERCOILING WITH A TWIST	etd.lsu.edu	0	0		HMGB1
814	chr12	30029755	30030101	3500083587	120		30029755	30030101	8421504	2	90,30	0,316	p	350008358700015001,350008358700015002	0-60,0-60						PREDICTED: Mus musculus similar to Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) (57 kDa RNA-binding protein PPTB-1) (LOC385310), mRNA. , XM_358182.3 - GenScript	www.genscript.com	0	0		
814	chr12	30030071	30032041	3500349354	450		30030071	30032041	8421504	3	146,175,129	0,618,1841	p	350034935400015001,350034935400015002	0-300,0-150						Sepsis: New Insights, New Therapies, Novartis Foundation Symposium	www.scribd.com	0	0		HMGB1
814	chr12	30030182	30032017	3500187738	120		30030182	30032017	8421504	3	21,54,45	0,616,1790	p,c	350018773800000000,350018773800015019,350018773800015037	0-21,0-57,0-45						Immunogenic Compositions Comprising Hmgb 1 Polypeptides - Patent application	www.faqs.org	0	0		
814	chr12	30030209	30030729	3500194466	48		30030209	30030729	8421504	2	8,40	0,480	p	350019446600015004	0-48						Proteomic Analysis of Phosphorylated Nuclear Proteins Underscores Novel Roles for Rapid Actions of Retinoic Acid in the Regulation of mRNA Splicing and Translation	digital.csic.es	0	0		HMGB1
814	chr12	30030730	30030754	3500369264	24		30030730	30030754	8421504	1	24	0	c	350036926400000000	0-24						HMGB1 Promotes Drug Resistance in Osteosarcoma	.aacrjournals.org	0	0		GGTA1P,SP100
814	chr12	30030730	30030754	3500325519	24		30030730	30030754	8421504	1	24	0	c	350032551900000000	0-24		22102692	10.1158/0008-5472.CAN-11-2001	0008-5472	Cancer Research	HMGB1 Promotes Drug Resistance in Osteosarcoma	Huang	2012	8		SP100,CTCFL
814	chr12	30030730	30030754	3500318083	24		30030730	30030754	8421504	1	24	0	c	350031808300000000	0-24						HMGB1 Promotes Drug Resistance in Osteosarcoma	.aacrjournals.org	0	0		SP100
814	chr12	30031951	30031999	3500330820	48		30031951	30031999	8421504	1	48	0	p	350033082000015001	0-48						&#x5358;&#x96e2;&#x3055;&#x308c;&#x305f;&#x591a;&#x91cd;&#x306b;&#x30a2;&#x30bb;&#x30c1;&#x30eb;&#x5316;&#x3055;&#x308c;&#x305f;&#x30bf;&#x30f3;&#x30d1;&#x30af;&#x8cea;&#xff28;&#xff2d;&#xff27;&#xff22;&#xff11;&#xff1b;&#x307e;&#x305f;&#x306f;&#x305d;&#x306e	biosciencedbc.jp	0	0		HMGB1
814	chr12	30031957	30032086	3500365620	129		30031957	30032086	8421504	1	129	0	p	350036562000015028	9-138						Splice variants of nuclear dot protein Sp100	cs.biologists.org	0	0		HMGB1
814	chr12	30032085	30032118	3500399199	24		30032085	30032118	8421504	2	20,4	0,29	c	350039919900000000	0-24					Journal of Korean Medical Science	Effects of HMGB-1 Overexpression on Cell-Cycle Progression in MCF-7 Cells - Scolaris	Yoon	2004	0		HMGB1
814	chr12	30032085	30032118	3500153086	24		30032085	30032118	8421504	2	20,4	0,29	c	350015308600000000	0-24			10.3346/jkms.2004.19.3.321		Journal of Korean Medical Science	Effects of HMGB-1 Overexpression on Cell-Cycle Progression in MCF-7 Cells	Sarah	June	0		HMGB1
814	chr12	30114878	30114902	3500190652	23		30114878	30114902	8421504	2	19,4	0,20	g	350019065200000072	0-26						Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probe specific for ribosomal RNA precursors	Britschgi	1996	0		
817	chr12	30421695	30421718	3500062329	23		30421695	30421718	8421504	1	23	0	g	350006232900000777	9-32						ISOLATION OF UNKNOWN REARRANGED T-CELL RECEPTORS FROM SINGLE CELLS - Patent application	www.faqs.org	0	0		
818	chr12	30554591	30554623	3500291399	27		30554591	30554623	8421504	3	12,7,8	0,16,24	c	350029139900000035	0-27						Down-regulation of MTUS1 in human colon tumors	-publications.com	0	0		
819	chr12	30680658	30680686	3500184404	24		30680658	30680686	8421504	2	11,13	0,15	c	350018440400000327,350018440400000176	0-24,21-45						Gastrointestinal proliferative factor and uses thereof - Patent application	www.faqs.org	0	0		
819	chr12	30687858	30687886	3500419803	28		30687858	30687886	8421504	1	28	0	c	350041980300000000	0-28		16371438	10.1152/ajpcell.00520.2005		American Journal of Physiology - Cell Physiolog	Granulocyte-macrophage colony-stimulating factor increases l-arginine transport through the induction of CAT2 in bone marrow-derived macrophages	Martin	2006	0		
819	chr12	30687901	30687924	3500200609	23		30687901	30687924	8421504	1	23	0	c	350020060900000001	0-23				0021-8812		Effect of amino acids supply in reduced crude protein diets on performance, efficiency of mammary uptake, and transporter gene expression in lactating sows 	animalscience.org	0	2		
821	chr12	30938083	30938109	3500179173	23		30938083	30938109	8421504	2	7,16	0,10	g	350017917300000016	5-29						Improved method for the biosynthesis of vitamin e	Geiger	2003	0		
821	chr12	31006301	31006324	3500252384	23		31006301	31006324	8421504	1	23	0	g	350025238400000014	12-37						Molecular Cloning of Dog Mast Cell Tryptase and a Related Protease: Structural Evidence a Unique Mode Serine Protease Activation+,$	craiklab.ucsf.edu	0	0		
823	chr12	31200590	31200615	3500063996	23		31200590	31200615	8421504	3	4,12,7	0,5,18	g	350006399600000331	5-28						Immunostimulatory rna/dna hybrid molecules	Flora	2001	0		
823	chr12	31211815	31222130	3500229168	423		31211815	31222130	8421504	6	65,94,102,61,98,3	0,2899,4483,5294,7051,10312	p	350022916800015009	0-423						64 human secreted proteins	Duan	1999	0		POMP
823	chr12	31211875	31217154	3500234397	153		31211875	31217154	8421504	9	5,10,33,15,9,24,15,9,33	0,2839,2852,2918,4423,4456,4510,5234,5246	p	350023439700015046,350023439700015029	168-285,24-81						Das Ump1-Protein, ein konservierter Reifungsfaktor eukaryotischer Proteasomen	ni-duesseldorf.de	0	0		
823	chr12	31214730	31222130	3500320902	342		31214730	31222130	8421504	5	78,102,61,98,3	0,1568,2379,4136,7397	p	350032090200015110,350032090200015109	0-171,0-171						Method for manufacturing a modified peptide	Bauer	2009	0		POMP
823	chr12	31214743	31217113	3500047878	40		31214743	31217113	8421504	3	20,16,4	0,1641,2366	c	350004787800000019,350004787800000018	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
823	chr12	31218921	31218947	3500259074	23		31218921	31218947	8421504	2	15,8	0,18	c	350025907400000166	5-28						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
824	chr12	31364418	31430705	3500307446	46		31364418	31430705	8421504	4	15,10,15,6	0,32413,62428,66281	c	350030744600000233,350030744600000236	1-26,0-21						Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties - Patent application	www.faqs.org	0	0		
824	chr12	31364418	31396841	3500333519	25		31364418	31396841	8421504	2	15,10	0,32413	c	350033351900000243	1-26						Methods of treating inflammatory skin diseases	Xia	2001	0		
824	chr12	31377805	31377829	3500200817	23		31377805	31377829	8421504	2	4,19	0,5	g	350020081700000050	11-34						 Use Of Multiple Recombination Sites With Unique Specificity In Recombinational Cloning 	www.docstoc.com	0	0		
824	chr12	31407812	31407836	3500016176	23		31407812	31407836	8421504	2	7,16	0,8	g	350001617600000006,350001617600000013	3-26,3-26						Ryegrass Pollen-specific Promoters And Expression Constructs 	.freshpatents.com	0	0		
824	chr12	31426839	31430705	3500344997	28		31426839	31430705	8421504	2	22,6	0,3860	c	350034499700000074	17-45						METHODS OF IDENTIFYING AGENTS THAT MODULATE METHYLATION OF VEGFR1 BY SMYD3 - Patent application	www.faqs.org	0	0		
825	chr12	31480723	31480748	3500444537	25		31480723	31480748	8421504	1	25	0	c	350044453700000000	0-25		9486038	10.1136/bjo.81.10.919	1468-2079	British Journal of Ophthalmology	Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes	Chen	1997	0		FLT1
825	chr12	31480939	31545300	3500344997	259		31480939	31545300	8421504	9	35,46,2,7,41,29,23,23,53	0,47667,53897,53995,57686,57771,59440,63717,64308	c	350034499700000104,350034499700000115,350034499700000118,350034499700000011,350034499700000162,350034499700000120,350034499700000123,350034499700000126,350034499700000153,350034499700000002	7-42,0-48,0-48,8-31,8-31,0-48,0-23,0-48,8-35,8-35						METHODS OF IDENTIFYING AGENTS THAT MODULATE METHYLATION OF VEGFR1 BY SMYD3 - Patent application	www.faqs.org	0	0		
825	chr12	31485954	31486080	3500327432	126		31485954	31486080	8421504	1	126	0	p	350032743200015005	0-126						ABSTRACT	ww.justice.gov.il	0	0		FLT1
825	chr12	31528603	31528631	3500375188	28		31528603	31528631	8421504	1	28	0	c	350037518800000020	0-28						Method of inhibiting angiogenesis	Gerritsen	2001	0		
825	chr12	31528603	31528631	3500221742	28		31528603	31528631	8421504	1	28	0	c	350022174200000020	0-28						Method of inhibiting angiogenesis	Gerritsen	2006	0		
825	chr12	31528603	31528631	3500174044	28		31528603	31528631	8421504	1	28	0	c	350017404400000020	0-28						Method of inhibiting angiogenesis	Gerritsen	2001	0		
825	chr12	31534931	31538645	3500423962	30		31534931	31538645	8421504	2	10,20	0,3694	c	350042396200000071	9-39						US Patent # 7,034,105. FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy - Patents.com	www.patents.com	0	0		
825	chr12	31537203	31537237	3500287957	26		31537203	31537237	8421504	3	7,13,6	0,12,28	g	350028795700000015	8-40						KOJI MOLD-ORIGIN PHOSPHOLIPASE A2 - Patent application	www.faqs.org	0	0		
825	chr12	31545257	31545286	3500406332	29		31545257	31545286	8421504	1	29	0	g	350040633200000011	0-29						Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc)	Gronthos	2009	0		CCR1,FLT1
825	chr12	31545257	31545286	3500338867	29		31545257	31545286	8421504	1	29	0	g	350033886700000011	0-29						Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC)	Gronthos	2011	0		CCR1,FLT1
825	chr12	31545257	31545286	3500276552	29		31545257	31545286	8421504	1	29	0	c	350027655200000006,350027655200000042	0-29,0-29						Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof - Patent application	www.faqs.org	0	0		
825	chr12	31545257	31545286	3500205828	29		31545257	31545286	8421504	1	29	0	c	350020582800000006	0-29						Multipotential Expanded Mesenchymal Precursor Cell Progeny (memp) And Uses Thereof 	.freshpatents.com	0	0		
825	chr12	31545257	31545286	3500189895	29		31545257	31545286	8421504	1	29	0	c	350018989500000002	6-35		11555584		1078-0432	Clinical Cancer Research	Vascular Endothelial Growth Factor and Cellular Chemotaxis	Hayashibara	2001	8		
825	chr12	31545257	31545286	3500187869	29		31545257	31545286	8421504	1	29	0	c	350018786900000006	6-35		9886983			American Journal of Physiology - Gastrointestinal and Liver Physiology	Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed Hep G2 cells	Suzuki	1999	0		FLT1
825	chr12	31545257	31545286	3500121994	29		31545257	31545286	8421504	1	29	0	c	350012199400000006	6-35		9886983			American Journal of Physiology - Gastrointestinal and Liver Physiology	Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed Hep G2 cells	Suzuki	1999	0		
825	chr12	31546531	31546554	3500351805	23		31546531	31546554	8421504	1	23	0	c	350035180500000117	21-44						Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2	Lemischka	1992	0		
825	chr12	31548335	31550160	3500365673	40		31548335	31550160	8421504	3	20,11,9	0,76,1816	c,g	350036567300000022,350036567300000022,350036567300000023	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
825	chr12	31548335	31550160	3500262357	40		31548335	31550160	8421504	3	20,11,9	0,76,1816	c	350026235700000022,350026235700000023	0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
825	chr12	31550242	31554361	3500453233	25		31550242	31554361	8421504	2	9,16	0,4103	c	350045323300000003	0-25						Mesenchymal Stem Cells Therapy in Acute Renal Failure: Possible Role of Hepatocyte Growth Factor	w.omicsonline.org	0	0		
825	chr12	31550242	31554361	3500438030	25		31550242	31554361	8421504	2	9,16	0,4103	c	350043803000000002	0-25						Express&#xe3;o de fatores angiog&#xea;nicos em corpo l&#xfa;teo c&#xed;clico e superovulado de b&#xfa;falas	www.teses.usp.br	0	0		
825	chr12	31554445	31554953	3500167681	23		31554445	31554953	8421504	2	6,17	0,491	c	350016768100000006	24-47		19697322	10.1002/ijc.24847	1097-0215	International Journal of Cancer	Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer - Lee - 2009 - International Journal of Cancer - Wiley Online Library	Lee	2010	0		
825	chr12	31554989	31555013	3500258471	24		31554989	31555013	8421504	1	24	0	c	350025847100000002	20-44						Virginia Tech : LIB 04212005 : Dissertation	ww.coursehero.com	0	0		
827	chr12	31783587	31806780	3500351805	71		31783587	31806780	8421504	2	48,23	0,23170	g	350035180500000086,350035180500000049	0-48,25-48						Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2	Lemischka	1992	0		
827	chr12	31840542	31841403	3500210117	61		31840542	31841403	8421504	3	20,20,21	0,353,840	c,g	350021011700000007,350021011700000000,350021011700000009,350021011700000009	0-20,0-20,0-21,0-21		19617623	10.1074/jbc.M109.030668	0021-9258	Journal of Biological Chemistry	POU Homeodomain Protein Oct-1 Functions as a Sensor for Cyclic AMP	Wang	2009	5		
827	chr12	31840872	31841012	3500382980	41		31840872	31841012	8421504	2	21,20	0,120	c,g	350038298000000002,350038298000000003	0-21,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
827	chr12	31840872	31841012	3500319127	41		31840872	31841012	8421504	2	21,20	0,120	c	350031912700000024,350031912700000025	0-21,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
827	chr12	31840872	31841012	3500280137	41		31840872	31841012	8421504	2	21,20	0,120	c,g	350028013700000002,350028013700000003	0-21,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
827	chr12	31840877	31840903	3500270944	26		31840877	31840903	8421504	1	26	0	c	350027094400000002,350027094400000001	0-25,0-25		19733166	10.1016/j.ydbio.2009.08.025		Developmental biology	CDX2 in the Formation of the Trophectoderm Lineage in Primate Embryos	Hathaitip	2009	0		CDX2
827	chr12	31840899	31840924	3500183566	25		31840899	31840924	8421504	1	25	0	c	350018356600000002	0-25		18192238	10.1634/stemcells.2007-0356	1549-4918	STEM CELLS	Lymphoid Enhancer Factor 1-Mediated Wnt Signaling Promotes the Initiation of Trophoblast Lineage Differentiation in Mouse Embryonic Stem Cells - He - 2008 - STEM CELLS - Wiley Online Library	He	2008	0		CDX2
827	chr12	31841119	31841145	3500244987	23		31841119	31841145	8421504	2	8,15	0,11	c	350024498700000131	3-40						Modulation of cytokinin activity in plants	C*Jin Sai Er Mai Er 	2008	0		
827	chr12	31841349	31844939	3500234543	50		31841349	31844939	8421504	2	25,25	0,3565	c	350023454300000002,350023454300000003	0-25,0-25		12163327		1055-9965	Cancer Epidemiology Biomarkers & Prevention	Ectopic Expression of Guanylyl Cyclase C in Adenocarcinomas of the Esophagus and Stomach	Park	2002	4		CDX2
827	chr12	31844929	31845997	3500059113	40		31844929	31845997	8421504	2	20,20	0,1048	c,g	350005911300000004,350005911300000004,350005911300000005,350005911300000005	0-20,0-20,0-20,0-20		22043807	10.1089/cell.2011.0021		Cellular Reprogramming	Efficient Production and Cellular Characterization of Sheep Androgenetic Embryos	Federica	2011	0		
827	chr12	31844930	31846001	3500328799	43		31844930	31846001	8421504	2	24,19	0,1052	c,g	350032879900000020,350032879900000020,350032879900000018,350032879900000018,350032879900000019	0-24,0-24,0-23,0-23,0-19						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
827	chr12	31844930	31846001	3500100652	42		31844930	31846001	8421504	2	23,19	0,1052	c,g	350010065200000010,350010065200000010,350010065200000011,350010065200000011	0-23,0-23,0-19,0-19						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
827	chr12	31845044	31845977	3500408509	24		31845044	31845977	8421504	2	16,8	0,925	c	350040850900000003	0-24		22749770	10.1016/j.ajpath.2012.04.028		The American Journal of Pathology	Methylation-Dependent Activation of CDX1 through NF-&#x03ba;B: A Link from Inflammation to Intestinal Metaplasia in the Human Stomach	Tilman	2012	0		CDX2
827	chr12	31845996	31846019	3500009456	23		31845996	31846019	8421504	1	23	0	c	350000945600000002	0-23						PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY	Fissore	2007	0		CDX2
828	chr12	31924735	31925071	3500076430	117		31924735	31925071	8421504	2	69,48	0,288	p	350007643000015012,350007643000015027,350007643000015008	0-48,0-45,0-48						A novel homeobox factor which stimulates insulin expression in pancreatic islet cells	Leonard	1995	0		PDX1
828	chr12	31924852	31931404	3500219868	44		31924852	31931404	8421504	2	20,24	0,6528	c,g	350021986800000023,350021986800000018	0-20,0-24		19843526	10.1074/jbc.M109.028852		The Journal of Biological Chemistry	MODY7 Gene, KLF11, Is a Novel p300-dependent Regulator of Pdx-1 (MODY4) Transcription in Pancreatic Islet &#x03b2; Cells	Martin	2009	0		
828	chr12	31924852	31931404	3500219618	44		31924852	31931404	8421504	2	20,24	0,6528	c,g	350021961800000023,350021961800000018	0-20,0-24		19843526	10.1074/jbc.M109.028852	0021-9258	Journal of Biological Chemistry	MODY7 Gene, KLF11, Is a Novel p300-dependent Regulator of Pdx-1 (MODY4) Transcription in Pancreatic Islet &#x03b2; Cells	Fernandez-Zapico	2009	5		
828	chr12	31932233	31932263	3500172840	30		31932233	31932263	8421504	1	30	0	g	350017284000000018,350017284000000023	20-43,0-23		11590182	10.1074/jbc.M109244200	0021-9258	Journal of Biological Chemistry	The Role of Hepatic Nuclear Factor 1&#x03b1; and PDX-1 in Transcriptional Regulation of the pdx-1 Gene	Gerrish	2001	5		
829	chr12	32099499	32099522	3500368465	23		32099499	32099522	8421504	1	23	0	g	350036846500000001	11-39						RESEARCH ARTICLE Differential expression of genes and proteins between electric organ and skeletal muscle in the mormyrid electric fish Brienomyrus brachyistius	h.zoology.msu.edu	0	0		
830	chr12	32204618	32204643	3500321554	24		32204618	32204643	8421504	2	16,8	0,17	c	350032155400000082	10-34						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1993	0		
830	chr12	32204618	32204643	3500279401	24		32204618	32204643	8421504	2	16,8	0,17	c	350027940100000082	10-34						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1992	0		
830	chr12	32211269	32211293	3500346126	23		32211269	32211293	8421504	2	6,17	0,7	g	350034612600000054	5-28						Real-time Multiplex Detection Of Three Bacterial Species Responsible For Sexually Transmitted Diseases 	.freshpatents.com	0	0		
831	chr12	32319173	32319204	3500318432	24		32319173	32319204	8421504	3	6,13,5	0,10,26	g	350031843200000005	13-39						Sequence-Dependent Upstream DNA&#x2013;RNA Polymerase Interactions in the Open Complex with &#x03bb;PR and &#x03bb;PRM Promoters and Implications for the Mechanism of Promoter Interference	lice.berkeley.edu	0	0		
832	chr12	32429498	32430634	3500164379	159		32429498	32430634	8421504	3	31,113,15	0,539,1121	p	350016437900015020	159-318						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPL21
835	chr12	32781984	32782071	3500080177	87		32781984	32782071	8421504	1	87	0	p	350008017700015011	0-87						Regulatory Mimicry in Listeria monocytogenes Actin-Based Motility	www.med.yale.edu	0	0		WASF3
835	chr12	32810715	32810745	3500119980	24		32810715	32810745	8421504	3	5,8,11	0,6,19	c	350011998000000087	19-45						Binding Molecules Capable Of Neutralizing Rabies Virus And Uses Thereof 	.freshpatents.com	0	0		
837	chr12	33043443	33043468	3500249974	23		33043443	33043468	8421504	2	7,16	0,9	c	350024997400000030,350024997400000012	0-23,6-27						Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay - US Patent 7148053 Description	ww.patentstorm.us	0	0		
842	chr12	33719536	33719561	3500409155	23		33719536	33719561	8421504	2	9,14	0,11	c	350040915500000028	12-36						Composition and method for detecting mutagens	Thomas	2000	0		
843	chr12	33860091	33860117	3500239446	26		33860091	33860117	8421504	1	26	0	c,g	350023944600000007,350023944600000007	5-31,5-31		22912588	10.1371/journal.pgen.1002853	1553-7404	PLOS Genetics	PLOS Genetics: Mutations in a P-Type ATPase Gene Cause Axonal Degeneration	Zhu	2012	0		ATP8A2
843	chr12	33907300	33907324	3500276823	23		33907300	33907324	8421504	2	16,7	0,17	g	350027682300000026	0-23						GENERATION OF INNER EAR CELLS - Patent application	www.faqs.org	0	0		
845	chr12	34179587	34179616	3500033307	24		34179587	34179616	8421504	2	17,7	0,22	g	350003330700000041	21-45						Production of gamma linolenic acid by a delta6-desaturase - Patent application	www.faqs.org	0	0		
848	chr12	34535858	34535886	3500240309	23		34535858	34535886	8421504	2	6,17	0,11	g	350024030900000148	14-37						Polypeptides of Strain Bacillus SP. P203 - Patent application	www.faqs.org	0	0		
850	chr12	34800403	34800433	3500155900	26		34800403	34800433	8421504	2	19,7	0,23	g	350015590000000362	4-30						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
850	chr12	34820549	34820572	3500332742	23		34820549	34820572	8421504	1	23	0	g	350033274200000040	10-33						Method of treating cell damage or depletion	Williams	1994	0		
852	chr12	35114774	35114800	3500062057	24		35114774	35114800	8421504	2	5,19	0,7	g	350006205700000121	23-48						Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases.	Barry	1993	0		
855	chr12	35408883	35408907	3500129658	23		35408883	35408907	8421504	2	8,15	0,9	g	350012965800000075	11-34						Animal model for fibroblast growth factor receptor associated chondrodysplasia	Yayon	1999	0		
857	chr12	35700926	35720166	3500122520	46		35700926	35720166	8421504	3	21,5,20	0,11414,19220	c	350012252000000007,350012252000000003	0-21,0-25		20334580	10.3109/09687681003616854		Molecular membrane biology	DHHC20: a human palmitoyl acyltransferase that causes cellular transformation	Jeremiah	2010	0		ZDHHC20,MIPEPP3
857	chr12	35737949	35738132	3500344774	96		35737949	35738132	8421504	2	48,48	0,135	c	350034477400000028,350034477400000031	0-48,0-48						NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 193P1E1B USEFUL IN TREATMENT AND DETECTION OF CANCER - Patent application	www.faqs.org	0	0		
857	chr12	35737955	35744228	3500056924	87		35737955	35744228	8421504	2	45,42	0,6231	c	350005692400000326,350005692400000259	0-45,0-42						Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer - US Patent 7615379 Description	ww.patentstorm.us	0	0		
857	chr12	35754306	35754330	3500135205	24		35754306	35754330	8421504	1	24	0	c	350013520500000034	23-47						Universit&#xe0; degli Studi di Trieste	enstarts.units.it	0	0		SAP18
857	chr12	35760270	35760485	3500299792	99		35760270	35760485	8421504	2	27,72	0,143	p	350029979200015002	9-108						Control of gene expression using a complex of an oligonucleotide and a regulatory peptide	Ali	2003	0		SAP18
857	chr12	35760270	35760485	3500259681	99		35760270	35760485	8421504	2	27,72	0,143	p	350025968100015000	9-108						Control of gene expression using a complex of an oligonucleotide and a regulatory peptide - Patent application	www.faqs.org	0	0		SAP18
857	chr12	35760270	35760485	3500178179	99		35760270	35760485	8421504	2	27,72	0,143	p	350017817900015000	9-108						Control Of Gene Expression Using A Complex Of An Oligonucleotide And A Regulatory Peptide 	.freshpatents.com	0	0		SAP18
857	chr12	35760270	35760485	3500101924	99		35760270	35760485	8421504	2	27,72	0,143	p	350010192400015003	9-108						Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide	Jenkinson	2004	0		SAP18
858	chr12	35884455	35884481	3500339012	23		35884455	35884481	8421504	2	13,10	0,16	g	350033901200000011	0-23		22433566	10.1186/1471-2199-13-8	1471-2199	BMC Molecular Biology	EGF activates TTP expression by activation of ELK-1 and EGR-1 transcription factors	Florkowska	2012	3		
858	chr12	35900548	35900576	3500102026	25		35900548	35900576	8421504	2	14,11	0,17	g	350010202600000571	5-30						Compositions and methods for vaccination against coronaviruses	Jones	1993	0		
858	chr12	35904646	35904672	3500297690	25		35904646	35904672	8421504	2	14,11	0,15	c	350029769000000120	10-48						US Patent # 5,556,781. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
859	chr12	35919850	35919878	3500314534	25		35919850	35919878	8421504	2	19,6	0,22	c	350031453400000020	6-31						CELL VISUAL CHARACTERISTIC-MODIFYING SEQUENCES - FLORIGENE LTD	www.sumobrain.com	0	0		
859	chr12	35947421	35947447	3500339681	23		35947421	35947447	8421504	2	6,17	0,9	g	350033968100000037	1-24						CANCER - Patent application	www.faqs.org	0	0		
861	chr12	36232526	36232958	3500056815	96		36232526	36232958	8421504	2	48,48	0,384	p	350005681500015018,350005681500015026	0-48,0-48						 <HTML> <HEAD><TITLE>ce>>C/cSS>>e1/2ae$?ae>>ae1ae3aaaa3ce>>C/cSS>>aeaPe!a(r)a1a-aaa1/4aa3a	www.j-tokkyo.com	0	0		
861	chr12	36232910	36232958	3500199563	48		36232910	36232958	8421504	1	48	0	p	350019956300015026	0-48						&#x764c;&#x8ee2;&#x79fb;&#x80fd;&#x691c;&#x67fb;&#x65b9;&#x6cd5;&#x3001;&#x304a;&#x3088;&#x3073;&#x764c;&#x8ee2;&#x79fb;&#x6291;&#x5236;&#x85ac;&#x306e;&#x30b9;&#x30af;&#x30ea;&#x30fc;&#x30cb;&#x30f3;&#x30b0;&#x65b9;&#x6cd5; - &#x682a;&#x5f0f;&#x4f1a;&#x7	www.patentjp.com	0	0		
861	chr12	36268497	36268560	3500422615	63		36268497	36268560	8421504	1	63	0	p	350042261500015046	0-63						TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES - FIRSTSTRING RESEARCH, INC.	www.sumobrain.com	0	0		
861	chr12	36268497	36268560	3500414025	63		36268497	36268560	8421504	1	63	0	p	350041402500015110	0-63						Compositions and methods for promoting wound healing and tissue regeneration	Ghatnekar	2011	0		
861	chr12	36268497	36268560	3500408014	63		36268497	36268560	8421504	1	63	0	p	350040801400015123,350040801400015174	0-63,0-48						Composition And Methods For Promoting Wound Healing And Tissue Regeneration 	.freshpatents.com	0	0		
861	chr12	36268497	36268560	3500374795	63		36268497	36268560	8421504	1	63	0	p	350037479500015099	0-63						COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION	Gourdie	2007	0		
861	chr12	36268497	36268560	3500332070	63		36268497	36268560	8421504	1	63	0	p	350033207000015104	0-63						 Composition And Methods For Promoting Wound Healing And Tissue Regeneration 	www.docstoc.com	0	0		
861	chr12	36268497	36268560	3500257959	63		36268497	36268560	8421504	1	63	0	p	350025795900015102	0-63						Composition and Methods for Promoting Wound Healing and tissue Regeneration	Ghatnekar	2008	0		
861	chr12	36268497	36268560	3500254081	63		36268497	36268560	8421504	1	63	0	p	350025408100015096	0-63						Compositions and methods for promoting wound healing and tissue regeneration	Gourdie	2009	0		
861	chr12	36268497	36268560	3500248458	63		36268497	36268560	8421504	1	63	0	p	350024845800015096	0-63					Patent	Compositions and methods for promoting wound healing and tissue regeneration (Patent US:7888319)	Ghatnekar	2011	0		
861	chr12	36268497	36268560	3500226091	63		36268497	36268560	8421504	1	63	0	p	350022609100015112	0-63						Compositions and methods for promoting wound healing and tissue regeneration	Gourdie	2011	0		
861	chr12	36268497	36268560	3500103084	63		36268497	36268560	8421504	1	63	0	p	350010308400015113	0-63						ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION - Patent application	www.faqs.org	0	0		
861	chr12	36268497	36268560	3500096913	63		36268497	36268560	8421504	1	63	0	p	350009691300015102	0-63					Patent	Composition and methods for promoting wound healing and tissue regeneration (Patent US:7786074)	Ghatnekar	2010	0		
861	chr12	36268497	36268560	3500079904	63		36268497	36268560	8421504	1	63	0	p	350007990400015097	0-63						COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION - Patent application	www.faqs.org	0	0		
862	chr12	36347436	36347487	3500126483	49		36347436	36347487	8421504	3	17,20,12	0,18,39	g	350012648300000389,350012648300000594,350012648300000548	0-22,0-29,0-30						MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - Patent application	www.faqs.org	0	0		
862	chr12	36347436	36347464	3500018682	27		36347436	36347464	8421504	2	17,10	0,18	g	350001868200000000	0-27		20140194	10.1371/journal.ppat.1000752	1553-7374	PLOS Pathogens	PLOS Pathogens: An Extensive Circuitry for Cell Wall Regulation in Candida albicans	Blankenship	2010	0		
862	chr12	36347436	36347462	3500129761	25		36347436	36347462	8421504	2	17,8	0,18	g	350012976100000004	0-25						US Patent # 6,054,564. Thermostable ligase mediated DNA amplification system for the detection of genetic diseases - Patents.com	www.patents.com	0	0		
862	chr12	36347436	36347461	3500443908	24		36347436	36347461	8421504	2	17,7	0,18	g	350044390800000010	0-24		15082793	10.1128/MCB.24.9.4004-4018.2004	0270-7306	Molecular and Cellular Biology	Enhancement of Sleeping Beauty Transposition by CpG Methylation: Possible Role of Heterochromatin Formation	Yusa	2004	6		
862	chr12	36347436	36347460	3500398193	23		36347436	36347460	8421504	2	17,6	0,18	g	350039819300000001	0-23						Menaquinone-7 regulates gene expression in osteoblastic MC3T3E1 cells	-publications.com	0	0		
862	chr12	36347446	36347474	3500219299	27		36347446	36347474	8421504	2	4,23	0,5	g	350021929900000051,350021929900000122	3-30,3-30						Production of Very Long Chain Polyunsaturated Fatty Acids in Oil Seed Plants - Patent application	www.faqs.org	0	0		
862	chr12	36347446	36347474	3500037063	27		36347446	36347474	8421504	2	4,23	0,5	g	350003706300000122,350003706300000051	3-30,3-30						PRODUCTION OF VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS IN OILSEED PLANTS - Patent application	www.faqs.org	0	0		
862	chr12	36347452	36347479	3500361826	26		36347452	36347479	8421504	2	22,4	0,23	g	350036182600000004	9-35						BMC Biotechnology BioMed Central	biomedcentral.com	0	0		
862	chr12	36347452	36347479	3500144012	26		36347452	36347479	8421504	2	22,4	0,23	g	350014401200000005	9-35		18840295	10.1186/1472-6750-8-77	1472-6750	BMC Biotechnology	A construct with fluorescent indicators for conditional expression of miRNA	Qiu	2008	2		
862	chr12	36347453	36347479	3500037187	25		36347453	36347479	8421504	2	21,4	0,22	g	350003718700000000	0-25		15930321	10.1095/biolreprod.105.041574	0006-3363	Biology of Reproduction	Genes Preferentially Expressed in Bovine Oocytes Revealed by Subtractive and Suppressive Hybridization	Pennetier	2005	4		
862	chr12	36347454	36347479	3500149660	24		36347454	36347479	8421504	2	20,4	0,21	g	350014966000000006,350014966000000020	0-24,0-24						POLYMERASE COMPOSITIONS AND USES - Patent application	www.faqs.org	0	0		
862	chr12	36347454	36347479	3500126495	24		36347454	36347479	8421504	2	20,4	0,21	g	350012649500000008	0-24						Liu et al. A transformation system for the basidiomycete Pleurotus ostreatus was established using PEG-mediated transformation. The homologous glyceraldehyde-3-phosphate dehydrogenase gene (gpd) promoter and terminator regions of P. ostreatus were amplifi	demicjournals.org	0	0		
862	chr12	36347455	36347481	3500452805	25		36347455	36347481	8421504	2	19,6	0,20	g	350045280500000002	0-25		20624216	10.1111/j.1365-2958.2010.07285.x	1365-2958	Molecular Microbiology	A sensor kinase recognizing the cell&#x2013;cell signal BDSF (cis-2-dodecenoic acid) regulates virulence in Burkholderia cenocepacia - McCarthy - 2010 - Molecular Microbiology - Wiley Online Library	McCarthy	2010	0		
862	chr12	36347457	36347485	3500402965	27		36347457	36347485	8421504	2	17,10	0,18	g	350040296500000012	0-27					Patent	Hemoglobin-like protein comprising genetically fused globin-like polypeptides (Patent US:5844088)	Anderson	1998	0		
862	chr12	36347457	36347481	3500102402	23		36347457	36347481	8421504	2	17,6	0,18	g	350010240200000013,350010240200000029	0-23,0-23					Patent	Recombinant segmented negative strand virus containing bicistronic vrna segment with a duplication of its 3&#x2032; noncoding flanking sequence, and vaccines and therapeutic compositions containing the same (Patent US:6723559)	Escriou	2004	0		
862	chr12	36347459	36347487	3500437190	27		36347459	36347487	8421504	2	15,12	0,16	g	350043719000000006	0-27					Patent	Modified hemoglobin-like compounds and methods of purifying same (Patent US:6150506)	Anderson	2000	0		
862	chr12	36347459	36347487	3500269714	27		36347459	36347487	8421504	2	15,12	0,16	g	350026971400000006	0-27						Modified hemoglobin-like compounds and methods of purifying same	Anderson	1998	0		
862	chr12	36347459	36347487	3500215132	27		36347459	36347487	8421504	2	15,12	0,16	g	350021513200000006	0-27						Modified hemoglobin-like compounds and methods of purifying same	Trimble	1998	0		
862	chr12	36347459	36347487	3500137635	27		36347459	36347487	8421504	2	15,12	0,16	g	350013763500000009	3-30						Gene Overexpression/Suppression Analysis of Candidate Virulence Factors of Candida albicans	ec.asm.org/conten	0	0		
862	chr12	36347459	36347487	3500029219	27		36347459	36347487	8421504	2	15,12	0,16	g	350002921900000006	0-27						 Modified Hemoglobin 	www.docstoc.com	0	0		
862	chr12	36395659	36395682	3500001762	23		36395659	36395682	8421504	1	23	0	c	350000176200000041	0-26						DNA profiling of captive Roseate Spoonbill (Ajaia ajaja) populations as a mechanism of determining lineage in colonial nesting birds.	l.library.unt.edu	0	0		
863	chr12	36470300	36494435	3500273192	480		36470300	36494435	8421504	4	78,58,170,174	0,17642,21591,23961	p	350027319200015012	0-480						Squamous cell carcinoma antigens and use therefor	Gires	2006	0		
863	chr12	36491903	36491927	3500201864	24		36491903	36491927	8421504	1	24	0	c	350020186400000492	10-34						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
863	chr12	36491903	36491927	3500005314	24		36491903	36491927	8421504	1	24	0	c	350000531400000496	10-34						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
866	chr12	36951175	36951200	3500239678	25		36951175	36951200	8421504	1	25	0	g	350023967800000020	7-32						Streptomyces Avermitilis Gene Directing The Ratio of B2:B1 Avermectins - Patent application	www.faqs.org	0	0		
876	chr12	38243519	38243544	3500154959	23		38243519	38243544	8421504	2	6,17	0,8	g	350015495900000012	3-26						Supplementary Materials for	ke.sciencemag.org	0	0		
878	chr12	38434568	38434592	3500016075	24		38434568	38434592	8421504	1	24	0	g	350001607500000046	7-37						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
878	chr12	38518063	38518087	3500454676	23		38518063	38518087	8421504	2	10,13	0,11	g	350045467600000017	3-34						Patrik1	www.scribd.com	0	0		
879	chr12	38569209	38569236	3500307446	26		38569209	38569236	8421504	2	6,20	0,7	g	350030744600000241	10-38						Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties - Patent application	www.faqs.org	0	0		
879	chr12	38569209	38569236	3500186204	26		38569209	38569236	8421504	2	6,20	0,7	g	350018620400000184	10-38						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
883	chr12	39126678	39126702	3500435151	23		39126678	39126702	8421504	2	15,8	0,16	g	350043515100000020	9-42						Regulatory sequences for transgenic plants	www.devileye.net	0	0		
883	chr12	39126678	39126702	3500272844	23		39126678	39126702	8421504	2	15,8	0,16	g	350027284400000020	9-42					Patent	Regulatory sequences for transgenic plants (Patent US:6699984)	Ainley	2004	0		
895	chr12	40691344	40691376	3500155900	24		40691344	40691376	8421504	3	8,5,11	0,11,21	g	350015590000000402	19-43						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
906	chr12	42096125	42096151	3500022398	23		42096125	42096151	8421504	3	13,5,5	0,15,21	g	350002239800000024,350002239800000510	4-27,4-27						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
906	chr12	42111508	42111532	3500070475	23		42111508	42111532	8421504	2	16,7	0,17	g	350007047500000003	7-30						Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1	library.ibp.ac.cn	0	0		
910	chr12	42686067	42686093	3500219299	24		42686067	42686093	8421504	2	19,5	0,21	g	350021929900000095,350021929900000026	16-40,16-40						Production of Very Long Chain Polyunsaturated Fatty Acids in Oil Seed Plants - Patent application	www.faqs.org	0	0		
915	chr12	43292006	43292031	3500127965	25		43292006	43292031	8421504	1	25	0	g	350012796500000038	0-38						METHODS AND COMPOSITIONS FOR MODIFICATION OF THE HPRT LOCUS - Patent application	www.faqs.org	0	0		
918	chr12	43703637	43703662	3500252331	23		43703637	43703662	8421504	2	9,14	0,11	g	350025233100000037	7-30					Patent	Method for diagnosing a predisposition for breast and ovarian cancer (Patent EP:0699754)	Futreal	2009	0		
929	chr12	45187705	45187733	3500404466	25		45187705	45187733	8421504	2	10,15	0,13	g	350040446600000019	1-36		9584171		0270-7306	Molecular and Cellular Biology	TFII-I Enhances Activation of the c-fosPromoter through Interactions with Upstream Elements	Kim	1998	6		
933	chr12	45717076	45717105	3500345454	25		45717076	45717105	8421504	2	5,20	0,9	g	350034545400000010	10-35			10.1111/j.1365-2958.2007.05859.x	1365-2958	Molecular Microbiology	Functional characterization of both MAP kinases of the human malaria parasite Plasmodium falciparum by reverse genetics - Dorin-Semblat - 2007 - Molecular Microbiology - Wiley Online Library	Dorin-Semblat	2007	0		
936	chr12	46071168	46071193	3500171513	23		46071168	46071193	8421504	2	16,7	0,18	g	350017151300000028	6-41						Compositions and Methods of Use of Mitogen-Activated Protein Kinase Kinase Kinase - Patent application	www.faqs.org	0	0		
950	chr12	47848444	47848558	3500066002	110		47848444	47848558	8421504	3	84,19,7	0,86,107	c	350006600200000165	433-543						Method for producing derivational pluripotent stem cell with meninges cell and uses thereof	He Wen Zhi 	2009	0		
950	chr12	47851054	47852933	3500216008	42		47851054	47852933	8421504	2	21,21	0,1858	c	350021600800000000,350021600800000001	0-21,0-21			10.1002/ijc.21533	1097-0215	International Journal of Cancer	KLF5 promotes cell proliferation and tumorigenesis through gene regulationin the TSU-Pr1 human bladder cancer cell line - Chen - 2005 - International Journal of Cancer - Wiley Online Library	Chen	2006	0		
119	chr12	48876961	48959550	3500309840	23		48876961	48959550	8421504	3	7,12,4	0,82572,82585	c	350030984000000835	7-30						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
958	chr12	48964224	48964252	3500231688	24		48964224	48964252	8421504	2	6,18	0,10	g	350023168800000102	9-33						Method of detecting neutophil inhibitory factor mimics	Moyle	1993	0		
963	chr12	49667011	49667038	3500062007	23		49667011	49667038	8421504	3	5,12,6	0,8,21	g	350006200700000010	17-43						Dendritic cell marker and uses thereof	Caminschi	2009	0		
969	chr12	50368825	50368848	3500205565	23		50368825	50368848	8421504	1	23	0	g	350020556500001240	2-25						HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE PROBES AND PRIMERS FOR DETECTION OF MICROORGANISMS - Patent application	www.faqs.org	0	0		
969	chr12	50402009	50402034	3500052549	23		50402009	50402034	8421504	2	14,9	0,16	c	350005254900000160	8-32						 Compositions Against SARS 	www.docstoc.com	0	0		
969	chr12	50403219	50403245	3500344204	23		50403219	50403245	8421504	2	6,17	0,9	c	350034420400000002	1-24			10.1111/j.1365-2958.2006.05532.x	1365-2958	Molecular Microbiology	Growth of Campylobacter jejuni on nitrate and nitrite: electron transport to NapA and NrfA via NrfH and distinct roles for NrfA and the globin Cgb in protection against nitrosative stress - Pittman - 2006 - Molecular Microbiology - Wiley Online Library	Pittman	2007	0		
972	chr12	50833520	50833549	3500378848	24		50833520	50833549	8421504	3	11,6,7	0,12,22	g	350037884800000012,350037884800000028	1-25,1-25						COMPOUNDS, KITS AND METHODS FOR CONFERRING CYTOPROTECTION - Patent application	www.faqs.org	0	0		
974	chr12	51057175	51057202	3500219075	23		51057175	51057202	8421504	2	13,10	0,17	g	350021907500000114	10-46						 Polynucleotides Encoding KAPPA Opiod Receptors 	www.docstoc.com	0	0		
975	chr12	51233855	51233878	3500374909	23		51233855	51233878	8421504	1	23	0	g	350037490900001038	3-26						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
980	chr12	51882702	51882731	3500252206	24		51882702	51882731	8421504	2	18,6	0,23	g	350025220600000105	0-24						Meningococcal antigens	V*Ma Si Ge A Ni 	2005	0		
981	chr12	51924677	51924707	3500343734	24		51924677	51924707	8421504	3	8,4,12	0,13,18	g	350034373400000340	4-34					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
984	chr12	52405465	52405618	3500287361	153		52405465	52405618	8421504	1	153	0	p	350028736100015065	0-153						50 human secreted proteins	Komatsoulis	2001	0		MYCBP2
984	chr12	52405465	52405618	3500274890	153		52405465	52405618	8421504	1	153	0	p	350027489000015065	0-153						50 human secreted proteins	Komatsoulis	2000	0		MYCBP2
984	chr12	52424189	52426780	3500219376	23		52424189	52426780	8421504	3	1,13,9	0,2564,2582	c	350021937600000134	1-24						TECHNIQUE FOR REGULATING REGENRATION OF TISSUE OR FAULTY OR ABNORMAL PART IN ORGAN USING NELL-1 - Patent application	www.faqs.org	0	0		
991	chr12	53312835	53312860	3500327446	25		53312835	53312860	8421504	1	25	0	c	350032744600000049	12-37						NOVEL ULTRASENSITIVE CELL BASED SENSORS AND USES THEREOF	Paz-rojas	2010	0		EDNRB
991	chr12	53312860	53312885	3500011153	25		53312860	53312885	8421504	1	25	0	c	350001115300000012	22-47			10.1111/j.1349-7006.2007.00496.x	1349-7006	Cancer Science	Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas - Murata - 2007 - Cancer Science - Wiley Online Library	Murata	2007	0		EDNRB
991	chr12	53312943	53324584	3500453380	40		53312943	53324584	8421504	2	20,20	0,11621	c	350045338000000003,350045338000000002	0-20,0-20		11454585			American Journal of Physiology - Heart and Circulatory Physiology	Mechanism of uterine vascular refractoriness to endothelin-1 in pregnant sheep	McElvy	2001	0		
991	chr12	53324884	53324908	3500129390	24		53324884	53324908	8421504	1	24	0	c	350012939000000013	0-24						Expression and Hypoxic Regulation of the Endothelin System in Endocrine Cells of Human and Rat Pancreatic Islets	www.joplink.net	0	0		
992	chr12	53365666	53365691	3500130248	23		53365666	53365691	8421504	2	9,14	0,11	g	350013024800000007	17-40						Standard methods for American foulbrood research	www.ibra.org.uk	0	0		
992	chr12	53475854	53475880	3500226498	23		53475854	53475880	8421504	3	5,13,5	0,6,21	g	350022649800000012	5-28					Patent	Haemophilus outer membrane protein (Patent US:6013514)	Chong	2000	0		
997	chr12	54034882	54034910	3500065355	23		54034882	54034910	8421504	2	15,8	0,20	c	350006535500000111	1-24						Method for detection and treatment of breast cancer	Holt	2004	0		
997	chr12	54076192	54076218	3500448182	23		54076192	54076218	8421504	2	5,18	0,8	g	350044818200000042	0-25						Transgenic non-human animals for producing heterologous antibodies	Lonberg	1994	0		
997	chr12	54076192	54076218	3500166201	23		54076192	54076218	8421504	2	5,18	0,8	g	350016620100000085	0-25						Transgenic non-human animals for producing chimeric antibodies	Lonberg	2004	0		
997	chr12	54076192	54076218	3500131771	23		54076192	54076218	8421504	2	5,18	0,8	g	350013177100000092	0-25					Patent	Transgenic non-human animals for producing heterologous antibodies (Patent US:5814318)	Kay	1998	0		
997	chr12	54102890	54102917	3500461849	24		54102890	54102917	8421504	3	15,5,4	0,17,23	g	350046184900000291	7-31						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
997	chr12	54102890	54102917	3500204773	24		54102890	54102917	8421504	3	15,5,4	0,17,23	g	350020477300000287	7-31						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
998	chr12	54170353	54170381	3500150151	23		54170353	54170381	8421504	2	16,7	0,21	g	350015015100000019	0-23						1420045296 Leo M L Nollet Fidel Toldr&#xe1; Handbook of Muscle Foods Analysis	www.docstoc.com	0	0		
1003	chr12	54846608	54846637	3500016751	24		54846608	54846637	8421504	2	13,11	0,18	c	350001675100000055	12-36						Entomopoxvirus spheroidin gene sequences	Moyer	1992	0		NDFIP2
1003	chr12	54860511	54860540	3500332435	26		54860511	54860540	8421504	3	15,7,4	0,17,25	g	350033243500000002	7-34						Prion Deletion Mutants	www.mad-cow.org	0	0		
1005	chr12	55114385	55114408	3500059804	23		55114385	55114408	8421504	1	23	0	g	350005980400000134	3-26						Isolation and characterisation of two chitinase and one novel glucanase genes for engineering plant defence against fungal pathogens	ry.murdoch.edu.au	0	0		
1009	chr12	55634061	55635009	3500406779	45		55634061	55635009	8421504	2	23,22	0,926	c	350040677900000003,350040677900000002	9-32,0-22						Kidney development: roles of Sprouty, Wnt2b and type XVIII collagen in the ureteric bud morphogenesis	herkules.oulu.fi	0	0		
1009	chr12	55634980	55635005	3500107613	25		55634980	55635005	8421504	1	25	0	c	350010761300000000	0-25						ScienceDirect.com - Developmental Biology - Overexpression of Spry1 in chondrocytes causes attenuated FGFR ubiquitination and sustained ERK activation resulting in chondrodysplasia	sciencedirect.com	0	0		SPRY2
1011	chr12	55869004	55869028	3500113379	23		55869004	55869028	8421504	2	9,14	0,10	g	350011337900000132	3-42						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
1021	chr12	57269913	57269937	3500076832	23		57269913	57269937	8421504	2	15,8	0,16	g	350007683200000033	0-30						Promoter Variants and Variant Promoters of the Hepatic Lipase Gene	repub.eur.nl	0	0		
1028	chr12	58192492	58192516	3500389139	23		58192492	58192516	8421504	2	14,9	0,15	g	350038913900000257	13-36						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		
1028	chr12	58192492	58192516	3500306561	23		58192492	58192516	8421504	2	14,9	0,15	g	350030656100000256	13-36						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
1028	chr12	58192492	58192516	3500257436	23		58192492	58192516	8421504	2	14,9	0,15	g	350025743600000256	13-36						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
1028	chr12	58192492	58192516	3500232262	23		58192492	58192516	8421504	2	14,9	0,15	g	350023226200000256	13-36					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
1029	chr12	58196114	58196140	3500439657	23		58196114	58196140	8421504	2	8,15	0,11	g	350043965700000001	0-25						Mutant cells having reduced expression of metallopeptidase, suitable for recombinant polypeptide production	Nielsen	2010	0		
1029	chr12	58269834	58269863	3500046238	23		58269834	58269863	8421504	3	4,13,6	0,5,23	g	350004623800000112	15-38						Alpha-amylase mutants	Tuo Bin *V*Bo Che Te 	2000	0		
1033	chr12	58836212	58836237	3500383784	23		58836212	58836237	8421504	2	16,7	0,18	g	350038378400000023	10-40						Expression-secretion vectors for the production of biologically active fv fragments	Anthony	1994	0		
1036	chr12	59191309	59191335	3500154222	25		59191309	59191335	8421504	2	7,18	0,8	g	350015422200000179	12-47						Molekularbiologische Untersuchungen der Ebola-Viren Zaire und Reston mit Hilfe reverser Genetik	ub.uni-marburg.de	0	0		
1039	chr12	59582934	59582957	3500037261	23		59582934	59582957	8421504	1	23	0	g	350003726100000182	15-39						ANTIBODIES TO IL-6 AND USE THEREOF - Patent application	www.faqs.org	0	0		
1041	chr12	59770239	59770263	3500368007	23		59770239	59770263	8421504	2	8,15	0,9	g	350036800700000017	0-23						M E T H O D S I N M O L E C U L A R M E D I C I N E Antibiotic Resistance	www.blogsua.com	0	0		
1041	chr12	59770239	59770263	3500165078	23		59770239	59770263	8421504	2	8,15	0,9	g	350016507800000001	0-23							ww.eurjmedres.com	0	0		
1042	chr12	59923535	59923563	3500271944	24		59923535	59923563	8421504	2	11,13	0,15	g	350027194400000041	0-24						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		
1044	chr12	60267648	60267677	3500228497	23		60267648	60267677	8421504	3	6,5,12	0,10,17	g	350022849700000029	24-47						Modulation of cytokinin activity in plants	J*E*Ha Ben 	2006	0		
1046	chr12	60493982	60494146	3500341810	50		60493982	60494146	8421504	2	45,5	0,159	g	350034181000000105	0-50						Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers	Challita-Eid	2004	0		
1046	chr12	60547878	60547902	3500046659	24		60547878	60547902	8421504	1	24	0	g	350004665900000051,350004665900000055	0-19,0-26						Impact of the innate immune response on mammary epithelia	ib.dr.iastate.edu	0	0		
1048	chr12	60736681	60736709	3500221376	25		60736681	60736709	8421504	2	5,20	0,8	g	350022137600000011	6-32						Martin-Luther-Universit&#xe4;t Halle-Wittenberg	thek.uni-halle.de	0	0		
1049	chr12	60912058	60912085	3500083925	25		60912058	60912085	8421504	2	14,11	0,16	g	350008392500000006	0-25						Hsp70-based treatment for autoimmune diseases	Holtet	2010	0		
1050	chr12	61056184	61056207	3500281686	23		61056184	61056207	8421504	1	23	0	g	350028168600000009,350028168600000000	0-23,0-23						Mannheimia Haemolytica Chimeric Outer Membrane Protein Pipe And Leukotoxin Epitopes As A Vaccine Or Vaccine Component Against Shipping Fever 	.freshpatents.com	0	0		
1058	chr12	62079169	62079370	3500076234	38		62079169	62079370	8421504	2	7,31	0,170	g	350007623400000106	22-60						PLASMA KALLIKREIN BINDING PROTEINS - Patent application	www.faqs.org	0	0		
1058	chr12	62079339	62079370	3500456704	31		62079339	62079370	8421504	1	31	0	g	350045670400000075	15-46						Detection of nucleic acid sequences by invader-directed cleavage	Brow	1996	0		
1058	chr12	62079339	62079370	3500425953	31		62079339	62079370	8421504	1	31	0	g	350042595300000088	15-46						Cleavage agents	www.devileye.net	0	0		
1058	chr12	62079339	62079370	3500396713	31		62079339	62079370	8421504	1	31	0	g	350039671300000004	93-124						THE dna joy OF	yon.eeb.uconn.edu	0	0		
1058	chr12	62079339	62079370	3500358015	31		62079339	62079370	8421504	1	31	0	g	350035801500000005,350035801500000011,350035801500000007	3-34,8-39,72-103						12 Appendix (243-278)	www.ebiotrade.com	0	0		
1058	chr12	62079339	62079370	3500327109	31		62079339	62079370	8421504	1	31	0	g	350032710900000092	15-46						Invasive cleavage of nucleic acids	Brow	1999	0		
1058	chr12	62079339	62079370	3500244146	31		62079339	62079370	8421504	1	31	0	g	350024414600000078	1-32						Recombinant equine herpesviruses	Chiang	1997	0		
1058	chr12	62079339	62079370	3500185527	31		62079339	62079370	8421504	1	31	0	g	350018552700000015	25-58						Plant parasitic nematode control	Gurr	1996	0		
1058	chr12	62079339	62079370	3500182146	31		62079339	62079370	8421504	1	31	0	g	350018214600000037	5-36						 Isolation And Identification Of Control Sequences And Genes Modulated By Transcription Factors 	www.docstoc.com	0	0		
1058	chr12	62079339	62079370	3500157423	31		62079339	62079370	8421504	1	31	0	g	350015742300000230	9-40						Vectors and methods for immunization or therapeutic protocols - Patent # 6339068 - PatentGenius	.patentgenius.com	0	0		
1058	chr12	62079339	62079370	3500152228	31		62079339	62079370	8421504	1	31	0	g	350015222800000100	15-46						Detection of nucleic acids by multiple sequential invasive cleavages	Hall	1997	0		
1058	chr12	62079339	62079370	3500139533	31		62079339	62079370	8421504	1	31	0	g	350013953300000092	15-46						Invasive cleavage of nucleic acids	Brow	1997	0		
1058	chr12	62079339	62079370	3500133350	31		62079339	62079370	8421504	1	31	0	g	350013335000000103	15-46						Fen-1 endonucleases, mixtures and cleavage methods	Kaiser	1998	0		
1058	chr12	62079339	62079370	3500110378	31		62079339	62079370	8421504	1	31	0	g	350011037800000078	1-32						Recombinant equine herpesviruses	Chiang	1995	0		
1058	chr12	62079339	62079370	3500089026	31		62079339	62079370	8421504	1	31	0	g	350008902600000072	1-32						Recombinant equine herpesviruses	Cochran	1994	0		
1058	chr12	62079339	62079370	3500068979	31		62079339	62079370	8421504	1	31	0	g	350006897900000072	1-32						Recombinant equine herpesviruses	Cochran	1995	0		
1058	chr12	62079339	62079370	3500016165	31		62079339	62079370	8421504	1	31	0	g	350001616500000071	15-46						 Detection Of Nucleic Acid Sequences By Invader 	www.docstoc.com	0	0		
1058	chr12	62079339	62079370	3500003486	31		62079339	62079370	8421504	1	31	0	g	350000348600000103	6-37						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		
1058	chr12	62079339	62079369	3500403475	30		62079339	62079369	8421504	1	30	0	g	350040347500000111,350040347500000020	9-39,0-19					Patent	DNA diagnostics based on mass spectrometry (Patent US:7198893)	Koster	2007	0		
1058	chr12	62079339	62079369	3500352650	30		62079339	62079369	8421504	1	30	0	g	350035265000000225,350035265000000111,350035265000000430,350035265000000020,350035265000000147	9-39,9-39,0-27,0-19,0-19						Dna Diagnostics Based On Mass Spectrometry 	.freshpatents.com	0	0		
1058	chr12	62079339	62079369	3500348251	30		62079339	62079369	8421504	1	30	0	g	350034825100000111,350034825100000021	9-39,0-19						DNA DIAGNOSTICS BASED ON MASS SPECTROMETRY	Koster	1999	0		
1058	chr12	62079339	62079369	3500297772	30		62079339	62079369	8421504	1	30	0	g	350029777200000000	11-41						ScienceDirect.com - Analytical Biochemistry - Characterization of DNA chips by nanogold staining	sciencedirect.com	0	0		
1058	chr12	62079339	62079369	3500218830	30		62079339	62079369	8421504	1	30	0	g	350021883000000014	57-87					Patent	Method of producing peptides or proteins as fusion proteins (Patent US:5506120)	Yamamoto	1996	0		
1058	chr12	62079339	62079369	3500210898	30		62079339	62079369	8421504	1	30	0	g	350021089800000001	7-37		19369543	10.1523/JNEUROSCI.0325-09.2009		The Journal of neuroscience : the official journal of the Society for Neuroscience	Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects	Irene	2009	0		
1058	chr12	62079339	62079369	3500179240	30		62079339	62079369	8421504	1	30	0	g	350017924000000010,350017924000000016	116-146,0-30						000 BST 2010Vol4No5-pp000-cover1234M	sciencetrends.com	0	0		
1058	chr12	62079339	62079369	3500171455	30		62079339	62079369	8421504	1	30	0	g	350017145500000092,350017145500000020	9-39,0-19						Dna diagnostics based on mass spectrometry	Braun	1998	0		
1058	chr12	62079339	62079369	3500157009	30		62079339	62079369	8421504	1	30	0	g	350015700900000000	11-41						Characterization Of Microarrays By Nanogold Staining 	.freshpatents.com	0	0		
1058	chr12	62079339	62079369	3500140868	30		62079339	62079369	8421504	1	30	0	g	350014086800000021	3-33					Patent	Replica amplification of nucleic acid arrays (Patent US:6511803)	Church	2003	0		
1058	chr12	62079339	62079369	3500132030	30		62079339	62079369	8421504	1	30	0	g	350013203000000016,350013203000000067,350013203000000018,350013203000000065	9-39,4-33,9-38,9-39						 Pfu Replication Accessory Factors And Methods Of Use 	www.docstoc.com	0	0		
1058	chr12	62079339	62079369	3500128303	30		62079339	62079369	8421504	1	30	0	g	350012830300000111,350012830300000379,350012830300000378,350012830300000020	9-39,0-27,74-101,0-19						 DNA Diagnostics Based On Mass Spectrometry 	www.docstoc.com	0	0		
1058	chr12	62079339	62079369	3500118887	30		62079339	62079369	8421504	1	30	0	g	350011888700000111,350011888700000381,350011888700000382,350011888700000020	9-39,74-101,0-27,0-19						DNA diagnostics based on mass spectrometry - US Patent 7198893 Description	ww.patentstorm.us	0	0		
1058	chr12	62079339	62079369	3500107493	30		62079339	62079369	8421504	1	30	0	g	350010749300000004	9-39						Methods for modulating fxr receptor activity	Beard	2002	0		
1058	chr12	62079339	62079369	3500076309	30		62079339	62079369	8421504	1	30	0	g	350007630900000105,350007630900000020	9-39,0-19						SureChem - Document - European Granted - Patent No. 1164203 - "DNA Diagnostics based on mass spectrometry" - Description	www.surechem.org	0	0		
1058	chr12	62079339	62079369	3500060414	30		62079339	62079369	8421504	1	30	0	g	350006041400000014,350006041400000007,350006041400000011,350006041400000005,350006041400000013,350006041400000003,350006041400000001,350006041400000009	9-39,0-27,0-27,0-27,0-27,0-27,0-27,0-27						The Candida albicans GAP gene family encodes permeases involved in general and specific amino acid uptake and sensing. - ResearchGate	.researchgate.net	0	0		
1058	chr12	62079339	62079369	3500051267	30		62079339	62079369	8421504	1	30	0	g	350005126700000105,350005126700000020	9-39,0-19						DNA Diagnostics based on mass spectrometry	Koster	1997	0		
1058	chr12	62079339	62079368	3500442232	29		62079339	62079368	8421504	1	29	0	g	350044223200000042	0-29						PCR Cloning Protocols	rary.bjcancer.org	0	0		
1058	chr12	62079339	62079368	3500391987	29		62079339	62079368	8421504	1	29	0	g	350039198700000001	8-37		18606811	10.1074/jbc.M803212200	0021-9258	Journal of Biological Chemistry	Cdt1 Forms a Complex with the Minichromosome Maintenance Protein (MCM) and Activates Its Helicase Activity	You	2008	5		
1058	chr12	62079339	62079368	3500326220	29		62079339	62079368	8421504	1	29	0	g	350032622000000037	0-29						Human prostaglandin receptors and methods of use thereof	Jonsson	2000	0		
1058	chr12	62079339	62079368	3500293458	29		62079339	62079368	8421504	1	29	0	g	350029345800000001	8-37		18606811	10.1074/jbc.M803212200		The Journal of Biological Chemistry	Cdt1 Forms a Complex with the Minichromosome Maintenance Protein (MCM) and Activates Its Helicase Activity	Zhiying	2008	0		
1058	chr12	62079339	62079368	3500281019	29		62079339	62079368	8421504	1	29	0	g	350028101900000049	0-29						Full text of "Protocols_molecular_biology"	archive.org	0	0		
1058	chr12	62079339	62079368	3500204835	29		62079339	62079368	8421504	1	29	0	g	350020483500000040,350020483500000041,350020483500000160,350020483500000159	1-30,0-29,0-29,1-30						Exogenous nucleic acid detection	www.devileye.net	0	0		
1058	chr12	62079339	62079368	3500154075	29		62079339	62079368	8421504	1	29	0	g	350015407500000121,350015407500000120,350015407500000119,350015407500000399,350015407500000598,350015407500000599	1-28,0-29,1-30,1-29,1-30,0-29						US Patent # 6,730,479. Detection of nucleic acid hybrids - Patents.com	www.patents.com	0	0		
1058	chr12	62079339	62079368	3500128873	29		62079339	62079368	8421504	1	29	0	g	350012887300000007	8-37						Compositions and methods utilizing DNA polymerases	Sorge	2000	0		
1058	chr12	62079339	62079368	3500104241	29		62079339	62079368	8421504	1	29	0	g	350010424100000082,350010424100000083	1-30,0-29						Methods for determining the presence of nucleic acid target sequences and applications thereof	Andrews	2000	0		
1058	chr12	62079339	62079367	3500443697	28		62079339	62079367	8421504	1	28	0	g	350044369700000009	3-31						Delta-5 Desaturase And Uses Thereof 	.freshpatents.com	0	0		
1058	chr12	62079339	62079367	3500250715	28		62079339	62079367	8421504	1	28	0	g	350025071500000009	3-31						Desaturase genes and uses thereof	Mukerji	2011	0		
1058	chr12	62079339	62079367	3500219299	28		62079339	62079367	8421504	1	28	0	g	350021929900000121	3-31						Production of Very Long Chain Polyunsaturated Fatty Acids in Oil Seed Plants - Patent application	www.faqs.org	0	0		
1058	chr12	62079339	62079367	3500037214	28		62079339	62079367	8421504	1	28	0	g	350003721400000003	21-49			10.1128/MCB.21.21.7199-7206.2001		Molecular and Cellular Biology	Physical and Functional Interactions of Human DNA Polymerase &#x03b7; with PCNA	Lajos	2001	0		
1058	chr12	62079339	62079367	3500020867	28		62079339	62079367	8421504	1	28	0	g	350002086700000041,350002086700000020	7-35,11-30						US Patent # 7,192,761. Actinobacillus succinogenes shuttle vector and methods of use - Patents.com	www.patents.com	0	0		
1058	chr12	62079339	62079366	3500402702	27		62079339	62079366	8421504	1	27	0	g	350040270200000029	0-27			10.1042/BJ20061004		Biochemical Journal	A novel interaction between DNA ligase III and DNA polymerase &#x03b3; plays an essential role in mitochondrial DNA stability	Ananya	2007	0		
1058	chr12	62079339	62079365	3500372918	26		62079339	62079365	8421504	1	26	0	g	350037291800000033	9-35						Polypeptide mit Nukleins&#xe4;urebindungsaktivit&#xe4;t und Zusammensetzungen und Verfahren zur Nukleins&#xe4;urenamplifikation - Dokument EP2208796	www.patent-de.com	0	0		
1058	chr12	62079339	62079365	3500296649	26		62079339	62079365	8421504	1	26	0	g	350029664900000005	9-35		16356773	10.1016/j.ymthe.2005.10.015	1525-0016	Molecular Therapy	Sleeping Beauty-Mediated Transposition and Long-term Expression in Vivo: Use of the LoxP/Cre Recombinase System to Distinguish Transposition-Specific Expression	Score	2006	7		
1058	chr12	62079339	62079365	3500252631	26		62079339	62079365	8421504	1	26	0	g	350025263100000004	10-36						Functional site of CD9 in gamete fusion	ev.biologists.org	0	0		
1058	chr12	62079339	62079365	3500230467	26		62079339	62079365	8421504	1	26	0	g	350023046700000011,350023046700000008	17-43,0-19						The Engineering of Riboswitch-Based Sensors of Small Molecules in Bacteria and Their Application in the Study of Vitamin B12 Biology	mmons.mcmaster.ca	0	0		
1058	chr12	62079339	62079365	3500150531	26		62079339	62079365	8421504	1	26	0	g	350015053100000008,350015053100000055	3-29,3-29						US Patent # 6,344,541. DKR polypeptides - Patents.com	www.patents.com	0	0		
1058	chr12	62079339	62079364	3500456435	25		62079339	62079364	8421504	1	25	0	g	350045643500000000	10-35		11784855	10.1128/MCB.22.3.784-791.2002	0270-7306	Molecular and Cellular Biology	Stimulation of DNA Synthesis Activity of Human DNA Polymerase &#x03ba; by PCNA	Haracska	2002	6		
1058	chr12	62079339	62079364	3500138507	25		62079339	62079364	8421504	1	25	0	g	350013850700000005	0-25						Laser-Induced Protein-DNA Cross-Links via Psoralen Furanside Monoadductst	chem.berkeley.edu	0	0		
1058	chr12	62079340	62079368	3500333376	23		62079340	62079368	8421504	2	6,17	0,11	g	350033337600000000	13-37		7559445	10.1074/jbc.270.39.23055	0021-9258	Journal of Biological Chemistry	L- and D-Enantiomers of 2&#x2032;,3&#x2032;-Dideoxycytidine 5&#x2032;-Triphosphate Analogs as Substrates for Human DNA Polymerases	Kukhanova	1995	5		
1058	chr12	62079340	62079365	3500073184	25		62079340	62079365	8421504	1	25	0	g	350007318400000001	21-46						Distance-dependent translational coupling and interference in 	b.eldoc.ub.rug.nl	0	0		
1058	chr12	62079340	62079364	3500263756	24		62079340	62079364	8421504	1	24	0	g	350026375600000038	0-24						GAMMA SATELLITE INSULATOR SEQUENCES AND THEIR USE IN PREVENTING GENE SILENCING - Patent application	www.faqs.org	0	0		
1058	chr12	62079340	62079363	3500166675	23		62079340	62079363	8421504	1	23	0	g	350016667500000088,350016667500000152	16-39,13-36						US Patent # 7,501,484. Methods and DNA constructs for high yield production of polypeptides - Patents.com	www.patents.com	0	0		
1058	chr12	62079340	62079363	3500022487	23		62079340	62079363	8421504	1	23	0	g	350002248700000028	16-39						Methods and dna constructs for high yield production of polypeptides	Harley	2003	0		
1058	chr12	62079341	62079379	3500439021	36		62079341	62079379	8421504	2	29,7	0,31	g	350043902100000000	5-41						Stimulation of RTH1 Nuclease of the Yeast Saccharomyces cereVisiae by Replication Protein A	www.bio.fsu.edu	0	0		
1058	chr12	62079341	62079370	3500448160	29		62079341	62079370	8421504	1	29	0	g	350044816000000000	1-31		17287860	10.1038/sj.gt.3302911	0969-7128	Gene Therapy	Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma	Hannay	2007	4		
1058	chr12	62079341	62079370	3500429955	29		62079341	62079370	8421504	1	29	0	g	350042995500000004	1-30						Cellular Transgenic Mice Expressing LHX3 Transcription Factor Isoforms in the Pituitary: Effects on the Gonadotrope Axis and Sex-Speci&#xfb01;c Reproductive Disease	lue.lib.umich.edu	0	0		
1058	chr12	62079341	62079370	3500341581	29		62079341	62079370	8421504	1	29	0	g	350034158100000027,350034158100000007	1-30,1-30						Hedgehog Inhibitor Assay 	.freshpatents.com	0	0		
1058	chr12	62079341	62079370	3500224087	29		62079341	62079370	8421504	1	29	0	g	350022408700000007	1-30						Hedgehog inhibitor assay	Toftgard	2008	0		
1058	chr12	62079341	62079370	3500107203	29		62079341	62079370	8421504	1	29	0	g	350010720300000006	1-30						Transgenic Mice Expressing LHX Transcription Factor Isoforms in	www.docstoc.com	0	0		
1058	chr12	62079341	62079370	3500096739	29		62079341	62079370	8421504	1	29	0	g	350009673900000011	1-30						Hedgehog inhibitor assay	Lauth	2012	0		
1058	chr12	62079341	62079370	3500066495	29		62079341	62079370	8421504	1	29	0	g	350006649500000002	17-46						Public data TCell Lymphoma Project	tagc.univ-mrs.fr	0	0		
1058	chr12	62079341	62079369	3500148799	28		62079341	62079369	8421504	1	28	0	g	350014879900000007	0-28						IL-17 receptor like molecules and uses thereof	Medlock	2001	0		
1058	chr12	62079341	62079369	3500060271	28		62079341	62079369	8421504	1	28	0	g	350006027100000007,350006027100000117	0-28,0-23						IL-17 receptor like molecules and uses thereof - US Patent 7094566 Description	ww.patentstorm.us	0	0		
1058	chr12	62079341	62079368	3500276902	27		62079341	62079368	8421504	1	27	0	g	350027690200000025,350027690200000056	16-43,16-43						Solubilization and Purification of a Target Protein fused to a Mutant Maltose-Binding Protein - Patent application	www.faqs.org	0	0		
1058	chr12	62079341	62079365	3500031927	24		62079341	62079365	8421504	1	24	0	g	350003192700000000	0-24		11602760	10.1128/JVI.75.22.11205-11217.2001	0022-538X	Journal of Virology	Folding of Hepatitis C Virus E1 Glycoprotein in a Cell-Free System	Merola	2001	5		
1058	chr12	62079342	62079370	3500146501	28		62079342	62079370	8421504	1	28	0	g	350014650100000332,350014650100000331	2-30,2-21					Patent	GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants (Patent CN:1665934)	D*E*A*Fu Luo La Ke 	2010	0		
1058	chr12	62079342	62079365	3500179831	23		62079342	62079365	8421504	1	23	0	g	350017983100000125	0-23						Composition for inducing pluripotent stem cell, and use thereof	Ban	2012	0		
1058	chr12	62079342	62079365	3500178819	23		62079342	62079365	8421504	1	23	0	g	350017881900000065	0-23						COMPOSITION FOR INDUCING PLURIPOTENT STEM CELL, AND USE THEREOF	Ban	2011	0		
1058	chr12	62079343	62079370	3500243985	27		62079343	62079370	8421504	1	27	0	g	350024398500000007	25-52						PLANT PARASITIC NEMATODE CONTROL - THE UNIVERSITY OF LEEDS GURR	www.sumobrain.com	0	0		
1058	chr12	62079343	62079370	3500071253	27		62079343	62079370	8421504	1	27	0	g	350007125300000007	25-52						Plant parasitic nematode control	Atkinson	1993	0		
1058	chr12	62079343	62079368	3500446540	25		62079343	62079368	8421504	1	25	0	g	350044654000000017	0-25						Method of preparing transgenic organism with use of methylation and system therefor	Takeda	2004	0		
1058	chr12	62079343	62079368	3500443908	25		62079343	62079368	8421504	1	25	0	g	350044390800000006	0-25		15082793	10.1128/MCB.24.9.4004-4018.2004	0270-7306	Molecular and Cellular Biology	Enhancement of Sleeping Beauty Transposition by CpG Methylation: Possible Role of Heterochromatin Formation	Yusa	2004	6		
1058	chr12	62079343	62079368	3500315289	25		62079343	62079368	8421504	1	25	0	g	350031528900000000	0-25						INTERNATIONAL MAIZE AND WHEAT IMPROVEMENT CENTER LABORATORY PROTOCOLS	sitory.cimmyt.org	0	0		
1058	chr12	62079343	62079368	3500292092	25		62079343	62079368	8421504	1	25	0	g	350029209200000006	0-25						Enhancement of Sleeping Beauty Transposition by CpG Methylation: Possible Role of Heterochromatin Formation	mcb.asm.org	0	0		
1058	chr12	62079343	62079368	3500217683	25		62079343	62079368	8421504	1	25	0	g	350021768300000017,350021768300000229	0-25,0-25						Method Of Preparing Transgenic Organism With Use Of Methylation And System Therefor 	.freshpatents.com	0	0		
1058	chr12	62079343	62079368	3500176768	25		62079343	62079368	8421504	1	25	0	g	350017676800000000	0-25						INTERNATIONAL MAIZE AND WHEAT IMPROVEMENT CENTER LABORATORY PROTOCOLS	sitory.cimmyt.org	0	0		
1058	chr12	62079343	62079367	3500437719	24		62079343	62079367	8421504	1	24	0	g	350043771900000116	0-24						[tel-00007807, v1] Expression et &#xe9;volution de g&#xe8;nes de la famille des ARN h&#xe9;licases &#xe0; bo&#xee;te DEAD chez Arabidopsis thaliana (L.) Heynh	hives-ouvertes.fr	0	0		
1058	chr12	62079343	62079367	3500362691	24		62079343	62079367	8421504	1	24	0	g	350036269100000079	0-24						Highly polymorphic microsatellites 00Graphicraft Limited, Hong Kong in the lacertid Gallotia galloti	ents.plant.wur.nl	0	0		
1058	chr12	62079343	62079367	3500221137	24		62079343	62079367	8421504	1	24	0	g	350022113700000116	0-24						[tel-00007807, v1] Expression et &#xe9;volution de g&#xe8;nes de la famille des ARN h&#xe9;licases &#xe0; bo&#xee;te DEAD chez Arabidopsis thaliana (L.) Heynh	hives-ouvertes.fr	0	0		
1058	chr12	62079343	62079367	3500041159	24		62079343	62079367	8421504	1	24	0	g	350004115900000000	0-24						Diversity and Abundance of Sulfur-Oxidizing Bacteria in Wadden Sea Sediments Revealed by DsrAB Phylogeny and dsrAB-Targeted Real-Time PCR	www.marmic.mpg.de	0	0		
1058	chr12	62079343	62079367	3500014982	24		62079343	62079367	8421504	1	24	0	g	350001498200000118	0-24						&#x201e;Das AUACCC-bindende Protein Khd4 kontrolliert Morphogenese und Pathogenit&#xe4;t in Ustilago maydis&#x201c;	ub.uni-marburg.de	0	0		
1058	chr12	62079343	62079367	3500008262	24		62079343	62079367	8421504	1	24	0	g	350000826200000023	0-24		16844832	10.1104/pp.106.083824	0032-0889	Plant Physiology	The Multigene Family Encoding Germin-Like Proteins of Barley. Regulation and Function in Basal Host Resistance	Zimmermann	2006	7		
1058	chr12	62079344	62079369	3500434772	25		62079344	62079369	8421504	1	25	0	g	350043477200000004	2-27						DNA polymerase having modified nucleotide binding site for DNA sequencing	Tabor	1994	0		
1058	chr12	62079344	62079369	3500245017	25		62079344	62079369	8421504	1	25	0	g	350024501700000003,350024501700000002	2-27,2-27					Patent	DNA polymerases (Patent EP:0727496)	Richardson	2009	0		
1058	chr12	62079344	62079369	3500143785	25		62079344	62079369	8421504	1	25	0	g	350014378500000002,350014378500000003	2-27,2-27						Dna polymerases having modified nucleotide binding site for dna sequencing		1996	0		
1058	chr12	62079344	62079368	3500459676	24		62079344	62079368	8421504	1	24	0	g	350045967600000001	0-24		9305914	10.1074/jbc.272.39.24508	0021-9258	Journal of Biological Chemistry	A DNA Helicase Activity Is Associated with an MCM4, -6, and -7 Protein Complex	Ishimi	1997	5		
1058	chr12	62079344	62079368	3500399853	24		62079344	62079368	8421504	1	24	0	g	350039985300000004	0-24						HCL-K1 Polypeptide Which Offers Collectin Activity	Wakamiya	2012	0		
1058	chr12	62079344	62079368	3500318663	24		62079344	62079368	8421504	1	24	0	g	350031866300000005	0-24		12513991	10.1128/AEM.69.1.162-169.2003	0099-2240	Applied and Environmental Microbiology	Collagenolytic Serine-Carboxyl Proteinase from Alicyclobacillus sendaiensis Strain NTAP-1: Purification, Characterization, Gene Cloning, and Heterologous Expression	Tsuruoka	2003	4		
1058	chr12	62079344	62079368	3500295686	24		62079344	62079368	8421504	1	24	0	g	350029568600000009	0-24						Struktur-Funktions-Beziehungen	ebdoc.sub.gwdg.de	0	0		
1058	chr12	62079344	62079368	3500293740	24		62079344	62079368	8421504	1	24	0	g	350029374000000000	0-24						Scavenger receptors	Wakamiya	2001	0		
1058	chr12	62079344	62079368	3500283498	24		62079344	62079368	8421504	1	24	0	g	350028349800000000	0-24						ANNUAL WHEAT NEWSLETTER	krex.k-state.edu	0	0		
1058	chr12	62079344	62079368	3500271338	24		62079344	62079368	8421504	1	24	0	g	350027133800000004	0-24						NOVEL COLLECTIN	Wakamiya	2011	0		
1058	chr12	62079344	62079368	3500259665	24		62079344	62079368	8421504	1	24	0	g	350025966500000004	0-24						HCL-K1 Polypeptide Which Offers Collectin Activity - Patent application	www.faqs.org	0	0		
1058	chr12	62079344	62079368	3500234195	24		62079344	62079368	8421504	1	24	0	g	350023419500000000,350023419500000118	0-24,24-48					Patent	Novel scavenger receptor (Patent CN:101319010)	Ruo Gong Shen Long 	2013	0		
1058	chr12	62079344	62079368	3500228947	24		62079344	62079368	8421504	1	24	0	g	350022894700000002	0-24						Allelic series of genomic modifications in cells	Avner	1999	0		
1058	chr12	62079344	62079368	3500163394	24		62079344	62079368	8421504	1	24	0	g	350016339400000016	0-24						Methods for producing probes capable of distinguishing DNA from related sources	Wigler	1993	0		
1058	chr12	62079344	62079368	3500079736	24		62079344	62079368	8421504	1	24	0	g	350007973600000011	0-24						METHODS IN MOLECULAR BIOLOGY	jpkc.yzu.edu.cn	0	0		
1058	chr12	62079344	62079368	3500079591	24		62079344	62079368	8421504	1	24	0	g	350007959100000004	0-24						Novel collectins	Keshi	2003	0		
1058	chr12	62079344	62079368	3500059709	24		62079344	62079368	8421504	1	24	0	g	350005970900000002	0-24						Methods in Molecular Biology Vol.133 Gene Targeting Protocols	www.scribd.com	0	0		
1058	chr12	62079344	62079368	3500029631	24		62079344	62079368	8421504	1	24	0	g	350002963100000004	0-24					Patent	Collectin (Patent US:7985833)	Wakamiya	2011	0		
1058	chr12	62079344	62079367	3500360535	23		62079344	62079367	8421504	1	23	0	g	350036053500000016	0-23						Loss of Heterozygosity and Mutation Analysis of DNA Repair Genes Rad51, XRCC2 and XRCC3 in Sporadic Breast Cancer Patients	d-nb.info/9639352	0	0		
1058	chr12	62079345	62079370	3500215746	25		62079345	62079370	8421504	1	25	0	g	350021574600000061,350021574600000013	27-52,32-57						US Patent # 7,314,925. Constructs and methods for expression of recombinant HCV envelope proteins - Patents.com	www.patents.com	0	0		
1058	chr12	62079345	62079370	3500085146	25		62079345	62079370	8421504	1	25	0	g	350008514600000059	27-52						US Patent # 7,238,356. Core-glycosylated HCV envelope proteins - Patents.com	www.patents.com	0	0		
1058	chr12	62079345	62079370	3500044348	25		62079345	62079370	8421504	1	25	0	g	350004434800000013,350004434800000055	32-57,27-52						 Constructs And Methods For Expression Of Recombinant HCV Envelope Proteins 	www.docstoc.com	0	0		
1058	chr12	62079345	62079368	3500380665	23		62079345	62079368	8421504	1	23	0	g	350038066500000022	0-23						Transgenic animals with alzheimer's amyloid precursor gene	Greenberg	1992	0		
1058	chr12	62079345	62079368	3500072753	23		62079345	62079368	8421504	1	23	0	g	350007275300000002	0-23						Two Component DNA Replicases with Modified Beta-Subunit Binding Motifs, and Uses Thereof	Peters	2006	0		
1058	chr12	62079345	62079368	3500017616	23		62079345	62079368	8421504	1	23	0	g	350001761600000045	0-23						Killer cell Immunoglobulin-like Receptor (KIR) polymorphism in Haematopoietic Stem Cell Transplantation (HSCT)	ive.library.uu.nl	0	0		
1058	chr12	62079346	62079379	3500132953	31		62079346	62079379	8421504	2	24,7	0,26	g	350013295300000005,350013295300000004	42-73,42-73		18006494	10.1074/jbc.M708072200	0021-9258	Journal of Biological Chemistry	Processing of a Psoralen DNA Interstrand Cross-link by XPF-ERCC1 Complex in Vitro	Fisher	2008	5		
1058	chr12	62079346	62079379	3500092397	31		62079346	62079379	8421504	2	24,7	0,26	g	350009239700000000,350009239700000001	0-31,42-73		14734547	10.1074/jbc.M313779200	0021-9258	Journal of Biological Chemistry	Physical and Functional Interaction between the XPF/ERCC1 Endonuclease and hRad52	Motycka	2004	5		
1058	chr12	62079347	62079370	3500116593	23		62079347	62079370	8421504	1	23	0	g	350011659300000020	4-27						Use of DNA polymerases	Janulaitis	2009	0		
1058	chr12	62079347	62079370	3500008545	23		62079347	62079370	8421504	1	23	0	g	350000854500000027	0-23						ADAPTIVE MUTATIONS ALLOW ESTABLISHMENT OF JFH1-BASED CELL CULTURE SYSTEMS FOR HEPATITIS C VIRUS GENOTYPE 4A	Scheel	2008	0		
1058	chr12	62079350	62079376	3500113280	26		62079350	62079376	8421504	1	26	0	g	350011328000000016,350011328000000023	0-20,0-25						Glutathione S-transferase Sequence Variants 	.freshpatents.com	0	0		
1058	chr12	62079351	62079378	3500235499	25		62079351	62079378	8421504	2	19,6	0,21	g	350023549900000046,350023549900000036	0-25,2-27						Double-strand nucleic acids with one or two individual strand 5' overhangs, method for production and use thereof	Postina	2002	0		
1062	chr12	62558965	62558994	3500443601	23		62558965	62558994	8421504	3	12,6,5	0,17,24	g	350044360100000041	25-48						Method of making a protein polymer and uses of the polymer	Short	2001	0		
1066	chr12	63123940	63123966	3500382274	26		63123940	63123966	8421504	1	26	0	g	350038227400000037	0-26						Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof	Dubensky	2004	0		
1070	chr12	63674200	63674224	3500343734	23		63674200	63674224	8421504	2	14,9	0,15	g	350034373400000174	5-28					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
1071	chr12	63806205	63806230	3500179832	25		63806205	63806230	8421504	1	25	0	g	350017983200000056	9-38						Hepatitis c virus epitopes	Kim	1991	0		
1072	chr12	63851606	63851632	3500228200	23		63851606	63851632	8421504	2	8,15	0,11	g	350022820000000643	24-47						Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence	F*Ke En Te Jin 	2005	0		
1074	chr12	64149180	64149208	3500155813	23		64149180	64149208	8421504	2	12,11	0,17	g	350015581300000005,350015581300000096	4-27,4-27						POLY-N-ACETYL GLUCOSAMINE (PNAG/DPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
1075	chr12	64292957	64292981	3500073501	23		64292957	64292981	8421504	2	9,14	0,10	g	350007350100000000	0-23		18614617	10.1152/ajprenal.90308.2008		American Journal of Physiology - Renal Physiology	Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension	Banday	2008	0		
1076	chr12	64462737	64463496	3500013455	139		64462737	64463496	8421504	6	26,22,25,23,21,22	0,137,319,447,623,737	c,g	350001345500000069,350001345500000069,350001345500000282,350001345500000283,350001345500000041,350001345500000001,350001345500000285,350001345500000285	0-26,0-26,0-22,0-23,0-46,0-23,0-22,0-22						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		MIR17HG
1076	chr12	64462737	64462762	3500000661	25		64462737	64462762	8421504	1	25	0	c	350000066100000008	0-25		23288173	10.1161/ATVBAHA.112.300415	1079-5642	Arteriosclerosis, Thrombosis, and Vascular Biology	Histone Deacetylase 9 Promotes Angiogenesis by Targeting the Antiangiogenic MicroRNA-17&#x2013;92 Cluster in Endothelial Cells	Kaluza	2013	6		MIR17HG
1076	chr12	64462739	64463496	3500125321	92		64462739	64463496	8421504	4	24,23,23,22	0,445,619,735	c	350012532100000002,350012532100000024,350012532100000051,350012532100000001,350012532100000062	0-24,0-23,0-23,0-23,0-22						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIR17HG
1076	chr12	64462739	64463242	3500114594	69		64462739	64463242	8421504	3	24,23,22	0,135,481	c	350011459400000385,350011459400000384,350011459400000811,350011459400000812,350011459400000386,350011459400000813,350011459400000388,350011459400000815	0-24,0-23,0-23,0-24,0-23,0-23,0-22,0-22						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		
1076	chr12	64462739	64463079	3500304886	67		64462739	64463079	8421504	3	24,20,23	0,37,317	c,g	350030488600000007,350030488600000065,350030488600000005,350030488600000005,350030488600000081	0-24,0-24,0-20,0-20,0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		MIR17HG
1076	chr12	64462739	64462796	3500208886	44		64462739	64462796	8421504	2	24,20	0,37	c,g	350020888600000007,350020888600000005,350020888600000005	0-24,0-20,0-20						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL	Soreq	2008	0		
1076	chr12	64462739	64462765	3500128948	26		64462739	64462765	8421504	1	26	0	g	350012894800000002	45-71						IdentificationofSmallMoleculesThatSuppressMicroRNA FunctionandReverseTumorigenesis	www.jbc.org	0	0		
1076	chr12	64462739	64462763	3500402920	24		64462739	64462763	8421504	1	24	0	c	350040292000000005,350040292000000004	5-29,5-29						Identification and Analysis of Dicer Associated Proteins in Human Cells Inaugurationsdissertation	edoc.unibas.ch	0	0		
1076	chr12	64462739	64462763	3500027914	24		64462739	64462763	8421504	1	24	0	c,g	350002791400000021,350002791400000021,350002791400000110,350002791400000110	0-24,0-24,0-24,0-24						QUANTITATIVE MOLECULAR PROBES - Patent application	www.faqs.org	0	0		
1076	chr12	64462739	64462763	3500010232	24		64462739	64462763	8421504	1	24	0	c	350001023200000002	0-24		21857646	10.1038/emboj.2011.301	ERROR! NO ISSN	The EMBO Journal	CAMTA1 is a novel tumour suppressor regulated by miR-9/9&ast; in glioblastoma stem cells	Schraivogel	2011	0		MIR17HG
1076	chr12	64462739	64462762	3500352593	23		64462739	64462762	8421504	1	23	0	c	350035259300000002	0-23						A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. - ResearchGate	.researchgate.net	0	0		
1076	chr12	64462739	64462762	3500139708	23		64462739	64462762	8421504	1	23	0	c	350013970800000032,350013970800000016	0-23,0-23						METHODS AND COMPOSITIONS FOR THE TREATMENT OF ERYTHROCYTE DISEASES - Patent application	www.faqs.org	0	0		
1076	chr12	64462869	64462940	3500465622	71		64462869	64462940	8421504	1	71	0	c,g	350046562200000023,350046562200000023	0-71,0-71						ISSN 1684 - 5315 Volume 10 Number 18 2 May, 2011	demicjournals.org	0	0		MIR17HG
1076	chr12	64462869	64462940	3500125620	71		64462869	64462940	8421504	1	71	0	c,g	350012562000000297,350012562000000297	0-71,0-71						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION - Patent application	www.faqs.org	0	0		MIR17HG
1076	chr12	64462874	64463079	3500287752	45		64462874	64463079	8421504	2	22,23	0,182	c,g	350028775200000029,350028775200000029,350028775200000030,350028775200000036,350028775200000035	0-22,0-22,0-22,0-23,0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		MIR17HG
1076	chr12	64462874	64462936	3500191604	43		64462874	64462936	8421504	2	22,21	0,41	c,g	350019160400000000,350019160400000001,350019160400000001	0-22,0-21,0-21						ScienceDirect.com - FEBS Letters - Regulation of chondrocytic phenotype by micro RNA 18a: Involvement of Ccn2/Ctgf as a major target gene	sciencedirect.com	0	0		MIR17HG
1076	chr12	64462874	64462897	3500428956	23		64462874	64462897	8421504	1	23	0	g	350042895600000067	0-23						Role and regulatory mechanisms of heat shock factor 2	www.doria.fi	0	0		MIR106A
1076	chr12	64462874	64462897	3500035080	23		64462874	64462897	8421504	1	23	0	c	350003508000000003	0-23						EXHALED NUCLEIC ACID DETECTION FOR NON-INVASIVE ASSESSMENT OF THE LUNG - ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY	www.sumobrain.com	0	0		MIR106A,MIR17HG
1076	chr12	64463056	64463382	3500306543	43		64463056	64463382	8421504	2	21,22	0,304	c	350030654300000011,350030654300000010	0-21,0-22		18694959	10.1128/MCB.00923-08		Molecular and Cellular Biology	Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells 	Li	2008	0		MIR17HG
1076	chr12	64463056	64463079	3500362605	23		64463056	64463079	8421504	1	23	0	c	350036260500000001	0-23		20689055	10.1152/ajpgi.00216.2010		American Journal of Physiology - Gastrointestinal and Liver Physiology	Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid	Rui	2010	0		MIR92A2,MIR17HG
1076	chr12	64463056	64463079	3500089055	23		64463056	64463079	8421504	1	23	0	c	350008905500000007,350008905500000006,350008905500000005,350008905500000004,350008905500000041	0-23,0-23,0-23,0-23,0-23						Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides	ELMEN	2010	0		MIR17HG
1076	chr12	64463184	64463243	3500044986	46		64463184	64463243	8421504	2	23,23	0,36	c,g	350004498600000000,350004498600000000,350004498600000001,350004498600000001	0-23,0-23,0-23,0-23						Tandem affinity purification of miRNA target mRNAs (TAP-Tar)	cancer.ucsf.edu	0	0		MIR17HG
1076	chr12	64463184	64463207	3500453264	23		64463184	64463207	8421504	1	23	0	c	350045326400000000	0-23						RESEARCH ARTICLE Open Access Unique small RNA signatures uncovered in the tammar wallaby genome	biomedcentral.com	0	0		MIR17HG
1076	chr12	64463184	64463207	3500286156	23		64463184	64463207	8421504	1	23	0	c	350028615600000000	0-23		23075437	10.1186/1471-2164-13-559	1471-2164	BMC Genomics	Unique small RNA signatures uncovered in the tammar wallaby genome	Lindsay	2012	4		MIR17HG
1076	chr12	64463184	64463207	3500131966	23		64463184	64463207	8421504	1	23	0	c	350013196600000067	0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR17HG
1076	chr12	64463220	64463343	3500254286	45		64463220	64463343	8421504	2	22,23	0,100	c,g	350025428600000015,350025428600000015,350025428600000014	0-22,0-22,0-23						Mirnas dysregulated in triple-negative breast cancer	Richer	2011	0		MIR17HG
1076	chr12	64463220	64463343	3500171540	45		64463220	64463343	8421504	2	22,23	0,100	c,g	350017154000000015,350017154000000015,350017154000000014	0-22,0-22,0-23						MiRNAs dysregulated in triple-negative breast cancer	Richer	2010	0		
1076	chr12	64463220	64463343	3500003566	45		64463220	64463343	8421504	2	22,23	0,100	c	350000356600000015,350000356600000014	0-22,0-23						MIRNAS DYSREGULATED IN TRIPLE-NEGATIVE BREAST CANCER	Richer	2010	0		MIR17HG
1076	chr12	64463320	64463381	3500172796	44		64463320	64463381	8421504	2	21,23	0,38	c	350017279600000007,350017279600000006	0-21,0-23		20008935	10.1101/gad.1861409	0890-9369	Genes & Development	miR-19 is a key oncogenic component of mir-17-92	Olive	2009	12		MIR17HG
1076	chr12	64463358	64463382	3500428031	24		64463358	64463382	8421504	1	24	0	c	350042803100000013,350042803100000012,350042803100000038,350042803100000015,350042803100000014	0-23,0-23,0-24,0-23,0-23						Pharmaceutical Composition 	.freshpatents.com	0	0		
1076	chr12	64463358	64463381	3500400605	23		64463358	64463381	8421504	1	23	0	c	350040060500000001	0-23		20689055	10.1152/ajpgi.00216.2010		American Journal of Physiology - Gastrointestinal and Liver Physiology	Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid	Castro	2010	0		MIR17HG
1076	chr12	64463358	64463381	3500185563	23		64463358	64463381	8421504	1	23	0	c	350018556300000031,350018556300000006,350018556300000007,350018556300000004	0-23,0-23,0-23,0-23						Pharmaceutical Composition	Elmen	2012	0		MIR17HG
1076	chr12	64463358	64463381	3500043594	23		64463358	64463381	8421504	1	23	0	c	350004359400000006,350004359400000005,350004359400000004,350004359400000043,350004359400000007	0-23,0-23,0-23,0-23,0-23						Pharmaceutical Composition - Patent application	www.faqs.org	0	0		MIR17HG
1076	chr12	64463358	64463381	3500006338	23		64463358	64463381	8421504	1	23	0	c	350000633800000001	0-23		20689055	10.1152/ajpgi.00216.2010		American Journal of Physiology - Gastrointestinal and Liver Physiology	Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid	Castro	2010	0		MIR17HG
1076	chr12	64475102	64475132	3500126303	28		64475102	64475132	8421504	3	9,4,15	0,10,15	g	350012630300000104	1-34						Recombinant Dna Constructs And Methods For Controlling Gene Expression 	.freshpatents.com	0	0		
1078	chr12	64709707	64709731	3500104098	24		64709707	64709731	8421504	1	24	0	g	350010409800000190	17-43						METHOD OF DETECTING HUMAN PAPILLOMA VIRUS BY USING NUCLEIC ACID AMPLIFICATION METHOD AND NUCLEIC ACID CHAIN-IMMOBILIZED CARRIER - Patent application	www.faqs.org	0	0		
1080	chr12	64992791	64992819	3500428920	27		64992791	64992819	8421504	2	4,23	0,5	g	350042892000000257	16-43					Patent	Chitinase encoding DNA molecules from cotton expressed preferentially in secondary walled cells during secondary wall deposition and a corresponding promoter (Patent CN:100564528)	C*H*Hai Ge Le 	2009	0		
1080	chr12	64992791	64992819	3500001057	27		64992791	64992819	8421504	2	4,23	0,5	g	350000105700000257	16-43					Patent	Chitinase encoding DNA molecules from cotton expressed preferentially in secondary walled cells during secondary wall deposition and a corresponding promoter (Patent CN:100564528)	C*H*Hai Ge Le 	2009	0		
1081	chr12	65071639	65071664	3500460185	23		65071639	65071664	8421504	2	16,7	0,18	g	350046018500000005	0-24						nucleic acid molecule for encoding xylose isomerase and xylose isomerase encoded by the nucleic acid molecule	Bao	2012	0		
1081	chr12	65071639	65071664	3500168588	23		65071639	65071664	8421504	2	16,7	0,18	g	350016858800000010	0-24						Nucleic acid molecule encoding xylose isomerase and xylose isomerase encoded thereof	Bao	2012	0		
1084	chr12	65482774	65482797	3500304200	23		65482774	65482797	8421504	1	23	0	c	350030420000000491	3-26					Patent	Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use (Patent CN:1578678)	G*Gao 	2010	0		
1084	chr12	65482774	65482797	3500115116	23		65482774	65482797	8421504	1	23	0	c	350011511600000191	15-38						Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use	J*M*Wei Er Sen 	2005	0		
1087	chr12	65828794	65829086	3500166204	279		65828794	65829086	8421504	3	11,160,108	0,13,184	g	350016620400000081	387-679						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1089	chr12	66082877	66082901	3500192599	23		66082877	66082901	8421504	2	8,15	0,9	g	350019259900000003	2-25						dubnium 257: Topics by Science.gov	www.science.gov	0	0		
1090	chr12	66236695	66236721	3500186204	23		66236695	66236721	8421504	2	15,8	0,18	g	350018620400000370	11-34						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
1091	chr12	66370859	66370883	3500200278	24		66370859	66370883	8421504	1	24	0	c	350020027800000027	0-24			10.1002/dvdy.10298	1097-0177	Developmental Dynamics	Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development - Ford-Perriss - 2003 - Developmental Dynamics - Wiley Online Library	Ford-Perriss	2003	0		
1092	chr12	66511386	66511415	3500216486	24		66511386	66511415	8421504	2	15,9	0,20	c	350021648600000012,350021648600000013	9-33,0-24						2 1-acid Jonathan SJOGREN*&#xa8; 4 Maria ALLHORN* 2 Biochemical Journal www.biochemj	nizetlab.ucsd.edu	0	0		
1092	chr12	66511567	66511659	3500175024	50		66511567	66511659	8421504	2	26,24	0,68	c	350017502400000016,350017502400000017	0-26,0-24						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
1092	chr12	66511818	66511842	3500124685	24		66511818	66511842	8421504	1	24	0	c	350012468500000029	23-47						Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide	www.jleukbio.org	0	0		
1092	chr12	66559719	66559746	3500461622	23		66559719	66559746	8421504	2	9,14	0,13	g	350046162200000330	9-46						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
1095	chr12	66851902	66851925	3500461622	23		66851902	66851925	8421504	1	23	0	g	350046162200000029	0-26						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
1095	chr12	66851902	66851925	3500119454	23		66851902	66851925	8421504	1	23	0	g	350011945400000051	0-26						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1095	chr12	66877542	66877568	3500306378	25		66877542	66877568	8421504	2	13,12	0,14	c	350030637800000012	9-34						Y-SNP Typing of U.S. African American and Caucasian Samples Using Allele-Speci&#xfb01;c Hybridization and Primer Extension	.bioforensics.com	0	0		
1095	chr12	66877542	66877568	3500253224	25		66877542	66877568	8421504	2	13,12	0,14	c	350025322400000012	9-34						Y-SNP Typing of U.S. African American and Caucasian Samples Using Allele-Speci&#xfb01;c Hybridization and Primer Extension	www.cstl.nist.gov	0	0		
1099	chr12	67453191	67482304	3500022398	42		67453191	67482304	8421504	2	21,21	0,29092	g	350002239800000045,350002239800000437	0-21,8-31						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
1101	chr12	67647458	67712895	3500413148	805		67647458	67712895	8421504	3	504,202,99	0,4552,65338	p,c,g	350041314800000096,350041314800000134,350041314800000135,350041314800000131,350041314800015090,350041314800015119,350041314800000141,350041314800000141,350041314800015089,350041314800000095,350041314800000095,350041314800000140,350041314800000140,350041314800000094,350041314800000094,350041314800015088,350041314800015117,350041314800000093,350041314800015087,350041314800000092,350041314800000092,350041314800015086,350041314800000091,350041314800000091,350041314800015085,350041314800015116	0-385,0-31,0-30,0-30,0-51,0-117,0-25,0-25,0-54,0-54,0-54,0-21,0-21,0-54,0-54,0-54,0-174,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180						G&#xe9;n&#xe9;tique de la coloration de la robe chez les bovins : Contribution &#xe0; l&#x2019;&#xe9;tude du r&#xf4;le des g&#xe8;nes de la famille tyrosinase	cations.unilim.fr	0	0		
1101	chr12	67652161	67729841	3500413148	1314		67652161	67729841	8421504	7	51,136,180,167,101,300,379	0,60635,62361,65072,65367,67485,77301	p,c,g	350041314800015084,350041314800000089,350041314800000089,350041314800015083,350041314800015082,350041314800000088,350041314800000088,350041314800015115,350041314800015081,350041314800000087,350041314800000087,350041314800015080,350041314800000086,350041314800000086,350041314800000085,350041314800000085,350041314800015079,350041314800015078,350041314800000084,350041314800015114,350041314800000083,350041314800000083,350041314800015077,350041314800015076,350041314800000082,350041314800000082,350041314800000081,350041314800015075,350041314800015113,350041314800000080,350041314800000080,350041314800015074,350041314800000079,350041314800015073,350041314800000078,350041314800000078,350041314800015072,350041314800015112,350041314800000077,350041314800000077,350041314800015071,350041314800000128,350041314800000128,350041314800000076,350041314800015070,350041314800000129,350041314800015069,350041314800000075,350041314800000075,350041314800015068,350041314800000074,350041314800000074,350041314800015111,350041314800015067,350041314800000073,350041314800000072,350041314800000072,350041314800015066,350041314800015065,350041314800000071,350041314800000071,350041314800015109,350041314800015064,350041314800000070,350041314800000070,350041314800000069,350041314800000069,350041314800015063,350041314800000068,350041314800000068,350041314800000133,350041314800000067,350041314800000067,350041314800000132	0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-55,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-30,0-30,0-54,0-54,0-30,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-55,0-55,0-54,0-55,0-55,0-29,1-72,1-72,0-30						G&#xe9;n&#xe9;tique de la coloration de la robe chez les bovins : Contribution &#xe0; l&#x2019;&#xe9;tude du r&#xf4;le des g&#xe8;nes de la famille tyrosinase	cations.unilim.fr	0	0		
1101	chr12	67652161	67712799	3500413148	54		67652161	67712799	8421504	2	51,3	0,60635	c	350041314800000090	0-54						G&#xe9;n&#xe9;tique de la coloration de la robe chez les bovins : Contribution &#xe0; l&#x2019;&#xe9;tude du r&#xf4;le des g&#xe8;nes de la famille tyrosinase	cations.unilim.fr	0	0		
1101	chr12	67719904	67719929	3500329835	25		67719904	67719929	8421504	1	25	0	c	350032983500000030	9-34						US Patent # 5,679,511. CDNA clones for a regulatory protein in the melanin-production pathway - Patents.com	www.patents.com	0	0		
1101	chr12	67729535	67729580	3500235889	45		67729535	67729580	8421504	1	45	0	p	350023588900015031	0-45						Peptides useful for diagnosis and therapy of TRP-2+ and/or TRP-1+ tumors	Kropshofer	2005	0		
1101	chr12	67729535	67729580	3500009805	45		67729535	67729580	8421504	1	45	0	p	350000980500015030	0-45						Peptides useful for diagnosis and therapy of TRP-2+ and/or TRP-1+ tumors	Schadendorf	2004	0		
1102	chr12	67801635	67801664	3500022955	28		67801635	67801664	8421504	2	11,17	0,12	c	350002295500000007	28-56						Molecular mechanisms of iNOS induction by IL-1 and IFN-&#x03b3; in rat aortic smooth muscle cells	ll.physiology.org	0	0		
1102	chr12	67828380	67828408	3500372468	24		67828380	67828408	8421504	3	13,6,5	0,14,23	g	350037246800000030,350037246800000006	4-28,4-28						INTERFERON ANTAGONISTS, ANTIBODIES THERETO AND ASSOCIATED METHODS OF USE - Patent application	www.faqs.org	0	0		
1108	chr12	68559883	68559908	3500060385	23		68559883	68559908	8421504	2	17,6	0,19	g	350006038500000011	0-24		19605557	10.1091/mbc.E09-04-0316	1059-1524	Molecular Biology of the Cell	Glucosidase II &#x03b2; Subunit Modulates N-Glycan Trimming in Fission Yeasts and Mammals	Stigliano	2009	5		
1108	chr12	68618569	68618595	3500031391	24		68618569	68618595	8421504	2	9,15	0,11	g	350003139100000022	10-34						METHOD FOR PRODUCTION OF POLYLACTATE USING RECOMBINANT MICROORGANISM - Patent application	www.faqs.org	0	0		
1108	chr12	68626589	68626616	3500119175	24		68626589	68626616	8421504	2	10,14	0,13	g	350011917500000079	0-24						 Nucleic Acid Enzyme Biosensors For Ions 	www.docstoc.com	0	0		
1109	chr12	68790593	68791212	3500166204	615		68790593	68791212	8421504	4	19,232,359,5	0,20,254,614	g	350016620400000101,350016620400000099	0-19,0-596						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1112	chr12	69133951	69133982	3500326034	25		69133951	69133982	8421504	3	7,6,12	0,8,19	g	350032603400000911	1-26						 Selection Method 	www.docstoc.com	0	0		
1117	chr12	69836371	69836403	3500193635	27		69836371	69836403	8421504	4	6,5,11,5	0,7,14,27	g	350019363500000482	21-48						Materials and methods for immunocontraception	Harris	1993	0		
1121	chr12	70347638	70358883	3500157219	39		70347638	70358883	8421504	2	19,20	0,11225	c,g	350015721900000001,350015721900000001,350015721900000025	0-19,0-19,0-20		18239051	10.1530/REP-07-0415	1470-1626	Reproduction	Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle	Mitko	2008	3		
1121	chr12	70366451	70366477	3500437093	23		70366451	70366477	8421504	2	8,15	0,11	g	350043709300001174	3-35						US Patent # 8,182,996. Compositions and methods for detecting Klebsiella pneumoniae - Patents.com	patents.com	0	0		
1122	chr12	70446854	70511856	3500428254	1515		70446854	70511856	8421504	12	82,111,125,75,153,182,120,106,121,133,149,158	0,23628,33321,35436,46235,48303,48924,53911,54101,62072,63040,64844	p,c,g	350042825400000009,350042825400000003,350042825400000003,350042825400015004	0-1515,0-19,0-19,0-60						Method for selective inactivation of viral replication	Miles	2000	0		
1122	chr12	70446854	70511856	3500247479	1515		70446854	70511856	8421504	12	82,111,125,75,153,182,120,106,121,133,149,158	0,23628,33321,35436,46235,48303,48924,53911,54101,62072,63040,64844	p,c	350024747900000009,350024747900000003,350024747900015003	0-1515,0-19,0-60						Method for selective inactivation of viral replication	Miles	2002	0		
1122	chr12	70446854	70511856	3500211192	1515		70446854	70511856	8421504	12	82,111,125,75,153,182,120,106,121,133,149,158	0,23628,33321,35436,46235,48303,48924,53911,54101,62072,63040,64844	p,c	350021119200000008,350021119200000003,350021119200015001	0-1515,0-19,0-60						Method for selective inactivation of viral replication - Patent # 5738985 - PatentGenius	.patentgenius.com	0	0		
1122	chr12	70493239	70495882	3500467047	44		70493239	70495882	8421504	3	3,19,22	0,1918,2621	c	350046704700000014,350046704700000015	0-22,0-22		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		DNAJC3
1122	chr12	70493239	70495882	3500411115	44		70493239	70495882	8421504	3	3,19,22	0,1918,2621	c	350041111500000003,350041111500000002	0-22,21-43						Coxsackievirus B3 infection activates the unfolded protein response and induces apoptosis through downregulation of p58IPK and activation of CHOP and SREBP1. - ResearchGate	.researchgate.net	0	0		
1122	chr12	70493239	70495882	3500300246	44		70493239	70495882	8421504	3	3,19,22	0,1918,2621	c,g	350030024600000014,350030024600000015,350030024600000015	0-22,0-22,0-22		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		DNAJC3
1122	chr12	70493239	70495882	3500168730	44		70493239	70495882	8421504	3	3,19,22	0,1918,2621	c	350016873000000014,350016873000000015	0-22,0-22		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		DNAJC3
1122	chr12	70495872	70508949	3500195103	79		70495872	70508949	8421504	3	19,37,23	0,5167,13054	p,c,g	350019510300000003,350019510300000003,350019510300015004	0-19,0-19,0-60						Method for selective inactivation of viral replication	Miles	2004	0		
1129	chr12	71422916	71424494	3500415955	48		71422916	71424494	8421504	2	24,24	0,1554	c,g	350041595500000014,350041595500000017	0-24,0-24						Letter The Heparan and Heparin Metabolism Pathway is Involved in Regulation of Fatty Acid Composition	www.ijbs.com	0	0		
1130	chr12	71441360	71441383	3500415057	23		71441360	71441383	8421504	1	23	0	g	350041505700000011	12-35						INAUGURAL-DISSERTATION I T E N E G E RS VE RE	eb.uni-giessen.de	0	0		
1133	chr12	71870415	71870447	3500418917	32		71870415	71870447	8421504	1	32	0	c	350041891700000000	0-32		19457059	10.1111/j.1471-4159.2009.06184.x	1471-4159	Journal of Neurochemistry	Muscleblind-like 2: circadian expression in the mammalian pineal gland is controlled by an adrenergic-cAMP mechanism - Kim - 2009 - Journal of Neurochemistry - Wiley Online Library	Kim	2009	0		
1134	chr12	71999679	71999727	3500373093	48		71999679	71999727	8421504	1	48	0	p	350037309300015050	0-48						Noey2 gene compositions and methods of use	Robert	1998	0		RAP2C
1135	chr12	72190809	72190837	3500022398	24		72190809	72190837	8421504	3	4,5,15	0,5,13	g	350002239800000488	14-38						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
1136	chr12	72285777	72285813	3500023426	28		72285777	72285813	8421504	3	7,14,7	0,11,29	g	350002342600000030	4-38						Use of collections of binding sites for sample profiling and other applications	Ault-riche	2003	0		
1137	chr12	72418187	72418244	3500388065	57		72418187	72418244	8421504	1	57	0	c	350038806500000013	3-60						A 1.3 kb Satellite DNA from Bubalus bubalis not Conserved Evolutionarily is Transcribed	.znaturforsch.com	0	0		
1137	chr12	72418780	72418924	3500038383	109		72418780	72418924	8421504	2	89,20	0,124	c	350003838300000003	46-198						UNIVERSIDADE DE S&#xc3;O PAULO FACULDADE DE MEDICINA DE RIBEIR&#xc3;O PRETO DEPARTAMENTO DE GEN&#xc9;TICA	www.teses.usp.br	0	0		
1140	chr12	72835024	72835050	3500083965	24		72835024	72835050	8421504	2	13,11	0,15	g	350008396500000005	16-41						Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable Haemophilus influenzae, Moraxella catarrhalis, TLR3, and type I and II int	link.springer.com	0	0		
1141	chr12	72877048	72877075	3500230046	23		72877048	72877075	8421504	2	16,7	0,20	g	350023004600000001	0-23						Protein expression system	Gjerdrum	2005	0		
1142	chr12	73092359	73092383	3500303283	23		73092359	73092383	8421504	2	8,15	0,9	g	350030328300000006	2-25			10.1128/IAI.72.2.972-979.2004		Infection and Immunity	The Staphylococcal Ferritins Are Differentially Regulated in Response to Iron and Manganese and via PerR and Fur 	Julie	2004	0		
1143	chr12	73142880	73189379	3500165267	2389		73142880	73189379	8421504	30	74,109,38,11,82,157,55,89,108,103,31,108,50,112,92,82,89,33,45,90,87,83,84,91,100,120,142,82,17,25	0,82,192,232,262,346,569,684,1988,3340,4119,4279,9339,10635,12051,13578,14320,14490,14663,17487,18119,18923,20561,22968,23277,26082,27113,27392,28182,46474	p,c,g	350016526700000040,350016526700000038,350016526700000036,350016526700015069,350016526700000035,350016526700015135,350016526700015136,350016526700015068,350016526700000034,350016526700015139,350016526700015067,350016526700000033,350016526700015066,350016526700000032,350016526700015063,350016526700000029,350016526700000028,350016526700015121,350016526700015061,350016526700000027,350016526700015060,350016526700000026,350016526700015059,350016526700000025,350016526700000023,350016526700015111,350016526700015057,350016526700015056,350016526700015055,350016526700000020,350016526700015105,350016526700015108,350016526700015054,350016526700000019,350016526700000018,350016526700015053,350016526700015100,350016526700015104,350016526700015024,350016526700015052,350016526700000017,350016526700000017,350016526700000016,350016526700015050,350016526700000015,350016526700015095,350016526700015049,350016526700000014,350016526700015048,350016526700000013,350016526700015022,350016526700015090,350016526700015091,350016526700015047,350016526700015094,350016526700015046,350016526700000011,350016526700000010,350016526700015084,350016526700015087,350016526700015089,350016526700015045,350016526700000009,350016526700015044,350016526700000008,350016526700015079,350016526700015043,350016526700000007,350016526700015042,350016526700000006,350016526700015010,350016526700000005,350016526700015074,350016526700015040,350016526700000004,350016526700015078,350016526700000003	0-531,0-60,0-60,0-60,0-60,0-150,0-150,0-60,0-60,0-81,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-147,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-150,0-60,0-63,3-66,0-60,0-150,0-150,0-60,1-60,0-61,0-60,0-150,0-48,0-45,0-60,0-60,0-60,0-60,0-60,0-60,0-150,0-60,0-60,0-60,0-60,0-54,0-150,0-150,0-60,0-90,0-60,0-60,0-60,0-150,0-81,0-60,9-69,9-60,0-60,0-60,0-150,0-60,0-60,0-60,0-60,0-57,0-60,0-150,0-63,1-60,0-51,58-120						Molecular Cloning, In Vitro Expression, and Functional Characterization of an Ovine Gastrointestinal Peptide Transporter (oPepT1)	cholar.lib.vt.edu	0	0		
1143	chr12	73246087	73248448	3500342962	132		73246087	73248448	8421504	3	6,114,12	0,1578,2349	p	350034296200015010,350034296200015006	0-132,0-120						CLASP proteins	Lu	2003	0		
1143	chr12	73246087	73248448	3500007887	132		73246087	73248448	8421504	3	6,114,12	0,1578,2349	p	350000788700015007,350000788700015003	0-132,0-120						Nucleic acid molecule encoding a CLASP-2 transmembrane protein	Lu	2003	0		
1146	chr12	73542295	73542321	3500188317	23		73542295	73542321	8421504	2	13,10	0,16	g	350018831700000001	5-28						IMP Dehydrogenase from the Protozoan Parasite Toxoplasma gondii	aac.asm.org	0	0		
1146	chr12	73625971	73625999	3500397484	28		73625971	73625999	8421504	1	28	0	c	350039748400000025	5-33					Patent	Non-endogenous, constitutively activated human G protein-coupled receptors (Patent CN:1329511)	Duo Mi Ni Ke *P*Bi Yi 	2007	0		
1147	chr12	73767037	73767062	3500000589	23		73767037	73767062	8421504	2	9,14	0,11	c	350000058900000036	14-37						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
1151	chr12	74251871	74252318	3500310861	63		74251871	74252318	8421504	2	30,33	0,414	p	350031086100015244	15-132						<Html><Title> Complet list of 1zwm hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		ZIC2
1151	chr12	74251874	74251897	3500363484	23		74251874	74251897	8421504	1	23	0	c	350036348400000053	19-42						Preparation of thaumatin sweeteners	Uriach-marsal	1995	0		
1151	chr12	74251874	74251897	3500156200	23		74251874	74251897	8421504	1	23	0	c	350015620000000053	19-42					Patent	Preparation of thaumatin sweeteners (Patent US:5932438)	Blade-Pique	1999	0		
1151	chr12	74252035	74252058	3500009659	23		74252035	74252058	8421504	1	23	0	c	350000965900000056	3-26						Virulencia, resistencia y elementos gen&#xe9;ticos m&#xf3;viles en serotipos no prevalentes de Salmonella enterica	www.tdx.cat	0	0		
1151	chr12	74252561	74254686	3500268114	165		74252561	74254686	8421504	3	60,60,45	0,1984,2080	p	350026811400015021,350026811400015049,350026811400015024,350026811400015052,350026811400015026	0-45,0-48,0-45,0-48,0-45						 <HTML> <HEAD><TITLE>cY=cucoceaadegeoa1/4a - c1ea13i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4 | j-tokkyo	www.j-tokkyo.com	0	0		
1151	chr12	74252561	74254686	3500134626	165		74252561	74254686	8421504	3	60,60,45	0,1984,2080	p	350013462600015021,350013462600015049,350013462600015024,350013462600015052,350013462600015026	0-45,0-48,0-45,0-48,0-45						&#x795e;&#x7d4c;&#x767a;&#x751f;&#x8a98;&#x5c0e;&#x907a;&#x4f1d;&#x5b50; - &#x7406;&#x5316;&#x5b66;&#x7814;&#x7a76;&#x6240;	www.patentjp.com	0	0		
17	chr12	74424358	74500691	3500335523	96		74424358	74500691	8421504	5	3,37,11,3,42	0,20740,43125,56899,76291	p	350033552300015030,350033552300015042	0-51,15-60						Acetyl-CoA Carboxylase from Escherichia coli: Gene Organization and Nucleotide Sequence of the Biotin Carboxylase Subunit	www.jstor.org	0	0		
1156	chr12	74942960	74942983	3500083602	23		74942960	74942983	8421504	1	23	0	g	350008360200000002	0-24						2 detection of Besnoitia besnoiti infections in bovine skin biopsies	dspace.uevora.pt	0	0		
1161	chr12	75561080	75561106	3500172904	23		75561080	75561106	8421504	2	17,6	0,20	g	350017290400000011	0-24		20570899	10.1158/0008-5472.CAN-09-4610	0008-5472	Cancer Research	Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells	Dai	2010	8		
1161	chr12	75591774	75591799	3500358504	23		75591774	75591799	8421504	3	13,6,4	0,14,21	g	350035850400000039	7-33						Inducible herbicide resistance	Ryals	1997	0		
1161	chr12	75619263	75619290	3500057990	23		75619263	75619290	8421504	2	16,7	0,20	g	350005799000000028	0-23						Alanine 2, 3-aminomutase	Gokarn	2010	0		
1162	chr12	75712587	75712610	3500223282	23		75712587	75712610	8421504	1	23	0	g	350022328200000050	0-23						FINAL PROJECT REPORT GUIDANCE	www.fws.gov	0	0		
1163	chr12	75770385	75770413	3500159282	23		75770385	75770413	8421504	3	12,7,4	0,16,24	g	350015928200000010	11-37						2-Nitrobenzoate 2-Nitroreductase (NbaA) Switches Its Substrate Speci&#xfb01;city from 2-Nitrobenzoic Acid to 2,4-Dinitrobenzoic Acid under Oxidizing Conditions	jb.asm.org/conten	0	0		
1163	chr12	75815399	75815424	3500230330	24		75815399	75815424	8421504	2	12,12	0,13	g	350023033000000857	4-28						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
1163	chr12	75853515	75853619	3500259232	104		75853515	75853619	8421504	1	104	0	g	350025923200000034	0-105						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
1163	chr12	75853515	75853619	3500000589	104		75853515	75853619	8421504	1	104	0	g	350000058900000059	0-105						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
1166	chr12	76236658	76236685	3500333669	23		76236658	76236685	8421504	2	15,8	0,19	g	350033366900000621	4-27						Transgenic Animal With Enhanced Immune Response And Method For The Preparation Thereof 	.freshpatents.com	0	0		
1177	chr12	77613611	77613634	3500104098	23		77613611	77613634	8421504	1	23	0	g	350010409800000815	3-26						METHOD OF DETECTING HUMAN PAPILLOMA VIRUS BY USING NUCLEIC ACID AMPLIFICATION METHOD AND NUCLEIC ACID CHAIN-IMMOBILIZED CARRIER - Patent application	www.faqs.org	0	0		
1178	chr12	77833185	77833214	3500253796	26		77833185	77833214	8421504	2	18,8	0,21	g	350025379600000504	9-36					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
1179	chr12	77891664	77891692	3500102026	27		77891664	77891692	8421504	2	7,20	0,8	g	350010202600000552	13-45						Compositions and methods for vaccination against coronaviruses	Jones	1993	0		
1179	chr12	77968374	77968400	3500190760	23		77968374	77968400	8421504	2	8,15	0,11	g	350019076000000145	11-34						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
1180	chr12	78020667	78020693	3500059645	23		78020667	78020693	8421504	3	5,13,5	0,6,21	g	350005964500000005	1-24						The regulatory PII protein controls arginine biosynthesis in Arabidopsis	ersailles.inra.fr	0	0		
1181	chr12	78134665	78134690	3500081046	23		78134665	78134690	8421504	2	6,17	0,8	g	350008104600000001	0-23						Expression of HBV Nuclear Core Antigen in Young Cirrhotic Patients: Materials and Methods	www.medscape.com	0	0		
1181	chr12	78238289	78238314	3500375164	24		78238289	78238314	8421504	2	9,15	0,10	g	350037516400000002	2-26			10.1128/JVI.01633-06		Journal of Virology	M135R Is a Novel Cell Surface Virulence Factor of Myxoma Virus 	John	2007	0		
1181	chr12	78238289	78238314	3500116217	24		78238289	78238314	8421504	2	9,15	0,10	g	350011621700000002	2-26		17065210	10.1128/JVI.01633-06	0022-538X	Journal of Virology	M135R Is a Novel Cell Surface Virulence Factor of Myxoma Virus	Barrett	2007	5		
1182	chr12	78263940	78263966	3500378282	23		78263940	78263966	8421504	2	12,11	0,15	g	350037828200000224	5-30						METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA - Patent application	www.faqs.org	0	0		
1183	chr12	78395679	78395704	3500022398	23		78395679	78395704	8421504	2	17,6	0,19	g	350002239800000460	10-33						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
1191	chr12	79434744	79434774	3500332204	26		79434744	79434774	8421504	2	11,15	0,15	g	350033220400000021	11-37						NOVEL PREBIOTICS - Patent application	www.faqs.org	0	0		
1194	chr12	79896447	79896477	3500022398	25		79896447	79896477	8421504	2	6,19	0,11	g	350002239800000406	17-42						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
1197	chr12	80241335	80241361	3500261892	24		80241335	80241361	8421504	2	9,15	0,11	g	350026189200000003	3-27						The Human Immunode&#xfb01;ciency Virus Type 1 Envelope Confers Higher Rates of Replicative Fitness to Perinatally Transmitted Viruses than to Nontransmitted Viruses	ncv.unl.edu	0	0		
1198	chr12	80434923	80434949	3500427186	23		80434923	80434949	8421504	2	8,15	0,11	g	350042718600000029	9-32						PREDICTOR SETS FOR TYROSINE KINASE PATHWAYS - BRISTOL-MYERS SQUIBB COMPANY	www.sumobrain.com	0	0		
1199	chr12	80598625	80598652	3500317276	26		80598625	80598652	8421504	2	21,5	0,22	g	350031727600000021	11-44						Detection of differences in nucleic acids by inhibition of spontaneous dna branch migration	Kurn	2001	0		
1204	chr12	81213115	81213139	3500135973	23		81213115	81213139	8421504	2	6,17	0,7	c	350013597300000229	11-34						CARRIER IMMUNOGLOBULINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1204	chr12	81213236	81213284	3500310861	48		81213236	81213284	8421504	1	48	0	p	350031086100015092	138-186						<Html><Title> Complet list of 1zwm hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		GSPT1
1204	chr12	81213262	81213288	3500307135	26		81213262	81213288	8421504	1	26	0	c	350030713500000434	7-33						NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1206	chr12	81440695	81466114	3500006449	56		81440695	81466114	8421504	2	24,32	0,25387	c	350000644900000058,350000644900000068	0-24,0-32						COMBINATION OF BLyS AND/OR APRIL INHIBITION AND IMMUNNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE DISEASE - Patent application	www.faqs.org	0	0		
1206	chr12	81441140	81466333	3500007198	142		81441140	81466333	8421504	4	12,35,47,48	0,17079,24915,25145	c	350000719800000021,350000719800000023,350000719800000026	1-48,0-47,0-48						NEUTROKINE $g(a)	Ebner	1998	0		
1206	chr12	81466055	81466102	3500243407	47		81466055	81466102	8421504	1	47	0	c	350024340700000023	0-47						Method of assaying Neutrokine-&#x03b1; mRNA level	Yu	1999	0		
1206	chr12	81466082	81466360	3500108268	80		81466082	81466360	8421504	2	32,48	0,230	c	350010826800000068,350010826800000071	0-32,0-48						COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE - Patent application	www.faqs.org	0	0		
1211	chr12	82159661	82159687	3500048026	23		82159661	82159687	8421504	2	6,17	0,9	g	350004802600000028	16-39						ANTI-IL-20, ANTI-IL-22 AND ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION - Patent application	www.faqs.org	0	0		
1213	chr12	82329934	82329960	3500333669	23		82329934	82329960	8421504	3	12,6,5	0,14,21	g	350033366900000628	10-35						Transgenic Animal With Enhanced Immune Response And Method For The Preparation Thereof 	.freshpatents.com	0	0		
1214	chr12	82462798	82462827	3500002117	24		82462798	82462827	8421504	3	7,12,5	0,11,24	g	350000211700000000	3-29						BIOMARKER FOR DIAGNOSIS OF CANINE CANCER - Patent application	www.faqs.org	0	0		
1215	chr12	82701898	82701930	3500170003	32		82701898	82701930	8421504	1	32	0	g	350017000300000005	0-32						Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-?1 in normal human lung fibroblasts (NHLF)	tory-research.com	0	0		
151	chr12	82702889	82710577	3500018164	687		82702889	82710577	8421504	5	79,173,115,178,142	0,1709,2867,6390,7546	p	350001816400015018,350001816400015019	0-687,0-180						Primary Structure Analysis Of Proteins Biology Essay	www.ukessays.com	0	0		COL4A1
1215	chr12	82704634	82705770	3500444600	45		82704634	82705770	8421504	3	23,8,14	0,129,1122	c	350044460000000007,350044460000000006	0-23,0-22						&#x4e3b;&#x9898;&#xff1a;NADPH | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1215	chr12	82704634	82705770	3500356162	45		82704634	82705770	8421504	3	23,8,14	0,129,1122	c	350035616200000001,350035616200000000	0-23,0-22						Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy	betesjournals.org	0	0		
1216	chr12	82709341	82709392	3500092967	51		82709341	82709392	8421504	1	51	0	p	350009296700015000	0-51		22998238	10.1111/j.1582-4934.2012.01648.x	1582-4934	Journal of Cellular and Molecular Medicine	Lamstatin &#x2013; a novel inhibitor of lymphangiogenesis derived from collagen IV - Weckmann - 2012 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Weckmann	2012	0		COL4A3
1216	chr12	82709437	82710484	3500064943	69		82709437	82710484	8421504	2	20,49	0,998	p	350006494300015008	135-204						ABSTRACT	tory.lib.ncsu.edu	0	0		COL4A5
1216	chr12	82724065	82724204	3500058951	24		82724065	82724204	8421504	2	11,13	0,126	c	350005895100000103	24-48						Collagen and uses therefor	Olsen	1993	0		
1216	chr12	82742040	82744735	3500379004	42		82742040	82744735	8421504	3	20,15,7	0,2589,2688	c,g	350037900400000005,350037900400000005,350037900400000004	0-20,0-20,0-22						Adaptation to High Grain Diets Proceeds Through Minimal Immune System Stimulation and Differences in Extracellular Matrix Protein Expression in A Model of Subacute Ruminal Acidosis in Non-lactating Dairy Cows	thescipub.com	0	0		
1216	chr12	82742040	82744735	3500249098	42		82742040	82744735	8421504	3	20,15,7	0,2589,2688	c,g	350024909800000003,350024909800000003,350024909800000002	0-20,0-20,0-22						A CHARACTERIZATION OF INFLAMMATORY AND STRUCTURAL MARKERS WITHIN THE RUMEN EPITHELIUM DURING GRAIN-INDUCED RUMINAL ACIDOSIS IN	thescipub.com	0	0		
1216	chr12	82746626	82746654	3500306608	24		82746626	82746654	8421504	3	7,3,14	0,8,14	g	350030660800000000	3-27						Combinatorial Chemistry & High Throughput Screening, 55-62 55 Accelerated Screening of Phage-Display Output with Alkaline Phosphatase Fusions	enthamscience.com	0	0		
1216	chr12	82758477	82758500	3500427097	23		82758477	82758500	8421504	1	23	0	g	350042709700000061	22-46						Probing method for identifying antibodies specific for selected antigens	Mezes	2000	0		
1217	chr12	82881755	82881783	3500101289	24		82881755	82881783	8421504	2	11,13	0,15	g	350010128900000335	0-24						NOVEL SURFACE ANTIGEN - Patent application	www.faqs.org	0	0		
1217	chr12	82939598	82939624	3500331034	23		82939598	82939624	8421504	2	15,8	0,18	g	350033103400000000	8-39						Epigenetic Inactivationof Wnt Inhibitory Factor-1Plays an Important Role in Bladder Cancer through Aberrant CanonicalWnt/ B-Catenin Signaling Pathway	.aacrjournals.org	0	0		
1219	chr12	83108176	83108371	3500415708	40		83108176	83108371	8421504	2	20,20	0,175	c,g	350041570800000002,350041570800000003,350041570800000003	0-20,0-20,0-20						Senescence evasion by MCF-7 human breast tumor-initiating cells	ncer-research.com	0	0		ING1
1219	chr12	83108411	83108443	3500244539	32		83108411	83108443	8421504	1	32	0	c	350024453900000033	0-32						US Patent # 6,117,633. DNA sequence encoding the tumor suppressor gene ING1 - Patents.com	www.patents.com	0	0		
1219	chr12	83108411	83108443	3500091803	32		83108411	83108443	8421504	1	32	0	c	350009180300000033	0-32						Antibodies against the tumor suppressor gene ING1	Garkavtsev	2000	0		
1219	chr12	83209920	83209947	3500161755	25		83209920	83209947	8421504	2	12,13	0,14	g	350016175500000172	13-38						Intermediates and enzymes of the non-mevalonate isoprenoid pathway - Patent application	www.faqs.org	0	0		
1223	chr12	83655964	83655991	3500281577	25		83655964	83655991	8421504	3	9,12,4	0,10,23	g	350028157700000009	21-46						Lead binding polypeptides and nucleotides coding therefor	Lopez	1996	0		
1225	chr12	83934610	83934639	3500311545	29		83934610	83934639	8421504	1	29	0	g	350031154500000062	4-33						Nuclear reprogramming factor and induced pluripotent stem cells	Yamanaka	2008	0		SPACA7
1225	chr12	83934610	83934639	3500018619	29		83934610	83934639	8421504	1	29	0	g	350001861900000064	4-33						Nuclear Reprogramming Factor And Induced Pluripotent Stem Cells 	.freshpatents.com	0	0		SPACA7
1225	chr12	83935192	83935335	3500370870	40		83935192	83935335	8421504	2	20,20	0,123	g	350037087000000012,350037087000000013	0-20,0-20						Methods for improving cardiac differentiation of human embryonic stem cells	Tran	2010	0		SPACA7
1225	chr12	83935192	83935335	3500330540	40		83935192	83935335	8421504	2	20,20	0,123	g	350033054000000012,350033054000000013	0-20,0-20						METHODS FOR IMPROVING CARDIAC DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS - NOVARTIS AG	www.sumobrain.com	0	0		SPACA7
1225	chr12	83935315	83935380	3500339794	40		83935315	83935380	8421504	2	19,21	0,44	g	350033979400000015,350033979400000016	0-19,0-21						Exploration du potentiel th&#xe9;rapeutique des cellules souches embryonnaires humaines pour la th&#xe9;rapie cellulaire de la maladie de Huntington.	blio.univ-evry.fr	0	0		
1225	chr12	83935315	83935380	3500301494	40		83935315	83935380	8421504	2	19,21	0,44	g	350030149400000053,350030149400000111,350030149400000054,350030149400000112	0-19,0-19,0-21,0-21						METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		SPACA7
1225	chr12	83935315	83935380	3500200603	40		83935315	83935380	8421504	2	19,21	0,44	g	350020060300000039,350020060300000040	0-19,0-21						CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS	Agulnick	2013	0		
1225	chr12	83935315	83935380	3500093061	40		83935315	83935380	8421504	2	19,21	0,44	g	350009306100000039,350009306100000040	0-19,0-21						Agents and methods for inhibiting human pluripotent stem cell growth	Robins	2012	0		SPACA7
1227	chr12	84213622	84213651	3500137155	23		84213622	84213651	8421504	3	5,5,13	0,8,16	g	350013715500000499	1-24					Patent	DNA methylation markers associated with the CpG island methylator phenotype (CIMP) in human colorectal cancer (Patent US:8110361)	Laird	2012	0		
1227	chr12	84225475	84225504	3500379167	27		84225475	84225504	8421504	3	5,15,7	0,6,22	g	350037916700000013	19-48						Transgenic production of ec-sod	Hansson	1995	0		
1228	chr12	84347833	84347860	3500015581	23		84347833	84347860	8421504	2	15,8	0,19	g	350001558100000145	15-38						Transcription Activation Complex And Utilization Thereof 	.freshpatents.com	0	0		
1228	chr12	84363246	84363270	3500454791	24		84363246	84363270	8421504	1	24	0	g	350045479100000007	0-24		23027613	10.1002/emmm.201201272	1757-4684	EMBO Molecular Medicine	A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation - Cheng - 2012 - EMBO Molecular Medicine - Wiley Online Library	Cheng	2012	0		
153	chr12	84408660	84422364	3500443182	240		84408660	84422364	8421504	4	99,21,99,21	0,1923,9617,13683	p	350044318200015031,350044318200015028	0-120,0-120						Bioinformatics sequence and genome analysis david w. mount	ww.slideshare.net	0	0		
153	chr12	84408660	84422364	3500425833	240		84408660	84422364	8421504	4	99,21,99,21	0,1923,9617,13683	p	350042583300015035,350042583300015032	0-120,0-120						Bioinformatics Sequence and Genome Analysis - David W. Mount.pdf	www.scribd.com	0	0		
153	chr12	84408660	84422364	3500338304	240		84408660	84422364	8421504	4	99,21,99,21	0,1923,9617,13683	p	350033830400015033,350033830400015030	0-120,0-120						Historical Introduction and Overview	nhjy.hzau.edu.cn	0	0		
153	chr12	84408660	84422364	3500193094	240		84408660	84422364	8421504	4	99,21,99,21	0,1923,9617,13683	p	350019309400015048,350019309400015045	0-120,0-120						NUCLEOTIDE SEQUENCE DATABASES	iosiva.50webs.org	0	0		
1229	chr12	84411325	84413303	3500293750	47		84411325	84413303	8421504	3	20,7,20	0,1950,1958	c	350029375000000624,350029375000000095,350029375000000256	9-29,17-44,0-19						Chimeric clotting factors	Salas	2012	0		
1229	chr12	84413285	84413473	3500432786	48		84413285	84413473	8421504	2	23,25	0,163	c	350043278600000029,350043278600000032	3-26,22-47					Patent	Factor VII or VIIa-like molecules (Patent US:6806063)	Pedersen	2004	0		
1229	chr12	84413285	84413473	3500281784	48		84413285	84413473	8421504	2	23,25	0,163	c	350028178400000036,350028178400000039	3-26,22-47						Factor VII or VIIa like molecules	Jin *V*An De Sen 	2003	0		
1229	chr12	84413285	84413473	3500023981	48		84413285	84413473	8421504	2	23,25	0,163	c	350002398100000029,350002398100000032	3-26,22-47						Factor VII or VIIa - Like Molecules - Patent application	www.faqs.org	0	0		
1229	chr12	84413383	84413407	3500110875	24		84413383	84413407	8421504	1	24	0	c	350011087500000156	0-24						Chimeric clotting factors	Bitonti	2012	0		
1229	chr12	84413448	84413473	3500375861	25		84413448	84413473	8421504	1	25	0	c	350037586100000032	22-47						Factor Vii Or Viia-like Molecules 	.freshpatents.com	0	0		
1229	chr12	84413448	84413473	3500295436	25		84413448	84413473	8421504	1	25	0	c	350029543600000032	22-47					Patent	Factor VII or VIIa-like molecules (Patent US:6806063)	Pedersen	2004	0		
1229	chr12	84413448	84413473	3500095675	25		84413448	84413473	8421504	1	25	0	c	350009567500000026	22-47						Factor VII or VIIa Polypeptide Variants - Patent application	www.faqs.org	0	0		
1229	chr12	84413448	84413473	3500053786	25		84413448	84413473	8421504	1	25	0	c	350005378600000032	22-47						Factor Vii Or Viia - Like Molecules 	.freshpatents.com	0	0		
1229	chr12	84413448	84413473	3500029671	25		84413448	84413473	8421504	1	25	0	c	350002967100000034	22-47						Factor VII or VIIa - Like Molecules - Patent application	www.faqs.org	0	0		
1229	chr12	84418337	84418362	3500272357	25		84418337	84418362	8421504	1	25	0	c	350027235700000011	14-39						Expression of factor VII activity in mammalian cells	Hagen	1986	0		
1229	chr12	84418337	84418362	3500220792	25		84418337	84418362	8421504	1	25	0	c	350022079200000011	14-39					Patent	Expression of factor VII activity in mammalian cells (Patent US:4784950)	Berkner	1988	0		
1229	chr12	84438518	84438545	3500011805	24		84438518	84438545	8421504	2	14,10	0,17	g	350001180500000004	0-27						Assay for the simulataneous detection of multiple nucleic acid sequences in a sample	Reijans	2007	0		
1229	chr12	84521522	84521573	3500373335	51		84521522	84521573	8421504	1	51	0	p	350037333500015002	3-54						Recombinant nucleic acid useful for inducing protective immune response against allergens	Chua	2004	0		LAMP1
1229	chr12	84521600	84521635	3500259065	35		84521600	84521635	8421504	1	35	0	c,g	350025906500000005,350025906500000005	9-44,9-44		17215335	10.1128/CVI.00363-06	1556-6811	Clinical and Vaccine Immunology	DNA Vaccine Construct Incorporating Intercellular Trafficking and Intracellular Targeting Motifs Effectively Primes and Induces Memory B- and T-Cell Responses in Outbred Animals	Mwangi	2007	3		
1230	chr12	84607373	84607401	3500144838	23		84607373	84607401	8421504	2	9,14	0,14	g	350014483800000079	2-25						Method of Providing Disease-Specific Binding Molecules and Targets - Patent application	www.faqs.org	0	0		
1230	chr12	84650109	84650451	3500367925	81		84650109	84650451	8421504	2	6,75	0,267	p	350036792500015023,350036792500015000,350036792500015011	3-84,3-84,0-45						E2F activity inhibitory compounds	Shibata	1999	0		
1230	chr12	84653938	84653961	3500047475	23		84653938	84653961	8421504	1	23	0	g	350004747500000010	0-23						THE ROLE OF PEROXIREDOXINS AS MECHANOSENSITIVE ANTIOXIDANTS IN ENDOTHELIAL CELLS	artech.gatech.edu	0	0		
1230	chr12	84659232	84659256	3500333669	23		84659232	84659256	8421504	2	7,16	0,8	g	350033366900000725	3-26						Transgenic Animal With Enhanced Immune Response And Method For The Preparation Thereof 	.freshpatents.com	0	0		
1231	chr12	84675972	84675995	3500374909	23		84675972	84675995	8421504	1	23	0	c	350037490900000658	0-23						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
1231	chr12	84691182	84691212	3500161237	26		84691182	84691212	8421504	3	5,9,12	0,6,18	c	350016123700000190	9-35						US Patent # 6,683,165. Human gene relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
1231	chr12	84761847	84761871	3500002446	23		84761847	84761871	8421504	2	16,7	0,17	g	350000244600000005	1-26						Parvovirus 4&#x2013;like Virus in Blood Products - Vol. 16 No. 3 - March 2010 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
1232	chr12	84839549	84873804	3500166675	45		84839549	84873804	8421504	4	12,9,9,15	0,13,34228,34240	g	350016667500000020,350016667500000050	3-24,0-24						US Patent # 7,501,484. Methods and DNA constructs for high yield production of polypeptides - Patents.com	www.patents.com	0	0		
1232	chr12	84839549	84873804	3500048033	45		84839549	84873804	8421504	4	12,9,9,15	0,13,34228,34240	g	350004803300000020,350004803300000047	3-24,0-24						METHODS AND DNA CONSTRUCTS FOR HIGH YIELD PRODUCTION OF POLYPEPTIDES - Patent application	www.faqs.org	0	0		
1234	chr12	85118561	85118767	3500373978	70		85118561	85118767	8421504	4	20,23,11,16	0,66,134,190	g	350037397800000014	0-120						REDUCING NON-TARGET NUCLEIC ACID DEPENDENT AMPLIFICATIONS: AMPLIFYING REPETITIVE NUCLEIC ACID SEQUENCES - Patent application	www.faqs.org	0	0		
9	chr13	840760	1725260	3500395001	3648		840760	1725260	8421504	32	99,78,69,138,80,54,76,101,167,147,158,83,85,178,68,97,85,125,155,165,100,105,110,133,54,220,181,77,90,58,87,225	0,27783,280814,597935,627963,630307,631379,640216,641542,671704,688098,700557,707382,708741,713112,715524,717889,719770,725178,730548,732402,733295,734410,749932,751929,755559,761452,784991,785172,785669,786540,884275	p	350039500100015000	0-3648						KEGG T01001: 23236	www.genome.jp	0	0		PLCB1
9	chr13	840760	1725260	3500171667	3648		840760	1725260	8421504	32	99,78,69,138,80,54,76,101,167,147,158,83,85,178,68,97,85,125,155,165,100,105,110,133,54,220,181,77,90,58,87,225	0,27783,280814,597935,627963,630307,631379,640216,641542,671704,688098,700557,707382,708741,713112,715524,717889,719770,725178,730548,732402,733295,734410,749932,751929,755559,761452,784991,785172,785669,786540,884275	p	350017166700015000	0-3648						KEGG T01001: 23236	www.genome.jp	0	0		PLCB1
594	chr13	1283122	1283149	3500323036	23		1283122	1283149	8421504	2	8,15	0,12	g	350032303600000193	6-38						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF A GENE FROM THE JC VIRUS - Patent application	www.faqs.org	0	0		
596	chr13	1549557	1549584	3500023053	24		1549557	1549584	8421504	2	19,5	0,22	c	350002305300000017	20-44						 Metadherin Polypeptides, Encoding Nucleic Acids And Methods Of Use 	www.docstoc.com	0	0		
597	chr13	1596393	1596504	3500228810	48		1596393	1596504	8421504	2	24,24	0,87	c	350022881000000000,350022881000000001	0-24,0-24						Expression analysis of regulatory MicroRNA in bovine cumulus oocyte complex and preimplantation embryos	s.ulb.uni-bonn.de	0	0		PLCB1
597	chr13	1625936	1626451	3500325939	108		1625936	1626451	8421504	2	86,22	0,493	p	350032593900015010,350032593900015009	0-84,0-90						STUDIO DELLE VIE DI TRASDUZIONE DEL SEGNALE INOSITIDE-DIPENDENTE NELLE SINDROMI MIELODISPLASTICHE	rato.cib.unibo.it	0	0		PLCB1
75	chr13	2234943	2433204	3500395001	3573		2234943	2433204	8421504	36	84,81,60,144,80,54,82,101,58,109,211,94,80,85,91,96,101,142,85,125,52,103,165,205,89,151,50,66,116,76,176,102,58,87,37,77	0,36340,38011,39511,62392,65096,71368,72456,73202,81226,85315,86738,90482,91078,94705,96597,114483,119587,120342,120773,122951,136262,139033,141866,154915,155748,161480,161667,174994,176412,178367,181858,192249,192744,195971,198184	p	350039500100015003	0-3573						KEGG T01001: 23236	www.genome.jp	0	0		
75	chr13	2234943	2433204	3500171667	3573		2234943	2433204	8421504	36	84,81,60,144,80,54,82,101,58,109,211,94,80,85,91,96,101,142,85,125,52,103,165,205,89,151,50,66,116,76,176,102,58,87,37,77	0,36340,38011,39511,62392,65096,71368,72456,73202,81226,85315,86738,90482,91078,94705,96597,114483,119587,120342,120773,122951,136262,139033,141866,154915,155748,161480,161667,174994,176412,178367,181858,192249,192744,195971,198184	p	350017166700015003	0-3573						KEGG T01001: 23236	www.genome.jp	0	0		
604	chr13	2502957	2502986	3500461622	24		2502957	2502986	8421504	2	15,9	0,20	g	350046162200000247	7-37						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
604	chr13	2610579	2610672	3500270093	90		2610579	2610672	8421504	2	45,45	0,48	p	350027009300015003,350027009300015001	0-45,0-45						US Patent # 7,482,138. PAK5-related compositions and methods - Patents.com	www.patents.com	0	0		PAK7
608	chr13	3119161	3119184	3500308662	23		3119161	3119184	8421504	1	23	0	g	350030866200000056	0-23						DNA	.lib.kobe-u.ac.jp	0	0		
608	chr13	3119759	3119788	3500029190	24		3119759	3119788	8421504	2	13,11	0,18	g	350002919000000102	0-24						Gene synthesis kit	Cox	2006	0		
611	chr13	3417903	3417929	3500352888	24		3417903	3417929	8421504	2	13,11	0,15	g	350035288800000010	0-24			10.1093/emboj/cdf592		The EMBO Journal	Human L1 element target-primed reverse transcription in vitro	Gregory	2002	0		
611	chr13	3441300	3451991	3500037393	45		3441300	3451991	8421504	2	31,14	0,10677	p	350003739300015001	180-225						ScienceDirect.com - Developmental Biology - Complexin I is required for mammalian sperm acrosomal exocytosis	sciencedirect.com	0	0		SNAP25
611	chr13	3455816	3463684	3500413096	195		3455816	3463684	8421504	3	2,145,48	0,2380,7820	p,c	350041309600015055,350041309600015059,350041309600015063,350041309600000016	0-69,0-63,0-69,0-63						Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)	Gilmore	2007	0		SNAP25
611	chr13	3458268	3458327	3500269671	38		3458268	3458327	8421504	2	19,19	0,40	c,g	350026967100000008,350026967100000008,350026967100000009,350026967100000009	0-19,0-19,0-19,0-19						Microarray analysis in caudal medulla of cattle orally challenged with bovine spongiform encephalopathy	w.funpecrp.com.br	0	0		
614	chr13	3884208	3884235	3500164699	26		3884208	3884235	8421504	2	13,13	0,14	g	350016469900000288	10-47						MODULATION OF SGLT2 EXPRESSION - Patent application	www.faqs.org	0	0		
614	chr13	3921602	3921629	3500081532	25		3921602	3921629	8421504	2	20,5	0,22	c	350008153200000001	2-34		19052364	10.1107/S1744309108032892		Acta Crystallographica Section F: Structural Biology and Crystallization Communications	Preliminary crystallographic analysis of GpgS, a key glucosyltransferase involved in methylglucose lipopolysaccharide biosynthesis in Mycobacterium tuberculosis 	Petra	2008	0		
614	chr13	3922533	3922559	3500465380	25		3922533	3922559	8421504	2	5,20	0,6	c	350046538000000017	7-32						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	quantification.de	0	0		
614	chr13	3922533	3922559	3500011924	25		3922533	3922559	8421504	2	5,20	0,6	c	350001192400000017	7-32						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	qpcrupdate.net	0	0		
614	chr13	3922813	3922840	3500001513	27		3922813	3922840	8421504	1	27	0	c	350000151300000004,350000151300000003	14-41,0-27		21887253	10.1371/journal.pone.0023461		PLoS ONE	MicroRNA Profiling in Subventricular Zone after Stroke: MiR-124a Regulates Proliferation of Neural Progenitor Cells through Notch Signaling Pathway	Xian	2011	0		JAG1
614	chr13	3924375	3924398	3500408259	23		3924375	3924398	8421504	1	23	0	c	350040825900000000	1-24		16837556	10.1124/jpet.106.108381	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Cannabinoid Treatment Suppresses the T-Helper Cell-Polarizing Function of Mouse Dendritic Cells Stimulated with Legionella pneumophila Infection	Lu	2006	0		
614	chr13	3924375	3924398	3500392075	23		3924375	3924398	8421504	1	23	0	c	350039207500000044	1-24						Pathogen-specific TLR2 activation programs macrophages to induce Wnt-&#x03b2; Catenin signaling	www.jbc.org	0	0		
614	chr13	3924375	3924398	3500344239	23		3924375	3924398	8421504	1	23	0	c	350034423900000014	1-24		19290049	10.1371/journal.pone.0004911		PLoS ONE	PIM2 Induced COX-2 and MMP-9 Expression in Macrophages Requires PI3K and Notch1 Signaling	Kushagra	2009	0		
614	chr13	3924375	3924398	3500310773	23		3924375	3924398	8421504	1	23	0	c	350031077300000002	1-24		19019093	10.1111/j.1365-2567.2008.02979.x		Immunology	Selective induction of the Notch ligand Jagged-1 in macrophages by soluble egg antigen from Schistosoma mansoni involves ERK signalling	Felicia	July	0		
614	chr13	3924375	3924398	3500286052	23		3924375	3924398	8421504	1	23	0	c	350028605200000000	1-24		16837556	10.1124/jpet.106.108381	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Cannabinoid Treatment Suppresses the T-Helper Cell-Polarizing Function of Mouse Dendritic Cells Stimulated with Legionella pneumophila Infection	Lu	2006	0		
614	chr13	3924977	3925002	3500352019	25		3924977	3925002	8421504	1	25	0	c	350035201900000001	0-25						Etude des propri&#xe9;t&#xe9;s h&#xe9;mato-supportives in vitro des cellules souches m&#xe9;senchymateuses	bictel.ulg.ac.be	0	0		JAG1
76	chr13	3925426	3965462	3500119167	327		3925426	3965462	8421504	10	27,10,25,29,18,30,45,48,48,47	0,243,897,12930,15681,16195,16276,19175,25848,39989	c	350011916700000093,350011916700000090,350011916700000085,350011916700000069,350011916700000067,350011916700000058,350011916700000049,350011916700000039	21-48,0-35,0-29,0-48,0-45,0-48,0-48,0-47						Human jagged polypeptide, encoding nucleic acids and methods of use	Li	1997	0		
76	chr13	3926408	3965282	3500350348	384		3926408	3965282	8421504	11	29,19,48,40,1,54,42,10,13,80,48	0,1372,13603,13706,14566,14663,15213,15764,16186,18164,38826	c	350035034800000163,350035034800000231,350035034800000150,350035034800000148,350035034800000145,350035034800000144,350035034800000297,350035034800000134,350035034800000133,350035034800000118	0-48,27-47,0-48,0-41,0-48,0-48,9-32,0-41,9-48,0-48						US Patent # 6,004,924. Protein sequences of serrate gene products - Patents.com	www.patents.com	0	0		
615	chr13	3938356	3965462	3500089347	124		3938356	3965462	8421504	3	29,48,47	0,6245,27059	c	350008934700000085,350008934700000058,350008934700000039	0-29,0-48,0-47						Methods of diagnosing alagille syndrome	Li	2000	0		
615	chr13	3951292	3951343	3500307787	51		3951292	3951343	8421504	1	51	0	p	350030778700015000	0-51						Semaphorin 3E&#x2013;Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism	enesdev.cshlp.org	0	0		JAG1
615	chr13	3951292	3951343	3500299497	51		3951292	3951343	8421504	1	51	0	p	350029949700015000	0-51		21724832	10.1101/gad.2042011	0890-9369	Genes & Development	Semaphorin 3E&#x2013;Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism	Kim	2011	12		JAG1
615	chr13	3951292	3951343	3500276811	51		3951292	3951343	8421504	1	51	0	p	350027681100015001	0-51						Culture medium for epithelial stem cells and organoids comprising said stem cells	Sato	2012	0		JAG1
615	chr13	3965465	3965950	3500462030	63		3965465	3965950	8421504	3	15,33,15	0,434,470	p	350046203000015004,350046203000015115	0-63,3-66						US Patent # 7,501,281. Compositions, methods and kits related to thrombin, Notch signaling and stamatogenesis and growth of stem cells - Patents.com	www.patents.com	0	0		
615	chr13	3965909	3965932	3500196360	23		3965909	3965932	8421504	1	23	0	c	350019636000000086,350019636000000079	0-23,0-20						DETERMINING CODON DISTRIBUTION AND/OR BASE PAIR DISTANCE BETWEEN CODONS IN A NUCLEIC ACID	Nayudu	2010	0		
615	chr13	3966042	3966066	3500230330	23		3966042	3966066	8421504	2	7,16	0,8	c	350023033000000919	14-48						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
634	chr13	6498997	6499024	3500431898	23		6498997	6499024	8421504	2	8,15	0,12	g	350043189800000063	1-26						 Globins Containing Binding Domains 	www.docstoc.com	0	0		
638	chr13	6991113	6991136	3500461618	23		6991113	6991136	8421504	1	23	0	g	350046161800000168	18-41						Characterization of cactus pear germplasm in South Africa	etd.uovs.ac.za	0	0		
639	chr13	7096586	7124610	3500308562	47		7096586	7124610	8421504	3	23,20,4	0,240,28020	c	350030856200000031,350030856200000030	0-23,0-24						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
642	chr13	7488281	7488315	3500269711	25		7488281	7488315	8421504	3	9,3,13	0,14,21	c	350026971100000019	23-48					Patent	Opioid antagonists and methods of their use (Patent US:5821219)	Grandy	1998	0		
642	chr13	7488308	7488332	3500354211	24		7488308	7488332	8421504	1	24	0	c	350035421100000015	0-24						Bacteria in clouds: PhD thesis | Tina Temkiv - Academia.edu	www.academia.edu	0	0		CDKN2B
642	chr13	7488308	7488332	3500289946	24		7488308	7488332	8421504	1	24	0	c	350028994600000000	0-24						Phylogenetic and population genetic studies in the genus Streptocarpus Lindl. (Gesneriaceae DC.) 	scholar.sun.ac.za	0	0		URI1
642	chr13	7506454	7506479	3500353659	23		7506454	7506479	8421504	2	9,14	0,11	g	350035365900000026	12-42						ORIGINAL ARTICLE Mutations of the UMODgene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy	jmg.highwire.org	0	0		
647	chr13	8128418	8128957	3500246268	81		8128418	8128957	8421504	2	45,36	0,503	c	350024626800000127,350024626800000117	0-45,1-37						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
647	chr13	8131942	8131965	3500011328	23		8131942	8131965	8421504	1	23	0	c	350001132800000331	1-24						US Patent # 7,119,183. Rapid immunoselection cloning method - Patents.com	www.patents.com	0	0		
648	chr13	8340702	8340729	3500461622	23		8340702	8340729	8421504	2	15,8	0,19	g	350046162200000021	24-48						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
651	chr13	8693268	8693294	3500129658	25		8693268	8693294	8421504	2	6,19	0,7	g	350012965800000077	16-44						Animal model for fibroblast growth factor receptor associated chondrodysplasia	Yayon	1999	0		
653	chr13	8991859	8991885	3500461849	23		8991859	8991885	8421504	2	18,5	0,21	g	350046184900000298	23-46						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
658	chr13	9589216	9589242	3500172045	23		9589216	9589242	8421504	2	8,15	0,11	g	350017204500000054	1-24						Vaccins adn pour animaux de compagnie et de sport	Audonnet	2000	0		
661	chr13	9974158	9974186	3500196657	24		9974158	9974186	8421504	2	6,18	0,10	g	350019665700000236	4-28						Human Platelet-derived Growth Factor Receptors 	.freshpatents.com	0	0		
663	chr13	10245030	10245056	3500029159	23		10245030	10245056	8421504	2	17,6	0,20	g	350002915900000062	22-48						Compositions for the prevention and treatment of verotoxin-induced disease	Williams	1997	0		
665	chr13	10532239	10532264	3500280030	24		10532239	10532264	8421504	2	7,17	0,8	g	350028003000000239	10-34						Ldl-receptor	Caskey	2000	0		
666	chr13	10724402	10724583	3500464458	60		10724402	10724583	8421504	2	2,58	0,123	p	350046445800015001	0-60		20375064	10.1242/jcs.055970	0021-9533	Journal of Cell Science	Asna1/TRC40-mediated membrane insertion of tail-anchored proteins	Favaloro	2010	6		SEC61A2
670	chr13	11218330	11218353	3500260609	23		11218330	11218353	8421504	1	23	0	g	350026060900000004	3-36					Patent	Materials and methods for the alteration of enzyme and acetyl CoA levels in plants (Patent US:6764851)	Nikolau	2004	0		
670	chr13	11218330	11218353	3500184337	23		11218330	11218353	8421504	1	23	0	g	350018433700000038,350018433700000019	3-36,3-36						Fatty acyl-CoA: fatty alcohol acyltransferases - US Patent 6492509 Description	ww.patentstorm.us	0	0		
670	chr13	11218330	11218353	3500074298	23		11218330	11218353	8421504	1	23	0	g	350007429800000019	3-36						FATTY ACYL-CoA: FATTY ALCOHOL ACYLTRANSFERASES	Lardizabal	2000	0		
671	chr13	11320635	11320663	3500386819	23		11320635	11320663	8421504	2	11,12	0,16	g	350038681900000589	1-25						Multi-functional chimeric hematopoietic receptor agonists	Feng	1998	0		
671	chr13	11372840	11372866	3500280030	23		11372840	11372866	8421504	2	17,6	0,20	g	350028003000000206	6-30						Ldl-receptor	Caskey	2000	0		
674	chr13	11774394	11787123	3500149197	41		11774394	11787123	8421504	2	20,21	0,12708	c,g	350014919700000002,350014919700000002,350014919700000004	0-20,0-20,0-21		18258790	10.1152/ajpgi.00540.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe	Ramalingam	2008	0		LINC00710
683	chr13	12900258	12900884	3500444517	102		12900258	12900884	8421504	3	53,31,18	0,576,608	g	350044451700000007,350044451700000012	0-54,0-49						The cDNA-deduced amino acid sequence for trichohyalin, a differentiation marker in the hair follicle, contains a 23 amino acid repeat | Michael Fietz - Academia.edu	www.academia.edu	0	0		
686	chr13	13340630	13340657	3500174027	23		13340630	13340657	8421504	2	16,7	0,20	g	350017402700000005	0-25		9624186	10.1074/jbc.273.25.15854	0021-9258	Journal of Biological Chemistry	Isolation and Characterization of Laminin-10/11 Secreted by Human Lung Carcinoma Cells	Kikkawa	1998	5		
693	chr13	14277341	14277365	3500355951	23		14277341	14277365	8421504	2	8,15	0,9	g	350035595100000060	2-25						Novel Bacterial Proteins with Pesticidal Activity - Patent application	www.faqs.org	0	0		
697	chr13	14681911	14682428	3500158871	309		14681911	14682428	8421504	2	287,22	0,495	c	350015887100000082,350015887100000058,350015887100000015,350015887100000014	0-288,0-22,0-20,0-22						ER UNTERSUCHUNG GENETISCHER URSACHEN DER HING UNTERSCHIEDLICHEN EMPF&#xc4;NGLICHKEIT F&#xdc;R DIE	eb.uni-giessen.de	0	0		
697	chr13	14682062	14682085	3500050704	23		14682062	14682085	8421504	1	23	0	c	350005070400000001	20-43						Characterizing physiological and genetic differences in the early immune response to	cholar.lib.vt.edu	0	0		GATA3
697	chr13	14682166	14682400	3500347624	40		14682166	14682400	8421504	2	20,20	0,214	c,g	350034762400000003,350034762400000003,350034762400000002,350034762400000002	0-20,0-20,0-20,0-20		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		
697	chr13	14682387	14691624	3500094055	192		14682387	14691624	8421504	3	48,126,18	0,4776,9219	p	350009405500015000,350009405500015004,350009405500015006,350009405500015001	30-96,0-177,0-144,0-48						Mutationof GATA3 inhumanbreasttumors	genome.unc.edu	0	0		
697	chr13	14687166	14691723	3500194813	180		14687166	14691723	8421504	3	60,3,117	0,120,4440	p	350019481300015018,350019481300015016,350019481300015015	0-60,0-60,0-60						Mus musculus GATA binding protein 2 (Gata2), mRNA. , NM_008090.3 - GenScript	www.genscript.com	0	0		
697	chr13	14687175	14687223	3500412025	48		14687175	14687223	8421504	1	48	0	p	350041202500015006	0-48						NPG.nature.vol.406.Issue.6794.Jul	www.scribd.com	0	0		GATA2
697	chr13	14687261	14691694	3500457411	40		14687261	14691694	8421504	2	20,20	0,4413	c,g	350045741100000003,350045741100000003,350045741100000002,350045741100000002	0-20,0-20,0-20,0-20		19515866	10.1128/CVI.00424-08	1556-6811	Clinical and Vaccine Immunology	T-Cell mRNA Expression in Response to Mycobacterium bovis BCG Vaccination and Mycobacterium bovis Infection of White-Tailed Deer	Thacker	2009	3		
697	chr13	14691639	14691664	3500311280	25		14691639	14691664	8421504	1	25	0	c	350031128000000016	0-25						Supplemental materials and methods	tologylibrary.org	0	0		
697	chr13	14691735	14696802	3500109053	24		14691735	14696802	8421504	2	14,10	0,5057	c	350010905300000014	0-24		12960249	10.1189/jlb.0902474	0741-5400	Journal of Leukocyte Biology	Different antigens trigger different Th1/Th2 reactions in neonatal mononuclear cells (MNCs) relating to T-bet/GATA-3 expression	Yu	2003	5		GATA3
697	chr13	14697090	14699916	3500207988	152		14697090	14699916	8421504	4	48,48,29,27	0,96,154,2799	c	350020798800000017,350020798800000015,350020798800000014,350020798800000040,350020798800000004	0-48,0-48,9-38,8-35,8-35						GATA-3 expression in human breast carcinoma	Wiegel	1998	0		
697	chr13	14697198	14699726	3500167894	42		14697198	14699726	8421504	2	23,19	0,2509	c,g	350016789400000030,350016789400000030,350016789400000193,350016789400000029,350016789400000029	0-19,0-19,0-23,0-19,0-19						&#xc9;COLE DOCTORALE SST	lis.univ-tours.fr	0	0		
697	chr13	14697198	14699726	3500157269	42		14697198	14699726	8421504	2	23,19	0,2509	c,g	350015726900000030,350015726900000030,350015726900000193,350015726900000029,350015726900000029	0-19,0-19,0-23,0-19,0-19						&#xc9;COLE DOCTORALE SST	scd.univ-tours.fr	0	0		
702	chr13	15356925	15357795	3500194490	23		15356925	15357795	8421504	3	1,8,14	0,846,856	c	350019449000000046	0-23						Abscisic acid signal transduction: Regulation by HAB1 and interaction with brassinosteroids mediated by BRX	digital.csic.es	0	0		
703	chr13	15469520	15469547	3500349167	23		15469520	15469547	8421504	2	9,14	0,13	g	350034916700000014	3-36		19120632	10.1111/j.1365-2672.2008.03949.x	1365-2672	Journal of Applied Microbiology	Archaea diversity within a commercial biogas plant utilizing herbal biomass determined by 16S rDNA and mcrA analysis - Nettmann - 2008 - Journal of Applied Microbiology - Wiley Online Library	Nettmann	2008	0		
703	chr13	15477340	15477365	3500043540	25		15477340	15477365	8421504	1	25	0	g	350004354000000415	14-44						US Patent # 6,987,212. Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use - Patents.com	www.patents.com	0	0		
705	chr13	15826728	15843941	3500088069	282		15826728	15843941	8421504	6	85,17,51,72,49,8	0,4498,4518,4626,8700,17205	p	350008806900015015,350008806900015016,350008806900015027,350008806900015028	0-102,0-51,0-72,0-57						UNIVERSIDAD DE MURCIA DEPARTAMENTO DE BIOQUAMICA Y BIOLOGAA MOLECULAR (A) ESTUDIO DE LA ESTRUCTUR	www.tdx.cat	0	0		PRKCQ
705	chr13	15831315	15831369	3500106421	54		15831315	15831369	8421504	1	54	0	p	350010642100015061	0-54						ISOZYME-SPECIFIC ANTAGONISTS OF PROTEIN KINASE C - Patent application	www.faqs.org	0	0		PRKCQ
705	chr13	15831315	15831369	3500042770	54		15831315	15831369	8421504	1	54	0	p	350004277000015055	0-54						Isozyme-specific antagonists of protein kinase C - Patent application	www.faqs.org	0	0		PRKCQ
705	chr13	15858241	15858267	3500303084	26		15858241	15858267	8421504	1	26	0	c	350030308400000065	6-32						Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof	Alvaro	1994	0		
706	chr13	15896568	15904864	3500356555	60		15896568	15904864	8421504	2	42,18	0,8278	p	350035655500015176	0-60						Methods of treating asthma	Chaudhary	2004	0		PRKCQ
707	chr13	16112850	16112874	3500357547	23		16112850	16112874	8421504	2	12,11	0,13	g	350035754700000010,350035754700000011	5-34,0-29		18347022	10.1074/jbc.M709487200	0021-9258	Journal of Biological Chemistry	Characterization of an Orphan G Protein-coupled Receptor, GPR20, That Constitutively Activates Gi Proteins	Hase	2008	5		
88	chr13	16121841	16126780	3500465611	43		16121841	16126780	8421504	2	22,21	0,4918	c,g	350046561100000007,350046561100000006,350046561100000006	0-22,0-21,0-21		22415873	10.2337/db11-1255	0012-1797	Diabetes	Liver X Receptor &#x03b1; Is Involved in the Transcriptional Regulation of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase Gene	Zhao	2012	8		PFKFB3
712	chr13	16674618	16674641	3500323036	23		16674618	16674641	8421504	1	23	0	g	350032303600000210	3-26						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF A GENE FROM THE JC VIRUS - Patent application	www.faqs.org	0	0		
714	chr13	16978161	16978206	3500405057	45		16978161	16978206	8421504	1	45	0	p	350040505700015063	3-48						&#x7d30;&#x80de;&#x6b7b;&#x3092;&#x8abf;&#x7bc0;&#x3059;&#x308b;&#x65b9;&#x6cd5; - &#x8fb2;&#x6797;&#x6c34;&#x7523;&#x7701;&#x8fb2;&#x696d;&#x751f;&#x7269;&#x8cc7;&#x6e90;&#x7814;&#x7a76;&#x6240;&#x9577;	www.patentjp.com	0	0		YME1L1
89	chr13	17030371	17058710	3500394586	1484		17030371	17058710	8421504	19	90,31,76,45,54,141,94,50,107,199,3,135,6,33,7,102,72,54,185	0,7928,7962,8906,10271,10330,12246,12464,13464,14614,14815,15724,19904,20254,20384,20397,22720,24246,28154	p,c,g	350039458600000023,350039458600000022,350039458600015032,350039458600000021,350039458600015031,350039458600000020,350039458600015030,350039458600000019,350039458600015029,350039458600000018,350039458600000018,350039458600015028,350039458600000017,350039458600015027,350039458600000016,350039458600000016,350039458600015026,350039458600000015,350039458600015025,350039458600000014,350039458600000014,350039458600015024,350039458600000013,350039458600015023,350039458600000012,350039458600000012,350039458600015022,350039458600000011,350039458600015021,350039458600000010,350039458600000009,350039458600015019,350039458600000008,350039458600000008,350039458600015018,350039458600000007,350039458600000006,350039458600015016,350039458600000005,350039458600015015,350039458600000004,350039458600000004,350039458600015014,350039458600015013,350039458600000003,350039458600000003,350039458600000002,350039458600015012,350039458600000001,350039458600000001,350039458600015011,350039458600000000	0-119,0-60,0-45,0-60,0-45,0-60,0-45,0-60,0-45,0-60,0-60,0-45,0-60,0-45,0-60,0-60,0-45,0-56,0-45,0-60,0-60,0-45,0-60,0-45,0-60,0-60,0-45,0-60,0-45,0-60,0-59,0-45,0-60,0-60,0-45,0-60,0-60,0-45,0-60,0-45,0-60,0-60,0-45,0-45,0-54,0-54,0-60,0-45,0-60,0-60,0-45,2-67						Brain derivable polypeptide factors and antibodies thereto	Shoyab	1986	0		
89	chr13	17030460	17058552	3500026241	1359		17030460	17058552	8421504	18	1,50,42,6,126,71,118,144,107,13,185,135,33,115,12,21,95,85	0,7839,7892,8856,10182,10311,12157,12281,13375,14525,14544,15635,20165,20295,22631,24154,24178,28007	p	350002624100015075,350002624100015072,350002624100015070,350002624100015068,350002624100015066,350002624100015064,350002624100015062,350002624100015061,350002624100015059,350002624100015057	0-93,0-177,0-177,0-180,0-177,0-180,0-180,18-168,0-114,0-87						Endozepine-like polypeptides and polynucleotides encoding same	Andrew	2001	0		
715	chr13	17142889	17144202	3500060061	25		17142889	17144202	8421504	2	6,19	0,1294	c	350006006100000010	0-25			10.1242/jcs.03311	0021-9533	Journal of Cell Science	Rac-WAVE-mediated actin reorganization is required for organization and maintenance of cell-cell adhesion	Yamazaki	2007	6		
718	chr13	17475585	17475613	3500441905	28		17475585	17475613	8421504	1	28	0	c	350044190500000008	5-33		17526487	10.1074/jbc.M703060200	0021-9258	Journal of Biological Chemistry	Transcriptional Regulation of the Bovine Leukemia Virus Promoter by the Cyclic AMP-response Element Modulator &#x03c4; Isoform	Nguyen	2007	5		
718	chr13	17502041	17502272	3500307353	87		17502041	17502272	8421504	3	28,17,42	0,169,189	p	350030735300015086	0-87						 Regulation Of Gene Expression Using Chromatin Remodelling Factors 	www.docstoc.com	0	0		CREM
719	chr13	17589712	17642061	3500367337	2235		17589712	17642061	8421504	20	119,103,95,106,83,97,111,163,125,108,60,129,87,153,78,67,203,102,117,129	0,5681,8608,14708,15512,23287,23480,25077,29716,31666,34962,35743,35968,37025,37676,42108,46843,48711,51356,52220	p	350036733700015000	0-2235						KEGG T01001: 8453	www.genome.jp	0	0		CUL2
719	chr13	17621438	17621462	3500089241	23		17621438	17621462	8421504	2	15,8	0,16	c	350008924100000001	10-33						Methods and compositions for increasing antibody production	Reilly	2004	0		CUL2
719	chr13	17638438	17638510	3500426290	72		17638438	17638510	8421504	1	72	0	p	350042629000015006	0-72						Methods to identify compounds useful for the treatment of proliferative and differentiative disorders	Pagano	2008	0		CUL2
719	chr13	17638438	17638510	3500421333	72		17638438	17638510	8421504	1	72	0	p	350042133300015005	0-72						Novel ubiquitin ligases as therapeutic targets	Chiaur	2003	0		CUL2
719	chr13	17638438	17638510	3500369274	72		17638438	17638510	8421504	1	72	0	p	350036927400015008	0-72						Novel ubiquitin ligases as therapeutic targets	Chiaur	2000	0		CUL2
719	chr13	17638438	17638510	3500083997	72		17638438	17638510	8421504	1	72	0	p	350008399700015002	0-72						&#x5897;&#x6b96;&#x6027;&#x304a;&#x3088;&#x3073;&#x5206;&#x5316;&#x6027;&#x75be;&#x60a3;&#x306e;&#x6cbb;&#x7642;&#x306b;&#x6709;&#x7528;&#x306a;&#x5316;&#x5408;&#x7269;&#x306e;&#x540c;&#x5b9a;&#x65b9;&#x6cd5; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 41218	astamuse.com	0	0		CUL2
719	chr13	17641995	17642055	3500456525	60		17641995	17642055	8421504	1	60	0	p	350045652500015000	0-60		10421634		0890-9369	Genes & Development	The von Hippel&#x2013;Lindau tumor suppressor protein is a component of an E3 ubiquitin&#x2013;protein ligase activity	Lisztwan	1999	12		CUL2
719	chr13	17641995	17642055	3500081080	60		17641995	17642055	8421504	1	60	0	p	350008108000015000	0-60					Genes & Development	The von Hippel&#x2013;Lindau tumor suppressor protein is a component of an E3 ubiquitin&#x2013;protein ligase activity	Joanna	July	0		CUL2
720	chr13	17794110	17794136	3500079626	24		17794110	17794136	8421504	3	14,6,4	0,15,22	g	350007962600000010	10-36						Bacillus strain for increased protein production	Ke Li Si Di Nuo *Bang Jiao Er Ni 	2012	0		
721	chr13	17941285	17941312	3500386802	24		17941285	17941312	8421504	3	14,5,5	0,15,22	g	350038680200000084	13-38					Patent	Recombinant antibodies specific for a growth factor receptor (Patent US:5571894)	Groner	1996	0		
723	chr13	18163393	18163422	3500102489	28		18163393	18163422	8421504	2	12,16	0,13	g	350010248900000143,350010248900000182	11-48,14-35						Nucleic acid transfer system	Fominaya	1996	0		
726	chr13	18529759	18529785	3500041925	24		18529759	18529785	8421504	2	15,9	0,17	g	350004192500000183	0-24						Nucleic acid sequences to proteins involved in tocopherol synthesis	B*Sa Wei Ji 	2003	0		
729	chr13	18898973	18902364	3500452702	24		18898973	18902364	8421504	2	10,14	0,3377	c	350045270200000006	0-24		12453880	10.1182/blood.V100.13.4622	0006-4971	Blood	In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo	Schuch	2002	10		
729	chr13	18898973	18902364	3500348428	24		18898973	18902364	8421504	2	10,14	0,3377	c	350034842800000002	0-24						Tissue Engineered Blood Vessels 	.freshpatents.com	0	0		
729	chr13	18902454	18902477	3500105501	23		18902454	18902477	8421504	1	23	0	c	350010550100000006	0-23						Original Article Gene Regulation by BCL3 in a Cervical Cancer Cell Line	fb.cuni.cz/Data/f	0	0		
729	chr13	18902509	18955778	3500167681	23		18902509	18955778	8421504	2	16,7	0,53262	c	350016768100000008	0-23		19697322	10.1002/ijc.24847	1097-0215	International Journal of Cancer	Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer - Lee - 2009 - International Journal of Cancer - Wiley Online Library	Lee	2010	0		
729	chr13	18955859	18962653	3500447590	72		18955859	18962653	8421504	2	48,24	0,6770	c	350044759000000129,350044759000000131	0-48,0-24						METHODS TO EVALUATE GLUCOCORTICOID RECEPTOR AGONISTS AND ANTAGONISTS FOR EFFECTS ON NEURON-LIKE CELLS - Patent application	www.faqs.org	0	0		
729	chr13	19005134	19005159	3500339717	24		19005134	19005159	8421504	2	9,15	0,10	c	350033971700000014	25-49						Online Methods	s.ahajournals.org	0	0		
730	chr13	19013346	19019041	3500299502	39		19013346	19019041	8421504	2	20,19	0,5676	c,g	350029950200000004,350029950200000005,350029950200000005	0-20,0-19,0-19		12368654	10.1097/01.wcb.0000037988.07114.98	0271-678X	Journal of Cerebral Blood Flow & Metabolism	Vascular Endothelial Growth Factor Protects Cultured Rat Hippocampal Neurons Against Hypoxic Injury via an Antiexcitotoxic, Caspase-Independent Mechanism	Svensson	2002	5		NRP1
730	chr13	19019064	19019089	3500310161	25		19019064	19019089	8421504	1	25	0	c	350031016100000000	0-25						Follicle Stimulating Hormone-Induced DNA Synthesis in the Granulosa Cells of Hamster Preantral Follicles Involves Activation of Cyclin-Dependent Kinase-4 Rather Than Cyclin D2 Synthesis	ww.biolreprod.org	0	0		
730	chr13	19019064	19019089	3500178976	25		19019064	19019089	8421504	1	25	0	c	350017897600000000	0-25		14561638	10.1095/biolreprod.103.023457	0006-3363	Biology of Reproduction	Follicle Stimulating Hormone-Induced DNA Synthesis in the Granulosa Cells of Hamster Preantral Follicles Involves Activation of Cyclin-Dependent Kinase-4 Rather Than Cyclin D2 Synthesis	Yang	2004	4		
730	chr13	19033796	19033821	3500362735	24		19033796	19033821	8421504	2	9,15	0,10	g	350036273500000330	0-43						Compositions containing nucleic acids and ligands for therapeutic treatment	Baird	1999	0		
730	chr13	19033796	19033821	3500155898	24		19033796	19033821	8421504	2	9,15	0,10	g	350015589800000240	0-43						Heparin-binding growth factors for gene therapy and anterior eye disorders	Sosnowski	1995	0		
730	chr13	19039050	19039080	3500059323	30		19039050	19039080	8421504	1	30	0	c	350005932300000001	0-30		11549731		0270-6474	The Journal of Neuroscience	Isolation and Expression Pattern of Human Unc-33-Like Phosphoprotein 6/Collapsin Response Mediator Protein 5 (Ulip6/CRMP5): Coexistence with Ulip2/CRMP2 in Sema3A- Sensitive Oligodendrocytes	Ricard	2001	7		NRP1
730	chr13	19039742	19042130	3500256977	42		19039742	19042130	8421504	3	22,16,4	0,40,2384	c,g	350025697700000003,350025697700000003,350025697700000004	0-22,0-22,0-20						REPRODUCTION	uction-online.org	0	0		
730	chr13	19044960	19044986	3500156991	26		19044960	19044986	8421504	1	26	0	c	350015699100000001	0-26					Biochemical Journal	Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas - Scolaris	Pellet-Many	2011	0		
730	chr13	19044962	19044985	3500346708	23		19044962	19044985	8421504	1	23	0	c	350034670800000003	0-23		20577048	10.1172/JCI41203		The Journal of Clinical Investigation	Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-&#x03b2; signaling in hepatic stellate cells	Sheng	July	0		NRP1
730	chr13	19045017	19045040	3500442456	23		19045017	19045040	8421504	1	23	0	c	350044245600000079	3-46						DNA expression systems based on alphaviruses	Garoff	2000	0		
731	chr13	19254088	19259955	3500445461	276		19254088	19259955	8421504	3	64,86,126	0,2115,5741	p	350044546100015040,350044546100015038	0-276,0-276						Moleculas de Adhesion	es.scribd.com	0	0		ITGB1
731	chr13	19254113	19254142	3500411416	29		19254113	19254142	8421504	1	29	0	c	350041141600000004	0-29		22131293	10.1002/iub.568	1521-6551	IUBMB Life	Feedback regulation of the &#x03b1;2(1) collagen gene via the Mek&#x2013;Erk signaling pathway - Dzobo - 2011 - IUBMB Life - Wiley Online Library	Dzobo	2012	0		
731	chr13	19254116	19254140	3500058609	24		19254116	19254140	8421504	1	24	0	c	350005860900000009	1-25						Supporting Information	www.pnas.org	0	0		
731	chr13	19260010	19264564	3500413440	40		19260010	19264564	8421504	2	20,20	0,4534	c	350041344000000046,350041344000000047,350041344000000016	0-20,0-20,20-40						Embryo Implantation Inhibitor 	.freshpatents.com	0	0		
731	chr13	19261561	19261586	3500245106	24		19261561	19261586	8421504	2	19,5	0,20	c	350024510600000004	10-34						BLADDER CANCER TUMOR MARKER, ANTIBODY AND USE THEREOF	Li	2011	0		
731	chr13	19261563	19261676	3500389132	40		19261563	19261676	8421504	2	20,20	0,93	c	350038913200000004,350038913200000005	0-20,0-21						Mesenchymal Stem Cells Sense Three Dimensional Type I Collagen through Discoidin Domain Receptor 1	enthamscience.com	0	0		
731	chr13	19265385	19265412	3500057000	27		19265385	19265412	8421504	1	27	0	g	350005700000000002	0-27						Temporal Analysis of Equine Bone Marrow Aspirate During Establishment of Putative Mesenchymal Progenitor Cell Populations	.primusequine.com	0	0		ITGB1
91	chr13	19267573	19267827	3500086084	81		19267573	19267827	8421504	3	24,24,33	0,27,221	p	350008608400015051	0-81						Amino Acid Sequence of the Human Fibronectin Receptor	jcb.rupress.org	0	0		
732	chr13	19269837	19269863	3500371683	24		19269837	19269863	8421504	2	18,6	0,20	c	350037168300000002	0-24		22039045	10.1074/jbc.M111.263996	0021-9258	Journal of Biological Chemistry	Enterolobium contortisiliquum Trypsin Inhibitor (EcTI), a Plant Proteinase Inhibitor, Decreases in Vitro Cell Adhesion and Invasion by Inhibition of Src Protein-Focal Adhesion Kinase (FAK) Signaling Pathways	Paula	2012	5		ITGB1
732	chr13	19270796	19270819	3500301077	23		19270796	19270819	8421504	1	23	0	c	350030107700000001	21-44						Trabajo Fin de M&#xe1;ster	zaguan.unizar.es	0	0		
732	chr13	19273323	19273347	3500428401	24		19273323	19273347	8421504	1	24	0	c	350042840100000005	0-24						A potential model for studying the plasticity and reprogramming of human epidermal stem cells through preimplantation blastocyst microinjection	R	2008	0		
732	chr13	19273357	19273381	3500212801	24		19273357	19273381	8421504	1	24	0	c	350021280100000009	0-24						Effects of 3,5,3 -Triiodothyronine on the Invasive Potential and the Expression of Integrins and Matrix Metalloproteinases in Cultured Early Placental Extravillous Trophoblasts	.endojournals.org	0	0		ITGB1
732	chr13	19273405	19279303	3500393364	48		19273405	19279303	8421504	2	24,24	0,5874	c	350039336400000002,350039336400000003	8-32,9-33						Inhibitors of beta integrin-g protein alpha subunit binding interactions	Du	2013	0		ITGB1
732	chr13	19273405	19279303	3500139288	48		19273405	19279303	8421504	2	24,24	0,5874	c	350013928800000002,350013928800000003	8-32,9-33						Inhibitors of beta integrin-g protein alpha subunit binding interactions	Du	2013	0		ITGB1
732	chr13	19273405	19279300	3500330764	141		19273405	19279300	8421504	2	78,63	0,5832	p	350033076400015001,350033076400015005	0-141,0-57						Charakterisierung der funktionalen Rolle von Cytohesin-1 in der LFA-1-vermittelten T-Zell-Adh&#xe4;sion	b.uni-muenchen.de	0	0		ITGB1
732	chr13	19273405	19279300	3500056865	141		19273405	19279300	8421504	2	78,63	0,5832	p	350005686500015000,350005686500015001	0-141,0-123						Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin &#x03b2;1A	cs.biologists.org	0	0		ITGB1
732	chr13	19273405	19279243	3500241060	84		19273405	19279243	8421504	2	78,6	0,5832	p	350024106000015005,350024106000015004	0-84,0-84						Dissertation zur Erlangung des Doktorgrades der Fakult&#xe4;t f&#xfc;r Chemie und Pharmazie der Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen	b.uni-muenchen.de	0	0		ITGB1
732	chr13	19273423	19279300	3500197411	123		19273423	19279300	8421504	2	60,63	0,5814	p	350019741100015101	0-123						HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLAY	Arap	2011	0		ITGB1
732	chr13	19273423	19279300	3500117014	123		19273423	19279300	8421504	2	60,63	0,5814	p	350011701400015095,350011701400015096	0-72,0-51					Patent	Peptide compositions for targeting adipose tissue (Patent US:8067377)	Arap	2011	0		ITGB1
732	chr13	19273426	19279300	3500078577	114		19273426	19279300	8421504	3	57,9,48	0,5811,5826	p	350007857700015099	0-114						Human And Mouse Targeting Peptides Identified By Phage Display 	.freshpatents.com	0	0		ITGB1
732	chr13	19276908	19276933	3500254608	23		19276908	19276933	8421504	2	7,16	0,9	g	350025460800000010	0-23						Human parainfluenza virus-1 assay - US Patent 5744299 Description	ww.patentstorm.us	0	0		
732	chr13	19276908	19276933	3500219219	23		19276908	19276933	8421504	2	7,16	0,9	g	350021921900000010	0-23					Patent	Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B (Patent US:6015664)	Fan	2000	0		
732	chr13	19279237	19279300	3500385690	63		19279237	19279300	8421504	1	63	0	p	350038569000015003,350038569000015000	75-138,0-63					The Journal of Cell Biology	ICAP-1, a Novel &#x03b2;1 Integrin Cytoplasmic Domain&#x2013;associated Protein, Binds to a Conserved and Functionally Important NPXY Sequence Motif of &#x03b2;1 Integrin 	David	1997	0		ITGB1
732	chr13	19279237	19279300	3500178016	63		19279237	19279300	8421504	1	63	0	p	350017801600015001	0-63						RGD-independentCellAdhesionviaaTissue Transglutaminase-FibronectinMatrixPromotesFibronectin FibrilDepositionandRequiresSyndecan-4/2and IntegrinCo-signaling S	www.jbc.org	0	0		ITGB1
732	chr13	19279237	19279300	3500107575	63		19279237	19279300	8421504	1	63	0	p	350010757500015000	0-63						The Importance of the Tissue Transglutaminase-Fibronectin Heterocomplex in the RGD-independent Cell Adhesion and Fibronectin Matrix Deposition	rints.aston.ac.uk	0	0		ITGB1
736	chr13	19899115	19899143	3500102026	24		19899115	19899143	8421504	3	14,3,7	0,15,21	g	350010202600000353,350010202600000069	8-32,8-32						Compositions and methods for vaccination against coronaviruses	Jones	1993	0		
740	chr13	20442382	20442408	3500363336	25		20442382	20442408	8421504	2	4,21	0,5	g	350036333600000007	15-40						UNIVERSIDADE FEDERAL DA PARA&#xcd;BA UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO UNIVERSIDADE FEDERAL DO CEAR&#xc1; PROGRAMA DE DOUTORADO INTEGRADO EM ZOOTECNIA	www.cca.ufpb.br	0	0		
740	chr13	20442382	20442408	3500072770	25		20442382	20442408	8421504	2	4,21	0,5	g	350007277000000021	15-40						UNIVERSIDAD POLITACNICA DE VALENCIA DEPARTAMENTO DE CIENCIA ANIMAL CARACTERIZACIAN GENATICA Y	dspace.upv.es	0	0		
741	chr13	20488732	20488760	3500196508	24		20488732	20488760	8421504	2	9,15	0,13	g	350019650800002334	17-41						 Conjugated Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
744	chr13	20868910	20868933	3500306662	23		20868910	20868933	8421504	1	23	0	g	350030666200000147	0-38						Nematode Fatty Acid Desaturase-Like Sequences - Patent application	www.faqs.org	0	0		
744	chr13	20868963	20868991	3500267209	24		20868963	20868991	8421504	2	13,11	0,17	g	350026720900000084	9-36					Patent	Method of preparation of pharmaceutically grade plasmid DNA (Patent CN:1882682)	Ni Gu La Si *Mei Si Te La Li 	2010	0		
745	chr13	21007584	21007613	3500396199	27		21007584	21007613	8421504	2	22,5	0,24	c	350039619900000007	11-38						Upstream Stimulating Factors 1 and 2 Enhance Transcription from the Placenta-Specific Promoter 1.1 of the Bovine Cyp19 Gene	biomedcentral.com	0	0		
747	chr13	21299653	21299677	3500201864	23		21299653	21299677	8421504	2	18,5	0,19	g	350020186400000495	4-27						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
747	chr13	21318107	21318131	3500168697	23		21318107	21318131	8421504	2	10,13	0,11	g	350016869700000001	12-35						Modified steptococcus pneumonia pneumolysin (ply) polypeptides	Oloo	2010	0		
747	chr13	21350673	21350707	3500461849	28		21350673	21350707	8421504	3	7,7,14	0,8,20	g	350046184900000208	0-34						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
748	chr13	21376011	21376035	3500361995	23		21376011	21376035	8421504	2	7,16	0,8	c	350036199500000074	0-23						<HTML> <HEAD> <BASE TARGET="_top"> <TITLE>United States Patent: 5,494,810</TITLE></HEAD> <BODY 	l.med.cornell.edu	0	0		
748	chr13	21376011	21376035	3500329421	23		21376011	21376035	8421504	2	7,16	0,8	c	350032942100000049	0-23						<HTML> <HEAD> <BASE TARGET="_top"> <TITLE>United States Patent: 6,054,564</TITLE></HEAD> <BODY B	l.med.cornell.edu	0	0		
748	chr13	21376011	21376035	3500197820	23		21376011	21376035	8421504	2	7,16	0,8	c	350019782000000030	0-23						US Patent # 5,830,711. Thermostable ligase mediated DNA amplification system for the detection of genetic diseases - Patents.com	www.patents.com	0	0		
748	chr13	21376011	21376035	3500165605	23		21376011	21376035	8421504	2	7,16	0,8	c	350016560500000000	0-23						Nucleic acids extension assay	Cardy	1993	0		
748	chr13	21376011	21376035	3500129761	23		21376011	21376035	8421504	2	7,16	0,8	c	350012976100000045	0-23						US Patent # 6,054,564. Thermostable ligase mediated DNA amplification system for the detection of genetic diseases - Patents.com	www.patents.com	0	0		
749	chr13	21524386	21567545	3500461622	40		21524386	21567545	8421504	4	15,5,15,5	0,16,43138,43154	g	350046162200000072,350046162200000261	24-46,7-27						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
759	chr13	22895008	22895521	3500257699	42		22895008	22895521	8421504	3	19,5,18	0,68,495	c,g	350025769900000012,350025769900000012,350025769900000013	0-19,0-19,0-23						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
759	chr13	22895522	22898628	3500307492	978		22895522	22898628	8421504	9	112,97,56,51,109,46,99,81,327	0,436,1142,1286,1487,1677,2122,2605,2779	p	350030749200015039	0-978					Patent	Cancer stem cell antigen vaccines and methods (Patent US:8129184)	Yu	2012	0		SPAG6
759	chr13	22895522	22898628	3500108695	978		22895522	22898628	8421504	9	112,97,56,51,109,46,99,81,327	0,436,1142,1286,1487,1677,2122,2605,2779	p	350010869500015041	0-978						CANCER STEM CELL ANTIGEN VACCINES AND METHODS - Patent application	www.faqs.org	0	0		SPAG6
759	chr13	22895522	22898628	3500023932	978		22895522	22898628	8421504	9	112,97,56,51,109,46,99,81,327	0,436,1142,1286,1487,1677,2122,2605,2779	p	350002393200015046	0-978						CANCER STEM CELL ANTIGEN VACCINES AND METHODS	Yu	2007	0		SPAG6
759	chr13	22895522	22895552	3500394554	30		22895522	22895552	8421504	1	30	0	c	350039455400000000	0-30		16778197	10.1158/0008-5472.CAN-06-0094	0008-5472	Cancer Research	Bmi-1 Is a Novel Molecular Marker of Nasopharyngeal Carcinoma Progression and Immortalizes Primary Human Nasopharyngeal Epithelial Cells	Song	2006	8		SPAG6
759	chr13	22895532	22895557	3500209416	25		22895532	22895557	8421504	1	25	0	c	350020941600000023	0-25			10.1128/MCB.25.12.5183-5195.2005		Molecular and Cellular Biology	Combination of hTERT and bmi-1, E6, or E7 Induces Prolongation of the Life Span of Bone Marrow Stromal Cells from an Elderly Donor without Affecting Their Neurogenic Potential 	Taisuke	June	0		SPAG6
759	chr13	22895589	22897678	3500455877	43		22895589	22897678	8421504	2	22,21	0,2068	c,g	350045587700000018,350045587700000018,350045587700000019	0-22,0-22,0-21		19337376	10.1371/journal.pone.0005060		PLoS ONE	The Synovial Sarcoma-Associated SYT-SSX2 Oncogene Antagonizes the Polycomb Complex Protein Bmi1	Roy	2009	0		SPAG6
759	chr13	22895593	22898338	3500261779	101		22895593	22898338	8421504	6	22,19,14,8,19,19	0,1419,1638,2051,2124,2726	c,g	350026177900000002,350026177900000010,350026177900000010,350026177900000003,350026177900000013,350026177900000013,350026177900000016,350026177900000016	0-22,0-19,0-19,0-22,0-19,0-19,0-19,0-19						Anti-proliferation effect of BMI-1 in U937 cells with siRNA	-publications.com	0	0		
759	chr13	22895599	22898545	3500193670	354		22895599	22898545	8421504	16	25,26,25,24,13,12,3,45,29,47,5,12,11,24,28,25	0,425,1096,1209,1247,1410,1516,1600,2055,2097,2528,2597,2702,2717,2888,2921	c	350019367000000068,350019367000000013,350019367000000014,350019367000000230,350019367000000019,350019367000000020,350019367000000231,350019367000000022,350019367000000032,350019367000000033,350019367000000272,350019367000000039,350019367000000044,350019367000000284,350019367000000049,350019367000000054,350019367000000300,350019367000000055,350019367000000302,350019367000000061,350019367000000063,350019367000000332,350019367000000334,350019367000000075,350019367000000074,350019367000000340	21-46,21-46,21-46,0-25,21-46,19-46,0-21,21-46,0-21,0-21,0-25,24-46,21-46,0-25,19-46,21-46,0-25,21-46,0-25,0-23,22-46,0-25,0-25,0-21,21-46,0-25						Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors - Patent application	www.faqs.org	0	0		
759	chr13	22895609	22895984	3500414850	51		22895609	22895984	8421504	2	25,26	0,349	p	350041485000015023	0-51						Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. - ResearchGate	.researchgate.net	0	0		SPAG6
759	chr13	22895609	22895984	3500080266	51		22895609	22895984	8421504	2	25,26	0,349	p	350008026600015045	33-84						Genomicbinding-site cloningreveals anestrogen-responsive gene that encodes aRING fingerprotein	www.pnas.org	0	0		SPAG6
759	chr13	22896033	22898133	3500186253	42		22896033	22898133	8421504	3	21,15,6	0,1695,2094	c,g	350018625300000001,350018625300000001,350018625300000002	0-21,0-21,0-21		20530672	10.1158/0008-5472.CAN-09-4229	0008-5472	Cancer Research	The Polycomb Group Protein Bmi-1 Is Essential for the Growth of Multiple Myeloma Cells	Jagani	2010	8		SPAG6
759	chr13	22896696	22898309	3500462030	44		22896696	22898309	8421504	3	22,14,8	0,1498,1605	c	350046203000000068,350046203000000035,350046203000000036,350046203000000069	0-22,0-22,0-22,0-22						US Patent # 7,501,281. Compositions, methods and kits related to thrombin, Notch signaling and stamatogenesis and growth of stem cells - Patents.com	www.patents.com	0	0		
759	chr13	22896813	22897737	3500360135	38		22896813	22897737	8421504	2	19,19	0,905	c	350036013500000000,350036013500000001	0-19,0-19			10.2353/ajpath.2007.060754		The American Journal of Pathology	Bmi-1 Is Essential for the Tumorigenicity of Neuroblastoma Cells	Hongjuan	2007	0		SPAG6
759	chr13	22896813	22897737	3500325316	38		22896813	22897737	8421504	2	19,19	0,905	c,g	350032531600000006,350032531600000007,350032531600000007	0-19,0-19,0-19						&#x4e3b;&#x9898;&#xff1a;Essential | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		SPAG6
759	chr13	22896813	22897737	3500016653	38		22896813	22897737	8421504	2	19,19	0,905	c,g	350001665300000000,350001665300000001,350001665300000001	0-19,0-19,0-19						Bmi- Is Essential for the Tumorigenicity of Neuroblastoma Cells 2007&#x5e74;&#x7b2c;169&#x5377;&#x7b2c;4&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		SPAG6
759	chr13	22896813	22897737	3500014422	38		22896813	22897737	8421504	2	19,19	0,905	c	350001442200000000,350001442200000001	0-19,0-19		16982619	10.1074/jbc.M604009200	0021-9258	Journal of Biological Chemistry	Bmi-1 Regulates the Differentiation and Clonogenic Self-renewal of I-type Neuroblastoma Cells in a Concentration-dependent Manner	Cui	2006	5		SPAG6
759	chr13	22897016	22897211	3500182513	41		22897016	22897211	8421504	3	21,8,12	0,94,183	c	350018251300000004,350018251300000005	0-21,0-20		17185465	10.1182/blood-2006-07-035287	0006-4971	Blood	Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential	Araki	2007	10		SPAG6
759	chr13	22897666	22898417	3500284335	40		22897666	22898417	8421504	2	20,20	0,731	c,g	350028433500000011,350028433500000011,350028433500000005	0-20,0-20,0-20						Regulation of anti-inflammatory cytokine IL-10 by the Polycomb Group Protein Bmi1	.uni-wuerzburg.de	0	0		SPAG6
759	chr13	22898487	22898511	3500169844	24		22898487	22898511	8421504	1	24	0	c	350016984400000005	0-24						SURGICAL ATTENUATION OF CONGENITAL PORTOSYSTEMIC SHUNTS IN DOGS	ive.library.uu.nl	0	0		
759	chr13	22898548	22898644	3500255521	40		22898548	22898644	8421504	2	19,21	0,75	c,g	350025552100000007,350025552100000007,350025552100000006,350025552100000006	0-19,0-19,0-21,0-21		24023859	10.1371/journal.pone.0073312	1932-6203	PLOS ONE	PLOS ONE: Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma	Yu	2013	4		SPAG6
761	chr13	23080455	23080482	3500287020	27		23080455	23080482	8421504	1	27	0	c,g	350028702000000001,350028702000000001	0-27,0-27		18753295	10.1152/ajprenal.90310.2008		American Journal of Physiology - Renal Physiology	Localization of phosphatidylinositol phosphate kinase II&#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	Clarke	2008	0		PIP4K2A
761	chr13	23080455	23080482	3500230851	27		23080455	23080482	8421504	1	27	0	c,g	350023085100000001,350023085100000001	0-27,0-27		18753295	10.1152/ajprenal.90310.2008		American Journal of Physiology - Renal Physiology	Localization of phosphatidylinositol phosphate kinase II&#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	Jonathan	2008	0		PIP4K2A
761	chr13	23080455	23080482	3500172832	27		23080455	23080482	8421504	1	27	0	c	350017283200000001	0-27		18753295	10.1152/ajprenal.90310.2008		American Journal of Physiology - Renal Physiology	Localization of phosphatidylinositol phosphate kinase II&#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	Clarke	2008	0		PIP4K2A
761	chr13	23080455	23080482	3500149531	27		23080455	23080482	8421504	1	27	0	c	350014953100000001	0-27		18753295	10.1152/ajprenal.90310.2008		American Journal of Physiology - Renal Physiology	Localization of phosphatidylinositol phosphate kinase II&#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	Clarke	2008	0		PIP4K2A
761	chr13	23080455	23080482	3500006396	27		23080455	23080482	8421504	1	27	0	c	350000639600000001	0-27						Localization of phosphatidylinositol phosphate kinase II &#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	g.library.pcc.edu	0	0		PIP4K2A
765	chr13	23640767	23640796	3500452070	28		23640767	23640796	8421504	2	15,13	0,16	g	350045207000000194,350045207000000193	7-35,10-38						Immunostimulatory nucleic acids	Krieg	2002	0		
769	chr13	24195179	24195207	3500455900	23		24195179	24195207	8421504	2	16,7	0,21	g	350045590000000013	8-31						Diacylglycerol acyl transferase proteins	Lardizabal	2002	0		
771	chr13	24380224	24380250	3500052584	23		24380224	24380250	8421504	2	7,16	0,10	g	350005258400000025	8-37						Compounds and methods for development of Ret modulators	Artis	2007	0		
780	chr13	25642963	25642986	3500452225	23		25642963	25642986	8421504	1	23	0	g	350045222500000001	6-35						Multiple molecular effect pathways of an environmental ...	ww.slideshare.net	0	0		
782	chr13	25914727	25914752	3500452170	25		25914727	25914752	8421504	1	25	0	g	350045217000000035	13-38						US Patent # 6,706,509. Oncoprotein protein kinase - Patents.com	www.patents.com	0	0		
784	chr13	26138135	26138166	3500316820	26		26138135	26138166	8421504	3	6,14,6	0,7,25	g	350031682000000009	4-31						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease	Potts	2002	0		
784	chr13	26183335	26183363	3500252134	23		26183335	26183363	8421504	2	17,6	0,22	g	350025213400000001	3-27		16738003	10.1152/ajpcell.00457.2005		American Journal of Physiology - Cell Physiolog	Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression	Searles	2006	0		
12	chr13	26211243	26272719	3500105503	1755		26211243	26272719	8421504	16	76,60,150,234,91,113,116,80,55,117,65,79,150,108,90,171	0,759,1023,2179,6989,7638,12836,26322,36076,37797,39441,47209,50728,57845,58485,61305	p	350010550300015035	0-1755						Medical treatment	Champion	2005	0		GAD2
12	chr13	26213475	26272689	3500316994	150		26213475	26272689	8421504	4	42,30,18,60	0,10690,24090,59154	p	350031699400015002	27-258						Methods and compositions to generate and control the effector profile of t cells	Bot	2007	0		GAD2
12	chr13	26213475	26272689	3500062604	150		26213475	26272689	8421504	4	42,30,18,60	0,10690,24090,59154	p	350006260400015002	27-258						Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells	Bot	2008	0		GAD2
12	chr13	26213478	26272689	3500316994	147		26213478	26272689	8421504	4	39,30,18,60	0,10687,24087,59151	p	350031699400015045	0-228						Methods and compositions to generate and control the effector profile of t cells	Bot	2007	0		GAD2
12	chr13	26213478	26272689	3500062604	147		26213478	26272689	8421504	4	39,30,18,60	0,10687,24087,59151	p	350006260400015045	0-228						Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells	Bot	2008	0		GAD2
785	chr13	26218885	26218930	3500200218	45		26218885	26218930	8421504	1	45	0	p	350020021800015001	0-45		19680229	10.1038/emboj.2009.212		The EMBO Journal	Thymus-specific deletion of insulin induces autoimmune diabetes	Yong	2009	0		GAD2
785	chr13	26218885	26218930	3500024567	45		26218885	26218930	8421504	1	45	0	p	350002456700015001	0-45		19680229	10.1038/emboj.2009.212	ERROR! NO ISSN	The EMBO Journal	Thymus-specific deletion of insulin induces autoimmune diabetes	Fan	2009	0		GAD2
785	chr13	26218885	26218930	3500024010	45		26218885	26218930	8421504	1	45	0	p	350002401000015000	0-45		16517713		0022-1767	The Journal of Immunology	Regulatory T Cells Can Mediate Their Function through the Stimulation of APCs to Produce Immunosuppressive Nitric Oxide	Chen	2006	6		GAD2
785	chr13	26249088	26258483	3500436926	141		26249088	26258483	8421504	4	69,21,20,31	0,1596,1641,9364	p	350043692600015006,350043692600015017	0-90,0-51						The neurobiology of operant learning: biophysical and molecular mechanisms in a hierarchical organization of multiple memory systems	uni-regensburg.de	0	0		GAD2
785	chr13	26272617	26272680	3500276554	63		26272617	26272680	8421504	1	63	0	p	350027655400015023,350027655400015022	0-63,0-51						ISOLATED HIGH AFFINITY ENTITIES WITH T-CELL RECEPTOR LIKE SPECIFICITY TOWARDS NATIVE COMPLEXES OF MHC CLASS II AND GLUTAMIC ACID DECARBOXYLASE (GAD) AUTOANTIGENIC PEPTIDES	Reiter	2011	0		GAD2
785	chr13	26272629	26272689	3500127053	60		26272629	26272689	8421504	1	60	0	p	350012705300015005	0-60						Immunogenic T-helper Epitopes From Human Tumour Antigens And Immunotherapeutic Methods Using Said Epitopes 	.freshpatents.com	0	0		GAD2
798	chr13	27950192	27950220	3500258483	23		27950192	27950220	8421504	2	14,9	0,19	c	350025848300000083	0-23						IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES - Patent application	www.faqs.org	0	0		
803	chr13	28601699	28601722	3500311011	23		28601699	28601722	8421504	1	23	0	g	350031101100000015,350031101100000031	12-35,12-35						BIFUNCTIONAL FUSION MOLECULES FOR THE DELIVERY OF ANTIGENS TO PROFESSIONAL ANTIGEN-PRESENTING CELLS - Patent application	www.faqs.org	0	0		
804	chr13	28779362	28779386	3500034199	24		28779362	28779386	8421504	1	24	0	g	350003419900000097,350003419900000104	19-44,25-48						MODULATION OF APOLIPOPROTEIN (a) EXPRESSION - Patent application	www.faqs.org	0	0		
807	chr13	29111681	29114232	3500047878	40		29111681	29114232	8421504	4	1,19,4,16	0,405,575,2535	c	350004787800000000,350004787800000001	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
807	chr13	29168673	29168704	3500174799	25		29168673	29168704	8421504	3	5,12,8	0,6,23	c	350017479900000049	21-46						Tie-2 ligand-3 - Patent # 6846914 - PatentGenius	.patentgenius.com	0	0		
808	chr13	29254081	29258686	3500026241	27		29254081	29258686	8421504	2	13,14	0,4591	c	350002624100000009	10-37						Endozepine-like polypeptides and polynucleotides encoding same	Andrew	2001	0		
812	chr13	29813405	29822973	3500319127	40		29813405	29822973	8421504	2	20,20	0,9548	g	350031912700000033,350031912700000032	0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
812	chr13	29865910	29865934	3500253796	23		29865910	29865934	8421504	2	4,19	0,5	g	350025379600000559	6-29					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
812	chr13	29865910	29865934	3500070088	23		29865910	29865934	8421504	2	4,19	0,5	g	350007008800000559	6-29						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
813	chr13	29957410	29957434	3500168776	23		29957410	29957434	8421504	2	11,12	0,12	g	350016877600000829,350016877600002090	1-24,1-24						Micrornas (mirnas) For Plant Growth And Development 	.freshpatents.com	0	0		
816	chr13	30309304	30309350	3500119257	46		30309304	30309350	8421504	1	46	0	g	350011925700000017,350011925700000043	54-100,54-100						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
819	chr13	30707437	30707463	3500461622	23		30707437	30707463	8421504	2	16,7	0,19	g	350046162200000206	15-48						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
819	chr13	30774867	30781454	3500331911	769		30774867	30781454	8421504	4	177,24,106,462	0,5978,6005,6125	p,c,g	350033191100015025,350033191100015030,350033191100015024,350033191100015029,350033191100015023,350033191100000022,350033191100015027,350033191100015022,350033191100000021,350033191100015026,350033191100000026,350033191100000025,350033191100000025	0-66,0-63,0-171,0-66,0-339,0-56,0-135,0-159,0-176,0-135,0-49,0-49,0-49						Therapeutic polypeptides, nucleic acids encoding same, and methods of use	Anderson	2003	0		
819	chr13	30781241	30781433	3500131676	192		30781241	30781433	8421504	1	192	0	p	350013167600015033	0-192						Treatment of metabolic disorders with a tnf receptor family member (fradj and/or cryptic) agonists or antagonists	Dialynas	2003	0		C1QL3
824	chr13	31431332	31436086	3500206937	86		31431332	31436086	8421504	4	22,23,20,21	0,826,1405,4733	c,g	350020693700000028,350020693700000029,350020693700000022,350020693700000022,350020693700000023,350020693700000023	10-32,9-32,0-20,0-20,0-21,0-21						terms and conditions of use	.era.lib.ed.ac.uk	0	0		
824	chr13	31432228	31432253	3500354301	25		31432228	31432253	8421504	1	25	0	c	350035430100000024	0-25						World J Gastroenterol	www.wjgnet.com	0	0		VIM
824	chr13	31432446	31438826	3500408788	102		31432446	31438826	8421504	2	69,33	0,6347	p	350040878800015002	45-186						Flightless I is a focal adhesion-associated actin-capping protein that regulates cell migration	www.fasebj.org	0	0		VIM
824	chr13	31432449	31432506	3500141684	57		31432449	31432506	8421504	1	57	0	p	350014168400015003	0-57						&#x4ee5;&#x7cfb;&#x7d71;&#x751f;&#x7269;&#x5b78;&#x7814;&#x7a76;&#x5e73;&#x53f0;&#x63a2;&#x8a0e;&#x4e2d;&#x8349;&#x85e5;&#x9632;&#x6cbb;&#x6557; &#x8840;&#x75c7;&#x4e4b;&#x75c5;&#x7406;&#x751f;&#x7406;&#x8207;&#x6cbb;&#x7642;&#x6a5f;&#x8f49;-&#x4ee5;&#x97	tcam.ccmp.gov.tw	0	0		VIM
824	chr13	31432477	31432734	3500421689	40		31432477	31432734	8421504	2	20,20	0,237	c,g	350042168900000008,350042168900000008,350042168900000009,350042168900000009	0-20,0-20,0-20,0-20						Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer	www.wjgnet.com	0	0		VIM
824	chr13	31432555	31436308	3500074825	48		31432555	31436308	8421504	2	24,24	0,3729	c,g	350007482500000008,350007482500000009,350007482500000009	0-24,0-24,0-24		18032479	10.1152/ajpgi.00328.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells	Yano	2008	0		
824	chr13	31432710	31436072	3500048779	102		31432710	31436072	8421504	3	54,21,27	0,739,3335	p	350004877900015011,350004877900015012,350004877900015006,350004877900015008	0-54,0-51,0-48,0-45						Novel MHC II associated peptides	Kropshofer	2003	0		VIM
824	chr13	31436386	31436985	3500279766	49		31436386	31436985	8421504	3	3,21,25	0,497,574	c	350027976600000002	0-73						Identi&#xfb01;cation of Differentially Expressed Genes in Individual Bovine Preimplantation Embryos Produced by Nuclear Transfer: Improper Reprogramming of Genes Required for Development	ww.biolreprod.org	0	0		
824	chr13	31436943	31437577	3500376584	87		31436943	31437577	8421504	3	39,18,30	0,48,604	p	350037658400015015	0-87						&#x201c;EFECTOS BIOL&#xd3;GICOS Y CARACTERIZACI&#xd3;N DE DIANAS DE LA PROSTAGLANDINA A : INTERACCIONES CON PROTE&#xcd;NAS DE FILAMENTOS INTERMEDIOS&#x201d;.	digital.csic.es	0	0		
824	chr13	31437562	31438777	3500262145	40		31437562	31438777	8421504	2	19,21	0,1194	c,g	350026214500000002,350026214500000003,350026214500000003	0-19,0-21,0-21		22134360		1019-6439	International Journal of Oncology	IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures	Xie	2012	2		VIM
824	chr13	31437562	31438777	3500105430	40		31437562	31438777	8421504	2	19,21	0,1194	c	350010543000000002,350010543000000003	0-19,0-21		22134360	10.3892/ijo.2011.1275		International Journal of Oncology	IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures	GUOZHU	2012	0		VIM
824	chr13	31437562	31438777	3500096873	40		31437562	31438777	8421504	2	19,21	0,1194	c	350009687300000002,350009687300000003	0-19,0-21						IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures	-publications.com	0	0		VIM
824	chr13	31437616	31437643	3500213738	26		31437616	31437643	8421504	2	19,7	0,20	c,g	350021373800000010,350021373800000010	0-26,0-26			10.1634/stemcells.2005-0292	1549-4918	STEM CELLS	Human Embryonic Stem Cells Reprogram Myeloid Precursors Following Cell&#x2013;Cell Fusion - Yu - 2006 - STEM CELLS - Wiley Online Library	Yu	2006	0		VIM
824	chr13	31437656	31437680	3500131497	24		31437656	31437680	8421504	1	24	0	c	350013149700000025	0-24						SIGNALING FROM MATRIX ELASTICITY AND TGF- 1 TO CELLS OF THE CARDIAC VALVE	gradworks.umi.com	0	0		
824	chr13	31437657	31438185	3500027719	42		31437657	31438185	8421504	3	20,15,7	0,96,521	c,g	350002771900000008,350002771900000008,350002771900000009	0-20,0-20,0-22						Effect of maternal methionine supplementation on the transcriptome of bovine preimplantation embryos. - ResearchGate	.researchgate.net	0	0		
824	chr13	31437687	31437710	3500316135	23		31437687	31437710	8421504	1	23	0	c	350031613500000009	17-40						Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma. - ResearchGate	.researchgate.net	0	0		
824	chr13	31438209	31439789	3500177682	39		31438209	31439789	8421504	3	13,7,19	0,540,1561	c	350017768200000008,350017768200000009	0-20,0-19		20615257	10.1186/1471-2407-10-364		BMC Cancer	Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion	Deshui	2010	0		VIM
824	chr13	31438209	31439789	3500125659	39		31438209	31439789	8421504	3	13,7,19	0,540,1561	c	350012565900000008,350012565900000009	0-20,0-19						Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion	biomedcentral.com	0	0		VIM
824	chr13	31438209	31439789	3500067369	39		31438209	31439789	8421504	3	13,7,19	0,540,1561	c	350006736900000008,350006736900000009	0-20,0-19		20615257	10.1186/1471-2407-10-364	1471-2407	BMC Cancer	Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion	Jia	2010	3		VIM
824	chr13	31439662	31439686	3500364288	24		31439662	31439686	8421504	1	24	0	c	350036428800000016	20-44						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		VIM
825	chr13	31518397	31518422	3500011146	25		31518397	31518422	8421504	1	25	0	c	350001114600000000	8-33		16197558	10.1186/1478-1336-3-3	1478-1336	Nuclear Receptor	Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms	Tachibana	2005	0		PXMP4
828	chr13	31935026	31935064	3500111430	28		31935026	31935064	8421504	4	7,3,4,14	0,11,19,24	g	350011143000000187	12-40						RECOMBINANT LACTOBACILLUS WITH DECREASED LIPOTEICHOIC ACID TO REDUCE INFLAMMATORY RESPONSES - Patent application	www.faqs.org	0	0		
829	chr13	32009069	32009096	3500023932	23		32009069	32009096	8421504	2	16,7	0,20	g	350002393200000000	0-23						CANCER STEM CELL ANTIGEN VACCINES AND METHODS	Yu	2007	0		
830	chr13	32139676	32139699	3500357902	23		32139676	32139699	8421504	1	23	0	g	350035790200000007	0-23						Identification of the ovine mannose receptor and its possible role in Visna/Maedi virus infection	inaryresearch.org	0	0		
831	chr13	32276217	32276242	3500378946	24		32276217	32276242	8421504	2	5,19	0,6	c	350037894600000021	11-35						Genetic test for the identification of dwarfism in cattle - US Patent 7700291 Description	ww.patentstorm.us	0	0		
831	chr13	32276217	32276242	3500206581	24		32276217	32276242	8421504	2	5,19	0,6	c	350020658100000021	11-35						 Genetic Test For The Identification Of Dwarfism In Cattle 	www.docstoc.com	0	0		
831	chr13	32342884	32342908	3500074316	23		32342884	32342908	8421504	2	5,18	0,6	g	350007431600000001	1-24						Identification of inhibitors of mitosis	Avruch	2003	0		
834	chr13	32722955	32723000	3500310866	45		32722955	32723000	8421504	1	45	0	p	350031086600015006	0-45		10593863		0892-6638	The FASEB Journal	Signaling from &#x03b2;-adrenoceptor to L-type calcium channel: identification of a novel cardiac protein kinase A target possessing similarities to AHNAK	HAASE	1999	6		CACNB2
835	chr13	32809655	32832686	3500394576	41		32809655	32832686	8421504	2	20,21	0,23010	c,g	350039457600000004,350039457600000004,350039457600000005	0-20,0-20,0-21		11158974			American Journal of Physiology - Heart and Circulatory Physiology	Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation	Golovina	2001	0		CACNB2
835	chr13	32809655	32832686	3500336882	41		32809655	32832686	8421504	2	20,21	0,23010	c,g	350033688200000004,350033688200000004,350033688200000005	0-20,0-20,0-21						Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation	rt.physiology.org	0	0		CACNB2
835	chr13	32832703	32845949	3500086004	24		32832703	32845949	8421504	2	17,7	0,13239	c	350008600400000017,350008600400000021	0-24,0-24			10.1371/journal.pone.0000292		PLoS ONE	Increased Expression of the Auxiliary &#x03b2;2-subunit of Ventricular L-type Ca2+ Channels Leads to Single-Channel Activity Characteristic of Heart Failure	Roger	2007	0		CACNB2
835	chr13	32850500	32850529	3500134741	29		32850500	32850529	8421504	1	29	0	c	350013474100000000	0-29			10.1113/jphysiol.2002.018515		The Journal of Physiology	Novel functional properties of Ca2+ channel &#x03b2; subunits revealed by their expression in adult rat heart cells	Henry	June	0		CACNB2
836	chr13	32909533	32909560	3500368569	23		32909533	32909560	8421504	2	8,15	0,12	g	350036856900000028	14-37						CORN PLANTS AND SEED ENHANCED FOR ASPARAGINE AND PROTEIN - Patent application	www.faqs.org	0	0		
836	chr13	32979912	32979936	3500280216	23		32979912	32979936	8421504	2	12,11	0,13	g	350028021600000072,350028021600000073	0-27,6-33						Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof	CEDRONE	2012	0		
837	chr13	33133305	33133330	3500431083	23		33133305	33133330	8421504	3	11,5,7	0,12,18	g	350043108300000019	17-42						Investigations of self-incompatibility (SI) in perennial ryegrass (Lolium perenne L.)	theses.bham.ac.uk	0	0		
838	chr13	33218181	33218205	3500216457	23		33218181	33218205	8421504	2	17,6	0,18	c	350021645700000000	8-31		18729850	10.1111/j.1365-2141.2008.07362.x	1365-2141	British Journal of Haematology	MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish - Zhuravleva - 2008 - British Journal of Haematology - Wiley Online Library	Zhuravleva	2008	0		
838	chr13	33221429	33221461	3500209653	25		33221429	33221461	8421504	3	7,3,15	0,9,17	g	350020965300000085	24-49					Patent	Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof (Patent US:6045997)	Ashworth	2000	0		
839	chr13	33394017	33394044	3500219384	24		33394017	33394044	8421504	2	12,12	0,15	c	350021938400000016	0-24		9799249	10.1093/emboj/17.21.6412	ERROR! NO ISSN	The EMBO Journal	Distinct roles of two separable in vitro activities of yeast Mre11 in mitotic and meiotic recombination	Furuse	1998	0		
841	chr13	33626646	33626676	3500465032	30		33626646	33626676	8421504	1	30	0	c	350046503200000007	6-36		23272142	10.1371/journal.pone.0051688	1932-6203	PLOS ONE	PLOS ONE: Regulation of Trabecular Meshwork Cell Contraction and Intraocular Pressure by miR-200c	Luna	2012	4		
841	chr13	33632381	33632667	3500460046	43		33632381	33632667	8421504	2	21,22	0,264	c	350046004600000050,350046004600000020	0-21,0-22						The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. - ResearchGate	.researchgate.net	0	0		ZEB1
105	chr13	34433454	34554417	3500408002	5412		34433454	34554417	8421504	50	6,83,311,549,156,18,59,144,37,23,134,77,48,29,67,36,48,240,133,176,146,148,117,96,48,30,61,178,87,90,148,130,122,48,38,104,88,105,244,131,23,35,86,240,192,25,70,58,92,58	0,302,407,719,1368,2863,2929,4257,5872,6005,8900,9763,9846,9942,10547,12920,12974,18875,19503,22117,34827,35094,36309,37679,39851,39907,39947,42582,44026,44198,48569,62897,75954,76124,77070,77203,77308,77444,77988,81786,82206,82891,99858,100040,100328,103634,103694,103878,113908,120905	c,g	350040800200000253,350040800200000252,350040800200000013,350040800200000013,350040800200000251,350040800200000251,350040800200000250,350040800200000250,350040800200000249,350040800200000248,350040800200000247,350040800200000246,350040800200000244,350040800200000243,350040800200000242,350040800200000242,350040800200000241,350040800200000240,350040800200000237,350040800200000236,350040800200000235,350040800200000234,350040800200000119,350040800200000232,350040800200000232,350040800200000230,350040800200000229,350040800200000113,350040800200000226,350040800200000224,350040800200000223,350040800200000222,350040800200000221,350040800200000220,350040800200000218,350040800200000217,350040800200000102,350040800200000216,350040800200000215,350040800200000214,350040800200000213,350040800200000212,350040800200000211,350040800200000210,350040800200000209,350040800200000094,350040800200000208,350040800200000207,350040800200000206,350040800200000205,350040800200000090,350040800200000204,350040800200000202,350040800200000087,350040800200000201,350040800200000199,350040800200000009,350040800200000009,350040800200000008,350040800200000008,350040800200000197,350040800200000197,350040800200000196,350040800200000006,350040800200000195,350040800200000194,350040800200000193,350040800200000078,350040800200000192,350040800200000191,350040800200000190,350040800200000189,350040800200000188,350040800200000187,350040800200000186,350040800200000185,350040800200000184,350040800200000183,350040800200000182,350040800200000002,350040800200000181,350040800200000179,350040800200000176,350040800200000173,350040800200000172,350040800200000171,350040800200000170,350040800200000168,350040800200000167,350040800200000166,350040800200000165,350040800200000164,350040800200000163,350040800200000011,350040800200000162,350040800200000161,350040800200000160,350040800200000159,350040800200000159,350040800200000157,350040800200000012,350040800200000156,350040800200000155,350040800200000152,350040800200000151,350040800200000150,350040800200000149,350040800200000148,350040800200000146,350040800200000145,350040800200000144,350040800200000143,350040800200000001,350040800200000001,350040800200000140,350040800200000000,350040800200000000,350040800200000139	0-89,0-739,0-30,0-30,0-56,0-56,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,12-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,21-48,0-48,0-48,0-48,0-48,0-48,0-30,0-30,0-22,0-22,0-48,0-48,0-48,7-27,0-48,0-48,0-48,1-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-25,0-48,0-48,0-38,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-30,0-48,0-48,0-48,0-48,0-48,0-48,0-29,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-25,0-25,0-48,0-25,0-25,0-230						Actin-binding polypeptides and nucleic acids encoding the same	Luna	1997	0		
105	chr13	34433985	34533319	3500198668	198		34433985	34533319	8421504	10	30,23,1,56,22,7,20,10,22,7	0,39384,39476,42051,77616,77639,81375,81636,82373,99327	p,c,g	350019866800000006,350019866800000002,350019866800015000,350019866800000001,350019866800000001,350019866800000004,350019866800000003,350019866800000005	0-30,0-23,0-57,0-20,0-20,0-29,0-30,0-29						Supervillin (p205): A novel membrane-associated, F-actin-binding protein in the villin/gelsolin superfamily	ship.umassmed.edu	0	0		
847	chr13	34434638	34434834	3500275412	96		34434638	34434834	8421504	2	84,12	0,184	p	350027541200015074,350027541200015075	0-93,0-96						45 human secreted proteins	Komatsoulis	2000	0		SVIL
847	chr13	34434638	34434834	3500051421	96		34434638	34434834	8421504	2	84,12	0,184	p	350005142100015076	0-96						45 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		SVIL
105	chr13	34452581	34477661	3500124210	52		34452581	34477661	8421504	4	24,3,16,9	0,364,24970,25071	c,g	350012421000000003,350012421000000003,350012421000000004,350012421000000002,350012421000000001	0-21,0-21,0-22,0-25,0-23						Domain analysis of supervillin	cs.biologists.org	0	0		
848	chr13	34477552	34509494	3500446091	50		34477552	34509494	8421504	3	15,10,25	0,100,31917	c	350044609100000004,350044609100000010	0-25,0-25		16880273	10.1083/jcb.200512051	0021-9525	The Journal of Cell Biology	Supervillin modulation of focal adhesions involving TRIP6/ZRP-1	Takizawa	2006	10		
848	chr13	34509469	34509494	3500434052	25		34509469	34509494	8421504	1	25	0	c	350043405200000001	0-25		19109420	10.1091/mbc.E08-08-0867	1059-1524	Molecular Biology of the Cell	Supervillin Reorganizes the Actin Cytoskeleton and Increases Invadopodial Efficiency	Crowley	2009	5		
848	chr13	34547383	34547408	3500124210	25		34547383	34547408	8421504	1	25	0	c	350012421000000000	0-25						Domain analysis of supervillin	cs.biologists.org	0	0		
851	chr13	34904118	34904143	3500389534	23		34904118	34904143	8421504	2	10,13	0,12	g	350038953400000008	1-24					Patent	Dns oder gene, die an der parkinsonschen krankheit beteiligt sind Dns or genes, which are involved in Parkinson's disease (Patent DE:69929417)	Mizuno	2006	0		
851	chr13	34904118	34904143	3500287451	23		34904118	34904143	8421504	2	10,13	0,12	g	350028745100000078	1-24					Patent	Isolated DNA or gene responsible for Parkinson's disease (Patent US:6716621)	Shimizu	2004	0		
851	chr13	34935583	34935616	3500297690	28		34935583	34935616	8421504	2	14,14	0,19	g	350029769000000054	10-38						US Patent # 5,556,781. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
851	chr13	34946373	34946403	3500037042	25		34946373	34946403	8421504	2	13,12	0,18	g	350003704200000053	14-46						Mutant Paramyxovirus and Method for Production Thereof - Patent application	www.faqs.org	0	0		
854	chr13	35338034	35338062	3500447456	24		35338034	35338062	8421504	3	7,5,12	0,9,16	g	350044745600000191	6-33						Linoleate isomerase	Rosson	1998	0		
858	chr13	35900574	35900597	3500383918	23		35900574	35900597	8421504	1	23	0	c	350038391800000005	17-40						Macular degeneration diagnostics and therapeutics	Stone	1999	0		
858	chr13	35906923	35906946	3500392139	23		35906923	35906946	8421504	1	23	0	c,g	350039213900000026,350039213900000026	14-37,14-37						Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer	Akiyama	2004	0		
858	chr13	35906923	35906946	3500103472	23		35906923	35906946	8421504	1	23	0	c	350010347200000013	14-37						Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer - Patent #07491802	w.strutpatent.com	0	0		
859	chr13	35998504	35998533	3500376203	24		35998504	35998533	8421504	3	14,6,4	0,18,25	g	350037620300000003	18-42						Methods for preventing and treating amyloidogenic diseases	Jacobsen	2007	0		
860	chr13	36063998	36064025	3500032868	26		36063998	36064025	8421504	2	20,6	0,21	g	350003286800000079	10-42						ASSAYS AND METHODS USING BIOMARKERS - Patent application	www.faqs.org	0	0		
863	chr13	36466797	36466823	3500097234	24		36466797	36466823	8421504	3	4,15,5	0,5,21	g	350009723400000037	1-25						MICROSATELLITE VARIABILITY IN FOUR CONTEMPORARY RHINOCEROS SPECIES: IMPLICATIONS FOR CONSERVATION	esourcecenter.com	0	0		
863	chr13	36556562	36556588	3500176792	23		36556562	36556588	8421504	2	9,14	0,12	c	350017679200000216	9-45						POLYPEPTIDE HAVING AFFINITY FOR ENVELOPE VIRUS CONSTITUENT AND USE THEREOF IN TRANSFERRING SUBSTANCE INTO CELL - Patent application	www.faqs.org	0	0		
864	chr13	36618948	36618971	3500412600	23		36618948	36618971	8421504	1	23	0	g	350041260000000019	15-38						Anti-vegf Antibodies 	.freshpatents.com	0	0		
864	chr13	36691807	36691832	3500444585	24		36691807	36691832	8421504	2	4,20	0,5	g	350044458500000068	24-48						NOVEL SHIGELLA PROTEIN ANTIGENS AND METHODS - Patent application	www.faqs.org	0	0		
867	chr13	37012506	37056075	3500016075	40		37012506	37056075	8421504	2	19,21	0,43548	g	350001607500000151,350001607500000054	30-49,1-22						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
867	chr13	37060559	37060587	3500111477	23		37060559	37060587	8421504	2	15,8	0,20	g	350011147700000019	3-26						BMC Evolutionary Biology BioMed Central	biomedcentral.com	0	0		
870	chr13	37392834	37421280	3500404429	90		37392834	37421280	8421504	2	45,45	0,28401	p	350040442900015045,350040442900015048	0-45,0-45						CROWN CORK COMPRISING 27 GROOVES - Tapon Corona V, DE S. A. C.	www.sumobrain.com	0	0		PCSK2
870	chr13	37392834	37421280	3500368545	90		37392834	37421280	8421504	2	45,45	0,28401	p	350036854500015045,350036854500015048	0-45,0-45						Prohormone convertase transformed cells	Gorman	1994	0		PCSK2
872	chr13	37628387	37628411	3500425243	24		37628387	37628411	8421504	1	24	0	c	350042524300000013	0-24		14576363	10.1189/jlb.0603264	0741-5400	Journal of Leukocyte Biology	Autocrine inhibitory influences of &#x03b1;-melanocyte-stimulating hormone in malignant pleural mesothelioma	Catania	2004	5		PCSK2
872	chr13	37628387	37628411	3500096106	24		37628387	37628411	8421504	1	24	0	c	350009610600000013	0-24						Autocrine inhibitory in&#xfb02;uences of -melanocyte-stimulating hormone in malignant pleural mesothelioma	www.jleukbio.org	0	0		PCSK2
872	chr13	37658415	37658913	3500022513	44		37658415	37658913	8421504	2	20,24	0,474	c,g	350002251300000002,350002251300000002,350002251300000003	0-20,0-20,0-24						Pharmaceutical for treatment of neurological and neuropsychiatric disorders	Ognyanov	2001	0		SLC6A9
872	chr13	37658415	37658913	3500000149	44		37658415	37658913	8421504	2	20,24	0,474	c,g	350000014900000002,350000014900000002,350000014900000003	0-20,0-20,0-24						Pharmaceutical for treatment of neurological and neuropsychiatric disorders	Ognyanov	1997	0		SLC6A9
872	chr13	37659565	37659613	3500116607	48		37659565	37659613	8421504	1	48	0	p	350011660700015006	0-48						Glycine transporter	Albert	1998	0		
873	chr13	37787375	37787401	3500402214	23		37787375	37787401	8421504	2	10,13	0,13	c	350040221400000001	17-40						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" > <HTML> <HEAD> <TITLE>a,eY=?a	w.jcimjournal.com	0	0		
873	chr13	37803891	37803914	3500072483	23		37803891	37803914	8421504	1	23	0	c	350007248300000417	8-31						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
874	chr13	37954395	37954421	3500311219	23		37954395	37954421	8421504	2	6,17	0,9	g	350031121900000046	11-34						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
876	chr13	38247669	38247693	3500095610	23		38247669	38247693	8421504	2	5,18	0,6	c	350009561000000238	0-23						Optimizing glycan processing in plants	D*E*A*Fu Luo La Ke 	2009	0		
877	chr13	38331616	38331685	3500385351	69		38331616	38331685	8421504	1	69	0	p	350038535100015073,350038535100015194	21-90,0-69						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZNF133
877	chr13	38331616	38331685	3500269504	69		38331616	38331685	8421504	1	69	0	p	350026950400015069	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZNF133
877	chr13	38331616	38331685	3500238410	69		38331616	38331685	8421504	1	69	0	p	350023841000015059	0-69						Zinc finger domains and methods of identifying same	Hwang	2007	0		ZNF133
877	chr13	38331616	38331685	3500176901	69		38331616	38331685	8421504	1	69	0	p	350017690100015052	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZNF133
877	chr13	38331616	38331685	3500160097	69		38331616	38331685	8421504	1	69	0	p	350016009700015066	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZNF133
877	chr13	38331616	38331685	3500075471	69		38331616	38331685	8421504	1	69	0	p	350007547100015097,350007547100015037	0-69,21-90						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZNF133
877	chr13	38331838	38331866	3500248703	28		38331838	38331866	8421504	1	28	0	c	350024870300000440,350024870300000435	9-37,0-25						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
878	chr13	38466296	38468164	3500298139	26		38466296	38468164	8421504	2	3,23	0,1845	c	350029813900000009	0-26						Patent Search: US Patent Number 7342099 - cDNA encoding a gene BOG (B5T over-expressed gene) and its protein product	ww.archpatent.com	0	0		
878	chr13	38501035	38501059	3500432405	24		38501035	38501059	8421504	1	24	0	c	350043240500000008	0-24						MicroRNA-30c-2* limits expression of proadaptive factor XBP1 in the unfolded protein response	jcb.rupress.org	0	0		SEC23B
878	chr13	38501035	38501059	3500401995	24		38501035	38501059	8421504	1	24	0	c	350040199500000008	0-24		22431749	10.1083/jcb.201201077	0021-9525	The Journal of Cell Biology	MicroRNA-30c-2* limits expression of proadaptive factor XBP1 in the unfolded protein response	Byrd	2012	10		SEC23B
879	chr13	38624894	38624918	3500263566	23		38624894	38624918	8421504	2	6,17	0,7	g	350026356600000038	0-27						GENE SELECTIVE REGULATION BY HEPATIC FARNESOID X RECEPTOR (FXR) IN HEALTH AND DISEASE	eals.illinois.edu	0	0		
880	chr13	38699078	38699110	3500119257	32		38699078	38699110	8421504	1	32	0	g	350011925700000036	4-36						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
881	chr13	38811680	38811704	3500412838	23		38811680	38811704	8421504	2	19,4	0,20	g	350041283800000010	0-26						RESEARCH Open Access The 0.3-kb fragment containing the R-U5-5 leader sequence of Friend murine leukemia virus influences the level of protein expression from	biomedcentral.com	0	0		
881	chr13	38811680	38811704	3500184029	23		38811680	38811704	8421504	2	19,4	0,20	g	350018402900000009	0-26		23602143	10.1186/1743-422X-10-124	1743-422X	Virology Journal	The 0.3-kb fragment containing the R-U5-5&#xe2; leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA	Choo	2013	2		
886	chr13	39469760	39469903	3500271050	95		39469760	39469903	8421504	2	47,48	0,95	c	350027105000000125,350027105000000127	1-48,0-48						Cloning by complementation and related processes	Colicelli	1991	0		
886	chr13	39523183	39523209	3500090125	23		39523183	39523209	8421504	2	7,16	0,10	c	350009012500000000	11-34		16354687	10.1128/MCB.26.1.155-168.2006	0270-7306	Molecular and Cellular Biology	The Forkhead Transcription Factor FoxI1 Remains Bound to Condensed Mitotic Chromosomes and Stably Remodels Chromatin Structure	Yan	2006	6		
886	chr13	39530619	39530647	3500102291	23		39530619	39530647	8421504	2	9,14	0,14	g	350010229100000304	23-47						Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods	Alvarez	2000	0		
888	chr13	39760237	39760380	3500462167	48		39760237	39760380	8421504	2	28,20	0,123	g	350046216700000008,350046216700000000	0-28,0-20		12890672	10.1074/jbc.M306795200	0021-9258	Journal of Biological Chemistry	NeuroD1/E47 Regulates the E-box Element of a Novel Zinc Finger Transcription Factor, IA-1, in Developing Nervous System	Breslin	2003	5		
888	chr13	39783925	39783956	3500081269	24		39783925	39783956	8421504	3	6,5,13	0,11,18	g	350008126900000023	10-34		15870272	10.1128/MCB.25.10.3982-3996.2005	0270-7306	Molecular and Cellular Biology	Negative Feedback Regulation of Met-Dependent Invasive Growth by Notch	Stella	2005	6		
889	chr13	39917443	39917472	3500200159	24		39917443	39917472	8421504	2	10,14	0,15	g	350020015900000014,350020015900000001	0-33,0-33						N-terminally extended proteins expressed in yeast	Kjeldsen	1999	0		
889	chr13	39923920	39923951	3500461622	25		39923920	39923951	8421504	3	15,6,4	0,20,27	g	350046162200000075	0-25						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
889	chr13	39923920	39923951	3500304843	25		39923920	39923951	8421504	3	15,6,4	0,20,27	g	350030484300000076	0-25						Vaccine and antitoxin for treatment and prevention of c. difficile disease	Firca	1997	0		
889	chr13	39939377	39939401	3500251828	23		39939377	39939401	8421504	2	4,19	0,5	g	350025182800000011	0-23						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
892	chr13	40336892	40336921	3500160249	24		40336892	40336921	8421504	2	15,9	0,20	g	350016024900000134	0-24						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN - Patent application	www.faqs.org	0	0		
894	chr13	40516972	40516999	3500032513	23		40516972	40516999	8421504	2	9,14	0,13	g	350003251300000019	4-27						Use of platelet-derived growth factor to improve collateral circulation	Khouri	1994	0		
894	chr13	40561271	40562785	3500301275	66		40561271	40562785	8421504	2	21,45	0,1469	p	350030127500015009	54-120						kem Mutations Affect Nuclear Fusion in Saccharomyces cerevisiae	www.genetics.org	0	0		XRN2
895	chr13	40693459	40694514	3500101334	40		40693459	40694514	8421504	2	20,20	0,1035	c,g	350010133400000035,350010133400000035,350010133400000034,350010133400000034	0-20,0-20,0-20,0-20						Neural crest development in a human embryonic stem cell-based model system	s.ulb.uni-bonn.de	0	0		XRN2
895	chr13	40693461	40694522	3500427675	40		40693461	40694522	8421504	2	20,20	0,1041	c,g	350042767500000007,350042767500000007,350042767500000006,350042767500000006	0-20,0-20,0-20,0-20						NeuroD1 in the Endocrine Pancreas: Localization and Dual Function as an Activator and Repressor	www.umassmed.edu	0	0		XRN2
895	chr13	40693461	40694522	3500222016	40		40693461	40694522	8421504	2	20,20	0,1041	c,g	350022201600000007,350022201600000007,350022201600000006,350022201600000006	0-20,0-20,0-20,0-20			10.1002/dvdy.20443	1097-0177	Developmental Dynamics	NeuroD1 in the endocrine pancreas: Localization and dual function as an activator and repressor - Itkin-Ansari - 2005 - Developmental Dynamics - Wiley Online Library	Itkin-Ansari	2005	0		XRN2
897	chr13	40934764	40934791	3500171595	23		40934764	40934791	8421504	2	9,14	0,13	g	350017159500000045	0-23						COMPOSITIONS AND METHODS FOR WT1 SPECIFIC IMMUNOTHERAPY - Patent application	www.faqs.org	0	0		
901	chr13	41497117	41497144	3500026523	25		41497117	41497144	8421504	2	6,19	0,8	g	350002652300000000,350002652300000001	5-30,5-30		20133840	10.1073/pnas.0910715107	0027-8424	Proceedings of the National Academy of Sciences	Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein	Hale	2010	10		
901	chr13	41535357	41535527	3500114775	48		41535357	41535527	8421504	2	24,24	0,146	g	350011477500000003,350011477500000002	0-24,0-24						Differentiation of the definitive endoderm from Wharton&#x2019;s Jelly Mesenchymal Stem Cells (WJMSC)	www.jbr.gr/main/p	0	0		FOXA2
902	chr13	41580186	41580216	3500290459	25		41580186	41580216	8421504	2	14,11	0,19	g	350029045900000015,350029045900000016	8-33,5-30		8647842	10.1074/jbc.271.21.12387	0021-9258	Journal of Biological Chemistry	Enhanced Expression of the Eosinophil-derived Neurotoxin Ribonuclease (RNS2) Gene Requires Interaction between the Promoter and Intron	Tiffany	1996	5		
902	chr13	41663559	41663589	3500186414	23		41663559	41663589	8421504	3	12,5,6	0,15,24	g	350018641400000094	0-23						Tissue plasminogen activator (TPA) analogs	Marotti	1991	0		
904	chr13	41825874	41826762	3500455443	46		41825874	41826762	8421504	2	23,23	0,865	c	350045544300000005,350045544300000023	11-34,9-32						Method for treating wounds using an EGF-like domain of thrombomodulin - Patent # 8293710 - PatentGenius	.patentgenius.com	0	0		
904	chr13	41826529	41827236	3500370135	55		41826529	41827236	8421504	2	27,28	0,679	c	350037013500000000,350037013500000001	0-27,0-28		8969798	10.1161/01.STR.27.12.2304	0039-2499	Stroke	Regulation of Brain Capillary Endothelial Thrombomodulin mRNA Expression	Tran	1996	6		
904	chr13	41826739	41826762	3500117925	23		41826739	41826762	8421504	1	23	0	c,g	350011792500000002,350011792500000002	3-26,3-26		16246255	10.1111/j.1538-7836.2005.01635.x	1538-7836	Journal of Thrombosis and Haemostasis	Anti-inflammatory effect of activated protein C in gastric epithelial cells - NAKAMURA - 2005 - Journal of Thrombosis and Haemostasis - Wiley Online Library	NAKAMURA	2005	0		
904	chr13	41827208	41827236	3500222946	28		41827208	41827236	8421504	1	28	0	c	350022294600000001	0-28		8969798	10.1161/01.STR.27.12.2304	0039-2499	Stroke	Regulation of Brain Capillary Endothelial Thrombomodulin mRNA Expression	Tran	1996	6		
906	chr13	42154389	42158314	3500177556	716		42154389	42158314	8421504	4	174,121,114,307	0,184,1097,3618	c,g	350017755600000044,350017755600000043,350017755600000042,350017755600000041,350017755600000040,350017755600000039,350017755600000038,350017755600000038,350017755600000037,350017755600000036,350017755600000035,350017755600000001,350017755600000034,350017755600000033,350017755600000033	0-174,0-52,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,5-38,0-48,0-58,0-58						Albumin Fusion Proteins 	.freshpatents.com	0	0		
906	chr13	42158025	42158142	3500378421	117		42158025	42158142	8421504	1	117	0	p	350037842100015173	60-177						University of Southampton Research Repository ePrints Soton	rints.soton.ac.uk	0	0		
907	chr13	42241645	42241668	3500158396	23		42241645	42241668	8421504	1	23	0	g	350015839600000083	0-23						Quantitative Analysis of Multi-Species Oral Biofilms by TaqMan Real-Time PCR	ww.clinmedres.org	0	0		
907	chr13	42290352	42290379	3500139533	27		42290352	42290379	8421504	1	27	0	g	350013953300000343	20-47						Invasive cleavage of nucleic acids	Brow	1997	0		
909	chr13	42579266	42579291	3500204665	23		42579266	42579291	8421504	3	5,14,4	0,6,21	c	350020466500000013	5-28						Virulence Genes Of M.marinum And M. Tuberculosis 	.freshpatents.com	0	0		
910	chr13	42684086	42684131	3500337504	45		42684086	42684131	8421504	1	45	0	p	350033750400015004	0-45						prdl-a, a gene marker for hydra apical differentiation related to triploblastic paired-like head-speci&#xfb01;c genes	ev.biologists.org	0	0		ARX
911	chr13	42795761	42797053	3500199211	25		42795761	42797053	8421504	2	9,16	0,1276	c	350019921100000048	28-53						Etude des voies metaboliques des sucres chez l'huitre creuse crassostrea gigas. Implication dans les mortalites estivales.	chimer.ifremer.fr	0	0		
912	chr13	42951090	42978234	3500390306	41		42951090	42978234	8421504	3	13,8,20	0,18,27124	c	350039030600000064,350039030600000219	3-24,0-20						Procaryotic xylose isomerase muteins and method to increase protein stability	Bloch	1989	0		
913	chr13	43047485	43047513	3500052852	24		43047485	43047513	8421504	2	14,10	0,18	g	350005285200000002	11-36		17537860	10.1128/JVI.00759-07	0022-538X	Journal of Virology	Coreceptor Switch in R5-Tropic Simian/Human Immunodeficiency Virus-Infected Macaques	Ho	2007	5		
913	chr13	43072976	43073002	3500209785	23		43072976	43073002	8421504	2	5,18	0,8	g	350020978500000000	6-30						Transferrin receptor genes	Loosmore	2002	0		
913	chr13	43086401	43086433	3500316396	28		43086401	43086433	8421504	3	4,6,18	0,5,14	g	350031639600000005,350031639600000003	1-30,1-26						Crystallization of m-csf	Bohm	1993	0		
913	chr13	43106268	43106292	3500077285	23		43106268	43106292	8421504	2	9,14	0,10	g	350007728500000009	2-27					Patent	&#x8868;&#x8fbe;&#x919b;&#x7cd6;-1-&#x5dee;&#x5411;&#x5f02;&#x6784;&#x9176;&#x7684;&#x5fae;&#x751f;&#x7269; (Patent CN:102144029)	Ao Li .Xi Bei Sen 	2013	0		
917	chr13	43573473	43580603	3500331697	50		43573473	43580603	8421504	3	25,3,22	0,6913,7108	c	350033169700000000,350033169700000001	0-25,0-25		10026113	10.1095/biolreprod60.3.656	0006-3363	Biology of Reproduction	Down-Regulation of Oxytocin-Induced Cyclooxygenase-2 and Prostaglandin F Synthase Expression by Interferon-&#x03c4; in Bovine Endometrial Cells	Xiao	1999	4		
917	chr13	43580239	43580264	3500281577	24		43580239	43580264	8421504	2	7,17	0,8	c	350028157700000137	5-35						Lead binding polypeptides and nucleotides coding therefor	Lopez	1996	0		
917	chr13	43618396	43618613	3500052885	25		43618396	43618613	8421504	2	3,22	0,195	c	350005288500000001	0-25						Down-Regulation of Oxytocin-Induced Cyclooxygenase: MATERIALS AND METHODS(5) | Government programs in medicine	acutelogic.com	0	0		
918	chr13	43690342	43710466	3500080650	951		43690342	43710466	8421504	11	31,56,24,51,111,108,123,78,117,168,84	0,2120,2179,4450,4504,5541,8329,8870,10514,16114,20040	p	350008065000015010,350008065000015011	15-963,18-963						Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia	Gustafson	2003	0		
918	chr13	43694847	43694871	3500073842	24		43694847	43694871	8421504	1	24	0	c	350007384200000081	0-24						Comparison of human and mouse AKR1C enzymes: implications for modeling human cancer	theses.bham.ac.uk	0	0		
918	chr13	43710413	43710438	3500052885	25		43710413	43710438	8421504	1	25	0	g	350005288500000000	0-25						Down-Regulation of Oxytocin-Induced Cyclooxygenase: MATERIALS AND METHODS(5) | Government programs in medicine	acutelogic.com	0	0		
923	chr13	44345253	44345281	3500452292	23		44345253	44345281	8421504	2	12,11	0,17	g	350045229200000032	4-27						Neutralizing anti-CCL20 antibodies	Imai	2011	0		
925	chr13	44566814	44569755	3500233798	45		44566814	44569755	8421504	3	19,3,23	0,2841,2918	c	350023379800000002,350023379800000003	0-22,0-23		16822846	10.1200/JCO.2005.05.1458	0732-183X	Journal of Clinical Oncology	Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis	Lin	2006	18		KLF6
925	chr13	44570167	44571668	3500254340	42		44570167	44571668	8421504	2	21,21	0,1480	c,g	350025434000000022,350025434000000023,350025434000000023	0-21,0-21,0-21		22347457	10.1371/journal.pone.0031286		PLoS ONE	Caffeic Acid Phenethyl Ester Causes p21Cip1 Induction, Akt Signaling Reduction, and Growth Inhibition in PC-3 Human Prostate Cancer Cells	Hui-Ping	2012	0		KLF6
925	chr13	44571637	44571700	3500112710	63		44571637	44571700	8421504	1	63	0	p	350011271000015000	0-63						Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and Spread	.aacrjournals.org	0	0		KLF6
925	chr13	44571648	44571723	3500385351	75		44571648	44571723	8421504	1	75	0	p	350038535100015123	0-75						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		KLF6
925	chr13	44571648	44571723	3500269504	75		44571648	44571723	8421504	1	75	0	p	350026950400015076	0-75					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		KLF6
925	chr13	44571648	44571723	3500176901	75		44571648	44571723	8421504	1	75	0	p	350017690100015059	0-75						Zinc finger domains and methods of identifying same	Hwang	2002	0		KLF6
925	chr13	44571648	44571723	3500160097	75		44571648	44571723	8421504	1	75	0	p	350016009700015095	0-75						Phenotypic screen of chimeric proteins	JANG	2004	0		KLF6
925	chr13	44571648	44571723	3500075471	75		44571648	44571723	8421504	1	75	0	p	350007547100015062	0-75						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		KLF6
927	chr13	44882205	44884943	3500431462	45		44882205	44884943	8421504	4	7,18,12,8	0,10,2713,2730	g	350043146200000761,350043146200000253	4-29,24-44						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
935	chr13	45950649	45950676	3500139752	24		45950649	45950676	8421504	2	16,8	0,19	g	350013975200000006	0-24						Modified interferon alpha with reduced immunogenicity	Baker	2002	0		
938	chr13	46293884	46293907	3500186547	23		46293884	46293907	8421504	1	23	0	c	350018654700000168	19-43						Polycystic kidney disease gene and protein	Klinger	1996	0		
938	chr13	46298377	46299354	3500073664	23		46298377	46299354	8421504	3	2,6,15	0,951,962	c	350007366400000151	20-43						Lepidopteran-active bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use - Patent application	www.faqs.org	0	0		
938	chr13	46298377	46299354	3500060533	23		46298377	46299354	8421504	3	2,6,15	0,951,962	c	350006053300000151	20-43						PLANT TRANSFORMED WITH POLYNUCLEOTIDE ENCODING LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS DELTA-ENDOTOXIN - Patent application	www.faqs.org	0	0		
938	chr13	46298377	46299354	3500025873	23		46298377	46299354	8421504	3	2,6,15	0,951,962	c	350002587300000148	20-43						US Patent # 6,593,293. Lepidopteran-active Bacillus thuringiensis .delta.-endotoxin compositions and methods of use - Patents.com	www.patents.com	0	0		
940	chr13	46586175	46586203	3500148959	24		46586175	46586203	8421504	3	8,11,5	0,10,23	g	350014895900000092	12-39						INTEIN-MODIFIED ENZYMES, THEIR PRODUCTION AND INDUSTRIAL APPLICATION - Patent application	www.faqs.org	0	0		
941	chr13	46738062	46738091	3500457081	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350045708100000052	2-26						 Methods of treating inflammatory skin diseases Patent (Patent # 6,833,349 issued December 21, 2004) - Justia Patents Database 	atents.justia.com	0	0		
941	chr13	46738062	46738091	3500391924	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350039192400000024	11-35						Tetravalent etanercept - US Patent 7229962 Description	ww.patentstorm.us	0	0		
941	chr13	46738062	46738091	3500341514	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350034151400000084	14-38					Patent	Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof (Patent US:5955364)	Brams	1999	0		
941	chr13	46738062	46738091	3500331579	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350033157900000057	14-38						Composition and method for treating inflammatory diseases - US Patent 6733753 Description	ww.patentstorm.us	0	0		
941	chr13	46738062	46738091	3500327731	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350032773100000067	5-29						Receptor for oncostatin m and leukemia inhibitory factor	Gearing	1995	0		
941	chr13	46738062	46738091	3500251828	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350025182800000326	14-38						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
941	chr13	46738062	46738091	3500186499	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350018649900000098,350018649900000068	14-38,26-48						Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity. - Patent application	www.faqs.org	0	0		
941	chr13	46738062	46738091	3500181609	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350018160900000080	5-29						METHODS AND COMPOSITIONS FOR MODULATING T CELL AND/OR B CELL ACTIVATION - Patent application	www.faqs.org	0	0		
941	chr13	46738062	46738091	3500070060	24		46738062	46738091	8421504	3	14,6,4	0,18,25	g	350007006000000219	2-26						 Soluble IL 	www.docstoc.com	0	0		
941	chr13	46775665	46775691	3500104979	24		46775665	46775691	8421504	2	11,13	0,13	g	350010497900000546	0-31						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
942	chr13	46834103	46834129	3500414631	23		46834103	46834129	8421504	2	13,10	0,16	c	350041463100000005	20-43						Gamma Radiation | adi setiadi - Academia.edu	www.academia.edu	0	0		
943	chr13	46954091	46954119	3500383918	24		46954091	46954119	8421504	3	8,11,5	0,9,23	g	350038391800000019	3-27						Macular degeneration diagnostics and therapeutics	Stone	1999	0		
943	chr13	47005154	47005598	3500435440	41		47005154	47005598	8421504	2	20,21	0,423	g	350043544000000007,350043544000000008	0-20,0-21						Detection of nucleic acids to assess risk for bovine spongiform encephalopathy	Schuetz	2005	0		
943	chr13	47033966	47054527	3500361033	3776		47033966	47054527	8421504	21	736,162,26,4,283,38,77,447,4,59,46,655,86,150,607,280,20,25,22,27,22	0,739,902,929,934,1220,1260,1338,1786,1791,1852,1899,2555,2642,2793,16393,17401,17422,17775,19523,20539	c,g	350036103300000035,350036103300000001,350036103300000008,350036103300000028,350036103300000021,350036103300000036,350036103300000010,350036103300000030,350036103300000019,350036103300000034,350036103300000004,350036103300000026,350036103300000024,350036103300000006,350036103300000002,350036103300000022,350036103300000007,350036103300000027,350036103300000025,350036103300000005,350036103300000003,350036103300000003,350036103300000023,350036103300000023	0-3404,0-22,0-22,0-22,0-22,0-280,0-23,0-23,0-20,0-20,0-24,1-25,0-25,1-24,0-22,0-22,0-24,0-27,0-27,0-24,0-22,0-22,0-22,0-22						Prion-free transgenic ungulates - Patent application	www.faqs.org	0	0		
943	chr13	47033975	47051339	3500044256	86		47033975	47051339	8421504	4	21,19,26,20	0,16976,17049,17344	c,g	350004425600000016,350004425600000037,350004425600000013,350004425600000043	0-21,0-19,0-26,0-20						Association analysis of PRNP gene region with chronic wasting disease in Rocky Mountain elk	aldc.nal.usda.gov	0	0		
943	chr13	47034385	47050941	3500427859	99		47034385	47050941	8421504	5	20,19,20,20,20	0,599,3043,16353,16536	c,g	350042785900000002,350042785900000003,350042785900000005,350042785900000006,350042785900000006,350042785900000007,350042785900000007	0-20,0-19,0-20,0-20,0-20,0-20,0-20						ScienceDirect.com - Genomics - Comparative genomic organization of the human and bovine PRNP locus	sciencedirect.com	0	0		
943	chr13	47034419	47050596	3500414885	880		47034419	47050596	8421504	11	283,162,12,13,4,39,40,52,47,167,61	0,286,449,462,476,481,530,2287,2340,2780,16116	c,g	350041488500000093,350041488500000085,350041488500000092,350041488500000099,350041488500000098,350041488500000141,350041488500000142,350041488500000104,350041488500000111,350041488500000110,350041488500000084,350041488500000000,350041488500000068,350041488500000067,350041488500000066,350041488500000024,350041488500000023,350041488500000064,350041488500000025,350041488500000026,350041488500000073,350041488500000073,350041488500000076,350041488500000144,350041488500000022,350041488500000017,350041488500000016,350041488500000016,350041488500000041,350041488500000049	0-73,0-401,3-73,0-95,0-95,0-83,0-83,0-82,0-164,107-163,327-389,0-37,0-47,0-47,0-77,0-160,0-164,0-73,53-153,58-158,0-111,0-111,10-50,0-99,0-167,0-98,0-98,0-98,0-61,1-62						Cryptic Exon 2 of human prion gene	mad-cow.org	0	0		
943	chr13	47034771	47050645	3500373639	40		47034771	47050645	8421504	2	20,20	0,15854	c,g	350037363900000000,350037363900000000,350037363900000001,350037363900000001	0-20,0-20,0-20,0-20		10792029	10.1073/pnas.080081197	0027-8424	Proceedings of the National Academy of Sciences	Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice	Lemaire-Vieille	2000	10		
943	chr13	47034771	47050645	3500135293	40		47034771	47050645	8421504	2	20,20	0,15854	c,g	350013529300000000,350013529300000000,350013529300000001,350013529300000001	0-20,0-20,0-20,0-20					Proceedings of the National Academy of Sciences of the United States of America	Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice	Catherine	2000	0		
943	chr13	47034779	47054366	3500006052	71		47034779	47054366	8421504	3	22,26,23	0,16455,19564	c	350000605200000001,350000605200000000,350000605200000006	0-22,0-26,0-23		10466827		0022-1317	Journal of General Virology	PrP (prion) gene expression in sheep may be modulated by alternative polyadenylation of its messenger RNA	Goldmann	1999	3		
943	chr13	47034779	47051260	3500335504	72		47034779	47051260	8421504	3	22,24,26	0,16420,16455	c	350033550400000001,350033550400000002,350033550400000000	0-22,0-24,0-26						The shortest known prion protein gene allele occurs in goats, has only three octapeptide repeats and is non-pathogenic	r.sgmjournals.org	0	0		
943	chr13	47034788	47054674	3500299654	3948		47034788	47054674	8421504	38	6,910,433,77,56,173,255,7,27,91,9,76,30,124,47,5,17,194,180,95,289,15,6,54,54,33,73,15,69,57,106,119,45,16,24,17,3,141	0,15797,16708,17142,17220,17281,17479,17735,17743,17774,17866,17882,17960,17995,18122,18171,18177,18199,18396,18592,18692,18986,19004,19013,19068,19123,19157,19231,19268,19339,19397,19504,19628,19674,19693,19723,19741,19745	p,c,g	350029965400000007,350029965400015005,350029965400015010,350029965400000003,350029965400000004,350029965400000004,350029965400015012,350029965400015007,350029965400015021,350029965400015017,350029965400015013,350029965400015018,350029965400015022,350029965400015014,350029965400015009,350029965400015023,350029965400015019,350029965400015015,350029965400015024,350029965400015020	0-803,0-180,0-180,0-4014,0-795,0-795,0-180,0-180,0-180,0-45,0-177,9-177,12-177,0-180,0-114,0-177,0-177,0-60,0-48,0-45						Use of cpg nucleic acids in prion-disease	Kretzschmar	2004	0		
943	chr13	47035027	47053087	3500186554	61		47035027	47053087	8421504	3	19,22,20	0,17963,18040	c,g	350018655400000003,350018655400000005,350018655400000006	0-19,0-22,0-20						Multiplexed PCR assay for detection of bovine spongiform encephalopathy (BSE)-associated bovine prion protein gene (PRNP) polymorphisms	Seabury	2006	0		
943	chr13	47035054	47035079	3500400174	25		47035054	47035079	8421504	1	25	0	g	350040017400000005	0-25		23217206	10.1186/1756-0500-5-674	1756-0500	BMC Research Notes	Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle &#xe2; an update	Konold	2012	0		
943	chr13	47036706	47036783	3500031946	77		47036706	47036783	8421504	1	77	0	g	350003194600000025,350003194600000024	0-76,0-70						Chapter 2: Sequence Alignment	w.cs.columbia.edu	0	0		
943	chr13	47037315	47050623	3500323836	78		47037315	47050623	8421504	4	23,18,15,22	0,24,13268,13286	c,g	350032383600000000,350032383600000002,350032383600000001,350032383600000001	0-23,0-33,0-22,0-22		19727393	10.1371/journal.pone.0006885		PLoS ONE	PrP Expression, PrPSc Accumulation and Innervation of Splenic Compartments in Sheep Experimentally Infected with Scrapie	Randi	2009	0		
943	chr13	47037315	47050623	3500044309	78		47037315	47050623	8421504	4	23,18,15,22	0,24,13268,13286	c,g	350004430900000000,350004430900000002,350004430900000001,350004430900000001	0-23,0-33,0-22,0-22		17030883	10.1099/vir.0.82008-0	0022-1317	Journal of General Virology	Lymphoid follicles of the ileal Peyer's patch of lambs express low levels of PrP, as demonstrated by quantitative real-time RT-PCR on microdissected tissue compartments, in situ hybridization and immunohistochemistry	Austbo	2006	3		
943	chr13	47037322	47054527	3500413991	171		47037322	47054527	8421504	7	22,37,20,24,22,24,22	0,13271,14045,14066,14419,16167,17183	c,g	350041399100000001,350041399100000008,350041399100000018,350041399100000010,350041399100000019,350041399100000004,350041399100000006,350041399100000002,350041399100000007,350041399100000003,350041399100000003	0-22,0-22,0-19,0-23,0-20,0-24,1-24,0-22,0-24,0-22,0-22						Prion-free transgenic ungulates	Good	2007	0		
943	chr13	47040209	47053061	3500424306	202		47040209	47053061	8421504	5	57,72,21,24,28	0,10384,10815,10921,12824	p,c,g	350042430600000139,350042430600015009,350042430600015008,350042430600000074,350042430600000074,350042430600000113,350042430600000254	0-57,0-72,0-72,0-21,0-21,0-24,1-29						10897 microsatellite 9668 control region 4597 Vector: pCMV-SPORT6.0 1738 Vector: pExpress1 1036 puta	www.ibio.jp	0	0		
943	chr13	47048762	47051097	3500030285	139		47048762	47051097	8421504	6	30,24,24,20,20,21	0,37,550,1903,2260,2314	c,g	350003028500000004,350003028500000012,350003028500000008,350003028500000016,350003028500000016,350003028500000001,350003028500000001,350003028500000017,350003028500000017	0-30,0-24,0-24,0-20,0-20,0-20,0-20,0-21,0-21					Patent	Transgenic ungulates having reduced prion protein activity and uses thereof (Patent CN:100526460)	I*Yi Shi Da 	2009	0		
943	chr13	47048799	47051097	3500123062	115		47048799	47051097	8421504	5	24,20,30,20,21	0,1805,1866,2223,2277	c,g	350012306200000014,350012306200000087,350012306200000089,350012306200000089,350012306200000123,350012306200000123,350012306200000095,350012306200000022,350012306200000017,350012306200000017,350012306200000090,350012306200000090,350012306200000051,350012306200000051,350012306200000124,350012306200000124	0-24,0-24,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-21,0-21,0-21,0-21						TRANSGENIC ANIMALS AND USES THEREOF - Patent application	www.faqs.org	0	0		
943	chr13	47048803	47051097	3500451179	101		47048803	47051097	8421504	5	20,20,20,20,21	0,1801,1872,2219,2273	c,g	350045117900000084,350045117900000110,350045117900000022,350045117900000089,350045117900000017,350045117900000090,350045117900000113,350045117900000051	0-20,0-20,0-20,0-20,0-20,0-20,0-21,0-21						 Transgenic Animals And Uses Thereof 	www.docstoc.com	0	0		
943	chr13	47050485	47051438	3500414443	46		47050485	47051438	8421504	2	22,24	0,929	c,g	350041444300000000,350041444300000001	0-22,0-24		19686637	10.1051/vetres/2009048	0928-4249	Veterinary Research	High prevalence of scrapie in a dairy goat herd: tissue distribution of disease-associated PrP and effect of PRNP genotype and age | Vet. Res.	Gonzalez	2009	4		
943	chr13	47050537	47051590	3500436121	142		47050537	47051590	8421504	6	21,19,20,42,20,20	0,413,575,664,965,1033	c,g	350043612100000002,350043612100000005,350043612100000006,350043612100000006,350043612100000008,350043612100000012,350043612100000013,350043612100000010,350043612100000017,350043612100000014,350043612100000015,350043612100000016,350043612100000021,350043612100000021,350043612100000019,350043612100000019,350043612100000022,350043612100000024,350043612100000024,350043612100000023,350043612100000023,350043612100000026,350043612100000003,350043612100000003,350043612100000001	0-21,0-19,0-20,0-20,10-30,0-42,0-42,3-45,0-42,0-42,0-42,0-42,0-21,0-21,0-19,0-19,0-21,0-20,0-20,0-19,0-19,0-19,0-20,0-20,0-20						 SpringerImages - Oligonucleotides for sequencing and genotyping Prnp alleles 	pringerimages.com	0	0		
943	chr13	47050537	47051590	3500318990	161		47050537	47051590	8421504	7	21,19,20,42,19,20,20	0,413,575,664,735,965,1033	c,g	350031899000000002,350031899000000005,350031899000000006,350031899000000006,350031899000000008,350031899000000016,350031899000000014,350031899000000012,350031899000000010,350031899000000022,350031899000000021,350031899000000011,350031899000000024,350031899000000026,350031899000000023,350031899000000028,350031899000000003,350031899000000003,350031899000000001	0-21,0-19,0-20,0-20,10-30,0-42,0-42,0-42,3-45,0-21,0-21,0-21,0-20,0-19,0-19,0-19,0-20,0-20,0-20						BMC Veterinary Research BioMed Central	www.ars.usda.gov	0	0		
943	chr13	47050537	47051590	3500196302	161		47050537	47051590	8421504	7	21,19,20,42,19,20,20	0,413,575,664,735,965,1033	c,g	350019630200000004,350019630200000007,350019630200000007,350019630200000010,350019630200000008,350019630200000008,350019630200000012,350019630200000014,350019630200000015,350019630200000016,350019630200000017,350019630200000018,350019630200000019,350019630200000013,350019630200000024,350019630200000021,350019630200000021,350019630200000023,350019630200000023,350019630200000026,350019630200000028,350019630200000025,350019630200000025,350019630200000001,350019630200000005,350019630200000005,350019630200000003,350019630200000003	0-21,0-19,0-19,10-30,0-20,0-20,3-45,0-42,0-42,0-42,0-42,0-42,0-42,0-42,0-21,0-19,0-19,0-21,0-21,0-20,0-19,0-19,0-19,0-19,0-20,0-20,0-20,0-20						BMC Veterinary Research	goodecattle.com	0	0		
943	chr13	47050548	47050574	3500447332	26		47050548	47050574	8421504	1	26	0	g	350044733200000000	0-26		22723928	10.1371/journal.pone.0039055		PLoS ONE	Experimental Oral Transmission of Chronic Wasting Disease to Reindeer (Rangifer tarandus tarandus)	Gordon	2012	0		
943	chr13	47050551	47051417	3500221039	372		47050551	47051417	8421504	8	20,54,45,96,18,42,75,22	0,42,99,186,597,618,762,844	p,c,g	350022103900000000,350022103900015002,350022103900015003,350022103900015006,350022103900000002,350022103900000002,350022103900000001	0-20,0-99,18-114,0-60,0-75,0-75,0-22						Identification and characterization of two bovine spongiform encephalopathy cases diagnosed in the United States	ddr.nal.usda.gov	0	0		
943	chr13	47050563	47051417	3500272380	68		47050563	47051417	8421504	3	20,26,22	0,800,832	c,g	350027238000000000,350027238000000004,350027238000000001	7-27,9-35,6-28		10970836	10.1093/emboj/19.17.4425	ERROR! NO ISSN	The EMBO Journal	Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease	Raymond	2000	0		
943	chr13	47050563	47051417	3500117248	88		47050563	47051417	8421504	4	20,23,23,22	0,30,613,832	c,g	350011724800000002,350011724800000000,350011724800000006,350011724800000001	0-20,0-23,0-23,0-22		15105552	10.1099/vir.0.79785-0	0022-1317	Journal of General Virology	Polymorphisms in the prion precursor functional gene but not the pseudogene are associated with susceptibility to chronic wasting disease in white-tailed deer	O'Rourke	2004	3		
943	chr13	47050563	47051417	3500006157	120		47050563	47051417	8421504	5	20,27,29,22,22	0,487,529,585,832	c,g	350000615700000008,350000615700000000,350000615700000005,350000615700000003,350000615700000006,350000615700000006,350000615700000009	7-27,0-27,0-25,0-24,0-22,0-22,6-28						DINAMICA E LOCALIZZAZIONE DELL&#x2019;ACCUMULO DI PROTEINA PRIONICA PATOLOGICA (PrP NELLE PLACENTE DI OVINI DI RAZZA SARDA ARQ/ARQ AFFETTI DA SCRAPIE NATURALE E SPERIMENTALE	eprints.uniss.it	0	0		
943	chr13	47050570	47054674	3500230782	3959		47050570	47054674	8421504	36	925,433,134,173,255,7,27,90,10,76,30,124,47,5,17,46,330,95,289,15,6,54,54,33,72,15,69,57,106,119,45,16,24,17,3,141	0,926,1360,1499,1697,1953,1961,1992,2083,2100,2178,2213,2340,2389,2395,2417,2464,2810,2910,3204,3222,3231,3286,3341,3375,3449,3486,3557,3615,3722,3846,3892,3911,3941,3959,3963	p,c,g	350023078200000013,350023078200000032,350023078200015007,350023078200000020,350023078200000033	5-32,63-2100,0-759,6-26,0-1983						Use of telomerase reverse transcriptase to create homozygous knockout animals	Clark	2002	0		
943	chr13	47050574	47051417	3500402980	41		47050574	47051417	8421504	2	19,22	0,821	c,g	350040298000000000,350040298000000002	0-19,0-22						PRION PROTEIN GENES IN CARIBOU FROM ALASKA	.jwildlifedis.org	0	0		
943	chr13	47050574	47051286	3500260496	622		47050574	47051286	8421504	3	22,120,480	0,88,232	p,c,g	350026049600000001,350026049600000002,350026049600000002,350026049600015000,350026049600000025,350026049600000005,350026049600000003,350026049600000004,350026049600015006,350026049600000006,350026049600015008,350026049600000007,350026049600015011,350026049600015025,350026049600000017,350026049600000008,350026049600000028,350026049600000009,350026049600015019,350026049600000030,350026049600000010,350026049600015022,350026049600000011	0-22,0-61,0-61,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						London to get CJD research centre	www.mad-cow.org	0	0		
943	chr13	47050583	47051417	3500110363	46		47050583	47051417	8421504	2	19,27	0,807	c	350011036300000000,350011036300000001,350011036300000003	8-27,0-27,0-22						Prion sequence polymorphisms and chronic wasting disease resistance in Illinois white-tailed deer (Odocoileus virginianus) - Keeping the Faith	pthefaith1296.com	0	0		
943	chr13	47050583	47051417	3500003669	74		47050583	47051417	8421504	3	19,28,27	0,394,807	c	350000366900000000,350000366900000003,350000366900000001	8-27,0-28,0-27		16760415	10.1099/vir.0.81615-0	0022-1317	Journal of General Virology	Prion protein polymorphisms in white-tailed deer influence susceptibility to chronic wasting disease	Johnson	2006	3		
943	chr13	47050585	47054674	3500074276	3945		47050585	47054674	8421504	35	910,433,134,173,255,7,27,91,9,76,30,124,47,5,17,377,95,289,15,6,54,54,33,72,15,69,57,106,119,45,16,24,17,3,141	0,911,1345,1484,1682,1938,1946,1977,2069,2085,2163,2198,2325,2374,2380,2402,2795,2895,3189,3207,3216,3271,3326,3360,3434,3471,3542,3600,3707,3831,3877,3896,3926,3944,3948	p,c	350007427600000033,350007427600000059,350007427600015058,350007427600015002,350007427600000060,350007427600015043,350007427600000061,350007427600015059,350007427600015045,350007427600015060,350007427600015061,350007427600000064,350007427600015062,350007427600015049,350007427600015063,350007427600015050,350007427600000067,350007427600000068,350007427600000069,350007427600015053,350007427600000070,350007427600015054,350007427600000072,350007427600015056,350007427600000073,350007427600000075,350007427600000076	63-4084,59-105,0-93,0-768,0-48,0-45,0-48,0-48,0-48,0-45,0-48,0-45,0-48,0-48,45-93,0-48,0-48,0-45,0-45,0-45,0-45,0-48,0-48,0-48,0-42,0-46,0-3124						 Telomerizing Nuclear Donor Cells And Improving The Efficiency On Nuclear Transfer 	www.docstoc.com	0	0		
943	chr13	47050587	47051388	3500439661	51		47050587	47051388	8421504	2	26,25	0,776	c	350043966100000003,350043966100000000,350043966100000001,350043966100000007	10-36,10-36,13-38,13-34		19451655	10.1074/jbc.M109.003566	0021-9258	Journal of Biological Chemistry	Alternative Translation Initiation Generates Cytoplasmic Sheep Prion Protein	Lund	2009	5		
943	chr13	47050589	47050896	3500452841	45		47050589	47050896	8421504	2	23,22	0,285	c	350045284100000000,350045284100000002	11-34,0-22			10.1099/vir.0.82568-0	0022-1317	Journal of General Virology	Reduced susceptibility to bovine spongiform encephalopathy prions in transgenic mice expressing a bovine PrP with five octapeptide repeats	Brun	2007	3		
943	chr13	47050593	47051388	3500458389	77		47050593	47051388	8421504	3	23,29,25	0,416,770	c	350045838900000000,350045838900000002,350045838900000001	11-34,0-29,9-34		19264659	10.1099/vir.0.007500-0	0022-1317	Journal of General Virology	Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein	Tamguney	2009	3		
943	chr13	47050593	47051388	3500396875	768		47050593	47051388	8421504	3	196,101,471	0,220,324	p,c,g	350039687500015000,350039687500000000,350039687500000000,350039687500015002,350039687500000001,350039687500015004,350039687500000002,350039687500000003,350039687500000004,350039687500015006,350039687500000018,350039687500015017,350039687500000005,350039687500015007,350039687500000019,350039687500015018,350039687500000006,350039687500000006,350039687500000007,350039687500015020,350039687500015009,350039687500000008,350039687500015010,350039687500000009,350039687500000023,350039687500000010,350039687500015012,350039687500000011,350039687500015013,350039687500000012,350039687500000012,350039687500015015	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-61,0-57,0-60,0-60,0-60,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-57,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-51,0-51,0-48						Prion disease	www.mad-cow.org	0	0		
943	chr13	47050593	47051388	3500371768	771		47050593	47051388	8421504	2	196,575	0,220	p,c,g	350037176800000000,350037176800000000,350037176800000026,350037176800000026,350037176800000039,350037176800015001,350037176800000040,350037176800000001,350037176800015004,350037176800000002,350037176800015007,350037176800000003,350037176800000004,350037176800000005,350037176800015010,350037176800000006,350037176800015013,350037176800000020,350037176800000007,350037176800000008,350037176800015017,350037176800000009,350037176800015020,350037176800015023,350037176800000010,350037176800015026,350037176800000011,350037176800000012,350037176800000012,350037176800015029	3-63,3-63,0-60,0-60,0-770,0-60,0-768,0-60,0-60,0-60,0-60,0-61,0-57,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-57,0-53,0-51,0-51,0-48						Odd Prion Allele Found In Goat	www.mad-cow.org	0	0		
943	chr13	47050593	47051388	3500257903	48		47050593	47051388	8421504	2	24,24	0,771	c,g	350025790300000010,350025790300000011,350025790300000011	0-24,0-24,0-24						ATTI DEL II CONGRESSO NAZIONALE	www.aipvet.it	0	0		
943	chr13	47050593	47051388	3500208402	88		47050593	47051388	8421504	3	21,43,24	0,678,771	c	350020840200000000,350020840200000002,350020840200000001	11-32,1-44,9-33		16940522	10.1128/JVI.00098-06	0022-538X	Journal of Virology	Transmission of Elk and Deer Prions to Transgenic Mice	Tamguney	2006	5		
943	chr13	47050593	47051388	3500130095	41		47050593	47051388	8421504	2	19,22	0,773	c	350013009500000000,350013009500000001	0-19,0-22		21699704	10.1186/1297-9716-42-79	1297-9716	Veterinary Research	Experimental H-type bovine spongiform encephalopathy characterized by plaques and glial- and stellate-type prion protein deposits	Okada	2011	0		
943	chr13	47050593	47051388	3500006109	48		47050593	47051388	8421504	2	24,24	0,771	c,g	350000610900000002,350000610900000003,350000610900000003	0-24,0-24,0-24						Prion protein gene polymorphisms in healthy and scrapie-affected sheep in Greece	r.sgmjournals.org	0	0		
943	chr13	47050593	47051385	3500324860	630		47050593	47051385	8421504	2	30,600	0,192	p	350032486000015008	0-768						<HTML><HEAD><TITLE>TP bioinfo</TITLE> </HEAD><FRAMESET border=0 cols=* frameBorder=NO frameSpacin	logie.univ-mrs.fr	0	0		
943	chr13	47050593	47051385	3500241990	792		47050593	47051385	8421504	1	792	0	p	350024199000015000	0-792						Protein sequence instability: a mathematical analysis	complexity.org.au	0	0		
943	chr13	47050593	47051385	3500141078	630		47050593	47051385	8421504	2	30,600	0,192	p	350014107800015000,350014107800015001,350014107800015003,350014107800015002,350014107800015005,350014107800015004,350014107800015006	0-768,27-627,27-627,27-627,27-627,27-627,27-627						Prions	www.mad-cow.org	0	0		
943	chr13	47050593	47051221	3500386014	362		47050593	47051221	8421504	5	23,74,18,120,127	0,120,297,321,501	p,c,g	350038601400000000,350038601400015003,350038601400000010,350038601400015004,350038601400015005,350038601400015007,350038601400015008,350038601400000003,350038601400000003,350038601400000005,350038601400000005	0-23,0-60,0-51,0-60,0-60,0-60,0-60,0-22,0-22,0-20,0-20						Transmissible mink encephalopathy species barrier effect between ferret and mink: PrP gene and protein analysis	r.sgmjournals.org	0	0		
943	chr13	47050596	47051364	3500028736	621		47050596	47051364	8421504	9	45,45,117,45,117,93,45,69,45	0,48,99,291,339,483,579,627,723	p	350002873600015047,350002873600015049,350002873600015051,350002873600015017,350002873600015053,350002873600015034,350002873600015057,350002873600015058,350002873600015059,350002873600015038,350002873600015023,350002873600015060,350002873600015070,350002873600015062,350002873600015072,350002873600015026,350002873600015063,350002873600015064,350002873600015065,350002873600015075,350002873600015067	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Recombinant construct encoding epitope tagged PrP protein	Prusiner	2000	0		
943	chr13	47050600	47051370	3500164274	40		47050600	47051370	8421504	2	19,21	0,749	c	350016427400000030,350016427400000031	0-19,0-21						RBI th on the Conservation of Animal Genetic Resources Tekirdag, TURKIYE 4 8 October 2011)	nf2011.nku.edu.tr	0	0		
943	chr13	47050654	47051369	3500140952	144		47050654	47051369	8421504	5	29,28,30,24,33	0,341,536,622,682	c,g	350014095200000002,350014095200000006,350014095200000006,350014095200000003,350014095200000005,350014095200000007,350014095200000008,350014095200000004	0-29,0-24,0-24,0-28,0-30,1-25,1-25,0-33						136	stinet.dtic.mil	0	0		
943	chr13	47050656	47050702	3500193115	46		47050656	47050702	8421504	1	46	0	c	350019311500000003,350019311500000000	0-35,5-51		17314157	10.1128/JVI.02762-06	0022-538X	Journal of Virology	Resistance to Chronic Wasting Disease in Transgenic Mice Expressing a Naturally Occurring Allelic Variant of Deer Prion Protein	Meade-White	2007	5		
943	chr13	47050661	47051316	3500351321	84		47050661	47051316	8421504	2	21,63	0,592	p,c,g	350035132100000002,350035132100000002,350035132100000008,350035132100000008,350035132100015007,350035132100015005,350035132100015006,350035132100015000	0-21,0-21,0-21,0-21,0-48,0-54,0-48,0-51						Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies	O'rourke	1999	0		
943	chr13	47050662	47051286	3500177788	600		47050662	47051286	8421504	2	120,480	0,144	p,c,g	350017778800000002,350017778800000002,350017778800015000,350017778800000025,350017778800000005,350017778800000003,350017778800000004,350017778800015006,350017778800015008,350017778800000006,350017778800015011,350017778800000007,350017778800000017,350017778800015025,350017778800000008,350017778800000028,350017778800000009,350017778800015019,350017778800000030,350017778800000010,350017778800000011,350017778800015022	0-61,0-61,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						London to get CJD research centre	mad-cow.org	0	0		
943	chr13	47050665	47051319	3500130747	654		47050665	47051319	8421504	1	654	0	p,c,g	350013074700000002,350013074700000002,350013074700015015,350013074700015016,350013074700015018,350013074700015019,350013074700015020,350013074700015021,350013074700015022,350013074700015023,350013074700015024,350013074700015025,350013074700015026,350013074700015027	3-657,3-657,3-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						IMMUNOLOGICAL DETECTION OF PRIONS - Kanton, Z&#xfffd;rich Vertreten Durch Die Erziehungsdirektion	www.sumobrain.com	0	0		
943	chr13	47050665	47051097	3500426402	61		47050665	47051097	8421504	3	20,20,21	0,357,411	c,g	350042640200000008,350042640200000008,350042640200000001,350042640200000009	0-20,0-20,0-20,0-21					Patent	Transgenic bovines having reduced prion protein production (Patent US:7429690)	Ishida	2008	0		
943	chr13	47050665	47051097	3500111880	61		47050665	47051097	8421504	3	20,20,21	0,357,411	c,g	350011188000000008,350011188000000008,350011188000000001,350011188000000009,350011188000000009	0-20,0-20,0-20,0-21,0-21						Transgenic ungulates having reduced prion protein activity and uses thereof - Patent application	www.faqs.org	0	0		
943	chr13	47050665	47051097	3500085335	61		47050665	47051097	8421504	3	20,20,21	0,357,411	c,g	350008533500000008,350008533500000008,350008533500000001,350008533500000009	0-20,0-20,0-20,0-21						Transgenic ungulates having reduced prion protein activity and uses thereof	Collas	2005	0		
943	chr13	47050665	47051097	3500075504	61		47050665	47051097	8421504	3	20,20,21	0,357,411	c,g	350007550400000008,350007550400000008,350007550400000001,350007550400000009,350007550400000009	0-20,0-20,0-20,0-21,0-21						Transgenic ungulates having reduced prion protein activity and uses thereof	Collas	2004	0		
943	chr13	47050675	47051097	3500319187	61		47050675	47051097	8421504	3	20,20,21	0,347,401	c	350031918700000022,350031918700000017,350031918700000051	0-20,0-20,0-21						Transgenic animals and uses thereof	Robl	2005	0		
943	chr13	47050684	47050902	3500313568	218		47050684	47050902	8421504	1	218	0	p,c,g	350031356800000000,350031356800000000,350031356800015000,350031356800000001,350031356800000001,350031356800000002,350031356800000003	0-62,0-62,0-60,0-60,0-60,0-60,0-60						Prion disease	www.mad-cow.org	0	0		
943	chr13	47050684	47050902	3500107179	218		47050684	47050902	8421504	1	218	0	p,c,g	350010717900000000,350010717900000000,350010717900015000,350010717900015001,350010717900000001,350010717900000001,350010717900000002,350010717900000003,350010717900000011	1-63,1-63,0-57,0-57,0-60,0-60,0-60,1-61,0-24						Prion Doppel Alternative Splicing	www.mad-cow.org	0	0		
943	chr13	47050724	47051362	3500456415	127		47050724	47051362	8421504	7	22,19,22,30,18,10,6	0,240,437,484,594,618,632	c,g	350045641500000000,350045641500000001,350045641500000001	19-351,0-19,0-19						 SpringerImages - Target sequences examined 	pringerimages.com	0	0		
943	chr13	47050752	47050902	3500409801	150		47050752	47050902	8421504	1	150	0	p,c	350040980100015000,350040980100000001,350040980100000002	0-150,0-24,0-24						<HTML><HEAD> <TITLE>Variability in Prion Octapeptide Repeat Region</TITLE> </HEAD> <BODY> <A HREF="#	www.mad-cow.org	0	0		
943	chr13	47050761	47050902	3500332435	141		47050761	47050902	8421504	1	141	0	p,c	350033243500015001,350033243500000006,350033243500000017,350033243500000011,350033243500000015,350033243500000014,350033243500000008	108-249,0-21,87-145,0-24,0-21,0-20,0-27						Prion Deletion Mutants	www.mad-cow.org	0	0		
943	chr13	47050761	47050902	3500301420	141		47050761	47050902	8421504	1	141	0	p,c	350030142000015001,350030142000000003,350030142000000006,350030142000000005,350030142000000017,350030142000000015,350030142000000014,350030142000000008	108-249,0-21,0-21,0-24,87-145,0-21,0-20,0-27						Prion Deletion Mutants	www.mad-cow.org	0	0		
943	chr13	47050761	47050902	3500276913	141		47050761	47050902	8421504	1	141	0	p,c	350027691300015001,350027691300000006,350027691300000017,350027691300000015,350027691300000014,350027691300000008	108-249,0-21,87-145,0-21,0-20,0-27						Prion Deletion Mutants	ww.cyber-dyne.com	0	0		
943	chr13	47050847	47051404	3500128075	44		47050847	47051404	8421504	2	20,24	0,533	c	350012807500000002,350012807500000001	0-20,0-24		19218225	10.1099/vir.0.006114-0	0022-1317	Journal of General Virology	Identification of seven haplotypes of the caprine PrP gene at codons 127, 142, 154, 211, 222 and 240 in French Alpine and Saanen breeds and their association with classical scrapie	Barillet	2009	3		
943	chr13	47050851	47050875	3500366104	24		47050851	47050875	8421504	1	24	0	c	350036610400000009	0-24						Transmissible Familial Creutzfeldt-Jakob Disease Associated with Five, Seven, and Eight Extra Octapeptide Coding Repeats in the PRNP Gene	www.jstor.org	0	0		
943	chr13	47050854	47051217	3500318059	77		47050854	47051217	8421504	3	33,11,33	0,36,330	c	350031805900000161,350031805900000154	0-44,15-48						Devices from Prion-Like Proteins - Patent application	www.faqs.org	0	0		
943	chr13	47050876	47051263	3500338549	40		47050876	47051263	8421504	2	20,20	0,367	c,g	350033854900000000,350033854900000001,350033854900000001	0-20,0-20,0-20						RESIST&#xca;NCIA OU SUSCETIBILIDADE &#xc0; SCRAPIE EM OVINOS PERTENCENTES AO GRUPAMENTO GEN&#xc9;TICO OVELHAS PANTANEIRAS	cnptia.embrapa.br	0	0		
943	chr13	47050878	47051728	3500425325	144		47050878	47051728	8421504	5	22,27,27,27,41	0,52,331,387,809	c	350042532500000005,350042532500000007,350042532500000006,350042532500000008,350042532500000001,350042532500000009,350042532500000003	0-22,0-27,0-27,0-27,0-32,0-31,5-34		17030846	10.1099/vir.0.81779-0	0022-1317	Journal of General Virology	PrP genotypes of atypical scrapie cases in Great Britain	Saunders	2006	3		
943	chr13	47050889	47051282	3500435285	46		47050889	47051282	8421504	2	22,24	0,369	c	350043528500000000,350043528500000001	0-22,0-24		20346155	10.1186/1746-6148-6-17	1746-6148	BMC Veterinary Research	Atypical/Nor98 scrapie in the Basque Country: a case report of eight outbreaks	RodrAguez-MartAnez	2010	2		
943	chr13	47050892	47051200	3500319637	44		47050892	47051200	8421504	2	20,24	0,284	c	350031963700000002,350031963700000003	0-20,0-24						Blood chimerism confounds genetic relative susceptibility testing for classical scrapie in sheep	alcommons.unl.edu	0	0		
943	chr13	47050896	47050941	3500437175	45		47050896	47050941	8421504	1	45	0	p	350043717500015023	0-45						AFFINITY MARKER COMPRISING A FIRST AND A SECOND TAG AND ITS USE - HELMHOLTZ ZENTRUM M&#xdc;NCHEN DEUTSCHES FORSCHUNGSZENTRUM F&#xdc;R GESUNDHEIT UND UMWELT (GMBH)	www.sumobrain.com	0	0		
943	chr13	47050908	47051319	3500151065	411		47050908	47051319	8421504	1	411	0	p	350015106500015008,350015106500015028,350015106500015029	0-96,0-315,0-315						CHARACTERIZATION OF SHADOO AND DPPX: TWO PROTEINS OF POTENTIAL RELEVANCE TO PRION BIOLOGY	brary.utoronto.ca	0	0		
943	chr13	47050917	47051298	3500423447	273		47050917	47051298	8421504	3	123,120,30	0,126,351	p,c	350042344700015000,350042344700015002,350042344700015001,350042344700000001	0-123,0-123,0-120,0-30						Comparison of the ovine prion protein genotype profiles of breeds Tigaie with Black Head and Merino	ls.tubitak.gov.tr	0	0		
943	chr13	47050941	47051004	3500430491	63		47050941	47051004	8421504	1	63	0	p	350043049100015000	0-63						The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation	oinflammation.com	0	0		PRNP
943	chr13	47050941	47051004	3500379340	63		47050941	47051004	8421504	1	63	0	p	350037934000015000	0-63			10.1093/emboj/cdf325		The EMBO Journal	Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection	Silvio	July	0		PRNP
943	chr13	47050941	47051004	3500377192	63		47050941	47051004	8421504	1	63	0	p	350037719200015002	0-63						<script language=javascript> function overCell(el) { el.style.background='#FCF7F2'; }	.chemicalbook.com	0	0		PRNP
943	chr13	47050941	47051004	3500022405	63		47050941	47051004	8421504	1	63	0	p	350002240500015048,350002240500015047	0-63,0-63						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
943	chr13	47050943	47051495	3500431854	65		47050943	47051495	8421504	3	20,21,24	0,259,528	c,g	350043185400000002,350043185400000002,350043185400000003,350043185400000001	0-20,0-20,0-21,1-25						Caprine prion gene polymorphisms are associated with decreased incidence of classical scrapie in goat herds in the United Kingdom	inaryresearch.org	0	0		
943	chr13	47050943	47051495	3500329175	65		47050943	47051495	8421504	3	20,21,24	0,259,528	c	350032917500000002,350032917500000003,350032917500000001	0-20,0-21,1-25		22040234	10.1186/1297-9716-42-110		Veterinary Research	Caprine prion gene polymorphisms are associated with decreased incidence of classical scrapie in goat herds in the United Kingdom	Wilfred	2011	0		
943	chr13	47050943	47051495	3500130665	65		47050943	47051495	8421504	3	20,21,24	0,259,528	c,g	350013066500000002,350013066500000002,350013066500000003,350013066500000001	0-20,0-20,0-21,1-25		20202205	10.1186/1746-6148-6-13		BMC Veterinary Research	Monitoring of clinical signs in goats with transmissible spongiform encephalopathies	Timm	2010	0		
943	chr13	47050943	47051388	3500226746	65		47050943	47051388	8421504	3	20,20,25	0,114,420	c,g	350022674600000002,350022674600000003,350022674600000003,350022674600000001	0-20,0-20,0-20,6-31		22296670	10.1186/1297-9716-43-8		Veterinary Research	Resistance to classical scrapie in experimentally challenged goats carrying mutation K222 of the prion protein gene	Pier	2012	0		
943	chr13	47050943	47051388	3500188513	65		47050943	47051388	8421504	3	20,20,25	0,114,420	c,g	350018851300000002,350018851300000003,350018851300000003,350018851300000001	0-20,0-20,0-20,6-31						Resistance to classical scrapie in experimentally challenged goats carrying mutation K222 of the prion protein gene	inaryresearch.org	0	0		
943	chr13	47050943	47051387	3500458986	64		47050943	47051387	8421504	3	20,20,24	0,114,420	c,g	350045898600000002,350045898600000002,350045898600000003,350045898600000003,350045898600000001	0-20,0-20,0-20,0-20,0-24		18217941	10.1111/j.1365-2672.2007.03703.x	1365-2672	Journal of Applied Microbiology	Genetic variability of the PRNP gene in goat breeds from Northern and Southern Italy - Acutis - 2008 - Journal of Applied Microbiology - Wiley Online Library	Acutis	2008	0		
943	chr13	47050943	47051295	3500410715	40		47050943	47051295	8421504	2	20,20	0,332	c	350041071500000000,350041071500000001	0-20,0-20		15448380	10.1099/vir.0.80053-0	0022-1317	Journal of General Virology	Low frequency of the scrapie resistance-associated allele and presence of lysine-171 allele of the prion protein gene in Italian Biellese ovine breed	Acutis	2004	3		
943	chr13	47050950	47051270	3500149270	39		47050950	47051270	8421504	2	19,20	0,300	c,g	350014927000000000,350014927000000003,350014927000000003	0-19,1-21,1-21						The PRNP gene polymorphism in Rough-coated Pomeranian Landrace sheep	www.ajol.info	0	0		
943	chr13	47050950	47051196	3500405253	43		47050950	47051196	8421504	2	20,23	0,223	c,g	350040525300000000,350040525300000001	0-20,0-23						Single nucleotide polymorphisms at 15 codons of the prion protein gene from a scrapie-affected herd of Suffolk sheep in Brazil1	www.scielo.br	0	0		
943	chr13	47050950	47051028	3500102458	78		47050950	47051028	8421504	1	78	0	p	350010245800015004	0-78						YRAIMA MOURA LOPES CORDEIRO	teses.ufrj.br	0	0		PRNP
943	chr13	47050969	47051504	3500319129	75		47050969	47051504	8421504	3	20,47,8	0,479,527	c	350031912900000005,350031912900000003,350031912900000001	0-20,0-25,0-30						Amino acid polymorphisms of PrP with reference to onset of scrapie in Suffolk and Corriedale sheep in Japan	r.sgmjournals.org	0	0		
943	chr13	47050997	47051020	3500311472	23		47050997	47051020	8421504	1	23	0	c	350031147200000001	0-23						Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products	Aguzzi	1999	0		
943	chr13	47051001	47051174	3500199873	44		47051001	47051174	8421504	2	21,23	0,150	c,g	350019987300000000,350019987300000000,350019987300000001	0-21,0-21,0-23		15753327		0021-8812	Journal of Animal Science	Technical Note: Determination of alleles of the ovine PRNP gene using PCR&#x2013;single-strand conformational polymorphism analysis	Zhou	2005	2		
943	chr13	47051001	47051174	3500065378	44		47051001	47051174	8421504	2	21,23	0,150	c,g	350006537800000000,350006537800000000,350006537800000001	0-21,0-21,0-23		15753327		0021-8812	Journal of Animal Science	Technical Note: Determination of alleles of the ovine PRNP gene using PCR&#x2013;single-strand conformational polymorphism analysis	Zhou	2005	2		
943	chr13	47051009	47051324	3500129334	66		47051009	47051324	8421504	3	29,33,4	0,277,311	c	350012933400000002,350012933400000003,350012933400000001	0-29,0-29,13-50			10.1046/j.1432-1033.2000.01347.x	1432-1033	European Journal of Biochemistry	High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility - Rezaei - 2003 - European Journal of Biochemistry - Wiley Online Library	Rezaei	2000	0		
943	chr13	47051009	47051032	3500207604	23		47051009	47051032	8421504	1	23	0	c	350020760400000031,350020760400000030	20-43,17-39						Human Molecular Genetics	005.pasteur.ac.ir	0	0		
943	chr13	47051019	47051094	3500456576	75		47051019	47051094	8421504	1	75	0	p	350045657600015021,350045657600015019,350045657600015020	3-78,3-78,3-48						Molecular antigen arrays	Bachmann	2003	0		
943	chr13	47051019	47051094	3500383796	75		47051019	47051094	8421504	1	75	0	p	350038379600015030,350038379600015029	3-78,3-48						Molecular Antigen Array	Renner	2011	0		PRNP
943	chr13	47051019	47051094	3500380208	75		47051019	47051094	8421504	1	75	0	p	350038020800015018,350038020800015020,350038020800015019	3-78,3-78,3-48					Patent	Molecular antigen arrays using a virus like particle derived from the ap205 coat protein (Patent EP:1532167)	Bachmann	2012	0		
943	chr13	47051019	47051094	3500374171	75		47051019	47051094	8421504	1	75	0	p	350037417100015029,350037417100015028	3-78,3-48						Molecular antigen array	Renner	2011	0		PRNP
943	chr13	47051019	47051094	3500370744	75		47051019	47051094	8421504	1	75	0	p	350037074400015018,350037074400015019	3-78,3-48						Molecular antigen arrays using a virus like particle derived from the ap205 coat protein	Bachmann	2011	0		PRNP
943	chr13	47051019	47051094	3500370493	75		47051019	47051094	8421504	1	75	0	p	350037049300015042,350037049300015040,350037049300015041	3-78,3-78,3-48						Molecular antigen array	Renner	2002	0		
943	chr13	47051019	47051094	3500363578	75		47051019	47051094	8421504	1	75	0	p	350036357800015029,350036357800015031,350036357800015030	3-78,3-78,3-48						Molecular antigen arrays	Bachmann	2006	0		
943	chr13	47051019	47051094	3500352639	75		47051019	47051094	8421504	1	75	0	p	350035263900015026,350035263900015023,350035263900015024	3-78,3-78,3-48						Molecular Antigen Arrays 	.freshpatents.com	0	0		PRNP
943	chr13	47051019	47051094	3500284318	75		47051019	47051094	8421504	1	75	0	p	350028431800015037,350028431800015033,350028431800015035	3-78,3-78,3-48						Molecular antigen arrays using a virus like particle derived from the AP205 coat protein	A*Di Suo 	2011	0		
943	chr13	47051019	47051094	3500279893	75		47051019	47051094	8421504	1	75	0	p	350027989300015039,350027989300015037	3-78,3-78					Patent	Molecular antigen array presenting amyloid beta (Patent EP:1353691)	Renner	2009	0		
943	chr13	47051019	47051094	3500271723	75		47051019	47051094	8421504	1	75	0	p	350027172300015042,350027172300015046,350027172300015044	3-78,3-78,3-48						Molecular antigen array	Wo Er Fu Gang *A*Lun Na 	2004	0		
943	chr13	47051019	47051094	3500261692	75		47051019	47051094	8421504	1	75	0	p	350026169200015020,350026169200015018,350026169200015019	3-78,3-78,3-48					Patent	Molecular antigen arrays (Patent US:7138252)	Bachmann	2006	0		
943	chr13	47051019	47051094	3500260645	75		47051019	47051094	8421504	1	75	0	p	350026064500015038,350026064500015040,350026064500015039	3-78,3-78,3-48						Molecular antigen arrary	Renner	2008	0		
943	chr13	47051019	47051094	3500256065	75		47051019	47051094	8421504	1	75	0	p	350025606500015020,350025606500015018,350025606500015019	3-78,3-78,3-48						Molecular Antigen Arrays	Bachmann	2010	0		
943	chr13	47051019	47051094	3500255293	75		47051019	47051094	8421504	1	75	0	p	350025529300015019,350025529300015017,350025529300015018	3-78,3-78,3-48						Molecular antigen arrays	Bachmann	2007	0		
943	chr13	47051019	47051094	3500241654	75		47051019	47051094	8421504	1	75	0	p	350024165400015053,350024165400015047,350024165400015049	3-78,3-78,3-48					Patent	Molecular antigen arrays using a virus like particle derived from the AP205 coat protein (Patent CN:1668637)	A*Di Suo 	2010	0		
943	chr13	47051019	47051094	3500227774	75		47051019	47051094	8421504	1	75	0	p	350022777400015064,350022777400015024	3-78,3-48						Molecular antigen arrays	Bachmann	2004	0		PRNP
943	chr13	47051019	47051094	3500225500	75		47051019	47051094	8421504	1	75	0	p	350022550000015020,350022550000015018,350022550000015019	3-78,3-78,3-48					Patent	Molecular antigen arrays (Patent US:7494656)	Bachmann	2009	0		
943	chr13	47051019	47051094	3500206521	75		47051019	47051094	8421504	1	75	0	p	350020652100015019,350020652100015021,350020652100015020	3-78,3-78,3-48						&#x041c;&#x043e;&#x043b;&#x0435;&#x043a;&#x0443;&#x043b;&#x044f;&#x0440;&#x043d;&#x044b;&#x0435; &#x043c;&#x0430;&#x0441;&#x0441;&#x0438;&#x0432;&#x044b; &#x0430;&#x043d;&#x0442;&#x0438;&#x0433;&#x0435;&#x043d;&#x043e;&#x0432;. &#x041f;&#x0430;&#x0442;&#x	www.findpatent.ru	0	0		
943	chr13	47051019	47051094	3500203729	75		47051019	47051094	8421504	1	75	0	p	350020372900015018,350020372900015085,350020372900015016,350020372900015086,350020372900015017	3-78,0-72,3-78,0-69,3-48						US Patent # 7,138,252. Molecular antigen arrays - Patents.com	www.patents.com	0	0		
943	chr13	47051019	47051094	3500180006	75		47051019	47051094	8421504	1	75	0	p	350018000600015018,350018000600015020,350018000600015019	3-78,3-78,3-48						Molecular antigen arrays	Bachmann	2004	0		
943	chr13	47051019	47051094	3500154312	75		47051019	47051094	8421504	1	75	0	p	350015431200015047,350015431200015049,350015431200015048	3-78,3-78,3-48						Molecular antigen array	Bachmann	2003	0		
943	chr13	47051019	47051094	3500143718	75		47051019	47051094	8421504	1	75	0	p	350014371800015023,350014371800015022	3-78,3-48						Molecular antigen array presenting amyloid beta	Bachmann	2003	0		
943	chr13	47051019	47051094	3500095833	75		47051019	47051094	8421504	1	75	0	p	350009583300015027,350009583300015029,350009583300015028	3-78,3-78,3-48					Patent	Molecular antigen array (Patent US:7264810)	Renner	2007	0		
943	chr13	47051019	47051094	3500089496	75		47051019	47051094	8421504	1	75	0	p	350008949600015023,350008949600015022	3-78,3-48						Molecular antigen array presenting amyloid beta	Renner	2002	0		
943	chr13	47051019	47051094	3500075936	75		47051019	47051094	8421504	1	75	0	p	350007593600015029,350007593600015026,350007593600015027	3-78,3-78,3-48					Patent	&#x4f7f;&#x7528;&#x884d;&#x751f;&#x81ea;ap205&#x5916;&#x58f3;&#x86cb;&#x767d;&#x7684;&#x75c5;&#x6bd2;&#x6837;&#x9897;&#x7c92;&#x7684;&#x5206;&#x5b50;&#x6297;&#x539f;&#x9635;&#x5217; (Patent CN:1668637)	A*Di Suo 	2010	0		
943	chr13	47051019	47051094	3500069495	75		47051019	47051094	8421504	1	75	0	p	350006949500015025,350006949500015027,350006949500015026	3-78,3-78,3-48						&#x4f7f;&#x7528;&#x884d;&#x751f;&#x81ea;ap205&#x5916;&#x58f3;&#x86cb;&#x767d;&#x7684;&#x75c5;&#x6bd2;&#x6837;&#x9897;&#x7c92;&#x7684;&#x5206;&#x5b50;&#x6297;&#x539f;&#x9635;&#x5217;	M*F*Ba He Man 	2005	0		
943	chr13	47051024	47051170	3500199164	100		47051024	47051170	8421504	4	25,27,25,23	0,26,68,123	c	350019916400000002,350019916400000001,350019916400000006,350019916400000007	0-25,0-27,0-25,0-23						Mise en &#xe9;vidence par technique de r&#xe9;action de polym&#xe9;risation en cha&#xee;ne en temps r&#xe9;el de polymorphismes au niveau du g&#xe8;ne PrP dans deux exploitations ovines belges d&#xe9;clar&#xe9;es positives aux enc&#xe9;phalopathies spongi	w.facmv.ulg.ac.be	0	0		
943	chr13	47051046	47051094	3500373345	48		47051046	47051094	8421504	1	48	0	p	350037334500015017,350037334500015018	0-48,3-48						Molecular antigen arrays using a virus like particle derived from the ap205 coat protein	Bachmann	2005	0		PRNP
943	chr13	47051049	47051073	3500255315	24		47051049	47051073	8421504	1	24	0	c,g	350025531500000003,350025531500000003,350025531500000002,350025531500000002	0-24,0-24,0-24,0-24		15483263	10.1099/vir.0.80043-0	0022-1317	Journal of General Virology	Propagation of a protease-resistant form of prion protein in long-term cultured human glioblastoma cell line T98G	Kikuchi	2004	3		PRNP
943	chr13	47051049	47051073	3500024480	24		47051049	47051073	8421504	1	24	0	c	350002448000000002,350002448000000003	0-24,0-24		15483263	10.1099/vir.0.80043-0	0022-1317	Journal of General Virology	Propagation of a protease-resistant form of prion protein in long-term cultured human glioblastoma cell line T98G	Kikuchi	2004	3		PRNP
943	chr13	47051050	47051719	3500013909	111		47051050	47051719	8421504	4	27,29,23,32	0,42,97,637	c	350001390900000005,350001390900000009,350001390900000007,350001390900000010,350001390900000001	0-27,0-25,0-24,0-23,0-32						Protective effect of the AT137RQ and ARQK176 PrP alleles against classical scrapie in Sarda breed sheep	www.vetres.org	0	0		
943	chr13	47051050	47051719	3500005206	133		47051050	47051719	8421504	5	27,29,23,22,32	0,42,97,345,637	c	350000520600000008,350000520600000012,350000520600000010,350000520600000013,350000520600000023,350000520600000018	0-27,0-25,0-24,0-23,6-28,0-32						X Congresso Nazionale S.I.Di.L.V.	www.sidilv.org	0	0		
943	chr13	47051050	47051417	3500170977	101		47051050	47051417	8421504	4	27,29,23,22	0,42,97,345	c,g	350017097700000000,350017097700000005,350017097700000003,350017097700000006,350017097700000006,350017097700000009	0-27,0-25,0-24,0-23,0-23,6-28						Dipartimento di Scienze Zootecniche Dottorato di Ricerca in Scienze e Tecnologie Zootecniche	eprints.uniss.it	0	0		
943	chr13	47051054	47051583	3500405356	42		47051054	47051583	8421504	2	21,21	0,508	c,g	350040535600000001,350040535600000001,350040535600000003,350040535600000003	0-21,0-21,0-21,0-21		17374784	10.1099/vir.0.82507-0	0022-1317	Journal of General Virology	Polymorphisms of the prion protein gene coding region in born-after-the-reinforced-ban (BARB) bovine spongiform encephalopathy cattle in Great Britain	Saunders	2007	3		
943	chr13	47051057	47051295	3500337693	40		47051057	47051295	8421504	2	20,20	0,218	c,g	350033769300000002,350033769300000002,350033769300000001,350033769300000001	0-20,0-20,0-20,0-20						Identification of a second bovine amyloidotic spongiform encephalopathy: Molecular similarities with sporadic Creutzfeldt&#x2013;Jakob disease (FULL TEXT)	www.vegsource.com	0	0		
943	chr13	47051057	47051295	3500271724	40		47051057	47051295	8421504	2	20,20	0,218	c,g	350027172400000002,350027172400000002,350027172400000001,350027172400000001	0-20,0-20,0-20,0-20						Identification of a second bovine amyloidotic spongiform encephalopathy: Molecular similarities with sporadic Creutzfeldt&#x2013;Jakob disease	www.pnas.org	0	0		
943	chr13	47051066	47051176	3500014479	71		47051066	47051176	8421504	3	25,25,21	0,52,89	c,g	350001447900000004,350001447900000009,350001447900000008,350001447900000006,350001447900000001	0-25,0-25,0-25,0-23,0-21						Prion genotypes of scrapie-infected Canadian sheep 1998&#x2013;2008 Abstract	aldc.nal.usda.gov	0	0		
943	chr13	47051078	47051230	3500300455	69		47051078	47051230	8421504	3	24,25,20	0,25,132	c,g	350030045500000003,350030045500000004,350030045500000001,350030045500000001	7-31,0-25,0-20,0-20						Methodology Adaptation of a low-cost medium-throughput genotyping system for ovine prion protein gene polymorphims associated with scrapie	w.funpecrp.com.br	0	0		
943	chr13	47051176	47051466	3500152165	76		47051176	47051466	8421504	3	24,28,24	0,218,266	c	350015216500000002,350015216500000003,350015216500000001	0-24,0-28,0-24		16033959	10.1099/vir.0.81077-0	0022-1317	Journal of General Virology	Low frequency of PrP genotype 225SF among free-ranging mule deer (Odocoileus hemionus) with chronic wasting disease	Jewell	2005	3		
943	chr13	47051176	47051466	3500129691	76		47051176	47051466	8421504	3	24,28,24	0,218,266	c	350012969100000002,350012969100000003,350012969100000001	0-24,0-28,0-24		16033959	10.1099/vir.0.81077-0	0022-1317	Journal of General Virology	Low frequency of PrP genotype 225SF among free-ranging mule deer (Odocoileus hemionus) with chronic wasting disease	Jewell	2005	3		
943	chr13	47051176	47051417	3500149384	45		47051176	47051417	8421504	2	23,22	0,219	c	350014938400000006,350014938400000001	0-23,0-22		15105552	10.1099/vir.0.79785-0	0022-1317	Journal of General Virology	Polymorphisms in the prion precursor functional gene but not the pseudogene are associated with susceptibility to chronic wasting disease in white-tailed deer	O'Rourke	2004	3		
943	chr13	47051182	47051205	3500015180	23		47051182	47051205	8421504	1	23	0	c	350001518000000028	0-23						Methods and compositions for genotyping	Derbyshire	2005	0		
943	chr13	47051209	47051286	3500435393	46		47051209	47051286	8421504	2	22,24	0,53	c,g	350043539300000019,350043539300000019,350043539300000018,350043539300000018	0-22,0-22,0-24,0-24						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
943	chr13	47051224	47051479	3500424700	50		47051224	47051479	8421504	2	26,24	0,231	c	350042470000000002,350042470000000000	0-26,0-24		16432036	10.1099/vir.0.81539-0	0022-1317	Journal of General Virology	Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme	Everest	2006	3		
943	chr13	47051224	47051479	3500350252	50		47051224	47051479	8421504	2	26,24	0,231	c	350035025200000002,350035025200000000	0-26,0-24						Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme	r.sgmjournals.org	0	0		
943	chr13	47051226	47051250	3500340216	24		47051226	47051250	8421504	1	24	0	c	350034021600000007,350034021600000016	0-24,0-24						Prion gene modified mouse which exhibits heart anomalies	Itohara	2001	0		
943	chr13	47051230	47051254	3500349174	24		47051230	47051254	8421504	1	24	0	c	350034917400000001	0-24						AN&#xc1;LISIS PARA LA IDENTIFICACI&#xd3;N DE NUEVAS VARIANTES AL&#xc9;LICAS (SHEEP GENOTYPED FOR SCRAPIE: ADJUSTMENT OF THE ANALYSIS METHOD FOR THE IDENTIFICATION OF NEW ALLELIC VARIANTS) PORTELA, C. ; BOUZADA, J.A.; PRADO, C.; ARE&#xc1;N, H.; FERN&#xc1;N	www2.vet.unibo.it	0	0		
943	chr13	47051258	47051282	3500366181	24		47051258	47051282	8421504	1	24	0	c	350036618100000001	0-24						Atypical/Nor98 scrapie in the Basque Country: a case report of eight outbreaks. - ResearchGate	.researchgate.net	0	0		
943	chr13	47051258	47051282	3500205754	24		47051258	47051282	8421504	1	24	0	c	350020575400000001	0-24						Atypical/Nor98 scrapie in the Basque Country: a case report of eight outbreaks	biomedcentral.com	0	0		
943	chr13	47051268	47051298	3500341671	30		47051268	47051298	8421504	1	30	0	c	350034167100000001	0-30						Analysis of the ORF region of the prion protein gene in the Botosani Karakul sheep breed from Romania - ResearchGate	.researchgate.net	0	0		
943	chr13	47051319	47054470	3500387790	1292		47051319	47054470	8421504	2	66,1226	0,1925	p,c	350038779000015000,350038779000000002,350038779000000003	0-66,0-1220,0-1226						September 1998 Prion Science News	www.mad-cow.org	0	0		
943	chr13	47051322	47051394	3500243585	44		47051322	47051394	8421504	2	22,22	0,50	c	350024358500000006,350024358500000004	0-22,0-22						XXVIIIXXVIII International ConferenceInternational Conference on Animal Geneticson Animal Genetics inin G&#xf6;ttingen -G&#xf6;ttingen -- Germany Germany Germany	www.isag.us	0	0		
943	chr13	47051322	47051394	3500226033	44		47051322	47051394	8421504	2	22,22	0,50	c,g	350022603300000006,350022603300000004,350022603300000004	0-22,0-22,0-22						Section A: Genome technologies	www.isag.us	0	0		
943	chr13	47051364	47051388	3500350479	24		47051364	47051388	8421504	1	24	0	c	350035047900000001	0-24		15218196	10.1099/vir.0.80047-0	0022-1317	Journal of General Virology	Prion protein gene polymorphisms in healthy and scrapie-affected Spanish sheep	Acin	2004	3		
943	chr13	47051364	47051388	3500323197	24		47051364	47051388	8421504	1	24	0	c,g	350032319700000001,350032319700000001	0-24,0-24		23249298	10.1186/1297-9716-43-87	1297-9716	Veterinary Research	Healthy goats naturally devoid of prion protein	Benestad	2012	0		
943	chr13	47051364	47051388	3500226651	24		47051364	47051388	8421504	1	24	0	c	350022665100000001	0-24		11842266		0022-1317	Journal of General Virology	Prion protein gene polymorphisms in natural goat scrapie	Billinis	2002	3		
943	chr13	47051364	47051388	3500151769	24		47051364	47051388	8421504	1	24	0	c	350015176900000001	0-24		17848990	10.1371/journal.pone.0000859	1932-6203	PLOS ONE	PLOS ONE: Intraepithelial and Interstitial Deposition of Pathological Prion Protein in Kidneys of Scrapie-Affected Sheep	Ligios	2007	4		
943	chr13	47051364	47051388	3500113886	24		47051364	47051388	8421504	1	24	0	c	350011388600000001	0-24						BMC Veterinary Research	biomedcentral.com	0	0		
943	chr13	47051364	47051388	3500047223	24		47051364	47051388	8421504	1	24	0	c	350004722300000001	0-24		23938169	10.1186/1746-6148-9-157		BMC Veterinary Research	In vitro prion protein conversion suggests risk of bighorn sheep (Ovis canadensis) to transmissible spongiform encephalopathies	Aaron	2013	0		
943	chr13	47051364	47051388	3500016659	24		47051364	47051388	8421504	1	24	0	c	350001665900000003	0-24		14769911	10.1099/vir.0.19520-0	0022-1317	Journal of General Virology	Prion protein gene polymorphisms in healthy and scrapie-affected sheep in Greece	Billinis	2004	3		
943	chr13	47051687	47051719	3500238025	32		47051687	47051719	8421504	1	32	0	c	350023802500000001	0-32		19171116	10.1051/vetres/2009002	0928-4249	Veterinary Research	Protective effect of the AT137RQ and ARQK176 PrP allele against classical scrapie in Sarda breed sheep | Vet. Res.	Vaccari	2009	4		
944	chr13	47082378	47082801	3500300133	423		47082378	47082801	8421504	1	423	0	p	350030013300015013	0-423						Prion Genomics Update: Xenopus and Fugu Prions	www.mad-cow.org	0	0		
944	chr13	47174538	47174563	3500323238	23		47174538	47174563	8421504	2	10,13	0,12	g	350032323800000012	11-34		22785533	10.1038/cddis.2012.85	false	Cell Death & Disease	Photofrin binds to procaspase-3 and mediates photodynamic treatment-triggered methionine oxidation and inactivation of procaspase-3	Hsieh	2012	0		
945	chr13	47209632	47209656	3500068521	23		47209632	47209656	8421504	2	17,6	0,18	c	350006852100000260	11-35						About ICRISAT	www.icrisat.org	0	0		
946	chr13	47436037	47436064	3500187053	23		47436037	47436064	8421504	2	11,12	0,15	c	350018705300000037	18-41						Production of Bacillus entomotoxins in methylotrophic yeast	Sreekrishna	1994	0		
946	chr13	47437037	47441911	3500286937	54		47437037	47441911	8421504	3	4,26,24	0,5,4850	c,g	350028693700000010,350028693700000010,350028693700000009,350028693700000009	4-34,4-34,10-34,10-34					Patent	Polypeptides comprising domains of the GAX protein implicated in the repression of transcription and/or interaction with other proteins, corresponding nucleic acids, and their use (Patent US:6121005)	Branellec	2000	0		
946	chr13	47437042	47441911	3500233663	50		47437042	47441911	8421504	2	26,24	0,4845	c	350023366300000009,350023366300000008	7-33,9-33						Polypeptides comprenant des domaines de la proteine gax, impliques dans la repression de transcription et/ou interagissant avec d'autres proteines, acides nucleiques correspondants et leurs utilisations	Branellec	1999	0		
946	chr13	47437043	47437067	3500021080	24		47437043	47437067	8421504	1	24	0	c	350002108000000023,350002108000000022	24-48,0-24		9305916	10.1074/jbc.272.39.24522	0021-9258	Journal of Biological Chemistry	The DNA Repair Endonuclease XPG Binds to Proliferating Cell Nuclear Antigen (PCNA) and Shares Sequence Elements with the PCNA-binding Regions of FEN-1 and Cyclin-dependent Kinase Inhibitor p21	Gary	1997	5		
946	chr13	47437046	47441912	3500270952	783		47437046	47441912	8421504	6	77,124,195,68,98,221	0,167,1886,2817,3019,4645	p	350027095200015009	0-783						&#x30d0;&#x30a4;&#x30aa;&#x30a4;&#x30f3;&#x30d5;&#x30a9;&#x30de;&#x30c6;&#x30a3;&#x30c3;&#x30af;&#x30b9;&#x6982;&#x8ad6;&#x6388;&#x696d;&#x4e88;&#x5b9a;	agri.tohoku.ac.jp	0	0		PCNA
946	chr13	47437046	47441912	3500229082	783		47437046	47441912	8421504	6	77,124,195,68,98,221	0,167,1886,2817,3019,4645	p	350022908200015009	0-783						&#x30d0;&#x30a4;&#x30aa;&#x30a4;&#x30f3;&#x30d5;&#x30a9;&#x30de;&#x30c6;&#x30a3;&#x30c3;&#x30af;&#x30b9;&#x6982;&#x8ad6;&#x6388;&#x696d;&#x4e88;&#x5b9a;	agri.tohoku.ac.jp	0	0		
946	chr13	47437046	47441912	3500179578	783		47437046	47441912	8421504	6	77,124,195,68,98,221	0,167,1886,2817,3019,4645	p	350017957800015009	0-783						&#x30d0;&#x30a4;&#x30aa;&#x30a4;&#x30f3;&#x30d5;&#x30a9;&#x30de;&#x30c6;&#x30a3;&#x30c3;&#x30af;&#x30b9;&#x6982;&#x8ad6;&#x6388;&#x696d;&#x4e88;&#x5b9a;	agri.tohoku.ac.jp	0	0		PCNA
946	chr13	47437046	47441912	3500072511	783		47437046	47441912	8421504	6	77,124,195,68,98,221	0,167,1886,2817,3019,4645	p	350007251100015031	0-783						&#x30d0;&#x30a4;&#x30aa;&#x30a4;&#x30f3;&#x30d5;&#x30a9;&#x30de;&#x30c6;&#x30a3;&#x30c3;&#x30af;&#x30b9;&#x6982;&#x8ad6;&#x6388;&#x696d;&#x4e88;&#x5b9a;	agri.tohoku.ac.jp	0	0		PCNA
946	chr13	47437046	47441912	3500048822	783		47437046	47441912	8421504	6	77,124,195,68,98,221	0,167,1886,2817,3019,4645	p	350004882200015053	0-783						Le coin du Bioinformaticien	ntunis.tripod.com	0	0		
946	chr13	47437046	47441912	3500035319	708		47437046	47441912	8421504	9	77,22,81,21,123,68,98,182,36	0,167,210,1886,1958,2817,3019,4645,4830	p	350003531900015022,350003531900015021,350003531900015019	0-99,0-102,0-507						METHODS OF PREDICTING PROGNOSIS IN CANCER - METAMARK GENETICS, INC.	www.sumobrain.com	0	0		PCNA
946	chr13	47437046	47439100	3500054122	369		47437046	47439100	8421504	3	77,124,168	0,167,1886	p	350005412200015002	0-369						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		PCNA
946	chr13	47437049	47439100	3500251406	366		47437049	47439100	8421504	3	74,124,168	0,164,1883	p	350025140600015001	0-366					Patent	Human cDNAs and proteins and uses thereof (Patent US:7285631)	Bejanin	2007	0		PCNA
946	chr13	47437050	47439037	3500428541	41		47437050	47439037	8421504	2	21,20	0,1967	c	350042854100000041,350042854100000040	0-21,0-20						Developmental Regulation and In Vitro Culture Effects on Expression of DNA Repair and Cell Cycle Checkpoint Control Genes in Rhesus Monkey Oocytes and Embryos1	ww.biolreprod.org	0	0		PCNA
946	chr13	47437115	47437298	3500328917	84		47437115	47437298	8421504	3	8,31,45	0,98,138	c	350032891700000011,350032891700000010	9-48,0-45						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
946	chr13	47437295	47441813	3500252708	453		47437295	47441813	8421504	11	42,9,39,93,45,45,17,28,45,45,45	0,1637,1649,1691,1787,2571,2619,2770,2801,4425,4473	p	350025270800015013,350025270800015012,350025270800015010,350025270800015009	0-318,0-45,0-45,0-45						 Inhibitors Of USP1 Deubiquitinating Enzyme Complex 	www.docstoc.com	0	0		PCNA
946	chr13	47437309	47438999	3500314048	45		47437309	47438999	8421504	2	24,21	0,1669	c	350031404800000032,350031404800000031	0-24,0-21						Molecular and Cellular Studies of Drosophila Neuroserpin Spn4A and its Polymer-Forming Mutants	crobiology.ubc.ca	0	0		PCNA
946	chr13	47439016	47441711	3500116800	49		47439016	47441711	8421504	3	26,3,20	0,1144,2675	c	350011680000000007,350011680000000006	0-26,0-23					The American Journal of Pathology	pp32 Reduction Induces Differentiation of TSU-Pr1 Cells	Jonathan	2004	0		PCNA
946	chr13	47439037	47439091	3500342679	45		47439037	47439091	8421504	3	18,6,21	0,23,33	g	350034267900000009,350034267900000008	0-54,0-52						Dysregulation of DNA polymerase &#x03ba; recruitment to replication forks results in genomic instability. - ResearchGate	.researchgate.net	0	0		
946	chr13	47439037	47439091	3500102817	45		47439037	47439091	8421504	3	18,6,21	0,23,33	g	350010281700000009,350010281700000008	0-54,0-54		22157819	10.1038/emboj.2011.457	ERROR! NO ISSN	The EMBO Journal	Dysregulation of DNA polymerase &#x03ba; recruitment to replication forks results in genomic instability	Jones	2011	0		
946	chr13	47439065	47441708	3500262011	40		47439065	47441708	8421504	3	20,3,17	0,1095,2626	c,g	350026201100000023,350026201100000023,350026201100000022	0-20,0-20,0-20		21551261	10.1158/1535-7163.MCT-10-1028		Molecular cancer therapeutics	Expression signatures of the lipid-based Akt inhibitors phosphatidylinositol ether lipid analogues (PIAs) in NSCLC cells	Chunyu	July	0		PCNA
946	chr13	47439112	47440072	3500390179	90		47439112	47440072	8421504	3	15,68,7	0,751,953	p	350039017900015009,350039017900015008	0-57,0-45						Compounds for the treatment of inflammation and neutropenia	WITKO-SARSAT	2011	0		PCNA
946	chr13	47439112	47440072	3500331037	90		47439112	47440072	8421504	3	15,68,7	0,751,953	p	350033103700015009,350033103700015008	0-57,0-45						Compounds for the treatment of inflammation and neutropenia	WITKO-SARSAT	2013	0		PCNA
946	chr13	47439112	47440072	3500121299	90		47439112	47440072	8421504	3	15,68,7	0,751,953	p	350012129900015015,350012129900015016,350012129900015009,350012129900015014,350012129900015013,350012129900015008	0-57,33-90,0-57,33-78,0-45,0-45						Compounds for the treatment of inflammation and neutropenia	Witko-Sarsat	2013	0		PCNA
946	chr13	47440082	47441706	3500379004	45		47440082	47441706	8421504	3	22,8,15	0,73,1609	c	350037900400000017,350037900400000016	0-22,0-23						Adaptation to High Grain Diets Proceeds Through Minimal Immune System Stimulation and Differences in Extracellular Matrix Protein Expression in A Model of Subacute Ruminal Acidosis in Non-lactating Dairy Cows	thescipub.com	0	0		
947	chr13	47555515	47563061	3500391741	173		47555515	47563061	8421504	6	23,46,27,30,25,22	0,810,863,7158,7201,7524	c,g	350039174100000017,350039174100000013,350039174100000010,350039174100000012,350039174100000011,350039174100000024,350039174100000026	0-23,0-29,0-30,0-27,0-30,0-25,0-22						Angiogenesis inhibitors	Masuda	2005	0		
947	chr13	47556007	47556030	3500023639	23		47556007	47556030	8421504	1	23	0	c	350002363900000012,350002363900000074	0-23,0-23						Compositions with Hematopoietic and Immune Activity - Patent application	www.faqs.org	0	0		PROKR1
947	chr13	47562802	47562827	3500397967	25		47562802	47562827	8421504	1	25	0	c	350039796700000030	0-25						G protein-coupled receptors	Hiebsch	2002	0		
947	chr13	47562802	47562827	3500289924	25		47562802	47562827	8421504	1	25	0	c	350028992400000007	0-25						Novel G protein-coupled receptors	Lind	2002	0		
118	chr13	47968522	47981441	3500006584	42		47968522	47981441	8421504	3	15,6,21	0,12844,12898	c	350000658400000004,350000658400000005	0-21,0-21						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
953	chr13	48256483	48256507	3500328959	24		48256483	48256507	8421504	1	24	0	c	350032895900000001	0-24		21746876	10.1128/MCB.05393-11	0270-7306	Molecular and Cellular Biology	Stomatin-Like Protein 2 Binds Cardiolipin and Regulates Mitochondrial Biogenesis and Function	Christie	2011	6		CRLS1
953	chr13	48306272	48306298	3500195024	26		48306272	48306298	8421504	1	26	0	c	350019502400000110	0-26						NOVEL TUMOR ANTIGEN PEPTIDES - Patent application	www.faqs.org	0	0		
956	chr13	48673929	48673956	3500425494	23		48673929	48673956	8421504	2	15,8	0,19	g	350042549400000010	0-23		18089750	10.1099/vir.0.83294-0	0022-1317	Journal of General Virology	Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats	Pletneva	2008	3		
960	chr13	49207586	49208912	3500295099	40		49207586	49208912	8421504	2	20,20	0,1306	c,g	350029509900000000,350029509900000001,350029509900000001	0-20,0-20,0-20						BMP-13 Emerges as a Potential Inhibitor of Bone Formation	www.ijbs.com	0	0		BMP2
960	chr13	49207638	49208869	3500034150	25		49207638	49208869	8421504	2	20,5	0,1226	c	350003415000000002	0-25		16020542	10.1074/jbc.M505465200	0021-9258	Journal of Biological Chemistry	Cross-talk between Bone Morphogenetic Protein and Transforming Growth Factor-&#x03b2; Signaling Is Essential for Exendin-4-induced Insulin-positive Differentiation of AR42J Cells	Yew	2005	5		BMP2
960	chr13	49208864	49217467	3500300553	67		49208864	49217467	8421504	3	5,18,44	0,6,8559	c	350030055300000008,350030055300000037	3-26,4-48						Osteogenic factor	Grinna	1993	0		
960	chr13	49208864	49217467	3500260926	67		49208864	49217467	8421504	3	5,18,44	0,6,8559	c	350026092600000008,350026092600000037	3-26,4-48						Osteogenic factor	Grinna	1993	0		
960	chr13	49208868	49208895	3500456827	27		49208868	49208895	8421504	1	27	0	c	350045682700000000	6-33						BMP GENE AND FUSION PROTEIN	Hidaka	2008	0		
960	chr13	49208868	49208895	3500259462	27		49208868	49208895	8421504	1	27	0	c	350025946200000000	6-33						Bmp gene and fusion protein	Hidaka	2006	0		BMP2
960	chr13	49208868	49208895	3500092268	27		49208868	49208895	8421504	1	27	0	c	350009226800000000,350009226800000008	6-33,6-33						BMP GENE AND FUSION PROTEIN - Patent application	www.faqs.org	0	0		
960	chr13	49208871	49208895	3500465781	24		49208871	49208895	8421504	1	24	0	c,g	350046578100000000,350046578100000000	0-24,0-24			10.1016/j.bone.2005.12.018		Bone	Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro	Wei	July	0		BMP2
960	chr13	49209012	49216833	3500385098	40		49209012	49216833	8421504	2	20,20	0,7801	c,g	350038509800000006,350038509800000006,350038509800000007	0-20,0-20,0-20						Author's personal copy	ss.bjmu.edu.cn	0	0		BMP2
960	chr13	49216866	49217467	3500394874	110		49216866	49217467	8421504	3	25,41,44	0,265,557	c	350039487400000012,350039487400000018,350039487400000024	23-48,0-41,4-48						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2002	0		
960	chr13	49216866	49217467	3500031651	133		49216866	49217467	8421504	4	25,41,23,44	0,265,526,557	c,g	350003165100000012,350003165100000012,350003165100000018,350003165100000023,350003165100000024	23-48,23-48,0-41,21-44,4-48						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2003	0		
960	chr13	49217182	49217772	3500018954	542		49217182	49217772	8421504	2	48,494	0,96	p,c,g	350001895400015013,350001895400000009,350001895400000011,350001895400000012,350001895400000013,350001895400000014,350001895400000015,350001895400000070,350001895400000016,350001895400000017,350001895400000018,350001895400000018	0-48,0-48,0-48,0-48,0-48,0-48,0-48,21-48,0-48,0-53,0-155,0-155						Novel Bmp Products 	.freshpatents.com	0	0		
960	chr13	49217185	49217772	3500149263	337		49217185	49217772	8421504	4	45,93,50,149	0,192,384,438	p,c,g	350014926300015008,350014926300000014,350014926300000015,350014926300000018,350014926300000019,350014926300000019	0-45,0-45,0-48,0-50,0-151,0-151						 Methods Of Treatment Of Periodontal Disease 	www.docstoc.com	0	0		
960	chr13	49217227	49217569	3500079459	342		49217227	49217569	8421504	1	342	0	p	350007945900015024,350007945900015027,350007945900015071,350007945900015075,350007945900015035,350007945900015032,350007945900015082,350007945900015086	0-168,0-168,0-45,0-45,0-174,0-174,0-45,0-45						Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		BMP2
960	chr13	49217257	49217550	3500392138	130		49217257	49217550	8421504	3	71,24,35	0,228,258	c	350039213800000208,350039213800000130,350039213800000209,350039213800000021,350039213800000267,350039213800000033	0-26,0-37,0-29,0-31,0-24,1-36						Designer ligands of tgf-beta superfamily	Choe	2010	0		
960	chr13	49217266	49217566	3500063913	276		49217266	49217566	8421504	2	165,111	0,189	p	350006391300015021,350006391300015022	0-165,0-111						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		BMP2
960	chr13	49217266	49217551	3500037926	225		49217266	49217551	8421504	5	45,45,45,45,45	0,48,96,192,240	p	350003792600015178,350003792600015179,350003792600015180,350003792600015182,350003792600015184	0-45,0-45,0-45,0-45,0-45						Polynucleotides Encoding Growth Differentiation Factor-8 - Patent application	www.faqs.org	0	0		BMP4,MIR5580
960	chr13	49217266	49217401	3500467295	135		49217266	49217401	8421504	1	135	0	p	350046729500015012	0-135						Anti-Dorsalizing Morphogenetic Protein is a novel TGF- homolog expressed in the Spemann organizer	ev.biologists.org	0	0		BMP2
960	chr13	49217272	49217530	3500189969	123		49217272	49217530	8421504	2	69,54	0,204	p	350018996900015004,350018996900015002,350018996900015008	0-69,0-69,0-54						Bone and cartilage inductive proteins	Hewick	1994	0		BMP4,MIR5580
960	chr13	49217281	49217485	3500388726	183		49217281	49217485	8421504	2	105,78	0,126	p	350038872600015001,350038872600015106,350038872600015002,350038872600015098,350038872600015149	0-105,0-45,0-78,0-45,0-45						METHODS FOR TREATING BONE TUMORS - Patent application	www.faqs.org	0	0		BMP2
960	chr13	49217281	49217485	3500327974	180		49217281	49217485	8421504	3	39,63,78	0,42,126	p	350032797400015001,350032797400015002	0-102,0-78						Methods for treating bone tumors using bone morphogenic proteins	Lee	2006	0		BMP2
960	chr13	49217281	49217485	3500136635	162		49217281	49217485	8421504	2	105,57	0,147	p	350013663500015001,350013663500015000,350013663500015002	0-105,0-60,15-72						Combination of morphogenic proteins having tissue inductive properties	Lee	2005	0		BMP2
960	chr13	49217281	49217461	3500175177	120		49217281	49217461	8421504	2	60,60	0,120	p	350017517700015015,350017517700015017	0-60,0-60						Homo sapiens bone morphogenetic protein 2 (BMP2), mRNA. , NM_001200.1 - GenScript	www.genscript.com	0	0		BMP4,MIR5580
960	chr13	49217287	49217533	3500205155	192		49217287	49217533	8421504	3	57,81,54	0,66,192	p	350020515500015011	51-300						Modified TGF-Beta Superfamily Polypeptides and Related Methods	Knopf	2009	0		BMP2
960	chr13	49217287	49217533	3500046369	192		49217287	49217533	8421504	3	57,81,54	0,66,192	p	350004636900015011	51-300						Modified TGF-Beta Superfamily Polypeptides and Related Methods	Knopf	2009	0		BMP2
960	chr13	49217392	49217563	3500432226	112		49217392	49217563	8421504	3	23,44,45	0,31,126	c	350043222600000039,350043222600000030,350043222600000040,350043222600000032	21-44,4-48,4-48,0-45						Optimized DNA sequences encoding recombinant human bone morphogenetic protein-2 (rhBMP-2), preparation method and the uses thereof - Patent # 7947821 - PatentGenius	.patentgenius.com	0	0		
960	chr13	49217392	49217467	3500186944	67		49217392	49217467	8421504	2	23,44	0,31	c	350018694400000028,350018694400000029	21-44,4-48						 Peptide And Protein Fusions To Thioredoxin And Thioredoxin 	www.docstoc.com	0	0		
960	chr13	49217392	49217415	3500245451	23		49217392	49217415	8421504	1	23	0	c	350024545100000028	21-44					Patent	Peptide and protein fusions to thioredoxin and thioredoxin-like molecules (Patent US:5292646)	LaVallie	1994	0		
960	chr13	49217423	49217467	3500178474	44		49217423	49217467	8421504	1	44	0	c	350017847400000029	4-48					Patent	Peptide and protein fusions to thioredoxin and thioredoxin-like molecules (Patent US:5270181)	LaVallie	1993	0		
960	chr13	49217428	49217488	3500402195	60		49217428	49217488	8421504	1	60	0	p	350040219500015090	0-60						Peptides and peptide compositions having osteoinductive activity - Patent application	www.faqs.org	0	0		MIR5580
960	chr13	49217527	49217568	3500454249	41		49217527	49217568	8421504	1	41	0	c	350045424900000137	0-41					Patent	Prosthetic devices having enhanced osteogenic properties (Patent US:5344654)	Kuberasampath	1994	0		
960	chr13	49217527	49217568	3500418018	41		49217527	49217568	8421504	1	41	0	c	350041801800000053	0-41						US Patent # 5,266,683. Osteogenic proteins - Patents.com	www.patents.com	0	0		
960	chr13	49217527	49217568	3500203533	41		49217527	49217568	8421504	1	41	0	c	350020353300000059	0-41						US Patent # 5,468,845. Antibodies to osteogenic proteins - Patents.com	www.patents.com	0	0		
966	chr13	49993155	49993181	3500227210	23		49993155	49993181	8421504	2	14,9	0,17	g	350022721000000007	7-31						Conservation, Surface Exposure, and In Vivo Expression of the Frp Family of Iron-Regulated Cell Wall Proteins in Staphylococcus aureus	iai.asm.org	0	0		
974	chr13	51057610	51057636	3500461622	23		51057610	51057636	8421504	2	18,5	0,21	g	350046162200000254	20-43						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
976	chr13	51277415	51277442	3500392619	27		51277415	51277442	8421504	1	27	0	c	350039261900000000	18-45						Iminopyridine derivatives and use thereof	Sakauchi	2011	0		
976	chr13	51277415	51277442	3500384370	27		51277415	51277442	8421504	1	27	0	c	350038437000000000	18-45						Iminopyridine derivative and use thereof	Zuo Teng Bu 	2011	0		
976	chr13	51277415	51277442	3500270998	27		51277415	51277442	8421504	1	27	0	c	350027099800000000	18-45						Iminopyridine derivative and use thereof	Kohara	2011	0		
976	chr13	51277415	51277442	3500222012	27		51277415	51277442	8421504	1	27	0	c	350022201200000000	18-45						Iminopyridine Derivatives and Use Thereof	Yoshida	2009	0		
976	chr13	51277415	51277442	3500213469	27		51277415	51277442	8421504	1	27	0	c	350021346900000002,350021346900000000	18-45,18-45						Iminopyridine Derivatives and Use Thereof - Patent application	www.faqs.org	0	0		
976	chr13	51277415	51277442	3500192935	27		51277415	51277442	8421504	1	27	0	c	350019293500000000	18-45						Iminopyridine Derivative and Use Thereof	Yoshida	2007	0		
976	chr13	51277415	51277442	3500172382	27		51277415	51277442	8421504	1	27	0	c	350017238200000001	18-45						Iminopyridine derivative and use thereof	Yoshida	2009	0		
976	chr13	51277415	51277442	3500157166	27		51277415	51277442	8421504	1	27	0	c	350015716600000000	18-45						Iminopyridine Derivative and Use Thereof	Yoshida	2010	0		
976	chr13	51277415	51277442	3500128928	27		51277415	51277442	8421504	1	27	0	c	350012892800000000	18-45						Iminopyridine derivatives and use thereof	Sakauchi	2011	0		
976	chr13	51277415	51277442	3500072693	27		51277415	51277442	8421504	1	27	0	c	350007269300000000,350007269300000002	18-45,18-45						IMINOPYRIDINE DERIVATIVE AND USE THEREOF - Patent application	www.faqs.org	0	0		
976	chr13	51277415	51277442	3500067609	27		51277415	51277442	8421504	1	27	0	c	350006760900000002,350006760900000000	18-45,18-45						IMINOPYRIDINE DERIVATIVES AND USE THEREOF - Patent application	www.faqs.org	0	0		
976	chr13	51277415	51277442	3500067543	27		51277415	51277442	8421504	1	27	0	c	350006754300000002,350006754300000000	18-45,18-45						IMINOPYRIDINE DERIVATIVES AND USE THEREOF - Patent application	www.faqs.org	0	0		
976	chr13	51277415	51277442	3500051768	27		51277415	51277442	8421504	1	27	0	c	350005176800000000,350005176800000002	18-45,18-45						IMINOPYRIDINE DERIVATIVES AND USE THEREOF - Patent application	www.faqs.org	0	0		
976	chr13	51277799	51277847	3500206531	48		51277799	51277847	8421504	1	48	0	p	350020653100015027	168-216						Insect Biochemistry and Molecular Biology	bio.kuleuven.be	0	0		ADRA1D
976	chr13	51320356	51320380	3500421233	24		51320356	51320380	8421504	1	24	0	c,g	350042123300000001,350042123300000001	0-24,0-24		17145855	10.1158/0008-5472.CAN-06-3174	0008-5472	Cancer Research	Tumor Necrosis Factor-&#x03b1; Increases Reactive Oxygen Species by Inducing Spermine Oxidase in Human Lung Epithelial Cells: A Potential Mechanism for Inflammation-Induced Carcinogenesis	Babbar	2006	8		
976	chr13	51378110	51378136	3500430879	23		51378110	51378136	8421504	2	11,12	0,14	g	350043087900000140	18-44						Unnatural Reactive Amino Acid Genetic Code Additions - Patent application	www.faqs.org	0	0		
976	chr13	51378110	51378136	3500310209	23		51378110	51378136	8421504	2	11,12	0,14	g	350031020900000113	18-44						Site Specific Incorporation of Non-Natural Amino Acids by Vertebrate Cells - Patent application	www.faqs.org	0	0		
976	chr13	51378110	51378136	3500258820	23		51378110	51378136	8421504	2	11,12	0,14	g	350025882000000140	18-44					Patent	Expanding the eukaryotic genetic code (Patent US:8357532)	Chin	2013	0		
976	chr13	51378110	51378136	3500227701	23		51378110	51378136	8421504	2	11,12	0,14	g	350022770100000141	18-44					Patent	Expanding the eukaryotic genetic code (Patent US:8173393)	Chin	2012	0		
976	chr13	51378110	51378136	3500215630	23		51378110	51378136	8421504	2	11,12	0,14	g	350021563000000140	18-44						Expanding the Eukaryotic Genetic Code	Chin	2012	0		
976	chr13	51378110	51378136	3500155303	23		51378110	51378136	8421504	2	11,12	0,14	g	350015530300000140	18-44						Expanding the eukaryotic genetic code	Chin	2010	0		
976	chr13	51378110	51378136	3500096176	23		51378110	51378136	8421504	2	11,12	0,14	g	350009617600000113	18-44						Site Specific Incorporation of Non-Natural Amino Acids by Vertebrate Cells	Tian	2010	0		
976	chr13	51378110	51378136	3500093532	23		51378110	51378136	8421504	2	11,12	0,14	g	350009353200000141	18-44						Expanding the Eukaryotic Genetic Code	Chin	2012	0		
976	chr13	51378110	51378136	3500013141	23		51378110	51378136	8421504	2	11,12	0,14	g	350001314100000113	18-44						Site Specific Incorporation of Non-Natural Amino Acids by Vertebrate Cells	Tian	2010	0		
977	chr13	51508659	51508685	3500036836	25		51508659	51508685	8421504	2	21,4	0,22	g	350003683600000035	9-34						ANTIBODY SELECTIVE FOR DR4 AND USES THEREOF - Patent application	www.faqs.org	0	0		
978	chr13	51543700	51543725	3500072967	24		51543700	51543725	8421504	2	12,12	0,13	g	350007296700000000	0-24						Monitoring the Activation State of Insulin/Insulin-Like Growth Factor-1 Hybrid Receptors Using Bioluminescence Resonance Energy Transfer 2006&#x5e74;&#x7b2c;68&#x5377;&#x7b2c;11&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
978	chr13	51543700	51543725	3500053175	24		51543700	51543725	8421504	2	12,12	0,13	g	350005317500000000	0-24			10.1124/mol.106.026989	1521-0111 (Online)	Molecular Pharmacology	Monitoring the Activation State of Insulin/Insulin-Like Growth Factor-1 Hybrid Receptors Using Bioluminescence Resonance Energy Transfer	Blanquart	2006	0		
978	chr13	51581898	51581926	3500462415	23		51581898	51581926	8421504	2	14,9	0,19	g	350046241500000177	5-28						Antibodies to CD40	Bedian	2009	0		
979	chr13	51665886	51665909	3500323428	23		51665886	51665909	8421504	1	23	0	g	350032342800000055	0-23						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		
979	chr13	51665886	51665909	3500191020	23		51665886	51665909	8421504	1	23	0	g	350019102000000020	0-23		23056445	10.1371/journal.pone.0046773	1932-6203	PLOS ONE	PLOS ONE: Neurofibromin 1 Is a miRNA Target in Neurons	Paschou	2012	4		MIR103B2,MIR103A2
980	chr13	51783313	51783337	3500246273	24		51783313	51783337	8421504	1	24	0	c	350024627300000076	24-48						Methods and compositions for treatment of diabetes and related disorders	Newgard	2007	0		CDC25B
980	chr13	51869926	51869949	3500306908	23		51869926	51869949	8421504	1	23	0	g	350030690800000025	0-23				0021-8812		Amount and source of dietary copper affects small intestine morphology, duodenal lipid peroxidation, hepatic oxidative stress,and mRNA expression of hepatic copper regulatory proteins in weanling pigs 	animalscience.org	0	2		
981	chr13	51960628	51960651	3500157867	23		51960628	51960651	8421504	1	23	0	g	350015786700000066	0-38					Patent	Therapeutic uses of inhibitors of RTP801 (Patent US:8309532)	Feinstein	2012	0		
984	chr13	52421219	52421408	3500023901	135		52421219	52421408	8421504	3	45,45,45	0,96,144	p	350002390100015079,350002390100015081,350002390100015082	0-45,0-45,0-45						US Patent # 7,141,417. Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene - Patents.com	www.patents.com	0	0		UBOX5
984	chr13	52421457	52421817	3500301529	23		52421457	52421817	8421504	3	8,2,13	0,342,347	c	350030152900000010	1-24		22448038	10.1242/jcs.097295	0021-9533	Journal of Cell Science	Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2&#x2013;Cul3&#x2013;Rbx1 complex to allow normal Nrf2 activation and repression	Kaspar	2012	6		
985	chr13	52500207	52500883	3500457334	53		52500207	52500883	8421504	3	12,15,26	0,102,650	c	350045733400000013,350045733400000016	1-28,0-26						Oxytocin As Cardiomyogenesis Inducer And Uses Thereof 	.freshpatents.com	0	0		
985	chr13	52528559	52539529	3500205994	192		52528559	52539529	8421504	3	75,7,110	0,10360,10860	p	350020599400015000,350020599400015011	0-75,0-117						Characterizing the cancer genome in lung adenocarcinoma	roadinstitute.org	0	0		PTPRA
985	chr13	52535553	52536067	3500068745	23		52535553	52536067	8421504	3	17,4,2	0,22,512	c	350006874500000011	0-23		18184649	10.1074/jbc.M709502200	0021-9258	Journal of Biological Chemistry	A Smad-binding Element in Intron 1 Participates in Activin-dependent Regulation of the Follistatin Gene	Blount	2008	5		
123	chr13	52538053	52568790	3500168617	900		52538053	52568790	8421504	9	66,136,167,120,98,37,77,91,108	0,737,1366,2358,3756,7900,16592,17841,30629	p	350016861700015012	0-900						Techniques & Applications of Sequence Comparison	w.comp.nus.edu.sg	0	0		PTPRA
123	chr13	52538053	52568790	3500104408	900		52538053	52568790	8421504	9	66,136,167,120,98,37,77,91,108	0,737,1366,2358,3756,7900,16592,17841,30629	p	350010440800015001	0-900						An Introduction to Knowledge Discovery Applications in Biomedical Sciences	w.comp.nus.edu.sg	0	0		PTPRA
986	chr13	52568706	52568751	3500331682	45		52568706	52568751	8421504	1	45	0	p	350033168200015008	0-45							lmol.fcien.edu.uy	0	0		PTPRA
990	chr13	53104215	53104243	3500444826	25		53104215	53104243	8421504	2	11,14	0,14	g	350044482600000011,350044482600000010	0-25,14-39			10.1042/BJ20060861		Biochemical Journal	Ubc9 interacts with Lu/BCAM adhesion glycoproteins and regulates their stability at the membrane of polarized MDCK cells	EmmanuCollec	2007	0		
990	chr13	53134709	53134734	3500016075	25		53134709	53134734	8421504	1	25	0	g	350001607500000105	24-49						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
990	chr13	53203314	53207955	3500196470	47		53203314	53207955	8421504	3	26,5,16	0,3267,4625	c	350019647000000311,350019647000000305	8-34,14-35						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
990	chr13	53205446	53205473	3500462213	24		53205446	53205473	8421504	2	11,13	0,14	g	350046221300000025	0-24						Antibodies directed to the testis-specific tubulin tyrosine-ligase-like protein, BGS42	osdir.com/patents	0	0		
990	chr13	53205446	53205473	3500452900	24		53205446	53205473	8421504	2	11,13	0,14	g	350045290000000033,350045290000000147	0-24,0-24						Vascular endothelial growth factor 2 - Patent application	www.faqs.org	0	0		
990	chr13	53205446	53205473	3500414903	24		53205446	53205473	8421504	2	11,13	0,14	g	350041490300000140,350041490300000021	0-24,0-24						Novel Human Leucine-rich Repeat Domain Containing Protein Hllrcr-1 	.freshpatents.com	0	0		
990	chr13	53205446	53205473	3500394525	24		53205446	53205473	8421504	2	11,13	0,14	g	350039452500000006	0-24						Antibodies that immunospecifically bind to trail receptors	Salcedo	2002	0		
990	chr13	53205446	53205473	3500378069	24		53205446	53205473	8421504	2	11,13	0,14	g	350037806900000034	0-24						Production of chimeric antibodies - a combinatorial approach	Baier	1994	0		
990	chr13	53205446	53205473	3500337518	24		53205446	53205473	8421504	2	11,13	0,14	g	350033751800000048,350033751800000050	11-35,11-32						Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens	Jylhae	2008	0		
990	chr13	53205446	53205473	3500205951	24		53205446	53205473	8421504	2	11,13	0,14	g	350020595100000106,350020595100000024	0-24,0-24						 Polynucleotide Encoding A Novel Human P2X7 Splice Variant, HBMYP2X7v 	www.docstoc.com	0	0		
990	chr13	53205446	53205473	3500065254	24		53205446	53205473	8421504	2	11,13	0,14	g	350006525400000007	0-24						Antibodies that immunospecifically bind to trail receptors	Albert	2003	0		
990	chr13	53205446	53205473	3500057438	24		53205446	53205473	8421504	2	11,13	0,14	g	350005743800000024	0-24						Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v	Franco	2004	0		
990	chr13	53205446	53205473	3500015533	24		53205446	53205473	8421504	2	11,13	0,14	g	350001553300000136,350001553300000029	0-24,0-24						 Method Of Diagnosing Lung Cancer Using BGS42 	www.docstoc.com	0	0		
990	chr13	53205448	53205474	3500368588	23		53205448	53205474	8421504	2	9,14	0,12	g	350036858800000111,350036858800000113	1-24,2-24						Methods for producing members of specific binding pairs	Mccafferty	1998	0		
990	chr13	53205448	53205474	3500252049	23		53205448	53205474	8421504	2	9,14	0,12	g	350025204900000270,350025204900000116,350025204900000272,350025204900000118	1-24,1-24,2-24,2-24						METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS - Patent application	www.faqs.org	0	0		
990	chr13	53205448	53205474	3500200157	23		53205448	53205474	8421504	2	9,14	0,12	g	350020015700000110,350020015700000112	1-24,2-24					Patent	Methods for producing members of specific binding pairs (Patent US:7723270)	McCafferty	2010	0		
990	chr13	53205449	53205483	3500219097	29		53205449	53205483	8421504	3	8,14,7	0,11,27	g	350021909700000076	12-41						Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques - Patent application	www.faqs.org	0	0		
993	chr13	53531187	53533136	3500446982	42		53531187	53533136	8421504	2	20,22	0,1927	c,g	350044698200000002,350044698200000002,350044698200000003,350044698200000003	0-20,0-20,0-22,0-22		20181609	10.1523/JNEUROSCI.5848-09.2010	0270-6474	The Journal of Neuroscience	Neurokinin B and Dynorphin A in Kisspeptin Neurons of the Arcuate Nucleus Participate in Generation of Periodic Oscillation of Neural Activity Driving Pulsatile Gonadotropin-Releasing Hormone Secretion in the Goat	Wakabayashi	2010	7		
993	chr13	53585213	53585236	3500172625	23		53585213	53585236	8421504	1	23	0	c	350017262500000036	0-23						INAUGURAL - DISSERTATION	uni-heidelberg.de	0	0		
997	chr13	54079642	54079666	3500391778	23		54079642	54079666	8421504	2	9,14	0,10	c	350039177800000126	25-48						Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof	Halbur	1996	0		
997	chr13	54079642	54079666	3500132067	23		54079642	54079666	8421504	2	9,14	0,10	c	350013206700000126	25-48						Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids	Paul	1994	0		
998	chr13	54194512	54194540	3500370584	23		54194512	54194540	8421504	2	6,17	0,11	c	350037058400000079	2-26						Protease inhibition - Patent application	www.faqs.org	0	0		
998	chr13	54219619	54219655	3500267209	36		54219619	54219655	8421504	1	36	0	c	350026720900000090	2-38					Patent	Method of preparation of pharmaceutically grade plasmid DNA (Patent CN:1882682)	Ni Gu La Si *Mei Si Te La Li 	2010	0		
999	chr13	54326897	54326927	3500370939	30		54326897	54326927	8421504	1	30	0	c	350037093900000012,350037093900000006	7-34,8-35						A new role of transcription factor SOX17 as potential interaction partner of KLF4 and EGR-1 in human coronary artery smooth muscle cells and in differentiating mouse ES-cells	b.uni-muenchen.de	0	0		
999	chr13	54327499	54327524	3500413087	25		54327499	54327524	8421504	1	25	0	c	350041308700000009	0-25		18413743	10.1158/0008-5472.CAN-07-6349	0008-5472	Cancer Research	Epigenetic Inactivation of the Canonical Wnt Antagonist SRY-Box Containing Gene 17 in Colorectal Cancer	Zhang	2008	8		
999	chr13	54327590	54327615	3500376390	23		54327590	54327615	8421504	2	5,18	0,7	c,g	350037639000000024,350037639000000024	17-40,17-40						Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof - Patent application	www.faqs.org	0	0		
999	chr13	54327590	54327615	3500104816	23		54327590	54327615	8421504	2	5,18	0,7	c	350010481600000024	17-40						VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) PROTEIN AND GENE, MUTANTS THEREOF, AND USES THEREOF - Patent application	www.faqs.org	0	0		
999	chr13	54327590	54327615	3500038401	23		54327590	54327615	8421504	2	5,18	0,7	c	350003840100000059	17-40						US Patent # 6,645,933. Receptor ligand VEGF-C - Patents.com	www.patents.com	0	0		
999	chr13	54367854	54368304	3500380174	28		54367854	54368304	8421504	4	13,5,9,1	0,17,24,449	c	350038017400000113	18-46						Goodpasture Antigen Binding Protein 	.freshpatents.com	0	0		
1000	chr13	54414383	54416754	3500465914	159		54414383	54416754	8421504	5	23,81,14,19,22	0,600,1326,1401,2349	p,c	350046591400000001,350046591400015005,350046591400000004,350046591400000003,350046591400000000	8-31,0-81,0-21,1-20,8-30						TH&#xc8;SE	tacell-cellbio.eu	0	0		
1000	chr13	54414383	54416754	3500209313	159		54414383	54416754	8421504	5	23,81,14,19,22	0,600,1326,1401,2349	p,c	350020931300000001,350020931300015005,350020931300000004,350020931300000003,350020931300000000	8-31,0-81,0-21,1-20,8-30						TH&#xc8;SE	mm.u-bordeaux1.fr	0	0		
1000	chr13	54414388	54414439	3500342863	51		54414388	54414439	8421504	1	51	0	p	350034286300015131	0-51							library.wiley.com	0	0		DNAJC5
1000	chr13	54455956	54455986	3500189141	26		54455956	54455986	8421504	3	15,7,4	0,18,26	c	350018914100000011	1-33						Acetyl-L-Carnitine Modulates TP53 and IL10 Gene Expression Induced by 3-NPA Evoked Toxicity in PC12 Cells. - ResearchGate	.researchgate.net	0	0		
1000	chr13	54465339	54465365	3500328627	23		54465339	54465365	8421504	2	17,6	0,20	g	350032862700000001	2-29		11060345		0022-2275	Journal of Lipid Research	Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr	Liu	2000	6		
1001	chr13	54558147	54558270	3500130574	36		54558147	54558270	8421504	2	35,1	0,122	c	350013057400000030	9-45						Tumor necrosis factor receptors 6&#x03b1; and 6&#x03b2; - US Patent 7709218 Description	ww.patentstorm.us	0	0		
1001	chr13	54587751	54590125	3500146314	414		54587751	54590125	8421504	4	1,176,192,45	0,260,1564,2329	p	350014631400015008,350014631400015010,350014631400015012	0-177,0-180,0-57						Use of tlr3 agonists for the treatment of neurodegenerative disorders	Van	2007	0		STMN3
1001	chr13	54587751	54590125	3500108880	414		54587751	54590125	8421504	4	1,176,192,45	0,260,1564,2329	p	350010888000015008,350010888000015010,350010888000015012	0-177,0-180,0-57						Use of tlr3 agonists for the treatment of neurodegenerative disorders	Van	2008	0		STMN3
1002	chr13	54662611	54662701	3500363581	90		54662611	54662701	8421504	1	90	0	p	350036358100015030	180-270						Lehninger - Biochemistry	www.scribd.com	0	0		EEF1A1
1002	chr13	54662611	54662701	3500256791	90		54662611	54662701	8421504	1	90	0	p	350025679100015014	180-270						acids Peptids Proteins Nelson Lehninger Principles of Biochemistry (4ed 2004)	www.scribd.com	0	0		EEF1A1
1002	chr13	54664407	54664430	3500038509	23		54664407	54664430	8421504	1	23	0	c	350003850900000002	0-23						ScienceDirect.com - Veterinary Parasitology - Tritrichomonas foetus isolates from cats and cattle show minor genetic differences in unrelated loci ITS-2 and EF-1&#x03b1;	sciencedirect.com	0	0		EEF1A2
1002	chr13	54665084	54665113	3500316692	29		54665084	54665113	8421504	1	29	0	c,g	350031669200000001,350031669200000001	0-29,0-29		20505761	10.1371/journal.pone.0010755		PLoS ONE	Eef1a2 Promotes Cell Growth, Inhibits Apoptosis and Activates JAK/STAT and AKT Signaling in Mouse Plasmacytomas	Zhaoyang	2010	0		EEF1A2
1002	chr13	54665084	54665113	3500092188	29		54665084	54665113	8421504	1	29	0	c	350009218800000001	0-29		20505761	10.1371/journal.pone.0010755	1932-6203	PLOS ONE	PLOS ONE: Eef1a2 Promotes Cell Growth, Inhibits Apoptosis and Activates JAK/STAT and AKT Signaling in Mouse Plasmacytomas	Li	2010	4		
1002	chr13	54667627	54667654	3500287307	27		54667627	54667654	8421504	1	27	0	c	350028730700000049	21-48					Patent	Human prostate tumor inducing gene-1 and uses thereof (Patent US:5851764)	Fisher	1998	0		
1002	chr13	54667693	54667724	3500423257	24		54667693	54667724	8421504	3	6,6,12	0,8,19	c	350042325700000742	19-43						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
1002	chr13	54667783	54668472	3500338732	32		54667783	54668472	8421504	2	1,31	0,658	c	350033873200000022	27-59						Diagnosis and treatment of infectious diseases through indel-differentiated proteins	Reiner	2002	0		
1002	chr13	54761821	54761844	3500266153	23		54761821	54761844	8421504	1	23	0	c	350026615300000010	0-23						&#xb0ea;&#xa5df;&#xa4a4;&#xa473;&#xa46a;&#xbec7; &#xa5cd;&#xaaab;&#xc2e5;&#xbec7;&#xace3;&#xa873;&#xa9d2; &#xbad3;&#xa468;&#xbdd7;&#xa4e5;	.lib.nsysu.edu.tw	0	0		CHRNA4
1003	chr13	54792249	54792275	3500032868	25		54792249	54792275	8421504	2	10,15	0,11	g	350003286800000121	1-26						ASSAYS AND METHODS USING BIOMARKERS - Patent application	www.faqs.org	0	0		
1003	chr13	54864110	54864197	3500006114	87		54864110	54864197	8421504	1	87	0	c	350000611400000051	0-87						A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT - INTERNA TECHNOLOGIES BV	www.sumobrain.com	0	0		
1003	chr13	54864112	54864197	3500268759	38		54864112	54864197	8421504	2	19,19	0,66	c,g	350026875900000001,350026875900000001,350026875900000000,350026875900000000	0-19,0-19,0-19,0-19						MicroRNA-124a and microRNA-34b/c are frequently methylated in all histological types of colorectal cancer and polyps, and in the adjacent normal mucosa	-publications.com	0	0		YTHDF1
1003	chr13	54864112	54864197	3500080648	38		54864112	54864197	8421504	2	19,19	0,66	c,g	350008064800000001,350008064800000000,350008064800000000	0-19,0-19,0-19			10.3892/ol.2010.222		Oncology Letters	MicroRNA-124a and microRNA-34b/c are frequently methylated in all histological types of colorectal cancer and polyps, and in the adjacent normal mucosa	GUOREN	2011	0		YTHDF1
1003	chr13	54864120	54864188	3500106998	39		54864120	54864188	8421504	2	20,19	0,49	c	350010699800000011,350010699800000010	0-20,0-19		18362916	10.1038/nature06863	0028-0836	Nature	REST maintains self-renewal and pluripotency of embryonic stem cells	Singh	2008	36		YTHDF1
1003	chr13	54864124	54864183	3500323428	42		54864124	54864183	8421504	2	21,21	0,38	g	350032342800000062,350032342800000063	0-21,0-21						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		YTHDF1
1004	chr13	54970898	54970925	3500367761	23		54970898	54970925	8421504	2	17,6	0,21	c	350036776100000117	9-32						NOVEL FUSION PROTEINS AND USE THEREOF FOR PREPARING HEPATITIS C VACCINES - Patent application	www.faqs.org	0	0		
1005	chr13	55147025	55147057	3500438192	25		55147025	55147057	8421504	3	6,7,12	0,9,20	g	350043819200000106	1-31						Porphorymonas gingivalis polypeptides and nucleotides	Ross	2006	0		
125	chr13	55150741	55198593	3500061628	144		55150741	55198593	8421504	3	40,8,96	0,1055,47756	c	350006162800000234,350006162800000224,350006162800000223	0-48,0-48,0-48						Method For Diagnosing Non-small Cell Lung Cancer 	.freshpatents.com	0	0		
1005	chr13	55150771	55151813	3500201864	24		55150771	55151813	8421504	3	10,8,6	0,1025,1036	c	350020186400000257	24-48						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1005	chr13	55150771	55151813	3500005314	24		55150771	55151813	8421504	3	10,8,6	0,1025,1036	c	350000531400000261	24-48						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
1005	chr13	55162193	55162217	3500432405	23		55162193	55162217	8421504	2	4,19	0,5	g	350043240500000020	1-24						MicroRNA-30c-2* limits expression of proadaptive factor XBP1 in the unfolded protein response	jcb.rupress.org	0	0		
1006	chr13	55215752	55222904	3500139688	151		55215752	55222904	8421504	5	48,48,19,7,29	0,1069,2214,3543,7123	c	350013968800000209,350013968800000205,350013968800000195,350013968800000188	0-48,0-48,0-26,0-29						TRANSPORTER GENES OATP-B, C, D, AND E - Patent application	www.faqs.org	0	0		
1006	chr13	55215762	55215786	3500149763	24		55215762	55215786	8421504	1	24	0	c	350014976300000048	22-46						Dehydroepiandrosterone and Dehydroepiandrosterone Sulphotransferase Activity and Expression in Human Disease	theses.bham.ac.uk	0	0		SLCO4A1
1006	chr13	55276119	55276142	3500389139	23		55276119	55276142	8421504	1	23	0	c	350038913900000260	21-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		MIB1
1006	chr13	55276119	55276142	3500306561	23		55276119	55276142	8421504	1	23	0	c,g	350030656100000259,350030656100000259	21-44,0-23						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		MIB1
1006	chr13	55276119	55276142	3500257436	23		55276119	55276142	8421504	1	23	0	c	350025743600000259	21-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
1006	chr13	55276119	55276142	3500232262	23		55276119	55276142	8421504	1	23	0	c	350023226200000259	21-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		MIB1
1006	chr13	55276120	55286390	3500352593	45		55276120	55286390	8421504	2	23,22	0,10248	c,g	350035259300000006,350035259300000006,350035259300000005,350035259300000005	0-23,0-23,1-23,1-23						A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. - ResearchGate	.researchgate.net	0	0		MIB1
1006	chr13	55276120	55286389	3500304886	43		55276120	55286389	8421504	2	22,21	0,10248	c,g	350030488600000093,350030488600000093,350030488600000079,350030488600000079	0-22,0-22,0-21,0-21						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		
1006	chr13	55276120	55286389	3500241683	41		55276120	55286389	8421504	2	22,19	0,10250	c	350024168300000026,350024168300000000	0-22,0-19						al Regulation of microRNA Expression in Drosophila melanogaster mediated by Hormonal Signals and Broad-Complex gene activity - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		MIB1
1006	chr13	55276120	55286389	3500131966	43		55276120	55286389	8421504	2	22,21	0,10248	c	350013196600000021,350013196600000014	0-22,0-21						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
1006	chr13	55276120	55286389	3500125321	43		55276120	55286389	8421504	2	22,21	0,10248	c	350012532100000210,350012532100000174,350012532100000014,350012532100000198,350012532100000166,350012532100000072,350012532100000122	0-22,0-22,0-22,0-22,0-21,0-21,0-19						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
1006	chr13	55276121	55276144	3500145368	23		55276121	55276144	8421504	1	23	0	c,g	350014536800000006,350014536800000006,350014536800000004,350014536800000004,350014536800000005,350014536800000005	0-22,0-22,0-22,0-22,0-21,0-21		22292984	10.1186/1471-2407-12-51		BMC Cancer	Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion	Zheng-sheng	2012	0		SLCO4A1
1006	chr13	55276121	55276144	3500120500	23		55276121	55276144	8421504	1	23	0	c	350012050000000006,350012050000000004,350012050000000005	0-22,0-22,0-21		22292984	10.1186/1471-2407-12-51	1471-2407	BMC Cancer	Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion	Wu	2012	3		MIB1
1007	chr13	55348045	55348358	3500007191	23		55348045	55348358	8421504	2	16,7	0,306	c	350000719100000148	8-40						Non-anaphylactogenic IgE fusion proteins	Morsey	2005	0		
1007	chr13	55423130	55423163	3500395043	25		55423130	55423163	8421504	3	12,6,7	0,16,26	g	350039504300000012	0-30						Neurotrophic factors	Johansen	2002	0		
1007	chr13	55423130	55423163	3500253811	25		55423130	55423163	8421504	3	12,6,7	0,16,26	g	350025381100000012	0-30						Novel neurotrophic factors	Johansen	2012	0		
1007	chr13	55423130	55423163	3500054979	25		55423130	55423163	8421504	3	12,6,7	0,16,26	g	350005497900000012	0-30					Patent	Neublastin neurotrophic factors (Patent US:6734284)	Johansen	2004	0		
1008	chr13	55550233	55550562	3500382965	40		55550233	55550562	8421504	2	20,20	0,309	g	350038296500000012,350038296500000008	0-20,0-20						Novel guanosine triphosphate (gtp)-binding protein-coupled receptor protein	HIDAKA	2001	0		
1008	chr13	55550233	55550562	3500272891	40		55550233	55550562	8421504	2	20,20	0,309	g	350027289100000012,350027289100000008	0-20,0-20						Novel guanosine triphosphate (gtp)-binding protein conjugate type receptor proteins	ITADANI	2000	0		
1009	chr13	55606562	55606594	3500339984	26		55606562	55606594	8421504	3	5,6,15	0,7,17	g	350033998400000005	5-32						POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF	Pier	2010	0		
1012	chr13	56072710	56072738	3500138386	24		56072710	56072738	8421504	2	14,10	0,18	g	350013838600000177	0-24						Method for detection and treatment of breast cancer	Holt	1998	0		
1014	chr13	56254823	56254848	3500255122	24		56254823	56254848	8421504	2	18,6	0,19	g	350025512200000059	0-24						ENHANCED PRODUCTION OF ISOPRENE USING HOST CELLS HAVING DECREASED ISPA ACTIVITY	Mcauliffe	2012	0		
1014	chr13	56254823	56254848	3500244857	24		56254823	56254848	8421504	2	18,6	0,19	g	350024485700000053	0-24						ENHANCED PRODUCTION OF ISOPRENE USING HOST CELLS HAVING DECREASED ISPA ACTIVITY - DANISCO US INC.	www.sumobrain.com	0	0		
1021	chr13	57148340	57148365	3500443003	24		57148340	57148365	8421504	2	17,7	0,18	g	350044300300000022	22-46						Pasteurella vaccine - Patent # 5369019 - PatentGenius	.patentgenius.com	0	0		
1025	chr13	57789922	57789946	3500171513	23		57789922	57789946	8421504	2	6,17	0,7	g	350017151300000078	13-36						Compositions and Methods of Use of Mitogen-Activated Protein Kinase Kinase Kinase - Patent application	www.faqs.org	0	0		
1026	chr13	57900573	57902397	3500375699	123		57900573	57902397	8421504	2	22,101	0,1723	c	350037569900000018	13-137						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1026	chr13	57906885	57906911	3500086165	24		57906885	57906911	8421504	2	8,16	0,10	g	350008616500000005	2-26						Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis	u.diva-portal.org	0	0		
1026	chr13	57908914	57908937	3500339523	23		57908914	57908937	8421504	1	23	0	g	350033952300000029	0-23						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPEITIC GROWTH FACTORS	Schaebitz	2007	0		TUBB2A
1026	chr13	57909041	57909065	3500419090	24		57909041	57909065	8421504	1	24	0	c	350041909000000029	0-24						International Journal for Parasitology	005.pasteur.ac.ir	0	0		
1026	chr13	57913151	57913202	3500137241	51		57913151	57913202	8421504	1	51	0	p	350013724100015053	0-51						Improved cancer therapeutics	Lewensohn	2009	0		TUBB1
1026	chr13	57924060	57924543	3500106871	23		57924060	57924543	8421504	3	16,1,6	0,473,477	c	350010687100000054,350010687100000053	4-27,0-23						Molecules having immunomodulatory activity	Chua	2004	0		
1026	chr13	57924060	57924543	3500067846	23		57924060	57924543	8421504	3	16,1,6	0,473,477	c	350006784600000054,350006784600000055,350006784600000117,350006784600000116	0-23,4-27,4-27,0-23						Molecule 	.freshpatents.com	0	0		
1026	chr13	57930801	57931466	3500435393	43		57930801	57931466	8421504	2	22,21	0,644	c,g	350043539300000048,350043539300000048,350043539300000049,350043539300000049	0-22,0-22,0-21,0-21						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
1027	chr13	58008109	58009214	3500125525	63		58008109	58009214	8421504	3	22,20,21	0,25,1084	c,g	350012552500000013,350012552500000015,350012552500000015,350012552500000012,350012552500000012	0-22,0-20,0-20,0-21,0-21		8764650		0270-6474	The Journal of Neuroscience	Selective G-Protein Regulation of Neuronal Calcium Channels	Toth	1996	7		
1027	chr13	58008210	58008971	3500383952	47		58008210	58008971	8421504	2	25,22	0,739	c,g	350038395200000016,350038395200000016,350038395200000007,350038395200000022	8-28,8-28,9-30,0-22						Yeast cells expressing modified g proteins and methods of use therefor	Benegal	2000	0		GNAS
1027	chr13	58008210	58008971	3500166324	47		58008210	58008971	8421504	2	25,22	0,739	c	350016632400000016,350016632400000007,350016632400000022	8-28,9-30,0-22						Yeast cells expressing modified g proteins and methods of use therefor	Benegal	1999	0		
1027	chr13	58008210	58008971	3500121688	47		58008210	58008971	8421504	2	25,22	0,739	c	350012168800000016,350012168800000007,350012168800000022	8-28,9-30,0-22						Yeast cells expressing modified G proteins and methods of use therefor	Fowlkes	1997	0		
1027	chr13	58008210	58008971	3500049768	47		58008210	58008971	8421504	2	25,22	0,739	c	350004976800000077,350004976800000016,350004976800000007,350004976800000068,350004976800000083,350004976800000022	8-28,8-28,9-30,9-30,0-22,0-22						YEAST CELLS EXPRESSING MODIFIED G PROTEINS AND METHODS OF USE THEREFOR - Patent application	www.faqs.org	0	0		GNAS
1027	chr13	58008222	58008285	3500070749	63		58008222	58008285	8421504	1	63	0	p	350007074900015003	0-63						Chimeric G proteins and uses thereof	Jones	1999	0		GNAS
1027	chr13	58008223	58009435	3500056533	44		58008223	58009435	8421504	2	23,21	0,1191	c,g	350005653300000035,350005653300000033,350005653300000027,350005653300000028	13-36,13-33,16-36,0-21						Supporting Information	www.pnas.org	0	0		
1027	chr13	58008237	58008976	3500405757	240		58008237	58008976	8421504	3	90,47,103	0,374,636	p	350040575700015047,350040575700015043	0-90,0-150						protein a subunit specifically expressed hematopoietic cells	brary.caltech.edu	0	0		GNAS
1027	chr13	58008309	58008956	3500326263	40		58008309	58008956	8421504	2	20,20	0,627	c,g	350032626300000001,350032626300000001,350032626300000000	0-20,0-20,0-20						SuppressionofG s SynthesisbySimvastatinTreatmentof VascularEndothelialCells	www.jbc.org	0	0		
1027	chr13	58008617	58009396	3500290055	119		58008617	58009396	8421504	5	25,15,19,53,7	0,26,256,611,772	c	350029005500000016,350029005500000012	0-59,0-60						Inhibitory of cDNA acid	www.pnas.org	0	0		
1027	chr13	58008932	58009392	3500339288	43		58008932	58009392	8421504	3	20,20,3	0,329,457	c	350033928800000022,350033928800000404	20-40,0-23						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		GNAS
1027	chr13	58008982	58009447	3500019822	44		58008982	58009447	8421504	2	22,22	0,443	c	350001982200000003,350001982200000002	0-22,0-22						A Novel Mutation Adjacent to the Switch III Domain of Gs in a Patient with Pseudohypoparathyroidism	.endojournals.org	0	0		GNAS
1027	chr13	58009568	58009596	3500358170	28		58009568	58009596	8421504	1	28	0	c	350035817000000003	10-40		17169148	10.1186/gb-2006-7-12-r119	1465-6906	Genome Biology	Inferring steady state single-cell gene expression distributions from analysis of mesoscopic samples	Mar	2006	0		
1027	chr13	58009577	58009601	3500399156	24		58009577	58009601	8421504	1	24	0	c	350039915600000008	24-48						Senescence is accelerated through donor cell specificity in cloned pigs	-publications.com	0	0		GNAS
1028	chr13	58106878	58107598	3500195045	672		58106878	58107598	8421504	3	576,48,48	0,603,672	p,c	350019504500015062,350019504500000015,350019504500015061,350019504500015060,350019504500015059,350019504500015058,350019504500015057,350019504500015056,350019504500015055,350019504500015054,350019504500015053,350019504500015052,350019504500000005,350019504500015051,350019504500000003,350019504500015048	0-48,6-39,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48						Human NESP55 polypeptides, polynucleotides and uses thereof	Fraser	1999	0		
1031	chr13	58525940	58525972	3500123749	26		58525940	58525972	8421504	3	7,6,13	0,12,19	g	350012374900000013,350012374900000014	7-33,2-28		14966295	10.1128/MCB.24.5.2181-2189.2004	0270-7306	Molecular and Cellular Biology	Control of Cyclin G2 mRNA Expression by Forkhead Transcription Factors: Novel Mechanism for Cell Cycle Control by Phosphoinositide 3-Kinase and Forkhead	Martinez-Gac	2004	6		
1031	chr13	58535793	58535818	3500440809	23		58535793	58535818	8421504	2	15,8	0,17	g	350044080900000039	0-23						Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof	D'andrea	2001	0		
1032	chr13	58599079	58599197	3500236407	25		58599079	58599197	8421504	3	19,2,4	0,111,114	c	350023640700000126	16-41						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2001	0		
1036	chr13	59126186	59130092	3500040711	157		59126186	59130092	8421504	3	66,43,48	0,3766,3858	p,c	350004071100015014,350004071100000009,350004071100015006	0-66,1-44,0-48						US Patent # 7,071,303. Androgen regulated prostate specific nucleic acids - Patents.com	www.patents.com	0	0		
1036	chr13	59129952	59130143	3500301895	95		59129952	59130143	8421504	2	47,48	0,143	c	350030189500000080,350030189500000083	1-48,0-48						Androgen-regulated gene expressed in prostate tissue - Patent # 6566130 - PatentGenius	.patentgenius.com	0	0		
1036	chr13	59130358	59130383	3500040440	24		59130358	59130383	8421504	2	5,19	0,6	c	350004044000000040	0-24						COMPOSITIONS AND METHODS FOR MODULATING CELL-CELL FUSION VIA INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS - Patent application	www.faqs.org	0	0		
1036	chr13	59200771	59201891	3500412853	48		59200771	59201891	8421504	2	24,24	0,1096	c,g	350041285300000003,350041285300000003,350041285300000002,350041285300000002	0-24,0-24,0-24,0-24						Effects of non-esteri&#xfb01;ed fatty acids on the gluconeogenesis in bovine hepatocytes	www.dairy973.com	0	0		
1036	chr13	59200771	59201891	3500191310	48		59200771	59201891	8421504	2	24,24	0,1096	c	350019131000000003,350019131000000002	0-24,0-24						Effects of non-esterified fatty acids on the gluconeogenesis in bovine hepatocytes. - ResearchGate	.researchgate.net	0	0		
1036	chr13	59202541	59202614	3500463464	73		59202541	59202614	8421504	1	73	0	c,g	350046346400000025,350046346400000051,350046346400000051	20-42,17-89,17-89						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
1036	chr13	59202543	59202647	3500174793	38		59202543	59202647	8421504	2	19,19	0,85	c,g	350017479300000001,350017479300000001,350017479300000000,350017479300000000	0-19,0-19,0-19,0-19						Effects of protein-free energy supplementation on blood	www.docstoc.com	0	0		
1036	chr13	59202543	59202647	3500158195	38		59202543	59202647	8421504	2	19,19	0,85	c,g	350015819500000001,350015819500000001,350015819500000000,350015819500000000	0-19,0-19,0-19,0-19						Effects of protein-free energy supplementation on blood metabolites, insulin and hepatic PEPCK gene expression in growing lambs offered rice straw-based diet	ulturejournals.cz	0	0		
1036	chr13	59202572	59203451	3500199211	150		59202572	59203451	8421504	2	146,4	0,875	p	350019921100015147	0-150						Etude des voies metaboliques des sucres chez l'huitre creuse crassostrea gigas. Implication dans les mortalites estivales.	chimer.ifremer.fr	0	0		
1036	chr13	59202592	59202657	3500078731	39		59202592	59202657	8421504	2	19,20	0,45	c,g	350007873100000008,350007873100000007,350007873100000007	0-19,0-20,0-20						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		
1037	chr13	59250840	59250868	3500096485	23		59250840	59250868	8421504	3	13,5,5	0,15,23	g	350009648500000341	25-48						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
1037	chr13	59251179	59251204	3500177913	23		59251179	59251204	8421504	3	7,12,4	0,8,21	c	350017791300000001	9-32						Universal detection of binding	Cull	2004	0		
1037	chr13	59254967	59255012	3500281640	45		59254967	59255012	8421504	1	45	0	p	350028164000015015	0-45						 Cancer Vaccine Based On Brother Of Regulator Of Imprinted Sites Molecule (BORIS) 	www.docstoc.com	0	0		CTCF
1037	chr13	59350293	59350495	3500424225	42		59350293	59350495	8421504	2	21,21	0,181	c,g	350042422500000015,350042422500000015,350042422500000014,350042422500000014	0-21,0-21,0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
1038	chr13	59413890	59413913	3500153276	23		59413890	59413913	8421504	1	23	0	c	350015327600000539	6-29						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
1038	chr13	59482359	59482391	3500438077	32		59482359	59482391	8421504	1	32	0	c	350043807700000000	0-32						Genetic engineering of cells to enhance healing and tissue regeneration	Breitbart	2000	0		BMP7
1038	chr13	59482359	59482391	3500428831	32		59482359	59482391	8421504	1	32	0	c	350042883100000000	0-32						 Genetic Engineering Of Cells To Enhance Healing And Tissue Regeneration 	www.docstoc.com	0	0		BMP7
129	chr13	59482377	59566908	3500008511	1293		59482377	59566908	8421504	7	418,193,149,198,77,111,147	0,32941,57042,75275,80631,82555,84384	p	350000851100015008	0-1293						KEGG T01001: 151449	www.genome.jp	0	0		BMP7
129	chr13	59482377	59566908	3500002402	1293		59482377	59566908	8421504	7	418,193,149,198,77,111,147	0,32941,57042,75275,80631,82555,84384	p	350000240200015008	0-1293						Bone Morphogenetic Proteins for Appetite Control	Tseng	2010	0		BMP7
129	chr13	59482401	59566776	3500197968	405		59482401	59566776	8421504	8	32,47,48,121,13,48,81,15	0,81,177,273,32917,57088,82561,84360	c	350019796800000013,350019796800000015,350019796800000017,350019796800000019,350019796800000020,350019796800000021,350019796800000027,350019796800000035,350019796800000036	15-47,0-47,0-48,0-48,0-48,0-38,0-48,0-48,0-48						Mutations of the C-terminal portion of TGF-&#x03b2; superfamily proteins	Oppermann	1999	0		
129	chr13	59482401	59539464	3500418018	195		59482401	59539464	8421504	5	32,48,48,35,32	0,33,345,32964,57031	c,g	350041801800000001,350041801800000002,350041801800000125,350041801800000127,350041801800000130	15-47,0-48,0-48,0-35,15-47						US Patent # 5,266,683. Osteogenic proteins - Patents.com	www.patents.com	0	0		
1038	chr13	59482401	59482787	3500422167	104		59482401	59482787	8421504	3	32,48,24	0,36,362	c	350042216700000001,350042216700000235,350042216700000295	15-47,0-48,23-47					Patent	Osteogenic proteins (Patent US:5266683)	Kuberasampath	1993	0		
129	chr13	59482437	59566800	3500203533	258		59482437	59566800	8421504	8	48,35,47,48,6,14,21,39	0,32928,56995,75334,80642,82495,82585,84324	c	350020353300000243,350020353300000133,350020353300000136,350020353300000107,350020353300000260,350020353300000174,350020353300000176,350020353300000147	0-48,0-35,15-47,0-41,0-48,0-20,0-48,0-48						US Patent # 5,468,845. Antibodies to osteogenic proteins - Patents.com	www.patents.com	0	0		
1038	chr13	59482437	59482529	3500008143	92		59482437	59482529	8421504	1	92	0	c	350000814300000032,350000814300000003	0-48,0-47						 Prosthetic Devices Having Enhanced Osteogenic Properties 	www.docstoc.com	0	0		
129	chr13	59482482	59566776	3500445829	181		59482482	59566776	8421504	6	47,25,13,48,33,15	0,288,32836,57007,82528,84279	c	350044582900000015,350044582900000021,350044582900000027,350044582900000036	0-47,0-38,0-48,0-48						US Patent # 6,677,432. Mutations of the C-terminal portion of TGF-.beta. superfamily proteins - Patents.com	www.patents.com	0	0		
1038	chr13	59482491	59482515	3500406604	24		59482491	59482515	8421504	1	24	0	c	350040660400000005	17-41					Patent	Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma (Patent US:7405192)	Clark	2008	0		BMP7
1038	chr13	59482491	59482515	3500168789	24		59482491	59482515	8421504	1	24	0	c,g	350016878900000005,350016878900000005	17-41,17-41						Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2002	0		BMP7
1038	chr13	59482491	59482515	3500121900	24		59482491	59482515	8421504	1	24	0	c,g	350012190000000005,350012190000000005	17-41,17-41						Bone morphogenic proteins (bmp),bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2005	0		BMP7
129	chr13	59482662	59566788	3500362999	201		59482662	59566788	8421504	7	48,23,38,30,14,21,27	0,32715,75043,80393,82270,82360,84099	c	350036299900000045,350036299900000049,350036299900000056,350036299900000013,350036299900000060,350036299900000037	0-48,0-23,0-38,0-31,0-44,0-48					Patent	Methods for producing BMP-7 proteins (Patent US:5366875)	Rosen	1994	0		
1038	chr13	59482680	59482706	3500374131	26		59482680	59482706	8421504	1	26	0	c	350037413100000078	0-26						&#x201c;ESTUDIO DE LOS MECANISMOS IMPLICADOS EN LA REGULACI&#xd3;N TRANSCRIPCIONAL DE LOS GENES CCNG2 Y C-MYC&#x201d;	greendata.es:1801	0	0		BMP7
129	chr13	59482695	59557828	3500391943	152		59482695	59557828	8421504	3	90,35,27	0,56791,75106	c,g	350039194300000118,350039194300000119,350039194300000126,350039194300000130,350039194300000130	0-45,0-45,0-35,0-27,0-27						Osteoinductive compositions	Celeste	1991	0		
1038	chr13	59482731	59482779	3500320185	48		59482731	59482779	8421504	1	48	0	c	350032018500000082	0-48						Recombinant bone morphogenetic protein heterodimers	Israel	1992	0		
1038	chr13	59482731	59482779	3500092036	48		59482731	59482779	8421504	1	48	0	c	350009203600000081	0-48					Patent	Recombinant bone morphogenetic protein heterodimers (Patent US:5866364)	Israel	1999	0		
1038	chr13	59482740	59482785	3500447411	45		59482740	59482785	8421504	1	45	0	c	350044741100000119	0-45						Osteoinductive compositions	Celeste	1990	0		
1038	chr13	59482740	59482785	3500090126	45		59482740	59482785	8421504	1	45	0	c	350009012600000119	0-45						Osteoinductive compositions	Celeste	1990	0		
1039	chr13	59557693	59566800	3500422167	174		59557693	59566800	8421504	4	48,66,21,39	0,78,7329,9068	c	350042216700000134,350042216700000252,350042216700000136,350042216700000169,350042216700000141	0-48,0-48,0-48,0-48,0-48					Patent	Osteogenic proteins (Patent US:5266683)	Kuberasampath	1993	0		
1039	chr13	59557702	59563040	3500459658	90		59557702	59563040	8421504	3	6,52,32	0,96,5306	c	350045965800000013	0-90						UNIVERSITA' DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1039	chr13	59557717	59557740	3500334789	23		59557717	59557740	8421504	1	23	0	c	350033478900000160	18-41						Recombinant bone morphogenetic protein heterodimers, compositions and methods of use	Israel	1994	0		
1039	chr13	59557759	59557804	3500038090	45		59557759	59557804	8421504	1	45	0	p	350003809000015118	0-45						Articular Cartilage Gene Therapy with Recombinant Vector Encoding BMP-7 - Patent application	www.faqs.org	0	0		
1039	chr13	59557768	59566779	3500260926	108		59557768	59566779	8421504	3	60,30,18	0,7245,8993	p,c	350026092600015024,350026092600000029	0-60,0-48						Osteogenic factor	Grinna	1993	0		
1039	chr13	59557768	59557828	3500300553	60		59557768	59557828	8421504	1	60	0	p	350030055300015024	0-60						Osteogenic factor	Grinna	1993	0		
1039	chr13	59557771	59557819	3500008143	48		59557771	59557819	8421504	1	48	0	c	350000814300000049	0-48						 Prosthetic Devices Having Enhanced Osteogenic Properties 	www.docstoc.com	0	0		
1039	chr13	59557795	59566805	3500348738	182		59557795	59566805	8421504	5	48,27,12,51,44	0,5263,7137,7197,8966	c	350034873800000007,350034873800000009,350034873800000011,350034873800000012	0-48,9-48,0-48,0-47						Methods for Recombinant Peptide Production - Patent application	www.faqs.org	0	0		
1039	chr13	59563028	59565021	3500053265	40		59563028	59565021	8421504	2	20,20	0,1973	c,g	350005326500000004,350005326500000005,350005326500000005	0-20,0-20,0-20						Levels of mRNA for BMP-7 in goat ovarian follicles and in vitro effects of BMP-7 on secondary follicle development	www.cbra.org.br	0	0		
1039	chr13	59563037	59566908	3500362819	303		59563037	59566908	8421504	4	48,96,12,147	0,1895,1994,3724	p	350036281900015021,350036281900015039	0-144,0-159						Characterization of a gonad-specific transforming growth factor-&#x03b2; superfamily member differentially expressed during the reproductive cycle of the oyster Crassostrea gigas	chimer.ifremer.fr	0	0		BMP7
1039	chr13	59563037	59566887	3500037926	225		59563037	59566887	8421504	5	45,45,45,45,45	0,1895,1943,3757,3805	p	350003792600015201,350003792600015203,350003792600015204,350003792600015206,350003792600015207	0-45,0-45,0-45,0-45,0-45						Polynucleotides Encoding Growth Differentiation Factor-8 - Patent application	www.faqs.org	0	0		BMP5
1039	chr13	59563037	59566884	3500467295	243		59563037	59566884	8421504	3	48,87,108	0,1895,3739	p	350046729500015017,350046729500015031	0-135,0-108						Anti-Dorsalizing Morphogenetic Protein is a novel TGF- homolog expressed in the Spemann organizer	ev.biologists.org	0	0		BMP7
1039	chr13	59563037	59566854	3500063913	249		59563037	59566854	8421504	4	48,111,6,84	0,1895,3724,3733	p	350006391300015037,350006391300015038	0-165,0-84						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		BMP7
1039	chr13	59563043	59566869	3500189969	123		59563043	59566869	8421504	3	42,27,54	0,1889,3772	p	350018996900015007,350018996900015005,350018996900015013	0-66,0-69,0-54						Bone and cartilage inductive proteins	Hewick	1994	0		BMP5
1039	chr13	59563076	59564949	3500406751	23		59563076	59564949	8421504	3	5,1,17	0,8,1856	c	350040675100000034	3-26						Growth differentiation factor-11	www.devileye.net	0	0		
1039	chr13	59563076	59564949	3500346883	23		59563076	59564949	8421504	3	5,1,17	0,8,1856	c	350034688300000024	12-35						Growth differentiation factor-11 transgenic mice	www.devileye.net	0	0		
1039	chr13	59563076	59564949	3500051486	23		59563076	59564949	8421504	3	5,1,17	0,8,1856	c	350005148600000039	24-47					Patent	DNA molecules encoding bone morpogenetic protein-11 (Patent US:5639638)	Celeste	1997	0		
1039	chr13	59566803	59566896	3500303480	93		59566803	59566896	8421504	1	93	0	p	350030348000015044,350030348000015046,350030348000015053,350030348000015037,350030348000015055,350030348000015054,350030348000015048,350030348000015049	0-93,0-72,0-72,0-93,0-93,0-72,3-72,3-54					Patent	Mutations of the C-terminal portion of TGF-&#x03b2; superfamily proteins (Patent US:6677432)	Oppermann	2004	0		
1039	chr13	59566827	59566896	3500103882	69		59566827	59566896	8421504	1	69	0	p	350010388200015007,350010388200015012	6-75,21-75						Chimaeric proteins between members of tgf-beta superfamily	Mccartney	2001	0		
1039	chr13	59566833	59566871	3500320185	38		59566833	59566871	8421504	1	38	0	c	350032018500000100	0-38						Recombinant bone morphogenetic protein heterodimers	Israel	1992	0		
1039	chr13	59599004	59599029	3500063996	24		59599004	59599029	8421504	2	17,7	0,18	g	350006399600000223	0-24						Immunostimulatory rna/dna hybrid molecules	Flora	2001	0		
1042	chr13	59958279	59958316	3500325127	30		59958279	59958316	8421504	3	10,5,15	0,15,22	c	350032512700000079	17-48						Method For Detecting Gene Specifying Allergic Predisposition 	.freshpatents.com	0	0		
130	chr13	60156229	60164048	3500241481	96		60156229	60164048	8421504	2	48,48	0,7771	p	350024148100015023,350024148100015049	0-48,0-48						Diagnosis and treatment of aur-1 and/or aur-2 related disorders	Mossie	1998	0		
1043	chr13	60156232	60156277	3500126416	45		60156232	60156277	8421504	1	45	0	p	350012641600015015	0-45						METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES - Patent application	www.faqs.org	0	0		AURKA
1044	chr13	60163968	60163992	3500257428	24		60163968	60163992	8421504	1	24	0	c	350025742800000001	0-24						Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders	Plowman	2006	0		AURKB
1044	chr13	60249575	60249631	3500002616	56		60249575	60249631	8421504	1	56	0	g	350000261600000092	0-56						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	dare.ubn.kun.nl	0	0		
1045	chr13	60384320	60408464	3500441632	324		60384320	60408464	8421504	4	52,48,113,111	0,137,19855,24033	p,c	350044163200015009,350044163200015010,350044163200000210,350044163200000212,350044163200000209,350044163200015020,350044163200015033,350044163200000106,350044163200015079,350044163200000192,350044163200015096,350044163200015058,350044163200000162,350044163200000044,350044163200000083,350044163200000084,350044163200015023	45-366,45-366,20-42,10-31,21-42,0-60,0-60,0-60,0-48,13-81,0-48,0-48,0-30,0-30,0-56,0-60,0-60						 Intramuscular Delivery Of Recombinant AAV 	www.docstoc.com	0	0		
1045	chr13	60384335	60408496	3500350566	46		60384335	60408496	8421504	2	23,23	0,24138	c	350035056600000010,350035056600000004,350035056600000005	6-29,0-23,0-23						Tesis Doctoral IDENTIFICACI&#xd3;N DE PROTE&#xcd;NAS QUE INTERACCIONAN CON CypA, CypB Y FKBP12 Y SU IMPLICACI&#xd3;N EN LA TOXICIDAD RENAL PRODUCIDA POR LOS INMUNOSUPRESORES CsA Y FK506	tdx.cat/bitstream	0	0		FKBP1A
1045	chr13	60384335	60408496	3500189713	45		60384335	60408496	8421504	2	23,22	0,24139	c	350018971300000010,350018971300000004,350018971300000005	6-29,0-23,0-22						GSR_TESIS-coinmunoprecipitacion	es.scribd.com	0	0		FKBP1A
1045	chr13	60384335	60408479	3500462350	324		60384335	60408479	8421504	4	37,48,113,126	0,122,19840,24018	p	350046235000015008,350046235000015009	0-177,0-147						HOMOGENEOUS DOUBLE RECEPTOR AGGLUTINATION ASSAY FOR IMMUNOSUPPRESSANT DRUGS	Sigler	2007	0		
1045	chr13	60384338	60408479	3500283782	321		60384338	60408479	8421504	4	34,48,113,126	0,119,19837,24015	p	350028378200015014	54-375						Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues	Geierstanger	2010	0		FKBP1A
1045	chr13	60384362	60404192	3500216375	75		60384362	60404192	8421504	3	10,48,17	0,95,19813	p	350021637500015011	0-75						ARGENT&#x2122; Regulated Heterodimerization Kit	www.fivazlab.org	0	0		
1045	chr13	60384474	60408449	3500128027	159		60384474	60408449	8421504	6	31,42,26,4,2,54	0,19701,19746,19810,23879,23921	c	350012802700000092,350012802700000087,350012802700000220,350012802700000051,350012802700000190,350012802700000095	0-60,13-80,13-81,0-30,0-30,0-60						Intramuscular delivery of recombinant AAV	Clackson	2000	0		
1045	chr13	60384492	60408383	3500230151	153		60384492	60408383	8421504	4	13,62,48,30	0,19683,19748,23861	c	350023015100000043,350023015100000044	0-75,0-78						Protein- protein interaction detection system using fluorescent protein microdomains	Waldo	2005	0		FKBP1A
1045	chr13	60384504	60404270	3500333908	86		60384504	60404270	8421504	3	1,37,48	0,19671,19718	c	350033390800000029,350033390800000030	0-38,0-48						Immunosuppressant Target Proteins - Patent application	www.faqs.org	0	0		
1045	chr13	60404180	60404276	3500091613	96		60404180	60404276	8421504	1	96	0	c	350009161300000018,350009161300000012,350009161300000019	0-48,0-48,0-48						FUSION PROTEIN COMPRISING FK506 BINDING PROTEIN AND METHOD OF MAKING AND USING THE SAME - Patent application	www.faqs.org	0	0		
1045	chr13	60404183	60404213	3500016250	30		60404183	60404213	8421504	1	30	0	c	350001625000000017	0-30						Regulation of biological events using novel compounds	Clackson	1998	0		
1045	chr13	60404198	60404276	3500411740	78		60404198	60404276	8421504	1	78	0	p	350041174000015046	0-78						Dissertation	thek.uni-halle.de	0	0		
1045	chr13	60404222	60404273	3500424804	51		60404222	60404273	8421504	1	51	0	p	350042480400015010	0-51						Expression characterization human FKBP52, 90-kDa protein	www.pnas.org	0	0		
1047	chr13	60572378	60572402	3500346924	23		60572378	60572402	8421504	2	4,19	0,5	g	350034692400000007	2-30						BUTANOL PRODUCTION BY METABOLICALLY ENGINEERED YEAST	Gunawardena	2007	0		
1047	chr13	60621772	60622485	3500408981	47		60621772	60622485	8421504	3	21,20,6	0,683,707	c	350040898100000050,350040898100000049	13-34,10-36						4 Materials and Methods	diss.fu-berlin.de	0	0		PSMF1
1047	chr13	60621773	60623728	3500193534	237		60621773	60623728	8421504	3	49,159,29	0,577,1926	p	350019353400015006	0-237						Modular transport platform for targeted delivery of therapeutic agents	Sobolev	2012	0		PSMF1
1048	chr13	60791528	60791557	3500029000	23		60791528	60791557	8421504	3	4,8,11	0,5,18	g	350002900000000005	16-39		24037187	10.1590/0074-0276108062013001	0074-0276	Mem&#xf3;rias do Instituto Oswaldo Cruz	Mem&#xf3;rias do Instituto Oswaldo Cruz - Kazal-type serine proteinase inhibitors in the midgut of Phlebotomus papatasi	Sigle	2013	2		
1049	chr13	60878920	60880499	3500281920	40		60878920	60880499	8421504	2	20,20	0,1559	c,g	350028192000000006,350028192000000006,350028192000000007,350028192000000007	0-20,0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
1050	chr13	60953520	60953550	3500066107	30		60953520	60953550	8421504	1	30	0	c	350006610700000004	0-30						COMPOSITIONS AND METHODS UTILIZING HUMAN GAMMA-HYDROXYBUTYRATE RECEPTOR - SLOWAVE, INC.	www.sumobrain.com	0	0		
1050	chr13	61063426	61063452	3500056924	24		61063426	61063452	8421504	2	13,11	0,15	c	350005692400000321	9-33						Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer - US Patent 7615379 Description	ww.patentstorm.us	0	0		
1051	chr13	61104740	61104914	3500409304	174		61104740	61104914	8421504	1	174	0	p	350040930400015014	0-174						Thylacine 1is expressed segmentally within the paraxial mesoderm of the Xenopusembryo and interacts with the Notch pathway	ev.biologists.org	0	0		TCF15
1051	chr13	61104770	61104890	3500340600	120		61104770	61104890	8421504	1	120	0	p	350034060000015003,350034060000015004	0-60,0-60						during mouse embr leraxis: a basic helix-loop-helix pr yog enesis	ev.biologists.org	0	0		SCXB
1051	chr13	61110578	61110602	3500038413	23		61110578	61110602	8421504	2	11,12	0,12	g	350003841300000003	0-23			10.1186/1471-2407-6-161		BMC Cancer	Endothelial progenitor cells display clonal restriction in multiple myeloma	Marc	2006	0		
1051	chr13	61186661	61202036	3500401374	40		61186661	61202036	8421504	2	20,20	0,15355	c,g	350040137400000003,350040137400000003,350040137400000001,350040137400000001,350040137400000000	0-20,0-20,0-20,0-20,0-20		14569058	10.1124/jpet.103.058768	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Cilostazol Enhances Casein Kinase 2 Phosphorylation and Suppresses Tumor Necrosis Factor-&#x03b1;-Induced Increased Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation and Apoptotic Cell Death in SK-N-SH Cells	Kim	2004	0		GALNT18
1051	chr13	61186670	61210151	3500077904	111		61186670	61210151	8421504	7	21,20,23,3,22,10,12	0,7055,8317,9803,19208,21445,23469	c,g	350007790400000010,350007790400000010,350007790400000008,350007790400000008,350007790400000012,350007790400000012,350007790400000013,350007790400000004,350007790400000005	17-38,17-38,15-36,15-36,0-20,0-20,0-26,0-22,0-22		20625391	10.1371/journal.pone.0011418		PLoS ONE	Functional Polymorphism of the CK2&#x03b1; Intronless Gene Plays Oncogenic Roles in Lung Cancer	Ming-Szu	2010	0		CSNK2A1
1051	chr13	61194950	61210157	3500053194	57		61194950	61210157	8421504	4	19,19,1,18	0,10978,13174,15189	c,g	350005319400000000,350005319400000001,350005319400000001,350005319400000002	0-19,0-19,0-19,0-19		21068236	10.1128/JVI.01734-10	0022-538X	Journal of Virology	Phosphorylation of RIG-I by Casein Kinase II Inhibits Its Antiviral Response	Sun	2011	5		CSNK2A1
1051	chr13	61201214	61210252	3500392945	107		61201214	61210252	8421504	2	20,87	0,8951	p,c	350039294500000025,350039294500015038	0-20,0-87						Tesi tutta word	arch.cab.unipd.it	0	0		CSNK2A1
1051	chr13	61205916	61205939	3500306279	23		61205916	61205939	8421504	1	23	0	c,g	350030627900000005,350030627900000005	0-23,0-23		16581776	10.1128/MCB.26.8.3008-3017.2006	0270-7306	Molecular and Cellular Biology	NKX3.1 Is Regulated by Protein Kinase CK2 in Prostate Tumor Cells	Li	2006	6		GALNT18
1052	chr13	61251764	61252987	3500466964	63		61251764	61252987	8421504	2	39,24	0,1199	p	350046696400015012	0-63						Structure of the human Parkin ligase domain in an autoinhibited state	mrc-lmb.cam.ac.uk	0	0		RBCK1
1052	chr13	61254321	61254399	3500306083	78		61254321	61254399	8421504	1	78	0	p	350030608300015029	57-135						Nature June 2 ,2011	www.calameo.com	0	0		RBCK1
1053	chr13	61385997	61386026	3500323036	24		61385997	61386026	8421504	2	14,10	0,19	g	350032303600000200	7-31						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF A GENE FROM THE JC VIRUS - Patent application	www.faqs.org	0	0		
1056	chr13	61846524	61846855	3500062286	39		61846524	61846855	8421504	2	20,19	0,312	c,g	350006228600000010,350006228600000010,350006228600000011,350006228600000011	0-20,0-20,0-19,0-19						Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells	logy-journals.org	0	0		
1057	chr13	61886333	61886361	3500052099	26		61886333	61886361	8421504	3	4,16,6	0,5,22	c	350005209900000055	0-26						Card Domain Containing Polypeptides, Encoding Nucleic Acids, And Methods Of Use 	.freshpatents.com	0	0		
1057	chr13	61887280	61887401	3500168090	48		61887280	61887401	8421504	2	24,24	0,97	c	350016809000000003,350016809000000002	0-24,0-24		19509265	10.1158/1535-7163.MCT-09-0068		Molecular cancer therapeutics	IKK&#x03b2;-mediated NF-&#x03ba;B Activation Attenuates Smac Mimetic-induced Apoptosis in Cancer Cells	Lang	June	0		COX4I2
1057	chr13	61887368	61936550	3500153410	139		61887368	61936550	8421504	3	43,48,48	0,48798,49134	c	350015341000000025,350015341000000020,350015341000000016	6-49,0-48,0-48						US Patent # 5,646,008. Vertebrate apoptosis gene: compositions and methods - Patents.com	www.patents.com	0	0		
1057	chr13	61887370	61936084	3500377452	42		61887370	61936084	8421504	2	21,21	0,48693	c,g	350037745200000003,350037745200000002,350037745200000002	3-24,0-21,0-21		21602054	10.1016/j.cyto.2011.04.014		Cytokine	T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules	Navtej	2011	0		
1057	chr13	61887372	61887396	3500217315	24		61887372	61887396	8421504	1	24	0	c	350021731500000006	24-48						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		COX4I2
1057	chr13	61887375	61936115	3500250943	42		61887375	61936115	8421504	2	22,20	0,48720	c,g	350025094300000003,350025094300000010,350025094300000011	11-33,17-37,0-20		20671748	10.1038/cdd.2010.89		Cell Death and Differentiation	Bcl-2 family interaction with the mitochondrial morphogenesis machinery	M	2011	0		
1057	chr13	61887375	61887400	3500409609	25		61887375	61887400	8421504	1	25	0	c	350040960900000004	0-25						IMPROVED METHODS AND CONSTRUCTS FOR MARKER FREE AGROBACTERIUM MEDIATED TRANSFORMATIOM - QUEENSLAND UNIVERSITY OF TECHNOLOGY	www.sumobrain.com	0	0		COX4I2
1057	chr13	61887375	61887399	3500065929	24		61887375	61887399	8421504	1	24	0	c	350006592900000002	0-24						 <HTML> <HEAD> <TITLE> Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) Inhi	.aacrjournals.org	0	0		COX4I2
1057	chr13	61887375	61887398	3500279111	23		61887375	61887398	8421504	1	23	0	c	350027911100000002	10-33						Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected &#xfb01;broblasts against virus-induced apoptosis and are required for ef&#xfb01;cient virus replication	r.sgmjournals.org	0	0		COX4I2
1057	chr13	61887378	61936586	3500307492	699		61887378	61936586	8421504	2	135,564	0,48644	p,c	350030749200015047,350030749200000023	0-699,22-46					Patent	Cancer stem cell antigen vaccines and methods (Patent US:8129184)	Yu	2012	0		
1057	chr13	61887378	61936586	3500264792	699		61887378	61936586	8421504	2	135,564	0,48644	p	350026479200015006	0-699						CANCER THERAPY - Patent application	www.faqs.org	0	0		
1057	chr13	61887378	61936586	3500108695	699		61887378	61936586	8421504	2	135,564	0,48644	p,c	350010869500015049,350010869500000023	0-699,22-46						CANCER STEM CELL ANTIGEN VACCINES AND METHODS - Patent application	www.faqs.org	0	0		
1057	chr13	61887378	61936586	3500023932	699		61887378	61936586	8421504	2	135,564	0,48644	p,c	350002393200015054,350002393200000023	0-699,22-46						CANCER STEM CELL ANTIGEN VACCINES AND METHODS	Yu	2007	0		
1057	chr13	61887378	61887401	3500278323	23		61887378	61887401	8421504	1	23	0	c	350027832300000011	12-35					Proceedings of the National Academy of Sciences of the United States of America	Synthetic activation of caspases: Artificial death switches	Rebecca	1998	0		COX4I2
1057	chr13	61887388	61936500	3500211732	46		61887388	61936500	8421504	2	22,24	0,49088	c	350021173200000020,350021173200000019	2-24,0-24						&#x4e3b;&#x9898;&#xff1a;Nuclear | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1057	chr13	61887388	61936500	3500187429	46		61887388	61936500	8421504	2	22,24	0,49088	c	350018742900000020,350018742900000019	2-24,0-24						&#x4e3b;&#x9898;&#xff1a;nuclear | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1057	chr13	61887404	61936312	3500366298	42		61887404	61936312	8421504	2	21,21	0,48887	c,g	350036629800000001,350036629800000000,350036629800000000	0-21,0-21,0-21						GASTRIC CANCER Effects of mifepristone on proliferation of human gastric adenocarcinoma cell line SGC-7901 in vitro	www.wjgnet.com	0	0		
1057	chr13	61887404	61936312	3500321867	42		61887404	61936312	8421504	2	21,21	0,48887	c,g	350032186700000001,350032186700000000,350032186700000000	0-21,0-21,0-21						World J Gastroenterol	www.wjgnet.com	0	0		
1057	chr13	61887404	61936312	3500034906	42		61887404	61936312	8421504	2	21,21	0,48887	c,g	350003490600000001,350003490600000000,350003490600000000	0-21,0-21,0-21						Effects of mifepristone on proliferation of human gastric adenocarcinoma cell line SGC-7901 in vitro. - ResearchGate	.researchgate.net	0	0		
1057	chr13	61887405	61936154	3500235907	93		61887405	61936154	8421504	2	48,45	0,48704	p	350023590700015071,350023590700015067	0-48,0-45						Interaction of proteins involved in a cell death pathway	Reed	1997	0		BCL2L1
1057	chr13	61887416	61936640	3500178494	40		61887416	61936640	8421504	2	19,21	0,49203	c,g	350017849400000005,350017849400000005,350017849400000004	0-19,0-19,0-21		15782132	10.1038/sj.onc.1208471	0950-9232	Oncogene	Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax&#x2009;:&#x2009;Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity	Tirado	2005	6		
1057	chr13	61887438	61936550	3500102552	40		61887438	61936550	8421504	2	19,21	0,49091	c,g	350010255200000007,350010255200000007,350010255200000006	0-19,0-19,0-21		17420275	10.1128/MCB.02212-06	0270-7306	Molecular and Cellular Biology	GATA-1 and Gfi-1B Interplay To Regulate Bcl-xL Transcription	Kuo	2007	6		BCL2L1
1057	chr13	61887450	61887479	3500334951	24		61887450	61887479	8421504	3	6,13,5	0,8,24	c	350033495100000055	8-32						US Patent # 5,928,888. Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities - Patents.com	www.patents.com	0	0		
1057	chr13	61887450	61887479	3500257400	24		61887450	61887479	8421504	3	6,13,5	0,8,24	c	350025740000000055	8-32					Patent	Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities (Patent US:5928888)	Whitney	1999	0		
1057	chr13	61887468	61936454	3500311618	140		61887468	61936454	8421504	3	45,48,47	0,48746,48939	p,c	350031161800015073,350031161800000022,350031161800000019	0-45,0-48,0-47						Vertebrate apoptosis gene: compositions and methods	Boise	1995	0		
1057	chr13	61887475	61936073	3500430203	56		61887475	61936073	8421504	2	28,28	0,48570	c	350043020300000004,350043020300000002	0-28,0-28						Research Report	biotechniques.com	0	0		BCL2L1
1057	chr13	61887485	61936107	3500364507	41		61887485	61936107	8421504	2	21,20	0,48602	c,g	350036450700000014,350036450700000013,350036450700000013	0-21,0-20,0-20						Maternal diabetes impairs gastrulation and insulin and IGF-I receptor expression in rabbit blastocysts. - ResearchGate	.researchgate.net	0	0		
1057	chr13	61887499	61936031	3500126974	23		61887499	61936031	8421504	2	14,9	0,48523	c	350012697400000003	0-23		22046442	10.1371/journal.pone.0027053	1932-6203	PLOS ONE	PLOS ONE: Sensitization of Glioma Cells to Tamoxifen-Induced Apoptosis by Pl3-Kinase Inhibitor through the GSK-3&#x03b2;/&#x03b2;-Catenin Signaling Pathway	Li	2011	4		
1057	chr13	61936022	61936065	3500450902	42		61936022	61936065	8421504	2	20,22	0,21	c	350045090200000018,350045090200000016	0-20,0-22						The proapoptotic factor Nix is coexpressed with Bcl-xLduring terminal erythroid differentiation	tologylibrary.org	0	0		BCL2L1
1057	chr13	61936042	61936111	3500374600	68		61936042	61936111	8421504	2	48,20	0,49	c	350037460000000010,350037460000000011,350037460000000009	0-22,0-26,0-20						Efficient Reduction of Target RNA s by siRNA and RNase H- Dependent Antisense Agents: A Comparative Analysis	www.genesil.com	0	0		BCL2L1
1057	chr13	61936042	61936111	3500345513	67		61936042	61936111	8421504	3	22,25,20	0,23,49	c,g	350034551300000091,350034551300000092,350034551300000090,350034551300000090	0-22,0-25,0-20,0-20						Efficient reduction of target RNA's by single-and double-stranded oligomeric compounds	Vickers	2003	0		BCL2L1
1057	chr13	61936051	61936569	3500394952	41		61936051	61936569	8421504	2	21,20	0,498	c	350039495200000003,350039495200000002	0-21,0-20						REPRODUCTION	www.um.es/grupo-f	0	0		BCL2L1
1057	chr13	61936051	61936569	3500330446	41		61936051	61936569	8421504	2	21,20	0,498	c,g	350033044600000003,350033044600000002,350033044600000002	0-21,0-20,0-20						In vitro and in vivo development of mice morulae after storage in non-frozen conditions	www.rbej.com	0	0		BCL2L1
1057	chr13	61936051	61936569	3500181711	41		61936051	61936569	8421504	2	21,20	0,498	c,g	350018171100000012,350018171100000012,350018171100000011,350018171100000011	0-21,0-21,0-20,0-20						REPRODUCTION	uction-online.org	0	0		BCL2L1
1057	chr13	61936051	61936569	3500133737	41		61936051	61936569	8421504	2	21,20	0,498	c	350013373700000005,350013373700000004	0-21,0-20						REPRODUCTION	uction-online.org	0	0		BCL2L1
1057	chr13	61936057	61936126	3500306933	67		61936057	61936126	8421504	3	22,23,22	0,23,47	c,g	350030693300000009,350030693300000009,350030693300000010,350030693300000008,350030693300000008	0-22,0-22,0-23,0-22,0-22			10.1002/ijc.21367	1097-0215	International Journal of Cancer	Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection - Asakawa - 2005 - International Journal of Cancer - Wiley Online Library	Asakawa	2006	0		
1057	chr13	61936082	61936106	3500071799	24		61936082	61936106	8421504	1	24	0	c	350007179900000005	0-24		19284555	10.1186/1476-4598-8-19		Molecular Cancer	&#x03b4;-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles	Yan	2009	0		BCL2L1
1057	chr13	61936082	61936106	3500057410	24		61936082	61936106	8421504	1	24	0	c	350005741000000005	0-24		19284555	10.1186/1476-4598-8-19	1476-4598	Molecular Cancer	&#xce;&#xb4;-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles	Zeng	2009	4		BCL2L1
1057	chr13	61936086	61936534	3500425355	40		61936086	61936534	8421504	2	20,20	0,428	c,g	350042535500000005,350042535500000005,350042535500000004	0-20,0-20,0-20						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		BCL2L1
1057	chr13	61936086	61936534	3500203544	40		61936086	61936534	8421504	2	20,20	0,428	c,g	350020354400000005,350020354400000005,350020354400000004	0-20,0-20,0-20						Volume 17 Number 25 July 7, 2011	www.wjgnet.com	0	0		
1057	chr13	61936086	61936534	3500194131	40		61936086	61936534	8421504	2	20,20	0,428	c,g	350019413100000003,350019413100000003,350019413100000002	0-20,0-20,0-20		23259599	10.1186/1756-9966-31-102	1756-9966	Journal of Experimental & Clinical Cancer Research	ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL	Li	2012	2		
1057	chr13	61936086	61936534	3500054511	40		61936086	61936534	8421504	2	20,20	0,428	c,g	350005451100000003,350005451100000003,350005451100000002	0-20,0-20,0-20		23259599	10.1186/1756-9966-31-102	1756-9966	Journal of Experimental & Clinical Cancer Research	ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL	Li	2012	2		
1057	chr13	61936086	61936534	3500020349	40		61936086	61936534	8421504	2	20,20	0,428	c,g	350002034900000005,350002034900000005,350002034900000004	0-20,0-20,0-20		21799645	10.3748/wjg.v17.i25.2992		World Journal of Gastroenterology : WJG	Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth	Chen	July	0		BCL2L1
1057	chr13	61936086	61936221	3500351268	44		61936086	61936221	8421504	2	21,23	0,112	c	350035126800000009,350035126800000008	0-21,0-23						JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells	al.physiology.org	0	0		BCL2L1
1057	chr13	61936087	61936569	3500209881	40		61936087	61936569	8421504	2	20,20	0,462	c,g	350020988100000003,350020988100000003,350020988100000002,350020988100000002	0-20,0-20,0-20,0-20		19067680	10.1111/j.1742-7843.2008.00292.x	1742-7843	Basic & Clinical Pharmacology & Toxicology	Involvement of Regulations of Nucleophosmin and Nucleoporins in Gambogic Acid-Induced Apoptosis in Jurkat Cells - Shu - 2008 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library	Shu	2008	0		BCL2L1
1057	chr13	61936094	61936117	3500265101	23		61936094	61936117	8421504	1	23	0	c,g	350026510100000000,350026510100000001	0-21,0-21		21852238	10.1074/jbc.M110.207134	0021-9258	Journal of Biological Chemistry	Oxidized DJ-1 Interacts with the Mitochondrial Protein BCL-XL	Ren	2011	5		BCL2L1
1057	chr13	61936216	61936240	3500146542	24		61936216	61936240	8421504	1	24	0	c	350014654200000000	0-24		12554699	10.1096/fj.02-0602com	0892-6638	The FASEB Journal	The prodomain of interleukin 1&#x03b1; interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells	POLLOCK	2003	6		BCL2L1
1057	chr13	61936277	61936340	3500027454	63		61936277	61936340	8421504	1	63	0	p	350002745400015002	0-63		15870695	10.1038/sj.onc.1208666	0950-9232	Oncogene	An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity	Yang	2005	6		BCL2L1
1057	chr13	61936283	61936306	3500399186	23		61936283	61936306	8421504	1	23	0	c	350039918600000003	0-23						Down syndrome fibroblasts and mouse Prep1-overexpressing cells display increased sensitivity to genotoxic stress - Keeping the Faith	pthefaith1296.com	0	0		BCL2L1
1057	chr13	61936514	61936589	3500290688	75		61936514	61936589	8421504	1	75	0	p	350029068800015044,350029068800015039,350029068800015032	0-72,3-78,0-72						Connexin-based intercellular signaling in cell death, to live or let die?	www.towo.ugent.be	0	0		BCL2L1
1057	chr13	61936514	61936586	3500152364	72		61936514	61936586	8421504	1	72	0	p	350015236400015011,350015236400015005	0-72,0-72						Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. - ResearchGate	.researchgate.net	0	0		BCL2L1
1057	chr13	61936526	61936574	3500105711	48		61936526	61936574	8421504	1	48	0	p	350010571100015128	0-48						BH3 interacting domain death agonist	Korsmeyer	1996	0		BCL2L1
1057	chr13	61936569	61936593	3500043878	24		61936569	61936593	8421504	1	24	0	c	350004387800000000	0-24						Cell Death and Differentiation - Figures and tables for article: Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9	www.nature.com	0	0		BCL2L1
1057	chr13	61936621	61936645	3500268381	24		61936621	61936645	8421504	1	24	0	c	350026838100000007	0-24		19103748	10.1128/MCB.01273-08	0270-7306	Molecular and Cellular Biology	Prep1 Directly Regulates the Intrinsic Apoptotic Pathway by Controlling Bcl-XL Levels	Micali	2009	6		
1057	chr13	61936621	61936644	3500395700	23		61936621	61936644	8421504	1	23	0	c	350039570000000010,350039570000000062	0-23,0-23						Compositions And Methods For Restoring Sensitivity Of Tumor Cells To Antitumor Therapy And Inducing Apoptosis 	.freshpatents.com	0	0		BCL2L1
132	chr13	61988200	62004188	3500456272	121		61988200	62004188	8421504	3	42,38,41	0,1590,15947	c	350045627200000042,350045627200000046,350045627200000066	6-48,0-38,0-41						Novel fetal genes - Patent application	www.faqs.org	0	0		
1058	chr13	62030252	62034478	3500068132	330		62030252	62034478	8421504	6	18,71,61,23,153,4	0,3285,3458,3564,3935,4222	p	350006813200015045,350006813200015036	0-150,0-180						Human proteins polynucleotides encoding them and methods of using the same	Gangolli	2001	0		
1058	chr13	62033723	62033748	3500228224	25		62033723	62033748	8421504	1	25	0	c	350022822400000027	21-46						Bedeutung der Myosin-Leichtketten-Kinase f&#xfc;r den alpha1-adrenergen positiv inotropen Effekt im Herzmuskel	ie.uni-hamburg.de	0	0		
1058	chr13	62034589	62036057	3500359537	81		62034589	62036057	8421504	2	18,63	0,1405	p	350035953700015000	0-81						&#x8868;&#x8fbe;&#x8f7d;&#x4f53;&#x7684;&#x603b;&#x7c7b;&#x53ca;&#x5176;&#x4f7f;&#x7528;&#x6ce8;&#x610f;&#x4e8b;&#x9879; - tom&#x7684;&#x65e5;&#x5fd7; - &#x7f51;&#x6613;&#x535a;&#x5ba2;	2008.blog.163.com	0	0		MYLK2
1058	chr13	62034589	62036057	3500279460	81		62034589	62036057	8421504	2	18,63	0,1405	p	350027946000015008	0-81		11027724	10.1104/pp.124.2.751	0032-0889	Plant Physiology	Recombinant Brassinosteroid Insensitive 1 Receptor-Like Kinase Autophosphorylates on Serine and Threonine Residues and Phosphorylates a Conserved Peptide Motif in Vitro	Oh	2000	7		MYLK2
1058	chr13	62034589	62036057	3500279260	81		62034589	62036057	8421504	2	18,63	0,1405	p	350027926000015004	0-81			10.1128/JB.187.2.522-533.2005		Journal of Bacteriology	Intimin-Mediated Export of Passenger Proteins Requires Maintenance of a Translocation-Competent Conformation	Thorsten	2005	0		MYLK2
1058	chr13	62034589	62036057	3500272366	81		62034589	62036057	8421504	2	18,63	0,1405	p	350027236600015004	0-81		15629924	10.1128/JB.187.2.522-533.2005	0021-9193	Journal of Bacteriology	Intimin-Mediated Export of Passenger Proteins Requires Maintenance of a Translocation-Competent Conformation	Adams	2005	4		MYLK2
1058	chr13	62034589	62036057	3500074085	81		62034589	62036057	8421504	2	18,63	0,1405	p	350007408500015002	0-81						Kristina B&#xfc;scher: &#xa0;Expression und biologische Funktion von humanen endogenen Retroviren (HERVs), insbesondere von HERV-K&#xa0; 	edoc.hu-berlin.de	0	0		MYLK2
1058	chr13	62034592	62036057	3500424071	78		62034592	62036057	8421504	2	15,63	0,1402	p	350042407100015013	0-78						Vector Name	www.docstoc.com	0	0		MYLK2
1058	chr13	62034592	62036057	3500403070	78		62034592	62036057	8421504	2	15,63	0,1402	p	350040307000015000,350040307000015009	0-75,0-54						Method for purification of a protein complex and identification of its components	Boniface	2004	0		MYLK2
1058	chr13	62034592	62036057	3500394170	78		62034592	62036057	8421504	2	15,63	0,1402	p	350039417000015001	0-78		17526750	10.1105/tpc.107.050880	1040-4651	The Plant Cell Online	Physical Association of the NB-LRR Resistance Protein Rx with a Ran GTPase&#x2013;Activating Protein Is Required for Extreme Resistance to Potato virus X	Tameling	2007	9		MYLK2
1058	chr13	62034592	62036057	3500389626	78		62034592	62036057	8421504	2	15,63	0,1402	p	350038962600015000	0-78						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		MYLK2
1058	chr13	62034592	62036057	3500356349	78		62034592	62036057	8421504	2	15,63	0,1402	p	350035634900015000	0-78						&#x5404;&#x79cd;&#x8868;&#x8fbe;&#x8f7d;&#x4f53;_&#x767e;&#x5ea6;&#x6587;&#x5e93;	wenku.baidu.com	0	0		MYLK2
1058	chr13	62034592	62036057	3500184251	78		62034592	62036057	8421504	2	15,63	0,1402	p	350018425100015005	0-78						Peptide binding by a fragment of calmodulin composed of EF-hands 2 and 3. - ResearchGate	.researchgate.net	0	0		MYLK2
1058	chr13	62034592	62036057	3500123795	78		62034592	62036057	8421504	2	15,63	0,1402	p	350012379500015000	0-78						&#x8868;&#x8fbe;&#x8f7d;&#x4f53;&#x7684;&#x603b;&#x7c7b;&#x53ca;&#x5176;&#x4f7f;&#x7528;&#x6ce8;&#x610f;&#x4e8b;&#x9879;_e&#x5bb6;&#x5065;&#x5eb7;&#x2013;&#x5bb6;&#x7528;&#x533b;&#x7597;&#x5668;&#x68b0;,&#x8001;&#x5e74;&#x62a4;&#x7406;,&#x5bb6;&#x5ead;&#x	www.jiayong16.com	0	0		MYLK2
1058	chr13	62034592	62036057	3500119927	78		62034592	62036057	8421504	2	15,63	0,1402	p	350011992700015001	0-78						Manual: InterPlay Mammalian TAP System	.chem-agilent.com	0	0		MYLK2
1058	chr13	62034592	62036057	3500070841	78		62034592	62036057	8421504	2	15,63	0,1402	p	350007084100015003	0-78		21343341	10.1128/MCB.00723-10	0270-7306	Molecular and Cellular Biology	Calmodulin Antagonizes a Calcium-Activated SCF Ubiquitin E3 Ligase Subunit, FBXL2, To Regulate Surfactant Homeostasis	Chen	2011	6		MYLK2
1058	chr13	62034592	62036057	3500065038	78		62034592	62036057	8421504	2	15,63	0,1402	p	350006503800015001	0-78		21146485	10.1016/j.ab.2010.12.007		Analytical biochemistry	Identification of cyclophilin-40 interacting proteins reveals potential cellular function of cyclophilin-40	Miki	2011	0		MYLK2
1058	chr13	62034592	62036057	3500061337	78		62034592	62036057	8421504	2	15,63	0,1402	p	350006133700015127,350006133700015012	0-48,0-78						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		MYLK2
1058	chr13	62034592	62036057	3500060807	78		62034592	62036057	8421504	2	15,63	0,1402	p	350006080700015001	0-78						Manual: InterPlay Mammalian TAP System	omics.agilent.com	0	0		MYLK2
1058	chr13	62034592	62036057	3500017368	78		62034592	62036057	8421504	2	15,63	0,1402	p	350001736800015027	0-78						Human Monoclonal Antibodies to Human Nucleolin	Sutkowski	2010	0		MYLK2
1058	chr13	62034592	62036051	3500092432	72		62034592	62036051	8421504	2	15,57	0,1402	p	350009243200015042	0-72						GATEWAY Binary Vector (pGWB)	shimane-u.org	0	0		MYLK2
1058	chr13	62034592	62036042	3500204510	63		62034592	62036042	8421504	2	15,48	0,1402	p,c	350020451000015000,350020451000000007	6-69,6-27						A Glucose Kinase From Mycobacterium Smegmatis | Johannes Amon - Academia.edu	www.academia.edu	0	0		MYLK2
1058	chr13	62034592	62036042	3500156701	63		62034592	62036042	8421504	2	15,48	0,1402	p	350015670100015086	6-69						pr&#xe9;sent&#xe9;e par Emilie HUET MOULARD DOCTEUR DE L&#x2019;UNIVERSITE JOSEPH FOURIER-GRENOBLE I	hives-ouvertes.fr	0	0		MYLK2
1058	chr13	62034592	62036042	3500003372	63		62034592	62036042	8421504	2	15,48	0,1402	p	350000337200015086	6-69						pr&#xe9;sent&#xe9;e par Emilie HUET MOULARD DOCTEUR DE L&#x2019;UNIVERSITE JOSEPH FOURIER-GRENOBLE I	hives-ouvertes.fr	0	0		MYLK2
1058	chr13	62034598	62036057	3500203744	72		62034598	62036057	8421504	2	9,63	0,1396	p	350020374400015005	0-72						Two-step error-prone bypass of the (+)- and (-)-trans-anti-BPDE-N2-dG adducts by human DNA polymerases eta and kappa. - ResearchGate	.researchgate.net	0	0		MYLK2
1058	chr13	62034598	62036051	3500329094	66		62034598	62036051	8421504	2	9,57	0,1396	p	350032909400015039	0-66						GATEWAY Binary Vector (pGWB) - DOC	www.docstoc.com	0	0		MYLK2
1058	chr13	62034598	62036042	3500153326	57		62034598	62036042	8421504	2	9,48	0,1396	p	350015332600015000	12-69						Effect of an industrial chemical waste on the uptake	www.shd.org.rs	0	0		MYLK2
1059	chr13	62242254	62242280	3500347059	25		62242254	62242280	8421504	2	9,16	0,10	g	350034705900000037	1-27					Patent	Process for producing 7-aminocephem compound or salts thereof (Patent US:5677141)	Aramori	1997	0		
132	chr13	62255590	62278446	3500173179	1323		62255590	62278446	8421504	10	89,99,104,150,153,180,77,154,132,185	0,818,5491,9176,9670,11332,12348,17267,19330,22671	p	350017317900015031	12-1335						Bioinformatika_timinskas	www.scribd.com	0	0		HCK
1060	chr13	62265841	62265865	3500016424	23		62265841	62265865	8421504	2	6,17	0,7	g	350001642400000072	25-48						Antibodies specific for platelet-activating factor acetylhydrolase	Cousens	1995	0		
1060	chr13	62266941	62266966	3500127451	25		62266941	62266966	8421504	1	25	0	c	350012745100000109	11-36						Axl oncogene	Liu	1995	0		HCK
1060	chr13	62272983	62274997	3500366238	102		62272983	62274997	8421504	3	28,32,42	0,1937,1972	p	350036623800015032	0-102						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		HCK
1060	chr13	62278329	62278556	3500424225	42		62278329	62278556	8421504	2	21,21	0,206	c	350042422500000030,350042422500000031	0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
1060	chr13	62292953	62329410	3500317862	720		62292953	62329410	8421504	7	15,114,100,169,130,124,68	0,19366,28349,33371,33639,34990,36389	p	350031786200015006,350031786200015007,350031786200015004,350031786200015008,350031786200015009	0-180,0-180,0-48,0-180,0-180						Molecular cloning and characterization of human age-related NADH oxidase (arNOX) proteins as members of the TM9 superfamily of transmembrane proteins	www.scirp.org	0	0		TM9SF4
1060	chr13	62292953	62329410	3500298774	720		62292953	62329410	8421504	7	15,114,100,169,130,124,68	0,19366,28349,33371,33639,34990,36389	p	350029877400015006,350029877400015007,350029877400015004,350029877400015008,350029877400015009	0-180,0-180,0-48,0-180,0-180						Molecular cloning and characterization of human age-related NADH oxidase (arNOX) proteins as members of the TM9 superfamily of transmembrane proteins	www.scirp.org	0	0		TM9SF4
1060	chr13	62326423	62326450	3500100330	26		62326423	62326450	8421504	2	14,12	0,15	c	350010033000000090	16-42						MUTATED STRUCTURAL PROTEIN OF A PARVOVIRUS - Patent application	www.faqs.org	0	0		
1060	chr13	62335633	62336422	3500430220	54		62335633	62336422	8421504	2	39,15	0,774	p	350043022000015217	111-165						49 human secreted proteins	A	2000	0		
1060	chr13	62335699	62343163	3500236662	567		62335699	62343163	8421504	7	55,82,76,84,176,64,30	0,654,829,3651,5532,6179,7434	p	350023666200015032,350023666200015033,350023666200015034,350023666200015035	0-141,0-141,0-138,0-147						33 human secreted proteins	Ebner	2000	0		TM9SF4
1060	chr13	62335699	62343163	3500102237	567		62335699	62343163	8421504	7	55,82,76,84,176,64,30	0,654,829,3651,5532,6179,7434	p	350010223700015032,350010223700015033,350010223700015034,350010223700015035	0-141,0-141,0-138,0-147						33 human secreted proteins	Ebner	2001	0		TM9SF4
1064	chr13	62815544	62815573	3500308897	25		62815544	62815573	8421504	3	9,11,5	0,12,24	c	350030889700000441	1-39						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
1064	chr13	62844821	62849352	3500308562	45		62844821	62849352	8421504	3	22,21,2	0,2892,4529	c	350030856200000004,350030856200000005	0-22,0-23						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
1064	chr13	62853355	62860127	3500162809	44		62853355	62860127	8421504	2	23,21	0,6751	c,g	350016280900000008,350016280900000008,350016280900000009	0-23,0-23,0-21						Epigenetic differences between male and female bovine blastocysts produced in vitro	cs.physiology.org	0	0		
1064	chr13	62853750	62855315	3500456772	234		62853750	62855315	8421504	3	76,149,9	0,393,1556	p	350045677200015007	0-234						Epigenomics	www.scribd.com	0	0		DNMT3B
1064	chr13	62860043	62860066	3500405329	23		62860043	62860066	8421504	1	23	0	c	350040532900000005	20-43						Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 &#x03b2;-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells 10.1016/j.febslet.2007.02.070 : FEBS Lette	sciencedirect.com	0	0		
1064	chr13	62860158	62860182	3500421623	24		62860158	62860182	8421504	1	24	0	c	350042162300000085	0-24						IDENTIFICATION OF FACTORS INVOLVED IN DNA METHYLATION OF CPG-ISLAND-PROMOTERS	s.library.tmc.edu	0	0		
1064	chr13	62883828	62883888	3500443178	60		62883828	62883888	8421504	1	60	0	p	350044317800015000	0-60						Casein kinase I delta controls centrosome positioning during T cell activation	jcb.rupress.org	0	0		MAPRE1
1066	chr13	63084760	63084788	3500067838	24		63084760	63084788	8421504	3	11,5,8	0,13,20	g	350006783800000005	0-24						&#x4e3b;&#x9898;&#xff1a;Nrf2 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1067	chr13	63195400	63223933	3500126690	63		63195400	63223933	8421504	3	20,20,23	0,4325,28510	c,g	350012669000000014,350012669000000015,350012669000000015,350012669000000010	0-20,0-20,0-20,0-23		17362520	10.1186/1471-2164-8-75	1471-2164	BMC Genomics	Expansion of the Bactericidal/Permeability Increasing-like (BPI-like) protein locus in cattle	Wheeler	2007	4		BPIFB2,BPIFB6
1068	chr13	63369723	63369755	3500184498	25		63369723	63369755	8421504	3	8,11,6	0,12,26	g	350018449800000047	16-41						US Patent # 7,341,731. HIV-2 antigen compositions - Patents.com	www.patents.com	0	0		
133	chr13	63559007	63606481	3500126690	66		63559007	63606481	8421504	3	21,24,21	0,120,47453	c	350012669000000006,350012669000000007,350012669000000004	0-21,0-24,0-21		17362520	10.1186/1471-2164-8-75	1471-2164	BMC Genomics	Expansion of the Bactericidal/Permeability Increasing-like (BPI-like) protein locus in cattle	Wheeler	2007	4		
1070	chr13	63694804	63695093	3500119257	81		63694804	63695093	8421504	3	29,18,34	0,31,255	g	350011925700000018	5-96						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
1071	chr13	63741193	63741244	3500052832	51		63741193	63741244	8421504	1	51	0	p	350005283200015166	51-102						NOTES ON SELECTED SOFTBERRY PRODUCTS	ux1.softberry.com	0	0		SNTA1
1072	chr13	63940269	63940300	3500226339	25		63940269	63940300	8421504	3	7,12,6	0,10,25	c	350022633900000002	0-25		19706623	10.1093/hmg/ddp411		Human Molecular Genetics	An allergy-associated polymorphism in a novel regulatory element enhances IL13 expression	Patricia	2009	0		
1072	chr13	63944818	63944841	3500032536	23		63944818	63944841	8421504	1	23	0	g	350003253600000002	10-33						Polypeptide Having An Activity To Support Proliferation Or Survival Of Hematopoietic Stem Cell And Hematopoietic Progenitor Cell, And Dna Coding For The Same 	.freshpatents.com	0	0		
1072	chr13	63962004	63962029	3500088353	25		63962004	63962029	8421504	1	25	0	c	350008835300000007	0-25		20805990	10.1371/journal.pone.0012452		PLoS ONE	CREB Inhibits AP-2&#x03b1; Expression to Regulate the Malignant Phenotype of Melanoma	Vladislava	2010	0		
1072	chr13	63962023	63962589	3500364541	40		63962023	63962589	8421504	2	20,20	0,546	c,g	350036454100000000,350036454100000001,350036454100000001	0-20,0-20,0-20		16909124	10.1038/sj.onc.1209817	0950-9232	Oncogene	Compensation and specificity of function within the E2F family	Kong	2006	6		
1072	chr13	63962040	63962094	3500434432	54		63962040	63962094	8421504	1	54	0	p	350043443200015000	0-54		15569940	10.1073/pnas.0405278101	0027-8424	Proceedings of the National Academy of Sciences of the United States of America	Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes	Venugopal	2004	10		E2F1
1072	chr13	63962040	63962094	3500387094	54		63962040	63962094	8421504	1	54	0	p	350038709400015000,350038709400015005	0-54,0-48						&#x30ac;&#x30f3;&#x907a;&#x4f1d;&#x5b50;&#x307e;&#x305f;&#x306f;&#x30a6;&#x30a4;&#x30eb;&#x30b9;&#x306b;&#x3088;&#x308a;&#x5236;&#x5fa1;&#x3055;&#x308c;&#x305f;&#x767a;&#x73fe;&#x7cfb; - &#x30d8;&#x30ad;&#x30b9;&#x30c8; &#x30de;&#x30ea;&#x30aa;&#x30f3; &#	www.patentjp.com	0	0		E2F1
1072	chr13	63962040	63962094	3500318362	54		63962040	63962094	8421504	1	54	0	p	350031836200015000,350031836200015004	0-54,0-48						Oncogene- or virus-controlled expression systems	R*Mi Le 	1999	0		E2F1
1072	chr13	63962040	63962094	3500292486	54		63962040	63962094	8421504	1	54	0	p	350029248600015000	0-54					Patent	Oncogene- or virus-controlled expression systems (Patent US:6465246)	Mueller	2002	0		E2F1
1072	chr13	63962040	63962094	3500150029	54		63962040	63962094	8421504	1	54	0	p	350015002900015009,350015002900015011	0-54,0-45						Oncogene- or virus-controlled expression systems	Mueller	1998	0		E2F1
1072	chr13	63962040	63962094	3500101527	54		63962040	63962094	8421504	1	54	0	p	350010152700015000	0-54						Oncogene or virus-driven expression systems	Muller	1999	0		E2F1
1072	chr13	63962040	63962094	3500063626	54		63962040	63962094	8421504	1	54	0	p	350006362600015000	0-54						Onkogen- oder virusgesteuerte Expressionssysteme	Mueller	1999	0		E2F1
1072	chr13	63962040	63962094	3500038485	54		63962040	63962094	8421504	1	54	0	p	350003848500015000,350003848500015005	0-54,0-48						&#x81f4;&#x764c;&#x57fa;&#x56e0;&#x6216;&#x75c5;&#x6bd2;&#x53d7;&#x63a7;&#x8868;&#x8fbe;&#x7cfb;&#x7edf;	R*Mi Le 	1999	0		E2F1
1072	chr13	63962591	63962711	3500183911	25		63962591	63962711	8421504	2	6,19	0,101	c	350018391100000009,350018391100000008	0-25,0-25		20530585	10.1158/1541-7786.MCR-09-0458	1541-7786	Molecular Cancer Research	Enhanced Expression of PCAF Endows Apoptosis Resistance in Cisplatin-Resistant Cells	Hirano	2010	4		E2F1
1073	chr13	63963876	63965307	3500368155	249		63963876	63965307	8421504	4	10,101,113,25	0,803,910,1406	p	350036815500015001	0-252						Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression	Andrews	2001	0		E2F1
1073	chr13	63963876	63965307	3500051964	255		63963876	63965307	8421504	3	10,220,25	0,803,1406	p	350005196400015001,350005196400015000	0-96,0-159						Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression	Andrews	2005	0		E2F1
1073	chr13	63964732	63964789	3500407860	57		63964732	63964789	8421504	1	57	0	p	350040786000015035	12-69						Bispecific Fusion Antibodies With Enhanced Serum Half-Life	Holt	2008	0		E2F1
1073	chr13	63964732	63964789	3500271925	57		63964732	63964789	8421504	1	57	0	p	350027192500015055	12-69						Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY	Holmes	2009	0		E2F1
1073	chr13	63964732	63964789	3500010257	57		63964732	63964789	8421504	1	57	0	p	350001025700015037	12-69						Bispecific Fusion Antibodies With Enhanced Serum Half-Life	Holt	2005	0		E2F1
1073	chr13	63964732	63964777	3500320911	45		63964732	63964777	8421504	1	45	0	p	350032091100015004	0-45						E2f activity inhibitory compounds	Mizukami	1999	0		E2F3
1073	chr13	63970389	63970416	3500377217	25		63970389	63970416	8421504	2	6,19	0,8	g	350037721700000038,350037721700000013	10-35,10-35					Patent	An oncolytic adenovirus (Patent EP:1230378)	Johnson	2007	0		
1073	chr13	63970389	63970416	3500352043	25		63970389	63970416	8421504	2	6,19	0,8	g	350035204300000040,350035204300000013	5-30,10-35						Oncolytic adenovirus - Patent # 7396679 - PatentGenius	.patentgenius.com	0	0		
1073	chr13	63970422	63970483	3500034126	61		63970422	63970483	8421504	1	61	0	g	350003412600000007,350003412600000005	0-24,0-41		18542057	10.1038/onc.2008.184	0950-9232	Oncogene	IKK&sol;NF-&#x03ba;B signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors	Araki	2008	6		E2F1
1073	chr13	63970440	63970492	3500375265	52		63970440	63970492	8421504	1	52	0	g	350037526500000002,350037526500000001	10-62,5-56						SelecciA3n positiva de cA(c)lulas modificadas con genes suicidas como estrategia terapA(c)utica contra e	www.tdx.cat	0	0		E2F1
1073	chr13	63970440	63970492	3500129119	52		63970440	63970492	8421504	1	52	0	g	350012911900000003,350012911900000002	10-62,5-56						Selecci&#xf3;n positiva de c&#xe9;lulas modificadas con genes suicidas como estrategia terap&#xe9;utica contra el c&#xe1;ncer	www.tdx.cat	0	0		E2F1
1073	chr13	63970440	63970492	3500014827	52		63970440	63970492	8421504	1	52	0	g	350001482700000002,350001482700000003	5-57,10-62		20808288	10.1038/mt.2010.173		Molecular Therapy	Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses	Juan	2010	0		E2F1
1073	chr13	63970441	63970479	3500171247	38		63970441	63970479	8421504	1	38	0	g	350017124700000016	0-38						Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells	rt.physiology.org	0	0		
1073	chr13	63970458	63970483	3500353965	25		63970458	63970483	8421504	1	25	0	g	350035396500000000	0-25		16269079	10.1186/1471-2164-6-151	1471-2164	BMC Genomics	cGMP-independent nitric oxide signaling and regulation of the cell cycle	Cui	2005	4		E2F1
1073	chr13	63970458	63970483	3500312271	25		63970458	63970483	8421504	1	25	0	g	350031227100000000	0-25						BMC Genomics BioMed Central	biomedcentral.com	0	0		E2F1
1075	chr13	64296377	64298646	3500139220	60		64296377	64298646	8421504	2	50,10	0,2259	p	350013922000015005	0-60						The embryonic lethality of homozygous lethal yellow mice (AY/A y) with the disruption of a novel RNA-binding protein	enesdev.cshlp.org	0	0		
1075	chr13	64323700	64328388	3500018380	66		64323700	64328388	8421504	2	51,15	0,4673	p	350001838000015003	0-66		19114502	10.1128/EC.00334-08	1535-9778	Eukaryotic Cell	Functional Analysis of Protein Kinase CK2 of the Human Malaria Parasite Plasmodium falciparum	Holland	2009	4		EIF2S2
1075	chr13	64323700	64323727	3500391022	24		64323700	64323727	8421504	2	18,6	0,21	c	350039102200000040,350039102200000000	4-28,1-25					Patent	Dna-molek&#xfc;l, herstellung und verwendung in der gentherapie DNA molecule, manufacturing and use in gene therapy (Patent DE:69637156)	Cameron	2008	0		EIF2S2
1075	chr13	64323700	64323727	3500077997	24		64323700	64323727	8421504	2	18,6	0,21	c	350007799700000015	1-25					Patent	Purification of plasmid DNA of pharmaceutical quality (Patent US:6730781)	Wils	2004	0		EIF2S2
1076	chr13	64394750	64460290	3500073722	2580		64394750	64460290	8421504	24	70,142,125,137,44,158,190,96,175,70,85,129,73,72,89,160,134,141,121,105,54,40,73,97	0,7803,11509,13362,16060,23634,24503,25842,26640,31009,38424,42074,45221,46251,49204,51033,51458,52346,56470,57024,59105,59162,63053,65443	p	350007372200015012	1428-4134						UNIVERSIT&#xc0; DEGLI STUDI DI ROMA TOR VERGATA	space.uniroma2.it	0	0		
1076	chr13	64418500	64419363	3500049238	44		64418500	64419363	8421504	2	21,23	0,840	c	350004923800000007,350004923800000008	0-21,0-23						TheUbiquitinLigaseItchRegulatesApoptosisbyTargeting Thioredoxin-interactingProteinforUbiquitin-dependent Degradation	www.jbc.org	0	0		ITCH
1077	chr13	64489492	64490557	3500307950	42		64489492	64490557	8421504	2	20,22	0,1043	c	350030795000000000,350030795000000001	9-29,8-30						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		MAP1LC3A
1077	chr13	64489495	64490553	3500335292	360		64489495	64490553	8421504	4	37,56,107,160	0,347,487,898	p	350033529200015025	732-1092						NOVEL HETEROCYCLIC DERIVATIVES - NOVARTIS AG	www.sumobrain.com	0	0		MAP1LC3A
1077	chr13	64489982	64490406	3500079809	120		64489982	64490406	8421504	2	107,13	0,411	p	350007980900015002	0-120						pEGFP-C1-rLC3	-db.ucsf.edu:8000	0	0		MAP1LC3A
1077	chr13	64490060	64490459	3500117656	42		64490060	64490459	8421504	2	22,20	0,379	c	350011765600000000,350011765600000001	0-22,0-20		22822377	10.3390/md10061345		Marine Drugs	SD118-Xanthocillin X (1), a Novel Marine Agent Extracted from Penicillium commune, Induces Autophagy through the Inhibition of the MEK/ERK Pathway	Ying	June	0		MAP1LC3A
1078	chr13	64640439	64640466	3500442456	23		64640439	64640466	8421504	2	15,8	0,19	g	350044245600000228	25-48						DNA expression systems based on alphaviruses	Garoff	2000	0		
1079	chr13	64795508	64795582	3500078731	42		64795508	64795582	8421504	2	21,21	0,53	c	350007873100000019,350007873100000020	0-21,0-21						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		ACSS2
1079	chr13	64800415	64801306	3500301078	45		64800415	64801306	8421504	3	20,7,18	0,75,873	c,g	350030107800000097,350030107800000097,350030107800000098	0-20,0-20,0-25						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
1079	chr13	64802008	64802130	3500172791	39		64802008	64802130	8421504	2	20,19	0,103	c,g	350017279100000016,350017279100000017,350017279100000017	0-20,0-19,0-19		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
1079	chr13	64802008	64802130	3500120290	39		64802008	64802130	8421504	2	20,19	0,103	c	350012029000000016,350012029000000017	0-20,0-19						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
1079	chr13	64802008	64802130	3500048191	39		64802008	64802130	8421504	2	20,19	0,103	c	350004819100000016,350004819100000017	0-20,0-19		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
1079	chr13	64804545	64816189	3500303532	69		64804545	64816189	8421504	4	22,3,20,24	0,1485,10346,11620	c,g	350030353200000087,350030353200000033,350030353200000033,350030353200000032	0-25,0-20,0-20,0-24						DEPARTAMENT DE GENATICA ESTUDIO DE FACTORES GENATICOS DE LOS SISTEMAS RELACIONADOS CON ESTRAS OX	www.tdx.cat	0	0		GSS
1079	chr13	64861439	64861498	3500353647	43		64861439	64861498	8421504	2	21,22	0,37	c,g	350035364700000078,350035364700000078,350035364700000077,350035364700000077	21-42,21-42,0-22,0-22						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		
1079	chr13	64861439	64861498	3500351139	43		64861439	64861498	8421504	2	21,22	0,37	c	350035113900000207,350035113900000078,350035113900000077,350035113900000205,350035113900000206	0-21,21-42,0-22,0-22,1-22						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
134	chr13	64874613	64943196	3500150528	1061		64874613	64943196	8421504	19	93,207,21,48,48,61,83,30,18,40,7,48,51,93,48,75,15,27,48	0,936,1305,1389,4132,5292,6694,8374,9982,12419,24349,31704,31800,36607,43227,51404,54117,54138,68535	c	350015052800000332,350015052800000079,350015052800000333,350015052800000081,350015052800000334,350015052800000082,350015052800000335,350015052800000083,350015052800000336,350015052800000084,350015052800000337,350015052800000085,350015052800000340,350015052800000325,350015052800000323,350015052800000070,350015052800000069,350015052800000321,350015052800000319,350015052800000313,350015052800000307,350015052800000305,350015052800000304,350015052800000303,350015052800000300,350015052800000298,350015052800000297,350015052800000296,350015052800000293	0-48,15-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,6-48,21-48,0-48						Anti-igf-1r Antibodies And Uses Thereof 	.freshpatents.com	0	0		
1080	chr13	64943191	64943220	3500205428	25		64943191	64943220	8421504	2	7,18	0,11	c	350020542800000043,350020542800000012	1-26,4-29						Bacterial pheromones and uses thereof - Patent application	www.faqs.org	0	0		
1080	chr13	64961886	64961936	3500024826	45		64961886	64961936	8421504	2	23,22	0,28	c	350002482600000038,350002482600000214	0-23,0-22						Udder Health Characteristics 	.freshpatents.com	0	0		
1081	chr13	65117143	65122478	3500374306	735		65117143	65122478	8421504	6	7,182,177,176,86,107	0,2218,2587,3299,5008,5228	p	350037430600015000	0-735						Inhibition of Tumorigenesis by Inhibition of a6b4 Integrin - Patent application	www.faqs.org	0	0		EIF6
1082	chr13	65250935	65254675	3500090973	425		65250935	65254675	8421504	6	48,48,96,48,89,96	0,576,768,3170,3458,3644	c	350009097300000031,350009097300000019,350009097300000015,350009097300000014,350009097300000012,350009097300000006,350009097300000005,350009097300000002,350009097300000001	0-48,0-48,0-48,0-48,0-48,0-48,7-48,0-48,0-48						Human mp52 arg protein	Fujino	1998	0		
1082	chr13	65250935	65254482	3500059732	233		65250935	65254482	8421504	5	48,48,48,48,41	0,432,816,3170,3506	c	350005973200000031,350005973200000022,350005973200000014,350005973200000012,350005973200000005	0-48,0-48,0-48,0-48,7-48						HUMAN MP52 ARG PROTEIN - Biopharm, Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Kimura	www.sumobrain.com	0	0		
1082	chr13	65250935	65251250	3500392138	141		65250935	65251250	8421504	3	57,44,40	0,188,275	c	350039213800000347,350039213800000343,350039213800000341	0-57,0-44,4-44						Designer ligands of tgf-beta superfamily	Choe	2010	0		GDF5OS,GDF5
1082	chr13	65250938	65251241	3500209254	303		65250938	65251241	8421504	1	303	0	p	350020925400015000	0-303					Patent	Monomeric protein of the TGF-&#x03b2; family (Patent US:6972321)	Hotten	2005	0		GDF5OS,GDF5
1082	chr13	65250953	65251241	3500467295	249		65250953	65251241	8421504	2	114,135	0,153	p	350046729500015035,350046729500015021	0-114,0-135						Anti-Dorsalizing Morphogenetic Protein is a novel TGF- homolog expressed in the Spemann organizer	ev.biologists.org	0	0		GDF5OS,GDF5
1082	chr13	65250974	65251389	3500032645	40		65250974	65251389	8421504	2	20,20	0,395	c	350003264500000013,350003264500000012	0-20,0-20		10620601	10.1084/jem.191.1.9	0022-1007	The Journal of Experimental Medicine	The Nuclear Factor of Activated T Cells (Nfat) Transcription Factor Nfatp (Nfatc2) Is a Repressor of Chondrogenesis	Ranger	2000	14		GDF5OS,GDF5
1082	chr13	65251040	65251063	3500108434	23		65251040	65251063	8421504	1	23	0	c	350010843400000008	0-23						NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY	Hotten	1996	0		
1082	chr13	65251749	65251773	3500326532	24		65251749	65251773	8421504	1	24	0	c	350032653200000016,350032653200000010	0-24,0-24					Patent	New growth-differentiation factor of the TGF-beta family (Patent CN:1185343)	G*Huo Dun 	2005	0		
1082	chr13	65251749	65251773	3500251989	24		65251749	65251773	8421504	1	24	0	c,g	350025198900000008,350025198900000008	0-24,0-24					Patent	Growth/differentiation factor of the TGF-&#x03b2; family (Patent US:5994094)	Hotten	1999	0		
1082	chr13	65251749	65251773	3500096680	24		65251749	65251773	8421504	1	24	0	c	350009668000000016	0-24					Patent	Growth differentiation factor of the TGF-B family (Patent EP:0713529)	Hotten	2000	0		
1082	chr13	65251757	65254133	3500401117	46		65251757	65254133	8421504	2	24,22	0,2354	c,g	350040111700000001,350040111700000001,350040111700000000	0-24,0-24,0-22					Patent	Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system (Patent US:7632808)	Hotten	2009	0		GDF5OS
1082	chr13	65251757	65254133	3500399471	46		65251757	65254133	8421504	2	24,22	0,2354	c,g	350039947100000001,350039947100000001,350039947100000000	0-24,0-24,0-22					Patent	Use of MP52 or MP121 for treating and preventing diseases of the nervous system (Patent US:6531450)	Hotten	2003	0		GDF5OS
1082	chr13	65251757	65254133	3500283063	46		65251757	65254133	8421504	2	24,22	0,2354	c,g	350028306300000001,350028306300000001,350028306300000000,350028306300000000	0-24,0-24,0-22,0-22						Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system	Bechtold	2003	0		GDF5OS
1082	chr13	65251757	65254133	3500271581	46		65251757	65254133	8421504	2	24,22	0,2354	c,g	350027158100000001,350027158100000001,350027158100000000,350027158100000000	0-24,0-24,0-22,0-22						Use of mp52 0r mp121 for treating and preventing diseases of the nervous system	Bechtold	2002	0		GDF5OS
1082	chr13	65251757	65254133	3500152107	46		65251757	65254133	8421504	2	24,22	0,2354	c,g	350015210700000001,350015210700000001,350015210700000000	0-24,0-24,0-22						Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system	Hotten	2003	0		
1082	chr13	65254942	65254966	3500057625	24		65254942	65254966	8421504	1	24	0	g	350005762500000001	0-24		16829522	10.1074/jbc.M603851200	0021-9258	Journal of Biological Chemistry	CDMP1/GDF5 Has Specific Processing Requirements That Restrict Its Action to Joint Surfaces	Thomas	2006	5		GDF5OS
1084	chr13	65414714	65414739	3500039476	23		65414714	65414739	8421504	2	5,18	0,7	c	350003947600000102	11-34						cloning Molecular Cvirus genomefrom Japanese	www.pnas.org	0	0		
1084	chr13	65445131	65446697	3500237513	402		65445131	65446697	8421504	2	225,177	0,1389	p	350023751300015128,350023751300015131,350023751300015132	0-78,0-180,0-177						50 human secreted proteins	Komatsoulis	2000	0		RBM12
1084	chr13	65445320	65445818	3500408981	41		65445320	65445818	8421504	2	22,19	0,479	c	350040898100000056,350040898100000055	14-36,16-35						4 Materials and Methods	diss.fu-berlin.de	0	0		RBM12
1084	chr13	65448011	65450633	3500191464	24		65448011	65450633	8421504	2	1,23	0,2599	c	350019146400000027	5-29						Expression Vectors With Improved Safety 	.freshpatents.com	0	0		
1084	chr13	65459506	65473690	3500307946	1017		65459506	65473690	8421504	10	61,90,84,82,106,158,135,94,153,54	0,2133,2823,3543,3704,4414,6145,7603,10201,14130	p	350030794600015068,350030794600015062,350030794600015056,350030794600015050,350030794600015044	0-75,0-234,0-240,0-240,0-228						BMC Evolutionary Biology BioMed Central	web.onetel.com	0	0		NFS1
1084	chr13	65463299	65463936	3500014156	27		65463299	65463936	8421504	4	8,4,11,4	0,13,621,633	c	350001415600000003	2-29						Tese Doutorado Benedito R Neto da Silva Neto	ensu.iptsp.ufg.br	0	0		NFS1
1084	chr13	65469797	65469842	3500055765	45		65469797	65469842	8421504	1	45	0	p	350005576500015002	0-45		19454487	10.1093/hmg/ddp239		Human Molecular Genetics	Human ISD11 is essential for both iron&#x2013;sulfur cluster assembly and maintenance of normal cellular iron homeostasis	Yanbo	2009	0		NFS1
1085	chr13	65628009	65629004	3500386405	23		65628009	65629004	8421504	2	16,7	0,988	c	350038640500000017	13-36						Chimeric mcp and daf proteins with cell surface localizing domain	Creasey	1998	0		PHF20
1090	chr13	66209647	66209707	3500035186	60		66209647	66209707	8421504	1	60	0	p	350003518600015001	0-60			10.1038/sj.emboj.7600578		The EMBO Journal	p38&#x03b3; regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP	Guadalupe	2005	0		DLGAP4
1090	chr13	66226107	66226191	3500076204	84		66226107	66226191	8421504	1	84	0	p	350007620400015005	0-84						ESTUDO DA LIGA&#xc7;&#xc3;O DE C&#xc1;TIONS DIVALENTES EM S&#xcd;TIOS EF-HAND UTILIZANDO A CADEIA LEVE REGULAT&#xd3;RIA DE MIOSINA DE M&#xda;SCULO LISO THARIN MARIA BLUMENSCHEIN DE ALMEIDA Tese de doutorado submetida ao Departamento de Bioqu&#xed;mica do 	www.teses.usp.br	0	0		
1090	chr13	66261122	66261149	3500391004	23		66261122	66261149	8421504	2	14,9	0,18	g	350039100400000282,350039100400000046	0-28,0-28						Therapeutic uses of keratinocyte growth factor-2	Jimenez	1999	0		
1090	chr13	66261122	66261149	3500034980	23		66261122	66261149	8421504	2	14,9	0,18	g	350003498000000046	0-28						Keratinocyte growth factor-2 - US Patent 6916786 Description	ww.patentstorm.us	0	0		
1090	chr13	66268501	66268527	3500345633	24		66268501	66268527	8421504	2	14,10	0,16	c	350034563300000004	1-25		21343904	10.1038/ijo.2011.12	0307-0565	International Journal of Obesity	Suppression of inflammation-associated factors by indole-3-carbinol in mice fed high-fat diets and in isolated, co-cultured macrophages and adipocytes	Chang	2011	5		
1090	chr13	66268501	66268527	3500196171	24		66268501	66268527	8421504	2	14,10	0,16	c	350019617100000004	1-25		21343904	10.1038/ijo.2011.12	0307-0565	International Journal of Obesity	Suppression of inflammation-associated factors by indole-3-carbinol in mice fed high-fat diets and in isolated, co-cultured macrophages and adipocytes	Chang	2011	5		
1092	chr13	66489784	66489810	3500450361	26		66489784	66489810	8421504	1	26	0	c	350045036100000007	4-30						Efficient integration of transgenes into a defined locus in human embryonic stem cells. - ResearchGate	.researchgate.net	0	0		
1092	chr13	66489784	66489810	3500277899	26		66489784	66489810	8421504	1	26	0	c	350027789900000007	4-30		20071742	10.1093/nar/gkp1234		Nucleic Acids Research	Efficient integration of transgenes into a defined locus in human embryonic stem cells	Kenji	2010	0		
1093	chr13	66592291	66592319	3500155980	27		66592291	66592319	8421504	2	4,23	0,5	c	350015598000000006	15-42						New perspectives on Rett syndrome: the role of MECP2 gene in cellular senescence and neural differentiation	www3.unisi.it	0	0		
1093	chr13	66629354	66634439	3500000744	38		66629354	66634439	8421504	3	3,16,19	0,188,5066	c,g	350000074400000015,350000074400000014,350000074400000014	0-19,0-19,0-19		10454584		0270-7306	Molecular and Cellular Biology	CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase	Vigo	1999	6		RBL1
1093	chr13	66649506	66649529	3500440860	23		66649506	66649529	8421504	1	23	0	c	350044086000000000,350044086000000003	1-24,1-24						Transcriptional activators with graded transactivation potential	Baron	2000	0		
1093	chr13	66649506	66649529	3500259544	23		66649506	66649529	8421504	1	23	0	c	350025954400000003,350025954400000000	1-24,1-24						Transcriptional activators with graded transactivation potential	Baron	2000	0		
1093	chr13	66649506	66649529	3500226420	23		66649506	66649529	8421504	1	23	0	c	350022642000000003,350022642000000000	1-24,1-24					Patent	Transcriptional activators with graded transactivation potential (Patent US:6271341)	Baron	2001	0		
1093	chr13	66649506	66649529	3500223666	23		66649506	66649529	8421504	1	23	0	c	350022366600000000,350022366600000003	1-24,1-24					Patent	Transcriptional activators with graded transactivation potential (Patent US:6087166)	Baron	2000	0		
1093	chr13	66649506	66649529	3500085385	23		66649506	66649529	8421504	1	23	0	c	350008538500000003,350008538500000000	1-24,1-24					Patent	Transcriptional activators with graded transactivation potential (Patent EP:0990030)	Baron	2010	0		
1094	chr13	66772937	66772974	3500309840	30		66772937	66772974	8421504	4	6,6,14,4	0,10,18,33	c	350030984000000688	18-48						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1094	chr13	66772937	66772974	3500119454	30		66772937	66772974	8421504	4	6,6,14,4	0,10,18,33	c	350011945400000691	18-48						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1094	chr13	66772937	66772974	3500004227	30		66772937	66772974	8421504	4	6,6,14,4	0,10,18,33	c	350000422700000691	18-48						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
1094	chr13	66787179	66787568	3500042386	389		66787179	66787568	8421504	1	389	0	g	350004238600000012,350004238600000013	0-389,0-390						Super-active porcine growth hormone releasing hormone analog	Schwartz	2000	0		
1094	chr13	66802834	66802863	3500070832	24		66802834	66802863	8421504	3	5,5,14	0,8,15	g	350007083200000122	12-36						EML4-ALK fusion gene - Patent # 7605131 - PatentGenius	.patentgenius.com	0	0		
1095	chr13	66905516	66924368	3500429380	1608		66905516	66924368	8421504	12	75,175,100,99,104,150,156,180,77,154,132,206	0,93,1908,9334,9604,11547,13197,15446,17088,17902,18212,18646	p	350042938000015001	0-1608						<HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY BGCOLOR="#FFFFFF"> <TABLE BORDER="0" CELLPADDING="0" 	w.dna.affrc.go.jp	0	0		SRC
1095	chr13	66905516	66924368	3500155684	1608		66905516	66924368	8421504	12	75,175,100,99,104,150,156,180,77,154,132,206	0,93,1908,9334,9604,11547,13197,15446,17088,17902,18212,18646	p	350015568400015046,350015568400015059,350015568400015060,350015568400015062	0-1608,0-51,0-57,0-60						Ultra-sensitive detection systems	Chait	2001	0		SRC
1095	chr13	66905516	66905564	3500456078	48		66905516	66905564	8421504	1	48	0	p	350045607800015004	0-48						METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS	Spencer	2009	0		SRC
1095	chr13	66905516	66905564	3500332409	48		66905516	66905564	8421504	1	48	0	p	350033240900015000	0-48						Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters	Spencer	2011	0		SRC
1095	chr13	66905516	66905564	3500305712	48		66905516	66905564	8421504	1	48	0	p	350030571200015000	0-48						Method for treating solid tumors	Slawin	2011	0		SRC
1095	chr13	66905516	66905564	3500263569	48		66905516	66905564	8421504	1	48	0	p	350026356900015000	0-48						Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters	Spencer	2010	0		SRC
1095	chr13	66905516	66905564	3500148493	48		66905516	66905564	8421504	1	48	0	p	350014849300015001	0-48						METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS - Patent application	www.faqs.org	0	0		SRC
1095	chr13	66905516	66905564	3500121710	48		66905516	66905564	8421504	1	48	0	p	350012171000015001	0-48						METHOD FOR TREATING SOLID TUMORS - Patent application	www.faqs.org	0	0		SRC
1095	chr13	66905516	66905564	3500120365	48		66905516	66905564	8421504	1	48	0	p	350012036500015003	0-48						Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters	Priyadharshini	2010	0		SRC
1095	chr13	66905516	66905539	3500026756	23		66905516	66905539	8421504	1	23	0	c	350002675600000000	0-23		12429837	10.1091/mbc.E02-03-0174	1059-1524	Molecular Biology of the Cell	pp60Src Mediates Insulin-stimulated Sequestration of the &#x03b2;2-Adrenergic Receptor: Insulin Stimulates pp60Src Phosphorylation and Activation	Shumay	2002	5		SRC
1095	chr13	66905518	66905547	3500277226	29		66905518	66905547	8421504	1	29	0	c	350027722600000013,350027722600000000	0-19,0-26		16107610	10.1095/biolreprod.105.041616	0006-3363	Biology of Reproduction	Impairment of Decidualization in SRC-Deficient Mice	Shimizu	2005	4		
1095	chr13	66905519	66905571	3500460206	47		66905519	66905571	8421504	2	39,8	0,44	c	350046020600000006	0-55						ScienceDirect.com - FEBS Letters - Analysis of estrogen receptor &#x03b1; signaling complex at the plasma membrane	sciencedirect.com	0	0		SRC
1095	chr13	66905523	66905550	3500312148	27		66905523	66905550	8421504	1	27	0	c	350031214800000006	0-27						&#xc2e0;&#xaddc; &#xd53c;&#xb77c;&#xc878; &#xbc0f; &#xbca4;&#xc988;&#xc625;&#xc0ac;&#xc878; &#xce58;&#xd658;&#xb41c; &#xd53c;&#xb9ac;&#xb518; &#xc720;&#xb3c4;&#xccb4; &#xb610;&#xb294; &#xc774;&#xc758; &#xc57d;&#xd559;&#xc801;&#xc73c;&#xb85c; &#xd5c8;&#xc6	Koh	2009	0		
1095	chr13	66905523	66905550	3500254553	27		66905523	66905550	8421504	1	27	0	c	350025455300000006	0-27						&#xc2e0;&#xaddc; &#xd53c;&#xb77c;&#xc878; &#xbc0f; &#xbca4;&#xc988;&#xc625;&#xc0ac;&#xc878; &#xce58;&#xd658;&#xb41c; &#xd53c;&#xb9ac;&#xb518; &#xc720;&#xb3c4;&#xccb4; &#xb610;&#xb294; &#xc774;&#xc758; &#xc57d;&#xd559;&#xc801;&#xc73c;&#xb85c; &#xd5c8;&#xc6	Koh	2009	0		
1095	chr13	66905523	66905550	3500243271	27		66905523	66905550	8421504	1	27	0	c	350024327100000015	0-27						Novel pyrazole and benzoxazole-substituted pyridine derivatives or pharmaceutically acceptable salts thereof, preparation process for same, and pharmaceutical composition for prevention and treatment of disorders involving aberrant cell proliferation cont	Koh	2009	0		
1095	chr13	66905523	66905550	3500053197	27		66905523	66905550	8421504	1	27	0	c	350005319700000006	0-27						NOVEL PYRAZOLE AND BENZOXAZOLE-SUBSTITUTED PYRIDINE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION PROCESS FOR SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DISORDERS INVOLVING ABERRANT CELL PROLIFERATION CONT	www.sumobrain.com	0	0		
1095	chr13	66905525	66905738	3500394669	42		66905525	66905738	8421504	2	21,21	0,192	c,g	350039466900000000,350039466900000000,350039466900000001,350039466900000001	0-21,0-21,0-21,0-21						Inhibition of Src Expression and Activity Inhibits Tumor Progression and Metastasis of Human Pancreatic Adenocarcinoma Cells in an Orthotopic Nude Mouse Model 2006&#x5e74;&#x7b2c;168&#x5377;&#x7b2c;3&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;	www.39kf.com	0	0		SRC
1095	chr13	66905525	66905738	3500138116	42		66905525	66905738	8421504	2	21,21	0,192	c,g	350013811600000000,350013811600000001,350013811600000001	0-21,0-21,0-21		16103072	10.1158/0008-5472.CAN-04-3858	0008-5472	Cancer Research	Expression and Activity of Src Regulate Interleukin-8 Expression in Pancreatic Adenocarcinoma Cells: Implications for Angiogenesis	Trevino	2005	8		SRC
1095	chr13	66905525	66905738	3500116126	42		66905525	66905738	8421504	2	21,21	0,192	c,g	350011612600000000,350011612600000000,350011612600000001,350011612600000001	0-21,0-21,0-21,0-21			10.1038/sj.bjc.6603143		British Journal of Cancer	Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases	D	2006	0		SRC
1095	chr13	66905525	66905738	3500082811	42		66905525	66905738	8421504	2	21,21	0,192	c,g	350008281100000000,350008281100000001,350008281100000001	0-21,0-21,0-21			10.2353/ajpath.2006.050570		The American Journal of Pathology	Inhibition of Src Expression and Activity Inhibits Tumor Progression and Metastasis of Human Pancreatic Adenocarcinoma Cells in an Orthotopic Nude Mouse Model	Jose	2006	0		SRC
1095	chr13	66907432	66914867	3500116995	44		66907432	66914867	8421504	3	22,5,17	0,87,7418	c	350011699500000005,350011699500000006	0-22,0-22						495-498 12.17 Ahmad Gholamhoseinian Najar[1] - ResearchGate	.researchgate.net	0	0		SRC
1095	chr13	66907432	66914867	3500084115	44		66907432	66914867	8421504	3	22,5,17	0,87,7418	c	350008411500000001,350008411500000002	0-22,0-22						c-SrcAnt isense Complexed with PAMAM Denderimes Decreases of c-Src Expression and EGFR-Dependent Downstream Genes in the Human HT-29 Colon Cancer Cell Line	.apocpcontrol.org	0	0		SRC
1095	chr13	66907450	66907495	3500095230	45		66907450	66907495	8421504	1	45	0	p	350009523000015000	0-45						St. Francis IL : CHEM 255 : exam 2 030609 key	ww.coursehero.com	0	0		SRC
1095	chr13	66914938	66918760	3500396186	312		66914938	66918760	8421504	4	11,104,150,47	0,182,2125,3775	p,c,g	350039618600015055,350039618600000015,350039618600000015,350039618600015056,350039618600015057	0-87,27-48,27-48,0-84,0-141						Compositions and Methods for the Delivery of Biologically Active RNAs	Polach	2012	0		SRC
1095	chr13	66915130	66918757	3500359428	240		66915130	66918757	8421504	4	94,98,4,44	0,1933,2079,3583	p	350035942800015007,350035942800015008,350035942800015009,350035942800015010,350035942800015011	0-48,0-48,0-48,0-48,0-48						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		SRC
1095	chr13	66915130	66918757	3500322942	240		66915130	66918757	8421504	4	94,98,4,44	0,1933,2079,3583	p	350032294200015007,350032294200015008,350032294200015009,350032294200015010,350032294200015011	0-48,0-48,0-48,0-48,0-48						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		SRC
1095	chr13	66915130	66918757	3500075196	240		66915130	66918757	8421504	4	94,98,4,44	0,1933,2079,3583	p	350007519600015012,350007519600015013,350007519600015014,350007519600015015,350007519600015016	0-48,0-48,0-48,0-48,0-48						USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS	Dunnington	1997	0		SRC
1095	chr13	66915178	66918757	3500335247	144		66915178	66918757	8421504	4	46,50,4,44	0,1885,2031,3535	p	350033524700015007,350033524700015008,350033524700015010	0-48,0-48,0-48						Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection	Dunnington	1997	0		SRC
1095	chr13	66918730	66922663	3500447238	240		66918730	66922663	8421504	4	78,51,57,54	0,2246,2354,3879	p	350044723800015005,350044723800015010,350044723800015015	9-87,0-51,9-120						Structure characterization	www.pnas.org	0	0		SRC
1095	chr13	66918766	66918811	3500355215	45		66918766	66918811	8421504	1	45	0	p	350035521500015117	0-45						US Patent # 7,384,913. PT32 sperm protein, sperm c-Yes, oocyte cytoplasmic c-Yes, and uses thereof - Patents.com	www.patents.com	0	0		SRC
1095	chr13	66918816	66921021	3500322643	40		66918816	66921021	8421504	2	19,21	0,2184	c	350032264300000000,350032264300000001	0-19,0-21		19568237	10.1038/sj.bjc.6605172	0007-0920	British Journal of Cancer	Episodic Src activation in uveal melanoma revealed by kinase activity profiling	Maat	2009	5		SRC
1095	chr13	66918816	66921021	3500308204	40		66918816	66921021	8421504	2	19,21	0,2184	c	350030820400000000,350030820400000001	0-19,0-21		19568237	10.1038/sj.bjc.6605172		British Journal of Cancer	Episodic Src activation in uveal melanoma revealed by kinase activity profiling	W	July	0		SRC
1095	chr13	66918816	66921021	3500233284	40		66918816	66921021	8421504	2	19,21	0,2184	c	350023328400000000,350023328400000001	0-19,0-21		19568237	10.1038/sj.bjc.6605172	0007-0920	British Journal of Cancer	Episodic Src activation in uveal melanoma revealed by kinase activity profiling	Maat	2009	5		SRC
1095	chr13	66921063	66921141	3500300287	78		66921063	66921141	8421504	1	78	0	p	350030028700015002	0-78						Engineered Protein Kinases Which Can Utilize Modified Nucleotide Triphosphate Substrates - Patent application	www.faqs.org	0	0		SRC
1095	chr13	66921063	66921141	3500222363	78		66921063	66921141	8421504	1	78	0	p	350022236300015002,350022236300015011	0-78,0-48						US Patent # 6,521,417. Engineered protein kinases which can utilize modified nucleotide triphosphate substrates - Patents.com	www.patents.com	0	0		SRC
1095	chr13	66921063	66921141	3500063398	78		66921063	66921141	8421504	1	78	0	p	350006339800015002	0-78						US Patent # 7,049,116. Engineered protein kinases which can utilize modified nucleotide triphosphate substrates - Patents.com	www.patents.com	0	0		SRC
1095	chr13	66921063	66921141	3500021948	78		66921063	66921141	8421504	1	78	0	p	350002194800015003	0-78						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		SRC
1095	chr13	66921063	66921141	3500008336	78		66921063	66921141	8421504	1	78	0	p	350000833600015002,350000833600015010	0-78,0-45						Engineered protein kinases which can utilize modified nucleotide triphosphate substrates	Shokat	2000	0		SRC
1095	chr13	66923526	66923745	3500393400	63		66923526	66923745	8421504	2	46,17	0,202	p	350039340000015004	0-63						METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS - Patent application	www.faqs.org	0	0		LYN
1095	chr13	66923544	66923805	3500366238	105		66923544	66923805	8421504	2	28,77	0,184	p	350036623800015013	0-105						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		SRC
1095	chr13	66923757	66923805	3500019454	48		66923757	66923805	8421504	1	48	0	p	350001945400015038	0-48						Introduction to Computational Molecular Biology - Carlos Setubal, Joao Meidanis	www.scribd.com	0	0		SRC
1095	chr13	66924286	66924311	3500408423	25		66924286	66924311	8421504	1	25	0	g	350040842300000001,350040842300000007	25-50,25-50						US Patent # 7,417,148. 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML) - Patents.com	www.patents.com	0	0		
1095	chr13	66924286	66924311	3500331456	25		66924286	66924311	8421504	1	25	0	g	350033145600000001	25-50						4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury	Arndt	2004	0		
1095	chr13	66924293	66924318	3500408876	25		66924293	66924318	8421504	1	25	0	c	350040887600000028	0-25						 Microarray Analysis and RNA Silencing Link fra-1 to cd44 and c-met Expression in Mesothelioma1 	www.docstoc.com	0	0		SRC
1095	chr13	66924349	66924373	3500241075	24		66924349	66924373	8421504	1	24	0	c	350024107500000013	6-30						Phosphatidylinositol Phosphate Kinase Type I Directly Associates with and Regulates Shp-1 Tyrosine Phosphatase--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x	journal.9med.net	0	0		
1096	chr13	67040264	67040289	3500435659	25		67040264	67040289	8421504	1	25	0	c	350043565900000070	0-25						 Proteins And Nucleic Acids Encoding Same 	www.docstoc.com	0	0		
1097	chr13	67178336	67178363	3500313646	25		67178336	67178363	8421504	2	7,18	0,9	c	350031364600000112	3-28						Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof	Frank	1996	0		
1097	chr13	67178336	67178363	3500265438	25		67178336	67178363	8421504	2	7,18	0,9	c	350026543800000112	3-28						Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof	Frank	1998	0		
1097	chr13	67212338	67216436	3500047637	24		67212338	67216436	8421504	3	13,4,7	0,16,4091	c	350004763700000480	22-46						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
1097	chr13	67227192	67227318	3500143893	48		67227192	67227318	8421504	2	24,24	0,102	c	350014389300000000,350014389300000001	0-24,0-24						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
1097	chr13	67227192	67227216	3500382906	24		67227192	67227216	8421504	1	24	0	c	350038290600000000	0-24						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		CTNNBL1
1098	chr13	67257367	67347321	3500307359	834		67257367	67347321	8421504	8	36,149,182,98,81,138,73,77	0,1543,23685,62753,64520,79023,79401,89877	p	350030735900015093,350030735900015096,350030735900015100,350030735900015102,350030735900015104	0-168,0-180,0-180,0-180,0-126						48 human secreted proteins	Komatsoulis	2000	0		CTNNBL1
1099	chr13	67473087	67473112	3500348845	23		67473087	67473112	8421504	2	11,12	0,13	c	350034884500000102	4-27						Nucleic acids encoding hencatoporetic stem cell receptor flk-2 - Patent # 5185438 - PatentGenius	.patentgenius.com	0	0		
1099	chr13	67473087	67473112	3500282272	23		67473087	67473112	8421504	2	11,12	0,13	c	350028227200000103	4-27					Patent	Nucleic acids encoding hencatoporetic stem cell receptor flk-2 (Patent US:5185438)	Lemischka	1993	0		
1100	chr13	67592160	67598315	3500071938	63		67592160	67598315	8421504	4	20,15,8,20	0,3433,4432,6135	c,g	350007193800000001,350007193800000001,350007193800000008,350007193800000000	0-20,0-20,0-23,0-20		10212262	10.1074/jbc.274.18.12774	0021-9258	Journal of Biological Chemistry	Differential Signaling by the Thromboxane Receptor Isoforms via the Novel GTP-binding Protein, Gh	Vezza	1999	5		
1100	chr13	67592834	67603349	3500281958	540		67592834	67603349	8421504	11	99,29,97,78,9,105,3,12,78,23,7	0,105,2596,2696,3758,3773,3884,5427,5442,5523,10508	p	350028195800015019	0-549						Modulators of angiogenesis and tumorigenesis	E	2004	0		
1100	chr13	67592834	67603349	3500211813	540		67592834	67603349	8421504	11	99,29,97,78,9,105,3,12,78,23,7	0,105,2596,2696,3758,3773,3884,5427,5442,5523,10508	p	350021181300015019	0-549						Modulators of angiogenesis and tumorigenesis	Atchison	2005	0		
1100	chr13	67596604	67596649	3500028305	45		67596604	67596649	8421504	1	45	0	p	350002830500015000	0-45		22759359	10.1186/1471-2407-12-277	1471-2407	BMC Cancer	Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN	Wang	2012	3		TGM2
1100	chr13	67608713	67608739	3500435181	23		67608713	67608739	8421504	2	18,5	0,21	g	350043518100000061	0-23						Jolly Thesis 1993 | Alain Dautant - Academia.edu	www.academia.edu	0	0		
1101	chr13	67747928	67749883	3500017737	40		67747928	67749883	8421504	2	20,20	0,1935	c,g	350001773700000000,350001773700000000,350001773700000001,350001773700000001	0-20,0-20,0-20,0-20		17012258	10.1096/05-5662com	0892-6638	The FASEB Journal	Bactericidal/permeability-increasing protein&#x2019;s signaling pathways and its retinal trophic and anti-angiogenic effects	Yamagata	2006	6		
137	chr13	67751437	67765458	3500348738	46		67751437	67765458	8421504	2	21,25	0,13996	c	350034873800000055,350034873800000069	0-21,17-42						Methods for Recombinant Peptide Production - Patent application	www.faqs.org	0	0		
1102	chr13	67765433	67765458	3500175480	25		67765433	67765458	8421504	1	25	0	c	350017548000000026	16-41						Therapeutic uses of BPI protein products in BPI-deficient humans - Patent # 7041644 - PatentGenius	.patentgenius.com	0	0		
1102	chr13	67772658	67772739	3500383646	46		67772658	67772739	8421504	2	25,21	0,60	c,g	350038364600000030,350038364600000031,350038364600000031	0-25,0-21,0-21						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
1102	chr13	67772718	67772785	3500380921	47		67772718	67772785	8421504	3	21,20,6	0,36,61	c	350038092100000012,350038092100000004	25-46,10-37						END OF PROJECT REPORT 5230 Animal Transport: Developing optimum animal handling procedures and effective transport strategies in the food production chain to improve animal welfare and food quality.	www.teagasc.ie	0	0		
1102	chr13	67802010	67802037	3500085271	27		67802010	67802037	8421504	1	27	0	c	350008527100000030	21-48						US Patent # 5,731,415. Lipopolysaccharide binding protein derivatives - Patents.com	www.patents.com	0	0		
1102	chr13	67815493	67817981	3500172791	40		67815493	67817981	8421504	2	20,20	0,2468	c	350017279100000011,350017279100000010	0-20,0-20		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
1102	chr13	67815493	67817981	3500120290	40		67815493	67817981	8421504	2	20,20	0,2468	c	350012029000000011,350012029000000010	0-20,0-20						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
1102	chr13	67815493	67817981	3500048191	40		67815493	67817981	8421504	2	20,20	0,2468	c	350004819100000011,350004819100000010	0-20,0-20		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
1103	chr13	67966193	67966218	3500209641	24		67966193	67966218	8421504	2	7,17	0,8	g	350020964100000008	6-36						AF catgtccagctttctggcatctaggttccctcccc R ggggagggaacctagatgccagaaagctggacatg AF cttccatgtccagctttctgtctgcaaggttccctccc R gggagggaaccttgcagacagaaagctggacatggaag AF | Epigenetics Guide	eptin-116-130.com	0	0		
1106	chr13	68288565	68288589	3500171941	23		68288565	68288589	8421504	2	17,6	0,18	c	350017194100000022	25-48						Novel Neurotrophic Factors - Patent application	www.faqs.org	0	0		
1106	chr13	68291826	68291850	3500139576	24		68291826	68291850	8421504	1	24	0	g	350013957600000004	0-24		12055102	10.1152/ajpcell.00442.2001		American Journal of Physiology - Cell Physiolog	TIMAP, a novel CAAX box protein regulated by TGF-&#x03b2;1 and expressed in endothelial cells	Cao	2002	0		
1110	chr13	68892761	68892785	3500311161	23		68892761	68892785	8421504	2	15,8	0,16	g	350031116100000127	11-34						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
1110	chr13	68892761	68892785	3500256323	23		68892761	68892785	8421504	2	15,8	0,16	g	350025632300000122	11-34						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - US Patent 5627061 Description	ww.patentstorm.us	0	0		
1112	chr13	69138801	69138826	3500016481	23		69138801	69138826	8421504	3	6,13,4	0,7,21	g	350001648100000073	3-26						GLYCOENGINEERED, RECOMBINANT ANTIBODY - Patent application	www.faqs.org	0	0		
1118	chr13	69898934	69898961	3500452053	23		69898934	69898961	8421504	3	5,13,5	0,6,22	g	350045205300000088	2-25						US Patent # 7,227,008. 13-transmembrane protein expressed in prostate cancer - Patents.com	www.patents.com	0	0		
140	chr13	70383849	70441145	3500266480	540		70383849	70441145	8421504	13	17,31,35,21,27,44,18,30,27,63,99,51,77	0,14967,15046,35587,37197,37678,48555,49629,50862,51401,52476,56087,57219	p,c	350026648000000011,350026648000000013,350026648000000028,350026648000000033,350026648000015029,350026648000015081,350026648000015126,350026648000000044,350026648000015084,350026648000015130,350026648000015038,350026648000015132,350026648000015088,350026648000015138,350026648000015045,350026648000015091,350026648000015144,350026648000000092	0-48,0-35,0-48,0-44,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-20						US Patent # 6,951,720. Use of phosphorothiolate polynucleotides in ligating nucleic acids - Patents.com	www.patents.com	0	0		
1122	chr13	70398842	70398882	3500147053	40		70398842	70398882	8421504	1	40	0	c	350014705300000000,350014705300000001	11-31,8-30						Deoxycholic acid | Online Peptides Guide	biting-factor.com	0	0		
1122	chr13	70436424	70439664	3500004970	87		70436424	70439664	8421504	2	27,60	0,3180	p	350000497000015017	108-195						Structure of the human type I DNA topoisomerase gene. - ResearchGate	.researchgate.net	0	0		
1122	chr13	70439622	70441161	3500081559	327		70439622	70441161	8421504	3	77,150,100	0,295,1439	p	350008155900015009,350008155900015005,350008155900015006,350008155900015002,350008155900015001,350008155900015008	165-819,0-60,0-63,0-60,0-51,0-60						Determination of an Epitope of the Diffuse Systemic Sclerosis Marker Antigen DNA Topoisomerase I: Sequence Similarity with Retroviral p30gag Protein Suggests a Possible Cause for Autoimmunity in Systemic Sclerosis	www.jstor.org	0	0		
1122	chr13	70439976	70441135	3500388018	43		70439976	70441135	8421504	2	23,20	0,1139	c,g	350038801800000001,350038801800000000,350038801800000000	0-23,0-20,0-20		22722827	10.1097/JTO.0b013e31825cca4c	1556-0864	Journal of Thoracic Oncology	 MET Increases the Sensitivity of Gefitinib-Resistant Cells t... : Journal of Thoracic Oncology 	Sakai	2012	4		
1122	chr13	70442178	70442208	3500155690	30		70442178	70442208	8421504	1	30	0	g	350015569000000029	0-30						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		TOP1
1122	chr13	70442269	70442294	3500445135	23		70442269	70442294	8421504	2	9,14	0,11	c	350044513500000218,350044513500000014	4-27,4-27						DNA molecules encoding bacterial lysine 2,3-aminomutase	Frey	1999	0		FMO4
1122	chr13	70442269	70442294	3500262697	23		70442269	70442294	8421504	2	9,14	0,11	c	350026269700000005	4-27						Methods for the preparation of beta-amino acids	Frey	2003	0		TOP1
1122	chr13	70442269	70442294	3500199854	23		70442269	70442294	8421504	2	9,14	0,11	c	350019985400000014	4-27						Method for producing L-&#x03b2;-lysine	Frey	2001	0		FMO4
1122	chr13	70442269	70442294	3500107506	23		70442269	70442294	8421504	2	9,14	0,11	c	350010750600000014,350010750600000218	4-27,4-27						METHOD FOR PRODUCING L-BETA-LYSINE - Patent application	www.faqs.org	0	0		TOP1
1122	chr13	70476947	70477007	3500258983	60		70476947	70477007	8421504	1	60	0	p	350025898300015000	0-60						Supporting Information	www.pnas.org	0	0		PLCG1
1122	chr13	70477110	70477674	3500399861	345		70477110	70477674	8421504	2	167,178	0,386	p	350039986100015040,350039986100015043	0-345,1149-1494						COINCIDENCE DETECTION	Parker	2011	0		
1122	chr13	70479814	70480073	3500068854	87		70479814	70480073	8421504	2	53,34	0,225	p	350006885400015025	0-87						The SH3 Domain of the Saccharomyces cerevisiae Membrane Protein Pex13p Functions as a Docking Site for Pex5p, a Mobile Receptor for the Import of PTSl-containing Proteins	jcb.rupress.org	0	0		PLCG1
1122	chr13	70482215	70482241	3500175882	26		70482215	70482241	8421504	1	26	0	c	350017588200000007,350017588200000018,350017588200000017,350017588200000006	0-25,0-26,0-26,0-25						Inhibitors of phosphoinositide-specific phospholipase C	Gibbs	1993	0		
1122	chr13	70482215	70482241	3500125432	26		70482215	70482241	8421504	1	26	0	c	350012543200000006,350012543200000016,350012543200000017,350012543200000005	0-25,0-26,0-26,0-25						Expression and purification of phosphoinositide-specific phospholipase C-.gamma. - Patent # 5474921 - PatentGenius	.patentgenius.com	0	0		
1122	chr13	70484252	70484312	3500376734	60		70484252	70484312	8421504	1	60	0	p	350037673400015006	0-60						Method of detecting ligand interactions	Lu	1995	0		PLCG1
1124	chr13	70703614	70703641	3500407384	23		70703614	70703641	8421504	2	11,12	0,15	c	350040738400000027	2-25						MN/CA IX and Cancer Prognosis - Patent application	www.faqs.org	0	0		
1124	chr13	70703614	70703641	3500247944	23		70703614	70703641	8421504	2	11,12	0,15	c	350024794400000037	2-25						MN Gene and Protein - Patent application	www.faqs.org	0	0		
1124	chr13	70703614	70703641	3500078831	23		70703614	70703641	8421504	2	11,12	0,15	c	350007883100000047	2-25						MN Gene and Protein - Patent application	www.faqs.org	0	0		
1124	chr13	70712721	70739044	3500070288	41		70712721	70739044	8421504	2	20,21	0,26302	g	350007028800000924,350007028800000529	0-20,7-28						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
1124	chr13	70721947	70721976	3500053431	26		70721947	70721976	8421504	2	11,15	0,14	g	350005343100000193	0-26					Patent	Binding agents which inhibit myostatin (Patent US:7928075)	Han	2011	0		
1124	chr13	70730403	70734488	3500342848	84		70730403	70734488	8421504	2	11,73	0,4012	p	350034284800015017	69-153						The DNA-binding domain of the Chd1 chromatin-remodelling enzyme contains SANT and SLIDE domains. - ResearchGate	.researchgate.net	0	0		
1125	chr13	70782035	70805238	3500245677	483		70782035	70805238	8421504	6	129,87,118,59,63,27	0,324,6300,7081,7996,23176	p	350024567700015014,350024567700015009,350024567700015004	0-180,0-147,0-156						CHD8, a Novel ATP-dependent Chromatin Remodeling Enzyme by	lue.lib.umich.edu	0	0		CHD6
1128	chr13	71218012	71218097	3500119257	84		71218012	71218097	8421504	2	18,66	0,19	g	350011925700000044	3-87						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
1139	chr13	72660857	72660881	3500461943	23		72660857	72660881	8421504	2	14,9	0,15	g	350046194300000001	0-25		19143868	10.1111/j.1751-553X.2007.00997.x	1751-553X	International Journal of Laboratory Hematology	Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation - NASEF - 2007 - International Journal of Laboratory Hematology - Wiley Online Library	NASEF	2009	0		
1139	chr13	72744786	72744814	3500280030	23		72744786	72744814	8421504	2	7,16	0,12	g	350028003000000283,350028003000000361	15-38,15-38						Ldl-receptor	Caskey	2000	0		
1140	chr13	72804495	72806053	3500215713	43		72804495	72806053	8421504	2	21,22	0,1536	c,g	350021571300000022,350021571300000022,350021571300000023	0-21,0-21,0-22		21750108	10.1101/gr.118638.110	1088-9051	Genome Research	Loss of exon identity is a common mechanism of human inherited disease	Sterne-Weiler	2011	14		SRSF6
1140	chr13	72809464	72809680	3500303839	213		72809464	72809680	8421504	2	156,57	0,159	c	350030383900000000	0-213						ASSESSMENT OF MYCOBACTERIUM INFECTION - THE UNVERSITY OF SYDNEY	www.sumobrain.com	0	0		
1140	chr13	72825692	72831843	3500028009	39		72825692	72831843	8421504	2	19,20	0,6131	g	350002800900000018,350002800900000019	0-19,0-20						Putative imprinted gene expression in uniparental bovine embryo models	library.uq.edu.au	0	0		
1141	chr13	72942807	72946708	3500180094	23		72942807	72946708	8421504	2	13,10	0,3891	c	350018009400000031	19-48						Antibodies directed against CD30 ligand	Goodwin	1995	0		
1141	chr13	72942807	72946708	3500088261	23		72942807	72946708	8421504	2	13,10	0,3891	c	350008826100000035	19-48						US Patent # 6,667,039. CD30 ligand - Patents.com	www.patents.com	0	0		
1141	chr13	72947641	72961454	3500196738	450		72947641	72961454	8421504	14	33,12,45,45,30,15,45,45,26,19,45,24,21,45	0,174,189,237,10433,10873,10891,10939,10987,12315,12337,12391,13744,13768	p	350019673800015060,350019673800015063,350019673800015064,350019673800015084,350019673800015085,350019673800015086,350019673800015087,350019673800015088,350019673800015089,350019673800015090	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Methods and compositions for regulating cell cycle progression	Bernstein	2001	0		MYBL2
1144	chr13	73280075	73282065	3500428237	23		73280075	73282065	8421504	3	7,4,12	0,8,1978	c	350042823700000025	12-35						Transferability of simple sequence repeat markers in blackgram (Vigna mungo). - ResearchGate	.researchgate.net	0	0		
1144	chr13	73280075	73282065	3500202352	23		73280075	73282065	8421504	3	7,4,12	0,8,1978	c	350020235200000025	12-35						Transferability of simple sequence repeat markers in blackgram (Vigna mungo). - ResearchGate	.researchgate.net	0	0		
1144	chr13	73297553	73297581	3500137915	25		73297553	73297581	8421504	2	16,9	0,19	g	350013791500000458	15-40						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1145	chr13	73417954	73441269	3500400966	200		73417954	73441269	8421504	2	180,20	0,23295	p,c	350040096600015026,350040096600000011	117-297,20-40						GEN&#xc9;TICA DE LA ENFERMEDAD DE CHARCOT-MARIE- TOOTH AUTOS&#xd3;MICA RECESIVA	digital.csic.es	0	0		GDAP1L1
143	chr13	73491324	73553455	3500014538	60		73491324	73553455	8421504	3	19,20,21	0,35662,62110	c,g	350001453800000009,350001453800000007,350001453800000007,350001453800000022	4-23,0-20,0-20,0-21			10.1002/hep.21592	1527-3350	Hepatology	Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4&#x03b1; isoforms - Pascussi - 2007 - Hepatology - Wiley Online Library	Pascussi	2007	0		
143	chr13	73526850	73744567	3500340968	62		73526850	73744567	8421504	7	11,6,7,9,9,7,13	0,12,93264,213140,217041,217065,217704	c	350034096800000085,350034096800000089	13-75,0-22						TARGETS FOR USE IN DIAGNOSIS, PROGNOSIS AND THERAPY OF CANCER - Patent application	www.faqs.org	0	0		
143	chr13	73526850	73744567	3500185291	62		73526850	73744567	8421504	7	11,6,7,9,9,7,13	0,12,93264,213140,217041,217065,217704	c	350018529100000053,350018529100000052	13-75,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		
143	chr13	73526850	73744567	3500166301	62		73526850	73744567	8421504	7	11,6,7,9,9,7,13	0,12,93264,213140,217041,217065,217704	c	350016630100000085,350016630100000089	13-75,0-22						Targets For Use In Diagnosis, Prognosis And Therapy Of Cancer - Patent application	www.faqs.org	0	0		
143	chr13	73526850	73744567	3500040785	62		73526850	73744567	8421504	7	11,6,7,9,9,7,13	0,12,93264,213140,217041,217065,217704	c	350004078500000115,350004078500000072	13-75,0-22						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		
1146	chr13	73531406	73553340	3500074017	119		73531406	73553340	8421504	5	29,7,45,10,28	0,1096,20710,20800,21906	c	350007401700000015,350007401700000035,350007401700000037	9-45,0-45,0-38						Liver enriched transcription factor	Sladek	1993	0		
1146	chr13	73531406	73531429	3500008900	23		73531406	73531429	8421504	1	23	0	c	350000890000000016	0-23						Di&#xfb00;erentiationofhumanEmbryonic StemCellsintohepatocytesasatoolto analysedynamicregulatoryevents duringhepatogenesis in vitro	diss.fu-berlin.de	0	0		HNF4A
1146	chr13	73532517	73547876	3500077888	59		73532517	73547876	8421504	3	20,19,20	0,12398,15339	c,g	350007788800000006,350007788800000006,350007788800000056,350007788800000056,350007788800000007	0-20,0-20,0-19,0-19,0-20						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1146	chr13	73538878	73538906	3500107715	24		73538878	73538906	8421504	2	10,14	0,14	c	350010771500000002	24-48						Urokinase-type plasminogen activator receptor	Danoe	1990	0		
1146	chr13	73539860	73547881	3500203394	48		73539860	73547881	8421504	2	24,24	0,7997	c	350020339400000014,350020339400000015	0-24,0-24						Human Embryonic Stem Cells: The Practical Handbook	www.scribd.com	0	0		HNF4A
1146	chr13	73544925	73552161	3500243981	72		73544925	73552161	8421504	2	27,45	0,7191	c	350024398100000028,350024398100000035	18-45,0-45						US Patent # 5,604,115. Liver enriched transcription factor - Patents.com	www.patents.com	0	0		
1146	chr13	73547790	73547820	3500182220	30		73547790	73547820	8421504	1	30	0	c	350018222000000020	0-30						Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily	enesdev.cshlp.org	0	0		
1146	chr13	73547935	73547958	3500257451	23		73547935	73547958	8421504	1	23	0	c	350025745100000061	7-30						METHOD FOR IDENTIFYING THERAPEUTICAL TARGETS IN SECONDARY TUMORS, THE USE OF THEREOF AND MEANS FOR IDENTIFYING, LABELLING AND TARGETING SECONDARY TUMORS - Patent application	www.faqs.org	0	0		HNF4A
1146	chr13	73547977	73552121	3500261436	38		73547977	73552121	8421504	2	19,19	0,4125	c,g	350026143600000055,350026143600000055,350026143600000056,350026143600000056	0-19,0-19,0-19,0-19						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1146	chr13	73553429	73553455	3500031457	26		73553429	73553455	8421504	1	26	0	c	350003145700000007	6-32						Hepatocyte nuclear factor-4&#x03b1; and bile acids regulate human concentrative nucleoside transporter-1 gene expression	gi.physiology.org	0	0		HNF4A
1147	chr13	73741958	73741988	3500096665	30		73741958	73741988	8421504	1	30	0	c	350009666500000001	6-36		11067872	10.1084/jem.192.9.1223	0022-1007	The Journal of Experimental Medicine	The Binding Site of Human Adenosine Deaminase for Cd26/Dipeptidyl Peptidase IV	Richard	2000	14		
1147	chr13	73748342	73765068	3500323180	77		73748342	73765068	8421504	3	24,25,28	0,5971,16698	g	350032318000000056,350032318000000017,350032318000000041	0-24,0-25,5-33						Bioinformatics	www.koshika.co.in	0	0		
1148	chr13	73835681	73837982	3500438570	33		73835681	73837982	8421504	2	10,23	0,2278	c	350043857000000019	0-33						Connective Tissue Growth Factor (CTGF-3) - Patent application	www.faqs.org	0	0		
1148	chr13	73862064	73867673	3500134806	120		73862064	73867673	8421504	5	40,17,18,24,21	0,5499,5540,5561,5588	p	350013480600015007,350013480600015011	0-57,0-63						A TASK-1 h&#xe1;tt&#xe9;r K csatorna &#xe9;s receptor medi&#xe1;lt szab&#xe1;lyoz&#xe1;sa	phd.sote.hu	0	0		KCNK9
1148	chr13	73862065	73867614	3500410534	87		73862065	73867614	8421504	3	20,16,51	0,23,5498	p,c	350041053400000223,350041053400015136,350041053400000225	0-20,0-48,0-19						NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
1148	chr13	73867844	73867904	3500317548	60		73867844	73867904	8421504	1	60	0	p	350031754800015013	0-60						Two pore potassium channels, nucleotide sequences encoding them, and methods of using same	Pausch	2001	0		KCNK9
1149	chr13	74005290	74005315	3500346177	24		74005290	74005315	8421504	2	13,11	0,14	c	350034617700000190	13-48						Rna Interference That Blocks Expression Of Pro-apoptotic Proteins Potentiates Immunity Induced By Dna And Transfected Dendritic Cell Vaccines 	.freshpatents.com	0	0		
1149	chr13	74005290	74005315	3500311484	24		74005290	74005315	8421504	2	13,11	0,14	c	350031148400000198	13-48						Anticancer Combination Therapies - Patent application	www.faqs.org	0	0		
1149	chr13	74005290	74005315	3500272641	24		74005290	74005315	8421504	2	13,11	0,14	c	350027264100000241	13-48						DNA Vaccine Enhancement with MHC Class II Activators - Patent application	www.faqs.org	0	0		
1149	chr13	74005290	74005315	3500070526	24		74005290	74005315	8421504	2	13,11	0,14	c	350007052600000124	13-48						T1r1 Nucleic Acid Sequences And Vectors Containing Same 	.freshpatents.com	0	0		
1149	chr13	74020085	74025291	3500337690	468		74020085	74025291	8421504	10	24,45,45,9,36,85,8,105,90,21	0,99,243,291,2449,2488,3686,3745,4764,5185	p,c,g	350033769000000006,350033769000015145,350033769000015148,350033769000015149,350033769000015150,350033769000015182,350033769000015151,350033769000015153,350033769000015169,350033769000015154,350033769000015171,350033769000015155,350033769000015186,350033769000015156,350033769000015173,350033769000000007,350033769000000007	4-28,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,7-28,7-28						14-3-3 Antagonists for the Prevention and Treatment of Arthritis - Patent application	www.faqs.org	0	0		
1149	chr13	74020085	74025291	3500072427	225		74020085	74025291	8421504	8	24,45,45,9,36,37,8,21	0,99,243,291,2449,2536,3686,5185	p,c	350007242700000006,350007242700015106,350007242700015109,350007242700015110,350007242700015112,350007242700000007	4-28,0-45,0-45,0-45,0-45,7-28						14-3-3 ETA Antibodies and Uses Thereof for the Diagnosis and Treatment of Arthritis - Patent application	www.faqs.org	0	0		YWHAB
1149	chr13	74020085	74025258	3500322286	702		74020085	74025258	8421504	6	300,42,76,164,96,24	0,2449,2497,3686,4764,5149	p	350032228600015003,350032228600015010,350032228600015017,350032228600015024,350032228600015023	0-180,0-162,0-180,0-180,0-180						Lysine acetylation targets protein complexes and co-regulates major cellular functions	ww.sciencemag.org	0	0		
1149	chr13	74020088	74025288	3500107179	735		74020088	74025288	8421504	5	297,124,164,96,54	0,2446,3683,4761,5146	p	350010717900015009	12-747						Prion Doppel Alternative Splicing	www.mad-cow.org	0	0		YWHAB
1149	chr13	74020094	74020148	3500326174	54		74020094	74020148	8421504	1	54	0	p	350032617400015000	0-54						14-3-3 Mediates Histone Cross-Talk during Transcription Elongation in Drosophila	biology.emory.edu	0	0		YWHAB
1149	chr13	74023863	74023911	3500334774	48		74023863	74023911	8421504	1	48	0	p	350033477400015125	0-48						Signal Transduction Stress-related Proteins And Methods Of Use In Plants 	.freshpatents.com	0	0		YWHAZ
1149	chr13	74024873	74025246	3500223227	84		74024873	74025246	8421504	2	72,12	0,361	p	350022322700015060,350022322700015072	0-84,0-84						Diverse localization of 14-3-3 proteins in Arabidopsis thaliana	ufdc.ufl.edu	0	0		YWHAB
1150	chr13	74059150	74072796	3500395309	137		74059150	74072796	8421504	3	42,48,47	0,8953,13599	c	350039530900000081,350039530900000074,350039530900000068,350039530900000025,350039530900000027	0-42,0-48,0-47,4-23,0-23						COLON CANCER RELATED GENE TOM34 - Patent application	www.faqs.org	0	0		
1150	chr13	74072759	74072782	3500202925	23		74072759	74072782	8421504	1	23	0	c	350020292500000027,350020292500000025	0-23,4-23						COLON CANCER RELATED GENE TOM34	Nakamura	2006	0		
1150	chr13	74081847	74168201	3500090569	1461		74081847	74168201	8421504	11	35,81,129,115,165,168,138,129,187,158,156	0,5724,12391,15347,18369,20918,23818,27362,28384,48608,86198	p	350009056900015017	0-1461						USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER	Concari	2006	0		STK4
1150	chr13	74081847	74168201	3500090569	1461		74081847	74168201	8421504	11	35,81,129,115,165,168,138,129,187,158,156	0,5724,12391,15347,18369,20918,23818,27362,28384,48608,86198	p	350009056900015014	0-1461						USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER	Concari	2006	0		STK4
1150	chr13	74081847	74168201	3500040490	1461		74081847	74168201	8421504	11	35,81,129,115,165,168,138,129,187,158,156	0,5724,12391,15347,18369,20918,23818,27362,28384,48608,86198	p	350004049000015034	0-1461						USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER - Patent application	www.faqs.org	0	0		STK4
1150	chr13	74168144	74168195	3500371634	51		74168144	74168195	8421504	1	51	0	p	350037163400015002	0-51						Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation	www.pnas.org	0	0		STK4
1152	chr13	74354098	74364191	3500331092	1551		74354098	74364191	8421504	12	19,109,126,71,116,175,138,110,153,156,104,274	0,1256,2668,4195,4444,4858,6857,7400,7776,9299,9608,9819	p	350033109200015000	0-1551						KEGG T01008: 540059	www.genome.jp	0	0		
1152	chr13	74444029	74444054	3500185766	25		74444029	74444054	8421504	1	25	0	c	350018576600000000	5-30						The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene. - ResearchGate	.researchgate.net	0	0		
1152	chr13	74444029	74444052	3500156127	23		74444029	74444052	8421504	1	23	0	c	350015612700000000	0-23		16135788	10.1128/MCB.25.18.7953-7965.2005	0270-7306	Molecular and Cellular Biology	The BRG1- and hBRM-Associated Factor BAF57 Induces Apoptosis by Stimulating Expression of the Cylindromatosis Tumor Suppressor Gene	Wang	2005	6		
1154	chr13	74646856	74646882	3500279401	24		74646856	74646882	8421504	2	5,19	0,7	g	350027940100000061	24-48						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1992	0		
1155	chr13	74804537	74804565	3500297690	25		74804537	74804565	8421504	2	14,11	0,17	c	350029769000000146	6-36						US Patent # 5,556,781. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
1155	chr13	74804537	74804565	3500039160	25		74804537	74804565	8421504	2	14,11	0,17	c	350003916000000146	6-36						US Patent # 5,830,715. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
1156	chr13	74935599	74960486	3500375699	412		74935599	74960486	8421504	4	71,42,178,121	0,2655,4367,24766	g	350037569900000003	10-422						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1156	chr13	74955854	74955881	3500431942	27		74955854	74955881	8421504	1	27	0	c	350043194200000000	0-27			10.1117/1.2805452	1932-5150	Journal of Micro/Nanolithography, MEMS, and MOEMS	 SPIE | Journal of Micro/Nanolithography, MEMS, and MOEMS | Micro&#x2013;Rayleigh-B&#xe9;nard convection polymerase chain reaction system 	Yao	2007	1		
1156	chr13	74956776	74956832	3500346351	54		74956776	74956832	8421504	3	18,11,25	0,19,31	g	350034635100000000	0-54						Fremstilling af rekombinant Bovine Pancreatic Trypsin Inhibitor i Escherichiu coli. NMR s	diggy.ruc.dk:8080	0	0		
1156	chr13	74956776	74956832	3500232565	54		74956776	74956832	8421504	3	18,11,25	0,19,31	g	350023256500000000	0-54						Fremstilling af rekombinant bovine pancreatic trypsin inhibitor i escher ixhia coli.	rudar.ruc.dk	0	0		
1156	chr13	74956777	74956806	3500288499	29		74956777	74956806	8421504	1	29	0	c	350028849900000019,350028849900000005,350028849900000004	6-35,0-24,16-35					Patent	Aprotinin analogues and a process for the production thereof (Patent US:5373090)	Norris	1994	0		
1156	chr13	74956777	74956806	3500192815	29		74956777	74956806	8421504	1	29	0	c	350019281500000047,350019281500000003,350019281500000020	6-35,3-24,16-35						Aprotinin analogs	Bj	1995	0		
1156	chr13	74956799	74956860	3500339719	61		74956799	74956860	8421504	1	61	0	g	350033971900000033	51-112					Patent	Method for determining nucleotide identity through extension of immobilized primer (Patent US:6004744)	Anderson	1999	0		
1156	chr13	74956799	74956860	3500216109	61		74956799	74956860	8421504	1	61	0	c,g	350021610900000033,350021610900000033	51-112,51-112						US Patent # 6,004,744. Method for determining nucleotide identity through extension of immobilized primer - Patents.com	www.patents.com	0	0		
1156	chr13	74956801	74956860	3500142125	59		74956801	74956860	8421504	1	59	0	g	350014212500000032	51-110						US Patent # 6,537,748. Reagent for nucleic acid typing by primer extension - Patents.com	www.patents.com	0	0		
1156	chr13	74956812	74956860	3500417221	48		74956812	74956860	8421504	1	48	0	p	350041722100015008,350041722100015011	0-48,0-48						Aprotinin analogues and a process for the production thereof	Norris	1989	0		
1156	chr13	74956812	74956860	3500395521	48		74956812	74956860	8421504	1	48	0	p	350039552100015027	0-48						Aprotininvarianten mit verbesserten eigenschaften und bikunine von aprotininvarianten	Apeler	2000	0		
1156	chr13	74956812	74956857	3500183903	45		74956812	74956857	8421504	1	45	0	p	350018390300015039	0-45						Polynucleotide molecules encoding proteins having proteinase inhibitor activity	Davies	2000	0		
1156	chr13	74956815	74956860	3500029099	45		74956815	74956860	8421504	1	45	0	p	350002909900015007	3-48						Compositions And Methods For Targeting A Polypeptide To The Central Nervous System 	freshpatents.com	0	0		
1156	chr13	74959132	74959372	3500186119	240		74959132	74959372	8421504	1	240	0	g	350018611900000010	0-240						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		
1156	chr13	74959132	74959372	3500095373	240		74959132	74959372	8421504	1	240	0	g	350009537300000010	0-240						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		
1157	chr13	75009412	75012949	3500186119	300		75009412	75012949	8421504	3	100,192,8	0,2888,3529	p	350018611900015116	0-300						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		
1157	chr13	75009412	75012949	3500095373	300		75009412	75012949	8421504	3	100,192,8	0,2888,3529	p	350009537300015116	0-300						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		
1157	chr13	75012305	75012942	3500463532	187		75012305	75012942	8421504	3	138,48,1	0,139,636	c	350046353200000021,350046353200000010,350046353200000011	51-237,0-32,0-32					Patent	Method for determining nucleotide identity through primer extension (Patent US:5888819)	Anderson	1999	0		
1157	chr13	75012305	75012942	3500397871	187		75012305	75012942	8421504	3	138,48,1	0,139,636	c	350039787100000020,350039787100000010,350039787100000009	51-237,0-32,0-32						Method for determining nucleotide identity through primer extension - US Patent 5888819 Description	ww.patentstorm.us	0	0		
1157	chr13	75012305	75012479	3500395521	168		75012305	75012479	8421504	2	90,78	0,96	p	350039552100015007,350039552100015008,350039552100015029	0-90,3-81,0-45						Aprotininvarianten mit verbesserten eigenschaften und bikunine von aprotininvarianten	Apeler	2000	0		
1157	chr13	75012305	75012479	3500331572	168		75012305	75012479	8421504	2	39,129	0,45	p	350033157200015088,350033157200015092	3-168,0-72						Compositions and methods for the transport of therapeutic agents	Castaigne	2011	0		
1157	chr13	75012305	75012479	3500242899	174		75012305	75012479	8421504	1	174	0	c	350024289900000011,350024289900000012,350024289900000013,350024289900000014	0-48,0-48,0-48,0-30						Transplastomic Plants Expressing Lumen-Targeted Protein - Patent application	www.faqs.org	0	0		
1157	chr13	75012305	75012473	3500369789	162		75012305	75012473	8421504	2	39,123	0,45	p	350036978900015128,350036978900015132	0-132,0-63						Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof	Castaigne	2012	0		
1157	chr13	75012305	75012446	3500074996	90		75012305	75012446	8421504	2	45,45	0,96	p	350007499600015007,350007499600015009	0-45,0-45						COMPOSITIONS AND METHODS FOR TARGETING A POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM - Patent application	www.faqs.org	0	0		
1157	chr13	75012305	75012395	3500183903	90		75012305	75012395	8421504	1	90	0	p	350018390300015023	0-90						Polynucleotide molecules encoding proteins having proteinase inhibitor activity	Davies	2000	0		
1157	chr13	75012305	75012386	3500435017	81		75012305	75012386	8421504	1	81	0	p	350043501700015040	69-150					Patent	Directed evolution of novel binding proteins (Patent US:6979538)	Ladner	2005	0		
1157	chr13	75012305	75012386	3500188056	81		75012305	75012386	8421504	1	81	0	p	350018805600015033	69-150						Directed evolution of novel binding proteins	Ladner	2001	0		
1157	chr13	75012305	75012386	3500012277	81		75012305	75012386	8421504	1	81	0	p	350001227700015038	69-150						 Directed Evolution Of Novel Binding Proteins 	www.docstoc.com	0	0		
1157	chr13	75012311	75012371	3500192815	60		75012311	75012371	8421504	1	60	0	p	350019281500015017	0-60						Aprotinin analogs	Bj	1995	0		
1157	chr13	75012323	75012398	3500087368	75		75012323	75012398	8421504	1	75	0	p	350008736800015069	15-90						Human bikunin	Davis	1999	0		
1157	chr13	75012353	75012388	3500288499	35		75012353	75012388	8421504	1	35	0	c	350028849900000022	99-134					Patent	Aprotinin analogues and a process for the production thereof (Patent US:5373090)	Norris	1994	0		
1157	chr13	75012353	75012378	3500246000	25		75012353	75012378	8421504	1	25	0	c	350024600000000002	10-35					Patent	Yeast processing system (Patent US:5395922)	Bjorn	1995	0		
1157	chr13	75012353	75012378	3500051668	25		75012353	75012378	8421504	1	25	0	c	350005166800000002	10-35					Patent	Yeast processing system (Patent US:5514585)	slashed.rn	1996	0		
1157	chr13	75012369	75012434	3500142125	65		75012369	75012434	8421504	1	65	0	c	350014212500000015,350014212500000033	0-22,0-60						US Patent # 6,537,748. Reagent for nucleic acid typing by primer extension - Patents.com	www.patents.com	0	0		
1157	chr13	75012374	75012434	3500339719	60		75012374	75012434	8421504	1	60	0	c	350033971900000034	0-60					Patent	Method for determining nucleotide identity through extension of immobilized primer (Patent US:6004744)	Anderson	1999	0		
1157	chr13	75012374	75012434	3500216109	60		75012374	75012434	8421504	1	60	0	c	350021610900000034	0-60						US Patent # 6,004,744. Method for determining nucleotide identity through extension of immobilized primer - Patents.com	www.patents.com	0	0		
1157	chr13	75012386	75012479	3500225272	93		75012386	75012479	8421504	1	93	0	p	350022527200015203,350022527200015199	0-60,0-63						aprotinin-like polypeptides for delivering agents conjugated thereto to tissues	Ke Li Si Di An *Qie 	2010	0		
1157	chr13	75012386	75012479	3500107188	93		75012386	75012479	8421504	1	93	0	p	350010718800015028,350010718800015027	0-60,0-72						Polypeptide-nucleic acid conjugates and uses thereof	Beliveau	2010	0		
1157	chr13	75012386	75012479	3500100353	93		75012386	75012479	8421504	1	93	0	p	350010035300015028,350010035300015027	0-60,0-72						Polypeptide-nucleic acid conjugates and uses thereof	Beliveau	2009	0		
1157	chr13	75012386	75012479	3500049290	93		75012386	75012479	8421504	1	93	0	p	350004929000015105,350004929000015103	0-60,0-63						&#x7528;&#x4e8e;&#x5c06;&#x8f6d;&#x5408;&#x81f3;&#x5176;&#x7684;&#x8bd5;&#x5242;&#x9012;&#x9001;&#x81f3;&#x7ec4;&#x7ec7;&#x7684;&#x6291;&#x80bd;&#x9176;&#x6837;&#x591a;&#x80bd;	Ke Li Si Di An *Qie 	2010	0		
1157	chr13	75012401	75012446	3500029099	45		75012401	75012446	8421504	1	45	0	p	350002909900015009	3-48						Compositions And Methods For Targeting A Polypeptide To The Central Nervous System 	freshpatents.com	0	0		
1157	chr13	75012407	75012479	3500368130	72		75012407	75012479	8421504	1	72	0	p	350036813000015052	0-72						Multimeric peptide conjugates and uses thereof	Demeule	2011	0		
1157	chr13	75012416	75012479	3500295882	63		75012416	75012479	8421504	1	63	0	p	350029588200015042	0-63						&#x7d2b;&#x6749;&#x9187;&#x3001;&#x7d2b;&#x6749;&#x9187;&#x7c7b;&#x4f3c;&#x7269;&#x6216;&#x7d2b;&#x6749;&#x9187;&#x7ed3;&#x5408;&#x7269;&#x7684;&#x836f;&#x7269;&#x7ec4;&#x5408;&#x7269;&#x53ca;&#x76f8;&#x5173;&#x5236;&#x5907;&#x65b9;&#x6cd5;&#x548c;&#x7528	Ke Li Si Di An *Qie 	2011	0		
1157	chr13	75012416	75012479	3500233505	63		75012416	75012479	8421504	1	63	0	p	350023350500015084	0-63						Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use	Ke Li Si Di An *Qie 	2011	0		
1157	chr13	75013283	75013680	3500392262	54		75013283	75013680	8421504	2	27,27	0,370	c,g	350039226200000000,350039226200000001	0-27,0-27						Sprint&#x2122; Titanium&#xae; Taq 384 Plate User Manual	www.clontech.com	0	0		
1157	chr13	75013653	75013680	3500108565	27		75013653	75013680	8421504	1	27	0	g	350010856500000001	0-27						Advantage 2 PCR Enzyme System	www.takara.co.kr	0	0		
1157	chr13	75073974	75074673	3500413249	90		75073974	75074673	8421504	2	76,14	0,685	p	350041324900015121	6-96						BMC Genomics BioMed Central	biomedcentral.com	0	0		
1158	chr13	75147388	75147414	3500439141	23		75147388	75147414	8421504	2	13,10	0,16	g	350043914100000028	0-27						MODIFIED FACTOR VIII - Patent application	www.faqs.org	0	0		
1159	chr13	75276095	75277821	3500413249	285		75276095	75277821	8421504	2	228,57	0,1669	p	350041324900015145	207-492						BMC Genomics BioMed Central	biomedcentral.com	0	0		
1159	chr13	75301785	75303434	3500287310	48		75301785	75303434	8421504	3	5,28,15	0,562,1634	p	350028731000015207	0-48						 Assays For Identifying Ubiquitin Agents And For Identifying Agents That Modify The Activity Of Ubiquitin Agents 	www.docstoc.com	0	0		
1159	chr13	75310396	75310614	3500378421	72		75310396	75310614	8421504	3	26,10,36	0,100,182	p	350037842100015238	3-75						University of Southampton Research Repository ePrints Soton	rints.soton.ac.uk	0	0		TNNC2
1160	chr13	75377231	75377256	3500199770	25		75377231	75377256	8421504	1	25	0	c	350019977000000007	0-25						NUOVO PROTOCOLLO BASATO SULL&#x2019;ANALISI DEGLI SNPs APPLICATO ALLA TRACCIABILIT&#xc0; DELLA CARNE BOVINA	www.anabic.it	0	0		
1160	chr13	75422521	75422554	3500311219	28		75422521	75422554	8421504	4	4,7,12,5	0,5,13,28	g	350031121900000363	12-40						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
1160	chr13	75459793	75460967	3500191939	41		75459793	75460967	8421504	2	21,20	0,1154	c,g	350019193900000004,350019193900000004,350019193900000005,350019193900000005	0-21,0-21,0-20,0-20						Regulation of MMP2 and MMP9 metalloproteinases by FSH and growth factors in bovine granulosa cells	www.scielo.br	0	0		
1160	chr13	75459793	75460967	3500041022	41		75459793	75460967	8421504	2	21,20	0,1154	c,g	350004102200000004,350004102200000004,350004102200000005,350004102200000005	0-21,0-21,0-20,0-20		21637514	10.1590/S1415-47572009005000048	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Regulation of MMP2 and MMP9 metalloproteinases by FSH and growth factors in bovine granulosa cells	Portela	2009	1		
1160	chr13	75459826	75460366	3500411315	28		75459826	75460366	8421504	2	13,15	0,525	c	350041131500000010	21-49						Glucosamine in Osteoarthritis	repub.eur.nl	0	0		
1160	chr13	75461463	75466740	3500380921	38		75461463	75466740	8421504	2	19,19	0,5258	c,g	350038092100000002,350038092100000002,350038092100000009	20-39,20-39,22-41						END OF PROJECT REPORT 5230 Animal Transport: Developing optimum animal handling procedures and effective transport strategies in the food production chain to improve animal welfare and food quality.	www.teagasc.ie	0	0		
1160	chr13	75461512	75461625	3500263461	25		75461512	75461625	8421504	2	2,23	0,90	c	350026346100000005	0-25						Isolation and culture of Preantral Follicles	www.cbra.org.br	0	0		
1160	chr13	75461769	75462000	3500461096	23		75461769	75462000	8421504	2	7,16	0,215	c	350046109600000017	17-40						2 Eigene Originalarbeiten (A1-A15)	thek.uni-halle.de	0	0		MMP9
1160	chr13	75462085	75462110	3500362395	25		75462085	75462110	8421504	1	25	0	c,g	350036239500000005,350036239500000005	0-25,0-25						Androgen Receptor Related Methods for Treating Bladder Cancer	Chang	2009	0		MMP9
1160	chr13	75462085	75462110	3500312238	25		75462085	75462110	8421504	1	25	0	c	350031223800000005,350031223800000026	0-25,0-25						Androgen Receptor Related Methods for Treating Bladder Cancer - Patent application	www.faqs.org	0	0		MMP9
1160	chr13	75462121	75462729	3500040185	40		75462121	75462729	8421504	2	20,20	0,588	c,g	350004018500000012,350004018500000012,350004018500000013	0-20,0-20,0-20						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
1160	chr13	75462121	75462627	3500134803	40		75462121	75462627	8421504	2	20,20	0,486	c,g	350013480300000016,350013480300000016,350013480300000017,350013480300000017	0-20,0-20,0-20,0-20						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
1160	chr13	75462896	75462919	3500220102	23		75462896	75462919	8421504	1	23	0	c,g	350022010200000001,350022010200000001	1-24,1-24		9536826	10.1136/ard.57.1.56	1468-2060	Annals of the Rheumatic Diseases	Basic calcium phosphate crystals induce synthesis and secretion of 92 kDa gelatinase (gelatinase B/matrix metalloprotease 9) in human fibroblasts	McCarthy	1998	0		
1160	chr13	75463986	75464054	3500103872	63		75463986	75464054	8421504	3	19,21,23	0,23,45	c,g	350010387200000009,350010387200000009,350010387200000010,350010387200000010,350010387200000011,350010387200000011	0-19,0-19,0-21,0-21,0-23,0-23						Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: Implication of NADPH oxidase	ww.uphs.upenn.edu	0	0		
1160	chr13	75463999	75465070	3500328833	201		75463999	75465070	8421504	4	65,40,51,45	0,187,823,1026	p	350032883300015016,350032883300015073,350032883300015123,350032883300015149	0-45,0-60,0-51,159-204						Hemopexin-like structure as polypeptide-scaffold	Lanzendoerfer	2007	0		
1160	chr13	75464006	75464192	3500233580	43		75464006	75464192	8421504	3	20,17,6	0,41,180	c,g	350023358000000006,350023358000000006,350023358000000016	0-20,0-20,0-23						Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle	biomedcentral.com	0	0		
1160	chr13	75464009	75466738	3500433630	40		75464009	75466738	8421504	2	20,20	0,2709	c,g	350043363000000015,350043363000000015,350043363000000016,350043363000000016	0-20,0-20,0-20,0-20						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation	Chang	2006	0		MMP9
1160	chr13	75464009	75466738	3500139519	40		75464009	75466738	8421504	2	20,20	0,2709	c,g	350013951900000015,350013951900000015,350013951900000016,350013951900000016	0-20,0-20,0-20,0-20						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation - US Patent 7435800 Description	ww.patentstorm.us	0	0		MMP9
1160	chr13	75464028	75464892	3500438499	42		75464028	75464892	8421504	2	21,21	0,843	c,g	350043849900000000,350043849900000000,350043849900000001	0-21,0-21,0-21						Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity	s.ahajournals.org	0	0		
1160	chr13	75464870	75466784	3500248474	43		75464870	75466784	8421504	2	21,22	0,1892	c,g	350024847400000036,350024847400000037,350024847400000037	0-21,0-22,0-22						REPRODUCTION	uction-online.org	0	0		
1160	chr13	75464905	75466738	3500267782	39		75464905	75466738	8421504	3	6,13,20	0,98,1813	c,g	350026778200000016,350026778200000017,350026778200000017	0-19,0-20,0-20						The effect of progesterone replacement on gene expression in the corpus luteum during induced regression and late luteal phase in the bonnet monkey (Macaca radiata)	www.rbej.com	0	0		MMP9
1160	chr13	75465005	75465105	3500221208	59		75465005	75465105	8421504	2	28,31	0,69	c	350022120800000004	0-76						Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium. - ResearchGate	.researchgate.net	0	0		
1160	chr13	75465005	75465105	3500070510	52		75465005	75465105	8421504	2	22,30	0,70	c,g	350007051000000009,350007051000000009,350007051000000011,350007051000000011	0-22,0-22,0-30,0-30						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
1160	chr13	75465078	75466785	3500181178	41		75465078	75466785	8421504	2	21,20	0,1687	c,g	350018117800000010,350018117800000004,350018117800000004,350018117800000011,350018117800000011,350018117800000005,350018117800000005	0-21,0-20,0-20,0-20,0-20,0-20,0-20						INHIBITOR OF INFLAMMATORY CONDITIONS - Patent application	www.faqs.org	0	0		
1160	chr13	75466834	75466859	3500175163	23		75466834	75466859	8421504	2	5,18	0,7	c	350017516300000004	5-28					Patent	Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts (Patent US:6274147)	Vakharia	2001	0		
1160	chr13	75466834	75466859	3500036686	23		75466834	75466859	8421504	2	5,18	0,7	c	350003668600000004	5-28						Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts	Vakharia	1999	0		
1160	chr13	75479684	75479707	3500111283	23		75479684	75479707	8421504	1	23	0	c	350011128300000000	0-23						CIP1 is an activator of the K+&#x2013;Cl&#x2212; cotransporter KCC2 - ResearchGate	.researchgate.net	0	0		SLC12A5
2	chr13	75479688	75505966	3500227974	1485		75479688	75505966	8421504	13	24,21,104,169,196,170,132,108,123,200,15,134,89	0,6450,17422,18996,21053,22096,22661,23840,24810,25025,25564,25846,26189	p,c	350022797400000004,350022797400000000,350022797400000001,350022797400015001	11-35,11-35,12-33,0-1440						Phospho-dependent modulation of potassium chloride co-transporter KCC2	eprints.ucl.ac.uk	0	0		
1160	chr13	75487679	75489846	3500196103	40		75487679	75489846	8421504	2	20,20	0,2147	c	350019610300000008,350019610300000009	0-20,0-20		21911617	10.1113/jphysiol.2011.214635	0022-3751	The Journal of Physiology	The potassium&#x2013;chloride cotransporter 2 promotes cervical cancer cell migration and invasion by an ion transport-independent mechanism	Wei	2011	5		SLC12A5
1161	chr13	75505625	75505658	3500289584	33		75505625	75505658	8421504	1	33	0	c	350028958400000102	0-33					Patent	CNS chloride modulation and uses thereof (Patent CN:100581621)	J*A*M*Ku Er 	2010	0		
1161	chr13	75510921	75510944	3500271944	23		75510921	75510944	8421504	1	23	0	c	350027194400000029	15-48						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		
1161	chr13	75510921	75510944	3500237109	23		75510921	75510944	8421504	1	23	0	c	350023710900000029	15-48						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		
1161	chr13	75510921	75510944	3500210939	23		75510921	75510944	8421504	1	23	0	c	350021093900000070	15-48						Starchless variety of pisum sativum having elevated levels of sucrose	Webster	2000	0		
1161	chr13	75511095	75511123	3500009269	23		75511095	75511123	8421504	2	11,12	0,16	c	350000926900000047	5-36					Patent	Method for expression of heterologous proteins in yeast (Patent US:6017731)	Merryweather	2000	0		
1161	chr13	75555052	75555075	3500308877	23		75555052	75555075	8421504	1	23	0	c	350030887700000000	7-30		11886848		0021-9258	Journal of Biological Chemistry	CD40 Induces Interleukin-6 Gene Transcription in Dendritic Cells	Mann	2002	5		
1161	chr13	75555060	75565313	3500162427	845		75555060	75565313	8421504	9	53,79,126,147,94,62,87,29,168	0,3443,3840,4236,4761,7656,9404,9596,10085	p,c,g	350016242700000015,350016242700000000,350016242700015022,350016242700000016,350016242700000016,350016242700000012	7-71,0-843,0-663,4-28,4-28,0-20						COMBINATION OF AN AGONISTIC ANTI-CD40 MONOCLONAL ANTIBODY OR A CD40 LIGAND AND INACTIVATED OR ATTENUATED BACTERIA FOR USE IN THE TREATMENT AND/OR PREVENTION OF MASTITIS - UNIVERSITE DE LIEGE	www.sumobrain.com	0	0		
1161	chr13	75587383	75587407	3500000430	23		75587383	75587407	8421504	2	8,15	0,9	g	350000043000001151,350000043000000356,350000043000000401,350000043000001136,350000043000001076,350000043000000656,350000043000000671,350000043000000926,350000043000000836,350000043000001046,350000043000001001	23-46,23-46,23-46,23-46,23-46,23-46,23-46,23-46,23-46,23-46,23-46						Nucleic acid sequence and methods for selectively expressing a protein in a target cell or tissue	Frazer	2000	0		
1161	chr13	75610148	75610328	3500065941	180		75610148	75610328	8421504	1	180	0	p	350006594100015018	0-180						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH22
1162	chr13	75692880	75692925	3500000104	45		75692880	75692925	8421504	1	45	0	p	350000010400015092	75-120						Tarantulas and Social Spiders: A Tale of Sex and Silk	.nottingham.ac.uk	0	0		MIR4466
1163	chr13	75823288	75823319	3500117975	28		75823288	75823319	8421504	3	6,18,4	0,8,27	c	350011797500000039,350011797500000040	1-29,10-29						NPG.nature.vol.433.Issue.7027.Feb	www.scribd.com	0	0		
1165	chr13	76029045	76029072	3500416329	23		76029045	76029072	8421504	2	8,15	0,12	g	350041632900000001	0-23						NUCLEOTIDE SEQUENCES ENCODING ENZYMES IN BIOSYNTHESIS OF DIHYDROARTEMISINIC ACID	Teoh	2007	0		
1165	chr13	76029045	76029072	3500089783	23		76029045	76029072	8421504	2	8,15	0,12	g	350008978300000001,350008978300000009	0-23,0-23						NUCLEOTIDE SEQUENCES ENCODING ENZYMES IN BIOSYNTHESIS OF DIHYDROARTEMISINIC ACID - Patent application	www.faqs.org	0	0		
18	chr13	76319878	76548478	3500106078	1473		76319878	76548478	8421504	15	20,143,117,68,178,143,84,90,59,161,115,122,56,39,78	0,3874,9390,73374,74909,81172,93994,187312,205951,211539,214308,215381,217810,217872,228522	p	350010607800015011	135-1611						Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications	Abdelhak	1998	0		
1167	chr13	76401177	76413936	3500264193	42		76401177	76413936	8421504	3	16,5,21	0,12695,12738	c	350026419300000011,350026419300000012	0-21,0-21						HighlyMethylatedGenesinColorectalNeoplasia: ImplicationsforScreening	.aacrjournals.org	0	0		EYA2
1172	chr13	77033866	77036012	3500319336	25		77033866	77036012	8421504	3	17,3,5	0,21,2141	c	350031933600000023	8-33						Subtilases 	.freshpatents.com	0	0		
1180	chr13	78040785	78040813	3500102323	28		78040785	78040813	8421504	1	28	0	g	350010232300000001	2-30							ingtechnology.com	0	0		
1180	chr13	78052345	78052370	3500137955	24		78052345	78052370	8421504	2	20,4	0,21	g	350013795500000073	11-35					Patent	Low-cost production for peptides (Patent CN:100489114)	I*A*Tang Mu Lin Sen 	2009	0		
1181	chr13	78193609	78193636	3500429717	23		78193609	78193636	8421504	3	12,6,5	0,14,22	g	350042971700000095	7-31						Rice promoters for regulation of plant expression	Budworth	2005	0		
1181	chr13	78203232	78208190	3500016451	40		78203232	78208190	8421504	2	20,20	0,4938	g	350001645100000001,350001645100000000	0-20,0-20		11788351	10.1152/ajpcell.00295.2001		American Journal of Physiology - Cell Physiolog	Peroxynitrite increases iNOS through NF-&#x03ba;B and decreases prostacyclin synthase in endothelial cells	Cooke	2002	0		
1181	chr13	78228781	78228809	3500030290	23		78228781	78228809	8421504	2	8,15	0,13	g	350003029000000038	6-37						RAPID DETECTION OF THE "HIGH-VIRULENT" ST-17 CLONE OF GROUP B STREPTOCOCCUS - Patent application	www.faqs.org	0	0		
1182	chr13	78300844	78300870	3500461622	24		78300844	78300870	8421504	2	15,9	0,17	g	350046162200000196	13-37						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		CHP2
1182	chr13	78331088	78331640	3500126050	552		78331088	78331640	8421504	1	552	0	p	350012605000015221,350012605000015219,350012605000015217,350012605000015215	0-51,0-180,0-180,3-144						GOS 1116020 - Metagenes	annotathon.org	0	0		ZFAS1
1183	chr13	78467651	78467675	3500321605	24		78467651	78467675	8421504	1	24	0	c	350032160500000009	0-24					Patent	Human-origin prostacyclin synthase (Patent EP:0727490)	Tanabe	2006	0		
1184	chr13	78542517	78542543	3500214416	24		78542517	78542543	8421504	2	16,8	0,18	g	350021441600002425	11-35						MOLECULAR CHARACTERIZATION OF THEILERIA spp. USING RIBOSOMAL RNA	pository.tamu.edu	0	0		
1185	chr13	78716748	78716776	3500417050	24		78716748	78716776	8421504	2	11,13	0,15	g	350041705000000049	10-42						Structural and Functional Characterization of the ATP- Driven Glycolipid-Efflux Pump DevBCA-TolC and its Homologues in the Filamentous Cyanobacterium	.uni-tuebingen.de	0	0		
1186	chr13	78895977	78896007	3500043838	30		78895977	78896007	8421504	1	30	0	c	350004383800000002	8-38		20166136	10.1002/pros.21132		The Prostate	Snail Transcription Factor Regulates Neuroendocrine Differentiation in LNCaP Prostate Cancer Cells	Danielle	June	0		
1186	chr13	78896783	78901171	3500434864	42		78896783	78901171	8421504	2	21,21	0,4367	c,g	350043486400000015,350043486400000015,350043486400000016	0-21,0-21,0-21		20049841	10.1002/ijc.25151	1097-0215	International Journal of Cancer	Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin - Hayashi - 2010 - International Journal of Cancer - Wiley Onlin	Hayashi	2010	0		SNAI1
1186	chr13	78897068	78897211	3500399137	42		78897068	78897211	8421504	2	21,21	0,122	c	350039913700000012,350039913700000013	0-21,0-21						Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line CNE-2 possess epithelial mesenchymal transition properties in association with metastasis	-publications.com	0	0		
1186	chr13	78897068	78897211	3500280099	42		78897068	78897211	8421504	2	21,21	0,122	c,g	350028009900000008,350028009900000008,350028009900000009,350028009900000009	0-21,0-21,0-21,0-21						Epithelial-MesenchymalTransitionEventsduringHuman EmbryonicStemCellDifferentiation	.aacrjournals.org	0	0		SNAI1
1186	chr13	78897068	78897211	3500252679	42		78897068	78897211	8421504	2	21,21	0,122	c	350025267900000004,350025267900000005	0-21,0-21						Epithelial-mesenchymal transition is associated with increased invasiveness of side population cells from hepatoma SMMC-7721 cells	www.ajol.info	0	0		SNAI1
1186	chr13	78897141	78897164	3500436009	23		78897141	78897164	8421504	1	23	0	c	350043600900000000	1-24		22857708	10.1186/1471-2407-12-336	1471-2407	BMC Cancer	Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells	Neal	2012	3		
1186	chr13	78897143	78901111	3500302759	43		78897143	78901111	8421504	2	22,21	0,3947	c	350030275900000004,350030275900000005	0-22,0-21		21464039	10.1158/1940-6207.CAPR-10-0306		Cancer prevention research (Philadelphia, Pa.)	Benzyl Isothiocyanate Inhibits Epithelial-Mesenchymal Transition in Cultured and Xenografted Human Breast Cancer Cells	Anuradha	July	0		SNAI1
1186	chr13	78897143	78901111	3500296632	43		78897143	78901111	8421504	2	22,21	0,3947	c	350029663200000008,350029663200000009	0-22,0-21		18535913	10.1007/s10585-008-9183-1		Clinical & experimental metastasis	Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model	Haiyen	2008	0		SNAI1
1186	chr13	78897143	78901111	3500222308	43		78897143	78901111	8421504	2	22,21	0,3947	c	350022230800000006,350022230800000007	0-22,0-21		22110740	10.1371/journal.pone.0027720		PLoS ONE	LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling	Hui-Wen	2011	0		SNAI1
1186	chr13	78897146	78897218	3500284332	41		78897146	78897218	8421504	2	21,20	0,52	c,g	350028433200000004,350028433200000004,350028433200000007	9-30,9-30,0-20						Notch1 binds and induces degradation of Snail in hepatocellular carcinoma	mgl.snu.ac.kr	0	0		
1187	chr13	78984959	79014425	3500248372	42		78984959	79014425	8421504	5	17,1,4,3,17	0,17578,17580,27430,29449	c	350024837200000004,350024837200000001	5-27,0-20		20420830	10.1016/j.yexcr.2010.04.017		Experimental cell research	Recruitment of Uev1B to Hrs-containing endosomes and its effect on endosomal trafficking	Jason	2010	0		
1187	chr13	79019450	79019474	3500232524	23		79019450	79019474	8421504	2	17,6	0,18	g	350023252400000023	7-30						Hepatitis C Virus Epitopes	Kim	2000	0		
1188	chr13	79089569	79089593	3500459406	23		79089569	79089593	8421504	2	17,6	0,18	g	350045940600000167	7-30						BIOSENSORS FOR DETECTING MACROMOLECULES AND OTHER ANALYTES - Patent application	www.faqs.org	0	0		
1189	chr13	79180750	79180779	3500461622	24		79180750	79180779	8421504	2	11,13	0,16	g	350046162200000146	2-28						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
1190	chr13	79329323	79329347	3500275058	23		79329323	79329347	8421504	2	5,18	0,6	g	350027505800000268,350027505800000269	2-25,2-24						Development of a Low Cost Ligation-based SNP Genotyping Assay to Trace Maternal Ancestry in Mitochondrial DNA	ase.tufts.edu	0	0		
1190	chr13	79389002	79389032	3500275135	30		79389002	79389032	8421504	1	30	0	c	350027513500000002	12-42						Phosphate mimics and methods of treatment using phosphatease inhibitors	Huang	2003	0		PTPN1
1190	chr13	79389002	79389032	3500238332	30		79389002	79389032	8421504	1	30	0	c	350023833200000002	12-42						Phosphate mimics and methods of treatment using phosphatase inhibitors	Biltz	2002	0		
1190	chr13	79389002	79389032	3500115184	30		79389002	79389032	8421504	1	30	0	c	350011518400000002	12-42					Patent	Phosphate mimics and methods of treatment using phosphatase inhibitors (Patent US:6596772)	Huang	2003	0		
148	chr13	79389041	79446615	3500191264	110		79389041	79446615	8421504	6	21,3,33,6,5,42	0,42926,48298,53795,57218,57532	c	350019126400000095,350019126400000044,350019126400000071,350019126400000079	0-24,0-24,9-48,1-48						Antisense Modulation of PTP1B Expression - Patent application	www.faqs.org	0	0		
1191	chr13	79432027	79434943	3500324626	51		79432027	79434943	8421504	2	31,20	0,2896	p	350032462600015003	3-54						METODOS Y COMPOSICIONES PARA EL TRATAMIENTO DE ENFERMEDADES MALIGNAS A LAS QUE ESTA ASOCIADA UNA PROTEINA QUINASA.(ES2073165)	ww.espatentes.com	0	0		PTPN1
1191	chr13	79442942	79446096	3500261436	42		79442942	79446096	8421504	2	22,20	0,3134	c,g	350026143600000087,350026143600000087,350026143600000088,350026143600000088	0-22,0-22,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1191	chr13	79461452	79461480	3500435132	23		79461452	79461480	8421504	2	17,6	0,22	g	350043513200000006	17-40						RESEARCH ARTICLE	.apocpcontrol.org	0	0		HDAC4
1191	chr13	79516772	79516796	3500316382	23		79516772	79516796	8421504	2	8,15	0,9	g	350031638200000012	0-23						Patent Search: US Patent Number 8058000 - Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment	ww.archpatent.com	0	0		
1192	chr13	79646960	79649264	3500159682	178		79646960	79649264	8421504	4	48,41,41,48	0,244,1087,2256	c	350015968200000173,350015968200000067,350015968200000100,350015968200000126	0-48,0-41,6-47,0-48						ACTIVITY DEPENDENT NEUROTROPHIC FACTOR III (ADNF III) - Patent application	www.faqs.org	0	0		
1192	chr13	79647200	79647422	3500429641	93		79647200	79647422	8421504	2	45,48	0,174	c	350042964100000168,350042964100000067,350042964100000114	6-48,0-41,0-48						Activity dependent neurotrophic factor III (ADNF III)	Gozes	1998	0		
1192	chr13	79650971	79651002	3500331508	24		79650971	79651002	8421504	3	6,5,13	0,11,18	g	350033150800000003	7-31					Patent	Synthetic peptide inhibitors of hiv transmission (Patent EP:0774971)	Barney	2005	0		
1192	chr13	79650971	79651002	3500073840	24		79650971	79651002	8421504	3	6,5,13	0,11,18	g	350007384000000012	7-31						Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission	Barney	1997	0		
1193	chr13	79745298	79745324	3500054009	25		79745298	79745324	8421504	2	15,10	0,16	c	350005400900000063	11-36						US Patent # 5,686,572. Domains of extracellular region of human platelet derived growth factor receptor polypeptides - Patents.com	www.patents.com	0	0		
1193	chr13	79749599	79749690	3500276041	38		79749599	79749690	8421504	2	19,19	0,72	c,g	350027604100000017,350027604100000017,350027604100000016	0-19,0-19,0-19		21813710	10.1152/ajpcell.00455.2010		American Journal of Physiology - Cell Physiolog	Contribution of Kv2.1 channels to the delayed rectifier current in freshly dispersed smooth muscle cells from rabbit urethra	Kyle	2011	0		KCNG1
1193	chr13	79756645	79756669	3500263901	24		79756645	79756669	8421504	1	24	0	g	350026390100000013	0-25						Human monoclonal antibodies against CD20	Baadsgaard	2011	0		
1195	chr13	79972225	79972250	3500080694	23		79972225	79972250	8421504	2	11,12	0,13	g	350008069400000591	25-48						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
1196	chr13	80161886	80175690	3500106920	42		80161886	80175690	8421504	4	15,6,5,16	0,18,13780,13788	g	350010692000000086,350010692000000101,350010692000000002	8-29,0-21,0-21						DNA METHYLATION BIOMARKERS IN LYMPHOID AND HEMATOPOIETIC MALIGNANCIES - Patent application	www.faqs.org	0	0		
1196	chr13	80182506	80182529	3500206841	23		80182506	80182529	8421504	1	23	0	g	350020684100000016	15-42						DELTA-6 DESATURASE AND USES THEREOF	Mukerji	2010	0		
1196	chr13	80182506	80182529	3500029796	23		80182506	80182529	8421504	1	23	0	g	350002979600000016,350002979600000032	15-42,15-42						Desaturase genes and uses thereof - Patent application	www.faqs.org	0	0		
149	chr13	80333695	80383367	3500135082	43		80333695	80383367	8421504	4	19,4,7,13	0,20,49651,49659	g	350013508200000043,350013508200000079,350013508200000046	18-41,18-41,15-35						Poly(ADP-ribose) polymerase-gene - US Patent 7754459 Description	ww.patentstorm.us	0	0		
1198	chr13	80416901	80416925	3500390269	24		80416901	80416925	8421504	1	24	0	c	350039026900000051	20-44					Patent	Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes (Patent US:5316931)	Dawson	1994	0		SALL3
1198	chr13	80416901	80416925	3500128791	24		80416901	80416925	8421504	1	24	0	c	350012879100000052	20-44						US Patent # 5,889,190. Recombinant plant viral nucleic acids - Patents.com	www.patents.com	0	0		SALL4
1198	chr13	80416901	80416925	3500084495	24		80416901	80416925	8421504	1	24	0	c	350008449500000052	20-44						Recombinant plant viral nucleic acids	Dawson	1994	0		SALL3
1198	chr13	80417865	80428192	3500328799	41		80417865	80428192	8421504	3	20,18,3	0,174,10324	c,g	350032879900000011,350032879900000011,350032879900000034,350032879900000010	0-20,0-20,0-21,0-20						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
1199	chr13	80480507	80480542	3500106615	31		80480507	80480542	8421504	3	14,4,13	0,15,22	g	350010661500000025	3-48						GASP1: A FOLLISTATIN DOMAIN CONTAINING PROTEIN - Patent application	www.faqs.org	0	0		
1199	chr13	80515584	80515612	3500332991	25		80515584	80515612	8421504	2	20,5	0,23	g	350033299100000094	13-38						Sp35 Antibodies And Uses Thereof 	.freshpatents.com	0	0		
1199	chr13	80515584	80515612	3500211406	25		80515584	80515612	8421504	2	20,5	0,23	g	350021140600000000	13-38						and Essays Scientific Research	demicjournals.org	0	0		
1201	chr13	80813442	80813467	3500113379	23		80813442	80813467	8421504	2	9,14	0,11	g	350011337900000034	5-28						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
1201	chr13	80813442	80813467	3500062787	23		80813442	80813467	8421504	2	9,14	0,11	g	350006278700000034	5-28						Polypeptides of Botryosphaeria Rhodina - Patent application	www.faqs.org	0	0		
1204	chr13	81196125	81196152	3500456727	26		81196125	81196152	8421504	2	11,15	0,12	g	350045672700000080	0-42					Patent	Recombinant plant expressing non-competitively binding insecticidal crystal proteins (Patent US:5866784)	Botterman	1999	0		
1206	chr13	81410005	81410030	3500115116	23		81410005	81410030	8421504	2	13,10	0,15	g	350011511600000391	11-34						Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use	J*M*Wei Er Sen 	2005	0		
1207	chr13	81633678	81633708	3500330323	24		81633678	81633708	8421504	3	6,5,13	0,11,17	g	350033032300000140	0-24						DNA Aptamers Have an Analog in Genomic DNA	ufdc.ufl.edu	0	0		
1208	chr13	81680938	81680969	3500280702	25		81680938	81680969	8421504	3	4,15,6	0,5,25	g	350028070200000003	6-31						Methods for the specific coagulation of vasculature	Thorpe	1995	0		
1208	chr13	81680938	81680969	3500131068	25		81680938	81680969	8421504	3	4,15,6	0,5,25	g	350013106800000003	6-31						Kits and methods for the specific coagulation of vasculature	Thorpe	1995	0		
1212	chr13	82278053	82278078	3500159339	24		82278053	82278078	8421504	2	14,10	0,15	g	350015933900000036	8-35						ScienceDirect.com - Biochimie - Role of the amino acid invariants in the active site of MurG as evaluated by site-directed mutagenesis	sciencedirect.com	0	0		
1213	chr13	82353395	82353426	3500431800	25		82353395	82353426	8421504	3	11,4,10	0,16,21	g	350043180000000001	22-47						Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system	Rodriguez	2001	0		
1213	chr13	82353395	82353426	3500354173	25		82353395	82353426	8421504	3	11,4,10	0,16,21	g	350035417300000001,350035417300000055	22-47,22-47						HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM - Patent application	www.faqs.org	0	0		
1214	chr13	82527070	82527094	3500154727	24		82527070	82527094	8421504	1	24	0	c,g	350015472700000003,350015472700000003	0-24,0-24						Increased vitamin D-driven signalling	ive.library.uu.nl	0	0		CYP24A1
1217	chr13	82886469	82886494	3500039223	23		82886469	82886494	8421504	2	7,16	0,9	g	350003922300000000	4-27		12584562	10.1038/sj.onc.1206203	0950-9232	Oncogene	&#x03b1;6&#x03b2;1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells	Shimizu	2003	6		
1226	chr13	84021285	84021333	3500251406	48		84021285	84021333	8421504	1	48	0	p	350025140600015101	0-48					Patent	Human cDNAs and proteins and uses thereof (Patent US:7285631)	Bejanin	2007	0		CBLN4
1226	chr13	84021285	84021333	3500054122	48		84021285	84021333	8421504	1	48	0	p	350005412200015095	0-48						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		CBLN4
1226	chr13	84137567	84137592	3500122099	24		84137567	84137592	8421504	2	8,16	0,9	g	350012209900000017	1-25					Patent	Methods for producing an immune response to tuberculosis (Patent US:8440206)	Lewinsohn	2013	0		
1226	chr13	84146250	84146276	3500131455	26		84146250	84146276	8421504	1	26	0	g	350013145500000107	5-31						PROKARYOTIC RNAi-LIKE SYSTEM AND METHODS OF USE - Patent application	www.faqs.org	0	0		
585	chr14	54036	54064	3500145090	23		54036	54064	8421504	2	9,14	0,14	g	350014509000000006	2-25		12679332	10.1074/jbc.M212437200	0021-9258	Journal of Biological Chemistry	Kinetic Analysis of the Interaction of the Copper Chaperone Atox1 with the Metal Binding Sites of the Menkes Protein	Strausak	2003	5		
585	chr14	80455	80479	3500363671	24		80455	80479	8421504	1	24	0	c	350036367100000057	0-24						PLAG GENE FAMILY AND TUMORIGENESIS - Vlaams, Interuniversitair Instituut Voor Biotechnologie	www.sumobrain.com	0	0		
585	chr14	80455	80479	3500361334	24		80455	80479	8421504	1	24	0	c	350036133400000015	0-24						in Oncology and Haematology	.irevues.inist.fr	0	0		
585	chr14	92535	94786	3500423761	720		92535	94786	8421504	5	105,116,219,142,138	0,333,1454,1889,2113	p	350042376100015016,350042376100015012,350042376100015007,350042376100015003	0-180,0-180,0-180,0-180						Bases de detection en reconnaissance des formes pour la bioInformatique	fesseurs.esiea.fr	0	0		RPL8
585	chr14	92535	94786	3500377403	720		92535	94786	8421504	5	105,116,219,142,138	0,333,1454,1889,2113	p	350037740300015020,350037740300015016,350037740300015011,350037740300015007	0-180,0-180,0-180,0-180						Introduction &#xe0; la bioinformatique PLU4199 Support de cours blog : http://professeurs.esiea.fr/wassner/	fesseurs.esiea.fr	0	0		RPL8
586	chr14	201014	201038	3500446153	23		201014	201038	8421504	2	10,13	0,11	c	350044615300000020	22-45						Isolated DNA encoding the SPHI restriction endonuclease and related methods for producing the same	Guthrie	1992	0		
586	chr14	207142	207169	3500068995	24		207142	207169	8421504	2	15,9	0,18	c	350006899500000184	3-27						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
586	chr14	218872	218897	3500013296	25		218872	218897	8421504	1	25	0	c	350001329600000018	0-25						Darwin in the Genome	www.scribd.com	0	0		TP53I11
586	chr14	243247	243284	3500072968	30		243247	243284	8421504	3	9,14,7	0,12,30	c	350007296800000130	15-45						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
587	chr14	269491	269517	3500239599	24		269491	269517	8421504	2	12,12	0,14	c	350023959900000271	0-24						F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy	Qia Li *A Li Ta Luo 	2002	0		
588	chr14	411473	457615	3500321684	1020		411473	457615	8421504	34	30,30,31,29,30,30,30,30,30,30,30,30,30,30,30,30,31,29,30,30,31,29,30,30,30,30,30,30,31,29,30,30,30,30	0,31,1287,1319,3335,3366,5462,5493,6143,6174,12898,12929,13847,13878,16197,16228,16607,16639,19694,19725,22133,22165,23517,23548,27096,27127,28638,28669,30678,30710,44542,44573,46081,46112	g	350032168400000040,350032168400000041,350032168400000042,350032168400000043,350032168400000044,350032168400000047,350032168400000048,350032168400000049,350032168400000050,350032168400000051,350032168400000052,350032168400000053,350032168400000055,350032168400000056,350032168400000057,350032168400000058,350032168400000059	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						EVALUATION OF SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH FERTILITY AND PRODUCTION TRAITS IN HOLSTEIN AND MULTI-GENERATIONAL ANGUS FEMALES	etd.lsu.edu	0	0		
588	chr14	447992	448694	3500255242	702		447992	448694	8421504	1	702	0	g	350025524200000001,350025524200000005,350025524200000006	0-720,0-20,0-20						POLIMORFISMO DE VNTR NA REGI&#xc3;O PROMOTORA DO GENE DGAT1 EM BOVINOS LEITEIROS, CAPRINOS E OVINOS	www.ppz.uem.br	0	0		
588	chr14	448290	460737	3500129342	81		448290	460737	8421504	4	20,20,20,21	0,108,12078,12426	c,g	350012934200000007,350012934200000008,350012934200000002,350012934200000002,350012934200000003,350012934200000003	0-20,0-20,0-20,0-20,0-21,0-21						Association of a lysine-232/alanine polymorphism in a bovine gene encoding acyl-CoA:diacylglycerol acyltransferase (DGAT1) with variation at a quantitative trait locus for milk fat content. - ResearchGate	.researchgate.net	0	0		
588	chr14	448398	460737	3500130672	61		448398	460737	8421504	3	20,20,21	0,11970,12318	c,g	350013067200000008,350013067200000002,350013067200000003	0-20,0-20,0-21			10.1073/pnas.142293799		Proceedings of the National Academy of Sciences of the United States of America	Association of a lysine-232/alanine polymorphism in a bovine gene encoding acyl-CoA:diacylglycerol acyltransferase (DGAT1) with variation at a quantitative trait locus for milk fat content	Andreas	July	0		
588	chr14	448398	457091	3500264687	66		448398	457091	8421504	3	20,23,23	0,5904,8670	c,g	350026468700000008,350026468700000005,350026468700000003	0-20,0-23,0-23		16534144	10.1152/physiolgenomics.00145.2005	1094-8341	Physiological Genomics	Alleles of the bovine DGAT1 variable number of tandem repeat associated with a milk fat QTL at chromosome 14 can stimulate gene expression	Furbass	2006	3		
588	chr14	450407	464018	3500109143	10100		450407	464018	8421504	36	1710,336,666,354,550,116,2013,56,30,159,106,96,477,24,45,26,21,227,88,533,180,127,311,60,510,96,115,50,165,195,50,60,190,45,70,243	0,1715,2081,2748,3152,3762,3888,5941,6015,6172,6381,6496,6617,7184,9273,9321,9465,9552,9782,9902,10485,10725,10853,11174,11243,11853,11956,12081,12287,12453,12768,12827,12947,13187,13238,13368	p,c,g	350010914300000128,350010914300000138,350010914300015021,350010914300000059,350010914300015029,350010914300000060,350010914300000060,350010914300015033,350010914300000061,350010914300000061,350010914300000062,350010914300000063,350010914300000064,350010914300000066,350010914300000139,350010914300000139,350010914300000068,350010914300000069,350010914300000071,350010914300000072,350010914300000140,350010914300000140,350010914300000074,350010914300000075,350010914300000077,350010914300000078,350010914300000028,350010914300000028,350010914300000079,350010914300000079,350010914300000026,350010914300000026,350010914300000141,350010914300000080,350010914300000007,350010914300000015,350010914300000005,350010914300000005,350010914300000027,350010914300000027,350010914300000016,350010914300000011,350010914300000011,350010914300000020,350010914300015082,350010914300015043,350010914300000083,350010914300000084,350010914300000017,350010914300000008,350010914300000029,350010914300000006,350010914300000006,350010914300000009,350010914300000009,350010914300000018,350010914300015087,350010914300000012,350010914300000021,350010914300000050,350010914300000010,350010914300000019,350010914300000004,350010914300000004,350010914300015045,350010914300000030,350010914300000030,350010914300000034,350010914300000034,350010914300000031,350010914300000031,350010914300015095,350010914300000096,350010914300000096,350010914300000036,350010914300000036,350010914300000098,350010914300000100,350010914300015117,350010914300015052,350010914300015101,350010914300000101,350010914300015118,350010914300000143,350010914300000102,350010914300000103,350010914300015119,350010914300000144,350010914300000105,350010914300015055,350010914300000108,350010914300000037,350010914300000109,350010914300000109,350010914300015122,350010914300000110,350010914300000111,350010914300000112,350010914300000113,350010914300000038,350010914300000114,350010914300000115,350010914300000116,350010914300000117,350010914300000119,350010914300000119,350010914300000120,350010914300000121,350010914300000122,350010914300000123,350010914300000124,350010914300000125,350010914300000127	0-31,15-245,0-48,0-33,0-48,0-30,0-30,0-48,0-27,0-27,0-1830,0-1020,0-550,0-96,0-70,0-70,0-56,0-1893,0-56,0-30,0-80,0-80,0-55,0-70,0-58,0-45,0-63,0-63,0-24,0-24,0-50,0-50,0-280,0-50,20-220,0-50,0-20,0-20,16-70,16-70,20-170,0-20,0-20,0-20,0-48,0-48,0-50,0-55,11-62,20-70,10-125,0-22,0-22,8-60,8-60,14-64,0-48,0-20,0-21,0-25,0-100,0-50,0-20,0-20,0-48,0-60,0-60,0-23,0-23,16-66,16-66,0-45,0-24,0-24,0-21,0-21,0-21,0-57,0-48,0-48,0-48,0-21,0-45,0-40,0-35,0-70,0-45,0-461,0-55,0-48,0-45,0-23,0-39,0-39,0-48,0-24,0-120,0-20,0-190,1-23,0-180,0-440,0-60,0-510,0-220,0-220,0-50,0-360,0-50,0-60,0-190,0-120,0-243						Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1	Coppieters	2002	0		
588	chr14	450407	460735	3500444638	228		450407	460735	8421504	10	31,20,21,22,20,25,23,21,23,22	0,6643,6681,6859,6901,6990,7066,9326,9962,10306	c,g	350044463800000065,350044463800000027,350044463800000027,350044463800000029,350044463800000029,350044463800000033,350044463800000033,350044463800000028,350044463800000028,350044463800000030,350044463800000034,350044463800000056,350044463800000026,350044463800000026,350044463800000018,350044463800000018,350044463800000020,350044463800000020,350044463800000021,350044463800000022	0-31,0-20,0-20,0-20,0-20,0-20,0-20,0-22,0-22,0-20,0-21,0-25,0-20,0-20,0-23,0-23,0-21,0-21,0-23,1-23						MARKER ASSISTED SELECTION OF BOVINE FOR IMPROVED MILK PRODUCTION USING DIACYLGLYCEROL ACYLTRANSFERASE GENE DGAT1	Georges	2001	0		
588	chr14	450426	460735	3500071254	69		450426	460735	8421504	3	26,21,22	0,10019,10287	c	350007125400000001,350007125400000002,350007125400000000	8-34,8-29,1-23		14983021	10.1073/pnas.0308518100	0027-8424	Proceedings of the National Academy of Sciences of the United States of America	Genetic and functional confirmation of the causality of the DGAT1 K232A quantitative trait nucleotide in affecting milk yield and composition	Grisart	2004	10		
588	chr14	450530	457398	3500419680	61		450530	457398	8421504	4	20,20,20,1	0,50,6777,6867	c,g	350041968000000004,350041968000000004,350041968000000001,350041968000000001,350041968000000005	0-20,0-20,0-20,0-20,0-21		23642106	10.1186/1476-511X-12-63		Lipids in Health and Disease	Upregulation of triglyceride synthesis in skeletal muscle overexpressing DGAT1	Feifei	2013	0		
588	chr14	450530	457398	3500316838	61		450530	457398	8421504	4	20,20,20,1	0,50,6777,6867	c,g	350031683800000004,350031683800000001,350031683800000001,350031683800000005	0-20,0-20,0-20,0-21						RESEARCH Open Access Upregulation of triglyceride synthesis in skeletal muscle overexpressing DGAT1	biomedcentral.com	0	0		
588	chr14	450530	457398	3500196381	61		450530	457398	8421504	4	20,20,20,1	0,50,6777,6867	c,g	350019638100000004,350019638100000001,350019638100000001,350019638100000005	0-20,0-20,0-20,0-21		23642106	10.1186/1476-511X-12-63	1476-511X	Lipids in Health and Disease	Upregulation of triglyceride synthesis in skeletal muscle overexpressing DGAT1	Yang	2013	2		
588	chr14	457068	457322	3500186556	40		457068	457322	8421504	2	20,20	0,234	c,g	350018655600000000,350018655600000001,350018655600000001	0-20,0-20,0-20			10.4081/ijas.2010.e16	1828-051X	Italian Journal of Animal Science	DGAT1 p.K232A polymorphism in dairy and dual purpose Italian cattle breeds	Scotti	2010	0		
588	chr14	457069	457421	3500236457	46		457069	457421	8421504	2	23,23	0,329	c	350023645700000000,350023645700000001	0-23,0-23						Curiosity has landed &#x2013; Interference Nibble, nibble, little mouse From coal dust to steel filters in current practice	www.shimadzu.de	0	0		
588	chr14	457069	457421	3500163587	46		457069	457421	8421504	2	23,23	0,329	c	350016358700000000,350016358700000001	0-23,0-23						Curiosity has landed &#x2013; Interference Nibble, nibble, little mouse From coal dust to steel filters in current practice	www.shimadzu.eu	0	0		
588	chr14	457069	457421	3500073459	46		457069	457421	8421504	2	23,23	0,329	c,g	350007345900000000,350007345900000001,350007345900000001	0-23,0-23,0-23						DETECTION OF DGAT-1 GENE POLYMORPHISM IN HOLSTEIN AND SLOVAK SPOTTED CATTLE BREEDS USING A MICROCHIP ELECTROPHORESIS	www.cvzv.sk	0	0		
588	chr14	457236	457614	3500435199	47		457236	457614	8421504	3	23,1,23	0,264,355	c,g	350043519900000000,350043519900000001	0-23,0-24						International Journal of Biological & Medical Research Differentiation and identification of biological samples obtained from indian cattle using dna fingerprinting technology (Minisatellites VNTR, AFLP and	omedscidirect.com	0	0		
588	chr14	457239	457327	3500030976	38		457239	457327	8421504	2	19,19	0,69	c,g	350003097600000000,350003097600000001,350003097600000001	0-19,0-19,0-19						DGAT1 K232A Polymorphism, Marbling And Shear Force In Swedish Beef Breeds	w.kongressband.de	0	0		
588	chr14	457266	457422	3500213480	42		457266	457422	8421504	2	22,20	0,136	c,g	350021348000000002,350021348000000002,350021348000000001	0-22,0-22,0-20						&#x201e;GEN ETI KA A &#x0160;LECHT&#x011a;N&#xcd; ZV&#xcd;&#x0158;AT&#x201c; &#x201e;GENETICS AND ANIMAL BREEDING&#x201c;	user.mendelu.cz	0	0		
588	chr14	459765	460006	3500450381	44		459765	460006	8421504	4	1,21,21,1	0,88,133,240	c	350045038100000002,350045038100000003	0-22,0-22						Gene expression patterns of bovine perimuscular preadipocytes during adipogenesis. - ResearchGate	.researchgate.net	0	0		
588	chr14	459906	460444	3500464199	66		459906	460444	8421504	4	13,9,23,21	0,99,463,517	c,g	350046419900000009,350046419900000011,350046419900000010,350046419900000010	0-22,0-23,0-21,0-21				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		
588	chr14	462290	462347	3500395230	57		462290	462347	8421504	1	57	0	p	350039523000015001	0-57		18434628	10.1095/biolreprod.107.066241	0006-3363	Biology of Reproduction	Interaction of HSF1 and HSF2 with the Hspa1b Promoter in Mouse Epididymal Spermatozoa	Wilkerson	2008	4		HSF1
588	chr14	462290	462347	3500278168	57		462290	462347	8421504	1	57	0	p	350027816800015001	0-57		18434628	10.1095/biolreprod.107.066241		Biology of Reproduction	Interaction of HSF1 and HSF2 with the Hspa1b Promoter in Mouse Epididymal Spermatozoa	Donald	2008	0		HSF1
588	chr14	462290	462347	3500265761	57		462290	462347	8421504	1	57	0	p	350026576100015001	0-57						Interaction of HSF1 and HSF2 with the Hspa1b Promoter in Mouse Epididymal Spermatozoa	ww.biolreprod.org	0	0		HSF1
588	chr14	462469	462930	3500000549	45		462469	462930	8421504	2	23,22	0,439	c	350000054900000001,350000054900000000	0-23,0-22						The Pendrin Anion Exchanger Gene is Transcriptionally Regulated by Uroguanylin: A Novel Entero-Renal Link	al.physiology.org	0	0		
588	chr14	462564	462941	3500294910	40		462564	462941	8421504	2	20,20	0,357	c	350029491000000005,350029491000000004	0-20,0-20						UNIVERSIDADE JOS&#xc9; DO ROS&#xc1;RIO VELLANO &#x2013; UNIFENAS TOCHIMARA APARECIDA MIYAUCHI	tede.unifenas.br	0	0		
588	chr14	466501	481238	3500285362	44		466501	481238	8421504	2	20,24	0,14713	c,g	350028536200000027,350028536200000026	20-40,18-42						Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy	onal-medicine.com	0	0		
588	chr14	466542	466872	3500175859	60		466542	466872	8421504	2	14,46	0,284	p	350017585900015003	0-60						Homo sapiens heat shock transcription factor 1 (HSF1), mRNA. , NM_005526.1 - GenScript	www.genscript.com	0	0		HSF4
589	chr14	571644	581317	3500129069	84		571644	581317	8421504	4	22,21,21,20	0,168,9423,9653	c,g	350012906900000090,350012906900000091,350012906900000056,350012906900000093,350012906900000093,350012906900000092,350012906900000092	0-22,1-22,18-39,0-21,0-21,0-20,0-20						und Charakterisierung diverser	eb.uni-giessen.de	0	0		
589	chr14	580146	580474	3500409160	40		580146	580474	8421504	2	20,20	0,308	c,g	350040916000000017,350040916000000017,350040916000000016,350040916000000016	0-20,0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
589	chr14	581010	581070	3500284273	60		581010	581070	8421504	1	60	0	p	350028427300015056	0-60						CHAPTER 3 INVESTIGATIONS INTO THE CONSERVED CORE MACHINERY OF REGULATED EXOCYTOSIS IN THE SALIVARY GLANDS OF O. savignyi	upetd.up.ac.za	0	0		CYC1
589	chr14	582295	582320	3500281780	23		582295	582320	8421504	3	9,6,8	0,10,17	c	350028178000000028	6-29						TETRACYCLIC IMIDAZOLE ANALOGS - Patent application	www.faqs.org	0	0		
589	chr14	582295	582320	3500080587	23		582295	582320	8421504	3	9,6,8	0,10,17	c	350008058700000017	6-29						Pyridinone analogs as cell proliferation inhibitors	Pierre	2007	0		
589	chr14	582295	582320	3500064396	23		582295	582320	8421504	3	9,6,8	0,10,17	c	350006439600000017	6-29						Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide	Nagasawa	2007	0		
590	chr14	680138	680180	3500007758	42		680138	680180	8421504	1	42	0	g	350000775800000031	0-42						Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates	Miskey	2006	0		
590	chr14	761588	761618	3500347208	27		761588	761618	8421504	3	13,8,6	0,15,24	g	350034720800000014	5-32			10.1128/JVI.02643-06		Journal of Virology	tRNA Isoacceptor Preference prior to Retrovirus Gag-Pol Junction Links Primer Selection and Viral Translation 	Matthew	2007	0		
591	chr14	801121	801286	3500059564	54		801121	801286	8421504	2	6,48	0,117	p	350005956400015002	0-54						ScienceDirect.com - Molecular Cell - Steroid Hormone Receptor Coactivation and Alternative RNA Splicing by U2AF65-Related Proteins CAPER&#x03b1; and CAPER&#x03b2;	sciencedirect.com	0	0		PUF60
591	chr14	801289	801313	3500207771	23		801289	801313	8421504	2	4,19	0,5	c	350020777100000029	12-35						US Patent # 7,173,115. Stra6 polypeptides - Patents.com	www.patents.com	0	0		
591	chr14	849481	849506	3500204665	23		849481	849506	8421504	2	10,13	0,12	g	350020466500000042	1-24						Virulence Genes Of M.marinum And M. Tuberculosis 	.freshpatents.com	0	0		
591	chr14	861700	861728	3500308897	23		861700	861728	8421504	3	13,5,5	0,16,23	c	350030889700000153	1-25						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
591	chr14	862170	862196	3500311219	23		862170	862196	8421504	2	11,12	0,14	c	350031121900000376	13-36						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
591	chr14	883006	883032	3500116257	25		883006	883032	8421504	2	11,14	0,12	g	350011625700000120	0-26						SAM-6 VARIANTS, TARGET AND METHODS OF USE - Patent application	www.faqs.org	0	0		
591	chr14	907908	917299	3500365031	45		907908	917299	8421504	4	20,5,6,14	0,9361,9369,9377	g	350036503100000399,350036503100000407	21-41,16-45						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
592	chr14	918407	918666	3500446081	45		918407	918666	8421504	2	43,2	0,257	p	350044608100015142	0-45						Antibody Composition-Producing Cell - Patent application	www.faqs.org	0	0		
592	chr14	918407	918666	3500386326	45		918407	918666	8421504	2	43,2	0,257	p	350038632600015118	0-45						 Antibody Composition 	www.docstoc.com	0	0		
592	chr14	918407	918666	3500016481	45		918407	918666	8421504	2	43,2	0,257	p	350001648100015142	0-45						GLYCOENGINEERED, RECOMBINANT ANTIBODY - Patent application	www.faqs.org	0	0		
592	chr14	918411	918665	3500124002	40		918411	918665	8421504	2	39,1	0,253	c	350012400200000053	7-47						PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION - Patent application	www.faqs.org	0	0		
592	chr14	918694	918720	3500289373	26		918694	918720	8421504	1	26	0	c,g	350028937300000038,350028937300000038	8-34,8-34						Production of glycoproteins with modified fucosylation	S*Ha Mi Er Dun 	2010	0		
592	chr14	918695	918720	3500347574	25		918695	918720	8421504	1	25	0	c	350034757400000003	8-33						PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION	Hamilton	2008	0		TSTA3
592	chr14	918695	918720	3500177555	25		918695	918720	8421504	1	25	0	c	350017755500000003	8-33						Production of glycoproteins with modified fucosylation	Hamilton	2010	0		TSTA3
592	chr14	918695	918720	3500104125	25		918695	918720	8421504	1	25	0	c	350010412500000003,350010412500000027	8-33,8-33					Patent	Production of glycoproteins with modified fucosylation (Patent EP:2134834)	Hamilton	2013	0		TSTA3
592	chr14	928226	928518	3500276249	43		928226	928518	8421504	2	21,22	0,270	c,g	350027624900000004,350027624900000004,350027624900000005,350027624900000005	0-21,0-21,0-22,0-22						0509_S1_article_02	www.jpp.krakow.pl	0	0		
592	chr14	945965	946124	3500381115	45		945965	946124	8421504	2	12,33	0,126	p	350038111500015004	0-45		12533507	10.1101/gad.1040803	0890-9369	Genes & Development	Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA	Pestova	2003	12		EEF1D
594	chr14	1206733	1236319	3500129069	818		1206733	1236319	8421504	6	20,20,20,37,31,690	0,10248,15661,27358,28864,28896	g	350012906900000076,350012906900000042,350012906900000066,350012906900000071,350012906900000098	0-20,0-20,0-20,0-20,0-760						und Charakterisierung diverser	eb.uni-giessen.de	0	0		
594	chr14	1216981	1255417	3500108002	40		1216981	1255417	8421504	2	20,20	0,38416	g	350010800200000002,350010800200000001	0-20,0-20		17179535	10.2527/jas.2005-753	0021-8812	Journal of Animal Science	Joint analysis of the influence of CYP11B1 and DGAT1 genetic variation on milk production, somatic cell score, conformation, reproduction, and productive lifespan in German Holstein cattle	Kaupe	2007	2		
594	chr14	1305354	1305506	3500129069	42		1305354	1305506	8421504	2	22,20	0,132	c,g	350012906900000008,350012906900000070,350012906900000070	19-41,0-20,0-20						und Charakterisierung diverser	eb.uni-giessen.de	0	0		
594	chr14	1305484	1310575	3500438452	110		1305484	1310575	8421504	4	21,36,23,30	0,1152,4998,5061	c,g	350043845200000091,350043845200000091,350043845200000023,350043845200000026,350043845200000024,350043845200000022	0-21,0-21,0-36,16-39,19-42,0-30						Process for oxidation of steroids and genetically engineered cells used therein	Slijkhuis	1998	0		
594	chr14	1305496	1310575	3500125587	1149		1305496	1310575	8421504	8	111,174,90,155,115,109,156,239	0,242,1086,2588,3014,3403,4310,4840	p	350012558700015085,350012558700015075,350012558700015055,350012558700015045,350012558700015024,350012558700015013,350012558700015003	0-105,0-180,0-180,0-180,0-174,0-180,0-150						Molecular genetic investigations of patients with defects in steroid hormone production	d-nb.info/9961581	0	0		
594	chr14	1306579	1308135	3500262447	144		1306579	1308135	8421504	2	93,51	0,1505	p	350026244700015018,350026244700015020	0-144,0-144						STUDIO MOLECOLARE IN PAZIENTI CON IPERPLASIA SURRENALE CONGENITA	rato.cib.unibo.it	0	0		
594	chr14	1310431	1310476	3500322309	45		1310431	1310476	8421504	1	45	0	p	350032230900015003	0-45						Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue 	.freshpatents.com	0	0		
596	chr14	1456174	1456199	3500021662	23		1456174	1456199	8421504	2	5,18	0,7	c	350002166200000325	20-43						FLAVIVIRUS IMMUNOGENS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
596	chr14	1456592	1456915	3500159119	27		1456592	1456915	8421504	2	25,2	0,321	c	350015911900000062	0-27						Genes That Are Up- Or Down-regulated During Differentiation Of Human Embryonic Stem Cells 	.freshpatents.com	0	0		
597	chr14	1603780	1603954	3500220831	94		1603780	1603954	8421504	3	30,32,32	0,66,142	g	350022083100000011,350022083100000009,350022083100000008,350022083100000053	0-30,0-32,0-32,0-28		20584984	10.1128/MCB.01396-09	0270-7306	Molecular and Cellular Biology	Islet &#x03b2;-Cell-Specific MafA Transcription Requires the 5&#x2032;-Flanking Conserved Region 3 Control Domain	Raum	2010	6		
598	chr14	1786396	1786420	3500417645	23		1786396	1786420	8421504	2	5,18	0,6	g	350041764500000001	3-26		18485098	10.1111/j.1471-4159.2008.05484.x	1471-4159	Journal of Neurochemistry	Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury - Onishchenko - 2008 - Journal of Neurochemistry - Wiley Online Library	Onishchenko	2008	0		
601	chr14	2186809	2212038	3500405741	43		2186809	2212038	8421504	3	22,14,7	0,11181,25222	c	350040574100000002,350040574100000003	0-22,0-21						Detection and treatment of glyco-enzyme-related disease	Moskal	2004	0		PTK2
601	chr14	2186809	2212038	3500147626	43		2186809	2212038	8421504	3	22,14,7	0,11181,25222	c	350014762600000002,350014762600000003	0-22,0-21						Methods for the detection and treatment of disease using a glycosyltransferase	R	1999	0		
601	chr14	2186809	2212038	3500139349	43		2186809	2212038	8421504	3	22,14,7	0,11181,25222	c	350013934900000002,350013934900000006,350013934900000003,350013934900000007	0-22,0-22,0-21,0-21						Detection and Treatment of Glyco-Enzyme-Related Disease - Patent application	www.faqs.org	0	0		PTK2
601	chr14	2186910	2197855	3500268016	40		2186910	2197855	8421504	3	21,1,18	0,93,10927	c	350026801600000006,350026801600000007	0-21,0-19		20473295	10.1038/ncb2062		Nature cell biology	A distinctive role for focal adhesion proteins in three-dimensional cell motility	Stephanie	June	0		
601	chr14	2186923	2186980	3500154330	57		2186923	2186980	8421504	1	57	0	p	350015433000015012	0-57						a complete set of instruments & reagents for microgenomics	7.discountasp.net	0	0		PTK2
601	chr14	2187003	2212081	3500454522	38		2187003	2212081	8421504	3	1,18,19	0,10834,25059	c	350045452200000004,350045452200000005	0-19,0-19		22870384	10.1038/srep00555	xxxx-xxxx	Scientific Reports	Actin cap associated focal adhesions and their distinct role in cellular mechanosensing	Kim	2012	0		PTK2
601	chr14	2187003	2212081	3500184446	38		2187003	2212081	8421504	3	1,18,19	0,10834,25059	c	350018444600000004,350018444600000005	0-19,0-19		22870384	10.1038/srep00555	xxxx-xxxx	Scientific Reports	Actin cap associated focal adhesions and their distinct role in cellular mechanosensing	Kim	2012	0		PTK2
601	chr14	2197873	2197943	3500320087	40		2197873	2197943	8421504	2	19,21	0,49	c,g	350032008700000004,350032008700000003,350032008700000003	0-19,0-21,0-21		16439548	10.1128/JVI.80.4.1922-1938.2006	0022-538X	Journal of Virology	Insights into Gene Expression Changes Impacting B-Cell Transformation: Cross-Species Microarray Analysis of Bovine Leukemia Virus Tax-Responsive Genes in Ovine B Cells	Klener	2006	5		
75	chr14	2197888	2293212	3500432351	117		2197888	2293212	8421504	4	47,23,8,39	0,40288,82148,95285	c	350043235100000086,350043235100000100,350043235100000123	0-47,0-23,0-47					Patent	Antisense inhibition of focal adhesion kinase expression (Patent US:6133031)	Gaarde	2000	0		
75	chr14	2223126	2237347	3500349939	40		2223126	2237347	8421504	3	21,3,16	0,13477,14205	c	350034993900000002,350034993900000003	0-21,0-19						Kinase protein binding inhibitors	Hochwald	2012	0		PTK2
602	chr14	2237343	2240465	3500129069	47		2237343	2240465	8421504	2	23,24	0,3098	c,g	350012906900000060,350012906900000048,350012906900000043	0-22,0-22,20-44						und Charakterisierung diverser	eb.uni-giessen.de	0	0		
602	chr14	2277280	2277307	3500271222	24		2277280	2277307	8421504	3	11,3,10	0,13,17	g	350027122200000007	12-36						Oligonucleotides complementary to mycobacterial nucleic acids	Liu	1993	0		
602	chr14	2316293	2316321	3500086063	24		2316293	2316321	8421504	3	14,5,5	0,15,23	c	350008606300000317,350008606300000159	22-46,19-43						Gastrointestinal proliferative foctor and uses thereof - Patent application	www.faqs.org	0	0		
603	chr14	2379190	2379218	3500376159	23		2379190	2379218	8421504	2	16,7	0,21	g	350037615900000045	0-27						Stabilized polypeptide compositions - Patent application	www.faqs.org	0	0		
603	chr14	2395510	2395573	3500201409	63		2395510	2395573	8421504	1	63	0	p	350020140900015002	0-63		22851315	10.1083/jcb.201111012		The Journal of Cell Biology	HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly	Jonathan	2012	0		AGO2
604	chr14	2500783	2500813	3500134916	24		2500783	2500813	8421504	3	5,13,6	0,7,24	g	350013491600000148	6-32						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
606	chr14	2866325	2866355	3500197100	25		2866325	2866355	8421504	2	7,18	0,12	c	350019710000000030	8-35						HPV PARTICLES AND USES THEREOF	Coursaget	2009	0		
606	chr14	2866325	2866355	3500095623	25		2866325	2866355	8421504	2	7,18	0,12	c	350009562300000030	8-35						Hpv particles and uses thereof	Pierre	2010	0		
607	chr14	3000234	3000754	3500288579	80		3000234	3000754	8421504	3	22,36,22	0,87,498	c,g	350028857900000010,350028857900000022,350028857900000022,350028857900000011,350028857900000023,350028857900000023	0-22,0-20,0-20,0-24,0-22,0-22						REPRODUCTION	uction-online.org	0	0		
608	chr14	3097268	3097297	3500072549	24		3097268	3097297	8421504	2	8,16	0,13	g	350007254900000002	0-28					Journal of Bacteriology	Genetic Analysis of the Serratia marcescens N28b O4 Antigen Gene Cluster	Francesc	1999	0		
612	chr14	3647732	3647757	3500347051	24		3647732	3647757	8421504	2	7,17	0,8	g	350034705100000031	23-47						MICROORGANISM EXPRESSING ALDOSE-1-EPIMERASE - Terranol A/S	www.sumobrain.com	0	0		
615	chr14	3947757	3994568	3500134916	46		3947757	3994568	8421504	3	24,9,13	0,46785,46798	g	350013491600000011,350013491600000009	0-24,11-33						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
615	chr14	3947757	3994568	3500072770	46		3947757	3994568	8421504	3	24,9,13	0,46785,46798	g	350007277000000006,350007277000000007	0-24,11-33						UNIVERSIDAD POLITACNICA DE VALENCIA DEPARTAMENTO DE CIENCIA ANIMAL CARACTERIZACIAN GENATICA Y	dspace.upv.es	0	0		
615	chr14	3947757	3947781	3500129069	24		3947757	3947781	8421504	1	24	0	g	350012906900000074	0-24						und Charakterisierung diverser	eb.uni-giessen.de	0	0		
621	chr14	4779689	4779716	3500125245	23		4779689	4779716	8421504	2	12,11	0,16	g	350012524500000001	1-31						Identi&#xfb01;cation and characterization of a cDNA and the gene encoding the mouse ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein	logy-journals.org	0	0		
621	chr14	4844527	4844557	3500220939	23		4844527	4844557	8421504	3	6,5,12	0,10,18	g	350022093900000001	0-23						Hussain et al., J Antivir Antiretrovir 2012, S15 Antivirals & Antiretrovirals	w.omicsonline.org	0	0		
625	chr14	5326158	5326186	3500347059	24		5326158	5326186	8421504	3	13,5,6	0,14,22	g	350034705900000086	11-37					Patent	Process for producing 7-aminocephem compound or salts thereof (Patent US:5677141)	Aramori	1997	0		
629	chr14	5863319	5863344	3500086010	23		5863319	5863344	8421504	3	4,13,6	0,5,19	g	350008601000000007	5-31						 DNA Sequences Encoding SAR8.2 Proteins And Uses Thereof 	www.docstoc.com	0	0		
633	chr14	6381721	6381745	3500417603	23		6381721	6381745	8421504	2	5,18	0,6	g	350041760300000000	0-23		12970415	10.1128/JVI.77.19.10304-10313.2003	0022-538X	Journal of Virology	The Vpu Protein of Human Immunodeficiency Virus Type 1 Plays a Protective Role against Virus-Induced Apoptosis in Primary CD4+ T Lymphocytes	Komoto	2003	5		
634	chr14	6481880	6481950	3500040785	70		6481880	6481950	8421504	1	70	0	c	350004078500000097,350004078500000057	0-70,0-22						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		
634	chr14	6481885	6486265	3500177892	47		6481885	6486265	8421504	2	22,25	0,4355	c	350017789200000017,350017789200000016	22-44,24-49						Supporting Information	www.pnas.org	0	0		
634	chr14	6481885	6486262	3500371464	44		6481885	6486262	8421504	2	22,22	0,4355	c	350037146400000063,350037146400000061	0-22,0-22						MICRORNAS THAT REGULATE MUSCLE CELL PROLIFERATION AND DIFFERENTIATION - Patent application	www.faqs.org	0	0		
634	chr14	6481885	6486261	3500423784	44		6481885	6486261	8421504	2	23,21	0,4355	c,g	350042378400000106,350042378400000104,350042378400000003,350042378400000105	0-22,0-23,0-23,0-21						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		LINC00472
634	chr14	6481885	6486261	3500125321	44		6481885	6486261	8421504	2	23,21	0,4355	c,g	350012532100000104,350012532100000104,350012532100000009,350012532100000009	0-23,0-23,0-21,0-21						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
634	chr14	6550953	6550980	3500374909	24		6550953	6550980	8421504	2	19,5	0,22	g	350037490900000581	24-48						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
635	chr14	6562278	6562301	3500417996	23		6562278	6562301	8421504	1	23	0	g	350041799600000007	20-43						Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use	Bowditch	1991	0		
636	chr14	6762275	6762302	3500354588	23		6762275	6762302	8421504	2	13,10	0,17	g	350035458800000029,350035458800000221	11-34,11-34						Peptides that specifically bind HGF receptor (CMET) and uses thereof - Patent application	www.faqs.org	0	0		
641	chr14	7357225	7357251	3500351142	23		7357225	7357251	8421504	2	11,12	0,14	g	350035114200000110	4-27						METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - Patent application	www.faqs.org	0	0		
641	chr14	7357225	7357251	3500248138	23		7357225	7357251	8421504	2	11,12	0,14	g	350024813800000113	4-27						Methods and compositions for the specific inhibition of gene expression by double-stranded RNA	Rossi	2007	0		
641	chr14	7357225	7357251	3500235523	23		7357225	7357251	8421504	2	11,12	0,14	g	350023552300000113	4-27						METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - Patent application	www.faqs.org	0	0		
642	chr14	7529230	7546858	3500204973	126		7529230	7546858	8421504	3	69,36,21	0,3945,17607	p	350020497300015001	114-420						Cap43,aNovelGeneSpecificallyInducedbyNi2+Compounds1	www.u.arizona.edu	0	0		
642	chr14	7531071	7531095	3500168274	24		7531071	7531095	8421504	1	24	0	g	350016827400000013	10-48						Detergent Composition 	.freshpatents.com	0	0		
642	chr14	7572323	7572346	3500245755	23		7572323	7572346	8421504	1	23	0	c	350024575500000005	10-33						SUPPLEMENTAL MATERIAL	c.ahajournals.org	0	0		
643	chr14	7665810	7665906	3500260285	96		7665810	7665906	8421504	1	96	0	p	350026028500015042	0-96						Molecularcloning G+C-rich	www.pnas.org	0	0		
643	chr14	7679730	7679758	3500048987	24		7679730	7679758	8421504	2	12,12	0,16	g	350004898700000002	0-24		14594825	10.1128/JB.185.22.6530-6539.2003	0021-9193	Journal of Bacteriology	Null Mutations in a Nudix Gene, ygdP, Implicate an Alarmone Response in a Novel Suppression of Hybrid Jamming	Hand	2003	4		
644	chr14	7762509	7762536	3500121878	24		7762509	7762536	8421504	2	10,14	0,13	c	350012187800000102	2-27						Plant fatty acid synthases	www.devileye.net	0	0		
644	chr14	7762509	7762536	3500109714	24		7762509	7762536	8421504	2	10,14	0,13	c	350010971400000102	2-27						Plant fatty acid synthases	Knauf	1991	0		
644	chr14	7762642	7762670	3500018414	24		7762642	7762670	8421504	2	10,14	0,14	c	350001841400000084	0-24						Expression of neurogenic bHLH genes in primitive neuroectodermal tumors	Tapscott	1997	0		
645	chr14	7868100	7868128	3500341162	27		7868100	7868128	8421504	2	7,20	0,8	g	350034116200000533,350034116200000317	7-34,2-29						Perhydrolase	Amin	2004	0		
645	chr14	7868100	7868128	3500134317	27		7868100	7868128	8421504	2	7,20	0,8	g	350013431700000317,350013431700000533	2-29,7-34						Perhydrolase 	.freshpatents.com	0	0		
645	chr14	7868100	7868128	3500129453	27		7868100	7868128	8421504	2	7,20	0,8	g	350012945300000189,350012945300000405	2-29,7-34					Patent	Perhydrolase (Patent EP:1689859)	Amin	2011	0		
645	chr14	7879747	7880646	3500008154	62		7879747	7880646	8421504	3	22,21,19	0,53,880	c	350000815400000006,350000815400000010,350000815400000005	0-22,0-21,0-19						Mining the Mammalian Genome for Artiodactyl Systematics	www.jstor.org	0	0		
645	chr14	7902171	7902231	3500014544	60		7902171	7902231	8421504	1	60	0	g	350001454400000005	0-60						Cloning and sequence analysis of TFE, a helix-loop-helix transcription factor able to recognize the thyroglobulin gene promoter in vitro. - ResearchGate	.researchgate.net	0	0		
645	chr14	7902261	7902806	3500176157	545		7902261	7902806	8421504	1	545	0	g	350017615700000012,350017615700000013,350017615700000011,350017615700000023,350017615700000022,350017615700000021,350017615700000019,350017615700000000	0-545,0-544,0-545,0-545,0-545,0-545,0-23,0-23						Assessing lipid metabolism	Barendse	1999	0		
645	chr14	7902781	7902806	3500370604	25		7902781	7902806	8421504	1	25	0	g	350037060400000002	0-25						MARCADORES MOLECULARES ASOCIADOS AL VETEADO DE LA CARNE EN BOVINOS CRIOLLOS URUGUAYOS	ion-animal.com.ar	0	0		
645	chr14	7902783	7902806	3500312836	23		7902783	7902806	8421504	1	23	0	g	350031283600000000	0-23						Method of amplifying nucleic acid	Hayden	2010	0		
645	chr14	7902783	7902806	3500096019	23		7902783	7902806	8421504	1	23	0	g	350009601900000000	0-23						Method of amplifying nucleic acid	Hayden	2009	0		
645	chr14	7902783	7902806	3500079179	23		7902783	7902806	8421504	1	23	0	g	350007917900000004	0-23						BTN1A1 FABP3 and TG genes polymorphism in East Anatolian red cattle breed and South Anatolian red cattle breed	demicjournals.org	0	0		
647	chr14	8233574	8233598	3500220074	23		8233574	8233598	8421504	2	8,15	0,9	g	350022007400000072	0-46					Patent	Thermophilic DNA polymerases from Thermotoga neapolitana (Patent US:6077664)	Bolchakova	2000	0		
649	chr14	8468517	8468547	3500179421	24		8468517	8468547	8421504	3	4,7,13	0,5,17	g	350017942100000066	0-25						SYNTHETIC BIOLOGY TOOLS	Lou	2012	0		
649	chr14	8482246	8482269	3500279682	23		8482246	8482269	8421504	1	23	0	c	350027968200000081	0-23						KCNQ2 and KCNQ3&#x2014;potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies	Singh	2002	0		
650	chr14	8599749	8599781	3500246732	26		8599749	8599781	8421504	3	6,13,7	0,9,25	c	350024673200000004,350024673200000001	3-29,3-29						GENERATION OF NEW BCG VACCINE STRAINS PROTECTING AGAINST THE ESTABLISHMENT OF LATENT MYCOBACTERIUM TUBERCULOSIS INFECTION AND REACTIVATION FROM THE LATENT OR PERSISTENT STATE - Patent application	www.faqs.org	0	0		
651	chr14	8723638	8723664	3500351898	24		8723638	8723664	8421504	2	10,14	0,12	g	350035189800000040	6-42						Plant Pest Diagnostics Branch	www.cdfa.ca.gov	0	0		
651	chr14	8741593	8741617	3500467196	24		8741593	8741617	8421504	1	24	0	g	350046719600000049	9-33						Recombinant hexose oxidase, a method of producing same and use of such enzyme	Stougaard	2007	0		
652	chr14	8826224	8826247	3500447808	23		8826224	8826247	8421504	1	23	0	g	350044780800000007	1-33						Tyrosine-containing cyclophilin and related methods	Carlow	2000	0		
653	chr14	8985647	8985672	3500453245	23		8985647	8985672	8421504	2	14,9	0,16	g	350045324500000104	5-29						ENZYMATIC PERACID GENERATION FOR USE IN ORAL CARE PRODUCTS - Patent application	www.faqs.org	0	0		
655	chr14	9209131	9209244	3500215286	40		9209131	9209244	8421504	2	20,20	0,93	c,g	350021528600000014,350021528600000014,350021528600000015	0-20,0-20,0-20		21054345	10.1111/j.1476-5381.2010.01107.x	1476-5381	British Journal of Pharmacology	Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells - Friedlander - 2011 - British Journal of Pharmacology - Wiley Online Library	Friedlander	2011	0		
656	chr14	9346222	9382519	3500298964	42		9346222	9382519	8421504	2	21,21	0,36276	c	350029896400000008,350029896400000009	0-21,0-21						Changes in the Expression of Adenylyl Cyclases in the Rat Uterus during the Course of Pregnancy'	ww.biolreprod.org	0	0		ADCY8
659	chr14	9765068	9810095	3500391891	165		9765068	9810095	8421504	2	59,106	0,44921	p	350039189100015005	0-165						Crosstalk and Integration of Membrane Trafficking Pathways	www.scribd.com	0	0		ASAP1
661	chr14	10013080	10072058	3500144509	233		10013080	10072058	8421504	11	20,20,20,20,20,20,20,30,21,20,22	0,601,904,16809,17346,18949,24274,24730,54873,58695,58956	c,g	350014450900000003,350014450900000011,350014450900000012,350014450900000019,350014450900000020,350014450900000021,350014450900000027,350014450900000028,350014450900000029,350014450900000031,350014450900000065,350014450900000065,350014450900000066,350014450900000066	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-21,0-20,0-20,0-22,0-22						METHODS AND KITS FOR THE IDENTIFICATION OF ANIMALS HAVING A GREATER POTENTIAL FOR DESIRABLE CHARACTERISTICS, AND FOR THE EARLY IDENTIFICATION OF FAT DEPOSITS IN BOVINES	Almeida	2010	0		
661	chr14	10073519	10073545	3500190747	25		10073519	10073545	8421504	2	9,16	0,10	g	350019074700000031	23-48						Methods of replicating a DNA molecule for repair of DNA lesion damage or for mutagenesis	Livneh	2000	0		
82	chr14	10208270	10239536	3500069023	720		10208270	10239536	8421504	9	73,122,51,49,137,54,102,71,61	0,6653,11687,11744,16925,18141,22153,23747,31205	p	350006902300015001	0-723						Identification of human gene sequences of cancer antigens expressed in metastatic carcinoma and involved in metastasis formation, and their use in cancer diagnosis, prognosis and therapy	Hentsch	2006	0		SNORA25,FAM49B
663	chr14	10315848	10337165	3500110329	41		10315848	10337165	8421504	3	19,12,10	0,21292,21307	g	350011032900000423,350011032900000258	11-30,0-27						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
669	chr14	11124090	11124117	3500305655	23		11124090	11124117	8421504	2	11,12	0,15	g	350030565500000067	0-23						IMMUNOGENIC COMPOSITIONS AGAINST TUBERCULOSIS	Talaat	2013	0		
677	chr14	12158044	12158082	3500440545	37		12158044	12158082	8421504	2	6,31	0,7	c	350044054500000046,350044054500000047	8-45,12-46						Constructs for gene expression analysis	Daly	2003	0		
677	chr14	12158118	12158144	3500171444	26		12158118	12158144	8421504	1	26	0	c	350017144400000015	8-34		21464222	10.1084/jem.20102384	0022-1007	The Journal of Experimental Medicine	Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL	Li	2011	14		
677	chr14	12158555	12158711	3500363345	156		12158555	12158711	8421504	1	156	0	p	350036334500015008	0-156						SPATULA, a bHLH carpel development gene	ev.biologists.org	0	0		MYC
677	chr14	12158621	12160982	3500432629	642		12158621	12160982	8421504	13	45,45,48,45,45,11,34,93,93,45,45,45,48	0,48,96,240,336,384,1652,1785,1929,2073,2217,2265,2313	p,c	350043262900015184,350043262900015182,350043262900015180,350043262900000109,350043262900015174,350043262900000104,350043262900015170,350043262900015168,350043262900015162,350043262900000100,350043262900015160,350043262900000097,350043262900015154,350043262900015150,350043262900015144,350043262900015142,350043262900015140,350043262900000089	0-45,0-45,0-45,0-48,0-45,9-48,0-45,0-45,0-45,0-48,0-45,0-48,0-45,0-45,0-45,0-45,0-45,0-48						CANINE iPS CELLS AND METHOD OF PRODUCING SAME - Patent application	www.faqs.org	0	0		
677	chr14	12158703	12158905	3500409160	40		12158703	12158905	8421504	2	20,20	0,182	c,g	350040916000000035,350040916000000035,350040916000000034,350040916000000034	0-20,0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
677	chr14	12158751	12160883	3500077684	40		12158751	12160883	8421504	2	20,20	0,2112	c,g	350007768400000012,350007768400000011,350007768400000011	0-20,0-20,0-20		18987311	10.1073/pnas.0710725105	0027-8424	Proceedings of the National Academy of Sciences	The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene	Lin	2008	10		
677	chr14	12158895	12160283	3500095765	40		12158895	12160283	8421504	3	20,10,10	0,111,1378	c,g	350009576500000022,350009576500000022,350009576500000021	0-20,0-20,0-20						Escape from Transcriptional Shutoff during Poliovirus Infection: NF- B-Responsive Genes I Ba and A20	jvi.asm.org	0	0		MYC
677	chr14	12158960	12160838	3500432740	116		12158960	12160838	8421504	3	45,48,23	0,1638,1855	c	350043274000000163,350043274000000155,350043274000000151	0-45,0-48,0-23						METHOD FOR PRODUCTION OF REPROGRAMMED CELL USING CHROMOSOMALLY UNINTEGRATED VIRUS VECTOR - Patent application	www.faqs.org	0	0		
677	chr14	12158963	12158987	3500010622	24		12158963	12158987	8421504	1	24	0	c	350001062200000007	0-24						Oncogene - Figures and tables for article: [beta]-Catenin regulates the expression of tenascin-C in human colorectal tumors	www.nature.com	0	0		MYC
677	chr14	12158966	12160600	3500011608	43		12158966	12160600	8421504	2	21,22	0,1612	c,g	350001160800000015,350001160800000015,350001160800000014	0-21,0-21,0-22						&#x718a;&#x672c;&#x5927;&#x5b66;&#x5b66;&#x8853;&#x30ea;&#x30dd;&#x30b8;&#x30c8;&#x30ea; Kumamoto University Repository System	.kumamoto-u.ac.jp	0	0		MYC
677	chr14	12158971	12158995	3500449946	24		12158971	12158995	8421504	1	24	0	c	350044994600000017	0-24		21118196	10.1111/j.1365-2141.2010.08471.x	1365-2141	British Journal of Haematology	Proliferation and bone marrow engraftment of AML blasts is dependent on &#x03b2;-catenin signalling - Siapati - 2010 - British Journal of Haematology - Wiley Online Library	Siapati	2011	0		MYC
677	chr14	12160615	12160641	3500316101	26		12160615	12160641	8421504	1	26	0	c	350031610100000001	0-26						Epigenetic regulation of hTERT promoter in hepatocellular carcinomas	-publications.com	0	0		
677	chr14	12160624	12160650	3500343116	26		12160624	12160650	8421504	1	26	0	c	350034311600000023	0-26		23197849	10.5966/sctm.2011-0044	2157-6564	Stem Cells Translational Medicine	Transgene-Free Disease-Specific Induced Pluripotent Stem Cells from Patients with Type 1 and Type 2 Diabetes	Kudva	2012	0		MYC
677	chr14	12160799	12160937	3500230063	138		12160799	12160937	8421504	1	138	0	p	350023006300015012	0-138						Method for rejuvenating cells	LAPASSET	2012	0		
677	chr14	12160820	12160877	3500336946	57		12160820	12160877	8421504	1	57	0	p	350033694600015008	0-57						METHOD FOR THE DETECTION OF POST-TRANSLATIONAL MODIFICATIONS - Patent application	www.faqs.org	0	0		MYC
677	chr14	12160823	12160880	3500172486	57		12160823	12160880	8421504	1	57	0	p	350017248600015000	0-57						(34). Cells were lysed, quantitated, electrophoresed, and West-	www.pnas.org	0	0		
677	chr14	12160823	12160880	3500007425	57		12160823	12160880	8421504	1	57	0	p	350000742500015000	0-57			10.1073/pnas.0402770101		Proceedings of the National Academy of Sciences of the United States of America	From the Cover: The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation	Markus	June	0		MYC
677	chr14	12160838	12160883	3500311230	45		12160838	12160883	8421504	1	45	0	p	350031123000015003	0-45						Conditionally-Immortalised Pancreatic Cells - Patent application	www.faqs.org	0	0		MYCN
677	chr14	12160844	12160892	3500348183	48		12160844	12160892	8421504	1	48	0	p	350034818300015000	0-48						US Patent # 5,723,581. Murine and human box-dependent myc-interacting protein (Bin1) - Patents.com	www.patents.com	0	0		MYCN
677	chr14	12160973	12160999	3500307762	26		12160973	12160999	8421504	1	26	0	c	350030776200000003	18-44						CHARAKTERISIERUNG PANKREATISCHER INS-1 INSULINOMA-ZELLEN UNTER CHRONISCH HOHER GLUKOSEKONZENTRATION ALS MODELL F&#xdc;R GLUKOSETOXIZIT&#xc4;T	diss.fu-berlin.de	0	0		MYC
677	chr14	12160974	12162919	3500277174	48		12160974	12162919	8421504	2	24,24	0,1921	c	350027717400000013,350027717400000012	0-24,0-24						Bone Morphogenetic Protein 7 Is and Eva Corey* Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment	www.neoplasia.com	0	0		MYC
677	chr14	12160983	12161008	3500211078	25		12160983	12161008	8421504	1	25	0	c	350021107800000007,350021107800000008	0-25,0-25		20631077	10.1158/0008-5472.CAN-10-0184	0008-5472	Cancer Research	Circadian Rhythm of Transferrin Receptor 1 Gene Expression Controlled by c-Myc in Colon Cancer&#x2013;Bearing Mice	Okazaki	2010	8		MYC
677	chr14	12161009	12161033	3500438700	24		12161009	12161033	8421504	1	24	0	c	350043870000000004	9-33		20426839	10.1186/1476-4598-9-92	1476-4598	Molecular Cancer	Myc interacts with Max and Miz1 to repress C/EBP&#xce;&#xb4; promoter activity and gene expression	Si	2010	4		
677	chr14	12161009	12161033	3500222250	24		12161009	12161033	8421504	1	24	0	c	350022225000000004	9-33		20426839	10.1186/1476-4598-9-92	1476-4598	Molecular Cancer	Myc interacts with Max and Miz1 to repress C/EBP&#xce;&#xb4; promoter activity and gene expression	Si	2010	4		
677	chr14	12161009	12161033	3500123026	24		12161009	12161033	8421504	1	24	0	c	350012302600000004	9-33		20426839	10.1186/1476-4598-9-92		Molecular Cancer	Myc interacts with Max and Miz1 to repress C/EBP&#x03b4; promoter activity and gene expression	Junling	2010	0		
677	chr14	12163114	12163137	3500402010	23		12163114	12163137	8421504	1	23	0	c	350040201000000012	0-23						Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by Directly Suppressing c-Myc Expression	mcb.asm.org	0	0		
677	chr14	12163117	12163141	3500345219	24		12163117	12163141	8421504	1	24	0	c	350034521900000003	0-24		22573234	10.1016/j.celrep.2012.02.010	2211-1247	Cell Reports	Cell Reports - Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis	Lin	2012	0		MYC
677	chr14	12163117	12163141	3500276875	24		12163117	12163141	8421504	1	24	0	c	350027687500000003	0-24		22573234	10.1016/j.celrep.2012.02.010	2211-1247	Cell Reports	Cell Reports - Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis	Lin	2012	0		MYC
677	chr14	12163117	12163141	3500197589	24		12163117	12163141	8421504	1	24	0	c	350019758900000003	0-24			10.1016/j.celrep.2012.02.010		Cell reports	Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis	Chen-Ju	2012	0		MYC
677	chr14	12163117	12163140	3500034344	23		12163117	12163140	8421504	1	23	0	c	350003434400000010	25-48						Supplemental Methods	www.nature.com	0	0		MYC
677	chr14	12163119	12163142	3500002039	23		12163119	12163142	8421504	1	23	0	c	350000203900000000	6-29			10.1046/j.1432-1033.2002.02974.x	1432-1033	European Journal of Biochemistry	Phosphorylation of initiation factor-2&#x03b1; is required for activation of internal translation initiation during cell differentiation - Gerlitz - 2002 - European Journal of Biochemistry - Wiley Online Library	Gerlitz	2002	0		
677	chr14	12163126	12163154	3500066002	28		12163126	12163154	8421504	1	28	0	g	350006600200000083	46-74						Method for producing derivational pluripotent stem cell with meninges cell and uses thereof	He Wen Zhi 	2009	0		
681	chr14	12702914	12702942	3500349135	23		12702914	12702942	8421504	2	16,7	0,21	g	350034913500000009	20-49						Ubiquitin is a heat shock protein in chicken embryo fibroblasts. - ResearchGate	.researchgate.net	0	0		
683	chr14	12879704	12879730	3500284394	25		12879704	12879730	8421504	2	15,10	0,16	g	350028439400000047	1-42						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2011	0		
683	chr14	12879704	12879730	3500253796	25		12879704	12879730	8421504	2	15,10	0,16	g	350025379600000047	1-42					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
683	chr14	12879704	12879730	3500070088	25		12879704	12879730	8421504	2	15,10	0,16	g	350007008800000047	1-42						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
685	chr14	13107765	13107794	3500420657	24		13107765	13107794	8421504	2	11,13	0,16	g	350042065700000202	24-48						Collection and Methods For Its Use - Patent application	www.faqs.org	0	0		
687	chr14	13396437	13396462	3500004289	24		13396437	13396462	8421504	2	4,20	0,5	g	350000428900000026	22-46						Glutamine-rich maize seed protein and promoter	Si Ke Te *Bei Ci 	2007	0		
688	chr14	13507484	13507511	3500108781	23		13507484	13507511	8421504	2	15,8	0,19	g	350010878100000000	4-27						Die Charakterisierung der Rolle B-Zell-spezifischer Transkriptionsfaktoren und des ID2 in der Dedifferenzierung und Pathogenese der Hodgkin/Reed-Sternberg Zellen im klassischen Hodgkin Lymphom	.uni-frankfurt.de	0	0		
693	chr14	14191693	14191719	3500260237	24		14191693	14191719	8421504	2	19,5	0,21	g	350026023700000251	9-34						Targeted immunoconjugates	Mossner	2011	0		
693	chr14	14191693	14191719	3500104289	24		14191693	14191719	8421504	2	19,5	0,21	g	350010428900000251	9-34						TARGETED IMMUNOCONJUGATES - Patent application	www.faqs.org	0	0		
693	chr14	14246301	14253238	3500464472	762		14246301	14253238	8421504	9	21,23,20,22,20,26,262,293,75	0,315,559,1005,1361,1448,1635,4382,6862	p,c,g	350046447200000013,350046447200000011,350046447200000012,350046447200000012,350046447200000010,350046447200000007,350046447200000008,350046447200015022,350046447200000005,350046447200000005,350046447200015021,350046447200015020,350046447200000003	0-21,0-23,0-20,0-20,0-22,0-20,0-26,0-210,0-19,0-19,0-210,0-210,0-26						CARACTERIZACI&#xd3;N DE GENES CANDIDATOS PARA CARACTERES LIP&#xcd;DICOS E IDENTIFICACI&#xd3;N DE COPY NUMBER VARIATION EN UNA POBLACI&#xd3;N PORCINA DUROC	www.tdx.cat	0	0		
693	chr14	14246301	14253238	3500081530	762		14246301	14253238	8421504	9	21,23,20,22,20,26,262,293,75	0,315,559,1005,1361,1448,1635,4382,6862	p,c,g	350008153000000015,350008153000000013,350008153000000014,350008153000000012,350008153000000009,350008153000000010,350008153000015005,350008153000000007,350008153000000007,350008153000015004,350008153000015003,350008153000000005	0-21,0-23,0-20,0-22,0-20,0-26,0-210,0-19,0-19,0-210,0-210,0-26						CAROLA TRINIDAD MELO ROJAS Dpto de Ciencia Animal y de los Alimentos UNIVERSIDAD AUT&#xd3;NOMA DE BARCELONA 2009	riunet.upv.es	0	0		
693	chr14	14247749	14253238	3500274639	656		14247749	14253238	8421504	4	26,262,293,75	0,187,2934,5414	p,c	350027463900000003,350027463900015021,350027463900015020,350027463900015019,350027463900000002	22-84,0-210,0-210,0-210,18-44						CARACTERIZACIAN DE GENES CANDIDATOS PARA CARACTERES LIPADICOS E IDENTIFICACIAN DE COPY NUMBER VAR	www.tdx.cat	0	0		TRIB1
693	chr14	14247795	14253521	3500329339	712		14247795	14253521	8421504	16	45,45,42,45,42,42,19,23,93,45,24,21,45,45,90,46	0,48,96,144,192,288,384,2888,3013,3109,3157,5368,5392,5536,5584,5680	c	350032933900000113,350032933900000089,350032933900000112,350032933900000111,350032933900000110,350032933900000109,350032933900000086,350032933900000084,350032933900000105,350032933900000102,350032933900000101,350032933900000100,350032933900000099,350032933900000076,350032933900000098,350032933900000075,350032933900000095,350032933900000072,350032933900000094,350032933900000093,350032933900000092	0-45,9-45,0-45,0-42,0-45,0-42,0-41,0-42,0-42,0-48,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-48,0-42,0-46						US Patent # 8,389,207. Methods for identifying candidate fat-mobilizing agents - Patents.com	patents.com	0	0		
694	chr14	14289768	14289795	3500313823	25		14289768	14289795	8421504	2	19,6	0,21	g	350031382300000034	0-26						Selection of Human TNFAlpha Specific Antibodies - Patent application	www.faqs.org	0	0		
694	chr14	14300078	14300104	3500423474	23		14300078	14300104	8421504	2	14,9	0,17	g	350042347400000004	0-23						Neuropathogenesis of herpesvirus papio 2 in mice parallels infection with Cercopithecine herpesvirus (B virus) in humans	r.sgmjournals.org	0	0		
694	chr14	14385007	14385039	3500165384	28		14385007	14385039	8421504	2	15,13	0,19	g	350016538400000301	0-28						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
696	chr14	14563483	14563508	3500326718	25		14563483	14563508	8421504	1	25	0	g	350032671800000066	0-25						Method Of Prognosing And Diagnosing Hereditary Spastic Paraplegia, Mutant Nucleic Acid Molecules And Polypeptides 	.freshpatents.com	0	0		
696	chr14	14563483	14563508	3500001073	25		14563483	14563508	8421504	1	25	0	g	350000107300000066	0-25						Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides	Rouleau	2007	0		
696	chr14	14612240	14612266	3500311609	23		14612240	14612266	8421504	2	8,15	0,11	c	350031160900000063	5-28						Use of multiple recombination sites with unique specificity in recombinational cloning	Brasch	2001	0		
696	chr14	14612240	14612266	3500102953	23		14612240	14612266	8421504	2	8,15	0,11	c	350010295300000063	5-28						Use of multiple recombination sites with unique specificity in recombinational cloning	Brasch	2001	0		
696	chr14	14622498	14622522	3500346255	24		14622498	14622522	8421504	1	24	0	c	350034625500000004	24-48						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		SQLE
696	chr14	14647563	14647608	3500057012	45		14647563	14647608	8421504	1	45	0	p	350005701200015037	0-45						Iterative optimization in the design of binding proteins	Eisenberg	2000	0		ZNF572
696	chr14	14647602	14647689	3500220702	87		14647602	14647689	8421504	1	87	0	p	350022070200015014,350022070200015086	0-69,72-120						Regulatory zinc finger proteins	Jin-Soo	2004	0		ZNF572
696	chr14	14647602	14647671	3500385351	69		14647602	14647671	8421504	1	69	0	p	350038535100015097	0-69						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZNF572
696	chr14	14647602	14647671	3500269504	69		14647602	14647671	8421504	1	69	0	p	350026950400015059	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZNF572
696	chr14	14647602	14647671	3500229015	69		14647602	14647671	8421504	1	69	0	p	350022901500015023	0-69						Figure S1 AB	genome.cshlp.org	0	0		ZNF572
696	chr14	14647602	14647671	3500176901	69		14647602	14647671	8421504	1	69	0	p	350017690100015042	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZNF572
696	chr14	14647602	14647671	3500160097	69		14647602	14647671	8421504	1	69	0	p	350016009700015080	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZNF572
696	chr14	14647602	14647671	3500105130	69		14647602	14647671	8421504	1	69	0	p	350010513000015017	0-69						Supplemental Figure 1	genome.cshlp.org	0	0		ZNF572
696	chr14	14647602	14647671	3500075471	69		14647602	14647671	8421504	1	69	0	p	350007547100015049	0-69						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZNF572
697	chr14	14761137	14761162	3500086323	24		14761137	14761162	8421504	2	4,20	0,5	g	350008632300000033	3-27						MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCINE AND RELATED COMPOUNDS, AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
699	chr14	15015590	15015623	3500114567	33		15015590	15015623	8421504	1	33	0	c	350011456700000000	7-40		22681717	10.1186/1471-2407-12-227	1471-2407	BMC Cancer	MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma	Wang	2012	3		MTSS1
700	chr14	15115018	15115043	3500393412	24		15115018	15115043	8421504	2	18,6	0,19	c	350039341200000025	18-42						Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform	Gerngross	2007	0		
700	chr14	15115018	15115043	3500371992	24		15115018	15115043	8421504	2	18,6	0,19	c	350037199200000025	18-42						Immunoglobulins comprising predominantly a man5glcnac2 glycoform	Gerngross	2006	0		
700	chr14	15115018	15115043	3500371344	24		15115018	15115043	8421504	2	18,6	0,19	c	350037134400000025	18-42						Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform	Gerngross	2006	0		
700	chr14	15115018	15115043	3500326853	24		15115018	15115043	8421504	2	18,6	0,19	c	350032685300000025	18-42						IMMUNOGLOBULINS COMPRISING PREDOMINANTLY A GlCNACMAN5GLCNAC2 GLYCOFORM	Gerngross	2007	0		
700	chr14	15115018	15115043	3500316543	24		15115018	15115043	8421504	2	18,6	0,19	c	350031654300000025	18-42						Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform - Patent application	www.faqs.org	0	0		
700	chr14	15115018	15115043	3500010992	24		15115018	15115043	8421504	2	18,6	0,19	c	350001099200000025	18-42						Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform	Gerngross	2005	0		
702	chr14	15402948	15402973	3500332961	24		15402948	15402973	8421504	2	7,17	0,8	g	350033296100000221	0-24						 Biosynthesis Of Commodity Chemicals 	www.docstoc.com	0	0		
703	chr14	15524419	15524442	3500060999	23		15524419	15524442	8421504	1	23	0	g	350006099900000007	0-23		22307295	10.1128/AEM.06412-11	0099-2240	Applied and Environmental Microbiology	NAD(P)+-Malic Enzyme Mutants of Sinorhizobium sp. Strain NGR234, but Not Azorhizobium caulinodans ORS571, Maintain Symbiotic N2 Fixation Capabilities	Zhang	2012	4		
703	chr14	15524419	15524442	3500029222	23		15524419	15524442	8421504	1	23	0	g	350002922200000007	0-23						ROLES OF MALIC ENZYMES OF RHIZOBIUM	mmons.mcmaster.ca	0	0		
705	chr14	15846898	15846974	3500299394	50		15846898	15846974	8421504	2	26,24	0,52	c	350029939400000000,350029939400000001	0-26,0-24		21622847	10.1152/ajplung.00040.2011		American Journal of Physiology - Lung Cellular and Molecular Physiology	Diaphragm muscle fiber function and structure in humans with hemidiaphragm paralysis	Welvaart	2011	0		FBXO32
705	chr14	15846898	15846974	3500211588	50		15846898	15846974	8421504	2	26,24	0,52	c	350021158800000000,350021158800000001	0-26,0-24						Diaphragm muscle &#xfb01;ber function and structure in humans with hemidiaphragm paralysis	ng.physiology.org	0	0		FBXO32
705	chr14	15853875	15853900	3500110236	25		15853875	15853900	8421504	1	25	0	c	350011023600000000	0-25						The role of the ubiquitin-proteasome pathway in muscle atrophy and remodeling	arno.unimaas.nl	0	0		
707	chr14	16031366	16060860	3500441374	42		16031366	16060860	8421504	2	21,21	0,29473	c,g	350044137400000003,350044137400000004	0-21,0-21		22645312	10.1128/MCB.00204-12	0270-7306	Molecular and Cellular Biology	Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-&#x03ba;B Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop	Yang	2012	6		ATAD2
707	chr14	16031366	16060860	3500101860	42		16031366	16060860	8421504	2	21,21	0,29473	c,g	350010186000000003,350010186000000003,350010186000000004	0-21,0-21,0-21						Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF- B Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop	mcb.asm.org	0	0		ATAD2
708	chr14	16198828	16198851	3500446700	23		16198828	16198851	8421504	1	23	0	c	350044670000000025	22-45						Immunotoxin fusion proteins and means for expression thereof	Neville	2004	0		
708	chr14	16198828	16198851	3500264834	23		16198828	16198851	8421504	1	23	0	c	350026483400000025	22-45						Immunotoxin fusion proteins and means for expression thereof	Neville	2001	0		
708	chr14	16198828	16198851	3500101091	23		16198828	16198851	8421504	1	23	0	c	350010109100000024,350010109100000069	22-45,22-45						IMMUNOTOXIN FUSION PROTEINS AND MEANS FOR EXPRESSION THEREOF - Patent application	www.faqs.org	0	0		
708	chr14	16221444	16226456	3500146615	23		16221444	16226456	8421504	3	10,5,8	0,4998,5004	c	350014661500000005	5-31						MYELIN OLIGODENDROCYTE GLYCOPROTEIN PEPTIDES AND USES THEREOF - IMMULOGIC PHARMACEUTICAL CORPORATION.	www.sumobrain.com	0	0		
709	chr14	16288048	16288635	3500458666	23		16288048	16288635	8421504	2	22,1	0,586	c,g	350045866600000024,350045866600000024,350045866600000023	0-21,0-21,0-21						DELIVERY SYSTEM AND CONJUGATES FOR COMPOUND DELIVERY VIA NATURALLY OCCURRING INTRACELLULAR TRANSPORT ROUTES - CENIX BIOSCIENCE GMBH	www.sumobrain.com	0	0		DERL1
709	chr14	16288048	16288635	3500235911	23		16288048	16288635	8421504	2	22,1	0,586	c,g	350023591100000024,350023591100000024,350023591100000023	0-21,0-21,0-21						Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes	Echeverri	2012	0		DERL1
709	chr14	16288048	16288635	3500132878	23		16288048	16288635	8421504	2	22,1	0,586	c	350013287800000024,350013287800000023	0-21,0-21						Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes	Echeverri	2011	0		DERL1
709	chr14	16288048	16288635	3500085619	23		16288048	16288635	8421504	2	22,1	0,586	c,g	350008561900000026,350008561900000026,350008561900000025	0-21,0-21,0-21						Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes	Echeverri	2012	0		DERL1
709	chr14	16349753	16349777	3500365031	23		16349753	16349777	8421504	2	6,17	0,7	c	350036503100000401	12-38						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
709	chr14	16349753	16349777	3500326924	23		16349753	16349777	8421504	2	6,17	0,7	c	350032692400000401	12-38						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
710	chr14	16457283	16457310	3500360095	25		16457283	16457310	8421504	2	8,17	0,10	g	350036009500000024	0-25						 Anti Hepatitis C Virus Antibody And Uses Thereof 	www.docstoc.com	0	0		
88	chr14	16495356	16522760	3500352177	44		16495356	16522760	8421504	3	6,18,20	0,7,27384	g	350035217700000158,350035217700000044	1-25,22-42						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
719	chr14	17671624	17685122	3500199456	48		17671624	17685122	8421504	2	24,24	0,13474	c	350019945600000004,350019945600000005	0-24,0-24		19874928	10.1016/j.joca.2009.10.007	1063-4584	Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society	Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways	I	2010	4		HAS2
719	chr14	17671624	17685122	3500149847	48		17671624	17685122	8421504	2	24,24	0,13474	c	350014984700000004,350014984700000005	0-24,0-24		19874928	10.1016/j.joca.2009.10.007	1063-4584	Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society	Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways	I	2010	4		HAS2
719	chr14	17685039	17685064	3500053973	25		17685039	17685064	8421504	1	25	0	c	350005397300000011	0-25						Hydrolyzed eggshell membrane immobilized on phosphorylcholine polymer supplies extracellular matrix environment for human dermal fibroblasts. - ResearchGate	.researchgate.net	0	0		HAS2
719	chr14	17685097	17685121	3500008335	24		17685097	17685121	8421504	1	24	0	c	350000833500000017	0-24						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		HAS2
719	chr14	17685101	17685452	3500090872	45		17685101	17685452	8421504	2	23,22	0,329	c	350009087200000002,350009087200000003	0-23,0-22		23484050	10.1371/journal.pone.0058760		PLoS ONE	Crucial Role of Hyaluronan in Neointimal Formation after Vascular Injury	Yuichiro	2013	0		
719	chr14	17685582	17685624	3500018984	42		17685582	17685624	8421504	1	42	0	c	350001898400000000	0-42		20507985	10.1074/jbc.M110.127050	0021-9258	Journal of Biological Chemistry	The Activity of Hyaluronan Synthase 2 Is Regulated by Dimerization and Ubiquitination	Karousou	2010	5		
89	chr14	17685589	17698036	3500176195	48		17685589	17698036	8421504	2	23,25	0,12422	c	350017619500000003,350017619500000008	0-23,0-25						Graves&#x2019; ophthalmopathy: a comprehensive role for platelet-derived growth factors a comprehensive role for platelet-derived growth factors	repub.eur.nl	0	0		HAS2
89	chr14	17685643	17697964	3500030720	24		17685643	17697964	8421504	2	17,7	0,12314	c	350003072000000010	0-24						Untersuchungen zur Regulation und Funktion der Hyalurons&#xe4;uresynthase-2 an humanen glatten Gef&#xe4;&#xdf;muskelzellen	ni-duesseldorf.de	0	0		
720	chr14	17699962	17699987	3500387417	25		17699962	17699987	8421504	1	25	0	c	350038741700000001	20-45						Express&#xe3;o g&#xea;nica das c&#xe9;lulas do cumulus oophorus de bovinos ap&#xf3;s a vitrifica&#xe7;&#xe3;o*	www.ufrgs.br	0	0		
720	chr14	17700299	17700349	3500199309	49		17700299	17700349	8421504	2	26,23	0,27	c	350019930900000017,350019930900000016	0-26,0-23						Preliminary Comparison of Quantity, Quality, and Microarray Performance of RNA Extracted From Formalin-fixed, Paraffin-embedded, and Unfixed Frozen Tissue Samples	quantification.de	0	0		HAS2
720	chr14	17700299	17700349	3500122571	49		17700299	17700349	8421504	2	26,23	0,27	c	350012257100000017,350012257100000016	0-26,0-23						Preliminary Comparison of Quantity, Quality, and Microarray Performance of RNA Extracted From Formalin-fixed, Paraffin-embedded, and Unfixed Frozen Tissue Samples	jhc.sagepub.com	0	0		HAS2
720	chr14	17700299	17700349	3500062144	49		17700299	17700349	8421504	2	26,23	0,27	c	350006214400000017,350006214400000016	0-26,0-23						Preliminary Comparison of Quantity, Quality, and Microarray Performance of RNA Extracted From Formalin-fixed, Paraffin-embedded, and Unfixed Frozen Tissue Samples	qpcr-analysis.com	0	0		HAS2
720	chr14	17700395	17700560	3500423043	40		17700395	17700560	8421504	2	20,20	0,145	c,g	350042304300000008,350042304300000008,350042304300000009,350042304300000009	0-20,0-20,0-20,0-20						Activin-A reduces follicular growth stimulated by FSH in bovine preantral follicles	www.uece.br	0	0		
720	chr14	17700538	17700722	3500145630	48		17700538	17700722	8421504	2	24,24	0,160	c,g	350014563000000020,350014563000000020,350014563000000021,350014563000000021	0-24,0-24,0-24,0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
720	chr14	17701243	17701267	3500055849	24		17701243	17701267	8421504	1	24	0	c	350005584900000007	18-42						Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells	s.ulb.uni-bonn.de	0	0		
724	chr14	18242631	18242654	3500194863	23		18242631	18242654	8421504	1	23	0	g	350019486300000022	2-25						Insulin-producing bone marrow derived cells and methods of generating and using same	Efrat	2004	0		
728	chr14	18792289	18792315	3500390631	26		18792289	18792315	8421504	1	26	0	c	350039063100000013,350039063100000010,350039063100000029,350039063100000025	0-26,0-26,0-26,0-26						Prodrugs of Short-Chain Fatty Acids and Treatment Methods - Patent application	www.faqs.org	0	0		CEBPD
728	chr14	18792289	18792315	3500294475	26		18792289	18792315	8421504	1	26	0	c	350029447500000013,350029447500000010	0-26,0-26						Prodrugs of Short-Chain Fatty Acids and Treatment Methods	Ganapathy	2006	0		CEBPD
728	chr14	18792523	18792923	3500446659	40		18792523	18792923	8421504	2	20,20	0,380	c,g	350044665900000009,350044665900000009,350044665900000010	0-20,0-20,0-20			10.1242/jcs.01207	0021-9533	Journal of Cell Science	Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPAR&#x03b3;2	Tanabe	2004	6		
728	chr14	18792523	18792923	3500225888	40		18792523	18792923	8421504	2	20,20	0,380	c,g	350022588800000009,350022588800000009,350022588800000010	0-20,0-20,0-20			10.1242/jcs.01207	0021-9533	Journal of Cell Science	Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPAR&#x03b3;2	Tanabe	2004	6		CEBPD
728	chr14	18792618	18792882	3500447590	75		18792618	18792882	8421504	2	27,48	0,216	c,g	350044759000000255,350044759000000260,350044759000000260	21-48,0-48,0-48						METHODS TO EVALUATE GLUCOCORTICOID RECEPTOR AGONISTS AND ANTAGONISTS FOR EFFECTS ON NEURON-LIKE CELLS - Patent application	www.faqs.org	0	0		CEBPD
730	chr14	19092133	19092157	3500260074	24		19092133	19092157	8421504	1	24	0	c	350026007400000000	11-35						Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease	Hashimoto	2004	0		
730	chr14	19092133	19092157	3500148977	24		19092133	19092157	8421504	1	24	0	c	350014897700000008,350014897700000000	11-35,11-35						Method For Screening For Anti-amyloidogenic Properties And Method For Treatment Of Neurodegenerative Disease 	.freshpatents.com	0	0		
730	chr14	19092133	19092157	3500096244	24		19092133	19092157	8421504	1	24	0	c	350009624400000000	11-35					Patent	Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents (Patent US:7276643)	Masliah	2007	0		
731	chr14	19137506	19139501	3500081476	24		19137506	19139501	8421504	3	11,4,9	0,14,1986	c	350008147600000229	8-33						US Patent # 5,602,096. Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis - Patents.com	www.patents.com	0	0		
731	chr14	19214239	19214274	3500231057	26		19214239	19214274	8421504	3	6,11,9	0,10,26	g	350023105700000014	7-33						S Chapter1 General introduction	upetd.up.ac.za	0	0		
733	chr14	19453344	19453371	3500425740	23		19453344	19453371	8421504	3	7,4,12	0,10,15	g	350042574000000036	19-42						MN gene and protein - US Patent 7713704 Description	ww.patentstorm.us	0	0		
734	chr14	19599236	19599315	3500291242	46		19599236	19599315	8421504	2	21,25	0,54	g	350029124200000016,350029124200000015	0-21,0-25						Fate-determining mechanisms in epithelial&#x2013; myofibroblast transition: major inhibitory role for Smad3	jcb.rupress.org	0	0		
734	chr14	19615885	19616827	3500206937	61		19615885	19616827	8421504	3	20,20,21	0,846,921	c,g	350020693700000021,350020693700000021,350020693700000020,350020693700000031	0-20,0-20,0-20,10-31						terms and conditions of use	.era.lib.ed.ac.uk	0	0		
734	chr14	19616919	19616949	3500421110	30		19616919	19616949	8421504	1	30	0	g	350042111000000007,350042111000000008	0-30,7-32						Transforming Growth Factor- 1 Represses E-Cadherin Production via Slug Expression in Lens Epithelial Cells	www.iovs.org	0	0		
736	chr14	19906549	19906577	3500157797	24		19906549	19906577	8421504	2	17,7	0,21	g	350015779700000246,350015779700000233	18-42,15-39						 Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	www.docstoc.com	0	0		
739	chr14	20200684	20212082	3500004130	39		20200684	20212082	8421504	3	20,7,12	0,11375,11386	g	350000413000000002,350000413000000155,350000413000000073	8-28,8-28,15-34						Alpha-Amylase Variants - Patent application	www.faqs.org	0	0		
744	chr14	20874626	20874655	3500370493	24		20874626	20874655	8421504	2	17,7	0,22	g	350037049300000084	7-31						Molecular antigen array	Renner	2002	0		
744	chr14	20874626	20874655	3500143718	24		20874626	20874655	8421504	2	17,7	0,22	g	350014371800000088	7-31						Molecular antigen array presenting amyloid beta	Bachmann	2003	0		
744	chr14	20874626	20874655	3500095833	24		20874626	20874655	8421504	2	17,7	0,22	g	350009583300000084	7-31					Patent	Molecular antigen array (Patent US:7264810)	Renner	2007	0		
744	chr14	20948302	20948328	3500099318	24		20948302	20948328	8421504	2	17,7	0,19	g	350009931800000075	7-31						Hepatitis c diagnostics and vaccines	Cho	1992	0		
745	chr14	20994038	20994064	3500326034	24		20994038	20994064	8421504	2	9,15	0,11	g	350032603400000439	0-33						 Selection Method 	www.docstoc.com	0	0		
749	chr14	21529885	21529932	3500270391	47		21529885	21529932	8421504	1	47	0	c	350027039100000123	0-47						Opioid receptors: compositions and methods	Bell	1994	0		
749	chr14	21530109	21530157	3500329566	48		21530109	21530157	8421504	1	48	0	p	350032956600015087	0-48						US Patent # 6,337,207. Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon - Patents.com	www.patents.com	0	0		OPRL1
750	chr14	21649234	21649263	3500240902	24		21649234	21649263	8421504	2	10,14	0,15	g	350024090200000000	0-24						STUDIES ON CONFORMATIONAL STABILITY OF THE ECTODOMAIN OF INFLUENZA VIRUS HEMAGGLUTININ	edoc.hu-berlin.de	0	0		
750	chr14	21714312	21714341	3500467352	24		21714312	21714341	8421504	2	9,15	0,14	g	350046735200000052	13-43					Patent	Recombinant fowlpox virus S-FPV-043 and uses thereof (Patent US:6123949)	Cochran	2000	0		
751	chr14	21779764	21780748	3500032622	120		21779764	21780748	8421504	2	48,72	0,912	p	350003262200015004	0-120						<h2>INPUT QUERY</h2> <pre> TYPE DNA TARGET PDB METHOD SW -G 13 MATRIX BLOSUM 62 SCORE 25 A	ncage.outness.net	0	0		TCEA1
753	chr14	22052526	22052550	3500441786	24		22052526	22052550	8421504	1	24	0	c,g	350044178600000026,350044178600000026	0-24,0-24						METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS	Kelly	2008	0		
753	chr14	22052526	22052550	3500210815	24		22052526	22052550	8421504	1	24	0	c	350021081500000037	0-24						Adult Stem Cell-derived Connective Tissue Progenitors For Tissue Engineering 	.freshpatents.com	0	0		
753	chr14	22052526	22052550	3500192479	24		22052526	22052550	8421504	1	24	0	c	350019247900000026	0-24						METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS	Kelly	2012	0		
753	chr14	22052527	22052550	3500467505	23		22052527	22052550	8421504	1	23	0	c,g	350046750500000002,350046750500000002	0-23,0-23						Differentiation of human embryonic stem cells	Rezania	2013	0		SOX17
753	chr14	22052527	22052550	3500414970	23		22052527	22052550	8421504	1	23	0	c	350041497000000006	0-23						Amniotic fluid derived cells	Rezania	2007	0		SOX17
753	chr14	22052527	22052550	3500344281	23		22052527	22052550	8421504	1	23	0	c,g	350034428100000002,350034428100000002	0-23,0-23						DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS - LIFESCAN, INC.	www.sumobrain.com	0	0		SOX17
753	chr14	22052527	22052550	3500295499	23		22052527	22052550	8421504	1	23	0	c	350029549900000006	0-23						CHORIONIC VILLUS DERIVED CELLS	Rezania	2007	0		
753	chr14	22052527	22052550	3500128636	23		22052527	22052550	8421504	1	23	0	c	350012863600000001	0-23						PLURIPOTENT CELLS - CENTOCOR ORTHO BIOTECH INC.	www.sumobrain.com	0	0		
753	chr14	22052527	22052550	3500115761	23		22052527	22052550	8421504	1	23	0	c	350011576100000002,350011576100000005	0-23,0-23						Differentiation of Human Embryonic Stem Cells - Patent application	www.faqs.org	0	0		SOX17
753	chr14	22052527	22052550	3500114576	23		22052527	22052550	8421504	1	23	0	c	350011457600000002	0-23						Differentiation of Human Embryonic Stem Cells	Rezania	2008	0		
753	chr14	22052527	22052550	3500094699	23		22052527	22052550	8421504	1	23	0	c	350009469900000005,350009469900000002	0-23,0-23						DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		
753	chr14	22052527	22052550	3500059131	23		22052527	22052550	8421504	1	23	0	c	350005913100000002	0-23						Differentiation of Human Embryonic Stem Cells	Rezania	2010	0		
753	chr14	22053189	22053215	3500463024	26		22053189	22053215	8421504	1	26	0	c	350046302400000025,350046302400000178	0-26,0-26						METHOD FOR PROLIFERATION OF PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		SOX7
753	chr14	22053189	22053215	3500311545	26		22053189	22053215	8421504	1	26	0	c	350031154500000036	0-26						Nuclear reprogramming factor and induced pluripotent stem cells	Yamanaka	2008	0		SOX17
753	chr14	22053189	22053215	3500177747	26		22053189	22053215	8421504	1	26	0	c	350017774700000025	0-26						Method for proliferation of pluripotent stem cells	Miyazaki	2011	0		SOX7
758	chr14	22683738	22683765	3500355472	23		22683738	22683765	8421504	2	14,9	0,18	g	350035547200000000	0-23						Rust-proofing wheat for a changing climate | Neil White - Academia.edu	www.academia.edu	0	0		
759	chr14	22906484	22908110	3500195530	45		22906484	22908110	8421504	2	31,14	0,1612	p	350019553000015001	3-48			10.1093/emboj/21.11.2736		The EMBO Journal	Mammalian and yeast U3 snoRNPs are matured in specific and related nuclear compartments	Celine	June	0		TGS1
759	chr14	22919373	22919399	3500057287	23		22919373	22919399	8421504	2	5,18	0,8	c	350005728700000207	0-23						METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS - Patent application	www.faqs.org	0	0		
760	chr14	23051418	23051481	3500448079	63		23051418	23051481	8421504	1	63	0	p	350044807900015015,350044807900015013,350044807900015006	0-45,0-45,0-63						Detection of transmembrane potentials by optical methods	Tsien	2002	0		
760	chr14	23051418	23051481	3500406375	63		23051418	23051481	8421504	1	63	0	p	350040637500015007,350040637500015018,350040637500015020	0-63,0-45,0-45					Patent	Detection of transmembrane potentials by optical methods (Patent EP:1409456)	Tsien	2012	0		
760	chr14	23051418	23051481	3500217916	63		23051418	23051481	8421504	1	63	0	p	350021791600015018,350021791600015020,350021791600015007	0-45,0-45,0-63					Patent	Detection of transmembrane potentials by optical methods (Patent EP:1409456)	Tsien	2012	0		
760	chr14	23051418	23051481	3500210044	63		23051418	23051481	8421504	1	63	0	p	350021004400015020,350021004400015009,350021004400015022	0-45,0-63,0-45						DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS - THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	www.sumobrain.com	0	0		
761	chr14	23093643	23095603	3500321498	63		23093643	23095603	8421504	2	46,17	0,1943	p	350032149800015004	0-63						Methods and compositions related to wrapping of dehydrons	Bornmann	2008	0		SRC
761	chr14	23133911	23135025	3500320902	342		23133911	23135025	8421504	4	165,74,100,3	0,494,827,1111	p	350032090200015137,350032090200015136	0-168,0-174						Method for manufacturing a modified peptide	Bauer	2009	0		SNORD54,RPS20
761	chr14	23133924	23133947	3500182814	23		23133924	23133947	8421504	1	23	0	c	350018281400000009	19-42						Aberrantly expressed Genes in HacaT Keratinocytes chronically exposed to Arsenic Trioxide	www.la-press.com	0	0		TMEM70
761	chr14	23152700	23194467	3500367859	57		23152700	23194467	8421504	2	23,34	0,41733	g	350036785900000002,350036785900000016	0-23,29-63						Biological markers and uses therefor	Spelman	2011	0		
761	chr14	23154999	23155327	3500357446	41		23154999	23155327	8421504	2	21,20	0,308	g	350035744600000014,350035744600000013	0-21,0-20						Spatio-Temporal Expression Patterns of Aurora Kinases A, B, and C and Cytoplasmic Polyadenylation-Element-Binding Protein in Bovine Oocytes During Meiotic Maturation	ww.biolreprod.org	0	0		
95	chr14	23283902	23360674	3500165278	1641		23283902	23360674	8421504	15	20,49,126,2,63,132,333,20,23,49,126,145,100,132,321	0,220,1662,2823,6117,8251,12151,12485,12688,48493,49919,54471,55536,57595,76451	p,c,g	350016527800000073,350016527800015031,350016527800015019,350016527800000202,350016527800000202,350016527800000201,350016527800000201,350016527800015013,350016527800015007,350016527800000163,350016527800000067,350016527800015032,350016527800015026,350016527800015020,350016527800015014,350016527800015008	0-20,0-177,0-180,0-20,0-20,0-20,0-20,0-180,12-180,0-20,0-23,0-177,0-180,0-180,0-180,0-156						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
763	chr14	23397560	23397702	3500251519	40		23397560	23397702	8421504	2	20,20	0,122	g	350025151900000013,350025151900000026,350025151900000012	0-20,0-20,0-20		15956356	10.1677/jme.1.01799	0952-5041	Journal of Molecular Endocrinology	Gene expression profiling of bovine endometrium during the oestrous cycle: detection of molecular pathways involved in functional changes	Bauersachs	2005	3		
763	chr14	23399897	23399969	3500341941	39		23399897	23399969	8421504	2	19,20	0,52	c	350034194100000001,350034194100000000	0-19,0-20			10.1124/mol.64.6.1503	1521-0111 (Online)	Molecular Pharmacology	A Calcium-Initiated Signaling Pathway Propagated through Calcineurin and cAMP Response Element-Binding Protein Activates Proenkephalin Gene Transcription after Depolarization	Hahm	2003	0		
763	chr14	23400005	23400065	3500384310	60		23400005	23400065	8421504	1	60	0	p	350038431000015101	0-60						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		
766	chr14	23826320	23826349	3500011767	26		23826320	23826349	8421504	3	11,9,6	0,12,23	g	350001176700000002	4-30						Efficacy of an immunotoxin to folate receptor beta in the intra-articular treatment of antigen-induced arthritis. - ResearchGate	.researchgate.net	0	0		
771	chr14	24455591	24456808	3500387170	25		24455591	24456808	8421504	2	24,1	0,1216	c	350038717000000015	22-47						Intervention in Hepatic Lipid Metabolism	www.tipharma.com	0	0		CYP7A1
772	chr14	24543009	24545585	3500194368	23		24543009	24545585	8421504	3	12,7,4	0,15,2572	c	350019436800000641	10-33						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
772	chr14	24546440	24546469	3500065430	24		24546440	24546469	8421504	2	17,7	0,22	c	350006543000000039	16-43						Method for preparing flour doughs and products made from such doughs using lipase - US Patent 7371423 Description	ww.patentstorm.us	0	0		
773	chr14	24739950	24739977	3500301316	23		24739950	24739977	8421504	3	12,6,5	0,15,22	g	350030131600000076	23-48						Protective helicobacter antigens	Doidge	1996	0		
773	chr14	24739950	24739977	3500115313	23		24739950	24739977	8421504	3	12,6,5	0,15,22	g	350011531300000076	23-48						Protective helicobacter antigens	Doidge	1997	0		
781	chr14	25808912	25818954	3500352806	30		25808912	25818954	8421504	2	4,26	0,10016	c	350035280600000009	1-31		19461874	10.1371/journal.pgen.1000487		PLoS Genetics	CA8 Mutations Cause a Novel Syndrome Characterized by Ataxia and Mild Mental Retardation with Predisposition to Quadrupedal Gait	SevTurkmen	2009	0		
781	chr14	25808912	25818954	3500307025	30		25808912	25818954	8421504	2	4,26	0,10016	c	350030702500000009	1-31		19461874	10.1371/journal.pgen.1000487	1553-7404	PLOS Genetics	PLOS Genetics: CA8 Mutations Cause a Novel Syndrome Characterized by Ataxia and Mild Mental Retardation with Predisposition to Quadrupedal Gait	Turkmen	2009	0		
781	chr14	25819046	25819094	3500311200	48		25819046	25819094	8421504	1	48	0	p	350031120000015000	0-48						Carbonic Anhydrase-Related Protein VIII Deficiency Is Associated With a Distinctive Lifelong Gait Disorder in Waddles Mice--&#x300a;&#x9057;&#x4f20;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b	journal.9med.net	0	0		CA8
783	chr14	26037631	26037655	3500425620	24		26037631	26037655	8421504	1	24	0	c	350042562000000001	0-24		19106097	10.1074/jbc.M807756200		The Journal of Biological Chemistry	Rab2 Utilizes Glyceraldehyde-3-phosphate Dehydrogenase and Protein Kinase C&#x03b9; to Associate with Microtubules and to Recruit Dynein	Ellen	2009	0		RAB2A
783	chr14	26045189	26051354	3500273330	114		26045189	26051354	8421504	2	2,112	0,6053	p	350027333000015004,350027333000015005	0-108,0-114						43 human secreted proteins	Komatsoulis	2001	0		
785	chr14	26263514	26263977	3500009683	49		26263514	26263977	8421504	2	24,25	0,438	g	350000968300000001	97-146						A candidate gene for choanal atresia in alpaca. - ResearchGate	.researchgate.net	0	0		
787	chr14	26584933	26584959	3500396418	25		26584933	26584959	8421504	2	13,12	0,14	g	350039641800000004	22-48						Bivalent IgY antibody constructs for diagnostic and therapeutic applications	Bredehorst	2006	0		
788	chr14	26639941	26639966	3500134916	25		26639941	26639966	8421504	1	25	0	g	350013491600000080	29-54						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
788	chr14	26639941	26639966	3500000428	25		26639941	26639966	8421504	1	25	0	g	350000042800000003	1-26						Analysis of genetic polymorphism and genetic distance among four sheep populations	demicjournals.org	0	0		
790	chr14	26898450	26898478	3500430364	23		26898450	26898478	8421504	3	12,5,6	0,15,22	g	350043036400000158	4-28						Non-Human Animals Expressing pH-Sensitive Immunoglobulin Sequences - Patent application	www.faqs.org	0	0		
790	chr14	26975054	26975082	3500392031	24		26975054	26975082	8421504	2	6,18	0,10	g	350039203100000003	7-33						CARACTERIZACI&#xd3;N DE UN REGULADOR TRANSCRICIONAL Mycobacterium tuberculosis CEPA VACUNAL Mycobacterium bovis BCG	hera.ugr.es	0	0		
98	chr14	26983471	27014148	3500219608	153		26983471	27014148	8421504	4	11,69,1,72	0,28315,29818,30605	p	350021960800015004	0-153						DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS - Patent application	www.faqs.org	0	0		
98	chr14	26983471	27014148	3500181547	153		26983471	27014148	8421504	4	11,69,1,72	0,28315,29818,30605	p	350018154700015009	0-153						DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS	Wands	1999	0		
98	chr14	26983471	27014148	3500068435	153		26983471	27014148	8421504	4	11,69,1,72	0,28315,29818,30605	p	350006843500015005	0-153						DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS - Patent application	www.faqs.org	0	0		
795	chr14	27652144	27652171	3500236604	24		27652144	27652171	8421504	2	6,18	0,9	g	350023660400000041	24-48						Fatty acid desaturases and mutant sequences thereof	Debonte	1998	0		
797	chr14	27888682	27888710	3500231685	23		27888682	27888710	8421504	2	14,9	0,19	c	350023168500000004	15-38						Stress tolerance and delayed senescence in plants	Mccourt	2004	0		
805	chr14	28949342	28949410	3500454666	61		28949342	28949410	8421504	2	33,28	0,40	c,g	350045466600000080,350045466600000116,350045466600000118,350045466600000082,350045466600000119,350045466600000119,350045466600000132,350045466600000132,350045466600000020,350045466600000020,350045466600000028,350045466600000028,350045466600000021,350045466600000021,350045466600000120,350045466600000120,350045466600000125,350045466600000125,350045466600000089,350045466600000089	0-22,0-22,0-22,0-22,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-22,0-22,0-22,0-22						Methods of diagnosis and treatment - Patent application	www.faqs.org	0	0		YTHDF1
805	chr14	28949352	28949410	3500323428	42		28949352	28949410	8421504	2	21,21	0,37	c	350032342800000063,350032342800000062	0-21,0-21						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		YTHDF1
805	chr14	28949379	28949441	3500273361	58		28949379	28949441	8421504	2	44,14	0,48	c	350027336100000007	4-62						MicroRNA-124aRegulatesFoxa2ExpressionandIntracellular SignalinginPancreatic -CellLines S	www.jbc.org	0	0		
813	chr14	29888673	29888696	3500150687	23		29888673	29888696	8421504	1	23	0	g	350015068700000007	11-34				1350-0872	Microbiology	Overexpression of a dominant-negative allele of YPT1 inhibits growth and aspartyl protease secretion in Candida albicans	Lee	2001	3		
816	chr14	30289386	30289415	3500452256	26		30289386	30289415	8421504	3	12,6,8	0,13,21	c	350045225600000074	0-26						 Modified Annexin Proteins And Methods For Their Use In Organ Transplantation 	www.docstoc.com	0	0		
816	chr14	30289386	30289415	3500425727	26		30289386	30289415	8421504	3	12,6,8	0,13,21	c	350042572700000077	0-26						US Patent # 7,635,678. Modified annexin compositions and methods of using same - Patents.com	www.patents.com	0	0		
816	chr14	30289386	30289413	3500068107	24		30289386	30289413	8421504	3	12,6,6	0,13,21	c	350006810700000073	5-29						Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia - Patent application	www.faqs.org	0	0		
816	chr14	30335731	30335758	3500335848	24		30335731	30335758	8421504	2	14,10	0,17	c	350033584800000076	0-42						Fusion proteins comprising tumor necrosis factor receptor	Smith	1995	0		
816	chr14	30335765	30337298	3500461078	23		30335765	30337298	8421504	3	3,3,17	0,1512,1516	c	350046107800000022	2-25						Molekularbiologische und biochemische Untersuchungen zu Resistenzmechanismen der Aminocoumarinantibiotika-Produzenten und zur Amidsynthetase CouL aus Streptomyces rishiriensis DSM 40489	.uni-tuebingen.de	0	0		
816	chr14	30372137	30372165	3500069735	25		30372137	30372165	8421504	3	12,7,6	0,14,22	c	350006973500000156	15-40						Neural thread protein gene expression and detection of alzheimer's disease	De	1996	0		
816	chr14	30372224	30372347	3500391273	123		30372224	30372347	8421504	1	123	0	p	350039127300015009	0-123						Urocortin peptides	Donaldson	1997	0		
816	chr14	30372671	30373571	3500428093	41		30372671	30373571	8421504	3	20,20,1	0,108,899	c,g	350042809300000003,350042809300000003,350042809300000002	0-20,0-20,0-21						CHR and POMC effects on animal growth	Buchanan	2007	0		
816	chr14	30373753	30374077	3500153964	320		30373753	30374077	8421504	4	57,27,30,206	0,58,86,118	g	350015396400000017,350015396400000013,350015396400000008,350015396400000009,350015396400000005,350015396400000029,350015396400000001	0-64,0-62,0-64,0-65,0-65,0-38,0-64						Characterisation of the Multifunctional Protein, CREAP	astle.edu.au:8080	0	0		
816	chr14	30373981	30374029	3500106759	44		30373981	30374029	8421504	2	23,21	0,27	g	350010675900000004	0-44						Neuroendocrine Consequences of Binge Alcohol Exposure During Peri-Puberty on Functioning of the Hypothalamo-Pituitary-Adrenal (HPA) Axis	ecommons.luc.edu	0	0		CRH
816	chr14	30373981	30374029	3500047473	44		30373981	30374029	8421504	2	23,21	0,27	g	350004747300000001	0-44		22039522	10.1371/journal.pone.0026647		PLoS ONE	Alcohol Dysregulates Corticotropin-Releasing-Hormone (CRH) Promoter Activity by Interfering with the Negative Glucocorticoid Response Element (nGRE)	Magdalena	2011	0		CRH
817	chr14	30460278	30474884	3500195935	40		30460278	30474884	8421504	4	13,7,15,5	0,17,14583,14601	c,g	350019593500000113,350019593500000243,350019593500000243	0-21,28-48,28-48						Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use	Simons	1995	0		
817	chr14	30475396	30475587	3500409160	40		30475396	30475587	8421504	2	20,20	0,171	c,g	350040916000000042,350040916000000042,350040916000000043	0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
817	chr14	30510770	30510872	3500048191	42		30510770	30510872	8421504	2	20,22	0,80	c	350004819100000018,350004819100000019	0-20,0-22		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
818	chr14	30550213	30550237	3500305579	23		30550213	30550237	8421504	2	11,12	0,12	c	350030557900000031	4-31						Novel mannanases	M*S*Kao Pi Nan 	2001	0		
818	chr14	30550213	30550237	3500089045	23		30550213	30550237	8421504	2	11,12	0,12	c	350008904500000054,350008904500000016	4-31,4-31						Mannanases	Kauppinen	1999	0		
818	chr14	30639883	30639908	3500245947	25		30639883	30639908	8421504	1	25	0	c	350024594700000016	0-25						B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells.	.biomedsearch.com	0	0		
820	chr14	30804775	30840585	3500111960	1307		30804775	30840585	8421504	15	52,76,88,50,58,84,132,113,37,87,96,156,90,168,20	0,5846,11443,14849,17366,22607,22800,23932,24138,25012,27285,29432,32745,35299,35790	p,c,g	350011196000015009,350011196000015016,350011196000000011,350011196000000019,350011196000000012,350011196000000009,350011196000015017,350011196000015018,350011196000000010,350011196000000010	0-1287,0-330,25-51,0-20,0-26,0-24,0-330,0-444,0-20,0-20						Methods	Cohen	2001	0		
820	chr14	30804775	30840585	3500051521	1307		30804775	30840585	8421504	15	52,76,88,50,58,84,132,113,37,87,96,156,90,168,20	0,5846,11443,14849,17366,22607,22800,23932,24138,25012,27285,29432,32745,35299,35790	p,c,g	350005152100015009,350005152100015016,350005152100000011,350005152100000019,350005152100000012,350005152100000009,350005152100015017,350005152100000010,350005152100000010	0-1287,0-330,25-51,0-20,0-26,0-24,0-330,0-20,0-20						Methods	Cohen	2000	0		
820	chr14	30810694	30840585	3500380402	97		30810694	30840585	8421504	5	3,23,27,24,20	0,5524,5550,16927,29871	c,g	350038040200000007,350038040200000015,350038040200000008,350038040200000005,350038040200000006,350038040200000006	25-51,0-20,0-26,0-24,0-20,0-20					Patent	Methods of activation of SGK by phosphorylation. (Patent EP:1141003)	Cohen	2007	0		
820	chr14	30810694	30840585	3500371117	97		30810694	30840585	8421504	5	3,23,27,24,20	0,5524,5550,16927,29871	c,g	350037111700000007,350037111700000015,350037111700000008,350037111700000005,350037111700000006,350037111700000006	25-51,0-20,0-26,0-24,0-20,0-20					Patent	Methods of activation of SGK by phosphorylation. (Patent EP:1141003)	Cohen	2008	0		
820	chr14	30810694	30816241	3500337660	26		30810694	30816241	8421504	2	3,23	0,5524	c	350033766000000015	0-26						Methods - US Patent 7083511 Description	ww.patentstorm.us	0	0		
821	chr14	30980699	30999369	3500288191	260		30980699	30999369	8421504	4	82,23,135,20	0,2017,15931,18650	p,c	350028819100015005,350028819100015007,350028819100015006,350028819100000001	0-105,0-54,0-135,1-21						JABI AS A PROGNOSTIC MARKER AND A THERAPEUTIC TARGET FOR HUMAN CANCER - BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMS	www.sumobrain.com	0	0		COPS5
825	chr14	31571618	31571642	3500304120	24		31571618	31571642	8421504	1	24	0	g	350030412000000023	7-39						 Cotton Promoter 	www.docstoc.com	0	0		
834	chr14	32688845	32688871	3500396491	23		32688845	32688871	8421504	2	11,12	0,14	g	350039649100000014	22-45						US Patent # 7,128,908. Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof - Patents.com	www.patents.com	0	0		
834	chr14	32688845	32688871	3500157510	23		32688845	32688871	8421504	2	11,12	0,14	g	350015751000000014	22-45						Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof - US Patent 7128908 Description	ww.patentstorm.us	0	0		
834	chr14	32688845	32688871	3500134515	23		32688845	32688871	8421504	2	11,12	0,14	g	350013451500000014	22-45						Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof - US Patent 7135179 Description	ww.patentstorm.us	0	0		
834	chr14	32688845	32688871	3500115193	23		32688845	32688871	8421504	2	11,12	0,14	g	350011519300000014	22-45						Methods of treating a blood pathology using anti-TNF antibodies and fragments thereof - Patent application	www.faqs.org	0	0		
843	chr14	33905043	33905066	3500430989	23		33905043	33905066	8421504	1	23	0	g	350043098900000904	10-33						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
844	chr14	34011885	34011911	3500266468	23		34011885	34011911	8421504	3	5,4,14	0,7,12	g	350026646800000083	9-33						Molecular and Biochemical Parasitology	005.pasteur.ac.ir	0	0		
852	chr14	35037507	35037531	3500431462	23		35037507	35037531	8421504	2	4,19	0,5	g	350043146200000434	18-41						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
856	chr14	35571747	35571772	3500350809	25		35571747	35571772	8421504	1	25	0	c	350035080900000029	0-25						Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase	Zern	2002	0		
863	chr14	36520585	36520609	3500231031	23		36520585	36520609	8421504	2	13,10	0,14	g	350023103100000160	11-34						Broad-spectrum delta-endotoxins		1998	0		
108	chr14	36795153	36891143	3500252245	186		36795153	36891143	8421504	7	23,4,27,26,49,29,28	0,63254,78763,85208,94513,95631,95962	c,g	350025224500000003,350025224500000001,350025224500000001,350025224500000008,350025224500000008,350025224500000011,350025224500000005,350025224500000017,350025224500000022	0-27,0-27,0-27,0-26,0-26,0-27,0-27,0-29,0-28						A Homeodomain-Zinc Finger Protein, ZFHX4, Is Expressed in Neuronal Differentiation Manner and Suppressed in Muscle Differentiation Manner	bpb.pharm.or.jp	0	0		ZFHX4
866	chr14	36880752	36880778	3500365031	24		36880752	36880778	8421504	2	6,18	0,8	c	350036503100000516	0-24						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
866	chr14	36880752	36880778	3500326924	24		36880752	36880778	8421504	2	6,18	0,8	c	350032692400000516	0-24						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
867	chr14	37032889	37032915	3500412838	24		37032889	37032915	8421504	2	9,15	0,11	g	350041283800000015	0-24						RESEARCH Open Access The 0.3-kb fragment containing the R-U5-5 leader sequence of Friend murine leukemia virus influences the level of protein expression from	biomedcentral.com	0	0		
867	chr14	37032889	37032915	3500184029	24		37032889	37032915	8421504	2	9,15	0,11	g	350018402900000014	0-24		23602143	10.1186/1743-422X-10-124	1743-422X	Virology Journal	The 0.3-kb fragment containing the R-U5-5&#xe2; leader sequence of Friend murine leukemia virus influences the level of protein expression from spliced mRNA	Choo	2013	2		
874	chr14	38007844	38007868	3500194595	23		38007844	38007868	8421504	2	9,14	0,10	g	350019459500000003	15-38						SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS	Rao	2009	0		
876	chr14	38266883	38266911	3500247025	23		38266883	38266911	8421504	2	9,14	0,14	g	350024702500000001	19-42						Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK	A*Ao Fu De Er Mao Er 	2009	0		
878	chr14	38533639	38533662	3500429819	23		38533639	38533662	8421504	1	23	0	g	350042981900000049,350042981900000379	1-24,1-24						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
880	chr14	38668954	38668978	3500426035	23		38668954	38668978	8421504	2	9,14	0,10	g	350042603500000007	1-25						Papilloma virus capsomere vaccine formulations and methods of use	Gissmann	2006	0		
880	chr14	38796038	38796098	3500402297	60		38796038	38796098	8421504	1	60	0	p	350040229700015024	0-60						cat&#xe1;logo promega	www.scribd.com	0	0		PKIA
880	chr14	38796038	38796098	3500396050	60		38796038	38796098	8421504	1	60	0	p	350039605000015012	0-60						Map kinases: polypeptides, polynucleotides and uses thereof	COHEN	1999	0		PKIA
880	chr14	38796038	38796098	3500390906	60		38796038	38796098	8421504	1	60	0	p	350039090600015003	0-60		22229648	10.1042/BJ20112000		Biochemical Journal	A novel non-canonical mechanism of regulation of MST3 (mammalian Sterile20-related kinase 3)	Stephen J.	2012	0		PKIA
880	chr14	38796038	38796098	3500342597	60		38796038	38796098	8421504	1	60	0	p	350034259700015010	0-60						Methods in Molecular Biology Vol. 099 Stress Response.. Methods and Protocols	www.scribd.com	0	0		PKIA
880	chr14	38796038	38796098	3500334391	60		38796038	38796098	8421504	1	60	0	p	350033439100015000	0-60		18433784	10.1016/j.juro.2008.01.081		The Journal of urology	PEDF and IL-6 CONTROL PROSTATE NEUROENDOCRINE DIFFERENTIATION VIA FEED-FORWARD MECHANISM	Norm	June	0		PKIA
880	chr14	38796038	38796098	3500329456	60		38796038	38796098	8421504	1	60	0	p	350032945600015002	0-60		12234923	10.1093/emboj/cdf478	ERROR! NO ISSN	The EMBO Journal	Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals	Eliopoulos	2002	0		PKIA
880	chr14	38796038	38796098	3500320767	60		38796038	38796098	8421504	1	60	0	p	350032076700015014	0-60						Method And Product For Regulating Cell Responsiveness To External Signals 	.freshpatents.com	0	0		PKIA
880	chr14	38796038	38796098	3500318073	60		38796038	38796098	8421504	1	60	0	p	350031807300015023	0-60						RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK - Patent application	www.faqs.org	0	0		PKIA
880	chr14	38796038	38796098	3500289308	60		38796038	38796098	8421504	1	60	0	p	350028930800015045	0-60					Patent	MAP kinases: polypeptides, polynucleotides and uses thereof (Patent US:6617117)	Cohen	2003	0		PKIA
880	chr14	38796038	38796098	3500288263	60		38796038	38796098	8421504	1	60	0	p	350028826300015001	0-60						MEKK protein, capable of phosphorylating MEK	Johnson	1993	0		PKIA
880	chr14	38796038	38796098	3500287967	60		38796038	38796098	8421504	1	60	0	p	350028796700015007	0-60						In vivo role of the phosphate groove of PDK1 de&#xfb01;ned by knockin mutation	cs.biologists.org	0	0		PKIA
880	chr14	38796038	38796098	3500269857	60		38796038	38796098	8421504	1	60	0	p	350026985700015000	0-60						Modulation of rsk	Watts	2009	0		PKIA
880	chr14	38796038	38796098	3500204497	60		38796038	38796098	8421504	1	60	0	p	350020449700015012	0-60						MAP kinases: polypeptides, polynucleotides and uses thereof	Cohen	2001	0		PKIA
880	chr14	38796038	38796098	3500195495	60		38796038	38796098	8421504	1	60	0	p	350019549500015017	0-60						3-phosphoinositide-dependent protein kinase	Alessi	1997	0		PKIA
880	chr14	38796038	38796098	3500193854	60		38796038	38796098	8421504	1	60	0	p	350019385400015023	0-60						ACTIVATION OF MUTATED RAC-PK	Alessi	2011	0		PKIA
880	chr14	38796038	38796098	3500108213	60		38796038	38796098	8421504	1	60	0	p	350010821300015010	0-60						1 - Stephen M. Keyse - Stress Response	www.scribd.com	0	0		PKIA
880	chr14	38796038	38796098	3500093647	60		38796038	38796098	8421504	1	60	0	p	350009364700015000	0-60						The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways	ww.mh-hannover.de	0	0		PKIA
880	chr14	38796038	38796098	3500055006	60		38796038	38796098	8421504	1	60	0	p	350005500600015001	0-60						THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF	Jin	2011	0		PKIA
880	chr14	38796038	38796098	3500043370	60		38796038	38796098	8421504	1	60	0	p	350004337000015001	0-60						Meiotic Abnormalities of c-mos Knockout Mouse Oocytes: Activation after First Meiosis or Entrance into Third Meiotic Metaphase	ww.biolreprod.org	0	0		PKIA
880	chr14	38796038	38796098	3500043275	60		38796038	38796098	8421504	1	60	0	p	350004327500015020	0-60						Phosphatidyl-3,4.5-triphosphate-dependent protein kinase	Alessi	1998	0		PKIA
880	chr14	38796038	38796098	3500037315	60		38796038	38796098	8421504	1	60	0	p	350003731500015023	0-60						ACTIVATION OF MUTATED RAC-PK - Patent application	www.faqs.org	0	0		PKIA
880	chr14	38796038	38796098	3500009828	60		38796038	38796098	8421504	1	60	0	p	350000982800015000	0-60						Cyclin B &#x84c4;&#x7a4d;&#x91cf;&#x306e;&#x5236;&#x5fa1;&#x6a5f;&#x69cb;	itc.u-tokyo.ac.jp	0	0		PKIA
880	chr14	38796038	38796095	3500167278	57		38796038	38796095	8421504	1	57	0	p	350016727800015000	0-57					The Journal of Cell Biology	Cdk1 uncouples CtIP-dependent resection and Rad51 filament formation during M-phase double-strand break repair - Scolaris	Peterson	2011	0		PKIA
880	chr14	38796038	38796095	3500052612	57		38796038	38796095	8421504	1	57	0	p	350005261200015008	0-57						Award Number: W81XWH- &RRUGLQDWLRQRI%5&$%$5'DQG05(5$'1%6'HSHQGHQW'1$ PRINCIPAL INVESTIGATOR: CONTRACTING ORGANIZATION	www.dtic.mil	0	0		PKIA
880	chr14	38796041	38796092	3500291727	51		38796041	38796092	8421504	1	51	0	p	350029172700015000	0-51						Imiquimod Suppresses Propagation of Herpes Simplex Virus 1 by Upregulation of Cystatin A via the Adenosine Receptor A Pathway	jvi.asm.org	0	0		PKIA
880	chr14	38796056	38796107	3500193046	51		38796056	38796107	8421504	1	51	0	p	350019304600015006	0-51						Posh Interacting Proteins And Related Methods 	.freshpatents.com	0	0		PKIA
13	chr14	38796122	38799938	3500346854	54		38796122	38799938	8421504	2	52,2	0,3814	p	350034685400015001	0-54					The Journal of Cell Biology	G protein &#x03b2; interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus - Scolaris	Kino	2005	0		PKIA
13	chr14	38796122	38799938	3500267322	54		38796122	38799938	8421504	2	52,2	0,3814	p	350026732200015005	0-54						Methods for the detection of molecular interactions within cells	Giuliano	2006	0		PKIA
880	chr14	38796128	38796167	3500060541	39		38796128	38796167	8421504	1	39	0	c	350006054100000004,350006054100000006	5-44,0-27		9746759		0006-4971	Blood	The Fanconi Anemia Proteins FAA and FAC Function in Different Cellular Compartments to Protect Against Cross-Linking Agent Cytotoxicity	Kruyt	1998	10		PKIA
13	chr14	38796131	38799938	3500209634	45		38796131	38799938	8421504	2	43,2	0,3805	p	350020963400015010	0-45						Nature CellBiology	www.scribd.com	0	0		PKIA
880	chr14	38796916	38796940	3500447421	23		38796916	38796940	8421504	2	19,4	0,20	g	350044742100000061	6-30						M. tuberculosis antigens	Andersen	2001	0		
881	chr14	38801007	38801031	3500456423	23		38801007	38801031	8421504	2	16,7	0,17	c	350045642300000043	25-48						Orpinomyces cellulases and coding sequences	Chen	1998	0		
110	chr14	38920223	38967419	3500374890	360		38920223	38967419	8421504	10	45,21,24,27,18,45,45,45,45,45	0,96,3491,3518,7084,7105,7153,8287,47103,47151	p	350037489000015028,350037489000015026,350037489000015024,350037489000015022,350037489000015021,350037489000015017,350037489000015016,350037489000015015	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						IL-7 Fusion Proteins - Patent application	www.faqs.org	0	0		
110	chr14	38920235	38967446	3500192835	40		38920235	38967446	8421504	2	20,20	0,47191	c	350019283500000001,350019283500000000	0-20,0-20		19047679	10.1182/blood-2008-07-166355	0006-4971	Blood	BLNK suppresses pre&#x2013;B-cell leukemogenesis through inhibition of JAK3	Nakayama	2009	10		
110	chr14	38920235	38967446	3500063935	40		38920235	38967446	8421504	2	20,20	0,47191	c	350006393500000001,350006393500000000	0-20,0-20		19047679	10.1182/blood-2008-07-166355		Blood	BLNK suppresses pre&#x2013;B-cell leukemogenesis through inhibition of JAK3	Joji	2009	0		
110	chr14	38923741	38973741	3500412742	189		38923741	38973741	8421504	6	27,21,15,33,83,10	0,3566,3683,4736,43636,49990	p	350041274200015032,350041274200015031,350041274200015128,350041274200015028	0-48,0-48,0-90,0-48						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
882	chr14	38967425	38973741	3500326914	45		38967425	38973741	8421504	2	35,10	0,6306	c	350032691400000053	3-48						Methods of inhibiting CD40L binding to CD40 with soluble monomeric CD40L	Armitage	1996	0		
882	chr14	38967425	38973741	3500190461	45		38967425	38973741	8421504	2	35,10	0,6306	c	350019046100000050	3-48						CD40 ligand polypeptide	Armitage	1998	0		
882	chr14	38967447	38973741	3500465589	23		38967447	38973741	8421504	2	13,10	0,6284	c	350046558900000010	12-35					Patent	Multifunctional cytokines (Patent US:7534585)	Paul	2009	0		IL7
882	chr14	38967447	38973741	3500330842	23		38967447	38973741	8421504	2	13,10	0,6284	c	350033084200000005	0-23		12543864	10.1182/blood-2002-08-2671	0006-4971	Blood	Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys	Storek	2003	10		
882	chr14	38967447	38973741	3500214843	23		38967447	38973741	8421504	2	13,10	0,6284	c	350021484300000010	12-35						Novel multifunctional cytokines	PAUL	2008	0		IL7
882	chr14	38967447	38973741	3500129777	23		38967447	38973741	8421504	2	13,10	0,6284	c	350012977700000010	12-35						Multifunctional cytokines	Paul	2010	0		IL7
882	chr14	38967447	38973741	3500121044	23		38967447	38973741	8421504	2	13,10	0,6284	c	350012104400000010	12-35						MULTIFUNCTIONAL CYTOKINES - Patent application	www.faqs.org	0	0		IL7
883	chr14	39091652	39091677	3500365031	24		39091652	39091677	8421504	2	8,16	0,9	g	350036503100000214	11-35						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
888	chr14	39801956	39832468	3500251032	31		39801956	39832468	8421504	2	22,9	0,30503	c	350025103200000002	0-31						The microtubule destabilizer stathmin mediates the development of dendritic arbors in neuronal cells	cs.biologists.org	0	0		
888	chr14	39801956	39832468	3500067147	31		39801956	39832468	8421504	2	22,9	0,30503	c	350006714700000002	0-31						The microtubule destabilizer stathmin mediates the development of dendritic arbors in neuronal cells	cs.biologists.org	0	0		
13	chr14	39832491	39859678	3500370298	315		39832491	39859678	8421504	8	45,16,29,45,45,45,45,45	0,48,4669,4701,18623,18671,18719,27142	p	350037029800015019,350037029800015020,350037029800015021,350037029800015024,350037029800015025,350037029800015026,350037029800015028	0-45,0-45,0-45,0-45,0-45,0-45,0-45						USE OF TLR3 AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS - Patent application	www.faqs.org	0	0		STMN2
13	chr14	39832554	39851297	3500146314	360		39832554	39851297	8421504	3	1,173,186	0,4606,18557	p	350014631400015002,350014631400015004	0-180,0-180						Use of tlr3 agonists for the treatment of neurodegenerative disorders	Van	2007	0		STMN2
13	chr14	39832554	39851297	3500108880	360		39832554	39851297	8421504	3	1,173,186	0,4606,18557	p	350010888000015002,350010888000015004	0-180,0-180						Use of tlr3 agonists for the treatment of neurodegenerative disorders	Van	2008	0		STMN2
889	chr14	39962222	39962245	3500460096	23		39962222	39962245	8421504	1	23	0	c	350046009600000004	0-23						ErbB-2inhibitionactivatesNotch-1andsensitizesbreastcancercells toa -secretaseinhibitor	load.bioon.com.cn	0	0		HEY1
889	chr14	39963249	39963274	3500454613	23		39963249	39963274	8421504	2	18,5	0,20	g	350045461300000006,350045461300000000	5-29,5-29						LprG AS A CHAPERONE OF IMMUNE ADJUVANTS - Patent application	www.faqs.org	0	0		
891	chr14	40205031	40205057	3500376118	23		40205031	40205057	8421504	3	5,5,13	0,6,13	g	350037611800000001	0-23						Positive Selection of BH14680 in Bartonella	www.ibg.uu.se	0	0		
892	chr14	40240058	40241883	3500334024	51		40240058	40241883	8421504	2	49,2	0,1823	p	350033402400015000	0-51		17314271	10.1158/1541-7786.MCR-06-0245	1541-7786	Molecular Cancer Research	Induction of Tumorigenesis and Metastasis by the Murine Orthologue of Tumor Protein D52	Lewis	2007	4		TPD52
895	chr14	40750518	40750547	3500425986	25		40750518	40750547	8421504	3	13,6,6	0,16,23	g	350042598600000069	5-34						LA FAMILIA DE GENES DE LA QUERATINA 6: CARACTERIZACION Y REGULACION	biblioteca.ucm.es	0	0		
900	chr14	41390031	41390054	3500347068	23		41390031	41390054	8421504	1	23	0	g	350034706800000017	0-23						Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1alpha,25-dihydroxyvitamin D3. - ResearchGate	.researchgate.net	0	0		
902	chr14	41658438	41658467	3500283124	29		41658438	41658467	8421504	1	29	0	c	350028312400000006	0-29						Fatty acid binding proteins as drug targets for modulation of endocannabinoids	Deutsch	2010	0		
904	chr14	41845652	41845730	3500019687	78		41845652	41845730	8421504	1	78	0	p	350001968700015001	0-78		19647880	10.1016/j.jneuroim.2009.07.006		Journal of neuroimmunology	Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy	Hye-Jung	2009	0		PMP2
904	chr14	41848025	41879212	3500190756	71		41848025	41879212	8421504	3	26,21,24	0,28379,31163	c	350019075600000014,350019075600000006,350019075600000004	0-26,0-21,0-24					Patent	Substituted tetralins and indanes and their use (Patent EP:1554240)	Chen	2009	0		
904	chr14	41848025	41879212	3500154203	71		41848025	41879212	8421504	3	26,21,24	0,28379,31163	c	350015420300000014,350015420300000006,350015420300000004	0-26,0-21,0-24						Treating syndrome X with substituted tetralins and indanes	Chen	2003	0		
904	chr14	41848039	41876364	3500464199	42		41848039	41876364	8421504	2	21,21	0,28304	c,g	350046419900000018,350046419900000019,350046419900000019	0-21,0-21,0-21				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		
904	chr14	41874984	41879198	3500018521	39		41874984	41879198	8421504	2	19,20	0,4194	c	350001852100000003,350001852100000002	0-19,0-20						REGULATION OF RETINOL BINDING PROTEIN 4 EXPRESSION AND ITS RELATION TO ADIPOGENESIS IN BOVINE ADIPOCYTES	thescipub.com	0	0		
904	chr14	41874985	41879293	3500095434	86		41874985	41879293	8421504	3	25,37,24	0,1119,4284	c,g	350009543400000005,350009543400000005,350009543400000004,350009543400000003,350009543400000000	0-25,0-25,0-25,0-25,0-24						BMC Genetics BioMed Central	biomedcentral.com	0	0		
904	chr14	41875008	41875572	3500301078	41		41875008	41875572	8421504	3	20,13,8	0,80,556	c,g	350030107800000122,350030107800000122,350030107800000121	0-20,0-20,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
904	chr14	41875042	41875565	3500450381	44		41875042	41875565	8421504	3	21,22,1	0,37,522	c	350045038100000009,350045038100000008	0-21,0-23						Gene expression patterns of bovine perimuscular preadipocytes during adipogenesis. - ResearchGate	.researchgate.net	0	0		
904	chr14	41875048	41879212	3500317693	73		41875048	41879212	8421504	3	28,21,24	0,1356,4140	c	350031769300000003,350031769300000006,350031769300000004	0-28,0-21,0-24						SureChem - Document - USPTO Applications - Publication No. 20040162352 - "Treating syndrome X with substituted tetralins and indanes" - Description	www.surechem.org	0	0		
904	chr14	41875048	41879212	3500287919	99		41875048	41879212	8421504	3	28,21,50	0,1356,4114	c	350028791900000003,350028791900000006,350028791900000014,350028791900000004	0-28,0-21,0-26,0-24					Patent	Methods of using substituted tetralins and indanes (Patent US:7351857)	Chen	2008	0		
904	chr14	41875048	41879188	3500346748	97		41875048	41879188	8421504	4	28,22,21,26	0,1262,1356,4114	c	350034674800000023,350034674800000003,350034674800000036,350034674800000026,350034674800000006,350034674800000014,350034674800000034	0-28,0-28,7-29,0-21,0-21,0-26,0-22						US Patent # 7,351,857. Methods of using substituted tetralins and indanes - Patents.com	www.patents.com	0	0		
904	chr14	41875076	41879215	3500445367	39		41875076	41879215	8421504	2	19,20	0,4119	c	350044536700000005,350044536700000000	0-19,0-20						&#x4e5d;&#x9f99;&#x7266;&#x725b;&#x8102;&#x80aa;&#x7ec6;&#x80de;&#x578b;&#x8102;&#x80aa;&#x9178;&#x7ed3;&#x5408;&#x86cb;&#x767d;&#x57fa;&#x56e0;(AFABP) &#x7684;&#x514b;&#x9686;&#x53ca;&#x5176;&#x8868;&#x8fbe;&#x8c31; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
904	chr14	41875092	41876392	3500198723	44		41875092	41876392	8421504	3	9,13,22	0,472,1278	c	350019872300000003,350019872300000002	0-22,0-22						Technical note: Determination of cell-specific gene expression in bovine skeletal muscle tissue using laser microdissection and reverse-transcription quantitative polymerase chain reaction	animalscience.org	0	0		
904	chr14	41876343	41879197	3500280425	66		41876343	41879197	8421504	4	21,9,15,21	0,81,2799,2833	c,g	350028042500000001,350028042500000001,350028042500000002,350028042500000000	0-21,0-21,0-24,0-21		17565066	10.2527/jas.2006-837	0021-8812	Journal of Animal Science	Adipocyte fatty acid-binding protein and mitochondrial enzyme activities in muscles as relevant indicators of marbling in cattle	Jurie	2007	2		
904	chr14	41876356	41879262	3500053805	41		41876356	41879262	8421504	2	20,21	0,2885	c,g	350005380500000013,350005380500000013,350005380500000012,350005380500000012	0-20,0-20,0-21,0-21						DIFFERENTIAL ANALYSIS OF GENE EXPRESSION DURING IN VITRO ADIPOGENESIS IN CATTLE	brary.okstate.edu	0	0		
904	chr14	41876364	41876387	3500078731	23		41876364	41876387	8421504	1	23	0	c	350007873100000026	0-23						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		
904	chr14	41876404	41879212	3500288753	45		41876404	41879212	8421504	2	21,24	0,2784	c	350028875300000006,350028875300000004	0-21,0-24						Methods of using substituted tetralins and indanes	Chen	2006	0		
904	chr14	41879144	41879170	3500354508	26		41879144	41879170	8421504	1	26	0	c	350035450800000024	0-26						DNMT1 Is Regulated by ATP-Citrate Lyase and Maintains Methylation Patterns during Adipocyte Differentiation	mcb.asm.org	0	0		
904	chr14	41879150	41879176	3500182892	26		41879150	41879176	8421504	1	26	0	g	350018289200000013	0-26		16778009	10.1124/mol.106.023820	1521-0111 (Online)	Molecular Pharmacology	The Farnesoid X Receptor Promotes Adipocyte Differentiation and Regulates Adipose Cell Function in Vivo	Rizzo	2006	0		
905	chr14	42047859	42047884	3500352238	24		42047859	42047884	8421504	2	17,7	0,18	g	350035223800000003	9-38		22438536	10.1128/JVI.07039-11	0022-538X	Journal of Virology	Hepatitis E Virus Replication Requires an Active Ubiquitin-Proteasome System	Karpe	2012	5		
909	chr14	42476134	42501184	3500422894	76		42476134	42501184	8421504	2	28,48	0,25002	c,g	350042289400000000,350042289400000000,350042289400000029,350042289400000029,350042289400000018	23-51,23-51,23-51,23-51,0-48						Osteoprotegerin Variant Proteins 	.freshpatents.com	0	0		
909	chr14	42476134	42494459	3500428995	76		42476134	42494459	8421504	2	28,48	0,18277	c,g	350042899500000027,350042899500000027,350042899500000001	23-51,23-51,0-48						Anti-tnf Alpha Fibronectin Type Iii Domain Based Scaffold Compositions, Methods And Uses 	.freshpatents.com	0	0		
909	chr14	42476134	42494420	3500364410	48		42476134	42494420	8421504	2	30,18	0,18268	p	350036441000015132	0-48						Osteoprotegerin	Boyle	1997	0		
909	chr14	42476134	42476162	3500422671	28		42476134	42476162	8421504	1	28	0	c,g	350042267100000000,350042267100000000	23-51,23-51						Osteoprotegerin variant proteins	Roberts	2005	0		
909	chr14	42476134	42476162	3500037323	28		42476134	42476162	8421504	1	28	0	c,g	350003732300000000,350003732300000000	23-51,23-51						Osteoprotegerin variant proteins	Roberts	2009	0		
909	chr14	42494490	42502919	3500254750	158		42494490	42502919	8421504	4	27,35,76,20	0,4247,6628,8409	c	350025475000000319,350025475000000327,350025475000000332,350025475000000333,350025475000000306	1-28,3-38,0-48,0-48,0-42						Osteoprotegerin	Boyle	1997	0		
909	chr14	42498658	42498681	3500442782	23		42498658	42498681	8421504	1	23	0	c	350044278200000003	0-23						A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis	logy-journals.org	0	0		TNFRSF11B
909	chr14	42498658	42498681	3500028547	23		42498658	42498681	8421504	1	23	0	c	350002854700000003	0-23			10.1210/en.2006-1587		Endocrinology	Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone	Oxana	June	0		
909	chr14	42498729	42500993	3500206937	42		42498729	42500993	8421504	2	21,21	0,2243	c	350020693700000014,350020693700000015	0-21,0-21						terms and conditions of use	.era.lib.ed.ac.uk	0	0		
909	chr14	42504025	42504050	3500347635	25		42504025	42504050	8421504	1	25	0	c	350034763500000009	8-33						Identification and characterization of miRNA-133b	edoc.hu-berlin.de	0	0		
915	chr14	43367320	43367347	3500376815	27		43367320	43367347	8421504	1	27	0	c	350037681500000003	0-27						Molecular and Biochemical Features of Cultured Cells Derived from Hereditary Multiple Exostoses (HME) Patients.	primage.tau.ac.il	0	0		SAMD12
916	chr14	43459380	43459405	3500323036	23		43459380	43459405	8421504	2	16,7	0,18	g	350032303600001252,350032303600001251	0-21,0-21						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF A GENE FROM THE JC VIRUS - Patent application	www.faqs.org	0	0		
916	chr14	43490633	43490661	3500129453	23		43490633	43490661	8421504	2	8,15	0,13	g	350012945300000117,350012945300000333	0-25,11-36					Patent	Perhydrolase (Patent EP:1689859)	Amin	2011	0		
114	chr14	43638245	43667922	3500340462	49		43638245	43667922	8421504	3	24,11,14	0,20174,29663	c	350034046200000013,350034046200000014	0-24,0-25						Studies of heparanase (HPA) gene expression, cellular localization andfunctions in neural tissues of the rat Author(s) Zhang, Yi; Issue Date 2007 URL http://hdl.handle.net/10722/50203	hub.hku.hk/bitstr	0	0		
918	chr14	43740295	43740322	3500289897	24		43740295	43740322	8421504	2	16,8	0,19	g	350028989700000027	0-27						Card domain containing polypeptides, encoding nucleic acids, and methods of use	Damiano	2001	0		
919	chr14	43837478	43837505	3500190832	24		43837478	43837505	8421504	2	16,8	0,19	g	350019083200000051	10-34						Method of extracting recombinant hexose oxidase	Johansen	2003	0		
920	chr14	43998918	44000895	3500440739	23		43998918	44000895	8421504	3	15,3,5	0,18,1972	c	350044073900000304	25-48						5' to 3' exonuclease mutations of thermostable DNA polymerases	Abramson	1993	0		
920	chr14	43998918	44000895	3500384749	23		43998918	44000895	8421504	3	15,3,5	0,18,1972	c	350038474900000294	25-48						5' to 3' exonuclease mutations of thermostable DNA polymerases - Patent # 5795762 - PatentGenius	.patentgenius.com	0	0		
920	chr14	43998918	44000895	3500321554	23		43998918	44000895	8421504	3	15,3,5	0,18,1972	c	350032155400000293	25-48						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1993	0		
920	chr14	43998918	44000895	3500279401	23		43998918	44000895	8421504	3	15,3,5	0,18,1972	c	350027940100000293	25-48						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1992	0		
924	chr14	44470055	44470570	3500089368	513		44470055	44470570	8421504	3	190,14,309	0,191,206	g	350008936800000019	2-519						Identification of Genetic Markers for Korean Native Cattle (Han- woo) by RAPD Analysis	www.bbe.or.kr	0	0		
925	chr14	44636643	44637301	3500217315	23		44636643	44637301	8421504	2	18,5	0,653	c	350021731500000083	0-23						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		RAD21
926	chr14	44751082	44751105	3500367859	23		44751082	44751105	8421504	1	23	0	c	350036785900000008	0-23						Biological markers and uses therefor	Spelman	2011	0		
928	chr14	44965852	44965877	3500007138	25		44965852	44965877	8421504	1	25	0	c	350000713800000005	13-38						Epitope-Tagging des humanen TSH-Rezeptors	ub.uni-hamburg.de	0	0		
928	chr14	44971149	44971176	3500207898	27		44971149	44971176	8421504	1	27	0	c	350020789800000001	7-34		17686838	10.1128/JVI.00570-07	0022-538X	Journal of Virology	Measles Virus N Protein Inhibits Host Translation by Binding to eIF3-p40	Sato	2007	5		EIF3H
931	chr14	45430089	45430112	3500116268	23		45430089	45430112	8421504	1	23	0	g	350011626800000004	2-25		15217951	10.1158/1078-0432.CCR-03-0574	1078-0432	Clinical Cancer Research	Evaluation of Nuclear Factor-&#x03ba;B, Urokinase-Type Plasminogen Activator, and HBx and Their Clinicopathological Significance in Hepatocellular Carcinoma	Chan	2004	8		
936	chr14	46022010	46022034	3500072770	23		46022010	46022034	8421504	2	19,4	0,20	g	350007277000000019	14-37						UNIVERSIDAD POLITACNICA DE VALENCIA DEPARTAMENTO DE CIENCIA ANIMAL CARACTERIZACIAN GENATICA Y	dspace.upv.es	0	0		
938	chr14	46275942	46276968	3500108058	162		46275942	46276968	8421504	3	66,69,27	0,711,999	p,c	350010805800015008,350010805800015010,350010805800000003	0-66,0-69,8-35						Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer	Berinstein	2004	0		
938	chr14	46276941	46276968	3500319425	27		46276941	46276968	8421504	1	27	0	c	350031942500000005,350031942500000054	8-35,8-35						TUMOR ANTIGEN BFY3 FOR PREVENTION AND/OR TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
938	chr14	46276941	46276968	3500266631	27		46276941	46276968	8421504	1	27	0	c	350026663100000002	8-35					Patent	Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer (Patent US:7851213)	Berinstein	2010	0		
946	chr14	47356229	47356255	3500115282	25		47356229	47356255	8421504	2	8,17	0,9	g	350011528200000049	5-30						Mutations in the 17q-linked breast and ovarian cancer susceptibility gene	Shattuck-eidens	1995	0		
949	chr14	47784259	47784288	3500168046	25		47784259	47784288	8421504	2	13,12	0,17	g	350016804600000000	6-31		19055692	10.1111/j.1600-0854.2008.00864.x		Traffic (Copenhagen, Denmark)	Role of the Plasmodium Export Element in Trafficking Parasite Proteins to the Infected Erythrocyte	Justin	2009	0		
956	chr14	48746687	48746714	3500306430	23		48746687	48746714	8421504	2	15,8	0,19	g	350030643000000075	11-44						Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars - Patent application	www.faqs.org	0	0		
978	chr14	51568593	51568620	3500016075	27		51568593	51568620	8421504	1	27	0	g	350001607500000069	26-53						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
982	chr14	52113960	52113984	3500376832	23		52113960	52113984	8421504	2	6,17	0,7	g	350037683200000115	2-25						Double Strand Compositions Comprising Differentially Modified Strands For Use In Gene Modulation 	.freshpatents.com	0	0		
982	chr14	52113960	52113984	3500376816	23		52113960	52113984	8421504	2	6,17	0,7	g	350037681600000207	2-25						Oligomeric compounds that facilitate risc loading	Allerson	2007	0		
982	chr14	52113960	52113984	3500161964	23		52113960	52113984	8421504	2	6,17	0,7	g	350016196400000201,350016196400000080	2-25,0-23						Double strand compositions comprising differentially modified strands for use in gene modulation	Allerson	2007	0		
985	chr14	52554453	52554479	3500265596	23		52554453	52554479	8421504	2	5,18	0,8	c	350026559600000377	6-29						NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)	Andersen	2000	0		
988	chr14	52849595	52898343	3500311219	119		52849595	52898343	8421504	4	23,7,41,48	0,46842,48563,48700	c	350031121900000215,350031121900000228,350031121900000231	0-23,0-48,0-48						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
991	chr14	53337819	53337846	3500110329	23		53337819	53337846	8421504	2	9,14	0,13	g	350011032900000578	20-45						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
997	chr14	54017050	54017405	3500134112	69		54017050	54017405	8421504	2	39,30	0,325	p	350013411200015004	0-69						BLAST Command Line Applications User Manual - OpenHero &#x5f00;&#x52c7; - &#x535a;&#x5ba2;&#x9891;&#x9053; - CSDN.NET	blog.csdn.net	0	0		EIF3E
997	chr14	54017086	54017432	3500431918	60		54017086	54017432	8421504	2	3,57	0,289	p	350043191800015015	0-60						Riboproteomics of the Hepatitis C Virus Internal Ribosomal Entry Site	gs.washington.edu	0	0		EIF3E
997	chr14	54018575	54018706	3500375699	131		54018575	54018706	8421504	1	131	0	c	350037569900000030	28-159						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
124	chr14	54114486	54283711	3500355085	729		54114486	54283711	8421504	5	94,189,144,189,113	0,85156,113078,115230,169112	p	350035508500015011	0-729						R-SPONDIN TRANSLOCATIONS AND METHODS USING THE SAME - Patent application	www.faqs.org	0	0		RSPO2
124	chr14	54114486	54283711	3500052867	729		54114486	54283711	8421504	5	94,189,144,189,113	0,85156,113078,115230,169112	p	350005286700015011	0-729						Compositions And Methods For Treating And Diagnosing Cancer 	.freshpatents.com	0	0		RSPO2
124	chr14	54114486	54283702	3500308835	720		54114486	54283702	8421504	5	94,189,144,189,104	0,85156,113078,115230,169112	p	350030883500015010	0-720						Rspo binding agents and uses thereof	Gurney	2013	0		RSPO2
124	chr14	54114486	54283702	3500052867	720		54114486	54283702	8421504	5	94,189,144,189,104	0,85156,113078,115230,169112	p	350005286700015002	0-720						Compositions And Methods For Treating And Diagnosing Cancer 	.freshpatents.com	0	0		RSPO2
124	chr14	54114542	54283600	3500258169	562		54114542	54283600	8421504	5	38,189,144,189,2	0,85100,113022,115174,169056	c	350025816900000011	52-618						ANTI-TUMOR AGENTS COMPRISING R-SPONDINS - Patent application	www.faqs.org	0	0		RSPO2
124	chr14	54114549	54283711	3500308835	666		54114549	54283711	8421504	5	31,189,144,189,113	0,85093,113015,115167,169049	p	350030883500015033	0-666						Rspo binding agents and uses thereof	Gurney	2013	0		RSPO2
124	chr14	54114549	54199659	3500395680	48		54114549	54199659	8421504	2	31,17	0,85093	c	350039568000000020	0-48						Stem cell factor-like proteins and uses thereof - Patent application	www.faqs.org	0	0		
124	chr14	54114564	54229892	3500308835	525		54114564	54229892	8421504	4	16,189,144,176	0,85078,113000,115152	p	350030883500015034,350030883500015035,350030883500015037	0-525,0-153,0-162						Rspo binding agents and uses thereof	Gurney	2013	0		RSPO2
124	chr14	54199644	54283714	3500395680	555		54199644	54283714	8421504	7	187,144,16,104,18,2,84	0,27920,30072,30092,30243,83954,83986	c	350039568000000187,350039568000000021,350039568000000133,350039568000000035,350039568000000188,350039568000000022,350039568000000048,350039568000000134,350039568000000006,350039568000000023,350039568000000135,350039568000000007,350039568000000037,350039568000000190,350039568000000024,350039568000000050,350039568000000136,350039568000000008,350039568000000038,350039568000000051,350039568000000039,350039568000000192,350039568000000026,350039568000000052,350039568000000138,350039568000000040,350039568000000193,350039568000000027,350039568000000028,350039568000000140,350039568000000012,350039568000000042,350039568000000195,350039568000000054,350039568000000029,350039568000000141,350039568000000201,350039568000000144,350039568000000016,350039568000000046,350039568000000199,350039568000000033	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-44,0-47,6-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-42,0-47,0-48,0-48,1-44,0-48,0-48,0-48,0-48,0-48,0-48,0-46,0-47,14-34,0-48,0-48,0-48,0-48,0-45						Stem cell factor-like proteins and uses thereof - Patent application	www.faqs.org	0	0		
124	chr14	54229886	54283624	3500263968	45		54229886	54283624	8421504	2	19,26	0,53712	p	350026396800015015	0-45						Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides - US Patent 7411052 Description	ww.patentstorm.us	0	0		RSPO2
1000	chr14	54467748	54467772	3500190461	23		54467748	54467772	8421504	2	4,19	0,5	g	350019046100000105	18-41						CD40 ligand polypeptide	Armitage	1998	0		
1002	chr14	54697875	54697898	3500343575	23		54697875	54697898	8421504	1	23	0	c	350034357500000000	17-40			10.5772/19590	978-953-307-540-2		Targets in Gene Therapy	Jianhua	2011	0		ANGPT1
125	chr14	54697880	54998865	3500125958	681		54697880	54998865	8421504	10	45,45,54,156,122,58,54,66,27,54	0,96,240,184937,202557,219483,239978,249777,260210,300931	p	350012595800015005,350012595800015007,350012595800015009,350012595800015060,350012595800015010,350012595800015061,350012595800015062,350012595800015011,350012595800015017,350012595800015067,350012595800015069,350012595800015020,350012595800015070,350012595800015027,350012595800015076	0-45,0-45,0-45,0-45,0-195,0-150,0-141,0-117,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids - US Patent 7067109 Description	ww.patentstorm.us	0	0		
125	chr14	54697964	54986020	3500189702	390		54697964	54986020	8421504	9	48,96,30,18,48,39,12,48,51	0,96,184979,202473,239885,249720,260126,260231,288005	c	350018970200000004,350018970200000006,350018970200000007,350018970200000011,350018970200000054,350018970200000023,350018970200000057,350018970200000026,350018970200000028,350018970200000062	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						US Patent # 5,851,797. Tie ligand-3, methods of making and uses thereof - Patents.com	www.patents.com	0	0		
1002	chr14	54698062	54698086	3500264993	24		54698062	54698086	8421504	1	24	0	c	350026499300000008	0-24						Angiogenesis-modulating compositions and uses	Ling	2003	0		ANGPT1
1002	chr14	54698062	54698086	3500162207	24		54698062	54698086	8421504	1	24	0	c	350016220700000008	0-24						Angiogenesis-modulating compositions and uses	Ling	2001	0		
1002	chr14	54698062	54698086	3500101088	24		54698062	54698086	8421504	1	24	0	c	350010108800000111,350010108800000008	0-24,0-24						Angiogenesis-modulating compositions and uses - Patent application	www.faqs.org	0	0		
1002	chr14	54698062	54698086	3500093417	24		54698062	54698086	8421504	1	24	0	c	350009341700000008	0-24						Angiogenesis-modulating compositions and uses	Ling	2010	0		
1002	chr14	54698062	54698086	3500090396	24		54698062	54698086	8421504	1	24	0	c	350009039600000008	0-24						Angiogenesis-modulating compositions and uses	Ling	2003	0		
125	chr14	54698069	54958252	3500149367	144		54698069	54958252	8421504	4	48,9,39,48	0,96,184748,260135	c	350014936700000079,350014936700000081,350014936700000099	0-48,0-48,0-48						Method For Treating Ischemic Diseases 	freshpatents.com	0	0		
1003	chr14	54869051	54869078	3500220214	25		54869051	54869078	8421504	2	8,17	0,10	g	350022021400000000	3-28		21177917	10.1128/CVI.00252-10		Clinical and Vaccine Immunology : CVI	Development of an Immunochromatographic Strip for Simple Detection of Penicillin-Binding Protein 2&#x2032; 	Hidehito	2011	0		
1003	chr14	54917523	54917547	3500264993	24		54917523	54917547	8421504	1	24	0	c	350026499300000009	0-24						Angiogenesis-modulating compositions and uses	Ling	2003	0		ANGPT1
1003	chr14	54917523	54917547	3500162207	24		54917523	54917547	8421504	1	24	0	c	350016220700000009	0-24						Angiogenesis-modulating compositions and uses	Ling	2001	0		ANGPT1
1003	chr14	54917523	54917547	3500101088	24		54917523	54917547	8421504	1	24	0	c	350010108800000112,350010108800000009	0-24,0-24						Angiogenesis-modulating compositions and uses - Patent application	www.faqs.org	0	0		ANGPT1
1003	chr14	54917523	54917547	3500093417	24		54917523	54917547	8421504	1	24	0	c	350009341700000009	0-24						Angiogenesis-modulating compositions and uses	Ling	2010	0		
1004	chr14	54937843	54958228	3500355878	312		54937843	54958228	8421504	4	66,6,102,138	0,78,9778,20247	p	350035587800015002,350035587800015003	0-66,0-246						Molecular Cloning of a New Angiopoietinlike Factor from the Human Cornea	www.iovs.org	0	0		ANGPT1
1004	chr14	54986034	54986058	3500217315	24		54986034	54986058	8421504	1	24	0	c	350021731500000013	0-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		
1004	chr14	54998901	54998958	3500243792	57		54998901	54998958	8421504	1	57	0	p	350024379200015004	0-57						Novel haptotactic peptides	Gorodetsky	2002	0		ANGPT1
1020	chr14	57093866	57093892	3500378872	23		57093866	57093892	8421504	2	15,8	0,18	g	350037887200000004	0-23						Phylogenetic Analysis of Cystic Fibrosis Transmembrane Conductance Regulator Gene in Mammalian Species Argues for the Development of a Rabbit Model for Cystic Fibrosis	brary.arizona.edu	0	0		
1024	chr14	57600763	57600791	3500356664	24		57600763	57600791	8421504	3	5,14,5	0,7,23	g	350035666400000033	16-40						An&#xe1;lise da express&#xe3;o dos genes pertencentes aos sistemas secret&#xf3;rios Tipo III e Tipo IV e genes pthAs em subsp. citri sob condi&#xe7;&#xf5;es infectante e n&#xe3;o infectante	ali.fcav.unesp.br	0	0		
1024	chr14	57622433	57622458	3500145186	24		57622433	57622458	8421504	2	9,15	0,10	g	350014518600000001	0-24						EST analysis of genes involved in secondary metabolism in Camellia sinensis (tea), using suppression subtractive hybridization	sugpark.com.ne.kr	0	0		
128	chr14	58056147	58076342	3500464472	2188		58056147	58076342	8421504	7	134,203,1105,133,381,22,210	0,10102,11597,14278,19394,19895,19985	p,c,g	350046447200015008,350046447200015009,350046447200015010,350046447200015011,350046447200000016,350046447200000015,350046447200015012,350046447200015013,350046447200015014,350046447200000018,350046447200000017,350046447200015015,350046447200015016,350046447200000020,350046447200000020,350046447200015018,350046447200000019	0-282,0-210,0-144,0-276,0-25,0-26,0-66,0-348,0-210,0-25,0-20,0-210,0-210,0-22,0-22,0-210,0-20						CARACTERIZACI&#xd3;N DE GENES CANDIDATOS PARA CARACTERES LIP&#xcd;DICOS E IDENTIFICACI&#xd3;N DE COPY NUMBER VARIATION EN UNA POBLACI&#xd3;N PORCINA DUROC	www.tdx.cat	0	0		
128	chr14	58056219	58076342	3500274639	2094		58056219	58076342	8421504	6	62,203,1105,133,381,210	0,10030,11525,14206,19322,19913	p	350027463900015007,350027463900015008,350027463900015009,350027463900015010,350027463900015011,350027463900015012,350027463900015013,350027463900015014,350027463900015015,350027463900015017	0-210,0-210,0-210,0-210,0-207,0-207,0-210,0-210,0-210,0-210						CARACTERIZACIAN DE GENES CANDIDATOS PARA CARACTERES LIPADICOS E IDENTIFICACIAN DE COPY NUMBER VAR	www.tdx.cat	0	0		
128	chr14	58056219	58076342	3500081530	2116		58056219	58076342	8421504	7	62,203,1105,133,381,22,210	0,10030,11525,14206,19322,19823,19913	p,c,g	350008153000015008,350008153000015009,350008153000015010,350008153000000018,350008153000015011,350008153000000017,350008153000015012,350008153000015013,350008153000015014,350008153000000020,350008153000000019,350008153000015015,350008153000015016,350008153000000022,350008153000000022,350008153000015018,350008153000000021	0-210,0-210,0-210,0-25,0-210,0-26,0-207,0-207,0-210,0-25,0-20,0-210,0-210,0-22,0-22,0-210,0-20						CAROLA TRINIDAD MELO ROJAS Dpto de Ciencia Animal y de los Alimentos UNIVERSIDAD AUT&#xd3;NOMA DE BARCELONA 2009	riunet.upv.es	0	0		
1028	chr14	58066446	58067766	3500201852	23		58066446	58067766	8421504	3	6,2,15	0,1298,1305	c	350020185200000331	0-34						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
1028	chr14	58068197	58070448	3500246268	90		58068197	58070448	8421504	3	45,22,23	0,630,2228	c	350024626800000497,350024626800000510	0-45,0-45						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
1028	chr14	58127294	58127320	3500204495	23		58127294	58127320	8421504	3	12,6,5	0,14,21	c	350020449500000018	0-24						Novel Tannase Gene And Protein Thereof - Patent application	www.faqs.org	0	0		
1036	chr14	59167607	59183045	3500090457	62		59167607	59183045	8421504	5	20,21,1,10,10	0,120,5327,8025,15428	c	350009045700000085,350009045700000020,350009045700000025,350009045700000060	0-20,16-37,21-42,17-37						Compositions and Methods Relating to STOP-1	Ackerly	2011	0		
1036	chr14	59167694	59183115	3500324564	93		59167694	59183115	8421504	2	45,48	0,15373	p	350032456400015056,350032456400015067	3-48,0-48						COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIAC AND VASCULAR DISEASE - Patent application	www.faqs.org	0	0		
1038	chr14	59425985	59426033	3500209399	48		59425985	59426033	8421504	1	48	0	p	350020939900015005	0-48						Novel PTH responsive gene	Robinson	2007	0		BAALC
1038	chr14	59425985	59426033	3500010155	48		59425985	59426033	8421504	1	48	0	p	350001015500015002	0-48						PTH responsive gene	Robinson	2003	0		BAALC
1040	chr14	59684118	59688922	3500375495	100		59684118	59688922	8421504	2	6,94	0,4710	c	350037549500000345	0-100						GENETIC POLYMORPHISMS ASSOCIATED WITH LIVER FIBROSIS, METHODS OF DETECTION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1040	chr14	59684118	59688922	3500252915	207		59684118	59688922	8421504	3	6,95,106	0,4028,4698	c	350025291500000045,350025291500000020,350025291500000019,350025291500000021	0-100,0-100,0-100,0-94						Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof	Huang	2013	0		AZIN1
1041	chr14	59849469	59849891	3500129344	40		59849469	59849891	8421504	2	20,20	0,402	c,g	350012934400000000,350012934400000001,350012934400000001	0-20,0-20,0-20						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		KLF10
1041	chr14	59849858	59849933	3500385351	75		59849858	59849933	8421504	1	75	0	p	350038535100015125	0-75						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		KLF10
1041	chr14	59849858	59849933	3500269504	75		59849858	59849933	8421504	1	75	0	p	350026950400015077	0-75					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		KLF10
1041	chr14	59849858	59849933	3500176901	75		59849858	59849933	8421504	1	75	0	p	350017690100015060	0-75						Zinc finger domains and methods of identifying same	Hwang	2002	0		KLF10
1041	chr14	59849858	59849933	3500160097	75		59849858	59849933	8421504	1	75	0	p	350016009700015096	0-75						Phenotypic screen of chimeric proteins	JANG	2004	0		KLF10
1041	chr14	59849858	59849933	3500075471	75		59849858	59849933	8421504	1	75	0	p	350007547100015063	0-75						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		KLF10
1042	chr14	59919865	59919891	3500270759	23		59919865	59919891	8421504	2	18,5	0,21	c	350027075900000002	16-39						A Novel Plant Protein-disulfide Isomerase Involved in the Oxidative Folding of Cystine Knot Defense Proteins--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x53	journal.9med.net	0	0		
1043	chr14	60065128	60110290	3500288565	150		60065128	60110290	8421504	3	62,45,43	0,44501,45119	p	350028856500015001	0-150					Patent	Neues, menschliches tumorsuppressorgen. (Patent DE:69823022)	CALLAGHAN	2005	0		UBR5
1043	chr14	60065128	60110290	3500274881	150		60065128	60110290	8421504	3	62,45,43	0,44501,45119	p	350027488100015001	0-150					Patent	Neues, menschliches tumorsuppressorgen. New human tumor suppressor gene. (Patent DE:69823022)	CALLAGHAN	2005	0		UBR5
1043	chr14	60065128	60110290	3500069435	150		60065128	60110290	8421504	3	62,45,43	0,44501,45119	p	350006943500015002	0-150					Patent	Human tumor suppressor gene (Patent US:7105652)	Callaghan	2006	0		UBR5
1043	chr14	60065128	60110290	3500037158	150		60065128	60110290	8421504	3	62,45,43	0,44501,45119	p	350003715800015004,350003715800015005,350003715800015006	0-147,0-141,0-150						Novel human tumor suppressor gene	Callaghan	2002	0		
1044	chr14	60174698	60201559	3500446572	867		60174698	60201559	8421504	7	200,74,86,66,145,86,210	0,680,1933,20151,21631,23353,26651	p	350044657200015021,350044657200015019	0-867,126-270						Tema 4: Secuenciaci&#xf3;n del ADN (3)	ocw.unia.es	0	0		
1044	chr14	60174698	60201559	3500193094	2667		60174698	60201559	8421504	19	200,74,173,114,221,121,99,244,112,145,131,61,176,85,156,114,145,86,210	0,680,1933,2195,3103,4756,4999,7422,9006,9714,11103,15804,17832,18205,19612,20103,21631,23353,26651	p	350019309400015007	0-2667						NUCLEOTIDE SEQUENCE DATABASES	iosiva.50webs.org	0	0		UBR5
1044	chr14	60201893	60201959	3500304088	66		60201893	60201959	8421504	1	66	0	p	350030408800015079	9-75						67 human secreted proteins	Carter	1999	0		UBR5
1048	chr14	60726645	60726672	3500169580	24		60726645	60726672	8421504	2	13,11	0,16	g	350016958000000016	9-33		18506892	10.1002/hep.22263	1527-3350	Hepatology	Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation - El Boustany - 2008 - Hepatology - Wiley Online Library	Boustany	2008	0		
1049	chr14	60934873	60934896	3500131208	23		60934873	60934896	8421504	1	23	0	g	350013120800000001	0-23						DIAGNOSTIC METHODS AND MARKERS - UNIVERSITY OF OTAGO	www.sumobrain.com	0	0		
1052	chr14	61271785	61271811	3500100734	24		61271785	61271811	8421504	2	19,5	0,21	c	350010073400000075	3-28						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
1053	chr14	61368745	61368771	3500348845	24		61368745	61368771	8421504	2	13,11	0,15	g	350034884500000146	0-26						Nucleic acids encoding hencatoporetic stem cell receptor flk-2 - Patent # 5185438 - PatentGenius	.patentgenius.com	0	0		
1054	chr14	61512810	61542363	3500353787	738		61512810	61542363	8421504	5	294,124,164,96,60	0,24024,24909,25154,29493	c	350035378700000006,350035378700000015,350035378700000016,350035378700000018,350035378700000017,350035378700000019,350035378700000020	0-738,0-25,0-25,0-25,0-25,0-25,0-25						Compositions, Kits, and Methods for Predicting Anti-Cancer Response to Anthracyclines	Richardson	2011	0		YWHAZ
1054	chr14	61512810	61537823	3500322286	459		61512810	61537823	8421504	5	117,120,42,76,104	0,174,24024,24072,24909	p	350032228600015034,350032228600015009,350032228600015016	0-117,0-162,0-180						Lysine acetylation targets protein complexes and co-regulates major cellular functions	ww.sciencemag.org	0	0		YWHAZ
1054	chr14	61512850	61513030	3500122793	40		61512850	61513030	8421504	2	20,20	0,160	c	350012279300000031,350012279300000032	0-20,0-20						Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine. - ResearchGate	.researchgate.net	0	0		YWHAZ
1054	chr14	61512850	61512874	3500360043	24		61512850	61512874	8421504	1	24	0	c	350036004300000022	0-24						&#x4e3b;&#x9898;&#xff1a;microarray | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		YWHAZ
1054	chr14	61512852	61512993	3500362403	41		61512852	61512993	8421504	2	21,20	0,121	c	350036240300000090,350036240300000091	0-21,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		YWHAZ,CASK
1054	chr14	61512861	61538054	3500072427	510		61512861	61538054	8421504	11	45,45,45,45,3,42,45,31,14,105,90	0,48,96,192,240,23973,24018,24066,24858,24917,25103	p	350007242700015120,350007242700015121,350007242700015123,350007242700015125,350007242700015126,350007242700015127,350007242700015128,350007242700015114,350007242700015130,350007242700015115,350007242700015132,350007242700015116,350007242700015133,350007242700015177,350007242700015117,350007242700015134	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						14-3-3 ETA Antibodies and Uses Thereof for the Diagnosis and Treatment of Arthritis - Patent application	www.faqs.org	0	0		YWHAZ
1054	chr14	61512861	61538006	3500337690	315		61512861	61538006	8421504	10	45,45,45,45,3,42,31,14,3,42	0,48,96,192,240,23973,24066,24858,25019,25103	p	350033769000015159,350033769000015160,350033769000015162,350033769000015164,350033769000015165,350033769000015167,350033769000015172	0-45,0-45,0-45,0-45,0-45,0-45,0-45						14-3-3 Antagonists for the Prevention and Treatment of Arthritis - Patent application	www.faqs.org	0	0		YWHAZ
1054	chr14	61512900	61512980	3500205284	69		61512900	61512980	8421504	3	21,28,20	0,23,60	c,g	350020528400000018,350020528400000018,350020528400000020,350020528400000019,350020528400000019	0-21,0-21,0-28,0-20,0-20		19047086	10.1158/1078-0432.CCR-08-1366	1078-0432	Clinical Cancer Research	14-3-3&#x03c3; Modulates Pancreatic Cancer Cell Survival and Invasiveness	Neupane	2008	8		
1054	chr14	61512972	61537725	3500115188	41		61512972	61537725	8421504	3	19,16,6	0,23970,24747	c,g	350011518800000019,350011518800000019,350011518800000020	0-19,0-19,0-22		23426688	10.1523/JNEUROSCI.1811-12.2013	0270-6474	The Journal of Neuroscience	Specific Trans-Synaptic Interaction with Inhibitory Interneuronal Neurexin Underlies Differential Ability of Neuroligins to Induce Functional Inhibitory Synapses	Futai	2013	7		YWHAZ
1054	chr14	61513012	61536865	3500447030	40		61513012	61536865	8421504	2	20,20	0,23833	c,g	350044703000000008,350044703000000009,350044703000000009	0-20,0-20,0-20						Evaluation of Internal Reference Genes for Quantitative Expression Analysis by Real-Time PCR in Ovine Whole Blood	www.mdpi.com	0	0		YWHAZ
1054	chr14	61513012	61536856	3500011608	44		61513012	61536856	8421504	3	20,2,22	0,90,23822	c	350001160800000032,350001160800000033	0-20,0-24						&#x718a;&#x672c;&#x5927;&#x5b66;&#x5b66;&#x8853;&#x30ea;&#x30dd;&#x30b8;&#x30c8;&#x30ea; Kumamoto University Repository System	.kumamoto-u.ac.jp	0	0		
1054	chr14	61513039	61513065	3500398003	26		61513039	61513065	8421504	1	26	0	c	350039800300000001	21-47						BMC Veterinary Research BioMed Central	quantification.de	0	0		YWHAZ
1054	chr14	61513039	61513065	3500376799	26		61513039	61513065	8421504	1	26	0	c	350037679900000001	21-47						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		YWHAZ
1054	chr14	61513079	61536838	3500417661	29		61513079	61536838	8421504	2	25,4	0,23755	c,g	350041766100000001,350041766100000000,350041766100000000	0-29,2-21,2-21		18695676	10.1038/onc.2008.265	0950-9232	Oncogene	Cyclin D1 in low-dose radiation-induced adaptive resistance	Ahmed	2008	6		YWHAZ
1054	chr14	61513090	61537730	3500313190	48		61513090	61537730	8421504	4	14,10,13,11	0,23744,23855,24629	c	350031319000000008,350031319000000009	0-24,0-24		19144956	10.1095/biolreprod.108.074294	0006-3363	Biology of Reproduction	Resistance to Lipopolysaccharide-Induced Preterm Delivery Mediated by Regulatory T Cell Function in Mice	Bizargity	2009	4		
1054	chr14	61513090	61537730	3500282848	48		61513090	61537730	8421504	4	14,10,13,11	0,23744,23855,24629	c	350028284800000008,350028284800000009	0-24,0-24		19144956	10.1095/biolreprod.108.074294		Biology of Reproduction	Resistance to Lipopolysaccharide-Induced Preterm Delivery Mediated by Regulatory T Cell Function in Mice	Peyman	2009	0		
1054	chr14	61536898	61537810	3500400505	50		61536898	61537810	8421504	2	25,25	0,887	c	350040050500000018,350040050500000019	0-25,0-25						Selection of reference genes for quantitative RT-PCR studies in striped dolphin (Stenella coeruleoalba) skin biopsies.	.biomedsearch.com	0	0		
1054	chr14	61536916	61537807	3500238514	45		61536916	61537807	8421504	2	22,23	0,868	c	350023851400000002,350023851400000003	0-22,0-23		22619252	10.1124/jpet.112.194662	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Copper Is Required for Cobalt-Induced Transcriptional Activity of Hypoxia-Inducible Factor-1	Qiu	2012	0		YWHAZ
1054	chr14	61536944	61537989	3500343582	43		61536944	61537989	8421504	3	14,9,20	0,775,1025	c	350034358200000102,350034358200000103	0-23,0-20						ABSTRACT	tory.lib.ncsu.edu	0	0		
1054	chr14	61536944	61537989	3500227307	43		61536944	61537989	8421504	3	14,9,20	0,775,1025	c	350022730700000022,350022730700000023	0-23,0-20						In Vitro Mimicking of Estrous Cycle Stages in Porcine Oviduct Epithelium Cells: Estradiol and Progesterone Regulate Differentiation, Gene Expression, and Cellular Function	ww.biolreprod.org	0	0		
1054	chr14	61536945	61537730	3500259338	24		61536945	61537730	8421504	2	13,11	0,774	c	350025933800000011	0-24		19369644	10.1095/biolreprod.109.076976	0006-3363	Biology of Reproduction	Pregnancy Alters the Proliferation and Apoptosis of Mouse Splenic Erythroid Lineage Cells and Leukocytes	Norton	2009	4		
1054	chr14	61537846	61542316	3500205057	40		61537846	61542316	8421504	3	20,7,13	0,207,4457	c,g	350020505700000026,350020505700000026,350020505700000027	0-20,0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1054	chr14	61537846	61542316	3500137197	40		61537846	61542316	8421504	3	20,7,13	0,207,4457	c	350013719700000026,350013719700000027	0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1054	chr14	61538012	61542312	3500351816	57		61538012	61542312	8421504	2	48,9	0,4291	p	350035181600015024	3-60						Molecular Cloning and Phylogenetic Analysis of Two Plant-Parasitic Nematode 14-3-3 Genes	www.ccsenet.org	0	0		YWHAZ
1054	chr14	61542334	61542357	3500291333	23		61542334	61542357	8421504	1	23	0	c	350029133300000260	0-23						Method for amplifying nucleic acid sequence - Patent # 6951722 - PatentGenius	.patentgenius.com	0	0		YWHAZ
1056	chr14	61862335	61862363	3500390609	24		61862335	61862363	8421504	2	10,14	0,14	g	350039060900000025,350039060900000007	0-23,0-24						A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same	Andersen	2000	0		
1056	chr14	61862335	61862363	3500242451	24		61862335	61862363	8421504	2	10,14	0,14	g	350024245100000007	0-24						A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same	Andersen	1999	0		
1056	chr14	61862335	61862362	3500290683	23		61862335	61862362	8421504	2	10,13	0,14	g	350029068300000015	0-23					Patent	Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same (Patent US:6436409)	Gicquel	2002	0		
1061	chr14	62417481	62418619	3500409160	40		62417481	62418619	8421504	2	20,20	0,1118	c	350040916000000020,350040916000000021	0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
1061	chr14	62418601	62418628	3500096220	27		62418601	62418628	8421504	1	27	0	c	350009622000000037	0-27						IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH - Patent application	www.faqs.org	0	0		
1064	chr14	62825635	62825662	3500428607	23		62825635	62825662	8421504	2	8,15	0,12	g	350042860700000007	4-27						Cytotoxin and Pyrogenic Toxin Superantigen Gene Profiles of Staphylococcus aureus Associated with Subclinical Mastitis in Dairy Cows and Relationships with Ma 2005&#x5e74;&#x7b2c;43&#x5377;&#x7b2c;3&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&	www.39kf.com	0	0		
133	chr14	63532307	63835726	3500090569	1323		63532307	63835726	8421504	11	26,81,129,115,165,168,138,78,91,176,156	0,32928,35878,55591,80186,80856,162043,172104,205435,217976,303263	p	350009056900015015,350009056900015016	0-900,0-423						USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER	Concari	2006	0		STK3
1070	chr14	63694389	63694434	3500040490	45		63694389	63694434	8421504	1	45	0	p	350004049000015110	0-45						USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER - Patent application	www.faqs.org	0	0		STK3
1074	chr14	64193129	64193154	3500236924	23		64193129	64193154	8421504	2	16,7	0,18	c	350023692400000168	25-48						EPF receptor assays, compounds and therapeutic compsns.	A*Bu Yi Si Te 	2004	0		
1075	chr14	64227400	64227424	3500355275	24		64227400	64227424	8421504	1	24	0	c	350035527500000017	0-24		15475466	10.1158/1078-0432.CCR-04-0223	1078-0432	Clinical Cancer Research	Sp1-Mediated Transcriptional Control of Fibroblast Growth Factor Receptor 4 in Sarcomas of Skeletal Muscle Lineage	Yu	2004	8		
1075	chr14	64227402	64227425	3500430358	23		64227402	64227425	8421504	1	23	0	c,g	350043035800000004,350043035800000004	0-23,0-23		16957079	10.1523/JNEUROSCI.0341-06.2006	0270-6474	The Journal of Neuroscience	The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease	Arawaka	2006	7		
1075	chr14	64227402	64227425	3500343054	23		64227402	64227425	8421504	1	23	0	c,g	350034305400000007,350034305400000007	0-23,0-23						Parkinson's Disease-Related Gene GRK5 and Uses Thereof - Patent application	www.faqs.org	0	0		
1075	chr14	64227402	64227425	3500236382	23		64227402	64227425	8421504	1	23	0	c	350023638200000007	0-23						Perkinson disease-related gene grk5 and use thereof	ARAWAKA	2008	0		
1075	chr14	64227402	64227425	3500207872	23		64227402	64227425	8421504	1	23	0	c	350020787200000004	0-23		16957079	10.1523/JNEUROSCI.0341-06.2006	0270-6474	The Journal of Neuroscience	The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease	Arawaka	2006	7		
1075	chr14	64227402	64227425	3500150834	23		64227402	64227425	8421504	1	23	0	c,g	350015083400000007,350015083400000007	0-23,0-23						PERKINSON DISEASE-RELATED GENE GRK5 AND USE THEREOF	ARAWAKA	2006	0		
1075	chr14	64227569	64230663	3500336681	345		64227569	64230663	8421504	4	21,146,131,47	0,413,2175,3047	p	350033668100015048,350033668100015049	0-345,0-294						FULL-LENGTH HUMAN CDNAS ENCODING POTENTIALLY SECRETED PROTEINS - GENSET S.A.	www.sumobrain.com	0	0		RPL30
1075	chr14	64227569	64230663	3500115779	345		64227569	64230663	8421504	4	21,146,131,47	0,413,2175,3047	p	350011577900015049,350011577900015050,350011577900015051	0-345,0-294,0-147						Full-length human cdnas encoding potentially secreted proteins	Bejanin	2001	0		RPL30
1075	chr14	64234362	64243008	3500235521	41		64234362	64243008	8421504	5	14,8,13,3,3	0,17,6907,6925,8643	c,g	350023552100000201,350023552100000402	5-27,3-22						IMPROVED METHODS FOR TRANSFORMING PHAFFIA STRAINS, TRANSFORMED PHAFFIA STRAINS SO OBTAINED AND RECOMBINANT DNA IN SAID METHODS - Gist-brocades B.	www.sumobrain.com	0	0		
1076	chr14	64430903	64430927	3500353787	24		64430903	64430927	8421504	1	24	0	c	350035378700000008,350035378700000007	1-25,0-24						Compositions, Kits, and Methods for Predicting Anti-Cancer Response to Anthracyclines	Richardson	2011	0		
1076	chr14	64430905	64455757	3500350825	192		64430905	64455757	8421504	3	33,96,63	0,20171,24789	p	350035082500015005	27-219						 Antibodies To HTEEB42 Protein 	www.docstoc.com	0	0		
1077	chr14	64562860	64586089	3500072735	89		64562860	64586089	8421504	5	4,15,40,10,20	0,701,818,2712,23209	c,g	350007273500000002,350007273500000004,350007273500000001,350007273500000001	0-19,0-71,0-20,0-20						Astrocyte Elevated Gene-1is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival	.aacrjournals.org	0	0		
1081	chr14	65051398	65051488	3500395807	90		65051398	65051488	8421504	1	90	0	p	350039580700015033	0-90						71 human secreted proteins	Brewer	2000	0		CPQ
1081	chr14	65051398	65051488	3500348941	90		65051398	65051488	8421504	1	90	0	p	350034894100015029	0-90						 Secreted Protein HT5GJ57 	www.docstoc.com	0	0		CPQ
1081	chr14	65066387	65066410	3500262312	23		65066387	65066410	8421504	1	23	0	g	350026231200000038	17-40						The role of DNA supercoiling in the coordinated regulation of gene expression in Helicobacter pylori	.uni-wuerzburg.de	0	0		
1085	chr14	65649745	65649789	3500380425	38		65649745	65649789	8421504	3	5,8,25	0,8,19	c	350038042500000291	0-57						Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same	Naito	2006	0		
1085	chr14	65649760	65649790	3500223687	30		65649760	65649790	8421504	1	30	0	c	350022368700000007	0-30		22238310	10.1128/JVI.05783-11	0022-538X	Journal of Virology	Entry of Human T-Cell Leukemia Virus Type 1 Is Augmented by Heparin Sulfate Proteoglycans Bearing Short Heparin-Like Structures	Tanaka	2012	5		SDC2
1085	chr14	65649763	65649862	3500254041	99		65649763	65649862	8421504	1	99	0	p	350025404100015003	0-99						Control of morphology, cytoskeleton and migration by syndecan-4	cs.biologists.org	0	0		SDC2
1085	chr14	65649763	65649859	3500295010	96		65649763	65649859	8421504	1	96	0	p	350029501000015000,350029501000015001	0-96,0-54						Syndecan-2 controls matrix assembly	cs.biologists.org	0	0		SDC2
1085	chr14	65649763	65649793	3500358973	30		65649763	65649793	8421504	1	30	0	c,g	350035897300000013,350035897300000013	9-39,9-39			10.1042/BJ20040558		Biochemical Journal	Mammalian and Drosophila cells adhere to the laminin &#x03b1;4 LG4 domain through syndecans, but not glypicans	Hironobu	2004	0		SDC2
1085	chr14	65649859	65651046	3500239233	75		65649859	65651046	8421504	2	65,10	0,1177	p	350023923300015023	0-75						Sequence of Human Syndecan Indicates a Novel Gene Family of Integral Membrane Proteoglycans*	www.jbc.org	0	0		SDC2
1085	chr14	65655910	65656112	3500323209	63		65655910	65656112	8421504	4	16,16,15,16	0,62,125,186	g	350032320900000198	91-287						2007 Characterization of arsenic resistant bacteria and a novel gene cluster in 'Bacillus' sp. CDB3	ro.uow.edu.au	0	0		
1087	chr14	65829158	65829186	3500220694	23		65829158	65829186	8421504	2	7,16	0,12	g	350022069400000024	12-35					Patent	Homogeneous amplification and detection of nucleic acids (Patent EP:0876510)	Kurn	2008	0		
1088	chr14	65961545	65961569	3500342151	24		65961545	65961569	8421504	1	24	0	c	350034215100000000	9-33			10.1042/BJ20031857		Biochemical Journal	Resistance to UV-induced apoptosis in Chinese-hamster ovary cells overexpressing phosphatidylserine synthases	Anan	2004	0		MTERFD1
16	chr14	66059366	66076291	3500335228	139		66059366	66076291	8421504	3	47,48,44	0,16707,16881	c	350033522800000021,350033522800000043,350033522800000108	0-47,0-48,0-44						Composition and Method for the Treatment or Prevention of Spinal Disorders III - Patent application	www.faqs.org	0	0		
16	chr14	66059450	66076277	3500108068	835		66059450	66076277	8421504	9	177,45,45,219,67,102,36,99,45	0,249,15990,16143,16368,16440,16545,16584,16782	p,c	350010806800015175,350010806800000182,350010806800000185,350010806800015182,350010806800000189,350010806800000192,350010806800015184,350010806800000194,350010806800015186,350010806800000198,350010806800000202	3-180,0-45,0-45,0-180,0-45,0-44,0-174,0-34,0-174,0-45,0-45						Protein amf-1 to amf-10 and nucleic acids encoding the same	Burgess	2001	0		
16	chr14	66059710	66075401	3500295099	40		66059710	66075401	8421504	2	20,20	0,15671	c,g	350029509900000004,350029509900000005,350029509900000005	0-20,0-20,0-20						BMP-13 Emerges as a Potential Inhibitor of Bone Formation	www.ijbs.com	0	0		GDF6
1089	chr14	66075919	66075944	3500193653	25		66075919	66075944	8421504	1	25	0	c	350019365300000004	0-25						Amplification of mRNA for distinguishing fetal cells in maternal blood	Asgari	1996	0		MNX1
1089	chr14	66076049	66076222	3500392138	129		66076049	66076222	8421504	2	86,43	0,130	c	350039213800000349,350039213800000350,350039213800000352	0-43,0-43,0-43						Designer ligands of tgf-beta superfamily	Choe	2010	0		
1096	chr14	67095209	67095248	3500215262	33		67095209	67095248	8421504	4	15,7,5,6	0,19,27,33	g	350021526200000036	0-39					Patent	Synthetic leader peptide sequences (Patent US:5795746)	Kjeldsen	1998	0		
1099	chr14	67381430	67381456	3500389666	23		67381430	67381456	8421504	2	16,7	0,19	g	350038966600000099	0-23						VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS - Patent application	www.faqs.org	0	0		
1100	chr14	67580683	67585025	3500127371	136		67580683	67585025	8421504	6	2,20,27,25,34,28	0,921,986,2048,2074,4314	c	350012737100000084,350012737100000086,350012737100000096,350012737100000100,350012737100000090	0-22,0-27,0-25,0-34,0-28					Patent	Methods and compositions for the detection of cervical disease (Patent CN:1957256)	T*J*Fei Xi Er 	2013	0		CCNE2
1100	chr14	67582728	67582751	3500156479	23		67582728	67582751	8421504	1	23	0	c	350015647900000043	0-23						TheCircadianClockComponentBMAL1IsaCriticalRegulator	www.jbc.org	0	0		
1100	chr14	67582728	67582751	3500057603	23		67582728	67582751	8421504	1	23	0	c	350005760300000040	0-23		18086663	10.1074/jbc.M705576200	0021-9258	Journal of Biological Chemistry	The Circadian Clock Component BMAL1 Is a Critical Regulator of p21WAF1/CIP1 Expression and Hepatocyte Proliferation	Grechez-Cassiau	2008	5		
1100	chr14	67590505	67590530	3500316755	25		67590505	67590530	8421504	1	25	0	c	350031675500000003	14-39					Patent	Thiazolyl urea compounds and methods of uses (Patent US:6645990)	Askew	2003	0		
1100	chr14	67590505	67590530	3500199355	25		67590505	67590530	8421504	1	25	0	c	350019935500000003	14-39						Thiazolyl urea compounds and methods of uses	Askew	2003	0		
1100	chr14	67590505	67590530	3500098053	25		67590505	67590530	8421504	1	25	0	c	350009805300000003	14-39						2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use	Huang	2003	0		
1100	chr14	67590505	67590530	3500009222	25		67590505	67590530	8421504	1	25	0	c	350000922200000003	14-39						Urea compounds and methods of uses	Santora	2001	0		
1100	chr14	67590785	67591259	3500155747	44		67590785	67591259	8421504	2	23,21	0,453	c	350015574700000006,350015574700000007	0-23,0-21		23341894	10.1371/journal.pone.0052197		PLoS ONE	Cell-Cell Interactions Influence Vascular Reprogramming by Prox1 during Embryonic Development	Harold	2013	0		
1101	chr14	67636615	67636640	3500355496	24		67636615	67636640	8421504	2	9,15	0,10	c	350035549600000016	9-33						High resolution typing of Chlamydophila psittaci by multilocus VNTR analysis (MLVA)	tal.umaryland.edu	0	0		
137	chr14	67762250	67786098	3500069023	1053		67762250	67786098	8421504	9	81,219,302,43,133,111,55,99,10	0,2501,6000,8352,8503,8759,10116,10318,23838	p	350006902300015003	0-1053						Identification of human gene sequences of cancer antigens expressed in metastatic carcinoma and involved in metastasis formation, and their use in cancer diagnosis, prognosis and therapy	Hentsch	2006	0		
137	chr14	67888879	67918880	3500115394	1869		67888879	67918880	8421504	20	27,27,18,74,79,5,49,48,118,8,43,273,50,366,48,123,30,114,75,294	0,30,13508,13550,17329,17411,18576,20105,20156,26050,26130,26741,28868,28921,29290,29341,29476,29509,29629,29707	p	350011539400015120	0-1968						Method for identification of genes involved in specific diseases	Harris	2002	0		
1108	chr14	68569178	68570055	3500414988	57		68569178	68570055	8421504	2	27,30	0,847	c	350041498800000011,350041498800000010	0-27,0-30			10.1111/j.1742-4658.2005.04713.x	1742-4658	FEBS Journal	Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells - Abbot - 2005 - FEBS Journal - Wiley Online Library	Abbot	2005	0		PDP1
1112	chr14	69086220	69086246	3500284463	23		69086220	69086246	8421504	2	15,8	0,18	g	350028446300000002	7-30						IMMUNOPROTECTIVE RECOMBINANT ANTIGEN FROM ANAPLASMA MARGINALE, VACCINE COMPOSITIONS AND METHODS OF USE - THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY	www.sumobrain.com	0	0		
1120	chr14	70165140	70165165	3500153655	23		70165140	70165165	8421504	2	13,10	0,15	g	350015365500000003	0-23						Nuclear factors and binding assay	Hoey	1995	0		
1121	chr14	70302821	70302847	3500115071	23		70302821	70302847	8421504	2	9,14	0,12	g	350011507100000458	0-23						DECEMBER 2005 PC LINICAL HARMACOLOGY HERAPEUTICS	005.pasteur.ac.ir	0	0		
1129	chr14	71417792	71417822	3500168057	23		71417792	71417822	8421504	3	5,11,7	0,8,23	g	350016805700000185	15-38						Method for modulating gene expression by modifying the cpg content - Patent application	www.faqs.org	0	0		
1135	chr14	72106890	72107514	3500019095	45		72106890	72107514	8421504	3	23,2,20	0,72,604	c	350001909500000000,350001909500000001	0-23,0-22		23197859	10.5966/sctm.2011-0063		Stem Cells Translational Medicine	Targeting p38 Mitogen-Activated Protein Kinase Signaling Restores Subventricular Zone Neural Stem Cells and Corrects Neuromotor Deficits in Atm Knockout Mouse	Jeesun	July	0		CALB1
1135	chr14	72125597	72125623	3500350427	26		72125597	72125623	8421504	1	26	0	c	350035042700000007	20-46		20553254	10.1111/j.1464-410X.2010.09444.x	1464-410X	BJU International	Adenovirus-delivered microRNA targeting the vitamin D receptor reduces intracellular Ca2+ concentrations by regulating the expression of Ca2+-transport proteins in renal epithelial cells - Xi - 2010 - BJU International - Wiley Online Library	Xi	2011	0		
1136	chr14	72256591	72256616	3500314972	24		72256591	72256616	8421504	2	11,13	0,12	c	350031497200000004,350031497200000005	3-27,8-32						154 Thai J Toxicology 2010; 25(2): 154 - 161	www.thaitox.org	0	0		
1143	chr14	73227684	73227715	3500329458	31		73227684	73227715	8421504	1	31	0	c,g	350032945800000008,350032945800000008	29-60,29-60						&#x0395;&#x03c0;&#x03af;&#x03b4;&#x03c1;&#x03b1;&#x03c3;&#x03b7; &#x03c4;&#x03b7;&#x03c2; LHRH &#x03ba;&#x03b1;&#x03b9; &#x03c4;&#x03bf;&#x03c5; &#x03b1;&#x03b3;&#x03c9;&#x03bd;&#x03b9;&#x03c3;&#x03c4;&#x03ae; (D-Lru6, Pro9 &#x2013; NHE+) LHRH &#x03c3;&#x	es.lis.upatras.gr	0	0		MMP16
1143	chr14	73227684	73227714	3500411389	30		73227684	73227714	8421504	1	30	0	c	350041138900000010	30-60			10.1002/ijc.10808	1097-0215	International Journal of Cancer	Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines - Ishii - 2002 - International Journal of Cancer - Wiley Online Library	Ishii	2003	0		MMP16
1150	chr14	74071304	74071336	3500417882	30		74071304	74071336	8421504	3	22,4,4	0,23,28	g	350041788200000008	7-45			10.1046/j.1365-2958.2000.01777.x	1365-2958	Molecular Microbiology	Regulation of competence for genetic transformation in Streptococcus pneumoniae: expression of dpnA, a late competence gene encoding a DNA methyltransferase of the DpnII restriction system - Lacks - 2002 - Molecular Microbiology - Wiley Online Library	Lacks	2000	0		
1156	chr14	74855218	74855242	3500161755	23		74855218	74855242	8421504	2	19,4	0,20	g	350016175500000167	12-35						Intermediates and enzymes of the non-mevalonate isoprenoid pathway - Patent application	www.faqs.org	0	0		
1157	chr14	74982368	75013121	3500314777	90		74982368	75013121	8421504	4	25,20,40,5	0,8426,26399,30748	p	350031477700015049,350031477700015032	0-45,0-45						Increasing lifespan by modulation of WWP-1 and UBC-18 - Patent application	www.faqs.org	0	0		ITCH
1157	chr14	75024811	75033058	3500382800	159		75024811	75033058	8421504	5	61,41,39,1,17	0,1448,1501,1543,8230	p	350038280000015102	0-162						Novel proteins and nucleic acids encoding same	Anderson	2003	0		
1159	chr14	75237389	75237418	3500454742	23		75237389	75237418	8421504	3	6,4,13	0,11,16	g	350045474200000001	0-24						Heat-stable carbonic anhydrases and their use - Patent application	www.faqs.org	0	0		
1159	chr14	75237389	75237418	3500403623	23		75237389	75237418	8421504	3	6,4,13	0,11,16	g	350040362300000001	0-24						Heat-stable carbonic anhydrases and their use	Borchert	2010	0		
1159	chr14	75237389	75237418	3500352465	23		75237389	75237418	8421504	3	6,4,13	0,11,16	g	350035246500000001	0-24						HEAT-STABLE CARBONIC ANHYDRASES AND THEIR USE - Patent application	www.faqs.org	0	0		
1159	chr14	75349625	75349652	3500084085	24		75349625	75349652	8421504	3	14,6,4	0,16,23	g	350008408500000002	2-30						Starch Binding Domain and Use Thereof	Chang	2010	0		
1159	chr14	75349625	75349652	3500016357	24		75349625	75349652	8421504	3	14,6,4	0,16,23	g	350001635700000002	2-30						Starch Binding Domain and Use Thereof	Chang	2006	0		
1159	chr14	75352681	75364956	3500050044	23		75352681	75364956	8421504	2	19,4	0,12271	c	350005004400000005	0-23						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
1160	chr14	75474167	75474194	3500086226	24		75474167	75474194	8421504	3	5,5,14	0,6,13	g	350008622600000028	0-24						Cross-linking oligonucleotides	Gall	1996	0		
1163	chr14	75780141	75780175	3500121073	34		75780141	75780175	8421504	1	34	0	c	350012107300000021	14-48					Patent	Purification cloning of peptides (Patent US:6127150)	Coolidge	2000	0		
1163	chr14	75808418	75810022	3500146047	44		75808418	75810022	8421504	3	22,20,2	0,85,1602	c	350014604700000005,350014604700000004	0-22,0-22						PASTURE-FEEDING OF CHAROLAIS STEERS INFLUENCES SKELETAL MUSCLE METABOLISM AND GENE EXPRESSION	www.jpp.krakow.pl	0	0		
1173	chr14	77121890	77121918	3500072583	23		77121890	77121918	8421504	2	8,15	0,13	g	350007258300000033,350007258300000101	16-42,16-42						ANTIBODIES FOR INHIBITING BLOOD COAGULATION AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
1175	chr14	77354254	77354286	3500117311	25		77354254	77354286	8421504	3	8,11,6	0,11,26	g	350011731100000048	9-38						CHIMERIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1181	chr14	78238558	78238581	3500430206	23		78238558	78238581	8421504	1	23	0	g	350043020600000074	1-35						Nucleic acid molecule, method and kit for selecting a nucleic acid having a desired feature	Lanctot	2000	0		
1193	chr14	79789601	79789629	3500022494	23		79789601	79789629	8421504	2	14,9	0,19	c	350002249400000139	0-24						Development Of Mammalian Genome Modification Technique Using Retrotransposon 	.freshpatents.com	0	0		
1194	chr14	79883202	79883247	3500045770	45		79883202	79883247	8421504	1	45	0	p	350004577000015136	0-45						US Patent # 6,465,185. Polymorphic human PC-1 sequences associated with insulin resistance - Patents.com	www.patents.com	0	0		ENPP2
1194	chr14	79884416	79884623	3500466010	48		79884416	79884623	8421504	2	33,15	0,192	p	350046601000015012	0-48						Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy	Stracke	1994	0		
1194	chr14	79884416	79884623	3500006252	48		79884416	79884623	8421504	2	33,15	0,192	p	350000625200015011	0-48						Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy	Stracke	2005	0		
1195	chr14	80075320	80075345	3500137955	25		80075320	80075345	8421504	1	25	0	c	350013795500000033	0-30					Patent	Low-cost production for peptides (Patent CN:100489114)	I*A*Tang Mu Lin Sen 	2009	0		POU3F3
1196	chr14	80173292	80173315	3500386802	23		80173292	80173315	8421504	1	23	0	g	350038680200000059	6-29					Patent	Recombinant antibodies specific for a growth factor receptor (Patent US:5571894)	Groner	1996	0		
1200	chr14	80660495	80660520	3500164450	23		80660495	80660520	8421504	2	18,5	0,20	g	350016445000000089	4-27						COMPOUNDS USEFUL IN THE DIAGNOSIS AND TREATMENT OF MALARIA - Patent application	www.faqs.org	0	0		
1203	chr14	81029847	81029872	3500459810	25		81029847	81029872	8421504	1	25	0	g	350045981000000101	0-25						Compositions, Methods, and Kits for (MIS)Ligating Oligonucleotides - Patent application	www.faqs.org	0	0		
588	chr15	479638	485825	3500436896	79		479638	485825	8421504	4	16,7,31,25	0,6099,6118,6162	c	350043689600000024,350043689600000029,350043689600000007,350043689600000023	0-23,0-31,15-37,0-25						Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer - Patent application	www.faqs.org	0	0		MRE11A
589	chr15	652253	652278	3500035109	25		652253	652278	8421504	1	25	0	g	350003510900000153	7-32						METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE - Patent application	www.faqs.org	0	0		
591	chr15	791751	791775	3500378665	23		791751	791775	8421504	2	18,5	0,19	c,g	350037866500000002,350037866500000002	5-28,5-28						Specific maternal transcripts in bovine oocytes and cleavaged embryos: Identification with novel DDRT-PCR methods	www.seegene.com	0	0		
592	chr15	981406	981429	3500342699	23		981406	981429	8421504	1	23	0	g	350034269900000153	4-27						US Patent # 6,426,447. Plant seed oils - Patents.com	www.patents.com	0	0		
601	chr15	2098026	2104041	3500426288	48		2098026	2104041	8421504	2	24,24	0,5991	c	350042628800000017,350042628800000015	0-24,0-24						Entwicklung muriner cDNA-Arrays zur Bestimmung der Proteinase-Expression arthritischer Fibroblasten im Modell der Antigen-induzierten Arthritis	.db-thueringen.de	0	0		
601	chr15	2104012	2104037	3500271060	25		2104012	2104037	8421504	1	25	0	c	350027106000000003	8-33						Programmed cell death and Ich-3	Fishman	2003	0		
601	chr15	2104012	2104037	3500087224	25		2104012	2104037	8421504	1	25	0	c	350008722400000003	8-33						Programmed cell death and ich-3	Fishman	1999	0		
609	chr15	3216688	3216715	3500265093	27		3216688	3216715	8421504	1	27	0	c	350026509300000084	11-38						Treatment of inflammatory bowel disease using growth factors	Jeffers	2002	0		
610	chr15	3365623	3370946	3500300777	48		3365623	3370946	8421504	2	41,7	0,5316	c	350030077700000015	0-48						Platelet-derived Growth Factor D, Dna Coding Therefor, And Uses Thereof 	.freshpatents.com	0	0		
610	chr15	3365649	3371104	3500265093	89		3365649	3371104	8421504	3	15,30,44	0,5290,5411	c	350026509300000018,350026509300000021	0-45,1-45						Treatment of inflammatory bowel disease using growth factors	Jeffers	2002	0		
610	chr15	3370994	3371041	3500360831	47		3370994	3371041	8421504	1	47	0	c	350036083100000019	0-47						Platelet-derived growth factor D, DNA coding therefor and uses thereof	Wu Er Fu *Ai Li Ke Song 	2001	0		
610	chr15	3370994	3371041	3500341932	47		3370994	3371041	8421504	1	47	0	c	350034193200000013	0-47						Platelet-derived growth factor D	Eriksson	1999	0		
611	chr15	3430080	3460962	3500265093	85		3430080	3460962	8421504	2	40,45	0,30837	c	350026509300000026,350026509300000046	0-40,0-45						Treatment of inflammatory bowel disease using growth factors	Jeffers	2002	0		
611	chr15	3460925	3460949	3500360831	24		3460925	3460949	8421504	1	24	0	c	350036083100000108	24-48						Platelet-derived growth factor D, DNA coding therefor and uses thereof	Wu Er Fu *Ai Li Ke Song 	2001	0		
611	chr15	3460925	3460949	3500341932	24		3460925	3460949	8421504	1	24	0	c	350034193200000053	24-48						Platelet-derived growth factor D	Eriksson	1999	0		
611	chr15	3460925	3460949	3500300777	24		3460925	3460949	8421504	1	24	0	c	350030077700000057	24-48						Platelet-derived Growth Factor D, Dna Coding Therefor, And Uses Thereof 	.freshpatents.com	0	0		
614	chr15	3865090	3865118	3500402697	23		3865090	3865118	8421504	2	12,11	0,17	g	350040269700000357	0-23						METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF - Patent application	www.faqs.org	0	0		
616	chr15	4159197	4159226	3500210105	24		4159197	4159226	8421504	2	18,6	0,23	g	350021010500000016,350021010500000017	10-34,8-32					Patent	Method for producing insulin analogs having a dibasic B chain terminus (Patent US:8410048)	Habermann	2013	0		
616	chr15	4159197	4159226	3500030869	24		4159197	4159226	8421504	2	18,6	0,23	g	350003086900000033,350003086900000031	8-32,10-34						Method for producing insulin analogs having a dibasic B chain terminus	F*Cuo He Er 	2009	0		DYNC2H1
619	chr15	4481270	4481296	3500048319	23		4481270	4481296	8421504	2	18,5	0,21	g	350004831900000003	14-37		20581187	10.1128/AEM.00441-10	0099-2240	Applied and Environmental Microbiology	Origin of the Putrescine-Producing Ability of the Coagulase-Negative Bacterium Staphylococcus epidermidis 2015B	Coton	2010	4		
619	chr15	4494217	4499543	3500237513	303		4494217	4499543	8421504	5	60,69,21,102,51	0,150,234,3181,5275	p	350023751300015055,350023751300015058	36-165,0-174						50 human secreted proteins	Komatsoulis	2000	0		DCUN1D5
620	chr15	4611099	4621870	3500186664	41		4611099	4621870	8421504	2	20,21	0,10750	c,g	350018666400000018,350018666400000009,350018666400000009	0-20,0-21,0-21		17116693	10.1128/MCB.00996-06	0270-7306	Molecular and Cellular Biology	Helix-Loop-Helix Protein p8, a Transcriptional Regulator Required for Cardiomyocyte Hypertrophy and Cardiac Fibroblast Matrix Metalloprotease Induction	Goruppi	2007	6		
620	chr15	4611598	4613125	3500401743	40		4611598	4613125	8421504	2	20,20	0,1507	c	350040174300000002,350040174300000003	0-20,0-20		18975308	10.1002/art.23958	1529-0131	Arthritis & Rheumatism	Inhibition of interleukin-1&#x03b2;&#x2013;induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2 - Zayed - 2008 - Arthritis & Rheumatism - Wiley Online Library	Zayed	2008	0		MMP13
620	chr15	4613108	4613132	3500174328	24		4613108	4613132	8421504	1	24	0	c	350017432800000011	0-24			10.1093/emboj/20.21.6071	ERROR! NO ISSN	The EMBO Journal	Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones	Rogatsky	2001	0		
620	chr15	4613108	4613132	3500019068	24		4613108	4613132	8421504	1	24	0	c	350001906800000011	0-24			10.1093/emboj/20.21.6071		The EMBO Journal	Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones	Inez	2001	0		
620	chr15	4613161	4613184	3500222744	23		4613161	4613184	8421504	1	23	0	c	350022274400000004	0-23						CLONING AND CHARACTERIZATION OF 5' FLANKING REGIONS OF A HUMAN AGGRECANASE-1 GENE	Kumar	2009	0		
620	chr15	4613161	4613184	3500171885	23		4613161	4613184	8421504	1	23	0	c	350017188500000004,350017188500000041	0-23,0-23						CLONING AND CHARACTERIZATION OF 5' FLANKING REGIONS OF A HUMAN AGGRECANASE-1 GENE - Patent application	www.faqs.org	0	0		
620	chr15	4615054	4615155	3500134803	42		4615054	4615155	8421504	2	20,22	0,79	c	350013480300000018,350013480300000019	0-20,0-22						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
620	chr15	4615181	4616682	3500116515	48		4615181	4616682	8421504	3	22,2,24	0,1433,1477	c	350011651500000406,350011651500000352,350011651500000407,350011651500000353	0-24,0-24,0-24,0-24						METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS - Patent application	www.faqs.org	0	0		MMP13
620	chr15	4616712	4617748	3500328833	54		4616712	4617748	8421504	2	20,34	0,1002	p	350032883300015079	0-54						Hemopexin-like structure as polypeptide-scaffold	Lanzendoerfer	2007	0		
620	chr15	4616716	4617724	3500343115	26		4616716	4617724	8421504	2	16,10	0,998	c	350034311500000008	1-27						Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension	j.ersjournals.com	0	0		
620	chr15	4617727	4620786	3500241866	39		4617727	4620786	8421504	2	19,20	0,3039	c	350024186600000000,350024186600000001	0-19,0-20						Differential expression of MMP-13 in breast cancer cell lines with different tumerogeniciy	biotechniques.org	0	0		MMP13
620	chr15	4617815	4618900	3500248474	44		4617815	4618900	8421504	2	22,22	0,1063	c	350024847400000038,350024847400000039	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
620	chr15	4620812	4620835	3500458473	23		4620812	4620835	8421504	1	23	0	c	350045847300000005	2-25		20506365	10.1002/art.27475	1529-0131	Arthritis & Rheumatism	Chondrocyte innate immune myeloid differentiation factor 88&#x2013;dependent signaling drives procatabolic effects of the endogenous toll-like receptor 2/toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal 	Liu-Bryan	2010	0		
620	chr15	4621788	4621814	3500359357	26		4621788	4621814	8421504	1	26	0	c	350035935700000004	0-26						Activation of WNT and BMP Signaling in Adult Human Articular Cartilage: Materials and Methods	www.medscape.com	0	0		MMP13
620	chr15	4621788	4621814	3500354856	26		4621788	4621814	8421504	1	26	0	c	350035485600000004	0-26		16893455	10.1186/ar2029	1478-6354	Arthritis Research & Therapy	Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury	Dell'Accio	2006	4		MMP13
620	chr15	4664923	4664952	3500258078	27		4664923	4664952	8421504	2	8,19	0,10	g	350025807800000037	15-48						Nematode PAN and ZP Receptor-Like Sequences - Patent application	www.faqs.org	0	0		
620	chr15	4666869	4666896	3500442057	23		4666869	4666896	8421504	2	15,8	0,19	g	350044205700000001	0-23						 SpringerImages - Primers 	pringerimages.com	0	0		
621	chr15	4721224	4754941	3500302580	86		4721224	4754941	8421504	5	20,25,9,12,20	0,1901,31917,31927,33697	c	350030258000000013,350030258000000014,350030258000000009,350030258000000010	0-20,0-25,0-22,0-20			10.1002/art.20596	1529-0131	Arthritis & Rheumatism	Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes - Martin - 2004 - Arthritis & Rheumatism - Wiley Online Library	Martin	2004	0		
621	chr15	4721277	4721820	3500248474	42		4721277	4721820	8421504	2	22,20	0,523	c,g	350024847400000034,350024847400000035,350024847400000035	0-22,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
621	chr15	4721773	4753673	3500134803	84		4721773	4753673	8421504	5	21,21,21,8,13	0,88,31569,31640,31887	c,g	350013480300000014,350013480300000014,350013480300000015,350013480300000015,350013480300000010,350013480300000011	0-21,0-21,0-21,0-21,0-21,0-21						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
621	chr15	4721773	4753363	3500083194	63		4721773	4753363	8421504	3	21,21,21	0,88,31569	c,g	350008319400000005,350008319400000005,350008319400000006,350008319400000006,350008319400000003	0-21,0-21,0-21,0-21,0-21						Role of infrapatellar fat pad in knee osteoarthritis	www.tipharma.com	0	0		
621	chr15	4721773	4721882	3500182158	42		4721773	4721882	8421504	2	21,21	0,88	c,g	350018215800000004,350018215800000004,350018215800000005,350018215800000005	0-21,0-21,0-21,0-21						METHODS AND USES OF HYPOXIC COMPARTMENT CELLS - Patent application	www.faqs.org	0	0		
621	chr15	4752936	4752961	3500247675	25		4752936	4752961	8421504	1	25	0	c	350024767500000002	0-25			10.1007/s00586-012-2371-3		European Spine Journal	BMP-2 and TGF-&#x03b2;3 do not prevent spontaneous degeneration in rabbit disc explants but induce ossification of the annulus fibrosus	DaniHaschtmann	2012	0		
621	chr15	4752936	4752961	3500137347	25		4752936	4752961	8421504	1	25	0	c	350013734700000008	0-25						Vertebral endplate trauma induces disc cell apoptosis and promotes organ degeneration in vitro	co-me.ch/news/200	0	0		
621	chr15	4753067	4753723	3500175411	40		4753067	4753723	8421504	2	20,20	0,636	c,g	350017541100000012,350017541100000013,350017541100000013	0-20,0-20,0-20		20396564	10.4143/crt.2004.36.1.43		Cancer Research and Treatment : Official Journal of Korean Cancer Association	The Differential Gene Expression Profiles between Sensitive and Resistant Breast Cancer Cells to Adriamycin by cDNA Microarray	Myung-Ju	2004	0		MMP1
621	chr15	4753067	4753394	3500446036	40		4753067	4753394	8421504	2	20,20	0,307	c	350044603600000008,350044603600000009	0-20,0-20						E&#xfb00;ekte mechanischer Reize auf osteogen di&#xfb00;erenzierte Zellen in einer dreidimensionalen Kollagen Typ I Matrix	vts.uni-ulm.de	0	0		MMP1
621	chr15	4753067	4753394	3500404841	40		4753067	4753394	8421504	2	20,20	0,307	c	350040484100000016,350040484100000017	0-20,0-20						Tissue Engineering von Bandersatz: Einfluss mechanischer Reize auf humane mesenchymale Progenitorzellen und humane Kreuzbandzellen	vts.uni-ulm.de	0	0		MMP1
621	chr15	4753067	4753394	3500174671	40		4753067	4753394	8421504	2	20,20	0,307	c	350017467100000000,350017467100000001	0-20,0-20					GMS German Medical Science	Water-filtered infrared-A radiation (wIRA) is not implicated in cellular degeneration of human skin	Narcisa	2007	0		MMP1
621	chr15	4753090	4753113	3500415337	23		4753090	4753113	8421504	1	23	0	c	350041533700000002	0-23						Secreted caveolin-1 enhances periodontal inflammation by targeting gingival fibroblasts	cellbiosignal.jp	0	0		
621	chr15	4753367	4753392	3500109429	25		4753367	4753392	8421504	1	25	0	c	350010942900000008	0-25		15044479	10.1074/jbc.M311430200	0021-9258	Journal of Biological Chemistry	Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK	Shi-wen	2004	5		
621	chr15	4753374	4753397	3500308604	23		4753374	4753397	8421504	1	23	0	c	350030860400000003	23-46						Targeting tumor vasculature	edoc.unibas.ch	0	0		
621	chr15	4753410	4753674	3500343115	25		4753410	4753674	8421504	2	11,14	0,250	c	350034311500000000	24-49						Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension	j.ersjournals.com	0	0		
621	chr15	4753703	4783300	3500233580	61		4753703	4783300	8421504	4	20,19,2,20	0,64,1086,29577	c	350023358000000002,350023358000000012,350023358000000003	0-20,0-21,0-20						Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle	biomedcentral.com	0	0		
621	chr15	4755118	4780578	3500328833	111		4755118	4780578	8421504	2	77,34	0,25426	p	350032883300015004,350032883300015062	0-57,57-111						Hemopexin-like structure as polypeptide-scaffold	Lanzendoerfer	2007	0		
621	chr15	4782728	4783303	3500202018	41		4782728	4783303	8421504	3	12,9,20	0,505,555	c,g	350020201800000003,350020201800000004,350020201800000004	0-21,0-20,0-20						Gene expression of single articular chondrocytes. - ResearchGate	.researchgate.net	0	0		
621	chr15	4783980	4784100	3500248474	47		4783980	4784100	8421504	2	25,22	0,98	c	350024847400000032,350024847400000033	0-25,0-22						REPRODUCTION	uction-online.org	0	0		
622	chr15	4886702	4888915	3500454678	24		4886702	4888915	8421504	2	21,3	0,2210	c	350045467800000363	0-24						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2004	0		MMP27
622	chr15	4892053	4892082	3500083996	25		4892053	4892082	8421504	3	4,7,14	0,5,15	c	350008399600000154	1-26						Antibodies to TNF alpha and use thereof - Patent application	www.faqs.org	0	0		
623	chr15	5070664	5070721	3500328833	57		5070664	5070721	8421504	1	57	0	p	350032883300015047	0-57						Hemopexin-like structure as polypeptide-scaffold	Lanzendoerfer	2007	0		
624	chr15	5170824	5170849	3500290642	25		5170824	5170849	8421504	1	25	0	c	350029064200000003	0-25						The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3- methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor	-publications.com	0	0		MMP7
625	chr15	5285180	5285208	3500048026	23		5285180	5285208	8421504	3	6,13,4	0,10,24	g	350004802600000169	11-37						ANTI-IL-20, ANTI-IL-22 AND ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION - Patent application	www.faqs.org	0	0		
625	chr15	5285180	5285208	3500036421	23		5285180	5285208	8421504	3	6,13,4	0,10,24	g	350003642100000349	11-37						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
626	chr15	5419610	5421301	3500465488	50		5419610	5421301	8421504	3	7,20,23	0,1647,1668	c	350046548800000005,350046548800000003	0-27,0-23		16951243	10.1158/1078-0432.CCR-06-0608	1078-0432	Clinical Cancer Research	Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis	LaCasse	2006	8		BIRC3,BIRC2
626	chr15	5421553	5421578	3500121372	25		5421553	5421578	8421504	1	25	0	c	350012137200000020	0-25						cDNA Microarray Analysis of Host-Pathogen Interactions in a Porcine In Vitro Model for Toxoplasma gondii Infection&#x2020;	iai.asm.org	0	0		
626	chr15	5421685	5422175	3500237044	40		5421685	5422175	8421504	2	20,20	0,470	c	350023704400000001,350023704400000000	0-20,0-20		10821872	10.1074/jbc.275.21.16309	0021-9258	Journal of Biological Chemistry	Anti-apoptotic Role of Focal Adhesion Kinase (FAK)	Sonoda	2000	5		BIRC3
629	chr15	5857989	5858016	3500062753	24		5857989	5858016	8421504	2	18,6	0,21	c	350006275300000053	8-32					Patent	Pseudorabies virus protein (Patent CA:1340848)	Petrovskis	1999	0		
630	chr15	5957684	6003929	3500423257	42		5957684	6003929	8421504	4	15,6,6,15	0,16,46220,46230	c	350042325700000195,350042325700000088	12-33,3-24						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
630	chr15	5988410	5995066	3500243526	43		5988410	5995066	8421504	2	21,22	0,6634	c,g	350024352600000002,350024352600000003	0-21,0-22						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
630	chr15	5988509	5995053	3500198647	46		5988509	5995053	8421504	3	22,13,11	0,27,6533	c	350019864700000008,350019864700000009	0-22,0-24						Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas	biomedcentral.com	0	0		
630	chr15	5988509	5995053	3500113767	46		5988509	5995053	8421504	3	22,13,11	0,27,6533	c	350011376700000008,350011376700000009	0-22,0-24							biomedcentral.com	0	0		
630	chr15	6001173	6001981	3500169580	23		6001173	6001981	8421504	2	9,14	0,794	c	350016958000000003,350016958000000004	21-44,24-45		18506892	10.1002/hep.22263	1527-3350	Hepatology	Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation - El Boustany - 2008 - Hepatology - Wiley Online Library	Boustany	2008	0		
630	chr15	6017489	6017513	3500419411	24		6017489	6017513	8421504	1	24	0	c	350041941100000059	0-24						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		
633	chr15	6396034	6396060	3500053431	23		6396034	6396060	8421504	2	5,18	0,8	g	350005343100000497	2-25					Patent	Binding agents which inhibit myostatin (Patent US:7928075)	Han	2011	0		
633	chr15	6401925	6402351	3500428584	426		6401925	6402351	8421504	1	426	0	p	350042858400015002	0-426						<HTML> <HEAD> <META http-equiv="content-type" content="text/html; charset=UTF-8"> <TITLE>KC4310	ry.ddbj.nig.ac.jp	0	0		
633	chr15	6403483	6404783	3500183992	46		6403483	6404783	8421504	2	22,24	0,1276	c	350018399200000000,350018399200000001	0-22,0-24		19797619	10.1124/jpet.109.160382	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Glyceollin I, a Novel Antiestrogenic Phytoalexin Isolated from Activated Soy	Zimmermann	2010	0		PGR
633	chr15	6403498	6404710	3500363369	23		6403498	6404710	8421504	2	11,12	0,1200	c	350036336900000002	15-38						Estrogen-like activity of aqueous extract from Agrimonia pilosa Ledeb. in MCF-7 cells. - ResearchGate	.researchgate.net	0	0		PGR
633	chr15	6403498	6404710	3500207666	23		6403498	6404710	8421504	2	11,12	0,1200	c	350020766600000012	17-40						Copyright By Gwen Ellen Dressing 2008	es.lib.utexas.edu	0	0		PGR
633	chr15	6404759	6404783	3500071946	24		6404759	6404783	8421504	1	24	0	c	350007194600000000	22-46					American Journal of Cancer Research	Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase	James	2012	0		
79	chr15	6404807	6461970	3500021751	45		6404807	6461970	8421504	2	43,2	0,57161	p	350002175100015007	0-45						Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same	Dedhar	1995	0		PGR
634	chr15	6462006	6490320	3500319127	46		6462006	6490320	8421504	2	23,23	0,28291	c	350031912700000002,350031912700000003	0-23,0-23						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
634	chr15	6462032	6462059	3500037777	27		6462032	6462059	8421504	1	27	0	g	350003777700000014	0-27		17591692	10.1128/MCB.00237-07	0270-7306	Molecular and Cellular Biology	The Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Corepressor Is Required for Full Estrogen Receptor &#x03b1; Transcriptional Activity	Peterson	2007	6		PGR
634	chr15	6462043	6490282	3500145630	40		6462043	6490282	8421504	2	20,20	0,28219	c,g	350014563000000006,350014563000000006,350014563000000007,350014563000000007	0-20,0-20,0-20,0-20						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		PGR
634	chr15	6462051	6490108	3500307353	48		6462051	6490108	8421504	2	34,14	0,28043	p	350030735300015035	0-48						 Regulation Of Gene Expression Using Chromatin Remodelling Factors 	www.docstoc.com	0	0		PGR
634	chr15	6490287	6500584	3500140406	39		6490287	6500584	8421504	3	20,9,10	0,104,10287	c,g	350014040600000011,350014040600000011,350014040600000012	0-20,0-20,0-19						Suppression of ovarian secretions before puberty strongly affects mammogenesis in the goat. - ResearchGate	.researchgate.net	0	0		
634	chr15	6490363	6500582	3500408713	45		6490363	6500582	8421504	2	37,8	0,10211	c	350040871300000002	0-45						Expression of oxytocin, oestrogen and progesterone receptors in uterine biopsy samples throughout the oestrous cycle and early pregnancy in cows	uction-online.org	0	0		
634	chr15	6490384	6500681	3500390063	120		6490384	6500681	8421504	3	16,50,54	0,10190,10243	p	350039006300015005	21-141						Crystallographic structure of the androgen receptor ligand binding domain	Attar	2001	0		
634	chr15	6490384	6500681	3500370557	120		6490384	6500681	8421504	3	16,50,54	0,10190,10243	p	350037055700015005	21-141						Crystallographic structure of the androgen receptor ligand binding domain	Attar	2002	0		
634	chr15	6490384	6500681	3500224863	120		6490384	6500681	8421504	3	16,50,54	0,10190,10243	p	350022486300015005	21-141						Crystallographic structure of the androgen receptor ligand binding domain	Attar	2003	0		
634	chr15	6515130	6518184	3500333063	41		6515130	6518184	8421504	2	19,22	0,3032	c,g	350033306300000000,350033306300000001	0-19,0-22						Characterisation of gene expression patterns in 22RV1 cells for determination of environmental androgenic/antiandrogenic compounds	quantification.de	0	0		PGR
634	chr15	6515175	6518126	3500320137	47		6515175	6518126	8421504	2	24,23	0,2928	c	350032013700000002,350032013700000003	0-24,0-23						Revista Brasileira de Zootecnia	www.scielo.br	0	0		
634	chr15	6515175	6518126	3500261447	47		6515175	6518126	8421504	2	24,23	0,2928	c	350026144700000008,350026144700000009	0-24,0-23						CRISTIANA LIBARDI MIRANDA	www.tede.ufv.br	0	0		
634	chr15	6515223	6518202	3500286280	102		6515223	6518202	8421504	3	3,54,45	0,2832,2934	p	350028628000015081,350028628000015083	0-57,0-45						BMC Evolutionary Biology BioMed Central	biomedcentral.com	0	0		PGR
634	chr15	6518139	6518162	3500308562	23		6518139	6518162	8421504	1	23	0	c	350030856200000011	0-23						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		PGR
644	chr15	7857241	7857273	3500293831	25		7857241	7857273	8421504	3	8,3,14	0,12,18	g	350029383100000003	0-25						Bovine respiratory syncytial virus (BRSV), bovine viral diarrhea (BVD) virus and	y.oregonstate.edu	0	0		
650	chr15	8608455	8608482	3500435328	23		8608455	8608482	8421504	2	14,9	0,18	g	350043532800000062	0-23						Transgenic fungal resistant plants expressing chitinase and glucanase, process for obtaining, and recombinant polynucleotides for uses therein	Cornelissen	1997	0		
652	chr15	8793170	8793193	3500092886	23		8793170	8793193	8421504	1	23	0	g	350009288600000086	11-34						A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same	Hung	2002	0		
656	chr15	9402813	9402836	3500328220	23		9402813	9402836	8421504	1	23	0	g	350032822000000014,350032822000000017	0-23,0-20						Synthese und Charakterisierung von	.uni-frankfurt.de	0	0		
662	chr15	10158014	10158040	3500296373	25		10158014	10158040	8421504	2	21,4	0,22	g	350029637300000034	9-34					Patent	Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof (Patent US:8067001)	Zhou	2011	0		
662	chr15	10158014	10158040	3500296144	25		10158014	10158040	8421504	2	21,4	0,22	g	350029614400000035	9-34						Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof	Ichikawa	2003	0		
662	chr15	10158014	10158040	3500292650	25		10158014	10158040	8421504	2	21,4	0,22	g	350029265000000034	9-34					Patent	Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof (Patent US:8329180)	Zhou	2012	0		
662	chr15	10158014	10158040	3500136668	25		10158014	10158040	8421504	2	21,4	0,22	g	350013666800000035	9-34					Patent	Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof (Patent US:7244429)	Zhou	2007	0		
675	chr15	11833421	11833448	3500170460	23		11833421	11833448	8421504	2	10,13	0,14	g	350017046000000330	10-36						US Patent # 6,946,256. Cell regulatory genes, encoded products, and uses related thereto - Patents.com	www.patents.com	0	0		
675	chr15	11856115	11856142	3500104575	24		11856115	11856142	8421504	2	8,16	0,11	c	350010457500000110	0-24						Peptide inhibitors of c-jun dimerization and uses thereof - Patent application	www.faqs.org	0	0		
676	chr15	11986657	11986682	3500131694	24		11986657	11986682	8421504	2	19,5	0,20	g	350013169400000002	12-37		19351399	10.1186/1471-2164-10-149	1471-2164	BMC Genomics	Identification and characterization of new miRNAs cloned from normal mouse mammary gland	Sdassi	2009	4		
677	chr15	12074497	12074524	3500435379	24		12074497	12074524	8421504	2	19,5	0,22	g	350043537900000005,350043537900000004	4-28,0-24						Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. - ResearchGate	.researchgate.net	0	0		
677	chr15	12122315	12122344	3500455974	24		12122315	12122344	8421504	2	8,16	0,13	g	350045597400000012,350045597400000042	24-48,24-48						GENETIC CONTROL OF MAMMALIAN CELLS WITH SYNTHETIC RNA REGULATORY SYSTEMS - Patent application	www.faqs.org	0	0		
678	chr15	12293146	12293209	3500023733	63		12293146	12293209	8421504	1	63	0	p	350002373300015015	81-156						Amplification of trpEG: adaptation of Buchnera aphidicola to an endosymbiotic association with aphids. - ResearchGate	.researchgate.net	0	0		
679	chr15	12427831	12427857	3500309840	24		12427831	12427857	8421504	2	11,13	0,13	c	350030984000000311	0-24						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
680	chr15	12554079	12554145	3500429889	66		12554079	12554145	8421504	1	66	0	p	350042988900015003	0-66		11673248	10.1095/biolreprod65.5.1340	0006-3363	Biology of Reproduction	A 22-Amino Acid Synthetic Peptide Corresponding to the Second Extracellular Loop of Rat Occludin Perturbs the Blood-Testis Barrier and Disrupts Spermatogenesis Reversibly In Vivo	Chung	2001	4		
681	chr15	12584605	12584663	3500388065	49		12584605	12584663	8421504	2	37,12	0,46	c	350038806500000016	0-60						A 1.3 kb Satellite DNA from Bubalus bubalis not Conserved Evolutionarily is Transcribed	.znaturforsch.com	0	0		
687	chr15	13404516	13404541	3500170408	23		13404516	13404541	8421504	3	4,6,13	0,5,12	g	350017040800000013	0-23						Emmalene J. Bartlett B.Sc. (Hons)	ry.murdoch.edu.au	0	0		
689	chr15	13751728	13751752	3500148665	23		13751728	13751752	8421504	2	7,16	0,8	g	350014866500000035	14-37						Reagents and method for modulating Dkk-mediated interactions	Allen	2007	0		
690	chr15	13860394	13860422	3500448578	24		13860394	13860422	8421504	3	7,3,14	0,9,14	g	350044857800000005	16-40						Thermostable cellulase	Wicher	2001	0		
692	chr15	14088379	14088407	3500296413	26		14088379	14088407	8421504	3	17,4,5	0,18,23	g	350029641300000003	11-37						ScienceDirect.com - Biomaterials - The promotion of osteoblastic differentiation of rat bone marrow stromal cells by a polyvalent plant mosaic virus	sciencedirect.com	0	0		
693	chr15	14183865	14184938	3500120673	39		14183865	14184938	8421504	4	13,7,5,14	0,14,1051,1059	g	350012067300000001,350012067300000006	0-20,6-25						Tumor-speci&#xfb01;cTh17-polarizedcellseradicatelargeestablishedmelanoma	tologylibrary.org	0	0		
695	chr15	14453374	14453401	3500359363	23		14453374	14453401	8421504	3	5,5,13	0,6,14	g	350035936300000184	19-42						Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments 	.freshpatents.com	0	0		
695	chr15	14453374	14453401	3500032480	23		14453374	14453401	8421504	3	5,5,13	0,6,14	g	350003248000000182	19-42						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments - US Patent 7964349 Description	ww.patentstorm.us	0	0		
702	chr15	15437682	15442862	3500338133	69		15437682	15442862	8421504	2	35,34	0,5146	p	350033813300015002	0-69						UNIVERSITETET I OSLO	www.fuimbv.com	0	0		
708	chr15	16163720	16163821	3500261436	40		16163720	16163821	8421504	2	20,20	0,81	c,g	350026143600000003,350026143600000002,350026143600000002	0-20,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
709	chr15	16299845	16307879	3500055914	44		16299845	16307879	8421504	2	23,21	0,8013	c	350005591400000010,350005591400000007	0-23,0-21						ATAXIA TELANGIECTASIA MUTATED (ATM) INHIBITION TRANSFORMS HUMAN MAMMARY GLAND EPITHELIAL CELLS *, Rapha&#xeb;le Buser , Laurence Lesne , Christelle Stouder , Vincent , Fr&#xe9;d&#xe9;rique B&#xe9; na , Virginie Cl&#xe9;ment , Curzio R&#xfc;egg and Andr&#x	www.jbc.org	0	0		ATM
709	chr15	16302264	16302287	3500358868	23		16302264	16302287	8421504	1	23	0	g	350035886800000000	8-37		20410281	10.1128/JVI.00294-10		Journal of Virology	Generation of Infectious Feline Immunodeficiency Virus (FIV) Encoding FIV/Human Immunodeficiency Virus Chimeric Protease 	Ying-Chuan	July	0		
709	chr15	16312002	16312032	3500388701	30		16312002	16312032	8421504	1	30	0	c	350038870100000029,350038870100000011	0-30,0-19						GENETIC CHANGES IN ATM AND ATR/CHEK1 AS PROGNOSTIC INDICATORS IN CANCER - Patent application	www.faqs.org	0	0		
709	chr15	16312002	16312032	3500089779	30		16312002	16312032	8421504	1	30	0	c,g	350008977900000029,350008977900000011,350008977900000011	0-30,0-19,0-19						Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer - Patent application	www.faqs.org	0	0		ATM
709	chr15	16316890	16317716	3500464947	40		16316890	16317716	8421504	2	20,20	0,806	c,g	350046494700000000,350046494700000000,350046494700000001,350046494700000001	0-20,0-20,0-20,0-20					The Indian Journal of Medical Research	Establishment & characterization of lymphoblastoid cell lines from patients with multiple primary neoplasms in the upper aero-digestive tract & healthy individuals	Tabish	June	0		ATM
709	chr15	16379756	16381114	3500234474	31		16379756	16381114	8421504	2	15,16	0,1342	c	350023447400000009	22-53		19996304	10.1158/1541-7786.MCR-09-0119	1541-7786	Molecular Cancer Research	Inhibition of Expression of the Chromatin Remodeling Gene, SNF2L, Selectively Leads to DNA Damage, Growth Inhibition, and Cancer Cell Death	Ye	2009	4		ATM
709	chr15	16379756	16381114	3500002351	31		16379756	16381114	8421504	2	15,16	0,1342	c	350000235100000031	0-31						POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF	Dongxu	2008	0		ATM
710	chr15	16398259	16398307	3500006433	48		16398259	16398307	8421504	1	48	0	p	350000643300015000	0-48		10567403	10.1074/jbc.274.48.34277	0021-9258	Journal of Biological Chemistry	Localization of a Portion of Extranuclear ATM to Peroxisomes	Watters	1999	5		ATM
712	chr15	16761607	16761631	3500188455	23		16761607	16761631	8421504	2	11,12	0,12	g	350018845500000295	22-45						 Polypeptide For A TRP Channel Family Member, TRP 	www.docstoc.com	0	0		
713	chr15	16868912	16868937	3500311161	24		16868912	16868937	8421504	2	9,15	0,10	c	350031116100000209	24-48						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
713	chr15	16868912	16868937	3500127679	24		16868912	16868937	8421504	2	9,15	0,10	c	350012767900000209	24-48						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
718	chr15	17514378	17514402	3500143153	23		17514378	17514402	8421504	2	15,8	0,16	g	350014315300000004	1-26					Patent	&#x6297;&#x6dc0;&#x7c89;&#x6837;&#x86cb;&#x767d;&#x514d;&#x75ab;&#x539f;&#x6027;&#x7ec4;&#x5408;&#x7269;&#x3001;&#x65b9;&#x6cd5;&#x548c;&#x7528;&#x9014; Anti-amyloid immunogenic compositions, methods and uses (Patent CN:101384279)	B*P*Ai Mu Bi Mu Bo 	2012	0		
721	chr15	17828895	17828923	3500444585	24		17828895	17828923	8421504	3	5,5,14	0,6,14	g	350044458500000061	5-29						NOVEL SHIGELLA PROTEIN ANTIGENS AND METHODS - Patent application	www.faqs.org	0	0		
723	chr15	18201416	18201442	3500006313	23		18201416	18201442	8421504	2	8,15	0,11	g	350000631300000214	11-42						METHODS FOR SELECTIVE ERADICATION OF METASTASIZING CANCER CELLS EX VIVO USING MULTIDOMAIN BIOTAGS - Patent application	www.faqs.org	0	0		
725	chr15	18369920	18370024	3500259232	104		18369920	18370024	8421504	1	104	0	g	350025923200000060	0-105						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
725	chr15	18369920	18369970	3500000589	50		18369920	18369970	8421504	1	50	0	g	350000058900000094	0-51						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
725	chr15	18436497	18436521	3500322309	24		18436497	18436521	8421504	1	24	0	c,g	350032230900000029,350032230900000029	0-24,0-24						Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue 	.freshpatents.com	0	0		
725	chr15	18436497	18436521	3500269115	24		18436497	18436521	8421504	1	24	0	c	350026911500000034	0-24					Patent	Souches de levures produisant des steroides de facon autonome (Patent EP:1385980)	Achstetter	2010	0		
725	chr15	18436571	18455075	3500451252	84		18436571	18455075	8421504	3	34,14,36	0,18394,18468	c	350045125200000086,350045125200000088	0-48,12-48						Cholesterol disposal fusion enzymes	www.devileye.net	0	0		
725	chr15	18454976	18455008	3500070811	32		18454976	18455008	8421504	1	32	0	c	350007081100000001,350007081100000000	0-32,0-32		8530396	10.1074/jbc.270.50.29959	0021-9258	Journal of Biological Chemistry	The Role of Threonine 54 in Adrenodoxin for the Properties of Its Iron-Sulfur Cluster and Its Electron Transfer Function	Uhlmann	1995	5		
726	chr15	18531446	18532605	3500380603	23		18531446	18532605	8421504	3	16,2,5	0,20,1154	c	350038060300000011	9-35						TH&#xc8;SE de Doctorat Discipline : Sciences des Aliments TO Thi Mai Huong	hives-ouvertes.fr	0	0		
726	chr15	18531446	18532605	3500322290	23		18531446	18532605	8421504	3	16,2,5	0,20,1154	c	350032229000000011	9-35						TH&#xc8;SE de Doctorat Discipline : Sciences des Aliments TO Thi Mai Huong	hives-ouvertes.fr	0	0		
726	chr15	18572922	18572952	3500107408	30		18572922	18572952	8421504	1	30	0	c	350010740800000078	0-30						Compositions and methods relating to mir-31	Weinberg	2011	0		
731	chr15	19192423	19192448	3500087638	23		19192423	19192448	8421504	3	6,11,6	0,7,19	g	350008763800000020	4-33						Stable igg4 antibodies	Winkel	2010	0		
735	chr15	19765309	19765337	3500034199	25		19765309	19765337	8421504	2	11,14	0,14	g	350003419900000332	4-33						MODULATION OF APOLIPOPROTEIN (a) EXPRESSION - Patent application	www.faqs.org	0	0		
736	chr15	19872758	19872784	3500278545	23		19872758	19872784	8421504	3	4,14,5	0,5,21	g	350027854500000006	9-32						Rasgap Derived Peptide For Selectively Killing Cancer Cells 	.freshpatents.com	0	0		
11	chr15	19916734	19926432	3500235713	38		19916734	19926432	8421504	2	19,19	0,9679	g	350023571300000008,350023571300000009	0-19,0-19						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
737	chr15	19941741	19942465	3500423784	46		19941741	19942465	8421504	2	23,23	0,701	c,g	350042378400000244,350042378400000126,350042378400000126,350042378400000245	0-23,0-22,0-22,0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		BTG4
737	chr15	19941741	19942465	3500389139	45		19941741	19942465	8421504	2	22,23	0,701	c	350038913900000125,350038913900000080	22-44,21-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		BTG4
737	chr15	19941741	19942465	3500306561	45		19941741	19942465	8421504	2	22,23	0,701	c	350030656100000124,350030656100000079	22-44,21-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		BTG4
737	chr15	19941741	19942465	3500257436	45		19941741	19942465	8421504	2	22,23	0,701	c	350025743600000124,350025743600000079	22-44,21-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
737	chr15	19941741	19941764	3500407236	23		19941741	19941764	8421504	1	23	0	c,g	350040723600000003,350040723600000003	0-23,0-23		18633141	10.1095/biolreprod.108.067827	0006-3363	Biology of Reproduction	Dicer1 Is Required for Differentiation of the Mouse Male Germline	Maatouk	2008	4		
737	chr15	19941741	19941764	3500148073	23		19941741	19941764	8421504	1	23	0	c	350014807300000003	0-23		18633141	10.1095/biolreprod.108.067827	0006-3363	Biology of Reproduction	Dicer1 Is Required for Differentiation of the Mouse Male Germline	Maatouk	2008	4		
737	chr15	19941742	19942497	3500439152	68		19941742	19942497	8421504	3	23,23,22	0,700,733	c	350043915200000170,350043915200000277,350043915200000093	0-23,0-23,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		BTG4
737	chr15	19942442	19942465	3500462877	23		19942442	19942465	8421504	1	23	0	c	350046287700000008	0-23		21893155	10.1016/j.tox.2011.08.013		Toxicology	Differential Programming of p53-Deficient Embryonic Cells During Rotenone Block	M.	2011	0		BTG4
737	chr15	19942442	19942465	3500349178	23		19942442	19942465	8421504	1	23	0	c	350034917800000022,350034917800000023,350034917800000021	0-23,0-21,0-23		22479460	10.1371/journal.pone.0033861	1932-6203	PLOS ONE	PLOS ONE: MicroRNA-34c Enhances Murine Male Germ Cell Apoptosis through Targeting ATF1	Liang	2012	4		
737	chr15	19942442	19942465	3500264779	23		19942442	19942465	8421504	1	23	0	c,g	350026477900000025,350026477900000025,350026477900000024,350026477900000024,350026477900000023,350026477900000023	0-21,0-21,0-23,0-23,0-23,0-23						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DT	www.plosone.org	0	0		
737	chr15	19942442	19942465	3500232262	23		19942442	19942465	8421504	1	23	0	c	350023226200000079	21-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		BTG4
737	chr15	19942442	19942465	3500032390	23		19942442	19942465	8421504	1	23	0	c,g	350003239000000021,350003239000000021,350003239000000023,350003239000000022,350003239000000022	0-23,0-23,0-21,0-23,0-23		22479460	10.1371/journal.pone.0033861		PLoS ONE	MicroRNA-34c Enhances Murine Male Germ Cell Apoptosis through Targeting ATF1	Xiaoxuan	2012	0		
737	chr15	19972810	19972837	3500022752	24		19972810	19972837	8421504	3	6,4,14	0,8,13	g	350002275200000015,350002275200000012	3-26,1-25		18684810	10.1128/JVI.01144-08	0022-538X	Journal of Virology	Evolutionarily Conserved Function of a Viral MicroRNA	Seo	2008	5		
738	chr15	20061840	20061867	3500174638	23		20061840	20061867	8421504	2	15,8	0,19	g	350017463800000352	22-45						US Patent # 8,318,908. Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof - Patents.com	patents.com	0	0		
738	chr15	20108311	20108336	3500308235	23		20108311	20108336	8421504	2	6,17	0,8	g	350030823500000012	6-29					Patent	Recombinant infectious bovine rhinotracheitis virus (Patent US:5874279)	Cochran	1999	0		
738	chr15	20172935	20172963	3500160249	23		20172935	20172963	8421504	2	14,9	0,19	g	350016024900000417	0-29						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN - Patent application	www.faqs.org	0	0		
738	chr15	20172935	20172963	3500104979	23		20172935	20172963	8421504	2	14,9	0,19	g	350010497900000417	0-29						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
740	chr15	20385255	20388307	3500247006	110		20385255	20388307	8421504	3	68,6,36	0,69,3016	c,g	350024700600000025,350024700600000003	0-74,36-72						Complete aB-crystallin Conservation	www.pnas.org	0	0		
740	chr15	20385274	20385463	3500146047	40		20385274	20385463	8421504	2	20,20	0,169	c,g	350014604700000009,350014604700000009,350014604700000008,350014604700000008	0-20,0-20,0-20,0-20						PASTURE-FEEDING OF CHAROLAIS STEERS INFLUENCES SKELETAL MUSCLE METABOLISM AND GENE EXPRESSION	www.jpp.krakow.pl	0	0		
740	chr15	20385274	20385463	3500053255	40		20385274	20385463	8421504	2	20,20	0,169	c,g	350005325500000009,350005325500000009,350005325500000008,350005325500000008	0-20,0-20,0-20,0-20						1009_S3_article_10	www.jpp.krakow.pl	0	0		
740	chr15	20385345	20388472	3500135112	360		20385345	20388472	8421504	3	186,24,150	0,1676,2977	p	350013511200015159	0-360						&#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x57f9;&#x8bad;&#x6559;&#x6750;	ibi.cqupt.edu.cn	0	0		CRYAB
740	chr15	20385485	20388277	3500144261	40		20385485	20388277	8421504	3	20,14,6	0,1645,2786	c	350014426100000005,350014426100000004	0-20,0-20						Gene expression profiling of bovine in vitro adipogenesis using a cDNA microarray	iotechnology.info	0	0		CRYAB
740	chr15	20385507	20387048	3500104165	51		20385507	20387048	8421504	2	24,27	0,1514	p	350010416500015130	0-51						The detection and role of human endogenous retroviruses in multiple sclerosis and other neurological diseases	penrepository.com	0	0		CRYAB
740	chr15	20385508	20387096	3500056162	41		20385508	20387096	8421504	2	21,20	0,1568	c,g	350005616200000007,350005616200000007,350005616200000006	0-21,0-21,0-20						Universidade de S&#xe3;o Paulo Escola Superior de Agricultura &#x201c;Luiz de Queiroz&#x201d;	www.teses.usp.br	0	0		
740	chr15	20387040	20387144	3500409932	40		20387040	20387144	8421504	2	20,20	0,84	c	350040993200000005,350040993200000006	0-20,0-20						Characterization of Canine Mammary Carcinoma using Dog-Specific cDNA arrays	ive.library.uu.nl	0	0		CRYAB
740	chr15	20387040	20387144	3500243312	40		20387040	20387144	8421504	2	20,20	0,84	c,g	350024331200000005,350024331200000006,350024331200000006	0-20,0-20,0-20						cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype	eterinaria.com.ar	0	0		CRYAB
741	chr15	20483577	20483628	3500391361	51		20483577	20483628	8421504	1	51	0	p	350039136100015155	0-51						Transcriptomic and Proteomic Approaches to the Discovery of New Markers of Pathology	n.library.ethz.ch	0	0		DLAT
741	chr15	20483600	20491460	3500423679	44		20483600	20491460	8421504	2	19,25	0,7835	c	350042367900000000,350042367900000001	0-19,0-25						Induction of Primary Biliary Cirrhosis in Guinea Pigs following Chemical Xenobiotic Immunization	www.jimmunol.org	0	0		
741	chr15	20487715	20489950	3500436803	90		20487715	20489950	8421504	2	67,23	0,2212	p	350043680300015002,350043680300015013	0-90,0-57						Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis	Gershwin	2004	0		DLAT
741	chr15	20537976	20539689	3500061911	162		20537976	20539689	8421504	3	57,21,84	0,129,1629	p	350006191100015022,350006191100015010	0-57,0-105						Molekulare Ursachen des Mohr-Tranebjaerg-Syndroms	b.uni-muenchen.de	0	0		SDHD,TIMM8B
742	chr15	20583725	20606044	3500265224	42		20583725	20606044	8421504	3	8,12,22	0,17126,22297	c,g	350026522400000014,350026522400000015,350026522400000015	0-20,0-22,0-22						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
742	chr15	20600882	20605916	3500370177	42		20600882	20605916	8421504	4	21,3,12,6	0,53,957,5028	c	350037017700000006,350037017700000007	0-21,0-21		18337375	10.1128/CVI.00034-08	1556-6811	Clinical and Vaccine Immunology	Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone	Wedlock	2008	3		
742	chr15	20600882	20605916	3500005370	42		20600882	20605916	8421504	4	21,3,12,6	0,53,957,5028	c,g	350000537000000006,350000537000000006,350000537000000007	0-21,0-21,0-21		18337375	10.1128/CVI.00034-08		Clinical and Vaccine Immunology : CVI	Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone 	D.	2008	0		
742	chr15	20605964	20606006	3500279437	42		20605964	20606006	8421504	1	42	0	c	350027943700000030	1-43						Interferon-gamma Inducing Polypeptide, Pharmaceutical Composition Thereof, Monoclonal Antibody Thereto, And Methods Of Use 	.freshpatents.com	0	0		
742	chr15	20606036	20606943	3500449915	49		20606036	20606943	8421504	3	9,14,26	0,816,881	c,g	350044991500000016,350044991500000017,350044991500000017	0-23,0-26,0-26						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
742	chr15	20606036	20606943	3500414028	49		20606036	20606943	8421504	3	9,14,26	0,816,881	c	350041402800000018,350041402800000019	0-23,0-26						Ganjam virus/Nairobi sheep disease virus induces a pro-inflammatory response in infected sheep	biomedcentral.com	0	0		
742	chr15	20606043	20609617	3500355031	40		20606043	20609617	8421504	3	2,18,20	0,809,3554	c,g	350035503100000008,350035503100000009,350035503100000009	0-20,0-20,0-20						OKAMATSU-OGURA, Yuko; SOLIMAN, Mohamed; ABD Citation Journal of Veterinary Medical Science, 69(5): 509-514 Issue Date 2007-05	lib.hokudai.ac.jp	0	0		
742	chr15	20609731	20609758	3500242704	27		20609731	20609758	8421504	1	27	0	c	350024270400000003	0-27		11818438		0741-5400	Journal of Leukocyte Biology	NK-like CD8+ cells in immunologically na&#xef;ve neonatal calves that respond to dendritic cells infected with Mycobacterium bovis BCG	Hope	2002	5		
742	chr15	20609733	20609758	3500362403	25		20609733	20609758	8421504	1	25	0	c	350036240300000067	0-25						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
742	chr15	20672809	20699497	3500165278	124		20672809	20699497	8421504	7	21,25,20,19,20,14,5	0,159,7696,10548,25683,25746,26683	c,g	350016527800000145,350016527800000001,350016527800000051,350016527800000053,350016527800000197,350016527800000197,350016527800000198	0-21,0-25,22-42,21-40,0-20,0-20,0-19						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
742	chr15	20697789	20698400	3500189431	23		20697789	20698400	8421504	2	9,14	0,597	c	350018943100000245	1-30						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
744	chr15	20887758	20887781	3500032445	23		20887758	20887781	8421504	1	23	0	g	350003244500000009	20-43						US Patent # 6,852,494. Nucleic acid amplification - Patents.com	www.patents.com	0	0		
746	chr15	21119141	21119164	3500079083	23		21119141	21119164	8421504	1	23	0	g	350007908300000003	0-23		11888895		0008-5472	Cancer Research	Differential Gene Expression Profiles of Jnk1- and Jnk2-deficient Murine Fibroblast Cells	Chen	2002	8		
751	chr15	21846148	21846172	3500459869	23		21846148	21846172	8421504	2	10,13	0,11	g	350045986900000224	0-23						 Highly Conserved Genes And Their Use To Generate Probes And Primers For Detection Of Microorganisms 	www.docstoc.com	0	0		
752	chr15	21920937	21921383	3500453530	51		21920937	21921383	8421504	2	43,8	0,438	p	350045353000015155	0-51						Compounds and methods for modulating OB-cadherin-mediated function	Blaschuk	2004	0		NCAM1
752	chr15	21945427	21945487	3500408186	60		21945427	21945487	8421504	1	60	0	p	350040818600015013	3-63						Isolation and encoding C-protein: An ofthe	www.pnas.org	0	0		NCAM1
752	chr15	21947040	21949338	3500100660	195		21947040	21949338	8421504	2	84,111	0,2187	p	350010066000015001,350010066000015005	0-84,0-111						Expressionsregulation, Glykosylierung und Funktion von Zelladh&#xe4;sionsmolek&#xfc;len der NCAM-Familie im Zebrafischembryo	.uni-karlsruhe.de	0	0		NCAM1
752	chr15	21983030	21983075	3500426037	45		21983030	21983075	8421504	1	45	0	p	350042603700015000	0-45			10.1111/j.1471-4159.2004.02779.x	1471-4159	Journal of Neurochemistry	An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons - Neiiendam - 2004 - Journal of Neurochemistry - Wiley Online Library	Neiiendam	2004	0		NCAM1
752	chr15	21993891	21995517	3500401126	23		21993891	21995517	8421504	2	7,16	0,1610	c	350040112600000016	21-44						Platelet-Rich Plasma Promotes the Proliferation of Human Muscle Derived Progenitor Cells and Maintains Their Stemness	olarship.pitt.edu	0	0		
752	chr15	21998989	21999236	3500358508	43		21998989	21999236	8421504	3	19,21,3	0,222,244	c,g	350035850800000028,350035850800000029	0-19,0-24						DIVERSIDADE GEN&#xc9;TICA, ANCESTRALIDADE INDIVIDUAL E MISCIGENA&#xc7;&#xc3;O NAS RA&#xc7;AS BOVINAS NO BRASIL COM BASE EM MICROSSAT&#xc9;LITES E HAPL&#xd3;TIPOS DE DNA MITOCONDRIAL: SUBS&#xcd;DIOS PARA A CONSERVA&#xc7;&#xc3;O	itorio.bce.unb.br	0	0		
752	chr15	21999211	21999237	3500366078	25		21999211	21999237	8421504	2	21,4	0,22	c	350036607800000023	23-48						UNIVERSIDAD POLITACNICA DE VALENCIA DEPARTAMENTO DE CIENCIA ANIMAL CARACTERIZACIAN GENATICA Y	riunet.upv.es	0	0		
752	chr15	21999211	21999237	3500363336	25		21999211	21999237	8421504	2	21,4	0,22	c	350036333600000009	23-48						UNIVERSIDADE FEDERAL DA PARA&#xcd;BA UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO UNIVERSIDADE FEDERAL DO CEAR&#xc1; PROGRAMA DE DOUTORADO INTEGRADO EM ZOOTECNIA	www.cca.ufpb.br	0	0		NCAM1
752	chr15	21999211	21999237	3500344178	25		21999211	21999237	8421504	2	21,4	0,22	c	350034417800000001	23-48						AN&#xc1;LISIS GEN&#xc9;TICO DE MARCADORES MICROSAT&#xc9;LITES EN DOS POBLACIONES DE LA RAZA BOVINA BERRENDA EN NEGRO (GENETIC ANALYSIS OF MICROSATELLITES MARKERS IN TWO POPULATIONS OF BERRENDA EN NEGRO BOVINE BREED) - Zamorano, M.J. - Otros	es.youscribe.com	0	0		
752	chr15	21999211	21999237	3500335144	25		21999211	21999237	8421504	2	21,4	0,22	c	350033514400000014	23-48						ESTRUCTURA GEN&#xc9;TICA Y CUELLO DE BOTELLA DE LA POBLACI&#xd3;N BOVINA GUAYM&#xcd; MEDIANTE MICROSAT&#xc9;LITES GENETIC STRUCTURE AND BOTTLENECK OF THE GUAYMI BOVINE POPULATION BY MEANS OF MICROSATELLITES - ResearchGate	.researchgate.net	0	0		
752	chr15	21999211	21999237	3500231057	25		21999211	21999237	8421504	2	21,4	0,22	c	350023105700000012	23-48						S Chapter1 General introduction	upetd.up.ac.za	0	0		NCAM1
752	chr15	21999211	21999237	3500196447	25		21999211	21999237	8421504	2	21,4	0,22	c	350019644700000000	23-48						&#x65b0;&#x5efa;&#x7f51;&#x9875; 1	brary.sdau.edu.cn	0	0		
752	chr15	21999211	21999237	3500165767	25		21999211	21999237	8421504	2	21,4	0,22	c	350016576700000015	23-48						Standard Operating Procedure for microsatellite based bovine breed identification	www.bats.ch	0	0		
752	chr15	21999211	21999237	3500134916	25		21999211	21999237	8421504	2	21,4	0,22	c	350013491600000029	23-48						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
752	chr15	21999211	21999237	3500072770	25		21999211	21999237	8421504	2	21,4	0,22	c	350007277000000023	23-48						UNIVERSIDAD POLITACNICA DE VALENCIA DEPARTAMENTO DE CIENCIA ANIMAL CARACTERIZACIAN GENATICA Y	dspace.upv.es	0	0		
752	chr15	21999211	21999237	3500005476	25		21999211	21999237	8421504	2	21,4	0,22	c	350000547600000005	23-48				0798-2259	Revista Cient&#xed;fica	Revista Cient&#xed;fica - Importance of parentage verification-assignment in extensive multiple-sired breeding herds	Arellano-Vera	2010	0		
752	chr15	21999211	21999236	3500460141	24		21999211	21999236	8421504	2	21,3	0,22	c	350046014100000017	0-24						Author's personal copy	www.dsa.unipd.it	0	0		
752	chr15	21999211	21999236	3500336592	24		21999211	21999236	8421504	2	21,3	0,22	c	350033659200000029	0-24						DIVERSIDADE GEN&#xc9;TICA, ANCESTRALIDADE INDIVIDUAL E MISCIGENA&#xc7;&#xc3;O NAS RA&#xc7;AS BOVINAS NO BRASIL COM BASE EM MICROSSAT&#xc9;LITES E HAPL&#xd3;TIPOS DE DNA MITOCONDRIAL: SUBS&#xcd;DIOS PARA A CONSERVA&#xc7;&#xc3;O	epositorio.unb.br	0	0		
752	chr15	21999211	21999236	3500328955	24		21999211	21999236	8421504	2	21,3	0,22	c	350032895500000023	0-24						T&#xfc;rkiye&#x2019;de Bulunan Baz&#x0131; Yerli S&#x0131;&#x011f;&#x0131;r Irklar&#x0131;n&#x0131;n STR Mark&#xf6;rler ile Genetik Karakterizasyonu	www.nobel.gen.tr	0	0		
752	chr15	21999211	21999236	3500275448	24		21999211	21999236	8421504	2	21,3	0,22	c	350027544800000010	0-24						Population Genetic Analysis of Sonoran Pronghorn (Antilocapra americana sonoriensis)	www.jstor.org	0	0		
752	chr15	21999211	21999236	3500162517	24		21999211	21999236	8421504	2	21,3	0,22	c	350016251700000017	0-24						Molecular markers as guarantee of bovine meat traceability	ources.ciheam.org	0	0		
752	chr15	21999211	21999236	3500147852	24		21999211	21999236	8421504	2	21,3	0,22	c	350014785200000016	0-24						Molecular markers as guarantee of bovine meat traceability | Albina Sanz - Academia.edu	www.academia.edu	0	0		
752	chr15	21999211	21999236	3500104236	24		21999211	21999236	8421504	2	21,3	0,22	c	350010423600000010	0-24						POPULATION GENETIC ANALYSIS OF SONORAN PRONGHORN (ANTILOCAPRA AMERICANA SONORIENSIS)	www.deernut.com	0	0		
753	chr15	22139520	22149950	3500203940	720		22139520	22149950	8421504	6	60,87,191,137,110,135	0,1614,2605,3971,5113,10295	p	350020394000015056,350020394000015055	0-360,0-360						NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
753	chr15	22139550	22142128	3500174695	120		22139550	22142128	8421504	3	30,87,3	0,1584,2575	c	350017469500000014	0-120						Cloning of the cDNA and gene for a human D2 dopamine receptor. - ResearchGate	.researchgate.net	0	0		
753	chr15	22141184	22143542	3500339010	40		22141184	22143542	8421504	2	20,20	0,2338	c	350033901000000009,350033901000000008	0-20,0-20						Method of treating huntington's disease using HNT neurons	Freed	1998	0		DRD2
753	chr15	22142238	22142263	3500265095	25		22142238	22142263	8421504	1	25	0	c	350026509500000003	0-25						Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells	.if-pan.krakow.pl	0	0		
753	chr15	22142281	22143516	3500243459	60		22142281	22143516	8421504	2	35,25	0,1210	p	350024345900015099	0-60						G-protein coupled receptor related polypeptides	Baumgartner	2001	0		
756	chr15	22538100	22538124	3500224089	23		22538100	22538124	8421504	2	4,19	0,5	c	350022408900000017	21-44						NEW METHODS FOR TREATMENT OF INFLAMMATORY DISEASES - Patent application	www.faqs.org	0	0		
758	chr15	22693845	22694007	3500170116	60		22693845	22694007	8421504	2	43,17	0,145	p	350017011600015017	0-60						NPG.nature.vol.438.Issue.7065.Nov	www.scribd.com	0	0		HTR3A
758	chr15	22704569	22704596	3500036421	23		22704569	22704596	8421504	2	6,17	0,10	g	350003642100000266,350003642100000308	20-44,20-44						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
758	chr15	22777978	22778010	3500069711	32		22777978	22778010	8421504	1	32	0	c	350006971100000000	10-42		23469216	10.1371/journal.pone.0057674		PLoS ONE	Distinct Signal Transduction Pathways Downstream of the (P)RR Revealed by Microarray and ChIP-chip Analyses	Daniela	2013	0		
758	chr15	22777984	22778007	3500158897	23		22777984	22778007	8421504	1	23	0	c	350015889700000000	0-23						DEVELOPMENT AND FUNCTION OF THYMOCYTE-SELECTED CD4 T CELLS	lue.lib.umich.edu	0	0		
760	chr15	22971959	22971987	3500069711	28		22971959	22971987	8421504	1	28	0	c	350006971100000001	7-35		23469216	10.1371/journal.pone.0057674		PLoS ONE	Distinct Signal Transduction Pathways Downstream of the (P)RR Revealed by Microarray and ChIP-chip Analyses	Daniela	2013	0		
762	chr15	23278525	23284492	3500091444	93		23278525	23284492	8421504	2	48,45	0,5922	p	350009144400015095,350009144400015039,350009144400015061	0-45,0-45,0-45						PROTEINACEOUS COMPOUNDS - Patent application	www.faqs.org	0	0		NXPE1,NXPE4
763	chr15	23374110	23374139	3500445038	27		23374110	23374139	8421504	3	14,4,9	0,15,20	g	350044503800000004	0-27						ARRAY FOR DETECTING MICROBES - Patent application	www.faqs.org	0	0		
764	chr15	23500832	23500862	3500361066	25		23500832	23500862	8421504	3	5,15,5	0,8,25	g	350036106600000912	7-33						Caev-based Vector Systems 	.freshpatents.com	0	0		
766	chr15	23785640	23785667	3500344980	23		23785640	23785667	8421504	3	6,13,4	0,9,23	g	350034498000000091	21-45						 Polymorphic Markers Of Prostate Carcinoma Tumor Antigen 	www.docstoc.com	0	0		
766	chr15	23842405	23842431	3500093714	24		23842405	23842431	8421504	2	13,11	0,15	g	350009371400000013	1-25						O GENE DA MIOGENINA: SEQUENCIAMENTO EM SU&#xcd;NOS E AN&#xc1;LISE FILOGEN&#xc9;TICA	www.tede.ufv.br	0	0		
95	chr15	23931310	23987867	3500066613	181		23931310	23987867	8421504	6	81,19,1,31,17,32	0,2342,37528,37670,40876,56525	c	350006661300000028,350006661300000051,350006661300000017,350006661300000010	0-81,15-35,0-48,0-32						Antagonists and agonists of ldcam and methods of use	Galibert	2005	0		
767	chr15	23931345	23931376	3500257668	31		23931345	23931376	8421504	1	31	0	c	350025766800000013,350025766800000009,350025766800000005	0-23,0-30,16-38						Diagnosis and treatment of tumor-suppressor associated disorders	Reeves	2007	0		CADM1
767	chr15	23931345	23931376	3500231018	31		23931345	23931376	8421504	1	31	0	c,g	350023101800000013,350023101800000009,350023101800000005,350023101800000005	0-23,0-30,16-38,16-38						Diagnosis and treatment of tumor-suppressor associated disorders	Murakami	2003	0		CADM1
767	chr15	23931345	23931376	3500033113	31		23931345	23931376	8421504	1	31	0	c,g	350003311300000013,350003311300000009,350003311300000005,350003311300000005	0-23,0-30,16-38,16-38						Diagnosis and treatment of tumor-suppressor associated disorders	Murakami	2003	0		CADM1
767	chr15	23931345	23931376	3500007788	31		23931345	23931376	8421504	1	31	0	c,g	350000778800000013,350000778800000013,350000778800000033,350000778800000033,350000778800000029,350000778800000009,350000778800000005,350000778800000025	0-23,0-23,0-23,0-23,0-30,0-30,16-38,16-38					Patent	Diagnosis and treatment of tumor-suppressor associated disorders (Patent EP:1339871)	Reeves	2008	0		CADM1
767	chr15	23931390	23931436	3500276138	46		23931390	23931436	8421504	1	46	0	p,c,g	350027613800000000,350027613800000000,350027613800015001	10-32,10-32,0-45						Expression and Functional Characterization of the Adhesion Molecule Spermatogenic Immunoglobulin Superfamily in the Mouse Testis	ww.biolreprod.org	0	0		CADM1
767	chr15	23931391	23931445	3500455674	54		23931391	23931445	8421504	1	54	0	p	350045567400015001	0-54		12234973		0008-5472	Cancer Research	Direct Association of TSLC1 and DAL-1, Two Distinct Tumor Suppressor Proteins in Lung Cancer	Yageta	2002	8		CADM1
767	chr15	23931391	23931445	3500085169	54		23931391	23931445	8421504	1	54	0	p	350008516900015001	0-54		12234973		0008-5472	Cancer Research	Direct Association of TSLC1 and DAL-1, Two Distinct Tumor Suppressor Proteins in Lung Cancer	Yageta	2002	8		CADM1
767	chr15	23955444	23955468	3500253796	23		23955444	23955468	8421504	2	17,6	0,18	g	350025379600000195	5-33					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
768	chr15	23987846	23987870	3500116822	24		23987846	23987870	8421504	1	24	0	c	350011682200000141,350011682200000041	0-24,0-24						Secreted And Transmembrane Polypeptides And Nucleic Acids Encoding The Same 	.freshpatents.com	0	0		
768	chr15	23987846	23987870	3500104360	24		23987846	23987870	8421504	1	24	0	c	350010436000000042	0-24						Polypeptides and nucleic acids encoding the same	Baker	2001	0		
768	chr15	23987846	23987870	3500034092	24		23987846	23987870	8421504	1	24	0	c,g	350003409200000141,350003409200000141,350003409200000041,350003409200000041	0-24,0-24,0-24,0-24						US Patent # 6,734,288. Antibodies against a secreted polypeptide that stimulates release of proteoglycans from cartilage - Patents.com	www.patents.com	0	0		
768	chr15	23987895	23995557	3500257668	29		23987895	23995557	8421504	2	16,13	0,7649	c	350025766800000008	1-30						Diagnosis and treatment of tumor-suppressor associated disorders	Reeves	2007	0		
768	chr15	23987895	23995557	3500033113	29		23987895	23995557	8421504	2	16,13	0,7649	c	350003311300000008	1-30						Diagnosis and treatment of tumor-suppressor associated disorders	Murakami	2003	0		
768	chr15	23987895	23995557	3500007788	29		23987895	23995557	8421504	2	16,13	0,7649	c	350000778800000028,350000778800000008	1-30,1-30					Patent	Diagnosis and treatment of tumor-suppressor associated disorders (Patent EP:1339871)	Reeves	2008	0		
768	chr15	23997292	23997317	3500370985	25		23997292	23997317	8421504	1	25	0	c	350037098500000294,350037098500000065	0-25,0-25						Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same - Patent application	www.faqs.org	0	0		CADM1
768	chr15	23997292	23997317	3500003368	25		23997292	23997317	8421504	1	25	0	c	350000336800000061	0-25						Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same	Sugioka	2009	0		CADM1
11	chr15	23997419	24281870	3500066613	78		23997419	24281870	8421504	2	8,70	0,284381	p	350006661300015032,350006661300015024	0-78,0-48						Antagonists and agonists of ldcam and methods of use	Galibert	2005	0		CADM1
768	chr15	24015535	24015565	3500193541	24		24015535	24015565	8421504	3	11,7,6	0,13,24	g	350019354100000005	6-31		14715571	10.1128/CDLI.11.1.216-218.2004	1556-6811	Clinical and Diagnostic Laboratory Immunology	Bacterial Expression of a Human Monoclonal Antibody-Alkaline Phosphatase Conjugate Specific for Entamoeba histolytica	Tachibana	2004	3		
770	chr15	24281890	24281938	3500049340	48		24281890	24281938	8421504	1	48	0	c	350004934000000000	0-48		16612000	10.1128/MCB.26.9.3610-3624.2006	0270-7306	Molecular and Cellular Biology	Disruption of Spermatogenic Cell Adhesion and Male Infertility in Mice Lacking TSLC1/IGSF4, an Immunoglobulin Superfamily Cell Adhesion Molecule	Yamada	2006	6		CADM1
770	chr15	24281921	24281954	3500157218	33		24281921	24281954	8421504	1	33	0	c	350015721800000008,350015721800000000	10-36,0-23		15184876	10.1038/sj.onc.1207761	0950-9232	Oncogene	Cloning of a soluble isoform of the SgIGSF adhesion molecule that binds the extracellular domain of the membrane-bound isoform	Koma	2004	6		
771	chr15	24414758	24414783	3500053431	23		24414758	24414783	8421504	2	8,15	0,10	g	350005343100000051	2-25					Patent	Binding agents which inhibit myostatin (Patent US:7928075)	Han	2011	0		
775	chr15	24981071	24981098	3500101538	23		24981071	24981098	8421504	3	5,5,13	0,8,14	g	350010153800000310	1-24						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
781	chr15	25752453	25752479	3500466707	24		25752453	25752479	8421504	2	8,16	0,10	c	350046670700000023,350046670700000082	18-42,18-42						US Patent # 6,887,705. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPs) - Patents.com	www.patents.com	0	0		
781	chr15	25752453	25752479	3500450152	24		25752453	25752479	8421504	2	8,16	0,10	c	350045015200000023	18-42						US Patent # 6,040,437. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPS) - Patents.com	www.patents.com	0	0		
781	chr15	25759470	25759936	3500311219	108		25759470	25759936	8421504	3	28,36,44	0,377,422	c	350031121900000375,350031121900000367,350031121900000366	0-28,5-41,0-44						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
781	chr15	25804363	25804387	3500008791	24		25804363	25804387	8421504	1	24	0	c	350000879100000020	18-42						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		APOC3
781	chr15	25807314	25807415	3500261436	40		25807314	25807415	8421504	2	20,20	0,81	g	350026143600000018,350026143600000017	0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
781	chr15	25819698	25819722	3500131305	24		25819698	25819722	8421504	1	24	0	c	350013130500000011	0-24		11473048	10.2337/diabetes.50.8.1851	0012-1797	Diabetes	Glucose Regulates the Transcription of Human Genes Relevant to HDL Metabolism	Tu	2001	8		
781	chr15	25820009	25820033	3500218839	24		25820009	25820033	8421504	1	24	0	c	350021883900000013	0-24					Patent	Membrane scaffold proteins (Patent US:7048949)	Sligar	2006	0		
781	chr15	25820009	25820033	3500189122	24		25820009	25820033	8421504	1	24	0	c	350018912200000013	0-24						 Membrane Scaffold Proteins 	www.docstoc.com	0	0		
781	chr15	25820009	25820033	3500185618	24		25820009	25820033	8421504	1	24	0	c	350018561800000013	0-24					Patent	Membrane scaffold proteins (Patent US:7592008)	Sligar	2009	0		
781	chr15	25820009	25820033	3500138181	24		25820009	25820033	8421504	1	24	0	c	350013818100000013	0-24						Membrane Scaffold Proteins 	.freshpatents.com	0	0		
781	chr15	25820009	25820033	3500102559	24		25820009	25820033	8421504	1	24	0	c	350010255900000014	0-24						Membrane scaffold proteins	Sligar	2003	0		
781	chr15	25820009	25820033	3500051709	24		25820009	25820033	8421504	1	24	0	c	350005170900000013	0-24						 Membrane Scaffold Proteins 	www.docstoc.com	0	0		
781	chr15	25820039	25820080	3500418946	36		25820039	25820080	8421504	2	19,17	0,24	c	350041894600000002	0-38		14718538	10.1074/jbc.M311718200	0021-9258	Journal of Biological Chemistry	Scavenger Receptor Class B Type I-mediated Cholesteryl Ester-selective Uptake and Efflux of Unesterified Cholesterol	Thuahnai	2004	5		
781	chr15	25820960	25820994	3500264901	34		25820960	25820994	8421504	1	34	0	c	350026490100000040	0-34						Lipoprotein assays using antibodies to a pan native epitope and recombinant antigens	Curtiss	1993	0		
97	chr15	25821168	25821197	3500360664	29		25821168	25821197	8421504	1	29	0	g	350036066400000001	0-30						&#x4e3b;&#x9898;&#xff1a;A-I | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
97	chr15	25821168	25821197	3500111360	29		25821168	25821197	8421504	1	29	0	g	350011136000000017	0-30						DEPARTAMENT DE MEDICINA PREVENTIVA I SALUT P&#xda;BLICA MODULACI&#xd3;N GEN&#xc9;TICA Y AMBIENTAL DE PAR&#xc1;METROS BIOQU&#xcd;MICOS Y CL&#xcd;NICOS EN POBLACI&#xd3;N MEDITERR&#xc1;NEA DE ALTO RIESGO PAULA CARRASCO ESP&#xcd;	www.tdx.cat	0	0		
97	chr15	25821168	25821197	3500067713	29		25821168	25821197	8421504	1	29	0	g	350006771300000003	0-30						Fachbereich Ern&#xe4;hrungs- und Haushaltswissenschaften der Justus-Liebig Universit&#xe4;t Giessen	eb.uni-giessen.de	0	0		
783	chr15	25976923	25976946	3500097202	23		25976923	25976946	8421504	1	23	0	g	350009720200000103	1-24					Patent	Sequences for detection and identification of methicillin-resistant staphyloccocus aureus (Patent EP:1397510)	Huletsky	2009	0		
783	chr15	26049575	26049600	3500430989	23		26049575	26049600	8421504	2	16,7	0,18	g	350043098900000233	25-48						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
784	chr15	26172012	26175947	3500349510	42		26172012	26175947	8421504	3	22,1,19	0,60,3916	c	350034951000000024,350034951000000025	0-22,0-20		22458960	10.1111/j.1439-0531.2012.02019.x	1439-0531	Reproduction in Domestic Animals	Vascular Endothelial (VEGF) and Epithelial Growth Factor (EGF) as Well as Platelet-Activating Factor (PAF) and Receptors are Expressed in the Early Pregnant Canine Uterus - Sch&#xe4;fer-Somi - 2012 - Reproduction in Domestic Animals - Wiley Online Library	Schafer-Somi	2013	0		
784	chr15	26208657	26208701	3500038888	44		26208657	26208701	8421504	1	44	0	g	350003888800000032	0-44					Patent	Promoter smooth muscle cell expression (Patent US:6331527)	Parmacek	2001	0		
784	chr15	26208657	26208701	3500034359	44		26208657	26208701	8421504	1	44	0	g	350003435900000032	0-44					Patent	Promoter for smooth muscle cell expression (Patent US:6291211)	Parmacek	2001	0		
784	chr15	26212320	26212398	3500350043	42		26212320	26212398	8421504	2	20,22	0,56	c	350035004300000004,350035004300000005	0-20,0-22		20858250	10.1186/1465-9921-11-127	1465-9921	Respiratory Research	Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype	Bentley	2010	0		TAGLN
784	chr15	26212320	26212398	3500010657	42		26212320	26212398	8421504	2	20,22	0,56	c,g	350001065700000004,350001065700000005,350001065700000005	0-20,0-22,0-22		20858250	10.1186/1465-9921-11-127		Respiratory Research	Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype	J	2010	0		TAGLN
784	chr15	26212330	26213583	3500348506	39		26212330	26213583	8421504	2	20,19	0,1234	c,g	350034850600000012,350034850600000013,350034850600000013	0-20,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
784	chr15	26212656	26212718	3500022437	39		26212656	26212718	8421504	2	19,20	0,42	c,g	350002243700000004,350002243700000004,350002243700000005	0-19,0-19,0-20						ONLINE MATERIALS AND METHODS	b.ahajournals.org	0	0		
784	chr15	26212684	26213520	3500062465	40		26212684	26213520	8421504	3	20,10,10	0,473,826	c,g	350006246500000013,350006246500000013,350006246500000036,350006246500000036,350006246500000014,350006246500000037	0-20,0-20,0-20,0-20,0-20,0-20						METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE VASCULAR DISORDERS - Patent application	www.faqs.org	0	0		TAGLN
784	chr15	26212747	26212771	3500402403	24		26212747	26212771	8421504	1	24	0	c	350040240300000094	1-25						Gene Expression Markers for Response to EGFR Inhibitor Drugs	Agus	2008	0		
784	chr15	26212766	26213530	3500413850	42		26212766	26213530	8421504	2	22,20	0,744	c	350041385000000000,350041385000000001	0-22,0-20						Role of calcium-phosphate deposition in vascular smooth muscle cell calci&#xfb01;cation	ll.physiology.org	0	0		
784	chr15	26212766	26213530	3500382466	42		26212766	26213530	8421504	2	22,20	0,744	c	350038246600000000,350038246600000001	0-22,0-20		20881235	10.1152/ajpcell.00229.2010		American Journal of Physiology - Cell Physiolog	Role of calcium-phosphate deposition in vascular smooth muscle cell calcification	Villa-Bellosta	2011	0		
784	chr15	26212766	26213530	3500120149	42		26212766	26213530	8421504	2	22,20	0,744	c	350012014900000000,350012014900000001	0-22,0-20		20881235	10.1152/ajpcell.00229.2010		American Journal of Physiology - Cell Physiolog	Role of calcium-phosphate deposition in vascular smooth muscle cell calcification	Villa-Bellosta	2011	0		
785	chr15	26226490	26226519	3500129658	25		26226490	26226519	8421504	3	5,13,7	0,8,22	g	350012965800000100	4-37						Animal model for fibroblast growth factor receptor associated chondrodysplasia	Yayon	1999	0		
785	chr15	26291217	26312376	3500134456	1701		26291217	26312376	8421504	14	24,27,33,21,87,245,172,150,102,135,138,217,89,261	0,122,181,220,335,465,1343,1777,2251,3280,4113,4715,6248,20898	p	350013445600015002,350013445600015001	0-1803,0-1503					Patent	Asp2 (Patent US:6319689)	Powell	2001	0		
785	chr15	26291682	26291717	3500274618	35		26291682	26291717	8421504	1	35	0	c	350027461800000011	3-38						Inhibitors of memapsin 2 and use thereof	Tang	2008	0		
785	chr15	26291682	26291717	3500259822	35		26291682	26291717	8421504	1	35	0	c	350025982200000001	3-38						Inhibitors of Memapsin 2 and use thereof	Ghosh	2004	0		
785	chr15	26291685	26291711	3500427424	26		26291685	26291711	8421504	1	26	0	c	350042742400000001	7-33		11152683	10.1074/jbc.M008861200	0021-9258	Journal of Biological Chemistry	A Splice Variant of &#x03b2;-Secretase Deficient in the Amyloidogenic Processing of the Amyloid Precursor Protein	Bodendorf	2001	5		
785	chr15	26291688	26312376	3500266236	1503		26291688	26312376	8421504	9	239,172,150,102,135,138,217,89,261	0,872,1306,1780,2809,3642,4244,5777,20427	p	350026623600015000	0-1503					Patent	Mouse aspartic secretase-2(mASP-2) (Patent US:6361975)	Christie	2002	0		BACE1,CEP164
785	chr15	26291688	26296148	3500365533	1152		26291688	26296148	8421504	7	239,172,150,102,135,138,216	0,872,1306,1780,2809,3642,4244	p	350036553300015003,350036553300015004,350036553300015005	51-1203,0-804,0-780						Serine carboxypeptidase hx (SCPhx) and compositions thereof	Bejanin	2001	0		BACE1
785	chr15	26291688	26296148	3500362636	1152		26291688	26296148	8421504	7	239,172,150,102,135,138,216	0,872,1306,1780,2809,3642,4244	p	350036263600015003,350036263600015004,350036263600015005	51-1200,0-804,0-780						Isolated human vCOL16A1 polypeptide and fragments thereof	Bejanin	2001	0		BACE1
785	chr15	26291688	26296148	3500222007	1152		26291688	26296148	8421504	7	239,172,150,102,135,138,216	0,872,1306,1780,2809,3642,4244	p	350022200700015002,350022200700015003,350022200700015005,350022200700015004	51-1203,0-804,0-780,0-177						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		BACE1
785	chr15	26291688	26296148	3500203017	1152		26291688	26296148	8421504	7	239,172,150,102,135,138,216	0,872,1306,1780,2809,3642,4244	p	350020301700015002,350020301700015003,350020301700015004	51-1203,0-804,0-780						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		BACE1
785	chr15	26291688	26296148	3500185026	1152		26291688	26296148	8421504	7	239,172,150,102,135,138,216	0,872,1306,1780,2809,3642,4244	p	350018502600015003,350018502600015004,350018502600015005	51-1203,0-804,0-780						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		BACE1
785	chr15	26291688	26296148	3500122082	1152		26291688	26296148	8421504	7	239,172,150,102,135,138,216	0,872,1306,1780,2809,3642,4244	p	350012208200015003,350012208200015004,350012208200015006,350012208200015005	51-1203,0-804,0-330,0-150						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		
785	chr15	26291688	26296016	3500227271	1014		26291688	26296016	8421504	7	239,172,150,102,129,138,84	0,872,1306,1780,2809,3642,4244	p	350022727100015006,350022727100015007,350022727100015009,350022727100015008	0-597,0-798,0-402,0-186						Human cdnas and proteins and uses thereof	Bejanin	2002	0		
785	chr15	26291688	26291850	3500085628	162		26291688	26291850	8421504	1	162	0	p	350008562800015001	0-162		20100910	10.1083/jcb.200910042	0021-9525	The Journal of Cell Biology	Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates	Bernasconi	2010	10		BACE1
785	chr15	26291832	26312223	3500403756	1206		26291832	26312223	8421504	9	95,172,150,102,135,138,217,89,108	0,728,1162,1636,2665,3498,4100,5633,20283	p	350040375600015015,350040375600015099,350040375600015063,350040375600015086,350040375600015174,350040375600015025,350040375600015152,350040375600015062,350040375600015173,350040375600015151	3-1209,15-147,9-102,0-147,0-117,3-279,0-132,0-147,0-195,0-135						Modified BACE - US Patent 7273743 Description	ww.patentstorm.us	0	0		
785	chr15	26291832	26312223	3500374721	1206		26291832	26312223	8421504	9	95,172,150,102,135,138,217,89,108	0,728,1162,1636,2665,3498,4100,5633,20283	p	350037472100015014	3-1209						Modified BACE	Chou	2003	0		
785	chr15	26293020	26293044	3500250218	24		26293020	26293044	8421504	1	24	0	c	350025021800000003	0-24		15466887	10.1242/jcs.01422	0021-9533	Journal of Cell Science	Demonstration of BACE (&#x03b2;-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy	Arnim	2004	6		BACE1
785	chr15	26293031	26312135	3500174358	238		26293031	26312135	8421504	6	95,48,34,14,27,20	0,1490,3084,4434,4496,19084	c	350017435800000025,350017435800000024,350017435800000020,350017435800000011,350017435800000009	0-47,0-48,0-48,0-48,1-48						Sirna Based Methods For Treating Alzheimer's Disease 	.freshpatents.com	0	0		
785	chr15	26293126	26293525	3500066112	75		26293126	26293525	8421504	2	18,57	0,342	p	350006611200015012	0-75						Modified bace	Chou	2003	0		
785	chr15	26293135	26294533	3500298665	108		26293135	26294533	8421504	4	9,45,18,36	0,333,417,1362	p,c	350029866500015008,350029866500000037,350029866500000012,350029866500000033,350029866500000034,350029866500000008,350029866500000009	0-54,0-45,0-45,0-39,0-39,0-39,0-39						IDENTIFICATION OF NOVEL POST-TRANSLATIONAL PROTEIN MODIFICATIONS - Patent application	www.faqs.org	0	0		
785	chr15	26294516	26294541	3500272964	25		26294516	26294541	8421504	1	25	0	c	350027296400000002,350027296400000003	0-25,0-25						&#x03b2;-Galactoside 2,6-Sialyltransferase I Cleavage by BACE1 Enhances the Sialylation of Soluble Glycoproteins--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&	journal.9med.net	0	0		BACE1
785	chr15	26294606	26294630	3500420499	24		26294606	26294630	8421504	1	24	0	c	350042049900000004	0-24						The potential role of amyloid ? in the pathogenesis of age-related macular degeneration 2005&#x5e74;&#x7b2c;115&#x5377;&#x7b2c;10&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		BACE1
785	chr15	26294606	26294630	3500350364	24		26294606	26294630	8421504	1	24	0	c	350035036400000000	0-24		20412384	10.1111/j.1471-4159.2010.06751.x	1471-4159	Journal of Neurochemistry	2,2&#x2032;,4&#x2032;-Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice - Zhu - 2010 - Journal of Neurochemistry - Wiley Online Library	Zhu	2010	0		BACE1
785	chr15	26296115	26312223	3500288883	87		26296115	26312223	8421504	3	34,14,39	0,1350,16069	c	350028888300000022,350028888300000018	0-48,9-48						Method of Screening Transmembrane Enzyme Inhibitory Substance - Patent application	www.faqs.org	0	0		
786	chr15	26372652	26372676	3500448679	23		26372652	26372676	8421504	2	17,6	0,18	g	350044867900000009	22-45						Serotonin receptor	Lobley	2003	0		
790	chr15	26888206	26893637	3500228456	39		26888206	26893637	8421504	3	20,6,13	0,5410,5418	g	350022845600000289,350022845600000382,350022845600000383	14-36,3-22,5-24						Interleukin-3 (il-3) mutant polypeptides	Abrams	1995	0		
790	chr15	26898435	26898461	3500308897	23		26898435	26898461	8421504	3	5,5,13	0,6,13	g	350030889700000150	10-34						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
790	chr15	26922770	26922796	3500163916	23		26922770	26922796	8421504	2	11,12	0,14	g	350016391600000001	0-23						Molecular aspects of transferrin expression in the tsetse &#xfb02;y Glossina morsitans morsitans	medicine.yale.edu	0	0		
790	chr15	26924865	26990495	3500258129	2300		26924865	26990495	8421504	9	184,297,115,191,170,22,148,122,1051	0,53767,56457,57173,58472,59480,59513,61676,64579	c,g	350025812900000089,350025812900000101,350025812900000004,350025812900000010,350025812900000010,350025812900000107,350025812900000107,350025812900000108,350025812900000108,350025812900000011,350025812900000011	0-2278,0-22,0-22,0-19,0-19,0-19,0-19,0-20,0-20,0-20,0-20						Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases - Patent application	www.faqs.org	0	0		
790	chr15	26924865	26990495	3500258129	2278		26924865	26990495	8421504	8	184,297,115,191,170,148,122,1051	0,53767,56457,57173,58472,59513,61676,64579	g	350025812900000088	0-2278						Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases - Patent application	www.faqs.org	0	0		
790	chr15	26982142	26982174	3500433864	32		26982142	26982174	8421504	1	32	0	c	350043386400000046	16-48						Antibodies which specifically bind mammalian receptors for interleukin-10 (IL-10)	Moore	1995	0		
790	chr15	26984345	26990179	3500234830	61		26984345	26990179	8421504	3	22,19,20	0,5390,5814	c,g	350023483000000004,350023483000000010,350023483000000010,350023483000000015,350023483000000015,350023483000000011,350023483000000013	0-22,0-19,0-19,0-20,0-20,0-20,0-20						Mycobacterium avium ssp. paratuberculosis infection status	biomedcentral.com	0	0		
790	chr15	26984345	26990179	3500027293	61		26984345	26990179	8421504	3	22,19,20	0,5390,5814	c,g	350002729300000004,350002729300000010,350002729300000010,350002729300000015,350002729300000015,350002729300000013,350002729300000013,350002729300000011,350002729300000011	0-22,0-19,0-19,0-20,0-20,0-20,0-20,0-20,0-20						 SpringerImages - Characteristics of SNPs discovered in IL10, IL10RA/B, TGFB1, and SLC11A1. 	pringerimages.com	0	0		
791	chr15	27112419	27112446	3500223796	24		27112419	27112446	8421504	2	7,17	0,10	g	350022379600000002	0-24						Direct Regulation of CLOCK Expression by REV-ERB | Christine Crumbley - Academia.edu	www.academia.edu	0	0		
792	chr15	27177667	27177769	3500284019	102		27177667	27177769	8421504	1	102	0	p	350028401900015000	0-102		16306410	10.1523/JNEUROSCI.3066-05.2005	0270-6474	The Journal of Neuroscience	Upregulation of the Voltage-Gated Sodium Channel &#x03b2;2 Subunit in Neuropathic Pain Models: Characterization of Expression in Injured and Non-Injured Primary Sensory Neurons	Pertin	2005	7		SCN2B
792	chr15	27177708	27177731	3500194368	23		27177708	27177731	8421504	1	23	0	c	350019436800000192	20-43						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
792	chr15	27189237	27189260	3500148306	23		27189237	27189260	8421504	1	23	0	c	350014830600000016	0-25						Method for identifying modulators of ion channels	Dubin	2002	0		
792	chr15	27234962	27234994	3500130848	27		27234962	27234994	8421504	3	5,9,13	0,6,19	c	350013084800000410	18-45						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
792	chr15	27234962	27234994	3500008756	27		27234962	27234994	8421504	3	5,9,13	0,6,19	c	350000875600000410	18-45						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
792	chr15	27261336	27261363	3500148414	24		27261336	27261363	8421504	2	10,14	0,13	c	350014841400000015	20-44						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
793	chr15	27267171	27267195	3500374932	24		27267171	27267195	8421504	1	24	0	c	350037493200000095	0-24						Compositions and methods for the treatment of immune related diseases	Ashkenazi	2000	0		MPZL2
793	chr15	27270371	27270419	3500440489	48		27270371	27270419	8421504	1	48	0	c	350044048900000005	0-48						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
793	chr15	27323775	27333498	3500191771	41		27323775	27333498	8421504	3	19,3,19	0,8961,9704	c	350019177100000007,350019177100000008	0-19,0-22		10775584	10.1128/JVI.74.10.4483-4494.2000	0022-538X	Journal of Virology	Posttranscriptional Inhibition of Class I Major Histocompatibility Complex Presentation on Hepatocytes and Lymphoid Cells in Chronic Woodchuck Hepatitis Virus Infection	Michalak	2000	5		
793	chr15	27323775	27333498	3500008650	41		27323775	27333498	8421504	3	19,3,19	0,8961,9704	c	350000865000000010,350000865000000011	0-19,0-22		17079319	10.1128/JVI.01537-06	0022-538X	Journal of Virology	Bicistronic Woodchuck Hepatitis Virus Core and Gamma Interferon DNA Vaccine Can Protect from Hepatitis but Does Not Elicit Sterilizing Antiviral Immunity	Wang	2007	5		
793	chr15	27332718	27333913	3500375699	455		27332718	27333913	8421504	2	21,434	0,761	c	350037569900000019	0-458						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
793	chr15	27338850	27338878	3500245625	28		27338850	27338878	8421504	1	28	0	c	350024562500000004	0-40						SHORT COMMUNICATION Genetic mapping of bovine T-cell receptor complex loci	enomics.liv.ac.uk	0	0		
793	chr15	27349671	27351961	3500272654	41		27349671	27351961	8421504	3	20,18,3	0,1157,2287	c	350027265400000006,350027265400000007	0-20,0-21		20435159	10.1016/j.bbalip.2010.04.012		Biochimica et biophysica acta	&#x03b2;3-adrenergic receptor induction of adipocyte inflammation requires lipolytic activation of stress kinases p38 and JNK	Emilio	2010	0		CD3G
793	chr15	27349693	27350815	3500009573	27		27349693	27350815	8421504	2	14,13	0,1109	c	350000957300000010	0-27						&#x4e3b;&#x9898;&#xff1a;IFN- | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		CD3G
794	chr15	27506597	27506621	3500069955	24		27506597	27506621	8421504	1	24	0	g	350006995500000017	0-24						ZEBRAFISH MODEL OF MLL LEUKEMOGENESIS - Patent application	www.faqs.org	0	0		TTC36
795	chr15	27599737	27602340	3500186075	84		27599737	27602340	8421504	3	6,21,57	0,2522,2546	p	350018607500015004	33-117						Cloning of LL5, a novel protein encoding cDNA from a rat pituitary library. - ResearchGate	.researchgate.net	0	0		
796	chr15	27685132	27707394	3500168497	42		27685132	27707394	8421504	3	11,9,22	0,410,22240	c	350016849700000011,350016849700000000	12-32,15-37		21791617	10.1128/MCB.01368-10	0270-7306	Molecular and Cellular Biology	DDX60, a DEXD/H Box Helicase, Is a Novel Antiviral Factor Promoting RIG-I-Like Receptor-Mediated Signaling	Miyashita	2011	6		DDX6
796	chr15	27692937	27695319	3500341558	48		27692937	27695319	8421504	2	24,24	0,2358	c	350034155800000001,350034155800000000	0-24,0-24			10.1002/dvdy.20429	1097-0177	Developmental Dynamics	Expression of rck/p54, a DEAD-box RNA helicase, in gametogenesis and early embryogenesis of mice - Matsumoto - 2005 - Developmental Dynamics - Wiley Online Library	Matsumoto	2005	0		DDX6
797	chr15	27821980	27822052	3500100085	72		27821980	27822052	8421504	1	72	0	p	350010008500015027,350010008500015036	0-72,0-66						Targeting the BCL9/B9L Binding Interaction with &#x03b2;-catenin as a Potential Anticancer Strategy by Steven Akira Kawamoto	lue.lib.umich.edu	0	0		BCL9L
797	chr15	27822899	27822925	3500267062	25		27822899	27822925	8421504	2	13,12	0,14	c	350026706200000014,350026706200000015	4-29,11-36		12665574	10.1128/MCB.23.8.2720-2732.2003	0270-7306	Molecular and Cellular Biology	A Nucleoprotein Complex Containing Sp1, C/EBP&#x03b2;, and HMGI-Y Controls Human Insulin Receptor Gene Transcription	Foti	2003	6		
798	chr15	27928112	27929331	3500000328	40		27928112	27929331	8421504	3	20,17,3	0,958,1216	c	350000032800000004,350000032800000005	0-20,0-20					The American Journal of Pathology	Uroplakin Gene Expression by Normal and Neoplastic Human Urothelium	E.	1998	0		
798	chr15	27969807	27970337	3500164379	174		27969807	27970337	8421504	2	68,106	0,424	p	350016437900015009	174-348						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPS25
798	chr15	27970361	27970415	3500410834	54		27970361	27970415	8421504	1	54	0	p	350041083400015004	0-54		18697920	10.1261/rna.1132008	1355-8382	RNA	The role of human ribosomal proteins in the maturation of rRNA and ribosome production	Robledo	2008	5		RPS25
798	chr15	27970361	27970415	3500182164	54		27970361	27970415	8421504	1	54	0	p	350018216400015004	0-54		18697920	10.1261/rna.1132008	1355-8382	RNA	The role of human ribosomal proteins in the maturation of rRNA and ribosome production	Robledo	2008	5		RPS25
798	chr15	27970361	27970415	3500103090	54		27970361	27970415	8421504	1	54	0	p	350010309000015005	0-54						The role of human ribosomal proteins in the maturation of rRNA and ribosome production	journal.cshlp.org	0	0		RPS25
798	chr15	27976612	27979048	3500320392	66		27976612	27979048	8421504	4	14,5,27,20	0,623,2263,2416	c	350032039200000265,350032039200000103,350032039200000024,350032039200000239	1-20,0-27,0-27,0-20						MODULATION OF GLUCOSE-6-PHOSPHATASE TRANSLOCASE EXPRESSION - Patent application	www.faqs.org	0	0		
798	chr15	27980445	27980471	3500400238	23		27980445	27980471	8421504	2	15,8	0,18	c	350040023800000555	16-45						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
798	chr15	28019560	28019585	3500244830	24		28019560	28019585	8421504	2	5,19	0,6	c	350024483000000410	3-27						METHODS FOR LOWERING SERUM CHOLESTROL IN A SUBJECT USING INHIBITION OF PCSK9 - ALNYLAM PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
798	chr15	28023844	28023871	3500202471	23		28023844	28023871	8421504	2	15,8	0,19	c	350020247100000128	0-23						US Patent # 6,737,519. Human genes relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
799	chr15	28050917	28050940	3500229615	23		28050917	28050940	8421504	1	23	0	c	350022961500000005	0-23		23483889	10.1371/journal.pone.0056715		PLoS ONE	Protein Arginine Methyltransferase 1 Interacts with and Activates p38&#x03b1; to Facilitate Erythroid Differentiation	Wei-Kai	2013	0		HMBS
799	chr15	28050963	28051501	3500201650	51		28050963	28051501	8421504	4	15,10,6,20	0,379,423,518	c	350020165000000000,350020165000000001	0-25,0-26			10.1002/hep.21971	1527-3350	Hepatology	Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia - Olivier - 2007 - Hepatology - Wiley Online Library	Olivier	2008	0		HMBS
799	chr15	28051351	28051934	3500237152	43		28051351	28051934	8421504	3	22,6,15	0,180,568	c	350023715200000002,350023715200000001	0-22,0-21		10559366		0022-538X	Journal of Virology	High Viral Load in the Cerebrospinal Fluid and Brain Correlates with Severity of Simian Immunodeficiency Virus Encephalitis	Zink	1999	5		HMBS
799	chr15	28053653	28054621	3500342467	231		28053653	28054621	8421504	8	27,21,12,12,102,36,9,12	0,270,297,433,451,769,814,956	p	350034246700015032	0-231						Structure and Expression of Chloroplast-Localized Porphobilinogen Deaminase from Pea (Pisum sativum 1.) lsolated by Redundant Polymerase Chain Reaction'	.plantphysiol.org	0	0		
799	chr15	28054461	28054623	3500062721	29		28054461	28054623	8421504	2	15,14	0,148	c	350006272100000004	0-29						Composition and method for determination of ck19 expression - Patent application	www.faqs.org	0	0		
799	chr15	28056354	28056687	3500400270	180		28056354	28056687	8421504	4	45,45,45,45	0,48,240,288	p	350040027000015042,350040027000015041,350040027000015037,350040027000015036	0-45,0-45,0-45,0-45						Method of Detecting Precancerous Lesions - Patent application	www.faqs.org	0	0		
799	chr15	28056384	28056453	3500281203	69		28056384	28056453	8421504	1	69	0	p	350028120300015010	0-69		17709392	10.1128/MCB.00579-07	0270-7306	Molecular and Cellular Biology	DNA Damage-Dependent Acetylation and Ubiquitination of H2AX Enhances Chromatin Dynamics	Ikura	2007	6		HIST3H2BB
799	chr15	28056542	28056565	3500436896	23		28056542	28056565	8421504	1	23	0	c	350043689600000030	0-23						Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer - Patent application	www.faqs.org	0	0		
799	chr15	28056542	28056565	3500388701	23		28056542	28056565	8421504	1	23	0	c	350038870100000009,350038870100000028	0-23,0-23						GENETIC CHANGES IN ATM AND ATR/CHEK1 AS PROGNOSTIC INDICATORS IN CANCER - Patent application	www.faqs.org	0	0		
799	chr15	28056630	28056684	3500279235	54		28056630	28056684	8421504	1	54	0	p	350027923500015023	0-54						SureChem - Document - WO/PCT - Patent No. 2008020596 - "TREATING OR PREVENTING CANCERS OVER-EXPRESSING REG4 OR KIAA0101" - Description	www.surechem.org	0	0		HIST3H2BB
799	chr15	28070862	28070889	3500210755	23		28070862	28070889	8421504	3	5,11,7	0,6,20	c	350021075500000007	17-40						Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1	Cregg	1999	0		
799	chr15	28086866	28086893	3500148989	25		28086866	28086893	8421504	3	6,14,5	0,7,22	g	350014898900000000	13-38						BMC Genomics BioMed Central	biomedcentral.com	0	0		
799	chr15	28159396	28159421	3500350236	25		28159396	28159421	8421504	1	25	0	c	350035023600000002	0-25		23227865	10.1186/1476-511X-11-169	1476-511X	Lipids in Health and Disease	Mitochondrial function is involved in regulation of cholesterol efflux to apolipoprotein (apo)A-I from murine RAW 264.7 macrophages	Allen	2012	2		ABCG4
800	chr15	28286329	28286459	3500013267	41		28286329	28286459	8421504	2	35,6	0,124	c	350001326700000074	0-41						Diagnostic for metastatic prostate cancer	Wu	2000	0		
801	chr15	28334925	28335655	3500131676	387		28334925	28335655	8421504	2	173,214	0,516	p	350013167600015028	0-387						Treatment of metabolic disorders with a tnf receptor family member (fradj and/or cryptic) agonists or antagonists	Dialynas	2003	0		MFRP
801	chr15	28395786	28395982	3500153648	40		28395786	28395982	8421504	2	20,20	0,176	c,g	350015364800000017,350015364800000017,350015364800000016,350015364800000016	0-20,0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
801	chr15	28397064	28397088	3500301077	24		28397064	28397088	8421504	1	24	0	c	350030107700000005	21-45						Trabajo Fin de M&#xe1;ster	zaguan.unizar.es	0	0		
801	chr15	28397064	28397088	3500165606	24		28397064	28397088	8421504	1	24	0	c	350016560600000005	21-45						Isolation and multilineage differentiation of bone marrow mesenchymal stem cells from abattoir-derived bovine fetuses	biomedcentral.com	0	0		
802	chr15	28533002	28533030	3500343043	24		28533002	28533030	8421504	2	14,10	0,18	g	350034304300000027	0-38						New aspects of N-form dependent growth retardation as found in physiological and microarray studies on seedlings of	w.zbm.uni-kiel.de	0	0		
803	chr15	28629415	28629438	3500379089	23		28629415	28629438	8421504	1	23	0	c	350037908900000001	25-48		9696799		0022-538X	Journal of Virology	Herpes Simplex Virus Glycoprotein D Can Bind to Poliovirus Receptor-Related Protein 1 or Herpesvirus Entry Mediator, Two Structurally Unrelated Mediators of Virus Entry	Krummenacher	1998	5		
803	chr15	28643443	28643466	3500148573	23		28643443	28643466	8421504	1	23	0	c	350014857300000008	9-32		20924362	10.1038/mt.2010.207	1525-0016	Molecular Therapy	Bispecific Adapter-Mediated Retargeting of a Receptor-Restricted HSV-1 Vector to CEA-Bearing Tumor Cells	Baek	2010	7		
803	chr15	28697118	28697145	3500148573	27		28697118	28697145	8421504	1	27	0	c	350014857300000010	15-42		20924362	10.1038/mt.2010.207	1525-0016	Molecular Therapy	Bispecific Adapter-Mediated Retargeting of a Receptor-Restricted HSV-1 Vector to CEA-Bearing Tumor Cells	Baek	2010	7		PVRL1
804	chr15	28748192	28748223	3500239911	25		28748192	28748223	8421504	3	4,8,13	0,5,18	g	350023991100000052	2-34						Virus vectors and methods of making and administering the same	Rabinowitz	2006	0		
804	chr15	28748192	28748223	3500133607	25		28748192	28748223	8421504	3	4,8,13	0,5,18	g	350013360700000052	2-34						Virus vectors and methods of making and administering the same	Rabinowitz	2000	0		
806	chr15	29003330	29003356	3500254512	25		29003330	29003356	8421504	2	17,8	0,18	g	350025451200000002	0-32						Novel CD19xCD3 specific polypeptides and uses thereof	Dorken	2006	0		
806	chr15	29003330	29003356	3500231639	25		29003330	29003356	8421504	2	17,8	0,18	g	350023163900000002	0-32					Patent	CD19xCD3 specific polypeptides and uses thereof (Patent US:7575923)	Dorken	2009	0		
807	chr15	29221628	29221652	3500370243	23		29221628	29221652	8421504	2	16,7	0,17	g	350037024300000026,350037024300000084	0-23,0-23						CELL CULTURE SYSTEM OF A HEPATITIS C GENOTYPE 3A AND 2A CHIMERA - Patent application	www.faqs.org	0	0		
807	chr15	29221628	29221652	3500175791	23		29221628	29221652	8421504	2	16,7	0,17	g	350017579100000026	0-23						CELL CULTURE SYSTEM OF A HEPATITIS C GENOTYPE 3A AND 2A CHIMERA	Gottwein	2008	0		
808	chr15	29241200	29241236	3500186176	28		29241200	29241236	8421504	3	13,6,9	0,16,27	g	350018617600000007	0-35						Methylation Ligation-Dependent Macroarray (MLM)	Benhattar	2012	0		
808	chr15	29312006	29312606	3500351427	54		29312006	29312606	8421504	2	34,20	0,580	c	350035142700000002,350035142700000010,350035142700000004	0-22,0-22,0-20		10473598	10.1074/jbc.274.37.26399	0021-9258	Journal of Biological Chemistry	Characterization of the Regulatory Domains of the Human Skn-1a/Epoc-1/Oct-11 POU Transcription Factor	Hildesheim	1999	5		
808	chr15	29324972	29324998	3500210494	23		29324972	29324998	8421504	2	9,14	0,12	g	350021049400000005	0-23		19380579	10.1074/jbc.M109.007625		The Journal of Biological Chemistry	The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication	Udayan	June	0		
809	chr15	29422316	29474542	3500047925	243		29422316	29474542	8421504	6	19,99,50,12,22,41	0,27211,28011,30493,51877,52185	p	350004792500015021,350004792500015066	0-180,0-63						BMC Biochemistry BioMed Central	biomedcentral.com	0	0		
810	chr15	29500970	29500994	3500290393	24		29500970	29500994	8421504	1	24	0	c	350029039300000000	6-30		16940504	10.1128/JVI.00649-06	0022-538X	Journal of Virology	Extremely Low Exposure of a Community to Severe Acute Respiratory Syndrome Coronavirus: False Seropositivity due to Use of Bacterially Derived Antigens	Leung	2006	5		
810	chr15	29500970	29500994	3500195436	24		29500970	29500994	8421504	1	24	0	c	350019543600000000	6-30						Extremely Low Exposure of a Community to Severe Acute Respiratory Syndrome Coronavirus: False Seropositivity due to Use of Bacterially Derived Antigens	jvi.asm.org	0	0		
810	chr15	29500971	29500994	3500417164	23		29500971	29500994	8421504	1	23	0	c	350041716400000000,350041716400000004	11-34,0-21		15681410	10.1128/JVI.79.4.2079-2086.2005	0022-538X	Journal of Virology	Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3	Spiegel	2005	5		
810	chr15	29500971	29500994	3500222895	23		29500971	29500994	8421504	1	23	0	c	350022289500000000	8-31		15184444	10.1128/JCM.42.6.2629-2635.2004	0095-1137	Journal of Clinical Microbiology	Sensitive and Specific Monoclonal Antibody-Based Capture Enzyme Immunoassay for Detection of Nucleocapsid Antigen in Sera from Patients with Severe Acute Respiratory Syndrome	Che	2004	4		
810	chr15	29516570	29516598	3500224614	24		29516570	29516598	8421504	2	18,6	0,22	g	350022461400000042	0-24						Process for the preparation of non-toxic anthrax vaccine	Bhatnagar	2002	0		
817	chr15	30484813	30484838	3500369623	25		30484813	30484838	8421504	1	25	0	g	350036962300000000,350036962300000001	0-25,0-24						Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator	cs.biologists.org	0	0		SORL1
818	chr15	30591690	30591713	3500399857	23		30591690	30591713	8421504	1	23	0	g	350039985700000047	25-48						 Glycosyltransferases For Biosynthesis Of Oligosaccharides, And Genes Encoding Them 	www.docstoc.com	0	0		
818	chr15	30638330	30638381	3500012817	51		30638330	30638381	8421504	1	51	0	p	350001281700015021	0-51						IDENTIFICATIOND&#x2019;EPITOPESTCD4+ D&#x2019;ANTIGENESTUMORAUX	hives-ouvertes.fr	0	0		SORL1
818	chr15	30648886	30650356	3500311303	87		30648886	30650356	8421504	3	37,2,48	0,1405,1422	p	350031130300015027,350031130300015025	0-87,0-48						Head-activator binding protein	ev.biologists.org	0	0		SORL1
819	chr15	30763118	30763149	3500035109	26		30763118	30763149	8421504	2	6,20	0,11	g	350003510900000056	19-47						METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE - Patent application	www.faqs.org	0	0		
820	chr15	30874877	30874906	3500002499	24		30874877	30874906	8421504	2	12,12	0,17	g	350000249900000089	13-44						Maize and cauliflower apetalai gene products and nucleic acid molecules encoding same	Yanofsky	1996	0		
821	chr15	31027204	31039728	3500430989	41		31027204	31039728	8421504	4	9,13,12,7	0,10,12500,12517	g	350043098900000816,350043098900000033,350043098900000470	0-22,0-22,29-48						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
823	chr15	31270985	31271028	3500131869	40		31270985	31271028	8421504	2	20,20	0,23	c,g	350013186900000006,350013186900000006,350013186900000002,350013186900000002	1-21,1-21,0-20,0-20						THE J BIOLOGICAL C &#xa9; 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Depletion of Human Micro-RNA miR-125b Reveals That It Is Critical for the Proliferation of Differentiated Cells but Not for the Down- reg	www.jbc.org	0	0		BLID
823	chr15	31271009	31271032	3500306561	23		31271009	31271032	8421504	1	23	0	c	350030656100000289	21-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		BLID
823	chr15	31271010	31325811	3500357539	66		31271010	31325811	8421504	3	22,22,22	0,48959,54779	c,g	350035753900000045,350035753900000045,350035753900000156,350035753900000156,350035753900000000,350035753900000220	0-22,0-22,0-22,0-22,1-23,0-22					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		
823	chr15	31271010	31325811	3500125321	66		31271010	31325811	8421504	3	22,22,22	0,48958,54779	c,g	350012532100000013,350012532100000013,350012532100000201,350012532100000154,350012532100000076,350012532100000189,350012532100000165,350012532100000010	0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-22						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
823	chr15	31271010	31319990	3500244257	44		31271010	31319990	8421504	2	22,22	0,48958	c,g	350024425700000017,350024425700000017,350024425700000000	0-22,0-22,0-22						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIRLET7DHG
823	chr15	31319922	31319994	3500408810	72		31319922	31319994	8421504	1	72	0	c,g	350040881000000012,350040881000000012	0-72,0-72						Compositions And Methods For Modulation Of Pdx-1 	freshpatents.com	0	0		MIR100
823	chr15	31319925	31319989	3500283035	45		31319925	31319989	8421504	2	19,26	0,38	c,g	350028303500000024,350028303500000024,350028303500000023	0-19,0-19,0-26		21929751	10.1186/1477-3155-9-40	1477-3155	Journal of Nanobiotechnology	Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism	Sureban	2011	0		
823	chr15	31319967	31319990	3500154773	23		31319967	31319990	8421504	1	23	0	g	350015477300000010	0-23		19229243	10.1038/cdd.2009.15	1350-9047	Cell Death & Differentiation	Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1	Ghodgaonkar	2009	9		
824	chr15	31343410	31343434	3500186557	23		31343410	31343434	8421504	2	18,5	0,19	g	350018655700000851	0-23						Oligonucleotide for Detection of a Microorganism, Diagnostic Kits and Methods for Detection of Microorganisms Using the Oligonucleotide - Patent application	www.faqs.org	0	0		
828	chr15	31883745	31883771	3500034442	23		31883745	31883771	8421504	2	7,16	0,10	g	350003444200000000	0-23						CR6-interactingFactor1(CRIF1)RegulatesNF-E2-related Factor2(NRF2)ProteinStabilitybyProteasome-mediated Degradation	www.jbc.org	0	0		
830	chr15	32213936	32213960	3500030036	24		32213936	32213960	8421504	1	24	0	c	350003003600000001	8-32		11404244			American Journal of Physiology - Lung Cellular and Molecular Physiology	Sodium 4-phenylbutyrate downregulates HSC70 expression by facilitating mRNA degradation	Rubenstein	2001	0		HSPA8
830	chr15	32213942	32214475	3500023106	234		32213942	32214475	8421504	3	93,87,54	0,105,479	p	350002310600015044	0-234						NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS	Tainsky	2010	0		HSPA8
830	chr15	32214527	32214550	3500075873	23		32214527	32214550	8421504	1	23	0	c	350007587300000000	0-23		12105196	10.1074/jbc.M203613200	0021-9258	Journal of Biological Chemistry	Colonization of Germ-free Transgenic Mice with Genotyped Helicobacter pylori Strains from a Case-Control Study of Gastric Cancer Reveals a Correlation between Host Responses and HsdS Components of Type I Restriction-Modification Systems ,	Bjorkholm	2002	5		HSPA8
830	chr15	32215033	32215345	3500156712	72		32215033	32215345	8421504	2	18,54	0,258	p	350015671200015030	0-72						DIETARY WHEAT GERM OIL INFLUENCES GENE EXPRESSION IN LARVAE AND EGGS OF THE ORIENTAL FRUIT FLY	www.ars.usda.gov	0	0		HSPA8
830	chr15	32215033	32215342	3500154043	69		32215033	32215342	8421504	2	18,51	0,258	p	350015404300015056	3-72						INTERACTION BETWEEN TRICHODERMA	library.brocku.ca	0	0		HSPA8
830	chr15	32215039	32217337	3500446547	465		32215039	32217337	8421504	4	12,203,109,141	0,252,660,2157	p	350044654700015042,350044654700015037,350044654700015038,350044654700015007	0-180,0-144,0-144,9-150						BIOCHEMICAL CHARACTERIZATION OF PLASMODIUM FALCIPARUM HEAT SHOCK PROTEIN 70	eprints.ru.ac.za	0	0		
830	chr15	32215370	32215793	3500449235	39		32215370	32215793	8421504	2	19,20	0,403	c	350044923500000003,350044923500000002	0-19,0-20		22895173	10.4161/cc.21595		Cell Cycle	Heat shock induces apoptosis in human embryonic stem cells but a premature senescence phenotype in their differentiated progeny	Larisa	2012	0		HSPA8
830	chr15	32215748	32217268	3500344459	108		32215748	32217268	8421504	3	27,48,33	0,363,1487	p	350034445900015021,350034445900015005	27-87,0-48						Af&#xfb01;nity puri&#xfb01;cation reveals the association of WD40 protein constitutive photomorphogenic 1 with the hetero-oligomeric TCP-1 chaperonin complex in mammalian cells	www.yale.edu	0	0		
830	chr15	32215784	32216354	3500420532	40		32215784	32216354	8421504	3	19,5,16	0,466,554	c,g	350042053200000001,350042053200000001,350042053200000000	0-19,0-19,0-21		19812207	10.4049/jimmunol.0901288	0022-1767	The Journal of Immunology	Transgenic Expression of Hsc70 in Pancreatic Islets Enhances Autoimmune Diabetes in Response to &#x03b2; Cell Damage	Alam	2009	6		
830	chr15	32215784	32216354	3500376787	40		32215784	32216354	8421504	3	19,5,16	0,466,554	c,g	350037678700000001,350037678700000001,350037678700000000	0-19,0-19,0-21						Transgenic Expression of Hsc70 in Pancreatic Islets Enhances Autoimmune Diabetes in Response to Cell Damage	www.jimmunol.org	0	0		
830	chr15	32216437	32217175	3500311730	99		32216437	32217175	8421504	3	54,8,37	0,399,701	p	350031173000015066,350031173000015065	48-102,36-81						The Lewisx glycan in mice	ie.uni-hamburg.de	0	0		HSPA8
830	chr15	32216644	32216704	3500060977	60		32216644	32216704	8421504	1	60	0	p	350006097700015013	0-60						Studies on molecular mechanisms underlying high pressure adaptation of &#x03b1;-actin from deep-sea fish	w.fra.affrc.go.jp	0	0		HSPA2
830	chr15	32217155	32217231	3500036931	39		32217155	32217231	8421504	2	20,19	0,57	c,g	350003693100000007,350003693100000006,350003693100000006	0-20,0-19,0-19						Maturation medium supplements affect transcript level of apoptosis and cell survival related genes in bovine blastocysts produced in vitro	www.ufpel.edu.br	0	0		
830	chr15	32217167	32217190	3500328515	23		32217167	32217190	8421504	1	23	0	c	350032851500000012	24-47					Patent	Cryptosporidium detection method (Patent US:5770368)	Leon	1998	0		
830	chr15	32217167	32217190	3500055721	23		32217167	32217190	8421504	1	23	0	c	350005572100000012	24-47						US Patent # 5,770,368. Cryptosporidium detection method - Patents.com	www.patents.com	0	0		
830	chr15	32217167	32217190	3500025064	23		32217167	32217190	8421504	1	23	0	c	350002506400000012	24-47						Cryptosporidium detection method	Leon	1996	0		
830	chr15	32217196	32217268	3500278688	72		32217196	32217268	8421504	1	72	0	p	350027868800015030	0-72						The global expression analysis of stress response against denatured proteins in yeast Saccharomyces cerevisiae	ane.ll.chiba-u.jp	0	0		HSPA2
830	chr15	32217217	32217298	3500225080	42		32217217	32217298	8421504	2	21,21	0,60	c	350022508000000005,350022508000000004	0-21,0-21		19434724	10.1002/hep.22852	1527-3350	Hepatology	The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity - Parent - 2009 - Hepatology - Wiley Online Library	Parent	2009	0		HSPA8
835	chr15	32804707	32807928	3500001882	66		32804707	32807928	8421504	2	51,15	0,3206	p	350000188200015000	0-66		15102918	10.1523/JNEUROSCI.4139-03.2004	0270-6474	The Journal of Neuroscience	Mice Lacking Sodium Channel &#x03b2;1 Subunits Display Defects in Neuronal Excitability, Sodium Channel Expression, and Nodal Architecture	Chen	2004	7		SCN3B
839	chr15	33299195	33299252	3500342863	57		33299195	33299252	8421504	1	57	0	p	350034286300015050	0-57							library.wiley.com	0	0		KCNC1
839	chr15	33308588	33342625	3500324750	522		33308588	33342625	8421504	2	429,93	0,33944	p	350032475000015019,350032475000015017,350032475000015015,350032475000015025,350032475000015011	0-69,0-180,0-180,0-87,0-81						Proteins, polynucleotides encoding them and methods of using the same	Shimkets	2001	0		KCNC1
839	chr15	33308666	33308783	3500192418	117		33308666	33308783	8421504	1	117	0	p	350019241800015009	0-117						vom Fachbereich Biologie der Technischen Universit&#xe4;t Darmstadt zur Erlangung des akademischen Grades eines Doctor rerum naturalium genehmigte Dissertation von	b.tu-darmstadt.de	0	0		KCNC1
839	chr15	33308825	33342658	3500358606	397		33308825	33342658	8421504	3	165,72,160	0,171,33673	p,c	350035860600015004,350035860600000000	0-240,362-522						HUMAN PROTEINS, POLYNUCLEOTIDES ENCODING THEM AND METHODS OF USING THE SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
839	chr15	33357764	33357791	3500415605	27		33357764	33357791	8421504	1	27	0	c	350041560500000005	7-34						Conferences, Proceedings, Journals, Open Access Journals, SCIRP	file.scirp.org	0	0		
839	chr15	33357922	33359223	3500235185	357		33357922	33359223	8421504	3	78,57,222	0,950,1079	p	350023518500015024,350023518500015009,350023518500015007	0-300,30-75,39-96						Somite formation and expression of MyoD myogenin and myosin in Atlantic halibut (Hippoglossus hippoglossus L.) embryos incubated at different temperatures: transient asymmetric expression of MyoD	eb.biologists.org	0	0		MYOD1
839	chr15	33358290	33359197	3500257699	79		33358290	33359197	8421504	5	20,10,10,19,20	0,54,579,737,887	c,g	350025769900000022,350025769900000022,350025769900000024,350025769900000023,350025769900000023,350025769900000021,350025769900000021	0-20,0-20,0-20,0-19,0-19,0-20,0-20						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
839	chr15	33359061	33359106	3500295536	45		33359061	33359106	8421504	1	45	0	p	350029553600015000	0-45					Patent	Materials and methods for modulating differentiation (Patent US:6071691)	Hoekstra	2000	0		MYOD1
839	chr15	33359061	33359106	3500231415	45		33359061	33359106	8421504	1	45	0	p	350023141500015000	0-45						Methods for modulating differentiation	Hoekstra	2001	0		MYOD1
839	chr15	33359180	33359451	3500194103	40		33359180	33359451	8421504	2	20,20	0,251	c,g	350019410300000041,350019410300000041,350019410300000040	0-20,0-20,0-20						AZ IZOM DIFFERENCI&#xc1;L&#xd3;D&#xc1;ST BEFOLY&#xc1;SOL&#xd3; G&#xc9;NEK IN VITRO VIZSG&#xc1;LATA EMBRION&#xc1;LIS EREDET&#x0170; &#x0150;S-SEJTVONALAKBAN EG&#xc9;R MODELLRENDSZERBEN	phd.szie.hu	0	0		
839	chr15	33359189	33359502	3500452577	39		33359189	33359502	8421504	2	20,19	0,294	c,g	350045257700000010,350045257700000010,350045257700000001,350045257700000001,350045257700000000,350045257700000000	0-20,0-20,0-20,0-20,0-19,0-19						US Patent # 7,396,537. Cell delivery patch for myocardial tissue engineering - Patents.com	www.patents.com	0	0		
839	chr15	33380510	33380539	3500026766	29		33380510	33380539	8421504	1	29	0	g	350002676600000018	0-29		22210883	10.1093/nar/gkr1297		Nucleic Acids Research	A non-canonical E-box within the MyoD core enhancer is necessary for circadian expression in skeletal muscle	Xiping	2012	0		
840	chr15	33526156	33538873	3500210079	90		33526156	33538873	8421504	4	36,9,8,37	0,11544,12530,12680	p	350021007900015000,350021007900015001	0-45,3-48			10.1073/pnas.232579599		Proceedings of the National Academy of Sciences of the United States of America	The Usher syndrome proteins cadherin 23 and harmonin form a complex by means of PDZ-domain interactions	Jan	2002	0		USH1C,OTOG
105	chr15	33593464	33698193	3500183808	4743		33593464	33698193	8421504	39	148,142,122,167,243,189,165,156,135,163,41,146,106,117,76,106,33,36,99,85,81,138,126,100,242,167,70,158,93,103,114,121,131,79,109,104,134,63,135	0,1406,5461,11190,12969,14111,22191,25595,31770,32226,41316,42534,44954,45198,45712,46527,55555,83136,83890,85045,86081,87949,89582,90644,90966,91306,92564,93450,95325,99430,100093,100535,100809,101758,102033,102529,103410,104019,104594	p	350018380800015000	0-4743						KEGG T01001: 6833	www.genome.jp	0	0		ABCC8
105	chr15	33593539	33697502	3500258315	1016		33593539	33697502	8421504	34	74,41,26,19,8,41,27,26,35,24,19,71,14,16,5,42,41,25,47,24,2,31,20,36,35,13,30,62,48,48,32,15,15,4	0,5459,11210,13118,14036,25523,31740,32157,42534,45122,45694,46452,46544,55480,83909,84970,85013,86049,91010,91109,91231,91274,92517,95247,95308,99355,99395,100060,100781,101695,102035,102454,103943,103959	c,g	350025831500000145,350025831500000259,350025831500000151,350025831500000154,350025831500000058,350025831500000168,350025831500000070,350025831500000287,350025831500000287,350025831500000293,350025831500000183,350025831500000085,350025831500000188,350025831500000188,350025831500000087,350025831500000091,350025831500000092,350025831500000309,350025831500000309,350025831500000320,350025831500000207,350025831500000322,350025831500000210,350025831500000213,350025831500000217,350025831500000014,350025831500000332,350025831500000220,350025831500000220,350025831500000019,350025831500000223,350025831500000024,350025831500000026,350025831500000029,350025831500000034	0-48,0-35,0-41,0-26,2-29,0-41,0-27,15-41,15-41,0-35,23-47,0-48,0-48,0-48,15-45,0-47,0-41,6-31,6-31,0-47,0-38,3-29,13-44,21-41,26-48,0-32,0-48,18-48,18-48,0-48,9-41,0-48,0-48,0-47,29-48					Patent	Nucleic acid and amino acid sequences for mammalian sulfonylurea receptor (Patent US:6054313)	Bryan	2000	0		
105	chr15	33593539	33696008	3500356355	339		33593539	33696008	8421504	10	48,41,41,25,20,24,45,48,32,15	0,5459,25523,86049,92517,100108,100460,100781,102035,102454	c	350035635500000142,350035635500000148,350035635500000164,350035635500000300,350035635500000205,350035635500000020,350035635500000215,350035635500000023,350035635500000028	0-48,0-41,0-41,6-31,21-41,0-48,0-48,0-48,0-47						Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy - Patent # 5863724 - PatentGenius	.patentgenius.com	0	0		
841	chr15	33594893	33594919	3500194863	26		33594893	33594919	8421504	1	26	0	c	350019486300000026	0-26						Insulin-producing bone marrow derived cells and methods of generating and using same	Efrat	2004	0		
841	chr15	33684207	33684492	3500152251	63		33684207	33684492	8421504	2	1,62	0,223	p	350015225100015001	0-63						HBTU | Proteasome Inhibitors Guide	zide-6-isomer.com	0	0		
842	chr15	33703186	33703360	3500325609	41		33703186	33703360	8421504	2	20,21	0,153	c	350032560900000000,350032560900000001	0-20,0-21		16501027	10.1152/ajpheart.00051.2006		American Journal of Physiology - Heart and Circulatory Physiology	Consequences of cardiac myocyte-specific ablation of KATP channels in transgenic mice expressing dominant negative Kir6 subunits	Tong	2006	0		
843	chr15	33917055	33917079	3500192369	23		33917055	33917079	8421504	2	17,6	0,18	c	350019236900000002,350019236900000001	13-36,0-23						Mitochondrial Localization and the Persistent Migration of Epithelial Cancer cells	lmrt.mit.edu	0	0		
843	chr15	33918093	33918138	3500021616	44		33918093	33918138	8421504	2	25,19	0,26	c	350002161600000005,350002161600000004	0-25,19-38						THE ROLE OF A2B ADENOSINE RECEPTOR SIGNALING IN ADENOSINE DEPENDENT LUNG DISEASE	s.library.tmc.edu	0	0		ADK
844	chr15	34025861	34026561	3500006920	90		34025861	34026561	8421504	2	59,31	0,669	p	350000692000015055	0-90						*U FBrf0075164 *a Laverty *b T. *t 1995 *T personal communication to FlyBase *u *F From todd_lavert	t.bio.indiana.edu	0	0		RPS13
846	chr15	34290061	34290086	3500294440	23		34290061	34290086	8421504	2	18,5	0,20	g	350029444000000103	0-26					Patent	Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors (Patent US:5712095)	Britschgi	1998	0		
846	chr15	34293902	34293927	3500430989	24		34293902	34293927	8421504	2	20,4	0,21	g	350043098900000629	13-39						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
847	chr15	34404041	34404067	3500006449	25		34404041	34404067	8421504	2	16,9	0,17	g	350000644900000016	20-45						COMBINATION OF BLyS AND/OR APRIL INHIBITION AND IMMUNNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE DISEASE - Patent application	www.faqs.org	0	0		
850	chr15	34794586	34794610	3500363476	24		34794586	34794610	8421504	1	24	0	c	350036347600000049	24-48						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - Patent application	www.faqs.org	0	0		SOX6
850	chr15	34794659	34794682	3500168733	23		34794659	34794682	8421504	1	23	0	c	350016873300000002	0-23						Thesis: Master of Science Graduate Institute of Cell & Molecular Biology	libir.tmu.edu.tw	0	0		SOX6
850	chr15	34818365	34818389	3500224614	24		34818365	34818389	8421504	1	24	0	g	350022461400000037	0-35						Process for the preparation of non-toxic anthrax vaccine	Bhatnagar	2002	0		
852	chr15	35046674	35081233	3500358742	26		35046674	35081233	8421504	2	25,1	0,34558	c	350035874200000001	0-26		17006542	10.1038/sj.emboj.7601352	ERROR! NO ISSN	The EMBO Journal	A molecular insight of Hes5-dependent inhibition of myelin gene expression: old partners and new players	Liu	2006	0		
852	chr15	35081793	35081821	3500063996	23		35081793	35081821	8421504	2	13,10	0,18	g	350006399600000225,350006399600000232,350006399600000251,350006399600000244	0-23,11-34,10-33,0-23						Immunostimulatory rna/dna hybrid molecules	Flora	2001	0		
853	chr15	35158428	35171540	3500403323	42		35158428	35171540	8421504	2	21,21	0,13091	c	350040332300000012,350040332300000013	0-21,0-21			10.1002/art.21651	1529-0131	Arthritis & Rheumatism	Higher chondrogenic potential of fibrous synovium&#x2013; and adipose synovium&#x2013;derived cells compared with subcutaneous fat&#x2013;derived cells: Distinguishing properties of mesenchymal stem cells in humans - Mochizuki - 2006 - Arthritis & Rheumat	Mochizuki	2006	0		SOX6
853	chr15	35158428	35171540	3500117371	42		35158428	35171540	8421504	2	21,21	0,13091	c,g	350011737100000012,350011737100000012,350011737100000013	0-21,0-21,0-21						In vitrocartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis	www.pnas.org	0	0		SOX6
857	chr15	35686904	35686931	3500369719	23		35686904	35686931	8421504	3	4,12,7	0,5,20	g	350036971900000035	19-42						Expression system for producing collagen - Patent application	www.faqs.org	0	0		
860	chr15	36156319	36156439	3500393987	45		36156319	36156439	8421504	3	22,7,16	0,96,104	c,g	350039398700000037,350039398700000036,350039398700000036	0-22,0-23,0-23						ABSTRACT	tory.lib.ncsu.edu	0	0		
860	chr15	36156319	36156439	3500372619	45		36156319	36156439	8421504	3	22,7,16	0,96,104	c,g	350037261900000009,350037261900000008,350037261900000008	0-22,0-23,0-23						2012 OPEN ACCESS nutrients	www.mdpi.com	0	0		
860	chr15	36156319	36156439	3500351434	45		36156319	36156439	8421504	3	22,7,16	0,96,104	c,g	350035143400000009,350035143400000008,350035143400000008	0-22,0-23,0-23						2012 OPEN ACCESS nutrients	www.mdpi.com	0	0		
861	chr15	36221372	36221399	3500448855	23		36221372	36221399	8421504	3	5,14,4	0,8,23	g	350044885500000013	3-26						Non-contiguous Protein Recombination	brary.caltech.edu	0	0		
862	chr15	36436155	36436180	3500060079	25		36436155	36436180	8421504	1	25	0	g	350006007900000005	41-66						RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. - ResearchGate	.researchgate.net	0	0		
864	chr15	36605744	36605797	3500463464	53		36605744	36605797	8421504	1	53	0	g	350046346400000054	4-57						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
865	chr15	36754015	36754222	3500264853	50		36754015	36754222	8421504	2	45,5	0,202	g	350026485300000008	0-50						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		
865	chr15	36754015	36754222	3500205152	50		36754015	36754222	8421504	2	45,5	0,202	g	350020515200000008	0-50						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		
866	chr15	36859839	36864452	3500360721	303		36859839	36864452	8421504	8	3,45,9,84,30,32,89,11	0,1360,1681,1699,1901,1973,3895,4602	p	350036072100015020,350036072100015021,350036072100015023	0-57,0-114,0-132						BMC Biochemistry BioMed Central	biomedcentral.com	0	0		
866	chr15	36861205	36861526	3500259199	45		36861205	36861526	8421504	2	39,6	0,315	p	350025919900015014	0-45						Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in Endothelial Progenitor Cells	www.mcponline.org	0	0		PSMA1
866	chr15	36864447	36864752	3500269923	46		36864447	36864752	8421504	3	21,20,5	0,279,300	c,g	350026992300000033,350026992300000012,350026992300000034,350026992300000034	0-21,16-41,0-20,0-20						Morphine and Morphine Precursors - Patent application	www.faqs.org	0	0		PSMA1
866	chr15	36864447	36864752	3500078972	46		36864447	36864752	8421504	3	21,20,5	0,279,300	c	350007897200000033,350007897200000034,350007897200000012	0-21,0-20,16-41						MORPHINE AND MORPHINE PRECURSORS - Patent application	www.faqs.org	0	0		PSMA1
866	chr15	36883541	36897115	3500247420	42		36883541	36897115	8421504	2	21,21	0,13553	c,g	350024742000000000,350024742000000000,350024742000000001,350024742000000001	0-21,0-21,0-21,0-21						RNAi Invitrogen	etechnologies.com	0	0		COPB1
866	chr15	36897014	36897065	3500342863	51		36897014	36897065	8421504	1	51	0	p	350034286300015120	0-51							library.wiley.com	0	0		COPB1
866	chr15	36956315	36956347	3500258001	24		36956315	36956347	8421504	3	11,6,7	0,14,25	g	350025800100000087	5-29						PROTEASE VARIANTS - Patent application	www.faqs.org	0	0		
868	chr15	37170401	37170426	3500459810	25		37170401	37170426	8421504	1	25	0	g	350045981000000089,350045981000000112,350045981000000111	1-26,1-26,0-24						Compositions, Methods, and Kits for (MIS)Ligating Oligonucleotides - Patent application	www.faqs.org	0	0		
870	chr15	37393667	37393690	3500253796	23		37393667	37393690	8421504	1	23	0	g	350025379600000080	11-34					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
870	chr15	37432771	37432795	3500224877	23		37432771	37432795	8421504	2	6,17	0,7	g	350022487700000001	0-23		21118569	10.1186/1471-2156-11-106	1471-2156	BMC Genetics	High resolution mapping and positional cloning of ENU-induced mutations in the Rw region of mouse chromosome 5	Ching	2010	2		
871	chr15	37550492	37550515	3500084218	23		37550492	37550515	8421504	1	23	0	g	350008421800000150	0-27						Attenuated Salmonella Sp12 Mutants As Antigen Carriers 	.freshpatents.com	0	0		
872	chr15	37633822	37633845	3500406027	23		37633822	37633845	8421504	1	23	0	g	350040602700000055	26-49						Polypeptide producing cells	Endl	2013	0		
872	chr15	37633822	37633845	3500369645	23		37633822	37633845	8421504	1	23	0	g	350036964500000078	26-49						POLYPEPTIDE PRODUCING CELLS - Patent application	www.faqs.org	0	0		
873	chr15	37844026	37844198	3500455534	55		37844026	37844198	8421504	2	30,25	0,147	c,g	350045553400000001,350045553400000011,350045553400000011	0-30,5-30,5-30						Contrasting Mammalian Parathyroid Hormone (PTH) Promoters: Nuclear Factor-Y Binds to a Deoxyribonucleic Acid Element Unique to the Human PTH Promoter and Acts as a Transcriptional Enhancer	.endojournals.org	0	0		
873	chr15	37845993	37846307	3500273012	195		37845993	37846307	8421504	2	86,109	0,205	p	350027301200015115,350027301200015010,350027301200015033,350027301200015018,350027301200015042,350027301200015023,350027301200015022,350027301200015046,350027301200015049	0-93,0-102,0-90,0-96,0-84,0-81,0-84,0-72,3-57						Rankl Antibody-PTH/PTHRP Chimeric Molecules	Boone	2011	0		
873	chr15	37845993	37846307	3500053757	165		37845993	37846307	8421504	2	63,102	0,212	p	350005375700015195,350005375700015190,350005375700015020,350005375700015043,350005375700015028,350005375700015052,350005375700015033,350005375700015056,350005375700015032,350005375700015059	0-63,0-63,0-102,0-90,0-96,0-84,0-81,0-72,0-84,3-57						Rankl antibody-PTH/PTHrP chimeric molecules	Kostenuik	2006	0		
873	chr15	37846226	37846250	3500393987	24		37846226	37846250	8421504	1	24	0	c	350039398700000034	0-24						ABSTRACT	tory.lib.ncsu.edu	0	0		
873	chr15	37846226	37846250	3500372619	24		37846226	37846250	8421504	1	24	0	c	350037261900000006	0-24						2012 OPEN ACCESS nutrients	www.mdpi.com	0	0		
873	chr15	37846226	37846250	3500351434	24		37846226	37846250	8421504	1	24	0	c	350035143400000006	0-24						2012 OPEN ACCESS nutrients	www.mdpi.com	0	0		
873	chr15	37846358	37846394	3500445965	36		37846358	37846394	8421504	1	36	0	c	350044596500000024	9-45						Production Of Human Parathyroid Hormone From Microorganisms 	.freshpatents.com	0	0		
874	chr15	37964276	37986372	3500148659	741		37964276	37986372	8421504	10	36,44,103,121,122,40,8,94,86,87	0,42,2403,3980,15622,15780,18217,18234,21911,22009	p	350014865900015056,350014865900015059,350014865900015064,350014865900015067,350014865900015068,350014865900015071	0-162,0-180,0-171,0-180,0-54,0-87						50 human secreted proteins	Komatsoulis	2002	0		
874	chr15	37964276	37986372	3500068672	741		37964276	37986372	8421504	10	36,44,103,121,122,40,8,94,86,87	0,42,2403,3980,15622,15780,18217,18234,21911,22009	p	350006867200015056,350006867200015059,350006867200015064,350006867200015067,350006867200015068,350006867200015071	0-162,0-180,0-171,0-180,0-54,0-87						50 human secreted proteins	Komatsoulis	2000	0		
874	chr15	37988558	37996805	3500202668	56		37988558	37996805	8421504	2	28,28	0,8219	c	350020266800000021,350020266800000020	0-28,0-28		19682069	10.1111/j.1742-4658.2009.07229.x	1742-4658	FEBS Journal	The miRNA-192/194 cluster regulates the Period gene family and the circadian clock - Nagel - 2009 - FEBS Journal - Wiley Online Library	Nagel	2009	0		ARNTL
874	chr15	38005214	38005237	3500247022	23		38005214	38005237	8421504	1	23	0	c	350024702200000001	21-44						Oscillation of clock and clock controlled Genes Induced by serum shock in Human Breast epithelial and Breast cancer cells: Regulation by Melatonin	www.la-press.com	0	0		ARNTL
875	chr15	38017131	38017657	3500015581	35		38017131	38017657	8421504	2	3,32	0,494	c	350001558100000049	0-35						Transcription Activation Complex And Utilization Thereof 	.freshpatents.com	0	0		
875	chr15	38017642	38019905	3500202440	25		38017642	38019905	8421504	2	22,3	0,2260	c	350020244000000004	0-25		17284666	10.1152/physiolgenomics.00199.2006	1094-8341	Physiological Genomics	Circadian profiling of the transcriptome in NIH/3T3 fibroblasts: comparison with rhythmic gene expression in SCN2.2 cells and the rat SCN	Menger	2007	3		ARNTL
875	chr15	38095983	38096050	3500403128	67		38095983	38096050	8421504	1	67	0	g	350040312800000000,350040312800000001	0-67,0-67						Colorado : MCDB 4650 : dudleyetal	ww.coursehero.com	0	0		
875	chr15	38095983	38096050	3500263479	67		38095983	38096050	8421504	1	67	0	g	350026347900000001,350026347900000000	0-67,0-67						Colorado : MCDB 4620 : dudleyetal	ww.coursehero.com	0	0		
875	chr15	38095983	38096050	3500020879	67		38095983	38096050	8421504	1	67	0	g	350002087900000008,350002087900000009	0-67,0-67						NPG.nature.vol.418.Issue.6897.Aug	www.scribd.com	0	0		
876	chr15	38164270	38164296	3500236370	23		38164270	38164296	8421504	2	10,13	0,13	g	350023637000000033	1-24						CYTOKINE PRODUCTION REGULATOR GENE AND USE THEREOF - Patent application	www.faqs.org	0	0		
879	chr15	38547416	38547443	3500193183	23		38547416	38547443	8421504	2	9,14	0,13	g	350019318300000045,350019318300000057	7-30,7-27						Diagnosis and management of infection caused by chlamydia	Mitchell	1998	0		
879	chr15	38603714	38603744	3500293750	25		38603714	38603744	8421504	2	6,19	0,11	g	350029375000000912	8-33						Chimeric clotting factors	Salas	2012	0		
881	chr15	38893084	38893112	3500460953	23		38893084	38893112	8421504	2	6,17	0,11	g	350046095300000018,350046095300000019	9-33,6-30						EXPRESSION OF RECOMBINANT GENES ENCODING RUBISCO PROTEINS IN C3 PLANTS	Caspar	2008	0		
881	chr15	38920259	38920288	3500296374	24		38920259	38920288	8421504	2	7,17	0,12	g	350029637400000005	4-28		17591700	10.1128/MCB.02273-06	0270-7306	Molecular and Cellular Biology	Phospholipase C&#x03b3;2 Contributes to Light-Chain Gene Activation and Receptor Editing	Bai	2007	6		
882	chr15	39052840	39052868	3500130057	23		39052840	39052868	8421504	3	12,6,5	0,16,23	g	350013005700000383	8-32						ABSTRACT BIRKENHEUER, ADAM JOSEPH. Canine Babesiosis: Epidemiological, Molecular and	tory.lib.ncsu.edu	0	0		
885	chr15	39340687	39340717	3500078254	24		39340687	39340717	8421504	3	5,7,12	0,6,18	g	350007825400000001	12-43						Capsid stability and replication of human immunode&#xfb01;ciency virus type 1 are in&#xfb02;uenced critically by charge and size of Gag residue 183	r.sgmjournals.org	0	0		
886	chr15	39468752	39516701	3500302241	108		39468752	39516701	8421504	2	65,43	0,47906	c	350030224100000027,350030224100000003,350030224100000044	1-47,0-48,0-43						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
886	chr15	39501064	39501093	3500459869	23		39501064	39501093	8421504	3	5,12,6	0,6,23	g	350045986900001741	0-25						 Highly Conserved Genes And Their Use To Generate Probes And Primers For Detection Of Microorganisms 	www.docstoc.com	0	0		
886	chr15	39501064	39501093	3500437093	23		39501064	39501093	8421504	3	5,12,6	0,6,23	g	350043709300001488	0-25						US Patent # 8,182,996. Compositions and methods for detecting Klebsiella pneumoniae - Patents.com	patents.com	0	0		
886	chr15	39514420	39516616	3500404639	249		39514420	39516616	8421504	3	52,157,40	0,1185,2156	p	350040463900015010,350040463900015011	27-162,90-204						NPG.nature.vol.412.Issue.6850.Aug	www.scribd.com	0	0		
886	chr15	39514423	39515745	3500427839	180		39514423	39515745	8421504	5	45,1,44,45,45	0,48,1182,1229,1277	p	350042783900015022,350042783900015023,350042783900015024,350042783900015025	0-45,0-45,0-45,0-45						EG-VEGF NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE - Patent application	www.faqs.org	0	0		DKK3
886	chr15	39514450	39515694	3500418174	111		39514450	39515694	8421504	2	22,89	0,1155	p	350041817400015035	0-111						An ancient Wnt-Dickkopf antagonism in Hydra	ev.biologists.org	0	0		DKK3
886	chr15	39514468	39516616	3500067235	198		39514468	39516616	8421504	4	4,146,8,40	0,1137,1286,2108	p	350006723500015012,350006723500015013	0-150,0-48					Patent	Eg-vegf nucleic acids and polypeptides and methods of use (Patent CA:2412612)	Ferrara	2013	0		DKK3
886	chr15	39514471	39515745	3500223705	135		39514471	39515745	8421504	4	1,44,45,45	0,1134,1181,1229	p	350022370500015023,350022370500015024,350022370500015025	0-45,0-45,0-45						EG-VEGF NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE - Patent application	www.faqs.org	0	0		DKK3
890	chr15	40017751	40017777	3500390028	23		40017751	40017777	8421504	2	6,17	0,9	g	350039002800000091	12-35						INHIBITORS FOR GROWTH HORMONE AND RELATED HORMONES, AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
894	chr15	40533828	40533852	3500048446	23		40533828	40533852	8421504	2	11,12	0,12	g	350004844600000057	9-32					Patent	Linked breast and ovarian cancer susceptibility gene (Patent US:5709999)	Durocher	1998	0		
895	chr15	40734567	40735726	3500311545	60		40734567	40735726	8421504	2	30,30	0,1129	c,g	350031154500000020,350031154500000020,350031154500000021,350031154500000021	0-30,0-30,0-30,0-30						Nuclear reprogramming factor and induced pluripotent stem cells	Yamanaka	2008	0		EIF4G2
895	chr15	40734567	40735726	3500222687	58		40734567	40735726	8421504	2	29,29	0,1130	c	350022268700000015,350022268700000011	0-29,0-29						Mechanosensitive hair cell-like cells from embryonic and induced pluripotent stem cells. - ResearchGate	.researchgate.net	0	0		EIF4G2
895	chr15	40734567	40734600	3500209110	33		40734567	40734600	8421504	1	33	0	g	350020911000000033	0-33						SINGLE LENTIVIRAL VECTOR SYSTEM FOR INDUCED PLURIPOTENT (IPS) STEM CELLS DERIVATION	Mostoslavsky	2011	0		EIF4G2
895	chr15	40734567	40734600	3500041938	33		40734567	40734600	8421504	1	33	0	g	350004193800000043	0-33						Method of efficiently establishing induced pluripotent stem cells	Yamanaka	2009	0		EIF4G2
895	chr15	40734573	40744784	3500282054	2883		40734573	40744784	8421504	29	59,66,141,103,132,67,8,111,84,99,142,44,69,114,126,105,18,102,42,169,23,134,10,10,122,12,4,115,652	0,370,1061,1692,2470,2687,3323,3840,4107,4279,4816,5047,5139,5599,6303,6592,6784,6898,7078,7168,7656,7727,8018,8220,8311,9378,9438,9443,9559	c	350028205400000038,350028205400000039,350028205400000040,350028205400000041,350028205400000042,350028205400000043,350028205400000044,350028205400000045,350028205400000046,350028205400000047,350028205400000048,350028205400000049,350028205400000053,350028205400000054,350028205400000055,350028205400000056,350028205400000057,350028205400000058,350028205400000059,350028205400000060,350028205400000061,350028205400000062,350028205400000064,350028205400000065,350028205400000066,350028205400000067,350028205400000068,350028205400000069,350028205400000070,350028205400000071,350028205400000072,350028205400000075,350028205400000076,350028205400000077,350028205400000079,350028205400000080,350028205400000081,350028205400000082,350028205400000084,350028205400000085,350028205400000086,350028205400000091,350028205400000092,350028205400000093,350028205400000095,350028205400000096	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-53,0-718					Patent	Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins (Patent US:6160106)	Kimchi	2000	0		EIF4G2,SNORD97
895	chr15	40734591	40744780	3500438386	3479		40734591	40744780	8421504	24	41,66,141,103,132,67,152,111,84,99,142,56,99,114,126,105,216,259,205,212,122,66,113,648	0,352,1043,1674,2452,2669,3305,3822,4089,4261,4798,5029,5091,5581,6285,6574,6766,7060,7638,8000,8293,9360,9427,9541	p,c,g	350043838600015169,350043838600000074,350043838600000075,350043838600015115,350043838600015171,350043838600000076,350043838600000076,350043838600015116,350043838600015172,350043838600000077,350043838600015117,350043838600015173,350043838600015118,350043838600000079,350043838600015175,350043838600000080,350043838600015120,350043838600015176,350043838600000081,350043838600000082,350043838600015122,350043838600015178,350043838600000083,350043838600015123,350043838600015179,350043838600000084,350043838600015124,350043838600015125,350043838600015181,350043838600015182,350043838600015127,350043838600015183,350043838600000088,350043838600015128,350043838600015184,350043838600000089,350043838600015129,350043838600015185,350043838600000090,350043838600015130,350043838600015186,350043838600000091,350043838600000092,350043838600015132,350043838600015188,350043838600000093,350043838600015189,350043838600000094,350043838600015134,350043838600000095,350043838600015135,350043838600015191,350043838600015136,350043838600015192,350043838600000097,350043838600015137,350043838600015194,350043838600000099,350043838600015139,350043838600015195,350043838600015140,350043838600000100,350043838600015196,350043838600015141,350043838600000101,350043838600015197,350043838600015142,350043838600000102,350043838600015198,350043838600000103,350043838600015199,350043838600015144,350043838600000104,350043838600015145,350043838600000105,350043838600015201,350043838600015146,350043838600000106,350043838600015202,350043838600015147,350043838600015148,350043838600015204,350043838600015149,350043838600000109,350043838600015205,350043838600000110,350043838600015151,350043838600000111,350043838600015207,350043838600015152,350043838600000112,350043838600015208,350043838600015153,350043838600000113,350043838600015154,350043838600000114,350043838600015210,350043838600000115,350043838600015211,350043838600015156,350043838600000116,350043838600015212,350043838600015157,350043838600015213,350043838600015158,350043838600000118,350043838600015214,350043838600015159,350043838600000119,350043838600015215,350043838600000120,350043838600015161,350043838600000121,350043838600015217,350043838600015218,350043838600015163,350043838600015164,350043838600015219,350043838600015165,350043838600015220,350043838600015166,350043838600000126,350043838600000127,350043838600015222,350043838600015168,350043838600000128,350043838600015223,350043838600000129,350043838600000130,350043838600000136,350043838600000136,350043838600000007,350043838600000007	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-42,0-761,10-31,10-31,10-31,10-31						US Patent # 6,316,225. Human Prt1-like subunit protein (hPrt1) polynucleotides - Patents.com	www.patents.com	0	0		
895	chr15	40734591	40744010	3500365297	44		40734591	40744010	8421504	2	24,20	0,9399	c	350036529700000000,350036529700000001	20-44,22-42		17237356	10.1261/rna.372307	1355-8382	RNA	The eIF4G&#x2013;homolog p97 can activate translation independent of caspase cleavage	Nousch	2007	5		EIF4G2
895	chr15	40740958	40740984	3500133607	23		40740958	40740984	8421504	2	6,17	0,9	g	350013360700000036	12-36						Virus vectors and methods of making and administering the same	Rabinowitz	2000	0		EIF4G2
895	chr15	40744009	40744087	3500175024	47		40744009	40744087	8421504	2	22,25	0,53	c	350017502400000008,350017502400000009	0-22,0-25						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
898	chr15	41038792	41044416	3500111450	228		41038792	41044416	8421504	2	101,127	0,5497	p	350011145000015028	0-228						24 human secreted proteins	Komatsoulis	2002	0		RNF141
898	chr15	41046068	41046094	3500098032	23		41046068	41046094	8421504	3	5,13,5	0,7,21	g	350009803200000745	8-31						Compositions and methods for increasing bone mineralization	Brunkow	2000	0		
899	chr15	41242949	41243184	3500345447	42		41242949	41243184	8421504	2	21,21	0,214	c,g	350034544700000001,350034544700000001,350034544700000000,350034544700000000	0-21,0-21,0-21,0-21		11514308			American Journal of Physiology - Heart and Circulatory Physiology	Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells	Saito	2001	0		
899	chr15	41242949	41243184	3500297845	42		41242949	41243184	8421504	2	21,21	0,214	c,g	350029784500000001,350029784500000001,350029784500000000,350029784500000000	0-21,0-21,0-21,0-21		11514308			American Journal of Physiology - Heart and Circulatory Physiology	Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells	Saito	2001	0		
903	chr15	41754643	41754718	3500258724	75		41754643	41754718	8421504	1	75	0	p	350025872400015015	0-75						Polypeptides	Dowler	2010	0		SBF2
903	chr15	41754643	41754709	3500102149	66		41754643	41754709	8421504	1	66	0	p	350010214900015019	0-66						Polypeptides	ALESSI	2004	0		SBF2
905	chr15	41946707	41946731	3500002984	24		41946707	41946731	8421504	1	24	0	c	350000298400000003	12-36						 <HTML> <HEAD> <TITLE> Binding of 14-3-3{beta} to the Carboxyl Terminus of Wee	.aacrjournals.org	0	0		WEE1
905	chr15	41955554	41957360	3500288727	40		41955554	41957360	8421504	3	13,7,20	0,579,1786	c	350028872700000003,350028872700000002	0-20,0-20		21918363	10.3858/emm.2011.43.12.074		Experimental & Molecular Medicine	Hypoxia induces Wee1 expression and attenuates hydrogen peroxide-induced endothelial damage in MS1 cells	Ki-Sun	2011	0		WEE1
905	chr15	41981484	41981532	3500096126	48		41981484	41981532	8421504	1	48	0	p	350009612600015000	0-48		17938208	10.1128/MCB.00846-07	0270-7306	Molecular and Cellular Biology	CHD8 Associates with Human Staf and Contributes to Efficient U6 RNA Polymerase III Transcription	Yuan	2007	6		ZNF143
906	chr15	42195418	42195447	3500284840	23		42195418	42195447	8421504	3	6,11,6	0,9,23	c	350028484000000034	5-28						Die Positionsklonierung als Strategie zur Isolierung und Charakterisierung retinaler Gene	.uni-wuerzburg.de	0	0		TMEM41B
907	chr15	42270224	42270255	3500228456	26		42270224	42270255	8421504	2	20,6	0,25	g	350022845600000532	0-32						Interleukin-3 (il-3) mutant polypeptides	Abrams	1995	0		
909	chr15	42508447	42513153	3500395807	270		42508447	42513153	8421504	4	120,81,36,33	0,4546,4632,4673	p	350039580700015036	0-282						71 human secreted proteins	Brewer	2000	0		
909	chr15	42514258	42514284	3500348062	26		42514258	42514284	8421504	1	26	0	c	350034806200000004	0-26						US Patent # 7,425,613. PRO1375 polypeptides - Patents.com	www.patents.com	0	0		
909	chr15	42514258	42514284	3500093458	26		42514258	42514284	8421504	1	26	0	c	350009345800000004	0-26						US Patent # 7,507,557. Nucleic acids encoding PRO1375 polypeptides - Patents.com	www.patents.com	0	0		
913	chr15	43039344	43039392	3500328758	48		43039344	43039392	8421504	1	48	0	p	350032875800015000	0-48			10.1111/j.1742-4658.2005.04900.x	1742-4658	FEBS Journal	Differential expression pattern of the novel serine/threonine kinase, STK33, in mice and men - Mujica - 2005 - FEBS Journal - Wiley Online Library	Mujica	2005	0		STK33
913	chr15	43042269	43042292	3500190042	23		43042269	43042292	8421504	1	23	0	g	350019004200000345	0-23						Oligonucleotide analogs having cationic intersubunit linkages - Patent application	www.faqs.org	0	0		
915	chr15	43342160	43363738	3500339663	60		43342160	43363738	8421504	3	21,1,38	0,12537,21540	c,g	350033966300000001,350033966300000008,350033966300000000,350033966300000000	0-21,0-21,0-20,0-20						OPEN-READING-FRAME (ORF) PHAGE DISPLAY	Li	2009	0		TUB
915	chr15	43342160	43363738	3500105072	60		43342160	43363738	8421504	3	21,1,38	0,12537,21540	c	350010507200000001,350010507200000039,350010507200000008,350010507200000031,350010507200000000	0-21,0-21,0-21,12-32,9-29						OPEN-READING-FRAME (ORF) PHAGE DISPLAY - Patent application	www.faqs.org	0	0		TUB
918	chr15	43661718	43661744	3500053431	24		43661718	43661744	8421504	2	9,15	0,11	g	350005343100000313	0-24					Patent	Binding agents which inhibit myostatin (Patent US:7928075)	Han	2011	0		
922	chr15	44227458	44227482	3500085939	23		44227458	44227482	8421504	2	5,18	0,6	g	350008593900000008	8-31		9547332	10.1084/jem.187.8.1205	0022-1007	The Journal of Experimental Medicine	Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity	Schneider	1998	14		
922	chr15	44264813	44265070	3500235713	44		44264813	44265070	8421504	2	22,22	0,235	c	350023571300000015,350023571300000014	0-22,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
926	chr15	44777830	44777855	3500403487	23		44777830	44777855	8421504	2	14,9	0,16	c	350040348700000017	8-31						Array-Based Identi&#xfb01;cation of Species of the Genera Enterococcus Granulicatella, and Streptococcus	jcm.asm.org	0	0		
931	chr15	45369649	45369681	3500289472	32		45369649	45369681	8421504	1	32	0	c	350028947200000037	13-45					Patent	Compositions and methods for the diagnosis of tumours (Patent EP:1626084)	Ashkenazi	2009	0		
931	chr15	45369649	45369681	3500286478	32		45369649	45369681	8421504	1	32	0	c	350028647800000039	13-45						Compositions and methods for the treatment of tumour	Ashkenazi	2002	0		
931	chr15	45372499	45372526	3500114509	23		45372499	45372526	8421504	2	10,13	0,14	c	350011450900000013,350011450900000017	3-26,3-26						&#x4e3b;&#x9898;&#xff1a;Exon | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
931	chr15	45383922	45390523	3500402165	1350		45383922	45390523	8421504	12	141,131,100,122,128,110,86,84,97,96,166,89	0,321,559,754,971,1206,1439,1624,1803,2070,2332,6512	p	350040216500015008	0-1350						REGENERATION AND SURVIVAL OF CARDIAC PROGENITORS AND CARDIOMYOCYTES WITH A STRETCH ACTIVATED TRANSCRIPTION FACTOR	Chien	2010	0		TAF10,ILK
931	chr15	45384282	45386037	3500431731	240		45384282	45386037	8421504	5	48,48,48,51,45	0,442,1298,1489,1710	c	350043173100000029,350043173100000024,350043173100000015,350043173100000013,350043173100000012	0-48,0-48,0-48,0-48,0-48						Integrin-linked kinase and its uses	Dedhar	2000	0		
931	chr15	45384571	45385390	3500422476	42		45384571	45385390	8421504	3	10,13,19	0,105,800	c,g	350042247600000003,350042247600000001,350042247600000001	0-23,0-19,0-19		22888305	10.1590/S1415-47572012005000028		Genetics and Molecular Biology	Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1)	Xiang-Yu	2012	0		ILK
931	chr15	45384571	45385390	3500411204	42		45384571	45385390	8421504	3	10,13,19	0,105,800	c,g	350041120400000003,350041120400000001,350041120400000001	0-23,0-19,0-19		22888305	10.1590/S1415-47572012005000028	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1)	Zhu	2012	1		ILK
931	chr15	45390502	45390525	3500227203	23		45390502	45390525	8421504	1	23	0	c,g	350022720300000000,350022720300000000	7-30,7-30		12631621		1078-0432	Clinical Cancer Research	Increased Resistance of Tumor Cells to Hyperthermia Mediated By Integrin-linked Kinase	Zhang	2003	8		ILK
931	chr15	45390502	45390525	3500072957	23		45390502	45390525	8421504	1	23	0	c,g	350007295700000000,350007295700000000	7-30,7-30		11733391	10.1161/hc4801.100792	0009-7322	Circulation	Protection Against Oxidized Low-Density Lipoprotein&#x2013;Induced Vascular Endothelial Cell Death by Integrin-Linked Kinase	Zhang	2001	15		ILK
932	chr15	45535920	45535949	3500273160	24		45535920	45535949	8421504	2	8,16	0,13	c	350027316000000047	14-38						Acetylcholine receptor subunits - Patent # 7198942 - PatentGenius	.patentgenius.com	0	0		
932	chr15	45567677	45567773	3500226249	96		45567677	45567773	8421504	1	96	0	p	350022624900015038,350022624900015039	0-48,0-48						Nima Interacting Proteins 	.freshpatents.com	0	0		APBB1
932	chr15	45567680	45567764	3500441152	81		45567680	45567764	8421504	2	45,36	0,48	p	350044115200015031	0-81						US Patent # 7,148,003. NIMA interacting proteins - Patents.com	www.patents.com	0	0		APBB1
932	chr15	45577356	45578006	3500217704	92		45577356	45578006	8421504	2	44,48	0,602	c	350021770400000070,350021770400000065	4-48,0-48					Patent	Acid sphingomyelinase gene (Patent US:5773278)	Desnick	1998	0		
932	chr15	45577392	45577695	3500050098	40		45577392	45577695	8421504	2	20,20	0,283	c,g	350005009800000001,350005009800000001,350005009800000000,350005009800000000	0-20,0-20,0-20,0-20		21893018	10.1016/j.ajpath.2011.07.019		The American Journal of Pathology	Acid Sphingomyelinase Gene Deficiency Ameliorates the Hyperhomocysteinemia-Induced Glomerular Injury in Mice	Krishna	2011	0		
932	chr15	45580736	45580764	3500235157	28		45580736	45580764	8421504	1	28	0	c	350023515700000053	19-47						METHODS AND COMPOSITIONS FOR TREATING P. ACNES - Patent application	www.faqs.org	0	0		
933	chr15	45655385	45655413	3500167246	23		45655385	45655413	8421504	2	11,12	0,16	g	350016724600000015	21-44						ANTIBODIES TO LYMPHOTOXIN-ALPHA	Adams	2011	0		
933	chr15	45655385	45655413	3500038669	23		45655385	45655413	8421504	2	11,12	0,16	g	350003866900000015	21-44						ANTIBODIES TO LYMPHOTOXIN-ALPHA - Patent application	www.faqs.org	0	0		
934	chr15	45745409	45748326	3500384752	288		45745409	45748326	8421504	3	10,179,99	0,2480,2818	p	350038475200015119,350038475200015121	0-180,0-108						48 human secreted proteins	Komatsoulis	2002	0		FAM160A2
934	chr15	45745409	45748326	3500375425	288		45745409	45748326	8421504	3	10,179,99	0,2480,2818	p	350037542500015119,350037542500015121	0-180,0-108						48 human secreted proteins	Komatsoulis	2000	0		FAM160A2
942	chr15	46859359	46859384	3500369501	23		46859359	46859384	8421504	2	13,10	0,15	g	350036950100000027	9-32						Protein kinases	Hoekstra	1994	0		
945	chr15	47194431	47194456	3500032952	25		47194431	47194456	8421504	1	25	0	c	350003295200000001	0-25		19494015	10.1128/JVI.00670-09	0022-538X	Journal of Virology	Truncation of TRIM5 in the Feliformia Explains the Absence of Retroviral Restriction in Cells of the Domestic Cat	McEwan	2009	5		TRIM5
949	chr15	47757389	47783875	3500358812	39		47757389	47783875	8421504	2	19,20	0,26466	g	350035881200000021,350035881200000011	1-20,0-20		16943425	10.1128/MCB.01770-05	0270-7306	Molecular and Cellular Biology	Antagonistic Regulation of &#x03b2;-Globin Gene Expression by Helix-Loop-Helix Proteins USF and TFII-I	Crusselle-Davis	2006	6		
949	chr15	47767910	47767935	3500193653	25		47767910	47767935	8421504	1	25	0	c	350019365300000018	0-25						Amplification of mRNA for distinguishing fetal cells in maternal blood	Asgari	1996	0		
949	chr15	47767910	47767935	3500169336	25		47767910	47767935	8421504	1	25	0	c	350016933600000017	0-25						Enriching and identifying fetal cells in maternal blood for in situ hybridization	Asgari	1995	0		
949	chr15	47768055	47794457	3500390269	64		47768055	47794457	8421504	2	24,40	0,26362	c	350039026900000077,350039026900000080	24-48,8-48					Patent	Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes (Patent US:5316931)	Dawson	1994	0		
949	chr15	47768055	47768079	3500420439	24		47768055	47768079	8421504	1	24	0	c	350042043900000080	24-48					Patent	Recombinant animal viral nucleic acids (Patent US:6054566)	Dawson	2000	0		
949	chr15	47768055	47768079	3500240042	24		47768055	47768079	8421504	1	24	0	c	350024004200000077	24-48						Recombinant plant viral nucleic acids	www.devileye.net	0	0		
949	chr15	47768055	47768079	3500229887	24		47768055	47768079	8421504	1	24	0	c	350022988700000078	24-48						US Patent # 5,589,367. Recombinant plant viral nucleic acids - Patents.com	www.patents.com	0	0		
949	chr15	47768055	47768079	3500128791	24		47768055	47768079	8421504	1	24	0	c	350012879100000078	24-48						US Patent # 5,889,190. Recombinant plant viral nucleic acids - Patents.com	www.patents.com	0	0		
949	chr15	47768055	47768079	3500096868	24		47768055	47768079	8421504	1	24	0	c	350009686800000077	24-48						US Patent # 5,316,931. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes - Patents.com	www.patents.com	0	0		
949	chr15	47768055	47768079	3500068931	24		47768055	47768079	8421504	1	24	0	c	350006893100000077	24-48					Patent	Recombinant plant viral nucleic acids (Patent US:5866785)	Dawson	1999	0		
118	chr15	47768097	47853497	3500090625	161		47768097	47853497	8421504	8	9,11,19,35,20,32,7,28	0,1099,9240,24966,63010,84900,85353,85372	c,g	350009062500000051,350009062500000138,350009062500000049,350009062500000078,350009062500000070,350009062500000157,350009062500000059,350009062500000146,350009062500000148,350009062500000079,350009062500000166,350009062500000002,350009062500000038,350009062500000080,350009062500000125,350009062500000042	0-20,0-20,7-26,0-24,0-24,0-26,0-20,0-20,7-27,0-24,0-27,0-27,0-27,0-24,0-30,0-28					Patent	Methods and compounds for curing diseases caused by mutations (Patent US:5760012)	Cole-Strauss	1998	0		
949	chr15	47769231	47793072	3500203465	54		47769231	47793072	8421504	2	24,30	0,23811	c	350020346500000049,350020346500000040	20-44,18-48						Detection of human .alpha.-thalassemia mutations and their use as predictors of blood-related disorders - Patent # 5750345 - PatentGenius	.patentgenius.com	0	0		
949	chr15	47777387	47777410	3500224203	23		47777387	47777410	8421504	1	23	0	c	350022420300000015	0-23						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		
949	chr15	47792951	47794594	3500375699	615		47792951	47794594	8421504	3	138,223,254	0,266,1389	c	350037569900000009,350037569900000011	10-543,25-361						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
949	chr15	47793003	47794466	3500288106	435		47793003	47794466	8421504	3	86,223,126	0,214,1337	p	350028810600015049,350028810600015048	0-435,0-420						Duke : SCIENCE 111 : complete notes on Bioinformatics	ww.coursehero.com	0	0		
949	chr15	47793003	47794466	3500204284	435		47793003	47794466	8421504	3	86,223,126	0,214,1337	p	350020428400015047	0-435						17727 Complete Notes on tics	www.scribd.com	0	0		
949	chr15	47793003	47794466	3500185699	435		47793003	47794466	8421504	3	86,223,126	0,214,1337	p	350018569900015049	0-435						Introduction to Bioinformatics	www.koshika.co.in	0	0		
949	chr15	47793003	47793089	3500324504	86		47793003	47793089	8421504	1	86	0	c,g	350032450400000004,350032450400000012,350032450400000012	0-86,0-86,0-86						A new 2D graphical representation&#x2014;Classi&#xfb01;cation curve and the analysis of similarity/dissimilarity of DNA sequences	.ds.wh.sdu.edu.cn	0	0		
949	chr15	47793003	47793089	3500028561	86		47793003	47793089	8421504	1	86	0	c,g	350002856100000009,350002856100000009	0-86,0-86						New spectral numerical characterization of DNA sequences	www.wseas.us	0	0		
949	chr15	47793003	47793089	3500020257	86		47793003	47793089	8421504	1	86	0	c,g	350002025700000016,350002025700000016,350002025700000008	0-86,0-86,0-86						Comparative DNA analysis	www.maths.lth.se	0	0		
949	chr15	47793006	47794466	3500448074	432		47793006	47794466	8421504	3	83,223,126	0,211,1334	c	350044807400000006,350044807400000005	0-431,0-432						Applications - CUNYHPC	wiki.csi.cuny.edu	0	0		
949	chr15	47793006	47794466	3500344424	432		47793006	47794466	8421504	3	83,223,126	0,211,1334	c,g	350034442400000005,350034442400000005,350034442400000006	0-432,0-432,0-431						Applications Environment - CUNYHPC	wiki.csi.cuny.edu	0	0		
949	chr15	47793006	47794466	3500035048	432		47793006	47794466	8421504	3	83,223,126	0,211,1334	c	350003504800000006,350003504800000005	0-431,0-432						Currently Supported User Level Applications - CUNYHPC	wiki.csi.cuny.edu	0	0		
949	chr15	47793006	47794466	3500027408	432		47793006	47794466	8421504	3	83,223,126	0,211,1334	c,g	350002740800000005,350002740800000005,350002740800000006	0-432,0-432,0-431						User Applications Currently Supported - CUNYHPC	wiki.csi.cuny.edu	0	0		
949	chr15	47793048	47793074	3500464628	26		47793048	47793074	8421504	1	26	0	c	350046462800000008	0-26						In Vivo Distribution of Human Adipose-Derived Mesenchymal Stem Cells in Novel Xenotransplantation Models	edivetarizona.com	0	0		
949	chr15	47793050	47793080	3500381460	30		47793050	47793080	8421504	1	30	0	c	350038146000000013	0-30					Patent	Process for amplifying and detecting nucleic acid sequences (Patent EP:0509612)	Arnheim	2001	0		
949	chr15	47793050	47793080	3500101486	30		47793050	47793080	8421504	1	30	0	c	350010148600000018	0-30						Process for amplifying nucleic acid sequences	Mullis	1992	0		
949	chr15	47793057	47793224	3500103146	39		47793057	47793224	8421504	2	32,7	0,160	c	350010314600000099,350010314600000002,350010314600000058	0-27,0-27,0-30						Methods and compounds for curing diseases caused by mutations	Cole-Strauss	1997	0		
949	chr15	47793063	47793385	3500369901	54		47793063	47793385	8421504	2	35,19	0,303	c,g	350036990100000078,350036990100000070,350036990100000157,350036990100000143,350036990100000056,350036990100000146,350036990100000059,350036990100000049,350036990100000136	0-24,0-24,0-26,0-23,0-23,0-20,0-20,7-26,7-26					Patent	Methods and compounds for curing diseases caused by mutations (Patent US:5760012)	Cole-Strauss	1998	0		
949	chr15	47793066	47793224	3500004405	30		47793066	47793224	8421504	2	23,7	0,151	c	350000440500000125	0-30						US Patent # 5,760,012. Methods and compounds for curing diseases caused by mutations - Patents.com	www.patents.com	0	0		
949	chr15	47793217	47793241	3500226355	24		47793217	47793241	8421504	1	24	0	c	350022635500000010	0-24						cAMP-responseElement-bindingProtein(CREB)Controls MSK1-mediatedPhosphorylationofHistoneH3atthec-fos Promoter inVitro S	www.jbc.org	0	0		HBB
949	chr15	47793270	47819279	3500021938	43		47793270	47819279	8421504	2	23,20	0,25989	c	350002193800000007,350002193800000005	9-32,0-20			10.1128/JVI.76.21.10942-10950.2002		Journal of Virology	A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration	Una	2002	0		HBB
949	chr15	47793371	47793425	3500153110	54		47793371	47793425	8421504	1	54	0	p	350015311000015024	0-54						0387097597	www.scribd.com	0	0		
949	chr15	47793378	47819286	3500394104	94		47793378	47819286	8421504	2	62,32	0,25876	c	350039410400000027,350039410400000034	4-66,8-40						Nucleotide Sequence Analysis of the Lemur P-Globin Gene Family: Evidence for Major Rate Fluctuations in Globin Polypeptide Evolution&#x2019;	brary.arizona.edu	0	0		
949	chr15	47793401	47793430	3500285325	29		47793401	47793430	8421504	1	29	0	c	350028532500000020	0-29			10.1128/MCB.01033-06		Molecular and Cellular Biology	Distinct Functions of Dispersed GATA Factor Complexes at an Endogenous Gene Locus	Jeffrey	2006	0		HBB
949	chr15	47794419	47794458	3500363337	39		47794419	47794458	8421504	1	39	0	c	350036333700000014	11-50						Thermostable DNA polymerase from Thermoanaerobacter thermohydrosulfuricus	Mamone	1996	0		
949	chr15	47794419	47794458	3500335612	39		47794419	47794458	8421504	1	39	0	c	350033561200000014	11-50						Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus and mutant enzymes thereof with exonuclease activity removed	Davis	1997	0		
118	chr15	47819263	47854272	3500229887	115		47819263	47854272	8421504	5	20,44,4,27,20	0,33722,34187,34383,34989	c	350022988700000075,350022988700000074,350022988700000079	15-35,0-48,0-47						US Patent # 5,589,367. Recombinant plant viral nucleic acids - Patents.com	www.patents.com	0	0		
118	chr15	47819263	47853027	3500033219	60		47819263	47853027	8421504	2	20,40	0,33724	c	350003321900000020,350003321900000019	21-41,5-45						Low oxygen affinity mutant hemoglobin	Ho	1995	0		
118	chr15	47819426	47852911	3500114290	40		47819426	47852911	8421504	2	20,20	0,33465	c	350011429000000009,350011429000000008	0-20,0-20						Alternative splicing of protein 4.1R exon 16: ordered excision of &#xfb02;anking introns ensures proper splice site choice	tologylibrary.org	0	0		HBB
950	chr15	47852886	47852911	3500207504	25		47852886	47852911	8421504	1	25	0	c	350020750400000002	0-25		16818958		0161-5505	Journal of Nuclear Medicine	Noninvasive Molecular Imaging to Detect Transgene Expression of Lentiviral Vector in Nonhuman Primates	Sander	2006	6		
950	chr15	47852897	47853013	3500154097	50		47852897	47853013	8421504	2	27,23	0,93	c	350015409700000000,350015409700000001	0-27,0-23						scholarship full: [PozHealth] NATAP: Diet/Exercise/Lifestyle Improves Aging-Related Measure Telomerase [1 Attachment]	full.blogspot.com	0	0		
950	chr15	47852897	47852924	3500022709	27		47852897	47852924	8421504	1	27	0	c	350002270900000009	0-27						Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIP	biomedcentral.com	0	0		HBB
950	chr15	47852898	47853017	3500324166	53		47852898	47853017	8421504	2	26,27	0,92	c	350032416600000003,350032416600000004	0-26,0-27						World Journal of Gastroenterology	www.wjgnet.com	0	0		HBB
950	chr15	47852898	47853017	3500206887	53		47852898	47853017	8421504	2	26,27	0,92	c	350020688700000003,350020688700000004	0-26,0-27						World Journal of Gastroenterology	www.wjgnet.com	0	0		HBB
950	chr15	47852898	47852924	3500104098	26		47852898	47852924	8421504	1	26	0	c	350010409800000831	20-46						METHOD OF DETECTING HUMAN PAPILLOMA VIRUS BY USING NUCLEIC ACID AMPLIFICATION METHOD AND NUCLEIC ACID CHAIN-IMMOBILIZED CARRIER - Patent application	www.faqs.org	0	0		
950	chr15	47852918	47852944	3500079928	24		47852918	47852944	8421504	2	9,15	0,11	c	350007992800000000	9-33		19098001	10.1074/jbc.M805681200		The Journal of Biological Chemistry	Humanized Mouse Model of Cooley's Anemia	Yongliang	2009	0		HBB
950	chr15	47852985	47853454	3500420439	48		47852985	47853454	8421504	2	44,4	0,465	c	350042043900000076	0-48					Patent	Recombinant animal viral nucleic acids (Patent US:6054566)	Dawson	2000	0		
950	chr15	47852985	47853454	3500240042	48		47852985	47853454	8421504	2	44,4	0,465	c	350024004200000073	0-48						Recombinant plant viral nucleic acids	www.devileye.net	0	0		
950	chr15	47852985	47853454	3500128791	48		47852985	47853454	8421504	2	44,4	0,465	c	350012879100000074	0-48						US Patent # 5,889,190. Recombinant plant viral nucleic acids - Patents.com	www.patents.com	0	0		
950	chr15	47852987	47853027	3500020257	40		47852987	47853027	8421504	1	40	0	g	350002025700000013	49-89						Comparative DNA analysis	www.maths.lth.se	0	0		
950	chr15	47852988	47853014	3500442885	26		47852988	47853014	8421504	1	26	0	c	350044288500000012	0-26						Aplicatii Clinice Al Tehnicii PCR	www.scribd.com	0	0		
950	chr15	47852988	47853014	3500308962	26		47852988	47853014	8421504	1	26	0	c	350030896200000029	0-26						METHODS IN MOLECULAR BIOLOGY Clinical Applications of PCR	.researchgate.net	0	0		
950	chr15	47852988	47853014	3500216500	26		47852988	47853014	8421504	1	26	0	c	350021650000000005	0-26		15113879	10.1128/JVI.78.10.4993-4998.2004	0022-538X	Journal of Virology	A Sequence-Independent Strategy for Detection and Cloning of Circular DNA Virus Genomes by Using Multiply Primed Rolling-Circle Amplification	Rector	2004	5		
950	chr15	47852988	47853014	3500184922	26		47852988	47853014	8421504	1	26	0	c	350018492200000002	0-26						UNIVERSITE DE VERSAILLES SAINT-QUENTIN-EN-YVELINES UFR des sciences Ecole doctorale des G&#xe9;nomes aux organismes THESE	www.irsn.fr	0	0		
950	chr15	47852988	47853014	3500153816	26		47852988	47853014	8421504	1	26	0	c	350015381600000029	0-26						METHODS IN MOLECULAR BIOLOGY Clinical Applications of PCR	.researchgate.net	0	0		
950	chr15	47852988	47853014	3500152777	26		47852988	47853014	8421504	1	26	0	c	350015277700000029	0-26						METHODS IN MOLECULAR BIOLOGY Clinical Applications of PCR	.researchgate.net	0	0		
950	chr15	47852988	47853014	3500068718	26		47852988	47853014	8421504	1	26	0	c	350006871800000017	0-26						Noninvasive Metabolic Assessment of Single Cells	lib.fk.uwks.ac.id	0	0		
950	chr15	47852988	47853014	3500051575	26		47852988	47853014	8421504	1	26	0	c	350005157500000002	0-26		17704326	10.1259/bjr/25927054	0007-1285	British Journal of Radiology	Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model	Mouiseddine	2007	1		
950	chr15	47852988	47853013	3500117448	25		47852988	47853013	8421504	1	25	0	c	350011744800000009	0-25						Inginerie Genetica	ro.scribd.com	0	0		
950	chr15	47852990	47853357	3500406453	49		47852990	47853357	8421504	2	30,19	0,348	c,g	350040645300000020,350040645300000022	0-30,3-22						Kit for use in amplifying and detecting nucleic acid sequences	Arnheim	1992	0		
950	chr15	47852990	47853020	3500375815	30		47852990	47853020	8421504	1	30	0	c	350037581500000020	0-30						Process for amplifying and detecting nucleic acid sequences	Arnheim	1992	0		
950	chr15	47852990	47853020	3500044571	30		47852990	47853020	8421504	1	30	0	c	350004457100000026	0-30						US Patent # 4,683,202. Process for amplifying nucleic acid sequences - Patents.com	www.patents.com	0	0		
950	chr15	47852990	47853013	3500432998	23		47852990	47853013	8421504	1	23	0	c	350043299800000001	0-23						Articles Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study	ess.thelancet.com	0	0		
950	chr15	47852992	47853451	3500113156	38		47852992	47853451	8421504	2	37,1	0,458	c	350011315600000094,350011315600000122,350011315600000124	0-26,0-26,0-25						M E T H O D S I N M O L E C U L A R M E D I C I N E Pediatric Hematology	dokteranakku.com	0	0		
950	chr15	47852997	47854272	3500369901	96		47852997	47854272	8421504	5	32,7,28,9,20	0,453,472,667,1255	c	350036990100000079,350036990100000166,350036990100000078,350036990100000002,350036990100000125,350036990100000167,350036990100000042,350036990100000051,350036990100000138	0-24,0-27,0-24,0-27,0-30,0-27,0-28,0-27,0-29					Patent	Methods and compounds for curing diseases caused by mutations (Patent US:5760012)	Cole-Strauss	1998	0		
950	chr15	47853003	47854297	3500413480	114		47853003	47854297	8421504	4	26,28,15,45	0,447,655,1249	c	350041348000000061,350041348000000069	6-60,0-60						and BLASTN AGAAACCAAAACGAAAGGTGCAGAA AACGAAAGGTGCAGAAGGGGAA GAAGGGGAA	arlandscience.com	0	0		
950	chr15	47853004	47853027	3500286292	23		47853004	47853027	8421504	1	23	0	c	350028629200000010	9-32						Recombinase-Based Methods for Producing Expression Vectors and Compositions for Use in Practicing the Same - Patent application	www.faqs.org	0	0		
950	chr15	47853005	47853029	3500295916	24		47853005	47853029	8421504	1	24	0	c	350029591600000011	0-24			10.1128/MCB.24.10.4174-4183.2004		Molecular and Cellular Biology	Polypyrimidine Tract Binding Protein Modulates Efficiency of Polyadenylation	Pedro	2004	0		
950	chr15	47853470	47853493	3500079736	23		47853470	47853493	8421504	1	23	0	c	350007973600000032	0-23						METHODS IN MOLECULAR BIOLOGY	jpkc.yzu.edu.cn	0	0		HBB
950	chr15	47853646	47853671	3500092608	25		47853646	47853671	8421504	1	25	0	c	350009260800000000	0-25		12773579	10.1128/MCB.23.12.4401-4415.2003	0270-7306	Molecular and Cellular Biology	Accumulation of Fra-1 in ras-Transformed Cells Depends on Both Transcriptional Autoregulation and MEK-Dependent Posttranslational Stabilization	Casalino	2003	6		
950	chr15	47853658	47854267	3500148947	30		47853658	47854267	8421504	2	15,15	0,594	c	350014894700000001	0-30		11827980	10.1083/jcb.200107017	0021-9525	The Journal of Cell Biology	Disassembly of interchromatin granule clusters alters the coordination of transcription and pre-mRNA splicing	Sacco-Bubulya	2002	10		HBB
950	chr15	47853660	47854265	3500416974	26		47853660	47854265	8421504	2	13,13	0,592	c	350041697400000045	0-26						Curriculum Vitae Beth E. Zucconi Education	hsl.umaryland.edu	0	0		
950	chr15	47853670	47854272	3500402965	23		47853670	47854272	8421504	2	3,20	0,582	c	350040296500000025	0-23					Patent	Hemoglobin-like protein comprising genetically fused globin-like polypeptides (Patent US:5844088)	Anderson	1998	0		
950	chr15	47853670	47854272	3500068793	23		47853670	47854272	8421504	2	3,20	0,582	c	350006879300000012	0-23					Patent	DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin (Patent US:5744329)	Anderson	1998	0		
950	chr15	47853670	47854272	3500013442	23		47853670	47854272	8421504	2	3,20	0,582	c	350001344200000088,350001344200000025	0-23,0-23						 DNA Encoding Fused Di 	www.docstoc.com	0	0		
960	chr15	49235558	49235584	3500425708	26		49235558	49235584	8421504	1	26	0	g	350042570800000017	0-26						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: "Exome sequencing identifies a missense mutation in Isl1 associated with low penetrance otitis media in dearisch mice" 	tailieu.vn/doc/ba	0	0		
963	chr15	49654033	49654056	3500361379	23		49654033	49654056	8421504	1	23	0	g	350036137900000020	4-27						Anti-pathogen system and methods of use thereof	Dowdy	1998	0		
963	chr15	49658965	49658993	3500258314	23		49658965	49658993	8421504	2	14,9	0,19	g	350025831400000106	22-45					Patent	Oligonucleotides for amplifying Chlamydophila pneumoniae nucleic acid (Patent US:8188258)	Cunningham	2012	0		
965	chr15	49920107	49920136	3500092584	24		49920107	49920136	8421504	2	15,9	0,20	g	350009258400000005	9-33						Genetically modified phage and use thereof	SZPIRER	2013	0		
966	chr15	49985686	49992272	3500104439	738		49985686	49992272	8421504	4	408,96,231,3	0,903,2259,6583	p	350010443900015003	0-738						Wisconsin : M M & I 740 : Mattinen_MMI740	ww.coursehero.com	0	0		
967	chr15	50075139	50075165	3500369845	25		50075139	50075165	8421504	2	12,13	0,13	g	350036984500000101	2-27						LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof - Patent application	www.faqs.org	0	0		
968	chr15	50317422	50317447	3500101722	25		50317422	50317447	8421504	1	25	0	c	350010172200000017	7-32						Oncolytic viruses and methods for treating neoplastic disorders	Evans	2011	0		RRM1
968	chr15	50317422	50317447	3500027604	25		50317422	50317447	8421504	1	25	0	c	350002760400000017	7-32						ONCOLYTIC VIRUSES AND METHODS FOR TREATING NEOPLASTIC DISORDERS - THE GOVERNORS OF THE UNIVERSITY OF ALBERTA	www.sumobrain.com	0	0		RRM1
969	chr15	50342268	50342296	3500157397	28		50342268	50342296	8421504	1	28	0	c	350015739700000004	0-28						The human cytomegalovirus UL45 gene product is a late, virion-associated protein and in&#xfb02;uences virus growth at low multiplicities of infection	v.sgmjournals.org	0	0		
969	chr15	50360891	50379013	3500096485	365		50360891	50379013	8421504	7	42,14,34,41,63,123,48	0,5016,8093,8182,8660,9231,18074	c	350009648500000322,350009648500000353,350009648500000068,350009648500000268,350009648500000064,350009648500000346,350009648500000345,350009648500000153,350009648500000061,350009648500000152,350009648500000053,350009648500000336	0-42,0-48,0-41,0-24,0-48,0-48,0-48,0-48,6-48,6-48,0-48,0-48						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
969	chr15	50360891	50379010	3500036684	357		50360891	50379010	8421504	7	87,35,51,41,66,30,47	0,151,8124,8182,8657,9231,18072	c	350003668400000242,350003668400000241,350003668400000166,350003668400000229,350003668400000156,350003668400000155,350003668400000224,350003668400000151,350003668400000223,350003668400000213	0-39,0-48,0-35,0-48,0-48,0-41,0-48,0-48,0-48,0-47						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
969	chr15	50360894	50360981	3500434154	87		50360894	50360981	8421504	1	87	0	p,c	350043415400000003,350043415400015001	12-33,3-90		18448669	10.1091/mbc.E08-02-0146	1059-1524	Molecular Biology of the Cell	Dynamic Movement of the Calcium Sensor STIM1 and the Calcium Channel Orai1 in Activated T-Cells: Puncta and Distal Caps	Barr	2008	5		RRM1
969	chr15	50360894	50360981	3500433782	87		50360894	50360981	8421504	1	87	0	p	350043378200015017	0-87						NPG.nature.vol.437.Issue.7060.Oct	www.scribd.com	0	0		RRM1
969	chr15	50360894	50360981	3500145888	87		50360894	50360981	8421504	1	87	0	p,c	350014588800000003,350014588800015002	12-33,3-90						Dynamic movement of the calcium sensor STIM1 and the calcium channel Orai1 in activated T cells: puncta and distal caps Valarie A. Barr*, Kelsie M. Bernot*, Sonal Srikanth&#x2020;&#x2021;, Yousang Gwack&#x2020;&#x2021;, Lakshmi	w.molbiolcell.org	0	0		RRM1
969	chr15	50360894	50360945	3500385688	51		50360894	50360945	8421504	1	51	0	p	350038568800015002	3-54		21746875	10.1128/MCB.05140-11	0270-7306	Molecular and Cellular Biology	Stanniocalcin 2 Is a Negative Modulator of Store-Operated Calcium Entry	Zeiger	2011	6		RRM1
969	chr15	50368997	50379007	3500399531	191		50368997	50379007	8421504	6	42,24,31,11,41,42	0,92,192,516,534,9968	c	350039953100000886,350039953100000266,350039953100000882,350039953100000881,350039953100000144,350039953100000333,350039953100000053	0-42,0-24,0-42,0-41,0-42,0-42,0-42						 Methods Of Modulating And Identifying Agents That Modulate Intracellular Calcium 	www.docstoc.com	0	0		
969	chr15	50369089	50370245	3500138257	114		50369089	50370245	8421504	3	24,48,42	0,462,1114	c	350013825700000268,350013825700000064,350013825700000344	0-24,0-48,6-48						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
969	chr15	50378928	50378955	3500432198	27		50378928	50378955	8421504	1	27	0	c	350043219800000003	0-27		19332490	10.1113/jphysiol.2009.172254	0022-3751	The Journal of Physiology	TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2009	5		STIM1
969	chr15	50378928	50378955	3500413046	27		50378928	50378955	8421504	1	27	0	c	350041304600000003	0-27		20739625	10.1152/ajpcell.00548.2009		American Journal of Physiology - Cell Physiolog	Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2010	0		STIM1
969	chr15	50378928	50378955	3500246914	27		50378928	50378955	8421504	1	27	0	c,g	350024691400000003,350024691400000003	0-27,0-27		20739625	10.1152/ajpcell.00548.2009	0363-6143	American Journal of Physiology - Cell Physiology	Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2010	4		STIM1
969	chr15	50378928	50378955	3500197829	27		50378928	50378955	8421504	1	27	0	c,g	350019782900000003,350019782900000003	0-27,0-27		20739625	10.1152/ajpcell.00548.2009		American Journal of Physiology - Cell Physiology	Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2010	0		STIM1
969	chr15	50378928	50378955	3500181400	27		50378928	50378955	8421504	1	27	0	c	350018140000000003	0-27		19332490	10.1113/jphysiol.2009.172254	1469-7793	The Journal of Physiology	TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells - Ng - 2009 - The Journal of Physiology - Wiley Online Library	Ng	2009	0		STIM1
969	chr15	50378928	50378955	3500045843	27		50378928	50378955	8421504	1	27	0	c	350004584300000003	0-27		19332490	10.1113/jphysiol.2009.172254		The Journal of Physiology	TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Lih	June	0		STIM1
121	chr15	50458906	50671336	3500036684	171		50458906	50671336	8421504	5	48,48,48,10,17	0,3277,35165,63149,212413	c	350003668400000211,350003668400000136,350003668400000134,350003668400000012	0-48,0-48,0-48,0-27						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
121	chr15	50458957	50671347	3500399531	246		50458957	50671347	8421504	7	31,62,45,18,57,5,28	0,3209,3274,35210,62977,63103,212362	c	350039953100000330,350039953100000049,350039953100000048,350039953100000045,350039953100000136,350039953100000861,350039953100000042	0-48,0-45,0-45,0-48,0-48,0-48,15-48						 Methods Of Modulating And Identifying Agents That Modulate Intracellular Calcium 	www.docstoc.com	0	0		
121	chr15	50462183	50494071	3500096485	96		50462183	50494071	8421504	2	95,1	0,31887	c	350009648500000049,350009648500000332,350009648500000048	0-48,0-41,0-48						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
969	chr15	50462183	50462231	3500138257	48		50462183	50462231	8421504	1	48	0	c	350013825700000049,350013825700000332	0-48,0-41						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
970	chr15	50521944	50521968	3500432198	24		50521944	50521968	8421504	1	24	0	c	350043219800000002	0-24		19332490	10.1113/jphysiol.2009.172254	0022-3751	The Journal of Physiology	TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2009	5		STIM1
970	chr15	50521944	50521968	3500413046	24		50521944	50521968	8421504	1	24	0	c	350041304600000002	0-24		20739625	10.1152/ajpcell.00548.2009		American Journal of Physiology - Cell Physiolog	Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2010	0		STIM1
970	chr15	50521944	50521968	3500246914	24		50521944	50521968	8421504	1	24	0	c,g	350024691400000002,350024691400000002	0-24,0-24		20739625	10.1152/ajpcell.00548.2009	0363-6143	American Journal of Physiology - Cell Physiology	Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2010	4		STIM1
970	chr15	50521944	50521968	3500197829	24		50521944	50521968	8421504	1	24	0	c	350019782900000002	0-24		20739625	10.1152/ajpcell.00548.2009		American Journal of Physiology - Cell Physiology	Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2010	0		
970	chr15	50521944	50521968	3500181400	24		50521944	50521968	8421504	1	24	0	c	350018140000000002	0-24		19332490	10.1113/jphysiol.2009.172254	1469-7793	The Journal of Physiology	TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells - Ng - 2009 - The Journal of Physiology - Wiley Online Library	Ng	2009	0		
970	chr15	50521944	50521968	3500045843	24		50521944	50521968	8421504	1	24	0	c	350004584300000002	0-24		19332490	10.1113/jphysiol.2009.172254		The Journal of Physiology	TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Lih	June	0		
970	chr15	50521947	50521976	3500353675	29		50521947	50521976	8421504	1	29	0	c	350035367500000003	0-29						ONLINE-SUPPLEMENT-ZHANG ET AL-CIRC-RES-Orai1-2011-R1	s.ahajournals.org	0	0		
970	chr15	50521947	50521976	3500209634	29		50521947	50521976	8421504	1	29	0	c	350020963400000037	0-29						Nature CellBiology	www.scribd.com	0	0		
121	chr15	50522060	50671452	3500399531	76		50522060	50671452	8421504	3	5,23,48	0,149259,149344	c	350039953100000809,350039953100000807	8-36,0-48						 Methods Of Modulating And Identifying Agents That Modulate Intracellular Calcium 	www.docstoc.com	0	0		
121	chr15	50522060	50671347	3500036684	33		50522060	50671347	8421504	2	5,28	0,149259	c	350003668400000129	15-48						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
971	chr15	50671404	50671452	3500138257	48		50671404	50671452	8421504	1	48	0	c	350013825700000323	0-48						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
971	chr15	50671404	50671452	3500096485	48		50671404	50671452	8421504	1	48	0	c	350009648500000323	0-48						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
971	chr15	50698371	50698973	3500382374	596		50698371	50698973	8421504	5	161,40,16,105,274	0,162,204,221,328	c	350038237400000002	29-685						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
971	chr15	50698371	50698973	3500360633	597		50698371	50698973	8421504	5	161,38,19,105,274	0,162,201,221,328	c	350036063300000001	29-685						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
971	chr15	50698371	50698973	3500221817	597		50698371	50698973	8421504	5	161,38,19,105,274	0,162,201,221,328	c	350022181700000002	29-685					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
971	chr15	50698371	50698973	3500101798	597		50698371	50698973	8421504	5	161,38,19,105,274	0,162,201,221,328	c	350010179800000002	29-685						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
971	chr15	50709016	50709043	3500308698	24		50709016	50709043	8421504	2	11,13	0,14	c	350030869800000078	4-28						METHODS OF TREATMENT UTILIZING BINDING PROTEINS OF THE INTERLEUKIN-21 RECEPTOR - Patent application	www.faqs.org	0	0		
974	chr15	51057013	51057038	3500408649	25		51057013	51057038	8421504	1	25	0	c	350040864900000178	0-25						HBM variants that modulate bone mass and lipid levels	Allen	2008	0		NUMA1
974	chr15	51057013	51057038	3500003080	25		51057013	51057038	8421504	1	25	0	c	350000308000000740	0-25						US Patent # 7,285,400. High bone mass gene of 11q13.3 - Patents.com	www.patents.com	0	0		
974	chr15	51067007	51067031	3500362353	24		51067007	51067031	8421504	1	24	0	c	350036235300000002	0-24		12944923	10.1038/sj.onc.1206855	0950-9232	Oncogene	Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders	Ota	2003	6		NUMA1
974	chr15	51069450	51069478	3500252985	24		51069450	51069478	8421504	3	11,8,5	0,13,23	c	350025298500000103	20-44					Patent	DNA encoding phosphoenolpyruvate carboxykinase, recombinant vector and transformed plant containing the same (Patent US:5880334)	Arai	1999	0		
974	chr15	51069450	51069478	3500021221	24		51069450	51069478	8421504	3	11,8,5	0,13,23	c	350002122100000103	20-44						US Patent # 5,880,334. DNA encoding phosphoenolpyruvate carboxykinase, recombinant vector and transformed plant containing the same - Patents.com	www.patents.com	0	0		
974	chr15	51109522	51109549	3500278645	25		51109522	51109549	8421504	2	6,19	0,8	g	350027864500000015	5-43						Recombinant vesiculoviruses and their uses		1997	0		
975	chr15	51146055	51146078	3500464289	23		51146055	51146078	8421504	1	23	0	c	350046428900000119,350046428900000172	18-40,0-20						High bone mass gene of 11q13.3	Carulli	2000	0		LAMTOR1
975	chr15	51146055	51146078	3500361009	23		51146055	51146078	8421504	1	23	0	c,g	350036100900000126,350036100900000179,350036100900000179	18-40,0-20,0-20						Transgenic Animal Model Of Bone Mass Modulation 	.freshpatents.com	0	0		
975	chr15	51200157	51204013	3500321598	666		51200157	51204013	8421504	4	108,189,136,233	0,2960,3349,3623	p,c	350032159800015035,350032159800015076,350032159800015093,350032159800015037,350032159800015077,350032159800000242	0-96,0-96,0-570,0-570,0-570,8-88						Induction of tumor immunity by variants of folate binding protein	Ioannides	2002	0		
975	chr15	51200262	51203195	3500249301	44		51200262	51203195	8421504	3	3,11,30	0,2855,2903	c	350024930100000241	8-88						Induction of tumor immunity by variants of folate binding protein - US Patent 7547759 Description	ww.patentstorm.us	0	0		
975	chr15	51217512	51217560	3500147454	48		51217512	51217560	8421504	1	48	0	p	350014745400015007	0-48						THERAPEUTIC AGENT FOR ARTERIOSCLEROSIS OR ARTERIOSCLEROTIC DISEASE, AND DIAGNOSTIC AGENT FOR ARTERIOSCLEROSIS OR ARTERIOSCLEROTIC DISEASE - Patent application	www.faqs.org	0	0		
976	chr15	51250354	51250493	3500041674	23		51250354	51250493	8421504	3	7,3,13	0,11,126	c	350004167400000132	7-37						Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries - Patent application	www.faqs.org	0	0		
976	chr15	51254789	51254814	3500230330	25		51254789	51254814	8421504	1	25	0	c	350023033000000074,350023033000000308,350023033000000914	26-48,11-33,0-24						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
122	chr15	51560124	51656772	3500007115	4149		51560124	51656772	8421504	35	391,1020,83,24,113,100,75,48,88,123,71,87,75,113,178,73,64,40,112,131,69,42,24,15,6,17,154,60,56,106,54,90,62,166,219	0,409,1773,2004,2396,2759,3010,4123,4408,4821,5217,5705,6697,7431,7760,8077,8890,9092,9610,13635,14036,14640,14784,14844,15043,15079,15326,16290,21595,22410,31920,35572,58114,68712,96429	c,g	350000711500000190,350000711500000190,350000711500000189,350000711500000252,350000711500000188,350000711500000187,350000711500000187,350000711500000251,350000711500000186,350000711500000250,350000711500000185,350000711500000249,350000711500000184,350000711500000308,350000711500000183,350000711500000248,350000711500000182,350000711500000181,350000711500000245,350000711500000179,350000711500000244,350000711500000178,350000711500000243,350000711500000177,350000711500000242,350000711500000176,350000711500000241,350000711500000175,350000711500000240,350000711500000174,350000711500000239,350000711500000173,350000711500000172,350000711500000237,350000711500000296,350000711500000171,350000711500000236,350000711500000295,350000711500000193,350000711500000235,350000711500000294,350000711500000169,350000711500000234,350000711500000293,350000711500000168,350000711500000233,350000711500000292,350000711500000232,350000711500000166,350000711500000231,350000711500000165,350000711500000229,350000711500000163,350000711500000228,350000711500000162,350000711500000227,350000711500000161,350000711500000226,350000711500000160,350000711500000225,350000711500000284,350000711500000159,350000711500000224,350000711500000158,350000711500000223,350000711500000157,350000711500000222,350000711500000156,350000711500000221,350000711500000280,350000711500000155,350000711500000220,350000711500000154,350000711500000153,350000711500000218,350000711500000277,350000711500000152,350000711500000276,350000711500000151,350000711500000216,350000711500000150,350000711500000149,350000711500000149,350000711500000214,350000711500000148,350000711500000213,350000711500000147,350000711500000212,350000711500000146,350000711500000145,350000711500000436,350000711500000208,350000711500000142,350000711500000207,350000711500000141,350000711500000141,350000711500000206,350000711500000205,350000711500000204,350000711500000138,350000711500000264,350000711500000203,350000711500000137,350000711500000202,350000711500000136,350000711500000201,350000711500000135,350000711500000199,350000711500000133,350000711500000198,350000711500000132,350000711500000131,350000711500000130,350000711500000254,350000711500000194	0-391,0-391,0-462,0-783,0-282,0-53,0-53,0-42,0-48,0-48,0-48,0-117,0-48,68-112,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,8-250,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,12-60,9-57,10-58,10-58,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-21,19-66,13-61,0-48,16-64,16-64,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-229,11-50,0-210						DNA encoding mammalian phosphodiesterases	Beavo	1992	0		
978	chr15	51561342	51566864	3500106629	70		51561342	51566864	8421504	3	23,1,46	0,4609,5476	c	350010662900000001,350010662900000020,350010662900000021	9-32,0-47,0-47						UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL CENTRO DE BIOTECNOLOGIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM BIOLOGIA CELULAR E MOLECULAR	www.lume.ufrgs.br	0	0		
978	chr15	51562526	51564947	3500441396	357		51562526	51564947	8421504	11	33,45,23,22,27,66,6,48,39,46,2	0,36,84,357,430,608,677,1721,2006,2048,2419	p	350044139600015050,350044139600015048,350044139600015047,350044139600015046,350044139600015045	0-123,0-48,0-45,0-48,0-93						US Patent # 7,270,975. Methods for regulating bud-hypha transitions and cAMP levels in Candida albicans - Patents.com	www.patents.com	0	0		PDE2A
978	chr15	51569253	51569779	3500441301	48		51569253	51569779	8421504	2	3,45	0,481	p	350044130100015001	0-48						Methods For Treatment Of Scleroderma 	.freshpatents.com	0	0		PDE2A
979	chr15	51656568	51656592	3500106629	24		51656568	51656592	8421504	1	24	0	c	350010662900000002,350010662900000000	13-37,9-33						UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL CENTRO DE BIOTECNOLOGIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM BIOLOGIA CELULAR E MOLECULAR	www.lume.ufrgs.br	0	0		
980	chr15	51791410	51792190	3500152738	66		51791410	51792190	8421504	2	64,2	0,778	p	350015273800015065	0-66						Molecular genetic strategies to identify Obsessive-compulsive disorder (OCD) and schizophrenia candidate genes in a South African sub-population group	scholar.sun.ac.za	0	0		
983	chr15	52182380	52183058	3500176314	144		52182380	52183058	8421504	3	48,48,48	0,483,630	c	350017631400000015,350017631400000024,350017631400000027	0-48,0-48,0-48						DNA Encoding the human P2U receptor and null cells expressing P2U receptors	Boucher	1995	0		
983	chr15	52246387	52246410	3500060896	23		52246387	52246410	8421504	1	23	0	c	350006089600000080	4-27						Polypeptides and polynucleotides from coagulase-negative staphylococci	Foster	1999	0		
983	chr15	52246387	52246410	3500028179	23		52246387	52246410	8421504	1	23	0	c	350002817900000086	4-27						Polypeptides And Polynucleotides From Coagulase-negative Staphylococci 	.freshpatents.com	0	0		
983	chr15	52248407	52248461	3500448143	54		52248407	52248461	8421504	1	54	0	p	350044814300015000	3-57		19124756		0022-1767	The Journal of Immunology	P2Y6 Receptors Require an Intact Cysteinyl Leukotriene Synthetic and Signaling System to Induce Survival and Activation of Mast Cells	Jiang	2009	6		ARHGEF17
983	chr15	52248407	52248461	3500185376	54		52248407	52248461	8421504	1	54	0	p	350018537600015000	3-57					Journal of immunology (Baltimore, Md. : 1950)	P2Y6 Receptors Require an Intact Cysteinyl Leukotriene Synthetic and Signaling System to Induce Survival and Activation of Mast Cells1	Yongfeng	2009	0		ARHGEF17
986	chr15	52629925	52629949	3500112878	24		52629925	52629949	8421504	1	24	0	c	350011287800000009	0-24		11259260	10.1095/biolreprod64.4.1138	0006-3363	Biology of Reproduction	Spermatid-Specific Expression of Iba1, an Ionized Calcium Binding Adapter Molecule-1, in Rat Testis	Iida	2001	4		RAB6A
986	chr15	52629977	52630004	3500258078	25		52629977	52630004	8421504	3	7,4,14	0,8,13	g	350025807800000045	9-36						Nematode PAN and ZP Receptor-Like Sequences - Patent application	www.faqs.org	0	0		
988	chr15	52891918	52892764	3500232370	43		52891918	52892764	8421504	2	24,19	0,827	c,g	350023237000000013,350023237000000012,350023237000000012	19-43,0-19,0-19						<HTML><!-- InstanceBegin template="/Templates/index.dwt" codeOutsideHTMLIsLocked="false" --> <HEAD>	ock.colostate.edu	0	0		
988	chr15	52892179	52894849	3500303814	52		52892179	52894849	8421504	2	25,27	0,2643	c	350030381400000001,350030381400000000	0-25,7-34						Uncoupling protein-2(hcp2): compositions and methods of use	Amaral	2000	0		
988	chr15	52892207	52892261	3500056931	54		52892207	52892261	8421504	1	54	0	p	350005693100015016	0-54						Polynucleotides and polypeptides belonging to the uncoupling proteins family	Beeley	1999	0		
988	chr15	52892286	52893101	3500409160	41		52892286	52893101	8421504	4	9,12,13,7	0,324,492,808	c	350040916000000025,350040916000000024	0-21,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
988	chr15	52894417	52894442	3500196360	23		52894417	52894442	8421504	2	8,15	0,10	c,g	350019636000000011,350019636000000011	0-35,0-35						DETERMINING CODON DISTRIBUTION AND/OR BASE PAIR DISTANCE BETWEEN CODONS IN A NUCLEIC ACID	Nayudu	2010	0		UCP3
988	chr15	52894817	52897385	3500417396	58		52894817	52897385	8421504	2	30,28	0,2540	c	350041739600000003,350041739600000005	0-30,0-28						Ucp-2 promoter and use thereof	Toyoda	1999	0		UCP2
989	chr15	53031879	53034460	3500467635	23		53031879	53034460	8421504	2	2,21	0,2560	c	350046763500000004	0-23						ScienceDirect.com - FEBS Letters - Properties of the human long and short isoforms of the uncoupling protein-3 expressed in yeast cells	sciencedirect.com	0	0		
989	chr15	53034606	53035384	3500345006	43		53034606	53035384	8421504	3	14,7,22	0,707,756	c	350034500600000001,350034500600000000	0-21,0-22		19826104	10.1152/ajpendo.00505.2009		American Journal of Physiology - Endocrinology and Metabolism	Changed mitochondrial function by pre- and/or postpartum diet alterations in sheep	Jorgensen	2009	0		
989	chr15	53034606	53035384	3500258055	43		53034606	53035384	8421504	3	14,7,22	0,707,756	c,g	350025805500000001,350025805500000000,350025805500000000	0-21,0-22,0-22		19826104	10.1152/ajpendo.00505.2009		American Journal of Physiology - Endocrinology and Metabolism	Changed mitochondrial function by pre- and/or postpartum diet alterations in sheep	Jorgensen	2009	0		
989	chr15	53037166	53037767	3500203346	84		53037166	53037767	8421504	3	18,42,24	0,485,577	p	350020334600015024	0-84						OBESITY ENVIRONMENTAL FACTORS AND OR GENETIC INFLUENCE	www.docstoc.com	0	0		
989	chr15	53041201	53041251	3500449893	50		53041201	53041251	8421504	1	50	0	g	350044989300000062	0-50						CONTRIBUTION A L&#x2019;ETUDE DE LA REGULATION DE L&#x2019;EXPRESSION DU GENE HUMAIN UCP3 DANS LE MUSCLE SQUELETTIQUE DE SOURIS ETUDE EXPERIMENTALE	.univ-toulouse.fr	0	0		
989	chr15	53064872	53073518	3500144627	24		53064872	53073518	8421504	4	13,3,1,7	0,14,20,8639	c	350014462700000043	1-25						Immunotherapy Regimes Dependent On Apoe Status 	.freshpatents.com	0	0		
990	chr15	53212208	53212234	3500065534	23		53212208	53212234	8421504	2	14,9	0,17	c	350006553400000035	11-35						University of Warwick institutional repository: http://go	rap.warwick.ac.uk	0	0		LENG1
991	chr15	53218367	53218617	3500016751	23		53218367	53218617	8421504	3	4,9,10	0,227,240	c	350001675100000103	10-33						Entomopoxvirus spheroidin gene sequences	Moyer	1992	0		
992	chr15	53464825	53464851	3500407090	24		53464825	53464851	8421504	2	19,5	0,21	c	350040709000000082,350040709000000389	0-28,0-28						HIV envelope polypeptides and vaccine	Berman	1997	0		
993	chr15	53521168	53525643	3500230311	162		53521168	53525643	8421504	3	47,25,90	0,4348,4385	p	350023031100015103	0-171						Nucleic acids, vectors, host cells, polypeptides, and uses thereof	Alvarez	2002	0		
993	chr15	53542637	53542681	3500194845	44		53542637	53542681	8421504	1	44	0	c	350019484500000032	0-44						Nucleic acids, vectors, host cells, polypeptides, and uses thereof	Alvarez	2002	0		
993	chr15	53548505	53548529	3500103660	23		53548505	53548529	8421504	2	6,17	0,7	g	350010366000000008,350010366000000002	2-25,0-23						Method for producing recombinant adenovirus	Blanche	1999	0		
993	chr15	53548505	53548529	3500074446	23		53548505	53548529	8421504	2	6,17	0,7	g	350007444600000001,350007444600000004	0-23,2-25						Procede de production d'adenovirus recombinants	Blanche	1999	0		
994	chr15	53680391	53680419	3500212872	28		53680391	53680419	8421504	1	28	0	g	350021287200000004	0-28		12908878	10.1186/1471-2164-4-32	1471-2164	BMC Genomics	Molecular cloning, genomic characterization and over-expression of a novel gene, XRRA1, identified from human colorectal cancer cell HCT116Clone2_XRR and macaque testis	Mesak	2003	4		XRRA1
995	chr15	53774939	53774966	3500377188	27		53774939	53774966	8421504	1	27	0	c	350037718800000000	0-27		10713120	10.1074/jbc.275.11.8007	0021-9258	Journal of Biological Chemistry	Molecular Cloning of Mouse Ganglioside Sialidase and Its Increased Expression in Neuro2a Cell Differentiation	Hasegawa	2000	5		
996	chr15	53903781	53939049	3500139688	306		53903781	53939049	8421504	8	90,58,31,40,12,28,34,13	0,6154,6445,6488,29275,33943,34073,35255	c	350013968800000035,350013968800000036,350013968800000045,350013968800000046,350013968800000047,350013968800000065,350013968800000068	6-48,0-48,0-48,0-41,5-45,3-43,1-48						TRANSPORTER GENES OATP-B, C, D, AND E - Patent application	www.faqs.org	0	0		
996	chr15	53995073	53995276	3500424225	42		53995073	53995276	8421504	2	21,21	0,182	c,g	350042422500000033,350042422500000032,350042422500000032	0-21,0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
996	chr15	53995311	53995337	3500136585	26		53995311	53995337	8421504	1	26	0	c,g	350013658500000001,350013658500000001,350013658500000003,350013658500000003,350013658500000005,350013658500000005	10-33,10-33,10-30,10-30,10-34,10-34		19711041	10.1007/s10059-009-0104-1		Molecules and cells	A Protein Tyrosine Phosphatase Inhibitor, Pervanadate, Inhibits Angiotensin II-Induced &#x03b2;-Arrestin Cleavage	Sei-Heon	July	0		
124	chr15	53995314	54003266	3500156701	243		53995314	54003266	8421504	5	63,13,24,84,59	0,2336,4530,6656,7893	p	350015670100015055,350015670100015043	0-63,0-180						pr&#xe9;sent&#xe9;e par Emilie HUET MOULARD DOCTEUR DE L&#x2019;UNIVERSITE JOSEPH FOURIER-GRENOBLE I	hives-ouvertes.fr	0	0		
124	chr15	53995314	54003266	3500003372	243		53995314	54003266	8421504	5	63,13,24,84,59	0,2336,4530,6656,7893	p	350000337200015055,350000337200015043	0-63,0-180						pr&#xe9;sent&#xe9;e par Emilie HUET MOULARD DOCTEUR DE L&#x2019;UNIVERSITE JOSEPH FOURIER-GRENOBLE I	hives-ouvertes.fr	0	0		
996	chr15	53995314	53996766	3500440598	129		53995314	53996766	8421504	2	109,20	0,1432	p	350044059800015001,350044059800015004	0-48,0-108						Regulation of arrestin-3 phosphorylation by casein kinase II	www.jbc.org	0	0		
997	chr15	54012377	54068086	3500156701	135		54012377	54068086	8421504	4	35,61,31,8	0,3320,5177,55701	p	350015670100015014	0-135						pr&#xe9;sent&#xe9;e par Emilie HUET MOULARD DOCTEUR DE L&#x2019;UNIVERSITE JOSEPH FOURIER-GRENOBLE I	hives-ouvertes.fr	0	0		MIR326,ARRB1
997	chr15	54012377	54068086	3500003372	135		54012377	54068086	8421504	4	35,61,31,8	0,3320,5177,55701	p	350000337200015014	0-135						pr&#xe9;sent&#xe9;e par Emilie HUET MOULARD DOCTEUR DE L&#x2019;UNIVERSITE JOSEPH FOURIER-GRENOBLE I	hives-ouvertes.fr	0	0		MIR326,ARRB1
997	chr15	54015725	54068083	3500424907	69		54015725	54068083	8421504	3	33,31,5	0,1829,52353	p	350042490700015002	0-69		19153083	10.1074/jbc.M806395200	0021-9258	Journal of Biological Chemistry	MEK1 Binds Directly to &#x03b2;Arrestin1, Influencing Both Its Phosphorylation by ERK and the Timing of Its Isoprenaline-stimulated Internalization	Meng	2009	5		MIR326,ARRB1
998	chr15	54257350	54257373	3500187283	23		54257350	54257373	8421504	1	23	0	c	350018728300000012,350018728300000001	0-23,0-23						Framework Residue Substituted Humanized Col-1 Antibodies and Their Use - Patent application	www.faqs.org	0	0		
998	chr15	54257354	54257420	3500430769	66		54257354	54257420	8421504	1	66	0	p	350043076900015001	3-69						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		SERPINH1
998	chr15	54257903	54259451	3500132294	69		54257903	54259451	8421504	2	16,53	0,1495	p	350013229400015012	0-69						CHARACTERIZATION OF HSP47 EXPRESSION IN XENOPUS LAEVIS CELL CULTURE AND EMBRYOS	seerx.ist.psu.edu	0	0		
998	chr15	54262637	54262697	3500456763	60		54262637	54262697	8421504	1	60	0	p	350045676300015009	0-60						Use Of Serine Protease Inhibitors In The Treatment Of Neutropenia	Fontana	2012	0		SERPINH1
999	chr15	54292769	54292798	3500442735	24		54292769	54292798	8421504	3	5,5,14	0,7,15	g	350044273500000062	0-24						Molecular Characterization of Mutant Germplasm	ww-naweb.iaea.org	0	0		
999	chr15	54292769	54292798	3500414317	24		54292769	54292798	8421504	3	5,5,14	0,7,15	g	350041431700000006,350041431700000054	0-24,0-24						US Patent # 7,408,100. Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene - Patents.com	www.patents.com	0	0		
999	chr15	54301959	54301986	3500002196	23		54301959	54301986	8421504	2	12,11	0,16	g	350000219600000009	0-23						Prostate/colon tumor suppressor gene located on human chromosome 8	Bookstein	1995	0		
1002	chr15	54665762	54696939	3500095434	46		54665762	54696939	8421504	2	23,23	0,31154	c,g	350009543400000026,350009543400000026,350009543400000027	0-23,0-23,0-23						BMC Genetics BioMed Central	biomedcentral.com	0	0		
1002	chr15	54686240	54686263	3500301078	23		54686240	54686263	8421504	1	23	0	c	350030107800000117	0-23						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
1002	chr15	54686319	54694751	3500037971	169		54686319	54694751	8421504	6	7,41,47,21,5,48	0,376,6582,6700,7290,8384	c	350003797100000127,350003797100000130,350003797100000132,350003797100000139	0-48,0-47,22-48,0-48						Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor - Patent application	www.faqs.org	0	0		
1002	chr15	54686319	54686736	3500263908	48		54686319	54686736	8421504	2	7,41	0,376	c	350026390800000127	0-48						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
1002	chr15	54694607	54694630	3500055849	23		54694607	54694630	8421504	1	23	0	c	350005584900000005	20-43						Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells	s.ulb.uni-bonn.de	0	0		
1002	chr15	54694691	54694784	3500145949	93		54694691	54694784	8421504	1	93	0	p	350014594900015068	0-93						Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor	Gimeno	2003	0		
1002	chr15	54717192	54717216	3500293750	24		54717192	54717216	8421504	1	24	0	c	350029375000001863	4-28						Chimeric clotting factors	Salas	2012	0		
1005	chr15	55110643	55110667	3500382906	24		55110643	55110667	8421504	1	24	0	c	350038290600000013	0-24						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
1005	chr15	55110643	55110667	3500143893	24		55110643	55110667	8421504	1	24	0	c	350014389300000013	0-24						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
1005	chr15	55110780	55110811	3500086451	26		55110780	55110811	8421504	3	5,10,11	0,6,20	c	350008645100000060	2-28						IMMEDIATE EARLY GENES AND METHODS OF USE THEREFOR	Worley	1999	0		
1005	chr15	55111006	55111032	3500148394	26		55111006	55111032	8421504	1	26	0	c	350014839400000074,350014839400000224,350014839400000118,350014839400000334,350014839400000161	0-25,0-22,8-34,14-40,26-48						Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	.freshpatents.com	0	0		
1005	chr15	55115038	55118266	3500366673	44		55115038	55118266	8421504	2	22,22	0,3206	c,g	350036667300000035,350036667300000034,350036667300000034	0-22,0-22,0-22			10.1111/j.1365-2141.2006.06442.x	1365-2141	British Journal of Haematology	Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines - Nygren - 2006 - British Journal of Haematology - Wiley Online Library	Nygren	2007	0		WNT11
1005	chr15	55115262	55118229	3500356083	40		55115262	55118229	8421504	2	20,20	0,2947	c,g	350035608300000001,350035608300000000,350035608300000000	0-20,0-20,0-20		20103596	10.1158/1541-7786.MCR-09-0238		Molecular cancer research : MCR	Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration	Takashi	2010	0		WNT11
1005	chr15	55115262	55118229	3500116383	40		55115262	55118229	8421504	2	20,20	0,2947	c,g	350011638300000001,350011638300000000,350011638300000000	0-20,0-20,0-20		20103596	10.1158/1541-7786.MCR-09-0238	1541-7786	Molecular Cancer Research	Noncanonical Wnt11 Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration	Toyama	2010	4		WNT11
1005	chr15	55118163	55118235	3500334149	49		55118163	55118235	8421504	2	25,24	0,48	c,g	350033414900000055,350033414900000055,350033414900000054	0-25,0-25,0-24						Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands	Arenas	2004	0		WNT11
1005	chr15	55118163	55118235	3500323014	49		55118163	55118235	8421504	2	25,24	0,48	c,g	350032301400000058,350032301400000058,350032301400000057,350032301400000057	0-25,0-25,0-24,0-24						Methods For Promoting Dopaminergic Neuronal Development By Using Ng4a-subfamily And Wnt-ligands 	.freshpatents.com	0	0		WNT11
1005	chr15	55118163	55118235	3500166158	49		55118163	55118235	8421504	2	25,24	0,48	c,g	350016615800000115,350016615800000115,350016615800000055,350016615800000055,350016615800000054,350016615800000054,350016615800000114,350016615800000114	0-25,0-25,0-25,0-25,0-24,0-24,0-24,0-24						METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS - Patent application	www.faqs.org	0	0		WNT11
1005	chr15	55118163	55118235	3500158928	49		55118163	55118235	8421504	2	25,24	0,48	c,g	350015892800000058,350015892800000058,350015892800000057,350015892800000057	0-25,0-25,0-24,0-24						Methods For Promoting Dopaminergic Neuronal Development By Using Ng4a-subfamily And Wnt-ligands 	.freshpatents.com	0	0		WNT11
1005	chr15	55166960	55166987	3500235521	23		55166960	55166987	8421504	2	7,16	0,11	g	350023552100000043	3-26						IMPROVED METHODS FOR TRANSFORMING PHAFFIA STRAINS, TRANSFORMED PHAFFIA STRAINS SO OBTAINED AND RECOMBINANT DNA IN SAID METHODS - Gist-brocades B.	www.sumobrain.com	0	0		
1006	chr15	55181689	55184247	3500420477	39		55181689	55184247	8421504	4	14,6,10,9	0,16,2534,2549	g	350042047700000358,350042047700000378	14-35,10-29						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
1006	chr15	55251054	55251078	3500333272	23		55251054	55251078	8421504	2	19,4	0,20	g	350033327200000009	11-37						Inhibitors of prenyl-protein transferase	William	2000	0		
1006	chr15	55251054	55251078	3500289096	23		55251054	55251078	8421504	2	19,4	0,20	g	350028909600000009	11-37						INHIBITORS OF PRENYL-PROTEIN TRANSFERASE - MERCK & CO., INC.	www.sumobrain.com	0	0		
1006	chr15	55251054	55251078	3500264949	23		55251054	55251078	8421504	2	19,4	0,20	g	350026494900000009	11-37						Inhibitors of prenyl-protein transferase	William	2002	0		
125	chr15	55308164	55328396	3500309883	288		55308164	55328396	8421504	3	78,121,89	0,3651,20143	p	350030988300015035,350030988300015044,350030988300015012	0-288,0-288,0-285						THAP1, UN REGULATEUR CLE DE LA PROLIFERATION DES CELLULES ENDOTHELIALES : RELATIONS STRUCTURE/FONCTION ET GENES CIBLES	esups.ups-tlse.fr	0	0		PRKRIR
1007	chr15	55382859	55382886	3500419697	23		55382859	55382886	8421504	2	12,11	0,16	g	350041969700000005	0-23		15689551	10.1523/JNEUROSCI.4736-04.2005	0270-6474	The Journal of Neuroscience	&#x03b2;-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w	Yao	2005	7		
1010	chr15	55720069	55720092	3500171455	23		55720069	55720092	8421504	1	23	0	c	350017145500000288	17-40						Dna diagnostics based on mass spectrometry	Braun	1998	0		
126	chr15	55823702	55846092	3500162553	24		55823702	55846092	8421504	2	12,12	0,22378	c	350016255300000017	0-24		16477081	10.1194/jlr.M600001-JLR200	0022-2275	Journal of Lipid Research	Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis	Houben	2006	6		ACER3
1011	chr15	55948165	55948210	3500153410	45		55948165	55948210	8421504	1	45	0	g	350015341000000019	140-185						US Patent # 5,646,008. Vertebrate apoptosis gene: compositions and methods - Patents.com	www.patents.com	0	0		
1012	chr15	56049467	56049490	3500189275	23		56049467	56049490	8421504	1	23	0	c	350018927500000009	7-32						August | 2013 | Protease Inhibitors Guide	w.aktantibody.com	0	0		
1012	chr15	56050281	56050304	3500401542	23		56050281	56050304	8421504	1	23	0	c	350040154200000006	0-23					Journal of Venom Research	In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines	Alexis	2013	0		
1013	chr15	56165349	56165374	3500165298	25		56165349	56165374	8421504	1	25	0	g	350016529800000002	49-74						Phylogeographic analysis of mitochondrial Oncorhyn&#xad;DNA variation in Alaskan coho salmon, chus kisutch Oncorhynchus kisutch	fishbull.noaa.gov	0	0		BMF
1013	chr15	56165350	56165374	3500344689	24		56165350	56165374	8421504	1	24	0	g	350034468900000005	23-47						Phylogeographic analysis of mitochondrial DNA variation in Alaskan coho salmon, Oncorhynchus kisutch.	.biomedsearch.com	0	0		
1013	chr15	56187504	56187529	3500306233	25		56187504	56187529	8421504	1	25	0	g	350030623300000020	0-25						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
1016	chr15	56606885	56606913	3500092680	23		56606885	56606913	8421504	3	6,12,5	0,10,23	g	350009268000000017	3-26						US Patent # 5,591,605. Plant structural gene expression - Patents.com	www.patents.com	0	0		
1018	chr15	56854035	56859106	3500222276	87		56854035	56859106	8421504	4	23,21,22,21	0,103,2513,5050	c	350022227600000008,350022227600000004,350022227600000012,350022227600000009,350022227600000003	0-23,0-21,0-20,0-22,0-21			10.1046/j.1432-1033.2002.02949.x	1432-1033	European Journal of Biochemistry	Isolation and characterization of MUC15, a novel cell membrane-associated mucin - Pallesen - 2002 - European Journal of Biochemistry - Wiley Online Library	Pallesen	2002	0		
1018	chr15	56854035	56859106	3500100784	87		56854035	56859106	8421504	4	23,21,22,21	0,103,2513,5050	c	350010078400000008,350010078400000004,350010078400000012,350010078400000009,350010078400000003	0-23,0-21,0-20,0-22,0-21						Isolation and characterization of MUC15, a novel cell membrane-associated mucin	w.genomed-dna.com	0	0		
1019	chr15	56971488	56971517	3500369966	24		56971488	56971517	8421504	3	6,14,4	0,10,25	g	350036996600000095	16-40						Proteins having glycosyltransferase activity	Berger	1997	0		
1021	chr15	57239357	57239385	3500302241	23		57239357	57239385	8421504	3	8,2,13	0,12,15	c	350030224100000080	0-23						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
1022	chr15	57341498	57341525	3500253796	23		57341498	57341525	8421504	3	4,14,5	0,5,22	g	350025379600000617	11-34					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
1024	chr15	57640465	57641233	3500395807	768		57640465	57641233	8421504	1	768	0	p	350039580700015075,350039580700015077,350039580700015074,350039580700015073,350039580700015072	9-777,0-66,0-141,0-201,9-90						71 human secreted proteins	Brewer	2000	0		LGR4
1024	chr15	57640465	57641233	3500348941	768		57640465	57641233	8421504	1	768	0	p	350034894100015066,350034894100015068,350034894100015065,350034894100015064	9-777,0-66,0-141,9-297						 Secreted Protein HT5GJ57 	www.docstoc.com	0	0		LGR4
1024	chr15	57645746	57645775	3500437423	26		57645746	57645775	8421504	2	18,8	0,21	c	350043742300000510	21-47						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
1024	chr15	57645746	57645775	3500251828	26		57645746	57645775	8421504	2	18,8	0,21	c	350025182800000517	21-47						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
1027	chr15	57967652	57967934	3500046140	97		57967652	57967934	8421504	3	32,41,24	0,170,258	g	350004614000000004,350004614000000001,350004614000000006	0-32,0-41,0-24		20573984	10.1091/mbc.E10-01-0015	1059-1524	Molecular Biology of the Cell	Regulation of Genotoxic Stress Response by Homeodomain-interacting Protein Kinase 2 through Phosphorylation of Cyclic AMP Response Element-binding Protein at Serine 271	Sakamoto	2010	5		
1027	chr15	57967825	57967848	3500417645	23		57967825	57967848	8421504	1	23	0	g	350041764500000003	0-23		18485098	10.1111/j.1471-4159.2008.05484.x	1471-4159	Journal of Neurochemistry	Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury - Onishchenko - 2008 - Journal of Neurochemistry - Wiley Online Library	Onishchenko	2008	0		BDNF
1028	chr15	58181646	58182242	3500038961	48		58181646	58182242	8421504	2	27,21	0,575	c,g	350003896100000001,350003896100000001,350003896100000003	26-53,26-53,0-21						&#x041c;&#x043e;&#x043b;&#x0435;&#x043a;&#x0443;&#x043b;&#x044f;&#x0440;&#x043d;&#x043e;-&#x0433;&#x0435;&#x043d;&#x0435;&#x0442;&#x0438;&#x0447;&#x0435;&#x0441;&#x043a;&#x0438;&#x0435; &#x043f;&#x043e;&#x0434;&#x0445;&#x043e;&#x0434;&#x044b; &#x043a; &#x	Griviennikov	2006	0		BDNF
1028	chr15	58181900	58181924	3500350057	24		58181900	58181924	8421504	1	24	0	c	350035005700000003	0-24						NMDA receptor activation modulates programmed cell death during early post-natal retinal development: a BDNF-dependent mechanism. - ResearchGate	.researchgate.net	0	0		
1028	chr15	58181900	58181924	3500005496	24		58181900	58181924	8421504	1	24	0	c	350000549600000003	0-24			10.1111/j.1471-4159.2005.03360.x	1471-4159	Journal of Neurochemistry	NMDA receptor activation modulates programmed cell death during early post-natal retinal development: a BDNF-dependent mechanism - Martins - 2005 - Journal of Neurochemistry - Wiley Online Library	Martins	2005	0		
1028	chr15	58181903	58182658	3500427965	374		58181903	58182658	8421504	3	178,177,19	0,184,736	p,c	350042796500000008,350042796500015004,350042796500015000,350042796500015002,350042796500015010,350042796500000007	9-28,0-174,0-168,3-180,0-45,8-27						US Patent # 5,438,121. Brain derived neurotrophic factor - Patents.com	www.patents.com	0	0		
1028	chr15	58181907	58182657	3500274825	741		58181907	58182657	8421504	2	570,171	0,579	p	350027482500015001	0-741						PowerPoint &#x30d7;&#x30ec;&#x30bc;&#x30f3;&#x30c6;&#x30fc;&#x30b7;&#x30e7;&#x30f3;	seika.kpu.ac.jp	0	0		
1028	chr15	58181907	58182657	3500235638	741		58181907	58182657	8421504	2	570,171	0,579	p	350023563800015000	0-741						KEGG T01001: 627	www.genome.jp	0	0		
1028	chr15	58181907	58182264	3500446194	357		58181907	58182264	8421504	1	357	0	p	350044619400015012,350044619400015003,350044619400015007,350044619400015009	0-357,0-45,21-129,3-102						&#x0414;&#x043d;&#x043a;-&#x0444;&#x0440;&#x0430;&#x0433;&#x043c;&#x0435;&#x043d;&#x0442;, &#x043a;&#x043e;&#x0434;&#x0438;&#x0440;&#x0443;&#x044e;&#x0449;&#x0438;&#x0439; &#x043d;&#x0435;&#x0439;&#x0440;&#x043e;&#x0442;&#x0440;&#x043e;&#x043f;&#x043d;&#x	www.findpatent.ru	0	0		BDNF
1028	chr15	58181917	58181947	3500110636	30		58181917	58181947	8421504	1	30	0	c	350011063600000097	9-39						Protein expression system	Sgarlato	1999	0		
1028	chr15	58181924	58181947	3500407720	23		58181924	58181947	8421504	1	23	0	c	350040772000000089	0-23						US Patent # 5,935,824. Protein expression system - Patents.com	www.patents.com	0	0		
1028	chr15	58181949	58182264	3500040499	315		58181949	58182264	8421504	1	315	0	p	350004049900015034,350004049900015033,350004049900015032,350004049900015031,350004049900015030,350004049900015029,350004049900015028	0-45,0-45,0-45,0-45,0-45,0-45,0-45					Patent	Pantropic neurotrophic factors (Patent US:5981480)	Presta	1999	0		BDNF
1028	chr15	58181979	58182183	3500388659	63		58181979	58182183	8421504	2	21,42	0,162	p	350038865900015003	0-63					Patent	Brain derived naurotrophic factor (Patent CN:1124343)	Qia Luo Lin *Hai Man 	2003	0		BDNF
1028	chr15	58181979	58182183	3500387316	63		58181979	58182183	8421504	2	21,42	0,162	p	350038731600015003	0-63						Brain derived naurotrophic factor	Qia Luo Lin *Hai Man 	1991	0		BDNF
1028	chr15	58182099	58182207	3500139696	108		58182099	58182207	8421504	1	108	0	p	350013969600015002,350013969600015005	63-171,0-99						&#x7531;&#x8111;&#x7ec4;&#x7ec7;&#x83b7;&#x5f97;&#x7684;&#x795e;&#x7ecf;&#x8425;&#x517b;&#x56e0;&#x5b50;	Qia Luo Lin *Hai Man 	1991	0		BDNF
1028	chr15	58182099	58182207	3500062096	108		58182099	58182207	8421504	1	108	0	p	350006209600015005,350006209600015008	63-171,0-99					Patent	&#x7531;&#x8111;&#x7ec4;&#x7ec7;&#x83b7;&#x5f97;&#x7684;&#x795e;&#x7ecf;&#x8425;&#x517b;&#x56e0;&#x5b50; (Patent CN:1124343)	Qia Luo Lin *Hai Man 	2003	0		BDNF
1028	chr15	58182116	58182144	3500102726	24		58182116	58182144	8421504	2	16,8	0,20	c	350010272600000014	5-29		19797053	10.1074/jbc.M109.033910		The Journal of Biological Chemistry	Myocardin-dependent Activation of the CArG Box-rich Smooth Muscle &#x03b3;-Actin Gene: PREFERENTIAL UTILIZATION OF A SINGLE CArG ELEMENT THROUGH FUNCTIONAL ASSOCIATION WITH THE NKX3.1 HOMEODOMAIN PROTEIN*	Qiang	2009	0		
1028	chr15	58182342	58182367	3500434053	25		58182342	58182367	8421504	1	25	0	c	350043405300000003	0-25						Neuronal characteristics of amniotic fluid derived cells after adenoviral transformation	S	2008	0		
1028	chr15	58182609	58182634	3500053465	25		58182609	58182634	8421504	1	25	0	c,g	350005346500000016,350005346500000016	24-49,24-49						Human Microglia Transplanted in Rat Focal Ischemia Brain Induce Neuroprotection and Behavioral Improvement	.researchgate.net	0	0		
1028	chr15	58182612	58182678	3500040360	55		58182612	58182678	8421504	2	26,29	0,37	c	350004036000000011,350004036000000012	0-26,0-29						Untersuchungen zur Rolle von Immunzell-BDNF w&#xe4;hrend autoimmuner Entz&#xfc;ndung im zentralen Nervensystem	uhr-uni-bochum.de	0	0		BDNF
1028	chr15	58182636	58182660	3500156944	24		58182636	58182660	8421504	1	24	0	c	350015694400000000	12-36		10407031		0270-6474	The Journal of Neuroscience	Overexpression of Brain-Derived Neurotrophic Factor Enhances Sensory Innervation and Selectively Increases Neuron Number	LeMaster	1999	7		BDNF
1028	chr15	58182649	58182672	3500385471	23		58182649	58182672	8421504	1	23	0	c	350038547100000017	20-43						Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain	roscience.jhu.edu	0	0		BDNF
1029	chr15	58317250	58317274	3500084218	23		58317250	58317274	8421504	2	9,14	0,10	g	350008421800000256	0-23						Attenuated Salmonella Sp12 Mutants As Antigen Carriers 	.freshpatents.com	0	0		
1030	chr15	58385153	58385187	3500060694	28		58385153	58385187	8421504	3	7,3,18	0,9,16	g	350006069400000010	13-41						Ardala Breda Caracteriza&#xe7;&#xe3;o Biof&#xed;sico-Qu&#xed;mica da Enzima	tede.pucrs.br	0	0		
1034	chr15	58953579	58953603	3500292931	23		58953579	58953603	8421504	2	19,4	0,20	g	350029293100000206	19-42					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent EP:2135950)	NATT	2012	0		FAF1
1034	chr15	58953579	58953603	3500095873	23		58953579	58953603	8421504	2	19,4	0,20	g	350009587300000206	19-42						Short interfering ribonucleic acid (siRNA) for oral administration	NATT	2011	0		
1035	chr15	59056775	59056805	3500234452	24		59056775	59056805	8421504	3	13,2,9	0,15,21	g	350023445200000008	0-24						DIFFERENTIATION OF STEM CELLS INTO DOPAMINERGIC CELLS	Freed	2009	0		
1043	chr15	60070208	60070234	3500369161	23		60070208	60070234	8421504	2	18,5	0,21	g	350036916100000066	3-29						Methods and compositions for phenotype identification based on nucleic acid methylation	Den	2004	0		
1045	chr15	60390685	60391177	3500126050	492		60390685	60391177	8421504	1	492	0	p	350012605000015226,350012605000015225,350012605000015223	0-180,0-180,0-132						GOS 1116020 - Metagenes	annotathon.org	0	0		KCNA4
1045	chr15	60391455	60391478	3500128308	23		60391455	60391478	8421504	1	23	0	c	350012830800000001	0-23						Molecular identification of Kvasubunits that contribute to the oxygen-sensitive K current of chemoreceptor cells of the rabbit carotid body	jp.physoc.org	0	0		
1047	chr15	60637640	60637668	3500192533	28		60637640	60637668	8421504	1	28	0	g	350019253300000011	0-28						ABSTRACT	tory.lib.ncsu.edu	0	0		
1047	chr15	60640018	60640186	3500312365	126		60640018	60640186	8421504	2	39,87	0,81	g	350031236500000036,350031236500000034,350031236500000035	37-76,36-78,42-88						&#x30c8;&#x30ad;&#x306e;&#x6ffe;&#x80de;&#x523a;&#x6fc0;&#x30db;&#x30eb;&#x30e2;&#x30f3;&#x53ca;&#x3073;&#x7532;&#x72b6;&#x817a;&#x523a;&#x6fc0;&#x30db;&#x30eb;&#x30e2;&#x30f3; &#x30b5;&#x30d6;&#x30e6;&#x30cb;&#x30c3;&#x30c8;&#x306e;&#x907a;&#x4f1d;&#x5b5	.wul.waseda.ac.jp	0	0		
1047	chr15	60640944	60642858	3500140642	331		60640944	60642858	8421504	2	100,231	0,1683	p,c,g	350014064200000028,350014064200000028,350014064200015016,350014064200000036,350014064200000036,350014064200000030,350014064200000030,350014064200015021,350014064200015022,350014064200015024,350014064200000000,350014064200000000,350014064200015017,350014064200000031,350014064200000031,350014064200000029,350014064200015018,350014064200000032,350014064200000041,350014064200000040,350014064200000040,350014064200015019,350014064200000033,350014064200015025,350014064200015026,350014064200015020,350014064200000044,350014064200000035,350014064200000001	5-81,5-81,0-60,0-60,0-60,0-60,0-60,27-351,0-189,0-189,0-21,0-21,0-60,0-60,0-60,0-255,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-138,0-138,0-60,0-60,0-30,0-23						SEQ&#xdc;ENCIAMENTO E AN&#xc1;LISE DOS GENES DAS SUBUNIDADES ALFA E BETA DO HORM&#xd4;NIO FOL&#xcd;CULO ESTIMULANTE DE BOVINO Bos taurus indicus	epositorio.unb.br	0	0		
1047	chr15	60640996	60641022	3500126951	26		60640996	60641022	8421504	1	26	0	c	350012695100000011	0-26		15917351	10.1095/biolreprod.104.039164	0006-3363	Biology of Reproduction	Conditional Induction of Ovulation in Mice	Su	2005	4		FSHB
1047	chr15	60642780	60642839	3500347400	59		60642780	60642839	8421504	1	59	0	c	350034740000000098,350034740000000247,350034740000000248	27-47,19-64,24-64						Single-chain forms of the glycoprotein hormone quartet	Boime	1999	0		
1047	chr15	60642828	60642856	3500025913	28		60642828	60642856	8421504	1	28	0	c	350002591300000003	12-40			10.1046/j.1432-1327.2001.02384.x	1432-1033	European Journal of Biochemistry	Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants - Dirnberger - 2001 - European Journal of Biochemistry - Wiley Online Library	Dirnberger	2001	0		
1047	chr15	60643088	60643146	3500082099	54		60643088	60643146	8421504	2	14,40	0,18	c,g	350008209900000009,350008209900000009	0-78,0-78						BMP-4 inhibits follicle-stimulating hormone secretion in ewe pituitary	logy-journals.org	0	0		
1047	chr15	60643370	60643394	3500400144	24		60643370	60643394	8421504	1	24	0	c	350040014400000007	22-46						Endocrine Characterization of the Reproductive Axis in Highly Prolific Lacaune	ww.biolreprod.org	0	0		
1048	chr15	60802609	60802640	3500408428	29		60802609	60802640	8421504	2	23,6	0,25	g	350040842800000018	21-51					Patent	G-CSF receptor agonists (Patent US:6100070)	Braford-Goldberg	2000	0		
1049	chr15	60839873	60839903	3500254774	25		60839873	60839903	8421504	3	14,7,4	0,18,26	g	350025477400000053	3-28						Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies - Patent application	www.faqs.org	0	0		
1050	chr15	60977151	60977176	3500088639	25		60977151	60977176	8421504	1	25	0	g	350008863900000000	0-27		23565812	10.1186/1471-2407-13-184		BMC Cancer	Expressional alterations in functional ultra-conserved non-coding rnas in response to all-trans retinoic acid - induced differentiation in neuroblastoma cells	Karen	2013	0		MPPED2
1050	chr15	60979853	60979876	3500430989	23		60979853	60979876	8421504	1	23	0	g	350043098900000498	25-48						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
1051	chr15	61205271	61205294	3500218600	23		61205271	61205294	8421504	1	23	0	g	350021860000000004	1-24		15367611	10.1128/JVI.78.19.10449-10459.2004	0022-538X	Journal of Virology	In Vivo Function of a Gammaherpesvirus Virion Glycoprotein: Influence on B-Cell Infection and Mononucleosis	Stewart	2004	5		
1052	chr15	61334023	61334050	3500143661	24		61334023	61334050	8421504	2	18,6	0,21	g	350014366100000003	5-32		16522745	10.1189/jlb.1005588	0741-5400	Journal of Leukocyte Biology	Molecular characterization of the murine homologue of the DC-derived protein DC-SCRIPT	Triantis	2006	5		
1060	chr15	62333215	62350083	3500186119	1266		62333215	62350083	8421504	10	83,151,116,151,83,159,166,216,131,10	0,1014,3741,3953,4333,4879,11084,12008,13156,16858	p	350018611900015092,350018611900015059,350018611900015057,350018611900015090,350018611900015088,350018611900015053,350018611900015086,350018611900015083,350018611900015081,350018611900015048,350018611900015049,350018611900015079,350018611900015046,350018611900015045,350018611900015044,350018611900015076,350018611900015073,350018611900015063,350018611900015041,350018611900015064,350018611900015062,350018611900015060,350018611900015061,350018611900015038,350018611900015070,350018611900015069	0-99,0-180,0-78,0-51,0-57,0-180,0-96,0-111,0-180,0-135,0-180,0-141,0-180,0-159,0-159,0-57,0-147,0-180,0-180,0-123,0-180,0-180,0-177,0-180,111-180,0-81						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		
1060	chr15	62333215	62333266	3500342863	51		62333215	62333266	8421504	1	51	0	p	350034286300015024,350034286300015123	60-111,0-51							library.wiley.com	0	0		PAX6
1060	chr15	62333215	62333266	3500146175	51		62333215	62333266	8421504	1	51	0	p	350014617500015001	0-51						The Transcriptome of Retinal Mu&#xa8;ller Glial Cells	h.med.harvard.edu	0	0		PAX6
1060	chr15	62333215	62333266	3500114119	51		62333215	62333266	8421504	1	51	0	p	350011411900015001	0-51		18465787	10.1002/cne.21730		The Journal of Comparative Neurology	The transcriptome of retinal M&#xfc;ller glial cells	Karin	July	0		PAX6
1060	chr15	62333256	62337038	3500444648	45		62333256	62337038	8421504	2	23,22	0,3760	c	350044464800000031,350044464800000006,350044464800000005,350044464800000030	0-23,0-23,0-22,0-22						COMPOSITION AND METHOD FOR ENABLING PROLIFERATION OF PLURIPOTENT HUMAN STEM CELLS - Patent application	www.faqs.org	0	0		
1060	chr15	62333256	62337038	3500439018	46		62333256	62337038	8421504	2	23,23	0,3759	c	350043901800000001,350043901800000000	0-23,0-23						COMPOSITIONS FOR INDUCING DIFFERENTIATION INTO RETINAL CELLS FROM RETINAL PROGENITOR CELLS OR INDUCING PROLIFERATION OF RETINAL CELLS COMPRISING WNT SIGNALING PATHWAY ACTIVATORS	Park	2010	0		PAX6
1060	chr15	62333256	62337038	3500382699	46		62333256	62337038	8421504	2	23,23	0,3759	c	350038269900000005,350038269900000027,350038269900000026,350038269900000004	0-23,0-23,0-23,0-23						EMBRYONIC STEM CELLS AND NEURAL PROGENITOR CELLS DERIVED THEREFROM - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62333256	62337038	3500367987	46		62333256	62337038	8421504	2	23,23	0,3759	c	350036798700000037,350036798700000005,350036798700000036,350036798700000004	0-23,0-23,0-23,0-23						Neural progenitor cells derived from embryonic stem cells - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62333256	62337038	3500287553	46		62333256	62337038	8421504	2	23,23	0,3759	c	350028755300000005,350028755300000004	0-23,0-23						Neural progenitor cells derived from embryonic stem cells	Reubinoff	2012	0		PAX6
1060	chr15	62333256	62337038	3500286294	46		62333256	62337038	8421504	2	23,23	0,3759	c	350028629400000005,350028629400000004	0-23,0-23						Embryonic stem cells and neural progenitor cells derived therefrom	Reubinoff	2005	0		PAX6
1060	chr15	62333256	62337038	3500281216	46		62333256	62337038	8421504	2	23,23	0,3759	c	350028121600000005,350028121600000004	0-23,0-23					Patent	Neural progenitor cells derived from embryonic stem cells (Patent US:8137969)	Ben-Hur	2012	0		PAX6
1060	chr15	62333256	62337038	3500271220	46		62333256	62337038	8421504	2	23,23	0,3759	c	350027122000000005,350027122000000037,350027122000000004,350027122000000036	0-23,0-23,0-23,0-23						NEURAL PROGENITOR CELLS DERIVED FROM EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62333256	62337038	3500265059	46		62333256	62337038	8421504	2	23,23	0,3759	c	350026505900000073,350026505900000015,350026505900000072,350026505900000014	0-23,0-23,0-23,0-23						CELL CULTURE - Patent application	www.faqs.org	0	0		
1060	chr15	62333256	62337038	3500253522	46		62333256	62337038	8421504	2	23,23	0,3759	c	350025352200000005,350025352200000013,350025352200000004,350025352200000012	0-23,0-23,0-23,0-23						 Embryonic Stem Cells 	www.docstoc.com	0	0		
1060	chr15	62333256	62337038	3500232870	46		62333256	62337038	8421504	2	23,23	0,3759	c	350023287000000005,350023287000000004	0-23,0-23						Neural progenitor cells derived from embryonic stem cells	Pera	2012	0		PAX6
1060	chr15	62333256	62337038	3500229416	46		62333256	62337038	8421504	2	23,23	0,3759	c	350022941600000005,350022941600000004	0-23,0-23					Patent	Neural progenitor cells derived from embryonic stem cells (Patent US:8460931)	Reubinoff	2013	0		PAX6
1060	chr15	62333256	62337038	3500218814	46		62333256	62337038	8421504	2	23,23	0,3759	c,g	350021881400000005,350021881400000004	0-23,0-23					Patent	Implanting neural progenitor cells derived for human embryonic stem cells (Patent US:7011828)	Reubinoff	2006	0		
1060	chr15	62333256	62337038	3500204585	46		62333256	62337038	8421504	2	23,23	0,3759	c	350020458500000005,350020458500000004	0-23,0-23					Patent	Embryonic stem cells and neural progenitor cells derived therefrom (Patent US:7947498)	Reubinoff	2011	0		PAX6
1060	chr15	62333256	62337038	3500144853	46		62333256	62337038	8421504	2	23,23	0,3759	c	350014485300000005,350014485300000004	0-23,0-23						Embryonic stem cells and neural progenitor cells derived therefrom	Reubinoff	2012	0		PAX6
1060	chr15	62333256	62337038	3500137855	46		62333256	62337038	8421504	2	23,23	0,3759	c	350013785500000005,350013785500000004	0-23,0-23					Patent	Embryonic stem cells and neural progenitor cells derived therefrom (Patent US:7504257)	Reubinoff	2009	0		PAX6
1060	chr15	62333256	62337038	3500133298	46		62333256	62337038	8421504	2	23,23	0,3759	c	350013329800000005,350013329800000004	0-23,0-23						Neural progenitor cells derived from embryonic stem cells	Reubinoff	2009	0		PAX6
1060	chr15	62333256	62337038	3500056801	46		62333256	62337038	8421504	2	23,23	0,3759	c,g	350005680100000005,350005680100000004	0-23,0-23						Implanting neural progenitor cells derived for human embryonic stem cells	Reubinoff	2001	0		
1060	chr15	62333256	62333279	3500267076	23		62333256	62333279	8421504	1	23	0	c	350026707600000005	0-23						Implanting neural progenitor cells derived for human embryonic stem cells - US Patent 7011828 Description	ww.patentstorm.us	0	0		PAX6
1060	chr15	62333256	62333279	3500026011	23		62333256	62333279	8421504	1	23	0	c	350002601100000017	0-23						Cotylenin A inhibits cell proliferation and induces apoptosis and PAX6 mRNA transcripts in retinoblastoma cell lines	www.molvis.org	0	0		
1060	chr15	62333258	62337037	3500385977	43		62333258	62337037	8421504	2	21,22	0,3757	c,g	350038597700000005,350038597700000005,350038597700000004	1-22,1-22,0-22						Embryonic stem cells	Bongso	2000	0		
1060	chr15	62334302	62334326	3500438382	24		62334302	62334326	8421504	1	24	0	c	350043838200000014	24-48						Original Article In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long- term culture running risk of malignant transformation	www.ajsc.us	0	0		PAX6
1060	chr15	62334335	62334367	3500201864	28		62334335	62334367	8421504	3	8,6,14	0,9,18	c	350020186400000666	7-39						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1060	chr15	62336978	62337620	3500463024	54		62336978	62337620	8421504	2	26,28	0,614	c	350046302400000186,350046302400000033,350046302400000185,350046302400000032	0-26,0-26,0-28,0-28						METHOD FOR PROLIFERATION OF PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62336978	62337620	3500337582	54		62336978	62337620	8421504	2	26,28	0,614	c	350033758200000038,350033758200000037	0-26,0-28		21706774	10.1002/term.428	1932-7005	Journal of Tissue Engineering and Regenerative Medicine	A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells - Ohnishi - 2011 - Journal of Tissue Engineering and Regenerative Medicine - Wiley Online Library	Ohnishi	2012	0		PAX6
1060	chr15	62336978	62337620	3500177747	54		62336978	62337620	8421504	2	26,28	0,614	c	350017774700000033,350017774700000032	0-26,0-28						Method for proliferation of pluripotent stem cells	Miyazaki	2011	0		PAX6
1060	chr15	62336978	62337620	3500057740	54		62336978	62337620	8421504	2	26,28	0,614	c,g	350005774000000036,350005774000000035,350005774000000035	0-26,0-28,0-28						www.biochemj	www.urogene.org	0	0		PAX6
1060	chr15	62336978	62337620	3500022304	54		62336978	62337620	8421504	2	26,28	0,614	c	350002230400000032,350002230400000031	0-26,0-28						&#x30d2;&#x30c8;&#x6b6f;&#x80da;&#x7531;&#x6765;&#x9593;&#x8449;&#x7cfb;&#x7d30;&#x80de;&#x304b;&#x3089;&#x306e;iPS &#x7d30;&#x80de;&#x306e;&#x6a39;&#x7acb;&#x3068; &#x521d;&#x671f;&#x5316;&#x6a5f;&#x5e8f;&#x306e;&#x89e3;&#x6790;	library.naist.jp	0	0		PAX6
1060	chr15	62336978	62337004	3500311545	26		62336978	62337004	8421504	1	26	0	c	350031154500000034	0-26						Nuclear reprogramming factor and induced pluripotent stem cells	Yamanaka	2008	0		PAX6
1060	chr15	62336978	62337002	3500018619	24		62336978	62337002	8421504	1	24	0	c	350001861900000037	0-24						Nuclear Reprogramming Factor And Induced Pluripotent Stem Cells 	.freshpatents.com	0	0		PAX6
1060	chr15	62336980	62337620	3500387415	52		62336980	62337620	8421504	2	24,28	0,612	c	350038741500000021,350038741500000020	0-24,0-28		21119622	10.1038/mt.2010.269		Molecular Therapy	Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell&#x2013;derived Induced Pluripotent Stem Cells	AmKambal	2011	0		PAX6
1060	chr15	62336980	62337620	3500119347	52		62336980	62337620	8421504	2	24,28	0,612	c	350011934700000021,350011934700000020	0-24,0-28		21119622	10.1038/mt.2010.269	1525-0016	Molecular Therapy	Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell&#x2013;derived Induced Pluripotent Stem Cells	Kambal	2010	7		PAX6
1060	chr15	62337019	62337253	3500339794	40		62337019	62337253	8421504	2	20,20	0,214	c	350033979400000018,350033979400000017	0-20,0-20						Exploration du potentiel th&#xe9;rapeutique des cellules souches embryonnaires humaines pour la th&#xe9;rapie cellulaire de la maladie de Huntington.	blio.univ-evry.fr	0	0		PAX6
1060	chr15	62337019	62337253	3500230360	40		62337019	62337253	8421504	2	20,20	0,214	c	350023036000000047,350023036000000012,350023036000000046	0-20,20-40,0-20						METHOD FOR GENERATING PRIMATE CARDIOVASCULAR PROGENITOR CELLS FOR CLINICAL USE FROM PRIMATE EMBRYONIC STEM CELLS OR EMBRYONIC-LIKE STATE CELLS, AND THEIR APPLICATIONS - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62337019	62337253	3500103242	40		62337019	62337253	8421504	2	20,20	0,214	c	350010324200000116,350010324200000059,350010324200000115,350010324200000016	0-20,0-20,0-20,0-20						LARGE-SCALE PROPAGATION AND MAINTENANCE METHOD OF EMBRYOID BODIES GENERATED FROM STEM CELLS - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62337021	62344314	3500042867	40		62337021	62344314	8421504	3	20,5,15	0,1227,7278	c	350004286700000021,350004286700000005,350004286700000020,350004286700000004	0-20,0-20,0-20,0-20						EFFICIENT GENERATION OF NEURAL PROGENITORS, NEURONS, AND DOPAMINERGIC NEURONS FROM HUMAN EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62337256	62350110	3500105057	675		62337256	62350110	8421504	7	63,83,94,51,216,131,37	0,292,838,7158,7967,9115,12817	p	350010505700015014,350010505700015013,350010505700015011,350010505700015008,350010505700015007,350010505700015005,350010505700015004,350010505700015000,350010505700015001,350010505700015002	0-60,0-180,0-60,0-78,0-63,0-180,0-165,42-180,12-147,0-177						Developing Bioinformatics Computer Skills	www.bio-nica.info	0	0		
1060	chr15	62337256	62350074	3500270278	609		62337256	62350074	8421504	7	63,83,73,42,216,131,1	0,292,838,7167,7967,9115,12817	p	350027027800015026,350027027800015017,350027027800015016,350027027800015025,350027027800015024	0-219,15-75,15-75,0-168,0-222						Planarian Pax6 genes	ev.biologists.org	0	0		PAX6
1060	chr15	62337256	62346500	3500224441	600		62337256	62346500	8421504	6	63,83,64,45,216,129	0,292,838,7164,7967,9115	p	350022444100015025,350022444100015030,350022444100015023,350022444100015022,350022444100015021	0-198,0-195,0-192,0-198,0-198						This page intentionally left blank	les.wordpress.com	0	0		PAX6
1060	chr15	62337283	62338149	3500190689	174		62337283	62338149	8421504	3	36,83,55	0,265,811	p	350019068900015147	0-174						Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins, Second Edition	www.zvlab.ru	0	0		PAX6
1060	chr15	62337291	62337315	3500135205	24		62337291	62337315	8421504	1	24	0	c	350013520500000008	21-45						Universit&#xe0; degli Studi di Trieste	enstarts.units.it	0	0		PAX6
1060	chr15	62337302	62344463	3500439604	46		62337302	62344463	8421504	3	17,6,23	0,246,7138	c,g	350043960400000001,350043960400000000	0-23,0-23						Nanog+, OCT-4+ Retinal Pigment Epithelial Stem Cells and Methods for Their Use and Manufacture - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62337302	62344463	3500432104	46		62337302	62344463	8421504	3	17,6,23	0,246,7138	c	350043210400000001,350043210400000000	0-23,0-23						Nanog+, OCT-4+ Retinal Pigment Epithelial Stem Cells and Methods for Their Use and Manufacture	Smirnova	2008	0		PAX6
1060	chr15	62337591	62337620	3500041938	29		62337591	62337620	8421504	1	29	0	c,g	350004193800000041,350004193800000041	0-29,0-29						Method of efficiently establishing induced pluripotent stem cells	Yamanaka	2009	0		PAX6
1060	chr15	62338153	62350075	3500420461	40		62338153	62350075	8421504	3	20,18,2	0,8331,11920	c,g	350042046100000031,350042046100000031,350042046100000030	0-20,0-20,0-20			10.1634/stemcells.22-6-1070	1549-4918	STEM CELLS	Adult Pancreas Generates Multipotent Stem Cells and Pancreatic and Nonpancreatic Progeny - Choi - 2004 - STEM CELLS - Wiley Online Library	Choi	2004	0		PAX6
1060	chr15	62338190	62338214	3500442774	24		62338190	62338214	8421504	1	24	0	c	350044277400000022	15-39						Reprogramming of somatic cells: a tool for modelling neurodegenerative diseases	works.unsw.edu.au	0	0		PAX6
1060	chr15	62338248	62350075	3500194863	46		62338248	62350075	8421504	4	5,18,21,2	0,6051,8233,11825	c	350019486300000039,350019486300000038	0-23,0-23						Insulin-producing bone marrow derived cells and methods of generating and using same	Efrat	2004	0		PAX6
1060	chr15	62338248	62350075	3500092988	46		62338248	62350075	8421504	4	5,18,21,2	0,6051,8233,11825	c	350009298800000039,350009298800000089,350009298800000038,350009298800000088	0-23,0-23,0-23,0-23						Insulin-producing Bone Marrow Derived Cells And Methods Of Generating And Using Same 	.freshpatents.com	0	0		PAX6
1060	chr15	62344365	62345301	3500116334	42		62344365	62345301	8421504	2	22,20	0,916	c,g	350011633400000001,350011633400000001,350011633400000000	0-22,0-22,0-20						Characterization of P19 Cells during Retinoic Acid Induced Differentiation	pmr.cuni.cz	0	0		PAX6
1060	chr15	62344369	62344437	3500115508	45		62344369	62344437	8421504	2	25,20	0,48	c,g	350011550800000017,350011550800000016,350011550800000016	0-25,0-20,0-20						An isolated population of cells and methods of generating and using same	Aberdam	2010	0		PAX6
1060	chr15	62344414	62350074	3500290108	399		62344414	62350074	8421504	4	51,216,131,1	0,809,1957,5659	p	350029010800015000	0-399						6pax - PDBWiki	pdbwiki.org	0	0		PAX6
1060	chr15	62344428	62345296	3500459269	40		62344428	62345296	8421504	2	20,20	0,848	c,g	350045926900000044,350045926900000044,350045926900000043	0-20,0-20,0-20						Enhanced efficiency of induced pluripotent stem cell generation	Wu	2011	0		PAX6
1060	chr15	62344428	62345296	3500449206	40		62344428	62345296	8421504	2	20,20	0,848	c,g	350044920600000046,350044920600000046,350044920600000006,350044920600000045	0-20,0-20,20-40,0-20						EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62344428	62345296	3500106573	40		62344428	62345296	8421504	2	20,20	0,848	c,g	350010657300000044,350010657300000044,350010657300000096,350010657300000096,350010657300000095,350010657300000043	0-20,0-20,0-20,0-20,0-20,0-20						Enhanced efficiency of induced pluripotent stem cell generation - Patent application	www.faqs.org	0	0		PAX6
1060	chr15	62345226	62345249	3500209988	23		62345226	62345249	8421504	1	23	0	c	350020998800000023	23-46						Maruotti MRD 2012 - ResearchGate	.researchgate.net	0	0		PAX6
1060	chr15	62345234	62346501	3500335680	50		62345234	62346501	8421504	3	24,5,21	0,1238,1246	c,g	350033568000000001,350033568000000001,350033568000000003,350033568000000003,350033568000000002,350033568000000000,350033568000000000	0-22,0-22,0-20,0-20,0-20,0-20,0-20						ScienceDirect.com - Developmental Biology - The proliferation and expansion of retinal stem cells require functional Pax6	sciencedirect.com	0	0		PAX6
1060	chr15	62345269	62345293	3500405538	24		62345269	62345293	8421504	1	24	0	c	350040553800000007	0-24						<?xml version="1.0" encoding="US-ASCII"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing	ke.sciencemag.org	0	0		PAX6
1060	chr15	62345274	62345297	3500062925	23		62345274	62345297	8421504	1	23	0	c	350006292500000009	0-23						Feeder independent extended culture of embryonic stem cells	Xu	2005	0		PAX6
1060	chr15	62345294	62345378	3500008900	40		62345294	62345378	8421504	2	20,20	0,64	c,g	350000890000000013,350000890000000013,350000890000000012,350000890000000012	0-20,0-20,0-20,0-20						Di&#xfb00;erentiationofhumanEmbryonic StemCellsintohepatocytesasatoolto analysedynamicregulatoryevents duringhepatogenesis in vitro	diss.fu-berlin.de	0	0		PAX6
1060	chr15	62345341	62346374	3500323774	41		62345341	62346374	8421504	3	22,16,3	0,82,1030	c,g	350032377400000009,350032377400000009,350032377400000008	0-22,0-22,0-19		23936178	10.1371/journal.pone.0070267	1932-6203	PLOS ONE	PLOS ONE: Effect of Antibiotics against Mycoplasma sp. on Human Embryonic Stem Cells Undifferentiated Status, Pluripotency, Cell Viability and Growth	Romorini	2013	4		PAX6
1060	chr15	62345379	62345406	3500412634	27		62345379	62345406	8421504	1	27	0	c	350041263400000012	17-44						ScienceDirect.com - Biochemical and Biophysical Research Communications - Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets	sciencedirect.com	0	0		PAX6
1060	chr15	62345380	62350083	3500011593	40		62345380	62350083	8421504	3	20,10,10	0,1112,4693	c,g	350001159300000013,350001159300000013,350001159300000012	0-20,0-20,0-20						Insulin-Producing Cells Differentiated from Human Adipose Tissue-Derived Stem Cells Ameliorate Hyperglycemia in Diabetic Mice	www.term.or.kr	0	0		PAX6
1062	chr15	62609976	62610006	3500186592	24		62609976	62610006	8421504	3	5,13,6	0,8,24	g	350018659200000011	5-31						Non-transgenic Tomato Varieties Having Increased Shelf Life Post-Harvest Due to Alterations in Beta-Galactosidase 4	Hurst	2010	0		
1064	chr15	62838575	62855851	3500010113	1122		62838575	62855851	8421504	11	42,133,139,124,95,84,100,82,144,61,118	0,2467,3337,3727,3951,9899,10925,11586,15107,16423,17158	p	350001011300015001,350001011300015003,350001011300015004,350001011300015005,350001011300015008,350001011300015009,350001011300015010	0-1122,0-45,0-51,0-54,0-51,0-78,0-54						32 Human Secreted Proteins	Ruben	2007	0		EIF3M
1064	chr15	62838575	62855839	3500179772	1110		62838575	62855839	8421504	11	42,133,139,124,95,84,100,82,144,61,106	0,2467,3337,3727,3951,9899,10925,11586,15107,16423,17158	p	350017977200015001,350017977200015004,350017977200015005,350017977200015008,350017977200015009,350017977200015010	0-1110,0-51,0-54,0-51,0-66,0-54						Antibodies to secreted protein HEMCM42	Ruben	2002	0		EIF3M
1064	chr15	62842375	62853711	3500431918	105		62842375	62853711	8421504	4	51,6,19,29	0,151,7849,11307	p	350043191800015023,350043191800015024	0-57,0-48						Riboproteomics of the Hepatitis C Virus Internal Ribosomal Entry Site	gs.washington.edu	0	0		EIF3M
1064	chr15	62855758	62855848	3500295481	90		62855758	62855848	8421504	1	90	0	p	350029548100015001	0-90			10.1128/JVI.79.12.7419-7430.2005		Journal of Virology	A New Class of Receptor for Herpes Simplex Virus Has Heptad Repeat Motifs That Are Common to Membrane Fusion Proteins	Aleida	June	0		EIF3M
1064	chr15	62855758	62855848	3500241110	90		62855758	62855848	8421504	1	90	0	p	350024111000015001	0-90		15919898	10.1128/JVI.79.12.7419-7430.2005	0022-538X	Journal of Virology	A New Class of Receptor for Herpes Simplex Virus Has Heptad Repeat Motifs That Are Common to Membrane Fusion Proteins	Perez	2005	5		EIF3M
1066	chr15	63136590	63136616	3500155608	23		63136590	63136616	8421504	2	9,14	0,12	c	350015560800000099	24-48						Borrelia burdorferi Osp A and B proteins and immunogenic peptides	Barbour	1995	0		
1067	chr15	63210342	63210373	3500248541	27		63210342	63210373	8421504	3	6,15,6	0,8,25	c,g	350024854100000020,350024854100000020	3-33,3-33						Albumin variants	Plumridge	2012	0		
1067	chr15	63210342	63210373	3500145285	27		63210342	63210373	8421504	3	6,15,6	0,8,25	c	350014528500000020	3-33						ALBUMIN VARIANTS	Plumridge	2010	0		
1068	chr15	63322257	63371153	3500420477	42		63322257	63371153	8421504	4	5,14,12,11	0,7,48868,48885	g	350042047700000185,350042047700000295	21-40,20-43						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
1068	chr15	63322257	63371153	3500359363	42		63322257	63371153	8421504	4	5,14,12,11	0,7,48868,48885	g	350035936300000191,350035936300000301	21-40,20-43						Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments 	.freshpatents.com	0	0		
1068	chr15	63322257	63371153	3500032480	42		63322257	63371153	8421504	4	5,14,12,11	0,7,48868,48885	g	350003248000000189,350003248000000532,350003248000000299	21-40,0-22,20-43						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments - US Patent 7964349 Description	ww.patentstorm.us	0	0		
1070	chr15	63620541	63620569	3500424891	24		63620541	63620569	8421504	2	14,10	0,18	c	350042489100000001	8-32		22422858	10.1128/JCM.00481-12	0095-1137	Journal of Clinical Microbiology	A New Loop-Mediated Isothermal Amplification Method for Rapid, Simple, and Sensitive Detection of Leptospira spp. in Urine	Koizumi	2012	4		
1070	chr15	63620541	63620569	3500400160	24		63620541	63620569	8421504	2	14,10	0,18	c	350040016000000001	8-32						JCM Accepts, published online ahead of print on 14 March 2012 J. Clin. Microbiol. doi:10.1128/JCM.00481-12 Copyright &#xa9; 2012, American Society for Microbiology. All Rights Reserved. 1	jcm.asm.org	0	0		HIPK3
1070	chr15	63620541	63620569	3500178660	24		63620541	63620569	8421504	2	14,10	0,18	c	350017866000000001	8-32		22422858	10.1128/JCM.00481-12		Journal of Clinical Microbiology	A New Loop-Mediated Isothermal Amplification Method for Rapid, Simple, and Sensitive Detection of Leptospira spp. in Urine	Nobuo	June	0		HIPK3
1074	chr15	64143679	64150144	3500073945	378		64143679	64150144	8421504	2	202,176	0,6289	p	350007394500015010,350007394500015005	0-192,0-186						The LIM Region of a Presumptive Caenorhabditis elegans Transcription Factor is an Iron-Sulfur- and Zinc-Containing Metallodomain	www.jstor.org	0	0		LMO2
1074	chr15	64143688	64143712	3500252203	24		64143688	64143712	8421504	1	24	0	c	350025220300000003	0-24						Hematopoietic differentiation of umbilical cord blood-derived very small embryonic&sol;epiblast-like stem cells	www.floegel.info	0	0		
1074	chr15	64143729	64150026	3500150954	202		64143729	64150026	8421504	4	40,110,5,47	0,45,194,6250	c,g	350015095400000000,350015095400000003,350015095400000004,350015095400000004	18-217,0-24,0-20,0-20						Nucleic acid preparation from whole blood for use in diagnosis of transmissible spongiform encephalopathy - US Patent 7569367 Description	ww.patentstorm.us	0	0		
1076	chr15	64358015	64358203	3500186146	66		64358015	64358203	8421504	2	45,21	0,167	p	350018614600015004	0-66			10.1128/MCB.02300-06		Molecular and Cellular Biology	Distinct Structural Features ofCaprin-1 Mediate Its Interaction with G3BP-1 and Its Induction of Phosphorylation of Eukaryotic Translation Initiation Factor 2&#x03b1;, Entry to Cytoplasmic Stress Granules, and Selective Interaction with a Subset of mRNAs 	SamuSolomon	2007	0		CAPRIN1
1076	chr15	64358015	64358203	3500108569	66		64358015	64358203	8421504	2	45,21	0,167	p	350010856900015004	0-66		17210633	10.1128/MCB.02300-06	0270-7306	Molecular and Cellular Biology	Distinct Structural Features ofCaprin-1 Mediate Its Interaction with G3BP-1 and Its Induction of Phosphorylation of Eukaryotic Translation Initiation Factor 2&#x03b1;, Entry to Cytoplasmic Stress Granules, and Selective Interaction with a Subset of mRNAs	Solomon	2007	6		CAPRIN1
1076	chr15	64425911	64425951	3500459521	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350045952100000226,350045952100000227	21-57,21-57						Single-Chain Multivalent Binding Proteins with Effector Function	Thompson	2008	0		
1076	chr15	64425911	64425951	3500395610	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350039561000000226,350039561000000227	21-57,21-57						Single-Chain Multivalent Binding Proteins with Effector Function - Patent application	www.faqs.org	0	0		
1076	chr15	64425911	64425951	3500379983	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350037998300000225	21-57						SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION - Patent application	www.faqs.org	0	0		
1076	chr15	64425911	64425951	3500370709	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350037070900000225	21-57						SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION	Thompson	2007	0		
1076	chr15	64425911	64425951	3500302327	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350030232700000029	21-57						Binding Peptides Having a C-terminally Disposed Specific Binding Domain - Patent application	www.faqs.org	0	0		
1076	chr15	64425911	64425951	3500217024	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350021702400000225	21-57						Single chain multivalent binding proteins with effector function	Thompson	2007	0		
1076	chr15	64425911	64425951	3500199815	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350019981500000225	21-57						SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION - Patent application	www.faqs.org	0	0		
1076	chr15	64425911	64425951	3500117381	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350011738100000029	21-57						Binding Peptides Having a C-terminally Disposed Specific Binding Domain	Ledbetter	2009	0		
1076	chr15	64425911	64425951	3500042281	35		64425911	64425951	8421504	3	22,3,10	0,24,30	g	350004228100000225	21-57					Patent	Single chain multivalent binding proteins with effector function (Patent US:8409577)	Thompson	2013	0		
1077	chr15	64570373	64570401	3500088706	25		64570373	64570401	8421504	3	9,12,4	0,11,24	g	350008870600000003	0-36		7559670	10.1074/jbc.270.42.25291	0021-9258	Journal of Biological Chemistry	Definition of a Minimal Domain of the Dioxin Receptor That Is Associated with Hsp90 and Maintains Wild Type Ligand Binding Affinity and Specificity	Coumailleau	1995	5		
1078	chr15	64665265	64666423	3500404848	48		64665265	64666423	8421504	3	25,7,16	0,101,1142	c	350040484800000014,350040484800000015	0-25,0-23		19863698	10.1111/j.1582-4934.2009.00946.x	1582-4934	Journal of Cellular and Molecular Medicine	Native LDL-induced oxidative stress in human proximal tubular cells: multiple players involved - Piccoli - 2009 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Piccoli	2011	0		CAT
1078	chr15	64665267	64667879	3500189331	40		64665267	64667879	8421504	2	20,20	0,2592	c,g	350018933100000000,350018933100000000,350018933100000001	0-20,0-20,0-20						Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship. - ResearchGate	.researchgate.net	0	0		CAT
1078	chr15	64665267	64667879	3500062478	40		64665267	64667879	8421504	2	20,20	0,2592	c	350006247800000000,350006247800000001	0-20,0-20						Antioxidant and Chemosensitizing Effects of Flavonoids with Hydroxy and/or Methoxy Groups and Structure-Activity Relationship	brary.ualberta.ca	0	0		CAT
1078	chr15	64665372	64666454	3500413711	48		64665372	64666454	8421504	2	1,47	0,1035	p	350041371100015008	0-48						Method for increasing life-span	Chalfie	1997	0		CAT
1078	chr15	64665916	64665939	3500153718	23		64665916	64665939	8421504	1	23	0	g	350015371800000035	0-40						Parasitic helminth venom allergen antigen 5-like genes and proteins	Tripp	1995	0		
1078	chr15	64667146	64667172	3500377579	26		64667146	64667172	8421504	1	26	0	c	350037757900000017	0-26						METHOD, DEVICE AND KIT FOR DETERMINING CONDITIONS RELATED TO A DYSFUNCTION OF THE RENAL PROXIMAL TUBULE	Jouret	2008	0		
1078	chr15	64667146	64667172	3500103866	26		64667146	64667172	8421504	1	26	0	c	350010386600000018	0-26						Method, device and kit for determining conditions related to a dysfunction of the renal proximal tubule	Devuyst	2008	0		
1078	chr15	64667156	64667179	3500221899	23		64667156	64667179	8421504	1	23	0	c	350022189900000000	25-48						DEPARTAMENTO DE BIOQUAMICA Y BIOLOGAA MOLECULAR ESTRAS OXIDATIVO Y EXPRESIAN DE PROTEANAS RELA	www.tdx.cat	0	0		
1078	chr15	64667847	64676385	3500328481	72		64667847	64676385	8421504	4	60,5,4,3	0,4218,5023,8535	c	350032848100000010	0-72						Promotion of peroxisomal catalase function in cells	Terlecky	2004	0		
1078	chr15	64676439	64676464	3500411693	25		64676439	64676464	8421504	1	25	0	c	350041169300000009	0-25						The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. - ResearchGate	.researchgate.net	0	0		CAT
1078	chr15	64683246	64685763	3500355362	40		64683246	64685763	8421504	2	20,20	0,2497	c,g	350035536200000000,350035536200000000,350035536200000001,350035536200000001	0-20,0-20,0-20,0-20		24039949	10.1371/journal.pone.0073457		PLoS ONE	Lipopolysaccharide-Induced Weakness in the Preterm Diaphragm Is Associated with Mitochondrial Electron Transport Chain Dysfunction and Oxidative Stress	Yong	2013	0		
1078	chr15	64697970	64708995	3500395093	48		64697970	64708995	8421504	3	5,19,24	0,6454,11001	c	350039509300000001,350039509300000000	0-24,0-24						Global gene expression of the inner cell mass and trophectoderm of the bovine blastocyst	imal.ifas.ufl.edu	0	0		
1078	chr15	64697970	64708995	3500282277	48		64697970	64708995	8421504	3	5,19,24	0,6454,11001	c	350028227700000001,350028227700000000	0-24,0-24						Global gene expression of the inner cell mass and trophectoderm of the bovine blastocyst	biomedcentral.com	0	0		
1078	chr15	64697970	64708995	3500280156	48		64697970	64708995	8421504	3	5,19,24	0,6454,11001	c	350028015600000001,350028015600000000	0-24,0-24						Global gene expression of the inner cell mass and trophectoderm of the bovine blastocyst	imal.ifas.ufl.edu	0	0		
1078	chr15	64697970	64708995	3500154653	48		64697970	64708995	8421504	3	5,19,24	0,6454,11001	c,g	350015465300000001,350015465300000000,350015465300000000	0-24,0-24,0-24		23126590	10.1186/1471-213X-12-33	1471-213X	BMC Developmental Biology	Global gene expression of the inner cell mass and trophectoderm of the bovine blastocyst	Ozawa	2012	3		
1080	chr15	64900666	64900711	3500455533	45		64900666	64900711	8421504	1	45	0	p	350045553300015002	0-45			10.1002/ijc.10584	1097-0215	International Journal of Cancer	Target validation for genomics using peptide-specific phage antibodies: A study of five gene products overexpressed in colorectal cancer - van Beijnum - 2002 - International Journal of Cancer - Wiley Online Library	Beijnum	2002	0		EHF
1082	chr15	65222698	65229060	3500304449	40		65222698	65229060	8421504	3	6,13,21	0,11,6341	g	350030444900000073,350030444900000088	16-35,17-38						C-MET MUTATIONS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1083	chr15	65365580	65365646	3500182158	41		65365580	65365646	8421504	2	21,20	0,46	c	350018215800000010,350018215800000011	0-21,0-20						METHODS AND USES OF HYPOXIC COMPARTMENT CELLS - Patent application	www.faqs.org	0	0		
1083	chr15	65365613	65404125	3500458476	49		65365613	65404125	8421504	2	24,25	0,38487	c	350045847600000003,350045847600000001	0-24,0-25			10.2353/ajpath.2007.060828		The American Journal of Pathology	Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells	Kozo	July	0		
1083	chr15	65365613	65404125	3500445263	49		65365613	65404125	8421504	2	24,25	0,38487	c,g	350044526300000003,350044526300000001,350044526300000001	0-24,0-25,0-25						&#x4e3b;&#x9898;&#xff1a;inhibit | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1083	chr15	65370569	65370593	3500058609	24		65370569	65370593	8421504	1	24	0	c	350005860900000021	24-48						Supporting Information	www.pnas.org	0	0		
135	chr15	65370583	65412724	3500398747	63		65370583	65412724	8421504	5	18,5,19,1,20	0,2430,31410,33489,42121	c,g	350039874700000003,350039874700000002,350039874700000006,350039874700000007,350039874700000007	0-21,0-21,0-20,0-20,0-20						Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and &#xc1;-adducin	-publications.com	0	0		
135	chr15	65404146	65412622	3500108695	23		65404146	65412622	8421504	2	5,18	0,8458	c	350010869500000010	0-23						CANCER STEM CELL ANTIGEN VACCINES AND METHODS - Patent application	www.faqs.org	0	0		
135	chr15	65404146	65412622	3500010825	23		65404146	65412622	8421504	2	5,18	0,8458	c	350001082500000003	0-23						Isolation and Characterization of Colon Cancer Initiating Cells	ir.ym.edu.tw	0	0		
1084	chr15	65412703	65412880	3500145630	47		65412703	65412880	8421504	2	23,24	0,153	c	350014563000000014,350014563000000015	0-23,0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1084	chr15	65412784	65412809	3500072233	25		65412784	65412809	8421504	1	25	0	c	350007223300000001	0-25						CD44 ANTIBODIES - MEDAREX, INC.	www.sumobrain.com	0	0		
1084	chr15	65412785	65412810	3500462007	25		65412785	65412810	8421504	1	25	0	c	350046200700000001	0-25		19321434	10.1074/mcp.M800061-MCP200	1535-9476	Molecular & Cellular Proteomics	Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry	Leth-Larsen	2009	7		CD44
1084	chr15	65412785	65412810	3500358412	25		65412785	65412810	8421504	1	25	0	c	350035841200000001	0-25		19321434	10.1074/mcp.M800061-MCP200		Molecular & Cellular Proteomics : MCP	Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry	Rikke	June	0		CD44
1084	chr15	65412785	65412810	3500279618	25		65412785	65412810	8421504	1	25	0	c	350027961800000001	0-25						Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry*	www.mcponline.org	0	0		CD44
1084	chr15	65413441	65413464	3500012452	23		65413441	65413464	8421504	1	23	0	c	350001245200000222	20-43						Rabies Virus Vector Systems and Compositions and Methods Thereof - Patent application	www.faqs.org	0	0		
1084	chr15	65528420	65528587	3500373947	40		65528420	65528587	8421504	2	20,20	0,147	g	350037394700000101,350037394700000100	0-20,0-20						Udder Health Characteristics	Lund	2007	0		
1084	chr15	65528420	65528587	3500024826	40		65528420	65528587	8421504	2	20,20	0,147	g	350002482600000110,350002482600000109	0-20,0-20						Udder Health Characteristics 	.freshpatents.com	0	0		
135	chr15	65630958	65680738	3500246268	88		65630958	65680738	8421504	3	44,27,17	0,43455,49763	c	350024626800000024,350024626800000005	0-44,0-44						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
1090	chr15	66258746	66258775	3500258315	24		66258746	66258775	8421504	2	15,9	0,20	g	350025831500000215	8-33					Patent	Nucleic acid and amino acid sequences for mammalian sulfonylurea receptor (Patent US:6054313)	Bryan	2000	0		
1090	chr15	66266026	66289186	3500365533	258		66266026	66289186	8421504	2	124,134	0,23026	p	350036553300015011	36-294						Serine carboxypeptidase hx (SCPhx) and compositions thereof	Bejanin	2001	0		LDLRAD3
1090	chr15	66266026	66289186	3500227271	258		66266026	66289186	8421504	2	124,134	0,23026	p	350022727100015019	36-294						Human cdnas and proteins and uses thereof	Bejanin	2002	0		LDLRAD3
1090	chr15	66266026	66289186	3500222007	258		66266026	66289186	8421504	2	124,134	0,23026	p	350022200700015011	36-294						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		LDLRAD3
1090	chr15	66266026	66289186	3500185026	258		66266026	66289186	8421504	2	124,134	0,23026	p	350018502600015011	36-294						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		LDLRAD3
1090	chr15	66266026	66289186	3500122082	258		66266026	66289186	8421504	2	124,134	0,23026	p	350012208200015014	36-294						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		LDLRAD3
1090	chr15	66289078	66289186	3500362636	108		66289078	66289186	8421504	1	108	0	p	350036263600015011	0-108						Isolated human vCOL16A1 polypeptide and fragments thereof	Bejanin	2001	0		LDLRAD3
1090	chr15	66289078	66289186	3500203017	108		66289078	66289186	8421504	1	108	0	p	350020301700015010	0-108						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		LDLRAD3
1090	chr15	66303028	66304292	3500072920	38		66303028	66304292	8421504	4	13,6,6,13	0,17,1241,1251	g	350007292000000027,350007292000000026	4-23,11-30						Transgenic microorganism provided with the ability to produce 1,3-butanediol, and usage therefor	Nakajima	2012	0		
1092	chr15	66459406	66465864	3500186547	24		66459406	66465864	8421504	3	5,7,12	0,6434,6446	c	350018654700000047	24-48						Polycystic kidney disease gene and protein	Klinger	1996	0		
1094	chr15	66793853	66793885	3500152228	30		66793853	66793885	8421504	2	15,15	0,17	c	350015222800000199	4-34						Detection of nucleic acids by multiple sequential invasive cleavages	Hall	1997	0		
1094	chr15	66793857	66793881	3500455546	24		66793857	66793881	8421504	1	24	0	c	350045554600000010	0-24						Urotensin 2 and its Receptor as Candidate Genes for Beef Marbling Score, Ribeye Area and Fatty Acid Composition	Jiang	2008	0		
1094	chr15	66794172	66796165	3500224533	1458		66794172	66796165	8421504	3	32,32,1394	0,566,599	c,g	350022453300000003,350022453300000003,350022453300000006,350022453300000001,350022453300000001,350022453300000000,350022453300000000	0-32,0-32,0-1430,0-25,0-25,0-23,0-23						Production of ungulates, preferably bovines that produce human immunoglobulins - Patent application	www.faqs.org	0	0		
1094	chr15	66794172	66795883	3500456465	80		66794172	66795883	8421504	3	32,25,23	0,1159,1688	c	350045646500000003,350045646500000001,350045646500000000	0-32,0-25,0-23						Production of ungulates, preferably bovines that produce human immunoglobulins	Goldsby	2008	0		
1094	chr15	66794702	66794727	3500434928	25		66794702	66794727	8421504	1	25	0	c	350043492800000738	0-25						Compositions, methods and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals - Patent application	www.faqs.org	0	0		
1094	chr15	66794947	66795013	3500059038	60		66794947	66795013	8421504	2	45,15	0,51	p	350005903800015010	6-66						Expression of human recombination activating genes (RAG1 and RAG2) in neoplastic lymphoid cells: correlation with cell differentiation and antigen receptor expression. - ResearchGate	.researchgate.net	0	0		
1102	chr15	67891927	67891951	3500317072	23		67891927	67891951	8421504	2	6,17	0,7	g	350031707200000097,350031707200000100	1-23,1-26						STRUCTURE AND USE OF 5'PHOSPHATE OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		
1105	chr15	68240384	68240408	3500156459	23		68240384	68240408	8421504	2	4,19	0,5	g	350015645900000009,350015645900000002	1-24,1-24						Degradable nucleic acid probes and nucleic acid detection methods	Vanatta	2000	0		
1107	chr15	68463798	68463822	3500035109	23		68463798	68463822	8421504	2	14,9	0,15	g	350003510900000152	7-30						METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE - Patent application	www.faqs.org	0	0		
1107	chr15	68476935	68476963	3500359474	25		68476935	68476963	8421504	2	20,5	0,23	g	350035947400000008	21-48						US Patent # 7,501,131. Haemophilus influenzae type IV pili - Patents.com	www.patents.com	0	0		
1109	chr15	68708536	68708561	3500402710	24		68708536	68708561	8421504	2	6,18	0,7	g	350040271000000004	8-34		14570887	10.1074/jbc.M310733200	0021-9258	Journal of Biological Chemistry	Genes malh and pagl of Clostridium acetobutylicum ATCC 824 Encode NAD+- and Mn2+-dependent Phospho-&#x03b1;-glucosidase(s)	Thompson	2004	5		
1118	chr15	69909897	69909927	3500190972	25		69909897	69909927	8421504	2	18,7	0,23	g	350019097200000021	0-25						Marine mela gene	Weiner	1995	0		
1118	chr15	69925607	69925635	3500129958	25		69925607	69925635	8421504	3	7,12,6	0,8,22	g	350012995800000178	16-45						Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains - Patent # 6495137 - PatentGenius	.patentgenius.com	0	0		
1124	chr15	70715254	70715282	3500248703	25		70715254	70715282	8421504	3	4,15,6	0,5,22	g	350024870300000087	8-33						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
1126	chr15	70921368	70921396	3500357034	26		70921368	70921396	8421504	3	9,13,4	0,10,24	g	350035703400000009	1-27						Export of cyst wall material and Golgi organelle neogenesis in Giardia lamblia depends on ER exit sites	mc.vanderbilt.edu	0	0		
1128	chr15	71253693	71253723	3500188455	25		71253693	71253723	8421504	2	6,19	0,11	g	350018845500000141	5-30						 Polypeptide For A TRP Channel Family Member, TRP 	www.docstoc.com	0	0		
1133	chr15	71840125	71840153	3500401329	23		71840125	71840153	8421504	3	5,5,13	0,7,15	g	350040132900000305	6-29						Influenza Therapeutic - Patent application	www.faqs.org	0	0		
1133	chr15	71840125	71840153	3500389693	23		71840125	71840153	8421504	3	5,5,13	0,7,15	g	350038969300000321	6-29						Influenza Therapeutic - Patent application	www.faqs.org	0	0		
1133	chr15	71914577	71914604	3500361339	23		71914577	71914604	8421504	2	7,16	0,11	g	350036133900000572	7-30						US Patent # 7,271,156. Immunostimulatory nucleic acids - Patents.com	www.patents.com	0	0		
1134	chr15	71969182	71969210	3500444695	23		71969182	71969210	8421504	2	15,8	0,20	g	350044469500000020	0-27						Antisense antibacterial method and compound	Geller	2006	0		
1134	chr15	71969182	71969210	3500254473	23		71969182	71969210	8421504	2	15,8	0,20	g	350025447300000031	0-27						Antisense antibacterial method and compound	Deere	2011	0		
1145	chr15	73434468	73434494	3500230330	23		73434468	73434494	8421504	2	7,16	0,10	c	350023033000000298,350023033000000413	0-23,24-47						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		API5
1146	chr15	73563005	73568669	3500289527	225		73563005	73568669	8421504	3	9,132,84	0,239,5580	p	350028952700015063,350028952700015065	12-237,0-111						101 human secreted proteins	Carter	2003	0		TTC17
1146	chr15	73563005	73568669	3500288953	225		73563005	73568669	8421504	3	9,132,84	0,239,5580	p	350028895300015018	12-237						101 human secreted proteins	Carter	1999	0		TTC17
1146	chr15	73563005	73568669	3500277995	225		73563005	73568669	8421504	3	9,132,84	0,239,5580	p	350027799500015018	12-237						101 human secreted proteins	Carter	2000	0		TTC17
1146	chr15	73571435	73571460	3500031051	23		73571435	73571460	8421504	2	16,7	0,18	c	350003105100000014,350003105100000048	3-30,3-30						REAGENTS FOR RECOMBINOGENIC ENGINEERING AND USE THEREOF - Patent application	www.faqs.org	0	0		
1147	chr15	73747697	73747761	3500125321	44		73747697	73747761	8421504	2	22,22	0,42	c,g	350012532100000038,350012532100000038,350012532100000039,350012532100000039	0-22,0-22,0-22,0-22						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIR670
1151	chr15	74283103	74283129	3500135136	25		74283103	74283129	8421504	2	8,17	0,9	c	350013513600000133,350013513600000134	4-29,0-25						AGENT FOR PREVENTING/TREATING CANCER - Patent application	www.faqs.org	0	0		
1152	chr15	74378610	74431509	3500141401	270		74378610	74431509	8421504	6	45,45,45,45,45,45	0,10161,41988,44414,46235,52854	p	350014140100015274,350014140100015279,350014140100015282,350014140100015284,350014140100015287,350014140100015289	0-45,0-45,0-45,0-45,0-45,0-45						Heparin/heparosan synthase from and methods of making and using same - US Patent 7771981 Description	ww.patentstorm.us	0	0		EXT2
1153	chr15	74478145	74525304	3500342820	47021		74478145	74525304	8421504	4	11532,5642,144,29703	0,11582,17311,17456	g	350034282000000008,350034282000000005,350034282000000009	19-1686,19-1686,0-45693						Screening for the Genetic Defect Causing Tibial Hemimelia in Bovines - Patent application	www.faqs.org	0	0		
1155	chr15	74718693	74718720	3500254774	23		74718693	74718720	8421504	2	13,10	0,17	g	350025477400000676	0-31						Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies - Patent application	www.faqs.org	0	0		
1156	chr15	74966561	74966585	3500317381	23		74966561	74966585	8421504	2	6,17	0,7	g	350031738100000017	23-46						Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A	Roth	1995	0		
1158	chr15	75151953	75151977	3500039441	24		75151953	75151977	8421504	1	24	0	c	350003944100000045	0-24						PROTEINS AND NUCLEIC ACIDS ENCODING THE SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
1160	chr15	75460209	75460320	3500373947	41		75460209	75460320	8421504	3	14,7,20	0,15,91	g	350037394700000109,350037394700000108	0-21,0-20						Udder Health Characteristics	Lund	2007	0		
1161	chr15	75602141	75602167	3500128306	23		75602141	75602167	8421504	2	7,16	0,10	g	350012830600000038	0-23						Means and Methods for Controlling Flowering in Plants - Patent application	www.faqs.org	0	0		
1164	chr15	75891317	75891365	3500058923	48		75891317	75891365	8421504	1	48	0	p	350005892300015072	0-48						US Patent # 6,933,142. HEC-G1CNAC6ST - Patents.com	www.patents.com	0	0		CHST1
1164	chr15	75914940	75914967	3500133654	23		75914940	75914967	8421504	3	7,4,12	0,8,15	g	350013365400000174,350013365400000095	0-23,0-23						FC-FREE ANTIBODIES COMPRISING TWO FAB FRAGMENTS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1164	chr15	75916966	75916994	3500036421	23		75916966	75916994	8421504	2	6,17	0,11	g	350003642100000541	23-46						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
1164	chr15	75977180	75977839	3500383268	659		75977180	75977839	8421504	1	659	0	g	350038326800000011,350038326800000005,350038326800000018	1-662,1-20,1-20						Gene markers for beef marbling and tenderness	Jackwood	2001	0		
1165	chr15	76041868	76041915	3500124002	47		76041868	76041915	8421504	1	47	0	c	350012400200000058	0-47						PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION - Patent application	www.faqs.org	0	0		
1165	chr15	76105470	76105496	3500369884	23		76105470	76105496	8421504	2	16,7	0,19	g	350036988400000026	11-34						Anti-Pancreatic Cancer Antibodies - Patent application	www.faqs.org	0	0		
1165	chr15	76109662	76109693	3500030524	26		76109662	76109693	8421504	3	6,14,6	0,10,25	g	350003052400000086	4-32						PROTEIN ELECTRON MEDIATOR - Patent application	www.faqs.org	0	0		
1165	chr15	76115597	76115626	3500258001	24		76115597	76115626	8421504	2	10,14	0,15	g	350025800100000009	21-45						PROTEASE VARIANTS - Patent application	www.faqs.org	0	0		
1165	chr15	76131035	76142081	3500295532	48		76131035	76142081	8421504	2	14,34	0,11012	c	350029553200000005	0-48						Transcription factor Islet-Brain 1 (IB1)	Waeber	1997	0		
1165	chr15	76144077	76144100	3500031523	23		76144077	76144100	8421504	1	23	0	c	350003152300000004	0-23						Transcription factor islet-brain 1 (ib1)	Bonny	1998	0		
1165	chr15	76144263	76145828	3500272037	69		76144263	76145828	8421504	2	63,6	0,1559	p	350027203700015002,350027203700015004	0-69,0-60						Cell-permeable peptide inhibitors of the jnk signal transduction pathway	Bonny	2003	0		MAPK8IP1
1165	chr15	76144272	76145828	3500370715	60		76144272	76145828	8421504	2	54,6	0,1550	p	350037071500015000	36-96		17005604	10.1152/ajpcell.00356.2006		American Journal of Physiology - Cell Physiolog	Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor	Alikhani	2007	0		MAPK8IP1
1165	chr15	76144272	76145828	3500317988	60		76144272	76145828	8421504	2	54,6	0,1550	p	350031798800015000	36-96		17005604	10.1152/ajpcell.00356.2006		American Journal of Physiology - Cell Physiolog	Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor	Alikhani	2007	0		MAPK8IP1
1165	chr15	76144272	76145828	3500201127	60		76144272	76145828	8421504	2	54,6	0,1550	p	350020112700015000	36-96		17005604	10.1152/ajpcell.00356.2006		American Journal of Physiology - Cell Physiology	Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor	Alikhani	2007	0		MAPK8IP1
1165	chr15	76144272	76145828	3500200652	60		76144272	76145828	8421504	2	54,6	0,1550	p	350020065200015000	36-96		17005604	10.1152/ajpcell.00356.2006		American Journal of Physiology - Cell Physiolog	Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor	Alikhani	2007	0		MAPK8IP1
1165	chr15	76144272	76145828	3500150537	60		76144272	76145828	8421504	2	54,6	0,1550	p	350015053700015001	0-60		19628795	10.1161/STROKEAHA.109.560250	0039-2499	Stroke	Alternate Pathways Preserve Tumor Necrosis Factor-&#x03b1; Production After Nuclear Factor-&#x03ba;B Inhibition in Neonatal Cerebral Hypoxia&#x2013;Ischemia	Nijboer	2009	6		MAPK8IP1
1165	chr15	76146583	76146607	3500270141	24		76146583	76146607	8421504	1	24	0	c,g	350027014100000011,350027014100000011	0-24,0-24		17108332	10.1095/biolreprod.106.057216	0006-3363	Biology of Reproduction	Low-Density Lipoprotein Receptor-Related Protein 8 (LRP8) Is Upregulated in Granulosa Cells of Bovine Dominant Follicle: Molecular Characterization and Spatio-Temporal Expression Studies	Fayad	2007	4		
1166	chr15	76164267	76165516	3500242436	204		76164267	76165516	8421504	5	75,36,21,19,53	0,636,678,702,1196	p	350024243600015018,350024243600015164	0-75,0-132						Novel polypeptides and nucleic acids encoding same	Burgess	2002	0		
1166	chr15	76170515	76170538	3500034199	23		76170515	76170538	8421504	1	23	0	g	350003419900000295	8-45						MODULATION OF APOLIPOPROTEIN (a) EXPRESSION - Patent application	www.faqs.org	0	0		
1167	chr15	76387265	76387291	3500435393	26		76387265	76387291	8421504	1	26	0	g	350043539300000023	0-26						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
1171	chr15	76901699	76923743	3500293877	39		76901699	76923743	8421504	4	14,5,16,4	0,15,22023,22040	g	350029387700000118,350029387700000030	9-28,8-28						Hypermethylation of GATA-4 and GATA-5 Transcription Factor Genes in Cancer - Patent application	www.faqs.org	0	0		
1172	chr15	76949507	76949534	3500444585	23		76949507	76949534	8421504	2	15,8	0,19	g	350044458500000051	10-38						NOVEL SHIGELLA PROTEIN ANTIGENS AND METHODS - Patent application	www.faqs.org	0	0		
1172	chr15	76976598	76976907	3500205420	57		76976598	76976907	8421504	2	53,4	0,305	p	350020542000015000	0-57		19812368	10.1152/ajpcell.00324.2009		American Journal of Physiology - Cell Physiology	Role of p47phox in regulating Cdc42GAP, vimentin, and contraction in smooth muscle cells	Li	2009	0		
1172	chr15	76976598	76976907	3500127268	57		76976598	76976907	8421504	2	53,4	0,305	p	350012726800015001	0-57		19812368	10.1152/ajpcell.00324.2009		American Journal of Physiology - Cell Physiology	Role of p47phox in regulating Cdc42GAP, vimentin, and contraction in smooth muscle cells	Qing-Fen	2009	0		
1172	chr15	76976598	76976907	3500007363	57		76976598	76976907	8421504	2	53,4	0,305	p	350000736300015000	0-57		19812368	10.1152/ajpcell.00324.2009		American Journal of Physiology - Cell Physiology	Role of p47phox in regulating Cdc42GAP, vimentin, and contraction in smooth muscle cells	Li	2009	0		
1172	chr15	76999732	77000579	3500052832	477		76999732	77000579	8421504	3	256,135,86	0,551,761	p	350005283200015158	0-477						NOTES ON SELECTED SOFTBERRY PRODUCTS	ux1.softberry.com	0	0		
1172	chr15	77000618	77009437	3500463897	87		77000618	77009437	8421504	4	2,12,26,47	0,983,996,8772	c	350046389700000022,350046389700000035	6-47,0-47						US Patent # 5,476,777. Methods for producing thrombin - Patents.com	www.patents.com	0	0		
1172	chr15	77001641	77001679	3500197193	38		77001641	77001679	8421504	1	38	0	c	350019719300000023	0-38						Methods for producing thrombin	www.devileye.net	0	0		
1172	chr15	77001641	77001679	3500186868	38		77001641	77001679	8421504	1	38	0	c	350018686800000023	0-38						Methods for producing thrombin	Holly	1995	0		
1172	chr15	77002845	77002869	3500354199	24		77002845	77002869	8421504	1	24	0	c	350035419900000095	13-37						Modified factor IX polypeptides and uses thereof	Madison	2011	0		
1172	chr15	77009166	77009214	3500013296	48		77009166	77009214	8421504	1	48	0	p	350001329600015002	0-48						Darwin in the Genome	www.scribd.com	0	0		
1172	chr15	77009462	77009499	3500442861	37		77009462	77009499	8421504	1	37	0	c	350044286100000085,350044286100000056,350044286100000084	8-45,5-24,8-45						REFERENCE MEASUREMENT SYSTEMS IN GENETIC TESTING: DEVELOPMENT OF DNA-BASED REFERENCE MATERIALS	.bibl.u-szeged.hu	0	0		
1173	chr15	77072732	77075875	3500188994	195		77072732	77075875	8421504	2	151,44	0,3099	p	350018899400015027	198-393						NPG.nature.vol.411.Issue.6837.May	www.scribd.com	0	0		CKAP5
1173	chr15	77143416	77145965	3500261465	486		77143416	77145965	8421504	7	49,32,24,144,95,37,105	0,1723,1758,1785,1932,2404,2444	p	350026146500015029	0-486						Lp mammalian proteins; related reagents	Amegadzie	2002	0		
1174	chr15	77292561	77292589	3500258483	25		77292561	77292589	8421504	2	15,10	0,18	g	350025848300000019	3-28						IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES - Patent application	www.faqs.org	0	0		
1174	chr15	77322392	77322420	3500174638	25		77322392	77322420	8421504	2	10,15	0,13	g	350017463800000393	17-42						US Patent # 8,318,908. Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof - Patents.com	patents.com	0	0		
1176	chr15	77464369	77464993	3500448886	51		77464369	77464993	8421504	2	42,9	0,615	p	350044888600015053	0-51					Patent	Recombinant cells that express phytate degrading enzymes in desired ratios (Patent US:5834286)	Cantrell	1998	0		
1176	chr15	77464369	77464993	3500009865	51		77464369	77464993	8421504	2	42,9	0,615	p	350000986500015054	0-51						Recombinant cells that express phytate degrading enzymes in desired ratios	Nevalainen	1995	0		
1176	chr15	77464372	77464993	3500460629	48		77464372	77464993	8421504	2	39,9	0,612	p	350046062900015121	0-48						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1176	chr15	77472011	77472564	3500465101	26		77472011	77472564	8421504	2	18,8	0,545	c	350046510100000009	3-29						THE ROLE OF PPAR&#x03b1; AND GROWTH HORMONE IN HEPATIC LIPID METABOLISM AND ATHEROSCLEROSIS	w.neurophys.gu.se	0	0		
1176	chr15	77472637	77478127	3500095434	96		77472637	77478127	8421504	4	26,25,25,20	0,459,1280,5470	c,g	350009543400000012,350009543400000008,350009543400000015,350009543400000011,350009543400000011	0-26,0-25,0-25,0-20,0-20						BMC Genetics BioMed Central	biomedcentral.com	0	0		
1176	chr15	77473280	77473303	3500047311	23		77473280	77473303	8421504	1	23	0	c	350004731100000009	0-23						Saleta Sierra &#xc1;vila Granada, 2006	hera.ugr.es	0	0		
1176	chr15	77473280	77473303	3500012973	23		77473280	77473303	8421504	1	23	0	c	350001297300000010	0-23						TESIS DOCTORAL CAMO ENGRASAR CORRECTAMENTE EL ORGANISMO: ?EFECTO DE LA GRASA SOBRE LA RESPUESTA	ww.digibug.ugr.es	0	0		
1176	chr15	77473323	77474383	3500074126	282		77473323	77474383	8421504	3	150,114,18	0,925,1042	p	350007412600015006,350007412600015014	0-150,0-132						Human lxr alpha variants	Liu	2006	0		
1176	chr15	77473506	77478039	3500159625	846		77473506	77478039	8421504	10	16,47,159,180,100,11,18,79,95,141	0,384,434,700,1062,3773,3787,3808,4106,4392	p	350015962500015167	0-846						Methods and compositions to promote bone homeostasis	Tomme	2007	0		
1176	chr15	77473985	77474051	3500387058	66		77473985	77474051	8421504	1	66	0	p	350038705800015004	0-66		18250151	10.1128/MCB.01575-07		Molecular and Cellular Biology	Phosphorylation of Liver X Receptor &#x03b1; Selectively Regulates Target Gene Expression in Macrophages 	Ines	2008	0		NR1H3
1176	chr15	77473985	77474051	3500118102	66		77473985	77474051	8421504	1	66	0	p	350011810200015004	0-66		18250151	10.1128/MCB.01575-07	0270-7306	Molecular and Cellular Biology	Phosphorylation of Liver X Receptor &#x03b1; Selectively Regulates Target Gene Expression in Macrophages	Torra	2008	6		NR1H3
1176	chr15	77474339	77477946	3500015890	45		77474339	77477946	8421504	2	21,24	0,3583	c	350001589000000009,350001589000000010	0-21,0-24						Curcumin induces changes in expression of genes involved in cholesterol homeostasis. - ResearchGate	.researchgate.net	0	0		NR1H3
1176	chr15	77474339	77477946	3500001887	45		77474339	77477946	8421504	2	21,24	0,3583	c	350000188700000014,350000188700000015	0-21,0-24						Curcumin induces changes in expression of genes involved in cholesterol homeostasis	biodiversity.info	0	0		NR1H3
1176	chr15	77474375	77477616	3500099123	39		77474375	77477616	8421504	4	11,9,15,4	0,193,3003,3237	c	350009912300000024,350009912300000007	0-20,0-19						Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin	g.library.pcc.edu	0	0		
1176	chr15	77477365	77477919	3500456201	96		77477365	77477919	8421504	4	28,20,27,21	0,247,315,533	c	350045620100000029,350045620100000031	0-48,0-48						Lxr ligand testing method - Patent application	www.faqs.org	0	0		
1176	chr15	77477636	77477659	3500282482	23		77477636	77477659	8421504	1	23	0	c	350028248200000038	19-42						Prevention and therapy of type 2 diabetes by selective modulation of the human peroxisome proliferator-activated receptor gamma (PPAR&#x03b3;	diss.fu-berlin.de	0	0		
1176	chr15	77484495	77484526	3500043362	27		77484495	77484526	8421504	2	19,8	0,23	c	350004336200000045	20-47						 ICAM 	www.docstoc.com	0	0		
1176	chr15	77484668	77484728	3500399072	60		77484668	77484728	8421504	1	60	0	p	350039907200015003	0-60						4495 Corrigendum SCD1 is required for cell cytokinesis and polarized cell expansion in Arabidopsis thaliana SCD1 is required for cytokinesis and polarized cell expansion in Arabidopsis thaliana	www.epernicus.com	0	0		MADD
1176	chr15	77484668	77484728	3500292441	60		77484668	77484728	8421504	1	60	0	p	350029244100015003	0-60						4495 Corrigendum SCD1 is required for cell cytokinesis and polarized cell expansion in Arabidopsis thaliana SCD1 is required for cytokinesis and polarized cell expansion in Arabidopsis thaliana	ev.biologists.org	0	0		MADD
1176	chr15	77496555	77515277	3500306351	1815		77496555	77515277	8421504	16	96,151,207,54,101,84,159,109,63,121,106,111,108,165,73,107	0,186,819,2707,3720,4817,5247,8121,8513,8815,9038,9839,12331,18001,18404,18615	p	350030635100015004	0-1815						REGULATION OF APOPTOSIS BY NEURAL SPECIFIC SPLICE VARIANTS OF IG20 - Patent application	www.faqs.org	0	0		
1176	chr15	77536509	77536659	3500417781	60		77536509	77536659	8421504	2	41,19	0,131	p	350041778100015016	0-60						Determina&#xe7;&#xe3;o de alvos antig&#xea;nicos na doen&#xe7;a reum&#xe1;tica card&#xed;aca utilizando phage display	www.teses.usp.br	0	0		MYBPC3
1176	chr15	77541212	77541353	3500024563	135		77541212	77541353	8421504	3	45,45,45	0,48,96	p	350002456300015063,350002456300015062,350002456300015061	0-45,0-45,0-45						PARP1 TARGETED THERAPY - Patent application	www.faqs.org	0	0		SPI1
1176	chr15	77541294	77554651	3500406446	40		77541294	77554651	8421504	3	20,1,19	0,1598,13338	c,g	350040644600000035,350040644600000035,350040644600000034	0-20,0-20,0-20						ACETYLCHOLINESTERASE (ACHE)-DERIVED PEPTIDE AS AN INDUCER OF GRANULOCYTOPOIESIS, USES AND METHODS THEREOF - Patent application	www.faqs.org	0	0		
1176	chr15	77554665	77554689	3500342127	24		77554665	77554689	8421504	1	24	0	c	350034212700000009	0-24						Methods of Ex Vivo Expansion of Blood Progenitor Cells, and Generation of Composite Grafts	Mahmud	2012	0		SPI1
1177	chr15	77611865	77611895	3500288510	30		77611865	77611895	8421504	1	30	0	c	350028851000000003	0-30		21148107	10.1095/biolreprod.110.088831	0006-3363	Biology of Reproduction	Generation of Viable Male and Female Mice from Two Fathers	Deng	2011	4		
1177	chr15	77611865	77611895	3500132037	30		77611865	77611895	8421504	1	30	0	c	350013203700000003	0-30						Methods for delivering nucleic acid molecules into cells and assessment thereof	Dejong	2004	0		
1177	chr15	77631942	77646412	3500196141	40		77631942	77646412	8421504	2	20,20	0,14450	c	350019614100000003,350019614100000000	11-31,12-32		11158314	10.1128/MCB.21.4.1285-1296.2001	0270-7306	Molecular and Cellular Biology	The CELF Family of RNA Binding Proteins Is Implicated in Cell-Specific and Developmentally Regulated Alternative Splicing	Ladd	2001	6		
1177	chr15	77646391	77646416	3500423563	25		77646391	77646416	8421504	1	25	0	c	350042356300000000	0-25		21444716	10.1128/MCB.05170-11	0270-7306	Molecular and Cellular Biology	Signal- and Development-Dependent Alternative Splicing of LEF1 in T Cells Is Controlled by CELF2	Mallory	2011	6		CELF1
1177	chr15	77719368	77719392	3500268611	23		77719368	77719392	8421504	2	19,4	0,20	g	350026861100000008	6-29			10.1128/JB.183.21.6253-6264.2001		Journal of Bacteriology	Gonococcal MinD Affects Cell Division in Neisseria gonorrhoeae and Escherichia coli and Exhibits a Novel Self-Interaction	Jason	2001	0		
1179	chr15	77898815	77898842	3500402708	24		77898815	77898842	8421504	3	6,5,13	0,8,14	c,g	350040270800000015,350040270800000015	9-33,9-33						DNA BINDING SITE OF A TRANSCRIPTIONAL ACTIVATOR USEFUL IN GENE EXPRESSION - Patent application	www.faqs.org	0	0		
1179	chr15	77957415	77957441	3500030519	23		77957415	77957441	8421504	3	4,5,14	0,5,12	g	350003051900000069	13-36						Nematode-extracted serine protease inhibitors and anticoagulant proteins - Patent application	www.faqs.org	0	0		
1190	chr15	79392504	79392527	3500373947	23		79392504	79392527	8421504	1	23	0	g	350037394700000110	0-23						Udder Health Characteristics	Lund	2007	0		
1190	chr15	79392504	79392527	3500024826	23		79392504	79392527	8421504	1	23	0	g	350002482600000119	0-23						Udder Health Characteristics 	.freshpatents.com	0	0		
1193	chr15	79708462	79708489	3500110329	24		79708462	79708489	8421504	3	14,4,6	0,15,21	g	350011032900000540	1-26						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
1195	chr15	79990960	79990992	3500015180	25		79990960	79990992	8421504	3	12,3,10	0,14,22	g	350001518000000003	0-25						Methods and compositions for genotyping	Derbyshire	2005	0		
1199	chr15	80552657	80552682	3500329538	24		80552657	80552682	8421504	2	20,4	0,21	g	350032953800000066	19-43						US Patent # 5,460,950. Expression of PACE in host cells and methods of use thereof - Patents.com	www.patents.com	0	0		
1204	chr15	81144880	81144946	3500356723	66		81144880	81144946	8421504	1	66	0	p	350035672300015020	0-66						Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses	Fraser	2005	0		SLC43A3
1204	chr15	81230491	81230646	3500072968	44		81230491	81230646	8421504	2	39,5	0,150	c	350007296800000369	3-47						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
1205	chr15	81395016	81395347	3500157219	39		81395016	81395347	8421504	3	19,5,15	0,129,316	c	350015721900000013,350015721900000014	0-19,0-20		18239051	10.1530/REP-07-0415	1470-1626	Reproduction	Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle	Mitko	2008	3		
1205	chr15	81395027	81395057	3500195935	25		81395027	81395057	8421504	2	16,9	0,21	c	350019593500000270	13-38						Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use	Simons	1995	0		
1205	chr15	81395068	81395347	3500362403	39		81395068	81395347	8421504	3	19,5,15	0,77,264	c	350036240300000080,350036240300000081	0-19,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
1205	chr15	81395068	81395347	3500049790	39		81395068	81395347	8421504	3	19,5,15	0,77,264	c,g	350004979000000013,350004979000000014	0-19,0-20						Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	ww.biolreprod.org	0	0		
1206	chr15	81459780	81465402	3500043960	165		81459780	81465402	8421504	3	45,75,45	0,1191,5577	p	350004396000015049,350004396000015007,350004396000015050,350004396000015004,350004396000015000	0-45,0-45,0-45,0-45,0-45						ALTERED ZDHHC8 EXPRESSION AS A MARKER OF INCREASED RISK OF SCHIZOPHRENIA - Patent application	www.faqs.org	0	0		ZDHHC5
1206	chr15	81521477	81521500	3500442237	23		81521477	81521500	8421504	1	23	0	c	350044223700000001	10-33		20971762	10.1152/ajpheart.00812.2010		American Journal of Physiology - Heart and Circulatory Physiology	p120 regulates endothelial permeability independently of its NH2 terminus and Rho binding	CrystR.	2011	0		
1206	chr15	81521477	81521500	3500193503	23		81521477	81521500	8421504	1	23	0	c	350019350300000001	10-33		20971762	10.1152/ajpheart.00812.2010		American Journal of Physiology - Heart and Circulatory Physiology	p120 regulates endothelial permeability independently of its NH2 terminus and Rho binding	Herron	2011	0		
1207	chr15	81603690	81603717	3500259466	25		81603690	81603717	8421504	2	13,12	0,15	g	350025946600000001	12-38						Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products	Paoletti	1994	0		
1208	chr15	81759284	81759313	3500447624	23		81759284	81759313	8421504	3	4,13,6	0,5,23	g	350044762400000181	19-42						USE OF R-GENES AS A SELECTION MARKER IN PLANT TRANSFORMATION AND USE OF CISGENES IN PLANT TRANSFORMATION - Patent application	www.faqs.org	0	0		
1214	chr15	82568333	82568359	3500424105	23		82568333	82568359	8421504	2	17,6	0,20	g	350042410500000014,350042410500000013	16-43,5-32						Generation of a dna nicking enzyme that stimulates site-specific gene conversion from a homing endonuclease	Mcconnell-Smith	2010	0		
1215	chr15	82612310	82616444	3500080694	41		82612310	82616444	8421504	3	21,6,14	0,4113,4120	g	350008069400000570,350008069400000548	11-39,12-32						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
1215	chr15	82617369	82617395	3500021769	26		82617369	82617395	8421504	1	26	0	g	350002176900000043	0-26						Compositions and methods for the treatment and diagnosis of cardiovascular disease	Falb	1997	0		
1215	chr15	82647662	82647686	3500252285	23		82647662	82647686	8421504	2	19,4	0,20	c	350025228500000108	22-45						HERPES SIMPLEX VIRUS MUTANT ICP0 - Patent application	www.faqs.org	0	0		
1217	chr15	82923632	82923656	3500211655	24		82923632	82923656	8421504	1	24	0	c	350021165500000003	0-24						Identi&#xfb01;cation of glycine N-acyltransferase-like 2 (GLYATL2) as a transferase that produces -acyl glycines in humans	www.fasebj.org	0	0		
1218	chr15	83012768	83013356	3500181674	588		83012768	83013356	8421504	1	588	0	g	350018167400000015	0-588						Methods For Determining Anti-tnf Therapeutic Response 	.freshpatents.com	0	0		
1218	chr15	83060839	83060866	3500395280	25		83060839	83060866	8421504	2	7,18	0,9	c	350039528000000199	1-33						Method of providing a hybrid polypeptide exhibiting an activity of interest - Patent # 6270968 - PatentGenius	.patentgenius.com	0	0		
1218	chr15	83060839	83060866	3500370232	25		83060839	83060866	8421504	2	7,18	0,9	c	350037023200000186	16-48						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
1218	chr15	83060839	83060866	3500187760	25		83060839	83060866	8421504	2	7,18	0,9	c	350018776000000168	16-48					Patent	Enzyme capable of degrading cellulose or hemicellulose (Patent US:5686593)	Hagen	1997	0		
1222	chr15	83530729	83530753	3500150563	24		83530729	83530753	8421504	1	24	0	c	350015056300000000	9-33			10.1091/mbc.E04-07-0578		Molecular Biology of the Cell	A Plasma Membrane Pool of Phosphatidylinositol 4-Phosphate Is Generated by Phosphatidylinositol 4-Kinase Type-III Alpha: Studies with the PH Domains of the Oxysterol Binding Protein and FAPP1	Andras	2005	0		OSBP
1222	chr15	83530729	83530753	3500120392	24		83530729	83530753	8421504	1	24	0	c	350012039200000000	9-33		15635101	10.1091/mbc.E04-07-0578	1059-1524	Molecular Biology of the Cell	A Plasma Membrane Pool of Phosphatidylinositol 4-Phosphate Is Generated by Phosphatidylinositol 4-Kinase Type-III Alpha: Studies with the PH Domains of the Oxysterol Binding Protein and FAPP1	Balla	2005	5		OSBP
1222	chr15	83530950	83530978	3500246066	24		83530950	83530978	8421504	2	10,14	0,14	c	350024606600000000	9-33						ModulationofReplicativeSenescenceofDiploidHumanCells byNuclearERKSignaling S	www.jbc.org	0	0		
1222	chr15	83531014	83531042	3500202695	23		83531014	83531042	8421504	2	16,7	0,21	c	350020269500000061	5-28						Chimeric genes and methods for increasing the lysine and threonine content of the seeds of plants	Falco	1997	0		
1222	chr15	83531014	83531042	3500107562	23		83531014	83531042	8421504	2	16,7	0,21	c	350010756200000061	5-28						Chimeric genes and methods for increasing the lysine content of the seeds of plants	Epelbaum	2000	0		
1222	chr15	83531014	83531042	3500027388	23		83531014	83531042	8421504	2	16,7	0,21	c	350002738800000016	5-28						US Patent # 5,773,691. Chimeric genes and methods for increasing the lysine and threonine content of the seeds of plants - Patents.com	www.patents.com	0	0		
1222	chr15	83566486	83566514	3500448182	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350044818200000013	0-24						Transgenic non-human animals for producing heterologous antibodies	Lonberg	1994	0		
1222	chr15	83566486	83566514	3500445631	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350044563100000090	12-36						Igm Production By Transformed Cells And Methods Of Quantifying Said Igm Production 	.freshpatents.com	0	0		
1222	chr15	83566486	83566514	3500444640	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350044464000000007	0-24						Transgenic non-human animals capable of producing heterologous antibodies of various isotypes	Lonberg	1991	0		
1222	chr15	83566486	83566514	3500385713	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350038571300000286	0-24						HETEROLOGOUS ANTIBODIES WHICH BIND HUMAN CD4 - Patent application	www.faqs.org	0	0		
1222	chr15	83566486	83566514	3500373969	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350037396900000034	0-24						Transgenic non-human animals capable of producing heterologous antibodies		1998	0		
1222	chr15	83566486	83566514	3500354489	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350035448900000034	0-24						Transgenic non-human animals capable of producing heterologous antibodies	Kay	1997	0		
1222	chr15	83566486	83566514	3500340691	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350034069100000036	0-24						Transgenic non-human animals capable of producing heterologous antibodies of various isotypes	Lonberg	1993	0		
1222	chr15	83566486	83566514	3500301738	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350030173800000007	0-24					Patent	Transgenic non-human animals capable of producing heterologous antibodies of various isotypes (Patent US:5569825)	Kay	1996	0		
1222	chr15	83566486	83566514	3500228494	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350022849400000089	12-36						IgM Production by Transformed Cell and Method of Quantifying the Same - Patent application	www.faqs.org	0	0		
1222	chr15	83566486	83566514	3500208985	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c,g	350020898500000012,350020898500000012	0-24,0-24						Ransgenic non-human animals for producing heterologous antibodies	Lonberg	1992	0		
1222	chr15	83566486	83566514	3500166201	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350016620100000036	0-24						Transgenic non-human animals for producing chimeric antibodies	Lonberg	2004	0		
1222	chr15	83566486	83566514	3500146358	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350014635800000034	0-24						Transgenic non-human animals capable of producing heterologous antibodies	Kay	1999	0		
1222	chr15	83566486	83566514	3500131771	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350013177100000036	0-24					Patent	Transgenic non-human animals for producing heterologous antibodies (Patent US:5814318)	Kay	1998	0		
1222	chr15	83566486	83566514	3500097379	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350009737900000030	0-24						Transgenic non-human animals capable of producing heterologous antibodies - Patent # 5633425 - PatentGenius	.patentgenius.com	0	0		
1222	chr15	83566486	83566514	3500078884	24		83566486	83566514	8421504	3	7,3,14	0,9,14	c	350007888400000279,350007888400000036	0-24,0-24						Transgenic Non-Human Animals For Producing Chimeric Antibodies - Patent application	www.faqs.org	0	0		
1224	chr15	83763303	83763328	3500206072	25		83763303	83763328	8421504	1	25	0	c	350020607200000005	13-38						Cloning, Expression And Purification Of Recombinant Porcine Intrinsic Factor For Use In Diagnostic Assay	Wonderling	2008	0		
1224	chr15	83832067	83832153	3500362403	40		83832067	83832153	8421504	2	20,20	0,66	c,g	350036240300000078,350036240300000078,350036240300000079	0-20,0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
1225	chr15	84009660	84009686	3500179690	23		84009660	84009686	8421504	2	11,12	0,14	g	350017969000000092	13-36						 Osp A And B Sequence Of Borrelia Burgdonferi Strains ACA1 And IP90 	www.docstoc.com	0	0		
1226	chr15	84099025	84099055	3500143098	23		84099025	84099055	8421504	3	11,6,6	0,15,24	g	350014309800000104	24-48						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS - Patent application	www.faqs.org	0	0		
1227	chr15	84210532	84210561	3500006449	24		84210532	84210561	8421504	2	6,18	0,11	c	350000644900000073	24-48						COMBINATION OF BLyS AND/OR APRIL INHIBITION AND IMMUNNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE DISEASE - Patent application	www.faqs.org	0	0		
1228	chr15	84286303	84286336	3500186547	25		84286303	84286336	8421504	3	13,6,6	0,17,27	g	350018654700000171	10-36						Polycystic kidney disease gene and protein	Klinger	1996	0		
1228	chr15	84342535	84342566	3500064129	29		84342535	84342566	8421504	3	6,19,4	0,7,27	g	350006412900000793	8-39						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"> <HTML> <HEAD> <META http-equiv="Cont	e.dna.affrc.go.jp	0	0		
1228	chr15	84404386	84404536	3500148659	150		84404386	84404536	8421504	1	150	0	p	350014865900015142	3-153						50 human secreted proteins	Komatsoulis	2002	0		B3GAT1
1228	chr15	84404386	84404536	3500068672	150		84404386	84404536	8421504	1	150	0	p	350006867200015142	3-153						50 human secreted proteins	Komatsoulis	2000	0		B3GAT1
1229	chr15	84435130	84435156	3500008143	24		84435130	84435156	8421504	2	14,10	0,16	g	350000814300000001	24-48						 Prosthetic Devices Having Enhanced Osteogenic Properties 	www.docstoc.com	0	0		
1229	chr15	84449435	84458107	3500157069	39		84449435	84458107	8421504	2	20,19	0,8653	g	350015706900000425,350015706900000009	0-20,0-19						US Patent # 6,545,137. Receptor - Patents.com	www.patents.com	0	0		
585	chr16	78125	78153	3500117381	25		78125	78153	8421504	3	13,6,6	0,14,22	g	350011738100000084	0-25						Binding Peptides Having a C-terminally Disposed Specific Binding Domain	Ledbetter	2009	0		
585	chr16	113332	118436	3500334709	45		113332	118436	8421504	2	23,22	0,5082	c	350033470900000019,350033470900000018	0-23,0-22						METHODS AND MATERIALS FOR REDUCING LIVER FIBROSIS	Charlton	2011	0		
585	chr16	113335	118117	3500075141	40		113335	118117	8421504	2	20,20	0,4762	c	350007514100000007,350007514100000006	0-20,0-20						Human Umbilical Cord Wharton s Jelly Stem Cells Undergo Enhanced Chondrogenic Differentiation when Grown on Nanofibrous Scaffolds and in a Sequential Two-stage Culture Medium Environment	link.springer.com	0	0		
585	chr16	118095	118146	3500302816	51		118095	118146	8421504	1	51	0	p	350030281600015022	0-51						Universit&#xe9; de Reims-Champagne Ardenne 2009 N&#xb0; THESE DIPLOME DE DOCTORAT DE L'UNIVERSITE DE REIMS-CHAMPAGNE ARDENNE	ses.univ-reims.fr	0	0		FMOD
586	chr16	248269	255766	3500422770	95		248269	255766	8421504	3	54,21,20	0,6897,7477	p,c,g	350042277000015001,350042277000000001,350042277000000001,350042277000000000,350042277000000000	0-54,0-21,0-21,0-20,0-20		12951322	10.1074/jbc.M303117200	0021-9258	Journal of Biological Chemistry	Characterization of Opticin and Evidence of Stable Dimerization in Solution	Goff	2003	5		
587	chr16	269281	269309	3500134754	25		269281	269309	8421504	2	6,19	0,9	g	350013475400000004	5-30						THE JOURNAL OF BIOLOGICAL CHEMISTRY Printed in U.S.A. Type I Collagen Triplet Duplication Mutation in Lethal Osteogenesis Imperfecta Shifts Register of Chains throughout the Helix and Disrupts Incorporation of Mutant Helices into Fibrils and Extracellular	www.jbc.org	0	0		
588	chr16	484381	484404	3500460253	23		484381	484404	8421504	1	23	0	g	350046025300000002	0-23		9828193	10.1095/biolreprod59.6.1464	0006-3363	Biology of Reproduction	Expression of Monocyte Chemoattractant Protein-1 in the Bovine Corpus Luteum Around the Time of Natural Luteolysis	Penny	1998	4		
589	chr16	594328	594351	3500205383	23		594328	594351	8421504	1	23	0	c	350020538300000028,350020538300000005	0-23,0-23						Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same - Patent application	www.faqs.org	0	0		
592	chr16	938476	938513	3500115988	37		938476	938513	8421504	1	37	0	c,g	350011598800000000,350011598800000000	28-65,28-65						Morphological evidences for an intrinsic angiotensin system in the bovine pineal gland - ResearchGate	.researchgate.net	0	0		
592	chr16	938518	938544	3500050223	26		938518	938544	8421504	1	26	0	c	350005022300000014	0-26		21993888	10.1152/ajprenal.00460.2011		American Journal of Physiology - Renal Physiology	Two microRNAs, miR-330 and miR-125b-5p, mark the juxtaglomerular cell and balance its smooth muscle phenotype	Medrano	2012	0		REN
592	chr16	951202	951228	3500379669	26		951202	951228	8421504	1	26	0	g	350037966900000003	1-27						EXPRESSION OF CATALASE IN TRICHODERMA - DANISCO US INC., GENENCOR DIVISION	www.sumobrain.com	0	0		
592	chr16	978793	978817	3500248094	24		978793	978817	8421504	1	24	0	g	350024809400001449	0-25						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
594	chr16	1290860	1290884	3500110866	24		1290860	1290884	8421504	1	24	0	c	350011086600000003,350011086600000004	0-24,0-24						UCSD : BIPN 144 BIPN 144 : Sprouty2 inhibits BDNF signalling	ww.coursehero.com	0	0		
594	chr16	1290967	1291144	3500117791	177		1290967	1291144	8421504	1	177	0	p,c	350011779100015007,350011779100000051,350011779100000052	0-177,21-42,0-21						Characterization of the Ubiquitin/Nedd8 E3 Ligase Activity of the Mdm2/MdmX complex	www.uni-koeln.de	0	0		MDM4
599	chr16	1882727	1889443	3500413479	57		1882727	1889443	8421504	2	26,31	0,6685	p	350041347900015004	3-60						Molecular Cell, Vol. 13, 587&#x2013;597, February 27, 2004, Copyright 2004 by Cell Press Menin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus	.researchgate.net	0	0		TMEM81,RBBP5
599	chr16	1953221	1957181	3500080694	43		1953221	1957181	8421504	4	14,6,5,18	0,19,3935,3942	c,g	350008069400000522,350008069400000160	2-23,22-45						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
599	chr16	1954449	1954475	3500223473	23		1954449	1954475	8421504	2	13,10	0,16	g	350022347300000421	0-23							ww.patentlens.net	0	0		
601	chr16	2207769	2207796	3500380836	23		2207769	2207796	8421504	3	5,6,12	0,7,15	g	350038083600000295	11-34						US Patent # 7,186,541. 3-hydroxypropionic acid and other organic compounds - Patents.com	www.patents.com	0	0		
601	chr16	2207769	2207796	3500166501	23		2207769	2207796	8421504	3	5,6,12	0,7,15	g	350016650100000295	11-34						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
602	chr16	2288459	2288485	3500412961	25		2288459	2288485	8421504	2	10,15	0,11	c	350041296100000027	0-27						Nucleic acids encoding regulators of FGF-2 transcription (RFT) and variants thereof	Gage	1998	0		
602	chr16	2289004	2289029	3500030821	23		2289004	2289029	8421504	2	12,11	0,14	c	350003082100000143,350003082100000213	4-27,7-30						Method of Determining Response to Treatment with Immunomodulatory Composition	George	2012	0		
603	chr16	2393270	2393295	3500305210	23		2393270	2393295	8421504	2	13,10	0,15	c	350030521000000038	23-46						METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-CDH3 ANTIBODIES - Patent application	www.faqs.org	0	0		
603	chr16	2434270	2434295	3500065368	23		2434270	2434295	8421504	2	17,6	0,19	g	350006536800000024	0-23						Methods and kits to detect hereditary angioedema type iii	Dewald	2005	0		
603	chr16	2483243	2484381	3500013566	135		2483243	2484381	8421504	4	45,32,13,45	0,48,1077,1093	p	350001356600015250,350001356600015249,350001356600015248	0-45,0-45,0-45						NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS - Patent application	www.faqs.org	0	0		NUCKS1
606	chr16	2773735	2773767	3500301314	23		2773735	2773767	8421504	3	11,6,6	0,15,26	g	350030131400000002	6-29		20870902	10.1182/blood-2010-03-271940		Blood	Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease	Yi	2011	0		CEACAM19
607	chr16	2897823	2898423	3500023963	71		2897823	2898423	8421504	2	51,20	0,580	p,g	350002396300015000,350002396300000001	0-51,0-20		19625690	10.1152/ajpregu.00220.2009		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Long-term hypoxia enhances ACTH response to arginine vasopressin but not corticotropin-releasing hormone in the near-term ovine fetus	Charles	2009	0		
607	chr16	2994704	2999679	3500446215	52		2994704	2999679	8421504	2	24,28	0,4947	c	350044621500000010,350044621500000008	0-24,0-28		18676834	10.1158/0008-5472.CAN-08-1259	0008-5472	Cancer Research	Ugene, a Newly Identified Protein That Is Commonly Overexpressed in Cancer and Binds Uracil DNA Glycosylase	Guo	2008	8		
608	chr16	3037325	3037354	3500424178	26		3037325	3037354	8421504	2	5,21	0,8	g	350042417800000029	3-29						METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION	Schwaeble	2010	0		
608	chr16	3102020	3113313	3500242028	40		3102020	3113313	8421504	2	20,20	0,11273	g	350024202800000726,350024202800001172	9-29,2-23						Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases	Silverman	2011	0		
610	chr16	3286307	3286332	3500341533	23		3286307	3286332	8421504	2	17,6	0,19	c	350034153300000091	20-43						Microbial system for formaldehyde sensing and remediation	Donohue	1998	0		
610	chr16	3395856	3397553	3500387607	61		3395856	3397553	8421504	2	38,23	0,1674	c	350038760700000005,350038760700000004	0-30,0-31						Molecular cloning of the cDNA for ligatin	cs.biologists.org	0	0		
610	chr16	3398216	3398242	3500167412	23		3398216	3398242	8421504	2	8,15	0,11	c	350016741200000042	19-42						The Molecular Mechanisms Utilised by Mesenchymal Stem Cells in Migration to Acute Myocardial Infarction Katarina Kollar	prints.qut.edu.au	0	0		
611	chr16	3530479	3530513	3500027512	33		3530479	3530513	8421504	2	26,7	0,27	g	350002751200000001	138-171						Antigen stimulation of peripheral blood mononuclear cells from Mycobacterium bovis infected cattle yields evidence for a novel gene expression program. - ResearchGate	.researchgate.net	0	0		
612	chr16	3568244	3568269	3500207646	25		3568244	3568269	8421504	1	25	0	c	350020764600000004	0-25		18796712	10.1099/vir.0.2008/001743-0	0022-1317	Journal of General Virology	A captured viral interleukin 10 gene with cellular exon structure	Jayawardane	2008	3		
612	chr16	3568313	3568396	3500260869	43		3568313	3568396	8421504	2	20,23	0,60	c,g	350026086900000005,350026086900000004	0-20,0-23		19751473	10.1111/j.1365-3024.2009.01135.x	1365-3024	Parasite Immunology	IL-10 and TGF-&#x03b2;1 are associated with variations in fluke burdens following experimental fasciolosis in sheep - HA&#xc7;ARIZ - 2009 - Parasite Immunology - Wiley Online Library	HACARIZ	2009	0		
612	chr16	3568313	3568396	3500083700	43		3568313	3568396	8421504	2	20,23	0,60	c,g	350008370000000055,350008370000000024,350008370000000054	0-20,0-23,0-23						COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE AGAINST MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
612	chr16	3568428	3568470	3500036948	42		3568428	3568470	8421504	1	42	0	c	350003694800000001	7-49						Open Access Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis	itis-research.com	0	0		
612	chr16	3568447	3568472	3500210495	25		3568447	3568472	8421504	1	25	0	c	350021049500000006	21-46						Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses	www.wjgnet.com	0	0		
612	chr16	3568460	3568486	3500449915	26		3568460	3568486	8421504	1	26	0	c	350044991500000009	0-26						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		IL10
612	chr16	3568466	3568495	3500209068	29		3568466	3568495	8421504	1	29	0	c	350020906800000110	11-40						Hepatitis therapeutics	Jolly	2001	0		
612	chr16	3568472	3568497	3500261631	25		3568472	3568497	8421504	1	25	0	c	350026163100000015	0-25						Innate immune markers that distinguish red deer (Cervus elaphus) selected for resistant or susceptible genotypes for Johne&#xfffd;s disease	inaryresearch.org	0	0		
612	chr16	3568484	3568507	3500361960	23		3568484	3568507	8421504	1	23	0	c	350036196000000024	18-41						Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation	biomedcentral.com	0	0		
612	chr16	3568488	3570818	3500199284	41		3568488	3570818	8421504	2	21,20	0,2310	c,g	350019928400000007,350019928400000007,350019928400000006,350019928400000006	0-21,0-21,0-20,0-20						Anthony Luyai thesis-Final[1]	brary.okstate.edu	0	0		
612	chr16	3568498	3570721	3500347624	40		3568498	3570721	8421504	3	13,7,20	0,1089,2203	c	350034762400000009,350034762400000008	0-20,0-20		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		
612	chr16	3568501	3572071	3500242795	41		3568501	3572071	8421504	3	10,10,21	0,1086,3549	c,g	350024279500000003,350024279500000002,350024279500000002	0-20,0-21,0-21		11739556		0741-5400	Journal of Leukocyte Biology	Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection	Haas	2001	5		
612	chr16	3569607	3569630	3500194695	23		3569607	3569630	8421504	1	23	0	c	350019469500000012	0-23						Veterinary Research	inaryresearch.org	0	0		IL10
612	chr16	3569621	3569646	3500296484	25		3569621	3569646	8421504	1	25	0	c	350029648400000004	0-25						Evaluation of cytokine expression by blood monocytes of lactating Holstein cows with or without postpartum uterine disease. - ResearchGate	.researchgate.net	0	0		
612	chr16	3569647	3570754	3500038090	93		3569647	3570754	8421504	2	6,87	0,1020	p	350003809000015173,350003809000015163,350003809000015151	0-45,0-45,0-45						Articular Cartilage Gene Therapy with Recombinant Vector Encoding BMP-7 - Patent application	www.faqs.org	0	0		
612	chr16	3570773	3570799	3500442188	26		3570773	3570799	8421504	1	26	0	c	350044218800000008	0-26			10.1111/j.1365-2567.2004.01993.x	1365-2567	Immunology	In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype - Goodridge - 2004 - Immunology - W	Goodridge	2004	0		
612	chr16	3570774	3571125	3500216948	44		3570774	3571125	8421504	3	25,10,9	0,36,342	c	350021694800000001,350021694800000002	0-25,0-19						Veterinary Immunology and Immunopathology	www.umass.edu	0	0		IL10
612	chr16	3570777	3570800	3500186781	23		3570777	3570800	8421504	1	23	0	c	350018678100000003	0-23						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
612	chr16	3570786	3571133	3500370177	44		3570786	3571133	8421504	3	20,7,17	0,27,330	c	350037017700000001,350037017700000000	0-20,0-24		18337375	10.1128/CVI.00034-08	1556-6811	Clinical and Vaccine Immunology	Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone	Wedlock	2008	3		
612	chr16	3570786	3571133	3500005370	44		3570786	3571133	8421504	3	20,7,17	0,27,330	c,g	350000537000000001,350000537000000001,350000537000000000	0-20,0-20,0-24		18337375	10.1128/CVI.00034-08		Clinical and Vaccine Immunology : CVI	Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone 	D.	2008	0		
612	chr16	3570787	3570811	3500073898	24		3570787	3570811	8421504	1	24	0	c	350007389800000010	0-24				1552-5783	Investigative Ophthalmology & Visual Science	Participation of Pigment Epithelium of Iris and Ciliary Body in Ocular Immune Privilege. 1. Inhibition of T-Cell Activation In Vitro by Direct Cell-to-Cell Contact	Yoshida	2000	0		
612	chr16	3570799	3571130	3500358468	35		3570799	3571130	8421504	2	21,14	0,317	c	350035846800000013,350035846800000009	0-35,0-35						Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same	Di Mo Fei *R*Mo Si Man 	1991	0		
612	chr16	3570799	3571130	3500226566	35		3570799	3571130	8421504	2	21,14	0,317	c	350022656600000009,350022656600000013	0-35,0-35						Method for preparing mammal cell kinetin synthetic inhibitory factor	Di Mo Fei *R*Mo Si Man 	2001	0		
612	chr16	3570801	3571123	3500299350	26		3570801	3571123	8421504	2	19,7	0,315	c	350029935000000000	0-26			10.1111/j.1348-0421.2008.00059.x	1348-0421	Microbiology and Immunology	Chlamydia pneumoniae induces interleukin-6 and interleukin-10 in human gingival fibroblasts - Rizzo - 2008 - Microbiology and Immunology - Wiley Online Library	Rizzo	2008	0		IL10
612	chr16	3570812	3571132	3500095924	24		3570812	3571132	8421504	2	8,16	0,304	c	350009592400000002	0-24						HUMAN MAST CELL LINE AND USES THEREOF - Patent application	www.faqs.org	0	0		IL10
612	chr16	3571147	3572139	3500349767	44		3571147	3572139	8421504	2	22,22	0,970	c,g	350034976700000023,350034976700000023,350034976700000022	0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
612	chr16	3572063	3580943	3500258129	8880		3572063	3580943	8421504	1	8880	0	g	350025812900000083,350025812900000082,350025812900000075,350025812900000100,350025812900000003	0-8880,0-8880,0-8880,0-19,0-19						Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases - Patent application	www.faqs.org	0	0		
612	chr16	3579519	3580274	3500027293	60		3579519	3580274	8421504	3	19,21,20	0,255,735	g	350002729300000001,350002729300000003,350002729300000002	0-19,0-21,0-20						 SpringerImages - Characteristics of SNPs discovered in IL10, IL10RA/B, TGFB1, and SLC11A1. 	pringerimages.com	0	0		
613	chr16	3735538	3738118	3500465655	46		3735538	3738118	8421504	3	22,3,21	0,1394,2559	c	350046565500000055,350046565500000046	21-43,10-34						Transgenic plants expressing assembled secretory antibodies	Hein	1996	0		
613	chr16	3736694	3739834	3500311787	40		3736694	3739834	8421504	2	20,20	0,3120	c,g	350031178700000001,350031178700000001,350031178700000000	0-20,0-20,0-20						&#x30a6;&#x30b7;&#x553e;&#x6db2;&#x817a;&#x7d44;&#x7e54;&#x306b;&#x304a;&#x3051;&#x308b; &#x514d;&#x75ab;&#x6a5f;&#x69cb;&#x306e;&#x89e3;&#x660e;	over.rakuno.ac.jp	0	0		
613	chr16	3736932	3738118	3500064950	24		3736932	3738118	8421504	2	3,21	0,1165	c	350006495000000055	7-31						US Patent # 7,282,625. Method of producing single chain protein in plant cells - Patents.com	www.patents.com	0	0		
614	chr16	3887600	3887626	3500329621	23		3887600	3887626	8421504	2	7,16	0,10	c	350032962100000006	19-42		19005213	10.1091/mbc.E08-07-0669		Molecular Biology of the Cell	Casein Kinase I&#x03b3;2 Down-Regulates Trafficking of Ceramide in the Synthesis of Sphingomyelin	Nario	2009	0		
614	chr16	3901380	3901406	3500256061	26		3901380	3901406	8421504	1	26	0	g	350025606100000030	54-80						Tesi doctoral: ESTUDI DEL PAPER DE LA FRUCTOSA-2,6-BISFOSFAT I LaENZIM FOSFOFRUCTO-2-QUINASA/FRUC	www.tdx.cat	0	0		
632	chr16	6258560	6258586	3500380933	23		6258560	6258586	8421504	2	15,8	0,18	g	350038093300000002	0-23						Antibody fragment-polymer conjugates and uses of same - US Patent 7507405 Description	ww.patentstorm.us	0	0		
632	chr16	6258560	6258586	3500312851	23		6258560	6258586	8421504	2	15,8	0,18	g	350031285100000002	0-23						Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders	Doerschuk	1995	0		
643	chr16	7655290	7655319	3500257349	24		7655290	7655319	8421504	2	8,16	0,13	g	350025734900000102	5-41					Patent	Muteins of tear lipocalin (Patent CN:1871256)	A*Si Ke La 	2010	0		
646	chr16	8030982	8031011	3500400300	26		8030982	8031011	8421504	2	13,13	0,16	g	350040030000000050,350040030000000025	0-26,0-26						PEPTIDE LINKERS FOR EFFECTIVE MULTIVALENT PEPTIDE BINDING - Patent application	www.faqs.org	0	0		
647	chr16	8220721	8220825	3500259232	104		8220721	8220825	8421504	1	104	0	g	350025923200000055	0-105						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
647	chr16	8220721	8220825	3500000589	104		8220721	8220825	8421504	1	104	0	g	350000058900000087	0-105						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
650	chr16	8589580	8589606	3500145861	25		8589580	8589606	8421504	2	11,14	0,12	g	350014586100000028	12-37						PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME FROM THERMOSIPHO AFRICANUS - Cetus	www.sumobrain.com	0	0		
655	chr16	9264039	9264063	3500286953	23		9264039	9264063	8421504	2	13,10	0,14	g	350028695300000016	0-23						Journal of Cell and Molecular Biology	jcmb.halic.edu.tr	0	0		
656	chr16	9344115	9344143	3500038173	23		9344115	9344143	8421504	2	15,8	0,20	g	350003817300000001	0-24		11694594	10.1091/mbc.12.11.3631	1059-1524	Molecular Biology of the Cell	Signaling through Adenylyl Cyclase Is Essential for Hyphal Growth and Virulence in the Pathogenic Fungus Candida albicans	Rocha	2001	5		
665	chr16	10610030	10610057	3500117209	25		10610030	10610057	8421504	2	12,13	0,14	g	350011720900000002	11-36						Fungal peroxygenases and methods of application	Pecyna	2012	0		GTF2H5
666	chr16	10663146	10664112	3500322341	57		10663146	10664112	8421504	2	34,23	0,943	p	350032234100015001	3-60			10.1128/MCB.25.12.5052-5060.2005		Molecular and Cellular Biology	The HRPT2 Tumor Suppressor Gene Product Parafibromin Associates with Human PAF1 and RNA Polymerase II	Armelle	June	0		CDC73
666	chr16	10673571	10673622	3500368529	51		10673571	10673622	8421504	1	51	0	p	350036852900015192	0-51						Analyse der differentiellen Expression von Transportfaktoren und deren F&#xe8;&#xf2;O &#xc8;Z@ &#xad;/ \\\\&#xa7; -&#xf3;&#xcc;[ S&#xc4;M&#xd0;Bt s&#xb1;G&#xa5;' &#xe1;fo \\\\&#xf9; &#xe2;&#xc7; &#xe8;&#xd9;&#xcc;Z&#xa9;&#xc7;.&#xe2; &#xff;;o&#xfd;c	uni-goettingen.de	0	0		CDC73
666	chr16	10682048	10744694	3500447267	85		10682048	10744694	8421504	5	20,22,23,19,1	0,47814,55510,62547,62645	c,g	350044726700000003,350044726700000003,350044726700000004,350044726700000001,350044726700000002	0-20,0-20,0-22,0-23,0-20		19169472	10.1590/S0004-27302008000800003	0004-2730	Arquivos Brasileiros de Endocrinologia &amp; Metabologia	Arquivos Brasileiros de Endocrinologia & Metabologia - HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach?	Silveira	2008	1		
666	chr16	10682048	10744694	3500396220	85		10682048	10744694	8421504	5	20,22,23,19,1	0,47814,55510,62547,62645	c	350039622000000003,350039622000000004,350039622000000001,350039622000000002	0-20,0-22,0-23,0-20						Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations	w.diabetes.org.br	0	0		CDC73
666	chr16	10682048	10744694	3500314720	85		10682048	10744694	8421504	5	20,22,23,19,1	0,47814,55510,62547,62645	c	350031472000000003,350031472000000004,350031472000000001,350031472000000002	0-20,0-22,0-23,0-20		19169472	10.1590/S0004-27302008000800003	0004-2730	Arquivos Brasileiros de Endocrinologia &amp; Metabologia	Arquivos Brasileiros de Endocrinologia & Metabologia - HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach?	Silveira	2008	1		CDC73
83	chr16	10737419	10753128	3500278000	41		10737419	10753128	8421504	2	21,20	0,15689	c	350027800000000009,350027800000000007	12-33,0-20		15632063	10.1128/MCB.25.2.612-620.2005	0270-7306	Molecular and Cellular Biology	The Parafibromin Tumor Suppressor Protein Is Part of a Human Paf1 Complex	Rozenblatt-Rosen	2005	6		CDC73
83	chr16	10746765	10750358	3500368529	51		10746765	10750358	8421504	2	39,12	0,3581	p	350036852900015191	0-51						Analyse der differentiellen Expression von Transportfaktoren und deren F&#xe8;&#xf2;O &#xc8;Z@ &#xad;/ \\\\&#xa7; -&#xf3;&#xcc;[ S&#xc4;M&#xd0;Bt s&#xb1;G&#xa5;' &#xe1;fo \\\\&#xf9; &#xe2;&#xc7; &#xe8;&#xd9;&#xcc;Z&#xa9;&#xc7;.&#xe2; &#xff;;o&#xfd;c	uni-goettingen.de	0	0		CDC73
667	chr16	10753022	10753105	3500140014	41		10753022	10753105	8421504	2	20,21	0,62	c	350014001400000001,350014001400000000	0-20,0-21						RESEARCH ARTICLE Effects of Parafibromin Expression on the Phenotypes and Relevant Mechanisms in the DLD-1 Colon Carcinoma Cell Line	.apocpcontrol.org	0	0		CDC73
667	chr16	10811753	10811798	3500221225	45		10811753	10811798	8421504	1	45	0	p	350022122500015000	0-45						Journal of Immunological Methods	005.pasteur.ac.ir	0	0		TROVE2
667	chr16	10837671	10851824	3500165278	40		10837671	10851824	8421504	2	19,21	0,14132	c	350016527800000209,350016527800000210	0-19,0-21						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
671	chr16	11352810	11355061	3500274037	40		11352810	11355061	8421504	2	20,20	0,2231	c,g	350027403700000119,350027403700000119,350027403700000118	0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
674	chr16	11763689	11763810	3500017823	121		11763689	11763810	8421504	1	121	0	g	350001782300000000	0-122							www.isag.us	0	0		
675	chr16	11814424	11814453	3500199393	24		11814424	11814453	8421504	2	13,11	0,18	c	350019939300000147	4-28						Multivalent antigen-binding proteins	Frenken	2000	0		
685	chr16	13124528	13124558	3500020942	26		13124528	13124558	8421504	3	8,12,6	0,11,24	g	350002094200000005	3-29						Phylogeny of the Mycoplasma mycoides cluster based on analysis of five conserved protein-coding sequences and possible implications for the taxonomy of the group	s.sgmjournals.org	0	0		
693	chr16	14197188	14197212	3500441689	24		14197188	14197212	8421504	1	24	0	c	350044168900000118	15-41						Patent Search: US Patent Number 8168602 - Compositions, kits and methods for identification, assessment, prevention and therapy of cancer	ww.archpatent.com	0	0		
698	chr16	14894979	14895008	3500425801	25		14894979	14895008	8421504	2	15,10	0,19	g	350042580100000029	20-45						US Patent # 6,066,467. High specificity homocysteine assays for biological samples - Patents.com	www.patents.com	0	0		
702	chr16	15339543	15339569	3500433280	23		15339543	15339569	8421504	3	14,5,4	0,16,22	g	350043328000000010	0-23		10037779	10.1074/jbc.274.10.6783	0021-9258	Journal of Biological Chemistry	Platelet-derived Growth Factor Induces Interleukin-6 Transcription in Osteoblasts through the Activator Protein-1 Complex and Activating Transcription Factor-2	Franchimont	1999	5		
712	chr16	16698604	16698629	3500080694	23		16698604	16698629	8421504	2	16,7	0,18	g	350008069400000078	23-46						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
713	chr16	16874969	16875001	3500351566	26		16874969	16875001	8421504	3	12,6,8	0,17,24	g	350035156600000015	0-27						Method for conducting a polymerase chain reaction using an improved electrochemiluminescent label	Gudibande	1995	0		
713	chr16	16874969	16875001	3500076319	26		16874969	16875001	8421504	3	12,6,8	0,17,24	g	350007631900000018	0-27					Patent	Purified thermostable enzyme (Patent EP:0395736)	Gelfand	2006	0		
713	chr16	16874969	16875001	3500012468	26		16874969	16875001	8421504	3	12,6,8	0,17,24	g	350001246800000004	0-27						La Macroestafa Del Sida	es.scribd.com	0	0		
715	chr16	17088280	17088306	3500431854	23		17088280	17088306	8421504	2	8,15	0,11	g	350043185400000000	0-23						Caprine prion gene polymorphisms are associated with decreased incidence of classical scrapie in goat herds in the United Kingdom	inaryresearch.org	0	0		
720	chr16	17757657	17757682	3500399634	24		17757657	17757682	8421504	2	14,10	0,15	g	350039963400000134	0-46						Recombinant vesiculoviruses and their uses	Rose	1998	0		
720	chr16	17792039	17792066	3500267580	24		17792039	17792066	8421504	2	10,14	0,13	c	350026758000000064	8-34						Non-edible oilseed base biofuels: Molecular Characterisation of Jatropha curcas as a source of biodiesel	theses.ncl.ac.uk	0	0		
724	chr16	18293328	18339120	3500166501	38		18293328	18339120	8421504	4	6,13,13,6	0,11,45772,45786	g	350016650100000145,350016650100000218	19-38,6-25						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
726	chr16	18498168	18498194	3500224300	25		18498168	18498194	8421504	2	7,18	0,8	g	350022430000000006	0-32		20162530	10.1002/yea.1762	1097-0061	Yeast	Functional characterization of the unconventional splicing of Yarrowia lipolytica HAC1 mRNA induced by unfolded protein response - Oh - 2010 - Yeast - Wiley Online Library	Oh	2010	0		
727	chr16	18645385	18645416	3500437739	25		18645385	18645416	8421504	3	15,3,7	0,16,24	g	350043773900000001	7-32		11390617	10.1128/JVI.75.13.6154-6165.2001	0022-538X	Journal of Virology	Formation of Wild-Type and Chimeric Influenza Virus-Like Particles following Simultaneous Expression of Only Four Structural Proteins	Latham	2001	5		
727	chr16	18710435	18710468	3500340855	27		18710435	18710468	8421504	3	7,16,4	0,12,29	g	350034085500000006	0-27		17167031	10.1124/mol.106.030254	1521-0111 (Online)	Molecular Pharmacology	Amino-Pyrrolidine Tricarboxylic Acids Give New Insight into Group III Metabotropic Glutamate Receptor Activation Mechanism	Frauli	2007	0		
738	chr16	20081985	20088306	3500430362	225		20081985	20088306	8421504	5	31,62,42,48,42	0,5683,6039,6183,6279	c	350043036200000027,350043036200000026,350043036200000019,350043036200000016,350043036200000014	0-48,0-45,0-42,0-48,0-42						US Patent # 7,510,855. 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer - Patents.com	www.patents.com	0	0		
738	chr16	20088158	20088183	3500247901	25		20088158	20088183	8421504	1	25	0	c	350024790100000022	0-25		19432882	10.1111/j.1349-7006.2009.01185.x	1349-7006	Cancer Science	Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis - Lin - 2009 - Cancer Science - Wiley Online Library	Lin	2009	0		
743	chr16	20711138	20711162	3500423264	23		20711138	20711162	8421504	2	14,9	0,15	g	350042326400000002	0-23						Identification of Sarcocystis hominis-like (Protozoa: Sarcocystidae) cyst in water buffalo (Bubalus bubalis) based on 18S rRNA gene sequences. - ResearchGate	.researchgate.net	0	0		
92	chr16	20832649	20924098	3500261238	1242		20832649	20924098	8421504	7	346,164,133,111,178,154,156	0,56855,82887,83144,84880,86690,91293	p	350026123800015005	0-1242						Norrin in the treatment of diseases associated with an increased tgf-beta activity	Tamm	2011	0		TGFB2,RRP15
92	chr16	20832649	20924098	3500246344	1227		20832649	20924098	8421504	8	168,163,164,133,111,178,154,156	0,183,56855,82887,83144,84880,86690,91293	p	350024634400015005,350024634400015006	0-168,0-1059						Norrin in the treatment of diseases associated with an increased tgf-beta activity	Tamm	2010	0		
92	chr16	20832649	20924098	3500158219	1227		20832649	20924098	8421504	11	222,121,101,60,133,29,79,143,29,154,156	0,225,56855,56959,82887,83144,83176,84880,85029,86690,91293	p	350015821900015029,350015821900015030,350015821900015031,350015821900015032,350015821900015033,350015821900015035,350015821900015051,350015821900015055,350015821900015071,350015821900015041,350015821900015061,350015821900015036,350015821900015057,350015821900015042,350015821900015037,350015821900015063,350015821900015043,350015821900015048,350015821900015038,350015821900015059,350015821900015082,350015821900015044,350015821900015053,350015821900015034,350015821900015072,350015821900015065,350015821900015039,350015821900015045	0-222,0-222,0-222,0-222,0-222,0-60,0-210,0-90,0-222,0-60,0-90,0-60,0-90,0-60,0-60,0-90,0-60,0-123,0-60,0-90,0-60,0-60,0-120,0-114,0-111,0-90,0-60,0-66						OLIGONUCLEOTIDE-, PROTEIN AND/OR PEPTIDE-POLYMER CONJUGATES - Patent application	www.faqs.org	0	0		
92	chr16	20832649	20924098	3500139285	1242		20832649	20924098	8421504	7	346,164,133,111,178,154,156	0,56855,82887,83144,84880,86690,91293	p	350013928500015006	0-1242						NORRIN IN THE TREATMENT OF DISEASES ASSOCIATED WITH AN INCREASED TGF-BETA ACTIVITY - Patent application	www.faqs.org	0	0		TGFB2,RRP15
92	chr16	20832649	20924098	3500121870	1239		20832649	20924098	8421504	8	346,164,133,111,143,32,154,156	0,56855,82887,83144,84880,85026,86690,91293	p	350012187000015023,350012187000015068,350012187000015041,350012187000015040,350012187000015024,350012187000015030,350012187000015047,350012187000015025,350012187000015031,350012187000015043,350012187000015026,350012187000015049,350012187000015032,350012187000015037,350012187000015027,350012187000015045,350012187000015063,350012187000015033,350012187000015051,350012187000015028,350012187000015034	0-1239,0-336,0-90,0-327,0-60,0-60,0-90,0-60,0-60,0-90,0-60,0-90,0-60,0-123,0-60,0-90,0-60,0-60,0-90,0-60,0-66						Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system	Schlingensiepen	2010	0		
92	chr16	20832649	20924098	3500039116	1239		20832649	20924098	8421504	8	346,164,133,111,143,32,154,156	0,56855,82887,83144,84880,85026,86690,91293	p	350003911600015023	0-1239						Pharmaceutical composition - Patent application	www.faqs.org	0	0		TGFB2,RRP15
743	chr16	20832951	20832978	3500120757	27		20832951	20832978	8421504	1	27	0	c	350012075700000033	0-27						Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor	Ikushima	2012	0		RRP15
744	chr16	20889596	20915575	3500134803	43		20889596	20915575	8421504	2	23,20	0,25959	c,g	350013480300000028,350013480300000028,350013480300000029,350013480300000029	0-23,0-23,0-20,0-20						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		TGFB2
744	chr16	20898929	20898953	3500308897	23		20898929	20898953	8421504	2	4,19	0,5	g	350030889700000607	15-38						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
744	chr16	20898929	20898953	3500195935	23		20898929	20898953	8421504	2	4,19	0,5	g	350019593500000258	15-38						Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use	Simons	1995	0		
744	chr16	20915545	20917604	3500218903	48		20915545	20917604	8421504	2	24,24	0,2035	c	350021890300000010,350021890300000011	0-24,0-24					Patent	Spondyloarthropathies (Patent US:7371725)	Luyten	2008	0		
744	chr16	20915545	20917604	3500111962	48		20915545	20917604	8421504	2	24,24	0,2035	c	350011196200000010,350011196200000011	0-24,0-24						Bmp inhibitors for the treatment of spondyloarthropathies	Lories	2004	0		TGFB2
744	chr16	20915809	20924592	3500372015	100		20915809	20924592	8421504	5	20,20,20,20,20	0,1748,1823,3561,8763	c,g	350037201500000230,350037201500000103,350037201500000233,350037201500000107,350037201500000235,350037201500000111,350037201500000115,350037201500000128	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						Method for selective oligonucleotide modification	Mitsch	2011	0		
744	chr16	20915889	20917624	3500394704	40		20915889	20917624	8421504	3	15,5,20	0,1640,1715	c	350039470400000022,350039470400000023	0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
744	chr16	20915889	20917624	3500292483	40		20915889	20917624	8421504	3	15,5,20	0,1640,1715	c,g	350029248300000022,350029248300000023,350029248300000023	0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
744	chr16	20917681	20924092	3500396205	330		20917681	20924092	8421504	3	26,154,150	0,1658,6261	p	350039620500015006,350039620500015009	0-180,0-150						HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS	Gold	2002	0		TGFB2
744	chr16	20917681	20924014	3500137557	252		20917681	20924014	8421504	3	26,154,72	0,1658,6261	p	350013755700015068	0-252						Identification of a novel transforming growth factor-? (TGF-?6) gene in fish: regulation in skeletal muscle by nutritional state	biomedcentral.com	0	0		TGFB2
744	chr16	20917703	20919360	3500363653	25		20917703	20919360	8421504	2	4,21	0,1636	c	350036365300000011	0-25		22466340	10.1210/jc.2011-3073	0021-972X	Journal of Clinical Endocrinology & Metabolism	Transforming Growth Factor &#x03b2;1 (TGF&#x03b2;1) and Progesterone Regulate Matrix Metalloproteinases (MMP) in Human Endometrial Stromal Cells	Itoh	2012	6		
744	chr16	20917703	20919360	3500345272	25		20917703	20919360	8421504	2	4,21	0,1636	c	350034527200000010	0-25						Transforming Growth Factor 1 (TGF 1) and Progesterone Regulate Matrix Metalloproteinases (MMP) in Human Endometrial Stromal Cells	.endojournals.org	0	0		TGFB2
744	chr16	20919355	20924095	3500063913	282		20919355	20924095	8421504	3	48,81,153	0,57,4587	p	350006391300015008,350006391300015009	0-48,0-234						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		TGFB2
744	chr16	20919355	20924089	3500037926	225		20919355	20924089	8421504	6	45,45,42,3,45,45	0,48,96,4587,4641,4689	p	350003792600015258,350003792600015259,350003792600015260,350003792600015262,350003792600015263	0-45,0-45,0-45,0-45,0-45						Polynucleotides Encoding Growth Differentiation Factor-8 - Patent application	www.faqs.org	0	0		TGFB2
744	chr16	20919359	20924079	3500392138	155		20919359	20924079	8421504	4	45,27,38,45	0,62,4589,4675	c	350039213800000455,350039213800000456,350039213800000458,350039213800000460	0-45,17-44,7-45,0-45						Designer ligands of tgf-beta superfamily	Choe	2010	0		
744	chr16	20919389	20924011	3500251989	43		20919389	20924011	8421504	2	22,21	0,4601	c,g	350025198900000029,350025198900000040,350025198900000040	0-22,0-21,0-21					Patent	Growth/differentiation factor of the TGF-&#x03b2; family (Patent US:5994094)	Hotten	1999	0		TGFB2
744	chr16	20919419	20924029	3500383097	49		20919419	20924029	8421504	2	26,23	0,4587	c	350038309700000004,350038309700000005	0-26,0-23						COMPOSITION COMPRISING S-ALLYLMERCAPTO-N-ACETYLCYSTEINE (ASSNAC) FOR UP-REGULATION OF CELLULAR GLUTATHIONE LEVEL	Savion	2008	0		
744	chr16	20924076	20924103	3500373693	27		20924076	20924103	8421504	1	27	0	c	350037369300000055	7-34						Chromosomal expression of heterologous genes in bacterial cells	Mascarenhas	1996	0		
744	chr16	20924077	20924100	3500038968	23		20924077	20924100	8421504	1	23	0	c	350003896800000009	0-23						Compositions and methods for modulating vascular development	Yan	2008	0		
749	chr16	21528244	21528270	3500029756	25		21528244	21528270	8421504	2	14,11	0,15	g	350002975600000041	0-25						Bacillus megaterium	etc.tu-bs.de:8080	0	0		
749	chr16	21547178	21547205	3500110550	23		21547178	21547205	8421504	2	6,17	0,10	g	350011055000000047	14-38						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
751	chr16	21830452	21840044	3500311219	178		21830452	21840044	8421504	4	3,116,11,48	0,8620,9520,9544	c	350031121900000068,350031121900000069,350031121900000070,350031121900000071	1-48,0-48,0-35,0-48						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
752	chr16	21949718	21949743	3500392582	23		21949718	21949743	8421504	2	8,15	0,10	g	350039258200000002	0-23		15375196	10.1152/physiolgenomics.00123.2004	1094-8341	Physiological Genomics	Generation of a bovine oocyte cDNA library and microarray: resources for identification of genes important for follicular development and early embryogenesis	Yao	2004	3		
752	chr16	21949718	21949743	3500358352	23		21949718	21949743	8421504	2	8,15	0,10	g	350035835200000024	0-23			10.1046/j.1365-313x.2000.00704.x	1365-313X	The Plant Journal	Display and isolation of transposon-flanking sequences starting from genomic DNA or RNA - Yephremov - 2001 - The Plant Journal - Wiley Online Library	Yephremov	2000	0		
752	chr16	21949718	21949743	3500341913	23		21949718	21949743	8421504	2	8,15	0,10	g	350034191300000013	0-23						Protein Kinases 	.freshpatents.com	0	0		
752	chr16	21949718	21949743	3500331535	23		21949718	21949743	8421504	2	8,15	0,10	g	350033153500000034	0-23						PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS)	Filippovich	1999	0		
752	chr16	21949718	21949743	3500303632	23		21949718	21949743	8421504	2	8,15	0,10	g	350030363200000018,350030363200000020	0-23,0-23						METHODS AND COMPOSITIONS FOR FULL-LENGTH cDNA CLONING	Chenchik	1997	0		
752	chr16	21949718	21949743	3500300019	23		21949718	21949743	8421504	2	8,15	0,10	g	350030001900000000	0-23						Polynucleotides and polypeptides associated with the nf-kb pathway	Carman	2005	0		
752	chr16	21949718	21949743	3500286310	23		21949718	21949743	8421504	2	8,15	0,10	g	350028631000000009	22-45					Patent	P-glycoproteins and uses thereof (Patent EP:1220911)	Crespi	2006	0		
752	chr16	21949718	21949743	3500271950	23		21949718	21949743	8421504	2	8,15	0,10	g	350027195000000015,350027195000000018	0-23,0-23						Novel human protein kinases and protein kinase-like enzymes	Clary	2001	0		
752	chr16	21949718	21949743	3500261386	23		21949718	21949743	8421504	2	8,15	0,10	g	350026138600000001,350026138600000004	0-23,0-23						Molecular markers of ecotoxicological interest in the rainbowfish Melanotaenia fluviatilis	hbank.rmit.edu.au	0	0		
752	chr16	21949718	21949743	3500221079	23		21949718	21949743	8421504	2	8,15	0,10	g	350022107900000000	0-23						Bex4 nucleic acids, polypeptides, and method of using	Shridhar	2007	0		
752	chr16	21949718	21949743	3500215436	23		21949718	21949743	8421504	2	8,15	0,10	g	350021543600000000	0-23		16388016	10.1530/rep.1.00849	1470-1626	Reproduction	Expression of protease nexin-1 and plasminogen activators during follicular growth and the periovulatory period in cattle	Cao	2006	3		
752	chr16	21949718	21949743	3500190039	23		21949718	21949743	8421504	2	8,15	0,10	g	350019003900000000,350019003900000002	0-23,0-23						US Patent # 7,060,437. Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof - Patents.com	www.patents.com	0	0		
752	chr16	21949718	21949743	3500176570	23		21949718	21949743	8421504	2	8,15	0,10	g	350017657000000000	0-23						BEX4 NUCLEIC ACIDS, POLYPEPTIDES, AND METHOD OF USING - MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH	www.sumobrain.com	0	0		
752	chr16	21949718	21949743	3500130040	23		21949718	21949743	8421504	2	8,15	0,10	g	350013004000000001	0-23						Gene discovery in genetically labeled single dopaminergic neurons of the retina	www.pnas.org	0	0		
752	chr16	21949718	21949743	3500110357	23		21949718	21949743	8421504	2	8,15	0,10	g	350011035700000003	0-23						Placental human neurokinin b precursor	Lowry	2002	0		
752	chr16	21949718	21949743	3500057748	23		21949718	21949743	8421504	2	8,15	0,10	g	350005774800000004,350005774800000000	0-23,0-23						A potato NOA gene increased salinity tolerance in Arabidopsis thaliana	demicjournals.org	0	0		
752	chr16	21949718	21949743	3500048010	23		21949718	21949743	8421504	2	8,15	0,10	g	350004801000000012,350004801000000000	0-23,0-23		14568916	10.1095/biolreprod.103.021709	0006-3363	Biology of Reproduction	Gene Expression Profiling of Differentially Expressed Genes in Granulosa Cells of Bovine Dominant Follicles Using Suppression Subtractive Hybridization	Fayad	2004	4		
761	chr16	23080713	23080741	3500181609	24		23080713	23080741	8421504	3	6,4,14	0,9,14	c	350018160900000612	16-40						METHODS AND COMPOSITIONS FOR MODULATING T CELL AND/OR B CELL ACTIVATION - Patent application	www.faqs.org	0	0		
761	chr16	23185276	23194840	3500178270	58		23185276	23194840	8421504	2	29,29	0,9535	c	350017827000000009,350017827000000017	1-30,1-30						PAL-18 polypeptides, nucleic acids encoding the same and methods for... - IP.com	ip.com/patfam/en/	0	0		
765	chr16	23621399	23621476	3500392970	42		23621399	23621476	8421504	2	20,22	0,55	c	350039297000000013,350039297000000012	0-20,0-22						Probiotic Bacteria Enhance the Antibacterial Barrier of Enterocytes: Insights into Their Mechanism of Action	.uni-hohenheim.de	0	0		TLR5
765	chr16	23621399	23621476	3500023389	42		23621399	23621476	8421504	2	20,22	0,55	c	350002338900000017,350002338900000015	0-20,0-22						Interaction of Human Primary Keratinocytes with Toll-Like Receptor Ligands and Resulting Pro- inflammatory Signals	d-nb.info/1001472	0	0		TLR5
765	chr16	23623456	23623628	3500018219	44		23623456	23623628	8421504	2	22,22	0,150	c	350001821900000013,350001821900000012	0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
765	chr16	23623586	23623610	3500361960	24		23623586	23623610	8421504	1	24	0	c	350036196000000005	20-44						Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation	biomedcentral.com	0	0		
767	chr16	23865107	23865136	3500015533	24		23865107	23865136	8421504	2	12,12	0,17	g	350001553300000126	0-24						 Method Of Diagnosing Lung Cancer Using BGS42 	www.docstoc.com	0	0		
768	chr16	24107563	24107617	3500217261	54		24107563	24107617	8421504	1	54	0	p	350021726100015006	0-54						Role of calpain in skeletal-muscle protein degradation. - ResearchGate	.researchgate.net	0	0		CAPN2
768	chr16	24107563	24107617	3500167358	54		24107563	24107617	8421504	1	54	0	p	350016735800015002	0-54						Role of calpain in skeletal-muscle protein degradation	www.pnas.org	0	0		CAPN2
768	chr16	24112956	24112980	3500152871	24		24112956	24112980	8421504	1	24	0	c	350015287100000001	19-43						[peer-00499027, v1] Involvement of the calcium-dependent proteolytic system in skeletal muscle aging	peer.ccsd.cnrs.fr	0	0		
11	chr16	24112976	24138716	3500291381	25		24112976	24138716	8421504	2	6,19	0,25721	c	350029138100000005,350029138100000006	0-25,0-25			10.1091/mbc.E06-09-0876		Molecular Biology of the Cell	Asymmetric Localization of Calpain 2 during Neutrophil Chemotaxis	Paul	2007	0		
11	chr16	24112976	24138716	3500215662	25		24112976	24138716	8421504	2	6,19	0,25721	c	350021566200000005,350021566200000006	0-25,0-25		17192410	10.1091/mbc.E06-09-0876	1059-1524	Molecular Biology of the Cell	Asymmetric Localization of Calpain 2 during Neutrophil Chemotaxis	Nuzzi	2007	5		
769	chr16	24148338	24154324	3500021577	56		24148338	24154324	8421504	3	26,13,17	0,5036,5969	c,g	350002157700000002,350002157700000002,350002157700000003	0-26,0-26,0-30						O-12	www.scribd.com	0	0		
778	chr16	25345749	25345772	3500121245	23		25345749	25345772	8421504	1	23	0	g	350012124500000072	18-41						Coleopteran-resistant transgenic plants and methods of their production using modified Bacillus thuringiensis Cry3Bb nucleic acids	English	1999	0		
782	chr16	25844598	25844623	3500252796	23		25844598	25844623	8421504	3	12,6,5	0,13,20	c	350025279600000081	19-42						METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF RSV INFECTION	Vaishnaw	2008	0		
782	chr16	25844598	25844623	3500179508	23		25844598	25844623	8421504	3	12,6,5	0,13,20	c	350017950800000084	19-42						Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules - Patent application	www.faqs.org	0	0		
782	chr16	25844598	25844623	3500147965	23		25844598	25844623	8421504	3	12,6,5	0,13,20	c	350014796500000081	19-42						Methods and compositions for prevention or treatment of RSV infection (&#x043f;&#x0430;&#x0442;&#x0435;&#x043d;&#x0442; US &#x2116; 8410073)	www.freepatent.ru	0	0		
782	chr16	25946557	25947123	3500328799	40		25946557	25947123	8421504	3	20,8,12	0,248,554	c	350032879900000015,350032879900000014,350032879900000028	0-20,0-20,0-20						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
784	chr16	26087083	26087109	3500416808	24		26087083	26087109	8421504	3	4,16,4	0,5,22	g	350041680800000216	18-42					Patent	Recombinant herpesvirus of turkeys and uses thereof (Patent US:5853733)	Cochran	1998	0		
784	chr16	26116482	26116514	3500370685	32		26116482	26116514	8421504	1	32	0	c	350037068500000001,350037068500000000	0-32,0-32						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		H3F3A
784	chr16	26116482	26116514	3500120672	32		26116482	26116514	8421504	1	32	0	c	350012067200000000,350012067200000001	0-32,0-32		16687578	10.1091/mbc.E05-09-0906	1059-1524	Molecular Biology of the Cell	Aurora-B/AIM-1 Regulates the Dynamic Behavior of HP1&#x03b1; at the G2&#x2013;M Transition	Terada	2006	5		H3F3A
784	chr16	26116527	26122376	3500398906	41		26116527	26122376	8421504	3	21,11,9	0,1363,5840	c	350039890600000016,350039890600000017	0-21,0-20						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
784	chr16	26116537	26122376	3500455254	41		26116537	26122376	8421504	3	21,11,9	0,1353,5830	c	350045525400000006,350045525400000007	0-21,0-20						Tie-2 Is Overexpressed by Monocytes in Autoimmune Thyroid Disorders and Participates in Their Recruitment to the Thyroid Gland	.endojournals.org	0	0		H3F3A
784	chr16	26116547	26122382	3500244483	67		26116547	26122382	8421504	4	21,25,6,15	0,1245,1348,5820	c	350024448300000007,350024448300000011,350024448300000008	0-21,0-25,0-21						High-affinity melatonin receptors and uses thereof	Ebisawa	1997	0		H3F3A
784	chr16	26117791	26122472	3500400334	40		26117791	26122472	8421504	2	20,20	0,4661	c	350040033400000002,350040033400000003	0-20,0-20		20881009	10.1158/1541-7786.MCR-10-0334	1541-7786	Molecular Cancer Research	TROY (TNFRSF19) Is Overexpressed in Advanced Glial Tumors and Promotes Glioblastoma Cell Invasion via Pyk2-Rac1 Signaling	Paulino	2010	4		H3F3A
784	chr16	26117791	26122472	3500290562	40		26117791	26122472	8421504	2	20,20	0,4661	c	350029056200000007,350029056200000008	0-20,0-20						Inhibition of STAT3 signal transduction for human cancer therapy	Dalton	2007	0		H3F3A
784	chr16	26117791	26122472	3500282934	40		26117791	26122472	8421504	2	20,20	0,4661	c	350028293400000002,350028293400000003	0-20,0-20		20881009	10.1158/1541-7786.MCR-10-0334	1541-7786	Molecular Cancer Research	TROY (TNFRSF19) Is Overexpressed in Advanced Glial Tumors and Promotes Glioblastoma Cell Invasion via Pyk2-Rac1 Signaling	Paulino	2010	4		
784	chr16	26117791	26122472	3500231570	40		26117791	26122472	8421504	2	20,20	0,4661	c	350023157000000007,350023157000000008	0-20,0-20						Inhibition of STAT3 signal transduction for human cancer therapy	Jove	2006	0		
784	chr16	26117791	26122472	3500194508	40		26117791	26122472	8421504	2	20,20	0,4661	c	350019450800000038,350019450800000039	0-20,0-20						Hemogen-EDAG: novel nuclear factors expressed in hematopoietic development	Li	2002	0		H3F3A
784	chr16	26117791	26122472	3500173937	40		26117791	26122472	8421504	2	20,20	0,4661	c	350017393700000000,350017393700000001	0-20,0-20		14718619	10.1099/vir.0.19491-0	0022-1317	Journal of General Virology	Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-&#x03b1; and interleukin 8	Radkowski	2004	3		H3F3A
784	chr16	26117791	26122472	3500057051	40		26117791	26122472	8421504	2	20,20	0,4661	c	350005705100000002,350005705100000003	0-20,0-20		19728339	10.1002/ijc.24849	1097-0215	International Journal of Cancer	The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion - Nakada - 2009 - International Journal of Cancer - Wiley Online Library	Nakada	2010	0		H3F3A
784	chr16	26117848	26122390	3500071939	58		26117848	26122390	8421504	3	31,4,23	0,49,4519	c	350007193900000018,350007193900000019	0-31,0-27						WWOX expression in colorectal cancer--a real-time quantitative RT-PCR study. - ResearchGate	.researchgate.net	0	0		H3F3A
784	chr16	26117869	26117901	3500210306	32		26117869	26117901	8421504	1	32	0	c	350021030600000008	0-32		21559369	10.1371/journal.pone.0019419		PLoS ONE	In Vivo Fate Analysis Reveals the Multipotent and Self-Renewal Features of Embryonic AspM Expressing Cells	Cinzia	2011	0		
784	chr16	26122423	26122614	3500172243	40		26122423	26122614	8421504	3	20,16,4	0,170,187	c	350017224300000002,350017224300000003	0-20,0-20						Mouse Emi2 as a distinctive regulatory hub in second meiotic metaphase	ev.biologists.org	0	0		H3F3A
784	chr16	26122423	26122614	3500078772	40		26122423	26122614	8421504	3	20,16,4	0,170,187	c	350007877200000002,350007877200000003	0-20,0-20		20724447	10.1242/dev.052480	0950-1991	Development	Mouse Emi2 as a distinctive regulatory hub in second meiotic metaphase	Suzuki	2010	7		H3F3A
786	chr16	26408492	26441730	3500460124	150		26408492	26441730	8421504	5	30,18,21,36,45	0,2857,2965,6000,33193	p	350046012400015011,350046012400015009,350046012400015010,350046012400015002	0-48,0-54,48-102,0-45						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		PARP1
788	chr16	26648446	26648472	3500204244	24		26648446	26648472	8421504	2	19,5	0,21	c,g	350020424400000111,350020424400000111	8-33,8-33						US Patent # 5,643,783. Collagen and uses therefor - Patents.com	www.patents.com	0	0		
788	chr16	26648446	26648472	3500058951	24		26648446	26648472	8421504	2	19,5	0,21	c	350005895100000111	8-33						Collagen and uses therefor	Olsen	1993	0		
790	chr16	26893090	26893113	3500282274	23		26893090	26893113	8421504	1	23	0	c	350028227400000008	13-36		9045726		0270-6474	The Journal of Neuroscience	Light and Electron Microscopic Localization of Presenilin-1 in Primate Brain	Lah	1997	7		
790	chr16	26893092	26908063	3500092152	1344		26893092	26908063	8421504	11	141,27,188,142,68,221,99,84,102,119,153	0,2143,2173,3532,5785,6546,7999,8833,9248,13203,14818	p	350009215200015001	0-1344						KEGG T01001: 5663	www.genome.jp	0	0		
790	chr16	26895319	26896760	3500190689	270		26895319	26896760	8421504	2	134,136	0,1305	p	350019068900015112,350019068900015110	0-90,0-180						Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins, Second Edition	www.zvlab.ru	0	0		
790	chr16	26896670	26896730	3500074876	60		26896670	26896730	8421504	1	60	0	p	350007487600015003	0-60					Patent	Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist. (Patent DE:69635207)	BIRD	2006	0		PSEN2
790	chr16	26896739	26896766	3500314256	27		26896739	26896766	8421504	1	27	0	c	350031425600000002	20-47			10.1111/j.1365-2443.2007.01123.x	1365-2443	Genes to Cells	HMGA1a: sequence-specific RNA-binding factor causing sporadic Alzheimer's disease-linked exon skipping of presenilin-2 pre-mRNA - Manabe - 2007 - Genes to Cells - Wiley Online Library	Manabe	2007	0		PSEN2
790	chr16	26899759	26901138	3500235038	105		26899759	26901138	8421504	3	51,7,47	0,93,1332	p	350023503800015035,350023503800015084,350023503800015039,350023503800015088	0-45,0-48,0-48,0-48						Genetic alterations related to familial alzheimer's disease	Tanzi	1997	0		PSEN2
790	chr16	26901105	26901162	3500183228	57		26901105	26901162	8421504	1	57	0	p	350018322800015058	0-57						SPE-4 peptides	L'hernault	1997	0		PSEN2
791	chr16	27003642	27003666	3500124682	24		27003642	27003666	8421504	1	24	0	c	350012468200000024	0-24		19289498	10.1128/MCB.01140-08	0270-7306	Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer	Liu	2009	6		
791	chr16	27003642	27003666	3500123810	24		27003642	27003666	8421504	1	24	0	c	350012381000000024	0-24						Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer	mcb.asm.org	0	0		ADCK3
791	chr16	27003642	27003666	3500115594	24		27003642	27003666	8421504	1	24	0	c	350011559400000024	0-24		19289498	10.1128/MCB.01140-08		Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer 	Kang	2009	0		
791	chr16	27057558	27069281	3500404375	40		27057558	27069281	8421504	2	20,20	0,11703	c,g	350040437500000002,350040437500000001,350040437500000001	0-20,0-20,0-20						Regulation of human serine/threonine kinase	Liou	2003	0		
792	chr16	27144786	27144811	3500034114	25		27144786	27144811	8421504	1	25	0	c	350003411400000007,350003411400000006	0-25,0-25		19934222	10.1242/jcs.050724	0021-9533	Journal of Cell Science	MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices	Fisher	2009	6		CDC42BPA
792	chr16	27190506	27190610	3500259232	104		27190506	27190610	8421504	1	104	0	g	350025923200000010	0-108						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
792	chr16	27190550	27190610	3500000589	60		27190550	27190610	8421504	1	60	0	g	350000058900000026	0-60						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
792	chr16	27240980	27241085	3500259232	105		27240980	27241085	8421504	1	105	0	g	350025923200000008	0-109						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
792	chr16	27240980	27241040	3500000589	60		27240980	27241040	8421504	1	60	0	g	350000058900000021	0-60						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
792	chr16	27252826	27252849	3500265664	23		27252826	27252849	8421504	1	23	0	c	350026566400000000,350026566400000001,350026566400000008	0-21,0-21,0-20						Method of killing cancer cells	Fesik	2004	0		CDC42BPA
793	chr16	27305976	27306006	3500180900	30		27305976	27306006	8421504	1	30	0	c	350018090000000014	14-44						SIGNALLING AND FUNCTION OF THE SMALL	theses.bham.ac.uk	0	0		CDC42BPA
797	chr16	27857934	27858917	3500409160	42		27857934	27858917	8421504	2	21,21	0,962	c,g	350040916000000028,350040916000000028,350040916000000029	0-21,0-21,0-21			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
799	chr16	28094637	28094681	3500456121	44		28094637	28094681	8421504	1	44	0	c	350045612100000013	0-44						METHODS OF MODULATING SMYD3 FOR TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
799	chr16	28094637	28094681	3500042388	44		28094637	28094681	8421504	1	44	0	c	350004238800000113	0-44						METHODS OF DETECTING METHYL TRANSFERASE ACTIVITY AND METHODS OF SCREENING FOR METHYL TRANSFERASE ACTIVITY MODULATORS - Patent application	www.faqs.org	0	0		
12	chr16	28096302	28551815	3500063853	57		28096302	28551815	8421504	4	1,35,4,17	0,1722,1855,455496	c	350006385300000009,350006385300000036	0-36,0-21						Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth	Furukawa	2004	0		
803	chr16	28614616	28614639	3500394794	23		28614616	28614639	8421504	1	23	0	c	350039479400000004	0-23						Genes and polypeptides relating to human colon cancers	Furukawa	2005	0		SMYD3
803	chr16	28614616	28614639	3500320588	23		28614616	28614639	8421504	1	23	0	c	350032058800000005,350032058800000030	0-23,0-23					Patent	Gene and protein relating to hepatocellular carcinoma (Patent EP:1430152)	Nakamura	2007	0		SMYD3
803	chr16	28614616	28614639	3500212214	23		28614616	28614639	8421504	1	23	0	c	350021221400000004	0-23						Genes and polypeptides relating to human colon cancers	Furukawa	2003	0		SMYD3
803	chr16	28614616	28614639	3500211755	23		28614616	28614639	8421504	1	23	0	c	350021175500000004	0-23						Genes and polypeptides relating to human colon cancers	Nakamura	2010	0		SMYD3
803	chr16	28614616	28614639	3500152550	23		28614616	28614639	8421504	1	23	0	c	350015255000000017	0-23						TheHistoneModificationsGoverning TFF1 Transcription MediatedbyEstrogenReceptor	www.tijmu.edu.cn	0	0		SMYD3
803	chr16	28614616	28614639	3500062793	23		28614616	28614639	8421504	1	23	0	c	350006279300000175,350006279300000004	0-23,0-23						GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS - Patent application	www.faqs.org	0	0		SMYD3
803	chr16	28614616	28614639	3500058493	23		28614616	28614639	8421504	1	23	0	c	350005849300000004	0-23						Genes and polypeptides relating to human colon cancers	Nakamura	2009	0		SMYD3
803	chr16	28614616	28614639	3500031710	23		28614616	28614639	8421504	1	23	0	c	350003171000000017	0-23						TheHistoneModificationsGoverning TFF1 Transcription MediatedbyEstrogenReceptor	icine.bjmu.edu.cn	0	0		SMYD3
803	chr16	28614616	28614639	3500026288	23		28614616	28614639	8421504	1	23	0	c	350002628800000004	0-23						CXADRL1 polypeptides relating to human cancers	Nakamura	2008	0		SMYD3
804	chr16	28721322	28721370	3500042388	48		28721322	28721370	8421504	1	48	0	c	350004238800000133	0-48						METHODS OF DETECTING METHYL TRANSFERASE ACTIVITY AND METHODS OF SCREENING FOR METHYL TRANSFERASE ACTIVITY MODULATORS - Patent application	www.faqs.org	0	0		
804	chr16	28721366	28721393	3500071775	27		28721366	28721393	8421504	1	27	0	c	350007177500000037	6-33						RNA-interference for ZNFN3A1-gene as a method for inhibiting cancer cell growth	Furukawa	2011	0		
804	chr16	28721366	28721393	3500063853	27		28721366	28721393	8421504	1	27	0	c	350006385300000085	6-33						Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth	Furukawa	2004	0		
804	chr16	28753731	28753754	3500212173	23		28753731	28753754	8421504	1	23	0	g	350021217300000007	4-27						Generation of human TRIM5&#x03b1; mutants with high HIV-1 restriction activity	www.bioc.uzh.ch	0	0		
811	chr16	29639126	29639154	3500446814	23		29639126	29639154	8421504	2	6,17	0,11	g	350044681400000032	5-28						Cellulosic Cultivation Of Oleaginous Microorganisms 	.freshpatents.com	0	0		
811	chr16	29673710	29673736	3500001821	23		29673710	29673736	8421504	2	7,16	0,10	g	350000182100000007,350000182100000026	2-25,2-25						Inhibitors of prenyl-protein transferase	Desolms	1999	0		
811	chr16	29682501	29691401	3500269445	42		29682501	29691401	8421504	2	21,21	0,8879	c,g	350026944500000000,350026944500000000,350026944500000002	4-25,4-25,10-31						Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkB	Alkalay	2002	0		HNRNPU
811	chr16	29682505	29691401	3500409382	137		29682505	29691401	8421504	5	24,21,20,48,24	0,2219,6603,6896,8872	p,c,g	350040938200000000,350040938200000001,350040938200000004,350040938200015001,350040938200000005	7-31,12-33,2-22,3-51,9-33		18710935	10.1128/MCB.00766-08	0270-7306	Molecular and Cellular Biology	The Histone Acetyltransferase PCAF Associates with Actin and hnRNP U for RNA Polymerase II Transcription	Obrdlik	2008	6		HNRNPU
812	chr16	29810186	29810209	3500253684	23		29810186	29810209	8421504	1	23	0	c	350025368400000001,350025368400000003	7-30,2-22					Journal of Biomedicine and Biotechnology	Identification, Characterization, and Effects of Xenopus laevis PNAS-4 Gene on Embryonic Development - Scolaris	Yan	2010	0		
812	chr16	29823437	29823464	3500012101	27		29823437	29823464	8421504	1	27	0	g	350001210100000016	8-35						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		
812	chr16	29824820	29824847	3500320957	23		29824820	29824847	8421504	2	12,11	0,16	g	350032095700000071	7-38						S-locus receptor kinase gene in a self-incompatible brassica napus line	Goring	1994	0		
812	chr16	29867800	29867827	3500211783	25		29867800	29867827	8421504	2	11,14	0,13	g	350021178300000001	1-28		12050354	10.1128/JVI.76.13.6425-6434.2002	0022-538X	Journal of Virology	Highly Pathogenic Simian Immunodeficiency Virus mne Variants That Emerge during the Course of Infection Evolve Enhanced Infectivity and the Ability To Downregulate CD4 but Not Class I Major Histocompatibility Complex Antigens	Patel	2002	5		
814	chr16	30083699	30083744	3500307147	45		30083699	30083744	8421504	1	45	0	p	350030714700015020	0-45						A Field Guide to GenBank.ppt	www.docstoc.com	0	0		ADSS
817	chr16	30465144	30465170	3500292094	23		30465144	30465170	8421504	2	18,5	0,21	g	350029209400000002	3-29		23533755	10.1155/2013/593020	2090-2107	Chemotherapy Research and Practice	Inhibition of NF-<i>&#x03ba;</i>B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and <i>&#x03b3;</i>-Radiation Cytotoxicity in Glioblastoma Cells	Brassesco	2013	0		
817	chr16	30469006	30469031	3500291600	24		30469006	30469031	8421504	2	12,12	0,13	c	350029160000000126	8-32						Bacteria mediated gene silencing	Fruehauf	2008	0		
819	chr16	30681007	30681031	3500391947	24		30681007	30681031	8421504	1	24	0	c,g	350039194700000006,350039194700000006,350039194700000008	14-36,14-36,27-47						Inhibitors of akt activity	Furuyama	2011	0		
819	chr16	30681007	30681031	3500365939	24		30681007	30681031	8421504	1	24	0	c,g	350036593900000006,350036593900000006,350036593900000008	14-36,14-36,27-47						INHIBITORS OF AKT ACTIVITY - MERCK SHARP & DOHME CORP.	www.sumobrain.com	0	0		AKT3
819	chr16	30681007	30681031	3500327314	24		30681007	30681031	8421504	1	24	0	c	350032731400000006,350032731400000008	14-36,27-47						Inhibitors of akt activity	Furuyama	2009	0		AKT3
102	chr16	30681008	30945769	3500078021	1437		30681008	30945769	8421504	13	46,126,112,145,132,66,69,123,129,215,88,103,83	0,128207,158213,163923,175322,183423,183946,207778,215008,225547,232919,257719,264678	p	350007802100015007	0-1437						MACROCYCLIC KINASE INHIBITORS AND USES THEREOF - PRESIDENT AND FELLOWS OF HARVARD COLLEGE	www.sumobrain.com	0	0		
102	chr16	30681011	30906759	3500011205	510		30681011	30906759	8421504	15	43,2,45,25,20,41,4,45,45,36,3,93,18,45,45	0,128204,128257,128305,158210,158281,163920,163927,163975,164029,175319,175325,175421,207850,225703	p	350001120500015085,350001120500015087,350001120500015088,350001120500015090,350001120500015091,350001120500015092,350001120500015097,350001120500015103	0-45,0-45,0-45,0-45,0-90,0-150,0-45,0-45						Determination of responders to chemotherapy - Patent # 7655414 - PatentGenius	.patentgenius.com	0	0		
102	chr16	30681011	30809265	3500245691	90		30681011	30809265	8421504	3	43,2,45	0,128204,128209	p	350024569100015217	0-90						 Transformation System In The Field Of Filamentous Fungal Hosts 	www.docstoc.com	0	0		AKT3
820	chr16	30809264	30809309	3500420183	45		30809264	30809309	8421504	1	45	0	c	350042018300000000,350042018300000001	0-45,0-45		18451171	10.1158/0008-5472.CAN-07-5867	0008-5472	Cancer Research	Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development	Cheung	2008	8		AKT3
102	chr16	30809289	30945959	3500167223	981		30809289	30945959	8421504	13	52,112,76,81,66,69,123,21,83,88,103,83,24	0,29932,35642,47092,55142,55665,79497,86727,97398,104638,129438,136397,136646	p,c	350016722300015025,350016722300015026,350016722300015028,350016722300015029,350016722300015030,350016722300000010,350016722300015033,350016722300015034,350016722300015035,350016722300000005	6-126,3-126,6-126,6-126,6-126,0-20,6-126,6-126,6-123,0-24						Molecular characterization of the encoding regions and tissue expression analyses for three novel buffalo AKT genes AKT1 AKT2 and AKT3	ls.tubitak.gov.tr	0	0		
820	chr16	30888800	30888878	3500353912	64		30888800	30888878	8421504	3	20,19,25	0,24,53	c,g	350035391200000004,350035391200000010,350035391200000010,350035391200000005	0-20,0-19,0-19,0-25		20018949	10.1152/ajpcell.00375.2009		American Journal of Physiology - Cell Physiolog	The Akt isoforms are present at distinct subcellular locations	Santi	2010	0		AKT3
102	chr16	30888863	30938814	3500063433	58		30888863	30938814	8421504	2	25,33	0,49918	c,g	350006343300000009,350006343300000009,350006343300000008,350006343300000008,350006343300000000,350006343300000005,350006343300000005,350006343300000010,350006343300000011,350006343300000006,350006343300000013,350006343300000012,350006343300000007	0-25,0-25,0-25,0-25,82-208,0-19,0-19,0-25,0-25,0-19,0-25,0-25,0-19						Combinatorial methods and compositions for treatment of melanoma	Kester	2007	0		
102	chr16	30888866	30945772	3500049643	77		30888866	30945772	8421504	3	22,22,33	0,49879,56873	c,g	350004964300000000,350004964300000000,350004964300000002,350004964300000002,350004964300000003	0-22,0-22,0-22,0-22,12-45						THE J B C &#xa9; 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Two Splice Variants of Protein Kinase BgHave Different Regulatory Capacity Depending on the Presence or Absence of the Regulatory Phosphorylation 	www.jbc.org	0	0		
821	chr16	30938777	30938803	3500029380	25		30938777	30938803	8421504	2	15,10	0,16	c	350002938000000002	17-42						The role of Akt2 and SGK1 in dendritic cells	.uni-tuebingen.de	0	0		SDCCAG8
821	chr16	30940337	30940361	3500212526	23		30940337	30940361	8421504	2	19,4	0,20	g	350021252600000016	15-38					Patent	Recombinant feline coronavirus S proteins (Patent US:6280974)	Miller	2001	0		
821	chr16	30945746	30945772	3500392477	26		30945746	30945772	8421504	1	26	0	c,g	350039247700000001,350039247700000001	0-26,0-26		20647317	10.1158/0008-5472.CAN-09-4471		Cancer research	Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells	Yongping	2010	0		SDCCAG8
821	chr16	30945750	30945773	3500428226	23		30945750	30945773	8421504	1	23	0	c,g	350042822600000007,350042822600000007	7-30,7-30						Inhibitors of AKT activity	Furuyama	2009	0		SDCCAG8
821	chr16	30945750	30945773	3500391947	23		30945750	30945773	8421504	1	23	0	c,g	350039194700000007,350039194700000007	7-30,7-30						Inhibitors of akt activity	Furuyama	2011	0		SDCCAG8
821	chr16	30945750	30945773	3500365939	23		30945750	30945773	8421504	1	23	0	c,g	350036593900000007,350036593900000007	7-30,7-30						INHIBITORS OF AKT ACTIVITY - MERCK SHARP & DOHME CORP.	www.sumobrain.com	0	0		SDCCAG8
821	chr16	30945750	30945773	3500327314	23		30945750	30945773	8421504	1	23	0	c,g	350032731400000007,350032731400000007	7-30,7-30						Inhibitors of akt activity	Furuyama	2009	0		SDCCAG8
102	chr16	31030567	31064556	3500395273	23		31030567	31064556	8421504	2	5,18	0,33971	c	350039527300000032	7-30						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
102	chr16	31030567	31064556	3500251828	23		31030567	31064556	8421504	2	6,17	0,33972	c	350025182800000425	1-24						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
827	chr16	31789483	31789507	3500034801	24		31789483	31789507	8421504	1	24	0	g	350003480100000079	15-39						SYSTEM FOR PROTEIN EXPRESSION AND SECRETION ESPECIALLY IN CORYNEBACTERIA - Orsan	www.sumobrain.com	0	0		
829	chr16	32107054	32107078	3500323925	24		32107054	32107078	8421504	1	24	0	g	350032392500000017	14-38						galov doktorat 2007	www.scribd.com	0	0		
832	chr16	32390569	32390592	3500145697	23		32390569	32390592	8421504	1	23	0	g	350014569700000077	15-42						ABSTRACT	tory.lib.ncsu.edu	0	0		
833	chr16	32614663	32614723	3500137334	60		32614663	32614723	8421504	1	60	0	p	350013733400015210,350013733400015149	0-48,12-72						ISOLATION OF ANTIGENIC PEPTIDES OF COWDRIA RUMINANTIUM AND THEIR ENCODING GENES USING A GENOME-DERIVED PHAGE DISPLAY LIBRARY	eprints.ru.ac.za	0	0		FH
833	chr16	32626708	32629511	3500380836	47		32626708	32629511	8421504	4	16,9,7,15	0,19,2780,2788	g	350038083600000196,350038083600000357	4-29,13-35						US Patent # 7,186,541. 3-hydroxypropionic acid and other organic compounds - Patents.com	www.patents.com	0	0		
836	chr16	33011479	33011555	3500301109	67		33011479	33011555	8421504	2	22,45	0,31	p,c,g	350030110900000017,350030110900000000,350030110900000000,350030110900015024	6-28,0-21,0-21,0-45						CONFORMATION AND ACTIVITY OF GBETA5 COMPLEXES - Patent application	www.faqs.org	0	0		
104	chr16	33119531	33163450	3500301109	111		33119531	33163450	8421504	4	45,1,44,21	0,48,36570,43898	p,c	350030110900015025,350030110900015026,350030110900000014,350030110900000031	0-45,0-45,0-27,0-27						CONFORMATION AND ACTIVITY OF GBETA5 COMPLEXES - Patent application	www.faqs.org	0	0		
838	chr16	33198390	33198417	3500327852	24		33198390	33198417	8421504	3	12,4,8	0,13,19	g	350032785200000040	3-27						Antibodies That Specifically Bind to Chemokine Beta-4 - Patent application	www.faqs.org	0	0		
840	chr16	33510142	33523379	3500173104	42		33510142	33523379	8421504	2	20,22	0,13215	c,g	350017310400000010,350017310400000011	0-20,0-22		20479118	10.1084/jem.20100223	0022-1007	The Journal of Experimental Medicine	The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8&#x03b1;+ dendritic cells	Crozat	2010	14		
841	chr16	33683445	33683469	3500424432	23		33683445	33683469	8421504	2	15,8	0,16	g	350042443200000058,350042443200000181	0-23,0-21						RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)	Mcswiggen	2006	0		
841	chr16	33683445	33683469	3500401682	23		33683445	33683469	8421504	2	15,8	0,16	g	350040168200000058	0-23						Rna Interference Mediated Inhibition Of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (sina) 	.freshpatents.com	0	0		
842	chr16	33702532	33737893	3500178134	603		33702532	33737893	8421504	4	64,108,126,305	0,5229,16678,35056	p	350017813400015002	0-603						Intelligent Bioinformatics: The Application of Artificial Intelligence Techniques to Bioinformatics Problems	www.scribd.com	0	0		DPT
845	chr16	34168345	34168370	3500284606	23		34168345	34168370	8421504	2	15,8	0,17	c	350028460600000034	9-35						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Identification of a Lactoferrin-derived Peptide Possessing Binding Activity to Hepatitis C Virus E2 Envelope Protein*	www.jbc.org	0	0		
845	chr16	34168399	34168422	3500269260	23		34168399	34168422	8421504	1	23	0	c	350026926000000018	0-23						&#xc9;COLE DOCTORALE : &#xab; Sant&#xe9;, Sciences, Technologies &#xbb;	lis.univ-tours.fr	0	0		
845	chr16	34168418	34192524	3500123648	44		34168418	34192524	8421504	2	24,20	0,24086	c,g	350012364800000004,350012364800000004,350012364800000000	0-24,0-24,0-20			10.1113/jphysiol.2004.081455		The Journal of Physiology	Subunit composition and role of Na+,K+-ATPases in adrenal chromaffin cells	Hai	2005	0		
847	chr16	34455226	34457744	3500408717	23		34455226	34457744	8421504	2	6,17	0,2501	c	350040871700000005	21-44						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
848	chr16	34531428	34531451	3500083012	23		34531428	34531451	8421504	1	23	0	c,g	350008301200000002,350008301200000002	0-23,0-23		23269813	10.1128/JVI.03203-12		Journal of Virology	Disruption of Thiamine Uptake and Growth of Cells by Feline Leukemia Virus Subgroup A	Ramon	2013	0		
848	chr16	34590639	34590662	3500295556	23		34590639	34590662	8421504	1	23	0	c	350029555600000041,350029555600000025	17-40,0-22						Seed plants exhibiting early reproductive development and methods of making same	Weigel	1997	0		
848	chr16	34590639	34590662	3500121284	23		34590639	34590662	8421504	1	23	0	c	350012128400000041,350012128400000025	17-40,0-22						Seed plants exhibiting inducible early reproductive development and methods of making same	Yanofsky	1999	0		
848	chr16	34590639	34590662	3500002499	23		34590639	34590662	8421504	1	23	0	c	350000249900000025,350000249900000041	0-22,17-40						Maize and cauliflower apetalai gene products and nucleic acid molecules encoding same	Yanofsky	1996	0		
848	chr16	34596826	34596851	3500032460	25		34596826	34596851	8421504	1	25	0	c	350003246000000024	0-25						Methods and materials for identifying the origin of a carcinoma of unknown primary origin	Wang	2012	0		F5
13	chr16	34602873	34603493	3500056637	60		34602873	34603493	8421504	2	21,39	0,581	p	350005663700015010,350005663700015009	3-63,3-63						ADVANCES IN EXPERIMENTAL	xa.yimg.com	0	0		F5
13	chr16	34602884	34603466	3500462802	32		34602884	34603466	8421504	2	10,22	0,560	c,g	350046280200000004,350046280200000010	0-22,0-22						Detection of nucleic acid hybrids	Andrews	2000	0		
13	chr16	34602884	34603466	3500154075	32		34602884	34603466	8421504	2	10,22	0,560	c,g	350015407500000552,350015407500000046,350015407500000183,350015407500000626	0-22,0-22,0-22,0-22						US Patent # 6,730,479. Detection of nucleic acid hybrids - Patents.com	www.patents.com	0	0		
849	chr16	34603470	34603652	3500100723	40		34603470	34603652	8421504	2	20,20	0,162	c	350010072300000004,350010072300000000	28-48,0-20		10926905		0009-9147	Clinical Chemistry	Colorimetric Microwell Plate Detection of the Factor V Leiden Mutation	Kowalski	2000	8		F5
849	chr16	34603542	34603588	3500371217	46		34603542	34603588	8421504	1	46	0	c	350037121700000006	0-46						Substrate functionalization method for high sensitivity applications	Bao	2006	0		
849	chr16	34603544	34603573	3500429837	29		34603544	34603573	8421504	1	29	0	c	350042983700000007	0-29						Substrate functionalization method for high sensitivity applications	Marla	2006	0		
849	chr16	34603544	34603568	3500016509	24		34603544	34603568	8421504	1	24	0	c,g	350001650900000101,350001650900000101	0-24,0-24						Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations 	.freshpatents.com	0	0		
849	chr16	34653692	34655544	3500399193	44		34653692	34655544	8421504	3	21,22,1	0,730,1851	c	350039919300000003,350039919300000002	0-21,0-23		22235260	10.1371/journal.pone.0029054		PLoS ONE	Rapid Accumulation of Polymorphonuclear Neutrophils in the Corpus luteum during Prostaglandin F2&#x03b1;-Induced Luteolysis in the Cow	Koumei	2012	0		
849	chr16	34653692	34655544	3500005411	44		34653692	34655544	8421504	3	21,22,1	0,730,1851	c,g	350000541100000003,350000541100000003,350000541100000002	0-21,0-21,0-23						Rapid accumulation of polymorphonuclear neutrophils in the Corpus luteum during prostaglandin F(2&#x03b1;)-induced luteolysis in the cow. - ResearchGate	.researchgate.net	0	0		
849	chr16	34658556	34658632	3500047620	69		34658556	34658632	8421504	3	22,27,20	0,28,56	c,g	350004762000000001,350004762000000001,350004762000000002,350004762000000000,350004762000000000	0-22,0-22,0-27,0-20,0-20						Monocyte recruitment to endothelial cells in response to oscillatory shear stress	www.fasebj.org	0	0		
849	chr16	34680110	34680134	3500298978	24		34680110	34680134	8421504	1	24	0	g	350029897800000006	0-24						&#x4e3b;&#x9898;&#xff1a;Modification | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		SELP
850	chr16	34752303	34752703	3500375699	400		34752303	34752703	8421504	1	400	0	c	350037569900000005	0-400						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
850	chr16	34753334	34775115	3500380921	45		34753334	34775115	8421504	2	24,21	0,21760	c,g	350038092100000010,350038092100000010,350038092100000003	0-24,0-24,0-21						END OF PROJECT REPORT 5230 Animal Transport: Developing optimum animal handling procedures and effective transport strategies in the food production chain to improve animal welfare and food quality.	www.teagasc.ie	0	0		
850	chr16	34753334	34753358	3500462576	24		34753334	34753358	8421504	1	24	0	c	350046257600000000	0-24		14761937	10.1189/jlb.1003505	0741-5400	Journal of Leukocyte Biology	Mechanisms of glucocorticoid-induced down-regulation of neutrophil L-selectin in cattle: evidence for effects at the gene-expression level and primarily on blood neutrophils	Weber	2004	5		
850	chr16	34763379	34763403	3500088602	24		34763379	34763403	8421504	1	24	0	c	350008860200000004	8-32						Microtopographically patterned surfaces promote the alignment of tenocytes and extracellular collagen	.scs.illinois.edu	0	0		SELL
850	chr16	34775169	34775363	3500383646	40		34775169	34775363	8421504	2	20,20	0,174	c,g	350038364600000027,350038364600000027,350038364600000026,350038364600000026	0-20,0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
850	chr16	34789261	34789344	3500399193	41		34789261	34789344	8421504	2	20,21	0,62	c	350039919300000005,350039919300000004	0-20,0-21		22235260	10.1371/journal.pone.0029054		PLoS ONE	Rapid Accumulation of Polymorphonuclear Neutrophils in the Corpus luteum during Prostaglandin F2&#x03b1;-Induced Luteolysis in the Cow	Koumei	2012	0		
850	chr16	34789261	34789344	3500005411	41		34789261	34789344	8421504	2	20,21	0,62	c	350000541100000005,350000541100000004	0-20,0-21						Rapid accumulation of polymorphonuclear neutrophils in the Corpus luteum during prostaglandin F(2&#x03b1;)-induced luteolysis in the cow. - ResearchGate	.researchgate.net	0	0		
850	chr16	34789297	34789322	3500366041	25		34789297	34789322	8421504	1	25	0	c	350036604100000006	0-25		18245814	10.2353/ajpath.2008.070312		The American Journal of Pathology	Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells	Yoichi	2008	0		
850	chr16	34789297	34789322	3500325952	25		34789297	34789322	8421504	1	25	0	c	350032595200000006	0-25						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		
850	chr16	34854815	34854847	3500168299	25		34854815	34854847	8421504	3	6,8,11	0,8,21	c	350016829900000001	0-25						Gain of Function Mutations in CgPDR1of Candida glabrataNot Only Mediate Antifungal Resistance but Also Enhance Virulence	uni-goettingen.de	0	0		
850	chr16	34854815	34854847	3500019199	25		34854815	34854847	8421504	3	6,8,11	0,8,21	c	350001919900000006	0-25		18312269	10.1111/j.1365-2958.2008.06143.x	1365-2958	Molecular Microbiology	The ATP-binding cassette transporter&#x2013;encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata - Torelli - 2008 - Molecular Microbiology - Wiley Online Library	Torelli	2008	0		
851	chr16	34874097	34874124	3500399717	23		34874097	34874124	8421504	3	5,13,5	0,7,22	g	350039971700000007	6-29						Phagemids and process of preparation	Collins	1997	0		
852	chr16	35093193	35093494	3500383268	301		35093193	35093494	8421504	1	301	0	g	350038326800000012	2-303						Gene markers for beef marbling and tenderness	Jackwood	2001	0		
854	chr16	35272285	35272313	3500425820	25		35272285	35272313	8421504	2	9,16	0,12	g	350042582000000005	5-40						A deletion and point mutation study of the human papillomavirus type 16 major capsid gene	sbio.uct.ac.za	0	0		
854	chr16	35368768	35368793	3500437989	23		35368768	35368793	8421504	2	5,18	0,7	g	350043798900000210	16-40						US Patent # 7,320,793. Molecular antigen array - Patents.com	www.patents.com	0	0		
857	chr16	35698789	35711916	3500179094	72		35698789	35711916	8421504	2	51,21	0,13106	c	350017909400000048,350017909400000079,350017909400000000,350017909400000081	0-45,0-48,0-21,0-21						Glaucoma therapeutics and diagnostics	www.devileye.net	0	0		
857	chr16	35698789	35698834	3500240827	45		35698789	35698834	8421504	1	45	0	c	350024082700000041	0-45						Glaucoma compositions	Stone	1997	0		
107	chr16	35859521	35980584	3500181378	45		35859521	35980584	8421504	2	23,22	0,121041	p	350018137800015001	0-45						The Major Yolk Protein of Sea Urchins Is Endocytosed by a Dynamin-Dependent Mechanism	www.brown.edu	0	0		DNM3
107	chr16	35859521	35980584	3500001771	45		35859521	35980584	8421504	2	23,22	0,121041	p	350000177100015001	0-45		15084478	10.1095/biolreprod.104.027730	0006-3363	Biology of Reproduction	The Major Yolk Protein of Sea Urchins Is Endocytosed by a Dynamin-Dependent Mechanism	Brooks	2004	4		DNM3
861	chr16	36226456	36226566	3500406570	110		36226456	36226566	8421504	1	110	0	c	350040657000000004	0-110		19641226	10.1074/jbc.M109.036541	0021-9258	Journal of Biological Chemistry	Unique MicroRNA Profile in End-stage Heart Failure Indicates Alterations in Specific Cardiovascular Signaling Networks	Prasad	2009	5		MIR3120
861	chr16	36226474	36232323	3500306561	66		36226474	36232323	8421504	3	22,22,22	0,5788,5827	c	350030656100000050,350030656100000035,350030656100000036,350030656100000091	22-44,22-44,22-44,22-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
861	chr16	36226474	36232323	3500257436	66		36226474	36232323	8421504	3	22,22,22	0,5788,5827	c,g	350025743600000050,350025743600000035,350025743600000035,350025743600000036	22-44,22-44,0-22,22-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
861	chr16	36226474	36226497	3500441572	23		36226474	36226497	8421504	1	23	0	c	350044157200000005,350044157200000004	0-23,0-22		22867052	10.1186/1476-4598-11-51	1476-4598	Molecular Cancer	MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma	Huang	2012	4		MIR3120
861	chr16	36226474	36226497	3500215979	23		36226474	36226497	8421504	1	23	0	c	350021597900000005,350021597900000004	0-23,0-22		22867052	10.1186/1476-4598-11-51	1476-4598	Molecular Cancer	MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma	Huang	2012	4		MIR3120
861	chr16	36226475	36232323	3500371873	44		36226475	36232323	8421504	2	21,23	0,5825	c,g	350037187300000152,350037187300000119,350037187300000119	0-21,0-23,0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		MIR3120,DNM3OS
861	chr16	36226475	36232323	3500304886	44		36226475	36232323	8421504	2	21,23	0,5825	c,g	350030488600000128,350030488600000095,350030488600000095	0-21,0-23,0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		MIR3120,DNM3OS
861	chr16	36226475	36232323	3500244257	44		36226475	36232323	8421504	2	21,23	0,5825	c	350024425700000078,350024425700000061	0-21,0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		
861	chr16	36226475	36232323	3500131966	44		36226475	36232323	8421504	2	21,23	0,5825	c	350013196600000078,350013196600000061	0-21,0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
861	chr16	36226475	36232323	3500125321	66		36226475	36232323	8421504	3	21,22,23	0,5788,5825	c	350012532100000025,350012532100000023,350012532100000022	0-21,0-22,0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
861	chr16	36226475	36232285	3500415602	43		36226475	36232285	8421504	2	21,22	0,5788	c	350041560200000001,350041560200000000	0-21,0-22		18199536	10.1158/0008-5472.CAN-07-2488	0008-5472	Cancer Research	MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN	Yang	2008	8		MIR3120
861	chr16	36232263	36232323	3500400478	44		36232263	36232323	8421504	2	22,22	0,38	g	350040047800000218,350040047800000209	0-22,0-22					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		DNM3OS
861	chr16	36232263	36232323	3500357539	44		36232263	36232323	8421504	2	22,22	0,38	c	350035753900000218,350035753900000209	0-22,0-22					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		MIR199A1
861	chr16	36232263	36232323	3500210973	44		36232263	36232323	8421504	2	22,22	0,38	c,g	350021097300000218,350021097300000209,350021097300000209	0-22,0-22,0-22						Microrna molecules	Tuschl	2002	0		MIR199A1,DNM3OS
861	chr16	36232300	36232323	3500415206	23		36232300	36232323	8421504	1	23	0	g	350041520600000002	0-23		17875710	10.1158/0008-5472.CAN-07-1936	0008-5472	Cancer Research	MicroRNA Signatures in Human Ovarian Cancer	Iorio	2007	8		DNM3OS
861	chr16	36232300	36232323	3500392693	23		36232300	36232323	8421504	1	23	0	c,g	350039269300000004,350039269300000004,350039269300000002,350039269300000002	0-23,0-23,0-23,0-23		22498306	10.1111/j.1742-4658.2012.08589.x	1742-4658	FEBS Journal	MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells - Cheng - 2012 - FEBS Journal - Wiley Online Library	Cheng	2012	0		DNM3OS
861	chr16	36232300	36232323	3500327675	23		36232300	36232323	8421504	1	23	0	g	350032767500000004	0-23		18408758	10.1038/onc.2008.112	0950-9232	Oncogene	Regulation of IKK&#x03b2; by miR-199a affects NF-&#x03ba;B activity in ovarian cancer cells	Chen	2008	6		MIR199A1
861	chr16	36232300	36232323	3500169217	23		36232300	36232323	8421504	1	23	0	c	350016921700000011	0-23		21959934	10.1038/cdd.2011.126	1350-9047	Cell Death & Differentiation	Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA	Eto	2011	9		MIR199A1
862	chr16	36399298	36399324	3500408428	23		36399298	36399324	8421504	2	16,7	0,19	g	350040842800000122	0-24					Patent	G-CSF receptor agonists (Patent US:6100070)	Braford-Goldberg	2000	0		
865	chr16	36805153	36811718	3500152135	136		36805153	36811718	8421504	5	35,28,8,32,33	0,725,5055,6407,6532	c	350015213500000100,350015213500000244,350015213500000085,350015213500000076,350015213500000090	0-35,6-36,12-48,1-33,9-42						DNA encoding Fas ligand	Nagata	1994	0		
865	chr16	36805166	36805191	3500019769	25		36805166	36805191	8421504	1	25	0	c	350001976900000002,350001976900000014	0-25,0-25						ADULT SERTOLI CELLS AND USES THEREOF - Patent application	www.faqs.org	0	0		
865	chr16	36805875	36811718	3500186499	113		36805875	36811718	8421504	4	31,17,32,33	0,4333,5685,5810	c	350018649900000125,350018649900000110,350018649900000494,350018649900000115	0-48,12-48,1-33,9-42						Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity. - Patent application	www.faqs.org	0	0		
865	chr16	36805885	36811661	3500040185	42		36805885	36811661	8421504	2	21,21	0,5755	c	350004018500000045,350004018500000046	0-21,0-21						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
865	chr16	36810245	36811538	3500264674	25		36810245	36811538	8421504	2	20,5	0,1288	c	350026467400000009	0-25						VITRIFICATION OF BOVINE OOCYTES	cholar.lib.vt.edu	0	0		
865	chr16	36811655	36811825	3500444841	47		36811655	36811825	8421504	2	26,21	0,149	c	350044484100000000,350044484100000001	0-26,0-21						Differentiation Potentials of Canine Bone Marrow Mesenchymal Stem Cells | Chalika Wangdee - Academia.edu	www.academia.edu	0	0		FASLG
865	chr16	36811655	36811825	3500014871	47		36811655	36811825	8421504	2	26,21	0,149	c	350001487100000000,350001487100000001	0-26,0-21						Fas Ligand in Swamp Buffalo Oviduct during Follicular and Luteal Phases	w.vet.chula.ac.th	0	0		FASLG
865	chr16	36811687	36811711	3500311002	24		36811687	36811711	8421504	1	24	0	c	350031100200000119,350031100200000118	21-45,0-24						RT-PCR protocols	www.docstoc.com	0	0		FASLG
865	chr16	36811687	36811711	3500059496	24		36811687	36811711	8421504	1	24	0	c	350005949600000014	24-48			10.1002/hep.21797	1527-3350	Hepatology	Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia - Harada - 2007 - Hepatology - Wiley Online Library	Harada	2007	0		FASLG
865	chr16	36811746	36811770	3500451489	24		36811746	36811770	8421504	1	24	0	c	350045148900000003	0-24		9207432		0006-4971	Blood	Constitutive Expression of Fas (Apo-1/CD95) Ligand on Multiple Myeloma Cells: A Potential Mechanism of Tumor-Induced Suppression of Immune Surveillance	Villunger	1997	10		
869	chr16	37316297	37316320	3500266348	23		37316297	37316320	8421504	1	23	0	c,g	350026634800000003,350026634800000003	0-23,0-23						Human endokine alpha and methods of use	Ni	2011	0		TNFSF18
869	chr16	37316297	37316320	3500250119	23		37316297	37316320	8421504	1	23	0	c	350025011900000003	0-23						Human endokine alpha	Yu	2002	0		TNFSF18
869	chr16	37316297	37316320	3500198049	23		37316297	37316320	8421504	1	23	0	c	350019804900000003	0-23						METHODS AND COMPOSITIONS FOR TREATING METABOLIC BONE DISEASES RELATING TO HUMAN ENDOKINE ALPHA - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		TNFSF18
869	chr16	37316297	37316320	3500106393	23		37316297	37316320	8421504	1	23	0	c	350010639300000003	0-23						Methods and compositions for treating metabolic bone diseases relating to human endokine alpha	Yu	2002	0		TNFSF18
869	chr16	37316297	37316320	3500084021	23		37316297	37316320	8421504	1	23	0	c	350008402100000005	0-23		15375382	10.1038/sj.cgt.7700778	0929-1903	Cancer Gene Therapy	Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein	Mincheff	2004	3		
869	chr16	37316297	37316320	3500076467	23		37316297	37316320	8421504	1	23	0	c	350007646700000007	0-23						AD AWARD NUMBER: DAMD17-02-1-0239 TITLE: Naked DNA Immunization for Prevention of Prostate Cancer in a Dunning Rat PRINCIPAL INVESTIGATOR: Milcho Mincheff, M.D., Ph.D. Washington, DC 20052	www.dtic.mil	0	0		
871	chr16	37506260	37506290	3500186499	30		37506260	37506290	8421504	1	30	0	c	350018649900000293	0-30						Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity. - Patent application	www.faqs.org	0	0		
871	chr16	37509489	37509516	3500017108	23		37509489	37509516	8421504	2	11,12	0,15	g	350001710800000045	0-36						Host cell specific binding molecules capable of neutralizing viruses and uses thereof	Throsby	2011	0		
871	chr16	37525518	37525541	3500095924	23		37525518	37525541	8421504	1	23	0	c	350009592400000008	0-23						HUMAN MAST CELL LINE AND USES THEREOF - Patent application	www.faqs.org	0	0		
871	chr16	37525532	37525558	3500391998	26		37525532	37525558	8421504	1	26	0	c	350039199800000002	4-30			10.1128/JVI.01020-07		Journal of Virology	Probing the Interaction between Feline Immunodeficiency Virus and CD134 by Using the Novel Monoclonal Antibody 7D6 and the CD134 (O&#xd7;40) Ligand 	Brian	2007	0		
871	chr16	37525532	37525558	3500179272	26		37525532	37525558	8421504	1	26	0	c	350017927200000002	4-30		17609274	10.1128/JVI.01020-07	0022-538X	Journal of Virology	Probing the Interaction between Feline Immunodeficiency Virus and CD134 by Using the Novel Monoclonal Antibody 7D6 and the CD134 (O&#xd7;40) Ligand	Willett	2007	5		
871	chr16	37570729	37570752	3500117316	23		37570729	37570752	8421504	1	23	0	g	350011731600000004	7-30		12048202	10.1074/jbc.M203570200	0021-9258	Journal of Biological Chemistry	The Polycystic Kidney Disease-1 Promoter Is a Target of the &#x03b2;-Catenin/T-cell Factor Pathway	Rodova	2002	5		
875	chr16	38092203	38092231	3500442421	24		38092203	38092231	8421504	2	6,18	0,10	g	350044242100000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2002	0		
875	chr16	38092203	38092231	3500423166	24		38092203	38092231	8421504	2	6,18	0,10	g	350042316600000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2008	0		
875	chr16	38092203	38092231	3500392345	24		38092203	38092231	8421504	2	6,18	0,10	g	350039234500000018	1-25					Patent	Compounds and methods for treatment and diagnosis of chlamydial infection (Patent EP:1144642)	Bhatia	2010	0		
875	chr16	38092203	38092231	3500380211	24		38092203	38092231	8421504	2	6,18	0,10	g	350038021100000018	1-25						Compounds And Methods For Treatment And Diagnosis Of Chlamydial Infection 	.freshpatents.com	0	0		
875	chr16	38092203	38092231	3500356597	24		38092203	38092231	8421504	2	6,18	0,10	g	350035659700000018	1-25					Patent	Compounds and methods for treatment and diagnosis of chlamydial infection (Patent US:8052975)	Bhatia	2011	0		
875	chr16	38092203	38092231	3500354056	24		38092203	38092231	8421504	2	6,18	0,10	g	350035405600000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2006	0		
875	chr16	38092203	38092231	3500312638	24		38092203	38092231	8421504	2	6,18	0,10	g	350031263800000034	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	P*Pu Luo Bu Si Te 	2003	0		
875	chr16	38092203	38092231	3500291943	24		38092203	38092231	8421504	2	6,18	0,10	g	350029194300000018	1-25						COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION - Patent application	www.faqs.org	0	0		
875	chr16	38092203	38092231	3500278467	24		38092203	38092231	8421504	2	6,18	0,10	g	350027846700000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2006	0		
875	chr16	38092203	38092231	3500273910	24		38092203	38092231	8421504	2	6,18	0,10	g	350027391000000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2000	0		
875	chr16	38092203	38092231	3500266934	24		38092203	38092231	8421504	2	6,18	0,10	g	350026693400000034	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	S*P*Fu Lai 	2004	0		
875	chr16	38092203	38092231	3500253337	24		38092203	38092231	8421504	2	6,18	0,10	g	350025333700000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2001	0		
875	chr16	38092203	38092231	3500253134	24		38092203	38092231	8421504	2	6,18	0,10	g	350025313400000034	1-25					Patent	Compounds and methods for treatment and diagnosis of chlamydial infection (Patent CN:100467600)	S*P*Fu Lai 	2009	0		
875	chr16	38092203	38092231	3500244541	24		38092203	38092231	8421504	2	6,18	0,10	g	350024454100000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2001	0		
875	chr16	38092203	38092231	3500241150	24		38092203	38092231	8421504	2	6,18	0,10	g	350024115000000035	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	P*Pu Luo Bu Si Te 	2002	0		
875	chr16	38092203	38092231	3500226425	24		38092203	38092231	8421504	2	6,18	0,10	g	350022642500000018	1-25					Patent	Compounds and methods for treatment and diagnosis of chlamydial infection (Patent US:8263089)	Bhatia	2012	0		
875	chr16	38092203	38092231	3500215702	24		38092203	38092231	8421504	2	6,18	0,10	g	350021570200000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2008	0		
875	chr16	38092203	38092231	3500215593	24		38092203	38092231	8421504	2	6,18	0,10	g	350021559300000018	1-25					Patent	Compounds and methods for treatment and diagnosis of chlamydial infection (Patent US:7462357)	Bhatia	2008	0		
875	chr16	38092203	38092231	3500211338	24		38092203	38092231	8421504	2	6,18	0,10	g	350021133800000018	1-25					Patent	Compounds and methods for treatment and diagnosis of chlamydial infection (Patent US:8052975)	Bhatia	2011	0		
875	chr16	38092203	38092231	3500186047	24		38092203	38092231	8421504	2	6,18	0,10	g	350018604700000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2002	0		
875	chr16	38092203	38092231	3500158847	24		38092203	38092231	8421504	2	6,18	0,10	g	350015884700000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2001	0		
875	chr16	38092203	38092231	3500133009	24		38092203	38092231	8421504	2	6,18	0,10	g	350013300900000018	1-25						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2002	0		
875	chr16	38092203	38092231	3500068705	24		38092203	38092231	8421504	2	6,18	0,10	g	350006870500000018	1-25						Compounds And Methods For Treatment And Diagnosis Of Chlamydial Infection 	.freshpatents.com	0	0		
876	chr16	38236278	38236900	3500345532	23		38236278	38236900	8421504	2	19,4	0,618	c	350034553200000010	10-33						Tumor necrosis factor receptor-associated factors	Goeddel	2009	0		
876	chr16	38236278	38236900	3500288096	23		38236278	38236900	8421504	2	19,4	0,618	c	350028809600000009	10-33					Patent	Tumor necrosis factor receptor-associated factors (Patent US:5869612)	Goeddel	1999	0		
876	chr16	38236278	38236900	3500280396	23		38236278	38236900	8421504	2	19,4	0,618	c	350028039600000009	10-33					Patent	Tumor necrosis factor receptor-associated factors (Patent US:6500922)	Goeddel	2002	0		
876	chr16	38239883	38242114	3500287328	45		38239883	38242114	8421504	2	25,20	0,2211	c	350028732800000033,350028732800000115	0-25,18-38						Concatameric immunoadhesion molecule - US Patent 7670602 Description	ww.patentstorm.us	0	0		
876	chr16	38239883	38239921	3500178243	37		38239883	38239921	8421504	2	27,10	0,28	g	350017824300000029	16-53						I IIIII	leonepartners.com	0	0		
876	chr16	38257460	38257492	3500164803	24		38257460	38257492	8421504	3	6,13,5	0,9,27	g	350016480300000039,350016480300000099	0-26,0-26						Lateral Flow Assay Device And Method 	.freshpatents.com	0	0		
877	chr16	38322815	38322840	3500297945	23		38322815	38322840	8421504	3	12,5,6	0,13,19	g	350029794500000005	5-28						Transgenic animals bearing human Ig-lambda light chain genes	Green	2003	0		
878	chr16	38411510	38435769	3500210456	68		38411510	38435769	8421504	3	24,20,24	0,5045,24235	c,g	350021045600000001,350021045600000002,350021045600000002,350021045600000000,350021045600000000	0-24,0-20,0-20,0-24,0-24						An unusual splice defect in the mitofusin 2 gene (MFN2) is associated with degenerative axonopathy in Tyrolean Grey cattle. - ResearchGate	.researchgate.net	0	0		
878	chr16	38415807	38415831	3500227498	24		38415807	38415831	8421504	1	24	0	c	350022749800000003	0-24		21643798	10.1007/s10048-011-0285-6		Neurogenetics	A novel mitofusin 2 mutation causes canine fetal-onset neuroaxonal dystrophy	John	2011	0		MFN2
878	chr16	38430734	38430760	3500261569	24		38430734	38430760	8421504	2	6,18	0,8	c	350026156900000001	4-28						ScienceDirect.com - Neuron - FGF-2-Responsive Neural Stem Cell Proliferation Requires CCg, a Novel Autocrine/Paracrine Cofactor	sciencedirect.com	0	0		
878	chr16	38445243	38445291	3500466715	48		38445243	38445291	8421504	1	48	0	p	350046671500015008	0-48						Novel lysyl hydroxylase isoforms	herkules.oulu.fi	0	0		
878	chr16	38484997	38485021	3500248703	23		38484997	38485021	8421504	2	8,15	0,9	g	350024870300000368	20-43						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
879	chr16	38547732	38549750	3500445344	1985		38547732	38549750	8421504	8	371,57,253,271,656,45,79,253	0,375,441,697,980,1639,1685,1765	p,g	350044534400000004,350044534400015023,350044534400015026	0-2125,0-45,0-45						Biomarkers - Patent application	www.faqs.org	0	0		
879	chr16	38559966	38559992	3500245153	26		38559966	38559992	8421504	1	26	0	g	350024515300000000,350024515300000002	5-31,0-21			10.1128/MCB.21.4.1036-1044.2001		Molecular and Cellular Biology	Serum Response Factor-GATA Ternary Complex Required for Nuclear Signaling by a G-Protein-Coupled Receptor	Steves	2001	0		
879	chr16	38560438	38560721	3500452577	42		38560438	38560721	8421504	2	21,21	0,262	c	350045257700000011,350045257700000002,350045257700000003,350045257700000012	0-21,0-21,0-21,0-21						US Patent # 7,396,537. Cell delivery patch for myocardial tissue engineering - Patents.com	www.patents.com	0	0		
879	chr16	38560661	38561286	3500169203	99		38560661	38561286	8421504	2	93,6	0,619	p	350016920300015007,350016920300015004,350016920300015018,350016920300015019,350016920300015020,350016920300015012,350016920300015013,350016920300015014,350016920300015015,350016920300015016,350016920300015017,350016920300015011,350016920300015034	0-96,0-84,0-87,0-87,0-87,0-87,0-87,0-87,0-87,0-87,0-87,3-87,0-45						LONG ACTING ATRIAL NATRIURETIC PEPTIDE (LA-ANP) AND METHODS FOR USE THEREOF - Patent application	www.faqs.org	0	0		
879	chr16	38560661	38561283	3500376640	96		38560661	38561283	8421504	2	93,3	0,619	p	350037664000015007,350037664000015002	0-48,0-96						Method for the production of natriuretic peptides through streptavidin-fusion proteins	Kopetzki	1998	0		NPPA
879	chr16	38560661	38561283	3500376185	96		38560661	38561283	8421504	2	93,3	0,619	p	350037618500015005,350037618500015001	0-48,0-96						Verfahren zur herstellung von natriuretischen peptiden &#xfc;ber streptavidin-fusionsproteine	Kopetzki	1998	0		NPPA
879	chr16	38560673	38561286	3500288246	87		38560673	38561286	8421504	2	81,6	0,607	p	350028824600015001	0-87						NATRIURETIC ACTIVITIES - Patent application	www.faqs.org	0	0		
879	chr16	38560673	38561283	3500181669	84		38560673	38561283	8421504	2	81,3	0,607	p	350018166900015019	0-84						Ubiquitin fusion-based vaccine system	Kenten	2003	0		NPPA
879	chr16	38560688	38560748	3500167829	60		38560688	38560748	8421504	1	60	0	p	350016782900015023	0-60						Heat shock fusion-based vaccine system	Kenten	2001	0		NPPA
879	chr16	38560688	38560748	3500166394	60		38560688	38560748	8421504	1	60	0	p	350016639400015017	0-60						Ubiquitin fusion-based vaccine system	Kenten	2001	0		NPPA
879	chr16	38560688	38560748	3500073094	60		38560688	38560748	8421504	1	60	0	p	350007309400015021	0-60						Heat shock fusion-based vaccine system	Kenten	1999	0		NPPA
879	chr16	38587960	38587984	3500121284	23		38587960	38587984	8421504	2	11,12	0,12	g	350012128400000104	24-48						Seed plants exhibiting inducible early reproductive development and methods of making same	Yanofsky	1999	0		
879	chr16	38601446	38601470	3500272961	23		38601446	38601470	8421504	2	22,1	0,23	c	350027296100000009	0-23						Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, HGRA4, and splice variant thereof	Feder	2002	0		
879	chr16	38604163	38612558	3500007779	325		38604163	38612558	8421504	11	19,24,48,26,48,48,3,26,21,11,51	0,3238,4445,4914,5200,5699,5795,6893,7918,8284,8344	c	350000777900000070,350000777900000033,350000777900000080,350000777900000040,350000777900000088,350000777900000045,350000777900000090,350000777900000051,350000777900000053,350000777900000096	0-43,0-48,0-26,0-48,0-48,3-48,0-29,15-47,0-48,6-48						 Method Of Diagnosing Schizophrenia By Detecting A Mutation In The (MTHFR) Gene 	www.docstoc.com	0	0		
879	chr16	38604163	38612555	3500395686	248		38604163	38612555	8421504	9	19,24,48,48,3,26,21,11,48	0,3238,4445,5699,5795,6893,7918,8284,8344	c	350039568600000070,350039568600000033,350039568600000088,350039568600000090,350039568600000051,350039568600000053	0-43,0-48,0-48,0-29,15-47,0-48						Method of diagnosing schizophrenia by detecting a mutation in the (MTHFR) gene - US Patent 6566065 Description	ww.patentstorm.us	0	0		
879	chr16	38604163	38611082	3500038499	145		38604163	38611082	8421504	6	19,24,26,47,3,26	0,3238,4914,5203,5795,6893	c	350003849900000070,350003849900000080,350003849900000083,350003849900000090	0-43,0-26,0-47,0-29						CDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF - Patent application	www.faqs.org	0	0		
879	chr16	38607517	38607540	3500320008	23		38607517	38607540	8421504	1	23	0	c	350032000800000076,350032000800000003	1-24,1-24						NUCLEOTIDE PRIMER SET AND NUCLEOTIDE PROBE FOR DETECTING GENOTYPE OF METHYLENE TETRAHYDROFOLATE REDUCTASE (MTHFR) - Patent application	www.faqs.org	0	0		
879	chr16	38607517	38607540	3500150332	23		38607517	38607540	8421504	1	23	0	c	350015033200000003	1-24						Nucleotide Primer Set And Nucleotide Probe For Detecting Genotype Of Methylene Tetrahydrofolate Reductase (mthfr) 	.freshpatents.com	0	0		
879	chr16	38609371	38609397	3500257250	26		38609371	38609397	8421504	1	26	0	c,g	350025725000000004,350025725000000004	0-26,0-26					Patent	Assay kit for use in method of detecting a target nucleic acid (Patent US:7951541)	Ito	2011	0		
879	chr16	38609372	38609402	3500030740	30		38609372	38609402	8421504	1	30	0	c	350003074000000044,350003074000000045	0-30,0-29						Primer Set for Amplification of MTHFR Gene, MTHFR Gene Amplification Reagent Containing the Same, and Use of the Same - Patent application	www.faqs.org	0	0		
880	chr16	38704224	38704252	3500249107	24		38704224	38704252	8421504	2	9,15	0,13	g	350024910700000051,350024910700000114	2-26,2-26						Method of preparation of pharmaceutically grade plasmid DNA	Fu Lang Xi Si *Bu Lan Qi 	2006	0		
880	chr16	38706254	38706278	3500408194	24		38706254	38706278	8421504	1	24	0	g	350040819400000066	5-30						ENHANCEMENT OF BACILLUS THURINGIENSIS CRY PROTEIN TOXICITIES TO COLEOPTERANS, AND NOVEL INSECT CADHERIN FRAGMENTS - Patent application	www.faqs.org	0	0		
880	chr16	38749761	38749794	3500423257	30		38749761	38749794	8421504	3	13,12,5	0,14,28	c	350042325700000646	12-42						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
881	chr16	38889101	38889131	3500443188	24		38889101	38889131	8421504	3	4,12,8	0,5,22	c	350044318800000031	0-27						Family GH-61 polypeptides - Patent # 7273738 - PatentGenius	.patentgenius.com	0	0		
883	chr16	39140354	39140386	3500333908	32		39140354	39140386	8421504	1	32	0	g	350033390800000048	0-32						Immunosuppressant Target Proteins - Patent application	www.faqs.org	0	0		
883	chr16	39172772	39172803	3500031136	31		39172772	39172803	8421504	1	31	0	c	350003113600000028	0-31						Compositions and methods for the treatment of immune related diseases	Ashkenazi	2001	0		
884	chr16	39227856	39227904	3500333908	48		39227856	39227904	8421504	1	48	0	g	350033390800000129	0-48						Immunosuppressant Target Proteins - Patent application	www.faqs.org	0	0		
884	chr16	39256318	39256348	3500400238	26		39256318	39256348	8421504	3	15,6,5	0,16,25	g	350040023800000143	1-27						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
110	chr16	39317073	39329828	3500212298	90		39317073	39329828	8421504	3	44,19,27	0,66,12728	c	350021229800000051,350021229800000052,350021229800000221	0-44,18-37,21-48						METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION - Patent application	www.faqs.org	0	0		
884	chr16	39317073	39319605	3500324741	90		39317073	39319605	8421504	3	44,19,27	0,2340,2505	c	350032474100000051,350032474100000068,350032474100000070	0-44,19-38,15-42						METHODS FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION - Patent application	www.faqs.org	0	0		
884	chr16	39317073	39317158	3500158245	63		39317073	39317158	8421504	2	44,19	0,66	c	350015824500000053,350015824500000054	0-44,18-37						METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION - Patent application	www.faqs.org	0	0		
885	chr16	39333730	39334459	3500423670	38		39333730	39334459	8421504	2	19,19	0,710	c,g	350042367000000001,350042367000000000,350042367000000000	0-19,0-19,0-19						Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. - ResearchGate	.researchgate.net	0	0		TARDBP
885	chr16	39334230	39337998	3500019727	282		39334230	39337998	8421504	3	75,21,186	0,78,3582	p	350001972700015011,350001972700015000	0-96,0-186						SEQUENCES ASSOCIATED WITH TDP-43 PROTEINOPATHIES AND METHODS OF USING THE SAME	Cairns	2009	0		
885	chr16	39334371	39336180	3500320279	73		39334371	39336180	8421504	2	51,22	0,1787	p,c	350032027900015000,350032027900000000	0-51,0-22		22761693	10.1371/journal.pone.0038658		PLoS ONE	Coaggregation of RNA-Binding Proteins in a Model of TDP-43 Proteinopathy with Selective RGG Motif Methylation and a Role for RRM1 Ubiquitination	Eric	2012	0		TARDBP
885	chr16	39336198	39337764	3500135127	54		39336198	39337764	8421504	2	50,4	0,1562	p	350013512700015000	0-54			10.1111/j.1471-4159.2007.05190.x	1471-4159	Journal of Neurochemistry	TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor - Wang - 2007 - Journal of Neurochemistry - Wiley Online Library	Wang	2008	0		TARDBP
885	chr16	39337963	39339005	3500111044	69		39337963	39339005	8421504	3	39,4,26	0,40,1016	c	350011104400000022	96-169						TDP-43-STORING CELL MODEL - Patent application	www.faqs.org	0	0		
887	chr16	39598148	39598172	3500012411	23		39598148	39598172	8421504	2	19,4	0,20	g	350001241100000011	8-37						Microbial ecology of the equine hindgut during oligofructose-induced laminitis | Athol Klieve - Academia.edu	www.academia.edu	0	0		
890	chr16	40032138	40032170	3500352874	32		40032138	40032170	8421504	1	32	0	c	350035287400000021	0-32						US Patent # 6,165,737. DNA fragmentation factor involved in apoptosis - Patents.com	www.patents.com	0	0		
890	chr16	40084701	40084724	3500154625	23		40084701	40084724	8421504	1	23	0	c	350015462500000000	0-23		21188075	10.1155/2010/512056	2090-2247	Biochemistry Research International	Enzymatic and mRNA Transcript Response of Ovine 6-Phosphogluconate Dehydrogenase (6PGD) in Respect to Different Milk Yield	Trivizaki	2009	0		
890	chr16	40084720	40084744	3500102652	24		40084720	40084744	8421504	1	24	0	c	350010265200000005	0-24						PLAN DE THESE	www.lacerta.de	0	0		
891	chr16	40162020	40162047	3500322352	23		40162020	40162047	8421504	2	8,15	0,12	g	350032235200000013	3-33						;i5i Mifi- P./f!&#xc5;&#xed; im. ?M N nv g CD .IIS st 8 -ta ,h II Ieli (D ne JEfi	ary.osaka-u.ac.jp	0	0		
891	chr16	40234721	40234749	3500135071	25		40234721	40234749	8421504	2	20,5	0,23	g	350013507100000000	6-31		19564412	10.1128/MCB.00352-09	0270-7306	Molecular and Cellular Biology	The Alternative TrkAIII Splice Variant Targets the Centrosome and Promotes Genetic Instability	Farina	2009	6		
893	chr16	40384894	40384926	3500179178	32		40384894	40384926	8421504	1	32	0	c	350017917800000001	5-37						Use of bacteriophages to control biofilms | Sanna Sillankorva - Academia.edu	www.academia.edu	0	0		
893	chr16	40384895	40384919	3500204678	24		40384895	40384919	8421504	1	24	0	c	350020467800000001	8-32		19933578	10.1074/jbc.M109.059881		The Journal of Biological Chemistry	Dominant Negative Mutant Actins Identified in Flightless Drosophila Can Be Classified into Three Classes	Taro	2010	0		PTPRZ1
893	chr16	40384897	40384942	3500270720	45		40384897	40384942	8421504	1	45	0	p	350027072000015165	0-45						<Html><Title> Complet list of 1qt1 hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		ECM2
893	chr16	40412273	40412324	3500417139	51		40412273	40412324	8421504	1	51	0	p	350041713900015000	0-51			10.1093/emboj/19.10.2181		The EMBO Journal	A complex of mammalian Ufd1 and Npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways	Hemmo	2000	0		UBE4B
893	chr16	40412273	40412324	3500118131	51		40412273	40412324	8421504	1	51	0	p	350011813100015000	0-51		10811609	10.1093/emboj/19.10.2181	ERROR! NO ISSN	The EMBO Journal	A complex of mammalian Ufd1 and Npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways	Meyer	2000	0		UBE4B
894	chr16	40614807	40614835	3500299131	23		40614807	40614835	8421504	2	15,8	0,20	c	350029913100000005	0-23						Nucleic acids and proteins from streptococcus groups a & b	Telford	2001	0		
895	chr16	40699269	40716653	3500205840	43		40699269	40716653	8421504	2	23,20	0,17364	c,g	350020584000000000,350020584000000000,350020584000000008,350020584000000008,350020584000000009	0-20,0-20,0-21,0-21,0-20		21885566	10.1210/me.2011-1023		Molecular Endocrinology	The &#x03b2;-Catenin Binding Protein ICAT Modulates Androgen Receptor Activity	Ming	2011	0		CTNNBIP1
896	chr16	40841530	40851068	3500283170	695		40841530	40851068	8421504	20	45,48,48,34,14,41,7,105,38,44,3,41,48,42,6,41,24,24,12,30	0,760,1159,1451,2245,3200,3460,3468,3671,3806,4018,4076,4381,5995,6692,8485,8574,8910,9078,9508	c	350028317000000067,350028317000000065,350028317000000061,350028317000000058,350028317000000053,350028317000000052,350028317000000051,350028317000000050,350028317000000047,350028317000000045,350028317000000042,350028317000000030,350028317000000022,350028317000000020,350028317000000016	0-45,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-47,0-41,0-48,0-48,0-41,0-48,6-48						QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA - Patent application	www.faqs.org	0	0		
896	chr16	40841530	40851068	3500249851	466		40841530	40851068	8421504	14	45,48,48,41,7,48,48,26,24,41,24,24,12,30	0,760,1159,3200,3460,3515,4381,6888,7896,8485,8574,8910,9078,9508	c	350024985100000123,350024985100000121,350024985100000117,350024985100000093,350024985100000091,350024985100000082,350024985100000035,350024985100000032,350024985100000030,350024985100000026	0-45,0-48,0-48,0-48,0-48,0-48,0-50,0-41,0-48,6-48						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	K*W*Fu Le 	2007	0		
896	chr16	40841588	40851068	3500311185	303		40841588	40851068	8421504	11	2,33,48,41,42,6,41,24,24,12,30	0,669,1101,4018,5937,6634,8427,8516,8852,9020,9450	c	350031118500000066,350031118500000061,350031118500000045,350031118500000030,350031118500000022,350031118500000020,350031118500000016	0-35,0-48,0-41,0-48,0-41,0-48,6-48						Quinazolinones as Inhibitors of Human Phosphatidylinositol 3-Kinase Delta - Patent application	www.faqs.org	0	0		
896	chr16	40841588	40851068	3500212714	157		40841588	40851068	8421504	5	2,81,32,12,30	0,669,4992,9020,9450	c	350021271400000066,350021271400000065,350021271400000036,350021271400000016	0-35,0-48,0-32,6-48						Inhibitors of human phosphatidyl-inositol 3-kinase delta	Sadhu	2004	0		
896	chr16	40842290	40851068	3500370270	316		40842290	40851068	8421504	10	48,48,41,42,6,41,24,24,12,30	0,399,3316,5235,5932,7725,7814,8150,8318,8748	c	350037027000000073,350037027000000069,350037027000000053,350037027000000038,350037027000000005,350037027000000030,350037027000000028,350037027000000024	0-48,0-48,0-41,0-48,0-25,0-41,0-48,6-48						Phosphatidylinositol 3-kinase p110 delta catalytic subunit	Chantry	1998	0		
896	chr16	40843801	40845953	3500267181	141		40843801	40845953	8421504	5	21,30,30,30,30	0,929,1426,1774,2122	p	350026718100015116	0-147						Bis-thiazole derivatives, process for their preparation and their use as medicaments	P*Yin Ba He 	2011	0		
896	chr16	40845862	40851068	3500241531	228		40845862	40851068	8421504	8	49,42,6,41,24,24,12,30	0,1663,2360,4153,4242,4578,4746,5176	c	350024153100000072,350024153100000059,350024153100000037,350024153100000035,350024153100000031	0-49,0-48,0-41,0-48,6-48						Inhibitors of human phosphatidyl-inositol 3-kinase delta	C*Sa Du 	2005	0		
896	chr16	40847546	40848226	3500370550	25		40847546	40848226	8421504	2	21,4	0,676	c	350037055000000004	0-25						Phosphatidylinositol 3-kinase p110 delta catalytic subunit	filed	2005	0		
896	chr16	40847546	40848226	3500200415	25		40847546	40848226	8421504	2	21,4	0,676	c	350020041500000005	0-25						Phosphatidylinositol 3-kinase p110 delta catalytic subunit	Chantry	1997	0		
896	chr16	40863085	40863110	3500416808	23		40863085	40863110	8421504	2	17,6	0,19	g	350041680800000095	19-42					Patent	Recombinant herpesvirus of turkeys and uses thereof (Patent US:5853733)	Cochran	1998	0		
897	chr16	40904866	40905574	3500455139	336		40904866	40905574	8421504	4	12,7,28,289	0,17,380,419	g	350045513900000048	494-838						lacto_sin	www.scribd.com	0	0		
897	chr16	40952012	40952037	3500309097	25		40952012	40952037	8421504	1	25	0	c	350030909700000011	0-25						- Royo, L.J. (2002). Secuenciaci&#xf3;n y an&#xe1;lisis del gen de la miostatina bovina. Tesis Doctoral. Universidad Complutense de Madrid, **pp	www.serida.org	0	0		
897	chr16	40952750	40952775	3500458079	23		40952750	40952775	8421504	2	9,14	0,11	c	350045807900000030	10-33						Dihydrocapsaicin Attenuates Plaque Formation through a PPAR&#x03b3;/LXR&#x03b1; Pathway in apoE(-/-) Mice Fed a High-Fat/High-Cholesterol Diet. - ResearchGate	.researchgate.net	0	0		
899	chr16	41221975	41222001	3500065110	23		41221975	41222001	8421504	3	4,14,5	0,5,21	g	350006511000000191	3-26					Patent	Method, tools and kits for the detection of members of the staphylococcus genus (Patent CA:2789369)	Bergeron	2013	0		
900	chr16	41385124	41385150	3500013455	26		41385124	41385150	8421504	1	26	0	c,g	350001345500000143,350001345500000143,350001345500000068	0-25,0-25,20-45						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		GPR157
900	chr16	41385124	41385149	3500005148	25		41385124	41385149	8421504	1	25	0	c,g	350000514800000000,350000514800000000,350000514800000001,350000514800000001	33-58,33-58,14-39,14-39		22496226	10.1128/JVI.07056-11		Journal of Virology	The Epstein-Barr Virus (EBV)-Induced Tumor Suppressor MicroRNA MiR-34a Is Growth Promoting in EBV-Infected B Cells	Eleonora	June	0		GPR157
900	chr16	41385126	41385212	3500407196	45		41385126	41385212	8421504	2	22,23	0,63	c	350040719600000014,350040719600000012	0-22,25-48						MicroRNAs regulate human hepatocyte nuclear factor 4&#x03b1;, modulating the expression of metabolic enzymes and cell cycle - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
900	chr16	41385126	41385149	3500125321	23		41385126	41385149	8421504	1	23	0	c	350012532100000011	0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		GPR157
900	chr16	41385126	41385149	3500075720	23		41385126	41385149	8421504	1	23	0	c	350007572000000055	0-23						Expression and function of the let-7 microRNA during stem cell specification and development of the CNS	diss.fu-berlin.de	0	0		GPR157
901	chr16	41429119	41429155	3500008403	28		41429119	41429155	8421504	3	14,9,5	0,19,31	g	350000840300000019,350000840300000147	0-28,0-28						HUMAN MONOCLONAL ANTIBODY NEUTRALIZING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND USE THEREOF - Patent application	www.faqs.org	0	0		
901	chr16	41480484	41482686	3500163467	612		41480484	41482686	8421504	6	129,111,102,76,128,66	0,245,987,1375,1917,2136	p,c,g	350016346700015014,350016346700000017,350016346700000017,350016346700015015,350016346700015016,350016346700015017	0-180,0-20,0-20,0-180,0-180,0-72						Entwicklungsspezifische Expression und m&#xf6;gliche funktionelle Bedeutung der Glukosetransporterisoformen in Pr&#xe4;implantationsembryonen des Rindes	ebdoc.sub.gwdg.de	0	0		
901	chr16	41482936	41483173	3500424225	42		41482936	41483173	8421504	2	21,21	0,216	c,g	350042422500000028,350042422500000028,350042422500000029,350042422500000029	0-21,0-21,0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
901	chr16	41516990	41517045	3500379260	55		41516990	41517045	8421504	1	55	0	c,g	350037926000000004,350037926000000004	1-56,1-56		22722940	10.1074/jbc.M112.371880		The Journal of Biological Chemistry	Peptide-specific Transfer of N-Acetylgalactosamine to O-Linked Glycans by the Glycosyltransferases &#x03b2;1,4-N-Acetylgalactosaminyl Transferase 3 (&#x03b2;4GalNAc-T3) and &#x03b2;4GalNAc-T4	Dorothy	2012	0		
902	chr16	41631753	41642728	3500409227	1302		41631753	41642728	8421504	11	85,96,59,70,134,223,198,202,109,59,67	0,2624,4020,5448,5974,6490,7937,8734,9324,9637,10908	p	350040922700015004	0-1302						Patent for Diagnosis of Early Diagnosis of Systemic Tissue Fibrosis	www.scribd.com	0	0		
902	chr16	41631753	41642728	3500407027	957		41631753	41642728	8421504	11	85,96,59,70,44,139,41,188,109,59,67	0,2624,4020,5448,5974,6574,7937,8748,9324,9637,10908	p	350040702700015026,350040702700015029,350040702700015030,350040702700015038,350040702700015045,350040702700015046,350040702700015049,350040702700015050,350040702700015053,350040702700015054	0-174,0-180,0-180,0-180,0-174,0-174,0-180,0-180,0-69,0-69						Burkholderia Pseudomallei	st.bic.nus.edu.sg	0	0		
902	chr16	41631753	41642728	3500141136	1302		41631753	41642728	8421504	11	85,96,59,70,134,223,198,202,109,59,67	0,2624,4020,5448,5974,6490,7937,8734,9324,9637,10908	p	350014113600015004	0-1302						BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS	DGaldo	2011	0		
902	chr16	41634388	41641414	3500027167	804		41634388	41641414	8421504	8	85,59,70,134,156,167,109,24	0,1385,2813,3339,3855,6134,6689,7002	p	350002716700015069,350002716700015070,350002716700015071,350002716700015072,350002716700015076,350002716700015077	0-54,0-150,0-150,0-150,0-150,0-150						Neela Devi Sing RAMBARUTH	search.wmin.ac.uk	0	0		ENO1
902	chr16	41638442	41638466	3500344742	24		41638442	41638466	8421504	1	24	0	c	350034474200000003	0-24						Feline infectious peritonitis (FIP) and systemic multi-organ coronavirus biomarkers and screening methods	Austin	2005	0		
902	chr16	41639782	41639830	3500316430	48		41639782	41639830	8421504	1	48	0	p	350031643000015001	0-48						Antigens for Vaccination Against and Detection of Mycoplasma Suis - Patent application	www.faqs.org	0	0		ENO1
902	chr16	41639876	41640554	3500367934	79		41639876	41640554	8421504	2	12,67	0,611	c	350036793400000399	0-79						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
909	chr16	42499650	42499933	3500046604	48		42499650	42499933	8421504	2	24,24	0,259	c,g	350004660400000006,350004660400000006,350004660400000007	0-24,0-24,0-24						REPRODUCTION	uction-online.org	0	0		
909	chr16	42534423	42548269	3500394155	444		42534423	42548269	8421504	5	158,87,70,60,69	0,6066,10968,11899,13777	p	350039415500015010	0-444						Serologische Identifikation von Pankreaskarzinom-spezifischen Antigenen	b.uni-saarland.de	0	0		PARK7
909	chr16	42545446	42548203	3500259199	78		42545446	42548203	8421504	3	15,60,3	0,876,2754	p	350025919900015002	0-78						Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in Endothelial Progenitor Cells	www.mcponline.org	0	0		PARK7
909	chr16	42548251	42549915	3500360666	47		42548251	42549915	8421504	2	25,22	0,1642	c	350036066600000007,350036066600000006	0-25,0-22		17804756	10.1158/0008-5472.CAN-06-4069	0008-5472	Cancer Research	Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms	Hudson	2007	8		PARK7
909	chr16	42548251	42549915	3500179385	47		42548251	42549915	8421504	2	25,22	0,1642	c	350017938500000007,350017938500000006	0-25,0-22		17804756	10.1158/0008-5472.CAN-06-4069	0008-5472	Cancer Research	Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms	Hudson	2007	8		
909	chr16	42548251	42549915	3500068500	47		42548251	42549915	8421504	2	25,22	0,1642	c	350006850000000007,350006850000000006	0-25,0-22		17804756	10.1158/0008-5472.CAN-06-4069	0008-5472	Cancer Research	Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms	Hudson	2007	8		
909	chr16	42574246	42574269	3500007373	23		42574246	42574269	8421504	1	23	0	c	350000737300000003	10-33						4-1BB polypeptides and DNA encoding 4-1BB polypeptides	Goodwin	1997	0		TNFRSF9
912	chr16	42875305	42875329	3500425870	23		42875305	42875329	8421504	2	19,4	0,20	g	350042587000000164	0-26							w.bhdsyndrome.org	0	0		
916	chr16	43431262	43431291	3500044715	24		43431262	43431291	8421504	2	11,13	0,16	g	350004471500000252	1-26						Antibody immunoreactive with a 5-enolpyruvylshikimate-3-phosphate synthase - US Patent 7183110 Description	ww.patentstorm.us	0	0		
918	chr16	43708789	43708817	3500196470	23		43708789	43708817	8421504	2	12,11	0,17	g	350019647000000051	19-42						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
918	chr16	43711785	43711810	3500079271	23		43711785	43711810	8421504	2	16,7	0,18	g	350007927100000000,350007927100000021	0-26,0-26						Campylobacter Pilus Protein, Compositions and Methods - Patent application	www.faqs.org	0	0		
919	chr16	43787254	43787279	3500165432	23		43787254	43787279	8421504	2	18,5	0,20	g	350016543200000063	2-25						DNA repair polypeptides and methods of use	Lloyd	2001	0		
920	chr16	43981319	43981342	3500407663	23		43981319	43981342	8421504	1	23	0	c,g	350040766300000066,350040766300000066	9-32,9-32						Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation	AMALRIC	2005	0		THAP3
920	chr16	44019342	44019367	3500185098	23		44019342	44019367	8421504	3	6,4,13	0,7,12	g	350018509800000029	7-30						PRRS Viruses, Infectious Clones, Mutants Thereof, and Methods of Use - Patent application	www.faqs.org	0	0		
920	chr16	44030585	44030611	3500463327	23		44030585	44030611	8421504	2	11,12	0,14	c	350046332700000036,350046332700000012	1-24,1-24					Patent	Vaccins adn ameliores pour herpesvirus-1 bovin (Patent EP:1248650)	Audonnet	2006	0		
920	chr16	44030585	44030611	3500378178	23		44030585	44030611	8421504	2	11,12	0,14	c	350037817800000018	1-24					Patent	Improved dna vaccines for bovine herpesvirus-1 (Patent EP:1248650)	Audonnet	2006	0		
920	chr16	44030585	44030611	3500367862	23		44030585	44030611	8421504	2	11,12	0,14	c	350036786200000019	1-24						Improved dna vaccines for production-type animals	Audonnet	2002	0		
920	chr16	44030585	44030611	3500303979	23		44030585	44030611	8421504	2	11,12	0,14	c	350030397900000012,350030397900000134	1-24,1-24						 DNA Vaccines For Farm Animals, In Particular Bovines And Porcines 	www.docstoc.com	0	0		
920	chr16	44030585	44030611	3500276508	23		44030585	44030611	8421504	2	11,12	0,14	c	350027650800000012,350027650800000036	1-24,1-24					Patent	Vaccins adn ameliores pour herpesvirus-1 bovin (Patent EP:1248650)	Audonnet	2006	0		
920	chr16	44030585	44030611	3500271240	23		44030585	44030611	8421504	2	11,12	0,14	c	350027124000000018	1-24					Patent	Improved dna vaccines for bovine herpesvirus-1 (Patent EP:1248650)	Audonnet	2006	0		
920	chr16	44030585	44030611	3500232418	23		44030585	44030611	8421504	2	11,12	0,14	c	350023241800000012	1-24						Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3	Audonnet	2005	0		
920	chr16	44030585	44030611	3500163096	23		44030585	44030611	8421504	2	11,12	0,14	c	350016309600000012	1-24						Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3	Audonnet	2004	0		
920	chr16	44030585	44030611	3500095783	23		44030585	44030611	8421504	2	11,12	0,14	c	350009578300000012	1-24						Vaccins adn ameliores pour animaux de rente	Audonnet	2002	0		
920	chr16	44030585	44030611	3500012787	23		44030585	44030611	8421504	2	11,12	0,14	c	350001278700000024	1-24						Improved DNA vaccines for production-type animals	J-C*F*Ao Duo Nai Te 	2003	0		
920	chr16	44030585	44030611	3500009333	23		44030585	44030611	8421504	2	11,12	0,14	c	350000933300000012,350000933300000134	1-24,1-24						DNA vaccines for farm animals, in particular bovines and porcines - Patent # 6852705 - PatentGenius	.patentgenius.com	0	0		
921	chr16	44067225	44067253	3500143098	23		44067225	44067253	8421504	2	12,11	0,17	g	350014309800000381	25-48						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS - Patent application	www.faqs.org	0	0		
921	chr16	44104088	44105028	3500261436	40		44104088	44105028	8421504	3	20,12,8	0,822,932	c	350026143600000105,350026143600000106	0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		TNFRSF25
921	chr16	44104913	44105035	3500461419	24		44104913	44105035	8421504	2	9,15	0,107	c	350046141900000033	11-35						Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta	Yu	2002	0		
921	chr16	44104913	44105035	3500388455	24		44104913	44105035	8421504	2	9,15	0,107	c	350038845500000010	11-35						DR3 antibodies	Yu	2008	0		
921	chr16	44104913	44105035	3500099739	24		44104913	44105035	8421504	2	9,15	0,107	c	350009973900000077	11-35						Death domain containing receptors	Dillon	1997	0		
921	chr16	44106436	44106565	3500279178	66		44106436	44106565	8421504	3	39,7,20	0,101,109	c	350027917800000049,350027917800000006	0-39,0-27						Apo-2li and apo-3 apoptosis polypeptides	Ashkenazi	1997	0		
921	chr16	44106537	44106565	3500289472	27		44106537	44106565	8421504	2	7,20	0,8	c	350028947200000045	0-27					Patent	Compositions and methods for the diagnosis of tumours (Patent EP:1626084)	Ashkenazi	2009	0		
921	chr16	44106537	44106565	3500286478	27		44106537	44106565	8421504	2	7,20	0,8	c	350028647800000047	0-27						Compositions and methods for the treatment of tumour	Ashkenazi	2002	0		
921	chr16	44106537	44106565	3500236207	27		44106537	44106565	8421504	2	7,20	0,8	c	350023620700000078	0-27						Novel gene disruptions, compositions and methods relating thereto	Brennan	2007	0		
921	chr16	44106537	44106565	3500061630	27		44106537	44106565	8421504	2	7,20	0,8	c	350006163000000005	0-27						Apo-2LI and Apo-3 polypeptides	Ashkenazi	2006	0		
921	chr16	44106537	44106565	3500029974	27		44106537	44106565	8421504	2	7,20	0,8	c	350002997400000004	0-27						Apo-2LI and Apo-3 polypeptides - Patent application	www.faqs.org	0	0		
921	chr16	44147003	44147115	3500178185	23		44147003	44147115	8421504	3	8,5,10	0,12,102	c	350017818500000056	0-38						Fc-free antibodies comprising two fab fragments and methods of use	Bruenker	2013	0		
921	chr16	44147003	44147115	3500133654	23		44147003	44147115	8421504	3	8,5,10	0,12,102	c	350013365400000056	0-38						FC-FREE ANTIBODIES COMPRISING TWO FAB FRAGMENTS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
923	chr16	44415598	44415630	3500451303	28		44415598	44415630	8421504	3	13,6,9	0,16,23	g	350045130300000067	9-41						US Patent # 5,856,177. Promoters derived from the maize phosphoenolpyruvate carboxylase gene involved in C.sub.4 photosynthesis - Patents.com	www.patents.com	0	0		
115	chr16	44425258	44481421	3500010450	758		44425258	44481421	8421504	24	5,8,58,17,27,11,7,34,12,36,47,10,89,16,69,21,21,21,38,44,36,82,20,29	0,8,18,104,134,170,182,190,227,2300,2342,2729,3722,4035,4060,16052,16076,16103,25823,26689,54726,56030,56113,56134	p,c,g	350001045000000021,350001045000000016,350001045000000015,350001045000015014,350001045000015013,350001045000000011,350001045000015011,350001045000000020,350001045000000009,350001045000000008,350001045000000008,350001045000000007,350001045000000007,350001045000000019,350001045000015010,350001045000000018,350001045000000018,350001045000000005	0-85,0-42,0-52,0-48,0-57,0-93,0-60,0-48,0-21,0-21,0-21,0-21,0-21,0-69,0-72,0-21,0-21,42-209						Primary structure of a beta subunit of alpha-dendrotoxin-sensitive K+ channels from bovine brain. - ResearchGate	.researchgate.net	0	0		
924	chr16	44485687	44485720	3500437641	28		44485687	44485720	8421504	4	6,12,5,5	0,7,20,28	g	350043764100000043	0-33						Eduardo Campos dos Santos Uma introdu&#xe7;&#xe3;o &#xe0; Bioinform&#xe1;tica atrav&#xe9;s da an&#xe1;lise de algumas ferramentas de software de seq&#xfc;&#xea;ncias	www.ginux.ufla.br	0	0		
925	chr16	44656424	44656451	3500258779	23		44656424	44656451	8421504	3	8,4,11	0,9,16	g	350025877900000004,350025877900000005	8-32,1-25						ANAPLASMA MARGINALE INFECTION OF CALVES By SUSHAN HAN DOCTOR OF PHILOSOPHY WASHINGTON STATE UNIVERSITY May 2010	ertations.wsu.edu	0	0		
926	chr16	44753672	44753698	3500437989	23		44753672	44753698	8421504	2	7,16	0,10	g	350043798900000122	0-23						US Patent # 7,320,793. Molecular antigen array - Patents.com	www.patents.com	0	0		
926	chr16	44753672	44753698	3500415445	23		44753672	44753698	8421504	2	7,16	0,10	g	350041544500000115	0-23						Molecular antigen array - US Patent 7264810 Description	ww.patentstorm.us	0	0		
927	chr16	44928522	44928547	3500110550	24		44928522	44928547	8421504	2	16,8	0,17	g	350011055000000772	12-36						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
929	chr16	45193045	45193070	3500326034	25		45193045	45193070	8421504	1	25	0	g	350032603400000673	8-33						 Selection Method 	www.docstoc.com	0	0		
931	chr16	45368259	45368286	3500464528	23		45368259	45368286	8421504	2	16,7	0,20	g	350046452800000034	0-23					Patent	Methods and compositions for use in spliceosome mediated RNA trans-splicing (Patent US:6280978)	Mitchell	2001	0		
116	chr16	45869505	45880623	3500071108	43		45869505	45880623	8421504	3	14,8,21	0,15,11097	g	350007110800000047,350007110800000019	0-29,0-21					Patent	&#x751f;&#x4ea7;&#x83ab;&#x7eb3;&#x751c;&#x548c;&#x83ab;&#x7eb3;&#x751c;&#x524d;&#x4f53; Production and Mona Mona Sweet Sweet precursors (Patent CN:1890377)	S*C*Mai Ke Fa Lan 	2013	0		
936	chr16	46105018	46105042	3500286315	23		46105018	46105042	8421504	2	14,9	0,15	g	350028631500000000	0-23						Enhanced variants of erythropoietin and methods of use	Evans	2004	0		
943	chr16	46952054	46952078	3500179123	23		46952054	46952078	8421504	2	4,19	0,5	g	350017912300000012	2-25						Isolation, characterization and genome sequence of a birnavirus strain from flounder Paralichthys olivaceus in China. - ResearchGate	.researchgate.net	0	0		
945	chr16	47189655	47189678	3500280030	23		47189655	47189678	8421504	1	23	0	g	350028003000000115	3-26						Ldl-receptor	Caskey	2000	0		
945	chr16	47189655	47189678	3500157069	23		47189655	47189678	8421504	1	23	0	g	350015706900000082	3-26						US Patent # 6,545,137. Receptor - Patents.com	www.patents.com	0	0		
946	chr16	47324058	47324088	3500430105	26		47324058	47324088	8421504	3	4,7,15	0,5,15	g	350043010500000017	0-34		19912344	10.1111/j.1365-2443.2009.01356.x	1365-2443	Genes to Cells	Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells - Nagata - 2009 - Genes to Cells - Wiley Online Library	Nagata	2009	0		
947	chr16	47519453	47537527	3500182786	402		47519453	47537527	8421504	13	29,28,35,22,13,54,40,23,23,13,34,40,48	0,1289,1363,1429,1624,4055,5936,12411,14845,16085,16555,16609,18026	c	350018278600000030,350018278600000195,350018278600000089,350018278600000041,350018278600000137,350018278600000031,350018278600000196,350018278600000139,350018278600000093,350018278600000050,350018278600000146,350018278600000101,350018278600000109,350018278600000163,350018278600000170,350018278600000124,350018278600000177	3-40,3-40,23-47,0-48,0-48,0-40,0-40,0-35,0-35,0-48,0-48,0-40,0-23,10-33,0-47,1-41,0-48						Screening and Treatment Methods Using IGS5 Enzymes of the Metalloprotease Family - Patent application	www.faqs.org	0	0		
947	chr16	47519453	47520750	3500333599	37		47519453	47520750	8421504	2	29,8	0,1289	c	350033359900000030	3-40						Screening and treatment methods using IGS5 enzymes of the metalloprotease family	Deleersnijder	2007	0		
947	chr16	47519453	47520750	3500209631	37		47519453	47520750	8421504	2	29,8	0,1289	c	350020963100000030	3-40					Patent	Human enzymes of the metalloprotease family (Patent US:6855532)	Deleersnijder	2005	0		
947	chr16	47535502	47535547	3500114800	45		47535502	47535547	8421504	1	45	0	p	350011480000015041	0-45						Neprilysin Gene Polymorphism and Amyloid Beta Plaques in Traumatic Brain Injury - Patent application	www.faqs.org	0	0		MMEL1
947	chr16	47570945	47571059	3500349312	23		47570945	47571059	8421504	2	18,5	0,109	c	350034931200000010	0-23		20865013	10.1038/cdd.2010.109	1350-9047	Cell Death & Differentiation	Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing	Zimmer	2010	9		HES5
947	chr16	47570945	47571059	3500328982	23		47570945	47571059	8421504	2	18,5	0,109	c	350032898200000010	0-23		20865013	10.1038/cdd.2010.109	1350-9047	Cell Death & Differentiation	Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing	Zimmer	2010	9		HES5
947	chr16	47571098	47571191	3500353322	90		47571098	47571191	8421504	2	45,45	0,48	p	350035332200015020,350035332200015021	0-45,0-45						Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor - Patent application	www.faqs.org	0	0		HES5
118	chr16	47829517	47849792	3500165258	1227		47829517	47849792	8421504	13	85,116,90,80,120,88,136,87,98,189,53,82,3	0,277,2163,2602,3474,4682,4957,6461,13963,17001,18208,19613,20272	p	350016525800015021	0-1227						T3DB: Showing Lead subacetate (T3D1331)	classic.t3db.org	0	0		
118	chr16	47836046	47843485	3500467509	24		47836046	47843485	8421504	2	19,5	0,7434	c	350046750900000004	6-30		16331246	10.1038/sj.onc.1209312	0950-9232	Oncogene	Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase C&#x03b9;-mediated attenuation of p38 MAP kinase signaling	Baldwin	2005	6		
118	chr16	47836046	47843485	3500123098	24		47836046	47843485	8421504	2	19,5	0,7434	c	350012309800000004	6-30		16331246	10.1038/sj.onc.1209312	0950-9232	Oncogene	Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase C&#x03b9;-mediated attenuation of p38 MAP kinase signaling	Baldwin	2005	6		
950	chr16	47947981	47948011	3500420477	25		47947981	47948011	8421504	2	11,14	0,16	g	350042047700000302	0-29						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
952	chr16	48141976	48161023	3500097423	681		48141976	48161023	8421504	9	57,39,107,64,163,67,25,141,18	0,3955,5528,9490,10622,16691,18114,18175,19029	p	350009742300015000	0-720						Ambystoma EST Database	alamander.uky.edu	0	0		GNB1
952	chr16	48141976	48142001	3500134214	25		48141976	48142001	8421504	1	25	0	c	350013421400000023,350013421400000011	19-44,19-44					Patent	Functional expression of mammalian adenylyl cyclase in yeast (Patent US:6001553)	Broach	1999	0		GNB1
952	chr16	48141976	48142001	3500110993	25		48141976	48142001	8421504	1	25	0	c	350011099300000011	19-44						Functional expression of heterologous adenylyl cyclase	Broach	1997	0		GNB1
952	chr16	48141976	48142001	3500066951	25		48141976	48142001	8421504	1	25	0	c	350006695100000011	19-44						Functional expression of mammalian adenylyl cyclase in yeast	Broach	1997	0		GNB1
952	chr16	48141976	48142001	3500011475	25		48141976	48142001	8421504	1	25	0	c	350001147500000011	19-44						FUNCTIONAL EXPRESSION OF HETEROLOGOUS ADENYLYL CYCLASE - CADUS PHARMACEUTICAL CORPORATION BROACH, James, R	www.sumobrain.com	0	0		GNB1
952	chr16	48182171	48182445	3500366733	23		48182171	48182445	8421504	3	8,9,6	0,12,268	c	350036673300000379	10-33						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
953	chr16	48235076	48235546	3500337487	102		48235076	48235546	8421504	4	29,16,45,12	0,391,410,458	p	350033748700015118	0-102						Methods and compositions for regulating bone and cartilage formation - Patent # 7251568 - PatentGenius	.patentgenius.com	0	0		
953	chr16	48235515	48235984	3500013443	68		48235515	48235984	8421504	3	20,25,23	0,90,446	c,g	350001344300000038,350001344300000009,350001344300000005,350001344300000005,350001344300000008	0-20,0-25,0-20,0-20,0-23						Molecular Characterization of Porcine MMP19 and MMP23B Genes and Its Association with Immune Traits	www.ijbs.com	0	0		
953	chr16	48244319	48244344	3500129749	25		48244319	48244344	8421504	1	25	0	g	350012974900000005	0-25						CS 395T: Computational Statistics with Application to Bioinformatics	www.nr.com/CS395T	0	0		
953	chr16	48246299	48246324	3500148192	23		48246299	48246324	8421504	2	16,7	0,18	g	350014819200000045,350014819200000088	5-28,5-28						COMPOSITIONS AND METHODS FOR DETECTING, IDENTIFYING AND QUANTITATING MYCOBACTERIAL-SPECIFIC NUCLEIC ACIDS - Patent application	www.faqs.org	0	0		
953	chr16	48321439	48321466	3500449315	25		48321439	48321466	8421504	2	8,17	0,10	g	350044931500000376	12-37						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
953	chr16	48321439	48321466	3500080694	25		48321439	48321466	8421504	2	8,17	0,10	g	350008069400000353	15-40						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
953	chr16	48325484	48325781	3500162432	26		48325484	48325781	8421504	3	8,7,11	0,276,286	c	350016243200000009	0-26		11861379		0008-5472	Cancer Research	Two Forms of Gonadotropin-releasing Hormone (GnRH) Are Expressed in Human Breast Tissue and Overexpressed in Breast Cancer	Chen	2002	8		
953	chr16	48333115	48333146	3500456078	23		48333115	48333146	8421504	3	12,6,5	0,17,26	g	350045607800000013	2-25						METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS	Spencer	2009	0		
953	chr16	48333115	48333146	3500332409	23		48333115	48333146	8421504	3	12,6,5	0,17,26	g	350033240900000013	2-25						Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters	Spencer	2011	0		
953	chr16	48333115	48333146	3500120365	23		48333115	48333146	8421504	3	12,6,5	0,17,26	g	350012036500000013	2-25						Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters	Priyadharshini	2010	0		
954	chr16	48418611	48418634	3500434024	23		48418611	48418634	8421504	1	23	0	c	350043402400000002	9-32						An Antagonist of Dishevelled Protein-Protein Interaction Suppresses B-Catenin&#x2013;Dependent Tumor Cell Growth	www.scribd.com	0	0		
954	chr16	48418611	48418634	3500351179	23		48418611	48418634	8421504	1	23	0	c	350035117900000002	9-32		17234765	10.1158/0008-5472.CAN-06-2726	0008-5472	Cancer Research	An Antagonist of Dishevelled Protein-Protein Interaction Suppresses &#x03b2;-Catenin&#x2013;Dependent Tumor Cell Growth	Fujii	2007	8		
954	chr16	48429791	48429816	3500390306	24		48429791	48429816	8421504	2	12,12	0,13	c	350039030600000052	0-24						Procaryotic xylose isomerase muteins and method to increase protein stability	Bloch	1989	0		
954	chr16	48429791	48429816	3500345689	24		48429791	48429816	8421504	2	12,12	0,13	c	350034568900000050	0-24						Procaryotic xylose isomerase muteins	Drummond	1987	0		
955	chr16	48504405	48504433	3500435248	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350043524800000072	0-24						Identification Of Oligonucleotides For The Capture, Detection And Quantitation Of West Nile Virus 	.freshpatents.com	0	0		
955	chr16	48504405	48504433	3500429541	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350042954100000007	0-24		16227249	10.1128/JVI.79.21.13262-13274.2005	0022-538X	Journal of Virology	N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity	Hanna	2005	5		
955	chr16	48504405	48504433	3500425448	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350042544800000010	0-24			10.1128/JCM.41.8.3661-3667.2003		Journal of Clinical Microbiology	Virus Detection Protocols for West Nile Virus in Vertebrate and Mosquito Specimens	Elizabeth	2003	0		
955	chr16	48504405	48504433	3500398238	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350039823800000067,350039823800000080,350039823800000027	0-22,0-24,0-24						Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus - US Patent 7132233 Description	ww.patentstorm.us	0	0		
955	chr16	48504405	48504433	3500367397	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350036739700000002	0-24						West Nile Virus Detection in Kidney, Cloacal, and Nasopharyngeal Specimens - Vol. 11 No. 9 - September 2005 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
955	chr16	48504405	48504433	3500353484	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350035348400000002	0-24						West Nile Virus Detection in Kidney, Cloacal, and Nasopharyngeal Specimens - Vol. 11 No. 9 - September 2005 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
955	chr16	48504405	48504433	3500324453	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350032445300000002	0-24						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
955	chr16	48504405	48504433	3500236814	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350023681400000010	0-24						Virus Detection Protocols for West Nile Virus in Vertebrate and Mosquito Specimens--&#x300a;&#x5fae;&#x751f;&#x7269;&#x4e34;&#x5e8a;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
955	chr16	48504405	48504433	3500208479	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350020847900000072	0-24						Identification Of Oligonucleotides For The Capture, Detection And Quantitation Of West Nile Virus 	.freshpatents.com	0	0		
955	chr16	48504405	48504433	3500135121	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350013512100000069	0-24						Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus - US Patent 7833758 Description	ww.patentstorm.us	0	0		
955	chr16	48504405	48504433	3500043809	24		48504405	48504433	8421504	3	5,6,13	0,8,15	g	350004380900000007	0-24			10.1128/JVI.79.21.13262-13274.2005		Journal of Virology	N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity	Sheri	2005	0		
955	chr16	48512310	48512340	3500405208	25		48512310	48512340	8421504	3	9,5,11	0,13,19	c	350040520800000034	1-26						Method and composition for detecting protein-protein and protein-nucleic acid interactions	Nibert	2008	0		
955	chr16	48541279	48541304	3500040083	23		48541279	48541304	8421504	2	18,5	0,20	g	350004008300000083,350004008300000091,350004008300000084,350004008300000087,350004008300000086	0-23,0-23,0-23,0-23,0-23						Comparisons among the complete genomes of four betanodavirus genotypes	int-res.com	0	0		
955	chr16	48552330	48553010	3500257436	47		48552330	48553010	8421504	2	22,25	0,655	c,g	350025743600000038,350025743600000038,350025743600000039	22-44,0-22,19-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
955	chr16	48552330	48553009	3500125321	45		48552330	48553009	8421504	2	22,23	0,656	c,g	350012532100000044,350012532100000082	0-22,0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIR200A
955	chr16	48552330	48553007	3500307429	44		48552330	48553007	8421504	2	22,22	0,655	c,g	350030742900000006,350030742900000006,350030742900000004	0-22,0-22,0-22						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - YEDA RESEARCH AND DEVELOPMENT CO. LTD.	www.sumobrain.com	0	0		
955	chr16	48552330	48553007	3500131061	44		48552330	48553007	8421504	2	22,22	0,655	c,g	350013106100000030,350013106100000063	0-22,0-22						MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES - Patent application	www.faqs.org	0	0		
955	chr16	48552330	48553007	3500031979	44		48552330	48553007	8421504	2	22,22	0,655	c,g	350003197900000352,350003197900000353	0-22,0-22						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR200A
955	chr16	48552331	48553007	3500400478	44		48552331	48553007	8421504	2	21,23	0,653	g	350040047800000196,350040047800000210	0-21,0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		
955	chr16	48552984	48553007	3500354653	23		48552984	48553007	8421504	1	23	0	g	350035465300000025	0-23						COMPOSITIONS AND METHODS RELATED TO MIRNA IN DIABETIC CONDITIONS - Patent application	www.faqs.org	0	0		
955	chr16	48552984	48553007	3500205029	23		48552984	48553007	8421504	1	23	0	g	350020502900000002,350020502900000006	0-23,0-23						METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME	Khew-goodall	2007	0		
955	chr16	48552985	48553010	3500389139	25		48552985	48553010	8421504	1	25	0	c	350038913900000039	19-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		
955	chr16	48552985	48553010	3500306561	25		48552985	48553010	8421504	1	25	0	c	350030656100000039	19-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
955	chr16	48552985	48553010	3500232262	25		48552985	48553010	8421504	1	25	0	c	350023226200000039	19-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
956	chr16	48657058	48692093	3500063345	34984		48657058	48692093	8421504	2	33164,1820	0,33215	g	350006334500000006,350006334500000015,350006334500000016,350006334500000007,350006334500000009,350006334500000010,350006334500000008,350006334500000023,350006334500000014,350006334500000024,350006334500000022,350006334500000002,350006334500000012,350006334500000005	0-33155,0-5165,0-5181,0-809,0-23363,0-23363,0-23347,0-4636,0-4627,0-429,0-4620,0-427,0-4611,0-1820						Screening for Arthrogryposis Multiplex in Bovines - Patent application	www.faqs.org	0	0		
956	chr16	48673856	48673879	3500366987	23		48673856	48673879	8421504	1	23	0	g	350036698700000020	4-27						Varicella-zoster virus	r.sgmjournals.org	0	0		
956	chr16	48677031	48677189	3500137193	40		48677031	48677189	8421504	2	20,20	0,138	c	350013719300000017,350013719300000016	0-20,0-20						Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system	biomedcentral.com	0	0		
956	chr16	48677161	48677277	3500443994	68		48677161	48677277	8421504	3	23,25,20	0,55,96	c	350044399400000001,350044399400000002,350044399400000000	0-23,0-25,0-20						 SpringerImages - Oligonucleotide primers and probes used for real-time RT-PCR analysis 	pringerimages.com	0	0		
956	chr16	48677161	48677277	3500030650	68		48677161	48677277	8421504	3	23,25,20	0,55,96	c	350003065000000001,350003065000000002,350003065000000000	0-23,0-25,0-20						Relationship between quantity of IFNT estimated by IFN-stimulated gene expression in peripheral blood mononuclear cells and bovine embryonic mortality after AI or ET	www.rbej.com	0	0		
956	chr16	48728106	48728129	3500466559	23		48728106	48728129	8421504	1	23	0	c	350046655900000051	11-34						ROLE OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS NON-STRUCTURAL PROTEIN 1 IN VIRAL REPLICATION AND PATHOGENESIS	alcommons.unl.edu	0	0		
956	chr16	48739386	48739414	3500201864	23		48739386	48739414	8421504	2	7,16	0,12	c	350020186400000729	12-35						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
959	chr16	49065045	49065643	3500122523	23		49065045	49065643	8421504	4	7,4,2,10	0,8,13,588	c	350012252300000049	13-38						POLYNUCLEOTIDES ENCODING NOVEL PCSK9 VARIANTS - Patent application	www.faqs.org	0	0		
959	chr16	49084399	49084422	3500327539	23		49084399	49084422	8421504	1	23	0	g	350032753900000241,350032753900000410	5-26,0-23						Albumin-Fused Kunitz Domain Peptides - Patent application	www.faqs.org	0	0		
960	chr16	49164933	49164956	3500338659	23		49164933	49164956	8421504	1	23	0	g	350033865900000004	9-32						Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction	biomedcentral.com	0	0		
960	chr16	49225798	49231166	3500441253	40		49225798	49231166	8421504	2	20,20	0,5348	c,g	350044125300000002,350044125300000002,350044125300000003,350044125300000003	0-20,0-20,0-20,0-20						1. INTRODU&#xc7;&#xc3;O	www.ufpel.tche.br	0	0		
960	chr16	49251443	49252659	3500339425	60		49251443	49252659	8421504	2	36,24	0,1192	p	350033942500015001	0-60						Western Kentucky University : BIOL 312 : Presentation	ww.coursehero.com	0	0		
961	chr16	49283863	49283886	3500110360	23		49283863	49283886	8421504	1	23	0	c	350011036000000021	3-26						List of Publications Using Genemed Synthesis Inc (GSI) Products and Custom Services (1992-June 2011); www.genemedsyn	io-protech.com.tw	0	0		
973	chr16	50938584	50938611	3500245482	27		50938584	50938611	8421504	1	27	0	g	350024548200000264	21-48						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
976	chr16	51272178	51272208	3500430382	26		51272178	51272208	8421504	3	4,7,15	0,5,15	g	350043038200000061	3-37						US Patent # 6,673,917. Antisense IAP nucleic acids and uses thereof - Patents.com	www.patents.com	0	0		
976	chr16	51342029	51342053	3500184467	24		51342029	51342053	8421504	1	24	0	c	350018446700000000	18-42		15150322	10.1242/jcs.01138	0021-9533	Journal of Cell Science	Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C	Persaud	2004	6		
122	chr16	51903226	51912144	3500326092	672		51903226	51912144	8421504	6	95,35,122,147,147,126	0,4229,4265,6241,7351,8792	p	350032609200015012,350032609200015011,350032609200015015,350032609200015014,350032609200015020,350032609200015021,350032609200015029,350032609200015031,350032609200015030,350032609200015039,350032609200015038,350032609200015040	0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-132,0-132,0-132						cDNA cloning, characterization, and expression analysis of channel cat&#xfb01;sh (Ictalurus punctatus Ra&#xfb01;nesque, 1818) Peroxiredoxin 6 gene	ddr.nal.usda.gov	0	0		
122	chr16	51903286	51909555	3500422958	42		51903286	51909555	8421504	2	20,22	0,6247	c	350042295800000031,350042295800000032	0-20,0-22						Supplementation of a grape seed and grape marc meal extract decreases activities of the oxidative stress-responsive transcription factors NF-?B and Nrf2 in the duodenal mucosa of pigs	.actavetscand.com	0	0		
122	chr16	51903286	51909555	3500355847	42		51903286	51909555	8421504	2	20,22	0,6247	c	350035584700000078,350035584700000079	0-20,0-22						Untersuchungen zu genomweiten Ver&#xe4;nderungen der Genexpression in der Leber von Sauen w&#xe4;hrend der Laktation	eb.uni-giessen.de	0	0		
122	chr16	51903286	51909555	3500090824	42		51903286	51909555	8421504	2	20,22	0,6247	c	350009082400000031,350009082400000032	0-20,0-22						Supplementation of a grape seed and grape marc meal extract decreases activities of the oxidative stress-responsive transcription factors NF-?B and Nrf2 in the duodenal mucosa of pigs	eb.uni-giessen.de	0	0		
122	chr16	51903319	51907476	3500245634	23		51903319	51907476	8421504	2	2,21	0,4136	c	350024563400000013	4-27						Identi&#xfb01;cation of the amino acid sequence that targets peroxiredoxin 6 to lysosome-like structures of lung epithelial cells	ng.physiology.org	0	0		
980	chr16	51903797	51903821	3500216412	23		51903797	51903821	8421504	2	7,16	0,8	g	350021641200000001	1-24		16923958	10.1128/MCB.00722-06	0270-7306	Molecular and Cellular Biology	Life with a Single Isoform of Akt: Mice Lacking Akt2 and Akt3 Are Viable but Display Impaired Glucose Homeostasis and Growth Deficiencies	Dummler	2006	6		
981	chr16	51909593	51912062	3500352313	41		51909593	51912062	8421504	2	21,20	0,2449	c	350035231300000006,350035231300000007	0-21,0-20		20410161	10.1677/ERC-09-0269	1351-0088	Endocrine-Related Cancer	Suppression of MG132-mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells	Du	2010	4		PRDX6
981	chr16	51910713	51912283	3500465087	41		51910713	51912283	8421504	3	11,9,21	0,1305,1549	c	350046508700000009,350046508700000008	0-20,0-21						REPRODUCTION	uction-online.org	0	0		
981	chr16	51912099	51912144	3500414438	45		51912099	51912144	8421504	1	45	0	p	350041443800015000	3-48						Peroxiredoxin Is a Potent Cytoprotective Enzyme in the Epidermis 2006&#x5e74;&#x7b2c;168&#x5377;&#x7b2c;10&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		PRDX6
993	chr16	53529372	53529406	3500225410	28		53529372	53529406	8421504	3	5,9,14	0,8,20	g	350022541000000203	4-33						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	osdir.com/patents	0	0		
994	chr16	53625816	53625847	3500021509	25		53625816	53625847	8421504	3	6,5,14	0,10,17	g	350002150900000044	11-36		12968022	10.1074/jbc.M308297200	0021-9258	Journal of Biological Chemistry	Biochemical Diversity among the 1-Amino-cyclopropane-1-Carboxylate Synthase Isozymes Encoded by the Arabidopsis Gene Family	Yamagami	2003	5		
994	chr16	53697969	53703994	3500295516	192		53697969	53703994	8421504	4	48,17,79,48	0,2793,3041,5977	c	350029551600000033,350029551600000038,350029551600000039,350029551600000043	0-48,0-48,0-48,0-48						NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
994	chr16	53697972	53698017	3500366927	45		53697972	53698017	8421504	1	45	0	c	350036692700000036	0-45						US Patent # 7,504,253. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof - Patents.com	www.patents.com	0	0		
994	chr16	53700762	53703994	3500347497	185		53700762	53703994	8421504	4	17,100,20,48	0,248,1608,3184	c	350034749700000038,350034749700000039,350034749700000040,350034749700000043	0-48,0-48,0-41,0-48						Nucleic Acid Encoding Proteins Involved In Protein Degradation, Products And Methods Related Thereto 	.freshpatents.com	0	0		
994	chr16	53702454	53703958	3500284578	51		53702454	53703958	8421504	2	14,37	0,1467	p	350028457800015002	0-51						ScienceDirect.com - Molecular Cell - Siah-1, SIP, and Ebi Collaborate in a Novel Pathway for &#x03b2;-Catenin Degradation Linked to p53 Responses	sciencedirect.com	0	0		CACYBP
994	chr16	53717893	53730071	3500398747	40		53717893	53730071	8421504	2	20,20	0,12158	c,g	350039874700000011,350039874700000011,350039874700000010,350039874700000010	0-20,0-20,0-20,0-20						Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and &#xc1;-adducin	-publications.com	0	0		
996	chr16	53898345	53898372	3500298532	23		53898345	53898372	8421504	2	15,8	0,19	g	350029853200000173	3-27						 Biocatalyst Inhibitors 	www.docstoc.com	0	0		
996	chr16	53968573	53968596	3500121372	23		53968573	53968596	8421504	1	23	0	g	350012137200000006	10-33						cDNA Microarray Analysis of Host-Pathogen Interactions in a Porcine In Vitro Model for Toxoplasma gondii Infection&#x2020;	iai.asm.org	0	0		
1002	chr16	54687340	54687363	3500303614	23		54687340	54687363	8421504	1	23	0	c	350030361400000005	0-26						NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation	www.vitrocom.com	0	0		
1002	chr16	54687340	54687363	3500175421	23		54687340	54687363	8421504	1	23	0	c	350017542100000007	0-26						Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics. - ResearchGate	.researchgate.net	0	0		
125	chr16	54716897	54829458	3500422541	81		54716897	54829458	8421504	5	21,9,10,21,20	0,57908,74266,112487,112541	c	350042254100000528,350042254100000024,350042254100000016,350042254100000338,350042254100000339,350042254100000509,350042254100000012	0-21,19-38,19-38,0-19,0-19,0-21,18-38						COMPOSITIONS AND METHODS FOR SILENCING GENES EXPRESSED IN CANCER - Patent application	www.faqs.org	0	0		
1008	chr16	55491070	55491097	3500308220	23		55491070	55491097	8421504	2	12,11	0,16	g	350030822000000005	0-23		10851000	10.1128/JB.182.13.3826-3831.2000	0021-9193	Journal of Bacteriology	Secretion of Nucleoside Diphosphate Kinase by Mucoid Pseudomonas aeruginosa 8821: Involvement of a Carboxy-Terminal Motif in Secretion	Kamath	2000	4		
1018	chr16	56879977	56880217	3500006591	180		56879977	56880217	8421504	4	45,45,45,45	0,48,147,195	p	350000659100015031,350000659100015039,350000659100015034,350000659100015035	0-45,0-45,0-45,0-45						Composition and method for the prevention and treatment of oxidative damage in ocular tissues	Lou	1998	0		
1025	chr16	57682848	57707039	3500085793	2551		57682848	57707039	8421504	6	50,898,271,194,846,292	0,51,2281,3689,18016,23899	p,c,g	350008579300000020,350008579300000019,350008579300000019,350008579300015019,350008579300000018,350008579300000018,350008579300000017,350008579300000017,350008579300015017,350008579300000016,350008579300000016,350008579300015016,350008579300000015,350008579300000015,350008579300015015,350008579300000014,350008579300000014,350008579300015014,350008579300000013,350008579300015013,350008579300000012,350008579300000012,350008579300015012,350008579300000011,350008579300015011,350008579300000010,350008579300000010,350008579300015010,350008579300015009,350008579300000009,350008579300000009,350008579300015008,350008579300000008,350008579300000008,350008579300015007,350008579300000007,350008579300000007,350008579300015006,350008579300000006,350008579300000006,350008579300000005,350008579300000005,350008579300015004,350008579300000004,350008579300000004,350008579300015003,350008579300000003,350008579300000003,350008579300000002,350008579300000002,350008579300000001,350008579300000001,350008579300015001,350008579300015000,350008579300000000,350008579300000000	0-751,0-75,0-75,0-63,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-76,0-76,0-75,0-63,0-375,0-375						&#x725b;ANGPTL1&#x57fa;&#x56e0;&#x7684;&#x7535;&#x5b50;&#x514b;&#x9686;&#x4e0e;&#x5e8f;&#x5217;&#x5206;&#x6790;	ww.starlunwen.com	0	0		
1026	chr16	57923640	57932758	3500381850	63		57923640	57932758	8421504	3	15,2,46	0,8124,9072	p	350038185000015004	0-63						Bcr-abl truncation mutations	Albitar	2011	0		
1026	chr16	57923663	57923686	3500155028	23		57923663	57923686	8421504	1	23	0	c	350015502800000062	7-30						Stereoselective reduction process for the preparation of pyrrolotriazine compounds	Patel	2006	0		
128	chr16	57929465	57937524	3500461145	315		57929465	57937524	8421504	10	45,26,19,5,40,42,3,45,45,45	0,48,1373,2296,3247,3290,4407,4461,4605,8014	p	350046114500015037,350046114500015036,350046114500015028,350046114500015027,350046114500015025,350046114500015022,350046114500015017	0-45,0-45,0-45,0-45,0-45,0-45,0-45						PYRROLO-PYRIDINE KINASE MODULATIORS - Patent application	www.faqs.org	0	0		ABL2
128	chr16	57929465	57937524	3500079349	315		57929465	57937524	8421504	10	45,26,19,5,40,42,3,45,45,45	0,48,1373,2296,3247,3290,4407,4461,4605,8014	p	350007934900015037,350007934900015036,350007934900015028,350007934900015027,350007934900015025,350007934900015022,350007934900015017	0-45,0-45,0-45,0-45,0-45,0-45,0-45						PYRROLO-PYRIDINE KINASE MODULATORS - Patent application	www.faqs.org	0	0		ABL2
128	chr16	57929465	57937524	3500000337	315		57929465	57937524	8421504	10	45,26,19,5,40,42,3,45,45,45	0,48,1373,2296,3247,3290,4407,4461,4605,8014	p	350000033700015031,350000033700015030,350000033700015022,350000033700015021,350000033700015019,350000033700015016,350000033700015011	0-45,0-45,0-45,0-45,0-45,0-45,0-45						Mutations in the BCR-ABL tyrosine kinase associated with resistance to ST1-571 - Patent application	www.faqs.org	0	0		ABL2
1026	chr16	57931022	57932764	3500182245	96		57931022	57932764	8421504	3	1,47,48	0,566,1694	p	350018224500015016,350018224500015014	0-96,0-48						University of Geneva Master&#x2019;s in Proteomics and Bioinformatics 2009	www.mpb.unige.ch	0	0		ABL2
1028	chr16	58133037	58161361	3500306305	40		58133037	58161361	8421504	4	13,7,14,6	0,17755,27062,28318	c	350030630500000027,350030630500000028	0-20,0-20						METHODS FOR THE DIAGNOSIS OF PROLIFERATIVE AND/OR CONFORMATIONAL DISEASES - Patent application	www.faqs.org	0	0		
1028	chr16	58154592	58156487	3500375699	254		58154592	58156487	8421504	3	13,186,55	0,14,1840	c,g	350037569900000023,350037569900000023	0-255,0-255						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1029	chr16	58263617	58263647	3500454351	30		58263617	58263647	8421504	1	30	0	c	350045435100000003	15-45		23648087	10.1186/1471-2369-14-102	1471-2369	BMC Nephrology	Characterization of a short isoform of the kidney protein podocin in human kidney	VAPlker	2013	2		
1029	chr16	58263620	58263671	3500449618	51		58263620	58263671	8421504	1	51	0	p	350044961800015003	0-51						A Conditionally Immortalized Human Podocyte Cell Line Demonstrating Nephrin and Podocin Expression	n.asnjournals.org	0	0		NPHS2
1029	chr16	58266701	58266724	3500175809	23		58266701	58266724	8421504	1	23	0	c	350017580900000002	0-23						1 Conditionally immortalized human	al.physiology.org	0	0		
1031	chr16	58471355	58471385	3500331149	24		58471355	58471385	8421504	3	4,14,6	0,5,24	g	350033114900000006	4-28						Steroid derivatives	Liao	2004	0		
1031	chr16	58471355	58471385	3500098147	24		58471355	58471385	8421504	3	4,14,6	0,5,24	g	350009814700000006	4-28						Steroid derivatives	Fukuchi	2006	0		
1032	chr16	58618950	58618974	3500245265	23		58618950	58618974	8421504	2	19,4	0,20	g	350024526500000075	8-31						US Patent # 5,466,596. Tissue specific transcriptional regulatory element - Patents.com	www.patents.com	0	0		
1033	chr16	58766639	58766667	3500145861	23		58766639	58766667	8421504	2	8,15	0,13	g	350014586100000037	7-38						PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME FROM THERMOSIPHO AFRICANUS - Cetus	www.sumobrain.com	0	0		
129	chr16	58841136	58863849	3500279273	67		58841136	58863849	8421504	4	24,17,7,19	0,18284,22686,22694	c	350027927300000004,350027927300000014	0-24,5-48						Placental-derived prostate growth factors	Farrell	1998	0		
1037	chr16	59347691	59347715	3500121878	23		59347691	59347715	8421504	2	8,15	0,9	g	350012187800000184	13-36						Plant fatty acid synthases	www.devileye.net	0	0		
1039	chr16	59562522	59562549	3500166654	23		59562522	59562549	8421504	2	17,6	0,21	c	350016665400000012	0-23						 GC Tag 	www.docstoc.com	0	0		
1039	chr16	59564009	59573690	3500288318	40		59564009	59573690	8421504	3	20,1,19	0,4083,9662	c	350028831800000007,350028831800000006	9-30,5-24		14993220	10.1074/jbc.M400798200	0021-9258	Journal of Biological Chemistry	Identification of SNAREs Involved in Synaptotagmin VII-regulated Lysosomal Exocytosis	Rao	2004	5		
1039	chr16	59564021	59609374	3500220246	54		59564021	59609374	8421504	3	8,16,30	0,4071,45323	c	350022024600000013,350022024600000005,350022024600000004,350022024600000012	12-31,10-34,4-31,10-35		9880331	10.1091/mbc.10.1.119	1059-1524	Molecular Biology of the Cell	GS32, a Novel Golgi SNARE of 32 kDa, Interacts Preferentially with Syntaxin 6	Wong	1999	5		
1043	chr16	60046007	60046031	3500173250	23		60046007	60046031	8421504	2	17,6	0,18	g	350017325000000079	0-26						Engineered Listeria and methods of use thereof	Dubensky	2006	0		
1043	chr16	60063166	60063190	3500340026	23		60063166	60063190	8421504	2	16,7	0,17	g	350034002600000116,350034002600000145,350034002600000174	4-27,19-42,28-48						Flea serine protease inhibitor proteins	Silver	1996	0		
1048	chr16	60708526	60708551	3500434648	24		60708526	60708551	8421504	2	5,19	0,6	g	350043464800000002	1-25			10.1111/j.1471-4159.2004.02486.x	1471-4159	Journal of Neurochemistry	CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70 - Urushitani - 2004 - Journal of Neurochemistry - Wiley Online Library	Urushitani	2004	0		
1049	chr16	60859882	60861609	3500353503	199		60859882	60861609	8421504	6	41,30,32,22,25,49	0,776,815,1152,1578,1678	c,g	350035350300000012,350035350300000008,350035350300000006,350035350300000004	0-41,3-72,0-47,26-75						The cloning and nucleotide sequence of cDNA for an amplified glutamine synthetase gene from the Chinese hamster. - ResearchGate	.researchgate.net	0	0		
1049	chr16	60860541	60860583	3500117313	41		60860541	60860583	8421504	2	21,20	0,22	c,g	350011731300000008,350011731300000006	0-21,1-21		15784656	10.1124/jpet.104.081257	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes	Jacobson	2005	0		
1049	chr16	60861553	60865978	3500134859	40		60861553	60865978	8421504	2	20,20	0,4405	c,g	350013485900000029,350013485900000029,350013485900000028,350013485900000028	0-20,0-20,0-20,0-20						Human Hepatic Stem Cell, Method for Preparation of the Same, Method for Induction of Differentiation of the Same, and Method for Utilization of the Same - Patent application	www.faqs.org	0	0		GLUL
1050	chr16	61038656	61040224	3500433790	86		61038656	61040224	8421504	2	38,48	0,1520	c	350043379000000012,350043379000000007	0-38,0-48						Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression - Patent # 6020155 - PatentGenius	.patentgenius.com	0	0		
1050	chr16	61040176	61040224	3500187127	48		61040176	61040224	8421504	1	48	0	c	350018712700000006	0-48						Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof	Smith	1995	0		
1050	chr16	61040209	61040550	3500360719	48		61040209	61040550	8421504	2	38,10	0,331	c	350036071900000028	0-48						Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders	Levinson	1997	0		
1051	chr16	61133875	61133900	3500258554	23		61133875	61133900	8421504	3	4,14,5	0,5,20	g	350025855400000398	18-41						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
1052	chr16	61302670	61305083	3500277338	51		61302670	61305083	8421504	2	44,7	0,2406	p	350027733800015003	0-51						pUNO1-hDHX9a	www.invivogen.com	0	0		
1053	chr16	61459027	61459053	3500400238	23		61459027	61459053	8421504	2	8,15	0,11	g	350040023800000271	3-26						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1054	chr16	61527201	61528166	3500349090	24		61527201	61528166	8421504	3	8,3,13	0,948,952	c	350034909000000020	0-24						DNA for expression of bovine growth hormone	Boer	1993	0		
1055	chr16	61663029	61670551	3500238590	50		61663029	61670551	8421504	2	25,25	0,7497	c	350023859000000022,350023859000000020	0-25,0-25						Modified laminin and use thereof	Nakagawa	2012	0		LAMC1
1055	chr16	61680101	61680124	3500352307	23		61680101	61680124	8421504	1	23	0	c	350035230700000036	19-43						Method Of Reverse Transcription 	.freshpatents.com	0	0		
1055	chr16	61715585	61715608	3500219702	23		61715585	61715608	8421504	1	23	0	g	350021970200000007	6-29					Patent	Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid (Patent US:6448070)	Koprowski	2002	0		
1058	chr16	62057509	62070393	3500360395	180		62057509	62070393	8421504	4	38,70,58,14	0,1750,11632,12870	p	350036039500015002,350036039500015010	0-108,0-72						Tel1ATM and Rad3ATR kinases promote Ccq1-Est1 interaction to maintain telomeres in fission yeast	www.uic.edu	0	0		SMG7
1058	chr16	62076479	62093472	3500016286	97		62076479	62093472	8421504	5	1,29,21,19,27	0,348,10022,10067,16966	c	350001628600000026,350001628600000020,350001628600000021,350001628600000027	12-42,0-21,0-19,12-39						Cancer associated antigens, sga-56m and sga-56mv, and uses thereof	Petroziello	2003	0		SMG7
1058	chr16	62091614	62092294	3500124495	23		62091614	62092294	8421504	4	11,4,4,4	0,12,17,676	c	350012449500000007	12-40						The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. - ResearchGate	.researchgate.net	0	0		
1058	chr16	62099757	62099787	3500287953	25		62099757	62099787	8421504	3	6,8,11	0,9,19	c	350028795300000839	22-48						Method For Increasing Pathogen Resistance In Transgenic Plants - Patent application	www.faqs.org	0	0		
1058	chr16	62103879	62103905	3500464376	26		62103879	62103905	8421504	1	26	0	c	350046437600000003	0-26		16373635	10.1161/01.STR.0000199033.06678.c3	0039-2499	Stroke	Role of NAD(P)H Oxidase in Alcohol-Induced Impairment of Endothelial Nitric Oxide Synthase&#x2013;Dependent Dilation of Cerebral Arterioles	Sun	2006	6		NCF2
1058	chr16	62113235	62118697	3500303532	24		62113235	62118697	8421504	2	8,16	0,5446	c	350030353200000065	0-24						DEPARTAMENT DE GENATICA ESTUDIO DE FACTORES GENATICOS DE LOS SISTEMAS RELACIONADOS CON ESTRAS OX	www.tdx.cat	0	0		
1060	chr16	62292028	62292061	3500212475	30		62292028	62292061	8421504	3	5,8,17	0,7,16	g	350021247500000019,350021247500000075	5-35,0-23						CELLS AND METHODOLOGY TO GENERATE NON-SEGMENTED NEGATIVE-STRAND RNA VIRUSES - Patent application	www.faqs.org	0	0		
1060	chr16	62306244	62357075	3500320193	37		62306244	62357075	8421504	2	1,36	0,50795	c	350032019300000001	11-48						RAS P21-interacting protein (RGL) and its RAS interacting domain (RID) - Patent # 5955354 - PatentGenius	.patentgenius.com	0	0		RGL1
1061	chr16	62475520	62475549	3500320193	29		62475520	62475549	8421504	1	29	0	c	350032019300000041	0-29						RAS P21-interacting protein (RGL) and its RAS interacting domain (RID) - Patent # 5955354 - PatentGenius	.patentgenius.com	0	0		
1062	chr16	62540597	62540624	3500175071	25		62540597	62540624	8421504	2	16,9	0,18	g	350017507100000029	5-30					Patent	Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same (Patent US:6132713)	Fiipula	2000	0		
1063	chr16	62669231	62669792	3500227970	27		62669231	62669792	8421504	2	6,21	0,540	c	350022797000000008	9-36						RNA processing protein complexes and uses thereof	Trotta	2008	0		
1064	chr16	62859002	62859027	3500198230	23		62859002	62859027	8421504	2	7,16	0,9	g	350019823000000002,350019823000000001	4-27,1-24		12902269	10.1128/AEM.69.8.4760-4769.2003	0099-2240	Applied and Environmental Microbiology	Characterization of Streptococcus mutans Strains Deficient in EIIABMan of the Sugar Phosphotransferase System	Abranches	2003	4		
1066	chr16	63111809	63111837	3500461946	23		63111809	63111837	8421504	3	12,7,4	0,16,24	g	350046194600000007	0-26						TRANSGENIC COVER PLANTS CONTAINING HEMICELLULASE AND CELLULASE WHICH DEGRADE LIGNIN AND CELLULOSE TO FERMENTABLE SUGARS - Patent application	www.faqs.org	0	0		
1066	chr16	63111809	63111837	3500306430	23		63111809	63111837	8421504	3	12,7,4	0,16,24	g	350030643000000007	0-26						Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars - Patent application	www.faqs.org	0	0		
1066	chr16	63111809	63111837	3500202468	23		63111809	63111837	8421504	3	12,7,4	0,16,24	g	350020246800000015	0-26						Production Of Beta-glucosidase, Hemicellulase And Ligninase In E1 And Flc-cellulase-transgenic Plants 	.freshpatents.com	0	0		
1066	chr16	63111809	63111837	3500189676	23		63111809	63111837	8421504	3	12,7,4	0,16,24	g	350018967600000007	0-26						 Transgenic Plants Containing Ligninase And Cellulase Which Degrade Lignin And Cellulose To Fermentab 	www.docstoc.com	0	0		
1068	chr16	63403980	63404004	3500408713	23		63403980	63404004	8421504	2	11,12	0,12	g	350040871300000001	8-34						Expression of oxytocin, oestrogen and progesterone receptors in uterine biopsy samples throughout the oestrous cycle and early pregnancy in cows	uction-online.org	0	0		
1071	chr16	63707613	63707707	3500199770	39		63707613	63707707	8421504	2	19,20	0,74	g	350019977000000027,350019977000000008	0-19,20-40						NUOVO PROTOCOLLO BASATO SULL&#x2019;ANALISI DEGLI SNPs APPLICATO ALLA TRACCIABILIT&#xc0; DELLA CARNE BOVINA	www.anabic.it	0	0		
1071	chr16	63749984	63750010	3500208271	24		63749984	63750010	8421504	2	15,9	0,17	g	350020827100000001	0-29						Development of Multiplex PCR for Simultaneous Detection of Six Non-O157 Shiga-toxin Producing Escherichia coli (STEC) Strains	arkafp.org/images	0	0		
1071	chr16	63824837	63824863	3500159288	24		63824837	63824863	8421504	2	6,18	0,8	g	350015928800000044	1-26						SOLUBLE SINGLE-CHAIN T-CELL RECEPTOR PROTEINS	Weidanz	1998	0		
1072	chr16	63894696	63896137	3500152337	43		63894696	63896137	8421504	3	2,20,21	0,1374,1420	c,g	350015233700000012,350015233700000011,350015233700000011	0-22,4-25,4-25		23825951	10.1371/journal.ppat.1003460	1553-7374	PLOS Pathogens	PLOS Pathogens: Cellular RNA Binding Proteins NS1-BP and hnRNP K Regulate Influenza A Virus RNA Splicing	Tsai	2013	0		IVNS1ABP
134	chr16	64725991	64834678	3500058966	148		64725991	64834678	8421504	4	47,32,21,48	0,83485,108615,108639	c	350005896600000366,350005896600000487,350005896600000168,350005896600000668,350005896600000514	0-47,16-48,0-21,0-21,0-48						Application # 2006/0127915. Gene mutation associated with age-related macular degeneration - Patents.com	patents.com	0	0		
1080	chr16	65007695	65007719	3500183631	24		65007695	65007719	8421504	1	24	0	c	350018363100000036	0-24						Use of histone chaperone activity of agrobacterium 6b protein - Patent application	www.faqs.org	0	0		
1080	chr16	65011551	65011575	3500370516	24		65011551	65011575	8421504	1	24	0	c	350037051600000085,350037051600000013	0-24,0-23						INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLYCYL-TRNA SYNTHETASES - Patent application	www.faqs.org	0	0		
1081	chr16	65013610	65014112	3500282907	73		65013610	65014112	8421504	3	35,14,24	0,461,478	c	350028290700000033,350028290700000053,350028290700000035,350028290700000034	0-23,0-26,0-25,0-24						ABSTRACT Title of Document: ENGINEERING ZONAL CARTILAGE THROUGH UTILIZATION OF A MESENCHYMAL STEM CELL POPULATION Articular	drum.lib.umd.edu	0	0		
1081	chr16	65014784	65015677	3500451176	43		65014784	65015677	8421504	2	21,22	0,871	c,g	350045117600000000,350045117600000001,350045117600000001	0-21,0-22,0-22		16469119	10.1186/ar1898	1478-6354	Arthritis Research & Therapy	Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis	Young	2006	4		
1083	chr16	65373954	65374174	3500031998	39		65373954	65374174	8421504	2	19,20	0,200	c,g	350003199800000022,350003199800000021,350003199800000021	0-19,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
1083	chr16	65374709	65374766	3500458666	57		65374709	65374766	8421504	1	57	0	p	350045866600015019	0-57						DELIVERY SYSTEM AND CONJUGATES FOR COMPOUND DELIVERY VIA NATURALLY OCCURRING INTRACELLULAR TRANSPORT ROUTES - CENIX BIOSCIENCE GMBH	www.sumobrain.com	0	0		
1083	chr16	65374709	65374766	3500235911	57		65374709	65374766	8421504	1	57	0	p	350023591100015012	0-57						Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes	Echeverri	2012	0		
1083	chr16	65374709	65374766	3500132878	57		65374709	65374766	8421504	1	57	0	p	350013287800015012	0-57						Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes	Echeverri	2011	0		
1083	chr16	65374709	65374766	3500085619	57		65374709	65374766	8421504	1	57	0	p	350008561900015015	0-57						Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes	Echeverri	2012	0		
1083	chr16	65374720	65374744	3500437714	24		65374720	65374744	8421504	1	24	0	c	350043771400000003	0-24						Accumulation of Cyclooxygenase-2 Gene Transcripts: MATERIALS AND METHODS(3) | Level of Health - Medical Blog	levelofhealth.com	0	0		PTGS2
1083	chr16	65374720	65374744	3500213083	24		65374720	65374744	8421504	1	24	0	c	350021308300000003	0-24		9916000	10.1095/biolreprod60.2.341	0006-3363	Biology of Reproduction	Accumulation of Cyclooxygenase-2 Gene Transcripts in Uterine Tissues of Pregnant and Parturient Cows: Stimulation by Oxytocin	Fuchs	1999	4		PTGS2
1083	chr16	65374742	65374910	3500008335	48		65374742	65374910	8421504	2	24,24	0,144	c,g	350000833500000015,350000833500000014	0-24,0-24						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
1083	chr16	65374945	65376599	3500321811	45		65374945	65376599	8421504	2	22,23	0,1631	c	350032181100000065,350032181100000064	0-22,0-23						PHARMACEUTICAL COMPOSITION INCLUDING AN HIF-2 ALPHA INHIBITOR AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ARTHRITIS	Chun	2010	0		PTGS2
1083	chr16	65374945	65376599	3500078241	46		65374945	65376599	8421504	2	22,24	0,1630	c	350007824100000003,350007824100000002	0-22,0-24						Protection by Quercetin Against Cooking Oil Fumes-Induced DNA Damage in Human Lung Adenocarcinoma CL-3 Cells: Role of COX-2	embers.linode.com	0	0		PTGS2
1083	chr16	65374945	65376599	3500024281	46		65374945	65376599	8421504	2	22,24	0,1630	c	350002428100000011,350002428100000010	0-22,0-24		16338931	10.1074/jbc.M506846200	0021-9258	Journal of Biological Chemistry	Targeting Prostaglandin E2 Receptors as an Alternative Strategy to Block Cyclooxygenase-2-dependent Extracellular Matrix-induced Matrix Metalloproteinase-9 Expression by Macrophages	Pavlovic	2006	5		PTGS2
1083	chr16	65375076	65376099	3500397756	44		65375076	65376099	8421504	2	22,22	0,1001	c	350039775600000003,350039775600000002	0-22,0-22						Epidermal Growth Factor Family Members: Endogenous Mediators of the Ovulatory Response--&#x300a;&#x5185;&#x5206;&#x6ccc;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
1083	chr16	65375076	65375934	3500439461	46		65375076	65375934	8421504	2	20,26	0,832	c	350043946100000040,350043946100000036	0-20,0-26						Method of inhibiting prostaglandin synthesis in a human host	Young	1995	0		
1083	chr16	65375076	65375934	3500412505	46		65375076	65375934	8421504	2	20,26	0,832	c	350041250500000039,350041250500000035	0-20,0-26						US Patent # 5,837,479. Screening assays for inhibitors of mammalian prostaglandin H synthase-2 - Patents.com	www.patents.com	0	0		
1083	chr16	65375076	65375934	3500380718	46		65375076	65375934	8421504	2	20,26	0,832	c	350038071800000040,350038071800000036	0-20,0-26						Mammalian prostaglandin h synthase-2	O'Banion	1996	0		
1083	chr16	65375076	65375934	3500166775	46		65375076	65375934	8421504	2	20,26	0,832	c	350016677500000040,350016677500000036	0-20,0-26						US Patent # 6,048,850. Method of inhibiting prostaglandin synthesis in a human host - Patents.com	www.patents.com	0	0		
1083	chr16	65375908	65375934	3500258533	26		65375908	65375934	8421504	1	26	0	c	350025853300000036	0-26					Patent	Method of inhibiting prostaglandin synthesis in a human host (Patent US:6048850)	O'Banion	2000	0		
1083	chr16	65376005	65376504	3500047878	40		65376005	65376504	8421504	2	20,20	0,479	c,g	350004787800000039,350004787800000039,350004787800000038	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1083	chr16	65376469	65376656	3500181711	42		65376469	65376656	8421504	2	21,21	0,166	c,g	350018171100000027,350018171100000026,350018171100000026	0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
1083	chr16	65376469	65376656	3500133737	42		65376469	65376656	8421504	2	21,21	0,166	c,g	350013373700000014,350013373700000013,350013373700000013	0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
1083	chr16	65376578	65376601	3500387059	23		65376578	65376601	8421504	1	23	0	c,g	350038705900000007,350038705900000007	0-23,0-23		18523303		0022-1767	The Journal of Immunology	Defective Generation of a Humoral Immune Response Is Associated with a Reduced Incidence and Severity of Collagen-Induced Arthritis in Microsomal Prostaglandin E Synthase-1 Null Mice	Kojima	2008	6		PTGS2
1083	chr16	65376582	65377591	3500254868	44		65376582	65377591	8421504	2	23,21	0,988	c,g	350025486800000003,350025486800000003,350025486800000002	0-23,0-23,0-21						Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammationassociated mouse colon carcinogenesis	.invitehealth.com	0	0		PTGS2
1083	chr16	65376583	65377590	3500454203	44		65376583	65377590	8421504	2	22,22	0,985	c,g	350045420300000003,350045420300000003,350045420300000002	0-22,0-22,0-22		12225989	10.1152/ajpcell.00609.2001		American Journal of Physiology - Cell Physiolog	Induction of cyclooxygenase-2 by heat shock protein 60 in macrophages and endothelial cells	Billack	2002	0		PTGS2
1083	chr16	65376673	65376698	3500316789	25		65376673	65376698	8421504	1	25	0	c	350031678900000001	0-25		17872375	10.1210/en.2007-0188	0013-7227	Endocrinology	Mechanism of the Divergent Effects of Estrogen on the Cell Proliferation of Human Umbilical Endothelial Versus Aortic Smooth Muscle Cells	Kawagoe	2007	4		
1083	chr16	65376676	65377637	3500397748	48		65376676	65377637	8421504	3	24,14,10	0,936,951	c	350039774800000003,350039774800000002	0-24,0-24		22194712	10.4110/in.2011.11.5.288		Immune Network	Role of Salvia miltiorrhiza for Modulation of Th2-derived Cytokines in the Resolution of Inflammation	Sunhee	2011	0		
1083	chr16	65376676	65377637	3500318562	49		65376676	65377637	8421504	2	24,25	0,936	c	350031856200000003,350031856200000002	0-24,0-25		24009539	10.4110/in.2013.13.4.123		Immune Network	Metformin Down-regulates TNF-&#x03b1; Secretion via Suppression of Scavenger Receptors in Macrophages	Bobae	2013	0		PTGS2
1083	chr16	65377518	65378348	3500145630	48		65377518	65378348	8421504	3	24,10,14	0,158,816	c,g	350014563000000001,350014563000000001,350014563000000000	0-24,0-24,0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1083	chr16	65377532	65377556	3500155690	24		65377532	65377556	8421504	1	24	0	c	350015569000000028	23-47						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		
1083	chr16	65377558	65377621	3500070615	60		65377558	65377621	8421504	2	45,15	0,48	p	350007061500015103	0-60						Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway - US Patent 7829535 Description	ww.patentstorm.us	0	0		
1083	chr16	65377573	65379498	3500338942	43		65377573	65379498	8421504	2	21,22	0,1903	c,g	350033894200000001,350033894200000000,350033894200000000	0-21,0-22,0-22		16971557	10.1095/biolreprod.106.054049	0006-3363	Biology of Reproduction	The Expression of Prostaglandin Endoperoxide Synthase 2 Messenger RNA and the Proportion of Smooth Muscle and Collagen in the Sheep Cervix During the Estrous Cycle	Kershaw	2007	4		PTGS2
1083	chr16	65377573	65379498	3500332885	42		65377573	65379498	8421504	2	20,22	0,1903	c	350033288500000003,350033288500000002	0-20,0-22		11058524	10.1095/biolreprod63.5.1229	0006-3363	Biology of Reproduction	Prostaglandin Metabolism in the Ovine Corpus Luteum: Catabolism of Prostaglandin F2&#x03b1; (PGF2&#x03b1;) Coincides with Resistance of the Corpus Luteum to PGF2&#x03b1;	Silva	2000	4		PTGS2
1083	chr16	65377573	65379498	3500225337	42		65377573	65379498	8421504	2	20,22	0,1903	c	350022533700000003,350022533700000002	0-20,0-22						Prostaglandin F2,, Regulates Distinct Physiological Changes in Early and Mid-Cycle Bovine Corpora Lutea'	ww.biolreprod.org	0	0		PTGS2
1083	chr16	65377573	65379498	3500130264	42		65377573	65379498	8421504	2	20,22	0,1903	c,g	350013026400000003,350013026400000002,350013026400000002	0-20,0-22,0-22						Prostaglandin Metabolism in the Ovine Corpus Luteum: MATERIALS AND METHODS | Medical Help Online	l-help-online.com	0	0		PTGS2
1083	chr16	65377577	65380589	3500428429	40		65377577	65380589	8421504	3	20,17,3	0,1938,3009	c	350042842900000001,350042842900000000	0-20,0-20		23031211	10.1186/1472-6882-12-171	1472-6882	BMC Complementary and Alternative Medicine	Anti-inflammatory effect of ethanolic extract from Myagropsis myagroides on murine macrophages and mouse ear edema	Joung	2012	2		PTGS2
1083	chr16	65377577	65380589	3500404490	41		65377577	65380589	8421504	3	21,17,3	0,1938,3009	c,g	350040449000000001,350040449000000001,350040449000000000	0-21,0-21,0-20						Modulation of inflammation-related genes of polysaccharides fractionated from mycelia of medicinal basidiomycete Antrodia camphorata	trimaxorganic.com	0	0		PTGS2
1083	chr16	65377577	65380589	3500321034	41		65377577	65380589	8421504	3	21,17,3	0,1938,3009	c,g	350032103400000011,350032103400000010	0-21,0-20					Patent	Mitogen- und stress-aktivierte proteinkinasen, die zwei kinase dom&#xe4;nen enthalten, und deren verwendungen Uses of mitogen-and stress-activated protein kinases that contain two kinase domains, and their (Patent DE:69933460)	Alessi	2007	0		PTGS2
1083	chr16	65377577	65380589	3500257178	41		65377577	65380589	8421504	3	21,17,3	0,1938,3009	c,g	350025717800000019,350025717800000019,350025717800000018	0-21,0-21,0-20						Polypeptides, polynucleotides and uses thereof	Alessi	2001	0		PTGS2
1083	chr16	65377577	65380589	3500247142	41		65377577	65380589	8421504	3	21,17,3	0,1938,3009	c,g	350024714200000017,350024714200000017,350024714200000016	0-21,0-21,0-20					Patent	Polypeptides, polynucleotides and uses thereof (Patent US:7122360)	Alessi	2006	0		PTGS2
1083	chr16	65378360	65379276	3500464942	41		65378360	65379276	8421504	2	20,21	0,895	c	350046494200000007,350046494200000006	0-20,0-21		19657391	10.1371/journal.pone.0006535	1932-6203	PLOS ONE	PLOS ONE: Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice	Yadav	2009	4		PTGS2
1083	chr16	65378360	65379276	3500390960	41		65378360	65379276	8421504	2	20,21	0,895	c	350039096000000027,350039096000000007,350039096000000026,350039096000000006	0-20,0-20,0-21,0-21						METHODS INVOLVING ALDOSE REDUCTASE INHIBITORS - Patent application	www.faqs.org	0	0		PTGS2
1083	chr16	65378360	65379276	3500252258	41		65378360	65379276	8421504	2	20,21	0,895	c	350025225800000007,350025225800000006	0-20,0-21						Methods Involving Aldose Reductase Inhibitors	Srivastava	2013	0		PTGS2
1083	chr16	65378360	65379276	3500249642	41		65378360	65379276	8421504	2	20,21	0,895	c	350024964200000007,350024964200000006	0-20,0-21						Methods involving aldose reductase inhibitors	Srivastava	2010	0		PTGS2
1083	chr16	65378360	65379276	3500186243	40		65378360	65379276	8421504	2	20,20	0,896	c,g	350018624300000027,350018624300000026	0-20,0-20						&#xd3ec;&#xb3c4;&#xadfc; &#xc5d0;&#xd0c4;&#xc62c; &#xcd94;&#xcd9c;&#xbb3c;&#xc774; Hep G2 &#xc790;&#xc5f0;&#xc0ac;&#xc5d0; &#xbbf8;&#xce58;&#xb294; &#xd6a8;&#xacfc;	www.hantopic.com	0	0		
1083	chr16	65378360	65379276	3500175030	41		65378360	65379276	8421504	2	20,21	0,895	c,g	350017503000000007,350017503000000007,350017503000000006	0-20,0-20,0-21					Patent	Methods involving aldose reductase inhibitors (Patent US:8273746)	Srivastava	2012	0		PTGS2
1083	chr16	65378360	65379276	3500145795	41		65378360	65379276	8421504	2	20,21	0,895	c,g	350014579500000007,350014579500000007,350014579500000027,350014579500000027,350014579500000006,350014579500000026	0-20,0-20,0-20,0-20,0-21,0-21						Methods Involving Aldose Reductase Inhibitors - Patent application	www.faqs.org	0	0		PTGS2
1083	chr16	65378360	65379276	3500124266	42		65378360	65379276	8421504	2	21,21	0,895	c,g	350012426600000003,350012426600000003,350012426600000002	0-21,0-21,0-21			10.1136/gut.45.4.529	1468-3288	Gut	Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells	Hull	1999	0		
1083	chr16	65378360	65379276	3500113991	41		65378360	65379276	8421504	2	20,21	0,895	c	350011399100000007,350011399100000006	0-20,0-21						Methods Involving Aldose Reductase Inhibitors	Srivastava	2013	0		PTGS2
1083	chr16	65378360	65379276	3500043389	41		65378360	65379276	8421504	2	20,21	0,895	c	350004338900000007,350004338900000006	0-20,0-21						Methods Involving Aldose Reductase Inhibitors	Srivastava	2013	0		PTGS2
1083	chr16	65378405	65379276	3500052908	40		65378405	65379276	8421504	2	20,20	0,851	c	350005290800000007,350005290800000006	0-20,0-20		20211985	10.1210/me.2009-0293	0888-8809	Molecular Endocrinology	Cytosolic Phospholipase A2 Activation Correlates with HER2 Overexpression and Mediates Estrogen-Dependent Breast Cancer Cell Growth	Caiazza	2010	5		PTGS2
1083	chr16	65379214	65379238	3500415790	24		65379214	65379238	8421504	1	24	0	c	350041579000000001	0-24						Molecular Characterization of Canine Prostaglandin G/H Synthase-2 and Regulation in Prostatic Adenocarcinoma Cells in Vitro	.endojournals.org	0	0		
1083	chr16	65379255	65380597	3500047577	42		65379255	65380597	8421504	3	21,10,11	0,267,1331	c	350004757700000005,350004757700000004	0-21,0-21		20176726	10.1210/en.2009-0767	0013-7227	Endocrinology	Induction of Endothelin-2 Expression by Luteinizing Hormone and Hypoxia: Possible Role in Bovine Corpus Luteum Formation	Klipper	2010	4		
1083	chr16	65380705	65380899	3500126770	65		65380705	65380899	8421504	4	7,13,26,19	0,8,98,175	c,g	350012677000000001,350012677000000002,350012677000000005	0-20,0-26,0-19		11967217	10.1095/biolreprod66.5.1505	0006-3363	Biology of Reproduction	Transcriptional Regulation of the Cyclooxygenase-2 Gene Changes from Protein Kinase (PK) A- to PKC-Dependence after Luteinization of Granulosa Cells	Wu	2002	4		
1085	chr16	65585694	65585717	3500463907	23		65585694	65585717	8421504	1	23	0	c	350046390700000000,350046390700000002	10-33,14-36		22456504	10.1091/mbc.E11-10-0881	1059-1524	Molecular Biology of the Cell	cPLA2&#x03b1; and EHD1 interact and regulate the vesiculation of cholesterol-rich, GPI-anchored, protein-containing endosomes	Cai	2012	5		
1086	chr16	65712228	65727205	3500243294	39		65712228	65727205	8421504	2	20,19	0,14958	c,g	350024329400000006,350024329400000006,350024329400000007	0-20,0-20,0-19						Endothelial cell-pericyte cocultures induce PLA protein expression through activation of PKCa and the MAPK/ERK cascade	www.jlr.org	0	0		
1089	chr16	66108192	66123835	3500192418	117		66108192	66123835	8421504	2	38,79	0,15564	p	350019241800015014	0-117						vom Fachbereich Biologie der Technischen Universit&#xe4;t Darmstadt zur Erlangung des akademischen Grades eines Doctor rerum naturalium genehmigte Dissertation von	b.tu-darmstadt.de	0	0		KCNK2
1089	chr16	66155130	66189962	3500380958	138		66155130	66189962	8421504	3	63,18,57	0,34754,34775	p	350038095800015016	0-138						Peptides aptes &#xe0; former un complexe covalent et leurs utilisations	DI	2012	0		KCNK2
1089	chr16	66155130	66189962	3500365929	138		66155130	66189962	8421504	3	63,18,57	0,34754,34775	p	350036592900015020	0-138						PEPTIDES CAPABLE OF FORMING A COVALENT COMPLEX, AND USES THEREOF - COMMISSARIAT &#xc0; L'&#xc9;NERGIE ATOMIQUE ET AUX &#xc9;NERGIES ALTERNATIVES	www.sumobrain.com	0	0		KCNK2
1089	chr16	66155130	66189962	3500140934	138		66155130	66189962	8421504	3	63,18,57	0,34754,34775	p	350014093400015034	0-138						Peptides capable of forming a covalent complex, and uses thereof	DI	2012	0		KCNK2
1089	chr16	66155131	66190186	3500288579	40		66155131	66190186	8421504	2	20,20	0,35035	c	350028857900000015,350028857900000014	0-20,0-20						REPRODUCTION	uction-online.org	0	0		
136	chr16	66190028	66193653	3500094837	64		66190028	66193653	8421504	3	19,44,1	0,123,3624	c,g	350009483700000069,350009483700000069,350009483700000051	0-19,0-19,0-45						DISSERTATION submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences	uni-heidelberg.de	0	0		
1090	chr16	66222649	66222679	3500380835	25		66222649	66222679	8421504	3	12,6,7	0,16,23	g	350038083500000096	3-38						Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies	Bejcek	1998	0		
1093	chr16	66670781	66678223	3500153384	40		66670781	66678223	8421504	4	17,3,3,17	0,1864,1997,7425	c	350015338400000008,350015338400000007	0-20,0-20		20610385	10.1074/jbc.M110.104513	0021-9258	Journal of Biological Chemistry	Essential Role of p400/mDomino Chromatin-remodeling ATPase in Bone Marrow Hematopoiesis and Cell-cycle Progression	Fujii	2010	5		
1093	chr16	66699724	66699750	3500033838	23		66699724	66699750	8421504	3	5,4,14	0,7,12	c	350003383800000004	0-23		21459326	10.1016/j.cmet.2011.02.014		Cell metabolism	TLE3 is a dual function transcriptional coregulator of adipogenesis	Claudio	2011	0		
1095	chr16	66912332	66912358	3500211552	25		66912332	66912358	8421504	2	10,15	0,11	c	350021155200000003	6-35						Cr-2 binding peptide p28 as molecular adjuvant for dna vaccines	Angov	2009	0		
1095	chr16	66933159	66933187	3500425870	23		66933159	66933187	8421504	2	17,6	0,22	g	350042587000000171	0-23							w.bhdsyndrome.org	0	0		
1095	chr16	66953328	66954038	3500132186	23		66953328	66954038	8421504	3	16,1,6	0,20,704	c	350013218600000119	10-33						Humanized anti-alpha 9 integrin antibodies and the uses thereof	Kon	2010	0		
1096	chr16	67078071	67078173	3500336592	44		67078071	67078173	8421504	2	22,22	0,80	g	350033659200000000,350033659200000001	0-22,0-22						DIVERSIDADE GEN&#xc9;TICA, ANCESTRALIDADE INDIVIDUAL E MISCIGENA&#xc7;&#xc3;O NAS RA&#xc7;AS BOVINAS NO BRASIL COM BASE EM MICROSSAT&#xc9;LITES E HAPL&#xd3;TIPOS DE DNA MITOCONDRIAL: SUBS&#xcd;DIOS PARA A CONSERVA&#xc7;&#xc3;O	epositorio.unb.br	0	0		
1096	chr16	67093026	67093052	3500187343	23		67093026	67093052	8421504	2	5,18	0,8	g	350018734300000121	4-27					Patent	Dye compositions containing purified polyporus laccases and nucleic acids encoding same (Patent US:5667531)	Aaslyng	1997	0		
1098	chr16	67250195	67290798	3500438624	43		67250195	67290798	8421504	2	23,20	0,40583	c,g	350043862400000000,350043862400000000,350043862400000001,350043862400000001,350043862400000003,350043862400000002	0-21,0-21,0-21,0-21,0-20,0-19						Materials and methods for colorectal cancer screening, diagnosis and therapy	Alitalo	2004	0		
1098	chr16	67250246	67276530	3500154758	43		67250246	67276530	8421504	2	21,22	0,26262	c,g	350015475800000001,350015475800000001,350015475800000000,350015475800000000	0-21,0-21,0-22,0-22		17018613	10.1158/0008-5472.CAN-06-1488	0008-5472	Cancer Research	Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis	Zeng	2006	8		PROX1
1098	chr16	67250246	67276530	3500149476	43		67250246	67276530	8421504	2	21,22	0,26262	c,g	350014947600000001,350014947600000001,350014947600000000,350014947600000000	0-21,0-21,0-22,0-22		17018613	10.1158/0008-5472.CAN-06-1488	0008-5472	Cancer Research	Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis	Zeng	2006	8		PROX1
1098	chr16	67291084	67291184	3500234350	44		67291084	67291184	8421504	2	21,23	0,77	c	350023435000000035,350023435000000034,350023435000000008	0-21,0-23,0-23						Biomatrix Scaffolds - Patent application	www.faqs.org	0	0		
1106	chr16	68344837	68344861	3500156473	23		68344837	68344861	8421504	2	4,19	0,5	g	350015647300000003	1-24						DIRECT SELECTION OF STRUCTURALLY DEFINED APTAMERS - Patent application	www.faqs.org	0	0		
1106	chr16	68344837	68344861	3500128057	23		68344837	68344861	8421504	2	4,19	0,5	g	350012805700000003	1-24						Direct Selection Of Structurally Defined Aptamers 	.freshpatents.com	0	0		
1109	chr16	68741193	68741240	3500004662	45		68741193	68741240	8421504	2	24,21	0,26	c	350000466200000009,350000466200000005	0-24,0-21						&#x30d2;&#x30c8;&#x8868;&#x76ae;&#x89d2;&#x5316;&#x7d30;&#x80de;&#x306b;&#x304a;&#x3051;&#x308b;&#x7d30;&#x80de;&#x5916; ATP &#x306e;&#x6a5f;&#x80fd;&#x89e3;&#x6790;	rary.tohoku.ac.jp	0	0		
1109	chr16	68741254	68741278	3500403785	24		68741254	68741278	8421504	1	24	0	c	350040378500000000	22-46						ScienceDirect.com - FEBS Letters - Mechanical stimulation suppresses phosphorylation of eIF2&#x03b1; and PERK-mediated responses to stress to the endoplasmic reticulum	sciencedirect.com	0	0		
1109	chr16	68747719	68747748	3500061629	24		68747719	68747748	8421504	2	14,10	0,19	c	350006162900000276	13-37						Zein-based Peptide Tags For The Expression And Purification Of Bioactive Peptides 	.freshpatents.com	0	0		
1111	chr16	68993686	69008480	3500215613	49		68993686	69008480	8421504	2	25,24	0,14770	c	350021561300000006,350021561300000000	0-25,12-36		10866685	10.1128/MCB.20.14.5285-5299.2000	0270-7306	Molecular and Cellular Biology	The B56&#x03b1; Regulatory Subunit of Protein Phosphatase 2A Is a Target for Regulation by Double-Stranded RNA-Dependent Protein Kinase PKR	Xu	2000	6		PPP2R5A,SNORA16B
1111	chr16	68993737	68995071	3500161519	44		68993737	68995071	8421504	2	21,23	0,1311	c,g	350016151900000034,350016151900000034,350016151900000033	0-21,0-21,0-23						Cell, Volume 136	download.cell.com	0	0		
1111	chr16	69062677	69062725	3500222929	48		69062677	69062725	8421504	1	48	0	p	350022292900015000	0-48		18957415	10.1074/jbc.M800951200		The Journal of Biological Chemistry	PKR Regulates B56&#x03b1;-mediated BCL2 Phosphatase Activity in Acute Lymphoblastic Leukemia-derived REH Cells	Vivian	2008	0		PPP2R5A
1113	chr16	69332001	69332025	3500424015	23		69332001	69332025	8421504	2	12,11	0,13	c	350042401500000006	0-23						US Patent # 6,184,024. Chimeric and/or growth-restricted flaviviruses - Patents.com	www.patents.com	0	0		
1113	chr16	69332001	69332025	3500281445	23		69332001	69332025	8421504	2	12,11	0,13	c	350028144500000005	0-23						Chimeric and/or growth-restricted flaviviruses	filed	1998	0		
1113	chr16	69332001	69332025	3500106798	23		69332001	69332025	8421504	2	12,11	0,13	c	350010679800000006	0-23						Chimeric and/or growth-restricted flaviviruses - The United States of America, as represented by The Secretary, Department of Health and Human Services	patentsonline.com	0	0		
1113	chr16	69332001	69332025	3500062954	23		69332001	69332025	8421504	2	12,11	0,13	c	350006295400000005	0-23						Chimeric and/or growth-restricted flaviviruses	filed	2000	0		
1113	chr16	69332001	69332025	3500013528	23		69332001	69332025	8421504	2	12,11	0,13	c	350001352800000006	0-23						Chimeric and/or growth-restricted flaviviruses	Bray	1993	0		
17	chr16	69960101	70434677	3500391334	2590		69960101	70434677	8421504	10	117,124,107,129,119,393,430,199,864,108	0,30232,34616,55220,64389,103221,182719,375933,473601,474468	c	350039133400000030	0-3041						METHOD OF DETECTING A CANCER CELL BY ABERRANT EXPRESSION OF A HUMAN K+ ION CHANNEL - Patent application	www.faqs.org	0	0		
1120	chr16	70142909	70142934	3500135136	23		70142909	70142934	8421504	2	14,9	0,16	c	350013513600000103,350013513600000104	0-23,7-30						AGENT FOR PREVENTING/TREATING CANCER - Patent application	www.faqs.org	0	0		
1120	chr16	70142909	70142934	3500116024	23		70142909	70142934	8421504	2	14,9	0,16	c	350011602400000104,350011602400000103	7-30,0-23						Preventive/Remedy for Cancer - Patent application	www.faqs.org	0	0		
1120	chr16	70142997	70143024	3500146321	25		70142997	70143024	8421504	2	18,7	0,20	c,g	350014632100000050,350014632100000050	9-42,9-42						Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use - US Patent 7056714 Description	ww.patentstorm.us	0	0		
1126	chr16	70989217	70989247	3500085048	24		70989217	70989247	8421504	3	5,6,13	0,7,17	c	350008504800000108	18-43						Guanosine triphosphate (GTP) binding protein-coupled receptor proteins	Itadani	2001	0		ACACA
1131	chr16	71585778	71585927	3500156044	40		71585778	71585927	8421504	2	20,20	0,129	c,g	350015604400000003,350015604400000002,350015604400000002	0-20,0-20,0-20						The role of glucocorticoid in the regulation of prostaglandin biosynthesis in non-pregnant bovine endometrium	logy-journals.org	0	0		
1131	chr16	71585838	71588022	3500266155	64		71585838	71588022	8421504	2	26,38	0,2146	c	350026615500000176,350026615500000145	0-26,0-38						ANTISENSE MODULATION OF HYDROXYSTEROID 11-BETA DEHYDROGENASE 1 EXPRESSION - Patent application	www.faqs.org	0	0		
1131	chr16	71585976	71629790	3500290208	42		71585976	71629790	8421504	2	22,20	0,43794	c,g	350029020800000001,350029020800000000,350029020800000000	0-22,0-20,0-20						b-Hydroxysteroid dehydrogenase expression and activities in bovine granulosa cells and corpora lutea implicate corticosteroids in bovine ovarian physiology	logy-journals.org	0	0		
1131	chr16	71585976	71629790	3500148140	42		71585976	71629790	8421504	2	22,20	0,43794	c,g	350014814000000001,350014814000000001,350014814000000000,350014814000000000	0-22,0-22,0-20,0-20		17470521	10.1677/joe.1.07025	0022-0795	Journal of Endocrinology	11&#x03b2;-Hydroxysteroid dehydrogenase expression and activities in bovine granulosa cells and corpora lutea implicate corticosteroids in bovine ovarian physiology	Thurston	2007	4		
141	chr16	71693247	71727140	3500335406	211		71693247	71727140	8421504	9	14,30,41,19,16,21,4,18,48	0,13644,14254,19381,19661,25612,28493,28635,33845	c	350033540600000107,350033540600000110,350033540600000116,350033540600000133,350033540600000148,350033540600000162	4-48,0-41,12-47,27-48,0-22,0-48						HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS	Kato	1998	0		
1132	chr16	71715850	71715877	3500154003	27		71715850	71715877	8421504	1	27	0	c	350015400300000017	0-27		21980285	10.1371/journal.ppat.1002256		PLoS Pathogens	The Human Papillomavirus E6 Oncogene Represses a Cell Adhesion Pathway and Disrupts Focal Adhesion through Degradation of TAp63&#x03b2; upon Transformation	Youcef	2011	0		
1132	chr16	71735249	71755541	3500221555	72		71735249	71755541	8421504	3	25,24,23	0,1532,20269	c	350022155500000002,350022155500000006,350022155500000003	6-31,6-30,7-30						Cancer associated protein kinases and their uses	Yoganathan	2010	0		
1132	chr16	71735249	71755541	3500049849	72		71735249	71755541	8421504	3	25,24,23	0,1532,20269	c	350004984900000002,350004984900000006,350004984900000003	6-31,6-30,7-30						Cancer associated protein kinases and their uses	Delaney	2004	0		CAMK1G
141	chr16	71938393	71985379	3500416808	40		71938393	71985379	8421504	4	8,12,14,6	0,13,46961,46980	g	350041680800000009,350041680800000119	4-24,9-29					Patent	Recombinant herpesvirus of turkeys and uses thereof (Patent US:5853733)	Cochran	1998	0		
1138	chr16	72497270	72497295	3500055245	23		72497270	72497295	8421504	2	12,11	0,14	g	350005524500000074	0-23						Papilloma virus capsomere vaccine formulations and methods of use	Gissmann	1999	0		
1141	chr16	72919844	72919868	3500200444	23		72919844	72919868	8421504	2	4,19	0,5	g	350020044400000011	0-23						Identification of candidate genes and testing for association with tuberculosis in humans. Cha	scholar.sun.ac.za	0	0		
1143	chr16	73144570	73144594	3500196409	24		73144570	73144594	8421504	1	24	0	g	350019640900000050	0-30						US Patent # 6,177,243. Nucleic acid sequence detection employing amplification probes - Patents.com	www.patents.com	0	0		
1144	chr16	73299606	73299630	3500305506	24		73299606	73299630	8421504	1	24	0	c	350030550600000006	0-24						Novel Gene Disruptions, Compositions and Methods Relating Thereto - Patent application	www.faqs.org	0	0		
1144	chr16	73299606	73299630	3500141101	24		73299606	73299630	8421504	1	24	0	c,g	350014110100000039,350014110100000039	0-24,0-24						Promotion or inhibition of angiogenesis and cardiovascularization	Ashkenazi	2000	0		
1144	chr16	73299606	73299630	3500053081	24		73299606	73299630	8421504	1	24	0	c	350005308100000006	0-24						GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO - Patent 2050335	data.epo.org	0	0		
1145	chr16	73434234	73434263	3500295556	23		73434234	73434263	8421504	3	6,12,5	0,10,24	g	350029555600000034	10-33						Seed plants exhibiting early reproductive development and methods of making same	Weigel	1997	0		
1145	chr16	73434234	73434263	3500121284	23		73434234	73434263	8421504	3	6,12,5	0,10,24	g	350012128400000034	10-33						Seed plants exhibiting inducible early reproductive development and methods of making same	Yanofsky	1999	0		
1145	chr16	73463629	73463658	3500008258	24		73463629	73463658	8421504	2	8,16	0,13	g	350000825800000046	4-28						Polypeptides having L-asparaginase activity	Ario	1997	0		
1145	chr16	73496334	73504069	3500281958	699		73496334	73504069	8421504	10	90,156,11,91,116,115,33,24,33,30	0,1901,2060,4849,4946,5678,5796,7642,7669,7705	p	350028195800015073	0-702						Modulators of angiogenesis and tumorigenesis	E	2004	0		PLXNA2
1145	chr16	73496334	73504069	3500211813	699		73496334	73504069	8421504	10	90,156,11,91,116,115,33,24,33,30	0,1901,2060,4849,4946,5678,5796,7642,7669,7705	p	350021181300015073	0-702						Modulators of angiogenesis and tumorigenesis	Atchison	2005	0		PLXNA2
1146	chr16	73621433	73621465	3500213854	31		73621433	73621465	8421504	2	13,18	0,14	c	350021385400000006	0-31						Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein. - ResearchGate	.researchgate.net	0	0		
1146	chr16	73642294	73643021	3500257699	43		73642294	73643021	8421504	2	21,22	0,705	c,g	350025769900000002,350025769900000003,350025769900000003	0-21,0-22,0-22						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
1146	chr16	73643162	73643442	3500153648	40		73643162	73643442	8421504	2	20,20	0,260	c,g	350015364800000010,350015364800000010,350015364800000011	0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
1147	chr16	73692654	73692677	3500128855	23		73692654	73692677	8421504	1	23	0	g	350012885500000023	0-23		16552054	10.1128/IAI.74.4.2233-2244.2006	0019-9567	Infection and Immunity	Cloning, Expression, and Characterization of Fimbrial Operon F9 from Enterohemorrhagic Escherichia coli O157:H7	Low	2006	4		
1147	chr16	73731763	73732352	3500430059	38		73731763	73732352	8421504	2	19,19	0,570	c,g	350043005900000004,350043005900000004,350043005900000006	0-19,0-19,0-19		20564213	10.1002/jcb.22630	0730-2312	Journal of cellular biochemistry	Transcriptional Suppression of mir-29b-1/mir-29a Promoter by c-Myc, Hedgehog, and NF-kappaB	JL	2010	3		MIR29C
1147	chr16	73731805	73731829	3500450448	24		73731805	73731829	8421504	1	24	0	c	350045044800000024,350045044800000039,350045044800000063,350045044800000062,350045044800000065,350045044800000064,350045044800000067,350045044800000066,350045044800000043,350045044800000042,350045044800000041,350045044800000046,350045044800000045,350045044800000044,350045044800000018,350045044800000068,350045044800000050,350045044800000051,350045044800000052,350045044800000053,350045044800000002,350045044800000001,350045044800000049,350045044800000048	0-21,0-21,0-23,1-23,0-23,0-23,0-23,0-23,0-21,0-22,0-21,0-23,0-21,0-23,0-23,1-23,0-23,0-23,0-22,2-23,0-20,0-23,1-21,0-23						Compositions And Methods For Inhibiting Or Reversing Fibrotic Disorders 	.freshpatents.com	0	0		
1147	chr16	73731805	73731829	3500280470	24		73731805	73731829	8421504	1	24	0	c	350028047000000033	10-34						NUCLEIC ACID DETECTION AND QUANTIFICATION BY POST-HYBRIDIZATION LABELING AND UNIVERSAL ENCODING - Patent application	www.faqs.org	0	0		
1147	chr16	73731805	73731828	3500459603	23		73731805	73731828	8421504	1	23	0	c	350045960300000058,350045960300000059	0-23,0-20						MICRORNAS THAT REGULATE MUSCLE CELL PROLIFERATION AND DIFFERENTIATION - Patent application	www.faqs.org	0	0		
1147	chr16	73731805	73731828	3500419600	23		73731805	73731828	8421504	1	23	0	c	350041960000000021,350041960000000022	0-23,0-20						Methods for Reverting Methylation by Targeting DNMT3A and DNMT3B - Patent application	www.faqs.org	0	0		
1147	chr16	73731805	73731828	3500168448	23		73731805	73731828	8421504	1	23	0	c	350016844800000055	0-23						Oligomeric compounds and compositions for use in modulation of small non-coding rnas	Baker	2005	0		
1147	chr16	73731805	73731828	3500059138	23		73731805	73731828	8421504	1	23	0	c	350005913800000055	0-23						Oligomeric compounds and compositions for use in modulation of small non-coding rnas	Baker	2005	0		MIR29B1
1147	chr16	73731805	73731828	3500001126	23		73731805	73731828	8421504	1	23	0	c	350000112600000057	23-46						Nucleotide Motifs Providing Localization Elements and Methods of Use	Mendell	2007	0		
1147	chr16	73737990	73738014	3500312517	24		73737990	73738014	8421504	1	24	0	c	350031251700000106,350031251700000015,350031251700000081	11-35,11-35,11-30						ENZYMES AND METHODS FOR PRODUCING OMEGA-3 FATTY ACIDS - Patent application	www.faqs.org	0	0		
1147	chr16	73737990	73738014	3500289209	24		73737990	73738014	8421504	1	24	0	c	350028920900000015	11-35						Enzymes and methods for producing omega-3 fatty acids	Petrie	2011	0		
1147	chr16	73738004	73738028	3500233649	23		73738004	73738028	8421504	2	8,15	0,9	c	350023364900000205,350023364900000204	0-21,0-23					Patent	Method of screening compounds that inhibit the biosynthesis of GPI in malaria parasites (Patent CN:100504392)	Zhong Ben He Xiao 	2009	0		
1151	chr16	74225458	74225482	3500292510	23		74225458	74225482	8421504	2	9,14	0,10	c	350029251000000154,350029251000000060	5-28,8-31					Patent	GnRH-leukotoxin chimeras (Patent US:5837268)	Manns	1998	0		
1151	chr16	74225458	74225482	3500013181	23		74225458	74225482	8421504	2	9,14	0,10	c	350001318100000154,350001318100000062	5-28,8-31						 GnRH 	www.docstoc.com	0	0		
1151	chr16	74225458	74225482	3500011316	23		74225458	74225482	8421504	2	9,14	0,10	c	350001131600000062,350001131600000154	8-31,5-28						Polynucleotides encoding LKT 111	Potter	1999	0		
1151	chr16	74225458	74225482	3500004520	23		74225458	74225482	8421504	2	9,14	0,10	c	350000452000000062,350000452000000154	8-31,5-28					Patent	GnRH-leukotoxin chimeras (Patent US:6022960)	Manns	2000	0		
1152	chr16	74402220	74402244	3500257166	24		74402220	74402244	8421504	1	24	0	c	350025716600000137	9-33						Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes - Patent application	www.faqs.org	0	0		
1153	chr16	74494865	74494892	3500350348	26		74494865	74494892	8421504	2	9,17	0,10	c	350035034800000220	0-26						US Patent # 6,004,924. Protein sequences of serrate gene products - Patents.com	www.patents.com	0	0		
1153	chr16	74556188	74556211	3500273481	23		74556188	74556211	8421504	1	23	0	c	350027348100000012	23-46						MPP5 Recruits MPP4 to the CRB1 Complex in Photoreceptors	www.iovs.org	0	0		
1155	chr16	74761110	74761133	3500335615	23		74761110	74761133	8421504	1	23	0	g	350033561500000134	0-24					Patent	Linked breast and ovarian cancer susceptibility gene (Patent US:5709999)	Durocher	1998	0		
1163	chr16	75776716	75778433	3500349767	44		75776716	75778433	8421504	2	22,22	0,1695	c,g	350034976700000000,350034976700000000,350034976700000001,350034976700000001	0-22,0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
1163	chr16	75783626	75787799	3500194103	40		75783626	75787799	8421504	2	20,20	0,4153	c,g	350019410300000046,350019410300000047,350019410300000047	0-20,0-20,0-20						AZ IZOM DIFFERENCI&#xc1;L&#xd3;D&#xc1;ST BEFOLY&#xc1;SOL&#xd3; G&#xc9;NEK IN VITRO VIZSG&#xc1;LATA EMBRION&#xc1;LIS EREDET&#x0170; &#x0150;S-SEJTVONALAKBAN EG&#xc9;R MODELLRENDSZERBEN	phd.szie.hu	0	0		
1163	chr16	75813735	75816765	3500291860	39		75813735	75816765	8421504	3	5,15,19	0,1890,3011	c,g	350029186000000020,350029186000000021,350029186000000021	0-20,0-19,0-19						Die Immunantwort boviner und capriner Euterepithelzellen auf verschiedene Mastitiserreger	b.uni-muenchen.de	0	0		
1164	chr16	75929820	75929844	3500243673	24		75929820	75929844	8421504	1	24	0	c	350024367300000031	0-24						TARGETING OF MIRNA PRECURSORS - UNIVERSITY OF DUNDEE	www.sumobrain.com	0	0		MIR181A1
1164	chr16	75929854	75929878	3500280470	24		75929854	75929878	8421504	1	24	0	c	350028047000000034	10-34						NUCLEIC ACID DETECTION AND QUANTIFICATION BY POST-HYBRIDIZATION LABELING AND UNIVERSAL ENCODING - Patent application	www.faqs.org	0	0		MIR181B2
1164	chr16	75929854	75929878	3500164893	24		75929854	75929878	8421504	1	24	0	c	350016489300001515	0-24						Methods for quantitating small rna molecules	Raymond	2007	0		MIR181B2
1164	chr16	75929855	75930062	3500031979	68		75929855	75930062	8421504	3	23,22,23	0,144,184	c,g	350003197900000340,350003197900000340,350003197900000342,350003197900000360,350003197900000360,350003197900000339,350003197900000341,350003197900000341	0-23,0-23,0-23,0-22,0-22,0-23,0-22,0-22						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		
1164	chr16	75929855	75929878	3500182009	23		75929855	75929878	8421504	1	23	0	c	350018200900000000	0-23		21332710	10.1111/j.1365-2141.2011.08581.x	1365-2141	British Journal of Haematology	Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes - Sokol - 2011 - British Journal of Haematology - Wiley Online Library	Sokol	2011	0		MIR181A1
1164	chr16	75929856	75930062	3500389139	67		75929856	75930062	8421504	3	22,22,23	0,143,183	c,g	350038913900000014,350038913900000049,350038913900000049,350038913900000015,350038913900000013	21-43,22-44,0-22,22-44,21-43						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		
1164	chr16	75929856	75930062	3500377404	45		75929856	75930062	8421504	2	22,23	0,183	c,g	350037740400000012,350037740400000012,350037740400000013	0-22,0-22,0-23						METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME - Patent application	www.faqs.org	0	0		MIR181B2
1164	chr16	75929856	75930062	3500257436	67		75929856	75930062	8421504	3	22,22,23	0,143,183	c,g	350025743600000014,350025743600000049,350025743600000049,350025743600000015,350025743600000013	0-22,22-44,0-22,0-22,0-22						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
1164	chr16	75929856	75930062	3500232262	67		75929856	75930062	8421504	3	22,22,23	0,143,183	c,g	350023226200000014,350023226200000049,350023226200000049,350023226200000015,350023226200000015,350023226200000013	22-44,22-44,0-22,22-44,0-22,22-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		MIR181A1
1164	chr16	75929856	75930062	3500205029	45		75929856	75930062	8421504	2	22,23	0,183	c,g	350020502900000012,350020502900000013,350020502900000013	0-22,0-23,0-23						METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME	Khew-goodall	2007	0		MIR181A1
1164	chr16	75930039	75930062	3500423784	23		75930039	75930062	8421504	1	23	0	c,g	350042378400000062,350042378400000062	0-23,0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR181A1,MIR181B2
1164	chr16	75930039	75930062	3500400478	23		75930039	75930062	8421504	1	23	0	c,g	350040047800000188,350040047800000188	0-23,0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		MIR181A1
1164	chr16	75930039	75930062	3500347866	23		75930039	75930062	8421504	1	23	0	c,g	350034786600000020,350034786600000021,350034786600000021	0-23,0-21,0-21						Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells.	.biomedsearch.com	0	0		MIR181A1
1164	chr16	75930039	75930062	3500287752	23		75930039	75930062	8421504	1	23	0	c	350028775200000027	0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		MIR181B2
1164	chr16	75930039	75930062	3500243960	23		75930039	75930062	8421504	1	23	0	c	350024396000000017	0-23		22984580	10.1371/journal.pone.0044873		PLoS ONE	Systematic Analysis of Small RNAs Associated with Human Mitochondria by Deep Sequencing: Detailed Analysis of Mitochondrial Associated miRNA	Lakshmi	2012	0		MIR181B2
1164	chr16	75930039	75930062	3500210973	23		75930039	75930062	8421504	1	23	0	g	350021097300000188	0-23						Microrna molecules	Tuschl	2002	0		MIR181A1
1164	chr16	75930039	75930062	3500139708	23		75930039	75930062	8421504	1	23	0	c	350013970800000030,350013970800000014	0-23,0-23						METHODS AND COMPOSITIONS FOR THE TREATMENT OF ERYTHROCYTE DISEASES - Patent application	www.faqs.org	0	0		MIR181B2
1164	chr16	75930039	75930062	3500006114	23		75930039	75930062	8421504	1	23	0	c	350000611400000065	0-23						A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT - INTERNA TECHNOLOGIES BV	www.sumobrain.com	0	0		MIR181B2
1167	chr16	76348156	76348183	3500089830	23		76348156	76348183	8421504	2	8,15	0,12	g	350008983000000000	4-27			10.1128/JVI.76.21.10598-10607.2002		Journal of Virology	Nuclear Localization of Human Immunodeficiency Virus Type 1 Preintegration Complexes (PICs): V165A and R166A Are Pleiotropic Integrase Mutants Primarily Defective for Integration, Not PIC Nuclear Import	Ana	2002	0		
1167	chr16	76348156	76348183	3500051405	23		76348156	76348183	8421504	2	8,15	0,12	g	350005140500000000	4-27		12368302	10.1128/JVI.76.21.10598-10607.2002	0022-538X	Journal of Virology	Nuclear Localization of Human Immunodeficiency Virus Type 1 Preintegration Complexes (PICs): V165A and R166A Are Pleiotropic Integrase Mutants Primarily Defective for Integration, Not PIC Nuclear Import	Limon	2002	5		
146	chr16	77147259	77404756	3500159625	1473		77147259	77404756	8421504	11	63,1,35,81,142,647,72,42,148,44,198	0,143891,147855,147893,149489,151832,208660,208738,215319,257252,257299	p	350015962500015004	0-1476						Methods and compositions to promote bone homeostasis	Tomme	2007	0		
1173	chr16	77147259	77147284	3500294046	25		77147259	77147284	8421504	1	25	0	c	350029404600000005	8-33						CELLS AND METHODS FOR OBTAINING THEM - GENOME RESEARCH LIMITED	www.sumobrain.com	0	0		
1173	chr16	77147259	77147284	3500277529	25		77147259	77147284	8421504	1	25	0	c	350027752900000040	8-33						CELLS AND METHODS FOR OBTAINING THEM	Liu	2010	0		NR5A2
1174	chr16	77295182	77296775	3500120494	78		77295182	77296775	8421504	2	51,27	0,1566	p	350012049400015053	0-78						UNIVERSIDAD DE BARCELONA DEPARTAMENTO DE FISIOLOGAA Programa de FisiologAa. Bienio 2000/01 RECEPT	www.tdx.cat	0	0		NR5A2
1174	chr16	77296829	77296852	3500048010	23		77296829	77296852	8421504	1	23	0	c	350004801000000013	0-23		14568916	10.1095/biolreprod.103.021709	0006-3363	Biology of Reproduction	Gene Expression Profiling of Differentially Expressed Genes in Granulosa Cells of Bovine Dominant Follicles Using Suppression Subtractive Hybridization	Fayad	2004	4		NR5A2
146	chr16	77299186	77404756	3500159625	1053		77299186	77404756	8421504	7	360,189,72,42,148,44,198	0,363,56733,56811,63392,105325,105372	p	350015962500015172	0-1056						Methods and compositions to promote bone homeostasis	Tomme	2007	0		NR5A2
146	chr16	77299321	77404756	3500159625	921		77299321	77404756	8421504	6	240,174,72,42,148,245	0,243,56598,56676,63257,105190	p	350015962500015173	0-924						Methods and compositions to promote bone homeostasis	Tomme	2007	0		NR5A2
146	chr16	77299489	77404756	3500157912	732		77299489	77404756	8421504	5	33,186,120,148,245	0,63,56430,63089,105022	p	350015791200015000	33-765						Lhr1 Activators As Medicaments 	.freshpatents.com	0	0		NR5A2
146	chr16	77299489	77404756	3500062743	732		77299489	77404756	8421504	5	33,186,120,148,245	0,63,56430,63089,105022	p	350006274300015000	33-765						Lhr1 Activators as Medicaments - Patent application	www.faqs.org	0	0		NR5A2
146	chr16	77299666	77404663	3500159625	492		77299666	77404663	8421504	4	72,120,148,152	0,56253,62912,104845	p	350015962500015174	0-492						Methods and compositions to promote bone homeostasis	Tomme	2007	0		NR5A2
1177	chr16	77679469	77681708	3500252575	154		77679469	77681708	8421504	3	92,42,20	0,1252,2219	c	350025257500000086,350025257500000042,350025257500000038,350025257500000055	0-44,0-48,6-48,0-20						ADIPONECTIN RECEPTOR AND GENE ENCODING THE SAME - Patent application	www.faqs.org	0	0		
1177	chr16	77679496	77679519	3500262929	23		77679496	77679519	8421504	1	23	0	c	350026292900000000	0-23		17914101	10.1677/ERC-07-0065	1351-0088	Endocrine-Related Cancer	Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95&#x2013;2	Cong	2007	4		
1177	chr16	77679496	77679519	3500215047	23		77679496	77679519	8421504	1	23	0	c	350021504700000000	0-23		17914101	10.1677/ERC-07-0065	1351-0088	Endocrine-Related Cancer	Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95&#x2013;2	Cong	2007	4		
1177	chr16	77680721	77681708	3500080939	62		77680721	77681708	8421504	2	42,20	0,967	c	350008093900000038,350008093900000055	6-48,0-20						Adiponectin receptor and gene encoding the same - Patent application	www.faqs.org	0	0		
585	chr17	102965	104129	3500407090	41		102965	104129	8421504	3	9,13,19	0,13,1145	g	350040709000000744,350040709000000391	11-33,18-37						HIV envelope polypeptides and vaccine	Berman	1997	0		
588	chr17	494387	497176	3500261436	52		494387	497176	8421504	2	26,26	0,2763	c,g	350026143600000092,350026143600000091,350026143600000091	0-26,0-26,0-26						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
588	chr17	494389	498937	3500039785	45		494389	498937	8421504	2	25,20	0,4528	c	350003978500000010,350003978500000008	0-25,0-20		21285510	10.1172/JCI42650		The Journal of Clinical Investigation	Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delay 	Miao	2011	0		
588	chr17	500086	505718	3500047878	40		500086	505718	8421504	2	20,20	0,5612	c,g	350004787800000035,350004787800000035,350004787800000034,350004787800000034	0-20,0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
590	chr17	713620	717719	3500008785	43		713620	717719	8421504	2	2,41	0,4058	c	350000878500000036	4-47						Clinical disorders associated with carboxypeptidase E mutation	Naggert	1996	0		
601	chr17	2179731	2179878	3500315071	40		2179731	2179878	8421504	2	20,20	0,127	c	350031507100000007,350031507100000006	0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
601	chr17	2179964	2180789	3500357802	169		2179964	2180789	8421504	3	62,71,36	0,363,789	c	350035780200000013,350035780200000037,350035780200000082,350035780200000055,350035780200000094	0-47,0-48,0-44,0-48,0-36						Uses of nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors nucleic acid encoding	Gerald	1996	0		
601	chr17	2180098	2180941	3500125608	141		2180098	2180941	8421504	3	72,22,47	0,151,796	c	350012560800000010,350012560800000034,350012560800000103,350012560800000018	0-45,0-48,1-23,0-47					Patent	Uses of nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors nucleic acid encoding (Patent US:5989834)	Branchek	1999	0		
601	chr17	2180167	2180212	3500213848	45		2180167	2180212	8421504	1	45	0	c	350021384800000016	0-45					Patent	Method of obtaining compositions comprising Y2 specific compounds (Patent US:6420532)	Gerald	2002	0		
601	chr17	2180734	2180797	3500163087	63		2180734	2180797	8421504	1	63	0	p,c	350016308700015009,350016308700000006	0-63,0-35						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		
601	chr17	2180898	2180922	3500244987	23		2180898	2180922	8421504	2	19,4	0,20	c	350024498700000011	5-28						Modulation of cytokinin activity in plants	C*Jin Sai Er Mai Er 	2008	0		
608	chr17	3080674	3080697	3500430637	23		3080674	3080697	8421504	1	23	0	c	350043063700000008	7-30						Transgenic non-human mammals producing fibrinogen in their milk	Velander	1995	0		
608	chr17	3080674	3080697	3500396667	23		3080674	3080697	8421504	1	23	0	c	350039666700000006	7-30					Patent	Transgenic fibrinogen (Patent EP:0744891)	Drohan	2007	0		
608	chr17	3080674	3080697	3500086384	23		3080674	3080697	8421504	1	23	0	c	350008638400000010	7-30						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
608	chr17	3080674	3080697	3500000873	23		3080674	3080697	8421504	1	23	0	c	350000087300000008	7-30						Transgenic nonhuman mammals producing fibrinogen in milk and methods of producing fibrin	Velander	2005	0		
608	chr17	3083850	3083882	3500206286	28		3083850	3083882	8421504	3	15,5,8	0,16,24	g	350020628600000137	8-36						Process for preparing human coagulation factor VIII protein complex	Yonemura	1994	0		
608	chr17	3105065	3105088	3500402055	23		3105065	3105088	8421504	1	23	0	c	350040205500000241,350040205500000501	1-24,1-24						Methods And Kits For Detecting Mutations 	.freshpatents.com	0	0		FGA
608	chr17	3105144	3105762	3500020081	42		3105144	3105762	8421504	2	13,29	0,589	c	350002008100000027,350002008100000025	18-60,4-46						Polypeptides, their preparation and their use	Mueller-Neumann	1990	0		FGA
608	chr17	3139070	3139093	3500086384	23		3139070	3139093	8421504	1	23	0	c	350008638400000002	0-23						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
610	chr17	3280988	3281013	3500206772	25		3280988	3281013	8421504	1	25	0	g	350020677200000007	13-38						Maize endo-1,3;1,4-&#x03b2;-glucanase nucleic acid	Nevins	1999	0		
614	chr17	3890925	3890951	3500183631	25		3890925	3890951	8421504	2	4,21	0,5	g	350018363100000017	19-44						Use of histone chaperone activity of agrobacterium 6b protein - Patent application	www.faqs.org	0	0		
616	chr17	4173076	4173099	3500461498	23		4173076	4173099	8421504	1	23	0	g	350046149800000020	0-23						NovelOligoamineAnaloguesInhibitLysine-SpecificDemethylase1 andInduceReexpressionofEpigeneticallySilencedGenes	.aacrjournals.org	0	0		
616	chr17	4173581	4173920	3500337812	333		4173581	4173920	8421504	3	87,198,48	0,90,291	p	350033781200015024	0-333						Wnt antagonists and methods of treatment and screening	Satyal	2011	0		SFRP2
616	chr17	4173581	4173920	3500039991	333		4173581	4173920	8421504	3	87,198,48	0,90,291	p	350003999100015026	0-333						WNT ANTAGONISTS AND METHODS OF TREATMENT AND SCREENING - ONCOMED PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		SFRP2
616	chr17	4173741	4180702	3500405660	41		4173741	4180702	8421504	2	20,21	0,6940	c,g	350040566000000004,350040566000000004,350040566000000005	0-20,0-20,0-21		17702698	10.1158/0008-5472.CAN-06-4666	0008-5472	Cancer Research	Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment	Giuliani	2007	8		SFRP2
616	chr17	4173903	4180695	3500270595	40		4173903	4180695	8421504	2	20,20	0,6772	c,g	350027059500000002,350027059500000002,350027059500000003	0-20,0-20,0-20						RESEARCH ARTICLE Open Access Secreted frizzled-related protein 4 expression is	biomedcentral.com	0	0		SFRP2
616	chr17	4173958	4180645	3500182917	46		4173958	4180645	8421504	4	8,12,3,23	0,2386,2464,6664	c	350018291700000000,350018291700000001	0-20,0-26		18404682	10.1002/ijc.23514	1097-0215	International Journal of Cancer	DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines - Kawamoto - 2008 - International Journal of Cancer - Wiley Online Library	Kawamoto	2008	0		SFRP2
617	chr17	4299626	4301765	3500163561	149		4299626	4301765	8421504	7	20,21,20,22,22,22,22	0,101,736,792,1586,1628,2117	c	350016356100000007,350016356100000005,350016356100000006,350016356100000004,350016356100000001,350016356100000003,350016356100000002	0-20,0-21,0-20,0-22,0-22,0-22,0-22						2009 OPEN ACCESS diversity	www.mdpi.com	0	0		
617	chr17	4299727	4301765	3500444535	129		4299727	4301765	8421504	6	21,20,22,22,22,22	0,635,691,1485,1527,2016	c,g	350044453500000005,350044453500000006,350044453500000004,350044453500000001,350044453500000001,350044453500000003,350044453500000002	0-21,0-20,0-22,0-22,0-22,0-22,0-22						2009 OPEN ACCESS diversity	dspace.unitus.it	0	0		
617	chr17	4299731	4302979	3500133335	223		4299731	4302979	8421504	11	20,20,20,20,20,22,21,19,20,21,20	0,313,416,894,1023,1522,1647,2025,2183,2432,3228	c,g	350013333500000017,350013333500000017,350013333500000015,350013333500000015,350013333500000016,350013333500000013,350013333500000013,350013333500000014,350013333500000014,350013333500000011,350013333500000012,350013333500000012,350013333500000009,350013333500000009,350013333500000010,350013333500000007,350013333500000006	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-22,0-21,0-21,0-19,0-19,0-20,0-21,0-20						ScienceDirect.com - Genomics - Analysis of sequence variability and protein domain architectures for bovine peptidoglycan recognition protein 1 and Toll-like receptors 2 and 6	sciencedirect.com	0	0		
617	chr17	4299766	4300200	3500086644	84		4299766	4300200	8421504	4	22,19,23,20	0,368,389,414	c,g	350008664400000003,350008664400000003,350008664400000011,350008664400000012,350008664400000012,350008664400000010,350008664400000010	0-22,0-22,0-19,0-23,0-23,0-20,0-20			10.1111/j.1365-2567.2004.01781.x	1365-2567	Immunology	Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists - Werling - 2003 - Immunology - Wiley Online Library	Werling	2004	0		
617	chr17	4299826	4299849	3500336225	23		4299826	4299849	8421504	1	23	0	c	350033622500000001	0-23			10.1046/j.1471-4159.2001.00603.x	1471-4159	Journal of Neurochemistry	Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS - Laflamme - 2008 - Journal of Neurochemistry - Wiley Online Library	Laflamme	2001	0		RNF175
617	chr17	4299852	4299970	3500181259	40		4299852	4299970	8421504	2	20,20	0,98	c,g	350018125900000001,350018125900000001,350018125900000000,350018125900000000	0-20,0-20,0-20,0-20						INFORME CIENT&#xcd;FICO TECNOL&#xd3;GICO 2009	www.ipen.gob.pe	0	0		
617	chr17	4299856	4300085	3500322039	66		4299856	4300085	8421504	3	22,22,22	0,28,207	c,g	350032203900000009,350032203900000009,350032203900000011,350032203900000011,350032203900000010	0-22,0-22,0-22,0-22,0-23			10.1128/CDLI.11.1.174-185.2004		Clinical and Diagnostic Laboratory Immunology	Mastitis Increases Mammary mRNA Abundance of &#x03b2;-Defensin 5, Toll-Like-Receptor 2 (TLR2), and TLR4 but Not TLR9 in Cattle	T.	2004	0		
617	chr17	4299869	4299991	3500096756	40		4299869	4299991	8421504	2	20,20	0,102	c	350009675600000001,350009675600000000	0-20,0-20		22645447	10.1100/2012/748572		The Scientific World Journal	Phosphodiesterase Inhibitors Suppress <i >Lactobacillus casei</i> Cell-Wall-Induced NF-<svg style="vertical-align:-0.0pt;width:13.8px;" id="M1" height="10.475" version="1.1" viewBox="0 0 13.8 10.475" width="13.8" xmlns="http://www.w3.org/2000/svg"> <g tra	Saito	2012	0		RNF175
617	chr17	4300142	4300166	3500170619	24		4300142	4300166	8421504	1	24	0	c	350017061900000000	0-24						Activation of Human DCs is Modulated by Components of the Outer Membranes of Nm 0390	www.scribd.com	0	0		RNF175
617	chr17	4300144	4313614	3500224243	239		4300144	4313614	8421504	11	22,22,21,22,23,22,22,22,20,20,23	0,117,478,611,959,1099,1428,1548,11782,12525,13447	c,g	350022424300000021,350022424300000021,350022424300000022,350022424300000022,350022424300000019,350022424300000020,350022424300000017,350022424300000018,350022424300000018,350022424300000015,350022424300000016,350022424300000013,350022424300000010,350022424300000006	0-22,0-22,0-22,0-22,0-21,0-22,0-23,0-22,0-22,0-22,0-22,0-20,0-20,0-23						BMC Genomics BioMed Central	biomedcentral.com	0	0		
617	chr17	4300756	4300946	3500018219	44		4300756	4300946	8421504	2	22,22	0,168	c,g	350001821900000007,350001821900000007,350001821900000006,350001821900000006	0-22,0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
617	chr17	4301401	4301713	3500263785	45		4301401	4301713	8421504	2	21,24	0,288	c	350026378500000004,350026378500000003	20-41,20-44						Exome-wide DNA capture and next generation sequencing in domestic and wild species	biomedcentral.com	0	0		
617	chr17	4301972	4311916	3500144320	40		4301972	4311916	8421504	2	20,20	0,9924	c,g	350014432000000001,350014432000000000,350014432000000000	0-20,0-20,0-20						 Variants and Gene Expression of the 	scialert.net	0	0		
619	chr17	4533373	4540737	3500323036	43		4533373	4540737	8421504	4	8,14,14,7	0,9,7341,7357	g	350032303600000109,350032303600000288,350032303600000287,350032303600000620	1-23,22-43,21-42,0-21						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF A GENE FROM THE JC VIRUS - Patent application	www.faqs.org	0	0		
619	chr17	4563956	4579002	3500104398	56		4563956	4579002	8421504	2	5,51	0,14995	c	350010439800000111	4-60						Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer	Challita-eid	2002	0		
620	chr17	4672305	4672329	3500151474	23		4672305	4672329	8421504	2	18,5	0,19	g	350015147400000027	2-26						HAFNIA PHYTASE VARIANTS - Patent application	www.faqs.org	0	0		
620	chr17	4672305	4672329	3500081124	23		4672305	4672329	8421504	2	18,5	0,19	g	350008112400000037	2-26						Hafnia Phytase - Patent application	www.faqs.org	0	0		
624	chr17	5116597	5116622	3500075280	24		5116597	5116622	8421504	2	8,16	0,9	g	350007528000000347	20-44						Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell - Patent application	www.faqs.org	0	0		
629	chr17	5801184	5801208	3500203057	24		5801184	5801208	8421504	1	24	0	c	350020305700000000	0-24		18391985	10.1038/onc.2008.77	0950-9232	Oncogene	Fbw7 regulates the activity of endoreduplication mediators and the p53 pathway to prevent drug-induced polyploidy	Finkin	2008	6		FBXW7
629	chr17	5804317	5830279	3500352447	78		5804317	5830279	8421504	5	19,17,3,20,19	0,20269,21589,23762,25943	c,g	350035244700000005,350035244700000005,350035244700000011,350035244700000012,350035244700000012,350035244700000006	0-19,0-19,0-20,0-20,0-20,0-19						The ubiquitin-specific protease USP28 is required for MYC stability	.uni-wuerzburg.de	0	0		FBXW7
629	chr17	5821528	5830231	3500437570	84		5821528	5830231	8421504	4	21,20,23,20	0,8560,8592,8683	c,g	350043757000000014,350043757000000001,350043757000000003,350043757000000003,350043757000000002,350043757000000002	0-21,0-20,0-23,0-23,0-20,0-20						BIOMARKERS FOR TREATMENT WITH ANTI-TUBULIN CHEMOTHERAPEUTIC COMPOUNDS - GENENTECH, INC.	www.sumobrain.com	0	0		FBXW7
632	chr17	6162000	6162034	3500257180	30		6162000	6162034	8421504	3	13,12,5	0,14,29	g	350025718000000004	0-30						BMC Microbiology BioMed Central	biomedcentral.com	0	0		
638	chr17	6981755	6981784	3500148407	25		6981755	6981784	8421504	2	8,17	0,12	g	350014840700000039	23-48						Modified Aerolysin And Methods Of Use For Treating Lung Cancer 	.freshpatents.com	0	0		
647	chr17	8162237	8162263	3500247922	25		8162237	8162263	8421504	2	11,14	0,12	g	350024792200000635	6-31						Human B2 integrin alpha subunit antibodies	Gallatin	1996	0		
648	chr17	8272126	8272151	3500161755	23		8272126	8272151	8421504	2	5,18	0,7	g	350016175500000099	1-24						Intermediates and enzymes of the non-mevalonate isoprenoid pathway - Patent application	www.faqs.org	0	0		
648	chr17	8288785	8288811	3500263964	23		8288785	8288811	8421504	2	5,18	0,8	g	350026396400000009	10-33						Methods and compositions for combating HIV infection	Karn	1998	0		
651	chr17	8715736	8715762	3500367982	23		8715736	8715762	8421504	2	11,12	0,14	g	350036798200000102	0-27						Recombinant RSV Virus Expression Systems And Vaccines - Patent application	www.faqs.org	0	0		
651	chr17	8715736	8715762	3500193135	23		8715736	8715762	8421504	2	11,12	0,14	g	350019313500000102	0-27						Recombinant RSV Virus Expression Systems And Vaccines - Patent application	www.faqs.org	0	0		
655	chr17	9264864	9264897	3500047637	26		9264864	9264897	8421504	3	15,5,6	0,18,27	g	350004763700000070	2-28						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
658	chr17	9643870	9643897	3500319233	25		9643870	9643897	8421504	2	9,16	0,11	g	350031923300000073	7-32						 Compositions And Methods For Dehydration And Cyclization Of Peptides, Synthetic Compounds, And Lantibiotics 	www.docstoc.com	0	0		
664	chr17	10473100	10473126	3500159364	23		10473100	10473126	8421504	2	16,7	0,19	g	350015936400000024,350015936400000078,350015936400000079,350015936400000023	10-33,9-32,10-33,9-32						Chondroitinase Abc I And Methods Of Analyzing Therewith 	.freshpatents.com	0	0		
83	chr17	10613744	10696064	3500021751	45		10613744	10696064	8421504	2	43,2	0,82318	p	350002175100015004	0-45						Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same	Dedhar	1995	0		NR3C1
83	chr17	10613762	10696133	3500440617	96		10613762	10696133	8421504	2	25,71	0,82300	p	350044061700015077,350044061700015079	0-48,0-48						Human Mlr Single Nucleotide Polymorphisms Associated With Dose-dependent Congestive Heart Failure And Methods Of Use Thereof 	.freshpatents.com	0	0		NR3C1
83	chr17	10696070	10832602	3500111757	450		10696070	10832602	8421504	7	93,60,51,49,74,30,93	0,45453,85533,85602,95232,95360,136439	p	350011175700015032,350011175700015055,350011175700015076,350011175700015089,350011175700015116	0-93,0-60,0-51,0-123,0-123						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers, Sources	www.scribd.com	0	0		NR3C2,ARHGAP10
666	chr17	10696088	10696133	3500041616	45		10696088	10696133	8421504	1	45	0	p	350004161600015041	0-45						DISEASE SUSCEPTIBILITY - Patent application	www.faqs.org	0	0		NR3C1
83	chr17	10739577	10832662	3500392554	768		10739577	10832662	8421504	5	181,145,131,158,153	0,1902,42013,51725,92932	p	350039255400015001	0-768						Biological applications of steroid binding domains	Hovens	2010	0		
83	chr17	10739577	10832662	3500162071	768		10739577	10832662	8421504	5	181,145,131,158,153	0,1902,42013,51725,92932	p	350016207100015001	0-768						Biological applications of steroid binding domains	Corcoran	2011	0		
83	chr17	10739601	10781654	3500356489	354		10739601	10781654	8421504	4	157,145,1,51	0,1878,41989,42002	p	350035648900015069,350035648900015070	0-303,0-51					Patent	Polynucleotide encoding insect ecdysone receptor (Patent US:6245531)	Hogness	2001	0		NR3C2
667	chr17	10781672	10832602	3500185455	246		10781672	10832602	8421504	4	49,74,30,93	0,9630,9758,50837	p	350018545500015080,350018545500015104	0-123,0-123						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers_ Sources	www.docstoc.com	0	0		NR3C2,ARHGAP10
667	chr17	10791436	10791459	3500280673	23		10791436	10791459	8421504	1	23	0	c	350028067300000069	9-32						Method and compositions for monitoring DNA binding molecules in living cells - Patent application	www.faqs.org	0	0		
667	chr17	10854415	10854445	3500323015	26		10854415	10854445	8421504	3	12,5,9	0,15,21	g	350032301500000033	0-27						US Patent # 5,998,191. High specificity homocysteine assays for biological samples - Patents.com	www.patents.com	0	0		
671	chr17	11338854	11338882	3500229178	24		11338854	11338882	8421504	2	11,13	0,15	c	350022917800000059	4-29						Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells - Patent application	www.faqs.org	0	0		
671	chr17	11346304	11370589	3500081673	134		11346304	11370589	8421504	4	34,10,45,45	0,24139,24150,24240	c	350008167300000509,350008167300000508,350008167300000506	1-45,0-45,0-45						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
672	chr17	11460553	11470204	3500063689	46		11460553	11470204	8421504	2	23,23	0,9628	c	350006368900000007,350006368900000006	0-23,0-23						Prostaglandin F2tt Regulation of the Bovine Corpus Luteum Endothelin System: RESULTS | Methods of Treatment	-of-treatment.com	0	0		
672	chr17	11464971	11477419	3500453380	42		11464971	11477419	8421504	2	21,21	0,12427	c,g	350045338000000001,350045338000000000,350045338000000000	0-21,0-21,0-21		11454585			American Journal of Physiology - Heart and Circulatory Physiology	Mechanism of uterine vascular refractoriness to endothelin-1 in pregnant sheep	McElvy	2001	0		
672	chr17	11477289	11477313	3500232777	24		11477289	11477313	8421504	1	24	0	c	350023277700000004	0-24						1 abstract title	tory.lib.ncsu.edu	0	0		EDNRA
672	chr17	11526894	11526960	3500163087	66		11526894	11526960	8421504	1	66	0	p,c	350016308700015015,350016308700000012	0-66,0-36						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		
672	chr17	11526898	11526923	3500032180	25		11526898	11526923	8421504	1	25	0	c	350003218000000000	0-25		10966495		1046-6673	Journal of the American Society of Nephrology	Endothelin A Receptor Blockade Prevents Capillary/Myocyte Mismatch in the Heart of Uremic Animals	AMANN	2000	10		
680	chr17	12569701	12569727	3500081452	26		12569701	12569727	8421504	1	26	0	c	350008145200000002	31-57						Retinoblastoma Protein Puri&#xfb01;cation and Transduction of Retina and Retinoblastoma Cells Using Improved Alphavirus Vectors	hnres.utoronto.ca	0	0		
683	chr17	12904664	12905422	3500044137	65		12904664	12905422	8421504	4	12,7,25,21	0,13,653,737	g	350004413700000136,350004413700000110,350004413700000131,350004413700000089,350004413700000125	0-19,0-19,24-49,0-21,0-21						Method for rapid amplification of DNA - Patent # 6638722 - PatentGenius	.patentgenius.com	0	0		
683	chr17	12904664	12905342	3500465548	43		12904664	12905342	8421504	3	12,7,24	0,13,654	g	350046554800000141,350046554800000115,350046554800000112,350046554800000138	0-19,0-19,25-49,25-49						 Method For Rapid Amplification Of DNA 	www.docstoc.com	0	0		
687	chr17	13443695	13443721	3500394950	24		13443695	13443721	8421504	2	11,13	0,13	g	350039495000000015	0-24						CORN EVENT MZDT09Y - Patent application	www.faqs.org	0	0		
689	chr17	13725518	13725554	3500273385	36		13725518	13725554	8421504	1	36	0	c	350027338500000006	8-44					Nucleic Acids Research	Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes	Geon	2002	0		
689	chr17	13729487	13729513	3500247773	23		13729487	13729513	8421504	2	10,13	0,13	g	350024777300000056	9-32						US Patent # 7,390,894. Glutathione S-transferase sequence variants - Patents.com	www.patents.com	0	0		
694	chr17	14387678	14387702	3500360584	24		14387678	14387702	8421504	1	24	0	c	350036058400000022	16-40						Tumor&#x2013;stromal Interactions with Direct Cell Contacts Enhance Motility of Non-small Cell Lung Cancer Cells Through the Hedgehog Signaling Pathway	.iiarjournals.org	0	0		
701	chr17	15211619	15211645	3500114519	24		15211619	15211645	8421504	2	19,5	0,21	g	350011451900000005	21-47						CHLAMYDIA POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF - Patent application	www.faqs.org	0	0		
702	chr17	15344747	15344774	3500455612	24		15344747	15344774	8421504	2	11,13	0,14	c	350045561200000024	5-29						Cardiac hypertrophy is a complex organ response of the heart to several biological stresses induced by many primary cardiovascu	e.ahajournals.org	0	0		
702	chr17	15344747	15344774	3500173677	24		15344747	15344774	8421504	2	11,13	0,14	c	350017367700000024	5-29						Cardiac hypertrophy is a complex organ response of the heart to several biological stresses induced by many primary cardiovascu	e.ahajournals.org	0	0		
87	chr17	15388328	15514325	3500380777	2082		15388328	15514325	8421504	10	156,123,124,94,304,86,602,226,295,72	0,986,4256,5639,16416,16911,18439,23259,34493,125925	p	350038077700015000	0-2082						KEGG T01001: 2549	www.genome.jp	0	0		GAB1
702	chr17	15388412	15389371	3500142144	129		15388412	15389371	8421504	2	72,57	0,902	p	350014214400015000	0-129		11323411	10.1074/jbc.M010275200	0021-9258	Journal of Biological Chemistry	Phosphotyrosines 627 and 659 of Gab1 Constitute a Bisphosphoryl Tyrosine-based Activation Motif (BTAM) Conferring Binding and Activation of SHP2	Cunnick	2001	5		GAB1
715	chr17	17081769	17081809	3500153707	40		17081769	17081809	8421504	1	40	0	c	350015370700000003	0-40		20538758	10.1189/jlb.0909648	0741-5400	Journal of Leukocyte Biology	IL-15 has innate anti-tumor activity independent of NK and CD8 T cells	Davies	2010	5		
715	chr17	17081769	17081793	3500162625	24		17081769	17081793	8421504	1	24	0	c	350016262500000007	9-33		20130057	10.1128/JVI.02638-09		Journal of Virology	Env-Expressing Autologous T Lymphocytes Induce Neutralizing Antibody and Afford Marked Protection against Feline Immunodeficiency Virus 	Mauro	2010	0		IL15
715	chr17	17081778	17081823	3500082117	45		17081778	17081823	8421504	1	45	0	c	350008211700000023	0-45						Compositions and methods for achieving immune suppression - US Patent 7347995 Description	ww.patentstorm.us	0	0		
721	chr17	17913800	17913824	3500148203	24		17913800	17913824	8421504	1	24	0	g	350014820300000101	21-46						 Anti 	www.docstoc.com	0	0		
724	chr17	18290455	18291801	3500464199	42		18290455	18291801	8421504	2	22,20	0,1326	c	350046419900000022,350046419900000023	0-22,0-20				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		
724	chr17	18290499	18291881	3500197718	40		18290499	18291881	8421504	2	20,20	0,1362	c,g	350019771800000000,350019771800000000,350019771800000005,350019771800000005	0-20,0-20,0-20,0-20						Saturated fatty acids stimulate and insulin suppresses CIDE-A expression in bovine mammary epithelial cells q - ResearchGate	.researchgate.net	0	0		
724	chr17	18293269	18293293	3500360837	24		18293269	18293293	8421504	1	24	0	c	350036083700000023	20-44						Positive Regulation by GABABR1 Subunit of Leptin Expression through Gene Transactivation in Adipocytes - ResearchGate	.researchgate.net	0	0		UCP1
724	chr17	18297557	18297582	3500137915	23		18297557	18297582	8421504	2	7,16	0,9	c	350013791500000185	3-26						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
724	chr17	18297597	18297624	3500025302	24		18297597	18297624	8421504	2	10,14	0,13	c	350002530200000112	10-34						Global Analysis of Gene Expression in the	brary.utoronto.ca	0	0		
724	chr17	18299630	18299657	3500035495	23		18299630	18299657	8421504	2	14,9	0,18	c	350003549500000005	10-33						IMMUNOGENIC COMPOSITIONS FOR GRAM POSITIVE BACTERIA - Patent application	www.faqs.org	0	0		
725	chr17	18399184	18399334	3500047878	40		18399184	18399334	8421504	2	20,20	0,130	c,g	350004787800000026,350004787800000026,350004787800000027	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
725	chr17	18408310	18409888	3500375753	150		18408310	18409888	8421504	2	89,61	0,1517	p	350037575300015025,350037575300015021	0-150,0-150						The short coiled-coil domain-containing protein UNC-69 cooperates with UNC-76 to regulate axonal outgrowth and normal presynaptic organization in Caenorhabditis	mit.dspace.org	0	0		SCOC
727	chr17	18701527	18701555	3500379318	24		18701527	18701555	8421504	2	17,7	0,21	g	350037931800000005	5-29						EIAV p26 deletion vaccine and diagnostic - US Patent 6461616 Description	ww.patentstorm.us	0	0		
728	chr17	18748233	18748259	3500167742	23		18748233	18748259	8421504	2	15,8	0,18	g	350016774200000027,350016774200000039	1-24,25-48						By Jonathan Seaman	www.rhizobium.net	0	0		
728	chr17	18832913	18832942	3500192533	24		18832913	18832942	8421504	2	11,13	0,16	g	350019253300000012	0-24						ABSTRACT	tory.lib.ncsu.edu	0	0		
733	chr17	19421801	19421827	3500235157	23		19421801	19421827	8421504	2	11,12	0,14	c	350023515700000004,350023515700000176	0-23,0-23						METHODS AND COMPOSITIONS FOR TREATING P. ACNES - Patent application	www.faqs.org	0	0		
733	chr17	19485001	19485028	3500028061	24		19485001	19485028	8421504	2	14,10	0,17	c	350002806100000238	2-26						Surface proteins of leptospira	www.devileye.net	0	0		NAA15
733	chr17	19505271	19508490	3500305167	40		19505271	19508490	8421504	3	20,10,10	0,86,3209	c	350030516700000001,350030516700000000	0-20,0-20		17332292	10.1158/1078-0432.CCR-06-1716	1078-0432	Clinical Cancer Research	Tubedown Expression Correlates with the Differentiation Status and Aggressiveness of Neuroblastic Tumors	Martin	2007	8		NAA15
734	chr17	19589680	19589705	3500256218	25		19589680	19589705	8421504	1	25	0	c,g	350025621800000133,350025621800000133	0-25,0-25						REPRODUCTION	uction-online.org	0	0		
91	chr17	19787238	19859991	3500212227	3041		19787238	19859991	8421504	23	40,162,76,166,114,138,87,193,207,7,92,36,504,119,18,261,207,248,118,29,170,28,21	0,1325,1488,20916,61723,63368,66102,68528,70076,70288,70296,70391,70882,71389,71563,71586,71848,72071,72321,72447,72477,72698,72732	c	350021222700000082	0-3218						Transgenic animals comprising gene fusions - Patent application	www.faqs.org	0	0		
736	chr17	19868862	19869155	3500235713	44		19868862	19869155	8421504	2	22,22	0,271	c	350023571300000019,350023571300000018	0-22,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
736	chr17	19885878	19885920	3500421659	40		19885878	19885920	8421504	2	32,8	0,34	c	350042165900000030	0-40						Journal of Microbiological Methods	005.pasteur.ac.ir	0	0		
738	chr17	20060176	20060205	3500174879	24		20060176	20060205	8421504	2	5,19	0,10	g	350017487900000017	0-24						 FLT4 (VEGFR 	www.docstoc.com	0	0		
738	chr17	20060176	20060205	3500100457	24		20060176	20060205	8421504	2	5,19	0,10	g	350010045700000015	0-24						US Patent # 6,107,046. Antibodies to Flt4, a receptor tyrosine kinase and uses thereof - Patents.com	www.patents.com	0	0		
742	chr17	20656470	20656499	3500361871	24		20656470	20656499	8421504	3	11,8,5	0,14,24	g	350036187100000017	11-35						PRODUCTION AND USE OF RAT SPERMATOGONIAL STEM CELL LINES	Hamra	2009	0		
742	chr17	20678990	20679014	3500397021	23		20678990	20679014	8421504	2	7,16	0,8	g	350039702100000001	19-42						ScienceDirect.com - Chemistry & Biology - Control of Gene Expression with Small Molecules: Biotin-Mediated Acylation of Targeted Lysine Residues in Recombinant Yeast	sciencedirect.com	0	0		
743	chr17	20802741	20802768	3500001820	24		20802741	20802768	8421504	2	15,9	0,18	g	350000182000000034	0-24						None	air.unimi.it	0	0		
751	chr17	21833065	21833089	3500182096	23		21833065	21833089	8421504	2	4,19	0,5	c	350018209600000002	3-26		21203470	10.1371/journal.pone.0015753	1932-6203	PLOS ONE	PLOS ONE: A Dominant-Negative Approach That Prevents Diphthamide Formation Confers Resistance to Pseudomonas Exotoxin A and Diphtheria Toxin	Roy	2010	4		
754	chr17	22225562	22225587	3500341162	24		22225562	22225587	8421504	2	9,15	0,10	g	350034116200000426,350034116200000210	6-34,2-30						Perhydrolase	Amin	2004	0		
754	chr17	22225562	22225587	3500134317	24		22225562	22225587	8421504	2	9,15	0,10	g	350013431700000210,350013431700000426	2-30,6-34						Perhydrolase 	.freshpatents.com	0	0		
754	chr17	22225562	22225587	3500129453	24		22225562	22225587	8421504	2	9,15	0,10	g	350012945300000298,350012945300000082	6-34,2-30					Patent	Perhydrolase (Patent EP:1689859)	Amin	2011	0		
761	chr17	23073922	23073947	3500166698	23		23073922	23073947	8421504	2	7,16	0,9	g	350016669800000004	1-24						Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles	Gerdes	1998	0		
761	chr17	23073922	23073947	3500016745	23		23073922	23073947	8421504	2	7,16	0,9	g	350001674500000005	2-25					Patent	Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles (Patent US:5989813)	Gerdes	1999	0		
764	chr17	23558458	23558482	3500059429	23		23558458	23558482	8421504	2	17,6	0,18	g	350005942900000014,350005942900000130	6-29,6-29						Method for Isolation of Transcription Termination Sequences - Patent application	www.faqs.org	0	0		
770	chr17	24290340	24290365	3500196339	23		24290340	24290365	8421504	2	18,5	0,20	g	350019633900000004	1-25						Improving palm oil quality through identification and mapping of the lipase gene causing oil deterioration. - ResearchGate	.researchgate.net	0	0		
770	chr17	24290340	24290365	3500100818	23		24290340	24290365	8421504	2	18,5	0,20	g	350010081800000004	1-25		23857501	10.1038/ncomms3160		Nature Communications	Improving palm oil quality through identification and mapping of the lipase gene causing oil deterioration	F.		0		
771	chr17	24419918	24419942	3500248094	23		24419918	24419942	8421504	2	9,14	0,10	g	350024809400001439	1-24						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
783	chr17	26078817	26078845	3500148414	23		26078817	26078845	8421504	2	17,6	0,22	g	350014841400000379	0-23						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
785	chr17	26298655	26298678	3500319233	23		26298655	26298678	8421504	1	23	0	g	350031923300000075	11-34						 Compositions And Methods For Dehydration And Cyclization Of Peptides, Synthetic Compounds, And Lantibiotics 	www.docstoc.com	0	0		
789	chr17	26787694	26787717	3500290344	23		26787694	26787717	8421504	1	23	0	c	350029034400000036	19-42						Molekulare Analysen zur Knochenregeneration im Alter und bei Osteoporose	.uni-wuerzburg.de	0	0		
789	chr17	26790203	26790230	3500152719	23		26790203	26790230	8421504	2	16,7	0,20	g	350015271900000010	17-41						A33 antigen specific immunoglobulin products and uses thereof	Barbas	1999	0		
791	chr17	27090451	27090476	3500238244	23		27090451	27090476	8421504	2	15,8	0,17	g	350023824400000017	15-38						Expression systems for making single-chain monellin analogs - US Patent 5487983 Description	ww.patentstorm.us	0	0		
792	chr17	27171273	27171298	3500363336	25		27171273	27171298	8421504	1	25	0	g	350036333600000020	0-25						UNIVERSIDADE FEDERAL DA PARA&#xcd;BA UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO UNIVERSIDADE FEDERAL DO CEAR&#xc1; PROGRAMA DE DOUTORADO INTEGRADO EM ZOOTECNIA	www.cca.ufpb.br	0	0		
792	chr17	27171273	27171298	3500211999	25		27171273	27171298	8421504	1	25	0	g	350021199900000003	0-25						Polymorphism Evaluation of Various Genomic Loci in the K&#xdd;v&#xdd;rc&#xdd;k Sheep Breed of Turkey	ls.tubitak.gov.tr	0	0		
792	chr17	27171273	27171298	3500164274	25		27171273	27171298	8421504	1	25	0	g	350016427400000022	0-25						RBI th on the Conservation of Animal Genetic Resources Tekirdag, TURKIYE 4 8 October 2011)	nf2011.nku.edu.tr	0	0		
792	chr17	27171273	27171298	3500134916	25		27171273	27171298	8421504	1	25	0	g	350013491600000096	0-25						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
793	chr17	27333839	27333866	3500020410	23		27333839	27333866	8421504	3	12,6,5	0,13,22	g	350002041000000019	2-25						Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the p - Patent # 6316004 - PatentGenius	.patentgenius.com	0	0		
809	chr17	29423845	29423869	3500148414	23		29423845	29423869	8421504	2	6,17	0,7	g	350014841400000645	4-27						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
815	chr17	30154721	30155081	3500285599	40		30154721	30155081	8421504	2	20,20	0,340	c	350028559900000009,350028559900000008	0-20,0-20					Infection and Immunity	Borrelia burgdorferi Induces the Production and Release of Proinflammatory Cytokines in Canine Synovial Explant Cultures	Reinhard	1998	0		
815	chr17	30154721	30155081	3500180956	40		30154721	30155081	8421504	2	20,20	0,340	c	350018095600000009,350018095600000008	0-20,0-20		9423865		0019-9567	Infection and Immunity	Borrelia burgdorferi Induces the Production and Release of Proinflammatory Cytokines in Canine Synovial Explant Cultures	Straubinger	1998	4		ACTR3
815	chr17	30155795	30155977	3500325286	42		30155795	30155977	8421504	2	21,21	0,161	c,g	350032528600000021,350032528600000020,350032528600000020	0-21,0-21,0-21						Metformin Decreases GnRH- and Activin-Induced Gonadotropin Secretion in Rat Pituitary Cells: Potential Involvement of Adenosine 5 Monophosphate-Activated Protein Kinase (PRKA)	ww.biolreprod.org	0	0		ACTR3
815	chr17	30155795	30155977	3500299757	42		30155795	30155977	8421504	2	21,21	0,161	c	350029975700000016,350029975700000008,350029975700000007	0-21,0-21,0-21						EXPRESSION, REGULATION ET ROLE DU SYSTEME ADIPONECTINE DANS L&#x2019;OVAIRE CHEZ TROIS ESPECES	lis.univ-tours.fr	0	0		
817	chr17	30430003	30430026	3500212475	23		30430003	30430026	8421504	1	23	0	g	350021247500000062	6-42						CELLS AND METHODOLOGY TO GENERATE NON-SEGMENTED NEGATIVE-STRAND RNA VIRUSES - Patent application	www.faqs.org	0	0		
823	chr17	31200119	31200326	3500133737	45		31200119	31200326	8421504	2	22,23	0,184	c,g	350013373700000025,350013373700000025,350013373700000026	0-22,0-22,0-23						REPRODUCTION	uction-online.org	0	0		
826	chr17	31605945	31605990	3500118455	45		31605945	31605990	8421504	1	45	0	p	350011845500015026	3-48						Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor	Anderson	2001	0		SLC25A31
827	chr17	31771484	31771509	3500148414	25		31771484	31771509	8421504	1	25	0	g	350014841400000773	4-31						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
830	chr17	32160600	32160625	3500206715	23		32160600	32160625	8421504	2	11,12	0,13	g	350020671500000002	11-34						METHODS AND COMPOSITIONS FOR TREATING P. ACNES	Gallo	2009	0		
834	chr17	32671877	32671903	3500035731	23		32671877	32671903	8421504	2	17,6	0,20	g	350003573100000006	0-23						Endoglucanases and cellulase preparations containing the same	Nakamura	1999	0		
838	chr17	33230847	33230876	3500412556	24		33230847	33230876	8421504	2	13,11	0,18	g	350041255600000002	7-31			10.1046/j.1365-313x.2000.00860.x	1365-313X	The Plant Journal	Evidence that endo-1,4-&#x03b2;-glucanases act on cellulose in suspension-cultured poplar cells - Ohmiya - 2001 - The Plant Journal - Wiley Online Library	Ohmiya	2000	0		
842	chr17	33695779	33695806	3500148407	26		33695779	33695806	8421504	2	14,12	0,15	g	350014840700000052	0-39						Modified Aerolysin And Methods Of Use For Treating Lung Cancer 	.freshpatents.com	0	0		
853	chr17	35197774	35197798	3500459899	24		35197774	35197798	8421504	1	24	0	g	350045989900000041	3-27						REASSESSMENT OF GENETIC DIVERSITY IN NATIVE TURKISH SHEEP BREEDS WITH LARGE NUMBERS OF MICROSATELLITE MARKERS AND MITOCHONDRIAL DNA (MTDNA) A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF NATURAL AND APPLIED SCIENCES OF MIDDLE EAST TECHNICAL UNIVERSITY BY FO	d.lib.metu.edu.tr	0	0		
859	chr17	35966014	35966040	3500415445	23		35966014	35966040	8421504	2	13,10	0,16	g	350041544500000138	11-48						Molecular antigen array - US Patent 7264810 Description	ww.patentstorm.us	0	0		
860	chr17	36113439	36113885	3500103005	45		36113439	36113885	8421504	2	21,24	0,422	c,g	350010300500000001,350010300500000001,350010300500000000	0-21,0-21,0-24		15306693	10.1152/physiolgenomics.00098.2004	1094-8341	Physiological Genomics	Identification and regulation of Sprouty1, a negative inhibitor of the ERK cascade, in the human heart	Huebert	2004	3		SPRY1
862	chr17	36352359	36352383	3500407417	23		36352359	36352383	8421504	2	18,5	0,19	g	350040741700000081	0-23						Method For Producing Carotenoids Or Their Precursors Using Genetically Modified Organisms Of The Blakeslea Genus, Carotenoids Or Their Precursors Produced By Said Method And Use Thereof 	.freshpatents.com	0	0		
863	chr17	36455364	36460107	3500136785	508		36455364	36460107	8421504	20	5,15,26,4,31,4,5,5,12,6,5,10,26,48,51,27,90,30,24,84	0,6,26,53,63,97,102,110,116,132,139,146,157,278,335,1607,1652,4441,4599,4659	p,c,g	350013678500000010,350013678500000009,350013678500015009,350013678500000008,350013678500000008,350013678500000007,350013678500015006,350013678500015005,350013678500000005,350013678500000004,350013678500000003,350013678500015002,350013678500000002	0-155,0-30,0-45,0-51,0-51,0-27,0-60,0-60,0-21,0-24,0-24,51-111,0-48						Cloning, sequence, and expression ofbovineinterleukin 2	www.pnas.org	0	0		
863	chr17	36455645	36460048	3500416780	244		36455645	36460048	8421504	7	108,30,21,27,18,12,28	0,1314,1440,4160,4205,4315,4375	c	350041678000000012,350041678000000011,350041678000000010,350041678000000007,350041678000000006,350041678000000004	0-42,0-48,0-48,0-48,0-30,20-48						Gamma-iterferon-leukotoxin gene fusions and uses thereof	Potter	1991	0		
863	chr17	36455660	36460047	3500464000	42		36455660	36460047	8421504	2	22,20	0,4367	c,g	350046400000000001,350046400000000000,350046400000000000	0-22,0-20,0-20			10.1046/j.1365-2567.2000.00124.x	1365-2567	Immunology	T helper 1-type cytokine transcription in peripheral blood mononuclear cells of pseudorabies virus (Suid herpesvirus 1)-primed swine indicates efficient immunization - Fischer - 2008 - Immunology - Wiley Online Library	Fischer	2000	0		IL2
863	chr17	36455660	36455702	3500186499	42		36455660	36455702	8421504	1	42	0	c	350018649900000537	0-42						Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity. - Patent application	www.faqs.org	0	0		
863	chr17	36455663	36460086	3500439378	40		36455663	36460086	8421504	2	20,20	0,4403	c	350043937800000001,350043937800000000	0-20,0-20		15150340	10.1099/jmm.0.45530-0	0022-2615	Journal of Medical Microbiology	Phenotypic and functional characterization of intraepithelial lymphocytes in a bovine ligated intestinal loop model of enterohaemorrhagic Escherichia coli infection	Menge	2004	3		IL2
863	chr17	36455663	36460086	3500408450	40		36455663	36460086	8421504	2	20,20	0,4403	c	350040845000000002,350040845000000001	0-20,0-20						Phenotypic and functional characterization of intraepithelial lymphocytes in a bovine ligated intestinal loop model of enterohaemorrhagic Escherichia coliinfection	m.sgmjournals.org	0	0		IL2
863	chr17	36455666	36455703	3500375186	37		36455666	36455703	8421504	1	37	0	c	350037518600000009	11-48						Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities - Patent application	www.faqs.org	0	0		
863	chr17	36455666	36455703	3500174807	37		36455666	36455703	8421504	1	37	0	c	350017480700000085	11-48						Nucleic acid transfer system	www.devileye.net	0	0		
863	chr17	36455666	36455703	3500120341	37		36455666	36455703	8421504	1	37	0	c	350012034100000009	11-48						CHIMERIC PROTEINS WITH CELL-TARGETING SPECIFICITY AND APOPTOSIS-INDUCING ACTIVITIES - Patent application	www.faqs.org	0	0		
863	chr17	36455680	36460090	3500325948	52		36455680	36460090	8421504	2	26,26	0,4384	c,g	350032594800000003,350032594800000002,350032594800000002	0-26,0-26,0-26						Regulation of Lymphocyte Proliferation by Uterine Serpin: Interleukin 3&#xf2;&#xd2;&#xf4;(-: ]&#xc4;J k &#xc1;&#xcf;&#xaf;&#xd9;&#xf5;&#xf2;&#xd7;; yHj&#xac; [:&#xd9;&#xca;&#xfa;f&G&#xbf;s8&#xb7;Ie7z^&#xda;IB 8&#xa9; $j j`[&#xf5;&#xe4;>k&#xdd;.&#xee;&#xd6	imal.ifas.ufl.edu	0	0		
863	chr17	36455701	36457035	3500399883	42		36455701	36457035	8421504	2	22,20	0,1314	c,g	350039988300000005,350039988300000005,350039988300000004	0-22,0-22,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	bdtd.ufscar.br	0	0		
863	chr17	36455701	36457035	3500177864	42		36455701	36457035	8421504	2	22,20	0,1314	c,g	350017786400000006,350017786400000006,350017786400000005	0-22,0-22,0-20						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
863	chr17	36455701	36457035	3500164845	42		36455701	36457035	8421504	2	22,20	0,1314	c,g	350016484500000005,350016484500000005,350016484500000004	0-22,0-22,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	ww.bdtd.ufscar.br	0	0		
863	chr17	36455701	36457035	3500136902	42		36455701	36457035	8421504	2	22,20	0,1314	c,g	350013690200000001,350013690200000001,350013690200000000	0-22,0-22,0-20						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
863	chr17	36455735	36456970	3500066560	27		36455735	36456970	8421504	4	5,12,2,8	0,6,1224,1227	c	350006656000000009	19-48						Quantitation ofmRNA bythe polymerasechain reaction	www.pnas.org	0	0		
863	chr17	36457002	36460043	3500275310	40		36457002	36460043	8421504	2	20,20	0,3021	c,g	350027531000000005,350027531000000004,350027531000000004	0-20,0-20,0-20						The Bovine Mammary Glands Cytokines at the Periparturient Period	apps.kfu.edu.sa	0	0		
863	chr17	36457022	36457055	3500245482	33		36457022	36457055	8421504	1	33	0	c	350024548200000171	6-39						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
863	chr17	36457034	36457058	3500131356	24		36457034	36457058	8421504	1	24	0	c	350013135600000004	0-24						Severe Combined Immunodeficiency Due to a Specific Defect in the Production of Interleukin-2 &#x2014; NEJM	www.nejm.org	0	0		
863	chr17	36457045	36459991	3500453465	52		36457045	36459991	8421504	2	27,25	0,2921	c	350045346500000001,350045346500000000	0-27,0-25						Expression profile of genes associated with mastitis in dairy cattle	cnptia.embrapa.br	0	0		
863	chr17	36457087	36460016	3500449915	50		36457087	36460016	8421504	3	19,7,24	0,2718,2905	c,g	350044991500000001,350044991500000000,350044991500000000	0-26,0-24,0-24						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
863	chr17	36459815	36460008	3500383646	40		36459815	36460008	8421504	2	20,20	0,173	c,g	350038364600000003,350038364600000002,350038364600000002	0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
863	chr17	36459948	36460308	3500124247	360		36459948	36460308	8421504	1	360	0	c,g	350012424700000010,350012424700000011,350012424700000008,350012424700000008,350012424700000006,350012424700000006,350012424700000004,350012424700000005,350012424700000002,350012424700000000	0-60,0-59,0-60,0-60,0-60,0-60,0-60,34-60,0-60,0-60						Flavia Aline Bressani Donatoni Prospec&#xe7;&#xe3;o de SNPs por eletroforese capilar e sua identifica&#xe7;&#xe3;o em genes candidatos relacionados &#xe0; resist&#xea;ncia de caprinos a nemat&#xf3;ides gastrintestinais	www.teses.usp.br	0	0		
863	chr17	36460036	36460100	3500128816	46		36460036	36460100	8421504	2	20,26	0,38	c,g	350012881600000001,350012881600000001,350012881600000000	0-20,0-20,0-26		19891613	10.1111/j.1365-3024.2009.01154.x	1365-3024	Parasite Immunology	A Lucilia cuprina excretory&#x2013;secretory protein inhibits the early phase of lymphocyte activation and subsequent proliferation - ELKINGTON - 2009 - Parasite Immunology - Wiley Online Library	ELKINGTON	2009	0		
863	chr17	36460260	36460352	3500076102	48		36460260	36460352	8421504	2	22,26	0,66	g	350007610200000013,350007610200000012	0-22,0-26						c-Rel Is Required for Chromatin Remodeling Across the IL-2 Gene Promoter	www.jimmunol.org	0	0		
863	chr17	36460292	36460319	3500276881	27		36460292	36460319	8421504	1	27	0	g	350027688100000000,350027688100000001	24-51,28-55						Method of isolating regulators of t cell activation	Batzer	1997	0		
864	chr17	36614578	36614731	3500311103	45		36614578	36614731	8421504	2	24,21	0,132	p	350031110300015016	0-45						Rat, rabbit, and cynomolgus monkey IL-21 and IL-22 nucleotide and polypeptide sequences - Patent application	www.faqs.org	0	0		
864	chr17	36614713	36614743	3500173079	30		36614713	36614743	8421504	1	30	0	c	350017307900000064,350017307900000030	0-30,0-30						Therapeutic application of isolated naturally-occuring soluble truncated forms of IL-23 receptor - Patent application	www.faqs.org	0	0		
864	chr17	36615108	36615136	3500282773	28		36615108	36615136	8421504	1	28	0	g	350028277300000162,350028277300000447	0-28,0-28						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT - Patent application	www.faqs.org	0	0		
864	chr17	36636163	36636186	3500056440	23		36636163	36636186	8421504	1	23	0	g	350005644000000000	0-23		19275886			Biochemical and Biophysical Research Communications	Functional aberration of myofibrils by cardiomyopathy-causing mutations in the coiled-coil region of the troponin-core domain.	Matsumoto	2009	0		
864	chr17	36675080	36675106	3500020064	23		36675080	36675106	8421504	2	16,7	0,19	g	350002006400000004	0-24						Risultati del 7&#xb0; test inter-laboratorio nazionale per l&#x2019;identificazione della presenza di ceppi di E. coli produttori di verocitotossina in alimenti di origine vegetale - 2011	www.iss.it/binary	0	0		
108	chr17	36815970	36870881	3500209717	245		36815970	36870881	8421504	12	20,20,22,20,21,20,22,20,21,19,20,20	0,321,1308,1341,3370,10811,11845,27691,30072,47641,54162,54891	c,g	350020971700000000,350020971700000028,350020971700000001,350020971700000012,350020971700000015,350020971700000017,350020971700000008,350020971700000019,350020971700000021,350020971700000025,350020971700000005,350020971700000005,350020971700000006,350020971700000006,350020971700000007,350020971700000007	0-20,0-20,0-22,0-20,0-21,0-20,0-22,0-20,0-21,0-19,0-20,0-20,0-20,0-20,0-20,0-20						METHODS AND COMPOSITIONS FOR IMPROVED FERTILIZATION AND EMBRYONIC SURVIAL	Khatib	2009	0		
108	chr17	36815970	36870881	3500067968	203		36815970	36870881	8421504	10	20,20,20,21,20,22,21,19,20,20	0,321,1341,3370,10811,11845,30072,47641,54162,54891	c,g	350006796800000000,350006796800000028,350006796800000012,350006796800000015,350006796800000017,350006796800000008,350006796800000021,350006796800000025,350006796800000006,350006796800000005,350006796800000007	0-20,0-20,0-20,0-21,0-20,0-22,0-21,0-19,0-20,0-20,0-20						Methods and compositions for improved fertilization and embryonic survival	Khatib	2009	0		
108	chr17	36816653	36870049	3500106681	121		36816653	36870049	8421504	3	31,48,42	0,90,53354	c	350010668100000015,350010668100000017,350010668100000024	7-38,0-48,0-42						Inhibitors of leaderless protein export	Baird	1998	0		
108	chr17	36816655	36870052	3500454205	468		36816655	36870052	8421504	4	31,147,104,186	0,32,39405,53211	c	350045420500000023	0-468						Team:Stockholm/Project Idea/Pre study - 2010.igem.org	2010.igem.org	0	0		FGF2,NUDT6
108	chr17	36816655	36870052	3500193866	468		36816655	36870052	8421504	4	31,147,104,186	0,32,39405,53211	c	350019386600000023	0-468						Team:Stockholm/Planning - 2010.igem.org	2010.igem.org	0	0		FGF2,NUDT6
108	chr17	36816655	36870052	3500157437	468		36816655	36870052	8421504	4	31,147,104,186	0,32,39405,53211	c,g	350015743700000004,350015743700000000,350015743700000000,350015743700000005,350015743700000005,350015743700000006,350015743700000007,350015743700000007,350015743700000008,350015743700000009,350015743700000009,350015743700000010,350015743700000010,350015743700000011,350015743700000001	0-60,0-19,0-19,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-48,0-21						SLOVENIAN VETERINARY RESEARCH	www.slovetres.si	0	0		
108	chr17	36816655	36870049	3500412831	465		36816655	36870049	8421504	4	31,147,104,183	0,32,39405,53211	p	350041283100015005	0-465						FGF-2 HAVING ENHANCED STABILITY - Patent application	www.faqs.org	0	0		FGF2,NUDT6
108	chr17	36816655	36870049	3500396186	465		36816655	36870049	8421504	4	31,147,104,183	0,32,39405,53211	p	350039618600015026,350039618600015027	0-87,0-378						Compositions and Methods for the Delivery of Biologically Active RNAs	Polach	2012	0		FGF2,NUDT6
108	chr17	36816655	36870049	3500380446	465		36816655	36870049	8421504	4	31,147,104,183	0,32,39405,53211	p	350038044600015029	0-465						FGF VARIANTS AND METHODS FOR USE THEREOF - Patent application	www.faqs.org	0	0		FGF2,NUDT6
108	chr17	36816655	36870049	3500322474	465		36816655	36870049	8421504	4	31,147,104,183	0,32,39405,53211	c	350032247400000024	60-525						ACTIVATED COLLAGEN SCAFFOLD MATERIALS AND THEIR SPECIAL FUSED ACTIVE RESTORATION FACTORS - Patent application	www.faqs.org	0	0		FGF2,NUDT6
108	chr17	36816655	36870049	3500236493	462		36816655	36870049	8421504	5	31,74,70,104,183	0,32,109,39405,53211	p	350023649300015005	0-462						Fgf-2 having enhanced stability	Chen	2013	0		FGF2,NUDT6
108	chr17	36816655	36870049	3500236493	462		36816655	36870049	8421504	5	31,74,70,104,183	0,32,109,39405,53211	p	350023649300015004	0-462						Fgf-2 having enhanced stability	Chen	2013	0		FGF2,NUDT6
108	chr17	36816655	36870049	3500175950	465		36816655	36870049	8421504	4	31,147,104,183	0,32,39405,53211	p	350017595000015022,350017595000015099,350017595000015023	0-87,0-45,0-378						Compositions And Methods For The Delivery Of Biologically Active RNAs - Patent application	www.faqs.org	0	0		FGF2,NUDT6
865	chr17	36816655	36816682	3500301622	27		36816655	36816682	8421504	1	27	0	c	350030162200000002	10-37						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
865	chr17	36816655	36816682	3500298212	27		36816655	36816682	8421504	1	27	0	c	350029821200000002	10-37					Patent	MEDICAL DEVICE comprising a synthetic surface having nucleic acid for in vivo induction of its endothelialisation (Patent EP:1235536)	Lahtinen	2003	0		
865	chr17	36816655	36816682	3500186272	27		36816655	36816682	8421504	1	27	0	c	350018627200000002	10-37						Medical device	Lahtinen	2003	0		FGF2
108	chr17	36816680	36870052	3500209179	443		36816680	36870052	8421504	4	6,147,104,186	0,7,39380,53186	c	350020917900000010	1-444						Sugar Chain-containing Albumin, Production Method Thereof And Use Thereof 	.freshpatents.com	0	0		
108	chr17	36816680	36870052	3500078770	443		36816680	36870052	8421504	4	6,147,104,186	0,7,39380,53186	c	350007877000000018	1-444						METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MALE ERECTILE DYSFUNCTION AND FEMALE SEXUAL AROUSAL DISORDER - Patent application	www.faqs.org	0	0		
108	chr17	36816682	36870049	3500322310	438		36816682	36870049	8421504	4	4,147,104,183	0,5,39378,53184	p	350032231000015000,350032231000015002,350032231000015001	0-216,0-438,0-219						Human basic fibroblast growth factor	Kurokawa	1987	0		FGF2,NUDT6
865	chr17	36816682	36816755	3500139283	72		36816682	36816755	8421504	2	4,68	0,5	p	350013928300015002	0-72						Heterologous expression and biochemical characterization - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		FGF2
108	chr17	36816707	36870040	3500303194	180		36816707	36870040	8421504	3	90,45,45	0,39406,53288	p	350030319400015001,350030319400015002,350030319400015005,350030319400015008	0-45,0-45,0-45,0-45						THE OF CHEMISTRY Vol. 263, No. 34, Issue of 5, pp. 18452-1&58,1988 1988 by The American Society for and in U. S. A. Production, Biological Activity, and Structure of Recombinant Basic Fibroblast Growth Factor and an Analog with Cysteine Replaced by Serine	www.jbc.org	0	0		FGF2,NUDT6
865	chr17	36816713	36816752	3500362735	39		36816713	36816752	8421504	1	39	0	c	350036273500000247	9-48						Compositions containing nucleic acids and ligands for therapeutic treatment	Baird	1999	0		
865	chr17	36816713	36816752	3500155898	39		36816713	36816752	8421504	1	39	0	c	350015589800000152	9-48						Heparin-binding growth factors for gene therapy and anterior eye disorders	Sosnowski	1995	0		
865	chr17	36816713	36816752	3500083500	39		36816713	36816752	8421504	1	39	0	c	350008350000000121	9-48						Recombinant production of saporin-containing proteins	Lappi	1995	0		
865	chr17	36816713	36816752	3500007922	39		36816713	36816752	8421504	1	39	0	c	350000792200000121	9-48						 Recombinant Production Of Saporin 	www.docstoc.com	0	0		
108	chr17	36816728	36870052	3500197853	396		36816728	36870052	8421504	3	106,104,186	0,39332,53138	c	350019785300000018	3-399						N-TERMINAL FGF VARIANTS HAVING INCREASED RECEPTOR SELECTIVITY AND USES THEREOF - Patent application	www.faqs.org	0	0		FGF2,NUDT6
865	chr17	36816730	36816755	3500124282	25		36816730	36816755	8421504	1	25	0	c	350012428200000039,350012428200000041	0-19,0-25						Me t h o d s in	torage.mjjw.co.uk	0	0		FGF2
108	chr17	36816731	36870052	3500197853	393		36816731	36870052	8421504	3	103,104,186	0,39329,53135	c	350019785300000030	6-399						N-TERMINAL FGF VARIANTS HAVING INCREASED RECEPTOR SELECTIVITY AND USES THEREOF - Patent application	www.faqs.org	0	0		FGF2,NUDT6
108	chr17	36816734	36870052	3500197853	390		36816734	36870052	8421504	3	100,104,186	0,39326,53132	c	350019785300000043	9-399						N-TERMINAL FGF VARIANTS HAVING INCREASED RECEPTOR SELECTIVITY AND USES THEREOF - Patent application	www.faqs.org	0	0		FGF2,NUDT6
108	chr17	36816740	36870052	3500197853	384		36816740	36870052	8421504	3	94,104,186	0,39320,53126	c	350019785300000022	3-387						N-TERMINAL FGF VARIANTS HAVING INCREASED RECEPTOR SELECTIVITY AND USES THEREOF - Patent application	www.faqs.org	0	0		FGF2,NUDT6
865	chr17	36816741	36816766	3500131006	25		36816741	36816766	8421504	1	25	0	c	350013100600000026	0-25						Role of Transcription Factors in the Pathomechanism of Cardiac Hypertrophy	phd.sote.hu	0	0		
108	chr17	36816743	36870052	3500197853	381		36816743	36870052	8421504	3	91,104,186	0,39317,53123	c	350019785300000024	0-381						N-TERMINAL FGF VARIANTS HAVING INCREASED RECEPTOR SELECTIVITY AND USES THEREOF - Patent application	www.faqs.org	0	0		FGF2,NUDT6
108	chr17	36816743	36870052	3500197853	381		36816743	36870052	8421504	3	91,104,186	0,39317,53123	c	350019785300000023	3-384						N-TERMINAL FGF VARIANTS HAVING INCREASED RECEPTOR SELECTIVITY AND USES THEREOF - Patent application	www.faqs.org	0	0		FGF2,NUDT6
108	chr17	36816781	36870010	3500465007	169		36816781	36870010	8421504	6	23,23,7,46,23,47	0,27,39376,53085,53138,53182	c	350046500700000023,350046500700000029,350046500700000018,350046500700000016,350046500700000038,350046500700000043,350046500700000070	0-23,0-23,0-23,0-23,0-23,0-23,1-48						US Patent # 6,294,359. Human basic fibroblast growth factor analog - Patents.com	www.patents.com	0	0		
108	chr17	36816781	36869942	3500351776	173		36816781	36869942	8421504	7	23,23,58,7,16,23,23	0,27,39287,39376,53085,53108,53138	c,g	350035177600000023,350035177600000029,350035177600000067,350035177600000017,350035177600000018,350035177600000038,350035177600000043	0-23,0-23,0-48,0-23,0-23,0-23,0-23						Human basic fibroblast growth factor analog	Fiddes	1998	0		
108	chr17	36816781	36869942	3500037694	115		36816781	36869942	8421504	6	23,23,7,16,23,23	0,27,39376,53085,53108,53138	c	350003769400000016,350003769400000022,350003769400000012,350003769400000031,350003769400000036	0-23,0-23,0-23,0-23,0-23						Recombinant fibroblast growth factor analogs	Fiddes	2005	0		
865	chr17	36816781	36816831	3500234684	46		36816781	36816831	8421504	2	23,23	0,27	c	350023468400000013,350023468400000019	0-23,0-23						Recombinant fibroblast growth factors	Abraham	1990	0		
865	chr17	36816781	36816831	3500104514	46		36816781	36816831	8421504	2	23,23	0,27	c	350010451400000011,350010451400000017	0-23,0-23						Recombinant fibroblast growth factors	Abraham	1989	0		
108	chr17	36816816	36870055	3500153648	69		36816816	36870055	8421504	4	18,3,21,27	0,39244,53144,53212	c,g	350015364800000032,350015364800000033,350015364800000033,350015364800000045,350015364800000045	0-21,0-21,0-21,35-62,35-62						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
108	chr17	36816817	36869965	3500014561	42		36816817	36869965	8421504	3	17,4,21	0,39243,53127	c	350001456100000012,350001456100000013	0-21,0-21						Immortalization of swine umbilical vein endothelial cells (SUVECs) with the simian virus 40 large-T antigen. - ResearchGate	.researchgate.net	0	0		
108	chr17	36816830	36856080	3500387134	24		36816830	36856080	8421504	2	4,20	0,39230	c	350038713400000001	0-24						Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications	Lee	2007	0		FGF2
866	chr17	36856065	36856090	3500188342	25		36856065	36856090	8421504	1	25	0	c	350018834200000001,350018834200000006	16-42,0-25						Mass Producing Method of Growth Factor Using Adipose Derived Adult Stem Cells - Patent application	www.faqs.org	0	0		
866	chr17	36856065	36856090	3500016548	25		36856065	36856090	8421504	1	25	0	c	350001654800000006	0-25		14993122	10.1161/01.CIR.0000121425.42966.F1	0009-7322	Circulation	Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells	Rehman	2004	15		
866	chr17	36856066	36870051	3500385098	40		36856066	36870051	8421504	2	20,20	0,13965	c	350038509800000010,350038509800000011	0-20,0-20						Author's personal copy	ss.bjmu.edu.cn	0	0		FGF2,NUDT6
866	chr17	36856066	36870051	3500264993	40		36856066	36870051	8421504	2	20,20	0,13965	c	350026499300000006,350026499300000007	0-20,0-20						Angiogenesis-modulating compositions and uses	Ling	2003	0		FGF2,NUDT6
866	chr17	36856066	36870051	3500236229	40		36856066	36870051	8421504	2	20,20	0,13965	c,g	350023622900000002,350023622900000002,350023622900000003,350023622900000003	0-20,0-20,0-20,0-20		10642573	10.1095/biolreprod62.2.355	0006-3363	Biology of Reproduction	Impact of Bovine Oocyte Maturation Media on Oocyte Transcript Levels, Blastocyst Development, Cell Number, and Apoptosis	Watson	2000	4		FGF2,NUDT6
866	chr17	36856066	36870051	3500228652	40		36856066	36870051	8421504	2	20,20	0,13965	c,g	350022865200000002,350022865200000002,350022865200000003,350022865200000003	0-20,0-20,0-20,0-20		10642573	10.1095/biolreprod62.2.355	0006-3363	Biology of Reproduction	Impact of Bovine Oocyte Maturation Media on Oocyte Transcript Levels, Blastocyst Development, Cell Number, and Apoptosis	Watson	2000	4		FGF2,NUDT6
866	chr17	36856066	36870051	3500162207	40		36856066	36870051	8421504	2	20,20	0,13965	c	350016220700000006,350016220700000007	0-20,0-20						Angiogenesis-modulating compositions and uses	Ling	2001	0		FGF2,NUDT6
866	chr17	36856066	36870051	3500101088	40		36856066	36870051	8421504	2	20,20	0,13965	c,g	350010108800000006,350010108800000006,350010108800000109,350010108800000109,350010108800000007,350010108800000110	0-20,0-20,0-20,0-20,0-20,0-20						Angiogenesis-modulating compositions and uses - Patent application	www.faqs.org	0	0		FGF2,NUDT6
866	chr17	36856066	36870051	3500093417	40		36856066	36870051	8421504	2	20,20	0,13965	c,g	350009341700000006,350009341700000006,350009341700000007	0-20,0-20,0-20						Angiogenesis-modulating compositions and uses	Ling	2010	0		FGF2,NUDT6
866	chr17	36856066	36870051	3500090396	40		36856066	36870051	8421504	2	20,20	0,13965	c,g	350009039600000006,350009039600000006,350009039600000007	0-20,0-20,0-20						Angiogenesis-modulating compositions and uses	Ling	2003	0		FGF2,NUDT6
866	chr17	36856103	36856127	3500171116	24		36856103	36856127	8421504	1	24	0	c	350017111600000017	17-41						Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells	www.iovs.org	0	0		FGF2
866	chr17	36856114	36869981	3500274037	50		36856114	36869981	8421504	2	20,30	0,13837	c,g	350027403700000148,350027403700000148,350027403700000147,350027403700000147,350027403700000149,350027403700000149	0-20,0-20,0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		FGF2,NUDT6
866	chr17	36869874	36869942	3500104514	68		36869874	36869942	8421504	1	68	0	c,g	350010451400000008,350010451400000026,350010451400000029,350010451400000031	0-23,0-23,0-23,0-23						Recombinant fibroblast growth factors	Abraham	1989	0		
866	chr17	36869889	36869942	3500234684	46		36869889	36869942	8421504	2	23,23	0,30	c	350023468400000028,350023468400000033	0-23,0-23						Recombinant fibroblast growth factors	Abraham	1990	0		
866	chr17	36869926	36869951	3500407656	25		36869926	36869951	8421504	1	25	0	c	350040765600000003	0-25		17409396	10.1158/0008-5472.CAN-06-4268	0008-5472	Cancer Research	Mammalian Tumor Xenografts Induce Neovascularization in Zebrafish Embryos	Nicoli	2007	8		
866	chr17	36869929	36869954	3500377667	25		36869929	36869954	8421504	1	25	0	c	350037766700000010	24-49						Caspase-1 Ablation Protects Photoreceptors in a Model of Autosomal Dominant Retinitis Pigmentosa	www.iovs.org	0	0		
866	chr17	36869945	36870006	3500078470	42		36869945	36870006	8421504	2	21,21	0,40	c,g	350007847000000004,350007847000000004,350007847000000005,350007847000000005	0-21,0-21,0-21,0-21						Transforming growth factor beta family expression at the bovine feto-maternal interface	biomedcentral.com	0	0		
866	chr17	36869965	36870052	3500189128	51		36869965	36870052	8421504	2	21,30	0,57	c,g	350018912800000000,350018912800000000,350018912800000005	0-21,0-21,0-30		16868034	10.1124/jpet.106.108803	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Fibroblast Growth Factor-2 Mediates Angiotensin-Converting Enzyme Inhibitor-Induced Angiogenesis in Coronary Endothelium	Donnini	2006	0		FGF2,NUDT6
866	chr17	36869986	36870009	3500047371	23		36869986	36870009	8421504	1	23	0	c	350004737100000001	0-23						Basic Fibroblast Growth Factor Expression Precedes Flow-Induced Arter{&#xd7;eZ &#xea;&#xf8;g&#xb9;&#xec;&#xdc;.&#xce;$q	slab.stanford.edu	0	0		NUDT6
866	chr17	36870016	36870049	3500155898	33		36870016	36870049	8421504	1	33	0	c	350015589800000261,350015589800000208,350015589800000342,350015589800000234,350015589800000134,350015589800000123	0-33,0-33,0-33,0-33,0-33,0-27						Heparin-binding growth factors for gene therapy and anterior eye disorders	Sosnowski	1995	0		
866	chr17	36870016	36870049	3500033367	33		36870016	36870049	8421504	1	33	0	c	350003336700000009	0-33						DNA encoding chimeric fibroblast growth factors - Patent # 5371206 - PatentGenius	.patentgenius.com	0	0		
866	chr17	36870021	36870049	3500454205	28		36870021	36870049	8421504	1	28	0	c	350045420500000038	10-38						Team:Stockholm/Project Idea/Pre study - 2010.igem.org	2010.igem.org	0	0		
866	chr17	36870022	36870052	3500352782	30		36870022	36870052	8421504	1	30	0	c	350035278200000001	0-30						Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. - ResearchGate	.researchgate.net	0	0		
866	chr17	36870022	36870052	3500022381	30		36870022	36870052	8421504	1	30	0	c	350002238100000001	0-30		10637205	10.1161/01.CIR.101.2.171	0009-7322	Circulation	Oxidized Low-Density Lipoproteins Inhibit Endothelial Cell Proliferation by Suppressing Basic Fibroblast Growth Factor Expression	Chen	2000	15		
866	chr17	36870022	36870045	3500140979	23		36870022	36870045	8421504	1	23	0	c,g	350014097900000000,350014097900000000	18-41,18-41		11874475	10.1046/j.0022-202x.2001.01705.x	0022-202X	Journal of Investigative Dermatology	Mast Cell&#x2013;Fibroblast Interactions: Human Mast Cells as Source and Inducers of Fibroblast and Epithelial Growth Factors	Artuc	2002	6		
866	chr17	36870025	36870052	3500301622	27		36870025	36870052	8421504	1	27	0	c	350030162200000003	10-37						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		NUDT6
866	chr17	36870025	36870052	3500298212	27		36870025	36870052	8421504	1	27	0	c	350029821200000003	10-37					Patent	MEDICAL DEVICE comprising a synthetic surface having nucleic acid for in vivo induction of its endothelialisation (Patent EP:1235536)	Lahtinen	2003	0		NUDT6
866	chr17	36870025	36870052	3500186272	27		36870025	36870052	8421504	1	27	0	c	350018627200000003	10-37						Medical device	Lahtinen	2003	0		NUDT6
866	chr17	36870027	36870052	3500312107	25		36870027	36870052	8421504	1	25	0	c,g	350031210700000006,350031210700000029,350031210700000026	10-32,10-34,10-34						Enhanced prodrug activation	Griffiths	2001	0		NUDT6
866	chr17	36870027	36870052	3500278462	25		36870027	36870052	8421504	1	25	0	c	350027846200000006,350027846200000026,350027846200000029	10-32,10-34,10-34						Enhanced prodrug activation	Griffiths	1999	0		
866	chr17	36870027	36870051	3500272203	24		36870027	36870051	8421504	1	24	0	c	350027220300000003	18-42						Increased Protein of the Secretory Leukocyte Protease Inhibitor(SLPI) and the Expression of Growth Factors in NIH3T3 Cells by LPS Stimulation	www.ksem.com	0	0		
866	chr17	36872956	36873035	3500091455	45		36872956	36873035	8421504	2	21,24	0,55	c,g	350009145500000010,350009145500000011,350009145500000011	0-21,0-24,0-24		22174022	10.1095/biolreprod.111.095067	0006-3363	Biology of Reproduction	Regulation of Angiogenesis-Related Prostaglandin F2alpha-Induced Genes in the Bovine Corpus Luteum	Zalman	2012	4		
866	chr17	36929318	36929341	3500214416	23		36929318	36929341	8421504	1	23	0	c	350021441600002420,350021441600002421,350021441600002434,350021441600002431	9-35,9-35,9-35,9-35						MOLECULAR CHARACTERIZATION OF THEILERIA spp. USING RIBOSOMAL RNA	pository.tamu.edu	0	0		
871	chr17	37509769	37516676	3500340567	65		37509769	37516676	8421504	4	23,4,16,22	0,123,6812,6885	c	350034056700000010,350034056700000001,350034056700000007	23-46,0-20,23-45						Transcriptome analysis of mammary tissues reveals complex patterns of transporter gene expression during pregnancy and lactation	w.cellbiolint.org	0	0		TRPC3
871	chr17	37530344	37534858	3500256575	50		37530344	37534858	8421504	3	12,12,26	0,1746,4488	c	350025657500000030,350025657500000031	0-24,0-26						Thrombin Activates Ca&#xc6cc;&#xc6b8;-permeating Nonselective Cation Channels through Protein Kinase C in Human Umbilical Vein Endothelial Cells	s-igaku.umin.jp	0	0		TRPC3
871	chr17	37534856	37538873	3500450003	24		37534856	37538873	8421504	2	13,11	0,4006	c	350045000300000002	4-28		20668213	10.1152/ajpcell.00036.2010		American Journal of Physiology - Cell Physiology	Somatic ATP release from guinea pig sympathetic neurons does not require calcium-induced calcium release from internal stores	Laura	2010	0		TRPC3
871	chr17	37534856	37538873	3500002946	24		37534856	37538873	8421504	2	13,11	0,4006	c	350000294600000002	4-28		20668213	10.1152/ajpcell.00036.2010		American Journal of Physiology - Cell Physiology	Somatic ATP release from guinea pig sympathetic neurons does not require calcium-induced calcium release from internal stores	Merriam	2010	0		TRPC3
871	chr17	37534865	37538881	3500278351	23		37534865	37538881	8421504	2	4,19	0,3997	c	350027835100000002	0-23						M4:07384- Revised TRPC1-Mediated Inhibition of MPP Neurotoxicity in Human SH-SY5Y Neuroblastoma Cells	www.jbc.org	0	0		
871	chr17	37539049	37540319	3500169580	23		37539049	37540319	8421504	2	9,14	0,1256	c	350016958000000001	24-47		18506892	10.1002/hep.22263	1527-3350	Hepatology	Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation - El Boustany - 2008 - Hepatology - Wiley Online Library	Boustany	2008	0		
876	chr17	38181671	38181698	3500183842	24		38181671	38181698	8421504	2	9,15	0,12	g	350018384200000006	1-43						NORISK_FinRep_Transmission Routes for Noroviruses Emerging Human Pathogens in Food	www.scribd.com	0	0		
877	chr17	38295473	38295497	3500247523	23		38295473	38295497	8421504	2	10,13	0,11	g	350024752300000070	3-28					Patent	Methods of detecting platelet-activating factor acetylhydrolase using antibodies (Patent US:5698403)	Cousens	1997	0		
878	chr17	38457313	38457338	3500278507	25		38457313	38457338	8421504	1	25	0	g	350027850700000008	14-45						Recombinant poxvirus expressing homologous genes inserted into the poxviral genome	Bao Luo *Hao Li 	2010	0		
882	chr17	38938692	38938717	3500248094	23		38938692	38938717	8421504	2	7,16	0,9	g	350024809400001412	1-24						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
900	chr17	41390078	41390111	3500300591	28		41390078	41390111	8421504	3	13,11,4	0,17,29	g	350030059100000390	1-29						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
902	chr17	41673420	41673448	3500179181	26		41673420	41673448	8421504	2	5,21	0,7	g	350017918100000158	5-31						Enzymatic DNA molecules	www.devileye.net	0	0		
906	chr17	42143604	42143664	3500433032	41		42143604	42143664	8421504	2	20,21	0,39	c,g	350043303200000002,350043303200000003,350043303200000003	0-20,0-21,0-21						Obesity and leptin resistance: The role of growth hormone - ResearchGate	.researchgate.net	0	0		
907	chr17	42297488	42297592	3500259232	104		42297488	42297592	8421504	1	104	0	g	350025923200000039	0-105						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
907	chr17	42297488	42297592	3500000589	104		42297488	42297592	8421504	1	104	0	g	350000058900000066	0-105						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
910	chr17	42612602	42612627	3500031179	23		42612602	42612627	8421504	2	16,7	0,18	c	350003117900000002	22-45						Molecular analysis of &#xfb01;ber type-speci&#xfb01;c expression of murine myostatin promoter	ll.physiology.org	0	0		
913	chr17	43020743	43020772	3500139533	25		43020743	43020772	8421504	3	14,6,5	0,17,24	g	350013953300000007	0-25						Invasive cleavage of nucleic acids	Brow	1997	0		
918	chr17	43743173	43746651	3500441562	47		43743173	43746651	8421504	3	24,20,3	0,2051,3475	c	350044156200000021,350044156200000020	0-24,0-23						Oncology drug innovation	Poulsen	2002	0		GRIA2
918	chr17	43743173	43746651	3500254665	47		43743173	43746651	8421504	3	24,20,3	0,2051,3475	c	350025466500000021,350025466500000020	0-24,0-23						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		GRIA2
918	chr17	43743173	43746651	3500060549	47		43743173	43746651	8421504	3	24,20,3	0,2051,3475	c	350006054900000021,350006054900000020	0-24,0-23						Oncology drug innovation	Poulsen	2005	0		GRIA2
918	chr17	43743735	43743759	3500238318	24		43743735	43743759	8421504	1	24	0	c	350023831800000001	18-42						Role of GluR1 expression in nucleus accumbens neurons in cocaine sensitization and cocaine-seeking behavior	tsouthwestern.edu	0	0		
114	chr17	43743797	43924565	3500338459	603		43743797	43924565	8421504	12	48,33,96,16,35,48,48,47,48,47,48,89	0,3057,36712,36856,41250,41333,41477,44926,45288,64955,89431,180679	c,g	350033845900000074,350033845900000064,350033845900000062,350033845900000061,350033845900000059,350033845900000000,350033845900000057,350033845900000054,350033845900000044,350033845900000042,350033845900000038,350033845900000028,350033845900000025,350033845900000024	0-48,0-33,0-48,0-48,0-48,0-23,0-48,0-48,0-47,0-48,1-48,0-48,0-41,0-48						Glutamate receptor (or EAA receptor) polynucleotides and their uses	Kamboj	1996	0		
918	chr17	43745129	43746650	3500356639	60		43745129	43746650	8421504	4	20,18,20,2	0,97,617,1519	c,g	350035663900000009,350035663900000011,350035663900000008,350035663900000006,350035663900000006	0-20,0-20,0-20,0-20,0-20						USE OF NON-STANDARD BASES AND PROXIMITY EFFECTS FOR GENE ASSEMBLY AND CONVERSION OF NON-STANDARD BASES TO STANDARD BASES DURING DNA SYNTHESIS	Prudent	2007	0		GRIA2
114	chr17	43745166	43785313	3500209897	69		43745166	43785313	8421504	3	22,23,24	0,35412,40123	c,g	350020989700000007,350020989700000017,350020989700000016	0-22,0-23,0-24			10.1046/j.1471-4159.2000.0740179.x	1471-4159	Journal of Neurochemistry	Characterization of the AMPA-Activated Receptors Present on Motoneurons - Greig - 2001 - Journal of Neurochemistry - Wiley Online Library	Greig	2000	0		GRIA2
918	chr17	43746653	43746679	3500037551	26		43746653	43746679	8421504	1	26	0	c	350003755100000009	0-26						THE J BIOLOGICAL C Vol. 279, No. 6, Issue of February 6, pp. 4952&#x2013;4961, 2004 Printed in U.S.A. Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene*	www.jbc.org	0	0		GRIA2
114	chr17	43746780	43780577	3500083717	44		43746780	43780577	8421504	2	20,24	0,33773	c,g	350008371700000001,350008371700000001,350008371700000002,350008371700000002	0-20,0-20,0-24,0-24						Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons	www.fasebj.org	0	0		GRIA2
919	chr17	43780615	43780638	3500249427	23		43780615	43780638	8421504	1	23	0	c	350024942700000000	0-23		8987751		0270-6474	The Journal of Neuroscience	Growth Factor-Induced Transcription of GluR1 Increases Functional AMPA Receptor Density in Glial Progenitor Cells	Chew	1997	7		GRIA2
919	chr17	43780625	43780653	3500391930	25		43780625	43780653	8421504	3	8,13,4	0,10,24	c	350039193000000040	5-30						Hepatoblast-Like Progenitor Cells Derived From Embryonic Stem Cells Can Repopulate Livers of Mice	library.ibp.ac.cn	0	0		
919	chr17	43785142	43785172	3500403336	27		43785142	43785172	8421504	3	8,5,14	0,9,16	c	350040333600000299	9-40					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
919	chr17	43785142	43785172	3500312985	27		43785142	43785172	8421504	3	8,5,14	0,9,16	c	350031298500000303	9-40					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
919	chr17	43785142	43785172	3500070162	27		43785142	43785172	8421504	3	8,5,14	0,9,16	c	350007016200000303	9-40					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6124104)	Couch	2000	0		
919	chr17	43785142	43785172	3500049566	27		43785142	43785172	8421504	3	8,5,14	0,9,16	c	350004956600000303	9-40					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
114	chr17	43785931	43925183	3500194997	1389		43785931	43925183	8421504	10	186,111,105,168,162,54,197,240,141,25	0,1975,2776,3148,22791,27786,32951,47200,138537,139227	p	350019499700015000	0-1389						&#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x4f5c;&#x4e1a;_&#x767e;&#x5ea6;&#x6587;&#x5e93;	wenku.baidu.com	0	0		
923	chr17	44363023	44363046	3500383422	23		44363023	44363046	8421504	1	23	0	g	350038342200000001	0-26						AEM Accepts, published online ahead of print on 20 April 2012 Appl. Environ. Microbiol. doi:10.1128/AEM.07718-11 Copyright &#xa9; 2012, American Society for Microbiology. All Rights Reserved. Heterologous Expression in Pichia pastoris -Glucosidase	aem.asm.org	0	0		
924	chr17	44531789	44531817	3500072073	23		44531789	44531817	8421504	2	17,6	0,22	g	350007207300000028	0-24		19211700	10.1104/pp.108.133298		Plant Physiology	SnRK1 Isoforms AKIN10 and AKIN11 Are Differentially Regulated in Arabidopsis Plants under Phosphate Starvation	Selene	2009	0		
933	chr17	45694079	45710873	3500276662	155		45694079	45710873	8421504	5	20,9,45,60,21	0,11525,12558,15302,16773	p,c,g	350027666200000001,350027666200000001,350027666200015003,350027666200015012,350027666200015009	0-20,0-20,0-54,0-66,0-45					Patent	ISOLIERTE UND GEREINIGTE HUMANE L&#xd6;SLICHE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGC ALPHA1/BETA1) (Patent EP:1105503)	Poller	2004	0		GUCY1B3
933	chr17	45702255	45702279	3500457504	24		45702255	45702279	8421504	1	24	0	c	350045750400000051	0-24						Molekularbiologische und pharmakologische Untersuchungen zur Aktivierung der l&#xf6;slichen Guanylatcyclase	thek.uni-halle.de	0	0		
933	chr17	45705421	45709432	3500365521	606		45705421	45709432	8421504	4	192,141,155,118	0,1216,3238,3893	p	350036552100015000	3-609						SGC | Structure Details	www.thesgc.org	0	0		GUCY1B3
933	chr17	45705421	45706667	3500187783	222		45705421	45706667	8421504	2	192,30	0,1216	p	350018778300015037	3-225						Oxford_SGC_Clones_web	www.docstoc.com	0	0		GUCY1B3
933	chr17	45709417	45710873	3500267660	45		45709417	45710873	8421504	2	24,21	0,1435	p	350026766000015005	0-45		11675397		1046-6673	Journal of the American Society of Nephrology	Cellular Distribution and Function of Soluble Guanylyl Cyclase in Rat Kidney and Liver	THEILIG	2001	10		
935	chr17	45943627	45943684	3500276662	57		45943627	45943684	8421504	1	57	0	p	350027666200015007	0-57					Patent	ISOLIERTE UND GEREINIGTE HUMANE L&#xd6;SLICHE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGC ALPHA1/BETA1) (Patent EP:1105503)	Poller	2004	0		
935	chr17	45957112	45960826	3500328592	29		45957112	45960826	8421504	2	5,24	0,3690	c	350032859200000016	0-29						Untersuchung des Einflusses des Gerinnungsfaktors Thrombin auf die pulmonalarterielle Hypertonie	uhr-uni-bochum.de	0	0		
935	chr17	45963321	45963621	3500457504	282		45963321	45963621	8421504	2	204,78	0,222	p	350045750400015020,350045750400015006	0-150,0-210						Molekularbiologische und pharmakologische Untersuchungen zur Aktivierung der l&#xf6;slichen Guanylatcyclase	thek.uni-halle.de	0	0		
935	chr17	45963812	45976693	3500008457	41		45963812	45976693	8421504	2	21,20	0,12861	c,g	350000845700000001,350000845700000000,350000845700000000	0-21,0-20,0-20			10.1186/1471-2091-3-26	1471-2091	BMC Biochemistry	Prolonged exposure of chromaffin cells to nitric oxide down-regulates the activity of soluble guanylyl cyclase and corresponding mRNA and protein levels	Ferrero	2002	2		
935	chr17	45998550	45998573	3500071383	23		45998550	45998573	8421504	1	23	0	g	350007138300000050	0-41						Nucieic acid amplification methods	Yi	2006	0		
936	chr17	46007701	46007725	3500284980	23		46007701	46007725	8421504	2	13,10	0,14	c	350028498000000209	6-29					Patent	Transgenic transchromosomal rodents for making human antibodies (Patent CN:1487996)	E*Ha Er Ke 	2010	0		
938	chr17	46316839	46316864	3500374404	23		46316839	46316864	8421504	2	16,7	0,18	g	350037440400000040,350037440400000041,350037440400000152,350037440400000153	0-23,2-25,0-23,2-25						Combinations of TGFBeta and COX-2 Inhibitors and Methods for Their Therapeutic Application - Patent application	www.faqs.org	0	0		
940	chr17	46534567	46534593	3500217406	23		46534567	46534593	8421504	3	6,12,5	0,8,21	g	350021740600000002	6-31						Dissertation	.uni-tuebingen.de	0	0		
940	chr17	46619175	46619199	3500093009	23		46619175	46619199	8421504	2	6,17	0,7	g	350009300900000029	1-24						Mechanisms and enzymes involved in SARS coronavirus genome expression	r.sgmjournals.org	0	0		
941	chr17	46745236	46745259	3500211934	23		46745236	46745259	8421504	1	23	0	c	350021193400000008	18-43						Genes From The 20q13 Amplicon And Their Uses 	.freshpatents.com	0	0		
942	chr17	46852848	46852950	3500039085	102		46852848	46852950	8421504	1	102	0	p	350003908500015003,350003908500015002	0-102,9-111						The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M112.357509	www.jbc.org	0	0		PGAM5
942	chr17	46875630	46875656	3500322287	25		46875630	46875656	8421504	2	9,16	0,10	c,g	350032228700000000,350032228700000000	7-38,7-38		22184289		1949-2553	Oncotarget	Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1	Velpula	2011	5		POLE
942	chr17	46878352	46878469	3500459021	25		46878352	46878469	8421504	2	13,12	0,105	c	350045902100000285	5-33						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
942	chr17	46915520	46915545	3500236933	23		46915520	46915545	8421504	2	8,15	0,10	c	350023693300000000	17-40						Deletion Mutational Mapping of the Catalytic Activities of Human Tyrosinase	rnal.kcsnet.or.kr	0	0		POLE
943	chr17	47037887	47037911	3500418514	23		47037887	47037911	8421504	2	10,13	0,11	g	350041851400000005	10-33						Human platelet-derived growth factor receptor extracellular domain antibodies	Wolf	1995	0		
945	chr17	47205632	47205662	3500415004	26		47205632	47205662	8421504	2	17,9	0,21	g	350041500400000004	7-33						Identi&#xfb01;cation, Characterization, and Application of a Recombinant Antigen for the Serological Investigation of Feline Hemotropic Mycoplasma Infections &#x2021;	cvi.asm.org	0	0		
946	chr17	47419858	47419906	3500378090	48		47419858	47419906	8421504	1	48	0	c	350037809000000028	0-48						Method and compositions for monitoring DNA binding molecules in living cells - Patent # 6455300 - PatentGenius	.patentgenius.com	0	0		DMPK
946	chr17	47419858	47419906	3500280673	48		47419858	47419906	8421504	1	48	0	c	350028067300000028	0-48						Method and compositions for monitoring DNA binding molecules in living cells - Patent application	www.faqs.org	0	0		DMPK
946	chr17	47419879	47419907	3500190571	28		47419879	47419907	8421504	1	28	0	c	350019057100000006	0-28						Compositions and methods for the prevention and treatment of Huntington's disease	Kmiec	2002	0		RPL14
954	chr17	48480304	48480327	3500394860	23		48480304	48480327	8421504	1	23	0	c	350039486000000187	12-35						METHODS AND COMPOSITIONS FOR TREATING TULAREMIA - Patent application	www.faqs.org	0	0		
955	chr17	48506520	48511063	3500106793	25		48506520	48511063	8421504	3	2,11,12	0,4518,4531	c	350010679300000377	1-26						Peptide That Elicits Neutralizing Antibodies Targeting The Hiv Co-receptor, Ccr5 	.freshpatents.com	0	0		
956	chr17	48651122	48653503	3500356261	543		48651122	48653503	8421504	5	138,188,126,85,6	0,266,1642,1847,2375	p	350035626100015050,350035626100015006	0-522,6-528						Dsrna as Insect Control Agent	Raemaekers	2009	0		RAN
956	chr17	48651143	48653033	3500376790	495		48651143	48653033	8421504	4	117,188,126,64	0,245,1621,1826	p	350037679000015005,350037679000015021	0-75,0-480						Dsrna as insect control agent	Raemaekers	2007	0		RAN
957	chr17	48883184	48883211	3500148414	24		48883184	48883211	8421504	2	7,17	0,10	g	350014841400000266	0-25						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
961	chr17	49298974	49300181	3500431462	66		49298974	49300181	8421504	2	23,43	0,1164	c	350043146200000316,350043146200000882	18-41,1-44						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
967	chr17	50160328	50160353	3500248443	23		50160328	50160353	8421504	2	7,16	0,9	g	350024844300000013	0-23						Production Of Mutant Strain Of Aspergillus Fumigatus, Method Of Assay For Inhibiting Siderophore Biosynthesis And Diagnostic Method For Detecting Likely Aspergillus Fumigatus Infection 	.freshpatents.com	0	0		
971	chr17	50619586	50619609	3500278603	23		50619586	50619609	8421504	1	23	0	g	350027860300000030	8-31						Transgenic non-human mammals producing a cholinesterase in their milk - US Patent 6987211 Description	ww.patentstorm.us	0	0		
975	chr17	51144612	51144660	3500047637	48		51144612	51144660	8421504	1	48	0	g	350004763700000737	0-48						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
976	chr17	51265678	51266206	3500047637	144		51265678	51266206	8421504	3	48,48,48	0,384,480	g	350004763700000731,350004763700000723,350004763700000721	0-48,0-48,0-48						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
980	chr17	51804345	51804373	3500271050	23		51804345	51804373	8421504	3	11,7,5	0,14,23	g	350027105000000218	21-44						Cloning by complementation and related processes	Colicelli	1991	0		
982	chr17	52045630	52045660	3500304200	24		52045630	52045660	8421504	3	11,7,6	0,13,24	g	350030420000000396	0-25					Patent	Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use (Patent CN:1578678)	G*Gao 	2010	0		
983	chr17	52204040	52204071	3500464482	25		52204040	52204071	8421504	3	14,6,5	0,19,26	g	350046448200000030	8-35					Patent	Expression of human serum albumin in Pichia pastoris (Patent US:5707828)	Barr	1998	0		
989	chr17	52998932	52998961	3500437989	23		52998932	52998961	8421504	3	7,3,13	0,8,16	g	350043798900000188,350043798900000076	10-33,10-33						US Patent # 7,320,793. Molecular antigen array - Patents.com	www.patents.com	0	0		
989	chr17	52998932	52998961	3500415445	23		52998932	52998961	8421504	3	7,3,13	0,8,16	g	350041544500000070,350041544500000181	10-33,10-33						Molecular antigen array - US Patent 7264810 Description	ww.patentstorm.us	0	0		
989	chr17	52998932	52998961	3500372580	23		52998932	52998961	8421504	3	7,3,13	0,8,16	g	350037258000000023	10-33						Antigen arrays for treatment of bone disease	Bachmann	2006	0		
989	chr17	52998932	52998961	3500289431	23		52998932	52998961	8421504	3	7,3,13	0,8,16	g	350028943100000184	10-33						ordered molecualr presentation of antigens, method of preparation and use	W*A*Lun Na 	2002	0		
989	chr17	52998932	52998961	3500123395	23		52998932	52998961	8421504	3	7,3,13	0,8,16	g	350012339500000023	10-33						Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases	Bachmann	2004	0		
989	chr17	52998932	52998961	3500020039	23		52998932	52998961	8421504	3	7,3,13	0,8,16	g	350002003900000075	10-33						Molecular antigen array	Renner	2002	0		
993	chr17	53561604	53561735	3500209140	130		53561604	53561735	8421504	2	100,30	0,101	g	350020914000000001,350020914000000000	0-100,0-60						Reference SNP(refSNP) Cluster Report: rs132901132&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;	.ncbi.nlm.nih.gov	0	0		
993	chr17	53561690	53561882	3500081282	68		53561690	53561882	8421504	3	23,24,21	0,144,171	c,g	350008128200000010,350008128200000027,350008128200000013,350008128200000013	0-23,12-36,27-48,27-48					Patent	Plant ubiquitin promoter system (Patent US:5614399)	Christensen	1997	0		UBA52
993	chr17	53561690	53561882	3500044851	68		53561690	53561882	8421504	3	23,24,21	0,144,171	c	350004485100000011,350004485100000028,350004485100000014	0-23,12-36,27-48					Patent	Plant ubiquitin promoter system (Patent US:6020190)	Christensen	2000	0		UBA52
993	chr17	53561816	53563502	3500124382	249		53561816	53563502	8421504	8	63,24,21,27,15,18,54,27	0,66,297,429,897,984,1176,1659	p	350012438200015021,350012438200015027,350012438200015023	0-63,0-123,0-81						ABSTRACT	tory.lib.ncsu.edu	0	0		UBC
993	chr17	53561834	53561858	3500347910	24		53561834	53561858	8421504	1	24	0	c	350034791000000028	12-36						Plant ubiquitin promoter system	Quail	1996	0		
993	chr17	53561834	53561858	3500044261	24		53561834	53561858	8421504	1	24	0	c	350004426100000026	12-36					Patent	Plant ubiquitin promoter system (Patent US:6054574)	Christensen	2000	0		
993	chr17	53561849	53561874	3500332107	25		53561849	53561874	8421504	1	25	0	c	350033210700000012,350033210700000011	0-20,0-25						Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof	Kolykhalov	1998	0		UBC
993	chr17	53561849	53561874	3500319900	25		53561849	53561874	8421504	1	25	0	c	350031990000000007,350031990000000008	0-25,0-20						Novel 3' terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof	Kolykhalov	2003	0		UBC
993	chr17	53561849	53561874	3500253699	25		53561849	53561874	8421504	1	25	0	c	350025369900000038,350025369900000037	0-20,0-25					Patent	Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus (Patent US:5874565)	Kolykhalov	1999	0		UBC
993	chr17	53561849	53561874	3500203446	25		53561849	53561874	8421504	1	25	0	c	350020344600000011,350020344600000012	0-25,0-20						US Patent # 6,297,003. Methods for the detection of a novel hepatitis C virus (HCV) terminal 3' noncoding region - Patents.com	www.patents.com	0	0		UBC
993	chr17	53561849	53561874	3500122062	25		53561849	53561874	8421504	1	25	0	c	350012206200000016,350012206200000015	0-20,0-25					Patent	3&#x2032;terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof (Patent US:6943246)	Rice	2005	0		UBC
993	chr17	53561849	53561874	3500068452	25		53561849	53561874	8421504	1	25	0	c	350006845200000016,350006845200000015	0-20,0-25						US Patent # 6,943,246. 3'terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof - Patents.com	www.patents.com	0	0		UBC
993	chr17	53561849	53561874	3500047937	25		53561849	53561874	8421504	1	25	0	c	350004793700000008,350004793700000007	0-20,0-25						Novel 3' terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof	Kolykhalov	2003	0		UBC
993	chr17	53561851	53562115	3500158657	65		53561851	53562115	8421504	2	24,41	0,223	c	350015865700000057	8-94						Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography	Ebersbach	2006	0		
993	chr17	53561885	53561954	3500446093	69		53561885	53561954	8421504	1	69	0	p	350044609300015033,350044609300015035,350044609300015038	0-45,0-45,0-45						Diagnostic Transcript and Splice Patterns of HR-HPV in Different Cervical Lesions - Patent application	www.faqs.org	0	0		UBB
993	chr17	53561915	53561962	3500354015	44		53561915	53561962	8421504	2	24,20	0,27	c	350035401500000006,350035401500000005,350035401500000001	2-25,0-23,0-20		14597671	10.1096/fj.03-0205com	0892-6638	The FASEB Journal	Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain	FISCHER	2003	6		UBB
993	chr17	53561918	53561944	3500314685	26		53561918	53561944	8421504	1	26	0	c	350031468500000078,350031468500000028	10-36,10-36						DNA molecules encoding MUC-1 and use thereof in tumor vaccination	D*Pa Lun Te 	2001	0		UBB
993	chr17	53561993	53562016	3500235521	23		53561993	53562016	8421504	1	23	0	c	350023552100000397	0-23						IMPROVED METHODS FOR TRANSFORMING PHAFFIA STRAINS, TRANSFORMED PHAFFIA STRAINS SO OBTAINED AND RECOMBINANT DNA IN SAID METHODS - Gist-brocades B.	www.sumobrain.com	0	0		
993	chr17	53562138	53562172	3500068459	31		53562138	53562172	8421504	2	5,26	0,8	c	350006845900000005,350006845900000011	12-40,0-31						NANOSCALE ARCHITECTURE	tations.ub.rug.nl	0	0		
994	chr17	53612557	53703458	3500165278	99		53612557	53703458	8421504	6	19,19,19,4,17,21	0,91,260,48425,51348,90880	c,g	350016527800000187,350016527800000188,350016527800000088,350016527800000090,350016527800000101	0-19,0-19,0-19,0-21,0-21						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
994	chr17	53660958	53663924	3500156475	45		53660958	53663924	8421504	3	25,1,19	0,27,2947	c	350015647500000032,350015647500000031	0-25,0-20						REPRODUCTION	uction-online.org	0	0		
994	chr17	53664008	53664039	3500390456	31		53664008	53664039	8421504	1	31	0	c	350039045600000013	0-31						Sr-bi nucleic acids and uses therefor	Acton	1999	0		
994	chr17	53689028	53698402	3500081129	41		53689028	53698402	8421504	3	20,8,13	0,5685,9361	c,g	350008112900000008,350008112900000009	0-20,0-21						Virus infectable stem cells	NEVENS	2013	0		SCARB1
994	chr17	53689028	53698402	3500046581	41		53689028	53698402	8421504	3	20,8,13	0,5685,9361	c,g	350004658100000008,350004658100000009	0-20,0-21						VIRUS INFECTABLE STEM CELLS - KATHOLIEKE UNIVERSITEIT LEUVEN	www.sumobrain.com	0	0		SCARB1
996	chr17	53933400	53933431	3500395029	25		53933400	53933431	8421504	3	12,8,5	0,15,26	g	350039502900000529	12-43						 Recombinant Infectious Laryngotracheitis Virus And Uses Thereof 	www.docstoc.com	0	0		
997	chr17	54012798	54012826	3500309840	25		54012798	54012826	8421504	2	18,7	0,21	g	350030984000000672	8-33						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
997	chr17	54012798	54012826	3500119454	25		54012798	54012826	8421504	2	18,7	0,21	g	350011945400000675	8-33						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
997	chr17	54021963	54021990	3500134077	23		54021963	54021990	8421504	2	14,9	0,18	g	350013407700000090	20-43						 Pectin Lyase Genes Of Aspergillus Niger 	www.docstoc.com	0	0		
1000	chr17	54472795	54473218	3500173849	27		54472795	54473218	8421504	2	17,10	0,413	c	350017384900000003	8-35						COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES - Patent application	www.faqs.org	0	0		
1001	chr17	54557490	54561631	3500375699	358		54557490	54561631	8421504	4	20,137,117,84	0,1652,1921,4057	c	350037569900000029	0-358						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1001	chr17	54595334	54595357	3500422148	23		54595334	54595357	8421504	1	23	0	c	350042214800000004	0-23						Characterizationofcellvolume-sensitivechloridecurrentsin freshlypreparedandculturedpancreaticacinarcellsfrom earlypostnatalrats	jp.physoc.org	0	0		TMED2
1001	chr17	54595334	54595357	3500020167	23		54595334	54595357	8421504	1	23	0	c,g	350002016700000004,350002016700000004	0-23,0-23			10.1111/j.1469-7793.1998.453bb.x	0022-3751	The Journal of Physiology	Characterization of cell volume-sensitive chloride currents in freshly prepared and cultured pancreatic acinar cells from early postnatal rats	Schmid	1998	5		TMED2
1002	chr17	54664799	54664824	3500167840	23		54664799	54664824	8421504	2	5,18	0,7	c	350016784000000058	15-38						Entwicklung von Real-Time PCR Nachweissystemen f&#xfc;r getr&#xe4;nkerelevante Hefen	opus4.kobv.de	0	0		
1003	chr17	54818018	54818066	3500369674	48		54818018	54818066	8421504	1	48	0	p	350036967400015002	0-48						Diego F. Mastroeni	ichtuniversity.nl	0	0		CDK2AP1
1006	chr17	55198081	55198109	3500159288	23		55198081	55198109	8421504	2	16,7	0,21	g	350015928800000093	9-32						SOLUBLE SINGLE-CHAIN T-CELL RECEPTOR PROTEINS	Weidanz	1998	0		
1006	chr17	55301340	55302348	3500113314	1008		55301340	55302348	8421504	1	1008	0	p,c,g	350011331400000040,350011331400000065,350011331400000065,350011331400000010,350011331400015135,350011331400015137,350011331400015138,350011331400015139,350011331400015142,350011331400015143,350011331400015145,350011331400015146,350011331400015148,350011331400015149,350011331400015150	18-45,0-1008,0-1008,18-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						GPR81-Ligand complexes and their preparation and use - Patent application	www.faqs.org	0	0		
1006	chr17	55301340	55301367	3500416138	27		55301340	55301367	8421504	1	27	0	c	350041613800000010	18-45					Patent	Methods of identifying modulators of GPR81 receptors (Patent US:8148056)	Liu	2012	0		
1006	chr17	55301340	55301367	3500405725	27		55301340	55301367	8421504	1	27	0	c	350040572500000010	18-45						Gpr81-ligand complexes and their preparation and use	Liu	2008	0		
1006	chr17	55301340	55301367	3500224586	27		55301340	55301367	8421504	1	27	0	c	350022458600000010	18-45						GPR81-Ligand complexes and their preparation and use	Liu	2008	0		
1007	chr17	55319147	55319722	3500431462	44		55319147	55319722	8421504	2	23,21	0,554	g	350043146200000674,350043146200000675	0-23,0-21						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
1007	chr17	55319147	55319722	3500031022	44		55319147	55319722	8421504	2	23,21	0,554	g	350003102200000664,350003102200000665	0-23,0-21						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
1007	chr17	55395153	55396097	3500031175	27		55395153	55396097	8421504	2	6,21	0,923	c	350003117500000177,350003117500000056	5-30,12-33						Prf protein and nucleic acid sequences: compositions and methods for plant pathogen resistance - Patent # 6245510 - PatentGenius	.patentgenius.com	0	0		
1007	chr17	55406009	55406032	3500025302	23		55406009	55406032	8421504	1	23	0	c	350002530200000132	1-24						Global Analysis of Gene Expression in the	brary.utoronto.ca	0	0		
1009	chr17	55605124	55605152	3500005314	23		55605124	55605152	8421504	2	13,10	0,18	g	350000531400000046	10-41						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
1011	chr17	55960469	55960532	3500350882	63		55960469	55960532	8421504	1	63	0	p	350035088200015021	0-63						HUMAN GENE	Fujiwara	2009	0		
1011	chr17	55960469	55960532	3500196150	63		55960469	55960532	8421504	1	63	0	p	350019615000015020	0-63						GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins	Fujiwara	1997	0		
1011	chr17	55960469	55960532	3500098563	63		55960469	55960532	8421504	1	63	0	p	350009856300015020	0-63						Human gene	Fujiwara	2001	0		
1013	chr17	56174964	56174990	3500110987	24		56174964	56174990	8421504	2	18,6	0,20	c	350011098700000001	6-30						Method of treating metabolic disorders using neuronatin polypeptides	Larsen	2004	0		
1013	chr17	56189018	56189063	3500434154	45		56189018	56189063	8421504	1	45	0	p	350043415400015000	3-48		18448669	10.1091/mbc.E08-02-0146	1059-1524	Molecular Biology of the Cell	Dynamic Movement of the Calcium Sensor STIM1 and the Calcium Channel Orai1 in Activated T-Cells: Puncta and Distal Caps	Barr	2008	5		MORN3
1013	chr17	56189018	56189063	3500145888	45		56189018	56189063	8421504	1	45	0	p	350014588800015001	3-48						Dynamic movement of the calcium sensor STIM1 and the calcium channel Orai1 in activated T cells: puncta and distal caps Valarie A. Barr*, Kelsie M. Bernot*, Sonal Srikanth&#x2020;&#x2021;, Yousang Gwack&#x2020;&#x2021;, Lakshmi	w.molbiolcell.org	0	0		MORN3
1013	chr17	56189141	56203326	3500036684	304		56189141	56203326	8421504	8	48,91,41,39,6,42,7,30	0,158,289,393,474,13877,14082,14155	c	350003668400000561,350003668400000535,350003668400000604,350003668400000534,350003668400000555,350003668400000530,350003668400000551,350003668400000098	0-48,0-43,0-48,0-48,0-41,9-48,0-48,14-51						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1013	chr17	56189164	56189189	3500294391	25		56189164	56189189	8421504	1	25	0	c,g	350029439100000002,350029439100000002	0-25,0-25		18768920	10.1152/ajpcell.00306.2008		American Journal of Physiology - Cell Physiolog	How strict is the correlation between STIM1 and Orai1 expression, puncta formation, and ICRAC activation?	Gwozdz	2008	0		MORN3
1013	chr17	56189354	56189534	3500148659	180		56189354	56189534	8421504	1	180	0	p	350014865900015146	0-180						50 human secreted proteins	Komatsoulis	2002	0		MORN3
1013	chr17	56189354	56189534	3500068672	180		56189354	56189534	8421504	1	180	0	p	350006867200015146	0-180						50 human secreted proteins	Komatsoulis	2000	0		MORN3
1013	chr17	56189502	56203137	3500011489	40		56189502	56203137	8421504	2	20,20	0,13615	c,g	350001148900000011,350001148900000011,350001148900000010,350001148900000010	0-20,0-20,0-20,0-20						STORE OPERATED CHANNELS IN THE PULMONARY CIRCULATION OF HIGH AND LOW ALTITUDE NEONATAL LAMBS. - ResearchGate	.researchgate.net	0	0		ORAI1,MORN3
1013	chr17	56203223	56203326	3500127641	37		56203223	56203326	8421504	2	7,30	0,73	c	350012764100000105,350012764100000007	14-51,14-39						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF	Nguyen	2010	0		
1014	chr17	56271661	56271685	3500212948	24		56271661	56271685	8421504	1	24	0	g	350021294800000227	15-41						TACI-IMMUNOGLOBULIN FUSION PROTEINS - Patent application	www.faqs.org	0	0		
1014	chr17	56277511	56277536	3500206857	23		56277511	56277536	8421504	3	4,6,13	0,5,12	g	350020685700000007	25-48						US Patent # 5,356,804. Cloning and expression of biologically active human .alpha.-galactosidase A - Patents.com	www.patents.com	0	0		
1015	chr17	56437447	56437472	3500022398	23		56437447	56437472	8421504	3	12,5,6	0,13,19	c	350002239800000093	21-46						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
1015	chr17	56440454	56440477	3500003440	23		56440454	56440477	8421504	1	23	0	c	350000344000000177	24-47						Ornithobacterium Rhinotracheale Subunit Vaccines 	.freshpatents.com	0	0		
126	chr17	56466609	56498177	3500290350	1737		56466609	56498177	8421504	16	450,48,54,52,134,37,22,89,200,54,74,88,129,101,43,162	0,4422,5141,5906,8158,10126,16561,16711,17869,18658,21575,21735,22915,27970,28570,31406	p	350029035000015000	0-1737						KEGG T01008: 509084	www.genome.jp	0	0		
1015	chr17	56474844	56484571	3500344333	70		56474844	56484571	8421504	3	22,24,24	0,8512,9703	c,g	350034433300000003,350034433300000003,350034433300000007,350034433300000008,350034433300000008	0-22,0-22,0-24,0-24,0-24						Signal Transduction: Epigallocatechin Gallate (EGCG) Stimulates Autophagy in Vascular Endothelial Cells: A POTENTIAL ROLE FOR REDUCING LIPID ACCUMULATION Hae-Suk Kim, Vedrana Montana, Hyun-Ju	.si.mahidol.ac.th	0	0		
1015	chr17	56474850	56484571	3500181589	67		56474850	56484571	8421504	3	19,24,24	0,8506,9697	c,g	350018158900000002,350018158900000006,350018158900000007,350018158900000007	0-19,0-24,0-24,0-24						JBC Papers in Press. Published on June 10, 2013 as Manuscript M113.477505 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M113.477505	www.jbc.org	0	0		CAMKK2
1015	chr17	56476769	56483325	3500411899	30		56476769	56483325	8421504	3	3,22,5	0,6401,6551	c	350041189900000022	0-30		12540834	10.1074/jbc.M213183200	0021-9258	Journal of Biological Chemistry	A Single Amino Acid Difference between &#x03b1; and &#x03b2; Ca2+/Calmodulin-dependent Protein Kinase Kinase Dictates Sensitivity to the Specific Inhibitor, STO-609	Tokumitsu	2003	5		
1015	chr17	56484582	56485282	3500366238	108		56484582	56485282	8421504	3	57,36,15	0,60,685	p	350036623800015040,350036623800015025	0-90,0-108						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		CAMKK2
1016	chr17	56508426	56508452	3500426152	26		56508426	56508452	8421504	1	26	0	c	350042615200000006	0-26						Life Sciences	144.82.108.63	0	0		
1016	chr17	56508426	56508452	3500141664	26		56508426	56508452	8421504	1	26	0	c	350014166400000006	0-26			10.1038/sj.bjp.0705685	1476-5381	British Journal of Pharmacology	P2X7 receptors stimulate AKT phosphorylation in astrocytes - Jacques-Silva - 2009 - British Journal of Pharmacology - Wiley Online Library	Jacques-Silva	2004	0		
1016	chr17	56516618	56519371	3500378510	29		56516618	56519371	8421504	2	10,19	0,2734	c	350037851000000087	19-48						P2x receptors (purinoceptor family)	Buell	1995	0		P2RX4
1016	chr17	56548528	56548570	3500205951	42		56548528	56548570	8421504	1	42	0	c	350020595100000079	0-42						 Polynucleotide Encoding A Novel Human P2X7 Splice Variant, HBMYP2X7v 	www.docstoc.com	0	0		
1016	chr17	56555162	56562903	3500247652	70		56555162	56562903	8421504	4	31,16,4,19	0,7561,7578,7722	c,g	350024765200000094,350024765200000018,350024765200000136	10-41,0-20,0-19						MEANS AND METHODS FOR DIAGNOSING AND TREATING AFFECTIVE DISORDERS - Patent application	www.faqs.org	0	0		
1016	chr17	56555239	56555376	3500057438	51		56555239	56555376	8421504	2	15,36	0,101	p	350005743800015002	3-54						Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v	Franco	2004	0		
1017	chr17	56647938	56648648	3500273253	183		56647938	56648648	8421504	2	144,39	0,671	p	350027325300015014	0-183						Supplementary Materials for	ww.sciencemag.org	0	0		
1018	chr17	56799072	56799096	3500017463	24		56799072	56799096	8421504	1	24	0	c	350001746300000066,350001746300000054	14-39,5-26						DbpA compositions and methods of use	Guo	2000	0		
1018	chr17	56842197	56843357	3500140738	50		56842197	56843357	8421504	2	26,24	0,1136	c	350014073800000002,350014073800000003	0-26,0-24		20489732	10.1038/cdd.2010.51	1350-9047	Cell Death & Differentiation	Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency	Mbaya	2010	9		ATP2A2
1018	chr17	56842197	56843207	3500131351	51		56842197	56843207	8421504	2	27,24	0,986	c	350013135100000012,350013135100000013	0-27,0-24						DOI:&#x20ac;10.1161/CIRCRESAHA.110.237206	ardiomyopathy.org	0	0		ATP2A2
1019	chr17	56916731	56916759	3500196396	25		56916731	56916759	8421504	2	16,9	0,19	g	350019639600000015,350019639600000014	0-29,6-35						&#x0e04;&#x0e27;&#x0e32;&#x0e21;&#x0e2a;&#x0e31;&#x0e21;&#x0e1e;&#x0e31;&#x0e19;&#x0e18;&#xf70e;&#x0e23;&#x0e30;&#x0e2b;&#x0e27;&#xf70a;&#x0e32;&#x0e07;&#x0e42;&#x0e04;&#x0e23;&#x0e07;&#x0e2a;&#x0e23; &#xf70b;&#x0e32;&#x0e07;&#x0e41;&#x0e25;&#x0e30;&#x0e2	ir.sut.ac.th:8080	0	0		
1019	chr17	56990977	56992389	3500027719	40		56990977	56992389	8421504	3	12,8,20	0,1336,1392	c,g	350002771900000007,350002771900000006,350002771900000006	0-20,0-20,0-20						Effect of maternal methionine supplementation on the transcriptome of bovine preimplantation embryos. - ResearchGate	.researchgate.net	0	0		PPTC7
1020	chr17	57114984	57115356	3500411767	23		57114984	57115356	8421504	4	6,12,1,4	0,7,20,368	c	350041176700000100	25-48						Recombinant adeno-associated virus virions for the treatment of lysosomal disorders	Podsakoff	2000	0		
1021	chr17	57149552	57154343	3500282713	189		57149552	57154343	8421504	5	81,2,22,56,28	0,84,1056,1105,4763	p	350028271300015010,350028271300015008,350028271300015003	0-105,0-54,0-84						THE BIOLOGICAL CHEMISTRY JOGRNAL 268, Vol. No. OF by U.S.A. in Expression, Purification, Crystallization, and Biochemical a Recombinant Protein Phosphatase* Characterization of	www.jbc.org	0	0		PPP1CC
1022	chr17	57331015	57337079	3500280522	42		57331015	57337079	8421504	3	21,16,5	0,3773,6059	c	350028052200000032,350028052200000065,350028052200000031,350028052200000064	0-21,0-21,0-21,0-21						METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CARDIOMYOCYTES - Patent application	www.faqs.org	0	0		MYL2
1022	chr17	57331015	57337079	3500202616	42		57331015	57337079	8421504	3	21,16,5	0,3773,6059	c,g	350020261600000032,350020261600000032,350020261600000031	0-21,0-21,0-21						Method for inducing differentiation of pluripotent stem cells into cardiomyocytes	Koshimizu	2012	0		MYL2
1022	chr17	57331015	57337079	3500192591	42		57331015	57337079	8421504	3	21,16,5	0,3773,6059	c,g	350019259100000015,350019259100000015,350019259100000014	0-21,0-21,0-21						Bone morphogenetic protein-4 enhances cardiomyocyte differentiation of cynomolgus monkey ESCs in knockout serum replacement medium. - ResearchGate	.researchgate.net	0	0		MYL2
1022	chr17	57331025	57332963	3500452808	54		57331025	57332963	8421504	2	5,49	0,1889	c	350045280800000024	0-54						Modelos computacionais para identifica&#xe7;&#xe3;o de informa&#xe7;&#xe3;o gen&#xf4;mica associada &#xe0; resist&#xea;ncia ao carrapato bovino | Wagner Arbex - Academia.edu	www.academia.edu	0	0		
1025	chr17	57696970	57696996	3500464783	25		57696970	57696996	8421504	2	21,4	0,22	c	350046478300000119	5-30						BGS 4 - US Patent 7456256 Description	ww.patentstorm.us	0	0		
1025	chr17	57718385	57718411	3500004727	23		57718385	57718411	8421504	2	12,11	0,15	c	350000472700000000	0-23		14699098	10.1074/jbc.M310788200	0021-9258	Journal of Biological Chemistry	Lectin-deficient Calnexin Is Capable of Binding Class I Histocompatibility Molecules in Vivo and Preventing Their Degradation	Leach	2004	5		
1029	chr17	58300697	58300722	3500364206	23		58300697	58300722	8421504	2	16,7	0,18	g	350036420600000000,350036420600000021	0-23,0-23						MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE QPCT-GENE - Patent application	www.faqs.org	0	0		
1031	chr17	58504499	58504582	3500315071	40		58504499	58504582	8421504	2	20,20	0,63	c,g	350031507100000011,350031507100000011,350031507100000010	0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1034	chr17	58907529	58907553	3500106826	23		58907529	58907553	8421504	2	6,17	0,7	g	350010682600000007	0-24						Characterization of Paired Ig-Like Receptors in Rats1,2	www.jimmunol.org	0	0		
1034	chr17	58911095	58911122	3500048605	23		58911095	58911122	8421504	2	15,8	0,19	g	350004860500000157	2-25						METHODS OF PRODUCING A LIBRARY AND METHODS OF SELECTING POLYNUCLEOTIDES OF INTEREST - UNIVERSITY OF ROCHESTER	www.sumobrain.com	0	0		
1035	chr17	58983521	58983546	3500375861	23		58983521	58983546	8421504	3	4,4,15	0,5,10	g	350037586100000034	0-23						Factor Vii Or Viia-like Molecules 	.freshpatents.com	0	0		
1035	chr17	58983521	58983546	3500281784	23		58983521	58983546	8421504	3	4,4,15	0,5,10	g	350028178400000041	0-23						Factor VII or VIIa like molecules	Jin *V*An De Sen 	2003	0		
1035	chr17	58983521	58983546	3500095675	23		58983521	58983546	8421504	3	4,4,15	0,5,10	g	350009567500000028	0-23						Factor VII or VIIa Polypeptide Variants - Patent application	www.faqs.org	0	0		
1035	chr17	58983521	58983546	3500053786	23		58983521	58983546	8421504	3	4,4,15	0,5,10	g	350005378600000034	0-23						Factor Vii Or Viia - Like Molecules 	.freshpatents.com	0	0		
1035	chr17	58983521	58983546	3500029671	23		58983521	58983546	8421504	3	4,4,15	0,5,10	g	350002967100000036	0-23						Factor VII or VIIa - Like Molecules - Patent application	www.faqs.org	0	0		
1035	chr17	58983521	58983546	3500023981	23		58983521	58983546	8421504	3	4,4,15	0,5,10	g	350002398100000034	0-23						Factor VII or VIIa - Like Molecules - Patent application	www.faqs.org	0	0		
1040	chr17	59731550	59732935	3500441703	45		59731550	59732935	8421504	2	32,13	0,1372	p	350044170300015023	0-45						STE20-RELATED PROTEIN KINASES	Plowman	1999	0		TAOK2
1041	chr17	59789395	59799378	3500441703	49		59789395	59799378	8421504	2	26,23	0,9960	c	350044170300000058,350044170300000063,350044170300000078	0-24,0-24,24-47						STE20-RELATED PROTEIN KINASES	Plowman	1999	0		
1042	chr17	59905044	59905239	3500241928	48		59905044	59905239	8421504	2	40,8	0,187	c	350024192800000130	0-48						THERAPEUTIC AND DIAGNOSTIC AGENTS CAPABLE OF MODULATING CELLULAR RESPONSIVENESS TO CYTOKINES - THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH	www.sumobrain.com	0	0		
1042	chr17	59905047	59908105	3500011698	80		59905047	59908105	8421504	3	37,8,35	0,184,3023	c	350001169800000133,350001169800000137	0-45,0-35						Therapeutic and diagnostic agents - US Patent 7279557 Description	ww.patentstorm.us	0	0		
130	chr17	60551273	60557657	3500019111	39		60551273	60557657	8421504	2	20,19	0,6365	c	350001911100000000,350001911100000001	0-20,0-19			10.1016/j.yexcr.2007.05.021		Experimental Cell Research	Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamn D3 and is required for optimal cell differentiation	Xuening	2007	0		KSR2
1047	chr17	60618785	60618811	3500068521	25		60618785	60618811	8421504	2	4,21	0,5	g	350006852100000540	8-37						About ICRISAT	www.icrisat.org	0	0		
1047	chr17	60629464	60629493	3500391989	26		60629464	60629493	8421504	2	20,6	0,23	g	350039198900000012	14-40						Avidin mutants	Hytoenen	2005	0		
1051	chr17	61088548	61088608	3500002166	60		61088548	61088608	8421504	1	60	0	p	350000216600015009	0-60		19948485	10.1083/jcb.200904049	0021-9525	The Journal of Cell Biology	MCL-1&#x2013;dependent leukemia cells are more sensitive to chemotherapy than BCL-2&#x2013;dependent counterparts	Brunelle	2009	10		HRK
1051	chr17	61088566	61088611	3500251491	45		61088566	61088611	8421504	1	45	0	p	350025149100015036	0-45						Biochemische und molekularbiologische Charakterisierung von Spike, einem neuen BH3-Dom&#xe4;nen Protein	b.uni-muenchen.de	0	0		HRK
1051	chr17	61088723	61088746	3500268811	23		61088723	61088746	8421504	1	23	0	c	350026881100000000	0-23						Gene expression profiling of KBH-A42, a novel histone deacetylase inhibitor, in human leukemia and bladder cancer cell lines	-publications.com	0	0		HRK
1056	chr17	61756734	61756762	3500297690	26		61756734	61756762	8421504	2	13,13	0,15	c	350029769000000042	19-45						US Patent # 5,556,781. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
1056	chr17	61756734	61756762	3500039160	26		61756734	61756762	8421504	2	13,13	0,15	c	350003916000000042	19-45						US Patent # 5,830,715. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
1062	chr17	62559299	62559325	3500036492	25		62559299	62559325	8421504	2	10,15	0,11	g	350003649200000230	20-45						UNIVERSIDAD DE SALAMANCA	gredos.usal.es	0	0		
133	chr17	63284033	63331996	3500176465	1554		63284033	63331996	8421504	9	147,95,120,148,153,92,227,530,42	0,1828,4045,5018,9133,17744,36130,47388,47921	p	350017646500015001	0-1554						MARKER FOR COLON CANCER AND METHOD FOR DETECTING COLON CANCER	Sung	2010	0		
1068	chr17	63346394	63346682	3500166204	241		63346394	63346682	8421504	7	9,13,56,49,39,47,28	0,10,24,85,138,210,260	g	350016620400000077	7-265						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1069	chr17	63448408	63448433	3500218344	24		63448408	63448433	8421504	2	6,18	0,7	g	350021834400000074	0-24						IgA allelic variants - Patent application	www.faqs.org	0	0		
1069	chr17	63542590	63542616	3500415474	23		63542590	63542616	8421504	2	6,17	0,9	g	350041547400000185	7-33						Humanized immunoglobulin loci	Buelow	2004	0		
1072	chr17	63934271	63934296	3500247713	23		63934271	63934296	8421504	2	5,18	0,7	g	350024771300000004	15-38		19696013	10.1095/biolreprod.109.078055	0006-3363	Biology of Reproduction	The Histone Demethylase JMJD2C Is Stage-Specifically Expressed in Preimplantation Mouse Embryos and Is Required for Embryonic Development	Wang	2010	4		
1073	chr17	64045287	64049467	3500212632	981		64045287	64049467	8421504	7	153,40,140,92,228,125,203	0,427,669,899,1769,2760,3977	p	350021263200015000	0-981						BMDB: Showing 2-Ketobutyric acid (BMDB00005)	www.cowmetdb.ca	0	0		
1073	chr17	64049300	64049326	3500195024	24		64049300	64049326	8421504	2	6,18	0,8	c	350019502400000065	12-36						NOVEL TUMOR ANTIGEN PEPTIDES - Patent application	www.faqs.org	0	0		
1073	chr17	64074645	64074671	3500344185	24		64074645	64074671	8421504	2	15,9	0,17	c	350034418500000150	15-47						Collagen Producing Plants And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
1074	chr17	64097747	64115206	3500367820	40		64097747	64115206	8421504	2	20,20	0,17439	c,g	350036782000000000,350036782000000000,350036782000000001	0-20,0-20,0-20						Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway	Condie	2004	0		DTX1
1074	chr17	64183314	64183343	3500429949	24		64183314	64183343	8421504	2	17,7	0,22	c	350042994900000314	0-24						Nucleic acid binding of multi-zinc finger transcription factors	Huylebroeck	2001	0		
1075	chr17	64312392	64312417	3500013528	23		64312392	64312417	8421504	2	18,5	0,20	c	350001352800000027	10-34						Chimeric and/or growth-restricted flaviviruses	Bray	1993	0		
134	chr17	64356249	64402257	3500395413	66		64356249	64402257	8421504	3	24,21,21	0,39567,45987	c	350039541300000006,350039541300000002,350039541300000000	0-24,0-21,0-21						Structure of equine 2 -5 oligoadenylate BTA17q24 q25	www.seegene.com	0	0		
1076	chr17	64386335	64402153	3500125041	65		64386335	64402153	8421504	3	20,20,25	0,10712,15793	c	350012504100000000,350012504100000001,350012504100000005,350012504100000004	0-20,0-20,0-25,0-25			10.1099/vir.0.81820-0	0022-1317	Journal of General Virology	The double-stranded RNA-induced apoptosis pathway is involved in the cytopathogenicity of cytopathogenic Bovine viral diarrhea virus	Yamane	2006	3		
1076	chr17	64386450	64401277	3500180394	46		64386450	64401277	8421504	2	19,27	0,14800	c,g	350018039400000001,350018039400000003	0-19,0-27		19553550	10.1128/CVI.00018-09		Clinical and Vaccine Immunology : CVI	Innate Immune Defenses Induced by CpG Do Not Promote Vaccine-Induced Protection against Foot-and-Mouth Disease Virus in Pigs 	M.	2009	0		
1076	chr17	64399718	64419542	3500317153	40		64399718	64419542	8421504	4	10,10,17,3	0,1397,19012,19821	c	350031715300000041,350031715300000013,350031715300000040,350031715300000012	0-20,0-20,0-20,0-20						Markers for Viral Infections and Other Inflammatory Responses - Patent application	www.faqs.org	0	0		OAS1
134	chr17	64453044	64489776	3500425189	408		64453044	64489776	8421504	5	48,130,147,12,71	0,1553,19217,31920,36661	p	350042518900015010,350042518900015006,350042518900015004	0-408,0-144,0-114						Molecular Evolutionary Genetics Analysis	.megasoftware.net	0	0		RPH3A
134	chr17	64453044	64489776	3500138667	408		64453044	64489776	8421504	5	48,130,147,12,71	0,1553,19217,31920,36661	p	350013866700015009,350013866700015008,350013866700015005,350013866700015003	0-408,0-396,0-144,0-114						Molecular Evolutionary Genetic Analysis	129.219.114.146	0	0		
1079	chr17	64867581	64867605	3500298630	23		64867581	64867605	8421504	2	13,10	0,14	c	350029863000000091	21-44						Proteins with increased levels of essential amino acids	Rao	1999	0		
1082	chr17	65253352	65253381	3500081476	24		65253352	65253381	8421504	2	8,16	0,13	g	350008147600000121	24-48						US Patent # 5,602,096. Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis - Patents.com	www.patents.com	0	0		
1083	chr17	65310183	65311832	3500073867	40		65310183	65311832	8421504	2	19,21	0,1628	c,g	350007386700000005,350007386700000014,350007386700000013,350007386700000004,350007386700000004	0-19,0-19,0-21,0-19,0-19						FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES - Patent application	www.faqs.org	0	0		MAPKAPK5
1083	chr17	65310183	65311832	3500049062	40		65310183	65311832	8421504	2	19,21	0,1628	c,g	350004906200000005,350004906200000014,350004906200000004,350004906200000004,350004906200000013	0-19,0-19,0-19,0-19,0-21						Fused pyrazine compounds useful for the treatment of degenerative and inflmmatory diseases - Patent application	www.faqs.org	0	0		
1083	chr17	65310183	65311832	3500029918	40		65310183	65311832	8421504	2	19,21	0,1628	c,g	350002991800000005,350002991800000005,350002991800000014,350002991800000014,350002991800000013,350002991800000004,350002991800000004	0-19,0-19,0-19,0-19,0-21,0-19,0-19						Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases - Patent application	www.faqs.org	0	0		MAPKAPK5
1083	chr17	65310183	65311830	3500389371	38		65310183	65311830	8421504	2	19,19	0,1628	c,g	350038937100000005,350038937100000014,350038937100000004,350038937100000004,350038937100000013,350038937100000013	0-19,0-19,0-19,0-19,0-19,0-19						Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases - Patent application	www.faqs.org	0	0		MAPKAPK5
1083	chr17	65310183	65311830	3500301296	38		65310183	65311830	8421504	2	19,19	0,1628	c,g	350030129600000005,350030129600000005,350030129600000004,350030129600000004	0-19,0-19,0-19,0-19						Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases	Andrews	2007	0		MAPKAPK5
1083	chr17	65310183	65311830	3500134130	38		65310183	65311830	8421504	2	19,19	0,1628	c,g	350013413000000005,350013413000000005,350013413000000004,350013413000000004	0-19,0-19,0-19,0-19					Patent	Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseases (Patent US:8012983)	Andrews	2011	0		MAPKAPK5
1083	chr17	65310183	65311830	3500076372	38		65310183	65311830	8421504	2	19,19	0,1628	c,g	350007637200000005,350007637200000005,350007637200000004,350007637200000004	0-19,0-19,0-19,0-19						FUSED PYRAZINE COMPOUNDS AS THEIR SALTS, USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES	Wigerinck	2010	0		MAPKAPK5
1083	chr17	65371497	65371537	3500075252	40		65371497	65371537	8421504	1	40	0	g	350007525200000143	0-40						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
1083	chr17	65371611	65371635	3500246117	24		65371611	65371635	8421504	1	24	0	c	350024611700000027	0-24						Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen	Buendia	2012	0		
1083	chr17	65373250	65373316	3500017866	66		65373250	65373316	8421504	1	66	0	p	350001786600015142	0-66						Molecular Characterization of an Aldehyde/Alcohol Dehydrogenase Gene Clostridium ATCC	w.papoutsakis.org	0	0		
1083	chr17	65379917	65383084	3500272268	90		65379917	65383084	8421504	3	4,80,6	0,2259,3161	p	350027226800015000	0-90						PCR&#x6cd5;&#x306b;&#x3088;&#x308b;&#x907a;&#x4f1d;&#x5b50;&#x578b;&#x306e;&#x89e3;&#x6790; &#x3000;&#x7b2c;&#xff15;&#x7ae0;&#x3000;&#x53c2;&#x8003;&#x30fb;&#x8ab2;&#x984c; &#x82a6;&#x7530;&#x5609;&#x4e4b;	ww2.biglobe.ne.jp	0	0		
1084	chr17	65529477	65529500	3500328451	23		65529477	65529500	8421504	1	23	0	g	350032845100000029	3-26						Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host	Della-Cioppa	1999	0		
1084	chr17	65529477	65529500	3500048879	23		65529477	65529500	8421504	1	23	0	g	350004887900000029	3-26						Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host	Della-Cioppa	2000	0		
1085	chr17	65546057	65546081	3500318923	24		65546057	65546081	8421504	1	24	0	c	350031892300000005	9-33						The role of Wnt signalling in thymic senescence	aok.pte.hu/docs/p	0	0		
1085	chr17	65627496	65627612	3500146047	45		65627496	65627612	8421504	2	23,22	0,94	c	350014604700000010,350014604700000011	0-23,0-22						PASTURE-FEEDING OF CHAROLAIS STEERS INFLUENCES SKELETAL MUSCLE METABOLISM AND GENE EXPRESSION	www.jpp.krakow.pl	0	0		
1085	chr17	65627496	65627612	3500053255	45		65627496	65627612	8421504	2	23,22	0,94	c,g	350005325500000010,350005325500000010,350005325500000011,350005325500000011	0-23,0-23,0-22,0-22						1009_S3_article_10	www.jpp.krakow.pl	0	0		
1085	chr17	65627552	65628310	3500421895	42		65627552	65628310	8421504	2	22,20	0,738	c	350042189500000003,350042189500000002	0-22,0-20		22216126	10.1371/journal.pone.0028851		PLoS ONE	Hypoxia-Induced Invadopodia Formation Involves Activation of NHE-1 by the p90 Ribosomal S6 Kinase (p90RSK)	Fabrice	2011	0		RPLP0
1085	chr17	65627557	65627693	3500202692	40		65627557	65627693	8421504	2	20,20	0,116	c,g	350020269200000018,350020269200000018,350020269200000017	0-20,0-20,0-20		20194507	10.1074/jbc.M109.056259		The Journal of Biological Chemistry	Ribosomal Protein L11 Associates with c-Myc at 5 S rRNA and tRNA Genes and Regulates Their Expression	Mu-Shui	2010	0		
1085	chr17	65627665	65628313	3500071939	61		65627665	65628313	8421504	3	28,3,30	0,36,618	c	350007193900000023,350007193900000022	0-28,0-33						WWOX expression in colorectal cancer--a real-time quantitative RT-PCR study. - ResearchGate	.researchgate.net	0	0		
1085	chr17	65627673	65629297	3500021577	40		65627673	65629297	8421504	2	19,21	0,1603	c,g	350002157700000021,350002157700000020,350002157700000020	0-19,0-21,0-21						O-12	www.scribd.com	0	0		RPLP0
1085	chr17	65627679	65630147	3500368224	49		65627679	65630147	8421504	2	25,24	0,2444	c	350036822400000031,350036822400000030	0-25,0-24						Regulation der Telomerase in Mammakarzinomen eines bitransgenen Mausmodells Mus musculus (Linnaeus, 1758)]	ub.uni-hamburg.de	0	0		RPLP0
1085	chr17	65627696	65630154	3500343416	40		65627696	65630154	8421504	3	8,12,20	0,587,2438	c,g	350034341600000013,350034341600000012,350034341600000012	0-20,0-20,0-20						Analysis of unannotated equine transcripts identified by mRNA sequencing. - ResearchGate	.researchgate.net	0	0		
1085	chr17	65628287	65628362	3500427864	47		65628287	65628362	8421504	2	23,24	0,51	c	350042786400000133,350042786400000049,350042786400000132,350042786400000048	0-23,0-23,0-24,0-24						Expression Profile Algorithm and Test for Cancer Prognosis - Patent application	www.faqs.org	0	0		RPLP0P2,RPLP0
1085	chr17	65628287	65628362	3500378391	47		65628287	65628362	8421504	2	23,24	0,51	c	350037839100000049,350037839100000048	0-23,0-24						Expression profile algorithm and test for cancer prognosis	Baker	2004	0		TENM2,RPLP0P2,RPLP0
1085	chr17	65628287	65628362	3500281268	47		65628287	65628362	8421504	2	23,24	0,51	c	350028126800000124,350028126800000123	0-23,0-24						Expression Profile Algorithm And Test For Cancer Prognosis 	.freshpatents.com	0	0		RPLP0P2,RPLP0
1085	chr17	65628296	65629366	3500396352	50		65628296	65629366	8421504	2	25,25	0,1045	c	350039635200000048,350039635200000008,350039635200000007,350039635200000047	0-25,0-25,0-25,0-25						Use of 15-Lipoxygenase Inhibitors for Treating Obesity - Patent application	www.faqs.org	0	0		
1085	chr17	65628296	65629366	3500099050	50		65628296	65629366	8421504	2	25,25	0,1045	c	350009905000000010,350009905000000009	0-25,0-25		15684402	10.1128/MCB.25.4.1537-1548.2005	0270-7306	Molecular and Cellular Biology	Insulin-Mediated Down-Regulation of Apolipoprotein A5 Gene Expression through the Phosphatidylinositol 3-Kinase Pathway: Role of Upstream Stimulatory Factor	Nowak	2005	6		HNRPLL
1085	chr17	65628296	65629366	3500084228	50		65628296	65629366	8421504	2	25,25	0,1045	c	350008422800000008,350008422800000007	0-25,0-25						Use of 15-Lipoxygenase Inhibitors for Treating Obesity	Martin	2009	0		
1085	chr17	65628296	65629366	3500030772	50		65628296	65629366	8421504	2	25,25	0,1045	c	350003077200000012,350003077200000011	0-25,0-25		15047603	10.2337/diabetes.53.4.890	0012-1797	Diabetes	Glucose Regulates the Expression of the Farnesoid X Receptor in Liver	Duran-Sandoval	2004	8		RPLP0
1085	chr17	65628296	65629366	3500016998	50		65628296	65629366	8421504	2	25,25	0,1045	c	350001699800000008,350001699800000007	0-25,0-25						Use of 15-Lipoxygenase Inhibitors for Treating Obesity	Martin	2008	0		
1085	chr17	65628338	65628363	3500373978	25		65628338	65628363	8421504	1	25	0	c	350037397800000016,350037397800000008	0-25,0-25						REDUCING NON-TARGET NUCLEIC ACID DEPENDENT AMPLIFICATIONS: AMPLIFYING REPETITIVE NUCLEIC ACID SEQUENCES - Patent application	www.faqs.org	0	0		RPLP0P2
1085	chr17	65628338	65628363	3500094442	25		65628338	65628363	8421504	1	25	0	c	350009444200000003	0-25		22359668	10.1371/journal.pone.0032185	1932-6203	PLOS ONE	PLOS ONE: Targeting Lysophosphatidic Acid Signaling Retards Culture-Associated Senescence of Human Marrow Stromal Cells	Kanehira	2012	4		RPLP0P2
1085	chr17	65628338	65628363	3500038616	25		65628338	65628363	8421504	1	25	0	c	350003861600000005	0-25		22787205	10.1128/JVI.01495-12		Journal of Virology	HIV-1 Induces Telomerase Activity in Monocyte-Derived Macrophages, Possibly Safeguarding One of Its Reservoirs	Rita	2012	0		RPLP0P2
1085	chr17	65628362	65629266	3500140406	40		65628362	65629266	8421504	2	20,20	0,884	c,g	350014040600000001,350014040600000001,350014040600000000	0-20,0-20,0-20						Suppression of ovarian secretions before puberty strongly affects mammogenesis in the goat. - ResearchGate	.researchgate.net	0	0		
1085	chr17	65628413	65629552	3500021429	49		65628413	65629552	8421504	4	11,11,9,18	0,829,1006,1121	c	350002142900000001,350002142900000000	0-22,0-27						Hh-Gli SIGNALING PATHWAY ACTIVITY IN ORAL AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA	.researchgate.net	0	0		
1085	chr17	65629312	65630119	3500420398	58		65629312	65630119	8421504	3	20,19,19	0,748,788	c,g	350042039800000005,350042039800000009,350042039800000009,350042039800000008,350042039800000008	0-20,0-19,0-19,0-19,0-19						Tumorigenesis and Neoplastic Progression	w.teitell-lab.com	0	0		RPLP0P2
1085	chr17	65629312	65629379	3500456653	39		65629312	65629379	8421504	2	20,19	0,48	c	350045665300000027,350045665300000052,350045665300000026,350045665300000049	0-20,0-20,0-19,0-19						Diagnostic Methods and Genetic Markers for Alzheimer Disease - Patent application	www.faqs.org	0	0		RPLP0
1085	chr17	65629312	65629379	3500439319	39		65629312	65629379	8421504	2	20,19	0,48	c	350043931900000027,350043931900000026	0-20,0-19						Diagnostic Methods And Genetic Markers For Alzheimer Disease 	.freshpatents.com	0	0		RPLP0
1085	chr17	65629312	65629379	3500401616	39		65629312	65629379	8421504	2	20,19	0,48	c	350040161600000000,350040161600000001	0-20,0-19						Human Beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions. - ResearchGate	.researchgate.net	0	0		RPLP0
1085	chr17	65629312	65629379	3500077051	39		65629312	65629379	8421504	2	20,19	0,48	c	350007705100000000,350007705100000001	0-20,0-19		23133681	10.1371/journal.pntd.0001869		PLoS Neglected Tropical Diseases	Human Beta-Defensin 3 Is Up-Regulated in Cutaneous Leprosy Type 1 Reactions	Anna	2012	0		RPLP0
1085	chr17	65629341	65629366	3500133086	25		65629341	65629366	8421504	1	25	0	c	350013308600000003	0-25						HepaticPCSK9ExpressionIsRegulatedbyNutritionalStatus viaInsulinandSterolRegulatoryElement-bindingProtein1c	www.jbc.org	0	0		
1085	chr17	65629351	65630134	3500464446	43		65629351	65630134	8421504	2	23,20	0,763	c,g	350046444600000007,350046444600000007,350046444600000006	0-23,0-23,0-20		15964799	10.1128/MCB.25.13.5417-5428.2005	0270-7306	Molecular and Cellular Biology	Differential Regulation of Estrogen-Inducible Proteolysis and Transcription by the Estrogen Receptor &#x03b1; N Terminus	Valley	2005	6		
1085	chr17	65629351	65629374	3500214120	23		65629351	65629374	8421504	1	23	0	c	350021412000000003	0-23			10.1042/BJ20040933		Biochemical Journal	Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids	Catherine	2005	0		
1085	chr17	65629354	65629378	3500435629	24		65629354	65629378	8421504	1	24	0	c	350043562900000009	18-42						&#x30ab;&#x30eb;&#x30b7;&#x30a6;&#x30e0;&#x62ee;&#x6297;&#x85ac;&#x30a2;&#x30bc;&#x30eb;&#x30cb;&#x30b8;&#x30d4;&#x30f3;&#x306e;3T3-L1 &#x8102;&#x80aa;&#x7d30;&#x80de;&#x306b;&#x304a;&#x3051;&#x308b;&#x30a4;&#x30f3;&#x30b9;&#x30ea;&#x30f3;&#x611f;&#x53d7;	www.docin.com	0	0		
1085	chr17	65629354	65629378	3500125473	24		65629354	65629378	8421504	1	24	0	c	350012547300000001	0-24						&#x8840;&#x7ba1;&#x5185;&#x76ae;&#x7d30;&#x80de;PDK1&#x30b7;&#x30b0;&#x30ca;&#x30eb;&#x306e;&#x751f;&#x7406;&#x7684;&#x5f79;&#x5272;&#x306e;&#x89e3;&#x660e; &#x301c;&#x8840;&#x7ba1;&#x5185;&#x76ae;&#x7d30;&#x80de;&#x7279;&#x7570;&#x7684;PDK1&#x6b20;&#x640	.kawasaki-m.ac.jp	0	0		
1085	chr17	65629383	65629588	3500165278	39		65629383	65629588	8421504	2	19,20	0,185	c	350016527800000206,350016527800000205	0-19,0-20						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
1085	chr17	65629409	65629604	3500284335	43		65629409	65629604	8421504	3	19,3,21	0,125,174	c	350028433500000006,350028433500000007	0-22,0-21						Regulation of anti-inflammatory cytokine IL-10 by the Polycomb Group Protein Bmi1	.uni-wuerzburg.de	0	0		RPLP0
1085	chr17	65629409	65629604	3500120180	43		65629409	65629604	8421504	3	19,3,21	0,125,174	c,g	350012018000000010,350012018000000011,350012018000000011	0-22,0-21,0-21						Orthotopic, controllable, and genetically tractable non-human animal model for cancer - Patent application	www.faqs.org	0	0		RPLP0
1085	chr17	65629415	65629599	3500211273	45		65629415	65629599	8421504	3	13,10,22	0,119,162	c	350021127300000007,350021127300000006	0-23,0-22						Abc expression promoters	Fuse	2004	0		
1085	chr17	65629420	65629550	3500426865	24		65629420	65629550	8421504	2	8,16	0,114	c	350042686500000002	0-24						VEGF and inhibitors of TGF&#x03b2;type-I receptor kinase synergistically promote blood-vessel formation by inducing &#x03b1;5-integrin expression	cs.biologists.org	0	0		
1085	chr17	65629420	65629550	3500303032	24		65629420	65629550	8421504	2	8,16	0,114	c	350030303200000004	0-24						Differentiation of human embryonic stem cells and cardiomyocytes and cardiomyocyte progenitors derived therefrom	Mummery	2006	0		
1085	chr17	65629420	65629550	3500102496	24		65629420	65629550	8421504	2	8,16	0,114	c	350010249600000002	0-24		19706683	10.1242/jcs.048942	0021-9533	Journal of Cell Science	VEGF and inhibitors of TGF&#x03b2; type-I receptor kinase synergistically promote blood-vessel formation by inducing &#x03b1;5-integrin expression	Liu	2009	6		RPLP0
1085	chr17	65629420	65629550	3500000528	24		65629420	65629550	8421504	2	8,16	0,114	c	350000052800000004	0-24						Differentiation of human embryonic stem cells and cardiomyocytes and cardiomyocyte progenitors derived therefrom	Mummery	2006	0		
1085	chr17	65629541	65629639	3500148069	40		65629541	65629639	8421504	2	20,20	0,78	c	350014806900000007,350014806900000006	0-20,0-20		17631492	10.1074/jbc.M704295200	0021-9258	Journal of Biological Chemistry	Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-&#x03b1; Degradation by the Estrogen Receptor-related Receptor-&#x03b1; Inverse Agonist XCT790	Lanvin	2007	5		PLCB2
1085	chr17	65629565	65630119	3500092231	39		65629565	65630119	8421504	2	20,19	0,535	c,g	350009223100000009,350009223100000008,350009223100000008	0-20,0-19,0-19						A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors	www.fasebj.org	0	0		
1085	chr17	65629574	65630076	3500156479	40		65629574	65630076	8421504	2	20,20	0,482	c	350015647900000045,350015647900000044	0-20,0-20						TheCircadianClockComponentBMAL1IsaCriticalRegulator	www.jbc.org	0	0		
1085	chr17	65629574	65630076	3500057603	40		65629574	65630076	8421504	2	20,20	0,482	c	350005760300000042,350005760300000041	0-20,0-20		18086663	10.1074/jbc.M705576200	0021-9258	Journal of Biological Chemistry	The Circadian Clock Component BMAL1 Is a Critical Regulator of p21WAF1/CIP1 Expression and Hepatocyte Proliferation	Grechez-Cassiau	2008	5		
1085	chr17	65629577	65629600	3500159448	23		65629577	65629600	8421504	1	23	0	c,g	350015944800000013,350015944800000013	0-23,0-23						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
1085	chr17	65629853	65630141	3500376631	52		65629853	65630141	8421504	2	26,26	0,262	c	350037663100000018,350037663100000017	0-26,0-26		16314495	10.1128/MCB.25.24.10684-10694.2005	0270-7306	Molecular and Cellular Biology	PGC-1&#x03b1; Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERR&#x03b1;: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism	Wende	2005	6		RPLP0
1085	chr17	65629853	65630141	3500302378	52		65629853	65630141	8421504	2	26,26	0,262	c	350030237800000006,350030237800000005	0-26,0-26						CD36ProteinIsInvolvedinStore-operatedCalciumFlux, PhospholipaseA2Activation,andProductionof ProstaglandinE2	www.jbc.org	0	0		RPLP0
1085	chr17	65629853	65630141	3500175919	52		65629853	65630141	8421504	2	26,26	0,262	c	350017591900000006,350017591900000005	0-26,0-26		21454644	10.1074/jbc.M111.232975	0021-9258	Journal of Biological Chemistry	CD36 Protein Is Involved in Store-operated Calcium Flux, Phospholipase A2 Activation, and Production of Prostaglandin E2	Kuda	2011	5		RPLP0
1085	chr17	65629853	65630141	3500161232	52		65629853	65630141	8421504	2	26,26	0,262	c	350016123200000018,350016123200000017	0-26,0-26			10.1128/MCB.25.24.10684-10694.2005		Molecular and Cellular Biology	PGC-1&#x03b1; Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERR&#x03b1;: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism	Adam	2005	0		
1085	chr17	65629864	65630091	3500425134	41		65629864	65630091	8421504	2	22,19	0,208	c,g	350042513400000007,350042513400000006,350042513400000006	0-22,0-19,0-19		23208413	10.1038/nutd.2012.25	false	Nutrition & Diabetes	Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells	Faber	2012	0		RPLP0
1085	chr17	65629864	65630091	3500270958	41		65629864	65630091	8421504	2	22,19	0,208	c,g	350027095800000007,350027095800000006,350027095800000006	0-22,0-19,0-19						The adipose tissue - liver axis in the pathogenesis of vascular diseases	ive.library.uu.nl	0	0		
1085	chr17	65629903	65630071	3500018119	42		65629903	65630071	8421504	3	3,19,20	0,101,148	c	350001811900000003,350001811900000002	0-22,0-20		19018264	10.1038/sj.bjc.6604755	0007-0920	British Journal of Cancer	Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival	Waldmann	2008	5		RPLP0
1085	chr17	65630060	65630119	3500274051	38		65630060	65630119	8421504	2	19,19	0,40	c,g	350027405100000001,350027405100000000,350027405100000000	0-19,0-19,0-19						ScienceDirect.com - FEBS Letters - Phosphorylation of the liver X receptors	sciencedirect.com	0	0		RPLP0
1085	chr17	65630060	65630119	3500177934	38		65630060	65630119	8421504	2	19,19	0,40	c,g	350017793400000007,350017793400000006,350017793400000006	0-19,0-19,0-19		21370225	10.1002/art.30312		Arthritis and rheumatism	Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?	Jun	June	0		RPLP0P2
1085	chr17	65630060	65630119	3500111059	38		65630060	65630119	8421504	2	19,19	0,40	c,g	350011105900000001,350011105900000000,350011105900000000	0-19,0-19,0-19						Reciprocal regulation of inflammation and lipid metabolism by liver x receptors	Castrillo	2005	0		RPLP0
1085	chr17	65630060	65630119	3500035969	38		65630060	65630119	8421504	2	19,19	0,40	c,g	350003596900000007,350003596900000006,350003596900000006	0-19,0-19,0-19		15826936	10.1074/jbc.M501759200	0021-9258	Journal of Biological Chemistry	Free Cholesterol-loaded Macrophages Are an Abundant Source of Tumor Necrosis Factor-&#x03b1; and Interleukin-6	Li	2005	5		RPLP0
1085	chr17	65630061	65630119	3500236219	44		65630061	65630119	8421504	2	25,19	0,39	c,g	350023621900000004,350023621900000004,350023621900000000,350023621900000000	0-25,0-25,0-19,0-19		16317102	10.1182/blood-2005-06-2265	0006-4971	Blood	SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells	Rethi	2006	10		RPLP0P2
1085	chr17	65630061	65630119	3500146467	44		65630061	65630119	8421504	2	25,19	0,39	c,g	350014646700000004,350014646700000000,350014646700000000	0-25,0-19,0-19			10.1182/blood-2005-06-2265		Blood	SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells	Bence	2006	0		RPLP0
1085	chr17	65630068	65631171	3500418135	40		65630068	65631171	8421504	2	20,20	0,1083	c,g	350041813500000007,350041813500000006,350041813500000006	0-20,0-20,0-20						CONSTRUCTION OF ADENOVIRAL VECTORS FOR CANCER GENE THERAPY AND EVALUATION OF TOXIC EFFECTS OF ADENOVIRAL INFECTION ON ADRENOCORTICAL CELLS	arch.cab.unipd.it	0	0		RPLP0
1085	chr17	65630068	65631171	3500343990	40		65630068	65631171	8421504	2	20,20	0,1083	c,g	350034399000000012,350034399000000011,350034399000000011	0-20,0-20,0-20		22675422	10.1371/journal.pone.0036762		PLoS ONE	Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells	Marine	2012	0		
1085	chr17	65630068	65631171	3500332205	40		65630068	65631171	8421504	2	20,20	0,1083	c,g	350033220500000009,350033220500000008,350033220500000008	0-20,0-20,0-20		17053056	10.1182/blood-2006-07-038372	0006-4971	Blood	Impaired ribosome biogenesis in Diamond-Blackfan anemia	Choesmel	2007	10		
1085	chr17	65630068	65631171	3500248992	65		65630068	65631171	8421504	3	20,25,20	0,38,1083	c,g	350024899200000043,350024899200000043,350024899200000044,350024899200000042,350024899200000042	0-20,0-20,0-25,0-20,0-20						Modifications for Antisense Compounds	Behlke	2012	0		
1085	chr17	65630068	65631171	3500181189	40		65630068	65631171	8421504	2	20,20	0,1083	c,g	350018118900000009,350018118900000008,350018118900000008	0-20,0-20,0-20		17053056	10.1182/blood-2006-07-038372	0006-4971	Blood	Impaired ribosome biogenesis in Diamond-Blackfan anemia	Choesmel	2007	10		RPLP0
1085	chr17	65630068	65631171	3500166920	40		65630068	65631171	8421504	2	20,20	0,1083	c,g	350016692000000017,350016692000000016,350016692000000016	0-20,0-20,0-20		12857727	10.1074/jbc.M305791200	0021-9258	Journal of Biological Chemistry	The IGF2 Receptor Is a USF2-specific Target in Nontumorigenic Mammary Epithelial Cells but Not in Breast Cancer Cells	Szentirmay	2003	5		
1085	chr17	65630068	65631171	3500074463	40		65630068	65631171	8421504	2	20,20	0,1083	c,g	350007446300000001,350007446300000000,350007446300000000	0-20,0-20,0-20						Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells	do.physiology.org	0	0		RPLP0
1085	chr17	65630068	65631171	3500041742	40		65630068	65631171	8421504	2	20,20	0,1083	c,g	350004174200000001,350004174200000000,350004174200000000	0-20,0-20,0-20						Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and	do.physiology.org	0	0		RPLP0
1085	chr17	65630104	65631171	3500375528	40		65630104	65631171	8421504	2	20,20	0,1047	c,g	350037552800000007,350037552800000006,350037552800000006	0-20,0-20,0-20						LH-induced ERK Activation Differently Modulates Progesterone and Androstenedione Production in Bovine Theca Cells.	.endojournals.org	0	0		
1085	chr17	65630104	65631171	3500322099	40		65630104	65631171	8421504	2	20,20	0,1047	c,g	350032209900000003,350032209900000002,350032209900000002	0-20,0-20,0-20						Analysis of Induction Mechanisms of an Insulin-Inducible Transcription Factor SHARP 2 Gene by ( )-Epigallocatechin-3-gallate	matsumoto-u.ac.jp	0	0		RPLP0
1085	chr17	65630104	65631171	3500283019	40		65630104	65631171	8421504	2	20,20	0,1047	c,g	350028301900000003,350028301900000002,350028301900000002	0-20,0-20,0-20						Genistein stimulates the insulin-dependent signaling pathway. - ResearchGate	.researchgate.net	0	0		
1085	chr17	65630104	65631171	3500171876	40		65630104	65631171	8421504	2	20,20	0,1047	c,g	350017187600000015,350017187600000015,350017187600000014,350017187600000014	0-20,0-20,0-20,0-20						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
1085	chr17	65630104	65631171	3500075026	40		65630104	65631171	8421504	2	20,20	0,1047	c,g	350007502600000005,350007502600000005,350007502600000004,350007502600000004	0-20,0-20,0-20,0-20		19917087	10.1186/1757-2215-2-17		Journal of Ovarian Research	Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells	Shin	2009	0		RPLP0
1085	chr17	65630104	65631171	3500048685	40		65630104	65631171	8421504	2	20,20	0,1047	c,g	350004868500000015,350004868500000015,350004868500000014,350004868500000014	0-20,0-20,0-20,0-20		19077323	10.1186/1477-7827-6-62		Reproductive Biology and Endocrinology : RB&E	Regulation of P450 oxidoreductase by gonadotropins in rat ovary and its effect on estrogen production	Yoshihiko	2008	0		RPLP0
1085	chr17	65630106	65631170	3500422263	40		65630106	65631170	8421504	2	19,21	0,1043	c	350042226300000010,350042226300000009	0-19,0-21		18441325	10.1074/jbc.M800109200		The Journal of Biological Chemistry	Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells	Lilly	June	0		RPLP0
1085	chr17	65630106	65631170	3500296687	40		65630106	65631170	8421504	2	19,21	0,1043	c	350029668700000012,350029668700000011	0-19,0-21						Hyaluronan-mediatedCD44Interactionwithp300andSIRT1 Regulates -CateninSignalingandNF B-specific TranscriptionActivityLeadingtoMDR1andBcl-xL Gene ExpressionandChemoresistanceinBreastTumorCells	www.jbc.org	0	0		RPLP0
1085	chr17	65630106	65631170	3500241053	40		65630106	65631170	8421504	2	19,21	0,1043	c,g	350024105300000010,350024105300000009,350024105300000009	0-19,0-21,0-21						Hyaluronan-CD44InteractionActivatesStemCellMarker Nanog,Stat-3-mediatedMDR1GeneExpression,and Ankyrin-regulatedMultidrugEffluxinBreastandOvarian TumorCells	www.jbc.org	0	0		RPLP0
1085	chr17	65630106	65631170	3500146749	40		65630106	65631170	8421504	2	19,21	0,1043	c	350014674900000008,350014674900000007	0-19,0-21						JBC Papers in Press. Published on July 30, 2012 as Manuscript M111.308528 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M111.308528	www.jbc.org	0	0		RPLP0
1085	chr17	65630109	65631165	3500071562	40		65630109	65631165	8421504	2	20,20	0,1036	c,g	350007156200000004,350007156200000004,350007156200000003,350007156200000003	0-20,0-20,0-20,0-20		21698222	10.1371/journal.ppat.1002084		PLoS Pathogens	The Intrinsic Antiviral Defense to Incoming HSV-1 Genomes Includes Specific DNA Repair Proteins and Is Counteracted by the Viral Protein ICP0	Caroline	June	0		RPLP0
1085	chr17	65630109	65631165	3500005175	40		65630109	65631165	8421504	2	20,20	0,1036	c,g	350000517500000004,350000517500000003,350000517500000003	0-20,0-20,0-20		21698222	10.1371/journal.ppat.1002084	1553-7374	PLOS Pathogens	PLOS Pathogens: The Intrinsic Antiviral Defense to Incoming HSV-1 Genomes Includes Specific DNA Repair Proteins and Is Counteracted by the Viral Protein ICP0	Lilley	2011	0		RPLP0
1085	chr17	65630146	65630170	3500211986	24		65630146	65630170	8421504	1	24	0	g	350021198600000008	0-24		18815134	10.1074/jbc.M801011200	0021-9258	Journal of Biological Chemistry	COP1 Functions as a FoxO1 Ubiquitin E3 Ligase to Regulate FoxO1-mediated Gene Expression	Kato	2008	5		
1085	chr17	65631210	65631487	3500393821	29		65631210	65631487	8421504	2	26,3	0,274	c	350039382100000005	0-29		21411736	10.4049/jimmunol.1000791	0022-1767	The Journal of Immunology	Dual Oxidase 1 Induced by Th2 Cytokines Promotes STAT6 Phosphorylation via Oxidative Inactivation of Protein Tyrosine Phosphatase 1B in Human Epidermal Keratinocytes	Hirakawa	2011	6		
1086	chr17	65744735	65749686	3500352760	45		65744735	65749686	8421504	2	22,23	0,4928	c,g	350035276000000025,350035276000000024,350035276000000024	0-22,0-23,0-23		21496021	10.1111/j.1471-4159.2011.07272.x	1471-4159	Journal of Neurochemistry	Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers - Garbayo - 2011 - Journal of Neurochemistry - Wiley Online Libr	Garbayo	2011	0		MSI1
1086	chr17	65744735	65749686	3500338564	45		65744735	65749686	8421504	2	22,23	0,4928	c,g	350033856400000025,350033856400000024,350033856400000024	0-22,0-23,0-23						Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers. - ResearchGate	.researchgate.net	0	0		MSI1
1087	chr17	65830308	65830331	3500256218	23		65830308	65830331	8421504	1	23	0	c	350025621800000126	0-23						REPRODUCTION	uction-online.org	0	0		
1087	chr17	65861484	65863359	3500378665	60		65861484	65863359	8421504	4	20,20,13,7	0,1788,1854,1868	c	350037866500000006,350037866500000007,350037866500000009	0-20,0-20,0-20						Specific maternal transcripts in bovine oocytes and cleavaged embryos: Identification with novel DDRT-PCR methods	www.seegene.com	0	0		
1087	chr17	65863407	65863436	3500383915	24		65863407	65863436	8421504	2	6,18	0,11	c	350038391500000228	1-26						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
1088	chr17	65972644	65989028	3500403171	67		65972644	65989028	8421504	3	23,22,22	0,8293,16362	c,g	350040317100000020,350040317100000003,350040317100000003,350040317100000013	3-26,0-22,0-22,0-22		10625670	10.1074/jbc.275.2.1247	0021-9258	Journal of Biological Chemistry	Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin	Haeseleer	2000	5		CABP1
1088	chr17	66032151	66032176	3500270590	23		66032151	66032176	8421504	2	7,16	0,9	c	350027059000000004	0-23						CELL EXTRACT-BASED REPROGRAMMING OF SOMATIC CELLS	etd.lsu.edu	0	0		
1090	chr17	66257779	66257804	3500307179	25		66257779	66257804	8421504	1	25	0	c	350030717900000006	7-32						Regulation of Flavin-Containing Monooxygenase 1 Expression by Ying Yang 1 and Hepatic Nuclear Factors 1 and 4	aspetjournals.org	0	0		
1090	chr17	66257844	66257870	3500054368	26		66257844	66257870	8421504	1	26	0	c	350005436800000002	3-29		12673196	10.1038/sj.onc.1206307	0950-9232	Oncogene	The C-terminal region of cellular Qin oligomerizes: correlation with oncogenic transformation and transcriptional repression	Sonderegger	2003	6		
1090	chr17	66258075	66258099	3500466638	24		66258075	66258099	8421504	1	24	0	c	350046663800000031	14-38		18492795	10.1261/rna.810208	1355-8382	RNA	Inducible expression of microRNA-194 is regulated by HNF-1&#x03b1; during intestinal epithelial cell differentiation	Hino	2008	5		HNF1A
1090	chr17	66266126	66266151	3500262392	25		66266126	66266151	8421504	1	25	0	c	350026239200000013	0-25						Gastroenterology	www.wjgnet.com	0	0		
1090	chr17	66266126	66266151	3500028964	25		66266126	66266151	8421504	1	25	0	c	350002896400000011	0-25						World J Gastroenterol	www.wjgnet.com	0	0		
1090	chr17	66266231	66267938	3500459021	23		66266231	66267938	8421504	3	6,9,8	0,1689,1699	c	350045902100000696	15-38						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
1090	chr17	66270425	66270449	3500273024	24		66270425	66270449	8421504	1	24	0	c	350027302400000000	0-24						Human salivary gland-origin stem cell - US Patent 7659121 Description	ww.patentstorm.us	0	0		
1090	chr17	66271207	66272556	3500146806	42		66271207	66272556	8421504	2	21,21	0,1328	c	350014680600000006,350014680600000007	0-21,0-21		11340160	10.1128/MCB.21.11.3662-3670.2001	0270-7306	Molecular and Cellular Biology	Embryonic but Not Postnatal Reexpression of Hepatocyte Nuclear Factor 1&#x03b1; (HNF1&#x03b1;) Can Reactivate the Silent Phenylalanine Hydroxylase Gene in HNF1&#x03b1;-Deficient Hepatocytes	Viollet	2001	6		HNF1A
1091	chr17	66396588	66396612	3500159407	23		66396588	66396612	8421504	2	18,5	0,19	g	350015940700000274	3-26						Glial mitogenic factors, their preparation and use	Goodearl	1995	0		
1091	chr17	66396651	66436176	3500219993	2037		66396651	66436176	8421504	19	52,134,113,106,87,131,95,46,52,73,98,112,140,3,249,83,189,64,210	0,4701,6385,7100,8716,8919,10779,13716,14892,18569,18891,20013,23511,25776,29515,35602,36289,38755,39315	p	350021999300015000	0-2043						KEGG T01001: 9815	www.genome.jp	0	0		GIT2
1091	chr17	66407524	66416748	3500219385	354		66407524	66416748	8421504	6	1,46,52,73,98,84	0,2843,4019,7696,8018,9140	p	350021938500015025,350021938500015027	0-177,0-177						The Spa2-related protein, Sph1p, is important for polarized growth in yeast	cs.biologists.org	0	0		GIT2
1091	chr17	66445294	66445319	3500177612	23		66445294	66445319	8421504	2	10,13	0,12	c	350017761200000010	0-23		14532127	10.1093/emboj/cdg516	ERROR! NO ISSN	The EMBO Journal	Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion	Bonaldi	2003	0		
1092	chr17	66469024	66490376	3500031257	624		66469024	66490376	8421504	5	100,59,134,151,180	0,14793,15809,18788,21172	p	350003125700015003,350003125700015004,350003125700015005,350003125700015006	0-360,0-90,0-90,0-84						Compositions and methods for treatment of neoplastic disease	Terman	2003	0		GLTP,TCHP
1092	chr17	66490247	66490292	3500257029	45		66490247	66490292	8421504	1	45	0	p	350025702900015012	0-45						Application # 2002/0177551. Compositions and methods for treatment of neoplastic disease - Patents.com	www.patents.com	0	0		
1092	chr17	66490358	66490390	3500038384	30		66490358	66490390	8421504	2	22,8	0,24	c	350003838400000001	0-30		18657186	10.1111/j.1742-4658.2008.06584.x		The FEBS journal	Human GLTP and mutant forms of ACD11 suppress cell death in the Arabidopsis acd11 mutant	Nikolaj	2008	0		
1092	chr17	66518896	66522218	3500442042	192		66518896	66522218	8421504	4	45,14,46,87	0,81,3186,3235	p	350044204200015080,350044204200015081	0-45,0-147						US Patent # 7,094,877. Human vanilloid receptor VR3 protein - Patents.com	www.patents.com	0	0		
1092	chr17	66518896	66522218	3500362490	192		66518896	66522218	8421504	4	45,14,46,87	0,81,3186,3235	p	350036249000015080,350036249000015081	0-45,0-147						US Patent # 7,186,803. Human vanilloid receptor VR3 protein - Patents.com	www.patents.com	0	0		
1092	chr17	66518896	66522218	3500133534	192		66518896	66522218	8421504	4	45,14,46,87	0,81,3186,3235	p	350013353400015080,350013353400015081	0-45,0-147						Human vanilloid receptor VR3 protein - Patent # 7186803 - PatentGenius	.patentgenius.com	0	0		
1092	chr17	66526985	66538584	3500340986	64		66526985	66538584	8421504	3	20,21,23	0,4279,11576	c	350034098600000004,350034098600000001,350034098600000009	0-20,0-21,9-32		17124270	10.1113/jphysiol.2006.121111	0022-3751	The Journal of Physiology	Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice	Grant	2007	5		TRPV4
1092	chr17	66528701	66529835	3500380647	288		66528701	66529835	8421504	3	75,48,165	0,99,969	p	350038064700015016	147-450						Non-selective cation channel	Harteneck	2001	0		
1092	chr17	66531995	66537041	3500287000	48		66531995	66537041	8421504	3	24,23,1	0,3747,5045	c	350028700000000000,350028700000000001	0-24,0-24						TRPV4 channels augment macrophage activation and ventilator-induced lung injury	ahealthsystem.com	0	0		TRPV4
1092	chr17	66531995	66537041	3500042822	48		66531995	66537041	8421504	3	24,23,1	0,3747,5045	c	350004282200000000,350004282200000001	0-24,0-24		20562229	10.1152/ajplung.00315.2009		American Journal of Physiology - Lung Cellular and Molecular Physiology	TRPV4 channels augment macrophage activation and ventilator-induced lung injury	Hamanaka	2010	0		
1092	chr17	66533313	66535578	3500055025	40		66533313	66535578	8421504	2	20,20	0,2245	c,g	350005502500000000,350005502500000000,350005502500000001	0-20,0-20,0-20						Efficacy of cancer therapy	Thodeti	2013	0		TRPV4
1092	chr17	66535679	66535706	3500465865	24		66535679	66535706	8421504	2	8,16	0,11	g	350046586500000078	11-35						 Nucleic Acid Sequences Encoding Capsaicin Receptor And Capsaicin Receptor 	www.docstoc.com	0	0		
1092	chr17	66537155	66537629	3500166888	26		66537155	66537629	8421504	2	13,13	0,461	c	350016688800000247	22-48						Nucleic acid sequences encoding capsaicin receptor and uses thereof	Julius	1999	0		
1092	chr17	66537155	66537629	3500027346	26		66537155	66537629	8421504	2	13,13	0,461	c	350002734600000245	22-48						US Patent # 6,335,180. Nucleic acid sequences encoding capsaicin receptor and uses thereof - Patents.com	www.patents.com	0	0		
1092	chr17	66537719	66538458	3500270302	51		66537719	66538458	8421504	2	19,32	0,707	p	350027030200015000	0-51		12724311	10.1074/jbc.M302590200	0021-9258	Journal of Biological Chemistry	Ca2+-dependent Potentiation of the Nonselective Cation Channel TRPV4 Is Mediated by a C-terminal Calmodulin Binding Site	Strotmann	2003	5		TRPV4
1092	chr17	66543464	66543488	3500279962	23		66543464	66543488	8421504	2	15,8	0,16	g	350027996200000002	1-24						SAT II Biology	www.scribd.com	0	0		
1094	chr17	66759240	66761150	3500259074	23		66759240	66761150	8421504	3	4,8,11	0,5,1899	c	350025907400000058	19-42						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
1094	chr17	66774363	66775261	3500349145	23		66774363	66775261	8421504	4	6,7,6,4	0,876,887,894	c	350034914500000313	22-46						Novel Human Beta-2 Integrin Alpha Subunit 	.freshpatents.com	0	0		
136	chr17	66832595	66858079	3500201864	42		66832595	66858079	8421504	4	14,9,12,7	0,19,25460,25477	g	350020186400000837,350020186400000473	9-40,0-19						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1094	chr17	66832595	66832623	3500005314	23		66832595	66832623	8421504	2	14,9	0,19	g	350000531400000841	9-40						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
1095	chr17	66946248	66946293	3500022667	45		66946248	66946293	8421504	1	45	0	p	350002266700015130	0-45						Acetyl Coa Carboxylase Splice Variant And Uses Thereof 	.freshpatents.com	0	0		
1096	chr17	67045711	67045747	3500363029	26		67045711	67045747	8421504	3	15,3,8	0,20,28	g	350036302900000029,350036302900000028	0-26,20-46						Adenovirus modifies pour changer leur tropisme, de preference pour le ciblage des lymphocytes b ou des cellules ovariennes	Colin	2004	0		
1096	chr17	67065558	67065612	3500078565	54		67065558	67065612	8421504	1	54	0	p	350007856500015002	0-54						Autoantigen discovery with a synthetic human peptidome	p.med.harvard.edu	0	0		UNG
1096	chr17	67087334	67087363	3500094946	24		67087334	67087363	8421504	2	16,8	0,21	g	350009494600000024	6-30						CONJUGATES OF BIOMOLECULES TO NANOPARTICLES	Nikiforov	2010	0		
1097	chr17	67200122	67200150	3500354850	25		67200122	67200150	8421504	2	10,15	0,13	g	350035485000000009	3-28						Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase	Abell	1995	0		
1098	chr17	67346045	67346072	3500075361	25		67346045	67346072	8421504	2	20,5	0,22	g	350007536100000044	6-31						FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS - Patent application	www.faqs.org	0	0		
1099	chr17	67403002	67403845	3500156331	61		67403002	67403845	8421504	2	19,42	0,801	c	350015633100000035,350015633100000043	3-22,6-48						US Patent # 5,827,817. P-selectin ligand protein - Patents.com	www.patents.com	0	0		
1099	chr17	67403414	67403438	3500135512	24		67403414	67403438	8421504	1	24	0	c,g	350013551200000007,350013551200000007	0-24,0-24						 SpringerImages - Sequences of primers used for RACE and RT-PCR analysis 	pringerimages.com	0	0		
1102	chr17	67826341	67826510	3500455501	40		67826341	67826510	8421504	2	20,20	0,149	c,g	350045550100000005,350045550100000005,350045550100000006,350045550100000006	0-20,0-20,0-20,0-20						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
1103	chr17	67951338	67951362	3500082661	23		67951338	67951362	8421504	2	10,13	0,11	g	350008266100000007	6-29		9882665		0021-9193	Journal of Bacteriology	Localization of FtsI (PBP3) to the Septal Ring Requires Its Membrane Anchor, the Z Ring, FtsA, FtsQ, and FtsL	Weiss	1999	4		
1105	chr17	68209824	68209849	3500187612	23		68209824	68209849	8421504	2	13,10	0,15	g	350018761200000197	10-33						US Patent # 5,635,617. Methods and compositions comprising the agfA gene for detection of Salmonella - Patents.com	www.patents.com	0	0		
1107	chr17	68457153	68457177	3500375860	23		68457153	68457177	8421504	2	18,5	0,19	g	350037586000000149	8-32						Phytase polypeptides	Bech	1998	0		
138	chr17	68537053	68559711	3500250561	141		68537053	68559711	8421504	3	48,48,45	0,15712,22613	p	350025056100015104,350025056100015113,350025056100015102	0-48,0-48,0-45						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		
1113	chr17	69248937	69311110	3500319336	63		69248937	69311110	8421504	5	9,12,20,15,7	0,13,49021,62149,62166	g	350031933600000026,350031933600000181,350031933600000024	12-33,28-48,7-29						Subtilases 	.freshpatents.com	0	0		
1114	chr17	69354906	69354929	3500140868	23		69354906	69354929	8421504	1	23	0	c	350014086800000017	2-29					Patent	Replica amplification of nucleic acid arrays (Patent US:6511803)	Church	2003	0		
1114	chr17	69451516	69451545	3500099369	24		69451516	69451545	8421504	2	18,6	0,23	c	350009936900000109	15-40						METHODS AND COMPOSITIONS FOR PREVENTING A CONDITION - Patent application	www.faqs.org	0	0		
1114	chr17	69455714	69455742	3500080900	27		69455714	69455742	8421504	2	4,23	0,5	c	350008090000000004	0-27						Impaired insulin secretion from the pancreatic islets of hypothyroidal growth-retarded mice	logy-journals.org	0	0		TPST2
1118	chr17	69941603	69941634	3500364255	23		69941603	69941634	8421504	3	6,12,5	0,11,26	g	350036425500000004	15-38						Rapid and simultaneous detection of Mycobacterium tuberculosis complex and Beijing/W genotype in sputum by an optimized DNA extraction protocol and a novel multiplex real-time PCR. - ResearchGate	.researchgate.net	0	0		
1118	chr17	69944778	69944804	3500260964	23		69944778	69944804	8421504	3	5,14,4	0,7,22	g	350026096400000043	24-48						NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM FORAXELLA CATARRHALIS - Patent application	www.faqs.org	0	0		
1122	chr17	70409263	70409290	3500404231	23		70409263	70409290	8421504	3	4,13,6	0,5,21	g	350040423100000045,350040423100000105	7-32,7-32						CD23 BINDING MOLECULES AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
1124	chr17	70750572	70750598	3500206065	24		70750572	70750598	8421504	3	5,15,4	0,6,22	g	350020606500000001	3-29						Methods of treating an inflammatory disorder and prohibiting proliferation, cytokine production, and signal transduction with antibody against costimulatory signal transduction molecule AILIM	Tsuji	2003	0		
1125	chr17	70858141	70858165	3500323015	23		70858141	70858165	8421504	2	7,16	0,8	g	350032301500000049	2-39						US Patent # 5,998,191. High specificity homocysteine assays for biological samples - Patents.com	www.patents.com	0	0		
1128	chr17	71293987	71294107	3500098998	120		71293987	71294107	8421504	1	120	0	p	350009899800015008	0-120						BMC Cancer BioMed Central	biomedcentral.com	0	0		
1129	chr17	71314330	71314353	3500156246	23		71314330	71314353	8421504	1	23	0	c	350015624600000010	0-23					Patent	Engineered zinc finger proteins for regulation of gene expression (Patent US:7407776)	Choo	2008	0		
1129	chr17	71363050	71365224	3500228611	40		71363050	71365224	8421504	2	20,20	0,2154	g	350022861100000003,350022861100000002	0-20,0-20			10.1152/ajpendo.00265.2006		American Journal of Physiology - Endocrinology and Metabolism	Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic &#x03b2;-cells	Rozance	2007	0		
1132	chr17	71785543	71789724	3500444370	26		71785543	71789724	8421504	2	19,7	0,4174	c	350044437000000002	7-33						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
1132	chr17	71785549	71810861	3500011487	1965		71785549	71810861	8421504	17	13,37,52,124,187,168,212,181,35,33,119,130,123,163,98,253,37	0,4168,4344,5643,10013,12143,14416,15517,18452,19026,19355,22302,23226,23701,24233,24773,25275	p	350001148700015000	0-1965						KEGG T01001: 2130	www.genome.jp	0	0		
1132	chr17	71791278	71800170	3500155584	44		71791278	71800170	8421504	2	24,20	0,8872	c,g	350015558400000002,350015558400000002,350015558400000000	0-24,0-24,0-20		18974141	10.1158/0008-5472.CAN-08-0573	0008-5472	Cancer Research	EWS-FLI1 Induces Developmental Abnormalities and Accelerates Sarcoma Formation in a Transgenic Mouse Model	Lin	2008	8		EWSR1
1132	chr17	71795616	71795643	3500068396	24		71795616	71795643	8421504	2	11,13	0,14	c	350006839600000032	14-38						Trophinin and trophinin-assisting protein agonists, antibodies and antagonists	Fukuda	1996	0		
1132	chr17	71799982	71800005	3500428924	23		71799982	71800005	8421504	1	23	0	c	350042892400000005	0-23		18084326	10.1038/sj.onc.1210991	0950-9232	Oncogene	The EWS&sol;FLI1 oncogenic transcription factor deregulates GLI1	Zwerner	2007	6		FLI1
1132	chr17	71799982	71800005	3500157907	23		71799982	71800005	8421504	1	23	0	c	350015790700000005	0-23		18084326	10.1038/sj.onc.1210991	0950-9232	Oncogene	The EWS&sol;FLI1 oncogenic transcription factor deregulates GLI1	Zwerner	2007	6		FLI1
1132	chr17	71799982	71800005	3500114424	23		71799982	71800005	8421504	1	23	0	c	350011442400000008	0-23		16204072	10.1158/0008-5472.CAN-05-0565	0008-5472	Cancer Research	Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's Sarcoma	Hu-Lieskovan	2005	8		EWSR1
1132	chr17	71800092	71800177	3500367930	85		71800092	71800177	8421504	1	85	0	c	350036793000000261	0-85						Recurrent gene fusions in prostate cancer - Patent application	www.faqs.org	0	0		EWSR1
1132	chr17	71800150	71800174	3500415338	24		71800150	71800174	8421504	1	24	0	g	350041533800000010	0-24						EWS-Fli1Up-RegulatesExpressionoftheAuroraAand AuroraBKinases	.aacrjournals.org	0	0		EWSR1
1132	chr17	71804012	71804941	3500328115	51		71804012	71804941	8421504	2	22,29	0,900	c	350032811500000006,350032811500000008	0-22,0-29		12881716	10.1038/sj.onc.1206472	0950-9232	Oncogene	UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines	Modena	2003	6		
1132	chr17	71804578	71804605	3500466678	27		71804578	71804605	8421504	1	27	0	c	350046667800000011	10-37		21244633	10.1111/j.1742-4658.2011.08020.x	1742-4658	FEBS Journal	Identification of Ewing&#x2019;s sarcoma protein as a G-quadruplex DNA- and RNA-binding protein - Takahama - 2011 - FEBS Journal - Wiley Online Library	Takahama	2011	0		
1132	chr17	71809387	71809813	3500431918	57		71809387	71809813	8421504	2	26,31	0,395	p	350043191800015030	0-57						Riboproteomics of the Hepatitis C Virus Internal Ribosomal Entry Site	gs.washington.edu	0	0		EWSR1
1134	chr17	71966558	71966581	3500367859	23		71966558	71966581	8421504	1	23	0	c	350036785900000027	1-24						Biological markers and uses therefor	Spelman	2011	0		
1134	chr17	71966626	71966946	3500307457	226		71966626	71966946	8421504	12	6,6,18,10,19,25,55,11,12,28,29,7	0,7,14,42,54,75,102,158,171,222,281,313	c	350030745700000078	416-711						Protein c production in transgenic animals	Cottingham	1997	0		
1134	chr17	71966842	71966865	3500407097	23		71966842	71966865	8421504	1	23	0	c	350040709700000000	0-23						Detection of Germ line and Somatic Copy Number Variations in Cattle	ddr.nal.usda.gov	0	0		
1134	chr17	72078629	72078653	3500248943	24		72078629	72078653	8421504	1	24	0	g	350024894300000011	2-26		21332448	10.1042/BJ20102131		Biochemical Journal	Recombinant Deg/HtrA proteases from Synechocystis sp. PCC 6803 differ in substrate specificity, biochemical characteristics and mechanism	Pitter F.	2011	0		
1135	chr17	72198012	72198038	3500148203	23		72198012	72198038	8421504	2	16,7	0,19	g	350014820300000165	20-45						 Anti 	www.docstoc.com	0	0		
1135	chr17	72207476	72207507	3500347802	27		72207476	72207507	8421504	3	7,8,12	0,10,19	g	350034780200000124	5-35						Genetic Markers For Skatole Metabolism 	.freshpatents.com	0	0		
1138	chr17	72491456	72491487	3500196470	25		72491456	72491487	8421504	3	4,15,6	0,5,25	g	350019647000000016	17-42						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
1138	chr17	72538874	72543672	3500384679	4786		72538874	72543672	8421504	4	412,538,2956,880	0,413,961,3918	p,c,g	350038467900000140,350038467900015023,350038467900015013,350038467900000060,350038467900015022,350038467900000059,350038467900015012,350038467900015021,350038467900000058,350038467900015011,350038467900000057,350038467900015019,350038467900000055,350038467900015008,350038467900000052,350038467900015005,350038467900015014,350038467900000050,350038467900000050	0-4786,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,0-108,0-108						Methods for the generation of primordial germ cells and transgenic animal species	Piedrahita	1998	0		
1138	chr17	72538874	72543672	3500348976	4787		72538874	72543672	8421504	3	951,2956,880	0,961,3918	p,c,g	350034897600000142,350034897600000064,350034897600015029,350034897600000063,350034897600015028,350034897600000062,350034897600015015,350034897600000061,350034897600015014,350034897600015026,350034897600000060,350034897600015013,350034897600015025,350034897600000059,350034897600015012,350034897600015024,350034897600000057,350034897600015010,350034897600015022,350034897600015009,350034897600000056,350034897600015021,350034897600000055,350034897600015008,350034897600015020,350034897600015007,350034897600000054,350034897600015019,350034897600015006,350034897600000053,350034897600015018,350034897600000052,350034897600000052	0-4787,0-39,0-45,0-48,0-45,0-48,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-45,0-48,0-45,0-48,0-45,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-108,0-108						Methods comprising apoptosis inhibitors for the generation of transgenic pigs	Piedrahita	2001	0		
1138	chr17	72538874	72543672	3500118441	4787		72538874	72543672	8421504	3	951,2956,880	0,961,3918	p,c,g	350011844100000140,350011844100000062,350011844100015028,350011844100015015,350011844100015027,350011844100000060,350011844100015013,350011844100000059,350011844100015025,350011844100015012,350011844100015024,350011844100015011,350011844100000057,350011844100015022,350011844100000055,350011844100015021,350011844100015008,350011844100000054,350011844100015020,350011844100000052,350011844100015006,350011844100015018,350011844100015005,350011844100015017,350011844100000050,350011844100000050	0-4787,0-39,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-108,0-108						US Patent # 6,271,436. Cells and methods for the generation of transgenic pigs - Patents.com	www.patents.com	0	0		
1138	chr17	72538874	72543672	3500090639	4787		72538874	72543672	8421504	3	951,2956,880	0,961,3918	p,c,g	350009063900000138,350009063900015028,350009063900015015,350009063900015027,350009063900015014,350009063900000058,350009063900015026,350009063900015013,350009063900000057,350009063900015025,350009063900015012,350009063900000056,350009063900015024,350009063900015011,350009063900000055,350009063900015022,350009063900000053,350009063900015009,350009063900015021,350009063900015008,350009063900015020,350009063900015007,350009063900015019,350009063900000050,350009063900015006,350009063900015018,350009063900015005,350009063900015017,350009063900000048,350009063900000048	0-4787,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-108,0-108						 Cells And Methods For The Generation Of Transgenic Pigs 	www.docstoc.com	0	0		
1138	chr17	72540631	72542423	3500136244	66		72540631	72542423	8421504	4	20,7,20,19	0,24,1742,1773	c	350013624400000001,350013624400000002,350013624400000000	0-20,0-27,0-19						ScienceDirect.com - Theriogenology - Gene expression of leukemia inhibitory factor (LIF) and macrophage colony stimulating factor (M-CSF) in bovine endometrium during early pregnancy	sciencedirect.com	0	0		
1138	chr17	72583408	72583435	3500145608	27		72583408	72583435	8421504	1	27	0	c	350014560800000013	37-64						Regulation of endocytosis and secretion by Rab GTPase activating proteins	b.uni-muenchen.de	0	0		TBC1D10A
1138	chr17	72584638	72584666	3500040440	23		72584638	72584666	8421504	2	17,6	0,22	c	350004044000000085	16-39						COMPOSITIONS AND METHODS FOR MODULATING CELL-CELL FUSION VIA INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS - Patent application	www.faqs.org	0	0		
1139	chr17	72620800	72620823	3500146501	23		72620800	72620823	8421504	1	23	0	c	350014650100000275	9-32					Patent	GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants (Patent CN:1665934)	D*E*A*Fu Luo La Ke 	2010	0		
1139	chr17	72621846	72622885	3500172791	40		72621846	72622885	8421504	3	20,15,5	0,64,1034	c,g	350017279100000029,350017279100000029,350017279100000028	0-20,0-20,0-20		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
1139	chr17	72621846	72622885	3500120290	40		72621846	72622885	8421504	3	20,15,5	0,64,1034	c	350012029000000029,350012029000000028	0-20,0-20						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
1139	chr17	72621846	72622885	3500048191	40		72621846	72622885	8421504	3	20,15,5	0,64,1034	c	350004819100000029,350004819100000028	0-20,0-20		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
1139	chr17	72695140	72695168	3500261184	28		72695140	72695168	8421504	1	28	0	c	350026118400000004	6-34						INSIGHTS INTO EXPRESSION, CELLULAR LOCALIZATION, AND REGULATION OF SUPERNATANT PROTEIN FACTOR, A PUTATIVE REGULATOR OF CHOLESTEROL BIOSYNTHESIS	knowledge.uky.edu	0	0		
1140	chr17	72753588	72794482	3500237468	53		72753588	72794482	8421504	2	23,30	0,40864	c,g	350023746800000000,350023746800000021	9-32,0-30		18417587	10.1128/JVI.02496-07	0022-538X	Journal of Virology	Sulfatide Is Required for Efficient Replication of Influenza A Virus	Takahashi	2008	5		
1140	chr17	72844976	72850025	3500248560	40		72844976	72850025	8421504	2	20,20	0,5029	c,g	350024856000000000,350024856000000000,350024856000000001,350024856000000001	0-20,0-20,0-20,0-20		11373332		1046-6673	Journal of the American Society of Nephrology	Transcellular Transport of Vitamin B12 in LLC-PK1 Renal Proximal Tubule Cells	NIELSEN	2001	10		TCN2
1140	chr17	72853316	72853342	3500148487	23		72853316	72853342	8421504	3	6,5,12	0,7,14	g	350014848700000072	13-36						Immunoglobulin fusion proteins	Cox	2000	0		
1141	chr17	72901717	72901750	3500024490	27		72901717	72901750	8421504	3	14,5,8	0,17,25	c	350002449000000283	8-39						Compositions and methods for inhibiting expression of Nav1.8 gene	Sah	2006	0		
142	chr17	72998245	73009270	3500402807	23		72998245	73009270	8421504	2	17,6	0,11019	c	350040280700000003,350040280700000004	22-45,0-23		20444975	10.1091/mbc.E10-02-0090	1059-1524	Molecular Biology of the Cell	Regulation of Oxysterol-binding Protein Golgi Localization through Protein Kinase D&#x2013;mediated Phosphorylation	Nhek	2010	5		
1142	chr17	73009938	73009963	3500190419	23		73009938	73009963	8421504	3	4,4,15	0,5,10	c	350019041900000004	0-23		18188185	10.1038/sj.cgt.7701117	0929-1903	Cancer Gene Therapy	Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad&lsqb;I&sol;PPT-E1A&rsqb; by reduction of the insulator size and introduction of the full-length E3 region	Danielsson	2008	3		
1142	chr17	73043549	73043576	3500099993	23		73043549	73043576	8421504	2	7,16	0,11	g	350009999300000029	0-23					Patent	Composition and methods for diagnosis of diseases associated with Actinobacillus actinomycetemcomitans infection (Patent US:5861255)	DeMuth	1999	0		
1143	chr17	73182114	73187211	3500420513	882		73182114	73187211	8421504	8	1,165,63,67,174,118,152,142	0,1093,1343,1618,2616,2937,3814,4955	p	350042051300015014	198-1083						44 Human Secreted Proteins	Lafleur	2009	0		
1143	chr17	73182114	73187211	3500107989	879		73182114	73187211	8421504	9	1,86,76,63,67,174,118,152,142	0,1093,1182,1343,1618,2616,2937,3814,4955	p	350010798900015014	198-1080					Patent	Protein HLQDR48 (Patent US:6569992)	Lafleur	2003	0		
1143	chr17	73182114	73187211	3500001570	882		73182114	73187211	8421504	8	1,165,63,67,174,118,152,142	0,1093,1343,1618,2616,2937,3814,4955	p	350000157000015065	198-1083						44 Human Secreted Proteins 	.freshpatents.com	0	0		
1143	chr17	73185982	73186008	3500425014	24		73185982	73186008	8421504	2	5,19	0,7	c	350042501400000006	18-42						Major taste loss in carnivorous mammals	www.pnas.org	0	0		
1144	chr17	73333318	73334550	3500334041	68		73333318	73334550	8421504	3	23,23,22	0,257,1210	c	350033404100000035,350033404100000031	0-23,0-45						Tissue plasminogen activator-like protease - US Patent 7205139 Description	ww.patentstorm.us	0	0		
1144	chr17	73372290	73372314	3500451017	24		73372290	73372314	8421504	1	24	0	c	350045101700000011,350045101700000010	0-24,1-25		22052190	10.1038/cdd.2011.142	1350-9047	Cell Death & Differentiation	POZ&sol;BTB and AT-hook-containing zinc finger protein 1 (PATZ1) inhibits endothelial cell senescence through a p53 dependent pathway	Cho	2011	9		
1144	chr17	73399341	73400210	3500381884	90		73399341	73400210	8421504	2	42,48	0,821	p	350038188400015012	0-90						Locally Sensitive Backtranslation based on Multiple Sequence Alignment	olab.dmi.unict.it	0	0		DRG1
1145	chr17	73412112	73412140	3500319233	25		73412112	73412140	8421504	2	5,20	0,8	g	350031923300000067	3-28						 Compositions And Methods For Dehydration And Cyclization Of Peptides, Synthetic Compounds, And Lantibiotics 	www.docstoc.com	0	0		
1145	chr17	73523440	73523466	3500377092	24		73523440	73523466	8421504	2	5,19	0,7	g	350037709200000047	24-48					Patent	Unique nucleotide and amino acid sequence and uses thereof (Patent US:6017734)	Braunagel	2000	0		
1146	chr17	73657827	73659271	3500338724	1444		73657827	73659271	8421504	1	1444	0	c	350033872400000006	252-1696						HME1 Nucleic Acids And Probes - Patent 5776676	www.docstoc.com	0	0		
1146	chr17	73657957	73657987	3500159260	24		73657957	73657987	8421504	3	7,11,6	0,8,24	g	350015926000000024	4-28						DNA-BASED METHODS FOR CLONE-SPECIFIC IDENTIFICATION OF STAPHYLOCOCCUS AUREUS - Patent application	www.faqs.org	0	0		
1147	chr17	73718017	73765584	3500449561	1557		73718017	73765584	8421504	20	135,72,105,60,105,106,81,56,45,15,91,108,151,130,9,111,45,72,31,29	0,3613,21442,22402,23844,32847,34005,35284,35460,35747,35792,37128,39630,42486,42646,43734,43905,45657,45732,47538	p	350044956100015001,350044956100015002,350044956100015003,350044956100015004,350044956100015005,350044956100015010,350044956100015012,350044956100015013,350044956100015014,350044956100015016,350044956100015017,350044956100015020,350044956100015021	0-180,0-60,0-120,0-180,0-180,0-60,0-150,0-180,0-150,0-60,0-60,0-117,0-60						sequence Na+-dependent D-glucose (SGLT1) and the	www.liv.ac.uk	0	0		
1147	chr17	73721687	73750865	3500164699	44		73721687	73750865	8421504	4	15,5,23,1	0,17772,20256,29177	c	350016469900000029,350016469900000182,350016469900000331	0-20,0-20,10-34						MODULATION OF SGLT2 EXPRESSION - Patent application	www.faqs.org	0	0		
1147	chr17	73750867	73761862	3500458917	171		73750867	73761862	8421504	4	60,9,51,51	0,9796,10884,10944	p,c	350045891700015009,350045891700015025,350045891700000060	0-60,0-60,9-60						Unser Haushund: Eine Spitzmaus im Wolfspelz?	www.weloennig.de	0	0		
1147	chr17	73752090	73782713	3500163467	561		73752090	73782713	8421504	7	13,221,136,108,62,16,5	0,1211,1674,3055,5557,28505,30618	p,c,g	350016346700015025,350016346700000027,350016346700000027,350016346700015026,350016346700015027,350016346700000026	0-180,0-23,0-23,0-180,0-180,0-21						Entwicklungsspezifische Expression und m&#xf6;gliche funktionelle Bedeutung der Glukosetransporterisoformen in Pr&#xe4;implantationsembryonen des Rindes	ebdoc.sub.gwdg.de	0	0		
1147	chr17	73753508	73757741	3500454783	42		73753508	73757741	8421504	3	14,8,20	0,256,4213	c,g	350045478300000001,350045478300000005,350045478300000005	0-22,0-20,0-20						Use of sglt homolog	IWAMOTO	2005	0		SLC5A10
1147	chr17	73757721	73757778	3500237079	57		73757721	73757778	8421504	1	57	0	p	350023707900015003	0-57						Molecular characterisation of carbohydrate digestion and absorption in	www.docstoc.com	0	0		
1147	chr17	73765662	73766013	3500230702	40		73765662	73766013	8421504	2	20,20	0,331	c	350023070200000006,350023070200000007	0-20,0-20						Effect of glucose availability on glucose transport in bovine mammary epithelial cells	cience.zju.edu.cn	0	0		
1148	chr17	73825608	73825633	3500348857	25		73825608	73825633	8421504	1	25	0	g	350034885700000241	13-38						Tie complex binding proteins	Wood	2005	0		TOP3B
1148	chr17	73828264	73828447	3500317567	44		73828264	73828447	8421504	2	18,26	0,157	g	350031756700000187	21-181						Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies	Cong	2013	0		
1148	chr17	73828264	73828447	3500068926	44		73828264	73828447	8421504	2	18,26	0,157	g	350006892600000187	21-181						Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies	Cong	2013	0		
1148	chr17	73831357	73864225	3500370985	54		73831357	73864225	8421504	3	23,10,21	0,32574,32847	g	350037098500000348	190-257						Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same - Patent application	www.faqs.org	0	0		
1148	chr17	73845997	73846426	3500013789	73		73845997	73846426	8421504	6	10,7,11,24,5,16	0,161,259,373,406,413	g	350001378900000347	101-282						Methods for using canine immunoglobulin variable domains and caninized antibodies	Krah	2002	0		
1148	chr17	73863965	73863992	3500040398	27		73863965	73863992	8421504	1	27	0	g	350004039800000040	81-108						Anti-rhesus d recombinant polyclonal antibody and methods of manufacture	Rasmussen	2009	0		
1149	chr17	74003192	74003355	3500390240	55		74003192	74003355	8421504	3	18,7,30	0,21,133	g	350039024000000467	64-233						METALLOPROTEINASE-BINDING PROTEINS - Patent application	www.faqs.org	0	0		
1149	chr17	74003279	74003355	3500366288	38		74003279	74003355	8421504	3	7,24,7	0,44,69	g	350036628800000136	0-41						US7959917B2	www.scribd.com	0	0		
1149	chr17	74006445	74006655	3500130054	69		74006445	74006655	8421504	2	27,42	0,168	p	350013005400015185	81-285						US Patent # 7,208,582. Vascular endothelial growth factor 2 - Patents.com	www.patents.com	0	0		
1149	chr17	74006445	74006472	3500200432	27		74006445	74006472	8421504	1	27	0	c	350020043200000065,350020043200000059,350020043200000030,350020043200000024	12-38,12-35,91-118,12-35						Anti-Rhesus D Recombinant Polyclonal Antibody and Methods of Manufacture - Patent application	www.faqs.org	0	0		
1149	chr17	74006445	74006472	3500089147	27		74006445	74006472	8421504	1	27	0	c	350008914700000054,350008914700000060,350008914700000029,350008914700000023	12-35,12-38,91-118,12-35						TREATMENT OF THROMBOCYTOPENIA - Patent application	www.faqs.org	0	0		
1149	chr17	74006445	74006472	3500035616	27		74006445	74006472	8421504	1	27	0	c	350003561600000030,350003561600000024,350003561600000059,350003561600000065	91-118,12-35,12-35,12-38						Anti-rhesus d recombinant polyclonal antibody and methods of manufacture - Patent application	www.faqs.org	0	0		
1149	chr17	74006445	74006472	3500032158	27		74006445	74006472	8421504	1	27	0	c	350003215800000040,350003215800000032	81-108,2-25					Patent	Anti-rhesus D recombinant polyclonal antibody (Patent US:8198415)	Rasmussen	2012	0		
1149	chr17	74006445	74006472	3500030923	27		74006445	74006472	8421504	1	27	0	c	350003092300000040,350003092300000032	81-108,2-25						Anti-Rhesus D Recombinant Polyclonal Antibody and Methods of Manufacture	Rasmussen	2012	0		
1149	chr17	74006445	74006468	3500175657	23		74006445	74006468	8421504	1	23	0	c	350017565700000033	23-46						Method for Linking Sequences of Interest	Andersen	2010	0		VPREB1
1149	chr17	74006445	74006468	3500140018	23		74006445	74006468	8421504	1	23	0	c	350014001800000130	23-46						Method for linking sequences of interest	M*B*Ao Lie Ke Xi Wei Qi 	2006	0		VPREB1
1149	chr17	74006445	74006468	3500086850	23		74006445	74006468	8421504	1	23	0	c	350008685000000119	23-46					Patent	Method for linking sequences of interest (Patent EP:1921144)	Andersen	2011	0		VPREB1
1149	chr17	74006446	74006708	3500258554	93		74006446	74006708	8421504	4	25,22,23,23	0,106,191,239	c	350025855400000069,350025855400000292,350025855400000267,350025855400001548,350025855400001494,350025855400000211,350025855400001231,350025855400001161,350025855400001385	0-25,18-41,0-23,8-30,0-23,0-23,0-23,0-23,0-23						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
1149	chr17	74006446	74006471	3500335035	25		74006446	74006471	8421504	1	25	0	c	350033503500000092	10-35					Patent	In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells (Patent EP:1340088)	Smith	2007	0		
1149	chr17	74006446	74006471	3500248086	25		74006446	74006471	8421504	1	25	0	c	350024808600000069	0-25					Patent	Human binding molecules having killing activity against staphylococci and uses thereof (Patent US:8211431)	Kruif	2012	0		
1149	chr17	74006446	74006471	3500214983	25		74006446	74006471	8421504	1	25	0	c	350021498300000069	0-25						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof	Kruif	2009	0		
1149	chr17	74006446	74006471	3500185890	25		74006446	74006471	8421504	1	25	0	c	350018589000000069	0-25						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof	Kruif	2009	0		
1149	chr17	74006446	74006471	3500152106	25		74006446	74006471	8421504	1	25	0	c	350015210600000039	10-35						In Vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells	Zauderer	2007	0		
1149	chr17	74006446	74006471	3500058442	25		74006446	74006471	8421504	1	25	0	c	350005844200000039	10-35						In Vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells	Smith	2008	0		
1149	chr17	74006448	74006710	3500073470	80		74006448	74006710	8421504	3	32,23,25	0,189,237	c	350007347000000085,350007347000000047,350007347000000048	0-32,0-23,0-25						COMBINATION METHODS OF INHIBITING TUMOR GROWTH WITH A VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTAGONIST - Patent application	www.faqs.org	0	0		
1149	chr17	74006448	74006660	3500186736	55		74006448	74006660	8421504	2	32,23	0,189	c	350018673600000085,350018673600000047	0-32,0-23						Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist - Patent application	www.faqs.org	0	0		
1149	chr17	74006448	74006656	3500234051	54		74006448	74006656	8421504	2	32,22	0,186	c	350023405100000511,350023405100000073,350023405100000609,350023405100000539,350023405100000585,350023405100000515,350023405100000557	6-32,0-23,18-41,6-38,0-23,0-22,0-22						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		
1149	chr17	74006448	74006471	3500465930	23		74006448	74006471	8421504	1	23	0	c	350046593000000070,350046593000000046	18-41,0-23					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent EP:1749029)	Bakker	2011	0		
1149	chr17	74006448	74006471	3500390366	23		74006448	74006471	8421504	1	23	0	c	350039036600000016	0-23					Patent	Fab fragment libraries and methods for their use (Patent EP:1054018)	Hoogenboom	2009	0		ZNF280B
1149	chr17	74006448	74006471	3500310375	23		74006448	74006471	8421504	1	23	0	c	350031037500000607,350031037500000011,350031037500000631,350031037500000058	0-23,0-20,18-41,0-19						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
1149	chr17	74006448	74006471	3500285046	23		74006448	74006471	8421504	1	23	0	c	350028504600000067	0-23					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent CA:2568162)	Bakker	2013	0		
1149	chr17	74006448	74006471	3500254292	23		74006448	74006471	8421504	1	23	0	c	350025429200000011,350025429200000058	0-23,0-20					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent US:7579446)	Bakker	2009	0		
1149	chr17	74006448	74006471	3500248979	23		74006448	74006471	8421504	1	23	0	c	350024897900000039,350024897900000011	18-41,0-23						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2007	0		
1149	chr17	74006448	74006471	3500245605	23		74006448	74006471	8421504	1	23	0	c	350024560500000012	0-23						Human binding molecules having killing activity against staphylococci and uses thereof	Kruif	2012	0		ZNF280B
1149	chr17	74006448	74006471	3500210431	23		74006448	74006471	8421504	1	23	0	c	350021043100000066	0-23						Binding molecules capable of neutralizing West Nile virus and uses thereof - Patent #07244430	w.strutpatent.com	0	0		
1149	chr17	74006448	74006471	3500181576	23		74006448	74006471	8421504	1	23	0	c	350018157600000012	0-23					Patent	Human binding molecules having killing activity against staphylococci and uses thereof (Patent US:8460666)	Throsby	2013	0		
1149	chr17	74006448	74006471	3500174373	23		74006448	74006471	8421504	1	23	0	c	350017437300000011,350017437300000058	0-20,0-19						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2010	0		
1149	chr17	74006448	74006471	3500119980	23		74006448	74006471	8421504	1	23	0	c	350011998000000011	0-23						Binding Molecules Capable Of Neutralizing Rabies Virus And Uses Thereof 	.freshpatents.com	0	0		
1149	chr17	74006448	74006471	3500107370	23		74006448	74006471	8421504	1	23	0	c	350010737000000011,350010737000000039	0-23,18-41						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2008	0		
1149	chr17	74006448	74006471	3500106505	23		74006448	74006471	8421504	1	23	0	c	350010650500000060,350010650500000012	0-23,0-21						Human Binding Molecules Having Killing Activity Against Enterococci and Uses Thereof - Patent application	www.faqs.org	0	0		ZNF280B
1149	chr17	74006448	74006471	3500100833	23		74006448	74006471	8421504	1	23	0	c	350010083300000011,350010083300000058	0-20,0-19						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2010	0		
1149	chr17	74006448	74006471	3500091064	23		74006448	74006471	8421504	1	23	0	c	350009106400000011	0-23						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2008	0		
1149	chr17	74006448	74006471	3500089102	23		74006448	74006471	8421504	1	23	0	c	350008910200000012	0-23					Patent	Human binding molecules having killing activity against staphylococci and uses thereof (Patent US:8460666)	Throsby	2013	0		
1149	chr17	74006448	74006471	3500088032	23		74006448	74006471	8421504	1	23	0	c	350008803200000011,350008803200000058	0-20,0-21					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent US:8148497)	Bakker	2012	0		
1149	chr17	74006448	74006471	3500086937	23		74006448	74006471	8421504	1	23	0	c	350008693700000011	0-23					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent US:7740852)	Bakker	2010	0		
1149	chr17	74006448	74006471	3500085058	23		74006448	74006471	8421504	1	23	0	c	350008505800000011,350008505800000058	0-23,0-20						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2007	0		
1149	chr17	74006448	74006471	3500068951	23		74006448	74006471	8421504	1	23	0	c	350006895100000011,350006895100000581	0-23,0-23						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
1149	chr17	74006448	74006471	3500052549	23		74006448	74006471	8421504	1	23	0	c	350005254900000145,350005254900000211	0-23,0-23						 Compositions Against SARS 	www.docstoc.com	0	0		
1149	chr17	74006451	74006656	3500194368	66		74006451	74006656	8421504	2	23,43	0,162	c	350019436800000834,350019436800000868	0-23,0-43						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
1149	chr17	74006610	74006676	3500077192	63		74006610	74006676	8421504	2	39,24	0,42	p	350007719200015020	57-369						Antibody inhibiting stem cell factor activity and use for treatment of asthma	Neben	2003	0		
1149	chr17	74006610	74006655	3500330584	45		74006610	74006655	8421504	1	45	0	p	350033058400015121	9-54						DEVIATION DE LA REPONSE IMMUNE A VISEE D&#x2019;IMMUNO- INTERVENTION A L&#x2019;AIDE DE PROTEINES RECOMBINANTES HETEROFONCTIONNELLES	ses.univ-reims.fr	0	0		
1149	chr17	74006613	74006661	3500385653	48		74006613	74006661	8421504	1	48	0	p	350038565300015097	0-48						Recombinant Antibodies And Compositions And Methods For Making And Using The Same 	.freshpatents.com	0	0		
1149	chr17	74006681	74006709	3500013789	28		74006681	74006709	8421504	1	28	0	c	350001378900000115	2-30						Methods for using canine immunoglobulin variable domains and caninized antibodies	Krah	2002	0		
1149	chr17	74027464	74027670	3500451133	55		74027464	74027670	8421504	2	34,21	0,185	g	350045113300000024	0-208						THERAPEUTIC COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		
1149	chr17	74027464	74027670	3500277171	55		74027464	74027670	8421504	2	34,21	0,185	g	350027717100000029	0-208						Therapeutic compositions and methods - Patent application	www.faqs.org	0	0		
1149	chr17	74027464	74027670	3500269841	55		74027464	74027670	8421504	2	34,21	0,185	g	350026984100000157,350026984100000025	0-208,0-208						Therapeutic compositions and methods - Patent application	www.faqs.org	0	0		
1149	chr17	74027464	74027670	3500096608	55		74027464	74027670	8421504	2	34,21	0,185	g	350009660800000027	0-208						Erbb2 binding proteins and use thereof	Algate	2008	0		
1149	chr17	74027567	74027726	3500308348	58		74027567	74027726	8421504	3	23,21,14	0,82,145	g	350030834800000005	104-267						PEPTIDE THAT ELICITS NEUTRALIZING ANTIBODIES TARGETING THE HIV CO-RECEPTOR, CCR5 - Patent application	www.faqs.org	0	0		
1149	chr17	74027567	74027726	3500106793	58		74027567	74027726	8421504	3	23,21,14	0,82,145	g	350010679300000865	104-267						Peptide That Elicits Neutralizing Antibodies Targeting The Hiv Co-receptor, Ccr5 	.freshpatents.com	0	0		
1150	chr17	74084331	74084462	3500365974	42		74084331	74084462	8421504	2	21,21	0,110	c	350036597400000000,350036597400000001	0-21,0-21			10.1071/RDv20n1Ab270	1448-5990	Reproduction, Fertility and Development	 270 STILL GLOWING AFTER ALL THESE YEARS: STORAGE LIFE OFA COMPLETE BOVINE SEXING PCR MIX		2007	0		
1150	chr17	74084331	74084462	3500198895	42		74084331	74084462	8421504	2	21,21	0,110	c	350019889500000010,350019889500000011	0-21,0-21						Determination of genetic sex in ruminants using Y-chromosome specific polynucleotides	Reed	1993	0		
1150	chr17	74084331	74084462	3500029854	42		74084331	74084462	8421504	2	21,21	0,110	c	350002985400000000,350002985400000001	0-21,0-21						Suitability Of Bovine Sexing Primers For Sex Determination Of Caprine Cells	w.biology.ewu.edu	0	0		
1150	chr17	74084497	74084521	3500324863	24		74084497	74084521	8421504	1	24	0	c	350032486300000000	0-24		20950427	10.1186/1477-7827-8-120		Reproductive Biology and Endocrinology : RB&E	Transforming growth factor beta family expression at the bovine feto-maternal interface	Kumiko	2010	0		
1150	chr17	74084497	74084521	3500078470	24		74084497	74084521	8421504	1	24	0	c	350007847000000000	0-24						Transforming growth factor beta family expression at the bovine feto-maternal interface	biomedcentral.com	0	0		
1150	chr17	74084497	74084521	3500022857	24		74084497	74084521	8421504	1	24	0	c	350002285700000000	0-24						Figure 1: Characteristics of fibroblastic cells (C cell) derived from trophoblastic... - Open-i	openi.nlm.nih.gov	0	0		
1150	chr17	74102116	74102142	3500036679	26		74102116	74102142	8421504	1	26	0	c	350003667900000004	0-26						OocyteSourceandHormonalStimulationfor InVitroFertilizationUsingSexedSpermatozoainCattle	loads.hindawi.com	0	0		ZNF280B
143	chr17	74116152	74309855	3500408683	78678		74116152	74309855	8421504	64	135,3781,2829,1680,772,2789,36,153,100,1871,1220,909,3523,1305,3339,250,2201,250,2462,53,48,1583,1380,952,8,2312,1740,4,209,68,399,2347,101,3501,2914,430,320,1933,590,1013,2120,2030,1747,111,3423,43,52,32,103,4,2859,39,9312,848,969,1729,123,32,20,15,5,21,1517,14	0,136,51432,54262,55993,56774,59564,59676,59843,59944,62157,68868,69787,73311,77674,89083,89341,91543,91794,94257,94311,94360,97527,99347,100300,100309,102622,104363,113976,114186,114255,120926,128886,128995,132506,136116,136556,136886,139634,140225,141239,163943,165994,167771,167883,171596,171640,171693,171815,171920,174357,177275,177315,188220,189072,190042,191808,191991,192032,192056,192080,192088,192171,193689	g	350040868300000030,350040868300000032,350040868300000039,350040868300000038,350040868300000028,350040868300000027,350040868300000025,350040868300000037,350040868300000035,350040868300000033,350040868300000018,350040868300000044,350040868300000045,350040868300000021,350040868300000020,350040868300000019,350040868300000029,350040868300000047,350040868300000040,350040868300000048,350040868300000046,350040868300000036	0-3918,0-4510,0-773,24-6450,0-910,0-4830,0-3340,350-7210,0-1380,20-5040,0-3032,451-4060,0-3130,0-430,0-320,556-2490,429-4153,0-7320,696-4049,578-9930,784-4330,111-1999						Ungulates with genetically modified immune systems	Wells	2006	0		
1150	chr17	74137715	74137756	3500390240	41		74137715	74137756	8421504	1	41	0	g	350039024000000242	60-101						METALLOPROTEINASE-BINDING PROTEINS - Patent application	www.faqs.org	0	0		
1150	chr17	74144026	74144059	3500084813	32		74144026	74144059	8421504	2	18,14	0,19	g	350008481300000094	52-84						Cross-species-specific cd3-epsilon binding domain	Hoffmann	2010	0		
1150	chr17	74144026	74144059	3500031756	32		74144026	74144059	8421504	2	18,14	0,19	g	350003175600000094	52-84						CROSS-SPECIES-SPECIFIC BINDING DOMAIN - Patent application	www.faqs.org	0	0		
1150	chr17	74144078	74144121	3500349434	43		74144078	74144121	8421504	1	43	0	g	350034943400000082,350034943400000059	20-63,19-62						Antibodies to west nile virus polypeptides - Patent application	www.faqs.org	0	0		
1150	chr17	74144078	74144121	3500316103	43		74144078	74144121	8421504	1	43	0	g	350031610300000269	137-180						SureChem - Document - USPTO Granted - Patent No. 7485297 - "Method of inhibition of vascular development using an antibody" - Description	www.surechem.org	0	0		
1150	chr17	74144079	74144121	3500249301	42		74144079	74144121	8421504	1	42	0	g	350024930100000301	161-203						Induction of tumor immunity by variants of folate binding protein - US Patent 7547759 Description	ww.patentstorm.us	0	0		
1150	chr17	74144089	74144121	3500348857	32		74144089	74144121	8421504	1	32	0	g	350034885700000256	0-32						Tie complex binding proteins	Wood	2005	0		
1151	chr17	74193108	74193136	3500236616	28		74193108	74193136	8421504	1	28	0	g	350023661600000136,350023661600000178	8-36,8-36					Patent	Multispecific deimmunized CD3-binders (Patent CN:100453556)	A*A*Han Mi Er Dun 	2009	0		
1151	chr17	74231134	74231161	3500166869	27		74231134	74231161	8421504	1	27	0	c	350016686900000061,350016686900000139	0-27,0-27						Rapid Isolation of Monoclonal Antibodies from Animals - Patent application	www.faqs.org	0	0		
1151	chr17	74231145	74231172	3500462439	27		74231145	74231172	8421504	1	27	0	c	350046243900000027	12-39						US Patent # 7,452,534. Recombinant anti-CD4 antibodies for human therapy - Patents.com	www.patents.com	0	0		
1151	chr17	74231145	74231172	3500151681	27		74231145	74231172	8421504	1	27	0	c	350015168100000027	12-39						US Patent # 7,338,658. Recombinant anti-CD4 antibodies for human therapy - Patents.com	www.patents.com	0	0		
1151	chr17	74231168	74231434	3500232921	50		74231168	74231434	8421504	2	25,25	0,241	c	350023292100000000,350023292100000001	0-25,0-25						ScienceDirect.com - Comparative Immunology, Microbiology and Infectious Diseases - Histological studies on the ontogeny of bovine palatine and pharyngeal tonsil: Germinal center formation, IgG, and IgA mRNA expression	sciencedirect.com	0	0		
1151	chr17	74231189	74231348	3500234051	81		74231189	74231348	8421504	2	40,41	0,118	c	350023405100000342,350023405100000550	8-48,0-41						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		
1151	chr17	74231189	74231230	3500395273	41		74231189	74231230	8421504	1	41	0	c	350039527300000175,350039527300000183	11-48,0-41						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
1151	chr17	74231189	74231229	3500258554	40		74231189	74231229	8421504	1	40	0	c	350025855400001179	8-48						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
1151	chr17	74231301	74231352	3500134270	51		74231301	74231352	8421504	1	51	0	c	350013427000000034,350013427000000031	0-39,0-37					Patent	Antibody against human parathormone related peptides (Patent CN:100335501)	Zuo Teng Gong 	2007	0		
1151	chr17	74231322	74231352	3500308014	30		74231322	74231352	8421504	1	30	0	c	350030801400000031	0-30						Recombinant anti-cd4 antibodies for human therapy	Hanna	1997	0		
1151	chr17	74231322	74231352	3500253347	30		74231322	74231352	8421504	1	30	0	c	350025334700000031	0-30						US Patent # 6,136,310. Recombinant anti-CD4 antibodies for human therapy - Patents.com	www.patents.com	0	0		
1151	chr17	74286316	74286344	3500449380	24		74286316	74286344	8421504	2	13,11	0,17	c	350044938000000101	2-26						Anti-hiv Antibody 	freshpatents.com	0	0		
1151	chr17	74307510	74309060	3500326332	120		74307510	74309060	8421504	2	112,8	0,1542	p	350032633200015003	0-120						Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1 (INI1)/hSNF5 - Patent application	www.faqs.org	0	0		
1151	chr17	74307551	74310903	3500391298	40		74307551	74310903	8421504	2	20,20	0,3332	c,g	350039129800000000,350039129800000000,350039129800000001	0-20,0-20,0-20						The Oncologist US - ONC_16.4_April2011	theoncologist.com	0	0		SMARCB1
1151	chr17	74307551	74310903	3500077601	40		74307551	74310903	8421504	2	20,20	0,3332	c	350007760100000000,350007760100000001	0-20,0-20		21357725	10.1634/theoncologist.2010-0174	1083-7159	The Oncologist	Epithelioid Sarcoma and Unclassified Sarcoma with Epithelioid Features: Clinicopathological Variables, Molecular Markers, and a New Experimental Model	Sakharpe	2011	4		SMARCB1
1152	chr17	74319815	74319860	3500205783	45		74319815	74319860	8421504	1	45	0	p	350020578300015000	0-45		15150092	10.1158/0008-5472.CAN-03-3004	0008-5472	Cancer Research	The Tumor Suppressor hSNF5/INI1 Modulates Cell Growth and Actin Cytoskeleton Organization	Medjkane	2004	8		SMARCB1
1152	chr17	74353810	74354377	3500047713	345		74353810	74354377	8421504	4	108,173,30,34	0,247,502,533	p	350004771300015016,350004771300015042	0-177,0-168						Clonagem e caracteriza&#xe7;&#xe3;o do Fator Inibit&#xf3;rio de Macr&#xf3;fago do fungo Paracoccidioides brasiliensis	bdtd.bce.unb.br	0	0		
1152	chr17	74354096	74354141	3500069495	45		74354096	74354141	8421504	1	45	0	p	350006949500015238	0-45						&#x4f7f;&#x7528;&#x884d;&#x751f;&#x81ea;ap205&#x5916;&#x58f3;&#x86cb;&#x767d;&#x7684;&#x75c5;&#x6bd2;&#x6837;&#x9897;&#x7c92;&#x7684;&#x5206;&#x5b50;&#x6297;&#x539f;&#x9635;&#x5217;	M*F*Ba He Man 	2005	0		MIF
1152	chr17	74392474	74394817	3500450702	23		74392474	74394817	8421504	3	1,18,4	0,2320,2339	c	350045070200000061,350045070200000068,350045070200000059	10-32,10-31,10-30						In vitro scanning saturation mutagenesis of proteins	Iverson	1998	0		
1152	chr17	74436329	74436360	3500238295	24		74436329	74436360	8421504	3	13,6,5	0,17,26	c,g	350023829500000001,350023829500000001	13-37,13-37						Estudio nutrigenA3mico de compuestos polifenA3licos del cacao y del cafA(c) en cA(c)lulas tumorales huma	www.tdx.cat	0	0		
1153	chr17	74450406	74450432	3500425740	23		74450406	74450432	8421504	2	16,7	0,19	c	350042574000000013	0-23						MN gene and protein - US Patent 7713704 Description	ww.patentstorm.us	0	0		
1153	chr17	74466231	74466260	3500332624	29		74466231	74466260	8421504	1	29	0	c	350033262400000006	3-32						Hepatic differentiation of mouse ES cells into BE cells in vitro	A	2006	0		GGT1
1153	chr17	74466231	74466260	3500303886	29		74466231	74466260	8421504	1	29	0	c	350030388600000006	3-32						Hepatic differentiation of mouse ES cells into BE cells in vitro	A	2006	0		GGT1
1153	chr17	74466254	74466279	3500051294	25		74466254	74466279	8421504	1	25	0	c	350005129400000011	8-33		11116135	10.1074/jbc.M004352200	0021-9258	Journal of Biological Chemistry	&#x03b3;-Glutamyltransferase and Its Isoform Mediate an Endoplasmic Reticulum Stress Response	Joyce-Brady	2001	5		
1153	chr17	74506393	74507873	3500224979	81		74506393	74507873	8421504	2	41,40	0,1440	p	350022497900015002	3-84		15494416	10.1074/jbc.M405295200	0021-9258	Journal of Biological Chemistry	PRMT7, a New Protein Arginine Methyltransferase That Synthesizes Symmetric Dimethylarginine	Lee	2005	5		SNRPD3
1153	chr17	74506402	74507852	3500336946	51		74506402	74507852	8421504	2	32,19	0,1431	p	350033694600015011	0-51						METHOD FOR THE DETECTION OF POST-TRANSLATIONAL MODIFICATIONS - Patent application	www.faqs.org	0	0		SNRPD3
1155	chr17	74804901	74804926	3500166578	25		74804901	74804926	8421504	1	25	0	g	350016657800000002	0-25					The Journal of molecular diagnostics : JMD	Single Monochrome Real-Time RT-PCR Assay for Identification, Quantification, and Breakpoint Cluster Region Determination of t(9;22) Transcripts	Marina	2005	0		
1157	chr17	75028404	75045473	3500366304	315		75028404	75045473	8421504	9	45,35,10,45,45,6,39,45,45	0,48,1583,6975,7023,7071,11065,16051,17024	p	350036630400015045,350036630400015046,350036630400015049,350036630400015055,350036630400015057	0-45,0-45,0-135,0-45,0-45						US Patent # 7,383,135. Methods of designing inhibitors for JNK kinases - Patents.com	www.patents.com	0	0		
1157	chr17	75028412	75035437	3500243041	41		75028412	75035437	8421504	2	19,22	0,7003	c,g	350024304100000003,350024304100000003,350024304100000004	0-19,0-19,0-22						Single and Combined Silencing of ERK1 and ERK2 Reveals Their Positive Contribution to Growth Signaling Depending on Their Expression Levels	mcb.asm.org	0	0		
1157	chr17	75030066	75035391	3500168455	138		75030066	75035391	8421504	2	111,27	0,5298	p	350016845500015025	3-141						Molekulare und funktionelle Analyse der pathogenresponsiven Rezeptorkinase DRK3 aus Arabidopsis thaliana	.uni-tuebingen.de	0	0		MAPK1
1157	chr17	75030124	75045525	3500291230	43		75030124	75045525	8421504	2	20,23	0,15378	c,g	350029123000000012,350029123000000014,350029123000000014	0-20,8-31,8-31						Proteomic and Functional Analyses Reveal MAPK1 Regulates Milk Protein Synthesis	www.mdpi.com	0	0		
1157	chr17	75030130	75035437	3500394704	61		75030130	75035437	8421504	3	20,20,21	0,5247,5286	c,g	350039470400000006,350039470400000006,350039470400000008,350039470400000008,350039470400000007,350039470400000007	0-20,0-20,0-20,0-20,0-21,0-21						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1157	chr17	75030130	75035437	3500292483	61		75030130	75035437	8421504	3	20,20,21	0,5247,5286	c,g	350029248300000006,350029248300000008,350029248300000008,350029248300000007	0-20,0-20,0-20,0-21						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1157	chr17	75030132	75039490	3500383663	42		75030132	75039490	8421504	2	21,21	0,9337	c,g	350038366300000010,350038366300000010,350038366300000009	0-21,0-21,0-21						MG132 treatment during oocyte maturation improves embryonic development after somatic cell nuclear transfer and alters oocyte and embryo transcript abundance in pigs	imal.ifas.ufl.edu	0	0		
1157	chr17	75030132	75039490	3500258434	42		75030132	75039490	8421504	2	21,21	0,9337	c,g	350025843400000010,350025843400000010,350025843400000009	0-21,0-21,0-21						MG132 Treatment During Oocyte Maturation Improves Embryonic Development After Somatic Cell Nuclear Transfer and Alters Oocyte and Embryo Transcript Abundance in Pigs	ww.animal.ufl.edu	0	0		
1157	chr17	75030132	75039490	3500145043	42		75030132	75039490	8421504	2	21,21	0,9337	c,g	350014504300000010,350014504300000009	0-21,0-21						MG132 treatment during oocyte maturation improves embryonic development after somatic cell nuclear transfer and alters oocyte and embryo transcript abundance in pigs	imal.ifas.ufl.edu	0	0		
1157	chr17	75035364	75035387	3500348580	23		75035364	75035387	8421504	1	23	0	c	350034858000000234	12-35						US Patent # 7,226,755. HPTPbeta as a target in treatment of angiogenesis mediated disorders - Patents.com	www.patents.com	0	0		
1157	chr17	75035382	75035472	3500165644	90		75035382	75035472	8421504	1	90	0	p	350016564400015016,350016564400015014	3-57,6-60						Methods and compositions using protein binding partners	Craig	2000	0		
1157	chr17	75035388	75039901	3500438143	147		75035388	75039901	8421504	3	57,31,59	0,4165,4454	p	350043814300015001,350043814300015005,350043814300015006	0-57,0-84,0-90						&#x4e3b;&#x9898;&#xff1a;ERK | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1157	chr17	75035391	75035454	3500340942	63		75035391	75035454	8421504	1	63	0	p	350034094200015000	0-63		15466208	10.1158/0008-5472.CAN-03-3500	0008-5472	Cancer Research	Inhibition of the Raf&#x2013;MEK1/2&#x2013;ERK1/2 Signaling Pathway, Bcl-xL Down-Regulation, and Chemosensitization of Non-Hodgkin&#x2019;s Lymphoma B Cells by Rituximab	Jazirehi	2004	8		MAPK1
1157	chr17	75035391	75035454	3500013901	63		75035391	75035454	8421504	1	63	0	p	350001390100015000	0-63		14749477		1535-7163	Molecular Cancer Therapeutics	Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis	Jazirehi	2004	5		MAPK1
1157	chr17	75035409	75035457	3500210212	48		75035409	75035457	8421504	1	48	0	p	350021021200015002	0-48						Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein. - ResearchGate	.researchgate.net	0	0		MAPK1
1157	chr17	75035451	75039484	3500144809	45		75035451	75039484	8421504	2	30,15	0,4018	p	350014480900015014	0-45						Trophectodermal Cell-Specific Gene Transfer Methods - Patent application	www.faqs.org	0	0		MAPK3
1157	chr17	75044461	75044530	3500237150	69		75044461	75044530	8421504	1	69	0	p	350023715000015007	33-102		17101779	10.1128/MCB.00601-06	0270-7306	Molecular and Cellular Biology	Interaction with MEK Causes Nuclear Export and Downregulation of Peroxisome Proliferator-Activated Receptor &#x03b3;	Burgermeister	2007	6		MAPK1
1157	chr17	75095221	75096108	3500428541	39		75095221	75096108	8421504	2	20,19	0,868	c,g	350042854100000072,350042854100000072,350042854100000073	0-20,0-20,0-19						Developmental Regulation and In Vitro Culture Effects on Expression of DNA Repair and Cell Cycle Checkpoint Control Genes in Rhesus Monkey Oocytes and Embryos1	ww.biolreprod.org	0	0		TOP3B
1158	chr17	75107457	75107480	3500238271	23		75107457	75107480	8421504	1	23	0	g	350023827100000013	0-25						Cdr-grafted anti-tissue factor antibodies and methods of use thereof	Joliffe	1998	0		
1158	chr17	75215474	75215503	3500357268	26		75215474	75215503	8421504	2	21,5	0,24	c,g	350035726800000003,350035726800000003	0-31,0-31		23805858	10.1186/1750-1172-8-94	1750-1172	Orphanet Journal of Rare Diseases	HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis	Lux	2013	5		
1158	chr17	75215474	75215503	3500125302	26		75215474	75215503	8421504	2	21,5	0,24	c,g	350012530200000003,350012530200000003	0-31,0-31		23805858	10.1186/1750-1172-8-94	1750-1172	Orphanet Journal of Rare Diseases	HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis	Lux	2013	5		
1159	chr17	75240101	75240125	3500180208	24		75240101	75240125	8421504	1	24	0	c	350018020800001544	0-24					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		MIR130B
1159	chr17	75240101	75240125	3500164893	24		75240101	75240125	8421504	1	24	0	c	350016489300001545,350016489300001544	0-24,0-24						Methods for quantitating small rna molecules	Raymond	2007	0		
1159	chr17	75292724	75335368	3500227613	39		75292724	75335368	8421504	2	19,20	0,42624	g	350022761300000193,350022761300000160	21-40,0-23						IMMUNODOMINANT MYCOBACTERIUM TUBERCULOSIS PEPTIDES FROM CELL WALL PROTEINS FOR EARLY DIAGNOSIS AND IMMUNIZATION - Patent application	www.faqs.org	0	0		
1159	chr17	75336707	75336733	3500449759	26		75336707	75336733	8421504	1	26	0	c,g	350044975900000005,350044975900000005	7-33,7-33		9218477	10.1074/jbc.272.29.18358	0021-9258	Journal of Biological Chemistry	Isolation and Molecular Cloning of Wortmannin-sensitive Bovine Type III Phosphatidylinositol 4-Kinases	Balla	1997	5		
1159	chr17	75339522	75339550	3500006920	24		75339522	75339550	8421504	2	16,8	0,20	c	350000692000000012	15-39						*U FBrf0075164 *a Laverty *b T. *t 1995 *T personal communication to FlyBase *u *F From todd_lavert	t.bio.indiana.edu	0	0		
1159	chr17	75345834	75346507	3500150563	54		75345834	75346507	8421504	2	20,34	0,639	p	350015056300015000	0-54			10.1091/mbc.E04-07-0578		Molecular Biology of the Cell	A Plasma Membrane Pool of Phosphatidylinositol 4-Phosphate Is Generated by Phosphatidylinositol 4-Kinase Type-III Alpha: Studies with the PH Domains of the Oxysterol Binding Protein and FAPP1	Andras	2005	0		PI4KA
1159	chr17	75345834	75346507	3500120392	54		75345834	75346507	8421504	2	20,34	0,639	p	350012039200015000	0-54		15635101	10.1091/mbc.E04-07-0578	1059-1524	Molecular Biology of the Cell	A Plasma Membrane Pool of Phosphatidylinositol 4-Phosphate Is Generated by Phosphatidylinositol 4-Kinase Type-III Alpha: Studies with the PH Domains of the Oxysterol Binding Protein and FAPP1	Balla	2005	5		PI4KA
1160	chr17	75396075	75396101	3500449759	26		75396075	75396101	8421504	1	26	0	c	350044975900000004	8-34		9218477	10.1074/jbc.272.29.18358	0021-9258	Journal of Biological Chemistry	Isolation and Molecular Cloning of Wortmannin-sensitive Bovine Type III Phosphatidylinositol 4-Kinases	Balla	1997	5		
1160	chr17	75407677	75407704	3500282807	23		75407677	75407704	8421504	2	7,16	0,11	g	350028280700000441,350028280700000330,350028280700000025,350028280700000129	0-23,3-26,3-26,3-25					Patent	Infectious etiologic agent detection probe and probe set, carrier, and genetic screening method (Patent EP:1464710)	Fukui	2011	0		
1160	chr17	75407677	75407704	3500091800	23		75407677	75407704	8421504	2	7,16	0,11	g	350009180000000025	3-26					Patent	Infectious etiologic agent detection probe and probe set, carrier, and genetic screening method (Patent US:8080381)	Fukui	2011	0		
1160	chr17	75467105	75467132	3500249275	27		75467105	75467132	8421504	1	27	0	c	350024927500000050	7-34						Activity of THAP-family chemokine-binding domains	Jullien	2006	0		
1161	chr17	75535020	75535046	3500328306	26		75535020	75535046	8421504	1	26	0	c,g	350032830600000003,350032830600000003	0-26,0-26						Drosophila Cytokine Unpaired 2 Regulates Physiological Homeostasis by Remotely Controlling Insulin Secretion	h.med.harvard.edu	0	0		TUBA1A
1161	chr17	75535151	75535176	3500260900	25		75535151	75535176	8421504	1	25	0	c,g	350026090000000006,350026090000000006	6-31,6-31			10.1371/journal.ppat.0020105		PLoS Pathogens	Changes in the Expression of Human Cell Division Autoantigen-1 Influence Toxoplasma gondii Growth and Development	Jay	2006	0		
1161	chr17	75535151	75535176	3500237985	25		75535151	75535176	8421504	1	25	0	c	350023798500000006	6-31			10.1371/journal.ppat.0020105	1553-7374	PLOS Pathogens	PLOS Pathogens: Changes in the Expression of Human Cell Division Autoantigen-1 Influence Toxoplasma gondii Growth and Development	Radke	2006	0		
1161	chr17	75537697	75537722	3500227536	23		75537697	75537722	8421504	2	12,11	0,14	c	350022753600000010	0-24		22621904	10.1091/mbc.E11-12-1025	1059-1524	Molecular Biology of the Cell	Mice expressing aberrant sperm-specific protein PMIS2 produce normal-looking but fertilization-incompetent spermatozoa	Yamaguchi	2012	5		
1161	chr17	75579298	75579329	3500352650	25		75579298	75579329	8421504	2	1,24	0,7	c	350035265000000330,350035265000000311,350035265000000303,350035265000000312,350035265000000320,350035265000000321,350035265000000322,350035265000000323,350035265000000319,350035265000000308,350035265000000309	18-43,18-43,18-43,18-43,18-43,18-43,18-43,18-43,18-43,18-43,18-43						Dna Diagnostics Based On Mass Spectrometry 	.freshpatents.com	0	0		
1161	chr17	75579298	75579329	3500128303	25		75579298	75579329	8421504	2	1,24	0,7	c	350012830300000146	29-54						 DNA Diagnostics Based On Mass Spectrometry 	www.docstoc.com	0	0		BPGM
1161	chr17	75579298	75579329	3500118887	25		75579298	75579329	8421504	2	1,24	0,7	c	350011888700000147	29-54						DNA diagnostics based on mass spectrometry - US Patent 7198893 Description	ww.patentstorm.us	0	0		BPGM
1163	chr17	75842174	75842199	3500111430	24		75842174	75842199	8421504	2	10,14	0,11	g	350011143000000154	16-40						RECOMBINANT LACTOBACILLUS WITH DECREASED LIPOTEICHOIC ACID TO REDUCE INFLAMMATORY RESPONSES - Patent application	www.faqs.org	0	0		
1163	chr17	75849259	75850387	3500442416	23		75849259	75850387	8421504	3	1,8,14	0,1102,1114	c	350044241600000022	15-38						HIV GROUP O POSITIVE CONTROL - ABBOTT LABORATORIES	www.sumobrain.com	0	0		
1163	chr17	75857011	75860987	3500288139	127		75857011	75860987	8421504	5	27,21,36,2,41	0,139,1571,2977,3935	c	350028813900000154,350028813900000157,350028813900000161	0-48,0-38,0-41						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
1163	chr17	75860946	75863591	3500219109	88		75860946	75863591	8421504	3	41,5,42	0,2158,2603	c	350021910900000161,350021910900000167	0-41,0-47						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
1163	chr17	75874825	75874887	3500022437	40		75874825	75874887	8421504	2	21,19	0,43	c,g	350002243700000013,350002243700000013,350002243700000012,350002243700000012	0-21,0-21,0-19,0-19						ONLINE MATERIALS AND METHODS	b.ahajournals.org	0	0		
1164	chr17	75979767	75979793	3500366733	23		75979767	75979793	8421504	2	7,16	0,10	c	350036673300000361	0-23						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
1164	chr17	75979767	75979793	3500193635	23		75979767	75979793	8421504	2	7,16	0,10	c	350019363500000360	0-23						Materials and methods for immunocontraception	Harris	1993	0		
1165	chr17	76050016	76052377	3500287953	25		76050016	76052377	8421504	3	11,6,8	0,2344,2353	c	350028795300000227	0-27						Method For Increasing Pathogen Resistance In Transgenic Plants - Patent application	www.faqs.org	0	0		
1165	chr17	76066095	76066119	3500115572	23		76066095	76066119	8421504	2	4,19	0,5	g	350011557200000167	1-25						METHOD FOR PRODUCING SCYLLO-INOSITOL - Patent application	www.faqs.org	0	0		
1165	chr17	76098551	76098768	3500368435	117		76098551	76098768	8421504	4	32,7,45,33	0,126,136,184	p	350036843500015011	12-129						ARTS C-terminus fragments and mimetics thereof - Patent # 7423115 - PatentGenius	.patentgenius.com	0	0		TBX1
1166	chr17	76195506	76195529	3500389139	23		76195506	76195529	8421504	1	23	0	c	350038913900000019	21-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		
1166	chr17	76195506	76195529	3500306561	23		76195506	76195529	8421504	1	23	0	c	350030656100000019	21-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
1166	chr17	76195506	76195529	3500257436	23		76195506	76195529	8421504	1	23	0	c	350025743600000019	21-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
1166	chr17	76195506	76195529	3500232262	23		76195506	76195529	8421504	1	23	0	c	350023226200000019	21-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
1166	chr17	76219758	76219787	3500247519	24		76219758	76219787	8421504	3	13,5,6	0,16,23	c,g	350024751900000012,350024751900000012	1-26,1-26			10.1128/JVI.77.17.9439-9450.2003		Journal of Virology	The Moloney Murine Leukemia Virus Repressor Binding Site Represses Expression in Murine and Human Hematopoietic Stem Cells	Dennis	2003	0		
1166	chr17	76236914	76236959	3500159212	45		76236914	76236959	8421504	1	45	0	p	350015921200015005	33-78						Hypusination of eukaryotic initiation factor 5A(eIF5A): a novel therapeutic target in BCR-ABL&#x2013;positive leukemias identi&#xfb01;ed by a proteomics approach	tologylibrary.org	0	0		RANBP1
587	chr18	280855	280879	3500217315	24		280855	280879	8421504	1	24	0	g	350021731500000034	0-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		
587	chr18	288846	288930	3500356384	84		288846	288930	8421504	1	84	0	p	350035638400015007	0-84						Functional Analysis in Yeast of cDNA Coding for the Mitochondrial Rieske Iron-Sulfur Protein of Higher Plants	www.jstor.org	0	0		UQCRFS1
590	chr18	675209	675234	3500406732	24		675209	675234	8421504	2	9,15	0,10	g	350040673200000072	0-39						Control of fruit ripening and senescence in plants	Klee	1991	0		
590	chr18	675209	675234	3500018595	24		675209	675234	8421504	2	9,15	0,10	g	350001859500000072	0-39						Control of fruit ripening and senescence in plants	Klee	1995	0		
590	chr18	756077	756104	3500404568	24		756077	756104	8421504	2	8,16	0,11	c	350040456800000144	1-25						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - US Patent 7700341 Description	ww.patentstorm.us	0	0		
590	chr18	778592	778616	3500451530	23		778592	778616	8421504	2	17,6	0,18	g	350045153000000012	17-40						Manganese De&#xfb01;ciency in Chlamydomonas Results in Loss of Photosystem II and MnSOD Function, Sensitivity to Peroxides, and Secondary Phosphorus	antphysiology.org	0	0		
591	chr18	810960	810987	3500353066	23		810960	810987	8421504	2	16,7	0,20	g	350035306600000015	12-35						US Patent # 5,359,046. Chimeric chains for receptor-associated signal transduction pathways - Patents.com	www.patents.com	0	0		
592	chr18	926024	926084	3500322371	60		926024	926084	8421504	1	60	0	p	350032237100015001	0-60		11406595	10.1093/emboj/20.12.3187	ERROR! NO ISSN	The EMBO Journal	UV-damaged DNA-binding protein in the TFTC complex links DNA damage recognition to nucleosome acetylation	Brand	2001	0		SF3B3
592	chr18	968285	968308	3500324273	23		968285	968308	8421504	1	23	0	c	350032427300000002	9-32		19651599	10.1073/pnas.0901966106	0027-8424	Proceedings of the National Academy of Sciences	Structural basis for a human glycosylation disorder caused by mutation of the COG4 gene	Richardson	2009	10		
592	chr18	968285	968308	3500183091	23		968285	968308	8421504	1	23	0	c	350018309100000002	9-32		19651599	10.1073/pnas.0901966106		Proceedings of the National Academy of Sciences of the United States of America	Structural basis for a human glycosylation disorder caused by mutation of the COG4 gene	Brian	2009	0		
593	chr18	1141046	1141112	3500190007	66		1141046	1141112	8421504	1	66	0	p	350019000700015001	0-66						&#xbbc3;&#xa5c0;&#xb5df;&#xc2e0;&#xc4b6;&#xb05f;&#xa96c;&#xbef7;&#xa8ee;&#xaaba;&#xace3;&#xa873;	is.lib.ncu.edu.tw	0	0		AARS
593	chr18	1144405	1153356	3500059586	180		1144405	1153356	8421504	4	44,47,48,41	0,809,1872,8910	c	350005958600000014,350005958600000017,350005958600000024,350005958600000046	0-44,0-47,0-48,0-41						Human alanyl-tRNA synthetase proteins, nucleic acids and tester strains comprising same	Shiba	1995	0		
594	chr18	1244251	1244281	3500133694	23		1244251	1244281	8421504	3	12,5,6	0,15,24	c	350013369400000010	20-43						DRUG-PHOSPHORYLATING ENZYME - Patent application	www.faqs.org	0	0		
594	chr18	1294988	1295012	3500432351	23		1294988	1295012	8421504	2	16,7	0,17	c	350043235100000144	1-24					Patent	Antisense inhibition of focal adhesion kinase expression (Patent US:6133031)	Gaarde	2000	0		
599	chr18	1961991	1962584	3500394288	114		1961991	1962584	8421504	3	42,45,27	0,48,566	p	350039428800015035	0-117						Microbial trypsin mutants having chymotrypsin activity and nucleic acids encoding same - US Patent 7705137 Description	ww.patentstorm.us	0	0		
600	chr18	1979201	1979681	3500252384	31		1979201	1979681	8421504	2	18,13	0,467	g	350025238400000003	0-31						Molecular Cloning of Dog Mast Cell Tryptase and a Related Protease: Structural Evidence a Unique Mode Serine Protease Activation+,$	craiklab.ucsf.edu	0	0		
600	chr18	1982807	1982831	3500362691	23		1982807	1982831	8421504	2	12,11	0,13	c	350036269100000038	9-32						Highly polymorphic microsatellites 00Graphicraft Limited, Hong Kong in the lacertid Gallotia galloti	ents.plant.wur.nl	0	0		
600	chr18	1987356	1987474	3500435393	42		1987356	1987474	8421504	2	21,21	0,97	c,g	350043539300000011,350043539300000011,350043539300000010	0-21,0-21,0-21						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
602	chr18	2244975	2245000	3500446274	23		2244975	2245000	8421504	2	12,11	0,14	g	350044627400000001	0-32		18281499	10.1158/0008-5472.CAN-07-6175	0008-5472	Cancer Research	Construction of Optimized Bispecific Antibodies for Selective Activation of the Death Receptor CD95	Herrmann	2008	8		
602	chr18	2272762	2272785	3500423108	23		2272762	2272785	8421504	1	23	0	g	350042310800000000	17-40			10.1590/S1516-35982003000500009	1516-3598	Revista Brasileira de Zootecnia	Revista Brasileira de Zootecnia - Hormonal induction of ovulation and early weaning in postpartum fertility of homozigous and heterozigous beef cows for the microsatellite BMS3004	Bastos	2003	0		
602	chr18	2315462	2315487	3500165546	25		2315462	2315487	8421504	1	25	0	c	350016554600000053	69-94						GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF - Patent application	www.faqs.org	0	0		
602	chr18	2347752	2347779	3500127308	23		2347752	2347779	8421504	2	7,16	0,11	c	350012730800000275	0-28						PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS - Patent application	www.faqs.org	0	0		TERF2IP
602	chr18	2347891	2351360	3500447618	96		2347891	2351360	8421504	2	55,41	0,3428	p	350044761800015001	57-153					Patent	Antibodies to HASAV70 polypeptide (Patent US:7169565)	Ruben	2007	0		
602	chr18	2347891	2351360	3500029713	96		2347891	2351360	8421504	2	55,41	0,3428	p	350002971300015001	57-153						87 human secreted proteins	Young	2005	0		
602	chr18	2352521	2352547	3500405334	26		2352521	2352547	8421504	1	26	0	c	350040533400000005	7-33						New protein vector ApE1 for targeted delivery of anticancer drugs. - ResearchGate	.researchgate.net	0	0		
602	chr18	2352890	2352915	3500309840	23		2352890	2352915	8421504	2	5,18	0,7	c	350030984000001025	1-24						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
611	chr18	3477552	3477575	3500331821	23		3477552	3477575	8421504	1	23	0	c	350033182100000034	0-23						Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma	.aacrjournals.org	0	0		ADAMTS18
615	chr18	4051033	4051060	3500098009	23		4051033	4051060	8421504	2	10,13	0,14	c	350009800900000089	5-36						PROSTATE-SPECIFIC POLYPEPTIDE PAMP AND ENCODING NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
615	chr18	4052807	4052833	3500133203	26		4052807	4052833	8421504	1	26	0	g	350013320300000198	0-26						[tel-00521428, v1] &#xc9;tude des voies de conduction cardiaque : identification des g&#xe8;nes sp&#xe9;cifiquement exprim&#xe9;s et impliqu&#xe9;s dans des troubles de conduction	hives-ouvertes.fr	0	0		
616	chr18	4089462	4089507	3500353279	45		4089462	4089507	8421504	1	45	0	p	350035327900015157	0-45						Enzyme Derived From Thermophilic Organisms That Functions As A Chromosomal Replicase, And Preparation And Uses Thereof 	.freshpatents.com	0	0		
616	chr18	4133576	4133633	3500223314	57		4133576	4133633	8421504	1	57	0	p	350022331400015004	0-57						Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. - ResearchGate	.researchgate.net	0	0		WWOX
625	chr18	5259090	5259117	3500375409	23		5259090	5259117	8421504	2	8,15	0,12	g	350037540900000017	19-48						Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase	Ingolia	1988	0		
626	chr18	5477695	5477723	3500195196	23		5477695	5477723	8421504	3	5,5,13	0,7,15	g	350019519600000000	20-43						Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis. - ResearchGate	.researchgate.net	0	0		
626	chr18	5480497	5480552	3500149382	54		5480497	5480552	8421504	2	47,7	0,48	p	350014938200015070,350014938200015025	0-48,0-48						Insulin Related Transcription Factor And Uses Thereof 	.freshpatents.com	0	0		
626	chr18	5480715	5480764	3500120381	48		5480715	5480764	8421504	2	26,22	0,27	p	350012038100015118	132-180						<Html><Title> Complet list of 1mpf hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
627	chr18	5578105	5578134	3500397944	26		5578105	5578134	8421504	2	14,12	0,17	g	350039794400000005	10-36						Antibodies	Cicortas	2013	0		
630	chr18	5986015	5986045	3500467352	24		5986015	5986045	8421504	3	12,7,5	0,17,25	g	350046735200000128	9-37					Patent	Recombinant fowlpox virus S-FPV-043 and uses thereof (Patent US:6123949)	Cochran	2000	0		
636	chr18	6728544	6729315	3500364288	23		6728544	6729315	8421504	2	10,13	0,758	c	350036428800000036	21-44						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
638	chr18	6988002	6988026	3500092117	23		6988002	6988026	8421504	2	11,12	0,12	g	350009211700000056	2-34						Expanding the eukaryotic genetic code	Chin	2008	0		
638	chr18	6988002	6988026	3500013141	23		6988002	6988026	8421504	2	11,12	0,12	g	350001314100000028	2-34						Site Specific Incorporation of Non-Natural Amino Acids by Vertebrate Cells	Tian	2010	0		
639	chr18	7115722	7115746	3500339288	23		7115722	7115746	8421504	2	4,19	0,5	g	350033928800000182	12-35						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		
640	chr18	7297227	7297253	3500269550	23		7297227	7297253	8421504	2	10,13	0,13	g	350026955000000274	5-29						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
80	chr18	7584988	7702184	3500077888	49		7584988	7702184	8421504	3	26,5,18	0,52,117178	c	350007788800000066,350007788800000067	0-26,0-23						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
647	chr18	8142419	8142445	3500037983	23		8142419	8142445	8421504	3	5,13,5	0,6,21	g	350003798300000005	15-38						Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)	Behrens	1996	0		
649	chr18	8464059	8464086	3500448386	27		8464059	8464086	8421504	1	27	0	c,g	350044838600000028,350044838600000028	0-27,0-27						P-cadherin as a target for anti-cancer therapy	Reinhard	2002	0		
649	chr18	8464059	8464086	3500439989	27		8464059	8464086	8421504	1	27	0	c	350043998900000031	0-27						P-cadherin as a target for anti-cancer therapy	Reinhard	2005	0		CDH13
81	chr18	8707826	8794978	3500276786	78		8707826	8794978	8421504	2	18,60	0,87092	p	350027678600015000	0-78		10987267		0008-5472	Cancer Research	Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels	Wyder	2000	8		CDH13
655	chr18	9264374	9268052	3500217532	25		9264374	9268052	8421504	2	22,3	0,3675	c	350021753200000000,350021753200000001	0-25,0-25						Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid&#x2013;guided resection of glioma	Tomonari	2013	0		CDH13
655	chr18	9264374	9268052	3500204227	25		9264374	9268052	8421504	2	22,3	0,3675	c	350020422700000001,350020422700000000	0-25,0-25						Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid&#x2013;guided resection of glioma	Tomonari	2013	0		CDH13
655	chr18	9275807	9275838	3500045202	26		9275807	9275838	8421504	3	4,15,7	0,5,24	c	350004520200000013	18-44						Stearoyl-CoA Desaturase 4 Gene - Patent application	www.faqs.org	0	0		
657	chr18	9501710	9535253	3500103209	351		9501710	9535253	8421504	12	14,34,41,22,20,23,31,22,41,24,31,48	0,891,974,10480,11202,11244,12000,26654,28195,28680,33311,33495	c	350010320900000244,350010320900000311,350010320900000242,350010320900000296,350010320900000228,350010320900000291,350010320900000335,350010320900000333,350010320900000264,350010320900000258,350010320900000321	0-45,0-42,0-41,0-42,0-23,1-32,10-32,0-41,18-42,0-31,0-48						Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity - US Patent 7211424 Description	ww.patentstorm.us	0	0		
657	chr18	9552625	9555544	3500139688	25		9552625	9555544	8421504	3	5,1,19	0,2898,2900	c	350013968800000172	2-27						TRANSPORTER GENES OATP-B, C, D, AND E - Patent application	www.faqs.org	0	0		
662	chr18	10139437	10139889	3500258554	24		10139437	10139889	8421504	3	5,18,1	0,8,451	c	350025855400000483	8-34						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
662	chr18	10139437	10139889	3500234051	24		10139437	10139889	8421504	3	5,18,1	0,8,451	c	350023405100000290	20-46						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		
664	chr18	10419069	10419095	3500337360	23		10419069	10419095	8421504	2	7,16	0,10	g	350033736000000457	12-36						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
665	chr18	10610956	10610979	3500131771	23		10610956	10610979	8421504	1	23	0	g	350013177100000152	12-35					Patent	Transgenic non-human animals for producing heterologous antibodies (Patent US:5814318)	Kay	1998	0		
668	chr18	10881344	10887105	3500343582	42		10881344	10887105	8421504	2	19,23	0,5738	c,g	350034358200000020,350034358200000020,350034358200000021	0-19,0-19,0-23						ABSTRACT	tory.lib.ncsu.edu	0	0		
668	chr18	10883314	10888953	3500309900	464		10883314	10888953	8421504	4	73,125,132,134	0,3768,4611,5505	p	350030990000015006,350030990000015052,350030990000015055,350030990000015056	0-510,0-45,0-120,9-84						Method to detect lung cancer - US Patent 7473530 Description	ww.patentstorm.us	0	0		
668	chr18	10883314	10888953	3500281459	464		10883314	10888953	8421504	4	73,125,132,134	0,3768,4611,5505	p	350028145900015003,350028145900015008,350028145900015013,350028145900015018	0-150,0-150,0-150,0-57						Appendice di bioinformatica A	cs.cribi.unipd.it	0	0		
668	chr18	10887175	10887199	3500153276	23		10887175	10887199	8421504	2	9,14	0,10	c	350015327600000372	22-45						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
668	chr18	10998259	11004557	3500436656	258		10998259	11004557	8421504	4	72,48,54,84	0,120,6148,6214	p	350043665600015020	0-309						Identification	www.pnas.org	0	0		
669	chr18	11077479	11077505	3500112083	23		11077479	11077505	8421504	2	8,15	0,11	g	350011208300000295,350011208300000005	1-24,1-24						 Mycobacterial Sulfation Pathway Proteins And Methods Of Use Thereof 	www.docstoc.com	0	0		
670	chr18	11149933	11149962	3500099318	25		11149933	11149962	8421504	3	7,13,5	0,10,24	g	350009931800000002	1-28						Hepatitis c diagnostics and vaccines	Cho	1992	0		
670	chr18	11171444	11171472	3500025965	23		11171444	11171472	8421504	2	11,12	0,16	g	350002596500000001	0-23			10.1098/rspb.2005.3339		Proceedings of the Royal Society B: Biological Sciences	Evaluating bacterial pathogen DNA preservation in museum osteological collections	Ian	2006	0		
670	chr18	11174833	11174862	3500385061	24		11174833	11174862	8421504	2	6,18	0,11	g	350038506100000011	0-25					Patent	Transgenic non-human animals for pharmacological and toxicological studies (Patent US:7544854)	Daly	2009	0		
672	chr18	11490014	11533358	3500427946	44		11490014	11533358	8421504	2	22,22	0,43322	c,g	350042794600000002,350042794600000000,350042794600000003	0-20,18-40,18-40						Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia	www.molvis.org	0	0		
672	chr18	11533084	11533321	3500452955	237		11533084	11533321	8421504	1	237	0	p	350045295500015047	0-237						Structural and functional analysis of genes encoding fork head proteins in Cryptococcus neoformans	biologia.savba.sk	0	0		GMDS
672	chr18	11533097	11533262	3500255343	81		11533097	11533262	8421504	2	32,49	0,116	c	350025534300000002,350025534300000003,350025534300000006,350025534300000007,350025534300000008,350025534300000009	0-32,0-32,0-33,0-33,0-32,0-32						ScienceDirect.com - The American Journal of Human Genetics - Analyses of the Effects That Disease-Causing Missense Mutations Have on the Structure and Function of the Winged-Helix Protein FOXC1	sciencedirect.com	0	0		
672	chr18	11533207	11533258	3500351312	51		11533207	11533258	8421504	1	51	0	p	350035131200015040,350035131200015009	0-48,0-48						Animal model	Enerback	2000	0		
672	chr18	11533312	11533381	3500272094	69		11533312	11533381	8421504	1	69	0	p	350027209400015040,350027209400015041	0-66,3-72						DNA-binding properties andsecondary structural model hepatocyte nuclearfactor 3/fork domain	www.pnas.org	0	0		GMDS
672	chr18	11533376	11533403	3500289584	23		11533376	11533403	8421504	2	10,13	0,14	c	350028958400000266	0-37					Patent	CNS chloride modulation and uses thereof (Patent CN:100581621)	J*A*M*Ku Er 	2010	0		
673	chr18	11534933	11535006	3500261436	47		11534933	11535006	8421504	2	23,24	0,49	c	350026143600000043,350026143600000044	0-23,0-24						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
677	chr18	12143794	12155630	3500447453	66		12143794	12155630	8421504	3	21,20,25	0,11747,11811	c	350044745300000028,350044745300000019,350044745300000029	10-31,9-29,9-34		15140988	10.1128/JVI.78.11.5900-5912.2004	0022-538X	Journal of Virology	Processing of a Pestivirus Protein by a Cellular Protease Specific for Light Chain 3 of Microtubule-Associated Proteins	Fricke	2004	5		
677	chr18	12143794	12155630	3500360325	375		12143794	12155630	8421504	4	40,56,107,172	0,8065,10727,11664	p	350036032500015003,350036032500015002	0-360,0-375						&#x8102;&#x86cb;&#x767d;LC3-II &#x7684;&#x534a;&#x5408;&#x6210; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		MAP1LC3B
677	chr18	12143794	12155630	3500133314	375		12143794	12155630	8421504	4	40,56,107,172	0,8065,10727,11664	p	350013331400015001,350013331400015002	0-48,783-1158						Methods and agents for modulating an immune response - Patent application	www.faqs.org	0	0		
677	chr18	12163907	12163935	3500387171	28		12163907	12163935	8421504	1	28	0	c	350038717100000008	66-94		19778960	10.1099/mic.0.033233-0	1350-0872	Microbiology	SLA2 mutations cause SWE1-mediated cell cycle phenotypes in Candida albicans and Saccharomyces cerevisiae	Gale	2009	3		
677	chr18	12163920	12163943	3500392839	23		12163920	12163943	8421504	1	23	0	c	350039283900000003	11-34					Patent	Identification and engineering of antibodies with variant Fc regions and methods of using same (Patent US:8003774)	Gorlatov	2011	0		
677	chr18	12163920	12163943	3500314196	23		12163920	12163943	8421504	1	23	0	c	350031419600000003	11-34					Patent	Identification and engineering of antibodies with variant Fc regions and methods of using same (Patent US:8003774)	Gorlatov	2011	0		
677	chr18	12163920	12163943	3500236968	23		12163920	12163943	8421504	1	23	0	c	350023696800000003	11-34						Engineering Fc Antibody Regions to Confer Effector Function	Koenig	2012	0		
677	chr18	12163920	12163943	3500076918	23		12163920	12163943	8421504	1	23	0	c	350007691800000003	11-34					Patent	Identification and engineering of antibodies with variant Fc regions and methods of using same (Patent US:8003774)	Gorlatov	2011	0		
677	chr18	12164568	12164591	3500144411	23		12164568	12164591	8421504	1	23	0	c	350014441100000065	2-25						Tumor-Targeting Monoclonal Antibodies to FZD10 and Uses Thereof - Patent application	www.faqs.org	0	0		
677	chr18	12164568	12164591	3500036421	23		12164568	12164591	8421504	1	23	0	c	350003642100000378	23-46						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
677	chr18	12166445	12166471	3500264958	23		12166445	12166471	8421504	2	14,9	0,17	c	350026495800000000	0-24						The Roles of Candida albicans Gpm1p and Tef1p in Immune Evasion and Tissue Invasion of the Human	.db-thueringen.de	0	0		
679	chr18	12428084	12428684	3500382374	597		12428084	12428684	8421504	4	346,4,189,58	0,347,352,542	g	350038237400000007,350038237400000008	29-219,0-448						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
679	chr18	12428084	12428684	3500360633	597		12428084	12428684	8421504	4	346,4,189,58	0,347,352,542	g	350036063300000005	29-677						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
679	chr18	12428084	12428684	3500221817	597		12428084	12428684	8421504	4	346,4,189,58	0,347,352,542	g	350022181700000007,350022181700000008	29-219,0-448					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
679	chr18	12428084	12428684	3500101798	585		12428084	12428684	8421504	5	288,46,4,189,58	0,300,347,352,542	g	350010179800000009,350010179800000010,350010179800000011	29-177,0-181,0-297						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
680	chr18	12472198	12472222	3500269148	23		12472198	12472222	8421504	2	10,13	0,11	c	350026914800000031,350026914800000032	17-40,17-40						ACTIVATION INDUCED DEAMINASE (AID) - Patent application	www.faqs.org	0	0		
680	chr18	12475366	12498869	3500190264	333		12475366	12498869	8421504	8	38,35,27,2,45,93,48,45	0,1617,1671,2060,23167,23218,23314,23458	p,c	350019026400000189,350019026400000182,350019026400000181,350019026400015202,350019026400015169,350019026400000173,350019026400015200,350019026400015168,350019026400000171,350019026400015164	0-38,0-35,0-29,0-45,0-45,0-48,0-45,0-45,0-48,0-45						NOVEL ANTI-CD98 ANTIBODY - Patent application	www.faqs.org	0	0		METTL9
681	chr18	12633700	12633728	3500160249	24		12633700	12633728	8421504	2	14,10	0,18	g	350016024900000230	0-25						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN - Patent application	www.faqs.org	0	0		
681	chr18	12633700	12633728	3500104979	24		12633700	12633728	8421504	2	14,10	0,18	g	350010497900000230	0-25						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
681	chr18	12711269	12711296	3500401291	24		12711269	12711296	8421504	2	12,12	0,15	g	350040129100000006	0-25						PORPHOBILINOGEN DEAMINASE GENE THERAPY - Patent application	www.faqs.org	0	0		
682	chr18	12786929	12789918	3500129809	40		12786929	12789918	8421504	4	8,12,10,10	0,1590,2537,2979	c	350012980900000001,350012980900000000	0-20,0-20		11711515	10.1161/hy1101.095993	0194-911X	Hypertension	Flow Pulsatility Is a Critical Determinant of Oxidative Stress in Endothelial Cells	Silacci	2001	6		
682	chr18	12824962	12824991	3500269358	25		12824962	12824991	8421504	3	6,14,5	0,8,24	c	350026935800000154	1-26						Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation	Hung	2002	0		
682	chr18	12824962	12824991	3500218307	25		12824962	12824991	8421504	3	6,14,5	0,8,24	c	350021830700000001	1-26		11221836		0008-5472	Cancer Research	Enhancement of DNA Vaccine Potency by Linkage of Antigen Gene to a Gene Encoding the Extracellular Domain of Fms-like Tyrosine Kinase 3-Ligand	Hung	2001	8		
685	chr18	13185835	13185858	3500112146	23		13185835	13185858	8421504	1	23	0	c	350011214600000121	0-23						Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use	Anderson	2002	0		
687	chr18	13387559	13388030	3500216761	46		13387559	13388030	8421504	2	24,22	0,449	c	350021676100000000,350021676100000001	0-24,0-22						Generic Peptides | Online Peptide Guide	www.myostatin.us	0	0		CHMP1A
687	chr18	13479434	13479460	3500457504	25		13479434	13479460	8421504	2	16,9	0,17	g	350045750400000027	8-33						Molekularbiologische und pharmakologische Untersuchungen zur Aktivierung der l&#xf6;slichen Guanylatcyclase	thek.uni-halle.de	0	0		
688	chr18	13552983	13554626	3500084329	81		13552983	13554626	8421504	3	33,35,13	0,1454,1630	c	350008432900000011,350008432900000049,350008432900000053	17-36,0-29,0-48						Novel human cyclin-dependent kinase-like proteins and methods of using the same	Giordano	1996	0		
689	chr18	13686164	13687107	3500178206	60		13686164	13687107	8421504	3	19,20,21	0,280,922	c,g	350017820600000000,350017820600000001,350017820600000004,350017820600000004	0-19,0-20,0-21,0-21						Identification of the e allele at the Extension MC1R) in Brazilian Creole sheep and its role in wool color variation	w.funpecrp.com.br	0	0		
689	chr18	13686164	13686207	3500208026	43		13686164	13686207	8421504	1	43	0	c	350020802600000004	5-48						Probes and methods for detecting melanocortin-5 receptor	Yamada	1997	0		
689	chr18	13686254	13686604	3500320452	40		13686254	13686604	8421504	2	20,20	0,330	c,g	350032045200000017,350032045200000017,350032045200000018	0-20,0-20,0-20						Methods for performing direct enzymatic reactions involving nucleic acid molecules	Kim	2009	0		
689	chr18	13686254	13686604	3500093767	40		13686254	13686604	8421504	2	20,20	0,330	c,g	350009376700000017,350009376700000017,350009376700000018,350009376700000018	0-20,0-20,0-20,0-20						Methods for performing direct enzymatic reactions involving nucleic acid molecules	Kim	2009	0		
689	chr18	13686270	13686914	3500097226	199		13686270	13686914	8421504	2	156,43	0,601	p,c	350009722600015020,350009722600000001	0-156,7-50						THESE	w2.vetagro-sup.fr	0	0		
689	chr18	13686690	13686736	3500258818	45		13686690	13686736	8421504	2	25,20	0,26	p	350025881800015243	0-45						METHODS AND MATERIALS RELATED TO HAIR PIGMENTATION AND CANCER - Patent application	www.faqs.org	0	0		
689	chr18	13686850	13686879	3500446401	29		13686850	13686879	8421504	1	29	0	c	350044640100000021	9-38						Human melanocyte stimulating hormone receptor polypeptide and DNA	Wikberg	1995	0		
689	chr18	13689486	13694820	3500113932	23		13689486	13694820	8421504	2	12,11	0,5323	c	350011393200000002	0-23		22742413	10.1186/1471-2180-12-126	1471-2180	BMC Microbiology	Cloning, expression and characterization of an aryl-alcohol dehydrogenase from the white-rot fungus Phanerochaete chrysosporium strain BKM-F-1767	Yang	2012	3		TUBB
689	chr18	13695407	13696325	3500391361	99		13695407	13696325	8421504	2	45,54	0,864	p	350039136100015127,350039136100015177	0-45,0-54						Transcriptomic and Proteomic Approaches to the Discovery of New Markers of Pathology	n.library.ethz.ch	0	0		
689	chr18	13696620	13696643	3500003314	23		13696620	13696643	8421504	1	23	0	g	350000331400000029	0-23						Treatment of neurological disorders with haematopoietic growth factors	Schaebitz	2007	0		TUBB2A
86	chr18	14416864	14427926	3500022313	519		14416864	14427926	8421504	12	36,99,41,28,6,54,23,43,58,8,63,60	0,60,805,981,1120,4472,4646,6218,6619,8976,9098,11002	p	350002231300015153,350002231300015154	0-1821,0-420						The characterisation of trypanosomal type 1 DnaJ-like proteins | Michael Ludewig - Academia.edu	www.academia.edu	0	0		
696	chr18	14564268	14564292	3500353558	23		14564268	14564292	8421504	2	18,5	0,19	g	350035355800000001	7-30						Structural Basis for the Inhibitory Effect of Brefeldin A on Guanine Nucleotide-Exchange Proteins for ADP-Ribosylation Factors	www.jstor.org	0	0		
706	chr18	15876504	15876528	3500177982	24		15876504	15876528	8421504	1	24	0	c	350017798200000968	16-40						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		LONP2
706	chr18	15963576	15964104	3500251200	90		15963576	15964104	8421504	2	42,48	0,480	c	350025120000000028,350025120000000018	0-42,0-48						Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof - US Patent 7504253 Description	ww.patentstorm.us	0	0		
706	chr18	15963576	15963618	3500393026	42		15963576	15963618	8421504	1	42	0	c	350039302600000025	0-42						US Patent # 7,390,656. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
706	chr18	15964056	15964104	3500396061	48		15964056	15964104	8421504	1	48	0	c	350039606100000015	0-48						Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto	Reed	2000	0		
706	chr18	15964056	15964104	3500366927	48		15964056	15964104	8421504	1	48	0	c	350036692700000018	0-48						US Patent # 7,504,253. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof - Patents.com	www.patents.com	0	0		
706	chr18	15964056	15964104	3500114953	48		15964056	15964104	8421504	1	48	0	c	350011495300000018	0-48						NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
706	chr18	15964056	15964104	3500096613	48		15964056	15964104	8421504	1	48	0	c	350009661300000015	0-48						US Patent # 6,638,734. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
708	chr18	16184523	16184549	3500180104	23		16184523	16184549	8421504	2	16,7	0,19	c	350018010400000088	12-35						Funktionelle und Strukturelle Charakterisierung von Ras-Effektoren Eigenschaften des kleinen Ras-Effektors Novel Ras Effector 1 (Nore1)	uhr-uni-bochum.de	0	0		
711	chr18	16521056	16521083	3500002667	23		16521056	16521083	8421504	3	5,13,5	0,7,22	g	350000266700000006	4-28						Detection Of Viable Agents 	.freshpatents.com	0	0		
714	chr18	16964252	16964362	3500301078	49		16964252	16964362	8421504	2	23,26	0,84	c,g	350030107800000175,350030107800000175,350030107800000176,350030107800000176	0-23,0-23,0-26,0-26						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		ZNF423
715	chr18	17129636	17129659	3500333211	23		17129636	17129659	8421504	1	23	0	c,g	350033321100000048,350033321100000048	0-23,0-23						Method of diagnosing and/or predicting the development of an allergic disorder	Bosco	2006	0		ZNF423
715	chr18	17129664	17129693	3500131771	26		17129664	17129693	8421504	3	7,13,6	0,9,23	g	350013177100000020	14-40					Patent	Transgenic non-human animals for producing heterologous antibodies (Patent US:5814318)	Kay	1998	0		
715	chr18	17150943	17150971	3500383409	24		17150943	17150971	8421504	2	9,15	0,13	g	350038340900000032	12-37						Humanized antibodies that bind to CD19 and their uses - Patent application	www.faqs.org	0	0		
719	chr18	17656407	17659577	3500416264	42		17656407	17659577	8421504	2	20,22	0,3148	c,g	350041626400000000,350041626400000001,350041626400000001	0-20,0-22,0-22		12554775	10.1210/me.2002-0369	0888-8809	Molecular Endocrinology	Short-Term Plasticity of Cyclic Adenosine 3&#x2032;,5&#x2032;-Monophosphate Signaling in Anterior Pituitary Corticotrope Cells: The Role of Adenylyl Cyclase Isotypes	Antoni	2003	5		ADCY7
719	chr18	17659541	17659609	3500444670	68		17659541	17659609	8421504	1	68	0	g	350044467000000004,350044467000000023	189-257,189-257						In Vitro Assay Based on Camp Levels Modulated by Gi-Coupled Receptors - Patent application	www.faqs.org	0	0		
719	chr18	17682284	17690431	3500172776	43		17682284	17690431	8421504	2	20,23	0,8124	c	350017277600000003,350017277600000002	0-20,0-23		18778484	10.1186/1471-2407-8-253	1471-2407	BMC Cancer	Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells	Liu	2008	3		BRD7
722	chr18	17974060	17974085	3500009551	25		17974060	17974085	8421504	1	25	0	g	350000955100000032	0-25						METHODS AND GENE EXPRESSION SIGNATURE FOR WNT/B-CATENIN SIGNALING PATHWAY - Patent application	www.faqs.org	0	0		NKD1
722	chr18	18030210	18062062	3500224243	559		18030210	18062062	8421504	25	22,22,25,25,23,21,23,21,24,20,23,23,27,25,21,22,25,3,19,22,24,25,24,24,26	0,1043,2275,6459,9619,9688,9998,10104,10522,10572,16214,24837,28313,29927,30213,30342,30684,30810,30814,31197,31301,31407,31488,31682,31826	c,g	350022424300000030,350022424300000026,350022424300000033,350022424300000037,350022424300000040,350022424300000040,350022424300000039,350022424300000039,350022424300000042,350022424300000042,350022424300000041,350022424300000041,350022424300000044,350022424300000043,350022424300000043,350022424300000046,350022424300000055,350022424300000000,350022424300000001,350022424300000060,350022424300000060,350022424300000059,350022424300000059,350022424300000062,350022424300000062,350022424300000061,350022424300000064,350022424300000063,350022424300000002,350022424300000066,350022424300000065,350022424300000003	0-22,0-22,0-25,0-25,0-23,0-23,0-21,0-21,0-23,0-23,0-21,0-21,0-24,0-20,0-20,0-23,0-23,27-54,26-51,0-21,0-21,0-22,0-22,0-25,0-25,0-22,0-22,0-24,28-53,0-24,0-24,0-26						BMC Genomics BioMed Central	biomedcentral.com	0	0		
722	chr18	18032346	18061588	3500104288	180		18032346	18061588	8421504	9	20,20,20,20,20,20,20,20,20	0,7178,7489,7830,8190,8327,27809,29181,29222	c,g	350010428800000004,350010428800000006,350010428800000005,350010428800000000,350010428800000008,350010428800000008,350010428800000007,350010428800000009,350010428800000003,350010428800000003,350010428800000002	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						Identi&#xfb01;cation of genetic variation and putative regulatory regions in bovine CARD15	nces.missouri.edu	0	0		
722	chr18	18033283	18060085	3500158871	2189		18033283	18060085	8421504	7	923,2,60,744,36,423,1	0,3267,6156,6219,25099,25136,26801	c,g	350015887100000065,350015887100000068,350015887100000067,350015887100000051,350015887100000069,350015887100000069,350015887100000070,350015887100000070,350015887100000071,350015887100000071,350015887100000052,350015887100000072,350015887100000072,350015887100000073,350015887100000073,350015887100000074,350015887100000074,350015887100000075,350015887100000075,350015887100000076,350015887100000076,350015887100000077,350015887100000077,350015887100000078,350015887100000078,350015887100000079,350015887100000079,350015887100000009,350015887100000009,350015887100000080,350015887100000084,350015887100000083,350015887100000085,350015887100000081	0-923,1-60,0-60,0-20,0-60,0-60,0-60,0-60,0-60,0-60,0-20,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-20,0-20,0-27,0-136,0-55,0-321,92-177						ER UNTERSUCHUNG GENETISCHER URSACHEN DER HING UNTERSCHIEDLICHEN EMPF&#xc4;NGLICHKEIT F&#xdc;R DIE	eb.uni-giessen.de	0	0		
722	chr18	18039733	18039759	3500344642	26		18039733	18039759	8421504	1	26	0	c	350034464200000001	0-26						Nod2 nucleic acids and proteins	Nunez	2004	0		
722	chr18	18039733	18039759	3500003045	26		18039733	18039759	8421504	1	26	0	c	350000304500000021,350000304500000001	0-26,0-26						Modulators Of NOD2 Signalling - Patent application	www.faqs.org	0	0		
722	chr18	18039843	18052996	3500052099	151		18039843	18052996	8421504	5	27,48,29,23,24	0,444,1231,12080,13129	c	350005209900000082,350005209900000282,350005209900000298,350005209900000401	0-27,0-48,19-48,0-47						Card Domain Containing Polypeptides, Encoding Nucleic Acids, And Methods Of Use 	.freshpatents.com	0	0		
90	chr18	18084436	18113176	3500030804	43		18084436	18113176	8421504	2	22,21	0,28719	c,g	350003080400000006,350003080400000006,350003080400000007	0-22,0-22,0-21						InhibitionofAutophagyRescuesPalmiticAcid-induced NecroptosisofEndothelialCells S	www.jbc.org	0	0		CYLD
726	chr18	18579602	18593712	3500312799	96		18579602	18593712	8421504	3	21,21,54	0,3814,14056	c,g	350031279900000001,350031279900000002,350031279900000003,350031279900000007,350031279900000007,350031279900000010,350031279900000011,350031279900000009,350031279900000012,350031279900000004,350031279900000004	11-32,9-30,12-33,8-30,8-30,3-41,5-43,5-42,6-42,11-32,11-32		16707490	10.1074/jbc.M513461200	0021-9258	Journal of Biological Chemistry	A Conserved 12-Amino Acid Motif in Sall1 Recruits the Nucleosome Remodeling and Deacetylase Corepressor Complex	Lauberth	2006	5		
736	chr18	19868520	19868548	3500195767	23		19868520	19868548	8421504	2	11,12	0,16	g	350019576700000099	0-23						Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules - Patent application	www.faqs.org	0	0		
739	chr18	20206957	20206982	3500042432	24		20206957	20206982	8421504	2	10,14	0,11	g	350004243200000021	6-30						Astrocyte Modulated Genes And Uses Thereof 	.freshpatents.com	0	0		
744	chr18	20879479	20880390	3500242697	23		20879479	20880390	8421504	3	1,4,18	0,886,893	c	350024269700000411	2-25						Non-endogenous, constitutively activated human G protein-coupled receptors	Duo Mi Ni Ke *P*Bi Yi 	2003	0		
744	chr18	20880374	20885189	3500245677	441		20880374	20885189	8421504	5	60,56,118,87,120	0,142,849,4378,4695	p	350024567700015003,350024567700015008,350024567700015013	0-123,0-147,0-171						CHD8, a Novel ATP-dependent Chromatin Remodeling Enzyme by	lue.lib.umich.edu	0	0		CHD9
744	chr18	20924652	20928860	3500342848	282		20924652	20928860	8421504	5	73,11,54,43,101	0,564,1303,3707,4107	p	350034284800015030,350034284800015038	0-84,0-198						The DNA-binding domain of the Chd1 chromatin-remodelling enzyme contains SANT and SLIDE domains. - ResearchGate	.researchgate.net	0	0		CHD9
744	chr18	20952772	20952798	3500423257	24		20952772	20952798	8421504	2	11,13	0,13	c	350042325700000242	1-25						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
745	chr18	21020886	21020912	3500275891	25		21020886	21020912	8421504	2	12,13	0,13	c	350027589100000006	20-46						Antibodies against flagellin and uses thereof - Patent application	www.faqs.org	0	0		
745	chr18	21028538	21028565	3500201655	23		21028538	21028565	8421504	2	14,9	0,18	g	350020165500000000	7-30						An Enrichment Medium for Increasing a Very Small Number of Vibrio parahaemolyticus Cells to the Detection Limit of the Loop-Mediated Isothermal Amplification (LAMP) Assay	www.nih.go.jp	0	0		
745	chr18	21061052	21061077	3500174638	24		21061052	21061077	8421504	2	6,18	0,7	g	350017463800000339	17-41						US Patent # 8,318,908. Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof - Patents.com	patents.com	0	0		
748	chr18	21393959	21394208	3500382710	40		21393959	21394208	8421504	2	19,21	0,228	g	350038271000000000,350038271000000001	0-19,0-21						Wei et al. Novel polymorphism of the bovine fat mass and obesity-associated (FTO) gene are related to backfat thickness and longissimus muscle area in five Chinese native cattle breeds. Afr. J. Biotechnol. 2011	demicjournals.org	0	0		
748	chr18	21393959	21394208	3500047819	40		21393959	21394208	8421504	2	19,21	0,228	g	350004781900000000,350004781900000001	0-19,0-21						Novel polymorphism of the bovine fat mass and obesity-associated (FTO) gene are related to backfat thickness and longissimus muscle area in five Chinese native cattle breeds	www.ajol.info	0	0		
752	chr18	21967587	21967616	3500057734	24		21967587	21967616	8421504	2	8,16	0,13	c	350005773400000037	24-48						Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same 	.freshpatents.com	0	0		
754	chr18	22216477	22216501	3500068995	23		22216477	22216501	8421504	2	9,14	0,10	g	350006899500000001	3-45						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
755	chr18	22315836	22315862	3500069074	25		22315836	22315862	8421504	2	4,21	0,5	g	350006907400000007,350006907400000003	3-25,3-28						Methods and compositions for producing fatty alcohols	Hu	2011	0		
761	chr18	23156382	23156445	3500261738	63		23156382	23156445	8421504	1	63	0	p	350026173800015033	0-63						Epitopanalyse von Matrix-Metalloproteinase-19- spezifischen monoklonalen Antik&#xf6;rpern Dissertation	b.uni-konstanz.de	0	0		MMP2
761	chr18	23156547	23157597	3500204837	90		23156547	23157597	8421504	2	59,31	0,1019	p	350020483700015000	0-90						Process for the production of gelatinase catalytic domain protein	Ye	1994	0		MMP2
761	chr18	23156580	23156603	3500337688	23		23156580	23156603	8421504	1	23	0	c	350033768800000008	0-23		20162608	10.1002/ijc.25245	1097-0215	International Journal of Cancer	Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas - Grymula - 2010 - International Journal of Cancer - Wiley Online Library	Grymula	2010	0		
761	chr18	23157595	23158903	3500040185	38		23157595	23158903	8421504	2	19,19	0,1289	c	350004018500000010,350004018500000011	0-19,0-19						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
761	chr18	23157597	23159221	3500233580	83		23157597	23159221	8421504	4	22,22,19,20	0,81,1197,1604	c	350023358000000004,350023358000000014,350023358000000015,350023358000000005	0-22,0-22,0-19,0-20						Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle	biomedcentral.com	0	0		
761	chr18	23157598	23157621	3500387037	23		23157598	23157621	8421504	1	23	0	c	350038703700000011	0-23						FoxM1RegulatesTranscriptionof JNK1 toPromotetheG1/S TransitionandTumorCellInvasiveness	www.jbc.org	0	0		
761	chr18	23157598	23157621	3500272048	23		23157598	23157621	8421504	1	23	0	c	350027204800000011	0-23		18524773	10.1074/jbc.M709892200	0021-9258	Journal of Biological Chemistry	FoxM1 Regulates Transcription of JNK1 to Promote the G1/S Transition and Tumor Cell Invasiveness	Wang	2008	5		
761	chr18	23157669	23157692	3500002875	23		23157669	23157692	8421504	1	23	0	c,g	350000287500000005,350000287500000005	0-23,0-23						TAMPONAMENTO CECAL: ASPECTOS CL&#xcd;NICO, FISIOPATOL&#xd3;GICO E TERAP&#xca;UTICO NA LAMINITE EXPERIMENTAL EM EQ&#xdc;INOS.	www.fcav.unesp.br	0	0		
761	chr18	23158900	23163062	3500066793	40		23158900	23163062	8421504	3	4,16,20	0,223,4142	c,g	350006679300000006,350006679300000007,350006679300000007	0-20,0-20,0-20						Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms	gelab.eng.uci.edu	0	0		MMP2
761	chr18	23158900	23159145	3500408268	26		23158900	23159145	8421504	2	4,22	0,223	c	350040826800000004	21-47			10.1002/ijc.1357	1097-0215	International Journal of Cancer	Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells - Hamada - 2001 - International Journal of Cancer - Wiley Online Library	Hamada	2001	0		
761	chr18	23163080	23172625	3500433630	41		23163080	23172625	8421504	4	4,16,17,4	0,2179,8047,9541	c	350043363000000013,350043363000000014	0-20,0-21						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation	Chang	2006	0		
761	chr18	23163080	23172625	3500139519	41		23163080	23172625	8421504	4	4,16,17,4	0,2179,8047,9541	c	350013951900000013,350013951900000014	0-20,0-21						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation - US Patent 7435800 Description	ww.patentstorm.us	0	0		MMP2
761	chr18	23166733	23171023	3500134803	40		23166733	23171023	8421504	3	21,3,16	0,47,4274	c,g	350013480300000012,350013480300000012,350013480300000013	0-21,0-21,0-19						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
761	chr18	23166751	23179372	3500337757	45		23166751	23179372	8421504	2	23,22	0,12599	c	350033775700000004,350033775700000005	0-23,0-22						EFFECTS OF TOBACCO ON HUMAN GINGIVAL FIBROBLASTS	arworks.iupui.edu	0	0		MMP2
761	chr18	23171062	23172690	3500267782	40		23171062	23172690	8421504	2	20,20	0,1608	c,g	350026778200000014,350026778200000015,350026778200000015	0-20,0-20,0-20						The effect of progesterone replacement on gene expression in the corpus luteum during induced regression and late luteal phase in the bonnet monkey (Macaca radiata)	www.rbej.com	0	0		MMP2
761	chr18	23171063	23181294	3500258048	45		23171063	23181294	8421504	2	22,23	0,10208	c	350025804800000000,350025804800000001	0-22,0-23						Biology of Sport, oVol. 24 N 4, 2007 THE EXPRESSION OF MMP-2, MMP-9, AND SOD ON DIFFERENT MUSCLE FIBERS IN TRAINED MUSCLES IN YOUNG RATS	biolsport.com	0	0		MMP2
761	chr18	23171137	23172668	3500358142	54		23171137	23172668	8421504	2	7,47	0,1484	p	350035814200015012	0-54						Methods and compositions for preventing and treating microbial infections	Shapiro	2003	0		
761	chr18	23172764	23181234	3500429657	66		23172764	23181234	8421504	4	17,4,23,22	0,6573,6599,8448	c	350042965700000000,350042965700000002,350042965700000001	4-25,0-23,0-22		20071690	10.1152/ajpcell.00305.2009		American Journal of Physiology - Cell Physiolog	Different activation forms of MMP-2 oppositely affect the fate of endothelial cells	Shapiro	2010	0		
761	chr18	23179356	23181239	3500070510	65		23179356	23181239	8421504	3	20,24,21	0,35,1862	c,g	350007051000000006,350007051000000008,350007051000000007,350007051000000007	0-20,0-24,0-21,0-21						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		MMP2
761	chr18	23179395	23179420	3500103872	25		23179395	23179420	8421504	1	25	0	c	350010387200000007	0-25						Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: Implication of NADPH oxidase	ww.uphs.upenn.edu	0	0		
761	chr18	23179437	23181257	3500069653	50		23179437	23181257	8421504	3	10,16,24	0,1772,1796	c	350006965300000005,350006965300000004	0-26,0-24		20332214	10.1158/1541-7786.MCR-09-0454	1541-7786	Molecular Cancer Research	Transcription Factor Egr-1 Is Essential for Maximal Matrix Metalloproteinase-9 Transcription by Tumor Necrosis Factor &#x03b1;	Shin	2010	4		MMP2
761	chr18	23181251	23181278	3500285199	27		23181251	23181278	8421504	1	27	0	c	350028519900000002	15-42						Biochimica et Biophysica Acta	www.tijmu.edu.cn	0	0		MMP2
763	chr18	23362798	23401116	3500422384	42		23362798	23401116	8421504	2	22,20	0,38298	c	350042238400000000,350042238400000001	10-32,0-20						Microorganisms For Imaging And/or Treatment Of Tumors 	.freshpatents.com	0	0		SLC6A2
763	chr18	23362798	23401116	3500370168	42		23362798	23401116	8421504	2	22,20	0,38298	c	350037016800000000,350037016800000001	10-32,0-20						Microorganisms for imaging and/or treatment of tumors - Patent application	www.faqs.org	0	0		SLC6A2
763	chr18	23362798	23401116	3500281990	42		23362798	23401116	8421504	2	22,20	0,38298	c	350028199000000000,350028199000000001	10-32,0-20						Microorganisms for imaging and/or treatment of tumors - Patent application	www.faqs.org	0	0		SLC6A2
763	chr18	23362798	23401116	3500129841	42		23362798	23401116	8421504	2	22,20	0,38298	c	350012984100000000,350012984100000001	10-32,0-20						Microorganisms for imaging and/or treatment of tumors - Patent application	www.faqs.org	0	0		SLC6A2
763	chr18	23362798	23401116	3500041223	42		23362798	23401116	8421504	2	22,20	0,38298	c	350004122300000000,350004122300000001	4-26,0-20		19287510	10.2119/molmed.2009.00014		Molecular Medicine	A Novel Recombinant Vaccinia Virus Expressing the Human Norepinephrine Transporter Retains Oncolytic Potential and Facilitates Deep-Tissue Imaging	Nanhai	2009	0		SLC6A2
763	chr18	23362800	23401116	3500264845	1794		23362800	23401116	8421504	15	60,154,132,238,139,135,104,125,113,129,100,101,168,72,24	0,114,11211,12295,19648,24511,26261,27584,28981,30289,33169,34816,35354,37294,38292	p,c,g	350026484500015002,350026484500000000,350026484500000000,350026484500015008,350026484500015007,350026484500015013,350026484500015010,350026484500015014,350026484500015021,350026484500015020,350026484500015019,350026484500015022,350026484500015028,350026484500015030,350026484500015033,350026484500015034,350026484500015041,350026484500015038,350026484500015044,350026484500015047,350026484500015053,350026484500015050,350026484500000002,350026484500015055,350026484500015056,350026484500015059,350026484500015063,350026484500000001	0-60,0-19,0-19,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-32,0-120,0-120,0-120,0-51,0-22						Klonierung und pharmakologische Charakterisie- rung des Noradrenalintransporters (NAT) der Maus und kovalente Markierung und partielle Aufreinigung des humanen NAT-Proteins	s.ulb.uni-bonn.de	0	0		SLC6A2
763	chr18	23370625	23370654	3500084751	24		23370625	23370654	8421504	3	7,11,6	0,10,23	g	350008475100000003	3-27						Apromoter mutation in the erythroid-speci&#xfb01;c 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia	tologylibrary.org	0	0		
763	chr18	23389160	23397639	3500043998	56		23389160	23397639	8421504	4	5,19,9,23	0,1224,6900,8456	c	350004399800000016,350004399800000017,350004399800000032,350004399800000033,350004399800000072,350004399800000073	12-36,0-24,12-36,0-24,0-32,0-32						Molekulare Interaktion von alkylierenden, noradrenergen Neurotoxinen mit dem humanen Noradrenalintransporter	s.ulb.uni-bonn.de	0	0		
763	chr18	23390394	23393166	3500461482	42		23390394	23393166	8421504	2	21,21	0,2751	c,g	350046148200000000,350046148200000000,350046148200000001,350046148200000001	0-21,0-21,0-21,0-21		11046223		0003-3022	Anesthesiology	 Dual Effects of Intravenous Anesthetics on the Function of N... : Anesthesiology 	Hara	2000	5		
764	chr18	23473421	23477151	3500105217	63		23473421	23477151	8421504	3	27,18,18	0,2372,3712	p	350010521700015000	0-63						RNA interference revealed the roles of two carboxylesterase genes in insecticide detoxification in Locusta migratoria	abi.sxu.edu.cn	0	0		CES1
764	chr18	23493941	23493969	3500104979	25		23493941	23493969	8421504	2	5,20	0,8	c	350010497900000216	5-32						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
764	chr18	23502398	23503986	3500343582	43		23502398	23503986	8421504	2	22,21	0,1567	c,g	350034358200000017,350034358200000017,350034358200000016,350034358200000016	0-22,0-22,0-21,0-21						ABSTRACT	tory.lib.ncsu.edu	0	0		
764	chr18	23502439	23514251	3500297480	40		23502439	23514251	8421504	2	20,20	0,11792	c,g	350029748000000001,350029748000000000,350029748000000000	0-20,0-20,0-20		18287334	10.1152/ajpcell.00361.2007		American Journal of Physiology - Cell Physiolog	Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells	Hamel	2008	0		MT1A
764	chr18	23502439	23514251	3500060761	40		23502439	23514251	8421504	2	20,20	0,11792	c,g	350006076100000001,350006076100000000,350006076100000000	0-20,0-20,0-20		18287334	10.1152/ajpcell.00361.2007		American Journal of Physiology - Cell Physiolog	Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells	Hamel	2008	0		MT1A
764	chr18	23502439	23514251	3500052732	40		23502439	23514251	8421504	2	20,20	0,11792	c,g	350005273200000001,350005273200000000	0-20,0-20						Effets des lipoprot&#xe9;ines de faible densit&#xe9; oxyd&#xe9;es sur les cellules ost&#xe9;oblastiques	.archipel.uqam.ca	0	0		
764	chr18	23502439	23514251	3500042144	40		23502439	23514251	8421504	2	20,20	0,11792	c,g	350004214400000001,350004214400000000	0-20,0-20						Characterization of oxidized low density lipoproteins-induced hormesis-like effects in osteoblastic cells	ll.physiology.org	0	0		MT1E,MT1M
764	chr18	23502467	23514252	3500355566	40		23502467	23514252	8421504	3	19,1,20	0,728,11765	c	350035556600000001,350035556600000000	0-20,0-20		15867382	10.1158/0008-5472.CAN-04-4099	0008-5472	Cancer Research	Motexafin Gadolinium Disrupts Zinc Metabolism in Human Cancer Cell Lines	Magda	2005	8		MT1G
764	chr18	23502469	23503210	3500097805	32		23502469	23503210	8421504	2	17,15	0,726	c	350009780500000000	0-32						Very low cadmium concentrations stimulate DNA synthesis and cell growth	cs.biologists.org	0	0		
764	chr18	23502470	23503206	3500386961	27		23502470	23503206	8421504	2	16,11	0,725	c	350038696100000001	0-27		17526490	10.1074/jbc.M702510200	0021-9258	Journal of Biological Chemistry	A Critical Role for I&#x03ba;B Kinase &#x03b2; in Metallothionein-1 Expression and Protection against Arsenic Toxicity	Peng	2007	5		
764	chr18	23508069	23514251	3500073075	40		23508069	23514251	8421504	2	20,20	0,6162	c	350007307500000001,350007307500000000	0-20,0-20		18287334	10.1152/ajpcell.00361.2007		American Journal of Physiology - Cell Physiolog	Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells	Hamel	2008	0		
764	chr18	23513106	23514253	3500391927	140		23513106	23514253	8421504	4	92,15,9,24	0,456,494,1123	c	350039192700000021	70-257						Methods for diagnosing and treating schizophrenia	Buxton	2004	0		
764	chr18	23513185	23514252	3500379159	43		23513185	23514252	8421504	3	13,11,19	0,377,1048	c	350037915900000010,350037915900000007	0-24,0-19		12808106	10.1128/MCB.23.13.4673-4686.2003	0270-7306	Molecular and Cellular Biology	Nrf1 Is Critical for Redox Balance and Survival of Liver Cells during Development	Chen	2003	6		MT1M
764	chr18	23521060	23521790	3500146762	42		23521060	23521790	8421504	2	21,21	0,709	c	350014676200000011,350014676200000010	0-21,0-21						ScienceDirect.com - FEBS Letters - Divalent metal-dependent regulation of hepcidin expression by MTF-1	sciencedirect.com	0	0		MT1E,MT1M
764	chr18	23521411	23521822	3500172791	41		23521411	23521822	8421504	2	21,20	0,391	c	350017279100000009,350017279100000008	0-21,0-20		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
764	chr18	23521411	23521822	3500120290	41		23521411	23521822	8421504	2	21,20	0,391	c,g	350012029000000009,350012029000000009,350012029000000008	0-21,0-21,0-20						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
764	chr18	23521411	23521822	3500048191	41		23521411	23521822	8421504	2	21,20	0,391	c	350004819100000009,350004819100000008	0-21,0-20		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
764	chr18	23529763	23529786	3500401999	23		23529763	23529786	8421504	1	23	0	c	350040199900000003	0-23		15190073	10.1074/jbc.M402530200	0021-9258	Journal of Biological Chemistry	Metallothionein-III Prevents &#x03b3;-Ray-induced 8-Oxoguanine Accumulation in Normal and hOGG1-depleted Cells	Jeong	2004	5		
765	chr18	23640604	23640627	3500391778	23		23640604	23640627	8421504	1	23	0	c	350039177800000290	21-47						Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof	Halbur	1996	0		
765	chr18	23640604	23640627	3500132067	23		23640604	23640627	8421504	1	23	0	c	350013206700000290	21-47						Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids	Paul	1994	0		
765	chr18	23665465	23670686	3500379780	96		23665465	23670686	8421504	3	41,7,48	0,5118,5173	c	350037978000000041,350037978000000043	0-48,0-48						AMELIORATING AGENT FOR INSULIN RESISTANCE - Patent application	www.faqs.org	0	0		
766	chr18	23754356	23754382	3500343562	26		23754356	23754382	8421504	1	26	0	c	350034356200000001	0-26						G alpha(o) is necessary for muscarinic regulation of Ca2+ channels in mouse heart. - ResearchGate	.researchgate.net	0	0		
766	chr18	23754429	23763114	3500136593	40		23754429	23763114	8421504	3	2,18,20	0,1749,8665	c,g	350013659300000021,350013659300000020,350013659300000020	0-20,0-20,0-20						ScienceDirect.com - Neuroscience - Distribution and localisation of G&#x03b1; proteins in the rostral ventrolateral medulla of normotensive and hypertensive rats: Focus on catecholaminergic neurons	sciencedirect.com	0	0		
767	chr18	23916301	23916331	3500081339	30		23916301	23916331	8421504	1	30	0	c	350008133900000003	0-30						Structure of the Human Gene and Two Rat cDNAs Encoding the &#x03b1; Chain of GTP-Binding Regulatory Protein Go: Two Different mRNAs are Generated by Alternative Splicing	www.jstor.org	0	0		
769	chr18	24167085	24190229	3500422717	220		24167085	24190229	8421504	6	66,18,19,45,46,26	0,5178,5297,6396,20556,23118	p,c,g	350042271700015001,350042271700000005,350042271700000005,350042271700000004	0-261,0-19,0-19,0-20		16251497	10.1095/biolreprod.105.046847	0006-3363	Biology of Reproduction	An Epididymal Form of Cauxin, a Carboxylesterase-Like Enzyme, Is Present and Active in Mammalian Male Reproductive Fluids	Ecroyd	2006	4		
771	chr18	24422757	24425752	3500337313	60		24422757	24425752	8421504	2	2,58	0,2937	p	350033731300015002	3-63						SORLA in Renal and Adrenal Function	edoc.hu-berlin.de	0	0		SLC12A3
771	chr18	24433085	24433115	3500406196	30		24433085	24433115	8421504	1	30	0	c	350040619600000001	10-40		18270262	10.1242/jcs.025312	0021-9533	Journal of Cell Science	Activation of the thiazide-sensitive Na+-Cl&#x2013; cotransporter by the WNK-regulated kinases SPAK and OSR1	Richardson	2008	6		
771	chr18	24433085	24433115	3500385742	30		24433085	24433115	8421504	1	30	0	c	350038574200000001	10-40		18270262	10.1242/jcs.025312	0021-9533	Journal of Cell Science	Activation of the thiazide-sensitive Na+-Cl&#x2013; cotransporter by the WNK-regulated kinases SPAK and OSR1	Richardson	2008	6		SLC12A3
775	chr18	24911014	24916121	3500304088	351		24911014	24916121	8421504	7	74,19,81,23,64,26,64	0,435,466,565,2759,2838,5043	p	350030408800015068,350030408800015069,350030408800015070,350030408800015071	0-93,0-81,0-87,0-90						67 human secreted proteins	Carter	1999	0		RSPRY1
775	chr18	24922532	24924225	3500328917	74		24922532	24924225	8421504	4	24,6,30,14	0,616,997,1679	c	350032891700000477,350032891700000481	12-42,0-44						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
776	chr18	25139503	25139528	3500317725	24		25139503	25139528	8421504	2	7,17	0,8	c	350031772500000150	12-36						Transcriptional Regulation of the Nickel and Iron Metabolism in Helicobacter pylori	repub.eur.nl	0	0		
776	chr18	25140109	25140297	3500298402	23		25140109	25140297	8421504	2	7,16	0,172	c	350029840200000024	9-42						TURKEY HERPESVIRUS VECTORED RECOMBINANT CONTAINING AVIAN INFLUENZA GENES - Patent application	www.faqs.org	0	0		
776	chr18	25140109	25140297	3500258483	23		25140109	25140297	8421504	2	7,16	0,172	c	350025848300000043	9-42						IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES - Patent application	www.faqs.org	0	0		
776	chr18	25140109	25140297	3500177324	23		25140109	25140297	8421504	2	7,16	0,172	c	350017732400000072	9-42						Methods Of Use For Hsv-1 And Hsv-2 Vaccines 	.freshpatents.com	0	0		
776	chr18	25146097	25146125	3500225213	24		25146097	25146125	8421504	2	17,7	0,21	c	350022521300000020	20-44					Patent	Cortistatin: nucleic acids that encode these neuropeptides (Patent US:6074872)	Lecea	2000	0		
776	chr18	25146097	25146125	3500151767	24		25146097	25146125	8421504	2	17,7	0,21	c	350015176700000020	20-44						Cortistatin: neuropeptides	Sutcliffe	1997	0		
776	chr18	25146097	25146125	3500111557	24		25146097	25146125	8421504	2	17,7	0,21	c	350011155700000020	20-44						Cortistatin: neuropeptides, compositions and methods	De	1999	0		
776	chr18	25146097	25146125	3500091279	24		25146097	25146125	8421504	2	17,7	0,21	c	350009127900000020	20-44					Patent	Antibodies to cortistatin: neuropeptides, compositions and methods (Patent US:6814967)	Sutcliffe	2004	0		
777	chr18	25188554	25189976	3500353391	27		25188554	25189976	8421504	2	19,8	0,1414	c	350035339100000003	21-48						US Patent # 6,498,015. Methods of identifying agents that modulate the binding between MDC and an MDC receptor - Patents.com	www.patents.com	0	0		
777	chr18	25190157	25190182	3500211515	24		25190157	25190182	8421504	2	15,9	0,16	g	350021151500000031	18-42						IN VIVO CTL ELICITATION BY HEAT SHOCK PROTEIN FUSION PROTEINS MAPS TO A DISCRETE DOMAIN AND IS CD4+ T CELL-INDEPENDENT - Patent application	www.faqs.org	0	0		
779	chr18	25447780	25447805	3500442420	25		25447780	25447805	8421504	1	25	0	c	350044242000000029	0-25						Polynucleotides encoding a novel human g-protein coupled receptor splice variant, hgprbmy29sv2	Feder	2007	0		
779	chr18	25447780	25447805	3500091080	25		25447780	25447805	8421504	1	25	0	c	350009108000000029	0-25						Splice variants of human g-protein coupled receptor hgprbmy29 (hgprmby29sv2)	Feder	2012	0		
779	chr18	25491581	25491607	3500072483	23		25491581	25491607	8421504	2	9,14	0,12	g	350007248300000482	23-47						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
780	chr18	25604379	25604407	3500430470	25		25604379	25604407	8421504	2	13,12	0,16	g	350043047000000021	10-35						Production Process for Fine Chemicals Using Microorganisms with Reduced Isocitrate Dehydrogenase Activity - Patent application	www.faqs.org	0	0		
781	chr18	25740667	25745351	3500012823	40		25740667	25745351	8421504	2	20,20	0,4664	c,g	350001282300000005,350001282300000005,350001282300000004,350001282300000004	0-20,0-20,0-20,0-20		19710238	10.1152/ajprenal.00403.2009		American Journal of Physiology - Renal Physiology	Presence of cyclic nucleotide-gated channels in the rat urethra and their involvement in nerve-mediated nitrergic relaxation	Triguero	2009	0		
781	chr18	25740667	25745351	3500007445	40		25740667	25745351	8421504	2	20,20	0,4664	c,g	350000744500000005,350000744500000004,350000744500000004	0-20,0-20,0-20		19710238	10.1152/ajprenal.00403.2009		American Journal of Physiology - Renal Physiology	Presence of cyclic nucleotide-gated channels in the rat urethra and their involvement in nerve-mediated nitrergic relaxation	Triguero	2009	0		
781	chr18	25744128	25751242	3500044594	59		25744128	25751242	8421504	4	20,20,3,16	0,1192,3532,7098	c,g	350004459400000001,350004459400000001,350004459400000007,350004459400000007,350004459400000010	0-20,0-20,0-20,0-20,0-19					The Journal of Cell Biology	Cyclic Nucleotide-gated Channels on the Flagellum Control Ca2+ Entry into Sperm 	Burkhard	July	0		
781	chr18	25753792	25753820	3500178917	24		25753792	25753820	8421504	2	15,9	0,19	c	350017891700000033	13-37						 IRAP Gene As Treatment For Arthritis 	www.docstoc.com	0	0		
781	chr18	25753792	25753820	3500106407	24		25753792	25753820	8421504	2	15,9	0,19	c	350010640700000033	13-37						IRAP gene as treatment for arthritis	Glorioso	1995	0		
781	chr18	25754053	25784926	3500041679	1934		25754053	25784926	8421504	21	80,33,12,71,37,257,335,7,169,37,76,160,40,76,37,46,121,73,58,158,51	0,87,128,455,6064,6764,13387,13731,14650,20694,21916,22986,23501,23782,25351,25796,25946,26863,27245,28365,30822	p,c,g	350004167900000022,350004167900000018,350004167900015017,350004167900015016,350004167900000017,350004167900000016,350004167900015015,350004167900000015,350004167900015014,350004167900000014,350004167900000013,350004167900015022,350004167900015019,350004167900000012,350004167900000011,350004167900015012,350004167900000010,350004167900000010,350004167900015011,350004167900000009,350004167900015010,350004167900015009,350004167900000008,350004167900000008,350004167900015008,350004167900000005,350004167900015007,350004167900000004,350004167900000004,350004167900015006,350004167900000003,350004167900000003,350004167900015005,350004167900000002,350004167900000002,350004167900015004,350004167900000001,350004167900015003,350004167900000000,350004167900000000	0-125,0-105,6-51,0-99,0-103,0-105,0-75,0-105,0-105,0-105,0-105,0-138,0-135,0-90,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-80,0-80,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-105,0-105,1-165,1-165						The Amino Acid Sequence of a Glutamic Acid-Rich Protein from Bovine Retina as Deduced from the cDNA Sequence	www.jstor.org	0	0		
782	chr18	25824732	25824758	3500152492	24		25824732	25824758	8421504	2	5,19	0,7	c	350015249200000064	5-29						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
782	chr18	25898733	25899536	3500378665	40		25898733	25899536	8421504	2	20,20	0,783	c	350037866500000015,350037866500000014	0-20,0-20						Specific maternal transcripts in bovine oocytes and cleavaged embryos: Identification with novel DDRT-PCR methods	www.seegene.com	0	0		
782	chr18	25918525	25926569	3500241702	39		25918525	25926569	8421504	3	19,18,2	0,7229,8042	c,g	350024170200000027,350024170200000027,350024170200000026	0-19,0-19,0-20		12556490	10.1128/MCB.23.4.1304-1315.2003	0270-7306	Molecular and Cellular Biology	Mouse Germ Cell-Less as an Essential Component for Nuclear Integrity	Kimura	2003	6		CSNK2A2
782	chr18	25918525	25926569	3500034072	39		25918525	25926569	8421504	3	19,18,2	0,7229,8042	c	350003407200000027,350003407200000026	0-19,0-20			10.1128/MCB.23.4.1304-1315.2003		Molecular and Cellular Biology	Mouse Germ Cell-Less as an Essential Component for Nuclear Integrity	Tohru	2003	0		CSNK2A2
97	chr18	25924138	25953030	3500392945	870		25924138	25953030	8421504	11	74,149,101,6,27,84,60,51,102,112,104	0,1485,2429,3367,3830,4662,7843,16894,19758,27904,28788	p	350039294500015037,350039294500015033,350039294500015025,350039294500015022,350039294500015018	0-162,0-180,0-180,0-180,0-180						Tesi tutta word	arch.cab.unipd.it	0	0		CSNK2A2
782	chr18	25927579	25927926	3500125234	45		25927579	25927926	8421504	2	23,22	0,325	c	350012523400000009,350012523400000008	0-23,0-22						Role of polyamines in determining the cellular response to chemotherapeutic agents: modulation of protein kinase CK2 expression and activity. - ResearchGate	.researchgate.net	0	0		CSNK2A2
782	chr18	25927586	25927911	3500228885	48		25927586	25927911	8421504	2	21,27	0,298	p	350022888500015094	0-48						METHOD AND SYSTEM OF PARTICLE-PHAGE EPITOPE COMPLEX - Patent application	www.faqs.org	0	0		
783	chr18	26022866	26022891	3500203887	23		26022866	26022891	8421504	2	7,16	0,9	c	350020388700000023	25-48					Patent	G-CSF analog compositions and methods (Patent US:6632426)	Osslund	2003	0		
783	chr18	26022866	26022891	3500164039	23		26022866	26022891	8421504	2	7,16	0,9	c	350016403900000023	25-48					Patent	G-CSF analog compositions and methods (Patent US:6632426)	Osslund	2003	0		
784	chr18	26193435	26195560	3500459219	35		26193435	26195560	8421504	3	15,5,15	0,947,2110	c	350045921900000010	74-109						AVALIA&#xc7;&#xc3;O DO PAPEL FUNCIONAL DO GENE NDRG4 NA TUMORIG&#xca;NESE DE MAMA	rgo.phlnet.com.br	0	0		
785	chr18	26335464	26341563	3500115394	879		26335464	26341563	8421504	18	18,2,190,4,74,21,47,43,63,42,10,83,4,92,32,28,51,75	0,21,868,1064,1604,1681,1705,3079,3131,3391,3439,4534,4629,5533,5646,5906,5946,6024	p	350011539400015140,350011539400015136,350011539400015139	0-120,21-114,0-795						Method for identification of genes involved in specific diseases	Harris	2002	0		
785	chr18	26335471	26336345	3500251038	26		26335471	26336345	8421504	2	13,13	0,861	c	350025103800000102	0-26						Blumeria graminis f.sp. hordei	thek.uni-halle.de	0	0		
786	chr18	26356959	26356983	3500256209	24		26356959	26356983	8421504	1	24	0	c	350025620900000068	16-40						Clo&#xfb01;brate causes an upregulation of PPAR- target genes but does not alter AQ:1 expression of S REBP target genes in liver and adipose tissue of pigs	thek.uni-halle.de	0	0		PLEC
786	chr18	26362754	26362779	3500147086	25		26362754	26362779	8421504	1	25	0	g	350014708600000043	87-112						Aus der III. Medizinischen Klinik und Poliklinik der Universit&#xe4;tsmedizin der Johannes Gutenberg-Universit&#xe4;t Mainz Evaluation von Nukleotidpolymorphismen f&#xfc;r die Analyse des h&#xe4;matopoetischen Spenderchim&#xe4;rismus auf Ebene der cDNA In	m.opus.hbz-nrw.de	0	0		
786	chr18	26373421	26373451	3500429819	24		26373421	26373451	8421504	3	10,10,4	0,15,26	c	350042981900000345,350042981900000015	9-33,9-33						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
786	chr18	26374420	26374448	3500216179	24		26374420	26374448	8421504	2	10,14	0,14	g	350021617900000003	7-31						Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells	ularsignaling.com	0	0		
795	chr18	27582203	27582227	3500382628	23		27582203	27582227	8421504	2	11,12	0,12	g	350038262800000011	2-25			10.1186/1471-213X-5-19		BMC Developmental Biology	D-glucuronyl C5-epimerase acts in dorso-ventral axis formation in zebrafish	Giancarlo	2005	0		
797	chr18	27836644	27836670	3500084283	23		27836644	27836670	8421504	2	12,11	0,15	g	350008428300000010	2-26						Methods of detection using a cellulose binding domain fusion product	Shoseyov	1994	0		
797	chr18	27862674	27862702	3500338349	24		27862674	27862702	8421504	2	13,11	0,17	g	350033834900000028	0-24						Emm and Emm-like Pharyngeal Streptococcal Isolates: Results	www.medscape.com	0	0		
799	chr18	28146634	28146657	3500084824	23		28146634	28146657	8421504	1	23	0	g	350008482400000037	11-34						OVER-EXPRESSION AND MUTATION OF A TYROSINE KINASE RECEPTOR FGFR4 IN TUMORS - Patent application	www.faqs.org	0	0		
803	chr18	28613608	28613633	3500389666	24		28613608	28613633	8421504	2	20,4	0,21	g	350038966600000146	22-46						VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS - Patent application	www.faqs.org	0	0		
807	chr18	29122674	29122704	3500336865	25		29122674	29122704	8421504	3	12,8,5	0,16,25	g	350033686500000128	0-26						Stem cell inhibiting proteins	Craig	1993	0		
808	chr18	29247344	29247369	3500152160	24		29247344	29247369	8421504	2	17,7	0,18	c	350015216000000026	11-35						Short Communication A 4 Mb high resolution BAC contig on bovine chromosome 1q12 and comparative analysis with human chromosome 21q22	loads.hindawi.com	0	0		
12	chr18	29348936	29471786	3500082944	90		29348936	29471786	8421504	3	27,18,45	0,122784,122805	p	350008294400015068,350008294400015067	0-45,0-45						Cadherin-11 EC1 Domain Antagonists for Treating Inflammatory Joint Disorders - Patent application	www.faqs.org	0	0		CDH8
12	chr18	29348936	29471741	3500180112	48		29348936	29471741	8421504	2	27,21	0,122784	p	350018011200015078	0-48						HUMANIZED ANTIBODIES TARGETING THE EC1 DOMAIN OF CADHERIN-11 AND RELATED COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		CDH8
12	chr18	29348936	29471738	3500194270	45		29348936	29471738	8421504	2	27,18	0,122784	p	350019427000015080	0-45						CADHERIN-11 ANTAGONISTS AND METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISORDERS - Patent application	www.faqs.org	0	0		CDH8
810	chr18	29491935	29495744	3500030519	38		29491935	29495744	8421504	3	19,5,14	0,3789,3795	g	350003051900000239,350003051900000173	9-28,3-22						Nematode-extracted serine protease inhibitors and anticoagulant proteins - Patent application	www.faqs.org	0	0		
811	chr18	29653251	29653283	3500205953	25		29653251	29653283	8421504	3	5,6,14	0,8,18	g	350020595300000006	1-26						Methods for Producing Antibodies - Patent application	www.faqs.org	0	0		
814	chr18	30117014	30117038	3500382910	23		30117014	30117038	8421504	2	12,11	0,13	g	350038291000000134	20-48					Patent	DNA expression systems based on alphaviruses (Patent US:5739026)	Garoff	1998	0		
816	chr18	30290919	30290945	3500444851	24		30290919	30290945	8421504	2	6,18	0,8	g	350044485100000143	7-32						Methods For Rapid Identification Of Pathogens In Humans And Animals - Patent application	www.faqs.org	0	0		
816	chr18	30290919	30290945	3500413648	24		30290919	30290945	8421504	2	6,18	0,8	g	350041364800000142	7-32						Methods for rapid identification of pathogens in humans and animals	Ecker	2003	0		
816	chr18	30290919	30290945	3500280951	24		30290919	30290945	8421504	2	6,18	0,8	g	350028095100000145	7-32					Patent	Methods for rapid identification of pathogens in humans and animals (Patent US:8071309)	Blyn	2011	0		
816	chr18	30290919	30290945	3500213885	24		30290919	30290945	8421504	2	6,18	0,8	g	350021388500000145	7-32						Methods For Rapid Identification Of Pathogens In Humans And Animals	Blyn	2009	0		
820	chr18	30837644	30837670	3500197351	23		30837644	30837670	8421504	2	8,15	0,11	g	350019735100000130	0-23						STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS	Birkett	2003	0		
824	chr18	31435354	31435383	3500346087	23		31435354	31435383	8421504	3	13,4,6	0,14,23	g	350034608700000003	1-24		20482749	10.1186/1476-4598-9-109	1476-4598	Molecular Cancer	The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma	Lee	2010	4		
826	chr18	31605283	31605529	3500365527	50		31605283	31605529	8421504	2	24,26	0,220	c	350036552700000017,350036552700000016	0-24,0-26			10.1002/art.10106	1529-0131	Arthritis & Rheumatism	Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis - Stokes - 2002 - Arthritis & Rheumatism - Wiley Online Library	Stokes	2002	0		CDH11
826	chr18	31606036	31641931	3500000852	592		31606036	31641931	8421504	9	93,144,96,23,25,45,48,96,22	0,192,21877,22021,25501,27670,30871,30967,35873	p,c	350000085200015052,350000085200015101,350000085200015051,350000085200000049,350000085200015097,350000085200015047,350000085200015096,350000085200000047,350000085200000026,350000085200000025,350000085200000023,350000085200015067,350000085200000015,350000085200000013,350000085200000012,350000085200000002,350000085200000058	0-45,0-45,0-45,0-48,0-45,0-45,0-45,0-44,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-22,0-22						Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents	Brenner	2000	0		
826	chr18	31606054	31633751	3500194270	180		31606054	31633751	8421504	4	45,45,45,45	0,192,240,27652	p	350019427000015069,350019427000015065,350019427000015064,350019427000015035	0-45,0-45,0-45,0-45						CADHERIN-11 ANTAGONISTS AND METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISORDERS - Patent application	www.faqs.org	0	0		
826	chr18	31606054	31606234	3500065941	180		31606054	31606234	8421504	1	180	0	p	350006594100015010	0-180						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH11
826	chr18	31606143	31606166	3500234757	23		31606143	31606166	8421504	1	23	0	c	350023475700000044,350023475700000072	0-23,0-23						Methods of inhibiting smooth muscle cell migration and proliferation - Patent application	www.faqs.org	0	0		CDH11
826	chr18	31636907	31641925	3500330802	128		31636907	31641925	8421504	4	27,6,69,26	0,216,4790,4992	p,c	350033080200000001,350033080200015001,350033080200000000	15-42,0-75,12-38						Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods	Macarthur	2012	0		CDH11
826	chr18	31636907	31641925	3500130330	128		31636907	31641925	8421504	4	27,6,69,26	0,216,4790,4992	p,c	350013033000000001,350013033000015001,350013033000000000	15-42,0-75,12-38						HUMANIZED ANTIBODIES TARGETING THE EC1 DOMAIN OF CADHERIN-11 AND RELATED COMPOSITIONS AND METHODS - SYNOVEX CORPORATION	www.sumobrain.com	0	0		
826	chr18	31636907	31641925	3500072553	128		31636907	31641925	8421504	4	27,6,69,26	0,216,4790,4992	p,c	350007255300000001,350007255300015001,350007255300000000	15-42,0-75,12-38						Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods	Mcarthur	2013	0		
826	chr18	31637021	31641761	3500006114	40		31637021	31641761	8421504	2	20,20	0,4720	c,g	350000611400000048,350000611400000048,350000611400000047	0-20,0-20,0-20						A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT - INTERNA TECHNOLOGIES BV	www.sumobrain.com	0	0		CDH11
831	chr18	32246280	32246341	3500321684	60		32246280	32246341	8421504	2	30,30	0,31	g	350032168400000006	0-60						EVALUATION OF SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH FERTILITY AND PRODUCTION TRAITS IN HOLSTEIN AND MULTI-GENERATIONAL ANGUS FEMALES	etd.lsu.edu	0	0		
836	chr18	32977182	32977211	3500189016	24		32977182	32977211	8421504	2	7,17	0,12	g	350018901600000580	24-48						Methods of inhibiting locomotor damage following spinal cord injury with &#x03b1; D-specific antibodies	Gallatin	2000	0		
837	chr18	33047931	33047956	3500061039	25		33047931	33047956	8421504	1	25	0	g	350006103900000017	13-45						Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus - Patent application	www.faqs.org	0	0		
837	chr18	33127988	33128015	3500209413	27		33127988	33128015	8421504	1	27	0	g	350020941300000010	0-27		19878914	10.1016/j.ajhg.2009.09.019		American Journal of Human Genetics	Spinocerebellar Ataxia Type 31 Is Associated with &#x201c;Inserted&#x201d; Penta-Nucleotide Repeats Containing (TGGAA)n	Nozomu	2009	0		
838	chr18	33196746	33196770	3500337115	23		33196746	33196770	8421504	2	6,17	0,7	g	350033711500000066	7-32						 Variant Lipid Acyltransferases And Methods Of Making 	www.docstoc.com	0	0		
838	chr18	33242195	33242291	3500284360	96		33242195	33242291	8421504	1	96	0	p	350028436000015022	9-105						95 human secreted proteins	Duan	1999	0		CMTM3
839	chr18	33326576	33326603	3500466707	23		33326576	33326603	8421504	2	10,13	0,14	c	350046670700000086,350046670700000027	1-24,1-24						US Patent # 6,887,705. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPs) - Patents.com	www.patents.com	0	0		
839	chr18	33326576	33326603	3500450152	23		33326576	33326603	8421504	2	10,13	0,14	c	350045015200000027	1-24						US Patent # 6,040,437. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPS) - Patents.com	www.patents.com	0	0		
840	chr18	33457392	33457422	3500101426	25		33457392	33457422	8421504	3	6,7,12	0,7,18	g	350010142600000003	20-45						Novel Antibody Hinge Regions for Efficient Production of CH2 Domain-deleted Antibodies--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
840	chr18	33513791	33513860	3500275061	69		33513791	33513860	8421504	1	69	0	p	350027506100015001	0-69						Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells	Egerton	2000	0		RRAD
840	chr18	33513791	33513860	3500095863	69		33513791	33513860	8421504	1	69	0	p	350009586300015000	0-69					Patent	Human lymph node derived GTPase (Patent US:5965396)	Egerton	1999	0		RRAD
841	chr18	33591958	33615527	3500408086	64		33591958	33615527	8421504	4	21,5,18,20	0,49,282,23549	c,g	350040808600000020,350040808600000020,350040808600000021,350040808600000010,350040808600000010	0-21,0-21,0-23,0-20,0-20		23028375	10.1371/journal.pgen.1002982	1553-7404	PLOS Genetics	PLOS Genetics: Proteome-Wide Analysis of Disease-Associated SNPs That Show Allele-Specific Transcription Factor Binding	Butter	2012	0		CBFB
841	chr18	33591958	33615527	3500245345	64		33591958	33615527	8421504	4	21,5,18,20	0,49,282,23549	c,g	350024534500000018,350024534500000018,350024534500000019,350024534500000008,350024534500000008	0-21,0-21,0-23,0-20,0-20						Proteome-Wide Analysis of Disease-Associated SNPs That Show Allele-Specific Transcription Factor Binding - Keeping the Faith	pthefaith1296.com	0	0		CBFB
841	chr18	33591958	33615527	3500034465	64		33591958	33615527	8421504	4	21,5,18,20	0,49,282,23549	c,g	350003446500000020,350003446500000020,350003446500000021,350003446500000010,350003446500000010	0-21,0-21,0-23,0-20,0-20		23028375	10.1371/journal.pgen.1002982	1553-7404	PLOS Genetics	PLOS Genetics: Proteome-Wide Analysis of Disease-Associated SNPs That Show Allele-Specific Transcription Factor Binding	Butter	2012	0		CBFB
841	chr18	33597297	33615600	3500440968	44		33597297	33615600	8421504	3	22,1,21	0,18205,18282	c	350044096800000008,350044096800000009	0-23,0-21		20591170	10.1186/1476-4598-9-171		Molecular Cancer	The Runx transcriptional co-activator, CBF&#x03b2;, is essential for invasion of breast cancer cells	DaniMendoza-Villanueva	2010	0		CBFB
841	chr18	33637921	33637944	3500058583	23		33637921	33637944	8421504	1	23	0	c	350005858300000008	9-32			10.1186/1742-4690-10-94	1742-4690	Retrovirology	Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-&#xce;&#xb2; binding to Vif	Wang	2013	6		CBFB
841	chr18	33680491	33680516	3500375860	24		33680491	33680516	8421504	2	18,6	0,19	c	350037586000000107	16-46						Phytase polypeptides	Bech	1998	0		
841	chr18	33680491	33680516	3500005571	24		33680491	33680516	8421504	2	18,6	0,19	c	350000557100000104	16-46						Phytase polypeptides - Patent # 6569659 - PatentGenius	.patentgenius.com	0	0		TRADD
842	chr18	33690290	33690316	3500089194	25		33690290	33690316	8421504	2	20,5	0,21	c,g	350008919400000087,350008919400000087	18-45,18-45						Antibodies That Bind M. Tuberculosis Polypeptides 	.freshpatents.com	0	0		
842	chr18	33715043	33715643	3500351913	180		33715043	33715643	8421504	2	135,45	0,555	p	350035191300015011	0-180						Gene therapy methods and compositions	Oin	1995	0		
842	chr18	33715043	33715643	3500179083	180		33715043	33715643	8421504	2	135,45	0,555	p	350017908300015011	0-180						Gene therapy methods and compositions	www.devileye.net	0	0		
842	chr18	33715073	33715850	3500368155	216		33715073	33715850	8421504	3	105,110,1	0,525,776	p	350036815500015002	0-216						Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression	Andrews	2001	0		
842	chr18	33715073	33715661	3500051964	168		33715073	33715661	8421504	2	105,63	0,525	p	350005196400015002	0-168						Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression	Andrews	2005	0		
842	chr18	33715124	33715694	3500352503	135		33715124	33715694	8421504	3	54,30,51	0,474,519	p	350035250300015017,350035250300015016	0-135,0-135						E2F AS A TARGET OF HORMONE REFRACTORY PROSTATE CANCER	Bertino	2011	0		E2F5
842	chr18	33715169	33715685	3500102409	93		33715169	33715685	8421504	3	9,39,45	0,429,471	p	350010240900015114,350010240900015115	0-48,0-45						Methods and compositions for regulating gene expression in plant cells - US Patent 7517689 Description	ww.patentstorm.us	0	0		E2F4
842	chr18	33720781	33720804	3500205755	23		33720781	33720804	8421504	1	23	0	c	350020575500000002	22-45		15867358	10.1158/0008-5472.CAN-04-3129	0008-5472	Cancer Research	Disruption of Rb/E2F Pathway Results in Increased Cyclooxygenase-2 Expression and Activity in Prostate Epithelial Cells	Davis	2005	8		
843	chr18	33932109	33935558	3500242108	24		33932109	33935558	8421504	2	2,22	0,3427	c	350024210800000000	0-24			10.1152/ajpendo.00396.2005		American Journal of Physiology - Endocrinology and Metabolism	11&#x03b2;-Hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites	Garbrecht	2006	0		
843	chr18	33936867	33936981	3500156044	40		33936867	33936981	8421504	2	20,20	0,94	c,g	350015604400000004,350015604400000004,350015604400000005,350015604400000005	0-20,0-20,0-20,0-20						The role of glucocorticoid in the regulation of prostaglandin biosynthesis in non-pregnant bovine endometrium	logy-journals.org	0	0		
105	chr18	33937916	33977234	3500153911	1311		33937916	33977234	8421504	33	47,15,43,54,16,54,25,93,212,73,6,8,13,54,20,19,45,39,12,40,20,2,3,4,26,22,72,38,52,5,26,73,80	0,50,70,116,172,190,249,276,372,683,758,892,901,916,972,994,1014,1232,4580,4595,4636,4658,6056,6060,6065,6213,14319,14393,14432,21346,39135,39163,39238	p,c,g	350015391100000010,350015391100000009,350015391100015011,350015391100000008,350015391100000008,350015391100000007,350015391100000006,350015391100000006,350015391100000000,350015391100000005,350015391100000005,350015391100015008,350015391100000003,350015391100000002,350015391100015005,350015391100000001	0-315,0-97,0-99,0-96,0-96,0-97,0-95,0-95,0-25,0-95,0-95,0-51,0-95,0-78,54-105,1-296						Cloning of cDNA encoding a 32-kDa protein. An accessory polypeptide of the H+-ATPase from chromaffin granules. - ResearchGate	.researchgate.net	0	0		
844	chr18	33978157	33978502	3500315071	40		33978157	33978502	8421504	2	20,20	0,325	c,g	350031507100000001,350031507100000000,350031507100000000	0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
844	chr18	34061368	34061901	3500329982	40		34061368	34061901	8421504	2	20,20	0,513	c,g	350032998200000002,350032998200000002,350032998200000003,350032998200000003	0-20,0-20,0-20,0-20			10.1590/S1415-47572007000600029	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Expression of the CTCF gene in bovine oocytes and preimplantation embryos	Rios	2007	1		CTCF
844	chr18	34062440	34074259	3500137388	78		34062440	34074259	8421504	4	30,24,10,14	0,5557,6328,11805	p	350013738800015004	18-234						Review TRENDS in Genetics Vol.17 No.9 September 2001 CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease	273a.stanford.edu	0	0		CTCF
845	chr18	34080397	34080445	3500267784	48		34080397	34080445	8421504	1	48	0	p	350026778400015004	0-48						NPG.nature.vol.405.Issue.6785.May	www.scribd.com	0	0		CTCF
845	chr18	34108319	34108343	3500279808	24		34108319	34108343	8421504	1	24	0	c	350027980800000005	7-31						Proteome identification of binding-partners interacting with cell polarity protein Par3 in Jurkat cells	www.abbs.info	0	0		PARD6A
845	chr18	34108762	34108913	3500411523	41		34108762	34108913	8421504	2	20,21	0,130	c	350041152300000033,350041152300000034	0-20,0-21						DNACytosineMethylationintheBovineLeukemiaVirus PromoterIsAssociatedwithLatencyinaLymphoma-derived B-cellLine	www.jbc.org	0	0		
845	chr18	34127614	34127639	3500383472	23		34127614	34127639	8421504	3	12,7,4	0,13,21	g	350038347200000021	0-25						Detection of Herpes Simplex Virus - Patent application	www.faqs.org	0	0		
846	chr18	34243182	34243452	3500309883	270		34243182	34243452	8421504	1	270	0	p	350030988300015033	0-270						THAP1, UN REGULATEUR CLE DE LA PROLIFERATION DES CELLULES ENDOTHELIALES : RELATIONS STRUCTURE/FONCTION ET GENES CIBLES	esups.ups-tlse.fr	0	0		THAP11
846	chr18	34258215	34258240	3500346002	23		34258215	34258240	8421504	2	13,10	0,15	g	350034600200000002	0-23		21965393	10.1128/AEM.05830-11	0099-2240	Applied and Environmental Microbiology	Cotransmission of Divergent Relapsing Fever Spirochetes by Artificially Infected Ornithodoros hermsi	Policastro	2011	4		
846	chr18	34278292	34278317	3500037971	24		34278292	34278317	8421504	2	20,4	0,21	g	350003797100000129	0-30						Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor - Patent application	www.faqs.org	0	0		
846	chr18	34291752	34291932	3500288106	180		34291752	34291932	8421504	1	180	0	p	350028810600015023,350028810600015032,350028810600015041	0-180,0-72,0-84						Duke : SCIENCE 111 : complete notes on Bioinformatics	ww.coursehero.com	0	0		PSKH1
846	chr18	34291752	34291932	3500204284	180		34291752	34291932	8421504	1	180	0	p	350020428400015031,350020428400015022,350020428400015040	0-72,0-180,0-84						17727 Complete Notes on tics	www.scribd.com	0	0		PSKH1
846	chr18	34291752	34291932	3500185699	180		34291752	34291932	8421504	1	180	0	p	350018569900015023,350018569900015033,350018569900015043	0-180,0-72,0-84						Introduction to Bioinformatics	www.koshika.co.in	0	0		PSKH1
846	chr18	34320334	34320361	3500289584	27		34320334	34320361	8421504	1	27	0	c	350028958400000199	0-27					Patent	CNS chloride modulation and uses thereof (Patent CN:100581621)	J*A*M*Ku Er 	2010	0		
846	chr18	34323693	34329541	3500271050	143		34323693	34329541	8421504	3	48,47,48	0,3577,5800	c	350027105000000282,350027105000000265,350027105000000260	0-48,0-47,0-48						Cloning by complementation and related processes	Colicelli	1991	0		
105	chr18	34442187	34481559	3500153655	1432		34442187	34481559	8421504	16	48,48,191,48,126,89,163,126,48,97,141,56,127,34,42,48	0,192,288,480,585,1029,2858,20131,26496,26565,29298,31942,33090,38860,39228,39324	p,c	350015365500000170,350015365500000174,350015365500000176,350015365500015029,350015365500000177,350015365500000179,350015365500000180,350015365500015031,350015365500000183,350015365500015037,350015365500000192,350015365500000193,350015365500015007,350015365500000194,350015365500000195,350015365500015011,350015365500000198,350015365500000201,350015365500015019,350015365500000205,350015365500015023,350015365500000206,350015365500000207,350015365500000208,350015365500015027,350015365500000209,350015365500000256,350015365500000311,350015365500000313	0-48,0-48,0-48,0-123,0-47,0-47,0-48,0-126,1-48,0-72,0-48,0-48,0-150,0-48,0-48,0-147,0-48,0-48,0-150,0-48,0-150,0-47,0-48,0-48,0-123,0-48,0-44,0-42,0-48						Nuclear factors and binding assay	Hoey	1995	0		ESRP2,NFATC3
847	chr18	34442835	34442952	3500411148	117		34442835	34442952	8421504	1	117	0	p	350041114800015007	0-117						transcription with calcineurin Interaction NFAT1	www.pnas.org	0	0		NFATC3
847	chr18	34443120	34443180	3500206983	60		34443120	34443180	8421504	1	60	0	p	350020698300015005	0-60		21474694	10.1152/japplphysiol.01383.2010	8750-7587	Journal of Applied Physiology	Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes	Lunde	2011	4		
847	chr18	34443234	34443279	3500274666	45		34443234	34443279	8421504	1	45	0	p	350027466600015004	0-45						CALCINEURIN INHIBITORS FOR USE IN THE TREATMENT OF LESIONAL VESTIBULAR DISORDERS - INSERM (INSTITUT NATIONAL DE LA SANT&#xc9; ET DE LA RECHERCHE M&#xc9;DICALE)	www.sumobrain.com	0	0		NFATC3
847	chr18	34445133	34445157	3500128842	24		34445133	34445157	8421504	1	24	0	c	350012884200000008	0-24						&#x718a;&#x672c;&#x5927;&#x5b66;&#x5b66;&#x8853;&#x30ea;&#x30dd;&#x30b8;&#x30c8;&#x30ea; Kumamoto University Repository System	.kumamoto-u.ac.jp	0	0		
848	chr18	34481051	34481074	3500215215	23		34481051	34481074	8421504	1	23	0	c	350021521500000201	0-23						Arrays and Methods for Reverse Genetic Functional Analysis - Patent application	www.faqs.org	0	0		
848	chr18	34481542	34481667	3500394704	40		34481542	34481667	8421504	2	20,20	0,105	c	350039470400000026,350039470400000027	0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
848	chr18	34481542	34481667	3500292483	40		34481542	34481667	8421504	2	20,20	0,105	c	350029248300000026,350029248300000027	0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
848	chr18	34557104	34559467	3500268145	126		34557104	34559467	8421504	2	77,49	0,2314	p	350026814500015056	480-606						Departament de BioquAmica i Biologia Molecular Facultat de Biologia Universitat de Barcelona aTr	www.tdx.cat	0	0		SLC7A6
848	chr18	34564922	34564952	3500434989	25		34564922	34564952	8421504	3	6,8,11	0,8,19	c	350043498900000171,350043498900000065	7-32,7-32						METHOD FOR MODIFYING CHROMOSOMES - Patent application	www.faqs.org	0	0		
848	chr18	34564922	34564952	3500386234	25		34564922	34564952	8421504	3	6,8,11	0,8,19	c	350038623400000065	7-32						Method for modifying chromosomes	Hanaoka	2009	0		
848	chr18	34564922	34564952	3500286897	25		34564922	34564952	8421504	3	6,8,11	0,8,19	c	350028689700000134,350028689700000063	7-32,7-32						Isolation of a rearranged human immunoglobulin gene from a chimeric mouse and recombinant production of the encoded immunoglobulin - Patent application	www.faqs.org	0	0		
848	chr18	34564922	34564952	3500259849	25		34564922	34564952	8421504	3	6,8,11	0,8,19	c	350025984900000065	7-32					Patent	Method for modifying chromosomes (Patent US:7371568)	Hanaoka	2008	0		
848	chr18	34564922	34564952	3500247665	25		34564922	34564952	8421504	3	6,8,11	0,8,19	c	350024766500000065	7-32					Patent	Method for modifying chromosomes (Patent US:8124406)	Hanaoka	2012	0		
848	chr18	34564922	34564952	3500137487	25		34564922	34564952	8421504	3	6,8,11	0,8,19	c	350013748700000171,350013748700000065	7-32,7-32						METHOD FOR MODIFYING CHROMOSOMES - Patent application	www.faqs.org	0	0		
848	chr18	34564922	34564952	3500085878	25		34564922	34564952	8421504	3	6,8,11	0,8,19	c	350008587800000065	7-32						Method for modifying chromosomes	Hanaoka	2011	0		
849	chr18	34608361	34609622	3500292734	75		34608361	34609622	8421504	2	1,74	0,1187	p	350029273400015000	141-216						29 human secreted proteins	Komatsoulis	2001	0		PRMT7
849	chr18	34608361	34609622	3500265377	75		34608361	34609622	8421504	2	1,74	0,1187	p	350026537700015000	141-216						29 human secreted proteins	Komatsoulis	2002	0		PRMT7
850	chr18	34769755	34769781	3500344774	23		34769755	34769781	8421504	2	7,16	0,10	g	350034477400000022	1-24						NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 193P1E1B USEFUL IN TREATMENT AND DETECTION OF CANCER - Patent application	www.faqs.org	0	0		
851	chr18	34890305	34906732	3500305210	194		34890305	34906732	8421504	6	29,32,45,46,31,11	0,277,1510,3242,16382,16416	c	350030521000000017,350030521000000021,350030521000000025,350030521000000030,350030521000000059	0-29,0-32,3-48,0-46,0-45						METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-CDH3 ANTIBODIES - Patent application	www.faqs.org	0	0		
851	chr18	34890308	34906732	3500428283	323		34890308	34906732	8421504	11	26,48,17,26,43,33,21,26,44,28,11	0,48,97,199,3242,5703,13102,13488,13567,16382,16413	c	350042828300000021,350042828300000022,350042828300000023,350042828300000034,350042828300000043,350042828300000056,350042828300000058,350042828300000063	0-26,0-48,1-44,0-43,15-48,0-47,4-48,0-42						HIGHLY EFFECTIVE ANTI-CADHERIN ANTIBODY FOR INDUCTION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN VIVO - Patent application	www.faqs.org	0	0		
851	chr18	34890308	34903919	3500154332	70		34890308	34903919	8421504	2	26,44	0,13567	c	350015433200000021,350015433200000058	0-26,4-48						HIGHLY EFFECTIVE ANTI-CADHERIN ANTIBODY FOR INDUCTION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN VIVO - Patent application	www.faqs.org	0	0		
851	chr18	34890579	34890604	3500448386	25		34890579	34890604	8421504	1	25	0	c	350044838600000011	0-25						P-cadherin as a target for anti-cancer therapy	Reinhard	2002	0		
851	chr18	34890579	34890604	3500439989	25		34890579	34890604	8421504	1	25	0	c	350043998900000010	0-25						P-cadherin as a target for anti-cancer therapy	Reinhard	2005	0		
851	chr18	34903850	34906609	3500065941	180		34903850	34906609	8421504	2	93,87	0,2672	p	350006594100015001	0-180						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH3
106	chr18	34938669	35009605	3500265059	2647		34938669	35009605	8421504	19	32,15,115,224,144,156,145,176,129,183,245,146,225,157,6,65,131,144,209	0,33,1006,49323,54305,54575,55673,57403,57853,59150,60950,64374,66743,67290,67448,67456,68175,69006,70727	c	350026505900000045	0-2648						CELL CULTURE - Patent application	www.faqs.org	0	0		
851	chr18	34988170	34993248	3500181711	44		34988170	34993248	8421504	3	22,18,4	0,4930,5074	c,g	350018171100000032,350018171100000032,350018171100000033	0-22,0-22,0-22						REPRODUCTION	uction-online.org	0	0		
851	chr18	34993049	34993082	3500448386	33		34993049	34993082	8421504	1	33	0	c	350044838600000031	0-33						P-cadherin as a target for anti-cancer therapy	Reinhard	2002	0		CDH1
851	chr18	34993049	34993082	3500439989	33		34993049	34993082	8421504	1	33	0	c	350043998900000034	0-33						P-cadherin as a target for anti-cancer therapy	Reinhard	2005	0		CDH1
851	chr18	34994354	34994415	3500269671	58		34994354	34994415	8421504	3	21,17,20	0,22,41	c,g	350026967100000015,350026967100000016,350026967100000016	0-38,0-20,0-20						Microarray analysis in caudal medulla of cattle orally challenged with bovine spongiform encephalopathy	w.funpecrp.com.br	0	0		
851	chr18	34994455	34996183	3500206937	41		34994455	34996183	8421504	2	21,20	0,1708	c,g	350020693700000018,350020693700000019,350020693700000019	0-21,0-20,0-20						terms and conditions of use	.era.lib.ed.ac.uk	0	0		
852	chr18	34997905	34998000	3500337770	50		34997905	34998000	8421504	2	26,24	0,71	c	350033777000000006,350033777000000007	0-26,0-24						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
852	chr18	34999619	34999649	3500387007	30		34999619	34999649	8421504	1	30	0	c	350038700700000014	0-30						Changes in C-terminal Binding Protein 2 (CtBP2) Corepressor Complex Induced by E1A and Modulation of E1A Transcriptional Activity by CtBP2--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&	journal.9med.net	0	0		CDH1
852	chr18	34999727	35003053	3500319127	43		34999727	35003053	8421504	3	22,11,10	0,126,3316	c	350031912700000040,350031912700000041	0-22,0-21						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
852	chr18	34999840	35003069	3500041905	50		34999840	35003069	8421504	2	24,26	0,3203	c	350004190500000000	100-150						Regulation of local expression of cell adhesion and motility-related mRNAs in breast cancer cells by IMP1/ ZBP1	w.einstein.yu.edu	0	0		
853	chr18	35216745	35219791	3500167277	40		35216745	35219791	8421504	3	19,11,10	0,172,3036	c	350016727700000010,350016727700000011	0-19,0-21		23922913	10.1371/journal.pone.0070077	1932-6203	PLOS ONE	PLOS ONE: Lysine-Specific Demethylase 1 (LSD1/KDM1A) Contributes to Colorectal Tumorigenesis via Activation of the Wnt/&#x0392;-Catenin Pathway by Down-Regulating Dickkopf-1 (DKK1)	Huang	2013	4		HAS3
853	chr18	35216745	35219791	3500004969	40		35216745	35219791	8421504	3	19,11,10	0,172,3036	c,g	350000496900000010,350000496900000010,350000496900000011	0-19,0-19,0-21						Kaul et al Manuscript	www.jbc.org	0	0		HAS3
853	chr18	35216920	35219873	3500176195	48		35216920	35219873	8421504	3	8,21,19	0,2861,2934	c	350017619500000014,350017619500000009	0-29,0-19						Graves&#x2019; ophthalmopathy: a comprehensive role for platelet-derived growth factors a comprehensive role for platelet-derived growth factors	repub.eur.nl	0	0		HAS3
853	chr18	35221137	35221161	3500080452	24		35221137	35221161	8421504	1	24	0	c	350008045200000011	0-24						Rheological and biological properties of a hydrogel support for cells intended for intervertebral disc repair	biomedcentral.com	0	0		HAS3
853	chr18	35221223	35221408	3500279686	40		35221223	35221408	8421504	2	20,20	0,165	c,g	350027968600000006,350027968600000006,350027968600000028,350027968600000028,350027968600000007,350027968600000029	0-19,0-19,0-20,0-20,0-20,0-20						METHODS OF TREATING THYROID EYE DISEASE - Patent application	www.faqs.org	0	0		HAS3
854	chr18	35280859	35280884	3500419884	25		35280859	35280884	8421504	1	25	0	g	350041988400000099,350041988400000090	17-42,16-40						Trehalose Metabolismus in (Hyper-) thermophilen Archaea	duisburg-essen.de	0	0		
854	chr18	35384319	35385254	3500045291	95		35384319	35385254	8421504	5	23,26,23,17,6	0,269,316,461,929	c,g	350004529100000007,350004529100000003,350004529100000005,350004529100000006,350004529100000006,350004529100000004	0-23,0-23,0-23,0-23,0-23,0-23		19864690	10.1074/jbc.M109.038026	0021-9258	Journal of Biological Chemistry	In Vivo Stoichiometry of Shelterin Components	Takai	2010	5		TERF2
854	chr18	35384588	35385254	3500394708	72		35384588	35385254	8421504	4	26,23,17,6	0,47,192,660	c	350039470800000002,350039470800000004,350039470800000005,350039470800000003	0-23,0-23,0-23,0-23						InVivo StoichiometryofShelterinComponents S	b.rockefeller.edu	0	0		TERF2
854	chr18	35384644	35385281	3500387928	183		35384644	35385281	8421504	3	96,54,33	0,99,604	p	350038792800015007,350038792800015008	12-195,0-45						THESE PRESENTEE A L UNIVERSITE D ORLEANS POUR OBTENIR LE GRADE DE DOCTEUR DE L UNIVERSITE D ORLEANS	hives-ouvertes.fr	0	0		TERF2
856	chr18	35631607	35631707	3500187025	42		35631607	35631707	8421504	2	21,21	0,79	g	350018702500000000,350018702500000001	0-21,0-21		20492652	10.1186/ar3031	1478-6354	Arthritis Research & Therapy	Physiological tonicity improves human chondrogenic marker expression through nuclear factor of activated T-cells 5 in vitro	Windt	2010	4		NFAT5
857	chr18	35672754	35672777	3500428793	23		35672754	35672777	8421504	1	23	0	g	350042879300000008	0-23						CELL	www.scribd.com	0	0		NFAT5
857	chr18	35677660	35677690	3500413907	25		35677660	35677690	8421504	2	13,12	0,18	g	350041390700000265	0-25						 Alvac Canarypox Virus Recombinants Comprising Heterlogous Inserts 	www.docstoc.com	0	0		
857	chr18	35677660	35677690	3500235948	25		35677660	35677690	8421504	2	13,12	0,18	g	350023594800000265	0-25						Alvac canarypox virus recombinants comprising heterlogous inserts	Paoletti	1995	0		
857	chr18	35683759	35683915	3500010002	48		35683759	35683915	8421504	2	24,24	0,132	c	350001000200000006,350001000200000005	0-24,0-24						Ras$GTPase)activating)likeprotein( IQGAP1) mediates$Nrf2$activation$ viaMEK)ERK$pathway$	www.jbc.org	0	0		
857	chr18	35687953	35687977	3500411693	24		35687953	35687977	8421504	1	24	0	c	350041169300000005	0-24						The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. - ResearchGate	.researchgate.net	0	0		NQO1
857	chr18	35688045	35688178	3500446330	25		35688045	35688178	8421504	2	12,13	0,120	c	350044633000000032,350044633000000027	21-46,0-25						Pim de Waard	arno.unimaas.nl	0	0		NQO1
857	chr18	35688045	35688178	3500421411	25		35688045	35688178	8421504	2	12,13	0,120	c	350042141100000023	21-46						Hypoxia, oxidative stress, and benzo[a]pyrene induced carcinogenesis	arno.unimaas.nl	0	0		NQO1
857	chr18	35720391	35720421	3500073146	23		35720391	35720421	8421504	3	6,11,6	0,9,24	c	350007314600000047	20-44						S-ADENOSYL-L-METHIONINE SYNTHETASE PROMOTER AND ITS USE IN EXPRESSION OF TRANSGENIC GENES IN PLANTS - Patent application	www.faqs.org	0	0		
857	chr18	35727439	35727467	3500063695	24		35727439	35727467	8421504	3	5,6,13	0,8,15	c	350006369500000290	10-37						G protein-coupled receptor-like receptors and modulators thereof - US Patent 7208591 Description	ww.patentstorm.us	0	0		
858	chr18	35857000	35857523	3500334583	100		35857000	35857523	8421504	2	6,94	0,429	c,g	350033458300000000,350033458300000001,350033458300000001	0-100,0-22,0-22						Mirnas in joint disease	Bartnik	2012	0		
858	chr18	35857000	35857523	3500320200	100		35857000	35857523	8421504	2	6,94	0,429	c,g	350032020000000003,350032020000000001,350032020000000001,350032020000000002,350032020000000002,350032020000000011,350032020000000011,350032020000000012,350032020000000012,350032020000000005,350032020000000005	0-100,0-22,0-22,0-21,0-21,0-22,0-22,0-19,0-19,0-19,0-19						miRNAS AS THERAPEUTIC TARGETS IN CANCER - Patent application	www.faqs.org	0	0		
858	chr18	35857000	35857523	3500311464	100		35857000	35857523	8421504	2	6,94	0,429	c,g	350031146400000003,350031146400000001,350031146400000001,350031146400000002,350031146400000002,350031146400000005	0-100,0-22,0-22,0-21,0-21,0-19						Mirnas as therapeutic targets in cancer	Ju	2010	0		
858	chr18	35857444	35857514	3500362752	54		35857444	35857514	8421504	2	23,31	0,39	c,g	350036275200000003,350036275200000002,350036275200000001,350036275200000001,350036275200000000,350036275200000045,350036275200000044,350036275200000047,350036275200000046	6-29,7-30,6-29,6-29,6-29,75-106,26-57,99-130,26-57						Method for inhibiting function of micro-rna	Iba	2011	0		
858	chr18	35857445	35857507	3500211052	44		35857445	35857507	8421504	2	22,22	0,40	c,g	350021105200000004,350021105200000004,350021105200000005	0-22,0-22,0-22		20466812	10.1101/gad.1915510	0890-9369	Genes & Development	MicroRNA-140 plays dual roles in both cartilage development and homeostasis	Miyaki	2010	12		WWP2
858	chr18	35857445	35857505	3500439152	43		35857445	35857505	8421504	2	22,21	0,39	c,g	350043915200000264,350043915200000264,350043915200000176,350043915200000176	0-22,0-22,0-21,0-21						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		WWP2
858	chr18	35857446	35857507	3500125321	44		35857446	35857507	8421504	2	21,23	0,38	c,g	350012532100000060,350012532100000060,350012532100000068,350012532100000068	0-21,0-21,0-23,0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		WWP2
858	chr18	35857446	35857506	3500400478	43		35857446	35857506	8421504	2	21,22	0,38	c,g	350040047800000171,350040047800000171,350040047800000202,350040047800000202	0-21,0-21,0-22,0-22					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		WWP2
858	chr18	35857446	35857506	3500357539	43		35857446	35857506	8421504	2	21,22	0,38	c,g	350035753900000171,350035753900000171,350035753900000202,350035753900000202	0-21,0-21,0-22,0-22					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		WWP2
858	chr18	35857446	35857506	3500210973	43		35857446	35857506	8421504	2	21,22	0,38	c,g	350021097300000171,350021097300000202,350021097300000202	0-21,0-22,0-22						Microrna molecules	Tuschl	2002	0		WWP2
858	chr18	35866175	35866204	3500040785	29		35866175	35866204	8421504	1	29	0	c	350004078500000039,350004078500000159	13-42,13-42						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		
863	chr18	36442175	36442201	3500279130	24		36442175	36442201	8421504	2	8,16	0,10	g	350027913000000053,350027913000000026	7-31,7-31						MULTIPLE MUTATION VARIANTS OF SERINE PROTEASE - Patent application	www.faqs.org	0	0		
864	chr18	36646803	36646831	3500235981	23		36646803	36646831	8421504	2	8,15	0,13	g	350023598100000001	0-23		18703516	10.1074/jbc.M806045200		The Journal of Biological Chemistry	CDK Inhibitor p21 Is Degraded by a Proliferating Cell Nuclear Antigen-coupled Cul4-DDB1Cdt2 Pathway during S Phase and after UV Irradiation	Hideo	2008	0		
871	chr18	37528913	37528938	3500276092	23		37528913	37528938	8421504	2	10,13	0,12	g	350027609200000071,350027609200000104	1-25,2-26						Antibodies to CD40	Bedian	2009	0		
874	chr18	37882426	37882461	3500059673	33		37882426	37882461	8421504	3	14,6,13	0,15,22	g	350005967300000020	41-74			10.1111/j.1365-2958.2004.04401.x	1365-2958	Molecular Microbiology	PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance - Prill - 2004 - Molecular Microbiology - Wiley Online Library	Prill	2005	0		
874	chr18	38007734	38007835	3500261436	40		38007734	38007835	8421504	2	20,20	0,81	c,g	350026143600000058,350026143600000058,350026143600000057,350026143600000057	0-20,0-20,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
874	chr18	38007806	38007831	3500350516	25		38007806	38007831	8421504	1	25	0	c,g	350035051600000001,350035051600000001	0-25,0-25		19094922	10.1051/vetres:2008055	0928-4249	Veterinary Research	Neutrophils as one of the major haptoglobin sources in mastitis affected milk | Vet. Res.	Lai	2008	4		
874	chr18	38007827	38007927	3500172791	43		38007827	38007927	8421504	2	24,19	0,81	c,g	350017279100000001,350017279100000000,350017279100000000	0-24,0-19,0-19		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
874	chr18	38007827	38007927	3500120290	43		38007827	38007927	8421504	2	24,19	0,81	c,g	350012029000000001,350012029000000000,350012029000000000	0-24,0-19,0-19						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
874	chr18	38007827	38007927	3500048191	43		38007827	38007927	8421504	2	24,19	0,81	c,g	350004819100000001,350004819100000000,350004819100000000	0-24,0-19,0-19		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
874	chr18	38008264	38008491	3500244812	67		38008264	38008491	8421504	3	21,23,23	0,53,204	c	350024481200000003,350024481200000001,350024481200000000	0-21,0-23,0-23						Qualitative detection of haptoglobin mRNA in bovine and human blood leukocytes and bovine milk somatic cells	vri.cz/docs/vetme	0	0		
874	chr18	38008264	38008491	3500110092	44		38008264	38008491	8421504	2	21,23	0,204	c	350011009200000003,350011009200000000	0-21,0-23						Qualitative detection of haptoglobin mRNA in bovine and human blood leukocytes and bovine milk somatic cells	ulturejournals.cz	0	0		HP
874	chr18	38008308	38008493	3500383646	40		38008308	38008493	8421504	2	20,20	0,165	c,g	350038364600000025,350038364600000025,350038364600000024	0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
876	chr18	38202002	38202030	3500018362	23		38202002	38202030	8421504	2	8,15	0,13	c	350001836200000004	0-23						METHOD FOR THE DIAGNOSIS OF THE PRESENCE OF AN OVARIAN CANCER	Leu	2011	0		
876	chr18	38202002	38202030	3500005486	23		38202002	38202030	8421504	2	8,15	0,13	c	350000548600000004,350000548600000013	0-23,0-23						Antigen polypeptide for the diagnosis and/or treatment of ovarian cancer - Patent # 7928188 - PatentGenius	.patentgenius.com	0	0		ZNF821
876	chr18	38208150	38208252	3500416436	54		38208150	38208252	8421504	2	31,23	0,79	c	350041643600000011,350041643600000018,350041643600000017	1-26,0-22,0-23						RTICLE Journal of	load.bioon.com.cn	0	0		
876	chr18	38208150	38208190	3500417948	40		38208150	38208190	8421504	1	40	0	c	350041794800000004	0-40						Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases	-publications.com	0	0		
876	chr18	38208150	38208190	3500213595	40		38208150	38208190	8421504	1	40	0	c	350021359500000089	0-40						EXPRESSION OF MIRNAS IN PLACENTAL TISSUE - UNIVERSITY OF BREMEN	www.sumobrain.com	0	0		
876	chr18	38208150	38208177	3500192580	27		38208150	38208177	8421504	1	27	0	c	350019258000000002	1-28						Developmental Cell Article	tsouthwestern.edu	0	0		
876	chr18	38208150	38208177	3500020669	27		38208150	38208177	8421504	1	27	0	c	350002066900000008	24-51						microRNA-21 ORCHESTRATES HIGH GLUCOSE-INDUCED SIGNALS TO TORC1 FOR RENAL CELL PATHOLOGY IN DIABETES	www.jbc.org	0	0		
876	chr18	38208150	38208177	3500009788	27		38208150	38208177	8421504	1	27	0	c	350000978800000001	1-28						ScienceDirect.com - Developmental Cell - A Family of microRNAs Encoded by Myosin Genes Governs Myosin Expression and Muscle Performance	sciencedirect.com	0	0		
876	chr18	38208151	38208176	3500453153	25		38208151	38208176	8421504	1	25	0	c	350045315300000013	21-46						MicroRNAs regulate human hepatocyte nuclear factor 4 modulating the expression of metabolic enzymes and cell cycle	www.jbc.org	0	0		
876	chr18	38208153	38208255	3500419612	61		38208153	38208255	8421504	2	36,25	0,77	c	350041961200000003,350041961200000009,350041961200000008	0-22,0-24,0-25		21507966	10.1128/JVI.02401-10		Journal of Virology	The SUMOylation of Matrix Protein M1 Modulates the Assembly and Morphogenesis of Influenza A Virus	Chung-Yi	July	0		
876	chr18	38208153	38208250	3500404251	46		38208153	38208250	8421504	2	23,23	0,74	c	350040425100000006,350040425100000005	0-23,0-23		22446874	10.1158/1541-7786.MCR-11-0473	1541-7786	Molecular Cancer Research	Downregulation of Human Farnesoid X Receptor by miR-421 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells	Zhang	2012	4		
876	chr18	38208153	38208250	3500330723	74		38208153	38208250	8421504	3	23,28,23	0,30,74	c	350033072300000007,350033072300000003,350033072300000006	0-23,0-28,0-23		16982751	10.1158/0008-5472.CAN-06-1403	0008-5472	Cancer Research	MicroRNA Regulates the Expression of Human Cytochrome P450 1B1	Tsuchiya	2006	8		
876	chr18	38208153	38208250	3500226450	46		38208153	38208250	8421504	2	23,23	0,74	c	350022645000000006,350022645000000005	0-23,0-23		22446874	10.1158/1541-7786.MCR-11-0473	1541-7786	Molecular Cancer Research	Downregulation of Human Farnesoid X Receptor by miR-421 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells	Zhang	2012	4		
876	chr18	38208153	38208176	3500407626	23		38208153	38208176	8421504	1	23	0	c	350040762600000012	0-23		20931557	10.1002/hep.23908	1527-3350	Hepatology	Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti&#x2013;hepatitis C virus microrna cluster - Yang - 2010 - Hepatology - Wiley Online Library	Yang	2010	0		TRMT5
876	chr18	38208153	38208176	3500393066	23		38208153	38208176	8421504	1	23	0	c	350039306600000011	0-23						Gene Therapy	005.pasteur.ac.ir	0	0		TRMT5
876	chr18	38208153	38208176	3500187052	23		38208153	38208176	8421504	1	23	0	c	350018705200000018	0-23						www.stemcell8.cn &#x2190;&#x70b9;&#x51fb;&#x8fdb;&#x5165;	www.bjcancer.org	0	0		TMEM222
876	chr18	38208153	38208176	3500026722	23		38208153	38208176	8421504	1	23	0	c	350002672200000013	0-23						NUCLEIC ACIDS FOR TARGETING MULTIPLE REGIONS OF THE HCV GENOME - THE CHILDREN'S HOSPITAL OF PHILADELPHIA	www.sumobrain.com	0	0		TMEM222
876	chr18	38208158	38208252	3500328971	40		38208158	38208252	8421504	2	20,20	0,74	c	350032897100000007,350032897100000006	0-20,0-20		23013439	10.1111/febs.12013	1742-4658	FEBS Journal	Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth - He - 2012 - FEBS Journal - Wiley Online Library	He	2012	0		
876	chr18	38208158	38208234	3500297711	45		38208158	38208234	8421504	2	20,25	0,51	c	350029771100000029,350029771100000030	0-20,0-25						MicroRNA let 7 Regulates 3T3-L1 Adipogenesis	.endojournals.org	0	0		
876	chr18	38208158	38208193	3500117689	35		38208158	38208193	8421504	1	35	0	c	350011768900000010	0-35			10.1002/jgm.860	1521-2254	The Journal of Gene Medicine	Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain - M&#xe4;kinen - 2006 - The Journal of Gene Medicine - Wiley Online Library	Makinen	2006	0		TRMT5
876	chr18	38208160	38208250	3500284449	44		38208160	38208250	8421504	2	22,22	0,68	c	350028444900000010,350028444900000009	0-22,0-22		19133651	10.1002/hep.22757	1527-3350	Hepatology	MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma - Li - 2008 - Hepatology - Wiley Online Library	Li	2009	0		
876	chr18	38208160	38208250	3500105686	44		38208160	38208250	8421504	2	22,22	0,68	c	350010568600000004,350010568600000003	0-22,0-22						miR-183&#x5728;&#x809d;&#x764c;&#x7ec6;&#x80de;&#x4e2d;&#x7684;&#x529f;&#x80fd;&#x53ca;&#x4eba;&#x5de5;miRNA&#x7c07;&#x8868;&#x8fbe;&#x8f7d;&#x4f53;&#x7684;&#x6784;&#x5efa;&#x7814;&#x7a76; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
876	chr18	38208160	38208249	3500462495	48		38208160	38208249	8421504	2	23,25	0,64	c	350046249500000006,350046249500000005	0-23,0-25		23680172	10.1186/1476-9255-10-20	1476-9255	Journal of Inflammation	MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts	Xie	2013	2		
876	chr18	38208160	38208249	3500457611	49		38208160	38208249	8421504	2	23,26	0,63	c	350045761100000022,350045761100000021	0-23,0-26						OLFML3 Expression is Decreased during Prenatal Muscle Development and Regulated by MicroRNA-155 in Pigs	www.ijbs.com	0	0		
876	chr18	38208160	38208249	3500411114	48		38208160	38208249	8421504	2	23,25	0,64	c	350041111400000004,350041111400000003	0-23,0-25						MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis	biomedcentral.com	0	0		
876	chr18	38208160	38208249	3500399493	48		38208160	38208249	8421504	2	23,25	0,64	c	350039949300000004,350039949300000003	0-23,0-25		20932331	10.1186/1471-2407-10-542	1471-2407	BMC Cancer	MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis	Wu	2010	3		
876	chr18	38208160	38208249	3500378841	48		38208160	38208249	8421504	2	23,25	0,64	c	350037884100000005,350037884100000004	0-23,0-25		21176164	10.1186/1472-6882-10-80		BMC Complementary and Alternative Medicine	Protective effect of the daming capsule on impaired baroreflexes in STZ-induced diabetic rats with hyperlipoidemia	Jing	2010	0		
876	chr18	38208160	38208249	3500363571	48		38208160	38208249	8421504	2	23,25	0,64	c	350036357100000010,350036357100000009	0-23,0-25		23689639	10.1038/srep01867	xxxx-xxxx	Scientific Reports	IRGM1 regulates oxidized LDL uptake by macrophage via actin-dependent receptor internalization during atherosclerosis	Xia	2013	0		
876	chr18	38208160	38208249	3500338850	48		38208160	38208249	8421504	2	23,25	0,64	c	350033885000000009,350033885000000008	0-23,0-25		21372826	10.1038/aps.2010.220	1671-4083	Acta Pharmacologica Sinica	Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128	Wu	2011	2		
876	chr18	38208160	38208249	3500338249	45		38208160	38208249	8421504	3	23,16,6	0,64,83	c	350033824900000005,350033824900000004	0-23,0-22		23951172	10.1371/journal.pone.0071472	1932-6203	PLOS ONE	PLOS ONE: In Vivo Monitoring of Angiogenesis Inhibition via Down-Regulation of Mir-21 in a VEGFR2-Luc Murine Breast Cancer Model Using Bioluminescent Imaging	Zhao	2013	4		
876	chr18	38208160	38208249	3500328259	48		38208160	38208249	8421504	2	23,25	0,64	c	350032825900000021,350032825900000022	0-23,0-25						MicroRNAs involved in neoplastic transformation of liver cancer stem cells	www.jeccr.com	0	0		
876	chr18	38208160	38208249	3500325224	52		38208160	38208249	8421504	2	27,25	0,64	c	350032522400000069,350032522400000002,350032522400000031,350032522400000070	0-23,22-45,0-22,0-25						Gut301083 SI clean 120115	gut.bmj.com	0	0		
876	chr18	38208160	38208249	3500315004	49		38208160	38208249	8421504	2	23,26	0,63	c	350031500400000022,350031500400000021	0-23,0-26						Research Paper OLFML3 Expression is Decreased during Prenatal Muscle Development and Regulated by MicroRNA-155 in Pigs	www.ijbs.com	0	0		
876	chr18	38208160	38208249	3500303615	49		38208160	38208249	8421504	2	23,26	0,63	c	350030361500000002,350030361500000004,350030361500000003	0-23,0-23,0-26						miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes	-publications.com	0	0		
876	chr18	38208160	38208249	3500303355	48		38208160	38208249	8421504	2	23,25	0,64	c	350030335500000006,350030335500000005	0-23,0-25		22696253	10.1002/stem.1154	1549-4918	STEM CELLS	microRNA-124 Regulates Cardiomyocyte Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Via Targeting STAT3 Signaling - Cai - 2012 - STEM CELLS - Wiley Online Library	Cai	2012	0		
876	chr18	38208160	38208249	3500279433	49		38208160	38208249	8421504	2	23,26	0,63	c	350027943300000003,350027943300000002	0-23,0-26						Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186 signaling pathway	-publications.com	0	0		
876	chr18	38208160	38208249	3500278628	48		38208160	38208249	8421504	2	23,25	0,64	c	350027862800000002,350027862800000004	0-23,0-25						Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells	-publications.com	0	0		
876	chr18	38208160	38208249	3500209503	48		38208160	38208249	8421504	2	23,25	0,64	c	350020950300000004,350020950300000003	0-23,0-25		19472311	10.1002/hep.23008	1527-3350	Hepatology	Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression - Zhang - 2009 - Hepatology - Wiley Online Library	Zhang	2009	0		
876	chr18	38208160	38208249	3500171351	48		38208160	38208249	8421504	2	23,25	0,64	c	350017135100000013,350017135100000012	0-23,0-25		23894385	10.1371/journal.pone.0068972		PLoS ONE	miR-27b Represses Migration of Mouse MSCs to Burned Margins and Prolongs Wound Repair through Silencing SDF-1a	Mu-Han	2013	0		
876	chr18	38208160	38208249	3500165883	48		38208160	38208249	8421504	2	23,25	0,64	c	350016588300000004,350016588300000003	0-23,0-25		21692045	10.1002/cncr.25860	1097-0142	Cancer	miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met - Wu - 2011 - Cancer - Wiley Online Library	Wu	2011	0		
876	chr18	38208160	38208249	3500154535	45		38208160	38208249	8421504	3	23,16,6	0,64,83	c	350015453500000005,350015453500000004	0-23,0-22		23951172	10.1371/journal.pone.0071472		PLoS ONE	In Vivo Monitoring of Angiogenesis Inhibition via Down-Regulation of Mir-21 in a VEGFR2-Luc Murine Breast Cancer Model Using Bioluminescent Imaging	Dongliang	2013	0		
876	chr18	38208160	38208249	3500147876	48		38208160	38208249	8421504	2	23,25	0,64	c	350014787600000005,350014787600000004	0-23,0-25		21176164	10.1186/1472-6882-10-80	1472-6882	BMC Complementary and Alternative Medicine	Protective effect of the daming capsule on impaired baroreflexes in STZ-induced diabetic rats with hyperlipoidemia	Ai	2010	2		
876	chr18	38208160	38208249	3500144250	48		38208160	38208249	8421504	2	23,25	0,64	c	350014425000000000,350014425000000002	0-23,0-25		23870168	10.1186/1471-2350-14-74	1471-2350	BMC Medical Genetics	The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML)	Yan-Fang	2013	2		
876	chr18	38208160	38208249	3500115353	48		38208160	38208249	8421504	2	23,25	0,64	c	350011535300000010,350011535300000009	0-23,0-25		23689639	10.1038/srep01867	xxxx-xxxx	Scientific Reports	IRGM1 regulates oxidized LDL uptake by macrophage via actin-dependent receptor internalization during atherosclerosis	Xia	2013	0		
876	chr18	38208160	38208249	3500094077	48		38208160	38208249	8421504	2	23,25	0,64	c	350009407700000010,350009407700000009	0-23,0-25						MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein	-publications.com	0	0		
876	chr18	38208161	38208250	3500141263	60		38208161	38208250	8421504	2	28,32	0,57	c	350014126300000011,350014126300000010	0-28,0-32		23469214	10.1371/journal.pone.0057652		PLoS ONE	Feedback Regulations of miR-21 and MAPKs via Pdcd4 and Spry1 Are Involved in Arsenite-Induced Cell Malignant Transformation	Lu	2013	0		
876	chr18	38208163	38208250	3500441995	44		38208163	38208250	8421504	2	24,20	0,67	c	350044199500000015,350044199500000030,350044199500000014	0-20,0-22,0-20		22383888	10.1371/journal.pgen.1002481	1553-7404	PLOS Genetics	PLOS Genetics: A Pathogenic Mechanism in Huntington's Disease Involves Small CAG-Repeated RNAs with Neurotoxic Activity	Banez-Coronel	2012	0		
876	chr18	38208163	38208250	3500390894	41		38208163	38208250	8421504	2	20,21	0,66	c	350039089400000006,350039089400000005	0-20,0-21		16882971	10.1101/gad.1444406	0890-9369	Genes & Development	Extensive post-transcriptional regulation of microRNAs and its implications for cancer	Thomson	2006	12		
876	chr18	38208163	38208250	3500277176	41		38208163	38208250	8421504	2	20,21	0,66	c	350027717600000008,350027717600000007	0-20,0-21						Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation	-publications.com	0	0		
876	chr18	38208163	38208250	3500274821	41		38208163	38208250	8421504	2	20,21	0,66	c	350027482100000006,350027482100000005	0-20,0-21						Expression levels of microRNA-375 in colorectal carcinoma	-publications.com	0	0		
876	chr18	38208163	38208250	3500212751	41		38208163	38208250	8421504	2	20,21	0,66	c	350021275100000006,350021275100000005	0-20,0-21			10.1101/gad.1444406		Genes & Development	Extensive post-transcriptional regulation of microRNAs and its implications for cancer	J.	2006	0		
876	chr18	38208163	38208250	3500191020	40		38208163	38208250	8421504	2	20,20	0,67	c	350019102000000035,350019102000000031	0-20,0-20		23056445	10.1371/journal.pone.0046773	1932-6203	PLOS ONE	PLOS ONE: Neurofibromin 1 Is a miRNA Target in Neurons	Paschou	2012	4		
876	chr18	38208163	38208250	3500156057	40		38208163	38208250	8421504	2	20,20	0,67	c	350015605700000003,350015605700000002	0-20,0-20		20831567	10.1111/j.1582-4934.2010.01170.x	1582-4934	Journal of Cellular and Molecular Medicine	Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b - Ma - 2011 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Ma	2011	0		
876	chr18	38208163	38208250	3500139190	40		38208163	38208250	8421504	2	20,20	0,67	c	350013919000000006,350013919000000005	0-20,0-20						IdentificationofMicroRNA-93asaNovelRegulatorof VascularEndothelialGrowthFactorinHyperglycemic Conditions S	www.jbc.org	0	0		
876	chr18	38208163	38208250	3500100677	40		38208163	38208250	8421504	2	20,20	0,67	c	350010067700000009,350010067700000008	0-20,0-20						Lysine-specificDemethylase2B(KDM2B)-let-7-Enhancerof ZesterHomolog2(EZH2)PathwayRegulatesCellCycle ProgressionandSenescenceinPrimaryCells S	www.jbc.org	0	0		
876	chr18	38208163	38208250	3500000743	41		38208163	38208250	8421504	2	20,21	0,66	c	350000074300000006,350000074300000005	0-20,0-21		16882971	10.1101/gad.1444406	0890-9369	Genes & Development	Extensive post-transcriptional regulation of microRNAs and its implications for cancer	Thomson	2006	12		
876	chr18	38208163	38208192	3500180277	29		38208163	38208192	8421504	1	29	0	c	350018027700000006	17-46		19351827	10.1158/0008-5472.CAN-08-4290	0008-5472	Cancer Research	Thrombin Induces Tumor Cell Cycle Activation and Spontaneous Growth by Down-regulation of p27Kip1, in Association with the Up-regulation of Skp2 and MiR-222	Hu	2009	8		
876	chr18	38208163	38208190	3500013338	27		38208163	38208190	8421504	1	27	0	c	350001333800000000	0-27		18439919	10.1016/j.bbagrm.2008.03.011		Biochimica et biophysica acta	A tightly regulated Pol III promoter for synthesis of miRNA genes in tandem	Hongxia	2008	0		TRMT5
876	chr18	38208165	38208255	3500059262	59		38208165	38208255	8421504	3	33,21,5	0,63,85	c	350005926200000007,350005926200000006	0-33,6-32						INTRACELLULAR EXPRESSION AND DELIVERY OF siRNAs IN MAMMALIAN CELLS	Engelke	2008	0		
876	chr18	38208165	38208255	3500017035	59		38208165	38208255	8421504	3	33,21,5	0,63,85	c	350001703500000007,350001703500000006	0-33,6-32						Intracellular expression and delivery of siRNAs in mammalian cells	Engelke	2002	0		
876	chr18	38208165	38208198	3500038487	31		38208165	38208198	8421504	2	24,7	0,26	c	350003848700000004	0-31						Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells	-publications.com	0	0		
876	chr18	38208166	38208190	3500351709	24		38208166	38208190	8421504	1	24	0	c	350035170900000006	0-24		21683814	10.1016/j.bbagrm.2011.05.015		Biochimica et biophysica acta	Drosha processing controls the specificity and efficiency of global microRNA expression	Yong	2011	0		TRMT5
876	chr18	38208168	38208205	3500450448	37		38208168	38208205	8421504	1	37	0	c	350045044800000021	0-37						Compositions And Methods For Inhibiting Or Reversing Fibrotic Disorders 	.freshpatents.com	0	0		
876	chr18	38208168	38208205	3500001126	37		38208168	38208205	8421504	1	37	0	c	350000112600000054	0-37						Nucleotide Motifs Providing Localization Elements and Methods of Use	Mendell	2007	0		
876	chr18	38208169	38208192	3500415563	23		38208169	38208192	8421504	1	23	0	c	350041556300000022	0-23						Gene products related to werner's syndrome	Fu	2000	0		TRMT5
876	chr18	38208169	38208192	3500149550	23		38208169	38208192	8421504	1	23	0	c	350014955000000022	0-23						Antibodies against gene products related to Werner's Syndrome	Fu	2003	0		TRMT5
876	chr18	38208169	38208192	3500048116	23		38208169	38208192	8421504	1	23	0	c	350004811600000022	0-23						 Antibodies Against Gene Products Related To Werner's Syndrome 	www.docstoc.com	0	0		TRMT5
876	chr18	38208169	38208192	3500014443	23		38208169	38208192	8421504	1	23	0	c	350001444300000022	0-23						Genes and gene products related to Werner's syndrome - US Patent 6090620 Description	ww.patentstorm.us	0	0		TRMT5
876	chr18	38208169	38208192	3500000908	23		38208169	38208192	8421504	1	23	0	c	350000090800000022	0-23						Genes and gene products related to Werner's syndrome	Fu	1996	0		TRMT5
876	chr18	38208170	38208226	3500431959	56		38208170	38208226	8421504	1	56	0	c	350043195900000001	46-102		15758027	10.1091/mbc.E04-11-0992	1059-1524	Molecular Biology of the Cell	Dynamic Sorting of Nuclear Components into Distinct Nucleolar Caps during Transcriptional Inhibition	Shav-Tal	2005	5		
876	chr18	38208170	38208226	3500059727	56		38208170	38208226	8421504	1	56	0	c	350005972700000001	46-102						Dynamic Sorting of Nuclear Components into Distinct Nucleolar Caps during Transcriptional Inhibition	w.molbiolcell.org	0	0		
876	chr18	38208170	38208226	3500041758	56		38208170	38208226	8421504	1	56	0	c	350004175800000001	46-102			10.1091/mbc.E04-11-0992		Molecular Biology of the Cell	Dynamic Sorting of Nuclear Components into Distinct Nucleolar Caps during Transcriptional Inhibition	Yaron	2005	0		
876	chr18	38208171	38208238	3500409516	40		38208171	38208238	8421504	2	20,20	0,47	c	350040951600000003,350040951600000002	10-30,10-30		15798209	10.1128/MCB.25.8.3247-3260.2005	0270-7306	Molecular and Cellular Biology	The p53 Tumor Suppressor Protein Represses Human snRNA Gene Transcription by RNA Polymerases II and III Independently of Sequence-Specific DNA Binding	Gridasova	2005	6		
876	chr18	38208171	38208238	3500028399	40		38208171	38208238	8421504	2	20,20	0,47	c	350002839900000022,350002839900000021	10-30,10-30		22357912	10.1261/rna.029587.111	1355-8382	RNA	Transcription regulates telomere dynamics in human cancer cells	Arora	2012	5		
876	chr18	38208174	38208198	3500233367	24		38208174	38208198	8421504	1	24	0	c	350023336700000003	0-24						High-Resolution Pro&#xfb01;ling and Analysis of Viral and Host Small RNAs during Human Cytomegalovirus Infection	yeolab.ucsd.edu	0	0		TMEM222
876	chr18	38208180	38208217	3500277975	37		38208180	38208217	8421504	1	37	0	c	350027797500000019	0-37						MicroRNA-9ControlstheExpressionofGranuphilin/Slp4 andtheSecretoryResponseofInsulin-producingCells	www.jbc.org	0	0		
876	chr18	38208183	38208207	3500326479	24		38208183	38208207	8421504	1	24	0	c	350032647900000001	0-24						Pharmaceutically active aromatic guanylhydrazones	Bacher	2001	0		PRKY
876	chr18	38208184	38208214	3500130291	30		38208184	38208214	8421504	1	30	0	c	350013029100000005	0-30		20668658	10.1371/journal.pmed.1000315		PLoS Medicine	Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma	William	July	0		TMEM222
876	chr18	38208189	38208219	3500466426	30		38208189	38208219	8421504	1	30	0	c	350046642600000001	0-30		17699775	10.1158/0008-5472.CAN-07-1083	0008-5472	Cancer Research	The let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells	Johnson	2007	8		
876	chr18	38208189	38208219	3500459779	30		38208189	38208219	8421504	1	30	0	c	350045977900000030,350045977900000008	0-30,0-30						MULTI-MICRORNA METHODS AND COMPOSITIONS - Patent application	www.faqs.org	0	0		TMEM222
876	chr18	38208189	38208219	3500438266	30		38208189	38208219	8421504	1	30	0	c	350043826600000015	0-30						MicroRNA Let-7a Suppresses Breast Cancer Cell Migration : Materials and Methods	www.medscape.com	0	0		
876	chr18	38208189	38208219	3500401232	30		38208189	38208219	8421504	1	30	0	c	350040123200000043	28-58		21149577	10.1128/MCB.00581-10	0270-7306	Molecular and Cellular Biology	MicroRNA-27a Regulates Beta Cardiac Myosin Heavy Chain Gene Expression by Targeting Thyroid Hormone Receptor &#x03b2;1 in Neonatal Rat Ventricular Myocytes	Nishi	2011	6		TMEM222
876	chr18	38208189	38208219	3500392693	30		38208189	38208219	8421504	1	30	0	c	350039269300000005	0-30		22498306	10.1111/j.1742-4658.2012.08589.x	1742-4658	FEBS Journal	MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells - Cheng - 2012 - FEBS Journal - Wiley Online Library	Cheng	2012	0		
876	chr18	38208189	38208219	3500381918	30		38208189	38208219	8421504	1	30	0	c	350038191800000001	0-30		20388800	10.1158/0008-5472.CAN-09-4456	0008-5472	Cancer Research	Oncogenic Role of miR-483-3p at the IGF2/483 Locus	Veronese	2010	8		
876	chr18	38208189	38208219	3500342920	30		38208189	38208219	8421504	1	30	0	c	350034292000000001	0-30		18262046	10.1016/j.cancergencyto.2007.10.008		Cancer genetics and cytogenetics	Coordinated Expression of MicroRNA-155 and Predicted Target Genes in Diffuse Large B-cell Lymphoma	Deepak	2008	0		TMEM222
876	chr18	38208189	38208219	3500313977	30		38208189	38208219	8421504	1	30	0	c	350031397700000001	0-30						let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells	s.idi.harvard.edu	0	0		
876	chr18	38208189	38208219	3500276498	30		38208189	38208219	8421504	1	30	0	c	350027649800000043	28-58		21149577	10.1128/MCB.00581-10	0270-7306	Molecular and Cellular Biology	MicroRNA-27a Regulates Beta Cardiac Myosin Heavy Chain Gene Expression by Targeting Thyroid Hormone Receptor &#x03b2;1 in Neonatal Rat Ventricular Myocytes	Nishi	2011	6		TMEM222
876	chr18	38208189	38208219	3500232186	30		38208189	38208219	8421504	1	30	0	c	350023218600000001	0-30						let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells	www.uni-lj.si	0	0		TMEM222
876	chr18	38208189	38208219	3500227901	30		38208189	38208219	8421504	1	30	0	c	350022790100000002	0-30						EFFECT OF TRICHOSTATIN A ON VIABILITY AND microRNA EXPRESSION IN HUMAN PANCREATIC CANCER CELL LINE BxPC-3	p-oncology.com.ua	0	0		
876	chr18	38208189	38208219	3500215969	30		38208189	38208219	8421504	1	30	0	c	350021596900000010	30-60		19816956	10.1002/stem.235	1549-4918	STEM CELLS	MiR-21 Regulates Adipogenic Differentiation through the Modulation of TGF-&#x03b2; Signaling in Mesenchymal Stem Cells Derived from Human Adipose Tissue - Kim - 2009 - STEM CELLS - Wiley Online Library	Kim	2009	0		TMEM222
876	chr18	38208189	38208219	3500072860	30		38208189	38208219	8421504	1	30	0	c	350007286000000022	0-30						Let-7 microrna and mimetics thereof as therapeutics for cancer	Hu	2008	0		TMEM222
876	chr18	38208189	38208219	3500039988	30		38208189	38208219	8421504	1	30	0	c	350003998800000019	30-60		22267003	10.1590/S0100-879X2012007500007	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - The miR-17-92 cluster regulates FOG-2 expression and inhibits proliferation of mouse embryonic cardiomyocytes	Xiang	2012	1		TMEM222
876	chr18	38208189	38208219	3500024844	30		38208189	38208219	8421504	1	30	0	c	350002484400000001	0-30		17699775	10.1158/0008-5472.CAN-07-1083	0008-5472	Cancer Research	The let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells	Johnson	2007	8		
876	chr18	38208189	38208219	3500023852	30		38208189	38208219	8421504	1	30	0	c	350002385200000010	0-30		23862015	10.1242/bio.20134507	2046-6390	Biology Open	hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression	Avasarala	2013	0		TMEM222
876	chr18	38208189	38208217	3500379040	28		38208189	38208217	8421504	1	28	0	c	350037904000000073	0-29						Nucleic acid aptamers	Giangrande	2011	0		TMEM222
876	chr18	38208189	38208217	3500040019	28		38208189	38208217	8421504	1	28	0	c	350004001900000073	0-29						NUCLEIC ACID APTAMERS - UNIVERSITY OF IOWA RESEARCH FOUNDATION	www.sumobrain.com	0	0		TMEM222
876	chr18	38208191	38208250	3500006114	40		38208191	38208250	8421504	2	20,20	0,39	c	350000611400000039,350000611400000038	0-20,0-20						A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT - INTERNA TECHNOLOGIES BV	www.sumobrain.com	0	0		
876	chr18	38208194	38208245	3500304342	40		38208194	38208245	8421504	2	20,20	0,31	c	350030434200000004,350030434200000005	0-20,0-20						BMC Biotechnology BioMed Central	biomedcentral.com	0	0		
876	chr18	38208195	38208218	3500363855	23		38208195	38208218	8421504	1	23	0	c	350036385500000002	0-23		20841420	10.1261/rna.2303610	1355-8382	RNA	Noncanonical cytoplasmic processing of viral microRNAs	Shapiro	2010	5		
876	chr18	38208200	38208224	3500437947	24		38208200	38208224	8421504	1	24	0	c	350043794700000001	0-24						Oncogenic microRNA-155 downregulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: Implications for cancer therapeutics	www.jbc.org	0	0		TMEM222
876	chr18	38208200	38208223	3500003710	23		38208200	38208223	8421504	1	23	0	c	350000371000000000	0-23						MicroRNAs in Development - Methods and Protocols	www.scribd.com	0	0		TMEM222
876	chr18	38208203	38208226	3500342564	23		38208203	38208226	8421504	1	23	0	c	350034256400000002	0-23		21939504	10.1186/1476-4598-10-117	1476-4598	Molecular Cancer	Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells	Yang	2011	4		TMEM222
876	chr18	38208205	38208245	3500181404	40		38208205	38208245	8421504	1	40	0	c	350018140400000001	0-40		20144199	10.1186/1476-4598-9-32	1476-4598	Molecular Cancer	EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis	Liu	2010	4		
876	chr18	38208209	38208235	3500265008	26		38208209	38208235	8421504	1	26	0	c	350026500800000040	0-26						Cns targeting aav vectors and methods of use thereof	Gao	2013	0		TMEM222
876	chr18	38208217	38208255	3500402920	38		38208217	38208255	8421504	1	38	0	c	350040292000000016	0-38						Identification and Analysis of Dicer Associated Proteins in Human Cells Inaugurationsdissertation	edoc.unibas.ch	0	0		
876	chr18	38208217	38208251	3500234875	34		38208217	38208251	8421504	1	34	0	c	350023487500000009	0-34						MicroRNA-221/222NegativelyRegulatesEstrogenReceptor andIsAssociatedwithTamoxifenResistancein BreastCancer	www.jbc.org	0	0		
876	chr18	38208217	38208251	3500000997	34		38208217	38208251	8421504	1	34	0	c	350000099700000009	0-34		18790736	10.1074/jbc.M806041200	0021-9258	Journal of Biological Chemistry	MicroRNA-221/222 Negatively Regulates Estrogen Receptor&#x03b1; and Is Associated with Tamoxifen Resistance in Breast Cancer	Zhao	2008	5		
876	chr18	38208217	38208244	3500467059	27		38208217	38208244	8421504	1	27	0	c	350046705900000022	0-27						Sj&#xf6;gren&#x2019;s syndrome antigen B (SSB)/La promotes global microRNA expression	www.jbc.org	0	0		
876	chr18	38208220	38208244	3500113184	24		38208220	38208244	8421504	1	24	0	c	350011318400000014	0-24		20881010	10.1158/1541-7786.MCR-10-0242	1541-7786	Molecular Cancer Research	Expression of Noncoding Vault RNA in Human Malignant Cells and Its Importance in Mitoxantrone Resistance	Gopinath	2010	4		
876	chr18	38208228	38208254	3500366537	26		38208228	38208254	8421504	1	26	0	c	350036653700000016	0-26		19324960	10.1261/rna.1268209		RNA	Optimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virus	Duckhyang	2009	0		FAM169A
876	chr18	38208230	38208255	3500381269	25		38208230	38208255	8421504	1	25	0	c	350038126900000015	0-25		22871741	10.4161/cc.21503		Cell Cycle	An anti-let-7 sponge decoys and decays endogenous let-7 functions	Xiangling	2012	0		FAM169A
876	chr18	38208230	38208253	3500271119	23		38208230	38208253	8421504	1	23	0	c	350027111900000013	0-23						Memphis, TN 38163, U.S.A Author Manuscript NIH Public Access Aixia Ren Sravya Penmatsa Biochem Biophys Res Commun	diyhpl.us/~bryan/	0	0		
876	chr18	38208230	38208253	3500230510	23		38208230	38208253	8421504	1	23	0	c	350023051000000001,350023051000000010	0-23,0-23						INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 FOR TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
877	chr18	38366366	38369836	3500164626	26		38366366	38369836	8421504	3	6,2,18	0,3447,3452	c	350016462600000097	0-26						Promotion or inhibition of angiogenesis and cardiovascularization	Ashkenazi	2000	0		
878	chr18	38424745	38424774	3500030963	24		38424745	38424774	8421504	2	17,7	0,22	g	350003096300000135	9-33						Novel scavenger receptor	Ruo Gong Shen Long 	2008	0		
878	chr18	38501664	38501712	3500118012	48		38501664	38501712	8421504	1	48	0	p	350011801200015012	0-48						Glycosly sulfortransferase-3	Bistrup	1998	0		
879	chr18	38649440	38657529	3500023212	40		38649440	38657529	8421504	2	20,20	0,8069	c,g	350002321200000005,350002321200000005,350002321200000004	0-20,0-20,0-20						LATERAL VENTRICLE CELL COMPOSITIONS AND USE FOR TREATING NEURAL DEGENERATIVE DISEASES	Yamoah	2009	0		
879	chr18	38649468	38650241	3500351366	24		38649468	38650241	8421504	3	13,7,4	0,761,769	c	350035136600000103	19-43						Calcium-binding photoprotein, gene encoding the same, and use thereof - Patent application	www.faqs.org	0	0		
882	chr18	38972507	38972534	3500330800	25		38972507	38972534	8421504	2	16,9	0,18	g	350033080000000124	20-45						Methods and Kits for Detecting Congenital Stationary Night Blindness and Selecting Different Coat Patterns - Patent application	www.faqs.org	0	0		
884	chr18	39305479	39305503	3500112108	23		39305479	39305503	8421504	2	4,19	0,5	g	350011210800000006	2-25						Antisense antibacterial method and composition - US Patent 6677153 Description	ww.patentstorm.us	0	0		
885	chr18	39411373	39411398	3500320588	23		39411373	39411398	8421504	2	9,14	0,11	g	350032058800000040	5-28					Patent	Gene and protein relating to hepatocellular carcinoma (Patent EP:1430152)	Nakamura	2007	0		
885	chr18	39429610	39429641	3500195312	31		39429610	39429641	8421504	1	31	0	g	350019531200000017	0-31			10.1093/emboj/18.7.1878	ERROR! NO ISSN	The EMBO Journal	Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex	Cam	1999	0		
885	chr18	39434625	39434650	3500427904	25		39434625	39434650	8421504	1	25	0	c	350042790400000022	0-25		22792167	10.1371/journal.pone.0039268		PLoS ONE	RBPJ Is a Novel Target for Rhabdomyosarcoma Therapy	Hiroko	2012	0		
885	chr18	39434720	39434863	3500123764	24		39434720	39434863	8421504	2	11,13	0,130	c	350012376400000006	0-24			10.1038/sj.bjp.0706987	1476-5381	British Journal of Pharmacology	Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-&#x03ba;B - Chen - 2009 - British Journal of Pharmacology - Wiley Online Library	Chen	2007	0		CCNE1
885	chr18	39434975	39438039	3500461927	23		39434975	39438039	8421504	2	11,12	0,3052	c	350046192700000012	0-23						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: "First somatic mutation of E2F1 in a critical DNA binding residue discovered in well- differentiated papillary mesothelioma of the peritoneum" 	tailieu.vn/doc/ba	0	0		
885	chr18	39434975	39438039	3500313040	23		39434975	39438039	8421504	2	11,12	0,3052	c	350031304000000012	0-23		21955916	10.1186/gb-2011-12-9-r96	1465-6906	Genome Biology	First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneum	Yu	2011	0		
885	chr18	39434975	39438039	3500271882	23		39434975	39438039	8421504	2	11,12	0,3052	c	350027188200000012	0-23		21955916	10.1186/gb-2011-12-9-r96		Genome Biology	First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneum	Willie	2011	0		
886	chr18	39569903	39569926	3500459899	23		39569903	39569926	8421504	1	23	0	g	350045989900000028	0-23						REASSESSMENT OF GENETIC DIVERSITY IN NATIVE TURKISH SHEEP BREEDS WITH LARGE NUMBERS OF MICROSATELLITE MARKERS AND MITOCHONDRIAL DNA (MTDNA) A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF NATURAL AND APPLIED SCIENCES OF MIDDLE EAST TECHNICAL UNIVERSITY BY FO	d.lib.metu.edu.tr	0	0		
905	chr18	41959975	41962358	3500332296	53		41959975	41962358	8421504	3	25,16,12	0,27,2371	c	350033229600000007,350033229600000008	0-25,0-28		16361542	10.1158/1078-0432.CCR-05-0039	1078-0432	Clinical Cancer Research	Two Single-Nucleotide Polymorphisms with Linkage Disequilibrium in the Human Programmed Cell Death 5 Gene 5&#x2032; Regulatory Region Affect Promoter Activity and the Susceptibility of Chronic Myelogenous Leukemia in Chinese Population	Ma	2005	8		
905	chr18	41999775	41999798	3500229739	23		41999775	41999798	8421504	1	23	0	g	350022973900000004	3-26		19679719		0006-3185	The Biological Bulletin	Nutrient Uptake by Marine Invertebrates: Cloning and Functional Analysis of Amino Acid Transporter Genes in Developing Sea Urchins (Strongylocentrotus purpuratus)	Meyer	2009	2		
907	chr18	42230077	42230105	3500300591	24		42230077	42230105	8421504	2	6,18	0,10	c	350030059100000341	21-48						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
907	chr18	42231007	42231035	3500111430	23		42231007	42231035	8421504	2	7,16	0,12	c	350011143000000085	3-26						RECOMBINANT LACTOBACILLUS WITH DECREASED LIPOTEICHOIC ACID TO REDUCE INFLAMMATORY RESPONSES - Patent application	www.faqs.org	0	0		
913	chr18	43008462	43008610	3500156937	147		43008462	43008610	8421504	2	55,92	0,56	p	350015693700015032	159-306						Extension of a protein-protein interaction surface to inactivate the function of a cellular protein	Vinson	2002	0		
913	chr18	43008463	43009525	3500278194	45		43008463	43009525	8421504	2	22,23	0,1039	c	350027819400000003,350027819400000002	9-31,20-43						32Dcl &#xc0dd;&#xc950;&#xace8;&#xc218;&#xc544;&#xad6c;&#xbc0f;#1111 &#xae09;&#xc131;&#xc804;&#xace8;&#xc218;&#xad6c;&#xc131;&#xbc31;&#xd608;&#xbcd1;&#xc138;&#xd3ec;&#xc5d0;&#xc11c; C/EBP &#xbc0f;C/EBP&#xc758;&#xc601;&#xd5a5;	www.kslm.org	0	0		
913	chr18	43008470	43008493	3500215969	23		43008470	43008493	8421504	1	23	0	c	350021596900000003	23-46		19816956	10.1002/stem.235	1549-4918	STEM CELLS	MiR-21 Regulates Adipogenic Differentiation through the Modulation of TGF-&#x03b2; Signaling in Mesenchymal Stem Cells Derived from Human Adipose Tissue - Kim - 2009 - STEM CELLS - Wiley Online Library	Kim	2009	0		
913	chr18	43008564	43008715	3500316425	42		43008564	43008715	8421504	2	19,23	0,128	c,g	350031642500000001,350031642500000001,350031642500000000	0-19,0-19,0-23		20179198	10.1158/0008-5472.CAN-09-3875	0008-5472	Cancer Research	Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers	Creighton	2010	8		CEBPG
913	chr18	43008570	43008711	3500443367	40		43008570	43008711	8421504	2	20,20	0,121	c,g	350044336700000005,350044336700000004,350044336700000004	0-20,0-20,0-20		16987965	10.1128/JVI.01171-06	0022-538X	Journal of Virology	A Protein Encoded by the Bovine Herpesvirus 1 Latency-Related Gene Interacts with Specific Cellular Regulatory Proteins, Including CCAAT Enhancer Binding Protein Alpha	Meyer	2007	5		
913	chr18	43008571	43008700	3500138951	38		43008571	43008700	8421504	2	19,19	0,110	c,g	350013895100000005,350013895100000004,350013895100000004	0-19,0-19,0-19		21659508	10.1074/jbc.M111.253609		The Journal of Biological Chemistry	Eicosapentaenoic Acid Demethylates a Single CpG That Mediates Expression of Tumor Suppressor CCAAT/Enhancer-binding Protein &#x03b4; in U937 Leukemia Cells	Veronica	2011	0		CEBPG
913	chr18	43008575	43009525	3500291541	43		43008575	43009525	8421504	2	21,22	0,928	c	350029154100000013,350029154100000002	0-21,4-26		17909026	10.1158/0008-5472.CAN-07-0932	0008-5472	Cancer Research	Snail-Induced Down-Regulation of &#x0394;Np63&#x03b1; Acquires Invasive Phenotype of Human Squamous Cell Carcinoma	Higashikawa	2007	8		
913	chr18	43008575	43008705	3500025915	40		43008575	43008705	8421504	2	20,20	0,110	c,g	350002591500000043,350002591500000042,350002591500000042	0-20,0-20,0-20						Tendon Stem Cells	Young	2008	0		CEBPG
913	chr18	43008654	43008705	3500182022	40		43008654	43008705	8421504	2	20,20	0,31	c,g	350018202200000015,350018202200000015,350018202200000013	0-20,0-20,0-20		22570737	10.1371/journal.pone.0036682	1932-6203	PLOS ONE	PLOS ONE: Myxoid Liposarcoma-Associated EWSR1-DDIT3 Selectively Represses Osteoblastic and Chondrocytic Transcription in Multipotent Mesenchymal Cells	Suzuki	2012	4		CEBPB
913	chr18	43008682	43008705	3500056904	23		43008682	43008705	8421504	1	23	0	c,g	350005690400000005,350005690400000005	0-23,0-23						CCAAT/enhancer binding protein &#x03b4; regulates glial pro-inflammatory gene expression - ResearchGate	.researchgate.net	0	0		CEBPG
913	chr18	43008692	43008715	3500325193	23		43008692	43008715	8421504	1	23	0	c	350032519300000009	0-23						RESEARCH ARTICLE Open Access	biomedcentral.com	0	0		CEBPG
913	chr18	43008692	43008715	3500001319	23		43008692	43008715	8421504	1	23	0	c	350000131900000009	0-23		20459638	10.1186/1471-213X-10-47		BMC Developmental Biology	Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow	Shu-Wen	2010	0		CEBPG
913	chr18	43008983	43009007	3500047088	23		43008983	43009007	8421504	2	9,14	0,10	c	350004708800000003	0-24		15618961	10.1038/sj.leu.2403608	0887-6924	Leukemia	CEBP&#x03b1; mutations in childhood acute myeloid leukemia	Liang	2004	10		
913	chr18	43009277	43009325	3500087302	48		43009277	43009325	8421504	1	48	0	p	350008730200015001	0-48		10082561		0270-7306	Molecular and Cellular Biology	C/EBP&#x03b1; Regulates Formation of S-Phase-Specific E2F-p107 Complexes in Livers of Newborn Mice	Timchenko	1999	6		CEBPG
913	chr18	43009487	43009512	3500420392	25		43009487	43009512	8421504	1	25	0	c	350042039200000003	0-25		18987666	10.1038/leu.2008.297		Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K	C/EBP&#x03b1; or C/EBP&#x03b1; oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-&#x03ba;B p50 bound to the bcl-2 and FLIP gene promoters	I	2009	0		CEBPG
913	chr18	43009487	43009512	3500387304	25		43009487	43009512	8421504	1	25	0	c	350038730400000002	0-25		15292250	10.1074/jbc.M405177200	0021-9258	Journal of Biological Chemistry	Disruption of Hepatic C/EBP&#x03b1; Results in Impaired Glucose Tolerance and Age-dependent Hepatosteatosis	Inoue	2004	5		
915	chr18	43345839	43345865	3500307423	24		43345839	43345865	8421504	2	16,8	0,18	g	350030742300000005	5-29						Methods for detecting pathogen specific nucleic acids in urine - US Patent 7914982 Description	ww.patentstorm.us	0	0		
915	chr18	43345839	43345865	3500016645	24		43345839	43345865	8421504	2	16,8	0,18	g	350001664500000005	5-29						Compositions And Methods For Detecting Pathogen Specific Nucleic Acids In Urine 	.freshpatents.com	0	0		
916	chr18	43499795	43499821	3500201852	23		43499795	43499821	8421504	2	11,12	0,14	c	350020185200000434	10-33						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
922	chr18	44239581	44239677	3500239328	57		44239581	44239677	8421504	2	27,30	0,66	p	350023932800015010	0-57						Social Amoebas Comparative Genome Browser	Suhnel		0		LSM14A
923	chr18	44385132	44401403	3500181421	73		44385132	44401403	8421504	4	9,38,11,15	0,470,14364,16256	c	350018142100000060,350018142100000071	0-47,7-33						A novel protein, neuroleukin	Gurney	1987	0		
923	chr18	44398159	44399263	3500293908	85		44398159	44399263	8421504	4	26,13,22,24	0,104,988,1080	c	350029390800000337,350029390800000346,350029390800000348,350029390800000355	1-27,0-35,0-30,0-24						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	hera.ugr.es	0	0		
923	chr18	44398193	44399263	3500192823	59		44398193	44399263	8421504	2	35,24	0,1046	c	350019282300000341,350019282300000355	0-35,0-24						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	digibug.ugr.es	0	0		
924	chr18	44477961	44477989	3500362588	23		44477961	44477989	8421504	3	6,12,5	0,10,23	c	350036258800000022	11-35						GENETIC DIVERSITY ANALYSIS IN SORGHUM GERMPLASM COLLECTIONS FROM EASTERN AFRICA AS ESTIMATED BY MORPHO-AGRONOMICAL AND SSR MARKERS	etd.uovs.ac.za	0	0		
928	chr18	45053818	45053863	3500086781	45		45053818	45053863	8421504	1	45	0	p	350008678100015195	0-45						NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES - Patent application	www.faqs.org	0	0		SCN1B
928	chr18	45054763	45061169	3500026865	44		45054763	45061169	8421504	2	22,22	0,6384	c	350002686500000002,350002686500000003	0-22,0-22		19176528	10.1074/jbc.M806891200		The Journal of Biological Chemistry	Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells	Ludovic	2009	0		SCN1B,HPN
928	chr18	45063694	45070201	3500037809	30		45063694	45070201	8421504	2	16,14	0,6493	c	350003780900000000	0-30		18726901	10.1002/ijc.23726	1097-0215	International Journal of Cancer	Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model - Miao - 2008 - International Journal of Cancer - Wiley Online Library	Miao	2008	0		HPN
928	chr18	45077307	45082359	3500318732	714		45077307	45082359	8421504	5	134,191,96,143,150	0,235,4286,4577,4902	p	350031873200015008	0-714						wEMBOSS interface to EMBOSS	www.ch.embnet.org	0	0		HPN
928	chr18	45081616	45082353	3500287412	354		45081616	45082353	8421504	5	18,52,143,78,63	0,21,268,593,674	p	350028741200015006	0-354						Methods for the diagnosis and treatment of tumors employing the hepsin gene	Mu	2002	0		
928	chr18	45082314	45082340	3500152826	26		45082314	45082340	8421504	1	26	0	c	350015282600000005	0-26						METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR	Kirchhofer	2012	0		
928	chr18	45082582	45082605	3500067243	23		45082582	45082605	8421504	1	23	0	c	350006724300000018	10-33						Modified hepsin molecules having a substitute activation sequence and uses thereof	Parry	2004	0		
930	chr18	45248328	45261335	3500064843	159		45248328	45261335	8421504	6	29,19,19,24,42,26	0,141,5863,5907,12448,12981	c	350006484300000301,350006484300000192,350006484300000304,350006484300000305,350006484300000084,350006484300000283	9-38,15-45,9-44,21-45,0-42,18-44						 Isolated Polypeptide Comprising A Leptin Fragment 	www.docstoc.com	0	0		
930	chr18	45261190	45261213	3500156331	23		45261190	45261213	8421504	1	23	0	c	350015633100000041	8-38						US Patent # 5,827,817. P-selectin ligand protein - Patents.com	www.patents.com	0	0		
930	chr18	45264116	45271791	3500439423	40		45264116	45271791	8421504	2	20,20	0,7655	c,g	350043942300000023,350043942300000024,350043942300000024	0-20,0-20,0-20						Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells	biomedcentral.com	0	0		USF2
930	chr18	45271803	45272254	3500148486	49		45271803	45272254	8421504	3	26,3,20	0,329,431	c	350014848600000013,350014848600000014	0-26,0-23		20082704	10.1186/1471-2199-11-5	1471-2199	BMC Molecular Biology	Upstream Stimulating Factors 1 and 2 Enhance Transcription from the Placenta-Specific Promoter 1.1 of the Bovine Cyp19 Gene	FA1/4rbass	2010	3		USF2
930	chr18	45275650	45276871	3500113795	135		45275650	45276871	8421504	3	30,30,75	0,972,1146	p	350011379500015028,350011379500015040,350011379500015059	0-60,0-57,0-75						The Role of Hepcidin in Regulation of Iron Balance in Bats	e.lib.uoguelph.ca	0	0		
930	chr18	45276796	45276871	3500180929	75		45276796	45276871	8421504	1	75	0	p	350018092900015022	0-75						IRON-REGULATORY FUNCTION OF HEPCIDIN IN THE CHANNEL CATFISH AND WESTERN CLAWED FROG	etd.auburn.edu	0	0		
930	chr18	45289654	45296389	3500133900	135		45289654	45296389	8421504	3	45,45,45	0,96,6690	p	350013390000015142,350013390000015144,350013390000015146	0-45,0-45,0-45						Intercellular adhesion molecules and their binding ligands - Patent application	www.faqs.org	0	0		
930	chr18	45338675	45339653	3500199227	978		45338675	45339653	8421504	1	978	0	p	350019922700015001,350019922700015003,350019922700015005,350019922700015007,350019922700015009,350019922700015011	0-177,0-180,0-177,0-174,0-156,0-114						Institut f&#xfc;r Tierwissenschaften Abteilung Physiologie und Hygiene Der Rheinischen Friedrich-Wilhelms-Universit&#xe4;t Bonn	s.ulb.uni-bonn.de	0	0		
930	chr18	45339456	45339524	3500345859	65		45339456	45339524	8421504	3	19,24,22	0,20,46	c	350034585900000033,350034585900000035,350034585900000034	0-19,0-24,0-22						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
931	chr18	45403287	45404274	3500199227	987		45403287	45404274	8421504	1	987	0	p,c	350019922700015000,350019922700015002,350019922700015004,350019922700015006,350019922700015008,350019922700000014,350019922700015010	0-159,0-180,0-180,0-180,0-180,20-40,0-108						Institut f&#xfc;r Tierwissenschaften Abteilung Physiologie und Hygiene Der Rheinischen Friedrich-Wilhelms-Universit&#xe4;t Bonn	s.ulb.uni-bonn.de	0	0		
931	chr18	45444504	45444532	3500272683	24		45444504	45444532	8421504	2	15,9	0,19	g	350027268300000002	0-24			10.1128/AAC.45.3.690-695.2001		Antimicrobial Agents and Chemotherapy	An ATP-Binding Cassette Transporter and Two rRNA Methyltransferases Are Involved in Resistance to Avilamycin in the Producer Organism Streptomyces viridochromogenes T&#xfc;57	Gabriele	2001	0		
931	chr18	45444919	45450144	3500452808	612		45444919	45450144	8421504	9	3,305,48,24,72,42,48,68,2	0,4,926,1082,2239,2637,3023,4837,5223	c,g	350045280800000001,350045280800000000,350045280800000002	12-607,102-697,0-583						Modelos computacionais para identifica&#xe7;&#xe3;o de informa&#xe7;&#xe3;o gen&#xf4;mica associada &#xe0; resist&#xea;ncia ao carrapato bovino | Wagner Arbex - Academia.edu	www.academia.edu	0	0		
931	chr18	45452389	45452692	3500144251	30		45452389	45452692	8421504	2	9,21	0,282	c	350014425100000171,350014425100000196	18-48,0-29						CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses - Patent application	www.faqs.org	0	0		
931	chr18	45468911	45468935	3500428535	24		45468911	45468935	8421504	1	24	0	c	350042853500000015	12-36						NOVEL GENE PARTICIPATING IN EPIDERMAL DIFFERENTIATION AND USE THEREOF	MATSUI	2005	0		
931	chr18	45470323	45470367	3500432752	44		45470323	45470367	8421504	1	44	0	c	350043275200000037	0-44						NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO - Patent application	www.faqs.org	0	0		
931	chr18	45470323	45470367	3500015936	44		45470323	45470367	8421504	1	44	0	c	350001593600000035	0-44						Novel Gene Disruptions, Compositions And Methods Relating Thereto 	.freshpatents.com	0	0		
931	chr18	45475228	45475285	3500080113	57		45475228	45475285	8421504	1	57	0	p	350008011300015015	15-72						Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception	Eddy	2004	0		GAPDHS
931	chr18	45477553	45478614	3500339302	48		45477553	45478614	8421504	2	14,34	0,1027	p	350033930200015081	0-48						Multiple Sequence Alignment	www.cs.uml.edu	0	0		GAPDHS
931	chr18	45477553	45478614	3500326081	48		45477553	45478614	8421504	2	14,34	0,1027	p	350032608100015038	0-48						Overview of the Bernoulli Sampler	web.ccv.brown.edu	0	0		GAPDHS
931	chr18	45477553	45478614	3500036433	48		45477553	45478614	8421504	2	14,34	0,1027	p	350003643300015038	0-48						Overview of the Gibbs Motif Sampler	web.ccv.brown.edu	0	0		GAPDHS
931	chr18	45478650	45478882	3500210057	48		45478650	45478882	8421504	2	27,21	0,211	p	350021005700015175	0-48						US Patent # 7,267,976. Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts - Patents.com	www.patents.com	0	0		
931	chr18	45481403	45481819	3500407729	51		45481403	45481819	8421504	2	11,40	0,376	p	350040772900015057	39-90						No Slide Title	bioinfbook.org	0	0		
931	chr18	45481403	45481819	3500355377	51		45481403	45481819	8421504	2	11,40	0,376	p	350035537700015057	39-90						COMP 571 Bioinformatics: Sequence Analysis	edick.rutgers.edu	0	0		
931	chr18	45481403	45481819	3500211485	51		45481403	45481819	8421504	2	11,40	0,376	p	350021148500015050	39-90						No Slide Title	www.cs.uml.edu	0	0		
931	chr18	45481403	45481819	3500188478	51		45481403	45481819	8421504	2	11,40	0,376	p	350018847800015033	39-90						Pairwise Alignments	www.csus.edu	0	0		
931	chr18	45481403	45481819	3500175176	51		45481403	45481819	8421504	2	11,40	0,376	p	350017517600015011	39-90						Contents	www.ctu.edu.vn	0	0		
931	chr18	45481403	45481819	3500168195	51		45481403	45481819	8421504	2	11,40	0,376	p	350016819500015033	39-90						No Slide Title	ennedykrieger.org	0	0		
931	chr18	45481403	45481819	3500122314	51		45481403	45481819	8421504	2	11,40	0,376	p	350012231400015015	39-90						Bioinformatica 20-10-2011-t3-scoring matrices	ww.slideshare.net	0	0		
931	chr18	45481406	45481822	3500144158	51		45481406	45481822	8421504	2	8,43	0,373	p	350014415800015041	12-63						TH&#xc8;SE DE DOCTORAT Influence des conditions environnementales sur le m&#xe9;tabolisme de Plasmodium falciparum	www.theses.fr	0	0		
931	chr18	45481409	45481798	3500200287	24		45481409	45481798	8421504	2	5,19	0,370	c	350020028700000007	0-24						SequentialSynthesisandMethylationof PhosphatidylethanolaminePromoteLipidDroplet BiosynthesisandStabilityinTissueCultureand inVivo	www.jbc.org	0	0		
931	chr18	45481411	45481800	3500325156	24		45481411	45481800	8421504	2	3,21	0,368	c	350032515600000022,350032515600000003	0-24,0-24						B7-H3 AS A BIOMARKER FOR DIAGNOSING THE PROGRESSION AND EARLY LYMPH NODE METASTASIS OF CANCER - Patent application	www.faqs.org	0	0		GAPDH
931	chr18	45481411	45481800	3500298319	24		45481411	45481800	8421504	2	3,21	0,368	c	350029831900000005	0-24						UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER	Hoon	2007	0		
931	chr18	45481411	45481800	3500248072	24		45481411	45481800	8421504	2	3,21	0,368	c	350024807200000004	0-24						Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr	Hoon	2004	0		
931	chr18	45481411	45481800	3500207118	24		45481411	45481800	8421504	2	3,21	0,368	c	350020711800000024,350020711800000005	0-24,0-24						Utility Of High Molecular Weight Melanoma Associated Antigen In Diagnosis And Treatment Of Cancer 	.freshpatents.com	0	0		
931	chr18	45481411	45481800	3500200589	24		45481411	45481800	8421504	2	3,21	0,368	c	350020058900000005	0-24						USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS	Hoon	2010	0		
931	chr18	45481411	45481800	3500160938	24		45481411	45481800	8421504	2	3,21	0,368	c	350016093800000065	0-24						Utility Of Ret Mutant In Diagnosis And Treatment Of Melanoma 	.freshpatents.com	0	0		
931	chr18	45481411	45481800	3500140947	24		45481411	45481800	8421504	2	3,21	0,368	c	350014094700000011	0-24						DetectionofCirculatingTumorCellsinEarly-StageBreastCancer MetastasistoAxillaryLymphNodes	.aacrjournals.org	0	0		
931	chr18	45481411	45481800	3500101829	24		45481411	45481800	8421504	2	3,21	0,368	c	350010182900000023,350010182900000005	0-24,0-24						USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS - Patent application	www.faqs.org	0	0		
931	chr18	45481411	45481800	3500085192	24		45481411	45481800	8421504	2	3,21	0,368	c	350008519200000004	0-24						Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR	Hoon	2003	0		
116	chr18	45481780	45483851	3500459558	41		45481780	45483851	8421504	2	20,21	0,2050	c,g	350045955800000002,350045955800000002,350045955800000003	0-20,0-20,0-21		19580651	10.1186/cc7949	1364-8535	Critical Care	Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment	Li	2009	0		
116	chr18	45481780	45483851	3500452706	41		45481780	45483851	8421504	2	20,21	0,2050	c	350045270600000002,350045270600000003	0-20,0-21		23244248	10.1186/1471-2407-12-605	1471-2407	BMC Cancer	Stat3 is a positive regulator of gap junctional intercellular communication in cultured, human lung carcinoma cells	Geletu	2012	3		
116	chr18	45481780	45483851	3500450971	41		45481780	45483851	8421504	2	20,21	0,2050	c	350045097100000000,350045097100000001	0-20,0-21						&#x4e3b;&#x9898;&#xff1a;apoptosis | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
116	chr18	45481780	45483851	3500448805	41		45481780	45483851	8421504	2	20,21	0,2050	c	350044880500000002,350044880500000003	0-20,0-21		12410849	10.1046/j.1523-1755.62.s82.4.x	0085-2538	Kidney International	Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney	Ruiz-Ortega	2002	7		
116	chr18	45481780	45483851	3500337677	41		45481780	45483851	8421504	2	20,21	0,2050	c	350033767700000003,350033767700000002	0-20,0-21						Differential effects of the charge variants of human follicle-stimulating hormone	logy-journals.org	0	0		
116	chr18	45481780	45483851	3500257524	41		45481780	45483851	8421504	2	20,21	0,2050	c	350025752400000002,350025752400000003	0-20,0-21		23244248	10.1186/1471-2407-12-605		BMC Cancer	Stat3 is a positive regulator of gap junctional intercellular communication in cultured, human lung carcinoma cells	Mulu	2012	0		
116	chr18	45481780	45483851	3500166283	41		45481780	45483851	8421504	2	20,21	0,2050	c	350016628300000004,350016628300000005	0-20,0-21						MS-275 Scientists have recently implemented elements | Online Peptides Guide	cyclocytidine.com	0	0		
931	chr18	45481780	45481804	3500383658	24		45481780	45481804	8421504	1	24	0	c	350038365800000003	0-24		9689019			American Journal of Physiology - Renal Physiology	Activation of kininogen expression during distal nephron differentiation	El-Dahr	1998	0		GAPDH
931	chr18	45481780	45481804	3500255064	24		45481780	45481804	8421504	1	24	0	c	350025506400000002	0-24		9931127	10.1161/01.HYP.33.1.340	0194-911X	Hypertension	Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II&#x2013;Induced Hypertension	Harrison-Bernard	1999	6		
931	chr18	45481780	45481804	3500197360	24		45481780	45481804	8421504	1	24	0	c	350019736000000013	0-24						Sciences pour l&#x2019;Environnement Gay Lussac Biologie Cellulaire et Neurosciences	.univ-poitiers.fr	0	0		
931	chr18	45481783	45481831	3500121926	48		45481783	45481831	8421504	1	48	0	p	350012192600015014	0-48						 <HTML> <HEAD><TITLE>aaaC/a1/4a?a1/4eoa1/4a - c1ei1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4 | j-tokkyo	www.j-tokkyo.com	0	0		GAPDHS
116	chr18	45481784	45483832	3500400263	39		45481784	45483832	8421504	3	19,17,3	0,1938,2045	c	350040026300000002,350040026300000003	0-19,0-20			10.1113/jphysiol.2003.041921		The Journal of Physiology	Inhibition of small-conductance Cl&#x2212; channels by the interleukin-1&#x03b2;-stimulated production of superoxide in rabbit gastric parietal cells	Hideki	2003	0		
116	chr18	45481784	45483832	3500204256	39		45481784	45483832	8421504	3	19,17,3	0,1938,2045	c	350020425600000002,350020425600000003	0-19,0-20			10.1111/j.1469-7793.2003.00207.x	1469-7793	The Journal of Physiology	Inhibition of small-conductance Cl&#x2212; channels by the interleukin-1&#x03b2;-stimulated production of superoxide in rabbit gastric parietal cells - Sakai - 2004 - The Journal of Physiology - Wiley Online Library	Sakai	2003	0		
116	chr18	45481849	45483841	3500177649	50		45481849	45483841	8421504	4	12,12,14,12	0,301,1876,1980	c	350017764900000000,350017764900000001	0-24,0-26			10.1111/j.1742-4658.2005.04976.x	1742-4658	FEBS Journal	Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases - Endres - 2005 - FEBS Journal - Wiley Online Library	Endres	2005	0		
116	chr18	45481849	45482175	3500243747	32		45481849	45482175	8421504	3	12,13,7	0,301,319	c	350024374700000004	16-48		22464285	10.1016/j.atherosclerosis.2012.02.040		Atherosclerosis	&#x03c9;-6 lipids regulate PPAR turnover via reciprocal switch between PGC-1 alpha and ubiquitination	Jia	June	0		
116	chr18	45481849	45482162	3500417404	24		45481849	45482162	8421504	2	12,12	0,301	c	350041740400000002	0-24		14752064	10.1124/jpet.103.063693	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Inhibition of Nitric Oxide Generation by 23,24-Dihydrocucurbitacin D in Mouse Peritoneal Macrophages	Park	2004	0		
116	chr18	45481849	45482162	3500403171	24		45481849	45482162	8421504	2	12,12	0,301	c	350040317100000018	0-24		10625670	10.1074/jbc.275.2.1247	0021-9258	Journal of Biological Chemistry	Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin	Haeseleer	2000	5		
116	chr18	45481849	45482162	3500301352	24		45481849	45482162	8421504	2	12,12	0,301	c	350030135200000018	0-24					The Journal of biological chemistry	Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin	Francoise	2000	0		
932	chr18	45482173	45482197	3500460711	24		45482173	45482197	8421504	1	24	0	c	350046071100000017	0-24		22573375	10.1152/ajprenal.00198.2011		American Journal of Physiology - Renal Physiology	Hypotonic stress upregulates &#x03b2;- and &#x03b3;-ENaC expression through suppression of ERK by inducing MKP-1	Niisato	2012	0		
932	chr18	45482512	45482535	3500317084	23		45482512	45482535	8421504	1	23	0	c	350031708400000014	0-23						Reprogramming of Human Gingival and Periodontal Fibroblasts to	www.docstoc.com	0	0		
932	chr18	45483725	45483839	3500445731	24		45483725	45483839	8421504	2	14,10	0,104	c	350044573100000017	0-24						&#x4e3b;&#x9898;&#xff1a;Genome-Wide | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
932	chr18	45483725	45483839	3500349075	24		45483725	45483839	8421504	2	14,10	0,104	c	350034907500000058,350034907500000019	0-24,0-24						Transgenic animal models of disease - Patent application	www.faqs.org	0	0		
932	chr18	45483725	45483838	3500326402	23		45483725	45483838	8421504	2	14,9	0,104	c	350032640200000014	0-23						Activation of Nicotinamide N-Methyltransferase Gene Promoter by Hepatocyte Nuclear Factor-1 in Human Papillary Thyroid Cancer Cells	.endojournals.org	0	0		GAPDH
932	chr18	45483725	45483838	3500290515	23		45483725	45483838	8421504	2	14,9	0,104	c	350029051500000020	26-49						Arthritis & Rheumatism (Jonuary 2005)	lib.ajaums.ac.ir	0	0		
932	chr18	45483726	45483839	3500418355	23		45483726	45483839	8421504	2	13,10	0,103	c	350041835500000014	20-43						Funconalanalysisofhumanhyaluronan )synthase3 splicingvariant2	duisburg-essen.de	0	0		
932	chr18	45483727	45483840	3500274287	23		45483727	45483840	8421504	2	12,11	0,102	c	350027428700000015	0-23						Supporting Information - ID6 piPSC cells were seeded onto 12-well plates ( 10	www.pnas.org	0	0		
932	chr18	45483736	45483853	3500291897	27		45483736	45483853	8421504	2	3,24	0,93	c	350029189700000003	0-27						Pharmacology Pharmacy and African Journal of	demicjournals.org	0	0		
932	chr18	45485885	45486082	3500299605	40		45485885	45486082	8421504	3	2,18,20	0,84,177	c	350029960500000026,350029960500000027	0-20,0-20						DIFFERENTIATION OF NON-EMBRYONIC STEM CELLS TO CELLS HAVING A PANCREATIC PHENOTYPE	Verfaillie	2006	0		TMEM147
932	chr18	45485885	45486082	3500251976	40		45485885	45486082	8421504	3	2,18,20	0,84,177	c	350025197600000104,350025197600000026,350025197600000105,350025197600000027	0-20,0-20,0-20,0-20						DIFFERENTIATION OF NON-EMBRYONIC STEM CELLS TO CELLS HAVING A PANCREATIC PHENOTYPE - Patent application	www.faqs.org	0	0		TMEM147
932	chr18	45489102	45492122	3500099979	40		45489102	45492122	8421504	2	20,20	0,3000	c,g	350009997900000015,350009997900000015,350009997900000014,350009997900000014	0-20,0-20,0-20,0-20		14734521	10.1084/jem.20031677	0022-1007	The Journal of Experimental Medicine	Medullary Epithelial Cells of the Human Thymus Express a Highly Diverse Selection of Tissue-specific Genes Colocalized in Chromosomal Clusters	Gotter	2004	14		ATP4A
932	chr18	45489102	45492122	3500099954	40		45489102	45492122	8421504	2	20,20	0,3000	c,g	350009995400000016,350009995400000016,350009995400000015,350009995400000015	0-20,0-20,0-20,0-20						Medullary Epithelial Cells of the Human Thymus Express a Highly Diverse Selection of Tissue-speci&#xfb01;c Genes Colocalized in Chromosomal Clusters	jem.rupress.org	0	0		ATP4A
932	chr18	45493705	45493980	3500233231	174		45493705	45493980	8421504	3	48,60,66	0,54,209	p	350023323100015032	0-177						Structure of a Plasmodium yoelii gene-encoded protein homologous to the Ca	cs.biologists.org	0	0		ATP4A
932	chr18	45498453	45498815	3500284049	69		45498453	45498815	8421504	2	41,28	0,334	p	350028404900015011	0-69						Purified vacuolating toxin from helicobacter pylori and methods to use same	Blaser	1993	0		ATP4A
932	chr18	45559383	45559406	3500201554	23		45559383	45559406	8421504	1	23	0	g	350020155400000039	12-35						Gene amplification methods	Denney	1996	0		
933	chr18	45621007	45622141	3500185560	24		45621007	45622141	8421504	3	1,18,5	0,1108,1129	c	350018556000000061	9-33						Family of high affinity, modified antibodies for cancer treatment	Mezes	1993	0		
933	chr18	45648351	45648724	3500186119	138		45648351	45648724	8421504	2	108,30	0,343	p	350018611900015105	0-138						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		ETV2
933	chr18	45648351	45648724	3500095373	138		45648351	45648724	8421504	2	108,30	0,343	p	350009537300015105	0-138						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		ETV2
933	chr18	45684633	45684656	3500370067	23		45684633	45684656	8421504	1	23	0	c	350037006700000076	6-29						SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 - Patent application	www.faqs.org	0	0		
933	chr18	45737386	45739393	3500449572	43		45737386	45739393	8421504	2	22,21	0,1986	c	350044957200000001,350044957200000000	0-22,0-21		18460468	10.1074/jbc.M801014200	0021-9258	Journal of Biological Chemistry	Differential Isoform Expression and Interaction with the P32 Regulatory Protein Controls the Subcellular Localization of the Splicing Factor U2AF26	Heyd	2008	5		
933	chr18	45739118	45739364	3500166809	70		45739118	45739364	8421504	3	23,25,22	0,94,224	g	350016680900000000	100-183		16449647	10.1128/MCB.26.4.1347-1354.2006	0270-7306	Molecular and Cellular Biology	Transcriptional Regulation of PEN-2, a Key Component of the &#x03b3;-Secretase Complex, by CREB	Wang	2006	6		
934	chr18	45749624	45749655	3500312497	31		45749624	45749655	8421504	1	31	0	g	350031249700000009	14-45						Transduction of phosphorylated heat shock-related protein 20, HSP20, prevents vasospasm of human umbilical artery smooth muscle	ap.physiology.org	0	0		
934	chr18	45814251	45814277	3500222415	26		45814251	45814277	8421504	1	26	0	c,g	350022241500000001,350022241500000002	8-34,9-30						PhosphorylationofNephrinTriggersCa2 Signalingby RecruitmentandActivationofPhospholipaseC-	www.jbc.org	0	0		
934	chr18	45830424	45830454	3500429623	24		45830424	45830454	8421504	3	4,12,8	0,5,22	g	350042962300000000	6-31						Mycobacterium fol A gene that encodes for the enzyme dihydrofolate reductase	Barrow	1999	0		
934	chr18	45830424	45830454	3500024274	24		45830424	45830454	8421504	3	4,12,8	0,5,22	g	350002427400000000	6-31						US Patent # 6,559,295. Mycobacterium fol A gene that encodes for the enzyme dihydrofolate reductase - Patents.com	www.patents.com	0	0		
934	chr18	45847314	45854181	3500382900	56		45847314	45854181	8421504	3	24,2,30	0,948,6837	c	350038290000000034,350038290000000055	0-26,18-48					Patent	Methods for modulating transcription from the amyloid &#x03b2;-protein precursor (APP) promoter (Patent US:5643726)	Kovacs	1997	0		
934	chr18	45847314	45854181	3500294547	97		45847314	45854181	8421504	5	24,2,24,17,30	0,948,1068,1906,6837	c	350029454700000034,350029454700000037,350029454700000055	0-26,0-41,18-48					Patent	Methods for modulating transcription from the amyloid &#x03b2;-protein precursor (APP) promoter (Patent US:5643726)	Kovacs	1997	0		
934	chr18	45847314	45850928	3500011575	74		45847314	45850928	8421504	3	24,2,48	0,948,3566	c	350001157500000032,350001157500000049	0-26,0-48						Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter	M	2001	0		
934	chr18	45848382	45854181	3500380736	119		45848382	45854181	8421504	4	24,17,48,30	0,838,2498,5769	c	350038073600000035,350038073600000049,350038073600000058	0-41,0-48,18-48						Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter	KOVACS	1997	0		
934	chr18	45852377	45852610	3500056556	132		45852377	45852610	8421504	3	39,27,66	0,137,167	p	350005655600015033	0-138						protein Identification IB protein amyloid Alzheimer	www.pnas.org	0	0		APLP1
934	chr18	45852601	45854181	3500080131	72		45852601	45854181	8421504	3	27,15,30	0,1517,1550	c	350008013100000057,350008013100000058	6-48,18-48						METHODS FOR MODULATING TRANSCRIPTION FROM THE AMYLOID &#x03b2;-PROTEIN PRECURSOR (APP) PROMOTER	Kovacs	1996	0		
934	chr18	45856464	45856509	3500457444	45		45856464	45856509	8421504	1	45	0	p	350045744400015009	0-45						REDUCTION OF BETA-AMYLOID LEVELS BY TREATMENT WITH THE SMALL MOLECULE DIFFERENTIATION-INDUCING FACTOR - Patent application	www.faqs.org	0	0		APLP1
934	chr18	45860605	45860633	3500189016	24		45860605	45860633	8421504	2	7,17	0,11	g	350018901600000648	0-24						Methods of inhibiting locomotor damage following spinal cord injury with &#x03b1; D-specific antibodies	Gallatin	2000	0		
934	chr18	45873783	45873849	3500198752	66		45873783	45873849	8421504	1	66	0	p	350019875200015016,350019875200015024,350019875200015034	0-63,0-63,12-78						Inhibition of trem receptor signaling with peptide variants	Sigalov	2011	0		
936	chr18	46083903	46085671	3500039797	40		46083903	46085671	8421504	3	20,15,5	0,1557,1763	c	350003979700000006,350003979700000007	0-20,0-20		19269960	10.1074/jbc.M900561200		The Journal of Biological Chemistry	Calpain Expression and Activity during Lens Fiber Cell Differentiation	Alicia	2009	0		
936	chr18	46083932	46085431	3500302104	23		46083932	46085431	8421504	2	8,15	0,1484	c	350030210400000027	0-23						DELINEAMENTO IN SILICO E AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS	www.ufpel.tche.br	0	0		CAPNS1
937	chr18	46182509	46182535	3500374909	26		46182509	46182535	8421504	1	26	0	c	350037490900000422	0-26						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
938	chr18	46349475	46349500	3500115313	23		46349475	46349500	8421504	2	11,12	0,13	g	350011531300000096	10-33						Protective helicobacter antigens	Doidge	1997	0		
940	chr18	46627999	46628022	3500359474	23		46627999	46628022	8421504	1	23	0	c	350035947400000024	2-25						US Patent # 7,501,131. Haemophilus influenzae type IV pili - Patents.com	www.patents.com	0	0		
940	chr18	46627999	46628022	3500246549	23		46627999	46628022	8421504	1	23	0	c	350024654900000023	5-28						Haemophilus influenzae type IV pili - Patent application	www.faqs.org	0	0		
941	chr18	46790446	46790472	3500349145	23		46790446	46790472	8421504	2	12,11	0,15	c	350034914500000598	12-35						Novel Human Beta-2 Integrin Alpha Subunit 	.freshpatents.com	0	0		
941	chr18	46790446	46790472	3500247922	23		46790446	46790472	8421504	2	12,11	0,15	c	350024792200000595	12-35						Human B2 integrin alpha subunit antibodies	Gallatin	1996	0		
942	chr18	46908994	46909017	3500011328	23		46908994	46909017	8421504	1	23	0	c	350001132800000239	11-34						US Patent # 7,119,183. Rapid immunoselection cloning method - Patents.com	www.patents.com	0	0		
946	chr18	47362492	47362519	3500052585	27		47362492	47362519	8421504	1	27	0	c	350005258500000003	0-27		15234908	10.1152/ajplung.00398.2003		American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of CPI-17 in the regulation of endothelial cytoskeleton	Kolosova	2004	0		
946	chr18	47395532	47400305	3500007194	83		47395532	47400305	8421504	3	42,19,22	0,3482,4751	c	350000719400000385,350000719400000382,350000719400000407,350000719400000252	0-42,0-38,16-49,0-34						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
946	chr18	47426808	47426834	3500317119	23		47426808	47426834	8421504	2	9,14	0,12	g	350031711900000022,350031711900000021	1-24,1-24						Molecular cloning of doublesex and mab-3-related transcription factor 1, forkhead transcription factor gene 2, and two types of cytochrome P450 aromatase in Southern cat&#xfb01;sh and their possible roles in sex differentiation	logy-journals.org	0	0		
946	chr18	47434678	47434703	3500158521	25		47434678	47434703	8421504	1	25	0	c	350015852100000010	0-25		19955484	10.1152/ajpcell.00251.2009		American journal of physiology Cell physiology	Electrophysiological properties of human induced pluripotent stem cells.	Jiang	2010	0		
947	chr18	47489943	47489970	3500006632	23		47489943	47489970	8421504	2	12,11	0,16	g	350000663200000030	0-23						Chimeric recombinant antigens of Toxoplasma gondii 	Gargano	2007	0		
947	chr18	47538034	47540291	3500164250	162		47538034	47540291	8421504	3	93,48,21	0,1141,2236	p,g	350016425000015004,350016425000000001	0-141,0-21						Retina expresses a novel variant of the ryanodine receptor	anatomy.upenn.edu	0	0		
947	chr18	47545096	47545122	3500398934	26		47545096	47545122	8421504	1	26	0	c	350039893400000000,350039893400000005	0-26,0-26						Genetic Test For PSE-Susceptible Turkeys - Patent application	www.faqs.org	0	0		
947	chr18	47545096	47545122	3500391571	26		47545096	47545122	8421504	1	26	0	c	350039157100000000	0-26						Genetic test for PSE-susceptible turkeys	Chiang	2005	0		
947	chr18	47550326	47550403	3500405016	48		47550326	47550403	8421504	2	28,20	0,57	c,g	350040501600000001,350040501600000004,350040501600000004	0-28,0-20,0-20						Novel ryanodine-binding properties in mammalian retina	anatomy.upenn.edu	0	0		
947	chr18	47551694	47551768	3500071352	45		47551694	47551768	8421504	3	14,7,24	0,17,50	c	350007135200000000,350007135200000001	0-21,9-33			10.1590/S1516-35982006000700021	1516-3598	Revista Brasileira de Zootecnia	Revista Brasileira de Zootecnia - Efeito do gen&#xf3;tipo halotano, da ractopamina e do sexo do animal na qualidade da carne su&#xed;na	Bridi	2006	0		
947	chr18	47551704	47551766	3500052918	62		47551704	47551766	8421504	1	62	0	c	350005291800000011,350005291800000003	0-47,0-25						UNIVERSITA' DEGLI STUDI DI PADOVA Sede Amministrativa: Universit&#xe0; degli Studi di Padova SCUOLA DI DOTTORATO DI RICERCA IN : Scienze Veterinarie CICLO XX	arch.cab.unipd.it	0	0		
947	chr18	47551787	47551812	3500110543	25		47551787	47551812	8421504	1	25	0	c	350011054300000003	0-25						&#x010c;ESK&#xc1; ZEM&#x011a;D&#x011a;LSK&#xc1; UNIVERZITA V PRAZE Fakulta agrobiologie, potravinov&#xfd;ch a p&#x0159;&#xed;rodn&#xed;ch zdroj&#x016f;	w.agrobiologie.cz	0	0		RYR1
948	chr18	47693854	47693878	3500344570	24		47693854	47693878	8421504	1	24	0	c	350034457000000190	20-44						Antibodies Directed to HER-3 and Uses Thereof - Patent application	www.faqs.org	0	0		
948	chr18	47704114	47704142	3500367838	25		47704114	47704142	8421504	2	5,20	0,8	c	350036783800000274	2-27						 <HTML> <HEAD><TITLE>Show BLAST File</TITLE></HEAD> <BODY BGCOLOR=ffffff><BR> <br> <A NAME=top> <P	rth.lab.nig.ac.jp	0	0		
948	chr18	47704600	47704629	3500405016	26		47704600	47704629	8421504	2	21,5	0,24	c	350040501600000006	14-40						Novel ryanodine-binding properties in mammalian retina	anatomy.upenn.edu	0	0		
949	chr18	47732399	47732423	3500464199	24		47732399	47732423	8421504	1	24	0	c	350046419900000031	0-24				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		EIF3K
949	chr18	47742841	47814470	3500417510	2733		47742841	47814470	8421504	21	162,115,120,87,88,79,82,86,93,231,148,151,109,141,183,135,180,147,81,159,156	0,43936,44281,47850,48753,50727,52028,52832,57332,59020,59822,63865,66372,66594,66824,67114,68264,69179,70178,71210,71473	p	350041751000015000	0-2733						KEGG T01001: 81	www.genome.jp	0	0		EIF3K,ACTN4
949	chr18	47742841	47814470	3500033422	2733		47742841	47814470	8421504	21	162,115,120,87,88,79,82,86,93,231,148,151,109,141,183,135,180,147,81,159,156	0,43936,44281,47850,48753,50727,52028,52832,57332,59020,59822,63865,66372,66594,66824,67114,68264,69179,70178,71210,71473	p	350003342200015000	0-2733						KEGG T01001: 81	www.genome.jp	0	0		EIF3K,ACTN4
949	chr18	47742841	47742866	3500366772	25		47742841	47742866	8421504	1	25	0	c	350036677200000012,350036677200000004	9-34,9-34						METHODS AND COMPOSITIONS RELATED TO IDENTIFYING PROTEIN-PROTEIN INTERACTIONS - Patent application	www.faqs.org	0	0		
949	chr18	47790757	47795743	3500174615	42		47790757	47795743	8421504	2	21,21	0,4965	c	350017461500000009,350017461500000011	0-21,0-21						Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis. - ResearchGate	.researchgate.net	0	0		
949	chr18	47801981	47802012	3500418514	24		47801981	47802012	8421504	3	6,6,12	0,10,19	c	350041851400000046	22-46						Human platelet-derived growth factor receptor extracellular domain antibodies	Wolf	1995	0		
949	chr18	47801981	47802012	3500196657	24		47801981	47802012	8421504	3	6,6,12	0,10,19	c	350019665700000162	22-46						Human Platelet-derived Growth Factor Receptors 	.freshpatents.com	0	0		
949	chr18	47806849	47809238	3500047406	33		47806849	47809238	8421504	2	8,25	0,2364	c	350004740600000008	0-33		18487604	10.1074/mcp.M800007-MCP200	1535-9476	Molecular & Cellular Proteomics	Targets of Caspase-6 Activity in Human Neurons and Alzheimer Disease	Klaiman	2008	7		
949	chr18	47809223	47809292	3500150092	69		47809223	47809292	8421504	1	69	0	p	350015009200015000	0-69		16751418		0022-1767	The Journal of Immunology	Differential Binding of Cross-Reactive Anti-DNA Antibodies to Mesangial Cells: The Role of &#x03b1;-Actinin	Zhao	2006	6		ACTN4
949	chr18	47812149	47813066	3500295286	39		47812149	47813066	8421504	3	18,2,19	0,870,898	c,g	350029528600000000,350029528600000001,350029528600000001	0-20,0-19,0-19						Molecular mechanisms underlying nucleocytoplasmic shuttling of actinin-4	cs.biologists.org	0	0		ACTN4
950	chr18	47910607	47910630	3500293286	23		47910607	47910630	8421504	1	23	0	g	350029328600000090	0-23					Patent	Method of prognosing cancers (Patent EP:2295602)	Nakamura	2012	0		HNRNPL
950	chr18	47910607	47910630	3500288139	23		47910607	47910630	8421504	1	23	0	g	350028813900000206	0-23						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		HNRNPL
951	chr18	48056659	48056704	3500060964	45		48056659	48056704	8421504	1	45	0	p	350006096400015109	0-45						METHODS TO IDENTIFY COMPOUNDS USEFUL FOR TUMOR SENSITIZATION TO DNA DAMAGE - Patent application	www.faqs.org	0	0		SIRT2
953	chr18	48269640	48269664	3500291324	24		48269640	48269664	8421504	1	24	0	g	350029132400000007	0-24		18217898	10.1111/j.1365-2141.2007.06930.x	1365-2141	British Journal of Haematology	Deficient RPS19 protein production induces cell cycle arrest in erythroid progenitor cells - Kuramitsu - 2008 - British Journal of Haematology - Wiley Online Library	Kuramitsu	2008	0		
953	chr18	48360778	48360803	3500034114	25		48360778	48360803	8421504	1	25	0	c	350003411400000012,350003411400000013	0-25,0-25		19934222	10.1242/jcs.050724	0021-9533	Journal of Cell Science	MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices	Fisher	2009	6		PAK4
953	chr18	48360778	48360803	3500003722	25		48360778	48360803	8421504	1	25	0	c	350000372200000013,350000372200000012	0-25,0-25		19934222	10.1242/jcs.050724		Journal of Cell Science	MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices	Kevin	2009	0		PAK4
953	chr18	48360811	48360835	3500272696	24		48360811	48360835	8421504	1	24	0	g	350027269600000067	7-31						US Patent # 6,861,239. Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof - Patents.com	www.patents.com	0	0		
954	chr18	48481516	48481541	3500077684	25		48481516	48481541	8421504	1	25	0	c	350007768400000007	0-25		18987311	10.1073/pnas.0710725105	0027-8424	Proceedings of the National Academy of Sciences	The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene	Lin	2008	10		
954	chr18	48485564	48487441	3500453732	105		48485564	48487441	8421504	2	60,45	0,1832	p	350045373200015012	0-105						intersex, a gene required for female sexual development in Drosophila, is expressed in both sexes and functions together with doublesexto regulate terminal differentiation	ev.biologists.org	0	0		MED29
954	chr18	48495464	48495683	3500396186	219		48495464	48495683	8421504	1	219	0	p	350039618600015011,350039618600015012,350039618600015013	3-84,0-84,0-54						Compositions and Methods for the Delivery of Biologically Active RNAs	Polach	2012	0		ZFP36
954	chr18	48495465	48495546	3500197002	41		48495465	48495546	8421504	2	22,19	0,62	c,g	350019700200000000,350019700200000001,350019700200000001	0-22,0-19,0-19		15280467	10.1128/JVI.78.16.8582-8592.2004	0022-538X	Journal of Virology	Herpes Simplex Virus 1 Induces Cytoplasmic Accumulation of TIA-1/TIAR and both Synthesis and Cytoplasmic Accumulation of Tristetraprolin, Two Cellular Proteins That Bind and Destabilize AU-Rich RNAs	Esclatine	2004	5		ZFP36
955	chr18	48511119	48511144	3500084218	24		48511119	48511144	8421504	2	19,5	0,20	g	350008421800000055	10-35						Attenuated Salmonella Sp12 Mutants As Antigen Carriers 	.freshpatents.com	0	0		
955	chr18	48514829	48517172	3500259057	402		48514829	48517172	8421504	6	143,48,7,54,102,48	0,263,412,455,2057,2295	p	350025905700015036,350025905700015035,350025905700015034,350025905700015033	0-78,0-120,0-84,0-120						Kernimport und nukleolare Akkumulation von bakteriellen ribosomalen Proteinen	ie.uni-hamburg.de	0	0		RPS16
955	chr18	48563997	48564021	3500235534	23		48563997	48564021	8421504	2	9,14	0,10	g	350023553400000083	9-32						PLANT SNF1-RELATED PROTEIN KINASE GENE - Patent application	www.faqs.org	0	0		
960	chr18	49162416	49188728	3500167223	1472		49162416	49188728	8421504	14	21,74,103,88,215,129,123,69,66,132,154,112,129,57	0,244,1286,1478,2068,2387,3554,4801,6099,7616,8203,16763,18272,26255	p,c,g	350016722300000003,350016722300000003,350016722300015023,350016722300000009,350016722300015022,350016722300015021,350016722300015032,350016722300015008,350016722300015020,350016722300015031,350016722300015007,350016722300015019,350016722300015018,350016722300015005,350016722300015017,350016722300015016,350016722300015015,350016722300015014,350016722300015013,350016722300015012,350016722300000002	0-21,0-21,6-126,0-20,6-126,6-126,6-126,6-126,6-126,6-126,6-126,6-126,6-126,6-126,6-126,6-126,6-126,6-126,6-126,0-126,0-20						Molecular characterization of the encoding regions and tissue expression analyses for three novel buffalo AKT genes AKT1 AKT2 and AKT3	ls.tubitak.gov.tr	0	0		
960	chr18	49164485	49164586	3500348876	40		49164485	49164586	8421504	2	20,20	0,81	c,g	350034887600000009,350034887600000008,350034887600000008	0-20,0-20,0-20						COMPOSITIONS AND METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER AND PROGRESSION, AND FOR SCREENING ANTI-CANCER AGENTS	Tsichlis	2011	0		AKT2
960	chr18	49164507	49180764	3500011205	474		49164507	49180764	8421504	12	45,96,45,45,3,42,18,45,1,44,45,45	0,93,1478,4023,4071,5525,5570,6217,6265,14672,14719,16212	p	350001120500015078,350001120500015051,350001120500015101,350001120500015076,350001120500015072,350001120500015068,350001120500015066,350001120500015065,350001120500015064,350001120500015062	0-45,0-45,0-45,0-45,0-45,0-108,0-45,0-45,0-45,0-45						Determination of responders to chemotherapy - Patent # 7655414 - PatentGenius	.patentgenius.com	0	0		AKT2
960	chr18	49164615	49180763	3500037315	73		49164615	49180763	8421504	2	48,25	0,16123	c	350003731500000028,350003731500000009	0-48,19-44						ACTIVATION OF MUTATED RAC-PK - Patent application	www.faqs.org	0	0		
960	chr18	49164672	49164830	3500219982	54		49164672	49164830	8421504	2	27,27	0,131	p	350021998200015001	0-54		21670275	10.1073/pnas.1011665108	0027-8424	Proceedings of the National Academy of Sciences	Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species	Wani	2011	10		AKT1
960	chr18	49164693	49164884	3500337660	60		49164693	49164884	8421504	3	6,33,21	0,110,170	p	350033766000015029	24-108						Methods - US Patent 7083511 Description	ww.patentstorm.us	0	0		AKT1
960	chr18	49179213	49179238	3500228308	25		49179213	49179238	8421504	1	25	0	c	350022830800000002	20-45						Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells	biomedcentral.com	0	0		
960	chr18	49179213	49179238	3500126191	25		49179213	49179238	8421504	1	25	0	c	350012619100000002	20-45		22799881	10.1186/1471-2407-12-291	1471-2407	BMC Cancer	Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells	Gaben	2012	3		
960	chr18	49180767	49188714	3500245691	90		49180767	49188714	8421504	3	45,2,43	0,48,7904	p	350024569100015194	0-90						 Transformation System In The Field Of Filamentous Fungal Hosts 	www.docstoc.com	0	0		
960	chr18	49180773	49188696	3500183613	69		49180773	49188696	8421504	2	44,25	0,7898	p	350018361300015053	0-69						Myosin-X associates with regions of dynamic actin	cs.biologists.org	0	0		AKT2
960	chr18	49188687	49188717	3500360666	30		49188687	49188717	8421504	1	30	0	c	350036066600000002	0-30		17804756	10.1158/0008-5472.CAN-06-4069	0008-5472	Cancer Research	Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms	Hudson	2007	8		
960	chr18	49188687	49188717	3500179385	30		49188687	49188717	8421504	1	30	0	c	350017938500000002	0-30		17804756	10.1158/0008-5472.CAN-06-4069	0008-5472	Cancer Research	Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms	Hudson	2007	8		
960	chr18	49206223	49206247	3500152160	23		49206223	49206247	8421504	2	13,10	0,14	g	350015216000000072	10-40						Short Communication A 4 Mb high resolution BAC contig on bovine chromosome 1q12 and comparative analysis with human chromosome 21q22	loads.hindawi.com	0	0		
960	chr18	49254648	49254777	3500134153	30		49254648	49254777	8421504	2	18,12	0,117	c	350013415300000000	0-30		9813063	10.1074/jbc.273.47.31494	0021-9258	Journal of Biological Chemistry	Expression of a Novel Murine Phospholipase D Homolog Coincides with Late Neuronal Development in the Forebrain	Pedersen	1998	5		PLD3
961	chr18	49385912	49385938	3500187973	23		49385912	49385938	8421504	2	16,7	0,19	c	350018797300000077	11-39						Tomatoes Having Reduced Polygalacturonase Activity Caused by Non-Transgenic Mutations in the Polygalacturonase Gene - Patent application	www.faqs.org	0	0		
962	chr18	49446604	49446634	3500405394	27		49446604	49446634	8421504	3	16,6,5	0,17,25	g	350040539400000011	3-30						Vaccine	005.pasteur.ac.ir	0	0		
963	chr18	49561228	49566613	3500396186	291		49561228	49566613	8421504	4	73,41,129,48	0,2904,2948,5337	p	350039618600015003,350039618600015004	0-87,0-204						Compositions and Methods for the Delivery of Biologically Active RNAs	Polach	2012	0		SNRPA
963	chr18	49561228	49566613	3500175950	294		49561228	49566613	8421504	3	73,173,48	0,2904,5337	p	350017595000015000,350017595000015043,350017595000015001,350017595000015044,350017595000015045,350017595000015047	0-87,0-45,0-207,0-45,0-45,0-45						Compositions And Methods For The Delivery Of Biologically Active RNAs - Patent application	www.faqs.org	0	0		SNRPA
963	chr18	49561231	49566613	3500447940	291		49561231	49566613	8421504	3	70,173,48	0,2901,5334	p	350044794000015011	0-291						MULTIPLE DOMAIN PROTEINS	Chalasani	2009	0		SNRPA
963	chr18	49561243	49566598	3500164237	264		49561243	49566598	8421504	3	58,173,33	0,2889,5322	p	350016423700015027,350016423700015030	9-171,0-102						Caracteritzaci&#xf3; cin&#xe8;tica de la formaci&#xf3; de fibres amiloides i cerca de funcions remotes de dominis d'activaci&#xf3; de procarboxipeptidases humanes	www.tdx.cat	0	0		SNRPA
963	chr18	49569175	49569241	3500408981	66		49569175	49569241	8421504	1	66	0	p	350040898100015012	0-66						4 Materials and Methods	diss.fu-berlin.de	0	0		SNRPA
963	chr18	49574086	49574870	3500058257	58		49574086	49574870	8421504	4	8,14,12,24	0,9,276,760	c,g	350005825700000005,350005825700000030	15-43,0-36						Melanoma-inhibiting protein	www.devileye.net	0	0		
963	chr18	49574109	49574278	3500257699	39		49574109	49574278	8421504	2	19,20	0,149	c,g	350025769900000019,350025769900000019,350025769900000020	0-19,0-19,0-20						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
963	chr18	49593485	49594428	3500307359	303		49593485	49594428	8421504	6	111,9,42,80,16,45	0,114,566,623,879,898	p	350030735900015106,350030735900015110	0-162,0-141						48 human secreted proteins	Komatsoulis	2000	0		
963	chr18	49593539	49593590	3500115394	51		49593539	49593590	8421504	1	51	0	p	350011539400015022	0-51						Method for identification of genes involved in specific diseases	Harris	2002	0		EGLN2
965	chr18	49834610	49838990	3500077888	39		49834610	49838990	8421504	3	20,5,14	0,4189,4366	c	350007788800000001,350007788800000017	0-20,0-19						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
965	chr18	49841441	49841470	3500155608	26		49841441	49841470	8421504	3	13,5,8	0,14,21	c	350015560800000085	3-29						Borrelia burdorferi Osp A and B proteins and immunogenic peptides	Barbour	1995	0		
965	chr18	49843059	49844533	3500015640	46		49843059	49844533	8421504	2	23,23	0,1451	c	350001564000000005,350001564000000004	0-23,0-23		15802384	10.1124/dmd.104.002741	1521-009X (Online)	Drug Metabolism and Disposition	IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR	Kobayashi	2005	0		CYP2B6
965	chr18	49844505	49844743	3500315671	90		49844505	49844743	8421504	2	83,7	0,231	p	350031567100015016	54-144						Cytochrome P450 1A-Substrate Interactions: Determinants of Substrate Selectivity and Stereo- and Regiospecificity of Oxidation	olar.wvu.edu:1801	0	0		
965	chr18	49844517	49844562	3500416267	45		49844517	49844562	8421504	1	45	0	p	350041626700015107	0-45						To my parents and my wife, Wakana	.nottingham.ac.uk	0	0		
965	chr18	49932537	49932562	3500194368	23		49932537	49932562	8421504	2	6,17	0,8	c	350019436800000901	0-23						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
966	chr18	50022387	50024384	3500063313	87		50022387	50024384	8421504	2	64,23	0,1974	p	350006331300015003	0-87		17693683	10.1074/mcp.M700120-MCP200	1535-9476	Molecular & Cellular Proteomics	Quantitative Phosphoproteome Profiling of Wnt3a-mediated Signaling Network	Tang	2007	7		HNRNPUL1
966	chr18	50047864	50047889	3500271820	24		50047864	50047889	8421504	2	15,9	0,16	c	350027182000000290	0-24						Cell cycle genes and related methods	Forster	2004	0		
966	chr18	50060688	50060717	3500400238	24		50060688	50060717	8421504	2	16,8	0,21	c	350040023800000475	23-48						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
120	chr18	50068307	50082988	3500258129	1475		50068307	50082988	8421504	9	174,154,148,78,118,161,64,13,565	0,878,6832,7139,9286,10600,13969,14035,14116	g	350025812900000094,350025812900000079	0-1475,0-1475						Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases - Patent application	www.faqs.org	0	0		
120	chr18	50068322	50082556	3500399804	41		50068322	50082556	8421504	2	20,21	0,14213	c,g	350039980400000001,350039980400000001,350039980400000000	0-20,0-20,0-21		17344902	10.1038/sj.gt.3302938	0969-7128	Gene Therapy	Adeno-associated viral gene transfer of transforming growth factor-&#x03b2;1 to human mesenchymal stem cells improves cartilage repair	Pagnotto	2007	4		TGFB1,B9D2
120	chr18	50068322	50082555	3500257458	43		50068322	50082555	8421504	2	21,22	0,14211	c	350025745800000001,350025745800000000	8-29,6-28						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
120	chr18	50068322	50075165	3500411771	41		50068322	50075165	8421504	2	20,21	0,6822	c	350041177100000009,350041177100000008	0-20,0-21		11689458	10.1096/fj.01-0150com	0892-6638	The FASEB Journal	5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor	ROMANO	2001	6		TGFB1
120	chr18	50068325	50075165	3500441333	42		50068325	50075165	8421504	2	21,21	0,6819	c,g	350044133300000009,350044133300000009,350044133300000008	0-21,0-21,0-21		11877472	10.1172/JCI14380	0021-9738	The Journal of Clinical Investigation	Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosis	Karandikar	2002	13		TGFB1
120	chr18	50068325	50075165	3500308037	42		50068325	50075165	8421504	2	21,21	0,6819	c,g	350030803700000009,350030803700000009,350030803700000008	0-21,0-21,0-21						Glatiramer acetate (Copaxone) therapy See related Commentary on pages 581&#x2013;584. induces CD8 T cell responses in patients with multiple sclerosis	www.jci.org	0	0		TGFB1
120	chr18	50068325	50075165	3500302580	42		50068325	50075165	8421504	2	21,21	0,6819	c,g	350030258000000024,350030258000000024,350030258000000023	0-21,0-21,0-21			10.1002/art.20596	1529-0131	Arthritis & Rheumatism	Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes - Martin - 2004 - Arthritis & Rheumatism - Wiley Online Library	Martin	2004	0		TGFB1
120	chr18	50068325	50075165	3500221158	42		50068325	50075165	8421504	2	21,21	0,6819	c,g	350022115800000009,350022115800000009,350022115800000008	0-21,0-21,0-21			10.1172/JCI14380		The Journal of Clinical Investigation	Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosis	Nitin	2002	0		TGFB1
966	chr18	50068325	50068360	3500392138	35		50068325	50068360	8421504	1	35	0	c	350039213800000453	1-36						Designer ligands of tgf-beta superfamily	Choe	2010	0		
120	chr18	50068327	50075151	3500324221	39		50068327	50075151	8421504	3	19,8,12	0,1004,6812	c,g	350032422100000005,350032422100000005,350032422100000004	0-19,0-19,0-20						DISEASE PREVENTION AND VACCINATION PRIOR TO THYMIC REACTIVATIONS - NORWOOD IMMUNOLOGY, LTD.	www.sumobrain.com	0	0		
120	chr18	50068327	50075151	3500151187	39		50068327	50075151	8421504	3	19,8,12	0,1004,6812	c,g	350015118700000005,350015118700000005,350015118700000004	0-19,0-19,0-20						Tolerance to Graft Prior to Thymic Reactivation	Boyd	2004	0		
120	chr18	50068331	50075165	3500396205	330		50068331	50075165	8421504	3	150,154,26	0,854,6808	p	350039620500015008,350039620500015005	0-150,0-180						HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS	Gold	2002	0		TGFB1
966	chr18	50068334	50069323	3500037926	225		50068334	50069323	8421504	6	45,45,3,42,45,45	0,48,144,851,896,944	p	350003792600015256,350003792600015255,350003792600015253,350003792600015252,350003792600015251	0-45,0-45,0-45,0-45,0-45						Polynucleotides Encoding Growth Differentiation Factor-8 - Patent application	www.faqs.org	0	0		TGFB1
120	chr18	50068341	50075154	3500199284	40		50068341	50075154	8421504	3	19,6,15	0,992,6798	c,g	350019928400000019,350019928400000019,350019928400000018	0-19,0-19,0-21						Anthony Luyai thesis-Final[1]	brary.okstate.edu	0	0		
120	chr18	50068343	50075145	3500413770	50		50068343	50075145	8421504	3	25,19,6	0,977,6796	c,g	350041377000000001,350041377000000001,350041377000000000	0-25,0-25,0-25						Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats	al.physiology.org	0	0		TGFB1
966	chr18	50068343	50068368	3500393263	25		50068343	50068368	8421504	1	25	0	c,g	350039326300000001,350039326300000001	0-25,0-25			10.1124/mol.106.022954	1521-0111 (Online)	Molecular Pharmacology	Peroxisome Proliferator-Activated Receptor-&#x03b3; and Retinoic Acid X Receptor &#x03b1; Represses the TGF&#x03b2;1 Gene via PTEN-Mediated p70 Ribosomal S6 Kinase-1 Inhibition: Role for Zf9 Dephosphorylation	Lee	2006	0		TGFB1
120	chr18	50068346	50075156	3500346093	44		50068346	50075156	8421504	3	22,5,17	0,988,6793	c,g	350034609300000007,350034609300000007,350034609300000006	0-22,0-22,0-22		19846754	10.1152/ajpcell.00417.2008		American Journal of Physiology - Cell Physiology	TGF-&#x03b2; suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB	Risinger	2010	0		TGFB1
966	chr18	50068346	50069329	3500234340	44		50068346	50069329	8421504	2	22,22	0,961	c	350023434000000001,350023434000000000	0-22,0-22		9822741		0270-6474	The Journal of Neuroscience	Glial Cell Line-Derived Neurotrophic Factor Requires Transforming Growth Factor-&#x03b2; for Exerting Its Full Neurotrophic Potential on Peripheral and CNS Neurons	Krieglstein	1998	7		
966	chr18	50068352	50069221	3500347624	40		50068352	50069221	8421504	2	20,20	0,849	c,g	350034762400000015,350034762400000014,350034762400000014	0-20,0-20,0-20		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		
966	chr18	50068358	50069287	3500205155	153		50068358	50069287	8421504	4	54,24,51,24	0,99,827,905	p	350020515500015033	63-288						Modified TGF-Beta Superfamily Polypeptides and Related Methods	Knopf	2009	0		TGFB1
966	chr18	50068358	50069287	3500046369	153		50068358	50069287	8421504	4	54,24,51,24	0,99,827,905	p	350004636900015033	63-288						Modified TGF-Beta Superfamily Polypeptides and Related Methods	Knopf	2009	0		TGFB1
966	chr18	50068361	50068388	3500125163	26		50068361	50068388	8421504	2	15,11	0,16	c	350012516300000011	0-26		18369328	10.1038/gt.2008.29	0969-7128	Gene Therapy	Baculovirus-mediated interferon alleviates dimethylnitrosamine-induced liver cirrhosis symptoms in a murine model	Nishibe	2008	4		TGFB1
120	chr18	50068380	50078931	3500433630	40		50068380	50078931	8421504	2	20,20	0,10531	c,g	350043363000000012,350043363000000012,350043363000000011	0-20,0-20,0-20						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation	Chang	2006	0		TGFB1
120	chr18	50068380	50078931	3500139519	40		50068380	50078931	8421504	2	20,20	0,10531	c,g	350013951900000012,350013951900000012,350013951900000011	0-20,0-20,0-20						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation - US Patent 7435800 Description	ww.patentstorm.us	0	0		TGFB1
966	chr18	50068382	50069254	3500203533	102		50068382	50069254	8421504	2	57,45	0,827	p	350020353300015026,350020353300015018	0-57,0-45						US Patent # 5,468,845. Antibodies to osteogenic proteins - Patents.com	www.patents.com	0	0		TGFB1
966	chr18	50068385	50069323	3500063913	225		50068385	50069323	8421504	3	96,81,48	0,800,890	p	350006391300015006,350006391300015005	0-177,0-48						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		TGFB1
966	chr18	50068453	50069327	3500265224	40		50068453	50069327	8421504	2	20,20	0,854	c,g	350026522400000021,350026522400000021,350026522400000020,350026522400000020	0-20,0-20,0-20,0-20						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
966	chr18	50068462	50069190	3500424598	23		50068462	50069190	8421504	2	19,4	0,724	c	350042459800000011	17-40							ww.jbiomedsci.com	0	0		
966	chr18	50068462	50069190	3500006397	23		50068462	50069190	8421504	2	19,4	0,724	c	350000639700000010	17-40						Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulation	biomedcentral.com	0	0		
966	chr18	50068469	50069196	3500341076	23		50068469	50069196	8421504	2	12,11	0,716	c	350034107600000002	0-23			10.1152/ajpheart.01372.2006		American Journal of Physiology - Heart and Circulatory Physiology	TGF-&#x03b2;- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling	Jiang	2007	0		TGFB1
120	chr18	50069263	50077597	3500023326	40		50069263	50077597	8421504	3	20,16,4	0,6245,8330	c,g	350002332600000015,350002332600000015,350002332600000014	0-20,0-20,0-20						Title Japanese Journal of Veterinary Research, 61(3): 109-116 Issue Date 2013-08	lib.hokudai.ac.jp	0	0		
120	chr18	50069292	50075147	3500340694	53		50069292	50075147	8421504	3	24,21,8	0,26,5847	c	350034069400000010,350034069400000011	20-44,0-29						Emprego da RT-PCR em tempo real para a quantifica&#xe7;&#xe3;o da express&#xe3;o de genes associados &#xe0; resposta imune em bezerros bovinos experimentalmente infectados por N caninum	pt.scribd.com	0	0		
967	chr18	50077602	50082312	3500023911	39		50077602	50082312	8421504	2	20,19	0,4691	c,g	350002391100000009,350002391100000008,350002391100000008	0-20,0-19,0-19		21630131	10.1007/s12079-011-0137-z		Journal of Cell Communication and Signaling	CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells	Xiaoyu	2011	0		TGFB1,B9D2
967	chr18	50077676	50082342	3500312145	44		50077676	50082342	8421504	2	24,20	0,4646	c,g	350031214500000015,350031214500000015,350031214500000014	0-24,0-24,0-20						Modulation of cytokine gene expression and secretion during the periparturient period in dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis	ddr.nal.usda.gov	0	0		
967	chr18	50077683	50082449	3500137858	40		50077683	50082449	8421504	2	20,20	0,4746	c,g	350013785800000003,350013785800000002,350013785800000002	0-20,0-20,0-20						TGF 2, LIF and FGF2 cooperate to induce nephrogenesis	ev.biologists.org	0	0		TGFB1,B9D2
967	chr18	50077686	50079024	3500055740	42		50077686	50079024	8421504	2	21,21	0,1317	c,g	350005574000000006,350005574000000006,350005574000000005,350005574000000005	0-21,0-21,0-21,0-21						Heat shock protein 70 vaccination induced immune responses in bovine paratuberculosis	ive.library.uu.nl	0	0		
967	chr18	50077690	50078910	3500389791	24		50077690	50078910	8421504	2	21,3	0,1217	c	350038979100000010	0-24						Synergistic inflammatory signaling in airway epithelial cells: control of expression levels of protease-activated receptors and interleukin-8 release	.uni-magdeburg.de	0	0		
967	chr18	50077690	50078910	3500194535	24		50077690	50078910	8421504	2	21,3	0,1217	c	350019453500000000	0-24		23372933	10.4103/2045-8932.105037		Pulmonary Circulation	Peroxisome proliferator-activated receptor gamma (PPAR&#x03b3;) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation	David	2012	0		
967	chr18	50077690	50078910	3500111962	24		50077690	50078910	8421504	2	21,3	0,1217	c	350011196200000012	0-24						Bmp inhibitors for the treatment of spondyloarthropathies	Lories	2004	0		
967	chr18	50077690	50078910	3500060449	24		50077690	50078910	8421504	2	21,3	0,1217	c	350006044900000000	0-24		23372933	10.4103/2045-8932.105037		Pulmonary Circulation	Peroxisome proliferator-activated receptor gamma (PPAR&#x03b3;) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation	Green	2012	0		
967	chr18	50077700	50078921	3500414463	25		50077700	50078921	8421504	2	11,14	0,1207	c	350041446300000007	0-25						Improved blastocyst development of single cow OPU-derived presumptive zygotes by group culture with agarose-embedded helper embryos	biomedcentral.com	0	0		TGFB1
967	chr18	50082279	50082342	3500449915	41		50082279	50082342	8421504	2	21,20	0,43	c,g	350044991500000027,350044991500000027,350044991500000026	0-21,0-21,0-20						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
967	chr18	50082279	50082341	3500078470	41		50082279	50082341	8421504	2	21,20	0,42	c,g	350007847000000017,350007847000000017,350007847000000016,350007847000000016	0-21,0-21,0-20,0-20						Transforming growth factor beta family expression at the bovine feto-maternal interface	biomedcentral.com	0	0		
967	chr18	50134520	50134772	3500255289	37		50134520	50134772	8421504	3	7,14,16	0,219,236	c	350025528900000001,350025528900000000	0-37,0-20						ScienceDirect.com - Structure - Molecular Mechanism for Regulation of the Human Mitochondrial Branched-Chain &#x03b1;-Ketoacid Dehydrogenase Complex by Phosphorylation	sciencedirect.com	0	0		BCKDHA
969	chr18	50396851	50396886	3500185999	34		50396851	50396886	8421504	2	30,4	0,31	g	350018599900000213	4-39						Vectors for expression of hml-2 polypeptides	Donnelly	2010	0		
970	chr18	50546013	50546511	3500460010	498		50546013	50546511	8421504	1	498	0	p,c,g	350046001000015000,350046001000000002,350046001000015003,350046001000015002,350046001000000005,350046001000000004,350046001000000004,350046001000015004,350046001000000006,350046001000000006,350046001000015006,350046001000000008,350046001000000008,350046001000015008,350046001000000010,350046001000000010,350046001000015010,350046001000000012,350046001000000012,350046001000015012,350046001000000014,350046001000015014,350046001000000016,350046001000000016,350046001000000001	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-61,0-61,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-21						Genotyping of the polymorphism within exon 1 of Hormone Sensitive Lipase (LIPE) Gene in three Chinese Yak (Bos grunniens) breeds by PCR-RFLP (Brief Report)	bn-dummerstorf.de	0	0		
970	chr18	50551435	50554604	3500301078	89		50551435	50554604	8421504	3	16,7,66	0,3078,3103	c	350030107800000047,350030107800000068,350030107800000048	0-23,0-66,0-20						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
970	chr18	50554538	50554604	3500463464	66		50554538	50554604	8421504	1	66	0	c	350046346400000055,350046346400000029	0-49,22-43						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
970	chr18	50558661	50558692	3500207782	26		50558661	50558692	8421504	2	7,19	0,12	g	350020778200000053	15-41						Recombinant human thymopoietin proteins and uses therefor	Harris	1993	0		
970	chr18	50583280	50583309	3500279178	25		50583280	50583309	8421504	2	18,7	0,22	g	350027917800000026	0-25						Apo-2li and apo-3 apoptosis polypeptides	Ashkenazi	1997	0		
971	chr18	50620924	50620951	3500329538	23		50620924	50620951	8421504	3	12,4,7	0,13,20	c	350032953800000105	2-25						US Patent # 5,460,950. Expression of PACE in host cells and methods of use thereof - Patents.com	www.patents.com	0	0		
971	chr18	50629773	50630609	3500287361	150		50629773	50630609	8421504	4	21,6,51,72	0,27,704,764	p	350028736100015059	12-168						50 human secreted proteins	Komatsoulis	2001	0		
971	chr18	50647259	50647289	3500003285	26		50647259	50647289	8421504	2	19,7	0,23	g	350000328500000039	14-42						Cofactors for Thrombin Activation of Factor VII and Uses Thereof	Light	2010	0		
971	chr18	50676632	50694177	3500421379	42		50676632	50694177	8421504	2	22,20	0,17525	c	350042137900000016,350042137900000097	18-40,17-37						 Antibody (11C7) Anti Nogo A And Its Pharmaceutical Use 	www.docstoc.com	0	0		
971	chr18	50676799	50676822	3500307902	23		50676799	50676822	8421504	1	23	0	c	350030790200000120	3-29						Mhc complexes and uses thereof	Chavaillaz	1996	0		
971	chr18	50684394	50685743	3500142140	51		50684394	50685743	8421504	2	24,27	0,1322	p	350014214000015001	0-51			10.1074/jbc.M700610200		The Journal of biological chemistry	Resolution of the Nuclear Localization Mechanism of Glycogen Synthase Kinase-3 : FUNCTIONAL EFFECTS IN APOPTOSIS	Gordon	June	0		GSK3B
971	chr18	50687913	50687979	3500346018	66		50687913	50687979	8421504	1	66	0	p	350034601800015014	0-66						CHARACTERIZATION OF LpSK6: A LYCOPERSICON	.diagnosisnet.com	0	0		GSK3A
971	chr18	50688991	50691489	3500356141	277		50688991	50691489	8421504	12	38,2,4,8,7,7,29,9,64,25,10,74	0,116,2161,2166,2181,2190,2205,2241,2264,2362,2390,2424	c	350035614100000009,350035614100000015	0-40,274-580						Molecular cloning and expression of glycogen synthase kinase-3/factor A. - ResearchGate	.researchgate.net	0	0		
971	chr18	50701189	50701236	3500294513	47		50701189	50701236	8421504	1	47	0	c	350029451300000103	0-47						NOVEL DEATH DOMAIN PROTEINS - Patent application	www.faqs.org	0	0		
971	chr18	50714780	50714804	3500340200	24		50714780	50714804	8421504	1	24	0	c	350034020000000061	22-46					Patent	Calcium receptor-active molecules (Patent US:6031003)	Balandrin	2000	0		
971	chr18	50714780	50714804	3500186968	24		50714780	50714804	8421504	1	24	0	c	350018696800000201,350018696800000061,350018696800000270	1-25,22-46,18-40						Calcium receptor-active molecules	Nemeth	1994	0		
971	chr18	50717249	50717277	3500408956	23		50717249	50717277	8421504	2	9,14	0,14	g	350040895600000019	0-23						Cell, Vol. 91, 531&#x2013;541, November 14, 1997, Copyright 1997 by Cell Press Crx,aNovel otx-like Homeobox Gene, Shows Photoreceptor-Specific Expression and Regulates Photoreceptor Differentiation	s.med.harvard.edu	0	0		
972	chr18	50836133	50836162	3500235534	26		50836133	50836162	8421504	3	14,4,8	0,16,21	g	350023553400000091	7-36						PLANT SNF1-RELATED PROTEIN KINASE GENE - Patent application	www.faqs.org	0	0		
974	chr18	50988133	50994170	3500291324	89		50988133	50994170	8421504	4	21,20,24,24	0,582,5620,6013	c,g	350029132400000028,350029132400000027,350029132400000008,350029132400000003,350029132400000002	0-21,0-20,0-24,0-24,0-22		18217898	10.1111/j.1365-2141.2007.06930.x	1365-2141	British Journal of Haematology	Deficient RPS19 protein production induces cell cycle arrest in erythroid progenitor cells - Kuramitsu - 2008 - British Journal of Haematology - Wiley Online Library	Kuramitsu	2008	0		
974	chr18	50993764	50994142	3500409932	41		50993764	50994142	8421504	3	21,7,13	0,75,365	c	350040993200000026,350040993200000025	0-21,0-20						Characterization of Canine Mammary Carcinoma using Dog-Specific cDNA arrays	ive.library.uu.nl	0	0		RPS19
974	chr18	50993764	50994142	3500367409	41		50993764	50994142	8421504	3	21,7,13	0,75,365	c	350036740900000024,350036740900000023	0-21,0-20						Recent developments in canine Cushing&#x2019;s syndrome	ive.library.uu.nl	0	0		RPS19
974	chr18	50993764	50994142	3500352532	41		50993764	50994142	8421504	3	21,7,13	0,75,365	c	350035253200000013,350035253200000012	0-21,0-20		21347402	10.1371/journal.pone.0014676		PLoS ONE	Jak2 Is a Negative Regulator of Ubiquitin-Dependent Endocytosis of the Growth Hormone Receptor	Joyce	2011	0		RPS19
974	chr18	50993764	50994142	3500243312	41		50993764	50994142	8421504	3	21,7,13	0,75,365	c	350024331200000026,350024331200000025	0-21,0-20						cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype	eterinaria.com.ar	0	0		RPS19
974	chr18	50993787	50993812	3500390515	25		50993787	50993812	8421504	1	25	0	c	350039051500000005	0-25		15771965	10.1016/j.ymthe.2004.12.001	1525-0016	Molecular Therapy	Development of cellular models for ribosomal protein S19 (RPS19)-deficient diamond&#x2013;blackfan anemia using inducible expression of siRNA against RPS19	Miyake	2005	7		FST
974	chr18	51000194	51000222	3500304335	24		51000194	51000222	8421504	2	9,15	0,13	g	350030433500000424	18-47						Diagnosis and Treatment of Cancer Using Anti-EREG Antibody - Patent application	www.faqs.org	0	0		
975	chr18	51140551	51140647	3500362403	40		51140551	51140647	8421504	2	20,20	0,76	c	350036240300000049,350036240300000048	0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
121	chr18	51238568	51253008	3500100319	935		51238568	51253008	8421504	12	76,5,16,132,137,76,48,81,75,132,137,20	0,1116,1175,1815,2461,10113,10375,11473,12429,12959,13578,14420	p,c	350010031900015052,350010031900015065,350010031900015072,350010031900015079,350010031900015053,350010031900000129,350010031900015060,350010031900015066,350010031900015073,350010031900000240,350010031900015080,350010031900000028	0-81,0-96,0-120,0-69,0-120,19-40,0-120,0-120,0-120,4-27,0-69,0-20						Aus dem Institut f&#xfc;r Reproduktionsmedizin der Tier&#xe4;rztlichen Hochschule Hannover	ierarzt-schupp.de	0	0		
976	chr18	51330195	51330223	3500162629	23		51330195	51330223	8421504	2	15,8	0,20	c	350016262900000057	0-31						Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor	Li	1998	0		
977	chr18	51383273	51383297	3500322591	24		51383273	51383297	8421504	1	24	0	c	350032259100000026	18-42						Fat regulated genes, uses thereof, and compounds for modulating same	Allen	2003	0		
978	chr18	51523523	51524519	3500040185	41		51523523	51524519	8421504	2	21,20	0,976	c,g	350004018500000027,350004018500000027,350004018500000026,350004018500000026	0-21,0-21,0-20,0-20						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
978	chr18	51523566	51530358	3500075880	42		51523566	51530358	8421504	2	20,22	0,6770	c,g	350007588000000006,350007588000000006,350007588000000005,350007588000000005	0-20,0-20,0-22,0-22						The Effects of the Phosphatase Inhibitor, Okadaic Acid, on Plasminogen Activator Expression in Bovine Oocyte-Cumulus	y.oregonstate.edu	0	0		
978	chr18	51592897	51592926	3500353759	23		51592897	51592926	8421504	3	12,5,6	0,13,23	c	350035375900000002	1-24						C5a receptor	Li	2002	0		
978	chr18	51624435	51624459	3500039160	24		51624435	51624459	8421504	1	24	0	c	350003916000000058	1-29						US Patent # 5,830,715. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		KCNN4
979	chr18	51650504	51650529	3500391220	25		51650504	51650529	8421504	1	25	0	c	350039122000000031,350039122000000044	0-22,0-25						ANTIBODIES AND RELATED MOLECULES THAT BIND TO PSCA PROTEINS - Patent application	www.faqs.org	0	0		
980	chr18	51823308	51823337	3500286296	29		51823308	51823337	8421504	1	29	0	c	350028629600000000	6-35						Wu et al. Origin and differentiation of a special fragment from Capra hircus agouti gene. Afr. J. Biotechnol. 2011	demicjournals.org	0	0		
980	chr18	51823606	51823629	3500415562	23		51823606	51823629	8421504	1	23	0	c	350041556200000000	9-35					Infection and Immunity	Identification of Group B Streptococcal Sip Protein, Which Elicits Cross-Protective Immunity	Bernard	2000	0		
981	chr18	51998755	51998792	3500120769	30		51998755	51998792	8421504	3	5,18,7	0,7,30	c	350012076900000000	0-30						Sesquiterpenes and Alkaloids from Lindera chunii and Their Inhibitory Activities against HIV-1 Integrase	cpb.pharm.or.jp	0	0		
981	chr18	51998762	51998792	3500467437	25		51998762	51998792	8421504	2	18,7	0,23	c	350046743700000000	0-25						Anti-HIV-1 integrase activity of medicinal plants used as self medication by AIDS patients	rdo.psu.ac.th	0	0		
981	chr18	51998762	51998792	3500462118	25		51998762	51998792	8421504	2	18,7	0,23	c	350046211800000002,350046211800000003	0-25,9-34			10.1046/j.1432-1327.2001.01932.x	1432-1033	European Journal of Biochemistry	Mapping DNA-binding sites of HIV-1 integrase by protein footprinting - Dirac - 2001 - European Journal of Biochemistry - Wiley Online Library	Dirac	2001	0		
981	chr18	51998762	51998792	3500457717	25		51998762	51998792	8421504	2	18,7	0,23	c	350045771700000003	0-25						Mechanism of HIV-1 Integrase Inhibition by Styrylquinoline Derivatives in Vitro	aspetjournals.org	0	0		
981	chr18	51998762	51998792	3500425080	25		51998762	51998792	8421504	2	18,7	0,23	c	350042508000000000	0-25						Anti-HIV-1 integrase activity of medicinal plants used as self medication by AIDS patients - ResearchGate	.researchgate.net	0	0		
981	chr18	51998762	51998792	3500401147	25		51998762	51998792	8421504	2	18,7	0,23	c	350040114700000000	0-25						International Journal of Phytomedicine 3 (2011) 312-318	arjournals.org	0	0		
981	chr18	51998762	51998792	3500386879	25		51998762	51998792	8421504	2	18,7	0,23	c	350038687900000000	0-25						Anti-HIV-1 integrase activity of medicinal plants used as self medication by AIDS patients	rdo.psu.ac.th	0	0		
981	chr18	51998762	51998792	3500353538	25		51998762	51998792	8421504	2	18,7	0,23	c	350035353800000002	0-25		22205735	10.1128/JVI.06591-11		Journal of Virology	Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir	PeK.	2012	0		
981	chr18	51998762	51998792	3500348072	25		51998762	51998792	8421504	2	18,7	0,23	c	350034807200000002	0-25		22205735	10.1128/JVI.06591-11	0022-538X	Journal of Virology	Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir	Quashie	2012	5		
981	chr18	51998762	51998792	3500250295	25		51998762	51998792	8421504	2	18,7	0,23	c	350025029500000000	0-25						Morore Katlego Mphahlele	dspace.wits.ac.za	0	0		
981	chr18	51998762	51998792	3500238267	25		51998762	51998792	8421504	2	18,7	0,23	c	350023826700000002	0-25						Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir	jvi.asm.org	0	0		
981	chr18	51998762	51998792	3500221430	25		51998762	51998792	8421504	2	18,7	0,23	c	350022143000000003	0-25		14722240	10.1124/mol.65.1.85	1521-0111 (Online)	Molecular Pharmacology	Mechanism of HIV-1 Integrase Inhibition by Styrylquinoline Derivatives in Vitro	Deprez	2004	0		
981	chr18	51998762	51998792	3500107197	25		51998762	51998792	8421504	2	18,7	0,23	c	350010719700000003	10-35		16537587	10.1128/JVI.80.7.3189-3204.2006	0022-538X	Journal of Virology	Acetylated Tat Regulates Human Immunodeficiency Virus Type 1 Splicing through Its Interaction with the Splicing Regulator p32	Berro	2006	5		
981	chr18	51998762	51998792	3500097306	25		51998762	51998792	8421504	2	18,7	0,23	c	350009730600000005	7-32						Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status	stemcellres.com	0	0		
981	chr18	51998762	51998792	3500059285	25		51998762	51998792	8421504	2	18,7	0,23	c	350005928500000005	7-32			10.1186/scrt246	1757-6512	Stem Cell Research & Therapy	Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status	Awe	2013	3		
983	chr18	52231058	52231084	3500370584	23		52231058	52231084	8421504	2	8,15	0,11	c	350037058400000462	25-48						Protease inhibition - Patent application	www.faqs.org	0	0		
983	chr18	52231075	52231732	3500391427	60		52231075	52231732	8421504	2	30,30	0,627	p	350039142700015004	0-60						Assays - Patent application	www.faqs.org	0	0		BCL3
983	chr18	52231075	52231717	3500208501	45		52231075	52231717	8421504	2	30,15	0,627	p	350020850100015006	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		BCL3
983	chr18	52231075	52231717	3500189065	45		52231075	52231717	8421504	2	30,15	0,627	p	350018906500015008	0-45						Assays	Schofield	2005	0		BCL3
983	chr18	52275654	52284303	3500093126	40		52275654	52284303	8421504	2	20,20	0,8629	c,g	350009312600000060,350009312600000085	21-44,22-42						Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase - US Patent 7700319 Description	ww.patentstorm.us	0	0		
984	chr18	52341395	52343818	3500384679	58		52341395	52343818	8421504	3	1,29,28	0,757,2395	c	350038467900000076,350038467900000094	26-56,16-44						Methods for the generation of primordial germ cells and transgenic animal species	Piedrahita	1998	0		
984	chr18	52341395	52343818	3500348976	58		52341395	52343818	8421504	3	1,29,28	0,757,2395	c	350034897600000078,350034897600000096	26-56,16-44						Methods comprising apoptosis inhibitors for the generation of transgenic pigs	Piedrahita	2001	0		
984	chr18	52341395	52343818	3500118441	58		52341395	52343818	8421504	3	1,29,28	0,757,2395	c	350011844100000076,350011844100000094	26-56,16-44						US Patent # 6,271,436. Cells and methods for the generation of transgenic pigs - Patents.com	www.patents.com	0	0		
984	chr18	52341395	52343818	3500090639	58		52341395	52343818	8421504	3	1,29,28	0,757,2395	c	350009063900000074,350009063900000092	26-56,16-44						 Cells And Methods For The Generation Of Transgenic Pigs 	www.docstoc.com	0	0		
984	chr18	52343183	52343816	3500157797	92		52343183	52343816	8421504	2	44,48	0,585	c,g	350015779700000317,350015779700000324	3-47,0-48						 Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	www.docstoc.com	0	0		
985	chr18	52444338	52449972	3500195290	75		52444338	52449972	8421504	5	15,11,13,14,22	0,213,1517,5332,5612	p	350019529000015001	9-99						Marker-assisted selection for leaf rust resistance genes Lr19 and Lr24 in wheat (Triticum aestivum L.). - ResearchGate	.researchgate.net	0	0		
985	chr18	52501309	52501340	3500465948	26		52501309	52501340	8421504	2	10,16	0,15	c	350046594800000139	11-48						&#x6d17;&#x6da4;&#x5242;&#x7ec4;&#x5408;&#x7269; Detergent compositions	K*Ji Bu Sen 	2006	0		
985	chr18	52501309	52501340	3500168274	26		52501309	52501340	8421504	2	10,16	0,15	c,g	350016827400000070,350016827400000070	11-48,11-48						Detergent Composition 	.freshpatents.com	0	0		
986	chr18	52641204	52641389	3500068159	78		52641204	52641389	8421504	2	75,3	0,182	p	350006815900015011	0-78						INAUGURAL - DISSERTATION	uni-heidelberg.de	0	0		MARK4
986	chr18	52656710	52657010	3500146047	40		52656710	52657010	8421504	2	20,20	0,280	c,g	350014604700000007,350014604700000007,350014604700000006,350014604700000006	0-20,0-20,0-20,0-20						PASTURE-FEEDING OF CHAROLAIS STEERS INFLUENCES SKELETAL MUSCLE METABOLISM AND GENE EXPRESSION	www.jpp.krakow.pl	0	0		
986	chr18	52656710	52657010	3500053255	40		52656710	52657010	8421504	2	20,20	0,280	c,g	350005325500000007,350005325500000007,350005325500000006,350005325500000006	0-20,0-20,0-20,0-20						1009_S3_article_10	www.jpp.krakow.pl	0	0		
986	chr18	52656894	52663607	3500406643	1152		52656894	52663607	8421504	7	176,190,124,172,133,155,202	0,679,1285,2659,4851,5323,6511	p	350040664300015001	3429-4581						&#x7121;&#x7d30;&#x80de;&#x30bf;&#x30f3;&#x30d1;&#x30af;&#x8cea;&#x5408;&#x6210;&#x65b9;&#x6cd5; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; 2007097438&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		CKM
986	chr18	52656894	52663475	3500234110	1020		52656894	52663475	8421504	7	176,190,124,172,133,155,70	0,679,1285,2659,4851,5323,6511	p	350023411000015230,350023411000015224,350023411000015218,350023411000015217,350023411000015212,350023411000015206,350023411000015199,350023411000015200	0-171,0-171,0-180,0-180,0-156,0-162,0-180,0-180						THE FLORIDA STATE UNIVERSITY	etd.lib.fsu.edu	0	0		
986	chr18	52657014	52663565	3500322660	147		52657014	52663565	8421504	5	56,7,42,3,39	0,559,4822,5203,6512	p	350032266000015012	162-360						Caracterizaci&#xf3;n gen&#xf3;mica y prote&#xf3;mica de la expresi&#xf3;n g&#xe9;nica diferencial en jabal&#xed;es infectados de forma natural con Mycobacterium bovis Identificaci&#xf3;n de biomarcadores asociados con la infecci&#xf3;n y la respuesta inmu	digital.csic.es	0	0		
986	chr18	52657655	52662360	3500075252	200		52657655	52662360	8421504	4	80,40,40,40	0,1946,4166,4665	c	350007525200000412,350007525200000410,350007525200000398,350007525200000390,350007525200000382	0-40,0-40,0-40,0-40,0-40						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
986	chr18	52659495	52659518	3500242494	23		52659495	52659518	8421504	1	23	0	g	350024249400000028	0-23						Taiwan Banded Krait -Bungarotoxins: Novel Isotoxins, Targeting and Gene Organization	.lib.nsysu.edu.tw	0	0		
986	chr18	52683518	52683764	3500090364	144		52683518	52683764	8421504	2	63,81	0,165	p	350009036400015074	0-144						CLONING AND CHARACTERIZATION OF GENES INVOLVED IN CARBOHYDRATE METABOLISM IN THE MARINE RED ALGA GRAClLARlA GRACILIS	tionscanada.gc.ca	0	0		ERCC2
987	chr18	52712027	52712081	3500218408	54		52712027	52712081	8421504	1	54	0	p	350021840800015000	0-54		15489900	10.1038/sj.onc.1208088	0950-9232	Oncogene	The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization	Slee	2004	6		PPP1R13L
987	chr18	52774289	52778838	3500346544	1014		52774289	52778838	8421504	5	126,321,108,129,330	0,2052,2623,4081,4219	p	350034654400015000,350034654400015002,350034654400015003,350034654400015005,350034654400015006,350034654400015009,350034654400015011,350034654400015010	0-180,0-180,0-180,0-180,0-180,0-180,0-114,0-114						ECOL 553L	omics.arizona.edu	0	0		FOSB
987	chr18	52774289	52778838	3500322907	1014		52774289	52778838	8421504	5	126,321,108,129,330	0,2052,2623,4081,4219	p	350032290700015001,350032290700015000	0-1014,0-1014						Why Sequence Alignment?	apadantonakis.com	0	0		FOSB
987	chr18	52774289	52778838	3500293771	1014		52774289	52778838	8421504	5	126,321,108,129,330	0,2052,2623,4081,4219	p	350029377100015005,350029377100015004,350029377100015006	0-540,0-1014,0-474						Attempted Cloning of a Wnt Gene from Botrylloides violaceus	mmons.calpoly.edu	0	0		
987	chr18	52774289	52776377	3500438209	162		52774289	52776377	8421504	2	126,36	0,2052	p	350043820900015004	0-162						6.0_SERCBW - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		FOSB
987	chr18	52774289	52776377	3500252693	162		52774289	52776377	8421504	2	126,36	0,2052	p	350025269300015005	0-162						 Bioinformatics Ppt Presentation 	.authorstream.com	0	0		FOSB
987	chr18	52774289	52776377	3500031946	162		52774289	52776377	8421504	2	126,36	0,2052	p	350003194600015003	0-162						Chapter 2: Sequence Alignment	w.cs.columbia.edu	0	0		FOSB
987	chr18	52776530	52778769	3500391760	52		52776530	52778769	8421504	2	26,26	0,2213	c	350039176000000004,350039176000000005	0-26,0-26		9566885		0270-7306	Molecular and Cellular Biology	Increased c-fos mRNA Expression By Human Fibroblasts Contracting Stressed Collagen Matrices	Rosenfeldt	1998	6		FOSB
987	chr18	52776530	52778769	3500020224	52		52776530	52778769	8421504	2	26,26	0,2213	c	350002022400000004,350002022400000005	0-26,0-26					Molecular and Cellular Biology	Increased c-fos mRNA Expression By Human Fibroblasts Contracting Stressed Collagen Matrices	Hans	1998	0		FOSB
988	chr18	52929108	52929170	3500114594	45		52929108	52929170	8421504	2	23,22	0,40	c	350011459400000459,350011459400000886,350011459400000458,350011459400000885	0-23,0-23,0-22,0-22						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		EML2
988	chr18	52929108	52929170	3500031979	45		52929108	52929170	8421504	2	23,22	0,40	c	350003197900000374,350003197900000373	0-23,0-22						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		EML2
988	chr18	52929108	52929131	3500423784	23		52929108	52929131	8421504	1	23	0	c,g	350042378400000117,350042378400000117	0-23,0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		EML2
988	chr18	52929108	52929131	3500371873	23		52929108	52929131	8421504	1	23	0	c	350037187300000120	0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		EML2
988	chr18	52929108	52929131	3500304886	23		52929108	52929131	8421504	1	23	0	c,g	350030488600000096,350030488600000096	0-23,0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		EML2
989	chr18	52959877	52964959	3500306227	1152		52959877	52964959	8421504	7	210,144,282,153,100,117,146	0,680,1555,3464,3717,4384,4936	c	350030622700000079	0-1152						NOVEL GENES RELATED TO GLUTAMINYL CYCLASE - Patent application	www.faqs.org	0	0		
989	chr18	52959877	52964959	3500270001	1152		52959877	52964959	8421504	7	210,144,282,153,100,117,146	0,680,1555,3464,3717,4384,4936	p,c	350027000100000059,350027000100015225,350027000100015226,350027000100015227,350027000100015229,350027000100015230,350027000100015231,350027000100015232,350027000100015235,350027000100015236,350027000100015237,350027000100015239,350027000100015240,350027000100015174,350027000100015243,350027000100015244	0-1152,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						IN VIVO SCREENING MODELS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER QPCT-RELATED DISORDERS - Patent application	www.faqs.org	0	0		
989	chr18	52959877	52964959	3500264192	1152		52959877	52964959	8421504	7	210,144,282,153,100,117,146	0,680,1555,3464,3717,4384,4936	c	350026419200000028	0-1152						TRANSGENIC MICE - Patent application	www.faqs.org	0	0		
989	chr18	53012419	53012442	3500124108	23		53012419	53012442	8421504	1	23	0	c,g	350012410800000004,350012410800000004	0-23,0-23						ScienceDirect.com - Developmental Biology - Pax&#x2013;Six&#x2013;Eya&#x2013;Dach network during amphioxus development: Conservation in vitro but context specificity in vivo	sciencedirect.com	0	0		
989	chr18	53023088	53023114	3500260603	24		53023088	53023114	8421504	2	18,6	0,20	g	350026060300000019	8-35						Polypeptides having endoglucanase activity and polynucleotides encoding same	Harris	2009	0		
989	chr18	53023088	53023114	3500247059	24		53023088	53023114	8421504	2	18,6	0,20	g	350024705900000019	8-35					Patent	Polypeptides having endoglucanase activity and polynucleotides encoding same (Patent US:8063267)	Harris	2011	0		
989	chr18	53023088	53023114	3500093929	24		53023088	53023114	8421504	2	18,6	0,20	g	350009392900000015	8-35						Polypeptides having endoglucanase activity and polynucleotides encoding same - Patent #08258370	w.strutpatent.com	0	0		
990	chr18	53093667	53093691	3500426474	24		53093667	53093691	8421504	1	24	0	c	350042647400000001	0-24						BASIC RESEARCH Selection, proliferation and differentiation of bone marrow-derived liver stem cells with a culture system containing cholestatic serum	www.wjgnet.com	0	0		
990	chr18	53093672	53093771	3500155061	99		53093672	53093771	8421504	1	99	0	p	350015506100015015,350015506100015012,350015506100015013	0-48,0-48,0-48						Methods For Inhibiting Adipogenesis And For Treating Type 2 Diabetes 	.freshpatents.com	0	0		
990	chr18	53093744	53093954	3500272094	114		53093744	53093954	8421504	2	45,69	0,141	p	350027209400015017,350027209400015030,350027209400015034	0-45,0-69,0-66						DNA-binding properties andsecondary structural model hepatocyte nuclearfactor 3/fork domain	www.pnas.org	0	0		FOXA2
990	chr18	53094841	53095017	3500281920	40		53094841	53095017	8421504	2	20,20	0,156	c,g	350028192000000004,350028192000000005,350028192000000005	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
990	chr18	53156165	53156423	3500447940	258		53156165	53156423	8421504	1	258	0	p	350044794000015014	3-261						MULTIPLE DOMAIN PROTEINS	Chalasani	2009	0		NOVA2
990	chr18	53171468	53171497	3500337203	26		53171468	53171497	8421504	2	13,13	0,16	c	350033720300000014	19-45						MOLECULES INVOLVED IN SYNAPTOGENESIS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
991	chr18	53226878	53228328	3500133335	79		53226878	53228328	8421504	4	19,20,20,20	0,945,1331,1430	c,g	350013333500000005,350013333500000005,350013333500000004,350013333500000004,350013333500000001,350013333500000002	0-19,0-19,0-20,0-20,0-20,0-20						ScienceDirect.com - Genomics - Analysis of sequence variability and protein domain architectures for bovine peptidoglycan recognition protein 1 and Toll-like receptors 2 and 6	sciencedirect.com	0	0		
991	chr18	53227739	53228589	3500205057	40		53227739	53228589	8421504	3	20,11,9	0,105,841	c	350020505700000017,350020505700000016	0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
991	chr18	53227739	53228589	3500137197	40		53227739	53228589	8421504	3	20,11,9	0,105,841	c	350013719700000017,350013719700000016	0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
991	chr18	53295866	53295920	3500301456	54		53295866	53295920	8421504	1	54	0	p	350030145600015005	3-57						Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase	Maxwell	2002	0		HIF3A
991	chr18	53295866	53295920	3500295114	54		53295866	53295920	8421504	1	54	0	p	350029511400015002	3-57					Patent	Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase (Patent EP:1379630)	MAXWELL	2012	0		HIF3A
991	chr18	53295866	53295920	3500250777	54		53295866	53295920	8421504	1	54	0	p	350025077700015005	3-57						Assays, methods and means	Maxwell	2010	0		HIF3A
991	chr18	53295866	53295920	3500199680	54		53295866	53295920	8421504	1	54	0	p	350019968000015005	3-57						Assay for identifying a modulator of HIF hydroxylase	Maxwell	2010	0		HIF3A
991	chr18	53295866	53295920	3500099088	54		53295866	53295920	8421504	1	54	0	p	350009908800015006	3-57						Assays, methods and means	Maxwell	2004	0		HIF3A
991	chr18	53305793	53305901	3500115505	108		53305793	53305901	8421504	1	108	0	p	350011550500015060	0-108						DANIELA CARVALHO GONZALEZ KRISTELLER	www.teses.usp.br	0	0		PPP5C
991	chr18	53319547	53319574	3500252985	25		53319547	53319574	8421504	3	15,4,6	0,16,21	g	350025298500000029	10-39					Patent	DNA encoding phosphoenolpyruvate carboxykinase, recombinant vector and transformed plant containing the same (Patent US:5880334)	Arai	1999	0		
991	chr18	53319547	53319574	3500021221	25		53319547	53319574	8421504	3	15,4,6	0,16,21	g	350002122100000029	10-39						US Patent # 5,880,334. DNA encoding phosphoenolpyruvate carboxykinase, recombinant vector and transformed plant containing the same - Patents.com	www.patents.com	0	0		
991	chr18	53326566	53326594	3500061039	23		53326566	53326594	8421504	2	15,8	0,20	g	350006103900000053	5-36						Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus - Patent application	www.faqs.org	0	0		
992	chr18	53454151	53457357	3500409638	48		53454151	53457357	8421504	2	24,24	0,3182	c,g	350040963800000060,350040963800000061	10-34,10-34						Luciferase biosensor	Fan	2011	0		
992	chr18	53454151	53457357	3500241536	48		53454151	53457357	8421504	2	24,24	0,3182	c	350024153600000049,350024153600000050	10-34,10-34						Luciferase biosensor	Fan	2011	0		CALM3
992	chr18	53475270	53475832	3500434299	192		53475270	53475832	8421504	2	108,84	0,478	p	350043429900015064,350043429900015063,350043429900015062,350043429900015061	0-48,0-48,0-48,0-48						Zebrafish Heterotrimer G-protein Gamma 2 Subunit (gng2) 	.freshpatents.com	0	0		GNG8
992	chr18	53475298	53475324	3500408013	23		53475298	53475324	8421504	2	5,18	0,8	c	350040801300000008,350040801300000031	0-24,0-24						Method for Producing Viral Vaccine and Therapeutic Peptide Antigens - Patent application	www.faqs.org	0	0		
992	chr18	53475298	53475324	3500397300	23		53475298	53475324	8421504	2	5,18	0,8	c	350039730000000008	0-24						Method for producing viral vaccine and therapeutic peptide antigens	Cappuccilli	2009	0		
993	chr18	53579657	53579698	3500175102	41		53579657	53579698	8421504	1	41	0	g	350017510200000062	0-41						EXPRESSION OF PORCINE INTESTINAL NUTRIENT TRANSPORTERS ALONG CRYPT-VILLUS AXIS AND DURING POSTNATAL DEVELOPMENT	e.lib.uoguelph.ca	0	0		
993	chr18	53586435	53586501	3500246944	66		53586435	53586501	8421504	1	66	0	p	350024694400015007	15-81						Washington State : SOC 250 : M_Ziegler_090904	ww.coursehero.com	0	0		SLC1A5
993	chr18	53586993	53587089	3500434170	45		53586993	53587089	8421504	2	22,23	0,73	c,g	350043417000000015,350043417000000015,350043417000000014	0-22,0-22,0-23						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
124	chr18	53703521	53775092	3500004833	4200		53703521	53775092	8421504	8	3060,444,145,78,132,106,175,60	0,3240,16268,62208,63793,70484,71216,71511	p	350000483300015000,350000483300015001,350000483300015002,350000483300015003,350000483300015004,350000483300015005,350000483300015006,350000483300015007,350000483300015008,350000483300015009,350000483300015010,350000483300015011,350000483300015012,350000483300015013,350000483300015014,350000483300015015,350000483300015016,350000483300015018,350000483300015019,350000483300015020,350000483300015021,350000483300015022,350000483300015023,350000483300015025	0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-60						Rho GTPase-activating protein 35 - Canis familiaris (Dog)	www.uniprot.org	0	0		
995	chr18	53775316	53775343	3500189823	23		53775316	53775343	8421504	2	15,8	0,19	c	350018982300000105,350018982300000613	11-34,0-22						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
995	chr18	53811930	53811954	3500196806	24		53811930	53811954	8421504	1	24	0	c	350019680600000083	0-24						Polynucleotides and polypeptides associated with the NF-kappaB pathway	Nadler	2004	0		
996	chr18	53948295	53948323	3500420439	23		53948295	53948323	8421504	2	8,15	0,13	c	350042043900000081	24-47					Patent	Recombinant animal viral nucleic acids (Patent US:6054566)	Dawson	2000	0		
996	chr18	53948295	53948323	3500240042	23		53948295	53948323	8421504	2	8,15	0,13	c	350024004200000078	24-47						Recombinant plant viral nucleic acids	www.devileye.net	0	0		
996	chr18	53948295	53948323	3500128791	23		53948295	53948323	8421504	2	8,15	0,13	c	350012879100000079	24-47						US Patent # 5,889,190. Recombinant plant viral nucleic acids - Patents.com	www.patents.com	0	0		
996	chr18	53953807	53954082	3500355283	40		53953807	53954082	8421504	2	20,20	0,255	g	350035528300000007,350035528300000006	0-20,0-20		16618797	10.1101/gad.1381906	0890-9369	Genes & Development	Requirement of clathrin heavy chain for p53-mediated transcription	Enari	2006	12		BBC3
996	chr18	53953807	53954082	3500279875	40		53953807	53954082	8421504	2	20,20	0,255	g	350027987500000011,350027987500000010	0-20,0-20		18505818	10.1128/MCB.01747-07	0270-7306	Molecular and Cellular Biology	Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4	Li	2008	6		BBC3
996	chr18	53953807	53954082	3500163294	40		53953807	53954082	8421504	2	20,20	0,255	g	350016329400000007,350016329400000006	0-20,0-20						Requirement of clathrin heavy chain for p53-mediated transcription--&#x300a;&#x57fa;&#x56e0;&#x8fdb;&#x5c55;&#x300b;&#x533b;&#x5b66;&#x671f;&#x520a;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		BBC3
996	chr18	53953807	53954082	3500054876	40		53953807	53954082	8421504	2	20,20	0,255	g	350005487600000007,350005487600000006	0-20,0-20			10.1101/gad.1381906		Genes & Development	Requirement of clathrin heavy chain for p53-mediated transcription	Masato	2006	0		BBC3
996	chr18	53953807	53954082	3500013468	40		53953807	53954082	8421504	2	20,20	0,255	g	350001346800000007,350001346800000006	0-20,0-20		17158927	10.1128/MCB.01520-06	0270-7306	Molecular and Cellular Biology	p53-Dependent p21 mRNA Elongation Is Impaired when DNA Replication Is Stalled	Mattia	2007	6		BBC3
996	chr18	53954007	53954092	3500063932	38		53954007	53954092	8421504	2	19,19	0,66	g	350006393200000014,350006393200000013	4-23,0-19		19798104	10.1038/cdd.2009.140		Cell death and differentiation	An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis	RC	2010	0		BBC3
996	chr18	53954007	53954092	3500020232	38		53954007	53954092	8421504	2	19,19	0,66	g	350002023200000014,350002023200000013	4-23,0-19		19798104	10.1038/cdd.2009.140	1350-9047	Cell Death & Differentiation	An ARF&sol;CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis	Kovi	2009	9		BBC3
996	chr18	53954019	53954089	3500149315	40		53954019	53954089	8421504	2	20,20	0,50	g	350014931500000010,350014931500000009	0-20,0-20						DEVELOPMENTOFGENEEXPRESSIONSIGNATURESFORPRACTICALRADIATION	www.crr-cu.org	0	0		BBC3
996	chr18	53954282	53954319	3500184233	37		53954282	53954319	8421504	1	37	0	g	350018423300000010,350018423300000011,350018423300000012	38-67,0-25,39-67						Use of miR-29 for Cell protection	Deshmukh	2011	0		
996	chr18	53954766	53954794	3500464661	28		53954766	53954794	8421504	1	28	0	g	350046466100000003,350046466100000008	0-19,0-22		16462759	10.1038/sj.onc.1209429	0950-9232	Oncogene	Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein	Vogt	2006	6		BBC3
996	chr18	53969555	53969580	3500220182	23		53969555	53969580	8421504	2	17,6	0,19	g	350022018200000068	6-29						MICROORGANISMS FOR THE PRODUCTION OF METHYL ETHYL KETONE AND 2-BUTANOL - Patent application	www.faqs.org	0	0		
997	chr18	54028394	54041710	3500466547	165		54028394	54041710	8421504	6	26,16,57,20,25,21	0,12115,12133,12445,12671,13295	p,c,g	350046654700000006,350046654700000004,350046654700015000,350046654700000007,350046654700000003,350046654700000003,350046654700000005	0-27,0-19,0-57,0-20,0-25,0-25,0-21		18480166	10.1189/jlb.0208142		Journal of Leukocyte Biology	Molecular analysis of the bovine anaphylatoxin C5a receptor	Sailasree	2008	0		
997	chr18	54028394	54041710	3500096686	165		54028394	54041710	8421504	6	26,16,57,20,25,21	0,12115,12133,12445,12671,13295	p,c,g	350009668600000006,350009668600000004,350009668600015000,350009668600000007,350009668600000003,350009668600000003,350009668600000005	0-27,0-19,0-57,0-20,0-25,0-25,0-21		18480166	10.1189/jlb.0208142	0741-5400	Journal of Leukocyte Biology	Molecular analysis of the bovine anaphylatoxin C5a receptor	Nemali	2008	5		
997	chr18	54040560	54040587	3500322425	23		54040560	54040587	8421504	2	12,11	0,16	c	350032242500000094	0-23						Genes and polypeptides relating to prostate cancers	Zhong Cun You Fu 	2007	0		
997	chr18	54041279	54041304	3500347237	25		54041279	54041304	8421504	1	25	0	c	350034723700000006,350034723700000014	14-39,0-25						Anti-C5aR Antibodies With Improved Properties	Mackay	2007	0		
998	chr18	54205569	54206394	3500133203	41		54205569	54206394	8421504	2	21,20	0,805	c,g	350013320300000202,350013320300000202,350013320300000201	0-21,0-21,0-20						[tel-00521428, v1] &#xc9;tude des voies de conduction cardiaque : identification des g&#xe8;nes sp&#xe9;cifiquement exprim&#xe9;s et impliqu&#xe9;s dans des troubles de conduction	hives-ouvertes.fr	0	0		
998	chr18	54212951	54212979	3500054009	24		54212951	54212979	8421504	2	8,16	0,12	c	350005400900000043	9-33						US Patent # 5,686,572. Domains of extracellular region of human platelet derived growth factor receptor polypeptides - Patents.com	www.patents.com	0	0		
998	chr18	54213423	54238561	3500301552	740		54213423	54238561	8421504	10	19,54,105,85,56,78,47,117,80,99	0,1609,3017,3915,4090,4306,5564,10029,13538,25039	p,c,g	350030155200000027,350030155200000027,350030155200015030,350030155200015026,350030155200015029,350030155200015022,350030155200015025,350030155200015021,350030155200015018,350030155200000026,350030155200000026	8-27,8-27,0-180,0-180,0-180,0-180,0-180,0-180,0-129,2-21,2-21						CHAPTER 4 INVESTIGATION INTO PROTEIN-PROTEIN INTERACTIONS BETWEEN RAT BRAIN SECRETORY PROTEINS AND AN O. savignyi cDNA LIBRARY BY MEANS OF THE GAL4 TWO-HYBRID SYSTEM	upetd.up.ac.za	0	0		
998	chr18	54227010	54238488	3500324130	57		54227010	54238488	8421504	2	31,26	0,11452	p	350032413000015000	0-57						A Potassium Channel Mutation in Neonatal Human Epilepsy	dlab.stanford.edu	0	0		NAPA
1000	chr18	54455962	54456157	3500262495	195		54455962	54456157	8421504	1	195	0	p	350026249500015023	0-195						est_a_palmata1012 | MarineGenomics.org	arinegenomics.org	0	0		EHD2
1000	chr18	54514996	54518202	3500440716	41		54514996	54518202	8421504	2	20,21	0,3185	c,g	350044071600000003,350044071600000003,350044071600000004	0-20,0-20,0-21					Molecular and Cellular Biology	Modulation of CRX Transactivation Activity by Phosducin Isoforms	Xuemei	July	0		CRX
1000	chr18	54514996	54517567	3500007804	40		54514996	54517567	8421504	3	20,7,13	0,973,2558	c,g	350000780400000022,350000780400000022,350000780400000023	0-20,0-20,0-20						RETINAL PIGMENT EPITHELIAL STEM CELLS	Temple	2009	0		CRX
1000	chr18	54515939	54518078	3500268806	48		54515939	54518078	8421504	2	24,24	0,2115	c	350026880600000011,350026880600000012	0-24,0-24		20949100	10.1371/journal.pone.0013075		PLoS ONE	Expression of Rod-Derived Cone Viability Factor: Dual Role of CRX in Regulating Promoter Activity and Cell-Type Specificity	Sophie	2010	0		CRX
1000	chr18	54518121	54518172	3500078283	51		54518121	54518172	8421504	1	51	0	p	350007828300015021	0-51						Annelid regeneration and fission	rm.biology.uh.edu	0	0		CRX
1001	chr18	54541606	54542744	3500077888	41		54541606	54542744	8421504	3	6,15,20	0,1063,1118	c,g	350007788800000065,350007788800000064	0-21,0-20						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
125	chr18	54655344	54664375	3500301352	69		54655344	54664375	8421504	4	26,1,21,21	0,2182,4826,9010	c,g	350030135200000028,350030135200000007,350030135200000026,350030135200000009,350030135200000016	0-25,0-25,22-45,0-21,3-24					The Journal of biological chemistry	Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin	Francoise	2000	0		
125	chr18	54655348	54657527	3500403171	23		54655348	54657527	8421504	2	22,1	0,2178	c	350040317100000026	22-45		10625670	10.1074/jbc.275.2.1247	0021-9258	Journal of Biological Chemistry	Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin	Haeseleer	2000	5		
1002	chr18	54661230	54681299	3500133203	40		54661230	54681299	8421504	3	20,13,7	0,20048,20062	c,g	350013320300000165,350013320300000165,350013320300000061,350013320300000061	0-20,0-20,0-20,0-20						[tel-00521428, v1] &#xc9;tude des voies de conduction cardiaque : identification des g&#xe8;nes sp&#xe9;cifiquement exprim&#xe9;s et impliqu&#xe9;s dans des troubles de conduction	hives-ouvertes.fr	0	0		CABP5
1003	chr18	54843789	54845069	3500053805	44		54843789	54845069	8421504	2	22,22	0,1258	c,g	350005380500000016,350005380500000017,350005380500000017	0-22,0-22,0-22						DIFFERENTIAL ANALYSIS OF GENE EXPRESSION DURING IN VITRO ADIPOGENESIS IN CATTLE	brary.okstate.edu	0	0		
1003	chr18	54882950	54882977	3500183026	24		54882950	54882977	8421504	2	9,15	0,12	c	350018302600000000	9-33		21818390	10.1371/journal.pone.0022786	1932-6203	PLOS ONE	PLOS ONE: An In Vivo Transfection Approach Elucidates a Role for Aedes aegypti Thioester-Containing Proteins in Flaviviral Infection	Cheng	2011	4		
1004	chr18	54950509	54953598	3500182420	174		54950509	54953598	8421504	4	34,2,78,60	0,2815,2847,3029	p	350018242000015035	0-174						Ein Protein f&#xfc;r neue Aufgaben: die cytosolische PH-Dom&#xe4;ne des Cytohesin-1 als Paratop und als Substrat f&#xfc;r Translokationen	b.uni-muenchen.de	0	0		
1004	chr18	54953807	54954088	3500375699	190		54953807	54954088	8421504	2	57,133	0,148	c,g	350037569900000034,350037569900000034	0-190,0-190						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1004	chr18	55047233	55050048	3500191222	237		55047233	55050048	8421504	2	150,87	0,2728	p	350019122200015018	0-237						Basic leucine zipper transcription factor Hac1 binds DNA in two distinct modes as revealed by microfluidic analyses	alterlab.ucsf.edu	0	0		DBP
1004	chr18	55047308	55050036	3500212679	150		55047308	55050036	8421504	2	75,75	0,2653	p	350021267900015004	0-150						BMC Bioinformatics BioMed Central	biomedcentral.com	0	0		DBP
1005	chr18	55069229	55069254	3500155900	23		55069229	55069254	8421504	2	17,6	0,19	g	350015590000000448	7-32						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
1005	chr18	55130529	55130556	3500073091	23		55130529	55130556	8421504	2	12,11	0,16	c	350007309100000006,350007309100000005	7-39,0-32		19054058	10.1111/j.1600-0625.2008.00801.x		Experimental dermatology	UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3*	Valerie	2009	0		
1005	chr18	55161569	55162652	3500095663	60		55161569	55162652	8421504	3	20,20,20	0,831,1063	g	350009566300000002,350009566300000003,350009566300000001	0-20,0-20,0-20						Growth Hormone Stimulates Transcription of the Fibroblast Growth Factor 21 Gene in the Liver through the Signal Transducer and Activator of Transcription 5	.endojournals.org	0	0		
1006	chr18	55199493	55199520	3500056924	23		55199493	55199520	8421504	2	8,15	0,12	c	350005692400000260	7-30						Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer - US Patent 7615379 Description	ww.patentstorm.us	0	0		
1006	chr18	55254991	55255423	3500150549	23		55254991	55255423	8421504	2	12,11	0,421	c	350015054900000005	18-41						Eukaryotic Initiation Factor 2&#x03b1; Phosphorylation Mediates Fetal Hemoglobin Induction through a Post-Transcriptional Mechanism	tologylibrary.org	0	0		
125	chr18	55308683	55312691	3500124969	573		55308683	55312691	8421504	8	34,52,147,137,8,36,57,102	0,620,762,1282,3410,3419,3458,3906	p	350012496900015110	0-579						Human serum albumin linkers and conjugates thereof	Mcdonagh	2009	0		FTL,BAX
125	chr18	55308683	55312691	3500060811	537		55308683	55312691	8421504	7	34,52,147,137,8,96,63	0,620,762,1282,3410,3419,3945	p	350006081100015010	0-537						Carl Herrmann - Bioinformatique Appliqu&#xe9;e - L2 SV	logie.univ-mrs.fr	0	0		FTL,BAX
125	chr18	55308683	55312661	3500218134	48		55308683	55312661	8421504	2	24,24	0,3954	c	350021813400000002,350021813400000003	0-24,0-24		12631622		1078-0432	Clinical Cancer Research	Raf-1 and Bcl-2 Induce Distinct and Common Pathways That Contribute to Breast Cancer Drug Resistance	Davis	2003	8		FTL,BAX
1006	chr18	55308683	55309973	3500319853	63		55308683	55309973	8421504	4	21,21,13,8	0,641,896,1282	c	350031985300000009,350031985300000008,350031985300000002,350031985300000003	0-21,0-20,0-21,0-21		14633124	10.1046/j.1523-1755.2003.00301.x	0085-2538	Kidney International	Hypoxia-induced apoptosis in cultured glomerular endothelial cells: Involvement of mitochondrial pathways	TANAKA	2003	7		
1006	chr18	55308683	55309332	3500055662	63		55308683	55309332	8421504	2	34,29	0,620	p	350005566200015002	0-63		11095643		1046-6673	Journal of the American Society of Nephrology	Basic Fibroblast Growth Factor Selectively Enhances TNF-&#x03b1;&#x2014;Induced Apoptotic Cell Death in Glomerular Endothelial Cells: Effects on Apoptotic Signaling Pathways	MESSMER	2000	10		BAX
125	chr18	55308686	55312675	3500337725	39		55308686	55312675	8421504	2	19,20	0,3969	c	350033772500000002,350033772500000003	0-19,0-20						Felipe Camargo Braga TESE	www.teses.usp.br	0	0		
1006	chr18	55309307	55309332	3500213540	25		55309307	55309332	8421504	1	25	0	c	350021354000000024	0-25		20200969	10.1002/jbmr.52	1523-4681	Journal of Bone and Mineral Research	TNF-&#x03b1;'s effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression - Ghali - 2010 - Journal of Bone and Mineral Research - Wiley Online Library	Ghali	2010	0		
125	chr18	55309310	55312691	3500435139	50		55309310	55312691	8421504	2	25,25	0,3356	c	350043513900000002,350043513900000003	0-25,0-25						Tamoxifen-induced Apoptosis in Breast Cancer Cells Relates to Down-Regulation of bcl-2, but not bax and bcl-X, without	.aacrjournals.org	0	0		
125	chr18	55309310	55312691	3500158870	50		55309310	55312691	8421504	2	25,25	0,3356	c	350015887000000002,350015887000000003	0-25,0-25					The American Journal of Pathology	A Prostacyclin Analog Prevents Radiocontrast Nephropathy via Phosphorylation of Cyclic AMP Response Element Binding Protein	Takahisa	2005	0		
125	chr18	55309310	55312691	3500155699	48		55309310	55312691	8421504	2	23,25	0,3356	c	350015569900000003,350015569900000004	0-23,0-25						Method For Preparing Citrinin-free Monascus Biomass And Use Of Citrinin-free Monascus Biomass 	.freshpatents.com	0	0		
125	chr18	55309310	55312691	3500100375	50		55309310	55312691	8421504	2	25,25	0,3356	c	350010037500000008,350010037500000009	0-25,0-25		15625237	10.1210/me.2004-0209	0888-8809	Molecular Endocrinology	Negative Cross-Talk between Nur77 and Small Heterodimer Partner and Its Role in Apoptotic Cell Death of Hepatoma Cells	Yeo	2005	5		
1006	chr18	55309312	55309339	3500233132	27		55309312	55309339	8421504	1	27	0	c	350023313200000005	0-27		9096145		0270-6474	The Journal of Neuroscience	bax Deficiency Prevents the Increased Cell Death of Immature Neurons in bcl-x-Deficient Mice	Shindler	1997	7		BAX
1006	chr18	55309312	55309335	3500455327	23		55309312	55309335	8421504	1	23	0	c	350045532700000006	0-23						Influence of Growth Factors on Bovine Embryo Development	cholar.lib.vt.edu	0	0		BAX
1006	chr18	55309316	55312148	3500359191	42		55309316	55312148	8421504	2	22,20	0,2812	c	350035919100000014,350035919100000015	0-22,0-20			10.1046/j.1471-4159.2001.00294.x	1471-4159	Journal of Neurochemistry	CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with A&#x03b2;-induced cortical neuron apoptosis - Bozyczko-Coyne - 2001 - Journal of Neurochemistry - Wiley Online Library	Bozyczko-Coyne	2001	0		FTL,BAX
1006	chr18	55309322	55310055	3500268878	40		55309322	55310055	8421504	2	20,20	0,713	c,g	350026887800000009,350026887800000009,350026887800000008,350026887800000008	0-20,0-20,0-20,0-20						p73 Is Effective in p53-null Pancreatic Cancer Cells Resistant to Wild-type Gene Replacement	.aacrjournals.org	0	0		BAX
1006	chr18	55309322	55310055	3500073746	40		55309322	55310055	8421504	2	20,20	0,713	c,g	350007374600000009,350007374600000009,350007374600000008	0-20,0-20,0-20		12782576		0008-5472	Cancer Research	p73 Is Effective in p53-null Pancreatic Cancer Cells Resistant to Wild-type TP53 Gene Replacement	Rodicker	2003	8		BAX
1006	chr18	55309324	55309973	3500292057	42		55309324	55309973	8421504	3	21,13,8	0,255,641	c	350029205700000000,350029205700000001	0-21,0-21						Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carc	www.gtmb.org	0	0		BAX
1006	chr18	55309330	55309589	3500185647	42		55309330	55309589	8421504	2	21,21	0,238	c,g	350018564700000007,350018564700000007,350018564700000008,350018564700000008	0-21,0-21,0-21,0-21						ActivinReceptor-LikeKinase7InducesApoptosis through Up-Regulation of Bax and Down- RegulationofXiapinNormalandMalignant OvarianEpithelialCellLines	.aacrjournals.org	0	0		BAX
1006	chr18	55309332	55309470	3500375186	48		55309332	55309470	8421504	2	23,25	0,113	c	350037518600000012	0-48						Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities - Patent application	www.faqs.org	0	0		
1006	chr18	55309338	55312149	3500129375	40		55309338	55312149	8421504	3	17,3,20	0,107,2791	c,g	350012937500000004,350012937500000005,350012937500000005	0-20,0-20,0-20		15659650	10.1091/mbc.E04-08-0689	1059-1524	Molecular Biology of the Cell	p53 C-Terminal Phosphorylation by CHK1 and CHK2 Participates in the Regulation of DNA-Damage-induced C-Terminal Acetylation	Ou	2005	5		FTL,BAX
1006	chr18	55309338	55312149	3500117660	40		55309338	55312149	8421504	3	17,3,20	0,107,2791	c,g	350011766000000004,350011766000000005,350011766000000005	0-20,0-20,0-20			10.1091/mbc.E04-08-0689		Molecular Biology of the Cell	p53 C-Terminal Phosphorylation by CHK1 and CHK2 Participates in the Regulation of DNA-Damage-induced C-Terminal Acetylation	Yi-Hung	2005	0		FTL,BAX
1006	chr18	55309340	55309455	3500306233	25		55309340	55309455	8421504	2	15,10	0,105	c	350030623300000019	0-25						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
125	chr18	55309343	55312620	3500172674	40		55309343	55312620	8421504	3	12,8,20	0,102,3257	c	350017267400000003,350017267400000002	0-20,0-20						Melanotan II | Epigenetics Guide	peptide-10-20.com	0	0		FTL,BAX
1006	chr18	55309343	55310052	3500404154	40		55309343	55310052	8421504	3	12,8,20	0,102,689	c,g	350040415400000012,350040415400000013,350040415400000013	0-20,0-20,0-20		19490146	10.1111/j.1365-2443.2009.01309.x	1365-2443	Genes to Cells	Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation - Sang - 2009 - Genes to Cells - Wiley Online Library	Sang	2009	0		BAX
1006	chr18	55309343	55310052	3500209933	40		55309343	55310052	8421504	3	12,8,20	0,102,689	c,g	350020993300000004,350020993300000005,350020993300000005	0-20,0-20,0-20						ActivationofAMP-activatedProteinKinaseInduces p53-dependentApoptoticCellDeathinResponseto EnergeticStress S	www.jbc.org	0	0		BAX
1006	chr18	55309343	55310052	3500010612	40		55309343	55310052	8421504	3	12,8,20	0,102,689	c,g	350001061200000000,350001061200000001,350001061200000001	0-20,0-20,0-20		20404718	10.1097/QAD.0b013e328337b0ab	0269-9370	AIDS	 HIV-1 viral protein r induces ERK and caspase-8-dependent ap... : AIDS 	Snyder	2010	6		BAX
1006	chr18	55309343	55310052	3500010364	40		55309343	55310052	8421504	3	12,8,20	0,102,689	c,g	350001036400000012,350001036400000013,350001036400000013	0-20,0-20,0-20						Waltonitone induces human hepatocellular carcinoma cells apoptosis in vitro and in vivo	www.beyotime.com	0	0		BAX
1006	chr18	55309343	55309456	3500216289	23		55309343	55309456	8421504	2	12,11	0,102	c	350021628900000002	0-23						 Proliferation and Apoptosis of Multiple Myeloma Cell Lines RPMI8226/U266 Treated with Bortezomib and Valproic Acid&#xa0;|&#xa0;Best Medical Research Papers For Sale 	w.res-medical.com	0	0		
125	chr18	55309345	55312617	3500336224	40		55309345	55312617	8421504	3	10,10,20	0,100,3252	c,g	350033622400000004,350033622400000005,350033622400000005	0-20,0-20,0-20		16322545	10.1530/rep.1.00761	1470-1626	Reproduction	Apoptosis in bovine cumulus&#x2013;oocyte complexes after exposure to polychlorinated biphenyl mixtures during in vitro maturation	Pocar	2005	3		FTL,BAX
125	chr18	55309345	55312617	3500036931	40		55309345	55312617	8421504	3	10,10,20	0,100,3252	c,g	350003693100000002,350003693100000003,350003693100000003	0-20,0-20,0-20						Maturation medium supplements affect transcript level of apoptosis and cell survival related genes in bovine blastocysts produced in vitro	www.ufpel.edu.br	0	0		FTL,BAX
1006	chr18	55309345	55310084	3500349590	42		55309345	55310084	8421504	3	10,11,21	0,100,718	c,g	350034959000000000,350034959000000001,350034959000000001	0-21,0-21,0-21		17984977	10.1038/sj.mt.6300340	1525-0016	Molecular Therapy	Telomerase Transcriptional Targeting of Inducible Bax/TRAIL Gene Therapy Improves Gemcitabine Treatment of Pancreatic Cancer	Wack	2007	7		
1006	chr18	55309351	55312099	3500115594	46		55309351	55312099	8421504	4	4,18,18,6	0,94,733,2742	c	350011559400000038,350011559400000039	0-22,0-24		19289498	10.1128/MCB.01140-08		Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer 	Kang	2009	0		BAX
125	chr18	55309354	55312689	3500261098	40		55309354	55312689	8421504	3	1,19,20	0,91,3315	c	350026109800000008,350026109800000009	0-20,0-20						Novel chemotherapeutic agents against inflammation and cancer	Bose	2010	0		FTL,BAX
125	chr18	55309354	55312688	3500274654	41		55309354	55312688	8421504	3	1,20,20	0,91,3314	c	350027465400000000,350027465400000001	0-21,0-20						Silymarin and hepatoprotection	xbyx.xysm.net	0	0		FTL,BAX
125	chr18	55309354	55312682	3500285606	41		55309354	55312682	8421504	3	1,20,20	0,91,3308	c,g	350028560600000002,350028560600000003,350028560600000003	0-21,0-20,0-20			10.1046/j.1365-2567.2003.01630.x		Immunology	Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-&#x03b1;	M	2003	0		
1006	chr18	55309455	55312108	3500163097	88		55309455	55312108	8421504	4	40,34,8,6	0,613,2638,2647	c	350016309700000020,350016309700000025	0-40,0-48						METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS - Patent application	www.faqs.org	0	0		
1006	chr18	55309512	55309575	3500266784	63		55309512	55309575	8421504	1	63	0	p	350026678400015001	0-63						Supplemental Material and Methods Peptide sequence information for binding studies and compound synthesis Pharmacokinetics and hematology studies	.aacrjournals.org	0	0		BAX
125	chr18	55309526	55312684	3500466107	40		55309526	55312684	8421504	2	19,21	0,3137	c,g	350046610700000000,350046610700000000,350046610700000001,350046610700000001	0-19,0-19,0-21,0-21		22059987	10.1111/j.1365-2249.2011.04478.x		Clinical and Experimental Immunology	Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sj&#xf6;gren's syndrome	V	2011	0		FTL,BAX
125	chr18	55309526	55312684	3500406178	40		55309526	55312684	8421504	2	19,21	0,3137	c,g	350040617800000000,350040617800000000,350040617800000001	0-19,0-19,0-21		19356238	10.1186/ar2671	1478-6354	Arthritis Research & Therapy	Vasoactive intestinal peptide inhibits TNF-&#xce;&#xb1;-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands	Calafat	2009	4		FTL,BAX
1006	chr18	55309526	55310051	3500444662	42		55309526	55310051	8421504	2	21,21	0,504	c,g	350044466200000012,350044466200000012,350044466200000013,350044466200000013	0-21,0-21,0-21,0-21						Cytotoxic effects of curcumin in human retinal pigment epithelial cells. - ResearchGate	.researchgate.net	0	0		BAX
1006	chr18	55309527	55309575	3500392347	48		55309527	55309575	8421504	1	48	0	p	350039234700015001	0-48			10.1371/journal.ppat.0010010	1553-7374	PLOS Pathogens	PLOS Pathogens: A Surface Groove Essential for Viral Bcl-2 Function During Chronic Infection In Vivo	Loh	2005	0		BAX
1006	chr18	55309527	55309575	3500363464	48		55309527	55309575	8421504	1	48	0	p	350036346400015030,350036346400015000	0-48,0-48						Anticancer fusion protein	Pieczykolan	2013	0		BAX
1006	chr18	55309527	55309575	3500181216	48		55309527	55309575	8421504	1	48	0	p	350018121600015001,350018121600015031	0-48,0-48						ANTICANCER FUSION PROTEIN - ADAMED SP. Z O.O.	www.sumobrain.com	0	0		BAX
1006	chr18	55309528	55312164	3500467614	42		55309528	55312164	8421504	2	22,20	0,2616	c,g	350046761400000000,350046761400000000,350046761400000001,350046761400000001	0-22,0-22,0-20,0-20						Analyse de l&#x2019;expression de g&#xe8;nes indicateurs de la mort cellulaire dans la glande mammaire, un indice du potentiel de production de la glande mammaire.	www.journees3r.fr	0	0		
1006	chr18	55309528	55312164	3500236181	42		55309528	55312164	8421504	2	22,20	0,2616	c,g	350023618100000003,350023618100000003,350023618100000004,350023618100000004	0-22,0-22,0-20,0-20						0605_s3_article_14	www.jpp.krakow.pl	0	0		
1006	chr18	55309533	55309578	3500251491	45		55309533	55309578	8421504	1	45	0	p	350025149100015032	0-45						Biochemische und molekularbiologische Charakterisierung von Spike, einem neuen BH3-Dom&#xe4;nen Protein	b.uni-muenchen.de	0	0		BAX
1006	chr18	55309575	55309971	3500353737	23		55309575	55309971	8421504	2	17,6	0,390	c	350035373700000001	0-23		17237268	10.1158/1535-7163.MCT-06-0349	1535-7163	Molecular Cancer Therapeutics	Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide&#x2013;resistant cancer cells	Park	2007	5		
1006	chr18	55309579	55310053	3500430306	42		55309579	55310053	8421504	3	13,8,21	0,386,453	c,g	350043030600000005,350043030600000006,350043030600000006	0-21,0-21,0-21		20562210	10.1158/1078-0432.CCR-10-0964	1078-0432	Clinical Cancer Research	Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-l-Carnitine	Pisano	2010	8		BAX
1006	chr18	55309579	55310053	3500224952	42		55309579	55310053	8421504	3	13,8,21	0,386,453	c,g	350022495200000005,350022495200000006,350022495200000006	0-21,0-21,0-21						Research Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-L-Carnitine Abstract	.aacrjournals.org	0	0		BAX
1006	chr18	55309579	55310053	3500043829	42		55309579	55310053	8421504	3	13,8,21	0,386,453	c,g	350004382900000005,350004382900000006,350004382900000006	0-21,0-21,0-21		20562210	10.1158/1078-0432.CCR-10-0964	1078-0432	Clinical Cancer Research	Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-l-Carnitine	Pisano	2010	8		BAX
1006	chr18	55309579	55310022	3500456427	41		55309579	55310022	8421504	3	13,8,20	0,386,423	c	350045642700000002,350045642700000003	0-21,0-20		19438511	10.1111/j.1476-5381.2009.00241.x	1476-5381	British Journal of Pharmacology	Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells - Gauthaman - 2009 - British Journal of Pharmacology - Wiley Online Library	Gauthaman	2009	0		BAX
1006	chr18	55309579	55310022	3500300835	41		55309579	55310022	8421504	3	13,8,20	0,386,423	c	350030083500000000,350030083500000001	0-21,0-20						Regulation of p53 expression, phosphorylation and subcellular localization by a G-protein-coupled receptor	www2.le.ac.uk	0	0		BAX
1006	chr18	55309585	55309981	3500081911	23		55309585	55309981	8421504	2	7,16	0,380	c	350008191100000006	0-23						UNIVERSIDADE DE BRAS&#xcd;LIA FACULDADE DE AGRONOMIA E MEDICINA VETERIN&#xc1;RIA	itorio.bce.unb.br	0	0		
1006	chr18	55309585	55309981	3500073604	23		55309585	55309981	8421504	2	7,16	0,380	c	350007360400000012	0-23						Changes in gene expression profiles of bovine embryos produced in vitro, by natural ovulation, or hormonal superstimulation	w.funpecrp.com.br	0	0		
125	chr18	55309990	55312694	3500386919	61		55309990	55312694	8421504	3	21,20,20	0,2123,2684	c,g	350038691900000000,350038691900000000,350038691900000003,350038691900000003,350038691900000001	0-21,0-21,0-20,0-20,0-20						Universidade Federal de Pelotas, Centro de Biotecnologia, Laborat&#xf3;rio de Embriologia Molecular e *karibegnini@gmail	www.ufpel.edu.br	0	0		
125	chr18	55309990	55312694	3500238922	61		55309990	55312694	8421504	3	21,20,20	0,2123,2684	c,g	350023892200000000,350023892200000000,350023892200000003,350023892200000003,350023892200000001,350023892200000001	0-21,0-21,0-20,0-20,0-20,0-20						AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS E DE ESTRESSE OXIDATIVO EM O&#xd3;CITOS E TECIDOS REPRODUTIVOS EQ&#xdc;INOS KAEFER, Cristian *; BEGNINI, Karine; LEON, Priscila Marques Moura; CAMPOS, Vinicius; COLLARES, Tha&#xed;s; AMARAL, M.G.; DES	www.ufpel.edu.br	0	0		
125	chr18	55309990	55312694	3500005355	61		55309990	55312694	8421504	3	21,20,20	0,2123,2684	c,g	350000535500000000,350000535500000000,350000535500000003,350000535500000003,350000535500000001	0-21,0-21,0-20,0-20,0-20						Universidade Federal de Pelotas, Centro de Biotecnologia, Laborat&#xf3;rio de Embriologia Molecular e *karibegnini@gmail	www.ufpel.tche.br	0	0		
125	chr18	55309990	55312694	3500003927	61		55309990	55312694	8421504	3	21,20,20	0,2123,2684	c,g	350000392700000000,350000392700000000,350000392700000003,350000392700000003,350000392700000001	0-21,0-21,0-20,0-20,0-20						AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS E DE ESTRESSE OXIDATIVO EM O&#xd3;CITOS E TECIDOS REPRODUTIVOS EQ&#xdc;INOS KAEFER, Cristian *; BEGNINI, Karine; LEON, Priscila Marques Moura; CAMPOS, Vinicius; COLLARES, Tha&#xed;s; AMARAL, M.G.; DES	www.ufpel.tche.br	0	0		
1006	chr18	55309990	55312133	3500302104	42		55309990	55312133	8421504	2	22,20	0,2123	c,g	350030210400000002,350030210400000002,350030210400000005	0-22,0-22,0-20						DELINEAMENTO IN SILICO E AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS	www.ufpel.tche.br	0	0		
1006	chr18	55310026	55312105	3500210125	84		55310026	55312105	8421504	4	45,28,8,3	0,48,2067,2076	p	350021012500015108	0-84						US Patent # 7,101,977. Therapeutic agents comprising pro-apoptotic proteins - Patents.com	www.patents.com	0	0		
125	chr18	55310031	55312684	3500378673	45		55310031	55312684	8421504	2	23,22	0,2631	c	350037867300000006,350037867300000007	0-23,0-22		16778832	10.1038/sj.cdd.4401996	1350-9047	Cell Death & Differentiation	Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-&#x03ba;B and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner	Wang	2006	9		FTL,BAX
125	chr18	55310032	55312609	3500040185	40		55310032	55312609	8421504	2	20,20	0,2557	c,g	350004018500000034,350004018500000034,350004018500000035,350004018500000035	0-20,0-20,0-20,0-20						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		FTL,BAX
1006	chr18	55310058	55310081	3500219220	23		55310058	55310081	8421504	1	23	0	c,g	350021922000000006,350021922000000006	0-23,0-23						InhibitionofI KBKinaseSubunit2inCutaneousT-CellLymphoma Down-RegulatesNuclearFactor- KBConstitutiveActivation, InducesCellDeath,andPotentiatestheApoptoticResponse toAntineoplasticChemotherapeuticAgents	.aacrjournals.org	0	0		BAX
1006	chr18	55310059	55310082	3500378602	23		55310059	55310082	8421504	1	23	0	c	350037860200000000	0-23						Bax - Free XLS downloads	pdfsdb.com/xls/ba	0	0		BAX
1006	chr18	55310059	55310082	3500355126	23		55310059	55310082	8421504	1	23	0	c	350035512600000029	0-23						Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis	biomedcentral.com	0	0		BAX
1006	chr18	55310072	55312144	3500386207	48		55310072	55312144	8421504	2	24,24	0,2048	c	350038620700000002,350038620700000003	0-24,0-24			10.1128/IAI.00622-06		Infection and Immunity	Autocrine Role for Interleukin-8 in Bartonella henselae-Induced Angiogenesis 	Amy	2006	0		BAX
1006	chr18	55310083	55312113	3500120341	38		55310083	55312113	8421504	3	19,8,11	0,2010,2019	c	350012034100000018	0-38						CHIMERIC PROTEINS WITH CELL-TARGETING SPECIFICITY AND APOPTOSIS-INDUCING ACTIVITIES - Patent application	www.faqs.org	0	0		
1006	chr18	55310089	55312106	3500227525	25		55310089	55312106	8421504	3	13,8,4	0,2004,2013	c	350022752500000028	0-25						REAL-TIME RT-PCR AND PROTEOMIC ANALYSIS OF ADIPOSE TISSUE FROM OB/OB MICE TREATED WITH LEPTIN WEI ZHANG	aeum.libs.uga.edu	0	0		
125	chr18	55310092	55312628	3500060717	147		55310092	55312628	8421504	6	10,8,9,45,36,39	0,2001,2010,2022,2070,2497	p	350006071700015106	0-147						US Patent # 7,371,723. Therapeutic agents comprising pro-apoptotic proteins - Patents.com	www.patents.com	0	0		
1007	chr18	55312592	55312659	3500448173	41		55312592	55312659	8421504	2	20,21	0,46	c	350044817300000002,350044817300000003	0-20,0-21		12684213	10.1152/ajpgi.00406.2002		American Journal of Physiology - Gastrointestinal and Liver Physiology	LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway	Deng	2003	0		
1007	chr18	55312592	55312659	3500187768	41		55312592	55312659	8421504	2	20,21	0,46	c	350018776800000002,350018776800000003	0-20,0-21		12684213	10.1152/ajpgi.00406.2002		American Journal of Physiology - Gastrointestinal and Liver Physiology	LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway	Deng	2003	0		
1007	chr18	55312610	55312694	3500401814	84		55312610	55312694	8421504	1	84	0	p,c	350040181400015012,350040181400015020,350040181400000001	0-81,0-81,10-33						MITOCHONDRIAL TARGETING OF THE PRO-APOPTOTIC PROTEIN BAX: ROLE OF THE BAX CARBOXY-TERMINAL TAIL	ry.louisville.edu	0	0		
1007	chr18	55312623	55312648	3500425501	25		55312623	55312648	8421504	1	25	0	c	350042550100000001	0-25						DEPARTAMENT DE FISIOLOGIA EFECTOS ANTICANCEROSOS DE POLIFENOLES NATURALES: PETEROSTILBENO Y QUERCET	www.tdx.cat	0	0		
1007	chr18	55312623	55312648	3500379221	25		55312623	55312648	8421504	1	25	0	c	350037922100000001	0-25						EFECTOS ANTICANCEROSOS DE POLIFENOLES NATURALES: PETEROSTILBENO Y QUERCETINA	www.tdx.cat	0	0		
1007	chr18	55312669	55312694	3500086573	25		55312669	55312694	8421504	1	25	0	c	350008657300000248,350008657300000092	6-31,9-34						US Patent # 7,220,583. Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof - Patents.com	www.patents.com	0	0		FTL
1007	chr18	55316582	55316612	3500245400	30		55316582	55316612	8421504	1	30	0	c	350024540000000008	21-51						Methods for magnetic resonance imaging	Ahrens	2006	0		
1007	chr18	55316582	55316612	3500194024	30		55316582	55316612	8421504	1	30	0	c	350019402400000007,350019402400000008	21-51,11-32						METHODS FOR MAGNETIC RESONANCE IMAGING	Ahrens	2011	0		FTL
1007	chr18	55316586	55316893	3500220770	114		55316586	55316893	8421504	3	48,24,42	0,75,265	p	350022077000015075,350022077000015088,350022077000015077	0-48,0-48,0-45						Three-Dimensional Structure of Functional Material - Patent application	www.faqs.org	0	0		FTL
1007	chr18	55316586	55316875	3500055765	40		55316586	55316875	8421504	2	20,20	0,269	c	350005576500000009,350005576500000010	0-20,0-20		19454487	10.1093/hmg/ddp239		Human Molecular Genetics	Human ISD11 is essential for both iron&#x2013;sulfur cluster assembly and maintenance of normal cellular iron homeostasis	Yanbo	2009	0		FTL
1007	chr18	55316586	55316872	3500011992	120		55316586	55316872	8421504	2	99,21	0,265	p	350001199200015000	0-120						Inorganic Biochemistry of Iron Metabolism From Molecular Mechanisms to Clinical Consequences 2d Ed - Robert Crichton	www.scribd.com	0	0		
1007	chr18	55320956	55321004	3500080587	48		55320956	55321004	8421504	1	48	0	p	350008058700015030	0-48						Pyridinone analogs as cell proliferation inhibitors	Pierre	2007	0		GYS1
1007	chr18	55320956	55321004	3500076541	48		55320956	55321004	8421504	1	48	0	p	350007654100015019	0-48						Tetracyclic imidazole analogs	Whitten	2008	0		GYS1
1007	chr18	55320956	55321004	3500064396	48		55320956	55321004	8421504	1	48	0	p	350006439600015026	0-48						Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide	Nagasawa	2007	0		GYS1
1007	chr18	55320968	55321016	3500351523	48		55320968	55321016	8421504	1	48	0	p	350035152300015006,350035152300015002	6-54,6-51		12928438	10.1074/jbc.M306268200	0021-9258	Journal of Biological Chemistry	Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418	Bhat	2003	5		GYS1
1007	chr18	55320971	55321016	3500415584	45		55320971	55321016	8421504	1	45	0	p	350041558400015000	6-51						GSK3 is a multifunctional regulator of Dictyosteliumdevelopment	ev.biologists.org	0	0		GYS1
1007	chr18	55320971	55321016	3500283523	45		55320971	55321016	8421504	1	45	0	p	350028352300015001	6-51						Supplementary Materials for	ww.sciencemag.org	0	0		GYS1
1007	chr18	55320971	55321016	3500149034	45		55320971	55321016	8421504	1	45	0	p	350014903400015000	6-51		15342480	10.1242/dev.01330	0950-1991	Development	GSK3 is a multifunctional regulator of Dictyostelium development	Schilde	2004	7		GYS1
1007	chr18	55329110	55329137	3500352616	27		55329110	55329137	8421504	1	27	0	c	350035261600000014	0-27						Cinnamon Increases Liver Glycogen in an Animal Model of Insulin Resistance	www.scribd.com	0	0		
1007	chr18	55334270	55334318	3500279913	48		55334270	55334318	8421504	1	48	0	p	350027991300015012	0-48						METHOD OF DETECTING EQUINE POLYSACCHARIDE STORAGE MYOPATHY - Patent application	www.faqs.org	0	0		
1007	chr18	55334270	55334315	3500196732	45		55334270	55334315	8421504	1	45	0	p	350019673200015009	0-45						Variant Tlr4 Nucleic Acid And Uses Thereof 	.freshpatents.com	0	0		
1007	chr18	55364591	55364634	3500137760	43		55364591	55364634	8421504	1	43	0	g	350013776000000042	25-68						A novel voltage-gated potassium channel gene	Chandy	1995	0		
1007	chr18	55382264	55383844	3500081559	63		55382264	55383844	8421504	3	3,30,30	0,1517,1550	p	350008155900015015	0-63						Determination of an Epitope of the Diffuse Systemic Sclerosis Marker Antigen DNA Topoisomerase I: Sequence Similarity with Retroviral p30gag Protein Suggests a Possible Cause for Autoimmunity in Systemic Sclerosis	www.jstor.org	0	0		SNRNP70
1007	chr18	55387887	55394842	3500349028	423		55387887	55394842	8421504	6	54,63,82,102,88,34	0,173,884,4132,6754,6921	p	350034902800015017,350034902800015018,350034902800015019,350034902800015020,350034902800015021,350034902800015022,350034902800015023,350034902800015024,350034902800015025,350034902800015026,350034902800015027,350034902800015028,350034902800015029,350034902800015030,350034902800015031,350034902800015032,350034902800015033	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						METHOD FOR TREATING AUTOIMMUNE DISORDERS - UNIVERSITY OF MIAMI	www.sumobrain.com	0	0		SNRNP70
1007	chr18	55432642	55433098	3500344270	60		55432642	55433098	8421504	3	21,27,12	0,354,444	p	350034427000015073	108-168						@IL23_3198:2:1:0:199/1 NCGGAACCGGGCGGAAACACCATCGTATGCCGTCTTC + &0;;;;:9:;:7;;;;;;;;;;;;;;;;;;;;;;;:8	rse.iop.kcl.ac.uk	0	0		
1008	chr18	55499563	55499588	3500155699	25		55499563	55499588	8421504	1	25	0	g	350015569900000000	25-50						Method For Preparing Citrinin-free Monascus Biomass And Use Of Citrinin-free Monascus Biomass 	.freshpatents.com	0	0		
1008	chr18	55523700	55526050	3500367023	24		55523700	55526050	8421504	2	10,14	0,2336	c	350036702300000005	1-25		18463163	10.1091/mbc.E07-11-1202	1059-1524	Molecular Biology of the Cell	Regulation of Microtubule Assembly and Organization in Mitosis by the AAA+ ATPase Pontin	Ducat	2008	5		
1008	chr18	55526795	55536250	3500387039	66		55526795	55536250	8421504	2	36,30	0,9425	p	350038703900015001	0-66		19299493	10.1093/hmg/ddp134		Human Molecular Genetics	Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery	Mariangels	June	0		RUVBL2
1008	chr18	55536780	55536858	3500146829	78		55536780	55536858	8421504	1	78	0	p	350014682900015028	0-78						Therapeutic polypeptides and methods for using same	Bryant	2001	0		
1008	chr18	55536780	55536858	3500063085	78		55536780	55536858	8421504	1	78	0	p	350006308500015024	0-78						Therapeutic polypeptides and methods for using same	Bryant	2001	0		
1008	chr18	55541391	55541420	3500092849	23		55541391	55541420	8421504	3	5,6,12	0,7,17	g	350009284900000077	5-29					Patent	Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probe specific for ribosomal RNA precursors (Patent US:5770373)	Britschgi	1998	0		
1010	chr18	55729915	55731451	3500054122	126		55729915	55731451	8421504	4	18,45,3,60	0,120,1346,1476	p	350005412200015081,350005412200015083	0-63,0-63						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		CD37
1010	chr18	55751709	55751746	3500302241	37		55751709	55751746	8421504	1	37	0	c	350030224100000143	1-38						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
1010	chr18	55786898	55786924	3500121878	25		55786898	55786924	8421504	2	6,19	0,7	c	350012187800000185,350012187800000170	21-44,6-30						Plant fatty acid synthases	www.devileye.net	0	0		
1010	chr18	55786899	55786924	3500342699	24		55786899	55786924	8421504	2	5,19	0,6	c	350034269900000266	6-30						US Patent # 6,426,447. Plant seed oils - Patents.com	www.patents.com	0	0		
1010	chr18	55786899	55786924	3500109714	24		55786899	55786924	8421504	2	5,19	0,6	c	350010971400000170	6-30						Plant fatty acid synthases	Knauf	1991	0		
1010	chr18	55790183	55790300	3500273012	117		55790183	55790300	8421504	1	117	0	p	350027301200015110	0-117						Rankl Antibody-PTH/PTHRP Chimeric Molecules	Boone	2011	0		PTH2
1010	chr18	55790183	55790300	3500053757	117		55790183	55790300	8421504	1	117	0	p	350005375700015181	0-117						Rankl antibody-PTH/PTHrP chimeric molecules	Kostenuik	2006	0		PTH2
1010	chr18	55790199	55790226	3500121502	27		55790199	55790226	8421504	1	27	0	c,g	350012150200000000,350012150200000000,350012150200000001,350012150200000001	0-21,0-21,0-21,0-21						Printed in U.S.A. Copyright &#xa9; 2002 by The Endocrine Society	.endojournals.org	0	0		PTH2
1010	chr18	55797735	55797777	3500276442	42		55797735	55797777	8421504	1	42	0	c	350027644200000003,350027644200000007	13-40,7-31		11756497		0270-6474	The Journal of Neuroscience	Identification of the Differentiation-Associated Na+/PI Transporter as a Novel Vesicular Glutamate Transporter Expressed in a Distinct Set of Glutamatergic Synapses	Varoqui	2002	7		SLC17A7
1010	chr18	55797756	55797813	3500342863	57		55797756	55797813	8421504	1	57	0	p	350034286300015115	0-57							library.wiley.com	0	0		
1010	chr18	55797756	55797813	3500076488	57		55797756	55797813	8421504	1	57	0	p	350007648800015000	0-57		19883736	10.1016/j.neuroscience.2009.10.054		Neuroscience	Differential Distribution of Epacs within the Adult Rat Retina	Christopher	2010	0		
1010	chr18	55797878	55799393	3500205199	40		55797878	55799393	8421504	2	20,20	0,1495	c,g	350020519900000001,350020519900000002,350020519900000002	0-20,0-20,0-20		12444014	10.1152/ajpgi.00333.2002		American Journal of Physiology - Gastrointestinal and Liver Physiology	Characterization of vesicular glutamate transporter in pancreatic &#x03b1;- and &#x03b2;-cells and its regulation by glucose	Bai	2003	0		SLC17A7
1010	chr18	55797878	55799393	3500132482	40		55797878	55799393	8421504	2	20,20	0,1495	c,g	350013248200000001,350013248200000002,350013248200000002	0-20,0-20,0-20		12444014	10.1152/ajpgi.00333.2002		American Journal of Physiology - Gastrointestinal and Liver Physiology	Characterization of vesicular glutamate transporter in pancreatic &#x03b1;- and &#x03b2;-cells and its regulation by glucose	Bai	2003	0		SLC17A7
1010	chr18	55798309	55803389	3500061010	447		55798309	55803389	8421504	5	50,97,147,3,150	0,254,1354,2129,4930	p	350006101000015016,350006101000015012,350006101000015003	0-147,0-150,0-150						Cloning and cDNA brain-specific Na+-dependent	www.pnas.org	0	0		
1010	chr18	55801300	55801723	3500130120	63		55801300	55801723	8421504	3	6,36,21	0,304,402	c	350013012000000000,350013012000000007,350013012000000001	23-46,0-21,0-21		19191347	10.1002/glia.20849		Glia	Dual regulation of Ca 2+- dependent glutamate release from astrocytes: Vesicular glutamate transporters and cytosolic glutamate levels	Yingchun	2009	0		
1011	chr18	55837303	55847087	3500201852	95		55837303	55847087	8421504	3	39,30,26	0,395,9758	c,g	350020185200000106,350020185200000144,350020185200000172,350020185200000192	0-107,78-106,28-48,22-48						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
1011	chr18	55840629	55912437	3500370589	406		55840629	55912437	8421504	19	20,19,20,20,20,50,22,22,20,16,4,21,25,25,20,20,20,20,22	0,528,18396,19163,28339,28908,29778,29976,30323,30376,33218,33383,33405,34768,37868,38114,57942,71513,71786	c,g	350037058900000082,350037058900000082,350037058900000014,350037058900000014,350037058900000083,350037058900000083,350037058900000015,350037058900000015,350037058900000084,350037058900000084,350037058900000016,350037058900000016,350037058900000085,350037058900000085,350037058900000017,350037058900000017,350037058900000008,350037058900000076,350037058900000105,350037058900000039,350037058900000106,350037058900000040,350037058900000009,350037058900000009,350037058900000077,350037058900000077,350037058900000000,350037058900000000,350037058900000068,350037058900000068,350037058900000001,350037058900000001,350037058900000069,350037058900000069,350037058900000087,350037058900000087,350037058900000019,350037058900000019,350037058900000103,350037058900000037,350037058900000101,350037058900000101,350037058900000033,350037058900000033,350037058900000031,350037058900000031,350037058900000099,350037058900000099,350037058900000107,350037058900000041,350037058900000108,350037058900000108,350037058900000047,350037058900000047,350037058900000020,350037058900000088,350037058900000021,350037058900000021,350037058900000089,350037058900000089,350037058900000023,350037058900000023,350037058900000091,350037058900000091,350037058900000024,350037058900000024,350037058900000092,350037058900000092,350037058900000025,350037058900000025,350037058900000093,350037058900000093	0-20,0-20,0-20,0-20,0-19,0-19,0-19,0-19,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,8-29,8-29,8-28,8-28,0-21,0-21,0-21,0-21,0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-20,0-20,0-20,0-20,0-20,0-20,0-21,0-21,0-21,0-21,0-25,0-25,0-25,0-25,8-33,8-33,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-22,0-22,0-22,0-22					Patent	Method using a transgenic animal with enhanced immune response (Patent EP:2097444)	BOSZE	2011	0		
1011	chr18	55840629	55912437	3500364569	428		55840629	55912437	8421504	21	20,19,20,20,20,20,20,20,20,22,19,20,21,25,20,20,20,20,20,20,22	0,528,17068,18396,18450,19120,19163,28339,28938,29778,29979,30323,33383,33405,34597,34772,37868,38114,57942,71513,71786	c,g	350036456900000026,350036456900000027,350036456900000027,350036456900000036,350036456900000028,350036456900000028,350036456900000037,350036456900000038,350036456900000029,350036456900000029,350036456900000022,350036456900000021,350036456900000021,350036456900000000,350036456900000000,350036456900000001,350036456900000001,350036456900000007,350036456900000017,350036456900000017,350036456900000015,350036456900000015,350036456900000045,350036456900000046,350036456900000030,350036456900000031,350036456900000031,350036456900000033,350036456900000033,350036456900000034,350036456900000034,350036456900000035,350036456900000035	0-20,0-19,0-19,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-21,0-21,0-22,0-22,0-19,0-19,0-20,0-21,0-21,0-25,0-25,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-22,0-22						TARTALOMJEGYZ&#xc9;K 1. BEVEZET&#xc9;S &#xc9;S C&#xc9;LKIT	www.szie.hu	0	0		
1011	chr18	55840629	55912437	3500333669	366		55840629	55912437	8421504	17	20,19,20,20,50,22,22,20,16,4,21,25,25,20,20,20,22	0,528,18396,19163,28908,29778,29976,30323,30376,33218,33383,33405,34768,38114,57942,71513,71786	c,g	350033366900000909,350033366900000910,350033366900000910,350033366900000911,350033366900000911,350033366900000912,350033366900000912,350033366900000934,350033366900000935,350033366900000904,350033366900000895,350033366900000896,350033366900000896,350033366900000914,350033366900000932,350033366900000928,350033366900000928,350033366900000926,350033366900000926,350033366900000936,350033366900000942,350033366900000916,350033366900000916,350033366900000918,350033366900000919,350033366900000919,350033366900000920	0-20,0-19,0-19,0-20,0-20,0-20,0-20,8-29,8-28,0-21,0-22,0-22,0-22,0-20,0-20,0-21,0-21,0-25,0-25,8-33,0-20,0-20,0-20,0-20,0-20,0-20,0-22						Transgenic Animal With Enhanced Immune Response And Method For The Preparation Thereof 	.freshpatents.com	0	0		
1011	chr18	55840629	55912437	3500253217	406		55840629	55912437	8421504	19	20,19,20,20,20,50,22,22,20,16,4,21,25,25,20,20,20,20,22	0,528,18396,19163,19760,28908,29778,29976,30323,30376,33218,33383,33405,34768,37868,38114,57942,71513,71786	c,g	350025321700000014,350025321700000015,350025321700000015,350025321700000016,350025321700000016,350025321700000017,350025321700000017,350025321700000062,350025321700000039,350025321700000039,350025321700000040,350025321700000009,350025321700000000,350025321700000000,350025321700000001,350025321700000001,350025321700000019,350025321700000019,350025321700000037,350025321700000033,350025321700000033,350025321700000031,350025321700000031,350025321700000041,350025321700000047,350025321700000020,350025321700000021,350025321700000021,350025321700000023,350025321700000023,350025321700000024,350025321700000024,350025321700000025,350025321700000025	0-20,0-19,0-19,0-20,0-20,0-20,0-20,0-20,8-29,8-29,8-28,0-21,0-22,0-22,0-22,0-22,0-20,0-20,0-20,0-21,0-21,0-25,0-25,8-33,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-22,0-22						Transgenic animal with enhanced immune response and method for the preparation thereof	Bosze	2010	0		
1011	chr18	55840629	55912437	3500222782	386		55840629	55912437	8421504	18	20,19,20,20,20,50,22,22,20,16,4,21,25,25,20,20,20,22	0,528,18396,19163,19760,28908,29778,29976,30323,30376,33218,33383,33405,34768,38114,57942,71513,71786	c,g	350022278200000014,350022278200000015,350022278200000015,350022278200000016,350022278200000016,350022278200000017,350022278200000017,350022278200000063,350022278200000039,350022278200000040,350022278200000009,350022278200000000,350022278200000001,350022278200000001,350022278200000019,350022278200000037,350022278200000033,350022278200000033,350022278200000031,350022278200000031,350022278200000041,350022278200000047,350022278200000021,350022278200000021,350022278200000023,350022278200000024,350022278200000024,350022278200000025,350022278200000025	0-20,0-19,0-19,0-20,0-20,0-20,0-20,0-20,8-29,8-28,0-21,0-22,0-22,0-22,0-20,0-20,0-21,0-21,0-25,0-25,8-33,0-20,0-20,0-20,0-20,0-20,0-20,0-22,0-22						Transgenic Animal with Enhanced Immune Response and Method for the Preparation Thereof	Bosze	2013	0		
1011	chr18	55840629	55912437	3500118217	4393		55840629	55912437	8421504	17	20,19,20,20,1804,575,603,87,249,276,270,117,251,20,20,20,22	0,528,18396,19163,25983,27788,28364,29381,29761,30116,33218,34112,34542,38114,57942,71513,71786	c,g	350011821700000014,350011821700000081,350011821700000015,350011821700000015,350011821700000082,350011821700000082,350011821700000016,350011821700000016,350011821700000083,350011821700000083,350011821700000017,350011821700000017,350011821700000084,350011821700000084,350011821700000107,350011821700000039,350011821700000104,350011821700000040,350011821700000105,350011821700000076,350011821700000009,350011821700000067,350011821700000000,350011821700000068,350011821700000068,350011821700000001,350011821700000001,350011821700000019,350011821700000086,350011821700000037,350011821700000102,350011821700000033,350011821700000033,350011821700000100,350011821700000100,350011821700000098,350011821700000098,350011821700000031,350011821700000031,350011821700000041,350011821700000106,350011821700000108,350011821700000047,350011821700000021,350011821700000021,350011821700000088,350011821700000088,350011821700000090,350011821700000023,350011821700000091,350011821700000091,350011821700000024,350011821700000024,350011821700000092,350011821700000025	0-20,0-20,0-19,0-19,0-19,0-19,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,5-4235,8-29,8-29,8-28,8-28,0-21,0-21,0-22,0-22,0-22,0-22,0-22,0-22,0-20,0-20,0-20,0-20,0-21,0-21,0-21,0-21,0-25,0-25,0-25,0-25,8-33,8-33,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-22,0-22						TRANSGENIC ANIMAL WITH ENHANCED IMMUNE RESPONSE AND METHOD FOR THE PREPARATION THEREOF - Patent application	www.faqs.org	0	0		
1011	chr18	55840629	55875422	3500376415	198		55840629	55875422	8421504	9	20,19,50,22,22,20,16,4,25	0,528,28908,29778,29976,30323,30376,33218,34768	c,g	350037641500000034,350037641500000035,350037641500000035,350037641500000017,350037641500000018,350037641500000009,350037641500000000,350037641500000000,350037641500000001,350037641500000001,350037641500000031,350037641500000031,350037641500000015,350037641500000019,350037641500000025,350037641500000025	0-20,0-19,0-19,8-29,8-28,0-21,0-22,0-22,0-22,0-22,0-20,0-20,0-20,8-33,0-20,0-20						Transgenic animal with enhanced immune response and method for the preparation thereof	Bender	2008	0		
1011	chr18	55840629	55875422	3500161111	218		55840629	55875422	8421504	10	20,19,20,50,22,22,20,16,4,25	0,528,28339,28908,29778,29976,30323,30376,33218,34768	c,g	350016111100000034,350016111100000034,350016111100000035,350016111100000035,350016111100000008,350016111100000017,350016111100000018,350016111100000009,350016111100000009,350016111100000000,350016111100000000,350016111100000001,350016111100000001,350016111100000031,350016111100000015,350016111100000019,350016111100000025	0-20,0-20,0-19,0-19,0-20,8-29,8-28,0-21,0-21,0-22,0-22,0-22,0-22,0-20,0-20,8-33,0-20						Transgenic animal with enhanced immune response and method for the preparation thereof	BOSZE	2009	0		
1011	chr18	55840647	55847175	3500398569	101		55840647	55847175	8421504	4	26,24,5,46	0,27,499,6482	c	350039856900000059,350039856900000060,350039856900000083	21-47,0-29,0-46						Purified mammalian flt3 ligands and agonists and antagonists thereof	Birnbaum	1994	0		
1011	chr18	55840647	55840689	3500148200	42		55840647	55840689	8421504	1	42	0	c	350014820000000010	6-48						Methods of stimulating hematopoietic cells with flt3-ligand	Lyman	1997	0		
1011	chr18	55851085	55851126	3500030801	41		55851085	55851126	8421504	1	41	0	c	350003080100000048	7-48						NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 151P3D4 USEFUL IN TREATMENT AND DETECTION OF CANCER - Patent application	www.faqs.org	0	0		
1011	chr18	55861695	55861718	3500400478	23		55861695	55861718	8421504	1	23	0	c	350040047800000182	0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		
1011	chr18	55861695	55861718	3500357539	23		55861695	55861718	8421504	1	23	0	c,g	350035753900000182,350035753900000182	0-23,0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		
1011	chr18	55861695	55861718	3500210973	23		55861695	55861718	8421504	1	23	0	c	350021097300000182	0-23						Microrna molecules	Tuschl	2002	0		
1011	chr18	55861696	55861719	3500405993	23		55861696	55861719	8421504	1	23	0	c,g	350040599300000005,350040599300000005,350040599300000014,350040599300000003,350040599300000003	0-22,0-22,0-20,0-19,0-19						Use of two microrna moleculars in lung cancer prognosis and medicine preparation	Zhan	2012	0		MIR150
1011	chr18	55869558	55875421	3500249001	180		55869558	55875421	8421504	8	20,19,16,32,6,18,45,24	0,1344,1447,4289,5112,5119,5149,5839	p,c,g	350024900100000011,350024900100000006,350024900100000006,350024900100000005,350024900100015001,350024900100000015,350024900100000010	0-20,0-19,0-19,0-20,0-45,28-105,0-24		10657638		0022-1767	The Journal of Immunology	Cloning and Characterization of the Bovine MHC Class I-Like Fc Receptor	Kacskovics	2000	6		
1011	chr18	55871008	55873879	3500344047	45		55871008	55873879	8421504	2	13,32	0,2839	p	350034404700015000	3-48		18566411		0022-1767	The Journal of Immunology	Activation of the JAK/STAT-1 Signaling Pathway by IFN-&#x03b3; Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG	Liu	2008	6		FCGRT
1011	chr18	55871008	55873879	3500230429	45		55871008	55873879	8421504	2	13,32	0,2839	p	350023042900015000	3-48						ScienceDirect.com - Veterinary Immunology and Immunopathology - Localization of the sheep FcRn in the mammary gland	sciencedirect.com	0	0		FCGRT
1012	chr18	55987628	55991697	3500453714	40		55987628	55991697	8421504	2	20,20	0,4049	c,g	350045371400000001,350045371400000001,350045371400000002,350045371400000002	0-20,0-20,0-20,0-20						pH uniquely modulates protein arginine methylation	demicjournals.org	0	0		PRMT1
1012	chr18	55987629	55997453	3500315567	45		55987629	55997453	8421504	2	23,22	0,9802	c,g	350031556700000002,350031556700000002,350031556700000003	0-23,0-23,0-22		16782888	10.1128/MCB.01360-05	0270-7306	Molecular and Cellular Biology	Btg2 Enhances Retinoic Acid-Induced Differentiation by Modulating Histone H4 Methylation and Acetylation	Passeri	2006	6		PRMT1
1012	chr18	55987635	55997453	3500464745	48		55987635	55997453	8421504	3	17,8,23	0,2866,9795	c	350046474500000004,350046474500000005	0-25,0-23		15911693	10.1124/mol.105.012104	1521-0111 (Online)	Molecular Pharmacology	The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes	Rizzo	2005	0		PRMT1
1012	chr18	55987635	55997453	3500440409	48		55987635	55997453	8421504	3	17,8,23	0,2866,9795	c	350044040900000004,350044040900000005	0-25,0-23		15911693	10.1124/mol.105.012104	1521-0111 (Online)	Molecular Pharmacology	The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes	Rizzo	2005	0		
1012	chr18	55987635	55997453	3500223671	48		55987635	55997453	8421504	3	17,8,23	0,2866,9795	c	350022367100000004,350022367100000005	0-25,0-23						&#x4e3b;&#x9898;&#xff1a;CIS | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1012	chr18	55987635	55997453	3500047581	48		55987635	55997453	8421504	3	17,8,23	0,2866,9795	c	350004758100000004,350004758100000005	0-25,0-23						The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive G 2006&#x5e74;&#x7b2c;68&#x5377;&#x7b2c;2&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&	www.39kf.com	0	0		
1012	chr18	55994615	55997379	3500162809	45		55994615	55997379	8421504	3	22,12,11	0,1230,2753	c	350016280900000010,350016280900000011	0-22,0-23						Epigenetic differences between male and female bovine blastocysts produced in vitro	cs.physiology.org	0	0		
1012	chr18	56068207	56068231	3500005715	24		56068207	56068231	8421504	1	24	0	g	350000571500000001,350000571500000000	1-22,0-23						Host Cell Factors and Functions Involved in Vesicular Stomatitis Virus Entry	jvi.asm.org	0	0		AP2A1
1012	chr18	56071186	56071214	3500242395	25		56071186	56071214	8421504	2	12,13	0,15	c	350024239500000496,350024239500000480,350024239500000508	4-24,4-24,1-24						Uses of myostatin antagonists	Han	2006	0		
1012	chr18	56071186	56071214	3500007099	25		56071186	56071214	8421504	2	12,13	0,15	c	350000709900000508,350000709900000480,350000709900000496	1-24,4-24,4-24						Uses Of Myostatin Antagonists 	.freshpatents.com	0	0		
1012	chr18	56074269	56074294	3500132071	23		56074269	56074294	8421504	2	11,12	0,13	c	350013207100000277	0-23						EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME	Schellenberger	2010	0		
1013	chr18	56141557	56141581	3500445688	23		56141557	56141581	8421504	2	6,17	0,7	c	350044568800000097	22-45						 Herpes Simplex Virus Mutant ICP0 Protein 	www.docstoc.com	0	0		TBC1D17
1013	chr18	56141557	56141581	3500252285	23		56141557	56141581	8421504	2	6,17	0,7	c	350025228500000107	25-48						HERPES SIMPLEX VIRUS MUTANT ICP0 - Patent application	www.faqs.org	0	0		TBC1D17
1013	chr18	56179169	56179201	3500296806	32		56179169	56179201	8421504	1	32	0	c	350029680600000001,350029680600000000	0-32,0-32		21791614	10.1128/MCB.05887-11	0270-7306	Molecular and Cellular Biology	p300-Dependent ATF5 Acetylation Is Essential for Egr-1 Gene Activation and Cell Proliferation and Survival	Liu	2011	6		
1013	chr18	56179169	56179201	3500201283	32		56179169	56179201	8421504	1	32	0	c	350020128300000000,350020128300000001	0-32,0-32		21791614	10.1128/MCB.05887-11		Molecular and Cellular Biology	p300-Dependent ATF5 Acetylation Is Essential for Egr-1 Gene Activation and Cell Proliferation and Survival	David	2011	0		
1013	chr18	56200365	56200388	3500229781	23		56200365	56200388	8421504	1	23	0	c	350022978100000001	15-38						Cloning, Sequencing, Purification, and Crystal Structure of Grenache (Vitis vinifera) Polyphenol Oxidase - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
1013	chr18	56200365	56200388	3500142557	23		56200365	56200388	8421504	1	23	0	c	350014255700000000	19-42		18603618	10.1093/jxb/ern161		Journal of Experimental Botany	Localization of myo-inositol-1-phosphate synthase to the endosperm in developing seeds of Arabidopsis	Naoto	2008	0		
1015	chr18	56397921	56397946	3500436116	25		56397921	56397946	8421504	1	25	0	g	350043611600000009	3-28						ADENOVIRAL VECTORS FOR INFLUENZA VIRUS PRODUCTION - Patent application	www.faqs.org	0	0		
1015	chr18	56453225	56457257	3500215511	207		56453225	56457257	8421504	6	60,24,22,41,10,50	0,87,150,254,1697,3982	p	350021551100015149,350021551100015005,350021551100015183	0-60,0-87,0-60						&#x9583;&#x8eb2;&#x662f;&#x70ba;&#x4e86;&#x5448;&#x73fe;&#x771f;&#x5be6;&#x4e0d;&#x9055;&#x80cc;&#x5fc3; :: &#x75de;&#x5ba2;&#x90a6; PIXNET ::	ts1231.pixnet.net	0	0		
1015	chr18	56453225	56457257	3500097182	207		56453225	56457257	8421504	6	60,24,22,41,10,50	0,87,150,254,1697,3982	p	350009718200015149,350009718200015005,350009718200015183	0-60,0-87,0-60						&#x9583;&#x8eb2;&#x662f;&#x70ba;&#x4e86;&#x5448;&#x73fe;&#x771f;&#x5be6;&#x4e0d;&#x9055;&#x80cc;&#x5fc3; :: &#x75de;&#x5ba2;&#x90a6; PIXNET ::	ts1231.pixnet.net	0	0		
1015	chr18	56453233	56453263	3500088205	30		56453233	56453263	8421504	1	30	0	c	350008820500000002	1-31						Methods for detection of acute promyelocytic leukemia (APL) - US Patent 5843642 Description	ww.patentstorm.us	0	0		
1015	chr18	56453491	56453532	3500456201	41		56453491	56453532	8421504	1	41	0	c	350045620100000077	7-48						Lxr ligand testing method - Patent application	www.faqs.org	0	0		
1015	chr18	56467643	56480305	3500085923	1212		56467643	56480305	8421504	24	189,112,2,85,8,109,86,18,84,44,14,54,8,12,27,54,9,51,30,29,64,30,20,73	0,563,2671,2733,2904,2921,3123,3431,3533,3620,3937,3957,4020,4039,4402,4432,7274,7380,7609,7645,7839,12393,12426,12589	p	350008592300015025,350008592300015026,350008592300015039,350008592300015040,350008592300015037,350008592300015059,350008592300015074,350008592300015093,350008592300015090,350008592300015111,350008592300015150	0-189,0-114,0-93,0-192,0-78,0-204,0-165,0-60,0-60,0-123,117-240						Isolation and sequence determination of the cDNA encoding DNA polymerase from Drosophila melanogaster	hman.stanford.edu	0	0		
1015	chr18	56486595	56488023	3500186119	174		56486595	56488023	8421504	2	1,173	0,1255	p	350018611900015113	144-318						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		
1016	chr18	56513967	56513991	3500237380	24		56513967	56513991	8421504	1	24	0	g	350023738000000000	9-33						Biofuel production	Van	2011	0		
1016	chr18	56551298	56552337	3500022149	137		56551298	56552337	8421504	3	19,22,96	0,142,943	p,c,g	350002214900000004,350002214900000004,350002214900000003,350002214900015037	0-19,0-19,0-22,0-96						Novel human leucine-rich repeat containing protein expressed predominately in nervous system tissues, HLRRNS1	Feder	2001	0		ASPDH,LRRC4B
1016	chr18	56552241	56552337	3500453917	96		56552241	56552337	8421504	1	96	0	p	350045391700015052	0-96						 Polynucleotide Encoding A Human Relaxin Receptor, HGPRBMY5v1 	www.docstoc.com	0	0		ASPDH
1016	chr18	56552241	56552337	3500386150	96		56552241	56552337	8421504	1	96	0	p	350038615000015052	0-96					Patent	Human relaxin receptor HGPRBMY5v1 (Patent US:7339032)	Ramanathan	2008	0		ASPDH
1016	chr18	56552241	56552337	3500331995	96		56552241	56552337	8421504	1	96	0	p	350033199500015052	0-96						 Human Relaxin Receptor HGPRBMY5v1 	www.docstoc.com	0	0		ASPDH
1016	chr18	56552241	56552337	3500094778	96		56552241	56552337	8421504	1	96	0	p	350009477800015048	0-96						Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof	Feder	2006	0		ASPDH
1018	chr18	56793774	56793798	3500322447	23		56793774	56793798	8421504	2	7,16	0,8	c	350032244700000099	14-37						US Patent # 7,544,492. OB polypeptides, modified forms and derivatives - Patents.com	patents.com	0	0		
1018	chr18	56797417	56797996	3500132181	71		56797417	56797996	8421504	3	36,30,5	0,541,574	g	350013218100000038	1-94						TARGETED MODULATION OF GENE EXPRESSION - Patent application	www.faqs.org	0	0		
1018	chr18	56817813	56817846	3500169920	33		56817813	56817846	8421504	1	33	0	c	350016992000000038	0-33						Human glandular kallikrein-1 (hK2)	Vihko	1998	0		
1018	chr18	56819900	56819923	3500265118	23		56819900	56819923	8421504	1	23	0	c	350026511800000002	0-23		16849544	10.1158/0008-5472.CAN-06-0411	0008-5472	Cancer Research	FOXO1A Is a Candidate for the 13q14 Tumor Suppressor Gene Inhibiting Androgen Receptor Signaling in Prostate Cancer	Dong	2006	8		KLK3
1018	chr18	56840410	56840435	3500245637	25		56840410	56840435	8421504	1	25	0	c	350024563700000010	0-25						Dna encoding prost 07 polypeptide	Bringmann	2001	0		
1019	chr18	56897032	56901148	3500087562	666		56897032	56901148	8421504	9	51,45,137,22,217,5,21,107,61	0,57,2511,2862,2887,3418,3426,3471,4055	p	350008756200015033,350008756200015003,350008756200015028,350008756200015023,350008756200015008,350008756200015014	0-177,0-69,0-177,21-168,0-114,0-165						Scce modified transgenic mammals and their use as models of human disease	Egelrud	2002	0		
1019	chr18	56897042	56897088	3500259252	46		56897042	56897088	8421504	1	46	0	c	350025925200000025	1-47					Patent	Recombinant stratum corneum chymotryptic enzyme (SCCE) (Patent US:5834290)	Egelrud	1998	0		
1019	chr18	56900452	56900482	3500325057	30		56900452	56900482	8421504	1	30	0	c	350032505700000028	18-48						Recombinant stratum corneum chymotryptic enzyme (SCCE)	T*Ai Ge Lu 	1996	0		
1019	chr18	56900452	56900482	3500248215	30		56900452	56900482	8421504	1	30	0	c	350024821500000011	18-48					Patent	Recombinant stratum corneum chymotryptic enzyme (SCCE) (Patent US:5981256)	Egelrud	1999	0		
1019	chr18	56925548	56925573	3500455720	23		56925548	56925573	8421504	2	8,15	0,10	c	350045572000000000,350045572000000014	16-39,16-38					Patent	Fusion proteins with an immunoglobulin hinge region linker (Patent US:6165476)	Strom	2000	0		
1019	chr18	56925548	56925573	3500144772	23		56925548	56925573	8421504	2	8,15	0,10	c	350014477200000014,350014477200000000	16-38,16-39						 Fusion Proteins With An Immunoglobulin Hinge Region Linker 	www.docstoc.com	0	0		
1019	chr18	56927635	56927680	3500438660	45		56927635	56927680	8421504	1	45	0	p	350043866000015000	0-45						 Detection Of Ovarian Cancer 	www.docstoc.com	0	0		KLK10
1019	chr18	56927635	56927680	3500380430	45		56927635	56927680	8421504	1	45	0	p	350038043000015001	0-45						Detection of ovarian cancer	Diamandis	2001	0		KLK10
1019	chr18	56938190	56939114	3500337360	29		56938190	56939114	8421504	2	21,8	0,916	c	350033736000000094	16-45						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
1019	chr18	56950914	56950942	3500009186	23		56950914	56950942	8421504	3	12,6,5	0,14,23	g	350000918600000011	5-28						BMC Genomics BioMed Central	biomedcentral.com	0	0		
1019	chr18	57015282	57015310	3500161237	23		57015282	57015310	8421504	2	15,8	0,20	g	350016123700000099	18-41						US Patent # 6,683,165. Human gene relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
1020	chr18	57067920	57067953	3500101463	27		57067920	57067953	8421504	3	12,9,6	0,15,27	c	350010146300000022	0-27						High throughput directed evolution by rational mutagenesis	Vega	2001	0		
1022	chr18	57323200	57323232	3500243885	32		57323200	57323232	8421504	1	32	0	c	350024388500000007	0-32						The mouse lens fiber-cell intrinsic membrane protein MP19 gene ) and granule membrane protein GMP-17 gene (Nkg7): Iso- lation and sequence analysis of two neighboring genes	www.molvis.org	0	0		
1024	chr18	57551772	57552014	3500433622	99		57551772	57552014	8421504	4	25,30,22,22	0,40,175,220	c,g	350043362200000050,350043362200000050,350043362200000051,350043362200000051,350043362200000012,350043362200000013,350043362200000014	0-25,0-25,0-30,0-30,0-22,0-22,0-22		23200856	10.1016/j.celrep.2012.10.023	2211-1247	Cell Reports	Cell Reports - Specific miRNA Stabilization by Gld2-Catalyzed Monoadenylation	D'Ambrogio	2012	0		MIR99B
1024	chr18	57551778	57552513	3500031979	44		57551778	57552513	8421504	2	22,22	0,713	c,g	350003197900000317,350003197900000317,350003197900000325	0-22,0-22,0-22						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR99B,MIR125A
1024	chr18	57551778	57552476	3500400478	45		57551778	57552476	8421504	2	22,23	0,675	c,g	350040047800000147,350040047800000147,350040047800000040,350040047800000040,350040047800000155,350040047800000044	0-22,0-22,0-22,0-22,0-23,0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		MIR99B,MIR125A
1024	chr18	57551778	57552476	3500287752	45		57551778	57552476	8421504	2	22,23	0,675	c,g	350028775200000058,350028775200000058,350028775200000004,350028775200000004	0-22,0-22,0-23,0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		MIR99B,MIR125A
1024	chr18	57551940	57552019	3500185291	79		57551940	57552019	8421504	1	79	0	c,g	350018529100000011,350018529100000011,350018529100000010,350018529100000010	0-79,0-79,0-22,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		
1024	chr18	57551947	57551977	3500013455	30		57551947	57551977	8421504	1	30	0	c	350001345500000023	11-42						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		MIR99B
1024	chr18	57552453	57552477	3500101178	24		57552453	57552477	8421504	1	24	0	c	350010117800000004	0-24		22723983	10.1371/journal.pone.0039276		PLoS ONE	TGF-&#x03b2; and Iron Differently Alter HBV Replication in Human Hepatocytes through TGF-&#x03b2;/BMP Signaling and Cellular MicroRNA Expression	Sun	2012	0		MIR125A
1024	chr18	57552453	57552476	3500371873	23		57552453	57552476	8421504	1	23	0	c	350037187300000155	0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		MIR125A
1024	chr18	57552453	57552476	3500357539	23		57552453	57552476	8421504	1	23	0	c	350035753900000044,350035753900000155	0-23,0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		MIR125A
1024	chr18	57552453	57552476	3500350545	23		57552453	57552476	8421504	1	23	0	c	350035054500000085	0-23						_4zArCHgf	www.scribd.com	0	0		MIR125A
1024	chr18	57552453	57552476	3500304886	23		57552453	57552476	8421504	1	23	0	c	350030488600000131	0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		MIR125A
1024	chr18	57552453	57552476	3500244257	23		57552453	57552476	8421504	1	23	0	c	350024425700000016	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR125A
1024	chr18	57552453	57552476	3500131966	23		57552453	57552476	8421504	1	23	0	c,g	350013196600000016,350013196600000016	0-23,0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR125A
1027	chr18	57988448	57996647	3500322383	80		57988448	57996647	8421504	3	60,3,17	0,8050,8182	p,c	350032238300015005,350032238300000001	0-60,0-20			10.1046/j.1432-1327.2000.01591.x	1432-1033	European Journal of Biochemistry	Biochemical characterization of recombinant subunits of type 2A protein phosphatase overexpressed in Pichia pastoris - Swiatek - 2001 - European Journal of Biochemistry - Wiley Online Library	Swiatek	2000	0		
1027	chr18	57988734	57989336	3500382374	602		57988734	57989336	8421504	1	602	0	g	350038237400000004	27-687						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
1027	chr18	57988734	57989336	3500221817	602		57988734	57989336	8421504	1	602	0	g	350022181700000004	27-687					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
1027	chr18	57988734	57989336	3500101798	601		57988734	57989336	8421504	2	563,38	0,564	g	350010179800000005	27-687						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
1027	chr18	57988742	57989336	3500360633	593		57988742	57989336	8421504	2	555,38	0,556	g	350036063300000002	27-679						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
1028	chr18	58137453	58137479	3500122736	24		58137453	58137479	8421504	2	14,10	0,16	g	350012273600000014	0-40						Protein production in plants	D'aoust	2008	0		
1030	chr18	58354559	58354584	3500006671	24		58354559	58354584	8421504	2	10,14	0,11	g	350000667100000000	10-34						Identification of genetic variants in differentially expressed sequences in cattle of different metabolic type &#x2013; potential genetic markers of nutrient utilization	bn-dummerstorf.de	0	0		
1034	chr18	58920868	58920892	3500406835	23		58920868	58920892	8421504	2	13,10	0,14	g	350040683500000011	0-23						Methods and compositions useful for stimulating an immune response	Schall	2002	0		
1038	chr18	59496030	59496059	3500000762	25		59496030	59496059	8421504	3	7,4,14	0,10,15	g	350000076200000013,350000076200000002	11-36,11-36						Amplification and detection of organisms of the Chlamydiaceae family	Wang	2000	0		
1043	chr18	60127253	60127281	3500344570	24		60127253	60127281	8421504	3	5,5,14	0,8,14	g	350034457000000189	0-24						Antibodies Directed to HER-3 and Uses Thereof - Patent application	www.faqs.org	0	0		
1047	chr18	60648894	60648918	3500069863	24		60648894	60648918	8421504	1	24	0	g	350006986300000083	11-35						 Oligonucleotide Probe And Primers Specific To Bovine Or Porcine Male Genomic DNA 	www.docstoc.com	0	0		
1048	chr18	60753563	60753590	3500224456	23		60753563	60753590	8421504	3	5,12,6	0,6,21	g	350022445600000005	5-29						NLRC5 AS A TARGET TO INTERVENE MHC CLASS 1-MEDIATED IMMUNE RESPONSES	Kobayashi	2011	0		
1049	chr18	60872282	60872305	3500245178	23		60872282	60872305	8421504	1	23	0	c	350024517800000027	15-39						Lichenase and coding sequences	Li	1999	0		
1049	chr18	60872282	60872305	3500239008	23		60872282	60872305	8421504	1	23	0	c	350023900800000027	15-39						FUNGAL LICHENASE AND CODING SEQUENCES - UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC.	www.sumobrain.com	0	0		
1050	chr18	61020004	61020031	3500450521	23		61020004	61020031	8421504	2	16,7	0,20	c	350045052100000008	0-23						Comparison of Caspase Genes for the Induction of Apoptosis Following Gene Delivery	tulane.edu/sse/cb	0	0		
1050	chr18	61020004	61020031	3500278323	23		61020004	61020031	8421504	2	16,7	0,20	c	350027832300000006	0-23					Proceedings of the National Academy of Sciences of the United States of America	Synthetic activation of caspases: Artificial death switches	Rebecca	1998	0		
1050	chr18	61026054	61026080	3500112083	24		61026054	61026080	8421504	2	7,17	0,9	c	350011208300000198	5-29						 Mycobacterial Sulfation Pathway Proteins And Methods Of Use Thereof 	www.docstoc.com	0	0		
1050	chr18	61077417	61077440	3500213595	23		61077417	61077440	8421504	1	23	0	c	350021359500000063	0-23						EXPRESSION OF MIRNAS IN PLACENTAL TISSUE - UNIVERSITY OF BREMEN	www.sumobrain.com	0	0		
1051	chr18	61080603	61099098	3500306361	202		61080603	61099098	8421504	7	30,25,37,30,49,8,23	0,6701,10744,14813,15004,18462,18472	c	350030636100000279,350030636100000266,350030636100000260,350030636100000249,350030636100000445,350030636100000245,350030636100000419	0-30,16-41,0-37,18-48,0-31,0-48,0-31						PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use - Patent application	www.faqs.org	0	0		
1053	chr18	61346040	61346063	3500346255	23		61346040	61346063	8421504	1	23	0	c	350034625500000014	1-24						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		
1053	chr18	61346794	61346820	3500401025	26		61346794	61346820	8421504	1	26	0	c	350040102500000000	7-33						Identification of Short Interspersed Elements (SINEs) in Iranian River Buffalo	www.eaap.org	0	0		
1056	chr18	61812847	61812877	3500186727	25		61812847	61812877	8421504	2	15,10	0,20	c	350018672700000136	17-48						US Patent # 6,291,220. Polynucleotides encoding phosphatidylinositol 3-kinases - Patents.com	www.patents.com	0	0		
1056	chr18	61817105	61835566	3500051750	2091		61817105	61835566	8421504	18	170,32,83,112,132,157,135,88,30,153,189,92,63,139,81,108,141,186	0,546,1587,5782,6058,6952,7724,8146,8746,12104,12557,13856,14044,14242,15384,16606,18038,18275	p	350005175000015000	0-2091						KEGG T01002: 18752	www.genome.jp	0	0		PRKCG
1056	chr18	61817105	61835566	3500000452	2091		61817105	61835566	8421504	18	170,32,83,112,132,157,135,88,30,153,189,92,63,139,81,108,141,186	0,546,1587,5782,6058,6952,7724,8146,8746,12104,12557,13856,14044,14242,15384,16606,18038,18275	p	350000045200015000	0-2091						KEGG T01007: 100855828	www.genome.jp	0	0		PRKCG
1056	chr18	61817151	61835688	3500264907	1447		61817151	61835688	8421504	47	40,40,4,32,4,39,41,40,40,40,3,37,39,41,40,40,41,22,18,38,41,26,14,38,42,35,5,40,7,33,10,29,41,29,11,40,41,37,2,40,40,40,40,40,41,39,7	0,60,120,500,1541,1565,5736,5797,6021,6081,6141,6906,6963,7022,7698,7758,8105,8166,8700,12066,12124,12185,12511,12545,12603,12665,13810,13835,13895,13998,14051,14196,14245,14306,15338,15369,16570,16631,17992,18014,18074,18230,18290,18350,18410,18471,18530	c	350026490700000081	0-1447						Eucaryotic cells transformed with a mammalian phospholipid kinase or protein kinase and assays using them	Goode	1994	0		
1056	chr18	61822893	61823219	3500033695	162		61822893	61823219	8421504	2	106,56	0,270	p	350003369500015007,350003369500015028,350003369500015035,350003369500015036,350003369500015029,350003369500015030	0-165,0-48,3-48,0-48,0-45,0-48						INHIBITING PROTEIN INTERACTIONS - THE GENERAL HOSPITAL CORPORATION INDIANA UNIVERSITY FOUNDATION.	www.sumobrain.com	0	0		PRKCG
1056	chr18	61823249	61835566	3500253152	1608		61823249	61835566	8421504	14	46,157,135,88,30,153,189,92,63,139,81,108,141,186	0,808,1580,2002,2602,5960,6413,7712,7900,8098,9240,10462,11894,12131	p	350025315200015040	0-1608						AN INTRODUCTION TO COMPUTATIONAL BIOCHEMISTRY - C Stan Tsai	www.docstoc.com	0	0		PRKCG
1056	chr18	61835395	61835418	3500303084	23		61835395	61835418	8421504	1	23	0	c	350030308400000095,350030308400000096	21-44,21-44						Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof	Alvaro	1994	0		
1057	chr18	61879670	61879694	3500122711	23		61879670	61879694	8421504	2	6,17	0,7	g	350012271100000048	22-45						Humanized antibodies that recognize beta amyloid peptide - US Patent 7790856 Description	ww.patentstorm.us	0	0		
1058	chr18	62003371	62004914	3500388350	39		62003371	62004914	8421504	2	20,19	0,1524	c,g	350038835000000036,350038835000000036,350038835000000035,350038835000000035	0-20,0-20,0-19,0-19						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
1058	chr18	62003371	62004914	3500027904	39		62003371	62004914	8421504	2	20,19	0,1524	c,g	350002790400000011,350002790400000011,350002790400000010	0-20,0-20,0-19						 SpringerImages - primers sequences 	pringerimages.com	0	0		
1058	chr18	62023547	62023573	3500051726	23		62023547	62023573	8421504	2	5,18	0,8	c	350005172600000026	16-39						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1058	chr18	62102509	62102541	3500219356	26		62102509	62102541	8421504	3	9,4,13	0,10,19	c	350021935600000073	2-30						US Patent # 6,512,103. Mammalian chemokine reagents - Patents.com	www.patents.com	0	0		
1059	chr18	62192787	62192814	3500032379	23		62192787	62192814	8421504	2	14,9	0,18	c	350003237900000011	15-38						Human Therapeutic Cells Secreting Nerve Growth Factor - Patent application	www.faqs.org	0	0		
1059	chr18	62200484	62200512	3500287953	23		62200484	62200512	8421504	2	8,15	0,13	c	350028795300000678	25-48						Method For Increasing Pathogen Resistance In Transgenic Plants - Patent application	www.faqs.org	0	0		
1060	chr18	62320675	62320699	3500255071	23		62320675	62320699	8421504	2	19,4	0,20	g	350025507100000009	0-23						FOXL2 Interacts with Steroidogenic Factor-1 (SF-1) and Represses SF-1-Induced CYP17 Transcription in Granulosa Cells	.endojournals.org	0	0		
1060	chr18	62362790	62362832	3500241703	42		62362790	62362832	8421504	1	42	0	g	350024170300000080	0-42						Method of treating cell damage or depletion	Clark	1995	0		
1060	chr18	62381494	62381518	3500258554	23		62381494	62381518	8421504	2	12,11	0,13	g	350025855400000820	1-24						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
1061	chr18	62510590	62510622	3500297463	29		62510590	62510622	8421504	2	23,6	0,26	g	350029746300000002	14-44						Aus dem Institut f&#xfc;r Chirurgische Forschung und Spitalmanagement des Universit&#xe4;tsspitals Basel, Schweiz	k.uni-freiburg.de	0	0		
1062	chr18	62537409	62537454	3500257087	45		62537409	62537454	8421504	1	45	0	p	350025708700015176	0-45						Chimeric GFP-aequorin as bioluminescent Ca&plus &plus reporters at the single cell level	Baubet	2001	0		SYT1
1062	chr18	62537495	62537779	3500400721	24		62537495	62537779	8421504	2	20,4	0,280	c	350040072100000007,350040072100000004	0-24,0-24						Synaptotagmin I is involved in the regulation of cortical granule exocytosis in the sea urchin	www.brown.edu	0	0		
1062	chr18	62549342	62550752	3500434446	255		62549342	62550752	8421504	5	11,16,87,42,99	0,310,475,991,1311	p	350043444600015009	0-255						That Dealtimeauto.com Fi The Was Hard Deal Time Auto cTnI &#x7279;&#x6b8a;&#x4f4d;&#x70b9;&#x6297;&#x539f;&#x7684;&#x91cd;&#x590d;&#x8868;&#x8fbe;&#x3001;&#x514d;&#x75ab;&#x53ca;&#x5176;&#x6297;&#x4f53;&#x6548;&#x4ef7;&#x68c0;&#x6d4b; - &#x8c46;&#x4e01;&#	.dealtimeauto.com	0	0		
1062	chr18	62549342	62550752	3500057822	255		62549342	62550752	8421504	5	11,16,87,42,99	0,310,475,991,1311	p	350005782200015009	0-255						cTnI &#x7279;&#x6b8a;&#x4f4d;&#x70b9;&#x6297;&#x539f;&#x7684;&#x91cd;&#x590d;&#x8868;&#x8fbe;&#x3001;&#x514d;&#x75ab;&#x53ca;&#x5176;&#x6297;&#x4f53;&#x6548;&#x4ef7;&#x68c0;&#x6d4b; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
1062	chr18	62549895	62552891	3500231053	249		62549895	62552891	8421504	9	9,36,45,39,6,24,18,27,45	0,438,803,851,1260,2150,2177,2921,2951	p	350023105300015056,350023105300015058,350023105300015059,350023105300015061	0-45,0-45,0-45,0-114						Assays for modulators of parkin activity using S5a as a parkin substrate - US Patent 7790365 Description	ww.patentstorm.us	0	0		TNNI3
1062	chr18	62550743	62551161	3500334412	48		62550743	62551161	8421504	2	42,6	0,412	p	350033441200015016	0-48						RECOMBINANT PROTEIN CAPABLE OF BINDING SPECIFICALLY AND QUICKLY TO TROPONIN I DERVIVED FROM HUMAN MYOCARDIUM	Fukunaga	2012	0		TNNI3
1062	chr18	62559947	62560423	3500146047	44		62559947	62560423	8421504	2	22,22	0,454	c,g	350014604700000016,350014604700000016,350014604700000017,350014604700000017	0-22,0-22,0-22,0-22						PASTURE-FEEDING OF CHAROLAIS STEERS INFLUENCES SKELETAL MUSCLE METABOLISM AND GENE EXPRESSION	www.jpp.krakow.pl	0	0		
1062	chr18	62559947	62560423	3500053255	44		62559947	62560423	8421504	2	22,22	0,454	c,g	350005325500000016,350005325500000016,350005325500000017,350005325500000017	0-22,0-22,0-22,0-22						1009_S3_article_10	www.jpp.krakow.pl	0	0		
1064	chr18	62896308	62896333	3500042999	24		62896308	62896333	8421504	2	18,6	0,19	c	350004299900000024	8-32					Patent	Cell-targeting molecule comprising a mutant human carboxypeptidase A (Patent US:6140100)	Blumenkopf	2000	0		
1064	chr18	62898450	62898476	3500399857	23		62898450	62898476	8421504	2	16,7	0,19	c	350039985700000074	14-37						 Glycosyltransferases For Biosynthesis Of Oligosaccharides, And Genes Encoding Them 	www.docstoc.com	0	0		
1064	chr18	62898450	62898476	3500246606	23		62898450	62898476	8421504	2	16,7	0,19	c	350024660600000069	14-37					Patent	Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them (Patent US:5545553)	Gotschlich	1996	0		
1064	chr18	62898450	62898476	3500091684	23		62898450	62898476	8421504	2	16,7	0,19	c	350009168400000074	14-37					Patent	Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them (Patent US:5945322)	Gotschlich	1999	0		
1065	chr18	63018033	63018074	3500328917	41		63018033	63018074	8421504	1	41	0	c	350032891700000334	7-48						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
1067	chr18	63267824	63267852	3500307135	23		63267824	63267852	8421504	2	13,10	0,18	g	350030713500000113	0-23						NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1067	chr18	63277653	63277680	3500115116	23		63277653	63277680	8421504	2	8,15	0,12	g	350011511600000956	11-39						Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use	J*M*Wei Er Sen 	2005	0		
1067	chr18	63292940	63292965	3500191464	25		63292940	63292965	8421504	1	25	0	g	350019146400000023	6-31						Expression Vectors With Improved Safety 	.freshpatents.com	0	0		CNOT3
1068	chr18	63330068	63330194	3500431060	24		63330068	63330194	8421504	4	7,7,6,4	0,107,115,122	c	350043106000000108,350043106000000107	0-24,7-31						Modified cytosine deaminases	Harris	2009	0		
1068	chr18	63330068	63330194	3500354494	24		63330068	63330194	8421504	4	7,7,6,4	0,107,115,122	c	350035449400000108,350035449400000107,350035449400000346,350035449400000347	0-24,7-31,7-31,0-24						Modified cytosine deaminases - Patent application	www.faqs.org	0	0		
1068	chr18	63340783	63340829	3500345859	43		63340783	63340829	8421504	2	20,23	0,23	c,g	350034585900000023,350034585900000023,350034585900000025,350034585900000025	0-20,0-20,0-23,0-23						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		RPS9
1068	chr18	63340783	63340829	3500243216	43		63340783	63340829	8421504	2	20,23	0,23	c,g	350024321600000018,350024321600000018,350024321600000020	0-20,0-20,0-23						EFFECT OF ZILPATEROL HYDROCHLORIDE AND STEROID IMPLANTATION ON YEARLING STEER FEEDLOT PERFORMANCE, CARCASS CHARACTERISTICS, AND SKELETAL MUSCLE GENE EXPRESSION TIMOTHY JOHN BAXA B.S., Kansas State University, 2004 A THESIS	krex.k-state.edu	0	0		RPS9
1068	chr18	63340783	63340829	3500093083	43		63340783	63340829	8421504	2	20,23	0,23	c,g	350009308300000015,350009308300000015,350009308300000017	0-20,0-20,0-23						messenger ribonucleic acid abundance in finishing steers1	animalscience.org	0	0		RPS9
1068	chr18	63340840	63341106	3500398906	41		63340840	63341106	8421504	2	19,22	0,244	c	350039890600000018,350039890600000019	0-19,0-22						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
1068	chr18	63340840	63341106	3500343582	41		63340840	63341106	8421504	2	19,22	0,244	c,g	350034358200000000,350034358200000000,350034358200000001,350034358200000001	0-19,0-19,0-22,0-22						ABSTRACT	tory.lib.ncsu.edu	0	0		
1068	chr18	63340840	63341106	3500315071	41		63340840	63341106	8421504	2	19,22	0,244	c	350031507100000058,350031507100000059	0-19,0-22						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1068	chr18	63341084	63346536	3500342852	43		63341084	63346536	8421504	3	22,16,5	0,91,5447	c	350034285200000002,350034285200000003	0-22,0-21						ANGIOPOIETIN-LIKE PROTEIN 4 IN BOVINE PHYSIOLOGY SHIHHUI LI A THESIS	krex.k-state.edu	0	0		
1068	chr18	63341092	63346540	3500137197	40		63341092	63346540	8421504	3	20,11,9	0,88,5439	c,g	350013719700000020,350013719700000020,350013719700000021	0-20,0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1068	chr18	63341151	63347659	3500147660	360		63341151	63347659	8421504	3	40,187,133	0,5380,6375	p	350014766000015103,350014766000015107,350014766000015105,350014766000015083,350014766000015119,350014766000015117,350014766000015113,350014766000015085	0-180,0-180,0-180,0-54,0-180,0-180,0-180,3-54						THESE L&#x2019;UNIVERSITE BORDEAUX 1	mm.u-bordeaux1.fr	0	0		RPS9
1068	chr18	63346583	63347652	3500395789	47		63346583	63347652	8421504	2	25,22	0,1047	c	350039578900000002,350039578900000003	0-25,0-22			10.1164/rccm.200506-848OC		American Journal of Respiratory and Critical Care Medicine	Vascular Remodeling Is Airway Generation-Specific in a Primate Model of Chronic Asthma	Mark	2006	0		CBR3
1068	chr18	63347534	63347559	3500019670	25		63347534	63347559	8421504	1	25	0	c,g	350001967000000008,350001967000000008	0-25,0-25			10.1002/cncr.10439	1097-0142	Cancer	Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis - Wang-Johanning - 2002 - Cancer - Wiley Online Library	Wang-Johanning	2002	0		RPS9
1069	chr18	63533279	63533409	3500309581	40		63533279	63533409	8421504	2	20,20	0,110	c,g	350030958100000002,350030958100000003,350030958100000003	0-20,0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Reproducci&#xf3;n		2011	0		
1069	chr18	63533279	63533409	3500303705	40		63533279	63533409	8421504	2	20,20	0,110	c,g	350030370500000002,350030370500000003,350030370500000003	0-20,0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Reproducci&#xf3;n		2011	0		
1069	chr18	63541837	63542003	3500388350	44		63541837	63542003	8421504	2	19,25	0,141	c,g	350038835000000033,350038835000000033,350038835000000034	0-19,0-19,0-25						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
1069	chr18	63541837	63542003	3500211375	44		63541837	63542003	8421504	2	19,25	0,141	c,g	350021137500000000,350021137500000000,350021137500000001	0-19,0-19,0-25			10.1186/1471-213X-6-26	1471-213X	BMC Developmental Biology	MATER protein expression and intracellular localization throughout folliculogenesis and preimplantation embryo development in the bovine	Pennetier	2006	3		
1069	chr18	63541837	63542003	3500027904	44		63541837	63542003	8421504	2	19,25	0,141	c,g	350002790400000008,350002790400000008,350002790400000009	0-19,0-19,0-25						 SpringerImages - primers sequences 	pringerimages.com	0	0		
1069	chr18	63547211	63547237	3500362735	26		63547211	63547237	8421504	1	26	0	c	350036273500000003	6-35						Compositions containing nucleic acids and ligands for therapeutic treatment	Baird	1999	0		
1069	chr18	63547211	63547237	3500155898	26		63547211	63547237	8421504	1	26	0	c	350015589800000003	6-35						Heparin-binding growth factors for gene therapy and anterior eye disorders	Sosnowski	1995	0		
1070	chr18	63571461	63571487	3500263908	23		63571461	63571487	8421504	2	9,14	0,12	g	350026390800000358	25-48						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
1073	chr18	64037401	64037683	3500028009	41		64037401	64037683	8421504	2	21,20	0,262	g	350002800900000031,350002800900000030	0-21,0-20						Putative imprinted gene expression in uniparental bovine embryo models	library.uq.edu.au	0	0		
1076	chr18	64383316	64383473	3500357446	43		64383316	64383473	8421504	2	22,21	0,136	c,g	350035744600000005,350035744600000006,350035744600000006	0-22,0-21,0-21						Spatio-Temporal Expression Patterns of Aurora Kinases A, B, and C and Cytoplasmic Polyadenylation-Element-Binding Protein in Bovine Oocytes During Meiotic Maturation	ww.biolreprod.org	0	0		
1076	chr18	64454395	64454420	3500135243	23		64454395	64454420	8421504	2	6,17	0,8	c	350013524300000148	9-33						Electrical Conductors and Devices from Prion-Like Proteins - Patent application	www.faqs.org	0	0		
1079	chr18	64771969	64771996	3500276233	23		64771969	64771996	8421504	2	14,9	0,18	g	350027623300000039	3-26						COMPOSITIONS AND METHODS FOR TREATING OSTEOLYTIC DISORDERS COMPRISING MMP-14 BINDING PROTEINS - Patent application	www.faqs.org	0	0		
1080	chr18	64979590	64979621	3500018503	23		64979590	64979621	8421504	3	11,7,5	0,16,26	g	350001850300000003	0-23						THE J B C Vol. 276, No. 42, Issue of October 19, pp. 38511&#x2013;38517, 2001 Printed in U.S.A. Lipoprotein Secretion and Triglyceride Stores in the Heart*	www.jbc.org	0	0		
1082	chr18	65182999	65183024	3500179961	23		65182999	65183024	8421504	2	15,8	0,17	g	350017996100000225,350017996100000092	10-34,10-34						RECOMBINANT BACULOVIRUS VACCINE - Patent application	www.faqs.org	0	0		
1084	chr18	65498879	65498904	3500248703	25		65498879	65498904	8421504	1	25	0	c	350024870300000423	11-36						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
1085	chr18	65635072	65639007	3500277353	1509		65635072	65639007	8421504	8	5,288,297,297,273,279,36,34	0,346,1262,2008,2529,3430,3793,3901	p	350027735300015000	0-1509						KEGG T01008: 518955	www.genome.jp	0	0		
1085	chr18	65658028	65659295	3500035193	162		65658028	65659295	8421504	6	30,12,43,17,18,42	0,176,191,235,1128,1225	p	350003519300015004,350003519300015005,350003519300015009	0-57,0-45,0-60						Conserved Ribosomal Protein Sequences S5, S18, S27, S30 in the Pacific Oyster Crassostrea gigas and Crassostrea virginica	clib.kindai.ac.jp	0	0		RPS5
1086	chr18	65681536	65681563	3500114128	25		65681536	65681563	8421504	2	10,15	0,12	g	350011412800000454	0-25						Hepatitis G virus protease	Belyaev	1996	0		
1086	chr18	65725866	65734507	3500352938	2070		65725866	65734507	8421504	10	174,131,98,199,91,195,125,159,210,688	0,254,496,853,1619,1790,3032,6914,7396,7953	p	350035293800015000	0-2070						KEGG T01008: 533016	www.genome.jp	0	0		
1086	chr18	65727528	65727560	3500415972	24		65727528	65727560	8421504	3	6,6,12	0,9,20	c	350041597200000005	10-34						Methods And Materials For Modulation Of The Immunosuppressive Activity And Toxicity Of Monoclonal Antibodies 	.freshpatents.com	0	0		
1086	chr18	65772076	65774388	3500381114	43		65772076	65774388	8421504	2	22,21	0,2291	c	350038111400000011,350038111400000010	0-22,0-21		10921923	10.1074/jbc.M004847200	0021-9258	Journal of Biological Chemistry	Conjugation of Nedd8 to CUL1 Enhances the Ability of the ROC1-CUL1 Complex to Promote Ubiquitin Polymerization	Wu	2000	5		UBE2M,UBE2MP1
1086	chr18	65772686	65774389	3500117791	54		65772686	65774389	8421504	2	35,19	0,1684	c,g	350011779100000086,350011779100000078,350011779100000078,350011779100000083	0-35,10-29,10-29,8-27						Characterization of the Ubiquitin/Nedd8 E3 Ligase Activity of the Mdm2/MdmX complex	www.uni-koeln.de	0	0		UBE2M
1086	chr18	65779672	65779695	3500024022	23		65779672	65779695	8421504	1	23	0	c	350002402200000046	0-23						RIP60 nucleic acid and polypeptide sequences and uses therefor	Heintz	2000	0		
1087	chr18	65800660	65800688	3500146321	23		65800660	65800688	8421504	3	4,13,6	0,5,22	g	350014632100000102	7-30						Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use - US Patent 7056714 Description	ww.patentstorm.us	0	0		
608	chr19	3051961	3051986	3500316898	23		3051961	3051986	8421504	3	6,13,4	0,7,21	g	350031689800000009,350031689800000036	4-27,4-27						Engineered Nucleases and Their Uses for Nucleic Acid Assembly - Patent application	www.faqs.org	0	0		
617	chr19	4226343	4228516	3500343582	43		4226343	4228516	8421504	2	23,20	0,2153	c,g	350034358200000019,350034358200000018,350034358200000018	0-23,0-20,0-20						ABSTRACT	tory.lib.ncsu.edu	0	0		
617	chr19	4307566	4307592	3500070972	26		4307566	4307592	8421504	1	26	0	c	350007097200000008	0-26						Gene encoding syntaxin interacting protein	Min	1999	0		
618	chr19	4405479	4405502	3500270868	23		4405479	4405502	8421504	1	23	0	g	350027086800000003	6-35		9079699	10.1074/jbc.272.13.8671	0021-9258	Journal of Biological Chemistry	The Enhanced Immune Response to the HIV gp160/LAMP Chimeric Gene Product Targeted to the Lysosome Membrane Protein Trafficking Pathway	Ruff	1997	5		
620	chr19	4680173	4685350	3500212679	150		4680173	4685350	8421504	2	75,75	0,5102	p	350021267900015005	0-150						BMC Bioinformatics BioMed Central	biomedcentral.com	0	0		HLF
621	chr19	4759257	4759305	3500307883	48		4759257	4759305	8421504	1	48	0	c	350030788300000264	0-48						Methods and materials relating to PAQR polypeptides and polynucleotides - Patent application	www.faqs.org	0	0		
622	chr19	4865229	4865256	3500410448	24		4865229	4865256	8421504	2	10,14	0,13	g	350041044800000002	14-38					Patent	Diagnostic assays for detection of Entamoeba histolytica (Patent US:6207395)	Valkirs	2001	0		
628	chr19	5661779	5661806	3500109110	23		5661779	5661806	8421504	3	7,3,13	0,8,14	g	350010911000000014,350010911000000013	6-29,6-29					Patent	Humanized antibody specific for tumor necrosis factor-alpha (Patent EP:1831257)	Kang	2011	0		
633	chr19	6346708	6346731	3500308662	23		6346708	6346731	8421504	1	23	0	g	350030866200000079	0-23						DNA	.lib.kobe-u.ac.jp	0	0		
634	chr19	6511769	6511836	3500406890	42		6511769	6511836	8421504	2	20,22	0,45	g	350040689000000010,350040689000000011	0-20,0-22						p57kip2 regulates glial fate decision in adult neural stem cells	ev.biologists.org	0	0		NOG
634	chr19	6511793	6512315	3500394874	90		6511793	6512315	8421504	2	42,48	0,474	g	350039487400000046,350039487400000041	6-48,0-48						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2002	0		
637	chr19	6850009	6850037	3500130848	23		6850009	6850037	8421504	2	14,9	0,19	c	350013084800000045	8-42						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
637	chr19	6858487	6858916	3500414850	54		6858487	6858916	8421504	2	5,49	0,380	c	350041485000000003	0-54						Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. - ResearchGate	.researchgate.net	0	0		
637	chr19	6858487	6858916	3500080266	54		6858487	6858916	8421504	2	5,49	0,380	c	350008026600000003	0-54						Genomicbinding-site cloningreveals anestrogen-responsive gene that encodes aRING fingerprotein	www.pnas.org	0	0		
638	chr19	7015144	7015170	3500444832	23		7015144	7015170	8421504	2	12,11	0,15	g	350044483200000020	3-26						 Escapin Protein, A Broadly Antimicrobial Compound From Ink Of The Sea Hare Aplysia Californica, And Uses Thereof 	www.docstoc.com	0	0		
641	chr19	7454038	7454066	3500406189	23		7454038	7454066	8421504	2	13,10	0,18	g	350040618900000001	4-27		19060156	10.1128/JB.01299-08	0021-9193	Journal of Bacteriology	Streptomyces Telomeres Contain a Promoter	Lin	2009	4		
643	chr19	7690732	7690762	3500080587	29		7690732	7690762	8421504	2	25,4	0,26	c	350008058700000026	25-54						Pyridinone analogs as cell proliferation inhibitors	Pierre	2007	0		
644	chr19	7810559	7810583	3500175287	23		7810559	7810583	8421504	2	16,7	0,17	g	350017528700000022	22-48					Patent	Methods and constructs for protein expression (Patent US:6051401)	Chan	2000	0		
645	chr19	7897442	7913044	3500228395	63		7897442	7913044	8421504	3	14,1,48	0,1093,15554	p	350022839500015024	75-147						<Html><Title> Complet list of 1hxt hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
646	chr19	8025701	8026506	3500144405	236		8025701	8026506	8421504	3	21,195,20	0,247,785	p,c,g	350014440500000091,350014440500000091,350014440500000177,350014440500015027,350014440500000090	0-21,0-21,0-195,585-777,0-20						Characterisation of heterogeneous nuclear ribonucleoprotein G (hnRNP G) and its role in splice site selection.	b.uni-erlangen.de	0	0		
646	chr19	8025946	8025975	3500381016	29		8025946	8025975	8421504	1	29	0	c,g	350038101600000006,350038101600000006	8-37,8-37		12612063	10.1128/MCB.23.6.1874-1884.2003	0270-7306	Molecular and Cellular Biology	Roles for SR Proteins and hnRNP A1 in the Regulation of c-src Exon N1	Rooke	2003	6		SRSF1
646	chr19	8025946	8025975	3500333839	29		8025946	8025975	8421504	1	29	0	c	350033383900000006	8-37			10.1128/MCB.23.6.1874-1884.2003		Molecular and Cellular Biology	Roles for SR Proteins and hnRNP A1 in the Regulation of c-src Exon N1	Nanette	2003	0		SRSF1
646	chr19	8025947	8027673	3500218941	72		8025947	8027673	8421504	3	25,20,27	0,1534,1699	c,g	350021894100000004,350021894100000030,350021894100000030,350021894100000003	9-34,0-20,0-20,8-35						Regulation of serine-arginine protein kinase 1 functions by human papillomavirus	theses.bham.ac.uk	0	0		SRSF1
646	chr19	8025948	8026484	3500249193	70		8025948	8026484	8421504	4	23,20,22,5	0,155,508,531	c,g	350024919300000001,350024919300000001,350024919300000005,350024919300000004	10-33,10-33,12-32,4-31						Arginine/Serine-rich Protein Interaction Domain-dependent Modulation of a Tau Exon 10 Splicing Enhancer--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#	journal.9med.net	0	0		SRSF1
649	chr19	8453941	8453989	3500289288	48		8453941	8453989	8421504	1	48	0	p	350028928800015127	0-48						Thyroid peroxidase epitopic regions - Patent # 6528059 - PatentGenius	.patentgenius.com	0	0		
649	chr19	8461079	8461104	3500048410	25		8461079	8461104	8421504	1	25	0	c	350004841000000026	0-25						Expression of myeloperoxidase (MPO) by neutrophils is necessary for their activation by anti-neutrophil cytoplasm autoantibodies (ANCA) against MPO	www.jleukbio.org	0	0		EPX
649	chr19	8465977	8466003	3500382499	26		8465977	8466003	8421504	1	26	0	c	350038249900000002	0-26		12223515		0741-5400	Journal of Leukocyte Biology	Molecular characterization and expression analysis of leucine-rich &#x03b1;2-glycoprotein, a novel marker of granulocytic differentiation	O'Donnell	2002	5		
649	chr19	8465977	8466003	3500256874	26		8465977	8466003	8421504	1	26	0	c	350025687400000002	0-26		12223515		0741-5400	Journal of Leukocyte Biology	Molecular characterization and expression analysis of leucine-rich &#x03b1;2-glycoprotein, a novel marker of granulocytic differentiation	O'Donnell	2002	5		
649	chr19	8511354	8511659	3500287752	51		8511354	8511659	8421504	3	7,24,20	0,246,285	c,g	350028775200000075,350028775200000015,350028775200000014	0-30,0-23,0-20						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		
649	chr19	8511587	8511674	3500185291	87		8511587	8511674	8421504	1	87	0	c,g	350018529100000025,350018529100000025,350018529100000024	0-87,0-87,0-23						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR142
649	chr19	8511587	8511674	3500087048	87		8511587	8511674	8421504	1	87	0	c,g	350008704800000034,350008704800000034,350008704800000035	0-87,0-87,0-23						Gene Vector - Patent application	www.faqs.org	0	0		MIR142
649	chr19	8511599	8511623	3500292735	24		8511599	8511623	8421504	1	24	0	c	350029273500000018	0-24						Targeting anti-apoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice	tologylibrary.org	0	0		MIR142
649	chr19	8511600	8512736	3500146846	64		8511600	8512736	8421504	3	23,21,20	0,38,1116	c,g	350014684600000001,350014684600000003,350014684600000002,350014684600000002,350014684600000004	0-23,0-23,0-21,0-21,0-20		22958478	10.1186/1471-2199-13-27		BMC Molecular Biology	Clock-controlled mir-142-3p can target its activator, Bmal1	Xiaochao	2012	0		
649	chr19	8511600	8511659	3500125321	43		8511600	8511659	8421504	2	23,20	0,39	c,g	350012532100000045,350012532100000046,350012532100000046	0-23,0-20,0-20						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIR142
649	chr19	8511600	8511659	3500114594	44		8511600	8511659	8421504	2	23,21	0,38	c,g	350011459400000846,350011459400000419,350011459400000420,350011459400000420,350011459400000847,350011459400000847	0-23,0-23,0-21,0-21,0-21,0-21						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR142
649	chr19	8511600	8511659	3500031979	44		8511600	8511659	8421504	2	23,21	0,38	c,g	350003197900000334,350003197900000335,350003197900000335	0-23,0-21,0-21						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR142
649	chr19	8511600	8511623	3500439152	23		8511600	8511623	8421504	1	23	0	c	350043915200000160	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR142
649	chr19	8511600	8511623	3500423784	23		8511600	8511623	8421504	1	23	0	c	350042378400000047,350042378400000166	0-23,0-22						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR142
649	chr19	8511600	8511623	3500244257	23		8511600	8511623	8421504	1	23	0	c	350024425700000028	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR142
649	chr19	8511600	8511623	3500226305	23		8511600	8511623	8421504	1	23	0	c	350022630500000001	0-23		23251659	10.1371/journal.pone.0051952	1932-6203	PLOS ONE	PLOS ONE: Specific Micro RNA-Regulated TetR-KRAB Transcriptional Control of Transgene Expression in Viral Vector-Transduced Cells	Pichard	2012	4		MIR142
649	chr19	8511600	8511623	3500131966	23		8511600	8511623	8421504	1	23	0	c	350013196600000028	0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR142
649	chr19	8511601	8511659	3500400478	42		8511601	8511659	8421504	2	22,20	0,38	c,g	350040047800000174,350040047800000173,350040047800000173	0-22,0-20,0-20					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		MIR142
649	chr19	8511601	8511659	3500357539	42		8511601	8511659	8421504	2	22,20	0,38	c,g	350035753900000174,350035753900000173,350035753900000173	0-22,0-20,0-20					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		MIR142
649	chr19	8511601	8511659	3500210973	42		8511601	8511659	8421504	2	22,20	0,38	c	350021097300000174,350021097300000173	0-22,0-20						Microrna molecules	Tuschl	2002	0		MIR142
650	chr19	8530281	8530325	3500291129	44		8530281	8530325	8421504	1	44	0	c	350029112900000000,350029112900000002	0-28,11-45			10.1046/j.1365-2443.2003.00638.x	1365-2443	Genes to Cells	Structure&#x2013;function analysis of human Spt4: evidence that hSpt4 and hSpt5 exert their roles in transcriptional elongation as parts of the DSIF complex - Kim - 2003 - Genes to Cells - Wiley Online Library	Kim	2003	0		SUPT4H1
650	chr19	8537127	8544334	3500062793	74		8537127	8544334	8421504	2	26,48	0,7159	c	350006279300000142,350006279300000131	15-41,0-48						GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS - Patent application	www.faqs.org	0	0		
650	chr19	8598273	8598360	3500062793	68		8598273	8598360	8421504	2	48,20	0,67	c	350006279300000123,350006279300000218	0-48,8-28						GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS - Patent application	www.faqs.org	0	0		
656	chr19	9362756	9362780	3500180208	24		9362756	9362780	8421504	1	24	0	c	350018020800001545	0-24					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		MIR301A
656	chr19	9362757	9362780	3500460589	23		9362757	9362780	8421504	1	23	0	c,g	350046058900000009,350046058900000009	0-23,0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Soreq	2010	0		MIR301A
656	chr19	9362757	9362780	3500323428	23		9362757	9362780	8421504	1	23	0	c,g	350032342800000058,350032342800000058	0-23,0-23						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		MIR301A
656	chr19	9362757	9362780	3500306561	23		9362757	9362780	8421504	1	23	0	c	350030656100000065	21-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
656	chr19	9362757	9362780	3500256738	23		9362757	9362780	8421504	1	23	0	g	350025673800000009	0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2007	0		MIR301A
656	chr19	9362757	9362780	3500254286	23		9362757	9362780	8421504	1	23	0	g	350025428600000002	0-23						Mirnas dysregulated in triple-negative breast cancer	Richer	2011	0		
656	chr19	9362757	9362780	3500246068	23		9362757	9362780	8421504	1	23	0	g	350024606800000009	0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2008	0		
656	chr19	9362757	9362780	3500208886	23		9362757	9362780	8421504	1	23	0	c,g	350020888600000009,350020888600000009	0-23,0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL	Soreq	2008	0		MIR301A
656	chr19	9362757	9362780	3500171540	23		9362757	9362780	8421504	1	23	0	c,g	350017154000000002,350017154000000002	0-23,0-23						MiRNAs dysregulated in triple-negative breast cancer	Richer	2010	0		MIR301A
656	chr19	9362757	9362780	3500010232	23		9362757	9362780	8421504	1	23	0	c,g	350001023200000006,350001023200000006	0-23,0-23		21857646	10.1038/emboj.2011.301	ERROR! NO ISSN	The EMBO Journal	CAMTA1 is a novel tumour suppressor regulated by miR-9/9&ast; in glioblastoma stem cells	Schraivogel	2011	0		
656	chr19	9362757	9362780	3500003566	23		9362757	9362780	8421504	1	23	0	c,g	350000356600000002,350000356600000002	0-23,0-23						MIRNAS DYSREGULATED IN TRIPLE-NEGATIVE BREAST CANCER	Richer	2010	0		MIR301A
656	chr19	9402969	9403014	3500457192	45		9402969	9403014	8421504	1	45	0	p	350045719200015091	18-63						Arabidopsis thaliana	.uni-tuebingen.de	0	0		
658	chr19	9599233	9603231	3500196890	114		9599233	9603231	8421504	3	36,6,72	0,39,3926	p	350019689000015003	0-114						50 human secreted proteins	George	2000	0		YPEL1
659	chr19	9820695	9820722	3500331440	23		9820695	9820722	8421504	2	15,8	0,19	g	350033144000000012	0-29						Alpha-Amylase Variants - Patent application	www.faqs.org	0	0		
659	chr19	9820695	9820722	3500079803	23		9820695	9820722	8421504	2	15,8	0,19	g	350007980300000012	0-29						Alpha-Amylase Variants	Svendsen	2012	0		
660	chr19	9836585	9863804	3500044954	46		9836585	9863804	8421504	2	23,23	0,27196	c,g	350004495400000045,350004495400000046,350004495400000046	0-23,0-23,0-23						Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16 - US Patent 7641899 Description	ww.patentstorm.us	0	0		
660	chr19	9836612	9900940	3500466332	5025		9836612	9900940	8421504	32	42,208,269,162,114,174,198,201,153,123,138,165,181,164,126,143,235,123,146,184,193,158,165,108,168,150,132,111,171,222,76,122	0,23223,26100,27168,29554,30075,33997,34891,37103,37847,38800,39247,39527,41100,45788,46548,49062,51439,52607,52986,53363,53931,54296,54586,54778,55079,55318,55558,56395,56928,62048,64206	p	350046633200015000	0-5025						KEGG T01001: 1213	www.genome.jp	0	0		DHX40,CLTC
660	chr19	9859967	9859990	3500338892	23		9859967	9859990	8421504	1	23	0	c	350033889200000000	0-23		17502389	10.1128/IAI.00106-07	0019-9567	Infection and Immunity	Mechanisms of Chlamydia trachomatis Entry into Nonphagocytic Cells	Hybiske	2007	4		CLTC
660	chr19	9891298	9891521	3500463719	45		9891298	9891521	8421504	3	8,16,21	0,92,202	c,g	350046371900000038,350046371900000039,350046371900000039	0-24,0-21,0-21			10.1111/j.1574-695X.2005.00035.x	1574-695X	FEMS Immunology & Medical Microbiology	Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and nontuberculous European wild boars naturally exposed to Mycobacterium bovis - Naranjo - 2006 - FEMS Immunology & Medical Microbiology - Wiley Online Libr	Naranjo	2006	0		
660	chr19	9891298	9891521	3500322660	45		9891298	9891521	8421504	3	8,16,21	0,92,202	c	350032266000000038,350032266000000039	0-24,0-21						Caracterizaci&#xf3;n gen&#xf3;mica y prote&#xf3;mica de la expresi&#xf3;n g&#xe9;nica diferencial en jabal&#xed;es infectados de forma natural con Mycobacterium bovis Identificaci&#xf3;n de biomarcadores asociados con la infecci&#xf3;n y la respuesta inmu	digital.csic.es	0	0		
660	chr19	9906867	9906957	3500022295	81		9906867	9906957	8421504	2	45,36	0,54	c	350002229500000007,350002229500000019	0-45,0-36						 Methods Of Modulating Cell Death Based On The Bit1/AES Regulatory Pathway 	www.docstoc.com	0	0		
661	chr19	10024312	10026232	3500374909	40		10024312	10026232	8421504	4	14,6,4,16	0,17,1899,1904	g	350037490900000406,350037490900000388	18-38,11-31						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
661	chr19	10043235	10044798	3500228010	112		10043235	10044798	8421504	3	20,20,72	0,1449,1491	c,g	350022801000000047,350022801000000106,350022801000000062,350022801000000013,350022801000000013,350022801000000086,350022801000000086,350022801000000048,350022801000000014,350022801000000014,350022801000000109,350022801000000109	0-20,0-20,0-67,0-20,0-20,0-22,0-22,0-23,0-20,0-20,0-19,0-19						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION	Hata	2009	0		VMP1
661	chr19	10043590	10043614	3500258078	23		10043590	10043614	8421504	2	9,14	0,10	c	350025807800000143	13-44						Nematode PAN and ZP Receptor-Like Sequences - Patent application	www.faqs.org	0	0		VMP1
661	chr19	10044726	10044798	3500191875	72		10044726	10044798	8421504	1	72	0	c	350019187500000007,350019187500000010	0-72,9-28						METHODS FOR DISTINGUISHING BETWEEN LUNG SQUAMOUS CARCINOMA AND OTHER NON SMALL CELL LUNG CANCERS - Patent application	www.faqs.org	0	0		VMP1
661	chr19	10044726	10044798	3500067964	47		10044726	10044798	8421504	2	27,20	0,52	c,g	350006796400000002,350006796400000002,350006796400000010,350006796400000010,350006796400000003,350006796400000003	0-20,0-20,0-20,0-20,0-20,0-20		23082189	10.1371/journal.pone.0047657		PLoS ONE	Mechanical Stretch Modulates MicroRNA 21 Expression, Participating in Proliferation and Apoptosis in Cultured Human Aortic Smooth Muscle Cells	Jian	2012	0		VMP1
661	chr19	10044726	10044796	3500062197	39		10044726	10044796	8421504	2	20,19	0,51	c,g	350006219700000000,350006219700000000,350006219700000001,350006219700000001	0-20,0-20,1-20,1-20		22685542	10.1371/journal.pone.0037366		PLoS ONE	microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion	Nirmalya	2012	0		VMP1
661	chr19	10044731	10044757	3500209418	26		10044731	10044757	8421504	1	26	0	c	350020941800000000	3-29		23028429	10.1371/journal.pone.0041804	1932-6203	PLOS ONE	PLOS ONE: Microarray Analysis of microRNA Expression during Axolotl Limb Regeneration	Holman	2012	4		VMP1
661	chr19	10044731	10044755	3500180001	24		10044731	10044755	8421504	1	24	0	c	350018000100000010	0-24						Glucocorticoid-Mediated Repression of the Oncogenic microRNA Cluster miR-17 92 Contributes to the Induction of Bim and Initiation of Apoptosis	.endojournals.org	0	0		VMP1
661	chr19	10044732	10044756	3500362752	24		10044732	10044756	8421504	1	24	0	c	350036275200000078,350036275200000088,350036275200000079	5-28,0-23,8-28						Method for inhibiting function of micro-rna	Iba	2011	0		VMP1
661	chr19	10044733	10044792	3500288770	40		10044733	10044792	8421504	2	20,20	0,39	c,g	350028877000000019,350028877000000019,350028877000000020	0-20,0-20,0-20						Nucleic acid methyl transferase	Xhemalce	2011	0		VMP1
661	chr19	10044733	10044783	3500467059	41		10044733	10044783	8421504	2	22,19	0,31	c,g	350046705900000016,350046705900000016,350046705900000026,350046705900000026,350046705900000017,350046705900000017	0-22,0-22,0-22,0-22,0-19,0-19						Sj&#xf6;gren&#x2019;s syndrome antigen B (SSB)/La promotes global microRNA expression	www.jbc.org	0	0		VMP1
661	chr19	10044733	10044756	3500413953	23		10044733	10044756	8421504	1	23	0	c	350041395300000001	0-23		16024602	10.1158/0008-5472.CAN-05-0137	0008-5472	Cancer Research	MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells	Chan	2005	8		VMP1
661	chr19	10044733	10044756	3500345202	23		10044733	10044756	8421504	1	23	0	c	350034520200000001,350034520200000003	0-23,0-22		20048743	10.1038/labinvest.2009.126	0023-6837	Laboratory Investigation	Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status	Zhou	2010	4		VMP1
661	chr19	10044733	10044756	3500260607	23		10044733	10044756	8421504	1	23	0	c,g	350026060700000007,350026060700000007,350026060700000003	0-22,0-22,0-23						Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA miRNA and piRNA by northern blot--&#x300a;&#x6838;&#x9178;&#x7814;&#x7a76;&#x533b;&#x5b66;&#x671f;&#x520a;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x90	journal.9med.net	0	0		VMP1
661	chr19	10044733	10044756	3500173907	23		10044733	10044756	8421504	1	23	0	c,g	350017390700000001,350017390700000002,350017390700000002	0-23,0-22,0-22		16024602	10.1158/0008-5472.CAN-05-0137	0008-5472	Cancer Research	MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells	Chan	2005	8		VMP1
661	chr19	10044733	10044756	3500122298	23		10044733	10044756	8421504	1	23	0	c,g	350012229800000001,350012229800000002,350012229800000002	0-23,0-22,0-22						MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells	.aacrjournals.org	0	0		VMP1
661	chr19	10044733	10044756	3500038487	23		10044733	10044756	8421504	1	23	0	c,g	350003848700000007,350003848700000007,350003848700000005,350003848700000005	0-23,0-23,0-22,0-22						Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells	-publications.com	0	0		VMP1
661	chr19	10044735	10044758	3500422139	23		10044735	10044758	8421504	1	23	0	g	350042213900000017	0-23						Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling - Keeping the Faith	pthefaith1296.com	0	0		VMP1
661	chr19	10044740	10044798	3500289073	42		10044740	10044798	8421504	2	23,19	0,39	c,g	350028907300000000,350028907300000001,350028907300000001	0-23,0-19,0-19						MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF&#x03b2;R2) in colon cancer cells. - ResearchGate	.researchgate.net	0	0		VMP1
661	chr19	10044740	10044798	3500063279	42		10044740	10044798	8421504	2	23,19	0,39	c,g	350006327900000000,350006327900000001,350006327900000001	0-23,0-19,0-19		22072622	10.1093/carcin/bgr246		Carcinogenesis	MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF&#x03b2;R2) in colon cancer cells	Yingjie	2012	0		VMP1
82	chr19	10082585	10119014	3500100900	1506		10082585	10119014	8421504	15	141,50,118,3,148,58,101,91,91,108,63,78,108,113,235	0,7631,8677,10392,21067,23324,24824,26705,26977,27618,28030,28289,32266,35172,36194	p	350010090000015000	0-1506						KEGG T01001: 6198	www.genome.jp	0	0		TUBD1,RPS6KB1
661	chr19	10082657	10082717	3500287967	60		10082657	10082717	8421504	1	60	0	p	350028796700015003	0-60						In vivo role of the phosphate groove of PDK1 de&#xfb01;ned by knockin mutation	cs.biologists.org	0	0		TUBD1
662	chr19	10114932	10117784	3500239298	54		10114932	10117784	8421504	2	27,27	0,2825	p	350023929800015025	0-54					Patent	Method for designing pdk1 modulators (Patent EP:1513947)	ALESSI	2007	0		RPS6KB1
662	chr19	10114932	10117784	3500043781	54		10114932	10117784	8421504	2	27,27	0,2825	p	350004378100015024	0-54					Patent	Verfahren zur entwicklung von pdk1-modulatoren (Patent DE:60313967)	ALESSI	2008	0		RPS6KB1
662	chr19	10118960	10119014	3500046924	54		10118960	10119014	8421504	1	54	0	p	350004692400015002	3-57						RegulationofmTORComplex1(mTORC1)byRaptorSer863 andMultisitePhosphorylation S	www.jbc.org	0	0		RPS6KB1
662	chr19	10118969	10119014	3500185111	45		10118969	10119014	8421504	1	45	0	p	350018511100015001	0-45			10.1042/BJ20041956		Biochemical Journal	Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi	Benoit	June	0		RPS6KB1
662	chr19	10213394	10213437	3500361851	43		10213394	10213437	8421504	1	43	0	g	350036185100000031	1-44						Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates - Patent application	www.faqs.org	0	0		
664	chr19	10392798	10392822	3500459603	24		10392798	10392822	8421504	1	24	0	g	350045960300000081	0-24						MICRORNAS THAT REGULATE MUSCLE CELL PROLIFERATION AND DIFFERENTIATION - Patent application	www.faqs.org	0	0		MED13
664	chr19	10392798	10392822	3500371464	24		10392798	10392822	8421504	1	24	0	g	350037146400000081	0-24						MICRORNAS THAT REGULATE MUSCLE CELL PROLIFERATION AND DIFFERENTIATION - Patent application	www.faqs.org	0	0		MED13
664	chr19	10392798	10392822	3500075367	24		10392798	10392822	8421504	1	24	0	g	350007536700000081	0-24						Micrornas That Regulate Muscle Cell Proliferation and Differentiation - Patent application	www.faqs.org	0	0		MED13
665	chr19	10610900	10610930	3500121878	24		10610900	10610930	8421504	3	7,11,6	0,10,24	g	350012187800000058	15-39						Plant fatty acid synthases	www.devileye.net	0	0		
667	chr19	10864318	10865448	3500083015	183		10864318	10865448	8421504	2	75,108	0,1022	p	350008301500015011	324-507						Differential regulation of T-box and homeobox transcription factors suggests roles in controlling chick limb-type identity	s.med.harvard.edu	0	0		TBX4
673	chr19	11566697	11594165	3500244247	44		11566697	11594165	8421504	2	23,21	0,27447	c	350024424700000021,350024424700000020	0-23,0-21		23907458	10.1038/cddis.2013.252	false	Cell Death & Disease	Wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to &#x03b3;-radiation	Song	2013	0		
673	chr19	11566697	11594165	3500232779	44		11566697	11594165	8421504	2	23,21	0,27447	c	350023277900000011,350023277900000010	0-23,0-21						Cancer Treatment Targeting BRCA1-IRIS	Elshamy	2011	0		PPM1D
673	chr19	11566697	11594165	3500187007	44		11566697	11594165	8421504	2	23,21	0,27447	c	350018700700000021,350018700700000020	0-23,0-21		23907458	10.1038/cddis.2013.252	false	Cell Death & Disease	Wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to &#x03b3;-radiation	Song	2013	0		PPM1D
673	chr19	11566697	11594165	3500044528	44		11566697	11594165	8421504	2	23,21	0,27447	c	350004452800000023,350004452800000011,350004452800000022,350004452800000010	0-23,0-23,0-21,0-21						Cancer Treatment Targeting BRCA1-IRIS - Patent application	www.faqs.org	0	0		PPM1D
673	chr19	11583956	11583985	3500313646	27		11583956	11583985	8421504	2	21,6	0,23	g	350031364600000013	7-34						Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof	Frank	1996	0		
676	chr19	11981935	11981962	3500322097	24		11981935	11981962	8421504	2	10,14	0,13	g	350032209700000199	11-36						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
677	chr19	12130043	12132432	3500436583	60		12130043	12132432	8421504	3	23,3,34	0,298,2355	c,g	350043658300000001,350043658300000003,350043658300000002,350043658300000002,350043658300000000	0-26,2-21,0-21,0-21,0-28		18326729	10.1167/iovs.07-1188		Investigative ophthalmology & visual science	Role of Carbonic Anhydrase IV in Corneal Endothelial HCO3- Transport	Xing	2008	0		
677	chr19	12130043	12132432	3500282362	60		12130043	12132432	8421504	3	23,3,34	0,298,2355	c,g	350028236200000001,350028236200000003,350028236200000002,350028236200000002,350028236200000000	0-26,2-21,0-21,0-21,0-26		18326729	10.1167/iovs.07-1188	1552-5783	Investigative Ophthalmology & Visual Science	Role of Carbonic Anhydrase IV in Corneal Endothelial HCO3&#x2212; Transport	Sun	2008	0		
677	chr19	12130621	12130645	3500445013	24		12130621	12130645	8421504	1	24	0	c	350044501300000035,350044501300000059	15-39,3-27						Lung cancer marker	www.devileye.net	0	0		
677	chr19	12148354	12148388	3500407806	26		12148354	12148388	8421504	3	11,5,10	0,16,24	g	350040780600000030,350040780600000334	8-34,23-48						METHOD RELATING TO SWEETNESS ENHANCEMENT - Patent application	www.faqs.org	0	0		
681	chr19	12599825	12599849	3500197185	24		12599825	12599849	8421504	1	24	0	g	350019718500000008	0-30						Methods in Molecular Biology Vol. 049 Plant Gene Transfer and Expression Protocols	www.scribd.com	0	0		
681	chr19	12699646	12699735	3500440489	89		12699646	12699735	8421504	1	89	0	c	350044048900000251,350044048900000252	0-48,0-41						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
85	chr19	12859530	13022808	3500022667	744		12859530	13022808	8421504	19	14,31,15,30,45,45,45,45,45,45,48,46,50,18,30,48,65,31,48	0,7924,8045,8901,35140,69079,71764,71854,72927,104331,124592,132062,135830,135976,136361,155954,157325,163151,163230	p	350002266700015131,350002266700015128,350002266700015116,350002266700015095,350002266700015093,350002266700015091,350002266700015087,350002266700015070,350002266700015059,350002266700015037,350002266700015036,350002266700015033,350002266700015014,350002266700015012,350002266700015011,350002266700015009	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Acetyl Coa Carboxylase Splice Variant And Uses Thereof 	.freshpatents.com	0	0		ACACA
683	chr19	12932499	12947240	3500232370	47		12932499	12947240	8421504	2	24,23	0,14718	c	350023237000000007,350023237000000006	19-43,0-23						<HTML><!-- InstanceBegin template="/Templates/index.dwt" codeOutsideHTMLIsLocked="false" --> <HEAD>	ock.colostate.edu	0	0		
683	chr19	12946352	12946406	3500247696	54		12946352	12946406	8421504	1	54	0	p	350024769600015001	0-54		17210641	10.1128/MCB.01122-06	0270-7306	Molecular and Cellular Biology	Hepatic De Novo Lipogenesis Is Present in Liver-Specific ACC1-Deficient Mice	Harada	2007	6		ACACA
683	chr19	12947311	12965161	3500306124	346		12947311	12965161	8421504	8	20,1,24,119,90,72,10,10	0,27,2677,13435,15398,16523,16627,17840	p,c,g	350030612400000001,350030612400015005,350030612400000025,350030612400000023,350030612400000021,350030612400000013,350030612400000016,350030612400000016,350030612400000014,350030612400015000,350030612400000012,350030612400000000	0-20,0-153,0-50,0-50,0-50,0-50,0-34,0-34,0-34,0-153,0-44,0-20						Proceedings of the VIII International Scientific Congress in Fur Animal Production III: Nutrition	www.ifasanet.org	0	0		
683	chr19	12960849	12962794	3500301078	42		12960849	12962794	8421504	3	16,5,21	0,1860,1924	c,g	350030107800000028,350030107800000027,350030107800000027	0-21,0-21,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
683	chr19	12960849	12962794	3500261436	42		12960849	12962794	8421504	3	16,5,21	0,1860,1924	c,g	350026143600000008,350026143600000006,350026143600000006	0-21,0-21,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
683	chr19	12962754	12963871	3500124900	48		12962754	12963871	8421504	2	24,24	0,1093	c	350012490000000002,350012490000000001	0-24,0-24						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
684	chr19	12986087	12986169	3500159234	44		12986087	12986169	8421504	2	22,22	0,60	c,g	350015923400000003,350015923400000002,350015923400000002	0-22,0-22,0-22						Trabajo Fin de Master . Olaia Urrutia Vera.	ica-e.unavarra.es	0	0		
684	chr19	12991502	13024471	3500290029	1620		12991502	13024471	8421504	12	136,164,162,171,210,111,107,99,82,110,139,129	0,3858,4389,5932,10701,18321,21395,23109,23951,25308,31179,32840	p	350029002900015039	63-1683							rcebioscience.com	0	0		ACACA
684	chr19	13002251	13002296	3500446443	45		13002251	13002296	8421504	1	45	0	p	350044644300015035	0-45						Nucleic acid segments encoding wheat acetyl-CoA carboxylase	Haselkorn	1997	0		MCCC1
684	chr19	13002251	13002296	3500209046	45		13002251	13002296	8421504	1	45	0	p	350020904600015025	0-45						Methods and a maize acetyl CoA carboxylase gene for altering the oil content of plants - Patent # 6268550 - PatentGenius	.patentgenius.com	0	0		ACACA
684	chr19	13002251	13002296	3500196343	45		13002251	13002296	8421504	1	45	0	p	350019634300015025	0-45						Methods for expressing a maize acetyl CoA carboxylase gene in host cells and encoded protein produced thereby - Patent # 6146867 - PatentGenius	.patentgenius.com	0	0		MCCC1
684	chr19	13002251	13002296	3500107018	45		13002251	13002296	8421504	1	45	0	p	350010701800015033	0-45						Methods and a maize acetyl CoA carboxylase gene for altering the oil content of plants	Gengenbach	1996	0		MCCC1
684	chr19	13002329	13009844	3500437228	105		13002329	13009844	8421504	2	84,21	0,7494	p	350043722800015003	0-105						US Patent # 5,559,220. Gene encoding acetyl-coenzyme A carboxylase - Patents.com	www.patents.com	0	0		ACACA
684	chr19	13024415	13024443	3500291056	28		13024415	13024443	8421504	1	28	0	c	350029105600000007	0-28		21454638	10.1074/jbc.M110.206904	0021-9258	Journal of Biological Chemistry	Peptidyl-prolyl Cis/Trans Isomerase NIMA-interacting 1 Associates with Insulin Receptor Substrate-1 and Enhances Insulin Actions and Adipogenesis	Nakatsu	2011	5		
684	chr19	13024438	13045902	3500254892	45		13024438	13045902	8421504	2	37,8	0,21456	p	350025489200015000	0-45		22454291	10.1152/ajpendo.00504.2011		American Journal of Physiology - Endocrinology and Metabolism	Glucagon regulates ACC activity in adipocytes through the CAMKK&#x03b2;/AMPK pathway	I-Chen	June	0		
684	chr19	13046049	13046112	3500027398	41		13046049	13046112	8421504	2	21,20	0,43	c,g	350002739800000004,350002739800000004,350002739800000003	0-21,0-21,0-20						ADIPOSE TISSUE-SPECIFIC EXPRESSION OF LIPOGENIC GENES IN DIFFERENT CATTLE BREEDS: RELATIONSHIP TO FATTY ACID COMPOSITION	www.vuzv.cz	0	0		
686	chr19	13255040	13255068	3500126578	23		13255040	13255068	8421504	2	16,7	0,21	g	350012657800000001	0-23			10.1124/jpet.106.117093	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	A Novel Family of Potent Negative Allosteric Modulators of Group II Metabotropic Glutamate Receptors	Hemstapat	2007	0		
686	chr19	13286299	13287028	3500022301	23		13286299	13287028	8421504	3	15,2,6	0,19,723	c	350002230100000001	0-23						Reverse transphosphorylation by ribonuclease A needs an intact p2-binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme. - ResearchGate	.researchgate.net	0	0		
687	chr19	13444142	13444166	3500069173	24		13444142	13444166	8421504	1	24	0	c	350006917300000007	24-48						JNK is required for lineage -specific differentiation, but not for stem cell self -renewal	mcb.asm.org	0	0		
687	chr19	13444143	13444188	3500034292	42		13444143	13444188	8421504	2	22,20	0,25	c	350003429200000138,350003429200000139	0-22,0-20						Methods and compositions for the response prediction of malig-nant neoplasia to treatment	Munnes	2005	0		HNF1B
687	chr19	13444219	13444245	3500027760	26		13444219	13444245	8421504	1	26	0	c	350002776000000000	0-26						Repression of Human GSTA1 by Interleukin-1 Is Mediated by Variant Hepatic Nuclear Factor-1C 2007&#x5e74;&#x7b2c;69&#x5377;&#x7b2c;1&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
687	chr19	13446360	13451311	3500298307	50		13446360	13451311	8421504	2	26,24	0,4927	c	350029830700000006,350029830700000005	0-26,0-24		11880302	10.1152/ajplung.00271.2001		American Journal of Physiology - Lung Cellular and Molecular Physiology	Cell-specific involvement of HNF-1&#x03b2; in &#x03b1;1-antitrypsin gene expression in human respiratory epithelial cells	Hu	2002	0		
687	chr19	13446360	13451311	3500158558	50		13446360	13451311	8421504	2	26,24	0,4927	c	350015855800000006,350015855800000005	0-26,0-24		11880302	10.1152/ajplung.00271.2001		American Journal of Physiology - Lung Cellular and Molecular Physiology	Cell-specific involvement of HNF-1&#x03b2; in &#x03b1;1-antitrypsin gene expression in human respiratory epithelial cells	Hu	2002	0		
687	chr19	13446360	13451311	3500006744	50		13446360	13451311	8421504	2	26,24	0,4927	c	350000674400000006,350000674400000005	0-26,0-24		11880302	10.1152/ajplung.00271.2001		American Journal of Physiology - Lung Cellular and Molecular Physiology	Cell-specific involvement of HNF-1&#x03b2; in &#x03b1;1-antitrypsin gene expression in human respiratory epithelial cells	Hu	2002	0		
687	chr19	13446599	13451295	3500112353	24		13446599	13451295	8421504	2	16,8	0,4688	c	350011235300000008	20-44						Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma	-publications.com	0	0		
688	chr19	13554711	13556008	3500228436	24		13554711	13556008	8421504	3	5,5,14	0,1275,1283	c	350022843600000001	16-42						Filamin A is required for vimentin-mediated cell adhesion and spreading	ll.physiology.org	0	0		
688	chr19	13559219	13559245	3500114065	23		13559219	13559245	8421504	2	10,13	0,13	c	350011406500000066	0-23						 NSP Molecules 	www.docstoc.com	0	0		
689	chr19	13746166	13746195	3500449315	26		13746166	13746195	8421504	2	9,17	0,12	g	350044931500000581	14-45						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
689	chr19	13760937	13762227	3500435313	40		13760937	13762227	8421504	2	20,20	0,1270	c,g	350043531300000003,350043531300000002,350043531300000002	0-20,0-20,0-20						Analysis of gene expression patterns by microarray hybridization in blood mononuclear cells of SLA-DRB1 defined Canadian Yorkshire pigs. - ResearchGate	.researchgate.net	0	0		
689	chr19	13761068	13762227	3500002504	42		13761068	13762227	8421504	2	21,21	0,1138	c,g	350000250400000006,350000250400000005,350000250400000005	0-21,0-21,0-21						University doctoral (Ph.D.) thesis Katalin Erd&#xe9;lyi Role of poly(ADP-ribose) polymerase-1 (PARP-1) and poly(ADP-ribose) glycohydrolase (PARG) in the regulation of cell death and in the expression of inflammatory mediators	ib.unideb.hu:8080	0	0		CCL4L2
689	chr19	13761636	13762161	3500336865	24		13761636	13762161	8421504	2	16,8	0,517	c	350033686500000199	11-35						Stem cell inhibiting proteins	Craig	1993	0		
689	chr19	13761647	13762175	3500248979	23		13761647	13762175	8421504	3	4,8,11	0,506,517	c	350024897900000085	0-23						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2007	0		
689	chr19	13761647	13762175	3500107370	23		13761647	13762175	8421504	3	4,8,11	0,506,517	c	350010737000000085	0-23						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2008	0		
689	chr19	13761647	13762175	3500086937	23		13761647	13762175	8421504	3	4,8,11	0,506,517	c	350008693700000085	0-23					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent US:7740852)	Bakker	2010	0		
689	chr19	13761647	13762175	3500068951	23		13761647	13762175	8421504	3	4,8,11	0,506,517	c	350006895100000085	0-23						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
690	chr19	13782265	13782333	3500457560	46		13782265	13782333	8421504	2	20,26	0,42	c	350045756000000010,350045756000000011	0-20,0-26						Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle	aldc.nal.usda.gov	0	0		
690	chr19	13782266	13782747	3500457732	60		13782266	13782747	8421504	3	12,13,35	0,60,446	g	350045773200000044	96-272						Method and device for optimizing a nucelotide sequence for the purpose of expression in a protein	Raab	2013	0		
690	chr19	13782266	13782747	3500282473	60		13782266	13782747	8421504	3	12,13,35	0,60,446	g	350028247300000164	96-272						Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein	Raab	2003	0		
690	chr19	13782266	13782747	3500168057	60		13782266	13782747	8421504	3	12,13,35	0,60,446	g	350016805700000029	96-272						Method for modulating gene expression by modifying the cpg content - Patent application	www.faqs.org	0	0		
690	chr19	13782329	13782352	3500101621	23		13782329	13782352	8421504	1	23	0	c	350010162100000058	0-23		14747532	10.1128/JVI.78.4.1665-1674.2004	0022-538X	Journal of Virology	Selective Induction of Th2-Attracting Chemokines CCL17 and CCL22 in Human B Cells by Latent Membrane Protein 1 of Epstein-Barr Virus	Nakayama	2004	5		
690	chr19	13782718	13782747	3500353024	29		13782718	13782747	8421504	1	29	0	g	350035302400000205	42-71						Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein	Graf	2005	0		
690	chr19	13870425	13871429	3500375699	586		13870425	13871429	8421504	5	3,15,321,7,240	0,418,434,756,764	c	350037569900000007	0-588						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
690	chr19	13886091	13886114	3500374740	23		13886091	13886114	8421504	1	23	0	c,g	350037474000000044,350037474000000044	3-26,3-26						Macrophage inflammatory protein-4 (MIP-4) polynucleotides	Ruben	1999	0		
690	chr19	13886091	13886114	3500100378	23		13886091	13886114	8421504	1	23	0	c	350010037800000040	3-26						Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4)	Antonaccio	1998	0		
691	chr19	13908137	13908162	3500442435	23		13908137	13908162	8421504	3	5,6,12	0,6,13	g	350044243500000019	19-44						US Patent # 7,226,593. Methods of treating cachexia with chimeric anti-TNF antibodies - Patents.com	www.patents.com	0	0		
691	chr19	13931752	13931778	3500354301	26		13931752	13931778	8421504	1	26	0	c	350035430100000013	0-26						World J Gastroenterol	www.wjgnet.com	0	0		
691	chr19	13936335	13936358	3500137193	23		13936335	13936358	8421504	1	23	0	c	350013719300000009	0-23						Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system	biomedcentral.com	0	0		
691	chr19	13936344	13936463	3500291860	41		13936344	13936463	8421504	2	20,21	0,98	c	350029186000000012,350029186000000013	0-20,0-21						Die Immunantwort boviner und capriner Euterepithelzellen auf verschiedene Mastitiserreger	b.uni-muenchen.de	0	0		
691	chr19	13936354	13936407	3500301078	53		13936354	13936407	8421504	1	53	0	c,g	350030107800000064,350030107800000064	0-53,0-53						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
692	chr19	14044521	14045366	3500408717	23		14044521	14045366	8421504	3	3,7,13	0,824,832	c	350040871700000016	1-24						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
692	chr19	14069427	14069454	3500113379	23		14069427	14069454	8421504	3	12,7,4	0,15,23	c	350011337900000063	20-43						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
692	chr19	14069427	14069454	3500062787	23		14069427	14069454	8421504	3	12,7,4	0,15,23	c	350006278700000063	20-43						Polypeptides of Botryosphaeria Rhodina - Patent application	www.faqs.org	0	0		
86	chr19	14074590	14162237	3500444616	966		14074590	14162237	8421504	16	60,60,60,39,99,102,4,116,96,84,60,5,1,60,60,60	0,48643,53140,53260,60237,61607,61769,62947,69880,70105,70898,70972,73021,73062,85731,87587	p,c	350044461600015041,350044461600015028,350044461600015024,350044461600015022,350044461600015021,350044461600015020,350044461600015019,350044461600015017,350044461600015016,350044461600015015,350044461600000021,350044461600015014,350044461600015013,350044461600015009,350044461600015007,350044461600015003,350044461600015001	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						Expression of a novel beta adaptin subunit mRNA splice variant in human testes	www.asiaandro.com	0	0		
692	chr19	14074700	14082664	3500103970	25		14074700	14082664	8421504	2	21,4	0,7960	c	350010397000000013	0-25						Funktionelle Regulation des Clathrin Adaptor Komplexes 2 (AP2)	www.uni-koeln.de	0	0		
692	chr19	14127672	14127700	3500164909	26		14127672	14127700	8421504	2	14,12	0,16	c	350016490900000016	10-36						Stable gene transfer and expression in cord blood&#x2013;derived CD34 hematopoietic stem and progenitor cells by a hyperactive SleepingBeauty transposon system	tologylibrary.org	0	0		
694	chr19	14376485	14376511	3500422081	23		14376485	14376511	8421504	2	5,18	0,8	c	350042208100000006	11-34		15665311		0008-5472	Cancer Research	Apolipoprotein E Is Required for Cell Proliferation and Survival in Ovarian Cancer	Chen	2005	8		
695	chr19	14504850	14504877	3500172455	23		14504850	14504877	8421504	2	14,9	0,18	c	350017245500000003	0-23						Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation	hives-ouvertes.fr	0	0		
696	chr19	14663549	14663573	3500256437	23		14663549	14663573	8421504	2	9,14	0,10	g	350025643700000003	21-44						Fibroblast growth factor-19	Botstein	2000	0		
696	chr19	14663549	14663573	3500143507	23		14663549	14663573	8421504	2	9,14	0,10	g	350014350700000015,350014350700000003	21-44,21-44						POLYPEPTIDES SHARING SEQUENCE IDENTITY WITH A FIBROBLAST GROWTH FACTOR POLYPEPTIDE AND NUCLEIC ACIDS ENCODING THE SAME - Patent application	www.faqs.org	0	0		
701	chr19	15297217	15297839	3500258579	216		15297217	15297839	8421504	2	103,113	0,509	p	350025857900015021	0-216						RESEARCH ARTICLE Open Access Pseudogenization of the MCP-2/ Oryctolagus not in species of Cottontail rabbit (Sylvilagus Lepus	biomedcentral.com	0	0		
701	chr19	15297237	15298706	3500177864	40		15297237	15298706	8421504	2	20,20	0,1449	c	350017786400000022,350017786400000021	0-20,0-20						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
701	chr19	15297237	15298706	3500136902	40		15297237	15298706	8421504	2	20,20	0,1449	c	350013690200000017,350013690200000016	0-20,0-20						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
703	chr19	15522312	15522336	3500345578	24		15522312	15522336	8421504	1	24	0	c	350034557800000007	0-24						R&#xf4;le des &#xe9;osinophiles dans la r&#xe9;gulation des populations d'Haemonchus contortus chez le mouton	s.inp-toulouse.fr	0	0		
703	chr19	15522312	15522336	3500307224	24		15522312	15522336	8421504	1	24	0	c	350030722400000007	0-24						Haemonchus contortus (Nematoda: Trichostrongylidae) infection in lambs elicits an unequivocal Th	etres-archive.org	0	0		
703	chr19	15522312	15522336	3500043402	24		15522312	15522336	8421504	1	24	0	c	350004340200000007	0-24						Haemonchus contortus (Nematoda: Trichostrongylidae) infection in lambs elicits an unequivocal Th	www.vetres.org	0	0		
703	chr19	15557839	15558661	3500139222	40		15557839	15558661	8421504	3	10,10,20	0,11,802	c,g	350013922200000000,350013922200000001,350013922200000001	0-20,0-20,0-20		11207217	10.1095/biolreprod64.3.992	0006-3363	Biology of Reproduction	Monocyte Chemotactic Protein-1 and -2 Messenger Ribonucleic Acids in the Ovine Uterus: Regulation by Pregnancy, Progesterone, and Interferon-&#x03c4;	Asselin	2001	4		
703	chr19	15558038	15558666	3500177864	40		15558038	15558666	8421504	2	20,20	0,608	c,g	350017786400000020,350017786400000020,350017786400000019	0-20,0-20,0-21						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
703	chr19	15558038	15558666	3500136902	40		15558038	15558666	8421504	2	20,20	0,608	c,g	350013690200000015,350013690200000015,350013690200000014	0-20,0-20,0-21						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
703	chr19	15558080	15558105	3500096920	25		15558080	15558105	8421504	1	25	0	c	350009692000000011	1-26						A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide.	Fukui	1991	0		
703	chr19	15558082	15558109	3500458362	27		15558082	15558109	8421504	1	27	0	c	350045836200000001	0-27						ScienceDirect.com - Atherosclerosis - Dehydroepiandrosterone inhibits the TNF-alpha-induced inflammatory response in human umbilical vein endothelial cells	sciencedirect.com	0	0		
703	chr19	15558082	15558109	3500347714	27		15558082	15558109	8421504	1	27	0	c	350034771400000001	0-27		11948121		1078-0432	Clinical Cancer Research	Analysis of Chemokines and Chemokine Receptor Expression in Ovarian Cancer Ascites	Milliken	2002	8		
703	chr19	15558082	15558109	3500341381	27		15558082	15558109	8421504	1	27	0	c	350034138100000001	0-27		11179307	10.1128/IAI.69.3.1420-1427.2001	0019-9567	Infection and Immunity	cDNA Array Analysis of Altered Gene Expression in Human Endothelial Cells in Response to Chlamydia pneumoniae Infection	Coombes	2001	4		
703	chr19	15558082	15558109	3500219588	27		15558082	15558109	8421504	1	27	0	c	350021958800000001	0-27					Infection and Immunity	Chemokine Production by a Human Alveolar Epithelial Cell Line in Response to Mycobacterium tuberculosis	Yuanguang	1998	0		
703	chr19	15558082	15558109	3500007223	27		15558082	15558109	8421504	1	27	0	c	350000722300000001	0-27						Analysis of Chemokines and Chemokine Receptor Expression in Ovarian Cancer Ascites	.aacrjournals.org	0	0		
703	chr19	15558085	15558109	3500220848	24		15558085	15558109	8421504	1	24	0	c	350022084800000003	20-44						&#xa9; Ivyspring International Publisher. All rights reserved Research Paper Lipocalin-2&#x2013;induced cytokine production enhances endometrial carci- noma cell survival and migration	www.ijbs.com	0	0		CCL2
703	chr19	15558118	15559504	3500055298	288		15558118	15559504	8421504	3	94,118,76	0,444,1310	p	350005529800015038,350005529800015037,350005529800015036,350005529800015035,350005529800015034,350005529800015033	0-48,0-48,0-48,0-48,0-48,0-48						Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2 - US Patent 6281200 Description	ww.patentstorm.us	0	0		
703	chr19	15558168	15559471	3500040185	41		15558168	15559471	8421504	2	20,21	0,1282	c,g	350004018500000033,350004018500000032,350004018500000032	0-20,0-21,0-21						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
703	chr19	15558197	15558570	3500305779	23		15558197	15558570	8421504	2	15,8	0,365	c	350030577900000009	0-23						Differential Expression of Ovine Innate Immune Genes by Preterm and Neonatal Lung Epithelia Infected with Respiratory Syncytial Virus	ddr.nal.usda.gov	0	0		
703	chr19	15558197	15558570	3500279721	23		15558197	15558570	8421504	2	15,8	0,365	c	350027972100000012	0-23			10.1251/bpo107		Biological Procedures Online	New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR	JM	2005	0		
703	chr19	15558197	15558570	3500256733	23		15558197	15558570	8421504	2	15,8	0,365	c	350025673300000000	0-23						Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q)	www.ijbs.org	0	0		
703	chr19	15558197	15558570	3500163064	23		15558197	15558570	8421504	2	15,8	0,365	c	350016306400000012	0-23			10.1251/bpo107		Biological Procedures Online	New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR	Jack	2005	0		
703	chr19	15558577	15559442	3500137193	42		15558577	15559442	8421504	3	22,6,14	0,97,851	c	350013719300000007,350013719300000006	0-22,0-20						Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system	biomedcentral.com	0	0		CCL2
703	chr19	15558579	15558661	3500365673	40		15558579	15558661	8421504	2	20,20	0,62	c,g	350036567300000021,350036567300000020,350036567300000020	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
703	chr19	15558579	15558661	3500262357	40		15558579	15558661	8421504	2	20,20	0,62	c,g	350026235700000021,350026235700000020,350026235700000020	0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
703	chr19	15559487	15559535	3500047620	47		15559487	15559535	8421504	2	20,27	0,21	c	350004762000000007,350004762000000008	0-20,0-27						Monocyte recruitment to endothelial cells in response to oscillatory shear stress	www.fasebj.org	0	0		
704	chr19	15674991	15675019	3500375219	28		15674991	15675019	8421504	1	28	0	c	350037521900000000	6-34						JBC Papers in Press. Published on December 13, 2012 as Manuscript M112.441063 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M112.441063	www.jbc.org	0	0		
704	chr19	15674992	15675040	3500377503	48		15674992	15675040	8421504	1	48	0	p	350037750300015001	0-48		12736332		0270-6474	The Journal of Neuroscience	Amiloride-Insensitive Currents of the Acid-Sensing Ion Channel-2a (ASIC2a)/ASIC2b Heteromeric Sour-Taste Receptor Channel	Ugawa	2003	7		ASIC2
704	chr19	15674992	15675040	3500342262	48		15674992	15675040	8421504	1	48	0	p	350034226200015001	0-48		15169849	10.1113/jphysiol.2004.066001	0022-3751	The Journal of Physiology	Knockout of the ASIC2 channel in mice does not impair cutaneous mechanosensation, visceral mechanonociception and hearing	Roza	2004	5		ASIC2
704	chr19	15674992	15675040	3500260047	48		15674992	15675040	8421504	1	48	0	p	350026004700015000	0-48			10.1113/jphysiol.2004.066001		The Journal of Physiology	Knockout of the ASIC2 channel in mice does not impair cutaneous mechanosensation, visceral mechanonociception and hearing	Carolina	July	0		ASIC2
706	chr19	15990517	15990541	3500333899	23		15990517	15990541	8421504	2	8,15	0,9	g	350033389900000001	2-33						Methicillin Resistance Profile and Molecular Typing of Staphylococcus aureus Strains Isolated from Noses of the Healthy Dogs	rgi.kafkas.edu.tr	0	0		
710	chr19	16460960	16460984	3500278580	23		16460960	16460984	8421504	2	14,9	0,15	g	350027858000000052	9-32						Nouveau anticorps anti-GF-IR et leurs applications	Corvaia	2007	0		
710	chr19	16460960	16460984	3500253952	23		16460960	16460984	8421504	2	14,9	0,15	g	350025395200000050	9-32						Nouveaux anticorps anti-igf-ir et leurs applications	Goetsch	2007	0		
713	chr19	16898246	16898273	3500210875	27		16898246	16898273	8421504	1	27	0	c	350021087500000000	0-27		21911609	10.1113/jphysiol.2011.213272		The Journal of Physiology	Cross-reactivity of acid-sensing ion channel and Na+&#x2013;H+ exchanger antagonists with nicotinic acetylcholine receptors	Julio	2011	0		ASIC2
714	chr19	16958327	16958375	3500311219	48		16958327	16958375	8421504	1	48	0	c	350031121900000050	0-48						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
714	chr19	16958489	16967992	3500284360	411		16958489	16967992	8421504	6	1,60,116,34,132,68	0,1320,4131,6700,7841,9435	p	350028436000015034	0-411						95 human secreted proteins	Duan	1999	0		TMEM98
714	chr19	16968132	16968157	3500396369	24		16968132	16968157	8421504	2	20,4	0,21	g	350039636900000187	5-29						 VMP 	www.docstoc.com	0	0		
714	chr19	16968132	16968157	3500389666	24		16968132	16968157	8421504	2	20,4	0,21	g	350038966600000190	5-29						VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS - Patent application	www.faqs.org	0	0		
717	chr19	17369740	17370115	3500177531	372		17369740	17370115	8421504	2	279,93	0,282	p	350017753100015000	0-375						Behandlung mit CDK5 Inhibitor bei der Myelin Oligo- dendrozyten Glykoprotein (MOG) induzierten experimentellen autoimmunen Encephalomyelitis (EAE)	.uni-tuebingen.de	0	0		CDK5R1
717	chr19	17376963	17382841	3500280352	528		17376963	17382841	8421504	7	50,52,36,126,63,61,140	0,348,657,1170,2925,4763,5738	p	350028035200015003,350028035200015004	0-528,0-249							y.engin.umich.edu	0	0		PSMD11
717	chr19	17376963	17382841	3500051404	528		17376963	17382841	8421504	7	50,52,36,126,63,61,140	0,348,657,1170,2925,4763,5738	p	350005140400015002,350005140400015003	0-528,0-249						README for stand-alone BLAST (last updated 7/30/99) This document provides information on s	io.lundberg.gu.se	0	0		PSMD11
717	chr19	17381886	17381914	3500035685	23		17381886	17381914	8421504	2	17,6	0,22	g	350003568500000096	8-31						METHOD OF PREDICTING POTENTIAL SEVERITY OF HEPATITIS E, PROBE SETS, AND PRIMER SETS - Patent application	www.faqs.org	0	0		
718	chr19	17502522	17502547	3500141193	23		17502522	17502547	8421504	2	7,16	0,9	g	350014119300000000	4-27						Zytokinrezeptor wie eine gemeinsame Gammakette - Dokument EP1982990	www.patent-de.com	0	0		
720	chr19	17761231	17761255	3500115843	23		17761231	17761255	8421504	2	6,17	0,7	c	350011584300000296	6-29						Methods And Compositions For Detecting Sars Virus And Other Infectious Agents 	.freshpatents.com	0	0		
721	chr19	17894362	17898074	3500213747	43		17894362	17898074	8421504	2	20,23	0,3689	c	350021374700000001,350021374700000000	0-20,0-23		22399519	10.1210/jc.2011-3068	0021-972X	Journal of Clinical Endocrinology & Metabolism	Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2	Esposito	2012	6		SUZ12
721	chr19	17894372	17902330	3500418723	47		17894372	17902330	8421504	3	23,13,11	0,3772,7947	c	350041872300000005,350041872300000004	0-23,0-24		24019906	10.1371/journal.pone.0073195		PLoS ONE	The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression	Saroj	2013	0		SUZ12
721	chr19	17903609	17924295	3500056891	116		17903609	17924295	8421504	5	26,21,25,22,22	0,42,18054,20566,20664	c,g	350005689100000005,350005689100000007,350005689100000011,350005689100000006,350005689100000004,350005689100000004	0-26,0-21,0-25,0-22,0-22,0-22						Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors	Koontz	2001	0		
721	chr19	17903644	17903725	3500330297	45		17903644	17903725	8421504	2	25,20	0,61	c,g	350033029700000006,350033029700000005,350033029700000005	43-68,0-20,0-20				1470-1626		Polycomb gene expression and histone H3 lysine 27 trimethylation changes during bovine preimplantation development 	uction-online.org	0	3		
721	chr19	17903651	17921688	3500418385	69		17903651	17921688	8421504	2	42,27	0,18010	c	350041838500000001,350041838500000013,350041838500000003,350041838500000005	0-21,0-24,0-24,0-27						Absence of the JAZF1/SUZ12 chimeric transcript in the immortalized non-neoplastic endometrial stromal cell line T HESCs. - ResearchGate	.researchgate.net	0	0		SUZ12
723	chr19	18189941	18202912	3500125321	42		18189941	18202912	8421504	2	21,21	0,12950	c,g	350012532100000016,350012532100000050	0-21,0-21						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
723	chr19	18202890	18202946	3500439152	44		18202890	18202946	8421504	2	22,22	0,34	c,g	350043915200000308,350043915200000308,350043915200000269,350043915200000241	0-22,0-22,0-22,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR193A
723	chr19	18202890	18202946	3500232262	44		18202890	18202946	8421504	2	22,22	0,34	c	350023226200000028,350023226200000029	22-44,22-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		MIR193A
726	chr19	18518872	18524095	3500191020	23		18518872	18524095	8421504	2	5,18	0,5205	c	350019102000000034	0-23		23056445	10.1371/journal.pone.0046773	1932-6203	PLOS ONE	PLOS ONE: Neurofibromin 1 Is a miRNA Target in Neurons	Paschou	2012	4		NF1
730	chr19	19059031	19059058	3500372261	24		19059031	19059058	8421504	3	5,14,5	0,6,22	g	350037226100000028	19-43					Patent	CTLA4/CD28Ig hybrid fusion proteins and uses thereof (Patent US:6090914)	Bajorath	2000	0		
730	chr19	19116719	19116743	3500195182	24		19116719	19116743	8421504	1	24	0	g	350019518200000203	1-25						CD4+ T-lymphocyte proteases and genes encoding said proteases	Franzusoff	1995	0		
730	chr19	19125843	19125867	3500442426	23		19125843	19125867	8421504	2	7,16	0,8	g	350044242600000199	24-47						Gene encoding protein antigens of Plasmodium falciparum and uses therefor	Inselburg	1994	0		
730	chr19	19129887	19132231	3500268248	43		19129887	19132231	8421504	2	19,24	0,2320	c,g	350026824800000008,350026824800000008,350026824800000024,350026824800000024,350026824800000009	0-19,0-19,0-20,0-20,0-19		16885540	10.1530/rep.1.00996	1470-1626	Reproduction	Embryo-induced transcriptome changes in bovine endometrium reveal species-specific and common molecular markers of uterine receptivity	Bauersachs	2006	3		
91	chr19	19135799	19136996	3500340694	39		19135799	19136996	8421504	2	20,19	0,1178	c	350034069400000004,350034069400000005	19-39,0-19						Emprego da RT-PCR em tempo real para a quantifica&#xe7;&#xe3;o da express&#xe3;o de genes associados &#xe0; resposta imune em bezerros bovinos experimentalmente infectados por N caninum	pt.scribd.com	0	0		
731	chr19	19137461	19137506	3500466453	45		19137461	19137506	8421504	1	45	0	p	350046645300015182	0-45						US Patent # 5,908,756. Protein inhibitor of neuronal nitric oxide synthase - Patents.com	www.patents.com	0	0		NOS2
731	chr19	19137463	19137488	3500385557	25		19137463	19137488	8421504	1	25	0	c	350038555700000000	0-25						)-Epigallocatechin-3-gallate Blocks the Induction of Nitric Oxide Synthase by Down-Regulating Lipopolysaccharide- Induced Activity of Transcription Factor Nuclear Factor- B	aspetjournals.org	0	0		
731	chr19	19137463	19137488	3500330457	25		19137463	19137488	8421504	1	25	0	c	350033045700000000	0-25						ScienceDirect.com - Biochemical Pharmacology - Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of I&#x03ba;B kinase and NF&#x03ba;B activation in macrophages	sciencedirect.com	0	0		
731	chr19	19137463	19137488	3500223603	25		19137463	19137488	8421504	1	25	0	c	350022360300000000	0-25						Molecular Characteristics and Biological Activities of Anionic Macromolecules from Codium fragile | Mehdi Tabarsa - Academia.edu	www.academia.edu	0	0		
731	chr19	19137463	19137488	3500220653	25		19137463	19137488	8421504	1	25	0	c	350022065300000000	0-25						Distinctive antioxidant and antiinflammatory effects of flavonols. - ResearchGate	.researchgate.net	0	0		
731	chr19	19137463	19137488	3500173620	25		19137463	19137488	8421504	1	25	0	c	350017362000000006	0-25		18454171	10.1038/bjp.2008.136	1476-5381	British Journal of Pharmacology	Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264.7 cells - Lee - 2009 - British Journal of Pharmacology - Wiley Online Library	Lee	2008	0		
731	chr19	19137463	19137488	3500155564	25		19137463	19137488	8421504	1	25	0	c	350015556400000052	0-25						Pharmaceutical Bioassays: Methods and Applications	www.scribd.com	0	0		
731	chr19	19138085	19155338	3500113861	67		19138085	19155338	8421504	3	29,26,12	0,17122,17241	c	350011386100000114,350011386100000080	9-38,0-38						Megsin/Rage/Inos-Overexpressing Renal Disease Model Animals and Methods for Evaluating Compounds Using the Model Animals - Patent application	www.faqs.org	0	0		
731	chr19	19140661	19142458	3500168429	24		19140661	19142458	8421504	2	16,8	0,1789	c	350016842900000000	0-24						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
731	chr19	19140661	19142458	3500081208	24		19140661	19142458	8421504	2	16,8	0,1789	c	350008120800000000	0-24						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
731	chr19	19142573	19143698	3500032199	40		19142573	19143698	8421504	2	20,20	0,1105	c	350003219900000009,350003219900000008	0-20,0-20		19141072	10.1111/j.1471-4159.2008.05862.x	1471-4159	Journal of Neurochemistry	Signaling mechanisms of interferon gamma induced apoptosis in chromaffin cells: involvement of nNOS, iNOS, and NF&#x03ba;B - P&#xe9;rez-Rodr&#xed;guez - 2008 - Journal of Neurochemistry - Wiley Online Library	Perez-Rodriguez	2009	0		
731	chr19	19144916	19174984	3500255734	158		19144916	19174984	8421504	5	47,39,47,20,5	0,12586,20070,21027,30063	c	350025573400000050,350025573400000023,350025573400000012,350025573400000009	0-47,9-48,0-47,0-25						Inducible nitric oxide synthase and gene therefor	Charles	1994	0		
731	chr19	19145894	19145917	3500289563	23		19145894	19145917	8421504	1	23	0	c	350028956300000001	0-23		10463945		0892-6638	The FASEB Journal	Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats	CRESPO	1999	6		
731	chr19	19145904	19148487	3500359591	48		19145904	19148487	8421504	3	24,11,13	0,1705,2570	c	350035959100000001,350035959100000000	0-24,0-24		12785010		1073-2322	Shock	 An AT1-Receptor Antagonist and an Angiotensin-Converting Enz... : Shock 	Matsumoto	2003	3		NOS2
731	chr19	19145916	19148500	3500181178	40		19145916	19148500	8421504	2	20,20	0,2564	c,g	350018117800000001,350018117800000001,350018117800000000,350018117800000000,350018117800000006,350018117800000006	0-20,0-20,0-20,0-20,0-20,0-20						INHIBITOR OF INFLAMMATORY CONDITIONS - Patent application	www.faqs.org	0	0		
731	chr19	19145924	19163327	3500297522	65		19145924	19163327	8421504	5	23,6,14,10,12	0,9303,9402,13829,17391	c,g	350029752200000014,350029752200000014,350029752200000003,350029752200000002	0-23,0-23,0-20,0-22						METHODS FOR TREATING INFLAMMATORY DISORDERS - Patent application	www.faqs.org	0	0		
731	chr19	19145927	19163327	3500128775	62		19145927	19163327	8421504	5	20,6,14,10,12	0,9300,9399,13826,17388	c	350012877500000005,350012877500000002,350012877500000009	0-20,0-20,0-22						Methods and Compositions for the Prevention and Treatment of Inflammatory Diseases or Conditions	Singh	2004	0		
731	chr19	19155227	19163327	3500215682	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350021568200000005,350021568200000004	0-20,0-22						Cellular/Molecular 5-Aminoimidazole-4-Carboxamide-1- -4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein Kinase	www.jneurosci.org	0	0		
731	chr19	19155227	19163327	3500196773	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350019677300000001,350019677300000000	0-20,0-22						Inhibitors of nitric oxide synthase	Singh	1999	0		
731	chr19	19155227	19163327	3500185505	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350018550500000001,350018550500000012,350018550500000000	0-20,0-20,0-22						 Methods For Suppressing The Induction Of Nitric Oxide Synthase In A Cell 	www.docstoc.com	0	0		
731	chr19	19155227	19163327	3500176470	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350017647000000001,350017647000000013,350017647000000012,350017647000000000	0-20,0-20,0-22,0-22						Use of Statins to Inhibit Inflammation and Vascular Disease - Patent application	www.faqs.org	0	0		NOS2
731	chr19	19155227	19163327	3500161741	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350016174100000001,350016174100000000	0-20,0-22						Method of treating inflammation with statins	Singh	2011	0		NOS2
731	chr19	19155227	19163327	3500126899	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350012689900000001,350012689900000013,350012689900000000,350012689900000012	0-20,0-20,0-22,0-22						INHIBITORS OF NITRIC OXIDE SYNTHASE - Patent application	www.faqs.org	0	0		
731	chr19	19155227	19163327	3500030001	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350003000100000001,350003000100000000	0-20,0-22			10.1111/j.1471-4159.2006.04354.x	1471-4159	Journal of Neurochemistry	Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury - Pannu - 2006 - Journal of Neurochemistry - Wiley Online Library	Pannu	2007	0		
731	chr19	19155227	19163327	3500023158	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350002315800000001,350002315800000000	0-20,0-22		11978730	10.1096/fj.01-0798com	0892-6638	The FASEB Journal	Galactosylsphingosine (psychosine) -induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease	GIRI	2002	6		
731	chr19	19155227	19163327	3500021266	42		19155227	19163327	8421504	4	6,14,10,12	0,99,4526,8088	c	350002126600000001,350002126600000000	0-20,0-22						Roy and Pahan, J Clin Cell Immunol Immunology	w.omicsonline.org	0	0		
731	chr19	19155228	19159757	3500035260	42		19155228	19159757	8421504	3	5,15,22	0,98,4507	c,g	350003526000000003,350003526000000002,350003526000000002	0-20,0-22,0-22			10.2164/jandrol.04178		Journal of andrology	Paracrine Modulation of Androgen Synthesis in Rat Leydig Cells by Nitric Oxide	BEN	2005	0		
731	chr19	19155228	19157514	3500443452	41		19155228	19157514	8421504	3	5,15,21	0,98,2265	c	350044345200000002,350044345200000001	0-20,0-21						Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. - ResearchGate	.researchgate.net	0	0		
731	chr19	19157580	19159704	3500339349	38		19157580	19159704	8421504	2	19,19	0,2105	c	350033934900000003,350033934900000002	0-19,0-19		11290515			American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction	Bove	2001	0		
731	chr19	19157580	19159704	3500280427	38		19157580	19159704	8421504	2	19,19	0,2105	c	350028042700000003,350028042700000002	0-19,0-19		11290515			American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction	Bove	2001	0		
731	chr19	19157580	19159704	3500042373	38		19157580	19159704	8421504	2	19,19	0,2105	c	350004237300000003,350004237300000002	0-19,0-19		11290515			American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction	Bove	2001	0		
731	chr19	19157587	19158556	3500009573	28		19157587	19158556	8421504	2	18,10	0,959	c	350000957300000031	0-28						&#x4e3b;&#x9898;&#xff1a;IFN- | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
731	chr19	19157591	19159674	3500017911	40		19157591	19159674	8421504	3	14,6,20	0,955,2063	c,g	350001791100000003,350001791100000002,350001791100000002	0-20,0-20,0-20		18296510	10.1530/REP-07-0496	1470-1626	Reproduction	Prostaglandin F2&#x03b1; increases endothelial nitric oxide synthase in the periphery of the bovine corpus luteum: the possible regulation of blood flow at an early stage of luteolysis	Shirasuna	2008	3		NOS2
731	chr19	19157592	19158560	3500226994	27		19157592	19158560	8421504	2	13,14	0,954	c	350022699400000000	0-27		16520738	10.1038/sj.bjp.0706718	1476-5381	British Journal of Pharmacology	Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-&#x03ba;B inactivation - Won - 2009 - British Journal of Pharmacology - Wiley Online Library	Won	2006	0		
731	chr19	19157592	19158560	3500068152	27		19157592	19158560	8421504	2	13,14	0,954	c	350006815200000000	0-27						DIDOX MODULATES REACTIVE OXYGEN SPECIES PRODUCTION AND INFLAMMATORY EVENTS INDUCED BY LIPOPOLYSACCHARIDE (LPS) AND ARYL HYDROCARBON RECEPTOR (AHR) LIGANDS IN RAW 264.7 MURINE MACROPHAGES.	d.lib.clemson.edu	0	0		
731	chr19	19157602	19159736	3500263272	42		19157602	19159736	8421504	3	3,18,21	0,944,2113	c	350026327200000011,350026327200000007,350026327200000010	0-21,0-20,0-21						Nitric oxide synthase (NOS) genes expression in catlle in vitro produced embryos	s.ulb.uni-bonn.de	0	0		
731	chr19	19157602	19159736	3500149409	42		19157602	19159736	8421504	3	3,18,21	0,944,2113	c	350014940900000007,350014940900000006	0-21,0-21						Up-regulation of Hypoxia Inducible Factor 1 by Iso&#xfb02;urane in Hep3B Cells	asic.shsmu.edu.cn	0	0		
731	chr19	19159684	19165922	3500389840	39		19159684	19165922	8421504	2	20,19	0,6219	c,g	350038984000000003,350038984000000003,350038984000000002,350038984000000002	0-20,0-20,0-19,0-19		16935840	10.1210/en.2005-1548	0013-7227	Endocrinology	Hormonal and Spatial Regulation of Nitric Oxide Synthases (NOS) (Neuronal NOS, Inducible NOS, and Endothelial NOS) in the Oviducts	Lapointe	2006	4		
731	chr19	19163401	19165889	3500349767	44		19163401	19165889	8421504	3	22,11,11	0,1675,2477	c	350034976700000021,350034976700000020	0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
731	chr19	19163412	19165083	3500188576	40		19163412	19165083	8421504	2	20,20	0,1651	c	350018857600000003,350018857600000002	0-20,0-20		16569760	10.1152/ajpendo.00007.2006		American Journal of Physiology - Endocrinology and Metabolism	Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+	O'Kane	2006	0		
731	chr19	19164974	19175043	3500420334	42		19164974	19175043	8421504	2	21,21	0,10048	c,g	350042033400000003,350042033400000003,350042033400000002	0-21,0-21,0-21		18621907	10.1152/ajplung.00504.2007		American Journal of Physiology - Lung Cellular and Molecular Physiology	Cytokine-induced arginase activity in pulmonary endothelial cells is dependent on Src family tyrosine kinase activity	Chang	2008	0		
731	chr19	19165067	19175036	3500059921	45		19165067	19175036	8421504	3	20,3,22	0,811,9947	c,g	350005992100000001,350005992100000000,350005992100000000	0-23,0-22,0-22						Cytokine mRNA Profiles in Bovine Macrophages Stimulated with Trypanosoma congolense	enomics.liv.ac.uk	0	0		
732	chr19	19270962	19270991	3500322446	24		19270962	19270991	8421504	3	7,5,12	0,11,17	g	350032244600000006	8-34						Isolating cells expressing secreted proteins	Chen	2004	0		
733	chr19	19498169	19504266	3500037586	138		19498169	19504266	8421504	3	1,86,51	0,1603,6046	p	350003758600015006	9-147						Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies	Ni	2001	0		NLK
733	chr19	19525453	19525478	3500319233	23		19525453	19525478	8421504	2	11,12	0,13	c	350031923300000061	0-23						 Compositions And Methods For Dehydration And Cyclization Of Peptides, Synthetic Compounds, And Lantibiotics 	www.docstoc.com	0	0		
734	chr19	19614146	19614174	3500373848	23		19614146	19614174	8421504	2	10,13	0,15	c	350037384800000009	0-27						Biofilm development and toxic compound resistance in Lactococcus lactis	tations.ub.rug.nl	0	0		
734	chr19	19621680	19621709	3500189032	24		19621680	19621709	8421504	2	17,7	0,22	g	350018903200000054	22-47						Genes encoding melanocortin receptors	Yamada	1994	0		
734	chr19	19621680	19621709	3500054240	24		19621680	19621709	8421504	2	17,7	0,22	c	350005424000000042	22-47						SCREENING METHOD OF NESFATIN-1-ACTION REGULATING SUBSTANCE OR NESFATIN-1-LIKE ACTION SUBSTANCE WITH THE USE OF RECEPTOR PROTEIN SELECTED FROM THE GROUP CONSISTING OF GPR3, GPR6 AND GPR12 - Patent application	www.faqs.org	0	0		
734	chr19	19633528	19633559	3500464289	23		19633528	19633559	8421504	3	12,6,5	0,17,26	c	350046428900000380	24-47						High bone mass gene of 11q13.3	Carulli	2000	0		
735	chr19	19777210	19780917	3500443049	264		19777210	19780917	8421504	2	87,177	0,3530	p	350044304900015000,350044304900015001	0-264,0-264						Bestimmung der Kopienzahl von FoxN1/ FoxN4-Homologen in Lampetra fluviatilis	k.uni-freiburg.de	0	0		FOXN1
736	chr19	19804080	19804104	3500098526	24		19804080	19804104	8421504	1	24	0	c	350009852600000059	0-24						Compositions and methods for the treatment of tumor	Ashkenazi	2001	0		
736	chr19	19860648	19860679	3500049883	25		19860648	19860679	8421504	3	5,14,6	0,8,25	c	350004988300000008	8-33						cGMP signalling via CNP-Npr2-cGKI, and its role in axonal branching during embryonic development	diss.fu-berlin.de	0	0		
736	chr19	19910840	19910869	3500284936	25		19910840	19910869	8421504	2	15,10	0,19	c	350028493600000015,350028493600000014	0-25,11-36		10805736	10.1128/MCB.20.11.3928-3941.2000	0270-7306	Molecular and Cellular Biology	Neoplastic Transformation by Notch Requires Nuclear Localization	Jeffries	2000	6		
737	chr19	19927774	19929085	3500228010	129		19927774	19929085	8421504	2	116,13	0,1298	p	350022801000015010	0-129						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION	Hata	2009	0		SNORD42B,SNORD4A
737	chr19	19927774	19929085	3500125620	129		19927774	19929085	8421504	2	116,13	0,1298	p	350012562000015008,350012562000015018	0-129,0-45						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION - Patent application	www.faqs.org	0	0		SNORD42B,SNORD4A
737	chr19	19927774	19927861	3500455148	87		19927774	19927861	8421504	1	87	0	p	350045514800015013	0-87						DIPLOMARBEIT	thes.univie.ac.at	0	0		SNORD42B
737	chr19	19927846	19929106	3500414263	78		19927846	19929106	8421504	2	44,34	0,1226	p	350041426300015007	3-81						Method of using HRG2-&#x03b1; to stimulate P185HeR2	Vandlen	1995	0		SNORD42B,SNORD4A
737	chr19	19927846	19929106	3500151518	78		19927846	19929106	8421504	2	44,34	0,1226	p	350015151800015003	3-81					Patent	Antibodies specific for heregulin 2-&#x03b1; (Patent US:5859206)	Holmes	1999	0		SNORD42B,SNORD4A
737	chr19	19927846	19929106	3500019008	78		19927846	19929106	8421504	2	44,34	0,1226	p	350001900800015005	3-81						Structure, production and use of heregulin 2 ligands	Vandlen	1998	0		SNORD42B,SNORD4A
737	chr19	19927888	19929211	3500164379	141		19927888	19929211	8421504	2	2,139	0,1184	p	350016437900015021	141-282						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		SNORD42B,SNORD4A
737	chr19	19950750	19950979	3500433612	86		19950750	19950979	8421504	3	18,27,41	0,107,188	c	350043361200000171,350043361200000173	0-45,0-41						US Patent # 7,132,399. Mammalian cell surface DNA receptor - Patents.com	www.patents.com	0	0		
737	chr19	19951333	19951414	3500156102	78		19951333	19951414	8421504	2	48,30	0,51	p	350015610200015023	0-78						TNF-.alpha. variants - Patent # 7056695 - PatentGenius	.patentgenius.com	0	0		TRAF4
737	chr19	20040839	20041002	3500139708	42		20040839	20041002	8421504	2	22,20	0,143	c,g	350013970800000020,350013970800000036,350013970800000018,350013970800000034	0-22,0-22,0-20,0-20						METHODS AND COMPOSITIONS FOR THE TREATMENT OF ERYTHROCYTE DISEASES - Patent application	www.faqs.org	0	0		MIR451B,MIR4732
738	chr19	20075231	20075276	3500374868	45		20075231	20075276	8421504	1	45	0	c	350037486800000026	0-45						Compositions and methods for the treatment of tumor	Botstein	2000	0		
738	chr19	20125178	20125222	3500246268	44		20125178	20125222	8421504	1	44	0	c	350024626800000244	0-44						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
738	chr19	20150054	20150082	3500074735	25		20150054	20150082	8421504	2	14,11	0,17	c	350007473500000034	9-34						Novel Use of MLN51 Gene and Protein - Patent application	www.faqs.org	0	0		
740	chr19	20330225	20330253	3500195182	23		20330225	20330253	8421504	2	15,8	0,20	g	350019518200000198	5-28						CD4+ T-lymphocyte proteases and genes encoding said proteases	Franzusoff	1995	0		
92	chr19	20564900	20584051	3500028732	102		20564900	20584051	8421504	3	32,13,57	0,4981,19094	p	350002873200015021,350002873200015011	0-45,0-57					Patent	Polypeptide fragments of human PAK5 protein kinase (Patent US:6656716)	Plowman	2003	0		TAOK1
742	chr19	20597089	20598094	3500391880	41		20597089	20598094	8421504	2	21,20	0,985	c,g	350039188000000000,350039188000000001	0-21,0-20						RUNX1T1 is overexpressed in imatinib mesylate-resistant cells	-publications.com	0	0		TAOK1
742	chr19	20667565	20670366	3500153590	40		20667565	20670366	8421504	2	20,20	0,2781	c,g	350015359000000015,350015359000000015,350015359000000014,350015359000000014	0-20,0-20,0-20,0-20		18162581	10.1091/mbc.E07-07-0640	1059-1524	Molecular Biology of the Cell	RNA Interference in J774 Macrophages Reveals a Role for Coronin 1 in Mycobacterial Trafficking but Not in Actin-dependent Processes	Jayachandran	2008	5		
745	chr19	21061835	21061858	3500439152	23		21061835	21061858	8421504	1	23	0	c	350043915200000135	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR3184
745	chr19	21061835	21061858	3500252752	23		21061835	21061858	8421504	1	23	0	c	350025275200000088,350025275200000019	0-23,0-23						MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY - Patent application	www.faqs.org	0	0		MIR3184
745	chr19	21061835	21061858	3500205806	23		21061835	21061858	8421504	1	23	0	c	350020580600000019	0-23						MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY	Wang	2010	0		MIR3184
745	chr19	21061871	21061894	3500206818	23		21061871	21061894	8421504	1	23	0	c	350020681800000035,350020681800000041,350020681800000050,350020681800000049,350020681800000042	0-23,0-23,0-22,0-22,0-22						Method For Producing Novel Hipsc By Means Of Sirna Introduction	Miura	2011	0		MIR3184
745	chr19	21101487	21101513	3500102458	23		21101487	21101513	8421504	3	12,4,7	0,14,19	c	350010245800000001	1-24						YRAIMA MOURA LOPES CORDEIRO	teses.ufrj.br	0	0		
746	chr19	21119433	21123184	3500065457	26		21119433	21123184	8421504	2	14,12	0,3739	c	350006545700000010	0-26						Supporting Information	www.pnas.org	0	0		SLC6A4
746	chr19	21124633	21129374	3500223844	40		21124633	21129374	8421504	3	20,4,16	0,4384,4725	c,g	350022384400000001,350022384400000001,350022384400000000	0-20,0-20,0-20						The prostate of cattle is | Epitope Tags/Tag Peptides Guide	eptor-peptide.com	0	0		
746	chr19	21129428	21129456	3500240241	27		21129428	21129456	8421504	2	22,5	0,23	c	350024024100000034	0-27						Allelic variation in the serotonin transporter (SERT) as an indicator of autism	Sutcliffe	2006	0		
748	chr19	21444962	21445000	3500304752	38		21444962	21445000	8421504	1	38	0	c	350030475200000001,350030475200000000	0-38,0-38						Characterization of Tusc5, an adipocyte gene co-expressed in peripheral neurons	ddr.nal.usda.gov	0	0		
756	chr19	22432777	22432801	3500126126	23		22432777	22432801	8421504	2	7,16	0,8	c	350012612600000020,350012612600000019	10-33,11-34						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2010	0		
756	chr19	22433096	22433142	3500418806	45		22433096	22433142	8421504	2	4,41	0,5	c	350041880600000004	0-45			10.1111/j.1742-4658.2005.04614.x	1742-4658	FEBS Journal	14-3-3 Proteins regulate glycogen synthase 3&#x03b2; phosphorylation and inhibit cardiomyocyte hypertrophy - Liao - 2005 - FEBS Journal - Wiley Online Library	Liao	2005	0		YWHAE
756	chr19	22433329	22467095	3500337690	473		22433329	22467095	8421504	14	23,45,45,45,45,13,32,45,24,21,45,45,32,13	0,4551,4599,6675,6771,6819,7465,7500,7548,10625,10697,10745,10793,33753	p,c	350033769000000009,350033769000015216,350033769000015215,350033769000015213,350033769000015211,350033769000015210,350033769000015209,350033769000015208,350033769000015206,350033769000015205,350033769000015204	5-28,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						14-3-3 Antagonists for the Prevention and Treatment of Arthritis - Patent application	www.faqs.org	0	0		
756	chr19	22433329	22467095	3500072427	428		22433329	22467095	8421504	13	23,45,45,45,13,32,45,24,21,45,45,32,13	0,4599,6675,6771,6819,7465,7500,7548,10625,10697,10745,10793,33753	p,c	350007242700000009,350007242700015176,350007242700015174,350007242700015172,350007242700015171,350007242700015170,350007242700015169,350007242700015167,350007242700015166,350007242700015165	5-28,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						14-3-3 ETA Antibodies and Uses Thereof for the Diagnosis and Treatment of Arthritis - Patent application	www.faqs.org	0	0		
756	chr19	22433334	22467146	3500007218	41		22433334	22467146	8421504	2	22,19	0,33793	c,g	350000721800000005,350000721800000004,350000721800000004	0-22,0-19,0-19		15773901	10.1111/j.1471-4159.2004.02967.x	1471-4159	Journal of Neurochemistry	14-3-3 epsilon modulates the stimulated secretion of endopeptidase 24.15 - Carre&#xf1;o - 2005 - Journal of Neurochemistry - Wiley Online Library	Carreno	2005	0		
756	chr19	22433334	22444041	3500322286	582		22433334	22444041	8421504	6	50,137,207,20,81,87	0,4503,6620,7460,7486,10620	p	350032228600015033,350032228600015029,350032228600015022,350032228600015015	0-54,0-180,0-180,0-168						Lysine acetylation targets protein complexes and co-regulates major cellular functions	ww.sciencemag.org	0	0		YWHAE
756	chr19	22437844	22467107	3500334774	141		22437844	22467107	8421504	3	93,23,25	0,6287,29238	p	350033477400015144,350033477400015127,350033477400015115	0-45,0-48,0-48						Signal Transduction Stress-related Proteins And Methods Of Use In Plants 	.freshpatents.com	0	0		
756	chr19	22437862	22444113	3500023149	405		22437862	22444113	8421504	5	112,68,93,87,45	0,2092,2946,6092,6206	p	350002314900015085,350002314900015003,350002314900015015,350002314900015020	0-180,0-180,114-159,126-171						Tomato 14-3-3 Protein 7 Positively Regulates Immunity-Associated Programmed Cell Death by Enhancing Protein Abundance and Signaling Ability of MAPKKK C W	bti.cornell.edu	0	0		YWHAE
756	chr19	22440022	22440073	3500187039	51		22440022	22440073	8421504	1	51	0	p	350018703900015004	0-51						Dephosphorylation of HDAC7 By Myosin Phosphatase	Verdin	2007	0		YWHAE
756	chr19	22444005	22444071	3500132981	66		22444005	22444071	8421504	1	66	0	p	350013298100015052	0-66						14-3-3 isoform specificity in barley	dare.ubvu.vu.nl	0	0		ZNF680
756	chr19	22487813	22504872	3500401572	48		22487813	22504872	8421504	3	24,13,11	0,9854,17048	c	350040157200000001,350040157200000000	0-24,0-24		12727859		0008-5472	Cancer Research	CrkI Adapter Protein Modulates Cell Migration and Invasion in Glioblastoma	Takino	2003	8		CRK,MYO1C
756	chr19	22497349	22497538	3500192065	182		22497349	22497538	8421504	2	174,8	0,181	c,g	350019206500000008,350019206500000001,350019206500000000,350019206500000002	874-1058,79-263,480-664,80-170						Supplementary Information et al.	limlab.ucsf.edu	0	0		
756	chr19	22497549	22504874	3500440489	96		22497549	22504874	8421504	3	48,35,13	0,96,7312	c	350044048900000103,350044048900000101	0-48,0-48						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
756	chr19	22504940	22504988	3500203149	48		22504940	22504988	8421504	1	48	0	p	350020314900015005	72-120						CED-2/CrkII and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans. - ResearchGate	.researchgate.net	0	0		MYO1C
756	chr19	22519844	22519944	3500100667	24		22519844	22519944	8421504	3	3,12,9	0,78,91	c	350010066700000033	0-24						Novel potassium channels and genes encoding these potassium channels	Jentsch	2000	0		
756	chr19	22519845	22519944	3500351330	23		22519845	22519944	8421504	3	2,12,9	0,77,90	c	350035133000000033	0-23						Potassium channels and genes encoding these potassium channels	Gentsch	2004	0		
756	chr19	22519845	22519944	3500348099	23		22519845	22519944	8421504	3	2,12,9	0,77,90	c	350034809900000033	0-23						Potassium channels and genes encoding these potassium channels	Jentsch	2004	0		MYO1C
757	chr19	22574752	22595788	3500133153	375		22574752	22595788	8421504	8	60,63,8,92,59,45,31,17	0,3331,4471,9173,12486,12587,17125,21019	p	350013315300015012,350013315300015004,350013315300015005,350013315300015000	0-60,0-180,0-63,0-177						The basics of bioinformatics including examples of similarity alignment pattern searching and phylogenetics	www.docstoc.com	0	0		PITPNA
757	chr19	22671852	22671877	3500238857	25		22671852	22671877	8421504	1	25	0	c	350023885700000000	0-25						The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity	lupusresearch.org	0	0		PRPF8
757	chr19	22672554	22673916	3500388903	75		22672554	22673916	8421504	3	3,33,39	0,994,1323	p	350038890300015006	63-138						p300-Mediated Acetylation Stabilizes the Th-Inducing POK Factor	www.jimmunol.org	0	0		PRPF8
758	chr19	22725127	22725153	3500304944	25		22725127	22725153	8421504	2	9,16	0,10	g	350030494400000154	11-36						Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto - Patent application	www.faqs.org	0	0		
758	chr19	22725127	22725153	3500259903	25		22725127	22725153	8421504	2	9,16	0,10	c	350025990300000163	11-36						Vertebrate embryonic pattern-inducing hedgehog-like proteins	Ingham	1995	0		
758	chr19	22725127	22725153	3500233278	25		22725127	22725153	8421504	2	9,16	0,10	c	350023327800000154	11-36						Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto - US Patent 6639051 Description	ww.patentstorm.us	0	0		
758	chr19	22729025	22729110	3500433622	48		22729025	22729110	8421504	2	23,25	0,60	c	350043362200000039,350043362200000038	0-23,0-25		23200856	10.1016/j.celrep.2012.10.023	2211-1247	Cell Reports	Cell Reports - Specific miRNA Stabilization by Gld2-Catalyzed Monoadenylation	D'Ambrogio	2012	0		MIR22HG
758	chr19	22729025	22729110	3500185291	85		22729025	22729110	8421504	1	85	0	c,g	350018529100000073,350018529100000073,350018529100000072	0-85,0-85,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR22HG
758	chr19	22729025	22729110	3500036860	85		22729025	22729110	8421504	1	85	0	c,g	350003686000000000,350003686000000000,350003686000000001,350003686000000001	0-85,0-85,0-22,0-22						Mirnas in joint disease	Bartnik	2012	0		MIR22HG
758	chr19	22729036	22729060	3500307472	24		22729036	22729060	8421504	1	24	0	c	350030747200000014,350030747200000013	1-23,0-23						MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development	www.mimg.ucla.edu	0	0		
758	chr19	22729036	22729060	3500181839	24		22729036	22729060	8421504	1	24	0	c	350018183900000014,350018183900000013	1-23,0-23						MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development	enesdev.cshlp.org	0	0		MIR22HG
758	chr19	22729036	22729060	3500176532	24		22729036	22729060	8421504	1	24	0	c	350017653200000014,350017653200000013	1-23,0-23			10.1101/gad.1500707		Genes & Development	MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development	Paul	2007	0		MIR22HG
758	chr19	22729074	22729100	3500301912	24		22729074	22729100	8421504	2	18,6	0,20	c	350030191200000011	0-26						METHODS AND COMPOSITIONS FOR RAPID DEVELOPMENT OF SCREENING ASSAYS NUCLEAR RECEPTORS - VERTEX PHARMACEUTICALS INCORPORATED	www.sumobrain.com	0	0		
758	chr19	22736990	22737023	3500410183	24		22736990	22737023	8421504	3	6,11,7	0,10,26	g	350041018300000025	0-25						Brassica polymorphisms	Lemieux	1999	0		
758	chr19	22756864	22757002	3500319412	138		22756864	22757002	8421504	1	138	0	p	350031941200015024	0-138						The molecular phylogeny of uterine serpins and its relationship to evolution of placentation	imal.ifas.ufl.edu	0	0		
758	chr19	22756864	22757002	3500280173	138		22756864	22757002	8421504	1	138	0	p	350028017300015024	0-138						The molecular phylogeny of uterine serpins and its relationship to evolution of placentation	imal.ifas.ufl.edu	0	0		
758	chr19	22769566	22777219	3500390135	1251		22769566	22777219	8421504	7	78,199,156,204,143,211,260	0,1442,2263,2834,4571,6519,7393	c	350039013500000020,350039013500000001	0-1251,0-1251						Raav Vector Compositions And Methods For The Treatment Of Choroidal Neovascularization 	.freshpatents.com	0	0		
758	chr19	22769566	22777219	3500123766	1251		22769566	22777219	8421504	7	78,199,156,204,143,211,260	0,1442,2263,2834,4571,6519,7393	p,c	350012376600000001,350012376600015013	0-1251,0-1230						Raav vector compositions and methods for the treatment of choroidal neovascularization	Hauswirth	2003	0		
758	chr19	22772438	22774149	3500311463	42		22772438	22774149	8421504	3	21,9,12	0,157,1699	c	350031146300000003,350031146300000004	0-21,0-21		19808909	10.1152/ajpendo.00252.2009		American Journal of Physiology - Endocrinology and Metabolism	Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes	Wang	2009	0		SERPINF1
758	chr19	22772438	22774149	3500212166	42		22772438	22774149	8421504	3	21,9,12	0,157,1699	c	350021216600000003,350021216600000004	0-21,0-21		19808909	10.1152/ajpendo.00252.2009		American Journal of Physiology - Endocrinology and Metabolism	Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes	Wang	2009	0		SERPINF1
758	chr19	22772438	22774149	3500179053	42		22772438	22774149	8421504	3	21,9,12	0,157,1699	c	350017905300000003,350017905300000004	0-21,0-21		19808909	10.1152/ajpendo.00252.2009		American Journal of Physiology - Endocrinology and Metabolism	Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes	Wang	2009	0		SERPINF1
758	chr19	22778670	22778698	3500449078	28		22778670	22778698	8421504	1	28	0	c	350044907800000006,350044907800000005	0-21,0-19						Optineurin nucleic acid molecules and uses thereof	Raymond	2002	0		
760	chr19	22988216	22988317	3500185291	101		22988216	22988317	8421504	1	101	0	c,g	350018529100000023,350018529100000022,350018529100000022	0-101,0-22,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR212
760	chr19	22988216	22988295	3500243673	48		22988216	22988295	8421504	2	24,24	0,55	c,g	350024367300000035,350024367300000035,350024367300000033	0-24,0-24,0-24						TARGETING OF MIRNA PRECURSORS - UNIVERSITY OF DUNDEE	www.sumobrain.com	0	0		
760	chr19	22988237	22988686	3500423784	43		22988237	22988686	8421504	2	22,21	0,428	c	350042378400000035,350042378400000085	0-22,0-21						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR212
760	chr19	22988237	22988686	3500411007	44		22988237	22988686	8421504	2	22,22	0,427	c,g	350041100700000011,350041100700000012,350041100700000012	0-22,0-22,0-22		19356622	10.1016/j.mce.2008.12.013		Molecular and cellular endocrinology	Microtranscriptome Regulation by Gonadotropin Releasing Hormone	Tony	2009	0		MIR212
760	chr19	22988237	22988686	3500371873	43		22988237	22988686	8421504	2	22,21	0,428	c,g	350037187300000110,350037187300000049,350037187300000049,350037187300000174,350037187300000165,350037187300000184,350037187300000184,350037187300000150	0-22,0-20,0-20,0-22,0-22,0-21,0-21,0-21						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		MIR212
760	chr19	22988237	22988686	3500304886	43		22988237	22988686	8421504	2	22,21	0,428	c,g	350030488600000086,350030488600000086,350030488600000126,350030488600000126	0-22,0-22,0-21,0-21						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		MIR212
760	chr19	22988237	22988686	3500287752	43		22988237	22988686	8421504	2	22,21	0,428	c	350028775200000009,350028775200000041	0-22,0-21						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		MIR212
760	chr19	22988237	22988686	3500114594	43		22988237	22988686	8421504	2	22,21	0,428	c	350011459400000414,350011459400000841,350011459400000444,350011459400000871	0-22,0-22,0-21,0-21						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR212
760	chr19	22988237	22988686	3500031979	43		22988237	22988686	8421504	2	22,21	0,428	c	350003197900000329,350003197900000359	0-22,0-21						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR212
760	chr19	22988237	22988260	3500353647	23		22988237	22988260	8421504	1	23	0	c	350035364700000070	21-44						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		MIR212
760	chr19	22988237	22988260	3500351139	23		22988237	22988260	8421504	1	23	0	c	350035113900000070,350035113900000191	21-44,0-22						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		MIR212
760	chr19	22988703	22988726	3500035080	23		22988703	22988726	8421504	1	23	0	c,g	350003508000000001,350003508000000001	0-23,0-23						EXHALED NUCLEIC ACID DETECTION FOR NON-INVASIVE ASSESSMENT OF THE LUNG - ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY	www.sumobrain.com	0	0		
760	chr19	22995862	22995886	3500123810	24		22995862	22995886	8421504	1	24	0	g	350012381000000028	0-24						Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer	mcb.asm.org	0	0		HIC1
761	chr19	23189298	23193381	3500360395	180		23189298	23193381	8421504	3	69,3,108	0,3245,3975	p	350036039500015012,350036039500015004	0-72,0-108						Tel1ATM and Rad3ATR kinases promote Ccq1-Est1 interaction to maintain telomeres in fission yeast	www.uic.edu	0	0		SMG6
762	chr19	23240611	23240641	3500242812	25		23240611	23240641	8421504	3	6,4,15	0,10,15	g	350024281200000089	0-25						Polynucleotides and aminoacid sequences from staphylococcus aureus	Burnham	1997	0		
95	chr19	23435005	23467662	3500152738	1164		23435005	23467662	8421504	14	32,25,48,75,33,90,36,169,103,229,102,3,148,71	0,18911,18948,19275,20227,20296,20398,24795,26882,27696,29111,31534,31543,32586	p	350015273800015099,350015273800015102,350015273800015105,350015273800015108,350015273800015111,350015273800015114,350015273800015117,350015273800015120,350015273800015123,350015273800015126	0-57,0-156,0-90,0-81,0-126,0-165,0-114,0-156,0-147,0-72						Molecular genetic strategies to identify Obsessive-compulsive disorder (OCD) and schizophrenia candidate genes in a South African sub-population group	scholar.sun.ac.za	0	0		PAFAH1B1
769	chr19	24140961	24157205	3500004918	461		24140961	24157205	8421504	11	45,84,44,1,45,45,45,63,21,23,45	0,96,192,4078,4082,4226,8634,13311,16127,16166,16199	p,c	350000491800015079,350000491800015080,350000491800015002,350000491800015090,350000491800015081,350000491800015082,350000491800015083,350000491800015084,350000491800015004,350000491800015086,350000491800000031,350000491800015088	0-45,0-45,0-78,0-45,0-45,0-45,0-45,0-45,3-72,0-45,0-23,0-45						Aspartoacylase Gene, Protein, And Methods Of Screening For Mutations Associated With Canavan Disease 	.freshpatents.com	0	0		
769	chr19	24141060	24157105	3500416135	302		24141060	24157105	8421504	7	81,60,42,34,5,63,17	0,3986,4052,8559,13165,13212,16028	p,c	350041613500015061,350041613500015003,350041613500000017,350041613500015063,350041613500000020,350041613500000021,350041613500000027,350041613500015005,350041613500000030	0-45,0-78,1-44,0-45,0-48,0-42,6-45,3-72,0-23						 Aspartoacylase Gene, Protein, And Methods Of Screening For Mutations Associated With Canavan Disease 	www.docstoc.com	0	0		
769	chr19	24141063	24157094	3500276110	147		24141063	24157094	8421504	3	78,63,6	0,13209,16025	p	350027611000015001,350027611000015003	0-78,3-72						Aspartoacylase gene, protein, and methods of screening for mutatons associated with canavan disease	Matalon	1994	0		
769	chr19	24157432	24157460	3500198920	24		24157432	24157460	8421504	2	16,8	0,20	c	350019892000000006,350019892000000016	0-24,0-24						US Patent # 6,555,343. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same - Patents.com	www.patents.com	0	0		
770	chr19	24309105	24347380	3500396306	41		24309105	24347380	8421504	5	11,4,7,13,6	0,12,21,38253,38269	g	350039630600000070,350039630600000064	0-22,6-25						Identification et caract&#xe9;risation fonctionnelle de deux g&#xe8;nes r&#xe9;gulateurs du m&#xe9;tabolisme des compos&#xe9;s ph&#xe9;noliques de la baie de raisin	mm.u-bordeaux1.fr	0	0		
771	chr19	24431819	24434187	3500214186	44		24431819	24434187	8421504	4	8,13,16,7	0,11,2341,2361	c,g	350021418600001308,350021418600001129	1-22,1-25						Highly conserved genes and their use to generate probes and primers for detection of microorganisms - Patent application	www.faqs.org	0	0		
771	chr19	24434160	24434187	3500205565	23		24434160	24434187	8421504	2	16,7	0,20	c	350020556500001109	1-25						HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE PROBES AND PRIMERS FOR DETECTION OF MICROORGANISMS - Patent application	www.faqs.org	0	0		
771	chr19	24434192	24434216	3500088205	24		24434192	24434216	8421504	1	24	0	c	350008820500000077	12-36						Methods for detection of acute promyelocytic leukemia (APL) - US Patent 5843642 Description	ww.patentstorm.us	0	0		
771	chr19	24451729	24451764	3500378510	35		24451729	24451764	8421504	1	35	0	c	350037851000000103	0-35						P2x receptors (purinoceptor family)	Buell	1995	0		
771	chr19	24474499	24474523	3500364300	24		24474499	24474523	8421504	1	24	0	c	350036430000000002	3-27			10.1046/j.1432-1033.2002.02921.x	1432-1033	European Journal of Biochemistry	Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1 - Leeksma - 2002 - European Journal of Biochemistry - Wiley Online Library	Leeksma	2002	0		
772	chr19	24566605	24566631	3500426473	24		24566605	24566631	8421504	2	7,17	0,9	c	350042647300000006	0-35		24019978	10.1371/journal.pone.0074732		PLoS ONE	Cataract-Causing Mutation of Human Connexin 46 Impairs Gap Junction, but Increases Hemichannel Function and Cell Death	Qian	2013	0		
96	chr19	24730663	24806300	3500342938	513		24730663	24806300	8421504	5	87,179,98,103,46	0,2825,5949,15942,75591	c	350034293800000007	0-513						Assays For Identifying Ubiquitin Agents And For Identifying Agents That Modify The Activity Of Ubiquitin Agents 	.freshpatents.com	0	0		UBE2G1
96	chr19	24730666	24806297	3500287310	489		24730666	24806297	8421504	11	75,6,39,45,45,41,98,2,93,2,43	0,78,2822,2864,2912,2960,5946,15939,15944,16040,75588	p	350028731000015193,350028731000015192,350028731000015191,350028731000015190,350028731000015189,350028731000015188	0-210,0-48,0-48,0-45,0-48,0-90						 Assays For Identifying Ubiquitin Agents And For Identifying Agents That Modify The Activity Of Ubiquitin Agents 	www.docstoc.com	0	0		UBE2G1
96	chr19	24730744	24806297	3500342938	405		24730744	24806297	8421504	13	6,39,45,45,41,4,45,43,2,45,45,2,43	0,2744,2786,2834,2882,5868,5875,5923,15861,15866,15914,15962,75510	p	350034293800015227,350034293800015226,350034293800015225,350034293800015224,350034293800015223,350034293800015222,350034293800015221,350034293800015220,350034293800015219	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Assays For Identifying Ubiquitin Agents And For Identifying Agents That Modify The Activity Of Ubiquitin Agents 	.freshpatents.com	0	0		UBE2G1
776	chr19	25074073	25074216	3500362403	39		25074073	25074216	8421504	2	19,20	0,123	c,g	350036240300000088,350036240300000089,350036240300000089	0-19,0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
776	chr19	25074073	25074216	3500121860	39		25074073	25074216	8421504	2	19,20	0,123	c,g	350012186000000007,350012186000000008,350012186000000008	0-19,0-20,0-20		16207835	10.1095/biolreprod.105.046748	0006-3363	Biology of Reproduction	Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	Klein	2006	4		
776	chr19	25074073	25074216	3500049790	39		25074073	25074216	8421504	2	19,20	0,123	c,g	350004979000000007,350004979000000008,350004979000000008	0-19,0-20,0-20						Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	ww.biolreprod.org	0	0		
776	chr19	25145633	25145656	3500442385	23		25145633	25145656	8421504	1	23	0	g	350044238500000062	5-28						Reciprocal Transcriptional Regulation of Pou5f1 Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells	mcb.asm.org	0	0		
784	chr19	26153061	26153090	3500031175	24		26153061	26153090	8421504	2	15,9	0,20	g	350003117500000162	0-26						Prf protein and nucleic acid sequences: compositions and methods for plant pathogen resistance - Patent # 6245510 - PatentGenius	.patentgenius.com	0	0		
784	chr19	26184364	26197872	3500406991	44		26184364	26197872	8421504	4	10,12,14,8	0,15,13484,13500	g	350040699100000041,350040699100000086	26-48,13-42						 Amylase Variants 	www.docstoc.com	0	0		
784	chr19	26194492	26194517	3500346255	25		26194492	26194517	8421504	1	25	0	c	350034625500000003	23-48						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		
784	chr19	26197847	26197872	3500442201	23		26197847	26197872	8421504	2	15,8	0,17	c	350044220100000118	7-37						Amylase variants	Bisgard-frantzen	1996	0		
784	chr19	26201793	26209900	3500284360	732		26201793	26209900	8421504	7	120,66,74,94,196,91,91	0,968,2956,4100,5156,5645,8016	p	350028436000015139,350028436000015146,350028436000015138,350028436000015140,350028436000015147,350028436000015142,350028436000015144,350028436000015145	0-324,0-84,0-591,0-69,0-81,0-45,0-63,0-75						95 human secreted proteins	Duan	1999	0		
785	chr19	26221241	26224048	3500221873	45		26221241	26224048	8421504	2	1,44	0,2763	p	350022187300015133	39-84						INVESTIGATION OF WHEAT GENES INVOLVED IN ZINC EFFICIENCY MECHANISM USING DIFFERENTIAL DISPLAY TECHNIQUE	d.lib.metu.edu.tr	0	0		DHX33
785	chr19	26245124	26245152	3500421898	23		26245124	26245152	8421504	2	11,12	0,16	c	350042189800000020	1-24						LAFORA'S DISEASE GENE - Patent application	www.faqs.org	0	0		
785	chr19	26245276	26245888	3500423428	23		26245276	26245888	8421504	2	11,12	0,600	c	350042342800000003	10-33		9531316		0022-1767	The Journal of Immunology	The Multiligand-Binding Protein gC1qR, Putative C1q Receptor, Is a Mitochondrial Protein	Dedio	1998	6		
788	chr19	26643505	26646077	3500465679	43		26643505	26646077	8421504	2	21,22	0,2550	c	350046567900000000,350046567900000001	0-21,0-22						Ultrastructure of Rickettsia rickettsii actin tails and localization of cytoskeletal proteins. - ResearchGate	.researchgate.net	0	0		
788	chr19	26645333	26646035	3500157219	41		26645333	26646035	8421504	2	20,21	0,681	c	350015721900000011,350015721900000012	0-20,0-21		18239051	10.1530/REP-07-0415	1470-1626	Reproduction	Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle	Mitko	2008	3		
788	chr19	26651752	26653969	3500055970	50		26651752	26653969	8421504	2	26,24	0,2193	c	350005597000000000,350005597000000001	10-36,10-34		16920706	10.1074/jbc.M604729200	0021-9258	Journal of Biological Chemistry	Porphyrin Accumulation in Mitochondria Is Mediated by 2-Oxoglutarate Carrier	Kabe	2006	5		
788	chr19	26651755	26653969	3500307245	915		26651755	26653969	8421504	12	92,4,72,65,85,113,91,27,61,100,52,153	0,687,694,775,936,1030,1330,1502,1532,1678,1870,2061	p	350030724500015009,350030724500015022,350030724500015032,350030724500015042,350030724500015052,350030724500015062	6-174,0-150,0-144,0-138,0-150,0-165						Struktur- und Funktionsanalyse der humanen Uncoupling Proteine 1, 2 und 3 (hUCP1, hUCP2 und hUCP3)	b.uni-muenchen.de	0	0		
788	chr19	26681892	26682462	3500202520	178		26681892	26682462	8421504	5	20,18,33,20,87	0,113,151,192,483	p,g	350020252000000003,350020252000015000,350020252000000004	0-20,0-138,0-20						Congenital myasthenic syndrome of Brahman cattle	ive.library.uu.nl	0	0		
788	chr19	26686641	26697925	3500028732	76		26686641	26697925	8421504	2	19,57	0,11227	p,c	350002873200000040,350002873200015017	0-19,0-60					Patent	Polypeptide fragments of human PAK5 protein kinase (Patent US:6656716)	Plowman	2003	0		
788	chr19	26687237	26698407	3500214020	360		26687237	26698407	8421504	7	87,75,5,40,24,68,61	0,194,3639,3796,10622,10649,11109	p	350021402000015179,350021402000015067,350021402000015041,350021402000015011,350021402000015138	0-87,0-75,0-45,0-150,0-93						US Patent # 7,265,214. Germinal center kinase proteins, compositions and methods of use - Patents.com	www.patents.com	0	0		
788	chr19	26687921	26687947	3500385029	24		26687921	26687947	8421504	2	13,11	0,15	c	350038502900000013	22-46						RAGE protein derivatives	O'keefe	2005	0		
788	chr19	26697264	26732865	3500349597	480		26697264	26732865	8421504	10	48,33,15,63,111,66,12,36,39,57	0,206,559,1110,1546,3420,3534,3647,5379,35544	p	350034959700015049,350034959700015045,350034959700015035,350034959700015034,350034959700015033,350034959700015032,350034959700015031,350034959700015027,350034959700015023,350034959700015022	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						 Methods For Identifying Compounds That Alter Kinase Activity 	www.docstoc.com	0	0		
788	chr19	26697868	26697925	3500441703	57		26697868	26697925	8421504	1	57	0	p	350044170300015020	0-60						STE20-RELATED PROTEIN KINASES	Plowman	1999	0		
788	chr19	26698356	26698404	3500272696	48		26698356	26698404	8421504	1	48	0	p	350027269600015146	0-48						US Patent # 6,861,239. Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof - Patents.com	www.patents.com	0	0		TNIK
789	chr19	26750195	26750908	3500317775	45		26750195	26750908	8421504	2	23,22	0,691	c	350031777500000004,350031777500000005,350031777500000006	0-21,0-21,0-22			10.1111/j.1471-4159.2007.05085.x	1471-4159	Journal of Neurochemistry	Depolarization-induced differentiation of PC12 cells is mediated by phospholipase D2 through the transcription factor CREB pathway - Banno - 2007 - Journal of Neurochemistry - Wiley Online Library	Banno	2008	0		
789	chr19	26761002	26762993	3500200281	579		26761002	26762993	8421504	6	2,145,130,132,68,102	0,143,473,704,1175,1889	p	350020028100015000	0-579						KEGG T01001: 5694	www.genome.jp	0	0		
789	chr19	26805291	26808549	3500037317	756		26805291	26808549	8421504	5	67,139,83,408,59	0,409,916,2334,3199	p	350003731700015000	0-756						KEGG T01008: 511671	www.genome.jp	0	0		
789	chr19	26824489	26824805	3500440598	28		26824489	26824805	8421504	2	23,5	0,311	c	350044059800000006,350044059800000007	0-27,0-28						Regulation of arrestin-3 phosphorylation by casein kinase II	www.jbc.org	0	0		
789	chr19	26824808	26824838	3500430789	30		26824808	26824838	8421504	1	30	0	c	350043078900000009,350043078900000008	0-30,0-30						Phosphorylation regulates TRPV1 association with &#x03b2;-arrestin-2. - ResearchGate	.researchgate.net	0	0		
789	chr19	26828456	26828615	3500107769	45		26828456	26828615	8421504	2	32,13	0,146	p	350010776900015000	0-45			10.1111/j.1471-4159.2007.04842.x		Journal of neurochemistry	Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites	Xiufeng	2007	0		ARRB2
789	chr19	26832391	26832415	3500140651	24		26832391	26832415	8421504	1	24	0	c	350014065100000032,350014065100000013	3-27,14-35						Method for assaying protein-protein interaction	filed	2011	0		
790	chr19	26894402	26894426	3500059562	24		26894402	26894426	8421504	1	24	0	c	350005956200000007	0-24					The American Journal of Pathology	Absence of 12/15 Lipoxygenase Reduces Brain Oxidative Stress in Apolipoprotein E-Deficient Mice	Cinzia	2005	0		
790	chr19	26895065	26895236	3500172791	44		26895065	26895236	8421504	2	22,22	0,149	c	350017279100000014,350017279100000015	0-22,0-22		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
790	chr19	26895065	26895236	3500120290	44		26895065	26895236	8421504	2	22,22	0,149	c	350012029000000014,350012029000000015	0-22,0-22						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
790	chr19	26895065	26895236	3500048191	44		26895065	26895236	8421504	2	22,22	0,149	c,g	350004819100000014,350004819100000015,350004819100000015	0-22,0-22,0-22		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
790	chr19	26944165	26944193	3500407090	24		26944165	26944193	8421504	2	6,18	0,10	c	350040709000000070	15-39						HIV envelope polypeptides and vaccine	Berman	1997	0		
790	chr19	26994097	26994258	3500375699	161		26994097	26994258	8421504	1	161	0	c	350037569900000006	141-302						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
791	chr19	27001476	27001822	3500439152	43		27001476	27001822	8421504	2	21,22	0,324	c	350043915200000178,350043915200000167	0-21,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR497HG
791	chr19	27001476	27001822	3500114594	42		27001476	27001822	8421504	2	21,21	0,325	c	350011459400000858,350011459400000431,350011459400000484,350011459400000911	0-21,0-21,0-21,0-21						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		
791	chr19	27001476	27001822	3500031979	42		27001476	27001822	8421504	2	21,21	0,325	c	350003197900000346,350003197900000399	0-21,0-21						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		
791	chr19	27112354	27112383	3500047505	29		27112354	27112383	8421504	1	29	0	c	350004750500000002	0-29		23424281	10.1371/journal.pbio.1001478		PLoS Biology	Impairment of TrkB-PSD-95 Signaling in Angelman Syndrome	Cong	2013	0		
791	chr19	27115175	27119828	3500396186	315		27115175	27119828	8421504	5	20,103,99,78,15	0,346,562,664,4638	p	350039618600015059,350039618600015058	3-225,0-93						Compositions and Methods for the Delivery of Biologically Active RNAs	Polach	2012	0		
98	chr19	27115529	27132269	3500435589	39		27115529	27132269	8421504	2	19,20	0,16720	c,g	350043558900000003,350043558900000003,350043558900000002	0-19,0-19,7-27			10.1124/mol.61.3.667	1521-0111 (Online)	Molecular Pharmacology	Reconstitution of the Cytoplasmic Interaction between Phospholamban and Ca2+-ATPase of Cardiac Sarcoplasmic Reticulum	Kimura	2002	0		DLG4
791	chr19	27115588	27115746	3500061714	45		27115588	27115746	8421504	2	36,9	0,149	p	350006171400015041	0-45						Loop-Variant Pdz Domains as Biotherapeutics, Diagnostics and Research Reagents - Patent application	www.faqs.org	0	0		DLG4
791	chr19	27119737	27119762	3500086938	25		27119737	27119762	8421504	1	25	0	c	350008693800000030	13-38		15082773	10.1128/MCB.24.9.3782-3793.2004	0270-7306	Molecular and Cellular Biology	Normal Development and Fertility of Knockout Mice Lacking the Tumor Suppressor Gene LRP1b Suggest Functional Compensation by LRP1	Marschang	2004	6		
791	chr19	27121062	27124560	3500378730	41		27121062	27124560	8421504	2	20,21	0,3477	c,g	350037873000000009,350037873000000008,350037873000000008	0-20,0-21,0-21		23922830	10.1371/journal.pone.0069864	1932-6203	PLOS ONE	PLOS ONE: The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43	Xu	2013	4		DLG4
792	chr19	27138490	27138547	3500423784	45		27138490	27138547	8421504	2	22,23	0,34	c	350042378400000111,350042378400000112	0-22,0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		
792	chr19	27142478	27142735	3500301109	135		27142478	27142735	8421504	3	45,45,45	0,48,212	p	350030110900015014,350030110900015013,350030110900015012	0-45,0-45,0-45						CONFORMATION AND ACTIVITY OF GBETA5 COMPLEXES - Patent application	www.faqs.org	0	0		DVL2
792	chr19	27145828	27148433	3500350541	144		27145828	27148433	8421504	2	61,83	0,2522	p	350035054100015245,350035054100015244,350035054100015243	0-48,0-48,0-48						Axin gene and uses thereof	Constantini	1997	0		DVL2
792	chr19	27155892	27155937	3500354278	45		27155892	27155937	8421504	1	45	0	p	350035427800015002	0-45		22049402	10.1152/ajprenal.00502.2010		American Journal of Physiology - Renal Physiology	Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice	Takagi-Akiba	2012	0		GABARAP
792	chr19	27155892	27155937	3500291757	45		27155892	27155937	8421504	1	45	0	p	350029175700015002	0-45		22049402	10.1152/ajprenal.00502.2010		American Journal of Physiology - Renal Physiology	Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice	Takagi-Akiba	2012	0		GABARAP
792	chr19	27170561	27170584	3500139126	23		27170561	27170584	8421504	1	23	0	c	350013912600000008	0-23						Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer	Kominsky	2003	0		
792	chr19	27170564	27170589	3500017603	25		27170564	27170589	8421504	1	25	0	c	350001760300000021,350001760300000020	0-25,0-25		18287530	10.1091/mbc.E07-09-0973	1059-1524	Molecular Biology of the Cell	Tight Junction Proteins Claudin-2 and -12 Are Critical for Vitamin D-dependent Ca2+ Absorption between Enterocytes	Fujita	2008	5		
792	chr19	27171515	27171560	3500438053	45		27171515	27171560	8421504	1	45	0	p	350043805300015000	0-45		16368003	10.1186/1742-4690-2-79	1742-4690	Retrovirology	Involvement of claudin-7 in HIV infection of CD4(-) cells	Zheng	2005	6		CLDN7
792	chr19	27184057	27185606	3500366309	38		27184057	27185606	8421504	3	19,4,15	0,1421,1534	c,g	350036630900000012,350036630900000012,350036630900000010	0-19,0-19,0-19						REPRODUCTION	uction-online.org	0	0		SLC2A4
792	chr19	27185399	27185600	3500301078	39		27185399	27185600	8421504	3	20,10,9	0,73,192	c,g	350030107800000169,350030107800000169,350030107800000167	0-20,0-20,0-19						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
792	chr19	27185399	27185446	3500345859	45		27185399	27185446	8421504	2	25,20	0,27	c	350034585900000032,350034585900000031	0-25,0-20						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
792	chr19	27185708	27185759	3500009445	51		27185708	27185759	8421504	1	51	0	p	350000944500015002	0-51						Funktionsanalyse des Saccharomyces cerevisiae Proteins Fgy1 und dessen Einfluss auf die heterologe Expression der Glukosetransporter GLUT1 und GLUT4 aus S&#xe4;ugetieren	.uni-frankfurt.de	0	0		SLC2A4
792	chr19	27185711	27186363	3500407458	40		27185711	27186363	8421504	2	20,20	0,632	c	350040745800000002,350040745800000003	0-20,0-20						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
792	chr19	27186114	27187801	3500187712	77		27186114	27187801	8421504	2	29,48	0,1639	c	350018771200000028,350018771200000042	9-38,0-48						Method of measuring plasma membrane targeting of GLUT4	Bogan	2001	0		
792	chr19	27186461	27186572	3500012378	25		27186461	27186572	8421504	2	12,13	0,98	c	350001237800000026	0-25						Link&#xf6;ping University Post Print Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes	w.diva-portal.org	0	0		SLC2A4
792	chr19	27187012	27187037	3500409280	25		27187012	27187037	8421504	1	25	0	c	350040928000000000	115-140						Changes in glucose transporter expression in monocytes of periparturient dairy cows. - ResearchGate	.researchgate.net	0	0		
792	chr19	27187246	27188549	3500306124	167		27187246	27188549	8421504	3	35,84,48	0,624,1255	p,c	350030612400000027,350030612400015022,350030612400015023,350030612400000038,350030612400015028	0-35,0-132,0-84,0-40,0-84						Proceedings of the VIII International Scientific Congress in Fur Animal Production III: Nutrition	www.ifasanet.org	0	0		SLC2A4
792	chr19	27187259	27188924	3500119526	40		27187259	27188924	8421504	3	20,14,6	0,1644,1659	c,g	350011952600000006,350011952600000006,350011952600000007	0-20,0-20,0-20						Authors: Chu Yan CHAN1,2, Jeremy A. GUGGENHEIM1, Chi Ho TO2	ll.physiology.org	0	0		
792	chr19	27187753	27187801	3500385390	48		27187753	27187801	8421504	1	48	0	c	350038539000000042	0-48						US Patent # 6,632,924. Method of measuring plasma membrane targeting of GLUT4 - Patents.com	www.patents.com	0	0		
792	chr19	27187917	27187944	3500099306	27		27187917	27187944	8421504	1	27	0	c	350009930600000017	0-27						Table of Contents	.nottingham.ac.uk	0	0		
792	chr19	27188644	27188675	3500306233	31		27188644	27188675	8421504	1	31	0	g	350030623300000017	0-31						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
792	chr19	27215750	27220026	3500304596	1177		27215750	27220026	8421504	17	31,72,186,107,132,74,28,11,9,78,56,59,25,75,5,74,155	0,46,1491,2847,3177,3404,3635,3666,3684,3698,3777,3844,3904,3931,4007,4042,4121	c,g	350030459600000090,350030459600000095,350030459600000040,350030459600000117,350030459600000116,350030459600000068,350030459600000020,350030459600000138,350030459600000126,350030459600000008,350030459600000140,350030459600000022,350030459600000033	9-1248,8-1235,8-53,0-21,0-21,28-48,2-21,2-21,7-27,7-27,3-22,3-22,0-22						Inhibition Of Apoptosis-specific Eif-5a (eif-5a1) With Antisense Oligonucleotides And Sirna As Anti-inflammatory Therapeutics 	.freshpatents.com	0	0		
792	chr19	27215865	27217283	3500277788	45		27215865	27217283	8421504	2	3,42	0,1376	c	350027778800000016,350027778800000054	2-47,3-48						Nucleic acids, polypeptides, and methods for modulating apoptosis - US Patent 7217517 Description	ww.patentstorm.us	0	0		
792	chr19	27217262	27219223	3500298889	44		27217262	27219223	8421504	2	22,22	0,1939	c	350029888900000002,350029888900000003	5-27,6-28						Suppression of Primary and Disseminated Murine Tumor Growth with eIF5A1 Gene Therapy	gtmb.org/volumes/	0	0		
792	chr19	27217262	27219223	3500115744	44		27217262	27219223	8421504	2	22,22	0,1939	c	350011574400000002,350011574400000003	5-27,6-28						Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carc	www.gtmb.org	0	0		
792	chr19	27217415	27219187	3500023106	282		27217415	27219187	8421504	4	12,105,132,33	0,1184,1512,1739	p	350002310600015021,350002310600015034	0-282,0-201						NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS	Tainsky	2010	0		EIF5A
792	chr19	27218598	27219500	3500292669	41		27218598	27219500	8421504	3	19,18,4	0,879,898	c,g	350029266900000138,350029266900000020,350029266900000033	2-21,2-21,0-22						Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics - Patent application	www.faqs.org	0	0		
792	chr19	27218598	27219495	3500079446	106		27218598	27219495	8421504	4	19,48,20,19	0,395,568,878	p,c,g	350007944600000020,350007944600015002,350007944600000008,350007944600000008,350007944600000022	2-21,3-51,7-27,7-27,3-22						USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1	Thompson	2004	0		
792	chr19	27218677	27218957	3500373689	57		27218677	27218957	8421504	2	27,30	0,250	p	350037368900015023	0-57						Identification and characterization of Risp: a new nucleocytoplasmic shuttle protein interacting with the HIV-1 Rev protein	b.uni-muenchen.de	0	0		EIF5A
792	chr19	27221860	27222048	3500241575	114		27221860	27222048	8421504	2	96,18	0,170	p	350024157500015001,350024157500015000	0-60,0-60		20159957	10.1101/gad.545110	0890-9369	Genes & Development	GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXR&#x03b2; in the hepatic acute phase response	Venteclef	2010	12		GPS2
792	chr19	27239966	27240554	3500391891	54		27239966	27240554	8421504	2	53,1	0,587	p	350039189100015009	0-54						Crosstalk and Integration of Membrane Trafficking Pathways	www.scribd.com	0	0		ACAP1
792	chr19	27249038	27249064	3500257776	23		27249038	27249064	8421504	2	10,13	0,13	c	350025777600000003	8-31						EXPRESSION OF AQUAPORIN WATER CHANNELS IN MOUSE SPINAL CORD	.bestcenteroc.com	0	0		
793	chr19	27319797	27319821	3500437989	23		27319797	27319821	8421504	2	4,19	0,5	g	350043798900000019	5-28						US Patent # 7,320,793. Molecular antigen array - Patents.com	www.patents.com	0	0		
793	chr19	27319797	27319821	3500373345	23		27319797	27319821	8421504	2	4,19	0,5	g	350037334500000026	5-28						Molecular antigen arrays using a virus like particle derived from the ap205 coat protein	Bachmann	2005	0		
793	chr19	27319797	27319821	3500370493	23		27319797	27319821	8421504	2	4,19	0,5	g	350037049300000013	5-28						Molecular antigen array	Renner	2002	0		
793	chr19	27319797	27319821	3500143718	23		27319797	27319821	8421504	2	4,19	0,5	g	350014371800000019	5-28						Molecular antigen array presenting amyloid beta	Bachmann	2003	0		
793	chr19	27319797	27319821	3500020039	23		27319797	27319821	8421504	2	4,19	0,5	g	350002003900000019	5-28						Molecular antigen array	Renner	2002	0		
793	chr19	27319904	27320223	3500127858	66		27319904	27320223	8421504	2	49,17	0,302	p	350012785800015000	45-111						TRANSLOCATION AND MUTANT TNK1 KINASE IN HUMAN LYMPHOMA - Patent application	www.faqs.org	0	0		
793	chr19	27325176	27325201	3500278603	25		27325176	27325201	8421504	1	25	0	c,g	350027860300000020,350027860300000020	17-42,17-42						Transgenic non-human mammals producing a cholinesterase in their milk - US Patent 6987211 Description	ww.patentstorm.us	0	0		NLGN2
793	chr19	27356622	27357777	3500213723	270		27356622	27357777	8421504	7	45,4,41,45,45,45,45	0,48,249,293,1014,1062,1110	p	350021372300015063,350021372300015064,350021372300015065,350021372300015067,350021372300015068,350021372300015069	0-45,0-45,0-45,0-45,0-45,0-45						Methods of Diagnosing Hypophosphatemic Disorders - Patent application	www.faqs.org	0	0		FGF11
793	chr19	27356670	27357777	3500142509	225		27356670	27357777	8421504	6	4,41,45,45,45,45	0,201,245,966,1014,1062	p	350014250900015050,350014250900015051,350014250900015053,350014250900015054	0-45,0-45,0-45,0-90						Fibroblast growth factor (FGF23) polypeptides - US Patent 7745406 Description	ww.patentstorm.us	0	0		FGF11
793	chr19	27362403	27366856	3500236632	156		27362403	27366856	8421504	7	1,26,21,15,42,30,21	0,454,483,3778,3796,3913,4432	p	350023663200015059	63-228						Recombinant chimeric acetylcholine receptors and their derivatives recognized by CD4 T cells of myasthenic patients for the treatment of myasthenia gravis - US Patent 7777003 Description	ww.patentstorm.us	0	0		
793	chr19	27375585	27375630	3500085938	45		27375585	27375630	8421504	1	45	0	p	350008593800015002	0-45		16354688	10.1128/MCB.26.1.169-181.2006	0270-7306	Molecular and Cellular Biology	A Family of Human Zinc Finger Proteins That Bind Methylated DNA and Repress Transcription	Filion	2006	6		ZBTB4
793	chr19	27375585	27375630	3500011340	45		27375585	27375630	8421504	1	45	0	p	350001134000015002	0-45			10.1128/MCB.26.1.169-181.2006		Molecular and Cellular Biology	A Family of Human Zinc Finger Proteins That Bind Methylated DNA and Repress Transcription	Guillaume	2006	0		ZBTB4
793	chr19	27389283	27389315	3500406951	32		27389283	27389315	8421504	1	32	0	g	350040695100000016	0-32						REGULATION OF LIPID DROPLET FORMATION BY MODULATION OF FIT1 AND FIT2 AND USES THEREOF - ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY	www.sumobrain.com	0	0		ZBTB4
794	chr19	27396793	27402459	3500384275	1035		27396793	27402459	8421504	12	105,78,45,125,211,3,124,50,60,42,37,155	0,759,1149,2404,2622,3646,3985,4297,4683,4871,5057,5511	p	350038427500015078,350038427500015104,350038427500015146,350038427500015012,350038427500015171,350038427500015186,350038427500015200,350038427500015233	0-105,0-123,0-123,0-153,33-195,18-192,48-150,0-192						Insect iridescent virus type 6 encodes a polypeptide related to the largest subunit of eukaryotic RNA polymerase II	r.sgmjournals.org	0	0		POLR2A
794	chr19	27398200	27398230	3500001518	30		27398200	27398230	8421504	1	30	0	c	350000151800000003	0-30		17060454	10.1128/MCB.00846-06	0270-7306	Molecular and Cellular Biology	Conditional Deletion of the Mouse Klf4 Gene Results in Corneal Epithelial Fragility, Stromal Edema, and Loss of Conjunctival Goblet Cells	Swamynathan	2007	6		POLR2A
794	chr19	27409046	27409151	3500425538	105		27409046	27409151	8421504	1	105	0	p	350042553800015001	0-105			10.1128/MCB.22.13.4622-4637.2002		Molecular and Cellular Biology	Phosphorylation of the RNA Polymerase II Carboxyl-Terminal Domain by CDK9 Is Directly Responsible for Human Immunodeficiency Virus Type 1 Tat-Activated Transcriptional Elongation	Young	July	0		POLR2A
795	chr19	27615951	27616178	3500349569	49		27615951	27616178	8421504	2	25,24	0,203	c	350034956900000027,350034956900000029,350034956900000026	0-24,0-24,0-24						Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents	M	1999	0		
795	chr19	27615951	27616178	3500242877	49		27615951	27616178	8421504	2	25,24	0,203	c	350024287700000027,350024287700000029,350024287700000026	0-24,0-24,0-24						Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents	Chaudhary	1999	0		
795	chr19	27618368	27618391	3500201864	23		27618368	27618391	8421504	1	23	0	c	350020186400000550	9-33						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
795	chr19	27618368	27618391	3500005314	23		27618368	27618391	8421504	1	23	0	c	350000531400000554	9-33						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
795	chr19	27618387	27618427	3500108268	40		27618387	27618427	8421504	1	40	0	c	350010826800000207	8-48						COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE - Patent application	www.faqs.org	0	0		
795	chr19	27618422	27618869	3500167894	40		27618422	27618869	8421504	2	20,20	0,427	c	350016789400000009,350016789400000010	0-20,0-20						&#xc9;COLE DOCTORALE SST	lis.univ-tours.fr	0	0		
795	chr19	27618422	27618869	3500157269	40		27618422	27618869	8421504	2	20,20	0,427	c,g	350015726900000009,350015726900000010,350015726900000010	0-20,0-20,0-20						&#xc9;COLE DOCTORALE SST	scd.univ-tours.fr	0	0		
795	chr19	27619149	27619178	3500280455	29		27619149	27619178	8421504	1	29	0	c	350028045500000090	9-38						TRIMERIZING POLYPEPTIDES - Patent application	www.faqs.org	0	0		
795	chr19	27629097	27629713	3500431628	153		27629097	27629713	8421504	2	51,102	0,514	p	350043162800015008	0-153						49 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		SENP3
795	chr19	27634666	27636438	3500021711	118		27634666	27636438	8421504	3	50,41,27	0,488,1745	c,g	350002171100000048,350002171100000051,350002171100000082	0-50,9-50,23-50						Forord	munin.uit.no	0	0		
795	chr19	27634765	27636217	3500048779	102		27634765	27636217	8421504	4	1,47,36,18	0,330,1140,1434	p	350004877900015013,350004877900015014,350004877900015015	0-48,0-45,0-54						Novel MHC II associated peptides	Kropshofer	2003	0		
795	chr19	27643816	27643839	3500233649	23		27643816	27643839	8421504	1	23	0	c	350023364900000341	24-47					Patent	Method of screening compounds that inhibit the biosynthesis of GPI in malaria parasites (Patent CN:100504392)	Zhong Ben He Xiao 	2009	0		
795	chr19	27647902	27648217	3500412745	45		27647902	27648217	8421504	2	22,23	0,292	c,g	350041274500000033,350041274500000033,350041274500000125,350041274500000125,350041274500000124,350041274500000124,350041274500000032,350041274500000032	0-22,0-22,0-22,0-22,0-23,0-23,0-23,0-23						Methods for EST-specific full length cDNA cloning	Xu	1999	0		FXR2
795	chr19	27648530	27648885	3500119728	24		27648530	27648885	8421504	2	22,2	0,353	c	350011972800000011	0-24						Isolation tool for viable c-kit expressing cells	Wouters	2002	0		FXR2
795	chr19	27648886	27648931	3500342863	45		27648886	27648931	8421504	1	45	0	p	350034286300015056	6-51							library.wiley.com	0	0		FXR2
796	chr19	27674912	27675158	3500261436	42		27674912	27675158	8421504	3	3,18,21	0,119,225	c,g	350026143600000097,350026143600000098,350026143600000098	0-21,0-21,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
796	chr19	27690007	27690032	3500462649	25		27690007	27690032	8421504	1	25	0	c	350046264900000002	34-59		15798201	10.1128/MCB.25.8.3151-3162.2005	0270-7306	Molecular and Cellular Biology	Akt-Dependent Cell Size Regulation by the Adhesion Molecule on Glia Occurs Independently of Phosphatidylinositol 3-Kinase and Rheb Signaling	Scheidenhelm	2005	6		
796	chr19	27690007	27690032	3500400849	25		27690007	27690032	8421504	1	25	0	c	350040084900000002	34-59						Akt-Dependent Cell Size Regulation by the Adhesion Molecule on Glia Occurs Independently of Phosphatidylinositol 3-Kinase and Rheb Signaling	mcb.asm.org	0	0		
796	chr19	27692705	27693047	3500324941	111		27692705	27693047	8421504	2	105,6	0,336	p	350032494100015017	0-111						46 human secreted proteins	Komatsoulis	2002	0		
796	chr19	27692705	27693047	3500279857	111		27692705	27693047	8421504	2	105,6	0,336	p	350027985700015017	0-111						46 human secreted proteins	Komatsoulis	2000	0		
796	chr19	27692705	27693047	3500122561	111		27692705	27693047	8421504	2	105,6	0,336	p	350012256100015018	0-111						46 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
796	chr19	27692804	27693939	3500010617	40		27692804	27693939	8421504	3	6,14,20	0,237,1115	c,g	350001061700000008,350001061700000009,350001061700000009	0-20,0-20,0-20						Revista Brasileira de Zootecnia	www.scielo.br	0	0		
796	chr19	27702113	27713673	3500059536	89		27702113	27713673	8421504	4	22,20,28,19	0,41,2627,11541	c	350005953600000011,350005953600000010,350005953600000012,350005953600000009	0-22,0-20,0-28,0-19						COMPARISON OF SEVERAL PROTOCOLS FOR THE INCREASE IN HOMOLOGOUS RECOMBINATION IN NORMAL PORCINE FETAL FIBROBLASTS AND THE APPLICATION TO AN ACTUAL LOCUS	pository.tamu.edu	0	0		
796	chr19	27702984	27704157	3500403930	80		27702984	27704157	8421504	2	32,48	0,1125	c	350040393000000112,350040393000000106	6-38,0-48						Human ubiquitin conjugating enzyme	Draetta	1994	0		
796	chr19	27702987	27703012	3500355477	24		27702987	27703012	8421504	2	5,19	0,6	c	350035547700000004	16-40						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		TP53
796	chr19	27702987	27703012	3500212744	24		27702987	27703012	8421504	2	5,19	0,6	c	350021274400000004	16-40						A Potential Daidzein Derivative Enhances Cytotoxicity of Epirubicin on Human Colon Adenocarcinoma Caco-2 Cells	www.mdpi.com	0	0		TP53
796	chr19	27703709	27703751	3500287207	42		27703709	27703751	8421504	1	42	0	c	350028720700000001,350028720700000000	0-42,0-22						Releasable nonvolatile mass-label molecules	Becker	2003	0		TP53
796	chr19	27703709	27703751	3500242777	42		27703709	27703751	8421504	1	42	0	c,g	350024277700000001,350024277700000000,350024277700000000	0-42,0-22,0-22					Patent	Releasable nonvolatile mass-label molecules (Patent EP:0963443)	Montforte	2006	0		TP53
796	chr19	27703709	27703751	3500228145	42		27703709	27703751	8421504	1	42	0	c	350022814500000001,350022814500000000,350022814500000018	0-42,0-22,0-20						Releasable nonvolatile mass-label molecules	Montforte	2002	0		
796	chr19	27703709	27703751	3500161935	42		27703709	27703751	8421504	1	42	0	c,g	350016193500000001,350016193500000000,350016193500000000,350016193500000018,350016193500000018	0-42,0-22,0-22,0-20,0-20						Releasable nonvolatile mass-label molecules	Becker	1998	0		TP53
796	chr19	27703709	27703751	3500135315	42		27703709	27703751	8421504	1	42	0	c	350013531500000001,350013531500000000	0-42,0-22						Releasable nonvolatile mass-label molecules	Becker	2004	0		TP53
796	chr19	27703709	27703751	3500134347	42		27703709	27703751	8421504	1	42	0	c	350013434700000001,350013434700000000	0-42,0-22					Patent	Releasable nonvolatile mass-label molecules (Patent US:7132519)	Monforte	2006	0		TP53
796	chr19	27703709	27703751	3500028274	42		27703709	27703751	8421504	1	42	0	c,g	350002827400000006,350002827400000000,350002827400000000	0-42,0-22,0-22					Patent	Abspaltbare, nicht-fl&#xfc;chtige molek&#xfc;le zur massenmarkierung Removable, nonvolatile molecules for mass marker (Patent DE:69735445)	BECKER	2006	0		
796	chr19	27703710	27704535	3500460481	46		27703710	27704535	8421504	2	23,23	0,802	c	350046048100000013,350046048100000012	0-23,0-23		19584293	10.1158/0008-5472.CAN-08-3820	0008-5472	Cancer Research	Computational Identification of a p38SAPK-Regulated Transcription Factor Network Required for Tumor Cell Quiescence	Adam	2009	8		TP53
796	chr19	27703718	27703742	3500376542	24		27703718	27703742	8421504	1	24	0	c	350037654200000008	0-24						 System And Method For Detecting Biological And Chemical Material 	www.docstoc.com	0	0		
796	chr19	27703720	27703743	3500351154	23		27703720	27703743	8421504	1	23	0	c	350035115400000003	0-23						Inhibitor of hepatitis B virus replication	Lee	1995	0		
796	chr19	27703721	27703756	3500130003	35		27703721	27703756	8421504	1	35	0	c	350013000300000003	0-35						System and method for detecting biological and chemical material - US Patent 7157050 Description	ww.patentstorm.us	0	0		
796	chr19	27703733	27704680	3500425641	38		27703733	27704680	8421504	2	19,19	0,928	c,g	350042564100000015,350042564100000009,350042564100000009	0-19,0-19,0-19						Oligonucleotide Compositions with Enhanced Efficiency	Woolf	2010	0		
796	chr19	27703733	27704678	3500116954	38		27703733	27704678	8421504	2	19,19	0,926	g	350011695400000030,350011695400000007	2-21,0-19						Amplification of target nucleotide sequence without polymerase chain reaction	Crothers	2005	0		
796	chr19	27704100	27704536	3500413318	43		27704100	27704536	8421504	2	22,21	0,415	c	350041331800000003,350041331800000002	0-22,0-21		17332330	10.1158/0008-5472.CAN-06-2601	0008-5472	Cancer Research	Effect of the Silybin-Phosphatidylcholine Complex (IdB 1016) on the Development of Mammary Tumors in HER-2/neu Transgenic Mice	Provinciali	2007	8		TP53
796	chr19	27704100	27704124	3500177321	24		27704100	27704124	8421504	1	24	0	c	350017732100000009	0-24						Homeopathic mother tincture of Phytolacca decandra induces apoptosis in skin melanoma cells by activating caspase-mediated signaling via reactive oxygen species elevation. - ResearchGate	.researchgate.net	0	0		TP53
796	chr19	27704100	27704123	3500457795	23		27704100	27704123	8421504	1	23	0	c	350045779500000001	0-23			10.1038/sj.onc.1210815		Oncogene	Ovarian Hyperstimulation Induces Centrosome Amplification and Aneuploid Mammary Tumors Independently of Alterations in p53 in a Transgenic Mouse Model of Breast Cancer	Erin	2008	0		TP53
796	chr19	27704100	27704123	3500335154	23		27704100	27704123	8421504	1	23	0	c	350033515400000015	0-23						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" > <HTML> <HEAD> <title>Journal	w.jcimjournal.com	0	0		TP53
796	chr19	27704100	27704123	3500204088	23		27704100	27704123	8421504	1	23	0	c	350020408800000015	0-23						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" > <HTML> <HEAD> <title>Journal	w.jcimjournal.com	0	0		TP53
796	chr19	27704105	27704501	3500446036	40		27704105	27704501	8421504	2	20,20	0,376	c,g	350044603600000019,350044603600000018,350044603600000018	0-20,0-20,0-20						E&#xfb00;ekte mechanischer Reize auf osteogen di&#xfb00;erenzierte Zellen in einer dreidimensionalen Kollagen Typ I Matrix	vts.uni-ulm.de	0	0		
796	chr19	27704105	27704501	3500404841	40		27704105	27704501	8421504	2	20,20	0,376	c,g	350040484100000021,350040484100000020,350040484100000020	0-20,0-20,0-20						Tissue Engineering von Bandersatz: Einfluss mechanischer Reize auf humane mesenchymale Progenitorzellen und humane Kreuzbandzellen	vts.uni-ulm.de	0	0		
796	chr19	27704105	27704501	3500389774	44		27704105	27704501	8421504	2	21,23	0,373	c,g	350038977400000003,350038977400000003,350038977400000002,350038977400000002	0-21,0-21,0-23,0-23						mRNA and microRNA quality control for RT-qPCR analysis	uantification.com	0	0		
796	chr19	27704105	27704501	3500107315	44		27704105	27704501	8421504	2	21,23	0,373	c,g	350010731500000003,350010731500000002,350010731500000002	0-21,0-23,0-23						mRNA and microRNA quality control for RT-qPCR analysis	uantification.net	0	0		
796	chr19	27704112	27704184	3500299267	72		27704112	27704184	8421504	1	72	0	p	350029926700015002	0-72						Informatics for Molecular Biologists	www.docstoc.com	0	0		TP53
796	chr19	27704186	27704679	3500040185	39		27704186	27704679	8421504	3	19,1,19	0,241,474	c,g	350004018500000048,350004018500000047,350004018500000047	0-20,0-19,0-19						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
796	chr19	27704443	27704500	3500071105	41		27704443	27704500	8421504	2	21,20	0,37	c,g	350007110500000005,350007110500000005,350007110500000004,350007110500000004	0-21,0-21,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
796	chr19	27704512	27704540	3500062523	28		27704512	27704540	8421504	1	28	0	c	350006252300000017	0-28						p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women	mp.bmj.com/conten	0	0		
796	chr19	27704641	27704682	3500402139	41		27704641	27704682	8421504	1	41	0	c	350040213900000000	0-41		16611888	10.1128/JVI.80.9.4292-4303.2006	0022-538X	Journal of Virology	Targeting of p300/CREB Binding Protein Coactivators by Simian Virus 40 Is Mediated through p53	Borger	2006	5		
796	chr19	27704708	27704733	3500158219	25		27704708	27704733	8421504	1	25	0	g	350015821900000027	112-137						OLIGONUCLEOTIDE-, PROTEIN AND/OR PEPTIDE-POLYMER CONJUGATES - Patent application	www.faqs.org	0	0		TP53
796	chr19	27713849	27713872	3500265877	23		27713849	27713872	8421504	1	23	0	g	350026587700000010	1-24						in normal Japanese individuals	www.scielo.br	0	0		
796	chr19	27715572	27715600	3500043085	28		27715572	27715600	8421504	1	28	0	c	350004308500000012,350004308500000025	14-36,1-22		22787161	10.1074/jbc.M112.367326		The Journal of Biological Chemistry	p53, a Target of Estrogen Receptor (ER) &#x03b1;, Modulates DNA Damage-induced Growth Suppression in ER-positive Breast Cancer Cells	CrystE.	2012	0		
796	chr19	27728880	27728908	3500389752	24		27728880	27728908	8421504	3	11,8,5	0,14,23	g	350038975200000218	0-24						Double-stranded nucleic acid	Graham	2004	0		
796	chr19	27730482	27730994	3500369032	40		27730482	27730994	8421504	2	20,20	0,492	c,g	350036903200000012,350036903200000012,350036903200000013,350036903200000013	0-20,0-20,0-20,0-20		15231694	10.1210/en.2004-0691	0013-7227	Endocrinology	Identification of Tissue-Restricted Transcripts in Human Islets	Maffei	2004	4		EFNB3
796	chr19	27730970	27731498	3500231882	41		27730970	27731498	8421504	2	22,19	0,509	c,g	350023188200000020,350023188200000020,350023188200000021,350023188200000021	0-22,0-22,0-19,0-19		23302882	10.1128/JVI.02576-12		Journal of Virology	Henipavirus Pathogenesis in Human Respiratory Epithelial Cells	Olivier	2013	0		EFNB3
796	chr19	27731781	27731838	3500439269	57		27731781	27731838	8421504	1	57	0	p	350043926900015001	0-57						Peptides that modulate the interaction of B class ephrins and PDZ domains	Lin	2001	0		EFNB3
796	chr19	27732873	27732900	3500301613	25		27732873	27732900	8421504	3	7,11,7	0,8,20	c	350030161300000006,350030161300000004	4-36,8-40			10.1007/s00335-007-9008-6		Mammalian Genome	Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene	Robert	July	0		
797	chr19	27827361	27827386	3500406372	24		27827361	27827386	8421504	2	9,15	0,10	c	350040637200000060	8-32						Compounds and methods for development of ret modulators	Ibrahim	2005	0		FGFR3
797	chr19	27827361	27827386	3500254199	24		27827361	27827386	8421504	2	9,15	0,10	c	350025419900000074	8-32						Compounds And Methods For Development Of Ret Modulators 	.freshpatents.com	0	0		
797	chr19	27827361	27827386	3500234586	24		27827361	27827386	8421504	2	9,15	0,10	c	350023458600000074,350023458600000073	8-32,0-23						Compounds and methods for development of Ret modulators	Artis	2007	0		
797	chr19	27827361	27827386	3500038256	24		27827361	27827386	8421504	2	9,15	0,10	c	350003825600000074,350003825600000073	8-32,0-23						Compounds and methods for development of Ret Modulators - Patent application	www.faqs.org	0	0		
797	chr19	27836324	27836351	3500087871	25		27836324	27836351	8421504	2	16,9	0,18	c	350008787100000013	9-34						Express&#xe3;o espa&#xe7;o-temporal do sistema VEGF e do EG-VEGF no timo de c&#xe3;es	www.teses.usp.br	0	0		
798	chr19	27926124	27926164	3500119438	40		27926124	27926164	8421504	1	40	0	c	350011943800000019	6-46						Sex Differences in Gene Expression in Dog Cortex	www.ibg.uu.se	0	0		
798	chr19	27932296	27932326	3500108068	26		27932296	27932326	8421504	2	16,10	0,20	c	350010806800000180	8-34						Protein amf-1 to amf-10 and nucleic acids encoding the same	Burgess	2001	0		
798	chr19	27983899	27996293	3500185087	3334		27983899	27996293	8421504	18	736,305,352,85,103,102,81,207,157,150,149,164,193,175,99,95,86,95	0,823,3916,4637,4990,5480,6507,8064,8366,9078,9886,10530,10789,11240,11713,11898,12092,12299	p,c	350018508700015008,350018508700000001	0-3330,11-36						rAAV-Guanylate Cyclase Compositions and Methods for Treating Lebers Congenital Amaurosis-1 (LCA1)	Boye	2011	0		
798	chr19	27984485	27984508	3500438309	23		27984485	27984508	8421504	1	23	0	c	350043830900000009	0-23						Protein kinase G-mediated stimulation of basal Leydig cell steroidogenesis	g.library.pcc.edu	0	0		GUCY2D
798	chr19	27984753	27984782	3500269550	24		27984753	27984782	8421504	2	9,15	0,14	c	350026955000000158	14-38						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
798	chr19	27994761	27995170	3500437151	64		27994761	27995170	8421504	3	20,13,31	0,107,378	c	350043715100000131,350043715100000063,350043715100000145	0-20,8-48,0-43						NATRIURETIC PEPTIDE RELATED FRAGMENT IN CARDIOVASCULAR DISEASE - Patent application	www.faqs.org	0	0		
798	chr19	27994869	27995170	3500318004	43		27994869	27995170	8421504	2	12,31	0,270	c	350031800400000145	0-43						NATRIURETIC PEPTIDE RELATED FRAGMENT IN CARDIOVASCULAR DISEASE - Patent application	www.faqs.org	0	0		
799	chr19	28085217	28085881	3500353322	90		28085217	28085881	8421504	3	42,3,45	0,613,619	p	350035332200015028,350035332200015027	0-45,0-45						Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor - Patent application	www.faqs.org	0	0		HES7
799	chr19	28118062	28120094	3500208573	48		28118062	28120094	8421504	4	17,7,22,2	0,624,1492,2030	c	350020857300000005,350020857300000004	11-35,7-31		9746583		0019-9567	Infection and Immunity	Characterization of Clostridium botulinum Type B Neurotoxin Associated with Infant Botulism in Japan	Kozaki	1998	4		
799	chr19	28118062	28120094	3500198487	48		28118062	28120094	8421504	4	17,7,22,2	0,624,1492,2030	c	350019848700000005,350019848700000004	11-35,7-31		9746583		0019-9567	Infection and Immunity	Characterization of Clostridium botulinum Type B Neurotoxin Associated with Infant Botulism in Japan	Kozaki	1998	4		
799	chr19	28118062	28120094	3500063375	48		28118062	28120094	8421504	4	17,7,22,2	0,624,1492,2030	c	350006337500000005,350006337500000004	11-35,7-31					Infection and Immunity	Characterization of Clostridium botulinum Type B Neurotoxin Associated with Infant Botulism in Japan	Shunji	1998	0		
799	chr19	28118827	28119470	3500195844	174		28118827	28119470	8421504	2	159,15	0,628	p	350019584400015035,350019584400015036	0-105,0-117						GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity	Steward	2004	0		VAMP2
799	chr19	28118848	28119506	3500336681	189		28118848	28119506	8421504	2	138,51	0,607	p	350033668100015009,350033668100015010,350033668100015011	0-177,165-246,0-60						FULL-LENGTH HUMAN CDNAS ENCODING POTENTIALLY SECRETED PROTEINS - GENSET S.A.	www.sumobrain.com	0	0		VAMP2
799	chr19	28118863	28118926	3500122558	60		28118863	28118926	8421504	2	45,15	0,48	p	350012255800015257	0-60						US Patent # 7,399,607. Fluorescence polarization assays for determining clostridial toxin activity - Patents.com	www.patents.com	0	0		
799	chr19	28144045	28144206	3500139665	60		28144045	28144206	8421504	2	25,35	0,126	p	350013966500015002	0-60						Homo sapiens hypothetical protein MGC10744 (MGC10744), transcript variant 2, mRNA. , NM_183065.1 - GenScript	www.genscript.com	0	0		
799	chr19	28157419	28157446	3500408992	23		28157419	28157446	8421504	2	9,14	0,13	c	350040899200000023	0-23						GENE EXPRESSION AND PAIN	Mamet	2008	0		
799	chr19	28157804	28159051	3500357446	43		28157804	28159051	8421504	2	21,22	0,1225	c	350035744600000004,350035744600000003	0-21,0-22						Spatio-Temporal Expression Patterns of Aurora Kinases A, B, and C and Cytoplasmic Polyadenylation-Element-Binding Protein in Bovine Oocytes During Meiotic Maturation	ww.biolreprod.org	0	0		
799	chr19	28158276	28159963	3500428426	48		28158276	28159963	8421504	2	24,24	0,1663	c	350042842600000006,350042842600000005	0-24,1-25					Patent	Diagnosis and treatment of AUR1 and/or AUR2 related disorders (Patent US:6716575)	Plowman	2004	0		AURKB
799	chr19	28158292	28159963	3500241481	72		28158292	28159963	8421504	3	34,14,24	0,670,1647	p,c	350024148100015027,350024148100000002	0-48,1-25						Diagnosis and treatment of aur-1 and/or aur-2 related disorders	Mossie	1998	0		
799	chr19	28159055	28159079	3500394833	24		28159055	28159079	8421504	1	24	0	c	350039483300000000	0-24						Compositions And Methods For Diagnosis And Treatment Of Tumors 	.freshpatents.com	0	0		
799	chr19	28159939	28159963	3500419926	24		28159939	28159963	8421504	1	24	0	c	350041992600000005	1-25					Patent	Diagnosis and treatment of AUR1 and/or AUR2 related disorders (Patent US:6716575)	Plowman	2004	0		
799	chr19	28159939	28159963	3500381686	24		28159939	28159963	8421504	1	24	0	c	350038168600000002	1-25						Diagnosis and treatment of aur-1 and/or aur-2 related disorders	Plowman	1997	0		
799	chr19	28159939	28159963	3500257428	24		28159939	28159963	8421504	1	24	0	c	350025742800000000	1-25						Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders	Plowman	2006	0		
799	chr19	28159957	28160014	3500194142	57		28159957	28160014	8421504	1	57	0	p	350019414200015002	93-150						CRYSTALLINE FORM OF THE CATALYTIC DOMAIN OF AURORA 2 KINASE AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		AURKC
799	chr19	28161768	28161795	3500311530	27		28161768	28161795	8421504	1	27	0	c	350031153000000000	10-37		12419797	10.1074/jbc.M211119200	0021-9258	Journal of Biological Chemistry	Survivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells	Chen	2003	5		
800	chr19	28213434	28213461	3500373336	23		28213434	28213461	8421504	3	13,5,5	0,15,22	c,g	350037333600000206,350037333600000206	0-24,0-24						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins - US Patent 7378506 Description	ww.patentstorm.us	0	0		
800	chr19	28295314	28299092	3500193957	315		28295314	28299092	8421504	5	126,12,102,21,54	0,2482,2521,3643,3724	p	350019395700015103,350019395700015102,350019395700015099,350019395700015104,350019395700015088,350019395700015093,350019395700015101,350019395700015095,350019395700015097	0-78,0-210,0-51,0-51,0-84,0-84,0-81,0-81,0-54						Methods For Regulation Of P53 Translation And Function 	.freshpatents.com	0	0		
800	chr19	28295318	28295389	3500096212	70		28295318	28295389	8421504	2	26,44	0,27	c	350009621200000035,350009621200000034	0-26,0-44						The Interaction between the Ribosomal Proteins and Endoplasmic Reticulum(ER)	ir.ym.edu.tw	0	0		TMCO1
801	chr19	28349401	28349431	3500322161	26		28349401	28349431	8421504	3	8,11,7	0,9,23	g	350032216100000001	4-31						Synthetic internal ribosome entry sites and methods of identifying same	Chappell	2001	0		
100	chr19	28390834	28466287	3500221414	5052		28390834	28466287	8421504	39	141,162,108,186,123,87,129,162,174,213,249,63,42,105,201,144,120,170,1,120,138,207,132,108,120,69,105,192,114,174,171,153,117,93,141,81,60,93,84	0,833,2351,4029,4289,5180,5611,10671,12181,13838,14318,14935,15046,15854,16373,17098,17648,18675,20009,20013,20596,23042,24128,24348,25467,25675,27460,27655,39239,39731,42455,46480,47262,50542,50889,52672,54554,68687,75369	p	350022141400015000	0-5184						 PigGIS&#x2192;GeneSnapshot&#x2192;ENST00000269243&#x2192;all	g.genomics.org.cn	0	0		
801	chr19	28401631	28401658	3500147485	24		28401631	28401658	8421504	2	13,11	0,16	c	350014748500000440	0-24						Antigen Binding Proteins Capable Of Binding Thymic Stromal Lymphopoietin 	.freshpatents.com	0	0		
802	chr19	28489741	28503635	3500177594	138		28489741	28503635	8421504	2	51,87	0,13807	p	350017759400015087	0-138						Novel nucleic acids and polypeptides and methods of use thereof	Shimkets	2002	0		
802	chr19	28503731	28503893	3500423761	162		28503731	28503893	8421504	1	162	0	p	350042376100015028	0-162						Bases de detection en reconnaissance des formes pour la bioInformatique	fesseurs.esiea.fr	0	0		MYH10
802	chr19	28503731	28503893	3500377403	162		28503731	28503893	8421504	1	162	0	p	350037740300015032	0-162						Introduction &#xe0; la bioinformatique PLU4199 Support de cours blog : http://professeurs.esiea.fr/wassner/	fesseurs.esiea.fr	0	0		MYH10
806	chr19	28978059	28978083	3500314685	24		28978059	28978083	8421504	1	24	0	c	350031468500000036,350031468500000059	0-24,0-24						DNA molecules encoding MUC-1 and use thereof in tumor vaccination	D*Pa Lun Te 	2001	0		
806	chr19	28994770	28994797	3500119642	24		28994770	28994797	8421504	3	6,13,5	0,8,22	g	350011964200000002	4-28		10198318			American Journal of Physiology - Endocrinology and Metabolism	Expression of 25(OH)D324-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3and cAMP or PTH	Yang	1999	0		
807	chr19	29181097	29181124	3500160984	27		29181097	29181124	8421504	1	27	0	c	350016098400000023	0-27						UNIVERSIT&#xc9; DU QU&#xc9;BEC M&#xc9;MOIRE PR&#xc9;SENT&#xc9; &#xc0; L'UNIVERSIT&#xc9; DU QU&#xc9;BEC fi.. TROIS-RIVI&#xc8;RES DE LA MA&#xce;TRISE EN BIOPHYSIQUE ET BIOLOGIE CELLULAIRES	depot-e.uqtr.ca	0	0		STX8
808	chr19	29236504	29236533	3500328515	26		29236504	29236533	8421504	2	18,8	0,21	g	350032851500000038	4-31					Patent	Cryptosporidium detection method (Patent US:5770368)	Leon	1998	0		
808	chr19	29236504	29236533	3500025064	26		29236504	29236533	8421504	2	18,8	0,21	g	350002506400000038	4-31						Cryptosporidium detection method	Leon	1996	0		
808	chr19	29284374	29284399	3500110285	23		29284374	29284399	8421504	2	17,6	0,19	g	350011028500000010	0-23						GENERATION, EXPRESSION AND CHARACTERIZATION OF THE HUMANIZED K33N MONOCLONAL ANTIBODY	Kumar	2010	0		
809	chr19	29421954	29421979	3500255035	23		29421954	29421979	8421504	2	9,14	0,11	g	350025503500000004	0-23						Methylocystis Strain SB2 Materials and Methods - Patent application	www.faqs.org	0	0		
810	chr19	29548770	29548796	3500455635	24		29548770	29548796	8421504	3	13,4,7	0,14,19	g	350045563500000011	0-30						Stabilized polypeptide compositions - Patent application	www.faqs.org	0	0		
810	chr19	29548770	29548796	3500376159	24		29548770	29548796	8421504	3	13,4,7	0,14,19	g	350037615900000108,350037615900000109,350037615900000011	0-30,11-41,0-30						Stabilized polypeptide compositions - Patent application	www.faqs.org	0	0		
811	chr19	29738522	29738546	3500370232	23		29738522	29738546	8421504	2	10,13	0,11	g	350037023200000175	14-37						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
811	chr19	29746607	29746635	3500302587	28		29746607	29746635	8421504	1	28	0	c,g	350030258700000001,350030258700000001	0-28,0-28						Expression of eight distinct MHC isoforms in bovine striated muscles: evidence for MHC-2B presence only in extraocular muscles	eb.biologists.org	0	0		
812	chr19	29764154	29764178	3500355979	24		29764154	29764178	8421504	1	24	0	c	350035597900000001	0-24						GATA4 transcription factor is required for ventral morphogenesis and heart tube formation	enesdev.cshlp.org	0	0		
812	chr19	29764184	29764208	3500207902	24		29764184	29764208	8421504	1	24	0	c	350020790200000014	0-24		19517013	10.1371/journal.pone.0005880		PLoS ONE	Regulation of Slow and Fast Muscle Myofibrillogenesis by Wnt/&#x03b2;-Catenin and Myostatin Signaling	Jin-Ming	2009	0		MYH3
812	chr19	29771276	29771301	3500243216	25		29771276	29771301	8421504	1	25	0	c,g	350024321600000014,350024321600000014	0-25,0-25						EFFECT OF ZILPATEROL HYDROCHLORIDE AND STEROID IMPLANTATION ON YEARLING STEER FEEDLOT PERFORMANCE, CARCASS CHARACTERISTICS, AND SKELETAL MUSCLE GENE EXPRESSION TIMOTHY JOHN BAXA B.S., Kansas State University, 2004 A THESIS	krex.k-state.edu	0	0		MYH13
812	chr19	29824132	29824174	3500028168	42		29824132	29824174	8421504	1	42	0	c	350002816800000003	2-44						JEPonline	www.docstoc.com	0	0		
812	chr19	29824247	29824298	3500202275	51		29824247	29824298	8421504	1	51	0	p	350020227500015005	0-51						Co-expression of Multiple Myosin Heavy Chain Genes, In Addition to a Tissue-Specific One, in Extraocular Musculature	jcb.rupress.org	0	0		MYH2
812	chr19	29827972	29828012	3500075252	40		29827972	29828012	8421504	1	40	0	c	350007525200000231	0-40						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
812	chr19	29833207	29834529	3500134920	477		29833207	29834529	8421504	5	243,3,114,12,105	0,867,948,1113,1217	p	350013492000015029,350013492000015028,350013492000015027,350013492000015026,350013492000015025,350013492000015012,350013492000015011,350013492000015008,350013492000015007	0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75,0-75						Cryptic Epitope Identi&#xfb01;ed in Rat and Human Cardiac Myosin S2 Region Induces Myocarditis in the Lewis Rat	www.jimmunol.org	0	0		MYH2
812	chr19	29839092	29872616	3500243216	60		29839092	29872616	8421504	4	19,20,6,15	0,79,33420,33509	c	350024321600000016,350024321600000015,350024321600000013	0-19,0-20,0-21						EFFECT OF ZILPATEROL HYDROCHLORIDE AND STEROID IMPLANTATION ON YEARLING STEER FEEDLOT PERFORMANCE, CARCASS CHARACTERISTICS, AND SKELETAL MUSCLE GENE EXPRESSION TIMOTHY JOHN BAXA B.S., Kansas State University, 2004 A THESIS	krex.k-state.edu	0	0		
812	chr19	29839092	29858627	3500345859	136		29839092	29858627	8421504	6	19,26,20,20,26,25	0,47,79,18331,18355,19510	c	350034585900000015,350034585900000016,350034585900000014,350034585900000012,350034585900000013,350034585900000011	0-19,0-26,0-20,0-20,0-26,0-25						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
812	chr19	29839171	29872616	3500093083	41		29839171	29872616	8421504	3	20,6,15	0,33341,33430	c	350009308300000012,350009308300000010	0-20,0-21						messenger ribonucleic acid abundance in finishing steers1	animalscience.org	0	0		
812	chr19	29846256	29875114	3500251794	63		29846256	29875114	8421504	2	31,32	0,28826	c,g	350025179400000001,350025179400000001,350025179400000000	0-31,0-31,0-32						Expression of Myosin Heavy Chain Isoforms in Porcine Muscles Determined by Multiplex PCR	lib3.dss.go.th	0	0		MYH1
812	chr19	29859576	29859883	3500410534	132		29859576	29859883	8421504	2	66,66	0,241	p	350041053400015034,350041053400015033	0-66,0-66						NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		MYH1
813	chr19	29918822	29920171	3500450956	231		29918822	29920171	8421504	2	161,70	0,1279	g	350045095600000122,350045095600000120,350045095600000117,350045095600000108	23-48,0-67,73-144,0-70						Analyse computationnelle des &#xe9;l&#xe9;ments cis-r&#xe9;gulateurs dans les g&#xe9;nomes des drosophiles et des mammif&#xe8;res | Marc Santolini - Academia.edu	www.academia.edu	0	0		
813	chr19	29940703	29940728	3500062617	25		29940703	29940728	8421504	1	25	0	c	350006261700000002	0-25		20587025	10.1186/1471-2199-11-52		BMC Molecular Biology	Characterisation of the sarcomeric myosin heavy chain multigene family in the laboratory guinea pig	DaniP	2010	0		
813	chr19	29950047	29950070	3500345859	23		29950047	29950070	8421504	1	23	0	c	350034585900000008	0-23						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
813	chr19	29958390	29958558	3500423761	168		29958390	29958558	8421504	1	168	0	p	350042376100015043	0-168						Bases de detection en reconnaissance des formes pour la bioInformatique	fesseurs.esiea.fr	0	0		MYH3
813	chr19	29958390	29958558	3500377403	168		29958390	29958558	8421504	1	168	0	p	350037740300015047	0-168						Introduction &#xe0; la bioinformatique PLU4199 Support de cours blog : http://professeurs.esiea.fr/wassner/	fesseurs.esiea.fr	0	0		MYH3
813	chr19	29987842	29995036	3500343582	44		29987842	29995036	8421504	2	21,23	0,7171	c	350034358200000023,350034358200000022	0-21,0-23						ABSTRACT	tory.lib.ncsu.edu	0	0		
815	chr19	30172295	30172320	3500078270	23		30172295	30172320	8421504	3	4,11,8	0,5,17	g	350007827000002291	8-31						Conjugated toxin peptide therapeutic agents - US Patent 7820623 Description	ww.patentstorm.us	0	0		
817	chr19	30477467	30477496	3500322008	24		30477467	30477496	8421504	3	5,5,14	0,7,15	g	350032200800000000	4-28						Humanized monoclonal antibodies against vascular endothelial cell growth factor	Asano	2000	0		
818	chr19	30605452	30628152	3500031022	41		30605452	30628152	8421504	4	14,5,6,16	0,17,22674,22684	g	350003102200000320,350003102200000843	0-19,8-30						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
822	chr19	31167767	31167821	3500009135	32		31167767	31167821	8421504	2	26,6	0,48	c	350000913500000008	32-64						METHOD FOR EXTRACTING QUANTITATIVE INFORMATION RELATING TO AN INFLUENCE ON A CELLULAR RESPONSE	Thastrup	2007	0		
823	chr19	31196797	31214643	3500299655	32		31196797	31214643	8421504	2	12,20	0,17826	c	350029965500000014,350029965500000005,350029965500000006,350029965500000015	0-20,0-20,0-20,0-20						INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS - Patent application	www.faqs.org	0	0		MAP2K4
823	chr19	31214775	31240922	3500452245	62		31214775	31240922	8421504	3	20,21,21	0,16403,26126	c	350045224500000368,350045224500000369,350045224500000371	0-20,0-21,0-21						Modulation of biological signal transduction by RNA interference	Klinghoffer	2003	0		MAP2K4
823	chr19	31214775	31240922	3500191905	62		31214775	31240922	8421504	3	20,21,21	0,16403,26126	c	350019190500000368,350019190500000369,350019190500000371	0-20,0-21,0-21						Modulation of biological signal transduction by RNA interference	Klinghoffer	2003	0		MAP2K4
823	chr19	31233029	31237498	3500366238	105		31233029	31237498	8421504	2	51,54	0,4415	p	350036623800015020	0-105						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		MAP2K4
839	chr19	33380345	33380537	3500209476	181		33380345	33380537	8421504	4	11,17,93,60	0,17,38,132	g	350020947600000000	0-186						 Tophat can't find Bowtie index files - Page 2 - SEQanswers	seqanswers.com	0	0		
839	chr19	33415914	33415937	3500355413	23		33415914	33415937	8421504	1	23	0	c	350035541300000002	1-24		16554459	10.1523/JNEUROSCI.3785-05.2006	0270-6474	The Journal of Neuroscience	Neuregulin 1&#x2013;erbB Signaling Is Necessary for Normal Myelination and Sensory Function	Chen	2006	7		
839	chr19	33415914	33415937	3500110547	23		33415914	33415937	8421504	1	23	0	c	350011054700000002	1-24						Cellular/Molecular Neuregulin1&#x2013;erbBSignalingIsNecessaryforNormal MyelinationandSensoryFunction	drenshospital.org	0	0		
840	chr19	33446341	33446368	3500415731	23		33446341	33446368	8421504	2	10,13	0,14	g	350041573100000013	0-23						Glutamic acid decarboxylase (GAD) based delivery systems	During	2004	0		
841	chr19	33636900	33636929	3500270485	25		33636900	33636929	8421504	2	17,8	0,21	c	350027048500000061	0-25						&#x308f;&#x304c;&#x56fd;&#x3067;&#x767a;&#x751f;&#x3057;&#x305f;&#xff21;&#x578b;&#x304a;&#x3088;&#x3073; B &#x578b;&#x4e73;&#x5150;&#x30dc;&#x30c4;&#x30ea;&#x30cc;&#x30b9;&#x75c7;&#x8d77;&#x56e0;&#x83cc;&#x306e;&#x907a;&#x4f1d; Title &#x5b66;&#x7684;&#x89	y.osakafu-u.ac.jp	0	0		
842	chr19	33778228	33778259	3500322097	26		33778228	33778259	8421504	2	16,10	0,21	g	350032209700000320	22-48						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
843	chr19	33866555	33875164	3500166888	305		33866555	33875164	8421504	11	30,17,21,30,46,40,4,44,25,21,27	0,825,932,1793,1830,1951,4097,4542,6596,6647,8582	c	350016688800000001,350016688800000132,350016688800000102,350016688800000294,350016688800000099,350016688800000283,350016688800000274,350016688800000273	0-47,0-48,0-30,1-47,0-40,0-48,23-48,0-48						Nucleic acid sequences encoding capsaicin receptor and uses thereof	Julius	1999	0		
843	chr19	33866560	33876382	3500403557	294		33866560	33876382	8421504	10	25,17,9,33,43,30,18,44,45,30	0,820,939,1788,1928,2243,3930,6502,9669,9792	p,c	350040355700000052,350040355700000049,350040355700000046,350040355700000041,350040355700000030,350040355700015109,350040355700000016	6-48,6-48,0-43,0-48,0-44,0-45,3-33						CANINE TRANSIENT RECEPTOR POTENTIAL V2 (CTRPV2) AND METHODS OF SCREENING FOR TRPV2 CHANNEL MODULATORS - Patent application	www.faqs.org	0	0		TRPV2
843	chr19	33867496	33873176	3500465865	173		33867496	33873176	8421504	8	12,30,4,41,20,8,33,25	0,852,3156,3601,3652,4448,5607,5655	c	350046586500000279,350046586500000267,350046586500000266,350046586500000259,350046586500000258	0-42,0-45,7-35,9-42,23-48						 Nucleic Acid Sequences Encoding Capsaicin Receptor And Capsaicin Receptor 	www.docstoc.com	0	0		
843	chr19	33868348	33875164	3500027346	182		33868348	33875164	8421504	7	30,31,4,44,25,21,27	0,420,2304,2749,4803,4854,6789	c	350002734600000101,350002734600000286,350002734600000281,350002734600000272,350002734600000271	0-30,4-35,0-48,23-48,0-48						US Patent # 6,335,180. Nucleic acid sequences encoding capsaicin receptor and uses thereof - Patents.com	www.patents.com	0	0		
843	chr19	33876337	33876366	3500294263	28		33876337	33876366	8421504	2	14,14	0,15	g	350029426300000011,350029426300000010,350029426300000031	3-31,0-28,4-25						ELUCIDATING THE MOLECULAR MECHANISMS OF VIBRIO CHOLERAE TOXIN COREGULATED PILUS ASSEMBLY, BUNDLING AND CTX&#x03c6; INTERACTIONS	summit.sfu.ca	0	0		
843	chr19	33902454	33902482	3500109617	23		33902454	33902482	8421504	3	12,6,5	0,14,23	c	350010961700000006	9-32						[tel-00855515, v1] Caract&#xe9;risation de facteurs bact&#xe9;riens essentiels &#xe0; la virulence des souches de Escherichia coli associ&#xe9;es &#xe0; la maladie de Crohn	hives-ouvertes.fr	0	0		
843	chr19	33902454	33902482	3500092679	23		33902454	33902482	8421504	3	12,6,5	0,14,23	c	350009267900000006	9-32						[tel-00855515, v1] Caract&#xe9;risation de facteurs bact&#xe9;riens essentiels &#xe0; la virulence des souches de Escherichia coli associ&#xe9;es &#xe0; la maladie de Crohn	hives-ouvertes.fr	0	0		
843	chr19	33902545	33902647	3500411508	47		33902545	33902647	8421504	3	5,18,24	0,6,78	g	350041150800000006,350041150800000007	0-23,0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Fol&#xed;culos ovarianos caprinos expressam diferentes n&#xed;veis de RNAm para subunidade &#xdf;A da inibina e ativina-A promove o crescimento de fol&#xed;culos secund&#xe1;rios in vitro	Leitao	2013	0		
843	chr19	33902550	33903377	3500376771	40		33902550	33903377	8421504	2	20,20	0,807	c,g	350037677100000002,350037677100000011,350037677100000001,350037677100000010	0-20,0-20,0-20,0-20						Method of Treatment Based on ATAD2 Inhibitors - Patent application	www.faqs.org	0	0		UBB
843	chr19	33902675	33903097	3500044851	49		33902675	33903097	8421504	2	20,29	0,393	c	350004485100000021,350004485100000022	0-20,6-35					Patent	Plant ubiquitin promoter system (Patent US:6020190)	Christensen	2000	0		
843	chr19	33902711	33904170	3500099123	40		33902711	33904170	8421504	3	20,13,7	0,685,1452	c,g	350009912300000017,350009912300000016	0-20,0-20						Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin	g.library.pcc.edu	0	0		
843	chr19	33902840	33903367	3500107315	41		33902840	33903367	8421504	2	22,19	0,508	c	350010731500000000,350010731500000001	0-23,0-19						mRNA and microRNA quality control for RT-qPCR analysis	uantification.net	0	0		
843	chr19	33902921	33902947	3500128684	26		33902921	33902947	8421504	1	26	0	c	350012868400000012	12-38						Ubiquitin-proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase	cs.biologists.org	0	0		
843	chr19	33903052	33903091	3500003004	38		33903052	33903091	8421504	2	18,20	0,19	c	350000300400000047	6-45						Compositions and methods for the modification of gene expression - Patent # 7211711 - PatentGenius	.patentgenius.com	0	0		
843	chr19	33903068	33903097	3500347910	29		33903068	33903097	8421504	1	29	0	c	350034791000000022	6-35						Plant ubiquitin promoter system	Quail	1996	0		
843	chr19	33903148	33903175	3500343584	27		33903148	33903175	8421504	1	27	0	c	350034358400000001,350034358400000000	18-45,15-42						Ubiquitin ligase assay	Huang	2001	0		UBB
843	chr19	33903148	33903175	3500332285	27		33903148	33903175	8421504	1	27	0	c	350033228500000001,350033228500000000	18-45,15-42						Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents	Huang	2003	0		UBB
843	chr19	33903148	33903175	3500108124	27		33903148	33903175	8421504	1	27	0	c	350010812400000000,350010812400000001	15-42,18-45						Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents	osdir.com/patents	0	0		
843	chr19	33903148	33903175	3500000128	27		33903148	33903175	8421504	1	27	0	c,g	350000012800000007,350000012800000001,350000012800000001,350000012800000000,350000012800000008,350000012800000008	15-42,18-45,18-45,15-42,18-45,18-45						Ubiquitin Ligase Assay 	.freshpatents.com	0	0		UBB
843	chr19	33903189	33903213	3500239338	24		33903189	33903213	8421504	1	24	0	c	350023933800000011	0-24		21191013	10.1128/JVI.01616-10	0022-538X	Journal of Virology	North American Porcine Reproductive and Respiratory Syndrome Viruses Inhibit Type I Interferon Production by Plasmacytoid Dendritic Cells	Calzada-Nova	2011	5		
843	chr19	33903189	33903213	3500168259	24		33903189	33903213	8421504	1	24	0	c	350016825900000011	0-24		21191013	10.1128/JVI.01616-10		Journal of Virology	North American Porcine Reproductive and Respiratory Syndrome Viruses Inhibit Type I Interferon Production by Plasmacytoid Dendritic Cells 	Gabriela	2011	0		
843	chr19	33903268	33903371	3500345831	40		33903268	33903371	8421504	2	19,21	0,82	c	350034583100000000,350034583100000006	0-19,0-21						Downregulation of ubiquitin level via knockdown of polyubiquitin gene Ubb as potential cancer therapeutic intervention.	.biomedsearch.com	0	0		UBB
843	chr19	33903296	33903367	3500016815	41		33903296	33903367	8421504	2	22,19	0,52	c	350001681500000000,350001681500000001	0-22,0-19						Standardization strategy for quantitative PCR in human seminoma and normal testis	quantification.de	0	0		
843	chr19	33903306	33903331	3500331184	25		33903306	33903331	8421504	1	25	0	c	350033118400000015	22-47						UNIVERSIDADE ESTADUAL DO CEAR&#xc1; PR&#xd3;-REITORIA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O E PESQUISA FACULDADE DE VETERIN&#xc1;RIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS VETERIN&#xc1;RIAS JULIANA JALES DE HOLLANDA CELESTINO EXX PPRREESSSS&#	cnptia.embrapa.br	0	0		
843	chr19	33903307	33903331	3500423043	24		33903307	33903331	8421504	1	24	0	c	350042304300000005	0-24						Activin-A reduces follicular growth stimulated by FSH in bovine preantral follicles	www.uece.br	0	0		
843	chr19	33903312	33903352	3500016406	40		33903312	33903352	8421504	1	40	0	c	350001640600000002	0-40		16946078	10.1152/ajpregu.00561.2006		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I	Lang	2007	0		UBB
843	chr19	33903321	33903370	3500209140	49		33903321	33903370	8421504	1	49	0	c	350020914000000002	18-67						Reference SNP(refSNP) Cluster Report: rs132901132&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;	.ncbi.nlm.nih.gov	0	0		
843	chr19	33903376	33903403	3500394813	27		33903376	33903403	8421504	1	27	0	c	350039481300000010	14-41						\\\\set{final} \\\\def\\<BR>uthor{Fernandes} \\\\def\\\\author{fernandes} \\\\def\\\\vol{12} \\\\def\\\\year{2006} \\\\def\\\\anum{17	www.molvis.org	0	0		
843	chr19	33937814	33937847	3500193936	26		33937814	33937847	8421504	4	4,11,7,4	0,5,21,29	c	350019393600000065	22-48						Polypeptides having kinase activity, their preparation and use	Hiles	1994	0		
843	chr19	33937814	33937847	3500152577	26		33937814	33937847	8421504	4	4,11,7,4	0,5,21,29	c	350015257700000058	16-42						US Patent # 7,422,849. Method for determining expression of a PI3 kinase gene - Patents.com	www.patents.com	0	0		
844	chr19	33995632	33995656	3500271996	24		33995632	33995656	8421504	1	24	0	c	350027199600000009	12-36					Patent	Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities (Patent US:6942980)	Klein	2005	0		NCOR1
844	chr19	34030278	34032234	3500202403	60		34030278	34032234	8421504	2	3,57	0,1899	p	350020240300015014	0-60						NPG.nature.vol.419.Issue.6910.Oct	www.scribd.com	0	0		NCOR1
844	chr19	34074138	34074165	3500304231	26		34074138	34074165	8421504	2	22,4	0,23	c	350030423100000001	17-43						Downregulation of liver X receptor- in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines	www.jlr.org	0	0		NCOR2
845	chr19	34080671	34088221	3500002742	138		34080671	34088221	8421504	3	39,30,69	0,204,7481	p	350000274200015006,350000274200015007	0-69,0-69			10.1073/pnas.0705517104		Proceedings of the National Academy of Sciences of the United States of America	Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein&#x2013;protein interaction profile	Jeffrey	2007	0		NCOR1
845	chr19	34088137	34088212	3500050126	75		34088137	34088212	8421504	1	75	0	p	350005012600015003	0-75		17356170	10.1210/me.2006-0524	0888-8809	Molecular Endocrinology	A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator	Madauss	2007	5		NCOR1
845	chr19	34088143	34088218	3500137367	75		34088143	34088218	8421504	1	75	0	p	350013736700015002	0-75						ANovelPrincipleforPartialAgonismofLiverX ReceptorLigands	www.dkfz.de	0	0		NCOR1
845	chr19	34135360	34135586	3500424225	42		34135360	34135586	8421504	2	21,21	0,205	c	350042422500000009,350042422500000008	0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
845	chr19	34157133	34157162	3500060533	25		34157133	34157162	8421504	3	5,8,12	0,7,17	g	350006053300000133	15-40						PLANT TRANSFORMED WITH POLYNUCLEOTIDE ENCODING LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS DELTA-ENDOTOXIN - Patent application	www.faqs.org	0	0		
847	chr19	34456752	34456800	3500377644	48		34456752	34456800	8421504	1	48	0	p	350037764400015062	0-48						Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma	Burton	2012	0		
850	chr19	34757229	34757256	3500387000	23		34757229	34757256	8421504	2	8,15	0,12	g	350038700000000002	0-26		9525626		0022-538X	Journal of Virology	Human Immunodeficiency Virus Type 1 (HIV-1) Viral Protein R (Vpr) Interacts with Lys-tRNA Synthetase: Implications for Priming of HIV-1 Reverse Transcription	Stark	1998	5		
851	chr19	34891368	34892251	3500100552	25		34891368	34892251	8421504	2	15,10	0,873	c	350010055200000011	0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		MAPK7
851	chr19	34916099	34917938	3500424649	63		34916099	34917938	8421504	2	53,10	0,1829	p	350042464900015000	0-63						Title page A novel peptide agonist of FPRL1 (ALX) displays anti-inflammatory and cardioprotective effects	aspetjournals.org	0	0		B9D1
851	chr19	34916099	34917938	3500289571	63		34916099	34917938	8421504	2	53,10	0,1829	p	350028957100015002	0-63		19023040	10.1124/jpet.108.145821	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects	Hecht	2009	0		B9D1
851	chr19	34918307	34918331	3500462786	24		34918307	34918331	8421504	1	24	0	c	350046278600000005	0-24		21493627	10.1093/hmg/ddr151		Human Molecular Genetics	B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis	Katharina	July	0		
852	chr19	35018890	35018915	3500282252	23		35018890	35018915	8421504	2	11,12	0,13	c	350028225200000277	0-23						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
852	chr19	35090360	35094105	3500359260	270		35090360	35094105	8421504	3	50,173,47	0,1732,3698	p	350035926000015003	0-270						<HTML> <HEAD> </HEAD> <BODY> <FONT FACE="Sabon"><H1><P ALIGN="CENTER"> V22.0480.002 <P ALIGN="CENTE	www.settheory.com	0	0		
853	chr19	35181788	35181813	3500194350	25		35181788	35181813	8421504	1	25	0	c	350019435000000116	15-44						Soybean peroxidase gene family and an assay for detecting soybean peroxidase activity	Vierling	1998	0		
853	chr19	35201103	35201190	3500117760	44		35201103	35201190	8421504	2	37,7	0,80	g	350011776000000066	22-66						Identifikation und Charakterisierung molekularer Komponenten des Verbindungsciliums der Photorezeptoren von Vertebraten	m.opus.hbz-nrw.de	0	0		
853	chr19	35202201	35202225	3500351536	23		35202201	35202225	8421504	2	7,16	0,8	c	350035153600000029,350035153600000015	1-24,1-24						Methods of diagnosing and treating hepatic cell proliferative disorders	Nelson	2000	0		
853	chr19	35242269	35242302	3500099344	28		35242269	35242302	8421504	2	22,6	0,27	c	350009934400000093	18-46						T cell epitopes of ryegrass pollen allergen	Griffith	1995	0		
853	chr19	35242429	35242456	3500380283	23		35242429	35242456	8421504	2	8,15	0,12	c	350038028300000049	15-38						TARGETED THERAPEUTIC PROTEINS - Patent application	www.faqs.org	0	0		
853	chr19	35242429	35242456	3500265346	23		35242429	35242456	8421504	2	8,15	0,12	c	350026534600000042	15-38						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
854	chr19	35307289	35308088	3500381884	84		35307289	35308088	8421504	2	23,61	0,738	p	350038188400015013	0-84						Locally Sensitive Backtranslation based on Multiple Sequence Alignment	olab.dmi.unict.it	0	0		DRG2
854	chr19	35338609	35339478	3500272641	23		35338609	35339478	8421504	3	4,7,12	0,847,857	c	350027264100000238	13-37						DNA Vaccine Enhancement with MHC Class II Activators - Patent application	www.faqs.org	0	0		
855	chr19	35433997	35451490	3500131986	17493		35433997	35451490	8421504	1	17493	0	c,g	350013198600000016,350013198600000036,350013198600000002,350013198600000037,350013198600000038,350013198600000039,350013198600000003,350013198600000040,350013198600000041,350013198600000004,350013198600000005,350013198600000046,350013198600000043,350013198600000044,350013198600000047	0-17493,0-60,0-301,0-80,0-141,0-120,0-300,0-141,0-150,0-300,0-301,0-120,0-70,0-21,0-141						SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK - Patent application	www.faqs.org	0	0		
855	chr19	35434976	35450984	3500428289	4129		35434976	35450984	8421504	22	99,424,188,138,956,221,202,179,262,167,169,109,110,133,166,201,84,119,132,13,21,36	0,8254,9038,9310,9548,10611,11057,11371,11791,12131,12435,13102,13450,13658,13940,14550,14850,15683,15803,15936,15950,15972	p,c,g	350042828900000012,350042828900000012,350042828900015072,350042828900000013,350042828900015003,350042828900015074,350042828900000015,350042828900015005,350042828900015075,350042828900000016,350042828900015006,350042828900015076,350042828900000017,350042828900015007,350042828900015077,350042828900000018,350042828900015008,350042828900015078,350042828900000019,350042828900015009,350042828900015079,350042828900000020,350042828900015010,350042828900015080,350042828900000021,350042828900015011,350042828900015081,350042828900000022,350042828900015012,350042828900000023,350042828900015083,350042828900000024,350042828900015014,350042828900015084,350042828900000025,350042828900015015,350042828900015085,350042828900000026,350042828900015016,350042828900015086,350042828900000027,350042828900015017,350042828900015087,350042828900000028,350042828900015018,350042828900015088,350042828900000029,350042828900015019,350042828900015089,350042828900000030,350042828900015020,350042828900015090,350042828900000031,350042828900015021,350042828900015091,350042828900000032,350042828900015022,350042828900015092,350042828900000011,350042828900000008,350042828900000008,350042828900000000,350042828900000000,350042828900000033,350042828900015023,350042828900015093,350042828900000034,350042828900015024,350042828900015094,350042828900000010,350042828900000035,350042828900015025,350042828900015095,350042828900000036,350042828900015026,350042828900015096,350042828900000037,350042828900015027,350042828900015097,350042828900000038,350042828900015028,350042828900015098,350042828900000039,350042828900015029,350042828900015099,350042828900000040,350042828900015030,350042828900015100,350042828900000041,350042828900015031,350042828900015101,350042828900015032,350042828900000042,350042828900015102,350042828900015033,350042828900000043,350042828900015103,350042828900000044,350042828900015034,350042828900015104,350042828900000045,350042828900015035,350042828900015105,350042828900015036,350042828900000046,350042828900015106,350042828900015037,350042828900000047,350042828900015107,350042828900000048,350042828900015038,350042828900015108,350042828900000049,350042828900015039,350042828900015109,350042828900000050,350042828900015040,350042828900015110,350042828900000051,350042828900015041,350042828900015111,350042828900000052,350042828900015042,350042828900015112,350042828900000053,350042828900015043,350042828900000054,350042828900015044,350042828900015114,350042828900000055,350042828900015045,350042828900015115,350042828900000056,350042828900015046,350042828900015116,350042828900000057,350042828900015047,350042828900015117,350042828900000058,350042828900015048,350042828900015118,350042828900000059,350042828900015049,350042828900015119,350042828900015050,350042828900000060,350042828900015120,350042828900015051,350042828900000061,350042828900015121,350042828900015052,350042828900000062,350042828900015122,350042828900000005,350042828900000005,350042828900000086,350042828900000086,350042828900000007,350042828900000088,350042828900015053,350042828900000063,350042828900015123,350042828900015054,350042828900000064,350042828900000006,350042828900000087,350042828900015124,350042828900015055,350042828900000065,350042828900015125,350042828900015056,350042828900000066,350042828900015126,350042828900015057,350042828900000067,350042828900015127,350042828900015058,350042828900000068,350042828900015128,350042828900015059,350042828900000069,350042828900015129,350042828900015060,350042828900000070,350042828900015130,350042828900015061,350042828900000071,350042828900015131,350042828900015062,350042828900000072,350042828900015132,350042828900015063,350042828900000073,350042828900015133,350042828900015064,350042828900000074,350042828900015134,350042828900015065,350042828900015135,350042828900015066,350042828900000076,350042828900015136,350042828900015067,350042828900000077,350042828900000078,350042828900015139,350042828900015070,350042828900000080,350042828900000081,350042828900000082	0-51,0-51,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-778,0-25,0-25,0-25,0-25,0-48,0-48,0-48,0-48,0-48,0-48,0-84,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-20,0-20,0-20,0-20,0-25,0-25,0-48,0-48,0-48,0-48,0-48,0-23,0-23,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-47,0-202						Method Of Determining Gene Relating To Favorable Beef Taste And Texture 	.freshpatents.com	0	0		
855	chr19	35444420	35446356	3500099123	60		35444420	35446356	8421504	6	4,16,9,11,11,9	0,104,1379,1613,1804,1927	c	350009912300000011,350009912300000028,350009912300000029	0-20,0-20,0-20						Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin	g.library.pcc.edu	0	0		
855	chr19	35444632	35456696	3500442334	46		35444632	35456696	8421504	5	13,9,14,6,4	0,16,12038,12053,12060	c,g	350044233400000005,350044233400000017	11-33,22-46						Methods and Compositions For Increasing the Nitrogen Storage Capacity of a Plant - Patent application	www.faqs.org	0	0		
855	chr19	35444655	35444680	3500325085	25		35444655	35444680	8421504	1	25	0	c,g	350032508500000002,350032508500000002	0-25,0-25						CHARACTERIZATION OF EXON 14 AND INTRON 5 OF THE SREBP-1 GENE IN SARDA BREED SHEEP	aas.bf.uni-lj.si	0	0		
855	chr19	35445419	35445449	3500185551	30		35445419	35445449	8421504	1	30	0	c,g	350018555100000009,350018555100000009	0-30,0-30						THE J BIOLOGICAL C &#xa9; 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Hepatic Glucokinase Is Required for the Synergistic Action of ChREBP and SREBP-1c on Glycolytic and Lipogenic Gene Expression*	www.jbc.org	0	0		
855	chr19	35445605	35446438	3500463464	92		35445605	35446438	8421504	2	69,23	0,810	c,g	350046346400000052,350046346400000052,350046346400000026	6-76,6-76,20-43						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
855	chr19	35446220	35449078	3500301078	102		35446220	35449078	8421504	4	15,5,62,20	0,127,156,2838	c,g	350030107800000059,350030107800000070,350030107800000070,350030107800000060,350030107800000171	0-20,6-68,6-68,0-23,0-20						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
855	chr19	35446382	35446408	3500374113	26		35446382	35446408	8421504	1	26	0	c	350037411300000000	0-26						Additional file 1 Candidate genes and their corresponding chip Download - SREBF1	wnload.cmclre.com	0	0		
855	chr19	35446382	35446408	3500275264	26		35446382	35446408	8421504	1	26	0	c	350027526400000000	0-26						BMC Genomics BioMed Central Download - SREBF1	wnload.cmclre.com	0	0		
857	chr19	35732661	35732686	3500425870	25		35732661	35732686	8421504	1	25	0	c	350042587000000170	17-42							w.bhdsyndrome.org	0	0		
857	chr19	35732661	35732686	3500419949	25		35732661	35732686	8421504	1	25	0	c	350041994900000170	17-42							w.bhdsyndrome.org	0	0		
857	chr19	35758240	35758263	3500391466	23		35758240	35758263	8421504	1	23	0	c	350039146600000002	20-43			10.1091/mbc.E04-04-0275		Molecular Biology of the Cell	p116Rip Targets Myosin Phosphatase to the Actin Cytoskeleton and Is Essential for RhoA/ROCK-regulated Neuritogenesis	Jacqueline	2004	0		
857	chr19	35761342	35761367	3500218688	24		35761342	35761367	8421504	2	11,13	0,12	c	350021868800000105	14-38						US Patent # 6,388,169. Maize orthologues of bacterial RecA proteins - Patents.com	www.patents.com	0	0		
857	chr19	35761342	35761367	3500101793	24		35761342	35761367	8421504	2	11,13	0,12	c	350010179300000105	14-38						Maize orthologues of bacterial RecA proteins	Mahajan	1999	0		
858	chr19	35821074	35821103	3500374932	24		35821074	35821103	8421504	3	4,14,6	0,5,23	g	350037493200000127	0-24						Compositions and methods for the treatment of immune related diseases	Ashkenazi	2000	0		
860	chr19	36166322	36166346	3500248568	24		36166322	36166346	8421504	1	24	0	c	350024856800000002	0-24			10.1113/jphysiol.2001.013439		The Journal of Physiology	Specific localization of an inwardly rectifying K+ channel, Kir4.1, at the apical membrane of rat gastric parietal cells; its possible involvement in K+ recycling for the H+&#x2013;K+-pump	Akikazu	2002	0		KCNJ12
860	chr19	36166322	36166346	3500003480	24		36166322	36166346	8421504	1	24	0	c	350000348000000002	0-24		11927671	10.1113/jphysiol.2001.013439	0022-3751	The Journal of Physiology	Specific localization of an inwardly rectifying K+ channel, Kir4.1, at the apical membrane of rat gastric parietal cells; its possible involvement in K+ recycling for the H+&#x2013;K+-pump	Fujita	2002	5		KCNJ12
862	chr19	36340142	36340171	3500442426	25		36340142	36340171	8421504	2	18,7	0,22	g	350044242600000103	17-45						Gene encoding protein antigens of Plasmodium falciparum and uses therefor	Inselburg	1994	0		
862	chr19	36382739	36382768	3500186993	24		36382739	36382768	8421504	3	14,6,4	0,18,25	g	350018699300000010	0-26		10639438	10.1128/IAI.68.2.716-724.2000	0019-9567	Infection and Immunity	Enzymatic Properties of Dipeptidyl Aminopeptidase IV Produced by the Periodontal Pathogen Porphyromonas gingivalis and Its Participation in Virulence	Kumagai	2000	4		
862	chr19	36390338	36393007	3500371671	183		36390338	36393007	8421504	3	6,102,75	0,1593,2594	p	350037167100015005	0-183						Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element. - ResearchGate	.researchgate.net	0	0		
862	chr19	36395003	36395027	3500373359	23		36395003	36395027	8421504	2	13,10	0,14	g	350037335900000009	0-23		19657392	10.1371/journal.pone.0006537	1932-6203	PLOS ONE	PLOS ONE: Human CD34+/CD90+ ASCs Are Capable of Growing as Sphere Clusters, Producing High Levels of VEGF and Forming Capillaries	Francesco	2009	4		
863	chr19	36499426	36500456	3500340732	47		36499426	36500456	8421504	2	23,24	0,1006	c	350034073200000000,350034073200000001	4-27,6-30		12151396	10.1074/jbc.M204506200	0021-9258	Journal of Biological Chemistry	Identification of the Anti-proliferative Protein Tob as a MAPK Substrate	Maekawa	2002	5		TOB1
865	chr19	36774375	36774404	3500391583	25		36774375	36774404	8421504	2	8,17	0,12	c	350039158300000012	20-45						MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE - IMMUNIVEST CORPORATION	www.sumobrain.com	0	0		WFIKKN2
865	chr19	36774375	36774404	3500171619	25		36774375	36774404	8421504	2	8,17	0,12	c	350017161900000012	20-45						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2003	0		
865	chr19	36774375	36774404	3500100860	25		36774375	36774404	8421504	2	8,17	0,12	c	350010086000000012	20-45						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2004	0		WFIKKN2
866	chr19	36853539	36853566	3500374909	23		36853539	36853566	8421504	2	7,16	0,11	g	350037490900000458	7-30						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
866	chr19	36857249	36857273	3500100250	23		36857249	36857273	8421504	2	4,19	0,5	c	350010025000000017	0-23						Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function	Kuchroo	2005	0		
866	chr19	36858951	36881761	3500099386	1230		36858951	36881761	8421504	11	152,161,137,87,162,105,75,145,40,67,99	0,3478,4312,4509,4974,6368,7752,8202,9278,12178,22711	p	350009938600015078,350009938600015077	0-450,0-780						Assay for Monitoring Activity of Jmjd6	Schofield	2009	0		LUC7L3
866	chr19	36862457	36863370	3500335119	240		36862457	36863370	8421504	2	133,107	0,806	p	350033511900015010	0-240						A. (2009) Science, 325 (5936), pp. 90-93.	penrepository.com	0	0		LUC7L3
866	chr19	36890727	36890753	3500369175	23		36890727	36890753	8421504	2	9,14	0,12	c	350036917500000223	0-23						TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6 - Patent application	www.faqs.org	0	0		
866	chr19	36890727	36890753	3500250061	23		36890727	36890753	8421504	2	9,14	0,12	c	350025006100000328	0-23						Anti-alpha(v)beta(6) antibodies and uses thereof - Patent application	www.faqs.org	0	0		
866	chr19	36890727	36890753	3500144838	23		36890727	36890753	8421504	2	9,14	0,12	c	350014483800000072	0-23						Method of Providing Disease-Specific Binding Molecules and Targets - Patent application	www.faqs.org	0	0		
866	chr19	36911832	36919595	3500406434	43		36911832	36919595	8421504	2	22,21	0,7742	c,g	350040643400000007,350040643400000006,350040643400000006	0-22,0-21,0-21						Cytotoxicity, Toxicity, and Anticancer Activity of Zingiber Officinale Roscoe Against Cholangiocarcinoma	.apocpcontrol.org	0	0		ABCC3
866	chr19	36911833	36919594	3500209021	41		36911833	36919594	8421504	2	21,20	0,7741	c,g	350020902100000007,350020902100000007,350020902100000006,350020902100000006	0-21,0-21,0-20,0-20						Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein. - ResearchGate	.researchgate.net	0	0		ABCC3
866	chr19	36911834	36911897	3500302073	63		36911834	36911897	8421504	1	63	0	p	350030207300015001	0-63			10.1046/j.1432-1327.2000.01106.x	1432-1033	European Journal of Biochemistry	Characterization of the 5&#x2032;-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene - St&#xf6;ckel - 2001 - European Journal of Biochemistry - Wiley 	Stockel	2000	0		ABCC3
866	chr19	36926121	36926144	3500100342	23		36926121	36926144	8421504	1	23	0	c	350010034200000018	20-43						&#x4e2d;&#x6587;&#x6458;&#x8981;	ir.cmu.edu.tw	0	0		
867	chr19	36974191	36974221	3500226249	26		36974191	36974221	8421504	3	6,6,14	0,7,16	c	350022624900000008	22-48						Nima Interacting Proteins 	.freshpatents.com	0	0		
867	chr19	36974191	36974221	3500203162	26		36974191	36974221	8421504	3	6,6,14	0,7,16	c	350020316200000008	22-48						US Patent # 5,952,467. NIMA interacting proteins - Patents.com	www.patents.com	0	0		
867	chr19	36974964	37017152	3500164853	384		36974964	37017152	8421504	12	39,9,14,34,7,41,48,1,47,60,36,48	0,165,222,547,12520,13287,22557,22877,22976,38709,41023,42140	p	350016485300015106,350016485300015104,350016485300015086,350016485300015059,350016485300015054,350016485300015024,350016485300015023,350016485300015013	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						US Patent # 6,358,706. DNA encoding human alpha1G-C T-Type calcium channel - Patents.com	www.patents.com	0	0		
867	chr19	36985160	36987412	3500130122	240		36985160	36987412	8421504	3	66,126,48	0,616,2204	p	350013012200015017,350013012200015015	0-90,0-150						0470723610 Pulmonary 1	www.scribd.com	0	0		CACNA1G
867	chr19	36987437	36987461	3500030524	23		36987437	36987461	8421504	2	7,16	0,8	c	350003052400000208	9-32						PROTEIN ELECTRON MEDIATOR - Patent application	www.faqs.org	0	0		
867	chr19	36997539	36997647	3500160606	105		36997539	36997647	8421504	2	21,84	0,24	p	350016060600015018	0-105						Human brain t calcium channel alpha-subunit splice variants	Agnew	2002	0		
867	chr19	36998046	36999054	3500121903	40		36998046	36999054	8421504	2	20,20	0,988	c	350012190300000013,350012190300000015	0-20,0-20		14736732	10.1210/en.2003-1257	0013-7227	Endocrinology	High Expression of the R-Type Voltage-Gated Ca2+ Channel and Its Involvement in Ca2+-Dependent Gonadotropin-Releasing Hormone Release in GT1&#x2013;7 Cells	Watanabe	2004	4		
868	chr19	37110987	37111012	3500169677	23		37110987	37111012	8421504	2	16,7	0,18	c	350016967700000004	17-43						extension by binding to Snapin and Snap25	mcb.asm.org	0	0		
868	chr19	37111387	37113650	3500286026	48		37111387	37113650	8421504	2	25,23	0,2240	c	350028602600000020,350028602600000021	0-25,0-23						Analysis of transcriptional regulation of the small leucine rich proteoglycans	www.molvis.org	0	0		
868	chr19	37165081	37165104	3500395209	23		37165081	37165104	8421504	1	23	0	c	350039520900000116	15-38						Cytokinin Oxidase Sequences and Methods of Use - Patent application	www.faqs.org	0	0		
868	chr19	37165094	37190307	3500198677	40		37165094	37190307	8421504	3	15,5,20	0,17,25193	c	350019867700000084,350019867700000170	6-27,1-22						NOVEL CANCER-ASSOCIATED GENES - Patent application	www.faqs.org	0	0		
868	chr19	37170875	37170906	3500219335	26		37170875	37170906	8421504	3	6,6,14	0,10,17	c	350021933500000011	4-30		14679196	10.1074/jbc.M312402200	0021-9258	Journal of Biological Chemistry	Steroid Hormones Induce bcl-X Gene Expression through Direct Activation of Distal Promoter P4	Viegas	2004	5		
868	chr19	37170875	37170906	3500075136	26		37170875	37170906	8421504	3	6,6,14	0,10,17	c	350007513600000011	4-30		14679196	10.1074/jbc.M312402200	0021-9258	Journal of Biological Chemistry	Steroid Hormones Induce bcl-X Gene Expression through Direct Activation of Distal Promoter P4	Viegas	2004	5		
868	chr19	37170881	37170908	3500342127	25		37170881	37170908	8421504	3	4,5,16	0,5,11	c	350034212700000020	0-25						Methods of Ex Vivo Expansion of Blood Progenitor Cells, and Generation of Composite Grafts	Mahmud	2012	0		
869	chr19	37326151	37338555	3500004188	46		37326151	37338555	8421504	2	25,21	0,12383	c	350000418800000034,350000418800000025	0-25,19-40						Gastroenterology	www.wjgnet.com	0	0		
869	chr19	37326175	37326201	3500335841	26		37326175	37326201	8421504	1	26	0	c,g	350033584100000002,350033584100000002	0-26,0-26						Materials Sciences and Applications	www.scirp.org	0	0		
869	chr19	37326175	37326201	3500255946	26		37326175	37326201	8421504	1	26	0	c	350025594600000002	0-26						et al. J Biotechnol Biomaterial 2011, 1:1 Biotechnology & Biomaterials	w.omicsonline.org	0	0		
869	chr19	37326175	37326201	3500128239	26		37326175	37326201	8421504	1	26	0	c,g	350012823900000002,350012823900000002	0-26,0-26						ISSUU - JOB Vol.1 - N.1 - 2010 by Paolo Trisi	issuu.com/paulbio	0	0		
869	chr19	37326175	37326201	3500028836	26		37326175	37326201	8421504	1	26	0	c	350002883600000002	0-26						Bio-Oss&#xae;acts on Stem cells derived from Peripheral Blood	www.omjournal.org	0	0		
869	chr19	37326177	37326202	3500335598	25		37326177	37326202	8421504	1	25	0	c,g	350033559800000006,350033559800000006	0-25,0-25		23236489	10.1371/journal.pone.0051371	1932-6203	PLOS ONE	PLOS ONE: Col1A1 Production and Apoptotic Resistance in TGF-&#x03b2;1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells	Liu	2012	4		
869	chr19	37326186	37342679	3500187078	181		37326186	37342679	8421504	11	20,21,20,14,8,19,19,20,8,12,20	0,3157,4982,6372,6514,10965,13732,15217,15309,15426,16473	c,g	350018707800000002,350018707800000008,350018707800000003,350018707800000004,350018707800000009,350018707800000005,350018707800000010,350018707800000006,350018707800000006,350018707800000011,350018707800000007	0-20,0-21,0-20,0-20,0-20,0-19,0-19,0-20,0-20,0-20,0-20						Molecular cloning of full-length coding sequences and characterization of &#x03b1; chains for donkey (Equus asinus) type I collagen	demicjournals.org	0	0		
869	chr19	37326187	37326211	3500194217	24		37326187	37326211	8421504	1	24	0	c	350019421700000001	0-24		11572876	10.1074/jbc.M108103200	0021-9258	Journal of Biological Chemistry	Lefty Contributes to the Remodeling of Extracellular Matrix by Inhibition of Connective Tissue Growth Factor and Collagen mRNA Expression and Increased Proteolytic Activity in a Fibrosarcoma Model	Mason	2002	5		COL1A1
869	chr19	37326188	37327806	3500018883	42		37326188	37327806	8421504	3	12,8,22	0,14,1596	c	350001888300000006,350001888300000007	0-20,0-22			10.1186/ar4229	1478-6354	Arthritis Research & Therapy	Adenosine A2A receptors promote collagen production by a Fli1- and CTGF-mediated mechanism	Chan	2013	4		
869	chr19	37326209	37327820	3500255169	40		37326209	37327820	8421504	2	20,20	0,1591	c,g	350025516900000002,350025516900000003,350025516900000003	0-20,0-20,0-20		18978407	10.2106/JBJS.H.00049	0021-9355	The Journal of Bone & Joint Surgery	 The Journal of Bone & Joint Surgery | Differentiation Potential of Multipotent Progenitor Cells Derived from War-Traumatized Muscle Tissue 	Nesti	2008	3		COL1A1
869	chr19	37326209	37327820	3500186171	40		37326209	37327820	8421504	2	20,20	0,1591	c,g	350018617100000003,350018617100000004,350018617100000004	0-20,0-20,0-20						Caveolin-1 Regulates Proliferation and Osteogenic Differentiation of Human Mesenchymal Stem Cells | Natasha Baker - Academia.edu	www.academia.edu	0	0		COL1A1
869	chr19	37326209	37327820	3500050405	40		37326209	37327820	8421504	2	20,20	0,1591	c,g	350005040500000002,350005040500000003,350005040500000003	0-20,0-20,0-20		18978407	10.2106/JBJS.H.00049	0021-9355	The Journal of Bone & Joint Surgery	 The Journal of Bone & Joint Surgery | Differentiation Potential of Multipotent Progenitor Cells Derived from War-Traumatized Muscle Tissue 	Nesti	2008	3		COL1A1
869	chr19	37327779	37327802	3500352414	23		37327779	37327802	8421504	1	23	0	c	350035241400000001	0-23						Composition For Stimulating Growth Of Dermal Papilla Cells And Promoting Hair Follicle Growth Comprising Vitamin C Derivatives 	.freshpatents.com	0	0		
869	chr19	37327779	37327802	3500233177	23		37327779	37327802	8421504	1	23	0	c	350023317700000002,350023317700000007	0-23,0-23						Aldosterone induced elastin production - Patent # 8148327 - PatentGenius	.patentgenius.com	0	0		COL1A1
869	chr19	37327779	37327802	3500161300	23		37327779	37327802	8421504	1	23	0	c	350016130000000002	0-23						ALDOSTERONE INDUCED VASCULAR ELASTIN PRODUCTION - Patent application	www.faqs.org	0	0		COL1A1
869	chr19	37327781	37327899	3500359099	43		37327781	37327899	8421504	2	22,21	0,97	c	350035909900000008,350035909900000009	0-22,0-21		18282267	10.1111/j.1524-475X.2007.00342.x	1524-475X	Wound Repair and Regeneration	Differential effects of hyaluronan and its fragments on fibroblasts: Relation to wound healing - David-Raoudi - 2008 - Wound Repair and Regeneration - Wiley Online Library	David-Raoudi	2008	0		COL1A1
869	chr19	37327798	37327899	3500147735	41		37327798	37327899	8421504	2	20,21	0,80	c,g	350014773500000000,350014773500000000,350014773500000001	0-20,0-20,0-21						Cartilage regeneration in SCID mice using a highly organized three-dimensional alginate scaffold	hys.sinica.edu.tw	0	0		COL1A1
869	chr19	37327798	37327899	3500134108	41		37327798	37327899	8421504	2	20,21	0,80	c,g	350013410800000000,350013410800000000,350013410800000001	0-20,0-20,0-21						A highly organized three-dimensional alginate scaffold for cartilage tissue engineering prepared by microfluidic technology	hys.sinica.edu.tw	0	0		COL1A1
869	chr19	37328464	37329335	3500259342	30		37328464	37329335	8421504	2	28,2	0,869	c	350025934200000004	15-45						Recombinant collagens and derived proteins produced by plants, methods of obtaining such and their uses	Bournat	2003	0		
869	chr19	37328464	37329335	3500248717	30		37328464	37329335	8421504	2	28,2	0,869	c	350024871700000006	15-45					Patent	Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses (Patent US:6617431)	Gruber	2003	0		
869	chr19	37328464	37329335	3500162802	30		37328464	37329335	8421504	2	28,2	0,869	c	350016280200000022	15-45						Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses	Bournat	1998	0		
869	chr19	37329357	37331177	3500400376	40		37329357	37331177	8421504	3	20,8,12	0,1468,1808	c	350040037600000003,350040037600000004	0-20,0-20						Function of cells producing type I collagen: potential influence of the vasculature	scovery.ucl.ac.uk	0	0		COL1A1
869	chr19	37330826	37331181	3500017696	23		37330826	37331181	8421504	2	7,16	0,339	c	350001769600000018	0-23						Equine Veterinary Journal ISSN 0425-1644 DOI: 10.1111/j.2042-3306.2010.00353.x Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells	library.hverf.org	0	0		
869	chr19	37331182	37331212	3500318627	30		37331182	37331212	8421504	1	30	0	c	350031862700000000	0-30		15728585	10.1074/jbc.M414698200	0021-9258	Journal of Biological Chemistry	Mutations Near Amino End of &#x03b1;1(I) Collagen Cause Combined Osteogenesis Imperfecta/Ehlers-Danlos Syndrome by Interference with N-propeptide Processing	Cabral	2005	5		
869	chr19	37332557	37336909	3500377137	97		37332557	37336909	8421504	6	15,11,24,12,11,24	0,143,3087,3289,3568,4328	c	350037713700000008,350037713700000012,350037713700000007,350037713700000004	22-48,13-37,22-45,16-40					Patent	Recombinant gelatins (Patent EP:1232181)	Chang	2013	0		
869	chr19	37332557	37336909	3500106921	97		37332557	37336909	8421504	6	15,11,24,12,11,24	0,143,3087,3289,3568,4328	c	350010692100000008,350010692100000012,350010692100000007,350010692100000004	22-48,13-37,22-45,16-40					Patent	Recombinant gelatin in vaccines (Patent EP:1232262)	Chang	2008	0		
869	chr19	37333492	37333521	3500454678	25		37333492	37333521	8421504	2	15,10	0,19	c	350045467800000071	4-30						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2004	0		
869	chr19	37334829	37335187	3500076526	156		37334829	37335187	8421504	3	48,54,54	0,152,304	p	350007652600015041	0-156						41 human secreted proteins	Komatsoulis	2001	0		COL1A1
869	chr19	37335845	37337689	3500344185	41		37335845	37337689	8421504	3	13,9,19	0,280,1825	c	350034418500000024,350034418500000035	26-48,13-32						Collagen Producing Plants And Methods Of Generating And Using Same 	.freshpatents.com	0	0		COL1A1
869	chr19	37336134	37336837	3500157825	108		37336134	37336837	8421504	3	45,27,36	0,72,667	p	350015782500015028,350015782500015029	0-45,0-63						High molecular weight collagen-like protein polymers	Cappello	1996	0		COL1A1
869	chr19	37336134	37336179	3500437369	45		37336134	37336179	8421504	1	45	0	p	350043736900015011	0-45						Products comprising substrates capable of enzymatic cross-linking	Cappello	1995	0		COL1A1
869	chr19	37336134	37336179	3500428940	45		37336134	37336179	8421504	1	45	0	p	350042894000015021	0-45						US Patent # 5,496,712. High molecular weight collagen-like protein polymers - Patents.com	www.patents.com	0	0		COL1A1
869	chr19	37336134	37336179	3500405739	45		37336134	37336179	8421504	1	45	0	p	350040573900015010	0-45					Patent	Products comprising substrates capable of enzymatic cross-linking (Patent US:5773577)	Cappello	1998	0		COL1A1
869	chr19	37336134	37336179	3500382280	45		37336134	37336179	8421504	1	45	0	p	350038228000015003	0-45						Methods for preparing synthetic repetitive dna	Cappello	1998	0		COL1A1
869	chr19	37336134	37336179	3500204359	45		37336134	37336179	8421504	1	45	0	p	350020435900015010	0-45						US Patent # 5,773,577. Products comprising substrates capable of enzymatic cross-linking - Patents.com	www.patents.com	0	0		COL1A1
869	chr19	37336134	37336179	3500145868	45		37336134	37336179	8421504	1	45	0	p	350014586800015032,350014586800015039	0-45,96-141						High molecular weight collagen-like protein polymers	Cappello	1995	0		COL1A1
869	chr19	37336206	37336837	3500139423	63		37336206	37336837	8421504	2	27,36	0,595	p	350013942300015017	0-63						Collagen-like polypeptides	Gardner	1993	0		COL1A1
869	chr19	37337872	37338517	3500292707	300		37337872	37338517	8421504	4	30,54,162,54	0,148,340,591	p	350029270700015036	0-300						Hydroxylation of recombinant human collagen type I alpha 1 in transgenic maize co-expressed with a recombinant human prolyl 4-hydroxylase	biomedcentral.com	0	0		
869	chr19	37338472	37338517	3500442590	45		37338472	37338517	8421504	1	45	0	p	350044259000015005	0-45						Cellular upregulation of VEGF receptor expression using nanofibrillar articles	Ross	2008	0		COL1A1
869	chr19	37338472	37338517	3500402195	45		37338472	37338517	8421504	1	45	0	p	350040219500015085	0-45						Peptides and peptide compositions having osteoinductive activity - Patent application	www.faqs.org	0	0		COL1A1
869	chr19	37338472	37338517	3500112417	45		37338472	37338517	8421504	1	45	0	p	350011241700015004	39-84						Bone tissue regenerating peptides	Gawande	2012	0		
869	chr19	37338472	37338517	3500005217	45		37338472	37338517	8421504	1	45	0	p	350000521700015007	0-45						Treatment of bony defects with osteoblast precursor cells	Frank	1999	0		COL1A1
869	chr19	37338536	37338973	3500058276	40		37338536	37338973	8421504	2	20,20	0,417	c,g	350005827600000002,350005827600000003,350005827600000003	0-20,0-20,0-20		15642136	10.1186/ar1471	1478-6354	Arthritis Research & Therapy	Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading	Lorenz	2004	4		
869	chr19	37338562	37339173	3500335102	105		37338562	37339173	8421504	3	9,45,51	0,154,560	p	350033510200015009,350033510200015013,350033510200015014	0-54,0-51,0-45						BiochemicalCharacterizationandN-terminomicsAnalysisof Leukolysin,theMembrane-type6MatrixMetalloprotease (MMP25)	www.jbc.org	0	0		COL1A1
869	chr19	37339699	37342731	3500030431	217		37339699	37342731	8421504	2	48,169	0,2863	c,g	350003043100000024,350003043100000023	17-65,0-169						Methods - Patent application	www.faqs.org	0	0		
869	chr19	37339915	37342190	3500199206	40		37339915	37342190	8421504	2	20,20	0,2255	c,g	350019920600000010,350019920600000010,350019920600000011,350019920600000001	0-20,0-20,0-20,20-40						Novel Herbal Composition 	.freshpatents.com	0	0		
869	chr19	37339915	37342190	3500056016	40		37339915	37342190	8421504	2	20,20	0,2255	c	350005601600000000,350005601600000001	0-20,0-20			10.1634/stemcells.22-3-313	1549-4918	STEM CELLS	Effects of Cyclic Compressive Loading on Chondrogenesis of Rabbit Bone-Marrow Derived Mesenchymal Stem Cells - Huang - 2004 - STEM CELLS - Wiley Online Library	Huang	2004	0		
869	chr19	37339915	37342190	3500020495	40		37339915	37342190	8421504	2	20,20	0,2255	c,g	350002049500000000,350002049500000001,350002049500000001	0-20,0-20,0-20			10.1002/ar.a.20010	1552-4892	The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology	Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture - Charles Huang - 2004 - The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology - Wiley Online Library	Charles	2004	0		COL1A1
869	chr19	37339925	37341310	3500447264	40		37339925	37341310	8421504	2	20,20	0,1365	c,g	350044726400000000,350044726400000000,350044726400000001,350044726400000001	0-20,0-20,0-20,0-20						USE OF MODIFIED CYCLOSPORINS - Patent application	www.faqs.org	0	0		COL1A1
869	chr19	37339942	37341431	3500358136	44		37339942	37341431	8421504	2	22,22	0,1467	c,g	350035813600000005,350035813600000004,350035813600000004	0-22,0-22,0-22						Untersuchungen zur gef&#xe4;&#xdf;protektiven Wirkung von Iloprost an humanen Gef&#xe4;&#xdf;muskelzellen	ni-duesseldorf.de	0	0		COL1A1
869	chr19	37339942	37341431	3500110311	44		37339942	37341431	8421504	2	22,22	0,1467	c,g	350011031100000005,350011031100000004,350011031100000004	0-22,0-22,0-22						Untersuchungen zur gef&#xe4;&#xdf;protektiven Wirkung von Iloprost an humanen Gef&#xe4;&#xdf;muskelzellen	ni-duesseldorf.de	0	0		COL1A1
869	chr19	37341269	37341371	3500412394	40		37341269	37341371	8421504	2	20,20	0,82	c,g	350041239400000004,350041239400000004,350041239400000005,350041239400000005	0-20,0-20,0-20,0-20						HYDROGELS BASED ON POLYMERS OF DEXTRAN TYRAMINE AND TYRAMINE CONJUGATES OF NATURAL POLYMERS - Patent application	www.faqs.org	0	0		
869	chr19	37341319	37341367	3500031258	48		37341319	37341367	8421504	1	48	0	p	350003125800015008	0-48						GENETIC VARIANTS ON CHR 15Q24 AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EXFOLIATION SYNDROME AND GLAUCOMA - Patent application	www.faqs.org	0	0		COL1A1
869	chr19	37341328	37342513	3500016669	47		37341328	37342513	8421504	2	23,24	0,1161	c,g	350001666900000000,350001666900000000,350001666900000001	0-23,0-23,0-24		20570839	10.1136/ard.2009.127761	1468-2060	Annals of the Rheumatic Diseases	Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis	Piera-Velazquez	2010	0		COL1A1
869	chr19	37341373	37342143	3500262820	40		37341373	37342143	8421504	2	20,20	0,750	c	350026282000000008,350026282000000001,350026282000000009	0-20,0-20,0-20						collagenous matrix with improved porosity and tensile strength and preparation method therefore by using mechanical stimulation system - Patent application	www.faqs.org	0	0		COL1A1
869	chr19	37341387	37341765	3500382747	40		37341387	37341765	8421504	2	20,20	0,358	c	350038274700000002,350038274700000003	0-20,0-20		22916269	10.1371/journal.pone.0043475		PLoS ONE	PAPSS2 Promotes Alkaline Phosphates Activity and Mineralization of Osteoblastic MC3T3-E1 Cells by Crosstalk and Smads Signal Pathways	Weizhuo	2012	0		
869	chr19	37341387	37341765	3500379087	40		37341387	37341765	8421504	2	20,20	0,358	c	350037908700000004,350037908700000005	0-20,0-20						HtrA1InhibitsMineralDepositionbyOsteoblasts	www.jbc.org	0	0		
869	chr19	37341387	37341765	3500026973	40		37341387	37341765	8421504	2	20,20	0,358	c	350002697300000002,350002697300000003	0-20,0-20		22916269	10.1371/journal.pone.0043475	1932-6203	PLOS ONE	PLOS ONE: PAPSS2 Promotes Alkaline Phosphates Activity and Mineralization of Osteoblastic MC3T3-E1 Cells by Crosstalk and Smads Signal Pathways	Wang	2012	4		
869	chr19	37341479	37342105	3500127714	41		37341479	37342105	8421504	3	20,8,13	0,316,613	c,g	350012771400000008,350012771400000008,350012771400000009	0-20,0-20,0-21		23325087	10.1038/ki.2012.448	0085-2538	Kidney International	p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase	Watanabe	2013	7		COL1A1
869	chr19	37341490	37341622	3500216107	23		37341490	37341622	8421504	2	13,10	0,122	c	350021610700000008	0-23		19296469	10.1002/hep.22820	1527-3350	Hepatology	Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury - Van Hul - 2009 - Hepatology - Wiley Online Library	Hul	2009	0		
869	chr19	37341721	37342105	3500263398	45		37341721	37342105	8421504	3	24,8,13	0,74,371	c	350026339800000000,350026339800000001	0-24,0-21						Do Dermis-Derived Stem Cells Have the Same Characteristics as Bone Marrow- and Adipose Tissue-Derived Stem Cells?	www.ijbbb.org	0	0		
869	chr19	37341721	37342105	3500033655	45		37341721	37342105	8421504	3	24,8,13	0,74,371	c	350003365500000006,350003365500000007	0-24,0-21						[pastel-00771963, v1] Effet des nanoparticules de dioxyde de titane sur les m&#xe9;talloprot&#xe9;ases, influence des param&#xe8;tres physicochimiques	hives-ouvertes.fr	0	0		
869	chr19	37341721	37341744	3500315503	23		37341721	37341744	8421504	1	23	0	c	350031550300000013	0-23						TransformingGrowthFactor- ReceptorTypeI-dependent FibrogenicGeneProgramIsMediatedviaActivationof Smad1andERK1/2Pathways S	www.jbc.org	0	0		COL1A1
869	chr19	37341721	37341744	3500152702	23		37341721	37341744	8421504	1	23	0	c	350015270200000002	0-23					PLoS ONE	The Transcriptional Cofactor Nab2 Is Induced by TGF-&#x03b2; and Suppresses Fibroblast Activation: Physiological Roles and Impaired Expression in Scleroderma - Scolaris	Bhattacharyya	2009	0		
869	chr19	37341742	37342200	3500042350	43		37341742	37342200	8421504	2	21,22	0,436	c,g	350004235000000002,350004235000000003,350004235000000003	0-21,0-22,0-22						Effects of SIRT6 silencing on collagen metabolism in human dermal fibroblasts	w.cellbiolint.org	0	0		
869	chr19	37342126	37342168	3500202396	40		37342126	37342168	8421504	2	19,21	0,21	c,g	350020239600000025,350020239600000029	0-19,0-21						Supporting Information	www.pnas.org	0	0		COL1A1
869	chr19	37342140	37342555	3500125737	48		37342140	37342555	8421504	2	24,24	0,391	c	350012573700000004,350012573700000005	0-24,0-24						Curso de P&#xf3;s-Gradua&#xe7;&#xe3;o em Engenharia Metal&#xfa;rgica e de Minas	cadigital.ufmg.br	0	0		COL1A1
869	chr19	37342174	37342606	3500352661	40		37342174	37342606	8421504	2	20,20	0,412	c	350035266100000008,350035266100000009	0-20,0-20						Archive of SID	www.sid.ir/en/VEW	0	0		COL1A1
869	chr19	37342184	37342813	3500032348	43		37342184	37342813	8421504	2	21,22	0,607	c	350003234800000012,350003234800000013	0-21,0-22			10.1186/1471-2164-8-63		BMC Genomics	Target genes of myostatin loss-of-function in muscles of late bovine fetuses	Isabelle	2007	0		
869	chr19	37342210	37342507	3500383497	42		37342210	37342507	8421504	2	21,21	0,276	c,g	350038349700000006,350038349700000008,350038349700000008,350038349700000007	0-21,0-21,0-21,0-21		21311029	10.1152/ajpgi.00316.2010		American Journal of Physiology - Gastrointestinal and Liver Physiology	SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-&#x03b2;1 and PDGF	Atorrasagasti	2011	0		
869	chr19	37342210	37342507	3500327194	42		37342210	37342507	8421504	2	21,21	0,276	c,g	350032719400000008,350032719400000008,350032719400000006,350032719400000007,350032719400000007	0-21,0-21,0-21,0-21,0-21		21311029	10.1152/ajpgi.00316.2010		American Journal of Physiology - Gastrointestinal and Liver Physiology	SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-&#x03b2;1 and PDGF	Catalina	2011	0		
869	chr19	37342210	37342507	3500020023	42		37342210	37342507	8421504	2	21,21	0,276	c,g	350002002300000002,350002002300000003,350002002300000003	0-21,0-21,0-21		23408952	10.1371/journal.pone.0054962	1932-6203	PLOS ONE	PLOS ONE: Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice	Atorrasagasti	2013	4		COL1A1
869	chr19	37342210	37342507	3500015037	42		37342210	37342507	8421504	2	21,21	0,276	c,g	350001503700000002,350001503700000002,350001503700000003,350001503700000003	0-21,0-21,0-21,0-21						Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice. - ResearchGate	.researchgate.net	0	0		COL1A1
869	chr19	37342258	37342596	3500027212	52		37342258	37342596	8421504	2	25,27	0,311	c,g	350002721200000000,350002721200000000,350002721200000001	0-25,0-25,0-27						Open Access Full Text Article isolation, characterization, and gene expression analysis of Wharton&#x2019;s jelly-derived mesenchymal stem cells under xeno-free culture conditions	w.stempeutics.com	0	0		COL1A1
869	chr19	37342287	37342507	3500101701	43		37342287	37342507	8421504	2	20,23	0,197	c,g	350010170100000010,350010170100000010,350010170100000011	0-20,0-20,0-23						Combination treatment with asiaticoside and rapamycin: A new hope for in&#x2011;stent restenosis	-publications.com	0	0		COL1A1
869	chr19	37342293	37342317	3500289555	24		37342293	37342317	8421504	1	24	0	c	350028955500000007	0-24		23451286	10.1371/journal.pone.0058000	1932-6203	PLOS ONE	PLOS ONE: Inhibition of TGF-&#x03b2; Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine	Okumura	2013	4		
869	chr19	37342293	37342317	3500027296	24		37342293	37342317	8421504	1	24	0	c	350002729600000015	0-24		21349841	10.1074/jbc.M110.166751		The Journal of Biological Chemistry	Keratinocyte-derived Laminin-332 Promotes Adhesion and Migration in Melanocytes and Melanoma	Heesung	2011	0		
869	chr19	37342295	37342460	3500268955	41		37342295	37342460	8421504	3	19,12,10	0,28,155	c,g	350026895500000002,350026895500000002,350026895500000003	0-19,0-19,26-48						Tendon Cell Behavior and Matrix Remodeling in Degenerative Tendinopathy	repub.eur.nl	0	0		
869	chr19	37342295	37342458	3500053461	40		37342295	37342458	8421504	3	19,13,8	0,27,155	c,g	350005346100000000,350005346100000000,350005346100000002	0-19,0-19,5-26		14645373	10.1074/jbc.M312549200	0021-9258	Journal of Biological Chemistry	Collagen Metabolism Is a Novel Target of the Neuropeptide &#x03b1;-Melanocyte-stimulating Hormone	Bohm	2004	5		COL1A1
869	chr19	37342297	37342506	3500184228	45		37342297	37342506	8421504	2	21,24	0,185	c,g	350018422800000280,350018422800000281,350018422800000281	0-21,0-24,0-24						IDENTIFICATION OF A MUTATION IN COL4A5 CAUSATIVE FOR X- LINKED ALPORT SYNDROME IN THE DOMESTIC DOG AND ANALYSIS OF GENE EXPRESSION IN THE KIDNEYS OF AFFECTED AND NONAFFECTED SIBLINGS	pository.tamu.edu	0	0		
869	chr19	37342329	37342594	3500102621	147		37342329	37342594	8421504	3	6,72,69	0,121,196	p	350010262100015000,350010262100015009,350010262100015010	0-147,0-78,0-78						ORIGINAL ARTICLE A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the pro&#x03b1;1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases	jmg.bmj.com	0	0		COL1A1
869	chr19	37342329	37342525	3500133642	81		37342329	37342525	8421504	2	6,75	0,121	p	350013364200015019,350013364200015018	0-57,0-60						Nanoparticle compositions, formulations thereof, and uses therefor	Edelson	2012	0		COL1A1
869	chr19	37342331	37342469	3500148308	23		37342331	37342469	8421504	2	4,19	0,119	c	350014830800000006	0-23						Effects of TRAP-1-Like Protein (TLP) Gene on Collagen Synthesis Induced by TGF-&#x03b2;/Smad Signaling in Human Dermal Fibroblasts. - ResearchGate	.researchgate.net	0	0		COL1A1
869	chr19	37342467	37342491	3500079553	24		37342467	37342491	8421504	1	24	0	c	350007955300000018	0-24						Role of von Hippel-Lindau protein in &#xfb01;broblast proliferation and &#xfb01;brosis	www.fasebj.org	0	0		COL1A1
869	chr19	37342476	37342500	3500325900	24		37342476	37342500	8421504	1	24	0	c	350032590000000001	24-48						Differential Expression of Collagen Type V and XI &#x03b1;-1 in Human Ascending Thoracic Aortic Aneurysms	tsnetjournals.org	0	0		
869	chr19	37342477	37342502	3500154172	25		37342477	37342502	8421504	1	25	0	c	350015417200000002	17-42						High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice. - ResearchGate	.researchgate.net	0	0		
869	chr19	37342477	37342501	3500388385	24		37342477	37342501	8421504	1	24	0	c	350038838500000002	0-24		19075000	10.1128/MCB.00349-08	0270-7306	Molecular and Cellular Biology	N-Cadherin Interacts with Axin and LRP5 To Negatively Regulate Wnt/&#x03b2;-Catenin Signaling, Osteoblast Function, and Bone Formation	Hay	2009	6		
869	chr19	37342477	37342501	3500246347	24		37342477	37342501	8421504	1	24	0	c	350024634700000004	0-24			10.2353/ajpath.2007.061069		The American Journal of Pathology	Overexpression of the Transcriptional Factor Runx2 in Osteoblasts Abolishes the Anabolic Effect of Parathyroid Hormone in Vivo	Didier	2007	0		
869	chr19	37342477	37342501	3500220212	24		37342477	37342501	8421504	1	24	0	c	350022021200000005	0-24						High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice	ddr.nal.usda.gov	0	0		
869	chr19	37342477	37342501	3500025897	24		37342477	37342501	8421504	1	24	0	c	350002589700000002	0-24		19075000	10.1128/MCB.00349-08	0270-7306	Molecular and Cellular Biology	N-Cadherin Interacts with Axin and LRP5 To Negatively Regulate Wnt/&#x03b2;-Catenin Signaling, Osteoblast Function, and Bone Formation	Hay	2009	6		
869	chr19	37342477	37342501	3500015685	24		37342477	37342501	8421504	1	24	0	c	350001568500000004	0-24						Overexpression of the Transcriptional Factor Runx in Osteoblasts Abolishes the Anabolic Effect of Parathyroid Hormone in Vivo 2007&#x5e74;&#x7b2c;169&#x5377;&#x7b2c;5&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
869	chr19	37342557	37342595	3500267902	38		37342557	37342595	8421504	1	38	0	c	350026790200000026	0-38		21746880	10.1128/MCB.05263-11	0270-7306	Molecular and Cellular Biology	A Novel Role of Vimentin Filaments: Binding and Stabilization of Collagen mRNAs	Challa	2011	6		COL1A1
869	chr19	37342740	37342769	3500188488	29		37342740	37342769	8421504	1	29	0	c	350018848800000004	0-29						Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-?1 in normal human lung fibroblasts (NHLF)	biomedcentral.com	0	0		
869	chr19	37342740	37342769	3500170003	29		37342740	37342769	8421504	1	29	0	c	350017000300000004	0-29						Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-?1 in normal human lung fibroblasts (NHLF)	tory-research.com	0	0		
869	chr19	37342769	37342792	3500446424	23		37342769	37342792	8421504	1	23	0	c	350044642400000000	21-44		20034962	10.1152/ajplung.00289.2009		American Journal of Physiology - Lung Cellular and Molecular Physiology	Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis	Tanaka	2010	0		
869	chr19	37342769	37342792	3500346614	23		37342769	37342792	8421504	1	23	0	c	350034661400000017,350034661400000024	21-44,20-43		20489727	10.1038/cdd.2010.64	1350-9047	Cell Death & Differentiation	Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis	Namba	2010	9		COL1A1
869	chr19	37342769	37342792	3500246527	23		37342769	37342792	8421504	1	23	0	c	350024652700000000	21-44		20034962	10.1152/ajplung.00289.2009		American Journal of Physiology - Lung Cellular and Molecular Physiology	Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis	Tanaka	2010	0		
869	chr19	37342769	37342792	3500246224	23		37342769	37342792	8421504	1	23	0	c	350024622400000000	21-44		20034962	10.1152/ajplung.00289.2009		American Journal of Physiology - Lung Cellular and Molecular Physiology	Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis	Tanaka	2010	0		
869	chr19	37342769	37342792	3500139326	23		37342769	37342792	8421504	1	23	0	c	350013932600000017,350013932600000024	21-44,20-43		20489727	10.1038/cdd.2010.64	1350-9047	Cell Death & Differentiation	Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis	Namba	2010	9		
869	chr19	37342769	37342792	3500098752	23		37342769	37342792	8421504	1	23	0	c	350009875200000000	21-44		20034962	10.1152/ajplung.00289.2009		American Journal of Physiology - Lung Cellular and Molecular Physiology	Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis	Tanaka	2010	0		
869	chr19	37342769	37342792	3500076369	23		37342769	37342792	8421504	1	23	0	c	350007636900000000	21-44						ScienceDirect.com - Biochemical Pharmacology - Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice	sciencedirect.com	0	0		COL1A1
869	chr19	37342785	37342808	3500465692	23		37342785	37342808	8421504	1	23	0	c	350046569200000000	0-23						Heat Shock Protein 90 Inhibitor Induces Apoptosis and Attenuates Activation of Hepatic Stellate Cells	aspetjournals.org	0	0		COL1A1
869	chr19	37342785	37342808	3500074580	23		37342785	37342808	8421504	1	23	0	c	350007458000000000	0-23		19329756	10.1124/jpet.109.151860	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Heat Shock Protein 90 Inhibitor Induces Apoptosis and Attenuates Activation of Hepatic Stellate Cells	Myung	2009	0		COL1A1
870	chr19	37357605	37358183	3500421044	147		37357605	37358183	8421504	2	88,59	0,519	p	350042104400015017	3-150						Positionsklonierung des Locus f&#xfc;r das Myoklonus-Dystonia-Syndrom (MDS) und Untersuchung des Epsilon-Sarkoglykan-Gens (SGCE) auf genomische Pr&#xe4;gung	b.uni-muenchen.de	0	0		
870	chr19	37413197	37413917	3500339239	48		37413197	37413917	8421504	2	39,9	0,711	p	350033923900015045	0-48						Plant pyruvate dehydrogenase kinase gene	Zou	2002	0		PDK2
870	chr19	37417808	37427620	3500457931	40		37417808	37427620	8421504	2	20,20	0,9792	c,g	350045793100000008,350045793100000007,350045793100000007	0-20,0-20,0-20						Hypoxia Induces PDK4 Gene Expression through Induction of the Orphan Nuclear Receptor ERR	plaza.snu.ac.kr	0	0		PDK2
871	chr19	37548357	37548385	3500187294	23		37548357	37548385	8421504	2	11,12	0,16	c	350018729400000065	9-32						Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease	Keith	2002	0		
871	chr19	37548632	37548656	3500133770	24		37548632	37548656	8421504	1	24	0	c	350013377000000001	9-33					FEBS letters	Phosphorylation of murine homeodomain protein Dlx3 by protein kinase C	Geon	2001	0		DLX3
872	chr19	37648060	37648086	3500129055	23		37648060	37648086	8421504	2	12,11	0,15	g	350012905500000078	11-35						Variants of glycoside hydrolases - Patent application	www.faqs.org	0	0		
874	chr19	37892323	37892350	3500176792	25		37892323	37892350	8421504	2	6,19	0,8	c	350017679200000415,350017679200000384	0-25,9-34						POLYPEPTIDE HAVING AFFINITY FOR ENVELOPE VIRUS CONSTITUENT AND USE THEREOF IN TRANSFERRING SUBSTANCE INTO CELL - Patent application	www.faqs.org	0	0		
874	chr19	37892323	37892350	3500075280	25		37892323	37892350	8421504	2	6,19	0,8	c	350007528000000415,350007528000000384	0-25,9-34						Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell - Patent application	www.faqs.org	0	0		
874	chr19	37988401	37988449	3500365533	48		37988401	37988449	8421504	1	48	0	p	350036553300015083	0-48						Serine carboxypeptidase hx (SCPhx) and compositions thereof	Bejanin	2001	0		NGFR
874	chr19	37988401	37988449	3500185026	48		37988401	37988449	8421504	1	48	0	p	350018502600015084	0-48						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		NGFR
874	chr19	37989327	37989364	3500040661	37		37989327	37989364	8421504	1	37	0	c	350004066100000014,350004066100000012,350004066100000013	0-26,0-30,0-30		19012753	10.1111/j.1471-4159.2008.05763.x	1471-4159	Journal of Neurochemistry	Association between Presenilin-1 and TRAF6 modulates regulated intramembrane proteolysis of the p75NTR neurotrophin receptor - Powell - 2008 - Journal of Neurochemistry - Wiley Online Library	Powell	2009	0		
874	chr19	37989343	37990607	3500222278	29		37989343	37990607	8421504	2	21,8	0,1256	c	350022227800000008	5-34						SCIENCE CHINA Life Sciences	scichina.com:8082	0	0		
874	chr19	37989349	37998271	3500287420	40		37989349	37998271	8421504	3	15,5,20	0,1250,8902	c	350028742000000005,350028742000000004	0-20,0-20						European Journal of Pharmacology	005.pasteur.ac.ir	0	0		NGFR
874	chr19	37989349	37998271	3500216988	40		37989349	37998271	8421504	3	15,5,20	0,1250,8902	c	350021698800000001,350021698800000000	0-20,0-20						Characterization of a p75NTR Apoptotic Signaling Pathway Using a Novel Cellular Model*	www.jbc.org	0	0		NGFR
874	chr19	37990614	37990711	3500141243	40		37990614	37990711	8421504	2	20,20	0,77	c,g	350014124300000003,350014124300000003,350014124300000002	0-20,0-20,0-20		23365678	10.1371/journal.pone.0054692		PLoS ONE	Diabetes and Overexpression of proNGF Cause Retinal Neurodegeneration via Activation of RhoA Pathway	Mohammed	2013	0		
874	chr19	37990636	37990659	3500248236	23		37990636	37990659	8421504	1	23	0	c	350024823600000007	0-23						Methods for the treatment and diagnosis of prostate cancer based on p75NTR tumor supression	Djakiew	2002	0		
874	chr19	37990640	37990663	3500404268	23		37990640	37990663	8421504	1	23	0	c	350040426800000011	20-43						UNIVERSIDAD DE CHILE Facultad de Ciencias Qu&#xed;micas y Farmac&#xe9;uticas	w.tesis.uchile.cl	0	0		
874	chr19	37998360	38005603	3500330584	45		37998360	38005603	8421504	2	18,27	0,7216	p	350033058400015079,350033058400015131	0-45,0-45						DEVIATION DE LA REPONSE IMMUNE A VISEE D&#x2019;IMMUNO- INTERVENTION A L&#x2019;AIDE DE PROTEINES RECOMBINANTES HETEROFONCTIONNELLES	ses.univ-reims.fr	0	0		
875	chr19	38091541	38091566	3500055970	25		38091541	38091566	8421504	1	25	0	c	350005597000000002	9-34		16920706	10.1074/jbc.M604729200	0021-9258	Journal of Biological Chemistry	Porphyrin Accumulation in Mitochondria Is Mediated by 2-Oxoglutarate Carrier	Kabe	2006	5		
875	chr19	38091542	38091567	3500209279	25		38091542	38091567	8421504	1	25	0	c,g	350020927900000002,350020927900000002	0-25,0-25						Coxsackievirus B3-induzierte Ver&#xe4;nderungen des Proteoms der Wirtszelle: Untersuchungen am Zellkulturmodell mit Hilfe der Zweidimensionalen Gelelektrophorese	sachsen-patent.de	0	0		TMEM202,ZNF781
875	chr19	38091575	38100712	3500178142	243		38091575	38100712	8421504	6	55,17,39,21,60,51	0,1514,5323,7493,8978,9086	p	350017814200015140,350017814200015145,350017814200015153,350017814200015158	0-72,0-60,0-60,0-51						TaiLieu.VN: b&#xe1;o c&#xe1;o khoa h&#x1ecd;c: "Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells" 	tailieu.vn/doc/ba	0	0		
875	chr19	38091596	38096865	3500224790	144		38091596	38096865	8421504	5	34,14,48,3,45	0,1493,1603,5086,5224	c,g	350022479000000012,350022479000000015,350022479000000003,350022479000000003,350022479000000019	0-48,0-48,0-20,0-20,0-48						Anti-human prohibitin antibodies	www.devileye.net	0	0		
875	chr19	38091615	38093098	3500081092	24		38091615	38093098	8421504	2	15,9	0,1474	c	350008109200000001	0-24		14968116	10.1038/sj.onc.1207444	0950-9232	Oncogene	Androgens target prohibitin to regulate proliferation of prostate cancer cells	Gamble	2004	6		
875	chr19	38093201	38093226	3500041320	25		38093201	38093226	8421504	1	25	0	c	350004132000000006	9-34						METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS - H&#xd4;PITAL STE-JUSTINE	www.sumobrain.com	0	0		PHB
875	chr19	38093232	38099074	3500395028	90		38093232	38099074	8421504	4	19,26,39,6	0,3310,3666,5836	p	350039502800015008,350039502800015013	0-45,0-45						PROHIBITIN AS TARGET FOR CANCER THERAPY - Patent application	www.faqs.org	0	0		
875	chr19	38096553	38096577	3500306755	24		38096553	38096577	8421504	1	24	0	c	350030675500000001	0-24		22949832	10.3390/ijms13089808		International Journal of Molecular Sciences	Less Expression of Prohibitin Is Associated with Increased Paired Box 2 (PAX2) in Renal Interstitial Fibrosis Rats	Tian-Biao	2012	0		PHB
875	chr19	38096553	38096577	3500265419	24		38096553	38096577	8421504	1	24	0	c	350026541900000001	0-24						Less Expression of Prohibitin Is Associated with Increased Paired Box 2 (PAX2) in Renal Interstitial Fibrosis Rats	www.mdpi.com	0	0		PHB
875	chr19	38096553	38096577	3500254073	24		38096553	38096577	8421504	1	24	0	c	350025407300000001	0-24						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		PHB
875	chr19	38096571	38100712	3500253203	279		38096571	38100712	8421504	4	105,30,90,54	0,255,3949,4087	p	350025320300015015	0-279						MorphofunctionalandBiochemicalApproachesforStudying MitochondrialChangesduringMyoblastsDifferentiation	loads.hindawi.com	0	0		PHB
875	chr19	38096898	38099089	3500234748	60		38096898	38099089	8421504	2	39,21	0,2170	p	350023474800015015	0-60						Differentially expressed proteins in prostate cancer and functional characterization of proteins with altered expression	d-nb.info/9907690	0	0		
875	chr19	38096922	38100712	3500153772	321		38096922	38100712	8421504	3	15,96,210	0,2146,3580	p	350015377200015144,350015377200015148	0-180,0-141						AN&#xc1;LISIS DE LAS INTERACCIONES MOLECULARES DE BACILLUS THURINGIENSIS EN LA MEMBRANA DEL EPITELIO INTESTINAL DE LEPTINOTARSA DECEMLINEATA PATATA). CAMILA OCHOA CAMPUZANO	www.tdx.cat	0	0		PHB
876	chr19	38241820	38241849	3500437895	25		38241820	38241849	8421504	3	12,6,7	0,15,22	g	350043789500000043	10-35						CROSS-SPECIES-SPECIFIC SINGLE DOMAIN BISPECIFIC SINGLE CHAIN ANTIBODY - Patent application	www.faqs.org	0	0		
876	chr19	38241820	38241847	3500411874	23		38241820	38241847	8421504	3	12,6,5	0,15,22	g	350041187400000013	6-29						NOGO-A binding molecules with enhanced affinity and pharmaceutical use thereof	Barske	2010	0		
876	chr19	38241820	38241847	3500410603	23		38241820	38241847	8421504	3	12,6,5	0,15,22	g	350041060300000087	0-23						B7-related nucleic acids and polypeptides useful for immunomodulation	Mikesell	2013	0		
876	chr19	38241820	38241847	3500252479	23		38241820	38241847	8421504	3	12,6,5	0,15,22	g	350025247900000002	0-23						Antibodies against Nogo receptor	Bell	2005	0		
876	chr19	38241820	38241847	3500252049	23		38241820	38241847	8421504	3	12,6,5	0,15,22	g	350025204900000064,350025204900000219	0-23,0-23						METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS - Patent application	www.faqs.org	0	0		
876	chr19	38241820	38241847	3500219239	23		38241820	38241847	8421504	3	12,6,5	0,15,22	g	350021923900000029	0-23					Patent	Vascular endothelial growth factor 2 (Patent US:7208582)	Rosen	2007	0		
876	chr19	38241820	38241847	3500219081	23		38241820	38241847	8421504	3	12,6,5	0,15,22	g	350021908100000038	0-23						Albumin fusion proteins - Patent # 6926898 - PatentGenius	.patentgenius.com	0	0		
876	chr19	38241820	38241847	3500121471	23		38241820	38241847	8421504	3	12,6,5	0,15,22	g	350012147100000017	0-23						Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1	Feder	2006	0		
877	chr19	38350509	38350535	3500101289	23		38350509	38350535	8421504	2	17,6	0,20	g	350010128900000076,350010128900000263	14-37,17-40						NOVEL SURFACE ANTIGEN - Patent application	www.faqs.org	0	0		
877	chr19	38403783	38403828	3500121470	45		38403783	38403828	8421504	1	45	0	p	350012147000015002	0-45		9620847	10.1101/gad.12.11.1593	0890-9369	Genes & Development	RNA-binding protein conserved in both microtubule- and microfilament-based RNA&#x2009;localization	Havin	1998	12		IGF2BP1
878	chr19	38406802	38406862	3500404324	60		38406802	38406862	8421504	1	60	0	p	350040432400015046	0-60						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER - Patent application	www.faqs.org	0	0		IGF2BP1
878	chr19	38406802	38406862	3500247743	60		38406802	38406862	8421504	1	60	0	p	350024774300015021	0-60						Compositions and methods for the therapy and diagnosis of lung cancer	Foy	2003	0		IGF2BP1
878	chr19	38406802	38406862	3500196583	60		38406802	38406862	8421504	1	60	0	p	350019658300015060	0-60						Compositions and methods for the therapy and diagnosis of lung cancer	Wang	2006	0		IGF2BP1
878	chr19	38406802	38406862	3500087105	60		38406802	38406862	8421504	1	60	0	p	350008710500015058	0-60						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER - Patent application	www.faqs.org	0	0		IGF2BP1
878	chr19	38406802	38406862	3500024144	60		38406802	38406862	8421504	1	60	0	p	350002414400015049	0-60						 Methods For The Detection Of Cervical Cancer 	www.docstoc.com	0	0		IGF2BP1
878	chr19	38466707	38467386	3500082184	126		38466707	38467386	8421504	2	104,22	0,657	p	350008218400015010	0-129					Patent	Vector for expression and secretion of polypeptide microorganism transformed by the vector and production of polypeptide with the same microorganism (Patent US:5545564)	Kajifusa	1996	0		GIP
878	chr19	38466707	38466803	3500341951	90		38466707	38466803	8421504	2	45,45	0,51	p	350034195100015009,350034195100015008,350034195100015196	24-69,0-45,0-45						Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof - Patent application	www.faqs.org	0	0		GIP
878	chr19	38466707	38466752	3500411224	45		38466707	38466752	8421504	1	45	0	p	350041122400015000	0-45					PLoS ONE	Vaccination against GIP for the Treatment of Obesity - Scolaris	Fulurija	2008	0		GIP
878	chr19	38466707	38466752	3500384104	45		38466707	38466752	8421504	1	45	0	p	350038410400015013,350038410400015015	0-45,24-69						Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof	A*Fu Lu Li Ya 	2008	0		GIP
878	chr19	38466707	38466752	3500272607	45		38466707	38466752	8421504	1	45	0	p	350027260700015013,350027260700015012	24-69,0-45						Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof	Bachmann	2007	0		GIP
878	chr19	38466707	38466752	3500266996	45		38466707	38466752	8421504	1	45	0	p	350026699600015013,350026699600015012	24-69,0-45						Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof	Bachmann	2007	0		GIP
878	chr19	38466707	38466752	3500253231	45		38466707	38466752	8421504	1	45	0	p	350025323100015013,350025323100015012	24-69,0-45						Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof	Bachmann	2006	0		GIP
878	chr19	38466707	38466752	3500235925	45		38466707	38466752	8421504	1	45	0	p	350023592500015008,350023592500015009	0-45,24-69					Patent	Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof (Patent US:7572451)	Bachmann	2009	0		GIP
878	chr19	38466707	38466752	3500215840	45		38466707	38466752	8421504	1	45	0	p	350021584000015008,350021584000015009	0-45,24-69					Patent	Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof (Patent US:7959924)	Bachmann	2011	0		GIP
878	chr19	38466707	38466752	3500214163	45		38466707	38466752	8421504	1	45	0	p	350021416300015009,350021416300015008	24-69,0-45						Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof	Bachmann	2010	0		GIP
878	chr19	38466707	38466752	3500080100	45		38466707	38466752	8421504	1	45	0	p	350008010000015014,350008010000015015	0-45,24-69						&#x80a0;&#x6291;&#x80c3;&#x80bd;(gip)&#x6297;&#x539f;&#x9635;&#x5217;&#x53ca;&#x5176;&#x7528;&#x9014;	A*Fu Lu Li Ya 	2008	0		GIP
878	chr19	38466707	38466752	3500005688	45		38466707	38466752	8421504	1	45	0	p	350000568800015016,350000568800015017	0-45,24-69						Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof	Bachmann	2005	0		GIP
878	chr19	38466710	38466794	3500242885	84		38466710	38466794	8421504	1	84	0	p	350024288500015025	0-84						GLP-1 exendin-4 peptide analogs and uses thereof	Greig	2002	0		GIP
878	chr19	38466710	38466794	3500214899	84		38466710	38466794	8421504	1	84	0	p	350021489900015012	0-84						Glp-1, exendin-4, peptide analogs and uses thereof	Greig	2012	0		GIP
878	chr19	38466710	38466794	3500050010	84		38466710	38466794	8421504	1	84	0	p	350005001000015012	0-84					Patent	GLP-1 exendin-4 peptide analogs and uses thereof (Patent US:7576050)	Greig	2009	0		GIP
878	chr19	38466710	38466788	3500435123	78		38466710	38466788	8421504	1	78	0	p	350043512300015036	0-78						Glp-1, Exendin-4, Peptide Analogs And Uses Thereof 	.freshpatents.com	0	0		GIP
878	chr19	38515409	38515810	3500261436	41		38515409	38515810	8421504	3	21,11,9	0,81,392	c,g	350026143600000024,350026143600000024,350026143600000023	0-21,0-21,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
878	chr19	38515449	38515926	3500320902	177		38515449	38515926	8421504	2	52,125	0,352	p	350032090200015116	0-177						Method for manufacturing a modified peptide	Bauer	2009	0		
880	chr19	38683041	38683067	3500412553	26		38683041	38683067	8421504	1	26	0	g	350041255300000023	0-26			10.1111/j.1752-4571.2010.00142.x	1752-4571	Evolutionary Applications	Broad and fine-scale genetic analysis of white-tailed deer populations: estimating the relative risk of chronic wasting disease spread - Cullingham - 2010 - Evolutionary Applications - Wiley Online Library	Cullingham	2011	5		
880	chr19	38683041	38683067	3500060702	26		38683041	38683067	8421504	1	26	0	g	350006070200000031	0-26		22423334	10.1002/ece3.97	2045-7758	Ecology and Evolution	Evaluation of experimental genetic management in reintroduced bighorn sheep - Olson - 2012 - Ecology and Evolution - Wiley Online Library	Olson	2012	0		
880	chr19	38778424	38778449	3500196807	25		38778424	38778449	8421504	1	25	0	c	350019680700000009	0-25						HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. - ResearchGate	.researchgate.net	0	0		
880	chr19	38780581	38780761	3500310687	180		38780581	38780761	8421504	1	180	0	p	350031068700015012	0-180						Induction of the organizer: expression and regulation of Xnot, a novel FGF and activin-regulated homeo box gene	enesdev.cshlp.org	0	0		
880	chr19	38780581	38780761	3500084212	180		38780581	38780761	8421504	1	180	0	p	350008421200015004	0-180						Homeobox-containing genes in the nemertean Key players in the antero-posterior body patterning and in the specification of the visual structures	eau.univ-reims.fr	0	0		
880	chr19	38780584	38780755	3500190689	171		38780584	38780755	8421504	1	171	0	p	350019068900015143	0-171						Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins, Second Edition	www.zvlab.ru	0	0		
880	chr19	38780617	38780710	3500307864	93		38780617	38780710	8421504	1	93	0	p	350030786400015001	0-93						NEUROTROPIC GROWTH FACTORS COMPRISING A HOMEOBOX PEPTIDE - CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) JOLIOT	www.sumobrain.com	0	0		HOXC6
13	chr19	38780623	38809823	3500457089	65		38780623	38809823	8421504	2	21,44	0,29156	c	350045708900000053,350045708900000008,350045708900000075	21-42,5-49,5-49						 Treatment Of Macular Degeneration With ADP 	www.docstoc.com	0	0		
880	chr19	38780656	38780701	3500157348	45		38780656	38780701	8421504	1	45	0	p	350015734800015020	0-45						Methods For Reducing Gnrh-positive Tumor Cell Proliferation 	.freshpatents.com	0	0		HOXB5
13	chr19	38780665	38809823	3500354878	92		38780665	38809823	8421504	2	48,44	0,29114	p,c	350035487800015005,350035487800000008	0-48,5-49						Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions	Lasko	2004	0		
13	chr19	38780707	38809827	3500368217	96		38780707	38809827	8421504	2	48,48	0,29072	p	350036821700015000,350036821700015001	3-51,3-51		18978205	10.1182/blood-2008-07-166595	0006-4971	Blood	TLR2-dependent eosinophil interactions with mycobacteria: role of &#x03b1;-defensins	Driss	2009	10		
13	chr19	38780707	38809827	3500255463	96		38780707	38809827	8421504	2	48,48	0,29072	p	350025546300015005,350025546300015002	0-48,0-48		10454568		0270-7306	Molecular and Cellular Biology	Grb10, a Positive, Stimulatory Signaling Adapter in Platelet-Derived Growth Factor BB-, Insulin-Like Growth Factor I-, and Insulin-Mediated Mitogenesis	Wang	1999	6		
880	chr19	38780707	38780761	3500369525	54		38780707	38780761	8421504	1	54	0	p	350036952500015004,350036952500015006	99-147,9-54						Mcl-1 Quadruplex Nucleic Acids And Uses Thereof 	.freshpatents.com	0	0		
880	chr19	38780707	38780755	3500459634	48		38780707	38780755	8421504	1	48	0	p	350045963400015001	0-48					Patent	Aptamer therapeutics useful in the treatment of complement-related disorders (Patent US:7579456)	Benedict	2009	0		MIR615
880	chr19	38780707	38780755	3500452946	48		38780707	38780755	8421504	1	48	0	p	350045294600015027	0-48						Trophinin-binding peptides and uses thereof	Fukuda	2008	0		MIR615
880	chr19	38780707	38780755	3500445336	48		38780707	38780755	8421504	1	48	0	p	350044533600015026	0-48						BREAST CANCER-ASSOCIATED GENE, MELK, AND ITS INTERACTIONS WITH BCL-G - ONCOTHERAPY SCIENCE, INC.	www.sumobrain.com	0	0		MIR615
880	chr19	38780707	38780755	3500441271	48		38780707	38780755	8421504	1	48	0	p	350044127100015010	0-48						TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500433573	48		38780707	38780755	8421504	1	48	0	p	350043357300015001	0-48						Methods of Inducing Tissue Regeneration	Blau	2010	0		MIR615
880	chr19	38780707	38780755	3500411153	48		38780707	38780755	8421504	1	48	0	p	350041115300015082	0-48					Patent	Compositions and methods of use of targeting peptides against placenta and adipose tissues (Patent US:8252764)	Pasqualini	2012	0		MIR615
880	chr19	38780707	38780755	3500408014	48		38780707	38780755	8421504	1	48	0	p	350040801400015104,350040801400015084,350040801400015126	0-48,0-48,0-48						Composition And Methods For Promoting Wound Healing And Tissue Regeneration 	.freshpatents.com	0	0		MIR615
880	chr19	38780707	38780755	3500396507	48		38780707	38780755	8421504	1	48	0	p	350039650700015004	0-48						COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS	WU	2009	0		MIR615
880	chr19	38780707	38780755	3500392700	48		38780707	38780755	8421504	1	48	0	p	350039270000015005	0-48						Trans-membrane-antibody induced inhibition of apoptosis	Brown	2004	0		MIR615
880	chr19	38780707	38780755	3500381827	48		38780707	38780755	8421504	1	48	0	p	350038182700015000	0-48						Tbc1d7 as tumor marker and therapeutic target for cancer	Nakamura	2011	0		MIR615
880	chr19	38780707	38780755	3500361876	48		38780707	38780755	8421504	1	48	0	p	350036187600015105	0-48						Transducible Polypeptides For Modifying Metabolism 	.freshpatents.com	0	0		MIR615
880	chr19	38780707	38780755	3500350992	48		38780707	38780755	8421504	1	48	0	p	350035099200015000	0-48						&#x7279;&#x958b;2010-501161&#x53f7; &#xff32;&#xff25;&#xff27;&#xff14;&#x307e;&#x305f;&#x306f;&#xff2b;&#xff29;&#xff21;&#xff21;&#xff10;&#xff11;&#xff10;&#xff11;&#x3092;&#x904e;&#x5270;&#x767a;&#x73fe;&#x3057;&#x3066;&#x3044;&#x308b;&#x764c;&#x306e;&#x6cbb;&#x	astamuse.com	0	0		MIR615
880	chr19	38780707	38780755	3500350744	48		38780707	38780755	8421504	1	48	0	p	350035074400015004	0-48						INHIBITION OF INFLAMMATION USING ANTAGONISTS OF MUC1	Kufe	2010	0		MIR615
880	chr19	38780707	38780755	3500336324	48		38780707	38780755	8421504	1	48	0	p	350033632400015000	0-48						Conjugate of a transport protein and a protein for modulation of notch signalling	Champion	2002	0		MIR615
880	chr19	38780707	38780755	3500335879	48		38780707	38780755	8421504	1	48	0	p	350033587900015006	0-48						METHOD FOR INTRODUCING A PNA MOLECULE CONJUGATED TO A POSITIVELY CHARGED PEPTIDE INTO THE CYTOSOL AND/OR THE NUCLEUS BY PHOTOCHEMICAL INTERNALISATION (PCI) - THE NORWEGIAN RADIUM HOSPITAL RESEARCH FOUNDATION	www.sumobrain.com	0	0		MIR615
880	chr19	38780707	38780755	3500324849	48		38780707	38780755	8421504	1	48	0	p	350032484900015011	0-48						Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells	Chen	2005	0		MIR615
880	chr19	38780707	38780755	3500324644	48		38780707	38780755	8421504	1	48	0	p	350032464400015000	3-51		19282837	10.1038/jid.2009.49	0022-202X	Journal of Investigative Dermatology	Bcl-3 Acts as an Innate Immune Modulator by Controlling Antimicrobial Responses in Keratinocytes	Buchau	2009	6		MIR615
880	chr19	38780707	38780755	3500316598	48		38780707	38780755	8421504	1	48	0	p	350031659800015003,350031659800015005	39-87,0-48						&#x7528;&#x4e8e;&#x9012;&#x9001;&#x6cbb;&#x7597;&#x5242;&#x7684;&#x65b0;&#x578b;&#x8102;&#x8d28;&#x548c;&#x7ec4;&#x5408;&#x7269; For the delivery of therapeutic agents and compositions of novel lipid	Kai Lan Tuo Ta Ti Er *G*La Ji Fu 	2011	0		MIR615
880	chr19	38780707	38780755	3500314426	48		38780707	38780755	8421504	1	48	0	p	350031442600015000	0-48						TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500293679	48		38780707	38780755	8421504	1	48	0	p	350029367900015009	0-48						LIPID FORMULATION - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500280211	48		38780707	38780755	8421504	1	48	0	p	350028021100015024	0-48						Compositions and methods for modulating nod-like receptor activity and uses thereof	Faustin	2011	0		MIR615
880	chr19	38780707	38780755	3500278948	48		38780707	38780755	8421504	1	48	0	p	350027894800015025	0-48					Patent	Mitochondria-targeted anti-tumor agents (Patent CN:101854955)	Jiang Bing Xian 	2012	0		MIR615
880	chr19	38780707	38780755	3500266522	48		38780707	38780755	8421504	1	48	0	p	350026652200015043	0-48						Peptide antiestrogen compositions and methods for treating breast cancer	Pietras	2000	0		MIR615
880	chr19	38780707	38780755	3500266404	48		38780707	38780755	8421504	1	48	0	p	350026640400015082,350026640400015081,350026640400015084,350026640400015011,350026640400015003,350026640400015012	18-63,15-60,27-72,0-48,0-45,0-48						Peptide oligonucleotide conjugates	Hanson	2012	0		MIR615
880	chr19	38780707	38780755	3500266262	48		38780707	38780755	8421504	1	48	0	p	350026626200015009	0-48						Methods and compositions for identifying RNA-binding proteins - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500257107	48		38780707	38780755	8421504	1	48	0	p	350025710700015003,350025710700015012,350025710700015011,350025710700015081,350025710700015082,350025710700015084	0-45,0-48,0-48,15-60,18-63,27-72						Peptide oligonucleotide conjugates	Hanson	2012	0		MIR615
880	chr19	38780707	38780755	3500254081	48		38780707	38780755	8421504	1	48	0	p	350025408100015034,350025408100015101	0-48,0-48						Compositions and methods for promoting wound healing and tissue regeneration	Gourdie	2009	0		MIR615
880	chr19	38780707	38780755	3500248458	48		38780707	38780755	8421504	1	48	0	p	350024845800015034,350024845800015101	0-48,0-48					Patent	Compositions and methods for promoting wound healing and tissue regeneration (Patent US:7888319)	Ghatnekar	2011	0		MIR615
880	chr19	38780707	38780755	3500246174	48		38780707	38780755	8421504	1	48	0	p	350024617400015075	0-48						Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9	Decaudin	2012	0		MIR615
880	chr19	38780707	38780755	3500245057	48		38780707	38780755	8421504	1	48	0	p	350024505700015001	0-48						Controlling gene expression in plastids	Muehlbauer	2005	0		MIR615
880	chr19	38780707	38780755	3500237127	48		38780707	38780755	8421504	1	48	0	p	350023712700015009	0-48						Hemangio-colony forming cells	Lanza	2007	0		MIR615
880	chr19	38780707	38780755	3500236863	48		38780707	38780755	8421504	1	48	0	p	350023686300015001	3-51					Patent	Anti-inflammatory compounds and uses thereof (Patent US:8217138)	Ghosh	2012	0		MIR615
880	chr19	38780707	38780755	3500217946	48		38780707	38780755	8421504	1	48	0	p	350021794600015005	0-48						TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500216592	48		38780707	38780755	8421504	1	48	0	p	350021659200015000	0-48						TTK AS TUMOR MARKER AND THERAPEUTIC TARGET FOR LUNG CANCER - ONCOTHERAPY SCIENCE, INC.	www.sumobrain.com	0	0		MIR615
880	chr19	38780707	38780755	3500216564	48		38780707	38780755	8421504	1	48	0	p	350021656400015000	0-48		21402890	10.4049/jimmunol.1002424	0022-1767	The Journal of Immunology	Targeting TLR4 Signaling by TLR4 Toll/IL-1 Receptor Domain-Derived Decoy Peptides: Identification of the TLR4 Toll/IL-1 Receptor Domain Dimerization Interface	Toshchakov	2011	6		MIR615
880	chr19	38780707	38780755	3500213268	48		38780707	38780755	8421504	1	48	0	p	350021326800015002	0-48						PEPTIDES TARGETED TO PROTEIN KINASE C ISOFORMS AND USES THEREOF - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500213265	48		38780707	38780755	8421504	1	48	0	p	350021326500015009,350021326500015016	0-48,18-66						MicroRNA Antisense PNAs, Compositions Comprising the Same, and Methods for Using and Evaluating the Same	Oh	2010	0		MIR615
880	chr19	38780707	38780755	3500202479	48		38780707	38780755	8421504	1	48	0	p	350020247900015001	0-48						Double-stranded oligonucleotides	Wiederholt	2003	0		MIR615
880	chr19	38780707	38780755	3500193251	48		38780707	38780755	8421504	1	48	0	p	350019325100015001	0-48						TTK AS TUMOR MARKER AND THERAPEUTIC TARGET FOR LUNG CANCER	Nakamura	2007	0		MIR615
880	chr19	38780707	38780755	3500192444	48		38780707	38780755	8421504	1	48	0	p	350019244400015000	0-48		22510693	10.1038/ncomms1773	2041-1733	Nature Communications	Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells	Rangel	2012	0		MIR615
880	chr19	38780707	38780755	3500191638	48		38780707	38780755	8421504	1	48	0	p	350019163800015086	0-48						Compositions and methods of use of targeting peptides against placenta and adipose tissues	Pasqualini	2002	0		MIR615
880	chr19	38780707	38780755	3500175950	48		38780707	38780755	8421504	1	48	0	p	350017595000015013	0-48						Compositions And Methods For The Delivery Of Biologically Active RNAs - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500172898	48		38780707	38780755	8421504	1	48	0	p	350017289800015006	0-48						Treatment of cancer via targeting of il-13 receptor-alpha2	Strober	2011	0		MIR615
880	chr19	38780707	38780755	3500127918	48		38780707	38780755	8421504	1	48	0	p	350012791800015000	0-48					Patent	PNA conjugate for the treatment of diseases associated with HIV (Patent US:7563761)	Braun	2009	0		MIR615
880	chr19	38780707	38780755	3500126353	48		38780707	38780755	8421504	1	48	0	p	350012635300015004	0-48						Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring	Bao	2003	0		MIR615
880	chr19	38780707	38780755	3500113737	48		38780707	38780755	8421504	1	48	0	p	350011373700015001	0-48						&#x4e3b;&#x9898;&#xff1a;CD40 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		MIR615
880	chr19	38780707	38780755	3500110810	48		38780707	38780755	8421504	1	48	0	p	350011081000015001,350011081000015000	3-51,3-51						TLR2-dependenteosinophilinteractionswithmycobacteria:roleof -defensins	tologylibrary.org	0	0		MIR615
880	chr19	38780707	38780755	3500103084	48		38780707	38780755	8421504	1	48	0	p	350010308400015039,350010308400015071	0-48,0-48						ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500100804	48		38780707	38780755	8421504	1	48	0	p	350010080400015003	0-48						METHOD OF TREATING NEURODEGENERATIVE DISEASE - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500090044	48		38780707	38780755	8421504	1	48	0	p	350009004400015001	0-48						DOI: 10.1093/nar/gkg160 Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation	ww.farm.ucl.ac.be	0	0		MIR615
880	chr19	38780707	38780755	3500079904	48		38780707	38780755	8421504	1	48	0	p	350007990400015036,350007990400015102	0-48,0-48						COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500078577	48		38780707	38780755	8421504	1	48	0	p	350007857700015127	0-48						Human And Mouse Targeting Peptides Identified By Phage Display 	.freshpatents.com	0	0		MIR615
880	chr19	38780707	38780755	3500069838	48		38780707	38780755	8421504	1	48	0	p	350006983800015009	0-48						Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders	CORCORAN	2003	0		MIR615
880	chr19	38780707	38780755	3500068922	48		38780707	38780755	8421504	1	48	0	p	350006892200015001	0-48		22913813	10.1186/1476-4598-11-59		Molecular Cancer	Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	Tomohisa	2012	0		MIR615
880	chr19	38780707	38780755	3500067379	48		38780707	38780755	8421504	1	48	0	p	350006737900015002	0-48						Production of Pluripotent Cells Through Inhibition of Bright/Arid3a Function - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500063035	48		38780707	38780755	8421504	1	48	0	p	350006303500015001,350006303500015009	0-48,0-45						Double-Stranded Oligonucleotides - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500062703	48		38780707	38780755	8421504	1	48	0	p	350006270300015011	0-48						Di-aliphatic substituted pegylated lipids	Manoharan	2013	0		MIR615
880	chr19	38780707	38780755	3500062415	48		38780707	38780755	8421504	1	48	0	p	350006241500015015	0-48						COMBINATION THERAPIES WITH MITOCHONDRIAL-TARGETED ANTI-TUMOR AGENTS - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500061735	48		38780707	38780755	8421504	1	48	0	p	350006173500015014	0-48						CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500048303	48		38780707	38780755	8421504	1	48	0	p	350004830300015000	0-48						Ttk as tumor marker and therapeutic target for lung cancer	Daigo	2009	0		MIR615
880	chr19	38780707	38780755	3500043198	48		38780707	38780755	8421504	1	48	0	p	350004319800015014	0-48						Genetically Intact Induced Pluripotent Cells Or Transdifferentiated Cells And Methods For The Production Thereof - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500043019	48		38780707	38780755	8421504	1	48	0	p	350004301900015166,350004301900015168	3-51,3-51					Patent	Entz&#xfc;ndungshemmende verbindungen und ihre verwendung Anti-inflammatory compounds, and their use (Patent DE:60106423)	Findeis	2005	0		MIR615
880	chr19	38780707	38780755	3500042218	48		38780707	38780755	8421504	1	48	0	p	350004221800015010	0-48						ERAP1&#x7531;&#x6765;&#x30da;&#x30d7;&#x30c1;&#x30c9;&#x53ca;&#x3073;&#x305d;&#x306e;&#x4f7f;&#x7528; - IP.com	ip.com/patfam/ja/	0	0		MIR615
880	chr19	38780707	38780755	3500040558	48		38780707	38780755	8421504	1	48	0	p	350004055800015009	0-48						Hemangio-colony forming cells	Lanza	2009	0		MIR615
880	chr19	38780707	38780755	3500024469	48		38780707	38780755	8421504	1	48	0	p	350002446900015004	0-48						Erap1-derived peptide and use thereof	Katagiri	2013	0		MIR615
880	chr19	38780707	38780755	3500024102	48		38780707	38780755	8421504	1	48	0	p	350002410200015000	0-48		16301656		0022-1767	The Journal of Immunology	Toll-IL-1 Receptor Domain-Containing Adaptor Protein Is Critical for Early Lung Immune Responses against Escherichia coli Lipopolysaccharide and Viable Escherichia coli	Jeyaseelan	2005	6		MIR615
880	chr19	38780707	38780755	3500023336	48		38780707	38780755	8421504	1	48	0	p	350002333600015000	0-48						 Immune System Function in Conditions Characterized by Elevated Double Strand Breaks - Patent application	www.faqs.org	0	0		MIR615
880	chr19	38780707	38780755	3500022158	48		38780707	38780755	8421504	1	48	0	p	350002215800015010	0-48						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX	Nakamura	2006	0		MIR615
880	chr19	38780707	38780755	3500018336	48		38780707	38780755	8421504	1	48	0	p	350001833600015008	0-48						Novel lipids and compositions for the delivery of therapeutics	Manoharan	2010	0		MIR615
880	chr19	38780707	38780755	3500008144	48		38780707	38780755	8421504	1	48	0	p	350000814400015005	3-51						Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics	Frelin	2006	0		MIR615
880	chr19	38780707	38780752	3500210061	45		38780707	38780752	8421504	1	45	0	p	350021006100015002	3-48						Methods of constructing and screening diverse expression libraries - US Patent 7270969 Description	ww.patentstorm.us	0	0		MIR615
880	chr19	38780710	38780755	3500158084	45		38780710	38780755	8421504	1	45	0	p	350015808400015009	0-45						Method for Treating and Preventing Ischemia-Reperfusion Injury Using Rna Interfering Agent - Patent application	www.faqs.org	0	0		MIR615
881	chr19	38807644	38807669	3500013455	25		38807644	38807669	8421504	1	25	0	c	350001345500000033	21-46						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		MIR10A
881	chr19	38807644	38807667	3500355688	23		38807644	38807667	8421504	1	23	0	c,g	350035568800000000,350035568800000000	0-23,0-23		22348345	10.1186/1476-4598-11-8	1476-4598	Molecular Cancer	miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death	Bryant	2012	4		MIR10A
881	chr19	38807644	38807667	3500347866	23		38807644	38807667	8421504	1	23	0	c,g	350034786600000026,350034786600000026,350034786600000027,350034786600000027	0-23,0-23,0-22,0-22						Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells.	.biomedsearch.com	0	0		MIR10A
881	chr19	38807644	38807667	3500323428	23		38807644	38807667	8421504	1	23	0	c,g	350032342800000037,350032342800000037	0-23,0-23						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		MIR10A
881	chr19	38807644	38807667	3500245499	23		38807644	38807667	8421504	1	23	0	c,g	350024549900000009,350024549900000009,350024549900000012,350024549900000012,350024549900000011,350024549900000011	0-23,0-23,1-23,1-23,0-21,0-21						BMC Genomics BioMed Central	biomedcentral.com	0	0		MIR10A
881	chr19	38807644	38807667	3500125321	23		38807644	38807667	8421504	1	23	0	c,g	350012532100000074,350012532100000074	0-23,0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIR10A
881	chr19	38807646	38807669	3500389139	23		38807646	38807669	8421504	1	23	0	c	350038913900000087	21-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		
881	chr19	38807646	38807669	3500232262	23		38807646	38807669	8421504	1	23	0	c	350023226200000086	21-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
881	chr19	38809702	38809726	3500016556	24		38809702	38809726	8421504	1	24	0	c	350001655600000005	0-24		24198842	10.1155/2013/349067	1740-2522	Clinical and Developmental Immunology	Lymphoid Progenitor Cells from Childhood Acute Lymphoblastic Leukemia Are Functionally Deficient and Express High Levels of the Transcriptional Repressor Gfi-1	Purizaca	2013	2		
881	chr19	38809734	38809783	3500068995	43		38809734	38809783	8421504	2	15,28	0,21	c,g	350006899500000632,350006899500000632	0-43,0-43						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
881	chr19	38809779	38810203	3500292820	69		38809779	38810203	8421504	2	48,21	0,403	p	350029282000015050,350029282000015033,350029282000015051	18-66,0-48,0-63						Lipopeptides for delivery of nucleic acids	Adami	2010	0		
881	chr19	38809779	38810175	3500212432	41		38809779	38810175	8421504	2	21,20	0,376	c	350021243200000023,350021243200000011	19-40,9-29		19365557	10.1371/journal.pone.0005213	1932-6203	PLOS ONE	PLOS ONE: Cytoplasmic Prep1 Interacts with 4EHP Inhibiting Hoxb4 Translation	Villaescusa	2009	4		
881	chr19	38809779	38809830	3500259965	51		38809779	38809830	8421504	1	51	0	p	350025996500015002,350025996500015001	0-48,0-51		12682052	10.1074/jbc.M212612200	0021-9258	Journal of Biological Chemistry	Inhibition of E2F Abrogates the Development of Cardiac Myocyte Hypertrophy	Vara	2003	5		HOXB4
881	chr19	38809779	38809830	3500259681	51		38809779	38809830	8421504	1	51	0	p	350025968100015010,350025968100015008,350025968100015007,350025968100015004	114-162,114-162,18-69,0-48						Control of gene expression using a complex of an oligonucleotide and a regulatory peptide - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500466191	48		38809779	38809827	8421504	1	48	0	p	350046619100015002	0-48						PYRROLIDINYL GROUPS FOR ATTACHING CONJUGATES TO OLIGOMERIC COMPOUNDS	Swayze	2005	0		HOXB4
881	chr19	38809779	38809827	3500465520	48		38809779	38809827	8421504	1	48	0	p	350046552000015000,350046552000015001	9-57,9-57		17347452	10.1152/ajpgi.00273.2006		American Journal of Physiology - Gastrointestinal and Liver Physiology	Ethanol induced NF-&#x03ba;B activation protects against cell injury in cultured rat gastric mucosal epithelium	Mustonen	2007	0		HOXB4
881	chr19	38809779	38809827	3500462929	48		38809779	38809827	8421504	1	48	0	p	350046292900015015,350046292900015009	0-48,0-48						GENE SILENCING USING SENSE DNA AND ANTISENSE RNA HYBRID CONSTRUCTS COUPLED TO PEPTIDES FACILITATING THE UPTAKE INTO CELLS - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500451805	48		38809779	38809827	8421504	1	48	0	p	350045180500015009	0-48						POLYMERIC CARRIER	Stayton	2009	0		HOXB4
881	chr19	38809779	38809827	3500450490	48		38809779	38809827	8421504	1	48	0	p	350045049000015000	0-48		12788645	10.1016/S1525-0016(03)00130-8	1525-0016	Molecular Therapy	A Novel TAT&#x2013;Mitochondrial Signal Sequence Fusion Protein is Processed, Stays in Mitochondria, and Crosses the Placenta	Gaizo	2003	7		HOXB4
881	chr19	38809779	38809827	3500450280	48		38809779	38809827	8421504	1	48	0	p	350045028000015001	3-51					Patent	Anti-inflammatory compounds and uses thereof (Patent US:6831065)	May	2004	0		HOXB4
881	chr19	38809779	38809827	3500447533	48		38809779	38809827	8421504	1	48	0	p	350044753300015019	0-48						&#x7279;&#x958b;2010-246542&#x53f7; &#xff36;&#xff28;&#xff2c;&#x816b;&#x760d;&#x30b5;&#x30d7;&#x30ec;&#x30c3;&#x30b5;&#x30fc;&#x3068;&#x4f4e;&#x9178;&#x7d20;&#x8a98;&#x5c0e;&#x56e0;&#x5b50;&#x3068;&#x306e;&#x76f8;&#x4e92;&#x4f5c;&#x7528;&#x3001;&#x304a;&#x	astamuse.com	0	0		HOXB4
881	chr19	38809779	38809827	3500437539	48		38809779	38809827	8421504	1	48	0	p	350043753900015023	0-48						COMPOSITIONS FOR NUCLEIC ACID DELIVERY - ALNYLAM PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		HOXB4
881	chr19	38809779	38809827	3500436372	48		38809779	38809827	8421504	1	48	0	p	350043637200015000,350043637200015002	0-48,0-48		18417477	10.1074/jbc.M710530200		The Journal of Biological Chemistry	The Apolipoprotein E-mimetic Peptide COG112 Inhibits the Inflammatory Response to Citrobacter rodentium in Colonic Epithelial Cells by Preventing NF-&#x03ba;B Activation	Kshipra	June	0		HOXB4
881	chr19	38809779	38809827	3500423875	48		38809779	38809827	8421504	1	48	0	p	350042387500015004	0-48						Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy	Xu	2007	0		HOXB4
881	chr19	38809779	38809827	3500422960	48		38809779	38809827	8421504	1	48	0	p	350042296000015000	0-48		12902516		0022-1767	The Journal of Immunology	Intracellular Domain of Brain Endothelial Intercellular Adhesion Molecule-1 Is Essential for T Lymphocyte-Mediated Signaling and Migration	Greenwood	2003	6		HOXB4
881	chr19	38809779	38809827	3500422615	48		38809779	38809827	8421504	1	48	0	p	350042261500015062,350042261500015021	0-48,0-48						TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES - FIRSTSTRING RESEARCH, INC.	www.sumobrain.com	0	0		HOXB4
881	chr19	38809779	38809827	3500403982	48		38809779	38809827	8421504	1	48	0	p	350040398200015016,350040398200015010,350040398200015008,350040398200015012	0-48,0-48,0-48,0-48						Disheveled pdz modulators	Costa	2007	0		HOXB4
881	chr19	38809779	38809827	3500401907	48		38809779	38809827	8421504	1	48	0	p	350040190700015003	0-48			10.1091/mbc.E06-08-0744		Molecular Biology of the Cell	RKIKK Motif in the Intracellular Domain Is Critical for Spatial and Dynamic Organization of ICAM-1: Functional Implication for the Leukocyte Adhesion and Transmigration 	Hyun-Mee	June	0		HOXB4
881	chr19	38809779	38809827	3500401579	48		38809779	38809827	8421504	1	48	0	p	350040157900015000	0-48						DSIP | Epitope Tags/Tag Peptides Guide	www.ubenimex.com	0	0		HOXB4
881	chr19	38809779	38809827	3500398751	48		38809779	38809827	8421504	1	48	0	p	350039875100015000	0-48						Direct Conversion of Cells to Cells of Other Lineages	Wernig	2013	0		HOXB4
881	chr19	38809779	38809827	3500392106	48		38809779	38809827	8421504	1	48	0	p	350039210600015037,350039210600015031	0-48,0-48						Mitochondria-targeted anti-tumor agents	Jiang Bing Xian 	2010	0		HOXB4
881	chr19	38809779	38809827	3500374795	48		38809779	38809827	8421504	1	48	0	p	350037479500015037,350037479500015104	0-48,0-48						COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION	Gourdie	2007	0		HOXB4
881	chr19	38809779	38809827	3500373900	48		38809779	38809827	8421504	1	48	0	p	350037390000015005	0-48						Therapeutic compositions	Manoharan	2010	0		HOXB4
881	chr19	38809779	38809827	3500372129	48		38809779	38809827	8421504	1	48	0	p	350037212900015002,350037212900015001	0-48,60-108						Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent	Spaenkuch-Schmitt	2003	0		HOXB4
881	chr19	38809779	38809827	3500372015	48		38809779	38809827	8421504	1	48	0	p	350037201500015002	0-48						Method for selective oligonucleotide modification	Mitsch	2011	0		HOXB4
881	chr19	38809779	38809827	3500368130	48		38809779	38809827	8421504	1	48	0	p	350036813000015044	0-48						Multimeric peptide conjugates and uses thereof	Demeule	2011	0		HOXB4
881	chr19	38809779	38809827	3500367262	48		38809779	38809827	8421504	1	48	0	p	350036726200015002	0-48						INHIBITION OF ANGIOGENESIS	Lagos-quintana	2009	0		HOXB4
881	chr19	38809779	38809827	3500367224	48		38809779	38809827	8421504	1	48	0	p	350036722400015001	0-48		17363608	10.1158/0008-5472.CAN-06-4082	0008-5472	Cancer Research	Caveolin-1&#x2013;Deficient Mice Have Increased Tumor Microvascular Permeability, Angiogenesis, and Growth	Lin	2007	8		HOXB4
881	chr19	38809779	38809827	3500358319	48		38809779	38809827	8421504	1	48	0	p	350035831900015001,350035831900015000	9-57,9-57						Ethanol induced NF- B activation protects against cell injury in cultured rat gastric mucosal epithelium--&#x300a;&#x7f8e;&#x56fd;&#x80c3;&#x80a0;&#x4e0e;&#x809d;&#x751f;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x	journal.9med.net	0	0		HOXB4
881	chr19	38809779	38809827	3500351230	48		38809779	38809827	8421504	1	48	0	p	350035123000015041	0-48						Peptide Antiestrogen Compositions And Methods For Treating Breast Cancer - Patent 6306832	www.docstoc.com	0	0		HOXB4
881	chr19	38809779	38809827	3500333591	48		38809779	38809827	8421504	1	48	0	p	350033359100015011	0-48						NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500328481	48		38809779	38809827	8421504	1	48	0	p	350032848100015009	0-48						Promotion of peroxisomal catalase function in cells	Terlecky	2004	0		HOXB4
881	chr19	38809779	38809827	3500328352	48		38809779	38809827	8421504	1	48	0	p	350032835200015005	0-48						Trans-membrane-antibody induced inhibition of apoptosis	Brown	2005	0		HOXB4
881	chr19	38809779	38809827	3500327955	48		38809779	38809827	8421504	1	48	0	p	350032795500015104,350032795500015105	3-51,3-51					Patent	Entz&#xfc;ndungshemmende verbindungen und ihre verwendung (Patent DE:60106423)	Findeis	2005	0		HOXB4
881	chr19	38809779	38809827	3500327712	48		38809779	38809827	8421504	1	48	0	p	350032771200015008,350032771200015000	3-51,3-51					Patent	Entz&#xfc;ndungshemmende verbindungen und ihre verwendung Anti-inflammatory compounds, and their use (Patent DE:60123041)	GHOSH	2007	0		HOXB4
881	chr19	38809779	38809827	3500325895	48		38809779	38809827	8421504	1	48	0	p	350032589500015000	0-48						ACTIVATION OF INNATE IMMUNITY FOR NUCLEAR REPROGRAMMING OF SOMATIC CELLS	Cooke	2013	0		HOXB4
881	chr19	38809779	38809827	3500282320	48		38809779	38809827	8421504	1	48	0	p	350028232000015001	0-48						INDUCED PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500281646	48		38809779	38809827	8421504	1	48	0	p	350028164600015013	0-48					Patent	&#x9776;&#x5411;&#x7ebf;&#x7c92;&#x4f53;&#x7684;&#x6297;&#x80bf;&#x7624;&#x5242; (Patent CN:101854955)	Jiang Bing Xian 	2012	0		HOXB4
881	chr19	38809779	38809827	3500264566	48		38809779	38809827	8421504	1	48	0	p	350026456600015017	0-48						Cell-killing molecules and methods of use thereof	Larrick	2005	0		HOXB4
881	chr19	38809779	38809827	3500264500	48		38809779	38809827	8421504	1	48	0	p	350026450000015173,350026450000015175,350026450000015174	3-51,3-48,3-51						Anti-inflammatory Compounds And Uses Thereof 	.freshpatents.com	0	0		HOXB4
881	chr19	38809779	38809827	3500263859	48		38809779	38809827	8421504	1	48	0	p	350026385900015001	0-48						COMPOSITIONS AND METHODS FOR MODIFYING THE GLYCOSYLATION PATTERN OF A POLYPEPTIDE	Rossomando	2011	0		HOXB4
881	chr19	38809779	38809827	3500259901	48		38809779	38809827	8421504	1	48	0	p	350025990100015008	0-48						Novel lipids and compositions for the delivery of therapeutics	Manoharan	2010	0		HOXB4
881	chr19	38809779	38809827	3500259558	48		38809779	38809827	8421504	1	48	0	p	350025955800015000	0-48		15536091	10.1074/jbc.M411380200	0021-9258	Journal of Biological Chemistry	Fyn Phosphorylates Human MAP-2c on Tyrosine 67	Zamora-Leon	2005	5		HOXB4
881	chr19	38809779	38809827	3500242047	48		38809779	38809827	8421504	1	48	0	p	350024204700015001	0-48						Prote&#xed;nas recombinantes ligadas a TAT e sua aplica&#xe7;&#xe3;o terap&#xea;utica na revers&#xe3;o de dano isqu&#xea;mico de ilhotas pancre&#xe1;ticas: impacto em transplante	bdtd.bce.unb.br	0	0		HOXB4
881	chr19	38809779	38809827	3500229598	48		38809779	38809827	8421504	1	48	0	p	350022959800015005,350022959800015020	0-48,0-45						ALGAL TRANSFORMATION SYSTEMS, COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500228854	48		38809779	38809827	8421504	1	48	0	p	350022885400015014	0-48						SITE-SPECIFIC DELIVERY OF NUCLEIC ACIDS BY COMBINING TARGETING LIGANDS WITH ENDOSOMOLYTIC COMPONENTS - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500227230	48		38809779	38809827	8421504	1	48	0	p	350022723000015003	0-48						COMPOSITIONS AND METHODS FOR DIAGNOSING AUTISM	Millonig	2013	0		HOXB4
881	chr19	38809779	38809827	3500226091	48		38809779	38809827	8421504	1	48	0	p	350022609100015038,350022609100015067	0-48,0-48						Compositions and methods for promoting wound healing and tissue regeneration	Gourdie	2011	0		HOXB4
881	chr19	38809779	38809827	3500225366	48		38809779	38809827	8421504	1	48	0	p	350022536600015010	0-48					Patent	Methods and compositions for delivering polynucleotides (Patent US:8039587)	Khan	2011	0		HOXB4
881	chr19	38809779	38809827	3500211965	48		38809779	38809827	8421504	1	48	0	p	350021196500015010	0-48						Immunogenic Polypeptides and Monoclonal Antibodies - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500211732	48		38809779	38809827	8421504	1	48	0	p	350021173200015005	0-48						&#x4e3b;&#x9898;&#xff1a;Nuclear | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		HOXB4
881	chr19	38809779	38809827	3500207888	48		38809779	38809827	8421504	1	48	0	p	350020788800015000	0-48						Promotion of peroxisomal catalase function in cells	Terlecky	2003	0		HOXB4
881	chr19	38809779	38809827	3500196917	48		38809779	38809827	8421504	1	48	0	p	350019691700015001,350019691700015000	60-108,60-108						Cyclin D1 Regulates Cellular Migration through the Inhibition of Thrombospondin 1 and ROCK Signaling	mcb.asm.org	0	0		HOXB4
881	chr19	38809779	38809827	3500196713	48		38809779	38809827	8421504	1	48	0	p	350019671300015002	0-48			10.5772/55518	978-953-51-1014-9		Gene Therapy - Tools and Potential Applications	Ian	2013	0		HOXB4
881	chr19	38809779	38809827	3500180627	48		38809779	38809827	8421504	1	48	0	p	350018062700015010	0-48						&#xff36;&#xff28;&#xff2c;&#x816b;&#x760d;&#x30b5;&#x30d7;&#x30ec;&#x30c3;&#x30b5;&#x30fc;&#x3068;&#x4f4e;&#x9178;&#x7d20;&#x8a98;&#x5c0e;&#x56e0;&#x5b50;&#x3068;&#x306e;&#x76f8;&#x4e92;&#x4f5c;&#x7528;&#x3001;&#x304a;&#x3088;&#x3073;&#x305d;&#x308c;&#x306b	astamuse.com	0	0		HOXB4
881	chr19	38809779	38809827	3500166999	48		38809779	38809827	8421504	1	48	0	p	350016699900015013	0-48						Nonviral vectors for delivering polynucleotides	Khan	2006	0		HOXB4
881	chr19	38809779	38809827	3500150181	48		38809779	38809827	8421504	1	48	0	p	350015018100015019	0-48						CHEMICALLY MODIFIED OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500142737	48		38809779	38809827	8421504	1	48	0	p	350014273700015003	0-48						TREATING OR PREVENTING CANCERS OVER-EXPRESSING REG4 OR KIAA0101 - ONCOTHERAPY SCIENCE, INC.	www.sumobrain.com	0	0		HOXB4
881	chr19	38809779	38809827	3500140678	48		38809779	38809827	8421504	1	48	0	p	350014067800015009	0-48						Novel lipids and compositions for the delivery of therapeutics	Manoharan	2011	0		HOXB4
881	chr19	38809779	38809827	3500139233	48		38809779	38809827	8421504	1	48	0	p	350013923300015001	0-48					Patent	Aptamer therapeutics useful in the treatment of complement-related disorders (Patent US:7538211)	Benedict	2009	0		HOXB4
881	chr19	38809779	38809827	3500139027	48		38809779	38809827	8421504	1	48	0	p	350013902700015014	0-48						Erap1&#x7531;&#x6765;&#x30da;&#x30d7;&#x30c1;&#x30c9;&#x53ca;&#x3073;&#x305d;&#x306e;&#x4f7f;&#x7528;	Katagiri	2013	0		HOXB4
881	chr19	38809779	38809827	3500138929	48		38809779	38809827	8421504	1	48	0	p	350013892900015002,350013892900015136	0-48,0-45						Secretion System and Methods for its Use - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500138711	48		38809779	38809827	8421504	1	48	0	p	350013871100015009	0-48						Novel lipids and compositions for the delivery of therapeutics	Manoharan	2011	0		HOXB4
881	chr19	38809779	38809827	3500138434	48		38809779	38809827	8421504	1	48	0	p	350013843400015012,350013843400015011,350013843400015017,350013843400015014	0-48,0-48,0-48,0-48						DISHEVELED PDZ MODULATORS - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500124891	48		38809779	38809827	8421504	1	48	0	p	350012489100015004	0-48		16822931	10.1124/mol.105.021741	1521-0111 (Online)	Molecular Pharmacology	Caveolin-1 Regulates Store-Operated Ca2+ Influx by Binding of Its Scaffolding Domain to Transient Receptor Potential Channel-1 in Endothelial Cells	Kwiatek	2006	0		HOXB4
881	chr19	38809779	38809827	3500122903	48		38809779	38809827	8421504	1	48	0	p	350012290300015013	0-48		20934997	10.3324/haematol.2010.030924	0390-6078	Haematologica	The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family	Bade-Doding	2011	6		HOXB4
881	chr19	38809779	38809827	3500117014	48		38809779	38809827	8421504	1	48	0	p	350011701400015123	0-48					Patent	Peptide compositions for targeting adipose tissue (Patent US:8067377)	Arap	2011	0		HOXB4
881	chr19	38809779	38809827	3500114543	48		38809779	38809827	8421504	1	48	0	p	350011454300015005	0-48						Therapeutic compositions	Manoharan	2010	0		HOXB4
881	chr19	38809779	38809827	3500101924	48		38809779	38809827	8421504	1	48	0	p	350010192400015000	0-48						Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide	Jenkinson	2004	0		HOXB4
881	chr19	38809779	38809827	3500101748	48		38809779	38809827	8421504	1	48	0	p	350010174800015007,350010174800015006,350010174800015005,350010174800015000,350010174800015009,350010174800015008	3-51,3-51,3-51,3-51,3-51,3-51						VOLTAGE DEPENDENT ANION CHANNEL (VDACl) COMPOSITIONS AND METHODS OF USE THEREOF FOR REGULATING APOPTOSIS	Shoshan-Barmatz	2006	0		HOXB4
881	chr19	38809779	38809827	3500101536	48		38809779	38809827	8421504	1	48	0	p	350010153600015000,350010153600015005	0-48,6-51						Pna-konjugat zur therapie von mit hiv in zusammenhang stehenden erkrankungen	Braun	2004	0		HOXB4
881	chr19	38809779	38809827	3500100085	48		38809779	38809827	8421504	1	48	0	p	350010008500015002	0-48						Targeting the BCL9/B9L Binding Interaction with &#x03b2;-catenin as a Potential Anticancer Strategy by Steven Akira Kawamoto	lue.lib.umich.edu	0	0		HOXB4
881	chr19	38809779	38809827	3500100022	48		38809779	38809827	8421504	1	48	0	p	350010002200015032	0-48						Peptide-dicer substrate rna conjugates as delivery vehicles for sirna	Ahmadian	2007	0		HOXB4
881	chr19	38809779	38809827	3500099731	48		38809779	38809827	8421504	1	48	0	p	350009973100015000	0-48					Patent	Pna-konjugat zur therapie von mit hiv in zusammenhang stehenden erkrankungen (Patent EP:1404373)	Braun	2008	0		HOXB4
881	chr19	38809779	38809827	3500099421	48		38809779	38809827	8421504	1	48	0	p	350009942100015001,350009942100015000	15-63,18-66						GENE AMPLIFICATION OF COACTIVATOR COAA AND USES THEREOF - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500096913	48		38809779	38809827	8421504	1	48	0	p	350009691300015065,350009691300015105,350009691300015085	0-48,0-48,0-48					Patent	Composition and methods for promoting wound healing and tissue regeneration (Patent US:7786074)	Ghatnekar	2010	0		HOXB4
881	chr19	38809779	38809827	3500089187	48		38809779	38809827	8421504	1	48	0	p	350008918700015004	0-48						Methods and compositions for delivering polynucleotides	Khan	2011	0		HOXB4
881	chr19	38809779	38809827	3500074550	48		38809779	38809827	8421504	1	48	0	p	350007455000015000	0-48						Ttk as tumor marker and therapeutic target for lung cancer	Daigo	2008	0		HOXB4
881	chr19	38809779	38809827	3500072930	48		38809779	38809827	8421504	1	48	0	p	350007293000015001	0-48		16020665	10.1158/1535-7163.MCT-04-0253	1535-7163	Molecular Cancer Therapeutics	Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy	III	2005	5		HOXB4
881	chr19	38809779	38809827	3500072678	48		38809779	38809827	8421504	1	48	0	p	350007267800015083	0-48						COMPOSITIONS AND METHODS OF USE OF TARGETING PEPTIDES AGAINST PLACENTA AND ADIPOSE TISSUES - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500070167	48		38809779	38809827	8421504	1	48	0	p	350007016700015001	0-48						DOUBLE-STRANDED OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500047773	48		38809779	38809827	8421504	1	48	0	p	350004777300015027	0-48						BLOCKADE OF TL1A-DR3 INTERACTIONS TO AMELIORATE T CELL MEDIATED DISEASE PATHOLOGY - Patent application	www.faqs.org	0	0		HOXB4
881	chr19	38809779	38809827	3500047571	48		38809779	38809827	8421504	1	48	0	p	350004757100015013,350004757100015007	18-66,0-48						MicroRNA antisense PNAs, compositions comprising the same, and methods for using and evaluating the same	Park	2012	0		HOXB4
881	chr19	38809779	38809827	3500046544	48		38809779	38809827	8421504	1	48	0	p	350004654400015010	0-48						CELL-BASED BIOPROCESSING - ALNYLAM PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		HOXB4
881	chr19	38809779	38809827	3500046272	48		38809779	38809827	8421504	1	48	0	p	350004627200015004	0-48						NOVEL A&#xdf;-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF - NATIONAL RESEARCH COUNCIL OF CANADA	www.sumobrain.com	0	0		HOXB4
881	chr19	38809779	38809827	3500032841	48		38809779	38809827	8421504	1	48	0	p	350003284100015000,350003284100015001	3-51,3-51						Treatment Of Human Multiple Myeloma By Curcumin 	.freshpatents.com	0	0		HOXB4
881	chr19	38809779	38809827	3500030957	48		38809779	38809827	8421504	1	48	0	p	350003095700015004	0-48						Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex	Daigo	2007	0		HOXB4
881	chr19	38809779	38809827	3500030856	48		38809779	38809827	8421504	1	48	0	p	350003085600015005	0-48						Method for detecting proteinaceous inhibitors of protein-protein or DNA-protein interactions	Watt	1999	0		HOXB4
881	chr19	38809779	38809827	3500030768	48		38809779	38809827	8421504	1	48	0	p	350003076800015016,350003076800015019	0-48,0-48					Patent	Mitochondria-targeted anti-tumor agents (Patent US:8466140)	Altieri	2013	0		HOXB4
881	chr19	38809779	38809827	3500030630	48		38809779	38809827	8421504	1	48	0	p	350003063000015000,350003063000015003	3-51,3-51						Anti-inflammatory compounds and uses thereof	May	2005	0		HOXB4
881	chr19	38809779	38809827	3500026374	48		38809779	38809827	8421504	1	48	0	p	350002637400015000	0-48						TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER - ONCOTHERAPY SCIENCE, INC.	www.sumobrain.com	0	0		HOXB4
881	chr19	38809779	38809827	3500025356	48		38809779	38809827	8421504	1	48	0	p	350002535600015001,350002535600015004	0-48,0-48						International Journal of Medical Sciences	www.medsci.org	0	0		HOXB4
881	chr19	38809779	38809823	3500160732	44		38809779	38809823	8421504	1	44	0	c	350016073200000008,350016073200000075	5-49,5-49						Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions - Patent application	www.faqs.org	0	0		
881	chr19	38809779	38809823	3500108636	44		38809779	38809823	8421504	1	44	0	c	350010863600000059	5-49						CLOSTRIDIUM BOTULINUM C3 EXOTRANSFERASE COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING - Patent application	www.faqs.org	0	0		
881	chr19	38810363	38810388	3500342127	24		38810363	38810388	8421504	2	13,11	0,14	c	350034212700000002	0-24						Methods of Ex Vivo Expansion of Blood Progenitor Cells, and Generation of Composite Grafts	Mahmud	2012	0		
881	chr19	38835288	38853313	3500010153	47		38835288	38853313	8421504	2	22,25	0,18000	c	350001015300000009,350001015300000010	3-25,0-25		19880879	10.1074/jbc.M109.065862	0021-9258	Journal of Biological Chemistry	ASXL1 Represses Retinoic Acid Receptor-mediated Transcription through Associating with HP1 and LSD1	Lee	2010	5		HOXA5,HOXA4,HOXA3,HOXA2,HOXA1,HOTAIRM1,HOXB1
881	chr19	38841369	38842481	3500423654	46		38841369	38842481	8421504	2	23,23	0,1089	c	350042365400000016,350042365400000017	0-23,0-23			10.1128/MCB.01290-07		Molecular and Cellular Biology	p160 Myb-Binding Protein Interacts with Prep1 and Inhibits Its Transcriptional Activity 	Victor	2007	0		HOXB2
881	chr19	38842408	38842474	3500241440	66		38842408	38842474	8421504	1	66	0	p	350024144000015005	15-81						Ectopic Hoxa2induction after neural crest migration results in homeosis of jaw elements in Xenopus	ev.biologists.org	0	0		HOXB2
884	chr19	39318571	39318597	3500060896	25		39318571	39318597	8421504	2	9,16	0,10	c	350006089600000020	19-48						Polypeptides and polynucleotides from coagulase-negative staphylococci	Foster	1999	0		
885	chr19	39328302	39328353	3500414482	51		39328302	39328353	8421504	1	51	0	p	350041448200015000	0-51		19187526	10.1186/1471-2121-10-9	1471-2121	BMC Cell Biology	MCRS2 represses the transactivation activities of Nrf1	Wu	2009	3		NFE2L1
885	chr19	39340030	39340057	3500455183	23		39340030	39340057	8421504	2	14,9	0,18	c	350045518300000028	8-31						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2004	0		
885	chr19	39340030	39340057	3500454103	23		39340030	39340057	8421504	2	14,9	0,18	c	350045410300000028	8-31					Patent	Immunoglobulin chimeric monomer-dimer hybrids (Patent US:7404956)	Peters	2008	0		
885	chr19	39340030	39340057	3500426462	23		39340030	39340057	8421504	2	14,9	0,18	c	350042646200000028	8-31						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2005	0		
885	chr19	39395808	39396058	3500235789	25		39395808	39396058	8421504	2	12,13	0,237	c	350023578900000000	0-25		21385901	10.1158/0008-5472.CAN-10-4046	0008-5472	Cancer Research	Overexpression of a Novel Activator of PAK4, the CDK5 Kinase&#x2013;Associated Protein CDK5RAP3, Promotes Hepatocellular Carcinoma Metastasis	Mak	2011	8		CDK5RAP3
110	chr19	39436417	39466906	3500446473	146		39436417	39466906	8421504	7	26,1,30,30,29,23,7	0,3666,3820,5724,8818,10218,30482	c	350044647300000010,350044647300000008,350044647300000015,350044647300000006,350044647300000004,350044647300000001	11-38,10-40,9-29,10-40,10-39,15-45		16467376	10.1091/mbc.E05-11-1063	1059-1524	Molecular Biology of the Cell	Sp2 Localizes to Subnuclear Foci Associated with the Nuclear Matrix	Moorefield	2006	5		SP2
885	chr19	39440153	39440539	3500100022	162		39440153	39440539	8421504	2	124,38	0,348	p	350010002200015070	0-162						Peptide-dicer substrate rna conjugates as delivery vehicles for sirna	Ahmadian	2007	0		SP2
885	chr19	39440153	39440273	3500208064	120		39440153	39440273	8421504	1	120	0	p	350020806400015027	0-120						COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY	Cui	2007	0		SP2
110	chr19	39446651	39466921	3500172976	24		39446651	39466921	8421504	4	7,1,4,12	0,20248,20250,20258	c	350017297600000006	3-33		11062235	10.1074/jbc.C000578200	0021-9258	Journal of Biological Chemistry	The Forkhead-associated Domain of NBS1 Is Essential for Nuclear Foci Formation after Irradiation but Not Essential for hRAD50&#xb7;hMRE11&#xb7;NBS1 Complex DNA Repair Activity	Tauchi	2001	5		
887	chr19	39649652	39649824	3500347624	40		39649652	39649824	8421504	2	20,20	0,152	c,g	350034762400000013,350034762400000013,350034762400000012,350034762400000012	0-20,0-20,0-20,0-20		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		TBX21
887	chr19	39649739	39649824	3500457411	40		39649739	39649824	8421504	2	20,20	0,65	c,g	350045741100000011,350045741100000011,350045741100000010	0-20,0-20,0-20		19515866	10.1128/CVI.00424-08	1556-6811	Clinical and Vaccine Immunology	T-Cell mRNA Expression in Response to Mycobacterium bovis BCG Vaccination and Mycobacterium bovis Infection of White-Tailed Deer	Thacker	2009	3		
887	chr19	39649794	39650118	3500213826	47		39649794	39650118	8421504	3	20,9,18	0,58,306	c	350021382600000020,350021382600000018	0-20,0-27						THELPER CELL TYPE 17 LINEAGE-SPECIFIC ADJUVANTS, COMPOSITIONS AND METHODS - MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY	www.sumobrain.com	0	0		
887	chr19	39649794	39650118	3500062858	48		39649794	39650118	8421504	3	21,9,18	0,58,306	c,g	350006285800000028,350006285800000028,350006285800000029	0-21,0-21,0-27						2001 by Cell Press Early Transcription and Silencing of Cytokine Genes Underlie Polarization of T Helper Cell Subsets	.microbio.uab.edu	0	0		
887	chr19	39650412	39650463	3500282415	51		39650412	39650463	8421504	1	51	0	p	350028241500015098,350028241500015034	0-48,0-48						Modulation Of Il-2 Production By T-bet 	.freshpatents.com	0	0		EOMES
887	chr19	39650412	39650460	3500099907	48		39650412	39650460	8421504	1	48	0	p	350009990700015102,350009990700015038	0-45,0-45						COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF ULCERATIVE COLITIS AND COLON CANCER AND SCREENING METHODS TO IDENTIFY SAME - Patent application	www.faqs.org	0	0		EOMES
888	chr19	39715449	39715473	3500364224	24		39715449	39715473	8421504	1	24	0	c	350036422400000002	13-37		9362503	10.1083/jcb.139.4.841	0021-9525	The Journal of Cell Biology	Ran-unassisted Nuclear Migration of a 97-kD Component of Nuclear Pore&#x2013;targeting Complex	Kose	1997	10		
888	chr19	39718237	39719317	3500368529	90		39718237	39719317	8421504	2	78,12	0,1068	p	350036852900015014	0-90						Analyse der differentiellen Expression von Transportfaktoren und deren F&#xe8;&#xf2;O &#xc8;Z@ &#xad;/ \\\\&#xa7; -&#xf3;&#xcc;[ S&#xc4;M&#xd0;Bt s&#xb1;G&#xa5;' &#xe1;fo \\\\&#xf9; &#xe2;&#xc7; &#xe8;&#xd9;&#xcc;Z&#xa9;&#xc7;.&#xe2; &#xff;;o&#xfd;c	uni-goettingen.de	0	0		KPNB1
13	chr19	39758719	39861313	3500432803	2250		39758719	39861313	8421504	23	93,48,156,108,57,143,220,75,50,64,110,61,105,165,115,34,46,102,108,122,78,85,105	0,2944,3262,3897,7041,7716,12560,14027,16101,17896,20720,22373,22848,23790,26175,27719,27868,28516,29878,37690,46784,94708,102489	p	350043280300015032,350043280300015031,350043280300015030,350043280300015029,350043280300015028,350043280300015027,350043280300015025,350043280300015024,350043280300015023,350043280300015022,350043280300015044,350043280300015021,350043280300015019,350043280300015018,350043280300015017,350043280300015016	0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-45,0-150,0-150,0-150,0-150,0-150						Isolierung und biochemische Charakterisierung einer zytosolischen Aminopeptidase aus der humanen T-Zelllinie H9	thek.uni-halle.de	0	0		
888	chr19	39758782	39761707	3500113740	41		39758782	39761707	8421504	2	20,21	0,2904	c	350011374000000001,350011374000000000	0-20,0-21						&#x4e3b;&#x9898;&#xff1a;renal | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
888	chr19	39761669	39765796	3500164379	342		39761669	39765796	8421504	4	42,156,108,36	0,312,947,4091	p	350016437900015040	174-681						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		
888	chr19	39786628	39786653	3500291087	25		39786628	39786653	8421504	1	25	0	c	350029108700000071	21-46						Transgenic mouse models for studying BC1 and BC200 RNA transport and purification of their RNPs, and SINEs as tools for reconstructing rodent phylogeny	i.uni-muenster.de	0	0		TBC1D3
889	chr19	39861316	39861343	3500359802	27		39861316	39861343	8421504	1	27	0	c	350035980200000000,350035980200000001	0-28,0-27		19969024	10.1016/j.antiviral.2009.12.003		Antiviral research	Puromycin-Sensitive Aminopeptidase: An Antiviral Prodrug Activating Enzyme	Ulrika	2010	0		TBC1D5
889	chr19	39866378	39866402	3500072797	23		39866378	39866402	8421504	2	8,15	0,9	g	350007279700000057	11-34						Production of monatin and monatin precursors	S*C*Mai Ke Fa Lan 	2007	0		
889	chr19	39959994	39969432	3500011698	125		39959994	39969432	8421504	4	35,45,8,37	0,8879,8975,9401	c	350001169800000184,350001169800000187,350001169800000189	0-35,0-45,0-45						Therapeutic and diagnostic agents - US Patent 7279557 Description	ww.patentstorm.us	0	0		
889	chr19	39968966	39969432	3500241928	48		39968966	39969432	8421504	2	11,37	0,429	c	350024192800000184	0-48						THERAPEUTIC AND DIAGNOSTIC AGENTS CAPABLE OF MODULATING CELLULAR RESPONSIVENESS TO CYTOKINES - THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH	www.sumobrain.com	0	0		
890	chr19	39989727	39989753	3500301895	26		39989727	39989753	8421504	1	26	0	g	350030189500000086	12-38						Androgen-regulated gene expressed in prostate tissue - Patent # 6566130 - PatentGenius	.patentgenius.com	0	0		
891	chr19	40140381	40140406	3500154043	24		40140381	40140406	8421504	2	13,11	0,14	g	350015404300000199	0-24						INTERACTION BETWEEN TRICHODERMA	library.brocku.ca	0	0		
892	chr19	40264094	40264800	3500451768	144		40264094	40264800	8421504	2	83,61	0,645	p	350045176800015009	0-144						Peroxisome-deficient Chinese hamster ovary cells with point mutations in peroxisome assembly factor-1. - ResearchGate	.researchgate.net	0	0		PCGF2
892	chr19	40281939	40281987	3500259199	48		40281939	40281987	8421504	1	48	0	p	350025919900015003	0-48						Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in Endothelial Progenitor Cells	www.mcponline.org	0	0		PSMB3
892	chr19	40290130	40312417	3500287020	51		40290130	40312417	8421504	2	25,26	0,22261	c	350028702000000003,350028702000000002	0-25,0-26		18753295	10.1152/ajprenal.90310.2008		American Journal of Physiology - Renal Physiology	Localization of phosphatidylinositol phosphate kinase II&#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	Clarke	2008	0		
892	chr19	40290130	40312417	3500230851	51		40290130	40312417	8421504	2	25,26	0,22261	c,g	350023085100000003,350023085100000002,350023085100000002	0-25,0-26,0-26		18753295	10.1152/ajprenal.90310.2008		American Journal of Physiology - Renal Physiology	Localization of phosphatidylinositol phosphate kinase II&#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	Jonathan	2008	0		PIP4K2B
892	chr19	40290130	40312417	3500149531	51		40290130	40312417	8421504	2	25,26	0,22261	c,g	350014953100000003,350014953100000002	0-25,0-26		18753295	10.1152/ajprenal.90310.2008		American Journal of Physiology - Renal Physiology	Localization of phosphatidylinositol phosphate kinase II&#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	Clarke	2008	0		
892	chr19	40290130	40312417	3500006396	51		40290130	40312417	8421504	2	25,26	0,22261	c,g	350000639600000003,350000639600000002	0-25,0-26						Localization of phosphatidylinositol phosphate kinase II &#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	g.library.pcc.edu	0	0		
892	chr19	40290130	40290155	3500172832	25		40290130	40290155	8421504	1	25	0	c	350017283200000003	0-25		18753295	10.1152/ajprenal.90310.2008		American Journal of Physiology - Renal Physiology	Localization of phosphatidylinositol phosphate kinase II&#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	Clarke	2008	0		PIP4K2B
892	chr19	40324811	40324960	3500166204	148		40324811	40324960	8421504	2	114,34	0,115	c	350016620400000030	82-230						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
892	chr19	40325188	40325888	3500408683	354		40325188	40325888	8421504	4	104,88,159,3	0,105,194,697	c	350040868300000034	0-364						Ungulates with genetically modified immune systems	Wells	2006	0		
892	chr19	40325236	40325260	3500254134	24		40325236	40325260	8421504	1	24	0	c	350025413400000004	25-49						C&#xcd;NTIA FERNANDES DA SILVA	ibb.unesp.br	0	0		
893	chr19	40370319	40374413	3500320902	336		40370319	40374413	8421504	4	110,129,84,13	0,2992,3411,4081	p	350032090200015130,350032090200015129	0-165,0-171						Method for manufacturing a modified peptide	Bauer	2009	0		RPL23
893	chr19	40373433	40374410	3500434170	40		40373433	40374410	8421504	4	7,13,10,10	0,297,371,967	c	350043417000000027,350043417000000026	0-20,0-20						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
893	chr19	40420209	40420263	3500111979	54		40420209	40420263	8421504	1	54	0	p	350011197900015000	3-57		18535670	10.1172/JCI33569	0021-9738	The Journal of Clinical Investigation	Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice	Jain	2008	13		LASP1
893	chr19	40462988	40463030	3500321684	41		40462988	40463030	8421504	2	30,11	0,31	c	350032168400000024	0-41						EVALUATION OF SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH FERTILITY AND PRODUCTION TRAITS IN HOLSTEIN AND MULTI-GENERATIONAL ANGUS FEMALES	etd.lsu.edu	0	0		
111	chr19	40624924	40639418	3500004246	192		40624924	40639418	8421504	6	42,6,6,42,48,48	0,545,623,3761,6933,14446	c	350000424600000375,350000424600000371,350000424600000360,350000424600000351	0-48,0-48,0-48,0-48						Assays for agonists and antagonists of recombinant human calcium channels	Harpold	1991	0		
894	chr19	40631938	40631961	3500104097	23		40631938	40631961	8421504	1	23	0	c	350010409700000002	0-23		11058528	10.1095/biolreprod63.5.1262	0006-3363	Biology of Reproduction	Gestational Changes in Uterine L-Type Calcium Channel Function and Expression in Guinea Pig	Collins	2000	4		
895	chr19	40633614	40639428	3500255562	43		40633614	40639428	8421504	2	22,21	0,5793	c	350025556200000001,350025556200000000	0-22,0-21		19996312	10.1074/jbc.M109.044271		The Journal of Biological Chemistry	Reciprocal Interactions Regulate Targeting of Calcium Channel &#x03b2; Subunits and Membrane Expression of &#x03b1;1 Subunits in Cultured Hippocampal Neurons	Gerald	2010	0		
895	chr19	40633637	40639425	3500086004	48		40633637	40639425	8421504	2	22,26	0,5762	c,g	350008600400000010,350008600400000012,350008600400000012	0-22,0-26,0-26			10.1371/journal.pone.0000292		PLoS ONE	Increased Expression of the Auxiliary &#x03b2;2-subunit of Ventricular L-type Ca2+ Channels Leads to Single-Channel Activity Characteristic of Heart Failure	Roger	2007	0		CACNB2
895	chr19	40642334	40642359	3500396369	23		40642334	40642359	8421504	2	12,11	0,14	g	350039636900000069,350039636900000087	4-27,4-27						 VMP 	www.docstoc.com	0	0		
895	chr19	40642334	40642359	3500389666	23		40642334	40642359	8421504	2	12,11	0,14	g	350038966600000079,350038966600000070	4-27,4-27						VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS - Patent application	www.faqs.org	0	0		
895	chr19	40644330	40645078	3500447030	40		40644330	40645078	8421504	2	20,20	0,728	c	350044703000000004,350044703000000005	0-20,0-20						Evaluation of Internal Reference Genes for Quantitative Expression Analysis by Real-Time PCR in Ovine Whole Blood	www.mdpi.com	0	0		
895	chr19	40645074	40645534	3500205057	42		40645074	40645534	8421504	3	20,6,16	0,71,444	c	350020505700000022,350020505700000023	0-20,0-22						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
895	chr19	40645074	40645534	3500137197	42		40645074	40645534	8421504	3	20,6,16	0,71,444	c	350013719700000022,350013719700000023	0-20,0-22						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
895	chr19	40645113	40645139	3500273964	26		40645113	40645139	8421504	1	26	0	c	350027396400000009	1-27						REPRODUCTION	uction-online.org	0	0		
895	chr19	40645149	40645954	3500430457	68		40645149	40645954	8421504	4	2,19,26,21	0,369,704,784	c	350043045700000015,350043045700000006,350043045700000008,350043045700000017,350043045700000016,350043045700000007	0-21,0-21,0-26,0-26,0-21,0-21						TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES - Patent application	www.faqs.org	0	0		RPL19
895	chr19	40645149	40645954	3500409111	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c	350040911100000002,350040911100000003	0-21,0-21		22219383	10.1091/mbc.E11-08-0663		Molecular Biology of the Cell	IRE1 directs proteasomal and lysosomal degradation of misfolded rhodopsin	Wei-Chieh	2012	0		
895	chr19	40645149	40645954	3500400338	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c	350040033800000000,350040033800000001	0-21,0-21		18337589	10.1210/me.2007-0360	0888-8809	Molecular Endocrinology	Cross Talk of Signaling Pathways in the Regulation of the Glucocorticoid Receptor Function	Davies	2008	5		RPL19
895	chr19	40645149	40645954	3500305637	68		40645149	40645954	8421504	4	2,19,26,21	0,369,704,784	c	350030563700000006,350030563700000008,350030563700000007	0-21,0-26,0-21					Patent	Treating prostate cancer with anti-ErbB2 antibodies (Patent US:7041292)	Sliwkowski	2006	0		
895	chr19	40645149	40645954	3500302804	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c	350030280400000004,350030280400000005	0-21,0-21		19619490	10.1016/j.devcel.2009.05.010		Developmental cell	Essential role of TGF-&#x03b2; signaling in glucose-induced cell hypertrophy	Liyu	July	0		
895	chr19	40645149	40645954	3500301659	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c,g	350030165900000008,350030165900000009,350030165900000009	0-21,0-21,0-21		21779470	10.1177/1947601910389604		Genes & Cancer	Transcriptional and Translational Downregulation of Thioredoxin Interacting Protein Is Required for Metabolic Reprogramming during G1	Marc	2010	0		RPL19
895	chr19	40645149	40645954	3500254405	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c	350025440500000005,350025440500000006	0-21,0-21		18562626	10.1210/me.2007-0581	0888-8809	Molecular Endocrinology	SUMO-Mediated Inhibition of Glucocorticoid Receptor Synergistic Activity Depends on Stable Assembly at the Promoter But Not on DAXX	Holmstrom	2008	5		
895	chr19	40645149	40645954	3500244629	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c	350024462900000002,350024462900000003	0-21,0-21						IRE1 Directs Proteasomal and Lysosomal Degradation of Misfolded Rhodopsin Wei-Chieh Chiang, Carissa Messah, Jonathan H. Lin Department of Pathology, University of California San Diego, La Jolla, 92093-0612	w.molbiolcell.org	0	0		
895	chr19	40645149	40645954	3500221570	68		40645149	40645954	8421504	4	2,19,26,21	0,369,704,784	c	350022157000000006,350022157000000008,350022157000000007	0-21,0-26,0-21						Treating prostate cancer with anti-ErbB2 antibodies	Sliwkowski	2006	0		
895	chr19	40645149	40645954	3500220423	68		40645149	40645954	8421504	4	2,19,26,21	0,369,704,784	c	350022042300000006,350022042300000008,350022042300000007	0-21,0-26,0-21						TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES	Sliwkowski	2009	0		
895	chr19	40645149	40645954	3500203580	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c	350020358000000002,350020358000000003	0-21,0-21		22219383	10.1091/mbc.E11-08-0663	1059-1524	Molecular Biology of the Cell	IRE1 directs proteasomal and lysosomal degradation of misfolded rhodopsin	Chiang	2012	5		RPL19
895	chr19	40645149	40645954	3500202580	68		40645149	40645954	8421504	4	2,19,26,21	0,369,704,784	c	350020258000000006,350020258000000008,350020258000000007	0-21,0-26,0-21						Treating prostate cancer with anti-ErbB2 antibodies	Sliwkowski	2005	0		
895	chr19	40645149	40645954	3500194538	68		40645149	40645954	8421504	4	2,19,26,21	0,369,704,784	c	350019453800000031,350019453800000033,350019453800000032	0-21,0-26,0-21						Treating Prostate Cancer With Anti-erbb2 Antibodies 	.freshpatents.com	0	0		
895	chr19	40645149	40645954	3500173886	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c	350017388600000018,350017388600000019	0-21,0-21		18665422	10.1007/s10162-008-0134-y		JARO: Journal of the Association for Research in Otolaryngology	Localization of Synucleins in the Mammalian Cochlea	O.	2008	0		RPL19
895	chr19	40645149	40645954	3500156810	42		40645149	40645954	8421504	3	2,19,21	0,369,784	c	350015681000000002,350015681000000003	0-21,0-21						IRE1 directs proteasomal and lysosomal degradation of misfolded rhodopsin	w.molbiolcell.org	0	0		
895	chr19	40645586	40645610	3500437570	24		40645586	40645610	8421504	1	24	0	c,g	350043757000000006,350043757000000006	0-24,0-24						BIOMARKERS FOR TREATMENT WITH ANTI-TUBULIN CHEMOTHERAPEUTIC COMPOUNDS - GENENTECH, INC.	www.sumobrain.com	0	0		
895	chr19	40645586	40645610	3500289454	24		40645586	40645610	8421504	1	24	0	c	350028945400000024	0-24						ANTI-FGF19 ANTIBODIES AND METHODS USING SAME	Desnoyers	2011	0		
895	chr19	40645586	40645610	3500062291	24		40645586	40645610	8421504	1	24	0	c	350006229100000031	0-24						Cop1 molecules and uses thereof	Dixit	2007	0		
895	chr19	40645858	40645881	3500145361	23		40645858	40645881	8421504	1	23	0	c	350014536100000036	0-23						Synthetic antibody phage libraries	Hai Di *A Ke Li 	2006	0		
895	chr19	40645911	40645934	3500167619	23		40645911	40645934	8421504	1	23	0	c	350016761900000014	0-23						Identification and characterization of new genes and pathways regulating spermatogonial cell fate	www.doria.fi	0	0		
895	chr19	40692323	40735680	3500177594	1291		40692323	40735680	8421504	14	130,213,57,45,61,131,75,127,96,69,95,75,55,62	0,1497,2709,4426,5592,7265,9815,11232,12938,21881,22422,23688,26657,43295	p,c	350017759400000034,350017759400015068	16-1382,0-1260						Novel nucleic acids and polypeptides and methods of use thereof	Shimkets	2002	0		
895	chr19	40692323	40735644	3500069181	1254		40692323	40735644	8421504	15	130,213,57,45,61,131,75,127,96,69,95,75,55,14,11	0,1497,2709,4426,5592,7265,9815,11232,12938,21881,22422,23688,26657,43295,43310	c	350006918100000166	0-1254						Human nucleic acids and polypeptides and methods of use thereof	Corporation	2002	0		
895	chr19	40700049	40700079	3500322097	26		40700049	40700079	8421504	2	8,18	0,12	g	350032209700000478	5-37						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
896	chr19	40797486	40797543	3500415138	57		40797486	40797543	8421504	1	57	0	p	350041513800015006	0-57		19903832	10.1124/mol.109.060541	1521-0111 (Online)	Molecular Pharmacology	15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor &#x03b2;/&#x03b4; Agonist	Naruhn	2010	0		MED1
896	chr19	40797486	40797543	3500311029	57		40797486	40797543	8421504	1	57	0	p	350031102900015003	0-57						PIM-1 kinase interacts with the DNA binding domain of the vitamin D receptor: a further kinase implicated in 1,25-(OH)2D3 signaling	biomedcentral.com	0	0		MED1
896	chr19	40797489	40797564	3500137367	75		40797489	40797564	8421504	1	75	0	p	350013736700015004	0-75						ANovelPrincipleforPartialAgonismofLiverX ReceptorLigands	www.dkfz.de	0	0		MED1
896	chr19	40797489	40797549	3500301923	60		40797489	40797549	8421504	1	60	0	p	350030192300015002	0-60						Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator	www.jlr.org	0	0		MED1
896	chr19	40797612	40797687	3500456201	75		40797612	40797687	8421504	1	75	0	p	350045620100015010	0-75						Lxr ligand testing method - Patent application	www.faqs.org	0	0		MED1
896	chr19	40797612	40797687	3500341244	75		40797612	40797687	8421504	1	75	0	p	350034124400015011	0-75						Lxr ligand testing method	Terasaka	2008	0		MED1
896	chr19	40797612	40797687	3500179198	75		40797612	40797687	8421504	1	75	0	p	350017919800015010	0-75					Patent	LXR ligand testing method (Patent US:7989179)	Honzumi	2011	0		MED1
896	chr19	40797792	40802509	3500463719	46		40797792	40802509	8421504	2	22,24	0,4693	c,g	350046371900000001,350046371900000001,350046371900000000	0-22,0-22,0-24			10.1111/j.1574-695X.2005.00035.x	1574-695X	FEMS Immunology & Medical Microbiology	Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and nontuberculous European wild boars naturally exposed to Mycobacterium bovis - Naranjo - 2006 - FEMS Immunology & Medical Microbiology - Wiley Online Libr	Naranjo	2006	0		
896	chr19	40797792	40802509	3500322660	46		40797792	40802509	8421504	2	22,24	0,4693	c,g	350032266000000001,350032266000000001,350032266000000000	0-22,0-22,0-24						Caracterizaci&#xf3;n gen&#xf3;mica y prote&#xf3;mica de la expresi&#xf3;n g&#xe9;nica diferencial en jabal&#xed;es infectados de forma natural con Mycobacterium bovis Identificaci&#xf3;n de biomarcadores asociados con la infecci&#xf3;n y la respuesta inmu	digital.csic.es	0	0		
896	chr19	40861090	40865050	3500393813	120		40861090	40865050	8421504	2	40,80	0,3880	p	350039381300015032	0-120						A novel cdc2-related kinase	cs.biologists.org	0	0		
897	chr19	40955769	40961469	3500417410	432		40955769	40961469	8421504	7	46,23,27,1,198,120,17	0,319,756,831,3960,5475,5683	p	350041741000015012,350041741000015014,350041741000015019,350041741000015049,350041741000015050,350041741000015051,350041741000015052,350041741000015053,350041741000015054	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						PHOSPHODIESTERASE ACTIVITY AND REGULATION OF PHOSPHODIESTERASE 1B-MEDIATED SIGNALING IN BRAIN - Patent application	www.faqs.org	0	0		
897	chr19	40958280	40958308	3500015213	23		40958280	40958308	8421504	2	11,12	0,16	g	350001521300000042	8-31						P53 binding T cell receptor molecules - Patent # 7456263 - PatentGenius	.patentgenius.com	0	0		
897	chr19	40959851	40961318	3500323393	147		40959851	40961318	8421504	3	69,4,74	0,72,1393	p	350032339300015035	0-147						US Patent # 7,320,785. Compositions and methods for modulation of DARPP-32 phosphorylation - Patents.com	www.patents.com	0	0		
897	chr19	40975772	40981227	3500137915	26		40975772	40981227	8421504	4	13,4,5,4	0,5438,5445,5451	c	350013791500000702,350013791500000037	4-30,4-30						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
897	chr19	41019844	41019870	3500276984	26		41019844	41019870	8421504	1	26	0	g	350027698400000005	0-26						Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes	Foulkes	1992	0		
897	chr19	41023751	41023777	3500442359	23		41023751	41023777	8421504	2	15,8	0,18	g	350044235900000005,350044235900000004	0-23,9-32						The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M112.403386 pIII and pIII:TolA	www.jbc.org	0	0		
898	chr19	41045487	41045532	3500108073	45		41045487	41045532	8421504	1	45	0	p	350010807300015070	0-45					Patent	C35 antibodies and their use in the treatment of cancer (Patent EP:2070949)	Zauderer	2013	0		MIEN1
898	chr19	41059872	41060088	3500424225	42		41059872	41060088	8421504	2	21,21	0,195	c	350042422500000002,350042422500000003	0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
898	chr19	41086375	41086420	3500349661	45		41086375	41086420	8421504	1	45	0	p	350034966100015011	0-45						Ikaros: a t cell pathway regulatory gene	Georgopoulos	1994	0		IKZF3
898	chr19	41098879	41098948	3500269504	69		41098879	41098948	8421504	1	69	0	p	350026950400015066	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		IKZF3
898	chr19	41098879	41098948	3500075471	69		41098879	41098948	8421504	1	69	0	p	350007547100015027,350007547100015094	21-90,0-69						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		IKZF3
899	chr19	41204265	41204292	3500034292	27		41204265	41204292	8421504	1	27	0	c	350003429200000107	1-28						Methods and compositions for the response prediction of malig-nant neoplasia to treatment	Munnes	2005	0		
899	chr19	41277338	41278792	3500309656	585		41277338	41278792	8421504	5	13,155,108,147,162	0,118,667,920,1292	p	350030965600015021	0-585						Alineamiento de secuencias. B&#xfa;squeda de parecidos.Alineamientos m&#xfa;ltiples. Parte te&#xf3;rica	www.wiphala.net	0	0		
899	chr19	41277506	41278792	3500118207	522		41277506	41278792	8421504	4	105,108,147,162	0,499,752,1124	p	350011820700015014,350011820700015011,350011820700015015,350011820700015012,350011820700015016,350011820700015013,350011820700015017,350011820700015018	3-96,0-96,0-96,0-96,0-96,0-330,0-96,0-141						Modified Bovine G-CSF Polypeptides And Their Uses	Hays	2009	0		
899	chr19	41277506	41278789	3500072421	501		41277506	41278789	8421504	9	93,9,84,21,72,72,18,90,42	0,96,499,586,752,827,1124,1148,1241	p	350007242100015012,350007242100015009,350007242100015013,350007242100015010,350007242100015014,350007242100015011,350007242100015015,350007242100015016	0-90,0-90,0-90,0-90,0-90,0-306,0-90,0-129						Modified Bovine G-csf Polypeptides And Their Uses 	.freshpatents.com	0	0		
899	chr19	41277525	41278323	3500222066	53		41277525	41278323	8421504	3	8,19,26	0,11,772	c	350022206600000015,350022206600000000,350022206600000022,350022206600000023,350022206600000004	4-24,9-28,0-19,0-19,0-20					Patent	Feline granulocyte colony-stimulating factor (Patent US:6610515)	Yamamoto	2003	0		
899	chr19	41277525	41277555	3500282009	27		41277525	41277555	8421504	2	8,19	0,11	c	350028200900000019,350028200900000031	4-24,0-19					Patent	Granulozyten-kolonie-stimulierender faktor aus der katze Granulocyte colony-stimulating factor from the cat (Patent DE:69834938)	IWATA	2007	0		CSF3
899	chr19	41277536	41277560	3500314711	24		41277536	41277560	8421504	1	24	0	c	350031471100000059	0-24						Glycosylated G-CSF - Patent application	www.faqs.org	0	0		
899	chr19	41277536	41277560	3500252917	24		41277536	41277560	8421504	1	24	0	c	350025291700000059	0-24						Glycosylated interferon alpha - Patent application	www.faqs.org	0	0		
899	chr19	41277536	41277560	3500037671	24		41277536	41277560	8421504	1	24	0	c	350003767100000047	0-24						Glycosylated Erythropoietin 	.freshpatents.com	0	0		
899	chr19	41277550	41277574	3500155690	24		41277550	41277574	8421504	1	24	0	c	350015569000000014	15-39						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		CSF3
899	chr19	41277551	41278330	3500167455	192		41277551	41278330	8421504	3	60,84,48	0,454,731	p	350016745500015125,350016745500015126,350016745500015127,350016745500015129	0-48,0-48,0-48,0-48						Cytokine-like Proteins 	.freshpatents.com	0	0		
899	chr19	41278045	41278075	3500391220	24		41278045	41278075	8421504	3	11,4,9	0,12,21	c	350039122000000026	22-46						ANTIBODIES AND RELATED MOLECULES THAT BIND TO PSCA PROTEINS - Patent application	www.faqs.org	0	0		
899	chr19	41278345	41278375	3500245482	30		41278345	41278375	8421504	1	30	0	c	350024548200000152	12-42						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
899	chr19	41278345	41278374	3500340510	29		41278345	41278374	8421504	1	29	0	c	350034051000000055	18-47					Patent	Polypeptide derivatives of granulocyte colony stimulating factor (Patent US:5416195)	Camble	1995	0		
899	chr19	41279118	41279141	3500375201	23		41279118	41279141	8421504	1	23	0	c	350037520100000028	0-23						Sodium channel regulators and modulators	BAKER	2004	0		CSF3
899	chr19	41279118	41279141	3500258255	23		41279118	41279141	8421504	1	23	0	c	350025825500000032	0-23						Method of identifying a modulator of a voltage-gated sodium channel using cells expressing Nav1.8 and p11	Okuse	2002	0		CSF3
899	chr19	41279118	41279141	3500182671	23		41279118	41279141	8421504	1	23	0	c	350018267100000032	0-23					Patent	Method of identifying a modulator of a voltage-gated sodium channel using cells expressing Nav1.8 and p11 (Patent US:7563586)	Baker	2009	0		CSF3
899	chr19	41279118	41279141	3500090094	23		41279118	41279141	8421504	1	23	0	c	350009009400000011	0-23						Sodium channel regulators and modulators	Baker	2004	0		CSF3
900	chr19	41324171	41333138	3500209035	50		41324171	41333138	8421504	2	25,25	0,8942	c,g	350020903500000006,350020903500000007	9-34,9-34						Mutant-Selective Thyromimetics for the Chemical Rescue of Thyroid Hormone Receptor Mutants Associated with Resistance to Thyroid Hormone	.scs.illinois.edu	0	0		
900	chr19	41324171	41324198	3500007848	27		41324171	41324198	8421504	1	27	0	c,g	350000784800000012,350000784800000012	0-27,0-27						Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy	g.library.pcc.edu	0	0		THRA
900	chr19	41327325	41329307	3500021751	45		41327325	41329307	8421504	2	18,27	0,1955	p	350002175100015002	0-45						Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same	Dedhar	1995	0		THRB
900	chr19	41330063	41330182	3500016688	45		41330063	41330182	8421504	2	23,22	0,97	c	350001668800000019,350001668800000018	0-23,0-22						N&#xb0; d'ordre THESE	mm.u-bordeaux1.fr	0	0		THRA
900	chr19	41332093	41332128	3500201814	29		41332093	41332128	8421504	3	10,4,15	0,15,20	c	350020181400000001	3-47						PTX sensitive G proteins, the production and use thereof	Siffert	1999	0		THRA
900	chr19	41332985	41333044	3500376186	56		41332985	41333044	8421504	2	27,29	0,30	c,g	350037618600000020,350037618600000021	0-27,0-29		15143152	10.1210/me.2003-0351	0888-8809	Molecular Endocrinology	Thyroid Hormone Positively Regulates the Enterocyte Differentiation Marker Intestinal Alkaline Phosphatase Gene via an Atypical Response Element	Malo	2004	5		THRA
900	chr19	41332995	41336801	3500078566	79		41332995	41336801	8421504	3	42,18,19	0,3768,3787	c,g	350007856600000007,350007856600000008	19-61,22-72						The Role of Thyroid Hormones in Placental Development and the Importance of the Thyroid Hormone Transporter MCT8	theses.bham.ac.uk	0	0		NR1D1,THRA
900	chr19	41333014	41336857	3500095488	65		41333014	41336857	8421504	4	1,22,21,21	0,3749,3774,3822	c	350009548800000007,350009548800000008,350009548800000004	21-44,0-21,21-42						ABSTRACT Title of dissertation: EFFECTS OF AGING AND MODERATE CALORIE RESTRICTION ON THE REPRODUCTIVE AXIS OF THE MALE RHESUS MACAQUE (MACACA MULATTA) Brandon Dale Sitzmann, Doctor of Philosophy, 2007	drum.lib.umd.edu	0	0		
900	chr19	41336937	41337007	3500316136	40		41336937	41337007	8421504	2	20,20	0,50	c,g	350031613600000001,350031613600000001,350031613600000000,350031613600000000	0-20,0-20,0-20,0-20						ScienceDirect.com - Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids - A second class of nuclear receptors for oxysterols: Regulation of ROR&#x03b1; and ROR&#x03b3; activity by 24S-hydroxycholesterol (cerebrosterol)	sciencedirect.com	0	0		THRA
900	chr19	41336937	41337007	3500223796	40		41336937	41337007	8421504	2	20,20	0,50	c,g	350022379600000009,350022379600000009,350022379600000008,350022379600000008	0-20,0-20,0-20,0-20						Direct Regulation of CLOCK Expression by REV-ERB | Christine Crumbley - Academia.edu	www.academia.edu	0	0		THRA
900	chr19	41336937	41337007	3500066580	40		41336937	41337007	8421504	2	20,20	0,50	c,g	350006658000000009,350006658000000009,350006658000000008,350006658000000008	0-20,0-20,0-20,0-20		21479263	10.1371/journal.pone.0017290	1932-6203	PLOS ONE	PLOS ONE: Direct Regulation of CLOCK Expression by REV-ERB	Crumbley	2011	4		THRA
900	chr19	41340666	41340689	3500282482	23		41340666	41340689	8421504	1	23	0	c	350028248200000036	20-43						Prevention and therapy of type 2 diabetes by selective modulation of the human peroxisome proliferator-activated receptor gamma (PPAR&#x03b3;	diss.fu-berlin.de	0	0		
900	chr19	41396603	41399210	3500074735	182		41396603	41399210	8421504	6	48,19,29,42,24,20	0,841,1095,1518,2377,2587	c	350007473500000041,350007473500000044,350007473500000048,350007473500000053	0-48,0-48,6-48,0-44						Novel Use of MLN51 Gene and Protein - Patent application	www.faqs.org	0	0		
900	chr19	41417962	41417992	3500433790	27		41417962	41417992	8421504	2	12,15	0,15	c	350043379000000002	10-37						Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression - Patent # 6020155 - PatentGenius	.patentgenius.com	0	0		
901	chr19	41457928	41457973	3500249107	36		41457928	41457973	8421504	2	21,15	0,30	c	350024910700000110	0-36						Method of preparation of pharmaceutically grade plasmid DNA	Fu Lang Xi Si *Bu Lan Qi 	2006	0		
901	chr19	41457928	41457973	3500236882	36		41457928	41457973	8421504	2	21,15	0,30	c	350023688200000152	0-36						Purification of triple heli formation with immobilized oligonucleotide	J*Ke Luo Sai Te 	2003	0		
901	chr19	41463280	41463325	3500079754	45		41463280	41463325	8421504	1	45	0	p	350007975400015092	0-45						Heparanase Specific Molecular Probes And Their Use In Research And Medical Applications 	.freshpatents.com	0	0		WIPF2
901	chr19	41472830	41472859	3500168057	23		41472830	41472859	8421504	3	6,5,12	0,9,17	c	350016805700000196	20-43						Method for modulating gene expression by modifying the cpg content - Patent application	www.faqs.org	0	0		
901	chr19	41491959	41491982	3500392375	23		41491959	41491982	8421504	1	23	0	c	350039237500000002	12-35						Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins	jcb.rupress.org	0	0		CDC6
901	chr19	41505442	41534479	3500165278	59		41505442	41534479	8421504	3	21,19,19	0,28892,29018	c,g	350016527800000151,350016527800000159,350016527800000160	0-21,0-19,0-19						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
901	chr19	41518787	41540442	3500241360	42		41518787	41540442	8421504	2	22,20	0,21635	c	350024136000000002,350024136000000003	8-30,8-28			10.1152/ajpgi.00191.2006		American journal of physiology. Gastrointestinal and liver physiology	Nuclear receptors RXR&#x03b1;:RAR&#x03b1; are repressors for human MRP3 expression	Wensheng	2007	0		
901	chr19	41518910	41518936	3500012216	26		41518910	41518936	8421504	1	26	0	c	350001221600000003	0-26						PML RAR and FLT3-ITD induce an APL-like disease in a mouse model	www.pnas.org	0	0		RARA
901	chr19	41518962	41540437	3500383900	289		41518962	41540437	8421504	10	4,15,40,5,45,45,9,36,45,45	0,13880,15462,17444,17452,17548,17596,17898,17985,21430	p,c	350038390000000002,350038390000015011,350038390000015013,350038390000015017,350038390000015019,350038390000015023,350038390000015047	11-30,0-45,0-45,0-45,0-45,0-45,0-45					Patent	Productivity augmenting protein factor, novel cell lines and uses thereof (Patent CN:101356265)	V*Sang Di Ge 	2013	0		RARA
901	chr19	41521042	41521066	3500157475	23		41521042	41521066	8421504	2	11,12	0,12	g	350015747500000002	7-33		17339332	10.1128/MCB.02187-06	0270-7306	Molecular and Cellular Biology	Rct1, a Nuclear RNA Recognition Motif-Containing Cyclophilin, Regulates Phosphorylation of the RNA Polymerase II C-Terminal Domain	Gullerova	2007	6		
901	chr19	41532844	41540795	3500326390	50		41532844	41540795	8421504	2	25,25	0,7926	c	350032639000000001,350032639000000009	0-25,0-25		20807888	10.1182/blood-2010-01-264432	0006-4971	Blood	BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia	Yamamoto	2010	10		
901	chr19	41532946	41532970	3500361384	24		41532946	41532970	8421504	1	24	0	c	350036138400000004	0-24						Characterization of Acute Promyelocytic Leukemia Cases With PML-RARa Break/Fusion Sites in PML Exon 6: Identification of a Subgroup With Decreased In Vitro Responsiveness to All-Trans Retinoic Acid	tologylibrary.org	0	0		RARG
901	chr19	41532949	41540406	3500408290	206		41532949	41540406	8421504	7	42,21,40,8,42,6,47	0,1373,1475,3457,4046,5301,7410	c	350040829000000029,350040829000000064,350040829000000032,350040829000000039,350040829000000085	0-48,0-48,0-48,0-48,0-47						Methods for detection of acute promyelocytic leukemia (APL)	Dmitrovsky	1993	0		
901	chr19	41532958	41534337	3500052842	48		41532958	41534337	8421504	2	33,15	0,1364	p	350005284200015018	0-48						DMD #24695 A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor	aspetjournals.org	0	0		RARA
901	chr19	41532973	41534349	3500021751	45		41532973	41534349	8421504	2	18,27	0,1349	p	350002175100015001	0-45						Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same	Dedhar	1995	0		RARB
901	chr19	41532975	41534329	3500014538	23		41532975	41534329	8421504	2	16,7	0,1347	c	350001453800000008	0-23			10.1002/hep.21592	1527-3350	Hepatology	Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4&#x03b1; isoforms - Pascussi - 2007 - Hepatology - Wiley Online Library	Pascussi	2007	0		
901	chr19	41532988	41534343	3500354450	24		41532988	41534343	8421504	2	3,21	0,1334	c	350035445000000001	0-24		9116296		0006-4971	Blood	Downregulation of RAR&#x03b1; in Mice by Antisense Transgene Leads to a Compensatory Increase in RAR&#x03b2; and RAR&#x03b3; and Development of Lymphoma	Manshouri	1997	10		
901	chr19	41534432	41534456	3500121176	24		41534432	41534456	8421504	1	24	0	c	350012117600000000	0-24						Therapeutic combinations of RAR antagonists and RXR agonists and use thereof - Patent # 6653322 - PatentGenius	.patentgenius.com	0	0		
901	chr19	41536534	41540299	3500356489	627		41536534	41540299	8421504	7	33,42,123,205,71,76,77	0,326,380,1716,2951,3034,3688	p	350035648900015058,350035648900015059,350035648900015077,350035648900015078	0-75,0-279,0-120,0-153					Patent	Polynucleotide encoding insect ecdysone receptor (Patent US:6245531)	Hogness	2001	0		RARA
901	chr19	41536914	41540299	3500185455	552		41536914	41540299	8421504	5	123,205,71,76,77	0,1336,2571,2654,3308	p	350018545500015032,350018545500015052,350018545500015111,350018545500015072,350018545500015088	0-144,0-135,0-138,0-96,0-153						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers_ Sources	www.docstoc.com	0	0		
901	chr19	41536914	41540299	3500111757	546		41536914	41540299	8421504	6	123,156,43,71,76,77	0,1336,1498,2571,2654,3308	p	350011175700015042,350011175700015065,350011175700015126,350011175700015081,350011175700015099	0-144,0-135,0-132,0-96,0-153						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers, Sources	www.scribd.com	0	0		RARA
901	chr19	41536995	41538256	3500088205	48		41536995	41538256	8421504	2	42,6	0,1255	c	350008820500000039	0-48						Methods for detection of acute promyelocytic leukemia (APL) - US Patent 5843642 Description	ww.patentstorm.us	0	0		
901	chr19	41538299	41538326	3500200513	27		41538299	41538326	8421504	1	27	0	c	350020051300000023	5-32						 Genes And Genetic Markers For Improved Reproductive Traits In Animals 	www.docstoc.com	0	0		
901	chr19	41538299	41538326	3500147561	27		41538299	41538326	8421504	1	27	0	c	350014756100000023	5-32						Genes and genetic markers for improved reproductive traits in animals - Patent # 5939264 - PatentGenius	.patentgenius.com	0	0		
901	chr19	41540284	41540307	3500061288	23		41540284	41540307	8421504	1	23	0	c	350006128800000016	0-23		23345238	10.1523/JNEUROSCI.1338-12.2013	0270-6474	The Journal of Neuroscience	Retinoic Acid Induces Blood&#x2013;Brain Barrier Development	Mizee	2013	7		
902	chr19	41626041	41629012	3500263468	40		41626041	41629012	8421504	3	20,19,1	0,1019,2970	c	350026346800000010,350026346800000011	0-20,0-20		16204335	10.1152/ajpendo.00363.2005		American Journal of Physiology - Endocrinology and Metabolism	Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5	Kiepe	2006	0		IGFBP4
902	chr19	41626041	41629012	3500022308	40		41626041	41629012	8421504	3	20,19,1	0,1019,2970	c	350002230800000010,350002230800000011	0-20,0-20		16204335	10.1152/ajpendo.00363.2005		American Journal of Physiology - Endocrinology and Metabolism	Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5	Kiepe	2006	0		IGFBP4
902	chr19	41627019	41629107	3500315971	67		41627019	41629107	8421504	2	22,45	0,2043	c,g	350031597100000014,350031597100000014,350031597100000046,350031597100000047	0-22,0-22,0-45,0-45						REPRODUCTION	uction-online.org	0	0		
902	chr19	41627045	41627069	3500281871	24		41627045	41627069	8421504	1	24	0	c	350028187100000007	0-24						A quantitative RT-PCR study of the mRNA expression pro&#xfb01;le of the IGF axis during mammary gland development	logy-journals.org	0	0		IGFBP4
903	chr19	41721657	41721984	3500277510	134		41721657	41721984	8421504	3	60,27,47	0,232,280	c	350027751000000104,350027751000000044,350027751000000125,350027751000000124	0-48,0-48,20-47,0-47						Novel seven transmembrane receptors	Godiska	1994	0		
903	chr19	41721693	41722226	3500344302	43		41721693	41722226	8421504	2	21,22	0,511	c	350034430200000003,350034430200000002	0-21,0-22		21548969	10.1186/1756-9966-30-51	1756-9966	Journal of Experimental & Clinical Cancer Research	Effect of Chemokine Receptors CCR7 on Disseminated Behavior of Human T cell Lymphoma: clinical and experimental study	Yang	2011	2		CCR7
903	chr19	41721693	41722226	3500022038	44		41721693	41722226	8421504	2	22,22	0,511	c	350002203800000001,350002203800000000	0-22,0-22						Expression of Chemokine Receptor CCR7 Is Associated with Lymph Node Metastasis of Gastric Carcinoma	.aacrjournals.org	0	0		
903	chr19	41721693	41722226	3500018431	44		41721693	41722226	8421504	2	22,22	0,511	c	350001843100000003,350001843100000002	0-22,0-22		9743376		0022-1767	The Journal of Immunology	EBI1/CCR7 Is a New Member of Dendritic Cell Chemokine Receptor That Is Up-Regulated upon Maturation	Yanagihara	1998	6		
903	chr19	41722051	41722077	3500000582	26		41722051	41722077	8421504	1	26	0	c	350000058200000003	0-26		11136819	10.1084/jem.193.1.35	0022-1007	The Journal of Experimental Medicine	Regulation by Chemokines of Circulating Dendritic Cell Precursors, and the Formation of Portal Tract&#x2013;Associated Lymphoid Tissue, in a Granulomatous Liver Disease	Yoneyama	2001	14		CCR7
903	chr19	41780136	41799480	3500328270	82		41780136	41799480	8421504	5	20,19,20,16,7	0,11148,16118,19145,19337	c,g	350032827000000035,350032827000000035,350032827000000033,350032827000000033,350032827000000034,350032827000000034,350032827000000018	0-20,0-20,0-19,0-19,0-20,0-20,14-37						Methods and compositions for predicting resistance to anticancer treatment	Bernards	2012	0		SMARCE1
904	chr19	41852274	41852325	3500334309	51		41852274	41852325	8421504	1	51	0	p	350033430900015038	9-60						Proteomic Analyses of Thyroid Hormone-sensitive Tissues During Frog Tadpole Metamorphosis	rary.uvic.ca:8080	0	0		
904	chr19	41853615	41853638	3500430831	23		41853615	41853638	8421504	1	23	0	c	350043083100000021	3-26						Exogenous and endogenous gene regulation for specific and efficient cancer gene therapy	tations.ub.rug.nl	0	0		
904	chr19	41853615	41853638	3500074012	23		41853615	41853638	8421504	1	23	0	c	350007401200000017	3-26						Chapter	tations.ub.rug.nl	0	0		
904	chr19	41916677	41916705	3500334309	28		41916677	41916705	8421504	1	28	0	c	350033430900000011	32-60						Proteomic Analyses of Thyroid Hormone-sensitive Tissues During Frog Tadpole Metamorphosis	rary.uvic.ca:8080	0	0		
904	chr19	41929337	41929391	3500065419	54		41929337	41929391	8421504	1	54	0	p	350006541900015010	0-54						The Genetic Basis of Weber-Cockayne Epidermolysis Bullosa Simplex	www.jstor.org	0	0		KRT27
904	chr19	41929337	41929382	3500427638	45		41929337	41929382	8421504	1	45	0	p	350042763800015000	0-45		11407994	10.1046/j.0022-202x.2001.01382.x	0022-202X	Journal of Investigative Dermatology	A Novel Leucine to Valine Mutation in Residue 7 of the Helix Initiation Motif of Keratin10 Leads to Bullous Congenital Ichthyosiform Erythroderma	Ishiko	2001	6		KRT14
905	chr19	41957349	41957462	3500177573	24		41957349	41957462	8421504	2	17,7	0,106	c	350017757300000012	0-24						TH&#xc8;SE	esups.ups-tlse.fr	0	0		
905	chr19	41957551	41957721	3500145827	78		41957551	41957721	8421504	4	36,24,3,15	0,42,149,155	p	350014582700015027	0-78						Nuclear and Mitochondrial Inheritance in Yeast Depends on Novel Cytoplasmic Structures Defined by the MDM1 Protein	jcb.rupress.org	0	0		
905	chr19	41957556	41957586	3500304799	30		41957556	41957586	8421504	1	30	0	c,g	350030479900000079,350030479900000079	28-58,28-58						www.stemcell8.cn &#x2190;&#x70b9;&#x51fb;&#x8fdb;&#x5165;	www.bjcancer.org	0	0		KRT10
905	chr19	41957558	41957581	3500459722	23		41957558	41957581	8421504	1	23	0	c	350045972200000012	0-23		18637117	10.1111/j.1742-4658.2008.06567.x	1742-4658	FEBS Journal	Truncated P-cadherin is produced in oral squamous cell carcinoma - Bauer - 2008 - FEBS Journal - Wiley Online Library	Bauer	2008	0		KRT10
905	chr19	41959199	41959225	3500024619	26		41959199	41959225	8421504	1	26	0	c	350002461900000013	0-26		19625175	10.1016/j.plefa.2009.05.025		Prostaglandins, leukotrienes, and essential fatty acids	The EP1 subtype of Prostaglandin E2 Receptor: Role in Keratinocyte Differentiation and Expression in Non-Melanoma Skin Cancer	R.	2009	0		
905	chr19	41959313	41959336	3500109816	23		41959313	41959336	8421504	1	23	0	c	350010981600000053	1-48						Crossless retroviral vectors		1998	0		
905	chr19	41959313	41959336	3500087615	23		41959313	41959336	8421504	1	23	0	c	350008761500000048	1-46						Crossless retroviral vectors	Bodner	1999	0		
905	chr19	41959313	41959336	3500016529	23		41959313	41959336	8421504	1	23	0	c	350001652900000042	1-48						US Patent # 6,333,195. Crossless retroviral vectors - Patents.com	www.patents.com	0	0		
905	chr19	41959626	41959652	3500160640	26		41959626	41959652	8421504	1	26	0	c	350016064000000039	0-26		22733990	10.1128/MCB.00174-12	0270-7306	Molecular and Cellular Biology	Alternative Splicing Regulates Prdm1/Blimp-1 DNA Binding Activities and Corepressor Interactions	Morgan	2012	6		KRT10
905	chr19	42012399	42012423	3500034292	24		42012399	42012423	8421504	1	24	0	c	350003429200000173	0-24						Methods and compositions for the response prediction of malig-nant neoplasia to treatment	Munnes	2005	0		
905	chr19	42012399	42012423	3500033254	24		42012399	42012423	8421504	1	24	0	c	350003325400000173	0-24						METHODS AND COMPOSITIONS FOR THE RESPONSE PREDICTION OF MALIG-NANT NEOPLASIA TO TREATMENT - BAYER HEALTHCARE AG	www.sumobrain.com	0	0		
907	chr19	42273711	42273738	3500279149	23		42273711	42273738	8421504	3	13,4,6	0,14,21	c	350027914900000001	12-35						Cell, Vol. 69, 795-807, May 29, 1992, Copyright 0 1992 by Cell Press Activation of C-WC Neuron-Specific Splicing by an Unusual RNA Element In Vivo and In Vitro	www.mimg.ucla.edu	0	0		
908	chr19	42362029	42362056	3500370435	23		42362029	42362056	8421504	2	11,12	0,15	g	350037043500000468	1-24						Neisseria meningitidis antigens and compositions	Fraser	2008	0		
910	chr19	42617852	42617876	3500180889	24		42617852	42617876	8421504	1	24	0	c	350018088900000005	7-31						Mechanoactive Tenogenic Differentiation of Human Mesenchymal Stem Cells	ncedbiomatrix.com	0	0		
911	chr19	42762823	42771127	3500082231	41		42762823	42771127	8421504	2	21,20	0,8284	c,g	350008223100000020,350008223100000020,350008223100000021	0-21,0-21,0-20						Supporting Information	www.pnas.org	0	0		
911	chr19	42771409	42771478	3500447096	43		42771409	42771478	8421504	2	24,19	0,50	c	350044709600000007,350044709600000006	0-24,0-19						Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage	Zern	2004	0		
911	chr19	42771451	42772267	3500372249	40		42771451	42772267	8421504	2	20,20	0,796	c,g	350037224900000007,350037224900000007,350037224900000006	0-20,0-20,0-20			10.1002/hep.20735	1527-3350	Hepatology	Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity - Nierhoff - 2005 - Hepatology - Wiley Online Library	Nierhoff	2005	0		KRT15
911	chr19	42771485	42772209	3500200949	40		42771485	42772209	8421504	3	20,2,18	0,481,706	c	350020094900000003,350020094900000002	0-20,0-20		18704763	10.1007/s12192-008-0070-0		Cell Stress & Chaperones	Caloric stress alters fat characteristics and Hsp70 expression in milk somatic cells of lactating beef cows	HarEitam	2009	0		
911	chr19	42771485	42772209	3500193901	40		42771485	42772209	8421504	3	20,2,18	0,481,706	c	350019390100000003,350019390100000002	0-20,0-20						Caloric stress alters fat characteristics and Hsp70 expression in milk somatic cells of lactating beef cows	web.oranim.ac.il	0	0		
911	chr19	42771815	42771838	3500385324	23		42771815	42771838	8421504	1	23	0	c	350038532400000048	20-43						METHODS FOR APCDD1 MEDIATED REGULATION OF HAIR GROWTH AND PIGMENTATION AND MUTANTS THEREOF - Patent application	www.faqs.org	0	0		KRT15
911	chr19	42771815	42771838	3500160136	23		42771815	42771838	8421504	1	23	0	c	350016013600000197	0-23						Use of WNT inhibitor to inhibit angiogenesis in the CNS - Patent application	www.faqs.org	0	0		
911	chr19	42774090	42774114	3500298705	24		42774090	42774114	8421504	1	24	0	c	350029870500000022	0-24		14699072	10.1091/mbc.E03-06-0360	1059-1524	Molecular Biology of the Cell	Estradiol and Selective Estrogen Receptor Modulators Differentially Regulate Target Genes with Estrogen Receptors &#x03b1; and &#x03b2;	Tee	2004	5		KRT17
911	chr19	42774099	42774129	3500178433	30		42774099	42774129	8421504	1	30	0	c	350017843300000000	0-30						Molecular Detection of Cytokeratin-19&#x2013;Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Signi&#xfb01;cance	jco.ascopubs.org	0	0		
911	chr19	42832261	42832285	3500204870	24		42832261	42832285	8421504	1	24	0	c	350020487000000000	0-24		18688029	10.2353/ajpath.2008.071089		The American Journal of Pathology	Hedgehog Signaling, Keratin 6 Induction, and Sebaceous Gland Morphogenesis : Implications for Pachyonychia Congenita and Related Conditions	Li-Hong	2008	0		
911	chr19	42835048	42835545	3500153050	40		42835048	42835545	8421504	2	20,20	0,477	c,g	350015305000000001,350015305000000001,350015305000000000	0-20,0-20,0-20						The Genomic Organization of Type I Keratin Genes in Mice	yer.lab.nig.ac.jp	0	0		
911	chr19	42835077	42835473	3500354445	41		42835077	42835473	8421504	2	21,20	0,376	c,g	350035444500000022,350035444500000023,350035444500000023	0-21,0-20,0-20						Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)	B	2007	0		
911	chr19	42835233	42835260	3500235521	24		42835233	42835260	8421504	2	19,5	0,22	c	350023552100000054	3-30						IMPROVED METHODS FOR TRANSFORMING PHAFFIA STRAINS, TRANSFORMED PHAFFIA STRAINS SO OBTAINED AND RECOMBINANT DNA IN SAID METHODS - Gist-brocades B.	www.sumobrain.com	0	0		
911	chr19	42835521	42835544	3500014305	23		42835521	42835544	8421504	1	23	0	c	350001430500000000	10-33		20497219	10.1111/j.1600-0625.2010.01071.x	1600-0625	Experimental Dermatology	K16 is a further new candidate for homotypic intermediate filament protein interactions - Trost - 2010 - Experimental Dermatology - Wiley Online Library	Trost	2010	0		KRT16
911	chr19	42835659	42835693	3500285820	34		42835659	42835693	8421504	1	34	0	c	350028582000000011	7-41		10825196	10.1128/MCB.20.12.4328-4339.2000	0270-7306	Molecular and Cellular Biology	Novel Mechanism of Steroid Action in Skin through Glucocorticoid Receptor Monomers	Radoja	2000	6		
911	chr19	42835662	42835693	3500203604	31		42835662	42835693	8421504	1	31	0	c	350020360400000104	5-36						Methods in Molecular Biology Vol. 057 in Vitro Mutagenesis Protocols	www.scribd.com	0	0		
912	chr19	42878669	42878729	3500334309	60		42878669	42878729	8421504	1	60	0	p	350033430900015026	0-60						Proteomic Analyses of Thyroid Hormone-sensitive Tissues During Frog Tadpole Metamorphosis	rary.uvic.ca:8080	0	0		
912	chr19	42946355	42947976	3500270119	43		42946355	42947976	8421504	2	21,22	0,1599	c	350027011900000028,350027011900000029	1-22,0-22		11073994	10.1128/MCB.20.23.8944-8957.2000	0270-7306	Molecular and Cellular Biology	Novel Upf2p Orthologues Suggest a Functional Link between Translation Initiation and Nonsense Surveillance Complexes	Mendell	2000	6		
912	chr19	42947149	42947206	3500373255	57		42947149	42947206	8421504	1	57	0	p	350037325500015001	0-57						Suppressor cerevisiae Encodes Translation Factor tRNAMet	mcb.asm.org	0	0		EIF1B
913	chr19	43044202	43044228	3500352650	23		43044202	43044228	8421504	2	5,18	0,8	c	350035265000000298	17-40						Dna Diagnostics Based On Mass Spectrometry 	.freshpatents.com	0	0		
913	chr19	43091751	43091817	3500078731	43		43091751	43091817	8421504	2	21,22	0,44	c	350007873100000014,350007873100000013	0-21,0-22						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		
913	chr19	43096289	43101973	3500407458	40		43096289	43101973	8421504	2	20,20	0,5664	c	350040745800000009,350040745800000008	0-20,0-20						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
913	chr19	43096289	43101375	3500301078	42		43096289	43101375	8421504	3	21,8,13	0,83,5073	c	350030107800000030,350030107800000029	0-21,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
913	chr19	43096289	43101375	3500006584	42		43096289	43101375	8421504	3	21,8,13	0,83,5073	c	350000658400000017,350000658400000016	0-21,0-21						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
914	chr19	43170340	43170372	3500228069	24		43170340	43170372	8421504	3	11,6,7	0,14,25	c	350022806900000104	19-44						Production of recombinant blood clotting factors in human cell lines	C*Hao Ze Er 	2003	0		
915	chr19	43273851	43278037	3500183386	44		43273851	43278037	8421504	3	9,14,21	0,12,4165	c	350018338600000007,350018338600000006	0-23,0-21		9852039	10.1074/jbc.273.51.33901	0021-9258	Journal of Biological Chemistry	Interferon-&#x03b3; Selectively Induces Rab5a Synthesis and Processing in Mononuclear Cells	Alvarez-Dominguez	1998	5		RAB5C
915	chr19	43273956	43277983	3500393978	492		43273956	43277983	8421504	5	11,94,123,152,112	0,539,1975,2302,3915	p	350039397800015023	0-492						Statistics Using R with Biological Examples	ww.math.wustl.edu	0	0		RAB5C
915	chr19	43273956	43277983	3500230747	492		43273956	43277983	8421504	5	11,94,123,152,112	0,539,1975,2302,3915	p	350023074700015023	0-492						Statistics Using R with Biological Examples	rrors.ibiblio.org	0	0		RAB5C
915	chr19	43273956	43277983	3500121978	492		43273956	43277983	8421504	5	11,94,123,152,112	0,539,1975,2302,3915	p	350012197800015023	0-492						Statistics Using R with Biological Examples	-lorenzomarini.eu	0	0		RAB5C
915	chr19	43307266	43307291	3500141368	25		43307266	43307291	8421504	1	25	0	g	350014136800000000	5-31		15220408	10.1128/JVI.78.14.7352-7359.2004	0022-538X	Journal of Virology	Sensitivity of NS3 Serine Proteases from Hepatitis C Virus Genotypes 2 and 3 to the Inhibitor BILN 2061	Thibeault	2004	5		
915	chr19	43316390	43316561	3500384310	138		43316390	43316561	8421504	2	60,78	0,93	p	350038431000015105,350038431000015103	0-60,0-78						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		HCRT
915	chr19	43316459	43316555	3500447424	96		43316459	43316555	8421504	1	96	0	p	350044742400015003,350044742400015000	0-96,0-66						Expression und Funktion des Orexinrezeptors 1 in Tumoren des humanen Gastrointestinaltrakts	diss.fu-berlin.de	0	0		HCRT
915	chr19	43316462	43316507	3500226512	45		43316462	43316507	8421504	1	45	0	p	350022651200015003	0-45						METHODS AND COMPOSITIONS FOR INDUCING WEIGHT LOSS - Patent application	www.faqs.org	0	0		HCRT
915	chr19	43316498	43316558	3500447303	60		43316498	43316558	8421504	1	60	0	p	350044730300015039	0-60						NOVEL GENES RELATED TO GLUTAMINYL CYCLASE	Schilling	2009	0		HCRT
915	chr19	43316498	43316558	3500343991	60		43316498	43316558	8421504	1	60	0	p	350034399100015091	0-60						Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases	Hoffman	2007	0		HCRT
915	chr19	43316498	43316558	3500279869	60		43316498	43316558	8421504	1	60	0	p	350027986900015036	0-60						Novel genes related to glutaminyl cyclase	Schilling	2008	0		HCRT
915	chr19	43316498	43316558	3500201309	60		43316498	43316558	8421504	1	60	0	p	350020130900015053	0-60						 Inhibitors Of Glutaminyl Cyclase For Treating Neurodegenerative Diseases 	www.docstoc.com	0	0		HCRT
915	chr19	43316498	43316558	3500121082	60		43316498	43316558	8421504	1	60	0	p	350012108200015054	0-60						USE OF EFFECTORS OF GLUTAMINYL AND GLUTAMATE CYCLASES	Hoffmann	2007	0		HCRT
915	chr19	43316498	43316558	3500090542	60		43316498	43316558	8421504	1	60	0	p	350009054200015061	0-60						USE OF INHIBITORS OF GLUTAMINYL CYCLASE AND GLUTAMATE CYCLASE FOR TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES	Hoffmann	2009	0		HCRT
915	chr19	43316630	43317494	3500457679	23		43316630	43317494	8421504	2	6,17	0,847	c	350045767900000000	0-23		18213704	10.1002/ar.20641	1932-8494	The Anatomical Record	Expression of Orexin A and its Receptor 1 in the Bovine Urethroprostatic Complex - Russo - 2008 - The Anatomical Record - Wiley Online Library	Russo	2008	0		
915	chr19	43335448	43356343	3500210273	115		43335448	43356343	8421504	5	30,25,20,20,20	0,34,13793,14478,20875	c,g	350021027300000155,350021027300000156,350021027300000236,350021027300000274,350021027300000099	0-30,0-25,0-20,0-20,0-20					Patent	Modulation of STAT5 expression (Patent US:7709628)	Freier	2010	0		
915	chr19	43336232	43356351	3500236302	267		43336232	43356351	8421504	9	48,27,5,48,48,28,20,24,19	0,64,374,6487,12449,13094,13567,17619,20100	c	350023630200000050,350023630200000049,350023630200000039,350023630200000027,350023630200000022,350023630200000013,350023630200000008	0-48,0-32,0-48,0-48,0-48,24-48,29-48						US Patent # 5,534,409. Cytokine regulated transcription factor - Patents.com	www.patents.com	0	0		
915	chr19	43336608	43353866	3500330636	885		43336608	43353866	8421504	7	48,129,177,153,150,129,99	0,4642,12007,12592,13193,13574,17159	p	350033063600015008,350033063600015006,350033063600015004,350033063600015003,350033063600015002,350033063600015014,350033063600015012	0-48,0-129,0-177,0-153,0-279,0-84,0-99						AceView: mRNA:STAT5A.cApr07, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.	.ncbi.nlm.nih.gov	0	0		STAT5B
915	chr19	43356281	43356326	3500252450	45		43356281	43356326	8421504	1	45	0	p	350025245000015000	3-48					Patent	Method of identifying inhibitors of the Jak-Stat signal transduction pathway (Patent US:6265160)	Leonard	2001	0		STAT5A
916	chr19	43409292	43429205	3500236302	2018		43409292	43429205	8421504	34	52,18,63,138,13,80,45,3,38,76,131,76,14,28,128,64,68,28,12,35,87,56,36,108,3,95,131,11,96,17,119,18,78,53	0,53,77,506,968,1029,2258,5302,5353,5401,10690,11052,11133,11151,11677,12210,12322,13853,13929,14048,14084,14734,14791,15274,15478,16192,16371,16924,16983,18603,19620,19740,19764,19860	c,g	350023630200000005,350023630200000006,350023630200000007,350023630200000009,350023630200000010,350023630200000012,350023630200000014,350023630200000015,350023630200000016,350023630200000017,350023630200000018,350023630200000019,350023630200000020,350023630200000021,350023630200000023,350023630200000024,350023630200000025,350023630200000026,350023630200000028,350023630200000029,350023630200000031,350023630200000032,350023630200000033,350023630200000034,350023630200000035,350023630200000036,350023630200000037,350023630200000040,350023630200000041,350023630200000042,350023630200000043,350023630200000044,350023630200000046,350023630200000047,350023630200000051,350023630200000052,350023630200000053,350023630200000054,350023630200000055,350023630200000056	99-288,0-48,0-48,0-48,0-32,0-48,0-38,0-48,0-48,0-48,0-48,0-48,0-43,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-53,0-42,0-53						US Patent # 5,534,409. Cytokine regulated transcription factor - Patents.com	www.patents.com	0	0		
916	chr19	43410080	43429201	3500327449	243		43410080	43429201	8421504	12	20,21,20,20,20,20,20,21,20,20,20,21	0,10865,10955,11640,11665,13850,14720,15359,16070,16860,17422,19100	c,g	350032744900000001,350032744900000002,350032744900000038,350032744900000040,350032744900000020,350032744900000039,350032744900000026,350032744900000025,350032744900000027,350032744900000028,350032744900000029,350032744900000030,350032744900000032,350032744900000031,350032744900000033,350032744900000034,350032744900000037	0-20,0-20,0-21,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-21,0-21,0-20,0-20,0-20,0-20,0-21						Methods and Compositions for Improved Fertilization and Embryonic Survival	Khatib	2008	0		
916	chr19	43410407	43414595	3500434170	40		43410407	43414595	8421504	4	10,10,19,1	0,1098,1169,4187	c	350043417000000040,350043417000000041	0-20,0-20						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
916	chr19	43420353	43421022	3500210273	40		43420353	43421022	8421504	2	20,20	0,649	c,g	350021027300000053,350021027300000053,350021027300000069	0-20,0-20,0-20					Patent	Modulation of STAT5 expression (Patent US:7709628)	Freier	2010	0		
916	chr19	43420945	43421765	3500458027	41		43420945	43421765	8421504	2	21,20	0,800	c,g	350045802700000002,350045802700000003	0-21,0-20						Effect of polymorphisms at the STAT5A and FGF2 gene loci on reproduction, milk yield and lameness of Holstein cows. - ResearchGate	.researchgate.net	0	0		
916	chr19	43420945	43421676	3500303956	41		43420945	43421676	8421504	2	21,20	0,711	c	350030395600000000,350030395600000001	0-21,0-20						Detection of lethality gene for improved fertility in mammals	Khatib	2007	0		
916	chr19	43423146	43425577	3500330636	510		43423146	43425577	8421504	4	87,123,207,93	0,194,1420,2338	p	350033063600015005	0-510						AceView: mRNA:STAT5A.cApr07, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.	.ncbi.nlm.nih.gov	0	0		
916	chr19	43423358	43445295	3500242915	567		43423358	43445295	8421504	9	105,93,72,72,99,6,54,48,18	0,668,1208,18468,18646,19632,19662,21767,21919	p	350024291500015012,350024291500015007,350024291500015006	0-270,0-177,0-120						A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain	enesdev.cshlp.org	0	0		
916	chr19	43425546	43426268	3500008154	40		43425546	43426268	8421504	2	20,20	0,702	c	350000815400000019,350000815400000022	0-20,0-20						Mining the Mammalian Genome for Artiodactyl Systematics	www.jstor.org	0	0		
916	chr19	43425549	43425746	3500262514	40		43425549	43425746	8421504	2	20,20	0,177	c,g	350026251400000002,350026251400000002,350026251400000003	0-20,0-20,0-20						Evaluation of STAT5A Gene Expression in Aflatoxin B1 Treated Bovine Mammary Epithelial Cells	apb.tbzmed.ac.ir	0	0		
916	chr19	43425549	43425746	3500096566	40		43425549	43425746	8421504	2	20,20	0,177	c,g	350009656600000002,350009656600000002,350009656600000003	0-20,0-20,0-20						Evaluation of STAT5A Gene Expression in Aflatoxin B1 Treated Bovine Mammary Epithelial Cells	nals.tbzmed.ac.ir	0	0		
916	chr19	43425699	43429135	3500348506	40		43425699	43429135	8421504	2	20,20	0,3416	c	350034850600000010,350034850600000011	0-20,0-20						REPRODUCTION	uction-online.org	0	0		
916	chr19	43426149	43426430	3500344936	39		43426149	43426430	8421504	2	20,19	0,262	g	350034493600000000,350034493600000001	0-20,0-19						Association of a sequence nucleotide polymorphism in exon 16 of the STAT5A gene with milk production traits in Polish Black-and-White (Polish Friesian) cows*	www.ighz.edu.pl	0	0		
916	chr19	43426149	43426430	3500322651	39		43426149	43426430	8421504	2	20,19	0,262	g	350032265100000000,350032265100000001	0-20,0-19						(1389 &#x0646;&#xfe8e;&#xfe98;&#xfeb4;&#xfee3;&#x0632; &#x0648; &#xfeb0;&#xfbff;&#xfbfe;&#xfe8e;&#xfb58; &#x060c;2 &#x0647;&#x0631;&#xfe8e;&#xfee4;&#xfeb7; &#x060c;2 &#x0647;&#x0631;&#x0648;&#x062f; &#x064a;&#x0632;&#x0631;&#x0648;&#xfe8e;&#xfeb8;&#xfb90;	joagribiotech.ir	0	0		
916	chr19	43426149	43426430	3500162821	39		43426149	43426430	8421504	2	20,19	0,262	g	350016282100000000,350016282100000001	0-20,0-19						Polymerase chain reaction-heteroduplex (PCR-HD) polymorphism	www.docstoc.com	0	0		
916	chr19	43431852	43431881	3500289895	25		43431852	43431881	8421504	2	7,18	0,11	c	350028989500000029	9-34		17182767	10.1523/JNEUROSCI.4238-06.2006	0270-6474	The Journal of Neuroscience	Deletion of the Ttf1 Gene in Differentiated Neurons Disrupts Female Reproduction without Impairing Basal Ganglia Function	Mastronardi	2006	7		
916	chr19	43433566	43464339	3500184286	2176		43433566	43464339	8421504	33	19,23,113,35,171,32,139,87,53,31,96,75,15,84,21,9,24,61,30,60,89,105,43,128,15,95,61,12,96,63,27,144,120	0,33,1395,1805,5160,5340,6645,6919,7248,8196,8236,8438,8522,9424,11559,11598,11711,11744,11905,14580,15487,15666,15780,18147,18284,18482,18773,18843,19027,28243,28315,28924,30653	p,c,g	350018428600000014,350018428600000014,350018428600000020,350018428600015108,350018428600015107,350018428600015106,350018428600015105,350018428600015104,350018428600015103,350018428600015102,350018428600015101,350018428600015084,350018428600015100,350018428600015099,350018428600015098,350018428600015097,350018428600015096,350018428600015095,350018428600015094,350018428600015093,350018428600015092,350018428600015091,350018428600015090,350018428600015089,350018428600015088,350018428600015087,350018428600015086,350018428600015085,350018428600000013,350018428600000013	0-19,0-19,11-30,0-120,0-51,0-120,0-51,0-120,0-51,0-120,0-51,0-108,0-120,0-51,0-120,0-120,0-120,0-54,0-51,0-120,0-51,0-120,0-51,0-120,0-51,0-120,0-51,0-120,0-20,0-20						[tel-00555532, v1] Etude des int&#xe9;ractions prot&#xe9;ine-prot&#xe9;ine par double hybride bact&#xe9;rien : applications en agro-alimentaire et en sant&#xe9;.	hives-ouvertes.fr	0	0		STAT3
916	chr19	43433566	43464339	3500138186	2056		43433566	43464339	8421504	33	19,23,113,35,51,32,139,87,53,31,96,75,15,84,21,9,24,61,30,60,89,105,43,128,15,95,61,12,96,63,27,144,120	0,33,1395,1805,5280,5340,6645,6919,7248,8196,8236,8438,8522,9424,11559,11598,11711,11744,11905,14580,15487,15666,15780,18147,18284,18482,18773,18843,19027,28243,28315,28924,30653	p,c,g	350013818600000014,350013818600000014,350013818600015108,350013818600015107,350013818600015105,350013818600015104,350013818600015103,350013818600015102,350013818600015101,350013818600015084,350013818600015100,350013818600015099,350013818600015098,350013818600015097,350013818600015096,350013818600015095,350013818600015094,350013818600015093,350013818600015092,350013818600015091,350013818600015090,350013818600015089,350013818600015088,350013818600015087,350013818600015086,350013818600015085,350013818600000013,350013818600000013	0-19,0-19,0-120,0-51,0-51,0-120,0-51,0-120,0-51,0-108,0-120,0-51,0-120,0-120,0-120,0-54,0-51,0-120,0-51,0-120,0-51,0-120,0-51,0-120,0-51,0-120,0-20,0-20						[tel-00555532, v1] Etude des int&#xe9;ractions prot&#xe9;ine-prot&#xe9;ine par double hybride bact&#xe9;rien : applications en agro-alimentaire et en sant&#xe9;.	hives-ouvertes.fr	0	0		STAT3
916	chr19	43433569	43464339	3500193042	43		43433569	43464339	8421504	2	21,22	0,30748	c	350019304200000001,350019304200000000	0-21,8-30		16926159	10.1074/jbc.M603762200	0021-9258	Journal of Biological Chemistry	Pyrrolidine Dithiocarbamate Inhibits Interleukin-6 Signaling through Impaired STAT3 Activation and Association with Transcriptional Coactivators in Hepatocytes	He	2006	5		STAT3
916	chr19	43433576	43449257	3500064891	48		43433576	43449257	8421504	2	24,24	0,15657	c	350006489100000001,350006489100000004	0-24,0-24		19223328	10.1093/nar/gkp058		Nucleic Acids Research	Manipulating transgenes using a chromosome vector	Masashi	2009	0		STAT3
916	chr19	43434999	43440849	3500412955	42		43434999	43440849	8421504	2	22,20	0,5830	c,g	350041295500000007,350041295500000007,350041295500000006	0-22,0-22,0-20		18162139	10.1186/bcr1840	1465-5411	Breast Cancer Research	Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-&#xce;&#xb1; mice	Dogan	2007	0		STAT3
916	chr19	43434999	43440849	3500351319	42		43434999	43440849	8421504	2	22,20	0,5830	c	350035131900000007,350035131900000006	0-22,0-20						Open Access Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF- mice	biomedcentral.com	0	0		STAT3
916	chr19	43435011	43435034	3500321365	23		43435011	43435034	8421504	1	23	0	c	350032136500000013	0-23						Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration	.aacrjournals.org	0	0		STAT3
916	chr19	43435011	43435034	3500007490	23		43435011	43435034	8421504	1	23	0	c	350000749000000013	0-23		17308082	10.1158/0008-5472.CAN-06-0850	0008-5472	Cancer Research	Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration	Bailly-Maitre	2007	8		STAT3
916	chr19	43435044	43438832	3500147441	40		43435044	43438832	8421504	2	20,20	0,3768	c,g	350014744100000013,350014744100000013,350014744100000012	0-20,0-20,0-20		23936533	10.1371/journal.pone.0071932	1932-6203	PLOS ONE	PLOS ONE: STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells	Okemoto	2013	4		STAT3
916	chr19	43435064	43440344	3500328322	69		43435064	43440344	8421504	3	10,38,21	0,307,5259	c	350032832200000309,350032832200000113	0-48,21-42						Functionally active regions of signal transducer and activator of transcription	Darnell	1997	0		STAT3
916	chr19	43435160	43435401	3500120129	42		43435160	43435401	8421504	2	20,22	0,219	c,g	350012012900000003,350012012900000002,350012012900000002	0-20,0-22,0-22						Essential Role of STAT3 in Body Weight and Glucose Homeostasis	mcb.asm.org	0	0		
916	chr19	43435385	43438801	3500209634	105		43435385	43438801	8421504	2	29,76	0,3340	p	350020963400015017	0-105						Nature CellBiology	www.scribd.com	0	0		STAT3
916	chr19	43438793	43445151	3500068995	114		43438793	43445151	8421504	4	18,43,27,26	0,19,4254,6332	c	350006899500000776,350006899500000763	10-71,8-61						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
916	chr19	43438864	43438912	3500295082	48		43438864	43438912	8421504	1	48	0	c	350029508200000305	0-48					Patent	Functionally active regions of signal transducer and activator of transcription (Patent US:5883228)	James	1999	0		
916	chr19	43438894	43440532	3500219497	40		43438894	43440532	8421504	2	20,20	0,1618	c,g	350021949700000007,350021949700000006,350021949700000006	0-20,0-20,0-20						Oct4 expression in in vitro-produced sheep blastocysts and embryonic-stem-like cells	w.cellbiolint.org	0	0		
916	chr19	43438894	43440532	3500081681	40		43438894	43440532	8421504	2	20,20	0,1618	c,g	350008168100000007,350008168100000007,350008168100000006,350008168100000006	0-20,0-20,0-20,0-20						Oct4 expression in in vitro-produced sheep blastocysts and embryonic-stem-like cells	.all-portland.net	0	0		
916	chr19	43438934	43440232	3500288200	25		43438934	43440232	8421504	2	4,21	0,1277	c	350028820000000024,350028820000000005	0-25,0-22						STEM-LIKE CELLS IN BONE SARCOMAS - Patent application	www.faqs.org	0	0		STAT3
916	chr19	43445161	43452129	3500422263	62		43445161	43452129	8421504	4	12,9,20,21	0,116,4167,6947	c	350042226300000006,350042226300000005,350042226300000004	0-21,0-20,0-21		18441325	10.1074/jbc.M800109200		The Journal of Biological Chemistry	Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells	Lilly	June	0		STAT3
916	chr19	43445310	43445473	3500442056	63		43445310	43445473	8421504	2	61,2	0,161	p	350044205600015018	36-99						infection. Cells at ~60% confluence were infected with viruses and microscopically analyzed at 3 dpi. (A) SCVC-infected HX1. (B)	r.sgmjournals.org	0	0		STAT3
916	chr19	43449072	43451780	3500319127	40		43449072	43451780	8421504	2	20,20	0,2688	c,g	350031912700000015,350031912700000015,350031912700000014,350031912700000014	0-20,0-20,0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
916	chr19	43451783	43462556	3500354445	41		43451783	43462556	8421504	2	21,20	0,10753	c,g	350035444500000011,350035444500000010,350035444500000010	0-21,0-20,0-20						Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)	B	2007	0		
916	chr19	43462532	43462557	3500141064	25		43462532	43462557	8421504	1	25	0	c	350014106400000010	0-25		17761947	10.1210/me.2007-0269	0888-8809	Molecular Endocrinology	Tumor Suppressor LKB1 Inhibits Activation of Signal Transducer and Activator of Transcription 3 (STAT3) by Thyroid Oncogenic Tyrosine Kinase Rearranged in Transformation (RET)/Papillary Thyroid Carcinoma (PTC)	Kim	2007	5		STAT3
917	chr19	43537172	43537199	3500390909	23		43537172	43537199	8421504	2	8,15	0,12	g	350039090900000021	8-31						Compositions and methods for generating an immune response utilizing alphavirus-based vector systems - Patent application	www.faqs.org	0	0		
917	chr19	43538930	43538957	3500333746	24		43538930	43538957	8421504	3	6,5,13	0,7,14	c	350033374600000067	9-33						Compounds and compositions for the treatment of illnesses caused by the hepatitis b virus	BLAZQUEZ	2012	0		
917	chr19	43621490	43621516	3500289717	23		43621490	43621516	8421504	2	16,7	0,19	c	350028971700000018	5-29						Identification of novel molecular mechanisms of tumor suppressor effect induced by soy isoflavones: Studies on EMP2 and ITM1 genes	u.lib.ncku.edu.tw	0	0		
917	chr19	43642680	43642705	3500251725	23		43642680	43642705	8421504	2	16,7	0,18	c,g	350025172500000008,350025172500000008	17-40,17-40						Method and kit for diagnosing Autism using gene expression profiling - Patent application	www.faqs.org	0	0		
917	chr19	43646058	43646271	3500275122	44		43646058	43646271	8421504	3	23,7,14	0,79,199	c,g	350027512200000004,350027512200000004,350027512200000005	0-23,0-23,0-21		20484739	10.1095/biolreprod.110.084277	0006-3363	Biology of Reproduction	Expression and Function of Fibroblast Growth Factor 18 in the Ovarian Follicle in Cattle	Portela	2010	4		
917	chr19	43646058	43646271	3500126808	44		43646058	43646271	8421504	3	23,7,14	0,79,199	c	350012680800000008,350012680800000009	0-23,0-21						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
917	chr19	43646058	43646271	3500001785	44		43646058	43646271	8421504	3	23,7,14	0,79,199	c,g	350000178500000004,350000178500000004,350000178500000005	0-23,0-23,0-21		20484739	10.1095/biolreprod.110.084277	0006-3363	Biology of Reproduction	Expression and Function of Fibroblast Growth Factor 18 in the Ovarian Follicle in Cattle	Portela	2010	4		
917	chr19	43646086	43646298	3500355801	99		43646086	43646298	8421504	2	58,41	0,171	p	350035580100015003	6-105						Cysteine-10 on 17&#x03b2;-hydroxysteroid dehydrogenase 1 has stabilizing interactions in the cofactor binding region and renders sensitivity to sulfhydryl modifying chemicals	loads.hindawi.com	0	0		
918	chr19	43646979	43647776	3500062112	46		43646979	43647776	8421504	2	23,23	0,774	c	350006211200000000,350006211200000001	0-23,0-23						REPRODUCTION	uction-online.org	0	0		
918	chr19	43660800	43660825	3500422426	23		43660800	43660825	8421504	2	12,11	0,14	g	350042242600000113	11-34						PII: B978-0-12-164730-8.50060-5	gitus.itk.ppke.hu	0	0		
918	chr19	43696017	43696492	3500353341	43		43696017	43696492	8421504	2	20,23	0,452	c	350035334100000000,350035334100000001	0-20,0-23		20529377	10.1186/1471-2407-10-268	1471-2407	BMC Cancer	Differential expression of centrosomal proteins at different stages of human glioma	Loh	2010	3		TUBG1,TUBG2
918	chr19	43737456	43737504	3500141660	48		43737456	43737504	8421504	1	48	0	p	350014166000015000	0-48					The Journal of Cell Biology	Insoluble &#x03b3;-Tubulin&#x2013;Containing Structures Are Anchored to the Apical Network of Intermediate Filaments in Polarized Caco-2 Epithelial Cells	Pedro	1999	0		TUBG2
918	chr19	43740900	43741598	3500069737	70		43740900	43741598	8421504	3	24,24,22	0,44,676	c	350006973700000002,350006973700000011,350006973700000012,350006973700000003,350006973700000001	0-23,0-24,0-24,0-24,0-22						DIRECTIONAL SELF-ASSEMBLY OF BIOLOGICAL ELECTRICAL INTERCONNECTS - Patent application	www.faqs.org	0	0		TUBG2
918	chr19	43754390	43754677	3500338718	95		43754390	43754677	8421504	2	47,48	0,239	c	350033871800000014,350033871800000009	0-47,0-48						US Patent # 6,824,781. Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist - Patents.com	www.patents.com	0	0		
919	chr19	43791361	43792722	3500241511	48		43791361	43792722	8421504	2	21,27	0,1334	p	350024151100015011	0-48						Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof - Patent application	www.faqs.org	0	0		EZH1
919	chr19	43855638	43855661	3500121372	23		43855638	43855661	8421504	1	23	0	c	350012137200000012	26-49						cDNA Microarray Analysis of Host-Pathogen Interactions in a Porcine In Vitro Model for Toxoplasma gondii Infection&#x2020;	iai.asm.org	0	0		
919	chr19	43855641	43856524	3500354743	40		43855641	43856524	8421504	3	21,18,1	0,133,882	c	350035474300000003,350035474300000002	0-21,0-19						Cathepsin L stimulates autophagy and inhibits apoptosis of ox-LDL-induced endothelial cells: Potential role in atherosclerosis	bio.cqu.edu.cn	0	0		
919	chr19	43856604	43863147	3500110938	44		43856604	43863147	8421504	3	21,20,3	0,5455,6540	c,g	350011093800000002,350011093800000002,350011093800000003,350011093800000003,350011093800000000,350011093800000001	0-21,0-21,0-21,0-21,0-23,0-23						Autophagy is involved in oligodendroglial precursor-mediated clearance of amyloid peptide	odegeneration.com	0	0		
919	chr19	43860897	43861087	3500213569	30		43860897	43861087	8421504	2	13,17	0,173	c	350021356900000000	0-31		19109422	10.1091/mbc.E08-08-0829	1059-1524	Molecular Biology of the Cell	Autophagy Provides Nutrients but Can Lead to Chop-dependent Induction of Bim to Sensitize Growth Factor&#x2013;deprived Cells to Apoptosis	Altman	2009	5		
919	chr19	43861078	43861329	3500467324	150		43861078	43861329	8421504	2	129,21	0,230	p	350046732400015000	0-150						Following Cytochrome c Release, Autophagy Is Inhibited during Chemotherapy-Induced Apoptosis by Caspase 8 Mediated Cleavage of Beclin 1	.aacrjournals.org	0	0		BECN1
919	chr19	43861086	43861399	3500459159	41		43861086	43861399	8421504	2	20,21	0,292	c	350045915900000000,350045915900000001	0-20,0-21						Beclin 1 Enhances Proteasome Inhibition-Mediated Cytotoxicity of Thyroid Cancer Cells in Macroautophagy-Independent Manner	.endojournals.org	0	0		BECN1
919	chr19	43861086	43861399	3500201951	41		43861086	43861399	8421504	2	20,21	0,292	c	350020195100000000,350020195100000001	0-20,0-21		23264393	10.1210/jc.2012-2679	0021-972X	Journal of Clinical Endocrinology & Metabolism	Beclin 1 Enhances Proteasome Inhibition-Mediated Cytotoxicity of Thyroid Cancer Cells in Macroautophagy-Independent Manner	Zhang	2013	6		
919	chr19	43861162	43861341	3500449628	78		43861162	43861341	8421504	2	45,33	0,146	p	350044962800015002,350044962800015001,350044962800015000	0-78,0-78,0-78			10.1038/sj.emboj.7601689	ERROR! NO ISSN	The EMBO Journal	Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1	Maiuri	2007	0		BECN1
919	chr19	43861363	43863150	3500439225	49		43861363	43863150	8421504	3	25,18,6	0,698,1781	c	350043922500000005,350043922500000004	0-25,0-24						Sulfabenzamide promotes autophagic cell death in T-47D breast cancer cells through p53/ DRAM pathway	jcmb.halic.edu.tr	0	0		BECN1
919	chr19	43861363	43863150	3500049854	49		43861363	43863150	8421504	3	25,18,6	0,698,1781	c	350004985400000013,350004985400000012	0-25,0-24						Journal of Cell and Molecular Biology	jcmb.halic.edu.tr	0	0		BECN1
920	chr19	43967401	43967425	3500070053	24		43967401	43967425	8421504	1	24	0	g	350007005300000003	0-24						Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1 /LRP130 complex	enesdev.cshlp.org	0	0		G6PC
920	chr19	43967653	43976885	3500044297	1071		43967653	43976885	8421504	5	230,110,106,116,509	0,3055,5523,6242,8723	p	350004429700015000	0-1071						KEGG T01008: 538710	www.genome.jp	0	0		
920	chr19	44034595	44034621	3500461622	23		44034595	44034621	8421504	2	17,6	0,20	c	350046162200000243	13-36						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
920	chr19	44034595	44034621	3500322097	23		44034595	44034621	8421504	2	17,6	0,20	c	350032209700000261	13-36						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
920	chr19	44034595	44034621	3500309840	23		44034595	44034621	8421504	2	17,6	0,20	c	350030984000000261	13-36						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
921	chr19	44044267	44045556	3500205057	39		44044267	44045556	8421504	3	20,4,15	0,350,1274	c,g	350020505700000024,350020505700000024,350020505700000025	0-20,0-20,0-19						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
921	chr19	44044267	44045556	3500137197	39		44044267	44045556	8421504	3	20,4,15	0,350,1274	c	350013719700000024,350013719700000025	0-20,0-19						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
921	chr19	44045670	44046519	3500164379	192		44045670	44046519	8421504	3	41,111,40	0,584,809	p	350016437900015022	168-360						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPL27
921	chr19	44088653	44157499	3500350682	324		44088653	44157499	8421504	13	29,39,9,29,22,35,28,19,19,28,20,15,32	0,8228,13686,41608,41810,41977,44186,46495,50545,53796,54790,63881,68814	c	350035068200000137,350035068200000130,350035068200000097,350035068200000093,350035068200000089,350035068200000043,350035068200000035,350035068200000028,350035068200000025	9-38,0-48,0-29,0-22,12-47,0-28,0-38,0-48,0-47						17Q-linked breast and ovarian cancer susceptibility gene	Skolnick	1995	0		
921	chr19	44088653	44157499	3500335615	359		44088653	44157499	8421504	13	29,39,9,35,29,22,35,28,48,19,19,15,32	0,8228,13686,41461,41608,41810,41977,44186,44262,46495,50545,63881,68814	c	350033561500000161,350033561500000154,350033561500000124,350033561500000121,350033561500000117,350033561500000113,350033561500000067,350033561500000065,350033561500000059,350033561500000049	9-38,0-48,0-35,0-29,0-22,12-47,0-28,0-48,0-38,0-47					Patent	Linked breast and ovarian cancer susceptibility gene (Patent US:5709999)	Durocher	1998	0		
921	chr19	44088653	44157499	3500006742	273		44088653	44157499	8421504	11	29,39,9,35,28,19,19,28,20,15,32	0,8228,13686,41461,44186,46495,50545,53796,54790,63881,68814	c	350000674200000137,350000674200000130,350000674200000100,350000674200000043,350000674200000035,350000674200000028,350000674200000025	9-38,0-48,0-35,0-28,0-38,0-48,0-47						17q-linked breast and ovarian cancer susceptibility gene	Skolnick	1995	0		
921	chr19	44096881	44157499	3500378054	172		44096881	44157499	8421504	6	39,9,29,48,15,32	0,5458,33380,36034,55653,60586	c	350037805400000153,350037805400000120,350037805400000064,350037805400000048	0-48,0-29,0-48,0-47					Patent	17Q-linked breast and ovarian cancer susceptibility gene (Patent US:5747282)	Futreal	1998	0		
921	chr19	44096881	44157499	3500371407	162		44096881	44157499	8421504	7	39,9,29,19,19,15,32	0,5458,33380,38267,42317,55653,60586	c	350037140700000130,350037140700000097,350037140700000035,350037140700000025	0-48,0-29,0-38,0-47						170-linked breast and ovarian cancer susceptibility gene	Skolnick	1996	0		
921	chr19	44096881	44157499	3500288475	232		44096881	44157499	8421504	9	39,9,35,29,35,19,19,15,32	0,5458,33233,33380,33749,38267,42317,55653,60586	c	350028847500000153,350028847500000123,350028847500000120,350028847500000112,350028847500000058,350028847500000048	0-48,0-35,0-29,12-47,0-38,0-47					Patent	170-linked breast and ovarian cancer susceptibility gene (Patent US:5753441)	Futreal	1998	0		
921	chr19	44096881	44157499	3500198696	178		44096881	44157499	8421504	6	39,9,35,48,15,32	0,5458,33233,36034,55653,60586	c	350019869600000131,350019869600000101,350019869600000042,350019869600000026	0-48,0-35,0-48,0-47						Linked breast and ovarian cancer susceptibility gene	Shattuck-eidens	1995	0		
921	chr19	44096881	44157499	3500089437	203		44096881	44157499	8421504	8	39,9,35,35,19,19,15,32	0,5458,33233,33749,38267,42317,55653,60586	c	350008943700000154,350008943700000124,350008943700000113,350008943700000059,350008943700000049	0-48,0-35,12-47,0-38,0-47					Patent	Linked breast and ovarian cancer susceptibility gene (Patent US:5693473)	Durocher	1997	0		
921	chr19	44096881	44157499	3500048446	321		44096881	44157499	8421504	12	39,9,35,29,28,48,19,19,28,20,15,32	0,5458,33233,33380,35958,36034,38267,42317,45568,46562,55653,60586	c	350004844600000154,350004844600000124,350004844600000121,350004844600000067,350004844600000065,350004844600000059,350004844600000052,350004844600000049	0-48,0-35,0-29,0-28,0-48,0-38,0-48,0-47					Patent	Linked breast and ovarian cancer susceptibility gene (Patent US:5709999)	Durocher	1998	0		
921	chr19	44096881	44157499	3500039576	226		44096881	44157499	8421504	8	39,9,35,48,28,20,15,32	0,5458,33749,36034,45568,46562,55653,60586	c	350003957600000124,350003957600000081,350003957600000033,350003957600000020,350003957600000017	0-48,12-47,0-48,0-48,0-47						METHOD FOR DIAGNOSING A PREDISPOSITION FOR BREAST AND OVARIAN CANCER - MYRIAD GENETICS, INC	www.sumobrain.com	0	0		
921	chr19	44096881	44157499	3500031485	210		44096881	44157499	8421504	8	39,9,29,48,19,19,15,32	0,5458,33380,36034,38267,42317,55653,60586	c	350003148500000153,350003148500000120,350003148500000064,350003148500000058,350003148500000048	0-48,0-29,0-48,0-38,0-47					Patent	17q-linked breast and ovarian cancer susceptibility gene (Patent US:5710001)	Futreal	1998	0		
921	chr19	44096881	44139217	3500065355	195		44096881	44139217	8421504	8	39,9,21,33,19,36,19,19	0,5458,6009,33235,33703,35515,38267,42317	c,g	350006535500000181,350006535500000179,350006535500000142,350006535500000131,350006535500000093,350006535500000072	0-48,0-21,0-33,5-24,0-36,0-38						Method for detection and treatment of breast cancer	Holt	2004	0		
921	chr19	44096881	44132963	3500138386	131		44096881	44132963	8421504	4	39,9,35,48	0,5458,33749,36034	c	350013838600000159,350013838600000116,350013838600000068	0-48,12-47,0-48						Method for detection and treatment of breast cancer	Holt	1998	0		
921	chr19	44096894	44102342	3500240598	29		44096894	44102342	8421504	2	26,3	0,5445	c	350024059800000015	0-29						/tardir/tiffs/a394205	www.dtic.mil	0	0		
921	chr19	44102880	44140367	3500040123	165		44102880	44140367	8421504	7	24,25,20,19,27,25,25	0,27121,27161,27325,29692,29904,37462	c,g	350004012300000006,350004012300000013,350004012300000014,350004012300000012,350004012300000012,350004012300000000,350004012300000000,350004012300000002,350004012300000005	0-24,0-25,0-20,0-19,0-19,0-27,0-27,0-25,0-25		12955082	10.1038/sj.onc.1206515	0950-9232	Oncogene	Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity	Krum	2003	6		
921	chr19	44129669	44129693	3500153714	24		44129669	44129693	8421504	1	24	0	g	350015371400000003	0-24						An ELISA-based Test for Inherited Breast Cancer: Conclusions	www.medscape.com	0	0		
921	chr19	44129759	44129798	3500448262	39		44129759	44129798	8421504	1	39	0	c	350044826200000000	0-39			10.1002/ijc.22597	1097-0215	International Journal of Cancer	BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR - Hao - 2007 - International Journal of Cancer - Wiley Online Library	Hao	2007	0		BRCA1
921	chr19	44129759	44129798	3500232779	39		44129759	44129798	8421504	1	39	0	c	350023277900000006	0-39						Cancer Treatment Targeting BRCA1-IRIS	Elshamy	2011	0		BRCA1
921	chr19	44129759	44129798	3500044528	39		44129759	44129798	8421504	1	39	0	c	350004452800000018,350004452800000006	0-39,0-39						Cancer Treatment Targeting BRCA1-IRIS - Patent application	www.faqs.org	0	0		
921	chr19	44130111	44132640	3500195941	52		44130111	44132640	8421504	2	26,26	0,2503	c	350019594100000020,350019594100000016	0-26,0-26						NPG.nature.vol.409.Issue.6820.Feb	www.scribd.com	0	0		BRCA1
921	chr19	44130630	44130653	3500119009	23		44130630	44130653	8421504	1	23	0	c	350011900900000044	0-23						Inventory of supplemental materials Supplemental Figures Supplemental Figure S1, related to Figure 1: Supplemental Figure S2, related to Figure 2: Cdk12 and Cdk13 colocalize only partly in	enesdev.cshlp.org	0	0		
921	chr19	44142468	44143461	3500002351	27		44142468	44143461	8421504	2	9,18	0,975	c	350000235100000043	0-27						POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF	Dongxu	2008	0		
922	chr19	44192412	44192441	3500258814	23		44192412	44192441	8421504	3	7,4,12	0,12,17	g	350025881400000015	1-26						Agglomeration protein cascades, compositions and methods regarding the same	Grossman	2006	0		
922	chr19	44272189	44272316	3500315930	47		44272189	44272316	8421504	2	22,25	0,102	g	350031593000000000,350031593000000001	0-22,1-26						VARSTVENA GENETIKA JELENJADI	web.bf.uni-lj.si	0	0		
923	chr19	44340226	44340254	3500189962	25		44340226	44340254	8421504	2	11,14	0,14	g	350018996200000029	0-25						Nucleic acid sequences encoding cell wall-degrading enzymes and use to engineer resistance to fusarium and other pathogens	Okubara	2002	0		
925	chr19	44588923	44588948	3500396120	24		44588923	44588948	8421504	2	5,19	0,6	g	350039612000000001	0-24						Novel CD19xCD3 specific polypeptides and uses thereof	Dorken	2006	0		
925	chr19	44588923	44588948	3500285663	24		44588923	44588948	8421504	2	5,19	0,6	g	350028566300000002	0-24					Patent	CD 19XCD3 specific polypeptides and uses thereof (Patent CN:1302103)	Bei Er En De *De Er Ken 	2007	0		
925	chr19	44588923	44588948	3500254512	24		44588923	44588948	8421504	2	5,19	0,6	g	350025451200000001	0-24						Novel CD19xCD3 specific polypeptides and uses thereof	Dorken	2006	0		
925	chr19	44588923	44588948	3500231639	24		44588923	44588948	8421504	2	5,19	0,6	g	350023163900000001	0-24					Patent	CD19xCD3 specific polypeptides and uses thereof (Patent US:7575923)	Dorken	2009	0		
925	chr19	44644582	44644608	3500013705	23		44644582	44644608	8421504	2	18,5	0,21	g	350001370500000013,350001370500000012	1-24,6-29						METHODS FOR MICROBIAL PRODUCTION OF TERPENOIDS	Leonard	2009	0		
925	chr19	44664544	44671572	3500098032	557		44664544	44671572	8421504	3	25,403,129	0,3870,6899	p,c,g	350009803200000780,350009803200001032,350009803200015145,350009803200000281,350009803200000278,350009803200000274,350009803200015141	0-25,0-532,0-96,0-30,0-51,0-21,0-75						Compositions and methods for increasing bone mineralization	Brunkow	2000	0		
925	chr19	44668395	44668704	3500448763	115		44668395	44668704	8421504	3	25,45,45	0,120,264	p,c	350044876300000006,350044876300015006,350044876300015004	5-30,0-45,0-45						Compositions and methods for use for antibodies against sclerostin	Kneissel	2008	0		SOST
925	chr19	44668395	44668704	3500254730	115		44668395	44668704	8421504	3	25,45,45	0,120,264	p,c	350025473000000006,350025473000015003,350025473000015001	5-30,0-45,0-45					Patent	Compositions and methods for use for antibodies against sclerostin (Patent US:8246953)	Kniessel	2012	0		SOST
925	chr19	44668395	44668704	3500250511	115		44668395	44668704	8421504	3	25,45,45	0,120,264	p,c	350025051100000006,350025051100015003,350025051100015001	5-30,0-45,0-45						Compositions and methods for use for antibodies against sclerostin	Diefenbach-Streiber	2009	0		SOST
925	chr19	44668395	44668704	3500194273	115		44668395	44668704	8421504	3	25,45,45	0,120,264	p,c	350019427300000006,350019427300015004,350019427300015002	5-30,0-45,0-45						Compositions and Methods for Use for Antibodies Against Sclerostin	Kneissel	2012	0		SOST
925	chr19	44668414	44671572	3500439970	532		44668414	44671572	8421504	2	403,129	0,3029	p,c	350043997000000030,350043997000000042,350043997000015010,350043997000015094,350043997000015091,350043997000015086,350043997000015085	0-532,0-532,0-528,0-45,0-45,0-45,0-45						Compositions and Methods for Increasing Bone Mineralization - Patent application	www.faqs.org	0	0		
925	chr19	44668414	44671572	3500171679	532		44668414	44671572	8421504	2	403,129	0,3029	p,c	350017167900000030,350017167900015011	0-532,0-528					Patent	Compositions and methods for increasing bone mineralization (Patent US:7994299)	Brunkow	2011	0		
925	chr19	44668414	44671572	3500067273	532		44668414	44671572	8421504	2	403,129	0,3029	p,c	350006727300000030,350006727300015015	0-532,0-528					Patent	Nucleic acids encoding a novel family of TGF-&#x03b2; binding proteins from humans (Patent US:6395511)	Brunkow	2002	0		
925	chr19	44668414	44671572	3500037354	532		44668414	44671572	8421504	2	403,129	0,3029	p,c	350003735400000030,350003735400015011	0-532,0-528						Compositions and Methods for Increasing Bone Mineralization	Brunkow	2008	0		
925	chr19	44668414	44668626	3500130251	145		44668414	44668626	8421504	2	84,61	0,151	c,g	350013025100000106,350013025100000106,350013025100000105,350013025100000105,350013025100000104,350013025100000102	9-61,9-61,1-51,1-51,0-32,0-61						COMPOSITIONS AND METHODS FOR INCREASING BONE MINERALIZATION - DARWIN DISCOVERY LTD.	www.sumobrain.com	0	0		
925	chr19	44668416	44671570	3500247343	528		44668416	44671570	8421504	2	401,127	0,3027	p	350024734300015016	0-528						Compositions and methods for increasing bone mineralization	M*E*Bu Lun Ke 	2002	0		
925	chr19	44668416	44671570	3500228104	528		44668416	44671570	8421504	2	401,127	0,3027	p	350022810400015008	0-528						&#x589e;&#x52a0;&#x9aa8;&#x77ff;&#x5316;&#x7684;&#x7ec4;&#x5408;&#x7269;&#x548c;&#x65b9;&#x6cd5;	M*E*Bu Lun Ke 	2002	0		
925	chr19	44668416	44668584	3500143100	168		44668416	44668584	8421504	1	168	0	p	350014310000015012	0-168						&#x589e;&#x52a0;&#x9aa8;&#x77ff;&#x5316;&#x7684;&#x7ec4;&#x5408;&#x7269;&#x548c;&#x65b9;&#x6cd5;	B*W*Pei Po 	2009	0		
925	chr19	44668446	44693850	3500189431	99		44668446	44693850	8421504	5	20,40,4,15,20	0,238,3002,3007,25384	c,g	350018943100000467,350018943100000467,350018943100000427,350018943100000300,350018943100000055,350018943100000055,350018943100000478	0-20,0-20,0-39,1-20,0-19,0-19,0-20						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
925	chr19	44668491	44668518	3500455912	27		44668491	44668518	8421504	1	27	0	c	350045591200000001	0-27						Peptides for treatment and diagnosis of bone diseases	Krumlauf	2013	0		SOST
925	chr19	44668605	44668713	3500461199	108		44668605	44668713	8421504	1	108	0	p	350046119900015004,350046119900015002	0-66,0-78						Binding agents	Paszty	2009	0		SOST
925	chr19	44668605	44668713	3500396381	108		44668605	44668713	8421504	1	108	0	p	350039638100015003,350039638100015001	0-66,0-78					Patent	Sclerostin-binding antibodies (Patent US:7872106)	Paszty	2011	0		SOST
925	chr19	44668767	44671465	3500013747	40		44668767	44671465	8421504	2	20,20	0,2678	c,g	350001374700000003,350001374700000003,350001374700000002	0-20,0-20,0-20						Cadmium exposure activates the ERK signaling pathway leading to altered osteoblast gene expression and apoptotic death in Saos-2 cells - Keeping the Faith	pthefaith1296.com	0	0		SOST
925	chr19	44684568	44694512	3500333481	552		44684568	44694512	8421504	4	200,226,1,125	0,6283,6844,9819	p	350033348100015002	0-552						Expression cloning of a human phosphatase	Aaronson	1992	0		
925	chr19	44684568	44694512	3500051787	552		44684568	44694512	8421504	4	200,226,1,125	0,6283,6844,9819	p	350005178700015004	0-552						KEGG T01001: 11072	www.genome.jp	0	0		
925	chr19	44684622	44691038	3500299297	270		44684622	44691038	8421504	6	45,45,45,45,45,45	0,48,96,6275,6323,6371	p	350029929700015155,350029929700015154,350029929700015153,350029929700015151,350029929700015150,350029929700015149	0-45,0-45,0-45,0-45,0-45,0-45						Phosphatases which activate map kinase pathways - Patent application	www.faqs.org	0	0		DUSP3
925	chr19	44690999	44694512	3500064631	204		44690999	44694512	8421504	3	78,1,125	0,413,3388	p	350006463100015037	0-204						Methods of diagnosing and treating diabetes and insulin resistance	Bernard	2003	0		
926	chr19	44727782	44727816	3500357772	34		44727782	44727816	8421504	1	34	0	c	350035777200000151	16-50						Functional Polymorphisms: Bovine Calpastatin Gene and Meat Tenderness	.nottingham.ac.uk	0	0		
926	chr19	44758425	44758449	3500053081	24		44758425	44758449	8421504	1	24	0	g	350005308100000024	0-24						GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO - Patent 2050335	data.epo.org	0	0		
926	chr19	44765397	44765426	3500031103	24		44765397	44765426	8421504	3	5,6,13	0,6,16	g	350003110300000253,350003110300000276	15-39,24-48						TRAIL RECEPTOR-BINDING AGENTS AND USES OF THE SAME - Patent application	www.faqs.org	0	0		
927	chr19	44835523	44836009	3500315071	40		44835523	44836009	8421504	2	20,20	0,466	c,g	350031507100000051,350031507100000050,350031507100000050	0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
927	chr19	44912619	44912644	3500037273	23		44912619	44912644	8421504	2	16,7	0,18	c	350003727300000088	4-30						Molecular Properties and Expression Mechanisms of	clib.kindai.ac.jp	0	0		
927	chr19	44943120	44944005	3500196470	25		44943120	44944005	8421504	3	15,3,7	0,871,878	c	350019647000000156	13-38						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		HDAC5
927	chr19	44946130	44946194	3500187039	42		44946130	44946194	8421504	2	20,22	0,42	c,g	350018703900000036,350018703900000035,350018703900000035	0-20,0-22,0-22						Dephosphorylation of HDAC7 By Myosin Phosphatase	Verdin	2007	0		HDAC5
927	chr19	44948059	44948107	3500120381	48		44948059	44948107	8421504	1	48	0	p	350012038100015087	105-153						<Html><Title> Complet list of 1mpf hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
927	chr19	44948061	44948089	3500001875	28		44948061	44948089	8421504	1	28	0	c	350000187500000036	15-43						BCL-1 locus nucleic acid probes and assay methods	Meeker	1992	0		ATRX
928	chr19	45035221	45035250	3500304753	25		45035221	45035250	8421504	2	12,13	0,16	c	350030475300000138	8-33						Compositions and methods for detection of antibody binding to cells - Patent application	www.faqs.org	0	0		
928	chr19	45052128	45052154	3500138064	26		45052128	45052154	8421504	1	26	0	g	350013806400000002	24-50						Improvement of the Developmental Capacity of Oocytes from Prepubertal Cattle by Intraovarian Insulin-Like Growth Factor-I Application	ww.biolreprod.org	0	0		
928	chr19	45056174	45056232	3500263568	47		45056174	45056232	8421504	2	24,23	0,35	g	350026356800000050,350026356800000051	0-24,0-23						Genomic characterization of remission in juvenile idiopathic arthritis	itis-research.com	0	0		UBTF
929	chr19	45096718	45098669	3500430446	42		45096718	45098669	8421504	2	20,22	0,1929	c,g	350043044600000017,350043044600000016,350043044600000016	0-20,0-22,0-22						DPOFA, a Cl-/HCO3- exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	biomedcentral.com	0	0		
929	chr19	45096718	45098669	3500198876	42		45096718	45098669	8421504	2	20,22	0,1929	c,g	350019887600000017,350019887600000017,350019887600000016,350019887600000016	0-20,0-20,0-22,0-22		22085910	10.1186/1471-2415-11-33	1471-2415	BMC Ophthalmology	DPOFA, a Cl-/HCO3 - exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	Iserovich	2011	1		
929	chr19	45152724	45152753	3500407668	24		45152724	45152753	8421504	2	18,6	0,23	c	350040766800000053	10-34						Spliced Variants Of Lgr6 	.freshpatents.com	0	0		
929	chr19	45156021	45157444	3500316620	327		45156021	45157444	8421504	8	54,99,8,45,28,14,13,66	0,616,718,993,1146,1192,1338,1357	p	350031662000015005	0-342						Cgi-69 compositions and methods of use	Adams	2001	0		
929	chr19	45179503	45182775	3500096358	675		45179503	45182775	8421504	9	40,30,18,15,124,98,246,32,72	0,1302,1430,1761,2013,2408,2597,3071,3200	c	350009635800000038,350009635800000046,350009635800000110,350009635800000111,350009635800000112,350009635800000113,350009635800000114,350009635800000115,350009635800000116,350009635800000117,350009635800000118,350009635800000119,350009635800000120,350009635800000064,350009635800000065	8-48,0-48,12-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,12-48,0-36					Patent	Epithelins: novel cysteine-rich growth modulating proteins (Patent US:5416192)	Plowman	1995	0		
929	chr19	45180802	45182977	3500353562	90		45180802	45182977	8421504	3	33,9,48	0,131,2127	c	350035356200000065,350035356200000086	6-48,0-48						 88kDa Tumorigenic Growth Factor And Antagonists 	www.docstoc.com	0	0		
929	chr19	45205216	45209028	3500090033	46		45205216	45209028	8421504	4	12,11,9,14	0,168,3580,3798	c	350009003300000076,350009003300000003,350009003300000075,350009003300000002	0-23,0-23,0-23,0-23						Methods of identifying agents that modulate P2Y12 receptor activity	Conley	2000	0		ITGA2B
929	chr19	45206265	45206289	3500395168	24		45206265	45206289	8421504	1	24	0	g	350039516800000002	0-24						Cross-talkofGATA-1andP-TEFbinmegakaryocytedifferentiation	tologylibrary.org	0	0		
931	chr19	45467570	45467598	3500131528	24		45467570	45467598	8421504	3	7,4,13	0,8,15	g	350013152800000003	6-30						Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation	biomedcentral.com	0	0		
932	chr19	45568438	45568461	3500114540	23		45568438	45568461	8421504	1	23	0	c	350011454000000003	0-23						NAOSITE: Nagasaki University's Academic Output SITE	.nagasaki-u.ac.jp	0	0		GJC1
932	chr19	45568532	45569723	3500037721	47		45568532	45569723	8421504	2	23,24	0,1167	c,g	350003772100000001,350003772100000001,350003772100000000	0-23,0-23,0-24		18815262	10.1523/JNEUROSCI.2137-08.2008		The Journal of neuroscience : the official journal of the Society for Neuroscience	Connexin45-containing neuronal gap junctions in rodent retina also contain connexin36 in both apposing hemiplaques, forming bi-homotypic gap junctions, with scaffolding contributed by zonula occludens-1	Xinbo	2008	0		GJC1
932	chr19	45569072	45569120	3500368428	48		45569072	45569120	8421504	1	48	0	p	350036842800015000	0-48		18579650	10.1152/ajpregu.00468.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Connexin45 is expressed in the juxtaglomerular apparatus and is involved in the regulation of renin secretion and blood pressure	Hanner	2008	0		GJC1
932	chr19	45569072	45569120	3500051148	48		45569072	45569120	8421504	1	48	0	p	350005114800015000	0-48		18579650	10.1152/ajpregu.00468.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Connexin45 is expressed in the juxtaglomerular apparatus and is involved in the regulation of renin secretion and blood pressure	Hanner	2008	0		GJC1
932	chr19	45569072	45569120	3500029590	48		45569072	45569120	8421504	1	48	0	p	350002959000015000	0-48		18579650	10.1152/ajpregu.00468.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Connexin45 is expressed in the juxtaglomerular apparatus and is involved in the regulation of renin secretion and blood pressure	Hanner	2008	0		GJC1
933	chr19	45659284	45659310	3500448129	23		45659284	45659310	8421504	2	15,8	0,18	c	350044812900000029	0-24		15933215	10.1124/mol.105.012245	1521-0111 (Online)	Molecular Pharmacology	Poly(C) Binding Protein Family Is a Transcription Factor in &#x03bc;-Opioid Receptor Gene Expression	Kim	2005	0		
933	chr19	45659606	45662801	3500162913	40		45659606	45662801	8421504	4	14,6,10,10	0,621,2453,3185	c	350016291300000001,350016291300000000	0-20,0-20		12118088	10.1097/01.LAB.0000018829.49754.DD	0023-6837	Laboratory Investigation	Photocoagulation-Induced Retinal Gliosis Is Inhibited by Systemically Expressed Soluble TGF-&bgr; Receptor Type II via Adenovirus Mediated Gene Transfer	Hisatomi	2002	4		
933	chr19	45659617	45662838	3500205806	180		45659617	45662838	8421504	4	3,86,44,47	0,610,2408,3174	p	350020580600015097	0-180						MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY	Wang	2010	0		
933	chr19	45660240	45662840	3500191431	40		45660240	45662840	8421504	2	20,20	0,2580	g	350019143100000022,350019143100000023	0-20,0-20						Methods for obtaining human embryoid body-derived cells	Shamblott	2001	0		
933	chr19	45660255	45662027	3500019095	47		45660255	45662027	8421504	3	23,22,2	0,36,1770	c	350001909500000003,350001909500000002	0-23,0-24		23197859	10.5966/sctm.2011-0063		Stem Cells Translational Medicine	Targeting p38 Mitogen-Activated Protein Kinase Signaling Restores Subventricular Zone Neural Stem Cells and Corrects Neuromotor Deficits in Atm Knockout Mouse	Jeesun	July	0		GFAP
933	chr19	45660284	45662808	3500027167	90		45660284	45662808	8421504	3	29,44,17	0,1741,2507	p	350002716700015115	0-90						Neela Devi Sing RAMBARUTH	search.wmin.ac.uk	0	0		
933	chr19	45662035	45662062	3500404708	27		45662035	45662062	8421504	1	27	0	c	350040470800000000	0-27		18685083	10.1091/mbc.E08-03-0284	1059-1524	Molecular Biology of the Cell	Glial Fibrillary Acidic Protein Filaments Can Tolerate the Incorporation of Assembly-compromised GFAP-&#x03b4;, but with Consequences for Filament Organization and &#x03b1;B-Crystallin Association	Perng	2008	5		
933	chr19	45662035	45662062	3500117651	27		45662035	45662062	8421504	1	27	0	c	350011765100000000	0-27						Glial Fibrillary Acidic Protein Filaments Can Tolerate the Incorporation of Assembly-compromised GFAP- , but with Consequences for Filament Organization and B-Crystallin Association	w.molbiolcell.org	0	0		
933	chr19	45665624	45666855	3500384567	40		45665624	45666855	8421504	3	20,16,4	0,298,1227	c	350038456700000001,350038456700000000	0-20,0-20		21075782	10.1093/neuonc/noq145		Neuro-Oncology	Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas	Andres	2011	0		GFAP
933	chr19	45665625	45666857	3500009244	48		45665625	45666857	8421504	3	24,18,6	0,295,1226	c	350000924400000005,350000924400000004	0-24,0-24		20824710	10.1002/ijc.25647	1097-0215	International Journal of Cancer	Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells - Ferletta - 2010 - International Journal of Cancer - Wiley Online Library	Ferletta	2011	0		GFAP
933	chr19	45665919	45666855	3500418632	23		45665919	45666855	8421504	2	19,4	0,932	c	350041863200000009	0-23			10.1038/onc.2013.67	0950-9232	Oncogene	Snail depletes the tumorigenic potential of glioblastoma	Savary	2013	6		GFAP
933	chr19	45665919	45666855	3500114503	23		45665919	45666855	8421504	2	19,4	0,932	c	350011450300000009	0-23			10.1038/onc.2013.67	0950-9232	Oncogene	Snail depletes the tumorigenic potential of glioblastoma	Savary	2013	6		GFAP
933	chr19	45665923	45667102	3500323013	50		45665923	45667102	8421504	3	15,10,25	0,928,1154	c	350032301300000005,350032301300000004	0-25,0-25		20498942	10.1590/S0102-86502010000300011	0102-8650	Acta Cirurgica Brasileira	Acta Cirurgica Brasileira - The review of the methods to obtain non-neuronal cells to study glial influence on Amyotrophic Lateral Sclerosis pathophysiology at molecular level in vitro	Scorisa	2010	1		GFAP
933	chr19	45665923	45667102	3500246436	50		45665923	45667102	8421504	3	15,10,25	0,928,1154	c	350024643600000049,350024643600000048	0-25,0-25						Immortalized human microglia cell line	Kim	2001	0		GFAP
933	chr19	45665923	45667102	3500022500	50		45665923	45667102	8421504	3	15,10,25	0,928,1154	c	350002250000000049,350002250000000048	0-25,0-25						Immortalized human microglia cell line	www.devileye.net	0	0		
933	chr19	45711472	45712024	3500131676	378		45711472	45712024	8421504	2	207,171	0,381	p	350013167600015035,350013167600015034	0-207,18-189						Treatment of metabolic disorders with a tnf receptor family member (fradj and/or cryptic) agonists or antagonists	Dialynas	2003	0		C1QL1
933	chr19	45711640	45711665	3500023269	24		45711640	45711665	8421504	2	20,4	0,21	c	350002326900000026	10-34						Full text of "RNA fen li yu jian ding shi yan zhi nan RNA yan jiu fang fa"	archive.org	0	0		C1QL1
934	chr19	45806544	45815283	3500069979	42		45806544	45815283	8421504	2	23,19	0,8720	c	350006997900000000,350006997900000003	0-23,0-19						Rundle, Mol Vis 2004; 10:177-185.	www.molvis.org	0	0		NMT1
934	chr19	45862184	45862416	3500432905	46		45862184	45862416	8421504	2	26,20	0,212	c,g	350043290500000004,350043290500000002,350043290500000002,350043290500000005,350043290500000005	0-20,0-19,0-19,0-20,0-20		23537346	10.1186/1297-9716-44-21	1297-9716	Veterinary Research	Bovine HEXIM1 inhibits bovine immunodeficiency virus replication through regulating BTat-mediated transactivation	Guo	2013	0		
934	chr19	45871480	45874872	3500237346	71		45871480	45874872	8421504	4	24,26,8,13	0,35,70,3379	c	350023734600000015,350023734600000017,350023734600000016	0-24,0-26,0-21						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
935	chr19	45957660	45977323	3500242083	49		45957660	45977323	8421504	2	24,25	0,19638	c	350024208300000001,350024208300000000	0-24,30-55			10.1128/JVI.79.14.8948-8959.2005		Journal of Virology	Respiratory Syncytial Virus Influences NF-&#x03ba;B-Dependent Gene Expression through a Novel Pathway Involving MAP3K14/NIK Expression and Nuclear Complex Formation with NF-&#x03ba;B2	Sanjeev	July	0		
935	chr19	45957660	45977323	3500135022	49		45957660	45977323	8421504	2	24,25	0,19638	c	350013502200000001,350013502200000000	0-24,30-55		15994789	10.1128/JVI.79.14.8948-8959.2005	0022-538X	Journal of Virology	Respiratory Syncytial Virus Influences NF-&#x03ba;B-Dependent Gene Expression through a Novel Pathway Involving MAP3K14/NIK Expression and Nuclear Complex Formation with NF-&#x03ba;B2	Choudhary	2005	5		
935	chr19	46001446	46001474	3500067129	23		46001446	46001474	8421504	2	10,13	0,15	g	350006712900000044	0-23						Method of identifying and quantifying specific fungi and bacteria	Haugland	2001	0		
937	chr19	46264398	46264426	3500076924	24		46264398	46264426	8421504	3	13,7,4	0,16,24	g	350007692400000028,350007692400000029	7-31,2-26					Patent	Antibodies for inhibiting blood coagulation and methods of use thereof (Patent EP:1446157)	Jiao	2010	0		
939	chr19	46462293	46512054	3500454229	1065		46462293	46512054	8421504	4	80,242,266,477	0,44406,48444,49284	p	350045422900015001,350045422900015004,350045422900015005,350045422900015006,350045422900015007,350045422900015008,350045422900015009,350045422900015026,350045422900015010,350045422900015027,350045422900015011,350045422900015028,350045422900015012,350045422900015013,350045422900015030,350045422900015014,350045422900015031,350045422900015015,350045422900015016,350045422900015017,350045422900015018,350045422900015020,350045422900015021,350045422900015022,350045422900015023,350045422900015024	0-1065,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,3-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Wnt-3 polynucleotides	Barnes	1998	0		
939	chr19	46506769	46511927	3500148394	110		46506769	46511927	8421504	3	27,57,26	0,4892,5132	c	350014839400000319,350014839400000078,350014839400000067,350014839400000089,350014839400000332	0-27,0-24,6-47,0-48,21-47						Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	.freshpatents.com	0	0		
939	chr19	46510827	46510995	3500382906	48		46510827	46510995	8421504	2	24,24	0,144	c,g	350038290600000010,350038290600000010,350038290600000011	0-24,0-24,0-24						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
939	chr19	46510827	46510995	3500143893	48		46510827	46510995	8421504	2	24,24	0,144	c,g	350014389300000010,350014389300000010,350014389300000011,350014389300000011	0-24,0-24,0-24,0-24						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
939	chr19	46510865	46510889	3500252803	24		46510865	46510889	8421504	1	24	0	c	350025280300000012	0-24						Wnt-7B-like polypeptides and nucleic acids encoding same	Vernet	2000	0		
939	chr19	46511713	46512054	3500300169	45		46511713	46512054	8421504	2	25,20	0,321	c,g	350030016900000005,350030016900000001,350030016900000001	0-25,9-29,9-29						Effects of Wnt proteins on cell proliferation and apoptosis in HEK293 cells	L	2008	0		
942	chr19	46916194	46920384	3500252016	68		46916194	46920384	8421504	3	23,21,24	0,4066,4166	c,g	350025201600000003,350025201600000031,350025201600000043,350025201600000043,350025201600000015,350025201600000015,350025201600000005,350025201600000033	0-23,0-23,0-21,0-21,0-21,0-21,0-24,0-24						Variants Of Corticotropin Releasing Hormone Receptor Type 1 And Uses Thereof 	.freshpatents.com	0	0		
942	chr19	46919358	46919384	3500432232	23		46919358	46919384	8421504	2	18,5	0,21	c	350043223200000004,350043223200000005	6-29,0-23		17204474	10.1074/jbc.M607309200	0021-9258	Journal of Biological Chemistry	Radical Sites in Mycobacterium tuberculosis KatG Identified Using Electron Paramagnetic Resonance Spectroscopy, the Three-dimensional Crystal Structure, and Electron Transfer Couplings	Ranguelova	2007	5		
942	chr19	46920360	46920384	3500250151	24		46920360	46920384	8421504	1	24	0	c,g	350025015100000015,350025015100000015	0-24,0-24						Human Mast Cells Express Corticotropin-Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of	astcellmaster.com	0	0		
943	chr19	46961251	46961304	3500296729	53		46961251	46961304	8421504	1	53	0	c	350029672900000010	0-53						In vivo screening models for treatment of alzheimer's disease and other qpct-related disorders	Cynis	2008	0		
943	chr19	46961251	46961304	3500270001	53		46961251	46961304	8421504	1	53	0	c	350027000100000010	0-53						IN VIVO SCREENING MODELS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER QPCT-RELATED DISORDERS - Patent application	www.faqs.org	0	0		
943	chr19	46961289	46961314	3500219342	24		46961289	46961314	8421504	2	20,4	0,21	c	350021934200000002	0-25		18305247	10.1523/JNEUROSCI.5185-07.2008	0270-6474	The Journal of Neuroscience	The Neurotrophic Effects of Glial Cell Line-Derived Neurotrophic Factor on Spinal Motoneurons Are Restricted to Fusimotor Subtypes	Gould	2008	7		
944	chr19	47065275	47114989	3500381891	66		47065275	47114989	8421504	2	34,32	0,49682	c	350038189100000000,350038189100000001	1-35,0-32						Diagnosis of tauopathies	Vanmechelen	2003	0		
944	chr19	47065275	47114989	3500353780	66		47065275	47114989	8421504	2	34,32	0,49682	c	350035378000000000,350035378000000001	1-35,0-32					Patent	Diagnosis of tauopathies (Patent US:6680173)	Vanmechelen	2004	0		
944	chr19	47065275	47114989	3500249122	66		47065275	47114989	8421504	2	34,32	0,49682	c	350024912200000000,350024912200000001	1-35,0-32					Patent	Diagnosis of tauopathies (Patent US:7387879)	Vanmechelen	2008	0		
944	chr19	47065275	47114989	3500248753	66		47065275	47114989	8421504	2	34,32	0,49682	c	350024875300000000,350024875300000001	1-35,0-32						Diagnosis of tauopathies	Vanderstichele	2004	0		
944	chr19	47065275	47114989	3500243955	66		47065275	47114989	8421504	2	34,32	0,49682	c	350024395500000004,350024395500000005	1-35,0-32					Patent	Diagnose von tauopathien durch bestimmung des verh&#xe4;ltnisses von tau/phospho-tau Diagnosis of tauopathies by determination of the ratio of tau / phospho-tau (Patent DE:60123752)	Vanderstichele	2007	0		
944	chr19	47065275	47114989	3500096439	66		47065275	47114989	8421504	2	34,32	0,49682	c	350009643900000000,350009643900000001	1-35,0-32						Diagnosis of tauopathies	Vanderstichele	2003	0		
944	chr19	47065275	47114989	3500093107	138		47065275	47114989	8421504	3	34,72,32	0,24918,49682	p,c	350009310700000002,350009310700015040,350009310700000003	1-35,0-72,0-32						Diagnosis of tauopathies determining tau/phospho-tau ratio	Vanderstichele	2002	0		
944	chr19	47065275	47114989	3500062479	66		47065275	47114989	8421504	2	34,32	0,49682	c	350006247900000002,350006247900000003	1-35,1-33					Patent	Diagnose von tauopathien durch bestimmung des verh&#xe4;ltnisses von tau/phospho-tau (Patent DE:60123752)	Vanderstichele	2007	0		MAPT
944	chr19	47065275	47114989	3500038802	66		47065275	47114989	8421504	2	34,32	0,49682	c	350003880200000005,350003880200000002,350003880200000006,350003880200000003	1-35,1-35,0-32,0-32					Patent	Diagnosis of tauopathies determining tau/phospho-tau ratio (Patent EP:1250600)	Vanmechelen	2006	0		
944	chr19	47065275	47114989	3500037415	66		47065275	47114989	8421504	2	34,32	0,49682	c	350003741500000000,350003741500000001	1-35,0-32						Diagnosis of tauopathies	Vanderstichele	2003	0		
944	chr19	47065298	47065325	3500401051	27		47065298	47065325	8421504	1	27	0	c	350040105100000002	0-27		11641220		0950-1991	Development	RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons	Enomoto	2001	7		
944	chr19	47065298	47065325	3500234381	27		47065298	47065325	8421504	1	27	0	c	350023438100000002	0-27						RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons	ev.biologists.org	0	0		
944	chr19	47070493	47086180	3500166806	46		47070493	47086180	8421504	2	22,24	0,15663	c	350016680600000003,350016680600000004	3-25,0-24						Brain-DerivedNeurotrophicFactorSignalingDoesNot StimulateSubventricularZoneNeurogenesisinAdultMice andRats	www.jneurosci.org	0	0		
944	chr19	47070493	47086180	3500034144	46		47070493	47086180	8421504	2	22,24	0,15663	c	350003414400000003,350003414400000004	3-25,0-24		19074010	10.1523/JNEUROSCI.2918-08.2008	0270-6474	The Journal of Neuroscience	Brain-Derived Neurotrophic Factor Signaling Does Not Stimulate Subventricular Zone Neurogenesis in Adult Mice and Rats	Galvao	2008	7		
944	chr19	47094196	47114786	3500320031	375		47094196	47114786	8421504	5	69,93,82,113,18	0,10926,14328,15943,20572	p	350032003100015041,350032003100015050,350032003100015053,350032003100015057	0-93,0-93,0-93,0-96						PTL-1, a microtubule-associated protein with tau-like repeats from the nematode Caenorhabditis elegans	cs.biologists.org	0	0		
944	chr19	47094208	47110243	3500219017	219		47094208	47110243	8421504	4	54,64,8,93	0,14334,15931,15942	p	350021901700015010,350021901700015011,350021901700015012	0-54,0-72,0-93						Screening method for polymorphic markers in htra1 gene in neurodegenerative disorders	Egensperger	2011	0		MAPT
944	chr19	47105140	47114985	3500373837	220		47105140	47114985	8421504	5	60,57,33,48,22	0,3405,5007,5043,9823	p,c	350037383700015003,350037383700015004,350037383700015002,350037383700000000	15-75,21-78,0-81,11-33						Cellular model of tauopathies for lead identification and drug discovery	Iliev	2005	0		MAPT
944	chr19	47105182	47114831	3500287572	291		47105182	47114831	8421504	4	33,82,113,63	0,3342,4957,9586	p	350028757200015002	0-291						Materials and methods relating to protein aggregation in neurodegenerative disease - Patent application	www.faqs.org	0	0		
944	chr19	47105182	47114831	3500155316	291		47105182	47114831	8421504	4	33,82,113,63	0,3342,4957,9586	p,c	350015531600015003,350015531600000002,350015531600000004	0-291,0-291,12-36						Materials and methods relating to protein aggregation in neurodegenerative disease	Wischik	2008	0		MAPT
944	chr19	47108577	47110140	3500300637	30		47108577	47110140	8421504	2	29,1	0,1562	c	350030063700000010	1-31		18658135	10.1074/jbc.M802645200		The Journal of Biological Chemistry	Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome	Jianhua	2008	0		MAPT
944	chr19	47108577	47110140	3500032763	30		47108577	47110140	8421504	2	29,1	0,1562	c	350003276300000009	1-31						Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron	mcb.asm.org	0	0		MAPT
944	chr19	47108577	47110140	3500016511	30		47108577	47110140	8421504	2	29,1	0,1562	c	350001651100000024	1-31						Spinal Muscular Atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences	Singh	2005	0		MAPT
944	chr19	47110168	47110243	3500381263	75		47110168	47110243	8421504	1	75	0	p	350038126300015009	0-75						Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders	Egensperger	2010	0		MAPT
944	chr19	47112227	47112250	3500370232	23		47112227	47112250	8421504	1	23	0	g	350037023200000142	23-46						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
944	chr19	47114807	47114837	3500251788	30		47114807	47114837	8421504	1	30	0	c	350025178800000007	0-30						Agents That Reduce Neuronal Overexcitation 	.freshpatents.com	0	0		
944	chr19	47114807	47114837	3500062530	30		47114807	47114837	8421504	1	30	0	c	350006253000000007	0-30						AGENTS THAT REDUCE NEURONAL OVEREXCITATION - THE J. DAVID GLADSTONE INSTITUTES	www.sumobrain.com	0	0		
944	chr19	47114828	47114879	3500317539	51		47114828	47114879	8421504	1	51	0	p	350031753900015000	0-51						Tissue-nonspecificAlkalinePhosphatasePromotesthe NeurotoxicityEffectofExtracellularTau	www.jbc.org	0	0		MAPT
944	chr19	47114828	47114879	3500284661	51		47114828	47114879	8421504	1	51	0	p	350028466100015001	0-51		20634292	10.1074/jbc.M110.145003		The Journal of Biological Chemistry	Tissue-nonspecific Alkaline Phosphatase Promotes the Neurotoxicity Effect of Extracellular Tau	MiguDiaz-Hernandez	2010	0		MAPT
944	chr19	47114828	47114873	3500048457	45		47114828	47114873	8421504	1	45	0	p	350004845700015000	0-45			10.1046/j.1471-4159.2000.0742583.x	1471-4159	Journal of Neurochemistry	The FTDP-17-Linked Mutation R406W Abolishes the Interaction of Phosphorylated Tau with Microtubules - P&#xe9;rez - 2002 - Journal of Neurochemistry - Wiley Online Library	Perez	2000	0		MAPT
944	chr19	47114876	47114921	3500010904	45		47114876	47114921	8421504	1	45	0	p	350001090400015003	0-45			10.1111/j.1471-4159.2006.04059.x	1471-4159	Journal of Neurochemistry	Tau-tubulin kinase&#xa0;1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation - Sato - 2006 - Journal of Neurochemistry - Wiley Online Library	Sato	2006	0		MAPT
944	chr19	47114903	47114948	3500236589	45		47114903	47114948	8421504	1	45	0	p	350023658900015007	0-45						Use of an anti-tau ps422 antibody for the treatment of brain diseases	Bohrmann	2012	0		MAPT
944	chr19	47114903	47114948	3500097251	45		47114903	47114948	8421504	1	45	0	p	350009725100015007	0-45						Use of an anti-tau ps422 antibody for the treatment of brain diseases	Bohrmann	2011	0		MAPT
944	chr19	47114957	47114984	3500026177	27		47114957	47114984	8421504	1	27	0	c	350002617700000001	12-39					The American Journal of Pathology	Transgenic Expression of the Shortest Human Tau Affects Its Compartmentalization and Its Phosphorylation as in the Pretangle Stage of Alzheimer&#x2019;s Disease	Jean-Pierre	1999	0		MAPT
944	chr19	47152615	47152640	3500374696	23		47152615	47152640	8421504	2	14,9	0,16	g	350037469600000005	12-35						Structural Analyses of Borna Disease Virus Nucleoprotein- Phosphoprotein and Nucleoprotein- RNA Interactions	ub.uni-marburg.de	0	0		
118	chr19	47442614	47472137	3500417996	70		47442614	47472137	8421504	3	1,43,26	0,17922,29497	c	350041799600000036,350041799600000042	0-44,22-48						Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use	Bowditch	1991	0		
947	chr19	47472233	47480457	3500445461	876		47472233	47480457	8421504	8	43,236,14,163,162,96,90,72	0,1451,1690,3615,4403,6846,7353,8152	p	350044546100015086	3-3282						Moleculas de Adhesion	es.scribd.com	0	0		
947	chr19	47473725	47473785	3500269738	60		47473725	47473785	8421504	1	60	0	p	350026973800015049,350026973800015000	0-48,0-60						TEMPERATURE SENSITIVE CONJUGATE COMPOSITIONS, AND USES RELATED THERETO	Chaikof	2011	0		ITGB3
947	chr19	47473725	47473785	3500115556	60		47473725	47473785	8421504	1	60	0	p	350011555600015049,350011555600015000	0-48,0-60						Temperature sensitive conjugate compositions, and uses related thereto	Chaikof	2013	0		ITGB3
947	chr19	47473725	47473785	3500056729	60		47473725	47473785	8421504	1	60	0	p	350005672900015049,350005672900015000	0-48,0-60						Temperature sensitive conjugate compositions, and uses related thereto	Chaikof	2013	0		ITGB3
947	chr19	47473827	47476648	3500319127	41		47473827	47476648	8421504	3	20,9,12	0,2175,2809	c,g	350031912700000036,350031912700000036,350031912700000037	0-20,0-20,0-21						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
947	chr19	47473835	47476698	3500445683	41		47473835	47476698	8421504	2	20,21	0,2842	c,g	350044568300000014,350044568300000014,350044568300000015,350044568300000015	0-20,0-20,0-21,0-21		20939933	10.1186/1471-2407-10-552	1471-2407	BMC Cancer	N-terminal and C-terminal heparin-binding domain polypeptides derived from fibronectin reduce adhesion and invasion of liver cancer cells	Tang	2010	3		ITGB3
947	chr19	47473835	47476698	3500077370	41		47473835	47476698	8421504	2	20,21	0,2842	c,g	350007737000000014,350007737000000014,350007737000000015,350007737000000015	0-20,0-20,0-21,0-21		20939933	10.1186/1471-2407-10-552		BMC Cancer	N-terminal and C-terminal heparin-binding domain polypeptides derived from fibronectin reduce adhesion and invasion of liver cancer cells	Nan-Hong	2010	0		ITGB3
947	chr19	47475936	47501095	3500459754	127		47475936	47501095	8421504	6	21,21,21,22,21,21	0,4452,6189,6536,12983,25138	c,g	350045975400000033,350045975400000033,350045975400000034,350045975400000037,350045975400000036,350045975400000036,350045975400000039,350045975400000039,350045975400000038,350045975400000043	0-21,0-21,0-21,0-21,0-22,0-22,0-21,0-21,0-21,0-21						CLINICAL, BIOCHEMICAL, AND MOLECULAR ASPECTS OF GLANZMANN THROMBASTHENIA IN HORSES Peter W. Christopherson Certificate of Approval	etd.auburn.edu	0	0		
947	chr19	47475936	47476658	3500455424	97		47475936	47476658	8421504	2	75,22	0,700	c	350045542400000001	0-97						Beta-8 integrin subunit antibodies	Moyle	1995	0		ITGB3
947	chr19	47475936	47476658	3500450362	97		47475936	47476658	8421504	2	75,22	0,700	c	350045036200000001	0-97						US Patent # 5,635,601. Beta-8 integrin subunit antibodies - Patents.com	www.patents.com	0	0		ITGB3
947	chr19	47475940	47475965	3500020282	25		47475940	47475965	8421504	1	25	0	c	350002028200000004	0-25						A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. - ResearchGate	.researchgate.net	0	0		ITGB3
947	chr19	47476677	47476703	3500090446	26		47476677	47476703	8421504	1	26	0	c	350009044600000020	0-26						Kaposi sarcoma herpesvirus microRNA function in lymphatic endothelial cells	scovery.ucl.ac.uk	0	0		
947	chr19	47488994	47489063	3500441388	40		47488994	47489063	8421504	2	19,21	0,48	c,g	350044138800000003,350044138800000004,350044138800000004	0-19,0-21,0-21						The avb6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle	v.sgmjournals.org	0	0		
947	chr19	47488994	47489063	3500271582	40		47488994	47489063	8421504	2	19,21	0,48	c,g	350027158200000003,350027158200000003,350027158200000004	0-19,0-19,0-21						The avb6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle	r.sgmjournals.org	0	0		
947	chr19	47499434	47499459	3500140676	25		47499434	47499459	8421504	1	25	0	c	350014067600000005	0-25						METHOD FOR PREPARING WATER SOLUBLE POLYPEPTIDES - GENENTECH, INC.	www.sumobrain.com	0	0		
947	chr19	47499518	47501113	3500330764	141		47499518	47501113	8421504	2	78,63	0,1532	p	350033076400015002	0-141						Charakterisierung der funktionalen Rolle von Cytohesin-1 in der LFA-1-vermittelten T-Zell-Adh&#xe4;sion	b.uni-muenchen.de	0	0		ITGB3
947	chr19	47499518	47501113	3500275013	141		47499518	47501113	8421504	2	78,63	0,1532	p	350027501300015000	0-141					The Journal of Cell Biology	Enhancement of Endothelial Cell Migration and in Vitro Tube Formation by Tap20, a Novel &#x03b2;5 Integrin&#x2013;Modulating, Pkc&#x03b8;-Dependent Protein	Shaoqing	1999	0		ITGB3
947	chr19	47499518	47501056	3500241060	84		47499518	47501056	8421504	2	78,6	0,1532	p	350024106000015007	0-84						Dissertation zur Erlangung des Doktorgrades der Fakult&#xe4;t f&#xfc;r Chemie und Pharmazie der Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen	b.uni-muenchen.de	0	0		ITGB3
947	chr19	47499536	47501113	3500056865	123		47499536	47501113	8421504	2	60,63	0,1514	p	350005686500015003	0-123						Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin &#x03b2;1A	cs.biologists.org	0	0		ITGB3
947	chr19	47499536	47501110	3500197411	120		47499536	47501110	8421504	2	60,60	0,1514	p	350019741100015103	0-120						HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLAY	Arap	2011	0		ITGB3
947	chr19	47499536	47501110	3500117014	120		47499536	47501110	8421504	2	60,60	0,1514	p	350011701400015099,350011701400015100	0-75,0-45					Patent	Peptide compositions for targeting adipose tissue (Patent US:8067377)	Arap	2011	0		ITGB3
947	chr19	47499566	47501110	3500078577	57		47499566	47501110	8421504	2	30,27	0,1517	p	350007857700015101	12-81						Human And Mouse Targeting Peptides Identified By Phage Display 	.freshpatents.com	0	0		ITGB3
947	chr19	47501068	47501113	3500263004	45		47501068	47501113	8421504	1	45	0	p	350026300400015002	0-45						Integrin &#x03b1;IIb&#x03b2; regulation in platelets	ive.library.uu.nl	0	0		ITGB3
950	chr19	47925789	47925812	3500128115	23		47925789	47925812	8421504	1	23	0	g	350012811500000006	0-32		18344358	10.1128/JB.00846-07	0021-9193	Journal of Bacteriology	Stabilization of pSW100 from Pantoea stewartii by the F Conjugation System	Lin	2008	4		
951	chr19	48100444	48100470	3500193635	24		48100444	48100470	8421504	2	12,12	0,14	c	350019363500000144	9-33						Materials and methods for immunocontraception	Harris	1993	0		
952	chr19	48166099	48166124	3500086420	24		48166099	48166124	8421504	2	14,10	0,15	c	350008642000000005	0-24						Functional Screening Yields &#x03b2;-1,4-Endoglucanase Gene from Heterodera glycines that May be the Product of Recent Gene Duplication	ath.cals.ncsu.edu	0	0		TLK2
952	chr19	48234034	48234057	3500301316	23		48234034	48234057	8421504	1	23	0	c	350030131600000075	4-45						Protective helicobacter antigens	Doidge	1996	0		
955	chr19	48627556	48627582	3500110329	23		48627556	48627582	8421504	2	6,17	0,9	g	350011032900000064	25-48						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
958	chr19	48890069	48890094	3500026622	24		48890069	48890094	8421504	2	19,5	0,20	c	350002662200000005	0-25		16280362	10.1091/mbc.E05-06-0488	1059-1524	Molecular Biology of the Cell	Proteolysis of Cortactin by Calpain Regulates Membrane Protrusion during Cell Migration	Perrin	2006	5		
958	chr19	48890845	48890872	3500013832	23		48890845	48890872	8421504	3	4,11,8	0,5,19	c	350001383200000022	7-30						Nucleoside cotransporter protein cDNA	Wright	1992	0		
958	chr19	48901055	48901080	3500125509	23		48901055	48901080	8421504	2	7,16	0,9	c	350012550900000009	0-23						TSG-Like Gene - Patent application	www.faqs.org	0	0		
958	chr19	48932433	48932459	3500401872	24		48932433	48932459	8421504	3	4,4,16	0,5,10	c	350040187200000051	23-47						Methods And Compositions For Treating And Preventing Peripheral Nerve Damage 	.freshpatents.com	0	0		ACE
958	chr19	48933563	48935110	3500144954	64		48933563	48935110	8421504	3	31,29,4	0,1148,1543	c	350014495400000032,350014495400000001,350014495400000003,350014495400000034	9-40,9-40,12-45,12-45						 Antisense Oligonucleotide Compositions Targeted To Angiotensin Converting Enzyme MRNA And Methods Of Use 	www.docstoc.com	0	0		
958	chr19	48936152	48951071	3500310121	81		48936152	48951071	8421504	5	4,16,20,20,21	0,252,1875,5138,14898	c,g	350031012100000001,350031012100000011,350031012100000011,350031012100000004,350031012100000003,350031012100000009	0-20,0-20,0-20,0-20,0-20,0-21		15987822	10.1095/biolreprod.105.042929	0006-3363	Biology of Reproduction	Shedding of the Germinal Angiotensin I-Converting Enzyme (gACE) Involves a Serine Protease and Is Activated by Epididymal Fluid	Thimon	2005	4		
958	chr19	48936152	48941310	3500426247	60		48936152	48941310	8421504	4	4,16,20,20	0,252,1875,5138	c,g	350042624700000001,350042624700000011,350042624700000011,350042624700000003,350042624700000004	0-20,0-20,0-20,0-19,0-20						Shedding of the Germinal Angiotensin I-Converting Enzyme (gACE) Involves a Serine Protease and Is Activated by Epididymal Fluid	ww.biolreprod.org	0	0		
958	chr19	48980673	48984139	3500382780	40		48980673	48984139	8421504	2	20,20	0,3446	c,g	350038278000000006,350038278000000007,350038278000000007	0-20,0-20,0-20		18184764	10.1152/ajpregu.00521.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Erg K+ channels modulate contractile activity in the bovine epididymal duct	Mewe	2008	0		
958	chr19	48980673	48984139	3500057255	40		48980673	48984139	8421504	2	20,20	0,3446	c,g	350005725500000006,350005725500000007,350005725500000007	0-20,0-20,0-20		18184764	10.1152/ajpregu.00521.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Erg K+ channels modulate contractile activity in the bovine epididymal duct	Mewe	2008	0		
119	chr19	49000083	49026190	3500106625	127		49000083	49026190	8421504	4	6,45,45,31	0,19352,19457,26076	p,c	350010662500015000,350010662500015001,350010662500000001	0-51,0-45,14-45		14593110	10.1074/jbc.M301769200	0021-9258	Journal of Biological Chemistry	Phosphorylation of Ser640 in Muscle Glycogen Synthase by DYRK Family Protein Kinases	Skurat	2004	5		KCNH6,DCAF7
958	chr19	49020338	49020366	3500097699	23		49020338	49020366	8421504	3	5,13,5	0,8,23	c	350009769900000025	10-33						/tardir/tiffs/a391939	www.dtic.mil	0	0		
959	chr19	49040600	49040626	3500422426	23		49040600	49040626	8421504	2	16,7	0,19	g	350042242600000067	3-26						PII: B978-0-12-164730-8.50060-5	gitus.itk.ppke.hu	0	0		
959	chr19	49104874	49104901	3500459757	24		49104874	49104901	8421504	2	11,13	0,14	g	350045975700000041	1-25						2'-Modified Oligonucleotides - Patent application	www.faqs.org	0	0		
959	chr19	49104874	49104901	3500185681	24		49104874	49104901	8421504	2	11,13	0,14	g	350018568100000034	1-25						Sugar-modified gapped oligonucleotides	Altmann	1997	0		
960	chr19	49209718	49210312	3500335102	60		49209718	49210312	8421504	2	21,39	0,555	p	350033510200015077	0-60						BiochemicalCharacterizationandN-terminomicsAnalysisof Leukolysin,theMembrane-type6MatrixMetalloprotease (MMP25)	www.jbc.org	0	0		PSMC5
960	chr19	49236476	49236505	3500318471	24		49236476	49236505	8421504	2	8,16	0,13	c	350031847100000008	9-33						modification of the aldehyde dehydrogenase ALDH3B1 Issue Date 2013-08	lib.hokudai.ac.jp	0	0		
960	chr19	49249576	49250126	3500374723	550		49249576	49250126	8421504	1	550	0	g	350037472300000011	89-639						Plasmids suitable for il-2 expression	Hobart	1996	0		
960	chr19	49249578	49250126	3500100644	548		49249578	49250126	8421504	1	548	0	c,g	350010064400000149,350010064400000001,350010064400000192,350010064400000192,350010064400000030,350010064400000005	1647-2195,0-26,0-26,0-26,1-24,0-21						Coordinate in vivo gene expression	Liu	1995	0		
960	chr19	49249660	49250126	3500231624	466		49249660	49250126	8421504	1	466	0	g	350023162400000009	2216-2682						Dna-based vaccination of retroviral-infected individuals undergoing treatment	Felber	2006	0		
960	chr19	49249866	49249893	3500124137	27		49249866	49249893	8421504	1	27	0	g	350012413700000010	9-36					Patent	Polynucleotide tuberculosis vaccine (Patent US:5736524)	Content	1998	0		
960	chr19	49249866	49249893	3500083422	27		49249866	49249893	8421504	1	27	0	g	350008342200000008	9-36						POLYNUCLEOTIDE VACCINE FORMULATIONS	Volkin	1998	0		
960	chr19	49249872	49250126	3500460984	47		49249872	49250126	8421504	2	21,26	0,228	c,g	350046098400000080,350046098400000047,350046098400000047,350046098400000068	0-21,0-26,0-26,4-27					Patent	Coordinate in vivo gene expression (Patent US:6995008)	Liu	2006	0		
960	chr19	49249872	49250126	3500212513	47		49249872	49250126	8421504	2	21,26	0,228	c,g	350021251300000080,350021251300000047,350021251300000047,350021251300000068	0-21,0-26,0-26,4-27						Coordinate in vivo gene expression	Liu	1999	0		
960	chr19	49249895	49250131	3500208798	65		49249895	49250131	8421504	3	4,30,31	0,5,205	c,g	350020879800000018,350020879800000017,350020879800000017,350020879800000007,350020879800000007	0-34,13-43,13-43,10-37,10-37						METHOD FOR THE EXPRESSION OF A RECOMBINANT PROTEIN IN A MAMMALIAN CELL	Vries	2010	0		
960	chr19	49249898	49250129	3500169993	39		49249898	49250129	8421504	2	19,20	0,211	g	350016999300000017,350016999300000042,350016999300000041	11-30,11-30,6-26						US Patent # 6,114,598. Generation of xenogeneic antibodies - Patents.com	www.patents.com	0	0		
960	chr19	49249899	49250125	3500086063	51		49249899	49250125	8421504	2	26,25	0,201	g	350008606300000368,350008606300000367,350008606300000046	7-33,16-41,16-41						Gastrointestinal proliferative foctor and uses thereof - Patent application	www.faqs.org	0	0		
960	chr19	49249900	49250125	3500465421	204		49249900	49250125	8421504	4	39,26,113,26	0,49,76,199	c,g	350046542100000245,350046542100000244,350046542100000243,350046542100000243	0-39,0-139,124-150,124-150						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
960	chr19	49249900	49250125	3500429415	225		49249900	49250125	8421504	1	225	0	g	350042941500000018	260-485						SIMIAN SUBFAMILY C ADENOVIRUSES SAdV-40, -31, AND -34 AND USES THEREOF	Roy	2010	0		
960	chr19	49249900	49250125	3500390862	225		49249900	49250125	8421504	1	225	0	c,g	350039086200000201,350039086200000013,350039086200000212	668-893,20-245,0-94						Protease inhibition	Ladner	2007	0		
960	chr19	49249900	49250125	3500362520	225		49249900	49250125	8421504	1	225	0	g	350036252000000056	851-1076						Analysis of the modifying influence of Plastin 3 (PLS3) on Spinal Muscular Atrophy (SMA) by generation of transgenic mouse models	s.ub.uni-koeln.de	0	0		
960	chr19	49249900	49250125	3500334531	225		49249900	49250125	8421504	1	225	0	g	350033453100000016	310-535						Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof	Roy	2009	0		
960	chr19	49249900	49250125	3500321569	216		49249900	49250125	8421504	8	14,43,23,71,14,10,28,13	0,15,59,84,156,171,183,212	g	350032156900000081	71-287						Protease-resistant thrombomodulin analogs	Andrews	1995	0		
960	chr19	49249900	49250125	3500297606	225		49249900	49250125	8421504	1	225	0	g	350029760600000012	260-485						SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38	Roy	2010	0		
960	chr19	49249900	49250125	3500296729	225		49249900	49250125	8421504	1	225	0	g	350029672900000018,350029672900000017	0-100,25-150						In vivo screening models for treatment of alzheimer's disease and other qpct-related disorders	Cynis	2008	0		
960	chr19	49249900	49250125	3500292270	225		49249900	49250125	8421504	1	225	0	g	350029227000000011	25-250						Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression	Limor	2008	0		
960	chr19	49249900	49250125	3500271613	225		49249900	49250125	8421504	1	225	0	g	350027161300000011	25-250						Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression	Limor	2009	0		
960	chr19	49249900	49250125	3500270001	225		49249900	49250125	8421504	1	225	0	g	350027000100000018,350027000100000017	0-100,25-150						IN VIVO SCREENING MODELS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER QPCT-RELATED DISORDERS - Patent application	www.faqs.org	0	0		
960	chr19	49249900	49250125	3500240936	225		49249900	49250125	8421504	1	225	0	g	350024093600000010	171-396						COMPOSITIONS AND METHOD FOR MANIPULATING PIM-1 ACTIVITY IN CIRCULATORY SYSTEM CELLS - Patent application	www.faqs.org	0	0		
960	chr19	49249900	49250125	3500195441	225		49249900	49250125	8421504	1	225	0	g	350019544100000140	201-426						PUUMALA VIRUS FULL-LENGTH M SEGMENT-BASED DNA VACCINES	Hooper	2008	0		
960	chr19	49249900	49250125	3500095690	225		49249900	49250125	8421504	1	225	0	c,g	350009569000000013,350009569000000201,350009569000000212	20-245,668-893,0-94						Protease inhibition	Ladner	2008	0		
960	chr19	49249900	49250125	3500062491	225		49249900	49250125	8421504	1	225	0	g	350006249100000015	970-1195						Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof	J*M*Wei Er Sen 	2010	0		
960	chr19	49249900	49250037	3500109816	70		49249900	49250037	8421504	3	20,20,30	0,86,107	c,g	350010981600000087,350010981600000022,350010981600000021,350010981600000088	18-38,19-47,11-37,12-38						Crossless retroviral vectors		1998	0		
960	chr19	49249901	49250125	3500359970	224		49249901	49250125	8421504	1	224	0	c,g	350035997000000096,350035997000000246,350035997000000095,350035997000000245,350035997000000094,350035997000000094,350035997000000244,350035997000000244,350035997000000093,350035997000000093	0-62,0-61,0-60,0-61,0-60,0-60,0-61,0-61,18-60,18-60						MODIFIED ANIMAL ERYTHROPOIETIN POLYPEPTIDES AND THEIR USES - Patent application	www.faqs.org	0	0		
960	chr19	49249901	49250125	3500269619	224		49249901	49250125	8421504	1	224	0	c,g	350026961900000087,350026961900000237,350026961900000086,350026961900000236,350026961900000085,350026961900000085,350026961900000235,350026961900000235,350026961900000084,350026961900000084	0-62,0-61,0-60,0-61,0-60,0-60,0-61,0-61,18-60,18-60						MODIFIED ANIMAL ERYTHROPOIETIN POLYPEPTIDES AND THEIR USES - Patent application	www.faqs.org	0	0		
960	chr19	49249901	49250125	3500026018	224		49249901	49250125	8421504	1	224	0	c,g	350002601800000079,350002601800000229,350002601800000078,350002601800000228,350002601800000077,350002601800000077,350002601800000227,350002601800000227,350002601800000076,350002601800000076	0-62,0-61,0-60,0-61,0-60,0-60,0-61,0-61,18-60,18-60						Modified Animal Erythropoietin Polypeptides And Their Uses 	.freshpatents.com	0	0		
960	chr19	49249904	49250125	3500146194	210		49249904	49250125	8421504	4	57,57,55,41	0,60,120,180	g	350014619400000035	19-229						Liver-specific gene expression cassettes, and methods of use - US Patent 7351813 Description	ww.patentstorm.us	0	0		
960	chr19	49249904	49250125	3500071726	210		49249904	49250125	8421504	4	57,57,55,41	0,60,120,180	g	350007172600000035	19-229						US Patent # 7,351,813. Liver-specific gene expression cassettes, and methods of use - Patents.com	www.patents.com	0	0		
960	chr19	49249904	49250124	3500406269	100		49249904	49250124	8421504	3	20,20,60	0,130,160	c,g	350040626900000358,350040626900000355,350040626900000354	0-20,0-80,0-31					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
960	chr19	49249905	49250125	3500023618	184		49249905	49250125	8421504	3	74,74,36	0,92,184	c,g	350002361800000072,350002361800000071,350002361800000070,350002361800000070	0-74,0-74,38-74,38-74						METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES - Patent application	www.faqs.org	0	0		
960	chr19	49249911	49250125	3500004373	214		49249911	49250125	8421504	1	214	0	c,g	350000437300000043,350000437300000042,350000437300000042,350000437300000012,350000437300000041,350000437300000041	0-120,0-60,0-60,0-20,146-180,146-180						Identifizierung von Liganden des G-Protein gekoppelten Rezeptors Mas und Mas-Sequenz-&#xe4;hnlicher Rezeptoren	diss.fu-berlin.de	0	0		
960	chr19	49249917	49250125	3500193213	208		49249917	49250125	8421504	1	208	0	c,g	350019321300000133,350019321300000131,350019321300000129,350019321300000129,350019321300000127,350019321300000127	0-44,0-60,0-60,0-60,16-60,16-60						Vectors and methods for immunization or therapeutic protocols	Krieg	1998	0		
960	chr19	49249917	49250125	3500157423	208		49249917	49250125	8421504	1	208	0	c,g	350015742300000132,350015742300000130,350015742300000128,350015742300000128,350015742300000126,350015742300000126	0-44,0-60,0-60,0-60,16-60,16-60						Vectors and methods for immunization or therapeutic protocols - Patent # 6339068 - PatentGenius	.patentgenius.com	0	0		
960	chr19	49249917	49250125	3500122872	208		49249917	49250125	8421504	1	208	0	c,g	350012287200000121,350012287200000119,350012287200000117,350012287200000117,350012287200000115,350012287200000115	0-44,0-60,0-60,0-60,16-60,16-60						Vectors and methods for immunization or therapeutic protocols	Krieg	2001	0		
960	chr19	49249917	49249949	3500086421	32		49249917	49249949	8421504	1	32	0	g	350008642100000057,350008642100000022	0-32,0-32						Tetramers - Patent application	www.faqs.org	0	0		
960	chr19	49249921	49250126	3500133906	205		49249921	49250126	8421504	1	205	0	c,g	350013390600000012,350013390600000049,350013390600000050,350013390600000014	34-239,34-239,33-142,0-95						 Method for Increasing Protein Expression in Cells - Patent application	www.faqs.org	0	0		
960	chr19	49249922	49250125	3500139988	203		49249922	49250125	8421504	1	203	0	c,g	350013998800000010,350013998800000000	25-228,3-25						PLASMID VECTOR, METHOD FOR DETECTING GENE PROMOTER ACTIVITY, AND ASSAY KIT - Patent application	www.faqs.org	0	0		
960	chr19	49249923	49250125	3500292328	202		49249923	49250125	8421504	1	202	0	g	350029232800000067	70-272						METHOD AND COMPOSITIONS FOR ENHANCED ANTI-TUMOR EFFECTOR FUNCTIONING OF T CELLS - Patent application	www.faqs.org	0	0		
960	chr19	49249923	49250125	3500288926	202		49249923	49250125	8421504	1	202	0	g	350028892600000001	921-1123						pUNO-hIRF1	www.invivogen.com	0	0		
960	chr19	49249923	49250125	3500267262	202		49249923	49250125	8421504	1	202	0	g	350026726200000001	746-948						pUNO-hASCa	www.invivogen.com	0	0		
960	chr19	49249923	49250002	3500346499	79		49249923	49250002	8421504	1	79	0	g	350034649900000002	0-79						pBLAST mATF	www.invivogen.com	0	0		
960	chr19	49249923	49249949	3500318543	26		49249923	49249949	8421504	1	26	0	g	350031854300000014	24-50						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		
960	chr19	49249924	49250125	3500265756	201		49249924	49250125	8421504	1	201	0	g	350026575600000069,350026575600000036,350026575600000108,350026575600000035	39-240,0-60,95-282,42-180						Tissue-specific transcription of dna sequence encoding a heterologous enzyme for use in prodrug therapy to lung cancer	Dev	1997	0		
960	chr19	49249943	49250125	3500238307	182		49249943	49250125	8421504	1	182	0	g	350023830700000047	598-780						COmpositions and methods for high-level, large-scale production of recombinant proteins	Te Li Shi *Ben Dun 	2004	0		
960	chr19	49249967	49250003	3500430515	36		49249967	49250003	8421504	1	36	0	g	350043051500000058	18-54					Patent	Chimeric alphavirus replicon particles (Patent EP:1399183)	Perri	2010	0		
960	chr19	49249967	49250003	3500376557	36		49249967	49250003	8421504	1	36	0	g	350037655700000041	18-54						Chimeric alphavirus replicon particles	Polo	2011	0		
960	chr19	49249967	49250003	3500374628	36		49249967	49250003	8421504	1	36	0	g	350037462800000071,350037462800000072	0-28,18-54						CHIMERIC ALPHAVIRUS REPLICON PARTICLES - Patent application	www.faqs.org	0	0		
960	chr19	49249967	49250003	3500214315	36		49249967	49250003	8421504	1	36	0	g	350021431500000070	18-54					Patent	Chimeric alphavirus replicon particles (Patent US:7531180)	Polo	2009	0		
960	chr19	49249967	49250003	3500213214	36		49249967	49250003	8421504	1	36	0	g	350021321400000041	18-54						Chimeric alphavirus replicon particles	Polo	2011	0		
960	chr19	49249967	49250003	3500199218	36		49249967	49250003	8421504	1	36	0	g	350019921800000057	18-54						Chimeric alphavirus replicon particles	Polo	2011	0		
960	chr19	49249967	49250003	3500190358	36		49249967	49250003	8421504	1	36	0	g	350019035800000070	18-54					Patent	Chimeric alphavirus replicon particles (Patent US:7531180)	Polo	2009	0		
960	chr19	49249967	49250003	3500111117	36		49249967	49250003	8421504	1	36	0	g	350011111700000058	18-54					Patent	Chimeric alphavirus replicon particles (Patent EP:1399183)	Perri	2010	0		
960	chr19	49249967	49250003	3500016898	36		49249967	49250003	8421504	1	36	0	g	350001689800000068	18-54						CHIMERIC ALPHAVIRUS REPLICON PARTICLES	Polo	2009	0		
960	chr19	49249971	49250125	3500068995	154		49249971	49250125	8421504	1	154	0	c,g	350006899500000206,350006899500000267,350006899500000297,350006899500000296,350006899500000205	6-255,29-127,0-28,0-35,6-48						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
960	chr19	49249986	49250037	3500400942	51		49249986	49250037	8421504	1	51	0	c,g	350040094200000046,350040094200000045	11-43,12-38						Recombinant alphavirus vectors	Belli	1996	0		
960	chr19	49249986	49250037	3500381325	51		49249986	49250037	8421504	1	51	0	c,g	350038132500000042,350038132500000041	11-43,12-38						Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis	Belli	2000	0		
960	chr19	49249986	49250037	3500087615	51		49249986	49250037	8421504	1	51	0	c,g	350008761500000023,350008761500000022	19-48,12-38						Crossless retroviral vectors	Bodner	1999	0		
960	chr19	49249993	49250045	3500379047	52		49249993	49250045	8421504	1	52	0	g	350037904700000000	0-52					Patent	Use of a bgh gdna polyadenylation signal in expression of non-bgh polypeptides in higher eukaryotic cells (Patent US:5122458)	Goodwin	1992	0		
960	chr19	49249993	49250045	3500124636	52		49249993	49250045	8421504	1	52	0	g	350012463600000000	0-52						Use of a bGH gDNA polyadenylation signal in expression of non-bGH polypeptides in higher eukaryotic cells - US Patent 5122458 Claims	ww.patentstorm.us	0	0		
960	chr19	49249993	49250018	3500197335	25		49249993	49250018	8421504	1	25	0	g	350019733500000001	0-25						Differential regulation of humoral immune responses to Gag and Env proteins of Simian Immunodeficiency Virus (SIV); Differentielle Regulation der humoralen Immunantwort gegen die Proteine Gag und Env des Affenimmundefizienzvirus (SIV)	uhr-uni-bochum.de	0	0		
960	chr19	49249994	49250125	3500043198	131		49249994	49250125	8421504	1	131	0	g	350004319800000036	478-609						Genetically Intact Induced Pluripotent Cells Or Transdifferentiated Cells And Methods For The Production Thereof - Patent application	www.faqs.org	0	0		
960	chr19	49249994	49250115	3500128433	42		49249994	49250115	8421504	2	20,22	0,99	c,g	350012843300000005,350012843300000003,350012843300000003	0-20,0-22,0-22		20363875	10.1210/me.2009-0461	0888-8809	Molecular Endocrinology	Granulosa Cell-Expressed BMPR1A and BMPR1B Have Unique Functions in Regulating Fertility but Act Redundantly to Suppress Ovarian Tumor Development	Edson	2010	5		
960	chr19	49249994	49250093	3500371020	99		49249994	49250093	8421504	1	99	0	g	350037102000000051	0-99						Substance Specific to Human PD-1 - Patent application	www.faqs.org	0	0		
960	chr19	49249994	49250093	3500370404	99		49249994	49250093	8421504	1	99	0	g	350037040400000051	0-99						Substance Specific To Human Pd-1 	.freshpatents.com	0	0		
960	chr19	49249995	49250021	3500466724	26		49249995	49250021	8421504	1	26	0	g	350046672400000000	0-26						Failure of Epithelial Tube Maintenance Causes Hydrocephalus and Renal Cysts in Dlg5	sciencedirect.com	0	0		
960	chr19	49249996	49250027	3500082965	31		49249996	49250027	8421504	1	31	0	g	350008296500000004	0-31						Differential functions of Interleukin-10 derived from different Dissertationsschrift zur Erlangung eines doctor rerum medicinalium (Dr. rer. medic.) der Medizinischen Fakult&#xe4;t Carl Gustav Carus der Technischen Universit&#xe4;t Dresden vorgelegt von S	www.qucosa.de	0	0		
960	chr19	49250001	49250115	3500150546	40		49250001	49250115	8421504	2	20,20	0,94	c,g	350015054600000010,350015054600000030,350015054600000035,350015054600000015	0-20,0-20,0-20,0-20						FUMARYLACETOACETATE HYDROLASE (FAH)-DEFICIENT PIGS AND USES THEREOF - Patent application	www.faqs.org	0	0		
960	chr19	49250004	49250028	3500154007	24		49250004	49250028	8421504	1	24	0	g	350015400700000001	0-24		19168558	10.1373/clinchem.2008.113373	0009-9147	Clinical Chemistry	Processing of Pro&#x2013;Brain Natriuretic Peptide Is Suppressed by O-Glycosylation in the Region Close to the Cleavage Site	Semenov	2009	8		
960	chr19	49250008	49250060	3500332775	48		49250008	49250060	8421504	2	21,27	0,25	c,g	350033277500000003,350033277500000005	0-21,0-27		19158239	10.1128/JVI.01721-08	0022-538X	Journal of Virology	Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector	Gallaher	2009	5		
960	chr19	49250010	49250111	3500343515	41		49250010	49250111	8421504	2	19,22	0,79	c,g	350034351500000002,350034351500000000	0-19,0-22		22314290	10.1038/mt.2011.303	1525-0016	Molecular Therapy	Microvesicle-associated AAV Vector as a Novel Gene Delivery System	Maguire	2012	7		
960	chr19	49250011	49250057	3500267007	45		49250011	49250057	8421504	2	21,24	0,22	c	350026700700000005,350026700700000004	0-21,0-24						Methods for the treatment of tay-sachs disease, sandhoff disease, and gm1-gangliosidosis	Sena-Esteves	2013	0		
960	chr19	49250011	49250037	3500457667	26		49250011	49250037	8421504	1	26	0	c	350045766700000017	12-38						US Patent # 6,013,517. Crossless retroviral vectors - Patents.com	www.patents.com	0	0		
960	chr19	49250011	49250037	3500448775	26		49250011	49250037	8421504	1	26	0	c	350044877500000043	12-38						Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis	Schlesinger	2000	0		
960	chr19	49250011	49250037	3500376873	26		49250011	49250037	8421504	1	26	0	c	350037687300000042	12-38						Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis	Belli	1999	0		
960	chr19	49250011	49250037	3500351170	26		49250011	49250037	8421504	1	26	0	c	350035117000000017	12-38						Crossless retroviral vectors	Respess	1997	0		
960	chr19	49250011	49250037	3500299643	26		49250011	49250037	8421504	1	26	0	c	350029964300000014	12-38						Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis	Belli	1999	0		
960	chr19	49250011	49250037	3500280736	26		49250011	49250037	8421504	1	26	0	c	350028073600000040	12-38					Patent	Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis (Patent CA:2304350)	Thomas	2013	0		
960	chr19	49250011	49250037	3500235652	26		49250011	49250037	8421504	1	26	0	c	350023565200000035	12-38						Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis	Thomas	2008	0		
960	chr19	49250011	49250037	3500230973	26		49250011	49250037	8421504	1	26	0	c	350023097300000043	12-38						US Patent # 6,451,592. Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis - Patents.com	www.patents.com	0	0		
960	chr19	49250011	49250037	3500230174	26		49250011	49250037	8421504	1	26	0	c	350023017400000015	12-38						Alphaviral vector with reduced inhibition of cellular macromolecular synthesis		1998	0		
960	chr19	49250011	49250037	3500219724	26		49250011	49250037	8421504	1	26	0	c	350021972400000046	12-38					Patent	Alphavirus structural protein expression cassettes (Patent US:5789245)	Chang	1998	0		
960	chr19	49250011	49250037	3500210757	26		49250011	49250037	8421504	1	26	0	c	350021075700000046	12-38						Alphavirus vector constructs	Dubensky	1996	0		
960	chr19	49250011	49250037	3500203324	26		49250011	49250037	8421504	1	26	0	c	350020332400000046	12-38						Alphavirus structural protein expression cassettes	Dubensky	1996	0		
960	chr19	49250011	49250037	3500150761	26		49250011	49250037	8421504	1	26	0	c	350015076100000046	12-38						US Patent # 5,814,482. Eukaryotic layered vector initiation systems - Patents.com	www.patents.com	0	0		
960	chr19	49250011	49250037	3500141671	26		49250011	49250037	8421504	1	26	0	c	350014167100000048	12-38						Eukaryotic Layered Vector Initiation Systems	Dubensky	2009	0		
960	chr19	49250011	49250037	3500110969	26		49250011	49250037	8421504	1	26	0	c	350011096900000043	12-38					Patent	Alphavirus structural protein expression cassettes (Patent US:6426196)	Thomas	2002	0		
960	chr19	49250011	49250037	3500105054	26		49250011	49250037	8421504	1	26	0	c	350010505400000043	12-38					Patent	Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis (Patent US:6451592)	Thomas	2002	0		
960	chr19	49250011	49250037	3500104593	26		49250011	49250037	8421504	1	26	0	c	350010459300000180,350010459300000046	12-38,12-38						Eukaryotic Layered Vector Initiation Systems - Patent application	www.faqs.org	0	0		
960	chr19	49250011	49250037	3500095243	26		49250011	49250037	8421504	1	26	0	c	350009524300000048	12-38						Eukaryotic layered vector initiation systems	Dubensky	2003	0		
960	chr19	49250011	49250037	3500085199	26		49250011	49250037	8421504	1	26	0	c	350008519900000043	12-38					Patent	Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis (Patent US:6391632)	Thomas	2002	0		
960	chr19	49250011	49250037	3500044134	26		49250011	49250037	8421504	1	26	0	c	350004413400000146,350004413400000043	12-38,12-38						RECOMBINANT ALPHAVIRUS-BASED VECTORS WITH REDUCED INHIBITION OF CELLULAR MACRO-MOLECULAR SYNTHESIS - Patent application	www.faqs.org	0	0		
960	chr19	49250011	49250037	3500037799	26		49250011	49250037	8421504	1	26	0	c	350003779900000043	12-38						Alphavirus structural protein expression cassettes	Dubensky	1999	0		
960	chr19	49250011	49250037	3500021676	26		49250011	49250037	8421504	1	26	0	c	350002167600000043	12-38						US Patent # 6,426,196. Alphavirus structural protein expression cassettes - Patents.com	www.patents.com	0	0		
960	chr19	49250011	49250037	3500016529	26		49250011	49250037	8421504	1	26	0	c	350001652900000018	12-38						US Patent # 6,333,195. Crossless retroviral vectors - Patents.com	www.patents.com	0	0		
960	chr19	49250011	49250035	3500453403	24		49250011	49250035	8421504	1	24	0	c	350045340300000074,350045340300000032	21-45,21-45						Virus-Like Particle Containing A Dengue Recombinant Replicon - Patent application	www.faqs.org	0	0		
960	chr19	49250029	49250055	3500385425	26		49250029	49250055	8421504	1	26	0	c	350038542500000001	0-26						Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta	www.jci.org	0	0		
960	chr19	49250029	49250055	3500003977	26		49250029	49250055	8421504	1	26	0	c	350000397700000001	0-26		23635772	10.1172/JCI67039	0021-9738	The Journal of Clinical Investigation	Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta	Li	2013	13		
960	chr19	49250032	49250125	3500221979	93		49250032	49250125	8421504	1	93	0	c,g	350022197900000134,350022197900000134,350022197900000135,350022197900000135,350022197900000136,350022197900000136,350022197900000137,350022197900000137,350022197900000139,350022197900000139	328-421,328-421,326-419,326-419,326-419,326-419,324-417,324-417,195-288,195-288						MULTICISTRONIC CONSTRUCTS WITH siRNA TO INHIBIT TUMORS	Rao	2007	0		
960	chr19	49250032	49250056	3500192570	24		49250032	49250056	8421504	1	24	0	c	350019257000000006	0-24						The &#x2018;cleavage&#x2019; activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring &#x2018;2A-like&#x2019; sequences	.st-andrews.ac.uk	0	0		
960	chr19	49250033	49250060	3500084991	27		49250033	49250060	8421504	1	27	0	c	350008499100000005	0-27						Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector	oscience.ucla.edu	0	0		
960	chr19	49250034	49250125	3500415749	91		49250034	49250125	8421504	1	91	0	c	350041574900000006	43-135						Methods and agents for screening for compounds capable of modulating gene expression	Cao	2005	0		
960	chr19	49250034	49250125	3500111528	91		49250034	49250125	8421504	1	91	0	c,g	350011152800000078,350011152800000078,350011152800000016,350011152800000016	16-107,16-107,43-133,43-133						Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Gdnf - Patent application	www.faqs.org	0	0		
960	chr19	49250035	49250059	3500375826	24		49250035	49250059	8421504	1	24	0	c	350037582600000001	0-24						A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line	Andersen	2009	0		
960	chr19	49250035	49250059	3500328040	24		49250035	49250059	8421504	1	24	0	c	350032804000000001,350032804000000016	0-24,0-24					Patent	A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line (Patent EP:2053408)	Andersen	2012	0		
960	chr19	49250035	49250059	3500241410	24		49250035	49250059	8421504	1	24	0	c	350024141000000001	0-24						Procedure for Structural Characterization of a Recombinant Polylonal Protein or a Polyclonal Cell Line	Andersen	2008	0		
960	chr19	49250035	49250059	3500200432	24		49250035	49250059	8421504	1	24	0	c	350020043200000036	0-24						Anti-Rhesus D Recombinant Polyclonal Antibody and Methods of Manufacture - Patent application	www.faqs.org	0	0		
960	chr19	49250035	49250059	3500111107	24		49250035	49250059	8421504	1	24	0	c	350011110700000001	0-24						A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line	Andersen	2007	0		
960	chr19	49250035	49250059	3500040398	24		49250035	49250059	8421504	1	24	0	c	350004039800000045	0-24						Anti-rhesus d recombinant polyclonal antibody and methods of manufacture	Rasmussen	2009	0		
960	chr19	49250035	49250059	3500035616	24		49250035	49250059	8421504	1	24	0	c	350003561600000036	0-24						Anti-rhesus d recombinant polyclonal antibody and methods of manufacture - Patent application	www.faqs.org	0	0		
960	chr19	49250035	49250059	3500032158	24		49250035	49250059	8421504	1	24	0	c	350003215800000045	0-24					Patent	Anti-rhesus D recombinant polyclonal antibody (Patent US:8198415)	Rasmussen	2012	0		
960	chr19	49250035	49250059	3500030923	24		49250035	49250059	8421504	1	24	0	c	350003092300000045	0-24						Anti-Rhesus D Recombinant Polyclonal Antibody and Methods of Manufacture	Rasmussen	2012	0		
960	chr19	49250035	49250059	3500019519	24		49250035	49250059	8421504	1	24	0	c	350001951900000001	0-24					Patent	Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line (Patent US:8288109)	Rasmussen	2012	0		
960	chr19	49250036	49250125	3500334948	89		49250036	49250125	8421504	1	89	0	c,g	350033494800000000,350033494800000000	71-160,71-160		21408612	10.1371/journal.pone.0017596	1932-6203	PLOS ONE	PLOS ONE: Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression	Fath	2011	4		
960	chr19	49250036	49250125	3500176237	89		49250036	49250125	8421504	1	89	0	c,g	350017623700000000,350017623700000000	71-160,71-160						Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression	ww.invitrogen.com	0	0		
960	chr19	49250037	49250060	3500238590	23		49250037	49250060	8421504	1	23	0	c	350023859000000042	0-23						Modified laminin and use thereof	Nakagawa	2012	0		
960	chr19	49250039	49250069	3500345732	30		49250039	49250069	8421504	1	30	0	c	350034573200000024	0-30						&#x4e3b;&#x9898;&#xff1a;paracrine | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
960	chr19	49250039	49250069	3500318478	30		49250039	49250069	8421504	1	30	0	c	350031847800000022	0-30						&#x4e3b;&#x9898;&#xff1a;Wnt | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
960	chr19	49250039	49250069	3500162257	30		49250039	49250069	8421504	1	30	0	c	350016225700000019	0-30		15841209	10.1172/JCI24140	0021-9738	The Journal of Clinical Investigation	Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals	Shao	2005	13		
960	chr19	49250039	49250069	3500005974	30		49250039	49250069	8421504	1	30	0	c	350000597400000019	0-30						Mitochondrial Research Group - &#xbbf8;&#xd1a0;&#xcf58;&#xb4dc;&#xb9ac;&#xc544; &#xc5f0;&#xad6c;&#xd68c; > 03_News > Msx2 Promotes Cardiovascular Calcification By Activating Paracrine Wnt Signals	ondria.inje.ac.kr	0	0		
960	chr19	49250041	49250064	3500054365	23		49250041	49250064	8421504	1	23	0	c	350005436500000002	0-23		12052898	10.1128/MCB.22.13.4943-4951.2002	0270-7306	Molecular and Cellular Biology	Maleylacetoacetate Isomerase (MAAI/GSTZ)-Deficient Mice Reveal a Glutathione-Dependent Nonenzymatic Bypass in Tyrosine Catabolism	Fernandez-Canon	2002	6		
960	chr19	49250048	49250078	3500276627	30		49250048	49250078	8421504	1	30	0	c	350027662700000019,350027662700000087	0-30,0-30						MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE DYSTROPHIN GENE AND USES THEREOF - Patent application	www.faqs.org	0	0		
960	chr19	49250052	49250125	3500430951	73		49250052	49250125	8421504	1	73	0	c,g	350043095100000188,350043095100000188	40-113,40-113						TAREGTED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES - Patent application	www.faqs.org	0	0		
960	chr19	49250052	49250125	3500137432	73		49250052	49250125	8421504	1	73	0	c,g	350013743200000188,350013743200000188	40-113,40-113						Targeted integration and expression of exogenous nucleic acid sequences - Patent application	www.faqs.org	0	0		
960	chr19	49250054	49250121	3500326849	59		49250054	49250121	8421504	3	19,20,20	0,23,47	c	350032684900000007,350032684900000006,350032684900000005	0-19,0-20,0-20						LIVER-SPECIFIC NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USE THEREOF	Chuah	2009	0		
960	chr19	49250054	49250097	3500304148	39		49250054	49250097	8421504	2	19,20	0,23	c,g	350030414800000007,350030414800000040,350030414800000041,350030414800000041,350030414800000008,350030414800000008	0-19,0-19,0-20,0-20,0-20,0-20						CARDIAC-SPECIFIC NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USE THEREOF - Patent application	www.faqs.org	0	0		
960	chr19	49250057	49250125	3500052013	68		49250057	49250125	8421504	1	68	0	c,g	350005201300000031,350005201300000031,350005201300000051,350005201300000051	22-90,22-90,28-90,28-90						A Soluble TNF Receptor 2 Agonist as a New Therapeutic Approach to Treat Autoimmune and Demyelinating Diseases	.uni-stuttgart.de	0	0		
960	chr19	49250058	49250125	3500023264	67		49250058	49250125	8421504	1	67	0	c,g	350002326400000015,350002326400000015	253-320,253-320						&#x570b;&#xf9f7;&#x6210;&#x529f;&#x5927;&#x5b78;&#x751f;&#x547d;&#x79d1;&#x5b78;&#x7814;&#x7a76;&#x6240; &#x78a9;&#x58eb;&#xf941;&#x6587;	u.lib.ncku.edu.tw	0	0		
960	chr19	49250065	49250092	3500391031	27		49250065	49250092	8421504	1	27	0	c	350039103100000000	0-27						Genetically Engineered Swine Influenza Virus and Uses Thereof	Palese	2005	0		
960	chr19	49250065	49250092	3500375208	27		49250065	49250092	8421504	1	27	0	c	350037520800000000	0-27						GENETICALLY ENGINEERED SWINE INFLUENZA VIRUS AND USES THEREOF	Palese	2011	0		
960	chr19	49250065	49250092	3500283497	27		49250065	49250092	8421504	1	27	0	c	350028349700000000	0-27						Genetically engineered swine influenza virus and uses thereof	Garcia-Sastre	2006	0		
960	chr19	49250065	49250092	3500212778	27		49250065	49250092	8421504	1	27	0	c	350021277800000000	0-27						Genetically Engineered Swine Influenza Virus and Uses Thereof	Garcia-Sastre	2009	0		
960	chr19	49250065	49250092	3500110100	27		49250065	49250092	8421504	1	27	0	c	350011010000000000,350011010000000021	0-27,0-27						Genetically Engineered Swine Influenza Virus and Uses Thereof	h1n1.no/wp-conten	0	0		
960	chr19	49250065	49250092	3500101077	27		49250065	49250092	8421504	1	27	0	c	350010107700000000	0-27						Genetically engineered swine influenza virus and uses thereof	Garcia-Sastre	2007	0		
960	chr19	49250065	49250092	3500093956	27		49250065	49250092	8421504	1	27	0	c	350009395600000000	0-27					Patent	Genetically engineered swine influenza virus and uses thereof (Patent US:8124101)	Garcia-Sastre	2012	0		
960	chr19	49250065	49250092	3500089551	27		49250065	49250092	8421504	1	27	0	c	350008955100000018,350008955100000000	0-27,0-27						Genetically Engineered Swine Influenza Virus and Uses Thereof - Patent application	www.faqs.org	0	0		
960	chr19	49250065	49250092	3500088168	27		49250065	49250092	8421504	1	27	0	c	350008816800000000	0-27						Genetically engineered swine influenza virus and uses thereof	Palese	2013	0		
960	chr19	49250065	49250092	3500069440	27		49250065	49250092	8421504	1	27	0	c	350006944000000000	0-27						Genetically engineered swine influenza virus and uses thereof	Qiao Gen *A*Li Xi Te 	2012	0		
960	chr19	49250065	49250092	3500064885	27		49250065	49250092	8421504	1	27	0	c	350006488500000000	0-27						Genetically engineered swine influenza virus and uses thereof - Patent #08124101	w.strutpatent.com	0	0		
960	chr19	49250065	49250092	3500055022	27		49250065	49250092	8421504	1	27	0	c	350005502200000018,350005502200000000	0-27,0-27						Genetically Engineered Swine Flu Patent Application	www.scribd.com	0	0		
960	chr19	49250066	49250117	3500370719	44		49250066	49250117	8421504	2	21,23	0,28	c,g	350037071900000005,350037071900000005,350037071900000003	0-21,0-21,0-23		17329330	10.1128/JVI.00055-07	0022-538X	Journal of Virology	Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques	Luckay	2007	5		
960	chr19	49250067	49250112	3500004859	45		49250067	49250112	8421504	1	45	0	p	350000485900015083	0-45						Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol - Patent # 7485713 - PatentGenius	.patentgenius.com	0	0		
960	chr19	49250074	49250125	3500347567	51		49250074	49250125	8421504	1	51	0	c,g	350034756700000009,350034756700000009	0-51,0-51						Evidence that a consensus element found in naturally intronless mRNAs promotes mRNA export The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.	dash.harvard.edu	0	0		
960	chr19	49250079	49251806	3500243005	83		49250079	49251806	8421504	4	22,21,20,20	0,776,1151,1707	c,g	350024300500000005,350024300500000010,350024300500000008,350024300500000000	0-22,0-21,0-20,0-20						Characterization of the Growth Hormone Gene (GH1) in Sudanese Kenana and Butana Cattle Breeds	ww.grjournals.com	0	0		
960	chr19	49250080	49250110	3500275960	30		49250080	49250110	8421504	1	30	0	c	350027596000000001	0-30		12376355	10.1152/ajplung.00049.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice	Sisson	2002	0		
960	chr19	49250080	49250110	3500125513	30		49250080	49250110	8421504	1	30	0	c	350012551300000001	0-30		12376355	10.1152/ajplung.00049.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice	Sisson	2002	0		
960	chr19	49250083	49250107	3500112187	24		49250083	49250107	8421504	1	24	0	c	350011218700000004	0-24						Therapeutic Effect of Interferon-&#x03b3; Gene Transfer in Experimental Visceral Leishmaniasis	www.jstor.org	0	0		
960	chr19	49250083	49250106	3500040716	23		49250083	49250106	8421504	1	23	0	c	350004071600000004	0-23						RECOMBINANT ANTI-MUC1 ANTIBODIES - LFB BIOTECHNOLOGIES	www.sumobrain.com	0	0		
960	chr19	49250085	49250126	3500433299	41		49250085	49250126	8421504	1	41	0	c,g	350043329900000055,350043329900000055	0-41,0-41						Nucleic acid pharmaceuticals-influenza matrix	Donnelly	2001	0		
960	chr19	49250085	49250115	3500183715	30		49250085	49250115	8421504	1	30	0	c	350018371500000002	0-30			10.1002/dvdy.21392	1097-0177	Developmental Dynamics	Developmental expression of LC3&#x03b1; and &#x03b2;: Absence of fibronectin or autophagy phenotype in LC3&#x03b2; knockout mice - Cann - 2007 - Developmental Dynamics - Wiley Online Library	Cann	2008	0		
960	chr19	49250085	49250113	3500456257	28		49250085	49250113	8421504	1	28	0	c	350045625700000091,350045625700000093,350045625700000095,350045625700000073,350045625700000071,350045625700000077,350045625700000053,350045625700000115,350045625700000111,350045625700000113,350045625700000135,350045625700000133,350045625700000139,350045625700000127,350045625700000069,350045625700000085,350045625700000083,350045625700000081,350045625700000087,350045625700000143,350045625700000141,350045625700000065,350045625700000067,350045625700000051,350045625700000107,350045625700000047,350045625700000103,350045625700000045,350045625700000101,350045625700000121,350045625700000049,350045625700000075,350045625700000125,350045625700000109,350045625700000145,350045625700000129	0-21,0-21,0-21,0-23,0-23,0-21,0-21,0-22,0-23,0-21,0-21,0-24,0-26,0-21,0-21,0-25,0-28,0-21,0-22,0-21,0-23,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-22,0-21,0-23,0-21,0-22,0-21						 Diagnosis of Copper Transport Disorders - Current Protocols 	rentprotocols.com	0	0		
960	chr19	49250088	49250113	3500037551	25		49250088	49250113	8421504	1	25	0	c	350003755100000008	0-25						THE J BIOLOGICAL C Vol. 279, No. 6, Issue of February 6, pp. 4952&#x2013;4961, 2004 Printed in U.S.A. Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene*	www.jbc.org	0	0		
960	chr19	49250090	49250125	3500327623	35		49250090	49250125	8421504	1	35	0	c,g	350032762300000089,350032762300000089	71-106,71-106						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA - Patent application	www.faqs.org	0	0		
960	chr19	49250090	49250125	3500091255	35		49250090	49250125	8421504	1	35	0	c,g	350009125500000055,350009125500000055	5-40,5-40						 Compositions And Methods For The Therapy And Diagnosis Of Influenza 	www.docstoc.com	0	0		
960	chr19	49250090	49250125	3500070530	35		49250090	49250125	8421504	1	35	0	c,g	350007053000000199,350007053000000199	46-81,46-81						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA - Patent application	www.faqs.org	0	0		
960	chr19	49250090	49250124	3500353368	34		49250090	49250124	8421504	1	34	0	c,g	350035336800000100,350035336800000100	0-34,0-34						Compositions and Methods for the Therapy and Diagnosis of Influenza - Patent application	www.faqs.org	0	0		
960	chr19	49250090	49250113	3500464441	23		49250090	49250113	8421504	1	23	0	c	350046444100000007	0-23		12697818	10.1128/MCB.23.9.3173-3185.2003	0270-7306	Molecular and Cellular Biology	Role for Human SIRT2 NAD-Dependent Deacetylase Activity in Control of Mitotic Exit in the Cell Cycle	Dryden	2003	6		
960	chr19	49250094	49250117	3500323121	23		49250094	49250117	8421504	1	23	0	c,g	350032312100000000,350032312100000000	0-23,0-23		23613948	10.1371/journal.pone.0061831		PLoS ONE	Early Vessel Destabilization Mediated by Angiopoietin-2 and Subsequent Vessel Maturation via Angiopoietin-1 Induce Functional Neovasculature after Ischemia	Di	2013	0		
960	chr19	49250094	49250117	3500242940	23		49250094	49250117	8421504	1	23	0	c,g	350024294000000004,350024294000000004	0-23,0-23			10.1172/JCI66549		The Journal of Clinical Investigation	Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis	Tilman	2013	0		
960	chr19	49250094	49250117	3500093985	23		49250094	49250117	8421504	1	23	0	c	350009398500000002	0-23						Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis	m.uni-muenchen.de	0	0		
960	chr19	49250095	49250125	3500363813	30		49250095	49250125	8421504	1	30	0	c	350036381300000002	0-30		18445292	10.1186/1471-213X-8-48	1471-213X	BMC Developmental Biology	In vivo consequences of deleting EGF repeats 8&#xe2; 12 including the ligand binding domain of mouse Notch1	Ge	2008	3		
960	chr19	49250095	49250118	3500091747	23		49250095	49250118	8421504	1	23	0	c	350009174700000015	0-23		17395701	10.1210/en.2006-1500	0013-7227	Endocrinology	Ectopic Expression of Myostatin Induces Atrophy of Adult Skeletal Muscle by Decreasing Muscle Gene Expression	Durieux	2007	4		
960	chr19	49250096	49250119	3500007467	23		49250096	49250119	8421504	1	23	0	c	350000746700000012	0-23						Transient Recombinant Protein Expression in Mammalian Cells: the Role of mRNA Level and Stability	biblion.epfl.ch	0	0		
960	chr19	49250097	49250125	3500451290	28		49250097	49250125	8421504	1	28	0	c	350045129000000012	11-39		16275162	10.1016/j.ymthe.2005.09.012	1525-0016	Molecular Therapy	Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector	Barde	2006	7		
960	chr19	49250098	49250121	3500242754	23		49250098	49250121	8421504	1	23	0	c,g	350024275400000001,350024275400000001	0-23,0-23						Cloningandcharacterisationofthegeneencodingreddeer Cervuselaphus)growthhormone:implicationsforthe molecularevolutionofgrowthhormoneinartiodactyls	logy-journals.org	0	0		
960	chr19	49250100	49250131	3500240778	31		49250100	49250131	8421504	1	31	0	c	350024077800000043,350024077800000017,350024077800000000,350024077800000027	10-37,10-37,13-43,13-40						METHOD FOR THE PRODUCTION OF RECOMBINANT POLYOMAVIRAL VECTOR PARTICLES - AMARNA THERAPEUTICS B.V.	www.sumobrain.com	0	0		
960	chr19	49250100	49250131	3500147553	31		49250100	49250131	8421504	1	31	0	c	350014755300000004,350014755300000089,350014755300000090,350014755300000105,350014755300000106,350014755300000049,350014755300000041,350014755300000050,350014755300000042	13-43,0-21,18-39,0-19,20-39,0-19,0-21,20-39,18-39						POLIOMA VECTOR EXPRESSING LONG DOUBLE-STRANDED RNAS - Patent application	www.faqs.org	0	0		
960	chr19	49250101	49250125	3500026722	24		49250101	49250125	8421504	1	24	0	c	350002672200000002	12-36						NUCLEIC ACIDS FOR TARGETING MULTIPLE REGIONS OF THE HCV GENOME - THE CHILDREN'S HOSPITAL OF PHILADELPHIA	www.sumobrain.com	0	0		
960	chr19	49250102	49250125	3500152494	23		49250102	49250125	8421504	1	23	0	c	350015249400000008	0-23						Preventive/remedy For Cancer 	.freshpatents.com	0	0		
960	chr19	49250112	49251543	3500382358	50		49250112	49251543	8421504	3	27,13,10	0,1160,1421	c,g	350038235800000007,350038235800000007,350038235800000013,350038235800000004	37-64,37-64,11-34,11-33						Canine growth hormone	Barrera-Saldana	1994	0		
960	chr19	49250112	49251220	3500223478	532		49250112	49251220	8421504	4	201,162,73,96	0,475,712,1012	c	350022347800000128,350022347800000051,350022347800000127,350022347800000126,350022347800000052	0-576,0-577,0-576,0-576,114-683						Elements for improved expression of bovine somatotropin - Patent application	www.faqs.org	0	0		
960	chr19	49250112	49251217	3500408857	529		49250112	49251217	8421504	4	201,162,73,93	0,475,712,1012	c,g	350040885700000017,350040885700000016,350040885700000015,350040885700000013	4-577,0-27,0-48,0-116					Patent	Method for increased expression of low molecular weight recombinant polypeptides (Patent US:5378613)	Belagaje	1995	0		
960	chr19	49250112	49251217	3500106860	529		49250112	49251217	8421504	4	201,162,73,93	0,475,712,1012	c	350010686000000000	0-573						Production of bovine growth hormone by microorganisms	Aviv	1995	0		
960	chr19	49250115	49251220	3500431457	529		49250115	49251220	8421504	4	198,162,73,96	0,472,709,1009	c	350043145700000000,350043145700000001,350043145700000005	3-576,3-578,3-27						DNA sequences, recombinant DNA molecules and processes for producing bovine growth hormone-like polypeptides in high yield	Buell	1983	0		
960	chr19	49250115	49251220	3500335442	529		49250115	49251220	8421504	4	198,162,73,96	0,472,709,1009	p,c,g	350033544200015010,350033544200000029,350033544200000032,350033544200015019,350033544200000028,350033544200000026,350033544200000026,350033544200015008,350033544200015006,350033544200015009,350033544200000023,350033544200000023,350033544200000021,350033544200000020,350033544200000022,350033544200000022,350033544200015015,350033544200015005,350033544200015003,350033544200000017,350033544200000017,350033544200000014,350033544200000014,350033544200000015,350033544200000011,350033544200015011,350033544200000008,350033544200015002,350033544200015000,350033544200000010,350033544200000005,350033544200000007,350033544200000006,350033544200000002,350033544200000002	0-48,0-33,0-573,15-174,0-61,0-60,0-60,3-183,0-51,0-495,0-60,0-60,1-60,0-60,0-58,0-58,33-180,36-183,0-48,0-60,0-60,0-60,0-60,0-60,33-60,0-169,0-49,3-172,0-40,0-49,0-60,6-60,0-60,0-60,0-60						PRODUCTION OF RECOMBINANT BOS TAURUS GROWTH HORMONE WITH PICHIA PASTORIS - OURO FINO PARTICIPA&#xc7;&#xd5;ES E EMPREENDIMENTOS S/A.	www.sumobrain.com	0	0		
960	chr19	49250115	49251217	3500349090	526		49250115	49251217	8421504	4	198,162,73,93	0,472,709,1009	p,c,g	350034909000015003,350034909000000032,350034909000000025,350034909000000025,350034909000015029,350034909000015028,350034909000015027,350034909000015026,350034909000015025,350034909000015024,350034909000015023,350034909000000019,350034909000000017,350034909000015021,350034909000015020,350034909000015019,350034909000015001,350034909000000052,350034909000000052,350034909000000049,350034909000000049	0-495,36-566,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-34,0-34,0-45,0-45,0-75,28-94,28-94,3-69,3-69						DNA for expression of bovine growth hormone	Boer	1993	0		
960	chr19	49250115	49251217	3500326927	303		49250115	49251217	8421504	5	150,57,21,24,51	0,511,571,710,1051	p,c,g	350032692700015019,350032692700015011,350032692700000017,350032692700015018,350032692700015010,350032692700000016,350032692700000016,350032692700015017,350032692700015009,350032692700000015,350032692700015015,350032692700015006,350032692700000013,350032692700000010,350032692700015020,350032692700015012	0-45,0-48,0-42,0-48,0-48,0-21,0-21,0-48,0-48,0-42,0-48,0-48,0-21,0-24,0-45,3-48						Dna construct comprising a cyanophage of cyanobacteria promoter and its use	Bogosian	2000	0		
960	chr19	49250115	49251205	3500452698	358		49250115	49251205	8421504	5	36,84,84,73,81	0,39,550,709,1009	p	350045269800015064,350045269800015052	24-144,12-291						Fish_Physiology_1994_Vol_13_Molecular_Endocrinology_of_Fish | Nguyen Thanh Vu - Academia.edu	www.academia.edu	0	0		
960	chr19	49250121	49251220	3500306022	523		49250121	49251220	8421504	4	192,162,73,96	0,466,703,1003	p	350030602200015182,350030602200015181,350030602200015180,350030602200015179	0-120,0-150,0-150,0-150						What's new on STN International	biblio.bo.cnr.it	0	0		
960	chr19	49250121	49251217	3500022387	514		49250121	49251217	8421504	6	93,96,36,123,73,93	0,96,466,505,703,1003	p,c,g	350002238700015011,350002238700015023,350002238700015010,350002238700000016,350002238700015009,350002238700015021,350002238700000015,350002238700015008,350002238700015020,350002238700015019,350002238700015006,350002238700000013,350002238700015018,350002238700015005,350002238700000012,350002238700015017,350002238700015016,350002238700000010,350002238700015003,350002238700015015,350002238700015002,350002238700015014,350002238700015001,350002238700015025,350002238700015012,350002238700000007,350002238700000007	0-45,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-45,0-45,0-48,0-45,0-45,0-48,18-45,0-22,0-34,0-31,0-45,0-45,0-45,0-45,0-45,0-45,135-171,135-171						DNA construct for regulating the expression of a polypeptide coding sequence in a transformed bacterial host cell	Bogosian	2000	0		
960	chr19	49250122	49251217	3500305803	519		49250122	49251217	8421504	4	191,162,73,93	0,465,702,1002	c,g	350030580300000018,350030580300000011,350030580300000009,350030580300000008,350030580300000006,350030580300000005,350030580300000003,350030580300000038,350030580300000038,350030580300000035,350030580300000035	36-566,0-42,0-42,0-42,0-39,0-42,0-31,28-94,28-94,3-69,3-69					Patent	DNA for expression of bovine growth hormone (Patent US:5489529)	Boer	1996	0		
960	chr19	49250139	49250702	3500209895	62		49250139	49250702	8421504	3	21,21,20	0,202,543	c,g	350020989500000003,350020989500000003,350020989500000002,350020989500000001	0-21,0-21,0-21,0-20						TaiLieu.VN: &#x0110;A H&#xcc;NH GEN HORMON SINH TR&#x01af;&#x1ede;NG C&#x1ee6;A M&#x1ed8;T S&#x1ed0; GI&#x1ed0;NG B&#xd2; NU&#xd4;I &#x1ede; VI&#x1ec6;T NAM 	tailieu.vn/doc/da	0	0		
960	chr19	49250139	49250702	3500012621	62		49250139	49250702	8421504	3	21,21,20	0,202,543	c,g	350001262100000001,350001262100000001,350001262100000000,350001262100000003	0-21,0-21,0-21,0-20						Genetic variations among Indonesian native cattle breeds based on polymorphisms analysis in the growth hormone loci and mitochondrial DNA	as.mipa.uns.ac.id	0	0		
960	chr19	49250139	49250362	3500437115	42		49250139	49250362	8421504	2	21,21	0,202	c,g	350043711500000001,350043711500000001,350043711500000000	0-21,0-21,0-21			10.1590/S0100-204X2004000200007	0100-204X	Pesquisa Agropecu&#xe1;ria Brasileira	Pesquisa Agropecu&#xe1;ria Brasileira - Associa&#xe7;&#xe3;o dos variantes dos genes bGH e Pit-1 com caracter&#xed;sticas de produ&#xe7;&#xe3;o leiteira em touros Gir leiteiro	Mattos	2004	1		
960	chr19	49250139	49250362	3500392209	42		49250139	49250362	8421504	2	21,21	0,202	c,g	350039220900000001,350039220900000001,350039220900000000	0-21,0-21,0-21						&#x0418;&#x0417;&#x0414;&#x0410;&#x0422;&#x0415;&#x041b;&#x042c;&#x0421;&#x041a;&#x0418;&#x0419; &#x0414;&#x041e;&#x041c; &#x0410;&#x041a;&#x0410;&#x0414;&#x0415;&#x041c;&#x0418;&#x042f; &#x0415;&#x0421;&#x0422;&#x0415;&#x0421;&#x0422;&#x0412;&#x041e;&#x0	www.rae.ru/fs/pdf	0	0		
960	chr19	49250139	49250362	3500356296	42		49250139	49250362	8421504	2	21,21	0,202	c,g	350035629600000003,350035629600000003,350035629600000002	0-21,0-21,0-21			10.5772/54756	978-953-51-0943-3		Prolactin	I.V.	2013	0		
960	chr19	49250139	49250362	3500208363	42		49250139	49250362	8421504	2	21,21	0,202	c,g	350020836300000001,350020836300000001,350020836300000000	0-21,0-21,0-21			10.1590/S0100-204X2004000200007	0100-204X	Pesquisa Agropecu&#xe1;ria Brasileira	Pesquisa Agropecu&#xe1;ria Brasileira - Association of bGH and Pit-1 gene variants with milk production traits in dairy Gyr bulls	Mattos	2004	1		
960	chr19	49250139	49250362	3500162742	62		49250139	49250362	8421504	3	21,20,21	0,90,202	c,g	350016274200000001,350016274200000001,350016274200000003,350016274200000003,350016274200000000	0-21,0-21,0-20,0-20,0-21						Associations of Growth Hormone Gene Polymorphisms with Milk Production Traits in South Anatolian and East Anatolian Red Cattle	dwelljournals.com	0	0		
960	chr19	49250148	49251220	3500064817	247		49250148	49251220	8421504	5	90,30,60,22,45	0,135,439,676,1027	p	350006481700015008,350006481700015007,350006481700015005,350006481700015002,350006481700015001	0-45,0-45,0-90,0-22,0-45						Somatotropin analogs.	Brems	1992	0		
960	chr19	49250151	49250774	3500004440	303		49250151	49250774	8421504	2	211,92	0,531	c,g	350000444000000003,350000444000000003,350000444000000005,350000444000000001,350000444000000004	0-23,0-23,0-188,0-20,235-307						Terakreditasi MEDIA PETERNAKAN	ository.ipb.ac.id	0	0		
960	chr19	49250151	49250362	3500293800	43		49250151	49250362	8421504	2	23,20	0,191	c,g	350029380000000001,350029380000000001,350029380000000000	0-23,0-23,0-20						Polymorphism Leu/Val of Growth Hormone Gene Identified from Limmousine Cross Local Cattle in Indonesia	fapet.ugm.ac.id	0	0		
960	chr19	49250151	49250174	3500223700	23		49250151	49250174	8421504	1	23	0	c	350022370000000001	0-23						Association between GH encoding gene polymorphism and semen characteristics in Iranian Holstein bulls | Arash Javanmard - Academia.edu	www.academia.edu	0	0		
960	chr19	49250151	49250174	3500185073	23		49250151	49250174	8421504	1	23	0	c	350018507300000001	0-23						Association between GH encoding gene polymorphism and semen characteristics in Iranian Holstein bulls	www.ajol.info	0	0		
960	chr19	49250229	49250511	3500348877	40		49250229	49250511	8421504	2	20,20	0,262	c,g	350034887700000001,350034887700000001,350034887700000000	0-20,0-20,0-20			10.1590/S0102-09352011000100023	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Relationship between polymorphism of growth hormone and precocity traits in Nellore heifers	Andrea	2011	0		
960	chr19	49250229	49250511	3500222714	40		49250229	49250511	8421504	2	20,20	0,262	c,g	350022271400000001,350022271400000001,350022271400000000	0-20,0-20,0-20						Arq. Bras. Med. Vet. Zootec., v.63, n.1, p.153-157, 2011	www.scielo.br	0	0		
960	chr19	49250257	49250282	3500150005	25		49250257	49250282	8421504	1	25	0	c,g	350015000500000004,350015000500000004	0-25,0-25						Validation of a real-time PCR assay for the detection of bovine herpesvirus 1 in bovine semen	.researchgate.net	0	0		
960	chr19	49250289	49250640	3500427622	77		49250289	49250640	8421504	2	24,53	0,298	p,c	350042762200000003,350042762200000001,350042762200000002,350042762200000000,350042762200015000	0-76,0-76,0-73,0-73,0-51					Patent	Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal (Patent US:5958879)	Chen	1999	0		
960	chr19	49250289	49250640	3500370874	77		49250289	49250640	8421504	2	24,53	0,298	p,c	350037087400000001,350037087400000003,350037087400000005,350037087400000000,350037087400000002,350037087400015000	0-76,0-76,0-29,0-72,0-73,0-51						Growth hormone antagonists	Chen	1993	0		
960	chr19	49250289	49250640	3500193823	77		49250289	49250640	8421504	2	24,53	0,298	p,c	350019382300000001,350019382300000003,350019382300000000,350019382300000002,350019382300000005,350019382300015000	0-58,0-51,0-73,0-73,0-29,0-51						 DNA Encoding Growth Hormone Antagonists 	www.docstoc.com	0	0		
960	chr19	49250289	49250640	3500190515	77		49250289	49250640	8421504	2	24,53	0,298	p,c	350019051500000003,350019051500000001,350019051500000005,350019051500000002,350019051500000000,350019051500015001	0-76,0-76,0-29,0-73,0-73,0-51						Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal	Kopchick	1995	0		
960	chr19	49250289	49250640	3500084796	77		49250289	49250640	8421504	2	24,53	0,298	p,c	350008479600000001,350008479600000003,350008479600000000,350008479600000002,350008479600015002	0-75,0-77,0-73,0-73,0-51						 Growth Hormone Antagonists 	www.docstoc.com	0	0		
960	chr19	49250295	49250596	3500348960	27		49250295	49250596	8421504	2	18,9	0,292	c	350034896000000001	0-27						Biologically active method using somatotropins	Krivi	1986	0		
960	chr19	49250295	49250596	3500277625	27		49250295	49250596	8421504	2	18,9	0,292	c	350027762500000002	0-27					Patent	Production of proteins in procaryotes (Patent US:6210928)	Krivi	2001	0		
960	chr19	49250295	49250596	3500218703	27		49250295	49250596	8421504	2	18,9	0,292	c	350021870300000002	0-27					Patent	Production of proteins in procaryotes (Patent US:5399489)	Krivi	1995	0		
960	chr19	49250300	49250650	3500082231	43		49250300	49250650	8421504	3	13,8,22	0,287,328	c,g	350008223100000015,350008223100000014,350008223100000014	0-21,0-22,0-22						Supporting Information	www.pnas.org	0	0		
960	chr19	49250301	49250626	3500377221	51		49250301	49250626	8421504	2	12,39	0,286	p	350037722100015000	0-51					Patent	Growth hormone antagonists (Patent EP:0556171)	Chen	2000	0		
960	chr19	49250339	49250362	3500455388	23		49250339	49250362	8421504	1	23	0	g	350045538800000002	0-23						&#x0421;&#x043f;&#x043e;&#x0441;&#x043e;&#x0431; &#x043e;&#x043f;&#x0440;&#x0435;&#x0434;&#x0435;&#x043b;&#x0435;&#x043d;&#x0438;&#x044f; &#x0433;&#x0435;&#x043d;&#x0435;&#x0442;&#x0438;&#x0447;&#x0435;&#x0441;&#x043a;&#x043e;&#x0433;&#x043e; &#x043f;&#x0	www.findpatent.ru	0	0		
960	chr19	49250721	49251274	3500466134	40		49250721	49251274	8421504	2	20,20	0,533	c,g	350046613400000006,350046613400000005	0-20,0-20						Activation of the Prolactin Receptor but Not the Growth Hormone Receptor is Important for Induction of Mammary Tumors in Transgenic Mice	www.jci.org	0	0		
960	chr19	49250721	49251274	3500297626	40		49250721	49251274	8421504	2	20,20	0,533	c,g	350029762600000002,350029762600000001	0-20,0-20						Cardiovascular, Behavioural and Metabolic Consequences of Growth Hormone Overexpression in Transgenic Mice	w.neurophys.gu.se	0	0		
960	chr19	49250852	49251127	3500146815	48		49250852	49251127	8421504	2	45,3	0,272	c	350014681500000014	0-48					Patent	Process for the production of recombinant polypeptides (Patent US:5747290)	Brandon	1998	0		
960	chr19	49251172	49251217	3500000901	45		49251172	49251217	8421504	1	45	0	c,g	350000090100000002,350000090100000002	7-52,7-52						Expression vectors containing &#x03bb;PL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methods	Oppenheim	1995	0		
960	chr19	49251172	49251208	3500140141	36		49251172	49251208	8421504	1	36	0	c,g	350014014100000002,350014014100000002	4-40,4-40						Untitled Document	.burstscience.com	0	0		
960	chr19	49251173	49251208	3500282075	35		49251173	49251208	8421504	1	35	0	c,g	350028207500000036,350028207500000036	35-70,0-35						Vectors and methods for expression of human protein c activity	Ni Er Si *Wu Er Li Ke *Ban 	1986	0		
960	chr19	49251173	49251208	3500170234	35		49251173	49251208	8421504	1	35	0	c	350017023400000004	4-39						Plasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methods - US Patent 5637495 Description	ww.patentstorm.us	0	0		
960	chr19	49251214	49251546	3500436867	84		49251214	49251546	8421504	2	71,13	0,319	p	350043686700015009	0-84						Chap27 Protein Metabolism	www.scribd.com	0	0		
960	chr19	49251275	49251558	3500380665	35		49251275	49251558	8421504	2	10,25	0,258	c	350038066500000007,350038066500000006	0-30,0-32						Transgenic animals with alzheimer's amyloid precursor gene	Greenberg	1992	0		
960	chr19	49251399	49251849	3500411940	450		49251399	49251849	8421504	1	450	0	c,g	350041194000000034,350041194000000030,350041194000000031,350041194000000026,350041194000000028,350041194000000022,350041194000000022,350041194000000018,350041194000000019,350041194000000014,350041194000000010,350041194000000009,350041194000000008,350041194000000006,350041194000000002,350041194000000000	0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,1-47,0-50,0-50,0-50,0-50,0-50,0-50,0-21						Gene study within the 5 flanking regions of growth hormone gene of first exon in Bos indicus	demicjournals.org	0	0		
960	chr19	49251399	49251849	3500338422	450		49251399	49251849	8421504	1	450	0	c,g	350033842200000034,350033842200000031,350033842200000030,350033842200000026,350033842200000028,350033842200000022,350033842200000022,350033842200000018,350033842200000014,350033842200000010,350033842200000006,350033842200000008,350033842200000009,350033842200000002	0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50						ISSN 1684 -5315 Volume 10 Number 3 17 January, 2011	demicjournals.org	0	0		
960	chr19	49251541	49251565	3500031707	24		49251541	49251565	8421504	1	24	0	c	350003170700000006	0-24						FACULTAD DE MEDICINA VETERINARIA Y ZOOTECNIA	cdigital.uv.mx	0	0		
960	chr19	49251552	49251602	3500232815	50		49251552	49251602	8421504	1	50	0	c,g	350023281500000018,350023281500000018,350023281500000017,350023281500000017	5-51,5-51,0-50,0-50						Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals.	Byrne	1995	0		
960	chr19	49251552	49251602	3500085514	50		49251552	49251602	8421504	1	50	0	c,g	350008551400000018,350008551400000018,350008551400000049,350008551400000017,350008551400000017,350008551400000050	5-51,5-51,0-37,0-50,0-50,0-38					Patent	Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic mice (Patent US:5917122)	Byrne	1999	0		
960	chr19	49251552	49251602	3500079786	50		49251552	49251602	8421504	1	50	0	c,g	350007978600000017,350007978600000017,350007978600000018,350007978600000018	0-50,0-50,5-51,5-51						Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals		1994	0		
960	chr19	49251552	49251602	3500000835	50		49251552	49251602	8421504	1	50	0	c,g	350000083500000018,350000083500000018,350000083500000017,350000083500000017,350000083500000049,350000083500000050	5-51,5-51,0-50,0-50,0-37,0-38						Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic mice	Byrne	1995	0		
961	chr19	49301378	49301404	3500048213	26		49301378	49301404	8421504	1	26	0	g	350004821300000003	0-26			10.1124/jpet.303.1.89	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Molecular Cloning and Functional Characterization of a Unique Mammalian Cardiac Nav Channel Isoform with Low Sensitivity to the Synthetic Inactivation Inhibitor (&#x2212;)-(S)-6-Amino-&#x03b1;-[(4-diphenylmethyl-1-piperazinyl)-methyl]-9H-purine-9-ethanol 	Denac	2002	0		SCN2A
961	chr19	49396905	49396934	3500304753	27		49396905	49396934	8421504	3	16,6,5	0,17,24	g	350030475300000168	0-27						Compositions and methods for detection of antibody binding to cells - Patent application	www.faqs.org	0	0		
964	chr19	49688247	49691318	3500365673	40		49688247	49691318	8421504	2	20,20	0,3051	c	350036567300000027,350036567300000026	0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
964	chr19	49688247	49691318	3500262357	40		49688247	49691318	8421504	2	20,20	0,3051	c	350026235700000027,350026235700000026	0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
964	chr19	49697845	49702015	3500298978	48		49697845	49702015	8421504	2	24,24	0,4146	c	350029897800000005,350029897800000004	0-24,0-24						&#x4e3b;&#x9898;&#xff1a;Modification | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
965	chr19	49809038	49809089	3500041289	51		49809038	49809089	8421504	1	51	0	p	350004128900015010	0-51						Nuclear Pyruvate Kinase M2 Functional Study in Cancer Cells	olarworks.gsu.edu	0	0		DDX5
965	chr19	49811871	49811895	3500125620	24		49811871	49811895	8421504	1	24	0	c	350012562000000039,350012562000000184	0-24,0-24						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION - Patent application	www.faqs.org	0	0		
966	chr19	50051809	50051832	3500400698	23		50051809	50051832	8421504	1	23	0	c	350040069800000000	24-47						Methods and kits for investigating cancer	Munnes	2008	0		
966	chr19	50055693	50055972	3500392743	132		50055693	50055972	8421504	2	87,45	0,234	p	350039274300015003	30-162						INSTITUT NATIONAL AGRONOMIQUE PARIS-GRIGNON THESE	hal.inria.fr	0	0		KPNA2
966	chr19	50055693	50055972	3500019553	132		50055693	50055972	8421504	2	87,45	0,234	p	350001955300015001	0-132		20818336	10.1038/emboj.2010.216		The EMBO Journal	An actin-regulated importin &#x03b1;/&#x03b2;-dependent extended bipartite NLS directs nuclear import of MRTF-A	Rafal	2010	0		KPNA2
968	chr19	50276040	50276535	3500165546	23		50276040	50276535	8421504	2	15,8	0,487	c	350016554600000270	21-44						GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF - Patent application	www.faqs.org	0	0		
121	chr19	50568273	50633382	3500031022	61		50568273	50633382	8421504	7	5,14,4,5,14,12,7	0,7,40993,40998,41005,65086,65102	g	350003102200000201,350003102200000298,350003102200000477	27-46,3-26,13-32						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
971	chr19	50609266	50609292	3500431462	23		50609266	50609292	8421504	3	4,5,14	0,5,12	g	350043146200000308	3-26						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
971	chr19	50685280	50685307	3500174807	26		50685280	50685307	8421504	2	13,13	0,14	g	350017480700000160	16-44						Nucleic acid transfer system	www.devileye.net	0	0		
971	chr19	50685283	50685307	3500067075	23		50685283	50685307	8421504	2	10,13	0,11	g	350006707500000001,350006707500000011	7-32,7-32						ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS - Patent application	www.faqs.org	0	0		
971	chr19	50695540	50695565	3500451401	24		50695540	50695565	8421504	2	15,9	0,16	g	350045140100000024	0-24					Patent	Detection and identification of pseudomonas species using the 16S-23S rRNA spacer (Patent US:6811978)	Jannes	2004	0		
972	chr19	50804368	50804396	3500270675	23		50804368	50804396	8421504	2	10,13	0,15	g	350027067500000005	1-24						Nested oligonucleotides containing a hairpin for nucleic acid amplification	Bowdish	2001	0		
973	chr19	50935816	50935839	3500002319	23		50935816	50935839	8421504	1	23	0	c	350000231900000003	7-40						Blood Group Antibody Screening 	.freshpatents.com	0	0		
973	chr19	50974633	50974661	3500201852	24		50974633	50974661	8421504	2	7,17	0,11	c	350020185200000232	4-29						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
973	chr19	50977021	50984475	3500133694	114		50977021	50984475	8421504	3	43,41,30	0,5078,7424	c	350013369400000015,350013369400000007,350013369400000000	0-43,0-41,0-30						DRUG-PHOSPHORYLATING ENZYME - Patent application	www.faqs.org	0	0		
973	chr19	50984445	50984475	3500263928	30		50984445	50984475	8421504	1	30	0	c	350026392800000000	0-30					Patent	Drug-phosphorylating enzyme (Patent US:8071300)	Kubota	2011	0		
975	chr19	51224987	51225016	3500236389	23		51224987	51225016	8421504	3	5,13,5	0,8,24	g	350023638900000025	14-37						T1r taste receptors and genes encoding same	J*E*A De Le 	2009	0		
976	chr19	51251163	51251191	3500025317	23		51251163	51251191	8421504	2	12,11	0,17	g	350002531700000025	7-32						Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof	Chang	1996	0		
976	chr19	51251436	51255663	3500455546	110		51251436	51255663	8421504	5	20,22,23,21,24	0,90,412,990,4203	c,g	350045554600000023,350045554600000024,350045554600000024,350045554600000021,350045554600000020,350045554600000017	0-20,0-22,0-22,0-23,0-21,0-24						Urotensin 2 and its Receptor as Candidate Genes for Beef Marbling Score, Ribeye Area and Fatty Acid Composition	Jiang	2008	0		
976	chr19	51251436	51255663	3500402155	155		51251436	51255663	8421504	7	20,22,23,21,24,21,24	0,90,412,510,937,990,4203	c,g	350040215500000023,350040215500000024,350040215500000021,350040215500000022,350040215500000019,350040215500000020,350040215500000017	0-20,0-22,0-23,0-21,0-24,0-21,0-24					Patent	Urotensin 2 and its receptor as candidate genes for beef marbling score, ribeye area and fatty acid composition (Patent US:7955803)	Jiang	2011	0		
976	chr19	51251436	51252447	3500058567	131		51251436	51252447	8421504	6	20,22,23,21,24,21	0,90,412,510,937,990	c,g	350005856700000023,350005856700000024,350005856700000021,350005856700000022,350005856700000019,350005856700000020	0-20,0-22,0-23,0-21,0-24,0-21						Urotensin 2 and its Receptor as Candidate Genes for Beef Marbling Score, Ribeye Area and Fatty Acid Composition	Jiang	2009	0		
977	chr19	51434968	51434996	3500031022	25		51434968	51434996	8421504	2	18,7	0,21	g	350003102200000327	9-42						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
978	chr19	51593165	51609279	3500222750	83		51593165	51609279	8421504	2	48,35	0,16079	c	350022275000000259,350022275000000261	0-48,0-35					Patent	Protein kinases (Patent US:6060296)	Hoekstra	2000	0		
978	chr19	51609244	51610334	3500177828	97		51609244	51610334	8421504	3	35,42,20	0,419,1070	c	350017782800000264,350017782800000267,350017782800000135	0-35,6-48,24-44					Patent	Protein kinases (Patent US:5756289)	Hoekstra	1998	0		
978	chr19	51609244	51609279	3500369501	35		51609244	51609279	8421504	1	35	0	c	350036950100000261	0-35						Protein kinases	Hoekstra	1994	0		
978	chr19	51609789	51610197	3500030773	78		51609789	51610197	8421504	2	76,2	0,406	p	350003077300015086	0-78					Patent	Protein kinase stress-related proteins and methods of use in plants (Patent CA:2405750)	Da	2013	0		CSNK1D
978	chr19	51609816	51610206	3500325977	60		51609816	51610206	8421504	2	49,11	0,379	p	350032597700015013	0-60						Purification of Casein Kinase I and Isolation of cDNAs Encoding Multiple Casein Kinase I-Like Enzymes	www.jstor.org	0	0		CSNK1D
978	chr19	51610959	51613682	3500208012	285		51610959	51613682	8421504	3	12,172,101	0,1917,2622	p	350020801200015009,350020801200015019	75-120,0-240						Multiple Isoforms of Arabidopsis Casein Kinase I Combine Conserved Catalytic Domains with Variable Carboxyl-Terminal Extensions&#x2019;	.plantphysiol.org	0	0		CSNK1D
979	chr19	51756734	51756760	3500210376	23		51756734	51756760	8421504	2	13,10	0,16	g	350021037600000040	11-34						US Patent # 6,248,876. Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patents.com	www.patents.com	0	0		
122	chr19	51763867	51779057	3500353095	45		51763867	51779057	8421504	2	23,22	0,15168	c	350035309500000000,350035309500000002	0-23,0-22						AN&#xc1;LISIS DEL EFECTO DE POLIMORFISMOS DE UN SOLO NUCLE&#xd3;TIDO DEL GEN FASN EN NOVILLOS	www.scielo.org.ar	0	0		
979	chr19	51765873	51766702	3500027398	42		51765873	51766702	8421504	2	23,19	0,810	c,g	350002739800000006,350002739800000007,350002739800000007	0-23,0-19,0-19						ADIPOSE TISSUE-SPECIFIC EXPRESSION OF LIPOGENIC GENES IN DIFFERENT CATTLE BREEDS: RELATIONSHIP TO FATTY ACID COMPOSITION	www.vuzv.cz	0	0		
979	chr19	51768978	51769023	3500241766	45		51768978	51769023	8421504	1	45	0	p	350024176600015015	0-45						COMPOSITIONS AND METHODS FOR PRODUCTION OF BIOFUELS - Patent application	www.faqs.org	0	0		
979	chr19	51769407	51769437	3500036684	26		51769407	51769437	8421504	3	4,5,17	0,5,13	c	350003668400000565	1-27						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
980	chr19	51777319	51777342	3500232370	23		51777319	51777342	8421504	1	23	0	c,g	350023237000000008,350023237000000008	0-23,0-23						<HTML><!-- InstanceBegin template="/Templates/index.dwt" codeOutsideHTMLIsLocked="false" --> <HEAD>	ock.colostate.edu	0	0		
980	chr19	51778502	51778661	3500450381	42		51778502	51778661	8421504	3	20,5,17	0,53,142	c	350045038100000011,350045038100000012	0-20,0-22						Gene expression patterns of bovine perimuscular preadipocytes during adipogenesis. - ResearchGate	.researchgate.net	0	0		
980	chr19	51779932	51780408	3500124900	41		51779932	51780408	8421504	2	21,20	0,456	c,g	350012490000000005,350012490000000006,350012490000000006	0-21,0-20,0-20						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
980	chr19	51779986	51780412	3500463464	64		51779986	51780412	8421504	3	30,12,22	0,364,404	c,g	350046346400000046,350046346400000046,350046346400000020	26-69,26-69,22-44						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
980	chr19	51779986	51780412	3500301078	44		51779986	51780412	8421504	2	22,22	0,404	c,g	350030107800000041,350030107800000041,350030107800000042,350030107800000042	0-22,0-22,0-22,0-22						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
980	chr19	51781254	51781643	3500464199	64		51781254	51781643	8421504	3	21,23,20	0,343,369	c,g	350046419900000006,350046419900000008,350046419900000008,350046419900000007,350046419900000007	0-21,0-23,0-23,0-20,0-20				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		
980	chr19	51885036	51885060	3500453245	23		51885036	51885060	8421504	2	4,19	0,5	c	350045324500000029	4-28						ENZYMATIC PERACID GENERATION FOR USE IN ORAL CARE PRODUCTS - Patent application	www.faqs.org	0	0		
980	chr19	51885036	51885060	3500199953	23		51885036	51885060	8421504	2	4,19	0,5	c	350019995300000011,350019995300000031	4-28,7-31						Cephalosporin acetylhydrolase gene from Bacillus subtilis	Mitsushima	1991	0		
980	chr19	51885036	51885060	3500156532	23		51885036	51885060	8421504	2	4,19	0,5	c,g	350015653200000031,350015653200000031,350015653200000011,350015653200000011	7-31,7-31,4-28,4-28						 Cephalosporin Acetylhydrolase Gene And Protein Encoded By Said Gene 	www.docstoc.com	0	0		
980	chr19	51887710	51887736	3500453368	23		51887710	51887736	8421504	2	11,12	0,14	c	350045336800000002	0-23		10913001			American Journal of Physiology - Cell Physiolog	Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle	Yamboliev	2000	0		PIK3CG
980	chr19	51887710	51887736	3500242712	23		51887710	51887736	8421504	2	11,12	0,14	c	350024271200000002	0-23		10913001			American Journal of Physiology - Cell Physiolog	Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle	Yamboliev	2000	0		
980	chr19	51887710	51887736	3500007112	23		51887710	51887736	8421504	2	11,12	0,14	c	350000711200000002	0-23		10913001			American Journal of Physiology - Cell Physiology	Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle	Yamboliev	2000	0		PIK3CG
981	chr19	51927036	51927063	3500027844	23		51927036	51927063	8421504	2	15,8	0,19	c	350002784400000079	0-36						Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells	Weng	2001	0		
981	chr19	51957221	51957738	3500466479	183		51957221	51957738	8421504	3	15,118,50	0,158,467	p	350046647900015000	183-366						Strukturelle Voraussetzungen der Rac2-vermittelten Aktivierung der Phospholipase C-&#x03b3;	vts.uni-ulm.de	0	0		
981	chr19	51957394	51957693	3500374989	108		51957394	51957693	8421504	2	103,5	0,294	p	350037498900015000	0-108						Method of identifying compounds useful to treat neuronal degenerative diseases - Patent application	www.faqs.org	0	0		RAC1
981	chr19	51957394	51957493	3500219678	99		51957394	51957493	8421504	1	99	0	p	350021967800015000	6-105						Method of identifying compounds useful to treat neuronal degenerative diseases	Engelhardt	2008	0		RAC1
981	chr19	51957424	51957472	3500377176	48		51957424	51957472	8421504	1	48	0	p	350037717600015006	0-48						Antivirals	Greber	2008	0		RAC1
981	chr19	51957424	51957472	3500361668	48		51957424	51957472	8421504	1	48	0	p	350036166800015004	0-48						ANTIVIRALS	Mercer	2008	0		RAC1
981	chr19	51958363	51958387	3500194581	24		51958363	51958387	8421504	1	24	0	c	350019458100000003	0-24		22916712	10.1186/1471-2164-13-418	1471-2164	BMC Genomics	Expression of cassini, a murine gamma-satellite sequence conserved in evolution, is regulated in normal and malignant hematopoietic cells	Arutyunyan	2012	4		RAC1
981	chr19	51958363	51958387	3500149993	24		51958363	51958387	8421504	1	24	0	c	350014999300000004	0-24		15867248	10.1158/1078-0432.CCR-04-2026	1078-0432	Clinical Cancer Research	Antimetastatic Effect of Salvicine on Human Breast Cancer MDA-MB-435 Orthotopic Xenograft Is Closely Related to Rho-Dependent Pathway	Lang	2005	8		RAC3
981	chr19	51969525	51969554	3500449359	26		51969525	51969554	8421504	2	9,17	0,12	c	350044935900000049	10-36						Gene Encoding a Guanine Nucleotide Exchange Factor and Its Gene Product - Patent application	www.faqs.org	0	0		
981	chr19	52032789	52032817	3500009213	23		52032789	52032817	8421504	2	16,7	0,21	c	350000921300000028	1-24						BMC Genomics BioMed Central	biomedcentral.com	0	0		
982	chr19	52037243	52037270	3500112874	27		52037243	52037270	8421504	1	27	0	c	350011287400000028,350011287400000012	0-27,0-27						PHOTO-PROTECTIVE DERMATOLOGICAL FORMULATIONS AND METHODS OF USING THE SAME - Patent application	www.faqs.org	0	0		
982	chr19	52050010	52050570	3500047323	59		52050010	52050570	8421504	3	19,19,21	0,342,539	c,g	350004732300000000,350004732300000000,350004732300000009,350004732300000006	10-29,10-29,11-30,0-21						ScienceDirect.com - FEBS Letters - MafG controls the hypoxic response of cells by accumulating HIF-1&#x03b1; in the nuclei	sciencedirect.com	0	0		MAFG
982	chr19	52050151	52050202	3500135205	51		52050151	52050202	8421504	1	51	0	p	350013520500015034	0-51						Universit&#xe0; degli Studi di Trieste	enstarts.units.it	0	0		MAFG
982	chr19	52050511	52050583	3500384752	72		52050511	52050583	8421504	1	72	0	p	350038475200015063	0-72						48 human secreted proteins	Komatsoulis	2002	0		MAFG
982	chr19	52050511	52050583	3500375425	72		52050511	52050583	8421504	1	72	0	p	350037542500015063	0-72						48 human secreted proteins	Komatsoulis	2000	0		MAFG
982	chr19	52060793	52060816	3500337968	23		52060793	52060816	8421504	1	23	0	c	350033796800000041	11-34						THE DISCOVERY AND FUNCTIONAL STUDIES OF TWO DIPHTHAMIDE BIOSYNTHETIC GENES	mmons.cornell.edu	0	0		
982	chr19	52060793	52060816	3500249757	23		52060793	52060816	8421504	1	23	0	c	350024975700000001	11-34						Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase	ww.sciencemag.org	0	0		
982	chr19	52060793	52060816	3500144118	23		52060793	52060816	8421504	1	23	0	c	350014411800000001	11-34						Modulators for sirt5 and assays for screening same	Lin	2012	0		
982	chr19	52060793	52060816	3500021643	23		52060793	52060816	8421504	1	23	0	c	350002164300000041	11-34						THE DISCOVERY AND FUNCTIONAL STUDIES OF TWO DIPHTHAMIDE BIOSYNTHETIC GENES	brary.cornell.edu	0	0		
982	chr19	52073856	52078433	3500336681	252		52073856	52078433	8421504	2	143,109	0,4468	p	350033668100015051	0-252						FULL-LENGTH HUMAN CDNAS ENCODING POTENTIALLY SECRETED PROTEINS - GENSET S.A.	www.sumobrain.com	0	0		ANAPC11
982	chr19	52073856	52078433	3500115779	252		52073856	52078433	8421504	2	143,109	0,4468	p	350011577900015053	0-252						Full-length human cdnas encoding potentially secreted proteins	Bejanin	2001	0		ANAPC11
982	chr19	52073922	52073970	3500311219	48		52073922	52073970	8421504	1	48	0	c	350031121900000194	0-48						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
982	chr19	52113435	52121392	3500154779	79		52113435	52121392	8421504	3	40,7,32	0,1121,7925	c	350015477900000010,350015477900000033	0-47,0-32						Recombinant co-expression system of protein disulfide isomerase gene, yeast receptor protein ERD2 gene and a foreign product polypeptide gene, and a process for producing the foreign polypeptide using such system	Hayano	1992	0		
982	chr19	52113435	52114563	3500245404	47		52113435	52114563	8421504	2	40,7	0,1121	c	350024540400000010	0-47					Patent	Recombinant co-expression system of protein disulfide isomerase gene, yeast receptor protein ERD2 gene and a foreign product polypeptide gene, and a process for producing the foreign polypeptide using such system (Patent US:5578466)	Hayano	1996	0		
982	chr19	52113456	52114560	3500204720	23		52113456	52114560	8421504	2	19,4	0,1100	c	350020472000000008	0-23		18680601	10.1186/cc6977	1364-8535	Critical Care	Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release	Zhou	2008	0		
982	chr19	52113459	52114600	3500359816	60		52113459	52114600	8421504	2	16,44	0,1097	p	350035981600015020	63-123						Molecular Cloning of a Putative Plant Endomembrane Protein Resembling Vertebrate Protein Disulfide-Isomerase and a Phosphatidylinositol-Specific Phospholipase C	www.jstor.org	0	0		PDIA2
982	chr19	52114630	52122421	3500218364	1281		52114630	52122421	8421504	17	133,107,24,120,12,42,60,126,72,126,18,100,182,18,66,6,69	0,1488,1598,1756,1882,5492,5537,5769,6079,6154,6398,6419,6602,6869,6890,7713,7722	p	350021836400015025	0-1284						Expression of soluble factor viii proteins in bacteria	Defrees	2007	0		
982	chr19	52116477	52120715	3500145718	40		52116477	52120715	8421504	3	20,14,6	0,4034,4232	c	350014571800000036,350014571800000037	0-20,0-20						Molecular markers of hepatocellular carcinoma and their applications	Avila	2007	0		P4HB
982	chr19	52120862	52121076	3500369719	89		52120862	52121076	8421504	2	41,48	0,166	c	350036971900000069,350036971900000070	0-41,0-48						Expression system for producing collagen - Patent application	www.faqs.org	0	0		
982	chr19	52121106	52121511	3500267862	237		52121106	52121511	8421504	3	43,182,12	0,126,393	p	350026786200015014	0-237						Glycosylation Site Binding Protein and Protein Disulfide Isomerase are Identical and Essential for Cell Viability in Yeast	www.jstor.org	0	0		
982	chr19	52122397	52122424	3500332470	27		52122397	52122424	8421504	1	27	0	c	350033247000000066	0-27						Fused protein containing insulin precursor of overexpression and secretion type, DNA encoding the same and method of producing insulin	Zuo Teng Jing Zhi 	2009	0		P4HB
982	chr19	52122397	52122424	3500275583	27		52122397	52122424	8421504	1	27	0	c	350027558300000033	0-27						Fusion protein containing highly-expressed and secreted insulin precursor, dna encoding same, and method of producing insulin	Endo	2010	0		P4HB
982	chr19	52122397	52122424	3500248708	27		52122397	52122424	8421504	1	27	0	c	350024870800000033	0-27						Fused protein containing insulin precursor of overexpression and secretion type, dna encoding the same and method of producing insulin	Endo	2009	0		P4HB
983	chr19	52172848	52172877	3500253796	23		52172848	52172877	8421504	3	7,11,5	0,12,24	g	350025379600000037	4-29					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
983	chr19	52242121	52243062	3500046143	48		52242121	52243062	8421504	3	2,41,5	0,457,936	c	350004614300000051	0-48						US Patent # 5,498,521. Diagnosis of hereditary retinal degenerative diseases - Patents.com	www.patents.com	0	0		
983	chr19	52242122	52243062	3500375653	47		52242122	52243062	8421504	3	1,41,5	0,456,935	c	350037565300000038	0-47						US Patent # 5,262,529. Diagnosis of hereditary retinal degenerative diseases - Patents.com	www.patents.com	0	0		
983	chr19	52266280	52266308	3500306946	24		52266280	52266308	8421504	3	11,6,7	0,12,21	g	350030694600000035	4-28						Methods for treating cardiovascular disease using a soluble CTLA4 Molecule - Patent application	www.faqs.org	0	0		
984	chr19	52343185	52343251	3500265043	66		52343185	52343251	8421504	1	66	0	p	350026504300015001	9-75						Dr. Campbell&#x2019;s Genomics Exam #1 &#x2013; Fall 2001	.bio.davidson.edu	0	0		ACTG1
984	chr19	52343293	52343516	3500178539	222		52343293	52343516	8421504	2	172,50	0,173	c	350017853900000010,350017853900000009	9-161,2-224						'EFEITO DO HORM&#xd4;NIO DO CRESCIMENTO RECOMBINANTE NA EXPRESS&#xc3;O G&#xca;NICA DE ENZIMAS REGULADORAS DA LIPOG&#xca;NESE EM ANIMAIS EM CRES	www.teses.usp.br	0	0		
984	chr19	52343325	52343348	3500352312	23		52343325	52343348	8421504	1	23	0	c	350035231200000004	0-23		21270316	10.1242/jeb.052076		The Journal of Experimental Biology	Amblyomma americanum (L.) (Acari: Ixodidae) tick salivary gland serine protease inhibitor (serpin) 6 is secreted into tick saliva during tick feeding	Katelyn	2011	0		
984	chr19	52343332	52344734	3500231857	238		52343332	52344734	8421504	4	60,130,26,22	0,520,655,1380	c,g	350023185700000078,350023185700000082,350023185700000083,350023185700000005,350023185700000004,350023185700000013	0-60,0-60,0-60,0-25,1-27,0-22						Toxicology and Applied Pharmacology	www.usask.ca	0	0		
984	chr19	52343341	52343999	3500366596	40		52343341	52343999	8421504	2	20,20	0,638	c	350036659600000002,350036659600000003	0-20,0-20		14500474	10.1128/IAI.71.10.5556-5564.2003	0019-9567	Infection and Immunity	The Urokinase Receptor Can Be Induced by Borrelia burgdorferi through Receptors of the Innate Immune System	Coleman	2003	4		ACTB
984	chr19	52343341	52343999	3500007018	40		52343341	52343999	8421504	2	20,20	0,638	c,g	350000701800000000,350000701800000001	0-20,0-20		10484465			American Journal of Physiology - Lung Cellular and Molecular Physiology	Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung	Hattori	1999	0		ACTG1
984	chr19	52343374	52343399	3500176303	25		52343374	52343399	8421504	1	25	0	c	350017630300000002	0-25		21764855	10.1101/gad.2069311	0890-9369	Genes & Development	Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas	Zhang	2011	12		POTEM
984	chr19	52343375	52343400	3500177565	25		52343375	52343400	8421504	1	25	0	c	350017756500000005	0-25		15827191	10.1128/JVI.79.9.5762-5773.2005	0022-538X	Journal of Virology	Binding and Transfer of Human Immunodeficiency Virus by DC-SIGN+ Cells in Human Rectal Mucosa	Gurney	2005	5		POTEM
984	chr19	52343380	52343987	3500424929	138		52343380	52343987	8421504	2	48,90	0,517	p	350042492900015048,350042492900015053	0-48,0-90						Algorithms for Peptide Identi&#xfb01;cation by Tandem Mass Spectrometry	ww.ti.inf.ethz.ch	0	0		ACTG1
984	chr19	52343384	52343408	3500200456	24		52343384	52343408	8421504	1	24	0	c	350020045600000014	0-24		22072783	10.1128/JVI.06169-11	0022-538X	Journal of Virology	Epigenetic Changes Mediated by MicroRNA miR29 Activate Cyclooxygenase 2 and Lambda-1 Interferon Production during Viral Infection	Fang	2012	5		ACTB
984	chr19	52343385	52343409	3500162718	24		52343385	52343409	8421504	1	24	0	g	350016271800000002	0-24						DEVICE AND METHOD FOR MANIPULATING DROPLETS USING GEL-STATE MEDIUM - Patent application	www.faqs.org	0	0		ACTB,TP53BP2
984	chr19	52343392	52344420	3500443394	40		52343392	52344420	8421504	2	19,21	0,1007	c	350044339400000008,350044339400000000	20-39,0-21		19133144	10.1186/1477-7827-7-2		Reproductive Biology and Endocrinology : RB&E	Modulation of human uterine smooth muscle cell collagen contractility by thrombin, Y-27632, TNF alpha and indomethacin	Joan	2009	0		
984	chr19	52343392	52343416	3500332839	24		52343392	52343416	8421504	1	24	0	c	350033283900000007	0-24				1552-5783	Investigative Ophthalmology & Visual Science	Promotion of Adhesion and Migration of RPE Cells to Provisional Extracellular Matrices by TNF-&#x03b1;	Jin	2000	0		ZP4
984	chr19	52343395	52343419	3500427977	24		52343395	52343419	8421504	1	24	0	g	350042797700000001	0-24						Human Intestinal V81 + T Lymphocytes Recognize Tumor Cells of Epithelial Origin By Markus J. Maeurer,*r Dina Martin,~ Wolfgang Walter,* Kaihong Liu,II Laurence Zitvogel,r Kathy Halusczcak,$ Hanna Kabinowichfi Rene Duquesnoy)l Walter Storkus,r and Michael 	jem.rupress.org	0	0		
984	chr19	52343398	52343426	3500335598	28		52343398	52343426	8421504	1	28	0	c,g	350033559800000002,350033559800000019,350033559800000019	0-21,0-20,0-20		23236489	10.1371/journal.pone.0051371	1932-6203	PLOS ONE	PLOS ONE: Col1A1 Production and Apoptotic Resistance in TGF-&#x03b2;1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells	Liu	2012	4		
984	chr19	52343400	52343425	3500353893	25		52343400	52343425	8421504	1	25	0	g	350035389300000000	0-25		20181667	10.1152/ajprenal.00529.2009		American Journal of Physiology - Renal Physiology	Upregulation of parathyroid VDR expression by extracellular calcium is mediated by ERK1/2-MAPK signaling pathway	Canadillas	2010	0		ACTB,ZP4
984	chr19	52343401	52344646	3500184482	42		52343401	52344646	8421504	3	21,10,11	0,1136,1234	c	350018448200000051,350018448200000055	0-21,0-21					Patent	Detection of carcinoma metastases by nucleic acid amplification (Patent US:5766888)	Green	1998	0		
984	chr19	52343402	52344125	3500236687	38		52343402	52344125	8421504	2	19,19	0,704	c	350023668700000002,350023668700000003	0-19,0-19						Overexpression of EGR-1 modulates the activity of NF- B and AP-1 in prostate carcinoma PC-3 and LNCaP cell lines	-publications.com	0	0		ACTG1
984	chr19	52343403	52344034	3500365019	40		52343403	52344034	8421504	2	20,20	0,611	c	350036501900000002,350036501900000003	0-20,0-20		19744348	10.1186/1471-2407-9-324		BMC Cancer	CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection	Chau-Ting	2009	0		ACTB
984	chr19	52343403	52344034	3500046307	40		52343403	52344034	8421504	2	20,20	0,611	c,g	350004630700000015,350004630700000015,350004630700000016	0-20,0-20,0-20			10.1038/sj.onc.1203903	${footerJournalISSN}		Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma		2000	0		TBCA
984	chr19	52343403	52344034	3500023774	40		52343403	52344034	8421504	2	20,20	0,611	c	350002377400000000,350002377400000001	0-20,0-20		12917632	10.1038/sj.onc.1206674	0950-9232	Oncogene	Antisense overexpression of BMAL2 enhances cell proliferation	Yeh	2003	6		ACTA2
984	chr19	52343404	52344735	3500359784	71		52343404	52344735	8421504	3	23,24,24	0,1084,1307	c	350035978400000009,350035978400000035,350035978400000036	0-23,0-24,0-24						THE CELLULAR NUCLEIC ACID BINDING PROTEIN REGULATES THE ALZHEIMER&#xe2; S DISEASE &#xce;&#xb2;-SECRETASE PROTEIN BACE1	knowledge.uky.edu	0	0		
984	chr19	52343404	52344138	3500009103	43		52343404	52344138	8421504	2	23,20	0,714	c	350000910300000000,350000910300000007	0-23,0-20		16926411	10.1128/IAI.00622-06	0019-9567	Infection and Immunity	Autocrine Role for Interleukin-8 in Bartonella henselae-Induced Angiogenesis	McCord	2006	4		
984	chr19	52343404	52344038	3500422043	45		52343404	52344038	8421504	2	21,24	0,610	c,g	350042204300000000,350042204300000000,350042204300000001	0-21,0-21,0-24						Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia	Freson	2010	0		
984	chr19	52343404	52344038	3500295476	45		52343404	52344038	8421504	2	21,24	0,610	c	350029547600000002,350029547600000003	0-21,0-24		12356823		1552-5783	Investigative Ophthalmology & Visual Science	Suppression of the TNF&#x03b1;-Induced Increase in IL-1&#x03b1; Expression by Hypochlorite in Human Corneal Epithelial Cells	Mohri	2002	0		
984	chr19	52343404	52344038	3500221132	45		52343404	52344038	8421504	2	21,24	0,610	c	350022113200000010,350022113200000000,350022113200000011,350022113200000001	0-21,0-21,0-24,0-24						Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia - Patent # 7615219 - PatentGenius	.patentgenius.com	0	0		
984	chr19	52343404	52344038	3500187804	45		52343404	52344038	8421504	2	21,24	0,610	c	350018780400000002,350018780400000003	0-21,0-24		12620898	10.1152/ajpcell.00476.2002		American Journal of Physiology - Cell Physiology	Colocalization but differential regulation of neuronal NO synthase and nicotinic acetylcholine receptor in C2C12 myotubes	Ebert	2003	0		
984	chr19	52343404	52344038	3500130062	42		52343404	52344038	8421504	2	21,21	0,613	c	350013006200000007,350013006200000008	0-21,0-21		16478720	10.1074/jbc.M513387200	0021-9258	Journal of Biological Chemistry	Dysfunctions of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1 and NDUFS4 Genes of Complex I	Iuso	2006	5		
984	chr19	52343404	52344038	3500054901	45		52343404	52344038	8421504	2	21,24	0,610	c	350005490100000000,350005490100000001	0-21,0-24					Patent	Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia (Patent US:7615219)	Freson	2009	0		
984	chr19	52343404	52344037	3500463087	44		52343404	52344037	8421504	2	21,23	0,610	c	350046308700000019,350046308700000020	0-21,0-23		19021771	10.1111/j.1742-4658.2008.06725.x	1742-4658	FEBS Journal	DNA-dependent protein kinase is involved in heat shock protein-mediated accumulation of hypoxia-inducible factor-1&#x03b1; in hypoxic preconditioned HepG2 cells - Kang - 2008 - FEBS Journal - Wiley Online Library	Kang	2008	0		ACTC1
984	chr19	52343404	52343833	3500006584	44		52343404	52343833	8421504	3	20,10,14	0,125,415	c	350000658400000008,350000658400000009	0-20,0-24						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
984	chr19	52343404	52343429	3500369516	25		52343404	52343429	8421504	1	25	0	c	350036951600000016	0-25		21187285	10.1074/jbc.M110.171223		The Journal of Biological Chemistry	Phospholipase C&#x03b4;3 Regulates RhoA/Rho Kinase Signaling and Neurite Outgrowth	Zen	2011	0		
984	chr19	52343404	52343429	3500331159	25		52343404	52343429	8421504	1	25	0	c	350033115900000006	0-25			10.1111/j.1742-4658.2005.04980.x	1742-4658	FEBS Journal	Chromosomal protein HMGN1 modulates the expression of N-cadherin - Rubinstein - 2005 - FEBS Journal - Wiley Online Library	Rubinstein	2005	0		CCDC74A
984	chr19	52343404	52343428	3500220655	24		52343404	52343428	8421504	1	24	0	c	350022065500000002	5-29		16698321	10.1016/j.ymthe.2006.03.015	1525-0016	Molecular Therapy	Mucopolysaccharidosis I Cats Mount a Cytotoxic T Lymphocyte Response after Neonatal Gene Therapy That Can Be Blocked with CTLA4-Ig	Ponder	2006	7		
984	chr19	52343404	52343427	3500229006	23		52343404	52343427	8421504	1	23	0	c	350022900600000008	0-23						Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts	biomedcentral.com	0	0		POTEF,POTEM
984	chr19	52343404	52343427	3500118757	23		52343404	52343427	8421504	1	23	0	c	350011875700000004	0-23						Endothelial cell mediators of angiogenesis in Bartonella henselae infection	arcommons.usf.edu	0	0		ACTG1
984	chr19	52343405	52343995	3500359927	40		52343405	52343995	8421504	2	20,20	0,570	c	350035992700000004,350035992700000005	0-20,0-20						Expression of the human a1,2-fucosyltransferase in transgenic pigs modi&#xfb01;es the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis	www.fasebj.org	0	0		
984	chr19	52343406	52344035	3500389718	60		52343406	52344035	8421504	2	30,30	0,599	c,g	350038971800000003,350038971800000003,350038971800000002,350038971800000002	0-30,0-30,0-30,0-30						Safety of Life and Health	fe-and-health.com	0	0		ACTG1
984	chr19	52343406	52343436	3500287832	30		52343406	52343436	8421504	1	30	0	c	350028783200000007	0-30						Reproductive Biology and Endocrinology BioMed	www.rbej.com	0	0		ACTC1
984	chr19	52343406	52343430	3500258588	24		52343406	52343430	8421504	1	24	0	c	350025858800000020	0-24						ASSAY FOR IDENTIFYING AGENTS THAT MODULATE EPIGENETIC SILENCING, AND AGENTS IDENTIFIED THEREBY - Patent application	www.faqs.org	0	0		ACTG1
984	chr19	52343406	52343430	3500096354	24		52343406	52343430	8421504	1	24	0	c	350009635400000020	0-24						Assay For Identifying Agents That Modulate Epigenetic Silencing, And Agents Identified Thereby 	.freshpatents.com	0	0		ZP4
984	chr19	52343406	52343430	3500076361	24		52343406	52343430	8421504	1	24	0	c	350007636100000007	0-24						Down-regulation of Smad4 enhances proliferation and invasion of colorectal carcinoma HCT116 cells and up-regulates Id2	-publications.com	0	0		ACTC1
984	chr19	52343407	52344736	3500149391	41		52343407	52344736	8421504	2	20,21	0,1308	c	350014939100000006,350014939100000007	0-20,0-21			10.1152/ajpcell.00631.2004		American Journal of Physiology - Cell Physiolog	Is myosin light-chain phosphorylation a regulatory signal for the osmotic activation of the Na+-K+-2Cl&#x2212; cotransporter?	Ciano-Oliveira	2005	0		
984	chr19	52343408	52343436	3500289942	28		52343408	52343436	8421504	1	28	0	c,g	350028994200000002,350028994200000002	0-28,0-28						ScienceDirect.com - Journal of Invertebrate Pathology - Determination of Cry toxin activity and identification of an aminopeptidase N receptor-like gene in Asymmathetes vulcanorum (Coleoptera: Curculionidae)	sciencedirect.com	0	0		ACTG1
984	chr19	52343412	52343435	3500145063	23		52343412	52343435	8421504	1	23	0	c	350014506300000030	0-23		22068145	10.1093/jxb/err323		Journal of Experimental Botany	Functional analysis reveals the possible role of the C-terminal sequences and PI motif in the function of lily (Lilium longiflorum) PISTILLATA (PI) orthologues	Ming-Kun	2012	0		ACTC1
984	chr19	52343420	52343951	3500268195	46		52343420	52343951	8421504	2	23,23	0,508	c	350026819500000002,350026819500000003	0-23,0-23						Effects of the activated mitogen-activated protein kinase pathway via the c-ros receptor tyrosine kinase on the T47D breast cancer cell line following alcohol exposure	-publications.com	0	0		
984	chr19	52343424	52344137	3500055343	424		52343424	52344137	8421504	5	111,136,22,86,69	0,392,529,552,644	g	350005534300000009	4-435						The effect of Echinorhynchus borealis (Acanthocephala) infection on the anti-predator behavior of a benthic amphipod. - ResearchGate	.researchgate.net	0	0		
984	chr19	52343427	52344725	3500419949	43		52343427	52344725	8421504	2	22,21	0,1277	c	350041994900000201,350041994900000010	0-22,0-21							w.bhdsyndrome.org	0	0		POTEF
984	chr19	52343428	52344741	3500035014	40		52343428	52344741	8421504	2	20,20	0,1293	c,g	350003501400000000,350003501400000001,350003501400000001	0-20,0-20,0-20						Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects	www.utoronto.ca	0	0		POTEF
984	chr19	52343428	52344741	3500011915	40		52343428	52344741	8421504	2	20,20	0,1293	c	350001191500000022,350001191500000023	0-20,0-20						Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study. - ResearchGate	.researchgate.net	0	0		POTEM
984	chr19	52343428	52343451	3500386671	23		52343428	52343451	8421504	1	23	0	c	350038667100000006	0-23			10.1186/1479-0556-5-10		Genetic Vaccines and Therapy	HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo	Blanca	2007	0		POTEF,ACTG1
984	chr19	52343429	52343536	3500184377	40		52343429	52343536	8421504	2	20,20	0,87	c	350018437700000002,350018437700000003	0-20,0-20		19432978	10.1186/1477-7827-7-42		Reproductive Biology and Endocrinology : RB&E	Binding characteristics of the ovine membrane progesterone receptor alpha and expression of the receptor during the estrous cycle	Ryan	2009	0		
984	chr19	52343430	52343880	3500132933	47		52343430	52343880	8421504	2	26,21	0,429	c	350013293300000004,350013293300000003	0-26,0-21						nchembio.1114-S1 - ResearchGate	.researchgate.net	0	0		
984	chr19	52343434	52344724	3500113403	46		52343434	52344724	8421504	2	24,22	0,1268	c	350011340300000000,350011340300000001	0-24,0-22		17234682	10.1189/jlb.0506331	0741-5400	Journal of Leukocyte Biology	Massive, sustained &#x03b3;&#x03b4; T cell migration from the bovine skin in vivo	Rhijn	2007	5		
984	chr19	52343445	52343850	3500134803	40		52343445	52343850	8421504	2	20,20	0,385	c,g	350013480300000034,350013480300000034,350013480300000035,350013480300000035	0-20,0-20,0-20,0-20						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
984	chr19	52343477	52344007	3500404251	39		52343477	52344007	8421504	2	20,19	0,511	c,g	350040425100000009,350040425100000010,350040425100000010	0-20,0-19,0-19		22446874	10.1158/1541-7786.MCR-11-0473	1541-7786	Molecular Cancer Research	Downregulation of Human Farnesoid X Receptor by miR-421 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells	Zhang	2012	4		
984	chr19	52343503	52343526	3500398863	23		52343503	52343526	8421504	1	23	0	c	350039886300000009	1-24		22471389	10.1186/1472-6882-12-31		BMC Complementary and Alternative Medicine	Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells	Gon-Sup	2012	0		POTEM
984	chr19	52343504	52344714	3500094008	45		52343504	52344714	8421504	2	22,23	0,1187	c	350009400800000002,350009400800000003	0-22,0-23						Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis 10.1016/j.febslet.2006.10.072 : FEBS Letters | ScienceDirect.com	sciencedirect.com	0	0		
984	chr19	52343506	52343536	3500002116	30		52343506	52343536	8421504	1	30	0	c	350000211600000001	0-30						Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases	Isacson	2003	0		POTEM
984	chr19	52343507	52343536	3500117345	29		52343507	52343536	8421504	1	29	0	c	350011734500000012	0-29		12869588	10.1210/me.2001-0336	0888-8809	Molecular Endocrinology	Translational Regulation of the Vasopressin V1b Receptor Involves an Internal Ribosome Entry Site	Rabadan-Diehl	2003	5		
984	chr19	52343509	52344008	3500403694	44		52343509	52344008	8421504	2	23,21	0,478	c	350040369400000003,350040369400000004	0-23,0-21						Viral Loads in Clinical Specimens and SARS Manifestations - Vol. 10 No. 9 - September 2004 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
984	chr19	52343509	52344008	3500052549	44		52343509	52344008	8421504	2	23,21	0,478	c,g	350005254900000014,350005254900000015,350005254900000015	0-23,0-21,0-21						 Compositions Against SARS 	www.docstoc.com	0	0		POTEE
984	chr19	52343509	52344008	3500019205	44		52343509	52344008	8421504	2	23,21	0,478	c,g	350001920500000008,350001920500000009,350001920500000009	0-23,0-21,0-21						Arthritis & Rheumatism	lib.ajaums.ac.ir	0	0		
984	chr19	52343510	52344046	3500335613	44		52343510	52344046	8421504	2	22,22	0,514	c,g	350033561300000004,350033561300000004,350033561300000005,350033561300000005	0-22,0-22,0-22,0-22						ScienceDirect.com - Molecular and Cellular Endocrinology - Luteinizing hormone (LH) regulates production of androstenedione and progesterone via control of histone acetylation of StAR and CYP17 promoters in ovarian theca cells	sciencedirect.com	0	0		
984	chr19	52343510	52343535	3500447055	25		52343510	52343535	8421504	1	25	0	c	350044705500000016	0-25		20228833	10.1038/cmi.2010.6	1672-7681	Cellular & Molecular Immunology	Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNF&agr; response and p53 activity	Li	2010	3		ACTC1
984	chr19	52343510	52343535	3500417231	25		52343510	52343535	8421504	1	25	0	c	350041723100000013	0-25			10.1359/JBMR.0301220	1523-4681	Journal of Bone and Mineral Research	Adipogenic Differentiation of Human Adult Stem Cells From Bone Marrow Stroma (MSCs) - Sekiya - 2003 - Journal of Bone and Mineral Research - Wiley Online Library	Sekiya	2004	0		POTEM
984	chr19	52343510	52343535	3500186664	25		52343510	52343535	8421504	1	25	0	c	350018666400000012	0-25		17116693	10.1128/MCB.00996-06	0270-7306	Molecular and Cellular Biology	Helix-Loop-Helix Protein p8, a Transcriptional Regulator Required for Cardiomyocyte Hypertrophy and Cardiac Fibroblast Matrix Metalloprotease Induction	Goruppi	2007	6		CCDC74A
984	chr19	52343510	52343535	3500117371	25		52343510	52343535	8421504	1	25	0	c	350011737100000024	0-25						In vitrocartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis	www.pnas.org	0	0		ACTA1
984	chr19	52343510	52343535	3500056300	25		52343510	52343535	8421504	1	25	0	c	350005630000000001	0-25						A single dose of caffeic acid phenethyl ester prevents initiation in a medium-term rat hepatocarcinogenesis model. - ResearchGate	.researchgate.net	0	0		ACTA1
984	chr19	52343510	52343535	3500040495	25		52343510	52343535	8421504	1	25	0	c	350004049500000002	0-25			10.1128/IAI.69.1.456-462.2001		Infection and Immunity	Borrelia Spirochetes Upregulate Release and Activation of Matrix Metalloproteinase Gelatinase B (MMP-9) and Collagenase 1 (MMP-1) in Human Cells	Joseph	2001	0		ACTA1
984	chr19	52343512	52343536	3500200721	24		52343512	52343536	8421504	1	24	0	c	350020072100000004	0-24		16908594	10.1158/1541-7786.MCR-05-0193	1541-7786	Molecular Cancer Research	&#x0394;9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria	Jia	2006	4		POTEM
984	chr19	52343512	52343536	3500117079	24		52343512	52343536	8421504	1	24	0	c	350011707900000007	0-24		19509252	10.1158/1535-7163.MCT-08-1106	1535-7163	Molecular Cancer Therapeutics	Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice	Li	2009	5		POTEM
984	chr19	52343512	52343536	3500006094	24		52343512	52343536	8421504	1	24	0	c	350000609400000004	0-24						Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. - ResearchGate	.researchgate.net	0	0		POTEM
984	chr19	52343513	52344125	3500455208	43		52343513	52344125	8421504	2	22,21	0,591	c,g	350045520800000008,350045520800000009,350045520800000009	0-22,0-21,0-21						Characterization of the p53 response to oncogene-induced senescence.	.biomedsearch.com	0	0		ACTB
984	chr19	52343513	52344125	3500439970	44		52343513	52344125	8421504	2	23,21	0,591	c	350043997000000048,350043997000000002,350043997000000049,350043997000000003	0-23,0-23,0-21,0-21						Compositions and Methods for Increasing Bone Mineralization - Patent application	www.faqs.org	0	0		
984	chr19	52343513	52344125	3500420955	43		52343513	52344125	8421504	2	23,20	0,592	c	350042095500000004,350042095500000005	0-23,0-20		10600886			American Journal of Physiology - Lung Cellular and Molecular Physiology	Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides	Wang	1999	0		
984	chr19	52343513	52344125	3500358071	44		52343513	52344125	8421504	2	23,21	0,591	c	350035807100000002,350035807100000003	0-23,0-21					Patent	Antibodies associated with alterations in bone density (Patent US:7758858)	Brunkow	2010	0		
984	chr19	52343513	52344125	3500344602	43		52343513	52344125	8421504	2	23,20	0,592	c,g	350034460200000003,350034460200000004,350034460200000004	0-23,0-20,0-20		16844946	10.1152/ajplung.00432.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis	Li	2006	0		
984	chr19	52343513	52344125	3500307788	44		52343513	52344125	8421504	2	23,21	0,591	c,g	350030778800000002,350030778800000003,350030778800000003	0-23,0-21,0-21						Antibodies associated with alterations in bone density	Brunkow	2004	0		
984	chr19	52343513	52344125	3500299966	43		52343513	52344125	8421504	2	23,20	0,592	c	350029996600000004,350029996600000005	0-23,0-20		10600897			American Journal of Physiology - Lung Cellular and Molecular Physiology	Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction	Wang	1999	0		
984	chr19	52343513	52344125	3500243387	44		52343513	52344125	8421504	2	23,21	0,591	c	350024338700000002,350024338700000003	0-23,0-21						Compositions and methods for increasing bone mineralisation	Brunkow	2006	0		
984	chr19	52343513	52344125	3500239684	43		52343513	52344125	8421504	2	23,20	0,592	c,g	350023968400000016,350023968400000017,350023968400000017	0-23,0-20,0-20						Methods for treating pulmonary fibrosis	Uhal	2003	0		
984	chr19	52343513	52344125	3500223900	43		52343513	52344125	8421504	2	23,20	0,592	c	350022390000000004,350022390000000005	0-23,0-20		10600886			American Journal of Physiology - Lung Cellular and Molecular Physiology	Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides	Wang	1999	0		
984	chr19	52343513	52344125	3500188789	44		52343513	52344125	8421504	2	23,21	0,591	c	350018878900000002,350018878900000003	0-23,0-21						Antibodies specific for sclerostin	Winkler	2006	0		
984	chr19	52343513	52344125	3500171679	44		52343513	52344125	8421504	2	23,21	0,591	c,g	350017167900000002,350017167900000003,350017167900000003	0-23,0-21,0-21					Patent	Compositions and methods for increasing bone mineralization (Patent US:7994299)	Brunkow	2011	0		
984	chr19	52343513	52344125	3500135150	44		52343513	52344125	8421504	2	23,21	0,591	c	350013515000000002,350013515000000003	0-23,0-21						Compostion and methods for increasing bone mineralization	Brunkow	2011	0		
984	chr19	52343513	52344125	3500130251	44		52343513	52344125	8421504	2	23,21	0,591	c	350013025100000002,350013025100000003	0-23,0-21						COMPOSITIONS AND METHODS FOR INCREASING BONE MINERALIZATION - DARWIN DISCOVERY LTD.	www.sumobrain.com	0	0		
984	chr19	52343513	52344125	3500073855	44		52343513	52344125	8421504	2	23,21	0,591	c	350007385500000002,350007385500000003	0-23,0-21						Compostion and methods for increasing bone mineralization	Brunkow	2011	0		
984	chr19	52343513	52344125	3500070722	44		52343513	52344125	8421504	2	23,21	0,591	c	350007072200000000,350007072200000001	0-23,0-21					Patent	Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma (Patent EP:1440159)	Clark	2006	0		
984	chr19	52343513	52344125	3500069731	44		52343513	52344125	8421504	2	23,21	0,591	c	350006973100000002,350006973100000003	0-23,0-21					Patent	Compositions and methods for increasing bone mineralization (Patent US:6495736)	Brunkow	2002	0		ACTB
984	chr19	52343513	52344125	3500067273	44		52343513	52344125	8421504	2	23,21	0,591	c,g	350006727300000002,350006727300000003,350006727300000003	0-23,0-21,0-21					Patent	Nucleic acids encoding a novel family of TGF-&#x03b2; binding proteins from humans (Patent US:6395511)	Brunkow	2002	0		
984	chr19	52343513	52344125	3500054864	43		52343513	52344125	8421504	2	23,20	0,592	c	350005486400000007,350005486400000008	0-23,0-20						MarAa Molina-Molina Investigadora IDIBAPS Servicio de NeumologAa. Instituto del TA3rax 2007 Depa	www.tdx.cat	0	0		
984	chr19	52343513	52344125	3500042895	44		52343513	52344125	8421504	2	23,21	0,591	c,g	350004289500000002,350004289500000003,350004289500000003	0-23,0-21,0-21					Patent	Compositions and methods for increasing bone mineralization (Patent US:7572899)	Brunkow	2009	0		
984	chr19	52343513	52344125	3500037354	44		52343513	52344125	8421504	2	23,21	0,591	c	350003735400000002,350003735400000003	0-23,0-21						Compositions and Methods for Increasing Bone Mineralization	Brunkow	2008	0		
984	chr19	52343513	52344125	3500030614	44		52343513	52344125	8421504	2	23,21	0,591	c,g	350003061400000002,350003061400000003,350003061400000003	0-23,0-21,0-21						Compositions and methods for increasing bone mineralization	Brunkow	2004	0		
984	chr19	52343513	52343536	3500450459	23		52343513	52343536	8421504	1	23	0	c	350045045900000000	0-23						Bone Morphogenic Proteins (bmp), Bmp Receptors And Bmp Binding Proteins And Their Use In The Diagnosis And Treatment Of Glaucoma 	.freshpatents.com	0	0		
984	chr19	52343513	52343536	3500445040	23		52343513	52343536	8421504	1	23	0	c	350044504000000000	0-23						T-614, a Novel Immunomodulator's Role in Collagen-induced Arthritis: Materials and Methods	www.medscape.com	0	0		
984	chr19	52343513	52343536	3500421110	23		52343513	52343536	8421504	1	23	0	c	350042111000000017	0-23						Transforming Growth Factor- 1 Represses E-Cadherin Production via Slug Expression in Lens Epithelial Cells	www.iovs.org	0	0		POTEF
984	chr19	52343513	52343536	3500416490	23		52343513	52343536	8421504	1	23	0	c	350041649000000008	0-23			10.1167/iovs.03-1371	1552-5783	Investigative Ophthalmology & Visual Science	Hepatocyte Growth Factor Induces Proliferation of Lens Epithelial Cells through Activation of ERK1/2 and JNK/SAPK	Choi	2004	0		POTEM
984	chr19	52343513	52343536	3500414182	23		52343513	52343536	8421504	1	23	0	c	350041418200000000	0-23						Bone morphonic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2009	0		POTEM
984	chr19	52343513	52343536	3500407685	23		52343513	52343536	8421504	1	23	0	c	350040768500000000	0-23				1552-5783	Investigative Ophthalmology & Visual Science	Human Trabecular Meshwork Cells Secrete Neurotrophins and Express Neurotrophin Receptors (Trk)	Wordinger	2000	0		ACTA1
984	chr19	52343513	52343536	3500390968	23		52343513	52343536	8421504	1	23	0	c	350039096800000000	0-23						Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2003	0		
984	chr19	52343513	52343536	3500335776	23		52343513	52343536	8421504	1	23	0	c	350033577600000000	0-23						Patent 8,389,496	www.pharmcast.com	0	0		
984	chr19	52343513	52343536	3500321070	23		52343513	52343536	8421504	1	23	0	c	350032107000000006	0-23		17554077	10.1095/biolreprod.107.061820	0006-3363	Biology of Reproduction	Expression of Endothelin 1 and Its Receptors in the Hypoxic Pregnant Rat	Thaete	2007	4		
984	chr19	52343513	52343536	3500307212	23		52343513	52343536	8421504	1	23	0	c	350030721200000007	0-23		10393042		1552-5783	Investigative Ophthalmology & Visual Science	A Transgenic Animal Model of Osmotic Cataract. Part 1: Over-expression of Bovine Na+/Myo-inositol Cotransporter in Lens Fibers	Cammarata	1999	0		POTEF
984	chr19	52343513	52343536	3500300319	23		52343513	52343536	8421504	1	23	0	c	350030031900000000	0-23						Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2012	0		POTEE
984	chr19	52343513	52343536	3500295080	23		52343513	52343536	8421504	1	23	0	c	350029508000000000	0-23					Patent	Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma (Patent US:8389496)	Clark	2013	0		
984	chr19	52343513	52343536	3500281320	23		52343513	52343536	8421504	1	23	0	c	350028132000000000	0-23						Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2010	0		POTEF
984	chr19	52343513	52343536	3500168789	23		52343513	52343536	8421504	1	23	0	c	350016878900000000	0-23						Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2002	0		ACTA1
984	chr19	52343513	52343536	3500135665	23		52343513	52343536	8421504	1	23	0	c	350013566500000000	0-23					Patent	Method of treating glaucoma comprising administering a composition comprising human BMP7 (Patent US:8063013)	Clark	2011	0		ACTB,POTEM
984	chr19	52343513	52343536	3500121900	23		52343513	52343536	8421504	1	23	0	c	350012190000000000	0-23						Bone morphogenic proteins (bmp),bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2005	0		POTEF,ACTA1
984	chr19	52343513	52343536	3500114901	23		52343513	52343536	8421504	1	23	0	c	350011490100000008	0-23						ORIGINAL ARTICLE Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma	jcp.bmj.com	0	0		POTEE
984	chr19	52343513	52343536	3500078429	23		52343513	52343536	8421504	1	23	0	c	350007842900000000	0-23						Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2004	0		ACTA1
984	chr19	52343513	52343536	3500005998	23		52343513	52343536	8421504	1	23	0	c	350000599800000008	0-23					Journal of Clinical Pathology	Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma	K	2003	0		
984	chr19	52343515	52344128	3500086046	47		52343515	52344128	8421504	2	24,23	0,590	c,g	350008604600000004,350008604600000005,350008604600000005	0-24,0-23,0-23			10.1091/mbc.E07-06-0570		Molecular Biology of the Cell	Tristetraprolin Inhibits Ras-dependent Tumor Vascularization by Inducing Vascular Endothelial Growth Factor mRNA Degradation	Khadija	2007	0		ACTB
984	chr19	52343515	52344128	3500032382	47		52343515	52344128	8421504	2	24,23	0,590	c	350003238200000004,350003238200000005	0-24,0-23		17855506	10.1091/mbc.E07-06-0570	1059-1524	Molecular Biology of the Cell	Tristetraprolin Inhibits Ras-dependent Tumor Vascularization by Inducing Vascular Endothelial Growth Factor mRNA Degradation	Essafi-Benkhadir	2007	5		
984	chr19	52343516	52343826	3500370586	30		52343516	52343826	8421504	2	23,7	0,303	c	350037058600000010	0-30		20025498	10.1089/hyb.2009.0049		Hybridoma	Detection of Amino-terminal Extracellular Domain of Somatostatin Receptor 2 by Specific Monoclonal Antibodies and Quantification of Receptor Density in Medulloblastoma	Chien-Tsun	2009	0		
984	chr19	52343516	52343826	3500126722	30		52343516	52343826	8421504	2	23,7	0,303	c	350012672200000006	0-30		16609006	10.1158/1078-0432.CCR-05-2797	1078-0432	Clinical Cancer Research	Glycoprotein Nonmetastatic Melanoma Protein B, a Potential Molecular Therapeutic Target in Patients with Glioblastoma Multiforme	Kuan	2006	8		
984	chr19	52343517	52343820	3500265999	23		52343517	52343820	8421504	2	22,1	0,302	c	350026599900000009	0-23						OULU 2010 D 1085 UNIVERSITY OF OULU P.O.B. 7500 FI-90014 UNIVERSITY OF OULU FINLAND ACTA UNIVERSITATIS OULUENSIS ACTA UNIVERSITATIS OULUENSIS D	herkules.oulu.fi	0	0		
984	chr19	52343518	52344037	3500119769	42		52343518	52344037	8421504	2	21,21	0,498	g	350011976900000053,350011976900000054	0-21,0-21						Diagnostic methods and markers - Patent application	www.faqs.org	0	0		
984	chr19	52343518	52343827	3500143290	29		52343518	52343827	8421504	2	21,8	0,301	c	350014329000000002	0-29		9458818			American Journal of Physiology - Renal Physiology	Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule	Cheng	1998	0		
984	chr19	52343518	52343827	3500105807	29		52343518	52343827	8421504	2	21,8	0,301	c	350010580700000006	0-29		9458826			American Journal of Physiology - Renal Physiology	Role of AT1 angiotensin II receptors in renal ischemic injury	Kontogiannis	1998	0		
984	chr19	52343518	52343827	3500009371	29		52343518	52343827	8421504	2	21,8	0,301	c	350000937100000002	0-29		9458818			American Journal of Physiology - Renal Physiology	Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule	Cheng	1998	0		
984	chr19	52343518	52343824	3500150133	26		52343518	52343824	8421504	2	21,5	0,301	c	350015013300000008	0-26		12142345	10.1161/01.RES.0000027813.55750.E7	0009-7330	Circulation Research	Intrauterine Growth Retardation Is Associated With Reduced Activity and Expression of the Cationic Amino Acid Transport Systems y+/hCAT-1 and y+/hCAT-2B and Lower Activity of Nitric Oxide Synthase in Human Umbilical Vein Endothelial Cells	Casanello	2002	9		
984	chr19	52343518	52343823	3500387170	25		52343518	52343823	8421504	2	21,4	0,301	c	350038717000000001	0-25						Intervention in Hepatic Lipid Metabolism	www.tipharma.com	0	0		
984	chr19	52343518	52343821	3500168203	23		52343518	52343821	8421504	2	21,2	0,301	c	350016820300000012	0-23						Fyn Regulates Adipogenesis through Pr omoting PIKE-A/STAT5a Interaction	mcb.asm.org	0	0		
984	chr19	52343519	52343822	3500365135	23		52343519	52343822	8421504	2	20,3	0,300	c	350036513500000004	0-23			10.1016/j.cellsig.2007.10.007		Cellular signalling	NUCLEAR TRANSLOCATION OF p65 NF-&#x03ba;B IS SUFFICIENT FOR VCAM-1, BUT NOT ICAM-1, EXPRESSION IN TNF-STIMULATED SMOOTH MUSCLE CELLS: DIFFERENTIAL REQUIREMENT FOR PARP-1 EXPRESSION AND INTERACTION	Mourad	2008	0		
984	chr19	52343519	52343822	3500063187	23		52343519	52343822	8421504	2	20,3	0,300	c	350006318700000003	0-23		15516339	10.1074/jbc.M409344200	0021-9258	Journal of Biological Chemistry	cis-Acting Element-specific Transcriptional Activity of Differentially Phosphorylated Nuclear Factor-&#x03ba;B	Anrather	2005	5		
984	chr19	52343519	52343822	3500054467	23		52343519	52343822	8421504	2	20,3	0,300	c	350005446700000003	0-23						Phosphorylationofp50NF- BataSingleSerineResidueby DNA-dependentProteinKinaseIsCriticalforVCAM-1 ExpressionuponTNFTreatment S	www.jbc.org	0	0		
984	chr19	52343520	52344516	3500248431	49		52343520	52344516	8421504	3	19,7,23	0,299,973	c	350024843100000006,350024843100000007	0-26,1-24		19376775	10.1074/jbc.M109.008938	0021-9258	Journal of Biological Chemistry	Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig	Esteban	2009	5		
984	chr19	52343520	52344516	3500001753	49		52343520	52344516	8421504	3	19,7,23	0,299,973	c	350000175300000006,350000175300000007	0-26,1-24		19376775	10.1074/jbc.M109.008938		The Journal of Biological Chemistry	Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig	MiguA.	June	0		
984	chr19	52343520	52343826	3500057234	26		52343520	52343826	8421504	2	19,7	0,299	c	350005723400000006	0-26						GenerationofInducedPluripotentStemCellLinesfrom TibetanMiniaturePig	www.jbc.org	0	0		
984	chr19	52343521	52343827	3500029548	26		52343521	52343827	8421504	2	18,8	0,298	c	350002954800000010	0-26		15358835	10.1210/me.2004-0211	0888-8809	Molecular Endocrinology	Orphan Nuclear Receptor Small Heterodimer Partner Represses Hepatocyte Nuclear Factor 3/Foxa Transactivation via Inhibition of Its DNA Binding	Kim	2004	5		
984	chr19	52343521	52343825	3500316174	24		52343521	52343825	8421504	2	18,6	0,298	c	350031617400000026,350031617400000005	0-24,0-24						CELL MASS CAPABLE OF SERVING AS A PRIMITIVE ORGAN-LIKE STRUCTURE COMPRISED OF A PLURALITY OF CELL TYPES OF SOMATIC ORIGIN - Patent application	www.faqs.org	0	0		
984	chr19	52343522	52344654	3500436354	44		52343522	52344654	8421504	4	17,5,3,19	0,297,1022,1113	c	350043635400000010,350043635400000011	0-22,0-22						Method for the detection of schizophrenia related gene transcripts in blood	Liew	2004	0		
984	chr19	52343522	52344654	3500357297	44		52343522	52344654	8421504	4	17,5,3,19	0,297,1022,1113	c	350035729700000007,350035729700000008	0-22,0-22						Tumor and Stem Cell Biology Cancer Research Suppression of Cyclin D1 by Hypoxia-Inducible Factor-1 via Direct Mechanism Inhibits the Proliferation and 5-Fluorouracil Induced Apoptosis of A549 Cells	.aacrjournals.org	0	0		
984	chr19	52343524	52343829	3500444469	25		52343524	52343829	8421504	2	15,10	0,295	c	350044446900000007	0-25		12969963	10.1182/blood-2003-06-1969	0006-4971	Blood	FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells	Zheng	2004	10		
984	chr19	52343524	52343829	3500417024	25		52343524	52343829	8421504	2	15,10	0,295	c	350041702400000021	0-25						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - STEMPEUTICS RESEARCH PRIVATE LIMITED	www.sumobrain.com	0	0		
984	chr19	52343524	52343829	3500322333	25		52343524	52343829	8421504	2	15,10	0,295	c	350032233300000005	0-25			10.1021/bc070066k		Bioconjugate chemistry	Optimizing Size and Copy Number For PEG-fMLF (N-Formyl-methionyl-leucyl-phenylalanine) Nanocarrier Uptake by Macrophages	Li	2008	0		
984	chr19	52343524	52343829	3500276483	25		52343524	52343829	8421504	2	15,10	0,295	c	350027648300000005	0-25						&#xc073;&#xb8aa;&#xa4f4;&#xb2ca;&#xa9e2;&#xaaab;&#xb9ef;&#xa448;&#xc3fe;&#xad47;&#xc0f9;&#xb2d3;&#xad4d;&#xaee8; (SC-M1)NAT1 &#xb0f2;&#xa65d;&#xaaed;&#xb27b;&#xaaba;&#xbc76;&#xc554;	www.nricm.edu.tw	0	0		ACTG2
984	chr19	52343524	52343829	3500228482	25		52343524	52343829	8421504	2	15,10	0,295	c	350022848200000007,350022848200000003	0-25,0-25						METHODS FOR TREATING VIRAL DISORDERS - Patent application	www.faqs.org	0	0		ACTG2
984	chr19	52343524	52343829	3500186633	25		52343524	52343829	8421504	2	15,10	0,295	c	350018663300000005	0-25		16322266	10.1158/0008-5472.CAN-05-2805	0008-5472	Cancer Research	Tumor Immunotherapy Targeting Fibroblast Activation Protein, a Product Expressed in Tumor-Associated Fibroblasts	Lee	2005	8		ACTG2
984	chr19	52343524	52343829	3500170745	25		52343524	52343829	8421504	2	15,10	0,295	c	350017074500000003	0-25		22249478	10.6061/clinics/2012(01)06	1807-5932	Clinics	Clinics - Regulation of hypoxia-inducible factor-1&#x03b1; (HIF-1&#x03b1;) expression by interleukin-1&#x03b2; (IL-1 &#x03b2;), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes	Sartori-Cintra	2012	2		
984	chr19	52343524	52343829	3500170470	25		52343524	52343829	8421504	2	15,10	0,295	c	350017047000000007	0-25						A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides. - ResearchGate	.researchgate.net	0	0		
984	chr19	52343524	52343829	3500117241	25		52343524	52343829	8421504	2	15,10	0,295	c	350011724100000011	0-25						THESE DE DOCTORAT DE L&#x2019;UNIVERSITE PARIS 6	bib.rilk.com	0	0		
984	chr19	52343524	52343829	3500073863	25		52343524	52343829	8421504	2	15,10	0,295	c	350007386300000003	0-25						[Frontiers in Bioscience 10, 803-808, January 1, 2005] INHIBITION OF CALCIUM PHOSPHATE-DNA COPRECIPITATES INDUCED CELL DEATH BY PHOSPHOCITRATES	.chemistry.uoc.gr	0	0		
984	chr19	52343524	52343829	3500063234	25		52343524	52343829	8421504	2	15,10	0,295	c	350006323400000008	0-25						Gamma secretase inhibitor for treatment of herpesvirus infection - Patent application	www.faqs.org	0	0		ACTG2
984	chr19	52343524	52343829	3500056016	25		52343524	52343829	8421504	2	15,10	0,295	c	350005601600000011	0-25			10.1634/stemcells.22-3-313	1549-4918	STEM CELLS	Effects of Cyclic Compressive Loading on Chondrogenesis of Rabbit Bone-Marrow Derived Mesenchymal Stem Cells - Huang - 2004 - STEM CELLS - Wiley Online Library	Huang	2004	0		
984	chr19	52343524	52343829	3500046486	25		52343524	52343829	8421504	2	15,10	0,295	c	350004648600000003	0-25						CLINICAL SCIENCE Regulation of hypoxia-inducible factor-1 (HIF-1 b (IL-1 ), insulin-like growth factors I (IGF-I) and II (IGF-II) in human	www.scielo.br	0	0		
984	chr19	52343524	52343829	3500008009	25		52343524	52343829	8421504	2	15,10	0,295	c	350000800900000061,350000800900000021	0-25,0-25						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - Patent application	www.faqs.org	0	0		
984	chr19	52343524	52343827	3500370998	23		52343524	52343827	8421504	2	15,8	0,295	c	350037099800000004	1-24		21389127	10.1128/JVI.02399-10		Journal of Virology	A Respiratory Syncytial Virus Replicon That Is Noncytotoxic and Capable of Long-Term Foreign Gene Expression	Olga	2011	0		
984	chr19	52343524	52343827	3500333351	23		52343524	52343827	8421504	2	15,8	0,295	c	350033335100000016,350033335100000037	0-23,0-23						Methods and Compositions for the Diagnosis and Treatment of Schizophrenia - Patent application	www.faqs.org	0	0		
984	chr19	52343524	52343827	3500040267	23		52343524	52343827	8421504	2	15,8	0,295	c	350004026700000000	23-46						GOLD NANOPARTICLE, A COMPOSITION AND A METHOD TO PERPETUATE STEMNESS THEREOF - Patent application	www.faqs.org	0	0		
984	chr19	52343527	52343999	3500433824	40		52343527	52343999	8421504	4	12,8,15,5	0,292,451,467	c,g	350043382400000000,350043382400000001,350043382400000001	0-20,0-20,0-20		24039959	10.1371/journal.pone.0073488		PLoS ONE	Respiratory Syncytial Virus Infection Induces Higher Toll-Like Receptor-3 Expression and TNF-&#x03b1; Production Than Human Metapneumovirus Infection	Ying	2013	0		
984	chr19	52343527	52343999	3500321753	40		52343527	52343999	8421504	4	12,8,15,5	0,292,451,467	c	350032175300000016,350032175300000017	0-20,0-20						2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF MESALAMINE, SENSITIZES COLON CANCER CELLS TO TRAIL-INDUCED APOPTOSIS BY REGULATING DEATH RECEPTOR 5 AND SURVIVIN EXPRESSION.	.aacrjournals.org	0	0		
984	chr19	52343527	52343831	3500339625	24		52343527	52343831	8421504	2	12,12	0,292	c	350033962500000004	0-24						Dysregulation of Platelet-Derived Growth Factor -Receptor Expression by &#x0394;Np73 in Neuroblastoma	.aacrjournals.org	0	0		
984	chr19	52343528	52343831	3500467494	23		52343528	52343831	8421504	2	11,12	0,291	c	350046749400000007	0-23		20228055	10.1074/jbc.M109.071456		The Journal of Biological Chemistry	A Simple Technique for the Prediction of Interacting Proteins Reveals a Direct Brn-3a-Androgen Receptor Interaction	DaniC.	2010	0		
984	chr19	52343528	52343831	3500057035	23		52343528	52343831	8421504	2	11,12	0,291	c	350005703500000007	0-23		20228055	10.1074/jbc.M109.071456	0021-9258	Journal of Biological Chemistry	A Simple Technique for the Prediction of Interacting Proteins Reveals a Direct Brn-3a-Androgen Receptor Interaction	Berwick	2010	5		
984	chr19	52343529	52344646	3500186369	41		52343529	52344646	8421504	4	10,10,10,11	0,290,1008,1106	c	350018636900000004,350018636900000005	0-20,0-21		9444988		0022-538X	Journal of Virology	In Vitro Infection and Type-Restricted Antibody-Mediated Neutralization of Authentic Human Papillomavirus Type 16	White	1998	5		ACTG2
984	chr19	52343529	52344136	3500201439	42		52343529	52344136	8421504	3	10,12,20	0,290,587	c	350020143900000000,350020143900000001	0-22,0-20		19276072	10.1074/jbc.M808949200	0021-9258	Journal of Biological Chemistry	Galectin-8 Induces Apoptosis in Jurkat T Cells by Phosphatidic Acid-mediated ERK1/2 Activation Supported by Protein Kinase A Down-regulation	Norambuena	2009	5		
984	chr19	52343529	52343833	3500362028	24		52343529	52343833	8421504	2	10,14	0,290	c	350036202800000001	0-24		17989114	10.1152/ajprenal.00370.2007		American Journal of Physiology - Renal Physiology	Tuberin regulates the DNA repair enzyme OGG1	Habib	2008	0		
984	chr19	52343530	52344647	3500363554	44		52343530	52344647	8421504	4	9,12,11,12	0,289,1006,1105	c	350036355400000004,350036355400000005	0-21,0-23		18806821	10.1038/bjp.2008.367	1476-5381	British Journal of Pharmacology	An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption - Herrera - 2009 - British Journal of Pharmacology - Wiley Online Library	Herrera	2008	0		
984	chr19	52343535	52344221	3500365462	44		52343535	52344221	8421504	3	4,18,22	0,284,664	c	350036546200000004,350036546200000005	0-22,0-22						&#x677e;&#x6c5f;&#x9c88;&#x808c;&#x8089;&#x751f;&#x957f;&#x6291;&#x5236;&#x7d20;&#x57fa;&#x56e0;&#x514b;&#x9686;&#x548c;&#x5e8f;&#x5217;&#x7279;&#x5f81;&#x5206;&#x6790;	www.zoores.ac.cn	0	0		
984	chr19	52343825	52343848	3500083700	23		52343825	52343848	8421504	1	23	0	c	350008370000000058,350008370000000028	0-23,0-23						COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE AGAINST MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
984	chr19	52343880	52344425	3500422371	41		52343880	52344425	8421504	2	20,21	0,524	c,g	350042237100000004,350042237100000005,350042237100000005	0-20,0-21,0-21		21904456	10.2147/IJN.S22293		International Journal of Nanomedicine	Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy	Zong-Xia	2011	0		ACTB
984	chr19	52343894	52344731	3500005601	82		52343894	52344731	8421504	5	20,20,5,16,21	0,186,648,741,816	c,g	350000560100000000,350000560100000000,350000560100000001,350000560100000001,350000560100000008,350000560100000009	0-20,0-20,0-20,0-20,0-21,0-21						GINGIVA DERIVED STEM CELL AND ITS APPLICATION IN IMMUNOMODULATION AND RECONSTRUCTION - UNIVERSITY OF SOUTHERN CALIFORNIA	www.sumobrain.com	0	0		
984	chr19	52343894	52344651	3500022683	61		52343894	52344651	8421504	4	20,20,5,16	0,186,648,741	c	350002268300000000,350002268300000001,350002268300000008	0-20,0-20,0-21						Gingiva Derived Stem Cell And Its Application In Immunodulation And Reconstruction	Le	2010	0		
984	chr19	52343894	52344100	3500399536	40		52343894	52344100	8421504	2	20,20	0,186	c	350039953600000000,350039953600000001	0-20,0-20		17848962	10.1038/sj.mt.6300300	1525-0016	Molecular Therapy	Oncolytic Adenoviruses Kill Breast Cancer Initiating CD44&plus;CD24&#x2013;/Low Cells	Eriksson	2007	7		
984	chr19	52343894	52344100	3500385977	40		52343894	52344100	8421504	2	20,20	0,186	c	350038597700000002,350038597700000003	0-20,0-20						Embryonic stem cells	Bongso	2000	0		
984	chr19	52343894	52344100	3500382699	40		52343894	52344100	8421504	2	20,20	0,186	c	350038269900000032,350038269900000010,350038269900000033,350038269900000003	0-20,0-20,0-20,0-20						EMBRYONIC STEM CELLS AND NEURAL PROGENITOR CELLS DERIVED THEREFROM - Patent application	www.faqs.org	0	0		
984	chr19	52343894	52344100	3500367987	40		52343894	52344100	8421504	2	20,20	0,186	c	350036798700000042,350036798700000002,350036798700000043,350036798700000003	0-20,0-20,0-20,0-20						Neural progenitor cells derived from embryonic stem cells - Patent application	www.faqs.org	0	0		ACTG1
984	chr19	52343894	52344100	3500350827	40		52343894	52344100	8421504	2	20,20	0,186	c	350035082700000018,350035082700000004,350035082700000026,350035082700000005	0-20,0-20,0-20,0-20						Method of Delivering Nucleic Acid Molecules Into Embryonic Stem Cells Using Baculoviral Vectors - Patent application	www.faqs.org	0	0		
984	chr19	52343894	52344100	3500306210	39		52343894	52344100	8421504	3	20,13,6	0,186,200	c,g	350030621000000003,350030621000000003,350030621000000004	0-20,0-20,0-19						RESEARCH ARTICLE Open Access Influence of untranslated regions on retroviral mRNA transfer and expression	hives-ouvertes.fr	0	0		
984	chr19	52343894	52344100	3500287553	40		52343894	52344100	8421504	2	20,20	0,186	c	350028755300000002,350028755300000003	0-20,0-20						Neural progenitor cells derived from embryonic stem cells	Reubinoff	2012	0		
984	chr19	52343894	52344100	3500286294	40		52343894	52344100	8421504	2	20,20	0,186	c	350028629400000002,350028629400000003	0-20,0-20						Embryonic stem cells and neural progenitor cells derived therefrom	Reubinoff	2005	0		
984	chr19	52343894	52344100	3500286241	40		52343894	52344100	8421504	2	20,20	0,186	c	350028624100000002,350028624100000003	0-20,0-20		21881000	10.1152/ajpcell.00065.2011		American Journal of Physiology - Cell Physiolog	A novel mechanism in maggot debridement therapy: protease in excretion/secretion promotes hepatocyte growth factor production	Honda	2011	0		
984	chr19	52343894	52344100	3500281216	40		52343894	52344100	8421504	2	20,20	0,186	c	350028121600000002,350028121600000003	0-20,0-20					Patent	Neural progenitor cells derived from embryonic stem cells (Patent US:8137969)	Ben-Hur	2012	0		
984	chr19	52343894	52344100	3500268901	40		52343894	52344100	8421504	2	20,20	0,186	c,g	350026890100000050,350026890100000022,350026890100000051,350026890100000051,350026890100000023,350026890100000023	0-20,0-20,0-20,0-20,0-20,0-20						GENERATION OF NEURAL STEM CELLS FROM UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		
984	chr19	52343894	52344100	3500253522	40		52343894	52344100	8421504	2	20,20	0,186	c,g	350025352200000010,350025352200000010,350025352200000002,350025352200000002,350025352200000011,350025352200000011,350025352200000003,350025352200000003	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						 Embryonic Stem Cells 	www.docstoc.com	0	0		
984	chr19	52343894	52344100	3500250771	40		52343894	52344100	8421504	2	20,20	0,186	c	350025077100000002,350025077100000003	0-20,0-20						Embryonic stem cells and neural progenitor cells derived therefrom	Ben-Hur	2002	0		
984	chr19	52343894	52344100	3500232870	40		52343894	52344100	8421504	2	20,20	0,186	c	350023287000000002,350023287000000003	0-20,0-20						Neural progenitor cells derived from embryonic stem cells	Pera	2012	0		
984	chr19	52343894	52344100	3500230377	40		52343894	52344100	8421504	2	20,20	0,186	c,g	350023037700000002,350023037700000002,350023037700000003	0-20,0-20,0-20						Embryonic stem cells	Bongso	2001	0		
984	chr19	52343894	52344100	3500229416	40		52343894	52344100	8421504	2	20,20	0,186	c	350022941600000002,350022941600000003	0-20,0-20					Patent	Neural progenitor cells derived from embryonic stem cells (Patent US:8460931)	Reubinoff	2013	0		
984	chr19	52343894	52344100	3500204585	40		52343894	52344100	8421504	2	20,20	0,186	c	350020458500000010,350020458500000003	0-20,0-20					Patent	Embryonic stem cells and neural progenitor cells derived therefrom (Patent US:7947498)	Reubinoff	2011	0		
984	chr19	52343894	52344100	3500179532	40		52343894	52344100	8421504	2	20,20	0,186	c	350017953200000002,350017953200000003	0-20,0-20		21881000	10.1152/ajpcell.00065.2011		American Journal of Physiology - Cell Physiolog	A novel mechanism in maggot debridement therapy: protease in excretion/secretion promotes hepatocyte growth factor production	Honda	2011	0		
984	chr19	52343894	52344100	3500144853	40		52343894	52344100	8421504	2	20,20	0,186	c	350014485300000002,350014485300000003	0-20,0-20						Embryonic stem cells and neural progenitor cells derived therefrom	Reubinoff	2012	0		
984	chr19	52343894	52344100	3500137855	40		52343894	52344100	8421504	2	20,20	0,186	c	350013785500000010,350013785500000002,350013785500000003	0-20,0-19,0-20					Patent	Embryonic stem cells and neural progenitor cells derived therefrom (Patent US:7504257)	Reubinoff	2009	0		
984	chr19	52343894	52344100	3500133298	40		52343894	52344100	8421504	2	20,20	0,186	c,g	350013329800000002,350013329800000002,350013329800000003,350013329800000003	0-20,0-20,0-20,0-20						Neural progenitor cells derived from embryonic stem cells	Reubinoff	2009	0		ACTG1
984	chr19	52343894	52344100	3500126690	40		52343894	52344100	8421504	2	20,20	0,186	c	350012669000000012,350012669000000013	0-20,0-20		17362520	10.1186/1471-2164-8-75	1471-2164	BMC Genomics	Expansion of the Bactericidal/Permeability Increasing-like (BPI-like) protein locus in cattle	Wheeler	2007	4		
984	chr19	52343894	52344100	3500126472	39		52343894	52344100	8421504	3	20,13,6	0,186,200	c,g	350012647200000003,350012647200000004	0-20,0-19		23586982	10.1186/1472-6750-13-35	1472-6750	BMC Biotechnology	Influence of untranslated regions on retroviral mRNA transfer and expression	Prel	2013	2		
984	chr19	52343894	52344100	3500078232	40		52343894	52344100	8421504	2	20,20	0,186	c,g	350007823200000002,350007823200000002,350007823200000013,350007823200000003,350007823200000003	0-20,0-20,0-20,0-20,0-20						CHARACTERIZATION AND ISOLATION OF SUBSETS OF HUMAN EMBRYONIC STEM CELLS (HES) AND CELLS ASSOCIATED OR DERIVED THEREFROM - ES CELL INTERNATIONAL PTE LTD	www.sumobrain.com	0	0		
984	chr19	52343897	52344102	3500176576	39		52343897	52344102	8421504	2	19,20	0,185	c,g	350017657600000006,350017657600000006,350017657600000007,350017657600000007	0-19,0-19,0-20,0-20						Role of NF-KB-Mediate Interleukin-d 8 Expression in Intraocular Neovascularization	www.iovs.org	0	0		
984	chr19	52343897	52343921	3500411508	24		52343897	52343921	8421504	1	24	0	c,g	350041150800000004,350041150800000004	0-24,0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Fol&#xed;culos ovarianos caprinos expressam diferentes n&#xed;veis de RNAm para subunidade &#xdf;A da inibina e ativina-A promove o crescimento de fol&#xed;culos secund&#xe1;rios in vitro	Leitao	2013	0		ACTG1
984	chr19	52343897	52343921	3500331184	24		52343897	52343921	8421504	1	24	0	c,g	350033118400000002,350033118400000002	0-24,0-24						UNIVERSIDADE ESTADUAL DO CEAR&#xc1; PR&#xd3;-REITORIA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O E PESQUISA FACULDADE DE VETERIN&#xc1;RIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS VETERIN&#xc1;RIAS JULIANA JALES DE HOLLANDA CELESTINO EXX PPRREESSSS&#	cnptia.embrapa.br	0	0		ACTG1
984	chr19	52343897	52343921	3500263461	24		52343897	52343921	8421504	1	24	0	c	350026346100000002	0-24						Isolation and culture of Preantral Follicles	www.cbra.org.br	0	0		ACTG1
984	chr19	52343897	52343921	3500053285	24		52343897	52343921	8421504	1	24	0	c	350005328500000004	0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Goat ovarian follicles express different levels of mRNA for inhibin-&#xdf;A subunit and activin-A stimulates secondary follicle growth in vitro	Leitao	2013	0		ACTG1
984	chr19	52343897	52343921	3500053265	24		52343897	52343921	8421504	1	24	0	c	350005326500000000	0-24						Levels of mRNA for BMP-7 in goat ovarian follicles and in vitro effects of BMP-7 on secondary follicle development	www.cbra.org.br	0	0		ACTG1
984	chr19	52343924	52344647	3500386733	42		52343924	52344647	8421504	3	20,10,12	0,613,711	c	350038673300000002,350038673300000003	0-20,0-22		21569123	10.1111/j.1574-695X.2011.00816.x		FEMS immunology and medical microbiology	Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes	Luciana	2011	0		
984	chr19	52343924	52344647	3500315956	42		52343924	52344647	8421504	3	20,10,12	0,613,711	c	350031595600000000,350031595600000001	0-20,0-22						&#x201c;AGREGADO DE TRI&#xd3;XIDO MINERAL (MTA) E RESPOSTA IMUNE: DA IMUNIDADE INATA &#xc0; REABSOR&#xc7;&#xc3;O &#xd3;SSEA PERIAPICAL.&#x201d;	pct.capes.gov.br	0	0		ACTB
984	chr19	52343924	52344647	3500188881	42		52343924	52344647	8421504	3	20,10,12	0,613,711	c	350018888100000010,350018888100000011	0-20,0-22		22435084	10.3402/jom.v4i0.14832	2000-2297	Journal of Oral Microbiology	Expression levels of novel cytokine IL-32 in periodontitis and its role in the suppression of IL-8 production by human gingival fibroblasts stimulated with Porphyromonas gingivalis 	Ouhara	2012	0		
984	chr19	52343924	52343953	3500295086	29		52343924	52343953	8421504	1	29	0	c	350029508600000010	0-29						Nestin expression and clonal analysis of islet-derived epithelial monolayers: insight into nestin-expressing cell heterogeneity and differentiation potential	logy-journals.org	0	0		POTEF,POTEM
984	chr19	52343924	52343953	3500291352	29		52343924	52343953	8421504	1	29	0	c	350029135200000002	0-29		23828577	10.1038/cddis.2013.244	false	Cell Death & Disease	TGF-&#x03b2;1 regulates cell fate during epithelial&#x2013;mesenchymal transition by upregulating survivin	Lee	2013	0		ACTG1
984	chr19	52343924	52343953	3500168735	29		52343924	52343953	8421504	1	29	0	c	350016873500000002	0-29		23828577	10.1038/cddis.2013.244	false	Cell Death & Disease	TGF-&#x03b2;1 regulates cell fate during epithelial&#x2013;mesenchymal transition by upregulating survivin	Lee	2013	0		ACTB,POTEH
984	chr19	52343924	52343953	3500045467	29		52343924	52343953	8421504	1	29	0	c	350004546700000002	0-29						Smad3RegulatesRhoSignalingviaNET1intheTransforming GrowthFactor- -inducedEpithelial-MesenchymalTransition ofHumanRetinalPigmentEpithelialCells	www.jbc.org	0	0		POTEM
984	chr19	52343931	52344778	3500268241	73		52343931	52344778	8421504	3	25,25,23	0,270,824	c	350026824100000008,350026824100000009,350026824100000002	0-25,0-25,0-23		20046830	10.1371/journal.pone.0008531		PLoS ONE	Mechanisms of c-Myc Degradation by Nickel Compounds and Hypoxia	Qin	2009	0		
984	chr19	52343931	52344741	3500323009	47		52343931	52344741	8421504	3	24,19,4	0,786,806	c	350032300900000004,350032300900000005	0-24,0-23		18474554	10.1099/vir.0.83568-0	0022-1317	Journal of General Virology	Peripheral blood mononuclear cells represent a reservoir of bovine papillomavirus DNA in sarcoid-affected equines	Brandt	2008	3		
984	chr19	52343931	52344226	3500461629	50		52343931	52344226	8421504	2	25,25	0,270	c	350046162900000001,350046162900000002	0-25,0-25		21943213	10.1186/1756-9966-30-86	1756-9966	Journal of Experimental & Clinical Cancer Research	Aquaporin-3 positively regulates matrix metalloproteinases via PI3K/AKT signal pathway in human gastric carcinoma SGC7901 cells	Xu	2011	2		ACTG1
984	chr19	52343931	52344226	3500447406	50		52343931	52344226	8421504	2	25,25	0,270	c	350044740600000006,350044740600000007	0-25,0-25						CRUDE BIOLOGICAL DERIVATIVES COMPETENT FOR NUCLEIC ACID DETECTION	Pasloske	2012	0		
984	chr19	52343931	52344226	3500443577	50		52343931	52344226	8421504	2	25,25	0,270	c	350044357700000002,350044357700000003	0-25,0-25			10.1634/stemcells.2004-0364	1549-4918	STEM CELLS	Promoter Dependence of Transgene Expression by Lentivirus-Transduced Human Blood&#x2013;Derived Endothelial Progenitor Cells - Liu - 2006 - STEM CELLS - Wiley Online Library	Liu	2006	0		
984	chr19	52343931	52344226	3500408618	50		52343931	52344226	8421504	2	25,25	0,270	c	350040861800000002,350040861800000003	0-25,0-25						Downregulation of GFAP, TSP-1, and p53 in Human Glioblastoma Cell Line, U373MG, by IE1 Protein From Human Cytomegalovirus	www.narrykim.org	0	0		ACTB
984	chr19	52343931	52344226	3500399665	50		52343931	52344226	8421504	2	25,25	0,270	c	350039966500000000,350039966500000004,350039966500000001,350039966500000005	0-25,0-25,0-25,0-25						METHOD AND DEVICE FOR DETECTING THE PRESENCE OF A SINGLE TARGET NUCLEIC ACID IN A SAMPLE - Patent application	www.faqs.org	0	0		
984	chr19	52343931	52344226	3500377123	48		52343931	52344226	8421504	2	24,24	0,271	c	350037712300000002,350037712300000003	0-24,0-24						Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants	Baroni	2008	0		ACTG1
984	chr19	52343931	52344226	3500363875	50		52343931	52344226	8421504	2	25,25	0,270	c	350036387500000004,350036387500000005	0-25,0-25						Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH and COOH termini of aggregation and Alzheimer&#x2019;s disease	proteom-msu.org	0	0		
984	chr19	52343931	52344226	3500362020	50		52343931	52344226	8421504	2	25,25	0,270	c	350036202000000008,350036202000000009	0-25,0-25		18071026	10.2337/db07-0847	0012-1797	Diabetes	Transcription Factor 7-Like 2 Regulates &#x03b2;-Cell Survival and Function in Human Pancreatic Islets	Shu	2008	8		
984	chr19	52343931	52344226	3500354109	50		52343931	52344226	8421504	2	25,25	0,270	c	350035410900000004,350035410900000005	0-25,0-25						Methods and compositions for modulating prostasin	Fan	2006	0		
984	chr19	52343931	52344226	3500349527	48		52343931	52344226	8421504	2	24,24	0,271	c	350034952700000002,350034952700000003	0-24,0-24						Rab5 and class III phosphoinositide 3-kinase Vps34 are involved in hepatitis C virus NS4B-induced autophagy. - ResearchGate	.researchgate.net	0	0		
984	chr19	52343931	52344226	3500323930	47		52343931	52344226	8421504	2	25,22	0,273	c	350032393000000002,350032393000000003	0-25,0-22						METHOD FOR IDENTIFICATION OF GENES INVOLVED IN SPECIFIC DISEASES - OXFORD BIOMEDICA (UK) LIMITED	www.sumobrain.com	0	0		ACTG1
984	chr19	52343931	52344226	3500323762	50		52343931	52344226	8421504	2	25,25	0,270	c	350032376200000002,350032376200000003	0-25,0-25		18483178	10.1210/me.2007-0253	0888-8809	Molecular Endocrinology	Estrogen Receptor &#x03b2; Isoform-Specific Induction of Transforming Growth Factor &#x03b2;-Inducible Early Gene-1 in Human Osteoblast Cells: An Essential Role for the Activation Function 1 Domain	Hawse	2008	5		ACTG1
984	chr19	52343931	52344226	3500322916	50		52343931	52344226	8421504	2	25,25	0,270	c	350032291600000000,350032291600000001	0-25,0-25		10889905	10.1136/mp.53.2.69	1472-4154	Molecular Pathology	Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?	O'Leary	2000	0		ACTG1
984	chr19	52343931	52344226	3500318887	50		52343931	52344226	8421504	2	25,25	0,270	c	350031888700000006,350031888700000007	0-25,0-25						Tetracycline-Regulated Adeno-Associated Viral (AAV) Vectors for Gene Delivery to the Nervous System	Bohn	2008	0		POTEM
984	chr19	52343931	52344226	3500318821	50		52343931	52344226	8421504	2	25,25	0,270	c	350031882100000006,350031882100000007	0-25,0-25						Crude biological derivatives competent for nucleic acid detection	Pasloske	2012	0		
984	chr19	52343931	52344226	3500317665	50		52343931	52344226	8421504	2	25,25	0,270	c	350031766500000000,350031766500000001	0-25,0-25						Papers Cellular localisation of HHV-8 in Castleman&#x2019;s disease: is there a link with lymph node vascularity?	mp.bmj.com/conten	0	0		ACTB
984	chr19	52343931	52344226	3500316144	50		52343931	52344226	8421504	2	25,25	0,270	c	350031614400000008,350031614400000009	0-25,0-25						Nerve growth factor and receptors are significantly affected by histamine stimulus through H1 receptor in pancreatic carcinoma cells	-publications.com	0	0		
984	chr19	52343931	52344226	3500297414	50		52343931	52344226	8421504	2	25,25	0,270	c	350029741400000000,350029741400000001	0-25,0-25						Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly	www.cytonix.com	0	0		ACTG1
984	chr19	52343931	52344226	3500295954	50		52343931	52344226	8421504	2	25,25	0,270	c	350029595400000000,350029595400000001	0-25,0-25						Device having regions of differing affinities to fluid, methods of making such devices, and methods of using such devices	Brown	2012	0		
984	chr19	52343931	52344226	3500295928	50		52343931	52344226	8421504	2	25,25	0,270	c	350029592800000005,350029592800000006	0-25,0-25						Development of a Real-Time PCR Assay for Detection of Toxoplasma gondii in Pig and Mouse Tissues	jcm.asm.org	0	0		
984	chr19	52343931	52344226	3500288168	50		52343931	52344226	8421504	2	25,25	0,270	c	350028816800000008,350028816800000009	0-25,0-25						ORIGINAL ARTICLE Transcription Factor 7-Like 2 Regulates -Cell Survival and Function in Human Pancreatic Islets	betesjournals.org	0	0		
984	chr19	52343931	52344226	3500284864	50		52343931	52344226	8421504	2	25,25	0,270	c	350028486400000004,350028486400000005	0-25,0-25		20962078	10.1128/JVI.00767-10	0022-538X	Journal of Virology	Chikungunya Virus Induces IPS-1-Dependent Innate Immune Activation and Protein Kinase R-Independent Translational Shutoff	White	2011	5		ACTG1
984	chr19	52343931	52344226	3500259376	48		52343931	52344226	8421504	3	9,14,25	0,11,270	c,g	350025937600000000,350025937600000000,350025937600000001	0-24,0-24,0-25					Patent	Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly (Patent US:6391559)	Brown	2002	0		
984	chr19	52343931	52344226	3500259019	50		52343931	52344226	8421504	2	25,25	0,270	c	350025901900000000,350025901900000001	0-25,0-25					Patent	Miniaturized assembly and method of filling assembly (Patent US:7459315)	Brown	2008	0		ACTG1
984	chr19	52343931	52344226	3500258477	50		52343931	52344226	8421504	2	25,25	0,270	c	350025847700000008,350025847700000009	0-25,0-25		16380484	10.2337/diabetes.55.01.06.db05-0943	0012-1797	Diabetes	Activation of AMP-Activated Protein Kinase Reduces Hyperglycemia-Induced Mitochondrial Reactive Oxygen Species Production and Promotes Mitochondrial Biogenesis in Human Umbilical Vein Endothelial Cells	Kukidome	2006	8		ACTG1
984	chr19	52343931	52344226	3500210747	50		52343931	52344226	8421504	2	25,25	0,270	c	350021074700000006,350021074700000007	0-25,0-25		18537849	10.1111/j.1469-7580.2008.00921.x	1469-7580	Journal of Anatomy	Costameric proteins in human skeletal muscle during muscular inactivity - Anastasi - 2008 - Journal of Anatomy - Wiley Online Library	Anastasi	2008	0		
984	chr19	52343931	52344226	3500201007	50		52343931	52344226	8421504	2	25,25	0,270	c	350020100700000002,350020100700000003	0-25,0-25						Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma	ecular-cancer.com	0	0		
984	chr19	52343931	52344226	3500179606	50		52343931	52344226	8421504	2	25,25	0,270	c	350017960600000010,350017960600000004,350017960600000011,350017960600000005	0-25,0-25,0-25,0-25						METHODS AND COMPOSITIONS FOR MODULATING PROSTASIN - Patent application	www.faqs.org	0	0		
984	chr19	52343931	52344226	3500176387	50		52343931	52344226	8421504	2	25,25	0,270	c	350017638700000008,350017638700000009	0-25,0-25		19376846	10.1093/carcin/bgp088		Carcinogenesis	Alterations of histone modifications by cobalt compounds	Qin	July	0		
984	chr19	52343931	52344226	3500135770	50		52343931	52344226	8421504	2	25,25	0,270	c	350013577000000000,350013577000000001	0-25,0-25						Method and device for detecting the presence of a single target nucleic acid in a sample	Brown	2008	0		ACTB
984	chr19	52343931	52344226	3500126903	50		52343931	52344226	8421504	2	25,25	0,270	c	350012690300000000,350012690300000001	0-25,0-25						Method and device for detecting the presence of a single target nucleic acid in a sample	Brown	2009	0		ACTB
984	chr19	52343931	52344226	3500121820	50		52343931	52344226	8421504	2	25,25	0,270	c	350012182000000002,350012182000000003	0-25,0-25						Real time quantitative PCR.	fou02.bioforsk.no	0	0		ACTB
984	chr19	52343931	52344226	3500115394	47		52343931	52344226	8421504	2	25,22	0,273	c	350011539400000003,350011539400000004	0-25,0-22						Method for identification of genes involved in specific diseases	Harris	2002	0		ACTB,ACTG1
984	chr19	52343931	52344226	3500107010	73		52343931	52344226	8421504	3	25,23,25	0,79,270	c	350010701000000000,350010701000000004,350010701000000001	0-25,0-23,0-25						US Patent # 6,225,061. Systems and methods for performing reactions in an unsealed environment - Patents.com	www.patents.com	0	0		
984	chr19	52343931	52344226	3500045501	50		52343931	52344226	8421504	2	25,25	0,270	c	350004550100000004,350004550100000005	0-25,0-25			10.1158/0008-5472.CAN-06-0346		Cancer research	Early Growth Response Gene-1 Regulates Hypoxia-Induced Expression of Tissue Factor in Glioblastoma Multiforme through Hypoxia-Inducible Factor-1&#x2013;Independent Mechanisms	Yuan	July	0		ACTG1
984	chr19	52343931	52344226	3500040498	50		52343931	52344226	8421504	2	25,25	0,270	c	350004049800000016,350004049800000017	0-25,0-25			10.1016/j.bbi.2007.07.008		Brain, behavior, and immunity	SIV infection decreases sympathetic innervation of primate lymph nodes: The role of neurotrophins	Erica	2008	0		ACTB
984	chr19	52343931	52344226	3500033966	50		52343931	52344226	8421504	2	25,25	0,270	c	350003396600000008,350003396600000009	0-25,0-25		20978475	10.1038/mt.2010.226		Molecular Therapy	Biochemical Correction of X-CGD by a Novel Chimeric Promoter Regulating High Levels of Transgene Expression in Myeloid Cells	Giorgia	2011	0		
984	chr19	52343931	52344226	3500029525	50		52343931	52344226	8421504	2	25,25	0,270	c	350002952500000004,350002952500000005	0-25,0-25		16849552	10.1158/0008-5472.CAN-06-0346	0008-5472	Cancer Research	Early Growth Response Gene-1 Regulates Hypoxia-Induced Expression of Tissue Factor in Glioblastoma Multiforme through Hypoxia-Inducible Factor-1&#x2013;Independent Mechanisms	Rong	2006	8		
984	chr19	52343931	52344226	3500013078	50		52343931	52344226	8421504	2	25,25	0,270	c	350001307800000020,350001307800000021	0-25,0-25			10.1002/ijc.11676	1097-0215	International Journal of Cancer	Expression profile of genes associated with antimetastatic gene: nm23-Mediated metastasis inhibition in breast carcinoma cells - Zhao - 2003 - International Journal of Cancer - Wiley Online Library	Zhao	2004	0		
984	chr19	52343931	52344226	3500009801	50		52343931	52344226	8421504	2	25,25	0,270	c	350000980100000004,350000980100000005	0-25,0-25						Papers Expression pro&#xfb01;le of human herpesvirus 8 (HHV-8) in pyothorax associated lymphoma and in eVusion lymphoma	mp.bmj.com/conten	0	0		POTEM
984	chr19	52343931	52343956	3500440133	25		52343931	52343956	8421504	1	25	0	c	350044013300000001	0-25						PII: B978-0-12-164730-8.50053-8	gitus.itk.ppke.hu	0	0		ACTG1
984	chr19	52343931	52343956	3500435501	25		52343931	52343956	8421504	1	25	0	c	350043550100000000	0-25		15824148	10.1158/1055-9965.EPI-04-0763	1055-9965	Cancer Epidemiology Biomarkers & Prevention	Lack of Association between EBV and Breast Carcinoma	Perrigoue	2005	4		
984	chr19	52343931	52343956	3500433696	25		52343931	52343956	8421504	1	25	0	c	350043369600000011	0-25						Methods of preparing and using single chain anti-tumor antibodies	Cheung	2002	0		POTEF
984	chr19	52343931	52343956	3500421849	25		52343931	52343956	8421504	1	25	0	c	350042184900000006	0-25		21193388	10.1289/ehp.1002733		Environmental Health Perspectives	Involvement of N-6 Adenine-Specific DNA Methyltransferase 1 (N6AMT1) in Arsenic Biomethylation and Its Role in Arsenic-Induced Toxicity	Xuefeng	June	0		
984	chr19	52343931	52343956	3500398044	25		52343931	52343956	8421504	1	25	0	c	350039804400000002	0-25						Prognostic value of matrix Gla protein in breast cancer	-publications.com	0	0		ACTG1
984	chr19	52343931	52343956	3500397893	25		52343931	52343956	8421504	1	25	0	c	350039789300000000	0-25					Patent	Method for detecting the presence of a single target nucleic acid in a sample (Patent US:8278071)	Brown	2012	0		POTEM
984	chr19	52343931	52343956	3500346127	25		52343931	52343956	8421504	1	25	0	c	350034612700000000	0-25						Nanoliter scale PCR with TaqMan detection	quantification.de	0	0		POTEF,TBCA
984	chr19	52343931	52343956	3500251011	25		52343931	52343956	8421504	1	25	0	c	350025101100000002	0-25		22580838		1791-2997	Molecular Medicine Reports	Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma	Wu	2012	0		POTEM
984	chr19	52343931	52343956	3500202409	25		52343931	52343956	8421504	1	25	0	c	350020240900000010	0-25		18059336	10.1038/sj.onc.1210964	0950-9232	Oncogene	Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer	Al-azawi	2007	6		POTEE
984	chr19	52343931	52343956	3500173789	25		52343931	52343956	8421504	1	25	0	c	350017378900000002	0-25						DEVELOPMENT OF A CANINE COCCIDIOSIS MODEL AND THE ANTICOCCIDIAL EFFECTS OF A NEW CHEMOTHERAPEUTIC AGENT	cholar.lib.vt.edu	0	0		POTEM,TBCA
984	chr19	52343931	52343956	3500167971	25		52343931	52343956	8421504	1	25	0	c	350016797100000000	0-25						Thermal reaction device and method for using the same	Mcbride	2007	0		POTEF
984	chr19	52343931	52343956	3500149845	25		52343931	52343956	8421504	1	25	0	c	350014984500000000,350014984500000006	0-25,0-25						Method for conducting PCR protected from evaporation - Patent # 6664044 - PatentGenius	.patentgenius.com	0	0		
984	chr19	52343931	52343956	3500134586	25		52343931	52343956	8421504	1	25	0	c	350013458600000000	0-25						Method and device for detecting the presence of a single target nucleic acid in samples	Brown	2008	0		POTEF
984	chr19	52343931	52343956	3500095424	25		52343931	52343956	8421504	1	25	0	c	350009542400000000	0-25						Microfluidic devices and methods of using same	Mcbride	2004	0		POTEM
984	chr19	52343931	52343956	3500068033	25		52343931	52343956	8421504	1	25	0	c	350006803300000000	0-25						Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly	www.cytonix.com	0	0		
984	chr19	52343931	52343956	3500018884	25		52343931	52343956	8421504	1	25	0	c	350001888400000006	0-25		14514642	10.2337/diabetes.52.10.2570	0012-1797	Diabetes	Reactive Oxygen Species from Mitochondria Induce Cyclooxygenase-2 Gene Expression in Human Mesangial Cells	Kiritoshi	2003	8		POTEF,TBCA
984	chr19	52343931	52343955	3500233309	24		52343931	52343955	8421504	1	24	0	c	350023330900000004	0-24						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DT	www.plosone.org	0	0		
984	chr19	52343931	52343955	3500181734	24		52343931	52343955	8421504	1	24	0	c	350018173400000003	0-24						PKC412demonstratesJNK-dependentactivityagainsthuman multiplemyelomacells	tologylibrary.org	0	0		
984	chr19	52343933	52344226	3500051097	46		52343933	52344226	8421504	2	22,24	0,269	c	350005109700000004,350005109700000005	0-22,0-24						inflammatory and PPAR Subtypes Transactivational Activities of Phenolics and Lignans from the Stem Bark of Kalopanax pictus	rnal.kcsnet.or.kr	0	0		
984	chr19	52343933	52343957	3500224742	24		52343933	52343957	8421504	1	24	0	c	350022474200000010	0-24		17428314	10.1186/bcr1667	1465-5411	Breast Cancer Research	Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer	Lin	2007	0		POTEF
984	chr19	52343933	52343957	3500110118	24		52343933	52343957	8421504	1	24	0	c	350011011800000043,350011011800000024	0-24,0-24						Single Nucleotide Polymorphism Within An Intronic P53 Binding Motif of the Prkag2 Gene - Patent application	www.faqs.org	0	0		ACTG1
984	chr19	52343933	52343957	3500106704	24		52343933	52343957	8421504	1	24	0	c	350010670400000026	0-24						SINGLE NUCLEOTIDE POLYMORPHISM WITHIN AN INTRONIC p53 BINDING MOTIF OF THE PRKAG2 GENE	Liu	2010	0		ACTG1
984	chr19	52343933	52343957	3500080508	24		52343933	52343957	8421504	1	24	0	c	350008050800000004	0-24		21119756	10.1007/s11568-010-9138-x		The HUGO Journal	Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development	Jianjun	2009	0		ACTG1
984	chr19	52343933	52343957	3500024934	24		52343933	52343957	8421504	1	24	0	c	350002493400000024	0-24						Single Nucleotide Polymorphism Within An Intronic P53 Binding Motif of the Prkag2 Gene	Liu	2010	0		ACTG1
984	chr19	52343933	52343957	3500003625	24		52343933	52343957	8421504	1	24	0	c	350000362500000004	0-24						Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development. - ResearchGate	.researchgate.net	0	0		POTEM
984	chr19	52343933	52343957	3500002923	24		52343933	52343957	8421504	1	24	0	c	350000292300000015	0-24						Methods, Compositions and Kits for Use in Prognosis, Characterization and Treatment of Cancer	Lin	2006	0		ACTG1
984	chr19	52343933	52343956	3500437318	23		52343933	52343956	8421504	1	23	0	c	350043731800000009	0-23		17339328	10.1128/MCB.02295-06	0270-7306	Molecular and Cellular Biology	Novel Role for Mitochondria: Protein Kinase C&#x03b8;-Dependent Oxidative Signaling Organelles in Activation-Induced T-Cell Death	Kaminski	2007	6		POTEF
984	chr19	52343934	52344046	3500293501	40		52343934	52344046	8421504	2	19,21	0,91	c,g	350029350100000002,350029350100000002,350029350100000003	0-19,0-19,0-21		21430053	10.1128/JVI.00859-10	0022-538X	Journal of Virology	Inhibition of Bovine Viral Diarrhea Virus RNA Synthesis by Thiosemicarbazone Derived from 5,6-Dimethoxy-1-Indanone	Castro	2011	5		
984	chr19	52343935	52344516	3500213465	46		52343935	52344516	8421504	2	26,20	0,561	c	350021346500000003,350021346500000002	0-26,6-26		11509635		0022-1767	The Journal of Immunology	A Role for IL-18 in Neutrophil Activation	Leung	2001	6		
984	chr19	52343943	52344002	3500308968	43		52343943	52344002	8421504	2	21,22	0,37	c	350030896800000005,350030896800000007	0-21,0-22						Tumor suppressive microRNA&#x2011;424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase	-publications.com	0	0		
984	chr19	52343946	52344130	3500352333	53		52343946	52344130	8421504	3	21,7,25	0,148,159	c,g	350035233300000000,350035233300000000,350035233300000004	0-21,0-21,0-32						Myostatin shows a specific expression pattern in pig skeletal and extraocular muscles during pre- and post-natal growth. - ResearchGate	.researchgate.net	0	0		ACTG1
984	chr19	52343972	52344742	3500313691	43		52343972	52344742	8421504	2	23,20	0,750	c,g	350031369100000005,350031369100000035,350031369100000003,350031369100000003,350031369100000033,350031369100000033	0-23,0-23,0-20,0-20,0-20,0-20						COMPOSITIONS AND METHODS FOR THE TREATMENT OF A NEOPLASIA - Patent application	www.faqs.org	0	0		ACTB
984	chr19	52343972	52343999	3500144512	27		52343972	52343999	8421504	1	27	0	c	350014451200000002	0-27			10.1167/iovs.06-1382	1552-5783	Investigative Ophthalmology & Visual Science	CaMKII&#x03b1;B Mediates a Survival Response in Retinal Ganglion Cells Subjected to a Glutamate Stimulus	Fan	2007	0		ACTG1
984	chr19	52343972	52343999	3500136873	27		52343972	52343999	8421504	1	27	0	c	350013687300000003	0-27						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		ACTG1
984	chr19	52343972	52343995	3500446410	23		52343972	52343995	8421504	1	23	0	c	350044641000000001	0-23		20969766	10.1186/1476-4598-9-280	1476-4598	Molecular Cancer	Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness	Saladi	2010	4		ACTG1
984	chr19	52343972	52343995	3500433246	23		52343972	52343995	8421504	1	23	0	c	350043324600000002	0-23		23429288	10.1038/cddis.2013.1	false	Cell Death & Disease	CUL1 promotes trophoblast cell invasion at the maternal&#x2013;fetal interface	Zhang	2013	0		
984	chr19	52343972	52343995	3500426268	23		52343972	52343995	8421504	1	23	0	c	350042626800000001	0-23		20969766	10.1186/1476-4598-9-280		Molecular Cancer	Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness	Srinivas	2010	0		
984	chr19	52343972	52343995	3500313367	23		52343972	52343995	8421504	1	23	0	c	350031336700000014	24-47						Regulation of obesity-associated inflammation and colon tumorigenesis by resveratrol and adiponectin	ib.dr.iastate.edu	0	0		
984	chr19	52343973	52343998	3500027694	25		52343973	52343998	8421504	1	25	0	c	350002769400000010	0-25						&#x4e3b;&#x9898;&#xff1a;EP4 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		ACTG1
984	chr19	52343975	52344747	3500419612	44		52343975	52344747	8421504	2	20,24	0,748	c	350041961200000002,350041961200000006	0-20,0-24		21507966	10.1128/JVI.02401-10		Journal of Virology	The SUMOylation of Matrix Protein M1 Modulates the Assembly and Morphogenesis of Influenza A Virus	Chung-Yi	July	0		
984	chr19	52343975	52344736	3500347687	44		52343975	52344736	8421504	2	22,22	0,739	c	350034768700000002,350034768700000003	0-22,0-22						Spinner preparation machine and cavity resonator	Bach	2003	0		ACTB
984	chr19	52343975	52344736	3500313839	44		52343975	52344736	8421504	2	22,22	0,739	c,g	350031383900000002,350031383900000002,350031383900000003,350031383900000003	0-22,0-22,0-22,0-22						USE OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION - BETH ISRAEL DEACONESS MEDICAL CENTER	www.sumobrain.com	0	0		
984	chr19	52343976	52344046	3500320087	39		52343976	52344046	8421504	2	19,20	0,50	c,g	350032008700000007,350032008700000008,350032008700000008	0-19,0-20,0-20		16439548	10.1128/JVI.80.4.1922-1938.2006	0022-538X	Journal of Virology	Insights into Gene Expression Changes Impacting B-Cell Transformation: Cross-Species Microarray Analysis of Bovine Leukemia Virus Tax-Responsive Genes in Ovine B Cells	Klener	2006	5		
984	chr19	52343976	52344000	3500354450	24		52343976	52344000	8421504	1	24	0	c	350035445000000009	0-24		9116296		0006-4971	Blood	Downregulation of RAR&#x03b1; in Mice by Antisense Transgene Leads to a Compensatory Increase in RAR&#x03b2; and RAR&#x03b3; and Development of Lymphoma	Manshouri	1997	10		PSMF1,ACTG1
984	chr19	52343978	52344732	3500419861	47		52343978	52344732	8421504	2	22,25	0,729	c,g	350041986100000006,350041986100000006,350041986100000007,350041986100000007	0-22,0-22,0-25,0-25						H2 Relaxin Is a Biased Ligand Relative to H3 Relaxin at the Relaxin Family Peptide Receptor 3 (RXFP3) S	aspetjournals.org	0	0		
984	chr19	52343980	52344026	3500442844	42		52343980	52344026	8421504	2	21,21	0,25	c,g	350044284400000005,350044284400000004,350044284400000004	0-21,0-21,0-21		18524814	10.1128/JVI.00789-08	0022-538X	Journal of Virology	A Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in Mice	Kim	2008	5		
984	chr19	52343980	52344026	3500323496	42		52343980	52344026	8421504	2	21,21	0,25	c,g	350032349600000005,350032349600000004,350032349600000004	0-21,0-21,0-21		19494005	10.1128/JVI.02541-08	0022-538X	Journal of Virology	3&#x2032; cis-Acting Elements That Contribute to the Competence and Efficiency of Japanese Encephalitis Virus Genome Replication: Functional Importance of Sequence Duplications, Deletions, and Substitutions	Yun	2009	5		
984	chr19	52343980	52344026	3500133170	42		52343980	52344026	8421504	2	21,21	0,25	c,g	350013317000000010,350013317000000009,350013317000000009	0-21,20-41,20-41		18669441	10.1261/rna.993608		RNA	A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication	Byung-Hak	2008	0		
984	chr19	52343993	52344020	3500433362	27		52343993	52344020	8421504	1	27	0	c	350043336200000002	0-27		21325440	10.1124/jpet.111.179994	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	The Expression Level of Ecto-NTP Diphosphohydrolase1/CD39 Modulates Exocytotic and Ischemic Release of Neurotransmitters in a Cellular Model of Sympathetic Neurons	Corti	2011	0		ACTG1
984	chr19	52344002	52344718	3500292054	43		52344002	52344718	8421504	2	21,22	0,694	c	350029205400000002,350029205400000003	0-21,0-22		19841066	10.1128/MCB.01844-08	0270-7306	Molecular and Cellular Biology	Prostaglandin Promotion of Osteocyte Gap Junction Function through Transcriptional Regulation of Connexin 43 by Glycogen Synthase Kinase 3/&#x03b2;-Catenin Signaling	Xia	2010	6		
984	chr19	52344002	52344027	3500171121	25		52344002	52344027	8421504	1	25	0	c	350017112100000005	0-25		19401549	10.1093/jnci/djp063		JNCI Journal of the National Cancer Institute	Clusterin, a Haploinsufficient Tumor Suppressor Gene in Neuroblastomas	Olesya	2009	0		ACTC1
984	chr19	52344002	52344025	3500338109	23		52344002	52344025	8421504	1	23	0	c,g	350033810900000005,350033810900000005	0-23,0-23						Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression	www.fasebj.org	0	0		ACTG1
984	chr19	52344002	52344025	3500269470	23		52344002	52344025	8421504	1	23	0	c	350026947000000005	0-23		17496160	10.1096/fj.07-8200com	0892-6638	The FASEB Journal	Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression	Shan	2007	6		ACTG1,PCDH17
984	chr19	52344002	52344025	3500127680	23		52344002	52344025	8421504	1	23	0	c	350012768000000005	0-23		20610602	10.1101/gr.105825.110		Genome Research	High-throughput profiling of amino acids in strains of the Saccharomyces cerevisiae deletion collection	Sara	2010	0		ACTC1
984	chr19	52344003	52344026	3500053272	23		52344003	52344026	8421504	1	23	0	g	350005327200000006	0-23						Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells	www.irme.org	0	0		
984	chr19	52344004	52344035	3500081361	31		52344004	52344035	8421504	1	31	0	c,g	350008136100000007,350008136100000007	0-31,0-31						Oxytocin Increases Invasive Properties of Endometrial Cancer Cells Through Phosphatidylinositol 3-Kinase/AKT-Dependent Up-Regulation of Cyclooxygenase-1, -2, and X-Linked Inhibitor of Apoptosis Protein	ww.biolreprod.org	0	0		ZP4
984	chr19	52344004	52344028	3500010253	24		52344004	52344028	8421504	1	24	0	c	350001025300000006	0-24						Treatment of cancer with aldose reductase inhibitors	Srivastava	2010	0		ACTG1
984	chr19	52344005	52344035	3500104791	30		52344005	52344035	8421504	1	30	0	c	350010479100000009	0-30		12810564	10.1210/en.2002-0088	0013-7227	Endocrinology	Molecular Cloning and Characterization of Bovine Prostaglandin E2 Receptors EP2 and EP4: Expression and Regulation in Endometrium and Myometrium during the Estrous Cycle and Early Pregnancy	Arosh	2003	4		
984	chr19	52344005	52344029	3500127062	24		52344005	52344029	8421504	1	24	0	c	350012706200000007	0-24		19155307	10.1158/0008-5472.CAN-08-2520	0008-5472	Cancer Research	IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor&#x2013;Initiated Apoptosis via Repression of FLICE-like Protein Expression	Yang	2009	8		ACTG1
984	chr19	52344009	52344731	3500002283	45		52344009	52344731	8421504	2	24,21	0,701	c	350000228300000015,350000228300000016	0-24,0-21		17652154	10.1152/ajpendo.00003.2007		American Journal of Physiology - Endocrinology and Metabolism	Molecular dissection of G protein preference using Gs&#x03b1; chimeras reveals novel ligand signaling of GPCRs	Hsu	2007	0		POTEM
984	chr19	52344010	52344033	3500462370	23		52344010	52344033	8421504	1	23	0	c	350046237000000017	0-23			10.1074/jbc.M510403200		The Journal of biological chemistry	Differential use of functional domains by CoCoA in its synergistic coactivator function with &#x03b2;-catenin or GRIP1	Catherine	2006	0		
984	chr19	52344010	52344033	3500441668	23		52344010	52344033	8421504	1	23	0	g	350044166800000027	0-23						Volume 41 Number 2	www.rdi.ku.ac.th	0	0		
984	chr19	52344010	52344033	3500431986	23		52344010	52344033	8421504	1	23	0	c	350043198600000003	0-23						Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. - ResearchGate	.researchgate.net	0	0		POTEM
984	chr19	52344010	52344033	3500417061	23		52344010	52344033	8421504	1	23	0	c	350041706100000003	0-23						Gene Cloning of Immunogenic Antigens Overexpressed in Pancreatic Canc&#xef;#%	.kumamoto-u.ac.jp	0	0		POTEM
984	chr19	52344010	52344033	3500355402	23		52344010	52344033	8421504	1	23	0	c	350035540200000013	0-23		16822955	10.1152/ajpendo.00436.2005		American Journal of Physiology - Endocrinology and Metabolism	Glucose-dependent expansion of pancreatic &#x03b2;-cells by the protein p8 in vitro and in vivo	Path	2006	0		
984	chr19	52344010	52344033	3500354162	23		52344010	52344033	8421504	1	23	0	c	350035416200000001	0-23						Human Cathelicidin (LL-37) | Blog | allyson-BLOG - Yahoo! Blog	blog.yahoo.com	0	0		POTEF
984	chr19	52344010	52344033	3500320875	23		52344010	52344033	8421504	1	23	0	c	350032087500000003	0-23						Compositions and methods for detecting and treating cancer	Loberg	2007	0		POTEG,SPZ1
984	chr19	52344010	52344033	3500250739	23		52344010	52344033	8421504	1	23	0	c	350025073900000005	0-23						ONCOLOGY LETTERS 5: 1205-1210, 2013	-publications.com	0	0		ACTB
984	chr19	52344010	52344033	3500126035	23		52344010	52344033	8421504	1	23	0	c	350012603500000003	0-23		11435291	10.1182/blood.V98.2.257	0006-4971	Blood	Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator	Kahr	2001	10		POTEM
984	chr19	52344010	52344033	3500118645	23		52344010	52344033	8421504	1	23	0	c	350011864500000005	0-23		12944903	10.1038/sj.onc.1206514	0950-9232	Oncogene	Metabolic labeling of human cells with tritiated nucleosides results in activation of the ATM-dependent p53 signaling pathway and acceleration of DNA repair	Mirzayans	2003	6		
984	chr19	52344010	52344033	3500072635	23		52344010	52344033	8421504	1	23	0	c	350007263500000003	0-23						Intermediate filaments Desmin Synemin Dystrophin Utrophin Protein protein interactions | Online Peptides Guide	w.adrenorphin.net	0	0		
984	chr19	52344010	52344033	3500015552	23		52344010	52344033	8421504	1	23	0	c	350001555200000013	0-23		16822955	10.1152/ajpendo.00436.2005		American Journal of Physiology - Endocrinology and Metabolism	Glucose-dependent expansion of pancreatic &#x03b2;-cells by the protein p8 in vitro and in vivo	Path	2006	0		
984	chr19	52344010	52344033	3500012257	23		52344010	52344033	8421504	1	23	0	c	350001225700000012	0-23		10586026		0022-1767	The Journal of Immunology	Characterization of Paired Ig-Like Receptors in Rats	Glynn	1999	6		POTEM
984	chr19	52344011	52344086	3500395013	75		52344011	52344086	8421504	1	75	0	p	350039501300015004	0-75						The role of actin isoforms in somatic embryogenesis in Norway spruce	biomedcentral.com	0	0		ACTG1
984	chr19	52344014	52344719	3500439463	40		52344014	52344719	8421504	2	20,20	0,685	c	350043946300000002,350043946300000003	0-20,0-20		22345865	10.4103/0253-7613.91862		Indian Journal of Pharmacology	Evaluation of anti-inflammatory effects of <i>Broussonetia papyrifera</i> stem bark	Wu	2012	0		
984	chr19	52344014	52344719	3500412688	40		52344014	52344719	8421504	2	20,20	0,685	g	350041268800000012,350041268800000013	0-20,0-20						Soluble Decoy Receptor 3 Induces Angiogenesis by Neutralization of TL1A, a Cytokine Belonging to Tumor Necrosis Factor Superfamily and Exhibiting Angiostatic Action	.aacrjournals.org	0	0		ACTG2
984	chr19	52344014	52344719	3500351244	40		52344014	52344719	8421504	2	20,20	0,685	c	350035124400000002,350035124400000003	0-20,0-20		14602578	10.1152/ajpcell.00283.2003		American Journal of Physiology - Cell Physiology	ATP-dependent regulation of SK4/IK1-like currents in rat submandibular acinar cells: possible role of cAMP-dependent protein kinase	Hayashi	2004	0		SPZ1
984	chr19	52344014	52344719	3500181320	40		52344014	52344719	8421504	2	20,20	0,685	c,g	350018132000000000,350018132000000000,350018132000000001,350018132000000001	0-20,0-20,0-20,0-20						Extracts of polygonum multiflorum thunb., and preparation process and uses of the same	Wu	2007	0		ACTG2
984	chr19	52344014	52344719	3500167143	40		52344014	52344719	8421504	2	20,20	0,685	g	350016714300000002,350016714300000003	0-20,0-20		14602578	10.1152/ajpcell.00283.2003		American Journal of Physiology - Cell Physiolog	ATP-dependent regulation of SK4/IK1-like currents in rat submandibular acinar cells: possible role of cAMP-dependent protein kinase	Hayashi	2004	0		POTEH
984	chr19	52344014	52344719	3500130499	40		52344014	52344719	8421504	2	20,20	0,685	c	350013049900000006,350013049900000007	0-20,0-20			10.1038/sj.bjp.0703375	1476-5381	British Journal of Pharmacology	Pyrimidinoceptor potentiation of macrophage PGE2 release involved in the induction of nitric oxide synthase - Chen - 2009 - British Journal of Pharmacology - Wiley Online Library	Chen	2000	0		POTEM
984	chr19	52344014	52344719	3500118501	40		52344014	52344719	8421504	2	20,20	0,685	c	350011850100000003,350011850100000004	0-20,0-20						ScienceDirect.com - Experimental Cell Research - HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBP&#x03b2;	sciencedirect.com	0	0		ACTA2,ACTG1
984	chr19	52344014	52344037	3500057118	23		52344014	52344037	8421504	1	23	0	c	350005711800000006	0-23						Inhibition of Hepatitis E virus replication using short hairpin RNA (shRNA) | Amit Kumar - Academia.edu	www.academia.edu	0	0		POTEF
984	chr19	52344015	52344651	3500384057	42		52344015	52344651	8421504	3	21,5,16	0,527,620	c	350038405700000002,350038405700000003	0-21,0-21						Bax is downregulated in in&#xfb02;amed colonic mucosa of ulcerative colitis	gut.bmj.com	0	0		
984	chr19	52344015	52344039	3500189624	24		52344015	52344039	8421504	1	24	0	c	350018962400000037	0-24						METHODS AND COMPOSITIONS FOR TREATMENT OF AUTISM	Talalay	2012	0		ACTC1
984	chr19	52344016	52344040	3500204376	24		52344016	52344040	8421504	1	24	0	c	350020437600000007	0-24		19264915	10.2353/ajpath.2009.080592		The American Journal of Pathology	RNA Interference-Mediated Inhibition of Erythropoietin Receptor Expression Suppresses Tumor Growth and Invasiveness in A2780 Human Ovarian Carcinoma Cells	Gyorgy	2009	0		POTEM
984	chr19	52344018	52344138	3500421175	39		52344018	52344138	8421504	2	19,20	0,100	c	350042117500000004,350042117500000005	0-19,0-20						DISSERTATION Molecular Epidemiology, Clinical Molecular Diagnosis and Genetic Diversity of Cutaneous Leishmaniasis in Jericho, Palestine	edoc.hu-berlin.de	0	0		
984	chr19	52344019	52344518	3500040497	41		52344019	52344518	8421504	2	20,21	0,478	c	350004049700000006,350004049700000007	0-20,0-21		19234136	10.2353/ajpath.2009.080079		The American Journal of Pathology	Ezrin-Radixin-Moesin-Binding Phosphoprotein (EBP50), an Estrogen-Inducible Scaffold Protein, Contributes to Biliary Epithelial Cell Proliferation	Laura	2009	0		
984	chr19	52344021	52344111	3500320137	46		52344021	52344111	8421504	2	22,24	0,66	c	350032013700000012,350032013700000013	0-22,0-24						Revista Brasileira de Zootecnia	www.scielo.br	0	0		ACTG1
984	chr19	52344031	52344075	3500350049	42		52344031	52344075	8421504	2	21,21	0,23	c,g	350035004900000005,350035004900000005,350035004900000007,350035004900000007	0-21,0-21,0-21,0-21		16288210	10.1038/sj.onc.1209245	0950-9232	Oncogene	The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus	Marchetti	2005	6		
984	chr19	52344068	52344091	3500070950	23		52344068	52344091	8421504	1	23	0	g	350007095000000001	0-23			10.1046/j.1365-2613.2001.iep0082-0201-x		International Journal of Experimental Pathology	Production and distribution of interleukin 15 and its receptors (IL-15R&#x03b1; and IL-R2&#x03b2;) in the implant interface tissues obtained during revision of failed total joint replacement	S	June	0		POTEJ
984	chr19	52344074	52344098	3500071490	24		52344074	52344098	8421504	1	24	0	c,g	350007149000000011,350007149000000011	0-24,0-24						Human Molecular Genetics	005.pasteur.ac.ir	0	0		CCDC74A
984	chr19	52344082	52344709	3500388350	40		52344082	52344709	8421504	2	20,20	0,607	c,g	350038835000000030,350038835000000032,350038835000000032	0-20,0-20,0-20						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
984	chr19	52344082	52344709	3500357446	40		52344082	52344709	8421504	2	20,20	0,607	c,g	350035744600000007,350035744600000007,350035744600000008	0-20,0-20,0-20						Spatio-Temporal Expression Patterns of Aurora Kinases A, B, and C and Cytoplasmic Polyadenylation-Element-Binding Protein in Bovine Oocytes During Meiotic Maturation	ww.biolreprod.org	0	0		
984	chr19	52344082	52344709	3500027904	40		52344082	52344709	8421504	2	20,20	0,607	c	350002790400000005,350002790400000007	0-20,0-20						 SpringerImages - primers sequences 	pringerimages.com	0	0		
984	chr19	52344083	52344109	3500305811	26		52344083	52344109	8421504	1	26	0	c	350030581100000048	26-52						Polymorphic microsatellite markers in the 100Graphicraft Limited, Hong Kong ornate dragon lizard, Ctenophorus ornatus	ww.chesapeake.org	0	0		
984	chr19	52344083	52344107	3500329425	24		52344083	52344107	8421504	1	24	0	c	350032942500000011	0-24		15901832	10.1091/mbc.E04-11-1029	1059-1524	Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Im	2005	5		
984	chr19	52344092	52344120	3500394813	28		52344092	52344120	8421504	1	28	0	c	350039481300000006	0-28						\\\\set{final} \\\\def\\<BR>uthor{Fernandes} \\\\def\\\\author{fernandes} \\\\def\\\\vol{12} \\\\def\\\\year{2006} \\\\def\\\\anum{17	www.molvis.org	0	0		ACTG1
984	chr19	52344092	52344120	3500274474	28		52344092	52344120	8421504	1	28	0	c	350027447400000006	0-28						Oxidative stress upregulates the ubiquitin proteasome pathway in retinal endothelial cells	www.molvis.org	0	0		ACTG1
984	chr19	52344097	52344121	3500328421	24		52344097	52344121	8421504	1	24	0	c	350032842100000008,350032842100000057	0-24,0-23					Patent	Methods relating to disorders associated with abnormal phosphate metabolism (Patent EP:1745151)	Bergman	2009	0		ACTG1
984	chr19	52344097	52344121	3500019395	24		52344097	52344121	8421504	1	24	0	c	350001939500000008	0-24						Compositions And Methods For Treating Disorders Associated With Abnormal Phosphate Metabolism 	.freshpatents.com	0	0		ACTG1
984	chr19	52344102	52344126	3500284416	24		52344102	52344126	8421504	1	24	0	c	350028441600000001	21-45						Methods and treatments for corneal healing with growth factors - Patent # 5703047 - PatentGenius	.patentgenius.com	0	0		
984	chr19	52344106	52344129	3500441760	23		52344106	52344129	8421504	1	23	0	g	350044176000000006	0-23						Endocrine therapy resistance can be associated with high estrogen receptor a (ERa) expression and reduced ERa phosphorylation in breast cancer models	logy-journals.org	0	0		ACTG1
984	chr19	52344106	52344129	3500266398	23		52344106	52344129	8421504	1	23	0	g	350026639800000000	0-23						Entwicklung eines gewebenahen Konstruktes aus einer Matrix mit in vitro kultivierten Fibroblasten und Keratinozyten zum Ersatz der Oralmukosa unter Einsatz von Tissue Engineering	.uni-wuerzburg.de	0	0		
984	chr19	52344106	52344129	3500210308	23		52344106	52344129	8421504	1	23	0	c,g	350021030800000006,350021030800000006	0-23,0-23						endocrine therapy resistance can be associated with high estrogen receptor (er) expression and reduced er phosphorylation in breast cancer models - &#x671f;&#x520a;&#x6742;&#x5fd7;|&#x514d;&#x8d39;&#x6742;&#x5fd7;|&#x7535;&#x5b50;&#x6742;&#x5fd7;|&#x6742;	qkzz.net/article/	0	0		ACTG1
984	chr19	52344106	52344129	3500014892	23		52344106	52344129	8421504	1	23	0	c	350001489200000002	0-23		19193763	10.1091/mbc.E08-12-1196	1059-1524	Molecular Biology of the Cell	Loss of E-Cadherin&#x2013;mediated Cell&#x2013;Cell Contacts Activates a Novel Mechanism for Up-Regulation of the Proto-Oncogene c-Jun	Knirsh	2009	5		ACTG1
984	chr19	52344110	52344134	3500416197	24		52344110	52344134	8421504	1	24	0	c	350041619700000010	0-24		14532290	10.1074/jbc.M307332200	0021-9258	Journal of Biological Chemistry	Down-regulation of Sp1 Activity through Modulation of O-Glycosylation by Treatment with a Low Glucose Mimetic, 2-Deoxyglucose	Kang	2003	5		ACTG1
984	chr19	52344111	52344137	3500042724	26		52344111	52344137	8421504	1	26	0	c	350004272400000005	0-26		19276188	10.1158/1541-7786.MCR-08-0056	1541-7786	Molecular Cancer Research	p31comet Induces Cellular Senescence through p21 Accumulation and Mad2 Disruption	Yun	2009	4		ACTG1
984	chr19	52344116	52344742	3500061027	40		52344116	52344742	8421504	2	20,20	0,606	c,g	350006102700000002,350006102700000003,350006102700000003	0-20,0-20,0-20		9108393		0006-4971	Blood	Selective Expression of the Receptor Tyrosine Kinase, HTK, on Human Erythroid Progenitor Cells	Inada	1997	10		
984	chr19	52344116	52344739	3500426273	64		52344116	52344739	8421504	3	20,20,24	0,294,599	c	350042627300000005,350042627300000006,350042627300000023	0-20,0-20,0-24						Forkhead transcription factor FOXO1A is critical for induction of human decidualization	logy-journals.org	0	0		
984	chr19	52344116	52344139	3500287770	23		52344116	52344139	8421504	1	23	0	c	350028777000000001	0-23						ScienceDirect.com - International Immunopharmacology - Withaferin A down-regulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1/3 activation in microglial cells	sciencedirect.com	0	0		POTEF
984	chr19	52344117	52344255	3500231449	42		52344117	52344255	8421504	2	21,21	0,117	c	350023144900000002,350023144900000003	0-21,0-21						Activation of the N-Ras-PI3K-Akt-mTOR Pathway by Hepatitis C Virus: Control of Cell Survival and Viral Replication - Keeping the Faith	pthefaith1296.com	0	0		ACTB
984	chr19	52344117	52344255	3500026467	42		52344117	52344255	8421504	2	21,21	0,117	c	350002646700000002,350002646700000003	0-21,0-21		15994768	10.1128/JVI.79.14.8742-8749.2005	0022-538X	Journal of Virology	Activation of the N-Ras&#x2013;PI3K&#x2013;Akt-mTOR Pathway by Hepatitis C Virus: Control of Cell Survival and Viral Replication	Mannova	2005	5		
984	chr19	52344118	52344742	3500010258	43		52344118	52344742	8421504	2	20,23	0,601	c	350001025800000006,350001025800000011	0-20,0-23			10.1124/jpet.107.124545	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Stimulation of the P2Y1 Receptor Up-Regulates Nucleoside-Triphosphate Diphosphohydrolase-1 in Human Retinal Pigment Epithelial Cells	Lu	2007	0		POTEE
984	chr19	52344118	52344717	3500433113	40		52344118	52344717	8421504	2	20,20	0,579	c	350043311300000004,350043311300000005	0-20,0-20		20003467	10.1186/1756-9966-28-154	1756-9966	Journal of Experimental & Clinical Cancer Research	Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway	Liu	2009	2		ACTG1
984	chr19	52344118	52344253	3500171876	40		52344118	52344253	8421504	2	20,20	0,115	c	350017187600000008,350017187600000009	0-20,0-20						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
984	chr19	52344155	52344179	3500020989	24		52344155	52344179	8421504	1	24	0	c	350002098900000007	0-24		18368035	10.1038/npp.2008.36	0893-133X	Neuropsychopharmacology	Neonatal Isolation Delays the Developmental Decline of Long-Term Depression in the CA1 Region of Rat Hippocampus	Ku	2008	8		
984	chr19	52344162	52344416	3500329598	41		52344162	52344416	8421504	2	20,21	0,233	c	350032959800000002,350032959800000003	0-20,0-21		10589684		1046-6673	Journal of the American Society of Nephrology	Calcitonin Induces 25-Hydroxyvitamin D3 1&#x03b1;-Hydroxylase mRNA Expression via Protein Kinase C Pathway in LLC-PK1 Cells	YOSHIDA	1999	10		SPZ1
984	chr19	52344162	52344186	3500186925	24		52344162	52344186	8421504	1	24	0	c	350018692500000002	0-24		9357851			American Journal of Physiology - Lung Cellular and Molecular Physiology	Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells	Michael	1997	0		ACTB
984	chr19	52344191	52344432	3500258576	50		52344191	52344432	8421504	2	25,25	0,216	c	350025857600000000,350025857600000001	0-25,0-25		16455633		0161-5505	Journal of Nuclear Medicine	Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct	Padmanabhan	2006	6		ACTG1
984	chr19	52344191	52344430	3500054213	48		52344191	52344430	8421504	2	25,23	0,216	c	350005421300000002,350005421300000003	0-25,0-23		12183409		0008-5472	Cancer Research	Telomerase Is Regulated by c-Jun NH2-Terminal Kinase in Ovarian Surface Epithelial Cells	Matte	2002	8		ACTG1
984	chr19	52344192	52344217	3500008149	25		52344192	52344217	8421504	1	25	0	c	350000814900000034	0-25						US Patent # 6,593,086. Nucleic acid amplification methods - Patents.com	www.patents.com	0	0		ACTG1
984	chr19	52344194	52344217	3500193567	23		52344194	52344217	8421504	1	23	0	c	350019356700000001	0-23		18322024	10.1152/ajprenal.00025.2007		American Journal of Physiology - Renal Physiology	Mechanisms underlying the long-term regulation of NHE3 by parathyroid hormone	Bezerra	2008	0		
984	chr19	52344197	52344743	3500452577	49		52344197	52344743	8421504	2	25,24	0,522	c	350045257700000017,350045257700000008,350045257700000018,350045257700000009	0-25,0-25,0-19,0-24						US Patent # 7,396,537. Cell delivery patch for myocardial tissue engineering - Patents.com	www.patents.com	0	0		
984	chr19	52344197	52344432	3500100725	45		52344197	52344432	8421504	2	25,20	0,215	c,g	350010072500000002,350010072500000002,350010072500000005,350010072500000005,350010072500000001,350010072500000001,350010072500000004,350010072500000004	0-25,0-25,0-25,0-25,0-20,0-20,0-20,0-20						Inhibition of mRNA Interferase-Induced Apoptosis in BAK-Deficient and BAK- and Bax-Deficient Mammalian Cells - Patent application	www.faqs.org	0	0		ACTG1
984	chr19	52344199	52344407	3500332182	65		52344199	52344407	8421504	4	21,10,12,22	0,49,166,186	c	350033218200000017,350033218200000019,350033218200000018	0-21,7-29,0-22						Molecular biology of channel cat&#xfb01;sh brain cytochrome P450 aromatase (CYP19A2): cloning, preovulatory induction of gene expression, hormonal gene regulation and analysis of promoter region	logy-journals.org	0	0		
984	chr19	52344201	52344226	3500447150	25		52344201	52344226	8421504	1	25	0	c	350044715000000005	0-25			10.1002/ijc.20719	1097-0215	International Journal of Cancer	Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines - Fujii - 2004 - International Journal of Cancer - Wiley Online Library	Fujii	2005	0		ACTG2
984	chr19	52344201	52344226	3500375972	25		52344201	52344226	8421504	1	25	0	c	350037597200000012,350037597200000001	0-25,0-25						Polytpeptide Specific To Liver Cancer, Polynucleotide Coding For The Polypeptide, And Rna Molecule Inhibiting Expression Of The Polypeptide 	.freshpatents.com	0	0		ACTG2
984	chr19	52344201	52344226	3500343890	25		52344201	52344226	8421504	1	25	0	c	350034389000000003	0-25						ABCA-1 Elevating compounds	Ibrahim	2002	0		ACTG1
984	chr19	52344201	52344226	3500244961	25		52344201	52344226	8421504	1	25	0	c	350024496100000005	0-25						Abca-1 elevating compounds against coronary artery disease or atherosclerosis	Mai Ke Er *Kang Pu Bei Er 	2004	0		ACTG1
984	chr19	52344201	52344226	3500218177	25		52344201	52344226	8421504	1	25	0	c	350021817700000006	0-25						SCREEN FOR INHIBITORS OF HIV REPLICATION - Patent application	www.faqs.org	0	0		ACTB
984	chr19	52344201	52344226	3500127733	25		52344201	52344226	8421504	1	25	0	c	350012773300000003	0-25					Patent	ABCA-1 elevating compounds (Patent US:6919339)	Campbell	2005	0		ACTG1
984	chr19	52344201	52344226	3500124469	25		52344201	52344226	8421504	1	25	0	c	350012446900000003	0-25						ABCA-1 elevating compounds	Campbell	2002	0		ACTG1
984	chr19	52344201	52344226	3500115208	25		52344201	52344226	8421504	1	25	0	c	350011520800000003	0-25					Patent	ABCA-1 elevating compounds (Patent US:6919339)	Campbell	2005	0		ACTB,ACTG1
984	chr19	52344201	52344226	3500065080	25		52344201	52344226	8421504	1	25	0	c	350006508000000007	0-25		19324905	10.1182/blood-2008-10-186403		Blood	Induction of CCL20 production by Kaposi sarcoma&#x2013;associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-&#x03ba;B activation	Vasu	2009	0		ACTB,ACTG1
984	chr19	52344201	52344226	3500054151	25		52344201	52344226	8421504	1	25	0	c	350005415100000009	0-25		23928703	10.1038/cddis.2013.270	false	Cell Death & Disease	Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling	Lin	2013	0		ACTG1
984	chr19	52344202	52344228	3500330141	26		52344202	52344228	8421504	1	26	0	c	350033014100000012	22-48						Expression of voltage-gated sodium channel subunit in human ovarian cancer	-publications.com	0	0		ACTG1
984	chr19	52344202	52344226	3500376295	24		52344202	52344226	8421504	1	24	0	c	350037629500000003	0-24						Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants	Baroni	2008	0		ACTG1
984	chr19	52344233	52344730	3500338475	44		52344233	52344730	8421504	2	22,22	0,475	c	350033847500000004,350033847500000005	0-22,0-22		10710532			American Journal of Physiology - Lung Cellular and Molecular Physiology	MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells	Nasreen	2000	0		
984	chr19	52344233	52344386	3500037949	41		52344233	52344386	8421504	2	22,19	0,134	c	350003794900000012,350003794900000003	0-22,0-19		21216957	10.1074/jbc.M110.185124		The Journal of Biological Chemistry	EZH2 Regulates Neuronal Differentiation of Mesenchymal Stem Cells through PIP5K1C-dependent Calcium Signaling	Yung-Luen	2011	0		
984	chr19	52344245	52344404	3500157784	48		52344245	52344404	8421504	3	13,13,22	0,120,137	c	350015778400000002,350015778400000001	0-26,0-22		18685126	10.1095/biolreprod.108.070052	0006-3363	Biology of Reproduction	Japanese Eel Follicle-Stimulating Hormone (Fsh) and Luteinizing Hormone (Lh): Production of Biologically Active Recombinant Fsh and Lh by Drosophila S2 Cells and Their Differential Actions on the Reproductive Biology	Kazeto	2008	4		
984	chr19	52344394	52344418	3500002875	24		52344394	52344418	8421504	1	24	0	c	350000287500000002	9-33						TAMPONAMENTO CECAL: ASPECTOS CL&#xcd;NICO, FISIOPATOL&#xd3;GICO E TERAP&#xca;UTICO NA LAMINITE EXPERIMENTAL EM EQ&#xdc;INOS.	www.fcav.unesp.br	0	0		RBP2,ACTG1
984	chr19	52344398	52344422	3500058790	24		52344398	52344422	8421504	1	24	0	c	350005879000000015	0-24						Cellular and molecular studies of the initial process of the photodynamic therapy in HEp-2 cells using LED light source and two different photosensitizers	AHA	2009	0		
984	chr19	52344399	52344422	3500097264	23		52344399	52344422	8421504	1	23	0	c	350009726400000013	0-23						Detection of cytomegalovirus dna using amplification from blood samples	Baker	2013	0		
984	chr19	52344400	52344735	3500333221	62		52344400	52344735	8421504	3	20,22,20	0,291,315	c	350033322100000014,350033322100000007,350033322100000015	0-20,0-22,0-20						CLIC4 mediates TGF-&#xdf;1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer	-publications.com	0	0		
984	chr19	52344400	52344735	3500301323	41		52344400	52344735	8421504	2	21,20	0,315	c,g	350030132300000035,350030132300000035,350030132300000036	0-21,0-21,0-20						Echinococcus multilocularis influence-t-il l'&#xe9;quilibre m&#xe9;tabolique 	www.docstoc.com	0	0		
984	chr19	52344400	52344735	3500268442	40		52344400	52344735	8421504	2	20,20	0,315	c	350026844200000002,350026844200000003	0-20,0-20						Effect of Smilax china L.-containing serum on the expression of POLD1 mRNA in human hepatocarcinoma SMMC-7721 cells	-publications.com	0	0		
984	chr19	52344400	52344735	3500125762	40		52344400	52344735	8421504	2	20,20	0,315	c	350012576200000012,350012576200000013	0-20,0-20						Molecular Cancer BioMed Central	ecular-cancer.com	0	0		SPZ1
984	chr19	52344400	52344722	3500389774	41		52344400	52344722	8421504	2	21,20	0,302	c,g	350038977400000008,350038977400000008,350038977400000009,350038977400000009	0-21,0-21,0-20,0-20						mRNA and microRNA quality control for RT-qPCR analysis	uantification.com	0	0		ACTB
984	chr19	52344400	52344722	3500362403	41		52344400	52344722	8421504	2	21,20	0,302	c,g	350036240300000002,350036240300000002,350036240300000003,350036240300000003	0-21,0-21,0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
984	chr19	52344400	52344722	3500107315	41		52344400	52344722	8421504	2	21,20	0,302	c	350010731500000008,350010731500000009	0-21,0-20						mRNA and microRNA quality control for RT-qPCR analysis	uantification.net	0	0		
984	chr19	52344400	52344722	3500040185	42		52344400	52344722	8421504	2	22,20	0,302	c	350004018500000000,350004018500000001	0-22,0-20						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
984	chr19	52344401	52344738	3500301089	42		52344401	52344738	8421504	2	21,21	0,316	c,g	350030108900000000,350030108900000000,350030108900000001,350030108900000001	0-21,0-21,0-21,0-21		21151495	10.1371/journal.pone.0015080		PLoS ONE	The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN&#x03b1; Production	Irene	2010	0		
984	chr19	52344401	52344738	3500173979	42		52344401	52344738	8421504	2	21,21	0,316	c,g	350017397900000000,350017397900000000,350017397900000001	0-21,0-21,0-21			10.1136/ard.2003.012211	1468-2060	Annals of the Rheumatic Diseases	Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages	Vossenaar	2004	0		
984	chr19	52344401	52344738	3500072883	42		52344401	52344738	8421504	2	21,21	0,316	c,g	350007288300000000,350007288300000000,350007288300000001,350007288300000001	0-21,0-21,0-21,0-21			10.1136/ard.2003.012211	1468-2060	Annals of the Rheumatic Diseases	Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages	Vossenaar	2004	0		
984	chr19	52344402	52344513	3500079000	43		52344402	52344513	8421504	2	21,22	0,89	c,g	350007900000000003,350007900000000004,350007900000000004	0-21,0-22,0-22						Transduction of Hepatocytes after Neonatal Delivery of a Moloney Murine&#xde;&#xb1;&#xc7;&#xb4;^ {'&#xbd;[k &#xc5;&#xe1; jvAny&#xad; &#xb2;L&#xc0;n &#xc7;'&#xa6;&#xea;@&#xe7;|&#xb3;v&#xf9;&#xe9;&#xf5;&#xf0;&#xf1;&#xfe;E&#xed;&#xf7;&#xd2;&#xa9;&#xc5; k-S &	dasher.wustl.edu	0	0		
984	chr19	52344402	52344426	3500333912	24		52344402	52344426	8421504	1	24	0	c	350033391200000002	0-24		20231287	10.1074/jbc.M109.078592	0021-9258	Journal of Biological Chemistry	Role for the Proapoptotic Factor BIM in Mediating Imatinib-induced Apoptosis in a c-KIT-dependent Gastrointestinal Stromal Tumor Cell Line	Gordon	2010	5		ACTG1
984	chr19	52344403	52344723	3500119294	40		52344403	52344723	8421504	2	20,20	0,300	c,g	350011929400000002,350011929400000002,350011929400000003	0-20,0-20,0-20		21454520	10.1074/jbc.M111.231639	0021-9258	Journal of Biological Chemistry	Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth Suppression	Yan	2011	5		
984	chr19	52344403	52344645	3500442843	42		52344403	52344645	8421504	3	20,12,10	0,132,232	c,g	350044284300000009,350044284300000010	0-20,0-22						Effects of transgenic overexpression of polysialyltransferase (PST) on myelination and impacts of increased sulfatide accumulation in arylsulfatase A deficient mice and its relevance to human metachromatic leukodystrophy	s.ulb.uni-bonn.de	0	0		
984	chr19	52344404	52344717	3500229458	40		52344404	52344717	8421504	2	20,20	0,293	c,g	350022945800000007,350022945800000007,350022945800000008	0-20,0-20,0-20						Journal of Ethnopharmacology	.researchgate.net	0	0		
984	chr19	52344404	52344642	3500369617	44		52344404	52344642	8421504	3	21,16,7	0,127,231	c	350036961700000000,350036961700000001	0-21,0-23		17971789	10.1038/sj.jcbfm.9600573	0271-678X	Journal of Cerebral Blood Flow & Metabolism	Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke	Teng	2007	5		
984	chr19	52344404	52344431	3500384570	27		52344404	52344431	8421504	1	27	0	c,g	350038457000000002,350038457000000002	0-27,0-27						Electron microscopic investigation of cytomegalovirus egress after high-pressure freezing, freeze-substitution and plastic embedding	vts.uni-ulm.de	0	0		ACTB
984	chr19	52344406	52344745	3500157709	42		52344406	52344745	8421504	2	21,21	0,318	c	350015770900000009,350015770900000010	0-21,0-21		16909123	10.1038/sj.onc.1209819	0950-9232	Oncogene	Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter	Delarue	2006	6		
984	chr19	52344406	52344430	3500252094	24		52344406	52344430	8421504	1	24	0	g	350025209400000010	0-24						Characterization of transcriptional regulation of neurogranin by nitric oxide and the role of neurogranin in SNP-induced cell death: implication of neurogranin in an increased neuronal susceptibility to oxidative stress	www.ijbs.com	0	0		ACTG1
984	chr19	52344407	52344777	3500437178	46		52344407	52344777	8421504	2	23,23	0,347	c	350043717800000002,350043717800000003	0-23,0-23						Ibogaine Scientific Literature Overview	iceers.org/docs/s	0	0		ACTG1
984	chr19	52344407	52344651	3500412489	47		52344407	52344651	8421504	3	23,8,16	0,132,228	c	350041248900000002,350041248900000003	0-23,0-24						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		
984	chr19	52344407	52344651	3500410631	47		52344407	52344651	8421504	3	23,8,16	0,132,228	c,g	350041063100000008,350041063100000009	0-23,0-24		23115281	10.1128/JVI.01851-12	0022-538X	Journal of Virology	The Viral Interferon Regulatory Factors of Kaposi's Sarcoma-Associated Herpesvirus Differ in Their Inhibition of Interferon Activation Mediated by Toll-Like Receptor 3	Jacobs	2013	5		
984	chr19	52344407	52344651	3500340573	42		52344407	52344651	8421504	3	20,6,16	0,134,228	c	350034057300000006,350034057300000007	0-20,0-22						RESEARCH Open Access HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia	biomedcentral.com	0	0		
984	chr19	52344407	52344651	3500340555	47		52344407	52344651	8421504	3	23,8,16	0,132,228	c	350034055500000004,350034055500000005	0-23,0-24						IDENTIFICATION AND TREATMENT OF CANCER SUBSETS	Bittner	2011	0		
984	chr19	52344407	52344651	3500283250	47		52344407	52344651	8421504	3	23,8,16	0,132,228	c,g	350028325000000002,350028325000000003	0-23,0-24			10.3748/wjg.15.1719		World Journal of Gastroenterology : WJG	Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer	Tie-Li	2009	0		ACTB
984	chr19	52344407	52344651	3500195971	47		52344407	52344651	8421504	3	23,8,16	0,132,228	c,g	350019597100000002,350019597100000003	0-23,0-24						World J Gastroenterol	www.wjgnet.com	0	0		
984	chr19	52344407	52344646	3500052856	44		52344407	52344646	8421504	3	22,11,11	0,129,228	c	350005285600000007,350005285600000009	0-22,0-22						Inhibition of urokinase-type plasminogen activator (uPA) activity	Bazan	2008	0		
984	chr19	52344407	52344432	3500121090	25		52344407	52344432	8421504	1	25	0	c	350012109000000013	0-25		12620891	10.1152/ajpcell.00322.2002		American Journal of Physiology - Cell Physiolog	Activation of gene expression in human neutrophils by high mobility group box 1 protein	Park	2003	0		TMEM222
984	chr19	52344407	52344432	3500045478	25		52344407	52344432	8421504	1	25	0	c	350004547800000002	0-25			10.1038/sj.bjp.0705249	1476-5381	British Journal of Pharmacology	Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by &#x03b1;2-adrenoceptors in the presence of experimental colitis - Blandizzi - 2009 - British Journal of Pharmacology - Wiley Online Library	Blandizzi	2003	0		ACTG1
984	chr19	52344407	52344432	3500038208	25		52344407	52344432	8421504	1	25	0	c	350003820800000004	0-25		16227395	10.1158/1535-7163.MCT-05-0198	1535-7163	Molecular Cancer Therapeutics	Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1&#x03b1; and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells	Zhang	2005	5		ACTG1
984	chr19	52344407	52344430	3500334107	23		52344407	52344430	8421504	1	23	0	c	350033410700000004	0-23		14694089	10.1128/JVI.78.2.576-584.2004	0022-538X	Journal of Virology	Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by a Retrovirus	Burzyn	2004	5		TMEM222
984	chr19	52344407	52344430	3500221815	23		52344407	52344430	8421504	1	23	0	c	350022181500000000	0-23						Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin	-publications.com	0	0		ACTG1
984	chr19	52344407	52344430	3500146034	23		52344407	52344430	8421504	1	23	0	c	350014603400000016	0-23		19864562	10.1523/JNEUROSCI.2243-09.2009		The Journal of neuroscience : the official journal of the Society for Neuroscience	ENDOGENOUS BDNF IN THE DORSOLATERAL STRIATUM GATES ALCOHOL DRINKING	Jerome	2009	0		ACTG2
984	chr19	52344407	52344430	3500015168	23		52344407	52344430	8421504	1	23	0	c	350001516800000004	0-23			10.1128/JVI.78.2.576-584.2004		Journal of Virology	Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by a Retrovirus	Dalia	2004	0		ACTB
984	chr19	52344409	52344729	3500179866	45		52344409	52344729	8421504	2	23,22	0,298	c	350017986600000008,350017986600000009	0-23,0-22		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		ACTB
984	chr19	52344410	52344744	3500252270	40		52344410	52344744	8421504	2	20,20	0,314	c,g	350025227000000002,350025227000000003,350025227000000003	0-20,0-20,0-20		11049992		0006-4971	Blood	Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease	Sumegi	2000	10		ACTB
984	chr19	52344410	52344649	3500157605	40		52344410	52344649	8421504	3	20,6,14	0,131,225	c,g	350015760500000004,350015760500000004,350015760500000005	0-20,0-20,0-20		24040035	10.1371/journal.pone.0073710		PLoS ONE	Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer	Kyle	2013	0		ACTB
984	chr19	52344410	52344649	3500101311	40		52344410	52344649	8421504	3	20,6,14	0,131,225	c,g	350010131100000003,350010131100000004	0-20,0-20						Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells	Agarwal	2009	0		ACTB
984	chr19	52344413	52344436	3500076124	23		52344413	52344436	8421504	1	23	0	c	350007612400000014	0-24		23441154	10.1371/journal.pone.0055714		PLoS ONE	Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer	Xiao-Min	2013	0		
984	chr19	52344429	52344452	3500423772	23		52344429	52344452	8421504	1	23	0	c	350042377200000007	0-23						Food-deprivation induces chronic stress and affects thyroid hormone metabolism in Senegalese sole (Solea senegalensis ) post-larvae	digital.csic.es	0	0		ACTC1
984	chr19	52344429	52344452	3500323429	23		52344429	52344452	8421504	1	23	0	c	350032342900000007	0-23						ScienceDirect.com - Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology - Food deprivation induces chronic stress and affects thyroid hormone metabolism in Senegalese sole (Solea senegalensis) post-larvae	sciencedirect.com	0	0		
984	chr19	52344436	52344459	3500154520	23		52344436	52344459	8421504	1	23	0	c	350015452000000002	0-23						4 THE USE OF FISH CELL LINES TO INVESTIGATE LCPUFA SYNTHESIS	s.flinders.edu.au	0	0		
984	chr19	52344442	52344468	3500405538	26		52344442	52344468	8421504	1	26	0	c	350040553800000018	0-26						<?xml version="1.0" encoding="US-ASCII"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing	ke.sciencemag.org	0	0		
984	chr19	52344485	52344508	3500340259	23		52344485	52344508	8421504	1	23	0	c	350034025900000004	21-44						&#x4e3b;&#x9898;&#xff1a;mRNA | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
984	chr19	52344486	52344509	3500291450	23		52344486	52344509	8421504	1	23	0	c	350029145000000007	0-23						BMC Biochemistry BioMed Central	biomedcentral.com	0	0		ACTG2
984	chr19	52344487	52344732	3500288228	69		52344487	52344732	8421504	4	21,5,17,26	0,55,148,219	c,g	350028822800000012,350028822800000012,350028822800000013,350028822800000016	0-21,0-21,0-22,0-26						mRNA and 18S&#x2013;RNA coapplication&#x2013;reverse transcription for quantitative gene expression analysis	uantification.com	0	0		
984	chr19	52344487	52344652	3500425894	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c,g	350042589400000003,350042589400000003,350042589400000004	0-21,0-21,0-22						Npc1l1 (npc3) and methods of use thereof	Altmann	2004	0		
984	chr19	52344487	52344652	3500384813	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c,g	350038481300000003,350038481300000003,350038481300000004	0-21,0-21,0-22						Npc1l1 (npc3) and methods of identifying ligands thereof	Garcia-Calvo	2006	0		
984	chr19	52344487	52344652	3500366606	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c,g	350036660600000003,350036660600000003,350036660600000004	0-21,0-21,0-22						NPC1L1 (NPC3) and methods of identifying ligands thereof	Garcia-calvo	2005	0		
984	chr19	52344487	52344652	3500333989	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c	350033398900000003,350033398900000004	0-21,0-22						Npc1l1 (npc3) and methods of use thereof	Altmann	2004	0		
984	chr19	52344487	52344652	3500282518	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c	350028251800000003,350028251800000004	0-21,0-22					Patent	NPC1L1 (NPC3) and methods of identifying ligands thereof (Patent US:7901893)	Garcia-Calvo	2011	0		
984	chr19	52344487	52344652	3500229213	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c	350022921300000003,350022921300000004	0-21,0-22						Npc1l1 (npc3) and methods of identifying ligands thereof	Garcia-Calvo	2008	0		
984	chr19	52344487	52344652	3500196028	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c	350019602800000003,350019602800000004	0-21,0-22						NPC1L1 (NPC3) and methods of use thereof	Altmann	2003	0		
984	chr19	52344487	52344652	3500160881	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c	350016088100000003,350016088100000004	0-21,0-22						Npc1l1 (npc3) and methods of identifying ligands thereof	Garcia-Calvo	2005	0		
984	chr19	52344487	52344652	3500137156	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c	350013715600000003,350013715600000004	0-21,0-22						Npcil1 (Npc3) And Methods Of Identifying Ligands Thereof	Garcia-Calvo	2010	0		
984	chr19	52344487	52344652	3500072425	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c	350007242500000003,350007242500000004	0-21,0-22						Npc1l1 (npc3) and methods of use thereof	Altmann	2005	0		
984	chr19	52344487	52344652	3500010704	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c	350001070400000003,350001070400000004	0-21,0-22						Npc1l1 (npc3) and methods of use thereof	Altmann	2006	0		
984	chr19	52344487	52344652	3500007696	43		52344487	52344652	8421504	3	21,5,17	0,55,148	c,g	350000769600000003,350000769600000003,350000769600000004	0-21,0-21,0-22						Npc1l1 (npc3) and methods of use thereof	Altmann	2005	0		
984	chr19	52344488	52344735	3500439100	48		52344488	52344735	8421504	2	24,24	0,223	c	350043910000000010,350043910000000011	0-24,0-24		22142890	10.1016/j.jaut.2011.11.001		Journal of Autoimmunity	Environmental Exposure, Estrogen and Two X Chromosomes are Required for Disease Development in an Epigenetic Model of Lupus	Faith	2012	0		
984	chr19	52344488	52344735	3500332189	48		52344488	52344735	8421504	2	24,24	0,223	c	350033218900000000,350033218900000001	0-24,0-24		20427713	10.1152/ajpcell.00550.2009		American Journal of Physiology - Cell Physiolog	Ca2+ release from the sarcoplasmic reticulum is required for sustained TRPM4 activity in cerebral artery smooth muscle cells	Gonzales	2010	0		
984	chr19	52344488	52344735	3500048031	48		52344488	52344735	8421504	2	24,24	0,223	c	350004803100000011,350004803100000012	0-24,0-24		19779014	10.1152/ajpgi.00165.2009		American Journal of Physiology - Gastrointestinal and Liver Physiology	Alternative promoter and GATA5 transcripts in mouse	Chen	2009	0		
984	chr19	52344488	52344735	3500011339	48		52344488	52344735	8421504	2	24,24	0,223	c	350001133900000011,350001133900000012	0-24,0-24		19779014	10.1152/ajpgi.00165.2009		American Journal of Physiology - Gastrointestinal and Liver Physiology	Alternative promoter and GATA5 transcripts in mouse	Bohao	2009	0		
984	chr19	52344488	52344513	3500224326	25		52344488	52344513	8421504	1	25	0	c	350022432600000011	5-30		19657116	10.1182/blood-2008-11-189308	0006-4971	Blood	Inhibition of the SDF-1&#x03b1;&#x2013;CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice	Kawaguchi	2009	10		
984	chr19	52344488	52344512	3500180330	24		52344488	52344512	8421504	1	24	0	c	350018033000000000	0-24		20610768	10.1152/ajpcell.00101.2010		American Journal of Physiology - Cell Physiolog	Vasoconstriction resulting from dynamic membrane trafficking of TRPM4 in vascular smooth muscle cells	Crnich	2010	0		
984	chr19	52344488	52344512	3500010242	24		52344488	52344512	8421504	1	24	0	c	350001024200000000	0-24		20610768	10.1152/ajpcell.00101.2010		American Journal of Physiology - Cell Physiology	Vasoconstriction resulting from dynamic membrane trafficking of TRPM4 in vascular smooth muscle cells	RachaCrnich	2010	0		ACTG1
984	chr19	52344488	52344511	3500166288	23		52344488	52344511	8421504	1	23	0	c	350016628800000008	0-23						UCP5	Adams	2008	0		
984	chr19	52344491	52344655	3500060224	44		52344491	52344655	8421504	3	20,4,20	0,52,144	c	350006022400000007,350006022400000009	0-20,0-24						TESTING FOR PARTIAL AGONISM OF THE ARYL HYDROCARBON RECEPTOR	.nottingham.ac.uk	0	0		
984	chr19	52344491	52344515	3500439989	24		52344491	52344515	8421504	1	24	0	c	350043998900000005	0-24						P-cadherin as a target for anti-cancer therapy	Reinhard	2005	0		
984	chr19	52344491	52344515	3500433284	24		52344491	52344515	8421504	1	24	0	c	350043328400000003	0-24						Materials And Methods Relating To Breast Cancer Classification 	.freshpatents.com	0	0		ACTG1
984	chr19	52344491	52344515	3500365262	24		52344491	52344515	8421504	1	24	0	c	350036526200000007	0-24		18559507	10.1158/0008-5472.CAN-07-5870	0008-5472	Cancer Research	Integrative Genomics Identifies RAB23 as an Invasion Mediator Gene in Diffuse-Type Gastric Cancer	Hou	2008	8		
984	chr19	52344491	52344515	3500213142	24		52344491	52344515	8421504	1	24	0	c	350021314200000002	0-24						The occurrence of Chlamydia spp. in pigs with and without clinical disease	biomedcentral.com	0	0		AMY2B
984	chr19	52344492	52344515	3500047565	23		52344492	52344515	8421504	1	23	0	c	350004756500000017,350004756500000007	0-23,0-23						PREVENTING OR REDUCING OXIDATIVE STRESS OR OXIDATIVE CELL INJURY - Patent application	www.faqs.org	0	0		
984	chr19	52344493	52344730	3500295781	40		52344493	52344730	8421504	2	20,20	0,217	c	350029578100000002,350029578100000003	0-20,0-20		22302519	10.1002/nbm.2776		NMR in biomedicine	Early prediction of response to Vorinostat in an orthotopic glioma rat model	Li	2012	0		
984	chr19	52344493	52344729	3500361779	39		52344493	52344729	8421504	3	20,11,8	0,216,228	c	350036177900000017,350036177900000025	0-20,0-19					Patent	Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases (Patent US:8383112)	Eriksson	2013	0		
984	chr19	52344493	52344729	3500275199	39		52344493	52344729	8421504	3	20,11,8	0,216,228	c	350027519900000017,350027519900000025	0-20,0-19						Targeting VEGF-B Regulation Of Fatty Acid Transporters To Modulate Human Diseases	Eriksson	2009	0		ACTB
984	chr19	52344493	52344729	3500254360	39		52344493	52344729	8421504	3	20,11,8	0,216,228	c	350025436000000017,350025436000000025	0-20,0-19						Targeting vegf-b regulation of fatty acid transporters to modulate human diseases	Eriksson	2012	0		
984	chr19	52344493	52344729	3500249255	39		52344493	52344729	8421504	3	20,11,8	0,216,228	c	350024925500000017,350024925500000025	0-20,0-19						Targeting vegf-b regulation of fatty acid transporters to modulate human diseases	Eriksson	2013	0		
984	chr19	52344493	52344729	3500165364	39		52344493	52344729	8421504	3	20,11,8	0,216,228	c	350016536400000017,350016536400000025	0-20,0-19						TARGETING VEGF-B REGULATION OF FATTY ACID TRANSPORTERS TO MODULATE HUMAN DISEASES - Patent application	www.faqs.org	0	0		
984	chr19	52344493	52344727	3500459704	40		52344493	52344727	8421504	2	20,20	0,214	c,g	350045970400000003,350045970400000004	0-20,0-20			10.1124/mol.65.3.720	1521-0111 (Online)	Molecular Pharmacology	Dehydroepiandrosterone Sulfotransferase Is a Target for Transcriptional Induction by the Vitamin D Receptor	Echchgadda	2004	0		AMY2B
984	chr19	52344493	52344727	3500361857	39		52344493	52344727	8421504	2	20,19	0,215	c	350036185700000007,350036185700000006	0-20,0-19						Impact of bile acids on the growth of human cholangiocarcinoma via FXR	biomedcentral.com	0	0		
984	chr19	52344493	52344727	3500351489	40		52344493	52344727	8421504	2	20,20	0,214	c	350035148900000028,350035148900000029	0-20,0-20		19822660	10.1128/MCB.00337-09	0270-7306	Molecular and Cellular Biology	Hypersensitivity of Aryl Hydrocarbon Receptor-Deficient Mice to Lipopolysaccharide-Induced Septic Shock	Sekine	2009	6		
984	chr19	52344493	52344727	3500276460	40		52344493	52344727	8421504	2	20,20	0,214	c	350027646000000008,350027646000000009	0-20,0-20						Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermis	cs.biologists.org	0	0		
984	chr19	52344493	52344727	3500204250	40		52344493	52344727	8421504	2	20,20	0,214	c	350020425000000030,350020425000000031	0-20,0-20		18194215	10.1111/j.1471-4159.2007.05167.x	1471-4159	Journal of Neurochemistry	SP1 regulates a human SNAP-25 gene expression - Cai - 2007 - Journal of Neurochemistry - Wiley Online Library	Cai	2008	0		
984	chr19	52344493	52344727	3500121631	40		52344493	52344727	8421504	2	20,20	0,214	c,g	350012163100000003,350012163100000002,350012163100000002	0-20,0-20,0-20		22267540	10.1177/1933719111430998		Reproductive Sciences	Statins Inhibit Monocyte Chemotactic Protein 1 Expression in Endometriosis	Hakan	June	0		
984	chr19	52344493	52344727	3500096970	40		52344493	52344727	8421504	2	20,20	0,214	c	350009697000000006,350009697000000007	0-20,0-20		18694926	10.1074/jbc.M805919200		The Journal of Biological Chemistry	Identification of an Alternative Mechanism of Degradation of the Hypoxia-inducible Factor-1&#x03b1;	Helder	2008	0		KRBOX4
984	chr19	52344493	52344727	3500057997	40		52344493	52344727	8421504	2	20,20	0,214	c	350005799700000007,350005799700000006	0-20,0-20						Curcumin Induces Apoptosis and Inhibits Growth of Human Burkitt&#x2019;s Lymphoma in Xenograft Mouse Model	beyotime.com	0	0		ACTG2
984	chr19	52344493	52344725	3500421355	41		52344493	52344725	8421504	2	20,21	0,211	c	350042135500000009,350042135500000010	0-20,0-21						NIH Public Access model: J Natl Cancer Inst Diana C. Haines Kidney-targeted Birt-Hogg-Dub&#xe9; gene inactivation in a mouse Laura S. Schmidt	w.bhdsyndrome.org	0	0		ACTG1
984	chr19	52344493	52344725	3500343009	44		52344493	52344725	8421504	2	23,21	0,211	c	350034300900000002,350034300900000003	0-23,0-21					Nucleic Acids Research	Phosphorylation of Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function	Zhiping	2003	0		
984	chr19	52344493	52344723	3500323213	42		52344493	52344723	8421504	2	20,22	0,208	c	350032321300000001,350032321300000002	0-20,0-22						Oral Quercetin Supplementation Lowers Plasma sICAM-1 Concentrations in Female db/db Mice	www.scirp.org	0	0		
984	chr19	52344493	52344723	3500296502	42		52344493	52344723	8421504	2	20,22	0,208	c	350029650200000004,350029650200000005	0-20,0-22		22754344	10.3390/ijms13055982		International Journal of Molecular Sciences	The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma	Al-Madhagi	2012	0		
984	chr19	52344493	52344723	3500048405	42		52344493	52344723	8421504	2	20,22	0,208	c	350004840500000004,350004840500000005	0-20,0-22						The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma	www.mdpi.com	0	0		
984	chr19	52344493	52344654	3500408369	45		52344493	52344654	8421504	3	23,3,19	0,51,142	c	350040836900000002,350040836900000003	0-23,0-22		11590192		0741-5400	Journal of Leukocyte Biology	Effects of intracellular zinc depletion on metallothionein and ZIP2 transporter expression and apoptosis	Cao	2001	5		
984	chr19	52344526	52344650	3500347591	36		52344526	52344650	8421504	2	21,15	0,109	c	350034759100000009,350034759100000007	0-36,0-30						A rapid real-time qRT-PCR assay for ovine -actin mRNA	quantification.de	0	0		
984	chr19	52344535	52344743	3500432343	72		52344535	52344743	8421504	3	12,13,47	0,100,161	c	350043234300000010,350043234300000011,350043234300000021	0-25,0-21,0-26		22808196	10.1371/journal.pone.0040572	1932-6203	PLOS ONE	PLOS ONE: Increases in Mitochondrial DNA Content and 4977-bp Deletion upon ATM/Chk2 Checkpoint Activation in HeLa Cells	Niu	2012	4		ACTB
984	chr19	52344536	52344731	3500067720	41		52344536	52344731	8421504	3	11,9,21	0,99,174	c,g	350006772000000004,350006772000000005	0-22,0-21		16361570	10.1158/1078-0432.CCR-05-1817	1078-0432	Clinical Cancer Research	AdCD40L Gene Therapy Counteracts T Regulatory Cells and Cures Aggressive Tumors in an Orthotopic Bladder Cancer Model	Loskog	2005	8		
984	chr19	52344537	52344649	3500423989	24		52344537	52344649	8421504	2	10,14	0,98	c	350042398900000114,350042398900000226,350042398900000228,350042398900000116	0-24,0-21,6-30,9-33						US Patent # 7,198,924. Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites - Patents.com	www.patents.com	0	0		
984	chr19	52344537	52344649	3500371591	24		52344537	52344649	8421504	2	10,14	0,98	c	350037159100000228,350037159100000226,350037159100000116,350037159100000114	6-30,0-21,9-33,0-24						Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites - US Patent 7198924 Description	ww.patentstorm.us	0	0		
984	chr19	52344537	52344649	3500218204	24		52344537	52344649	8421504	2	10,14	0,98	c	350021820400000001	0-24		11289125		0008-5472	Cancer Research	Detection of Blood-borne Cells in Colorectal Cancer Patients by Nested Reverse Transcription-Polymerase Chain Reaction for Carcinoembryonic Antigen Messenger RNA	Guadagni	2001	8		
984	chr19	52344537	52344649	3500138518	24		52344537	52344649	8421504	2	10,14	0,98	c	350013851800000001	0-24		11289125		0008-5472	Cancer Research	Detection of Blood-borne Cells in Colorectal Cancer Patients by Nested Reverse Transcription-Polymerase Chain Reaction for Carcinoembryonic Antigen Messenger RNA	Guadagni	2001	8		ACTA2
984	chr19	52344537	52344649	3500037470	24		52344537	52344649	8421504	2	10,14	0,98	c	350003747000000004	0-24						Use of il-18 inhibitors	Chvatchko	2003	0		ACTB
984	chr19	52344537	52344649	3500035567	24		52344537	52344649	8421504	2	10,14	0,98	c	350003556700000134,350003556700000132	9-33,0-24						Methods and compositions for synthesis of nucleic acid molecules using multiplerecognition sites	Chesnut	2013	0		
984	chr19	52344538	52344741	3500128014	47		52344538	52344741	8421504	3	9,18,20	0,97,183	c,g	350012801400000009,350012801400000008,350012801400000008	0-27,0-20,0-20						DIAGNOSTIC AND THERAPEUTIC TARGET	Rabbani	2011	0		
984	chr19	52344538	52344649	3500287474	23		52344538	52344649	8421504	2	9,14	0,97	c	350028747400000005	1-24		19952113	10.1158/1541-7786.MCR-08-0501	1541-7786	Molecular Cancer Research	Dysregulation of Platelet-Derived Growth Factor &#x03b2;-Receptor Expression by &#x0394;Np73 in Neuroblastoma	Wetterskog	2009	4		
984	chr19	52344538	52344649	3500222796	23		52344538	52344649	8421504	2	9,14	0,97	c	350022279600000001	1-24		18219662	10.1002/cncr.23285	1097-0142	Cancer	Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells - Nakano - 2008 - Cancer - Wiley Online Library	Nakano	2008	0		
984	chr19	52344541	52344741	3500355427	59		52344541	52344741	8421504	3	6,21,32	0,94,168	c,g	350035542700000006,350035542700000000	0-27,32-64						TH17 cells contribute to uveitis and scleritis and are inhibited by IL-27/STAT1 in the retina (1) Detection of TH17 cells in human blood | MolMeth	www.molmeth.org	0	0		
984	chr19	52344541	52344741	3500223692	54		52344541	52344741	8421504	3	6,16,32	0,94,168	c,g	350022369200000014,350022369200000002	0-22,32-64						&#x4e3b;&#x9898;&#xff1a;C-JUN | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
984	chr19	52344541	52344725	3500246999	48		52344541	52344725	8421504	3	6,21,21	0,94,163	c,g	350024699900000002,350024699900000001,350024699900000001	0-27,0-21,0-21						Volume 13 Number 24 June 28, 2007	www.wjgnet.com	0	0		
984	chr19	52344541	52344656	3500237112	27		52344541	52344656	8421504	2	6,21	0,94	c	350023711200000007	0-27		18245667	10.1158/1535-7163.MCT-07-0478	1535-7163	Molecular Cancer Therapeutics	The role of TRPV6 in breast carcinogenesis	Bolanz	2008	5		ACTB
984	chr19	52344541	52344656	3500054012	27		52344541	52344656	8421504	2	6,21	0,94	c	350005401200000150,350005401200000014	0-27,0-27						DIAGNOSTIC BIOMARKERS OF DIABETES - Patent application	www.faqs.org	0	0		
984	chr19	52344541	52344654	3500126190	25		52344541	52344654	8421504	2	6,19	0,94	c	350012619000000017	19-44						PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop	al.physiology.org	0	0		
984	chr19	52344541	52344653	3500458355	24		52344541	52344653	8421504	2	6,18	0,94	c	350045835500000011	0-24		18218703	10.1261/rna.739308	1355-8382	RNA	Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions	Zhang	2008	5		
984	chr19	52344541	52344653	3500428535	24		52344541	52344653	8421504	2	6,18	0,94	c	350042853500000040	0-24						NOVEL GENE PARTICIPATING IN EPIDERMAL DIFFERENTIATION AND USE THEREOF	MATSUI	2005	0		ACTB
984	chr19	52344541	52344653	3500318615	24		52344541	52344653	8421504	2	6,18	0,94	c	350031861500000005	0-24						&#xc9;tude des effets endocriniens produits par les organochlor&#xe9;s en lien avec la carcinogen&#xe8;se mammaire	de.bibl.ulaval.ca	0	0		ACTB
984	chr19	52344541	52344653	3500141478	24		52344541	52344653	8421504	2	6,18	0,94	c	350014147800000003	0-24						PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Patent application	www.faqs.org	0	0		
984	chr19	52344541	52344653	3500128734	24		52344541	52344653	8421504	2	6,18	0,94	c	350012873400000000	0-24		23472073	10.1371/journal.pone.0056929		PLoS ONE	SPLUNC1 Regulates Cell Progression and Apoptosis through the miR-141-PTEN/p27 Pathway, but Is Hindered by LMP1	Pan	2013	0		
984	chr19	52344542	52344731	3500079900	42		52344542	52344731	8421504	3	5,16,21	0,93,168	c,g	350007990000000004,350007990000000005	0-21,0-21			10.3978/j.issn.2218-676X.2012.05.02		Translational cancer research	Oncolytic virus-mediated tumor radiosensitization in mice through DNA-PKcs-specific shRNA	Takashi	June	0		
984	chr19	52344542	52344731	3500014341	42		52344542	52344731	8421504	3	5,16,21	0,93,168	c,g	350001434100000004,350001434100000005	0-21,0-21		19349962	10.1038/aps.2009.8	1671-4083	Acta Pharmacologica Sinica	Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1&#x03b1; protein accumulation and vascular endothelial growth factor expression in human breast cancer cells	Tang	2009	2		ACTB
984	chr19	52344542	52344717	3500008900	44		52344542	52344717	8421504	3	5,18,21	0,93,154	c	350000890000000008,350000890000000009	0-23,0-21						Di&#xfb00;erentiationofhumanEmbryonic StemCellsintohepatocytesasatoolto analysedynamicregulatoryevents duringhepatogenesis in vitro	diss.fu-berlin.de	0	0		
984	chr19	52344542	52344656	3500306987	26		52344542	52344656	8421504	2	5,21	0,93	c	350030698700000008	0-26			10.1136/gut.2003.021105		Gut	Effect of peroxisome proliferator activated receptor &#x03b3; ligands on growth and gene expression profiles of gastric cancer cells	W	2004	0		
984	chr19	52344542	52344656	3500190828	26		52344542	52344656	8421504	2	5,21	0,93	c	350019082800000008	0-26						STOMACH Effect of peroxisome proliferator activated receptor ligands on growth and gene expression profiles of gastric cancer cells	gut.bmj.com	0	0		
984	chr19	52344542	52344656	3500181353	26		52344542	52344656	8421504	2	5,21	0,93	c	350018135300000008	0-26		14960510	10.1136/gut.2003.021105	1468-3288	Gut	Effect of peroxisome proliferator activated receptor &#x03b3; ligands on growth and gene expression profiles of gastric cancer cells	Leung	2004	0		ACTB
984	chr19	52344542	52344656	3500152811	26		52344542	52344656	8421504	2	5,21	0,93	c	350015281100000003	0-26		17339340	10.1128/MCB.02249-06	0270-7306	Molecular and Cellular Biology	Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members	Goetz	2007	6		
984	chr19	52344542	52344656	3500117034	26		52344542	52344656	8421504	2	5,21	0,93	c	350011703400000007	0-26		22968430	10.4161/epi.22103		Epigenetics	miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues	Tatiana	2012	0		
984	chr19	52344542	52344656	3500037991	26		52344542	52344656	8421504	2	5,21	0,93	c	350003799100000013	0-26		16682957	10.1038/sj.onc.1209579	0950-9232	Oncogene	Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB	Benoit	2006	6		
984	chr19	52344542	52344656	3500035624	23		52344542	52344656	8421504	3	5,12,6	0,93,108	c	350003562400000017,350003562400000008	0-23,0-23						PAPILLOMAVIRUS VIRUS-LIKE PARTICLE OR CAPSOMERE FORMULATION AND ITS USE AS MICROBICIDE - Patent application	www.faqs.org	0	0		
984	chr19	52344542	52344654	3500315078	24		52344542	52344654	8421504	2	5,19	0,93	c	350031507800000002	0-24		19372484	10.2967/jnumed.108.058438	0161-5505	Journal of Nuclear Medicine	Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor	Johnson	2009	6		ACTB
984	chr19	52344542	52344654	3500285194	24		52344542	52344654	8421504	2	5,19	0,93	c	350028519400000002	0-24						Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of F-FHBG PET Imaging in a Prostate Tumor	m.snmjournals.org	0	0		
984	chr19	52344542	52344654	3500163540	24		52344542	52344654	8421504	2	5,19	0,93	c	350016354000000014	0-24		19847012	10.1074/jbc.M109.057729	0021-9258	Journal of Biological Chemistry	Thioredoxin-interacting Protein (Txnip) Is a Feedback Regulator of S-Nitrosylation	Forrester	2009	5		
984	chr19	52344542	52344654	3500125719	24		52344542	52344654	8421504	2	5,19	0,93	c	350012571900000006	0-24						1,25-dihydroxyvitamin D inhibits renal interstitial myo&#xfb01;broblast activation by inducing hepatocyte growth factor expression	www.cmdrchina.org	0	0		
984	chr19	52344542	52344654	3500077143	24		52344542	52344654	8421504	2	5,19	0,93	c	350007714300000002	0-24		22220168	10.1155/2011/178967		Journal of Oncology	Evaluation of Lentiviral-Mediated Expression of Sodium Iodide Symporter in Anaplastic Thyroid Cancer and the Efficacy of In Vivo Imaging and Therapy	Chien-Chih	2011	0		
984	chr19	52344542	52344653	3500315101	23		52344542	52344653	8421504	2	5,18	0,93	c	350031510100000001	0-23		11378668	10.1590/S0100-879X2001000600013	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Expression of CD40 ligand, interferon-gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts: correlation with acute rejection	Shulzhenko	2001	1		ACTB
984	chr19	52344542	52344653	3500157188	23		52344542	52344653	8421504	2	5,18	0,93	c	350015718800000001	0-23		11378668	10.1590/S0100-879X2001000600013	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Expression of CD40 ligand, interferon-gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts: correlation with acute rejection	Shulzhenko	2001	1		
984	chr19	52344543	52344731	3500025381	44		52344543	52344731	8421504	3	4,16,24	0,92,164	c	350002538100000003,350002538100000004	0-20,0-24		15075359	10.1124/jpet.103.064329	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor	Brobst	2004	0		
984	chr19	52344543	52344725	3500210811	47		52344543	52344725	8421504	3	4,22,21	0,92,161	c	350021081100000010,350021081100000009	0-26,21-42						ISSUU - Fundamentos de Inmunolog&#xed;a B&#xe1;sica y Cl&#xed;nica Tomo 02 by Fernando Velez	issuu.com/fernand	0	0		
984	chr19	52344543	52344725	3500040360	47		52344543	52344725	8421504	3	4,22,21	0,92,161	c	350004036000000009,350004036000000008	0-26,0-21						Untersuchungen zur Rolle von Immunzell-BDNF w&#xe4;hrend autoimmuner Entz&#xfc;ndung im zentralen Nervensystem	uhr-uni-bochum.de	0	0		
984	chr19	52344543	52344725	3500037125	47		52344543	52344725	8421504	3	4,22,21	0,92,161	c	350003712500000005,350003712500000006	0-26,0-21						Inhaled CD86 Antisense Oligonucleotide Suppresses Pulmonary Inflammation and Airway Hyper-Responsiveness in Allergic Mice	aspetjournals.org	0	0		ACTB
984	chr19	52344543	52344657	3500223898	26		52344543	52344657	8421504	2	4,22	0,92	c	350022389800000013	0-26						Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells	www.jleukbio.org	0	0		
984	chr19	52344544	52344738	3500232271	44		52344544	52344738	8421504	3	3,19,22	0,91,172	c	350023227100000006,350023227100000007	0-22,0-22		18674748	10.1016/j.ajhg.2008.07.003		American Journal of Human Genetics	ATM Gene Mutations Result in Both Recessive and Dominant Expression Phenotypes of Genes and MicroRNAs	Denis	2008	0		
984	chr19	52344545	52344660	3500040462	27		52344545	52344660	8421504	2	2,25	0,90	c	350004046200000009	0-27		21290563	10.1002/bdra.20763		Birth defects research. Part A, Clinical and molecular teratology	Functional Effects of Genetic Polymorphisms in the N-acetyltransferase 1 Coding and 3&#x2032; Untranslated Regions	Yuanqi	2011	0		
984	chr19	52344546	52344741	3500134677	40		52344546	52344741	8421504	3	1,19,20	0,89,175	c,g	350013467700000004,350013467700000005,350013467700000005	0-20,0-20,0-20						Sebastian D. Hayes , Han Liu &#xa7; #, Ewan MacDonald , Christopher M. Sanderson , Judy M. Coulson , Michael J. Clague , Sylvie Urb&#xe9;	www.jbc.org	0	0		
984	chr19	52344546	52344735	3500463295	40		52344546	52344735	8421504	3	1,19,20	0,89,169	c	350046329500000004,350046329500000005	0-20,0-20		21029241	10.1111/j.1750-3639.2010.00445.x		Brain pathology (Zurich, Switzerland)	Neuronal MCP-1 Mediates Microglia Recruitment and Neurodegeneration Induced by the Mild Impairment of Oxidative Metabolism	Guang	2011	0		
984	chr19	52344546	52344735	3500044993	40		52344546	52344735	8421504	3	1,19,20	0,89,169	c	350004499300000010,350004499300000011	0-20,0-20		22262830	10.1074/jbc.M111.315416		The Journal of Biological Chemistry	RACK1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway	Shuo	2012	0		
984	chr19	52344546	52344735	3500007156	40		52344546	52344735	8421504	3	1,19,20	0,89,169	c	350000715600000010,350000715600000011	0-20,0-20		22262830	10.1074/jbc.M111.315416	0021-9258	Journal of Biological Chemistry	RACK1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway	Shi	2012	5		
984	chr19	52344546	52344717	3500366761	40		52344546	52344717	8421504	3	1,19,20	0,89,151	c	350036676100000002,350036676100000003	0-20,0-20						Perlecan/Hspg2 Deficiency Alters the Pericellular Space of the Lacuno-Canalicular System Surrounding Osteocytic Processes in C	www2.udel.edu	0	0		
984	chr19	52344546	52344717	3500174633	40		52344546	52344717	8421504	3	1,19,20	0,89,151	c,g	350017463300000002,350017463300000003	0-20,0-20		20814969	10.1002/jbmr.236	1523-4681	Journal of Bone and Mineral Research	Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone - Thompson - 2011 - Journal of Bone and Mineral Research - Wiley Online Library	Thompson	2011	0		
984	chr19	52344679	52344715	3500127703	36		52344679	52344715	8421504	1	36	0	c	350012770300000005	0-36		15149334	10.1111/j.1523-1755.2004.00641.x	0085-2538	Kidney International	Matrilysin (MMP-7) expression in renal tubular damage: Association with Wnt4	SURENDRAN	2004	7		POTEM
984	chr19	52344684	52344711	3500349534	27		52344684	52344711	8421504	1	27	0	c	350034953400000002	24-51			10.1046/j.1365-3083.2001.00994.x	1365-3083	Scandinavian Journal of Immunology	Morphologic and Functional Changes in Bovine Monocytes Infected In vitro with the Bovine Leukaemia Virus - Altreuther - 2002 - Scandinavian Journal of Immunology - Wiley Online Library	Altreuther	2001	0		
984	chr19	52344692	52344717	3500320056	25		52344692	52344717	8421504	1	25	0	c	350032005600000002	0-25		19759828	10.1371/journal.pone.0006943	1932-6203	PLOS ONE	PLOS ONE: Earlier Onset of &#x03b4;-Retrovirus-Induced Leukemia after Splenectomy	Florins	2009	4		CCDC74A,ACTA1
984	chr19	52344692	52344715	3500432260	23		52344692	52344715	8421504	1	23	0	c	350043226000000002	0-23						Function of regulatory T-cells improved by dexamethasone in Graves&#x2019; disease	ww.eje-online.org	0	0		ACTG1
984	chr19	52344697	52344722	3500409357	25		52344697	52344722	8421504	1	25	0	c	350040935700000008	0-25						&#x79bd;&#x7528;&#x75ab;&#x82d7;&#x4e4b; CpG DNA &#x4f50;&#x5291;	csvs.org.tw	0	0		POTEG,SPZ1
984	chr19	52344698	52344751	3500132566	45		52344698	52344751	8421504	2	20,25	0,28	c	350013256600000019,350013256600000021	0-20,0-25		16260592	10.1128/MCB.25.22.9741-9752.2005	0270-7306	Molecular and Cellular Biology	Interleukin-21 Receptor Gene Induction in Human T Cells Is Mediated by T-Cell Receptor-Induced Sp1 Activity	Wu	2005	6		ACTB
984	chr19	52344698	52344751	3500045726	45		52344698	52344751	8421504	2	20,25	0,28	c	350004572600000019,350004572600000021	0-20,0-25			10.1128/MCB.25.22.9741-9752.2005		Molecular and Cellular Biology	Interleukin-21 Receptor Gene Induction in Human T Cells Is Mediated by T-Cell Receptor-Induced Sp1 Activity	Zheng	2005	0		ACTB
984	chr19	52344703	52344727	3500444424	24		52344703	52344727	8421504	1	24	0	c	350044442400000004	0-24						NOVEL ANTI AGING AGENTS AND METHODS TO IDENTIFY THEM	QI	2010	0		ACTA2,CCDC74A
984	chr19	52344707	52344773	3500427864	66		52344707	52344773	8421504	1	66	0	c	350042786400000147,350042786400000063,350042786400000086,350042786400000002	0-66,0-62,0-23,0-23						Expression Profile Algorithm and Test for Cancer Prognosis - Patent application	www.faqs.org	0	0		
984	chr19	52344707	52344773	3500196047	66		52344707	52344773	8421504	1	66	0	c	350019604700000063,350019604700000002	0-66,0-23						Expression profile algorithm and test for cancer prognosis	Baker	2004	0		
984	chr19	52344707	52344769	3500281268	62		52344707	52344769	8421504	1	62	0	c	350028126800000075,350028126800000138,350028126800000077	0-21,0-62,0-23						Expression Profile Algorithm And Test For Cancer Prognosis 	.freshpatents.com	0	0		
984	chr19	52344707	52344752	3500378391	44		52344707	52344752	8421504	2	21,23	0,22	c,g	350037839100000000,350037839100000002	0-21,0-23						Expression profile algorithm and test for cancer prognosis	Baker	2004	0		POTEF
984	chr19	52344707	52344732	3500432978	25		52344707	52344732	8421504	1	25	0	c	350043297800000003	0-25		18768663	10.1677/JME-08-0026	0952-5041	Journal of Molecular Endocrinology	Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells	Chen	2008	3		
984	chr19	52344707	52344732	3500313745	25		52344707	52344732	8421504	1	25	0	c,g	350031374500000005,350031374500000005	0-25,0-25					Patent	Cancer diagnosis and treatment using anti-robo1 antibody (Patent EP:1744162)	Aburatani	2010	0		POTEE
984	chr19	52344708	52344741	3500143356	33		52344708	52344741	8421504	1	33	0	c,g	350014335600000000,350014335600000000	32-65,32-65						Rainbow Universal CPG: A Versatile Solid Support for Oligonucleotide Synthesis	biotechniques.com	0	0		
984	chr19	52344709	52344744	3500303632	35		52344709	52344744	8421504	1	35	0	c	350030363200000009,350030363200000030	0-35,3-38						METHODS AND COMPOSITIONS FOR FULL-LENGTH cDNA CLONING	Chenchik	1997	0		POTEE
984	chr19	52344709	52344742	3500042708	33		52344709	52344742	8421504	1	33	0	c	350004270800000009,350004270800000019	0-32,23-50						METHODS AND COMPOSITIONS FOR GROWTH OF CELLS AND EMBRYONIC TISSUE ON A SYNTHETIC POLYMER MATRIX - Patent application	www.faqs.org	0	0		POTEE
984	chr19	52344709	52344741	3500463514	32		52344709	52344741	8421504	1	32	0	c	350046351400000009	0-32			10.3748/wjg.14.2308		World Journal of Gastroenterology : WJG	Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro	Ji-Kun	2008	0		TMEM222
984	chr19	52344709	52344741	3500461897	32		52344709	52344741	8421504	1	32	0	c	350046189700000011,350046189700000041	0-32,0-32						CULTURE MEDIA, CELL CULTURES AND METHODS OF CULTURING PLURIPOTENT STEM CELLS IN AN UNDIFFERENTIATED STATE - Patent application	www.faqs.org	0	0		
984	chr19	52344709	52344741	3500439728	32		52344709	52344741	8421504	1	32	0	c	350043972800000005	0-32						The Cell Adhesion Molecules N-Cadherin and Neural Cell Adhesion Molecule Regulate Human Growth Hormone: A Novel Mechanism for Regulating Pituitary Hormone Secretion	.endojournals.org	0	0		TMEM222
984	chr19	52344709	52344741	3500434352	32		52344709	52344741	8421504	1	32	0	c	350043435200000001	0-32						PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. - ResearchGate	.researchgate.net	0	0		
984	chr19	52344709	52344741	3500426691	32		52344709	52344741	8421504	1	32	0	c	350042669100000003	0-32		16983343	10.1038/sj.onc.1209961	0950-9232	Oncogene	Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells	Neesse	2006	6		
984	chr19	52344709	52344741	3500425565	32		52344709	52344741	8421504	1	32	0	c	350042556500000009	0-32		11535826	10.1073/pnas.191362598	0027-8424	Proceedings of the National Academy of Sciences	Hematopoietic colony-forming cells derived from human embryonic stem cells	Kaufman	2001	10		POTEF
984	chr19	52344709	52344741	3500404069	32		52344709	52344741	8421504	1	32	0	c	350040406900000003	0-32			10.3748/wjg.15.3874		World Journal of Gastroenterology : WJG	Peroxisome proliferator-activated receptor-&#x03b3; is essential in the pathogenesis of gastric carcinoma	Xiu-Mei	2009	0		
984	chr19	52344709	52344741	3500402801	32		52344709	52344741	8421504	1	32	0	c,g	350040280100000003,350040280100000003	0-32,0-32						Cross-talkbetweenEpidermalGrowthFactorReceptor andHypoxia-inducibleFactor-1 SignalPathways IncreasesResistancetoApoptosisbyUp-regulating SurvivinGeneExpression	www.jbc.org	0	0		POTEM
984	chr19	52344709	52344741	3500398321	32		52344709	52344741	8421504	1	32	0	c	350039832100000003	0-32						Hyperglycemia regulates mdr drug uptake and ros levels	www.ukessays.com	0	0		
984	chr19	52344709	52344741	3500396653	32		52344709	52344741	8421504	1	32	0	g	350039665300000002	32-64						METHOD AND COMPOSITION FOR INDUCING HUMAN PLURIPOTENT STEM CELLS - THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	www.sumobrain.com	0	0		ACTB
984	chr19	52344709	52344741	3500390960	32		52344709	52344741	8421504	1	32	0	c	350039096000000009,350039096000000029	0-32,0-32						METHODS INVOLVING ALDOSE REDUCTASE INHIBITORS - Patent application	www.faqs.org	0	0		NAALADL2
984	chr19	52344709	52344741	3500385999	32		52344709	52344741	8421504	1	32	0	c	350038599900000005	0-32						Effects of Genistein on the Polyamine Metabolism and Cell Growth in DLD-1 Human Colon Cancer Cells	embers.linode.com	0	0		POTEM
984	chr19	52344709	52344741	3500381639	32		52344709	52344741	8421504	1	32	0	c	350038163900000001	0-32						World J Gastroenterol	www.wjgnet.com	0	0		
984	chr19	52344709	52344741	3500361492	32		52344709	52344741	8421504	1	32	0	g	350036149200000011	0-32						Hcv Neutralizing Epitopes 	.freshpatents.com	0	0		TMEM222
984	chr19	52344709	52344741	3500361312	32		52344709	52344741	8421504	1	32	0	g	350036131200000062	0-32						Tumour associated antigens	Banham	2004	0		TMEM222
984	chr19	52344709	52344741	3500356848	32		52344709	52344741	8421504	1	32	0	c	350035684800000018,350035684800000201	0-32,0-32						P450rai-2 (p450 Cytochrome 26b), Encoding Nucleic Acid Molecules And Methods And Uses Thereof 	.freshpatents.com	0	0		POTEF
984	chr19	52344709	52344741	3500339428	32		52344709	52344741	8421504	1	32	0	c	350033942800000012	0-32						T-cell receptor&#x03b3; alternate reading frame protein, (TARP) and uses thereof	Pastan	2000	0		POTEM
984	chr19	52344709	52344741	3500338718	32		52344709	52344741	8421504	1	32	0	c	350033871800000005,350033871800000100	0-32,0-32						US Patent # 6,824,781. Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist - Patents.com	www.patents.com	0	0		
984	chr19	52344709	52344741	3500323010	31		52344709	52344741	8421504	2	13,18	0,14	c	350032301000000042	0-31					Patent	Modulation of &#x03b2;-catenin/TCF-activated transcription (Patent US:7531320)	Ha	2009	0		
984	chr19	52344709	52344741	3500321867	32		52344709	52344741	8421504	1	32	0	c	350032186700000003	0-32						World J Gastroenterol	www.wjgnet.com	0	0		TMEM222
984	chr19	52344709	52344741	3500305635	32		52344709	52344741	8421504	1	32	0	c	350030563500000004	0-32		19851306	10.1038/oby.2009.337	1930-739X	Obesity	Hypolipidemic Effect of Fenugreek Seeds Is Mediated Through Inhibition of Fat Accumulation and Upregulation of LDL Receptor - Vijayakumar - 2012 - Obesity - Wiley Online Library	Vijayakumar	2010	0		POTEF,NAALADL2
984	chr19	52344709	52344741	3500305608	32		52344709	52344741	8421504	1	32	0	c	350030560800000029	0-32						UNCONVENTIONAL ANTIGEN TRANSLATED BY A NOVEL INTERNAL RIBOSOME ENTRY SITE ELICITS ANTITUMOR HUMORAL IMMUNE REACTIONS - Patent application	www.faqs.org	0	0		POTEF,NAALADL2
984	chr19	52344709	52344741	3500305044	31		52344709	52344741	8421504	2	13,18	0,14	c	350030504400000042	0-31						Modulation of beta-catenin/TCF-activated transcription	Kahn	2005	0		
984	chr19	52344709	52344741	3500298286	32		52344709	52344741	8421504	1	32	0	g	350029828600000006	32-64		15668483		1055-9965	Cancer Epidemiology Biomarkers & Prevention	Expression of the Epidermal Growth Factor Seven-Transmembrane Member CD97 Correlates with Grading and Staging in Human Oral Squamous Cell Carcinomas	Mustafa	2005	4		POTEM
984	chr19	52344709	52344741	3500291793	32		52344709	52344741	8421504	1	32	0	c	350029179300000005	0-32						Characterization of mesenchymal stem cells isolated from the human umbilical cord	w.cellbiolint.org	0	0		POTEE
984	chr19	52344709	52344741	3500288814	32		52344709	52344741	8421504	1	32	0	c	350028881400000011,350028881400000041	0-32,0-32						METHODS OF EXPANDING EMBRYONIC STEM CEELS IN A SUSPENSION CULTURE - Patent application	www.faqs.org	0	0		
984	chr19	52344709	52344741	3500288773	32		52344709	52344741	8421504	1	32	0	c	350028877300000062	0-32						Tumour associated antigens	Banham	2003	0		
984	chr19	52344709	52344741	3500288606	32		52344709	52344741	8421504	1	32	0	c	350028860600000005	0-32						Polyunsaturated fatty acids reduce Fatty Acid Synthase and Hydroxy-Methyl-Glutaryl CoA-Reductase gene expression and promote apoptosis in HepG2 cell line	ww.lipidworld.com	0	0		
984	chr19	52344709	52344741	3500286780	32		52344709	52344741	8421504	1	32	0	c	350028678000000010	0-32						Agents for retarding change of hormone-dependent cancer into hormone-independent cancer	Song Gu Yue Zai 	2001	0		
984	chr19	52344709	52344741	3500274728	32		52344709	52344741	8421504	1	32	0	c	350027472800000009	0-32						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		TMEM222
984	chr19	52344709	52344741	3500263064	32		52344709	52344741	8421504	1	32	0	c	350026306400000005	0-32						Effects of Genistein on the Polyamine Metabolism and Cell Growth in DLD-1 Human Colon Cancer Cells	embers.linode.com	0	0		POTEE
984	chr19	52344709	52344741	3500239824	32		52344709	52344741	8421504	1	32	0	c,g	350023982400000009,350023982400000009	0-32,0-32						Interleukin- Receptor-Mediated Activation of Signal Transducer and Activator of Transcription- (STAT) Promotes Choroidal Neovascularization 2007&#x5e74;&#x7b2c;169&#x5377;&#x7b2c;6&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
984	chr19	52344709	52344741	3500218382	32		52344709	52344741	8421504	1	32	0	c	350021838200000013	0-32					Patent	Tissue culture medium comprising transforming growth factor beta 1 and basic fibroblast growth factor (Patent US:8222034)	Amit	2012	0		TMEM222
984	chr19	52344709	52344741	3500213360	32		52344709	52344741	8421504	1	32	0	c	350021336000000005	0-32						THE J BIOLOGICAL C &#xa9; 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced Apoptosis*	www.jbc.org	0	0		TMEM222
984	chr19	52344709	52344741	3500189751	32		52344709	52344741	8421504	1	32	0	g	350018975100000006	32-64		15668483		1055-9965	Cancer Epidemiology Biomarkers & Prevention	Expression of the Epidermal Growth Factor Seven-Transmembrane Member CD97 Correlates with Grading and Staging in Human Oral Squamous Cell Carcinomas	Mustafa	2005	4		POTEH
984	chr19	52344709	52344741	3500189250	32		52344709	52344741	8421504	1	32	0	g	350018925000000018,350018925000000201	0-32,0-32						P450RAI-2 (P450 CYTOCHROME 26B), ENCODING NUCLEIC ACID MOLECULES AND METHODS AND USES THEREOF - Patent application	www.faqs.org	0	0		
984	chr19	52344709	52344741	3500188830	32		52344709	52344741	8421504	1	32	0	c	350018883000000028	0-32						FRIEDRICH-SCHILLER-UNIVERSITAT JENA BIOLOGISCH-PHARMAZEUTISCHE FAKULTAT Experimentelle Unter	.db-thueringen.de	0	0		POTEE
984	chr19	52344709	52344741	3500187949	32		52344709	52344741	8421504	1	32	0	c	350018794900000011	0-32		12186908	10.1128/JVI.76.18.9242-9252.2002	0022-538X	Journal of Virology	Upregulation of Surface Feline CXCR4 Expression following Ectopic Expression of CCR5: Implications for Studies of the Cell Tropism of Feline Immunodeficiency Virus	Willett	2002	5		
984	chr19	52344709	52344741	3500186343	32		52344709	52344741	8421504	1	32	0	c	350018634300000011	0-32						CULTURE MEDIA, CELL CULTURES AND METHODS OF CULTURING PLURIPOTENT STEM CELLS IN AN UNDIFFERENTIATED STATE	Amit	2010	0		POTEE
984	chr19	52344709	52344741	3500185226	32		52344709	52344741	8421504	1	32	0	c	350018522600000011	0-32						Media for culturing stem cells	Amit	2006	0		TMEM222
984	chr19	52344709	52344741	3500175030	32		52344709	52344741	8421504	1	32	0	c,g	350017503000000009,350017503000000009	0-32,0-32					Patent	Methods involving aldose reductase inhibitors (Patent US:8273746)	Srivastava	2012	0		POTEM
984	chr19	52344709	52344741	3500171169	32		52344709	52344741	8421504	1	32	0	c	350017116900000003	0-32		10103198		0066-4804	Antimicrobial Agents and Chemotherapy	Fourteen-Member Macrolides Inhibit Interleukin-8 Release by Human Eosinophils from Atopic Donors	Kohyama	1999	5		POTEM
984	chr19	52344709	52344741	3500156992	32		52344709	52344741	8421504	1	32	0	c	350015699200000003	0-32		15385510	10.1128/IAI.72.10.6061-6067.2004	0019-9567	Infection and Immunity	Cryptosporidium parvum at Different Developmental Stages Modulates Host Cell Apoptosis In Vitro	Mele	2004	4		POTEE
984	chr19	52344709	52344741	3500154545	32		52344709	52344741	8421504	1	32	0	c	350015454500000009	0-32						Hematopoietic colony-forming cells derived from human embryonic stem cells. - ResearchGate	.researchgate.net	0	0		POTEF
984	chr19	52344709	52344741	3500148871	32		52344709	52344741	8421504	1	32	0	c	350014887100000005	0-32		10781420			American Journal of Physiology - Lung Cellular and Molecular Physiology	Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers	Takizawa	2000	0		POTEF
984	chr19	52344709	52344741	3500140067	32		52344709	52344741	8421504	1	32	0	c	350014006700000003	0-32		11668031			American Journal of Physiology - Gastrointestinal and Liver Physiology	Dietary induction of angiotensin-converting enzyme in proximal and distal rat small intestine	Erickson	2001	0		ACTB
984	chr19	52344709	52344741	3500132876	32		52344709	52344741	8421504	1	32	0	c	350013287600000019	0-32		19147749	10.1158/1078-0432.CCR-08-1631	1078-0432	Clinical Cancer Research	Targeted Knockdown of Notch1 Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen Activator	Hafeez	2009	8		POTEE
984	chr19	52344709	52344741	3500125919	32		52344709	52344741	8421504	1	32	0	c	350012591900000017	0-32						Translational Dysfunction Based Therapeutics - Patent application	www.faqs.org	0	0		POTEE
984	chr19	52344709	52344741	3500124924	32		52344709	52344741	8421504	1	32	0	c	350012492400000007	0-32		19752229	10.4049/jimmunol.0901177	0022-1767	The Journal of Immunology	Aldose Reductase Inhibition Suppresses the Expression of Th2 Cytokines and Airway Inflammation in Ovalbumin-Induced Asthma in Mice	Yadav	2009	6		
984	chr19	52344709	52344741	3500118659	32		52344709	52344741	8421504	1	32	0	c	350011865900000009,350011865900000045,350011865900000039,350011865900000075	0-32,0-32,0-30,0-30						Nonsense-mediated mrna decay - US Patent Application 20060154883 Description	ww.patentstorm.us	0	0		TMEM222
984	chr19	52344709	52344741	3500104925	32		52344709	52344741	8421504	1	32	0	c	350010492500000005	0-32		15604281	10.1158/0008-5472.CAN-04-2740	0008-5472	Cancer Research	Agents with Selective Estrogen Receptor (ER) Modulator Activity Induce Apoptosis In vitro and In vivo in ER-Negative Glioma Cells	Hui	2004	8		ACTB
984	chr19	52344709	52344741	3500104795	32		52344709	52344741	8421504	1	32	0	c	350010479500000001	0-32						Volume 5 / Number 3 / 2011 ISSN 1840-2291 HealthMED	onel.duzce.edu.tr	0	0		ACTB
984	chr19	52344709	52344741	3500078740	32		52344709	52344741	8421504	1	32	0	c	350007874000000010	0-32		19359429	10.1152/ajpgi.90223.2008		American Journal of Physiology - Gastrointestinal and Liver Physiology	Inflammasome-mediated regulation of hepatic stellate cells	Watanabe	2009	0		
984	chr19	52344709	52344741	3500078465	32		52344709	52344741	8421504	1	32	0	c	350007846500000005	0-32						Antibody and Uses Thereof	Burden	2009	0		TMEM222
984	chr19	52344709	52344741	3500074525	32		52344709	52344741	8421504	1	32	0	c	350007452500000013	0-32						Methods and applications of molecular beacon imaging for cancer cell detection	Yang	2006	0		ACTB
984	chr19	52344709	52344741	3500073560	31		52344709	52344741	8421504	2	13,18	0,14	c	350007356000000041	0-31						MODULATION OF &#xdf;-CATENIN/TCF ACTIVATED TRANSCRIPTION	Ha	2006	0		
984	chr19	52344709	52344741	3500070839	32		52344709	52344741	8421504	1	32	0	c	350007083900000009	0-32						Interleukin- Receptor-Mediated Activation of Signal Transducer and Activator of Transcription- (STAT) Promotes Choroidal Neovascularization--&#x300a;&#x7f8e;&#x56fd;&#x75c5;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;	journal.9med.net	0	0		TMEM222
984	chr19	52344709	52344741	3500069781	32		52344709	52344741	8421504	1	32	0	c	350006978100000005	0-32						Antibody and uses thereof	Burden	2009	0		TMEM222
984	chr19	52344709	52344741	3500045743	32		52344709	52344741	8421504	1	32	0	c	350004574300000013	0-32						Methods of culturing cells in a medium comprising transforming growth factor beta 1 and basic fibroblast growth factor	Amit	2012	0		ACTB
984	chr19	52344709	52344741	3500030970	32		52344709	52344741	8421504	1	32	0	c	350003097000000005	0-32		23887626	10.1038/cddis.2013.241	false	Cell Death & Disease	Role of fucosyltransferase IV in epithelial&#x2013;mesenchymal transition in breast cancer cells	Yang	2013	0		
984	chr19	52344709	52344741	3500026211	32		52344709	52344741	8421504	1	32	0	c	350002621100000010,350002621100000020	0-32,32-64						METHODS AND COMPOSITIONS FOR GROWTH OF EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		
984	chr19	52344709	52344741	3500020623	32		52344709	52344741	8421504	1	32	0	c	350002062300000007	0-32		12218071	10.1097/01.LAB.0000027838.69455.39	0023-6837	Laboratory Investigation	Functional Expression of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Human Colonic Adenocarcinoma Cells	Inoue	2002	4		
984	chr19	52344709	52344741	3500020349	32		52344709	52344741	8421504	1	32	0	c	350002034900000009	0-32		21799645	10.3748/wjg.v17.i25.2992		World Journal of Gastroenterology : WJG	Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth	Chen	July	0		TMEM222
984	chr19	52344709	52344741	3500014816	32		52344709	52344741	8421504	1	32	0	c	350001481600000005	0-32						NPG.nature.vol.413.Issue.6854.Sep	www.scribd.com	0	0		TMEM222
984	chr19	52344709	52344741	3500007841	32		52344709	52344741	8421504	1	32	0	c	350000784100000003	0-32			10.1128/IAI.72.10.6061-6067.2004		Infection and Immunity	Cryptosporidium parvum at Different Developmental Stages Modulates Host Cell Apoptosis In Vitro 	Raffaella	2004	0		POTEE
984	chr19	52344709	52344741	3500002798	32		52344709	52344741	8421504	1	32	0	c	350000279800000009	0-32						Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice	www.plosone.org	0	0		
984	chr19	52344709	52344740	3500056215	31		52344709	52344740	8421504	1	31	0	c	350005621500000007	0-31						Research report Molecular analysis of nicotinic receptor expression in autism	www.utdallas.edu	0	0		
984	chr19	52344709	52344736	3500076605	27		52344709	52344736	8421504	1	27	0	g	350007660500000003	5-32						BBRC	nri.bjmu.edu.cn	0	0		SPZ1
984	chr19	52344710	52344741	3500161843	30		52344710	52344741	8421504	2	24,6	0,25	c	350016184300000003	0-30			10.1002/ijc.23049	1097-0215	International Journal of Cancer	Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death - Yu - 2007 - International Journal of Cancer - Wiley Online Library	Yu	2008	0		
984	chr19	52344711	52344735	3500340462	24		52344711	52344735	8421504	1	24	0	c	350034046200000016	0-24						Studies of heparanase (HPA) gene expression, cellular localization andfunctions in neural tissues of the rat Author(s) Zhang, Yi; Issue Date 2007 URL http://hdl.handle.net/10722/50203	hub.hku.hk/bitstr	0	0		POTEF,NAALADL2
984	chr19	52344712	52344747	3500217154	35		52344712	52344747	8421504	1	35	0	c	350021715400000004	0-35		16227268	10.1128/JVI.79.21.13473-13482.2005	0022-538X	Journal of Virology	Human VAP-B Is Involved in Hepatitis C Virus Replication through Interaction with NS5A and NS5B	Hamamoto	2005	5		
984	chr19	52344712	52344735	3500417194	23		52344712	52344735	8421504	1	23	0	c	350041719400000009	0-23						El-denshary et al., Clin Exp Pharmacol 2012, S5 http://dx.doi.org/10.4172/2161-1459.S5-003 Clinical and Experimental Pharmacology	w.omicsonline.org	0	0		POTEM
984	chr19	52344715	52344741	3500096136	26		52344715	52344741	8421504	1	26	0	c	350009613600000007	0-26		12855567	10.1182/blood-2003-05-1585	0006-4971	Blood	Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone	Albesiano	2003	10		
984	chr19	52344716	52344741	3500256914	25		52344716	52344741	8421504	1	25	0	c	350025691400000022	0-25						Volume 12 Number 16 April 28, 2006	www.wjgnet.com	0	0		POTEF,NAALADL2
984	chr19	52344716	52344740	3500192756	24		52344716	52344740	8421504	1	24	0	c	350019275600000009	0-24		15576401	10.1242/dev.01570	0950-1991	Development	Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung	Serls	2005	7		
984	chr19	52344717	52344741	3500409133	24		52344717	52344741	8421504	1	24	0	c	350040913300000006	0-24		18688877	10.1002/hep.22464	1527-3350	Hepatology	Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response - Sir - 2008 - Hepatology - Wiley Online Library	Sir	2008	0		POTEF
984	chr19	52344718	52344741	3500175582	23		52344718	52344741	8421504	1	23	0	c	350017558200000003	0-23		18573902	10.1128/IAI.00109-08	0019-9567	Infection and Immunity	CD46 Contributes to the Severity of Group A Streptococcal Infection	Lovkvist	2008	4		POTEF
984	chr19	52344719	52344743	3500424562	24		52344719	52344743	8421504	1	24	0	c	350042456200000005	0-24		17363579	10.1158/0008-5472.CAN-06-3436	0008-5472	Cancer Research	p53-Independent Abrogation of a Postmitotic Checkpoint Contributes to Human Papillomavirus E6-Induced Polyploidy	Liu	2007	8		
984	chr19	52344719	52344743	3500411841	24		52344719	52344743	8421504	1	24	0	c,g	350041184100000003,350041184100000003	0-24,0-24		22771636	10.4103/0377-4929.97849		Indian Journal of Pathology and Microbiology	Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration	Liu	2012	0		POTEE,NAALADL2
984	chr19	52344719	52344742	3500020232	23		52344719	52344742	8421504	1	23	0	c	350002023200000016	0-23		19798104	10.1038/cdd.2009.140	1350-9047	Cell Death & Differentiation	An ARF&sol;CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis	Kovi	2009	9		TMEM222
984	chr19	52344720	52344744	3500457384	24		52344720	52344744	8421504	1	24	0	c	350045738400000001	0-24						Detection of seven viruses and Mycoplasma in fetal bovine serum by real time PCR	rccp.udea.edu.co	0	0		POTEM,TNFRSF11A
984	chr19	52344720	52344744	3500100680	24		52344720	52344744	8421504	1	24	0	c	350010068000000001	0-24				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Detection of seven viruses and Mycoplasma in fetal bovine serum by real time PCR	Cordero	2011	0		POTEE,TNFRSF11A
984	chr19	52344722	52344745	3500372734	23		52344722	52344745	8421504	1	23	0	c,g	350037273400000007,350037273400000007	0-23,0-23		19148268	10.1371/journal.ppat.1000263		PLoS Pathogens	miR-198 Inhibits HIV-1 Gene Expression and Replication in Monocytes and Its Mechanism of Action Appears To Involve Repression of Cyclin T1	Tzu-Ling	2009	0		ACTG1
984	chr19	52344722	52344745	3500334488	23		52344722	52344745	8421504	1	23	0	c,g	350033448800000007,350033448800000007	0-23,0-23						ScienceDirect.com - Vascular Pharmacology - Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia	sciencedirect.com	0	0		ACTG1
984	chr19	52344724	52344748	3500223772	24		52344724	52344748	8421504	1	24	0	c	350022377200000003	0-24		11176986	10-1001/pubs.Ophthalmol.-ISSN-0003-9950-119-2-els00027	0003-9950	Archives of Ophthalmology	 JAMA Network | JAMA Ophthalmology | Nitric Oxide Synthase-2 in Human Optic Nerve Head Astrocytes Induced by Elevated Pressure In Vitro 	Liu	2001	4		TMEM222
984	chr19	52344730	52344753	3500095488	23		52344730	52344753	8421504	1	23	0	c	350009548800000006	20-43						ABSTRACT Title of dissertation: EFFECTS OF AGING AND MODERATE CALORIE RESTRICTION ON THE REPRODUCTIVE AXIS OF THE MALE RHESUS MACAQUE (MACACA MULATTA) Brandon Dale Sitzmann, Doctor of Philosophy, 2007	drum.lib.umd.edu	0	0		
984	chr19	52344732	52344755	3500337261	23		52344732	52344755	8421504	1	23	0	c	350033726100000001	19-42			10.1002/hep.21804	1527-3350	Hepatology	Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma - Lu - 2007 - Hepatology - Wiley Online Library	Lu	2007	0		
984	chr19	52344732	52344755	3500120692	23		52344732	52344755	8421504	1	23	0	c	350012069200000010	19-42						Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases S	aspetjournals.org	0	0		
984	chr19	52344746	52344776	3500411602	30		52344746	52344776	8421504	1	30	0	c	350041160200000005	3-33			10.1111/j.1471-4159.2005.03275.x	1471-4159	Journal of Neurochemistry	Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation - Zhao - 2005 - Journal of Neurochemistry - Wiley Online Library	Zhao	2005	0		ACTG1
984	chr19	52344749	52344778	3500459983	29		52344749	52344778	8421504	1	29	0	c	350045998300000001	1-30		16760261	10.1152/ajpcell.00523.2005		American Journal of Physiology - Cell Physiolog	Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line	Zhang	2006	0		ACTG1,AMY2B
984	chr19	52344749	52344778	3500198371	29		52344749	52344778	8421504	1	29	0	c	350019837100000007	1-30		15254160	10.1128/JVI.78.15.7874-7882.2004	0022-538X	Journal of Virology	Adeno-Associated Virus Site-Specific Integration and AAVS1 Disruption	Hamilton	2004	5		ACTG1
984	chr19	52344749	52344778	3500126851	29		52344749	52344778	8421504	1	29	0	c	350012685100000005	1-30		18520705	10.1097/SHK.0b013e31817c0c69	1073-2322	Shock	 A Role for Il-18 in Human Neutrophil Apoptosis : Shock 	Hirata	2008	3		AMY2B
984	chr19	52344749	52344776	3500246801	27		52344749	52344776	8421504	1	27	0	c	350024680100000021	3-30						Tesis 15 diciembre	hera.ugr.es	0	0		ACTG1,SPZ1
984	chr19	52344750	52344775	3500324437	25		52344750	52344775	8421504	1	25	0	c	350032443700000009	0-25						SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells	-publications.com	0	0		POTEF
984	chr19	52344752	52344780	3500376646	28		52344752	52344780	8421504	1	28	0	c,g	350037664600000018,350037664600000018	130-158,130-158						Methods and compositions for synthesis of long chain polyunsaturated fatty acids	Chaudhary	1998	0		
984	chr19	52344754	52344779	3500026256	25		52344754	52344779	8421504	1	25	0	c	350002625600000001	0-25						Establishment of a laboratory colony of taiga tick Ixodes persulcatus for tick-borne pathogen transmission studies. - ResearchGate	.researchgate.net	0	0		ACTA2
984	chr19	52344754	52344778	3500467003	24		52344754	52344778	8421504	1	24	0	c	350046700300000002,350046700300000003,350046700300000000,350046700300000001	0-24,0-24,0-24,0-24						PARTICLE FOR MEDICAL USE, PARTICLE FOR ANLAYSIS AND METHOD OF PRODUCING THE SAME - Patent application	www.faqs.org	0	0		ACTG1
984	chr19	52344754	52344778	3500143323	24		52344754	52344778	8421504	1	24	0	c	350014332300000003	1-25						Decreased EGFR mRNA expression in response to antipsoriatic drug dithranol in vitro	www.ajol.info	0	0		ACTG1
984	chr19	52344755	52344778	3500093092	23		52344755	52344778	8421504	1	23	0	c	350009309200000003	1-24						Gene regulation by targeting putative intramolecular triple helix	Lu	1994	0		ACTG1
985	chr19	52505647	52505673	3500449315	23		52505647	52505673	8421504	2	9,14	0,12	g	350044931500000684	18-42						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
986	chr19	52650000	52650024	3500367773	23		52650000	52650024	8421504	2	7,16	0,8	g	350036777300000019,350036777300000049	0-23,0-23						CHLAMYDOMONAS GLUCAN DIKINASE GENE, ENZYME AND MODIFIED STARCH, USES, METHODS FOR PRODUCTION THEREOF - Patent application	www.faqs.org	0	0		
986	chr19	52651957	52651980	3500423784	23		52651957	52651980	8421504	1	23	0	c	350042378400000120	0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR338,MIR3065
986	chr19	52651957	52651980	3500114594	23		52651957	52651980	8421504	1	23	0	c	350011459400000888,350011459400000461	0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR338,MIR3065
986	chr19	52651957	52651980	3500031979	23		52651957	52651980	8421504	1	23	0	c	350003197900000376	0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR338,MIR3065
987	chr19	52716305	52716331	3500141134	24		52716305	52716331	8421504	3	5,4,15	0,6,11	g	350014113400000098	1-25						Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy 	.freshpatents.com	0	0		
123	chr19	52770033	53100616	3500110560	3531		52770033	53100616	8421504	30	66,130,117,87,128,107,105,125,115,106,111,184,104,119,159,141,118,111,84,102,76,145,101,60,176,147,159,83,103,162	0,734,1133,2125,3886,4723,15157,16373,17792,21081,30933,32214,32962,38022,43626,44073,45371,78735,80115,87239,93672,102650,103288,128532,157891,172622,188071,253556,262902,330421	p	350011056000015000	0-3531						KEGG T01001: 57521	www.genome.jp	0	0		RPTOR,NPTX1
987	chr19	52772646	52772672	3500324057	23		52772646	52772672	8421504	3	5,5,13	0,7,13	g	350032405700000095	23-46						Endoglucanase gene promoter upregulated by nematodes - US Patent 6906241 Description	ww.patentstorm.us	0	0		
990	chr19	53150440	53150464	3500147660	23		53150440	53150464	8421504	2	16,7	0,17	c	350014766000000000,350014766000000001	0-23,0-23						THESE L&#x2019;UNIVERSITE BORDEAUX 1	mm.u-bordeaux1.fr	0	0		NPTX1
990	chr19	53151198	53156091	3500398619	744		53151198	53156091	8421504	11	39,87,43,125,99,63,9,84,3,24,168	0,42,135,2249,2395,3727,3808,3823,4686,4695,4725	p	350039861900015004	30-1923						Composition and method for treatment and prevention of restenosis - US Patent 7101852 Description	ww.patentstorm.us	0	0		
990	chr19	53154955	53154990	3500170547	35		53154955	53154990	8421504	1	35	0	c	350017054700000077	0-35						Methods of preventing or treating brain ischemia or brain injury - US Patent 7202211 Description	ww.patentstorm.us	0	0		
993	chr19	53579424	53579543	3500140892	66		53579424	53579543	8421504	2	45,21	0,98	p,c,g	350014089200015000,350014089200000003,350014089200000003	0-45,0-21,0-21						Eukaryotic Translation Initiation Factor 4AIII (eIF4AIII) Is Functionally Distinct from eIF4AI and eIF4AII	mcb.asm.org	0	0		EIF4A3
993	chr19	53596902	53603291	3500136956	141		53596902	53603291	8421504	4	45,46,2,48	0,48,1285,6341	p	350013695600015039,350013695600015038,350013695600015029	0-45,0-48,0-48						IDENTIFICACI&#xd3;N Y CARACTERIZACI&#xd3;N FUNCIONAL DE MUTACIONES EN EL GEN GAA EN PACIENTES COLOMBIANOS AFECTADOS POR LA ENFERMEDAD DE POMPE	y.urosario.edu.co	0	0		
993	chr19	53603261	53606813	3500265346	99		53603261	53606813	8421504	3	33,39,27	0,154,3525	c	350026534600000124,350026534600000122,350026534600000108	0-33,9-48,21-48						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
995	chr19	53850885	53850913	3500191325	24		53850885	53850913	8421504	2	14,10	0,18	g	350019132500000051	11-38						Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms	Stearns	2002	0		
996	chr19	53897844	53899038	3500263908	26		53897844	53899038	8421504	3	9,3,14	0,10,1180	c	350026390800000216	7-33						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
996	chr19	53897844	53899038	3500037971	26		53897844	53899038	8421504	3	9,3,14	0,10,1180	c	350003797100000216	7-33						Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor - Patent application	www.faqs.org	0	0		
998	chr19	54160615	54160639	3500459021	23		54160615	54160639	8421504	2	9,14	0,10	g	350045902100000558	10-45						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
1001	chr19	54569747	54569771	3500368576	24		54569747	54569771	8421504	1	24	0	c	350036857600000281	10-40						Alanine 2, 3 aminomutases - Patent application	www.faqs.org	0	0		
1001	chr19	54604996	54605047	3500338854	51		54604996	54605047	8421504	1	51	0	c	350033885400000000	0-51						COMPOSITION AND METHOD TO INCREASE MAMMALIAN SPERM FUNCTION	Mccauley	2007	0		
1001	chr19	54605034	54605057	3500121297	23		54605034	54605057	8421504	1	23	0	g	350012129700000004	0-23		11133694	10.1095/biolreprod64.1.359	0006-3363	Biology of Reproduction	Feed Restriction and Insulin Treatment Affect Subsequent Luteal Function in the Immediate Postovulatory Period in Pigs: Progesterone Production In Vitro and Messenger Ribonucleic Acid Expression for Key Steroidogenic Enzymes	Mao	2001	4		TIMP2
1001	chr19	54605047	54654654	3500257787	270		54605047	54654654	8421504	8	45,31,14,45,45,1,44,45	0,48,37298,37315,39703,39751,49515,49562	p	350025778700015092,350025778700015093,350025778700015094,350025778700015099,350025778700015100,350025778700015101	0-45,0-45,0-45,0-45,0-45,0-45						Human Antibodies Derived From Immunized Xenomice 	.freshpatents.com	0	0		
1001	chr19	54605074	54656202	3500098466	210		54605074	54656202	8421504	3	45,102,63	0,49511,51065	p	350009846600015002,350009846600015001,350009846600015006,350009846600015000	0-45,0-72,3-72,45-147						Matrix metalloproteinase inhibitor peptides	Krutzsh	1990	0		
1001	chr19	54629498	54629525	3500115982	23		54629498	54629525	8421504	2	10,13	0,14	c	350011598200000388	2-25						Human telomerase catalytic subunit: diagnostic and therapeutic methods	Cech	1997	0		
1001	chr19	54642353	54656334	3500271973	192		54642353	54656334	8421504	4	60,36,45,51	0,12295,13840,13930	p,c,g	350027197300015011,350027197300000004,350027197300000004,350027197300000003,350027197300000002,350027197300000001,350027197300000001	0-60,0-51,0-51,0-36,0-45,0-51,0-51						Metalloproteinase inhibitor	Boone	1990	0		
1001	chr19	54642353	54656334	3500211724	162		54642353	54656334	8421504	3	60,51,51	0,13840,13930	p,c,g	350021172400015012,350021172400000004,350021172400000004,350021172400000002,350021172400000002,350021172400000001,350021172400000001	0-60,0-51,0-51,0-51,0-51,0-51,0-51					Patent	Metalloproteinase inhibitor (Patent US:6946264)	Langley	2005	0		
1001	chr19	54642353	54656334	3500198360	162		54642353	54656334	8421504	3	60,51,51	0,13840,13930	p,c,g	350019836000015014,350019836000000004,350019836000000004,350019836000000002,350019836000000002,350019836000000001,350019836000000001	0-60,0-51,0-51,0-51,0-51,0-51,0-51						Metalloproteinase inhibitor	Langley	2004	0		
1001	chr19	54642353	54656334	3500101469	162		54642353	54656334	8421504	3	60,51,51	0,13840,13930	p,c,g	350010146900015013,350010146900000004,350010146900000004,350010146900000002,350010146900000002,350010146900000001,350010146900000001	0-60,0-51,0-51,0-51,0-51,0-51,0-51						Metalloproteinase inhibitor - Patent #06946264	w.strutpatent.com	0	0		
1001	chr19	54642426	54644695	3500423027	25		54642426	54644695	8421504	2	20,5	0,2264	c	350042302700000004	0-25						Danelle Badenhorst Sympathetic Activation and Heart Failure	dspace.wits.ac.za	0	0		
1001	chr19	54642427	54644698	3500299698	27		54642427	54644698	8421504	2	19,8	0,2263	c	350029969800000010	0-27						Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways	-publications.com	0	0		TIMP2
1001	chr19	54642427	54644698	3500228877	27		54642427	54644698	8421504	2	19,8	0,2263	c	350022887700000010	0-27						Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways	ir.cmu.edu.tw	0	0		TIMP2
1001	chr19	54642435	54654615	3500267914	41		54642435	54654615	8421504	3	11,11,19	0,2255,12161	c	350026791400000006,350026791400000007	0-22,0-19						Total Flavonoids of Scutellaria barbata Inhibit Invasion of Hepatocarcinoma via MMP/TIMP in Vitro	www.mdpi.com	0	0		TIMP2
1001	chr19	54654592	54654661	3500402403	69		54654592	54654661	8421504	1	69	0	c	350040240300000023,350040240300000096,350040240300000097	0-69,0-22,0-22						Gene Expression Markers for Response to EGFR Inhibitor Drugs	Agus	2008	0		TIMP2
1001	chr19	54654638	54656224	3500134803	42		54654638	54656224	8421504	2	21,21	0,1565	c	350013480300000024,350013480300000025	0-21,0-21						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
1001	chr19	54654640	54656224	3500263461	48		54654640	54656224	8421504	2	24,24	0,1560	c	350026346100000006,350026346100000007	0-24,0-24						Isolation and culture of Preantral Follicles	www.cbra.org.br	0	0		
1001	chr19	54656232	54656316	3500111035	84		54656232	54656316	8421504	1	84	0	p	350011103500015072,350011103500015071	0-57,0-60						Cysteine-containing or methioine-containing peptides with immunomodulatory effects	Bergstrand	1997	0		TIMP2
1001	chr19	54656310	54656334	3500338854	24		54656310	54656334	8421504	1	24	0	c	350033885400000003	0-24						COMPOSITION AND METHOD TO INCREASE MAMMALIAN SPERM FUNCTION	Mccauley	2007	0		
1002	chr19	54773682	54773705	3500258455	23		54773682	54773705	8421504	1	23	0	g	350025845500000007	0-23			10.1093/emboj/cdg101		The EMBO Journal	Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration	Thomas	2003	0		
1004	chr19	54971869	54972181	3500007194	82		54971869	54972181	8421504	6	13,12,22,3,16,16	0,15,103,162,194,296	g	350000719400000528	18-114						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1004	chr19	55003472	55003588	3500270416	73		55003472	55003588	8421504	2	22,51	0,65	c,g	350027041600000029,350027041600000097,350027041600000008,350027041600000076,350027041600000028,350027041600000096,350027041600000091	0-22,0-22,2-53,0-50,3-26,0-23,0-21						IMMUNOMODULATORY AGENTS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1004	chr19	55003553	55003586	3500337493	33		55003553	55003586	8421504	1	33	0	c	350033749300000000,350033749300000002	5-35,17-37						Functional fragment of the lectine receptor	Eyckerman	2002	0		
1004	chr19	55003553	55003586	3500220148	33		55003553	55003586	8421504	1	33	0	c	350022014800000041,350022014800000000,350022014800000005,350022014800000053	5-35,5-35,17-37,17-37						Reversed mammalian protein-protein interaction trap - Patent application	www.faqs.org	0	0		
1004	chr19	55003553	55003586	3500094209	33		55003553	55003586	8421504	1	33	0	c	350009420900000000,350009420900000002	5-35,17-37						ScienceDirect.com - FEBS Letters - Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor	sciencedirect.com	0	0		
1004	chr19	55003553	55003578	3500368322	25		55003553	55003578	8421504	1	25	0	c	350036832200000000	5-30						Reversed mammalian protein-protein interaction trap	Eyckerman	2003	0		
1004	chr19	55003557	55003584	3500081711	27		55003557	55003584	8421504	1	27	0	c	350008171100000014	0-27		21294722	10.1111/j.1365-2567.2010.03379.x		Immunology	Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10	Yun	2011	0		
1004	chr19	55003562	55003842	3500463894	63		55003562	55003842	8421504	3	23,20,20	0,72,260	c	350046389400000000,350046389400000002,350046389400000003	0-23,0-20,0-20		16914720	10.1128/MCB.00207-06	0270-7306	Molecular and Cellular Biology	Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells	Sands	2006	6		SOCS3
1004	chr19	55003562	55003842	3500146751	63		55003562	55003842	8421504	3	23,20,20	0,72,260	c	350014675100000000,350014675100000002,350014675100000003	0-23,0-20,0-20			10.1128/MCB.00207-06		Molecular and Cellular Biology	Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells	William	2006	0		SOCS3
1004	chr19	55003562	55003585	3500272708	23		55003562	55003585	8421504	1	23	0	c	350027270800000007	0-23						Copyright &#xa9; 2012, American Society for Microbiology. All Rights Reserved.	jvi.asm.org	0	0		SOCS3
1004	chr19	55003562	55003585	3500268929	23		55003562	55003585	8421504	1	23	0	c	350026892900000008	0-23		22491449	10.1128/JVI.06872-11	0022-538X	Journal of Virology	CD44 Participates in IP-10 Induction in Cells in Which Hepatitis C Virus RNA Is Replicating, through an Interaction with Toll-Like Receptor 2 and Hyaluronan	Abe	2012	5		SOCS3
1004	chr19	55003563	55003700	3500283310	40		55003563	55003700	8421504	2	20,20	0,117	c	350028331000000004,350028331000000005	0-20,0-20			10.1128/IAI.73.11.7332-7339.2005		Infection and Immunity	Burkholderia pseudomallei-Induced Expression of Suppressor of Cytokine Signaling 3 and Cytokine-Inducible Src Homology 2-Containing Protein in Mouse Macrophages: a Possible Mechanism for Suppression of the Response to Gamma Interferon Stimulation 	P.	2005	0		SOCS3
1004	chr19	55003611	55004247	3500004083	240		55003611	55004247	8421504	4	96,48,48,48	0,192,288,588	c	350000408300000327,350000408300000328,350000408300000331,350000408300000333,350000408300000339	0-48,0-48,0-48,0-48,0-48						Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins	Hancock	2001	0		
1004	chr19	55003626	55004192	3500347609	40		55003626	55004192	8421504	2	20,20	0,546	c	350034760900000010,350034760900000002,350034760900000003	26-46,0-20,0-20		16306613	10.1128/JVI.79.24.15417-15429.2005	0022-538X	Journal of Virology	SOCS1 and SOCS3 Are Targeted by Hepatitis C Virus Core/gC1qR Ligation To Inhibit T-Cell Function	Yao	2005	5		
1004	chr19	55003637	55003681	3500221463	42		55003637	55003681	8421504	2	21,21	0,23	c,g	350022146300000009,350022146300000011,350022146300000011	0-21,0-21,0-21		16199887	10.1128/MCB.25.20.9115-9126.2005	0270-7306	Molecular and Cellular Biology	SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation	Tannahill	2005	6		SOCS3
1004	chr19	55004132	55004231	3500371489	65		55004132	55004231	8421504	3	22,24,19	0,30,80	c,g	350037148900000005,350037148900000007,350037148900000007,350037148900000006,350037148900000006	0-22,0-24,0-24,0-19,0-19						Mammary Response to Exogenous Prolactin or Frequent Milking During Early Lactation in Dairy Cows	circlescience.biz	0	0		
1005	chr19	55105011	55105037	3500374909	23		55105011	55105037	8421504	2	9,14	0,12	c	350037490900000460	3-26						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
1005	chr19	55109616	55111635	3500040185	42		55109616	55111635	8421504	3	5,16,21	0,1495,1998	c,g	350004018500000052,350004018500000051,350004018500000051	0-21,0-21,0-21						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
1005	chr19	55111186	55111641	3500409932	40		55111186	55111641	8421504	2	20,20	0,435	c,g	350040993200000066,350040993200000066,350040993200000065,350040993200000065	0-20,0-20,0-20,0-20						Characterization of Canine Mammary Carcinoma using Dog-Specific cDNA arrays	ive.library.uu.nl	0	0		
1005	chr19	55111215	55111582	3500130085	33		55111215	55111582	8421504	2	6,27	0,340	c	350013008500000001,350013008500000000	0-33,0-33		12789262	10.1038/sj.onc.1206417	0950-9232	Oncogene	Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy	McKay	2003	6		
1005	chr19	55111217	55111578	3500211171	27		55111217	55111578	8421504	2	4,23	0,338	c	350021117100000005,350021117100000004	0-27,0-27						Sensitization of DNA damage&#x2013;induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3S and survivin	.aacrjournals.org	0	0		
1005	chr19	55111218	55111578	3500393543	26		55111218	55111578	8421504	2	3,23	0,337	c	350039354300000003	0-26			10.1091/mbc.E02-04-0182		Molecular Biology of the Cell	Localization, Dynamics, and Function of Survivin Revealed by Expression of Functional SurvivinDsRed Fusion Proteins in the Living Cell	Achim	2003	0		
1005	chr19	55111218	55111578	3500308094	26		55111218	55111578	8421504	2	3,23	0,337	c	350030809400000003	0-26		12529428	10.1091/mbc.E02-04-0182	1059-1524	Molecular Biology of the Cell	Localization, Dynamics, and Function of Survivin Revealed by Expression of Functional SurvivinDsRed Fusion Proteins in the Living Cell	Temme	2003	5		
1005	chr19	55111218	55111577	3500268041	25		55111218	55111577	8421504	2	3,22	0,337	c	350026804100000000	0-25						Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer	-publications.com	0	0		
1005	chr19	55111555	55111581	3500200787	26		55111555	55111581	8421504	1	26	0	c	350020078700000005	0-26		14699067	10.1091/mbc.E03-07-0512	1059-1524	Molecular Biology of the Cell	A Single Amino Acid Change (Asp 53&#x2192; Ala53) Converts Survivin from Anti-apoptotic to Pro-apoptotic	Song	2004	5		
1008	chr19	55485279	55485305	3500242093	23		55485279	55485305	8421504	2	18,5	0,21	g	350024209300000036	13-39						Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof	D'andrea	2003	0		
1008	chr19	55525234	55525260	3500275017	24		55525234	55525260	8421504	3	4,5,15	0,5,11	g	350027501700000000	0-24						Antisense oligomers and methods for inducing immune tolerance and immunosuppression	Iversen	2005	0		
1008	chr19	55525234	55525260	3500207662	24		55525234	55525260	8421504	3	4,5,15	0,5,11	g	350020766200000026	0-24						Antisense oligomers and methods for inducing immune tolerance and immunosuppression	Iversen	2005	0		
1012	chr19	56096913	56096941	3500384623	23		56096913	56096941	8421504	2	11,12	0,16	g	350038462300000000	12-35						Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes	Meyer	2010	0		
1013	chr19	56132984	56185202	3500322319	102		56132984	56185202	8421504	3	45,24,33	0,8372,52185	g	350032231900000084,350032231900000107,350032231900000046	0-45,0-24,0-33						N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS	Kamar	2005	0		
1014	chr19	56278195	56278218	3500435629	23		56278195	56278218	8421504	1	23	0	c	350043562900000000	1-32						&#x30ab;&#x30eb;&#x30b7;&#x30a6;&#x30e0;&#x62ee;&#x6297;&#x85ac;&#x30a2;&#x30bc;&#x30eb;&#x30cb;&#x30b8;&#x30d4;&#x30f3;&#x306e;3T3-L1 &#x8102;&#x80aa;&#x7d30;&#x80de;&#x306b;&#x304a;&#x3051;&#x308b;&#x30a4;&#x30f3;&#x30b9;&#x30ea;&#x30f3;&#x611f;&#x53d7;	www.docin.com	0	0		
1014	chr19	56279513	56279558	3500318162	45		56279513	56279558	8421504	1	45	0	p	350031816200015002	6-51		19116344	10.1210/en.2008-0818	0013-7227	Endocrinology	Akt2 Regulation of Cdc2-Like Kinases (Clk/Sty), Serine/Arginine-Rich (SR) Protein Phosphorylation, and Insulin-Induced Alternative Splicing of PKC&#x03b2;II Messenger Ribonucleic Acid	Jiang	2009	4		MIR636
1014	chr19	56279513	56279558	3500170728	45		56279513	56279558	8421504	1	45	0	p	350017072800015002	6-51		19116344	10.1210/en.2008-0818		Endocrinology	Akt2 Regulation of Cdc2-Like Kinases (Clk/Sty), Serine/Arginine-Rich (SR) Protein Phosphorylation, and Insulin-Induced Alternative Splicing of PKC&#x03b2;II Messenger Ribonucleic Acid	Kun	2009	0		MIR636
1014	chr19	56279995	56280124	3500303775	129		56279995	56280124	8421504	1	129	0	p	350030377500015000	0-129			10.1083/jcb.200010059		The Journal of Cell Biology	ZNF265&#x2014;a novel spliceosomal protein able to induce alternative splicing	David	July	0		MIR636
1014	chr19	56281394	56281662	3500019989	40		56281394	56281662	8421504	2	20,20	0,248	c,g	350001998900000243,350001998900000243,350001998900000244	0-20,0-20,0-20						Genexpressions-Profil einer dysmyelinisierenden Doppel knock out-Mausmutante (mbp-/- plp-/-) und Rescue-Versuch des normalen Ph&#xe4;notyps	www.uni-koeln.de	0	0		SRSF2
1014	chr19	56288555	56293054	3500290029	1026		56288555	56293054	8421504	6	129,285,101,287,136,88	0,657,945,1863,2987,4411	p	350029002900015052	60-1086							rcebioscience.com	0	0		JMJD6
1014	chr19	56327989	56328014	3500335527	24		56327989	56328014	8421504	2	5,19	0,6	g	350033552700000012	4-28						PROCEEDINGS OF THE 3-rd MOSCOW CONFERENCE ON COMPUTATIONAL MOLECULAR BIOLOGY	lab6.iitp.ru	0	0		
1015	chr19	56424757	56467530	3500199785	107		56424757	56467530	8421504	5	22,22,21,21,21	0,26584,34589,42171,42752	c,g	350019978500000006,350019978500000006,350019978500000192,350019978500000192,350019978500000101,350019978500000004,350019978500000190,350019978500000074,350019978500000005,350019978500000005,350019978500000191,350019978500000191	0-22,0-22,0-22,0-22,0-22,0-21,0-21,0-21,0-21,0-21,0-21,0-21						Method For Identifying Progressive Rod-cone Degeneration In Dogs 	.freshpatents.com	0	0		
1015	chr19	56424757	56467530	3500191293	64		56424757	56467530	8421504	3	22,21,21	0,34589,42752	c,g	350019129300000006,350019129300000006,350019129300000004,350019129300000005,350019129300000005	0-22,0-22,0-21,0-21,0-21						Method for identifying progressive rod-cone degeneration in dogs	Acland	2006	0		
1015	chr19	56424757	56467530	3500098630	64		56424757	56467530	8421504	3	22,21,21	0,34589,42752	c,g	350009863000000006,350009863000000006,350009863000000004,350009863000000005,350009863000000005	0-22,0-22,0-21,0-21,0-21						Method for identifying progressive rod-cone degeneration in dogs	Acland	2006	0		
1015	chr19	56450130	56456707	3500383416	196		56450130	56456707	8421504	6	23,22,98,30,6,17	0,34,6398,6501,6550,6560	g	350038341600000051,350038341600000012,350038341600000084,350038341600000032,350038341600000083	61-118,7-186,0-67,15-113,53-110						Identification of the Gene and Mutation Responsible for Progressive Rod-Cone Degeneration in Dog and a Method for Testing Same - Patent application	www.faqs.org	0	0		
1015	chr19	56450130	56456707	3500037886	196		56450130	56456707	8421504	6	23,22,98,30,6,17	0,34,6398,6501,6550,6560	g	350003788600000051,350003788600000012,350003788600000084,350003788600000032,350003788600000083	61-118,7-186,0-67,15-114,53-110						Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same - Patent application	www.faqs.org	0	0		
1015	chr19	56451775	56456707	3500370042	281		56451775	56456707	8421504	10	12,13,16,34,16,33,104,30,6,17	0,13,61,81,155,181,4747,4856,4905,4915	g	350037004200000047,350037004200000036,350037004200000012,350037004200000084,350037004200000032,350037004200000030	194-392,0-70,7-186,0-20,15-114,0-20						US Patent # 7,312,037. Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same - Patents.com	www.patents.com	0	0		
1015	chr19	56456528	56456661	3500358064	128		56456528	56456661	8421504	2	98,30	0,103	g	350035806400000013,350035806400000034	0-70,15-114						Identification Of The Gene And Mutation Responsible For Progressive Rod-cone Degeneration In Dog And A Method For Testing Same 	.freshpatents.com	0	0		
1015	chr19	56456528	56456661	3500276079	128		56456528	56456661	8421504	2	98,30	0,103	g	350027607900000013,350027607900000035,350027607900000033	0-70,15-114,0-20						Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same	Aguirre	2005	0		
1015	chr19	56456565	56456661	3500414177	91		56456565	56456661	8421504	2	61,30	0,66	g	350041417700000023	15-114						Identification of the gene and mutation for progressive rod-cone degeneration in dog and method for testing same	Aguirre	2005	0		
1015	chr19	56456565	56456661	3500226898	91		56456565	56456661	8421504	2	61,30	0,66	g	350022689800000022	15-114						&#x02d9;& &#x02d8;	data.epo.org	0	0		
1015	chr19	56462375	56462402	3500197586	23		56462375	56462402	8421504	3	4,6,13	0,5,14	g	350019758600000000	1-24						Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice. - ResearchGate	.researchgate.net	0	0		
1015	chr19	56468018	56468041	3500155689	23		56468018	56468041	8421504	1	23	0	c	350015568900000038,350015568900000017	15-38,15-38						Antibodies Against Inducible Th2 Cell Factors 	.freshpatents.com	0	0		
1016	chr19	56511206	56511638	3500081673	77		56511206	56511638	8421504	3	6,38,33	0,348,399	g	350008167300000450	0-109						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
1016	chr19	56529993	56530502	3500065409	75		56529993	56530502	8421504	4	27,18,3,27	0,77,418,482	c	350006540900000009,350006540900000013,350006540900000007	0-27,0-21,0-27		19538336	10.1111/j.1600-079X.2009.00690.x		Journal of pineal research	Posttranscriptional regulation of pineal melatonin synthesis in Octodon degus	Soo	2009	0		
1018	chr19	56817001	56818242	3500199785	42		56817001	56818242	8421504	2	20,22	0,1219	c	350019978500000022,350019978500000023	0-20,0-22						Method For Identifying Progressive Rod-cone Degeneration In Dogs 	.freshpatents.com	0	0		
1018	chr19	56837687	56837712	3500337360	23		56837687	56837712	8421504	2	12,11	0,14	c	350033736000000087	13-36						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
1018	chr19	56837744	56837767	3500085378	23		56837744	56837767	8421504	1	23	0	c	350008537800000051	5-28					Patent	Cross-species-specific cd3-epsilon binding domain (Patent EP:2155783)	Klinger	2013	0		
1018	chr19	56837744	56837767	3500031756	23		56837744	56837767	8421504	1	23	0	c	350003175600000102	5-28						CROSS-SPECIES-SPECIFIC BINDING DOMAIN - Patent application	www.faqs.org	0	0		
1018	chr19	56871872	56871905	3500182619	29		56871872	56871905	8421504	4	10,10,5,4	0,12,23,29	c	350018261900000009,350018261900000008	1-30,10-39		20368359	10.1128/MCB.01566-09	0270-7306	Molecular and Cellular Biology	Disruption of CK2&#x03b2; in Embryonic Neural Stem Cells Compromises Proliferation and Oligodendrogenesis in the Mouse Telencephalon	Huillard	2010	6		
1018	chr19	56878254	56879614	3500209712	48		56878254	56879614	8421504	2	16,32	0,1328	c	350020971200000022	0-48						US Patent # 5,972,624. Method of identifying ligands which bind recombinant galanin receptor (GALR2) - Patents.com	www.patents.com	0	0		GALR2
1018	chr19	56879590	56879635	3500101008	45		56879590	56879635	8421504	1	45	0	c	350010100800000005	0-45						US Patent # 6,329,197. DNA encoding galanin GALR3 receptors and uses thereof - Patents.com	www.patents.com	0	0		
1018	chr19	56879686	56879731	3500077080	45		56879686	56879731	8421504	1	45	0	c	350007708000000093	0-45						Method of using cells expressing galanin receptor 3 (GALR3) - Patent # 7022489 - PatentGenius	.patentgenius.com	0	0		
1018	chr19	56879826	56879854	3500258285	28		56879826	56879854	8421504	1	28	0	c	350025828500000000	17-45					Patent	Process for determining the agonist or antagonist of galanin receptor (GALR3) (Patent US:6368812)	Bard	2002	0		
1018	chr19	56879826	56879854	3500249485	28		56879826	56879854	8421504	1	28	0	c	350024948500000000	17-45						Dna encoding galanin galr3 receptors and uses thereof	Bard	2001	0		
1019	chr19	56930476	56930501	3500106793	24		56930476	56930501	8421504	2	12,12	0,13	c	350010679300000775	19-43						Peptide That Elicits Neutralizing Antibodies Targeting The Hiv Co-receptor, Ccr5 	.freshpatents.com	0	0		
1019	chr19	56936771	56936831	3500461966	60		56936771	56936831	8421504	1	60	0	p	350046196600015025	0-60						Page de Garde	hives-ouvertes.fr	0	0		CDK3
1019	chr19	56941159	56941204	3500097734	45		56941159	56941204	8421504	1	45	0	p	350009773400015040	0-45						Cell-cycle regulatory proteins from human pathogens, and uses related thereto	Cottarel	1996	0		CDK3
1019	chr19	56942087	56942132	3500438749	45		56942087	56942132	8421504	1	45	0	p	350043874900015033	0-45						Tethering Small Molecules to a Phage Display Library: Discovery of a Selective Bivalent Inhibitor of Protein Kinase A Supporting Information	cbc.arizona.edu	0	0		CDK2
1019	chr19	56942087	56942132	3500395225	45		56942087	56942132	8421504	1	45	0	p	350039522500015001	0-45		12941801		0008-5472	Cancer Research	Targeted Expression of c-Src in Epidermal Basal Cells Leads to Enhanced Skin Tumor Promotion, Malignant Progression, and Metastasis	Matsumoto	2003	8		CDK2
1019	chr19	56942087	56942132	3500393400	45		56942087	56942132	8421504	1	45	0	p	350039340000015009	0-45						METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS - Patent application	www.faqs.org	0	0		CDK2
1019	chr19	56942087	56942132	3500339158	45		56942087	56942132	8421504	1	45	0	p	350033915800015000	0-45			10.1152/ajplung.00109.2006		American Journal of Physiology - Lung Cellular and Molecular Physiology	TNF-&#x03b1; increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia	Angelini	2006	0		CDK2
1019	chr19	56942087	56942132	3500332829	45		56942087	56942132	8421504	1	45	0	p	350033282900015003	0-45						Bicyclic pyrazolo protein kinase modulators	Bounaud	2010	0		CDK2
1019	chr19	56942087	56942132	3500275153	45		56942087	56942132	8421504	1	45	0	p	350027515300015033	0-45						Tethering Small Molecules to a Phage Display Library: Discovery of a Selective Bivalent Inhibitor of Protein Kinase A Supporting Information	.chem.arizona.edu	0	0		CDK2
1019	chr19	56942087	56942132	3500224898	45		56942087	56942132	8421504	1	45	0	p	350022489800015002	3-48		16698944	10.1105/tpc.105.040485	1040-4651	The Plant Cell Online	Arabidopsis PASTICCINO2 Is an Antiphosphatase Involved in Regulation of Cyclin-Dependent Kinase A	Costa	2006	9		CDK2
1019	chr19	56942087	56942132	3500172378	45		56942087	56942132	8421504	1	45	0	p	350017237800015000	0-45						THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 277, No. 43, Issue of October 25, pp. 41046&#x2013;41059, 2002 &#xa9; 2002 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Angiogenic Oligosaccharides of Hyaluronan Induce Mul	www.jbc.org	0	0		CDK3
1019	chr19	56942087	56942132	3500170240	45		56942087	56942132	8421504	1	45	0	p	350017024000015012	0-45						articles RhoD regulates endosome dynamics through Diaphanous-related Formin and Src tyrosine kinase	a-srv1.mpi-cbg.de	0	0		CDK2
1019	chr19	56942087	56942132	3500102099	45		56942087	56942132	8421504	1	45	0	p	350010209900015000	0-45			10.1083/jcb.200405053		The Journal of Cell Biology	Phosphorylation of DCC by Fyn mediates Netrin-1 signaling in growth cone guidance	Mayya	2004	0		CDK2
1019	chr19	56942087	56942132	3500075172	45		56942087	56942132	8421504	1	45	0	p	350007517200015000	0-45						Cbl-Mediated Degradation of Lyn and Fyn Induced by Constitutive FGFR-2 Activation Supports Osteoblast Differentiation	www.jbc.org	0	0		CDK3
1019	chr19	56942087	56942132	3500074693	45		56942087	56942132	8421504	1	45	0	p	350007469300015000	0-45		12194965	10.1074/jbc.M109443200	0021-9258	Journal of Biological Chemistry	Angiogenic Oligosaccharides of Hyaluronan Induce Multiple Signaling Pathways Affecting Vascular Endothelial Cell Mitogenic and Wound Healing Responses	Slevin	2002	5		CDK2
1019	chr19	56942087	56942132	3500047003	45		56942087	56942132	8421504	1	45	0	p	350004700300015023	0-45						Emerald Luc -pELuc&#x30d9;&#x30af;&#x30bf;&#x30fc;&#x30b7;&#x30ea;&#x30fc;&#x30ba;-	www.toyobo.co.jp	0	0		CDK2
1019	chr19	56942087	56942132	3500026756	45		56942087	56942132	8421504	1	45	0	p	350002675600015000	0-45		12429837	10.1091/mbc.E02-03-0174	1059-1524	Molecular Biology of the Cell	pp60Src Mediates Insulin-stimulated Sequestration of the &#x03b2;2-Adrenergic Receptor: Insulin Stimulates pp60Src Phosphorylation and Activation	Shumay	2002	5		CDK2
1019	chr19	56942087	56942132	3500026662	45		56942087	56942132	8421504	1	45	0	p	350002666200015018	0-45						HUMAN RIBOSOMAL DNA(rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF - CYLENE PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		CDK2
1019	chr19	56942087	56942132	3500001859	45		56942087	56942132	8421504	1	45	0	p	350000185900015000	0-45		12055094	10.1152/ajpcell.00601.2001		American Journal of Physiology - Cell Physiology	ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells	Robin	2002	0		CDK2
1019	chr19	56963906	56963930	3500054534	24		56963906	56963930	8421504	1	24	0	c	350005453400000002	19-43						&#xa9; 2011 Jing Li	eals.illinois.edu	0	0		
1019	chr19	56978964	56980034	3500261436	47		56978964	56980034	8421504	2	20,27	0,1043	c,g	350026143600000009,350026143600000009,350026143600000010	0-20,0-20,0-27						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1019	chr19	56980007	56980034	3500354668	27		56980007	56980034	8421504	1	27	0	g	350035466800000000	62-89						Characterization of Madin-Darby bovine kidney cell line for peroxisome proliferator-activated receptors: temporal response and sensitivity to fatty acids. | Massimo Bionaz - Academia.edu	www.academia.edu	0	0		
1020	chr19	57034699	57034724	3500101088	25		57034699	57034724	8421504	1	25	0	c	350010108800000020	3-30						Angiogenesis-modulating compositions and uses - Patent application	www.faqs.org	0	0		
1020	chr19	57079221	57079244	3500394944	23		57079221	57079244	8421504	1	23	0	c	350039494400000002	5-28						THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. No. Printed in U. S. A. Insulin-like Growth Factor-I Regulates Transcription of the Elastin Gene*	www.jbc.org	0	0		
1020	chr19	57117931	57118506	3500209291	357		57117931	57118506	8421504	4	81,44,154,78	0,84,243,497	p	350020929100015003,350020929100015009,350020929100015007,350020929100015010,350020929100015012,350020929100015013,350020929100015014	0-81,0-96,0-96,0-84,0-180,0-180,0-81						H3K27me3 and Cancer	Munger	2010	0		H3F3A
1020	chr19	57117940	57117988	3500335119	48		57117940	57117988	8421504	1	48	0	p	350033511900015003	0-48						A. (2009) Science, 325 (5936), pp. 90-93.	penrepository.com	0	0		H3F3A
1020	chr19	57117946	57117997	3500322713	51		57117946	57117997	8421504	1	51	0	p	350032271300015001	0-51						&#x30b7;&#x30af;&#x30ed;&#x30d7;&#x30ed;&#x30d1;&#x30f3;&#x30a2;&#x30df;&#x30f3;&#x5316;&#x5408;&#x7269;	Tomita	2013	0		H3F3A
1020	chr19	57118275	57118527	3500361312	39		57118275	57118527	8421504	2	20,19	0,233	c,g	350036131200000027,350036131200000028,350036131200000028	0-20,0-19,0-19						Tumour associated antigens	Banham	2004	0		
1021	chr19	57153693	57153718	3500039223	25		57153693	57153718	8421504	1	25	0	c	350003922300000001	12-37		12584562	10.1038/sj.onc.1206203	0950-9232	Oncogene	&#x03b1;6&#x03b2;1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells	Shimizu	2003	6		ITGB4
1021	chr19	57211689	57211716	3500393275	27		57211689	57211716	8421504	1	27	0	c	350039327500000030	5-32						Polypeptide-human actin-binding protein 54 and a polynucleotide encoding the same - US Patent 7273724 Description	ww.patentstorm.us	0	0		
1021	chr19	57241973	57241999	3500401624	25		57241973	57241999	8421504	2	21,4	0,22	c	350040162400000008	8-33						Erythropoietin forms with improved properties	Brandt	2002	0		
1021	chr19	57241973	57241999	3500245482	25		57241973	57241999	8421504	2	21,4	0,22	c	350024548200000240	19-44						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
1021	chr19	57248439	57248468	3500141286	24		57248439	57248468	8421504	2	17,7	0,22	g	350014128600000001	5-29					Patent	Alkanoic acid derivatives process for their production and use thereof (Patent US:7238716)	Momose	2007	0		
1022	chr19	57286321	57286348	3500066560	23		57286321	57286348	8421504	2	17,6	0,21	c	350006656000000002	2-28						Quantitation ofmRNA bythe polymerasechain reaction	www.pnas.org	0	0		
1022	chr19	57339296	57339319	3500214178	23		57339296	57339319	8421504	1	23	0	c	350021417800000090	6-43					Patent	Cytokine designated 4-IBB ligand (Patent US:5674704)	Alderson	1997	0		
1023	chr19	57423121	57423145	3500081860	24		57423121	57423145	8421504	1	24	0	c,g	350008186000000006,350008186000000006	4-28,4-28		18420583	10.1074/jbc.M801687200		The Journal of Biological Chemistry	Insulin-like Growth Factor-I Stimulates Shc-dependent Phosphatidylinositol 3-Kinase Activation via Grb2-associated p85 in Vascular Smooth Muscle Cells	Yashwanth	June	0		GRB2
1023	chr19	57423124	57423148	3500084112	24		57423124	57423148	8421504	1	24	0	c,g	350008411200000008,350008411200000008	9-33,9-33						Corelease of Two Fast Neurotransmitters at a Central Synapse	.meduniwien.ac.at	0	0		GRB2
1023	chr19	57423187	57535234	3500376469	48		57423187	57535234	8421504	2	12,36	0,112011	c,g	350037646900000017,350037646900000018	0-48,27-48						Grb3-3 gene, variants and uses thereof	Schweighoffer	1995	0		
127	chr19	57535279	57541492	3500441271	30		57535279	57541492	8421504	2	17,13	0,6200	c	350044127100000002,350044127100000008	10-40,10-40						TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS - Patent application	www.faqs.org	0	0		
127	chr19	57535279	57541492	3500392700	30		57535279	57541492	8421504	2	17,13	0,6200	c	350039270000000002	10-40						Trans-membrane-antibody induced inhibition of apoptosis	Brown	2004	0		GRB2
127	chr19	57535279	57541492	3500328352	30		57535279	57541492	8421504	2	17,13	0,6200	c	350032835200000002	10-40						Trans-membrane-antibody induced inhibition of apoptosis	Brown	2005	0		
127	chr19	57535291	57544398	3500359428	189		57535291	57544398	8421504	5	5,43,32,16,93	0,6188,6279,8995,9014	p	350035942800015079,350035942800015081,350035942800015082,350035942800015083	0-48,0-48,0-45,0-48						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		GRB2
127	chr19	57535291	57544398	3500322942	189		57535291	57544398	8421504	5	5,43,32,16,93	0,6188,6279,8995,9014	p	350032294200015079,350032294200015081,350032294200015082,350032294200015083	0-48,0-48,0-45,0-48						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		GRB2
127	chr19	57535291	57544398	3500075196	189		57535291	57544398	8421504	5	5,43,32,16,93	0,6188,6279,8995,9014	p	350007519600015085,350007519600015087,350007519600015088,350007519600015089	0-48,0-48,0-45,0-48						USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS	Dunnington	1997	0		GRB2
127	chr19	57535294	57544446	3500263315	285		57535294	57544446	8421504	3	2,123,160	0,6185,8992	p	350026331500015016,350026331500015014	0-285,12-288						Compositions and methods for producing bioactive fusion proteins	Walker	2008	0		GRB2
127	chr19	57535294	57544446	3500236543	285		57535294	57544446	8421504	3	2,123,160	0,6185,8992	p	350023654300015032,350023654300015028,350023654300015033,350023654300015029	0-150,12-177,0-135,0-111					Patent	Compositions and methods for producing bioactive fusion proteins (Patent US:8420779)	Walker	2013	0		GRB2
127	chr19	57535294	57544446	3500227699	285		57535294	57544446	8421504	3	2,123,160	0,6185,8992	p	350022769900015032,350022769900015028,350022769900015033,350022769900015029	0-150,12-177,0-135,0-111						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		GRB2
127	chr19	57535294	57544446	3500004002	285		57535294	57544446	8421504	3	2,123,160	0,6185,8992	p	350000400200015018,350000400200015016	0-285,12-288						COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS	Walker	2013	0		GRB2
1024	chr19	57541570	57544398	3500335247	141		57541570	57544398	8421504	3	32,16,93	0,2716,2735	p	350033524700015067,350033524700015068,350033524700015069	0-48,0-45,0-48						Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection	Dunnington	1997	0		GRB2
1024	chr19	57545303	57545369	3500056508	66		57545303	57545369	8421504	1	66	0	p	350005650800015000	0-66			10.1111/j.1365-2443.2006.00926.x	1365-2443	Genes to Cells	Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases - Honma - 2006 - Genes to Cells - Wiley Online Library	Honma	2006	0		GRB2
1024	chr19	57545345	57545371	3500081860	26		57545345	57545371	8421504	1	26	0	g	350008186000000007	28-54		18420583	10.1074/jbc.M801687200		The Journal of Biological Chemistry	Insulin-like Growth Factor-I Stimulates Shc-dependent Phosphatidylinositol 3-Kinase Activation via Grb2-associated p85 in Vascular Smooth Muscle Cells	Yashwanth	June	0		GRB2
1024	chr19	57545345	57545370	3500084112	25		57545345	57545370	8421504	1	25	0	c,g	350008411200000009,350008411200000009	8-33,8-33						Corelease of Two Fast Neurotransmitters at a Central Synapse	.meduniwien.ac.at	0	0		GRB2
1024	chr19	57563520	57563546	3500451940	23		57563520	57563546	8421504	3	11,4,8	0,12,18	g	350045194000000029	0-26						US Patent # 5,482,853. Position-specific insertion vectors and method of using same - Patents.com	www.patents.com	0	0		
1025	chr19	57764685	57764710	3500119728	25		57764685	57764710	8421504	1	25	0	g	350011972800000005	0-25						Isolation tool for viable c-kit expressing cells	Wouters	2002	0		
1025	chr19	57779832	57779876	3500156475	42		57779832	57779876	8421504	2	20,22	0,22	c	350015647500000020,350015647500000019	0-20,0-22						REPRODUCTION	uction-online.org	0	0		
1025	chr19	57781231	57782174	3500394704	40		57781231	57782174	8421504	2	20,20	0,923	c,g	350039470400000030,350039470400000030,350039470400000031	0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1025	chr19	57781231	57782174	3500292483	40		57781231	57782174	8421504	2	20,20	0,923	c,g	350029248300000030,350029248300000030,350029248300000031	0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1025	chr19	57788664	57799731	3500275298	1451		57788664	57799731	8421504	17	79,98,69,5,20,100,13,114,102,108,85,161,27,50,121,171,128	0,860,5380,5450,5456,5674,5784,5937,6359,8799,9133,9349,9522,9632,9683,10635,10939	p	350027529800015000	0-1476						KEGG T01008: 282604	www.genome.jp	0	0		
1025	chr19	57789541	57799735	3500438452	94		57789541	57799735	8421504	4	36,4,32,22	0,8337,8472,10172	c	350043845200000029,350043845200000030,350043845200000032	0-36,0-36,14-36						Process for oxidation of steroids and genetically engineered cells used therein	Slijkhuis	1998	0		
1025	chr19	57789571	57789619	3500451252	48		57789571	57789619	8421504	1	48	0	c	350045125200000050	0-48						Cholesterol disposal fusion enzymes	www.devileye.net	0	0		
1026	chr19	57809583	57809607	3500093126	23		57809583	57809607	8421504	2	19,4	0,20	c	350009312600000070	11-35						Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase - US Patent 7700319 Description	ww.patentstorm.us	0	0		
1026	chr19	57813253	57813277	3500329081	24		57813253	57813277	8421504	1	24	0	c	350032908100000001	9-33						Parallel methods for genomic analysis	Strathmann	2001	0		
1026	chr19	57813253	57813277	3500297794	24		57813253	57813277	8421504	1	24	0	c	350029779400000001	12-36						Parallel Methods For Insertional Mutagenesis	Strathmann	2007	0		
1026	chr19	57813253	57813277	3500107057	24		57813253	57813277	8421504	1	24	0	c	350010705700000001,350010705700000056	12-36,12-36						Parallel Methods For Insertional Mutagenesis - Patent application	www.faqs.org	0	0		
1026	chr19	57853350	57853379	3500385713	26		57853350	57853379	8421504	3	6,5,15	0,7,14	c	350038571300000308,350038571300000169	17-43,17-37						HETEROLOGOUS ANTIBODIES WHICH BIND HUMAN CD4 - Patent application	www.faqs.org	0	0		
1026	chr19	57853350	57853379	3500340691	26		57853350	57853379	8421504	3	6,5,15	0,7,14	c	350034069100000057,350034069100000181	17-43,17-43						Transgenic non-human animals capable of producing heterologous antibodies of various isotypes	Lonberg	1993	0		
1026	chr19	57853350	57853379	3500166201	26		57853350	57853379	8421504	3	6,5,15	0,7,14	c	350016620100000062	17-43						Transgenic non-human animals for producing chimeric antibodies	Lonberg	2004	0		
1026	chr19	57853350	57853379	3500131771	26		57853350	57853379	8421504	3	6,5,15	0,7,14	c	350013177100000230,350013177100000061	17-43,17-43					Patent	Transgenic non-human animals for producing heterologous antibodies (Patent US:5814318)	Kay	1998	0		
1026	chr19	57853350	57853379	3500097379	26		57853350	57853379	8421504	3	6,5,15	0,7,14	c	350009737900000134,350009737900000058	17-43,17-43						Transgenic non-human animals capable of producing heterologous antibodies - Patent # 5633425 - PatentGenius	.patentgenius.com	0	0		
1026	chr19	57853350	57853379	3500078884	26		57853350	57853379	8421504	3	6,5,15	0,7,14	c	350007888400000062	17-43						Transgenic Non-Human Animals For Producing Chimeric Antibodies - Patent application	www.faqs.org	0	0		
1026	chr19	57883083	57883284	3500164647	87		57883083	57883284	8421504	2	22,65	0,136	c	350016464700000010	223-453						Compositions, Splice Variants And Methods Relating To Breast Specific Genes And Proteins 	.freshpatents.com	0	0		
1026	chr19	57899362	57899458	3500061714	96		57899362	57899458	8421504	1	96	0	p,c	350006171400015032,350006171400000016	0-45,21-90						Loop-Variant Pdz Domains as Biotherapeutics, Diagnostics and Research Reagents - Patent application	www.faqs.org	0	0		
1033	chr19	58846611	58846636	3500253860	23		58846611	58846636	8421504	2	17,6	0,19	g	350025386000000035	11-37		15078966	10.1128/JVI.78.9.4847-4865.2004	0022-538X	Journal of Virology	CCAAT/Enhancer Binding Protein &#x03b1; Binds to the Epstein-Barr Virus (EBV) ZTA Protein through Oligomeric Interactions and Contributes to Cooperative Transcriptional Activation of the ZTA Promoter through Direct Binding to the ZII and ZIIIB Motifs duri	Wu	2004	5		
1037	chr19	59363250	59363274	3500391615	24		59363250	59363274	8421504	1	24	0	c	350039161500000008	11-35						Mass spectrometric detection of polypeptides	Higgins	1999	0		
1037	chr19	59367062	59367919	3500430220	69		59367062	59367919	8421504	2	66,3	0,854	p	350043022000015101	0-69						49 human secreted proteins	A	2000	0		
1038	chr19	59376447	59376597	3500386372	150		59376447	59376597	8421504	1	150	0	p	350038637200015057	0-150						Human proteins, polynucleotides encoding them and methods of using the same	Anderson	2002	0		
1038	chr19	59376447	59376597	3500082980	150		59376447	59376597	8421504	1	150	0	p	350008298000015057	0-150						Human proteins, polynucleotides encoding them and methods of using the same	Anderson	2004	0		
1042	chr19	60005844	60005876	3500402660	28		60005844	60005876	8421504	3	5,13,10	0,6,22	g	350040266000000028	2-32						Lactobacillus delbrueckii subsp. lactis DSM7290 pepG gene encodes a novel cysteine aminopeptidase	c.sgmjournals.org	0	0		
1043	chr19	60101714	60101740	3500001320	26		60101714	60101740	8421504	1	26	0	c	350000132000000001	0-26						Transcriptional and pathway analysis in the hypothalamus of newly hatched chicks during fasting and delayed feeding	biomedcentral.com	0	0		
1043	chr19	60102075	60102217	3500332640	49		60102075	60102217	8421504	2	25,24	0,118	c	350033264000000003,350033264000000002	0-25,0-24						Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion*	.endojournals.org	0	0		
1043	chr19	60102075	60102217	3500254795	49		60102075	60102217	8421504	2	25,24	0,118	c	350025479500000003,350025479500000002	0-25,0-24		16543371	10.1210/en.2005-1559	0013-7227	Endocrinology	Identification of the Somatostatin Receptor Subtypes (sst) Mediating the Divergent, Stimulatory/Inhibitory Actions of Somatostatin on Growth Hormone Secretion	Luque	2006	4		SSTR2
1043	chr19	60102386	60102409	3500236064	23		60102386	60102409	8421504	1	23	0	g	350023606400000001	0-23						Body weight gain inhibitor	Matsumoto	2004	0		
1046	chr19	60540197	60540802	3500383268	605		60540197	60540802	8421504	1	605	0	g	350038326800000009	5-610						Gene markers for beef marbling and tenderness	Jackwood	2001	0		
1052	chr19	61238595	61238618	3500189260	23		61238595	61238618	8421504	1	23	0	g	350018926000000014	5-28		20837639	10.1113/jphysiol.2010.198598	0022-3751	The Journal of Physiology	Increased fatigue resistance linked to Ca2+-stimulated mitochondrial biogenesis in muscle fibres of cold-acclimated mice	Bruton	2010	5		
1052	chr19	61264450	61264478	3500408830	23		61264450	61264478	8421504	2	15,8	0,20	g	350040883000000017	8-31						Prenatal bovine sex determination using male-specific oligonucleotides	Gingeras	1990	0		
1052	chr19	61284472	61284497	3500121284	23		61284472	61284497	8421504	2	15,8	0,17	g	350012128400000198	6-39						Seed plants exhibiting inducible early reproductive development and methods of making same	Yanofsky	1999	0		
1054	chr19	61503782	61503806	3500294433	23		61503782	61503806	8421504	2	5,18	0,6	g	350029443300000186	22-45						Polypeptide compositions toxic to anthonomus insects, and methods of use	Isaac	2001	0		
1058	chr19	62094226	62096193	3500361362	56		62094226	62096193	8421504	2	36,20	0,1947	c,g	350036136200000003,350036136200000000,350036136200000000	0-36,0-20,0-20		14602583	10.1152/ajpcell.00386.2003		American Journal of Physiology - Cell Physiolog	Gastric parietal cell secretory membrane contains PKA- and acid-activated Kir2.1 K+ channels	Malinowska	2004	0		
1058	chr19	62094226	62096193	3500346489	56		62094226	62096193	8421504	2	36,20	0,1947	c,g	350034648900000003,350034648900000000,350034648900000000	0-36,0-20,0-20		14602583	10.1152/ajpcell.00386.2003		American Journal of Physiology - Cell Physiology	Gastric parietal cell secretory membrane contains PKA- and acid-activated Kir2.1 K+ channels	Malinowska	2004	0		KCNJ2
1058	chr19	62094226	62096193	3500293015	56		62094226	62096193	8421504	2	36,20	0,1947	c,g	350029301500000003,350029301500000000,350029301500000000	0-36,0-20,0-20		14602583	10.1152/ajpcell.00386.2003		American Journal of Physiology - Cell Physiolog	Gastric parietal cell secretory membrane contains PKA- and acid-activated Kir2.1 K+ channels	Malinowska	2004	0		
1058	chr19	62095431	62095491	3500439309	60		62095431	62095491	8421504	1	60	0	p	350043930900015002	0-60						Light-Sensitive Ion-Passing Molecules	Deisseroth	2011	0		KCNJ2
1058	chr19	62095632	62095788	3500154352	156		62095632	62095788	8421504	1	156	0	p	350015435200015014	0-156						NPG.nature.vol.417.Issue.6888.May	www.scribd.com	0	0		KCNJ2
1058	chr19	62096061	62096115	3500234124	54		62096061	62096115	8421504	1	54	0	p	350023412400015000	0-54						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		KCNJ2
132	chr19	62611781	62718732	3500394810	1002		62611781	62718732	8421504	12	75,46,140,78,128,52,117,120,114,49,67,16	0,6113,12559,14551,15653,19199,19924,21259,22984,24097,34605,106935	p	350039481000015001	0-1002						KEGG T01001: 5606	www.genome.jp	0	0		ABCA5,MAP2K6
1062	chr19	62633046	62633070	3500025312	24		62633046	62633070	8421504	1	24	0	c	350002531200000012	1-25						TaiLieu.VN: B&#xe1;o c&#xe1;o Y h&#x1ecd;c: Atlantic salmon possess three mitogen activated protein kinase kinase 6 paralogs responding differently to stress 	tailieu.vn/doc/ba	0	0		
132	chr19	62646421	62718732	3500214663	48		62646421	62718732	8421504	2	32,16	0,72295	p	350021466300015001	0-48						Mitogen-activated Protein Kinase Kinase Mek6 And Methods Of Use Thereof 	.freshpatents.com	0	0		ABCA5,MAP2K6
1063	chr19	62718842	62718871	3500394185	29		62718842	62718871	8421504	1	29	0	c	350039418500000012	0-29						Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development	www.ucdenver.edu	0	0		ABCA5
1066	chr19	63096834	63099585	3500166204	837		63096834	63099585	8421504	5	20,19,159,450,189	0,792,1911,2091,2562	g	350016620400000095,350016620400000096,350016620400000092,350016620400000093,350016620400000094	0-20,0-19,0-159,0-450,0-189						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1066	chr19	63132393	63132416	3500219032	23		63132393	63132416	8421504	1	23	0	g	350021903200000040,350021903200000130	0-23,0-23						Phased Small Rnas 	.freshpatents.com	0	0		
1067	chr19	63235111	63239982	3500345122	44		63235111	63239982	8421504	2	24,20	0,4851	c	350034512200000021,350034512200000020	9-33,3-23						DPY-30 Binding Peptides	Yang	2012	0		
1067	chr19	63235165	63239946	3500430125	150		63235165	63239946	8421504	2	12,138	0,4643	p	350043012500015026,350043012500015023,350043012500015022	0-153,15-165,0-150						Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer	Gold	2012	0		PRKAR1A
1067	chr19	63235165	63239946	3500427070	150		63235165	63239946	8421504	2	12,138	0,4643	p	350042707000015051,350042707000015049,350042707000015048	0-153,15-165,0-135						Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases	Chang	2011	0		PRKAR1A
1067	chr19	63235165	63239946	3500404766	150		63235165	63239946	8421504	2	12,138	0,4643	p	350040476600015029,350040476600015032,350040476600015030	0-150,0-150,15-150						FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death	Alinari	2013	0		PRKAR1A
1067	chr19	63235165	63239946	3500377644	150		63235165	63239946	8421504	2	12,138	0,4643	p	350037764400015044,350037764400015041,350037764400015042	0-153,0-147,15-165						Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma	Burton	2012	0		PRKAR1A
1067	chr19	63235165	63239946	3500221336	150		63235165	63239946	8421504	2	12,138	0,4643	p	350022133600015043,350022133600015040,350022133600015041	0-153,0-150,15-159						COMBINATION THERAPY WITH ANTI-CD74 ANTIBODIES PROVIDES ENHANCED TOXICITY TO MALIGNANCIES, AUTOIMMUNE DISEASE AND OTHER DISEASES - IMMUNOMEDICS, INC.	www.sumobrain.com	0	0		PRKAR1A
1067	chr19	63235165	63239946	3500165028	150		63235165	63239946	8421504	2	12,138	0,4643	p	350016502800015012,350016502800015010,350016502800015009	0-153,15-165,0-150						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting	Mcbride	2012	0		PRKAR1A
1067	chr19	63235165	63239946	3500147691	150		63235165	63239946	8421504	2	12,138	0,4643	p	350014769100015042,350014769100015040,350014769100015039	0-153,15-165,0-135						Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases	Chang	2011	0		PRKAR1A
1067	chr19	63235165	63239946	3500111111	150		63235165	63239946	8421504	2	12,138	0,4643	p	350011111100015025,350011111100015026	0-150,15-165						Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity	Chang	2012	0		PRKAR1A
1067	chr19	63235165	63239946	3500100255	150		63235165	63239946	8421504	2	12,138	0,4643	p	350010025500015012,350010025500015011	15-162,0-135						Dock-and-lock (dnl) complexes for delivery of interference rna	Chang	2012	0		PRKAR1A
1067	chr19	63235165	63239946	3500080236	150		63235165	63239946	8421504	2	12,138	0,4643	p	350008023600015038,350008023600015040,350008023600015037	15-165,0-153,0-135						Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases	Chang	2011	0		PRKAR1A
1067	chr19	63235165	63239946	3500036974	150		63235165	63239946	8421504	2	12,138	0,4643	p	350003697400015011,350003697400015010,350003697400015015	15-165,0-144,0-144						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting - Patent application	www.faqs.org	0	0		PRKAR1A
1067	chr19	63235168	63239946	3500289124	147		63235168	63239946	8421504	2	9,138	0,4640	p	350028912400015015,350028912400015018,350028912400015016	0-147,0-147,15-147						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells	Chang	2011	0		PRKAR1A
1067	chr19	63235168	63239946	3500196739	147		63235168	63239946	8421504	2	9,138	0,4640	p	350019673900015021,350019673900015024,350019673900015022	0-147,0-147,15-147						Anti-HLA-DR Antibodies Suppress Allogeneic and Xenogeneic Immune Responses to Organ Transplants	Sawada	2012	0		PRKAR1A
1067	chr19	63235174	63239853	3500446950	48		63235174	63239853	8421504	2	3,45	0,4634	p	350044695000015106	0-48						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells - Patent application	www.faqs.org	0	0		
1067	chr19	63235174	63239853	3500096413	48		63235174	63239853	8421504	2	3,45	0,4634	p	350009641300015105	0-48						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting - Patent application	www.faqs.org	0	0		
1067	chr19	63235174	63239850	3500382936	45		63235174	63239850	8421504	2	3,42	0,4634	p	350038293600015184	0-45						Detection of Early-Stage Pancreatic Adenocarcinoma - Patent application	www.faqs.org	0	0		
1067	chr19	63235174	63239850	3500304681	45		63235174	63239850	8421504	2	3,42	0,4634	p	350030468100015180	0-45						Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer - Patent application	www.faqs.org	0	0		
1067	chr19	63235174	63239850	3500249189	45		63235174	63239850	8421504	2	3,42	0,4634	p	350024918900015098	0-45						Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity - Patent application	www.faqs.org	0	0		
1067	chr19	63235174	63239850	3500240466	45		63235174	63239850	8421504	2	3,42	0,4634	p	350024046600015067	0-45						FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death - Patent application	www.faqs.org	0	0		
1067	chr19	63235174	63239850	3500089169	45		63235174	63239850	8421504	2	3,42	0,4634	p	350008916900015104	0-45						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells - Patent application	www.faqs.org	0	0		
133	chr19	63436045	63439551	3500301109	182		63436045	63439551	8421504	7	21,45,45,1,44,21,5	0,51,2079,2127,3168,3477,3501	p,c	350030110900000021,350030110900000004,350030110900015044,350030110900015045,350030110900015046,350030110900000005,350030110900000022	11-32,11-32,0-45,0-45,0-45,3-29,3-29						CONFORMATION AND ACTIVITY OF GBETA5 COMPLEXES - Patent application	www.faqs.org	0	0		
1069	chr19	63460891	63470811	3500103992	44		63460891	63470811	8421504	3	3,18,23	0,1958,9897	c	350010399200000004,350010399200000005	9-30,7-30		15534226	10.1073/pnas.0407416101	0027-8424	Proceedings of the National Academy of Sciences of the United States of America	RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons	Cabrera-Vera	2004	10		
1069	chr19	63460891	63470739	3500433750	40		63460891	63470739	8421504	3	3,18,19	0,1958,9829	c	350043375000000000,350043375000000001	9-30,10-29						The &#x03b1;-Helical Domain of G&#x03b1;t Determines Specific Interaction with Regulator of G Protein Signaling 9 - ResearchGate	.researchgate.net	0	0		
1069	chr19	63466559	63466584	3500413273	25		63466559	63466584	8421504	1	25	0	c	350041327300000014	0-25		20032508	10.1152/ajpcell.00517.2008		American Journal of Physiology - Cell Physiolog	Ischemia induces regulator of G protein signaling 2 (RGS2) protein upregulation and enhances apoptosis in astrocytes	Endale	2010	0		
1069	chr19	63466559	63466584	3500016212	25		63466559	63466584	8421504	1	25	0	c	350001621200000014	0-25		20032508	10.1152/ajpcell.00517.2008		American Journal of Physiology - Cell Physiolog	Ischemia induces regulator of G protein signaling 2 (RGS2) protein upregulation and enhances apoptosis in astrocytes	Endale	2010	0		
1073	chr19	63977908	63977933	3500047399	25		63977908	63977933	8421504	1	25	0	g	350004739900000007	13-38						Phosphorylation of Nonmuscle Myosin Heavy Chain IIA on	www.jimmunol.org	0	0		
134	chr19	63977990	64234146	3500303084	119		63977990	64234146	8421504	4	5,32,58,24	0,2324,132822,256132	c	350030308400000025,350030308400000027,350030308400000059	0-48,0-47,0-24						Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof	Alvaro	1994	0		
134	chr19	64110814	64271618	3500000452	1809		64110814	64271618	8421504	15	81,112,129,157,135,97,138,174,92,63,139,81,108,141,162	0,80120,84359,105909,107104,107486,123290,124606,126714,128698,129808,144816,147256,147963,160642	p	350000045200015003	27-1836						KEGG T01007: 100855828	www.genome.jp	0	0		PRKCA,MIR634
1074	chr19	64190936	64190963	3500172162	27		64190936	64190963	8421504	1	27	0	c	350017216200000005	0-27						ProteinKinaseC PhosphorylatesaNovelArgininosuccinate SynthaseSiteatSerine328duringCalcium-dependent StimulationofEndothelialNitric-oxideSynthaseinVascular EndothelialCells	www.uncnri.org	0	0		
1074	chr19	64191030	64195180	3500232777	23		64191030	64195180	8421504	2	16,7	0,4143	c	350023277700000013	0-23						1 abstract title	tory.lib.ncsu.edu	0	0		
1074	chr19	64218356	64218388	3500448373	32		64218356	64218388	8421504	1	32	0	c	350044837300000007	0-32		16849455		0022-1767	The Journal of Immunology	Phosphorylation of Nonmuscle Myosin Heavy Chain IIA on Ser1917 Is Mediated by Protein Kinase C&#x03b2;II and Coincides with the Onset of Stimulated Degranulation of RBL-2H3 Mast Cells	Ludowyke	2006	6		
1074	chr19	64218356	64218388	3500047399	32		64218356	64218388	8421504	1	32	0	c	350004739900000008	0-32						Phosphorylation of Nonmuscle Myosin Heavy Chain IIA on	www.jimmunol.org	0	0		
591	chr2	867460	867488	3500265346	23		867460	867488	8421504	2	6,17	0,11	c	350026534600000152	20-43						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
592	chr2	1030049	1030077	3500109358	26		1030049	1030077	8421504	2	21,5	0,23	c	350010935800000036	15-41						Hepoxilins and modulators of ichthyin for treatment skin disorders	Fischer	2005	0		
592	chr2	1032837	1032897	3500071490	60		1032837	1032897	8421504	1	60	0	p	350007149000015005	0-60						Human Molecular Genetics	005.pasteur.ac.ir	0	0		CYFIP1
593	chr2	1074240	1074354	3500131070	114		1074240	1074354	8421504	1	114	0	p	350013107000015001	0-114		16597702	10.1091/mbc.E05-11-1088	1059-1524	Molecular Biology of the Cell	Filopodia Formation in the Absence of Functional WAVE- and Arp2/3-Complexes	Steffen	2006	5		CYFIP1
593	chr2	1074240	1074354	3500109568	114		1074240	1074354	8421504	1	114	0	p	350010956800015002,350010956800015001	0-114,0-108						Filopodia Formation in the Absence of Functional WAVE- and Arp2/3-Complexes D V	w.molbiolcell.org	0	0		CYFIP1
594	chr2	1285103	1286935	3500320174	23		1285103	1286935	8421504	2	17,6	0,1826	c	350032017400000046,350032017400000021	9-36,10-36						 Proteinase K Resistant Surface Protein Of Neisseria Meningitidis 	www.docstoc.com	0	0		
595	chr2	1315896	1315920	3500218972	23		1315896	1315920	8421504	2	7,16	0,8	c	350021897200000012	0-23						MOLECULAR MARKERS OF OBESITY AND DIABETES	prints.qut.edu.au	0	0		
615	chr2	3970605	3970630	3500023955	23		3970605	3970630	8421504	3	15,4,4	0,16,21	g	350002395500000002	2-25		19863663	10.1111/j.1574-695X.2009.00622.x		FEMS immunology and medical microbiology	Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages	Erin	2010	0		
617	chr2	4203259	4240364	3500079912	45		4203259	4240364	8421504	2	20,25	0,37080	c,g	350007991200000001,350007991200000001,350007991200000000	0-20,0-20,0-25						Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations	Beeler	2002	0		
620	chr2	4653332	4653360	3500134916	25		4653332	4653360	8421504	3	4,14,7	0,5,21	c	350013491600000237	6-31						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
622	chr2	4861834	4861989	3500309097	59		4861834	4861989	8421504	2	28,31	0,124	g	350030909700000066,350030909700000067	77-105,29-60						- Royo, L.J. (2002). Secuenciaci&#xf3;n y an&#xe1;lisis del gen de la miostatina bovina. Tesis Doctoral. Universidad Complutense de Madrid, **pp	www.serida.org	0	0		
622	chr2	4947510	4947538	3500092685	24		4947510	4947538	8421504	2	18,6	0,22	c	350009268500000033	4-29						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		GPR17
624	chr2	5162797	5162820	3500239616	23		5162797	5162820	8421504	1	23	0	c	350023961600000015	6-29						Nuclear Pore Behaviour in Interphase and &#x201c;Open&#x201d; Mitosis of Ustilago maydis	ub.uni-marburg.de	0	0		
624	chr2	5188718	5188742	3500197193	24		5188718	5188742	8421504	1	24	0	c	350019719300000044,350019719300000042,350019719300000043	12-35,0-20,0-19						Methods for producing thrombin	www.devileye.net	0	0		
625	chr2	5332237	5332519	3500157999	50		5332237	5332519	8421504	2	25,25	0,257	c	350015799900000003,350015799900000002	0-25,0-25		11302954	10.1136/gut.48.5.598	1468-3288	Gut	Helicobacter pylori infection induced alteration of gene expression in human gastric cells	Chiou	2001	0		ERCC3
627	chr2	5626120	5626149	3500329687	23		5626120	5626149	8421504	3	12,6,5	0,17,24	g	350032968700000015	9-34						Enzymes - Patent # 7256032 - PatentGenius	.patentgenius.com	0	0		
628	chr2	5646843	5646866	3500348183	23		5646843	5646866	8421504	1	23	0	g	350034818300000029	9-32						US Patent # 5,723,581. Murine and human box-dependent myc-interacting protein (Bin1) - Patents.com	www.patents.com	0	0		
631	chr2	6155195	6155276	3500428536	48		6155195	6155276	8421504	3	23,16,9	0,55,72	c	350042853600000003,350042853600000002	0-23,0-25						Double-muscling in mammals	Grobet	1997	0		
631	chr2	6155195	6155276	3500279741	49		6155195	6155276	8421504	2	23,26	0,55	c	350027974100000003,350027974100000002	0-23,0-26						Mutations in the myostation gene cause double-muscling in mammals	Georges	1999	0		
631	chr2	6155195	6155276	3500236344	49		6155195	6155276	8421504	2	23,26	0,55	c	350023634400000004,350023634400000003	0-23,0-26						Double-muscling in mammals	Georges	2006	0		
631	chr2	6155195	6155276	3500033147	48		6155195	6155276	8421504	3	23,16,9	0,55,72	c	350003314700000003,350003314700000002	0-23,0-25					Patent	Double-muscling in mammals (Patent US:6103466)	Georges	2000	0		
634	chr2	6530489	6530707	3500337272	40		6530489	6530707	8421504	2	20,20	0,198	g	350033727200000000,350033727200000001	0-20,0-20						Polymorphism in the 5&#x2019;flanking region of the myostatin gene affects myostatin and TGF-&#x03b2; expression in bovine skeletal muscle	www.ifzz.pl	0	0		
634	chr2	6537082	6543179	3500138395	449		6537082	6543179	8421504	4	20,219,23,187	0,756,1294,5910	c,g	350013839500000004,350013839500000007,350013839500000005,350013839500000003,350013839500000003,350013839500000000,350013839500000000,350013839500000006,350013839500000006,350013839500000001,350013839500000001	0-20,0-220,0-21,0-23,0-23,0-21,0-21,0-188,0-188,0-23,0-23						MEDOTI DI DIAGNOSI DELLE MUTAZIONI NEL GENE DELLA MIOSTATINA NELLA RAZZA MARCHIGIANA	www.anabic.it	0	0		
634	chr2	6538042	6545150	3500346706	212		6538042	6545150	8421504	8	23,20,20,20,24,20,19,66	0,67,2516,4986,5180,5868,6507,7042	c,g	350034670600000016,350034670600000013,350034670600000012,350034670600000042,350034670600000044,350034670600000044,350034670600000000,350034670600000002,350034670600000003,350034670600000004,350034670600000005,350034670600000031	0-23,0-20,0-20,0-20,0-20,0-20,0-24,0-20,0-20,0-19,1-20,0-66						METHOD FOR PREDICTING THE ATHLETIC PERFORMANCE POTENTIAL OF A SUBJECT	Hill	2011	0		
634	chr2	6538042	6538065	3500419665	23		6538042	6538065	8421504	1	23	0	g	350041966500000000	0-23		20932346	10.1186/1471-2164-11-552	1471-2164	BMC Genomics	A genome-wide SNP-association study confirms a sequence variant (g.66493737C>T) in the equine myostatin (MSTN) gene as the most powerful predictor of optimum racing distance for Thoroughbred racehorses	Hill	2010	4		MSTN
634	chr2	6538042	6538065	3500382502	23		6538042	6538065	8421504	1	23	0	g	350038250200000000	0-23						A genome-wide SNP-association study confirms a sequence variant (g.66493737C>T) in the equine myostatin (MSTN) gene as the most powerful predictor of optimum racing distance for Thoroughbred racehorses	biomedcentral.com	0	0		
634	chr2	6538046	6544520	3500428492	403		6538046	6544520	8421504	19	20,21,22,23,21,21,21,22,21,21,21,20,21,22,20,20,23,21,22	0,164,255,296,361,489,755,2343,2666,2702,2827,2963,4836,4914,5119,5254,5343,5387,6452	c,g	350042849200000007,350042849200000011,350042849200000011,350042849200000000,350042849200000008,350042849200000001,350042849200000009,350042849200000009,350042849200000026,350042849200000012,350042849200000018,350042849200000013,350042849200000013,350042849200000004,350042849200000004,350042849200000003,350042849200000003,350042849200000010,350042849200000010,350042849200000020,350042849200000023,350042849200000005,350042849200000005,350042849200000014,350042849200000014,350042849200000015,350042849200000015,350042849200000006,350042849200000006,350042849200000024,350042849200000025,350042849200000025,350042849200000016,350042849200000016	0-20,0-21,0-21,0-22,0-23,0-21,0-19,0-19,0-20,0-21,0-22,0-21,0-21,0-21,0-21,0-20,0-20,0-21,0-21,0-20,0-21,0-22,0-22,0-20,0-20,0-20,0-20,0-20,0-20,0-23,0-21,0-21,0-22,0-22						Myostatin Rapid Sequence Evolution In Ruminants Predates Domestication | Christine Janis - Academia.edu	www.academia.edu	0	0		
634	chr2	6538109	6545150	3500165929	189		6538109	6545150	8421504	7	20,20,20,24,20,19,66	0,2449,4919,5113,5801,6440,6975	c,g	350016592900000013,350016592900000012,350016592900000057,350016592900000058,350016592900000042,350016592900000044,350016592900000044,350016592900000000,350016592900000045,350016592900000002,350016592900000003,350016592900000047,350016592900000048,350016592900000004,350016592900000005,350016592900000050,350016592900000049,350016592900000031	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-24,0-24,0-20,0-20,0-20,0-20,0-19,1-20,1-20,0-19,0-66						METHOD FOR PREDICTING THE ATHLETIC PERFORMANCE POTENTIAL OF A SUBJECT - Patent application	www.faqs.org	0	0		
634	chr2	6538113	6544965	3500309097	3390		6538113	6544965	8421504	5	150,588,147,445,2060	0,155,2231,2383,4792	p,c,g	350030909700000031,350030909700000027,350030909700000053,350030909700000032,350030909700015000,350030909700000033,350030909700000033,350030909700015002,350030909700000015,350030909700000013,350030909700000059,350030909700000059,350030909700000014,350030909700000060,350030909700000016,350030909700000034,350030909700015003,350030909700000012,350030909700000049,350030909700000049,350030909700015004,350030909700000035,350030909700000036,350030909700000050,350030909700015005,350030909700000062,350030909700000063,350030909700000063,350030909700000038,350030909700015006,350030909700000047,350030909700000039,350030909700015007,350030909700015008,350030909700000040,350030909700000040,350030909700000017,350030909700000064,350030909700015009,350030909700000041,350030909700000041,350030909700000018,350030909700000019,350030909700000020,350030909700000042,350030909700000043,350030909700000022,350030909700000044,350030909700000026,350030909700000045	0-150,0-72,0-30,0-144,0-69,0-150,0-150,0-150,0-24,0-24,0-20,0-20,0-23,0-23,0-24,0-294,0-150,0-29,0-27,0-27,0-99,0-147,5-150,0-27,0-150,0-27,0-27,0-27,0-150,0-126,0-21,0-150,0-105,0-150,0-150,0-150,0-25,0-25,0-123,0-730,0-730,0-27,0-25,0-25,0-289,0-446,0-25,0-149,0-67,0-146						- Royo, L.J. (2002). Secuenciaci&#xf3;n y an&#xe1;lisis del gen de la miostatina bovina. Tesis Doctoral. Universidad Complutense de Madrid, **pp	www.serida.org	0	0		
634	chr2	6538114	6544106	3500466978	160		6538114	6544106	8421504	7	20,21,20,20,20,37,22	0,511,2905,5002,5194,5487,5970	c,g	350046697800000003,350046697800000002,350046697800000006,350046697800000009,350046697800000009,350046697800000008,350046697800000011,350046697800000010,350046697800000013,350046697800000012	0-20,0-21,0-20,0-20,0-20,0-20,0-20,0-21,0-20,0-20						A Limousin specific myostatin allele affects longissimus muscle area and fatty acid profiles in a Wagyu-Limousin F2 population	ountaincattle.com	0	0		
634	chr2	6538212	6543221	3500334574	207		6538212	6543221	8421504	8	30,20,23,27,27,27,27,26	0,265,293,449,2386,2436,2506,4983	c,g	350033457400000004,350033457400000010,350033457400000010,350033457400000011,350033457400000000,350033457400000000,350033457400000001,350033457400000013,350033457400000014,350033457400000014,350033457400000016,350033457400000015	0-30,0-20,0-20,0-23,0-27,0-27,0-27,0-27,0-27,0-27,0-25,0-25						Molecular definition of an allelic series of mutations disrupting the my ostatin function and causing double-muscling in cattle	emigracion.ucm.es	0	0		
634	chr2	6538212	6538242	3500365570	30		6538212	6538242	8421504	1	30	0	c	350036557000000000	0-30						Effects of the myostatin F94L substitution on beef traits. - ResearchGate	.researchgate.net	0	0		MSTN
634	chr2	6538212	6538242	3500024584	30		6538212	6538242	8421504	1	30	0	c	350002458400000000	0-30						Sequence characterization of coding regions of the myostatin gene (GDF8 from Brazilian Murrah buffaloes (Bubalus bubalis) and comparison with the Bos taurus sequence	www.scielo.br	0	0		MSTN
634	chr2	6538214	6543507	3500132190	3194		6538214	6543507	8421504	10	20,373,555,166,23,814,201,330,692,20	0,129,2330,2886,3053,3077,3892,4094,4425,5273	c,g	350013219000000007,350013219000000007,350013219000000011,350013219000000014,350013219000000016,350013219000000004,350013219000000004,350013219000000000,350013219000000003,350013219000000006,350013219000000006,350013219000000015,350013219000000005,350013219000000005,350013219000000008,350013219000000008	0-20,0-20,0-1128,0-1077,0-2540,0-20,0-20,0-20,0-25,0-19,0-19,0-118,0-20,0-20,0-20,0-20						Diagnostic method	Blichfeldt	2007	0		
634	chr2	6538343	6543331	3500253265	984		6538343	6543331	8421504	5	192,133,155,123,381	0,240,2201,2452,4607	c,g	350025326500000102,350025326500000222,350025326500000103,350025326500000104,350025326500000105,350025326500000225,350025326500000107,350025326500000227,350025326500000108,350025326500000108,350025326500000228,350025326500000109,350025326500000229,350025326500000110,350025326500000230,350025326500000111,350025326500000231,350025326500000207,350025326500000112,350025326500000115,350025326500000064,350025326500000117,350025326500000118,350025326500000215,350025326500000119,350025326500000119,350025326500000018,350025326500000192,350025326500000120,350025326500000120,350025326500000068,350025326500000019,350025326500000241,350025326500000121,350025326500000122,350025326500000219,350025326500000071,350025326500000123,350025326500000022,350025326500000124,350025326500000125,350025326500000125	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,5-48,0-48,14-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-24,0-24						Growth Differentiation Factor-8 - Patent application	www.faqs.org	0	0		
634	chr2	6538352	6543407	3500428536	1128		6538352	6543407	8421504	6	236,48,28,374,432,10	0,240,336,2192,4598,5045	c,g	350042853600000049,350042853600000074,350042853600000050,350042853600000075,350042853600000051,350042853600000052,350042853600000098,350042853600000054,350042853600000056,350042853600000057,350042853600000058,350042853600000059,350042853600000104,350042853600000084,350042853600000039,350042853600000060,350042853600000061,350042853600000106,350042853600000062,350042853600000040,350042853600000063,350042853600000108,350042853600000041,350042853600000001,350042853600000064,350042853600000065,350042853600000090,350042853600000046,350042853600000066,350042853600000091,350042853600000067,350042853600000092,350042853600000047,350042853600000047,350042853600000069,350042853600000070,350042853600000071	0-48,0-48,0-48,0-48,0-48,0-48,0-44,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-25,0-48,0-48,0-48,0-48,0-25,0-48,0-48,0-25,0-21,0-48,0-48,0-40,0-21,0-48,0-43,0-48,0-310,0-23,0-23,0-48,0-48,0-48						Double-muscling in mammals	Grobet	1997	0		
634	chr2	6538352	6543316	3500367490	728		6538352	6543316	8421504	9	48,48,47,76,116,114,78,153,48	0,96,192,288,2192,2452,4598,4715,4916	p,c	350036749000000102,350036749000000079,350036749000000104,350036749000015121,350036749000000083,350036749000015123,350036749000000109,350036749000000110,350036749000000111,350036749000000115,350036749000000040,350036749000000116,350036749000015131,350036749000000118,350036749000000069,350036749000000120,350036749000000020,350036749000000121,350036749000000190,350036749000000122,350036749000000124	0-48,11-47,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-30,0-48,0-48						Growth differentiation factor-8	Lee	1998	0		
634	chr2	6538352	6543316	3500239104	969		6538352	6543316	8421504	4	364,116,123,366	0,2192,2443,4598	c	350023910400000102,350023910400000079,350023910400000103,350023910400000104,350023910400000105,350023910400000083,350023910400000106,350023910400000107,350023910400000108,350023910400000109,350023910400000110,350023910400000111,350023910400000064,350023910400000115,350023910400000065,350023910400000116,350023910400000093,350023910400000117,350023910400000118,350023910400000119,350023910400000096,350023910400000019,350023910400000069,350023910400000120,350023910400000020,350023910400000190,350023910400000121,350023910400000122,350023910400000072,350023910400000123,350023910400000100,350023910400000023,350023910400000124	0-48,11-47,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-30,0-48,0-48,0-48,0-48,0-48,0-48,0-48						SureChem - Document - USPTO Granted - Patent No. 5994618 - "Growth differentiation factor-8 transgenic mice" - Description	www.surechem.org	0	0		
634	chr2	6538374	6538551	3500196310	46		6538374	6538551	8421504	2	23,23	0,154	c	350019631000000002,350019631000000003	0-23,0-23		22426697	10.1038/aps.2012.12	1671-4083	Acta Pharmacologica Sinica	Contribution of Myostatin gene polymorphisms to normal variation in lean mass, fat mass and peak BMD in Chinese male offspring	Yue	2012	2		MSTN
634	chr2	6538397	6543019	3500333358	366		6538397	6543019	8421504	10	24,48,27,82,8,36,21,24,27,69	0,42,207,237,2147,2254,2398,2461,2494,4553	p,c,g	350033335800000099,350033335800015113,350033335800000100,350033335800000101,350033335800015115,350033335800000102,350033335800000102,350033335800000103,350033335800000136,350033335800000107,350033335800000110,350033335800000035,350033335800015125,350033335800000113	0-24,0-48,0-33,0-27,0-45,0-21,0-21,0-45,5-45,0-36,0-21,0-24,0-48,0-48						Promyostatin peptides and methods of using same	A*C*Mai Ke Fu Lun 	2008	0		
634	chr2	6538400	6543407	3500033147	865		6538400	6543407	8421504	10	48,48,76,164,96,18,30,21,354,10	0,96,240,2144,2356,2500,4550,4592,4628,4997	c,g	350003314700000050,350003314700000075,350003314700000052,350003314700000055,350003314700000055,350003314700000056,350003314700000057,350003314700000058,350003314700000084,350003314700000059,350003314700000061,350003314700000062,350003314700000064,350003314700000046,350003314700000046,350003314700000066,350003314700000091,350003314700000092,350003314700000047,350003314700000047,350003314700000070,350003314700000071	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-21,0-21,0-48,0-43,0-310,0-23,0-23,0-48,0-48					Patent	Double-muscling in mammals (Patent US:6103466)	Georges	2000	0		
634	chr2	6538439	6542971	3500064222	141		6538439	6542971	8421504	4	48,45,27,21	0,195,2452,4511	p	350006422200015106,350006422200015108,350006422200015118	0-48,0-45,0-48						&#x539f;&#x808c;&#x751f;&#x957f;&#x6291;&#x5236;&#x7d20;&#x80bd;&#x53ca;&#x5176;&#x4f7f;&#x7528;&#x65b9;&#x6cd5;	A*C*Mai Ke Fu Lun 	2008	0		
634	chr2	6538478	6543218	3500236344	247		6538478	6543218	8421504	10	19,22,19,43,27,25,25,21,23,23	0,27,2057,2176,2240,2344,2401,4514,4678,4717	c,g	350023634400000061,350023634400000061,350023634400000062,350023634400000063,350023634400000064,350023634400000040,350023634400000065,350023634400000065,350023634400000041,350023634400000042,350023634400000046,350023634400000049,350023634400000050,350023634400000067	0-19,0-19,0-22,0-19,0-21,0-25,0-27,0-27,0-25,0-25,0-21,0-21,0-23,0-23						Double-muscling in mammals	Georges	2006	0		
634	chr2	6540472	6543432	3500129023	1131		6540472	6543432	8421504	2	548,583	0,2377	g	350012902300000014,350012902300000001,350012902300000002,350012902300000015	0-549,0-20,0-20,0-584						INSTITUTO POLITECNICO NACIONAL	.bnct.ipn.mx:8080	0	0		
634	chr2	6540472	6543398	3500128529	95		6540472	6543398	8421504	4	23,24,24,24	0,515,2423,2902	c,g	350012852900000002,350012852900000003,350012852900000004,350012852900000005	9-32,9-33,9-33,9-33		9356471		0027-8424	Proceedings of the National Academy of Sciences	Double muscling in cattle due to mutations in the myostatin&#x2009;gene	McPherron	1997	10		
634	chr2	6540472	6540584	3500323508	40		6540472	6540584	8421504	2	20,20	0,92	c,g	350032350800000000,350032350800000005	0-20,0-20							ngaonline.uach.cl	0	0		
634	chr2	6540472	6540584	3500159818	40		6540472	6540584	8421504	2	20,20	0,92	c,g	350015981800000000,350015981800000005	0-20,0-20						Evaluaci&#xf3;n de regiones polim&#xf3;rficas del gen de la miostatina en ganado Beefmaster	www.scielo.cl	0	0		
634	chr2	6540472	6540584	3500087314	40		6540472	6540584	8421504	2	20,20	0,92	c,g	350008731400000000,350008731400000005	0-20,0-20			10.4067/S0301-732X2008000100008	0301-732X	Archivos de medicina veterinaria	Archivos de medicina veterinaria - Evaluation of polymorphic regions of myostatin gene in Beefmaster cattle breed	Moreno	2008	1		
634	chr2	6540557	6540918	3500446284	40		6540557	6540918	8421504	2	20,20	0,341	c	350044628400000000,350044628400000001	0-20,0-20						SNP identification and polymorphism analysis in exon 2 of the horse myostatin gene. - ResearchGate	.researchgate.net	0	0		
634	chr2	6540649	6543140	3500194103	107		6540649	6543140	8421504	4	20,45,20,22	0,99,2357,2469	c,g	350019410300000048,350019410300000048,350019410300000049,350019410300000049,350019410300000085,350019410300000012,350019410300000012,350019410300000013,350019410300000013	0-20,0-20,0-20,0-20,0-29,0-20,0-20,0-22,0-22						AZ IZOM DIFFERENCI&#xc1;L&#xd3;D&#xc1;ST BEFOLY&#xc1;SOL&#xd3; G&#xc9;NEK IN VITRO VIZSG&#xc1;LATA EMBRION&#xc1;LIS EREDET&#x0170; &#x0150;S-SEJTVONALAKBAN EG&#xc9;R MODELLRENDSZERBEN	phd.szie.hu	0	0		
634	chr2	6540660	6543127	3500023924	192		6540660	6543127	8421504	3	48,48,96	0,183,2371	c	350002392400000033,350002392400000063,350002392400000017,350002392400000018	0-48,0-48,0-48,0-48						Growth differentiation factor-8 (GDF-8) and polynucleotides encoding same	Lee	1995	0		
634	chr2	6540672	6543179	3500279741	119		6540672	6543179	8421504	5	25,25,25,21,23	0,150,207,2320,2484	c,g	350027974100000039,350027974100000040,350027974100000040,350027974100000041,350027974100000045,350027974100000048,350027974100000048,350027974100000049,350027974100000049	0-25,0-25,0-25,0-25,0-21,0-21,0-21,0-23,0-23						Mutations in the myostation gene cause double-muscling in mammals	Georges	1999	0		
634	chr2	6540679	6540776	3500422382	70		6540679	6540776	8421504	3	22,28,20	0,26,77	c	350042238200000000,350042238200000006,350042238200000001	0-22,0-28,0-20						&#xb0f2;&#xa65d;&#xa7ef;&#xb379;&#xadb9;&#xab7e;&#xc0cb;&#xc5e7;&#xa874;&#xb2ce;&#xa4a7;&#xabd8;&#xa5df;	www.fda.gov.tw	0	0		MSTN
634	chr2	6540679	6540776	3500414314	70		6540679	6540776	8421504	3	22,28,20	0,26,77	c,g	350041431400000000,350041431400000000,350041431400000006,350041431400000001,350041431400000001	0-22,0-22,0-28,0-20,0-20						&#xb0f2;&#xa65d;&#xa7ef;&#xb379;&#xadb9;&#xab7e;&#xc0cb;&#xc5e7;&#xa874;&#xb2ce;&#xa4a7;&#xabd8;&#xa5df;	blog.roodo.com	0	0		MSTN
634	chr2	6540679	6540776	3500194202	42		6540679	6540776	8421504	2	22,20	0,77	c,g	350019420200000002,350019420200000002,350019420200000003	0-22,0-22,0-20						Method of test for animal-derived ingredients in foods	Shih	2005	0		MSTN
634	chr2	6540679	6540776	3500018861	97		6540679	6540776	8421504	1	97	0	c,g	350001886100000034,350001886100000034,350001886100000037,350001886100000037,350001886100000051,350001886100000051,350001886100000036,350001886100000036,350001886100000035,350001886100000035	0-22,0-22,0-22,0-22,0-97,0-97,0-28,0-28,0-20,0-20						Primers, Probes And Reference Plasmid For Detection Of Meat Adulteration 	.freshpatents.com	0	0		MSTN
634	chr2	6540679	6540776	3500014515	70		6540679	6540776	8421504	3	22,28,20	0,26,77	c,g	350001451500000034,350001451500000034,350001451500000037,350001451500000037,350001451500000036,350001451500000036,350001451500000035,350001451500000035	0-22,0-22,0-22,0-22,0-28,0-28,0-20,0-20						Primers, probes and reference plasmid for detection of meat adulteration	Chiueh	2005	0		MSTN
634	chr2	6540705	6540733	3500172805	28		6540705	6540733	8421504	1	28	0	c,g	350017280500000007,350017280500000007	132-160,132-160						Safety Analysis of Foods of Animal Origin	www.scribd.com	0	0		
634	chr2	6540717	6540798	3500137273	47		6540717	6540798	8421504	2	26,21	0,60	c	350013727300000000,350013727300000001	0-26,0-21		21270350	10.1152/japplphysiol.01183.2010	8750-7587	Journal of Applied Physiology	Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice	Murphy	2011	4		MSTN
634	chr2	6540719	6540875	3500152867	52		6540719	6540875	8421504	2	27,25	0,131	c	350015286700000001,350015286700000002	0-27,0-25						Knockdown of the myostatin gene by RNA interference in caprine fibroblast cells	www.scribd.com	0	0		MSTN
634	chr2	6540726	6540819	3500201231	93		6540726	6540819	8421504	1	93	0	c	350020123100000004,350020123100000001	0-93,0-21						Assessment of the myostatin Q204X allele using an allelic discrimination assay--&#x300a;&#x9057;&#x4f20;&#x5b66;&#x548c;&#x5206;&#x5b50;&#x751f;&#x7269;&#x5b66;&#x533b;&#x5b66;&#x671f;&#x520a;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x	journal.9med.net	0	0		
634	chr2	6540726	6540819	3500080961	93		6540726	6540819	8421504	1	93	0	c	350008096100000004,350008096100000000,350008096100000001	0-93,0-26,0-21			10.1590/S1415-47572006000300017	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Assessment of the myostatin Q204X allele using an allelic discrimination assay	Sifuentes-Rincon	2006	1		
634	chr2	6540726	6540819	3500049192	93		6540726	6540819	8421504	1	93	0	c	350004919200000004,350004919200000000,350004919200000001	0-93,0-26,0-21			10.1590/S1415-47572006000300017	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Assessment of the myostatin Q204X allele using an allelic discrimination assay	Sifuentes-Rincon	2006	1		
634	chr2	6540732	6543239	3500009417	66		6540732	6543239	8421504	3	25,20,21	0,2197,2486	c,g	350000941700000000,350000941700000000,350000941700000004,350000941700000005	0-25,0-25,0-20,0-21						Doctorat ParisTech T H &#xc8; S E L Institut des Sciences et Industries (AgroParisTech)	hives-ouvertes.fr	0	0		
634	chr2	6540732	6540813	3500012705	46		6540732	6540813	8421504	2	25,21	0,60	c	350001270500000008,350001270500000009	0-26,0-21						Parra-Bracamonte GM et al. Marcadores gen&#xe9;ticos en ganado Charolais 257 Art&#xed;culos originales	alnet.unirioja.es	0	0		
634	chr2	6540735	6540917	3500450946	45		6540735	6540917	8421504	2	23,22	0,160	c,g	350045094600000000,350045094600000000,350045094600000001	0-23,0-23,0-22						 Sheep 7SK promoter for short hairpin RNA expression | Ni | Electronic Journal of Biotechnology	iotechnology.info	0	0		
634	chr2	6540735	6540917	3500383168	45		6540735	6540917	8421504	2	23,22	0,160	c,g	350038316800000011,350038316800000011,350038316800000012	0-23,0-23,0-22						Sheep 7SK promoter for short hairpin RNA expression	iotechnology.info	0	0		
634	chr2	6540747	6543271	3500344882	156		6540747	6543271	8421504	3	48,48,60	0,105,2464	c	350034488200000063,350034488200000040,350034488200000072,350034488200000023	0-48,0-48,0-48,0-48						Growth differentiation factor-8	Lee	1994	0		
634	chr2	6540771	6543313	3500405704	42		6540771	6543313	8421504	2	21,21	0,2521	c,g	350040570400000000,350040570400000001,350040570400000001	0-21,0-21,0-21		12388123	10.1152/ajpendo.00282.2002		American Journal of Physiology - Endocrinology and Metabolism	Sexual dimorphism is associated with decreased expression of processed myostatin in males	McMahon	2003	0		
634	chr2	6540771	6543313	3500345216	42		6540771	6543313	8421504	2	21,21	0,2521	c,g	350034521600000000,350034521600000001,350034521600000001	0-21,0-21,0-21		12388123	10.1152/ajpendo.00282.2002		American Journal of Physiology - Endocrinology and Metabolism	Sexual dimorphism is associated with decreased expression of processed myostatin in males	McMahon	2003	0		
634	chr2	6540771	6543313	3500007480	42		6540771	6543313	8421504	2	21,21	0,2521	c,g	350000748000000000,350000748000000001,350000748000000001	0-21,0-21,0-21		12388123	10.1152/ajpendo.00282.2002		American Journal of Physiology - Endocrinology and Metabolism	Sexual dimorphism is associated with decreased expression of processed myostatin in males	McMahon	2003	0		
634	chr2	6540801	6544838	3500152152	88		6540801	6544838	8421504	4	20,20,25,23	0,2227,2530,4014	c,g	350015215200000014,350015215200000015,350015215200000015,350015215200000016,350015215200000017	0-20,0-20,0-20,0-25,0-23						Functional effect of mir-27b on myostatin expression: a relationship in piedmontese cattle with double-muscled phenotype	biomedcentral.com	0	0		
634	chr2	6540881	6540904	3500342338	23		6540881	6540904	8421504	1	23	0	c	350034233800000001	0-23						Adaptation of tendon and muscle connective tissue to mechanical loading	www.ismc.dk	0	0		MSTN
634	chr2	6540881	6540904	3500274446	23		6540881	6540904	8421504	1	23	0	c	350027444600000004	0-23						Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans	jp.physoc.org	0	0		
634	chr2	6540881	6540904	3500245155	23		6540881	6540904	8421504	1	23	0	c	350024515500000000	0-23						Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of speci&#xfb01;c contraction types	ap.physiology.org	0	0		MSTN
634	chr2	6540881	6540904	3500148054	23		6540881	6540904	8421504	1	23	0	c	350014805400000000	0-23						Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of speci&#xfb01;c contraction types	g.library.pcc.edu	0	0		MSTN
634	chr2	6540888	6543052	3500244928	47		6540888	6543052	8421504	2	21,26	0,2138	c	350024492800000001,350024492800000002,350024492800000003	0-21,23-46,23-44						167	www.aaabg.org	0	0		
634	chr2	6540917	6543188	3500053548	239		6540917	6543188	8421504	2	1,238	0,2033	p,c,g	350005354800000003,350005354800000004,350005354800015002,350005354800000005,350005354800000005,350005354800015003,350005354800000006,350005354800000007,350005354800000001	0-60,0-60,0-60,0-60,0-60,0-60,0-59,0-25,0-21						IDENTIFICATION OF MYOSTATIN GENE c.960delG LOCUS POLYMORPHISM IN INDONESIAN LOCAL SHEEP BY USING PCR-SSCP METHOD	.jppt.undip.ac.id	0	0		
634	chr2	6540994	6542870	3500143569	53		6540994	6542870	8421504	2	26,27	0,1849	g	350014356900000000,350014356900000001	27-53,0-27						SHORT COMMUNICATION 31 Convenient genotyping of six myostatin mutations causing double-muscling in cattle using a multiplex oligonucleotide ligation assay	dspace.unitus.it	0	0		
634	chr2	6542126	6543832	3500314401	300		6542126	6543832	8421504	6	25,28,82,102,25,38	0,828,870,978,1491,1668	c,g	350031440100000000,350031440100000011,350031440100000057,350031440100000057,350031440100000084,350031440100000083,350031440100000083,350031440100000082,350031440100000019,350031440100000019,350031440100000060,350031440100000059,350031440100000058,350031440100000010,350031440100000010,350031440100000013,350031440100000013,350031440100000086,350031440100000086,350031440100000009,350031440100000003,350031440100000003,350031440100000001	0-25,0-28,0-71,0-71,5-26,6-26,6-26,0-20,0-58,0-58,0-90,0-90,0-90,0-24,0-24,0-24,0-24,0-19,0-19,0-25,0-20,0-20,0-24						SI appendix for	www.pnas.org	0	0		
634	chr2	6542895	6543398	3500463579	48		6542895	6543398	8421504	2	24,24	0,479	c,g	350046357900000004,350046357900000005	9-33,9-33		9356471			Proceedings of the National Academy of Sciences of the United States of America	Double muscling in cattle due to mutations in the myostatin&#x2009;gene	McPherron	1997	0		
634	chr2	6542895	6543398	3500352427	48		6542895	6543398	8421504	2	24,24	0,479	c,g	350035242700000000,350035242700000002,350035242700000022,350035242700000001,350035242700000003,350035242700000025	0-24,9-32,9-33,0-24,9-33,9-33						Methods For Detection Of Mutations In Myostatin Variants 	.freshpatents.com	0	0		
634	chr2	6542895	6543398	3500095484	48		6542895	6543398	8421504	2	24,24	0,479	c,g	350009548400000022,350009548400000000,350009548400000002,350009548400000001,350009548400000025,350009548400000003	9-33,0-24,9-32,0-24,9-33,9-33						Methods for Detection of Mutations in Myostatin Variants - Patent application	www.faqs.org	0	0		
634	chr2	6543026	6543071	3500148507	45		6543026	6543071	8421504	1	45	0	c,g	350014850700000002,350014850700000002,350014850700000001,350014850700000001,350014850700000006,350014850700000006	0-19,0-19,0-45,0-45,0-44,0-44						GENETICALLY MODIFIED ANIMALS AND METHODS FOR MAKING THE SAME	Fahrenkrug	2012	0		
634	chr2	6543046	6543259	3500045446	147		6543046	6543259	8421504	2	69,78	0,135	p	350004544600015005,350004544600015051,350004544600015024,350004544600015008,350004544600015019,350004544600015054	0-60,0-45,276-336,0-60,3-63,0-45						Neutralizing Epitope-Based Growth Enhancing Vaccine - Patent application	www.faqs.org	0	0		GDF11
634	chr2	6543047	6543142	3500392138	86		6543047	6543142	8421504	2	47,39	0,56	c	350039213800000365,350039213800000366,350039213800000238	0-47,9-46,0-36						Designer ligands of tgf-beta superfamily	Choe	2010	0		
634	chr2	6543049	6543316	3500390912	246		6543049	6543316	8421504	3	78,75,93	0,93,174	p	350039091200015001,350039091200015002,350039091200015003	0-78,0-75,0-93						UNIVERSITE DE LIMOGES	cations.unilim.fr	0	0		
634	chr2	6543079	6543127	3500037926	48		6543079	6543127	8421504	1	48	0	c	350003792600000019	0-48						Polynucleotides Encoding Growth Differentiation Factor-8 - Patent application	www.faqs.org	0	0		
634	chr2	6543142	6543193	3500249432	51		6543142	6543193	8421504	1	51	0	p	350024943200015000	0-51						Anti-myostatin antibodies	Smith	2007	0		MSTN
634	chr2	6543142	6543193	3500105023	51		6543142	6543193	8421504	1	51	0	p	350010502300015000	0-51						Anti-myostatin antibodies	Smith	2005	0		MSTN
634	chr2	6543181	6543241	3500449699	60		6543181	6543241	8421504	1	60	0	p	350044969900015016,350044969900015024,350044969900015027,350044969900015033,350044969900015030,350044969900015044	0-60,267-327,0-60,264-324,0-60,204-264						Purification of viruses, proteins and nucleic acids	Smith	2005	0		GDF11
634	chr2	6543355	6543378	3500178783	23		6543355	6543378	8421504	1	23	0	c	350017878300000005	0-23						MOLECULAR CLONING AND CHARACTERIZATION OF RABBIT MYOSTATIN GENE | Chetan Jawale - Academia.edu	www.academia.edu	0	0		
634	chr2	6543358	6543381	3500183398	23		6543358	6543381	8421504	1	23	0	c	350018339800000004	19-42						RESEARCH ARTICLE OPEN ACCESS MOLECULAR CLONING AND CHARACTERIZATION OF RABBIT MYOSTATIN GENE	www.iioab.org	0	0		MSTN
634	chr2	6543373	6543398	3500370703	25		6543373	6543398	8421504	1	25	0	c	350037070300000013,350037070300000001,350037070300000015	9-34,0-24,9-33						Methods for detection of mutations in myostatin variants	Lee	2003	0		MSTN
634	chr2	6543374	6543398	3500322321	24		6543374	6543398	8421504	1	24	0	c	350032232100000003,350032232100000001	9-33,0-24						Methods for detection of mutations in myostatin variants	Lee	1999	0		MSTN
634	chr2	6543374	6543398	3500144211	24		6543374	6543398	8421504	1	24	0	c	350014421100000001,350014421100000003,350014421100000025	0-24,9-33,9-33						Methods for Detection of Mutations in Myostatin Variants	Lee	2008	0		MSTN
634	chr2	6543374	6543398	3500140000	24		6543374	6543398	8421504	1	24	0	c	350014000000000001,350014000000000003	0-24,9-33						Methods for detection of mutations in myostatin variants	Lee	1999	0		MSTN
634	chr2	6544417	6544742	3500278753	48		6544417	6544742	8421504	2	23,25	0,300	c	350027875300000000,350027875300000001	0-23,0-25						Investigations into the GDF8 g 6723G-A polymorphism	animalscience.org	0	0		
637	chr2	6815988	6816015	3500167023	23		6815988	6816015	8421504	2	12,11	0,16	g	350016702300000048	0-23						Method for design and selection of efficacious antisense oligonucleotides	Tu	1998	0		
637	chr2	6852300	6858291	3500209147	41		6852300	6858291	8421504	2	20,21	0,5970	c,g	350020914700000012,350020914700000012,350020914700000013	0-20,0-20,0-21						Selection of New Appropriate Reference Genes for RT-qPCR Analysis via Transcriptome Sequencing of Cynomolgus Monkeys (Macaca fascicularis). - ResearchGate	.researchgate.net	0	0		ORMDL1
637	chr2	6913995	6914021	3500226354	23		6913995	6914021	8421504	3	7,4,12	0,8,14	g	350022635400000016,350022635400000089	13-36,13-36						Rapid Expression Cloning of Human Monoclonal Antibodies from Memory B Cells - Patent application	www.faqs.org	0	0		
639	chr2	7079995	7080020	3500241617	24		7079995	7080020	8421504	2	17,7	0,18	g	350024161700000026	0-24					Patent	Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites (Patent CN:101092628)	Zhong Ben He Xiao 	2010	0		
639	chr2	7082185	7164052	3500180929	342		7082185	7164052	8421504	6	28,68,66,30,127,23	0,515,5809,8207,9498,81844	p	350018092900015038,350018092900015072	15-177,0-180						IRON-REGULATORY FUNCTION OF HEPCIDIN IN THE CHANNEL CATFISH AND WESTERN CLAWED FROG	etd.auburn.edu	0	0		
639	chr2	7164052	7167140	3500180929	585		7164052	7167140	8421504	4	180,105,180,120	0,1042,1327,2968	p	350018092900015094,350018092900015112,350018092900015144,350018092900015201	0-180,0-105,0-180,0-120						IRON-REGULATORY FUNCTION OF HEPCIDIN IN THE CHANNEL CATFISH AND WESTERN CLAWED FROG	etd.auburn.edu	0	0		
639	chr2	7165437	7165731	3500366655	44		7165437	7165731	8421504	2	22,22	0,272	c	350036665500000001,350036665500000000	0-22,0-22						Increased intracellular iron and mineralization of cultured hFOB 1.19 cells following hepcidin activation through ferroportin-1	www.smj.org.sa	0	0		SLC40A1
639	chr2	7165698	7165739	3500169268	41		7165698	7165739	8421504	1	41	0	c	350016926800000074	6-47						Ferroportin1 antibodies and methods - US Patent 7521055 Description	ww.patentstorm.us	0	0		
640	chr2	7293072	7293100	3500193119	23		7293072	7293100	8421504	2	12,11	0,17	c	350019311900000045	9-32						NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF - Patent application	www.faqs.org	0	0		
641	chr2	7407426	7407452	3500035731	23		7407426	7407452	8421504	2	10,13	0,13	g	350003573100000002	0-23						Endoglucanases and cellulase preparations containing the same	Nakamura	1999	0		
643	chr2	7645413	7645438	3500033147	25		7645413	7645438	8421504	1	25	0	g	350003314700000030	0-25					Patent	Double-muscling in mammals (Patent US:6103466)	Georges	2000	0		
643	chr2	7674593	7674621	3500004592	26		7674593	7674621	8421504	3	15,7,4	0,16,24	g	350000459200000049	18-48						US Patent # 6,929,921. Antibody which binds human blue-light photoreceptor hCRY2 - Patents.com	www.patents.com	0	0		
80	chr2	7717922	7763745	3500236344	71		7717922	7763745	8421504	3	25,23,23	0,45657,45800	c,g	350023634400000032,350023634400000006,350023634400000005	0-25,0-23,0-23						Double-muscling in mammals	Georges	2006	0		
80	chr2	7717922	7763745	3500033147	71		7717922	7763745	8421504	3	25,23,23	0,45657,45800	c,g	350003314700000031,350003314700000005,350003314700000004,350003314700000004	0-25,0-23,0-23,0-23					Patent	Double-muscling in mammals (Patent US:6103466)	Georges	2000	0		
80	chr2	7717922	7763602	3500279741	48		7717922	7763602	8421504	2	25,23	0,45657	c,g	350027974100000031,350027974100000005	0-25,0-23						Mutations in the myostation gene cause double-muscling in mammals	Georges	1999	0		
644	chr2	7760880	7762184	3500348506	40		7760880	7762184	8421504	2	20,20	0,1284	c,g	350034850600000003,350034850600000002,350034850600000002	0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
644	chr2	7761189	7761217	3500400553	28		7761189	7761217	8421504	1	28	0	c	350040055300000149,350040055300000079	6-34,6-34						TRANSFORMANT WHICH PRODUCES GLYCINE REPEAT SEQUENCE PROTEIN - Patent application	www.faqs.org	0	0		
644	chr2	7761191	7789242	3500247627	61		7761191	7789242	8421504	3	21,20,20	0,945,28031	c,g	350024762700000042,350024762700000037,350024762700000037,350024762700000040,350024762700000040	9-30,0-20,0-20,0-20,0-20						Synthesis of human procollagens and collagens in recombinant dna systems	Kivirikki	1997	0		COL3A1
644	chr2	7761326	7762885	3500207027	40		7761326	7762885	8421504	3	12,8,20	0,764,1539	c	350020702700000005,350020702700000004	0-20,0-20						Keratocyte behavior in three-dimensional photopolymerizable poly(ethylene glycol) hydrogels	pkinsmedicine.org	0	0		
644	chr2	7762097	7763594	3500188514	46		7762097	7763594	8421504	3	22,1,23	0,795,1474	c	350018851400000003,350018851400000002	0-22,0-24						Proliferation and collagen production of human patellar tendon &#xfb01;broblasts in response to cyclic uniaxial stretching in serum-free conditions	www.pitt.edu	0	0		
644	chr2	7763579	7763745	3500428536	46		7763579	7763745	8421504	2	23,23	0,143	c	350042853600000005,350042853600000004	0-23,0-23						Double-muscling in mammals	Grobet	1997	0		
644	chr2	7788830	7788853	3500390805	23		7788830	7788853	8421504	1	23	0	c	350039080500000005	24-47						Composition for Stimulating Growth of Dermal Papilla Cells and Promoting Hair Follicle Growth Comprising Vitamin C Derivatives	Kim	2008	0		COL3A1
644	chr2	7788830	7788853	3500133135	23		7788830	7788853	8421504	1	23	0	c	350013313500000006	0-23						Composition for stimulating growth of dermal papilla cells and promoting hair follicle growth comprising vitamin c derivatives	Kim	2006	0		COL3A1
644	chr2	7788830	7788853	3500101731	23		7788830	7788853	8421504	1	23	0	c	350010173100000006	0-23						Composition for stimulating growth of dermal papilla cells and promoting hair follicle growth comprising vitamin c derivatives	KIM	2007	0		COL3A1
644	chr2	7788830	7788853	3500075205	23		7788830	7788853	8421504	1	23	0	c	350007520500000006	0-23						Composition for stimulating growth of dermal papilla cells and promoting hair follicle growth comprising vitamin c derivatives	Kim	2008	0		COL3A1
644	chr2	7789224	7799779	3500416864	44		7789224	7799779	8421504	2	22,22	0,10533	c	350041686400000005,350041686400000004	0-22,0-22						Tendon Cell Behavior and Matrix Remodeling in Degenerative Tendinopathy	www.erasmusmc.nl	0	0		COL3A1,MIR1245B
644	chr2	7789224	7799779	3500268955	44		7789224	7799779	8421504	2	22,22	0,10533	c,g	350026895500000005,350026895500000005,350026895500000004	0-22,0-22,0-22						Tendon Cell Behavior and Matrix Remodeling in Degenerative Tendinopathy	repub.eur.nl	0	0		COL3A1,MIR1245B
644	chr2	7789276	7789324	3500106263	48		7789276	7789324	8421504	1	48	0	p	350010626300015060	0-48						Protein modification method	Sato	1995	0		
644	chr2	7799785	7799811	3500331878	26		7799785	7799811	8421504	1	26	0	c	350033187800000006	11-37						Methods of producing proteins having triple-helix structure	KASE	2007	0		
648	chr2	8344834	8344975	3500408792	45		8344834	8344975	8421504	2	22,23	0,118	c	350040879200000070,350040879200000067	0-22,25-48						Engulfment gene and uses thereof	Liu	1998	0		
10	chr2	9417069	9453826	3500248879	134		9417069	9453826	8421504	6	63,6,3,38,4,20	0,65,13757,16945,35835,36737	c	350024887900000185,350024887900000037,350024887900000039,350024887900000090	0-45,0-45,1-42,20-44						Protease Inhibition 	.freshpatents.com	0	0		
656	chr2	9417069	9417114	3500390862	45		9417069	9417114	8421504	1	45	0	c	350039086200000160	0-45						Protease inhibition	Ladner	2007	0		
10	chr2	9417093	9453826	3500370584	151		9417093	9453826	8421504	7	39,6,3,38,41,4,20	0,41,13733,16921,35698,35811,36713	c	350037058400000038,350037058400000040,350037058400000448,350037058400000339,350037058400000106	0-45,1-42,7-48,20-44,20-44						Protease inhibition - Patent application	www.faqs.org	0	0		
657	chr2	9452781	9452805	3500445239	24		9452781	9452805	8421504	1	24	0	c	350044523900000017	24-48						Robert W. Li, Matthew J. Meyer, Curtis. P. Van Tassell, Tad S. Sonstegard, Erin E. Connor, Michael E. Van Amburgh, Yves R. Boisclair and Anthony V. Capuco Physiol Genomics 27:42-53, 2006. First published Jun 20, 2006; This article cites 42 articles, 25 of	ddr.nal.usda.gov	0	0		
657	chr2	9556843	9558302	3500333181	47		9556843	9558302	8421504	2	23,24	0,1435	c	350033318100000000,350033318100000002	0-23,0-24						Pharmacological and Kinetic Characterization of Adrenomedullin 1 and Calcitonin Gene-Related Peptide 1 Receptor Reporter Cell Lines S	aspetjournals.org	0	0		CALCRL
82	chr2	9558354	9594241	3500081395	42		9558354	9594241	8421504	3	4,17,21	0,24565,35866	c,g	350008139500000000,350008139500000001,350008139500000001	0-21,0-21,0-21		21334428	10.1016/j.bbi.2011.02.007		Brain, behavior, and immunity	Calcitonin Gene-related Peptide Inhibits Chemokine Production by Human Dermal Microvascular Endothelial Cells	Jing	2011	0		CALCRL
82	chr2	9558357	9594242	3500407622	40		9558357	9594242	8421504	3	1,19,20	0,24562,35865	c	350040762200000004,350040762200000005	0-20,0-20					Patent	Compounds and methods for increasing neurogenesis (Patent US:6969702)	Bertilsson	2005	0		CALCRL
82	chr2	9558357	9594242	3500007204	40		9558357	9594242	8421504	3	1,19,20	0,24562,35865	c	350000720400000004,350000720400000005	0-20,0-20						Compounds and methods for increasing neurogenesis	Bertilsson	2004	0		CALCRL
658	chr2	9585554	9585581	3500057796	23		9585554	9585581	8421504	2	7,16	0,11	g	350005779600000107	1-25						CHROMOSOME-BASED PLATFORMS - Patent application	www.faqs.org	0	0		
658	chr2	9601051	9601074	3500279987	23		9601051	9601074	8421504	1	23	0	c	350027998700000040	5-28						Process of producing glutamate derivatives - Patent # 7297800 - PatentGenius	.patentgenius.com	0	0		
661	chr2	10074903	10075059	3500279741	40		10074903	10075059	8421504	2	20,20	0,136	g	350027974100000035,350027974100000034	0-20,0-20						Mutations in the myostation gene cause double-muscling in mammals	Georges	1999	0		
663	chr2	10233739	10233919	3500279741	41		10233739	10233919	8421504	2	21,20	0,160	g	350027974100000036,350027974100000037	0-21,0-20						Mutations in the myostation gene cause double-muscling in mammals	Georges	1999	0		
663	chr2	10233741	10233798	3500419411	57		10233741	10233798	8421504	1	57	0	g	350041941100000058	0-57						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		
663	chr2	10234292	10234317	3500453829	25		10234292	10234317	8421504	1	25	0	c	350045382900000024	34-59						Solid support for mass spectrometry	Koster	2001	0		BPGM
663	chr2	10234292	10234317	3500441286	25		10234292	10234317	8421504	1	25	0	c	350044128600000015	34-59						US Patent # 6,238,871. DNA sequences by mass spectrometry - Patents.com	www.patents.com	0	0		BPGM
663	chr2	10234292	10234317	3500425166	25		10234292	10234317	8421504	1	25	0	c	350042516600000024	34-59						US Patent # 6,428,955. DNA diagnostics based on mass spectrometry - Patents.com	www.patents.com	0	0		BPGM
663	chr2	10234292	10234317	3500403475	25		10234292	10234317	8421504	1	25	0	c	350040347500000028	34-59					Patent	DNA diagnostics based on mass spectrometry (Patent US:7198893)	Koster	2007	0		BPGM
663	chr2	10234292	10234317	3500375585	25		10234292	10234317	8421504	1	25	0	c	350037558500000015,350037558500000037	34-59,34-59						 DNA Sequences By Mass Spectrometry 	www.docstoc.com	0	0		
663	chr2	10234292	10234317	3500352650	25		10234292	10234317	8421504	1	25	0	c	350035265000000028	34-59						Dna Diagnostics Based On Mass Spectrometry 	.freshpatents.com	0	0		BPGM
663	chr2	10234292	10234317	3500348251	25		10234292	10234317	8421504	1	25	0	c	350034825100000029	34-59						DNA DIAGNOSTICS BASED ON MASS SPECTROMETRY	Koster	1999	0		BPGM
663	chr2	10234292	10234317	3500335693	25		10234292	10234317	8421504	1	25	0	c	350033569300000013	34-59						US Patent # 6,194,144. DNA sequencing by mass spectrometry - Patents.com	www.patents.com	0	0		BPGM
663	chr2	10234292	10234317	3500319863	25		10234292	10234317	8421504	1	25	0	c	350031986300000013	34-59						DNA sequencing by mass spectrometry	www.devileye.net	0	0		BPGM
663	chr2	10234292	10234317	3500272332	25		10234292	10234317	8421504	1	25	0	c	350027233200000024	34-59					Patent	DNA diagnostics based on mass spectrometry (Patent US:6300076)	Koster	2001	0		BPGM
663	chr2	10234292	10234317	3500263051	25		10234292	10234317	8421504	1	25	0	c	350026305100000024	34-59					Patent	DNA diagnostics based on mass spectrometry (Patent US:6277573)	Koster	2001	0		BPGM
663	chr2	10234292	10234317	3500258338	25		10234292	10234317	8421504	1	25	0	c	350025833800000024	34-59					Patent	DNA diagnostics based on mass spectrometry (Patent US:6500621)	Koster	2002	0		BPGM
663	chr2	10234292	10234317	3500171455	25		10234292	10234317	8421504	1	25	0	c	350017145500000134,350017145500000028	34-59,34-59						Dna diagnostics based on mass spectrometry	Braun	1998	0		BPGM
663	chr2	10234292	10234317	3500128303	25		10234292	10234317	8421504	1	25	0	c	350012830300000287,350012830300000280,350012830300000289,350012830300000288,350012830300000268,350012830300000262,350012830300000261,350012830300000260,350012830300000266,350012830300000265,350012830300000028,350012830300000290,350012830300000291,350012830300000275,350012830300000276,350012830300000277,350012830300000271,350012830300000278,350012830300000279,350012830300000256,350012830300000255,350012830300000254,350012830300000253	8-33,8-33,8-33,8-33,9-34,9-34,9-34,9-34,9-34,9-34,34-59,8-33,8-33,8-33,8-33,8-33,9-34,8-33,8-33,9-32,9-31,9-30,9-29						 DNA Diagnostics Based On Mass Spectrometry 	www.docstoc.com	0	0		
663	chr2	10234292	10234317	3500118887	25		10234292	10234317	8421504	1	25	0	c	350011888700000028,350011888700000271,350011888700000265,350011888700000264,350011888700000263,350011888700000274,350011888700000269,350011888700000268,350011888700000256	34-59,9-34,9-34,9-34,9-34,9-34,9-34,9-34,9-29						DNA diagnostics based on mass spectrometry - US Patent 7198893 Description	ww.patentstorm.us	0	0		
663	chr2	10234292	10234317	3500008531	25		10234292	10234317	8421504	1	25	0	c	350000853100000015	34-59					Patent	DNA sequences by mass spectrometry (Patent US:6238871)	Koster	2001	0		BPGM
663	chr2	10247154	10353321	3500008365	3110		10247154	10353321	8421504	30	93,123,108,114,114,159,106,81,80,93,148,68,138,155,59,108,46,161,203,53,57,44,45,126,46,62,115,92,128,185	0,370,1207,1415,6474,7413,8144,9056,9518,13900,14525,15276,19246,22501,24170,25839,27341,29961,35248,35856,38722,38867,39644,40566,46532,48494,53293,56271,92625,105982	p	350000836500015000	3-3147						DrugBank: Integrin alpha-V	www.drugbank.ca	0	0		
663	chr2	10247154	10247181	3500247987	27		10247154	10247181	8421504	1	27	0	c	350024798700000003	13-40						Differential Transmission of Actin Motion Within Focal Adhesions www.sciencemag.org (this information is current as of January 5, 2007 )	dir.nhlbi.nih.gov	0	0		
663	chr2	10247578	10248647	3500006151	255		10247578	10248647	8421504	3	69,108,78	0,783,991	p	350000615100015003	918-1173						BMC Evolutionary Biology BioMed Central	biomedcentral.com	0	0		ITGAV
663	chr2	10256741	10261067	3500454191	24		10256741	10261067	8421504	2	11,13	0,4313	c	350045419100000001	0-24		10645910			American Journal of Physiology - Lung Cellular and Molecular Physiology	Vascular expression of the &#x03b1;v&#x03b2;3-integrin in lung and other organs	Singh	2000	0		ITGAV
663	chr2	10256741	10261067	3500353358	24		10256741	10261067	8421504	2	11,13	0,4313	c	350035335800000001	0-24		10645910			American Journal of Physiology - Lung Cellular and Molecular Physiology	Vascular expression of the &#x03b1;v&#x03b2;3-integrin in lung and other organs	Singh	2000	0		ITGAV
663	chr2	10256741	10261067	3500286550	24		10256741	10261067	8421504	2	11,13	0,4313	c	350028655000000001	0-24		10645910			American Journal of Physiology - Lung Cellular and Molecular Physiology	Vascular expression of the &#x03b1;v&#x03b2;3-integrin in lung and other organs	Singh	2000	0		ITGAV
663	chr2	10256741	10261067	3500271478	24		10256741	10261067	8421504	2	11,13	0,4313	c	350027147800000011	0-24						Role of Vimentin in the Inhibitory Effects of Low-Molecular- Weight Heparin on PC-3M Cell Adhesion to, and Migration through, Endothelium	aspetjournals.org	0	0		ITGAV
663	chr2	10256741	10261067	3500216362	24		10256741	10261067	8421504	2	11,13	0,4313	c	350021636200000011	0-24		21733881	10.1124/jpet.111.182055	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Role of Vimentin in the Inhibitory Effects of Low-Molecular-Weight Heparin on PC-3M Cell Adhesion to, and Migration through, Endothelium	Pan	2011	0		ITGAV
663	chr2	10277133	10300527	3500413440	40		10277133	10300527	8421504	2	20,20	0,23374	c,g	350041344000000045,350041344000000045,350041344000000015,350041344000000044	0-20,0-20,20-40,0-20						Embryo Implantation Inhibitor 	.freshpatents.com	0	0		
663	chr2	10286055	10287842	3500319127	43		10286055	10287842	8421504	3	10,11,22	0,743,1765	c	350031912700000031,350031912700000030	0-21,0-22						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
663	chr2	10353293	10353321	3500247987	28		10353293	10353321	8421504	1	28	0	c	350024798700000002	16-44						Differential Transmission of Actin Motion Within Focal Adhesions www.sciencemag.org (this information is current as of January 5, 2007 )	dir.nhlbi.nih.gov	0	0		
664	chr2	10445958	10446462	3500179772	192		10445958	10446462	8421504	2	63,129	0,375	p	350017977200015069,350017977200015070	0-192,0-66						Antibodies to secreted protein HEMCM42	Ruben	2002	0		ZC3H15
664	chr2	10445958	10446462	3500010113	192		10445958	10446462	8421504	2	63,129	0,375	p	350001011300015069,350001011300015070	0-192,0-66						32 Human Secreted Proteins	Ruben	2007	0		ZC3H15
664	chr2	10467977	10468001	3500298066	23		10467977	10468001	8421504	2	11,12	0,12	g	350029806600000004	2-25						TOXOPLASMA GONDII aND BORRELIA BURGDORFERI IXODES RICINUS TICKS FROM EaSTERN POLaND WITH THE USE OF PCR	www.aaem.pl	0	0		
665	chr2	10560177	10560207	3500128562	25		10560177	10560207	8421504	3	4,7,14	0,5,16	g	350012856200000000	1-33		19240692	10.1038/mt.2009.22		Molecular Therapy: the Journal of the American Society of Gene Therapy	High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma Treatment	Poonam	2009	0		
684	chr2	13038245	13038279	3500102363	27		13038245	13038279	8421504	4	11,4,8,4	0,12,21,30	g	350010236300000256	11-38						Ion channel	Akopian	1997	0		
692	chr2	14115875	14116214	3500337812	336		14115875	14116214	8421504	2	54,282	0,57	p	350033781200015025	0-336						Wnt antagonists and methods of treatment and screening	Satyal	2011	0		FRZB
692	chr2	14115875	14116214	3500039991	336		14115875	14116214	8421504	2	54,282	0,57	p	350003999100015027	0-336						WNT ANTAGONISTS AND METHODS OF TREATMENT AND SCREENING - ONCOMED PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		FRZB
692	chr2	14115914	14147049	3500300909	125		14115914	14147049	8421504	3	21,20,84	0,266,31051	p,c	350030090900000003,350030090900000004,350030090900015000,350030090900015004,350030090900000002	0-21,0-20,0-84,0-84,0-30					Patent	Method of modulating tissue growth using Frzb protein (Patent US:7563596)	Luyten	2009	0		
692	chr2	14115914	14147049	3500249099	125		14115914	14147049	8421504	3	21,20,84	0,266,31051	p,c	350024909900000000,350024909900000001,350024909900015005,350024909900015004,350024909900015000	0-21,0-20,0-84,0-84,0-81						Method of modulating tissue growth using Frzb protein	Hoang	2002	0		
692	chr2	14115914	14147049	3500248799	125		14115914	14147049	8421504	3	21,20,84	0,266,31051	p,c	350024879900000003,350024879900000004,350024879900015005,350024879900015004,350024879900015000,350024879900000002	0-21,0-20,0-84,0-84,0-84,0-30					Patent	Method of modulating tissue growth using Frzb Protein (Patent US:6924367)	Luyten	2005	0		
692	chr2	14115918	14115941	3500405660	23		14115918	14115941	8421504	1	23	0	c,g	350040566000000006,350040566000000006	0-23,0-23		17702698	10.1158/0008-5472.CAN-06-4666	0008-5472	Cancer Research	Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment	Giuliani	2007	8		FRZB
693	chr2	14223986	14224016	3500365635	25		14223986	14224016	8421504	3	5,7,13	0,7,17	c	350036563500000015	0-26						ALANINE 2, 3 AMINOMUTASES - CARGILL INCORPORATED	www.sumobrain.com	0	0		
693	chr2	14223986	14224016	3500122390	25		14223986	14224016	8421504	3	5,7,13	0,7,17	c	350012239000000019	0-26						Alanine 2, 3 aminomutases	Brazeau	2009	0		
693	chr2	14250068	14252473	3500202675	74		14250068	14252473	8421504	3	24,45,5	0,2009,2400	c	350020267500000001,350020267500000002	0-24,0-50						NOVEL POLYPEPTIDE AND NUCLEIC ACIDS ENCODING THE SAME	Wood	1999	0		DNAJC10
693	chr2	14261704	14261822	3500096702	48		14261704	14261822	8421504	3	29,7,12	0,95,106	c	350009670200000002,350009670200000000	11-40,0-19		12446677	10.1074/jbc.M208346200	0021-9258	Journal of Biological Chemistry	JPDI, a Novel Endoplasmic Reticulum-resident Protein Containing Both a BiP-interacting J-domain and Thioredoxin-like Motifs	Hosoda	2003	5		DNAJC10
695	chr2	14519343	14519735	3500007115	112		14519343	14519735	8421504	2	87,25	0,367	g	350000711500000001	2-114						DNA encoding mammalian phosphodiesterases	Beavo	1992	0		
10	chr2	14607383	14807329	3500007115	201		14607383	14807329	8421504	2	179,22	0,199924	c,g	350000711500000042,350000711500000042,350000711500000038	9-171,9-171,18-75						DNA encoding mammalian phosphodiesterases	Beavo	1992	0		
10	chr2	14607530	14807338	3500389626	63		14607530	14807338	8421504	2	32,31	0,199777	p	350038962600015010	0-63						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		
10	chr2	14607530	14807323	3500061337	48		14607530	14807323	8421504	2	32,16	0,199777	p	350006133700015143	0-48						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		
10	chr2	14607545	14934916	3500007115	2838		14607545	14934916	8421504	20	17,114,40,71,22,18,117,141,101,126,73,8,40,54,82,80,142,114,554,924	0,199762,225259,225371,232920,232969,236320,237275,245508,251089,257335,257429,257545,257612,270784,272921,274371,324219,325073,326447	c,g	350000711500000043,350000711500000037,350000711500000037,350000711500000004,350000711500000044,350000711500000320,350000711500000005,350000711500000006,350000711500000324,350000711500000009,350000711500000049,350000711500000011,350000711500000051,350000711500000012,350000711500000052,350000711500000013,350000711500000053,350000711500000329,350000711500000014,350000711500000054,350000711500000015,350000711500000055,350000711500000331,350000711500000056,350000711500000332,350000711500000017,350000711500000057,350000711500000018,350000711500000019,350000711500000059,350000711500000020,350000711500000020,350000711500000061,350000711500000337,350000711500000021,350000711500000063,350000711500000024,350000711500000065,350000711500000341,350000711500000066,350000711500000026,350000711500000067,350000711500000027,350000711500000068,350000711500000344,350000711500000070,350000711500000030,350000711500000071,350000711500000072,350000711500000349,350000711500000032,350000711500000033,350000711500000074,350000711500000034,350000711500000075	0-48,0-21,0-21,0-48,0-48,0-48,0-48,0-48,0-43,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-116,0-116,0-48,0-47,0-48,0-48,0-48,0-48,0-49,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-37,0-48,0-49,0-48,0-590,0-940						DNA encoding mammalian phosphodiesterases	Beavo	1992	0		
701	chr2	15273432	15273459	3500004518	23		15273432	15273459	8421504	2	8,15	0,12	g	350000451800000026	4-35						Nucleotides sequences of canola and soybean palmitoyl-acp thioesterase genes and their use in the regulation of fatty acid content of the oils of soybean and canola plants	Hitz	1997	0		
702	chr2	15356132	15356163	3500228351	25		15356132	15356163	8421504	3	4,7,14	0,5,17	g	350022835100000000	7-33						Combined strategies for the improvement of heterologous expression of a His-tagged lipolytica lipase Lip2 in Pichia pastoris	demicjournals.org	0	0		
702	chr2	15404186	15404211	3500464694	25		15404186	15404211	8421504	1	25	0	g	350046469400000002	0-25		18617687	10.1634/stemcells.2008-0108	1549-4918	STEM CELLS	Neural Induction with Neurogenin1 Increases the Therapeutic Effects of Mesenchymal Stem Cells in the Ischemic Brain - Kim - 2008 - STEM CELLS - Wiley Online Library	Kim	2008	0		
702	chr2	15404186	15404211	3500439018	25		15404186	15404211	8421504	1	25	0	g	350043901800000028	0-25						COMPOSITIONS FOR INDUCING DIFFERENTIATION INTO RETINAL CELLS FROM RETINAL PROGENITOR CELLS OR INDUCING PROLIFERATION OF RETINAL CELLS COMPRISING WNT SIGNALING PATHWAY ACTIVATORS	Park	2010	0		
702	chr2	15405809	15405833	3500075182	24		15405809	15405833	8421504	1	24	0	c	350007518200000014	0-24						NEURAL DEVELOPMENT	aldevelopment.com	0	0		
702	chr2	15405821	15405844	3500311369	23		15405821	15405844	8421504	1	23	0	c	350031136900000031	0-23						Adult Stem Cell-derived Connective Tissue Progenitors For Tissue Engineering 	.freshpatents.com	0	0		
702	chr2	15405821	15405844	3500210815	23		15405821	15405844	8421504	1	23	0	c	350021081500000031	0-23						Adult Stem Cell-derived Connective Tissue Progenitors For Tissue Engineering 	.freshpatents.com	0	0		NEUROD1
702	chr2	15406397	15406420	3500194863	23		15406397	15406420	8421504	1	23	0	c	350019486300000006	0-23						Insulin-producing bone marrow derived cells and methods of generating and using same	Efrat	2004	0		
702	chr2	15406397	15406420	3500092988	23		15406397	15406420	8421504	1	23	0	c	350009298800000056,350009298800000006	0-23,0-23						Insulin-producing Bone Marrow Derived Cells And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
702	chr2	15406658	15406955	3500215439	40		15406658	15406955	8421504	2	19,21	0,276	c,g	350021543900000025,350021543900000025,350021543900000026,350021543900000026	0-19,0-19,0-21,0-21						Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential	cs.biologists.org	0	0		NEUROD1
704	chr2	15604405	15607660	3500319127	43		15604405	15607660	8421504	3	12,10,21	0,1979,3234	c	350031912700000027,350031912700000026	0-22,0-21						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
704	chr2	15622289	15685382	3500036437	136		15622289	15685382	8421504	4	48,37,6,45	0,39620,39752,63048	c	350003643700000169,350003643700000141,350003643700000239	0-48,0-43,0-45						Antisense modulation of integrin &#x03b1;4 expression	Bennett	1999	0		
706	chr2	15887083	15887110	3500352178	23		15887083	15887110	8421504	3	5,12,6	0,6,21	g	350035217800000060	7-30						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
709	chr2	16362487	16362512	3500034292	23		16362487	16362512	8421504	2	9,14	0,11	g	350003429200000135	8-32						Methods and compositions for the response prediction of malig-nant neoplasia to treatment	Munnes	2005	0		
712	chr2	16647525	16647552	3500415445	23		16647525	16647552	8421504	2	14,9	0,18	g	350041544500000088	8-31						Molecular antigen array - US Patent 7264810 Description	ww.patentstorm.us	0	0		
712	chr2	16653733	16653759	3500032417	23		16653733	16653759	8421504	2	7,16	0,10	g	350003241700000007	6-29		16882664	10.1074/jbc.M602651200	0021-9258	Journal of Biological Chemistry	Jab1 Mediates Cytoplasmic Localization and Degradation of West Nile Virus Capsid Protein	Oh	2006	5		
722	chr2	18067775	18067799	3500376741	23		18067775	18067799	8421504	2	6,17	0,7	c	350037674100000047	0-26					Patent	F-box genes and proteins (Patent US:6573094)	Harper	2003	0		
727	chr2	18651221	18651245	3500143796	23		18651221	18651245	8421504	2	8,15	0,9	g	350014379600000057	19-45						PROTEASE VARIANTS - Patent application	www.faqs.org	0	0		
728	chr2	18802652	18802676	3500294263	23		18802652	18802676	8421504	2	9,14	0,10	g	350029426300000021,350029426300000020	0-35,0-34						ELUCIDATING THE MOLECULAR MECHANISMS OF VIBRIO CHOLERAE TOXIN COREGULATED PILUS ASSEMBLY, BUNDLING AND CTX&#x03c6; INTERACTIONS	summit.sfu.ca	0	0		
728	chr2	18827824	18827848	3500028175	23		18827824	18827848	8421504	2	13,10	0,14	g	350002817500000048	5-28						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
729	chr2	18983217	18983243	3500120392	26		18983217	18983243	8421504	1	26	0	c	350012039200000003	9-35		15635101	10.1091/mbc.E04-07-0578	1059-1524	Molecular Biology of the Cell	A Plasma Membrane Pool of Phosphatidylinositol 4-Phosphate Is Generated by Phosphatidylinositol 4-Kinase Type-III Alpha: Studies with the PH Domains of the Oxysterol Binding Protein and FAPP1	Balla	2005	5		PLEKHA3
730	chr2	19018011	19021439	3500402920	72		19018011	19021439	8421504	2	70,2	0,3426	p	350040292000015025	0-72						Identification and Analysis of Dicer Associated Proteins in Human Cells Inaugurationsdissertation	edoc.unibas.ch	0	0		PRKRA
730	chr2	19099129	19099155	3500006751	23		19099129	19099155	8421504	2	7,16	0,10	g	350000675100000007	0-23						Manufacture of five-carbon sugars and sugar alcohols	Miasnikov	2001	0		
731	chr2	19138207	19138233	3500278067	24		19138207	19138233	8421504	2	7,17	0,9	g	350027806700000003	0-24		11717296	10.1128/JB.183.24.7371-7380.2001	0021-9193	Journal of Bacteriology	RNA Expression Analysis Using an AntisenseBacillus subtilis Genome Array	Lee	2001	4		
731	chr2	19138207	19138233	3500191983	24		19138207	19138233	8421504	2	7,17	0,9	g	350019198300000003	0-24			10.1128/JB.183.24.7371-7380.2001		Journal of Bacteriology	RNA Expression Analysis Using an Antisense Bacillus subtilis Genome Array	Jian-Ming	2001	0		
734	chr2	19582785	19582809	3500193575	23		19582785	19582809	8421504	2	19,4	0,20	g	350019357500000002	6-29		20089651	10.1128/JVI.02028-09		Journal of Virology	Extralymphoid CD8+ T Cells Resident in Tissue from Simian Immunodeficiency Virus SIVmac239&#x0394;nef-Vaccinated Macaques Suppress SIVmac239 Replication Ex Vivo 	Justin	2010	0		
734	chr2	19582785	19582809	3500057550	23		19582785	19582809	8421504	2	19,4	0,20	g	350005755000000002	6-29		20089651	10.1128/JVI.02028-09	0022-538X	Journal of Virology	Extralymphoid CD8+ T Cells Resident in Tissue from Simian Immunodeficiency Virus SIVmac239&#x0394;nef-Vaccinated Macaques Suppress SIVmac239 Replication Ex Vivo	Greene	2010	5		
734	chr2	19591055	19591079	3500013112	24		19591055	19591079	8421504	1	24	0	c	350001311200000001	0-24						Regulation of human phosphodiesterase-like enzyme	Ramakrishnan	2001	0		PDE11A
735	chr2	19710241	19757270	3500460060	50		19710241	19757270	8421504	3	3,22,25	0,46900,47004	c	350046006000000001,350046006000000000	0-25,0-25						Use of agents that modulate pde11a activity	Burslem	2003	0		PDE11A
735	chr2	19710241	19757270	3500166801	50		19710241	19757270	8421504	3	3,22,25	0,46900,47004	c,g	350016680100000001,350016680100000000,350016680100000000	0-25,0-25,0-25						Modulation of PDE11A activity	Burslem	2002	0		PDE11A
735	chr2	19741154	19741185	3500337447	28		19741154	19741185	8421504	2	21,7	0,24	g	350033744700000088	3-31						Lipases preduodenales recombinantes et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations	Baudino	1996	0		
736	chr2	19809315	19814830	3500460060	45		19809315	19814830	8421504	2	3,42	0,5473	p	350046006000015000	0-45						Use of agents that modulate pde11a activity	Burslem	2003	0		PDE11A
736	chr2	19809315	19814830	3500166801	45		19809315	19814830	8421504	2	3,42	0,5473	p	350016680100015001	0-45						Modulation of PDE11A activity	Burslem	2002	0		PDE11A
736	chr2	19847890	19847926	3500025641	27		19847890	19847926	8421504	3	14,7,6	0,18,30	c	350002564100000003	6-33						CadC, the transcriptional regulatory protein of the cadmium resistance system of Staphylococcus aureus plasmid pI258. - ResearchGate	.researchgate.net	0	0		
736	chr2	19887664	19887695	3500200369	26		19887664	19887695	8421504	2	10,16	0,15	g	350020036900000126	4-30						High level expression of proteins	Seed	1996	0		
737	chr2	19957706	19961305	3500206909	42		19957706	19961305	8421504	3	20,19,3	0,39,3596	c	350020690900000007	0-60						Modulation des NF-&#x03ba;B-Signalwegs in prim&#xe4;ren Maushepatozyten	k.uni-freiburg.de	0	0		
739	chr2	20246724	20250267	3500407955	64		20246724	20250267	8421504	3	21,25,18	0,3493,3525	c	350040795500000003,350040795500000000,350040795500000001	0-21,9-57,0-48		21638050	10.1007/s10549-011-1604-1		Breast cancer research and treatment	MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism	Muhua	2011	0		
739	chr2	20247485	20248356	3500435726	25		20247485	20248356	8421504	2	22,3	0,868	c	350043572600000002	4-29		15020583	10.1074/jbc.M401368200	0021-9258	Journal of Biological Chemistry	Regulation of Nrf2 Transactivation Domain Activity	Shen	2004	5		
739	chr2	20248409	20248985	3500047878	40		20248409	20248985	8421504	2	20,20	0,556	c	350004787800000050,350004787800000051	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
739	chr2	20248965	20249096	3500355362	40		20248965	20249096	8421504	2	20,20	0,111	c,g	350035536200000002,350035536200000002,350035536200000003	0-20,0-20,0-20		24039949	10.1371/journal.pone.0073457		PLoS ONE	Lipopolysaccharide-Induced Weakness in the Preterm Diaphragm Is Associated with Mitochondrial Electron Transport Chain Dysfunction and Oxidative Stress	Yong	2013	0		
739	chr2	20249131	20249454	3500047475	45		20249131	20249454	8421504	2	24,21	0,302	c	350004747500000009,350004747500000014	0-24,0-21						THE ROLE OF PEROXIREDOXINS AS MECHANOSENSITIVE ANTIOXIDANTS IN ENDOTHELIAL CELLS	artech.gatech.edu	0	0		
739	chr2	20249460	20250267	3500398640	40		20249460	20250267	8421504	2	20,20	0,787	c	350039864000000000,350039864000000001	0-20,0-20		22532848	10.1371/journal.pone.0035313		PLoS ONE	Mild Hypothermia Attenuates Mitochondrial Oxidative Stress by Protecting Respiratory Enzymes and Upregulating MnSOD in a Pig Model of Cardiac Arrest	Ping	2012	0		
739	chr2	20249460	20250267	3500045417	40		20249460	20250267	8421504	2	20,20	0,787	c,g	350004541700000000,350004541700000001,350004541700000001	0-20,0-20,0-20		22532848	10.1371/journal.pone.0035313	1932-6203	PLOS ONE	PLOS ONE: Mild Hypothermia Attenuates Mitochondrial Oxidative Stress by Protecting Respiratory Enzymes and Upregulating MnSOD in a Pig Model of Cardiac Arrest	Gong	2012	4		
739	chr2	20259456	20264601	3500347541	69		20259456	20264601	8421504	2	24,45	0,5100	p,c	350034754100000001,350034754100015005,350034754100015002	0-24,0-45,0-45		11886857	10.1074/jbc.M200050200	0021-9258	Journal of Biological Chemistry	Heterogeneous Nuclear Ribonucleoprotein A3, a Novel RNA Trafficking Response Element-binding Protein	Ma	2002	5		HNRNPA3
739	chr2	20261528	20261995	3500225370	52		20261528	20261995	8421504	2	25,27	0,440	c	350022537000000005,350022537000000004	0-25,0-27		16014382	10.1242/jcs.02448	0021-9533	Journal of Cell Science	Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation	He	2005	6		LINC00619
739	chr2	20261528	20261995	3500210713	52		20261528	20261995	8421504	2	25,27	0,440	c	350021071300000005,350021071300000004	0-25,0-27		16014382	10.1242/jcs.02448	0021-9533	Journal of Cell Science	Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation	He	2005	6		HNRNPA3
747	chr2	21259597	21260612	3500048481	23		21259597	21260612	8421504	2	1,22	0,993	c	350004848100000007	23-46						PROTEIN IMPORT, CHOLESTEROL TRANSPORT AND	ry.georgetown.edu	0	0		
748	chr2	21442646	21442697	3500430809	51		21442646	21442697	8421504	1	51	0	p	350043080900015049,350043080900015003	0-51,0-48						Patent Search: US Patent Number 8299236 - Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells	ww.archpatent.com	0	0		HOXB4
748	chr2	21442646	21442697	3500188627	51		21442646	21442697	8421504	1	51	0	p	350018862700015054	0-51						COMPOSITIONS AND METHODS FOR ENHANCING DELIVERY OF NUCLEIC ACIDS INTO CELLS AND FOR MODIFYING EXPRESSION OF TARGET GENES IN CELLS - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500463762	48		21442649	21442697	8421504	1	48	0	p	350046376200015015	0-48						Combination therapies with mitochondrial-targeted anti-tumor agents	Altieri	2011	0		HOXB4
748	chr2	21442649	21442697	3500463753	48		21442649	21442697	8421504	1	48	0	p	350046375300015002	0-48		17429072	10.1091/mbc.E06-08-0744	1059-1524	Molecular Biology of the Cell	RKIKK Motif in the Intracellular Domain Is Critical for Spatial and Dynamic Organization of ICAM-1: Functional Implication for the Leukocyte Adhesion and Transmigration	Oh	2007	5		HOXB4
748	chr2	21442649	21442697	3500459444	48		21442649	21442697	8421504	1	48	0	p	350045944400015021	0-48						Inhibition Of Gasc1 	.freshpatents.com	0	0		HOXB4
748	chr2	21442649	21442697	3500459269	48		21442649	21442697	8421504	1	48	0	p	350045926900015001	0-48						Enhanced efficiency of induced pluripotent stem cell generation	Wu	2011	0		HOXB4
748	chr2	21442649	21442697	3500457784	48		21442649	21442697	8421504	1	48	0	p	350045778400015006	0-48						Modified iRNA agents	Manoharan	2004	0		HOXB4
748	chr2	21442649	21442697	3500457315	48		21442649	21442697	8421504	1	48	0	p	350045731500015001	0-48		23940795	10.1371/journal.pone.0071957		PLoS ONE	Phosphorylation of the Actin Binding Protein Drebrin at S647 Is Regulated by Neuronal Activity and PTEN	Patricia	2013	0		HOXB4
748	chr2	21442649	21442697	3500453589	48		21442649	21442697	8421504	1	48	0	p	350045358900015016,350045358900015019	0-48,0-48						Mitochondria-targeted anti-tumor agents	Altieri	2009	0		HOXB4
748	chr2	21442649	21442697	3500452430	48		21442649	21442697	8421504	1	48	0	p	350045243000015002	0-48						METHODS OF INDUCING PLURIPOTENCY INVOLVING OCT4 PROTEIN	Kirkland	2008	0		HOXB4
748	chr2	21442649	21442697	3500449540	48		21442649	21442697	8421504	1	48	0	p	350044954000015005	0-48						Therapeutic Compositions	Manoharan	2010	0		HOXB4
748	chr2	21442649	21442697	3500446274	48		21442649	21442697	8421504	1	48	0	p	350044627400015000	21-69		18281499	10.1158/0008-5472.CAN-07-6175	0008-5472	Cancer Research	Construction of Optimized Bispecific Antibodies for Selective Activation of the Death Receptor CD95	Herrmann	2008	8		HOXB4
748	chr2	21442649	21442697	3500446139	48		21442649	21442697	8421504	1	48	0	p	350044613900015064,350044613900015085	0-48,0-48						Targeted immunogens	Uger	2003	0		HOXB4
748	chr2	21442649	21442697	3500445605	48		21442649	21442697	8421504	1	48	0	p	350044560500015005	0-48						Therapeutic compositions	Manoharan	2010	0		HOXB4
748	chr2	21442649	21442697	3500439758	48		21442649	21442697	8421504	1	48	0	p	350043975800015003,350043975800015004	3-51,3-51						Methods of Treating Hepatitis C Virus Infection - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500436508	48		21442649	21442697	8421504	1	48	0	p	350043650800015004	0-48						Aptamer therapeutics useful in the treatment of complement-related disorders	Benedict	2006	0		HOXB4
748	chr2	21442649	21442697	3500430608	48		21442649	21442697	8421504	1	48	0	p	350043060800015001,350043060800015000,350043060800015002	3-51,3-51,3-51			10.1002/ijc.20333	1097-0215	International Journal of Cancer	Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-&#x03ba;B signaling - Aggarwal - 2004 - International Journal of Cancer - Wiley Online Library	Aggarwal	2004	0		HOXB4
748	chr2	21442649	21442697	3500421823	48		21442649	21442697	8421504	1	48	0	p	350042182300015006	0-48						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500412288	48		21442649	21442697	8421504	1	48	0	p	350041228800015002	0-48		18717816	10.1111/j.1471-4159.2008.05630.x	1471-4159	Journal of Neurochemistry	Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells - Shen - 2008 - Journal of Neurochemistry - Wiley Online Library	Shen	2008	0		HOXB4
748	chr2	21442649	21442697	3500402001	48		21442649	21442697	8421504	1	48	0	p	350040200100015005	0-48					Patent	Therapeutic compositions (Patent US:8420799)	Manoharan	2013	0		HOXB4
748	chr2	21442649	21442697	3500396186	48		21442649	21442697	8421504	1	48	0	p	350039618600015017	0-48						Compositions and Methods for the Delivery of Biologically Active RNAs	Polach	2012	0		HOXB4
748	chr2	21442649	21442697	3500387505	48		21442649	21442697	8421504	1	48	0	p	350038750500015002	0-48						Pharmaceutical composition for treating autoimmune, allergic and inflammatory diseases and delivery method thereof	Lee	2009	0		HOXB4
748	chr2	21442649	21442697	3500366636	48		21442649	21442697	8421504	1	48	0	p	350036663600015001	0-48						Carbohydrate conjugates as delivery agents for oligonucleotides - US Patent 8106022 Description	ww.patentstorm.us	0	0		HOXB4
748	chr2	21442649	21442697	3500366555	48		21442649	21442697	8421504	1	48	0	p	350036655500015000	0-48						&#x0421;&#x043f;&#x043e;&#x0441;&#x043e;&#x0431; &#x0432;&#x0432;&#x0435;&#x0434;&#x0435;&#x043d;&#x0438;&#x044f; &#x043c;&#x043e;&#x043b;&#x0435;&#x043a;&#x0443;&#x043b;&#x044b; &#x043f;&#x043d;&#x043a;, &#x043a;&#x043e;&#x043d;&#x044a;&#x044e;&#x0433;&#	www.freepatent.ru	0	0		HOXB4
748	chr2	21442649	21442697	3500361143	48		21442649	21442697	8421504	1	48	0	p	350036114300015228	0-48						Peptidic modulators of the androgen receptor	Joyal	2002	0		HOXB4
748	chr2	21442649	21442697	3500348094	48		21442649	21442697	8421504	1	48	0	p	350034809400015005	0-48						Pharmaceutical Composition for Treating Autoimmune, Allergic and Inflammatory Diseases and Delivery Method Thereof - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500345122	48		21442649	21442697	8421504	1	48	0	p	350034512200015013	0-48						DPY-30 Binding Peptides	Yang	2012	0		HOXB4
748	chr2	21442649	21442697	3500333330	48		21442649	21442697	8421504	1	48	0	p	350033333000015009	0-48						METHODS AND COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS	Manoharan	2011	0		HOXB4
748	chr2	21442649	21442697	3500294875	48		21442649	21442697	8421504	1	48	0	p	350029487500015007	0-48						PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500294824	48		21442649	21442697	8421504	1	48	0	p	350029482400015011	0-48						Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components	Manoharan	2011	0		HOXB4
748	chr2	21442649	21442697	3500293397	48		21442649	21442697	8421504	1	48	0	p	350029339700015009	0-48						Novel lipids and compositions for the delivery of therapeutics	Manoharan	2011	0		HOXB4
748	chr2	21442649	21442697	3500293383	48		21442649	21442697	8421504	1	48	0	p	350029338300015000	0-48		22676333	10.1186/1756-0500-5-268		BMC Research Notes	Ribozyme-mediated gene knock down strategy to dissect the consequences of PDGF stimulation in vascular smooth muscle cells	Caterina	2012	0		HOXB4
748	chr2	21442649	21442697	3500293304	48		21442649	21442697	8421504	1	48	0	p	350029330400015007	0-48						MODIFIED MOLECULAR BEACONS - GEORGIA TECH RESEARCH CORPORATION	www.sumobrain.com	0	0		HOXB4
748	chr2	21442649	21442697	3500292474	48		21442649	21442697	8421504	1	48	0	p	350029247400015009	0-48						NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500291281	48		21442649	21442697	8421504	1	48	0	p	350029128100015005	0-48						Pharmaceutical Composition for Treating Autoimmune, Allergic and Inflammatory Diseases and Delivery Method Thereof	Lee	2010	0		HOXB4
748	chr2	21442649	21442697	3500285212	48		21442649	21442697	8421504	1	48	0	p	350028521200015009	0-48		11102469		0270-6474	The Journal of Neuroscience	GABAC Receptor Sensitivity Is Modulated by Interaction with MAP1B	Billups	2000	7		HOXB4
748	chr2	21442649	21442697	3500285062	48		21442649	21442697	8421504	1	48	0	p	350028506200015004	0-48						Method for introducing a pna molecule conjugated to a positively charged peptide into the cytosol and/or the nucleus by photochemical internalisation (pci)	Boee	2006	0		HOXB4
748	chr2	21442649	21442697	3500284191	48		21442649	21442697	8421504	1	48	0	p	350028419100015001	0-48			10.1182/blood-2006-07-034009		Blood	Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells	Li	2007	0		HOXB4
748	chr2	21442649	21442697	3500280799	48		21442649	21442697	8421504	1	48	0	p	350028079900015006	0-48						Toxin compounds with enhanced membrane translocation characteristics	Aoki	2006	0		HOXB4
748	chr2	21442649	21442697	3500279235	48		21442649	21442697	8421504	1	48	0	p	350027923500015022	0-48						SureChem - Document - WO/PCT - Patent No. 2008020596 - "TREATING OR PREVENTING CANCERS OVER-EXPRESSING REG4 OR KIAA0101" - Description	www.surechem.org	0	0		HOXB4
748	chr2	21442649	21442697	3500275354	48		21442649	21442697	8421504	1	48	0	p	350027535400015009	0-48						LIPID FORMULATION - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500256607	48		21442649	21442697	8421504	1	48	0	p	350025660700015002	0-48					Patent	Carbohydrate conjugates as delivery agents for oligonucleotides (Patent US:8106022)	Manoharan	2012	0		HOXB4
748	chr2	21442649	21442697	3500243302	48		21442649	21442697	8421504	1	48	0	p	350024330200015006	0-48						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500239691	48		21442649	21442697	8421504	1	48	0	p	350023969100015001	3-51					Patent	Inhibition of NF-&#x03ba;B activation by blockade of IKK&#x03b2;-NEMO interactions at the NEMO binding domain (Patent US:6864355)	Ghosh	2005	0		HOXB4
748	chr2	21442649	21442697	3500239523	48		21442649	21442697	8421504	1	48	0	p	350023952300015000	0-48		19006449	10.1089/oli.2008.0152		Oligonucleotides	Immunological Response to Peptide Nucleic Acid and its Peptide Conjugate Targeted to Transactivation Response (TAR) Region of HIV-1 RNA Genome	Alok	2008	0		HOXB4
748	chr2	21442649	21442697	3500233517	48		21442649	21442697	8421504	1	48	0	p	350023351700015002	0-48						Bacteriophage preparation for the treatment of intracellular bacterial infection	Pasechnik	2003	0		HOXB4
748	chr2	21442649	21442697	3500231908	48		21442649	21442697	8421504	1	48	0	p	350023190800015019,350023190800015051	30-78,0-48					Patent	Inhibitions of the interaction between p53 and mdm2 (Patent EP:0958305)	BOTTGER	2008	0		HOXB4
748	chr2	21442649	21442697	3500231526	48		21442649	21442697	8421504	1	48	0	p	350023152600015002	0-48						INHIBITION OF INFLAMMATION USING ANTAGONISTS OF MUC1 - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500208092	48		21442649	21442697	8421504	1	48	0	p	350020809200015019,350020809200015020	3-51,0-48						Molecular vaccine linking intercellular spreading protein to an antigen	Wu	2003	0		HOXB4
748	chr2	21442649	21442697	3500208064	48		21442649	21442697	8421504	1	48	0	p	350020806400015012	0-48						COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY	Cui	2007	0		HOXB4
748	chr2	21442649	21442697	3500197411	48		21442649	21442697	8421504	1	48	0	p	350019741100015125	0-48						HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLAY	Arap	2011	0		HOXB4
748	chr2	21442649	21442697	3500196159	48		21442649	21442697	8421504	1	48	0	p	350019615900015018,350019615900015022	0-48,0-45						Interaction Between the VHL Tumour Suppressor and Hypoxia Inducible Factor, and Assay Methods Relating Thereto - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500196068	48		21442649	21442697	8421504	1	48	0	p	350019606800015004	0-48						FACTOR	Maden	2009	0		HOXB4
748	chr2	21442649	21442697	3500191320	48		21442649	21442697	8421504	1	48	0	p	350019132000015008	0-48						Novel lipids and compositions for the delivery of therapeutics	Manoharan	2010	0		HOXB4
748	chr2	21442649	21442697	3500188425	48		21442649	21442697	8421504	1	48	0	p	350018842500015003	0-48						CYCLIC DI-AMP INDUCTION OF TYPE I INTERFERON	Portnoy	2011	0		HOXB4
748	chr2	21442649	21442697	3500180482	48		21442649	21442697	8421504	1	48	0	p	350018048200015004	0-48						Methods and compositions for delivering polynucleotides	Khan	2005	0		HOXB4
748	chr2	21442649	21442697	3500177658	48		21442649	21442697	8421504	1	48	0	p	350017765800015000,350017765800015001	3-51,3-51		20139273	10.4049/jimmunol.0903133	0022-1767	The Journal of Immunology	IL-17 Activates the Canonical NF-&#x03ba;B Signaling Pathway in Autoimmune B Cells of BXD2 Mice To Upregulate the Expression of Regulators of G-Protein Signaling 16	Xie	2010	6		HOXB4
748	chr2	21442649	21442697	3500175345	48		21442649	21442697	8421504	1	48	0	p	350017534500015014	0-48						Genetically Intact Induced Pluripotent Cells Or Transdifferentiated Cells And Methods For The Production Thereof	Klimanskaya	2010	0		HOXB4
748	chr2	21442649	21442697	3500170470	48		21442649	21442697	8421504	1	48	0	p	350017047000015003	0-48						A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides. - ResearchGate	.researchgate.net	0	0		HOXB4
748	chr2	21442649	21442697	3500162909	48		21442649	21442697	8421504	1	48	0	p	350016290900015007	0-48						Modified iRNA agents	Manoharan	2010	0		HOXB4
748	chr2	21442649	21442697	3500160787	48		21442649	21442697	8421504	1	48	0	p	350016078700015005	0-48						TOXIN COMPOUNDS WITH ENHANCED MEMBRANE TRANSLOCATION CHARACTERISTICS	Fernandez-salas	2008	0		HOXB4
748	chr2	21442649	21442697	3500160610	48		21442649	21442697	8421504	1	48	0	p	350016061000015004	0-48						METHOD FOR TREATING OR PREVENTING BLADDER CANCER USING THE DEPDC1 POLYPEPTIDE	Nakamura	2009	0		HOXB4
748	chr2	21442649	21442697	3500157819	48		21442649	21442697	8421504	1	48	0	p	350015781900015002	0-48						Oligonucleotide Compositions with Enhanced Efficiency	Woolf	2009	0		HOXB4
748	chr2	21442649	21442697	3500154541	48		21442649	21442697	8421504	1	48	0	p	350015454100015025	0-48					Patent	Peptide antiestrogen compositions and methods for treating breast cancer (Patent US:6306832)	Pietras	2001	0		HOXB4
748	chr2	21442649	21442697	3500148476	48		21442649	21442697	8421504	1	48	0	p	350014847600015034,350014847600015033,350014847600015032	0-48,0-48,0-48						TARGETING OF EWS-FLI1 AS ANTI-TUMOR THERAPY	Toretsky	2009	0		HOXB4
748	chr2	21442649	21442697	3500147023	48		21442649	21442697	8421504	1	48	0	p	350014702300015003,350014702300015002	0-48,6-54						Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent	Juping	2005	0		HOXB4
748	chr2	21442649	21442697	3500136130	48		21442649	21442697	8421504	1	48	0	p	350013613000015009	0-48						MICELLIC ASSEMBLIES - UNIVERSITY OF WASHINGTON	www.sumobrain.com	0	0		HOXB4
748	chr2	21442649	21442697	3500125474	48		21442649	21442697	8421504	1	48	0	p	350012547400015011,350012547400015012,350012547400015003,350012547400015084,350012547400015082,350012547400015081	0-48,0-48,0-45,27-72,18-63,15-60						PEPTIDE OLIGONUCLEOTIDE CONJUGATES - AVI BIOPHARMA, INC.	www.sumobrain.com	0	0		HOXB4
748	chr2	21442649	21442697	3500120941	48		21442649	21442697	8421504	1	48	0	p	350012094100015001	0-48		18160487	10.1152/ajpcell.00360.2007		American Journal of Physiology - Cell Physiolog	Role of PKC-&#x03b4; on substance P-induced chemokine synthesis in pancreatic acinar cells	Ramnath	2008	0		HOXB4
748	chr2	21442649	21442697	3500119318	48		21442649	21442697	8421504	1	48	0	p	350011931800015005	0-48					Patent	Therapeutic compositions (Patent US:8445665)	Manoharan	2013	0		HOXB4
748	chr2	21442649	21442697	3500105384	48		21442649	21442697	8421504	1	48	0	p	350010538400015006	0-48						Activatable toxin complexes comprising a cleavable inhibitory peptide	Benhar	2012	0		HOXB4
748	chr2	21442649	21442697	3500102288	48		21442649	21442697	8421504	1	48	0	p	350010228800015005,350010228800015010	0-48,0-45						Antisense compounds which prevent cell death and uses thereof	Troy	1997	0		HOXB4
748	chr2	21442649	21442697	3500087478	48		21442649	21442697	8421504	1	48	0	p	350008747800015000	0-48						Cell cycle progression proteins	Deak	2003	0		HOXB4
748	chr2	21442649	21442697	3500075826	48		21442649	21442697	8421504	1	48	0	p	350007582600015006	0-48						TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500073937	48		21442649	21442697	8421504	1	48	0	p	350007393700015000	0-48					Patent	Nachweisverfahren f&#xfc;r peptide Detection method for peptide (Patent DE:69935313)	KEES	2007	0		HOXB4
748	chr2	21442649	21442697	3500073624	48		21442649	21442697	8421504	1	48	0	p	350007362400015055,350007362400015019,350007362400015056	39-87,36-84,0-48						Inhibitors of the interaction between P53 and MDM2 - Patent # 7083983 - PatentGenius	.patentgenius.com	0	0		HOXB4
748	chr2	21442649	21442697	3500073579	48		21442649	21442697	8421504	1	48	0	p	350007357900015004	0-48						Compositons, methods and kits for real-time nucleic acid analysis in live cells - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500038048	48		21442649	21442697	8421504	1	48	0	p	350003804800015002,350003804800015000	3-51,3-51					Patent	Anti-inflammatory compounds and uses thereof (Patent US:7538089)	May	2009	0		HOXB4
748	chr2	21442649	21442697	3500038025	48		21442649	21442697	8421504	1	48	0	p	350003802500015001	0-48						Oligonucleotide Compositions with Enhanced Efficiency - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442697	3500037875	48		21442649	21442697	8421504	1	48	0	p	350003787500015004	0-48						Improved lipid formulation	Akinc	2012	0		HOXB4
748	chr2	21442649	21442697	3500032423	48		21442649	21442697	8421504	1	48	0	p	350003242300015001	0-48		23940795	10.1371/journal.pone.0071957	1932-6203	PLOS ONE	PLOS ONE: Phosphorylation of the Actin Binding Protein Drebrin at S647 Is Regulated by Neuronal Activity and PTEN	Kreis	2013	4		HOXB4
748	chr2	21442649	21442697	3500029692	48		21442649	21442697	8421504	1	48	0	p	350002969200015008	0-48						Immunogenic polypeptides and monoclonal antibodies	Brookes	2009	0		HOXB4
748	chr2	21442649	21442697	3500013103	48		21442649	21442697	8421504	1	48	0	p	350001310300015000,350001310300015001	3-51,3-51		18607384	10.1038/ijo.2008.101	0307-0565	International Journal of Obesity	Characterization of the human CIDEA promoter in fat cells	Pettersson	2008	5		HOXB4
748	chr2	21442649	21442697	3500011010	48		21442649	21442697	8421504	1	48	0	p	350001101000015007	0-48						Autogene nucleic acids encoding a secretable RNA polymerase	Finn	2002	0		HOXB4
748	chr2	21442649	21442697	3500006423	48		21442649	21442697	8421504	1	48	0	p	350000642300015002	0-48						Compositions and methods for detecting and treating HIV infections - Patent # 7662547 - PatentGenius	.patentgenius.com	0	0		HOXB4
748	chr2	21442649	21442697	3500006066	48		21442649	21442697	8421504	1	48	0	p	350000606600015000	18-66		18073344	10.1261/rna.844108	1355-8382	RNA	miR-122 targeting with LNA/2&#x2032;-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA&#x2013;peptide conjugates	Fabani	2008	5		HOXB4
748	chr2	21442649	21442697	3500001458	48		21442649	21442697	8421504	1	48	0	p	350000145800015001	0-48						Cell-penetrating peptides and bioactive cargoes. Strategies and mechanisms.	w.diva-portal.org	0	0		HOXB4
748	chr2	21442649	21442694	3500389892	45		21442649	21442694	8421504	1	45	0	p	350038989200015010	0-45						METHODS AND COMPOUNDS FOR REDUCING INTRACELLULAR LIPID STORAGE - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442649	21442694	3500366688	45		21442649	21442694	8421504	1	45	0	p	350036668800015052	0-45						Modified Bacteriophage Vectors and Uses Thereof - Patent application	www.faqs.org	0	0		HOXB4
748	chr2	21442652	21442697	3500412250	45		21442652	21442697	8421504	1	45	0	p	350041225000015006	0-45						SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT - ALNYLAM PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		HOXB4
748	chr2	21442823	21443430	3500376059	63		21442823	21443430	8421504	2	26,37	0,570	p	350037605900015017	0-63		8600458			Nucleic Acids Research	Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA.	Shen	1996	0		HOXD4
748	chr2	21445031	21445055	3500347866	24		21445031	21445055	8421504	1	24	0	c,g	350034786600000025,350034786600000025,350034786600000024,350034786600000024	0-22,0-22,0-23,0-23						Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells.	.biomedsearch.com	0	0		HOXD4
748	chr2	21445031	21445055	3500257436	24		21445031	21445055	8421504	1	24	0	c,g	350025743600000086,350025743600000086,350025743600000006,350025743600000006	22-44,0-22,22-44,0-22						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		HOXD4
748	chr2	21445031	21445055	3500125321	24		21445031	21445055	8421504	1	24	0	c,g	350012532100000020,350012532100000020,350012532100000019,350012532100000019	0-22,0-22,0-22,0-22						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		HOXD4
748	chr2	21445032	21445055	3500447367	23		21445032	21445055	8421504	1	23	0	c,g	350044736700000027,350044736700000027,350044736700000000,350044736700000000,350044736700000018,350044736700000018	0-23,0-23,0-23,0-23,0-23,0-23						MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY	Yu	2009	0		HOXD4
748	chr2	21445032	21445055	3500439152	23		21445032	21445055	8421504	1	23	0	c,g	350043915200000088,350043915200000088	0-23,0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		HOXD4
748	chr2	21445032	21445055	3500367476	23		21445032	21445055	8421504	1	23	0	c,g	350036747600000006,350036747600000006	0-23,0-23						Polymorphism discovery and allele frequency estimation using high-throughput DNA sequencing of target-enriched pooled DNA samples. - ResearchGate	.researchgate.net	0	0		HOXD4
748	chr2	21445032	21445055	3500176000	23		21445032	21445055	8421504	1	23	0	c,g	350017600000000000,350017600000000000,350017600000000027,350017600000000027,350017600000000058,350017600000000058,350017600000000018,350017600000000018,350017600000000080,350017600000000080	0-23,0-23,0-23,0-23,0-23,0-23,0-23,0-23,0-22,0-22						MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY - Patent application	www.faqs.org	0	0		HOXD4
748	chr2	21445033	21486288	3500131966	42		21445033	21486288	8421504	3	22,13,7	0,41231,41248	c,g	350013196600000013,350013196600000013,350013196600000254	0-22,0-22,8-28						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
748	chr2	21476639	21476662	3500014473	23		21476639	21476662	8421504	1	23	0	c	350001447300000012	20-43		21642433	10.1074/jbc.M111.224212	0021-9258	Journal of Biological Chemistry	Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b	Shen	2011	5		
748	chr2	21486712	21488723	3500157005	64		21486712	21488723	8421504	3	22,20,22	0,1393,1989	c,g	350015700500000030,350015700500000026,350015700500000025,350015700500000025	0-22,0-20,0-22,0-22			10.1046/j.1365-2141.2002.03263.x	1365-2141	British Journal of Haematology	Absence of mutations in the HoxA10, HoxA11 and HoxD11 nucleotide coding sequences in thrombocytopenia with absent radius syndrome - Fleischman - 2002 - British Journal of Haematology - Wiley Online Library	Fleischman	2002	0		
748	chr2	21487013	21487043	3500251633	30		21487013	21487043	8421504	1	30	0	g	350025163300000000	0-30		11493536		0950-1991	Development	Hoxa11 and Hoxd11 regulate branching morphogenesis of the ureteric bud in the developing kidney	Patterson	2001	7		
749	chr2	21506965	21506992	3500023667	23		21506965	21506992	8421504	3	6,12,5	0,9,22	g	350002366700000000	0-25						HEMOJUVELIN FUSION PROTEINS AND USES THEREOF	Lin	2008	0		
749	chr2	21519905	21520050	3500056175	48		21519905	21520050	8421504	2	24,24	0,121	g	350005617500000007,350005617500000006	0-24,0-24		18941441	10.1038/mt.2008.225	1525-0016	Molecular Therapy	Transduction Efficiency and Immune Response Associated With the Administration of AAV8 Vector Into Dog Skeletal Muscle	Ohshima	2008	7		
751	chr2	21772926	21772949	3500028119	23		21772926	21772949	8421504	1	23	0	g	350002811900000024	5-34						METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS - Patent application	www.faqs.org	0	0		
753	chr2	22063370	22063397	3500017652	24		22063370	22063397	8421504	2	12,12	0,15	g	350001765200000041	0-24						Insect Biochemistry and Molecular Biology	005.pasteur.ac.ir	0	0		
755	chr2	22333298	22333324	3500166045	23		22333298	22333324	8421504	2	7,16	0,10	c	350016604500000023	7-30		11333908	10.1128/JVI.75.11.5263-5276.2001	0022-538X	Journal of Virology	Identification of Two Sequences in the Cytoplasmic Tail of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Inhibit Cell Surface Expression	Bultmann	2001	5		
756	chr2	22419326	22475950	3500194334	1515		22419326	22475950	8421504	12	32,70,97,119,129,179,115,87,150,207,106,224	0,1510,13624,16455,16699,20788,22463,25560,37079,39857,51927,56400	p	350019433400015002	0-1515						KEGG T01001: 10488	www.genome.jp	0	0		ATF2
756	chr2	22419329	22419356	3500039771	27		22419329	22419356	8421504	1	27	0	c	350003977100000020	10-37		9660836	10.1074/jbc.273.29.18623	0021-9258	Journal of Biological Chemistry	Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase	Favata	1998	5		
756	chr2	22419329	22419356	3500030319	27		22419329	22419356	8421504	1	27	0	c	350003031900000020	10-37						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 1998 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase*	www.jbc.org	0	0		
756	chr2	22420836	22436034	3500214237	46		22420836	22436034	8421504	3	22,15,9	0,15049,15189	c	350021423700000000,350021423700000001	5-27,15-39		9295308	10.1074/jbc.272.38.23668	0021-9258	Journal of Biological Chemistry	Molecular Cloning and Characterization of a Novel p38 Mitogen-activated Protein Kinase	Wang	1997	5		ATF2
756	chr2	22420855	22420878	3500458366	23		22420855	22420878	8421504	1	23	0	c	350045836600000000	7-30		15767263	10.1074/jbc.M408862200	0021-9258	Journal of Biological Chemistry	Exercise Stimulates Pgc-1&#x03b1; Transcription in Skeletal Muscle through Activation of the p38 MAPK Pathway	Akimoto	2005	5		ATF2
756	chr2	22432956	22433043	3500399055	87		22432956	22433043	8421504	1	87	0	p	350039905500015023	0-87						Cell-permeable peptide inhibitors of the JNK signal transduction pathway	Bonny	2009	0		
756	chr2	22432956	22433043	3500323422	87		22432956	22433043	8421504	1	87	0	p	350032342200015024	0-87						Cell-permeable peptide inhibitors of the JNK signal transduction pathway	Bonny	2007	0		
756	chr2	22432956	22433043	3500310202	87		22432956	22433043	8421504	1	87	0	p	350031020200015025	0-87					Patent	Cell-permeable peptide inhibitors of the JNK signal transduction pathway (Patent EP:1776958)	Bonny	2008	0		ATF2
756	chr2	22432956	22433043	3500309409	87		22432956	22433043	8421504	1	87	0	p	350030940900015024	0-87					Patent	Cell-permeable peptide inhibitors of the jnk signal transduction pathway (Patent EP:1511507)	Bonny	2007	0		
756	chr2	22432956	22433043	3500112441	87		22432956	22433043	8421504	1	87	0	p	350011244100015114	0-87						Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases	Abadie	2012	0		
756	chr2	22432956	22433043	3500063794	87		22432956	22433043	8421504	1	87	0	p	350006379400015055,350006379400015027	0-48,0-87						CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY - Patent application	www.faqs.org	0	0		
756	chr2	22433025	22435804	3500350411	45		22433025	22435804	8421504	2	22,23	0,2756	p	350035041100015013	0-45						&#xb1d0;&#xa87c;&#xb3a1;&#xc555;&#xb0dd;&#xabc7;&#xa5cd;&#xaaab;&#xa7de;&#xb34e;&#xacec;&#xa7de;&#xb1d0;&#xa87c;&#xa7ef;&#xb669;&#xad70;&#xb565;	www.ym.edu.tw	0	0		ATF2
756	chr2	22456543	22471292	3500191222	258		22456543	22471292	8421504	3	12,207,39	0,2640,14710	p	350019122200015008	0-258						Basic leucine zipper transcription factor Hac1 binds DNA in two distinct modes as revealed by microfluidic analyses	alterlab.ucsf.edu	0	0		ATF2
756	chr2	22459333	22471289	3500148060	93		22459333	22471289	8421504	2	57,36	0,11920	p	350014806000015018,350014806000015148,350014806000015149	0-84,0-45,0-45						MULTIMERIC PROTEINS AND METHODS OF MAKING AND USING SAME - Patent application	www.faqs.org	0	0		ATF2
756	chr2	22471319	22475895	3500117918	44		22471319	22475895	8421504	2	22,22	0,4554	c,g	350011791800000005,350011791800000005,350011791800000006	0-22,0-22,0-22		22049513	10.1182/blood-2011-02-339473		Blood	Cyclic AMP response element-binding protein prevents endothelial permeability increase through transcriptional controlling p190RhoGAP expression	Koteswara	2012	0		ATF2
756	chr2	22475511	22475536	3500074623	23		22475511	22475536	8421504	3	15,4,4	0,16,21	g	350007462300000247	18-41						Toxin peptide therapeutic agents	Adler	2009	0		
756	chr2	22475927	22475950	3500435763	23		22475927	22475950	8421504	1	23	0	c	350043576300000004,350043576300000092	9-32,11-34						Single chain monoclonal antibody fusion reagents that regulate transcription in vivo	Hoeffler	2000	0		
756	chr2	22475927	22475950	3500096131	23		22475927	22475950	8421504	1	23	0	c	350009613100000004,350009613100000092	9-32,11-34						Single chain monoclonal antibody fusion reagents that regulate transcription in vivo	Hoeffler	2000	0		
757	chr2	22655239	22655263	3500428536	23		22655239	22655263	8421504	2	4,19	0,5	c,g	350042853600000012,350042853600000012	0-23,0-23						Double-muscling in mammals	Grobet	1997	0		
757	chr2	22655239	22655263	3500279741	23		22655239	22655263	8421504	2	4,19	0,5	c,g	350027974100000012,350027974100000012	0-23,0-23						Mutations in the myostation gene cause double-muscling in mammals	Georges	1999	0		
757	chr2	22655239	22655263	3500236344	23		22655239	22655263	8421504	2	4,19	0,5	c,g	350023634400000013,350023634400000013	0-23,0-23						Double-muscling in mammals	Georges	2006	0		
757	chr2	22655239	22655263	3500033147	23		22655239	22655263	8421504	2	4,19	0,5	c,g	350003314700000012,350003314700000012	0-23,0-23					Patent	Double-muscling in mammals (Patent US:6103466)	Georges	2000	0		
758	chr2	22754297	22754320	3500089375	23		22754297	22754320	8421504	1	23	0	c	350008937500000008	0-23						Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists	Kai Wen *J*Cui Xi 	2006	0		
758	chr2	22757269	22757296	3500214179	24		22757269	22757296	8421504	2	12,12	0,15	c	350021417900000112	15-39						Compositions and Methods Relating to Stop-1	Ackerly	2008	0		
758	chr2	22757269	22757296	3500145361	24		22757269	22757296	8421504	2	12,12	0,15	c	350014536100000017	15-39						Synthetic antibody phage libraries	Hai Di *A Ke Li 	2006	0		
758	chr2	22757269	22757296	3500083374	24		22757269	22757296	8421504	2	12,12	0,15	c	350008337400000112	15-39					Patent	Compositions and methods relating to STOP-1 (Patent US:7799899)	Ackerly	2010	0		
758	chr2	22758730	22758784	3500466395	54		22758730	22758784	8421504	1	54	0	p	350046639500015049	0-54						Methods of generating antigen-specific CD4+CD25+ regulatory T cells, compositions and methods of use	Buckner	2005	0		CHRNA1
758	chr2	22759365	22759389	3500147877	23		22759365	22759389	8421504	2	13,10	0,14	c	350014787700000026	10-33						Method Of Constructing Recombinant Proteoliposome For Diagnostic Use 	.freshpatents.com	0	0		CHRNA1
758	chr2	22761549	22761579	3500104740	30		22761549	22761579	8421504	1	30	0	c	350010474000000067	12-42						Untersuchungen zur transkriptionellen Regulation des humanen Chromogranin A Gens und seine Anwendung zum zellspezifischen therapeutischen Gentransfer in neuroendokrine Pankreastumorzellen	ub.uni-marburg.de	0	0		
759	chr2	22901151	22901175	3500176969	24		22901151	22901175	8421504	1	24	0	c	350017696900000000	0-24						WIP, a protein associated with Wiskott&#x2013;Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells	www.pnas.org	0	0		WIPF1
759	chr2	22901151	22901175	3500008097	24		22901151	22901175	8421504	1	24	0	c	350000809700000000	0-24						WIP, a WASP-associated protein	Ramesh	2005	0		WIPF1
759	chr2	22905994	22906778	3500143843	60		22905994	22906778	8421504	2	7,53	0,731	p	350014384300015036	0-60						Quantitative Analyse von T-Zell Stimulation und Costimulation durch zellul&#xe4;re Mikrosysteme	.uni-tuebingen.de	0	0		WIPF1
764	chr2	23571335	23574694	3500402178	40		23571335	23574694	8421504	2	20,20	0,3339	g	350040217800000003,350040217800000004	0-20,0-20		16087722	10.1677/jme.1.01765	0952-5041	Journal of Molecular Endocrinology	The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing&#x2019;s syndrome	Baldacchino	2005	3		SP3
768	chr2	24042105	24042131	3500258001	23		24042105	24042131	8421504	2	12,11	0,15	g	350025800100000034	1-26						PROTEASE VARIANTS - Patent application	www.faqs.org	0	0		
768	chr2	24094410	24094436	3500171043	26		24094410	24094436	8421504	1	26	0	c	350017104300000007	0-26						Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis	Lees	2003	0		MIR4785
769	chr2	24158343	24158369	3500058463	24		24158343	24158369	8421504	3	4,5,15	0,5,11	g	350005846300000320	1-25						Lyme disease vaccines	Choi	1998	0		
769	chr2	24230334	24230359	3500413325	24		24230334	24230359	8421504	2	9,15	0,10	c	350041332500000000	3-27						Fusion Proteins Useful For Detecting Analytes 	.freshpatents.com	0	0		
769	chr2	24230334	24230359	3500224039	24		24230334	24230359	8421504	2	9,15	0,10	c	350022403900000000	3-27						Fusion proteins useful for detecting analytes	Frommer	2002	0		
770	chr2	24358183	24358208	3500445135	24		24358183	24358208	8421504	2	17,7	0,18	c	350044513500000067	1-25						DNA molecules encoding bacterial lysine 2,3-aminomutase	Frey	1999	0		
770	chr2	24358183	24358208	3500107506	24		24358183	24358208	8421504	2	17,7	0,18	c	350010750600000067	1-25						METHOD FOR PRODUCING L-BETA-LYSINE - Patent application	www.faqs.org	0	0		
96	chr2	24358246	24712492	3500282634	1478		24358246	24712492	8421504	34	48,29,55,65,42,48,43,5,47,77,18,12,36,14,34,31,17,48,62,34,54,116,69,48,90,54,20,73,3,89,7,42,40,8	0,96,2876,15230,15712,16585,20775,24007,24061,24109,24599,24713,30844,30928,33005,34577,35319,37212,53441,56965,57000,80108,81979,82562,113691,114096,161659,165722,269198,286643,289570,289625,289673,354238	c	350028263400000125,350028263400000123,350028263400000122,350028263400000121,350028263400000120,350028263400000118,350028263400000116,350028263400000114,350028263400000113,350028263400000112,350028263400000109,350028263400000107,350028263400000102,350028263400000098,350028263400000096,350028263400000095,350028263400000094,350028263400000093,350028263400000092,350028263400000091,350028263400000090,350028263400000087,350028263400000076,350028263400000075,350028263400000074,350028263400000073,350028263400000072,350028263400000068,350028263400000067,350028263400000065,350028263400000064	0-48,0-48,0-48,0-48,1-48,0-48,0-48,0-47,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,6-48,0-48						Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy - Patent application	www.faqs.org	0	0		
771	chr2	24382354	24389138	3500044463	40		24382354	24389138	8421504	2	20,20	0,6764	c	350004446300000007,350004446300000006	0-20,0-20		18577515	10.1074/jbc.M800754200		The Journal of Biological Chemistry	Rap1 Activation Plays a Regulatory Role in Pancreatic Amylase Secretion	Maria	2008	0		
772	chr2	24519906	24523977	3500273077	23		24519906	24523977	8421504	3	13,1,9	0,18,4062	c	350027307700000000	10-33					BMC Cancer	HIF2&#x03b1; reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma - Scolaris	Favier	2007	0		
772	chr2	24624365	24624390	3500430320	23		24624365	24624390	8421504	3	11,5,7	0,12,18	g	350043032000000037	0-25						METHOD FOR EXAMINATION OF ACTION OF ANTI-CANCER AGENT UTILIZING SPLICING DEFECT AS MEASURE	Mizui	2008	0		
774	chr2	24827182	24830890	3500136867	168		24827182	24830890	8421504	3	42,77,49	0,1858,3659	p	350013686700015027	0-168						Regulation of pyruvate dehydrogenase kinase 4 (PDK4) through protein-protein interaction and its role in apoptosis	dspace.wits.ac.za	0	0		
774	chr2	24829085	24837042	3500261568	66		24829085	24837042	8421504	3	21,23,22	0,1807,7935	c,g	350026156800000005,350026156800000005,350026156800000004,350026156800000004,350026156800000018	0-21,0-21,0-23,0-23,0-22		22431524	10.1128/MCB.06248-11		Molecular and Cellular Biology	Glucose Oxidation Modulates Anoikis and Tumor Metastasis	Sushama	2012	0		PDK1
775	chr2	24997337	25002810	3500222089	24		24997337	25002810	8421504	2	1,23	0,5450	c	350022208900000010	0-24						Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection. - ResearchGate	.researchgate.net	0	0		
775	chr2	25026398	25026422	3500216107	24		25026398	25026422	8421504	1	24	0	c	350021610700000003	0-24		19296469	10.1002/hep.22820	1527-3350	Hepatology	Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury - Van Hul - 2009 - Hepatology - Wiley Online Library	Hul	2009	0		ITGA6
777	chr2	25241311	25256806	3500332089	330		25241311	25256806	8421504	6	1,143,36,54,48,48	0,502,651,1199,14136,15447	p	350033208900015064,350033208900015065,350033208900015070,350033208900015066,350033208900015072,350033208900015068,350033208900015079,350033208900015076	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						US Patent # 6,350,867. Compositions and methods for enhancing osseous growth, repair and regeneration - Patents.com	www.patents.com	0	0		
777	chr2	25242858	25242886	3500314613	26		25242858	25242886	8421504	2	13,13	0,15	c	350031461300000107	8-34						Vaccine for house dust mite allergen using naked DNA - US Patent 7439233 Description	ww.patentstorm.us	0	0		
777	chr2	25242858	25242886	3500061916	26		25242858	25242886	8421504	2	13,13	0,15	c	350006191600000108,350006191600000008	8-34,8-34						Vaccine for House Dust Mite Allergen Using Naked DNA - Patent application	www.faqs.org	0	0		
777	chr2	25255420	25256704	3500091246	44		25255420	25256704	8421504	2	22,22	0,1262	c	350009124600000022,350009124600000021	0-22,0-22						PROSTATE CANCER MARKERS AND USES THEREOF - Patent application	www.faqs.org	0	0		DLX1
777	chr2	25255465	25256809	3500190689	177		25255465	25256809	8421504	2	42,135	0,1209	p	350019068900015145	0-177						Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins, Second Edition	www.zvlab.ru	0	0		DLX6
97	chr2	25272793	25340888	3500391435	553		25272793	25340888	8421504	6	18,43,149,150,158,35	0,3486,4061,5615,7758,68060	c	350039143500000080	0-553						Proteins, polynucleotides encoding them and methods of using the same	Casman	2002	0		HAT1,METAP1D
777	chr2	25278473	25278498	3500407307	25		25278473	25278498	8421504	1	25	0	c	350040730700000008	14-39						Polynucleotide encoding a novel methionine aminopeptidase, protease-39	Chen	2003	0		
778	chr2	25357396	25357424	3500287948	23		25357396	25357424	8421504	2	17,6	0,22	c	350028794800000011	3-28						Novel alanine transaminase enzyme and methods of use	Gong	2004	0		
778	chr2	25374176	25374201	3500075995	25		25374176	25374201	8421504	1	25	0	c,g	350007599500000012,350007599500000012,350007599500000013,350007599500000013	0-25,0-25,0-25,0-25		18458078	10.1074/jbc.M802332200	0021-9258	Journal of Biological Chemistry	Tip60 Is Regulated by Circadian Transcription Factor Clock and Is Involved in Cisplatin Resistance	Miyamoto	2008	5		HAT1
778	chr2	25374628	25375607	3500453695	47		25374628	25375607	8421504	2	23,24	0,955	c	350045369500000007,350045369500000006	0-23,0-24						CHEN, WEI-YANG, M.S. Inhibition of Cytochrome P450 by Lemongrass and the	libres.uncg.edu	0	0		HAT1
780	chr2	25577269	25598101	3500195705	159		25577269	25598101	8421504	4	33,18,51,57	0,389,446,20775	p	350019570500015034,350019570500015032,350019570500015004	0-51,0-51,0-57						Homology of the 74-kD cytoplasmic dynein subunit with a flagellar dynein polypeptide suggests an intracellular targeting function. - ResearchGate	.researchgate.net	0	0		
780	chr2	25648478	25648503	3500217581	23		25648478	25648503	8421504	2	18,5	0,20	g	350021758100000001,350021758100000059,350021758100000061	1-24,1-24,1-24					Patent	Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods (Patent US:5604116)	Abrams	1997	0		
780	chr2	25655391	25655417	3500288335	23		25655391	25655417	8421504	2	6,17	0,9	g	350028833500000084	0-24						Nematode Fatty Acid Desaturase-Like Sequences - Patent application	www.faqs.org	0	0		
782	chr2	25869307	25869345	3500230259	38		25869307	25869345	8421504	1	38	0	c	350023025900000114	4-42						Therapeutic polypeptides, nucleic acids encoding same, and methods of use	Alsobrook	2003	0		
786	chr2	26418881	26419434	3500389033	40		26418881	26419434	8421504	2	20,20	0,533	c,g	350038903300000000,350038903300000001,350038903300000001	0-20,0-20,0-20						Isolation, mapping and association study with carcass and feed covertion ratio trait of the bovine GAD and GAL genes	www.ajol.info	0	0		
786	chr2	26420047	26425634	3500412982	48		26420047	26425634	8421504	2	24,24	0,5563	c	350041298200000003,350041298200000002	0-24,0-24						&#x4e3b;&#x9898;&#xff1a;Inhibitors | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
786	chr2	26420047	26425634	3500346866	48		26420047	26425634	8421504	2	24,24	0,5563	c	350034686600000003,350034686600000002	0-24,0-24						DNA Methyltransferase Inhibitors Coordinately Induce Expression of the Human Reelin and Glutamic Acid Decarboxylase 67 Genes--&#x300a;&#x5206;&#x5b50;&#x836f;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x99	journal.9med.net	0	0		GAD1
786	chr2	26426812	26431153	3500436926	141		26426812	26431153	8421504	4	31,20,21,69	0,3029,3073,4272	p	350043692600015015,350043692600015005	0-51,0-90						The neurobiology of operant learning: biophysical and molecular mechanisms in a hierarchical organization of multiple memory systems	uni-regensburg.de	0	0		
786	chr2	26433061	26433225	3500428536	44		26433061	26433225	8421504	3	8,14,22	0,9,142	c	350042853600000015,350042853600000014	0-22,0-22						Double-muscling in mammals	Grobet	1997	0		
786	chr2	26433061	26433225	3500279741	44		26433061	26433225	8421504	3	8,14,22	0,9,142	c	350027974100000015,350027974100000014	0-22,0-22						Mutations in the myostation gene cause double-muscling in mammals	Georges	1999	0		GAD1
786	chr2	26433061	26433225	3500236344	44		26433061	26433225	8421504	3	8,14,22	0,9,142	c	350023634400000016,350023634400000015	0-22,0-22						Double-muscling in mammals	Georges	2006	0		
786	chr2	26433061	26433225	3500033147	44		26433061	26433225	8421504	3	8,14,22	0,9,142	c	350003314700000015,350003314700000014	0-22,0-22					Patent	Double-muscling in mammals (Patent US:6103466)	Georges	2000	0		GAD1
786	chr2	26434675	26444822	3500339010	51		26434675	26444822	8421504	2	28,23	0,10124	c,g	350033901000000003,350033901000000003,350033901000000002,350033901000000002	0-28,0-28,0-23,0-23						Method of treating huntington's disease using HNT neurons	Freed	1998	0		GAD1
787	chr2	26477758	26478413	3500213165	23		26477758	26478413	8421504	3	2,11,10	0,633,645	c	350021316500000091	0-23						COMPOSITIONS AND METHODS FOR REGULATING POLYSACCHARIDES OF A PLANT CELL - Patent application	www.faqs.org	0	0		
790	chr2	26947186	26947210	3500271950	24		26947186	26947210	8421504	1	24	0	g	350027195000000070	0-24						Novel human protein kinases and protein kinase-like enzymes	Clary	2001	0		MYO3B
793	chr2	27297321	27297378	3500385872	57		27297321	27297378	8421504	1	57	0	p	350038587200015009	0-57						&#x03a0;&#x0391;&#x039d;5&#x03a0;&#x0399;&#x03a2;&#x03a3;&#x0397;&#x039c;&#x0399;&#x039f; &#x03a0;&#x0391;&#x03a3;&#x03a1;&#x03a9;&#x039d; &#x03a3;&#x039f;&#x039c;5&#x0391;&#x03a2; &#x0391;&#x03a2;&#x0399;&#x039a;&#x03a9;&#x039d; &#x0399;&#x0391;&#x03a3;&	es.lis.upatras.gr	0	0		SSB
793	chr2	27297331	27297366	3500248138	35		27297331	27297366	8421504	1	35	0	c	350024813800000109,350024813800000100,350024813800000112,350024813800000110	0-35,0-27,0-25,0-21						Methods and compositions for the specific inhibition of gene expression by double-stranded RNA	Rossi	2007	0		METTL5,SSB
793	chr2	27297331	27297366	3500132197	35		27297331	27297366	8421504	1	35	0	c,g	350013219700000106,350013219700000097,350013219700000097,350013219700000109,350013219700000109,350013219700000107	0-35,0-27,0-27,0-25,0-25,0-21						Methods and compositions for the specific inhibition of gene expression by double-stranded rna	Rossi	2010	0		
793	chr2	27297345	27299073	3500069077	50		27297345	27299073	8421504	3	23,4,23	0,68,1705	c	350006907700000005,350006907700000004	0-23,0-27		16046615	10.1124/jpet.105.090399	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Inhibition of Autoantigen Expression by (-)-Epigallocatechin-3-gallate (the Major Constituent of Green Tea) in Normal Human Cells	Hsu	2005	0		SSB
793	chr2	27297345	27299073	3500043769	50		27297345	27299073	8421504	3	23,4,23	0,68,1705	c	350004376900000005,350004376900000004	0-23,0-27						Inhibition of Autoantigen Expression by ( )-Epigallocatechin-3- gallate (the Major Constituent of Green Tea) in Normal Human Cells	aspetjournals.org	0	0		
793	chr2	27297345	27297368	3500170848	23		27297345	27297368	8421504	1	23	0	c	350017084800000005,350017084800000011	0-23,0-23						COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISORDERS - Patent application	www.faqs.org	0	0		VWDE,SSB
794	chr2	27409966	27415648	3500418311	41		27409966	27415648	8421504	3	18,3,20	0,111,5662	c	350041831100000015,350041831100000014	0-21,0-20		23969856	10.1038/cddis.2013.297		Cell Death & Disease	Multiple mechanisms repress N-Bak mRNA translation in the healthy and apoptotic neurons	M	2013	0		PPIG
794	chr2	27409966	27415648	3500238808	41		27409966	27415648	8421504	3	18,3,20	0,111,5662	c	350023880800000015,350023880800000014	0-21,0-20		23969856	10.1038/cddis.2013.297	false	Cell Death & Disease	Multiple mechanisms repress N-Bak mRNA translation in the healthy and apoptotic neurons	Jakobson	2013	0		PPIG
794	chr2	27409966	27415648	3500201176	41		27409966	27415648	8421504	3	18,3,20	0,111,5662	c	350020117600000015,350020117600000014	0-21,0-20		23969856	10.1038/cddis.2013.297	false	Cell Death & Disease	Multiple mechanisms repress N-Bak mRNA translation in the healthy and apoptotic neurons	Jakobson	2013	0		PPIG
794	chr2	27409982	27415653	3500368690	44		27409982	27415653	8421504	3	2,21,21	0,95,5650	c	350036869000000027,350036869000000056,350036869000000026,350036869000000055	0-23,0-23,0-21,0-21						PHYSIOLOGICAL METHODS FOR ISOLATION OF HIGH PURITY CELL POPULATIONS - Patent application	www.faqs.org	0	0		PPIG
794	chr2	27409982	27415653	3500120349	44		27409982	27415653	8421504	3	2,21,21	0,95,5650	c	350012034900000001,350012034900000037,350012034900000000,350012034900000036	0-23,0-23,0-21,0-21						GROWTH FACTORS FOR PRODUCTION OF DEFINITIVE ENDODERM - Patent application	www.faqs.org	0	0		PPIG
794	chr2	27497855	27498008	3500430220	132		27497855	27498008	8421504	2	87,45	0,108	p	350043022000015058	18-174						49 human secreted proteins	A	2000	0		
797	chr2	27900938	27901037	3500355801	99		27900938	27901037	8421504	1	99	0	p	350035580100015019	6-105						Cysteine-10 on 17&#x03b2;-hydroxysteroid dehydrogenase 1 has stabilizing interactions in the cofactor binding region and renders sensitivity to sulfhydryl modifying chemicals	loads.hindawi.com	0	0		DHRS9
798	chr2	27949509	27949535	3500423173	23		27949509	27949535	8421504	2	12,11	0,15	g	350042317300000031	22-48						ANTI-IL-20 ANTIBODY AND ITS USE IN TREATING IL-20 ASSOCIATED INFLAMMATORY DISEASES - Patent application	www.faqs.org	0	0		
798	chr2	28014373	28014397	3500392648	24		28014373	28014397	8421504	1	24	0	c	350039264800000000	24-48		12519787	10.1074/jbc.M208312200	0021-9258	Journal of Biological Chemistry	Retinoid X Receptor (RXR) Agonist-induced Antagonism of Farnesoid X Receptor (FXR) Activity due to Absence of Coactivator Recruitment and Decreased DNA Binding	Kassam	2003	5		
798	chr2	28014377	28022210	3500320004	40		28014377	28022210	8421504	3	20,4,16	0,109,7817	c	350032000400000013,350032000400000014	0-20,0-20						Wisconsin : BIOCHEM 911 : Adachi	ww.coursehero.com	0	0		ABCB11
799	chr2	28067824	28067896	3500001891	72		28067824	28067896	8421504	1	72	0	p	350000189100015071,350000189100015074	0-72,0-72						Comparative gene expression studies of anthelmintic resistance in the parasitic nematode,	www.eblex.org.uk	0	0		
805	chr2	28869472	28885719	3500253004	38		28869472	28885719	8421504	3	13,6,19	0,17,16228	c,g	350025300400000042,350025300400000023,350025300400000023	0-19,0-19,0-19						Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation	Groot	2012	0		
805	chr2	28870185	28885772	3500028732	40		28870185	28885772	8421504	3	11,8,21	0,13,15566	c,g	350002873200000088,350002873200000016,350002873200000016	0-19,0-21,0-21					Patent	Polypeptide fragments of human PAK5 protein kinase (Patent US:6656716)	Plowman	2003	0		
805	chr2	28882340	28920944	3500420398	81		28882340	28920944	8421504	4	19,20,23,19	0,22,3315,38585	c,g	350042039800000011,350042039800000002,350042039800000002,350042039800000003,350042039800000012	0-19,0-20,0-20,0-23,0-19						Tumorigenesis and Neoplastic Progression	w.teitell-lab.com	0	0		STK39
806	chr2	28996448	28996476	3500183874	23		28996448	28996476	8421504	2	13,10	0,18	g	350018387400000023	0-23		22053180	10.1371/journal.pone.0025800		PLoS ONE	Dengue Type 4 Live-Attenuated Vaccine Viruses Passaged in Vero Cells Affect Genetic Stability and Dengue-Induced Hemorrhaging in Mice	Hsiang-Chi	2011	0		
813	chr2	29920068	29920093	3500327539	24		29920068	29920093	8421504	2	18,6	0,19	g	350032753900000110	12-36						Albumin-Fused Kunitz Domain Peptides - Patent application	www.faqs.org	0	0		
821	chr2	30960442	30995350	3500353264	71		30960442	30995350	8421504	3	19,19,33	0,23871,34875	c	350035326400000039,350035326400000025,350035326400000043,350035326400000006	0-19,0-19,0-19,0-19						Suppression of SCN9A gene expression and/or function for the treatment of pain	Thakker	2008	0		SCN2A
821	chr2	30960442	30984332	3500196647	38		30960442	30984332	8421504	2	19,19	0,23871	c	350019664700000100,350019664700000039,350019664700000025,350019664700000086	0-19,0-19,0-19,0-19						SUPPRESSION OF SCN9A GENE EXPRESSION AND/OR FUNCTION FOR THE TREATMENT OF PAIN - Patent application	www.faqs.org	0	0		
821	chr2	30968131	30968176	3500114998	45		30968131	30968176	8421504	1	45	0	p	350011499800015010	0-45						Neuropeptide Release Assay For Sodium Channels - Patent application	www.faqs.org	0	0		SCN5A
821	chr2	30968233	30998176	3500226062	108		30968233	30998176	8421504	4	11,34,39,24	0,1415,27266,29919	p	350022606200015060,350022606200015076	21-66,0-66						Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases	Brys	2007	0		
821	chr2	30968233	30969682	3500108932	45		30968233	30969682	8421504	2	11,34	0,1415	p	350010893200015060	21-66						Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases	Brys	2006	0		
821	chr2	30978192	31050635	3500026200	136		30978192	31050635	8421504	5	30,30,3,43,30	0,17238,56943,57865,72413	p,c	350002620000015005,350002620000000004	0-120,0-43						channel (Nav1.7)	www.pnas.org	0	0		
821	chr2	30978192	31050635	3500026200	111		30978192	31050635	8421504	5	30,30,3,18,30	0,17238,56943,57865,72413	p	350002620000015002	0-120						channel (Nav1.7)	www.pnas.org	0	0		
821	chr2	30982443	30982524	3500126493	78		30982443	30982524	8421504	2	45,33	0,48	p	350012649300015132	0-78						 Screen For Sodium Channel Modulators 	www.docstoc.com	0	0		SCN9A
821	chr2	30987050	30989888	3500421845	40		30987050	30989888	8421504	3	20,9,11	0,21,2827	c	350042184500000004,350042184500000003	0-20,0-20		18978189	10.1152/ajpheart.00960.2008		American Journal of Physiology - Heart and Circulatory Physiology	Function and role of voltage-gated sodium channel NaV1.7 expressed in aortic smooth muscle cells	Meguro	2009	0		
821	chr2	30987050	30989888	3500228680	40		30987050	30989888	8421504	3	20,9,11	0,21,2827	c	350022868000000004,350022868000000003	0-20,0-20		18978189	10.1152/ajpheart.00960.2008		American Journal of Physiology - Heart and Circulatory Physiology	Function and role of voltage-gated sodium channel NaV1.7 expressed in aortic smooth muscle cells	Meguro	2009	0		
821	chr2	30987050	30989888	3500198808	40		30987050	30989888	8421504	3	20,9,11	0,21,2827	c	350019880800000004,350019880800000003	0-20,0-20		18978189	10.1152/ajpheart.00960.2008		American Journal of Physiology - Heart and Circulatory Physiology	Function and role of voltage-gated sodium channel NaV1.7 expressed in aortic smooth muscle cells	Meguro	2009	0		
821	chr2	31045690	31047177	3500426089	132		31045690	31047177	8421504	2	105,27	0,1460	p	350042608900015003	54-186						&#x4e3b;&#x9898;&#xff1a;src | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		SCN10A
821	chr2	31050743	31050766	3500465659	23		31050743	31050766	8421504	1	23	0	c	350046565900000004	0-23						Vasa recta voltage-gated Na + channel Na v 1.3 is regulated by calmodulin 2007&#x5e74;&#x7b2c;290&#x5377;&#x7b2c;1&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		SCN1A
821	chr2	31050743	31050766	3500120509	23		31050743	31050766	8421504	1	23	0	c	350012050900000004	0-23		16912065	10.1152/ajprenal.00070.2006		American Journal of Physiology - Renal Physiology	Vasa recta voltage-gated Na+ channel Nav1.3 is regulated by calmodulin	Lee-Kwon	2007	0		SCN2A
822	chr2	31124019	31124044	3500004661	25		31124019	31124044	8421504	1	25	0	g	350000466100000000	13-38		17088356	10.1128/IAI.01349-06	0019-9567	Infection and Immunity	The TolC Homologue of Brucella suis Is Involved in Resistance to Antimicrobial Compounds and Virulence	Posadas	2007	4		
102	chr2	31188671	31282415	3500410413	5994		31188671	31282415	8421504	26	264,119,90,129,92,270,64,142,207,285,348,133,239,174,357,483,121,155,174,123,282,54,138,105,271,1175	0,19163,21384,23403,26015,27247,33123,33750,34543,36897,38400,40031,45369,46911,48611,50146,68061,68921,70770,74991,82154,84712,86754,88746,90457,92569	p	350041041300015000	0-6027						KEGG T01001: 6323	www.genome.jp	0	0		SCN1A
102	chr2	31188671	31282415	3500027193	5994		31188671	31282415	8421504	26	264,119,90,129,92,270,64,142,207,285,348,133,239,174,357,483,121,155,174,123,282,54,138,105,271,1175	0,19163,21384,23403,26015,27247,33123,33750,34543,36897,38400,40031,45369,46911,48611,50146,68061,68921,70770,74991,82154,84712,86754,88746,90457,92569	p	350002719300015000	0-6027						 DMC Target SPDP00138 	r2d2drug.org	0	0		SCN1A
823	chr2	31207846	31207945	3500238228	84		31207846	31207945	8421504	2	63,21	0,78	p	350023822800015014	0-84						A Novel, Abundant Sodium Channel Expressed in Neurons and Glia	www.jneurosci.org	0	0		
823	chr2	31214699	31214747	3500195471	48		31214699	31214747	8421504	1	48	0	p	350019547100015015	0-48						MATERIAL FOR SCREENING FOR COMPOUND ACTING ON ION CHANNEL AND USE THEREOF - Patent application	www.faqs.org	0	0		SCN3A
823	chr2	31215920	31215946	3500048213	26		31215920	31215946	8421504	1	26	0	c	350004821300000003	0-26			10.1124/jpet.303.1.89	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Molecular Cloning and Functional Characterization of a Unique Mammalian Cardiac Nav Channel Isoform with Low Sensitivity to the Synthetic Inactivation Inhibitor (&#x2212;)-(S)-6-Amino-&#x03b1;-[(4-diphenylmethyl-1-piperazinyl)-methyl]-9H-purine-9-ethanol 	Denac	2002	0		SCN2A
823	chr2	31223253	31225634	3500383465	71		31223253	31225634	8421504	2	20,51	0,2330	p,c	350038346500000006,350038346500015000	20-40,0-51							olecularbrain.com	0	0		SCN1A
823	chr2	31271005	31271050	3500299371	45		31271005	31271050	8421504	1	45	0	c	350029937100000020	3-48					Patent	Diagnosis and treatment of breast cancer based upon scn5a (Patent EP:1377680)	DISS	2011	0		
823	chr2	31271005	31271050	3500033506	45		31271005	31271050	8421504	1	45	0	c	350003350600000032	3-48						Diagnosis and treatment of prostate cancer	Djamgoz	2002	0		
823	chr2	31281366	31281390	3500435555	24		31281366	31281390	8421504	1	24	0	c	350043555500000012	0-24						UNIVERSIT&#xc1; DEGLI STUDI DI MILANO DOTTORATO DI RICERCA IN FISIOLOGIA	air.unimi.it	0	0		
824	chr2	31356516	31356542	3500149565	23		31356516	31356542	8421504	3	4,5,14	0,5,12	g	350014956500000005	0-23		19088312	10.1128/AEM.01296-08	0099-2240	Applied and Environmental Microbiology	Linking Sequence to Function in Soil Bacteria: Sequence-Directed Isolation of Novel Bacteria Contributing to Soilborne Plant Disease Suppression	Benitez	2009	4		
825	chr2	31508916	31521823	3500432139	116		31508916	31521823	8421504	4	21,40,7,48	0,6116,10923,12859	c,g	350043213900000013,350043213900000028,350043213900000034	9-30,0-47,0-48						UDP-N-ACETYL-&#x03b1;-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE, GalNAc-T3	Paul	1997	0		
825	chr2	31509172	31523998	3500032868	192		31509172	31523998	8421504	4	48,48,30,66	0,12588,13300,14760	c	350003286800000112,350003286800000129,350003286800000134,350003286800000135	0-48,0-48,0-48,0-48						ASSAYS AND METHODS USING BIOMARKERS - Patent application	www.faqs.org	0	0		
825	chr2	31523861	31532598	3500116079	48		31523861	31532598	8421504	2	24,24	0,8713	c,g	350011607900000039,350011607900000046	0-24,0-24						Characterization of native FGF23 protein and mutant forms causing autosomal dominant hypophosphatemic rickets and familial tumoral calcinosis	b.uni-muenchen.de	0	0		
825	chr2	31526191	31526218	3500399667	27		31526191	31526218	8421504	1	27	0	c	350039966700000047	10-37						ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES	Clausen	2007	0		
825	chr2	31526191	31526218	3500265908	27		31526191	31526218	8421504	1	27	0	c	350026590800000047,350026590800000133	10-37,10-37						Isolated Lectin Polypeptides Consisting Of Truncated Mammalian Udp-galnac:polypeptide N- Acetylgalactosaminyltransferases 	.freshpatents.com	0	0		
827	chr2	31845936	31845964	3500207581	25		31845936	31845964	8421504	2	18,7	0,21	c	350020758100000098	13-45						US Patent # 5,403,484. Viruses expressing chimeric binding proteins - Patents.com	www.patents.com	0	0		
827	chr2	31845936	31845964	3500113261	25		31845936	31845964	8421504	2	18,7	0,21	c	350011326100000093	14-46					Patent	Directed evolution of novel binding proteins (Patent US:5571698)	Guterman	1996	0		
103	chr2	31846160	31934727	3500344931	3552		31846160	31934727	8421504	42	144,96,48,96,48,96,26,271,39,60,54,78,48,39,153,128,16,57,39,384,48,48,48,60,132,48,48,297,87,96,48,48,96,38,10,48,19,129,44,117,27,96	0,288,480,576,816,912,1152,2755,8005,8558,11187,12504,12630,14065,17550,18903,27778,27842,38029,38116,43866,43962,46135,46231,48945,49125,53497,57355,63263,63398,65685,65781,66017,67682,72726,72832,73955,74543,75408,87294,88300,88471	p	350034493100015124,350034493100015123,350034493100015122,350034493100015118,350034493100015117,350034493100015114,350034493100015112,350034493100015111,350034493100015107,350034493100015105,350034493100015104,350034493100015100,350034493100015099,350034493100015098,350034493100015097,350034493100015096,350034493100015095,350034493100015094,350034493100015090,350034493100015089,350034493100015088,350034493100015087,350034493100015085,350034493100015080,350034493100015079,350034493100015078,350034493100015077,350034493100015075,350034493100015074,350034493100015073,350034493100015071,350034493100015070,350034493100015068,350034493100015067,350034493100015066,350034493100015065,350034493100015064,350034493100015063,350034493100015062,350034493100015061,350034493100015059,350034493100015057,350034493100015052,350034493100015050,350034493100015049,350034493100015048,350034493100015047,350034493100015045,350034493100015042,350034493100015040,350034493100015039,350034493100015038,350034493100015037,350034493100015036,350034493100015035,350034493100015034,350034493100015033,350034493100015031,350034493100015030,350034493100015027,350034493100015025,350034493100015023,350034493100015022,350034493100015020,350034493100015017,350034493100015012,350034493100015011,350034493100015010,350034493100015009,350034493100015007,350034493100015006,350034493100015005,350034493100015001,350034493100015000	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Diagnostic And Therapeutic Use Of A Voltage-gated Ion Channel Scn2a For Neurodegenerative Diseases 	.freshpatents.com	0	0		SCN2A
103	chr2	31846607	31920103	3500114998	765		31846607	31920103	8421504	19	45,45,45,45,45,45,45,45,3,42,45,45,45,45,45,12,33,45,45	0,144,240,384,528,576,7564,7612,10791,12057,12246,13537,43437,43629,43677,43725,45670,72472,73451	p	350011499800015113,350011499800015110,350011499800015108,350011499800015105,350011499800015102,350011499800015101,350011499800015092,350011499800015091,350011499800015086,350011499800015082,350011499800015080,350011499800015057,350011499800015053,350011499800015052,350011499800015051,350011499800015015,350011499800015013	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Neuropeptide Release Assay For Sodium Channels - Patent application	www.faqs.org	0	0		SCN2A
828	chr2	31865046	31865072	3500429819	23		31865046	31865072	8421504	2	17,6	0,20	c	350042981900000102,350042981900000183,350042981900000131	12-35,0-23,15-38						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
828	chr2	31884204	31884285	3500435555	81		31884204	31884285	8421504	1	81	0	p	350043555500015001	0-81						UNIVERSIT&#xc1; DEGLI STUDI DI MILANO DOTTORATO DI RICERCA IN FISIOLOGIA	air.unimi.it	0	0		SCN2A
828	chr2	31890305	31892283	3500189005	45		31890305	31892283	8421504	2	39,6	0,1972	p	350018900500015001	0-45						2196158 . T3	www.oepm.es	0	0		SCN2A
828	chr2	31911851	31912261	3500196575	153		31911851	31912261	8421504	2	45,108	0,302	p	350019657500015012,350019657500015006	0-45,0-108						Tight Genetic Linkage between the kdr Insecticide Resistance Trait and a Voltage-Sensitive Sodium Channel Gene in the House Fly	www.jstor.org	0	0		SCN2A
828	chr2	31912160	31913871	3500074767	65		31912160	31913871	8421504	2	20,45	0,1666	c,g	350007476700000001,350007476700000002	20-40,41-86						FAMILIAL EPILEPSY Dissertation Submitted to the Faculty of the in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY	ry.vanderbilt.edu	0	0		
828	chr2	31933464	31933488	3500374909	24		31933464	31933488	8421504	1	24	0	c	350037490900001191	23-47						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
828	chr2	31934742	31934767	3500086833	25		31934742	31934767	8421504	1	25	0	c	350008683300000004	14-39						ScienceDirect.com - Neuroscience - Generalized epilepsy with febrile seizures plus&#x2013;associated sodium channel &#x03b2;1 subunit mutations severely reduce beta subunit&#x2013;mediated modulation of sodium channel function	sciencedirect.com	0	0		SCN2A
832	chr2	32455527	32455553	3500023988	23		32455527	32455553	8421504	2	17,6	0,20	g	350002398800000028	1-24						Polynucleotides and Polypeptides of the IL-12 Family of Cytokines - Patent application	www.faqs.org	0	0		
833	chr2	32506240	32506271	3500028061	25		32506240	32506271	8421504	3	8,13,4	0,13,27	g	350002806100000357	10-36						Surface proteins of leptospira	www.devileye.net	0	0		
835	chr2	32853567	32853596	3500292361	23		32853567	32853596	8421504	3	6,6,11	0,9,18	g	350029236100000003	0-23						A Paradigm for Virus&#x2013;Host Coevolution: Sequential Counter-Adaptations between Endogenous and Exogenous Retroviruses	www.ars.usda.gov	0	0		
843	chr2	33863867	33863893	3500018529	23		33863867	33863893	8421504	2	7,16	0,10	g	350001852900000252	10-33						***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Streptococcus pneumoniae antigens and vaccines	Choi	1997	0		
850	chr2	34764694	34764718	3500104575	23		34764694	34764718	8421504	2	14,9	0,15	g	350010457500000226	0-23						Peptide inhibitors of c-jun dimerization and uses thereof - Patent application	www.faqs.org	0	0		
850	chr2	34830197	34830230	3500006522	27		34830197	34830230	8421504	3	6,16,5	0,9,28	g	350000652200000040	3-30						FLAVIVIRUS NS1 SUBUNIT VACCINE - Patent application	www.faqs.org	0	0		
853	chr2	35216453	35229749	3500250706	42		35216453	35229749	8421504	2	21,21	0,13275	g	350025070600000015,350025070600000014	0-21,0-21						Virology Journal	www.virologyj.com	0	0		IFIH1
854	chr2	35290264	35332601	3500068850	43		35290264	35332601	8421504	2	21,22	0,42315	c,g	350006885000000009,350006885000000007	1-22,0-22						Methods and Compositions for Seprase Inactivation - Patent application	www.faqs.org	0	0		
854	chr2	35291610	35299682	3500312065	89		35291610	35299682	8421504	6	6,18,19,13,15,18	0,924,980,3468,7343,8054	c	350031206500000002,350031206500000003,350031206500000001	0-24,0-32,0-33			10.1186/ar1877		Arthritis Research & Therapy	Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis	Jennifer	2006	0		
854	chr2	35299766	35300712	3500162293	25		35299766	35300712	8421504	2	19,6	0,940	c	350016229300000275,350016229300000047	0-25,0-25						BISPECIFIC SINGLE CHAIN ANTIBODIES WITH SPECIFICITY FOR HIGH MOLECULAR WEIGHT TARGET ANTIGENS - Patent application	www.faqs.org	0	0		
854	chr2	35349753	35349778	3500461879	25		35349753	35349778	8421504	1	25	0	c	350046187900000001	12-37						Peptide prodrugs	Aggarwal	2007	0		FAP
854	chr2	35349753	35349778	3500426532	25		35349753	35349778	8421504	1	25	0	c	350042653200000035,350042653200000001	12-37,12-37						PEPTIDE PRODRUGS - Patent application	www.faqs.org	0	0		FAP
854	chr2	35349753	35349778	3500089925	25		35349753	35349778	8421504	1	25	0	c	350008992500000035,350008992500000001	12-37,12-37						Peptide Prodrugs - Patent application	www.faqs.org	0	0		FAP
854	chr2	35371263	35381644	3500140451	981		35371263	35381644	8421504	16	42,35,36,24,2,22,24,74,130,134,92,12,208,20,40,86	0,45,3287,3335,3386,4848,4897,4936,7260,9123,9906,10000,10013,10223,10253,10295	p,c,g	350014045100000001,350014045100000001,350014045100000002,350014045100000003,350014045100000004,350014045100000005,350014045100000005,350014045100000006,350014045100000006,350014045100015006,350014045100000007,350014045100015008,350014045100000008,350014045100000009,350014045100000009,350014045100015009,350014045100000010,350014045100000011,350014045100000011,350014045100015012,350014045100000012,350014045100000013,350014045100000013	1-60,1-60,0-55,0-24,0-24,0-24,0-24,0-51,0-51,0-51,0-51,0-51,0-33,0-51,0-51,0-51,0-33,0-51,0-51,0-48,0-51,0-461,0-461						Mammalian pancreatic preproglucagon containsthree glucagon- relatedpeptides	www.pnas.org	0	0		
854	chr2	35371298	35381183	3500303959	45		35371298	35381183	8421504	3	24,7,14	0,9215,9871	c	350030395900000002,350030395900000003	0-24,0-21						Diminished -cell mass in fetal sheep with intrauterine growth restriction	gu.physiology.org	0	0		
854	chr2	35371298	35381183	3500212325	45		35371298	35381183	8421504	3	24,7,14	0,9215,9871	c	350021232500000002,350021232500000003	0-24,0-21		15650129	10.1152/ajpregu.00494.2004		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Diminished &#x03b2;-cell replication contributes to reduced &#x03b2;-cell mass in fetal sheep with intrauterine growth restriction	Limesand	2005	0		
854	chr2	35374564	35374588	3500200603	24		35374564	35374588	8421504	1	24	0	c	350020060300000010	0-24						CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS	Agulnick	2013	0		
854	chr2	35374564	35374588	3500120349	24		35374564	35374588	8421504	1	24	0	c	350012034900000049,350012034900000014	0-24,0-24						GROWTH FACTORS FOR PRODUCTION OF DEFINITIVE ENDODERM - Patent application	www.faqs.org	0	0		
854	chr2	35374564	35374588	3500093061	24		35374564	35374588	8421504	1	24	0	c	350009306100000010	0-24						Agents and methods for inhibiting human pluripotent stem cell growth	Robins	2012	0		
854	chr2	35374564	35374588	3500071111	24		35374564	35374588	8421504	1	24	0	c	350007111100000010	0-24						SMALL MOLECULES SUPPORTING PLURIPOTENT CELL GROWTH AND METHODS THEREOF - SCHULZ, Thomas C.	www.sumobrain.com	0	0		
854	chr2	35376175	35378653	3500371800	180		35376175	35378653	8421504	2	87,93	0,2385	p	350037180000015023,350037180000015022,350037180000015020,350037180000015005,350037180000015017,350037180000015007,350037180000015006,350037180000015018,350037180000015019,350037180000015014	3-90,0-87,3-93,0-93,9-99,0-87,0-84,3-93,12-102,0-63						Combination therapy using transferrin fusion proteins comprising glp-1	Balance	2006	0		GCG
854	chr2	35376175	35378653	3500325700	180		35376175	35378653	8421504	2	87,93	0,2385	p	350032570000015028,350032570000015027,350032570000015012,350032570000015013,350032570000015003,350032570000015002,350032570000015005,350032570000015024,350032570000015014,350032570000015021,350032570000015020,350032570000015023,350032570000015022	3-90,0-87,3-96,0-84,3-93,3-96,3-96,3-93,0-87,0-90,0-90,6-96,3-93						Dipeptidyl-peptidase protected proteins	Ballance	2006	0		GCG
854	chr2	35376175	35378653	3500266973	180		35376175	35378653	8421504	2	87,93	0,2385	p	350026697300015023,350026697300015022,350026697300015020,350026697300015005,350026697300015017,350026697300015007,350026697300015006,350026697300015018,350026697300015019,350026697300015014	3-90,0-87,3-93,0-93,9-99,0-87,0-84,3-93,12-102,0-63						Combination therapy using transferrin fusion proteins comprising glp-1	Ballance	2008	0		GCG
854	chr2	35376175	35378653	3500144116	180		35376175	35378653	8421504	2	87,93	0,2385	p	350014411600015024,350014411600015023,350014411600015042,350014411600015018,350014411600015020,350014411600015008,350014411600015007,350014411600015006,350014411600015015,350014411600015016,350014411600015017,350014411600015019	3-90,0-87,0-45,3-93,3-93,0-87,0-84,3-96,0-90,0-90,3-93,6-96						&#x4f7f;&#x7528;&#x5305;&#x542b;glp&#xff0d;1&#x7684;&#x8fd0;&#x94c1;&#x86cb;&#x767d;&#x878d;&#x5408;&#x86cb;&#x767d;&#x7684;&#x7ec4;&#x5408;&#x6cbb;&#x7597;	Huo Ma Yang *Sa De Ji 	2007	0		GCG
854	chr2	35376175	35376262	3500441488	87		35376175	35376262	8421504	1	87	0	p	350044148800015000	0-87						<HTML> <HEAD> <TITLE>Biology</TITLE> <META NAME="description" content="The Book of Biology of The	terscientific.org	0	0		GCG
854	chr2	35376175	35376262	3500431863	87		35376175	35376262	8421504	1	87	0	p	350043186300015000	0-87						A Mixed Mirror-image DNA/RNA Aptamer Inhibits Glucagon and Acutely Improves Glucose Tolerance in Models of Type 1 and Type 2 Diabetes*	www.jbc.org	0	0		GCG
854	chr2	35376175	35376262	3500421168	87		35376175	35376262	8421504	1	87	0	p	350042116800015002	0-87						Le basi biochimiche della medicina di laboratorio	www.bayes.it	0	0		GCG
854	chr2	35376175	35376262	3500378136	87		35376175	35376262	8421504	1	87	0	p	350037813600015000	0-87						A method for the production of glucagon	Ishizaki	1990	0		GCG
854	chr2	35376175	35376235	3500384310	60		35376175	35376235	8421504	1	60	0	p	350038431000015074	0-60						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		GCG
854	chr2	35376175	35376232	3500375779	57		35376175	35376232	8421504	1	57	0	p	350037577900015000	0-57					Patent	A process for preparing glucagon or derivatives thereof in a transformed yeast strain (Patent EP:0189998)	Norris	1989	0		GCG
854	chr2	35376184	35380510	3500315071	121		35376184	35380510	8421504	6	21,20,20,20,20,20	0,55,2411,4209,4239,4306	c,g	350031507100000048,350031507100000049,350031507100000032,350031507100000033,350031507100000033,350031507100000034,350031507100000034,350031507100000035,350031507100000035	0-21,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
854	chr2	35376193	35376262	3500389626	69		35376193	35376262	8421504	1	69	0	p	350038962600015024	21-90						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		GCG
854	chr2	35376193	35376262	3500061337	69		35376193	35376262	8421504	1	69	0	p	350006133700015036	21-90						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		GCG
854	chr2	35376199	35376247	3500237680	48		35376199	35376247	8421504	1	48	0	p	350023768000015041	0-48					Patent	DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs (Patent US:6506595)	Sato	2003	0		GCG
854	chr2	35376202	35376247	3500140661	45		35376202	35376247	8421504	1	45	0	p	350014066100015036	0-45						 <HTML> <HEAD><TITLE>coc3/4aa-a?a1/4a(r)aeSSc-ae1ae3aa3aaaa>>aaa$?(c)cPaa$?aeY=aa	www.j-tokkyo.com	0	0		GCG
854	chr2	35376205	35376253	3500106263	48		35376205	35376253	8421504	1	48	0	p	350010626300015067	0-48						Protein modification method	Sato	1995	0		GCG
854	chr2	35378542	35378653	3500407622	111		35378542	35378653	8421504	1	111	0	p	350040762200015021,350040762200015028,350040762200015031,350040762200015000	0-111,0-93,0-90,0-84					Patent	Compounds and methods for increasing neurogenesis (Patent US:6969702)	Bertilsson	2005	0		GCG
854	chr2	35378542	35378653	3500007204	111		35378542	35378653	8421504	1	111	0	p	350000720400015022,350000720400015032,350000720400015029	0-111,0-90,0-93						Compounds and methods for increasing neurogenesis	Bertilsson	2004	0		GCG
854	chr2	35378542	35378638	3500436193	96		35378542	35378638	8421504	1	96	0	p	350043619300015001,350043619300015002	0-48,0-48						Customized proteases with altered transacylation activity	Breddam	1995	0		GCG
854	chr2	35378543	35378569	3500412634	26		35378543	35378569	8421504	1	26	0	c	350041263400000007	20-46						ScienceDirect.com - Biochemical and Biophysical Research Communications - Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets	sciencedirect.com	0	0		
854	chr2	35378554	35378650	3500435123	96		35378554	35378650	8421504	1	96	0	p	350043512300015040,350043512300015039,350043512300015030,350043512300015048,350043512300015049,350043512300015046,350043512300015033,350043512300015037	0-96,0-90,0-78,0-84,0-84,0-84,0-75,0-66						Glp-1, Exendin-4, Peptide Analogs And Uses Thereof 	.freshpatents.com	0	0		GCG
854	chr2	35378557	35378653	3500319825	96		35378557	35378653	8421504	1	96	0	p	350031982500015057,350031982500015084,350031982500015056,350031982500015055,350031982500015075,350031982500015072,350031982500015081,350031982500015074,350031982500015082,350031982500015054,350031982500015063,350031982500015062,350031982500015079,350031982500015073,350031982500015071,350031982500015069,350031982500015059,350031982500015061,350031982500015039,350031982500015038,350031982500015077,350031982500015076,350031982500015035,350031982500015034,350031982500015037,350031982500015036,350031982500015030,350031982500015033,350031982500015032,350031982500015064,350031982500015067,350031982500015078,350031982500015065,350031982500015053,350031982500015049,350031982500015052,350031982500015080,350031982500015070,350031982500015066,350031982500015083,350031982500015051,350031982500015050,350031982500015031,350031982500015044,350031982500015045,350031982500015046,350031982500015047,350031982500015040,350031982500015041,350031982500015042,350031982500015043,350031982500015068,350031982500015025,350031982500015048,350031982500015023,350031982500015135,350031982500015161	9-99,9-93,9-99,75-147,0-93,0-93,0-93,0-93,0-93,75-147,0-93,0-93,0-93,0-96,0-93,0-93,0-93,0-93,78-150,78-150,0-93,0-93,78-150,78-150,78-150,78-150,57-129,78-150,78-150,0-93,0-93,0-93,0-93,75-147,75-147,75-147,0-93,0-93,0-93,0-93,75-147,75-147,78-150,75-147,75-147,75-147,75-147,78-150,81-150,75-147,75-147,0-93,0-93,75-147,0-90,0-45,0-48						METHOD FOR SUSTAINEDLY RELEASING BIOACTIVE PEPTIDES AND APPLICATION THEREOF - Patent application	www.faqs.org	0	0		GCG
854	chr2	35378560	35378653	3500440631	93		35378560	35378653	8421504	1	93	0	p,c,g	350044063100000010,350044063100015004,350044063100000011,350044063100000011,350044063100015005	6-54,0-48,0-45,0-45,0-45						Expression technology for proteins containing a hybrid isotype antibody moiety	Gillies	2002	0		GCG
854	chr2	35378560	35378653	3500440013	93		35378560	35378653	8421504	1	93	0	p	350044001300015003,350044001300015005	0-93,0-78						KEGG T01001: 2740	www.genome.jp	0	0		GCG
854	chr2	35378560	35378653	3500437721	93		35378560	35378653	8421504	1	93	0	p	350043772100015167,350043772100015166,350043772100015164	0-93,0-90,0-57						CARRIER IMMUNOGLOBULINS AND USES THEREOF - AMGEN INC.	www.sumobrain.com	0	0		GCG
854	chr2	35378560	35378653	3500424300	75		35378560	35378653	8421504	2	30,45	0,48	c,g	350042430000000010,350042430000000012,350042430000000012,350042430000000013	0-30,0-21,0-21,0-24						Expression technology for proteins containing a hybrid isotype antibody moiety	Gillies	2006	0		
854	chr2	35378560	35378653	3500409535	93		35378560	35378653	8421504	1	93	0	p,c,g	350040953500000010,350040953500015004,350040953500000011,350040953500000011,350040953500015005	6-54,0-48,0-45,0-45,0-45					Patent	Expression technology for proteins containing a hybrid isotype antibody moiety (Patent US:7148321)	Gillies	2006	0		GCG
854	chr2	35378560	35378653	3500407620	93		35378560	35378653	8421504	1	93	0	p	350040762000015005,350040762000015004,350040762000015000,350040762000015003	0-87,0-84,0-93,0-90					Patent	Modified transferrin fusion proteins (Patent US:7176278)	Prior	2007	0		GCG
854	chr2	35378560	35378653	3500370944	93		35378560	35378653	8421504	1	93	0	p	350037094400015043,350037094400015042,350037094400015041	0-93,0-93,0-90						Carrier immunoglobulins and uses thereof	Walker	2012	0		GCG
854	chr2	35378560	35378653	3500344949	93		35378560	35378653	8421504	1	93	0	p	350034494900015077,350034494900015139,350034494900015088,350034494900015227,350034494900015226,350034494900015220	0-93,0-93,0-90,0-93,0-93,0-90						GLP-1 fusion proteins	Glaesner	2001	0		GCG
854	chr2	35378560	35378653	3500333130	93		35378560	35378653	8421504	1	93	0	p	350033313000015002,350033313000015001	0-90,0-93						Glp-1 peptide having sugar chain attached thereto	Asai	2010	0		GCG
854	chr2	35378560	35378653	3500331572	93		35378560	35378653	8421504	1	93	0	p	350033157200015122,350033157200015117,350033157200015123,350033157200015125,350033157200015138	0-60,0-93,0-90,0-81,0-84						Compositions and methods for the transport of therapeutic agents	Castaigne	2011	0		GCG
854	chr2	35378560	35378653	3500276742	45		35378560	35378653	8421504	2	24,21	0,72	c	350027674200000002,350027674200000004,350027674200000005,350027674200000003	0-24,20-44,0-24,1-22					Patent	In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy (Patent US:6846676)	Selden	2005	0		
854	chr2	35378560	35378653	3500263315	93		35378560	35378653	8421504	1	93	0	p	350026331500015033,350026331500015035,350026331500015034	0-90,0-93,0-93						Compositions and methods for producing bioactive fusion proteins	Walker	2008	0		GCG
854	chr2	35378560	35378653	3500236543	93		35378560	35378653	8421504	1	93	0	p	350023654300015056,350023654300015054,350023654300015055	0-93,0-90,0-93					Patent	Compositions and methods for producing bioactive fusion proteins (Patent US:8420779)	Walker	2013	0		GCG
854	chr2	35378560	35378653	3500227699	93		35378560	35378653	8421504	1	93	0	p	350022769900015056,350022769900015054,350022769900015055	0-93,0-90,0-93						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		GCG
854	chr2	35378560	35378653	3500214648	93		35378560	35378653	8421504	1	93	0	p	350021464800015001,350021464800015002	0-93,0-90						Glp-1 peptide having sugar chain attached thereto	Asai	2010	0		GCG
854	chr2	35378560	35378653	3500213313	93		35378560	35378653	8421504	1	93	0	p	350021331300015001,350021331300015002,350021331300015065	0-93,0-57,0-45						SUGAR CHAIN ADDED GLP-1 PEPTIDE - Patent application	www.faqs.org	0	0		GCG
854	chr2	35378560	35378653	3500198279	93		35378560	35378653	8421504	1	93	0	p	350019827900015002,350019827900015011,350019827900015014	0-48,0-48,0-45						Glp-1 And Methods For Treating Diabetes 	.freshpatents.com	0	0		GCG
854	chr2	35378560	35378653	3500145711	93		35378560	35378653	8421504	1	93	0	p	350014571100015049,350014571100015005,350014571100015004,350014571100015007,350014571100015006,350014571100015022	0-93,0-72,0-81,0-72,0-81,0-72					Patent	Glp-1 analog fusion proteins (Patent CA:2528591)	Glaesner	2013	0		GCG
854	chr2	35378560	35378653	3500083088	93		35378560	35378653	8421504	1	93	0	p	350008308800015001,350008308800015002	0-93,0-90						Sugar chain added glp-1 peptide	Kajihara	2011	0		GCG
854	chr2	35378560	35378653	3500051329	93		35378560	35378653	8421504	1	93	0	p	350005132900015136,350005132900015134,350005132900015135	0-93,0-90,0-93						CARRIER IMMUNOGLOBULINS AND USES THEREOF	Walker	2011	0		GCG
854	chr2	35378560	35378653	3500048949	93		35378560	35378653	8421504	1	93	0	p	350004894900015004,350004894900015005,350004894900015000,350004894900015003	0-84,0-87,0-93,0-90					Patent	Modified transferrin fusion proteins (Patent US:7176278)	Prior	2007	0		GCG
854	chr2	35378560	35378653	3500045924	93		35378560	35378653	8421504	1	93	0	p	350004592400015167,350004592400015166,350004592400015164	0-93,0-90,0-57						Carrier immunoglobulins and uses thereof	Arora	2012	0		GCG
854	chr2	35378560	35378653	3500045378	93		35378560	35378653	8421504	1	93	0	p	350004537800015225,350004537800015138,350004537800015087,350004537800015226,350004537800015219	0-93,0-93,0-90,0-93,0-90					Patent	GLP-1 fusion proteins (Patent US:7271149)	Glaesner	2007	0		GCG
854	chr2	35378560	35378653	3500008791	93		35378560	35378653	8421504	1	93	0	p	350000879100015000	0-93						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		GCG
854	chr2	35378560	35378653	3500004002	93		35378560	35378653	8421504	1	93	0	p	350000400200015037,350000400200015036,350000400200015035	0-93,0-93,0-90						COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS	Walker	2013	0		GCG
854	chr2	35378560	35378653	3500001726	45		35378560	35378653	8421504	2	24,21	0,72	c	350000172600000002,350000172600000010,350000172600000011,350000172600000003	0-24,0-24,11-32,11-32						In vivo production and delivery of erythropoietin	Selden	1999	0		
854	chr2	35378560	35378650	3500467632	90		35378560	35378650	8421504	1	90	0	p	350046763200015066,350046763200015072,350046763200015017,350046763200015016,350046763200015068,350046763200015023,350046763200015024,350046763200015025,350046763200015038,350046763200015006,350046763200015000,350046763200015037,350046763200015086,350046763200015009,350046763200015073,350046763200015026,350046763200015014,350046763200015084,350046763200015097,350046763200015030	0-84,0-87,0-90,0-90,0-87,0-90,0-90,0-90,0-84,0-84,0-84,6-81,9-90,0-81,0-81,0-81,0-78,0-72,0-66,0-66						US Patent # 7,576,050. GLP-1 exendin-4 peptide analogs and uses thereof - Patents.com	www.patents.com	0	0		GCG
854	chr2	35378560	35378650	3500461232	90		35378560	35378650	8421504	1	90	0	p	350046123200015004,350046123200015010,350046123200015002	0-90,0-48,0-57						Process For Producing Plant Storage Organ With High Production Of Recombinant Protein And Novel Recombinant Protein 	.freshpatents.com	0	0		GCG
854	chr2	35378560	35378650	3500454221	90		35378560	35378650	8421504	1	90	0	p	350045422100015002,350045422100015003,350045422100015013,350045422100015012,350045422100015011,350045422100015010	0-90,0-90,0-90,0-90,0-90,0-90						Glp-1 exendin-4 peptide analogs and uses thereof	Doyle	2003	0		GCG
854	chr2	35378560	35378650	3500453483	90		35378560	35378650	8421504	1	90	0	p	350045348300015003	21-111						BIOMOLECULE POLYMER CONJUGATES AND METHODS FOR MAKING THE SAME - Patent application	www.faqs.org	0	0		GCG
854	chr2	35378560	35378650	3500395091	90		35378560	35378650	8421504	1	90	0	p,c,g	350039509100015004,350039509100000006,350039509100000001	0-90,78-103,0-23						Composition and method for prevention and treatment of type i diabetes	Kumar	2008	0		
854	chr2	35378560	35378650	3500388296	90		35378560	35378650	8421504	1	90	0	p	350038829600015002	0-90						Transferrin fusion protein libraries	Prior	2007	0		GCG
854	chr2	35378560	35378650	3500371611	90		35378560	35378650	8421504	1	90	0	p	350037161100015005,350037161100015004	0-90,0-90						Therapeutic agents comprising elastin-like peptides	Chilkoti	2009	0		GCG
854	chr2	35378560	35378650	3500371173	90		35378560	35378650	8421504	1	90	0	p	350037117300015001,350037117300015000	0-90,0-87						Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein	EBINUMA	2005	0		GCG
854	chr2	35378560	35378650	3500334889	90		35378560	35378650	8421504	1	90	0	p,c,g	350033488900015006,350033488900000006,350033488900000001	0-90,78-103,0-23						Composition and method for prevention and treatment of type I diabetes - Patent #08278420	w.strutpatent.com	0	0		
854	chr2	35378560	35378650	3500334717	90		35378560	35378650	8421504	1	90	0	p	350033471700015001,350033471700015009,350033471700015002,350033471700015011	0-90,0-90,0-84,0-54						Methods and compositions for inhibiting delayed graft function	SHANNON	2013	0		GCG
854	chr2	35378560	35378650	3500333689	90		35378560	35378650	8421504	1	90	0	p	350033368900015000	0-90					Patent	Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein (Patent CN:1816622)	Cheng Sen Xiao Ren 	2011	0		GCG
854	chr2	35378560	35378650	3500331647	90		35378560	35378650	8421504	1	90	0	p	350033164700015004,350033164700015003,350033164700015013,350033164700015012,350033164700015011,350033164700015014	0-90,0-90,0-90,0-90,0-90,0-90						Glp-1 exendin-4 peptide analogs and uses thereof	Doyle	2004	0		GCG
854	chr2	35378560	35378650	3500327682	90		35378560	35378650	8421504	1	90	0	p	350032768200015000	0-90						Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein	Shan Tian Geng [?] 	2006	0		GCG
854	chr2	35378560	35378650	3500310813	90		35378560	35378650	8421504	1	90	0	p,c,g	350031081300000007,350031081300000017,350031081300015002,350031081300000002	77-102,78-103,0-90,0-23						GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES - Patent application	www.faqs.org	0	0		
854	chr2	35378560	35378650	3500299863	90		35378560	35378650	8421504	1	90	0	p,c,g	350029986300015007,350029986300000006,350029986300000001	0-90,78-103,0-23						COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF TYPE I DIABETES - Patent application	www.faqs.org	0	0		
854	chr2	35378560	35378650	3500266223	90		35378560	35378650	8421504	1	90	0	p	350026622300015016,350026622300015017,350026622300015026,350026622300015025,350026622300015024,350026622300015023,350026622300015000,350026622300015009,350026622300015014,350026622300015048,350026622300015046	0-90,0-90,0-90,0-90,0-90,0-90,0-78,0-75,0-66,0-45,0-45						GLP-1, exendin-4, peptide analogs and uses thereof - Patent application	www.faqs.org	0	0		GCG
854	chr2	35378560	35378650	3500257706	90		35378560	35378650	8421504	1	90	0	p,c,g	350025770600000017,350025770600000007,350025770600015003,350025770600000002	78-103,77-102,0-90,0-23						GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES	Wang	2009	0		
854	chr2	35378560	35378650	3500242885	90		35378560	35378650	8421504	1	90	0	p	350024288500015031,350024288500015032,350024288500015038,350024288500015041,350024288500015040,350024288500015013,350024288500015027,350024288500015022	0-90,0-90,0-90,0-90,0-90,0-84,0-78,0-81						GLP-1 exendin-4 peptide analogs and uses thereof	Greig	2002	0		GCG
854	chr2	35378560	35378650	3500241933	90		35378560	35378650	8421504	1	90	0	p	350024193300015008	0-90						Fgfr1c antibody combinations	Beaton	2012	0		GCG
854	chr2	35378560	35378650	3500239395	90		35378560	35378650	8421504	1	90	0	p	350023939500015005	0-90						Strukturelle und funktionelle Charakterisierung der Ligandenbindungsdom&#xe4;ne des humanen GLP-1 Rezeptors	thek.uni-halle.de	0	0		GCG
854	chr2	35378560	35378650	3500225673	90		35378560	35378650	8421504	1	90	0	p	350022567300015000	0-90						Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein	S*Li Yuan 	2011	0		GCG
854	chr2	35378560	35378650	3500214899	90		35378560	35378650	8421504	1	90	0	p	350021489900015028,350021489900015018,350021489900015019,350021489900015027,350021489900015025,350021489900015000,350021489900015014,350021489900015009	0-90,0-90,0-90,0-90,0-90,0-84,0-78,0-81						Glp-1, exendin-4, peptide analogs and uses thereof	Greig	2012	0		GCG
854	chr2	35378560	35378650	3500171964	90		35378560	35378650	8421504	1	90	0	p	350017196400015008	0-90						Fgfr1c antibody combinations	Beaton	2012	0		GCG
854	chr2	35378560	35378650	3500166876	90		35378560	35378650	8421504	1	90	0	p	350016687600015004,350016687600015005,350016687600015081	0-90,0-90,0-45						THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES - Patent application	www.faqs.org	0	0		GCG
854	chr2	35378560	35378650	3500159228	90		35378560	35378650	8421504	1	90	0	p,c,g	350015922800000006,350015922800015004,350015922800000001	78-103,0-90,0-23						Composition and method for prevention and treatment of type i diabetes	Kumar	2007	0		GCG
854	chr2	35378560	35378650	3500156501	90		35378560	35378650	8421504	1	90	0	p	350015650100015023,350015650100015026,350015650100015025,350015650100015017,350015650100015016,350015650100015000,350015650100015009,350015650100015014	0-90,0-90,0-90,0-90,0-90,0-78,0-75,0-66					Patent	GLP-1, exendin-4, peptide analogs and uses thereof (Patent US:8278272)	Greig	2012	0		GCG
854	chr2	35378560	35378650	3500112883	90		35378560	35378650	8421504	1	90	0	p	350011288300015003	0-90						Transferrin fusion proteins libraries	Prior	2003	0		GCG
854	chr2	35378560	35378650	3500050010	90		35378560	35378650	8421504	1	90	0	p	350005001000015025,350005001000015027,350005001000015019,350005001000015018,350005001000015028,350005001000015000,350005001000015014,350005001000015009	0-90,0-90,0-90,0-90,0-90,0-84,0-78,0-81					Patent	GLP-1 exendin-4 peptide analogs and uses thereof (Patent US:7576050)	Greig	2009	0		GCG
854	chr2	35378560	35378644	3500368130	84		35378560	35378644	8421504	1	84	0	p	350036813000015089,350036813000015094,350036813000015083,350036813000015099	0-78,0-81,0-60,0-66						Multimeric peptide conjugates and uses thereof	Demeule	2011	0		GCG
854	chr2	35378560	35378644	3500146530	84		35378560	35378644	8421504	1	84	0	p	350014653000015011	0-84						POLYPEPTIDE SCAFFOLD - CYCLOGENIX LTD	www.sumobrain.com	0	0		GCG
854	chr2	35378560	35378644	3500139950	84		35378560	35378644	8421504	1	84	0	p	350013995000015011	0-84						Polypeptide scaffold	Eldridge	2012	0		GCG
854	chr2	35378560	35378644	3500010107	84		35378560	35378644	8421504	1	84	0	p	350001010700015000	0-84						WORD&#x6587;&#x4ef6; - &#x751f;&#x7269;&#x901a;--------&#x4e2d;&#x56fd;&#x751f;&#x547d;&#x79d1;&#x5b66;&#x7b2c;&#x4e00;&#x7f51; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		GCG
854	chr2	35378560	35378638	3500046583	78		35378560	35378638	8421504	1	78	0	c,g	350004658300000004,350004658300000023,350004658300000023,350004658300000005	12-45,0-20,0-20,0-45						Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists - US Patent 7833531 Description	ww.patentstorm.us	0	0		
854	chr2	35378560	35378626	3500277467	66		35378560	35378626	8421504	1	66	0	p	350027746700015000	0-66						Melanocortin and transferrin fusion proteins	Prior	2008	0		GCG
854	chr2	35378560	35378617	3500405758	57		35378560	35378617	8421504	1	57	0	p	350040575800015002	0-57						PROCESS FOR PRODUCING PLANT STORAGE ORGAN WITH HIGH PRODUCTION OF RECOMBINANT PROTEIN AND NOVEL RECOMBINANT PROTEIN - Patent application	www.faqs.org	0	0		GCG
854	chr2	35378560	35378585	3500391999	25		35378560	35378585	8421504	1	25	0	c,g	350039199900000026,350039199900000005	78-103,0-23					Patent	Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes and method (Patent CN:101273134)	Jie La Er De *J*Pu Lu De Huo Mu 	2012	0		GCG
854	chr2	35378560	35378585	3500175945	25		35378560	35378585	8421504	1	25	0	g	350017594500000013	9-34						US Patent # 5,994,127. In vivo production and delivery of erythropoietin or insulinotropin for gene therapy - Patents.com	www.patents.com	0	0		GCG
854	chr2	35378563	35378650	3500374067	87		35378563	35378650	8421504	1	87	0	p	350037406700015002,350037406700015001,350037406700015000,350037406700015003,350037406700015007,350037406700015005,350037406700015004	0-87,0-87,0-87,0-84,0-78,0-84,0-84						GLP-1, exendin-4, peptide analogs and uses thereof	Greig	2011	0		GCG
854	chr2	35378566	35378650	3500367378	84		35378566	35378650	8421504	1	84	0	p	350036737800015003	0-84						Biomolecule polymer conjugates and methods for making the same	Chilkoti	2011	0		GCG
854	chr2	35378566	35378650	3500352810	84		35378566	35378650	8421504	1	84	0	p	350035281000015004	0-84						BIOMOLECULE POLYMER CONJUGATES AND METHODS FOR MAKING THE SAME	Chilkoti	2010	0		GCG
854	chr2	35378566	35378650	3500293461	84		35378566	35378650	8421504	1	84	0	p	350029346100015003	0-84						Biomolecule polymer conjugates and methods for making the same	Chilkoti	2011	0		GCG
854	chr2	35378566	35378647	3500450991	81		35378566	35378647	8421504	1	81	0	p	350045099100015019,350045099100015020,350045099100015021	0-81,0-72,0-81						GLP-1 analog fusion proteins	Glaesner	2008	0		GCG
854	chr2	35378566	35378647	3500437009	81		35378566	35378647	8421504	1	81	0	p	350043700900015020,350043700900015018,350043700900015019	0-81,0-81,0-72					Patent	GLP-1 analog fusion proteins (Patent US:8273854)	Glaesner	2012	0		GCG
854	chr2	35378566	35378647	3500414055	81		35378566	35378647	8421504	1	81	0	p	350041405500015010,350041405500015011,350041405500015012	0-81,0-72,0-81						GLP-1 ANALOG FUSION PROTEINS - Patent application	www.faqs.org	0	0		GCG
854	chr2	35378566	35378647	3500313858	81		35378566	35378647	8421504	1	81	0	p	350031385800015026,350031385800015020,350031385800015022	0-72,0-81,0-72						GLP-1 analog fusion proteins	A*M*Wei Ke 	2011	0		GCG
854	chr2	35378566	35378647	3500279552	81		35378566	35378647	8421504	1	81	0	p	350027955200015011,350027955200015010,350027955200015012	0-72,0-81,0-81						Glp-1 analog fusion proteins	Glaesner	2009	0		GCG
854	chr2	35378566	35378647	3500092868	81		35378566	35378647	8421504	1	81	0	p	350009286800015006,350009286800015008,350009286800015010,350009286800015013	0-81,0-72,0-81,0-72						Glp-1 analog fusion plroteins	Glaesner	2005	0		GCG
854	chr2	35378566	35378647	3500074808	81		35378566	35378647	8421504	1	81	0	p	350007480800015006,350007480800015012,350007480800015015,350007480800015009	0-81,0-81,0-72,0-72						Glp&#xff0d;1&#x7c7b;&#x4f3c;&#x7269;&#x878d;&#x5408;&#x86cb;&#x767d;&#x8d28;	W*Ge Lai Si Na 	2006	0		GCG
854	chr2	35378566	35378647	3500072137	81		35378566	35378647	8421504	1	81	0	p	350007213700015006,350007213700015007,350007213700015004,350007213700015005	0-81,0-72,0-81,0-72					Patent	Glp-1&#x7c7b;&#x4f3c;&#x7269;&#x878d;&#x5408;&#x86cb;&#x767d;&#x8d28; (Patent CN:1802386)	A*M*Wei Ke 	2010	0		GCG
854	chr2	35378566	35378647	3500071007	81		35378566	35378647	8421504	1	81	0	p	350007100700015010,350007100700015012,350007100700015014,350007100700015008	0-72,0-81,0-72,0-81					Patent	GLP-1 analog fusion proteins (Patent CN:1802386)	A*M*Wei Ke 	2010	0		GCG
854	chr2	35378566	35378647	3500068906	81		35378566	35378647	8421504	1	81	0	p	350006890600015013,350006890600015010,350006890600015011	0-72,0-81,0-72						Glp-1&#x7c7b;&#x4f3c;&#x7269;&#x878d;&#x5408;&#x86cb;&#x767d;&#x8d28;	A*M*Wei Ke 	2011	0		GCG
854	chr2	35378566	35378638	3500250823	72		35378566	35378638	8421504	1	72	0	p	350025082300015009,350025082300015018,350025082300015003	0-72,0-48,0-54					Patent	Enzymatic method for modification of recombinant polypeptides (Patent US:6403361)	Wagner	2002	0		GCG
854	chr2	35378584	35378647	3500383023	63		35378584	35378647	8421504	1	63	0	p	350038302300015004,350038302300015008	0-63,0-63						Glp-1 analog fusion proteins	Glaesner	2007	0		GCG
854	chr2	35378584	35378647	3500245479	63		35378584	35378647	8421504	1	63	0	p	350024547900015022,350024547900015020	0-63,0-63						GLP-1 analog fusion proteins	Glaesner	2004	0		GCG
854	chr2	35378611	35380378	3500441786	44		35378611	35380378	8421504	3	20,22,2	0,28,1765	c,g	350044178600000015,350044178600000015,350044178600000017	0-20,0-20,0-24						METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS	Kelly	2008	0		GCG
854	chr2	35378611	35380378	3500210815	44		35378611	35380378	8421504	3	20,22,2	0,28,1765	c	350021081500000023,350021081500000025	0-20,0-24						Adult Stem Cell-derived Connective Tissue Progenitors For Tissue Engineering 	.freshpatents.com	0	0		GCG
854	chr2	35378617	35378640	3500420984	23		35378617	35378640	8421504	1	23	0	c	350042098400000018	21-44						Albumin fusion proteins	Haseltine	2004	0		
854	chr2	35378617	35378640	3500349387	23		35378617	35378640	8421504	1	23	0	c	350034938700000018	21-44						Albumin fusion proteins	Haseltine	2003	0		
854	chr2	35378617	35378640	3500329131	23		35378617	35378640	8421504	1	23	0	c	350032913100000007	0-23						Embryogenesis of the murine endocrine pancreas; early expression of pancreatic polypeptide gene	ev.biologists.org	0	0		GCG
854	chr2	35378633	35378659	3500197449	26		35378633	35378659	8421504	1	26	0	c	350019744900000007	22-48		21539888	10.1016/j.mce.2011.04.008		Molecular and cellular endocrinology	Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers	Craig	June	0		GCG
854	chr2	35378639	35380378	3500390129	24		35378639	35380378	8421504	2	22,2	0,1737	c	350039012900000016	0-24						Differentiation and Enrichment of Islet-like Cells from Human Pluripotent Stem Cells - Patent application	www.faqs.org	0	0		
855	chr2	35442404	35442607	3500089357	45		35442404	35442607	8421504	2	23,22	0,181	c,g	350008935700000000,350008935700000000,350008935700000001	0-23,0-23,0-22						Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism	-publications.com	0	0		DPP4
855	chr2	35476070	35493352	3500311258	40		35476070	35493352	8421504	3	17,3,20	0,2463,17262	c	350031125800000010,350031125800000044,350031125800000011,350031125800000045	0-20,0-20,0-20,0-20						BIOMARKERS FOR MELANOMA - Patent application	www.faqs.org	0	0		DPP4
855	chr2	35476070	35493352	3500069246	40		35476070	35493352	8421504	3	17,3,20	0,2463,17262	c	350006924600000010,350006924600000011	0-20,0-20						BIOMARKERS FOR MELANOMA - THE JOHNS HOPKINS UNIVERSITY	www.sumobrain.com	0	0		DPP4
857	chr2	35696499	35696528	3500423469	23		35696499	35696528	8421504	3	5,6,12	0,6,17	c	350042346900000085	0-23						A gene from Solanum bulbocastanum conferring resistance to Phytophthora infestans	Allefs	2011	0		SMARCA2
857	chr2	35696499	35696528	3500382913	23		35696499	35696528	8421504	3	5,6,12	0,6,17	c	350038291300000085	0-23						FUNGUS RESISTANT PLANTS AND THEIR USES	Der	2009	0		SMARCA2
857	chr2	35696499	35696528	3500290366	23		35696499	35696528	8421504	3	5,6,12	0,6,17	c	350029036600000085,350029036600000473	0-23,0-23						FUNGUS RESISTANT PLANTS AND THEIR USES - Patent application	www.faqs.org	0	0		
857	chr2	35696499	35696528	3500242037	23		35696499	35696528	8421504	3	5,6,12	0,6,17	c	350024203700000085	0-23						Fungus resistant plants and their uses	Allefs	2005	0		
857	chr2	35696499	35696528	3500160309	23		35696499	35696528	8421504	3	5,6,12	0,6,17	c	350016030900000085	0-23						A gene from Solanum bulbocastanum conferring resistance to Phytophthora infestans	Allefs	2011	0		
859	chr2	36006955	36009989	3500112209	564		36006955	36009989	8421504	5	51,159,122,155,77	0,983,1719,2196,2957	p	350011220900015043,350011220900015040,350011220900015033,350011220900015028,350011220900015026	33-144,0-144,0-210,0-210,0-210						T-brainhomologue (HpTb) is involved in the archenteron induction signals of micromere descendant cells in the sea urchin embryo	ev.biologists.org	0	0		TBR1
859	chr2	36013621	36013647	3500348195	24		36013621	36013647	8421504	2	5,19	0,7	g	350034819500000070	2-27						 Nucleic Acid Probes For Detection And/or Quantitation Of Non 	www.docstoc.com	0	0		
859	chr2	36013621	36013647	3500002784	24		36013621	36013647	8421504	2	5,19	0,7	g	350000278400000071	2-27						Nucleic acid probes for detection and/or quantitation of non-viral organisms	Hogan	1994	0		
859	chr2	36015507	36015774	3500365249	74		36015507	36015774	8421504	3	19,19,36	0,110,231	c	350036524900000002,350036524900000001,350036524900000006	0-19,20-39,5-41		17237285	10.1158/1535-7163.MCT-06-0542	1535-7163	Molecular Cancer Therapeutics	The JAMM motif of human deubiquitinase Poh1 is essential for cell viability	Gallery	2007	5		PSMD14
860	chr2	36057449	36061048	3500376790	375		36057449	36061048	8421504	6	30,99,10,71,120,45	0,33,138,1137,3207,3554	p	350037679000015022	12-390						Dsrna as insect control agent	Raemaekers	2007	0		PSMD14
860	chr2	36057473	36061042	3500356261	354		36057473	36061042	8421504	4	124,71,120,39	0,1113,3183,3530	p	350035626100015052	0-354						Dsrna as Insect Control Agent	Raemaekers	2009	0		PSMD14
860	chr2	36114732	36114760	3500365249	28		36114732	36114760	8421504	1	28	0	c	350036524900000005	15-43		17237285	10.1158/1535-7163.MCT-06-0542	1535-7163	Molecular Cancer Therapeutics	The JAMM motif of human deubiquitinase Poh1 is essential for cell viability	Gallery	2007	5		PSMD14
861	chr2	36252373	36252402	3500132215	23		36252373	36252402	8421504	3	4,13,6	0,5,23	g	350013221500000001	10-33		16825706	10.1152/ajpgi.00099.2006		American Journal of Physiology - Gastrointestinal and Liver Physiology	A vH+-ATPase is present in cultured sheep ruminal epithelial cells	Etschmann	2006	0		
869	chr2	37233116	37233144	3500423173	23		37233116	37233144	8421504	2	17,6	0,22	g	350042317300000024	25-48						ANTI-IL-20 ANTIBODY AND ITS USE IN TREATING IL-20 ASSOCIATED INFLAMMATORY DISEASES - Patent application	www.faqs.org	0	0		
870	chr2	37378036	37385260	3500441388	50		37378036	37385260	8421504	2	25,25	0,7199	c	350044138800000000,350044138800000001	0-25,0-25						The avb6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle	v.sgmjournals.org	0	0		
870	chr2	37378036	37385260	3500271582	50		37378036	37385260	8421504	2	25,25	0,7199	c	350027158200000000,350027158200000001	0-25,0-25						The avb6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle	r.sgmjournals.org	0	0		
871	chr2	37548469	37576291	3500278578	71		37548469	37576291	8421504	3	26,24,21	0,2151,27801	c	350027857800000017,350027857800000016,350027857800000012	0-26,0-24,0-21						ScienceDirect.com - Developmental & Comparative Immunology - Characterization of porcine CD205	sciencedirect.com	0	0		
871	chr2	37616215	37616240	3500132707	23		37616215	37616240	8421504	2	18,5	0,20	g	350013270700000003	1-24						Epstein-Barr Virus (EBV) LMP2Ainduces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma	tologylibrary.org	0	0		PCDH9
872	chr2	37696366	37731045	3500102384	493		37696366	37731045	8421504	5	20,40,54,27,352	0,30915,30964,33087,34327	c,g	350010238400000107,350010238400000176,350010238400000177	3-23,0-40,0-433						Dec-205 (ly 75)/dcl-1 Intergenic Splice Variants Associated With Hodgkin's Disease, And Uses Thereof 	.freshpatents.com	0	0		
872	chr2	37727281	37731045	3500388742	473		37727281	37731045	8421504	4	40,54,27,352	0,49,2172,3412	c,g	350038874200000019,350038874200000020	0-40,0-433						DCL-1 AND USES THEREOF - Patent application	www.faqs.org	0	0		
873	chr2	37870800	37870826	3500255912	23		37870800	37870826	8421504	2	12,11	0,15	g	350025591200000007,350025591200000008	9-32,0-23					Patent	DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof (Patent US:6723552)	Salon	2004	0		
874	chr2	37997288	37997315	3500241545	23		37997288	37997315	8421504	3	13,4,6	0,14,21	g	350024154500000026	0-23						vascular setting protocol: Topics by Science.gov	www.science.gov	0	0		
876	chr2	38158873	38158896	3500335361	23		38158873	38158896	8421504	1	23	0	c	350033536100000000	4-27		22240397	10.1186/1297-9716-43-2	1297-9716	Veterinary Research	Type IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia	Sadilkova	2012	0		
876	chr2	38195884	38200247	3500011965	345		38195884	38200247	8421504	3	50,144,151	0,289,4212	p	350001196500015000	69-414						SGC | Structure Details	www.thesgc.org	0	0		BAZ2B
880	chr2	38796242	38796269	3500068521	23		38796242	38796269	8421504	2	9,14	0,13	c	350006852100000242	8-43						About ICRISAT	www.icrisat.org	0	0		
110	chr2	39697052	39749891	3500340997	1527		39697052	39749891	8421504	9	67,264,212,100,147,276,198,131,132	0,19532,21966,26247,29928,37167,41505,51851,52707	p	350034099700015022,350034099700015006,350034099700015018,350034099700015000,350034099700015002,350034099700015012,350034099700015016,350034099700015020,350034099700015017,350034099700015001,350034099700015004,350034099700015019,350034099700015011,350034099700015009,350034099700015013,350034099700015021	0-1527,0-981,0-771,0-615,0-618,0-1065,0-576,0-1122,0-933,0-909,0-906,0-753,3-546,0-543,0-450,3-405						Sirna-based therapy of fibrodyplasia ossificans progressiva (fop)	Kaplan	2013	0		
110	chr2	39697100	39750975	3500252871	1072		39697100	39750975	8421504	10	19,17,30,105,84,42,45,399,135,196	0,19484,19504,19537,22046,26199,52731,53143,53543,53679	p,c	350025287100015002,350025287100015004,350025287100015007,350025287100000002	21-192,0-126,0-45,0-730						Method and composition for modulating bone growth	Agius	2002	0		ACVR1
888	chr2	39723341	39734482	3500042004	56		39723341	39734482	8421504	2	29,27	0,11114	c	350004200400000002,350004200400000064,350004200400000112,350004200400000051	4-33,4-33,0-27,0-27						CONVERSION OF VASCULAR ENDOTHELIAL CELLS INTO MULTIPOTENT STEM-LIKE CELLS - Patent application	www.faqs.org	0	0		
888	chr2	39734466	39749033	3500226292	53		39734466	39749033	8421504	3	29,1,23	0,4091,14544	c	350022629200000005,350022629200000017	0-30,21-44						MolecularConsequencesoftheACVR1R206H Mutationof FibrodysplasiaOssificansProgressiva S	www.jbc.org	0	0		ACVR1
888	chr2	39738607	39738718	3500099578	111		39738607	39738718	8421504	1	111	0	p	350009957800015003,350009957800015001,350009957800015016,350009957800015008	0-48,0-51,0-111,0-51						TransformingGrowthFactor&#xc3;&#x0178;TypeIReceptorKinaseMutantAssociatedwith MetastaticBreastCancer1	.aacrjournals.org	0	0		
889	chr2	39933657	39933882	3500059681	225		39933657	39933882	8421504	1	225	0	p	350005968100015022,350005968100015055,350005968100015056,350005968100015057	0-225,0-66,0-48,0-45						Cerberus/Coco derivatives and uses thereof - US Patent 7316998 Description	ww.patentstorm.us	0	0		
890	chr2	40077539	40080356	3500258455	23		40077539	40080356	8421504	2	4,19	0,2798	c	350025845500000006	10-33			10.1093/emboj/cdg101		The EMBO Journal	Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration	Thomas	2003	0		
896	chr2	40835688	40853080	3500117611	42		40835688	40853080	8421504	3	19,1,22	0,8762,17370	c	350011761100000007,350011761100000006	1-21,0-22			10.1016/j.bone.2007.01.011		Bone	The Post-Translational Phenotype of Collagen Synthesized by Saos-2 Osteosarcoma Cells	Russell	2007	0		GPD2
896	chr2	40888996	40889019	3500199581	23		40888996	40889019	8421504	1	23	0	c	350019958100000005	0-23		18388301	10.1634/stemcells.2008-0068	1549-4918	STEM CELLS	Human Bone Marrow Adipocytes Block Granulopoiesis Through Neuropilin-1-Induced Granulocyte Colony-Stimulating Factor Inhibition - Belaid-Choucair - 2008 - STEM CELLS - Wiley Online Library	Belaid-Choucair	2008	0		GPD2
897	chr2	41025109	41025139	3500363813	24		41025109	41025139	8421504	3	4,13,7	0,5,23	g	350036381300000005	1-25		18445292	10.1186/1471-213X-8-48	1471-213X	BMC Developmental Biology	In vivo consequences of deleting EGF repeats 8&#xe2; 12 including the ligand binding domain of mouse Notch1	Ge	2008	3		
898	chr2	41067834	41067858	3500209416	24		41067834	41067858	8421504	1	24	0	c	350020941600000029	1-25			10.1128/MCB.25.12.5183-5195.2005		Molecular and Cellular Biology	Combination of hTERT and bmi-1, E6, or E7 Induces Prolongation of the Life Span of Bone Marrow Stromal Cells from an Elderly Donor without Affecting Their Neurogenic Potential 	Taisuke	June	0		
898	chr2	41068371	41072772	3500460691	1794		41068371	41072772	8421504	6	864,130,164,203,179,254	0,1648,2192,3247,3842,4147	p	350046069100015016	0-1794						Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph	Cotsarelis	2011	0		NR4A2
898	chr2	41068622	41070118	3500037043	48		41068622	41070118	8421504	2	24,24	0,1472	c,g	350003704300000022,350003704300000022,350003704300000023	0-24,0-24,0-24						METHOD OF GROWING MESENCHYMAL STEM CELLS FROM BONE MARROW - Patent application	www.faqs.org	0	0		NR4A2
898	chr2	41068659	41068684	3500352884	24		41068659	41068684	8421504	2	8,16	0,9	c,g	350035288400000005,350035288400000005	9-33,9-33						The N-Terminal Region of Nurr1 (a.a 1-31) Is Essential for Its Efficient Degradation by the Ubiquitin Proteasome Pathway. - ResearchGate	.researchgate.net	0	0		
898	chr2	41068665	41068688	3500440679	23		41068665	41068688	8421504	1	23	0	c	350044067900000006	21-44						GENERATION OF NEURAL STEM CELLS UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS	Reubinoff	2008	0		
898	chr2	41068665	41068688	3500419705	23		41068665	41068688	8421504	1	23	0	c	350041970500000006	21-44						Generation Of Neural Stem Cells Undifferentiated Human Embryonic Stem Cells 	.freshpatents.com	0	0		
898	chr2	41068665	41068688	3500319274	23		41068665	41068688	8421504	1	23	0	c	350031927400000006	21-44						GENERATION OF NEURAL STEM CELLS UNDIFFERENTIATED HUMAN EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		
898	chr2	41068665	41068688	3500312413	23		41068665	41068688	8421504	1	23	0	c	350031241300000006	21-44						Generation of neural stem cells from undifferentiated human embryonic stem cells	Reubinoff	2004	0		NR4A2
898	chr2	41068665	41068688	3500234370	23		41068665	41068688	8421504	1	23	0	c	350023437000000006	21-44						Generation of neural stem cells from undifferentiated human embryonic stem cells	Reubinoff	2005	0		NR4A2
898	chr2	41068665	41068688	3500068608	23		41068665	41068688	8421504	1	23	0	c	350006860800000006	21-44						Stem cells	Reubinoff	2011	0		NR4A2
898	chr2	41069205	41070034	3500021751	45		41069205	41070034	8421504	2	30,15	0,814	p	350002175100015012	0-45						Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same	Dedhar	1995	0		NR4A1
898	chr2	41070093	41070117	3500076359	24		41070093	41070117	8421504	1	24	0	c	350007635900000012	0-24						UNCOVERING p53 MUTATIONS AND ABNORMAL GENE EXPRESSION IN PEDIATRIC ADRENOCORTICAL CANCER	etd.uthsc.edu	0	0		NR4A2
898	chr2	41070130	41070572	3500170203	27		41070130	41070572	8421504	3	11,7,9	0,12,433	c	350017020300000038	0-27						9-Methyl- -carboline has restorative effects in an animal model of Parkinson&#x2019;s disease	.if-pan.krakow.pl	0	0		NR4A2
898	chr2	41071630	41072275	3500466790	40		41071630	41072275	8421504	2	20,20	0,625	c,g	350046679000000000,350046679000000001,350046679000000001	0-20,0-20,0-20		20533997	10.1111/j.1471-4159.2010.06841.x	1471-4159	Journal of Neurochemistry	Nurr1 regulates RET expression in dopamine neurons of adult rat midbrain - Galleguillos - 2010 - Journal of Neurochemistry - Wiley Online Library	Galleguillos	2010	0		
898	chr2	41072345	41072768	3500426843	39		41072345	41072768	8421504	2	19,20	0,403	c,g	350042684300000002,350042684300000003,350042684300000003	0-19,0-20,0-20		18577687	10.1124/mol.107.044800	1521-0111 (Online)	Molecular Pharmacology	The Induction of Orphan Nuclear Receptor Nur77 Expression by n-Butylenephthalide as Pharmaceuticals on Hepatocellular Carcinoma Cell Therapy	Chen	2008	0		
898	chr2	41072345	41072768	3500275146	39		41072345	41072768	8421504	2	19,20	0,403	c	350027514600000012,350027514600000013	0-19,0-20						&#x4e3b;&#x9898;&#xff1a;Hormone | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
898	chr2	41072345	41072768	3500216249	39		41072345	41072768	8421504	2	19,20	0,403	c	350021624900000002,350021624900000003	0-19,0-20		18577687	10.1124/mol.107.044800	1521-0111 (Online)	Molecular Pharmacology	The Induction of Orphan Nuclear Receptor Nur77 Expression by n-Butylenephthalide as Pharmaceuticals on Hepatocellular Carcinoma Cell Therapy	Chen	2008	0		NR4A2
898	chr2	41072744	41072775	3500017518	31		41072744	41072775	8421504	1	31	0	c	350001751800000001	9-40			10.1046/j.1471-4159.2003.01780.x	1471-4159	Journal of Neurochemistry	Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression - Kim - 2003 - Journal of Neurochemistry - Wiley Online Library	Kim	2003	0		NR4A2
901	chr2	41447772	41447795	3500256708	23		41447772	41447795	8421504	1	23	0	g	350025670800000007	2-25					Clinical and Diagnostic Laboratory Immunology	New Immunofluorescence Assays for Detection of Human Herpesvirus 8-Specific Antibodies	Naoki	2000	0		
902	chr2	41676552	41676578	3500157069	24		41676552	41676578	8421504	2	16,8	0,18	g	350015706900000164	10-34						US Patent # 6,545,137. Receptor - Patents.com	www.patents.com	0	0		
908	chr2	42424175	42424206	3500212475	27		42424175	42424206	8421504	2	11,16	0,15	c	350021247500000195	4-31						CELLS AND METHODOLOGY TO GENERATE NON-SEGMENTED NEGATIVE-STRAND RNA VIRUSES - Patent application	www.faqs.org	0	0		
908	chr2	42424250	42424340	3500418769	90		42424250	42424340	8421504	1	90	0	p	350041876900015001	3-93		8929423		0270-6474	The Journal of Neuroscience	Heteromultimerization of G-Protein-Gated Inwardly Rectifying K+ Channel Proteins GIRK1 and GIRK2 and Their Altered Expression in weaver Brain	Liao	1996	7		KCNJ3
909	chr2	42570923	42581236	3500309351	45		42570923	42581236	8421504	2	22,23	0,10290	c	350030935100000091,350030935100000090	0-22,0-23						Molecular components and functionality of the GABA signaling during development: a study on two model systems	phd.sote.hu	0	0		KCNJ3
909	chr2	42580968	42581670	3500057829	702		42580968	42581670	8421504	1	702	0	p	350005782900015000	0-702						KEGG T01001: 3760	www.genome.jp	0	0		KCNJ3
909	chr2	42581178	42581295	3500192418	117		42581178	42581295	8421504	1	117	0	p	350019241800015013	0-117						vom Fachbereich Biologie der Technischen Universit&#xe4;t Darmstadt zur Erlangung des akademischen Grades eines Doctor rerum naturalium genehmigte Dissertation von	b.tu-darmstadt.de	0	0		KCNJ3
909	chr2	42581544	42581655	3500418769	111		42581544	42581655	8421504	1	111	0	p	350041876900015000	0-111		8929423		0270-6474	The Journal of Neuroscience	Heteromultimerization of G-Protein-Gated Inwardly Rectifying K+ Channel Proteins GIRK1 and GIRK2 and Their Altered Expression in weaver Brain	Liao	1996	7		KCNJ3
909	chr2	42581645	42581673	3500002871	28		42581645	42581673	8421504	1	28	0	g	350000287100000023	9-37					Patent	Method of identifying compounds that bind galanin receptor (GALR2) (Patent US:6586191)	Smith	2003	0		KCNJ3
911	chr2	42825488	42825516	3500006742	23		42825488	42825516	8421504	3	13,5,5	0,15,23	g	350000674200000042	15-38						17q-linked breast and ovarian cancer susceptibility gene	Skolnick	1995	0		
920	chr2	44003915	44003941	3500204954	24		44003915	44003941	8421504	2	11,13	0,13	g	350020495400000028	11-41						Vaccines against circovirus infections	Poet	1999	0		
922	chr2	44289712	44289736	3500410165	23		44289712	44289736	8421504	2	10,13	0,11	g	350041016500000000	4-27						Multiple variants of meningococcal protein nmb1870	Comanducci	2004	0		
925	chr2	44617600	44617628	3500083851	23		44617600	44617628	8421504	3	11,6,6	0,12,22	g	350008385100000077	0-25						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
925	chr2	44628392	44628416	3500055245	23		44628392	44628416	8421504	2	5,18	0,6	g	350005524500000001	6-29						Papilloma virus capsomere vaccine formulations and methods of use	Gissmann	1999	0		
926	chr2	44821037	44821062	3500028175	24		44821037	44821062	8421504	2	16,8	0,17	g	350002817500000094	0-24						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
116	chr2	45490995	45761822	3500328440	1551		45490995	45761822	8421504	16	63,84,120,123,131,77,20,24,51,59,110,152,96,78,105,258	0,549,214005,216434,221255,223027,224611,224856,224886,226222,238166,243915,246091,267622,267703,270569	p	350032844000015014	0-1554						Methods for identifying ion channel modulators	Friden	2004	0		
116	chr2	45705000	45761822	3500328440	1392		45705000	45761822	8421504	17	120,123,15,110,77,20,24,51,59,110,134,15,3,36,51,186,258	0,2429,7250,7271,9022,10606,10851,10881,12217,24161,29910,30047,32086,32092,32131,53617,56564	p	350032844000015030	30-1425						Methods for identifying ion channel modulators	Friden	2004	0		
934	chr2	45761639	45761687	3500014078	48		45761639	45761687	8421504	1	48	0	p	350001407800015000	0-48			10.1038/nn1904		Nature Neuroscience	RIM1 confers sustained activity and neurotransmitter vesicle anchoring to presynaptic Ca2+ channels	Shigeki	June	0		CACNB4
935	chr2	45902880	45902911	3500306561	26		45902880	45902911	8421504	3	11,10,5	0,14,26	g	350030656100000272	6-33						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
935	chr2	45902880	45902911	3500232262	26		45902880	45902911	8421504	3	11,10,5	0,14,26	g	350023226200000272	6-33					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
937	chr2	46191905	46195796	3500008335	48		46191905	46195796	8421504	3	24,23,1	0,111,3890	c,g	350000833500000021,350000833500000021,350000833500000020	0-24,0-24,0-24						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
937	chr2	46191969	46201916	3500217113	181		46191969	46201916	8421504	3	38,96,47	0,3890,9900	c	350021711300000011,350021711300000008,350021711300000007,350021711300000004	0-38,0-48,0-48,1-48						Tumor necrosis factor-induced protein TSG-6 - Patent # 5386013 - PatentGenius	.patentgenius.com	0	0		
937	chr2	46192008	46197493	3500145630	46		46192008	46197493	8421504	2	23,23	0,5462	c	350014563000000009,350014563000000008	0-23,0-23						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
937	chr2	46192008	46197493	3500046604	46		46192008	46197493	8421504	2	23,23	0,5462	c	350004660400000011,350004660400000010	0-23,0-23						REPRODUCTION	uction-online.org	0	0		
937	chr2	46195881	46197390	3500298062	45		46195881	46197390	8421504	3	20,24,1	0,52,1508	c,g	350029806200000009,350029806200000009,350029806200000008	0-20,0-20,0-25						Kathryn Michelle Gebhardt	y.adelaide.edu.au	0	0		TNFAIP6
937	chr2	46195904	46195927	3500358404	23		46195904	46195927	8421504	1	23	0	c	350035840400000002	19-42		22514539	10.3389/fphys.2012.00085		Frontiers in Physiology	Implications of TGF&#x03b2; on Transcriptome and Cellular Biofunctions of Palatal Mesenchyme	Xiujuan	2012	0		
943	chr2	46976448	46976473	3500306817	23		46976448	46976473	8421504	2	13,10	0,15	g	350030681700000198	0-23						Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus 	.freshpatents.com	0	0		
945	chr2	47228091	47228116	3500426638	23		47228091	47228116	8421504	2	15,8	0,17	g	350042663800000016,350042663800000006	0-23,0-23						Fatty Acid Dehydratases and Uses Thereof	Bauer	2009	0		
945	chr2	47228091	47228116	3500263751	23		47228091	47228116	8421504	2	15,8	0,17	g	350026375100000012	0-23						Fetts&#xe4;ure-Dehydratasen und Anwendungen davon Fatty acid dehydratases and uses thereof	BAUER	2011	0		
945	chr2	47228091	47228116	3500074627	23		47228091	47228116	8421504	2	15,8	0,17	g	350007462700000006	0-23						Fatty acid dehydratases and uses thereof	BAUER	2011	0		
949	chr2	47835849	47835873	3500028061	23		47835849	47835873	8421504	2	18,5	0,19	g	350002806100000211	3-26						Surface proteins of leptospira	www.devileye.net	0	0		
957	chr2	48766606	48777040	3500462129	41		48766606	48777040	8421504	2	20,21	0,10413	c,g	350046212900000010,350046212900000009,350046212900000009	0-20,0-21,0-21						Protrudin serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation	w.molbiolcell.org	0	0		KIF5C
957	chr2	48766606	48777040	3500361336	41		48766606	48777040	8421504	2	20,21	0,10413	c	350036133600000010,350036133600000009	0-20,0-21		21976701	10.1091/mbc.E11-01-0068	1059-1524	Molecular Biology of the Cell	Protrudin serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation	Matsuzaki	2011	5		KIF5C
960	chr2	49223611	49223634	3500416625	23		49223611	49223634	8421504	1	23	0	c	350041662500000011	5-28						UNIVERSIDAD DE MURCIA FACULTAD DE BIOLOG&#xcd;A NUEVOS PROBI&#xd3;TICOS Y PREBI&#xd3;TICOS PARA DORADA (SPARUS AURATA L.).	digitum.um.es	0	0		
961	chr2	49363248	49363276	3500128972	24		49363248	49363276	8421504	3	5,13,6	0,7,22	g	350012897200000017	8-32						MUTANT DNA POLYMERASES - Patent application	www.faqs.org	0	0		
961	chr2	49376955	49377037	3500302965	50		49376955	49377037	8421504	3	21,17,12	0,52,70	c	350030296500000006,350030296500000007	0-21,0-29			10.1002/hep.21367	1527-3350	Hepatology	Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis - Zindy - 2006 - Hepatology - Wiley Online Library	Zindy	2006	0		PTMA
964	chr2	49759687	49760769	3500181554	40		49759687	49760769	8421504	2	20,20	0,1062	c	350018155400000021,350018155400000020	0-20,0-20						D E D B J -M -U W	.uni-wuerzburg.de	0	0		ACVR2A
964	chr2	49769604	49769628	3500098010	24		49769604	49769628	8421504	1	24	0	c	350009801000000008	24-48						Aus der Klinik f&#xfc;r Gastroenterologie mit Sektionen Infektiologie und Tropenmedizin	ub.uni-hamburg.de	0	0		
964	chr2	49770972	49770998	3500342669	26		49770972	49770998	8421504	1	26	0	c	350034266900000024	16-42						US Patent # 5,693,607. Uses of TGF-.beta. receptor fragment as a therapeutic agent - Patents.com	www.patents.com	0	0		
964	chr2	49770972	49770998	3500174939	26		49770972	49770998	8421504	1	26	0	c	350017493900000099	7-33						 Silencing Of TGF.beta. Type II Receptor Expression By SiRNA 	www.docstoc.com	0	0		
120	chr2	49794288	49851708	3500467376	62		49794288	49851708	8421504	2	7,55	0,57365	c	350046737600000001	0-62					Patent	Activin-ActRIIa antagonists and uses for treating multiple myeloma (Patent US:8173601)	Knopf	2012	0		ACVR2A
120	chr2	49794288	49851708	3500421033	62		49794288	49851708	8421504	2	7,55	0,57365	c	350042103300000001	0-62						Activin-actriia antagonists and uses for promoting bone growth in cancer patients	Knopf	2009	0		ACVR2A
120	chr2	49794288	49851708	3500290107	62		49794288	49851708	8421504	2	7,55	0,57365	c	350029010700000001	0-62					Patent	Method for promoting bone growth using activin-ActRIIa antagonists (Patent US:8067360)	Knopf	2011	0		ACVR2A
120	chr2	49794288	49851708	3500281910	62		49794288	49851708	8421504	2	7,55	0,57365	c	350028191000000001	0-62						Activin-ActRIIa antagonists and uses for promoting bone growth	Knopf	2009	0		ACVR2A
120	chr2	49794288	49851708	3500191496	62		49794288	49851708	8421504	2	7,55	0,57365	c	350019149600000001	0-62						Activin-actriia antagonists and uses for promoting bone growth in cancer patients	Knopf	2008	0		ACVR2A
120	chr2	49794288	49851708	3500165870	62		49794288	49851708	8421504	2	7,55	0,57365	c	350016587000000000	0-62						Activin-ActRIIa antagonists and uses for promoting bone growth - Patent application	www.faqs.org	0	0		
120	chr2	49794288	49851708	3500161798	62		49794288	49851708	8421504	2	7,55	0,57365	c	350016179800000000	0-62						Activin-actriia antagonists and uses for promoting bone growth in cancer patients - Patent application	www.faqs.org	0	0		
120	chr2	49794290	49851708	3500379858	60		49794290	49851708	8421504	2	5,55	0,57363	p	350037985800015018	0-60						Activin-actrii antagonists and uses for increasing red blood cell levels - Patent application	www.faqs.org	0	0		ACVR2A
120	chr2	49794290	49851708	3500250951	60		49794290	49851708	8421504	2	5,55	0,57363	p	350025095100015017	0-60						Activin-actriia antagonists and uses for treating or preventing breast cancer	Knopf	2009	0		ACVR2A
120	chr2	49794290	49851708	3500171454	60		49794290	49851708	8421504	2	5,55	0,57363	p	350017145400015013	0-60						Activin-ActRIIa antagonists and uses for promoting bone growth - Patent application	www.faqs.org	0	0		ACVR2A
120	chr2	49794290	49851708	3500165870	60		49794290	49851708	8421504	2	5,55	0,57363	p	350016587000015013	0-60						Activin-ActRIIa antagonists and uses for promoting bone growth - Patent application	www.faqs.org	0	0		ACVR2A
120	chr2	49794290	49851708	3500135957	60		49794290	49851708	8421504	2	5,55	0,57363	p	350013595700015017	0-60						Antagonists of activin-actriia and uses for increasing red blood cell levels - Patent application	www.faqs.org	0	0		ACVR2A
120	chr2	49794290	49851708	3500023631	60		49794290	49851708	8421504	2	5,55	0,57363	p	350002363100015018	0-60						Antagonists of actriib and uses for increasing red blood cell levels	Sherman	2009	0		ACVR2A
120	chr2	49794290	49851708	3500000255	60		49794290	49851708	8421504	2	5,55	0,57363	p	350000025500015018	0-60						Methods for dosing an actriib antagonist and monitoring of treated patients	Sherman	2009	0		ACVR2A
970	chr2	50552877	50552900	3500043606	23		50552877	50552900	8421504	1	23	0	g	350004360600000006	14-37						Method of production of para-hydroxycinnamic acid using a thermostable TAL enzyme - Patent application	www.faqs.org	0	0		
970	chr2	50569428	50569456	3500455990	23		50569428	50569456	8421504	2	16,7	0,21	g	350045599000000008	23-47						Practical biotransformations~ a beginner's guide 1405193670 - wiley	fr.slideshare.net	0	0		
971	chr2	50602479	50602508	3500376612	24		50602479	50602508	8421504	3	6,4,14	0,10,15	g	350037661200000001	1-26			10.1099/mic.0.26397-0	1350-0872	Microbiology	The roles of SsrA&#x2013;SsrB and OmpR&#x2013;EnvZ in the regulation of genes encoding the Salmonella typhimurium SPI-2 type III secretion system	Garmendia	2003	3		
981	chr2	51956326	51956352	3500447590	24		51956326	51956352	8421504	2	15,9	0,17	c	350044759000000138	24-48						METHODS TO EVALUATE GLUCOCORTICOID RECEPTOR AGONISTS AND ANTAGONISTS FOR EFFECTS ON NEURON-LIKE CELLS - Patent application	www.faqs.org	0	0		SNX6
982	chr2	52106712	52106740	3500089211	25		52106712	52106740	8421504	2	17,8	0,20	g	350008921100000027	3-40						PLANTS HAVING IMPROVED TOLERANCE TO VARIOUS TYPES OF ENVIRONMENTAL STRESS, THEIR PRODUCTION, AND POLYAMINE METABOLISM-RELATED ENZYME GENES - Patent application	www.faqs.org	0	0		
983	chr2	52238811	52238838	3500306953	24		52238811	52238838	8421504	2	18,6	0,21	g	350030695300000002	0-24		14676131		1078-0432	Clinical Cancer Research	Decreased Expression of Bone Morphogenetic Protein (BMP) Receptor Type II Correlates with Insensitivity to BMP-6 in Human Renal Cell Carcinoma Cells	Kim	2003	8		BMPR1B
988	chr2	52823803	52823829	3500023895	23		52823803	52823829	8421504	2	14,9	0,17	g	350002389500000000	9-32			10.1083/jcb.200406025		The Journal of Cell Biology	Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases	Xiang-Tian	2004	0		
994	chr2	53673585	53676204	3500135213	41		53673585	53676204	8421504	3	19,18,4	0,54,2615	c,g	350013521300000004,350013521300000004,350013521300000005	0-19,0-19,0-22		17060462	10.1128/MCB.00892-06	0270-7306	Molecular and Cellular Biology	VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail	Evans	2007	6		ZEB2
994	chr2	53676234	53676264	3500190311	30		53676234	53676264	8421504	1	30	0	c	350019031100000004,350019031100000014	0-30,0-30						Lymph Nodes as a Site for Regeneration - Patent application	www.faqs.org	0	0		ZEB2
1004	chr2	54958410	54958436	3500288335	23		54958410	54958436	8421504	3	13,5,5	0,15,21	g	350028833500000079	23-46						Nematode Fatty Acid Desaturase-Like Sequences - Patent application	www.faqs.org	0	0		
1005	chr2	55142235	55142263	3500150528	24		55142235	55142263	8421504	2	18,6	0,22	g	350015052800000387	4-29						Anti-igf-1r Antibodies And Uses Thereof 	.freshpatents.com	0	0		
1009	chr2	55578837	55578862	3500199438	24		55578837	55578862	8421504	2	12,12	0,13	g	350019943800000087,350019943800000079,350019943800000080	0-24,1-25,0-23						Analyse quantitative des r&#xe9;ponses pr&#xe9;coces &#xe0; l&#x2019;auxine dans une suspension de cellules de Tabac	mm.u-bordeaux1.fr	0	0		
1009	chr2	55604332	55604358	3500004521	25		55604332	55604358	8421504	2	9,16	0,10	g	350000452100000498	2-27						US Patent # 6,680,209. Human antibodies as diagnostic reagents - Patents.com	www.patents.com	0	0		
1015	chr2	56477341	56477366	3500253052	23		56477341	56477366	8421504	3	5,5,13	0,6,12	g	350025305200000022	0-23					Proceedings of the National Academy of Sciences of the United States of America	The poly(A)-limiting element is a conserved cis-acting sequence that regulates poly(A) tail length on nuclear pre-mRNAs	Haidong	1999	0		
1015	chr2	56477341	56477366	3500058932	23		56477341	56477366	8421504	3	5,5,13	0,6,12	g	350005893200000022	0-23		10430875	10.1073/pnas.96.16.8943	0027-8424	Proceedings of the National Academy of Sciences	The poly(A)-limiting element is a conserved cis-acting sequence that regulates poly(A) tail length on nuclear pre-mRNAs	Gu	1999	10		
1021	chr2	57150019	57150048	3500230155	25		57150019	57150048	8421504	2	12,13	0,16	g	350023015500000019	0-38						Chimeric recombinant protein and in vitro diagnosis of hiv	Letourneur	2004	0		
1052	chr2	61284760	61284786	3500455313	23		61284760	61284786	8421504	2	7,16	0,10	c	350045531300000068	18-41						GLYPHOSATE TOLERANT 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASES - MONSANTO COMPANY.	www.sumobrain.com	0	0		
1052	chr2	61284760	61284786	3500386731	23		61284760	61284786	8421504	2	7,16	0,10	c	350038673100000069	18-41						Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases	Barry	1992	0		
1052	chr2	61284760	61284786	3500311161	23		61284760	61284786	8421504	2	7,16	0,10	c	350031116100000078	18-41						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
1052	chr2	61284760	61284786	3500256323	23		61284760	61284786	8421504	2	7,16	0,10	c,g	350025632300000072,350025632300000099	18-41,24-47						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - US Patent 5627061 Description	ww.patentstorm.us	0	0		
1052	chr2	61284760	61284786	3500210376	23		61284760	61284786	8421504	2	7,16	0,10	c	350021037600000078	18-41						US Patent # 6,248,876. Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patents.com	www.patents.com	0	0		
1052	chr2	61284760	61284786	3500127679	23		61284760	61284786	8421504	2	7,16	0,10	c	350012767900000078	18-41						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
1052	chr2	61284760	61284786	3500062057	23		61284760	61284786	8421504	2	7,16	0,10	c	350006205700000068	18-41						Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases.	Barry	1993	0		
1052	chr2	61284760	61284786	3500044715	23		61284760	61284786	8421504	2	7,16	0,10	c	350004471500000109	18-41						Antibody immunoreactive with a 5-enolpyruvylshikimate-3-phosphate synthase - US Patent 7183110 Description	ww.patentstorm.us	0	0		
1064	chr2	62875096	62875122	3500250179	24		62875096	62875122	8421504	3	4,7,13	0,5,13	g	350025017900000018	1-25					Patent	Combination therapy of her expressing tumors (Patent US:8163287)	Kelsey	2012	0		
1069	chr2	63473024	63475157	3500036559	42		63473024	63475157	8421504	2	20,22	0,2111	c	350003655900000007,350003655900000006	0-20,0-22		17332343	10.1158/0008-5472.CAN-06-1021	0008-5472	Cancer Research	Leukemia Inhibitory Factor: A Newly Identified Metastatic Factor in Rhabdomyosarcomas	Wysoczynski	2007	8		CXCR4
1069	chr2	63473024	63475156	3500393282	43		63473024	63475156	8421504	2	20,23	0,2109	c	350039328200000001,350039328200000000	0-20,0-23		20068066	10.1158/1541-7786.MCR-09-0259		Molecular cancer research : MCR	REGULATION OF EXPRESSION OF STROMAL-DERIVED FACTOR-1 (SDF-1) RECEPTORS: CXCR4 AND CXCR7 IN HUMAN RHADOMYOSARCOMAS	Maciej	2010	0		CXCR4
1069	chr2	63473024	63475156	3500337688	43		63473024	63475156	8421504	2	20,23	0,2109	c	350033768800000001,350033768800000000	0-20,0-23		20162608	10.1002/ijc.25245	1097-0215	International Journal of Cancer	Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas - Grymula - 2010 - International Journal of Cancer - Wiley Online Library	Grymula	2010	0		CXCR4
1069	chr2	63473024	63475156	3500009932	43		63473024	63475156	8421504	2	20,23	0,2109	c	350000993200000001,350000993200000000	0-20,0-23		20068066	10.1158/1541-7786.MCR-09-0259	1541-7786	Molecular Cancer Research	Regulation of Expression of Stromal-Derived Factor-1 Receptors: CXCR4 and CXCR7 in Human Rhabdomyosarcomas	Tarnowski	2010	4		CXCR4
1069	chr2	63475133	63475157	3500337355	24		63475133	63475157	8421504	1	24	0	c	350033735500000004	0-24		15184910	10.1038/labinvest.3700125	0023-6837	Laboratory Investigation	Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression	Tomescu	2004	4		CXCR4
1069	chr2	63475343	63476201	3500277510	89		63475343	63476201	8421504	3	48,26,15	0,768,843	c,g	350027751000000282,350027751000000298	0-48,0-41						Novel seven transmembrane receptors	Godiska	1994	0		
1069	chr2	63475394	63475940	3500327497	78		63475394	63475940	8421504	2	39,39	0,507	c	350032749700000038,350032749700000051	0-39,0-39						Methods for treating inflammatory disorders	Chuntharapai	1994	0		
1069	chr2	63475402	63475918	3500386804	49		63475402	63475918	8421504	2	24,25	0,491	c	350038680400000000,350038680400000001	0-24,0-25						Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals. - ResearchGate	.researchgate.net	0	0		CXCR4
1069	chr2	63475402	63475918	3500185470	49		63475402	63475918	8421504	2	24,25	0,491	c	350018547000000000,350018547000000001	0-24,0-25						Depletion of CD34 CD4 cells in bone marrow from HIV-1&#x2013;infected individuals	mmserver.cjp.com	0	0		CXCR4
1069	chr2	63475486	63475864	3500023326	40		63475486	63475864	8421504	2	20,20	0,358	c,g	350002332600000000,350002332600000000,350002332600000001	0-20,0-20,0-20						Title Japanese Journal of Veterinary Research, 61(3): 109-116 Issue Date 2013-08	lib.hokudai.ac.jp	0	0		
1069	chr2	63475537	63475764	3500412731	40		63475537	63475764	8421504	2	20,20	0,207	c	350041273100000004,350041273100000005	0-20,0-20			10.1002/art.22047	1529-0131	Arthritis & Rheumatism	Differential expression of stromal cell&#x2013;derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications - Cipriani - 2006 - Arthritis & Rheumatism - Wiley Online Library	Cipriani	2006	0		CXCR4
1069	chr2	63475537	63475764	3500350121	40		63475537	63475764	8421504	2	20,20	0,207	c	350035012100000008,350035012100000009	0-20,0-20						AVERTISSEMENT	.scd.uhp-nancy.fr	0	0		CXCR4
1069	chr2	63475537	63475764	3500337556	40		63475537	63475764	8421504	2	20,20	0,207	c	350033755600000000,350033755600000001	0-20,0-20						ScienceDirect.com - Biochemical and Biophysical Research Communications - Differences in donor CXCR4 expression levels are correlated with functional capacity and therapeutic outcome of angiogenic treatment with endothelial colony forming cells	sciencedirect.com	0	0		CXCR4
1069	chr2	63475537	63475764	3500310288	40		63475537	63475764	8421504	2	20,20	0,207	c	350031028800000018,350031028800000019	0-20,0-20						Asubsetofhumanrapidlyself-renewingmarrowstromalcellspreferentially engraftinmice	tologylibrary.org	0	0		CXCR4
1069	chr2	63475537	63475764	3500142261	40		63475537	63475764	8421504	2	20,20	0,207	c	350014226100000004,350014226100000005	0-20,0-20		20018810	10.1124/mol.109.060400	1521-0111 (Online)	Molecular Pharmacology	Phosphatidylinositol 3,4,5-Triphosphate-Dependent Rac Exchanger 1 (P-Rex-1), a Guanine Nucleotide Exchange Factor for Rac, Mediates Angiogenic Responses to Stromal Cell-Derived Factor-1/Chemokine Stromal Cell Derived Factor-1 (SDF-1/CXCL-12) Linked to Rac	Carretero-Ortega	2010	0		CXCR4
1069	chr2	63475573	63475853	3500214395	46		63475573	63475853	8421504	2	24,22	0,258	c	350021439500000009,350021439500000007	0-24,0-22		9658135		0022-538X	Journal of Virology	CXCR4 Is Required by a Nonprimate Lentivirus: Heterologous Expression of Feline Immunodeficiency Virus in Human, Rodent, and Feline Cells	Poeschla	1998	5		CXCR4
1069	chr2	63475605	63475723	3500262357	40		63475605	63475723	8421504	2	20,20	0,98	c	350026235700000006,350026235700000007	0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
1069	chr2	63475764	63475864	3500432118	40		63475764	63475864	8421504	2	20,20	0,80	c,g	350043211800000004,350043211800000004,350043211800000005	0-20,0-20,0-20						The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep. - ResearchGate	.researchgate.net	0	0		
1069	chr2	63475764	63475864	3500027225	40		63475764	63475864	8421504	2	20,20	0,80	c,g	350002722500000004,350002722500000004,350002722500000005	0-20,0-20,0-20		22053725	10.1186/1477-7827-9-148	1477-7827	Reproductive Biology and Endocrinology	The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep	Ashley	2011	2		
1069	chr2	63475783	63476135	3500401128	43		63475783	63476135	8421504	2	20,23	0,329	c	350040112800000000,350040112800000001	0-20,0-23		12702590		0008-5472	Cancer Research	Stromal Cell-derived Factor 1&#x03b1; Stimulates Human Glioblastoma Cell Growth through the Activation of Both Extracellular Signal-regulated Kinases 1/2 and Akt	Barbero	2003	8		CXCR4
1069	chr2	63475856	63475950	3500266202	94		63475856	63475950	8421504	1	94	0	c,g	350026620200000011,350026620200000010,350026620200000010	0-93,11-33,11-33						Method for generating and selecting antibodies against target protein	Hua	2006	0		CXCR4
1069	chr2	63476105	63476136	3500302489	31		63476105	63476136	8421504	1	31	0	c	350030248900000003,350030248900000001	8-36,11-40						CXCR4 nuclear localization follows binding of its ligand SDF-1 and occurs in metastatic but not primary renal cell carcinoma	-publications.com	0	0		CXCR4
1069	chr2	63523206	63523310	3500259232	104		63523206	63523310	8421504	1	104	0	g	350025923200000044	0-105						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
1070	chr2	63630754	63653411	3500280721	24		63630754	63653411	8421504	3	9,4,11	0,22639,22646	c	350028072100000239	8-41						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1070	chr2	63657078	63657103	3500147786	23		63657078	63657103	8421504	2	17,6	0,19	c	350014778600000014	5-28						GL-7ACA acylase	www.devileye.net	0	0		
1071	chr2	63716319	63716367	3500324808	48		63716319	63716367	8421504	1	48	0	p	350032480800015003	0-48		20156367	10.1186/1423-0127-17-11	1423-0127	Journal of Biomedical Science	Functional cooperation between FACT and MCM is coordinated with cell cycle and differential complex formation	Tan	2010	0		MCM6
1071	chr2	63716319	63716367	3500164974	48		63716319	63716367	8421504	1	48	0	p	350016497400015003	0-48		20156367	10.1186/1423-0127-17-11	1423-0127	Journal of Biomedical Science	Functional cooperation between FACT and MCM is coordinated with cell cycle and differential complex formation	Tan	2010	0		MCM6
1071	chr2	63809528	63809582	3500453271	54		63809528	63809582	8421504	1	54	0	p	350045327100015001	6-60		22238364	10.1091/mbc.E11-11-0950		Molecular Biology of the Cell	Derlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid droplets	Michitaka	2012	0		UBXN4
1071	chr2	63809528	63809582	3500055114	54		63809528	63809582	8421504	1	54	0	p	350005511400015001	6-60						Derlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid droplets	w.molbiolcell.org	0	0		UBXN4
1077	chr2	64566610	64566710	3500419113	41		64566610	64566710	8421504	2	21,20	0,80	c,g	350041911300000005,350041911300000004	0-21,0-20						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		CCNT2
1077	chr2	64566610	64566710	3500013835	41		64566610	64566710	8421504	2	21,20	0,80	c	350001383500000005,350001383500000004	0-21,0-20		22690072	10.3748/wjg.v18.i21.2640		World Journal of Gastroenterology : WJG	Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition	Hou-Min	June	0		CCNT2
1077	chr2	64571766	64595624	3500256436	96		64571766	64595624	8421504	3	48,31,17	0,23025,23841	p	350025643600015141,350025643600015131	0-48,0-48						US Patent # 6,391,567. Identifying compounds inhibiting DC-sign facilitation of HIV into cells - Patents.com	www.patents.com	0	0		CCNT2
1077	chr2	64576752	64580643	3500441970	150		64576752	64580643	8421504	6	39,2,43,15,30,21	0,42,1976,2022,3837,3870	p	350044197000015169	0-150						US Patent # 7,018,836. P-TEFb compositions, methods and screening assays - Patents.com	www.patents.com	0	0		
1080	chr2	64892453	64892477	3500089356	23		64892453	64892477	8421504	2	6,17	0,7	g	350008935600000023	2-25						Isolation and characterization of twenty polymorphic microsatellite markers for the endangered Dupont s lark (Chersophilus duponti) and cross-amplification in crested lark (Galerida cristata) and thekla lark (Galerida theklae)	digital.csic.es	0	0		
16	chr2	64988737	65034544	3500264868	327		64988737	65034544	8421504	4	15,112,142,58	0,35738,44293,45749	p	350026486800015057	60-387						21 human secreted proteins	Baker	2002	0		TMEM163
1081	chr2	65042258	65042282	3500320404	24		65042258	65042282	8421504	1	24	0	c	350032040400000050	24-48						N-ACETYLGLUCOSAMINYLTRANSFERASE VB CODING SEQUENCES, RECOMBINANT CELLS AND METHODS - Patent application	www.faqs.org	0	0		
1081	chr2	65042258	65042282	3500065628	24		65042258	65042282	8421504	1	24	0	c	350006562800000050	24-48						US Patent # 7,348,171. N-acetylglucosaminyltransferase Vb coding sequences, recombinant cells and methods - Patents.com	www.patents.com	0	0		
1081	chr2	65100863	65100887	3500003642	23		65100863	65100887	8421504	2	16,7	0,17	g	350000364200000094	1-24						Method and materials for introducing DNA into Prevotella ruminicola	Salyers	1991	0		
1083	chr2	65296202	65296308	3500117207	41		65296202	65296308	8421504	2	20,21	0,85	c,g	350011720700000000,350011720700000000,350011720700000001	0-20,0-20,0-21		22132163	10.1371/journal.pone.0027892	1932-6203	PLOS ONE	PLOS ONE: The Recognition of N-Glycans by the Lectin ArtinM Mediates Cell Death of a Human Myeloid Leukemia Cell Line	Carvalho	2011	4		MGAT5
1083	chr2	65296202	65296308	3500064679	41		65296202	65296308	8421504	2	20,21	0,85	c,g	350006467900000000,350006467900000000,350006467900000001	0-20,0-20,0-21		22132163	10.1371/journal.pone.0027892		PLoS ONE	The Recognition of N-Glycans by the Lectin ArtinM Mediates Cell Death of a Human Myeloid Leukemia Cell Line	Fernanda	2011	0		MGAT5
1084	chr2	65474644	65474672	3500057734	24		65474644	65474672	8421504	3	7,3,14	0,9,14	g	350005773400000014	1-25						Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same 	.freshpatents.com	0	0		
1084	chr2	65499160	65499186	3500376159	24		65499160	65499186	8421504	2	17,7	0,19	g	350037615900000054	3-30						Stabilized polypeptide compositions - Patent application	www.faqs.org	0	0		
1092	chr2	66519854	66519882	3500128598	23		66519854	66519882	8421504	2	10,13	0,15	g	350012859800000012	8-31						Copyright by Laura Elizabeth Corina 2005	ww.lib.utexas.edu	0	0		
1095	chr2	66962926	66962952	3500423257	25		66962926	66962952	8421504	2	7,18	0,8	g	350042325700000595	4-29						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
1099	chr2	67461493	67461517	3500130140	24		67461493	67461517	8421504	1	24	0	c	350013014000000002,350013014000000012	0-24,0-24						Novel Screening Method 	.freshpatents.com	0	0		
1099	chr2	67486311	67486340	3500459021	25		67486311	67486340	8421504	3	6,14,5	0,8,24	g	350045902100000384,350045902100000528,350045902100000456	2-30,11-39,8-27						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
1101	chr2	67735884	67758820	3500259232	208		67735884	67758820	8421504	2	104,104	0,22832	g	350025923200000030,350025923200000032	0-105,0-105						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
1101	chr2	67735884	67735988	3500000589	104		67735884	67735988	8421504	1	104	0	g	350000058900000054	0-105						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
1102	chr2	67778453	67778479	3500241625	25		67778453	67778479	8421504	2	10,15	0,11	g	350024162500000011	0-25						Unsealed tubewells lead to increased fecal contamination of drinking water. - ResearchGate	.researchgate.net	0	0		
1102	chr2	67778453	67778479	3500166781	25		67778453	67778479	8421504	2	10,15	0,11	g	350016678100000005	0-25						Science of the Total Environment	ldeo.columbia.edu	0	0		
1102	chr2	67885116	67885220	3500259232	104		67885116	67885220	8421504	1	104	0	g	350025923200000026	0-105						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
1102	chr2	67885116	67885220	3500000589	104		67885116	67885220	8421504	1	104	0	g	350000058900000049	0-105						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
1109	chr2	68766434	68766545	3500024337	40		68766434	68766545	8421504	2	20,20	0,91	g	350002433700000046,350002433700000047	0-20,0-20						Genetic Diversity Analysis of the Gohilwari Breed of Indian Goat Capra hircus ) Using Microsatellite Markers	thescipub.com	0	0		
1109	chr2	68805793	68805819	3500292436	24		68805793	68805819	8421504	2	19,5	0,21	g	350029243600000009	6-31						Transgenic high tryptophan plants	Weaver	2002	0		
1109	chr2	68805793	68805819	3500282953	24		68805793	68805819	8421504	2	19,5	0,21	g	350028295300000008	6-31						Transgenic high tryptophan plants	Liang	2003	0		
1121	chr2	70316606	70316629	3500133022	23		70316606	70316629	8421504	1	23	0	c	350013302200000013	0-23						Enzyme and snp marker for disease	Allen	2005	0		DPP10
17	chr2	72341023	72355584	3500131986	14558		72341023	72355584	8421504	4	14,80,3313,11151	0,15,96,3410	g	350013198600000025,350013198600000063,350013198600000011,350013198600000065,350013198600000066,350013198600000012,350013198600000067,350013198600000068,350013198600000013,350013198600000069	0-14558,0-110,0-301,0-141,0-150,0-302,0-141,0-150,0-301,0-70						SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK - Patent application	www.faqs.org	0	0		
1138	chr2	72501694	72501719	3500003642	24		72501694	72501719	8421504	2	7,17	0,8	g	350000364200000033	11-35						Method and materials for introducing DNA into Prevotella ruminicola	Salyers	1991	0		
1142	chr2	73133454	73133480	3500032429	24		73133454	73133480	8421504	2	12,12	0,14	g	350003242900000392	20-44						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2012	0		
1145	chr2	73457110	73457134	3500032096	23		73457110	73457134	8421504	2	9,14	0,10	g	350003209600000007	0-23						A Dominant-negative Form of Mouse SOX2 Induces Trophectoderm Differentiation and Progressive Polyploidy in Mouse Embryonic Stem Cells--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x905	journal.9med.net	0	0		
1148	chr2	73882629	73887810	3500394586	513		73882629	73887810	8421504	7	64,9,118,54,4,20,244	0,124,1170,3504,3563,4887,4937	p,c,g	350039458600000024,350039458600000024,350039458600015034,350039458600000025,350039458600015035,350039458600000026,350039458600000026,350039458600015008,350039458600015003,350039458600015004,350039458600015036,350039458600000027,350039458600000028,350039458600000028	0-64,0-64,6-66,0-61,21-81,0-60,0-60,0-141,0-48,0-60,18-78,0-61,0-271,0-271						Brain derivable polypeptide factors and antibodies thereto	Shoyab	1986	0		
1148	chr2	73882753	73887527	3500026241	201		73882753	73887527	8421504	4	9,118,63,11	0,1046,3380,4763	p	350002624100015079,350002624100015017,350002624100015178,350002624100015171	0-174,0-180,0-66,0-96						Endozepine-like polypeptides and polynucleotides encoding same	Andrew	2001	0		
1148	chr2	73883876	73886163	3500261436	45		73883876	73886163	8421504	2	23,22	0,2265	c	350026143600000033,350026143600000034	0-23,0-22						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1148	chr2	73883892	73886159	3500177137	51		73883892	73886159	8421504	2	25,26	0,2241	p	350017713700015189	3-54						Therapeutic polypeptides, nucleic acids encoding same, and methods of use	Alsobrook	2005	0		
1148	chr2	73886159	73886196	3500175559	37		73886159	73886196	8421504	1	37	0	c	350017555900000099,350017555900000117	0-19,0-19						Functional and hyperfunctional siRNA directed against Bcl-2	Khvorova	2008	0		
1148	chr2	73886159	73886196	3500088299	37		73886159	73886196	8421504	1	37	0	c	350008829900000099,350008829900000117	0-19,0-19						siRNA targeting cyclin-dependent kinase 4 (CDK4)	Khvorova	2009	0		
1148	chr2	73886159	73886196	3500087372	37		73886159	73886196	8421504	1	37	0	c	350008737200000100,350008737200000118	0-19,0-19					Patent	siRNA targeting transducin (beta)-like 3 (TBL3) (Patent US:7576196)	Khvorova	2009	0		
1148	chr2	73886159	73886196	3500074682	37		73886159	73886196	8421504	1	37	0	c,g	350007468200000099,350007468200000099,350007468200000117,350007468200000117	0-19,0-19,0-19,0-19						Sirna Targeting Hypoxia-inducible Factor 1 	.freshpatents.com	0	0		
1149	chr2	73960710	73960733	3500195684	23		73960710	73960733	8421504	1	23	0	c	350019568400000015	0-23						Establishment of immortalized human periodontal ligament cells derived from deciduous teeth. - ResearchGate	.researchgate.net	0	0		VIPR1
1149	chr2	73960710	73960733	3500005217	23		73960710	73960733	8421504	1	23	0	c	350000521700000007	0-23						Treatment of bony defects with osteoblast precursor cells	Frank	1999	0		GLP2R
1149	chr2	73960713	73960738	3500218087	25		73960713	73960738	8421504	1	25	0	c	350021808700000000	0-25		15951329	10.1152/ajplung.00358.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation	Rehan	2005	0		GLP2R
1151	chr2	74221524	74221557	3500432226	26		74221524	74221557	8421504	3	5,13,8	0,8,25	g	350043222600000004	1-27						Optimized DNA sequences encoding recombinant human bone morphogenetic protein-2 (rhBMP-2), preparation method and the uses thereof - Patent # 7947821 - PatentGenius	.patentgenius.com	0	0		
1153	chr2	74527475	74527523	3500247108	48		74527475	74527523	8421504	1	48	0	p	350024710800015074	0-48						 Human Protein Tyrosine Phosphatase Polynucleotides, Polypeptides, And Antibodies 	www.docstoc.com	0	0		EPB41L5
1154	chr2	74662960	74662986	3500173478	24		74662960	74662986	8421504	3	5,5,14	0,6,12	c	350017347800000061	16-42						Pharmaceutical Antibody Compositions With Resistance To Soluble Cea 	.freshpatents.com	0	0		
1155	chr2	74713916	74731028	3500219377	618		74713916	74731028	8421504	4	114,209,178,117	0,7686,13680,16995	p	350021937700015124,350021937700015130,350021937700015127,350021937700015128,350021937700015125,350021937700015129	0-360,0-618,0-180,0-180,0-249,0-78						PPT &#x2013; Bioinformatics Tools for Sequences and Structures Tim Stevens, 29th January 2008 Department of Bioch PowerPoint presentation | free to view 	www.powershow.com	0	0		RALB
1158	chr2	75133172	75164801	3500423257	39		75133172	75164801	8421504	3	20,7,12	0,31608,31617	g	350042325700000206,350042325700000630,350042325700000106	6-26,0-19,17-36						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
1159	chr2	75304082	75304107	3500063647	24		75304082	75304107	8421504	2	17,7	0,18	g	350006364700000006,350006364700000007	21-45,0-24		22798390	10.1128/EC.00175-12		Eukaryotic Cell	Multifunctional G-Rich and RRM-Containing Domains of TbRGG2 Perform Separate yet Essential Functions in Trypanosome RNA Editing	Bardees	2012	0		
1160	chr2	75440285	75440308	3500264432	23		75440285	75440308	8421504	1	23	0	c,g	350026443200000002,350026443200000002	0-23,0-23		18794086	10.1158/1078-0432.CCR-07-4282	1078-0432	Clinical Cancer Research	GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate Cancer	Narita	2008	8		GLI2
1161	chr2	75501088	75502815	3500449910	43		75501088	75502815	8421504	2	23,20	0,1707	c,g	350044991000000006,350044991000000007,350044991000000007	0-23,0-20,0-20						Anti-apoptotic role of the sonic hedgehog signaling pathway in the proliferation of ameloblastoma. - ResearchGate	.researchgate.net	0	0		GLI2
1161	chr2	75508682	75511585	3500224127	225		75508682	75511585	8421504	2	84,141	0,2762	p	350022412700015018	0-225						Genetic analysis of zebra&#xfb01;sh gli1and gli2reveals divergent requirements for gligenes in vertebrate development	ev.biologists.org	0	0		GLI3
1161	chr2	75511478	75511569	3500440355	43		75511478	75511569	8421504	2	22,21	0,70	c	350044035500000000,350044035500000001	0-22,0-21						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
1161	chr2	75511579	75511603	3500176785	24		75511579	75511603	8421504	1	24	0	c	350017678500000006	0-24		9925646		0890-9369	Genes & Development	Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling	Murtaugh	1999	12		
1161	chr2	75511579	75511603	3500113555	24		75511579	75511603	8421504	1	24	0	c	350011355500000006	0-24		9925646		0890-9369	Genes & Development	Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling	Murtaugh	1999	12		
145	chr2	75610733	75640188	3500058951	39		75610733	75640188	8421504	4	14,5,7,13	0,17,29433,29442	g	350005895100000125,350005895100000089	22-41,14-35						Collagen and uses therefor	Olsen	1993	0		
1163	chr2	75797630	75797654	3500269550	24		75797630	75797654	8421504	1	24	0	c	350026955000000379,350026955000000380,350026955000000384,350026955000000374,350026955000000376	9-33,9-33,7-31,8-32,2-26						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
1164	chr2	76014910	76014934	3500265877	23		76014910	76014934	8421504	2	16,7	0,17	g	350026587700000018	0-23						in normal Japanese individuals	www.scielo.br	0	0		
1166	chr2	76224673	76224825	3500091444	26		76224673	76224825	8421504	3	1,13,12	0,124,140	c	350009144400000043	10-36						PROTEINACEOUS COMPOUNDS - Patent application	www.faqs.org	0	0		
1166	chr2	76251680	76251707	3500070165	23		76251680	76251707	8421504	3	5,6,12	0,6,15	c	350007016500000194	0-23						US Patent # 7,309,597. Alanine 2,3-Aminomutase - Patents.com	www.patents.com	0	0		
1169	chr2	76620392	76620416	3500420850	23		76620392	76620416	8421504	2	5,18	0,6	g	350042085000000001	9-32					Patent	Diagnostic assays for detection of Giardia lamblia (Patent US:6908739)	Buechler	2005	0		
1174	chr2	77323240	77323267	3500058241	23		77323240	77323267	8421504	2	16,7	0,20	g	350005824100000279	13-36						Detection of nucleic acid hybrids	Shultz	2001	0		
1194	chr2	79940985	79941009	3500189823	23		79940985	79941009	8421504	2	6,17	0,7	g	350018982300000801	1-24						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
1200	chr2	80660726	80660751	3500044638	23		80660726	80660751	8421504	2	8,15	0,10	g	350004463800000022	2-25						Recombinant n-propanol and isopropanol production	Grotkjaer	2012	0		
1203	chr2	81006084	81006110	3500324765	23		81006084	81006110	8421504	3	13,6,4	0,15,22	g	350032476500000003	9-33						V&#xcd;RUS ENT&#xc9;RICOS E INDICADORES BACTERIOL&#xd3;GICOS DE POLUI&#xc7;&#xc3;O FECAL EM AMOSTRAS DE &#xc1;GUA NA REGI&#xc3;O DA ILHA DAS CAIEIRAS, NA BA&#xcd;A DE VIT&#xd3;RIA, ES	www.ct.ufes.br	0	0		
1206	chr2	81494562	81494586	3500068173	23		81494562	81494586	8421504	2	7,16	0,8	g	350006817300000110	6-38						HUMANIZED ANTI-CD47 ANTIBODY - Patent application	www.faqs.org	0	0		
1211	chr2	82067052	82069442	3500447030	40		82067052	82069442	8421504	2	20,20	0,2370	c,g	350044703000000002,350044703000000002,350044703000000003,350044703000000003	0-20,0-20,0-20,0-20						Evaluation of Internal Reference Genes for Quantitative Expression Analysis by Real-Time PCR in Ovine Whole Blood	www.mdpi.com	0	0		
1214	chr2	82526303	82560724	3500268018	75		82526303	82560724	8421504	4	24,2,24,25	0,980,32238,34396	c	350026801800000002,350026801800000004,350026801800000006	0-26,0-24,0-25						Cloning and analysis of unique human glutaminase isoforms generated by tissue-speci&#xfb01;c alternative splicing	cs.physiology.org	0	0		
1214	chr2	82560630	82560769	3500273863	100		82560630	82560769	8421504	3	25,50,25	0,56,114	c	350027386300000009,350027386300000006,350027386300000008,350027386300000007	0-25,0-26,0-24,0-25		22479354	10.1371/journal.pone.0032995		PLoS ONE	Interferon-&#x03b1; Regulates Glutaminase 1 Promoter through STAT1 Phosphorylation: Relevance to HIV-1 Associated Neurocognitive Disorders	Lixia	2012	0		
1214	chr2	82562323	82562347	3500175510	24		82562323	82562347	8421504	1	24	0	g	350017551000000000	0-24		19585612	10.1002/hep.23076	1527-3350	Hepatology	Porcine liver sinusoidal endothelial cells contribute significantly to intrahepatic ammonia metabolism - Nedredal - 2009 - Hepatology - Wiley Online Library	Nedredal	2009	0		
1215	chr2	82597232	82597855	3500084821	623		82597232	82597855	8421504	1	623	0	g	350008482100000016,350008482100000008,350008482100000020,350008482100000007,350008482100000019	0-623,0-20,0-20,0-20,0-20						 DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE - Patent application	www.faqs.org	0	0		
1215	chr2	82597232	82597855	3500002891	623		82597232	82597855	8421504	1	623	0	g	350000289100000009,350000289100000001,350000289100000013,350000289100000000,350000289100000012	0-623,0-20,0-20,0-20,0-20						Dairy Cattle Breeding For Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
1215	chr2	82597530	82597844	3500355754	40		82597530	82597844	8421504	2	20,20	0,294	g	350035575400000008,350035575400000007	0-20,0-20						DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE	Khatib	2007	0		
1215	chr2	82597530	82597844	3500319127	39		82597530	82597844	8421504	2	19,20	0,294	g	350031912700000011,350031912700000010	0-19,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
1215	chr2	82597530	82597844	3500001677	40		82597530	82597844	8421504	2	20,20	0,294	g	350000167700000008,350000167700000007	0-20,0-20						Dairy Cattle Breeding For Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
1215	chr2	82603303	82630258	3500296816	364		82603303	82630258	8421504	10	49,44,48,10,30,55,1,44,42,41	0,4230,6516,11010,11113,13098,15233,16926,17009,26914	c	350029681600000170,350029681600000112,350029681600000108,350029681600000100,350029681600000099,350029681600000096,350029681600000188,350029681600000083	0-49,0-44,0-48,0-48,1-48,3-48,6-48,0-41					Patent	Functionally active regions of signal transducer and activators of transcription (Patent US:5716622)	James	1998	0		
1215	chr2	82603303	82620354	3500404279	91		82603303	82620354	8421504	2	49,42	0,17009	c	350040427900000170,350040427900000188	0-49,6-48						US Patent # 5,716,622. Functionally active regions of signal transducer and activators of transcription - Patents.com	www.patents.com	0	0		
1215	chr2	82603309	82603333	3500045756	24		82603309	82603333	8421504	1	24	0	c	350004575600000005	10-34		19279093	10.1128/JVI.02516-08		Journal of Virology	A Kaposi's Sarcoma-Associated Herpesvirus Protein That Forms Inhibitory Complexes with Type I Interferon Receptor Subunits, Jak and STAT Proteins, and Blocks Interferon-Mediated Signal Transduction 	Sabine	2009	0		
1215	chr2	82603310	82603334	3500323835	24		82603310	82603334	8421504	1	24	0	c	350032383500000001	0-24		16731929	10.1128/JVI.02714-05	0022-538X	Journal of Virology	Blocking of Interferon-Induced Jak-Stat Signaling by Japanese Encephalitis Virus NS5 through a Protein Tyrosine Phosphatase-Mediated Mechanism	Lin	2006	5		
1215	chr2	82603310	82603334	3500081891	24		82603310	82603334	8421504	1	24	0	c,g	350008189100000001,350008189100000001	0-24,0-24						Blocking of Interferon-Induced Jak-Stat Signaling by Japanese Encephalitis Virus NS5 through a Protein Tyrosine Phosphatase-Mediated Mechanism--&#x300a;&#x75c5;&#x83cc;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x	journal.9med.net	0	0		
1215	chr2	82603313	82632733	3500327308	2136		82603313	82632733	8421504	21	77,186,146,95,50,136,99,84,42,94,30,60,93,159,152,92,79,90,99,145,128	0,1289,2982,4202,4999,6445,7641,8359,9645,10916,11103,13088,15131,16916,21430,21771,23362,24461,26846,28235,29292	p	350032730800015010,350032730800015009	0-1989,0-150						Modulation of SOCS expression in therapeutic regimens	Antwerp	2004	0		STAT1
1215	chr2	82603313	82632733	3500211097	2136		82603313	82632733	8421504	21	77,186,146,95,50,136,99,84,42,94,30,60,93,159,152,92,79,90,99,145,128	0,1289,2982,4202,4999,6445,7641,8359,9645,10916,11103,13088,15131,16916,21430,21771,23362,24461,26846,28235,29292	p	350021109700015004	0-2136						MODULATION OF SOCS EXPRESSION IN THERAPEUTIC REGIMENS	Antwerp	2011	0		STAT1
1215	chr2	82603319	82603367	3500108389	48		82603319	82603367	8421504	1	48	0	p	350010838900015004	0-48						ILKKA JUNTTILA	tampub.uta.fi	0	0		STAT1
1215	chr2	82609821	82609845	3500463683	24		82609821	82609845	8421504	1	24	0	c	350046368300000014	16-40						THE J B C &#xa9; 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Synergistic Transcriptional Activation of Human Acyl-coenzyme A: Cholesterol Acyltransterase-1 Gene by Interferon- and All-trans Retinoic Acid THP	www.sibcb.ac.cn	0	0		
1215	chr2	82609822	82611678	3500242915	177		82609822	82611678	8421504	3	72,99,6	0,1132,1850	p	350024291500015005	0-177						A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain	enesdev.cshlp.org	0	0		STAT1
1215	chr2	82609875	82620354	3500328322	175		82609875	82620354	8421504	8	19,21,10,30,8,1,44,42	0,1079,4438,4541,6526,8661,10354,10437	c	350032832200000107,350032832200000100,350032832200000096,350032832200000188	0-40,0-48,3-48,6-48						Functionally active regions of signal transducer and activator of transcription	Darnell	1997	0		
1215	chr2	82612958	82614295	3500362403	42		82612958	82614295	8421504	2	21,21	0,1316	c	350036240300000082,350036240300000083	0-21,0-21						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
1215	chr2	82612958	82614295	3500268248	42		82612958	82614295	8421504	2	21,21	0,1316	c	350026824800000010,350026824800000011	0-21,0-21		16885540	10.1530/rep.1.00996	1470-1626	Reproduction	Embryo-induced transcriptome changes in bovine endometrium reveal species-specific and common molecular markers of uterine receptivity	Bauersachs	2006	3		
1215	chr2	82616406	82631581	3500004083	225		82616406	82631581	8421504	6	48,47,48,46,3,33	0,2080,8366,8415,13849,15142	c	350000408300000074,350000408300000072,350000408300000067,350000408300000066,350000408300000057	0-48,0-47,0-48,1-47,12-48						Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins	Hancock	2001	0		
1215	chr2	82618536	82620273	3500295082	45		82618536	82620273	8421504	2	1,44	0,1693	c	350029508200000096	3-48					Patent	Functionally active regions of signal transducer and activator of transcription (Patent US:5883228)	James	1999	0		
1215	chr2	82626676	82627832	3500082342	40		82626676	82627832	8421504	2	20,20	0,1136	c	350008234200000005,350008234200000004	0-20,0-20		20664578	10.1038/mi.2010.39		Mucosal immunology	Intestinal epithelia activate anti-viral signaling via intracellular sensing of rotavirus structural components	Amena	2010	0		STAT1
1215	chr2	82648615	82648640	3500133516	25		82648615	82648640	8421504	1	25	0	c	350013351600000005,350013351600000009	0-25,6-31						STAT PROTEIN REGULATION OF FOXP3 EXPRESSION AND INFLAMMATORY CYTOKINE PRODUCTION IN T HELPER CELL SUBSETS	arworks.iupui.edu	0	0		STAT4
1216	chr2	82711276	82711303	3500404279	27		82711276	82711303	8421504	1	27	0	c	350040427900000258	21-48						US Patent # 5,716,622. Functionally active regions of signal transducer and activators of transcription - Patents.com	www.patents.com	0	0		
1216	chr2	82711276	82711303	3500328322	27		82711276	82711303	8421504	1	27	0	c	350032832200000258	21-48						Functionally active regions of signal transducer and activator of transcription	Darnell	1997	0		
1216	chr2	82711276	82711303	3500295082	27		82711276	82711303	8421504	1	27	0	c	350029508200000258	21-48					Patent	Functionally active regions of signal transducer and activator of transcription (Patent US:5883228)	James	1999	0		
1216	chr2	82748169	82803991	3500004083	48		82748169	82803991	8421504	2	45,3	0,55819	c	350000408300000213	0-48						Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins	Hancock	2001	0		
1217	chr2	82882370	82882395	3500265170	23		82882370	82882395	8421504	2	18,5	0,20	g	350026517000000048	10-33					Patent	Purified thermostable nucleic acid polymerase enzyme from thermosipho africanus (Patent US:5968799)	Gelfand	1999	0		
1219	chr2	83113792	83126011	3500350670	597		83113792	83126011	8421504	6	72,87,75,132,107,124	0,1862,5550,7226,9386,12095	p	350035067000015007	132-729						 PigGIS&#x2192;GeneSnapshot&#x2192;ENST00000304164&#x2192;reads	g.genomics.org.cn	0	0		
1219	chr2	83204498	83204526	3500123068	23		83204498	83204526	8421504	3	13,6,4	0,17,24	g	350012306800000183	1-27						Human E3&#x03b1; ubiquitin ligase family	Han	2000	0		
1221	chr2	83396673	83396696	3500324667	23		83396673	83396696	8421504	1	23	0	g	350032466700000012	6-30					Patent	Activatable recombinant neurotoxins (Patent US:7132259)	Chan	2006	0		
1221	chr2	83396673	83396696	3500084944	23		83396673	83396696	8421504	1	23	0	g	350008494400000012	6-30						Activatable recombinant neurotoxins	Chan	2009	0		
1222	chr2	83603845	83603873	3500442231	23		83603845	83603873	8421504	3	11,6,6	0,13,22	g	350044223100000089	5-29						High Affinity Nucleic Acid Ligands To Lectins - Patent application	www.faqs.org	0	0		
1232	chr2	84862920	84862943	3500023744	23		84862920	84862943	8421504	1	23	0	g	350002374400000032	12-35						R. longirostris R. elegans	ww.museum.lsu.edu	0	0		
1244	chr2	86429586	86429611	3500014029	23		86429586	86429611	8421504	2	5,18	0,7	g	350001402900000255	5-29						D&#xe9;veloppement d&#x2019;une m&#xe9;thodologie d&#x2019;analyse de la conservation de synt&#xe9;nie chez les plantes. Du g&#xe9;nome d&#x2019;Arabidopsis &#xe0; celui du Tournesol	s.inp-toulouse.fr	0	0		
1244	chr2	86495798	86495825	3500105414	25		86495798	86495825	8421504	2	14,11	0,16	g	350010541400000028	0-27						Compositions And Methods Comprising Variant Microbial Proteases - Patent application	www.faqs.org	0	0		
1247	chr2	86852662	86852689	3500366078	23		86852662	86852689	8421504	2	17,6	0,21	g	350036607800000025	11-37						UNIVERSIDAD POLITACNICA DE VALENCIA DEPARTAMENTO DE CIENCIA ANIMAL CARACTERIZACIAN GENATICA Y	riunet.upv.es	0	0		
1252	chr2	87516632	87524802	3500316377	45		87516632	87524802	8421504	2	1,44	0,8126	p	350031637700015104	0-45						Compositions Against Cancer Antigen LIV-1 and Uses Thereof - Patent application	www.faqs.org	0	0		SLC39A10
1252	chr2	87554535	87554561	3500020490	23		87554535	87554561	8421504	2	7,16	0,10	g	350002049000000000	0-23						(Peri&#xf3;dico) (Andrioli, 2006) Fatores de risco na transmiss&#xe3;o do lentiv&#xed;rus caprino pelo s&#xea;men 31709	pt.scribd.com	0	0		
1253	chr2	87621026	87621050	3500262626	24		87621026	87621050	8421504	1	24	0	c	350026262600000065,350026262600000025	8-39,8-39						Interferon-beta fusion proteins and uses	Whitty	2001	0		
1253	chr2	87677313	87677376	3500381398	63		87677313	87677376	8421504	1	63	0	p	350038139800015061	54-117						47 human secreted proteins	Komatsoulis	2002	0		DNAH1
1257	chr2	88118015	88118042	3500459417	23		88118015	88118042	8421504	2	11,12	0,15	g	350045941700000036	9-32						Newcastle disease virus infectious clones, vaccines and new diagnostic assays	Peeters	2004	0		
1257	chr2	88118015	88118042	3500050560	23		88118015	88118042	8421504	2	11,12	0,15	g	350005056000000041,350005056000000191	9-32,9-32						NEWCASTLE DISEASE VIRUS INFECTIOUS CLONES, VACCINES AND DIAGNOSTIC ASSAYS	Peeters	1999	0		
1257	chr2	88191405	88191432	3500218185	23		88191405	88191432	8421504	2	8,15	0,12	g	350021818500000031	12-42						Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
1265	chr2	89154784	89154812	3500386780	23		89154784	89154812	8421504	3	4,7,12	0,5,16	g	350038678000000001	6-29						Secretion and Assembly of Zona Pellucida Glycoproteins by Growing Mouse Oocytes Microinjected with Epitope-tagged cDNAs for mZP2 and mZP3*	w.molbiolcell.org	0	0		
1265	chr2	89169325	89169352	3500364155	23		89169325	89169352	8421504	3	6,5,12	0,9,15	g	350036415500000074	10-33						US Patent # 7,501,498. Alpha-fetoprotein Immu31 antibodies and fusion proteins - Patents.com	www.patents.com	0	0		
1266	chr2	89345384	89345411	3500152135	24		89345384	89345411	8421504	2	13,11	0,16	g	350015213500000057	0-26						DNA encoding Fas ligand	Nagata	1994	0		
1266	chr2	89352810	89352870	3500122257	60		89352810	89352870	8421504	1	60	0	p	350012225700015002	0-60			10.1186/1471-2091-7-7		BMC Biochemistry	The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site	Katrin	2006	0		SF3B1
1267	chr2	89430765	89430816	3500221835	51		89430765	89430816	8421504	1	51	0	p	350022183500015000	0-51			10.1111/j.1574-6968.2006.00412.x	1574-6968	FEMS Microbiology Letters	The arbuscular mycorrhizal fungal protein glomalin is a putative homolog of heat shock protein 60 - Gadkar - 2006 - FEMS Microbiology Letters - Wiley Online Library	Gadkar	2006	0		HSPD1
1267	chr2	89430795	89430934	3500254625	45		89430795	89430934	8421504	2	30,15	0,124	p	350025462500015007	0-45						Suppression of the pathogenic responses in an animal model of adjuvant-induced arthritis by a peptide corresponding	ntiae.cigb.edu.cu	0	0		HSPD1
1267	chr2	89431495	89431525	3500017463	24		89431495	89431525	8421504	3	12,6,6	0,14,24	c	350001746300000064	22-47						DbpA compositions and methods of use	Guo	2000	0		
1267	chr2	89431515	89431542	3500001998	27		89431515	89431542	8421504	1	27	0	c	350000199800000005	0-27		23074380	10.7150/jca.4280		Journal of Cancer	Promising Urinary Protein Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients	Moemen	2012	0		
1267	chr2	89432562	89434705	3500262882	45		89432562	89434705	8421504	2	13,32	0,2111	p	350026288200015000	0-45						Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and immune regulatory network	tologylibrary.org	0	0		HSPD1
1267	chr2	89437974	89438004	3500339323	27		89437974	89438004	8421504	2	6,21	0,9	c	350033932300000013	2-29		17122403	10.1128/AEM.02079-06	0099-2240	Applied and Environmental Microbiology	Characterization of Chimeric Bacillus thuringiensis Vip3 Toxins	Fang	2007	4		
1267	chr2	89438010	89438070	3500227258	60		89438010	89438070	8421504	1	60	0	p	350022725800015009	0-60						B-CELL EPITOPE PEPTIDES OF HSP 65, NOVEL AMINO ACID SEQUENCES, DNA ENCODING THE AMINO ACID SEQUENCES OF SAID PEPTIDES, ANTIBODIES DIRECTED AGAINST SAID PEPTIDES AND DIFFERENT USES THEREOF IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES	Naparstek	2008	0		HSPD1
1267	chr2	89438010	89438070	3500055207	60		89438010	89438070	8421504	1	60	0	p	350005520700015004,350005520700015015	0-60,0-48						Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof - Patent # 7247305 - PatentGenius	.patentgenius.com	0	0		HSPD1
1267	chr2	89439194	89440204	3500431621	40		89439194	89440204	8421504	3	16,4,20	0,939,990	c	350043162100000009,350043162100000008	0-20,0-20			10.1111/j.1349-7006.2007.00650.x	1349-7006	Cancer Science	Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1 - Nagahama - 2007 - Cancer Science - Wiley Online Library	Nagahama	2008	0		HSPD1
1267	chr2	89439976	89440000	3500062753	23		89439976	89440000	8421504	2	15,8	0,16	c	350006275300000035	16-39					Patent	Pseudorabies virus protein (Patent CA:1340848)	Petrovskis	1999	0		
1267	chr2	89440752	89442451	3500047878	40		89440752	89442451	8421504	3	20,7,13	0,759,1686	c,g	350004787800000006,350004787800000006,350004787800000007	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1267	chr2	89441356	89441416	3500234214	60		89441356	89441416	8421504	1	60	0	p	350023421400015009,350023421400015004,350023421400015000	3-48,3-54,0-54					Patent	Epf receptor assays, compounds and therapeutic compositions (Patent EP:1399744)	Bender	2008	0		HSPD1
1267	chr2	89441362	89441416	3500232462	54		89441362	89441416	8421504	1	54	0	p	350023246200015009	0-54						Epf receptor assays, compounds and therapeutic compositions	Bender	2004	0		HSPD1
1267	chr2	89441371	89442452	3500141597	42		89441371	89442452	8421504	3	22,6,14	0,141,1067	c	350014159700000004,350014159700000005	0-22,0-20			10.1124/mol.105.017525	1521-0111 (Online)	Molecular Pharmacology	Identification by Functional Cloning from a Retroviral cDNA Library of cDNAs for Ribosomal Protein L36 and the 10-kDa Heat Shock Protein that Confer Cisplatin Resistance	Shen	2006	0		HSPD1
1267	chr2	89441371	89442452	3500055800	42		89441371	89442452	8421504	3	22,6,14	0,141,1067	c	350005580000000004,350005580000000005	0-22,0-20						Identification by Functional Cloning From a Retroviral cDNA Library of cDNAs for Ribosomal Protein L36 and Heat Shock Protein 10 That Confer Cisplatin Resistance	aspetjournals.org	0	0		HSPD1
1267	chr2	89441509	89442525	3500236924	96		89441509	89442525	8421504	2	9,87	0,929	c	350023692400000081,350023692400000082	0-48,0-48						EPF receptor assays, compounds and therapeutic compsns.	A*Bu Yi Si Te 	2004	0		
1267	chr2	89481533	89482991	3500196806	48		89481533	89482991	8421504	2	23,25	0,1433	c	350019680600000059,350019680600000060	0-23,0-25						Polynucleotides and polypeptides associated with the NF-kappaB pathway	Nadler	2004	0		RFTN2
1268	chr2	89626429	89626453	3500373947	23		89626429	89626453	8421504	2	5,18	0,6	g	350037394700000019	0-23						Udder Health Characteristics	Lund	2007	0		
1269	chr2	89679625	89681344	3500298636	57		89679625	89681344	8421504	2	21,36	0,1683	p	350029863600015000	0-57						Differentiation of murine male germ cells to spermatozoa in a soft agar culture system	www.asiaandro.com	0	0		BOLL
1269	chr2	89679625	89681344	3500206436	57		89679625	89681344	8421504	2	21,36	0,1683	p	350020643600015000	0-57						Differentiation of murine male germ cells to spermatozoa in a soft agar culture system - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		BOLL
1269	chr2	89750963	89750988	3500263908	23		89750963	89750988	8421504	3	5,4,14	0,6,11	g	350026390800000342,350026390800000033	1-24,1-24						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
1271	chr2	90008443	90008469	3500175008	23		90008443	90008469	8421504	2	7,16	0,10	c	350017500800000012	7-30						Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase	tologylibrary.org	0	0		
1273	chr2	90269216	90269241	3500308897	23		90269216	90269241	8421504	3	4,7,12	0,5,13	g	350030889700000595	20-43						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
1279	chr2	90965713	90965736	3500308662	23		90965713	90965736	8421504	1	23	0	g	350030866200000011	0-23						DNA	.lib.kobe-u.ac.jp	0	0		
1281	chr2	91283624	91283647	3500187127	23		91283624	91283647	8421504	1	23	0	c	350018712700000088	25-48						Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof	Smith	1995	0		
1281	chr2	91330647	91356187	3500416491	158		91330647	91356187	8421504	5	19,27,45,48,19	0,84,4701,4797,25521	p,c	350041649100000001,350041649100015008,350041649100015002,350041649100000000	0-19,0-72,0-48,0-19						Epitopes derived from satb2 and uses thereof	Jirsrtom	2011	0		SATB2
1281	chr2	91330647	91356187	3500404504	38		91330647	91356187	8421504	2	19,19	0,25521	c	350040450400000001,350040450400000000	0-19,0-19					Patent	Use of protein SATB2 as a marker for colorectal cancer (Patent US:8241859)	Uhlen	2012	0		SATB2
1281	chr2	91330647	91356187	3500385777	158		91330647	91356187	8421504	5	19,27,45,48,19	0,84,4701,4797,25521	p,c	350038577700000001,350038577700015007,350038577700015001,350038577700000000	0-19,0-72,0-48,0-19					Patent	Epitopes derived from satb2 and uses thereof (Patent EP:2344525)	JIRSTROM	2013	0		SATB2
1281	chr2	91330647	91356187	3500286826	38		91330647	91356187	8421504	2	19,19	0,25521	c	350028682600000001,350028682600000000	0-19,0-19						Use of protein satb2 as a marker for colorectal cancer	Ponten	2012	0		SATB2
1281	chr2	91330647	91356187	3500257750	86		91330647	91356187	8421504	3	19,48,19	0,4797,25521	p,c	350025775000000001,350025775000015001,350025775000000000	0-19,0-48,0-19						Epitopes derived from satb2 and uses thereof	JIRSTROM	2011	0		SATB2
1281	chr2	91330647	91356187	3500242597	86		91330647	91356187	8421504	3	19,48,19	0,4797,25521	p,c	350024259700000002,350024259700015002,350024259700000001	0-19,0-48,0-19						Epitopes derived from SATB2 and uses thereof	F*Pang Dun 	2011	0		SATB2
1281	chr2	91330647	91356187	3500237233	86		91330647	91356187	8421504	3	19,48,19	0,4797,25521	p,c	350023723300000001,350023723300015002,350023723300000000	0-19,0-48,0-19					Patent	Epitopes derived from SATB2 and uses thereof (Patent US:8420788)	Jirsrtom	2013	0		SATB2
1281	chr2	91330647	91356187	3500235483	38		91330647	91356187	8421504	2	19,19	0,25521	c	350023548300000001,350023548300000000	0-19,0-19						Use of protein satb2 as a marker for colorectal cancer	Ponten	2007	0		SATB2
1281	chr2	91330647	91356187	3500229317	38		91330647	91356187	8421504	2	19,19	0,25521	c,g	350022931700000001,350022931700000001,350022931700000000,350022931700000000	0-19,0-19,0-19,0-19						Use of protein SATB2 as a marker for colorectal cancer	Ponten	2007	0		SATB2
1281	chr2	91330647	91356187	3500142686	38		91330647	91356187	8421504	2	19,19	0,25521	c,g	350014268600000001,350014268600000001,350014268600000000	0-19,0-19,0-19						Use of protein satb2 as a marker for colorectal cancer	Uhlen	2009	0		SATB2
1281	chr2	91330647	91356187	3500140719	38		91330647	91356187	8421504	2	19,19	0,25521	c	350014071900000001,350014071900000000	0-19,0-19						Use of protein satb2 as a marker for colorectal cancer	Ponten	2012	0		SATB2
1281	chr2	91330647	91356187	3500125862	38		91330647	91356187	8421504	2	19,19	0,25521	c	350012586200000001,350012586200000000	0-19,0-19					Patent	Use of protein SATB2 as a marker for colorectal cancer (Patent US:8465934)	Uhlen	2013	0		SATB2
1281	chr2	91330647	91356187	3500015477	38		91330647	91356187	8421504	2	19,19	0,25521	c	350001547700000001,350001547700000000	0-19,0-19						USE OF PROTEIN SATB2 AS A MARKER FOR COLORECTAL CANCER	Uhlen	2011	0		
1281	chr2	91335444	91335492	3500141418	48		91335444	91335492	8421504	1	48	0	p	350014141800015001	0-48						&#x4ece;satb2&#x884d;&#x751f;&#x7684;&#x8868;&#x4f4d;&#x53ca;&#x5176;&#x7528;&#x9014;	F*Pang Dun 	2011	0		SATB2
1285	chr2	91753865	91753895	3500217840	26		91753865	91753895	8421504	4	4,11,7,4	0,5,18,26	g	350021784000000104	4-30					Patent	Purified DNA polymerase from bacillus stearothermophilus ATCC 12980 (Patent US:6100078)	Riggs	2000	0		
1288	chr2	92190833	92190860	3500255702	27		92190833	92190860	8421504	1	27	0	g	350025570200000014	0-27						Transcriptional activation of histone H4 &#x03b2; during the mitotic clonal expansion of 3T3-L1 adipocyte differentiation	w.molbiolcell.org	0	0		
1289	chr2	92282940	92282963	3500014152	23		92282940	92282963	8421504	1	23	0	g	350001415200000045	6-30						Materials and Methods Bacterial and eukaryotic cell growth conditions. Listeria monocytogenes	h.med.harvard.edu	0	0		
1289	chr2	92382883	92382914	3500175980	27		92382883	92382914	8421504	2	9,18	0,13	g	350017598000000034	7-34						Streptococcus pneumoniae proteins and nucleic acids	Masignani	2005	0		
1289	chr2	92382883	92382914	3500099159	27		92382883	92382914	8421504	2	9,18	0,13	g	350009915900000034	7-34						Streptococcus pneumoniae proteins and nucleic acids	Masignani	2011	0		
1290	chr2	92462281	92462304	3500277616	23		92462281	92462304	8421504	1	23	0	c,g	350027761600000011,350027761600000011,350027761600000012,350027761600000012	0-20,0-20,0-20,0-20						Novel marker genes for regulatory T cells from human blood	Schultze	2012	0		SPATS2L
1290	chr2	92462281	92462304	3500119251	23		92462281	92462304	8421504	1	23	0	c,g	350011925100000011,350011925100000011,350011925100000012	0-20,0-20,0-20						Novel Marker Genes for Regulatory T Cells from Human Blood - Patent application	www.faqs.org	0	0		SPATS2L
1290	chr2	92462430	92462458	3500266568	23		92462430	92462458	8421504	2	11,12	0,16	c	350026656800000079	0-23						Virus assay method	Fan	2001	0		
1290	chr2	92462430	92462458	3500253862	23		92462430	92462458	8421504	2	11,12	0,16	c	350025386200000079	0-23						Virus assay method	Fan	1998	0		
1290	chr2	92462430	92462458	3500219219	23		92462430	92462458	8421504	2	11,12	0,16	c	350021921900000051	0-23					Patent	Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B (Patent US:6015664)	Fan	2000	0		
1290	chr2	92462430	92462458	3500008225	23		92462430	92462458	8421504	2	11,12	0,16	c	350000822500000051	0-23						Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B	Henrickson	1996	0		
1290	chr2	92491842	92491869	3500262089	23		92491842	92491869	8421504	2	11,12	0,15	c	350026208900000035	19-42						US Patent # 6,080,912. Methods for creating transgenic animals - Patents.com	www.patents.com	0	0		
1291	chr2	92557745	92608133	3500281343	57		92557745	92608133	8421504	3	35,6,16	0,49608,50372	c	350028134300000001,350028134300000000	0-35,0-22		8537361	10.1074/jbc.270.52.31037	0021-9258	Journal of Biological Chemistry	Purification, cDNA Cloning, and Tissue Distribution of Bovine Liver Aldehyde Oxidase	Li-Calzi	1995	5		
1292	chr2	92770209	92770235	3500340015	24		92770209	92770235	8421504	3	12,6,6	0,13,20	g	350034001500000007	6-30						Molecular typing of Japanese Escherichia coli O157:H7 isolates from clinical specimens by multilocus variable-number tandem repeat analysis and PFGE	m.sgmjournals.org	0	0		
1293	chr2	92919626	92919652	3500430320	26		92919626	92919652	8421504	1	26	0	c	350043032000000008	0-26						METHOD FOR EXAMINATION OF ACTION OF ANTI-CANCER AGENT UTILIZING SPLICING DEFECT AS MEASURE	Mizui	2008	0		
1293	chr2	92919626	92919652	3500383862	26		92919626	92919652	8421504	1	26	0	c	350038386200000008	0-26						METHOD FOR ASSAYING ACTION OF ANTITUMOR AGENT USING SPLICING DEFECTS AS INDEX	Mizui	2008	0		
1293	chr2	92919626	92919652	3500259963	26		92919626	92919652	8421504	1	26	0	c,g	350025996300000008,350025996300000008	0-26,0-26						Method for examination of action of anti-cancer agent utilizing splicing defect as measure	Hata	2009	0		
1293	chr2	92919626	92919652	3500006534	26		92919626	92919652	8421504	1	26	0	c	350000653400000008,350000653400000061	0-26,0-26						METHOD FOR ASSAYING ACTION OF ANTITUMOR AGENT USING SPLICING DEFECTS AS INDEX - Patent application	www.faqs.org	0	0		
1294	chr2	92946246	92946272	3500346255	26		92946246	92946272	8421504	1	26	0	c	350034625500000009	24-50						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		
1294	chr2	92950027	92950054	3500461949	25		92950027	92950054	8421504	2	20,5	0,22	c	350046194900000019	6-31						RESSOURCES G&#xc9;N&#xc9;TIQUES ANIMALES	www.fao.org	0	0		
1294	chr2	92950027	92950054	3500400964	25		92950027	92950054	8421504	2	20,5	0,22	c	350040096400000019	6-31						RESSOURCES G&#xc9;N&#xc9;TIQUES ANIMALES	www.fao.org	0	0		CLK1
1294	chr2	92950027	92950054	3500373947	25		92950027	92950054	8421504	2	20,5	0,22	c	350037394700000089	6-31						Udder Health Characteristics	Lund	2007	0		CLK1
1294	chr2	92950027	92950054	3500024826	25		92950027	92950054	8421504	2	20,5	0,22	c	350002482600000098	6-31						Udder Health Characteristics 	.freshpatents.com	0	0		
1294	chr2	92950027	92950054	3500024337	25		92950027	92950054	8421504	2	20,5	0,22	c	350002433700000045	6-31						Genetic Diversity Analysis of the Gohilwari Breed of Indian Goat Capra hircus ) Using Microsatellite Markers	thescipub.com	0	0		
1294	chr2	92950054	92950077	3500385072	23		92950054	92950077	8421504	1	23	0	c,g	350038507200000012,350038507200000012	0-23,0-23						Analysis of FOXO transcriptional networks	ive.library.uu.nl	0	0		CLK1
1294	chr2	92988570	92988596	3500313011	23		92988570	92988596	8421504	2	15,8	0,18	c	350031301100000048	10-37						CYTOLETHAL DISTENDING TOXINS AND DETECTION OF CAMPYLOBACTER BACTERIA USING THE SAME AS A TARGET - Patent application	www.faqs.org	0	0		
1294	chr2	93022072	93022715	3500152214	23		93022072	93022715	8421504	2	1,22	0,621	c	350015221400000001	1-24						US Patent # 6,890,743. Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses - Patents.com	www.patents.com	0	0		ORC2
1295	chr2	93085598	93085627	3500003517	23		93085598	93085627	8421504	3	7,4,12	0,8,17	g	350000351700000444	7-30						 Neisseria Meningitidis Antigens And Compositions 	www.docstoc.com	0	0		
161	chr2	93164509	93198056	3500299365	40		93164509	93198056	8421504	2	20,20	0,33527	c,g	350029936500000000,350029936500000000,350029936500000001,350029936500000001	0-20,0-20,0-20,0-20						Construction of mammalian cell expression vector for pAcGFP-bFLIP(L) fusion protein and its expression in follicular granulosa cells.	.biomedsearch.com	0	0		
1295	chr2	93164708	93164731	3500127062	23		93164708	93164731	8421504	1	23	0	c	350012706200000004	0-23		19155307	10.1158/0008-5472.CAN-08-2520	0008-5472	Cancer Research	IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor&#x2013;Initiated Apoptosis via Repression of FLICE-like Protein Expression	Yang	2009	8		
161	chr2	93164801	93198028	3500195491	132		93164801	93198028	8421504	6	13,5,26,38,20,30	0,2281,2289,30315,30708,33197	c	350019549100000022,350019549100000073,350019549100000002,350019549100000033,350019549100000065,350019549100000045,350019549100000089	1-48,5-26,5-26,1-39,28-48,18-48,16-40						I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis	Ni	1998	0		
1295	chr2	93169933	93169959	3500155690	26		93169933	93169959	8421504	1	26	0	c	350015569000000003	19-45						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		
1296	chr2	93312503	93315113	3500404944	40		93312503	93315113	8421504	3	9,11,20	0,2515,2590	c	350040494400000000,350040494400000001	0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
1296	chr2	93321019	93321089	3500049463	50		93321019	93321089	8421504	2	25,25	0,45	c,g	350004946300000002,350004946300000002,350004946300000003	0-25,0-25,0-25			10.1590/S0102-09352010000200003	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Apoptosis and expression of Bcl-2 and caspases 3 and 8 in placenta of cows at different pregnancy stages	Meca	2010	0		
1296	chr2	93321104	93322945	3500022796	66		93321104	93322945	8421504	3	20,20,26	0,206,1815	c,g	350002279600000008,350002279600000008,350002279600000009,350002279600000001	0-20,0-20,0-20,20-46						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
162	chr2	93450822	93477735	3500351065	48		93450822	93477735	8421504	3	12,14,22	0,3425,26891	c	350035106500000000,350035106500000001	9-35,10-32		18256292	10.1091/mbc.E07-05-0454	1059-1524	Molecular Biology of the Cell	STRAD&#x03b1; Regulates LKB1 Localization by Blocking Access to Importin-&#x03b1;, and by Association with Crm1 and Exportin-7	Dorfman	2008	5		STRADB
162	chr2	93450822	93477735	3500221077	48		93450822	93477735	8421504	3	12,14,22	0,3425,26891	c	350022107700000000,350022107700000001	9-35,10-32						Regulates LKB1 Localization by Blocking Access to Importin- , and by Association with Crm1 and Exportin-7	w.molbiolcell.org	0	0		STRADB
162	chr2	93450822	93477735	3500076008	48		93450822	93477735	8421504	3	12,14,22	0,3425,26891	c	350007600800000000,350007600800000001	9-35,10-32		18256292	10.1091/mbc.E07-05-0454		Molecular Biology of the Cell	STRAD&#x03b1; Regulates LKB1 Localization by Blocking Access to Importin-&#x03b1;, and by Association with Crm1 and Exportin-7	Julia	2008	0		STRADB
1298	chr2	93468730	93475876	3500121800	702		93468730	93475876	8421504	7	40,122,109,124,172,105,30	0,3246,4252,5207,6376,6848,7116	p	350012180000015092,350012180000015094,350012180000015096,350012180000015098	0-180,0-180,0-180,0-162						49 human secreted proteins	Komatsoulis	2000	0		STRADB
1298	chr2	93520924	93520950	3500445074	26		93520924	93520950	8421504	1	26	0	g	350044507400000001	0-26						&#x041c;&#x0418;&#x041d;&#x0418;&#x0421;&#x0422;&#x0415;&#x0420;&#x0421;&#x0422;&#x0412;&#x041e; &#x041e;&#x0411;&#x0420;&#x0410;&#x0417;&#x041e;&#x0412;&#x0410;&#x041d;&#x0418;&#x042f; &#x0418; &#x041d;&#x0410;&#x0423;&#x041a;&#x0418; &#x0420;&#x0424; &#	issc.nsu.ru	0	0		
1298	chr2	93520924	93520950	3500343539	26		93520924	93520950	8421504	1	26	0	g	350034353900000002	0-26						Credit Seminar of M.F.Sc., Students	www.tnfu.org.in	0	0		
1298	chr2	93520924	93520950	3500228600	26		93520924	93520950	8421504	1	26	0	g	350022860000000001	0-26		15049087	10.1590/S0074-02762003000800011	0074-0276	Mem&#xf3;rias do Instituto Oswaldo Cruz	Mem&#xf3;rias do Instituto Oswaldo Cruz - Molecular differentiation of Angiostrongylus costaricensis, A. cantonensis, and A. vasorum by polymerase chain reaction- restriction fragment length polymorphism	Caldeira	2003	2		
1298	chr2	93520924	93520950	3500218157	26		93520924	93520950	8421504	1	26	0	g	350021815700000001	0-26						Bioline International Official Site (site up-dated regularly)	ww.bioline.org.br	0	0		
1298	chr2	93520924	93520950	3500193989	26		93520924	93520950	8421504	1	26	0	g	350019398900000003	0-26						Ayudando a descifrar el enigma taxon&#xf3;mico, el c&#xf3;digo de barras de ADN de Megalobulimus spp. (Mollusca, Gastropoda) del departamento de San Mart&#xed;n &#x2013; Per&#xfa;	cybertesis.edu.pe	0	0		
1298	chr2	93520924	93520950	3500154741	26		93520924	93520950	8421504	1	26	0	g	350015474100000000	0-26						ISSUU - JoTT 3(8): 1961-2032 26aug2011 by ZOO-WILD	issuu.com/zoo-wil	0	0		
1298	chr2	93520924	93520950	3500146731	26		93520924	93520950	8421504	1	26	0	g	350014673100000000	25-51						Visual and Molecular Analysis of French Grunt Stomach Contents from St. John, U.S. Virgin Islands	ufdc.ufl.edu	0	0		
1298	chr2	93520924	93520950	3500109199	26		93520924	93520950	8421504	1	26	0	g	350010919900000001	0-26						A skeleton-less sponge of Caribbean mangroves: invasive or undescribed?	si-pddr.si.edu	0	0		
1298	chr2	93520924	93520950	3500083239	26		93520924	93520950	8421504	1	26	0	g	350008323900000001	0-26						A molecular phylogeny of nephilid spiders: Evolutionary history of a model lineage	ezlab.zrc-sazu.si	0	0		
1301	chr2	93927127	93927151	3500123212	23		93927127	93927151	8421504	2	19,4	0,20	g	350012321200000000	0-23			10.1128/JB.185.24.7140-7144.2003		Journal of Bacteriology	Transcriptional Regulation and Posttranslational Activity of the Betaine Transporter BetL in Listeria monocytogenes Are Controlled by Environmental Salinity	Roy	2003	0		
1303	chr2	94208337	94208361	3500326353	23		94208337	94208361	8421504	2	14,9	0,15	g	350032635300000007	0-23						Method for diagnosing acute lymphomic leukemia (all) using mir-221	Croce	2012	0		
1304	chr2	94306131	94307847	3500460691	1716		94306131	94307847	8421504	1	1716	0	p	350046069100015024	0-1716						Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph	Cotsarelis	2011	0		CDK15
1304	chr2	94306853	94306880	3500208288	27		94306853	94306880	8421504	1	27	0	c	350020828800000008	0-27		19773752	10.1038/sj.bjc.6605307	0007-0920	British Journal of Cancer	Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells	Ueno	2009	5		
1304	chr2	94307799	94307832	3500235155	33		94307799	94307832	8421504	1	33	0	c	350023515500000000	1-34		23095888	10.1242/dev.083352	0950-1991	Development	Frizzled 2 and frizzled 7 function redundantly in convergent extension and closure of the ventricular septum and palate: evidence for a network of interacting genes	Yu	2012	7		
1304	chr2	94307803	94307857	3500355764	38		94307803	94307857	8421504	2	19,19	0,35	c,g	350035576400000107,350035576400000107,350035576400000010,350035576400000010,350035576400000011,350035576400000011,350035576400000108,350035576400000108	0-19,0-19,0-19,0-19,0-19,0-19,0-19,0-19						WNT PROTEINS AND DETECTION AND TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
1304	chr2	94307832	94307856	3500434024	24		94307832	94307856	8421504	1	24	0	c	350043402400000001	13-37						An Antagonist of Dishevelled Protein-Protein Interaction Suppresses B-Catenin&#x2013;Dependent Tumor Cell Growth	www.scribd.com	0	0		CDK15
1304	chr2	94307832	94307856	3500351179	24		94307832	94307856	8421504	1	24	0	c	350035117900000001	13-37		17234765	10.1158/0008-5472.CAN-06-2726	0008-5472	Cancer Research	An Antagonist of Dishevelled Protein-Protein Interaction Suppresses &#x03b2;-Catenin&#x2013;Dependent Tumor Cell Growth	Fujii	2007	8		CDK15
1304	chr2	94307939	94308085	3500143893	48		94307939	94308085	8421504	2	24,24	0,122	c	350014389300000004,350014389300000005	0-24,0-24						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
1304	chr2	94307939	94307963	3500382906	24		94307939	94307963	8421504	1	24	0	c	350038290600000004	0-24						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
1304	chr2	94311255	94311281	3500031500	23		94311255	94311281	8421504	3	4,6,13	0,5,13	g	350003150000000018	0-23						Vergleichende Genomanalyse und Evaluation von Stammtypisierungsmethoden	d-nb.info/1022029	0	0		
1305	chr2	94469578	94469605	3500088205	23		94469578	94469605	8421504	3	5,14,4	0,8,23	c	350008820500000113	18-41						Methods for detection of acute promyelocytic leukemia (APL) - US Patent 5843642 Description	ww.patentstorm.us	0	0		
1305	chr2	94474600	94474645	3500357890	45		94474600	94474645	8421504	1	45	0	p	350035789000015005	0-45						SENP1 as a marker for cancer - Patent application	www.faqs.org	0	0		SUMO1
1305	chr2	94474600	94474645	3500127717	45		94474600	94474645	8421504	1	45	0	p	350012771700015004	0-45						 SENP1 As A Marker For Cancer 	www.docstoc.com	0	0		SUMO1
1305	chr2	94474600	94474645	3500108449	45		94474600	94474645	8421504	1	45	0	p	350010844900015003	0-45					Patent	Senp1 as a marker for cancer (Patent CA:2564484)	Holcomb	2013	0		SUMO1
1305	chr2	94474600	94474645	3500096041	45		94474600	94474645	8421504	1	45	0	p	350009604100015004	0-45						Senp1 as a marker for cancer	Holcomb	2007	0		SUMO1
163	chr2	94474612	94532413	3500044816	57		94474612	94532413	8421504	2	54,3	0,57798	p	350004481600015002	0-57		18212042	10.1128/MCB.01159-07	0270-7306	Molecular and Cellular Biology	Identification of a New Site of Sumoylation on Tel (ETV6) Uncovers a PIAS-Dependent Mode of Regulating Tel Function	Roukens	2008	6		SUMO1
163	chr2	94474636	94532440	3500231008	60		94474636	94532440	8421504	2	30,30	0,57774	p	350023100800015010	0-60						A Novel Ubiquitin-like Modification Modulates the Partitioning of the Ran-GTPase-activating Protein RanGAP1 between the Cytosol and the Nuclear Pore Complex	jcb.rupress.org	0	0		
1317	chr2	95960373	95966912	3500218129	93		95960373	95966912	8421504	3	28,17,48	0,279,6491	p	350021812900015130,350021812900015138	0-45,0-48						Feline Ctla-4 Nucleic Acid And Polypeptides 	.freshpatents.com	0	0		
1317	chr2	95966867	95966912	3500119124	45		95966867	95966912	8421504	1	45	0	p	350011912400015138	0-45						FELINE CD80, FELINE CD86, FELINE CD28, AND FELINE CTLA-4 NUCLEIC ACID AND POLYPEPTIDES - Patent application	www.faqs.org	0	0		
1317	chr2	96040605	96040629	3500025345	23		96040605	96040629	8421504	2	4,19	0,5	g	350002534500000081	7-35						Pygopus In Diagnosis And Treatment Of Cancer 	.freshpatents.com	0	0		
1318	chr2	96094174	96099571	3500243646	666		96094174	96099571	8421504	4	103,348,110,105	0,2825,3941,5292	p,c	350024364600000031,350024364600015140,350024364600015141,350024364600015142,350024364600015144,350024364600015145,350024364600015146,350024364600015147	0-666,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction) - Patent application	www.faqs.org	0	0		
1318	chr2	96094174	96098137	3500417058	45		96094174	96098137	8421504	2	25,20	0,3943	c,g	350041705800000000,350041705800000001,350041705800000001	9-34,0-20,0-20		10569760		0019-9567	Infection and Immunity	Targeting Improves the Efficacy of a DNA Vaccine against Corynebacterium pseudotuberculosis in Sheep	Chaplin	1999	4		
1318	chr2	96094174	96098137	3500023946	45		96094174	96098137	8421504	2	25,20	0,3943	c,g	350002394600000000,350002394600000001,350002394600000001	9-34,0-20,0-20					Infection and Immunity	Targeting Improves the Efficacy of a DNA Vaccine against Corynebacterium pseudotuberculosis in Sheep	Paul	1999	0		
1318	chr2	96097250	96099559	3500121852	297		96097250	96099559	8421504	4	97,83,24,93	0,865,951,2216	p	350012185200015002,350012185200015003	0-180,3-120						METHODS FOR DETECTING AND REGULATING ALOPECIA AREATA AND GENE COHORTS THEREOF - Patent application	www.faqs.org	0	0		
1318	chr2	96097280	96098123	3500011569	72		96097280	96098123	8421504	3	24,40,8	0,27,835	p	350001156900015030	0-72						CD86 and CD80 receptor competition assays - Patent # 7510844 - PatentGenius	.patentgenius.com	0	0		
1318	chr2	96098199	96099571	3500372261	74		96098199	96099571	8421504	3	26,21,27	0,1267,1345	c	350037226100000035,350037226100000025	1-48,2-29					Patent	CTLA4/CD28Ig hybrid fusion proteins and uses thereof (Patent US:6090914)	Bajorath	2000	0		
1318	chr2	96098199	96099571	3500364269	83		96098199	96099571	8421504	3	26,21,36	0,1267,1336	c,g	350036426900000035,350036426900000037,350036426900000037,350036426900000025	1-48,0-33,0-33,18-45						US Patent # 5,968,510. CTLA4 receptor and uses thereof - Patents.com	www.patents.com	0	0		
1318	chr2	96098199	96099568	3500418214	80		96098199	96099568	8421504	3	26,21,33	0,1267,1336	c	350041821400000033,350041821400000035	1-48,0-33						US Patent # 5,844,095. CTLA4 Ig fusion proteins - Patents.com	www.patents.com	0	0		
1318	chr2	96098199	96099556	3500306946	68		96098199	96099556	8421504	2	20,48	0,1309	c,g	350030694600000143,350030694600000143,350030694600000145	28-48,28-48,0-48						Methods for treating cardiovascular disease using a soluble CTLA4 Molecule - Patent application	www.faqs.org	0	0		
1318	chr2	96098199	96099556	3500013487	116		96098199	96099556	8421504	2	26,90	0,1267	c	350001348700000143,350001348700000144,350001348700000145	28-48,0-48,0-48						METHODS FOR TREATING SJOGRENS SYNDROME BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE - Patent application	www.faqs.org	0	0		
1318	chr2	96098199	96099508	3500029696	68		96098199	96099508	8421504	2	26,42	0,1267	c	350002969600000143,350002969600000144	28-48,0-48						Methods for treating cardiovascular disease using a soluble CTLA4 molecule - Patent application	www.faqs.org	0	0		
1318	chr2	96098199	96099508	3500009980	68		96098199	96099508	8421504	2	26,42	0,1267	c	350000998000000143,350000998000000144	28-48,0-48						METHOD FOR TREATING AN AUTOIMMUNE DISEASE USING A SOLUBLE CTLA4 MOLECULE AND A DMARD OR NSAID - Patent application	www.faqs.org	0	0		
1318	chr2	96098199	96099487	3500465860	47		96098199	96099487	8421504	2	26,21	0,1267	c	350046586000000035	1-48					Patent	Soluble CTLA4 molecules and uses thereof (Patent US:5851795)	Brady	1998	0		
1318	chr2	96098199	96099487	3500439222	47		96098199	96099487	8421504	2	26,21	0,1267	c	350043922200000035	1-48						CTLA4 receptor and uses thereof	Linsley	1997	0		
1318	chr2	96098199	96099487	3500324075	47		96098199	96099487	8421504	2	26,21	0,1267	c	350032407500000035	1-48						US Patent # 6,090,914. CTLA4/CD28Ig hybrid fusion proteins and uses thereof - Patents.com	www.patents.com	0	0		
1318	chr2	96098199	96099487	3500320819	47		96098199	96099487	8421504	2	26,21	0,1267	c	350032081900000035	1-48						Ctla4 Molecules And Il4-binding Molecules And Uses Thereof 	.freshpatents.com	0	0		
1318	chr2	96098199	96099487	3500250034	47		96098199	96099487	8421504	2	26,21	0,1267	c	350025003400000035	1-48						US Patent # 6,887,471. Method to inhibit T cell interactions with soluble B7 - Patents.com	www.patents.com	0	0		
1318	chr2	96098199	96099487	3500058536	47		96098199	96099487	8421504	2	26,21	0,1267	c	350005853600000035	1-48						US Patent # 5,885,579. CTLA4 receptor and uses thereof - Patents.com	www.patents.com	0	0		
1318	chr2	96098199	96099487	3500055168	47		96098199	96099487	8421504	2	26,21	0,1267	c	350005516800000035	1-48						US Patent # 5,977,318. CTLA4 receptor and uses thereof - Patents.com	www.patents.com	0	0		
1318	chr2	96099535	96099568	3500263816	33		96099535	96099568	8421504	1	33	0	c	350026381600000022	0-33						Ligands for induction of antigen specific apoptosis in t cells	Freeman	1995	0		
1318	chr2	96099535	96099568	3500220275	33		96099535	96099568	8421504	1	33	0	c	350022027500000037	0-33						CTLA4 Ig fusion proteins	Linsley	1995	0		
1318	chr2	96099535	96099568	3500220241	33		96099535	96099568	8421504	1	33	0	c	350022024100000037	0-33						US Patent # 5,851,795. Soluble CTLA4 molecules and uses thereof - Patents.com	www.patents.com	0	0		
1318	chr2	96099544	96099571	3500192328	27		96099544	96099571	8421504	1	27	0	c	350019232800000025	14-41						US Patent # 7,311,910. Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions - Patents.com	www.patents.com	0	0		
1318	chr2	96099544	96099571	3500115793	27		96099544	96099571	8421504	1	27	0	c	350011579300000011	18-45						 CTLA4 Ig Fusion Proteins 	www.docstoc.com	0	0		
1318	chr2	96188471	96190814	3500125071	156		96188471	96190814	8421504	7	41,24,24,7,38,16,6	0,51,243,294,885,976,2337	c	350012507100000008,350012507100000022,350012507100000013,350012507100000014,350012507100000016	0-41,24-48,0-24,0-45,5-27						US Patent # 7,294,473. Methods of identifying substances that interact with JTT-1 protein - Patents.com	www.patents.com	0	0		
1318	chr2	96188471	96189394	3500378491	134		96188471	96189394	8421504	5	41,24,24,7,38	0,51,243,294,885	c	350037849100000008,350037849100000022,350037849100000013,350037849100000014	0-41,24-48,0-24,0-45						US Patent # 7,226,909. Methods of inhibiting transmission of a costimulatory signal of lymphocytes - Patents.com	www.patents.com	0	0		
1322	chr2	96716408	96716436	3500127027	24		96716408	96716436	8421504	3	5,6,13	0,7,15	g	350012702700000003	0-25		21489246	10.1186/1746-1596-6-34	1746-1596	Diagnostic Pathology	Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer	Angelucci	2011	2		
1332	chr2	97994773	97994799	3500397025	25		97994773	97994799	8421504	2	21,4	0,22	g	350039702500000033	9-34						Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents	Buchsbaum	2005	0		
1332	chr2	98007587	98007610	3500020197	23		98007587	98007610	8421504	1	23	0	g	350002019700000003	4-30						Process for the Purification of Recombinant Albumin	Ballance	2011	0		
1334	chr2	98172964	98172988	3500171732	24		98172964	98172988	8421504	1	24	0	c	350017173200000002	0-24						ScienceDirect.com - Virology - Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1	sciencedirect.com	0	0		NRP2
1334	chr2	98173438	98173461	3500240456	23		98173438	98173461	8421504	1	23	0	g	350024045600000007	0-23		17428830	10.1242/dev.002402	0950-1991	Development	Selective requirements for NRP1 ligands during neurovascular patterning	Vieira	2007	7		NRP2
1334	chr2	98187641	98187664	3500192058	23		98187641	98187664	8421504	1	23	0	c,g	350019205800000007,350019205800000007,350019205800000006,350019205800000006	0-21,0-21,0-21,0-21		22828632	10.1038/ncomms1977	2041-1733	Nature Communications	The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis	Cudmore	2012	0		NRP2
1334	chr2	98214074	98214227	3500432900	147		98214074	98214227	8421504	3	81,45,21	0,84,132	p	350043290000015156	0-147						US Patent # 7,273,612. Soluble inhibitors of vascular endothelial growth factor and use thereof - Patents.com	www.patents.com	0	0		
1334	chr2	98221060	98221090	3500258709	28		98221060	98221090	8421504	2	15,13	0,17	g	350025870900000055	11-39					Patent	Fungal resistant plants, process for obtaining fungal resistant plants and recombinant polynucleotides for use therein (Patent US:5670706)	Bol	1997	0		
1337	chr2	98589520	98589546	3500057796	24		98589520	98589546	8421504	2	16,8	0,18	c	350005779600000254	1-25						CHROMOSOME-BASED PLATFORMS - Patent application	www.faqs.org	0	0		
1337	chr2	98665849	98665874	3500449315	25		98665849	98665874	8421504	1	25	0	g	350044931500000070	11-36						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
1337	chr2	98674832	98674861	3500263903	26		98674832	98674861	8421504	3	15,4,7	0,17,22	c	350026390300000031	1-27						Modified transferrin fusion proteins	Prior	2003	0		
1337	chr2	98675033	98675106	3500440764	70		98675033	98675106	8421504	3	25,24,21	0,27,52	c	350044076400000002,350044076400000000,350044076400000001	0-25,0-24,0-21		16731849	10.2337/db05-1438	0012-1797	Diabetes	Diabetic Nephropathy Is Associated With Gene Expression Levels of Oxidative Phosphorylation and Related Pathways	Huang	2006	8		NDUFS1
1338	chr2	98704008	98704053	3500381115	45		98704008	98704053	8421504	1	45	0	p	350038111500015005	0-45		12533507	10.1101/gad.1040803	0890-9369	Genes & Development	Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA	Pestova	2003	12		EEF1B2
1338	chr2	98706847	98706874	3500222056	23		98706847	98706874	8421504	3	5,4,14	0,8,13	c	350022205600000002	15-38		22705370	10.1016/j.molcel.2012.05.025		Molecular cell	The HARP-like domain-containing protein AH2/ZRANB3 binds to PCNA and participates in cellular response to replication stress	Jingsong	2012	0		
1338	chr2	98720889	98720915	3500341278	23		98720889	98720915	8421504	2	8,15	0,11	c	350034127800000140	5-39						Method of distinguishing an IBRV-vaccinated bovine from a bovine infected with a wild type virus	Cochran	1996	0		
1340	chr2	99071585	99071609	3500025039	23		99071585	99071609	8421504	2	8,15	0,9	g	350002503900000114	3-26						Recombinant swinepox virus	Cochran	1996	0		
1340	chr2	99073412	99086689	3500156415	47		99073412	99086689	8421504	4	8,16,13,10	0,3305,6319,13267	c	350015641500000000,350015641500000001	0-24,0-23		10749942	10.1091/mbc.11.4.1457	1059-1524	Molecular Biology of the Cell	ADAM 23/MDC3, a Human Disintegrin That Promotes Cell Adhesion via Interaction with the &#x03b1;v&#x03b2;3 Integrin through an RGD-independent Mechanism	Cal	2000	5		ADAM23
1340	chr2	99076309	99076343	3500175973	25		99076309	99076343	8421504	3	12,7,6	0,17,28	g	350017597300000040	9-37					Patent	DNA encoding the Canine coronavirus spike protein (Patent US:5661006)	Brown	1997	0		
1342	chr2	99267964	99267998	3500445405	29		99267964	99267998	8421504	3	5,13,11	0,6,23	c	350044540500000206	11-45						Haemophilus outer membrane protein	Chong	1998	0		
1342	chr2	99267964	99267998	3500226498	29		99267964	99267998	8421504	3	5,13,11	0,6,23	c	350022649800000206,350022649800000050,350022649800000257	11-45,17-46,17-46					Patent	Haemophilus outer membrane protein (Patent US:6013514)	Chong	2000	0		
1342	chr2	99267970	99267998	3500093232	24		99267970	99267998	8421504	2	13,11	0,17	c	350009323200000050,350009323200000257	17-46,17-46					Patent	Haemophilus outer membrane protein (Patent US:6083743)	Chong	2000	0		
1343	chr2	99411434	99411460	3500456727	24		99411434	99411460	8421504	3	4,5,15	0,5,11	g	350045672700000129	24-48					Patent	Recombinant plant expressing non-competitively binding insecticidal crystal proteins (Patent US:5866784)	Botterman	1999	0		
1343	chr2	99474300	99474369	3500248692	69		99474300	99474369	8421504	1	69	0	p	350024869200015001	0-69						Mammalian proteins and in particular CD200	Bhatt	2006	0		CPO
1344	chr2	99591515	99599335	3500465595	57		99591515	99599335	8421504	2	43,14	0,7806	p	350046559500015013	0-57						Co-expression of mKlf7 and TrkA	ev.biologists.org	0	0		
1347	chr2	99958195	99958218	3500208479	23		99958195	99958218	8421504	1	23	0	g	350020847900000059	5-28						Identification Of Oligonucleotides For The Capture, Detection And Quantitation Of West Nile Virus 	.freshpatents.com	0	0		
1348	chr2	100105252	100137567	3500403907	47		100105252	100137567	8421504	2	22,25	0,32290	c	350040390700000006,350040390700000007	10-32,13-38						SilencingcAMP-responseElement-bindingProtein(CREB) Identifies CYR61 asaTumorSuppressorGeneinMelanoma	www.jbc.org	0	0		CREB1
1348	chr2	100105252	100137567	3500209762	47		100105252	100137567	8421504	2	22,25	0,32290	c	350020976200000005,350020976200000006	10-32,13-38		19632997	10.1074/jbc.M109.019836	0021-9258	Journal of Biological Chemistry	Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma	Dobroff	2009	5		CREB1
1348	chr2	100105276	100111770	3500386132	41		100105276	100111770	8421504	2	20,21	0,6473	c,g	350038613200000004,350038613200000005,350038613200000005	0-20,0-21,0-21		19333917	10.1002/art.24360		Arthritis and rheumatism	Variants within MECP2, a key transcriptional regulator, are associated with increased susceptibility to lupus and differential gene expression in lupus patients	Ryan	2009	0		CREB1
1348	chr2	100105276	100111770	3500250228	41		100105276	100111770	8421504	2	20,21	0,6473	c	350025022800000027,350025022800000008,350025022800000009,350025022800000028	0-20,0-20,0-21,0-21						Predicting and Diagnosing Patients With Autoimmune Disease - Patent application	www.faqs.org	0	0		CREB1
1348	chr2	100119521	100122684	3500307353	93		100119521	100122684	8421504	3	48,17,28	0,51,3135	p	350030735300015080	0-93						 Regulation Of Gene Expression Using Chromatin Remodelling Factors 	www.docstoc.com	0	0		CREB1
1348	chr2	100119565	100119589	3500017416	24		100119565	100119589	8421504	1	24	0	g	350001741600000007	0-24		16280361	10.1091/mbc.E05-06-0519	1059-1524	Molecular Biology of the Cell	Nonclassical Action of Retinoic Acid on the Activation of the cAMP Response Element-binding Protein in Normal Human Bronchial Epithelial Cells	Aggarwal	2006	5		CREB1
1348	chr2	100122657	100122702	3500182728	45		100122657	100122702	8421504	1	45	0	p	350018272800015003	0-45		16105844	10.1074/jbc.M503912200	0021-9258	Journal of Biological Chemistry	Phosphorylation of Numb Family Proteins	Tokumitsu	2005	5		CREB1
1348	chr2	100127663	100129678	3500251295	42		100127663	100129678	8421504	3	7,14,21	0,1903,1994	c	350025129500000000,350025129500000001	0-21,0-21						CHINESE MEDICAL SCIENCES JOURNAL	www.actacams.com	0	0		
1348	chr2	100137431	100137566	3500268215	48		100137431	100137566	8421504	2	21,27	0,108	c,g	350026821500000000,350026821500000000,350026821500000001	9-30,9-30,6-33		20007269	10.1128/JVI.02022-09	0022-538X	Journal of Virology	Effect of Dimerizing Domains and Basic Residues on In Vitro and In Vivo Assembly of Mason-Pfizer Monkey Virus and Human Immunodeficiency Virus	Bohmova	2010	5		CREB1
1348	chr2	100137458	100137563	3500127746	105		100137458	100137563	8421504	1	105	0	p	350012774600015034	87-192						Transcriptional Repression by Member ofthe bZIP Family of Transcription	mcb.asm.org	0	0		
1348	chr2	100137533	100137566	3500355861	33		100137533	100137566	8421504	1	33	0	c	350035586100000025	8-41			10.1042/BJ20070245		The Biochemical Journal	Identification of a responsible promoter region and a key transcription factor, CCAAT/enhancer-binding protein &#x03f5;, for up-regulation of PHGPx in HL60 cells stimulated with TNF&#x03b1;	Hiroyuki	2007	0		CREB1
1348	chr2	100137542	100137568	3500188053	26		100137542	100137568	8421504	1	26	0	c	350018805300000001	13-39		21576335	10.1128/IAI.05070-11	0019-9567	Infection and Immunity	Glycogen Synthase Kinase 3 Activation Is Important for Anthrax Edema Toxin-Induced Dendritic Cell Maturation and Anthrax Toxin Receptor 2 Expression in Macrophages	Larabee	2011	4		CREB1
1349	chr2	100151061	100151089	3500339288	28		100151061	100151089	8421504	1	28	0	c,g	350033928800000064,350033928800000376,350033928800000376	20-40,0-24,0-24						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		
1350	chr2	100342189	100342214	3500443458	23		100342189	100342214	8421504	2	14,9	0,16	c	350044345800000028	1-24						US Patent # 5,990,275. Linker and linked fusion polypeptides - Patents.com	www.patents.com	0	0		
1350	chr2	100342189	100342214	3500082679	23		100342189	100342214	8421504	2	14,9	0,16	c	350008267900000030	1-24						US Patent # 5,856,456. Linker for linked fusion polypeptides - Patents.com	www.patents.com	0	0		
1352	chr2	100612913	100612947	3500445013	25		100612913	100612947	8421504	3	7,11,7	0,11,27	g	350044501300000009	17-48						Lung cancer marker	www.devileye.net	0	0		
1352	chr2	100645877	100645906	3500366182	29		100645877	100645906	8421504	1	29	0	c	350036618200000002,350036618200000003	0-29,1-30						A missense mutation in the D crystallin gene ( ) associated with autosomal dominant &#x201c;coral-like&#x201d; cataract linked to chromo- some 2q	www.molvis.org	0	0		
2	chr2	100656172	100668313	3500113513	453		100656172	100668313	8421504	10	93,6,93,60,17,4,13,58,99,10	0,123,10020,10116,10276,11791,11842,11864,11935,12131	p,c,g	350011351300000024,350011351300000000,350011351300015064,350011351300015028,350011351300015060,350011351300015056,350011351300015020,350011351300000005,350011351300000017,350011351300000032,350011351300000009,350011351300000013,350011351300000029,350011351300000029,350011351300000030,350011351300000019,350011351300000019,350011351300000001	0-180,18-48,0-45,0-48,0-48,0-45,0-48,0-21,0-21,0-52,49-100,74-118,0-20,0-20,6-26,13-60,13-60,27-55						Design of beta-sheet proteins with specific binding properties	Wu Er Li Ke *Fei De Le 	2010	0		
1353	chr2	100666192	100668313	3500428236	79		100666192	100668313	8421504	5	30,17,4,18,10	0,256,1771,1996,2111	c	350042823600000000,350042823600000005,350042823600000001	18-48,0-21,27-55						Fabrication of beta-pleated sheet proteins with specific binding properties	Fiedler	2002	0		
1353	chr2	100666192	100668313	3500247403	79		100666192	100668313	8421504	5	30,17,4,18,10	0,256,1771,1996,2111	c,g	350024740300000000,350024740300000000,350024740300000005,350024740300000001	18-48,18-48,0-21,27-55						Fabrication of beta-pleated sheet proteins with specific binding properties	Fiedler	2007	0		
1353	chr2	100666192	100668313	3500122934	79		100666192	100668313	8421504	5	30,17,4,18,10	0,256,1771,1996,2111	c	350012293400000000,350012293400000005,350012293400000001	18-48,0-21,27-55						Fabrication of beta-pleated sheet proteins with specific binding properties	Fiedler	2007	0		
1353	chr2	100666192	100668313	3500107550	79		100666192	100668313	8421504	5	30,17,4,18,10	0,256,1771,1996,2111	c	350010755000000000,350010755000000005,350010755000000001	18-48,0-21,27-55						Design von Beta-Faltblatt-Proteinen mit spezifischen Bindungseigenschaften Design of beta-sheet proteins with specific binding properties	Boehm	2001	0		
1353	chr2	100666192	100668313	3500100567	74		100666192	100668313	8421504	5	25,17,4,18,10	0,256,1771,1996,2111	c	350010056700000000,350010056700000003,350010056700000001	18-43,0-21,27-55						Fabrication of beta-pleated sheet proteins with specific binding properties	Fiedler	2000	0		
1353	chr2	100666192	100668313	3500042405	74		100666192	100668313	8421504	5	25,17,4,18,10	0,256,1771,1996,2111	c	350004240500000000,350004240500000003,350004240500000001	18-43,0-21,27-55					Patent	Fabrication of beta-pleated sheet proteins with specific binding properties (Patent US:7601803)	Boehm	2009	0		
1353	chr2	100666192	100668313	3500040678	79		100666192	100668313	8421504	5	30,17,4,18,10	0,256,1771,1996,2111	c	350004067800000000,350004067800000003,350004067800000001	18-48,0-21,27-55						Design of beta-sheet proteins with specific binding properties	Fiedler	2007	0		
1353	chr2	100666192	100668313	3500037765	79		100666192	100668313	8421504	5	30,17,4,18,10	0,256,1771,1996,2111	c	350003776500000000,350003776500000003,350003776500000001	18-48,0-21,27-55						Design von Beta-Faltblatt-Proteinen mit spezifischen Bindungseigenschaften	Fiedler	2007	0		
1353	chr2	100666192	100668313	3500029831	198		100666192	100668313	8421504	8	30,17,4,13,58,47,19,10	0,256,1771,1822,1844,1915,1995,2111	c,g	350002983100000011,350002983100000011,350002983100000000,350002983100000015,350002983100000005,350002983100000022,350002983100000009,350002983100000012,350002983100000020,350002983100000020,350002983100000013,350002983100000001	66-96,18-48,18-48,0-21,0-21,0-52,49-100,74-118,47-94,0-47,27-56,27-55					Patent	Fabrication of beta-pleated sheet proteins with specific binding properties (Patent EP:1200583)	Fiedler	2006	0		
1353	chr2	100666192	100668313	3500000962	79		100666192	100668313	8421504	5	30,17,4,18,10	0,256,1771,1996,2111	c	350000096200000000,350000096200000003,350000096200000001	18-48,0-21,27-55						Design of beta-sheet proteins with specific binding properties	Fiedler	2007	0		
1353	chr2	100666192	100666348	3500067642	153		100666192	100666348	8421504	2	93,60	0,96	p	350006764200015033,350006764200015015,350006764200015031,350006764200015029,350006764200015011	0-45,0-48,0-48,0-45,0-48						&#x5177;&#x6709;&#x7279;&#x5f02;&#x7ed3;&#x5408;&#x6027;&#x8d28;&#x7684;&#x03b2;-&#x6298;&#x53e0;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8bbe;&#x8ba1;	Wu Er Li Ke *Fei De Le 	2010	0		
1353	chr2	100724254	100724279	3500114128	23		100724254	100724279	8421504	2	16,7	0,18	g	350011412800000026	16-39						Hepatitis G virus protease	Belyaev	1996	0		
1354	chr2	100801686	100806606	3500274311	50		100801686	100806606	8421504	2	29,21	0,4899	c,g	350027431100000002,350027431100000000,350027431100000001,350027431100000001	0-19,0-21,0-21,0-21		17056794		0022-3166	The Journal of Nutrition	Trans-10, Cis-12 Conjugated Linoleic Acid Inhibits Prolactin-Induced Cytosolic NADP+-Dependent Isocitrate Dehydrogenase Expression in Bovine Mammary Epithelial Cells	Liu	2006	4		
1354	chr2	100801713	100817720	3500272162	226		100801713	100817720	8421504	8	48,30,11,32,9,48,8,40	0,4870,7543,9043,10357,13282,14536,15967	c	350027216200000003,350027216200000010,350027216200000016,350027216200000020,350027216200000026	0-48,6-47,0-41,0-48,0-48						Isociatrate dehydrogenase and uses therof - Patent application	www.faqs.org	0	0		
1354	chr2	100801763	100809324	3500283558	39		100801763	100809324	8421504	2	20,19	0,7542	c,g	350028355800000005,350028355800000005,350028355800000006,350028355800000006	0-20,0-20,0-19,0-19						IDENTIFICATION OF ENDOMETRIAL GENES IMPORTANT FOR CONCEPTUS SURVIVAL AND DEVELOPMENT IN SHEEP	pository.tamu.edu	0	0		
1354	chr2	100806496	100817726	3500322660	99		100806496	100817726	8421504	4	27,35,1,36	0,4257,5574,11194	p	350032266000015013	66-165						Caracterizaci&#xf3;n gen&#xf3;mica y prote&#xf3;mica de la expresi&#xf3;n g&#xe9;nica diferencial en jabal&#xed;es infectados de forma natural con Mycobacterium bovis Identificaci&#xf3;n de biomarcadores asociados con la infecci&#xf3;n y la respuesta inmu	digital.csic.es	0	0		IDH1
1354	chr2	100812168	100812192	3500078731	24		100812168	100812192	8421504	1	24	0	c	350007873100000021	0-24						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		
1354	chr2	100814990	100815091	3500301078	43		100814990	100815091	8421504	2	21,22	0,79	c	350030107800000133,350030107800000134	0-21,0-22						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
1355	chr2	100965850	101049480	3500188761	143		100965850	101049480	8421504	5	3,45,25,23,47	0,6191,18804,18940,83583	c	350018876100000008,350018876100000012,350018876100000033	0-48,0-48,0-47						G-protein parathyroid hormone receptor HLTDG74	www.devileye.net	0	0		
1361	chr2	101798799	101821562	3500446950	54		101798799	101821562	8421504	2	7,47	0,22716	p	350044695000015043,350044695000015130	0-54,0-45						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells - Patent application	www.faqs.org	0	0		MAP2
1361	chr2	101798799	101821562	3500430125	54		101798799	101821562	8421504	2	7,47	0,22716	p	350043012500015038	0-54						Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer	Gold	2012	0		MAP2
1361	chr2	101798799	101821562	3500427070	54		101798799	101821562	8421504	2	7,47	0,22716	p	350042707000015102	0-54						Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases	Chang	2011	0		MAP2
1361	chr2	101798799	101821562	3500382936	54		101798799	101821562	8421504	2	7,47	0,22716	p	350038293600015042	0-54						Detection of Early-Stage Pancreatic Adenocarcinoma - Patent application	www.faqs.org	0	0		MAP2
1361	chr2	101798799	101821562	3500377644	54		101798799	101821562	8421504	2	7,47	0,22716	p	350037764400015060	0-54						Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma	Burton	2012	0		MAP2
1361	chr2	101798799	101821562	3500304681	54		101798799	101821562	8421504	2	7,47	0,22716	p	350030468100015043	0-54						Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer - Patent application	www.faqs.org	0	0		MAP2
1361	chr2	101798799	101821562	3500289124	54		101798799	101821562	8421504	2	7,47	0,22716	p	350028912400015030	0-54						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells	Chang	2011	0		MAP2
1361	chr2	101798799	101821562	3500249189	54		101798799	101821562	8421504	2	7,47	0,22716	p	350024918900015038	0-54						Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity - Patent application	www.faqs.org	0	0		MAP2
1361	chr2	101798799	101821562	3500221336	54		101798799	101821562	8421504	2	7,47	0,22716	p	350022133600015093	0-54						COMBINATION THERAPY WITH ANTI-CD74 ANTIBODIES PROVIDES ENHANCED TOXICITY TO MALIGNANCIES, AUTOIMMUNE DISEASE AND OTHER DISEASES - IMMUNOMEDICS, INC.	www.sumobrain.com	0	0		MAP2
1361	chr2	101798799	101821562	3500196739	54		101798799	101821562	8421504	2	7,47	0,22716	p	350019673900015038	0-54						Anti-HLA-DR Antibodies Suppress Allogeneic and Xenogeneic Immune Responses to Organ Transplants	Sawada	2012	0		MAP2
1361	chr2	101798799	101821562	3500165028	54		101798799	101821562	8421504	2	7,47	0,22716	p	350016502800015024	0-54						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting	Mcbride	2012	0		MAP2
1361	chr2	101798799	101821562	3500147691	54		101798799	101821562	8421504	2	7,47	0,22716	p	350014769100015093	0-54						Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases	Chang	2011	0		MAP2
1361	chr2	101798799	101821562	3500111111	54		101798799	101821562	8421504	2	7,47	0,22716	p	350011111100015043	0-54						Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity	Chang	2012	0		MAP2
1361	chr2	101798799	101821562	3500100255	54		101798799	101821562	8421504	2	7,47	0,22716	p	350010025500015030	0-54						Dock-and-lock (dnl) complexes for delivery of interference rna	Chang	2012	0		MAP2
1361	chr2	101798799	101821562	3500096413	54		101798799	101821562	8421504	2	7,47	0,22716	p	350009641300015146,350009641300015030	0-48,0-54						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting - Patent application	www.faqs.org	0	0		MAP2
1361	chr2	101798799	101821562	3500089169	54		101798799	101821562	8421504	2	7,47	0,22716	p	350008916900015043	0-54						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells - Patent application	www.faqs.org	0	0		MAP2
1361	chr2	101798799	101821562	3500080236	54		101798799	101821562	8421504	2	7,47	0,22716	p	350008023600015093	0-54						Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases	Chang	2011	0		MAP2
1361	chr2	101798799	101821562	3500036974	54		101798799	101821562	8421504	2	7,47	0,22716	p	350003697400015030	0-54						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting - Patent application	www.faqs.org	0	0		MAP2
1361	chr2	101837981	101838009	3500115080	23		101837981	101838009	8421504	3	11,4,8	0,12,20	c	350011508000000026	0-23						Strain-dependent variation in the early transcriptional response to CNS injury using a cortical explant system	oinflammation.com	0	0		
1361	chr2	101839555	101839581	3500145512	24		101839555	101839581	8421504	2	6,18	0,8	c	350014551200000003	2-26				1350-0872	Microbiology	Molecular characterization, enzyme properties and transcriptional regulation of phosphoenolpyruvate carboxykinase and pyruvate kinase in a ruminal bacterium, Selenomonas ruminantium	Asanuma	2001	3		MAP2
1362	chr2	101847857	101847882	3500127346	25		101847857	101847882	8421504	1	25	0	c	350012734600000033	0-25						Generation of an HVS-based Episomally Maintained Gene Delivery System for Reprogramming Adult Somatic Cells	s.whiterose.ac.uk	0	0		
1362	chr2	101870870	101870896	3500311545	26		101870870	101870896	8421504	1	26	0	c	350031154500000039	0-26						Nuclear reprogramming factor and induced pluripotent stem cells	Yamanaka	2008	0		MAP2
1362	chr2	101870870	101870896	3500041938	26		101870870	101870896	8421504	1	26	0	g	350004193800000042	30-56						Method of efficiently establishing induced pluripotent stem cells	Yamanaka	2009	0		MAP2
1366	chr2	102455257	102455280	3500320185	23		102455257	102455280	8421504	1	23	0	c	350032018500000109	11-34						Recombinant bone morphogenetic protein heterodimers	Israel	1992	0		
1366	chr2	102455257	102455280	3500092036	23		102455257	102455280	8421504	1	23	0	c	350009203600000108	11-34					Patent	Recombinant bone morphogenetic protein heterodimers (Patent US:5866364)	Israel	1999	0		
1368	chr2	102651620	102695077	3500331156	40		102651620	102695077	8421504	2	21,19	0,43438	c,g	350033115600000010,350033115600000008,350033115600000008	0-21,0-19,0-19						Human carbamyl phosphate synthetase i polymorphism and diagnostic and therapeutic methods relating thereto	Christman	2000	0		CPS1
1368	chr2	102675059	102675083	3500388989	23		102675059	102675083	8421504	2	5,18	0,6	g	350038898900000000	0-23						Curcumin Inhibition of Integrin (&#x03b1; &#x03b2; )-Dependent Breast Cancer Cell Motility and Invasion	.aacrjournals.org	0	0		
21	chr2	102675532	102789474	3500009738	944		102675532	102789474	8421504	25	91,3,93,18,30,47,30,18,15,33,124,48,2,46,45,41,45,45,36,9,35,15,30,38,7	0,10137,13165,23843,26713,28227,28323,29864,29978,32987,34980,37016,44092,66516,70418,79740,79830,95020,100113,102907,102961,111254,111992,112067,113935	c	350000973800000019,350000973800000020,350000973800000027,350000973800000028,350000973800000044,350000973800000049,350000973800000051,350000973800000054,350000973800000059,350000973800000060,350000973800000061,350000973800000064,350000973800000072,350000973800000080,350000973800000082,350000973800000084,350000973800000094,350000973800000100,350000973800000102,350000973800000104,350000973800000106	0-48,0-43,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-28,0-48,0-48,0-45,0-41,0-45,0-45,0-45,0-35,0-45,0-45						Therapeutic methods relating to human carbamyl phosphate synthetase I polymorphism	Summar	2000	0		
21	chr2	102675580	102778528	3500289264	266		102675580	102778528	8421504	7	43,18,30,47,48,45,35	0,23795,26665,28179,34932,70370,102913	c	350028926400000010,350028926400000034,350028926400000039,350028926400000049,350028926400000070,350028926400000092	0-43,0-48,0-47,0-48,0-45,0-35						US Patent # 6,346,382. Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto - Patents.com	www.patents.com	0	0		
1368	chr2	102710948	102710977	3500267580	24		102710948	102710977	8421504	3	14,5,5	0,17,24	g	350026758000000227	11-35						Non-edible oilseed base biofuels: Molecular Characterisation of Jatropha curcas as a source of biodiesel	theses.ncl.ac.uk	0	0		
1369	chr2	102789473	102789497	3500349145	24		102789473	102789497	8421504	1	24	0	c	350034914500000272	8-32						Novel Human Beta-2 Integrin Alpha Subunit 	.freshpatents.com	0	0		
1369	chr2	102789473	102789497	3500247922	24		102789473	102789497	8421504	1	24	0	c	350024792200000274	8-32						Human B2 integrin alpha subunit antibodies	Gallatin	1996	0		
1372	chr2	103198154	103198186	3500366400	26		103198154	103198186	8421504	3	7,3,16	0,8,16	g	350036640000000103	0-26						Methods for creating transgenic animals	www.devileye.net	0	0		
1377	chr2	103936789	103936812	3500025494	23		103936789	103936812	8421504	1	23	0	g	350002549400000146	24-47						ERBB3 Mutations In Cancer - Patent application	www.faqs.org	0	0		
1381	chr2	104367663	104367689	3500464472	24		104367663	104367689	8421504	2	9,15	0,11	g	350046447200000052	0-24						CARACTERIZACI&#xd3;N DE GENES CANDIDATOS PARA CARACTERES LIP&#xcd;DICOS E IDENTIFICACI&#xd3;N DE COPY NUMBER VARIATION EN UNA POBLACI&#xd3;N PORCINA DUROC	www.tdx.cat	0	0		
1381	chr2	104367663	104367689	3500081530	24		104367663	104367689	8421504	2	9,15	0,11	g	350008153000000025	0-24						CAROLA TRINIDAD MELO ROJAS Dpto de Ciencia Animal y de los Alimentos UNIVERSIDAD AUT&#xd3;NOMA DE BARCELONA 2009	riunet.upv.es	0	0		
1381	chr2	104453489	104453519	3500325589	23		104453489	104453519	8421504	3	12,5,6	0,15,24	g	350032558900000022,350032558900000122	0-24,0-24						ATLASTIN - Patent application	www.faqs.org	0	0		
1383	chr2	104619303	104619327	3500193635	23		104619303	104619327	8421504	2	7,16	0,8	g	350019363500000284	2-25						Materials and methods for immunocontraception	Harris	1993	0		
1384	chr2	104753634	104753659	3500116045	24		104753634	104753659	8421504	2	17,7	0,18	g	350011604500000008	5-29						Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease	Progulske-fox	1994	0		
1385	chr2	104968545	104968571	3500020016	23		104968545	104968571	8421504	2	14,9	0,17	g	350002001600000034	0-23						US Patent # 7,172,893. Virus vectors and methods of making and administering the same - Patents.com	www.patents.com	0	0		
1388	chr2	105320911	105320938	3500235551	23		105320911	105320938	8421504	2	8,15	0,12	g	350023555100000051	9-32					Patent	Production of L-glutamic acid by fermentation (Patent CN:100358999)	Zhong Song Gen 	2008	0		
1388	chr2	105320911	105320938	3500096256	23		105320911	105320938	8421504	2	8,15	0,12	g	350009625600000212	9-32						Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium	Zhao Cang Yang Zi 	2001	0		
1388	chr2	105330405	105354178	3500175973	39		105330405	105354178	8421504	3	20,6,13	0,23749,23760	g	350017597300000123,350017597300000083	11-31,12-31					Patent	DNA encoding the Canine coronavirus spike protein (Patent US:5661006)	Brown	1997	0		
1393	chr2	105933271	105933296	3500017844	23		105933271	105933296	8421504	2	17,6	0,19	g	350001784400000020	9-33						FGF21 MUTANTS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1394	chr2	106065016	106065041	3500333669	23		106065016	106065041	8421504	2	15,8	0,17	g	350033366900000566	9-32						Transgenic Animal With Enhanced Immune Response And Method For The Preparation Thereof 	.freshpatents.com	0	0		
1400	chr2	106924519	106924549	3500388920	25		106924519	106924549	8421504	3	13,5,7	0,14,23	g	350038892000000181	22-48						Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof	Cochran	1996	0		
1403	chr2	107307267	107307372	3500041679	105		107307267	107307372	8421504	1	105	0	c	350004167900000021	0-105						The Amino Acid Sequence of a Glutamic Acid-Rich Protein from Bovine Retina as Deduced from the cDNA Sequence	www.jstor.org	0	0		
1404	chr2	107380997	107385904	3500431172	23		107380997	107385904	8421504	2	4,19	0,4888	c	350043117200000037,350043117200000102	7-30,7-28						 Recombinant Attenuated Dengue Viruses Comprising A Deletion In The 3' Untranslated Region And Additional Attenuating Mutations Induced By Chemical Mutagenesis 	www.docstoc.com	0	0		
1405	chr2	107591115	107591141	3500003533	23		107591115	107591141	8421504	2	9,14	0,12	g	350000353300000009	5-28						US Patent # 6,261,561. Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens - Patents.com	www.patents.com	0	0		
1406	chr2	107615838	107616882	3500175103	147		107615838	107616882	8421504	2	36,111	0,933	p	350017510300015004	0-147						Temperatursynchronisation der circadianen Uhr von Drosophila melanogaster Eine genetische und molekulare Untersuchung beteiligter Mechanismen und Rezeptoren.	uni-regensburg.de	0	0		PRRC2C
1408	chr2	107873732	107873777	3500173359	45		107873732	107873777	8421504	1	45	0	p	350017335900015005	0-45						NUCLEOTIDE SEQUENCE CODING FOR A FLAVIN-CONTAINING MONOOXYGENASE, CORRESPONDING PROTEIN AND THEIR APPLICATIONS IN THE FIELDS OF DIAGNOSIS AND THERAPY - Genset	www.sumobrain.com	0	0		FMO4
21	chr2	108002123	108028162	3500075098	1798		108002123	108028162	8421504	13	50,240,640,74,24,147,67,170,48,144,144,39,11	0,98,363,1004,3620,3689,3884,8750,10095,10675,13585,25294,26028	c,g	350007509800000073,350007509800000073,350007509800000071,350007509800000071,350007509800000070,350007509800000069,350007509800000037,350007509800000036,350007509800000067,350007509800000039,350007509800000034,350007509800000062,350007509800000032,350007509800000061,350007509800000031,350007509800000060,350007509800000030,350007509800000028,350007509800000057,350007509800000076,350007509800000076,350007509800000010,350007509800000010,350007509800000056,350007509800000027,350007509800000055,350007509800000026,350007509800000054,350007509800000009,350007509800000075,350007509800000051,350007509800000049,350007509800000048,350007509800000047,350007509800000015,350007509800000002,350007509800000024,350007509800000045,350007509800000023,350007509800000044,350007509800000040	0-50,0-50,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-714,0-24,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-24,0-24,0-24,0-24,0-48,0-48,0-48,0-48,0-48,0-21,0-21,0-48,0-48,0-48,0-48,0-27,0-23,0-45,0-48,0-48,0-48,0-50						Detection of Mutations - Patent application	www.faqs.org	0	0		
1409	chr2	108010878	108015735	3500188635	72		108010878	108015735	8421504	3	24,21,27	0,126,4830	c,g	350018863500000010,350018863500000010,350018863500000009,350018863500000002	0-24,0-24,0-21,0-27						Detection of mutations	Lunden	2003	0		
1409	chr2	108010878	108015735	3500080390	72		108010878	108015735	8421504	3	24,21,27	0,126,4830	c,g	350008039000000010,350008039000000010,350008039000000009,350008039000000002	0-24,0-24,0-21,0-27						ANonsenseMutationinthe FMO3 GeneUnderlies FishyOff-FlavorinCow&#x2019;sMilk	genome.cshlp.org	0	0		
1409	chr2	108010878	108011025	3500409332	45		108010878	108011025	8421504	2	24,21	0,126	c,g	350040933200000002,350040933200000002,350040933200000001	0-24,0-24,0-21		12466292	10.1101/gr.240202	1088-9051	Genome Research	A Nonsense Mutation in the FMO3 Gene Underlies Fishy Off-Flavor in Cow's Milk	Lunden	2002	14		
1411	chr2	108302896	108302926	3500218343	23		108302896	108302926	8421504	3	6,6,11	0,10,19	g	350021834300000041	4-28					Patent	Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides (Patent US:5817486)	Bauer	1998	0		
1413	chr2	108536340	108536368	3500275185	24		108536340	108536368	8421504	3	11,8,5	0,13,23	g	350027518500000002	7-31						Resistance to erythromycin of Staphylococcus spp. isolates from the	www.docstoc.com	0	0		
1414	chr2	108681230	108687430	3500155900	25		108681230	108687430	8421504	4	6,5,2,12	0,10,18,6188	c	350015590000000516	0-25						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
1415	chr2	108796162	108796192	3500020016	24		108796162	108796192	8421504	3	6,5,13	0,11,17	g	350002001600000105	9-35						US Patent # 7,172,893. Virus vectors and methods of making and administering the same - Patents.com	www.patents.com	0	0		
1416	chr2	108938948	108940370	3500022819	63		108938948	108940370	8421504	2	33,30	0,1392	c	350002281900000052,350002281900000056	15-48,0-30						Genomic Sequence Of The Purh Gene And Purh-related Biallelic Markers 	.freshpatents.com	0	0		
1416	chr2	108953501	108956707	3500331864	40		108953501	108956707	8421504	2	20,20	0,3186	c	350033186400000003,350033186400000002	11-31,11-31						Neural Tube Defects in Embryos of Diabetic Mice Role of the Pax-3 Gene and Apoptosis	betesjournals.org	0	0		
1416	chr2	108953993	109019528	3500119310	735		108953993	109019528	8421504	20	30,15,45,8,37,45,45,45,45,45,45,45,45,45,17,43,45,2,43,45	0,2654,2672,2753,3283,3323,51837,51885,53390,56912,59361,59409,62504,62552,62621,63838,63884,63968,65444,65490	p,c	350011931000015058,350011931000015057,350011931000015055,350011931000015054,350011931000015046,350011931000015045,350011931000015042,350011931000015039,350011931000015037,350011931000015036,350011931000015034,350011931000015033,350011931000000007,350011931000000028,350011931000015031,350011931000015030,350011931000015028,350011931000015027	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,10-31,10-31,0-45,0-45,0-45,0-45						CROSS- STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS- STRUCTURE, FOR MODULATING CROSS- STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS- STRUCTURE-MEDIATED TOXICITY - Patent application	www.faqs.org	0	0		
1416	chr2	108953993	109019528	3500044014	720		108953993	109019528	8421504	20	30,15,45,8,37,45,45,45,45,45,45,45,45,45,2,43,45,2,43,45	0,2654,2672,2753,3283,3323,51837,51885,53390,56912,59361,59409,62504,62552,62636,63838,63884,63968,65444,65490	p	350004401400015071,350004401400015070,350004401400015068,350004401400015067,350004401400015059,350004401400015058,350004401400015055,350004401400015052,350004401400015050,350004401400015049,350004401400015047,350004401400015046,350004401400015044,350004401400015043,350004401400015041,350004401400015040	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With	www.faqs.org	0	0		FN1
1416	chr2	108953993	108963463	3500095865	42		108953993	108963463	8421504	2	20,22	0,9448	c,g	350009586500000009,350009586500000009,350009586500000008,350009586500000008	0-20,0-20,0-22,0-22						Transforming Growth Factor- 2 Modulated Extracellular Matrix Component Expression in Cultured Human Optic Nerve Head Astrocytes	www.iovs.org	0	0		FN1
1416	chr2	108956753	108957298	3500465716	23		108956753	108957298	8421504	2	1,22	0,523	c	350046571600000004	0-23						TNF- a Suppresses a-Smooth Muscle Actin Expression in Human Dermal Fibroblasts: An Implication for Abnormal Wound Healing	www.lacusc.org	0	0		
1416	chr2	108957292	108957317	3500114630	25		108957292	108957317	8421504	1	25	0	c	350011463000000013	23-48						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
1416	chr2	108963754	108964783	3500452721	75		108963754	108964783	8421504	2	74,1	0,1028	p	350045272100015007,350045272100015002,350045272100015008	0-57,0-75,0-60						USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN - Patent application	www.faqs.org	0	0		FN1
1416	chr2	108963754	108964783	3500442548	75		108963754	108964783	8421504	2	74,1	0,1028	p	350044254800015001	0-75						Methods for Inhibition of Lymphangiogenesis and Tumor Metastasis	Varner	2007	0		FN1
1416	chr2	108963754	108964783	3500190607	75		108963754	108964783	8421504	2	74,1	0,1028	p	350019060700015001,350019060700015015	0-75,0-48						Methods for Inhibition of Lymphangiogenesis and Tumor Metastasis - Patent application	www.faqs.org	0	0		FN1
1416	chr2	108963754	108964783	3500127121	75		108963754	108964783	8421504	2	74,1	0,1028	p	350012712100015000	0-75		18927433	10.1182/blood-2008-05-158584	0006-4971	Blood	Integrin &#x03b1;v&#x03b2;3 on human endothelial cells binds von Willebrand factor strings under fluid shear stress	Huang	2009	10		FN1
1416	chr2	108963754	108964783	3500052713	75		108963754	108964783	8421504	2	74,1	0,1028	p	350005271300015002	0-75						&#x4e3b;&#x9898;&#xff1a;Integrin | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		FN1
1416	chr2	108963761	108963785	3500188488	24		108963761	108963785	8421504	1	24	0	c	350018848800000006	0-24						Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-?1 in normal human lung fibroblasts (NHLF)	biomedcentral.com	0	0		FN1
1416	chr2	108963761	108963785	3500170003	24		108963761	108963785	8421504	1	24	0	c	350017000300000006	0-24						Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-?1 in normal human lung fibroblasts (NHLF)	tory-research.com	0	0		FN1
1416	chr2	108963772	108970774	3500431901	60		108963772	108970774	8421504	2	30,30	0,6972	c	350043190100000001,350043190100000000	0-30,0-30		11251083	10.1091/mbc.12.3.725	1059-1524	Molecular Biology of the Cell	Mechanism in the Sequential Control of Cell Morphology and S Phase Entry by Epidermal Growth Factor Involves Distinct MEK/ERK Activations	Rescan	2001	5		
1416	chr2	108963772	108970774	3500049405	60		108963772	108970774	8421504	2	30,30	0,6972	c	350004940500000001,350004940500000000	0-30,0-30					Molecular Biology of the Cell	Mechanism in the Sequential Control of Cell Morphology and S Phase Entry by Epidermal Growth Factor Involves Distinct MEK/ERK Activations	ClauRescan	2001	0		
1416	chr2	108964783	108964828	3500385090	45		108964783	108964828	8421504	1	45	0	p	350038509000015008	0-45					Patent	Growth factor modified protein matrices for tissue engineering (Patent US:6894022)	Hubbell	2005	0		FN1
1416	chr2	108964783	108964828	3500347706	45		108964783	108964828	8421504	1	45	0	p	350034770600015008	0-45						Growth factor modified protein matrices for tissue engineering	Hubbell	2000	0		FN1
1416	chr2	108964783	108964828	3500338068	45		108964783	108964828	8421504	1	45	0	p	350033806800015000	6-51		18833295	10.1371/journal.ppat.1000169		PLoS Pathogens	Molecular Mechanisms Involved in Vascular Interactions of the Lyme Disease Pathogen in a Living Host	M.	2008	0		FN1
1416	chr2	108964783	108964828	3500203744	45		108964783	108964828	8421504	1	45	0	p	350020374400015004	9-54						Two-step error-prone bypass of the (+)- and (-)-trans-anti-BPDE-N2-dG adducts by human DNA polymerases eta and kappa. - ResearchGate	.researchgate.net	0	0		FN1
1416	chr2	108964783	108964828	3500188920	45		108964783	108964828	8421504	1	45	0	p	350018892000015009	0-45						Growth factor modified protein matrices for tissue engineering	Hubbell	2002	0		FN1
1416	chr2	108964828	108965990	3500242186	63		108964828	108965990	8421504	2	44,19	0,1143	p	350024218600015000	0-63						 <HTML> <HEAD><TITLE>aec1/2e!cae'>>aeSSaC/a1/4*a$? - c1ei1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4 | j-tok	www.j-tokkyo.com	0	0		FN1
1416	chr2	108965990	108966047	3500283855	57		108965990	108966047	8421504	1	57	0	p	350028385500015009	0-57					Patent	Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups (Patent US:7744912)	Hubbell	2010	0		FN1
1416	chr2	108965990	108966047	3500013096	57		108965990	108966047	8421504	1	57	0	p	350001309600015010,350001309600015030	0-57,0-45						 Biomaterials Formed By Nucleophilic Addition Reaction To Conjugated Unsaturated Groups 	www.docstoc.com	0	0		FN1
1416	chr2	108966068	108986074	3500291968	117		108966068	108986074	8421504	3	39,39,39	0,8165,19967	p	350029196800015001	363-480						Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene	Schlingensiepen	2001	0		FN1
1416	chr2	108966068	108986074	3500013462	117		108966068	108986074	8421504	3	39,39,39	0,8165,19967	p	350001346200015001	363-480						Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene - Patent application	www.faqs.org	0	0		FN1
1416	chr2	108966389	108967260	3500038908	84		108966389	108967260	8421504	2	68,16	0,855	p	350003890800015045	9-93						&#x57fa;&#x4e8e;&#x7ea4;&#x8fde;&#x86cb;&#x767d;iii&#x578b;&#x7ed3;&#x6784;&#x57df;&#x7684;&#x591a;&#x805a;&#x4f53;&#x652f;&#x67b6;	M*Ba Qia 	2012	0		
1416	chr2	108967356	108968297	3500093514	66		108967356	108968297	8421504	2	65,1	0,940	p	350009351400015004	0-66						Vectors and methods for gene transfer to cells	Wickham	1997	0		FN1
1416	chr2	108967356	108968297	3500034966	66		108967356	108968297	8421504	2	65,1	0,940	p	350003496600015003	0-66						Vectors and methods for gene transfer to cells	Wickham	2006	0		FN1
1416	chr2	108968349	108971718	3500308297	52		108968349	108971718	8421504	2	26,26	0,3343	c	350030829700000000,350030829700000001	0-26,0-26			10.1002/(SICI)1097-0215(19990730)82:3<449::AID-IJC20>3.0.CO;2-H	1097-0215	International Journal of Cancer	Role of fibroblasts in HGF/SF-induced cohort migration of human colorectal carcinoma cells: Fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-&#x03b2;1 - Shimao - 1999 - International Journal of Cancer - 	Shimao	1999	0		FN1
1416	chr2	108969210	108970758	3500432120	40		108969210	108970758	8421504	2	20,20	0,1528	c,g	350043212000000009,350043212000000009,350043212000000008	0-20,0-20,0-20						Therapeutics SKI-606 (Bosutinib) Blocks Prostate Cancer Invasion, Growth, and Metastasis In vitro and In vivo through Regulation of Genes Involved in Cancer Growth and Skeletal Metastasis	.aacrjournals.org	0	0		FN1
1416	chr2	108969254	108971693	3500397531	42		108969254	108971693	8421504	2	21,21	0,2418	c	350039753100000001,350039753100000000	0-21,0-21		18264122	10.1038/bjp.2008.26		British Journal of Pharmacology	Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway	J-M	2008	0		FN1
1416	chr2	108969393	108971608	3500119382	272		108969393	108971608	8421504	3	1,270,1	0,1181,2214	c	350011938200000003,350011938200000013,350011938200000012,350011938200000016,350011938200000008,350011938200000009,350011938200000010,350011938200000011,350011938200000002,350011938200000000,350011938200000014	7-33,3-275,3-275,7-33,3-273,0-255,3-171,0-168,7-30,7-30,7-30						Agents and methods based on the use of the eda domian of fibronectin - Patent application	www.faqs.org	0	0		FN1
1416	chr2	108970617	108970831	3500049760	73		108970617	108970831	8421504	3	20,29,24	0,86,190	c	350004976000000001,350004976000000002,350004976000000000	0-20,0-29,0-24						Reversal of TGF-&#x03b2;1 stimulation of &#x03b1;-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's - derived fibroblasts	biomedcentral.com	0	0		FN1
1416	chr2	108970726	108970827	3500210919	101		108970726	108970827	8421504	1	101	0	c	350021091900000013	0-101						Alternative Ribonucleic Acid Processing in Endocrine Systems	.endojournals.org	0	0		FN1
1416	chr2	108971620	108981154	3500299330	47		108971620	108981154	8421504	2	24,23	0,9511	c,g	350029933000000004,350029933000000005,350029933000000005	0-24,1-24,1-24						Clinical Impact of Germ Cell Tumor Cells in Apheresis Products of Patients Receiving High-Dose Chemotherapy	jco.ascopubs.org	0	0		
1416	chr2	108971620	108971644	3500414481	24		108971620	108971644	8421504	1	24	0	c	350041448100000004	0-24						mRNA Expression and Protein Distribution of Fibronectin Splice Variants and High-Molecular Weight Tenascin-C in Different Phases of Human Fracture Healing	www.cof.org.cn	0	0		
1416	chr2	108972537	108975026	3500263315	306		108972537	108975026	8421504	4	20,165,117,4	0,546,1662,2485	p	350026331500015003,350026331500015039,350026331500015004,350026331500015005,350026331500015047,350026331500015046	0-303,33-318,0-285,0-288,0-66,30-174						Compositions and methods for producing bioactive fusion proteins	Walker	2008	0		FN1
1416	chr2	108972537	108975026	3500236543	306		108972537	108975026	8421504	4	20,165,117,4	0,546,1662,2485	p	350023654300015010,350023654300015011,350023654300015063,350023654300015077,350023654300015062,350023654300015076	0-123,0-105,0-129,0-144,33-192,30-174					Patent	Compositions and methods for producing bioactive fusion proteins (Patent US:8420779)	Walker	2013	0		FN1
1416	chr2	108972537	108975026	3500227699	306		108972537	108975026	8421504	4	20,165,117,4	0,546,1662,2485	p	350022769900015010,350022769900015077,350022769900015063,350022769900015011,350022769900015062,350022769900015076	0-123,0-144,0-129,0-105,33-192,30-174						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		FN1
1416	chr2	108972537	108975026	3500004002	306		108972537	108975026	8421504	4	20,165,117,4	0,546,1662,2485	p	350000400200015005,350000400200015006,350000400200015007,350000400200015042,350000400200015049	0-303,0-285,0-288,33-321,30-318						COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS	Walker	2013	0		FN1
1416	chr2	108973084	108975023	3500405311	276		108973084	108975023	8421504	4	164,85,26,1	0,1115,1206,1938	p	350040531100015008	0-279						ADZYMES AND USES THEREOF - COMPOUND THERAPEUTICS, INC.	www.sumobrain.com	0	0		FN1
1416	chr2	108973084	108974299	3500165491	264		108973084	108974299	8421504	2	164,100	0,1115	p	350016549100015088,350016549100015067	0-114,0-183						Fc fusion proteins comprising novel linkers or arrangements	Camphausen	2012	0		FN1
1416	chr2	108973084	108973198	3500108333	111		108973084	108973198	8421504	2	24,87	0,27	p	350010833300015016	0-111						Trail r2-specific multimeric scaffolds	Baca	2013	0		
1416	chr2	108973087	108973177	3500100282	90		108973087	108973177	8421504	1	90	0	p	350010028200015000	0-90					Patent	Implants with attached silylated therapeutic agents (Patent EP:1673113)	Hickok	2010	0		FN1
1416	chr2	108973087	108973177	3500096363	90		108973087	108973177	8421504	1	90	0	p	350009636300015000	0-90						Implants with attached silylated therapeutic agents	Wickstrom	2006	0		FN1
1416	chr2	108973090	108973165	3500382280	75		108973090	108973165	8421504	1	75	0	p	350038228000015002	0-75						Methods for preparing synthetic repetitive dna	Cappello	1998	0		FN1
1416	chr2	108973096	108975023	3500375723	261		108973096	108975023	8421504	5	144,5,85,26,1	0,147,1103,1194,1926	p	350037572300015006	0-264						Adzymes and uses thereof	Afeyan	2006	0		FN1
1416	chr2	108973099	108973177	3500375876	78		108973099	108973177	8421504	1	78	0	p	350037587600015000	0-78						Implants with attached silylated therapeutic agents	Hickok	2006	0		FN1
1416	chr2	108973201	108974218	3500041628	66		108973201	108974218	8421504	2	47,19	0,998	p	350004162800015007	0-66						Cellular/Molecular ProcessingofNeuregulin-1byNeuropsinRegulates GABAergicNeurontoControlNeuralPlasticityoftheMouse Hippocampus	www.jneurosci.org	0	0		FN1
1416	chr2	108973213	108974206	3500351593	42		108973213	108974206	8421504	2	35,7	0,986	c	350035159300000012	0-42						Inhibitors of type 2 vascular endothelial growth factor receptors	Chen	2007	0		
1416	chr2	108973213	108974206	3500176890	42		108973213	108974206	8421504	2	35,7	0,986	c	350017689000000012,350017689000000009,350017689000000030	0-42,0-24,0-20						Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors 	.freshpatents.com	0	0		
1416	chr2	108974245	108974314	3500364661	66		108974245	108974314	8421504	2	21,45	0,24	p	350036466100015037	0-66						US Patent # 7,119,171. Binding polypeptides - Patents.com	www.patents.com	0	0		
1416	chr2	108974245	108974314	3500222850	66		108974245	108974314	8421504	2	18,48	0,21	p	350022285000015027	0-66						US Patent # 7,078,490. Artificial antibody polypeptides - Patents.com	www.patents.com	0	0		
1416	chr2	108978438	108981187	3500290531	114		108978438	108981187	8421504	2	2,112	0,2637	p	350029053100015012	0-114						&#x57fa;&#x4e8e;&#x2162;&#x578b;&#x7ea4;&#x8fde;&#x86cb;&#x767d;&#x7ed3;&#x6784;&#x57df;&#x7684;&#x652f;&#x67b6;&#x7ec4;&#x5408;&#x7269;&#x3001;&#x65b9;&#x6cd5;&#x53ca;&#x7528;&#x9014;	K*Ao Nai Er 	2012	0		
1416	chr2	108981089	108981114	3500040982	25		108981089	108981114	8421504	1	25	0	c	350004098200000017	0-25					Patent	Biomarkers and targets for diagnosis, prognosis and management of prostate disease (Patent US:5882864)	An	1999	0		
1416	chr2	108981232	108983694	3500119182	69		108981232	108983694	8421504	2	30,39	0,2423	p	350011918200015140	6-93						Structure for presenting desired peptide sequences	Houtzager	2003	0		FN1
1416	chr2	108992662	108992685	3500260964	23		108992662	108992685	8421504	1	23	0	c	350026096400000130	18-47						NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM FORAXELLA CATARRHALIS - Patent application	www.faqs.org	0	0		
1416	chr2	108994708	108994935	3500379004	40		108994708	108994935	8421504	3	12,8,20	0,104,207	c	350037900400000007,350037900400000006	0-20,0-20						Adaptation to High Grain Diets Proceeds Through Minimal Immune System Stimulation and Differences in Extracellular Matrix Protein Expression in A Model of Subacute Ruminal Acidosis in Non-lactating Dairy Cows	thescipub.com	0	0		
1416	chr2	108994708	108994935	3500249098	40		108994708	108994935	8421504	3	12,8,20	0,104,207	c,g	350024909800000005,350024909800000004,350024909800000004	0-20,0-20,0-20						A CHARACTERIZATION OF INFLAMMATORY AND STRUCTURAL MARKERS WITHIN THE RUMEN EPITHELIUM DURING GRAIN-INDUCED RUMINAL ACIDOSIS IN	thescipub.com	0	0		
1416	chr2	109007338	109013408	3500110641	98		109007338	109013408	8421504	2	45,53	0,6017	p,c	350011064100015049,350011064100015014,350011064100015050,350011064100000012,350011064100000005,350011064100015010	90-309,0-45,72-291,16-41,16-41,0-48						Conjugation Product - Patent application	www.faqs.org	0	0		FN1
1416	chr2	109019502	109019526	3500335598	24		109019502	109019526	8421504	1	24	0	c	350033559800000004	0-24		23236489	10.1371/journal.pone.0051371	1932-6203	PLOS ONE	PLOS ONE: Col1A1 Production and Apoptotic Resistance in TGF-&#x03b2;1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells	Liu	2012	4		FN1
1416	chr2	109019502	109019526	3500203357	24		109019502	109019526	8421504	1	24	0	c	350020335700000004	0-24		23236489	10.1371/journal.pone.0051371		PLoS ONE	Col1A1 Production and Apoptotic Resistance in TGF-&#x03b2;1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells	Jun	2012	0		FN1
1416	chr2	109019516	109019564	3500114630	48		109019516	109019564	8421504	1	48	0	c	350011463000000009	0-48						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
1418	chr2	109257598	109257624	3500388918	23		109257598	109257624	8421504	2	16,7	0,19	g	350038891800000058	1-24						Polypeptide Mutagenesis Method - Patent application	www.faqs.org	0	0		
1422	chr2	109723943	109755768	3500152228	39		109723943	109755768	8421504	2	19,20	0,31805	g	350015222800000357,350015222800000163	10-29,19-39						Detection of nucleic acids by multiple sequential invasive cleavages	Hall	1997	0		
1425	chr2	110151267	110201453	3500421648	2857		110151267	110201453	8421504	21	802,51,240,51,61,117,151,159,36,23,141,124,94,71,103,50,38,93,102,97,253	0,1410,5647,8721,16290,16360,18880,19924,21711,21754,28791,32264,32389,39152,43104,44498,44549,44588,45708,46763,49933	p,c,g	350042164800000083,350042164800000092,350042164800000087,350042164800015021,350042164800015023,350042164800000011,350042164800000011,350042164800015024,350042164800000055,350042164800000055,350042164800000010,350042164800000010,350042164800015026,350042164800015027,350042164800000021,350042164800015028,350042164800015029,350042164800000012,350042164800000012,350042164800015033,350042164800015034,350042164800015006,350042164800015007,350042164800015080,350042164800015036,350042164800015081,350042164800015037,350042164800000017,350042164800015082,350042164800015038,350042164800015003,350042164800015039,350042164800015084,350042164800015085,350042164800015041,350042164800015086,350042164800015042,350042164800015087,350042164800015043,350042164800015044,350042164800000013,350042164800000013,350042164800015089,350042164800015090,350042164800015046,350042164800000088,350042164800000093,350042164800015091,350042164800015047,350042164800015092,350042164800015048,350042164800015049,350042164800015094,350042164800000091,350042164800000091,350042164800015125,350042164800015095,350042164800015126,350042164800015051,350042164800000040,350042164800000040,350042164800015096,350042164800015127,350042164800015052,350042164800015097,350042164800015128,350042164800015053,350042164800015054,350042164800015099,350042164800015130,350042164800015100,350042164800015131,350042164800015056,350042164800015001,350042164800015011,350042164800015134,350042164800015101,350042164800015132,350042164800015057,350042164800015000,350042164800000095,350042164800015008,350042164800015102,350042164800000090,350042164800015124,350042164800000026,350042164800000026,350042164800000025,350042164800000025,350042164800015058,350042164800015135,350042164800015059,350042164800015136,350042164800015104,350042164800015105,350042164800015061,350042164800015138,350042164800015106,350042164800000097,350042164800000094,350042164800015062,350042164800015139,350042164800015107,350042164800015063,350042164800015140,350042164800000032,350042164800000032,350042164800015005,350042164800015160,350042164800015016,350042164800015064,350042164800015141,350042164800015109,350042164800015110,350042164800015163,350042164800000089,350042164800000096,350042164800015067,350042164800015144,350042164800015112,350042164800015164,350042164800015068,350042164800015145,350042164800015069,350042164800015146,350042164800015114,350042164800015115,350042164800015071,350042164800015148,350042164800015116,350042164800015168,350042164800015072,350042164800015149,350042164800015117,350042164800015073,350042164800015150,350042164800015074,350042164800015151,350042164800015119,350042164800015120,350042164800000038,350042164800015076,350042164800015153,350042164800015121,350042164800015077,350042164800000037,350042164800000037,350042164800015154,350042164800015122,350042164800015078,350042164800000039,350042164800000005,350042164800000050	9-30,185-1390,0-1193,0-45,0-45,0-19,0-19,0-45,0-21,0-21,0-20,0-20,0-45,0-45,0-20,0-45,0-45,0-21,0-21,0-45,0-45,0-60,0-60,0-45,0-45,0-45,0-45,0-21,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-20,0-20,0-45,0-45,0-45,1-954,0-1611,0-45,0-45,0-45,0-45,0-45,0-45,0-430,0-430,0-45,0-45,0-45,0-45,0-19,0-19,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-51,0-45,0-45,0-45,0-45,0-45,0-102,0-440,0-45,0-45,0-59,0-45,0-20,0-20,0-21,0-21,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,197-892,241-936,0-45,0-45,0-45,0-45,0-45,0-21,0-21,0-54,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-665,0-505,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-21,0-45,0-45,0-45,0-45,0-21,0-21,0-45,0-45,0-45,0-21,10-31,0-21						Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives	Hockensmith	2000	0		
1425	chr2	110151268	110201453	3500022202	2855		110151268	110201453	8421504	21	801,51,240,51,61,117,151,159,36,23,141,124,94,71,103,89,4,88,101,97,253	0,1409,5646,8720,16289,16359,18879,19923,21710,21753,28790,32263,32388,39151,43103,44497,44587,44592,45707,46762,49932	p,c,g	350002220200000084,350002220200000089,350002220200000039,350002220200015032,350002220200015034,350002220200000012,350002220200015035,350002220200000011,350002220200015037,350002220200015038,350002220200000021,350002220200015039,350002220200015040,350002220200000013,350002220200015044,350002220200015045,350002220200015016,350002220200015017,350002220200015091,350002220200015047,350002220200015092,350002220200015048,350002220200000017,350002220200015093,350002220200015049,350002220200015013,350002220200015050,350002220200015095,350002220200015096,350002220200015052,350002220200015097,350002220200015053,350002220200015098,350002220200015054,350002220200015055,350002220200000014,350002220200015100,350002220200015101,350002220200015057,350002220200000085,350002220200000090,350002220200015102,350002220200015058,350002220200015103,350002220200015059,350002220200015060,350002220200015105,350002220200000088,350002220200000088,350002220200015136,350002220200015106,350002220200015137,350002220200015062,350002220200000038,350002220200000038,350002220200015107,350002220200015138,350002220200015063,350002220200015108,350002220200015139,350002220200015064,350002220200015065,350002220200015110,350002220200015141,350002220200015111,350002220200015142,350002220200015067,350002220200015011,350002220200015022,350002220200015145,350002220200015112,350002220200015143,350002220200015068,350002220200015010,350002220200000092,350002220200015019,350002220200015113,350002220200000087,350002220200015135,350002220200000026,350002220200000026,350002220200015069,350002220200000025,350002220200015146,350002220200015070,350002220200015147,350002220200015115,350002220200015116,350002220200015072,350002220200015149,350002220200015117,350002220200000091,350002220200000094,350002220200015073,350002220200015150,350002220200015118,350002220200015074,350002220200015151,350002220200000032,350002220200000032,350002220200015015,350002220200015171,350002220200015027,350002220200015075,350002220200015152,350002220200015120,350002220200015121,350002220200015174,350002220200000086,350002220200000093,350002220200015078,350002220200015155,350002220200015123,350002220200015175,350002220200015079,350002220200015156,350002220200015080,350002220200015157,350002220200015125,350002220200015126,350002220200015082,350002220200015159,350002220200015127,350002220200015179,350002220200015083,350002220200015160,350002220200015128,350002220200015084,350002220200015161,350002220200015085,350002220200015162,350002220200015130,350002220200015131,350002220200000036,350002220200015087,350002220200015164,350002220200015132,350002220200015088,350002220200000035,350002220200015165,350002220200015133,350002220200015089,350002220200000037	0-1200,185-1390,10-30,0-45,0-45,0-19,0-45,0-21,0-45,0-45,0-20,0-45,0-45,0-21,0-45,0-45,0-60,0-60,0-45,0-45,0-45,0-45,0-21,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-20,0-45,0-45,0-45,1-970,0-1611,0-45,0-45,0-45,0-45,0-45,0-45,0-430,0-430,0-45,0-45,0-45,0-45,0-19,0-19,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-51,0-45,0-45,0-45,0-45,0-45,0-102,0-440,0-45,0-45,0-59,0-45,0-20,0-20,0-45,0-21,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,241-936,197-892,0-45,0-45,0-45,0-45,0-45,0-21,0-21,0-54,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-676,0-505,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-21,0-45,0-45,0-45,0-45,0-21,0-45,0-45,0-45,0-21						Polynucleotides encoding mammalian DNA-dependent ATPase A polypeptides	Hockensmith	2000	0		
1425	chr2	110151394	110201413	3500211491	457		110151394	110201413	8421504	17	19,20,21,84,15,6,45,20,19,12,39,27,26,36,21,21,26	0,185,295,515,660,1283,5522,8610,18883,21638,28664,28736,32330,39025,49832,49891,49993	p,c,g	350021149100000012,350021149100000022,350021149100000013,350021149100015022,350021149100015023,350021149100000018,350021149100015019,350021149100000014,350021149100000041,350021149100000041,350021149100015017,350021149100000027,350021149100000027,350021149100000026,350021149100000033,350021149100015021,350021149100000039,350021149100000038,350021149100000040,350021149100000006	0-19,0-20,0-21,0-60,0-60,0-21,0-45,0-20,0-19,0-19,0-51,0-20,0-20,0-21,0-21,0-54,0-21,0-21,0-21,10-31						US Patent # 6,180,612. Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives - Patents.com	www.patents.com	0	0		
1425	chr2	110210230	110210253	3500068155	23		110210230	110210253	8421504	1	23	0	g	350006815500000065	25-48						AMPLIFICATION DYNAMICS OF PRIMATE RETROTRANSPOSONS	etd.lsu.edu	0	0		
1425	chr2	110217448	110217478	3500104252	30		110217448	110217478	8421504	1	30	0	c	350010425200000004	9-39						Method for Isolating Cell-Type Specific mRNAS - Patent application	www.faqs.org	0	0		
1427	chr2	110370872	110404727	3500315971	131		110370872	110404727	8421504	6	26,19,19,45,9,13	0,173,1292,18892,18983,33842	c,g	350031597100000042,350031597100000043,350031597100000010,350031597100000011,350031597100000011,350031597100000048,350031597100000049,350031597100000016	19-45,0-26,0-19,0-19,0-19,0-45,0-45,0-22						REPRODUCTION	uction-online.org	0	0		
1427	chr2	110370924	110389825	3500126808	63		110370924	110389825	8421504	3	21,19,23	0,52,18878	c,g	350012680800000022,350012680800000023,350012680800000023,350012680800000027	0-21,0-19,0-19,0-23						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
1427	chr2	110371045	110404727	3500248474	60		110371045	110404727	8421504	4	19,19,9,13	0,1119,18810,33669	c,g	350024847400000006,350024847400000006,350024847400000007,350024847400000012	0-19,0-19,0-19,0-22						REPRODUCTION	uction-online.org	0	0		
1427	chr2	110371045	110404727	3500024081	60		110371045	110404727	8421504	4	19,19,9,13	0,1119,18810,33669	c,g	350002408100000010,350002408100000010,350002408100000011,350002408100000016	0-19,0-19,0-19,0-22						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
1427	chr2	110372213	110404758	3500159827	82		110372213	110404758	8421504	4	22,21,19,20	0,2298,17583,32525	c,g	350015982700000004,350015982700000005,350015982700000007,350015982700000007,350015982700000006,350015982700000006	0-22,0-21,0-19,0-19,0-20,0-20						Microarray Analysis on the Differences in Gene Expression Related t	docsdrive.com	0	0		
1427	chr2	110372221	110389262	3500454815	273		110372221	110389262	8421504	4	45,93,90,45	0,2241,14488,16996	p	350045481500015077,350045481500015074	0-138,0-135						Insulin-Like Growth Factor Binding Protein-4 Compounds and Methods for Inhibiting Angiogenesis and Tumor Growth in Mammalian Cells - Patent application	www.faqs.org	0	0		IGFBP2,IGFBP5
1427	chr2	110372232	110374508	3500249582	40		110372232	110374508	8421504	2	21,19	0,2257	c	350024958200000012,350024958200000013	0-21,0-19		12134042	10.1128/JVI.76.16.8383-8399.2002	0022-538X	Journal of Virology	Kaposi's Sarcoma-Associated Herpesvirus-Induced Upregulation of the c-kit Proto-Oncogene, as Identified by Gene Expression Profiling, Is Essential for the Transformation of Endothelial Cells	Moses	2002	5		IGFBP2
1427	chr2	110372240	110404854	3500344201	39		110372240	110404854	8421504	2	20,19	0,32595	c	350034420100000004,350034420100000007	19-39,0-19						Effects of Milk Replacer Composition on Measures of Mammary Development in Holstein Heifer Calves Kristy Marie Daniels	cholar.lib.vt.edu	0	0		
1427	chr2	110372240	110404854	3500186308	39		110372240	110404854	8421504	2	20,19	0,32595	c	350018630800000014,350018630800000017	19-39,0-19						EFFECTS OF GROWTH HORMONE AND INSULIN-LIKE GROWTH FACTOR-I ON MILK PROTEIN GENE EXPRESSION AND NUTRIENT UPTAKE AND CELL PROLIFERATION IN CLONAL BOVINE MAMMARY EPITHELIAL CELLS	cholar.lib.vt.edu	0	0		
1427	chr2	110372240	110404728	3500202638	94		110372240	110404728	8421504	5	24,23,24,9,14	0,2328,17480,17615,32474	c,g	350020263800000006,350020263800000007,350020263800000007,350020263800000013,350020263800000012	0-24,0-23,0-23,0-24,0-23						EXPRESS&#xc3;O G&#xca;NICA EM FOL&#xcd;CULOS E TECIDO OVARIANO DURANTE O CICLO ESTRAL DE SU&#xcd;NOS	www.tede.ufv.br	0	0		IGFBP2,IGFBP5
1427	chr2	110372240	110404728	3500021304	94		110372240	110404728	8421504	5	24,23,24,9,14	0,2328,17480,17615,32474	c,g	350002130400000006,350002130400000007,350002130400000007,350002130400000013,350002130400000012	0-24,0-23,0-23,0-24,0-23						EXPRESS&#xc3;O G&#xca;NICA EM FOL&#xcd;CULOS E TECIDO OVARIANO DURANTE O CICLO ESTRAL DE SU&#xcd;NOS	www.tede.ufv.br	0	0		IGFBP2,IGFBP5
1427	chr2	110374465	110374592	3500217315	50		110374465	110374592	8421504	2	24,26	0,101	c	350021731500000047,350021731500000048	0-24,0-26						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		IGFBP2
1427	chr2	110386667	110386697	3500042956	30		110386667	110386697	8421504	1	30	0	c,g	350004295600000001,350004295600000001,350004295600000003,350004295600000003	0-30,0-30,12-40,12-40						BMC Cancer BioMed Central	biomedcentral.com	0	0		IGFBP5
1427	chr2	110386667	110386691	3500324166	24		110386667	110386691	8421504	1	24	0	c,g	350032416600000002,350032416600000002	0-24,0-24						World Journal of Gastroenterology	www.wjgnet.com	0	0		IGFBP5
1427	chr2	110386667	110386691	3500206887	24		110386667	110386691	8421504	1	24	0	c,g	350020688700000002,350020688700000002	0-24,0-24						World Journal of Gastroenterology	www.wjgnet.com	0	0		IGFBP5
1427	chr2	110386667	110386691	3500198317	24		110386667	110386691	8421504	1	24	0	c,g	350019831700000003,350019831700000003	0-24,0-24		20955597	10.1186/1471-2407-10-562	1471-2407	BMC Cancer	Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis	Reeves	2010	3		IGFBP5
1427	chr2	110386667	110386691	3500195196	24		110386667	110386691	8421504	1	24	0	c,g	350019519600000003,350019519600000003	0-24,0-24						Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis. - ResearchGate	.researchgate.net	0	0		IGFBP5
1427	chr2	110386748	110404856	3500150528	185		110386748	110404856	8421504	4	51,45,41,48	0,2469,2521,18060	c	350015052800000046,350015052800000065,350015052800000045,350015052800000044,350015052800000055	0-48,0-48,0-48,0-41,0-48						Anti-igf-1r Antibodies And Uses Thereof 	.freshpatents.com	0	0		
1427	chr2	110386771	110389245	3500446973	56		110386771	110389245	8421504	2	28,28	0,2446	p,c	350044697300000050,350044697300000051,350044697300000016,350044697300000017,350044697300015004	4-60,5-61,4-60,5-61,0-54						BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE - Patent application	www.faqs.org	0	0		IGFBP5
1427	chr2	110386771	110389245	3500408909	56		110386771	110389245	8421504	2	28,28	0,2446	p,c	350040890900000017,350040890900000016,350040890900015004	5-60,4-60,0-54					Patent	Bone delivery conjugates and method of using same to target proteins to bone (Patent US:7763712)	Crine	2010	0		IGFBP5
1427	chr2	110386771	110389245	3500405045	56		110386771	110389245	8421504	2	28,28	0,2446	p,c	350040504500000017,350040504500000016,350040504500015004	5-61,4-60,0-54						Bone delivery conjugates and method of using same to target proteins to bone	Crine	2010	0		IGFBP5
1427	chr2	110386771	110389245	3500400271	56		110386771	110389245	8421504	2	28,28	0,2446	p,c	350040027100000017,350040027100000016,350040027100015003	5-61,4-60,0-54						Bone delivery conjugates and method of using same to target proteins to bone	Crine	2010	0		IGFBP5
1427	chr2	110386771	110389245	3500332199	56		110386771	110389245	8421504	2	28,28	0,2446	p,c	350033219900000016,350033219900000017,350033219900015004	4-60,5-60,0-54						Bone delivery conjugates and method of using same to target proteins to bone	Crine	2006	0		IGFBP5
1427	chr2	110386771	110389245	3500122566	56		110386771	110389245	8421504	2	28,28	0,2446	p,c	350012256600000017,350012256600000016,350012256600015004	5-61,4-60,0-54					Patent	Bone delivery conjugates and method of using same to target proteins to bone (Patent US:7960529)	Crine	2011	0		IGFBP5
1427	chr2	110389238	110389286	3500462088	48		110389238	110389286	8421504	1	48	0	c	350046208800000062	0-48						Insulin-like growth factor binding protein	Ling	1992	0		
1427	chr2	110464174	110464201	3500449315	23		110464174	110464201	8421504	3	5,13,5	0,6,22	g	350044931500000085	3-28						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
1429	chr2	110631905	110632436	3500359799	41		110631905	110632436	8421504	2	21,20	0,511	c,g	350035979900000009,350035979900000008,350035979900000008	0-21,0-20,0-20						Sequencing primers and SNPs for rapidly evolving reproductive loci in endangered ibex and their kin (Bovidae, Capra spp.) - ResearchGate	.researchgate.net	0	0		
1429	chr2	110631905	110632436	3500270029	41		110631905	110632436	8421504	2	21,20	0,511	c,g	350027002900000009,350027002900000008,350027002900000008	0-21,0-20,0-20						Sequencing primers and SNPs for rapidly evolving reproductive loci in endangered ibex and their kin (Bovidae, Capra spp	taff.bucknell.edu	0	0		
1430	chr2	110834316	110834342	3500143098	24		110834316	110834342	8421504	3	7,13,4	0,8,22	g	350014309800000236	21-47						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS - Patent application	www.faqs.org	0	0		
1436	chr2	111612094	111612120	3500360661	26		111612094	111612120	8421504	1	26	0	g	350036066100000147	16-42						 Isoprenoid Biosynthesis 	www.docstoc.com	0	0		
1439	chr2	112037810	112037838	3500286453	23		112037810	112037838	8421504	2	15,8	0,20	g	350028645300000020,350028645300000105	4-31,4-31						Interleukin-1 Conjugates and Uses Thereof - Patent application	www.faqs.org	0	0		
1440	chr2	112118010	112143320	3500088096	60		112118010	112143320	8421504	3	20,20,20	0,206,25290	c,g	350008809600000002,350008809600000002,350008809600000001,350008809600000001,350008809600000000,350008809600000000	0-20,0-20,0-20,0-20,0-20,0-20						Differential Neutrophil Function and Intracellular Signaling in Dairy Cows with Specific CXCR1 Genotypes	ace.tennessee.edu	0	0		
1440	chr2	112118327	112118423	3500173819	93		112118327	112118423	8421504	2	48,45	0,51	p	350017381900015115	9-102						MCP-1 receptor antibodies - Patent # 7105641 - PatentGenius	.patentgenius.com	0	0		
1440	chr2	112118520	112143734	3500265613	81		112118520	112143734	8421504	4	20,20,20,21	0,203,24776,25193	c,g	350026561300000004,350026561300000005,350026561300000003,350026561300000002	0-20,0-20,0-20,0-21						&#x5229;&#x7528;&#x591a;&#x56e0;&#x5b50;&#x964d;&#x7ef4;&#x6cd5;&#x7814;&#x7a76;CXCR1 &#x548c;IL-8 &#x57fa;&#x56e0;&#x4ea4;&#x4e92;&#x4f5c;&#x7528;&#x4e0e;&#x4e2d;&#x56fd;&#x8377;&#x65af;&#x5766;&#x725b;&#x4e73;&#x623f;&#x708e;&#x7684;&#x5173;&#x7cfb; - &	www.docin.com	0	0		
1440	chr2	112118800	112142819	3500298058	40		112118800	112142819	8421504	2	20,20	0,23999	c,g	350029805800000012,350029805800000011,350029805800000011	0-20,0-20,0-20						Arkansas Animal Science	asagnews.uark.edu	0	0		
1440	chr2	112142342	112142365	3500327497	23		112142342	112142365	8421504	1	23	0	c	350032749700000026	0-23						Methods for treating inflammatory disorders	Chuntharapai	1994	0		
1440	chr2	112142396	112142420	3500254105	24		112142396	112142420	8421504	1	24	0	c	350025410500000012	0-24						Assays for Allosteric Modulators of G-Protein Coupled Receptors (GPCRs) - Patent application	www.faqs.org	0	0		
1440	chr2	112142508	112142819	3500081431	40		112142508	112142819	8421504	2	20,20	0,291	c,g	350008143100000002,350008143100000002,350008143100000001,350008143100000001	0-20,0-20,0-20,0-20						The chemokine receptor 1 gene polymorphism and its association with Somatic Cell Score and milk production traits in dairy cattle*	www.ighz.edu.pl	0	0		
1440	chr2	112142536	112142932	3500246343	149		112142536	112142932	8421504	3	53,54,42	0,54,354	c	350024634300000021,350024634300000048,350024634300000070,350024634300000047,350024634300000041	0-48,7-45,0-48,0-48,0-42						Interleukin-8 receptors and related molecules and methods	Navarro	1992	0		
1440	chr2	112176690	112176719	3500032299	24		112176690	112176719	8421504	2	18,6	0,23	g	350003229900000005	0-24			10.1128/JVI.75.5.2119-2129.2001		Journal of Virology	Self-Assembly of Nucleocapsid-Like Particles from Recombinant Hepatitis C Virus Core Protein	Meghan	2001	0		
1441	chr2	112218641	112219633	3500343610	957		112218641	112219633	8421504	9	62,115,357,115,55,116,54,56,27	0,67,185,547,667,727,848,906,965	p,c	350034361000000033,350034361000015079,350034361000000031,350034361000015081,350034361000015083,350034361000015084,350034361000000011,350034361000000012,350034361000015085,350034361000000014,350034361000000016,350034361000015088,350034361000000034	0-29,0-45,0-913,0-48,0-48,0-228,0-41,0-47,0-72,0-45,13-42,0-45,2-29						US Patent # 7,354,726. Screening method - Patents.com	www.patents.com	0	0		
1441	chr2	112218706	112218983	3500202402	41		112218706	112218983	8421504	2	20,21	0,256	c,g	350020240200000011,350020240200000011,350020240200000012	0-20,0-20,0-21		19926617	10.1136/gut.2009.188375		Gut	Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma	Jie	2010	0		GPBAR1
1441	chr2	112225443	112225486	3500310637	43		112225443	112225486	8421504	1	43	0	c,g	350031063700000000,350031063700000000,350031063700000006,350031063700000006,350031063700000009,350031063700000009,350031063700000008,350031063700000008	0-24,0-24,0-24,0-24,0-21,0-21,0-19,0-19						METHODS FOR DIAGNOSING EPISODIC MOVEMENT DISORDERS AND RELATED CONDITIONS - Patent application	www.faqs.org	0	0		PNKD
1441	chr2	112225450	112226281	3500416239	43		112225450	112226281	8421504	3	22,9,12	0,59,819	c	350041623900000002,350041623900000000,350041623900000004	9-31,0-21,0-21		16100249	10.1152/ajpheart.00247.2005		American Journal of Physiology - Heart and Circulatory Physiology	Role of myofibrillogenesis regulator-1 in myocardial hypertrophy	Liu	2006	0		
1441	chr2	112225450	112226281	3500188173	43		112225450	112226281	8421504	3	22,9,12	0,59,819	c	350018817300000002,350018817300000000,350018817300000004	9-31,0-21,0-21		16100249	10.1152/ajpheart.00247.2005		American Journal of Physiology - Heart and Circulatory Physiology	Role of myofibrillogenesis regulator-1 in myocardial hypertrophy	Liu	2006	0		PNKD
1441	chr2	112231470	112231832	3500242436	44		112231470	112231832	8421504	2	3,41	0,321	c	350024243600000093,350024243600000094	0-43,0-44						Novel polypeptides and nucleic acids encoding same	Burgess	2002	0		
1441	chr2	112292204	112292228	3500310637	24		112292204	112292228	8421504	1	24	0	c	350031063700000001,350031063700000007	0-24,0-24						METHODS FOR DIAGNOSING EPISODIC MOVEMENT DISORDERS AND RELATED CONDITIONS - Patent application	www.faqs.org	0	0		PNKD
1441	chr2	112298128	112298156	3500289772	23		112298128	112298156	8421504	2	10,13	0,15	c	350028977200000002	22-45					Patent	Cloning, expression and uses of dorsalin-1 (Patent US:6333168)	Jessell	2001	0		
1441	chr2	112298128	112298156	3500281862	23		112298128	112298156	8421504	2	10,13	0,15	c	350028186200000002	22-45					Patent	Dorsalin-1 polypeptide and uses thereof (Patent US:6916913)	Jessell	2005	0		
1441	chr2	112298128	112298156	3500126611	23		112298128	112298156	8421504	2	10,13	0,15	c	350012661100000002	22-45						Cloning, expression and uses of dorsalin-1	Basler	2002	0		
180	chr2	112319510	112330436	3500258129	2275		112319510	112330436	8421504	16	80,134,123,120,107,71,68,156,159,90,120,20,150,74,154,649	0,620,1783,2216,3442,3972,4383,4860,5629,7139,7370,7528,7899,9525,9989,10277	c,g	350025812900000095,350025812900000081,350025812900000096,350025812900000025,350025812900000122	0-2255,0-2255,0-2255,0-20,0-20						Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases - Patent application	www.faqs.org	0	0		
180	chr2	112319544	112330035	3500104303	41		112319544	112330035	8421504	2	19,22	0,10469	c	350010430300000001,350010430300000007	0-19,19-41						Molecular characterization of the NRAMP1 gene in buffalo	jas.pagepress.org	0	0		
1441	chr2	112320221	112327419	3500058897	324		112320221	112327419	8421504	10	30,48,78,10,16,29,26,44,33,10	0,1072,1547,2731,3316,3672,4212,4966,6746,7188	c	350005889700000128,350005889700000129,350005889700000049,350005889700000207,350005889700000133,350005889700000050,350005889700000054,350005889700000140,350005889700000024,350005889700000060,350005889700000066	5-35,0-48,0-48,0-48,0-47,0-40,0-45,24-48,12-38,0-44,0-43						Methods of screening for compounds that regulate the level of Nramp	Gros	2000	0		
1441	chr2	112321293	112324459	3500159886	119		112321293	112324459	8421504	4	48,16,29,26	0,2244,2600,3140	c	350015988600000129,350015988600000054,350015988600000024	0-48,0-45,12-38						 Methods Of Screening For Compounds That Regulate The Level Of Nramp 	www.docstoc.com	0	0		
180	chr2	112321372	112329945	3500374088	62		112321372	112329945	8421504	4	21,15,6,20	0,459,1580,8553	c	350037408800000005,350037408800000006,350037408800000000	0-21,0-21,0-20		16552040	10.1128/IAI.74.4.2115-2120.2006	0019-9567	Infection and Immunity	Genetic Resistance to Brucella abortus in the Water Buffalo (Bubalus bubalis)	Borriello	2006	4		
180	chr2	112321372	112329945	3500015801	62		112321372	112329945	8421504	4	21,15,6,20	0,459,1580,8553	c,g	350001580100000005,350001580100000005,350001580100000006,350001580100000000,350001580100000000	0-21,0-21,0-21,0-20,0-20			10.1128/IAI.74.4.2115-2120.2006		Infection and Immunity	Genetic Resistance to Brucella abortus in the Water Buffalo (Bubalus bubalis) 	Giorgia	2006	0		
180	chr2	112322811	112330221	3500158871	559		112322811	112330221	8421504	3	19,180,360	0,365,7050	c,g	350015887100000000,350015887100000063,350015887100000046,350015887100000041,350015887100000041,350015887100000042,350015887100000043,350015887100000044,350015887100000018,350015887100000018	0-19,0-180,0-19,0-60,0-60,0-60,0-122,0-120,0-20,0-20						ER UNTERSUCHUNG GENETISCHER URSACHEN DER HING UNTERSCHIEDLICHEN EMPF&#xc4;NGLICHKEIT F&#xdc;R DIE	eb.uni-giessen.de	0	0		
180	chr2	112326578	112330005	3500297776	80		112326578	112330005	8421504	4	20,21,19,20	0,155,3269,3407	c,g	350029777600000000,350029777600000002,350029777600000001,350029777600000004,350029777600000004,350029777600000005	0-20,0-20,0-20,0-19,0-19,0-20			10.1590/S0102-09352012000400041	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Polymorphisms of the coding region of Slc11a1 (Nramp1) gene associated to natural resistance against bovine brucellosis	Paixao	2012	0		
1442	chr2	112329787	112330278	3500018376	259		112329787	112330278	8421504	3	21,218,20	0,138,471	c,g	350001837600000000,350001837600000014,350001837600000006,350001837600000011,350001837600000011,350001837600000012,350001837600000012,350001837600000016,350001837600000017,350001837600000004,350001837600000005,350001837600000009,350001837600000001	0-21,0-53,0-60,0-56,0-56,1-53,1-53,0-54,0-60,0-36,0-35,0-34,0-20						STTUUDDIIOO IDDE ELLLLAA EVVAARRIIAAZZIOONNE GGEENNETTIICCAA AALL LOOC CUUSS N SSLLCC1111AA11 IIN CCAAPPRRAA HHIIRRCUUSS	eprints.uniss.it	0	0		
1442	chr2	112329877	112330384	3500296163	79		112329877	112330384	8421504	4	20,20,19,20	0,117,273,487	c,g	350029616300000002,350029616300000000,350029616300000001,350029616300000001,350029616300000003,350029616300000003	0-20,0-20,0-19,0-19,0-20,0-20						Ciencias Pecuarias Vol 19 No.1	rccp.udea.edu.co	0	0		
1442	chr2	112329877	112330384	3500251224	79		112329877	112330384	8421504	4	20,20,19,20	0,117,273,487	c,g	350025122400000002,350025122400000000,350025122400000001,350025122400000001,350025122400000003	0-20,0-20,0-19,0-19,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Polymorphism in 1908STR1934 locus of the 3 UTR of the Nramp1 bovine gene in eight cattle breeds	Gonzalez	2006	0		
1442	chr2	112329925	112330136	3500431040	40		112329925	112330136	8421504	2	20,20	0,191	c,g	350043104000000000,350043104000000001,350043104000000001	0-20,0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Genotipificaci&#xf3;n de la regi&#xf3;n 3&#xb4;UTR del gen Nramp1, en ganado Holstein y en criollo Hart&#xf3;n del Valle	Trujillo	2006	0		
1442	chr2	112329925	112330136	3500366957	40		112329925	112330136	8421504	2	20,20	0,191	c,g	350036695700000000,350036695700000001,350036695700000001	0-20,0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Genotipificaci&#xf3;n de la regi&#xf3;n 3&#xb4;UTR del gen Nramp1, en ganado Holstein y en criollo Hart&#xf3;n del Valle	Trujillo	2006	0		
1442	chr2	112329925	112330136	3500274065	40		112329925	112330136	8421504	2	20,20	0,191	c,g	350027406500000000,350027406500000001,350027406500000001	0-20,0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Genotipificaci&#xf3;n de la regi&#xf3;n 3&#xb4;UTR del gen Nramp1, en ganado Holstein y en criollo Hart&#xf3;n del Valle	Trujillo	2006	0		
1442	chr2	112329925	112330136	3500134953	40		112329925	112330136	8421504	2	20,20	0,191	c,g	350013495300000000,350013495300000001,350013495300000001	0-20,0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Genotipificaci&#xf3;n de la regi&#xf3;n 3&#xb4;UTR del gen Nramp1, en ganado Holstein y en criollo Hart&#xf3;n del Valle	Trujillo	2006	0		
1442	chr2	112329994	112330169	3500181679	39		112329994	112330169	8421504	2	20,19	0,156	c,g	350018167900000000,350018167900000001,350018167900000001	0-20,0-19,0-19		17353292	10.1128/IAI.01855-06	0019-9567	Infection and Immunity	NRAMP1 3&#x2032; Untranslated Region Polymorphisms Are Not Associated with Natural Resistance to Brucella abortus in Cattle	Paixao	2007	4		
1442	chr2	112329994	112330169	3500037672	39		112329994	112330169	8421504	2	20,19	0,156	c,g	350003767200000000,350003767200000001,350003767200000001	0-20,0-19,0-19			10.1128/IAI.01855-06		Infection and Immunity	NRAMP1 3&#x2032; Untranslated Region Polymorphisms Are Not Associated with Natural Resistance to Brucella abortus in Cattle 	Tatiane	2007	0		
1442	chr2	112330068	112330138	3500201013	70		112330068	112330138	8421504	1	70	0	c	350020101300000001	0-76		11292730	10.1128/IAI.69.5.3110-3119.2001	0019-9567	Infection and Immunity	Stable Transfection of the BovineNRAMP1 Gene into Murine RAW264.7 Cells: Effect onBrucella abortus Survival	Barthel	2001	4		
1442	chr2	112337584	112338541	3500242436	52		112337584	112338541	8421504	3	5,30,17	0,257,940	c	350024243600000234	0-52						Novel polypeptides and nucleic acids encoding same	Burgess	2002	0		
1442	chr2	112338111	112338190	3500139175	79		112338111	112338190	8421504	1	79	0	c	350013917500000008	5-84						Functional characterisation of microRNA-containing Argonaute Protein complexes	b.uni-muenchen.de	0	0		CTDSP1
1442	chr2	112338112	112338189	3500362304	77		112338112	112338189	8421504	1	77	0	c,g	350036230400000006,350036230400000008,350036230400000008	0-77,0-57,0-57						COMPOSITIONS AND METHODS FOR TREATING HEPATIC NEOPLASIA	Mendell	2009	0		CTDSP1
1442	chr2	112338112	112338189	3500040785	77		112338112	112338189	8421504	1	77	0	c	350004078500000095,350004078500000055	0-77,0-21						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		CTDSP1
1442	chr2	112344040	112344066	3500394358	23		112344040	112344066	8421504	2	9,14	0,12	g	350039435800000000	0-23		18292207	10.1634/stemcells.2007-1102	1549-4918	STEM CELLS	Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells - Agarwal - 2008 - STEM CELLS - Wiley Online Library	Agarwal	2008	0		
1442	chr2	112367262	112373464	3500076232	95		112367262	112373464	8421504	4	9,33,21,32	0,1580,3047,6170	c,g	350007623200000000,350007623200000007,350007623200000007,350007623200000013	0-42,21-42,21-42,0-32						Means for in vitro diagnostic of malignant cells originating from the digestive tube	Monique	1986	0		
1442	chr2	112379507	112382314	3500113257	129		112379507	112382314	8421504	3	69,33,27	0,854,2780	p	350011325700015039,350011325700015040	0-177,0-129						48 human secreted proteins	Komatsoulis	2000	0		USP37
1442	chr2	112379507	112382314	3500110754	129		112379507	112382314	8421504	3	69,33,27	0,854,2780	p	350011075400015039,350011075400015040	0-177,0-129						48 human secreted proteins	Komatsoulis	2002	0		USP37
1443	chr2	112461190	112490036	3500449906	46		112461190	112490036	8421504	3	21,1,24	0,12308,28822	c	350044990600000000,350044990600000003	15-37,0-24		18180299	10.1074/jbc.M706986200	0021-9258	Journal of Biological Chemistry	Components of the CCR4-NOT Complex Function as Nuclear Hormone Receptor Coactivators via Association with the NRC-interacting Factor NIF-1	Garapaty	2008	5		RQCD1
1443	chr2	112492091	112492118	3500098088	27		112492091	112492118	8421504	1	27	0	c	350009808800000003	11-38			10.1110/ps.062600507		Protein Science : A Publication of the Protein Society	Atomic model of human Rcd-1 reveals an armadillo-like-repeat protein with in vitro nucleic acid binding properties	Robert	2007	0		
1443	chr2	112500530	112500558	3500105362	23		112500530	112500558	8421504	3	11,6,6	0,12,22	g	350010536200000039	1-26						Live attenuated vaccines	Browning	2010	0		
1443	chr2	112560854	112560878	3500355894	23		112560854	112560878	8421504	2	9,14	0,10	g	350035589400000003	2-25			10.1289/ehp.9425		Environmental Health Perspectives	New Insight into Intrachromosomal Deletions Induced by Chrysotile in the gpt delta Transgenic Mutation Assay	An	2007	0		
1443	chr2	112561122	112586889	3500139966	489		112561122	112586889	8421504	19	18,20,3,39,20,21,33,39,33,24,38,35,3,4,23,30,32,35,39	0,946,1084,1199,2470,2729,2754,2904,6676,6754,15268,15307,15817,19088,19448,21543,23832,24144,25728	c	350013996600000226,350013996600000230,350013996600000019,350013996600000130,350013996600000235,350013996600000131,350013996600000135,350013996600000145,350013996600000250,350013996600000147,350013996600000160,350013996600000161,350013996600000151,350013996600000273,350013996600000078,350013996600000209,350013996600000217,350013996600000113	0-38,0-39,0-39,0-39,0-38,6-39,0-39,0-33,0-30,0-24,0-38,0-38,0-19,12-39,9-39,0-32,0-35,0-39						US Patent # 6,531,579. Fused polypeptides - Patents.com	www.patents.com	0	0		
1443	chr2	112561122	112585301	3500007563	301		112561122	112585301	8421504	11	18,20,39,38,33,38,4,23,21,32,35	0,946,1199,2754,6676,15268,19088,19448,22118,23832,24144	c	350000756300000227,350000756300000019,350000756300000025,350000756300000132,350000756300000146,350000756300000161,350000756300000274,350000756300000304,350000756300000009,350000756300000210,350000756300000218	0-38,0-39,0-38,6-39,0-33,0-38,12-39,0-21,0-21,0-32,0-35						Fused	Sauvage	1998	0		
1444	chr2	112719257	112720267	3500006355	102		112719257	112720267	8421504	2	48,54	0,956	p	350000635500015213,350000635500015102,350000635500015036,350000635500015211	0-48,0-48,0-48,0-48						Variants Of The Gamma Chain Of Ampx, Dna Sequences Encoding The Same, And Uses Thereof 	.freshpatents.com	0	0		
1444	chr2	112720184	112720484	3500325286	40		112720184	112720484	8421504	2	20,20	0,280	c,g	350032528600000019,350032528600000019,350032528600000018,350032528600000018	0-20,0-20,0-20,0-20						Metformin Decreases GnRH- and Activin-Induced Gonadotropin Secretion in Rat Pituitary Cells: Potential Involvement of Adenosine 5 Monophosphate-Activated Protein Kinase (PRKA)	ww.biolreprod.org	0	0		
1445	chr2	112749704	112759523	3500227271	300		112749704	112759523	8421504	2	80,220	0,9599	p	350022727100015135,350022727100015139,350022727100015140,350022727100015138,350022727100015136	0-297,0-297,24-294,0-153,0-60						Human cdnas and proteins and uses thereof	Bejanin	2002	0		WNT6
1446	chr2	112872998	112873062	3500411023	39		112872998	112873062	8421504	2	19,20	0,44	c	350041102300000001,350041102300000000	16-35,10-30		23778521	10.1038/bjc.2013.308	0007-0920	British Journal of Cancer	miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer	Shen	2013	5		CCDC108
1446	chr2	112872998	112873062	3500339060	39		112872998	112873062	8421504	2	19,20	0,44	c	350033906000000001,350033906000000000	16-35,10-30		23778521	10.1038/bjc.2013.308	0007-0920	British Journal of Cancer	miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer	Shen	2013	5		CCDC108
1446	chr2	112872998	112873062	3500183677	39		112872998	112873062	8421504	2	19,20	0,44	c	350018367700000001,350018367700000000	16-35,10-30		23778521	10.1038/bjc.2013.308	0007-0920	British Journal of Cancer	miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer	Shen	2013	5		CCDC108
1446	chr2	112872998	112873062	3500112182	39		112872998	112873062	8421504	2	19,20	0,44	c	350011218200000001,350011218200000000	16-35,10-30		23778521	10.1038/bjc.2013.308	0007-0920	British Journal of Cancer	miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer	Shen	2013	5		CCDC108
1446	chr2	112872998	112873062	3500026456	39		112872998	112873062	8421504	2	19,20	0,44	c	350002645600000001,350002645600000000	16-35,10-30		23778521	10.1038/bjc.2013.308	0007-0920	British Journal of Cancer	miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer	Shen	2013	5		CCDC108
1446	chr2	112928069	112928092	3500367022	23		112928069	112928092	8421504	1	23	0	c	350036702200000007	0-23		18438858	10.1002/art.23370	1529-0131	Arthritis & Rheumatism	Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells - Mueller - 2008 - Arthritis & Rheumatism - Wiley Online Library	Mueller	2008	0		
1446	chr2	112928514	112928737	3500030345	38		112928514	112928737	8421504	2	19,19	0,204	c,g	350003034500000001,350003034500000001,350003034500000000	0-19,0-19,0-19						The Hedgehog System in Ovarian Follicles of Cattle Selected for Twin Ovulations and Births: Evidence of a Link between the IGF and Hedgehog Systems	ww.biolreprod.org	0	0		
1446	chr2	112928521	112931077	3500192940	124		112928521	112931077	8421504	3	48,56,20	0,49,2536	c	350019294000000197,350019294000000196,350019294000000092,350019294000000130	0-48,0-47,0-48,27-47						Nucleic acids encoding hedgehog proteins	Ingham	2000	0		
1446	chr2	112928572	112933483	3500080098	116		112928572	112933483	8421504	3	48,20,48	0,2485,4863	c	350008009800000191,350008009800000118,350008009800000174	0-48,27-47,0-48						Methods and compositions for treating disorders involving excitotoxicity - Patent application	www.faqs.org	0	0		
1446	chr2	112928578	112933531	3500304944	164		112928578	112933531	8421504	3	48,20,96	0,70,4857	c	350030494400000078,350030494400000188,350030494400000172,350030494400000171	0-48,0-20,0-48,0-48						Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto - Patent application	www.faqs.org	0	0		
1446	chr2	112928648	112933531	3500233278	116		112928648	112933531	8421504	2	20,96	0,4787	c	350023327800000188,350023327800000172,350023327800000171	0-20,0-48,0-48						Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto - US Patent 6639051 Description	ww.patentstorm.us	0	0		
1446	chr2	112930879	112933486	3500042372	180		112930879	112933486	8421504	4	45,45,45,45	0,96,144,2562	p	350004237200015011,350004237200015009,350004237200015008,350004237200015006	0-45,0-45,0-45,0-45						Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA - Patent application	www.faqs.org	0	0		
1446	chr2	112933423	112933468	3500433564	45		112933423	112933468	8421504	1	45	0	p	350043356400015001	3-48						miR-196 is an essential early-stage regulator of tail regeneration, upstream of key spinal cord patterning events	alamander.uky.edu	0	0		SHH
1446	chr2	112933435	112933483	3500158750	48		112933435	112933483	8421504	1	48	0	c	350015875000000176	0-48						Method of treating dopaminergic and gaba-nergic disorders	Miao	1999	0		
1446	chr2	112933461	112933487	3500032366	26		112933461	112933487	8421504	1	26	0	c	350003236600000000	0-26			10.1002/dvdy.21036	1097-0177	Developmental Dynamics	Temporomandibular joint formation and condyle growth require Indian hedgehog signaling - Shibukawa - 2006 - Developmental Dynamics - Wiley Online Library	Shibukawa	2007	0		
1447	chr2	113042820	113042849	3500298067	24		113042820	113042849	8421504	2	10,14	0,15	c	350029806700000002	3-27						Calcium-Sensing Receptor Autoantibodies and Idiopathic Hypoparathyroidism	.endojournals.org	0	0		
1447	chr2	113042820	113042849	3500139973	24		113042820	113042849	8421504	2	10,14	0,15	c	350013997300000002	3-27		23873991	10.1210/jc.2013-2158	0021-972X	Journal of Clinical Endocrinology & Metabolism	Calcium-Sensing Receptor Autoantibodies and Idiopathic Hypoparathyroidism	Tomar	2013	6		
1447	chr2	113056574	113057139	3500466452	156		113056574	113057139	8421504	2	90,66	0,499	p	350046645200015013	6-162						Antibodies to HFXJW48 polypeptide	Ruben	2004	0		FAM134A
1447	chr2	113056574	113057139	3500436879	156		113056574	113057139	8421504	2	90,66	0,499	p	350043687900015014	6-162						70 human secreted proteins	Ruben	2002	0		FAM134A
1447	chr2	113059159	113059183	3500420736	24		113059159	113059183	8421504	1	24	0	c	350042073600000001	0-24						Bacteria from Fish and Other Aquatic Animals - Nicky Buller.pdf	www.scribd.com	0	0		AGO1
1447	chr2	113059159	113059183	3500261028	24		113059159	113059183	8421504	1	24	0	c	350026102800000086	0-24						Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups	Cai	2012	0		AGO1
1447	chr2	113059159	113059183	3500055135	24		113059159	113059183	8421504	1	24	0	c	350005513500000001	0-24						Bacteria from Fish.pdf	www.scribd.com	0	0		AGO1
1447	chr2	113059159	113059183	3500043196	24		113059159	113059183	8421504	1	24	0	c	350004319600000087,350004319600000129	0-24,0-24						OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS - Patent application	www.faqs.org	0	0		AGO1
1448	chr2	113127678	113127701	3500168546	23		113127678	113127701	8421504	1	23	0	c	350016854600000003	0-23						IL-1 decreases the elastic modulus of human tenocytes--&#x300a;&#x5e94;&#x7528;&#x751f;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		TUBA4A
1448	chr2	113128422	113128446	3500396026	24		113128422	113128446	8421504	1	24	0	c	350039602600000008	0-24						Zebrafish male germ cells in culture	ev.biologists.org	0	0		TUBA8
1448	chr2	113146155	113146510	3500387039	48		113146155	113146510	8421504	2	37,11	0,344	p	350038703900015006	123-171		19299493	10.1093/hmg/ddp134		Human Molecular Genetics	Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery	Mariangels	June	0		TUBA1A
1448	chr2	113171889	113174502	3500316994	150		113171889	113174502	8421504	3	54,87,9	0,517,2604	p	350031699400015018,350031699400015012,350031699400015011,350031699400015047,350031699400015048,350031699400015014,350031699400015010	36-135,0-144,0-144,255-336,0-72,57-129,147-219						Methods and compositions to generate and control the effector profile of t cells	Bot	2007	0		PTPRN
1448	chr2	113171889	113174502	3500062604	150		113171889	113174502	8421504	3	54,87,9	0,517,2604	p	350006260400015018,350006260400015011,350006260400015012,350006260400015048,350006260400015047,350006260400015010,350006260400015014	36-135,0-144,0-144,0-72,255-336,147-219,57-129						Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells	Bot	2008	0		PTPRN
1448	chr2	113182129	113182156	3500407033	27		113182129	113182156	8421504	1	27	0	c	350040703300000000	0-27		12031972	10.2337/diabetes.51.6.1842	0012-1797	Diabetes	Targeted Disruption of the Protein Tyrosine Phosphatase-Like Molecule IA-2 Results in Alterations in Glucose Tolerance Tests and Insulin Secretion	Saeki	2002	8		PTPRN
1448	chr2	113187202	113187309	3500272492	42		113187202	113187309	8421504	2	21,21	0,86	g	350027249200000003,350027249200000002	0-21,0-21						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
1448	chr2	113187206	113187229	3500123238	23		113187206	113187229	8421504	1	23	0	g	350012323800000003	0-23		15905730		1525-4135	JAIDS Journal of Acquired Immune Deficiency Syndromes	 Effects of HIV Protease Inhibitor Ritonavir on Vasomotor Fun... : JAIDS Journal of Acquired Immune Deficiency Syndromes 	Fu	2005	4		GAPDH,MCHR1
1448	chr2	113187232	113187257	3500134187	24		113187232	113187257	8421504	2	5,19	0,6	g	350013418700000018	0-24		20829348	10.1074/jbc.M110.139113		The Journal of Biological Chemistry	Cactin Targets the MHC Class III Protein I&#x03ba;B-like (I&#x03ba;BL) and Inhibits NF-&#x03ba;B and Interferon-regulatory Factor Signaling Pathways	Paola	2010	0		
1448	chr2	113187417	113187441	3500111578	24		113187417	113187441	8421504	1	24	0	g	350011157800000003	0-24						ScienceDirect.com - Biochemical and Biophysical Research Communications - Anti-mitotic potential of 7-diethylamino-3(2&#x2032;-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU	sciencedirect.com	0	0		
1448	chr2	113187549	113187573	3500326402	24		113187549	113187573	8421504	1	24	0	g	350032640200000013	0-24						Activation of Nicotinamide N-Methyltransferase Gene Promoter by Hepatocyte Nuclear Factor-1 in Human Papillary Thyroid Cancer Cells	.endojournals.org	0	0		
1448	chr2	113187681	113188107	3500449034	40		113187681	113188107	8421504	2	20,20	0,406	g	350044903400000001,350044903400000000	0-20,0-20		16033767	10.1074/jbc.M504553200	0021-9258	Journal of Biological Chemistry	TRPC4 Knockdown Suppresses Epidermal Growth Factor-induced Store-operated Channel Activation and Growth in Human Corneal Epithelial Cells	Yang	2005	5		
1448	chr2	113187700	113188202	3500198876	40		113187700	113188202	8421504	2	20,20	0,482	g	350019887600000031,350019887600000030	0-20,0-20		22085910	10.1186/1471-2415-11-33	1471-2415	BMC Ophthalmology	DPOFA, a Cl-/HCO3 - exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	Iserovich	2011	1		
1448	chr2	113187947	113187995	3500221208	46		113187947	113187995	8421504	2	26,20	0,28	g	350022120800000005	0-67						Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium. - ResearchGate	.researchgate.net	0	0		
1448	chr2	113188011	113188035	3500306609	24		113188011	113188035	8421504	1	24	0	g	350030660900000009	20-44						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
1448	chr2	113188090	113188115	3500132181	25		113188090	113188115	8421504	1	25	0	g	350013218100000019,350013218100000065	0-25,0-25						TARGETED MODULATION OF GENE EXPRESSION - Patent application	www.faqs.org	0	0		
22	chr2	113235960	113248107	3500086458	44		113235960	113248107	8421504	2	23,21	0,12126	c	350008645800000001,350008645800000000	6-29,5-26		22356908	10.1074/jbc.M112.347518		The Journal of Biological Chemistry	Insights into Substrate Specificity and Metal Activation of Mammalian Tetrahedral Aspartyl Aminopeptidase	Yuanyuan	2012	0		
1449	chr2	113280251	113280311	3500247412	60		113280251	113280311	8421504	1	60	0	p	350024741200015019	0-60						Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS) - Patent application	www.faqs.org	0	0		DES
1449	chr2	113280278	113280301	3500252772	23		113280278	113280301	8421504	1	23	0	c	350025277200000000	0-23						The QIAGEN Transfection Resource Book Second Edition	ric.postech.ac.kr	0	0		VIM
1449	chr2	113281666	113282003	3500038120	41		113281666	113282003	8421504	2	20,21	0,316	c,g	350003812000000000,350003812000000000,350003812000000001	0-20,0-20,0-21						An improved transplantation strategy for mouse mesenchymal stem cells in an acute myocardial infarction model. - ResearchGate	.researchgate.net	0	0		
1449	chr2	113281936	113282291	3500247541	40		113281936	113282291	8421504	2	20,20	0,335	c,g	350024754100000002,350024754100000002,350024754100000003	0-20,0-20,0-20						Effect of sex steroid hormones on bovine myogenic satellite cell proliferation, differentiation and lipid accumulation in myotube.	.biomedsearch.com	0	0		
1449	chr2	113281966	113282291	3500194103	40		113281966	113282291	8421504	2	20,20	0,305	c,g	350019410300000058,350019410300000059,350019410300000059	0-20,0-20,0-20						AZ IZOM DIFFERENCI&#xc1;L&#xd3;D&#xc1;ST BEFOLY&#xc1;SOL&#xd3; G&#xc9;NEK IN VITRO VIZSG&#xc1;LATA EMBRION&#xc1;LIS EREDET&#x0170; &#x0150;S-SEJTVONALAKBAN EG&#xc9;R MODELLRENDSZERBEN	phd.szie.hu	0	0		
1449	chr2	113282291	113285844	3500425795	47		113282291	113285844	8421504	3	24,13,10	0,1993,3543	c	350042579500000002,350042579500000003	0-24,0-23						ScienceDirect.com - Journal of Advanced Research - Expression and function of calcium-activated potassium channels following in-stent restenosis in a porcine coronary artery model	sciencedirect.com	0	0		DES
1449	chr2	113285842	113285893	3500417847	51		113285842	113285893	8421504	1	51	0	c	350041784700000003	0-51						Transient expression of the intermediate &#xfb01;lament nestin during skeletal muscle development	cs.biologists.org	0	0		DES
1450	chr2	113396083	113396130	3500370207	47		113396083	113396130	8421504	1	47	0	c	350037020700000070	0-47						Chondroitin Sulfate Synthesis Promoter 	.freshpatents.com	0	0		
1450	chr2	113401556	113406120	3500196101	175		113401556	113406120	8421504	4	32,48,48,47	0,2477,3903,4517	c	350019610100000009,350019610100000016,350019610100000025,350019610100000030	15-47,0-48,0-48,0-47						Novel Antibodies That Bind To Antigenic Polypeptides, Nucleic Acids Encoding The Antigens, And Methods Of Use 	.freshpatents.com	0	0		
1450	chr2	113428414	113428442	3500311161	24		113428414	113428442	8421504	2	8,16	0,12	c	350031116100000027	10-48						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
1450	chr2	113428414	113428442	3500044715	24		113428414	113428442	8421504	2	8,16	0,12	c	350004471500000027	7-45						Antibody immunoreactive with a 5-enolpyruvylshikimate-3-phosphate synthase - US Patent 7183110 Description	ww.patentstorm.us	0	0		
1450	chr2	113430359	113430437	3500382508	78		113430359	113430437	8421504	1	78	0	p	350038250800015000	0-78					Patent	Recombinant inhibin (Patent CA:1341619)	De	2011	0		
1450	chr2	113432316	113432410	3500078470	41		113432316	113432410	8421504	2	21,20	0,74	c,g	350007847000000010,350007847000000010,350007847000000011	0-21,0-21,0-20						Transforming growth factor beta family expression at the bovine feto-maternal interface	biomedcentral.com	0	0		
1450	chr2	113432720	113432771	3500371444	51		113432720	113432771	8421504	1	51	0	p	350037144400015066	24-75						Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis	Friede	2005	0		
1450	chr2	113432720	113432771	3500280084	51		113432720	113432771	8421504	1	51	0	p	350028008400015070	24-75						STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS	Friede	2004	0		
1450	chr2	113433025	113433105	3500256218	75		113433025	113433105	8421504	3	26,25,24	0,27,56	c,g	350025621800000099,350025621800000101,350025621800000100,350025621800000100	0-26,0-25,0-24,0-24						REPRODUCTION	uction-online.org	0	0		
1450	chr2	113478548	113478573	3500199661	23		113478548	113478573	8421504	3	6,5,12	0,7,13	c	350019966100000140	8-35						Promoters for regulated gene expression	Kim	2001	0		
1452	chr2	113716235	113716261	3500015511	23		113716235	113716261	8421504	3	7,4,12	0,9,14	g	350001551100000009	0-23		21179475	10.1371/journal.pone.0014325		PLoS ONE	A Key Role for E-cadherin in Intestinal Homeostasis and Paneth Cell Maturation	Marlon	2010	0		
1453	chr2	113809455	113809481	3500445397	26		113809455	113809481	8421504	1	26	0	g	350044539700000065	7-36						Vector - Patent application	www.faqs.org	0	0		
1453	chr2	113809455	113809481	3500333519	26		113809455	113809481	8421504	1	26	0	g	350033351900000209	5-34						Methods of treating inflammatory skin diseases	Xia	2001	0		
1453	chr2	113809455	113809481	3500307446	26		113809455	113809481	8421504	1	26	0	g	350030744600000134,350030744600000199	11-40,5-34						Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties - Patent application	www.faqs.org	0	0		
1453	chr2	113809455	113809481	3500289762	26		113809455	113809481	8421504	1	26	0	g	350028976200000191,350028976200000391	8-37,5-34						TACI-immunoglobulin fusion proteins	J*A*Ge Luo Si 	2010	0		
1453	chr2	113809455	113809481	3500280524	26		113809455	113809481	8421504	1	26	0	g	350028052400000432	5-34						TACI-immunoglobulin fusion proteins	M*W*Li Ke Sen 	2005	0		
1453	chr2	113809455	113809481	3500227237	25		113809455	113809481	8421504	2	13,12	0,14	g	350022723700000049,350022723700000048	1-30,0-29						Heterodimeric proteins and methods for producing and purifying them	Ho	2013	0		
1453	chr2	113809455	113809481	3500106793	26		113809455	113809481	8421504	1	26	0	g	350010679300000235	5-34						Peptide That Elicits Neutralizing Antibodies Targeting The Hiv Co-receptor, Ccr5 	.freshpatents.com	0	0		
1453	chr2	113809455	113809481	3500105003	26		113809455	113809481	8421504	1	26	0	g	350010500300000031	5-34						Recombinant Method For Making Multimeric Proteins 	.freshpatents.com	0	0		
1453	chr2	113809455	113809481	3500075519	25		113809455	113809481	8421504	2	13,12	0,14	g	350007551900000047,350007551900000046	1-30,0-29						Heterodimeric proteins and methods for producing and purifying them	Ho	2013	0		
1454	chr2	114002570	114002595	3500028749	25		114002570	114002595	8421504	1	25	0	g	350002874900000066	8-40						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
1455	chr2	114046775	114046801	3500136137	23		114046775	114046801	8421504	2	12,11	0,15	g	350013613700000019	1-24					Patent	Amplification processes (Patent US:5525494)	Newton	1996	0		
1455	chr2	114159445	114159468	3500111578	23		114159445	114159468	8421504	1	23	0	g	350011157800000002	1-24						ScienceDirect.com - Biochemical and Biophysical Research Communications - Anti-mitotic potential of 7-diethylamino-3(2&#x2032;-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU	sciencedirect.com	0	0		
1455	chr2	114159450	114159474	3500003629	24		114159450	114159474	8421504	1	24	0	g	350000362900000003	0-24						CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain. - ResearchGate	.researchgate.net	0	0		GAPDH
1455	chr2	114159452	114159932	3500319170	40		114159452	114159932	8421504	2	20,20	0,460	g	350031917000000016,350031917000000017	0-20,0-20		21115974	10.1182/blood-2010-08-303073	0006-4971	Blood	The tumor suppressor gene WWOX links the canonical and noncanonical NF-&#x03ba;B pathways in HTLV-I Tax-mediated tumorigenesis	Fu	2011	10		GAPDH
1455	chr2	114159452	114159932	3500076629	40		114159452	114159932	8421504	2	20,20	0,460	g	350007662900000000,350007662900000001	0-20,0-20		20185823	10.1074/jbc.M109.086561		The Journal of Biological Chemistry	Epigenetic Repression of PDZ-LIM Domain-containing Protein 2: IMPLICATIONS FOR THE BIOLOGY AND TREATMENT OF BREAST CANCER*	Zhaoxia	2010	0		GAPDH
1455	chr2	114159458	114159482	3500134187	24		114159458	114159482	8421504	1	24	0	g	350013418700000017	0-24		20829348	10.1074/jbc.M110.139113		The Journal of Biological Chemistry	Cactin Targets the MHC Class III Protein I&#x03ba;B-like (I&#x03ba;BL) and Inhibits NF-&#x03ba;B and Interferon-regulatory Factor Signaling Pathways	Paola	2010	0		GAPDH
1462	chr2	115049641	115049670	3500175973	24		115049641	115049670	8421504	2	13,11	0,18	g	350017597300000147	21-45					Patent	DNA encoding the Canine coronavirus spike protein (Patent US:5661006)	Brown	1997	0		
1464	chr2	115341317	115341344	3500267907	23		115341317	115341344	8421504	2	9,14	0,13	g	350026790700000012	2-40						Therapeutic molecules for use in the suppression of parkinson's disease	Sibley	2012	0		
1464	chr2	115341424	115341449	3500068155	23		115341424	115341449	8421504	2	18,5	0,20	g	350006815500000101	9-32						AMPLIFICATION DYNAMICS OF PRIMATE RETROTRANSPOSONS	etd.lsu.edu	0	0		
1467	chr2	115672227	115716421	3500384355	60		115672227	115716421	8421504	2	15,45	0,44149	p	350038435500015005	0-60						EphA4 as therapeutic target of PRC and PDACa	Zhong Cun You Fu 	2007	0		
1467	chr2	115716441	115716466	3500072743	25		115716441	115716466	8421504	1	25	0	c	350007274300000001	9-34						Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1	tologylibrary.org	0	0		EPHA4
1467	chr2	115723976	115723999	3500259529	23		115723976	115723999	8421504	1	23	0	c	350025952900000009	0-23						Methods for production of receptor and ligand isoforms	Jin	2006	0		EPHA4
1472	chr2	116332185	116332210	3500083476	23		116332185	116332210	8421504	3	11,4,8	0,12,17	g	350008347600000070	0-24						Anti-a33 antibody	Kataoka	2007	0		
1473	chr2	116424040	116424557	3500448201	23		116424040	116424557	8421504	2	9,14	0,503	c	350044820100000003	0-23		23970178	10.1038/srep02498	xxxx-xxxx	Scientific Reports	Induction of Pax3 gene expression impedes cardiac differentiation	Li	2013	0		
1473	chr2	116424040	116424557	3500195206	23		116424040	116424557	8421504	2	9,14	0,503	c	350019520600000003	0-23		23970178	10.1038/srep02498	xxxx-xxxx	Scientific Reports	Induction of Pax3 gene expression impedes cardiac differentiation	Li	2013	0		PAX3
1473	chr2	116433046	116433072	3500319074	24		116433046	116433072	8421504	2	7,17	0,9	g	350031907400000003	1-25		9835519		0066-4804	Antimicrobial Agents and Chemotherapy	Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071	Tai	1998	5		
1473	chr2	116460662	116460707	3500420004	45		116460662	116460707	8421504	1	45	0	p	350042000400015000	0-45		22679108	10.1158/1541-7786.MCR-11-0387	1541-7786	Molecular Cancer Research	GSK-3 Promotes Cell Survival, Growth, and PAX3 Levels in Human Melanoma Cells	Kubic	2012	4		PAX3
1473	chr2	116522461	116522484	3500331864	23		116522461	116522484	8421504	1	23	0	c	350033186400000001	1-24						Neural Tube Defects in Embryos of Diabetic Mice Role of the Pax-3 Gene and Apoptosis	betesjournals.org	0	0		PAX3
1474	chr2	116525340	116525364	3500393987	24		116525340	116525364	8421504	1	24	0	c	350039398700000014	0-24						ABSTRACT	tory.lib.ncsu.edu	0	0		PAX3
1474	chr2	116525340	116525364	3500372619	24		116525340	116525364	8421504	1	24	0	c	350037261900000000	0-24						2012 OPEN ACCESS nutrients	www.mdpi.com	0	0		
1474	chr2	116525340	116525364	3500351434	24		116525340	116525364	8421504	1	24	0	c	350035143400000000	0-24						2012 OPEN ACCESS nutrients	www.mdpi.com	0	0		PAX3
1475	chr2	116688040	116688065	3500445268	23		116688040	116688065	8421504	2	8,15	0,10	g	350044526800000103	11-34						ANTIBODIES TO VLA-1 - Patent application	www.faqs.org	0	0		
1475	chr2	116743768	116743797	3500023736	24		116743768	116743797	8421504	3	5,12,7	0,7,22	c	350002373600000010	6-32						Virulence And Antibiotic Resistance Array And Uses Thereof 	.freshpatents.com	0	0		
1475	chr2	116759133	116767369	3500263908	124		116759133	116767369	8421504	4	22,36,41,25	0,672,7454,8211	c	350026390800000292,350026390800000272,350026390800000278,350026390800000282	0-22,0-36,0-41,19-44						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
1475	chr2	116759133	116767369	3500037971	88		116759133	116767369	8421504	3	22,41,25	0,7454,8211	c	350003797100000292,350003797100000278,350003797100000282	0-22,0-41,19-44						Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor - Patent application	www.faqs.org	0	0		
1477	chr2	116918680	116918707	3500111698	24		116918680	116918707	8421504	3	5,6,13	0,6,14	g	350011169800000044	10-34						NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
1477	chr2	116948009	116948050	3500449299	41		116948009	116948050	8421504	1	41	0	c,g	350044929900000007,350044929900000006,350044929900000010,350044929900000010,350044929900000011,350044929900000011,350044929900000014,350044929900000014,350044929900000015,350044929900000015	0-37,0-37,9-45,9-45,0-36,0-36,9-39,9-39,0-30,0-30		21233202	10.1074/jbc.M110.141754	0021-9258	Journal of Biological Chemistry	Regulation of Ribosomal Protein S6 Phosphorylation by Casein Kinase 1 and Protein Phosphatase 1	Hutchinson	2011	5		
1477	chr2	116948011	116948071	3500104546	60		116948011	116948071	8421504	1	60	0	p	350010454600015003	0-60						Inhibition of s6 kinase activity for the treatment of insulin resistance	Auwerx	2005	0		RPS6
1477	chr2	116948015	116948044	3500408019	29		116948015	116948044	8421504	1	29	0	c	350040801900000027	0-29						SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF- 1 activity	jcb.rupress.org	0	0		
1478	chr2	117116397	117116428	3500021221	27		117116397	117116428	8421504	2	20,7	0,24	c	350002122100000011	7-43						US Patent # 5,880,334. DNA encoding phosphoenolpyruvate carboxykinase, recombinant vector and transformed plant containing the same - Patents.com	www.patents.com	0	0		
1482	chr2	117674829	117675065	3500274037	40		117674829	117675065	8421504	2	20,20	0,216	c	350027403700000123,350027403700000122	0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1482	chr2	117676031	117676082	3500032776	51		117676031	117676082	8421504	1	51	0	p	350003277600015000	0-51					The Journal of Cell Biology	Essential Role of the Disulfide-bonded Loop of Chromogranin B for Sorting to Secretory Granules Is Revealed by Expression of a Deletion Mutant in the Absence of Endogenous Granin Synthesis 	Andreas	1998	0		SCG2
1482	chr2	117676168	117679336	3500082141	23		117676168	117679336	8421504	2	18,5	0,3163	c	350008214100000005	4-27		19118055	10.1158/1078-0432.CCR-08-1163	1078-0432	Clinical Cancer Research	SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer	Moss	2009	8		
1482	chr2	117691055	117691082	3500326034	25		117691055	117691082	8421504	2	15,10	0,17	g	350032603400000180	10-35						 Selection Method 	www.docstoc.com	0	0		
1485	chr2	117991519	117992757	3500205057	41		117991519	117992757	8421504	3	19,6,16	0,60,1222	c,g	350020505700000019,350020505700000019,350020505700000018	0-19,0-19,0-22						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1485	chr2	117991519	117992757	3500137197	41		117991519	117992757	8421504	3	19,6,16	0,60,1222	c,g	350013719700000019,350013719700000019,350013719700000018	0-19,0-19,0-22						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1485	chr2	117992790	117995892	3500456763	60		117992790	117995892	8421504	2	35,25	0,3077	p	350045676300015011	0-60						Use Of Serine Protease Inhibitors In The Treatment Of Neutropenia	Fontana	2012	0		SERPINE2
1485	chr2	118010601	118021333	3500145630	42		118010601	118021333	8421504	2	21,21	0,10711	c,g	350014563000000029,350014563000000028,350014563000000028	0-21,0-21,0-21						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1485	chr2	118018001	118021118	3500256218	45		118018001	118021118	8421504	3	22,12,11	0,31,3106	c,g	350025621800000105,350025621800000105,350025621800000106	0-22,0-22,0-23						REPRODUCTION	uction-online.org	0	0		
1488	chr2	118421874	118421897	3500045044	23		118421874	118421897	8421504	1	23	0	g	350004504400000085,350004504400000086	1-24,11-34						Replication and stability of the linear plasmid pBSSB2	ository.cam.ac.uk	0	0		
1489	chr2	118499704	118499728	3500408348	23		118499704	118499728	8421504	2	18,5	0,19	c	350040834800000116	14-37						Methods and systems for producing recombinant viral antigens	Zebedee	1997	0		
1489	chr2	118499704	118499728	3500160732	23		118499704	118499728	8421504	2	18,5	0,19	c,g	350016073200000126,350016073200000126	2-25,2-25						Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions - Patent application	www.faqs.org	0	0		CUL3
1489	chr2	118499704	118499728	3500146173	23		118499704	118499728	8421504	2	18,5	0,19	c	350014617300000030	2-25						 Rapid Subcloning Using Site 	www.docstoc.com	0	0		CUL3
1489	chr2	118499704	118499728	3500108636	23		118499704	118499728	8421504	2	18,5	0,19	c	350010863600000110	2-25						CLOSTRIDIUM BOTULINUM C3 EXOTRANSFERASE COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING - Patent application	www.faqs.org	0	0		CUL3
1489	chr2	118499704	118499728	3500102291	23		118499704	118499728	8421504	2	18,5	0,19	c	350010229100000355	2-25						Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods	Alvarez	2000	0		CUL3
1489	chr2	118534444	118552771	3500245658	114		118534444	118552771	8421504	2	96,18	0,18309	p	350024565800015027	0-114						Supplemental data Supplemental Methods	tologylibrary.org	0	0		
1489	chr2	118612544	118612569	3500274224	25		118612544	118612569	8421504	1	25	0	c,g	350027422400000035,350027422400000033,350027422400000033	6-31,0-20,0-20						Rho GTPasen der RhoBTB Familie: Charakterisierung und Rolle in der Tumorentstehung	www.uni-koeln.de	0	0		
1490	chr2	118695214	118695238	3500326234	23		118695214	118695238	8421504	2	4,19	0,5	g	350032623400000071	9-33						CONSTRU&#xc7;&#xc3;O E AVALIA&#xc7;&#xc3;O DE VETORES DE EXPRESS&#xc3;O HETER&#xd3;LOGA EM Angomonas deanei	pace.c3sl.ufpr.br	0	0		
1491	chr2	118784244	118823418	3500002716	130		118784244	118823418	8421504	6	23,48,1,27,5,26	0,23751,38927,39054,39142,39148	c	350000271600000103,350000271600000073,350000271600000008,350000271600000042	0-23,0-48,15-43,0-31						Cadherin-like asymmetry protein-1, and methods for its use	Lu	2000	0		
1491	chr2	118810416	118810441	3500262505	24		118810416	118810441	8421504	2	14,10	0,15	c	350026250500000094	9-33						US Patent # 6,274,140. Calcium independent cytosolic phospholipase A2/B enzymes - Patents.com	www.patents.com	0	0		
1491	chr2	118823171	118823325	3500122618	28		118823171	118823325	8421504	2	1,27	0,127	c	350012261800000027	15-43						CLASP-1 TRANSMEMBRANE PROTEIN - THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY	www.sumobrain.com	0	0		
1493	chr2	119020570	119020595	3500204773	23		119020570	119020595	8421504	2	5,18	0,7	g	350020477300000290	15-38						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
1493	chr2	119020570	119020595	3500017979	23		119020570	119020595	8421504	2	5,18	0,7	g	350001797900000290	15-38						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
1500	chr2	119983327	119983356	3500464585	25		119983327	119983356	8421504	2	13,12	0,17	g	350046458500000452	5-30						Caracteriza&#xe7;&#xe3;o de Metaloproteinases PIII a partir do DNA gen&#xf4;mico de Bothrops jararaca	www.teses.usp.br	0	0		
1505	chr2	120655115	120655146	3500445203	24		120655115	120655146	8421504	3	12,6,6	0,17,25	g	350044520300000100,350044520300000103	22-47,22-47						Detecting foot-and-mouth disease virus	Engelhard	2005	0		
1507	chr2	120881422	120881534	3500006584	43		120881422	120881534	8421504	2	21,22	0,90	g	350000658400000023,350000658400000022	0-21,0-22						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
1511	chr2	121458055	121480370	3500316994	90		121458055	121480370	8421504	2	21,69	0,22246	p	350031699400015028,350031699400015054	9-87,60-129						Methods and compositions to generate and control the effector profile of t cells	Bot	2007	0		
1511	chr2	121458055	121480370	3500062604	90		121458055	121480370	8421504	2	21,69	0,22246	p	350006260400015028,350006260400015054	9-87,60-129						Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells	Bot	2008	0		
1511	chr2	121464894	121464922	3500291453	23		121464894	121464922	8421504	2	12,11	0,17	c	350029145300000048	12-43						Development of type I markers in channel cat&#xfb01;sh through intron sequencing	ddr.nal.usda.gov	0	0		
1511	chr2	121466594	121481594	3500298811	1052		121466594	121481594	8421504	13	44,90,73,72,126,23,28,116,49,178,109,131,13	0,804,4195,6799,6960,9369,9440,11190,11354,12328,12633,13722,14987	c	350029881100000015,350029881100000018,350029881100000019,350029881100000020,350029881100000021,350029881100000022,350029881100000023,350029881100000024,350029881100000025,350029881100000027,350029881100000028,350029881100000029,350029881100000031,350029881100000032,350029881100000033,350029881100000034,350029881100000035,350029881100000036,350029881100000037,350029881100000039,350029881100000040,350029881100000041	4-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48					Patent	&#x03b1;-3 chain type IV collagen polypeptides (Patent US:5973120)	Hudson	1999	0		
1511	chr2	121477816	121477882	3500135587	66		121477816	121477882	8421504	1	66	0	p	350013558700015015	0-66						Novel Goodpasture Antigen-binding Protein Isoforms And Protein Misfolded-mediated Disorders 	.freshpatents.com	0	0		
1511	chr2	121478930	121478978	3500380174	48		121478930	121478978	8421504	1	48	0	c	350038017400000454	0-48						Goodpasture Antigen Binding Protein 	.freshpatents.com	0	0		
1511	chr2	121478942	121479020	3500180763	78		121478942	121479020	8421504	1	78	0	p	350018076300015005	3-81						Tumstatin Peptide, an Inhibitor of Angiogenesis, Prevents Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy	betesjournals.org	0	0		COL4A3
1511	chr2	121479081	121479232	3500184228	24		121479081	121479232	8421504	2	19,5	0,146	c	350018422800000292	0-24						IDENTIFICATION OF A MUTATION IN COL4A5 CAUSATIVE FOR X- LINKED ALPORT SYNDROME IN THE DOMESTIC DOG AND ANALYSIS OF GENE EXPRESSION IN THE KIDNEYS OF AFFECTED AND NONAFFECTED SIBLINGS	pository.tamu.edu	0	0		
1511	chr2	121480353	121480377	3500074260	24		121480353	121480377	8421504	1	24	0	c	350007426000000185	24-48						 Human E3.alpha. Ubiquitin Ligase Family 	www.docstoc.com	0	0		
1511	chr2	121495528	121496756	3500134343	46		121495528	121496756	8421504	2	23,23	0,1205	c	350013434300000002,350013434300000003	0-23,0-23						Assessing the complex nature of behavior: Sequence-based and transcriptomic analyses in a mouse model of extremes in trait anxiety	b.uni-muenchen.de	0	0		
1513	chr2	121708897	121708957	3500373689	60		121708897	121708957	8421504	1	60	0	p	350037368900015027	0-60						Identification and characterization of Risp: a new nucleocytoplasmic shuttle protein interacting with the HIV-1 Rev protein	b.uni-muenchen.de	0	0		AGFG1
1515	chr2	121950455	121950481	3500174839	23		121950455	121950481	8421504	3	12,5,6	0,14,20	g	350017483900000004	7-31		20363950	10.1128/JB.01534-09	0021-9193	Journal of Bacteriology	Selective Depletion of Sulfolobus solfataricus Transcription Factor E under Heat Shock Conditions	Iqbal	2010	4		
1515	chr2	121959260	121959284	3500069335	23		121959260	121959284	8421504	2	12,11	0,13	g	350006933500000163	0-23						AVERTISSEMENT	.scd.uhp-nancy.fr	0	0		
1515	chr2	121960357	121961665	3500327852	77		121960357	121961665	8421504	2	36,41	0,1267	c	350032785200000036,350032785200000039	11-47,0-41						Antibodies That Specifically Bind to Chemokine Beta-4 - Patent application	www.faqs.org	0	0		
1515	chr2	121960366	121961646	3500167894	41		121960366	121961646	8421504	2	21,20	0,1260	c,g	350016789400000013,350016789400000013,350016789400000014	0-21,0-21,0-20						&#xc9;COLE DOCTORALE SST	lis.univ-tours.fr	0	0		
1515	chr2	121960366	121961646	3500157269	41		121960366	121961646	8421504	2	21,20	0,1260	c	350015726900000013,350015726900000014	0-21,0-20						&#xc9;COLE DOCTORALE SST	scd.univ-tours.fr	0	0		
1515	chr2	121960366	121960393	3500396554	27		121960366	121960393	8421504	1	27	0	c,g	350039655400000034,350039655400000034,350039655400000021	0-20,0-20,0-19						Untersuchungen zur Rolle des Regulatorproteins TviA bei der Immunevasion von Salmonella enterica Serovar Typhi	b.uni-muenchen.de	0	0		
1515	chr2	121960415	121961660	3500222430	62		121960415	121961660	8421504	3	7,14,41	0,1144,1204	c	350022243000000000,350022243000000002,350022243000000001	0-21,0-21,0-20		23124835	10.1002/eji.201242736	1521-4141	European Journal of Immunology	Differential recruitment and activation of natural killer cell sub-populations by Mycobacterium bovis-infected dendritic cells - Siddiqui - 2012 - European Journal of Immunology - Wiley Online Library	Siddiqui	2013	0		
1515	chr2	121961567	121962452	3500137193	41		121961567	121962452	8421504	2	20,21	0,864	c,g	350013719300000010,350013719300000010,350013719300000011,350013719300000011	0-20,0-20,0-21,0-21						Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system	biomedcentral.com	0	0		
1515	chr2	121963356	121963380	3500173326	24		121963356	121963380	8421504	1	24	0	c	350017332600000010	0-24		12928424		0022-1767	The Journal of Immunology	Activation of Cutaneous Protein Kinase C&#x03b1; Induces Keratinocyte Apoptosis and Intraepidermal Inflammation by Independent Signaling Pathways	Cataisson	2003	6		
1520	chr2	122653006	122653031	3500155230	23		122653006	122653031	8421504	2	8,15	0,10	g	350015523000000138	10-45						 Microbially Expresses Xylanases And Their Use As Feed Additives And Other Uses 	www.docstoc.com	0	0		
1524	chr2	123152388	123152412	3500405377	23		123152388	123152412	8421504	2	11,12	0,12	g	350040537700000112,350040537700000002	2-25,2-25						US Patent # 6,472,191. DNA FRAGMENT CARRYING TOLUENE MONOOXYGENASE GENE, RECOMBINANT PLASMID, TRANSFORMED MICROORGANISM, METHOD FOR DEGRADING CHLORINATED ALIPHATIC HYDROCARBON COMPOUNDS AND AROMATIC COMPOUNDS, AND METHOD FOR ENVIRONMENTAL REMEDIATION - Pa	www.patents.com	0	0		
1524	chr2	123152388	123152412	3500029202	23		123152388	123152412	8421504	2	11,12	0,12	g	350002920200000002	2-25						DNA FRAGMENT CARRYING TOLUENE MONOOXYGENASE, GENE, RECOMBINANT PLASMID, TRANSFORMED MICROORGANISM, METHOD FOR DEGRADING CHLORINATED ALIPHATIC HYDROCARBON COMPOUNDS AND AROMATIC COMPOUNDS, AND METHOD FOR ENVIRONMENTAL REMEDIATION	Yano	2002	0		
1526	chr2	123355428	123359640	3500276249	41		123355428	123359640	8421504	2	21,20	0,4192	c	350027624900000003,350027624900000002	0-21,0-20						0509_S1_article_02	www.jpp.krakow.pl	0	0		
1527	chr2	123567818	123567844	3500394860	23		123567818	123567844	8421504	2	8,15	0,11	c	350039486000000151	13-45						METHODS AND COMPOSITIONS FOR TREATING TULAREMIA - Patent application	www.faqs.org	0	0		
1527	chr2	123568606	123568632	3500157778	24		123568606	123568632	8421504	2	7,17	0,9	c	350015777800000007	20-44			10.1073/pnas.0602461103		Proceedings of the National Academy of Sciences of the United States of America	Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza	Jutta	2006	0		
1528	chr2	123682061	123682084	3500256218	23		123682061	123682084	8421504	1	23	0	g	350025621800000126	0-23						REPRODUCTION	uction-online.org	0	0		
1529	chr2	123817730	123818620	3500150954	276		123817730	123818620	8421504	6	46,58,32,25,57,58	0,51,112,742,770,832	g	350015095400000005	0-276						Nucleic acid preparation from whole blood for use in diagnosis of transmissible spongiform encephalopathy - US Patent 7569367 Description	ww.patentstorm.us	0	0		
1530	chr2	123901275	123901298	3500301112	23		123901275	123901298	8421504	1	23	0	c	350030111200000015,350030111200000014	19-40,0-19		23302075	10.1111/j.1740-0929.2012.01036.x	1740-0929	Animal Science Journal	Application of highly differentiated SNPs between Japanese Black and Holstein to a breed assignment test between Japanese Black and F1 (Japanese Black x Holstein) and Holstein - NISHIMURA - 2012 - Animal Science Journal - Wiley Online Library	NISHIMURA	2013	0		
1530	chr2	123921180	123921209	3500003517	26		123921180	123921209	8421504	2	8,18	0,11	g	350000351700000710	8-34						 Neisseria Meningitidis Antigens And Compositions 	www.docstoc.com	0	0		
1531	chr2	124054029	124054058	3500306817	25		124054029	124054058	8421504	3	5,12,8	0,6,21	g	350030681700000206	10-35						Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus 	.freshpatents.com	0	0		
1532	chr2	124180611	124191817	3500111653	573		124180611	124191817	8421504	4	132,141,189,111	0,8197,10217,11095	p	350011165300015001,350011165300015008	0-567,0-573						est_o_mossambicus207 | MarineGenomics.org	arinegenomics.org	0	0		
1532	chr2	124229531	124229554	3500183397	23		124229531	124229554	8421504	1	23	0	g	350018339700000001	0-23			10.1038/sj.bjp.0707460	1476-5381	British Journal of Pharmacology	The orphan receptor GPR55 is a novel cannabinoid receptor - Ryberg - 2009 - British Journal of Pharmacology - Wiley Online Library	Ryberg	2007	0		
1533	chr2	124323473	124323505	3500464585	25		124323473	124323505	8421504	3	5,14,6	0,8,26	c	350046458500000423	3-28						Caracteriza&#xe7;&#xe3;o de Metaloproteinases PIII a partir do DNA gen&#xf4;mico de Bothrops jararaca	www.teses.usp.br	0	0		
1534	chr2	124410144	124410180	3500416244	36		124410144	124410180	8421504	1	36	0	c	350041624400000006	0-36						Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier	Davidson	2007	0		
1534	chr2	124410144	124410180	3500349359	36		124410144	124410180	8421504	1	36	0	c	350034935900000006	0-36						Immunomodulation and effect on cell processes relating to serotonin family receptors	Albert	2002	0		
1534	chr2	124410144	124410180	3500345883	36		124410144	124410180	8421504	1	36	0	c	350034588300000006	0-36						Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier	Jameson	2006	0		
1534	chr2	124410144	124410180	3500326686	36		124410144	124410180	8421504	1	36	0	c	350032668600000006	0-36						Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier	B*A*Zhan Mu Sen 	2005	0		
1534	chr2	124410144	124410180	3500223954	36		124410144	124410180	8421504	1	36	0	c	350022395400000006	0-36						Immunomodulation and effect on cell processes relating to serotonin family receptors	Albert	2003	0		
1534	chr2	124410144	124410180	3500122964	36		124410144	124410180	8421504	1	36	0	c	350012296400000006	0-36						Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier	Jameson	2006	0		
1534	chr2	124410144	124410180	3500111780	36		124410144	124410180	8421504	1	36	0	c	350011178000000006	0-36						Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier	Davidson	2005	0		
1535	chr2	124573464	124573488	3500353024	24		124573464	124573488	8421504	1	24	0	c	350035302400000019	0-33						Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein	Graf	2005	0		
1536	chr2	124742537	124747760	3500465426	153		124742537	124747760	8421504	4	24,66,56,7	0,1804,4977,5216	p,c	350046542600000001,350046542600015006,350046542600015005	3-27,0-66,0-63			10.1046/j.1432-1033.2003.03929.x	1432-1033	European Journal of Biochemistry	Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells - Legrand - 2003 - European Journal of Biochemistry - Wiley Online Library	Legrand	2004	0		NCL
1536	chr2	124742542	124742791	3500115846	45		124742542	124742791	8421504	2	39,6	0,243	g	350011584600000001	11-56		22318319	10.1128/mBio.00301-11	2150-7511	mBio	Host Cell Nucleolin Is Required To Maintain the Architecture of Human Cytomegalovirus Replication Compartments	Strang	2012	5		
1536	chr2	124742542	124742568	3500424280	26		124742542	124742568	8421504	1	26	0	c	350042428000000000	6-32		16672376	10.1091/mbc.E06-02-0162	1059-1524	Molecular Biology of the Cell	Substrate-dependent Contribution of Double-stranded RNA-binding Motifs to ADAR2 Function	Xu	2006	5		CDH9,NCL
1536	chr2	124742545	124742956	3500204719	243		124742545	124742956	8421504	2	74,169	0,242	p	350020471900015023,350020471900015028,350020471900015026,350020471900015030,350020471900015027,350020471900015019	0-48,3-96,0-132,0-162,0-120,0-78						Title Functional interaction of hepatitis C virus NS5B with nucleolin GAR Author(s) Citation Journal of Biochemistry, 141(6): 917-927 Issue Date Type Journal Article Text version	.kanazawa-u.ac.jp	0	0		
1536	chr2	124742545	124742902	3500211687	189		124742545	124742902	8421504	2	74,115	0,242	p	350021168700015000	0-189		18789156	10.1186/1471-2180-8-145	1471-2180	BMC Microbiology	A novel receptor &#xe2; ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu	Barel	2008	3		SNORA75,NCL
1536	chr2	124747770	124747811	3500017368	41		124747770	124747811	8421504	1	41	0	c	350001736800000011	0-41						Human Monoclonal Antibodies to Human Nucleolin	Sutkowski	2010	0		
1536	chr2	124748079	124748139	3500159091	60		124748079	124748139	8421504	1	60	0	p	350015909100015003	6-66		15284292	10.1097/01.ASN.0000133024.83256.C8	1046-6673	Journal of the American Society of Nephrology	An Acidic Peptide Sequence of Nucleolin-Related Protein Can Mediate the Attachment of Calcium Oxalate to Renal Tubule Cells	Sorokina	2004	10		
1539	chr2	125093349	125093415	3500169203	66		125093349	125093415	8421504	1	66	0	p	350016920300015006	0-66						LONG ACTING ATRIAL NATRIURETIC PEPTIDE (LA-ANP) AND METHODS FOR USE THEREOF - Patent application	www.faqs.org	0	0		NPPC
1539	chr2	125093349	125093415	3500139283	66		125093349	125093415	8421504	1	66	0	p	350013928300015009	0-66						Heterologous expression and biochemical characterization - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		NPPC
1539	chr2	125093355	125093415	3500384310	60		125093355	125093415	8421504	1	60	0	p	350038431000015138	0-60						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		NPPC
1539	chr2	125093367	125093415	3500085007	48		125093367	125093415	8421504	1	48	0	p	350008500700015022	0-48						Adenovirus Vectors Encoding Brain Natriuretic Peptide 	freshpatents.com	0	0		NPPC
1541	chr2	125370245	125370271	3500449156	25		125370245	125370271	8421504	2	6,19	0,7	g	350044915600000088	8-34					Patent	DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor (Patent US:5426048)	Gearing	1995	0		
192	chr2	125557203	125610601	3500191214	4597		125557203	125610601	8421504	44	15,26,48,54,50,241,110,171,43,221,122,16,69,250,160,46,44,304,54,110,46,71,57,25,23,180,242,71,219,3,307,203,1,329,103,68,6,10,7,25,4,19,27,397	0,77,44120,46081,46415,46860,47939,48050,48222,48266,48490,48613,48630,48701,48952,49113,49160,49205,49539,49735,49893,49940,50012,50070,50096,50120,50310,50562,50634,50943,51033,51360,51954,52060,52631,52735,52807,52816,52837,52845,52871,52899,52970,53001	c,g	350019121400000046,350019121400000020,350019121400000045,350019121400000049,350019121400000057,350019121400000017,350019121400000018,350019121400000019,350019121400000022,350019121400000024,350019121400000025,350019121400000026,350019121400000027,350019121400000028,350019121400000029,350019121400000030,350019121400000031,350019121400000032,350019121400000033,350019121400000036,350019121400000037,350019121400000038,350019121400000039,350019121400000040,350019121400000041,350019121400000042,350019121400000043,350019121400000050,350019121400000051,350019121400000052,350019121400000053,350019121400000054,350019121400000055,350019121400000056	59-152,69-117,0-54,0-50,0-970,0-1548,0-19,0-54,0-110,0-42,0-227,0-48,0-48,0-38,0-107,0-48,0-48,0-42,0-290,82-169,0-114,0-48,0-48,0-26,0-107,0-48,0-48,64-106,0-48,0-48,0-48,0-48,0-48,0-48						Recombinant calf intestinal alkaline phosphatase	Millan	1995	0		
192	chr2	125557203	125610601	3500187155	4482		125557203	125610601	8421504	48	15,26,48,48,54,50,96,241,110,171,43,221,122,16,69,250,160,46,44,285,54,110,46,71,57,25,23,180,242,71,219,3,186,73,155,1,89,96,103,68,6,10,7,25,4,19,27,397	0,77,44120,45689,46081,46415,46668,46860,47939,48050,48222,48266,48490,48613,48630,48701,48952,49113,49160,49205,49539,49735,49893,49940,50012,50070,50096,50120,50310,50562,50634,50943,51033,51267,51360,51954,52060,52293,52631,52735,52807,52816,52837,52845,52871,52899,52970,53001	c,g	350018715500000046,350018715500000020,350018715500000038,350018715500000045,350018715500000049,350018715500000053,350018715500000054,350018715500000057,350018715500000017,350018715500000019,350018715500000022,350018715500000024,350018715500000025,350018715500000026,350018715500000027,350018715500000028,350018715500000029,350018715500000030,350018715500000031,350018715500000031,350018715500000032,350018715500000033,350018715500000036,350018715500000037,350018715500000039,350018715500000040,350018715500000041,350018715500000042,350018715500000050,350018715500000051,350018715500000055,350018715500000056	59-152,69-117,0-48,0-54,0-50,0-48,0-48,0-970,0-1548,0-54,0-110,0-42,0-227,0-48,0-48,0-38,0-107,0-48,0-48,0-48,0-42,0-290,82-169,0-114,0-48,0-26,0-107,0-48,64-106,0-48,0-48,0-48						Nucleic acid encoding calf intestinal alkaline phosphatase	Millan	1995	0		
1543	chr2	125603618	125610601	3500238128	4945		125603618	125610601	8421504	49	63,92,241,110,171,43,221,122,16,69,250,160,46,44,285,3,101,204,71,57,25,23,180,242,71,267,3,307,305,37,11,16,8,6,17,5,4,95,288,103,68,6,10,7,25,4,19,27,397	0,65,445,1524,1635,1807,1851,2075,2198,2215,2286,2537,2698,2745,2790,3091,3173,3320,3525,3597,3655,3681,3705,3895,4147,4219,4528,4618,4945,5255,5293,5310,5328,5337,5354,5375,5382,5387,5686,6216,6320,6392,6401,6422,6430,6456,6484,6555,6586	c,g	350023812800000047,350023812800000054,350023812800000017,350023812800000019,350023812800000021,350023812800000022,350023812800000023,350023812800000024,350023812800000025,350023812800000026,350023812800000027,350023812800000028,350023812800000029,350023812800000030,350023812800000031,350023812800000032,350023812800000033,350023812800000035,350023812800000036,350023812800000037,350023812800000038,350023812800000039,350023812800000040,350023812800000041,350023812800000042,350023812800000043,350023812800000044,350023812800000045,350023812800000048,350023812800000049,350023812800000050,350023812800000051,350023812800000052,350023812800000053	0-157,0-970,0-1548,46-174,0-110,0-48,0-42,0-227,0-48,0-48,0-38,0-107,0-48,0-48,0-42,0-290,0-48,82-169,0-114,0-48,0-48,0-26,0-107,0-48,0-48,0-48,0-227,0-48,0-48,0-48,0-48,0-48,0-48,0-48					Patent	Recombinant calf intestinal alkaline phosphatase (Patent US:5773226)	Millan	1998	0		
1543	chr2	125607118	125607335	3500160984	27		125607118	125607335	8421504	2	20,7	0,210	c	350016098400000007	0-27						UNIVERSIT&#xc9; DU QU&#xc9;BEC M&#xc9;MOIRE PR&#xc9;SENT&#xc9; &#xc0; L'UNIVERSIT&#xc9; DU QU&#xc9;BEC fi.. TROIS-RIVI&#xc8;RES DE LA MA&#xce;TRISE EN BIOPHYSIQUE ET BIOLOGIE CELLULAIRES	depot-e.uqtr.ca	0	0		
1543	chr2	125608293	125608415	3500362160	23		125608293	125608415	8421504	2	16,7	0,115	c	350036216000000011	17-40						Understanding intestinal lipopolysaccharide permeability and associated inflammation	ib.dr.iastate.edu	0	0		
1543	chr2	125609319	125609361	3500261697	42		125609319	125609361	8421504	1	42	0	c	350026169700000117	6-48						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease	Potts	2001	0		
1543	chr2	125671148	125671202	3500081559	54		125671148	125671202	8421504	1	54	0	p	350008155900015011	0-54						Determination of an Epitope of the Diffuse Systemic Sclerosis Marker Antigen DNA Topoisomerase I: Sequence Similarity with Retroviral p30gag Protein Suggests a Possible Cause for Autoimmunity in Systemic Sclerosis	www.jstor.org	0	0		
1543	chr2	125671211	125671701	3500336956	48		125671211	125671701	8421504	2	9,39	0,451	p	350033695600015004	0-48						Isolation characterization cDNA complete protein region	brary.caltech.edu	0	0		CHRND
1544	chr2	125737558	125737582	3500155190	23		125737558	125737582	8421504	2	8,15	0,9	c	350015519000000003	2-25						Incorporation of modified nucleotides by archaeon dna polymerases and related methods	Buzby	2002	0		
1544	chr2	125737558	125737582	3500121592	23		125737558	125737582	8421504	2	8,15	0,9	c	350012159200000036	11-34						MODIFIED IL-4 MUTEIN RECEPTOR ANTAGONISTS - Patent application	www.faqs.org	0	0		
1544	chr2	125737558	125737582	3500008620	23		125737558	125737582	8421504	2	8,15	0,9	c	350000862000000002	2-25						Incorporation of modified nucleotides by archaeon DNA polymerases and related methods	Jack	2006	0		
1545	chr2	125917128	125920433	3500431628	180		125917128	125920433	8421504	2	61,119	0,3186	p	350043162800015046	0-180						49 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		PHC2
1545	chr2	125939217	125939251	3500135310	25		125939217	125939251	8421504	3	6,7,12	0,11,22	c	350013531000000009	5-30						Novel c-type lectin and gene thereof	Akira	2002	0		
1546	chr2	126077898	126077924	3500287824	24		126077898	126077924	8421504	2	13,11	0,15	c	350028782400000292	7-45						Improved isoprenoid production	Ai Lun *Bei Li 	2005	0		
1548	chr2	126262513	126263197	3500080696	25		126262513	126263197	8421504	2	12,13	0,671	c	350008069600000043	8-33						Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof	Kerr	2002	0		
1549	chr2	126438325	126438353	3500155222	23		126438325	126438353	8421504	2	18,5	0,23	g	350015522200000002	11-34						***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***B. braunii, race B gene for a triterpene methyltransferase enzyme and uses thereof	Chappell	2009	0		
1550	chr2	126486950	126486974	3500132003	24		126486950	126486974	8421504	1	24	0	c	350013200300000004	0-24		18367591	10.1152/ajpcell.00049.2008		American Journal of Physiology - Cell Physiolog	Syncoilin is required for generating maximum isometric stress in skeletal muscle but dispensable for muscle cytoarchitecture	Zhang	2008	0		
1550	chr2	126486950	126486974	3500000490	24		126486950	126486974	8421504	1	24	0	c	350000049000000004	0-24		18367591	10.1152/ajpcell.00049.2008		American Journal of Physiology - Cell Physiology	Syncoilin is required for generating maximum isometric stress in skeletal muscle but dispensable for muscle cytoarchitecture	Zhang	2008	0		
1550	chr2	126512334	126512391	3500110397	54		126512334	126512391	8421504	2	33,21	0,36	p	350011039700015031	0-54						Method for producing recombinant organisms	Badur	2004	0		RBBP4
1550	chr2	126568371	126568401	3500055012	26		126568371	126568401	8421504	3	10,12,4	0,13,26	g	350005501200000040	13-47						Elastische Deformierbarkeit des ab c -Komplexes und Rekonstitution in biomimetische Modellmembranen	uni-osnabrueck.de	0	0		
1552	chr2	126784830	126784902	3500389626	72		126784830	126784902	8421504	1	72	0	p	350038962600015017	0-72						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		MARCKSL1
1552	chr2	126784830	126784902	3500061337	72		126784830	126784902	8421504	1	72	0	p	350006133700015028,350006133700015155	0-72,0-48						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		MARCKSL1
1552	chr2	126787545	126787574	3500185781	26		126787545	126787574	8421504	3	5,15,6	0,7,23	c	350018578100000170	14-40						US Patent # 7,192,915. Methods for treating multiple sclerosis with GGF-related polypeptides - Patents.com	www.patents.com	0	0		
1552	chr2	126787545	126787574	3500022936	26		126787545	126787574	8421504	3	5,15,6	0,7,23	c	350002293600000170	14-40						US Patent # 7,094,749. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
1552	chr2	126788132	126798427	3500299630	150		126788132	126798427	8421504	4	57,14,75,4	0,4079,5785,10291	p	350029963000015057,350029963000015058	0-57,3-96						ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis	icine.bjmu.edu.cn	0	0		
1552	chr2	126788132	126798427	3500216346	150		126788132	126798427	8421504	4	57,14,75,4	0,4079,5785,10291	p	350021634600015057,350021634600015058	0-57,3-96						ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis	icine.bjmu.edu.cn	0	0		
1552	chr2	126798511	126810624	3500302543	40		126798511	126810624	8421504	2	20,20	0,12093	c	350030254300000000,350030254300000001	0-20,0-20		21248725	10.1038/mi.2010.83	1933-0219	Mucosal Immunology	Epigenetic regulation of human &#x03b2;-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria	Yin	2011	7		HDAC1
1552	chr2	126826279	126826463	3500366238	102		126826279	126826463	8421504	2	74,28	0,156	p	350036623800015012	0-102						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		LCK
1552	chr2	126859179	126859227	3500431918	48		126859179	126859227	8421504	1	48	0	p	350043191800015011	0-48						Riboproteomics of the Hepatitis C Virus Internal Ribosomal Entry Site	gs.washington.edu	0	0		EIF3IP1
1552	chr2	126863435	126863459	3500211566	24		126863435	126863459	8421504	1	24	0	c	350021156600000001	0-24		21378021	10.1152/ajplung.00350.2010		American Journal of Physiology - Lung Cellular and Molecular Physiology	TRIP-1 regulates TGF-&#x03b2;1-induced epithelial-mesenchymal transition of human lung epithelial cell line A549	Perez	2011	0		
1553	chr2	126884252	126884278	3500265276	23		126884252	126884278	8421504	3	6,12,5	0,8,21	g	350026527600000007	4-27			10.1128/IAI.01544-06		Infection and Immunity	The Glycan Moieties and the N-Terminal Polypeptide Backbone of a Fimbria-Associated Adhesin, Fap1, Play Distinct Roles in the Biofilm Development of Streptococcus parasanguinis 	Hui	2007	0		
1553	chr2	126884252	126884278	3500007942	23		126884252	126884278	8421504	3	6,12,5	0,8,21	g	350000794200000007	4-27		17296746	10.1128/IAI.01544-06	0019-9567	Infection and Immunity	The Glycan Moieties and the N-Terminal Polypeptide Backbone of a Fimbria-Associated Adhesin, Fap1, Play Distinct Roles in the Biofilm Development of Streptococcus parasanguinis	Wu	2007	4		
1553	chr2	126911767	126965857	3500368529	1248		126911767	126965857	8421504	12	185,179,128,39,70,89,132,95,100,93,134,4	0,1950,3085,3528,6040,6880,8403,9521,10762,13047,13995,54086	p	350036852900015053,350036852900015052,350036852900015051,350036852900015048,350036852900015108,350036852900015047,350036852900015046,350036852900015045	3-177,0-180,0-180,0-180,39-132,0-180,0-177,0-180						Analyse der differentiellen Expression von Transportfaktoren und deren F&#xe8;&#xf2;O &#xc8;Z@ &#xad;/ \\\\&#xa7; -&#xf3;&#xcc;[ S&#xc4;M&#xd0;Bt s&#xb1;G&#xa5;' &#xe1;fo \\\\&#xf9; &#xe2;&#xc7; &#xe8;&#xd9;&#xcc;Z&#xa9;&#xc7;.&#xe2; &#xff;;o&#xfd;c	uni-goettingen.de	0	0		
1554	chr2	127009213	127009238	3500008216	24		127009213	127009238	8421504	2	10,14	0,11	c	350000821600000048,350000821600000043	0-24,0-24						Caracterizaci&#xf3;n estructural del polimorfismo del microsat&#xe9;lite MSTN01 del gen de miostatina bovina	.bnct.ipn.mx:8080	0	0		
1554	chr2	127011903	127032265	3500366935	45		127011903	127032265	8421504	2	25,20	0,20342	c	350036693500000001,350036693500000000	0-25,23-43						THE J B C &#xa9; 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. The Tyrosine Kinase Hck Is an Inhibitor of HIV-1 Replication Counteracted by the Viral Vif Protein*	www.jbc.org	0	0		
1554	chr2	127017097	127032142	3500123358	231		127017097	127032142	8421504	4	41,47,47,96	0,89,1404,14949	c,g	350012335800000112,350012335800000110,350012335800000110,350012335800000108,350012335800000101,350012335800000100	0-41,1-48,1-48,0-47,0-48,0-48					Patent	53BP2 complexes (Patent US:5977311)	Nandabalan	1999	0		
1554	chr2	127119294	127119658	3500152218	41		127119294	127119658	8421504	2	21,20	0,344	g	350015221800000007,350015221800000008	0-21,1-21		23657814	10.1091/mbc.E13-01-0017		Molecular Biology of the Cell	Transforming growth factor-&#x03b2;1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199&#x2013;dependent posttranscriptional mechanism	Ognoon	July	0		TUBA1A
1554	chr2	127125922	127134783	3500227435	309		127125922	127134783	8421504	4	96,75,44,94	0,2290,7749,8767	p	350022743500015003,350022743500015011	0-171,0-138						The Role of the Protein Tyrosine Phosphatase PRL-3 in Regulating Cell Signaling in Cancerous and Non-Cancerous Cell Lines by DARRELL CHRISTOPHER BESSETTE B.Sc., Simon Fraser University, 1999 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FO	mussenbindery.com	0	0		PTP4A2
1554	chr2	127125922	127134783	3500099141	309		127125922	127134783	8421504	4	96,75,44,94	0,2290,7749,8767	p	350009914100015003,350009914100015011	0-171,0-138						The Role of the Protein Tyrosine Phosphatase PRL-3 in Regulating Cell Signaling in Cancerous and Non-Cancerous Cell Lines by DARRELL CHRISTOPHER BESSETTE B.Sc., Simon Fraser University, 1999 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FO	mussenbindery.com	0	0		PTP4A2
1557	chr2	127418091	127425632	3500008577	172		127418091	127425632	8421504	4	65,31,48,28	0,1949,5488,7513	p,c	350000857700000029,350000857700015007,350000857700000053,350000857700000017,350000857700000055	0-48,0-48,0-33,0-48,20-48						Human Neuropeptide Receptor 	.freshpatents.com	0	0		
1557	chr2	127418139	127425279	3500113307	96		127418139	127425279	8421504	3	17,31,48	0,1901,7092	p	350011330700015047,350011330700015030	0-48,0-48						Human narcolepsy gene	Olafsdottir	2000	0		
1557	chr2	127418143	127425516	3500361343	195		127418143	127425516	8421504	12	13,22,16,21,15,13,19,15,16,15,15,15	0,1897,2003,3079,3291,4917,5014,5390,5618,6998,7162,7358	c	350036134300000012,350036134300000011,350036134300000010,350036134300000009,350036134300000008,350036134300000007,350036134300000006,350036134300000005,350036134300000004,350036134300000003,350036134300000001	0-21,0-27,0-24,0-28,0-21,0-19,0-26,0-23,0-23,0-23,0-30						&#x5f20;&#x4e3d; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
1557	chr2	127425231	127425276	3500439359	45		127425231	127425276	8421504	1	45	0	p	350043935900015053	0-45						Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72	Hagan	1998	0		HCRTR2
1557	chr2	127425271	127425299	3500170203	28		127425271	127425299	8421504	1	28	0	c	350017020300000028	0-28						9-Methyl- -carboline has restorative effects in an animal model of Parkinson&#x2019;s disease	.if-pan.krakow.pl	0	0		HCRTR1
1558	chr2	127552371	127552397	3500265656	23		127552371	127552397	8421504	2	5,18	0,8	c	350026565600000016	2-25						CA6 Antigen-Specific Cytotoxic Conjugate and Methods of Using the Same - Patent application	www.faqs.org	0	0		
1558	chr2	127552371	127552397	3500064473	23		127552371	127552397	8421504	2	5,18	0,8	c	350006447300000016	0-23						CA6 antigen-specific cytotoxic conjugate and methods of using the same - US Patent 7834155 Description	ww.patentstorm.us	0	0		
1558	chr2	127602219	127609546	3500004621	402		127602219	127609546	8421504	4	76,173,102,51	0,3551,5683,7276	c,g	350000462100000026,350000462100000013,350000462100000022,350000462100000008,350000462100000008	693-1095,0-22,26-78,0-39,0-39						Anhang	ebdoc.sub.gwdg.de	0	0		
1558	chr2	127605808	127605910	3500261436	43		127605808	127605910	8421504	2	22,21	0,81	c,g	350026143600000038,350026143600000038,350026143600000037	0-22,0-22,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1558	chr2	127605919	127607903	3500330881	25		127605919	127607903	8421504	2	24,1	0,1983	c	350033088100000001	0-25						[tel-00624381, v1] D&#xe9;terminants mitochondriaux de l'oxydation des acides gras : modulation par l'entra&#xee;nement, l'hypoxie et un agoniste PPAR-*	hives-ouvertes.fr	0	0		
1558	chr2	127609554	127609763	3500280425	64		127609554	127609763	8421504	3	20,24,20	0,51,189	c	350028042500000003,350028042500000005,350028042500000004	0-20,0-24,0-20		17565066	10.2527/jas.2006-837	0021-8812	Journal of Animal Science	Adipocyte fatty acid-binding protein and mitochondrial enzyme activities in muscles as relevant indicators of marbling in cattle	Jurie	2007	2		
1558	chr2	127611245	127611273	3500266480	23		127611245	127611273	8421504	2	7,16	0,12	c	350026648000000020	0-26						US Patent # 6,951,720. Use of phosphorothiolate polynucleotides in ligating nucleic acids - Patents.com	www.patents.com	0	0		PHIP
1558	chr2	127633982	127635197	3500462735	23		127633982	127635197	8421504	3	3,8,12	0,1194,1203	c	350046273500000000	0-25		15613298	10.1128/JVI.79.2.705-716.2005	0022-538X	Journal of Virology	In Vitro and In Vivo Relevance of Infectious Laryngotracheitis Virus gJ Proteins That Are Expressed from Spliced and Nonspliced mRNAs	Fuchs	2005	5		ZCCHC17
1558	chr2	127633982	127635197	3500259946	23		127633982	127635197	8421504	3	3,8,12	0,1194,1203	c	350025994600000000	0-25			10.1128/JVI.79.2.705-716.2005		Journal of Virology	In Vitro and In Vivo Relevance of Infectious Laryngotracheitis Virus gJ Proteins That Are Expressed from Spliced and Nonspliced mRNAs	WalFuchs	2005	0		ZCCHC17
1558	chr2	127635265	127635291	3500388949	23		127635265	127635291	8421504	2	5,18	0,8	g	350038894900000015	8-31						METHOD TO PRODUCE INDUCED PLURIPOTENT STEM (IPS) CELLS FROM NON-EMBRYONIC HUMAN CELLS - Patent application	www.faqs.org	0	0		
1559	chr2	127669891	127687437	3500439093	528		127669891	127687437	8421504	6	111,121,83,62,104,47	0,8062,10390,11549,16863,17499	p	350043909300015072,350043909300015071,350043909300015068,350043909300015069,350043909300015070	0-120,15-423,0-66,0-90,0-90						Secreted protein HFEAF41	Brewer	2003	0		SNRNP40
1559	chr2	127669891	127687437	3500080223	528		127669891	127687437	8421504	6	111,121,83,62,104,47	0,8062,10390,11549,16863,17499	p	350008022300015076,350008022300015075,350008022300015072,350008022300015073,350008022300015074	0-120,15-423,0-66,0-90,0-90						87 Human Secreted Proteins	Young	2007	0		SNRNP40
1559	chr2	127669891	127687437	3500064227	528		127669891	127687437	8421504	6	111,121,83,62,104,47	0,8062,10390,11549,16863,17499	p	350006422700015072,350006422700015071,350006422700015068,350006422700015069,350006422700015070	0-120,15-423,0-66,0-90,0-90						Secreted protein HFEAF41	Brewer	2003	0		SNRNP40
1559	chr2	127669891	127687437	3500032881	528		127669891	127687437	8421504	6	111,121,83,62,104,47	0,8062,10390,11549,16863,17499	p	350003288100015073,350003288100015072,350003288100015069,350003288100015070,350003288100015071	0-120,15-423,0-66,0-90,0-90						87 human secreted proteins	Brewer	2003	0		SNRNP40
1559	chr2	127669891	127686857	3500447618	366		127669891	127686857	8421504	5	111,9,81,62,103	0,8062,10392,11549,16863	p	350044761800015074,350044761800015070,350044761800015071,350044761800015072	0-120,0-66,0-90,0-90					Patent	Antibodies to HASAV70 polypeptide (Patent US:7169565)	Ruben	2007	0		SNRNP40
1559	chr2	127669891	127686857	3500029713	366		127669891	127686857	8421504	5	111,9,81,62,103	0,8062,10392,11549,16863	p	350002971300015074,350002971300015070,350002971300015071,350002971300015072	0-120,0-66,0-90,0-90						87 human secreted proteins	Young	2005	0		SNRNP40
1560	chr2	127842808	127846994	3500038979	40		127842808	127846994	8421504	2	20,20	0,4166	c,g	350003897900000000,350003897900000001,350003897900000001	0-20,0-20,0-20						Human adipose derived stroma/stem cells grow in serum-free medium as floating spheres	les.wordpress.com	0	0		PUM1
1561	chr2	128012609	128016622	3500436211	40		128012609	128016622	8421504	2	20,20	0,3993	c,g	350043621100000017,350043621100000037,350043621100000037	0-20,0-20,0-20						Role of Heparan sulfate in initiation and propagation of Islet amyloid polypeptide aggregation	ibg.uu.se/digital	0	0		SDC3
1561	chr2	128017517	128017549	3500436998	23		128017517	128017549	8421504	3	5,12,6	0,9,26	c	350043699800000005	7-30					Patent	Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens (Patent US:7067110)	Gillies	2006	0		
1561	chr2	128017517	128017549	3500206192	23		128017517	128017549	8421504	3	5,12,6	0,9,26	c	350020619200000005	7-30						&#x0421;&#x043b;&#x0438;&#x0442;&#x044b;&#x0435; &#x0431;&#x0435;&#x043b;&#x043a;&#x0438; &#x0441; fc-&#x0444;&#x0440;&#x0430;&#x0433;&#x043c;&#x0435;&#x043d;&#x0442;&#x043e;&#x043c; &#x0438;&#x043c;&#x043c;&#x0443;&#x043d;&#x043e;&#x0433;&#x043b;&#x043e;	www.findpatent.ru	0	0		
1562	chr2	128151128	128151153	3500162207	23		128151128	128151153	8421504	2	10,13	0,12	g	350016220700000031	10-33						Angiogenesis-modulating compositions and uses	Ling	2001	0		
1562	chr2	128170171	128171560	3500164379	492		128170171	128171560	8421504	2	403,89	0,1300	p	350016437900015055	177-993						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		MATN1
1569	chr2	129034146	129034170	3500146089	23		129034146	129034170	8421504	2	6,17	0,7	g	350014608900000017	0-23						Antimicrobial polypeptides from pseudoplectania nigrella	Schnorr	2005	0		
1570	chr2	129154395	129154420	3500326034	23		129154395	129154420	8421504	2	12,11	0,14	g	350032603400000234	9-32						 Selection Method 	www.docstoc.com	0	0		
1573	chr2	129557092	129557116	3500412253	24		129557092	129557116	8421504	1	24	0	g	350041225300000003	0-24						Method for the synthesis of a bifunctional complex	Freskgard	2011	0		
1573	chr2	129557092	129557116	3500286434	24		129557092	129557116	8421504	1	24	0	g	350028643400000003	0-24						Method for the synthesis of a bifunctional complex	Freskgard	2011	0		
1574	chr2	129643576	129652815	3500205994	195		129643576	129652815	8421504	3	78,7,110	0,7699,9129	p	350020599400015007,350020599400015018	0-78,0-117						Characterizing the cancer genome in lung adenocarcinoma	roadinstitute.org	0	0		PTPRU
1575	chr2	129785776	129785801	3500325902	23		129785776	129785801	8421504	2	11,12	0,13	g	350032590200000011	0-23						Nucleotide Sequence Encoding Artemisinic Aldehyde Double Bond Reductase, Artemisinic Aldehyde Double Bond Reductase And Uses Thereof 	.freshpatents.com	0	0		
1575	chr2	129785776	129785801	3500298373	23		129785776	129785801	8421504	2	11,12	0,13	g	350029837300000016,350029837300000002	0-23,0-23						NUCLEOTIDE SEQUENCE ENCODING ARTEMISINIC ALDEHYDE DOUBLE BOND REDUCTASE, ARTEMISINIC ALDEHYDE DOUBLE BOND REDUCTASE AND USES THEREOF - Patent application	www.faqs.org	0	0		
1575	chr2	129814667	129815614	3500392921	41		129814667	129815614	8421504	2	20,21	0,926	c,g	350039292100000002,350039292100000002,350039292100000003	0-20,0-20,0-21						Overexpression of the RD RNA binding protein in hepatitis C virus-related hepatocellular carcinoma	-publications.com	0	0		SRSF4
1575	chr2	129815650	129818598	3500084617	106		129815650	129818598	8421504	2	36,70	0,2878	c,g	350008461700000063,350008461700000061,350008461700000062,350008461700000062	0-106,0-21,0-20,0-20						POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - Patent application	www.faqs.org	0	0		SRSF4
1577	chr2	130052299	130092112	3500445690	1116		130052299	130092112	8421504	3	539,350,227	0,3364,39586	p	350044569000015015	0-1116						GPCR Arrestin Assays	Bassoni	2009	0		YTHDF2,OPRD1
1577	chr2	130052299	130092112	3500100443	1116		130052299	130092112	8421504	3	539,350,227	0,3364,39586	p	350010044300015015	0-1116						GPCR Arrestin Assays - Patent application	www.faqs.org	0	0		YTHDF2,OPRD1
1577	chr2	130052417	130091965	3500270391	178		130052417	130091965	8421504	3	47,96,35	0,143,39513	c	350027039100000076,350027039100000073,350027039100000072,350027039100000059	0-47,0-48,0-48,12-47						Opioid receptors: compositions and methods	Bell	1994	0		
1577	chr2	130052417	130091965	3500219075	82		130052417	130091965	8421504	2	47,35	0,39513	c	350021907500000073,350021907500000056	0-47,12-47						 Polynucleotides Encoding KAPPA Opiod Receptors 	www.docstoc.com	0	0		
1577	chr2	130055928	130056006	3500279190	75		130055928	130056006	8421504	2	30,45	0,33	p	350027919000015067	0-75						Mu-Opiod receptor splice variant polypeptides - Patent # 7087714 - PatentGenius	.patentgenius.com	0	0		
1577	chr2	130100348	130100373	3500096081	23		130100348	130100373	8421504	3	5,5,13	0,6,12	g	350009608100000005	14-39						USE OF POLYPEPTIDES AS COCCIOSTAT AND/OR HISTOMONASTAT - Patent application	www.faqs.org	0	0		
1577	chr2	130100348	130100373	3500006714	23		130100348	130100373	8421504	3	5,5,13	0,6,12	g	350000671400000005	14-39						POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME - Patent application	www.faqs.org	0	0		
1578	chr2	130162221	130162249	3500193766	25		130162221	130162249	8421504	2	5,20	0,8	g	350019376600000072	16-45						Use of Hydrophobin-Polypeptides and Conjugates From Hydrophobin-Polypeptides Having Active and Effect Agents and the Production Thereof and Use Thereof In the Cosmetic Industry - Patent application	www.faqs.org	0	0		
1578	chr2	130182260	130182284	3500098009	23		130182260	130182284	8421504	2	10,13	0,11	c	350009800900000081	21-44						PROSTATE-SPECIFIC POLYPEPTIDE PAMP AND ENCODING NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
1578	chr2	130197790	130197859	3500117968	69		130197790	130197859	8421504	1	69	0	p	350011796800015007	0-69		10894151	10.1210/me.14.7.1010	0888-8809	Molecular Endocrinology	Properties of the Glucocorticoid Modulatory Element Binding Proteins GMEB-1 and -2: Potential New Modifiers of Glucocorticoid Receptor Transactivation and Members of the Family of KDWK Proteins	Kaul	2000	5		GMEB2
1578	chr2	130234132	130234162	3500306604	25		130234132	130234162	8421504	3	14,3,8	0,16,22	g	350030660400000023,350030660400000131	5-30,5-30						COMPOSITIONS, KITS AND RELATED METHODS FOR THE DETECTION AND/OR MONITORING OF LISTERIA - Patent application	www.faqs.org	0	0		
1578	chr2	130244602	130255874	3500341148	44		130244602	130255874	8421504	2	22,22	0,11250	c	350034114800000000,350034114800000001	11-33,8-30						(23S)-25-Dehydro-1 -Hydroxyvitamin D3-26,23-Lactone, a Vitamin D Receptor Antagonist that Inhibits Osteoclast Formation and Bone Resorption in Bone Marrow Cultures from Patients with Paget&#x2019;s Disease	.endojournals.org	0	0		
1578	chr2	130244602	130255874	3500148745	194		130244602	130255874	8421504	4	58,108,6,22	0,61,2053,11250	p,c	350014874500000000,350014874500015001,350014874500000001	10-32,0-171,8-30						Treating agent for Paget's disease of bone	Ishizuka	2003	0		TAF12
1579	chr2	130306321	130306405	3500335348	84		130306321	130306405	8421504	1	84	0	p	350033534800015011	0-84						Supporting Information	www.pnas.org	0	0		RCC1
1581	chr2	130559681	130559708	3500106818	23		130559681	130559708	8421504	3	4,6,13	0,5,14	g	350010681800000015	12-35						&#xa9; Tanhia Denys Gonzalez 2012	nservancy.umn.edu	0	0		
1581	chr2	130560540	130560565	3500150528	23		130560540	130560565	8421504	3	6,13,4	0,7,21	c	350015052800000093	5-33						Anti-igf-1r Antibodies And Uses Thereof 	.freshpatents.com	0	0		
1581	chr2	130560552	130560575	3500403011	23		130560552	130560575	8421504	1	23	0	c	350040301100000000	0-23		14991075	10.1172/JCI19528	0021-9738	The Journal of Clinical Investigation	Increased CD36 protein as a response to defective insulin signaling in macrophages	Liang	2004	13		
1581	chr2	130574160	130574314	3500047878	40		130574160	130574314	8421504	2	20,20	0,134	c,g	350004787800000015,350004787800000015,350004787800000014,350004787800000014	0-20,0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1583	chr2	130848811	130848838	3500101538	24		130848811	130848838	8421504	2	16,8	0,19	g	350010153800000275	0-24						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
1584	chr2	130968274	130968299	3500438553	23		130968274	130968299	8421504	2	13,10	0,15	g	350043855300000020	5-39						Eph-related tyrosine kinases, nucleotide sequences and methods of use	Pasquale	1993	0		
1584	chr2	130980876	130980901	3500370258	23		130980876	130980901	8421504	2	12,11	0,14	c	350037025800000043	9-33						Hepatitis virus vaccines	Pachuk	1996	0		
1584	chr2	131004866	131004890	3500285212	23		131004866	131004890	8421504	2	6,17	0,7	c	350028521200000008	10-33		11102469		0270-6474	The Journal of Neuroscience	GABAC Receptor Sensitivity Is Modulated by Interaction with MAP1B	Billups	2000	7		
1584	chr2	131024540	131024566	3500259074	23		131024540	131024566	8421504	2	5,18	0,8	c	350025907400000129	0-23						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
1585	chr2	131115898	131117784	3500027719	42		131115898	131117784	8421504	4	10,12,14,6	0,1415,1505,1880	c	350002771900000004,350002771900000005	0-22,0-20						Effect of maternal methionine supplementation on the transcriptome of bovine preimplantation embryos. - ResearchGate	.researchgate.net	0	0		
1585	chr2	131156398	131157035	3500211925	180		131156398	131157035	8421504	2	103,77	0,560	p	350021192500015005	0-180						 Phylogeography Ppt Presentation 	.authorstream.com	0	0		FGR
1585	chr2	131157820	131157847	3500465421	23		131157820	131157847	8421504	3	6,11,6	0,7,21	c	350046542100000069	5-29						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1585	chr2	131157820	131157847	3500400942	23		131157820	131157847	8421504	3	6,11,6	0,7,21	c	350040094200000105	5-29						Recombinant alphavirus vectors	Belli	1996	0		
1585	chr2	131196450	131196476	3500388902	23		131196450	131196476	8421504	2	17,6	0,20	g	350038890200000012	8-31						GENOME-WIDE QTL MAPPING FOR POST- FLOWERING DROUGHT TOLERANCE AND VALIDATION OF CHARCOAL ROT RESISTANCE QTLs IN NILs OF SORGHUM	etd.uasd.edu	0	0		
1587	chr2	131339204	131339240	3500055843	36		131339204	131339240	8421504	1	36	0	c,g	350005584300000004,350005584300000004	10-46,10-46		10970852	10.1093/emboj/19.17.4589	ERROR! NO ISSN	The EMBO Journal	Scar/WAVE-1, a Wiskott&#x2013;Aldrich syndrome protein, assembles an actin-associated multi-kinase scaffold	Westphal	2000	0		
1587	chr2	131349894	131349972	3500416843	78		131349894	131349972	8421504	1	78	0	p	350041684300015000	0-78		19732055	10.1111/j.1462-5822.2009.01380.x	1462-5822	Cellular Microbiology	Molecular dissection of Salmonella-induced membrane ruffling versus invasion - H&#xe4;nisch - 2009 - Cellular Microbiology - Wiley Online Library	Hanisch	2010	0		WASF2
1587	chr2	131355728	131355751	3500238110	23		131355728	131355751	8421504	1	23	0	c	350023811000000008	12-35		22303962	10.1021/bi2016469		Biochemistry	Binding of filamentous actin to anthrax toxin receptor 1 decreases its association with protective antigen	Kristopher	2012	0		
1587	chr2	131355754	131355853	3500080177	99		131355754	131355853	8421504	1	99	0	p	350008017700015002,350008017700015010	0-99,0-90						Regulatory Mimicry in Listeria monocytogenes Actin-Based Motility	www.med.yale.edu	0	0		
1587	chr2	131457639	131457667	3500411538	25		131457639	131457667	8421504	2	15,10	0,18	g	350041153800000034	8-33						Perfil de express&#xe3;o de genes modulados pela Pioglitazona em ilhotas pancre&#xe1;ticas mur&#xed;deas	www.teses.usp.br	0	0		
1589	chr2	131616876	131616899	3500239762	23		131616876	131616899	8421504	1	23	0	c	350023976200000000	0-23		15140751	10.1152/ajpcell.00552.2003		American Journal of Physiology - Cell Physiolog	Inhibition of NHE-1 Na+/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium	Fidzinski	2004	0		
1589	chr2	131616876	131616899	3500206296	23		131616876	131616899	8421504	1	23	0	c	350020629600000000	0-23		15140751	10.1152/ajpcell.00552.2003		American Journal of Physiology - Cell Physiology	Inhibition of NHE-1 Na+/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium	Fidzinski	2004	0		
1589	chr2	131616998	131618165	3500387359	24		131616998	131618165	8421504	3	5,7,12	0,6,1155	c	350038735900000020	5-33						Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof - Patent # 7211713 - PatentGenius	.patentgenius.com	0	0		
1589	chr2	131618250	131618274	3500036421	23		131618250	131618274	8421504	2	17,6	0,18	c	350003642100000599	19-42						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
1589	chr2	131620726	131620875	3500122589	25		131620726	131620875	8421504	2	11,14	0,135	c	350012258900000000	10-35		21345796	10.1074/jbc.M110.165134		The Journal of Biological Chemistry	B-Raf Associates with and Activates the NHE1 Isoform of the Na+/H+ Exchanger	Pratap	2011	0		
1589	chr2	131621326	131621560	3500439826	56		131621326	131621560	8421504	2	33,23	0,211	g	350043982600000002	0-70		17209001	10.1152/ajpheart.00855.2006		American Journal of Physiology - Heart and Circulatory Physiology	Overexpression of the Na+/H+ exchanger and ischemia-reperfusion injury in the myocardium	Imahashi	2007	0		SLC9A1
1589	chr2	131621326	131621560	3500354397	56		131621326	131621560	8421504	2	33,23	0,211	g	350035439700000002	0-70		17209001	10.1152/ajpheart.00855.2006		American Journal of Physiology - Heart and Circulatory Physiology	Overexpression of the Na+/H+ exchanger and ischemia-reperfusion injury in the myocardium	Imahashi	2007	0		SLC9A1
1589	chr2	131623762	131623788	3500235753	23		131623762	131623788	8421504	2	10,13	0,13	c,g	350023575300000091,350023575300000091	17-46,17-46						Protein Fragment Complementation Assays For High-throughput And High-content Screening 	.freshpatents.com	0	0		
1590	chr2	131819356	131819573	3500047878	40		131819356	131819573	8421504	2	20,20	0,197	c,g	350004787800000057,350004787800000057,350004787800000056	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1590	chr2	131819420	131819444	3500317072	24		131819420	131819444	8421504	1	24	0	c	350031707200000281,350031707200000280	0-24,2-24						STRUCTURE AND USE OF 5'PHOSPHATE OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		
1590	chr2	131820107	131820589	3500124682	39		131820107	131820589	8421504	2	20,19	0,463	c,g	350012468200000037,350012468200000037,350012468200000036,350012468200000036	0-20,0-20,0-19,0-19		19289498	10.1128/MCB.01140-08	0270-7306	Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer	Liu	2009	6		SFN
1590	chr2	131820107	131820589	3500115594	39		131820107	131820589	8421504	2	20,19	0,463	c,g	350011559400000037,350011559400000037,350011559400000036,350011559400000036	0-20,0-20,0-19,0-19		19289498	10.1128/MCB.01140-08		Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer 	Kang	2009	0		SFN
1591	chr2	131907067	131907093	3500252414	24		131907067	131907093	8421504	3	6,13,5	0,7,21	c	350025241400000008	0-24		23478018	10.1016/j.celrep.2013.02.004	2211-1247	Cell Reports	Cell Reports - Sequestration of DROSHA and DGCR8 by Expanded CGG RNA Repeats Alters MicroRNA Processing in Fragile X-Associated Tremor/Ataxia Syndrome	Sellier	2013	0		
1591	chr2	131928982	131929005	3500323462	23		131928982	131929005	8421504	1	23	0	c	350032346200000001	18-41			10.1093/nar/gkh277		Nucleic Acids Research	The DNA-binding properties of the ARID-containing subunits of yeast and mammalian SWI/SNF complexes	Deborah	2004	0		ARID1A
1591	chr2	131933767	131933793	3500003642	23		131933767	131933793	8421504	2	7,16	0,10	g	350000364200000123	0-23						Method and materials for introducing DNA into Prevotella ruminicola	Salyers	1991	0		
1591	chr2	131987615	131988282	3500033101	81		131987615	131988282	8421504	3	21,12,48	0,261,619	p	350003310100015012	192-456						The wheat orthologs of the barley cleistogamy gene: characterization and potential exploitation for wheat improvement	ane.ll.chiba-u.jp	0	0		
24	chr2	132087110	132124067	3500295452	2199		132087110	132124067	8421504	24	120,138,118,77,162,159,90,126,131,103,3,59,89,17,51,143,38,107,80,81,82,117,45,63	0,467,1829,2228,2533,9932,10462,11070,12657,14178,14541,14547,15568,15970,15990,16456,16938,17945,19682,19944,21846,22203,30728,36894	p	350029545200015023	0-2199						Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer	Fritz	2011	0		RPS6KA1,MIR1976
24	chr2	132087110	132124067	3500042215	2205		132087110	132124067	8421504	22	120,138,118,77,162,159,90,126,131,103,65,89,71,143,38,107,80,81,82,117,45,63	0,467,1829,2228,2533,9932,10462,11070,12657,14178,14541,15568,15970,16456,16938,17945,19682,19944,21846,22203,30728,36894	p	350004221500015077,350004221500015073,350004221500015069,350004221500015065,350004221500015061,350004221500015057,350004221500015053,350004221500015049,350004221500015045,350004221500015041,350004221500015036	0-132,0-213,0-213,0-213,0-213,0-213,0-213,0-213,0-213,0-213,0-156						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	dare.ubn.kun.nl	0	0		
1592	chr2	132087110	132087170	3500298158	60		132087110	132087170	8421504	1	60	0	p	350029815800015017,350029815800015058	0-60,0-45						INTRACELLULAR REPORTERS - Patent application	www.faqs.org	0	0		RPS6KA1
1592	chr2	132087208	132087578	3500316702	23		132087208	132087578	8421504	2	22,1	0,369	c	350031670200000065	8-31						COMPOSITIONS AND METHODS FOR ALTERING ALPHA- AND BETA-TOCOTRIENOL CONTENT USING MULTIPLE TRANSGENES - Patent application	www.faqs.org	0	0		
1592	chr2	132087577	132109412	3500134840	900		132087577	132109412	8421504	23	84,30,48,93,27,24,30,69,12,30,95,4,65,7,48,14,38,17,20,49,42,30,24	0,96,1365,2135,9465,9525,9579,10001,10717,12190,12226,13711,14074,15101,15138,16118,16471,17478,19275,19477,21404,21736,21811	p	350013484000015007	0-903						Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation. - ResearchGate	.researchgate.net	0	0		
1593	chr2	132174072	132175090	3500211687	102		132174072	132175090	8421504	4	3,51,30,18	0,394,775,1000	p	350021168700015001	0-102		18789156	10.1186/1471-2180-8-145	1471-2180	BMC Microbiology	A novel receptor &#xe2; ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu	Barel	2008	3		
1593	chr2	132174072	132175081	3500458780	93		132174072	132175081	8421504	4	3,51,30,9	0,394,775,1000	p	350045878000015001	0-93						Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform. - ResearchGate	.researchgate.net	0	0		HMGN2
1593	chr2	132174072	132175081	3500383130	93		132174072	132175081	8421504	4	3,51,30,9	0,394,775,1000	p	350038313000015004	0-93						R-ras activity in vascular regulation	Komatsu	2008	0		
1593	chr2	132174072	132175081	3500335412	93		132174072	132175081	8421504	4	3,51,30,9	0,394,775,1000	p	350033541200015000	3-96						Peptide-Conjugated Oligonucleotide Therapeutic and Method of Making and Using Same - Patent application	www.faqs.org	0	0		
1593	chr2	132174072	132175081	3500288080	93		132174072	132175081	8421504	4	3,51,30,9	0,394,775,1000	p	350028808000015004,350028808000015005	0-93,3-96						R-ras activity in vascular regulation	Komatsu	2009	0		
1593	chr2	132174072	132175081	3500270266	93		132174072	132175081	8421504	4	3,51,30,9	0,394,775,1000	p	350027026600015051	0-93						Award Number: W81 XWH-06-1-0482 TITLE: Targeting Therapy Resistant Tumor Vessels PRINCIPAL INVESTIGATOR: Erkki Ruoslahti, M.D., Ph.D. CONTRACTING ORGANIZATION: Burnham Institute TYPE OF REPORT: Final DISTRIBUTION STATEMENT: Approved for Public Release;	www.dtic.mil	0	0		HMGN2
1593	chr2	132174072	132175081	3500177546	93		132174072	132175081	8421504	4	3,51,30,9	0,394,775,1000	p	350017754600015004,350017754600015005	0-93,3-96						R-RAS ACTIVITY IN VASCULAR REGULATION - Patent application	www.faqs.org	0	0		HMGN2
1593	chr2	132174072	132175081	3500139806	93		132174072	132175081	8421504	4	3,51,30,9	0,394,775,1000	p	350013980600015000	0-93						Design and synthesis of biofunctional magnetic/fluorescent glyco -nanoparticles	w.cicbiomagune.es	0	0		HMGN2
1593	chr2	132174484	132175081	3500024585	72		132174484	132175081	8421504	3	33,30,9	0,363,588	p	350002458500015001	0-72						Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment. - ResearchGate	.researchgate.net	0	0		
1593	chr2	132213389	132213415	3500354285	23		132213389	132213415	8421504	2	15,8	0,18	c	350035428500000005	0-23					Patent	Control of gene expression (Patent US:8168774)	Graham	2012	0		
1593	chr2	132213389	132213415	3500350377	23		132213389	132213415	8421504	2	15,8	0,18	c	350035037700000005	0-23						CONTROL OF GENE EXPRESSION	Graham	2012	0		
1593	chr2	132213389	132213415	3500323226	23		132213389	132213415	8421504	2	15,8	0,18	c	350032322600000007	0-23						Control of gene expression	M*W*Ge Lei E Mu 	2010	0		
1593	chr2	132213389	132213415	3500319541	23		132213389	132213415	8421504	2	15,8	0,18	c	350031954100000009	0-23						Control of gene expression	M*W*Ge Lei E Mu 	2006	0		
1593	chr2	132213389	132213415	3500278095	23		132213389	132213415	8421504	2	15,8	0,18	c	350027809500000005	0-23						Control of gene expression	Graham	2006	0		
1593	chr2	132213389	132213415	3500255137	23		132213389	132213415	8421504	2	15,8	0,18	c	350025513700000005	0-23					Patent	Control of gene expression (Patent US:7754697)	Graham	2010	0		
1593	chr2	132213389	132213415	3500238148	23		132213389	132213415	8421504	2	15,8	0,18	c	350023814800000005	0-23						Control of gene expression	Graham	2012	0		
1593	chr2	132213389	132213415	3500227250	23		132213389	132213415	8421504	2	15,8	0,18	c	350022725000000005	0-23						Control of gene expression	Graham	2003	0		
1593	chr2	132213389	132213415	3500200383	23		132213389	132213415	8421504	2	15,8	0,18	c	350020038300000005	0-23					Patent	Control of gene expression (Patent US:7754697)	Graham	2010	0		
1593	chr2	132213389	132213415	3500186107	23		132213389	132213415	8421504	2	15,8	0,18	c	350018610700000005	0-23					Patent	Control of gene expression (Patent US:8168774)	Graham	2012	0		
1593	chr2	132213389	132213415	3500135369	23		132213389	132213415	8421504	2	15,8	0,18	c	350013536900000009	0-23						Control of gene expression	M*W*Ge Lei E Mu 	2001	0		
1593	chr2	132213389	132213415	3500116600	23		132213389	132213415	8421504	2	15,8	0,18	c	350011660000000005	0-23						Control of gene expression	Graham	2011	0		
1593	chr2	132213389	132213415	3500000923	23		132213389	132213415	8421504	2	15,8	0,18	c	350000092300000005	0-23						Control of gene expression	Graham	2001	0		
1593	chr2	132213392	132213440	3500092225	48		132213392	132213440	8421504	1	48	0	p	350009222500015088,350009222500015074	0-45,0-45						US Patent # 7,273,737. cis-prenyltransferases from plants - Patents.com	www.patents.com	0	0		DHDDS
1593	chr2	132219683	132220371	3500465380	40		132219683	132220371	8421504	2	20,20	0,668	g	350046538000000007,350046538000000006	0-20,0-20						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	quantification.de	0	0		
1593	chr2	132221783	132231328	3500248431	60		132221783	132231328	8421504	3	9,21,30	0,9456,9515	c,g	350024843100000005,350024843100000004,350024843100000004	0-30,0-30,0-30		19376775	10.1074/jbc.M109.008938	0021-9258	Journal of Biological Chemistry	Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig	Esteban	2009	5		LIN28A
1593	chr2	132221783	132231328	3500057234	60		132221783	132231328	8421504	3	9,21,30	0,9456,9515	c	350005723400000005,350005723400000004	0-30,0-30						GenerationofInducedPluripotentStemCellLinesfrom TibetanMiniaturePig	www.jbc.org	0	0		LIN28A
1593	chr2	132221783	132231328	3500001753	60		132221783	132231328	8421504	3	9,21,30	0,9456,9515	c,g	350000175300000005,350000175300000004,350000175300000004	0-30,0-30,0-30		19376775	10.1074/jbc.M109.008938		The Journal of Biological Chemistry	Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig	MiguA.	June	0		LIN28A
1594	chr2	132314469	132314494	3500428366	23		132314469	132314494	8421504	3	13,6,4	0,14,21	c	350042836600000079	11-39						Mpl ligand analogs	Elliott	1997	0		
1594	chr2	132315922	132317520	3500375699	481		132315922	132317520	8421504	2	364,117	0,1481	c,g	350037569900000038,350037569900000038	0-481,0-481						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1594	chr2	132317564	132317589	3500214344	24		132317564	132317589	8421504	2	4,20	0,5	c	350021434400000011,350021434400000010	4-28,0-24						Master bone formation transcription factor: compositions and methods of use	Crombrugghe	2000	0		
1595	chr2	132440950	132440976	3500200742	24		132440950	132440976	8421504	2	8,16	0,10	g	350020074200000018	1-26						Plant Cells And Plants With Increased Tolerance To Environmental Stress 	.freshpatents.com	0	0		
1595	chr2	132447844	132447867	3500318543	23		132447844	132447867	8421504	1	23	0	c	350031854300000047	0-23						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		
1595	chr2	132508985	132509126	3500336592	42		132508985	132509126	8421504	2	21,21	0,120	g	350033659200000024,350033659200000025	0-21,0-21						DIVERSIDADE GEN&#xc9;TICA, ANCESTRALIDADE INDIVIDUAL E MISCIGENA&#xc7;&#xc3;O NAS RA&#xc7;AS BOVINAS NO BRASIL COM BASE EM MICROSSAT&#xc9;LITES E HAPL&#xd3;TIPOS DE DNA MITOCONDRIAL: SUBS&#xcd;DIOS PARA A CONSERVA&#xc7;&#xc3;O	epositorio.unb.br	0	0		
1596	chr2	132537916	132539237	3500434784	40		132537916	132539237	8421504	2	20,20	0,1301	c,g	350043478400000011,350043478400000012,350043478400000012	0-20,0-20,0-20		23915343	10.1186/1478-811X-11-55	1478-811X	Cell Communication and Signaling	Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling	Jaafar	2013	6		
1596	chr2	132537916	132539237	3500316609	40		132537916	132539237	8421504	2	20,20	0,1301	c,g	350031660900000011,350031660900000011,350031660900000012,350031660900000012	0-20,0-20,0-20,0-20		23915343	10.1186/1478-811X-11-55		Cell Communication and Signaling : CCS	Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling	Rami	2013	0		
1596	chr2	132537916	132539237	3500061264	40		132537916	132539237	8421504	2	20,20	0,1301	c,g	350006126400000011,350006126400000011,350006126400000012,350006126400000012	0-20,0-20,0-20,0-20						Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling	.biosignaling.com	0	0		
1596	chr2	132564734	132565932	3500415955	96		132564734	132565932	8421504	4	24,24,24,24	0,565,627,1174	c,g	350041595500000011,350041595500000010,350041595500000009,350041595500000009,350041595500000008,350041595500000008	0-24,0-24,0-24,0-24,0-24,0-24						Letter The Heparan and Heparin Metabolism Pathway is Involved in Regulation of Fatty Acid Composition	www.ijbs.com	0	0		
1596	chr2	132601427	132637611	3500278616	1636		132601427	132637611	8421504	12	43,142,154,97,69,142,114,92,171,155,251,206	0,7687,8757,9738,17389,17824,18880,23039,25375,27316,35725,35978	c,g	350027861600000000,350027861600000002,350027861600000003,350027861600000004,350027861600000005,350027861600000006,350027861600000007,350027861600000034,350027861600000008,350027861600000009,350027861600000010,350027861600000011,350027861600000012,350027861600000013,350027861600000014,350027861600000015,350027861600000016,350027861600000043,350027861600000017,350027861600000018,350027861600000019,350027861600000020,350027861600000021,350027861600000022,350027861600000022,350027861600000023,350027861600000023,350027861600000024,350027861600000025,350027861600000027	15-1656,15-166,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-340					Patent	Platelet activating factor acetylhydrolase, and gene thereof (Patent US:5880273)	Adachi	1999	0		
1596	chr2	132601427	132637611	3500255206	1636		132601427	132637611	8421504	12	43,142,154,97,69,142,114,92,171,155,251,206	0,7687,8757,9738,17389,17824,18880,23039,25375,27316,35725,35978	p,c	350025520600000000,350025520600015000,350025520600015001	15-1656,0-1113,0-60					Patent	Platelet activating factor acetylhydrolase, and gene thereof (Patent US:6323017)	Adachi	2001	0		
1597	chr2	132693070	132693733	3500463357	51		132693070	132693733	8421504	3	20,6,25	0,523,638	c	350046335700000063,350046335700000059	8-34,11-36						Genes And Polypeptides Relating To Hepatocellular Or Colorectal Carcinoma 	.freshpatents.com	0	0		
1597	chr2	132693086	132696341	3500146314	420		132693086	132696341	8421504	4	4,173,192,51	0,507,2602,3204	p	350014631400015013,350014631400015001,350014631400015007,350014631400015009,350014631400015015,350014631400015003,350014631400015011,350014631400015017	0-180,0-180,0-174,0-180,0-180,0-180,0-57,0-60						Use of tlr3 agonists for the treatment of neurodegenerative disorders	Van	2007	0		STMN1
1597	chr2	132693086	132696341	3500108880	420		132693086	132696341	8421504	4	4,173,192,51	0,507,2602,3204	p	350010888000015013,350010888000015007,350010888000015001,350010888000015009,350010888000015015,350010888000015003,350010888000015011,350010888000015017	0-180,0-174,0-180,0-180,0-180,0-180,0-57,0-60						Use of tlr3 agonists for the treatment of neurodegenerative disorders	Van	2008	0		STMN1
1597	chr2	132693631	132696344	3500370298	372		132693631	132696344	8421504	6	45,87,39,108,39,54	0,48,2057,2099,2210,2659	p	350037029800015004,350037029800015053,350037029800015023,350037029800015007,350037029800015056,350037029800015057,350037029800015011,350037029800015058,350037029800015054,350037029800015014,350037029800015060,350037029800015016	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						USE OF TLR3 AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS - Patent application	www.faqs.org	0	0		STMN1
1597	chr2	132693708	132693733	3500229865	25		132693708	132693733	8421504	1	25	0	c	350022986500000059,350022986500000256	11-36,11-36						GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA - Patent application	www.faqs.org	0	0		
1597	chr2	132734774	132735782	3500307883	227		132734774	132735782	8421504	4	42,89,48,48	0,384,768,960	c	350030788300000161,350030788300000169,350030788300000170,350030788300000177,350030788300000181	0-42,0-48,0-41,0-48,0-48						Methods and materials relating to PAQR polypeptides and polynucleotides - Patent application	www.faqs.org	0	0		
1597	chr2	132735039	132735136	3500184377	41		132735039	132735136	8421504	2	20,21	0,76	c,g	350018437700000000,350018437700000000,350018437700000001	0-20,0-20,0-21		19432978	10.1186/1477-7827-7-42		Reproductive Biology and Endocrinology : RB&E	Binding characteristics of the ovine membrane progesterone receptor alpha and expression of the receptor during the estrous cycle	Ryan	2009	0		
1597	chr2	132769856	132769882	3500370457	23		132769856	132769882	8421504	2	17,6	0,20	c	350037045700000004	0-23						Leaf Development in the Single-Cell C&#x2084; System in Bienertia sinuspersici: Expression of Genes and Peptide Levels for C&#x2084; Metabolism in Relation to Chlorenchyma Structure under Different Light Conditions	www.jstor.org	0	0		
1599	chr2	133030782	133030807	3500400238	23		133030782	133030807	8421504	2	15,8	0,17	c	350040023800000260	13-41						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1602	chr2	133318042	133320478	3500059790	44		133318042	133320478	8421504	2	42,2	0,2434	c	350005979000000100	0-44						MOLECULAR STRUCTURE OF RHD NEGATIVE - Patent application	www.faqs.org	0	0		
1604	chr2	133653545	133653578	3500111552	24		133653545	133653578	8421504	3	12,6,6	0,17,27	g	350011155200000159	21-45						ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
1605	chr2	133762807	133765228	3500125762	45		133762807	133765228	8421504	2	21,24	0,2397	c,g	350012576200000000,350012576200000006	0-21,0-24						Molecular Cancer BioMed Central	ecular-cancer.com	0	0		CLIC4
1605	chr2	133765204	133765228	3500168712	24		133765204	133765228	8421504	1	24	0	c	350016871200000006	0-24		20533548	10.1002/ijc.25506	1097-0215	International Journal of Cancer	Micro-RNA-21 regulates TGF-&#x03b2;-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction - Yao - 2010 - International Journal of Cancer - Wiley Online Library	Yao	2011	0		CLIC4
1605	chr2	133815767	133815815	3500352210	48		133815767	133815815	8421504	1	48	0	p	350035221000015012	0-48						Proteomic analysis of porcine alveolar macrophages infected with porcine circovirus type 2. - ResearchGate	.researchgate.net	0	0		CLIC4
1607	chr2	134046656	134048126	3500215059	78		134046656	134048126	8421504	2	68,10	0,1460	p	350021505900015071,350021505900015070,350021505900015054	0-78,0-78,0-63						ESTUDI DE LA FUNCI&#xc3;&#x201c; DE LES PROTE&#xc3;&#x2022;NES RCAN EN L&#xe2;&#x20ac;&#x2122;ACTIVACI&#xc3;&#x201c; LIMFOCIT&#xc3;&#x20ac;RIA: APLICACI&#xc3;&#x201c; EN LA CERCA DE NOUS F&#xc3;&#x20ac;RMACS IMMUNOSUPRESSORS	www.tdx.cat	0	0		RCAN2
1609	chr2	134246530	134246556	3500088261	25		134246530	134246556	8421504	2	11,14	0,12	g	350008826100000008	1-26						US Patent # 6,667,039. CD30 ligand - Patents.com	www.patents.com	0	0		
1609	chr2	134267635	134267660	3500436843	23		134267635	134267660	8421504	2	11,12	0,13	g	350043684300000079	0-23						US Patent # 5,766,581. Method for treating mammals with monopegylated proteins that stimulates megakaryocyte growth and differentiation - Patents.com	www.patents.com	0	0		
1610	chr2	134429261	134444628	3500048026	108		134429261	134444628	8421504	3	42,20,46	0,3383,15321	c	350004802600000143,350004802600000149,350004802600000153	0-42,0-20,1-47						ANTI-IL-20, ANTI-IL-22 AND ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION - Patent application	www.faqs.org	0	0		
1610	chr2	134450508	134450535	3500433279	23		134450508	134450535	8421504	2	9,14	0,13	c	350043327900000024	2-25						Transgenic plants presenting a modified inulin producing profile	Koops	2000	0		
1611	chr2	134609586	134609762	3500047878	40		134609586	134609762	8421504	2	20,20	0,156	c,g	350004787800000025,350004787800000025,350004787800000024,350004787800000024	0-20,0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1611	chr2	134610530	134610826	3500375699	296		134610530	134610826	8421504	1	296	0	c	350037569900000045	0-296						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1612	chr2	134611012	134611043	3500174217	30		134611012	134611043	8421504	2	6,24	0,7	c	350017421700000009	15-45						The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha. - ResearchGate	.researchgate.net	0	0		
1612	chr2	134704394	134704695	3500066094	41		134704394	134704695	8421504	2	21,20	0,281	c	350006609400000000,350006609400000003,350006609400000002	0-20,0-20,0-20			10.1038/sj.bjp.0705529		British Journal of Pharmacology	Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells	Cristina	2003	0		CNR2
1612	chr2	134704663	134704763	3500463464	78		134704663	134704763	8421504	3	23,15,40	0,40,60	c,g	350046346400000010,350046346400000010,350046346400000001	7-94,7-94,0-20						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
1612	chr2	134705079	134705102	3500404332	23		134705079	134705102	8421504	1	23	0	c	350040433200000005	0-23		15044630	10.1124/mol.65.4.999	1521-0111 (Online)	Molecular Pharmacology	Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism	Carrier	2004	0		
1613	chr2	134781062	134782049	3500114242	138		134781062	134782049	8421504	3	15,78,45	0,103,942	p	350011424200015070,350011424200015139,350011424200015067,350011424200015117	0-84,84-147,9-63,0-45						BMC Genetics BioMed Central	biomedcentral.com	0	0		GALE
1613	chr2	134791241	134798044	3500453694	149		134791241	134798044	8421504	4	34,47,48,20	0,908,1647,6783	c	350045369400000079,350045369400000076,350045369400000074,350045369400000067	14-48,0-47,0-48,0-20						Diagnosis of disease state using mrna profiles	An	1999	0		
1613	chr2	134791241	134798044	3500002159	150		134791241	134798044	8421504	5	34,48,4,44,20	0,1647,5495,5870,6783	c	350000215900000079,350000215900000074,350000215900000071,350000215900000067	14-48,0-48,0-48,0-20						Diagnosis of disease state using mrna profiles	An	1998	0		
1613	chr2	134792888	134798044	3500232459	164		134792888	134798044	8421504	5	70,26,4,44,20	0,3774,3848,4223,5136	c	350023245900000074,350023245900000073,350023245900000071,350023245900000067	0-48,0-48,0-48,0-20						Diagnosis of disease state using mrna profiles	An	1999	0		
1613	chr2	134863748	134864671	3500164379	207		134863748	134864671	8421504	2	62,145	0,778	p	350016437900015017	180-387						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPL11
1614	chr2	134964594	134964620	3500267888	26		134964594	134964620	8421504	1	26	0	g	350026788800000017	0-26						Activins regulate 17b-hydroxysteroid dehydrogenase type I ...	ww.slideshare.net	0	0		ID3
1614	chr2	134965353	134965656	3500388350	46		134965353	134965656	8421504	3	24,17,5	0,161,298	c,g	350038835000000070,350038835000000070,350038835000000071	0-24,0-24,0-22						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
1614	chr2	134965353	134965656	3500027904	46		134965353	134965656	8421504	3	24,17,5	0,161,298	c	350002790400000045,350002790400000046	0-24,0-22						 SpringerImages - primers sequences 	pringerimages.com	0	0		
1614	chr2	134998506	134998548	3500164528	42		134998506	134998548	8421504	1	42	0	g	350016452800000110	6-48						JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS - Patent application	www.faqs.org	0	0		
1615	chr2	135037065	135037096	3500153276	28		135037065	135037096	8421504	2	5,23	0,8	c	350015327600000064	17-45						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
1615	chr2	135037072	135037162	3500391891	90		135037072	135037162	8421504	1	90	0	p	350039189100015007	0-90						Crosstalk and Integration of Membrane Trafficking Pathways	www.scribd.com	0	0		E2F2
1616	chr2	135192669	135196033	3500351779	357		135192669	135196033	8421504	3	51,136,170	0,1610,3194	p	350035177900015013	180-717						DETERMINATION ET COMPARAISON DE NOEC &#xab; MATRICIELLES &#xbb; A L&#x2019;AIDE DE PUCES A ADN CHEZ DREISSENA POLYMORPHA ET MYTILUS EDULIS	ne-aval.crihan.fr	0	0		HNRNPR
1619	chr2	135626337	135626364	3500141155	27		135626337	135626364	8421504	1	27	0	c	350014115500000002,350014115500000011	0-27,0-27						ANTI-EPHB2 ANTIBODIES AND METHODS USING SAME - Patent application	www.faqs.org	0	0		
202	chr2	135627988	135708009	3500330320	138		135627988	135708009	8421504	2	35,103	0,79918	p	350033032000015041	0-138						Structure, Function & Control of the EphA3 Receptor Tyrosine Kinase	.swinburne.edu.au	0	0		EPHB2
1620	chr2	135707960	135707985	3500036421	25		135707960	135707985	8421504	1	25	0	c	350003642100000111	9-34						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
1621	chr2	135879488	135903130	3500274037	100		135879488	135903130	8421504	5	20,20,20,20,20	0,213,23280,23410,23622	c,g	350027403700000047,350027403700000046,350027403700000046,350027403700000043,350027403700000042,350027403700000040	0-20,0-20,0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1621	chr2	135903178	135903322	3500362403	40		135903178	135903322	8421504	2	21,19	0,125	c	350036240300000009,350036240300000008	0-21,0-19						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
1623	chr2	136113333	136113356	3500260488	23		136113333	136113356	8421504	1	23	0	g	350026048800000179	8-40						Hemoglobin receptors from neisseriae	Heffron	1996	0		
1624	chr2	136233966	136233991	3500299297	24		136233966	136233991	8421504	2	11,13	0,12	g	350029929700000017	1-27						Phosphatases which activate map kinase pathways - Patent application	www.faqs.org	0	0		
203	chr2	136445491	136446861	3500416463	44		136445491	136446861	8421504	2	24,20	0,1350	c	350041646300000001,350041646300000000	9-33,8-28		21288881	10.1093/nar/gkr020		Nucleic Acids Research	Uracils at nucleotide position 9&#x2013;11 are required for the rapid turnover of miR-29 family	Zhuo	2011	0		
1626	chr2	136446808	136446912	3500091015	44		136446808	136446912	8421504	2	22,22	0,82	c	350009101500000010,350009101500000011	0-22,0-22						Co&#xfb01;lin 1-Mediated Biphasic F-Actin Dynamics of Neuronal Cells Affect Herpes Simplex Virus 1 Infection and Replication	jvi.asm.org	0	0		
1626	chr2	136446864	136446888	3500271334	24		136446864	136446888	8421504	1	24	0	c,g	350027133400000003,350027133400000003	9-33,9-33						University of Texas : SMITHG 01228 : smithg01228	ww.coursehero.com	0	0		CDC42
1626	chr2	136446864	136446888	3500005582	24		136446864	136446888	8421504	1	24	0	c	350000558200000002	9-33						Copyright by Gail Perry Smith 2005	es.lib.utexas.edu	0	0		CDC42
1626	chr2	136446875	136451662	3500460541	93		136446875	136451662	8421504	5	20,31,3,20,19	0,49,4705,4733,4768	c,g	350046054100000013,350046054100000013,350046054100000014,350046054100000012,350046054100000012,350046054100000004,350046054100000004	0-20,0-20,0-34,0-20,0-20,0-19,0-19						Multiple gene knock-down by a single lentiviral vector expressing an array of short hairpin RNAs	iotechnology.info	0	0		CDC42
1626	chr2	136446875	136451662	3500032693	93		136446875	136451662	8421504	5	20,31,3,20,19	0,49,4705,4733,4768	c,g	350003269300000013,350003269300000013,350003269300000014,350003269300000012,350003269300000012,350003269300000004,350003269300000004	0-20,0-20,0-34,0-20,0-20,0-19,0-19				0717-3458	Electronic Journal of Biotechnology	Electronic Journal of Biotechnology - Multiple gene knock-down by a single lentiviral vector expressing an array of short hairpin RNAs	Stove	2006	1		CDC42
1626	chr2	136446880	136446946	3500287453	66		136446880	136446946	8421504	1	66	0	p	350028745300015067,350028745300015075,350028745300015072	0-66,0-51,0-45					Patent	Regulation of oxidative burst using LMWG-derived peptides and analogs (Patent US:6184203)	Bokoch	2001	0		CDC42
1626	chr2	136446880	136446946	3500169488	66		136446880	136446946	8421504	1	66	0	p	350016948800015052,350016948800015061,350016948800015058	0-66,0-51,0-45						Regulation of oxidative burst using lmwg-derived peptides and analogs	Bokoch	1995	0		CDC42
1626	chr2	136451604	136451998	3500374944	48		136451604	136451998	8421504	2	24,24	0,370	c	350037494400000005,350037494400000027,350037494400000026,350037494400000004	0-24,0-24,0-24,0-24						MAMMALIAN OOCYTE DEVELOPMENT COMPETENCY GRANULOSA MARKERS AND USES THEREOF - Patent application	www.faqs.org	0	0		CDC42
1626	chr2	136451714	136451995	3500351918	48		136451714	136451995	8421504	2	24,24	0,257	c	350035191800000017,350035191800000016	0-24,0-24		18980974	10.1158/1078-0432.CCR-07-4820	1078-0432	Clinical Cancer Research	Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells via Targeting RhoC In vitro and In vivo	Wang	2008	8		CDC42
1626	chr2	136451714	136451995	3500115262	48		136451714	136451995	8421504	2	24,24	0,257	c	350011526200000017,350011526200000016	0-24,0-24		18980974	10.1158/1078-0432.CCR-07-4820	1078-0432	Clinical Cancer Research	Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells via Targeting RhoC In vitro and In vivo	Wang	2008	8		CDC42
1626	chr2	136451728	136451765	3500157417	37		136451728	136451765	8421504	1	37	0	c	350015741700000001,350015741700000000	0-19,0-19		19741094	10.1091/mbc.E09-03-0230	1059-1524	Molecular Biology of the Cell	Cdc42 Regulates Fc&#x03b3; Receptor-mediated Phagocytosis through the Activation and Phosphorylation of Wiskott-Aldrich Syndrome Protein (WASP) and Neural-WASP	Park	2009	5		CDC42
1626	chr2	136451733	136451758	3500063394	25		136451733	136451758	8421504	1	25	0	c	350006339400000005,350006339400000006	0-25,0-25		23439680	10.1083/jcb.201208150		The Journal of Cell Biology	The WD40 protein Morg1 facilitates Par6&#x2013;aPKC binding to Crb3 for apical identity in epithelial cells	Junya	2013	0		
1626	chr2	136451768	136463605	3500270362	39		136451768	136463605	8421504	4	10,10,9,10	0,142,243,11827	c	350027036200000021,350027036200000009,350027036200000020,350027036200000008	0-20,0-20,0-19,0-19						Cells And Methods For Estimation Of Effects On Neurological Dysfunction 	.freshpatents.com	0	0		CDC42
1626	chr2	136452000	136463620	3500046035	45		136452000	136463620	8421504	2	20,25	0,11595	p	350004603500015276	0-45						Method of identifying compounds useful to treat neuronal degenerative diseases - Patent application	www.faqs.org	0	0		CDC42
1626	chr2	136529441	136530660	3500186119	60		136529441	136530660	8421504	2	39,21	0,1198	p	350018611900015181	0-60						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		
1626	chr2	136529441	136530660	3500095373	60		136529441	136530660	8421504	2	39,21	0,1198	p	350009537300015181	0-60						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		
1629	chr2	136855957	136859954	3500415920	40		136855957	136859954	8421504	3	20,10,10	0,3610,3987	c,g	350041592000000085,350041592000000085,350041592000000024,350041592000000086	0-20,0-20,20-40,0-20						METHOD FOR DETECTING NEUROBLASTOMA - Patent application	www.faqs.org	0	0		RAP1GAP
1629	chr2	136894896	136895438	3500022437	39		136894896	136895438	8421504	2	20,19	0,523	c,g	350002243700000023,350002243700000023,350002243700000022,350002243700000022	0-20,0-20,0-19,0-19						ONLINE MATERIALS AND METHODS	b.ahajournals.org	0	0		
1629	chr2	136894904	136895437	3500335841	49		136894904	136895437	8421504	3	28,1,20	0,36,513	c	350033584100000007,350033584100000006	19-47,0-21						Materials Sciences and Applications	www.scirp.org	0	0		
1629	chr2	136894904	136895437	3500255946	49		136894904	136895437	8421504	3	28,1,20	0,36,513	c	350025594600000007,350025594600000006	19-47,0-21						et al. J Biotechnol Biomaterial 2011, 1:1 Biotechnology & Biomaterials	w.omicsonline.org	0	0		
1629	chr2	136894904	136895437	3500028836	49		136894904	136895437	8421504	3	28,1,20	0,36,513	c	350002883600000007,350002883600000006	19-47,0-21						Bio-Oss&#xae;acts on Stem cells derived from Peripheral Blood	www.omjournal.org	0	0		
1629	chr2	136897979	136898002	3500252518	23		136897979	136898002	8421504	1	23	0	c	350025251800000002	0-23						Osteoblastsresponsetoallogenicandxenogenicsolventdehydrated cancellousboneinvitro	www.3go.si/brands	0	0		
1629	chr2	136905523	136905547	3500429761	24		136905523	136905547	8421504	1	24	0	c	350042976100000001	24-48						Mesenchymal Stem Cell Characteristics of Human Anterior Cruciate Ligament Outgrowth Cells	divet-america.com	0	0		ALPL
1629	chr2	136905523	136905547	3500318051	24		136905523	136905547	8421504	1	24	0	c	350031805100000008	24-48						Controlling the Fibroblastic Differentiation of Mesenchymal Stem Cells Via the Combination of Fibrous Scaffolds and Connective Tissue Growth Factor	dspace.mit.edu	0	0		ALPL
1629	chr2	136905523	136905547	3500290344	24		136905523	136905547	8421504	1	24	0	c	350029034400000000	24-48						Molekulare Analysen zur Knochenregeneration im Alter und bei Osteoporose	.uni-wuerzburg.de	0	0		ALPL
1629	chr2	136905523	136905547	3500272824	24		136905523	136905547	8421504	1	24	0	c	350027282400000011	24-48						Identification and Functional Analysis of Candidate Genes Regulating Mesenchymal Stem Cell Self-Renewal and Multipotency--&#x300a;&#x5e72;&#x7ec6;&#x80de;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&	journal.9med.net	0	0		ALPL
1629	chr2	136905523	136905547	3500261622	24		136905523	136905547	8421504	1	24	0	c	350026162200000023	24-48						Pluripotent embryonic-like stem cells derived from teeth and uses thereof	Schierholz	2003	0		ALPL
1629	chr2	136905523	136905547	3500023532	24		136905523	136905547	8421504	1	24	0	c	350002353200000010	24-48		23521530	10.1111/boc.201200064	1768-322X	Biology of the Cell	Inflammatory environment induces gingival tissue-specific mesenchymal stem cells to differentiate towards a pro-fibrotic phenotype - Li - 2013 - Biology of the Cell - Wiley Online Library	Li	2013	0		ALPL
1629	chr2	136905523	136905547	3500005224	24		136905523	136905547	8421504	1	24	0	c	350000522400000011	24-48						Identification and Functional Analysis of Candidate Genes Regulating Mesenchymal - &#x300a;stemcells&#x300b;&#x5e72;&#x7ec6;&#x80de;&#x5b66;&#x6742;&#x5fd7; &#x5e72;&#x7ec6;&#x80de;&#x4e4b;&#x5bb6; - &#x4e2d;&#x56fd;&#x5e72;&#x7ec6;&#x80de;&#x7814;&#x7a76	www.stemcell8.cn	0	0		ALPL
1629	chr2	136906748	136908210	3500180045	29		136906748	136908210	8421504	2	20,9	0,1453	c	350018004500000003	0-29						Cellular behavior of human mesenchymal stem cells cultured on single-walled carbon nanotube film	idv.sinica.edu.tw	0	0		
1629	chr2	136906752	136908210	3500275289	25		136906752	136908210	8421504	2	16,9	0,1449	c	350027528900000001	0-25						TETRACYCLINE EFFECTS ON DIABETIC BONE REGENERATION	orio-aberto.up.pt	0	0		
1629	chr2	136908233	136908257	3500058394	24		136908233	136908257	8421504	1	24	0	c	350005839400000012	7-31						Production of humanized antibodies in transgenic animals	Buelow	2006	0		
1629	chr2	136908279	136908607	3500194091	45		136908279	136908607	8421504	2	38,7	0,321	p	350019409100015097	0-45						NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF - Patent application	www.faqs.org	0	0		ALPL
1629	chr2	136908279	136908607	3500099137	45		136908279	136908607	8421504	2	38,7	0,321	p	350009913700015097	0-45						NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF - Patent application	www.faqs.org	0	0		ALPL
1629	chr2	136908285	136908616	3500089817	48		136908285	136908616	8421504	2	32,16	0,315	p	350008981700015014	0-48						Vegf fusion proteins	Kessler	2002	0		ALPL
1629	chr2	136908285	136908613	3500460964	45		136908285	136908613	8421504	2	32,13	0,315	p	350046096400015006	0-45						ELEC - - EAP	www.invivogen.com	0	0		ALPL
1629	chr2	136908285	136908613	3500443128	45		136908285	136908613	8421504	2	32,13	0,315	p	350044312800015004	0-45						pNiFty3-SEAP	www.invivogen.com	0	0		ALPL
1629	chr2	136908285	136908613	3500095976	45		136908285	136908613	8421504	2	32,13	0,315	p	350009597600015002	0-45						pDRIVE5SEAP-mGFAP	www.invivogen.com	0	0		ALPL
1629	chr2	136908285	136908613	3500094920	45		136908285	136908613	8421504	2	32,13	0,315	p	350009492000015152	3-48						Compositions And Methods Of Mutant Nogo-66 Domain Proteins 	.freshpatents.com	0	0		ALPL
1630	chr2	137073410	137073438	3500310730	23		137073410	137073438	8421504	2	8,15	0,13	g	350031073000000000	0-29						Expression of ABCB1, ABCC2 and ABCG2 in porcine tissues	ive.library.uu.nl	0	0		
203	chr2	137092150	137142124	3500431533	137		137092150	137142124	8421504	6	22,25,25,21,25,19	0,46,8642,49907,49929,49955	c,g	350043153300000004,350043153300000002,350043153300000008,350043153300000012,350043153300000000,350043153300000006,350043153300000006,350043153300000009,350043153300000007,350043153300000007	0-22,0-22,0-25,5-30,0-21,0-21,0-21,0-25,0-19,0-19		9880527	10.1074/jbc.274.3.1509	0021-9258	Journal of Biological Chemistry	Constitutive Lysosomal Targeting and Degradation of Bovine Endothelin-converting Enzyme-1a Mediated by Novel Signals in Its Alternatively Spliced Cytoplasmic Tail	Emoto	1999	5		
1630	chr2	137092150	137100817	3500385274	62		137092150	137100817	8421504	3	22,19,21	0,70,8646	c,g	350038527400000003,350038527400000004,350038527400000001	0-22,3-22,0-21						ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression	rt.physiology.org	0	0		
1631	chr2	137107266	137125229	3500232777	40		137107266	137125229	8421504	2	20,20	0,17943	c	350023277700000003,350023277700000002	0-20,0-20						1 abstract title	tory.lib.ncsu.edu	0	0		
1631	chr2	137107266	137125229	3500063689	40		137107266	137125229	8421504	2	20,20	0,17943	c,g	350006368900000003,350006368900000002,350006368900000002	0-20,0-20,0-20						Prostaglandin F2tt Regulation of the Bovine Corpus Luteum Endothelin System: RESULTS | Methods of Treatment	-of-treatment.com	0	0		
1631	chr2	137133763	137148053	3500047577	63		137133763	137148053	8421504	4	21,8,13,21	0,9039,10534,14269	c,g	350004757700000016,350004757700000008,350004757700000009,350004757700000009	0-21,0-21,0-21,0-21		20176726	10.1210/en.2009-0767	0013-7227	Endocrinology	Induction of Endothelin-2 Expression by Luteinizing Hormone and Hypoxia: Possible Role in Bovine Corpus Luteum Formation	Klipper	2010	4		
1631	chr2	137153528	137153555	3500356276	27		137153528	137153555	8421504	1	27	0	c	350035627600000000	0-27		12827039		0160-2446	Journal of Cardiovascular Pharmacology	 The Effects of Phosphoramidon on the Expression of Human End... : Journal of Cardiovascular Pharmacology 	Isaka	2003	2		ECE1
1631	chr2	137177335	137177359	3500114128	23		137177335	137177359	8421504	2	4,19	0,5	g	350011412800000486	7-33						Hepatitis G virus protease	Belyaev	1996	0		
1634	chr2	137577130	137577850	3500459241	23		137577130	137577850	8421504	3	7,10,6	0,703,714	c	350045924100000009	11-34						Twenty-five Years of Exploration into Protein Science	www.jbc.org	0	0		
1634	chr2	137618439	137618464	3500340821	25		137618439	137618464	8421504	1	25	0	c	350034082100000062	0-25						Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation	Makarov	2005	0		
1635	chr2	137636614	137636640	3500011350	26		137636614	137636640	8421504	1	26	0	c	350001135000000011	0-26						Cellular/Molecular RegulationofNMDAReceptorTransport:AKIF17&#x2013;Cargo Binding/ReleasingUnderliesSynapticPlasticityandMemory InVivo	www.jneurosci.org	0	0		
1635	chr2	137690489	137692490	3500327037	42		137690489	137692490	8421504	2	21,21	0,1980	c,g	350032703700000000,350032703700000001,350032703700000001	0-21,0-21,0-21						AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-{delta}: implications for vascular disease	www.im.org/Academ	0	0		
1635	chr2	137690489	137692490	3500078433	42		137690489	137692490	8421504	2	21,21	0,1980	c	350007843300000000,350007843300000001	0-21,0-21		19955485	10.1152/ajpcell.00463.2009		American Journal of Physiology - Cell Physiolog	AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-&#x03b4;: implications for vascular disease	Cai	2010	0		
1635	chr2	137690489	137692490	3500070372	42		137690489	137692490	8421504	2	21,21	0,1980	c	350007037200000000,350007037200000001	0-21,0-21		19955485	10.1152/ajpcell.00463.2009		American Journal of Physiology - Cell Physiology	AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-&#x03b4;: implications for vascular disease	Weijing	2010	0		
1635	chr2	137690489	137692490	3500042302	42		137690489	137692490	8421504	2	21,21	0,1980	c,g	350004230200000000,350004230200000001,350004230200000001	0-21,0-21,0-21		19955485	10.1152/ajpcell.00463.2009		American Journal of Physiology - Cell Physiolog	AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-&#x03b4;: implications for vascular disease	Cai	2010	0		
1635	chr2	137690489	137692490	3500000869	42		137690489	137692490	8421504	2	21,21	0,1980	c,g	350000086900000000,350000086900000001,350000086900000001	0-21,0-21,0-21		19955485	10.1152/ajpcell.00463.2009		American Journal of Physiology - Cell Physiology	AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-&#x03b4;: implications for vascular disease	Cai	2010	0		DDOST
1635	chr2	137691106	137691129	3500302241	23		137691106	137691129	8421504	1	23	0	c	350030224100000050	16-39						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
1635	chr2	137691799	137692736	3500256316	40		137691799	137692736	8421504	2	20,20	0,917	c,g	350025631600000000,350025631600000001,350025631600000001	0-20,0-20,0-20						Die altersabh&#xe4;ngige Expression von Advanced Glycation Endproducts (AGE) - Rezeptoren am menschlichen Herzen	thek.uni-halle.de	0	0		DDOST
1635	chr2	137737826	137737851	3500270815	25		137737826	137737851	8421504	1	25	0	c	350027081500000010	0-25						Differential Gene Expression Profiles of Scirrhous Gastric Cancer Cells with High	.aacrjournals.org	0	0		
1636	chr2	137869129	137869156	3500123430	24		137869129	137869156	8421504	2	13,11	0,16	g	350012343000000007,350012343000000005	1-25,0-24		16963569	10.1128/JB.00773-06	0021-9193	Journal of Bacteriology	C-Terminal WxL Domain Mediates Cell Wall Binding in Enterococcus faecalis and Other Gram-Positive Bacteria	Brinster	2007	4		
1637	chr2	137904911	137904936	3500411690	23		137904911	137904936	8421504	3	7,12,4	0,8,21	g	350041169000000038	11-34						Treating eye disorders using intestinal trefoil proteins - US Patent 6525018 Description	ww.patentstorm.us	0	0		
1638	chr2	138125388	138125418	3500196470	25		138125388	138125418	8421504	3	8,3,14	0,12,16	g	350019647000000287	13-38						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
1639	chr2	138267264	138267295	3500144055	28		138267264	138267295	8421504	2	13,15	0,16	c	350014405500000229	20-48						GENERATION AND REPRODUCTION OF DNA SEQUENCES AND ANALYSIS OF POLYMORPHISMS AND MUTATIONS BY USING ERROR-CORRECTING CODES - Patent application	www.faqs.org	0	0		
1639	chr2	138275375	138275405	3500307663	27		138275375	138275405	8421504	2	20,7	0,23	c	350030766300000001,350030766300000003	0-21,0-28		22615246	10.1128/IAI.00206-12	0019-9567	Infection and Immunity	Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes	Siddiqui	2012	4		
1641	chr2	138477061	138477085	3500384133	23		138477061	138477085	8421504	2	16,7	0,17	c	350038413300000071	3-33						Aptamers as agonists - Patent application	www.faqs.org	0	0		
1644	chr2	138883651	138883681	3500416244	30		138883651	138883681	8421504	1	30	0	c	350041624400000012	0-30						Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier	Davidson	2007	0		
1644	chr2	138883651	138883681	3500349359	30		138883651	138883681	8421504	1	30	0	c	350034935900000012	0-30						Immunomodulation and effect on cell processes relating to serotonin family receptors	Albert	2002	0		NBL1
1644	chr2	138883651	138883681	3500223954	30		138883651	138883681	8421504	1	30	0	c	350022395400000012	0-30						Immunomodulation and effect on cell processes relating to serotonin family receptors	Albert	2003	0		
1644	chr2	138883651	138883681	3500122964	30		138883651	138883681	8421504	1	30	0	c	350012296400000012	0-30						Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier	Jameson	2006	0		
1644	chr2	138920469	138920497	3500267906	23		138920469	138920497	8421504	3	6,12,5	0,10,23	g	350026790600000011	4-29						Modulation of Biological Processes in the Nuleus by Delivery of DNA	www.scribd.com	0	0		
1645	chr2	139027679	139027705	3500267888	23		139027679	139027705	8421504	2	13,10	0,16	g	350026788800000006	0-24						Activins regulate 17b-hydroxysteroid dehydrogenase type I ...	ww.slideshare.net	0	0		
1645	chr2	139051197	139051227	3500063338	25		139051197	139051227	8421504	2	9,16	0,14	g	350006333800000023	1-26						Methods for producing polypeptides in protease-deficient mutants of trichoderma	A.Zhan 	2012	0		
1647	chr2	139260625	139262834	3500031202	41		139260625	139262834	8421504	3	21,1,19	0,295,2190	c	350003120200000025,350003120200000024	0-21,0-20						Comparative genotypic and pathogenic examination of Campylobacter concisus isolates from diarrheic and non-diarrheic humans	biomedcentral.com	0	0		EMC1,MRTO4
1648	chr2	139337356	139337382	3500069961	23		139337356	139337382	8421504	2	11,12	0,14	g	350006996100000058,350006996100000013	6-30,6-30						THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES - Patent application	www.faqs.org	0	0		
1648	chr2	139353891	139355782	3500225389	1891		139353891	139355782	8421504	1	1891	0	g	350022538900000022,350022538900000017	0-1079,0-1891						Pegasoferae? - Genomewiki	nomewiki.ucsc.edu	0	0		
1648	chr2	139378361	139378387	3500119167	23		139378361	139378387	8421504	2	17,6	0,20	c	350011916700000173	18-41						Human jagged polypeptide, encoding nucleic acids and methods of use	Li	1997	0		
1648	chr2	139456486	139456515	3500373014	26		139456486	139456515	8421504	3	5,13,8	0,7,21	g	350037301400000031	16-45						Process and materials for production of glucosamine - Patent # 6372457 - PatentGenius	.patentgenius.com	0	0		
1650	chr2	139668253	139668280	3500025345	23		139668253	139668280	8421504	3	13,6,4	0,16,23	g	350002534500000049	11-34						Pygopus In Diagnosis And Treatment Of Cancer 	.freshpatents.com	0	0		
1651	chr2	139751259	139751283	3500193635	23		139751259	139751283	8421504	2	4,19	0,5	g	350019363500000198	17-41						Materials and methods for immunocontraception	Harris	1993	0		
1652	chr2	139949375	139949401	3500097642	24		139949375	139949401	8421504	3	12,4,8	0,13,18	g	350009764200000035	0-26						VACCINE COMPRISING BETA-HERPESVIRUS	Jonjic	2012	0		
1653	chr2	140090848	140090879	3500388701	26		140090848	140090879	8421504	2	9,17	0,14	g	350038870100000020	7-33						GENETIC CHANGES IN ATM AND ATR/CHEK1 AS PROGNOSTIC INDICATORS IN CANCER - Patent application	www.faqs.org	0	0		
1654	chr2	140190750	140190777	3500063952	23		140190750	140190777	8421504	2	15,8	0,19	g	350006395200000001	9-32						Ireneusz T. Padol and Richard H. Hunt	combe.mcmaster.ca	0	0		
1659	chr2	140845906	140845931	3500099318	24		140845906	140845931	8421504	2	18,6	0,19	g	350009931800000022	2-26						Hepatitis c diagnostics and vaccines	Cho	1992	0		
1660	chr2	140921904	140921931	3500003832	24		140921904	140921931	8421504	2	19,5	0,22	g	350000383200000096	6-32						Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof	Falini	2007	0		
1660	chr2	140942358	140942382	3500094112	23		140942358	140942382	8421504	2	13,10	0,14	g	350009411200000008	0-28						In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of Y- and In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor&#x2013;Bearing Nude Mice	m.snmjournals.org	0	0		
1664	chr2	141456904	141456935	3500290449	26		141456904	141456935	8421504	2	15,11	0,20	c	350029044900000031	10-36						Biochimica et Biophysica Acta (BBA)-Molecular and cell	005.pasteur.ac.ir	0	0		
1664	chr2	141456948	141459376	3500464127	57		141456948	141459376	8421504	2	28,29	0,2399	p	350046412700015007	0-57						KURENAI : Kyoto University Research Information Repository	lib.kyoto-u.ac.jp	0	0		SDHB
1664	chr2	141462419	141463714	3500268847	23		141462419	141463714	8421504	2	2,21	0,1274	c	350026884700000049	0-23						Transcriptomic analysis of the challenged gut barrier	edepot.wur.nl	0	0		
1664	chr2	141484733	141484759	3500350348	23		141484733	141484759	8421504	2	8,15	0,11	c	350035034800000248	0-23						US Patent # 6,004,924. Protein sequences of serrate gene products - Patents.com	www.patents.com	0	0		
1665	chr2	141627651	141627680	3500079394	24		141627651	141627680	8421504	3	5,7,12	0,8,17	c	350007939400000007	10-34						Tat-028 And Methods Of Assessing And Treating Cancer 	.freshpatents.com	0	0		
1667	chr2	141836697	141858303	3500036421	523		141836697	141858303	8421504	17	31,23,34,10,46,2,37,10,19,27,32,48,69,39,41,7,48	0,1846,2298,10549,12486,12949,13745,13948,14055,14165,14282,14880,15877,16659,16707,21530,21558	c	350003642100000032,350003642100000173,350003642100000112,350003642100000062,350003642100000131,350003642100000134,350003642100000071,350003642100000077,350003642100000082,350003642100000148,350003642100000087,350003642100000088,350003642100000155	17-48,25-48,0-44,0-48,0-47,0-46,16-48,0-48,0-48,0-48,0-39,0-48,0-48						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
1667	chr2	141838926	141847281	3500330320	138		141838926	141847281	8421504	2	103,35	0,8320	p	350033032000015033	0-138						Structure, Function & Control of the EphA3 Receptor Tyrosine Kinase	.swinburne.edu.au	0	0		EPHA2
587	chr20	356039	356067	3500164528	23		356039	356067	8421504	2	14,9	0,19	g	350016452800000116	7-30						JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS - Patent application	www.faqs.org	0	0		
588	chr20	450823	450846	3500210532	23		450823	450846	8421504	1	23	0	c	350021053200000034	22-45						Different Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T Lymphocytes	u.diva-portal.org	0	0		
73	chr20	507636	767938	3500119552	639		507636	767938	8421504	8	45,63,105,108,71,70,125,52	0,3414,5050,13194,14007,15552,16376,260250	p	350011955200015097,350011955200015092,350011955200015087,350011955200015082	0-90,0-240,0-240,0-69						A potassium channel (Kv4) cloned from the heart of the tunicate Ciona intestinalis and its modulation by a KChIP subunit	eb.biologists.org	0	0		
591	chr20	879474	892134	3500074330	2186		879474	892134	8421504	7	76,158,172,716,387,337,340	0,3943,5454,10867,11584,11981,12320	p,c	350007433000000012,350007433000000000,350007433000000001,350007433000015000,350007433000015001,350007433000015014,350007433000015008,350007433000015002,350007433000000003,350007433000000004,350007433000000005,350007433000000013,350007433000000006,350007433000000007	0-1510,0-40,0-750,0-132,0-180,0-48,0-45,0-210,0-510,0-180,0-170,0-678,0-380,0-127						Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel	Folander	1997	0		
591	chr20	891967	891991	3500344093	23		891967	891991	8421504	2	9,14	0,10	c	350034409300000006	0-23			10.1128/MCB.25.14.5846-5858.2005		Molecular and Cellular Biology	GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells	Gaoxiang	July	0		
593	chr20	1122371	1122401	3500282252	24		1122371	1122401	8421504	3	6,6,12	0,10,18	g	350028225200000149	21-45						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
595	chr20	1361979	1362005	3500463825	23		1361979	1362005	8421504	2	12,11	0,15	g	350046382500000012	0-23						Deformylation of f-Met peptides in bacterial expression systems	Bogosian	1997	0		
604	chr20	2519037	2519066	3500070088	24		2519037	2519066	8421504	2	13,11	0,18	g	350007008800000144	8-32						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
606	chr20	2853771	2853800	3500013455	29		2853771	2853800	8421504	1	29	0	c,g	350001345500000084,350001345500000080,350001345500000080	0-27,21-47,21-47						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		
606	chr20	2853775	2853798	3500302345	23		2853775	2853798	8421504	1	23	0	c,g	350030234500000012,350030234500000012,350030234500000003	0-23,0-23,0-21						Irak-related interventions and diagnosis	Holvoet	2012	0		MIR103B2,MIR103A2
606	chr20	2853775	2853798	3500277393	23		2853775	2853798	8421504	1	23	0	c,g	350027739300000034,350027739300000034	0-23,0-23						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		MIR103B1,MIR103B2,MIR103A2
606	chr20	2853775	2853798	3500243960	23		2853775	2853798	8421504	1	23	0	c	350024396000000016	0-23		22984580	10.1371/journal.pone.0044873		PLoS ONE	Systematic Analysis of Small RNAs Associated with Human Mitochondria by Deep Sequencing: Detailed Analysis of Mitochondrial Associated miRNA	Lakshmi	2012	0		MIR103B1
606	chr20	2853775	2853798	3500191020	23		2853775	2853798	8421504	1	23	0	c	350019102000000020	0-23		23056445	10.1371/journal.pone.0046773	1932-6203	PLOS ONE	PLOS ONE: Neurofibromin 1 Is a miRNA Target in Neurons	Paschou	2012	4		MIR103B2,MIR103A2
606	chr20	2853775	2853798	3500131966	23		2853775	2853798	8421504	1	23	0	c	350013196600000009,350013196600000012	0-23,0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
606	chr20	2853775	2853798	3500125321	23		2853775	2853798	8421504	1	23	0	c	350012532100000017,350012532100000037	0-23,0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
606	chr20	2857983	2858011	3500152492	24		2857983	2858011	8421504	3	5,13,6	0,7,22	g	350015249200000180	6-30						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
606	chr20	2881570	2881594	3500465350	24		2881570	2881594	8421504	1	24	0	g	350046535000000002	6-30						Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor	Cho	2012	0		
606	chr20	2883253	2883276	3500408624	23		2883253	2883276	8421504	1	23	0	g	350040862400000007	0-36						MELiSSA	ecls.esa.int	0	0		
608	chr20	3101646	3101826	3500122793	40		3101646	3101826	8421504	2	20,20	0,160	g	350012279300000032,350012279300000031	0-20,0-20						Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine. - ResearchGate	.researchgate.net	0	0		YWHAZ
608	chr20	3101683	3101824	3500362403	41		3101683	3101824	8421504	2	20,21	0,120	g	350036240300000091,350036240300000090	0-20,0-21						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		YWHAZ,CASK
609	chr20	3164870	3164898	3500351664	23		3164870	3164898	8421504	2	16,7	0,21	g	350035166400000003	0-23		11294834	10.1074/jbc.M100072200	0021-9258	Journal of Biological Chemistry	The Absence of Oligonucleosomal DNA Fragmentation during Apoptosis of IMR-5 Neuroblastoma Cells	Yuste	2001	5		
609	chr20	3171640	3171664	3500359350	24		3171640	3171664	8421504	1	24	0	c	350035935000000004	0-24		12023301	10.1101/gad.982802	0890-9369	Genes & Development	Proper development of relay somatic sensory neurons and D2/D4 interneurons requires homeobox genes Rnx/Tlx-3 and Tlx-1	Qian	2002	12		TLX3
609	chr20	3172075	3173254	3500303018	44		3172075	3173254	8421504	2	23,21	0,1158	c	350030301800000002,350030301800000003	0-23,0-21						Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer	-publications.com	0	0		TLX3
609	chr20	3218274	3230795	3500090093	879		3218274	3230795	8421504	14	58,80,21,20,79,94,107,30,38,55,84,102,75,36	0,1835,2471,2493,2563,2933,3227,3429,3462,6974,7381,8218,10083,12485	p	350009009300015000	0-882						Treball Bioinform&#xe0;tica	formatica.upf.edu	0	0		
609	chr20	3220783	3230790	3500340064	40		3220783	3230790	8421504	3	4,16,20	0,54,9987	c	350034006400000001,350034006400000002	0-20,0-20						&#x4e3b;&#x9898;&#xff1a;c-Myc | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		NPM1
609	chr20	3220783	3230790	3500240966	40		3220783	3230790	8421504	3	4,16,20	0,54,9987	c	350024096600000001,350024096600000002	0-20,0-20			10.1124/mol.106.024810	1521-0111 (Online)	Molecular Pharmacology	Ras-Dependent Recruitment of c-Myc for Transcriptional Activation of Nucleophosmin/B23 in Highly Malignant U1 Bladder Cancer Cells	Yeh	2006	0		
609	chr20	3220783	3230790	3500143269	40		3220783	3230790	8421504	3	4,16,20	0,54,9987	c	350014326900000001,350014326900000002	0-20,0-20						&#x4e3b;&#x984c;&#xff1a;C-myc | &#x91ab;&#x6e90;&#x4e16;&#x754c;	big5.39kf.com	0	0		
609	chr20	3220901	3221237	3500032732	45		3220901	3221237	8421504	2	15,30	0,306	p	350003273200015005	0-45						Serum Dna Methylation Screening For Cancer 	.freshpatents.com	0	0		
609	chr20	3221242	3230928	3500298189	153		3221242	3230928	8421504	6	22,22,7,47,28,27	0,7159,7183,9517,9589,9659	c	350029818900000108,350029818900000002,350029818900000122,350029818900000100,350029818900000016,350029818900000085,350029818900000087,350029818900000086,350029818900000088,350029818900000069,350029818900000061,350029818900000008,350029818900000004,350029818900000006,350029818900000116,350029818900000112,350029818900000110,350029818900000080,350029818900000095,350029818900000047,350029818900000109,350029818900000003,350029818900000011	0-22,0-22,0-22,0-22,0-22,0-58,0-58,0-58,0-58,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,9-42,5-32,0-26,0-28,0-28,0-27						Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof - Patent application	www.faqs.org	0	0		
609	chr20	3221242	3230928	3500003832	151		3221242	3230928	8421504	7	22,22,7,47,7,19,27	0,7159,7183,9517,9589,9598,9659	c	350000383200000002,350000383200000016,350000383200000100,350000383200000085,350000383200000086,350000383200000087,350000383200000088,350000383200000008,350000383200000004,350000383200000006,350000383200000061,350000383200000094,350000383200000097,350000383200000080,350000383200000095,350000383200000047,350000383200000011	0-22,0-22,0-22,0-58,0-58,0-58,0-58,0-20,0-20,0-20,0-20,0-42,5-43,9-42,5-32,0-26,0-27						Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof	Falini	2007	0		
609	chr20	3221242	3230806	3500109802	98		3221242	3230806	8421504	4	22,22,7,47	0,7159,7183,9517	c	350010980200000088,350010980200000002,350010980200000080,350010980200000016,350010980200000102,350010980200000068,350010980200000067,350010980200000065,350010980200000010,350010980200000004,350010980200000092,350010980200000006,350010980200000090,350010980200000096,350010980200000008,350010980200000073,350010980200000077,350010980200000060,350010980200000075	0-22,0-22,0-22,0-22,0-22,0-58,0-58,0-58,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-35,5-43,9-42,5-32						Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof - Patent application	www.faqs.org	0	0		
609	chr20	3221252	3221300	3500274866	48		3221252	3221300	8421504	1	48	0	p	350027486600015000	0-48		16651537	10.1073/pnas.0506514103	0027-8424	Proceedings of the National Academy of Sciences	Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins	Elenitoba-Johnson	2006	10		NPM1
609	chr20	3221756	3225278	3500281528	48		3221756	3225278	8421504	2	18,30	0,3492	p	350028152800015019,350028152800015013	3-51,66-111						<Html><Title> Complet list of 2pfl hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
609	chr20	3226575	3228364	3500253449	26		3226575	3228364	8421504	2	19,7	0,1782	c	350025344900000003	7-33		15684379	10.1128/MCB.25.4.1258-1271.2005	0270-7306	Molecular and Cellular Biology	Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its Function	Korgaonkar	2005	6		
609	chr20	3228408	3230780	3500413958	45		3228408	3230780	8421504	2	24,21	0,2351	p	350041395800015006	0-45		22592607	10.1182/blood-2011-11-394395	0006-4971	Blood	Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia	Greiner	2012	10		NPM1
609	chr20	3228408	3230780	3500233756	45		3228408	3230780	8421504	2	24,21	0,2351	p	350023375600015006	0-45		22592607	10.1182/blood-2011-11-394395	0006-4971	Blood	Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia	Greiner	2012	10		NPM1
609	chr20	3228420	3230792	3500388463	45		3228420	3230792	8421504	2	12,33	0,2339	p	350038846300015016	0-45						Synthetic Gene Control Region 	.freshpatents.com	0	0		
609	chr20	3228425	3230849	3500159935	73		3228425	3230849	8421504	3	7,47,19	0,2334,2405	c	350015993500000002,350015993500000003,350015993500000001,350015993500000004,350015993500000008,350015993500000006	0-58,0-58,0-58,0-58,5-32,10-29		16455950	10.1182/blood-2005-11-4745	0006-4971	Blood	Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML	Falini	2006	10		
609	chr20	3230771	3230799	3500418605	28		3230771	3230799	8421504	1	28	0	c	350041860500000001	8-36		15485902	10.1128/MCB.24.21.9327-9338.2004	0270-7306	Molecular and Cellular Biology	ARF Impedes NPM/B23 Shuttling in an Mdm2-Sensitive Tumor Suppressor Pathway	Brady	2004	6		NPM1
609	chr20	3230771	3230799	3500077712	28		3230771	3230799	8421504	1	28	0	c	350007771200000001	8-36			10.1128/MCB.24.21.9327-9338.2004		Molecular and Cellular Biology	ARF Impedes NPM/B23 Shuttling in an Mdm2-Sensitive Tumor Suppressor Pathway	Suzanne	2004	0		CLEC2D
609	chr20	3230887	3230938	3500240603	44		3230887	3230938	8421504	2	24,20	0,31	c,g	350024060300000000,350024060300000001,350024060300000001	0-24,0-20,0-20		15616222	10.1095/biolreprod.104.034801	0006-3363	Biology of Reproduction	Identification of Differentially Regulated Genes During Elongation and Early Implantation in the Ovine Trophoblast Using Complementary DNA Array Screening	Cammas	2005	4		
609	chr20	3239857	3254957	3500275122	38		3239857	3254957	8421504	2	19,19	0,15081	c,g	350027512200000002,350027512200000002,350027512200000003,350027512200000003	0-19,0-19,0-19,0-19		20484739	10.1095/biolreprod.110.084277	0006-3363	Biology of Reproduction	Expression and Function of Fibroblast Growth Factor 18 in the Ovarian Follicle in Cattle	Portela	2010	4		FGF18
609	chr20	3239857	3254957	3500001785	38		3239857	3254957	8421504	2	19,19	0,15081	c,g	350000178500000002,350000178500000002,350000178500000003,350000178500000003	0-19,0-19,0-19,0-19		20484739	10.1095/biolreprod.110.084277	0006-3363	Biology of Reproduction	Expression and Function of Fibroblast Growth Factor 18 in the Ovarian Follicle in Cattle	Portela	2010	4		
609	chr20	3255043	3274926	3500213723	225		3255043	3274926	8421504	6	45,13,32,45,45,45	0,48,12739,19742,19790,19838	p	350021372300015157,350021372300015158,350021372300015161,350021372300015162,350021372300015163	0-45,0-45,0-45,0-45,0-45						Methods of Diagnosing Hypophosphatemic Disorders - Patent application	www.faqs.org	0	0		FGF18
609	chr20	3275003	3275028	3500223289	25		3275003	3275028	8421504	1	25	0	c	350022328900000001	9-34		9742123		0270-7306	Molecular and Cellular Biology	FGF-18, a Novel Member of the Fibroblast Growth Factor Family, Stimulates Hepatic and Intestinal Proliferation	Hu	1998	6		
615	chr20	3966584	3991965	3500125417	46		3966584	3991965	8421504	3	2,18,26	0,25249,25355	c,g	350012541700000003,350012541700000000,350012541700000000,350012541700000002,350012541700000002	0-20,0-19,0-19,0-20,0-20						Off-Target Serine/Threonine Kinase 10 Inhibition by Erlotinib Enhances Lymphocytic Activity Leading to Severe Skin Disorders	aspetjournals.org	0	0		STK10
615	chr20	3973768	3973797	3500465169	24		3973768	3973797	8421504	2	8,16	0,13	g	350046516900000414	14-38						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
617	chr20	4237218	4237246	3500184300	23		4237218	4237246	8421504	2	6,17	0,11	g	350018430000000003	20-45						The ftsZ Gene of Mycobacterium smegmatis is expressed Through Multiple Transcripts. - ResearchGate	.researchgate.net	0	0		
619	chr20	4567085	4567152	3500404944	40		4567085	4567152	8421504	2	20,20	0,47	c,g	350040494400000036,350040494400000036,350040494400000037,350040494400000037	0-20,0-20,0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
619	chr20	4567729	4567777	3500074304	48		4567729	4567777	8421504	1	48	0	p	350007430400015032	0-48						Expression cloning of a human phosphatase	Aaronson	1994	0		DUSP1
619	chr20	4567741	4568406	3500299297	135		4567741	4568406	8421504	3	45,45,45	0,48,620	p	350029929700015122,350029929700015121,350029929700015119	0-45,0-45,0-45						Phosphatases which activate map kinase pathways - Patent application	www.faqs.org	0	0		DUSP1
619	chr20	4567854	4568307	3500124284	25		4567854	4568307	8421504	2	9,16	0,437	c	350012428400000008	0-25		20017901	10.1186/1471-2172-10-64		BMC Immunology	A novel anti-mycobacterial function of mitogen-activated protein kinase phosphatase-1	Benny	2009	0		
619	chr20	4568475	4568996	3500386061	40		4568475	4568996	8421504	2	20,20	0,501	c,g	350038606100000007,350038606100000007,350038606100000006,350038606100000006	0-20,0-20,0-20,0-20						Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells	-publications.com	0	0		DUSP1
619	chr20	4569520	4569566	3500109960	42		4569520	4569566	8421504	2	22,20	0,26	c,g	350010996000000002,350010996000000000,350010996000000000	0-22,0-20,0-20						Identification of androgen-regulated genes in human prostate	-publications.com	0	0		DUSP1
621	chr20	4735239	4735266	3500430989	23		4735239	4735266	8421504	2	12,11	0,16	c	350043098900000600	25-48						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
621	chr20	4735239	4735266	3500070288	23		4735239	4735266	8421504	2	12,11	0,16	c	350007028800000604	25-48						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
621	chr20	4743805	4743856	3500369674	51		4743805	4743856	8421504	1	51	0	p	350036967400015003	0-51						Diego F. Mastroeni	ichtuniversity.nl	0	0		RPL26
622	chr20	4903370	4903394	3500375146	23		4903370	4903394	8421504	2	7,16	0,8	g	350037514600000060	12-35						A radiation hybrid map of river buffalo (Bubalus bubalis) chromosome 1 (BBU1)	ticabovina.com.br	0	0		
622	chr20	4937011	4937056	3500030046	45		4937011	4937056	8421504	1	45	0	p	350003004600015022	0-45						CARDIOVASCULAR STEM CELLS, METHODS FOR STEM CELL ISOLATION, AND USES THEREOF - Patent application	www.faqs.org	0	0		SLC25A37
622	chr20	4937140	4939096	3500327455	41		4937140	4939096	8421504	2	21,20	0,1936	c	350032745500000006,350032745500000010	24-45,8-28					Molecular and Cellular Biology	Identification of the In Vivo Casein Kinase II Phosphorylation Site within the Homeodomain of the Cardiac Tisue-Specifying Homeobox Gene Product Csx/Nkx2.5	Hideko	1999	0		
622	chr20	4939026	4939050	3500176414	24		4939026	4939050	8421504	1	24	0	c	350017641400000014	0-24						AMNIOTIC FLUID STEM CELLS AND KIDNEY REGENERATION	arch.cab.unipd.it	0	0		
623	chr20	5026252	5031929	3500277503	49		5026252	5031929	8421504	3	26,10,13	0,393,5664	c,g	350027750300000001,350027750300000003	0-26,0-23		19131501	10.1677/JME-08-0161	0952-5041	Journal of Molecular Endocrinology	Stanniocalcin 2 is positively and negatively controlled by 1,25(OH)2D3 and PTH in renal proximal tubular cells	Takei	2009	3		
623	chr20	5026252	5026285	3500053152	33		5026252	5026285	8421504	1	33	0	c	350005315200000001	10-43						Supplementary table 1 Quantification of the hMSC secretome during osteogenesis	www.mcponline.org	0	0		
623	chr20	5026364	5034599	3500036737	40		5026364	5034599	8421504	2	20,20	0,8215	c,g	350003673700000003,350003673700000003,350003673700000002,350003673700000002	0-20,0-20,0-20,0-20		16452456	10.1095/biolreprod.106.050807	0006-3363	Biology of Reproduction	Stanniocalcin (STC) in the Endometrial Glands of the Ovine Uterus: Regulation by Progesterone and Placental Hormones	Song	2006	4		STC2
629	chr20	5896119	5896143	3500207388	23		5896119	5896143	8421504	2	15,8	0,16	c	350020738800000073	7-30						Computational and enzymatic digestion methods for the mass spectrometric analysis of oligonucleotide adducts	iris.lib.neu.edu	0	0		
631	chr20	6059230	6059258	3500389666	23		6059230	6059258	8421504	3	12,5,6	0,14,22	g	350038966600000281	0-24						VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS - Patent application	www.faqs.org	0	0		
631	chr20	6097924	6098163	3500180594	41		6097924	6098163	8421504	2	20,21	0,218	g	350018059400000005,350018059400000004	0-20,0-21						ART&#x02dd;CULO ESPECIAL	rccp.udea.edu.co	0	0		
633	chr20	6317805	6317833	3500311269	26		6317805	6317833	8421504	2	6,20	0,8	g	350031126900000041	7-34					Patent	Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used (Patent CN:100572556)	Si Di Na *Luo Te 	2009	0		
635	chr20	6600657	6605096	3500335228	81		6600657	6605096	8421504	2	33,48	0,4391	c	350033522800000072,350033522800000085	79-112,0-48						Composition and Method for the Treatment or Prevention of Spinal Disorders III - Patent application	www.faqs.org	0	0		
635	chr20	6600738	6600783	3500154727	45		6600738	6600783	8421504	1	45	0	p	350015472700015000	0-45						Increased vitamin D-driven signalling	ive.library.uu.nl	0	0		MSX2
635	chr20	6604964	6604988	3500206152	24		6604964	6604988	8421504	1	24	0	c	350020615200000004	0-24						Neonatal Exposure to Estrogen and Estrogen Receptor Agonists and Antagonists: Effects on the Adult Endometrial Proteome and Morphoregulatory Gene Expression in the Neonatal Uterus	etd.auburn.edu	0	0		MSX2
635	chr20	6605112	6605291	3500031998	41		6605112	6605291	8421504	2	21,20	0,159	c,g	350003199800000007,350003199800000007,350003199800000008,350003199800000008	0-21,0-21,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
635	chr20	6605231	6605254	3500213737	23		6605231	6605254	8421504	1	23	0	c	350021373700000015	19-42			10.1128/MCB.23.13.4627-4636.2003		Molecular and Cellular Biology	Bone Morphogenetic Protein 4 Mediates Apoptosis of Capillary Endothelial Cells during Rat Pupillary Membrane Regression	Mari	July	0		MSX2
635	chr20	6610397	6610425	3500196508	25		6610397	6610425	8421504	2	14,11	0,17	g	350019650800000914	0-25						 Conjugated Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
638	chr20	6998667	6998690	3500404444	23		6998667	6998690	8421504	1	23	0	c	350040444400000018	22-45			10.1111/j.1471-4159.2007.04910.x	1471-4159	Journal of Neurochemistry	Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains - Ngamukote - 2007 - Journal of Neurochemistry - Wiley Online Library	Ngamukote	2007	0		
639	chr20	7177880	7177903	3500359118	23		7177880	7177903	8421504	1	23	0	c	350035911800000004	11-34		19816559	10.1371/journal.ppat.1000611		PLoS Pathogens	A Granulin-Like Growth Factor Secreted by the Carcinogenic Liver Fluke, Opisthorchis viverrini, Promotes Proliferation of Host Cells	MichaJ.	2009	0		
639	chr20	7178610	7178637	3500013932	27		7178610	7178637	8421504	1	27	0	c,g	350001393200000001,350001393200000001	0-27,0-27		15208678	10.1038/sj.onc.1207776	0950-9232	Oncogene	Genetic alterations of the NRP&sol;B gene are associated with human brain tumors	Liang	2004	6		
642	chr20	7508722	7508748	3500106438	23		7508722	7508748	8421504	2	14,9	0,17	g	350010643800000056	0-38						 Interferon 	www.docstoc.com	0	0		
645	chr20	7983073	7983097	3500317100	23		7983073	7983097	8421504	2	17,6	0,18	c	350031710000000011	12-37						THE JOURNAL OF BIOLOGICAL C &#xa9; 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Determination of the Border between the Transmembrane and Cytoplasmic Domains of Human Integrin Subunits*	www.sbc.su.se	0	0		
648	chr20	8304015	8304043	3500070165	24		8304015	8304043	8421504	2	16,8	0,20	g	350007016500000198,350007016500000031	0-24,0-24						US Patent # 7,309,597. Alanine 2,3-Aminomutase - Patents.com	www.patents.com	0	0		
649	chr20	8399382	8399408	3500346255	26		8399382	8399408	8421504	1	26	0	c	350034625500000017	25-51						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		
649	chr20	8420659	8427233	3500298092	537		8420659	8427233	8421504	13	16,29,123,1,44,19,98,42,45,3,42,4,71	0,634,666,792,2794,2841,4980,5556,5601,5679,5935,5998,6503	p	350029809200015085,350029809200015086,350029809200015073,350029809200015087,350029809200015074,350029809200015075,350029809200015076,350029809200015090,350029809200015077,350029809200015091,350029809200015078,350029809200015092,350029809200015093,350029809200015081,350029809200015096,350029809200015083	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Transcription factor MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances - Patent application	www.faqs.org	0	0		ANKRA2
649	chr20	8466254	8469594	3500425977	40		8466254	8469594	8421504	3	20,19,1	0,500,3339	c	350042597700000003,350042597700000002	0-20,0-20						Role of chromosome stability and telomere length in the production of viable cell lines for somatic cell nuclear transfer | Gabriela Mastromonaco - Academia.edu	www.academia.edu	0	0		BTF3
649	chr20	8466254	8469594	3500223606	40		8466254	8469594	8421504	3	20,19,1	0,500,3339	c	350022360600000003,350022360600000002	0-20,0-20			10.1186/1471-213X-6-41	1471-213X	BMC Developmental Biology	Role of chromosome stability and telomere length in the production of viable cell lines for somatic cell nuclear transfer	Mastromonaco	2006	3		BTF3
649	chr20	8492333	8492448	3500308095	48		8492333	8492448	8421504	2	24,24	0,91	c	350030809500000006,350030809500000007	0-24,0-24		19166506	10.1111/j.1471-4159.2009.05920.x	1471-4159	Journal of Neurochemistry	Essential roles of dopamine D4 receptors and the type 1 adenylyl cyclase in photic control of cyclic AMP in photoreceptor cells - Jackson - 2009 - Journal of Neurochemistry - Wiley Online Library	Jackson	2009	0		CALM2
650	chr20	8557303	8557331	3500037450	24		8557303	8557331	8421504	2	12,12	0,16	g	350003745000000000,350003745000000012	3-33,3-33						 Isolating Cells Expressing Secreted Proteins 	www.docstoc.com	0	0		
650	chr20	8557303	8557331	3500013918	24		8557303	8557331	8421504	2	12,12	0,16	g	350001391800000012	3-33						Isolating Cells Expressing Secreted Proteins 	.freshpatents.com	0	0		
651	chr20	8656717	8656748	3500004227	26		8656717	8656748	8421504	2	7,19	0,12	g	350000422700000113	10-36						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
655	chr20	9186922	9186947	3500269870	25		9186922	9186947	8421504	1	25	0	g	350026987000000048	3-28						Evolution of the Mammalian Mitochondrial Control Region-Comparisons of Control Region Sequences Between Monotreme and Therian Mammals	brary.arizona.edu	0	0		
656	chr20	9348643	9394700	3500123460	48		9348643	9394700	8421504	2	24,24	0,46033	c	350012346000000003,350012346000000002	12-36,12-36		10198061	10.1091/mbc.10.4.1119	1059-1524	Molecular Biology of the Cell	&#x03b2;-Catenin Can Be Transported into the Nucleus in a Ran-unassisted Manner	Yokoya	1999	5		
656	chr20	9348643	9348667	3500348108	24		9348643	9348667	8421504	1	24	0	c	350034810800000003	12-36						-Catenin Can Be Transported into the Nucleus in a Ran-unassisted Manner	w.molbiolcell.org	0	0		TNPO1
656	chr20	9351842	9355761	3500352871	50		9351842	9355761	8421504	2	24,26	0,3893	c,g	350035287100000001,350035287100000001,350035287100000000	0-24,0-24,0-26		15037768	10.1261/rna.5224304	1355-8382	RNA	Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR	REBANE	2004	5		TNPO1
656	chr20	9351842	9355761	3500278989	50		9351842	9355761	8421504	2	24,26	0,3893	c	350027898900000001,350027898900000000	0-24,0-26		15037768	10.1261/rna.5224304	1355-8382	RNA	Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR	REBANE	2004	5		TNPO1
660	chr20	9872761	9872787	3500072968	23		9872761	9872787	8421504	2	10,13	0,13	g	350007296800000359	22-45						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
662	chr20	10128963	10128987	3500018399	24		10128963	10128987	8421504	1	24	0	g	350001839900000015	0-24						Restore 89 315.336 373	www.bio.tamu.edu	0	0		
662	chr20	10143610	10143638	3500256414	25		10143610	10143638	8421504	3	12,5,8	0,14,20	g	350025641400000006	0-25		14764100			The Federation of European Biochemical Societies Journal	Identification of a gene encoding Lon protease from Brevibacillus thermoruber WR-249 and biochemical characterization of its thermostable recombinant enzyme.	Lee	2004	0		
662	chr20	10143610	10143638	3500140550	25		10143610	10143638	8421504	3	12,5,8	0,14,20	g	350014055000000006	0-25			10.1111/j.1432-1033.2004.03988.x	1432-1033	European Journal of Biochemistry	Identification of a gene encoding Lon protease from Brevibacillus thermoruber WR-249 and biochemical characterization of its thermostable recombinant enzyme - Lee Tsay - 2004 - European Journal of Biochemistry - Wiley Online Library	Lee	2004	0		
662	chr20	10143610	10143638	3500049456	25		10143610	10143638	8421504	3	12,5,8	0,14,20	g	350004945600000006	0-25						Identification of a gene encoding Lon protease from Brevibacillus thermoruber WR-249 and biochemical characterization of its thermostable recombinant enzyme	ur.lib.ntu.edu.tw	0	0		
662	chr20	10185451	10194118	3500041256	23		10185451	10194118	8421504	2	22,1	0,8666	c	350004125600000004	0-23		20408908	10.1111/j.1469-7580.2010.01228.x	1469-7580	Journal of Anatomy	Evolution of the spatial distribution of MAP1B phosphorylation sites in vertebrate neurons - Tymanskyj - 2010 - Journal of Anatomy - Wiley Online Library	Tymanskyj	2010	0		MAP1B
663	chr20	10250876	10250904	3500243952	23		10250876	10250904	8421504	2	15,8	0,20	g	350024395200000258	4-39						BIOTECHNOLOGICAL APPROACHES ON THE FERMENTATIVE PRODUCTION OF BACTERIOCIN AS BIOPRESERVATIVE	ir.cftri.com	0	0		
666	chr20	10699750	10699777	3500367071	27		10699750	10699777	8421504	1	27	0	c	350036707100000001	8-35						ARYLTHIAZOLYL PIPERIDINES AND RELATED COMPOUNDS AS MODULATORS OF SURVIVAL MOTOR NEURON (SMN) PROTEIN PRODUCTION - THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	www.sumobrain.com	0	0		
666	chr20	10699750	10699777	3500263372	27		10699750	10699777	8421504	1	27	0	c	350026337200000001	8-35						Arylthiazolyl piperidines and related compounds as modulators of survival motor neuron (smn) protein production	Marugan	2011	0		
666	chr20	10699750	10699777	3500216758	27		10699750	10699777	8421504	1	27	0	c	350021675800000001	8-35						Arylthiazolyl piperidines and related compounds as modulators of survival motor neuron (smn) protein production	Marugan	2013	0		
666	chr20	10700594	10700618	3500356243	24		10700594	10700618	8421504	1	24	0	c	350035624300000003	0-24						Development of Therapies for Spinal Muscular Atrophy Using Gene Therapy and Nanotechnology	s.whiterose.ac.uk	0	0		SMN2
666	chr20	10700605	10700630	3500059779	24		10700605	10700630	8421504	2	10,14	0,11	c	350005977900000058	10-34						CE7-specific chimeric T cell receptor - Patent # 7265209 - PatentGenius	.patentgenius.com	0	0		SMN2
666	chr20	10705766	10705790	3500023099	24		10705766	10705790	8421504	1	24	0	c	350002309900000231,350002309900000232	0-24,0-24						Conceptions of Power Held by Educational Leaders: The Impact on Collaborative Decision-Making Processes | meredith mountford - Academia.edu	www.academia.edu	0	0		SMN2
667	chr20	10779126	10779150	3500161770	24		10779126	10779150	8421504	1	24	0	c	350016177000000000	0-24		11319235	10.1074/jbc.M102457200	0021-9258	Journal of Biological Chemistry	A Role of the C-terminal Part of p44 in the Promoter Escape Activity of Transcription Factor IIH	Tremeau-Bravard	2001	5		GTF2H2C
667	chr20	10803675	10803699	3500387669	24		10803675	10803699	8421504	1	24	0	c	350038766900000007	21-45						The effect of chronic oxytocin-treatment on the bovine mammary gland immune system	vri.cz/docs/vetme	0	0		
667	chr20	10803675	10803699	3500316054	24		10803675	10803699	8421504	1	24	0	c	350031605400000007	21-45						The effect of chronic oxytocin-treatment on the bovine mammary gland immune system - ResearchGate	.researchgate.net	0	0		
667	chr20	10803829	10805699	3500234879	60		10803829	10805699	8421504	3	13,17,30	0,1663,1840	c	350023487900000000,350023487900000005	0-30,0-30						Hemodynamic Regulation of Occludin and ZO-1: Effect on Barrier Function	doras.dcu.ie	0	0		
667	chr20	10803836	10805514	3500365887	28		10803836	10805514	8421504	2	6,22	0,1656	c	350036588700000002	0-28			10.1046/j.0022-3042.2001.00740.x	1471-4159	Journal of Neurochemistry	Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin - Antonetti - 2002 - Journal of Neurochemistry - Wiley Online Library	Antonetti	2002	0		
667	chr20	10835383	10835407	3500075092	24		10835383	10835407	8421504	1	24	0	c	350007509200000003	22-46						Association of the Actin-Binding ,&#xb6; Protein Transgelin with Lymph	www.neoplasia.com	0	0		
668	chr20	10968030	10968822	3500447940	792		10968030	10968822	8421504	1	792	0	p	350044794000015022	0-792						MULTIPLE DOMAIN PROTEINS	Chalasani	2009	0		TAF9
668	chr20	10988080	10988106	3500463625	23		10988080	10988106	8421504	2	7,16	0,10	g	350046362500000013	17-40						Methods and compositions for polypeptide engineering	Patten	2009	0		
668	chr20	10988080	10988106	3500128024	23		10988080	10988106	8421504	2	7,16	0,10	g	350012802400000013	17-40						Methods and compositions for polypeptide engineering	Patten	2006	0		
669	chr20	11088308	11088773	3500060864	81		11088308	11088773	8421504	3	20,24,37	0,161,428	c	350006086400000010,350006086400000012,350006086400000009,350006086400000011,350006086400000002	6-26,0-24,0-20,0-20,0-24		15601923	10.1095/biolreprod.104.034793	0006-3363	Biology of Reproduction	Expression of Cyclin B1 Messenger RNA Isoforms and Initiation of Cytoplasmic Polyadenylation in the Bovine Oocyte	Tremblay	2005	4		
669	chr20	11088421	11088444	3500003378	23		11088421	11088444	8421504	1	23	0	c	350000337800000001	7-30		17409430	10.1158/0008-5472.CAN-06-2728	0008-5472	Cancer Research	Nuclear Factor-&#x03ba;B and Manganese Superoxide Dismutase Mediate Adaptive Radioresistance in Low-Dose Irradiated Mouse Skin Epithelial Cells	Fan	2007	8		
669	chr20	11088469	11088756	3500235713	44		11088469	11088756	8421504	2	24,20	0,267	c	350023571300000005,350023571300000004	0-24,0-20						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
669	chr20	11088750	11089508	3500435447	40		11088750	11089508	8421504	2	20,20	0,738	c	350043544700000009,350043544700000008	0-20,0-20						Effect of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate on in vitro developmental competence of bovine oocytes	health.huji.ac.il	0	0		
669	chr20	11089475	11095104	3500236229	42		11089475	11095104	8421504	2	21,21	0,5608	c	350023622900000009,350023622900000008	0-21,0-21		10642573	10.1095/biolreprod62.2.355	0006-3363	Biology of Reproduction	Impact of Bovine Oocyte Maturation Media on Oocyte Transcript Levels, Blastocyst Development, Cell Number, and Apoptosis	Watson	2000	4		
669	chr20	11089475	11095104	3500228652	42		11089475	11095104	8421504	2	21,21	0,5608	c	350022865200000009,350022865200000008	0-21,0-21		10642573	10.1095/biolreprod62.2.355	0006-3363	Biology of Reproduction	Impact of Bovine Oocyte Maturation Media on Oocyte Transcript Levels, Blastocyst Development, Cell Number, and Apoptosis	Watson	2000	4		
669	chr20	11089857	11090398	3500426746	40		11089857	11090398	8421504	2	19,21	0,520	c,g	350042674600000008,350042674600000008,350042674600000007,350042674600000007	0-19,0-19,0-21,0-21						Tesis doctoral Estudio molecular y de apoptosis en ovocitos de cabras prepAoberes y su relaciA3n	ddd.uab.cat	0	0		
669	chr20	11090430	11095025	3500464865	27		11090430	11095025	8421504	3	7,16,4	0,10,4591	c	350046486500000006	13-40						Influence of resveratrol on rheumatoid fibroblast-like synoviocytes analysed with gene chip transcription. - ResearchGate	.researchgate.net	0	0		CCNB1
669	chr20	11113076	11113121	3500448017	45		11113076	11113121	8421504	1	45	0	p	350044801700015001	0-45		19451265	10.1084/jem.20082533	0022-1007	The Journal of Experimental Medicine	Zinc transporter Znt5/Slc30a5 is required for the mast cell&#x2013;mediated delayed-type allergic reaction but not the immediate-type reaction	Nishida	2009	14		SLC30A5
669	chr20	11113076	11113121	3500405401	45		11113076	11113121	8421504	1	45	0	p	350040540100015000	0-45		19451265	10.1084/jem.20082533		The Journal of Experimental Medicine	Zinc transporter Znt5/Slc30a5 is required for the mast cell&#x2013;mediated delayed-type allergic reaction but not the immediate-type reaction	Keigo	June	0		SLC30A5
670	chr20	11243708	11243737	3500136326	25		11243708	11243737	8421504	3	7,5,13	0,8,16	g	350013632600000003	4-37					Patent	Hefest&#xe4;mme zur herstellung von milchs&#xe4;ure Yeast strains for the production of lactic acid (Patent DE:69832624)	Alberghina	2006	0		
677	chr20	12085624	12085654	3500276595	30		12085624	12085654	8421504	1	30	0	c	350027659500000001	41-71			10.1093/emboj/20.6.1245	ERROR! NO ISSN	The EMBO Journal	Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways	Celli	2001	0		
677	chr20	12086712	12101882	3500272260	106		12086712	12101882	8421504	6	36,1,20,28,11,10	0,148,866,3027,3714,15160	c	350027226000000008,350027226000000003,350027226000000007,350027226000000001	0-36,9-30,0-28,9-30		16135792	10.1128/MCB.25.18.8001-8008.2005	0270-7306	Molecular and Cellular Biology	Phosphatidylinositol 3-Kinase p85&#x03b1; Subunit-Dependent Interaction with BCR/ABL-Related Fusion Tyrosine Kinases: Molecular Mechanisms and Biological Consequences	Ren	2005	6		
677	chr20	12086712	12089767	3500271768	85		12086712	12089767	8421504	4	36,1,20,28	0,148,866,3027	c	350027176800000008,350027176800000003,350027176800000007	0-36,9-30,0-28			10.1128/MCB.25.18.8001-8008.2005		Molecular and Cellular Biology	Phosphatidylinositol 3-Kinase p85&#x03b1; Subunit-Dependent Interaction with BCR/ABL-Related Fusion Tyrosine Kinases: Molecular Mechanisms and Biological Consequences	Shu-yue	2005	0		
677	chr20	12086822	12088200	3500260994	46		12086822	12088200	8421504	2	23,23	0,1355	c,g	350026099400000001,350026099400000000,350026099400000000	0-23,0-23,0-23						Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis	www.wjgnet.com	0	0		
677	chr20	12086822	12088200	3500069922	46		12086822	12088200	8421504	2	23,23	0,1355	c,g	350006992200000001,350006992200000000,350006992200000000	0-23,0-23,0-23			10.3748/wjg.14.5186		World Journal of Gastroenterology : WJG	Phosphatidylinositol 3-kinase/Akt pathway regulates hepatic stellate cell apoptosis	Yan	2008	0		
677	chr20	12087785	12087813	3500303141	28		12087785	12087813	8421504	1	28	0	c	350030314100000022	17-45						QUINAZOLINE DERIVATIVES AS PI3K MODULATORS - NOVARTIS AG	www.sumobrain.com	0	0		
677	chr20	12089020	12089050	3500121467	30		12089020	12089050	8421504	1	30	0	c	350012146700000009,350012146700000037	12-42,12-42						Tetrahydro-Pyrido-Pyrimidine Derivatives - Patent application	www.faqs.org	0	0		
677	chr20	12089020	12089050	3500033081	30		12089020	12089050	8421504	1	30	0	c	350003308100000009	12-42						DIHYDRO-BENZO-OXAZINE AND DIHYDRO-PYRIDO-OXAZINE DERIVATIVES - NOVARTIS AG	www.sumobrain.com	0	0		
677	chr20	12089020	12089049	3500165080	29		12089020	12089049	8421504	1	29	0	c	350016508000000009	0-29						Use of inhibitors of the activity or function of PI3K	Cooke	2013	0		
677	chr20	12103258	12165374	3500394704	40		12103258	12165374	8421504	4	14,6,12,8	0,6126,6721,62108	c	350039470400000017,350039470400000016	0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
677	chr20	12103258	12165374	3500292483	40		12103258	12165374	8421504	4	14,6,12,8	0,6126,6721,62108	c	350029248300000017,350029248300000016	0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
677	chr20	12165388	12165448	3500143843	60		12165388	12165448	8421504	1	60	0	p	350014384300015030	3-63						Quantitative Analyse von T-Zell Stimulation und Costimulation durch zellul&#xe4;re Mikrosysteme	.uni-tuebingen.de	0	0		PIK3R1
677	chr20	12165409	12165460	3500380251	51		12165409	12165460	8421504	1	51	0	p	350038025100015010	0-51						 <HTML> <HEAD><TITLE>i1/43i1/2i1/2i1/43i1/4"i1/4cuaaeSSaaaaa"aa(r)aeC/ae3a"a(c)c"ae3 - c1e	www.j-tokkyo.com	0	0		PIK3R1
677	chr20	12165409	12165460	3500027049	51		12165409	12165460	8421504	1	51	0	p	350002704900015049	0-51						Src SH3 BINDENDE PEPTIDE UND VERFAHREN ZU IHRER ISOLIERUNG UND VERWENDUNG - Dokument DE69534920T2	www.patent-de.com	0	0		PIK3R1
677	chr20	12165445	12165694	3500214246	249		12165445	12165694	8421504	1	249	0	p	350021424600015091	0-249						Alignement multiple ClustalW	polytech.unice.fr	0	0		PIK3R1
677	chr20	12165448	12165697	3500263315	249		12165448	12165697	8421504	1	249	0	p	350026331500015040,350026331500015011	33-282,0-249						Compositions and methods for producing bioactive fusion proteins	Walker	2008	0		PIK3R1
677	chr20	12165448	12165697	3500236543	249		12165448	12165697	8421504	1	249	0	p	350023654300015065,350023654300015023,350023654300015064	0-90,0-177,33-192					Patent	Compositions and methods for producing bioactive fusion proteins (Patent US:8420779)	Walker	2013	0		PIK3R1
677	chr20	12165448	12165697	3500227699	249		12165448	12165697	8421504	1	249	0	p	350022769900015065,350022769900015023,350022769900015064	0-90,0-177,33-192						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		PIK3R1
677	chr20	12165448	12165697	3500004002	249		12165448	12165697	8421504	1	249	0	p	350000400200015043,350000400200015013	33-282,0-249						COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS	Walker	2013	0		PIK3R1
677	chr20	12165467	12165559	3500272260	78		12165467	12165559	8421504	2	38,40	0,52	c	350027226000000006,350027226000000005	0-38,0-40		16135792	10.1128/MCB.25.18.8001-8008.2005	0270-7306	Molecular and Cellular Biology	Phosphatidylinositol 3-Kinase p85&#x03b1; Subunit-Dependent Interaction with BCR/ABL-Related Fusion Tyrosine Kinases: Molecular Mechanisms and Biological Consequences	Ren	2005	6		
677	chr20	12165467	12165559	3500271768	78		12165467	12165559	8421504	2	38,40	0,52	c	350027176800000006,350027176800000005	0-38,0-40			10.1128/MCB.25.18.8001-8008.2005		Molecular and Cellular Biology	Phosphatidylinositol 3-Kinase p85&#x03b1; Subunit-Dependent Interaction with BCR/ABL-Related Fusion Tyrosine Kinases: Molecular Mechanisms and Biological Consequences	Shu-yue	2005	0		
677	chr20	12165670	12165700	3500276595	30		12165670	12165700	8421504	1	30	0	c	350027659500000000	8-38			10.1093/emboj/20.6.1245	ERROR! NO ISSN	The EMBO Journal	Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways	Celli	2001	0		
685	chr20	13118520	13118552	3500201185	28		13118520	13118552	8421504	3	11,9,8	0,12,24	g	350020118500000013	8-44		17164002	10.1186/1742-4690-3-91	1742-4690	Retrovirology	Influence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination	Baird	2006	6		
685	chr20	13153498	13153521	3500392970	23		13153498	13153521	8421504	1	23	0	c	350039297000000028	0-23						Probiotic Bacteria Enhance the Antibacterial Barrier of Enterocytes: Insights into Their Mechanism of Action	.uni-hohenheim.de	0	0		CD180
685	chr20	13216643	13216667	3500248094	23		13216643	13216667	8421504	2	11,12	0,12	g	350024809400001630	0-23						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
685	chr20	13217966	13217992	3500407806	25		13217966	13217992	8421504	2	5,20	0,6	g	350040780600000065	18-46						METHOD RELATING TO SWEETNESS ENHANCEMENT - Patent application	www.faqs.org	0	0		
689	chr20	13634625	13634650	3500407806	24		13634625	13634650	8421504	2	4,20	0,5	g	350040780600000129	17-41						METHOD RELATING TO SWEETNESS ENHANCEMENT - Patent application	www.faqs.org	0	0		
86	chr20	14282184	14289188	3500263315	276		14282184	14289188	8421504	4	105,75,93,3	0,5262,5825,7001	p	350026331500015006	9-285						Compositions and methods for producing bioactive fusion proteins	Walker	2008	0		ERBB2IP
86	chr20	14282184	14289188	3500236543	276		14282184	14289188	8421504	4	105,75,93,3	0,5262,5825,7001	p	350023654300015015,350023654300015014	0-102,9-183					Patent	Compositions and methods for producing bioactive fusion proteins (Patent US:8420779)	Walker	2013	0		ERBB2IP
86	chr20	14282184	14289188	3500227699	276		14282184	14289188	8421504	4	105,75,93,3	0,5262,5825,7001	p	350022769900015015,350022769900015014	0-102,9-183						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		ERBB2IP
86	chr20	14282184	14289188	3500004002	276		14282184	14289188	8421504	4	105,75,93,3	0,5262,5825,7001	p	350000400200015008	9-285						COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS	Walker	2013	0		ERBB2IP
696	chr20	14644782	14673711	3500240006	531		14644782	14673711	8421504	13	20,19,83,7,78,18,18,33,27,38,84,43,63	0,20724,20746,25584,25603,25684,25705,25818,25854,26790,27684,28820,28866	p	350024000600015019,350024000600015020	0-129,0-402						Novel human proteins, polynucleotides encoding them and methods of using the same	Edinger	2002	0		
697	chr20	14784479	14784511	3500143808	27		14784479	14784511	8421504	3	6,6,15	0,9,17	g	350014380800000027	2-29						E6AP antisense constructs and methods of use	Beer-romero	1995	0		
697	chr20	14810202	14810226	3500352827	23		14810202	14810226	8421504	2	14,9	0,15	g	350035282700000003	1-28						Isolation and cloning of the K+-independent, ouabain-insensitive Na+-ATPase. - ResearchGate	.researchgate.net	0	0		
699	chr20	15043055	15043083	3500162473	23		15043055	15043083	8421504	2	16,7	0,21	g	350016247300000075	13-38						COMPOSITIONS AND METHODS FOR USE IN RECOMBINATIONAL CLONING OF NUCELIC ACIDS - Patent application	www.faqs.org	0	0		
700	chr20	15118885	15158141	3500431628	501		15118885	15158141	8421504	5	1,130,34,165,171	0,19422,29308,29348,39085	p	350043162800015108,350043162800015110,350043162800015113	12-177,0-171,0-165						49 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		ADAMTS6
702	chr20	15349201	15349228	3500457990	23		15349201	15349228	8421504	3	6,4,13	0,9,14	c	350045799000000045	0-23						US Patent # 7,217,554. Proteases and variants thereof - Patents.com	www.patents.com	0	0		CWC27
702	chr20	15378937	15378964	3500139064	25		15378937	15378964	8421504	2	16,9	0,18	g	350013906400000018,350013906400000017	18-43,3-28		12805420	10.1128/JVI.77.13.7214-7224.2003	0022-538X	Journal of Virology	The Influenza A Virus PB1-F2 Protein Targets the Inner Mitochondrial Membrane via a Predicted Basic Amphipathic Helix That Disrupts Mitochondrial Function	Gibbs	2003	5		
703	chr20	15500744	15500769	3500276438	24		15500744	15500769	8421504	2	4,20	0,5	c	350027643800000007	7-31						ABSTRACT Document: POLLEN TUBE S FAIL TO TARGET OVULE Doctor of Philosophy , 2010	drum.lib.umd.edu	0	0		
703	chr20	15501279	15501308	3500407090	26		15501279	15501308	8421504	2	15,11	0,18	c	350040709000000924	2-28						HIV envelope polypeptides and vaccine	Berman	1997	0		
710	chr20	16421582	16421605	3500125321	23		16421582	16421605	8421504	1	23	0	g	350012532100000147	0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
715	chr20	17113100	17113127	3500269711	23		17113100	17113127	8421504	3	11,6,6	0,14,21	g	350026971100000012	21-44					Patent	Opioid antagonists and methods of their use (Patent US:5821219)	Grandy	1998	0		
717	chr20	17402329	17402356	3500139067	24		17402329	17402356	8421504	2	5,19	0,8	g	350013906700000180	1-25						Methods of treatment using specific binding agents of human angiopoietin-2	Oliner	2007	0		
718	chr20	17467545	17467573	3500070288	23		17467545	17467573	8421504	3	12,3,8	0,13,20	g	350007028800001017	7-30						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
89	chr20	17678269	17711833	3500004227	39		17678269	17711833	8421504	3	14,5,20	0,16,33544	g	350000422700000756,350000422700000591	5-24,5-26						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
720	chr20	17823205	17823230	3500070088	23		17823205	17823230	8421504	2	6,17	0,8	g	350007008800000342	15-39						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
723	chr20	18168780	18168808	3500310379	25		18168780	18168808	8421504	2	19,6	0,22	g	350031037900000014	16-41						Immunizing Against Hiv Infection 	.freshpatents.com	0	0		
724	chr20	18241954	18246533	3500322289	78		18241954	18246533	8421504	5	6,21,23,1,27	0,94,2694,3304,4552	p	350032228900015007	0-78						Award Number: W81XWH-05-1-0233 TITLE: A Proteomic Approach to Identify Phosphorylation-Dependent Targets of BRCT PRINCIPAL INVESTIGATOR: Zhou Songyang, Ph.D. 9 TYPE OF REPORT: Final DISTRIBUTION STATEMENT: Approved for Public Release;	www.dtic.mil	0	0		DIMT1
724	chr20	18332990	18333015	3500310375	23		18332990	18333015	8421504	2	16,7	0,18	g	350031037500000404	3-28						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
726	chr20	18527886	18528487	3500382374	595		18527886	18528487	8421504	6	7,165,160,167,30,66	0,8,174,335,504,535	g	350038237400000000	28-684						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
726	chr20	18527886	18528487	3500360633	595		18527886	18528487	8421504	6	7,165,78,80,199,66	0,8,174,254,335,535	g	350036063300000000	28-683						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
726	chr20	18527886	18528487	3500221817	597		18527886	18528487	8421504	5	7,165,160,199,66	0,8,174,335,535	g	350022181700000000	28-685					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
726	chr20	18527886	18528487	3500101798	595		18527886	18528487	8421504	6	7,165,78,80,199,66	0,8,174,254,335,535	g	350010179800000000	28-683						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
732	chr20	19319874	19319897	3500112455	23		19319874	19319897	8421504	1	23	0	g	350011245500000001	5-31		20921146	10.1128/IAI.00267-10	0019-9567	Infection and Immunity	Surface Expression of MPT64 as a Fusion with the PE Domain of PE_PGRS33 Enhances Mycobacterium bovis BCG Protective Activity against Mycobacterium tuberculosis in Mice	Sali	2010	4		
734	chr20	19548893	19548919	3500235158	24		19548893	19548919	8421504	2	5,19	0,7	g	350023515800000003	5-29						Isolation and Physical Characterization of Random Insertions in Staphylo z&#xca;&#xb8;&#xf6;]&#xf9;(ft&#xd3;Q!	gene.bio.jhu.edu	0	0		
734	chr20	19587214	19587238	3500419338	23		19587214	19587238	8421504	2	14,9	0,15	g	350041933800000797	10-36						US Patent # 6,063,597. Polypeptide compositions toxic to coleopteran insects - Patents.com	www.patents.com	0	0		
735	chr20	19727904	19727927	3500441689	23		19727904	19727927	8421504	1	23	0	c	350044168900000125	0-23						Patent Search: US Patent Number 8168602 - Compositions, kits and methods for identification, assessment, prevention and therapy of cancer	ww.archpatent.com	0	0		
735	chr20	19774883	19774909	3500086219	23		19774883	19774909	8421504	2	15,8	0,18	g	350008621900000008	2-25						Methods and vectors for display of molecules and displayed molecules and collections - Patent application	www.faqs.org	0	0		
737	chr20	19927861	19927886	3500401025	25		19927861	19927886	8421504	1	25	0	c	350040102500000003	5-30						Identification of Short Interspersed Elements (SINEs) in Iranian River Buffalo	www.eaap.org	0	0		
739	chr20	20208473	20208507	3500028179	30		20208473	20208507	8421504	3	8,7,15	0,11,19	g	350002817900000034	14-45						Polypeptides And Polynucleotides From Coagulase-negative Staphylococci 	.freshpatents.com	0	0		
741	chr20	20458365	20458394	3500386326	25		20458365	20458394	8421504	3	11,8,6	0,12,23	g	350038632600000093	0-25						 Antibody Composition 	www.docstoc.com	0	0		
743	chr20	20756614	20756641	3500162159	24		20756614	20756641	8421504	3	12,6,6	0,13,21	g	350016215900000008,350016215900000009	8-35,0-27						IKK-i And TBK-1 Are Enzymatically Distinct From The Homologous Enzyme, IKK-2	www.jbc.org	0	0		
743	chr20	20825998	20826021	3500418707	23		20825998	20826021	8421504	1	23	0	g	350041870700000003	9-32			10.1128/JVI.80.2.929-940.2006		Journal of Virology	Functional Analysis of the Triplex Proteins (VP19C and VP23) of Herpes Simplex Virus Type 1	Mercy	2006	0		
745	chr20	21029151	21029177	3500337510	23		21029151	21029177	8421504	2	8,15	0,11	g	350033751000000001	0-23						Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells. - ResearchGate	.researchgate.net	0	0		
750	chr20	21640153	21640180	3500277403	24		21640153	21640180	8421504	2	5,19	0,8	g	350027740300000007	7-31					Patent	Variants of beta-glucosidase (Patent US:7638616)	Fidantsef	2009	0		
751	chr20	21833978	21834004	3500044595	23		21833978	21834004	8421504	3	5,12,6	0,6,20	g	350004459500000003	0-24		11418567	10.1128/JB.183.14.4259-4268.2001	0021-9193	Journal of Bacteriology	Characterization of an Aminoacylase from the Hyperthermophilic Archaeon Pyrococcus furiosus	Story	2001	4		
751	chr20	21833978	21834004	3500033263	23		21833978	21834004	8421504	3	5,12,6	0,6,20	g	350003326300000003	0-24			10.1128/JB.183.14.4259-4268.2001		Journal of Bacteriology	Characterization of an Aminoacylase from the Hyperthermophilic Archaeon Pyrococcus furiosus	Sherry	July	0		
753	chr20	22087865	22087891	3500400459	24		22087865	22087891	8421504	3	11,6,7	0,12,19	g	350040045900000019	0-24						Supplementary data for: Human histone H3K79 methyltransferase DOT1L binds actively transcribing RNA polymerase II to regulate gene expression	www.jbc.org	0	0		
755	chr20	22397502	22397529	3500332571	27		22397502	22397529	8421504	1	27	0	g	350033257100000003,350033257100000009	33-60,33-60						SUBSTITUTED DIHYDROPTERIDIN-6-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS - Patent application	www.faqs.org	0	0		PLK2
756	chr20	22494344	22494373	3500393855	27		22494344	22494373	8421504	2	20,7	0,22	g	350039385500000004	7-34						Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma	-publications.com	0	0		
757	chr20	22590655	22590683	3500248094	23		22590655	22590683	8421504	2	14,9	0,19	g	350024809400001300	0-23						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
759	chr20	22826383	22826410	3500433725	23		22826383	22826410	8421504	3	5,13,5	0,7,22	g	350043372500000009	15-38						Allergy & Therapy	w.omicsonline.org	0	0		
760	chr20	23061915	23061941	3500312357	23		23061915	23061941	8421504	2	7,16	0,10	g	350031235700000332,350031235700000074	1-24,1-24						Artificial Plant Minichromosomes - Patent application	www.faqs.org	0	0		
765	chr20	23599371	23599398	3500101220	23		23599371	23599398	8421504	2	8,15	0,12	c	350010122000000041	0-23						36 human secreted proteins	Brewer	2000	0		
766	chr20	23772591	23772617	3500229425	26		23772591	23772617	8421504	1	26	0	g	350022942500000012	0-26						JINKEE JUNG 2012	www.naqs.go.kr	0	0		
766	chr20	23772592	23772617	3500196447	25		23772592	23772617	8421504	1	25	0	g	350019644700000006	0-25						&#x65b0;&#x5efa;&#x7f51;&#x9875; 1	brary.sdau.edu.cn	0	0		
766	chr20	23772592	23772617	3500165767	25		23772592	23772617	8421504	1	25	0	g	350016576700000012	0-25						Standard Operating Procedure for microsatellite based bovine breed identification	www.bats.ch	0	0		
766	chr20	23772592	23772617	3500137185	25		23772592	23772617	8421504	1	25	0	g	350013718500000019	0-25						2004 ANIMAL GENETIC RESOURCES INFORMATION	tr.ilri.cgiar.org	0	0		
766	chr20	23772592	23772617	3500134916	25		23772592	23772617	8421504	1	25	0	g	350013491600000026	0-25						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
766	chr20	23772592	23772617	3500005476	25		23772592	23772617	8421504	1	25	0	g	350000547600000006	0-25				0798-2259	Revista Cient&#xed;fica	Revista Cient&#xed;fica - Importance of parentage verification-assignment in extensive multiple-sired breeding herds	Arellano-Vera	2010	0		
767	chr20	23926114	23926138	3500164696	24		23926114	23926138	8421504	1	24	0	c	350016469600000007	23-47						Expression pro&#xfb01;ling reveals functionally important genes and coordinately regulated signaling pathway genes during in vitro angiogenesis	cs.physiology.org	0	0		MAP3K1
767	chr20	23927521	23927569	3500288263	48		23927521	23927569	8421504	1	48	0	c	350028826300000037	0-48						MEKK protein, capable of phosphorylating MEK	Johnson	1993	0		
767	chr20	23928549	23928645	3500426490	96		23928549	23928645	8421504	1	96	0	p	350042649000015097,350042649000015096	0-48,0-48						Signal Transduction Protein Tab2 	.freshpatents.com	0	0		MAP3K1
773	chr20	24676070	24676094	3500106413	24		24676070	24676094	8421504	1	24	0	g	350010641300000003	0-24		18160403	10.1074/jbc.M703456200	0021-9258	Journal of Biological Chemistry	Ferritin L and H Subunits Are Differentially Regulated on a Post-transcriptional Level	Sammarco	2008	5		
774	chr20	24820931	24831069	3500050535	130		24820931	24831069	8421504	4	35,27,20,48	0,680,5638,10090	g	350005053500000031,350005053500000035,350005053500000133,350005053500000038,350005053500000043	0-35,21-48,15-34,18-38,0-48						DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor	Gearing	1993	0		
774	chr20	24831040	24831063	3500277476	23		24831040	24831063	8421504	1	23	0	g	350027747600000018	22-45						Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer	www.mdpi.com	0	0		
774	chr20	24869007	24883016	3500328855	121		24869007	24883016	8421504	4	32,25,22,42	0,4362,4447,13967	c	350032885500000553,350032885500000550,350032885500000185,350032885500000496	9-41,21-46,0-22,0-42						Polynucleotide encoding cytokine receptor zcytor17 multimer - US Patent 7494804 Description	ww.patentstorm.us	0	0		
774	chr20	24869007	24883016	3500106793	119		24869007	24883016	8421504	4	32,23,22,42	0,4364,4447,13967	c	350010679300000590,350010679300000587,350010679300000179,350010679300000443	15-47,24-47,0-22,0-42						Peptide That Elicits Neutralizing Antibodies Targeting The Hiv Co-receptor, Ccr5 	.freshpatents.com	0	0		
774	chr20	24877500	24883001	3500354445	40		24877500	24883001	8421504	2	20,20	0,5481	c,g	350035444500000009,350035444500000008,350035444500000008	0-20,0-20,0-20						Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)	B	2007	0		
775	chr20	24960644	24962528	3500207120	44		24960644	24962528	8421504	3	17,5,22	0,1838,1862	c	350020712000000053,350020712000000052	0-22,0-22						GPR125 AS A MARKER FOR STEM AND PROGENITOR CELLS AND METHODS USE THEREOF	Rafii	2007	0		
775	chr20	24960644	24962528	3500033108	44		24960644	24962528	8421504	3	17,5,22	0,1838,1862	c,g	350003310800000108,350003310800000053,350003310800000052,350003310800000052,350003310800000107,350003310800000107	0-22,0-22,0-22,0-22,0-22,0-22						GPR125 AS A MARKER FOR STEM AND PROGENITOR CELLS AND METHODS USE THEREOF - Patent application	www.faqs.org	0	0		
97	chr20	25276823	25314133	3500035000	42		25276823	25314133	8421504	2	21,21	0,37289	c	350003500000000000,350003500000000006	0-21,0-21			10.1074/jbc.M201530200		The Journal of Biological Chemistry	Expression of ecto-lipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production	Marie	June	0		
779	chr20	25437601	25437626	3500003052	24		25437601	25437626	8421504	2	16,8	0,17	c	350000305200000001	23-47			10.1128/JVI.79.4.2614-2619.2005		Journal of Virology	Inhibition of Virus DNA Replication by Artificial Zinc Finger Proteins	Takashi	2005	0		
780	chr20	25608806	25608833	3500083127	23		25608806	25608833	8421504	2	10,13	0,14	g	350008312700000016	10-33		21571921	10.1128/EC.05012-11		Eukaryotic Cell	Ubiquitylation and Developmental Regulation of Invariant Surface Protein Expression in Trypanosomes 	Ka	July	0		
781	chr20	25702885	25704758	3500404568	28		25702885	25704758	8421504	2	11,17	0,1856	c	350040456800000139,350040456800000190	1-29,0-26						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - US Patent 7700341 Description	ww.patentstorm.us	0	0		
782	chr20	25855263	25855286	3500337543	23		25855263	25855286	8421504	1	23	0	g	350033754300000069,350033754300000073	6-29,6-29						Process for allele discrimination utilizing primer extension	Abarzua	2001	0		
791	chr20	27036632	27036656	3500063033	24		27036632	27036656	8421504	1	24	0	c	350006303300000071	0-24						UNIVERSIDAD COMPLUTENSE DE MADRID	eprints.ucm.es	0	0		NDUFS4
792	chr20	27216703	27223381	3500390912	6673		27216703	27223381	8421504	5	547,1087,2794,2228,17	0,549,1637,4432,6661	p,c,g	350039091200000051,350039091200000104,350039091200000113,350039091200000113,350039091200000112,350039091200000103,350039091200000111,350039091200000102,350039091200000110,350039091200000109,350039091200000101,350039091200015105,350039091200000158,350039091200000100,350039091200000100,350039091200015098,350039091200015099,350039091200000050,350039091200000155,350039091200015063,350039091200015045,350039091200015046,350039091200000153,350039091200000153,350039091200000152,350039091200000152,350039091200015041,350039091200015042,350039091200015040,350039091200000151,350039091200000151,350039091200000124,350039091200000163,350039091200000171,350039091200000171,350039091200000150,350039091200000150,350039091200000097,350039091200000093,350039091200000089,350039091200000089,350039091200000169,350039091200000169,350039091200000085,350039091200000081,350039091200000077,350039091200000167,350039091200000073,350039091200000166,350039091200000123,350039091200000071,350039091200000069,350039091200000164,350039091200000065,350039091200000067,350039091200000061,350039091200000053,350039091200000161	0-1218,0-168,0-50,0-50,96-150,0-50,0-50,0-400,0-50,0-291,0-300,0-45,0-20,0-50,0-50,0-87,0-87,4-5450,0-23,0-48,0-171,0-171,0-20,0-20,0-22,0-22,0-180,0-180,0-180,0-21,0-21,0-350,0-24,0-21,0-21,0-20,0-20,0-31,0-60,0-60,0-60,0-21,0-21,0-60,0-60,0-60,0-21,0-59,0-23,0-350,1-57,0-58,0-26,0-60,0-48,0-60,0-58,0-24						UNIVERSITE DE LIMOGES	cations.unilim.fr	0	0		
792	chr20	27216807	27217619	3500078470	38		27216807	27217619	8421504	3	18,1,19	0,773,793	c	350007847000000007,350007847000000006	0-19,0-19						Transforming growth factor beta family expression at the bovine feto-maternal interface	biomedcentral.com	0	0		
792	chr20	27217581	27221935	3500351101	951		27217581	27221935	8421504	5	230,225,219,192,85	0,909,1455,2111,4269	p	350035110100015011,350035110100015014,350035110100015013,350035110100015012	0-951,0-78,0-75,0-189						Antagonists of activin-actriia and uses for increasing red blood cell levels	Sherman	2009	0		FST
792	chr20	27217581	27221935	3500150003	951		27217581	27221935	8421504	5	230,225,219,192,85	0,909,1455,2111,4269	p	350015000300015011,350015000300015014,350015000300015013,350015000300015012	0-951,0-78,0-75,0-189						Methods for dosing an activin-actriia antagonist and monitoring of treated patients	Sherman	2009	0		FST
792	chr20	27217581	27221935	3500023631	951		27217581	27221935	8421504	5	230,225,219,192,85	0,909,1455,2111,4269	p	350002363100015010,350002363100015013,350002363100015012,350002363100015011	0-951,0-78,0-75,0-189						Antagonists of actriib and uses for increasing red blood cell levels	Sherman	2009	0		FST
792	chr20	27217581	27221935	3500000255	951		27217581	27221935	8421504	5	230,225,219,192,85	0,909,1455,2111,4269	p	350000025500015010,350000025500015013,350000025500015012,350000025500015011	0-951,0-78,0-75,0-189						Methods for dosing an actriib antagonist and monitoring of treated patients	Sherman	2009	0		FST
792	chr20	27217582	27217655	3500388552	39		27217582	27217655	8421504	2	20,19	0,54	c,g	350038855200000025,350038855200000025,350038855200000024	0-20,0-20,0-19						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		FST
792	chr20	27217582	27217655	3500143254	39		27217582	27217655	8421504	2	20,19	0,54	c,g	350014325400000025,350014325400000025,350014325400000024	0-20,0-20,0-19						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		FST
792	chr20	27217684	27219250	3500212126	60		27217684	27219250	8421504	3	20,20,20	0,912,1546	c,g	350021212600000005,350021212600000004,350021212600000003,350021212600000003	0-20,0-20,0-20,0-20						The activin-follistatin system and in vitro early follicle development in goats	logy-journals.org	0	0		
792	chr20	27218497	27218614	3500192823	75		27218497	27218614	8421504	3	31,23,21	0,43,96	c	350019282300000017,350019282300000303,350019282300000298,350019282300000016	0-22,0-31,0-23,0-21						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	digibug.ugr.es	0	0		FST
792	chr20	27218681	27219124	3500309581	40		27218681	27219124	8421504	2	20,20	0,423	c,g	350030958100000005,350030958100000004,350030958100000004	0-20,0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Reproducci&#xf3;n		2011	0		
792	chr20	27218681	27219124	3500303705	40		27218681	27219124	8421504	2	20,20	0,423	c,g	350030370500000005,350030370500000004,350030370500000004	0-20,0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Reproducci&#xf3;n		2011	0		
792	chr20	27219089	27219136	3500143229	46		27219089	27219136	8421504	2	26,20	0,27	c	350014322900000004	0-56						Regulation of the molecular control of ovarian function by gene targeting	.era.lib.ed.ac.uk	0	0		
795	chr20	27602589	27602616	3500049915	24		27602589	27602616	8421504	2	7,17	0,10	c	350004991500000056	11-35						Trehalose transporter gene and method of introducing trehalose into cells - Patent application	www.faqs.org	0	0		
795	chr20	27611812	27612265	3500188440	23		27611812	27612265	8421504	2	18,5	0,448	c	350018844000000008	16-39		18647959	10.1182/blood-2007-12-126433		Blood	Functional analysis of the cytoplasmic domain of the integrin &#x03b1;1 subunit in endothelial cells	Tristin	2008	0		
795	chr20	27645100	27645128	3500353938	28		27645100	27645128	8421504	1	28	0	c	350035393800000079	0-28						DNA and RNA Profiling in Human Blood	www.bjcancer.org	0	0		ITGA2
99	chr20	27645146	27668440	3500231462	60		27645146	27668440	8421504	2	45,15	0,23279	p	350023146200015060	36-96						Anti-alpha2 integrin antibodies and their uses	E*La Zha Li De Si 	2009	0		
795	chr20	27646735	27646759	3500058609	24		27646735	27646759	8421504	1	24	0	c	350005860900000003	24-48						Supporting Information	www.pnas.org	0	0		
796	chr20	27658252	27658276	3500289977	24		27658252	27658276	8421504	1	24	0	c	350028997700000111	9-33					Patent	Anti-&#x03b1;2 integrin antibodies and their uses (Patent US:7807794)	Bernard	2010	0		
796	chr20	27660917	27660943	3500180114	26		27660917	27660943	8421504	1	26	0	c	350018011400000005	6-32		9065422	10.1074/jbc.272.12.7661	0021-9258	Journal of Biological Chemistry	Contributions of the I and EF Hand Domains to the Divalent Cation-dependent Collagen Binding Activity of the &#x03b1;2&#x03b2;1 Integrin	Dickeson	1997	5		
796	chr20	27787100	27787127	3500407568	24		27787100	27787127	8421504	2	17,7	0,20	g	350040756800000036	6-37						Co-suppressed glutamine synthetase2 gene modifies nitrogen metabolism and plant growth in rice	scichina.com:8080	0	0		
797	chr20	27902816	27902842	3500285439	25		27902816	27902842	8421504	2	4,21	0,5	g	350028543900000081	21-46						 6017734 Patent | Unique nucleotide and amino acid sequence and uses thereof | PTO Direct	www.ptodirect.com	0	0		
809	chr20	29429645	29429693	3500430809	48		29429645	29429693	8421504	1	48	0	p	350043080900015023	0-48						Patent Search: US Patent Number 8299236 - Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells	ww.archpatent.com	0	0		ISL1
809	chr20	29429645	29429693	3500415188	48		29429645	29429693	8421504	1	48	0	p	350041518800015007	0-48						Synthetic Lipid Rafts and Methods of Use	Khan	2007	0		ISL1
809	chr20	29429645	29429693	3500313912	48		29429645	29429693	8421504	1	48	0	p	350031391200015006	0-48						Synthetic lipid rafts and methods of use	Khan	2007	0		ISL1
809	chr20	29429645	29429693	3500292820	48		29429645	29429693	8421504	1	48	0	p	350029282000015079	0-48						Lipopeptides for delivery of nucleic acids	Adami	2010	0		ISL2
809	chr20	29429645	29429693	3500208064	48		29429645	29429693	8421504	1	48	0	p	350020806400015038	0-48						COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY	Cui	2007	0		ISL1
809	chr20	29429645	29429693	3500188627	48		29429645	29429693	8421504	1	48	0	p	350018862700015022	0-48						COMPOSITIONS AND METHODS FOR ENHANCING DELIVERY OF NUCLEIC ACIDS INTO CELLS AND FOR MODIFYING EXPRESSION OF TARGET GENES IN CELLS - Patent application	www.faqs.org	0	0		ISL1
809	chr20	29429645	29429693	3500100022	48		29429645	29429693	8421504	1	48	0	p	350010002200015087	0-48						Peptide-dicer substrate rna conjugates as delivery vehicles for sirna	Ahmadian	2007	0		ISL2
809	chr20	29429645	29429693	3500001458	48		29429645	29429693	8421504	1	48	0	p	350000145800015006	0-48						Cell-penetrating peptides and bioactive cargoes. Strategies and mechanisms.	w.diva-portal.org	0	0		ISL1
809	chr20	29429706	29434709	3500194863	48		29429706	29434709	8421504	2	24,24	0,4979	c	350019486300000013,350019486300000012	0-24,0-24						Insulin-producing bone marrow derived cells and methods of generating and using same	Efrat	2004	0		ISL1
809	chr20	29429706	29434709	3500092988	48		29429706	29434709	8421504	2	24,24	0,4979	c	350009298800000013,350009298800000063,350009298800000012,350009298800000062	0-24,0-24,0-24,0-24						Insulin-producing Bone Marrow Derived Cells And Methods Of Generating And Using Same 	.freshpatents.com	0	0		ISL1
809	chr20	29429760	29434703	3500101498	48		29429760	29434703	8421504	2	23,25	0,4918	c	350010149800000029,350010149800000113,350010149800000028,350010149800000112	0-23,0-23,0-25,0-25						MESOANGIOBLAST-LIKE CELL AS WELL AS METHODS AND USES RELATING THERETO - Patent application	www.faqs.org	0	0		ISL1
809	chr20	29431744	29434800	3500073945	372		29431744	29434800	8421504	2	196,176	0,2880	p	350007394500015007,350007394500015002	0-189,0-186						The LIM Region of a Presumptive Caenorhabditis elegans Transcription Factor is an Iron-Sulfur- and Zinc-Containing Metallodomain	www.jstor.org	0	0		ISL1
809	chr20	29431920	29434627	3500141933	23		29431920	29434627	8421504	2	20,3	0,2704	c	350014193300000019	0-23						MESENCHYMAL STEM CELLS FOR THE CELL-BASED THERAPY OF TYPE 1 DIABETES	repositorio.ul.pt	0	0		
817	chr20	30424137	30424161	3500449219	23		30424137	30424161	8421504	2	7,16	0,8	g	350044921900000011	5-38						Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines	Schmidt	2006	0		
820	chr20	30869730	30870006	3500449651	41		30869730	30870006	8421504	3	13,6,22	0,15,254	c	350044965100000005,350044965100000004	8-27,0-22						THE J B C &#xa9; 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Hyperpolarization-activated Cyclic Nucleotide-gated Channel 1 Is a Molecular Determinant of the Cardiac Pacemaker Current If	www.jbc.org	0	0		HCN1
822	chr20	31098425	31098454	3500050809	23		31098425	31098454	8421504	3	12,6,5	0,16,24	g	350005080900000000	0-23		18559591	10.1158/1078-0432.CCR-07-5144	1078-0432	Clinical Cancer Research	A Metastasis Modifier Locus on Human Chromosome 8p in Uveal Melanoma Identified by Integrative Genomic Analysis	Onken	2008	8		
823	chr20	31197481	31197505	3500068662	24		31197481	31197505	8421504	1	24	0	c	350006866200000001	0-24		22090507	10.1523/JNEUROSCI.3064-11.2011	0270-6474	The Journal of Neuroscience	HCN Channels Expressed in the Inner Ear Are Necessary for Normal Balance Function	Horwitz	2011	7		
823	chr20	31267944	31319461	3500249481	363		31267944	31319461	8421504	3	178,165,20	0,47813,51497	p	350024948100015016,350024948100015004,350024948100015005,350024948100015006,350024948100015008	0-180,0-183,0-183,0-183,0-183						Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. - ResearchGate	.researchgate.net	0	0		POLRMT,HCN2
823	chr20	31320028	31320085	3500449651	57		31320028	31320085	8421504	1	57	0	p	350044965100015000	0-57						THE J B C &#xa9; 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Hyperpolarization-activated Cyclic Nucleotide-gated Channel 1 Is a Molecular Determinant of the Cardiac Pacemaker Current If	www.jbc.org	0	0		HCN1
823	chr20	31320284	31320310	3500371771	26		31320284	31320310	8421504	1	26	0	c	350037177100000001	13-39		12598605		0270-6474	The Journal of Neuroscience	Neuronal Hyperpolarization-Activated Pacemaker Channels Drive Neuropathic Pain	Chaplan	2003	7		HCN1
823	chr20	31320284	31320310	3500323066	26		31320284	31320310	8421504	1	26	0	c	350032306600000001	14-40						Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels	Brown	2002	0		HCN1
823	chr20	31325866	31325891	3500293521	23		31325866	31325891	8421504	2	8,15	0,10	g	350029352100000035	0-23						MODIFIED FREE-LIVING MICROBES, VACCINE COMPOSITIONS AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
823	chr20	31325866	31325891	3500026674	23		31325866	31325891	8421504	2	8,15	0,10	g	350002667400000035	0-23						Modified free-living microbes, vaccine compositions and methods of use thereof	Dubensky	2004	0		
828	chr20	31879670	31881141	3500276249	42		31879670	31881141	8421504	2	21,21	0,1450	c,g	350027624900000001,350027624900000001,350027624900000000,350027624900000000	0-21,0-21,0-21,0-21						0509_S1_article_02	www.jpp.krakow.pl	0	0		
831	chr20	32324514	32324537	3500229859	23		32324514	32324537	8421504	1	23	0	c	350022985900000000	0-23		22258084	10.1038/pr.2011.41	0031-3998	Pediatric Research	Lung hypoplasia in rats with esophageal atresia and tracheo-esophageal fistula	Xiaomei		3		FGF10
831	chr20	32324514	32324537	3500181743	23		32324514	32324537	8421504	1	23	0	c	350018174300000000	0-23		22258084	10.1038/pr.2011.41	0031-3998	Pediatric Research	Lung hypoplasia in rats with esophageal atresia and tracheo-esophageal fistula	Xiaomei		3		FGF10
103	chr20	32324517	32417462	3500391004	185		32324517	32417462	8421504	4	48,89,37,11	0,204,297,92934	c	350039100400000115,350039100400000095,350039100400000119,350039100400000096,350039100400000166,350039100400000097	0-48,0-48,0-48,0-41,0-20,0-48						Therapeutic uses of keratinocyte growth factor-2	Jimenez	1999	0		
103	chr20	32324517	32417462	3500190185	185		32324517	32417462	8421504	4	48,89,37,11	0,204,297,92934	c	350019018500000174,350019018500000154,350019018500000155,350019018500000225,350019018500000156	0-48,0-48,0-41,0-20,0-48						Application # 2005/0037966. Keratinocyte growth factor-2 - Patents.com	patents.com	0	0		
831	chr20	32324521	32324545	3500346487	24		32324521	32324545	8421504	1	24	0	c	350034648700000009	0-24			10.1002/dvdy.10208	1097-0177	Developmental Dynamics	T-box gene products are required for mesenchymal induction of epithelial branching in the embryonic mouse lung - Cebra-Thomas - 2002 - Developmental Dynamics - Wiley Online Library	Cebra-Thomas	2003	0		FGF10
831	chr20	32324521	32324545	3500188396	24		32324521	32324545	8421504	1	24	0	c	350018839600000001	0-24		15800000	10.1242/dev.01795	0950-1991	Development	Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for their entry into the smooth muscle cell lineage	Mailleux	2005	7		FGF10
831	chr20	32324521	32324545	3500050370	24		32324521	32324545	8421504	1	24	0	c	350005037000000001	0-24		15800000	10.1242/dev.01795	0950-1991	Development	Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for their entry into the smooth muscle cell lineage	Mailleux	2005	7		FGF10
831	chr20	32324589	32324613	3500353259	24		32324589	32324613	8421504	1	24	0	c	350035325900000001	0-24		12922982	10.1152/ajplung.00226.2003		American Journal of Physiology - Lung Cellular and Molecular Physiology	Chondroitin sulfate proteoglycans are required for lung growth and morphogenesis in vitro	Shannon	2003	0		FGF10
831	chr20	32324589	32324613	3500281275	24		32324589	32324613	8421504	1	24	0	c	350028127500000001	0-24		12922982	10.1152/ajplung.00226.2003		American Journal of Physiology - Lung Cellular and Molecular Physiology	Chondroitin sulfate proteoglycans are required for lung growth and morphogenesis in vitro	Shannon	2003	0		FGF10
103	chr20	32324721	32417462	3500034980	141		32324721	32417462	8421504	2	130,11	0,92730	c	350003498000000114,350003498000000138,350003498000000115,350003498000000139,350003498000000116	0-48,0-48,0-41,0-48,0-48						Keratinocyte growth factor-2 - US Patent 6916786 Description	ww.patentstorm.us	0	0		
103	chr20	32324749	32417453	3500126808	50		32324749	32417453	8421504	3	26,22,2	0,80,92702	c	350012680800000028,350012680800000029	0-26,0-24						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
103	chr20	32324749	32417453	3500008335	49		32324749	32417453	8421504	3	25,22,2	0,80,92702	c	350000833500000034,350000833500000035	0-25,0-24						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
103	chr20	32324808	32422614	3500369588	71		32324808	32422614	8421504	3	43,2,26	0,92643,97780	p,c	350036958800015007,350036958800000029	12-57,18-44						Keratinocyte growth factor-2	Coleman	2002	0		
103	chr20	32324808	32417468	3500230531	60		32324808	32417468	8421504	2	43,17	0,92643	p	350023053100015050	0-60						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		FGF10
103	chr20	32324817	32417465	3500034980	48		32324817	32417465	8421504	2	34,14	0,92634	c	350003498000000140	0-48						Keratinocyte growth factor-2 - US Patent 6916786 Description	ww.patentstorm.us	0	0		
103	chr20	32324820	32417467	3500391004	47		32324820	32417467	8421504	2	31,16	0,92631	c	350039100400000121	0-47						Therapeutic uses of keratinocyte growth factor-2	Jimenez	1999	0		
103	chr20	32324820	32417467	3500190185	47		32324820	32417467	8421504	2	31,16	0,92631	c	350019018500000180	0-47						Application # 2005/0037966. Keratinocyte growth factor-2 - Patents.com	patents.com	0	0		
103	chr20	32324826	32422615	3500391004	284		32324826	32422615	8421504	4	25,1,60,198	0,92625,92669,97591	c	350039100400000217,350039100400000227,350039100400000219,350039100400000099,350039100400000123,350039100400000243,350039100400000249,350039100400000228,350039100400000220,350039100400000100,350039100400000124,350039100400000244,350039100400000137,350039100400000250,350039100400000229,350039100400000245,350039100400000138,350039100400000251,350039100400000102,350039100400000246,350039100400000231,350039100400000139,350039100400000183,350039100400000030,350039100400000140,350039100400000009	21-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-47,0-47,9-47,18-44,18-44,0-27,12-36						Therapeutic uses of keratinocyte growth factor-2	Jimenez	1999	0		
103	chr20	32324826	32422615	3500190185	278		32324826	32422615	8421504	5	25,11,45,170,27	0,92625,92684,97591,97762	c	350019018500000213,350019018500000158,350019018500000182,350019018500000159,350019018500000196,350019018500000197,350019018500000161,350019018500000185,350019018500000198,350019018500000094,350019018500000035,350019018500000242,350019018500000199	12-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,9-47,6-38,18-44,18-44,0-27						Application # 2005/0037966. Keratinocyte growth factor-2 - Patents.com	patents.com	0	0		
103	chr20	32324826	32422615	3500034980	283		32324826	32422615	8421504	5	25,1,60,170,27	0,92625,92669,97591,97762	c	350003498000000236,350003498000000246,350003498000000238,350003498000000118,350003498000000142,350003498000000188,350003498000000119,350003498000000143,350003498000000156,350003498000000248,350003498000000157,350003498000000121,350003498000000145,350003498000000158,350003498000000087,350003498000000009,350003498000000030,350003498000000159	21-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,9-47,1-33,12-36,18-44,0-27						Keratinocyte growth factor-2 - US Patent 6916786 Description	ww.patentstorm.us	0	0		
103	chr20	32324826	32417467	3500391004	41		32324826	32417467	8421504	2	25,16	0,92625	c	350039100400000167	6-47						Therapeutic uses of keratinocyte growth factor-2	Jimenez	1999	0		
103	chr20	32324829	32422612	3500449570	315		32324829	32422612	8421504	5	22,104,84,42,63	0,92622,97588,97675,97720	p	350044957000015010	0-315						Keratinocyte growth factor-2	osdir.com/patents	0	0		FGF10
103	chr20	32324829	32422612	3500430375	321		32324829	32422612	8421504	3	22,104,195	0,92622,97588	p	350043037500015022	0-321						KERATINOCYTE GROWTH FACTOR-2	Ruben	1999	0		FGF10
103	chr20	32324832	32422600	3500430375	306		32324832	32422600	8421504	3	19,104,183	0,92619,97585	p	350043037500015021	0-306						KERATINOCYTE GROWTH FACTOR-2	Ruben	1999	0		FGF10
103	chr20	32324835	32422612	3500449570	315		32324835	32422612	8421504	3	16,104,195	0,92616,97582	p,c	350044957000015009,350044957000000009,350044957000000007	0-315,12-36,12-36						Keratinocyte growth factor-2	osdir.com/patents	0	0		FGF10
103	chr20	32324835	32422612	3500430375	315		32324835	32422612	8421504	3	16,104,195	0,92616,97582	p,c	350043037500015012,350043037500000009,350043037500000007	0-315,12-36,12-36						KERATINOCYTE GROWTH FACTOR-2	Ruben	1999	0		
103	chr20	32324841	32422591	3500142509	168		32324841	32422591	8421504	5	10,35,45,33,45	0,92610,92648,97669,97705	p	350014250900015071,350014250900015072,350014250900015075	0-45,0-45,12-90						Fibroblast growth factor (FGF23) polypeptides - US Patent 7745406 Description	ww.patentstorm.us	0	0		FGF10
832	chr20	32417480	32422614	3500224761	272		32417480	32422614	8421504	2	75,197	0,4937	p,c	350022476100015041,350022476100015004,350022476100015006,350022476100000007,350022476100000036	0-270,0-90,0-57,12-36,18-44						 Keratinocyte Growth Factor 	www.docstoc.com	0	0		FGF10
832	chr20	32422510	32422606	3500445910	96		32422510	32422606	8421504	1	96	0	p	350044591000015085,350044591000015086	0-48,0-48						Human Fgf-23 Gene And Gene Expression Products 	.freshpatents.com	0	0		FGF10
832	chr20	32422510	32422534	3500149122	24		32422510	32422534	8421504	1	24	0	c	350014912200000008	0-24		16299054	10.1152/ajplung.00293.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	Iroquois genes influence proximo-distal morphogenesis during rat lung development	Tuyl	2006	0		FGF10
832	chr20	32422588	32422614	3500190004	26		32422588	32422614	8421504	1	26	0	c	350019000400000036	18-44						Keratinocyte growth factor-2 polynucleotides	Ruben	2003	0		
834	chr20	32651844	32651867	3500052287	23		32651844	32651867	8421504	1	23	0	g	350005228700000009	0-23						Serotoninergic and melatoninergic systems are fully expressed in human skin	www.fasebj.org	0	0		
836	chr20	32943613	32943640	3500419338	24		32943613	32943640	8421504	2	8,16	0,11	g	350041933800001119	9-33						US Patent # 6,063,597. Polypeptide compositions toxic to coleopteran insects - Patents.com	www.patents.com	0	0		
837	chr20	33063948	33063976	3500310044	25		33063948	33063976	8421504	3	13,6,6	0,15,22	g	350031004400000116	0-31						Gene Differentially Expressed In Breast And Bladder Cancer And Encoded Polypeptides 	.freshpatents.com	0	0		
104	chr20	33285129	33303318	3500338718	82		33285129	33303318	8421504	3	9,35,38	0,14593,18151	c	350033871800000054,350033871800000057	4-48,0-38						US Patent # 6,824,781. Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist - Patents.com	www.patents.com	0	0		
839	chr20	33359551	33362618	3500103760	47		33359551	33362618	8421504	2	25,22	0,3045	c	350010376000000000,350010376000000001	0-25,0-22		15514256		0022-3166	The Journal of Nutrition	Soy Isoflavones Affect Sterol Regulatory Element Binding Proteins (SREBPs) and SREBP-Regulated Genes in HepG2 Cells	Mullen	2004	4		HMGCS1
839	chr20	33363550	33363575	3500068155	24		33363550	33363575	8421504	2	17,7	0,18	c	350006815500000024	14-38						AMPLIFICATION DYNAMICS OF PRIMATE RETROTRANSPOSONS	etd.lsu.edu	0	0		
839	chr20	33365716	33365929	3500261436	40		33365716	33365929	8421504	3	4,16,20	0,116,193	c,g	350026143600000053,350026143600000054,350026143600000054	0-20,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
839	chr20	33366989	33367034	3500236208	45		33366989	33367034	8421504	1	45	0	p	350023620800015000	0-45						Feasibility of Pathways for Transfer of Acyl Groups from Mitochondria to the Cytosol to Form Short Chain Acyl-CoAs in the Pancreatic Beta Cell--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x98	journal.9med.net	0	0		HMGCS1
839	chr20	33403851	33403879	3500271950	28		33403851	33403879	8421504	1	28	0	c	350027195000000086	0-28						Novel human protein kinases and protein kinase-like enzymes	Clary	2001	0		
840	chr20	33493880	33493910	3500257400	25		33493880	33493910	8421504	3	12,5,8	0,14,22	g	350025740000000042	9-35					Patent	Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities (Patent US:5928888)	Whitney	1999	0		
841	chr20	33675504	33675531	3500343894	27		33675504	33675531	8421504	1	27	0	c	350034389400000000	3-30						Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1&#x03b1; Pathway. - ResearchGate	.researchgate.net	0	0		
842	chr20	33783500	33783849	3500039348	46		33783500	33783849	8421504	2	26,20	0,329	c	350003934800000001,350003934800000000	0-26,0-20						Inconsistency of associations between growth hormone receptor gene polymorphism and milk performance traits in Polish Holstein-Friesian cows and bulls*	www.ighz.edu.pl	0	0		
842	chr20	33783578	33783626	3500160045	48		33783578	33783626	8421504	1	48	0	c	350016004500000041	0-48						Methods For Predicting Therapeutic Response To Agents Acting On The Growth Hormone Receptor 	.freshpatents.com	0	0		
842	chr20	33783752	33783849	3500315071	40		33783752	33783849	8421504	2	20,20	0,77	c,g	350031507100000037,350031507100000037,350031507100000036	0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
842	chr20	33783979	33784042	3500463464	61		33783979	33784042	8421504	2	46,15	0,48	c,g	350046346400000066,350046346400000066,350046346400000040	12-74,12-74,21-43						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
842	chr20	33795182	33802195	3500315971	44		33795182	33802195	8421504	2	22,22	0,6991	c	350031597100000025,350031597100000024	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
842	chr20	33795182	33802195	3500248474	44		33795182	33802195	8421504	2	22,22	0,6991	c	350024847400000025,350024847400000024	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
842	chr20	33795182	33802195	3500124900	44		33795182	33802195	8421504	2	22,22	0,6991	c,g	350012490000000010,350012490000000009,350012490000000009	0-22,0-22,0-22						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
842	chr20	33795182	33802195	3500024081	44		33795182	33802195	8421504	2	22,22	0,6991	c,g	350002408100000027,350002408100000027,350002408100000026	0-22,0-22,0-22						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
842	chr20	33802172	33802204	3500431471	32		33802172	33802204	8421504	1	32	0	c	350043147100000000	0-32						Methods and Compositions for Testing and Breeding Cattle for Improved Fertility and Embryonic Survival - Patent application	www.faqs.org	0	0		
842	chr20	33802172	33802204	3500263846	32		33802172	33802204	8421504	1	32	0	c	350026384600000000	0-32						Methods and compositions for testing and breeding cattle for improved fertility and embryonic survival	Khatib	2010	0		
843	chr20	33825774	33825865	3500129021	49		33825774	33825865	8421504	2	25,24	0,67	c	350012902100000001,350012902100000000	0-25,0-24						Early pregnancy alters the metabolic responses to restricted nutrition in sheep. - ResearchGate	.researchgate.net	0	0		
843	chr20	33825787	33878911	3500301078	48		33825787	33878911	8421504	3	21,9,18	0,73,53106	c,g	350030107800000130,350030107800000130,350030107800000129	0-21,0-21,0-27						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
843	chr20	33825817	33825852	3500114601	35		33825817	33825852	8421504	1	35	0	c	350011460100000025	6-41						The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor	enesdev.cshlp.org	0	0		
105	chr20	33878942	34092731	3500261436	42		33878942	34092731	8421504	4	17,4,16,5	0,78111,78176,213784	c	350026143600000048,350026143600000047	0-21,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
105	chr20	33957054	34092727	3500004859	78		33957054	34092727	8421504	3	51,26,1	0,54,135672	p	350000485900015030	12-90						Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol - Patent # 7485713 - PatentGenius	.patentgenius.com	0	0		
844	chr20	33957100	33957123	3500451603	23		33957100	33957123	8421504	1	23	0	c	350045160300000000	16-39					Patent	Methods for making proteins containing free cysteine residues (Patent US:6753165)	Cox	2004	0		GHR
844	chr20	33957100	33957123	3500407865	23		33957100	33957123	8421504	1	23	0	c	350040786500000000	16-39						Methods for making proteins containing free cysteine residues	Cox	2000	0		GHR
844	chr20	33957100	33957123	3500370914	23		33957100	33957123	8421504	1	23	0	c	350037091400000019	16-39						Cysteine variants of alpha interferon-2	Cox	2003	0		GHR
844	chr20	33957100	33957123	3500369910	23		33957100	33957123	8421504	1	23	0	c	350036991000000000	16-39					Patent	Methods for making proteins containing free cysteine residues (Patent EP:1144613)	Cox	2011	0		GHR
844	chr20	33957100	33957123	3500340450	23		33957100	33957123	8421504	1	23	0	c	350034045000000000	16-39						METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES	Cox	2009	0		GHR
844	chr20	33957100	33957123	3500218469	23		33957100	33957123	8421504	1	23	0	c	350021846900000090,350021846900000000	16-39,16-39						METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES - Patent application	www.faqs.org	0	0		GHR
844	chr20	33957100	33957123	3500175158	23		33957100	33957123	8421504	1	23	0	c	350017515800000000	16-39					Patent	Methods for making proteins containing free cysteine residues (Patent US:7629314)	George	2009	0		GHR
844	chr20	33957100	33957123	3500169873	23		33957100	33957123	8421504	1	23	0	c,g	350016987300000009,350016987300000009	16-39,16-39						CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		GHR
844	chr20	33957100	33957123	3500109757	23		33957100	33957123	8421504	1	23	0	c	350010975700000000	16-39						Methods for making proteins containing free cysteine residues	Cox	2004	0		
844	chr20	33957107	33972454	3500129021	41		33957107	33972454	8421504	3	16,5,20	0,18,15327	c,g	350012902100000003,350012902100000002	0-22,0-20						Early pregnancy alters the metabolic responses to restricted nutrition in sheep. - ResearchGate	.researchgate.net	0	0		
844	chr20	33972605	33972919	3500236181	40		33972605	33972919	8421504	2	20,20	0,294	g	350023618100000006,350023618100000005	0-20,0-20						0605_s3_article_14	www.jpp.krakow.pl	0	0		
844	chr20	33972661	33972776	3500249061	112		33972661	33972776	8421504	2	23,89	0,26	g	350024906100000003	0-120						Nucleotide sequence polymorphisms in the promoter region of bovine growth hormone receptor gene ( have no effect on its expression level in liver*	www.ighz.edu.pl	0	0		
850	chr20	34773736	34809917	3500261436	42		34773736	34809917	8421504	2	20,22	0,36159	c,g	350026143600000075,350026143600000076,350026143600000076	0-20,0-22,0-22						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
851	chr20	34912806	34912832	3500050570	23		34912806	34912832	8421504	2	9,14	0,12	g	350005057000000017	3-26						Establishment of a Novel In Vivo Sex-Speci&#xfb01;c Splicing Assay System To Identify a trans-Acting Factor That Negatively Regulates Splicing of Bombyx mori dsx Female Exons	mcb.asm.org	0	0		
854	chr20	35361375	35361402	3500269873	24		35361375	35361402	8421504	2	16,8	0,19	g	350026987300000070	12-36						Methods and Nucleic Acids for Analyses of Cellular Proliferative Disorders	Distler	2011	0		
856	chr20	35589439	35589468	3500372235	24		35589439	35589468	8421504	2	9,15	0,14	g	350037223500000000	8-32						Who was g t woods	wiki.answers.com	0	0		
856	chr20	35599358	35603745	3500274037	40		35599358	35603745	8421504	2	20,20	0,4367	c,g	350027403700000055,350027403700000054,350027403700000054	0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
856	chr20	35614296	35614327	3500282482	25		35614296	35614327	8421504	3	8,12,5	0,13,26	g	350028248200000040	3-30						Prevention and therapy of type 2 diabetes by selective modulation of the human peroxisome proliferator-activated receptor gamma (PPAR&#x03b3;	diss.fu-berlin.de	0	0		
857	chr20	35674807	35674832	3500401809	25		35674807	35674832	8421504	1	25	0	c	350040180900000002	0-25						Reproduction(2003) , 337&#x2013;346 Research	uction-online.org	0	0		
857	chr20	35707351	35707396	3500346697	45		35707351	35707396	8421504	1	45	0	p	350034669700015001	0-45		14512293	10.1152/ajpcell.00319.2003		American Journal of Physiology - Cell Physiology	Cloning and characterization of mouse 5&#x2032;-AMP-activated protein kinase &#x03b3;3 subunit	Yu	2004	0		PRKAA1
857	chr20	35707351	35707396	3500265927	45		35707351	35707396	8421504	1	45	0	p	350026592700015001	0-45		16638825	10.1152/ajpendo.00073.2006		American Journal of Physiology - Endocrinology and Metabolism	Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase &#x03b3;3-subunit differentially regulates glycogen accumulation	Yu	2006	0		PRKAA2
857	chr20	35707355	35717924	3500068104	42		35707355	35717924	8421504	2	20,22	0,10547	c,g	350006810400000012,350006810400000012,350006810400000013	0-20,0-20,0-22						THE ROLE OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN MEDIATING RADIATION RESPONSES IN CANCER CELLS	mmons.mcmaster.ca	0	0		PRKAA1
857	chr20	35717832	35732851	3500255841	173		35717832	35732851	8421504	4	44,42,45,42	0,10485,10626,14977	c,g	350025584100000005,350025584100000016,350025584100000019,350025584100000019,350025584100000035	4-48,0-42,0-45,0-45,0-42						Variants of the alpha 1 subunit of human AMPK - US Patent 7476731 Description	ww.patentstorm.us	0	0		
857	chr20	35719731	35723783	3500100552	25		35719731	35723783	8421504	2	8,17	0,4035	c	350010055200000017	0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		
857	chr20	35728452	35730480	3500064585	81		35728452	35730480	8421504	3	15,56,10	0,18,2018	p	350006458500015008	0-81						Ampk pathway components	Apfeld	2004	0		
857	chr20	35730537	35730562	3500161202	25		35730537	35730562	8421504	1	25	0	c	350016120200000010	0-25		23334421	10.1038/nature11776		Nature	Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence	Peng	2013	0		PRKAA1
857	chr20	35730537	35730562	3500040914	25		35730537	35730562	8421504	1	25	0	c	350004091400000002	0-25		17513605	10.1158/1535-7163.MCT-06-0800	1535-7163	Molecular Cancer Therapeutics	5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF&#x03b1;-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling	Su	2007	5		PRKAA1
857	chr20	35730773	35730853	3500345859	65		35730773	35730853	8421504	3	23,20,22	0,24,58	c,g	350034585900000017,350034585900000017,350034585900000019,350034585900000019,350034585900000018,350034585900000018	0-23,0-23,0-20,0-20,0-22,0-22						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
857	chr20	35730868	35731079	3500006584	45		35730868	35731079	8421504	3	23,10,12	0,79,199	c	350000658400000026,350000658400000027	0-23,0-22						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
857	chr20	35730909	35731080	3500463464	60		35730909	35731080	8421504	3	7,40,13	0,8,158	c	350046346400000068,350046346400000042	16-70,22-45						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
857	chr20	35781692	35781718	3500089718	26		35781692	35781718	8421504	1	26	0	c	350008971800000006	0-26		16540639	10.1158/0008-5472.CAN-05-4348	0008-5472	Cancer Research	Prostaglandin E Receptor EP4 Antagonism Inhibits Breast Cancer Metastasis	Ma	2006	8		PTGER4
857	chr20	35781692	35781718	3500058739	26		35781692	35781718	8421504	1	26	0	c	350005873900000006	0-26		16540639	10.1158/0008-5472.CAN-05-4348	0008-5472	Cancer Research	Prostaglandin E Receptor EP4 Antagonism Inhibits Breast Cancer Metastasis	Ma	2006	8		PTGER4
107	chr20	35781695	35792325	3500210545	58		35781695	35792325	8421504	2	29,29	0,10601	c	350021054500000000,350021054500000001	0-29,0-29		20503412	10.1002/cncr.25167	1097-0142	Cancer	Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4 - Robertson - 2010 - Cancer - Wiley Online Library	Robertson	2010	0		PTGER4
857	chr20	35782125	35782215	3500222581	87		35782125	35782215	8421504	2	45,42	0,48	p	350022258100015003	0-87			10.1016/j.prostaglandins.2005.12.002		Prostaglandins & other lipid mediators	Involvement of EP1 and EP2 receptors in the regulation of the Na,K-ATPase by prostaglandins in MDCK cells	Keikantse	2006	0		PTGER4
857	chr20	35782543	35782566	3500427857	23		35782543	35782566	8421504	1	23	0	c	350042785700000003,350042785700000010	0-23,0-21						Prevention and treatment of amyloid-associated disorders	Hyslop	2000	0		PTGER4
107	chr20	35782577	35792379	3500104791	72		35782577	35792379	8421504	3	24,24,24	0,94,9778	c	350010479100000005,350010479100000007,350010479100000004	0-24,0-24,0-24		12810564	10.1210/en.2002-0088	0013-7227	Endocrinology	Molecular Cloning and Characterization of Bovine Prostaglandin E2 Receptors EP2 and EP4: Expression and Regulation in Endometrium and Myometrium during the Estrous Cycle and Early Pregnancy	Arosh	2003	4		
107	chr20	35782621	35792123	3500102451	48		35782621	35792123	8421504	2	24,24	0,9478	c,g	350010245100000019,350010245100000018,350010245100000018	0-24,0-24,0-24		19180509	10.1002/art.24258	1529-0131	Arthritis & Rheumatism	Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis - Li - 2009 - Arthritis & Rheumatism - Wiley Online Library	Li	2009	0		PTGER4
857	chr20	35782626	35782651	3500325301	25		35782626	35782651	8421504	1	25	0	c,g	350032530100000004,350032530100000004	0-25,0-25		16357326	10.1182/blood-2005-07-2772	0006-4971	Blood	Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses	Feng	2006	10		PTGER4
857	chr20	35782626	35782651	3500314478	25		35782626	35782651	8421504	1	25	0	c,g	350031447800000004,350031447800000004	0-25,0-25			10.1182/blood-2005-07-2772		Blood	Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses	Chunli	2006	0		PTGER4
858	chr20	35792561	35792584	3500304150	23		35792561	35792584	8421504	1	23	0	c	350030415000000003	17-40		20130120	10.1152/ajprenal.00467.2009		American Journal of Physiology - Renal Physiology	Regulation of renal proximal tubule Na-K-ATPase by prostaglandins	Herman	2010	0		
858	chr20	35792561	35792584	3500196208	23		35792561	35792584	8421504	1	23	0	c	350019620800000003	17-40		20130120	10.1152/ajprenal.00467.2009		American Journal of Physiology - Renal Physiology	Regulation of renal proximal tubule Na-K-ATPase by prostaglandins	Maryann	2010	0		
858	chr20	35792608	35792834	3500349767	40		35792608	35792834	8421504	2	20,20	0,206	c,g	350034976700000029,350034976700000029,350034976700000028	0-20,0-20,0-20						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
858	chr20	35792624	35792651	3500134080	23		35792624	35792651	8421504	2	10,13	0,14	c	350013408000000041	19-42						Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)	Agre	1995	0		
858	chr20	35792769	35792901	3500121852	132		35792769	35792901	8421504	1	132	0	p	350012185200015022	48-180						METHODS FOR DETECTING AND REGULATING ALOPECIA AREATA AND GENE COHORTS THEREOF - Patent application	www.faqs.org	0	0		
858	chr20	35792820	35792892	3500163087	72		35792820	35792892	8421504	1	72	0	p,c	350016308700015043,350016308700000040	0-72,0-36						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		
859	chr20	35942655	35942680	3500129486	23		35942655	35942680	8421504	2	11,12	0,13	g	350012948600000004	0-26						US Patent # 5,850,016. Alteration of amino acid compositions in seeds - Patents.com	www.patents.com	0	0		
867	chr20	37035134	37035161	3500108381	23		37035134	37035161	8421504	3	12,5,6	0,14,21	g	350010838100000075	0-23						Functional Analysis of the Plasma Membrane Alr1 and Alr2 Proteins in Yeast Saccharomyces cerevisiae	thes.univie.ac.at	0	0		
868	chr20	37166664	37166689	3500366011	25		37166664	37166689	8421504	1	25	0	c	350036601100000017	0-25			10.1634/stemcells.2005-0067	1549-4918	STEM CELLS	Quantitative Oct4 Overproduction in Mouse Embryonic Stem Cells Results in Prolonged Mesoderm Commitment During Hematopoietic Differentiation In Vitro - Camara-Clayette - 2006 - STEM CELLS - Wiley Online Library	Camara-Clayette	2006	0		
868	chr20	37166664	37166689	3500174345	25		37166664	37166689	8421504	1	25	0	c	350017434500000012	22-47						Table S1. Components for knockout serum replacer medium (KSR medium) (500 ml) Component Supplier Catalogue Stock Final Volume number Concentration concentration used Advanced DMEM/F12 Invitrogen 12634010 - 78% 400 ml Knockout serum replacer Invitrogen 108	ev.biologists.org	0	0		DAB2
868	chr20	37178087	37178114	3500312985	24		37178087	37178114	8421504	2	14,10	0,17	c	350031298500000265	24-48					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
868	chr20	37178087	37178114	3500199448	24		37178087	37178114	8421504	2	14,10	0,17	c	350019944800000174	24-48						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1996	0		
868	chr20	37178087	37178114	3500070162	24		37178087	37178114	8421504	2	14,10	0,17	c	350007016200000265	24-48					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6124104)	Couch	2000	0		
868	chr20	37178638	37179157	3500465380	44		37178638	37179157	8421504	2	20,24	0,495	c,g	350046538000000002,350046538000000002,350046538000000003	0-20,0-20,6-30						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	quantification.de	0	0		
868	chr20	37178638	37179157	3500011924	44		37178638	37179157	8421504	2	20,24	0,495	c,g	350001192400000002,350001192400000002,350001192400000003	0-20,0-20,6-30						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	qpcrupdate.net	0	0		
869	chr20	37230327	37239964	3500362403	41		37230327	37239964	8421504	2	20,21	0,9616	c,g	350036240300000026,350036240300000026,350036240300000027,350036240300000027	0-20,0-20,0-21,0-21						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
869	chr20	37252883	37252961	3500396251	78		37252883	37252961	8421504	1	78	0	p	350039625100015026	0-78						 Plants Genetically Enhanced For Disease Resistance 	www.docstoc.com	0	0		C9
869	chr20	37252883	37252961	3500300230	78		37252883	37252961	8421504	1	78	0	p	350030023000015027	0-78						Plants genetically enhanced for disease resistance	Jaynes	1995	0		C9
869	chr20	37252883	37252961	3500219102	78		37252883	37252961	8421504	1	78	0	p	350021910200015016	0-78					Patent	Plants genetically enhanced for nutritional quality (Patent US:5811654)	Derrick	1998	0		C9
869	chr20	37252883	37252961	3500211090	78		37252883	37252961	8421504	1	78	0	p	350021109000015029	0-78						Plants genetically enhanced for nutritional quality	Jaynes	1997	0		C9
869	chr20	37252883	37252961	3500201657	78		37252883	37252961	8421504	1	78	0	p	350020165700015026	0-78						Plants genetically enhanced for nutritional quality - Patent # 5811654 - PatentGenius	.patentgenius.com	0	0		C9
869	chr20	37252883	37252961	3500051882	78		37252883	37252961	8421504	1	78	0	p	350005188200015016	0-78					Patent	Plants genetically enhanced for disease resistance (Patent US:5597945)	Derrick	1997	0		C9
871	chr20	37555459	37562121	3500270457	48		37555459	37562121	8421504	2	35,13	0,6649	p	350027045700015001	3-51		16798736	10.1074/jbc.M603566200	0021-9258	Journal of Biological Chemistry	Activation of Mammalian Target of Rapamycin (mTOR) by Insulin Is Associated with Stimulation of 4EBP1 Binding to Dimeric mTOR Complex 1	Wang	2006	5		RICTOR
871	chr20	37570277	37572310	3500153019	46		37570277	37572310	8421504	3	4,17,25	0,116,2008	c	350015301900000003,350015301900000001	1-22,0-25		23555046	10.1371/journal.pone.0059597	1932-6203	PLOS ONE	PLOS ONE: Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model	Verreault	2013	4		
871	chr20	37610505	37610537	3500378226	30		37610505	37610537	8421504	3	5,20,5	0,6,27	c	350037822600000012	66-96						Diagnostic detection of nucleic acids	Schuetz	2004	0		
871	chr20	37610505	37610537	3500134371	30		37610505	37610537	8421504	3	5,20,5	0,6,27	c	350013437100000012	66-96						Diagnostic detection of nucleic acids	Schuetz	2002	0		
872	chr20	37619995	37658560	3500328855	258		37619995	37658560	8421504	12	20,5,31,23,23,10,6,6,17,36,54,27	0,21,250,3814,10868,20865,20877,20884,21419,23027,30318,38538	c	350032885500000264,350032885500000118,350032885500000105,350032885500000297,350032885500000285,350032885500000277,350032885500000071,350032885500000274,350032885500000068,350032885500000065	0-25,11-42,0-23,0-23,0-42,8-44,14-45,0-45,0-43,1-28						Polynucleotide encoding cytokine receptor zcytor17 multimer - US Patent 7494804 Description	ww.patentstorm.us	0	0		
872	chr20	37620245	37620276	3500106793	31		37620245	37620276	8421504	1	31	0	c	350010679300000111	17-48						Peptide That Elicits Neutralizing Antibodies Targeting The Hiv Co-receptor, Ccr5 	.freshpatents.com	0	0		
875	chr20	38025975	38026001	3500351984	23		38025975	38026001	8421504	2	8,15	0,11	g	350035198400000009	0-25						Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase	Kishore	1988	0		
875	chr20	38025975	38026001	3500276013	23		38025975	38026001	8421504	2	8,15	0,11	g	350027601300000008	0-25						Glyphosate tolerant 5-enolpyruvyl-3-phosphoshikimate synthase	Kishore	1988	0		
875	chr20	38025975	38026001	3500199340	23		38025975	38026001	8421504	2	8,15	0,11	g	350019934000000012	0-25						Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases	Eichholtz	1989	0		
875	chr20	38025975	38026001	3500161354	23		38025975	38026001	8421504	2	8,15	0,11	g	350016135400000008	0-25					Patent	Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase (Patent US:5312910)	Kishore	1994	0		
875	chr20	38033935	38064230	3500449156	117		38033935	38064230	8421504	4	14,7,48,48	0,19,29767,30247	c	350044915600000019,350044915600000114,350044915600000116	18-39,0-48,0-48					Patent	DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor (Patent US:5426048)	Gearing	1995	0		
875	chr20	38036155	38064182	3500327731	123		38036155	38064182	8421504	4	45,30,30,18	0,50,27595,28009	c	350032773100000089,350032773100000090,350032773100000126	3-48,5-35,0-48						Receptor for oncostatin m and leukemia inhibitory factor	Gearing	1995	0		
875	chr20	38036255	38040353	3500382980	43		38036255	38040353	8421504	2	23,20	0,4078	c,g	350038298000000014,350038298000000014,350038298000000015,350038298000000015	0-23,0-23,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
875	chr20	38036255	38040353	3500280137	43		38036255	38040353	8421504	2	23,20	0,4078	c	350028013700000014,350028013700000015	0-23,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
875	chr20	38049884	38049925	3500355012	40		38049884	38049925	8421504	2	35,5	0,36	c	350035501200000102	0-40						Leukemia inhibitory factor receptors and fusion proteins	Gearing	1993	0		
875	chr20	38060965	38060989	3500182029	24		38060965	38060989	8421504	1	24	0	c	350018202900000002	23-47						MTA Doktori &#xc9;rtekez&#xe9;s Endokrin daganatok &#xe9;s immun-neuroendokrin	real-d.mtak.hu	0	0		
880	chr20	38729324	38750211	3500286212	46		38729324	38750211	8421504	2	21,25	0,20862	c	350028621200000000,350028621200000001	12-33,8-33						&#x8110;&#x8840;&#x95f4;&#x5145;&#x8d28;&#x5e72;&#x7ec6;&#x80de;&#x7684;&#x9274;&#x5b9a;&#x2014;&#x2014;&#x661f;&#x95ee;&#x7b54;&#x2014;&#x2014;&#x4e0a;&#x6d77;&#x7814;&#x53d1;&#x516c;&#x5171;&#x670d;&#x52a1;&#x5e73;&#x53f0;	expert.sgst.cn	0	0		
880	chr20	38729324	38750211	3500208590	52		38729324	38750211	8421504	2	26,26	0,20861	c,g	350020859000000000,350020859000000001,350020859000000001	13-39,7-33,7-33		15585410	10.1016/j.ymthe.2004.09.020	1525-0016	Molecular Therapy	Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model	Kurozumi	2005	7		
880	chr20	38729324	38750192	3500036353	40		38729324	38750192	8421504	2	20,20	0,20848	c,g	350003635300000018,350003635300000018,350003635300000019,350003635300000019	0-20,0-20,0-20,0-20						www.stemcell8.c &#x2190;&#x70b9;&#x51fb;&#x8fdb;&#x5165;	rary.bjcancer.org	0	0		GDNF
880	chr20	38729324	38749755	3500111528	180		38729324	38749755	8421504	2	151,29	0,20402	p,c	350011152800015004,350011152800000064,350011152800000065,350011152800000019,350011152800000004,350011152800000020,350011152800000005	0-180,0-48,0-48,0-48,0-48,0-38,0-48						Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Gdnf - Patent application	www.faqs.org	0	0		
880	chr20	38729324	38749728	3500352106	153		38729324	38749728	8421504	2	151,2	0,20402	p	350035210600015022	0-153						NOVEL NEUROTROPHIC FACTORS	Sah	2009	0		
880	chr20	38729324	38749728	3500305726	153		38729324	38749728	8421504	2	151,2	0,20402	p	350030572600015019	0-153					Patent	Methods of treating pain using neurotrophic factors (Patent US:7358228)	Sah	2008	0		
880	chr20	38729324	38749728	3500054979	153		38729324	38749728	8421504	2	151,2	0,20402	p	350005497900015019	0-153					Patent	Neublastin neurotrophic factors (Patent US:6734284)	Johansen	2004	0		
880	chr20	38729324	38749728	3500043689	153		38729324	38749728	8421504	2	151,2	0,20402	p	350004368900015019,350004368900015258	0-153,0-87						 Methods Of Treating Pain Using Neurotrophic Factors 	www.docstoc.com	0	0		
880	chr20	38729324	38729417	3500262927	93		38729324	38729417	8421504	1	93	0	c	350026292700000042,350026292700000043	3-48,0-48						Glial derived neurotrophic factor	Bektesh	1993	0		
880	chr20	38729331	38750199	3500176414	40		38729331	38750199	8421504	2	19,21	0,20847	c,g	350017641400000031,350017641400000031,350017641400000044,350017641400000044,350017641400000032,350017641400000032,350017641400000015,350017641400000015	0-19,0-19,19-40,19-40,0-21,0-21,19-40,19-40						AMNIOTIC FLUID STEM CELLS AND KIDNEY REGENERATION	arch.cab.unipd.it	0	0		GDNF
880	chr20	38729338	38750126	3500078913	47		38729338	38750126	8421504	2	23,24	0,20764	c	350007891300000000,350007891300000001	0-23,0-24		12021034	10.1095/biolreprod66.6.1579	0006-3363	Biology of Reproduction	Transplantation of Germ Cells from Glial Cell Line-Derived Neurotrophic Factor-Overexpressing Mice to Host Testes Depleted of Endogenous Spermatogenesis by Fractionated Irradiation	Creemers	2002	4		GDNF
880	chr20	38729420	38729468	3500280350	48		38729420	38729468	8421504	1	48	0	c	350028035000000044	0-48						EXPRESSION OF NEUROPEPTIDES IN MAMMALIAN CELLS - Patent application	www.faqs.org	0	0		
880	chr20	38729467	38750209	3500301585	48		38729467	38750209	8421504	3	8,16,24	0,20259,20718	c	350030158500000008,350030158500000009	0-24,0-24						GDNF Family Ligands Trigger Indirect Neuroprotective Signaling in Retinal Glial Cells - Keeping the Faith	pthefaith1296.com	0	0		
880	chr20	38729467	38750209	3500151975	48		38729467	38750209	8421504	3	8,16,24	0,20259,20718	c	350015197500000008,350015197500000009	0-24,0-24			10.1128/MCB.26.7.2746-2757.2006		Molecular and Cellular Biology	GDNF Family Ligands Trigger Indirect Neuroprotective Signaling in Retinal Glial Cells	Stefanie	2006	0		
880	chr20	38750088	38750139	3500344800	51		38750088	38750139	8421504	1	51	0	p	350034480000015002	0-51						14 GENOMPR OJEKT Jagten p&#xe5; generne	biotechacademy.dk	0	0		GDNF
880	chr20	38750088	38750139	3500129853	51		38750088	38750139	8421504	1	51	0	p	350012985300015002	0-51						14 GENOMPR OJEKT Jagten p&#xe5; generne	viden.jp.dk	0	0		GDNF
880	chr20	38750172	38750197	3500385920	25		38750172	38750197	8421504	1	25	0	c	350038592000000044	0-25						BIOCHEMICAL AND CELL CULTURE APPROACH TO STUDY THE MOLECULAR ASPECTS OF METACHROMATIC LEUKODYSTROPHY	s.ulb.uni-bonn.de	0	0		GDNF
880	chr20	38750186	38750211	3500382126	25		38750186	38750211	8421504	1	25	0	c	350038212600000001	8-33		19430401	10.1097/CMR.0b013e32831bc42f	0960-8931	Melanoma Research	 Inhibitor of growth 4 is involved in melanomagenesis and ind... : Melanoma Research 	Cai	2009	2		GDNF
883	chr20	39105136	39105160	3500440158	23		39105136	39105160	8421504	2	18,5	0,19	c	350044015800000012	2-28						Alternative splicing factors polynucleotides polypeptides and uses therof	Lyznik	2004	0		
883	chr20	39136354	39136411	3500085918	57		39136354	39136411	8421504	1	57	0	p	350008591800015000	0-57		16000379	10.1091/mbc.E04-11-0998	1059-1524	Molecular Biology of the Cell	Interaction between the Shuttling mRNA Export Factor Gle1 and the Nucleoporin hCG1: A Conserved Mechanism in the Export of Hsp70 mRNA	Kendirgi	2005	5		NUP155
883	chr20	39136354	39136411	3500034797	57		39136354	39136411	8421504	1	57	0	p	350003479700015000	0-57			10.1091/mbc.E04-11-0998		Molecular Biology of the Cell	Interaction between the Shuttling mRNA Export Factor Gle1 and the Nucleoporin hCG1: A Conserved Mechanism in the Export of Hsp70 mRNA	Frederic	2005	0		NUP155
884	chr20	39278878	39278902	3500456012	24		39278878	39278902	8421504	1	24	0	c	350045601200000081	0-24						Expression profiling and gene discovery in the mouse lens	www.molvis.org	0	0		NIPBL
884	chr20	39298411	39298439	3500440656	23		39298411	39298439	8421504	2	7,16	0,12	c	350044065600000106	5-28						Therapeutic uses of inhibitors of RTP801	Feinstein	2005	0		
884	chr20	39298411	39298439	3500314588	23		39298411	39298439	8421504	2	7,16	0,12	c	350031458800000131	5-28						Therapeutic uses of inhibitors of RTP801	filed	2011	0		
884	chr20	39298411	39298439	3500271179	23		39298411	39298439	8421504	2	7,16	0,12	c	350027117900000131	5-28						Therapeutic uses of inhibitors of RTP801	The	2005	0		
884	chr20	39298411	39298439	3500250136	23		39298411	39298439	8421504	2	7,16	0,12	c	350025013600000118	5-28						Therapeutic uses of inhibitors of RTP801	Feinstein	2011	0		
884	chr20	39298411	39298439	3500246296	23		39298411	39298439	8421504	2	7,16	0,12	c	350024629600000106	5-28						Methods of treating eye diseases in diabetic patients	Feinstein	2011	0		
884	chr20	39298411	39298439	3500157867	23		39298411	39298439	8421504	2	7,16	0,12	c	350015786700000113	5-28					Patent	Therapeutic uses of inhibitors of RTP801 (Patent US:8309532)	Feinstein	2012	0		
884	chr20	39298411	39298439	3500092809	23		39298411	39298439	8421504	2	7,16	0,12	c	350009280900000106	5-28						Therapeutic uses of inhibitors of RTP801	Feinstein	2006	0		
110	chr20	39693145	39770439	3500438816	1482		39693145	39770439	8421504	9	58,135,195,234,293,43,205,138,181	0,1706,2745,3540,6330,9633,12827,54055,77113	p	350043881600015112,350043881600015209,350043881600015213,350043881600015186,350043881600015147,350043881600015109,350043881600015181,350043881600015196,350043881600015143,350043881600015106,350043881600015176,350043881600015103,350043881600015172,350043881600015168,350043881600015165,350043881600015162,350043881600015159	0-180,0-186,0-186,0-180,0-111,0-180,0-162,0-177,0-102,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180						Caracterizaci&#xf3;n de transportadores de amino&#xe1;cidos en Echinococcus granulosus	al.bl.fcen.uba.ar	0	0		
887	chr20	39699575	39699681	3500078571	40		39699575	39699681	8421504	2	20,20	0,86	c	350007857100000019,350007857100000003,350007857100000018,350007857100000002	0-20,0-20,0-20,0-20						Methods of Treating Neurological Disorders - Patent application	www.faqs.org	0	0		SLC1A3
887	chr20	39699575	39699681	3500025070	40		39699575	39699681	8421504	2	20,20	0,86	c,g	350002507000000003,350002507000000003,350002507000000002,350002507000000002	0-20,0-20,0-20,0-20						Methods of Treating Neurological Disorders	Kaufer	2009	0		SLC1A3
891	chr20	40169385	40169413	3500022398	23		40169385	40169413	8421504	3	6,5,12	0,9,16	c	350002239800000226	0-24						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
891	chr20	40185998	40188992	3500194103	40		40185998	40188992	8421504	2	20,20	0,2974	c,g	350019410300000051,350019410300000051,350019410300000050	0-20,0-20,0-20						AZ IZOM DIFFERENCI&#xc1;L&#xd3;D&#xc1;ST BEFOLY&#xc1;SOL&#xd3; G&#xc9;NEK IN VITRO VIZSG&#xc1;LATA EMBRION&#xc1;LIS EREDET&#x0170; &#x0150;S-SEJTVONALAKBAN EG&#xc9;R MODELLRENDSZERBEN	phd.szie.hu	0	0		
893	chr20	40380835	40389777	3500058136	522		40380835	40389777	8421504	4	68,178,210,66	0,3407,3869,8876	p	350005813600015020,350005813600015013	0-522,3-522						Palaemonetes_pugio-Contig_263-v1 | MarineGenomics.org	arinegenomics.org	0	0		CAPSL
900	chr20	41294745	41357268	3500009187	2426		41294745	41357268	8421504	9	37,117,133,170,170,142,100,70,1487	0,40295,43160,45196,55529,57354,59125,59920,61036	c	350000918700000001,350000918700000024	2-60,2-2428						INTRODUCTION	www.ppsk.usm.my	0	0		
900	chr20	41294745	41355817	3500009187	975		41294745	41355817	8421504	9	37,117,133,170,170,142,100,70,36	0,40295,43160,45196,55529,57354,59125,59920,61036	c,g	350000918700000025,350000918700000004,350000918700000004,350000918700000000,350000918700000009,350000918700000011	2-60,0-60,0-60,0-891,0-23,0-23						INTRODUCTION	www.ppsk.usm.my	0	0		
900	chr20	41294761	41353962	3500159340	41		41294761	41353962	8421504	2	20,21	0,59180	c	350015934000000000,350015934000000004	0-20,0-21						receptor (PRLR) and its relation to ovulation rate and piglet survival traits1	nimal-science.org	0	0		PRLR
900	chr20	41337956	41354695	3500316577	42		41337956	41354695	8421504	2	22,20	0,16719	c	350031657700000000,350031657700000001	0-22,0-20		9716555	10.1095/biolreprod59.3.571	0006-3363	Biology of Reproduction	Luteotropic Hormone Receptors in the Ovary of the Mink (Mustela vison) during Delayed Implantation and Early-Postimplantation Gestation	Douglas	1998	4		
900	chr20	41337956	41354695	3500204456	42		41337956	41354695	8421504	2	22,20	0,16719	c	350020445600000000,350020445600000001	0-22,0-20						Luteotropic Hormone Receptors in the Ovary of the Mink (Mustela vison) during Delayed Implantation and Early-Postimplantation Gestation	ww.biolreprod.org	0	0		
900	chr20	41353966	41355837	3500434170	41		41353966	41355837	8421504	4	4,17,3,17	0,699,766,1854	c	350043417000000038,350043417000000039	0-21,0-20						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
900	chr20	41353969	41354706	3500307320	41		41353969	41354706	8421504	3	1,18,22	0,696,715	c	350030732000000006,350030732000000008	0-19,0-22						Animal treatment	Montenegro-lohr	2002	0		
900	chr20	41353969	41354706	3500257727	41		41353969	41354706	8421504	3	1,18,22	0,696,715	c	350025772700000006,350025772700000008	0-19,0-22						Animal treatment	Montenegro-Lohr	2005	0		
900	chr20	41354715	41355896	3500124900	65		41354715	41355896	8421504	4	20,22,3,20	0,1074,1105,1161	c,g	350012490000000021,350012490000000019,350012490000000019,350012490000000020,350012490000000020	0-23,0-22,0-22,0-20,0-20						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
900	chr20	41355916	41356223	3500371489	40		41355916	41356223	8421504	2	20,20	0,287	c,g	350037148900000008,350037148900000008,350037148900000009	0-20,0-20,0-20						Mammary Response to Exogenous Prolactin or Frequent Milking During Early Lactation in Dairy Cows	circlescience.biz	0	0		
900	chr20	41356623	41356652	3500400089	24		41356623	41356652	8421504	2	13,11	0,18	c	350040008900000110	0-24						 Aspergillus Ochraceus 11 Alpha Hydroxylase And Oxidoreductase 	www.docstoc.com	0	0		
900	chr20	41389553	41391165	3500108314	23		41389553	41391165	8421504	2	20,3	0,1609	c	350010831400000000	1-24		18197253	10.1371/journal.pone.0001443		PLoS ONE	A Mitochondrial Kinase Complex Is Essential to Mediate an ERK1/2-Dependent Phosphorylation of a Key Regulatory Protein in Steroid Biosynthesis	Cecilia	2008	0		
906	chr20	42085210	42085233	3500364288	23		42085210	42085233	8421504	1	23	0	c	350036428800000002	0-23						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
906	chr20	42132742	42132768	3500016075	23		42132742	42132768	8421504	2	16,7	0,19	g	350001607500000032	0-33						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
908	chr20	42381081	42381109	3500260547	23		42381081	42381109	8421504	2	10,13	0,15	g	350026054700000056	2-25						Analysis of the function and regulation of the centrosomal protein NEDD1 during cell division and development	y.adelaide.edu.au	0	0		
910	chr20	42646205	42646229	3500182484	23		42646205	42646229	8421504	2	17,6	0,18	c	350018248400000013	2-25						PLASMODIAL POLYNUCLEOTIDES, PROTEINS AND USES THEREOF - WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH	www.sumobrain.com	0	0		
915	chr20	43258842	43260630	3500236211	38		43258842	43260630	8421504	2	23,15	0,1773	c	350023621100000005	6-44		10067864	10.1210/en.140.3.1365	0013-7227	Endocrinology	Regulation of Natriuretic Peptide Receptors by Thyrotropin in FRTL-5 Rat Thyroid Cells: Evidence for Nonguanylate Cyclase Atrial Natriuretic Factor-Binding Sites in Cells Lacking the Natriuretic Peptide Receptor C	Sellitti	1999	4		
915	chr20	43258849	43268553	3500200697	43		43258849	43268553	8421504	3	16,6,21	0,1766,9683	c	350020069700000001,350020069700000000	0-22,0-21		10444562			American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Basic FGF decreases clearance receptor of natriuretic peptides in fetoplacental artery endothelium	Itoh	1999	0		
915	chr20	43258849	43268553	3500009047	43		43258849	43268553	8421504	3	16,6,21	0,1766,9683	c	350000904700000001,350000904700000000	0-22,0-21		10444562			American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Basic FGF decreases clearance receptor of natriuretic peptides in fetoplacental artery endothelium	Itoh	1999	0		
915	chr20	43327933	43327960	3500236211	27		43327933	43327960	8421504	1	27	0	g	350023621100000004	5-32		10067864	10.1210/en.140.3.1365	0013-7227	Endocrinology	Regulation of Natriuretic Peptide Receptors by Thyrotropin in FRTL-5 Rat Thyroid Cells: Evidence for Nonguanylate Cyclase Atrial Natriuretic Factor-Binding Sites in Cells Lacking the Natriuretic Peptide Receptor C	Sellitti	1999	4		
915	chr20	43327975	43327998	3500340674	23		43327975	43327998	8421504	1	23	0	c	350034067400000004	0-23						ANP inhibits LPS-induced stimulation of rat microglial cells by suppressing NF-kappaB and AP-1 activations. - ResearchGate	.researchgate.net	0	0		
916	chr20	43408145	43408172	3500277510	24		43408145	43408172	8421504	2	11,13	0,14	g	350027751000000122	10-34						Novel seven transmembrane receptors	Godiska	1994	0		
916	chr20	43408515	43408543	3500386669	24		43408515	43408543	8421504	2	6,18	0,10	c	350038666900000000	8-32		18725935	10.1371/journal.ppat.1000132		PLoS Pathogens	Bacillus anthracis Secretes Proteins That Mediate Heme Acquisition from Hemoglobin	Anthony	2008	0		
916	chr20	43409677	43409705	3500135205	28		43409677	43409705	8421504	1	28	0	c	350013520500000035	17-45						Universit&#xe0; degli Studi di Trieste	enstarts.units.it	0	0		
916	chr20	43415058	43415081	3500422007	23		43415058	43415081	8421504	1	23	0	g	350042200700000023	11-36						Development of an anhydrotetracycline-inducible gene expression system for solvent-producing Clostridium acetobutylicum A useful tool for strain engineering	www.im.ac.cn	0	0		
918	chr20	43708920	43708944	3500393965	24		43708920	43708944	8421504	1	24	0	g	350039396500000006	0-24						Resistance to telomerase inhibition by human squamous cell carcinoma cell lines	-publications.com	0	0		ACTB
918	chr20	43708920	43708944	3500186425	24		43708920	43708944	8421504	1	24	0	g	350018642500000003	0-24		18443043	10.1128/MCB.01489-07	0270-7306	Molecular and Cellular Biology	Extracellular Signals Regulate Rapid Coactivator Recruitment at AP-1 Sites by Altered Phosphorylation of both CREB Binding Protein and c-jun	Tsai	2008	6		
922	chr20	44195410	44195437	3500237963	23		44195410	44195437	8421504	2	10,13	0,14	g	350023796300000052	0-25						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
922	chr20	44195410	44195437	3500028179	23		44195410	44195437	8421504	2	10,13	0,14	g	350002817900000058	0-25						Polypeptides And Polynucleotides From Coagulase-negative Staphylococci 	.freshpatents.com	0	0		
924	chr20	44458760	44458787	3500113379	24		44458760	44458787	8421504	2	6,18	0,9	g	350011337900000015	20-45						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
925	chr20	44582739	44582916	3500065941	177		44582739	44582916	8421504	1	177	0	p	350006594100015005	0-177						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH6
925	chr20	44606783	44606808	3500313803	25		44606783	44606808	8421504	1	25	0	c	350031380300000004	0-25			10.1359/jbmr.1998.13.4.633	1523-4681	Journal of Bone and Mineral Research	Human Osteoblasts Express a Repertoire of Cadherins, Which Are Critical for BMP-2&#x2013;Induced Osteogenic Differentiation - Cheng - 1998 - Journal of Bone and Mineral Research - Wiley Online Library	Cheng	1998	0		CDH6
925	chr20	44613594	44643285	3500141933	31		44613594	44643285	8421504	3	5,6,20	0,6,29671	c	350014193300000005	0-32						MESENCHYMAL STEM CELLS FOR THE CELL-BASED THERAPY OF TYPE 1 DIABETES	repositorio.ul.pt	0	0		
928	chr20	45039295	45039325	3500028179	25		45039295	45039325	8421504	2	6,19	0,11	g	350002817900000050	15-41						Polypeptides And Polynucleotides From Coagulase-negative Staphylococci 	.freshpatents.com	0	0		
947	chr20	47533935	47533958	3500463625	23		47533935	47533958	8421504	1	23	0	g	350046362500000004	8-31						Methods and compositions for polypeptide engineering	Patten	2009	0		
958	chr20	48992353	48992378	3500106078	23		48992353	48992378	8421504	2	10,13	0,12	g	350010607800000186	11-34						Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications	Abdelhak	1998	0		
959	chr20	49147495	49147518	3500049288	23		49147495	49147518	8421504	1	23	0	g	350004928800000069	0-24						IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF GENETIC VARIANTS IN THE HUMAN INDOLEAMINE 2,3-DIOXYGENASE (INDO	arworks.iupui.edu	0	0		
962	chr20	49493899	49493924	3500307086	24		49493899	49493924	8421504	2	6,18	0,7	g	350030708600000005	0-24		21632763	10.1128/JVI.00290-11		Journal of Virology	Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo	Rodolphe	2011	0		
964	chr20	49699869	49699896	3500371190	23		49699869	49699896	8421504	2	14,9	0,18	g	350037119000000011	9-32						Review of microsatellites in ecology and parentage analysis of Norwegian beavers (Castor fiber based on cross-specific microsatellites	teora.hit.no	0	0		
976	chr20	51279381	51279407	3500269873	23		51279381	51279407	8421504	2	16,7	0,19	g	350026987300000047	4-28						Methods and Nucleic Acids for Analyses of Cellular Proliferative Disorders	Distler	2011	0		
978	chr20	51591898	51592075	3500065941	177		51591898	51592075	8421504	1	177	0	p	350006594100015009	0-177						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH10
997	chr20	54027594	54027618	3500301112	24		54027594	54027618	8421504	1	24	0	g	350030111200000000	0-24		23302075	10.1111/j.1740-0929.2012.01036.x	1740-0929	Animal Science Journal	Application of highly differentiated SNPs between Japanese Black and Holstein to a breed assignment test between Japanese Black and F1 (Japanese Black x Holstein) and Holstein - NISHIMURA - 2012 - Animal Science Journal - Wiley Online Library	NISHIMURA	2013	0		
997	chr20	54123304	54123333	3500116045	28		54123304	54123333	8421504	2	7,21	0,8	g	350011604500000073,350011604500000051	7-48,4-45						Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease	Progulske-fox	1994	0		
1000	chr20	54414246	54414270	3500256291	24		54414246	54414270	8421504	1	24	0	g	350025629100000014	11-35		17644627	10.1104/pp.107.101162	0032-0889	Plant Physiology	Enzymatic Properties and Subcellular Localization of Arabidopsis &#x03b2;-N-Acetylhexosaminidases	Strasser	2007	7		
1004	chr20	54990434	54990460	3500178783	23		54990434	54990460	8421504	2	16,7	0,19	g	350017878300000001	0-23						MOLECULAR CLONING AND CHARACTERIZATION OF RABBIT MYOSTATIN GENE | Chetan Jawale - Academia.edu	www.academia.edu	0	0		MSTN
1007	chr20	55356820	55356848	3500393619	23		55356820	55356848	8421504	3	12,6,5	0,14,23	g	350039361900000050	22-45						Method of reducing the viscosity of mucus - US Patent 7704718 Description	ww.patentstorm.us	0	0		
1011	chr20	55907223	55907247	3500055588	24		55907223	55907247	8421504	1	24	0	g	350005558800000000	9-33			10.1186/1471-2091-8-29		BMC Biochemistry	Binding to DPF-motif by the POB1 EH domain is responsible for POB1-Eps15 interaction	Elena	2007	0		
1019	chr20	56926805	56926829	3500248094	23		56926805	56926829	8421504	2	14,9	0,15	g	350024809400001676	2-25						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
1020	chr20	57053174	57053354	3500065941	180		57053174	57053354	8421504	1	180	0	p	350006594100015015	0-180						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH18
1026	chr20	57875611	57875638	3500169965	23		57875611	57875638	8421504	2	8,15	0,12	g	350016996500000015	0-23						Equus zebra zebra and Equus zebra hartmannae) populations	upetd.up.ac.za	0	0		
128	chr20	57932214	57952552	3500310375	39		57932214	57952552	8421504	3	12,7,20	0,14,20318	g	350031037500000361,350031037500000204	0-19,28-48						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
1027	chr20	58022568	58022592	3500118045	23		58022568	58022592	8421504	2	8,15	0,9	g	350011804500000118	2-34						Proteases and variants thereof - US Patent 7537922 Description	ww.patentstorm.us	0	0		
1031	chr20	58567833	58567858	3500152402	23		58567833	58567858	8421504	2	10,13	0,12	g	350015240200000005	1-24		11401961	10.1128/IAI.69.7.4248-4256.2001	0019-9567	Infection and Immunity	S-Fimbria-Encoding Determinant sfa I Is Located on Pathogenicity Island III536 of UropathogenicEscherichia coli Strain 536	Dobrindt	2001	4		
1036	chr20	59214770	59214795	3500120768	25		59214770	59214795	8421504	1	25	0	c	350012076800000016	22-47						RESEARCH ARTICLE Open Access	itis-research.com	0	0		
1036	chr20	59215243	59215287	3500166204	43		59215243	59215287	8421504	2	34,9	0,35	c	350016620400000065	3-46						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
129	chr20	59541407	59707325	3500183613	600		59541407	59707325	8421504	5	21,99,159,188,133	0,56177,132312,152711,165785	p	350018361300015001,350018361300015003	0-300,0-300						Myosin-X associates with regions of dynamic actin	cs.biologists.org	0	0		
1041	chr20	59783375	59822970	3500183613	1713		59783375	59822970	8421504	10	69,82,25,184,36,354,363,36,453,111	0,8420,8503,9355,10637,11692,12049,36525,36984,39484	p	350018361300015015,350018361300015019,350018361300015020,350018361300015022,350018361300015023,350018361300015025,350018361300015041,350018361300015043	0-300,0-60,0-180,0-210,0-81,0-282,0-300,0-300						Myosin-X associates with regions of dynamic actin	cs.biologists.org	0	0		
1041	chr20	59795308	59795334	3500422167	26		59795308	59795334	8421504	1	26	0	c	350042216700000031	6-32					Patent	Osteogenic proteins (Patent US:5266683)	Kuberasampath	1993	0		
1041	chr20	59795308	59795334	3500418018	26		59795308	59795334	8421504	1	26	0	c	350041801800000031	6-32						US Patent # 5,266,683. Osteogenic proteins - Patents.com	www.patents.com	0	0		
1041	chr20	59795308	59795334	3500394874	26		59795308	59795334	8421504	1	26	0	c	350039487400000003	18-44						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2002	0		
1041	chr20	59795308	59795331	3500334789	23		59795308	59795331	8421504	1	23	0	c	350033478900000025	0-23						Recombinant bone morphogenetic protein heterodimers, compositions and methods of use	Israel	1994	0		
1041	chr20	59818603	59824635	3500464037	42		59818603	59824635	8421504	3	11,10,21	0,1212,6011	c,g	350046403700000000,350046403700000001,350046403700000001	0-21,13-34,13-34		20123970	10.1128/MCB.01226-09	0270-7306	Molecular and Cellular Biology	The Motor Protein Myosin-X Transports VE-Cadherin along Filopodia To Allow the Formation of Early Endothelial Cell-Cell Contacts	Almagro	2010	6		
1041	chr20	59818603	59824635	3500387407	42		59818603	59824635	8421504	3	11,10,21	0,1212,6011	c,g	350038740700000000,350038740700000001,350038740700000001	0-21,13-34,13-34		20123970	10.1128/MCB.01226-09		Molecular and Cellular Biology	The Motor Protein Myosin-X Transports VE-Cadherin along Filopodia To Allow the Formation of Early Endothelial Cell-Cell Contacts 	Sebastien	2010	0		
1043	chr20	60078918	60078945	3500004227	23		60078918	60078945	8421504	2	6,17	0,10	g	350000422700000987	8-32						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
1045	chr20	60370949	60370977	3500073739	23		60370949	60370977	8421504	2	13,10	0,18	g	350007373900000245	18-41						ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION - Patent application	www.faqs.org	0	0		
1045	chr20	60415745	60415773	3500014443	23		60415745	60415773	8421504	2	7,16	0,12	g	350001444300000015	1-24						Genes and gene products related to Werner's syndrome - US Patent 6090620 Description	ww.patentstorm.us	0	0		
1050	chr20	60993730	60993758	3500013979	23		60993730	60993758	8421504	2	9,14	0,14	g	350001397900000271,350001397900000272	7-33,12-36					Patent	Interleukin-3 (IL-3) mutant polypeptides and their recombinant production (Patent US:5677149)	Abrams	1997	0		
1053	chr20	61349087	61349110	3500449076	23		61349087	61349110	8421504	1	23	0	g	350044907600000346,350044907600000341,350044907600000408	5-28,5-26,5-26						SUBTILISIN VARIANTS - Patent application	www.faqs.org	0	0		
1056	chr20	61741624	61741648	3500455072	24		61741624	61741648	8421504	1	24	0	c	350045507200000005	0-24						Secreted and transmembrane polypeptides and nucleic acids encoding the same	Ashkenazi	2005	0		MIR4637
1056	chr20	61741624	61741648	3500440364	24		61741624	61741648	8421504	1	24	0	c	350044036400000009	0-24						Secreted and transmembrane polypeptides and nucleic acids encoding the same	Ashkenazi	2001	0		MIR4637
1056	chr20	61741624	61741648	3500379432	24		61741624	61741648	8421504	1	24	0	c	350037943200000007	0-24						PRO792 nucleic acids - US Patent 7189529 Description	ww.patentstorm.us	0	0		MIR4637
1056	chr20	61741624	61741648	3500289472	24		61741624	61741648	8421504	1	24	0	c	350028947200000026	0-24					Patent	Compositions and methods for the diagnosis of tumours (Patent EP:1626084)	Ashkenazi	2009	0		MIR4637
1056	chr20	61741624	61741648	3500286478	24		61741624	61741648	8421504	1	24	0	c	350028647800000028	0-24						Compositions and methods for the treatment of tumour	Ashkenazi	2002	0		MIR4637
1056	chr20	61741624	61741648	3500241022	24		61741624	61741648	8421504	1	24	0	c	350024102200000005	0-24						PRO731 polypeptides	Goddard	2001	0		MIR4637
1056	chr20	61741624	61741648	3500205880	24		61741624	61741648	8421504	1	24	0	c	350020588000000005	0-24						Secreted and transmembrane polypeptides and nucleic acids encoding the same	Baker	2001	0		MIR4637
1056	chr20	61741624	61741648	3500202825	24		61741624	61741648	8421504	1	24	0	c	350020282500000007	0-24						Secreted and transmembrane polypeptides and nucleic acids encoding the same	Ashkenazi	2001	0		MIR4637
1056	chr20	61741624	61741648	3500114329	24		61741624	61741648	8421504	1	24	0	c	350011432900000026	0-24						Compositions and methods for the treatment of tumor	Ashkenazi	2002	0		MIR4637
1057	chr20	61874627	61874651	3500385027	24		61874627	61874651	8421504	1	24	0	c	350038502700000001	0-24		20496369	10.1002/art.27558		Arthritis and rheumatism	HIF Regulation of ANK Expression in Nucleus Pulposus Cells: Possible Implications in Controlling Dystrophic Mineralization in the Intervertebral Disc	Renata	2010	0		ANKH
1058	chr20	62093607	62093632	3500036686	23		62093607	62093632	8421504	2	14,9	0,16	c	350003668600000047	4-30						Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts	Vakharia	1999	0		
1058	chr20	62098775	62107990	3500141481	597		62098775	62107990	8421504	9	51,78,51,93,90,27,40,104,63	0,987,1273,2091,3643,5917,5947,7715,9152	p	350014148100015023,350014148100015013,350014148100015006	0-231,0-159,0-207						A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2	dlab.stanford.edu	0	0		TRIO
1058	chr20	62109928	62117475	3500304335	23		62109928	62117475	8421504	3	12,9,2	0,17,7545	c	350030433500000392	19-43						Diagnosis and Treatment of Cancer Using Anti-EREG Antibody - Patent application	www.faqs.org	0	0		
1060	chr20	62376508	62376531	3500162249	23		62376508	62376531	8421504	1	23	0	g	350016224900000026	10-33						Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence	Koentgen	2003	0		
1065	chr20	63040578	63040605	3500277855	24		63040578	63040605	8421504	2	14,10	0,17	g	350027785500000043	14-39						Group a streptococcal vaccines - Patent # 6716433 - PatentGenius	.patentgenius.com	0	0		
1075	chr20	64335264	64335294	3500162031	26		64335264	64335294	8421504	2	18,8	0,22	g	350016203100000057	8-36						Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5	Gerald	1996	0		
1076	chr20	64398585	64398613	3500393512	24		64398585	64398613	8421504	2	11,13	0,15	g	350039351200000029,350039351200000028	5-37,11-43						Protein c or activated protein c-like molecules	Andersen	2003	0		
1080	chr20	64930196	64930228	3500130848	25		64930196	64930228	8421504	3	7,3,15	0,10,17	g	350013084800000906	4-29						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
1089	chr20	66083770	66083798	3500077080	24		66083770	66083798	8421504	3	5,5,14	0,6,14	c	350007708000000068	13-37						Method of using cells expressing galanin receptor 3 (GALR3) - Patent # 7022489 - PatentGenius	.patentgenius.com	0	0		
136	chr20	66582663	66588566	3500259199	78		66582663	66588566	8421504	2	48,30	0,5873	p	350025919900015007	0-78						Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in Endothelial Progenitor Cells	www.mcponline.org	0	0		CCT5
1100	chr20	67506765	67506795	3500378525	25		67506765	67506795	8421504	2	10,15	0,15	g	350037852500000000	2-27						Anti-bacterial pyruvate kinase modulator compounds, compositions, uses, and methods	Axerio-Cilies	2012	0		
1100	chr20	67506765	67506795	3500356543	25		67506765	67506795	8421504	2	10,15	0,15	g	350035654300000000	2-27		21357306	10.1128/AAC.01250-10		Antimicrobial Agents and Chemotherapy	Identification of Pyruvate Kinase in Methicillin-Resistant Staphylococcus aureus as a Novel Antimicrobial Drug Target	Roya	2011	0		
1100	chr20	67566520	67566547	3500386149	24		67566520	67566547	8421504	2	12,12	0,15	g	350038614900000040	8-33						Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon - US Patent 7105333 Description	ww.patentstorm.us	0	0		
1101	chr20	67706599	67708577	3500366217	46		67706599	67708577	8421504	2	23,23	0,1955	g	350036621700000011,350036621700000010	0-23,0-23			10.1073/pnas.0601015103		Proceedings of the National Academy of Sciences of the United States of America	Evidence that bovine forebrain embryonic zinc finger-like gene influences immune response associated with mastitis resistance	Mayumi	2006	0		
1102	chr20	67894100	67894125	3500165664	24		67894100	67894125	8421504	2	15,9	0,16	g	350016566400000042	0-24						Cysteine-containing peptide tag for site-specific conjugation of proteins - Patent application	www.faqs.org	0	0		
1107	chr20	68467835	68467862	3500037377	24		68467835	68467862	8421504	2	12,12	0,15	g	350003737700000007	0-24						University of Warwick institutional repository: http://go	rap.warwick.ac.uk	0	0		
1113	chr20	69248092	69288261	3500004227	40		69248092	69288261	8421504	3	7,12,21	0,12,40148	g	350000422700000087,350000422700000284	12-31,15-39						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
1116	chr20	69665214	69665242	3500331169	26		69665214	69665242	8421504	2	21,5	0,23	g	350033116900000001	10-39						Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse	oinflammation.com	0	0		
1116	chr20	69674856	69674886	3500070088	25		69674856	69674886	8421504	3	7,4,14	0,8,16	g	350007008800000506	15-40						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
1117	chr20	69819762	69819785	3500197876	23		69819762	69819785	8421504	1	23	0	g	350019787600000012	0-24		21917984	10.1128/JVI.05296-11	0022-538X	Journal of Virology	Human T-Cell Lymphotropic Virus Type 3 (HTLV-3)- and HTLV-4-Derived Antisense Transcripts Encode Proteins with Similar Tax-Inhibiting Functions but Distinct Subcellular Localization	Larocque	2011	5		
1119	chr20	70075605	70075630	3500465421	23		70075605	70075630	8421504	2	14,9	0,16	g	350046542100000021	0-23						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1120	chr20	70137305	70137332	3500345689	24		70137305	70137332	8421504	2	6,18	0,9	g	350034568900000194	0-24						Procaryotic xylose isomerase muteins	Drummond	1987	0		
1120	chr20	70142617	70142644	3500152492	23		70142617	70142644	8421504	2	14,9	0,18	c	350015249200000005	5-28						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
1121	chr20	70347389	70347416	3500386203	25		70347389	70347416	8421504	2	6,19	0,8	g	350038620300000287	22-48						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
1122	chr20	70447416	70447439	3500035992	23		70447416	70447439	8421504	1	23	0	g	350003599200000063	22-45						Fusion Proteins Between Plant Cell-Wall Degrading Enzymes, and Their Uses - Patent application	www.faqs.org	0	0		
1123	chr20	70517069	70517096	3500385149	24		70517069	70517096	8421504	2	15,9	0,18	c	350038514900000034	4-28						Hyaluronate Synthase Gene And Uses Thereof 	.freshpatents.com	0	0		
1123	chr20	70517069	70517096	3500157894	24		70517069	70517096	8421504	2	15,9	0,18	c	350015789400000035	1-25						US Patent # 7,026,159. Hyaluronate synthase gene and uses thereof - Patents.com	www.patents.com	0	0		
1123	chr20	70517069	70517096	3500124005	24		70517069	70517096	8421504	2	15,9	0,18	c	350012400500000035	4-28						US Patent # 6,852,514. Hyaluronate synthase gene and uses thereof - Patents.com	www.patents.com	0	0		
1123	chr20	70517069	70517096	3500100227	24		70517069	70517096	8421504	2	15,9	0,18	c	350010022700000034	4-28						Hyaluronate synthase gene and uses thereof - Patent application	www.faqs.org	0	0		
1123	chr20	70517069	70517096	3500030890	24		70517069	70517096	8421504	2	15,9	0,18	c	350003089000000030	4-28						Hyaluronate Synthase Gene And Uses Thereof 	.freshpatents.com	0	0		
1123	chr20	70517069	70517096	3500028137	24		70517069	70517096	8421504	2	15,9	0,18	c	350002813700000035	4-28						US Patent # 6,855,502. Hyaluronate synthase gene and uses thereof - Patents.com	www.patents.com	0	0		
1132	chr20	71747303	71747331	3500004227	25		71747303	71747331	8421504	3	5,12,8	0,7,20	g	350000422700000464	5-42						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
1146	chr20	73581659	73581684	3500306361	24		73581659	73581684	8421504	2	6,18	0,7	g	350030636100000101	13-37						PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use - Patent application	www.faqs.org	0	0		
1147	chr20	73722770	73722796	3500043083	24		73722770	73722796	8421504	2	12,12	0,14	g	350004308300000028	14-38						Humanized L243 Antibodies - Patent application	www.faqs.org	0	0		
1154	chr20	74599002	74599031	3500086466	25		74599002	74599031	8421504	3	6,6,13	0,8,16	g	350008646600000142	0-25						GENETIC POLYMORPHISMS ASSOCIATED WITH RHEUMATOID ARTHRITIS, METHODS OF DETECTION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1154	chr20	74638177	74638206	3500430504	24		74638177	74638206	8421504	3	6,13,5	0,7,24	g	350043050400000003	0-24						C3G forms complexes with Bcr-Abl and p38a MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion	.biosignaling.com	0	0		
1154	chr20	74647596	74647794	3500265271	198		74647596	74647794	8421504	1	198	0	p	350026527100015004	0-198						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> <!--Converted with LaTeX2HTML 2002-2	www.eead.csic.es	0	0		IRX4
1155	chr20	74726535	74726564	3500335264	23		74726535	74726564	8421504	3	12,6,5	0,16,24	g	350033526400000000	0-24		20631680	10.1038/msb.2010.39	false	Molecular Systems Biology	Proteome-wide identification of mycobacterial pupylation targets	Poulsen	2010	0		
1155	chr20	74819795	74819829	3500070088	26		74819795	74819829	8421504	3	5,15,6	0,8,28	g	350007008800000358	10-37						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
1157	chr20	75004932	75021530	3500374718	72		75004932	75021530	8421504	3	25,25,22	0,167,16576	c	350037471800000058,350037471800000062,350037471800000122	0-25,0-25,5-27						 Human Telomerase Reverse Transcriptase Polypeptides 	www.docstoc.com	0	0		
1157	chr20	75004932	75021530	3500258819	72		75004932	75021530	8421504	3	25,25,22	0,167,16576	c	350025881900000054,350025881900000058,350025881900000118	0-25,0-25,5-27						Increasing the proliferative capacity of cells using telomerase reverse transcriptase - US Patent 7585622 Description	ww.patentstorm.us	0	0		
1157	chr20	75004932	75021530	3500115982	102		75004932	75021530	8421504	4	25,25,30,22	0,167,442,16576	c	350011598200000058,350011598200000062,350011598200000220,350011598200000114	0-25,0-25,11-41,5-27						Human telomerase catalytic subunit: diagnostic and therapeutic methods	Cech	1997	0		
1157	chr20	75004932	75021530	3500115845	72		75004932	75021530	8421504	3	25,25,22	0,167,16576	c	350011584500000058,350011584500000062,350011584500000114	0-25,0-25,5-27						Human telomerase catalytic subunit: diagnostic and therapeutic methods	Cech	2002	0		
1157	chr20	75004932	75021530	3500080782	47		75004932	75021530	8421504	2	25,22	0,16576	c	350008078200000058,350008078200000122	0-25,5-27						Human Telomerase Catalytic Subunit - Patent application	www.faqs.org	0	0		
1157	chr20	75004932	75005124	3500233843	50		75004932	75005124	8421504	2	25,25	0,167	c	350023384300000059,350023384300000063	0-25,0-25						Segments of the Human Gene for Telomerase Reverse Transcriptase	Morin	2007	0		
1157	chr20	75004932	75005124	3500135688	50		75004932	75005124	8421504	2	25,25	0,167	c	350013568800000058,350013568800000062	0-25,0-25					Patent	Human telomerase reverse transcriptase (Patent CA:2267664)	Cech	2013	0		
1157	chr20	75004932	75005124	3500063393	50		75004932	75005124	8421504	2	25,25	0,167	c	350006339300000094,350006339300000098	0-25,0-25						Human telomerase catalytic subunit	Tuo Ma Si *R*Qie He 	2001	0		
1157	chr20	75004932	75004957	3500406260	25		75004932	75004957	8421504	1	25	0	c	350040626000000059	0-25						Human Telomerase Catalytic Subunit	Cech	2009	0		
1157	chr20	75004932	75004957	3500251098	25		75004932	75004957	8421504	1	25	0	c	350025109800000059	0-25					Patent	Kit for detection of telomerase reverse transcriptase nucleic acids (Patent US:8222392)	Cech	2012	0		
1157	chr20	75005099	75021530	3500440051	47		75005099	75021530	8421504	2	25,22	0,16409	c	350044005100000058,350044005100000118	0-25,5-27						 Increasing The Proliferative Capacity Of Cells Using Telomerase Reverse Transcriptase 	www.docstoc.com	0	0		
1157	chr20	75005099	75021530	3500375191	47		75005099	75021530	8421504	2	25,22	0,16409	c	350037519100000062,350037519100000122	0-25,5-27						Vector encoding inactivated telomerase for treating cancer	Cech	2004	0		
1157	chr20	75005099	75005124	3500031496	25		75005099	75005124	8421504	1	25	0	c	350003149600000062	0-25						Kit for detection of telomerase reverse transcriptase nucleic acids - Patent application	www.faqs.org	0	0		
1157	chr20	75005288	75016800	3500327926	150		75005288	75016800	8421504	3	51,48,51	0,1005,11461	p	350032792600015029,350032792600015019,350032792600015009,350032792600015008	0-51,0-48,0-51,0-48						Adult-onset pulmonary fibrosis caused by mutations in telomerase Kalliopi D. Tsakiri, Jennifer T. Cronkhite, Phillip J. Kuan, Chao Xing, Ganesh Raghu, Jonathan C. Weissler, Randall L. Rosenblatt, Jerry W. Shay, and Christine Kim Garcia PNAS 2007;104;7552-	www.im.org/Academ	0	0		TERT
1157	chr20	75005870	75005936	3500092953	39		75005870	75005936	8421504	2	20,19	0,47	c,g	350009295300000008,350009295300000008,350009295300000009,350009295300000009	0-20,0-20,5-24,5-24						Fibroblast growth factor receptor 3 effects on proliferation and telomerase activity in sheep growth plate chondrocytes	www.jasbsci.com	0	0		
1157	chr20	75014281	75014306	3500050930	24		75014281	75014306	8421504	2	9,15	0,10	g	350005093000000026	6-30						The Cell Cycle Checkpoint Gene Rad9 Is a Novel Oncogene Activated by 11q13 Amplification and DNA Methylation in Breast Cancer	.aacrjournals.org	0	0		
1157	chr20	75014636	75015063	3500253781	25		75014636	75015063	8421504	2	11,14	0,413	c	350025378100000015	0-25						SENP1 as a marker for cancer	Holcomb	2006	0		
1157	chr20	75014636	75015063	3500245710	25		75014636	75015063	8421504	2	11,14	0,413	c	350024571000000015	0-25						SENP1 as a marker for cancer	Holcomb	2009	0		
1157	chr20	75014636	75015063	3500084167	25		75014636	75015063	8421504	2	11,14	0,413	c	350008416700000015	0-25						SENP1 as a marker for cancer	Holcomb	2008	0		
1157	chr20	75021508	75021532	3500436092	24		75021508	75021532	8421504	1	24	0	c	350043609200000010	0-24						BMP antibodies and methods of treating kidney disease using the same - Patent # 8025881 - PatentGenius	.patentgenius.com	0	0		
1157	chr20	75021508	75021532	3500168943	24		75021508	75021532	8421504	1	24	0	c	350016894300000003	12-36		16507993	10.1128/MCB.26.6.2146-2159.2006	0270-7306	Molecular and Cellular Biology	Regulation of Cellular Immortalization and Steady-State Levels of the Telomerase Reverse Transcriptase through Its Carboxy-Terminal Domain	Middleman	2006	6		
1157	chr20	75048130	75048372	3500175102	70		75048130	75048372	8421504	2	20,50	0,192	g	350017510200000006,350017510200000014	0-20,0-50						EXPRESSION OF PORCINE INTESTINAL NUTRIENT TRANSPORTERS ALONG CRYPT-VILLUS AXIS AND DURING POSTNATAL DEVELOPMENT	e.lib.uoguelph.ca	0	0		
1159	chr20	75269214	75269241	3500430989	24		75269214	75269241	8421504	2	11,13	0,14	g	350043098900000428	0-24						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
1159	chr20	75269214	75269241	3500070288	24		75269214	75269241	8421504	2	11,13	0,14	g	350007028800000432	0-24						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
1159	chr20	75304804	75304831	3500386802	24		75304804	75304831	8421504	2	16,8	0,19	g	350038680200000072	14-38					Patent	Recombinant antibodies specific for a growth factor receptor (Patent US:5571894)	Groner	1996	0		
1160	chr20	75389379	75389404	3500348064	24		75389379	75389404	8421504	2	5,19	0,6	g	350034806400000001	0-25						Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein	Corbeau	1997	0		
1160	chr20	75389379	75389404	3500345584	24		75389379	75389404	8421504	2	5,19	0,6	g	350034558400000001	0-25						Design of novel highly efficient HIV based packaging systems for gene therapy	Corbeau	1998	0		
1160	chr20	75389379	75389404	3500143590	24		75389379	75389404	8421504	2	5,19	0,6	g	350014359000000000	21-46						Design of novel highly efficient hiv based packaging systems for gene therapy	Corbeau	1999	0		
1160	chr20	75398143	75403463	3500233111	252		75398143	75403463	8421504	3	84,60,108	0,90,5212	p	350023311100015042,350023311100015043,350023311100015058,350023311100015022,350023311100015059,350023311100015060,350023311100015057	0-84,0-60,0-108,0-84,0-60,0-60,0-60						A rendezetlen TPPP/p25 szerkezeti sokf&#xe9;les&#xe9;ge &#xe9;s funkci&#xf3;i	teo.elte.hu	0	0		TPPP
1160	chr20	75403147	75403282	3500291921	23		75403147	75403282	8421504	2	14,9	0,126	c	350029192100000148	10-33						DOWN-REGULATION OF MORTALIN BY siRNA - Patent application	www.faqs.org	0	0		
1160	chr20	75411304	75411329	3500311161	23		75411304	75411329	8421504	2	18,5	0,20	g	350031116100000008,350031116100000138	1-27,1-27						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
1160	chr20	75411304	75411329	3500256323	23		75411304	75411329	8421504	2	18,5	0,20	g	350025632300000008	1-27						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - US Patent 5627061 Description	ww.patentstorm.us	0	0		
1160	chr20	75411304	75411329	3500210376	23		75411304	75411329	8421504	2	18,5	0,20	g	350021037600000008	1-27						US Patent # 6,248,876. Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patents.com	www.patents.com	0	0		
1161	chr20	75512436	75512464	3500213695	24		75512436	75512464	8421504	3	8,11,5	0,9,23	g	350021369500000019	0-27		11274040		0009-9147	Clinical Chemistry	ARMS&#x2122; Allele-specific Amplification-based Detection of Mutant p53 DNA and mRNA in Tumors of the Breast,	Hodgson	2001	8		
1161	chr20	75548618	75560309	3500445952	59		75548618	75560309	8421504	5	20,11,9,15,4	0,8853,9295,11002,11687	c	350044595200000007,350044595200000012,350044595200000001	0-20,4-24,0-19		10446932		1046-6673	Journal of the American Society of Nephrology	Molecular Cloning of NHE3 from LLC-PK1 Cells and Localization in Pig Kidney	SHUGRUE	1999	10		
1161	chr20	75553488	75555419	3500353232	40		75553488	75555419	8421504	2	20,20	0,1911	c,g	350035323200000000,350035323200000000,350035323200000001	0-20,0-20,0-20		12176733	10.1152/ajpcell.00029.2002		American Journal of Physiology - Cell Physiology	Endogenous and exogenous glucocorticoid regulation of ENaC mRNA expression in developing kidney and lung	Nakamura	2002	0		
1161	chr20	75553488	75555419	3500138169	40		75553488	75555419	8421504	2	20,20	0,1911	c	350013816900000000,350013816900000001	0-20,0-20						Endogenous and exogenous glucocorticoid regulation of ENaC mRNA expression in developing kidney and lung	ll.physiology.org	0	0		
1161	chr20	75553576	75557416	3500239762	44		75553576	75557416	8421504	3	16,8,20	0,997,3820	c	350023976200000002,350023976200000003	0-24,0-20		15140751	10.1152/ajpcell.00552.2003		American Journal of Physiology - Cell Physiolog	Inhibition of NHE-1 Na+/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium	Fidzinski	2004	0		
1161	chr20	75553576	75557416	3500206296	44		75553576	75557416	8421504	3	16,8,20	0,997,3820	c,g	350020629600000002,350020629600000003,350020629600000003	0-24,0-20,0-20		15140751	10.1152/ajpcell.00552.2003		American Journal of Physiology - Cell Physiology	Inhibition of NHE-1 Na+/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium	Fidzinski	2004	0		
1161	chr20	75553576	75555286	3500237214	119		75553576	75555286	8421504	5	16,8,29,28,38	0,997,1031,1111,1672	c,g	350023721400000008,350023721400000015,350023721400000017,350023721400000017,350023721400000020,350023721400000009,350023721400000009	0-24,0-29,0-28,0-28,0-29,0-25,0-25						Aus dem Veterin&#xe4;r-Physiologischen Institut der Veterin&#xe4;rmedizinischen Fakult&#xe4;t der Universit&#xe4;t Leipzig	www.qucosa.de	0	0		
1161	chr20	75555462	75556256	3500120918	50		75555462	75556256	8421504	2	2,48	0,746	c,g	350012091800000002,350012091800000003	6-56,28-76		21245831	10.1038/emboj.2010.356		The EMBO Journal	Membrane surface charge dictates the structure and function of the epithelial Na+/H+ exchanger	Robert	2011	0		
1161	chr20	75556314	75556338	3500050851	24		75556314	75556338	8421504	1	24	0	c	350005085100000001	0-24			10.1152/ajpgi.00128.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-&#x03b3;/TNF-&#x03b1;	Amin	2007	0		SLC9A3
1162	chr20	75642144	75642169	3500066984	23		75642144	75642169	8421504	2	17,6	0,19	c	350006698400000122	6-29						Proteases - Patent application	www.faqs.org	0	0		
1162	chr20	75642144	75642169	3500041857	23		75642144	75642169	8421504	2	17,6	0,19	c	350004185700000122	6-29						Proteases - Patent application	www.faqs.org	0	0		
586	chr21	220336	228611	3500425018	44		220336	228611	8421504	2	20,24	0,8251	c	350042501800000001,350042501800000009	15-35,15-39		9891052		0270-7306	Molecular and Cellular Biology	The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily	Nawaz	1999	6		
73	chr21	220338	301624	3500058326	443		220338	301624	8421504	12	24,48,40,7,48,48,17,31,48,48,48,36	0,33,1211,8008,8016,10551,10695,72264,80317,80413,80557,81250	c	350005832600000258,350005832600000203,350005832600000199,350005832600000198,350005832600000189,350005832600000186,350005832600000182,350005832600000180,350005832600000177,350005832600000162	12-36,0-48,1-48,0-48,0-48,0-48,0-48,0-48,0-48,12-48						Ubiquitin conjugating enzymes	Rolfe	1996	0		
73	chr21	220371	308695	3500143808	367		220371	308695	8421504	10	48,18,30,17,31,48,43,48,36,48	0,8031,8144,10662,72231,72310,80833,80881,81217,88276	c	350014380800000058,350014380800000052,350014380800000041,350014380800000039,350014380800000025,350014380800000024,350014380800000017,350014380800000009	0-48,0-48,0-48,0-48,5-48,0-48,80-116,0-48						E6AP antisense constructs and methods of use	Beer-romero	1995	0		
586	chr21	220371	220419	3500403930	48		220371	220419	8421504	1	48	0	c	350040393000000079	0-48						Human ubiquitin conjugating enzyme	Draetta	1994	0		
586	chr21	220432	221447	3500047505	29		220432	221447	8421504	2	27,2	0,1013	c	350004750500000003,350004750500000000	0-27,0-28		23424281	10.1371/journal.pbio.1001478		PLoS Biology	Impairment of TrkB-PSD-95 Signaling in Angelman Syndrome	Cong	2013	0		UBE3A
587	chr21	301333	301357	3500399156	24		301333	301357	8421504	1	24	0	c	350039915600000009	24-48						Senescence is accelerated through donor cell specificity in cloned pigs	-publications.com	0	0		UBE3A
590	chr21	697894	727426	3500062329	41		697894	727426	8421504	3	21,11,9	0,29511,29523	g	350006232900000306,350006232900001026,350006232900000515,350006232900000854,350006232900000122,350006232900000670	0-23,15-38,15-38,0-23,0-20,0-20						ISOLATION OF UNKNOWN REARRANGED T-CELL RECEPTORS FROM SINGLE CELLS - Patent application	www.faqs.org	0	0		
603	chr21	2377550	2377576	3500003368	24		2377550	2377576	8421504	3	11,8,5	0,12,21	g	350000336800000020	0-26						Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same	Sugioka	2009	0		
608	chr21	3140533	3140557	3500456601	23		3140533	3140557	8421504	2	9,14	0,10	g	350045660100000201	4-27						US Patent # 6,455,253. Methods and compositions for polypeptide engineering - Patents.com	www.patents.com	0	0		
615	chr21	3936166	3936189	3500131497	23		3936166	3936189	8421504	1	23	0	c	350013149700000005	20-43						SIGNALING FROM MATRIX ELASTICITY AND TGF- 1 TO CELLS OF THE CARDIAC VALVE	gradworks.umi.com	0	0		
615	chr21	4007952	4007981	3500316863	29		4007952	4007981	8421504	1	29	0	c	350031686300000005	0-29						Chondroitin sulfate synthesis promoter - Patent application	www.faqs.org	0	0		
615	chr21	4038024	4038053	3500180995	24		4038024	4038053	8421504	2	10,14	0,15	g	350018099500000011	15-39		12354931	10.1136/mp.55.5.294	1472-4154	Molecular Pathology	Further evidence to support the melanocytic origin of MDA-MB-435	Ellison	2002	0		
616	chr21	4172303	4172329	3500241434	23		4172303	4172329	8421504	2	17,6	0,20	g	350024143400000653	0-23						GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME	Schellenberger	2010	0		
620	chr21	4645889	4645915	3500324238	23		4645889	4645915	8421504	2	14,9	0,17	g	350032423800000002	9-32					Journal of Virology	SPI-1-Dependent Host Range of Rabbitpox Virus and Complex Formation with Cathepsin G Is Associated with Serpin Motifs	Kristin	1999	0		
620	chr21	4678247	4678271	3500435248	24		4678247	4678271	8421504	1	24	0	g	350043524800000066	2-26						Identification Of Oligonucleotides For The Capture, Detection And Quantitation Of West Nile Virus 	.freshpatents.com	0	0		SMAD6
621	chr21	4725254	4725279	3500190760	24		4725254	4725279	8421504	2	8,16	0,9	g	350019076000000046	0-24						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
621	chr21	4765500	4765528	3500070768	24		4765500	4765528	8421504	3	8,12,4	0,11,24	c	350007076800000048	4-28			10.1046/j.1365-2958.2003.03621.x	1365-2958	Molecular Microbiology	Characterization of the roles of NikR, a nickel-responsive pleiotropic autoregulator of Helicobacter pylori - Contreras - 2003 - Molecular Microbiology - Wiley Online Library	Contreras	2003	0		
621	chr21	4769370	4769396	3500455612	24		4769370	4769396	8421504	2	17,7	0,19	c	350045561200000034	9-33						Cardiac hypertrophy is a complex organ response of the heart to several biological stresses induced by many primary cardiovascu	e.ahajournals.org	0	0		
621	chr21	4769370	4769396	3500173677	24		4769370	4769396	8421504	2	17,7	0,19	c	350017367700000034	9-33						Cardiac hypertrophy is a complex organ response of the heart to several biological stresses induced by many primary cardiovascu	e.ahajournals.org	0	0		
622	chr21	4956614	4956639	3500379868	23		4956614	4956639	8421504	3	11,4,8	0,12,17	c	350037986800000054	10-33						Sparc Promoter Mutations Associated with Drug Resistance, and Methods, Oligonucleotides, Cells and Arrays Associated Therewith - Patent application	www.faqs.org	0	0		
625	chr21	5263737	5263767	3500025494	26		5263737	5263767	8421504	2	11,15	0,15	g	350002549400000040	7-33						ERBB3 Mutations In Cancer - Patent application	www.faqs.org	0	0		
626	chr21	5467009	5467036	3500440489	23		5467009	5467036	8421504	2	13,10	0,17	g	350044048900000176	6-38						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
627	chr21	5557042	5557066	3500344185	23		5557042	5557066	8421504	2	15,8	0,16	g	350034418500000139	25-48						Collagen Producing Plants And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
627	chr21	5610184	5610211	3500309840	24		5610184	5610211	8421504	2	19,5	0,22	c	350030984000000706	14-38						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
627	chr21	5610184	5610211	3500119454	24		5610184	5610211	8421504	2	19,5	0,22	c	350011945400000709	14-38						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
627	chr21	5610184	5610211	3500004227	24		5610184	5610211	8421504	2	19,5	0,22	c	350000422700000709	14-38						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
78	chr21	5611052	5691999	3500222740	1443		5611052	5691999	8421504	15	78,277,59,65,112,141,44,60,73,144,36,99,75,126,54	0,81,1602,1664,5528,23278,23422,37217,38028,38104,40361,40400,61599,61677,80893	p	350022274000015037	0-1497						Presentazione di PowerPoint	thon.bio.unipd.it	0	0		
78	chr21	5611052	5691999	3500034461	1443		5611052	5691999	8421504	15	78,277,59,65,112,141,44,60,73,144,36,99,75,126,54	0,81,1602,1664,5528,23278,23422,37217,38028,38104,40361,40400,61599,61677,80893	p	350003446100015041	0-1497						PATTERN DISCOVERY IN SEQUENZE PROMOTORIALI PER LA RICERCA DI NUOVI ELEMENTI FUNZIONALI	thon.bio.unipd.it	0	0		
627	chr21	5611265	5611295	3500254166	27		5611265	5611295	8421504	2	12,15	0,15	c	350025416600000049	3-30						Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family - Patent application	www.faqs.org	0	0		
78	chr21	5620460	5651615	3500054963	93		5620460	5651615	8421504	3	19,48,26	0,13918,31129	p,g	350005496300000026,350005496300015034,350005496300000003	4-23,0-48,0-26						Pathogenic Gene For Coronary Artery Disease 	.freshpatents.com	0	0		
628	chr21	5651636	5691990	3500109438	42		5651636	5691990	8421504	2	21,21	0,40333	c,g	350010943800000001,350010943800000000	0-21,0-21						Vasopressin-dependent myogenic cell differentiation is mediated by both Ca /calmodulin-dependent kinase and calcineurin pathways	w.molbiolcell.org	0	0		MEF2A
631	chr21	6093840	6093866	3500160446	23		6093840	6093866	8421504	2	5,18	0,8	g	350016044600000132	2-26						COMPOSITIONS THAT BIND MULTIPLE EPITOPES OF IGF-1R	Glaser	2008	0		
634	chr21	6435269	6435296	3500395935	25		6435269	6435296	8421504	2	14,11	0,16	g	350039593500000009	0-25						Viral vector	Limited	2005	0		
635	chr21	6571006	6623939	3500162293	65		6571006	6623939	8421504	2	29,36	0,52897	c	350016229300000337	0-65						BISPECIFIC SINGLE CHAIN ANTIBODIES WITH SPECIFICITY FOR HIGH MOLECULAR WEIGHT TARGET ANTIGENS - Patent application	www.faqs.org	0	0		IGF1R
635	chr21	6591785	6591813	3500132721	23		6591785	6591813	8421504	2	17,6	0,22	g	350013272100000095	22-48						 Hepadnavirus Receptor 	www.docstoc.com	0	0		
635	chr21	6623917	6624169	3500433386	180		6623917	6624169	8421504	3	45,90,45	0,51,207	p	350043338600015024,350043338600015021,350043338600015023,350043338600015016	0-45,0-45,0-45,0-45						MOLECULES AND METHODS FOR TREATMENT AND DETECTION OF CANCER - UNIVERSITY OF WASHINGTON	www.sumobrain.com	0	0		IGF1R
635	chr21	6623917	6624169	3500396694	180		6623917	6624169	8421504	3	45,90,45	0,51,207	p	350039669400015041,350039669400015035,350039669400015037,350039669400015027	0-45,0-45,0-45,0-45						MOLECULES AND METHODS FOR TREATMENT AND DETECTION OF CANCER - Patent application	www.faqs.org	0	0		IGF1R
635	chr21	6623918	6624159	3500427957	44		6623918	6624159	8421504	2	21,23	0,218	c	350042795700000004,350042795700000005	0-21,0-23						ScienceDirect.com - FEBS Letters - Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway	sciencedirect.com	0	0		IGF1R
635	chr21	6624088	6624178	3500022916	90		6624088	6624178	8421504	1	90	0	c	350002291600000011,350002291600000012	0-45,0-45						Inducing resistance to tumor growth with soluble IGF-1 receptor	Baserga	1996	0		
635	chr21	6624088	6624133	3500432124	45		6624088	6624133	8421504	1	45	0	c	350043212400000026	0-45						US Patent # 6,340,674. Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides - Patents.com	www.patents.com	0	0		
635	chr21	6624115	6624160	3500315971	45		6624115	6624160	8421504	1	45	0	c	350031597100000039,350031597100000038	0-45,0-45						REPRODUCTION	uction-online.org	0	0		IGF1R
79	chr21	6811847	6856609	3500022916	422		6811847	6856609	8421504	16	44,1,45,58,32,7,38,32,1,44,3,42,26,4,28,17	0,4014,15766,15856,17810,22476,22613,26394,26439,27703,27837,28319,32513,33036,41733,44745	c	350002291600000025,350002291600000034,350002291600000036,350002291600000037,350002291600000049,350002291600000059,350002291600000060,350002291600000063,350002291600000068,350002291600000081	0-45,0-45,0-45,0-45,0-45,0-32,0-45,0-45,15-45,0-45						Inducing resistance to tumor growth with soluble IGF-1 receptor	Baserga	1996	0		
637	chr21	6829751	6831343	3500071105	42		6829751	6831343	8421504	2	23,19	0,1573	c,g	350007110500000000,350007110500000001,350007110500000001	0-23,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
637	chr21	6831435	6834241	3500152152	40		6831435	6834241	8421504	2	20,20	0,2786	c,g	350015215200000002,350015215200000002,350015215200000003	0-20,0-20,0-20						Functional effect of mir-27b on myostatin expression: a relationship in piedmontese cattle with double-muscled phenotype	biomedcentral.com	0	0		
637	chr21	6838270	6839638	3500299869	43		6838270	6839638	8421504	3	17,4,22	0,1280,1346	c	350029986900000002,350029986900000003	0-21,0-22						REPRODUCTION	uction-online.org	0	0		
637	chr21	6839582	6853541	3500394704	85		6839582	6853541	8421504	4	20,21,23,21	0,10065,13880,13938	c,g	350039470400000013,350039470400000000,350039470400000002,350039470400000001,350039470400000001	0-20,0-21,0-23,0-21,0-21						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
637	chr21	6839582	6853541	3500292483	85		6839582	6853541	8421504	4	20,21,23,21	0,10065,13880,13938	c,g	350029248300000013,350029248300000000,350029248300000002,350029248300000001	0-20,0-21,0-23,0-21						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
637	chr21	6839612	6844362	3500141821	41		6839612	6844362	8421504	2	21,20	0,4730	c,g	350014182100000006,350014182100000006,350014182100000007,350014182100000007	0-21,0-21,0-20,0-20						The mRNA expression of the members of the IGF-system in bovine corpus luteum during induced luteolysis	quantification.de	0	0		
637	chr21	6839612	6844362	3500036931	41		6839612	6844362	8421504	2	21,20	0,4730	c	350003693100000010,350003693100000011	0-21,0-20						Maturation medium supplements affect transcript level of apoptosis and cell survival related genes in bovine blastocysts produced in vitro	www.ufpel.edu.br	0	0		
637	chr21	6839612	6844362	3500016815	41		6839612	6844362	8421504	2	21,20	0,4730	c	350001681500000012,350001681500000013	0-21,0-20						Standardization strategy for quantitative PCR in human seminoma and normal testis	quantification.de	0	0		
637	chr21	6839628	6840288	3500211107	44		6839628	6840288	8421504	2	23,21	0,639	c	350021110700000004,350021110700000001	0-23,0-21		14704286		0022-3166	The Journal of Nutrition	An Energy-Rich Diet Causes Rumen Papillae Proliferation Associated with More IGF Type 1 Receptors and Increased Plasma IGF-1 Concentrations in Young Goats	Shen	2004	4		
637	chr21	6839636	6840252	3500294489	616		6839636	6840252	8421504	1	616	0	c,g	350029448900000014,350029448900000013,350029448900000017,350029448900000016,350029448900000019,350029448900000021,350029448900000022,350029448900000023,350029448900000024,350029448900000026,350029448900000028,350029448900000029,350029448900000031,350029448900000030,350029448900000032,350029448900000032,350029448900000001	0-52,0-616,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,22-42						Genetic Characterization of Insulin Growth Factor-1 and Its Receptor Genes in Egyptian Buffalo (Bubalus bubalis	sciencedomain.org	0	0		
637	chr21	6839636	6840252	3500078097	616		6839636	6840252	8421504	1	616	0	c,g	350007809700000014,350007809700000013,350007809700000016,350007809700000017,350007809700000019,350007809700000021,350007809700000023,350007809700000022,350007809700000024,350007809700000026,350007809700000029,350007809700000028,350007809700000030,350007809700000031,350007809700000032,350007809700000032,350007809700000001	0-52,0-616,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,22-42						Genetic Characterization of Insulin Growth Factor-1 and Its Receptor Genes in Egyptian Buffalo (Bubalus bubalis	sciencedomain.org	0	0		
637	chr21	6839684	6862051	3500432124	97		6839684	6862051	8421504	4	3,42,29,23	0,482,9424,22344	c,g	350043212400000078,350043212400000086,350043212400000099	0-45,0-29,22-45						US Patent # 6,340,674. Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides - Patents.com	www.patents.com	0	0		
637	chr21	6839886	6840217	3500142374	41		6839886	6840217	8421504	2	20,21	0,310	c,g	350014237400000000,350014237400000001,350014237400000001	0-20,0-21,0-21			10.1590/S0102-09352005000600011	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Association between IGF-IR gene polymorphisms and productive and reproductive traits in Holstein cows	Schoenau	2005	0		
637	chr21	6839886	6840217	3500028410	41		6839886	6840217	8421504	2	20,21	0,310	c,g	350002841000000000,350002841000000001,350002841000000001	0-20,0-21,0-21						<HTML> <HEAD> <TITLE>Full Text - Isolation of high quality DNA: a protocol combining &ldquo;rennet	jbiotechnology.cl	0	0		
637	chr21	6840295	6844353	3500315971	44		6840295	6844353	8421504	2	22,22	0,4036	c,g	350031597100000002,350031597100000002,350031597100000003,350031597100000003	0-22,0-22,0-22,0-22						REPRODUCTION	uction-online.org	0	0		
637	chr21	6840295	6844353	3500248474	44		6840295	6844353	8421504	2	22,22	0,4036	c,g	350024847400000018,350024847400000018,350024847400000019,350024847400000019	0-22,0-22,0-22,0-22						REPRODUCTION	uction-online.org	0	0		
637	chr21	6840295	6844353	3500124900	44		6840295	6844353	8421504	2	22,22	0,4036	c,g	350012490000000013,350012490000000013,350012490000000014	0-22,0-22,0-22						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
637	chr21	6840295	6844353	3500024081	44		6840295	6844353	8421504	2	22,22	0,4036	c,g	350002408100000002,350002408100000002,350002408100000003,350002408100000003	0-22,0-22,0-22,0-22						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
637	chr21	6853529	6853592	3500071841	63		6853529	6853592	8421504	1	63	0	p	350007184100015013,350007184100015010	0-63,3-63						UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CI&#xca;NCIAS B&#xc1;SICAS DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS BIOL&#xd3;GICAS: FISIOLOGIA	www.lume.ufrgs.br	0	0		IGF1R
637	chr21	6856600	6856654	3500087671	54		6856600	6856654	8421504	1	54	0	p	350008767100015001	0-54		15169905	10.1128/MCB.24.12.5434-5446.2004	0270-7306	Molecular and Cellular Biology	Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms	Ueki	2004	6		IGF1R
637	chr21	6856618	6856699	3500447238	78		6856618	6856699	8421504	2	48,30	0,51	p	350044723800015024	18-96						Structure characterization	www.pnas.org	0	0		
637	chr21	6870696	6870726	3500154959	30		6870696	6870726	8421504	1	30	0	c	350015495900000076,350015495900000075	0-30,0-30						Supplementary Materials for	ke.sciencemag.org	0	0		
637	chr21	6870785	6870809	3500016670	24		6870785	6870809	8421504	1	24	0	c,g	350001667000000011,350001667000000011	0-24,0-24						Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos | daniel rappolee - Academia.edu	www.academia.edu	0	0		IGF1R
647	chr21	8129754	8129783	3500391841	24		8129754	8129783	8421504	2	12,12	0,17	g	350039184100000066,350039184100000067	4-29,0-25						FEMS MICROBIOLOGY LETTERS	005.pasteur.ac.ir	0	0		
652	chr21	8893878	8893904	3500150172	24		8893878	8893904	8421504	2	17,7	0,19	g	350015017200000007	0-24						UNIVERSIDADE FEDERAL DE MINAS GERAIS	cadigital.ufmg.br	0	0		
654	chr21	9170633	9170659	3500003087	23		9170633	9170659	8421504	3	13,5,5	0,14,21	g	350000308700000038	3-26						Chimeric mammalian NPY Y5 receptors	Parker	1998	0		
657	chr21	9512391	9512416	3500275142	25		9512391	9512416	8421504	1	25	0	c	350027514200000001	7-32		15289311	10.1158/0008-5472.CAN-03-1185	0008-5472	Cancer Research	Expression of Chicken Ovalbumin Upstream Promoter-Transcription Factor II Enhances Invasiveness of Human Lung Carcinoma Cells	Navab	2004	8		
657	chr21	9512421	9517732	3500185455	864		9512421	9517732	8421504	5	245,76,144,201,198	0,2967,3046,3199,5113	p	350018545500015096,350018545500015114,350018545500015075,350018545500015058,350018545500015038,350018545500015014	0-174,6-171,6-153,6-114,6-258,6-204						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers_ Sources	www.docstoc.com	0	0		NR2F2
657	chr21	9512421	9515821	3500356489	675		9512421	9515821	8421504	3	245,76,354	0,2967,3046	p	350035648900015082,350035648900015062	0-321,0-354					Patent	Polynucleotide encoding insect ecdysone receptor (Patent US:6245531)	Hogness	2001	0		NR2F2
657	chr21	9515791	9517966	3500139523	252		9515791	9517966	8421504	3	63,126,63	0,1968,2112	p	350013952300015004,350013952300015002,350013952300015005,350013952300015001	0-63,0-63,0-63,9-72						Spatiotemporal upstream	www.pnas.org	0	0		NR2F2
657	chr21	9517539	9517645	3500358653	41		9517539	9517645	8421504	2	21,20	0,86	c,g	350035865300000013,350035865300000013,350035865300000012,350035865300000012	0-21,0-21,0-20,0-20		22615892	10.1371/journal.pone.0037064	1932-6203	PLOS ONE	PLOS ONE: Proposed Role for COUP-TFII in Regulating Fetal Leydig Cell Steroidogenesis, Perturbation of Which Leads to Masculinization Disorders in Rodents	Driesche	2012	4		NR2F2
659	chr21	9755944	9761357	3500395930	40		9755944	9761357	8421504	4	14,7,7,12	0,18,5391,5401	g	350039593000000189,350039593000000149	6-27,16-35						Recombinant infectious laryngotracheitis virus and uses thereof	Cochran	1995	0		
659	chr21	9779495	9779527	3500190760	26		9779495	9779527	8421504	3	9,11,6	0,10,26	g	350019076000000647	3-31						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
659	chr21	9797349	9797376	3500151825	25		9797349	9797376	8421504	3	8,4,13	0,9,14	g	350015182500000084	4-36						 Amylase Variants 	www.docstoc.com	0	0		
662	chr21	10191121	10191145	3500281438	23		10191121	10191145	8421504	2	6,17	0,7	g	350028143800000002,350028143800000032	8-31,8-31						Human G-protein chemokine receptor (CCR5) HDGNR10 - Patent # 7160546 - PatentGenius	.patentgenius.com	0	0		
662	chr21	10191121	10191145	3500004941	23		10191121	10191145	8421504	2	6,17	0,7	g	350000494100000002	8-31						Human G-protein Chemokine receptor (CCR5) HDGNR10	Rosen	2001	0		
667	chr21	10819869	10819892	3500080694	23		10819869	10819892	8421504	1	23	0	g	350008069400000156	19-45						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
667	chr21	10835483	10835509	3500383486	23		10835483	10835509	8421504	2	8,15	0,11	g	350038348600000357,350038348600000460	25-48,5-25						 NYVAC Vaccinia Virus Recombinants Comprising Heterologous Inserts 	www.docstoc.com	0	0		
667	chr21	10835483	10835509	3500247365	23		10835483	10835509	8421504	2	8,15	0,11	g	350024736500000022	18-41						Vaccination contre le virus de l'immunodeficience feline	Fischer	2004	0		
669	chr21	11013840	11013867	3500003080	24		11013840	11013867	8421504	3	6,6,12	0,7,15	g	350000308000000053	9-34						US Patent # 7,285,400. High bone mass gene of 11q13.3 - Patents.com	www.patents.com	0	0		
672	chr21	11463434	11463459	3500136386	23		11463434	11463459	8421504	2	13,10	0,15	g	350013638600000019	3-30						Phenylalanine Hydroxylase from Legionella pneumophilaIs a Thermostable Enzyme with a Major Functional Role in Pyomelanin Synthesis	pkuworld.org	0	0		
84	chr21	12053609	12082093	3500327539	42		12053609	12082093	8421504	4	12,10,6,14	0,15,28459,28470	g	350032753900000119,350032753900000314	0-22,16-36						Albumin-Fused Kunitz Domain Peptides - Patent application	www.faqs.org	0	0		
680	chr21	12459920	12459947	3500383088	23		12459920	12459947	8421504	2	9,14	0,13	g	350038308800000146	15-38						METHODS AND COMPOSITIONS FOR TREATING TUMOR DISEASES - Patent application	www.faqs.org	0	0		
684	chr21	13054281	13064867	3500435354	38		13054281	13064867	8421504	4	7,12,6,13	0,8,10563,10573	g	350043535400000028,350043535400000024	3-22,26-45						Novel Wheat Allergens - Patent application	www.faqs.org	0	0		
686	chr21	13258653	13258901	3500373947	49		13258653	13258901	8421504	2	24,25	0,223	g	350037394700000117,350037394700000116	0-24,0-25						Udder Health Characteristics	Lund	2007	0		
686	chr21	13258876	13258901	3500024826	25		13258876	13258901	8421504	1	25	0	g	350002482600000125	0-25						Udder Health Characteristics 	.freshpatents.com	0	0		
687	chr21	13419684	13419711	3500110705	27		13419684	13419711	8421504	1	27	0	g	350011070500000122	18-45						DIAGNOSTIC MARKER FOR ALLERGY - Patent application	www.faqs.org	0	0		
687	chr21	13487547	13487574	3500021388	24		13487547	13487574	8421504	2	9,15	0,12	g	350002138800000014	0-24						Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1 -induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes	www.pnas.org	0	0		
687	chr21	13490467	13490490	3500110705	23		13490467	13490490	8421504	1	23	0	g	350011070500000027	0-23						DIAGNOSTIC MARKER FOR ALLERGY - Patent application	www.faqs.org	0	0		
689	chr21	13747374	13747398	3500356923	23		13747374	13747398	8421504	2	8,15	0,9	g	350035692300000003	10-33						from Latex of Rubber Tree ( Hevea brasiliensis	kb.psu.ac.th	0	0		
693	chr21	14156651	14156682	3500403140	25		14156651	14156682	8421504	3	7,13,5	0,12,26	g	350040314000000013	0-29		11035748	10.1128/IAI.68.11.6378-6383.2000	0019-9567	Infection and Immunity	Characterization of the Catalytic Domain ofClostridium novyi Alpha-Toxin	Busch	2000	4		
86	chr21	14262838	14343060	3500139688	322		14262838	14343060	8421504	10	48,48,10,25,48,26,22,47,1,47	0,192,253,12865,29703,31230,39360,39478,65938,80175	c	350013968800000163,350013968800000159,350013968800000158,350013968800000151,350013968800000146,350013968800000143,350013968800000136	0-48,0-48,0-35,0-48,0-48,0-48,0-47						TRANSPORTER GENES OATP-B, C, D, AND E - Patent application	www.faqs.org	0	0		
694	chr21	14292328	14292353	3500130848	23		14292328	14292353	8421504	2	15,8	0,17	g	350013084800000552	16-40						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
694	chr21	14328950	14328974	3500430575	24		14328950	14328974	8421504	1	24	0	c	350043057500000011	0-24						Transporter genes OATP-B, C, D, and E	Nezu	2006	0		SLCO3A1
694	chr21	14328950	14328974	3500024353	24		14328950	14328974	8421504	1	24	0	c,g	350002435300000011,350002435300000011	0-24,0-24						Transporter genes oatp-b, c, d, and e	Nezu	2010	0		SLCO3A1
697	chr21	14720653	14720681	3500278114	23		14720653	14720681	8421504	2	13,10	0,18	g	350027811400000113	21-44					Patent	Hog cholera virus vaccine and diagnostic (Patent US:5811103)	Meyers	1998	0		
697	chr21	14737291	14737319	3500360958	23		14737291	14737319	8421504	2	9,14	0,14	g	350036095800000003	0-23		15561975	10.1152/ajprenal.00288.2004		American Journal of Physiology - Renal Physiology	Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells	Rickard	2005	0		
713	chr21	16794155	16794179	3500283495	23		16794155	16794179	8421504	2	7,16	0,8	g	350028349500000001	7-30						AGONISTIC ANTIBODIES THAT BIND TO THE TWEAK RECEPTOR FN14 AND THEREBY MODULATE ADIPOSITY-ASSOCIATED PHENOTYPES AS WELL AS THEIR USE IN THERAPY - RECHTSANWALT DR. MARTIN PRAGER ALS INSOLVENZVERWALTER &#xdc;BER DAS VERM&#xd6;GEN DER XANTOS BIOMEDICINE AG, P	www.sumobrain.com	0	0		
713	chr21	16794155	16794179	3500123443	23		16794155	16794179	8421504	2	7,16	0,8	g	350012344300000002	7-30						Agonist antibodies that bind to the TWEAK receptor Fn14, thereby modulating adiposity-associated phenotypes, and their use in therapy	Link	2007	0		
722	chr21	18015957	18015980	3500205215	23		18015957	18015980	8421504	1	23	0	g	350020521500000108	21-44						Control of ostrinia	www.devileye.net	0	0		
726	chr21	18546547	18546571	3500461849	24		18546547	18546571	8421504	1	24	0	c	350046184900000268	20-44						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
726	chr21	18546547	18546571	3500420477	24		18546547	18546571	8421504	1	24	0	c	350042047700000264	20-44						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
726	chr21	18546547	18546571	3500359363	24		18546547	18546571	8421504	1	24	0	c	350035936300000270	20-44						Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments 	.freshpatents.com	0	0		
726	chr21	18546547	18546571	3500204773	24		18546547	18546571	8421504	1	24	0	c	350020477300000264	20-44						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
726	chr21	18546547	18546571	3500054041	24		18546547	18546571	8421504	1	24	0	c	350005404100000271	20-44						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2012	0		
726	chr21	18546547	18546571	3500017979	24		18546547	18546571	8421504	1	24	0	c	350001797900000264	20-44						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
726	chr21	18546648	18551068	3500353330	63		18546648	18551068	8421504	3	21,22,20	0,310,4400	c	350035333000000001,350035333000000000,350035333000000004	12-33,10-32,0-20					BMC Molecular Biology	Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells - Scolaris	Guidi	2010	0		NTRK3
726	chr21	18546648	18551068	3500144134	63		18546648	18551068	8421504	3	21,22,20	0,310,4400	c,g	350014413400000001,350014413400000000,350014413400000000,350014413400000004	12-33,10-32,10-32,0-20						Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells	biomedcentral.com	0	0		NTRK3
11	chr21	18546882	18907473	3500291637	1691		18546882	18907473	8421504	19	141,159,244,173,131,189,1,57,33,35,55,45,37,8,90,135,90,45,23	0,4156,47620,50859,59232,170635,272120,272166,273016,297380,342001,355987,356077,357125,357178,357895,360344,360479,360568	p,c	350029163700015187,350029163700015186,350029163700015185,350029163700015184,350029163700015183,350029163700015092,350029163700015182,350029163700015091,350029163700015090,350029163700015179,350029163700015178,350029163700015177,350029163700015176,350029163700015175,350029163700015084,350029163700015174,350029163700015173,350029163700015172,350029163700015171,350029163700015078,350029163700015170,350029163700015168,350029163700015166,350029163700015164,350029163700015162,350029163700015158,350029163700015156,350029163700015116,350029163700015118,350029163700015122,350029163700015126,350029163700015130,350029163700015132,350029163700015134,350029163700015136,350029163700015138,350029163700015142,350029163700015144,350029163700015148,350029163700000018	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-23					Patent	Human trk receptors and neurotrophic factor inhibitors (Patent US:6025166)	Presta	2000	0		
726	chr21	18551040	18551064	3500361249	24		18551040	18551064	8421504	1	24	0	c	350036124900000006	0-24						BDNF Enhances the Differentiation but Not the Survival of CNS Stem Cell-Derived Neuronal Precursors	www.jneurosci.org	0	0		
726	chr21	18551040	18551064	3500224732	24		18551040	18551064	8421504	1	24	0	c	350022473200000006	0-24		10611077	10.1095/biolreprod62.1.132	0006-3363	Biology of Reproduction	Role of Neurotropins in Rat Embryonic Testis Morphogenesis (Cord Formation)	Levine	2000	4		
726	chr21	18551080	18551107	3500424039	27		18551080	18551107	8421504	1	27	0	c	350042403900000083	0-27						FLT4 (VEGFR-3) as a Target for Tumor Imaging and Anti-Tumor Therapy - Patent application	www.faqs.org	0	0		
726	chr21	18551080	18551107	3500423962	27		18551080	18551107	8421504	1	27	0	c	350042396200000085	0-27						US Patent # 7,034,105. FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy - Patents.com	www.patents.com	0	0		
726	chr21	18551080	18551107	3500404929	27		18551080	18551107	8421504	1	27	0	c	350040492900000076	0-27						US Patent # 5,776,755. FLT4, a receptor tyrosine kinase - Patents.com	www.patents.com	0	0		
726	chr21	18551080	18551107	3500383615	27		18551080	18551107	8421504	1	27	0	c	350038361500000158	0-27					Patent	F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy (Patent CN:100340291)	Qia Li *A Li Ta Luo 	2007	0		
726	chr21	18551080	18551107	3500174879	27		18551080	18551107	8421504	1	27	0	c	350017487900000085	0-27						 FLT4 (VEGFR 	www.docstoc.com	0	0		
726	chr21	18551080	18551107	3500100457	27		18551080	18551107	8421504	1	27	0	c	350010045700000083	0-27						US Patent # 6,107,046. Antibodies to Flt4, a receptor tyrosine kinase and uses thereof - Patents.com	www.patents.com	0	0		
726	chr21	18606135	18606160	3500405373	24		18606135	18606160	8421504	2	20,4	0,21	c	350040537300000068	11-45						Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection - US Patent 7410795 Description	ww.patentstorm.us	0	0		
727	chr21	18717529	18717553	3500403858	24		18717529	18717553	8421504	1	24	0	c	350040385800000002	0-24						Differentiation of Human Embryonic Stem Cells into Cells with Corneal Keratocyte Phenotype - ResearchGate	.researchgate.net	0	0		
729	chr21	18907393	18907473	3500096933	39		18907393	18907473	8421504	2	15,24	0,56	c,g	350009693300000004,350009693300000004	5-69,5-69						Human TRK receptors and neurotrophic factor inhibitors	Presta	1998	0		
729	chr21	18907450	18907473	3500293622	23		18907450	18907473	8421504	1	23	0	c	350029362200000018	0-23					Patent	Human trk receptors and neurotrophic factor inhibitors (Patent US:6027927)	Presta	2000	0		
729	chr21	18907450	18907473	3500243505	23		18907450	18907473	8421504	1	23	0	c	350024350500000019	0-23						HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS	Presta	1995	0		
729	chr21	18973724	18973748	3500393151	24		18973724	18973748	8421504	1	24	0	c	350039315100000012	0-24						BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells	-publications.com	0	0		NTRK3
729	chr21	18973863	18973886	3500116416	23		18973863	18973886	8421504	1	23	0	c	350011641600000003	0-23						The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells	www.pnas.org	0	0		NTRK3
729	chr21	18998989	18999016	3500409708	24		18998989	18999016	8421504	2	7,17	0,10	g	350040970800000002	7-34						Drosophila Mi-2 Negatively Regulates dDREF by Inhibiting Its DNA-Binding Activity	mcb.asm.org	0	0		
732	chr21	19299856	19299881	3500013455	25		19299856	19299881	8421504	1	25	0	c	350001345500000031	21-46						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		MIR3529
733	chr21	19430807	19430834	3500201864	24		19430807	19430834	8421504	2	16,8	0,19	c	350020186400000089	10-34						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
733	chr21	19430807	19430834	3500005314	24		19430807	19430834	8421504	2	16,8	0,19	c	350000531400000094	10-34						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
739	chr21	20253645	20268853	3500054369	1107		20253645	20268853	8421504	17	22,170,96,61,74,5,91,144,43,5,96,16,32,47,97,85,23	0,2292,2510,2615,3992,4162,5470,5937,6129,7424,7619,7811,10044,10172,11006,12418,15185	c,g	350005436900000013,350005436900000014,350005436900000015,350005436900000016,350005436900000018,350005436900000019,350005436900000020,350005436900000021,350005436900000022,350005436900000025,350005436900000026,350005436900000026,350005436900000029,350005436900000030,350005436900000031,350005436900000033,350005436900000038,350005436900000039,350005436900000042,350005436900000045,350005436900000046,350005436900000047,350005436900000047,350005436900000053,350005436900000054,350005436900000005	0-48,0-48,0-48,0-48,0-48,0-48,0-39,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,11-35						NOVEL PROTEIN CAPABLE OF BINDING TO HYALURONIC ACID, AND METHOD FOR MEASUREMENT OF HYALURONIC ACID USING THE SAME - Patent application	www.faqs.org	0	0		
739	chr21	20256116	20256167	3500273345	51		20256116	20256167	8421504	1	51	0	p	350027334500015002	0-51		22182481	10.1111/j.1365-2567.2011.03548.x	1365-2567	Immunology	Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4+ T helper type 1 subset differentiation - Wilson - 2012 - Immunology - Wiley Online Library	Wilson	2012	0		ACAN
739	chr21	20256131	20256176	3500459709	45		20256131	20256176	8421504	1	45	0	p	350045970900015004	0-45						Fiziol&#xf3;gi&#xe1;s &#xe9;s pathol&#xf3;gi&#xe1;s autoimmun modellek &#xf6;sszehasonl&#xed;t&#xf3; vizsg&#xe1;lata	aok.pte.hu/docs/p	0	0		ACAN
739	chr21	20256131	20256176	3500240400	45		20256131	20256176	8421504	1	45	0	p	350024040000015000	0-45						Fiziol&#xf3;gi&#xe1;s &#xe9;s pathol&#xf3;gi&#xe1;s autoimmun modellek &#xf6;sszehasonl&#xed;t&#xf3; vizsg&#xe1;lata	aok.pte.hu/docs/p	0	0		ACAN
739	chr21	20256131	20256176	3500228758	45		20256131	20256176	8421504	1	45	0	p	350022875800015000	0-45						Comparative study of physiological and pathological autoimmune models	aok.pte.hu/docs/p	0	0		ACAN
739	chr21	20256317	20269007	3500120768	43		20256317	20269007	8421504	3	4,18,21	0,1320,12669	c	350012076800000025,350012076800000002	19-41,20-41						RESEARCH ARTICLE Open Access	itis-research.com	0	0		
739	chr21	20257676	20259169	3500425762	39		20257676	20259169	8421504	2	19,20	0,1473	c	350042576200000007,350042576200000008	0-19,1-21						JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. - ResearchGat	.researchgate.net	0	0		
739	chr21	20257676	20259169	3500302580	39		20257676	20259169	8421504	2	19,20	0,1473	c,g	350030258000000005,350030258000000005,350030258000000006,350030258000000006	0-19,0-19,1-21,1-21			10.1002/art.20596	1529-0131	Arthritis & Rheumatism	Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes - Martin - 2004 - Arthritis & Rheumatism - Wiley Online Library	Martin	2004	0		
739	chr21	20259733	20259760	3500408486	27		20259733	20259760	8421504	1	27	0	c	350040848600000000	0-38						Characterisation and developmental potential of ovine bone marrow	www.docstoc.com	0	0		
739	chr21	20259772	20261073	3500465085	43		20259772	20261073	8421504	3	19,20,4	0,25,1297	c	350046508500000009,350046508500000011	0-19,0-24			10.1002/art.22300	1529-0131	Arthritis & Rheumatism	Isolation and chondroinduction of a dermis-isolated, aggrecan-sensitive subpopulation with high chondrogenic potential - Deng - 2006 - Arthritis & Rheumatism - Wiley Online Library	Deng	2007	0		
739	chr21	20259772	20261073	3500096061	43		20259772	20261073	8421504	3	19,20,4	0,25,1297	c	350009606100000021,350009606100000009,350009606100000023,350009606100000011	0-19,0-19,0-24,0-24						Dermis-Derived Cells for Tissue Engineering Applications - Patent application	www.faqs.org	0	0		
739	chr21	20259777	20261304	3500309716	42		20259777	20261304	8421504	2	21,21	0,1506	c,g	350030971600000000,350030971600000001,350030971600000001	0-21,0-21,0-21		19101611	10.1016/j.bbagen.2008.11.008		Biochimica et biophysica acta	CONSERVED SEQUENCE IN THE AGGRECAN INTERGLOBULAR DOMAIN MODULATES CLEAVAGE BY ADAMTS-4 AND ADAMTS-5	Hazuki	2009	0		
739	chr21	20263722	20263746	3500220839	24		20263722	20263746	8421504	1	24	0	c	350022083900000005	0-24						METHOD FOR PREPARATION OF CARTILAGE CELL - Patent application	www.faqs.org	0	0		
739	chr21	20263722	20263746	3500200098	24		20263722	20263746	8421504	1	24	0	c	350020009800000005	0-24						METHOD FOR PREPARATION OF CARTILAGE CELL	Taniguchi	2008	0		
739	chr21	20266147	20268853	3500361728	24		20266147	20268853	8421504	2	1,23	0,2683	c	350036172800000005	11-35						NOVEL PROTEIN CAPABLE OF BINDING TO HYALURONIC ACID, AND METHOD FOR MEASUREMENT OF HYALURONIC ACID USING THE SAME	Terashima	2009	0		
739	chr21	20266147	20268853	3500058537	24		20266147	20268853	8421504	2	1,23	0,2683	c	350005853700000001	11-35						&#x65b0;&#x898f;&#x306a;&#x30d2;&#x30a2;&#x30eb;&#x30ed;&#x30f3;&#x9178;&#x7d50;&#x5408;&#x80fd;&#x3092;&#x6709;&#x3059;&#x308b;&#x30bf;&#x30f3;&#x30d1;&#x30af;&#x8cea;&#x53ca;&#x3073;&#x3053;&#x308c;&#x3092;&#x7528;&#x3044;&#x305f;&#x30d2;&#x30a2;&#x30eb	Terashima	2009	0		
739	chr21	20268947	20269007	3500282907	41		20268947	20269007	8421504	2	20,21	0,39	c	350028290700000009,350028290700000010	0-20,0-21						ABSTRACT Title of Document: ENGINEERING ZONAL CARTILAGE THROUGH UTILIZATION OF A MESENCHYMAL STEM CELL POPULATION Articular	drum.lib.umd.edu	0	0		
739	chr21	20274059	20274255	3500274729	196		20274059	20274255	8421504	1	196	0	c	350027472900000019	0-196						Ex vivo Expansion and Differentiation of Mesenchymal Stem Cells from Goat Bone Marrow	www.mums.ac.ir	0	0		
739	chr21	20274333	20274364	3500422266	26		20274333	20274364	8421504	2	17,9	0,22	c	350042226600000062,350042226600000065	0-26,0-25						Method and materials for producing a genetically modified animal	Fahrenkrug	2013	0		
739	chr21	20274333	20274364	3500106996	26		20274333	20274364	8421504	2	17,9	0,22	c	350010699600000042,350010699600000045	0-26,0-25						BMC Biotechnology BioMed Central	biomedcentral.com	0	0		
739	chr21	20274333	20274364	3500089886	26		20274333	20274364	8421504	2	17,9	0,22	c	350008988600000062,350008988600000141,350008988600000065,350008988600000144	0-26,0-26,0-25,0-25						METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ANIMALS - Patent application	www.faqs.org	0	0		
739	chr21	20274333	20274364	3500071888	26		20274333	20274364	8421504	2	17,9	0,22	c	350007188800000004,350007188800000007	0-26,0-25		11904379	10.1073/pnas.062630599	0027-8424	Proceedings of the National Academy of Sciences	Mammalian germ-line transgenesis by transposition	Dupuy	2002	10		
739	chr21	20274333	20274364	3500012563	26		20274333	20274364	8421504	2	17,9	0,22	c	350001256300000062,350001256300000065	0-26,0-25						METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ANIMALS	Fahrenkrug	2009	0		
739	chr21	20274527	20274555	3500345448	28		20274527	20274555	8421504	1	28	0	g	350034544800000000	23-51						Chondrocyte intracellular calcium, cytoskeletal organization, and gene expression responses to dynamic osmotic loading	g.library.pcc.edu	0	0		
739	chr21	20274708	20274897	3500153648	40		20274708	20274897	8421504	2	20,20	0,169	c	350015364800000018,350015364800000019	0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
739	chr21	20275575	20276022	3500373489	41		20275575	20276022	8421504	2	21,20	0,427	c,g	350037348900000000,350037348900000000,350037348900000001,350037348900000001	0-21,0-21,0-20,0-20			10.1186/ar1991		Arthritis Research & Therapy	Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary	Ilse-GerlinSunk	2006	0		
739	chr21	20275575	20276022	3500001250	41		20275575	20276022	8421504	2	21,20	0,427	c,g	350000125000000000,350000125000000000,350000125000000001,350000125000000001	0-21,0-21,0-20,0-20		16831232	10.1186/ar1991	1478-6354	Arthritis Research & Therapy	Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary	Sunk	2006	4		
739	chr21	20276126	20291571	3500412394	40		20276126	20291571	8421504	3	1,19,20	0,13638,15425	c,g	350041239400000000,350041239400000001,350041239400000001	0-20,0-20,0-20						HYDROGELS BASED ON POLYMERS OF DEXTRAN TYRAMINE AND TYRAMINE CONJUGATES OF NATURAL POLYMERS - Patent application	www.faqs.org	0	0		
739	chr21	20289791	20289814	3500095190	23		20289791	20289814	8421504	1	23	0	c	350009519000000010	0-23			10.1111/j.1440-169X.2006.00874.x	1440-169X	Development, Growth & Differentiation	Murine mesenchymal stem cells isolated by low density primary culture system - Eslaminejad - 2006 - Development, Growth & Differentiation - Wiley Online Library	Eslaminejad	2006	0		
739	chr21	20289805	20291597	3500211132	40		20289805	20291597	8421504	2	20,20	0,1772	c,g	350021113200000002,350021113200000003,350021113200000003	0-20,0-20,0-20			10.1007/s10561-005-5810-0		Cell and tissue banking	Phenotypic analysis of bovine chondrocytes cultured in 3D collagen sponges: effect of serum substitutes	Karen	2005	0		
739	chr21	20289805	20291597	3500171783	40		20289805	20291597	8421504	2	20,20	0,1772	c,g	350017178300000002,350017178300000003,350017178300000003	0-20,0-20,0-20						The Effects of Inhibiting Hedgehog Signaling Pathways by Using Specific Antagonist Cyclopamine on the Chondrogenic Differentiation of Mesenchymal Stem Cells	www.mdpi.com	0	0		
739	chr21	20289805	20290393	3500449972	40		20289805	20290393	8421504	2	20,20	0,568	c	350044997200000000,350044997200000001	0-20,0-20		19602052	10.1111/j.1582-4934.2009.00848.x	1582-4934	Journal of Cellular and Molecular Medicine	Explant-derived human dental pulp stem cells enhance differentiation and proliferation potentials - Spath - 2009 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Spath	2010	0		ACAN
739	chr21	20289805	20290393	3500276552	40		20289805	20290393	8421504	2	20,20	0,568	c,g	350027655200000070,350027655200000070,350027655200000034,350027655200000034,350027655200000035,350027655200000035,350027655200000071,350027655200000071	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof - Patent application	www.faqs.org	0	0		ACAN
739	chr21	20289805	20290393	3500205828	40		20289805	20290393	8421504	2	20,20	0,568	c	350020582800000034,350020582800000035	5-25,0-20						Multipotential Expanded Mesenchymal Precursor Cell Progeny (memp) And Uses Thereof 	.freshpatents.com	0	0		ACAN
739	chr21	20289805	20290393	3500111162	40		20289805	20290393	8421504	2	20,20	0,568	c,g	350011116200000034,350011116200000034,350011116200000035,350011116200000035	0-20,0-20,0-20,0-20						Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof	Gronthos	2011	0		ACAN
739	chr21	20289805	20290393	3500101334	40		20289805	20290393	8421504	2	20,20	0,568	c,g	350010133400000000,350010133400000001,350010133400000001	0-20,0-20,0-20						Neural crest development in a human embryonic stem cell-based model system	s.ulb.uni-bonn.de	0	0		ACAN
739	chr21	20289869	20290362	3500021311	42		20289869	20290362	8421504	2	21,21	0,472	c,g	350002131100000006,350002131100000006,350002131100000007,350002131100000007	0-21,0-21,0-21,0-21		19714620	10.1002/art.24864	1529-0131	Arthritis & Rheumatism	SIRT1 regulation of apoptosis of human chondrocytes - Takayama - 2009 - Arthritis & Rheumatism - Wiley Online Library	Takayama	2009	0		ACAN
739	chr21	20289891	20289914	3500427885	23		20289891	20289914	8421504	1	23	0	c	350042788500000002	0-23						Species-specific alternative splicing of the epidermal growth factor-like domain 1 of cartilage aggrecan. - ResearchGate	.researchgate.net	0	0		ACAN
739	chr21	20289891	20289914	3500020495	23		20289891	20289914	8421504	1	23	0	c,g	350002049500000007,350002049500000007	0-23,0-23			10.1002/ar.a.20010	1552-4892	The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology	Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture - Charles Huang - 2004 - The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology - Wiley Online Library	Charles	2004	0		ACAN
739	chr21	20291552	20291576	3500456458	24		20291552	20291576	8421504	1	24	0	c	350045645800000004	0-24						AlternativelySplicedType11ProcollagenmRNAsDefine DistinctPopulationsofCellsduringVertebral Development: DifferentialExpressionoftheAmino-Propeptide	jcb.rupress.org	0	0		ACAN
739	chr21	20291603	20292489	3500134803	65		20291603	20292489	8421504	4	25,9,11,20	0,28,839,866	c,g	350013480300000004,350013480300000006,350013480300000005,350013480300000005	0-25,0-20,0-20,0-20						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
739	chr21	20291603	20292489	3500083194	65		20291603	20292489	8421504	4	25,9,11,20	0,28,839,866	c,g	350008319400000016,350008319400000018,350008319400000017,350008319400000017	0-25,0-20,0-20,0-20						Role of infrapatellar fat pad in knee osteoarthritis	www.tipharma.com	0	0		ACAN
739	chr21	20291620	20292518	3500257699	43		20291620	20292518	8421504	3	20,2,21	0,822,877	c,g	350025769900000017,350025769900000018,350025769900000018	0-22,0-21,0-21						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
92	chr21	20315039	20321739	3500045404	69		20315039	20321739	8421504	4	22,23,12,12	0,1586,6675,6688	c	350004540400000001,350004540400000003,350004540400000000	0-22,7-30,0-24		18160406	10.1074/jbc.M705195200	0021-9258	Journal of Biological Chemistry	Crystal Structure of Lactadherin C2 Domain at 1.7&#xc5; Resolution with Mutational and Computational Analyses of Its Membrane-binding Motif	Shao	2008	5		
92	chr21	20315039	20321739	3500028219	132		20315039	20321739	8421504	5	39,44,25,12,12	0,1546,1620,6675,6688	c	350002821900000001,350002821900000013,350002821900000004,350002821900000005,350002821900000002,350002821900000000	0-22,12-36,0-44,0-44,12-37,0-24						Supporting Online Material for	www.dbm.ufpb.br	0	0		
740	chr21	20326392	20329351	3500324582	27		20326392	20329351	8421504	2	26,1	0,2958	c	350032458200000000	0-27						Molecular Cloning and Characterization of P47: MATERIALS AND METHODS(7) | Fitness	efitness.info	0	0		
741	chr21	20505630	20505661	3500021662	25		20505630	20505661	8421504	3	4,9,12	0,5,19	g	350002166200000186	11-45						FLAVIVIRUS IMMUNOGENS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
741	chr21	20521711	20530987	3500256454	495		20521711	20530987	8421504	9	39,23,40,68,70,85,92,24,54	0,42,3255,3298,5222,6836,9082,9195,9222	p	350025645400015016	0-510						Prostate specific genes and the use thereof in design or therapeutics	Gately	2003	0		
741	chr21	20535926	20535956	3500341162	24		20535926	20535956	8421504	3	8,5,11	0,13,19	g	350034116200000399,350034116200000609	6-33,3-30						Perhydrolase	Amin	2004	0		
741	chr21	20535926	20535956	3500129453	24		20535926	20535956	8421504	3	8,5,11	0,13,19	g	350012945300000271,350012945300000487	6-33,3-30					Patent	Perhydrolase (Patent EP:1689859)	Amin	2011	0		
741	chr21	20542445	20542470	3500463188	25		20542445	20542470	8421504	1	25	0	c	350046318800000007	8-33			10.1021/bi050226k		Biochemistry	Biochemical Properties of Purified Human Retinol Dehydrogenase 12 (RDH12): Catalytic Efficiency toward Retinoids and C9 Aldehydes and Effects of Cellular Retinol-Binding Protein Type I (CRBPI) and Cellular Retinaldehyde-Binding Protein (CRALBP) on the Oxi	Olga	2005	0		
741	chr21	20542445	20542470	3500296956	25		20542445	20542470	8421504	1	25	0	c	350029695600000007	8-33						Biochemical Properties of Purified Human Retinol Dehydrogenase 12 (RDH12): Catalytic Efficiency toward Retinoids and C Aldehydes and Effects of Cellular Retinol-Binding Protein Type I (CRBPI) and Cellular Retinaldehyde-Binding Protein (CRALBP) on the Oxid	www.pedb.org	0	0		
742	chr21	20629222	20629247	3500105774	25		20629222	20629247	8421504	1	25	0	c	350010577400000000	0-25		24167712	10.1242/bio.20135801	2046-6390	Biology Open	FancJ regulates interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1	Zou	2013	0		FANCI
742	chr21	20636206	20636230	3500205076	23		20636206	20636230	8421504	2	17,6	0,18	c	350020507600000001	5-28					Journal of Virology	Autographa californica Nuclear Polyhedrosis Virus DNA Polymerase: Measurements of Processivity and Strand Displacement	Vivien	June	0		
742	chr21	20688329	20688390	3500357539	44		20688329	20688390	8421504	2	23,21	0,40	g	350035753900000012,350035753900000071,350035753900000050,350035753900000162	0-23,0-23,0-21,0-21					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		LINC00461
742	chr21	20688329	20688390	3500125321	44		20688329	20688390	8421504	2	23,21	0,40	c	350012532100000077,350012532100000061	0-23,0-21						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		LINC00461
742	chr21	20688329	20688352	3500160286	23		20688329	20688352	8421504	1	23	0	c,g	350016028600000005,350016028600000005	0-23,0-23						MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis	ncer-research.com	0	0		LINC00461
742	chr21	20688329	20688352	3500131966	23		20688329	20688352	8421504	1	23	0	c,g	350013196600000007,350013196600000007	0-23,0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		RHBG,LINC00461
742	chr21	20688329	20688352	3500084107	23		20688329	20688352	8421504	1	23	0	c	350008410700000008,350008410700000009	3-26,0-23						Improved Methods Controlling Gene Expression	REN	2009	0		LINC00461
742	chr21	20688329	20688352	3500043993	23		20688329	20688352	8421504	1	23	0	c	350004399300000019,350004399300000109	0-23,0-23						Invertebrate MicroRNAs - Patent application	www.faqs.org	0	0		RHBG,LINC00461
742	chr21	20688329	20688352	3500028619	23		20688329	20688352	8421504	1	23	0	c,g	350002861900000005,350002861900000005	0-23,0-23			10.1186/bcr3194		Breast Cancer Research : BCR	MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis	Chang	2012	0		POLG,LINC00461
743	chr21	20722250	20722275	3500376700	23		20722250	20722275	8421504	2	13,10	0,15	g	350037670000000000	1-24						Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications	Penger	2002	0		
744	chr21	20926446	20931789	3500003486	68		20926446	20931789	8421504	2	28,40	0,5303	c,g	350000348600000190,350000348600000207	3-31,7-47						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		
744	chr21	20929606	20929715	3500464199	40		20929606	20929715	8421504	2	20,20	0,89	c,g	350046419900000021,350046419900000020,350046419900000020	0-20,0-20,0-20				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		
744	chr21	20929748	20931725	3500301078	39		20929748	20931725	8421504	3	19,19,1	0,88,1976	c,g	350030107800000156,350030107800000156,350030107800000155	0-19,0-19,0-20						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
745	chr21	21045371	21053596	3500083687	177		21045371	21053596	8421504	8	6,15,2,17,41,21,27,48	0,1295,5205,5372,5620,5709,5994,8177	c	350008368700000060,350008368700000048,350008368700000045,350008368700000043,350008368700000026	26-47,28-47,0-41,0-48,0-48						NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same - Patent application	www.faqs.org	0	0		
745	chr21	21051365	21051410	3500432803	45		21051365	21051410	8421504	1	45	0	p	350043280300015043	0-45						Isolierung und biochemische Charakterisierung einer zytosolischen Aminopeptidase aus der humanen T-Zelllinie H9	thek.uni-halle.de	0	0		ANPEP
745	chr21	21051454	21053364	3500062542	46		21051454	21053364	8421504	2	23,23	0,1887	c,g	350006254200000001,350006254200000000,350006254200000000	0-23,0-23,0-23		10958809		0022-3166	The Journal of Nutrition	Partial Sequence and Expression of the Gene for and Activity of the Sodium Glucose Transporter in the Small Intestine of Fed, Starved and Refed Chickens	Gal-Garber	2000	4		ANPEP
748	chr21	21451142	21451167	3500266431	23		21451142	21451167	8421504	3	6,4,13	0,7,12	c	350026643100000137	10-33						US Patent # 7,135,312. Circular DNA vectors for synthesis of RNA and DNA - Patents.com	www.patents.com	0	0		
748	chr21	21453460	21453650	3500392830	48		21453460	21453650	8421504	2	6,42	0,148	c	350039283000000007	0-48						DNA molecules encoding a calcium-integrin binding protein	Naik	1996	0		
748	chr21	21463229	21463253	3500193093	23		21463229	21463253	8421504	2	4,19	0,5	c	350019309300000132	6-30						 Recombinant Vesiculoviruses And Their Uses 	www.docstoc.com	0	0		
749	chr21	21501706	21502426	3500028288	87		21501706	21502426	8421504	2	58,29	0,691	p	350002828800015000	0-87		19109425	10.1091/mbc.E08-07-0728	1059-1524	Molecular Biology of the Cell	SPE-39 Family Proteins Interact with the HOPS Complex and Function in Lysosomal Delivery	Zhu	2009	5		VPS33B
749	chr21	21530431	21559672	3500153276	45		21530431	21559672	8421504	5	4,15,6,7,13	0,5,27273,29216,29228	c	350015327600000060,350015327600000398	20-39,0-26						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
749	chr21	21542789	21542816	3500440489	25		21542789	21542816	8421504	2	18,7	0,20	c	350044048900000253	9-34						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
749	chr21	21546199	21546223	3500365263	23		21546199	21546223	8421504	2	9,14	0,10	c	350036526300000001,350036526300000000	3-26,22-45						Impact of Hepatitis C Virus NS5A Genetic Variability on Liver Pathogenesis and Viral Replication	hives-ouvertes.fr	0	0		
749	chr21	21546565	21560362	3500150528	172		21546565	21560362	8421504	5	48,29,48,11,36	0,381,13089,13564,13761	c,g	350015052800000032,350015052800000180,350015052800000137,350015052800000133	0-48,18-47,0-48,0-47						Anti-igf-1r Antibodies And Uses Thereof 	.freshpatents.com	0	0		
749	chr21	21548918	21555741	3500234773	170		21548918	21555741	8421504	6	5,42,6,21,35,61	0,789,1319,1955,2213,6762	c	350023477300000094,350023477300000155,350023477300000033	0-61,0-48,0-61						UNC-45A SPLICE VARIANTS BASED CANCER DIAGNOSTICS AND THERAPEUTICS - Patent application	www.faqs.org	0	0		
749	chr21	21600029	21601091	3500100763	168		21600029	21601091	8421504	3	2,123,43	0,781,1019	p	350010076300015003	15-183						5 Multiple Sequence Alignment 5.1 Introduction	.inf.fu-berlin.de	0	0		FES
749	chr21	21614233	21621132	3500329538	608		21614233	21621132	8421504	19	48,11,20,48,33,16,48,39,27,35,12,45,48,7,50,48,24,24,25	0,253,268,306,497,755,979,1548,2094,2237,2326,3337,3469,5283,5579,5811,6430,6801,6874	c	350032953800000094,350032953800000090,350032953800000037,350032953800000085,350032953800000033,350032953800000030,350032953800000027,350032953800000021,350032953800000072,350032953800000070,350032953800000018,350032953800000067,350032953800000062,350032953800000011,350032953800000008,350032953800000054,350032953800000052	0-48,9-47,0-48,0-40,0-48,0-48,9-48,0-29,6-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,22-47						US Patent # 5,460,950. Expression of PACE in host cells and methods of use thereof - Patents.com	www.patents.com	0	0		
749	chr21	21614236	21614260	3500401266	24		21614236	21614260	8421504	1	24	0	c	350040126600000022	0-24		18544638	10.1242/jcs.019745	0021-9533	Journal of Cell Science	Interaction of Mint3 with Furin regulates the localization of Furin in the trans-Golgi network	Han	2008	6		
749	chr21	21614383	21614414	3500001546	31		21614383	21614414	8421504	1	31	0	c	350000154600000006,350000154600000014,350000154600000004,350000154600000016	15-45,14-45,14-45,15-45						Furin polypeptides with improved characteristics	Plaimauer	2000	0		
749	chr21	21614731	21616558	3500117235	60		21614731	21616558	8421504	3	20,20,20	0,513,1807	c,g	350011723500000008,350011723500000003,350011723500000003,350011723500000001	0-20,0-20,0-20,0-20		17127750	10.1530/REP-06-0077	1470-1626	Reproduction	Analysis of furin ectodomain shedding in epididymal fluid of mammals: demonstration that shedding of furin occurs in vivo	Thimon	2006	3		
749	chr21	21615233	21621213	3500434645	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c,g	350043464500000005,350043464500000019,350043464500000020,350043464500000006,350043464500000004,350043464500000018	0-27,0-27,0-23,0-23,10-33,10-33						CLOTTING FACTOR-Fc CHIMERIC PROTEINS TO TREAT HEMOPHILIA - Patent application	www.faqs.org	0	0		
749	chr21	21615233	21621213	3500282145	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350028214500000009,350028214500000010,350028214500000008	0-27,0-23,10-33					Patent	Immunoglobulin chimeric monomer-dimer hybrids (Patent US:7348004)	Peters	2008	0		
749	chr21	21615233	21621213	3500274318	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350027431800000020,350027431800000022,350027431800000018	0-27,0-23,10-33						Immunoglobulin chimeric monomer - dimer heterozygote	A*J*Bi Tong Di 	2011	0		
749	chr21	21615233	21621213	3500269150	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350026915000000020,350026915000000022,350026915000000018	0-27,0-23,10-33					Patent	Immunoglobulin chimeric monomer-dimer hybrids (Patent CN:1852736)	A*J*Bi Tong Di 	2011	0		
749	chr21	21615233	21621213	3500238484	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350023848400000037,350023848400000077,350023848400000038,350023848400000078,350023848400000036,350023848400000076	0-27,0-27,0-23,0-23,10-33,10-33						PC5 as a factor IX propeptide processing enzyme - US Patent 8021880 Description	ww.patentstorm.us	0	0		
749	chr21	21615233	21621213	3500235466	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350023546600000005,350023546600000006,350023546600000004	0-27,0-23,10-33						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2011	0		
749	chr21	21615233	21621213	3500222316	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350022231600000009,350022231600000010,350022231600000008	0-27,0-23,10-33						Immunoglobulin Chimeric Monomer-Dimer Hybrids	Peters	2013	0		
749	chr21	21615233	21621213	3500212870	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350021287000000009,350021287000000010,350021287000000008	0-27,0-23,10-33					Patent	Immunoglobulin chimeric monomer-dimer hybrids (Patent US:7862820)	Bitonti	2011	0		
749	chr21	21615233	21621213	3500159597	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350015959700000005,350015959700000006,350015959700000004	0-27,0-23,10-33						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2011	0		
749	chr21	21615233	21621213	3500145612	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350014561200000009,350014561200000010,350014561200000008	0-27,0-23,10-33						Immunoglobulin chimeric monomer-dimer hybrids	Bitonti	2005	0		
749	chr21	21615233	21621213	3500119178	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c	350011917800000009,350011917800000010,350011917800000008	0-27,0-23,10-33						Immunoglobulin Chimeric Monomer-Dimer Hybrids	Peters	2012	0		FURIN
749	chr21	21615233	21621213	3500110745	73		21615233	21621213	8421504	4	27,18,5,23	0,85,528,5957	c,g	350011074500000009,350011074500000010,350011074500000008	0-27,0-23,10-33					Patent	Immunoglobulin chimeric monomer-dimer hybrids (Patent US:8329182)	Peters	2012	0		
749	chr21	21615233	21615766	3500463154	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350046315400000009,350046315400000010	0-27,0-23						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2007	0		FURIN
749	chr21	21615233	21615766	3500455183	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350045518300000012,350045518300000013	0-27,0-23						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2004	0		FURIN
749	chr21	21615233	21615766	3500422123	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350042212300000009,350042212300000010	0-27,0-23						Immunoglobulin Chimeric Monomer-Dimer Hybrids	Peters	2011	0		FURIN
749	chr21	21615233	21615766	3500330968	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350033096800000009,350033096800000010	0-27,0-23						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2006	0		FURIN
749	chr21	21615233	21615766	3500330750	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350033075000000002,350033075000000003	0-27,0-23						Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder	Bitonti	2009	0		FURIN
749	chr21	21615233	21615766	3500308936	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350030893600000005,350030893600000006	0-27,0-23						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2011	0		FURIN
749	chr21	21615233	21615766	3500293109	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350029310900000009,350029310900000075,350029310900000010	0-27,0-21,0-23						 Immunoglobulin Chimeric Monomer 	www.docstoc.com	0	0		FURIN
749	chr21	21615233	21615766	3500267699	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350026769900000017,350026769900000018	0-27,0-23						Immunoglobulin chimeric monomer-dimer hybrids	R*T*Bi De Si 	2006	0		FURIN
749	chr21	21615233	21615766	3500126007	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350012600700000037,350012600700000078,350012600700000079,350012600700000038	0-27,0-27,0-23,0-23						PC5 as a Factor IX Propeptide Processing Enzyme - Patent application	www.faqs.org	0	0		FURIN
749	chr21	21615233	21615766	3500121434	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350012143400000005,350012143400000006	0-27,0-23					Patent	Clotting factor-fc chimeric proteins to treat hemophilia (Patent US:8449884)	Rivera	2013	0		FURIN
749	chr21	21615233	21615766	3500038085	50		21615233	21615766	8421504	3	27,18,5	0,85,528	c	350003808500000002,350003808500000003	0-27,0-23						Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder	Bitonti	2009	0		FURIN
749	chr21	21616348	21619837	3500374367	76		21616348	21619837	8421504	5	6,13,19,19,19	0,122,1226,2040,3470	c,g	350037436700000296,350037436700000117,350037436700000269,350037436700000293,350037436700000293,350037436700000116,350037436700000116,350037436700000268,350037436700000268	0-19,0-19,0-19,0-19,0-19,0-19,0-19,0-19,0-19						Compositions and Methods for Regulating T-Cell Activity - Patent application	www.faqs.org	0	0		
749	chr21	21617681	21617707	3500104979	23		21617681	21617707	8421504	2	7,16	0,10	g	350010497900000055	13-36						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
749	chr21	21619461	21619486	3500447679	25		21619461	21619486	8421504	1	25	0	c	350044767900000147	12-37						HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR AND HUMAN CELL MEDICINE COMPRISING SAME	Kakeda	2007	0		FURIN
749	chr21	21619461	21619486	3500433685	25		21619461	21619486	8421504	1	25	0	c	350043368500000147	12-37						Human Artificial Chromosome (hac) Vector And Human Cell Medicine Comprising Same 	.freshpatents.com	0	0		FURIN
749	chr21	21619461	21619486	3500336461	25		21619461	21619486	8421504	1	25	0	c	350033646100000145	12-37						SureChem - Document - European Applications - Patent No. 2048229 - "HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR, AND HUMAN CELL PHARMACEUTICAL COMPRISING HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR" - Description	www.surechem.org	0	0		FURIN
749	chr21	21619461	21619486	3500030891	25		21619461	21619486	8421504	1	25	0	c	350003089100000296,350003089100000147	12-37,12-37						HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR AND HUMAN CELL MEDICINE COMPRISING SAME - Patent application	www.faqs.org	0	0		FURIN
749	chr21	21619461	21619486	3500019479	25		21619461	21619486	8421504	1	25	0	c	350001947900000017	10-35		19997091	10.1038/mt.2009.274	1525-0016	Molecular Therapy	Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy	Kazuki	2009	7		FURIN
749	chr21	21619461	21619486	3500011021	25		21619461	21619486	8421504	1	25	0	c	350001102100000017	10-35		19997091	10.1038/mt.2009.274	1525-0016	Molecular Therapy	Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy	Kazuki	2009	7		
752	chr21	21893055	21893079	3500234844	24		21893055	21893079	8421504	1	24	0	g	350023484400000004	4-28						Antibodies to VLA-1	Karpusas	2010	0		
752	chr21	21984854	21984877	3500374258	23		21984854	21984877	8421504	1	23	0	g	350037425800000015	17-40						Broad-spectrum &dgr -endotoxins	Malvar	2000	0		
753	chr21	22048313	22048373	3500370595	60		22048313	22048373	8421504	1	60	0	p	350037059500015011	12-72						Regulation of angiogenesis with zinc finger proteins	Eisenberg	2002	0		SCAND2P
753	chr21	22059061	22059086	3500311484	23		22059061	22059086	8421504	2	15,8	0,17	c	350031148400000103	25-48						Anticancer Combination Therapies - Patent application	www.faqs.org	0	0		
753	chr21	22143409	22143529	3500315071	40		22143409	22143529	8421504	2	20,20	0,100	c	350031507100000021,350031507100000020	0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
754	chr21	22156691	22189192	3500359806	513		22156691	22189192	8421504	8	48,39,7,120,92,46,110,51	0,230,281,6266,12442,12546,17472,32450	p	350035980600015143,350035980600015134,350035980600015125,350035980600015116	0-87,0-168,0-51,0-207						&#x201c;Identification and functions of type I signal peptidases of Bacillus amyloliquefaciens	thek.uni-halle.de	0	0		SEC11A
754	chr21	22156691	22189192	3500072968	537		22156691	22189192	8421504	6	48,58,120,150,110,51	0,230,6266,12442,17472,32450	c	350007296800000014,350007296800000084,350007296800000083,350007296800000082,350007296800000081,350007296800000080,350007296800000078	0-537,0-48,0-47,0-48,0-48,0-48,0-48						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
754	chr21	22253037	22253064	3500115533	24		22253037	22253064	8421504	2	10,14	0,13	c	350011553300000016	2-26						flt3-L mutants and method of use	Graddis	1998	0		
754	chr21	22271223	22271286	3500244161	63		22271223	22271286	8421504	1	63	0	p	350024416100015013	0-63						Helene Touzet	www.lifl.fr	0	0		ZNF592
754	chr21	22271242	22271270	3500446792	24		22271242	22271270	8421504	2	6,18	0,10	c	350044679200000077,350044679200000057	10-34,1-25						Galectin-11 polypeptides	Ni	2000	0		
755	chr21	22301534	22325792	3500194368	38		22301534	22325792	8421504	4	7,12,6,13	0,11,24237,24245	g	350019436800000567,350019436800000427	25-44,26-45						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
755	chr21	22348722	22348747	3500100734	24		22348722	22348747	8421504	2	5,19	0,6	g	350010073400000490	1-25						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
755	chr21	22413262	22413295	3500262573	27		22413262	22413295	8421504	3	8,11,8	0,9,25	c	350026257300000045	3-30						Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof - Patent application	www.faqs.org	0	0		
758	chr21	22799458	22806372	3500030715	40		22799458	22806372	8421504	2	20,20	0,6894	c,g	350003071500000001,350003071500000001,350003071500000000	0-20,0-20,0-20		20442321	10.1152/ajpendo.00664.2009		American Journal of Physiology - Endocrinology and Metabolism	An AP-3-dependent mechanism drives synaptic-like microvesicle biogenesis in pancreatic islet &#x03b2;-cells	Suckow	2010	0		AP3B2
759	chr21	22827665	22827692	3500108268	23		22827665	22827692	8421504	2	11,12	0,15	c	350010826800000034	25-48						COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE - Patent application	www.faqs.org	0	0		
759	chr21	22859142	22859205	3500139175	50		22859142	22859205	8421504	2	22,28	0,35	c	350013917500000046,350013917500000043,350013917500000041	0-22,0-20,8-36						Functional characterisation of microRNA-containing Argonaute Protein complexes	b.uni-muenchen.de	0	0		FSD2
760	chr21	22939058	22939118	3500407182	60		22939058	22939118	8421504	1	60	0	p	350040718200015006	0-60		20492691	10.1186/1471-2202-11-61	1471-2202	BMC Neuroscience	The TRPC2 channel forms protein-protein interactions with Homer and RTP in the rat vomeronasal organ	Mast	2010	3		HOMER2
760	chr21	22968667	22968727	3500276633	60		22968667	22968727	8421504	1	60	0	p	350027663300015003	0-60						Homo sapiens homer homolog 2 (Drosophila) (HOMER2), transcript variant 4, mRNA. , NM_199332.1 - GenScript	www.genscript.com	0	0		
763	chr21	23356259	23356285	3500077337	23		23356259	23356285	8421504	2	15,8	0,18	g	350007733700000001	1-24						ScienceDirect.com - Molecular Cell - A Bidirectional Origin of Replication Maps to the Major Noncoding Region of Human Mitochondrial DNA	sciencedirect.com	0	0		
768	chr21	24016678	24016705	3500041044	23		24016678	24016705	8421504	2	17,6	0,21	g	350004104400000018	25-48						US Patent # 7,446,169. Human tumor necrosis factor receptor-like 2 - Patents.com	www.patents.com	0	0		
769	chr21	24175434	24175461	3500151866	23		24175434	24175461	8421504	2	7,16	0,11	g	350015186600000043	9-32						Yeast strains and modified albumins	Gilbert	1996	0		
771	chr21	24446171	24446199	3500109951	27		24446171	24446199	8421504	2	9,18	0,10	g	350010995100000007	0-27		19850938	10.1074/jbc.M109.070565	0021-9258	Journal of Biological Chemistry	Secretory Phospholipase A2, Group IIA Is a Novel Serum Amyloid A Target Gene	Sullivan	2010	5		
773	chr21	24673569	24673600	3500374502	25		24673569	24673600	8421504	3	13,4,8	0,14,23	g	350037450200000164	24-49						STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES	Birkett	2005	0		
773	chr21	24673569	24673600	3500371444	25		24673569	24673600	8421504	3	13,4,8	0,14,23	g	350037144400000090	24-49						Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis	Friede	2005	0		
773	chr21	24673569	24673600	3500158866	25		24673569	24673600	8421504	3	13,4,8	0,14,23	g	350015886600000032	24-49						Influenza immunogen and vaccine	Birkett	2012	0		
773	chr21	24673569	24673600	3500021850	25		24673569	24673600	8421504	3	13,4,8	0,14,23	g	350002185000000038	24-49					Patent	Influenza immunogen and vaccine (Patent US:7361352)	Birkett	2008	0		
773	chr21	24724098	24731936	3500464481	258		24724098	24731936	8421504	3	5,139,114	0,4872,7724	p	350046448100015013	0-258						Antibodies to HBIMF63 polypeptide - US Patent 7381800 Description	ww.patentstorm.us	0	0		TM6SF1
774	chr21	24824130	24824153	3500217915	23		24824130	24824153	8421504	1	23	0	c	350021791500000012	0-23						BMC Genomics BioMed Central	biomedcentral.com	0	0		
775	chr21	24979348	24979471	3500100654	40		24979348	24979471	8421504	2	21,19	0,104	g	350010065400000035,350010065400000037	0-21,0-19						Screening Method For Anti-diabetic Compounds 	.freshpatents.com	0	0		TUBA1A
775	chr21	24979751	24979774	3500230941	23		24979751	24979774	8421504	1	23	0	g	350023094100000007	0-23						Treating or preventing cancers over-expressing reg4 or kiaa0101	Nakagawa	2008	0		
775	chr21	24979751	24979774	3500090103	23		24979751	24979774	8421504	1	23	0	g	350009010300000005,350009010300000074	0-23,0-23						Genes and polypeptides relating to human pancreatic cancer	Zhong Cun You Fu 	2005	0		TUBA1A
775	chr21	25023328	25023379	3500052115	51		25023328	25023379	8421504	1	51	0	p	350005211500015001	0-51		15923606	10.1128/MCB.25.12.4873-4880.2005	0270-7306	Molecular and Cellular Biology	MrgX Is Not Essential for Cell Growth and Development in the Mouse	Tominaga	2005	6		MORF4L1
775	chr21	25023897	25023982	3500207809	82		25023897	25023982	8421504	3	56,18,8	0,57,77	g	350020780900000095	0-82						 Neural Thread Protein Gene Expression And Detection Of Alzheimer's Disease 	www.docstoc.com	0	0		
775	chr21	25023897	25023982	3500111311	82		25023897	25023982	8421504	3	56,18,8	0,57,77	g	350011131100000095	0-82						Neural thread protein gene expression and detection of Alzheimer's disease	La	1995	0		
775	chr21	25023897	25023982	3500058433	82		25023897	25023982	8421504	3	56,18,8	0,57,77	g	350005843300000095	0-82					Patent	Neural thread protein gene expression and detection of Alzheimer's disease (Patent US:5830670)	Monte	1998	0		
1	chr21	25070019	25172105	3500337458	3771		25070019	25172105	8421504	27	90,69,118,80,198,85,104,61,113,107,171,126,374,249,83,137,64,161,119,110,194,80,254,93,148,107,276	0,3455,5979,12422,16482,20669,22228,26163,28588,29119,29694,32091,33569,34977,39620,40455,42946,45933,47781,52871,53286,56570,64333,67084,71957,77595,101810	p	350033745800015000	0-3771						KEGG T01001: 5923	www.genome.jp	0	0		RASGRF1
1	chr21	25070019	25172105	3500293780	3771		25070019	25172105	8421504	27	90,69,118,80,198,85,104,61,113,107,171,126,374,249,83,137,64,161,119,110,194,80,254,93,148,107,276	0,3455,5979,12422,16482,20669,22228,26163,28588,29119,29694,32091,33569,34977,39620,40455,42946,45933,47781,52871,53286,56570,64333,67084,71957,77595,101810	p	350029378000015152	0-3771					Patent	Nucleic acid encoding a NOVX13 polypeptide (Patent US:7122345)	Padigaru	2006	0		RASGRF1
1	chr21	25070019	25172105	3500198133	3771		25070019	25172105	8421504	27	90,69,118,80,198,85,104,61,113,107,171,126,374,249,83,137,64,161,119,110,194,80,254,93,148,107,276	0,3455,5979,12422,16482,20669,22228,26163,28588,29119,29694,32091,33569,34977,39620,40455,42946,45933,47781,52871,53286,56570,64333,67084,71957,77595,101810	p	350019813300015000	0-3771						KEGG T01001: 5923	www.genome.jp	0	0		RASGRF1
1	chr21	25070031	25172036	3500293780	1728		25070031	25172036	8421504	16	78,69,118,80,198,85,80,162,4,110,194,80,149,7,107,207	0,3443,5967,12410,16470,20657,22216,34994,47884,52859,53274,56558,64321,72086,77583,101798	p	350029378000015160,350029378000015166,350029378000015158,350029378000015164,350029378000015156,350029378000015162,350029378000015154,350029378000015180,350029378000015172,350029378000015178,350029378000015170,350029378000015176,350029378000015168,350029378000015174,350029378000015184,350029378000015182	0-174,0-177,0-177,0-180,0-180,0-177,0-177,0-162,0-180,0-180,0-177,0-171,0-180,0-180,0-153,0-168					Patent	Nucleic acid encoding a NOVX13 polypeptide (Patent US:7122345)	Padigaru	2006	0		RASGRF1
776	chr21	25103749	25103774	3500355249	23		25103749	25103774	8421504	3	14,5,4	0,15,21	c	350035524900000007	8-31						A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia	ev.biologists.org	0	0		
777	chr21	25208019	25208043	3500228456	23		25208019	25208043	8421504	2	6,17	0,7	g	350022845600000302	4-27						Interleukin-3 (il-3) mutant polypeptides	Abrams	1995	0		
777	chr21	25208019	25208043	3500139650	23		25208019	25208043	8421504	2	6,17	0,7	g	350013965000000350	4-27					Patent	Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells (Patent US:6479261)	Bauer	2002	0		
777	chr21	25208019	25208043	3500013979	23		25208019	25208043	8421504	2	6,17	0,7	g	350001397900000287	4-27					Patent	Interleukin-3 (IL-3) mutant polypeptides and their recombinant production (Patent US:5677149)	Abrams	1997	0		
777	chr21	25269594	25269617	3500389139	23		25269594	25269617	8421504	1	23	0	c,g	350038913900000018,350038913900000018	21-44,21-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		ANKRD34C
777	chr21	25269594	25269617	3500306561	23		25269594	25269617	8421504	1	23	0	c	350030656100000018	21-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		ANKRD34C
777	chr21	25269594	25269617	3500257436	23		25269594	25269617	8421504	1	23	0	c,g	350025743600000018,350025743600000018	21-44,21-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		ANKRD34C
777	chr21	25269594	25269617	3500232262	23		25269594	25269617	8421504	1	23	0	c	350023226200000018	21-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		ANKRD34C
777	chr21	25281453	25281481	3500041331	25		25281453	25281481	8421504	2	10,15	0,13	g	350004133100000008	10-44						Juvenile Parkinson disease caused by parkin mutations: large deletions and pathogenic mechanisms	run.unl.pt/bitstr	0	0		
779	chr21	25470462	25470490	3500049915	24		25470462	25470490	8421504	2	17,7	0,21	g	350004991500000110	13-48						Trehalose transporter gene and method of introducing trehalose into cells - Patent application	www.faqs.org	0	0		
780	chr21	25644558	25645482	3500436421	44		25644558	25645482	8421504	4	18,4,4,18	0,19,901,906	g	350043642100000006,350043642100000005	0-22,21-43						Hapten-carrier conjugates and uses thereof	Bachmann	2008	0		
780	chr21	25644558	25645482	3500363578	44		25644558	25645482	8421504	4	18,4,4,18	0,19,901,906	g	350036357800000008,350036357800000007	0-22,21-43						Molecular antigen arrays	Bachmann	2006	0		
782	chr21	25843145	25843176	3500219514	29		25843145	25843176	8421504	2	23,6	0,25	c	350021951400000086	14-43						Supplemental Materials and Methods	ymphochip.nih.gov	0	0		
782	chr21	25852207	25852285	3500175024	45		25852207	25852285	8421504	2	21,24	0,54	c,g	350017502400000001,350017502400000001,350017502400000000	0-21,0-21,0-24						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
782	chr21	25852349	25852448	3500404944	40		25852349	25852448	8421504	2	20,20	0,79	c	350040494400000011,350040494400000010	0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
12	chr21	26191950	26295608	3500113768	648		26191950	26295608	8421504	7	196,103,16,99,75,152,7	0,36764,39495,84215,86789,93373,103651	p	350011376800015070,350011376800015073	0-315,0-333						Signaltransduktion durch Zwei-Komponenten Systeme in dem halophilen Archaeon Halobacterium salinarum	b.uni-muenchen.de	0	0		ARNT2
784	chr21	26195290	26195316	3500338349	23		26195290	26195316	8421504	2	15,8	0,18	g	350033834900000006	7-30						Emm and Emm-like Pharyngeal Streptococcal Isolates: Results	www.medscape.com	0	0		
784	chr21	26195290	26195316	3500236132	23		26195290	26195316	8421504	2	15,8	0,18	g	350023613200000006	7-30						Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India	nn-clinmicrob.com	0	0		
784	chr21	26195290	26195316	3500219169	23		26195290	26195316	8421504	2	15,8	0,18	g	350021916900000006	7-30						Emm and Emm-like Pharyngeal Streptococcal Isolates	www.medscape.com	0	0		
785	chr21	26232055	26285377	3500166513	62		26232055	26285377	8421504	2	55,7	0,53315	c	350016651300000128	0-62						Isolation and Functional Characterization of a Dioxin-Inducible CYP1A Regulatory Region From Zebrafish ( Gary T. ZeRuth A dissertation submitted in partial fulfillment	gradworks.umi.com	0	0		
785	chr21	26265286	26285392	3500166513	60		26265286	26285392	8421504	2	6,54	0,20052	c	350016651300000134	0-60						Isolation and Functional Characterization of a Dioxin-Inducible CYP1A Regulatory Region From Zebrafish ( Gary T. ZeRuth A dissertation submitted in partial fulfillment	gradworks.umi.com	0	0		
789	chr21	26763033	26763306	3500354859	261		26763033	26763306	8421504	2	141,120	0,153	p	350035485900015057,350035485900015059,350035485900015058,350035485900015060	0-102,81-150,0-102,0-75						64 human secreted proteins	Ruben	2001	0		MESDC1
790	chr21	26926403	26926430	3500464877	25		26926403	26926430	8421504	2	10,15	0,12	g	350046487700000000	20-45			10.1111/j.1432-1033.2004.04128.x	1432-1033	European Journal of Biochemistry	Poneratoxin, a neurotoxin from ant venom - Szolajska - 2004 - European Journal of Biochemistry - Wiley Online Library	Szolajska	2004	0		
791	chr21	27010750	27010777	3500340807	24		27010750	27010777	8421504	2	12,12	0,15	g	350034080700000006	0-24						Polynucleotide encoding a novel immunoglobulin superfamily member, APEX4, and variants and splice variants thereof	Finger	2002	0		
791	chr21	27117784	27117808	3500387607	23		27117784	27117808	8421504	2	17,6	0,18	g	350038760700000000	0-23						Molecular cloning of the cDNA for ligatin	cs.biologists.org	0	0		
793	chr21	27304104	27304131	3500025848	26		27304104	27304131	8421504	2	14,12	0,15	c	350002584800000025	7-34			10.1111/j.1365-313X.2007.03374.x	1365-313X	The Plant Journal	Role of a GDSL lipase-like protein as sinapine esterase in Brassicaceae - Clau&#xdf; - 2007 - The Plant Journal - Wiley Online Library	Clauss	2008	0		
793	chr21	27312383	27318229	3500330800	25		27312383	27318229	8421504	2	1,24	0,5822	c	350033080000000020,350033080000000144	0-25,0-25						Methods and Kits for Detecting Congenital Stationary Night Blindness and Selecting Different Coat Patterns - Patent application	www.faqs.org	0	0		
795	chr21	27532133	27532157	3500317082	24		27532133	27532157	8421504	1	24	0	c	350031708200000038	0-24		18687676	10.1074/jbc.M804831200	0021-9258	Journal of Biological Chemistry	A Network of Kr&#xfc;ppel-like Factors (Klfs)	Eaton	2008	5		KLF13
795	chr21	27545481	27545504	3500367234	23		27545481	27545504	8421504	1	23	0	g	350036723400000036	3-27						Staphylococcus aureus isolated from	www.ias.ac.in	0	0		
795	chr21	27568629	27568704	3500385351	75		27568629	27568704	8421504	1	75	0	p	350038535100015127	0-75						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		KLF13
795	chr21	27568629	27568704	3500269504	75		27568629	27568704	8421504	1	75	0	p	350026950400015078	0-75					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		KLF13
795	chr21	27568629	27568704	3500176901	75		27568629	27568704	8421504	1	75	0	p	350017690100015061	0-75						Zinc finger domains and methods of identifying same	Hwang	2002	0		KLF13
795	chr21	27568629	27568704	3500160097	75		27568629	27568704	8421504	1	75	0	p	350016009700015097	0-75						Phenotypic screen of chimeric proteins	JANG	2004	0		KLF13
795	chr21	27568629	27568704	3500075471	75		27568629	27568704	8421504	1	75	0	p	350007547100015064	0-75						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		KLF13
795	chr21	27641916	27641942	3500365300	24		27641916	27641942	8421504	2	10,14	0,12	g	350036530000000093	0-29						*EP001340088B1*	data.epo.org	0	0		
795	chr21	27641916	27641942	3500058442	24		27641916	27641942	8421504	2	10,14	0,12	g	350005844200000038	0-29						In Vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells	Smith	2008	0		
798	chr21	27919921	27919945	3500029282	23		27919921	27919945	8421504	2	9,14	0,10	c	350002928200000102	9-32						Antagonistic Anti-human Cd40 Monoclonal Antibody 	.freshpatents.com	0	0		
798	chr21	27921652	27921677	3500262942	23		27921652	27921677	8421504	2	5,18	0,7	g	350026294200000024	2-25						Identificaci&#xf3;n de prote&#xed;nas que participan en una ruta de desmetilaci&#xf3;n activa de DNA en	helvia.uco.es	0	0		
798	chr21	27981132	27981159	3500357703	25		27981132	27981159	8421504	3	7,4,14	0,8,13	g	350035770300000003	1-36						Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells	Preville	2007	0		
798	chr21	27984837	27984861	3500125991	23		27984837	27984861	8421504	2	4,19	0,5	c	350012599100000011	21-44						Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof - Patent application	www.faqs.org	0	0		
799	chr21	28155870	28155899	3500289887	23		28155870	28155899	8421504	3	13,4,6	0,14,23	g	350028988700000010	1-25					Patent	Packaging systems for human recombinant adenovirus to be used in gene therapy (Patent US:6878549)	Vogels	2005	0		
805	chr21	28906694	28906724	3500194368	24		28906694	28906724	8421504	3	12,5,7	0,14,23	g	350019436800000081	22-47						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
809	chr21	29386193	29386218	3500330232	23		29386193	29386218	8421504	2	18,5	0,20	g	350033023200000029	0-23		17189268	10.1074/jbc.M607825200	0021-9258	Journal of Biological Chemistry	Interferon Regulatory Factor-8 Is Indispensable for the Expression of Promyelocytic Leukemia and the Formation of Nuclear Bodies in Myeloid Cells	Dror	2007	5		
809	chr21	29473582	29473607	3500391906	23		29473582	29473607	8421504	2	6,17	0,8	g	350039190600000005	1-24			10.1038/sj.onc.1203004		Oncogene	Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation	Sarmila	1999	0		
101	chr21	29637850	29784151	3500181459	1479		29637850	29784151	8421504	10	516,110,87,195,168,80,110,45,140,28	0,5506,9100,10547,18378,22874,72776,81122,145883,146273	p	350018145900015000	27-1506						KEGG T01001: 1139	www.genome.jp	0	0		
811	chr21	29656310	29710640	3500312447	180		29656310	29710640	8421504	3	86,80,14	0,4414,54316	p	350031244700015078	0-180						Heterogenit&#xe4;t humaner 5-HT -Rezeptoren	s.ulb.uni-bonn.de	0	0		
814	chr21	30021279	30021306	3500132606	23		30021279	30021306	8421504	2	7,16	0,11	g	350013260600000044	1-24						 Ostertagia Vaccine 	www.docstoc.com	0	0		
814	chr21	30033052	30033078	3500141676	26		30033052	30033078	8421504	1	26	0	g	350014167600000000	6-32						Vol. 17, 3819&#x2013;3831, September 2006 Inhibition of Transforming Growth Factor- 1&#x2013;induced Signaling and Epithelial-to-Mesenchymal Transition by the Smad-binding Peptide Aptamer Trx-SARA	w.molbiolcell.org	0	0		
815	chr21	30154453	30154482	3500205215	23		30154453	30154482	8421504	3	7,4,12	0,12,17	g	350020521500000081	13-36						Control of ostrinia	www.devileye.net	0	0		
815	chr21	30202639	30202689	3500330800	44		30202639	30202689	8421504	2	19,25	0,25	c,g	350033080000000021,350033080000000021,350033080000000145,350033080000000145,350033080000000023,350033080000000147	0-19,0-19,0-19,0-19,0-25,0-25						Methods and Kits for Detecting Congenital Stationary Night Blindness and Selecting Different Coat Patterns - Patent application	www.faqs.org	0	0		HERC2P10
819	chr21	30755669	30755695	3500021662	23		30755669	30755695	8421504	2	6,17	0,9	g	350002166200000077	1-24						FLAVIVIRUS IMMUNOGENS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
820	chr21	30816302	30816327	3500270693	25		30816302	30816327	8421504	1	25	0	g	350027069300000036,350027069300000025	7-32,61-86						Reproduction of the Bluefin Tuna in Captivity - feasibility study for the domestication of Thunnus thynnus	epositorio.ieo.es	0	0		
820	chr21	30816302	30816327	3500175245	25		30816302	30816327	8421504	1	25	0	g	350017524500000036,350017524500000025	7-32,61-86						Reproduction of the Bluefin Tuna in Captivity - feasibility study for the domestication of Thunnus thynnus	epositorio.ieo.es	0	0		
820	chr21	30876883	30876910	3500139798	23		30876883	30876910	8421504	2	6,17	0,10	c	350013979800000053	1-24						High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins	Dimitrov	2011	0		
822	chr21	31076364	31076391	3500062329	23		31076364	31076391	8421504	2	17,6	0,21	g	350006232900000225	0-25						ISOLATION OF UNKNOWN REARRANGED T-CELL RECEPTORS FROM SINGLE CELLS - Patent application	www.faqs.org	0	0		
822	chr21	31151510	31151567	3500306790	57		31151510	31151567	8421504	1	57	0	p	350030679000015007	0-57						Annual Review of Pharmacology and Toxicology Volume 31 (1991) - IsSN 0362-1642 03621642 0066-4251 00664251	www.scribd.com	0	0		CHRNB2
823	chr21	31200592	31200621	3500376795	24		31200592	31200621	8421504	3	5,6,13	0,6,16	g	350037679500000066	23-48						Recombinant plant expressing non-competitively binding insecticidal crystal proteins	Mellaert	1995	0		
823	chr21	31221476	31221502	3500083716	25		31221476	31221502	8421504	2	16,9	0,17	g	350008371600000283	0-25					Patent	Streptococcus pneumoniae antigens and vaccines (Patent US:6573082)	Choi	2003	0		
823	chr21	31286197	31286220	3500332577	23		31286197	31286220	8421504	1	23	0	g	350033257700000061,350033257700000006	2-25,2-25						METHODS AND COMPOSITIONS FOR RAPID MULTIPLEX AMPLIFICATION OF STR LOCI - Patent application	www.faqs.org	0	0		
826	chr21	31638639	31638667	3500339309	24		31638639	31638667	8421504	2	16,8	0,20	c	350033930900000001,350033930900000000	4-37,3-36		17376913	10.1128/JVI.02524-06	0022-538X	Journal of Virology	Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro	Robida	2007	5		
826	chr21	31693418	31695662	3500217315	48		31693418	31695662	8421504	4	19,5,5,19	0,120,197,2225	c	350021731500000082,350021731500000081	0-24,0-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		ETFA
827	chr21	31754956	31755327	3500418301	371		31754956	31755327	8421504	1	371	0	g	350041830100000007,350041830100000026,350041830100000028,350041830100000027,350041830100000025	0-373,0-20,0-20,0-20,0-20					Patent	Sexing method of bovine embyros (Patent US:5461145)	Itagaki	1995	0		
827	chr21	31754956	31755327	3500160638	371		31754956	31755327	8421504	1	371	0	g	350016063800000007,350016063800000026,350016063800000028,350016063800000027,350016063800000025	0-373,0-20,0-20,0-20,0-20						Sexing method of bovine embyros	Kudo	1992	0		
827	chr21	31758612	31758660	3500324849	48		31758612	31758660	8421504	1	48	0	p	350032484900015003,350032484900015036	48-96,0-48						Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells	Chen	2005	0		ISL1
831	chr21	32267082	32267107	3500190800	23		32267082	32267107	8421504	2	9,14	0,11	g	350019080000000006	12-35						Recombinant IgG expression in mammalian cells	etc.tu-bs.de:8080	0	0		
831	chr21	32296291	32296317	3500327428	23		32296291	32296317	8421504	2	5,18	0,8	g	350032742800000017	11-34						Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation	Quinn	2007	0		
831	chr21	32312047	32312075	3500466707	28		32312047	32312075	8421504	1	28	0	c	350046670700000106,350046670700000047	0-28,0-28						US Patent # 6,887,705. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPs) - Patents.com	www.patents.com	0	0		
831	chr21	32312047	32312075	3500450152	28		32312047	32312075	8421504	1	28	0	c	350045015200000047	0-28						US Patent # 6,040,437. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPS) - Patents.com	www.patents.com	0	0		
831	chr21	32335835	32348050	3500247462	225		32335835	32348050	8421504	8	15,48,21,21,24,42,9,45	0,18,6592,8091,8115,11846,11912,12170	p	350024746200015048,350024746200015044,350024746200015043	0-84,0-87,6-60						Polynucleotides and polypeptides encoding receptors	Gentz	1998	0		
831	chr21	32335835	32347723	3500137667	171		32335835	32347723	8421504	6	15,48,21,21,24,42	0,18,6592,8091,8115,11846	p	350013766700015048,350013766700015044	0-84,0-87						Polynucleotides and polypeptides encoding receptors	Gentz	2000	0		
831	chr21	32342448	32342792	3500075676	87		32342448	32342792	8421504	3	21,39,27	0,24,317	p	350007567600015044	0-87						Polynucleotides and polypeptides encoding receptors		1998	0		
835	chr21	32867643	32867673	3500031400	25		32867643	32867673	8421504	3	13,7,5	0,17,25	g	350003140000000063	0-25						N&#xb0;/ / / / / / / / / / /	hives-ouvertes.fr	0	0		
835	chr21	32887173	32887197	3500121930	24		32887173	32887197	8421504	1	24	0	g	350012193000000007	4-28		12882970	10.1074/jbc.M306425200	0021-9258	Journal of Biological Chemistry	The Receptor Tyrosine Kinase Regulator Sprouty1 Is a Target of the Tumor Suppressor WT1 and Important for Kidney Development	Gross	2003	5		
836	chr21	32921370	32921422	3500461121	45		32921370	32921422	8421504	2	23,22	0,30	g	350046112100000007,350046112100000028,350046112100000005,350046112100000026	0-23,0-23,0-22,0-22						Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination - Patent application	www.faqs.org	0	0		LINGO1
836	chr21	32921370	32921422	3500417102	45		32921370	32921422	8421504	2	23,22	0,30	g	350041710200000013,350041710200000011	0-23,0-22						ScienceDirect.com - Neuron - TAJ/TROY, an Orphan TNF Receptor Family Member, Binds Nogo-66 Receptor 1 and Regulates Axonal Regeneration	sciencedirect.com	0	0		LINGO1
838	chr21	33265229	33265254	3500405929	25		33265229	33265254	8421504	1	25	0	c	350040592900000033	0-25						Cross-species-specific bispecific binders	Kufer	2012	0		
838	chr21	33265229	33265254	3500280164	25		33265229	33265254	8421504	1	25	0	c	350028016400000027	0-25						CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY	Kufer	2011	0		
838	chr21	33265229	33265254	3500242286	25		33265229	33265254	8421504	1	25	0	c	350024228600000051	0-25						Cross-species-specific PSMAxCD3 bispecific single chain antibody	E*Sha Le 	2011	0		
838	chr21	33265229	33265254	3500169027	25		33265229	33265254	8421504	1	25	0	c	350016902700000027	0-25						CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY - Patent application	www.faqs.org	0	0		
838	chr21	33265229	33265254	3500084813	25		33265229	33265254	8421504	1	25	0	c	350008481300000033	0-25						Cross-species-specific cd3-epsilon binding domain	Hoffmann	2010	0		
838	chr21	33265229	33265254	3500053073	25		33265229	33265254	8421504	1	25	0	c	350005307300000027	0-25						CROSS-SPECIES-SPECIFIC PSMAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY - MICROMET AG	www.sumobrain.com	0	0		
838	chr21	33290030	33290061	3500094946	25		33290030	33290061	8421504	3	6,6,13	0,9,18	c	350009494600000029	16-41						CONJUGATES OF BIOMOLECULES TO NANOPARTICLES	Nikiforov	2010	0		
838	chr21	33290031	33290063	3500408909	26		33290031	33290063	8421504	3	5,6,15	0,8,17	c	350040890900000002	8-34					Patent	Bone delivery conjugates and method of using same to target proteins to bone (Patent US:7763712)	Crine	2010	0		
838	chr21	33290031	33290063	3500405045	26		33290031	33290063	8421504	3	5,6,15	0,8,17	c	350040504500000020	8-34						Bone delivery conjugates and method of using same to target proteins to bone	Crine	2010	0		
838	chr21	33290031	33290063	3500400271	26		33290031	33290063	8421504	3	5,6,15	0,8,17	c	350040027100000002,350040027100000020	8-34,8-34						Bone delivery conjugates and method of using same to target proteins to bone	Crine	2010	0		
838	chr21	33290031	33290063	3500122566	26		33290031	33290063	8421504	3	5,6,15	0,8,17	c	350012256600000020	8-34					Patent	Bone delivery conjugates and method of using same to target proteins to bone (Patent US:7960529)	Crine	2011	0		
842	chr21	33762520	33762543	3500406269	23		33762520	33762543	8421504	1	23	0	c	350040626900000565	5-28					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
843	chr21	33838061	33841693	3500047878	40		33838061	33841693	8421504	3	20,4,16	0,2358,3616	c	350004787800000012,350004787800000013	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
843	chr21	33914769	33914803	3500112739	25		33914769	33914803	8421504	3	12,7,6	0,16,28	c	350011273900000080	13-39						Multi Plasmid System For The Production Of Influenza Virus - Patent application	www.faqs.org	0	0		
843	chr21	33914769	33914803	3500101001	25		33914769	33914803	8421504	3	12,7,6	0,16,28	c	350010100100000080	13-39						MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS - Patent application	www.faqs.org	0	0		
843	chr21	33914769	33914803	3500091280	25		33914769	33914803	8421504	3	12,7,6	0,16,28	c	350009128000000030	13-39						Multi plasmid system for the production of influenza virus	Duke	2006	0		
843	chr21	33914769	33914803	3500007239	25		33914769	33914803	8421504	3	12,7,6	0,16,28	c	350000723900000081	13-39						Multi plasmid system for the production of influenza virus	Hoffmann	2005	0		
843	chr21	33941912	33941941	3500396428	29		33941912	33941941	8421504	1	29	0	c	350039642800000003	0-29		11588053	10.1182/blood.V98.8.2544	0006-4971	Blood	Bifurcation of osteoclasts and dendritic cells from common progenitors	Miyamoto	2001	10		CSK
843	chr21	33941972	33942001	3500201500	24		33941972	33942001	8421504	3	13,7,4	0,17,25	c	350020150000000039	9-33						Funktionelle Charakterisierung der pestiviralen	eb.uni-giessen.de	0	0		
843	chr21	33942834	33943093	3500353736	153		33942834	33943093	8421504	2	18,135	0,124	p	350035373600015002	0-153						Two Additional Protein-Tyrosine Kinases Expressed in Human Lung: Fourth Member of the Fibroblast Growth Factor Receptor Family and an Intracellular Protein-Tyrosine Kinase	www.jstor.org	0	0		CSK
843	chr21	33942969	33946465	3500155684	1068		33942969	33946465	8421504	11	48,133,74,91,100,66,94,220,113,114,15	0,52,273,800,985,1166,1441,2293,2827,3044,3481	p	350015568400015045,350015568400015055,350015568400015053,350015568400015052,350015568400015051,350015568400015050	0-1071,0-60,0-87,0-54,0-45,0-51						Ultra-sensitive detection systems	Chait	2001	0		CSK
843	chr21	33944178	33944453	3500056508	66		33944178	33944453	8421504	2	23,43	0,232	p	350005650800015004	0-66			10.1111/j.1365-2443.2006.00926.x	1365-2443	Genes to Cells	Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases - Honma - 2006 - Genes to Cells - Wiley Online Library	Honma	2006	0		CSK
843	chr21	33945828	33946465	3500158280	210		33945828	33946465	8421504	3	81,114,15	0,185,622	p	350015828000015000	0-210						Map&#xfa;a Institute of Technology : BIO 101 : Sequence Databases	ww.coursehero.com	0	0		CSK
844	chr21	33991635	33996846	3500231857	210		33991635	33996846	8421504	5	33,50,24,60,43	0,123,2717,4945,5168	p,c,g	350023185700000045,350023185700000045,350023185700000070,350023185700000010,350023185700015031,350023185700000022	0-33,0-33,10-60,4-28,0-60,1-44						Toxicology and Applied Pharmacology	www.usask.ca	0	0		
844	chr21	33991832	33992628	3500077888	39		33991832	33992628	8421504	3	20,9,10	0,59,786	c,g	350007788800000015,350007788800000015,350007788800000014	0-20,0-20,0-19						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
844	chr21	33992702	33994298	3500227039	23		33992702	33994298	8421504	2	3,20	0,1576	c	350022703900000000	0-23						No Job Name	oxicology.usu.edu	0	0		CYP1A1
844	chr21	33995286	34021588	3500112685	265		33995286	34021588	8421504	5	48,58,44,85,30	0,25219,25278,26095,26272	c,g	350011268500000032,350011268500000029,350011268500000031,350011268500000037,350011268500000039	0-56,0-58,0-44,0-59,0-57						Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle	web1.sssup.it	0	0		
845	chr21	34113599	34113913	3500366238	90		34113599	34113913	8421504	3	32,10,48	0,253,266	p	350036623800015023	0-90						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		CLK3
847	chr21	34372533	34372556	3500194026	23		34372533	34372556	8421504	1	23	0	g	350019402600000021	0-23						KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies	Singh	2007	0		
847	chr21	34387243	34387414	3500449900	110		34387243	34387414	8421504	2	57,53	0,118	c,g	350044990000000020,350044990000000021,350044990000000021	0-57,4-57,4-57						US Patent # 5,420,027. Methods and compositions for the expression of biologically active fusion proteins comprising a eukaryotic cytochrome P450 fused to a reductase in bacteria - Patents.com	www.patents.com	0	0		
847	chr21	34387369	34390011	3500438452	152		34387369	34390011	8421504	2	143,9	0,2633	c	350043845200000056	25-177						Process for oxidation of steroids and genetically engineered cells used therein	Slijkhuis	1998	0		
847	chr21	34387469	34390076	3500196808	39		34387469	34390076	8421504	2	19,20	0,2587	c,g	350019680800000004,350019680800000004,350019680800000005	0-19,0-19,0-20		16731777	10.1677/joe.1.06278	0022-0795	Journal of Endocrinology	Effect of copper and thiomolybdates on bovine theca cell differentiation in vitro	Kendall	2006	4		
847	chr21	34390010	34390085	3500156475	70		34390010	34390085	8421504	3	21,24,25	0,23,50	c,g	350015647500000003,350015647500000005,350015647500000004	0-21,0-24,0-25						REPRODUCTION	uction-online.org	0	0		
847	chr21	34390026	34390084	3500127481	55		34390026	34390084	8421504	2	32,23	0,35	c	350012748100000003,350012748100000002	0-32,21-44						Insulin-Like Growth Factor (IGF) 2 Stimulates Steroidogenesis and Mitosis of Bovine Granulosa Cells Through the IGF1 Receptor: Role of Follicle-Stimulating Hormone and IGF2 Receptor	ww.biolreprod.org	0	0		
847	chr21	34390047	34393554	3500033775	88		34390047	34393554	8421504	4	24,24,20,20	0,2210,2313,3487	c,g	350003377500000000,350003377500000001,350003377500000002,350003377500000002,350003377500000003,350003377500000003	0-24,0-24,0-20,0-20,0-20,0-20		19747959	10.1016/j.mce.2009.09.004		Molecular and cellular endocrinology	Progesterone Regulation of Primordial Follicle Assembly In Bovine Fetal Ovaries	Eric	2009	0		
847	chr21	34390120	34393441	3500180860	41		34390120	34393441	8421504	3	21,9,11	0,2284,3310	c,g	350018086000000002,350018086000000002,350018086000000003	0-21,0-21,0-20						Evidence That High Variation in Ovarian Reserves of Healthy Young Adults Has a Negative Impact on the Corpus Luteum and Endometrium During Estrous Cycles in Cattle	ww.biolreprod.org	0	0		
847	chr21	34392360	34392383	3500338834	23		34392360	34392383	8421504	1	23	0	c	350033883400000001	23-46						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
847	chr21	34392360	34392383	3500306609	23		34392360	34392383	8421504	1	23	0	c	350030660900000001	23-46						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
847	chr21	34393548	34394594	3500062286	40		34393548	34394594	8421504	2	20,20	0,1026	c,g	350006228600000009,350006228600000009,350006228600000008,350006228600000008	0-20,0-20,0-20,0-20						Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells	logy-journals.org	0	0		
847	chr21	34393549	34398843	3500319611	44		34393549	34398843	8421504	2	22,22	0,5272	c,g	350031961100000004,350031961100000004,350031961100000005,350031961100000005	0-22,0-22,0-22,0-22						Medicine Chest - About your prescription and over-the-counter medicines, herbs and supplements - Part 6	medicinechest.com	0	0		
847	chr21	34399780	34400393	3500405697	43		34399780	34400393	8421504	2	22,21	0,592	c,g	350040569700000004,350040569700000004,350040569700000005	0-22,0-22,0-21						Intrafollicular Steroids and Anti-Mu&#xa8;llerian Hormone During Normal and Cystic Ovarian Follicular Development in the Cow	ww.biolreprod.org	0	0		
847	chr21	34399780	34400393	3500016549	43		34399780	34400393	8421504	2	22,21	0,592	c,g	350001654900000004,350001654900000004,350001654900000005	0-22,0-22,0-21		18448844	10.1095/biolreprod.107.065847	0006-3363	Biology of Reproduction	Intrafollicular Steroids and Anti-M&#xfc;llerian Hormone During Normal and Cystic Ovarian Follicular Development in the Cow	Monniaux	2008	4		
848	chr21	34476472	34476497	3500387932	23		34476472	34476497	8421504	2	11,12	0,13	g	350038793200000014	0-23						Chimeric promoter molecules for gene expression in prokaryotes	Ye	2009	0		
848	chr21	34502476	34502568	3500129036	44		34502476	34502568	8421504	2	21,23	0,69	g	350012903600000007,350012903600000006	0-21,0-23						Chromosomallocalization ofthe callipyge sheep(Ovis aries) using bovine DNAmarkers	www.pnas.org	0	0		
848	chr21	34524644	34524672	3500303286	23		34524644	34524672	8421504	2	6,17	0,11	g	350030328600000007	10-33						Methods of producing peptides in plants and peptides produced thereby	Kieliszewski	2010	0		
848	chr21	34524644	34524672	3500222755	23		34524644	34524672	8421504	2	6,17	0,11	g	350022275500000005	10-33						High-yields and extended serum half-life of human interferon [alpha]2b expressed in tobacco cells as arabinogalactan-protein fusions	www.ohio.edu	0	0		
848	chr21	34542541	34564834	3500112746	278		34542541	34564834	8421504	11	25,25,22,21,4,73,14,15,1,24,54	0,51,9350,12086,12378,18639,20073,20175,21095,21318,22239	p,c	350011274600000019,350011274600000009,350011274600000007,350011274600000017,350011274600000018,350011274600000008,350011274600000005,350011274600000015,350011274600015002,350011274600000010,350011274600000000,350011274600000013,350011274600000003,350011274600000006,350011274600000016,350011274600015001,350011274600015003	0-25,0-25,0-25,0-25,0-22,0-22,0-25,0-25,0-60,0-25,0-25,0-29,0-29,0-25,0-25,0-54,0-45						Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions - Patent application	www.faqs.org	0	0		
848	chr21	34548114	34564771	3500001775	199		34548114	34564771	8421504	7	35,48,6,23,2,43,42	0,3766,3847,6211,14512,14602,16615	c	350000177500000059,350000177500000023,350000177500000069,350000177500000084,350000177500000094,350000177500000049	9-44,0-48,18-47,0-45,6-48,21-48						Novel Stra6 Polypeptides 	.freshpatents.com	0	0		
848	chr21	34551961	34564771	3500048680	211		34551961	34564771	8421504	8	6,23,9,39,47,2,43,42	0,2364,3938,3950,3990,10665,10755,12768	c	350004868000000069,350004868000000074,350004868000000075,350004868000000084,350004868000000049,350004868000000094	18-47,0-48,1-48,0-45,21-48,6-48						Novel Stra6 Polypeptides - Patent application	www.faqs.org	0	0		
848	chr21	34555941	34555983	3500207771	41		34555941	34555983	8421504	2	9,32	0,10	c	350020777100000030	0-42						US Patent # 7,173,115. Stra6 polypeptides - Patents.com	www.patents.com	0	0		
849	chr21	34657031	34686249	3500408290	163		34657031	34686249	8421504	5	24,15,32,68,24	0,481,29000,29108,29194	c	350040829000000024,350040829000000017,350040829000000097,350040829000000014,350040829000000095	24-48,0-47,0-32,0-48,18-42						Methods for detection of acute promyelocytic leukemia (APL)	Dmitrovsky	1993	0		
849	chr21	34657031	34657055	3500088205	24		34657031	34657055	8421504	1	24	0	c	350008820500000024	24-48						Methods for detection of acute promyelocytic leukemia (APL) - US Patent 5843642 Description	ww.patentstorm.us	0	0		
849	chr21	34686057	34686083	3500307935	26		34686057	34686083	8421504	1	26	0	c	350030793500000001	1-27						Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines	-publications.com	0	0		
849	chr21	34686129	34686183	3500336946	54		34686129	34686183	8421504	1	54	0	p	350033694600015021	0-54						METHOD FOR THE DETECTION OF POST-TRANSLATIONAL MODIFICATIONS - Patent application	www.faqs.org	0	0		PML
849	chr21	34723972	34730361	3500138647	345		34723972	34730361	8421504	10	45,27,48,27,18,45,45,34,11,45	0,48,1815,1884,2508,2529,2577,3197,6330,6344	p	350013864700015144,350013864700015143,350013864700015118,350013864700015141,350013864700015140,350013864700015139,350013864700015137,350013864700015136	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						CATALYTIC DOMAINS FROM LYSYL OXIDASE AND LOXL2 - Patent application	www.faqs.org	0	0		LOXL1
849	chr21	34723992	34725804	3500018210	47		34723992	34725804	8421504	3	24,6,17	0,49,1795	c	350001821000000005,350001821000000004	0-24,0-23		21800203	10.1007/s10439-011-0365-7		Annals of biomedical engineering	Fiber Stretch and Reorientation Modulates Mesenchymal Stem Cell Morphology and Fibrous Gene Expression on Oriented Nanofibrous Microenvironments	Su-Jin	2011	0		
106	chr21	34726549	34745657	3500375700	801		34726549	34745657	8421504	19	45,37,8,45,45,45,45,45,45,45,45,45,45,81,36,9,45,45,45	0,617,3753,18004,18100,18196,18244,18292,18340,18436,18484,18532,18580,18736,18820,18859,18919,19015,19063	p	350037570000015132,350037570000015028,350037570000015127,350037570000015126,350037570000015124,350037570000015123,350037570000015122,350037570000015121,350037570000015119,350037570000015118,350037570000015117,350037570000015116,350037570000015010,350037570000015112,350037570000015111,350037570000015109,350037570000015107,350037570000015106	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Lysyl oxidase-like 1 (LOXL1) and elastogenesis - Patent application	www.faqs.org	0	0		
106	chr21	34726594	34745067	3500403968	67		34726594	34745067	8421504	3	22,23,22	0,482,18451	c	350040396800000016,350040396800000017,350040396800000049	0-22,0-23,0-22						Therapeutic methods and compositions	Smith	2012	0		LOXL1
106	chr21	34726594	34745067	3500328676	67		34726594	34745067	8421504	3	22,23,22	0,482,18451	c	350032867600000016,350032867600000017,350032867600000049	0-22,0-23,0-22						THERAPEUTIC METHODS AND COMPOSITIONS	Smith	2010	0		LOXL1
106	chr21	34726594	34745067	3500264771	67		34726594	34745067	8421504	3	22,23,22	0,482,18451	c	350026477100000016,350026477100000017,350026477100000049	0-22,0-23,0-22						Therapeutic methods and compositions	Smith	2011	0		LOXL1
106	chr21	34726594	34745067	3500074248	67		34726594	34745067	8421504	3	22,23,22	0,482,18451	c	350007424800000016,350007424800000091,350007424800000092,350007424800000017,350007424800000124,350007424800000049	0-22,0-22,0-23,0-23,0-22,0-22						THERAPEUTIC METHODS AND COMPOSITIONS - Patent application	www.faqs.org	0	0		LOXL1
849	chr21	34726603	34727076	3500159336	45		34726603	34727076	8421504	2	34,11	0,462	p	350015933600015024	0-45						SUBSTANCE FOR RESTORING NORMAL CO-EXPRESSION AND INTERACTION BETWEEN THE LOX AND NRAGE PROTEINS - Patent application	www.faqs.org	0	0		LOXL1
106	chr21	34730409	34744547	3500096057	45		34730409	34744547	8421504	2	2,43	0,14095	p	350009605700015021	0-45						Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers. - Patent application	www.faqs.org	0	0		
850	chr21	34744649	34745513	3500379109	333		34744649	34745513	8421504	8	45,45,45,45,63,36,9,45	0,96,384,432,480,720,759,819	p	350037910900015099,350037910900015098,350037910900015092,350037910900015090,350037910900015088	0-45,0-45,0-153,0-45,0-45						Lysyl oxidase-like 1 (LOXL1) and elastogenesis - US Patent 7255856 Description	ww.patentstorm.us	0	0		
851	chr21	34912419	34912447	3500104992	25		34912419	34912447	8421504	3	4,5,16	0,5,12	g	350010499200000014	1-26						IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING - Patent application	www.faqs.org	0	0		
852	chr21	35093324	35093352	3500181472	24		35093324	35093352	8421504	3	13,6,5	0,15,23	g	350018147200000004	4-31						Impact of the Staphylococcus epidermidis LytSR two-component regulatory system on murein hydrolase activity, pyruvate utilization and global transcriptional profile.	.biomedsearch.com	0	0		
853	chr21	35139760	35189917	3500374916	48		35139760	35189917	8421504	2	38,10	0,50147	c	350037491600000081	0-48						Autism Genes And Regulated Secretion 	.freshpatents.com	0	0		
106	chr21	35189983	35335468	3500374916	121		35189983	35335468	8421504	4	25,48,47,1	0,30,1096,145484	p,c	350037491600000002,350037491600000105,350037491600000078,350037491600015036	0-25,0-25,0-48,0-48						Autism Genes And Regulated Secretion 	.freshpatents.com	0	0		
854	chr21	35281883	35281908	3500348760	24		35281883	35281908	8421504	2	19,5	0,20	g	350034876000000020	3-27		22383874	10.1371/journal.ppat.1002539	1553-7374	PLOS Pathogens	PLOS Pathogens: Novel Transmembrane Receptor Involved in Phagosome Transport of Lysozymes and &#x03b2;-Hexosaminidase in the Enteric Protozoan Entamoeba histolytica	Furukawa	2012	0		
857	chr21	35662401	35662424	3500373947	23		35662401	35662424	8421504	1	23	0	g	350037394700000127	0-23						Udder Health Characteristics	Lund	2007	0		
857	chr21	35662401	35662424	3500024826	23		35662401	35662424	8421504	1	23	0	g	350002482600000136	0-23						Udder Health Characteristics 	.freshpatents.com	0	0		
865	chr21	36800036	36800062	3500003440	25		36800036	36800062	8421504	2	12,13	0,13	g	350000344000000037	12-45						Ornithobacterium Rhinotracheale Subunit Vaccines 	.freshpatents.com	0	0		
872	chr21	37715900	37715931	3500429742	23		37715900	37715931	8421504	3	11,7,5	0,16,26	g	350042974200000008	10-34						PRODU&#xc7;&#xc3;O DE FERRAMENTAS BIOL&#xd3;GICAS E ESTUDO DE PROTE&#xcd;NAS DERMONECR&#xd3;TICAS RECOMBINANTES DE ARANHA MARROM Loxosceles intermedia	pace.c3sl.ufpr.br	0	0		
875	chr21	38086398	38086422	3500325528	24		38086398	38086422	8421504	1	24	0	g	350032552800000000	5-29						UNIVERSIDAD COMPLUTENSE DE MADRID	biblioteca.ucm.es	0	0		
883	chr21	39132255	39132281	3500034129	24		39132255	39132281	8421504	3	13,5,6	0,14,20	g	350003412900000042,350003412900000041	11-37,6-32		11022033	10.1074/jbc.M003672200	0021-9258	Journal of Biological Chemistry	Localization of Sequences within the C-terminal Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Which Impact Maturation and Stability	Gentzsch	2001	5		
888	chr21	39728310	39728340	3500110550	27		39728310	39728340	8421504	3	18,5,4	0,20,26	g	350011055000000200	12-39						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
889	chr21	39966245	39966269	3500223478	23		39966245	39966269	8421504	2	8,15	0,9	g	350022347800000044	0-23						Elements for improved expression of bovine somatotropin - Patent application	www.faqs.org	0	0		
890	chr21	40032095	40032750	3500233611	52		40032095	40032750	8421504	3	11,34,7	0,127,648	g	350023361100000075	215-275						STAT6 EFFECTS ON LIVESTOCK ANIMAL GROWTH	Medrano	2008	0		
894	chr21	40522722	40522752	3500283384	24		40522722	40522752	8421504	3	6,14,4	0,11,26	g	350028338400000022	3-28					Patent	Alanine 2,3-aminomutase (Patent US:7655451)	Gokarn	2010	0		
894	chr21	40522722	40522752	3500248161	24		40522722	40522752	8421504	3	6,14,4	0,11,26	g	350024816100000022	3-28						Alanine 2, 3-aminomutase	Gokarn	2011	0		
895	chr21	40659544	40659568	3500322097	23		40659544	40659568	8421504	2	16,7	0,17	g	350032209700000591	10-33						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
895	chr21	40751311	40751342	3500013487	25		40751311	40751342	8421504	3	7,3,15	0,12,16	g	350001348700000142	10-35						METHODS FOR TREATING SJOGRENS SYNDROME BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE - Patent application	www.faqs.org	0	0		
897	chr21	40919845	40919941	3500147941	42		40919845	40919941	8421504	2	21,21	0,75	g	350014794100000001,350014794100000000	0-21,0-21			10.1128/MCB.26.10.3875-3888.2006		Molecular and Cellular Biology	Regulation of Cardiac Stress Signaling by Protein Kinase D1	Brooke	2006	0		PRKD1
899	chr21	41229453	41229482	3500275284	27		41229453	41229482	8421504	2	7,20	0,9	g	350027528400000002	6-33					Patent	Coagulation factor vii polypeptides (Patent CN:1863908)	H*E Si Te Gao 	2010	0		
902	chr21	41610404	41610432	3500312985	23		41610404	41610432	8421504	2	11,12	0,16	g	350031298500000092	0-23					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
902	chr21	41610404	41610432	3500049566	23		41610404	41610432	8421504	2	11,12	0,16	g	350004956600000092	0-23					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
904	chr21	41851847	41851872	3500213088	24		41851847	41851872	8421504	2	18,6	0,19	g	350021308800000065	16-40						Canine coronavirus S gene and uses therefor	Miller	2001	0		
908	chr21	42444606	42447977	3500251801	64		42444606	42447977	8421504	3	21,22,21	0,56,3350	c,g	350025180100000003,350025180100000003,350025180100000000,350025180100000001	10-31,10-31,9-31,15-36						ScienceDirect.com - FEBS Letters - The second von Willebrand type A domain of cochlin has high affinity for type I, type II and type IV collagens	sciencedirect.com	0	0		
908	chr21	42466663	42466688	3500049398	23		42466663	42466688	8421504	2	14,9	0,16	g	350004939800000007	9-32						Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis	www.virologyj.com	0	0		
909	chr21	42488189	42488264	3500441097	75		42488189	42488264	8421504	1	75	0	p	350044109700015000	0-75		21561862	10.1074/jbc.M110.214486		The Journal of Biological Chemistry	Structure-Function Analysis of Core STRIPAK Proteins: A SIGNALING COMPLEX IMPLICATED IN GOLGI POLARIZATION*	Michelle	July	0		STRN3
909	chr21	42488189	42488264	3500307414	75		42488189	42488264	8421504	1	75	0	p	350030741400015000	0-75		21561862	10.1074/jbc.M110.214486	0021-9258	Journal of Biological Chemistry	Structure-Function Analysis of Core STRIPAK Proteins	Kean	2011	5		STRN3
914	chr21	43206999	43207032	3500322097	28		43206999	43207032	8421504	3	14,7,7	0,15,26	g	350032209700000434	0-28						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
914	chr21	43229543	43229570	3500025621	25		43229543	43229570	8421504	2	10,15	0,12	g	350002562100000000	0-25						Pharmaceutical composition containing calcineurin B subunit	Wei	1999	0		
915	chr21	43297100	43297126	3500414030	25		43297100	43297126	8421504	2	11,14	0,12	g	350041403000000009,350041403000000001	5-30,5-30						Stereoselective reductive amination of ketones	www.devileye.net	0	0		
915	chr21	43353770	43353798	3500184754	24		43353770	43353798	8421504	2	13,11	0,17	g	350018475400000013,350018475400000002	18-42,0-22						Biochemical Mechanism and Molecular Basis for ALS-Inhibiting Herbicide Resistance in Sugarbeet (Beta vulgaris) Somatic Cell Selections	www.jstor.org	0	0		
915	chr21	43380895	43380921	3500022301	23		43380895	43380921	8421504	2	11,12	0,14	g	350002230100000003	15-39						Reverse transphosphorylation by ribonuclease A needs an intact p2-binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme. - ResearchGate	.researchgate.net	0	0		
920	chr21	43979099	43998755	3500036492	46		43979099	43998755	8421504	4	13,4,8,21	0,14,19,19635	g	350003649200000117,350003649200000242	18-45,8-35						UNIVERSIDAD DE SALAMANCA	gredos.usal.es	0	0		
921	chr21	44117723	44117749	3500160249	24		44117723	44117749	8421504	2	7,17	0,9	g	350016024900000122	8-32						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN - Patent application	www.faqs.org	0	0		
925	chr21	44591905	44591933	3500109617	24		44591905	44591933	8421504	2	17,7	0,21	g	350010961700000014	13-37						[tel-00855515, v1] Caract&#xe9;risation de facteurs bact&#xe9;riens essentiels &#xe0; la virulence des souches de Escherichia coli associ&#xe9;es &#xe0; la maladie de Crohn	hives-ouvertes.fr	0	0		
926	chr21	44731189	44731217	3500198087	23		44731189	44731217	8421504	2	7,16	0,12	g	350019808700000156	21-44						Peptide Vaccine For Influenza Virus 	.freshpatents.com	0	0		
926	chr21	44762466	44762496	3500043691	25		44762466	44762496	8421504	3	5,15,5	0,6,25	g	350004369100000035	0-25						Genes encoding the NAD-reducing hydrogenase of Rhodococcus opacus MRI I	c.sgmjournals.org	0	0		
926	chr21	44777174	44777202	3500180733	23		44777174	44777202	8421504	2	7,16	0,12	g	350018073300000112	11-35						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
927	chr21	44900008	44900032	3500049566	23		44900008	44900032	8421504	2	6,17	0,7	g	350004956600000273	23-46					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
929	chr21	45166548	45166575	3500393957	23		45166548	45166575	8421504	2	14,9	0,18	g	350039395700000031	6-29			10.1128/MCB.22.24.8539-8551.2002		Molecular and Cellular Biology	Early B-Cell Factor, E2A, and Pax-5 Cooperate To Activate the Early B Cell-Specific mb-1 Promoter	MikaSigvardsson	2002	0		
929	chr21	45169465	45195838	3500307359	321		45169465	45195838	8421504	5	45,16,137,120,3	0,48,2202,4207,26370	p	350030735900015113,350030735900015109,350030735900015107	0-141,0-180,0-96						48 human secreted proteins	Komatsoulis	2000	0		
929	chr21	45196129	45196201	3500461382	72		45196129	45196201	8421504	1	72	0	p	350046138200015041	0-72						Analysis method	Ward	2002	0		
929	chr21	45196129	45196201	3500323930	72		45196129	45196201	8421504	1	72	0	p	350032393000015021	0-72						METHOD FOR IDENTIFICATION OF GENES INVOLVED IN SPECIFIC DISEASES - OXFORD BIOMEDICA (UK) LIMITED	www.sumobrain.com	0	0		
933	chr21	45722357	45722387	3500449156	25		45722357	45722387	8421504	3	12,6,7	0,16,23	c	350044915600000061	4-35					Patent	DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor (Patent US:5426048)	Gearing	1995	0		
934	chr21	45753861	45754050	3500386452	48		45753861	45754050	8421504	3	11,31,6	0,63,183	g	350038645200000757	0-70						NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES	Anderson	2011	0		
934	chr21	45753861	45754050	3500235647	48		45753861	45754050	8421504	3	11,31,6	0,63,183	g	350023564700001550,350023564700000757	0-70,0-70						NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES - Patent application	www.faqs.org	0	0		
934	chr21	45854746	45854776	3500100734	25		45854746	45854776	8421504	3	8,5,12	0,11,18	g	350010073400000474	13-42						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
935	chr21	45888753	45888918	3500165478	48		45888753	45888918	8421504	2	25,23	0,142	p	350016547800015012	0-48						Compositions And Methods For Detecting And Treating Hiv Infections 	.freshpatents.com	0	0		CFL2
936	chr21	46035982	46036009	3500100734	24		46035982	46036009	8421504	3	5,4,15	0,7,12	g	350010073400000297,350010073400000314	1-25,10-34						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
936	chr21	46096775	46096804	3500155809	24		46096775	46096804	8421504	3	13,6,5	0,17,24	g	350015580900000171	4-31						NUCLEIC ACID CONSTRUCT AND COMPLEX FORMATION METHOD AND SCREENING METHOD USING THE SAME - Patent application	www.faqs.org	0	0		
936	chr21	46099295	46099322	3500136323	23		46099295	46099322	8421504	2	13,10	0,17	g	350013632300000000	2-25		23347460	10.1186/1471-2350-14-14		BMC Medical Genetics	The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma	Yang	2013	0		
936	chr21	46125087	46125110	3500031192	23		46125087	46125110	8421504	1	23	0	c	350003119200000009	10-33						PRODUCTS AND METHODS FOR ENHANCED TRANSGENE EXPRESSION AND PROCESSING - Patent application	www.faqs.org	0	0		
937	chr21	46172569	46183332	3500115394	480		46172569	46183332	8421504	14	2,64,31,47,63,3,15,57,21,60,21,41,25,30	0,845,912,1339,1389,2377,2383,2401,2461,5806,5869,5893,10705,10733	p	350011539400015142	0-480						Method for identification of genes involved in specific diseases	Harris	2002	0		
938	chr21	46310942	46310965	3500025266	23		46310942	46310965	8421504	1	23	0	g	350002526600000020	0-29						Sp35 Antibodies and Uses Thereof	Graff	2011	0		
938	chr21	46354120	46354147	3500457314	27		46354120	46354147	8421504	1	27	0	c	350045731400000005	0-27		19012754	10.1111/j.1471-4159.2008.05762.x	1471-4159	Journal of Neurochemistry	Age-related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects - Gavil&#xe1;n - 2008 - Journal of Neurochemistry - Wiley Online Library	Gavilan	2009	0		
939	chr21	46428254	46430086	3500333156	49		46428254	46430086	8421504	2	25,24	0,1808	c	350033315600000002,350033315600000001	0-25,0-24			10.1093/emboj/cdf407		The EMBO Journal	Role of &#x03b6;PKC in B-cell signaling and function	Pilar	2002	0		
939	chr21	46428680	46429643	3500436070	40		46428680	46429643	8421504	2	20,20	0,943	c,g	350043607000000007,350043607000000007,350043607000000006,350043607000000006	0-20,0-20,0-20,0-20		22186408	10.1210/en.2011-1413	0013-7227	Endocrinology	Curcumin Down-Regulates Visfatin Expression and Inhibits Breast Cancer Cell Invasion	Kim	2012	4		NFKBIA
939	chr21	46428717	46428771	3500267322	54		46428717	46428771	8421504	1	54	0	p	350026732200015009	0-54						Methods for the detection of molecular interactions within cells	Giuliano	2006	0		NFKBIA
939	chr21	46428807	46429092	3500191068	123		46428807	46429092	8421504	3	60,9,54	0,99,231	p	350019106800015009	120-243						Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). - ResearchGate	.researchgate.net	0	0		NFKBIA
939	chr21	46428814	46430983	3500351378	72		46428814	46430983	8421504	2	47,25	0,2144	c	350035137800000042,350035137800000029	0-47,12-37						Method of identifying a chemical that alters dissociation of an NF-KB/IKB complex	Haskill	1995	0		
939	chr21	46428906	46429092	3500391427	63		46428906	46429092	8421504	2	9,54	0,132	p	350039142700015001	0-63						Assays - Patent application	www.faqs.org	0	0		NFKBIA
939	chr21	46429047	46429092	3500208501	45		46429047	46429092	8421504	1	45	0	p	350020850100015003	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		NFKBIA
939	chr21	46429047	46429092	3500189065	45		46429047	46429092	8421504	1	45	0	p	350018906500015005	0-45						Assays	Schofield	2005	0		NFKBIA
939	chr21	46429114	46430902	3500321358	40		46429114	46430902	8421504	3	13,7,20	0,401,1768	c	350032135800000010,350032135800000009	0-20,0-20		12761567	10.1038/sj.gene.6363949	1466-4879	Genes and Immunity	Identification, structural characterization, and tissue distribution of Tsg-5: a new TNF-stimulated gene	Abrantes	2003	4		
939	chr21	46429115	46430916	3500074804	40		46429115	46430916	8421504	3	12,8,20	0,400,1781	c	350007480400000034,350007480400000003,350007480400000002,350007480400000033	0-20,0-20,0-20,0-20						Compositions and methods for indentifying transforming and tumor suppressor genes - Patent application	www.faqs.org	0	0		NFKBIA
939	chr21	46429626	46429651	3500161899	25		46429626	46429651	8421504	1	25	0	c	350016189900000004	0-25		21399639	10.1038/ni.2007		Nature immunology	IKK&#x03b2; phosphorylation regulates RPS3 nuclear translocation and NF-&#x03ba;B function during Escherichia coli O157:H7 infection	Fengyi	2011	0		NFKBIA
939	chr21	46429626	46429651	3500009548	25		46429626	46429651	8421504	1	25	0	c	350000954800000003	0-25		21778270	10.1167/iovs.11-7805	1552-5783	Investigative Ophthalmology & Visual Science	Roles Played by Toll-like Receptor-9 in Corneal Endothelial Cells after Herpes Simplex Virus Type 1 Infection	Takeda	2011	0		NFKBIA
939	chr21	46429626	46429651	3500006323	25		46429626	46429651	8421504	1	25	0	c	350000632300000003	0-25						Cornea Roles Played by Toll-like Receptor-9 in Corneal Endothelial Cells after Herpes Simplex Virus Type 1 Infection	www.iovs.org	0	0		NFKBIA
939	chr21	46429664	46430792	3500013493	40		46429664	46430792	8421504	3	20,14,6	0,484,1122	c	350001349300000011,350001349300000010	0-20,0-20		22247465	10.1167/iovs.11-8531	1552-5783	Investigative Ophthalmology & Visual Science	Effects of Antioxidant Components of AREDS Vitamins and Zinc Ions on Endothelial Cell Activation: Implications for Macular Degeneration	Zeng	2012	0		
939	chr21	46429679	46430071	3500149557	39		46429679	46430071	8421504	3	20,1,18	0,46,374	c	350014955700000019,350014955700000018	0-20,0-19						MODULATION OF CYTOKINE-INDUCED CHRONIC INFLAMMATORY RESPONSES	Mookherjee	2011	0		NFKBIA
939	chr21	46430884	46430956	3500254584	72		46430884	46430956	8421504	1	72	0	p	350025458400015020	0-72						Methods, reagents, kits and apparatus for protein function analysis	Biebuyck	2004	0		NFKBIA
939	chr21	46430884	46430956	3500041602	72		46430884	46430956	8421504	1	72	0	p	350004160200015035	0-72					Patent	Methods, reagents, kits and apparatus for protein function analysis (Patent US:7063946)	Kenten	2006	0		NFKBIA
939	chr21	46430884	46430956	3500041347	72		46430884	46430956	8421504	1	72	0	p	350004134700015038	0-72						METHODS, REAGENTS, KITS AND APPARATUS FOR PROTEIN FUNCTION ANALYSIS - MESO SCALE TECHNOLOGIES, LLC	www.sumobrain.com	0	0		NFKBIA
939	chr21	46430890	46430953	3500008503	63		46430890	46430953	8421504	1	63	0	p	350000850300015001,350000850300015104	0-63,0-48						F-box proteins and genes	Elledge	1999	0		NFKBIA
939	chr21	46430896	46430941	3500060964	45		46430896	46430941	8421504	1	45	0	p	350006096400015108	0-45						METHODS TO IDENTIFY COMPOUNDS USEFUL FOR TUMOR SENSITIZATION TO DNA DAMAGE - Patent application	www.faqs.org	0	0		NFKBIA
939	chr21	46431191	46431214	3500230565	23		46431191	46431214	8421504	1	23	0	g	350023056500000025,350023056500000023	0-21,0-19					Molecular and Cellular Biology	Identification by In Vivo Genomic Footprinting of a Transcriptional Switch Containing NF-&#x03ba;B and Sp1 That Regulates the I&#x03ba;B&#x03b1; Promoter	Michele	1999	0		
940	chr21	46576223	46576249	3500214416	23		46576223	46576249	8421504	2	7,16	0,10	g	350021441600003367	0-23						MOLECULAR CHARACTERIZATION OF THEILERIA spp. USING RIBOSOMAL RNA	pository.tamu.edu	0	0		
942	chr21	46883231	46883254	3500394874	23		46883231	46883254	8421504	1	23	0	c	350039487400000127	21-44						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2002	0		
942	chr21	46883231	46883254	3500031651	23		46883231	46883254	8421504	1	23	0	c	350003165100000127	21-44						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2003	0		
943	chr21	47053498	47053524	3500043729	23		47053498	47053524	8421504	2	9,14	0,12	g	350004372900000200	1-24						Molecular Identi&#xfb01;cation of Fungi	dlx.bookos.org	0	0		
945	chr21	47289127	47289155	3500205215	24		47289127	47289155	8421504	2	18,6	0,22	g	350020521500000144	10-35						Control of ostrinia	www.devileye.net	0	0		
946	chr21	47417673	47417701	3500049566	23		47417673	47417701	8421504	2	8,15	0,13	g	350004956600000256	13-45					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
946	chr21	47444050	47444079	3500434741	23		47444050	47444079	8421504	3	6,11,6	0,10,23	g	350043474100000032	12-35						Single nucleotide polymorphism markers in the bovine CAPN1 gene to identify meat tenderness	Smith	2003	0		
947	chr21	47545075	47547542	3500464324	42		47545075	47547542	8421504	2	21,21	0,2446	c	350046432400000000,350046432400000001	0-21,0-21		17982442	10.1038/nature06358	0028-0836	Nature	Characterizing the cancer genome in lung adenocarcinoma	Weir	2007	36		SFTA3
947	chr21	47545075	47547542	3500205994	42		47545075	47547542	8421504	2	21,21	0,2446	c	350020599400000000,350020599400000001	0-21,0-21						Characterizing the cancer genome in lung adenocarcinoma	roadinstitute.org	0	0		SFTA3
947	chr21	47545075	47547542	3500186854	42		47545075	47547542	8421504	2	21,21	0,2446	c	350018685400000000,350018685400000001	0-21,0-21		17982442	10.1038/nature06358	0028-0836	Nature	Characterizing the cancer genome in lung adenocarcinoma	Weir	2007	36		SFTA3
947	chr21	47545075	47547542	3500067406	42		47545075	47547542	8421504	2	21,21	0,2446	c	350006740600000000,350006740600000001	0-21,0-21						LETTERS	cmgm.stanford.edu	0	0		SFTA3
947	chr21	47545535	47547568	3500088669	41		47545535	47547568	8421504	2	21,20	0,2013	c,g	350008866900000007,350008866900000007,350008866900000006,350008866900000006	0-21,0-21,0-20,0-20						Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells	-publications.com	0	0		SFTA3
947	chr21	47545553	47545602	3500142832	45		47545553	47545602	8421504	2	23,22	0,27	g	350014283200000004	0-65						BMC Cancer BioMed Central	biomedcentral.com	0	0		
947	chr21	47545823	47546156	3500415375	234		47545823	47546156	8421504	2	54,180	0,153	p	350041537500015023,350041537500015038	0-54,0-180						Zebra&#xfb01;sh tinman homolog demarcates the heart &#xfb01;eld and initiates myocardial differentiation	ev.biologists.org	0	0		SFTA3
947	chr21	47545982	47546153	3500190689	171		47545982	47546153	8421504	1	171	0	p	350019068900015146	0-171						Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins, Second Edition	www.zvlab.ru	0	0		SFTA3
947	chr21	47545987	47546011	3500438382	24		47545987	47546011	8421504	1	24	0	c	350043838200000011	24-48						Original Article In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long- term culture running risk of malignant transformation	www.ajsc.us	0	0		SFTA3
947	chr21	47546019	47546058	3500031477	39		47546019	47546058	8421504	1	39	0	c	350003147700000001	0-39		18957494	10.1210/jc.2008-1402	0021-972X	Journal of Clinical Endocrinology & Metabolism	Lethal Respiratory Failure and Mild Primary Hypothyroidism in a Term Girl with a de Novo Heterozygous Mutation in the TITF1/NKX2.1 Gene	Maquet	2009	6		XRN2
947	chr21	47546174	47547269	3500199991	40		47546174	47547269	8421504	2	20,20	0,1075	c,g	350019999100000001,350019999100000000	0-20,0-20		15576401	10.1242/dev.01570	0950-1991	Development	Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung	Serls	2005	7		SFTA3
947	chr21	47546212	47547202	3500079640	42		47546212	47547202	8421504	3	21,14,7	0,37,983	c,g	350007964000000004,350007964000000004,350007964000000005	0-21,0-21,0-21						Methods and materials for identifying the origin of a carcinoma of unknown primary origin	Wang	2012	0		SFTA3
947	chr21	47546212	47547202	3500032460	42		47546212	47547202	8421504	3	21,14,7	0,37,983	c,g	350003246000000004,350003246000000004,350003246000000005	0-21,0-21,0-21						Methods and materials for identifying the origin of a carcinoma of unknown primary origin	Wang	2012	0		SFTA3
947	chr21	47547476	47547632	3500303234	40		47547476	47547632	8421504	2	21,19	0,137	c,g	350030323400000010,350030323400000010,350030323400000009,350030323400000009	0-21,0-21,0-19,0-19						Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR	-publications.com	0	0		
947	chr21	47547555	47547579	3500263662	24		47547555	47547579	8421504	1	24	0	c	350026366200000039	0-24						TTF-1 Action on the Transcriptional Regulation of Cyclooxygenase-2 Gene in the Rat Brain	.biomedsearch.com	0	0		SFTA3
948	chr21	47707407	47707740	3500090449	225		47707407	47707740	8421504	5	45,45,45,45,45	0,48,96,240,288	p	350009044900015003,350009044900015004,350009044900015005,350009044900015008,350009044900015009	0-45,0-45,0-45,0-45,0-45						ANDROGENETIC ALOPECIA - Patent application	www.faqs.org	0	0		PAX9
118	chr21	47707455	47720294	3500444466	215		47707455	47720294	8421504	7	48,4,41,3,42,47,30	0,528,3452,3592,12647,12743,12809	p,c,g	350044446600000004,350044446600000004,350044446600015055,350044446600015058,350044446600000020,350044446600000021	0-48,0-48,0-45,0-45,0-47,18-48						Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas	Peters	1998	0		
948	chr21	47707922	47707945	3500407806	23		47707922	47707945	8421504	1	23	0	c	350040780600000117	16-39						METHOD RELATING TO SWEETNESS ENHANCEMENT - Patent application	www.faqs.org	0	0		
948	chr21	47707922	47707945	3500326993	23		47707922	47707945	8421504	1	23	0	c	350032699300000205	16-39						Nucleic Acid, Polypeptide and Its Use - Patent application	www.faqs.org	0	0		
950	chr21	47944044	47944071	3500003080	24		47944044	47944071	8421504	2	11,13	0,14	g	350000308000000581,350000308000000303	21-45,21-45						US Patent # 7,285,400. High bone mass gene of 11q13.3 - Patents.com	www.patents.com	0	0		
950	chr21	47947039	47947065	3500367930	26		47947039	47947065	8421504	1	26	0	c	350036793000000070,350036793000000375	0-26,0-26						Recurrent gene fusions in prostate cancer - Patent application	www.faqs.org	0	0		SLC25A21
950	chr21	47947039	47947065	3500017630	26		47947039	47947065	8421504	1	26	0	c	350001763000000394,350001763000000076	0-26,0-26						RECURRENT GENE FUSIONS IN PROSTATE CANCER - Patent application	www.faqs.org	0	0		SLC25A21
951	chr21	48030094	48030126	3500361851	30		48030094	48030126	8421504	2	25,5	0,27	g	350036185100000030,350036185100000111	8-38,8-38						Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates - Patent application	www.faqs.org	0	0		
952	chr21	48191634	48191661	3500201864	24		48191634	48191661	8421504	2	18,6	0,21	g	350020186400000546	3-29						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
952	chr21	48191634	48191661	3500005314	24		48191634	48191661	8421504	2	18,6	0,21	g	350000531400000550	3-29						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
954	chr21	48389401	48389426	3500194063	24		48389401	48389426	8421504	2	18,6	0,19	g	350019406300000025	18-42						 Flea Serine Protease Inhibitor Proteins 	www.docstoc.com	0	0		
956	chr21	48678272	48678368	3500155061	96		48678272	48678368	8421504	1	96	0	p	350015506100015010,350015506100015007	0-48,0-48						Methods For Inhibiting Adipogenesis And For Treating Type 2 Diabetes 	.freshpatents.com	0	0		FOXA1
956	chr21	48678301	48678325	3500398499	24		48678301	48678325	8421504	1	24	0	c	350039849900000001	0-24						World J Gastroenterol	www.wjgnet.com	0	0		
957	chr21	48874583	48874606	3500391984	23		48874583	48874606	8421504	1	23	0	g	350039198400000008	5-28						Identification and Biochemical Characterization of Unique Secretory Nucleases of the Human Enteric Pathogen, Entamoeba histolytica--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;-	journal.9med.net	0	0		
959	chr21	49113983	49114012	3500333019	28		49113983	49114012	8421504	2	5,23	0,6	g	350033301900000002	9-38						Human prostate specific g-protein receptor hpraj70	Li	2003	0		
960	chr21	49256379	49256736	3500219075	138		49256379	49256736	8421504	2	54,84	0,273	p	350021907500015004,350021907500015001	0-54,0-84						 Polynucleotides Encoding KAPPA Opiod Receptors 	www.docstoc.com	0	0		SSTR1
960	chr21	49256735	49256761	3500448499	25		49256735	49256761	8421504	2	20,5	0,21	c	350044849900000009,350044849900000008	0-19,0-24					Patent	Rekombinante PilC-Proteine, Verfahren zu ihrer Herstellung und ihre Verwendung (Patent EP:1520860)	Meyer	2013	0		
960	chr21	49256735	49256761	3500298961	25		49256735	49256761	8421504	2	20,5	0,21	c	350029896100000013,350029896100000012	0-19,0-24						RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE	Meyer	1995	0		
960	chr21	49256735	49256761	3500089916	25		49256735	49256761	8421504	2	20,5	0,21	c	350008991600000013,350008991600000012	0-19,0-24						RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE	Meyer	1996	0		
960	chr21	49256735	49256761	3500068766	25		49256735	49256761	8421504	2	20,5	0,21	c	350006876600000007,350006876600000006	0-19,0-24					Patent	VERFAHREN ZUR HERSTELLUNG REKOMBINANTER PilC-PROTEINE (Patent EP:0725792)	Meyer	2004	0		
960	chr21	49256736	49256761	3500028453	24		49256736	49256761	8421504	2	19,5	0,20	c	350002845300000006	0-24					Patent	Recombinant PilC proteins, methods for producing them and their use (Patent US:6268171)	Meyer	2001	0		
962	chr21	49438653	49438677	3500045837	23		49438653	49438677	8421504	2	4,19	0,5	g	350004583700000207	18-41						Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same - US Patent 7105345 Description	ww.patentstorm.us	0	0		
962	chr21	49477116	49477142	3500283291	23		49477116	49477142	8421504	2	17,6	0,20	g	350028329100000044	8-31						Apo-2 RECEPTOR	Adams	1998	0		
966	chr21	50046948	50047062	3500166204	114		50046948	50047062	8421504	1	114	0	c	350016620400000029	63-372						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
967	chr21	50168316	50173327	3500260924	82		50168316	50173327	8421504	3	20,38,24	0,4947,4987	c	350026092400000021,350026092400000079,350026092400000078	0-20,0-38,0-24						Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen	Buendia	2011	0		
967	chr21	50168316	50173327	3500246117	82		50168316	50173327	8421504	3	20,38,24	0,4947,4987	c,g	350024611700000021,350024611700000079,350024611700000079,350024611700000078	0-20,0-38,0-38,0-24						Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen	Buendia	2012	0		
967	chr21	50173263	50173327	3500030096	62		50173263	50173327	8421504	2	38,24	0,40	c	350003009600000079,350003009600000078	0-38,0-24						Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen	Buendia	2009	0		PNN
968	chr21	50319924	50319947	3500458105	23		50319924	50319947	8421504	1	23	0	g	350045810500000002	2-25						Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope	miao.zjams.com.cn	0	0		
969	chr21	50400298	50400321	3500129036	23		50400298	50400321	8421504	1	23	0	g	350012903600000004	0-23						Chromosomallocalization ofthe callipyge sheep(Ovis aries) using bovine DNAmarkers	www.pnas.org	0	0		
978	chr21	51571208	51571236	3500100734	23		51571208	51571236	8421504	2	14,9	0,19	g	350010073400000543	4-36						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
980	chr21	51811006	51811033	3500151825	24		51811006	51811033	8421504	3	6,5,13	0,8,14	g	350015182500000073	14-38						 Amylase Variants 	www.docstoc.com	0	0		
982	chr21	52131140	52131170	3500180791	25		52131140	52131170	8421504	3	6,15,4	0,10,26	g	350018079100000176	19-47						Modified hookworm neutrophil inhibitors	Moyle	1995	0		
992	chr21	53475168	53475195	3500380600	25		53475168	53475195	8421504	3	4,13,8	0,5,19	g	350038060000000003	7-32		19203395	10.1186/1471-2199-10-9		BMC Molecular Biology	Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci	I-Cheng	2009	0		
997	chr21	54060288	54060316	3500201864	23		54060288	54060316	8421504	2	8,15	0,13	g	350020186400000302	19-42						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1004	chr21	54928565	54928592	3500330141	23		54928565	54928592	8421504	2	10,13	0,14	g	350033014100000010	24-47						Expression of voltage-gated sodium channel subunit in human ovarian cancer	-publications.com	0	0		
1006	chr21	55265688	55275790	3500097306	69		55265688	55275790	8421504	3	21,25,23	0,4858,10079	c,g	350009730600000014,350009730600000010,350009730600000011,350009730600000011	0-21,0-25,0-23,0-23						Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status	stemcellres.com	0	0		
1006	chr21	55265688	55275790	3500059285	69		55265688	55275790	8421504	3	21,25,23	0,4858,10079	c,g	350005928500000014,350005928500000010,350005928500000011,350005928500000011	0-21,0-25,0-23,0-23			10.1186/scrt246	1757-6512	Stem Cell Research & Therapy	Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status	Awe	2013	3		
1006	chr21	55287340	55294094	3500424804	219		55287340	55294094	8421504	4	52,92,9,66	0,1361,3844,6688	p	350042480400015058,350042480400015023	0-144,12-87						Expression characterization human FKBP52, 90-kDa protein	www.pnas.org	0	0		FKBP3
125	chr21	55441953	55468067	3500299191	122		55441953	55468067	8421504	4	24,23,52,23	0,7977,8665,26091	c	350029919100000020,350029919100000013,350029919100000011,350029919100000012,350029919100000006	0-24,0-23,0-29,0-29,0-23		11390390	10.1074/jbc.M102553200	0021-9258	Journal of Biological Chemistry	Evolution of Transglutaminase Genes: Identification of a Transglutaminase Gene Cluster on Human Chromosome 15q15	Grenard	2001	5		
1008	chr21	55464522	55467983	3500196470	23		55464522	55467983	8421504	2	5,18	0,3443	c	350019647000000065	18-41						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
1008	chr21	55486237	55486263	3500241434	24		55486237	55486263	8421504	2	10,14	0,12	g	350024143400000629,350024143400000679	1-23,2-24						GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME	Schellenberger	2010	0		
1009	chr21	55601335	55601782	3500352177	23		55601335	55601782	8421504	2	9,14	0,433	c	350035217700000193	22-45						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
1009	chr21	55606623	55607324	3500400270	45		55606623	55607324	8421504	2	25,20	0,681	c	350040027000000001,350040027000000000	0-25,0-20						Method of Detecting Precancerous Lesions - Patent application	www.faqs.org	0	0		TP53BP1
1009	chr21	55617354	55617377	3500213480	23		55617354	55617377	8421504	1	23	0	c	350021348000000035	19-42						&#x201e;GEN ETI KA A &#x0160;LECHT&#x011a;N&#xcd; ZV&#xcd;&#x0158;AT&#x201c; &#x201e;GENETICS AND ANIMAL BREEDING&#x201c;	user.mendelu.cz	0	0		
1009	chr21	55617785	55617808	3500041863	23		55617785	55617808	8421504	1	23	0	c	350004186300000018	0-23						Investigating the Role of 53BP1 in Regulating Gene Transcription	theses.bham.ac.uk	0	0		
1009	chr21	55673485	55673508	3500349935	23		55673485	55673508	8421504	1	23	0	c	350034993500000013	0-23		17297460	10.1038/sj.onc.1210260	0950-9232	Oncogene	Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference	Jiang	2007	6		TP53BP1
1009	chr21	55673485	55673508	3500205729	23		55673485	55673508	8421504	1	23	0	c	350020572900000013	0-23		17297460	10.1038/sj.onc.1210260	0950-9232	Oncogene	Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference	Jiang	2007	6		TP53BP1
1010	chr21	55798860	55799207	3500002498	24		55798860	55799207	8421504	2	3,21	0,326	c	350000249800000113	0-24						Tissue specific genes and gene clusters	Jay	2003	0		CATSPER2
1010	chr21	55811536	55833324	3500388209	1080		55811536	55833324	8421504	17	60,47,79,24,52,77,119,117,55,32,183,22,6,78,54,6,69	0,120,5886,7778,7844,13066,14679,17782,18051,18145,18667,19686,20443,20979,21411,21677,21719	p	350038820900015067,350038820900015069,350038820900015070,350038820900015071,350038820900015072,350038820900015074,350038820900015075,350038820900015076,350038820900015078,350038820900015079,350038820900015082,350038820900015083,350038820900015085	0-60,0-60,0-90,0-48,0-81,0-57,0-180,0-54,0-87,0-150,0-84,0-60,0-69						Estudio de la composici&#xf3;n de los gr&#xe1;nulos corticales y del oolema de ovocitos porcinos y bovinos madurados y fecundados in vitro	tdx.cat/bitstream	0	0		
1010	chr21	55811542	55833331	3500438785	45		55811542	55833331	8421504	2	20,25	0,21764	c	350043878500000024,350043878500000025	19-39,9-34						Chaperone expression genomes	Belyaev	2007	0		
1010	chr21	55811542	55833331	3500008269	45		55811542	55833331	8421504	2	20,25	0,21764	c	350000826900000024,350000826900000073,350000826900000025,350000826900000074	19-39,19-39,9-34,9-34						Chaperone Expression Genomes 	.freshpatents.com	0	0		PDIA3,CATSPER2P1
1010	chr21	55811656	55833321	3500293064	328		55811656	55833321	8421504	12	47,1,41,5,17,25,48,9,39,26,22,48	0,5766,17708,17756,17762,17931,18004,19666,20200,20913,21287,21617	c	350029306400000051,350029306400000062,350029306400000063,350029306400000065,350029306400000072,350029306400000076,350029306400000079	0-48,0-41,1-48,0-48,0-48,0-48,0-48						Methods and Compositions for Modulating Apoptosis - Patent application	www.faqs.org	0	0		
1010	chr21	55811677	55833312	3500277012	1362		55811677	55833312	8421504	13	26,79,118,108,130,117,126,183,109,129,80,58,99	0,5745,7637,12925,14527,17641,17910,18526,19545,20179,20838,21266,21536	p	350027701200015068	0-1362						Vectors and yeast strains for protein production	Bobrowicz	2010	0		
1010	chr21	55811677	55833312	3500221916	1362		55811677	55833312	8421504	13	26,79,118,108,130,117,126,183,109,129,80,58,99	0,5745,7637,12925,14527,17641,17910,18526,19545,20179,20838,21266,21536	p	350022191600015070	0-1362						VECTORS AND YEAST STRAINS FOR PROTEIN PRODUCTION	Choi	2009	0		
1010	chr21	55812329	55812358	3500374258	24		55812329	55812358	8421504	2	12,12	0,17	g	350037425800000126	16-45						Broad-spectrum &dgr -endotoxins	Malvar	2000	0		
1010	chr21	55817447	55833297	3500328917	134		55817447	55833297	8421504	3	48,42,44	0,15500,15806	c	350032891700000446,350032891700000470,350032891700000472	0-48,0-42,3-47						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
1010	chr21	55831911	55831945	3500359816	34		55831911	55831945	8421504	1	34	0	c	350035981600000009	7-41						Molecular Cloning of a Putative Plant Endomembrane Protein Resembling Vertebrate Protein Disulfide-Isomerase and a Phosphatidylinositol-Specific Phospholipase C	www.jstor.org	0	0		
1010	chr21	55832548	55832593	3500038361	45		55832548	55832593	8421504	1	45	0	p	350003836100015034	0-45						Proteomic analysis of differentially expressed proteins in colorectal cancer	.lib.nsysu.edu.tw	0	0		PDIA3
1011	chr21	55855884	55855912	3500329088	23		55855884	55855912	8421504	3	5,12,6	0,6,22	c	350032908800000092	5-28						Expression cassettes for seed-preferential expression in plants - US Patent 7790873 Description	ww.patentstorm.us	0	0		
1013	chr21	56192816	56192844	3500084680	23		56192816	56192844	8421504	2	6,17	0,11	g	350008468000000000	1-24						T cell receptor libraries	Schumacher	2002	0		
1014	chr21	56232450	56232476	3500307736	23		56232450	56232476	8421504	2	5,18	0,8	g	350030773600000095	19-42						 Cysteine 	www.docstoc.com	0	0		
1017	chr21	56670087	56670112	3500284229	23		56670087	56670112	8421504	2	15,8	0,17	c	350028422900000004	1-24						Physiological role of S-formylglutathione hydrolase in C metabolism of the methylotrophic yeast Candida boidinii	c.sgmjournals.org	0	0		
1018	chr21	56754558	56754586	3500033066	24		56754558	56754586	8421504	2	11,13	0,15	g	350003306600000006	0-24			10.1128/IAI.71.8.4463-4471.2003		Infection and Immunity	Identification of the agr Locus of Listeria monocytogenes: Role in Bacterial Virulence 	Nicolas	2003	0		
1020	chr21	57052563	57057294	3500231766	23		57052563	57057294	8421504	2	13,10	0,4721	c	350023176600000003	0-23						29 human secreted proteins	Birse	2001	0		FBLN5
1021	chr21	57241241	57241325	3500372405	84		57241241	57241325	8421504	1	84	0	p	350037240500015000	0-84						METHODS	www.nature.com	0	0		ATXN3
1021	chr21	57254570	57254593	3500303242	23		57254570	57254593	8421504	1	23	0	c,g	350030324200000004,350030324200000004	0-23,0-23		18841197	10.1371/journal.pone.0003341		PLoS ONE	Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease	Sandro	2008	0		
1021	chr21	57268803	57268828	3500078731	25		57268803	57268828	8421504	1	25	0	c	350007873100000028	0-25						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		
1025	chr21	57749430	57759085	3500351484	46		57749430	57759085	8421504	3	10,13,23	0,5220,9632	c	350035148400000004,350035148400000005	0-23,0-23		16617138	10.1152/ajpheart.00196.2006		American Journal of Physiology - Heart and Circulatory Physiology	Novel role for K+-dependent Na+/Ca2+ exchangers in regulation of cytoplasmic free Ca2+ and contractility in arterial smooth muscle	Dong	2006	0		
1025	chr21	57749430	57759085	3500166241	46		57749430	57759085	8421504	3	10,13,23	0,5220,9632	c	350016624100000004,350016624100000005	0-23,0-23		16617138	10.1152/ajpheart.00196.2006		American Journal of Physiology - Heart and Circulatory Physiology	Novel role for K+-dependent Na+/Ca2+ exchangers in regulation of cytoplasmic free Ca2+ and contractility in arterial smooth muscle	Dong	2006	0		
1026	chr21	57853373	57853398	3500166587	23		57853373	57853398	8421504	3	4,4,15	0,5,10	g	350016658700000007,350016658700000062	0-23,17-40						Characterisation of the Membrane and Protein Interactions of the Hepatitis C Virus NS2	s.whiterose.ac.uk	0	0		
1027	chr21	57953170	57953199	3500084751	24		57953170	57953199	8421504	2	17,7	0,22	g	350008475100000000	8-37						Apromoter mutation in the erythroid-speci&#xfb01;c 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia	tologylibrary.org	0	0		
1027	chr21	57986602	57987030	3500104740	381		57986602	57987030	8421504	3	55,83,243	0,101,185	c,g	350010474000000172,350010474000000182,350010474000000216,350010474000000188,350010474000000192,350010474000000194,350010474000000198,350010474000000198,350010474000000202,350010474000000202,350010474000000208,350010474000000208	0-55,0-54,0-34,0-29,0-39,0-40,0-51,0-51,0-53,0-53,0-60,0-60						Untersuchungen zur transkriptionellen Regulation des humanen Chromogranin A Gens und seine Anwendung zum zellspezifischen therapeutischen Gentransfer in neuroendokrine Pankreastumorzellen	ub.uni-marburg.de	0	0		
1027	chr21	57990367	57990445	3500291511	73		57990367	57990445	8421504	2	42,31	0,47	c	350029151100000000,350029151100000001	9-51,8-39		10409115			American Journal of Physiology - Cell Physiolog	Disruption of disulfide bonds exhibits differential effects on trafficking of regulated secretory proteins	Gorr	1999	0		
1027	chr21	57990367	57990445	3500073231	73		57990367	57990445	8421504	2	42,31	0,47	c	350007323100000000,350007323100000001	9-51,8-39		10409115			American Journal of Physiology - Cell Physiolog	Disruption of disulfide bonds exhibits differential effects on trafficking of regulated secretory proteins	Gorr	1999	0		
1027	chr21	57990431	57990455	3500462941	24		57990431	57990455	8421504	1	24	0	c	350046294100000005	0-24						From chromaffin cells to Phaeochromocytoma: insight into the sympathoadrenal cell lineage	ry.murdoch.edu.au	0	0		
1027	chr21	57994102	57995903	3500277905	48		57994102	57995903	8421504	2	10,38	0,1763	c	350027790500000000	0-48		11408599	10.1124/mol.60.1.42	1521-0111 (Online)	Molecular Pharmacology	Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Secretoneurin Release and Secretogranin II Gene Transcription in Bovine Adrenochromaffin Cells through Multiple Signaling Pathways and Increased Binding of Pre-Existing Activator Protein-1-Like	Turquier	2001	0		
1027	chr21	57996302	57999716	3500258602	231		57996302	57999716	8421504	9	4,20,42,27,23,34,15,13,53	0,709,759,804,916,1145,3329,3346,3361	p,c	350025860200015005,350025860200000001,350025860200000004	9-126,0-23,51-166						Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. - ResearchGate	.researchgate.net	0	0		
1027	chr21	57997298	57997343	3500144223	45		57997298	57997343	8421504	1	45	0	p	350014422300015001	0-45		12799369	10.1074/jbc.M305545200	0021-9258	Journal of Biological Chemistry	Catecholamine Secretory Vesicle Stimulus-Transcription Coupling in Vivo	Mahata	2003	5		
1028	chr21	58136635	58136658	3500340510	23		58136635	58136658	8421504	1	23	0	g	350034051000000052	15-39					Patent	Polypeptide derivatives of granulocyte colony stimulating factor (Patent US:5416195)	Camble	1995	0		
1029	chr21	58204141	58204170	3500104717	24		58204141	58204170	8421504	2	9,15	0,14	g	350010471700000094	7-34						Optimierung einer Lipase aus Bacillus subtilis mit neuen Methoden der gerichteten Evolution	ni-duesseldorf.de	0	0		
1033	chr21	58815693	58815722	3500172805	25		58815693	58815722	8421504	2	14,11	0,18	g	350017280500000019	10-35						Safety Analysis of Foods of Animal Origin	www.scribd.com	0	0		
1034	chr21	58882846	58882869	3500186595	23		58882846	58882869	8421504	1	23	0	c	350018659500000026	3-26						 Modified Annexin Proteins And Methods For Preventing Thrombosis 	www.docstoc.com	0	0		
1037	chr21	59273355	59282725	3500079222	1325		59273355	59282725	8421504	6	46,189,148,271,644,27	0,86,1090,2230,3358,9343	p,c	350007922200000009,350007922200015000,350007922200000007,350007922200000008	1-466,0-1248,2-71,1-70						 Centraldogma Ppt Presentation 	.authorstream.com	0	0		
1037	chr21	59273361	59282725	3500327205	1319		59273361	59282725	8421504	6	40,189,148,271,644,27	0,80,1084,2224,3352,9337	p,c	350032720500000008,350032720500015001,350032720500000006	1-320,0-1248,1-70						Central Dogma of Molecular Biology_2_	www.docstoc.com	0	0		
1037	chr21	59274446	59277353	3500440542	60		59274446	59277353	8421504	3	20,20,20	0,2459,2887	c,g	350044054200000007,350044054200000006,350044054200000006,350044054200000005,350044054200000005	0-20,0-20,0-20,0-20,0-20						Methods And Compositions For Genetically Detecting Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
1037	chr21	59277116	59277140	3500338889	24		59277116	59277140	8421504	1	24	0	c	350033888900000016	9-33						Anti-Cancer Agent Comprising Protein C Inhibitor - Patent application	www.faqs.org	0	0		
1037	chr21	59362235	59370874	3500084821	1422		59362235	59370874	8421504	4	353,148,268,653	0,2558,4514,7986	c,g	350008482100000015,350008482100000005,350008482100000005,350008482100000006,350008482100000004,350008482100000001,350008482100000001,350008482100000000,350008482100000000	2-1463,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						 DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE - Patent application	www.faqs.org	0	0		
1037	chr21	59362235	59370874	3500002891	1422		59362235	59370874	8421504	4	353,148,268,653	0,2558,4514,7986	c	350000289100000008	2-1463						Dairy Cattle Breeding For Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
1037	chr21	59362300	59370865	3500341580	70		59362300	59370865	8421504	4	23,20,9,18	0,2520,8537,8547	c,g	350034158000000001,350034158000000002,350034158000000002,350034158000000000	0-23,0-20,0-20,0-27						Molecular characterization and expression profile of uterine serpin (SERPINA14) during different reproductive phases in water buffalo (Bubalus bubalis)	www.docstoc.com	0	0		
1037	chr21	59362300	59370858	3500355754	100		59362300	59370858	8421504	6	20,20,19,1,20,20	0,181,269,2493,4672,8538	c,g	350035575400000005,350035575400000005,350035575400000006,350035575400000004,350035575400000001,350035575400000000,350035575400000000	0-20,0-20,0-20,0-20,0-20,0-20,0-20						DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE	Khatib	2007	0		
1037	chr21	59362300	59370858	3500180185	100		59362300	59370858	8421504	6	20,20,19,1,20,20	0,181,269,2493,4672,8538	c,g	350018018500000005,350018018500000005,350018018500000006,350018018500000004,350018018500000001,350018018500000000,350018018500000000	0-20,0-20,0-20,0-20,0-20,0-20,0-20						DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE	Khatib	2010	0		
1037	chr21	59362300	59370858	3500001677	100		59362300	59370858	8421504	6	20,20,19,1,20,20	0,181,269,2493,4672,8538	c,g	350000167700000005,350000167700000005,350000167700000006,350000167700000004,350000167700000001,350000167700000000,350000167700000000	0-20,0-20,0-20,0-20,0-20,0-20,0-20						Dairy Cattle Breeding For Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
1037	chr21	59362303	59370536	3500465480	131		59362303	59370536	8421504	3	63,48,20	0,8036,8213	p,c	350046548000015001,350046548000015002,350046548000000005	0-63,0-48,0-20		19494250	10.1095/biolreprod.108.075184	0006-3363	Biology of Reproduction	Evidence for Estrogen-Dependent Uterine Serpin (SERPINA14) Expression During Estrus in the Bovine Endometrial Glandular Epithelium and Lumen	Ulbrich	2009	4		
1037	chr21	59362303	59370536	3500137782	131		59362303	59370536	8421504	3	63,48,20	0,8036,8213	p,c	350013778200015001,350013778200015002,350013778200000005	0-63,0-48,0-20		19494250	10.1095/biolreprod.108.075184	0006-3363	Biology of Reproduction	Evidence for Estrogen-Dependent Uterine Serpin (SERPINA14) Expression During Estrus in the Bovine Endometrial Glandular Epithelium and Lumen	Ulbrich	2009	4		
1037	chr21	59362457	59366917	3500319412	206		59362457	59366917	8421504	3	131,51,24	0,2336,4436	p,c	350031941200015016,350031941200015017,350031941200000000	0-182,0-138,0-24						The molecular phylogeny of uterine serpins and its relationship to evolution of placentation	imal.ifas.ufl.edu	0	0		
1037	chr21	59362457	59366917	3500280173	206		59362457	59366917	8421504	3	131,51,24	0,2336,4436	p,c	350028017300015016,350028017300015017,350028017300000000	0-182,0-138,0-24						The molecular phylogeny of uterine serpins and its relationship to evolution of placentation	imal.ifas.ufl.edu	0	0		
1038	chr21	59419726	59419753	3500382274	23		59419726	59419753	8421504	3	4,6,13	0,5,14	g	350038227400000074	8-31						Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof	Dubensky	2004	0		
1038	chr21	59485812	59485854	3500338889	42		59485812	59485854	8421504	1	42	0	c	350033888900000023	0-42						Anti-Cancer Agent Comprising Protein C Inhibitor - Patent application	www.faqs.org	0	0		
1038	chr21	59488478	59489188	3500319412	141		59488478	59489188	8421504	2	51,90	0,620	p	350031941200015007	0-141						The molecular phylogeny of uterine serpins and its relationship to evolution of placentation	imal.ifas.ufl.edu	0	0		
1038	chr21	59488478	59489188	3500280173	141		59488478	59489188	8421504	2	51,90	0,620	p	350028017300015007	0-141						The molecular phylogeny of uterine serpins and its relationship to evolution of placentation	imal.ifas.ufl.edu	0	0		
129	chr21	59489491	59513154	3500261436	65		59489491	59513154	8421504	3	20,20,25	0,81,23638	c	350026143600000096,350026143600000095,350026143600000094	0-20,0-20,0-25						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
129	chr21	59508682	59686262	3500395338	1282		59508682	59686262	8421504	15	60,420,68,97,33,81,30,22,4,203,24,35,31,90,84	0,201,3236,4441,4556,58798,82976,104635,104800,106639,109422,131439,139253,170618,177496	p,c,g	350039533800015000,350039533800000000,350039533800000014,350039533800015002,350039533800000007,350039533800015003,350039533800015006,350039533800000011,350039533800015009,350039533800000012,350039533800000001,350039533800015004,350039533800000013,350039533800000010,350039533800015005,350039533800000015,350039533800000003,350039533800000004,350039533800000005,350039533800015001,350039533800015010	0-60,0-23,0-27,0-210,0-21,0-210,0-165,0-24,0-90,0-30,0-22,0-90,0-26,0-20,0-108,0-27,0-24,0-35,0-31,48-138,0-84						BMC Genomics BioMed Central	biomedcentral.com	0	0		
1040	chr21	59679379	59679408	3500328917	29		59679379	59679408	8421504	1	29	0	c	350032891700000136	19-48						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
1041	chr21	59863919	59864256	3500441786	23		59863919	59864256	8421504	2	8,15	0,322	c	350044178600000047	0-23						METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS	Kelly	2008	0		
1041	chr21	59863919	59864256	3500301494	23		59863919	59864256	8421504	2	8,15	0,322	c	350030149400000106,350030149400000047	0-23,0-23						METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		
1041	chr21	59863919	59864256	3500200603	23		59863919	59864256	8421504	2	8,15	0,322	c	350020060300000033	0-23						CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS	Agulnick	2013	0		
1041	chr21	59863919	59864256	3500192479	23		59863919	59864256	8421504	2	8,15	0,322	c	350019247900000047	0-23						METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS	Kelly	2012	0		
1041	chr21	59863919	59864256	3500093061	23		59863919	59864256	8421504	2	8,15	0,322	c	350009306100000034	0-23						Agents and methods for inhibiting human pluripotent stem cell growth	Robins	2012	0		
1041	chr21	59863919	59864256	3500071111	23		59863919	59864256	8421504	2	8,15	0,322	c	350007111100000033	0-23						SMALL MOLECULES SUPPORTING PLURIPOTENT CELL GROWTH AND METHODS THEREOF - SCHULZ, Thomas C.	www.sumobrain.com	0	0		
1041	chr21	59866953	59866982	3500235521	25		59866953	59866982	8421504	2	18,7	0,22	g	350023552100000469	5-30						IMPROVED METHODS FOR TRANSFORMING PHAFFIA STRAINS, TRANSFORMED PHAFFIA STRAINS SO OBTAINED AND RECOMBINANT DNA IN SAID METHODS - Gist-brocades B.	www.sumobrain.com	0	0		
1044	chr21	60209248	60209946	3500452517	267		60209248	60209946	8421504	3	163,76,28	0,488,670	p	350045251700015001	0-270						The double-stranded RNA binding domain of human Dicer functions as a nuclear localization signal	journal.cshlp.org	0	0		DICER1
1044	chr21	60210075	60251875	3500042254	756		60210075	60251875	8421504	18	6,42,12,36,48,44,48,36,11,48,48,10,86,42,47,48,48,96	0,3245,6083,9092,12307,12551,12694,12743,13837,13944,19380,25938,33415,35269,37519,38111,39643,41704	c,g	350004225400000164,350004225400000140,350004225400000130,350004225400000125,350004225400000122,350004225400000121,350004225400000118,350004225400000099,350004225400000081,350004225400000080,350004225400000069,350004225400000069,350004225400000067,350004225400000064,350004225400000061,350004225400000055,350004225400000054	0-48,0-48,0-48,0-44,0-48,0-47,0-48,0-48,0-48,0-48,6-48,6-48,1-48,0-48,0-48,0-48,0-48						Methods and compositions for RNA interference - Patent application	www.faqs.org	0	0		
1044	chr21	60213551	60251923	3500096750	477		60213551	60251923	8421504	15	38,7,38,45,44,19,26,20,6,48,42,48,23,25,48	0,1730,5731,8606,9101,9284,10361,14013,15898,17493,31793,36167,36263,37264,38324	c	350009675000000113,350009675000000090,350009675000000087,350009675000000076,350009675000000072,350009675000000051,350009675000000045,350009675000000020,350009675000000012,350009675000000010,350009675000000004	0-45,0-38,0-45,1-45,0-45,0-26,0-48,6-48,0-48,0-48,0-48						Methods and compositions for RNA Interference - Patent application	www.faqs.org	0	0		
1044	chr21	60219278	60222076	3500463397	51		60219278	60222076	8421504	2	45,6	0,2792	p	350046339700015000	0-51		23882114	10.1261/rna.039255.113	1355-8382	RNA	The double-stranded RNA binding domain of human Dicer functions as a nuclear localization signal	Doyle	2013	5		DICER1
1044	chr21	60222703	60251853	3500105701	59		60222703	60251853	8421504	4	19,8,12,20	0,27126,28112,29130	c,g	350010570100000008,350010570100000008,350010570100000001,350010570100000000,350010570100000000	0-19,0-19,0-20,0-20,0-20		18978195	10.1152/ajpheart.00233.2008		American Journal of Physiology - Heart and Circulatory Physiology	Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis	Asada	2008	0		DICER1
1044	chr21	60222703	60251853	3500100648	59		60222703	60251853	8421504	4	19,8,12,20	0,27126,28112,29130	c,g	350010064800000008,350010064800000008,350010064800000001,350010064800000000,350010064800000000	0-19,0-19,0-20,0-20,0-20		18978195	10.1152/ajpheart.00233.2008		American Journal of Physiology - Heart and Circulatory Physiology	Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis	Asada	2008	0		DICER1
1044	chr21	60224659	60227482	3500273746	156		60224659	60227482	8421504	3	43,41,72	0,309,2751	p	350027374600015013,350027374600015011,350027374600015004,350027374600015003	0-84,0-84,39-111,0-72						Dicer recognizes the 5&#x2032; end of RNA for efficient and accurate processing	tbiotech.um.ac.ir	0	0		DICER1
1044	chr21	60227579	60230279	3500000595	40		60227579	60230279	8421504	4	5,15,14,6	0,1870,1996,2694	c	350000059500000003,350000059500000002	0-20,0-20		19789347	10.1158/0008-5472.CAN-09-0986	0008-5472	Cancer Research	An A13 Repeat within the 3&#x2032;-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression	Yuan	2009	8		DICER1
1044	chr21	60234607	60249709	3500111171	43		60234607	60249709	8421504	4	18,3,19,3	0,1283,13692,15099	c	350011117100000004,350011117100000005,350011117100000006,350011117100000007	0-19,0-21,0-20,0-21						Docherty, Louise E. (2007) Idendification and characterisation of novel small RNAs from repetitve elements in mammals.	theses.gla.ac.uk	0	0		DICER1
1044	chr21	60248186	60248231	3500122942	45		60248186	60248231	8421504	1	45	0	c	350012294200000064	0-45						 Methods And Compositions For RNA Interference 	www.docstoc.com	0	0		
1044	chr21	60248194	60248318	3500363090	49		60248194	60248318	8421504	2	23,26	0,98	c	350036309000000006,350036309000000005	0-23,0-26						The adenoviral control of the RNAi-microRNA pathway: How and why	ibg.uu.se/digital	0	0		DICER1
1044	chr21	60250953	60251853	3500343501	38		60250953	60251853	8421504	2	19,19	0,881	c,g	350034350100000030,350034350100000028,350034350100000028,350034350100000029,350034350100000029	0-19,0-19,0-19,0-19,0-19						Inhibitory polynucleotide compositions and methods for treating cancer	Liu	2008	0		DICER1
1044	chr21	60251841	60251864	3500349612	23		60251841	60251864	8421504	1	23	0	c,g	350034961200000016,350034961200000015,350034961200000015	0-21,0-21,0-21		16227573	10.1128/MCB.25.21.9198-9208.2005	0270-7306	Molecular and Cellular Biology	Micro-RNA Regulation of the Mammalian lin-28 Gene during Neuronal Differentiation of Embryonal Carcinoma Cells	Wu	2005	6		DICER1
1044	chr21	60251841	60251864	3500168241	23		60251841	60251864	8421504	1	23	0	c,g	350016824100000016,350016824100000015,350016824100000015	0-21,0-21,0-21		16227573	10.1128/MCB.25.21.9198-9208.2005		Molecular and Cellular Biology	Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells.	Wu	2005	0		DICER1
1046	chr21	60433303	60433331	3500448386	23		60433303	60433331	8421504	3	7,12,4	0,11,24	g	350044838600000021	2-26						P-cadherin as a target for anti-cancer therapy	Reinhard	2002	0		
1046	chr21	60537210	60537242	3500194368	27		60537210	60537242	8421504	3	6,16,5	0,9,27	g	350019436800000622,350019436800000435,350019436800000053,350019436800000482,350019436800000591,350019436800000701	2-24,2-24,3-24,3-24,3-30,3-24						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
1049	chr21	60943675	60943706	3500026102	23		60943675	60943706	8421504	3	11,5,7	0,14,24	g	350002610200000003	6-29		23936053	10.1371/journal.pone.0069582		PLoS ONE	Biochemical and Biophysical Characterization of the Deadenylase CrCaf1 from Chlamydomonas reinhardtii	Jia-Quan	2013	0		
1050	chr21	61065726	61065754	3500222750	23		61065726	61065754	8421504	2	7,16	0,12	g	350022275000000054	13-40					Patent	Protein kinases (Patent US:6060296)	Hoekstra	2000	0		
1051	chr21	61202912	61202940	3500344178	24		61202912	61202940	8421504	2	14,10	0,18	g	350034417800000014	8-32						AN&#xc1;LISIS GEN&#xc9;TICO DE MARCADORES MICROSAT&#xc9;LITES EN DOS POBLACIONES DE LA RAZA BOVINA BERRENDA EN NEGRO (GENETIC ANALYSIS OF MICROSATELLITES MARKERS IN TWO POPULATIONS OF BERRENDA EN NEGRO BOVINE BREED) - Zamorano, M.J. - Otros	es.youscribe.com	0	0		
131	chr21	61320665	61348635	3500058101	82		61320665	61348635	8421504	4	23,20,19,20	0,120,27870,27950	c,g	350005810100000002,350005810100000003,350005810100000004,350005810100000004,350005810100000005,350005810100000005	0-23,0-20,0-19,0-19,0-20,0-20						CARACTERIZA&#xc7;&#xc3;O DO SISTEMA CALICRE&#xcd;NA- CININA DURANTE O PROCESSO OVULAT&#xd3;RIO DE BOVINOS	cavel.cpd.ufsm.br	0	0		
1054	chr21	61543291	61543830	3500204964	43		61543291	61543830	8421504	2	20,23	0,516	c	350020496400000011,350020496400000012	0-20,0-23						CHARACTERIZATION OF PORCINE ADIPOSE TISSUE-DERIVED STEM CELLS	etd.lsu.edu	0	0		
1054	chr21	61549013	61552619	3500444068	180		61549013	61552619	8421504	4	38,52,59,31	0,2813,2866,3575	c	350044406800000005,350044406800000007	0-90,0-90						 STAR: ultrafast universal RNA-seq aligner - Page 3 - SEQanswers	seqanswers.com	0	0		
1054	chr21	61552588	61556222	3500116987	41		61552588	61556222	8421504	2	20,21	0,3613	c,g	350011698700000012,350011698700000012,350011698700000013,350011698700000013	0-20,0-20,0-21,0-21						Analysis of Gene Transcription in Bovine Nuclear Transfer Embryos: RESULTS | Medicine Healthiest	ne-healthiest.com	0	0		PAPOLA
1054	chr21	61557282	61561906	3500419427	51		61557282	61561906	8421504	2	26,25	0,4599	c	350041942700000066,350041942700000202	0-26,0-25						AIMP2-DX2 Gene and its Uses - Patent application	www.faqs.org	0	0		PAPOLA
1054	chr21	61557282	61561906	3500233541	51		61557282	61561906	8421504	2	26,25	0,4599	c	350023354100000066,350023354100000016,350023354100000202	0-26,15-37,0-25						Antibody Specific to the AIMP2-DX2 - Patent application	www.faqs.org	0	0		PAPOLA
1054	chr21	61557282	61561906	3500084892	51		61557282	61561906	8421504	2	26,25	0,4599	c,g	350008489200000066,350008489200000066,350008489200000202	0-26,0-26,0-25						AIMP2-DX2 Gene and SiRNA Targeting AIMP2-DX2 - Patent application	www.faqs.org	0	0		PAPOLA
1054	chr21	61566271	61569409	3500270590	40		61566271	61569409	8421504	2	21,19	0,3119	c,g	350027059000000006,350027059000000006,350027059000000007,350027059000000007	0-21,0-21,0-19,0-19						CELL EXTRACT-BASED REPROGRAMMING OF SOMATIC CELLS	etd.lsu.edu	0	0		
1055	chr21	61642274	61642303	3500041044	26		61642274	61642303	8421504	3	4,8,14	0,5,15	g	350004104400000067	12-38						US Patent # 7,446,169. Human tumor necrosis factor receptor-like 2 - Patents.com	www.patents.com	0	0		
1055	chr21	61656849	61656872	3500344082	23		61656849	61656872	8421504	1	23	0	g	350034408200000027	15-38						US Patent # 6,265,639. Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use - Patents.com	www.patents.com	0	0		
1056	chr21	61823474	61823498	3500227853	23		61823474	61823498	8421504	2	12,11	0,13	g	350022785300000012	11-34						ATTENUATED LISTERIA SPP. AND METHODS FOR USING THE SAME - Patent application	www.faqs.org	0	0		
1057	chr21	61874623	61874647	3500271231	24		61874623	61874647	8421504	1	24	0	c	350027123100000000,350027123100000001	7-31,0-24		19103756	10.1128/MCB.01341-08	0270-7306	Molecular and Cellular Biology	Plk3 Interacts with and Specifically Phosphorylates VRK1 in Ser342, a Downstream Target in a Pathway That Induces Golgi Fragmentation	Lopez-Sanchez	2009	6		
1057	chr21	61874623	61874647	3500238252	24		61874623	61874647	8421504	1	24	0	c	350023825200000000,350023825200000001	7-31,0-24		19103756	10.1128/MCB.01341-08	0270-7306	Molecular and Cellular Biology	Plk3 Interacts with and Specifically Phosphorylates VRK1 in Ser342, a Downstream Target in a Pathway That Induces Golgi Fragmentation	Lopez-Sanchez	2009	6		
1057	chr21	61894862	61894896	3500291921	29		61894862	61894896	8421504	2	10,19	0,15	c	350029192100000132	4-33						DOWN-REGULATION OF MORTALIN BY siRNA - Patent application	www.faqs.org	0	0		
1058	chr21	62108748	62108773	3500361995	23		62108748	62108773	8421504	2	9,14	0,11	g	350036199500000008	0-23						<HTML> <HEAD> <BASE TARGET="_top"> <TITLE>United States Patent: 5,494,810</TITLE></HEAD> <BODY 	l.med.cornell.edu	0	0		
1069	chr21	63569249	63569276	3500033264	23		63569249	63569276	8421504	3	13,5,5	0,15,22	g	350003326400000010	0-23						DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes - Patent application	www.faqs.org	0	0		
1076	chr21	64413544	64413570	3500214416	23		64413544	64413570	8421504	2	14,9	0,17	g	350021441600004267	20-43						MOLECULAR CHARACTERIZATION OF THEILERIA spp. USING RIBOSOMAL RNA	pository.tamu.edu	0	0		
1076	chr21	64461837	64461862	3500129036	25		64461837	64461862	8421504	1	25	0	g	350012903600000001	0-25						Chromosomallocalization ofthe callipyge sheep(Ovis aries) using bovine DNAmarkers	www.pnas.org	0	0		
1078	chr21	64705856	64708107	3500081248	120		64705856	64708107	8421504	3	2,82,36	0,680,2215	p	350008124800015018	0-120						NPG.nature.vol.409.Issue.6822.Feb	www.scribd.com	0	0		CCNK
1078	chr21	64714361	64720774	3500213673	39		64714361	64720774	8421504	2	19,20	0,6393	c	350021367300000004,350021367300000003	0-19,0-20		22988298	10.1128/MCB.06267-11		Molecular and Cellular Biology	Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II	S.-W.	2012	0		CCDC85C,CCNK
1078	chr21	64714361	64720774	3500089965	39		64714361	64720774	8421504	2	19,20	0,6393	c	350008996500000004,350008996500000003	0-19,0-20		22988298	10.1128/MCB.06267-11	0270-7306	Molecular and Cellular Biology	Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II	Cheng	2012	6		CCDC85C,CCNK
1079	chr21	64799224	64799248	3500306285	23		64799224	64799248	8421504	2	4,19	0,5	c	350030628500000000	0-23						Petra Riedl, J&#xf6;rg Reimann, and Reinhold Schirmbeck for DNA Vaccines, Methods and Protocols	www.scribd.com	0	0		
1079	chr21	64861910	64865947	3500190573	116		64861910	64865947	8421504	3	25,31,60	0,3766,3977	c	350019057300000051,350019057300000057,350019057300000058	23-48,5-48,0-48						Use of the CYP46A1 Gene for the Treatment of Alzheimer's Disease - Patent application	www.faqs.org	0	0		
1081	chr21	65038010	65038033	3500104979	23		65038010	65038033	8421504	1	23	0	g	350010497900000418	25-48						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
1082	chr21	65258031	65258054	3500242595	23		65258031	65258054	8421504	1	23	0	c	350024259500000019	0-23						Method for identifying alzheimer's disease therapeutics using transgenic animal models	Mcconlogue	1996	0		
1082	chr21	65258120	65258143	3500219075	23		65258120	65258143	8421504	1	23	0	c	350021907500000118	9-39						 Polynucleotides Encoding KAPPA Opiod Receptors 	www.docstoc.com	0	0		
1082	chr21	65258279	65258351	3500323709	63		65258279	65258351	8421504	2	39,24	0,48	p	350032370900015007	0-63						Isolation of a Candidate Repressor/Activator, NF-E1 (YY-1, &#x03b4;), that Binds to the Immunoglobulin &#x03ba; 3' Enhancer and the Immunoglobulin Heavy-Chain &#x03bc;E1 Site	www.jstor.org	0	0		
135	chr21	65258443	65282676	3500426896	67		65258443	65282676	8421504	3	19,24,24	0,23905,24209	c	350042689600000002,350042689600000007,350042689600000008	0-19,0-24,0-24		17050536	10.1074/jbc.M605820200	0021-9258	Journal of Biological Chemistry	The Repression of Human Differentiation-related Gene NDRG2 Expression by Myc via Miz-1-dependent Interaction with the NDRG2 Core Promoter	Zhang	2006	5		YY1
1082	chr21	65272067	65272091	3500404408	24		65272067	65272091	8421504	1	24	0	c	350040440800000002	0-24		17353273	10.1128/MCB.01761-06	0270-7306	Molecular and Cellular Biology	PIASy-Mediated Sumoylation of Yin Yang 1 Depends on Their Interaction but Not the RING Finger	Deng	2007	6		YY1
135	chr21	65272084	65282147	3500176332	291		65272084	65282147	8421504	4	60,111,9,111	0,8993,9883,9952	p	350017633200015012,350017633200015015,350017633200015016,350017633200015018,350017633200015019	0-60,0-60,0-60,0-60,0-51						&#x570b;&#x7acb;&#x6210;&#x529f;&#x5927;&#x5b78; &#x751f;&#x7269;&#x79d1;&#x6280;&#x7814;&#x7a76;&#x6240;	u.lib.ncku.edu.tw	0	0		
1083	chr21	65279309	65281042	3500435857	38		65279309	65281042	8421504	3	19,6,13	0,32,1720	c,g	350043585700000008,350043585700000008,350043585700000009	0-19,0-19,0-19		19566924	10.1186/bcr2329	1465-5411	Breast Cancer Research	The role of YY1 in reduced HP1&#xce;&#xb1; gene expression in invasive human breast cancer cells	Lieberthal	2009	0		YY1
1083	chr21	65279309	65281042	3500400119	38		65279309	65281042	8421504	3	19,6,13	0,32,1720	c,g	350040011900000007,350040011900000007,350040011900000008	0-19,0-19,0-19						Vol 11 No 3Research article Open Access The role of YY1 in reduced HP1 gene expression in invasive human breast cancer cells	biomedcentral.com	0	0		YY1
1083	chr21	65279320	65282150	3500347923	47		65279320	65282150	8421504	2	22,25	0,2805	c,g	350034792300000003,350034792300000003,350034792300000004	0-22,0-22,0-25						EVOLUTION OF YY1, YY2, REX1 AND DNA-BINDING MOTIFS IN VERTEBRATE GENOMES	etd.lsu.edu	0	0		
1083	chr21	65279320	65282150	3500210160	47		65279320	65282150	8421504	2	22,25	0,2805	c	350021016000000007,350021016000000008	0-22,0-25		18950698	10.1016/j.ygeno.2008.09.013		Genomics	YY1's longer DNA-binding motifs	Jeong	2009	0		
1083	chr21	65281030	65281055	3500239410	25		65281030	65281055	8421504	1	25	0	c	350023941000000011	0-25		19237543	10.1074/jbc.M808747200	0021-9258	Journal of Biological Chemistry	FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action	Shin	2009	5		
1083	chr21	65282051	65282123	3500244161	72		65282051	65282123	8421504	1	72	0	p	350024416100015008	0-72						Helene Touzet	www.lifl.fr	0	0		YY1
1083	chr21	65282051	65282120	3500214246	69		65282051	65282120	8421504	1	69	0	p	350021424600015000,350021424600015019	0-69,0-54						Alignement multiple ClustalW	polytech.unice.fr	0	0		YY1
1083	chr21	65282349	65282374	3500215215	25		65282349	65282374	8421504	1	25	0	c	350021521500000219	0-25						Arrays and Methods for Reverse Genetic Functional Analysis - Patent application	www.faqs.org	0	0		
1083	chr21	65301961	65301988	3500180733	23		65301961	65301988	8421504	3	4,5,14	0,5,13	g	350018073300000008	12-35						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
1086	chr21	65707512	65707660	3500108401	142		65707512	65707660	8421504	7	29,28,9,20,28,9,19	0,30,59,69,90,119,129	g	350010840100000000,350010840100000001	18-160,210-352						Herman Raadsma	sydney.edu.au	0	0		
1086	chr21	65707888	65707915	3500114334	27		65707888	65707915	8421504	1	27	0	c	350011433400000004	0-27			10.1016/j.mce.2007.04.002		Molecular and cellular endocrinology	Regulation of Growth Hormone Expression by Delta-Like Protein 1 (Dlk1)	PeJ.	June	0		
1086	chr21	65765210	65765300	3500314401	90		65765210	65765300	8421504	1	90	0	g	350031440100000056,350031440100000034	0-90,0-52						SI appendix for	www.pnas.org	0	0		
1086	chr21	65775211	65775239	3500360236	23		65775211	65775239	8421504	2	9,14	0,14	g	350036023600000006	10-33						Molecular Cloning and Characterization of the Fern	cdn.intechweb.org	0	0		
1086	chr21	65775211	65775239	3500119220	23		65775211	65775239	8421504	2	9,14	0,14	g	350011922000000006	10-33						Molecular cloning and characterization of fe superoxide dismutase fe sod from the fern ceratopteris thalictroides	www.docstoc.com	0	0		
1087	chr21	65801000	65801174	3500062421	43		65801000	65801174	8421504	2	21,22	0,152	g	350006242100000002,350006242100000003	0-21,0-22		15044262	10.1095/biolreprod.103.025775	0006-3363	Biology of Reproduction	Epigenetic and Genomic Imprinting Analysis in Nuclear Transfer Derived Bos gaurus/Bos taurus Hybrid Fetuses	Dindot	2004	4		
1087	chr21	65855938	65855963	3500046565	25		65855938	65855963	8421504	1	25	0	c	350004656500000001	106-131		22829954	10.1371/journal.pone.0041504		PLoS ONE	A Novel Vector-Based Method for Exclusive Overexpression of Star-Form MicroRNAs	Bo	2012	0		MIR127
1087	chr21	65855939	65857601	3500423784	45		65855939	65857601	8421504	2	22,23	0,1639	c,g	350042378400000029,350042378400000029,350042378400000041,350042378400000041	0-22,0-22,0-23,0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR136,MIR127
1087	chr21	65857391	65857414	3500322980	23		65857391	65857414	8421504	1	23	0	c	350032298000000004	0-23						AD (Leave blank)	handle.dtic.mil	0	0		MIR136
1087	chr21	65857578	65857601	3500400478	23		65857578	65857601	8421504	1	23	0	c	350040047800000167	0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		MIR136
1087	chr21	65857578	65857601	3500367476	23		65857578	65857601	8421504	1	23	0	c	350036747600000008	0-23						Polymorphism discovery and allele frequency estimation using high-throughput DNA sequencing of target-enriched pooled DNA samples. - ResearchGate	.researchgate.net	0	0		
1087	chr21	65857578	65857601	3500357539	23		65857578	65857601	8421504	1	23	0	c,g	350035753900000167,350035753900000167	0-23,0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		MIR136
1087	chr21	65857578	65857601	3500244257	23		65857578	65857601	8421504	1	23	0	c	350024425700000024	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR136
1087	chr21	65857578	65857601	3500210973	23		65857578	65857601	8421504	1	23	0	c	350021097300000167	0-23						Microrna molecules	Tuschl	2002	0		MIR136
1087	chr21	65857578	65857601	3500131966	23		65857578	65857601	8421504	1	23	0	c,g	350013196600000024,350013196600000024	0-23,0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR136
1088	chr21	65988204	66026889	3500080517	280		65988204	66026889	8421504	8	19,19,25,24,25,22,77,69	0,43,2917,17555,17598,21234,31002,38616	c,g	350008051700000047,350008051700000047,350008051700000010,350008051700000010,350008051700000033,350008051700000048,350008051700000048,350008051700000024,350008051700000002,350008051700000044,350008051700000044,350008051700000054,350008051700000004,350008051700000004,350008051700000049,350008051700000049,350008051700000015,350008051700000050,350008051700000050,350008051700000016,350008051700000005,350008051700000045,350008051700000006,350008051700000006,350008051700000028,350008051700000028	0-19,0-19,0-19,0-19,13-38,0-19,0-19,14-38,13-37,0-21,0-21,0-21,0-20,0-20,0-22,0-22,12-70,0-22,0-22,0-28,13-70,0-22,0-21,0-21,0-20,0-20						Microrna And Methods For Inhibiting Same 	.freshpatents.com	0	0		MIR494,MIR496,MIR668,MIR655,MIR654,MIR323A,MIR323B,MIR381,MIR380,MIR382,MIR376C,MIR539,MIR411,MIR543,MIR376A1
1088	chr21	65989889	65989952	3500178078	63		65989889	65989952	8421504	1	63	0	c	350017807800000003,350017807800000002	7-70,6-69		19538464	10.1111/j.1582-4934.2009.00821.x	1582-4934	Journal of Cellular and Molecular Medicine	Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299&#x2013;5p regulated de novo expression of osteopontin - Shevde - 2009 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Shevde	2010	0		MIR411
1088	chr21	65989923	66009458	3500306561	64		65989923	66009458	8421504	3	22,22,20	0,1913,19515	c,g	350030656100000064,350030656100000071,350030656100000071,350030656100000108	1-23,22-44,22-44,24-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
1088	chr21	65991121	66026886	3500460660	147		65991121	66026886	8421504	5	25,24,27,49,22	0,14638,18317,28085,35743	c,g	350046066000000034,350046066000000025,350046066000000015,350046066000000016,350046066000000046,350046066000000074,350046066000000114	13-38,14-38,0-27,12-70,0-22,0-22,0-22						MICRORNA AND METHODS FOR INHIBITING SAME - Patent application	www.faqs.org	0	0		
1088	chr21	65991121	66019255	3500325524	77		65991121	66019255	8421504	2	25,52	0,28082	c,g	350032552400000033,350032552400000037,350032552400000015	13-38,10-70,12-70						MicroRNA and methods for inhibiting same	Stoffel	2008	0		
1088	chr21	65991836	66024404	3500423784	65		65991836	66024404	8421504	3	22,21,22	0,27757,32546	c,g	350042378400000110,350042378400000110,350042378400000038,350042378400000055	0-22,0-22,0-21,0-22						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR494,MIR496,MIR668,MIR655,MIR654,MIR323A,MIR323B,MIR381,MIR382,MIR376C,MIR539,MIR543,MIR376A1
1088	chr21	65992876	66024404	3500114594	133		65992876	66024404	8421504	6	22,22,22,22,23,22	0,6730,16562,26717,28182,31506	c,g	350011459400000884,350011459400000457,350011459400000910,350011459400000483,350011459400000897,350011459400000470,350011459400000415,350011459400000842,350011459400000478,350011459400000478,350011459400000905,350011459400000905,350011459400000423,350011459400000850	0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-23,0-23,0-23,0-23,0-22,0-22						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR494,MIR496,MIR668,MIR655,MIR654,MIR323A,MIR323B,MIR381,MIR380,MIR382,MIR376C,MIR539,MIR411,MIR543,MIR376A1
1088	chr21	66007701	66007724	3500325982	23		66007701	66007724	8421504	1	23	0	c	350032598200000003	0-23						Human Villous Trophoblasts Express and Secrete Placenta-Specific MicroRNAs into Maternal Circulation via Exosomes	ww.biolreprod.org	0	0		MIR381
1088	chr21	66019593	66024404	3500244257	43		66019593	66024404	8421504	2	21,22	0,4789	c	350024425700000022,350024425700000036	0-21,0-22						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR323B,MIR382,MIR496,MIR668
1088	chr21	66019593	66024404	3500131966	43		66019593	66024404	8421504	2	21,22	0,4789	c	350013196600000022,350013196600000036	0-21,0-22						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR323B,MIR382,MIR496,MIR668
1088	chr21	66029770	66029793	3500432440	23		66029770	66029793	8421504	1	23	0	c	350043244000000008	0-23		19892711	10.1074/jbc.M109.057141		The Journal of Biological Chemistry	MicroRNA-7 Modulates CD98 Expression during Intestinal Epithelial Cell Differentiation	Hang	2010	0		MIR412
1089	chr21	66088984	66089015	3500007191	23		66088984	66089015	8421504	3	6,12,5	0,11,26	g	350000719100000081	16-39						Non-anaphylactogenic IgE fusion proteins	Morsey	2005	0		
1090	chr21	66319266	66319291	3500059076	23		66319266	66319291	8421504	2	10,13	0,12	g	350005907600000254	19-42						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE	Frank-Kamenetsky	2009	0		
1090	chr21	66319266	66319291	3500024490	23		66319266	66319291	8421504	2	10,13	0,12	g	350002449000000254	19-42						Compositions and methods for inhibiting expression of Nav1.8 gene	Sah	2006	0		
1092	chr21	66568882	66568912	3500172400	25		66568882	66568912	8421504	2	10,15	0,15	c	350017240000000022	24-49		10722749	10.1074/jbc.275.12.9001	0021-9258	Journal of Biological Chemistry	Identification of Endoglycan, a Member of the CD34/Podocalyxin Family of Sialomucins	Sassetti	2000	5		
1095	chr21	66905694	66905720	3500003486	24		66905694	66905720	8421504	3	5,4,15	0,6,11	g	350000348600000402,350000348600000390	21-45,5-24						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		
1095	chr21	66958745	66962440	3500423353	432		66958745	66962440	8421504	5	123,18,18,201,72	0,1630,3228,3338,3623	p	350042335300015015,350042335300015019,350042335300015021	0-141,0-147,0-150						Disruption	labs.bio.unc.edu	0	0		DYNC1H1
1096	chr21	67012278	67012555	3500145630	50		67012278	67012555	8421504	2	25,25	0,252	c	350014563000000022,350014563000000023	0-25,0-25						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1096	chr21	67012797	67016864	3500298955	1683		67012797	67016864	8421504	11	107,334,75,134,148,39,72,111,134,367,162	0,386,1008,1143,1439,1695,1743,2609,3006,3449,3905	p	350029895500015106,350029895500015093,350029895500015080,350029895500015079,350029895500015045,350029895500015033	0-144,0-372,0-321,0-72,0-441,0-333						Plant Molecular Biology & Biotechnology	ciencejournal.net	0	0		HSP90AA1
1096	chr21	67013453	67013812	3500337770	43		67013453	67013812	8421504	3	20,16,7	0,48,352	c	350033777000000009,350033777000000008	0-20,0-23						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		HSP90AA1
1096	chr21	67014003	67014066	3500389626	63		67014003	67014066	8421504	1	63	0	p	350038962600015019	0-63						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		HSP90AA1
1096	chr21	67014003	67014066	3500061337	63		67014003	67014066	8421504	1	63	0	p	350006133700015030	0-63						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		HSP90AA1
1096	chr21	67014294	67014318	3500133501	24		67014294	67014318	8421504	1	24	0	c	350013350100000006	0-24						Expression of K6W-ubiquitin in lens epithelial cells leads to upregulation of a broad spectrum of molecular chaperones	www.molvis.org	0	0		AADAT
1096	chr21	67015466	67016849	3500158729	696		67015466	67016849	8421504	5	51,134,157,207,147	0,337,780,940,1236	p	350015872900015012,350015872900015009,350015872900015006,350015872900015003	0-165,0-177,0-174,0-180						Malaria Journal BioMed Central	alariajournal.com	0	0		HSP90AA1
1096	chr21	67016284	67016403	3500281920	40		67016284	67016403	8421504	2	20,20	0,99	c,g	350028192000000035,350028192000000035,350028192000000034	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
1096	chr21	67016606	67017353	3500395598	41		67016606	67017353	8421504	3	7,13,21	0,96,726	c,g	350039559800000007,350039559800000006,350039559800000006	0-20,0-21,0-21						Consequences of physiological heat shock beginning at the zygote stage on embryonic development and expression of stress response genes in cattle	imal.ifas.ufl.edu	0	0		
1096	chr21	67016606	67017353	3500280109	41		67016606	67017353	8421504	3	7,13,21	0,96,726	c,g	350028010900000007,350028010900000006,350028010900000006	0-20,0-21,0-21						Consequences of physiological heat shock beginning at the zygote stage on embryonic development and expression of stress response genes in cattle	imal.ifas.ufl.edu	0	0		
1098	chr21	67284317	67284346	3500408122	24		67284317	67284346	8421504	2	10,14	0,15	c	350040812200000023	12-36						Sequences encoding ADAMTS13 genes and proteins	Ginsburg	2006	0		
1098	chr21	67340893	67340917	3500184695	23		67340893	67340917	8421504	2	10,13	0,11	g	350018469500000007	6-34			10.1111/j.1365-313X.2005.02436.x	1365-313X	The Plant Journal	Necrotizing activity of five Botrytis cinerea endopolygalacturonases produced in Pichia pastoris - Kars - 2005 - The Plant Journal - Wiley Online Library	Kars	2005	0		
1098	chr21	67351673	67351706	3500042432	26		67351673	67351706	8421504	4	4,6,5,11	0,5,15,22	g	350004243200000178	14-43						Astrocyte Modulated Genes And Uses Thereof 	.freshpatents.com	0	0		
1101	chr21	67718975	67718999	3500023748	24		67718975	67718999	8421504	1	24	0	c	350002374800000004	0-24		12970138	10.1136/gut.52.10.1448	1468-3288	Gut	Inducible CD40 expression mediates NF&#x03ba;B activation and cytokine secretion in human colonic fibroblasts	Gelbmann	2003	0		
1101	chr21	67738247	67738979	3500256587	174		67738247	67738979	8421504	2	7,167	0,565	p	350025658700015032,350025658700015033	0-120,0-54						Polypeptides that bind Trail-R1 and Trail-R2	Bowdish	2010	0		TRAF3
1101	chr21	67738247	67738979	3500095845	174		67738247	67738979	8421504	2	7,167	0,565	p	350009584500015031,350009584500015032	0-72,0-102						Polypeptides that Bind TRAIL-R1 and TRAIL-R2	Bowdish	2012	0		TRAF3
1101	chr21	67738247	67738967	3500198756	162		67738247	67738967	8421504	2	7,155	0,565	p	350019875600015037,350019875600015038	0-81,0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Le	2010	0		TRAF3
1101	chr21	67738247	67738967	3500117727	162		67738247	67738967	8421504	2	7,155	0,565	p	350011772700015035,350011772700015036	0-81,0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Holtet	2011	0		TRAF3
1101	chr21	67738817	67738892	3500156102	72		67738817	67738892	8421504	2	27,45	0,30	p	350015610200015013	0-72						TNF-.alpha. variants - Patent # 7056695 - PatentGenius	.patentgenius.com	0	0		TRAF3
1103	chr21	67919828	67919865	3500440489	37		67919828	67919865	8421504	1	37	0	g	350044048900000024	11-48						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
1104	chr21	68099793	68099822	3500300591	24		68099793	68099822	8421504	2	16,8	0,21	g	350030059100000336	11-35						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
1106	chr21	68291115	68291144	3500352177	24		68291115	68291144	8421504	2	14,10	0,19	g	350035217700000258	24-48						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
1106	chr21	68291115	68291144	3500241103	24		68291115	68291144	8421504	2	14,10	0,19	g	350024110300000133	24-48						Antibodies That Bind OV064 and Methods of Use Therefor - Patent application	www.faqs.org	0	0		
1106	chr21	68294022	68294046	3500249537	24		68294022	68294046	8421504	1	24	0	c	350024953700000006	3-27						The Generation of the Oxidized Form of Creatine Kinase Is a Negative Regulation on Muscle Creatine Kinase--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;	journal.9med.net	0	0		
1106	chr21	68295094	68295123	3500075252	29		68295094	68295123	8421504	1	29	0	c	350007525200000400	10-39						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
1107	chr21	68531135	68531242	3500354494	25		68531135	68531242	8421504	2	18,7	0,100	c	350035449400000294,350035449400000295	0-28,3-31						Modified cytosine deaminases - Patent application	www.faqs.org	0	0		
1110	chr21	68854289	68854314	3500007099	23		68854289	68854314	8421504	3	12,5,6	0,13,19	g	350000709900000271	0-25						Uses Of Myostatin Antagonists 	.freshpatents.com	0	0		
1111	chr21	68987315	68987340	3500122973	23		68987315	68987340	8421504	2	12,11	0,14	g	350012297300000004	18-42						METHOD FOR DIAGNOSING ACUTE LYMPHOMIC LEUKEMIA (ALL) USING MIR-146a	Croce	2012	0		
585	chr22	37691	41126	3500214246	180		37691	41126	8421504	3	15,78,87	0,104,3348	p	350021424600015060,350021424600015064	0-180,0-180						Alignement multiple ClustalW	polytech.unice.fr	0	0		UBE2D3
585	chr22	41081	41132	3500463174	51		41081	41132	8421504	1	51	0	p	350046317400015008	0-51						Identification ubiquitin-conjugating E6-AP-dependent	www.pnas.org	0	0		UBE2D3
589	chr22	593238	593262	3500145630	24		593238	593262	8421504	1	24	0	g	350014563000000017	0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
589	chr22	628097	628121	3500173918	24		628097	628121	8421504	1	24	0	g	350017391800000008,350017391800000042	11-35,11-35						 Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof 	www.docstoc.com	0	0		
590	chr22	664002	664027	3500364871	25		664002	664027	8421504	1	25	0	g	350036487100000005	56-81						EGFR APTAMER INHIBITOR FOR USE IN THERAPY AND DIAGNOSIS	Franciscis	2011	0		EGFR
590	chr22	664002	664027	3500247841	25		664002	664027	8421504	1	25	0	g	350024784100000005,350024784100000010	56-81,56-81						EGFR APTAMER INHIBITOR FOR USE IN THERAPY AND DIAGNOSIS - Patent application	www.faqs.org	0	0		EGFR
593	chr22	1075644	1075668	3500299832	23		1075644	1075668	8421504	2	19,4	0,20	g	350029983200000032	25-48						Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby	Hall	2004	0		
593	chr22	1096786	1096809	3500199448	23		1096786	1096809	8421504	1	23	0	g	350019944800000242	25-48						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1996	0		
74	chr22	1179465	1180943	3500233903	23		1179465	1180943	8421504	4	4,4,4,11	0,5,1462,1467	c	350023390300000305	12-35						VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS - Patent application	www.faqs.org	0	0		
74	chr22	1179465	1180943	3500135823	23		1179465	1180943	8421504	4	4,4,4,11	0,5,1462,1467	c	350013582300000305	12-35						VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS - Patent application	www.faqs.org	0	0		
594	chr22	1180930	1186277	3500031192	208		1180930	1186277	8421504	3	95,103,10	0,1446,5337	c	350003119200000018,350003119200000030,350003119200000019	18-45,0-207,10-34						PRODUCTS AND METHODS FOR ENHANCED TRANSGENE EXPRESSION AND PROCESSING - Patent application	www.faqs.org	0	0		SEC61G
594	chr22	1188730	1188758	3500399153	25		1188730	1188758	8421504	2	13,12	0,16	g	350039915300000035	21-46						 Method Of Diagnosing Esophageal Cancer 	www.docstoc.com	0	0		
594	chr22	1279013	1279041	3500173591	23		1279013	1279041	8421504	2	13,10	0,18	g	350017359100000145	21-45						 Methods Of Using The OB Receptor Antibodies To Treat Bodyweight Disorders 	www.docstoc.com	0	0		
597	chr22	1575803	1578149	3500376368	177		1575803	1578149	8421504	2	175,2	0,2344	p	350037636800015027,350037636800015029,350037636800015028	21-198,0-69,3-72						148 human secreted proteins	Brewer	1999	0		
597	chr22	1606297	1613752	3500344185	26		1606297	1613752	8421504	3	4,1,21	0,7432,7434	c	350034418500000007	10-42						Collagen Producing Plants And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
597	chr22	1606297	1613752	3500114897	26		1606297	1613752	8421504	3	4,1,21	0,7432,7434	c	350011489700000007	10-42						COLLAGEN PRODUCING PLANTS AND METHODS OF GENERATING AND USING SAME - Patent application	www.faqs.org	0	0		
599	chr22	1888243	1888275	3500142942	24		1888243	1888275	8421504	3	13,3,8	0,16,24	g	350014294200000029	3-27						Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide	Takahashi	1995	0		
599	chr22	1917553	1917927	3500203394	46		1917553	1917927	8421504	2	24,22	0,352	c	350020339400000023,350020339400000022	0-24,0-22						Human Embryonic Stem Cells: The Practical Handbook	www.scribd.com	0	0		EOMES
599	chr22	1919042	1919690	3500335697	40		1919042	1919690	8421504	2	20,20	0,628	c,g	350033569700000003,350033569700000002,350033569700000002	0-20,0-20,0-20						Down-regulation of Interferon Tau Gene Transcription With a Transcription Factor, EOMES. - ResearchGate	.researchgate.net	0	0		
599	chr22	1919091	1919616	3500322435	42		1919091	1919616	8421504	3	20,9,13	0,80,512	c	350032243500000003,350032243500000002	0-20,0-22		20686115	10.1189/jlb.0310172	0741-5400	Journal of Leukocyte Biology	Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells	Pelletier	2010	5		EOMES
599	chr22	1919710	1920377	3500370870	23		1919710	1920377	8421504	2	15,8	0,659	c	350037087000000000	0-23						Methods for improving cardiac differentiation of human embryonic stem cells	Tran	2010	0		EOMES
599	chr22	1919710	1920377	3500330540	23		1919710	1920377	8421504	2	15,8	0,659	c	350033054000000000	0-23						METHODS FOR IMPROVING CARDIAC DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS - NOVARTIS AG	www.sumobrain.com	0	0		EOMES
603	chr22	2458864	2458888	3500406430	23		2458864	2458888	8421504	2	8,15	0,9	g	350040643000000000	1-24						<HTML> <HEAD> <META NAME="GENERATOR" CONTENT="Adobe PageMill 2.0 Mac"> <META HTTP-EQUIV="Cont	.bio.davidson.edu	0	0		
603	chr22	2458864	2458888	3500042700	23		2458864	2458888	8421504	2	8,15	0,9	g	350004270000000000	1-24						<HTML> <HEAD> <META NAME="GENERATOR" CONTENT="Adobe PageMill 2.0 Mac"> <META HTTP-EQUIV="Cont	.bio.davidson.edu	0	0		
608	chr22	3036371	3036398	3500251324	25		3036371	3036398	8421504	3	17,4,4	0,18,23	g	350025132400000000	6-31						StructuralFeaturesofGalectin-9andGalectin-1That DetermineDistinctTCellDeathPathways	www.jbc.org	0	0		
614	chr22	3833490	3833518	3500430364	26		3833490	3833518	8421504	2	11,15	0,13	g	350043036400000168	0-26						Non-Human Animals Expressing pH-Sensitive Immunoglobulin Sequences - Patent application	www.faqs.org	0	0		
615	chr22	3970489	3970520	3500292101	23		3970489	3970520	8421504	3	6,12,5	0,10,26	g	350029210100000000	25-49						Human papillomavirus detection assay	Brown	1995	0		
621	chr22	4720744	4720768	3500117918	23		4720744	4720768	8421504	2	4,19	0,5	g	350011791800000014	5-28		22049513	10.1182/blood-2011-02-339473		Blood	Cyclic AMP response element-binding protein prevents endothelial permeability increase through transcriptional controlling p190RhoGAP expression	Koteswara	2012	0		
621	chr22	4722124	4722152	3500249456	24		4722124	4722152	8421504	2	11,13	0,15	g	350024945600000044,350024945600000005	0-24,0-24						Method for producing l-amino acids - Patent application	www.faqs.org	0	0		UNC5C
621	chr22	4843962	4843992	3500210455	24		4843962	4843992	8421504	3	14,5,5	0,17,25	g	350021045500000018,350021045500000041	8-32,8-32						Patched-2 Antibodies 	.freshpatents.com	0	0		
623	chr22	5018656	5110524	3500258129	4280		5018656	5110524	8421504	7	324,169,191,800,142,128,2526	0,37368,41810,65931,68577,86431,89342	c	350025812900000080	0-4280						Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases - Patent application	www.faqs.org	0	0		
623	chr22	5018907	5087341	3500174939	182		5018907	5087341	8421504	5	45,42,21,29,45	0,65922,66003,66354,68389	c	350017493900000081,350017493900000095,350017493900000005,350017493900000008,350017493900000104,350017493900000108	0-45,0-42,0-21,0-21,0-29,0-45						 Silencing Of TGF.beta. Type II Receptor Expression By SiRNA 	www.docstoc.com	0	0		
623	chr22	5056104	5084868	3500342669	69		5056104	5084868	8421504	2	27,42	0,28722	c	350034266900000009,350034266900000020	15-42,6-48						US Patent # 5,693,607. Uses of TGF-.beta. receptor fragment as a therapeutic agent - Patents.com	www.patents.com	0	0		
623	chr22	5084840	5084867	3500098010	27		5084840	5084867	8421504	1	27	0	c	350009801000000007	22-49						Aus der Klinik f&#xfc;r Gastroenterologie mit Sektionen Infektiologie und Tropenmedizin	ub.uni-hamburg.de	0	0		
623	chr22	5085378	5087335	3500099578	111		5085378	5087335	8421504	2	9,102	0,1855	p	350009957800015015	6-117						TransformingGrowthFactor&#xc3;&#x0178;TypeIReceptorKinaseMutantAssociatedwith MetastaticBreastCancer1	.aacrjournals.org	0	0		TGFBR2
623	chr22	5087296	5087341	3500338129	45		5087296	5087341	8421504	1	45	0	c	350033812900000194	3-48						SILENCING OF TGF BETA TYPE II RECEPTOR EXPRESSION BY SIRNA - Patent application	www.faqs.org	0	0		
623	chr22	5087296	5087319	3500217315	23		5087296	5087319	8421504	1	23	0	c	350021731500000008	1-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		
623	chr22	5105202	5108010	3500070357	25		5105202	5108010	8421504	2	13,12	0,2796	c	350007035700000010	0-25						Matrix and TGF-&#x03b2;-Related Gene Expression during Human Dental Pulp Stem Cell (DPSC) Mineralization	www.jstor.org	0	0		TGFBR2
623	chr22	5109548	5109574	3500313308	23		5109548	5109574	8421504	2	18,5	0,21	c	350031330800000001	3-29						Trail receptor 2 polypeptides and antibodies	Feng	2007	0		
623	chr22	5109548	5109574	3500201388	23		5109548	5109574	8421504	2	18,5	0,21	c	350020138800000022,350020138800000144	3-29,3-29						Polypeptides And Antibodies 	.freshpatents.com	0	0		
633	chr22	6395060	6398328	3500068199	41		6395060	6398328	8421504	3	21,14,6	0,3245,3262	g	350006819900000344,350006819900000543	4-25,11-31						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
79	chr22	6671409	6821953	3500284360	81		6671409	6821953	8421504	2	9,72	0,150472	p	350028436000015167	21-102						95 human secreted proteins	Duan	1999	0		CMTM8
637	chr22	6895858	6895883	3500236924	23		6895858	6895883	8421504	2	14,9	0,16	g	350023692400000113	25-48						EPF receptor assays, compounds and therapeutic compsns.	A*Bu Yi Si Te 	2004	0		
638	chr22	7017690	7019849	3500205573	23		7017690	7019849	8421504	4	5,7,4,7	0,6,15,2152	c	350020557300000089	0-23					Patent	Process for detection of water-borne microbial pathogens and indicators of human fecal contamination in water samples and kits therefor (Patent US:5298392)	Atlas	1994	0		
641	chr22	7355096	7355121	3500264661	25		7355096	7355121	8421504	1	25	0	c	350026466100000003	23-48		17185357	10.1189/jlb.0606391	0741-5400	Journal of Leukocyte Biology	Estrogen selectively regulates chemokines in murine splenocytes	Lengi	2007	5		
641	chr22	7355114	7355137	3500325157	23		7355114	7355137	8421504	1	23	0	g	350032515700000039	1-24						Identifikation und Charakterisierung von im Thymus exprimierten Chemokinrezeptoren	k.uni-freiburg.de	0	0		
641	chr22	7355454	7355478	3500294130	24		7355454	7355478	8421504	1	24	0	c	350029413000000005	0-24						General introduction and objective of this thesis	www.tipharma.com	0	0		
641	chr22	7355479	7355503	3500438119	24		7355479	7355503	8421504	1	24	0	c	350043811900000026	0-24						Regulation of human eosinophil serine protease 1-like enzyme	Xiao	2003	0		
641	chr22	7355633	7355789	3500274037	40		7355633	7355789	8421504	2	20,20	0,136	c,g	350027403700000030,350027403700000030,350027403700000031,350027403700000031	0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		CCR4
641	chr22	7355767	7355801	3500353391	34		7355767	7355801	8421504	1	34	0	c	350035339100000050	13-47						US Patent # 6,498,015. Methods of identifying agents that modulate the binding between MDC and an MDC receptor - Patents.com	www.patents.com	0	0		
641	chr22	7386125	7386151	3500396369	23		7386125	7386151	8421504	2	18,5	0,21	g	350039636900000032	9-34						 VMP 	www.docstoc.com	0	0		
641	chr22	7437957	7440129	3500313060	27		7437957	7440129	8421504	2	5,22	0,2150	c	350031306000000109,350031306000000018	15-41,15-42						Gene specific universal mammalian sequence-tagged sites	Brewer	1997	0		
641	chr22	7447294	7458592	3500195438	71		7447294	7458592	8421504	5	13,12,6,19,21	0,7495,8867,9412,11277	c	350019543800000002,350019543800000001,350019543800000004	0-25,0-25,0-21					The American Journal of Pathology	Primary and Secondary Elastin-Binding Protein Defect Leads to Impaired Elastogenesis in Fibroblasts from GM1-Gangliosidosis Patients	Anna	2005	0		
643	chr22	7632715	7652002	3500148841	114		7632715	7652002	8421504	3	23,55,36	0,18881,19251	p,c	350014884100015003,350014884100000091	0-114,0-114						F-box genes and proteins	Harper	1997	0		
643	chr22	7636798	7636828	3500333041	24		7636798	7636828	8421504	3	7,13,4	0,12,26	g	350033304100000005	12-36						Structural characterization of ribosomal complexes involved in ribosome biogenesis and protein folding	b.uni-muenchen.de	0	0		
647	chr22	8142105	8142132	3500136149	25		8142105	8142132	8421504	2	19,6	0,21	g	350013614900000012	3-29						Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis - Patent application	www.faqs.org	0	0		
647	chr22	8177609	8177637	3500377718	23		8177609	8177637	8421504	2	9,14	0,14	g	350037771800000002	1-24						Constructs and their use in metabolic pathway engineering	Liu	2002	0		
647	chr22	8216918	8216945	3500166501	24		8216918	8216945	8421504	2	18,6	0,21	g	350016650100000306	3-27						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
648	chr22	8379138	8379166	3500428076	24		8379138	8379166	8421504	3	14,5,5	0,17,23	g	350042807600000000	0-26			10.1128/JVI.79.5.2950-2955.2005		Journal of Virology	Growth of Hepatitis A Virus in a Mouse Liver Cell Line	Dino	2005	0		
655	chr22	9284877	9284906	3500339481	25		9284877	9284906	8421504	3	6,8,11	0,7,18	g	350033948100000073,350033948100000072	8-33,3-28						Mutant Receptors And Their Use In A Nuclear Receptor-based Inducible Gene Expression System 	.freshpatents.com	0	0		
655	chr22	9284877	9284906	3500072596	25		9284877	9284906	8421504	3	6,8,11	0,7,18	g	350007259600000072,350007259600000073	3-28,7-32						Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression	Palli	2012	0		
658	chr22	9671844	9671872	3500322097	26		9671844	9671872	8421504	2	10,16	0,12	c	350032209700000473	8-37						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
659	chr22	9730746	9730824	3500191020	78		9730746	9730824	8421504	1	78	0	c,g	350019102000000004,350019102000000005,350019102000000022,350019102000000022	3-81,4-81,0-21,0-21		23056445	10.1371/journal.pone.0046773	1932-6203	PLOS ONE	PLOS ONE: Neurofibromin 1 Is a miRNA Target in Neurons	Paschou	2012	4		ARPP21
659	chr22	9790546	9790577	3500045770	25		9790546	9790577	8421504	3	6,11,8	0,9,23	g	350004577000000035	15-41						US Patent # 6,465,185. Polymorphic human PC-1 sequences associated with insulin resistance - Patents.com	www.patents.com	0	0		
660	chr22	9941014	9941042	3500000104	23		9941014	9941042	8421504	3	4,12,7	0,5,21	g	350000010400000158	5-28						Tarantulas and Social Spiders: A Tale of Sex and Silk	.nottingham.ac.uk	0	0		
663	chr22	10247391	10247415	3500440489	23		10247391	10247415	8421504	2	14,9	0,15	c	350044048900000067	15-38						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
663	chr22	10277880	10277908	3500175170	24		10277880	10277908	8421504	2	7,17	0,11	c	350017517000000005	8-32			10.1046/j.1432-1033.2003.03408.x	1432-1033	European Journal of Biochemistry	The transthyretin-related protein family - Eneqvist - 2003 - European Journal of Biochemistry - Wiley Online Library	Eneqvist	2003	0		
665	chr22	10505989	10506019	3500408290	27		10505989	10506019	8421504	2	10,17	0,13	c	350040829000000089	1-28						Methods for detection of acute promyelocytic leukemia (APL)	Dmitrovsky	1993	0		
665	chr22	10505989	10506019	3500088205	27		10505989	10506019	8421504	2	10,17	0,13	c	350008820500000089	1-28						Methods for detection of acute promyelocytic leukemia (APL) - US Patent 5843642 Description	ww.patentstorm.us	0	0		
665	chr22	10508172	10510410	3500428541	40		10508172	10510410	8421504	2	20,20	0,2218	c,g	350042854100000027,350042854100000027,350042854100000026	0-20,0-20,0-20						Developmental Regulation and In Vitro Culture Effects on Expression of DNA Repair and Cell Cycle Checkpoint Control Genes in Rhesus Monkey Oocytes and Embryos1	ww.biolreprod.org	0	0		MLH1
665	chr22	10508172	10509538	3500280883	40		10508172	10509538	8421504	3	20,8,12	0,134,1354	c	350028088300000015,350028088300000014	0-20,0-20			10.1111/j.1349-7006.2006.00253.x	1349-7006	Cancer Science	Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma - Zhang - 2006 - Cancer Science - Wiley Online Library	Zhang	2006	0		MLH1
665	chr22	10509945	10574775	3500409496	96		10509945	10574775	8421504	3	42,33,21	0,474,64809	p	350040949600015000	0-120						Untersuchungen zur Funktion von MutL und MutS in humaner DNA-Mismatch-Reparatur. Von der Fakult&#xe4;t f&#xfc;r Lebenswissenschaften	etc.tu-bs.de:8080	0	0		
665	chr22	10571279	10571312	3500267744	32		10571279	10571312	8421504	2	18,14	0,19	g	350026774400000008	7-42						STUDY OF THE REGULATION AND SIGNALLING OF CDK2-CYCLIN O COMPLEXES DURING APOPTOSIS	ww.tesisenred.net	0	0		
665	chr22	10581687	10581717	3500374740	25		10581687	10581717	8421504	3	4,7,14	0,5,16	c	350037474000000103	11-42						Macrophage inflammatory protein-4 (MIP-4) polynucleotides	Ruben	1999	0		
665	chr22	10590730	10591872	3500437191	66		10590730	10591872	8421504	2	51,15	0,1127	p	350043719100015047	0-66						Carlos P. Sosa	www.msi.umn.edu	0	0		MLH1
665	chr22	10590730	10591872	3500294812	66		10590730	10591872	8421504	2	51,15	0,1127	p	350029481200015018	0-66						Introduction to BLAST	www.msi.umn.edu	0	0		MLH1
665	chr22	10602192	10602220	3500425953	23		10602192	10602220	8421504	2	6,17	0,11	g	350042595300000154	0-23						Cleavage agents	www.devileye.net	0	0		
665	chr22	10602192	10602220	3500417793	23		10602192	10602220	8421504	2	6,17	0,11	g	350041779300000182	0-23						US Patent # 6,458,535. Detection of nucleic acids by multiple sequential invasive cleavages 02 - Patents.com	www.patents.com	0	0		
668	chr22	10955394	10955421	3500406269	24		10955394	10955421	8421504	3	7,13,4	0,9,23	c	350040626900000186	12-37					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
668	chr22	11007841	11007962	3500259232	121		11007841	11007962	8421504	1	121	0	g	350025923200000047	0-123						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
668	chr22	11007841	11007945	3500000589	104		11007841	11007945	8421504	1	104	0	g	350000058900000078	0-105						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
669	chr22	11088541	11088569	3500459021	23		11088541	11088569	8421504	2	8,15	0,13	g	350045902100000040	24-48						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
672	chr22	11461190	11468071	3500113901	42		11461190	11468071	8421504	3	21,13,8	0,3495,6873	c	350011390100000132,350011390100000134	0-21,0-21						Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence	Al-Murrani	2005	0		CTDSPL
672	chr22	11461190	11468071	3500107440	42		11461190	11468071	8421504	3	21,13,8	0,3495,6873	c	350010744000000132,350010744000000134	0-21,0-21					Patent	Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer (Patent US:7700280)	Al-Murrani	2010	0		CTDSPL
672	chr22	11466200	11466267	3500139175	67		11466200	11466267	8421504	1	67	0	c	350013917500000007	4-71						Functional characterisation of microRNA-containing Argonaute Protein complexes	b.uni-muenchen.de	0	0		CTDSPL
672	chr22	11466202	11466279	3500362304	77		11466202	11466279	8421504	1	77	0	c	350036230400000000,350036230400000002	0-56,0-77						COMPOSITIONS AND METHODS FOR TREATING HEPATIC NEOPLASIA	Mendell	2009	0		
672	chr22	11466202	11466279	3500040785	77		11466202	11466279	8421504	1	77	0	c	350004078500000093,350004078500000054	0-77,0-22						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		CTDSPL
672	chr22	11466210	11466235	3500225114	25		11466210	11466235	8421504	1	25	0	g	350022511400000004	0-25						Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy	cs.biologists.org	0	0		CTDSPL
672	chr22	11477325	11477353	3500108622	23		11477325	11477353	8421504	2	10,13	0,15	g	350010862200000180	0-23						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
672	chr22	11508203	11508226	3500256118	23		11508203	11508226	8421504	1	23	0	c	350025611800000015	11-34					Patent	Mammalian ob polypeptides capable of modulating body weight, corresponding nucleic acids, and diagnostic and therapeutic uses thereof (Patent US:5935810)	Burley	1999	0		
672	chr22	11508203	11508226	3500128790	23		11508203	11508226	8421504	1	23	0	c	350012879000000069	11-34						US Patent # 6,309,853. Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof - Patents.com	www.patents.com	0	0		
672	chr22	11508276	11508778	3500049955	243		11508276	11508778	8421504	5	54,12,51,34,92	0,60,149,260,410	p	350004995500015053,350004995500015054,350004995500015051,350004995500015044,350004995500015040,350004995500015045	54-108,0-120,0-120,0-126,0-117,0-120						Genetic characterization of a phospholipase C gene from Candida albicans: presence of homologous sequences in Candida species other than Candida albicans	c.sgmjournals.org	0	0		
672	chr22	11516369	11516395	3500053411	26		11516369	11516395	8421504	1	26	0	c	350005341100000009	10-36		16000311	10.1074/jbc.M500629200	0021-9258	Journal of Biological Chemistry	Role of Phospholipase C-&#x03b6; Domains in Ca2+-dependent Phosphatidylinositol 4,5-Bisphosphate Hydrolysis and Cytoplasmic Ca2+ Oscillations	Nomikos	2005	5		
674	chr22	11703353	11703548	3500261436	40		11703353	11703548	8421504	2	21,19	0,176	c,g	350026143600000001,350026143600000000,350026143600000000	0-21,0-19,0-19						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
674	chr22	11703374	11703552	3500055164	48		11703374	11703552	8421504	2	5,43	0,135	p	350005516400015002	0-48						Patent 7,605,005	www.pharmcast.com	0	0		
674	chr22	11705873	11707946	3500251406	63		11705873	11707946	8421504	3	26,1,36	0,1692,2037	p	350025140600015015	0-63					Patent	Human cDNAs and proteins and uses thereof (Patent US:7285631)	Bejanin	2007	0		
674	chr22	11705873	11707946	3500054122	63		11705873	11707946	8421504	3	26,1,36	0,1692,2037	p	350005412200015016	0-63						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		
674	chr22	11707942	11707969	3500447646	23		11707942	11707969	8421504	2	7,16	0,11	c	350044764600000007	8-34						Leukocyte expression profiling	Wohlgemuth	2001	0		
674	chr22	11707942	11707969	3500430587	23		11707942	11707969	8421504	2	7,16	0,11	c	350043058700000009	8-34						Leukocyte expression profiling	Altman	2003	0		
674	chr22	11707942	11707969	3500346467	23		11707942	11707969	8421504	2	7,16	0,11	c	350034646700000026	8-34						METHODS AND COMPOSITIONS FOR DIAGNOSING AND MONITORING TRANSPLANT REJECTION	Wohlgemuth	2011	0		
674	chr22	11707942	11707969	3500171286	23		11707942	11707969	8421504	2	7,16	0,11	c	350017128600000009	8-34						Leukocyte expression profiling	Altman	2002	0		
674	chr22	11707942	11707969	3500102581	23		11707942	11707969	8421504	2	7,16	0,11	c	350010258100000030	8-34						Methods and compositions for diagnosing and monitoring transplant rejection	Wohlgemuth	2009	0		
674	chr22	11707942	11707969	3500062377	23		11707942	11707969	8421504	2	7,16	0,11	c	350006237700000026	8-34						METHODS AND COMPOSITIONS FOR DIAGNOSING AND MONITORING TRANSPLANT REJECTION - Patent application	www.faqs.org	0	0		
674	chr22	11707942	11707969	3500048424	23		11707942	11707969	8421504	2	7,16	0,11	c	350004842400000007	8-34						METHODS AND COMPOSITIONS FOR DIAGNOSING AND MONITORING TRANSPLANT REJECTION - Patent application	www.faqs.org	0	0		
674	chr22	11707942	11707969	3500029579	23		11707942	11707969	8421504	2	7,16	0,11	c	350002957900000035	8-34						METHODS AND COMPOSITIONS FOR DIAGNOSING AND MONITORING TRANSPLANT REJECTION - Patent application	www.faqs.org	0	0		
674	chr22	11707942	11707969	3500001198	23		11707942	11707969	8421504	2	7,16	0,11	c	350000119800000031	8-34						METHODS AND COMPOSITIONS FOR DIAGNOSING AND MONITORING TRANSPLANT REJECTION	Wohlgemuth	2011	0		
674	chr22	11729190	11731727	3500066952	690		11729190	11731727	8421504	5	328,135,47,34,146	0,1206,1679,2088,2391	p,c	350006695200015019,350006695200015026,350006695200015033,350006695200015049,350006695200000001	0-174,0-174,0-162,0-180,19-40						Article Molecular Cloning and Functional Characterization of Porcine MyD88 Essential for TLR Signaling	w.cmi.ustc.edu.cn	0	0		MYD88
674	chr22	11730521	11731672	3500277894	86		11730521	11731672	8421504	3	25,41,20	0,461,1131	c,g	350027789400000140,350027789400000307,350027789400000141,350027789400000308,350027789400000168,350027789400000069	0-20,0-20,0-20,0-20,0-41,0-20						MODIFICATION OF MYD88 SPLICING USING MODIFIED OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		
674	chr22	11730521	11730546	3500267811	25		11730521	11730546	8421504	1	25	0	g	350026781100000140,350026781100000141	0-20,0-20						Modification of MyD88 splicing using modified oligonucleotides - US Patent 7879992 Description	ww.patentstorm.us	0	0		
674	chr22	11730898	11730974	3500328613	40		11730898	11730974	8421504	2	19,21	0,55	c,g	350032861300000062,350032861300000062,350032861300000017,350032861300000017,350032861300000016,350032861300000016	0-19,0-19,0-21,0-21,0-19,0-19						High Yield Production of Influenza Virus in Madin Darby Canine Kidney (MDCK) Cells with Stable Knockdown of IRF7. - ResearchGate	.researchgate.net	0	0		
674	chr22	11730909	11731277	3500022796	40		11730909	11731277	8421504	2	20,20	0,348	c,g	350002279600000014,350002279600000014,350002279600000015,350002279600000015	0-20,0-20,0-20,0-20						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
676	chr22	11944474	11975655	3500390912	8179		11944474	11975655	8421504	8	723,677,36,256,1817,5,1144,3521	0,724,1402,1447,24691,26509,26515,27660	p,c,g	350039091200000001,350039091200000007,350039091200000010,350039091200000013,350039091200000016,350039091200000019,350039091200000022,350039091200000025,350039091200000028,350039091200000029,350039091200000030,350039091200000145,350039091200000040,350039091200000043,350039091200000043,350039091200000144,350039091200000047,350039091200000048,350039091200000130,350039091200000128,350039091200015004,350039091200015007,350039091200000129,350039091200000002,350039091200000131,350039091200000131,350039091200015011,350039091200015010,350039091200015008,350039091200015009,350039091200000132,350039091200000132,350039091200015015,350039091200000149,350039091200000149,350039091200015017,350039091200000133,350039091200000133,350039091200000134,350039091200015023,350039091200015020,350039091200000135,350039091200000135,350039091200015024,350039091200000136,350039091200000136,350039091200000003,350039091200000137,350039091200000137,350039091200015028,350039091200000138,350039091200000138,350039091200000139,350039091200000139,350039091200015035,350039091200015032,350039091200000140,350039091200000140,350039091200000141,350039091200000141,350039091200000142,350039091200000142,350039091200015036,350039091200015038,350039091200000004,350039091200000143	21-1709,0-43,0-58,0-57,0-52,0-58,0-60,0-60,0-60,0-60,1-57,0-21,0-59,0-55,0-55,0-20,0-60,0-60,0-23,0-21,0-180,0-180,0-21,0-3350,0-22,0-22,0-180,0-180,0-180,0-180,0-21,0-21,0-162,0-21,0-21,0-126,0-21,0-21,0-23,0-177,0-177,0-20,0-20,0-180,0-21,0-21,0-3090,0-20,0-20,0-180,0-21,0-21,0-19,0-19,0-180,0-180,0-20,0-20,0-23,0-23,0-21,0-21,0-171,0-171,0-40,0-25						UNIVERSITE DE LIMOGES	cations.unilim.fr	0	0		
676	chr22	11946125	11975619	3500361277	1536		11946125	11975619	8421504	11	52,208,110,152,144,144,149,115,139,131,192	0,23040,23495,23759,23989,24648,25109,26830,27594,27838,29302	p	350036127700015010,350036127700015014	0-1536,0-1536						BONE MORPHOGENETIC PROTEIN RECEPTOR BINDING AGENTS AND METHODS OF THEIR USE	Chartier-courtaud	2011	0		ACVR2B
676	chr22	11969179	11969915	3500282085	47		11969179	11969915	8421504	2	24,23	0,713	c	350028208500000020,350028208500000021,350028208500000052	0-24,7-30,7-30						ANTAGONIST OF LIGANDS AND USES THEREOF - Patent application	www.faqs.org	0	0		
676	chr22	11969188	11970224	3500111234	50		11969188	11970224	8421504	2	25,25	0,1011	c,g	350011123400000154,350011123400000154,350011123400000155	0-25,0-25,0-25						Znf206: A Novel Regulator Of Embryonic Stem Cell Self-renewal And Pluripotency 	.freshpatents.com	0	0		
676	chr22	11969188	11969228	3500351981	32		11969188	11969228	8421504	2	25,7	0,33	g	350035198100000001	0-37						Mammalian extraembryonic endoderm cells and methods of isolation	Snyder	2007	0		ACVR2B
676	chr22	11969221	11969365	3500191339	93		11969221	11969365	8421504	3	48,30,15	0,96,129	c	350019133900000013,350019133900000015	0-48,0-48						Use of GDF traps to increase red blood cell levels - Patent application	www.faqs.org	0	0		
676	chr22	11969221	11969269	3500334327	48		11969221	11969269	8421504	1	48	0	c	350033432700000011	0-48						METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING ANEMIA USING A COMBINATION OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS - Patent application	www.faqs.org	0	0		
676	chr22	11969317	11969365	3500029697	45		11969317	11969365	8421504	2	30,15	0,33	c	350002969700000014	0-48						USE OF GDF TRAPS TO INCREASE RED BLOOD CELL LEVELS - Patent application	www.faqs.org	0	0		
676	chr22	11969317	11969365	3500028119	45		11969317	11969365	8421504	2	30,15	0,33	c	350002811900000014	0-48						METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS - Patent application	www.faqs.org	0	0		
676	chr22	11969711	11969916	3500079406	51		11969711	11969916	8421504	2	19,32	0,173	p,c	350007940600015007,350007940600015011,350007940600015025,350007940600000012	0-51,0-51,0-51,7-30						Antagonists of ligands and uses thereof	O'connor-Mccourt	2013	0		ACVR2B
677	chr22	12097817	12098623	3500048213	51		12097817	12098623	8421504	2	24,27	0,779	c	350004821300000006,350004821300000004	0-24,0-27			10.1124/jpet.303.1.89	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Molecular Cloning and Functional Characterization of a Unique Mammalian Cardiac Nav Channel Isoform with Low Sensitivity to the Synthetic Inactivation Inhibitor (&#x2212;)-(S)-6-Amino-&#x03b1;-[(4-diphenylmethyl-1-piperazinyl)-methyl]-9H-purine-9-ethanol 	Denac	2002	0		
677	chr22	12098555	12156230	3500126493	324		12098555	12156230	8421504	8	36,45,33,48,33,3,42,84	0,39,8667,8703,34348,34384,39505,57591	p	350012649300015155,350012649300015143,350012649300015140,350012649300015147,350012649300015145,350012649300015137,350012649300015165,350012649300015121,350012649300015122,350012649300015123,350012649300015133,350012649300015131,350012649300015127,350012649300015008,350012649300015003	0-81,0-81,0-78,0-81,0-81,0-78,0-81,0-84,0-75,0-81,0-78,0-78,0-81,0-60,0-60						 Screen For Sodium Channel Modulators 	www.docstoc.com	0	0		
677	chr22	12098561	12098630	3500284049	69		12098561	12098630	8421504	1	69	0	p	350028404900015002	0-69						Purified vacuolating toxin from helicobacter pylori and methods to use same	Blaser	1993	0		SCN5A
677	chr22	12098566	12098807	3500388191	40		12098566	12098807	8421504	2	20,20	0,221	c,g	350038819100000006,350038819100000005,350038819100000005	0-20,0-20,0-20		20816971	10.1016/j.mcn.2010.08.017		Molecular and cellular neurosciences	Single-cell analysis of sodium channel expression in dorsal root ganglion neurons	Cojen	2011	0		SCN4A,SCN5A
677	chr22	12098580	12098632	3500119283	47		12098580	12098632	8421504	2	25,22	0,30	c,g	350011928300000036,350011928300000034,350011928300000034	0-25,0-22,0-22						Methods And Compositions For Treating Neuropathic Pain 	.freshpatents.com	0	0		SCN5A
677	chr22	12106487	12106541	3500383465	54		12106487	12106541	8421504	1	54	0	p	350038346500015001	0-54							olecularbrain.com	0	0		SCN2A
677	chr22	12106520	12138405	3500305494	90		12106520	12138405	8421504	2	45,45	0,31840	p	350030549400015082,350030549400015043	0-45,0-45						 <HTML> <HEAD><TITLE>cY=cucuc1a(r)aaaaa|a aaPSa3aa<<aa3a1/4aaaae ,e, - c1e	www.j-tokkyo.com	0	0		SCN10A
677	chr22	12106550	12107234	3500257345	45		12106550	12107234	8421504	2	15,30	0,654	p	350025734500015001	0-45						&#x30a4;&#x30aa;&#x30f3;&#x30c1;&#x30e3;&#x30cd;&#x30eb;&#x306b;&#x4f5c;&#x7528;&#x3059;&#x308b;&#x5316;&#x5408;&#x7269;&#x306e;&#x30b9;&#x30af;&#x30ea;&#x30fc;&#x30cb;&#x30f3;&#x30b0;&#x7528;&#x6750;&#x6599;&#x53ca;&#x3073;&#x305d;&#x306e;&#x5229;&#x7528	Masato	2012	0		SCN10A
677	chr22	12106550	12107234	3500000794	45		12106550	12107234	8421504	2	15,30	0,654	p	350000079400015004	0-45						MATERIAL FOR SCREENING FOR COMPOUND ACTING ON ION CHANNEL AND USE THEREOF	Imaizumi	2011	0		SCN9A
677	chr22	12156146	12156230	3500360420	84		12156146	12156230	8421504	1	84	0	p	350036042000015102,350036042000015001,350036042000015006	0-84,0-60,0-60						Screen for sodium channel modulators	Wang	2003	0		SCN5A
677	chr22	12162989	12183151	3500048213	49		12162989	12183151	8421504	3	21,2,26	0,6782,20136	c	350004821300000001,350004821300000005	0-23,0-26			10.1124/jpet.303.1.89	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Molecular Cloning and Functional Characterization of a Unique Mammalian Cardiac Nav Channel Isoform with Low Sensitivity to the Synthetic Inactivation Inhibitor (&#x2212;)-(S)-6-Amino-&#x03b1;-[(4-diphenylmethyl-1-piperazinyl)-methyl]-9H-purine-9-ethanol 	Denac	2002	0		SCN5A
681	chr22	12587849	12587876	3500236407	23		12587849	12587876	8421504	2	8,15	0,12	g	350023640700000009	2-28						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2001	0		
682	chr22	12739687	12740056	3500277510	112		12739687	12740056	8421504	3	23,42,47	0,33,322	c	350027751000000156,350027751000000155,350027751000000149	10-33,6-48,0-47						Novel seven transmembrane receptors	Godiska	1994	0		
682	chr22	12739946	12740418	3500166815	48		12739946	12740418	8421504	2	24,24	0,448	c	350016681500000035,350016681500000034	0-24,0-24		11861876	10.1128/JVI.76.6.3072-3077.2002	0022-538X	Journal of Virology	Human B Cells Immortalized with Epstein-Barr Virus Upregulate CCR6 and CCR10 and Downregulate CXCR4 and CXCR5	Nakayama	2002	5		CX3CR1
682	chr22	12768938	12768964	3500199170	23		12768938	12768964	8421504	2	17,6	0,20	g	350019917000000188	4-27							biomedcentral.com	0	0		
682	chr22	12818493	12818973	3500166815	45		12818493	12818973	8421504	2	22,23	0,457	c	350016681500000026,350016681500000027	0-22,0-23		11861876	10.1128/JVI.76.6.3072-3077.2002	0022-538X	Journal of Virology	Human B Cells Immortalized with Epstein-Barr Virus Upregulate CCR6 and CCR10 and Downregulate CXCR4 and CXCR5	Nakayama	2002	5		CCR8
683	chr22	12869415	12880973	3500354392	642		12869415	12880973	8421504	8	133,101,12,48,120,6,129,93	0,1248,1355,10222,10330,10462,11217,11465	p	350035439200015003,350035439200015004,350035439200015005,350035439200015006,350035439200015007,350035439200015009,350035439200015010,350035439200015011,350035439200015012,350035439200015013,350035439200015014	0-60,0-60,0-60,0-54,0-60,0-60,0-60,9-57,0-60,0-60,0-60						human Increased Complete	www.pnas.org	0	0		
683	chr22	12870719	12870770	3500431918	51		12870719	12870770	8421504	1	51	0	p	350043191800015010	0-51						Riboproteomics of the Hepatitis C Virus Internal Ribosomal Entry Site	gs.washington.edu	0	0		RPSAP58
683	chr22	12870780	12880641	3500264759	40		12870780	12880641	8421504	4	2,18,11,9	0,8857,9092,9852	c	350026475900000000,350026475900000001	0-20,0-20						Synergetic downregulation of 67&#xfffd;kDa laminin receptor by the green tea (Camellia sinensis) secondary plant compound epigallocatechin gallate: a new gateway in metastasis prevention?	biomedcentral.com	0	0		
683	chr22	12879865	12880674	3500407860	60		12879865	12880674	8421504	2	18,42	0,767	p	350040786000015044	0-60						Bispecific Fusion Antibodies With Enhanced Serum Half-Life	Holt	2008	0		
683	chr22	12879865	12880674	3500325676	60		12879865	12880674	8421504	2	18,42	0,767	p	350032567600015057	0-60						&#x0421;&#x043b;&#x0438;&#x0442;&#x044b;&#x0435; &#x043a;&#x043e;&#x043d;&#x0441;&#x0442;&#x0440;&#x0443;&#x043a;&#x0446;&#x0438;&#x0438; &#x043b;&#x0435;&#x043a;&#x0430;&#x0440;&#x0441;&#x0442;&#x0432;&#x0435;&#x043d;&#x043d;&#x043e;&#x0433;&#x043e; &#x0	www.findpatent.ru	0	0		
683	chr22	12879865	12880674	3500010257	60		12879865	12880674	8421504	2	18,42	0,767	p	350001025700015046	0-60						Bispecific Fusion Antibodies With Enhanced Serum Half-Life	Holt	2005	0		
683	chr22	12879877	12880706	3500228885	40		12879877	12880706	8421504	3	6,14,20	0,755,809	c	350022888500000169,350022888500000166	0-20,0-20						METHOD AND SYSTEM OF PARTICLE-PHAGE EPITOPE COMPLEX - Patent application	www.faqs.org	0	0		
683	chr22	12930621	12930646	3500441689	25		12930621	12930646	8421504	1	25	0	c	350044168900000027	19-44						Patent Search: US Patent Number 8168602 - Compositions, kits and methods for identification, assessment, prevention and therapy of cancer	ww.archpatent.com	0	0		
683	chr22	12951491	12951522	3500055113	25		12951491	12951522	8421504	3	12,6,7	0,13,24	c	350005511300000041	12-38						US Patent # 6,120,991. Epiligrin, an epithelial ligand for integrins - Patents.com	www.patents.com	0	0		
683	chr22	12956446	12956469	3500096102	23		12956446	12956469	8421504	1	23	0	g	350009610200000048	1-28						REPROGRAMMING OF SOMATIC CELLS - Patent application	www.faqs.org	0	0		
684	chr22	13059221	13059246	3500461849	24		13059221	13059246	8421504	2	13,11	0,14	g	350046184900000139	0-24						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
684	chr22	13059221	13059246	3500420477	24		13059221	13059246	8421504	2	13,11	0,14	g	350042047700000142	0-24						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
684	chr22	13059221	13059246	3500359363	24		13059221	13059246	8421504	2	13,11	0,14	g	350035936300000141	0-24						Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments 	.freshpatents.com	0	0		
684	chr22	13059221	13059246	3500204773	24		13059221	13059246	8421504	2	13,11	0,14	g	350020477300000142	0-24						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
687	chr22	13376561	13376905	3500354437	114		13376561	13376905	8421504	3	42,12,60	0,257,284	p	350035443700015000,350035443700015016,350035443700015001,350035443700015017	0-54,0-48,0-60,0-48						Hepatocellular Carcinoma Screening 	.freshpatents.com	0	0		EIF1B
689	chr22	13759140	13759163	3500377958	23		13759140	13759163	8421504	1	23	0	g	350037795800000014	0-28						Dinucleotide restriction endonuclease preparations and methods of use	Mead	1994	0		
689	chr22	13759140	13759163	3500299728	23		13759140	13759163	8421504	1	23	0	g	350029972800000013	0-28					Patent	Recombinant CviJI restriction endonuclease (Patent US:5472872)	Mead	1995	0		
690	chr22	13819270	13819294	3500440557	23		13819270	13819294	8421504	2	11,12	0,12	g	350044055700000037	0-23						Methods of selecting T cell receptor V peptides for therapeutic use	Vandenbark	2003	0		
692	chr22	14044585	14044613	3500201864	24		14044585	14044613	8421504	2	15,9	0,19	g	350020186400000156	9-33						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
692	chr22	14044585	14044613	3500005314	24		14044585	14044613	8421504	2	15,9	0,19	g	350000531400000161	9-33						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
692	chr22	14045791	14045815	3500382215	23		14045791	14045815	8421504	2	4,19	0,5	g	350038221500000009,350038221500000003	8-30,7-30						Design and Production in Aspergillus niger of a Chimeric Protein Associating a Fungal Feruloyl Esterase and a Clostridial Dockerin Domain	aem.asm.org	0	0		
86	chr22	14154919	14167321	3500431486	45		14154919	14167321	8421504	3	22,2,21	0,470,12381	c	350043148600000002,350043148600000003	0-24,0-21		15280374	10.1074/jbc.M402540200	0021-9258	Journal of Biological Chemistry	Disabled-2 Is a Negative Regulator of Integrin &#x03b1;IIb&#x03b2;3-mediated Fibrinogen Adhesion and Cell Signaling	Huang	2004	5		CTNNB1
86	chr22	14154920	14155886	3500213129	40		14154920	14155886	8421504	2	20,20	0,946	c,g	350021312900000007,350021312900000008,350021312900000008	0-20,0-20,0-20		15060160	10.1128/MCB.24.8.3396-3403.2004	0270-7306	Molecular and Cellular Biology	Melanocytes and Pigmentation Are Affected in Dopachrome Tautomerase Knockout Mice	Guyonneau	2004	6		
86	chr22	14154928	14167311	3500345389	45		14154928	14167311	8421504	3	13,11,21	0,461,12362	c	350034538900000001,350034538900000002	11-35,16-37		17711861	10.1074/jbc.M705895200	0021-9258	Journal of Biological Chemistry	Glycogen Synthase Kinase-3&#x03b2; Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase 3	Mishra	2007	5		CTNNB1
692	chr22	14154929	14155484	3500337770	45		14154929	14155484	8421504	3	12,9,24	0,460,531	c	350033777000000012,350033777000000013	0-21,0-24						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
692	chr22	14154940	14155615	3500400423	40		14154940	14155615	8421504	3	1,19,20	0,449,655	c,g	350040042300000000,350040042300000001,350040042300000001	0-20,0-20,0-20		15814622	10.1158/1078-0432.CCR-04-2199	1078-0432	Clinical Cancer Research	&#x03b2;-Catenin Functions Mainly as an Adhesion Molecule in Patients with Squamous Cell Cancer of the Head and Neck	Yu	2005	8		CTNNB1
692	chr22	14154940	14155508	3500353134	51		14154940	14155508	8421504	3	1,20,30	0,449,538	c	350035313400000000,350035313400000001	0-21,0-30			10.1002/hep.21973	1527-3350	Hepatology	Wnt/&#x03b2;-catenin signaling mediates oval cell response in rodents - Apte - 2007 - Hepatology - Wiley Online Library	Apte	2008	0		CTNNB1
86	chr22	14155389	14155813	3500136095	41		14155389	14155813	8421504	3	20,18,3	0,210,421	c	350013609500000000,350013609500000001	0-20,0-21			10.1124/mol.107.035287	1521-0111 (Online)	Molecular Pharmacology	Thiazolidinediones Modulate the Expression of &#x03b2;-Catenin and Other Cell-Cycle Regulatory Proteins by Targeting the F-Box Proteins of Skp1-Cul1-F-box Protein E3 Ubiquitin Ligase Independently of Peroxisome Proliferator-Activated Receptor &#x03b3;	Wei	2007	0		CTNNB1
86	chr22	14155389	14155813	3500068440	41		14155389	14155813	8421504	3	20,18,3	0,210,421	c	350006844000000000,350006844000000001	0-20,0-21						Thiazolidinediones Modulate the Expression of -Catenin and Other Cell-Cycle Regulatory Proteins by Targeting the F-Box Proteins of Skp1-Cul1-F-box Protein E3 2007&#x5e74;&#x7b2c;69&#x5377;&#x7b2c;9&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#	www.39kf.com	0	0		CTNNB1
692	chr22	14155395	14155575	3500466748	47		14155395	14155575	8421504	2	23,24	0,156	c	350046674800000000,350046674800000001	0-23,0-24			10.1038/sj.onc.1203617	${footerJournalISSN}		Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of &#x03b2;-catenin and synergistic effect of p53 null alleles		2000	0		
692	chr22	14155427	14155517	3500282962	90		14155427	14155517	8421504	1	90	0	p	350028296200015005,350028296200015004	3-93,0-90						Expression vectors able to elicit improved immune response and methods of using same	Felber	2002	0		CTNNB1
692	chr22	14155427	14155517	3500111449	90		14155427	14155517	8421504	1	90	0	p	350011144900015001,350011144900015016	0-90,3-93						Improved dna vaccination protocols	Felber	2008	0		CTNNB1
692	chr22	14155430	14155508	3500451070	78		14155430	14155508	8421504	1	78	0	p	350045107000015002	0-78						WilmsTumorGeneonXChromosome(WTX)Inhibits DegradationofNRF2ProteinthroughCompetitiveBindingto KEAP1Protein S	cancer.unc.edu	0	0		CTNNB1
692	chr22	14155446	14155472	3500361183	26		14155446	14155472	8421504	1	26	0	c	350036118300000001	16-42						Research Paper ATF4 Promotes &#x03b2; -Catenin Expression and Osteoblastic Differentiation of Bone Marrow Mesenchymal Stem Cells	www.ijbs.com	0	0		
692	chr22	14155451	14155496	3500060964	45		14155451	14155496	8421504	1	45	0	p	350006096400015107	0-45						METHODS TO IDENTIFY COMPOUNDS USEFUL FOR TUMOR SENSITIZATION TO DNA DAMAGE - Patent application	www.faqs.org	0	0		CTNNB1
692	chr22	14155460	14155523	3500255953	63		14155460	14155523	8421504	1	63	0	p	350025595300015001	9-72		19933277	10.1074/jbc.M109.070326		The Journal of Biological Chemistry	&#x03b2;-Catenin/T-cell Factor Signaling Is Activated during Lung Injury and Promotes the Survival and Migration of Alveolar Epithelial Cells	Annette	2010	0		CTNNB1
693	chr22	14155954	14167314	3500245677	60		14155954	14167314	8421504	4	20,6,14,20	0,9245,10214,11340	c,g	350024567700000009,350024567700000009,350024567700000010,350024567700000011	9-29,9-29,9-29,9-29						CHD8, a Novel ATP-dependent Chromatin Remodeling Enzyme by	lue.lib.umich.edu	0	0		CTNNB1
693	chr22	14156265	14156289	3500147297	24		14156265	14156289	8421504	1	24	0	c	350014729700000003	0-24		16920823	10.1128/JVI.00739-06	0022-538X	Journal of Virology	Human T-Cell Leukemia Virus Type 1 Tax Dysregulates &#x03b2;-Catenin Signaling	Tomita	2006	5		CTNNB1
693	chr22	14156629	14157965	3500277174	43		14156629	14157965	8421504	2	19,24	0,1312	c	350027717400000002,350027717400000003	0-19,0-24						Bone Morphogenetic Protein 7 Is and Eva Corey* Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment	www.neoplasia.com	0	0		CTNNB1
693	chr22	14156659	14167265	3500040877	72		14156659	14167265	8421504	4	24,15,9,24	0,8531,9509,10582	c	350004087700000136,350004087700000144,350004087700000146	0-24,0-24,0-24						COMPOUNDS FOR THE MODULATION OF BETA-CATENIN EXPRESSION - Patent application	www.faqs.org	0	0		
693	chr22	14161324	14161348	3500195934	24		14161324	14161348	8421504	1	24	0	c	350019593400000001	0-24						Activation of Liver X Receptor Is Protective Against Ethanol-Induced Developmental Impairment of Bergmann Glia and Purkinje Neurons in the Mouse Cerebellum. - ResearchGate	.researchgate.net	0	0		CTNNB1
693	chr22	14161340	14165161	3500442630	48		14161340	14165161	8421504	2	24,24	0,3797	c	350044263000000005,350044263000000006	0-24,0-24						Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells. - ResearchGate	.researchgate.net	0	0		CTNNB1
693	chr22	14161466	14161795	3500449946	46		14161466	14161795	8421504	3	10,16,20	0,267,309	c	350044994600000000,350044994600000001	0-26,0-20		21118196	10.1111/j.1365-2141.2010.08471.x	1365-2141	British Journal of Haematology	Proliferation and bone marrow engraftment of AML blasts is dependent on &#x03b2;-catenin signalling - Siapati - 2010 - British Journal of Haematology - Wiley Online Library	Siapati	2011	0		CTNNB1
693	chr22	14161739	14161765	3500402937	26		14161739	14161765	8421504	1	26	0	c,g	350040293700000014,350040293700000014	0-26,0-26						Rhou maintains the epithelial architecture and facilitates differentiation of the foregut endoderm	ev.biologists.org	0	0		CTNNB1
693	chr22	14161797	14164204	3500056244	40		14161797	14164204	8421504	2	20,20	0,2387	c,g	350005624400000008,350005624400000008,350005624400000009,350005624400000009	0-20,0-20,0-20,0-20		20331626	10.1111/j.1349-7006.2010.01528.x	1349-7006	Cancer Science	Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2&#x2013;&#x03b2;-catenin/TCF4-survivin pathway in ErbB2-overexpressed breast cancer cells - Zhu - 2010 - Cancer Science - Wiley Online Library	Zhu	2010	0		CTNNB1
693	chr22	14161834	14164907	3500452936	40		14161834	14164907	8421504	2	20,20	0,3053	c,g	350045293600000002,350045293600000002,350045293600000003	0-20,0-20,0-20						Induction of &#x03b2;-catenin by the suppression of signal regulatory protein &#x03b1;1 in K562 cells	.kitasato-u.ac.jp	0	0		CTNNB1
693	chr22	14161859	14164141	3500391361	45		14161859	14164141	8421504	2	33,12	0,2270	p	350039136100015087	0-45						Transcriptomic and Proteomic Approaches to the Discovery of New Markers of Pathology	n.library.ethz.ch	0	0		CTNNB1
693	chr22	14164183	14166192	3500233391	48		14164183	14166192	8421504	2	24,24	0,1985	c,g	350023339100000008,350023339100000008,350023339100000009	0-24,0-24,0-24		22238358	10.1091/mbc.E11-06-0517		Molecular Biology of the Cell	A Highlights from MBoC Selection: Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	Tohru	2012	0		CTNNB1
693	chr22	14164183	14166192	3500226180	48		14164183	14166192	8421504	2	24,24	0,1985	c,g	350022618000000008,350022618000000008,350022618000000009	0-24,0-24,0-24		22238358	10.1091/mbc.E11-06-0517	1059-1524	Molecular Biology of the Cell	Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	Yoneyama	2012	5		CTNNB1
693	chr22	14164183	14166192	3500207967	48		14164183	14166192	8421504	2	24,24	0,1985	c,g	350020796700000008,350020796700000008,350020796700000009	0-24,0-24,0-24						Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	w.molbiolcell.org	0	0		CTNNB1
693	chr22	14164183	14166192	3500025891	48		14164183	14166192	8421504	2	24,24	0,1985	c,g	350002589100000008,350002589100000008,350002589100000009	0-24,0-24,0-24						Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation. - ResearchGate	.researchgate.net	0	0		CTNNB1
693	chr22	14164215	14164249	3500312165	34		14164215	14164249	8421504	1	34	0	c	350031216500000275	0-34						Multitargeting Interfering RNAs Having Two Active Strands And Methods For Their Design And Use - Patent application	www.faqs.org	0	0		CTNNB1
693	chr22	14164225	14165162	3500133180	44		14164225	14165162	8421504	2	24,20	0,917	c	350013318000000002,350013318000000003	0-24,0-20						These articles have been accepted for publication in the British Journal of Dermatology and are Dermatologists	www.hairsite.com	0	0		CTNNB1
693	chr22	14164227	14165179	3500364573	44		14164227	14165179	8421504	2	22,22	0,930	c	350036457300000000,350036457300000001	0-22,0-22		18824543	10.1128/MCB.00947-08	0270-7306	Molecular and Cellular Biology	Tumor Hypoxia Blocks Wnt Processing and Secretion through the Induction of Endoplasmic Reticulum Stress	Verras	2008	6		CTNNB1
693	chr22	14164227	14165179	3500210930	44		14164227	14165179	8421504	2	22,22	0,930	c	350021093000000000,350021093000000001	0-22,0-22						Tumor Hypoxia Blocks Wnt Processing and Secretion through the Induction of Endoplasmic Reticulum Stress	mcb.asm.org	0	0		CTNNB1
693	chr22	14164889	14167719	3500440537	58		14164889	14167719	8421504	2	29,29	0,2801	c,g	350044053700000032,350044053700000032,350044053700000001,350044053700000001,350044053700000033,350044053700000002	0-29,0-29,0-29,0-29,0-29,0-29						EMX2 IN CANCER DIAGNOSIS AND PROGNOSIS - Patent application	www.faqs.org	0	0		CTNNB1
693	chr22	14164889	14167719	3500433413	58		14164889	14167719	8421504	2	29,29	0,2801	c,g	350043341300000001,350043341300000001,350043341300000002	0-29,0-29,0-29						EMX2 IN CANCER DIAGNOSIS AND PROGNOSIS	He	2010	0		CTNNB1
693	chr22	14164889	14167719	3500147295	58		14164889	14167719	8421504	2	29,29	0,2801	c	350014729500000001,350014729500000002	0-29,0-29						EMX2 IN CANCER DIAGNOSIS AND PROGNOSIS - THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	www.sumobrain.com	0	0		CTNNB1
693	chr22	14164975	14167721	3500122746	44		14164975	14167721	8421504	3	21,1,22	0,108,2724	c	350012274600000004,350012274600000005	0-22,0-22		20835687	10.1590/S0100-879X2010007500091	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Evaluation of anti-Wnt/&#x03b2;-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system	Chuang	2010	1		CTNNB1
693	chr22	14164975	14167721	3500026516	44		14164975	14167721	8421504	3	21,1,22	0,108,2724	c	350002651600000004,350002651600000005	0-22,0-22						doi: 10.1590/S0100-879X2010007500091 Evaluation of anti-Wnt/&#x03b2;-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system	www.scielo.br	0	0		CTNNB1
693	chr22	14165109	14167258	3500262444	41		14165109	14167258	8421504	2	22,19	0,2130	c,g	350026244400000000,350026244400000001	0-22,0-19						Antitumor efficacy induced by a B16F10 tumor cell vaccine treated with mitoxantrone alone or in combination with reserpine and verapamil in mice	-publications.com	0	0		CTNNB1
693	chr22	14165109	14167258	3500120398	41		14165109	14167258	8421504	2	22,19	0,2130	c	350012039800000002,350012039800000003	0-22,0-19						RESEARCH ARTICLE Open Access Evaluation of characteristics of CD44 CD117 ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures	biomedcentral.com	0	0		CTNNB1
693	chr22	14165111	14167220	3500277720	42		14165111	14167220	8421504	2	21,21	0,2088	c,g	350027772000000008,350027772000000009,350027772000000009	0-21,0-21,0-21						&#x201c;An&#xe1;lisis de la expresi&#xf3;n g&#xe9;nica diferencial en un modelo experimental de endometriosis&#x201d;	eciencia.urjc.es	0	0		CTNNB1
693	chr22	14167115	14167138	3500050706	23		14167115	14167138	8421504	1	23	0	c	350005070600000000	0-23		12460454	10.1186/1471-2407-2-33	1471-2407	BMC Cancer	Expression of stabilized &#xce;&#xb2;-catenin in differentiated neurons of transgenic mice does not result in tumor formation	Kratz	2002	3		CTNNB1
693	chr22	14167281	14167660	3500012142	41		14167281	14167660	8421504	2	20,21	0,358	c,g	350001214200000018,350001214200000018,350001214200000017	0-20,0-20,0-21						Prade-Houdellier_Nais	www.scribd.com	0	0		CTNNB1
693	chr22	14167287	14167313	3500297881	26		14167287	14167313	8421504	1	26	0	c,g	350029788100000035,350029788100000035,350029788100000036	1-25,1-25,2-28						Translocation dependent complementation for drug screening	Dahl	2003	0		CTNNB1
693	chr22	14167288	14167667	3500120386	44		14167288	14167667	8421504	2	22,22	0,357	c	350012038600000006,350012038600000007	0-22,0-22		15313925	10.1158/0008-5472.CAN-04-0754	0008-5472	Cancer Research	EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy	Osta	2004	8		CTNNB1
693	chr22	14167289	14167314	3500291687	25		14167289	14167314	8421504	1	25	0	c	350029168700000008	0-25		19188438	10.1128/MCB.01274-08	0270-7306	Molecular and Cellular Biology	Myocilin Is a Modulator of Wnt Signaling	Kwon	2009	6		CTNNB1
693	chr22	14167976	14168026	3500212894	50		14167976	14168026	8421504	1	50	0	c,g	350021289400000000,350021289400000001,350021289400000001	4-45,13-63,13-63						Downregulated MicroRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-Cadherin and Activating the Wnt/ -Catenin Signaling Pathway	isp.ncifcrf.gov	0	0		CTNNB1
693	chr22	14167976	14168026	3500127404	50		14167976	14168026	8421504	1	50	0	c,g	350012740400000000,350012740400000000,350012740400000001,350012740400000001	4-54,4-54,13-63,13-63		19703993	10.1128/MCB.00332-09	0270-7306	Molecular and Cellular Biology	Downregulated MicroRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-Cadherin and Activating the Wnt/&#x03b2;-Catenin Signaling Pathway	Saydam	2009	6		CTNNB1
693	chr22	14168278	14168338	3500389735	60		14168278	14168338	8421504	1	60	0	c	350038973500000002	0-60						Reverse transcription using random pentadecamer primers increases yield and quality of resulting cDNA	quantification.de	0	0		CTNNB1
693	chr22	14235865	14235891	3500433404	24		14235865	14235891	8421504	2	11,13	0,13	g	350043340400000011	5-29						Mouse models carrying a knock-out mutation of the qpctl-gene	Cynis	2012	0		
693	chr22	14235865	14235891	3500072892	24		14235865	14235891	8421504	2	11,13	0,13	g	350007289200000013	5-29						MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE QPCTL-GENE - Patent application	www.faqs.org	0	0		
696	chr22	14550628	14550658	3500343421	27		14550628	14550658	8421504	3	8,14,5	0,9,25	g	350034342100000326	21-48						NOVEL NUCLEIC ACID SEQUENCES AND THEIR USE IN METHODS FOR ACHIEVING PATHOGEN RESISTANCE IN PLANTS - Patent application	www.faqs.org	0	0		
698	chr22	14916442	14916467	3500294433	23		14916442	14916467	8421504	3	5,14,4	0,6,21	c	350029443300000184	0-25						Polypeptide compositions toxic to anthonomus insects, and methods of use	Isaac	2001	0		
698	chr22	14916512	14916635	3500315071	40		14916512	14916635	8421504	2	20,20	0,103	c,g	350031507100000029,350031507100000029,350031507100000028,350031507100000028	0-20,0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
699	chr22	14997626	14997654	3500377603	23		14997626	14997654	8421504	2	6,17	0,11	g	350037760300000008	4-28					Patent	Combination of blys inhibition and mycophenolate mofetil for treatment of autoimmune disease (Patent EP:2139517)	Ponce	2013	0		
699	chr22	14997626	14997654	3500104989	23		14997626	14997654	8421504	2	6,17	0,11	g	350010498900000009	4-28						COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE	Ponce	2008	0		
701	chr22	15221167	15223765	3500368242	40		15221167	15223765	8421504	4	6,13,13,8	0,9,2572,2590	c,g	350036824200000002,350036824200000010	1-20,14-37						Erythropoietin with altered biological activity	Grodberg	1999	0		
701	chr22	15229010	15232262	3500084378	24		15229010	15232262	8421504	2	2,22	0,3230	c	350008437800000066	0-24						Novel polypeptides and nucleic acids encoding same	Shimkets	2000	0		
702	chr22	15412265	15412289	3500064600	23		15412265	15412289	8421504	2	11,12	0,12	g	350006460000000022	1-25						E. coli mediated gene silencing of beta-catenin	Fruehauf	2010	0		
703	chr22	15483670	15484700	3500246268	85		15483670	15484700	8421504	2	45,40	0,990	c	350024626800000153,350024626800000174	0-45,0-40						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
703	chr22	15544526	15544647	3500158219	64		15544526	15544647	8421504	4	11,12,29,12	0,14,36,109	g	350015821900000033	3-79						OLIGONUCLEOTIDE-, PROTEIN AND/OR PEPTIDE-POLYMER CONJUGATES - Patent application	www.faqs.org	0	0		
704	chr22	15698359	15698386	3500010815	23		15698359	15698386	8421504	2	11,12	0,15	g	350001081500000266	21-44						Polynucleotide encoding a propionibacterium linoleate isomerase and uses thereof	Rosson	2000	0		
704	chr22	15712538	15712568	3500298630	24		15712538	15712568	8421504	3	13,4,7	0,18,23	c	350029863000000059	14-39						Proteins with increased levels of essential amino acids	Rao	1999	0		
707	chr22	16036770	16036819	3500463464	49		16036770	16036819	8421504	1	49	0	c,g	350046346400000058,350046346400000058	17-68,17-68						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
708	chr22	16181575	16181602	3500272696	25		16181575	16181602	8421504	2	17,8	0,19	g	350027269600000053	14-45						US Patent # 6,861,239. Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof - Patents.com	www.patents.com	0	0		
709	chr22	16257950	16257975	3500343421	24		16257950	16257975	8421504	2	18,6	0,19	g	350034342100000220	11-37						NOVEL NUCLEIC ACID SEQUENCES AND THEIR USE IN METHODS FOR ACHIEVING PATHOGEN RESISTANCE IN PLANTS - Patent application	www.faqs.org	0	0		
709	chr22	16287074	16287097	3500068780	23		16287074	16287097	8421504	1	23	0	g	350006878000000111	9-32						THREE-COMPONENT BIOSENSORS FOR DETECTING MACROMOLECULES AND OTHER ANALYTES - Patent application	www.faqs.org	0	0		
710	chr22	16415192	16415215	3500114594	23		16415192	16415215	8421504	1	23	0	c	350011459400000417,350011459400000844	0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		SLC12A3
712	chr22	16730044	16730072	3500061921	25		16730044	16730072	8421504	2	10,15	0,13	g	350006192100000013,350006192100000065	8-33,8-33						NOVEL VIRAL VECTOR - Patent application	www.faqs.org	0	0		
713	chr22	16813638	16813671	3500074919	24		16813638	16813671	8421504	3	6,6,12	0,10,21	c	350007491900000004	0-24						[tel-00652595, v1] R&#xf4;le du couple Flt3-ligand/Flt3 et de l'activation des 'Mitogen-activated protein kinases' p38 dans la dysm&#xe9;gacaryopo&#xef;&#xe8;se des patients atteints de my&#xe9;lofibrose primitive.	hives-ouvertes.fr	0	0		
713	chr22	16813702	16813762	3500182015	60		16813702	16813762	8421504	1	60	0	p	350018201500015018	0-60						Homo sapiens zinc finger protein 306 (ZNF306), mRNA. , NM_024493.1 - GenScript	www.genscript.com	0	0		ZNF300
713	chr22	16832277	16832301	3500332991	23		16832277	16832301	8421504	2	10,13	0,11	g	350033299100000025	4-27						Sp35 Antibodies And Uses Thereof 	.freshpatents.com	0	0		
713	chr22	16869981	16870164	3500220702	117		16869981	16870164	8421504	2	30,87	0,96	p	350022070200015080,350022070200015013	18-207,0-69						Regulatory zinc finger proteins	Jin-Soo	2004	0		ZNF35
713	chr22	16870095	16870164	3500385351	69		16870095	16870164	8421504	1	69	0	p	350038535100015087	0-69						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZNF35
713	chr22	16870095	16870164	3500269504	69		16870095	16870164	8421504	1	69	0	p	350026950400015056	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZNF35
713	chr22	16870095	16870164	3500229015	69		16870095	16870164	8421504	1	69	0	p	350022901500015022	0-69						Figure S1 AB	genome.cshlp.org	0	0		ZNF35
713	chr22	16870095	16870164	3500176901	69		16870095	16870164	8421504	1	69	0	p	350017690100015039	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZNF35
713	chr22	16870095	16870164	3500160097	69		16870095	16870164	8421504	1	69	0	p	350016009700015075	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZNF35
713	chr22	16870095	16870164	3500105130	69		16870095	16870164	8421504	1	69	0	p	350010513000015016	0-69						Supplemental Figure 1	genome.cshlp.org	0	0		ZNF35
713	chr22	16870095	16870164	3500075471	69		16870095	16870164	8421504	1	69	0	p	350007547100015044	0-69						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZNF35
713	chr22	16889660	16889705	3500220460	45		16889660	16889705	8421504	1	45	0	p	350022046000015042	0-45						PLANT VIRAL EXPRESSION VECTORS AND USE OF SAME FOR GENERATING GENOTYPIC VARIATIONS IN PLANT GENOMES - Patent application	www.faqs.org	0	0		
713	chr22	16889660	16889705	3500014944	45		16889660	16889705	8421504	1	45	0	p	350001494400015041	0-45						Application # 2011/0126317. PLANT VIRAL EXPRESSION VECTORS AND USE OF SAME FOR GENERATING GENOTYPIC VARIATIONS IN PLANT GENOMES - Patents.com	patents.com	0	0		
714	chr22	16955607	16955639	3500031190	25		16955607	16955639	8421504	3	8,11,6	0,13,26	g	350003119000000002	6-32						INVESTIGATION OF THE ASSOCIATION BETWEEN GENETIC AND ACTIVITY POLYMORPHISMS OF PARAOXONASE 1 AND ISCHEMIC STROKE RISK A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF NATURAL AND APPLIED SCIENCES OF MIDDLE EAST TECHNICAL UNIVERSITY	d.lib.metu.edu.tr	0	0		
714	chr22	16972330	16972356	3500299704	24		16972330	16972356	8421504	2	8,16	0,10	g	350029970400000006	10-34		21575138	10.1111/j.1742-4658.2011.08180.x	1742-4658	FEBS Journal	N-glycosylation influences the structure and self-association abilities of recombinant nucleolin - Losfeld - 2011 - FEBS Journal - Wiley Online Library	Losfeld	2011	0		
715	chr22	17066294	17066326	3500223802	24		17066294	17066326	8421504	3	6,13,5	0,11,27	g	350022380200000021	3-29						Production of functional antibodies in filamentous fungi	Power	2004	0		
715	chr22	17066294	17066326	3500042001	24		17066294	17066326	8421504	3	6,13,5	0,11,27	g	350004200100000021	3-29					Patent	Production of functional antibodies in filamentous fungi (Patent US:7977067)	Power	2011	0		
715	chr22	17135099	17139506	3500160945	360		17135099	17139506	8421504	3	77,123,160	0,1851,4247	p	350016094500015003,350016094500015002	0-180,0-180						Diagnostic Genetics at a Distance: Von Hippel-Lindau Disease and a Novel Mutation	loads.hindawi.com	0	0		
715	chr22	17135126	17135174	3500070867	48		17135126	17135174	8421504	1	48	0	p	350007086700015001	0-48						&#x8b1b;&#x6f14;&#x30fb;&#x5b66;&#x4f1a;&#x767a;&#x8868;&#x30ea;&#x30b9;&#x30c8;	ww.konan-fiber.jp	0	0		VHL
715	chr22	17145336	17151879	3500404999	111		17145336	17151879	8421504	3	24,83,4	0,294,6539	p	350040499900015025	0-111						COMBINATORIAL LIBRARIES BASED ON C-TYPE LECTIN DOMAIN - ANPHORE, INC	www.sumobrain.com	0	0		BRK1
715	chr22	17145336	17151879	3500256587	111		17145336	17151879	8421504	3	24,83,4	0,294,6539	p	350025658700015035	0-111						Polypeptides that bind Trail-R1 and Trail-R2	Bowdish	2010	0		BRK1
715	chr22	17145636	17151879	3500198756	81		17145636	17151879	8421504	2	77,4	0,6239	p	350019875600015040	0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Le	2010	0		BRK1
715	chr22	17145636	17151879	3500117727	81		17145636	17151879	8421504	2	77,4	0,6239	p	350011772700015038	0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Holtet	2011	0		BRK1
715	chr22	17145642	17151879	3500095845	75		17145642	17151879	8421504	2	71,4	0,6233	p	350009584500015034	0-75						Polypeptides that Bind TRAIL-R1 and TRAIL-R2	Bowdish	2012	0		BRK1
715	chr22	17157065	17157091	3500307492	25		17157065	17157091	8421504	2	17,8	0,18	c	350030749200000017	10-35					Patent	Cancer stem cell antigen vaccines and methods (Patent US:8129184)	Yu	2012	0		
715	chr22	17157065	17157091	3500108695	25		17157065	17157091	8421504	2	17,8	0,18	c	350010869500000017	10-35						CANCER STEM CELL ANTIGEN VACCINES AND METHODS - Patent application	www.faqs.org	0	0		
716	chr22	17174416	17188033	3500318091	43		17174416	17188033	8421504	2	20,23	0,13594	c,g	350031809100000093,350031809100000038	0-20,16-39					Patent	Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof (Patent EP:1451343)	D'andrea	2012	0		
716	chr22	17188010	17188033	3500245724	23		17188010	17188033	8421504	1	23	0	c,g	350024572400000038,350024572400000038	16-39,16-39						Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof	D'Andrea	2004	0		
716	chr22	17188010	17188033	3500242093	23		17188010	17188033	8421504	1	23	0	c	350024209300000038	16-39						Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof	D'andrea	2003	0		
716	chr22	17192663	17196502	3500335593	42		17192663	17196502	8421504	2	21,21	0,3818	c,g	350033559300000003,350033559300000003,350033559300000002	0-21,0-21,21-42		17172419	10.1158/1535-7163.MCT-06-0427	1535-7163	Molecular Cancer Therapeutics	Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven	Wang	2006	5		FANCD2
716	chr22	17192663	17196502	3500261594	42		17192663	17196502	8421504	2	21,21	0,3818	c	350026159400000003,350026159400000002	0-21,21-42		17172419	10.1158/1535-7163.MCT-06-0427	1535-7163	Molecular Cancer Therapeutics	Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven	Wang	2006	5		EMC3
716	chr22	17196542	17196571	3500457755	25		17196542	17196571	8421504	3	5,6,14	0,8,15	g	350045775500000001	0-25		19812612	10.1038/hdy.2009.131	0018-067X	Heredity	Contrasting modes for loss of pungency between cultivated and wild species of Capsicum	Stellari	2009	5		
716	chr22	17229510	17229534	3500097770	23		17229510	17229534	8421504	2	4,19	0,5	g	350009777000000000	6-32					Infection and Immunity	The Collagen-Binding Adhesin Is a Virulence Factor in Staphylococcus aureus Keratitis	Marcus	June	0		
716	chr22	17253381	17253409	3500412397	23		17253381	17253409	8421504	2	14,9	0,19	c	350041239700000086,350041239700000311	7-33,0-24						Polypeptides Having Glucoamylase Activity And Polynucleotides Encoding Same 	.freshpatents.com	0	0		
716	chr22	17253535	17257376	3500070060	58		17253535	17257376	8421504	4	11,20,26,1	0,96,2292,3840	c	350007006000000254,350007006000000249	11-42,21-48						 Soluble IL 	www.docstoc.com	0	0		
716	chr22	17253672	17258519	3500167290	68		17253672	17258519	8421504	3	14,6,48	0,1757,4799	c	350016729000000088,350016729000000080	0-20,0-48						METHODS OF TREATING INFLAMMATION USING SOLUBLE IL-17RA/RC FUSION PROTEINS - Patent application	www.faqs.org	0	0		
716	chr22	17253672	17255797	3500091560	61		17253672	17255797	8421504	3	14,6,41	0,1757,2084	c	350009156000000088,350009156000000085	0-20,6-47						IL-17A AND IL-17F ANTAGONISTS AND METHODS OF USING THE SAME - Patent application	www.faqs.org	0	0		
716	chr22	17300871	17300894	3500431462	23		17300871	17300894	8421504	1	23	0	c	350043146200000388	0-23						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
716	chr22	17300871	17300894	3500110550	23		17300871	17300894	8421504	1	23	0	c	350011055000000378	0-23						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
716	chr22	17300871	17300894	3500031022	23		17300871	17300894	8421504	1	23	0	c	350003102200000378	0-23						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
717	chr22	17333659	17342753	3500397524	41		17333659	17342753	8421504	4	15,6,2,18	0,16,6590,9076	c,g	350039752400000015,350039752400000014	0-21,0-20		15923655	10.1242/jcs.02371	0021-9533	Journal of Cell Science	Localization of all seven messenger RNAs for the actin-polymerization nucleator Arp2/3 complex in the protrusions of fibroblasts	Mingle	2005	6		TTLL3,TADA3
717	chr22	17370768	17376352	3500456790	636		17370768	17376352	8421504	9	74,70,121,29,44,113,79,88,18	0,1280,2417,2631,2663,3398,4039,4214,5566	p	350045679000015016,350045679000015018,350045679000015019,350045679000015020,350045679000015021	0-144,0-150,0-129,0-123,0-90						Insulin receptor, AMPK and CPT-2: Crystallization experiments a nd structural characterization of three proteins relevant to diabetes mellitus	s.ub.uni-koeln.de	0	0		
717	chr22	17370831	17374215	3500218806	408		17370831	17374215	8421504	11	11,34,45,45,33,9,48,64,29,42,48	0,1217,1411,1459,1507,2348,2360,2411,2568,2600,3336	p	350021880600015005,350021880600015007,350021880600015008	0-45,0-45,0-318						 Crystallographic Structure Of Mnk 	www.docstoc.com	0	0		CAMK1
717	chr22	17375037	17376376	3500184177	75		17375037	17376376	8421504	2	33,42	0,1297	p	350018417700015008	0-75						Biophysical Tools -1	www.scribd.com	0	0		CAMK1
717	chr22	17375049	17376376	3500403302	63		17375049	17376376	8421504	2	21,42	0,1285	p	350040330200015009	0-63						84 Biophysical Tools for Biologists Volume 1 in Vitro Techniques	www.scribd.com	0	0		CAMK1D
717	chr22	17377704	17378768	3500315106	25		17377704	17378768	8421504	2	6,19	0,1045	c	350031510600000005	22-47						ScienceDirect.com - DNA Repair - Functional crosstalk between hOgg1 and the helicase domain of Cockayne syndrome group B protein	sciencedirect.com	0	0		OGG1
717	chr22	17377705	17381985	3500040488	47		17377705	17381985	8421504	4	5,19,5,18	0,1044,3950,4262	c	350004048800000001,350004048800000000	0-24,0-23		16052235	10.1038/sj.cdd.4401736	1350-9047	Cell Death & Differentiation	Human 8-oxoguanine DNA glycosylase increases resistance to hyperoxic cytotoxicity in lung epithelial cells and involvement with altered MAPK activity	Kannan	2005	9		OGG1
717	chr22	17392704	17393214	3500030508	306		17392704	17393214	8421504	4	84,99,51,72	0,123,309,438	p	350003050800015015,350003050800015011,350003050800015008,350003050800015007	0-84,0-99,0-51,6-78						A Zinc Finger/Leucine Zipper Genes Identified From the Molecular Cloning of the t(10; 11) Translocation in Acute Leukemia	tologylibrary.org	0	0		BRPF1
718	chr22	17443593	17443622	3500220054	23		17443593	17443622	8421504	3	5,6,12	0,6,17	g	350022005400000033	1-24						Peer-Reviewed Journal Tracking and Analyzing Disease Trends pages 1&#x2013;182	wwwnc.cdc.gov	0	0		
718	chr22	17443593	17443622	3500059880	23		17443593	17443622	8421504	3	5,6,12	0,6,17	g	350005988000000033	1-24						Peer-Reviewed Journal Tracking and Analyzing Disease Trends pages 1&#x2013;182	s3.amazonaws.com	0	0		
718	chr22	17471588	17471627	3500166869	32		17471588	17471627	8421504	5	11,4,5,6,6	0,12,17,26,33	c	350016686900000022,350016686900000023	10-36,10-42						Rapid Isolation of Monoclonal Antibodies from Animals - Patent application	www.faqs.org	0	0		
719	chr22	17597268	17597293	3500177198	23		17597268	17597293	8421504	2	7,16	0,9	c	350017719800000008	1-24						No. THE Issue Vol. OF 267, pp. CHEMISTRY 21, 25, 14998-15004,1992 for 1992 Inc. U.S.A. in Cloning and Expression of a Cell Surface Receptor for Advanced Glycosylation End Products of Proteins*	www.jbc.org	0	0		
719	chr22	17606439	17644355	3500068199	39		17606439	17644355	8421504	3	14,5,20	0,16,37896	g	350006819900000397,350006819900000526	19-38,9-29						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
719	chr22	17675090	17675150	3500314401	60		17675090	17675150	8421504	1	60	0	g	350031440100000053	0-94						SI appendix for	www.pnas.org	0	0		
721	chr22	17856082	17856114	3500236539	26		17856082	17856114	8421504	3	7,13,6	0,8,26	g	350023653900000013	10-38		21464222	10.1084/jem.20102384	0022-1007	The Journal of Experimental Medicine	Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL	Li	2011	14		
722	chr22	17976169	17976197	3500300562	27		17976169	17976197	8421504	2	5,22	0,6	c	350030056200000084	0-28						Method of identifying transmembrane protein-interacting compounds	George	2005	0		
722	chr22	17976169	17976197	3500289629	27		17976169	17976197	8421504	2	5,22	0,6	c	350028962900000181,350028962900000084	0-28,0-28						METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - Patent application	www.faqs.org	0	0		
722	chr22	17976169	17976197	3500127324	27		17976169	17976197	8421504	2	5,22	0,6	c,g	350012732400000084,350012732400000084	0-28,0-28						Method of Identifying Transmembrane Protein-Interacting Compounds	O'Dowd	2013	0		
722	chr22	17976169	17976197	3500126126	27		17976169	17976197	8421504	2	5,22	0,6	c	350012612600000084	0-28						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2010	0		
722	chr22	17976169	17976197	3500083847	27		17976169	17976197	8421504	2	5,22	0,6	c	350008384700000084	0-28						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2003	0		
722	chr22	17976169	17976197	3500043017	27		17976169	17976197	8421504	2	5,22	0,6	c	350004301700000181,350004301700000084	0-28,0-28						METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - Patent application	www.faqs.org	0	0		
724	chr22	18275238	18275261	3500079203	23		18275238	18275261	8421504	1	23	0	g	350007920300000001	0-23		12604656	10.1095/biolreprod.102.008961	0006-3363	Biology of Reproduction	Transcriptional Regulation of the Bovine Oxytocin Receptor Gene	Telgmann	2003	4		
724	chr22	18279463	18279569	3500103878	40		18279463	18279569	8421504	2	20,20	0,86	c,g	350010387800000000,350010387800000001,350010387800000001	0-20,0-20,0-20						Molecular regulation of progesterone synthesis in the bovine corpus luteum	www.vri.cz/docs/v	0	0		
724	chr22	18279485	18279902	3500298653	40		18279485	18279902	8421504	2	20,20	0,397	c,g	350029865300000000,350029865300000000,350029865300000001,350029865300000001	0-20,0-20,0-20,0-20						Pregnancy and Bovine Somatotropin in Nonlactating Dairy Cows: II. Endometrial Gene Expression Related to Maintenance of Pregnancy	ww.animal.ufl.edu	0	0		
724	chr22	18279659	18287819	3500054903	96		18279659	18287819	8421504	4	24,24,24,24	0,414,481,8136	c	350005490300000004,350005490300000007,350005490300000008,350005490300000005	0-24,0-24,0-24,0-24						Regulation of oxytocin receptor gene expression in sheep: tissue speci&#xfb01;city, multiple transcripts and mRNAediting	uction-online.org	0	0		
724	chr22	18279729	18280084	3500457334	127		18279729	18280084	8421504	3	30,66,31	0,126,324	p,c	350045733400000027,350045733400015033,350045733400015058,350045733400000034	18-48,0-48,0-48,0-31						Oxytocin As Cardiomyogenesis Inducer And Uses Thereof 	.freshpatents.com	0	0		
724	chr22	18279759	18279884	3500175553	42		18279759	18279884	8421504	2	22,20	0,105	c,g	350017555300000001,350017555300000000,350017555300000000	0-22,24-44,24-44						UNIVERSIDADE FEDERAL DO PAMPA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIA ANIMAL	s.unipampa.edu.br	0	0		
724	chr22	18279882	18279933	3500047582	51		18279882	18279933	8421504	1	51	0	p	350004758200015013	0-51						Human oxytocin receptor (OXTR) in pcDNA 3.1 GCTAGCGTTTAAACTTAAGCTTGGTACCGAGCTCGGATCCACTAGTCCAG CGATCGCAAATTTGAATTCGAACCATGGCTCGAGCCTAGGTGATCAGGTC TGTGGTGGAATTCACCATGGAGGGCGCGCTCGCAGCCAACTGGAGCGCCG ACACCACCTTAAGTGGTACCTCCCGCGCGAGCGTCGGTTGACCTCGCGGC AGGCAGC	www.cdna.org	0	0		
724	chr22	18280131	18280176	3500408713	45		18280131	18280176	8421504	1	45	0	c	350040871300000000	0-45						Expression of oxytocin, oestrogen and progesterone receptors in uterine biopsy samples throughout the oestrous cycle and early pregnancy in cows	uction-online.org	0	0		
724	chr22	18287807	18288011	3500319127	40		18287807	18288011	8421504	2	20,20	0,184	c,g	350031912700000004,350031912700000004,350031912700000005	0-20,0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
724	chr22	18294909	18294934	3500024755	25		18294909	18294934	8421504	1	25	0	c	350002475500000008	0-25		23283951	10.1128/JVI.00552-12	0022-538X	Journal of Virology	Mandarin Fish Caveolin 1 Interaction with Major Capsid Protein of Infectious Spleen and Kidney Necrosis Virus and Its Role in Early Stages of Infection	Jia	2013	5		
730	chr22	19039235	19039263	3500325001	24		19039235	19039263	8421504	2	18,6	0,22	g	350032500100000001	0-24		12121928	10.1128/AAC.46.8.2525-2532.2002	0066-4804	Antimicrobial Agents and Chemotherapy	Efficacies of Entecavir against Lamivudine-Resistant Hepatitis B Virus Replication and Recombinant Polymerases In Vitro	Levine	2002	5		
730	chr22	19039235	19039263	3500265630	24		19039235	19039263	8421504	2	18,6	0,22	g	350026563000000001	0-24			10.1128/AAC.46.8.2525-2532.2002		Antimicrobial Agents and Chemotherapy	Efficacies of Entecavir against Lamivudine-Resistant Hepatitis B Virus Replication and Recombinant Polymerases In Vitro	S.	2002	0		
91	chr22	19152806	19346864	3500232044	348		19152806	19346864	8421504	3	50,247,51	0,50740,194007	c	350023204400000175	0-348						Endogenous and non-endogenous versions of human G protein-coupled receptors	Liao Wang Zhen 	2004	0		GRM7
731	chr22	19225209	19225234	3500370232	23		19225209	19225234	8421504	3	13,6,4	0,14,21	g	350037023200000230	2-30						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
732	chr22	19311549	19311573	3500154972	23		19311549	19311573	8421504	2	16,7	0,17	g	350015497200000005,350015497200000023	18-41,18-41						Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof - Patent application	www.faqs.org	0	0		
11	chr22	19613137	20098459	3500232044	1020		19613137	20098459	8421504	4	142,142,217,519	0,7141,187541,484803	c	350023204400000060	0-1020						Endogenous and non-endogenous versions of human G protein-coupled receptors	Liao Wang Zhen 	2004	0		
11	chr22	19800694	20098459	3500232044	720		19800694	20098459	8421504	2	201,519	0,297246	c	350023204400000176	0-720						Endogenous and non-endogenous versions of human G protein-coupled receptors	Liao Wang Zhen 	2004	0		GRM7
738	chr22	20097989	20098435	3500343669	42		20097989	20098435	8421504	2	22,20	0,426	c,g	350034366900000042,350034366900000041,350034366900000041	0-22,0-20,0-20						Gastroenterology (February 2005)	005.pasteur.ac.ir	0	0		GRM7
738	chr22	20098107	20098363	3500385544	70		20098107	20098363	8421504	3	19,30,21	0,199,235	c,g	350038554400000004,350038554400000004,350038554400000003,350038554400000010,350038554400000010,350038554400000006,350038554400000006	0-19,0-19,0-30,0-21,0-21,0-21,0-21						Chimeric metabotropic glutamate receptors and uses thereof	Gupta	2005	0		
738	chr22	20098107	20098363	3500263396	70		20098107	20098363	8421504	3	19,30,21	0,199,235	c,g	350026339600000004,350026339600000004,350026339600000010,350026339600000010,350026339600000003,350026339600000006	0-19,0-19,0-21,0-21,0-30,0-21						Chimeric metabotropic glutamate receptors and uses thereof	Gupta	2007	0		CASR
739	chr22	20190808	20190833	3500199392	24		20190808	20190833	8421504	2	7,17	0,8	g	350019939200000049	0-24						Alpha-amylase Variants 	.freshpatents.com	0	0		
739	chr22	20209906	20209932	3500375668	23		20209906	20209932	8421504	3	7,11,5	0,9,21	g	350037566800000022	4-27						CGTase and DNA sequence encoding same - US Patent 7700338 Description	ww.patentstorm.us	0	0		
739	chr22	20297558	20297583	3500034780	24		20297558	20297583	8421504	2	5,19	0,6	g	350003478000000025	14-38						Microsatellite-based characterization of southern African domestic pig Sus scrofa domestica) breeds	ul.netd.ac.za	0	0		
744	chr22	20948896	20948924	3500271050	23		20948896	20948924	8421504	2	7,16	0,12	g	350027105000000230	16-46						Cloning by complementation and related processes	Colicelli	1991	0		
744	chr22	20970450	20970478	3500162031	25		20970450	20970478	8421504	2	13,12	0,16	g	350016203100000064	23-48						Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5	Gerald	1996	0		
748	chr22	21471389	21471417	3500197873	23		21471389	21471417	8421504	2	16,7	0,21	g	350019787300001122,350019787300000097	10-37,13-40						Nucleic acid compositions encoding modified Bacillus thuringiensis coleopteran-toxic crystal proteins	English	1999	0		
750	chr22	21741002	21741029	3500328146	24		21741002	21741029	8421504	2	7,17	0,10	g	350032814600000056	18-48						Binding Molecules For Treatment And Detection Of Cancer 	.freshpatents.com	0	0		
751	chr22	21858392	21858415	3500068260	23		21858392	21858415	8421504	1	23	0	c	350006826000000024	11-34						Mouse lacking heart-muscle adenine nucleotide translocator protein and methods	Graham	1998	0		
752	chr22	21893589	21939407	3500184474	49		21893589	21939407	8421504	2	29,20	0,45798	c	350018447400000016,350018447400000015	0-29,0-20		20484575	10.1091/mbc.E09-12-1010	1059-1524	Molecular Biology of the Cell	The Arf-like GTPase Arl8 Mediates Delivery of Endocytosed Macromolecules to Lysosomes in Caenorhabditis elegans	Nakae	2010	5		
752	chr22	21893589	21939407	3500145167	49		21893589	21939407	8421504	2	29,20	0,45798	c,g	350014516700000016,350014516700000015,350014516700000015	0-29,0-20,0-20						The Arf-like GTPase Arl8 Mediates Delivery of Endocytosed Macromolecules to Lysosomes in Caenorhabditis elegans	w.molbiolcell.org	0	0		
753	chr22	22060193	22060225	3500321535	32		22060193	22060225	8421504	1	32	0	c	350032153500000048	6-38						US Patent # 5,571,677. Convergent synthesis of branched and multiply connected macromomolecular structures - Patents.com	www.patents.com	0	0		
753	chr22	22060193	22060220	3500130251	25		22060193	22060220	8421504	3	5,4,16	0,6,11	c	350013025100000309	11-36						COMPOSITIONS AND METHODS FOR INCREASING BONE MINERALIZATION - DARWIN DISCOVERY LTD.	www.sumobrain.com	0	0		
753	chr22	22060322	22064322	3500056689	38		22060322	22064322	8421504	2	19,19	0,3981	c,g	350005668900000005,350005668900000004,350005668900000004	0-19,3-22,3-22						JBC Papers in Press. Published on July 11, 2012 as Manuscript M112.367326 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M112.367326	www.jbc.org	0	0		
753	chr22	22060322	22064322	3500043085	38		22060322	22064322	8421504	2	19,19	0,3981	c,g	350004308500000005,350004308500000004,350004308500000004	0-19,3-22,3-22		22787161	10.1074/jbc.M112.367326		The Journal of Biological Chemistry	p53, a Target of Estrogen Receptor (ER) &#x03b1;, Modulates DNA Damage-induced Growth Suppression in ER-positive Breast Cancer Cells	CrystE.	2012	0		
753	chr22	22060362	22064827	3500367128	65		22060362	22064827	8421504	2	45,20	0,4445	p,g	350036712800015001,350036712800000018	3-48,0-20		18411297	10.1128/MCB.02168-07	0270-7306	Molecular and Cellular Biology	DEC1 Modulates the Circadian Phase of Clock Gene Expression	Nakashima	2008	6		BHLHE40
753	chr22	22060446	22062612	3500433790	243		22060446	22062612	8421504	6	48,29,47,24,47,48	0,115,193,480,673,2118	c	350043379000000187,350043379000000185,350043379000000183,350043379000000177,350043379000000173,350043379000000170	0-48,0-29,0-47,24-48,0-47,0-48						Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression - Patent # 6020155 - PatentGenius	.patentgenius.com	0	0		
753	chr22	22062608	22063713	3500025190	42		22062608	22063713	8421504	2	21,21	0,1084	c,g	350002519000000031,350002519000000030,350002519000000030	0-21,0-21,0-21						Agents And Methods For Osteogenic Oxysterols Inhibition Of Oxidative Stress On Osteogenic Cellular Differentiation 	.freshpatents.com	0	0		BHLHE40
753	chr22	22063733	22064027	3500347440	34		22063733	22064027	8421504	2	18,16	0,278	c	350034744000000023	0-34			10.1111/j.1432-1033.2004.04379.x	1432-1033	European Journal of Biochemistry	Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian regulation - Sato - 2004 - European Journal of Biochemistry - Wiley Online Library	Sato	2004	0		
753	chr22	22063741	22064027	3500004521	24		22063741	22064027	8421504	4	7,2,11,4	0,8,270,282	c	350000452100000098	18-46						US Patent # 6,680,209. Human antibodies as diagnostic reagents - Patents.com	www.patents.com	0	0		
754	chr22	22192381	22192407	3500404568	23		22192381	22192407	8421504	3	6,5,12	0,8,14	g	350040456800000001	1-24						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - US Patent 7700341 Description	ww.patentstorm.us	0	0		
754	chr22	22197397	22197427	3500406455	25		22197397	22197427	8421504	3	6,13,6	0,8,24	g	350040645500000007	11-36						&#x9ad8;&#x3044;&#x30a8;&#x30cd;&#x30eb;&#x30ae;&#x30fc;&#x79fb;&#x52d5;&#x52b9;&#x7387;&#x3092;&#x6709;&#x3059;&#x308b;&#xff22;&#xff32;&#xff25;&#xff34;&#x767a;&#x73fe;&#x7cfb; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; 2008283959&#xff09;&#xff5c;&#x30a2;&#x	astamuse.com	0	0		
754	chr22	22198904	22198931	3500272920	23		22198904	22198931	8421504	3	14,4,5	0,15,22	g	350027292000000052	8-31						Antibodies to CD40 - Patent application	www.faqs.org	0	0		
754	chr22	22214730	22214763	3500103319	33		22214730	22214763	8421504	1	33	0	c,g	350010331900000000,350010331900000000	17-50,17-50		18635540	10.1074/jbc.M803321200	0021-9258	Journal of Biological Chemistry	Effects of Redox Potential and Ca2+ on the Inositol 1,4,5-Trisphosphate Receptor L3-1 Loop Region	Kang	2008	5		
755	chr22	22326637	22326663	3500460467	23		22326637	22326663	8421504	2	9,14	0,12	c	350046046700000099	4-27						 Neutrophil Inhibitors 	www.docstoc.com	0	0		
755	chr22	22326637	22326663	3500231688	23		22326637	22326663	8421504	2	9,14	0,12	c	350023168800000106	4-27						Method of detecting neutophil inhibitory factor mimics	Moyle	1993	0		
755	chr22	22326637	22326663	3500192210	23		22326637	22326663	8421504	2	9,14	0,12	c	350019221000000101	4-27						Neutrophil inhibitors	Moyle	1995	0		
755	chr22	22326637	22326663	3500180791	23		22326637	22326663	8421504	2	9,14	0,12	c	350018079100000075	4-27						Modified hookworm neutrophil inhibitors	Moyle	1995	0		
755	chr22	22326637	22326663	3500034224	23		22326637	22326663	8421504	2	9,14	0,12	c	350003422400000097	4-27					Patent	Neutrophil inhibitors (Patent US:5789178)	Foster	1998	0		
755	chr22	22326637	22326663	3500017068	23		22326637	22326663	8421504	2	9,14	0,12	c	350001706800000099	4-27						Neutrophil inhibitors	Moyle	1995	0		
755	chr22	22357888	22359309	3500228810	38		22357888	22359309	8421504	2	19,19	0,1402	c	350022881000000005,350022881000000004	0-19,0-19						Expression analysis of regulatory MicroRNA in bovine cumulus oocyte complex and preimplantation embryos	s.ulb.uni-bonn.de	0	0		
755	chr22	22359350	22399684	3500152250	295		22359350	22399684	8421504	11	33,15,42,2,48,48,20,24,15,30,18	0,2665,4663,5376,5426,25199,26506,26554,28573,30812,40316	c	350015225000000054,350015225000000048,350015225000000046,350015225000000033,350015225000000031,350015225000000030,350015225000000025	0-48,0-44,0-48,0-48,28-48,9-48,0-48						Biosensors to measure InsP3 concentration in living cells - Patent application	www.faqs.org	0	0		ITPR1
94	chr22	22399781	22500259	3500152250	47		22399781	22500259	8421504	2	1,46	0,100432	c	350015225000000022	0-47						Biosensors to measure InsP3 concentration in living cells - Patent application	www.faqs.org	0	0		
756	chr22	22436617	22436642	3500142873	23		22436617	22436642	8421504	2	14,9	0,16	g	350014287300000117,350014287300000303	1-24,1-22						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
756	chr22	22504802	22504835	3500068046	33		22504802	22504835	8421504	1	33	0	c,g	350006804600000000,350006804600000000	12-45,12-45						Global dynamic conformational changes in the suppressor domain of IP3 receptor by stepwise binding of the two lobes of calmodulin	www.fasebj.org	0	0		
757	chr22	22571719	22571776	3500158699	57		22571719	22571776	8421504	1	57	0	p	350015869900015011	0-57						Descripci&#xf3;n y reivindicaciones de la patente: diagn&#xf3;stico y tratamiento de deficiencia m&#xfa;ltiple de sulfatasas y otras usando una enzima generadora de formilglicina(fge) (21 de marzo de 2012).	patentados.com	0	0		SUMF1
757	chr22	22571719	22571776	3500127891	57		22571719	22571776	8421504	1	57	0	p	350012789100015013	0-57						GENE THERAPY FOR SULFATASE DEFICIENCY	Figura	2012	0		SUMF1
757	chr22	22571719	22571776	3500083518	57		22571719	22571776	8421504	1	57	0	p	350008351800015004	0-57						ScienceDirect.com - Cell - Multiple Sulfatase Deficiency Is Caused by Mutations in the Gene Encoding the Human C&#x03b1;-Formylglycine Generating Enzyme	sciencedirect.com	0	0		SUMF1
757	chr22	22571719	22571776	3500045549	57		22571719	22571776	8421504	1	57	0	p	350004554900015009	0-57						Invenes	invenes.oepm.es	0	0		SUMF1
757	chr22	22571866	22659192	3500084979	668		22571866	22659192	8421504	10	27,21,6,42,104,114,60,247,26,21	0,3473,3542,27828,31306,36430,68477,87029,87278,87305	c	350008497900000016,350008497900000018,350008497900000082	0-48,0-48,11-587						GENE THERAPY FOR SULFATASE DEFICIENCY - Patent application	www.faqs.org	0	0		
757	chr22	22571866	22659192	3500061508	698		22571866	22659192	8421504	11	27,21,30,6,42,104,114,60,247,26,21	0,3473,3500,3542,27828,31306,36430,68477,87029,87278,87305	c	350006150800000016,350006150800000017,350006150800000018,350006150800000082	0-48,6-36,0-48,11-587						DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIES - Patent application	www.faqs.org	0	0		
757	chr22	22608402	22640382	3500084979	47		22608402	22640382	8421504	2	8,39	0,31941	c	350008497900000027	1-48						GENE THERAPY FOR SULFATASE DEFICIENCY - Patent application	www.faqs.org	0	0		
757	chr22	22608402	22640382	3500061508	47		22608402	22640382	8421504	2	8,39	0,31941	c	350006150800000027	1-48						DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIES - Patent application	www.faqs.org	0	0		
758	chr22	22683559	22683590	3500461622	25		22683559	22683590	8421504	3	8,4,13	0,13,18	c	350046162200000291	11-48						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
758	chr22	22683559	22683590	3500322097	25		22683559	22683590	8421504	3	8,4,13	0,13,18	c	350032209700000309	11-48						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
758	chr22	22683559	22683590	3500309840	25		22683559	22683590	8421504	3	8,4,13	0,13,18	c	350030984000000309	11-48						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
758	chr22	22683559	22683590	3500119454	25		22683559	22683590	8421504	3	8,4,13	0,13,18	c	350011945400000313	11-48						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
758	chr22	22683559	22683590	3500004227	25		22683559	22683590	8421504	3	8,4,13	0,13,18	c	350000422700000313	11-48						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
758	chr22	22683848	22683872	3500193093	23		22683848	22683872	8421504	2	19,4	0,20	c	350019309300000138	3-27						 Recombinant Vesiculoviruses And Their Uses 	www.docstoc.com	0	0		
758	chr22	22685885	22685910	3500369164	25		22685885	22685910	8421504	1	25	0	c	350036916400000001	23-48						Desarrollo de un multiplex de microsat&#xe9;lites para diagn&#xf3;stico de paternidad en ovinos Corriedale del Uruguay	duccionbovina.com	0	0		
758	chr22	22685885	22685910	3500070613	25		22685885	22685910	8421504	1	25	0	c	350007061300000001	23-48						Desarrollo de un multiplex de microsat&#xe9;lites para diagn&#xf3;stico de paternidad en ovinos Corriedale del Uruguay	www.scielo.edu.uy	0	0		
760	chr22	23029787	23029810	3500233649	23		23029787	23029810	8421504	1	23	0	c	350023364900000015	3-26					Patent	Method of screening compounds that inhibit the biosynthesis of GPI in malaria parasites (Patent CN:100504392)	Zhong Ben He Xiao 	2009	0		
760	chr22	23031072	23031147	3500117965	75		23031072	23031147	8421504	1	75	0	p	350011796500015063	18-93						22 human secreted proteins	Komatsoulis	2001	0		LRRN1
770	chr22	24258849	24258877	3500137174	23		24258849	24258877	8421504	2	14,9	0,19	g	350013717400000005	0-23						The ClgR protein regulates transcription of the clpP operon in Bifidobacterium breve UCC2003. | John Kenny - Academia.edu	www.academia.edu	0	0		
771	chr22	24386440	24386473	3500078623	26		24386440	24386473	8421504	3	14,6,6	0,17,27	g	350007862300000029	1-27						Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof	Cavacini	2005	0		
771	chr22	24452591	24452614	3500068547	23		24452591	24452614	8421504	1	23	0	g	350006854700000442,350006854700000139	0-23,0-23						HUMAN ERYTHROVIRUS - Patent application	www.faqs.org	0	0		
775	chr22	24934722	24934747	3500446719	23		24934722	24934747	8421504	3	6,4,13	0,7,12	g	350044671900000069	0-23						Antibodies To Myeloid Progenitor Inhibitory Factor-1 (mpif-1) 	.freshpatents.com	0	0		
780	chr22	25572892	25572918	3500133350	25		25572892	25572918	8421504	2	8,17	0,9	g	350013335000000276	5-30						Fen-1 endonucleases, mixtures and cleavage methods	Kaiser	1998	0		
97	chr22	25674633	25697230	3500095796	105		25674633	25697230	8421504	3	45,36,24	0,22534,22573	p	350009579600015006	0-144						Novel proteins and nucleic acids encoding same	Ellerman	2002	0		
781	chr22	25796868	25796895	3500031485	23		25796868	25796895	8421504	2	13,10	0,17	g	350003148500000008	0-26					Patent	17q-linked breast and ovarian cancer susceptibility gene (Patent US:5710001)	Futreal	1998	0		
782	chr22	25838154	25838182	3500173587	23		25838154	25838182	8421504	2	8,15	0,13	g	350017358700000003	0-23						Cell preparations comprising cells of the T cell lineage and methods of making and using them	Schmitt	2003	0		
783	chr22	25998681	25998708	3500245243	23		25998681	25998708	8421504	3	5,4,14	0,8,13	g	350024524300000130	25-48						Broad-spectrum delta-endotoxins	Gilmer	1999	0		
783	chr22	26032623	26047498	3500415318	41		26032623	26047498	8421504	2	20,21	0,14854	g	350041531800000014,350041531800000007	0-20,0-21						Multiplex PCR Assay for Direct Identification of - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
788	chr22	26645032	26670844	3500169519	104		26645032	26670844	8421504	5	43,6,27,20,8	0,5300,5639,19084,25804	c	350016951900001657,350016951900001656,350016951900001643,350016951900000992,350016951900000096	0-49,0-49,0-27,14-42,14-36						Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer - Patent # 7115727 - PatentGenius	.patentgenius.com	0	0		
791	chr22	27028364	27028392	3500023434	23		27028364	27028392	8421504	2	9,14	0,14	g	350002343400000001	10-35						Expression of EBV Encoded viral RNA 1, 2 and anti-inflammatory Cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in Pakistan	sticpathology.org	0	0		
792	chr22	27144456	27144482	3500430150	23		27144456	27144482	8421504	2	7,16	0,10	g	350043015000000017	4-34						GEOMETRIC PATTERNS AND LIPID BILAYERS FOR DNA MOLECULE ORGANIZATION AND USES THEREOF	Greene	2010	0		
793	chr22	27301100	27301126	3500433279	23		27301100	27301126	8421504	2	10,13	0,13	g	350043327900000113	25-48						Transgenic plants presenting a modified inulin producing profile	Koops	2000	0		
795	chr22	27626009	27626037	3500450388	24		27626009	27626037	8421504	2	17,7	0,21	g	350045038800000013	2-31		9557645		0022-538X	Journal of Virology	Grossly Defective nef Gene Sequences in a Human Immunodeficiency Virus Type 1-Seropositive Long-Term Nonprogressor	Salvi	1998	5		
799	chr22	28054685	28054711	3500440731	23		28054685	28054711	8421504	2	18,5	0,21	g	350044073100000048	0-24						Oxidatively stable alpha-amylase	Antrim	1994	0		
799	chr22	28054685	28054711	3500434205	23		28054685	28054711	8421504	2	18,5	0,21	g	350043420500000048	0-24						Oxidatively stable alpha-amylase	Antrim	1994	0		
799	chr22	28056591	28056618	3500189016	23		28056591	28056618	8421504	2	6,17	0,10	g	350018901600000630	25-48						Methods of inhibiting locomotor damage following spinal cord injury with &#x03b1; D-specific antibodies	Gallatin	2000	0		
799	chr22	28107487	28107514	3500099993	23		28107487	28107514	8421504	2	14,9	0,18	g	350009999300000020	9-32					Patent	Composition and methods for diagnosis of diseases associated with Actinobacillus actinomycetemcomitans infection (Patent US:5861255)	DeMuth	1999	0		
802	chr22	28492372	28492400	3500061543	23		28492372	28492400	8421504	2	13,10	0,18	g	350006154300000038	3-26					Patent	Sequences for detection and identification of methicillin-resistant staphyloccocus aureus (Patent EP:1397510)	Huletsky	2009	0		
809	chr22	29405826	29405851	3500249176	23		29405826	29405851	8421504	2	5,18	0,7	g	350024917600000044	2-26						Compositions and methods relating to glucagon receptor antibodies - Patent application	www.faqs.org	0	0		
813	chr22	29945760	29945790	3500251315	25		29945760	29945790	8421504	3	15,5,5	0,18,25	g	350025131500000039	13-38						Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions	Pedersen	2011	0		
813	chr22	29945760	29945790	3500223593	25		29945760	29945790	8421504	3	15,5,5	0,18,25	g	350022359300000039	13-38					Patent	Recombinant anti-epidermal growth factor receptor antibody compositions (Patent US:8414896)	Pedersen	2013	0		
813	chr22	30007504	30007531	3500308897	26		30007504	30007531	8421504	2	6,20	0,7	g	350030889700000906	9-35						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
815	chr22	30192155	30192180	3500272920	24		30192155	30192180	8421504	2	18,6	0,19	g	350027292000000262,350027292000000185	11-35,11-35						Antibodies to CD40 - Patent application	www.faqs.org	0	0		
818	chr22	30606579	30606607	3500012452	23		30606579	30606607	8421504	3	11,8,4	0,15,24	c	350001245200000169	0-25						Rabies Virus Vector Systems and Compositions and Methods Thereof - Patent application	www.faqs.org	0	0		
820	chr22	30802870	30802894	3500452250	23		30802870	30802894	8421504	2	4,19	0,5	g	350045225000000026	5-28						Compositions And Methods For Binding Lysophosphatidic Acid 	.freshpatents.com	0	0		
820	chr22	30802870	30802894	3500408979	23		30802870	30802894	8421504	2	4,19	0,5	g	350040897900000027	5-28						Compositions and Methods for Binding Lysophosphatidic Acid - US Patent Application 20120195901 Description	ww.patentstorm.us	0	0		
820	chr22	30802870	30802894	3500154834	23		30802870	30802894	8421504	2	4,19	0,5	g	350015483400000094	15-38						Transferrin receptor antibodies	Mather	2005	0		
820	chr22	30802870	30802894	3500001809	23		30802870	30802894	8421504	2	4,19	0,5	g	350000180900000003	5-28						DIAGNOSTIC ANTIBODY ASSAY	Demuth	2009	0		
820	chr22	30851804	30851832	3500385713	24		30851804	30851832	8421504	2	6,18	0,10	g	350038571300000514	7-34						HETEROLOGOUS ANTIBODIES WHICH BIND HUMAN CD4 - Patent application	www.faqs.org	0	0		
823	chr22	31252194	31252221	3500142717	23		31252194	31252221	8421504	3	6,4,13	0,9,14	g	350014271700000005	0-23						Glen E. Palmer, Michelle N. Kelly and Joy E. Sturtevant	c.sgmjournals.org	0	0		
823	chr22	31262527	31262550	3500399383	23		31262527	31262550	8421504	1	23	0	g	350039938300000001	14-37						Cloning and characterization of the 5' flanking region of microRNA let-7a-1/let-7f-1 gene cluster in human lung cancer cell	demicjournals.org	0	0		
823	chr22	31262527	31262550	3500328284	23		31262527	31262550	8421504	1	23	0	g	350032828400000010	14-37						Genome-Wide Search and Identi&#xfb01;cation of a Novel Gel-Forming Mucin MUC19/Muc19 in Glandular Tissues	www.nehrkelab.com	0	0		
823	chr22	31262527	31262550	3500017564	23		31262527	31262550	8421504	1	23	0	g	350001756400000041	14-37						&#x201e;Immunpathologische Folgen von Infektionen des ZNS durch das lymphotrope Maus-Herpesvirus 68 als Modell f&#xfc;r Epstein-Barr Virus assoziierte ZNS-Erkrankungen des Menschen&#x201c;	th.rwth-aachen.de	0	0		
825	chr22	31491807	31491834	3500415057	24		31491807	31491834	8421504	2	7,17	0,10	g	350041505700000108	0-24						INAUGURAL-DISSERTATION I T E N E G E RS VE RE	eb.uni-giessen.de	0	0		
827	chr22	31735951	31735975	3500385718	24		31735951	31735975	8421504	1	24	0	g	350038571800000019,350038571800000003	17-41,17-41						ADENOVIRUS PARTICLES HAVING A CHIMERIC ADENOVIRUS SPIKE PROTEIN, USE THEREOF AND METHODS FOR PRODUCING SUCH PARTICLES - Patent application	www.faqs.org	0	0		
828	chr22	31890410	31890437	3500305030	23		31890410	31890437	8421504	2	13,10	0,17	g	350030503000000326	14-37						Biological methods for preparing a fatty dicarboxylic acid	Beardslee	2013	0		
830	chr22	32200535	32200558	3500191998	23		32200535	32200558	8421504	1	23	0	g	350019199800000026	13-36						Production of very long chain polyunsaturated fatty acids in oilseed plants	Cahoon	2012	0		
831	chr22	32291548	32324674	3500399406	1239		32291548	32324674	8421504	9	399,148,76,57,118,96,84,228,33	0,6136,10218,16004,18031,28448,30676,31811,33093	p	350039940600015000	0-1257						KEGG T01001: 4286	www.kegg.jp	0	0		
831	chr22	32291911	32307598	3500336590	306		32291911	32307598	8421504	4	36,148,76,46	0,5773,9855,15641	p	350033659000015024,350033659000015022	0-306,612-918						Supporting Information	www.pnas.org	0	0		
831	chr22	32291917	32309580	3500002606	312		32291917	32309580	8421504	5	30,148,76,57,1	0,5767,9849,15635,17662	p	350000260600015006,350000260600015003	0-153,0-159						Untersuchung der Regulation und Interaktionen der Aktivierungsinduzierten Cytidindeaminase (AID) in humanen B-Lymphozyten	b.uni-muenchen.de	0	0		
831	chr22	32322224	32322308	3500137076	84		32322224	32322308	8421504	1	84	0	p	350013707600015004	0-84						nacreencodes a zebra&#xfb01;sh microphthalmia-related protein that regulates neural-crest-derived pigment cell fate	ev.biologists.org	0	0		MITF
831	chr22	32324641	32324674	3500245928	33		32324641	32324674	8421504	1	33	0	c	350024592800000001	0-33		11929831		0008-5472	Cancer Research	The Melanocyte-specific Isoform of the Microphthalmia Transcription Factor Affects the Phenotype of Human Melanoma	Selzer	2002	8		
831	chr22	32324650	32324674	3500223901	24		32324650	32324674	8421504	1	24	0	c	350022390100000000	0-24						patent for hair/skin darkening: DIY version?	sentialdayspa.com	0	0		
832	chr22	32381947	32381971	3500420545	24		32381947	32381971	8421504	1	24	0	g	350042054500000026	0-24						Role of the Mitogen-Activated Protein Kinase SignalingPathwayintheRegulationofHuman MelanocyticAntigenExpression	.aacrjournals.org	0	0		MITF
832	chr22	32381956	32381984	3500245928	28		32381956	32381984	8421504	1	28	0	g	350024592800000004	0-28		11929831		0008-5472	Cancer Research	The Melanocyte-specific Isoform of the Microphthalmia Transcription Factor Affects the Phenotype of Human Melanoma	Selzer	2002	8		MITF
833	chr22	32529740	32529768	3500362286	24		32529740	32529768	8421504	3	4,11,9	0,5,19	g	350036228600000013	5-29		14977942	10.1128/IAI.72.3.1383-1390.2004	0019-9567	Infection and Immunity	Effect of Metabolic Imbalance on Expression of Type III Secretion Genes in Pseudomonas aeruginosa	Rietsch	2004	4		
834	chr22	32703302	32703326	3500005592	23		32703302	32703326	8421504	2	19,4	0,20	g	350000559200000030,350000559200000031	10-36,0-26						zzuurr PPrroodduukkttiioonn vvoonn MMeetthhiioonniinn	b.uni-saarland.de	0	0		
835	chr22	32879080	32879104	3500310553	23		32879080	32879104	8421504	2	13,10	0,14	g	350031055300000003	0-23			10.1167/iovs.07-0041	1552-5783	Investigative Ophthalmology & Visual Science	Linkage Mapping of Ovine Microphthalmia to Chromosome 23, the Sheep Orthologue of Human Chromosome 18	Tetens	2007	0		
838	chr22	33255890	33255916	3500241583	24		33255890	33255916	8421504	2	5,19	0,7	g	350024158300000035,350024158300000003	3-27,3-27						METHODS FOR MAKING AND USING MOLECULAR SWITCHES INVOLVING CIRCULAR PERMUTATION - Patent application	www.faqs.org	0	0		
104	chr22	33342507	33468662	3500426851	420		33342507	33468662	8421504	6	14,116,155,1,125,9	0,5304,97208,118253,118891,126146	p	350042685100015013	0-420						Therapeutic use of growth factors,nsg29 and nsg31 - Patent application	www.faqs.org	0	0		FAM19A4
104	chr22	33342507	33468662	3500225038	420		33342507	33468662	8421504	6	14,116,155,1,125,9	0,5304,97208,118253,118891,126146	p	350022503800015047	0-420						Growth factors nsg28, nsg30, and nsg32 - Patent application	www.faqs.org	0	0		
104	chr22	33347812	33468662	3500426851	405		33347812	33468662	8421504	5	115,156,5,120,9	0,91903,92975,113591,120841	p	350042685100015014	0-405						Therapeutic use of growth factors,nsg29 and nsg31 - Patent application	www.faqs.org	0	0		
104	chr22	33347812	33468662	3500225038	405		33347812	33468662	8421504	5	115,155,1,125,9	0,91903,112948,113586,120841	p	350022503800015018	0-405						Growth factors nsg28, nsg30, and nsg32 - Patent application	www.faqs.org	0	0		
104	chr22	33347899	33461523	3500225038	315		33347899	33461523	8421504	5	28,156,5,1,125	0,91816,92888,112861,113499	p	350022503800015055,350022503800015050,350022503800015053,350022503800015057,350022503800015049,350022503800015056	0-309,0-261,0-261,0-261,0-225,0-225						Growth factors nsg28, nsg30, and nsg32 - Patent application	www.faqs.org	0	0		
840	chr22	33424322	33424382	3500419411	51		33424322	33424382	8421504	3	28,7,16	0,34,44	g	350041941100000052	0-60						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		
105	chr22	33650545	34154419	3500426851	324		33650545	34154419	8421504	4	15,125,141,43	0,5263,109730,503831	p	350042685100015043	0-324						Therapeutic use of growth factors,nsg29 and nsg31 - Patent application	www.faqs.org	0	0		FAM19A1
105	chr22	33650554	34154494	3500426851	390		33650554	34154494	8421504	4	6,125,141,118	0,5254,109721,503822	p	350042685100015046	0-390						Therapeutic use of growth factors,nsg29 and nsg31 - Patent application	www.faqs.org	0	0		FAM19A1
105	chr22	33650554	34154494	3500225038	390		33650554	34154494	8421504	4	6,125,141,118	0,5254,109721,503822	p	350022503800015023	0-390						Growth factors nsg28, nsg30, and nsg32 - Patent application	www.faqs.org	0	0		FAM19A1
105	chr22	33655808	33760411	3500426851	261		33655808	33760411	8421504	2	125,136	0,104467	p	350042685100015045	0-261						Therapeutic use of growth factors,nsg29 and nsg31 - Patent application	www.faqs.org	0	0		FAM19A1
105	chr22	33655808	33760291	3500225038	138		33655808	33760291	8421504	3	93,29,16	0,96,104467	p	350022503800015092,350022503800015143,350022503800015090,350022503800015088	0-45,0-45,0-45,0-45						Growth factors nsg28, nsg30, and nsg32 - Patent application	www.faqs.org	0	0		FAM19A1
844	chr22	33998495	33998519	3500457990	23		33998495	33998519	8421504	2	17,6	0,18	g	350045799000000044	0-23						US Patent # 7,217,554. Proteases and variants thereof - Patents.com	www.patents.com	0	0		
844	chr22	34015021	34015051	3500328239	24		34015021	34015051	8421504	3	7,5,12	0,12,18	g	350032823900000002	19-43						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: " Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells" 	tailieu.vn/doc/ba	0	0		
846	chr22	34285089	34285116	3500101373	23		34285089	34285116	8421504	2	17,6	0,21	g	350010137300000072	5-30						NOVEL SHIGELLA PROTEIN ANTIGENS AND METHODS - Patent application	www.faqs.org	0	0		
848	chr22	34549300	34549327	3500412014	23		34549300	34549327	8421504	2	12,11	0,16	g	350041201400000003	16-39		10429666	10.1084/jem.190.1.9	0022-1007	The Journal of Experimental Medicine	Interleukin 15 Induces Endothelial Hyaluronan Expression in Vitro and Promotes Activated T Cell Extravasation through a Cd44-Dependent Pathway in Vivo	Estess	1999	14		
848	chr22	34579778	34579806	3500274620	23		34579778	34579806	8421504	2	9,14	0,14	g	350027462000000000	1-24						A modified protocol for in vitro maturation of mouse oocytes from secondary preantral follicles	www.scirp.org	0	0		
849	chr22	34690473	34690501	3500045837	24		34690473	34690501	8421504	2	16,8	0,20	c	350004583700000117,350004583700000176	6-30,9-33						Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same - US Patent 7105345 Description	ww.patentstorm.us	0	0		
849	chr22	34711556	34711584	3500404972	24		34711556	34711584	8421504	3	5,12,7	0,8,21	c	350040497200000022	6-30						Page i	jpkc.yzu.edu.cn	0	0		
849	chr22	34711556	34711584	3500402055	24		34711556	34711584	8421504	3	5,12,7	0,8,21	c	350040205500000507,350040205500000247	6-30,6-30						Methods And Kits For Detecting Mutations 	.freshpatents.com	0	0		
849	chr22	34711556	34711584	3500131235	24		34711556	34711584	8421504	3	5,12,7	0,8,21	c	350013123500000012	6-30						Molecular Studies of an Alternative Lengthening of Telomeres (ALT) Mechanism	brary.usyd.edu.au	0	0		
853	chr22	35213705	35213731	3500333671	23		35213705	35213731	8421504	2	7,16	0,10	g	350033367100000014	5-28		21687429	10.3389/fmicb.2011.00120		Frontiers in Microbiology	Characterization of EhaJ, a New Autotransporter Protein from Enterohemorrhagic and Enteropathogenic Escherichia coli	Donna	2011	0		
853	chr22	35213705	35213731	3500257132	23		35213705	35213731	8421504	2	7,16	0,10	g	350025713200000014	5-28		21687429	10.3389/fmicb.2011.00120	1664-302X	Frontiers in Microbiology	 Frontiers | Characterization of EhaJ, a New Autotransporter Protein from Enterohemorrhagic and Enteropathogenic Escherichia coli | Frontiers in Cellular and Infection Microbiology - closed section 	Easton	2011	0		
857	chr22	35695512	35695536	3500165581	23		35695512	35695536	8421504	2	15,8	0,16	c	350016558100000003	3-26						THE J B C Vol. 276, No. 10, Issue of March 9, pp. 7654&#x2013;7660, 2001 Printed in U.S.A. Mutagenic Analysis of Functional Residues in Putative Substrate- binding Site and Acidic Domains of Vacuolar H -Pyrophosphatase*	gr.nagoya-u.ac.jp	0	0		
858	chr22	35830525	35830554	3500446700	25		35830525	35830554	8421504	2	12,13	0,16	g	350044670000000030	0-33						Immunotoxin fusion proteins and means for expression thereof	Neville	2004	0		
860	chr22	36066357	36066381	3500385713	24		36066357	36066381	8421504	1	24	0	g	350038571300000428,350038571300000214	20-44,20-44						HETEROLOGOUS ANTIBODIES WHICH BIND HUMAN CD4 - Patent application	www.faqs.org	0	0		
863	chr22	36467327	36467359	3500007784	25		36467327	36467359	8421504	3	5,11,9	0,8,23	g	350000778400000155,350000778400000019	1-27,1-27						IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF - Patent application	www.faqs.org	0	0		
871	chr22	37539806	37539836	3500331821	30		37539806	37539836	8421504	1	30	0	c	350033182100000018	0-30						Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma	.aacrjournals.org	0	0		ADAMTS9
871	chr22	37544249	37544393	3500275412	144		37544249	37544393	8421504	1	144	0	p	350027541200015041	30-174						45 human secreted proteins	Komatsoulis	2000	0		ADAMTS9
871	chr22	37544249	37544393	3500051421	144		37544249	37544393	8421504	1	144	0	p	350005142100015044	30-174						45 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		ADAMTS9
871	chr22	37605753	37605778	3500217278	23		37605753	37605778	8421504	2	9,14	0,11	g	350021727800000021	22-45						US Patent # 6,331,411. TopA - Patents.com	www.patents.com	0	0		
871	chr22	37605753	37605778	3500008069	23		37605753	37605778	8421504	2	9,14	0,11	g	350000806900000021	22-45						TopA	www.devileye.net	0	0		
874	chr22	37977483	37977508	3500012991	24		37977483	37977508	8421504	2	11,13	0,12	g	350001299100000025	9-33						METHODS FOR CLONING AND MANIPULATING GENOMES	Benders	2010	0		
876	chr22	38223022	38226639	3500280352	249		38223022	38226639	8421504	3	161,78,10	0,3392,3607	p	350028035200015015	0-249							y.engin.umich.edu	0	0		PSMD6
876	chr22	38223022	38226639	3500051404	249		38223022	38226639	8421504	3	161,78,10	0,3392,3607	p	350005140400015014	0-249						README for stand-alone BLAST (last updated 7/30/99) This document provides information on s	io.lundberg.gu.se	0	0		PSMD6
876	chr22	38226415	38226723	3500301607	171		38226415	38226723	8421504	2	77,94	0,214	p	350030160700015084,350030160700015083	6-84,36-132						31 human secreted proteins	Ferrie	1999	0		PSMD6
877	chr22	38320607	38320631	3500173677	24		38320607	38320631	8421504	1	24	0	g	350017367700000007	6-30						Cardiac hypertrophy is a complex organ response of the heart to several biological stresses induced by many primary cardiovascu	e.ahajournals.org	0	0		
879	chr22	38613334	38613359	3500251038	23		38613334	38613359	8421504	3	12,5,6	0,13,19	g	350025103800000000	0-26						Blumeria graminis f.sp. hordei	thek.uni-halle.de	0	0		
881	chr22	38901794	38901827	3500054119	27		38901794	38901827	8421504	3	6,9,12	0,8,21	g	350005411900000007	4-31		22086489	10.1128/mBio.00233-11	2150-7511	mBio	Assembly of Xylanases into Designer Cellulosomes Promotes Efficient Hydrolysis of the Xylan Component of a Natural Recalcitrant Cellulosic Substrate	Morais	2011	5		
885	chr22	39430636	39430660	3500096506	24		39430636	39430660	8421504	1	24	0	g	350009650600000173	4-28						HUMAN E3ALPHA UBIQUITIN LIGASE FAMILY - Patent application	www.faqs.org	0	0		
886	chr22	39479765	39479791	3500412397	24		39479765	39479791	8421504	3	13,4,7	0,14,19	g	350041239700000165	20-48						Polypeptides Having Glucoamylase Activity And Polynucleotides Encoding Same 	.freshpatents.com	0	0		
886	chr22	39551944	39551969	3500165384	23		39551944	39551969	8421504	2	16,7	0,18	g	350016538400000339	6-30						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
887	chr22	39595204	39595231	3500417611	23		39595204	39595231	8421504	2	7,16	0,11	g	350041761100000000	1-25						Mitogenic Effect of Bartonella bacilliformis on Human Vascular Endothelial Cells and Involvement of GroEL	iai.highwire.org	0	0		
888	chr22	39721281	39723529	3500366217	105		39721281	39723529	8421504	5	20,20,23,21,21	0,204,1065,2000,2227	c,g	350036621700000000,350036621700000000,350036621700000003,350036621700000003,350036621700000006,350036621700000006,350036621700000007,350036621700000001	0-20,0-20,0-20,0-20,0-23,0-23,0-21,0-21			10.1073/pnas.0601015103		Proceedings of the National Academy of Sciences of the United States of America	Evidence that bovine forebrain embryonic zinc finger-like gene influences immune response associated with mastitis resistance	Mayumi	2006	0		
888	chr22	39721564	39723272	3500283859	225		39721564	39723272	8421504	8	15,30,45,45,6,39,43,2	0,362,395,443,491,699,789,1706	p	350028385900015018,350028385900015019,350028385900015020,350028385900015021,350028385900015023	0-45,0-45,0-45,0-45,0-45						GASTRIC CARCINOMA GENE ZNF312B, A PROTEIN TRANSLATED FROM THE GENE, AND A DIAGNOSTIC KIT AND A SCREENING METHOD FOR ANTICANCER AGENTS USING THE SAME - Patent application	www.faqs.org	0	0		FEZF2
888	chr22	39817984	39818009	3500202695	23		39817984	39818009	8421504	2	16,7	0,18	g	350020269500000090,350020269500000092	18-44,10-36						Chimeric genes and methods for increasing the lysine and threonine content of the seeds of plants	Falco	1997	0		
13	chr22	39844547	39846580	3500186204	24		39844547	39846580	8421504	2	13,11	0,2022	c	350018620400000162	15-39						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
13	chr22	39844547	39846580	3500150372	24		39844547	39846580	8421504	2	13,11	0,2022	c	350015037200000162	15-39						Hptpbeta As A Target In Treatment Of Angiogenesis Mediated Disorders 	.freshpatents.com	0	0		
889	chr22	39850631	39865966	3500187783	222		39850631	39865966	8421504	3	44,97,81	0,6636,15254	p	350018778300015020	3-225						Oxford_SGC_Clones_web	www.docstoc.com	0	0		PTPRG
889	chr22	39896999	39897024	3500173625	23		39896999	39897024	8421504	3	4,13,6	0,5,19	g	350017362500000019	4-27						Transcriptional Repression Of Sodium-iodide Symporter In Thyroid Carcinoma 	.freshpatents.com	0	0		
889	chr22	39911275	39911302	3500433259	24		39911275	39911302	8421504	2	18,6	0,21	g	350043325900000001	0-24		15767405	10.1128/JVI.79.7.4033-4042.2005	0022-538X	Journal of Virology	Circumventing Tolerance to the Prion Protein (PrP): Vaccination with PrP-Displaying Retrovirus Particles Induces Humoral Immune Responses against the Native Form of Cellular PrP	Nikles	2005	5		
111	chr22	39921800	40133574	3500266957	117		39921800	40133574	8421504	5	56,1,23,5,32	0,1866,133553,133665,211742	p	350026695700015046,350026695700015031	3-60,0-60						ANTIBODY AND METHOD FOR IDENTIFICATION OF DENDRITIC CELLS - Patent application	www.faqs.org	0	0		
889	chr22	39921800	39923667	3500207749	57		39921800	39923667	8421504	2	56,1	0,1866	p	350020774900015041	3-60						ANTIBODY AND METHOD FOR IDENTIFICATION OF DENDRITIC CELLS	Sorio	2005	0		
893	chr22	40494545	40494570	3500215603	23		40494545	40494570	8421504	2	8,15	0,10	g	350021560300000002	1-24		12810707	10.1074/jbc.M305361200	0021-9258	Journal of Biological Chemistry	Peroxisome Proliferator-activated Receptor &#x03b1; Induces Hepatic Expression of the Human Bile Acid Glucuronidating UDP-glucuronosyltransferase 2B4 Enzyme	Barbier	2003	5		
895	chr22	40738534	40738558	3500140749	23		40738534	40738558	8421504	2	19,4	0,20	g	350014074900000000	1-24		18718916	10.1074/jbc.M801813200		The Journal of Biological Chemistry	In Vivo and in Vitro Studies of a Functional Peroxisome Proliferator-activated Receptor &#x03b3; Response Element in the Mouse pdx-1 Promoter	Dhananjay	2008	0		
896	chr22	40801475	40801502	3500386704	23		40801475	40801502	8421504	2	14,9	0,18	g	350038670400000051	0-23						Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications	Kerb	2011	0		
897	chr22	40960844	40960876	3500217873	24		40960844	40960876	8421504	3	6,8,10	0,10,22	g	350021787300000048	8-33						 Methods And Compositions For Controlling Insects 	www.docstoc.com	0	0		
900	chr22	41289585	41289609	3500293589	23		41289585	41289609	8421504	2	9,14	0,10	g	350029358900000061	9-32					Patent	Protein expression systems (Patent US:8288127)	Schneider	2012	0		
900	chr22	41289585	41289609	3500095694	23		41289585	41289609	8421504	2	9,14	0,10	g	350009569400000061	9-32						PROTEIN EXPRESSION SYSTEMS	Schneider	2009	0		
1	chr22	41558680	42091533	3500213328	114		41558680	42091533	8421504	2	103,11	0,532842	p	350021332800015095	0-114						PPT &#x2013; An Example PowerPoint presentation | free to download 	www.powershow.com	0	0		
1	chr22	41558689	42091533	3500213328	105		41558689	42091533	8421504	2	94,11	0,532833	p	350021332800015103	0-105						PPT &#x2013; An Example PowerPoint presentation | free to download 	www.powershow.com	0	0		FHIT
1	chr22	41558692	42091533	3500213328	102		41558692	42091533	8421504	2	91,11	0,532830	p	350021332800015113	0-102						PPT &#x2013; An Example PowerPoint presentation | free to download 	www.powershow.com	0	0		FHIT
904	chr22	41889607	41889631	3500068166	23		41889607	41889631	8421504	2	8,15	0,9	g	350006816600000176	14-44						Attenuated SP12 mutants as antigen carriers - US Patent 7700104 Description	ww.patentstorm.us	0	0		
904	chr22	41906629	41906653	3500282807	23		41906629	41906653	8421504	2	19,4	0,20	g	350028280700000288	0-23					Patent	Infectious etiologic agent detection probe and probe set, carrier, and genetic screening method (Patent EP:1464710)	Fukui	2011	0		
905	chr22	42073807	42073831	3500374909	23		42073807	42073831	8421504	2	6,17	0,7	g	350037490900000479	3-26						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
907	chr22	42313050	42313081	3500112644	23		42313050	42313081	8421504	3	6,5,12	0,11,19	g	350011264400000080	25-48					Patent	Nucleic acids encoding a chloride channel protein (Patent US:6716603)	Holroyd	2004	0		
908	chr22	42387888	42387912	3500127308	24		42387888	42387912	8421504	1	24	0	g	350012730800000182	14-38						PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS - Patent application	www.faqs.org	0	0		
910	chr22	42613991	42614018	3500000469	24		42613991	42614018	8421504	2	11,13	0,14	g	350000046900000006	15-39						Cellulose binding domain fusion proteins	Shoseyov	1995	0		
911	chr22	42848931	42848962	3500255826	26		42848931	42848962	8421504	3	10,11,5	0,14,26	g	350025582600000000	1-29		16880528	10.1128/MCB.00018-06	0270-7306	Molecular and Cellular Biology	Sleeping Beauty Transposon-Based Phenotypic Analysis of Mice: Lack of Arpc3 Results in Defective Trophoblast Outgrowth	Yae	2006	6		
912	chr22	42940294	42940321	3500001820	25		42940294	42940321	8421504	3	5,14,6	0,6,21	g	350000182000000057	0-25						None	air.unimi.it	0	0		
916	chr22	43414570	43414598	3500371904	23		43414570	43414598	8421504	3	6,12,5	0,9,23	g	350037190400000002	6-30						BCL-x$g(g), A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO	Cantor	1999	0		
917	chr22	43643218	43643378	3500436803	57		43643218	43643378	8421504	2	51,6	0,154	p	350043680300015015	0-57						Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis	Gershwin	2004	0		PDHB
918	chr22	43675576	43680879	3500139801	75		43675576	43680879	8421504	6	11,9,4,22,22,7	0,986,4030,4718,4770,5296	c	350013980100000006,350013980100000004,350013980100000005	0-20,0-26,0-29		16135750	10.1523/JNEUROSCI.0635-05.2005	0270-6474	The Journal of Neuroscience	MONaKA, a Novel Modulator of the Plasma Membrane Na,K-ATPase	Mao	2005	7		PXK
918	chr22	43696375	43696406	3500441298	25		43696375	43696406	8421504	3	14,6,5	0,19,26	g	350044129800000000	0-27					Patent	Compounds and methods for development of Ret modulators (Patent US:8067434)	Artis	2011	0		
918	chr22	43696375	43696406	3500325527	25		43696375	43696406	8421504	3	14,6,5	0,19,26	g	350032552700000000	0-27						Compounds and methods for development of RET modulators	Ibrahim	2006	0		
918	chr22	43704815	43704840	3500034801	23		43704815	43704840	8421504	2	15,8	0,17	g	350003480100000130	9-32						SYSTEM FOR PROTEIN EXPRESSION AND SECRETION ESPECIALLY IN CORYNEBACTERIA - Orsan	www.sumobrain.com	0	0		
919	chr22	43819444	43838622	3500284554	848		43819444	43838622	8421504	8	183,89,90,113,113,158,97,5	0,4554,7777,8425,11045,13747,18766,19173	c	350028455400000000	0-1628						PPT &#x2013; A 25Year Chronology of a Seminal Protein: Diagnostic and Therapeutic Utility PowerPoint presentation | free to download 	www.powershow.com	0	0		
919	chr22	43829843	43829885	3500171619	33		43829843	43829885	8421504	3	13,6,14	0,18,28	g	350017161900000021	3-40						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2003	0		
919	chr22	43838618	43838658	3500214415	40		43838618	43838658	8421504	1	40	0	c	350021441500000000	5-45						Human DNase	www.devileye.net	0	0		
919	chr22	43838618	43838658	3500188276	40		43838618	43838658	8421504	1	40	0	c	350018827600000000	5-45					Patent	Human dnase resistant to actin inhibition (Patent EP:0879289)	Baker	2006	0		
919	chr22	43838618	43838658	3500155601	40		43838618	43838658	8421504	1	40	0	c	350015560100000000	5-45						 Human DNase 	www.docstoc.com	0	0		
919	chr22	43858687	43858713	3500147086	26		43858687	43858713	8421504	1	26	0	c	350014708600000011	0-26						Aus der III. Medizinischen Klinik und Poliklinik der Universit&#xe4;tsmedizin der Johannes Gutenberg-Universit&#xe4;t Mainz Evaluation von Nukleotidpolymorphismen f&#xfc;r die Analyse des h&#xe4;matopoetischen Spenderchim&#xe4;rismus auf Ebene der cDNA In	m.opus.hbz-nrw.de	0	0		
919	chr22	43870867	43870927	3500396649	60		43870867	43870927	8421504	1	60	0	p	350039664900015012	0-60						Integrated Systems and Technologies Cancer Research Proteomic Characterization of Novel Alternative Splice Variant Proteins in Human Epidermal Growth Factor Receptor 2/neu Induced Breast Cancers	.aacrjournals.org	0	0		FLNB
919	chr22	43870867	43870927	3500122305	60		43870867	43870927	8421504	1	60	0	p	350012230500015012	0-60		20388783	10.1158/0008-5472.CAN-09-2631		Cancer research	Proteomic Characterization of Novel Alternative Splice Variant Proteins in HER2/neu-induced Breast Cancers	Rajasree	2010	0		FLNB
919	chr22	43894775	43894800	3500217683	24		43894775	43894800	8421504	2	4,20	0,5	g	350021768300000131	7-31						Method Of Preparing Transgenic Organism With Use Of Methylation And System Therefor 	.freshpatents.com	0	0		
921	chr22	44052876	44096847	3500446694	38		44052876	44096847	8421504	2	19,19	0,43952	g	350044669400000009,350044669400000005	14-33,0-19			10.1042/BJ20031723		Biochemical Journal	Regulated expression and temporal induction of the tail-anchored sarcolemmal-membrane-associated protein is critical for myoblast fusion	Rosa M.	2004	0		
923	chr22	44315525	44315573	3500287453	48		44315525	44315573	8421504	1	48	0	p	350028745300015004	0-48					Patent	Regulation of oxidative burst using LMWG-derived peptides and analogs (Patent US:6184203)	Bokoch	2001	0		ARF4
923	chr22	44345038	44345068	3500320127	30		44345038	44345068	8421504	1	30	0	c	350032012700000004	0-30		21245038	10.1093/nar/gkq1282		Nucleic Acids Research	Human 2&#x2032;-phosphodiesterase localizes to the mitochondrial matrix with a putative function in mitochondrial RNA turnover	Jesper	2011	0		
923	chr22	44345042	44347934	3500382749	47		44345042	44347934	8421504	2	26,21	0,2871	c,g	350038274900000003,350038274900000005	1-27,0-21						2&#x2032;, 5&#x2032;-oligoadenylate phosphodiesterase	Kubota	2005	0		
924	chr22	44555689	44555713	3500223473	23		44555689	44555713	8421504	2	4,19	0,5	c	350022347300000456	25-48							ww.patentlens.net	0	0		
924	chr22	44555689	44555713	3500115982	23		44555689	44555713	8421504	2	4,19	0,5	c	350011598200000449	25-48						Human telomerase catalytic subunit: diagnostic and therapeutic methods	Cech	1997	0		
924	chr22	44561937	44561961	3500370305	23		44561937	44561961	8421504	2	6,17	0,7	g	350037030500000213	1-28						 3 	www.docstoc.com	0	0		
924	chr22	44561937	44561961	3500166501	23		44561937	44561961	8421504	2	6,17	0,7	g	350016650100000221	1-28						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
925	chr22	44590600	44590626	3500265596	24		44590600	44590626	8421504	2	11,13	0,13	g	350026559600000659	0-33						NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)	Andersen	2000	0		
927	chr22	44886165	44886189	3500318543	23		44886165	44886189	8421504	2	17,6	0,18	g	350031854300000019	15-39						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		
927	chr22	44910205	44910233	3500285982	23		44910205	44910233	8421504	2	12,11	0,17	g	350028598200000006	0-27						&#x4e3b;&#x9898;&#xff1a;Cell | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
928	chr22	44995770	44995801	3500257436	24		44995770	44995801	8421504	3	10,9,5	0,14,26	g	350025743600000245	9-33						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
930	chr22	45319508	45319534	3500068628	24		45319508	45319534	8421504	3	5,15,4	0,6,22	g	350006862800000003	7-31						FUSED HETEROCYCLIC COMPOUND - Patent application	www.faqs.org	0	0		
938	chr22	46350351	46350379	3500354249	24		46350351	46350379	8421504	2	17,7	0,21	g	350035424900000000	0-24		14612586	10.1104/pp.103.026591	0032-0889	Plant Physiology	Ozone-Induced Cell Death in Tobacco Cultivar Bel W3 Plants. The Role of Programmed Cell Death in Lesion Formation	Pasqualini	2003	7		
939	chr22	46435942	46448112	3500339762	68		46435942	46448112	8421504	3	20,27,21	0,1342,12149	c,g	350033976200000012,350033976200000012,350033976200000013,350033976200000069,350033976200000119	0-20,0-20,0-27,0-26,0-21						Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas	Rhee	2002	0		WNT5A
939	chr22	46435942	46448112	3500102190	68		46435942	46448112	8421504	3	20,27,21	0,1342,12149	c,g	350010219000000011,350010219000000011,350010219000000012,350010219000000068,350010219000000118	0-20,0-20,0-27,0-26,0-21						Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas	Carson	2004	0		WNT5A
939	chr22	46437280	46445818	3500280522	585		46437280	46445818	8421504	14	45,45,45,45,4,41,45,45,45,45,45,45,45,45	0,96,144,192,240,4445,4636,8157,8205,8253,8301,8397,8445,8493	p	350028052200015064,350028052200015066,350028052200015067,350028052200015068,350028052200015069,350028052200015073,350028052200015076,350028052200015077,350028052200015078,350028052200015079,350028052200015081,350028052200015082,350028052200015083	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CARDIOMYOCYTES - Patent application	www.faqs.org	0	0		
939	chr22	46437286	46437408	3500398188	41		46437286	46437408	8421504	2	21,20	0,102	c,g	350039818800000002,350039818800000002,350039818800000003,350039818800000003	0-21,0-21,0-20,0-20		21483795	10.1371/journal.pone.0018373		PLoS ONE	Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance	Brette	2011	0		WNT5A
939	chr22	46437286	46437408	3500334149	41		46437286	46437408	8421504	2	21,20	0,102	c,g	350033414900000004,350033414900000004,350033414900000005	0-21,0-21,0-20						Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands	Arenas	2004	0		WNT5A
939	chr22	46437286	46437408	3500323014	41		46437286	46437408	8421504	2	21,20	0,102	c,g	350032301400000007,350032301400000007,350032301400000008	0-21,0-21,0-20						Methods For Promoting Dopaminergic Neuronal Development By Using Ng4a-subfamily And Wnt-ligands 	.freshpatents.com	0	0		WNT5A
939	chr22	46437286	46437408	3500166158	41		46437286	46437408	8421504	2	21,20	0,102	c,g	350016615800000004,350016615800000004,350016615800000064,350016615800000064,350016615800000005,350016615800000065	0-21,0-21,0-21,0-21,0-20,0-20						METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS - Patent application	www.faqs.org	0	0		WNT5A
939	chr22	46437286	46437408	3500158928	41		46437286	46437408	8421504	2	21,20	0,102	c,g	350015892800000007,350015892800000007,350015892800000008	0-21,0-21,0-20						Methods For Promoting Dopaminergic Neuronal Development By Using Ng4a-subfamily And Wnt-ligands 	.freshpatents.com	0	0		WNT5A
939	chr22	46437289	46445467	3500108640	552		46437289	46445467	8421504	10	81,96,49,44,75,21,99,18,9,60	0,84,186,4436,4486,4564,4609,4711,8106,8118	p	350010864000015077	0-576						Proteins and nucleic acids encoding same	Alsobrook	2002	0		
939	chr22	46437316	46437379	3500443333	63		46437316	46437379	8421504	1	63	0	p	350044333300015000	0-63			10.1371/journal.pbio.0040115	1545-7885	PLOS Biology	PLOS Biology: Purified Wnt5a Protein Activates or Inhibits &#x03b2;-Catenin&#x2013;TCF Signaling Depending on Receptor Context	Mikels	2006	0		WNT5A
939	chr22	46441953	46445843	3500399284	40		46441953	46445843	8421504	2	20,20	0,3870	c,g	350039928400000000,350039928400000000,350039928400000001,350039928400000001	0-20,0-20,0-20,0-20		20511395	10.1074/mcp.M110.001131	1535-9476	Molecular & Cellular Proteomics	Proteomics Profiling of Madin-Darby Canine Kidney Plasma Membranes Reveals Wnt-5a Involvement during Oncogenic H-Ras/TGF-&#x03b2;-mediated Epithelial-Mesenchymal Transition	Chen	2011	7		
939	chr22	46441953	46445843	3500068240	40		46441953	46445843	8421504	2	20,20	0,3870	c,g	350006824000000000,350006824000000000,350006824000000001,350006824000000001	0-20,0-20,0-20,0-20		20511395	10.1074/mcp.M110.001131	1535-9476	Molecular & Cellular Proteomics	Proteomics Profiling of Madin-Darby Canine Kidney Plasma Membranes Reveals Wnt-5a Involvement during Oncogenic H-Ras/TGF-&#x03b2;-mediated Epithelial-Mesenchymal Transition	Chen	2011	7		
939	chr22	46445490	46445515	3500399790	25		46445490	46445515	8421504	1	25	0	c	350039979000000005	0-25						Wntsinducemigrationandinvasionofmyelomaplasmacells	tologylibrary.org	0	0		WNT5A
939	chr22	46445662	46448112	3500176454	81		46445662	46448112	8421504	2	60,21	0,2429	p,g	350017645400015019,350017645400015018,350017645400015017,350017645400015016,350017645400015015,350017645400015014,350017645400000002	0-60,0-57,0-54,0-51,0-48,0-45,0-21						THE USE OF WNT5-A PEPTIDE DERIVATES FOR THE TREATMENT OF MELANOMA AND GASTRIC CANCER - FORSKARPATENT I SYD AB	www.sumobrain.com	0	0		
117	chr22	46978026	47084629	3500228217	171		46978026	47084629	8421504	6	7,20,30,72,18,24	0,165,45061,46340,65949,106579	p,c	350022821700000009,350022821700015101	0-27,0-144						Novel rat calcium channel subunits and related probes, cell lines and methods	Khawaja	2007	0		
117	chr22	47024426	47084635	3500228217	60		47024426	47084635	8421504	3	12,18,30	0,19549,60179	p	350022821700015075	0-60						Novel rat calcium channel subunits and related probes, cell lines and methods	Khawaja	2007	0		CACNA2D3
946	chr22	47331072	47331096	3500308897	23		47331072	47331096	8421504	2	7,16	0,8	g	350030889700000306,350030889700000736,350030889700000505	10-33,4-27,13-36						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
946	chr22	47406364	47406391	3500013788	24		47406364	47406391	8421504	2	9,15	0,12	g	350001378800000018	0-24						HISTONE MODIFICATION INHIBITOR SPECIFIC TO TARGET GENE - Patent application	www.faqs.org	0	0		
949	chr22	47816678	47816968	3500068121	40		47816678	47816968	8421504	2	20,20	0,270	g	350006812100000028,350006812100000027	0-20,0-20						Analyse einzelner disseminierter Mammakarzinomzellen durch SSH: Identifizierung eines differentiell exprimierten ERV9-LTR Transkripes	b.uni-muenchen.de	0	0		EEF1A1
949	chr22	47834095	47834122	3500000908	24		47834095	47834122	8421504	2	11,13	0,14	g	350000090800000159	0-24						Genes and gene products related to Werner's syndrome	Fu	1996	0		
950	chr22	47955843	47960331	3500060271	116		47955843	47960331	8421504	4	26,45,23,22	0,2629,2725,4466	c	350006027100000026,350006027100000022,350006027100000020	0-26,0-45,0-45						IL-17 receptor like molecules and uses thereof - US Patent 7094566 Description	ww.patentstorm.us	0	0		
951	chr22	48027005	48027032	3500338659	24		48027005	48027032	8421504	2	11,13	0,14	g	350033865900000041	0-27						Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction	biomedcentral.com	0	0		
951	chr22	48034580	48034605	3500308897	23		48034580	48034605	8421504	2	9,14	0,11	c	350030889700000541	25-49						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
951	chr22	48045431	48045458	3500466167	27		48045431	48045458	8421504	1	27	0	g	350046616700000003,350046616700000000	0-20,0-21						ABORDAGENS FILOGEN&#xc9;TICAS, FILOGEOGR&#xc1;FICAS E POPULACIONAIS EM CAN&#xcd;DEOS SUL-AMERICANOS Ligia Tchaicka	www.lume.ufrgs.br	0	0		
14	chr22	48059984	48405401	3500048226	6183		48059984	48405401	8421504	48	291,321,122,154,10,150,27,368,117,131,102,103,97,128,160,92,66,129,45,84,111,159,202,147,53,108,88,107,60,130,148,67,70,115,121,208,226,161,5,130,20,131,153,143,140,106,310,67	0,809,1904,4890,5050,6221,7668,8696,9779,22387,27319,27735,31143,31374,32094,33143,35237,37499,38041,45650,55438,56851,59091,60945,62875,63014,63788,65608,68376,71659,74169,75151,76063,76585,80295,83838,84153,85315,90213,106686,142462,149347,150029,154808,164801,339248,343075,345350	p	350004822600015022,350004822600015021,350004822600015019,350004822600015017,350004822600015014,350004822600015012,350004822600015010,350004822600015008,350004822600015006,350004822600015004	0-4833,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150						Novel calcium channel	Franco	2005	0		
118	chr22	48059984	48150202	3500215742	4983		48059984	48150202	8421504	39	291,321,122,154,10,150,27,368,117,131,102,103,97,128,160,92,66,129,45,84,111,159,202,147,53,108,88,107,60,130,148,67,70,115,121,208,226,161,5	0,809,1904,4890,5050,6221,7668,8696,9779,22387,27319,27735,31143,31374,32094,33143,35237,37499,38041,45650,55438,56851,59091,60945,62875,63014,63788,65608,68376,71659,74169,75151,76063,76585,80295,83838,84153,85315,90213	p	350021574200015020	0-4983					Patent	&#x03b1;1D calcium channel expressed in atrium (Patent US:7442767)	Franco	2008	0		
118	chr22	48059993	48224862	3500073683	5613		48059993	48224862	8421504	45	282,321,122,154,10,150,27,368,117,131,102,103,97,128,160,92,66,129,45,84,111,159,202,147,53,108,88,107,60,130,148,67,70,115,121,208,226,161,26,86,170,104,180,1,77	0,800,1895,4881,5041,6212,7659,8687,9770,22378,27310,27726,31134,31365,32085,33134,35228,37490,38032,45641,55429,56842,59082,60936,62866,63005,63779,65599,68367,71650,74160,75142,76054,76576,80286,83829,84144,85306,90204,91539,106637,142453,149272,154941,164792	p	350007368300015023,350007368300015018	0-5538,0-78						Alpha-1d calcium channel expressed in atrium	Franco	2009	0		
118	chr22	48066340	48144349	3500004246	532		48066340	48144349	8421504	18	15,27,5,48,47,8,40,23,21,27,21,27,4,60,15,48,48,48	0,1312,2340,3471,16059,16154,20963,25108,31251,31685,49172,50495,59355,62020,65303,65366,77614,77961	c	350000424600000119,350000424600000118,350000424600000109,350000424600000107,350000424600000105,350000424600000097,350000424600000087,350000424600000082,350000424600000064,350000424600000063,350000424600000061,350000424600000046,350000424600000041	0-26,27-48,0-48,0-47,0-48,8-31,0-48,0-48,0-31,0-48,0-48,0-48,0-48						Assays for agonists and antagonists of recombinant human calcium channels	Harpold	1991	0		
951	chr22	48068874	48068899	3500083357	25		48068874	48068899	8421504	1	25	0	c	350008335700000002	0-25						 Proc. Au.P.S. 39:99-114	aups.org.au	0	0		CACNA1D
951	chr22	48082398	48087310	3500273669	111		48082398	48087310	8421504	2	104,7	0,4905	p	350027366900015001	0-111						SwitchingofCa2 -DependentInactivationofCa ChannelsbyCalciumBindingProteinsofAuditoryHairCells	www.jneurosci.org	0	0		CACNA1D
118	chr22	48097562	48119158	3500430429	40		48097562	48119158	8421504	2	20,20	0,21576	c,g	350043042900000005,350043042900000005,350043042900000003	0-20,0-20,0-20		22460715	10.1152/ajpcell.00068.2012		American Journal of Physiology - Cell Physiolog	Calcium influx through a possible coupling of cation channels impacts skeletal muscle satellite cell activation in response to mechanical stretch	Hara	2012	0		CACNA1D
118	chr22	48097562	48119158	3500061642	40		48097562	48119158	8421504	2	20,20	0,21576	c,g	350006164200000005,350006164200000005,350006164200000003	0-20,0-20,0-20		22460715	10.1152/ajpcell.00068.2012		American Journal of Physiology - Cell Physiolog	Calcium influx through a possible coupling of cation channels impacts skeletal muscle satellite cell activation in response to mechanical stretch	Hara	2012	0		
952	chr22	48116967	48119108	3500284630	60		48116967	48119108	8421504	2	27,33	0,2108	p	350028463000015006	0-60						Molecular diversity of L-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes. - ResearchGate	.researchgate.net	0	0		CACNA1D
952	chr22	48202473	48202496	3500196175	23		48202473	48202496	8421504	1	23	0	c	350019617500000001	18-41						Tracking Stem Cell Differentiation in the Setting of Automated Optogenetic Stimulation	zlab.mit.edu	0	0		
952	chr22	48202523	48210053	3500358213	42		48202523	48210053	8421504	2	21,21	0,7509	c	350035821300000001,350035821300000000	9-30,9-30		19640679	10.1016/j.jaut.2009.06.005		Journal of autoimmunity	Congenital Heart Block: Identification of Autoantibody Binding Site on the Extracellular Loop (Domain I, S5&#x2013;S6) of &#x03b1; 1D L-type Ca Channel	Eddy	2010	0		
952	chr22	48205571	48205598	3500374909	23		48205571	48205598	8421504	2	8,15	0,12	g	350037490900000399	24-47						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
952	chr22	48209277	48209325	3500004246	48		48209277	48209325	8421504	1	48	0	c	350000424600000029	0-48						Assays for agonists and antagonists of recombinant human calcium channels	Harpold	1991	0		
955	chr22	48578623	48578651	3500194368	23		48578623	48578651	8421504	2	13,10	0,18	c	350019436800000930,350019436800000460	21-44,21-44						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
956	chr22	48651178	48651206	3500320185	26		48651178	48651206	8421504	3	4,8,14	0,5,14	c	350032018500000044	1-27						Recombinant bone morphogenetic protein heterodimers	Israel	1992	0		
956	chr22	48651178	48651206	3500092036	26		48651178	48651206	8421504	3	4,8,14	0,5,14	c	350009203600000043	1-27					Patent	Recombinant bone morphogenetic protein heterodimers (Patent US:5866364)	Israel	1999	0		
956	chr22	48662810	48662841	3500265690	27		48662810	48662841	8421504	3	15,6,6	0,18,25	g	350026569000000611	20-47						Polycystic kidney disease 12 gene and uses thereof	Harris	1998	0		
956	chr22	48669648	48669672	3500002578	23		48669648	48669672	8421504	2	5,18	0,6	g	350000257800000022,350000257800000113	14-37,14-37						COMPOSITIONS AND METHODS FOR GENERATING AND SCREENING ADENOVIRAL LIBRARIES - Patent application	www.faqs.org	0	0		
956	chr22	48729923	48729950	3500306175	23		48729923	48729950	8421504	2	7,16	0,11	g	350030617500000017	0-26						Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa	Tanaka	2012	0		STX18
961	chr22	49307968	49308012	3500093706	44		49307968	49308012	8421504	1	44	0	g	350009370600000114,350009370600000025,350009370600000031,350009370600000023,350009370600000017	0-44,0-39,0-39,0-39,0-39						An in vivo Approach to Elucidating the Function of Mitochondrial Porin by the Characterisation of Neurospora crassa Strains Deficient in Porin	.lib.umanitoba.ca	0	0		
961	chr22	49307969	49308014	3500291333	45		49307969	49308014	8421504	1	45	0	g	350029133300000070,350029133300000071,350029133300000069,350029133300000059,350029133300000061,350029133300000060,350029133300000062,350029133300000072	5-49,5-43,5-42,5-42,38-75,5-42,38-75,5-42						Method for amplifying nucleic acid sequence - Patent # 6951722 - PatentGenius	.patentgenius.com	0	0		
961	chr22	49307971	49307994	3500276110	23		49307971	49307994	8421504	1	23	0	g	350027611000000133,350027611000000053	0-23,0-23						Aspartoacylase gene, protein, and methods of screening for mutatons associated with canavan disease	Matalon	1994	0		
961	chr22	49307973	49308498	3500113497	42		49307973	49308498	8421504	2	35,7	0,518	g	350011349700000026,350011349700000024	0-42,0-42						The role of the LAMMER kinase Kns1 and the calcium/calmodulin-dependent kinase Cmk2 in the aaptation of Saccharomyces cerevisiae to alkaline pH stress	edoc.hu-berlin.de	0	0		
961	chr22	49307973	49308014	3500399456	41		49307973	49308014	8421504	1	41	0	g	350039945600000049	58-99						GRAS Notice 000428: Asparaginase from Apergillus niger	ccessdata.fda.gov	0	0		
961	chr22	49307973	49308014	3500389152	41		49307973	49308014	8421504	1	41	0	g	350038915200000211	140-181					Patent	Heterodimeric receptor libraries using phagemids (Patent US:5759817)	Barbas	1998	0		
961	chr22	49307973	49308014	3500383046	41		49307973	49308014	8421504	1	41	0	g	350038304600000000,350038304600000001	8-55,0-47						Compositions and methods for generating chimeric heteromultimers	Li	2003	0		
961	chr22	49307973	49308014	3500361995	41		49307973	49308014	8421504	1	41	0	g	350036199500000042,350036199500000001	24-65,14-50						<HTML> <HEAD> <BASE TARGET="_top"> <TITLE>United States Patent: 5,494,810</TITLE></HEAD> <BODY 	l.med.cornell.edu	0	0		
961	chr22	49307973	49308014	3500358662	41		49307973	49308014	8421504	1	41	0	g	350035866200000000	14-55						DNA construct comprising a vector for expression of human cytoplasmic Cu/Zn superoxide dismutase in E. coli and method of use of same	Hallewell	1995	0		
961	chr22	49307973	49308014	3500342103	41		49307973	49308014	8421504	1	41	0	g	350034210300000028	179-220						Composition And Method For Nucleic Acid Sequencing 	.freshpatents.com	0	0		
961	chr22	49307973	49308014	3500265756	41		49307973	49308014	8421504	1	41	0	g	350026575600000115,350026575600000041,350026575600000076	79-120,69-110,126-167						Tissue-specific transcription of dna sequence encoding a heterologous enzyme for use in prodrug therapy to lung cancer	Dev	1997	0		
961	chr22	49307973	49308014	3500262421	41		49307973	49308014	8421504	1	41	0	g	350026242100000005	55-96					Journal of Virology	The P236L Delavirdine-Resistant Human Immunodeficiency Virus Type 1 Mutant Is Replication Defective and Demonstrates Alterations in both RNA 5&#x2032;-End- and DNA 3&#x2032;-End-Directed RNase H Activities	PeGerondelis	July	0		
961	chr22	49307973	49308014	3500261036	41		49307973	49308014	8421504	1	41	0	g	350026103600000064,350026103600000065,350026103600000000,350026103600000001	3-50,0-47,8-55,0-47						Compositions and methods for generating chimeric heteromultimers - US Patent 7429652 Description	ww.patentstorm.us	0	0		
961	chr22	49307973	49308014	3500255012	41		49307973	49308014	8421504	1	41	0	g	350025501200000315	92-133						Omega-amino carboxylic acids, omega-amino carboxylic acid esters, or recombinant cells which produce lactams thereof	A*Qia Lao 	2009	0		
961	chr22	49307973	49308014	3500197820	41		49307973	49308014	8421504	1	41	0	g	350019782000000054	24-65						US Patent # 5,830,711. Thermostable ligase mediated DNA amplification system for the detection of genetic diseases - Patents.com	www.patents.com	0	0		
961	chr22	49307973	49308014	3500191279	41		49307973	49308014	8421504	1	41	0	g	350019127900000202	140-181						Heterodimeric receptor libraries using phagemids	Kang	2000	0		
961	chr22	49307973	49308014	3500155603	41		49307973	49308014	8421504	1	41	0	g	350015560300000000	14-55						Superoxide dismutase cloning and expression in microorganisms	Hallewell	1985	0		
961	chr22	49307973	49308014	3500127909	41		49307973	49308014	8421504	1	41	0	g	350012790900000143	89-130						Protease inhibition	Ladner	2008	0		
961	chr22	49307973	49308014	3500122900	41		49307973	49308014	8421504	1	41	0	g	350012290000001168,350012290000000733,350012290000000990,350012290000001030,350012290000000875,350012290000000569	31-67,27-68,30-70,12-49,43-78,43-78						Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library. application to the detection of mycobacteria - Patent #07842781	w.strutpatent.com	0	0		
961	chr22	49307973	49308014	3500114752	41		49307973	49308014	8421504	1	41	0	g	350011475200000000	14-55					Patent	DNA construct comprising a vector for expression of human cytoplasmic Cu/Zn superoxide dismutase in E. coli and method of use of same (Patent US:6331421)	Hallewell	2001	0		
961	chr22	49307973	49308014	3500089118	41		49307973	49308014	8421504	1	41	0	g	350008911800000036	0-42						36 human secreted proteins	LaFleur	2001	0		
961	chr22	49307973	49308014	3500076234	41		49307973	49308014	8421504	1	41	0	g	350007623400000045	145-186						PLASMA KALLIKREIN BINDING PROTEINS - Patent application	www.faqs.org	0	0		
961	chr22	49307973	49308014	3500074791	41		49307973	49308014	8421504	1	41	0	g	350007479100000000	14-55						Superoxide dismutase cloning and expression in microorganisms	Hallewell	1985	0		
961	chr22	49307973	49308014	3500010909	41		49307973	49308014	8421504	1	41	0	g	350001090900000450,350001090900000508,350001090900000528	43-84,30-70,12-49						Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria	Cole	1998	0		
961	chr22	49307973	49308014	3500009863	41		49307973	49308014	8421504	1	41	0	g	350000986300000000,350000986300000001,350000986300000066,350000986300000065	8-55,0-47,0-47,8-55						US Patent # 6,833,441. Compositions and methods for generating chimeric heteromultimers - Patents.com	www.patents.com	0	0		
961	chr22	49307973	49308013	3500299105	40		49307973	49308013	8421504	1	40	0	g	350029910500000092	166-206						DETECTION OF NUCEIC ACIDS BY MULTIPLE SEQUENTIAL INVASIVE CLEAVAGES - Patent application	www.faqs.org	0	0		
961	chr22	49307973	49308013	3500228725	40		49307973	49308013	8421504	1	40	0	g	350022872500000073	166-206						Nucleic acid detection assays	www.devileye.net	0	0		
961	chr22	49307973	49308013	3500205290	40		49307973	49308013	8421504	1	40	0	g	350020529000000072	166-206						Detection of nucleic acid sequences by invader-directed cleavage	Brow	1999	0		
961	chr22	49307973	49308013	3500159977	40		49307973	49308013	8421504	1	40	0	g	350015997700000095	166-206						Detection of nucleic acids by multiple sequential invasive cleavages 02	Hall	1999	0		
961	chr22	49307973	49308013	3500008318	40		49307973	49308013	8421504	1	40	0	g	350000831800000086,350000831800000069,350000831800000005	0-40,166-206,0-24						Cleavase fragment length polymorphism	Dahlberg	1997	0		
961	chr22	49307973	49308009	3500388920	36		49307973	49308009	8421504	1	36	0	g	350038892000000050	24-60						Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof	Cochran	1996	0		
961	chr22	49307973	49308009	3500341278	36		49307973	49308009	8421504	1	36	0	g	350034127800000029	24-60						Method of distinguishing an IBRV-vaccinated bovine from a bovine infected with a wild type virus	Cochran	1996	0		
961	chr22	49307973	49308009	3500308235	36		49307973	49308009	8421504	1	36	0	g	350030823500000041	24-60					Patent	Recombinant infectious bovine rhinotracheitis virus (Patent US:5874279)	Cochran	1999	0		
961	chr22	49307973	49308009	3500069576	36		49307973	49308009	8421504	1	36	0	g	350006957600000050	24-60						Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof	Cochran	1995	0		
961	chr22	49307973	49308007	3500377958	34		49307973	49308007	8421504	1	34	0	g	350037795800000041,350037795800000002	0-34,0-25						Dinucleotide restriction endonuclease preparations and methods of use	Mead	1994	0		
961	chr22	49307973	49308007	3500299728	34		49307973	49308007	8421504	1	34	0	g	350029972800000039,350029972800000002	0-34,0-25					Patent	Recombinant CviJI restriction endonuclease (Patent US:5472872)	Mead	1995	0		
961	chr22	49307973	49308006	3500369207	28		49307973	49308006	8421504	2	6,22	0,11	g	350036920700000216,350036920700000215	22-50,0-28						Microbial systems for producing commodity chemicals	Yoshikuni	2011	0		
961	chr22	49307973	49308006	3500064074	28		49307973	49308006	8421504	2	6,22	0,11	g	350006407400000215,350006407400000216	0-28,22-50						MICROBIAL SYSTEMS FOR PRODUCING COMMODITY CHEMICALS - BIO ARCHITECTURE LAB, INC.	www.sumobrain.com	0	0		
961	chr22	49307973	49308004	3500318250	31		49307973	49308004	8421504	1	31	0	g	350031825000000014	17-49						Lambdoid bacteriophage vectors for expression of foreign proteins - US Patent 7732150 Description	ww.patentstorm.us	0	0		
961	chr22	49307973	49308004	3500156293	31		49307973	49308004	8421504	1	31	0	g	350015629300000004	18-50						1A	www.pnas.org	0	0		
961	chr22	49307973	49308002	3500048492	29		49307973	49308002	8421504	1	29	0	g	350004849200000006,350004849200000035	158-187,161-190						Analyte detection via antibody-associated enzyme assay - Patent application	www.faqs.org	0	0		
961	chr22	49307973	49308001	3500353284	28		49307973	49308001	8421504	1	28	0	g	350035328400000049	29-57						Recombinant swinepox virus	Cochran	1993	0		
961	chr22	49307973	49308001	3500299601	28		49307973	49308001	8421504	1	28	0	g	350029960100000040	29-57						Recombinant swinepox virus	Cochran	1993	0		
961	chr22	49307973	49308001	3500210007	28		49307973	49308001	8421504	1	28	0	g	350021000700000039	29-57						Recombinant swinepox virus	Cochran	1992	0		
961	chr22	49307973	49308001	3500141736	28		49307973	49308001	8421504	1	28	0	g	350014173600000118	29-57						US Patent # 6,497,882. Recombinant swinepox virus - Patents.com	www.patents.com	0	0		
961	chr22	49307973	49308001	3500110077	28		49307973	49308001	8421504	1	28	0	g	350011007700000046	0-28						Novel dna capable of being amplified by pcr with high selectivity and high efficiency	Hirao	2009	0		
961	chr22	49307973	49308001	3500025039	28		49307973	49308001	8421504	1	28	0	g	350002503900000086	29-57						Recombinant swinepox virus	Cochran	1996	0		
961	chr22	49307973	49307998	3500342581	25		49307973	49307998	8421504	1	25	0	g	350034258100000026,350034258100000024,350034258100000028	0-25,0-25,0-25		18454192	10.1371/journal.pgen.1000005	1553-7404	PLOS Genetics	PLOS Genetics: Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic Screen	Arnoldo	2008	0		
961	chr22	49307973	49307998	3500248148	25		49307973	49307998	8421504	1	25	0	g	350024814800000016	0-25					Patent	Representational approach to DNA analysis (Patent US:5876929)	Lisitsyn	1999	0		
961	chr22	49307973	49307998	3500241803	25		49307973	49307998	8421504	1	25	0	g	350024180300000026,350024180300000024,350024180300000028	0-25,0-25,0-25		18454192	10.1371/journal.pgen.1000005		PLoS Genetics	Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic Screen	Anthony	2008	0		
961	chr22	49307973	49307998	3500215575	25		49307973	49307998	8421504	1	25	0	g	350021557500000008	0-25						Tesis_4687_Alzogaray	es.scribd.com	0	0		
961	chr22	49307973	49307998	3500086361	25		49307973	49307998	8421504	1	25	0	g	350008636100000026,350008636100000024,350008636100000028	0-25,0-25,0-25						Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen.	.biomedsearch.com	0	0		
961	chr22	49307973	49307997	3500446540	24		49307973	49307997	8421504	1	24	0	g	350044654000000020	0-24						Method of preparing transgenic organism with use of methylation and system therefor	Takeda	2004	0		
961	chr22	49307975	49308006	3500284980	31		49307975	49308006	8421504	1	31	0	g	350028498000000124	97-128					Patent	Transgenic transchromosomal rodents for making human antibodies (Patent CN:1487996)	E*Ha Er Ke 	2010	0		
961	chr22	49307976	49308000	3500375667	24		49307976	49308000	8421504	1	24	0	g	350037566700000001	5-29		8923969			Analytical Biochemistry	Real-time DNA sequencing using detection of pyrophosphate release.	Ronaghi	1996	0		
961	chr22	49307979	49308014	3500078476	35		49307979	49308014	8421504	1	35	0	g	350007847600000008	44-79		18456657	10.1074/jbc.M800233200	0021-9258	Journal of Biological Chemistry	Modified Uridines with C5-methylene Substituents at the First Position of the tRNA Anticodon Stabilize U&#xb7;G Wobble Pairing during Decoding	Kurata	2008	5		
961	chr22	49307980	49308014	3500431485	33		49307980	49308014	8421504	2	29,4	0,30	g	350043148500000004	9-42						Nucleic acid encoding a fragment of bovine luteinizing hormone/chorionic gonadotropin receptor	Saxena	1993	0		
961	chr22	49307980	49308014	3500194396	33		49307980	49308014	8421504	2	29,4	0,30	g	350019439600000004	9-42						hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine	Saxena	2003	0		
961	chr22	49307983	49308497	3500266812	31		49307983	49308497	8421504	2	25,6	0,508	g	350026681200000095	0-31					Patent	Production of odd chain fatty acid derivatives in recombinant microbial cells (Patent US:8372610)	Lee	2013	0		
961	chr22	49307983	49308497	3500103434	37		49307983	49308497	8421504	2	31,6	0,508	g	350010343400000207,350010343400000206,350010343400000095	44-75,44-75,0-31						PRODUCTION OF ODD CHAIN FATTY ACID DERIVATIVES IN RECOMBINANT MICROBIAL CELLS - Patent application	www.faqs.org	0	0		
961	chr22	49307983	49308014	3500167771	31		49307983	49308014	8421504	1	31	0	g	350016777100000000	18-49						An Amino-Terminal Fragment of lac Repressor Binds Specifically to lac Operator	www.jstor.org	0	0		
961	chr22	49307983	49308014	3500134988	31		49307983	49308014	8421504	1	31	0	g	350013498800000095,350013498800000091,350013498800000087,350013498800000210,350013498800000214,350013498800000206	2-33,0-29,0-29,0-29,2-33,0-29						Toxoplasma Gondii Vaccines and Uses Thereof - Patent application	www.faqs.org	0	0		
961	chr22	49307983	49308014	3500064250	31		49307983	49308014	8421504	1	31	0	g	350006425000000002	40-71						MONOSPECIFIC INHIBITORS SHOW THAT BOTH MASP-1 AND MASP-2 ARE ESSENTIAL FOR LECTIN PATHWAY ACTIVATION AND REVEAL STRUCTURAL PLASTICITY OF MASP-2	www.jbc.org	0	0		
961	chr22	49307983	49308012	3500120472	29		49307983	49308012	8421504	1	29	0	g	350012047200000011,350012047200000007	0-29,0-29		20642838	10.1186/1471-2164-11-441	1471-2164	BMC Genomics	Array comparative genomic hybridization analysis of Trichoderma reesei strains with enhanced cellulase production properties	Vitikainen	2010	4		
961	chr22	49307984	49308014	3500447147	30		49307984	49308014	8421504	1	30	0	g	350044714700000000	18-48			10.1099/mic.0.28063-0	1350-0872	Microbiology	Influence of fusaric acid on phenazine-1-carboxamide synthesis and gene expression of Pseudomonas chlororaphis strain PCL1391	Rij	2005	3		
961	chr22	49307984	49308014	3500384026	30		49307984	49308014	8421504	1	30	0	g	350038402600000007,350038402600000136,350038402600000005,350038402600000004,350038402600000003,350038402600000137,350038402600000135	62-92,62-92,62-92,62-92,62-92,62-92,62-92						 Biotechnological Method Of Producing Biotin 	www.docstoc.com	0	0		
961	chr22	49307984	49308014	3500335231	30		49307984	49308014	8421504	1	30	0	g	350033523100000003,350033523100000005,350033523100000004,350033523100000007,350033523100000135,350033523100000137,350033523100000136	62-92,62-92,62-92,62-92,62-92,62-92,62-92						Biotechnological method of producing biotin - Patent # 6083712 - PatentGenius	.patentgenius.com	0	0		
961	chr22	49307984	49308014	3500255122	30		49307984	49308014	8421504	1	30	0	g	350025512200000057	42-72						ENHANCED PRODUCTION OF ISOPRENE USING HOST CELLS HAVING DECREASED ISPA ACTIVITY	Mcauliffe	2012	0		
961	chr22	49307984	49308014	3500244857	30		49307984	49308014	8421504	1	30	0	g	350024485700000051	42-72						ENHANCED PRODUCTION OF ISOPRENE USING HOST CELLS HAVING DECREASED ISPA ACTIVITY - DANISCO US INC.	www.sumobrain.com	0	0		
961	chr22	49307984	49308014	3500240181	30		49307984	49308014	8421504	1	30	0	g	350024018100000009	2-32						Strains for production of RcoMBx-1 proteins and assay of in vivo activity.	www.addgene.org	0	0		
961	chr22	49307984	49308012	3500409370	28		49307984	49308012	8421504	1	28	0	g	350040937000000001	0-28						Process for synthesizing protein using cell-free protein synthesis system	Tajima	2002	0		
961	chr22	49307984	49308012	3500128881	28		49307984	49308012	8421504	1	28	0	g	350012888100000007,350012888100000001	0-28,0-28						US Patent # 7,045,593. Process for synthesizing protein using cell-free protein synthesis system - Patents.com	www.patents.com	0	0		
961	chr22	49307988	49308012	3500184056	24		49307988	49308012	8421504	1	24	0	g	350018405600000006	0-24						Targeted Delivery of Compounds Using Multimerization Technology	Abulrob	2006	0		
961	chr22	49307989	49308014	3500417955	25		49307989	49308014	8421504	1	25	0	g	350041795500000001	0-25						Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence	.researchgate.net	0	0		
961	chr22	49307989	49308014	3500045500	25		49307989	49308014	8421504	1	25	0	g	350004550000000001	0-25		19889083	10.1111/j.1462-5822.2009.01408.x	1462-5822	Cellular Microbiology	Aspergillus fumigatus MedA governs adherence, host cell interactions and virulence - Gravelat - 2009 - Cellular Microbiology - Wiley Online Library	Gravelat	2010	0		
961	chr22	49307989	49308013	3500446054	24		49307989	49308013	8421504	1	24	0	g	350044605400000045	0-24						UNIVERSIDAD COMPLUTENSE DE MADRID	digital.csic.es	0	0		
961	chr22	49307989	49308013	3500432065	24		49307989	49308013	8421504	1	24	0	g	350043206500000000	0-24						Process for nucleic acid hybridization and amplification	Zarling	1990	0		
961	chr22	49307989	49308013	3500352553	24		49307989	49308013	8421504	1	24	0	g	350035255300000032	0-24						Methods and compositions for DNA manipulation	Bitinaite	2003	0		
961	chr22	49307989	49308013	3500297818	24		49307989	49308013	8421504	1	24	0	g	350029781800000010	0-24		19889097	10.1111/j.1365-2958.2009.06930.x	1365-2958	Molecular Microbiology	Novel Sinorhizobium meliloti quorum sensing positive and negative regulatory feedback mechanisms respond to phosphate availability - McIntosh - 2009 - Molecular Microbiology - Wiley Online Library	McIntosh	2009	0		
961	chr22	49307989	49308013	3500292050	24		49307989	49308013	8421504	1	24	0	g	350029205000000003	0-24						Methods of identifying and treating individuals exhibiting complex karyotypes	Lee	2007	0		
961	chr22	49307989	49308013	3500272670	24		49307989	49308013	8421504	1	24	0	g	350027267000000006	0-24						US Patent # 5,597,895. Transdominant tat mutants and uses thereof - Patents.com	www.patents.com	0	0		
961	chr22	49307989	49308013	3500243952	24		49307989	49308013	8421504	1	24	0	g	350024395200000009	0-24						BIOTECHNOLOGICAL APPROACHES ON THE FERMENTATIVE PRODUCTION OF BACTERIOCIN AS BIOPRESERVATIVE	ir.cftri.com	0	0		
961	chr22	49307989	49308013	3500242535	24		49307989	49308013	8421504	1	24	0	g	350024253500000000	0-24					Patent	A thermostable ligase mediated dna amplification system for the detection of genetic diseases (Patent EP:0528882)	Barany	2007	0		
961	chr22	49307989	49308013	3500202587	24		49307989	49308013	8421504	1	24	0	g	350020258700000031	0-24						World Journal of Gastroenterology	www.wjgnet.com	0	0		
961	chr22	49307989	49308013	3500191728	24		49307989	49308013	8421504	1	24	0	g	350019172800000011,350019172800000014	0-20,0-24						BIM1 Encodes a Microtubule-binding Protein in Yeast	www.princeton.edu	0	0		
961	chr22	49307989	49308013	3500165826	24		49307989	49308013	8421504	1	24	0	g	350016582600000000	0-24		20802082	10.1128/AEM.01248-10	0099-2240	Applied and Environmental Microbiology	Development of a Genetic System for Combinatorial Biosynthesis of Lipopeptides in Streptomyces fradiae and Heterologous Expression of the A54145 Biosynthesis Gene Cluster	Alexander	2010	4		
961	chr22	49307989	49308013	3500116441	24		49307989	49308013	8421504	1	24	0	g	350011644100000058	0-24						[tel-00597741, v1] R&#xe9;gulation des principaux transporteurs de glucose et leurs effets sur l'expression des g&#xe8;nes de virulence chez Listeria monocytogenes	hives-ouvertes.fr	0	0		
961	chr22	49307989	49308013	3500023742	24		49307989	49308013	8421504	1	24	0	g	350002374200000010	0-24						Nematode-extracted anticoagulant protein	Vlasuk	1994	0		
961	chr22	49307990	49308013	3500425975	23		49307990	49308013	8421504	1	23	0	g	350042597500000000	0-23						Expression in Escherichia coli of flaB, the gene coding for a periplasmic flagellin of Leptospira interrogans serovar pomona	m.sgmjournals.org	0	0		
961	chr22	49307990	49308013	3500370079	23		49307990	49308013	8421504	1	23	0	g	350037007900000000,350037007900000017	0-23,0-23						METHODS OF DIAGNOSING AND TREATING CYTOMEGALOVIRUS DISEASES - Patent application	www.faqs.org	0	0		
961	chr22	49307990	49308013	3500328868	23		49307990	49308013	8421504	1	23	0	g	350032886800000011	0-23						US Patent # 6,958,214. Polymorphic kinase anchor proteins and nucleic acids encoding the same - Patents.com	www.patents.com	0	0		
961	chr22	49307990	49308013	3500296518	23		49307990	49308013	8421504	1	23	0	g	350029651800000073,350029651800000031	0-23,0-23						US Patent # 7,220,897. .DELTA.4-desaturase genes and uses thereof - Patents.com	www.patents.com	0	0		
961	chr22	49307990	49308013	3500190336	23		49307990	49308013	8421504	1	23	0	g	350019033600000062,350019033600000030	0-23,0-23						DELTA-4 DESATURASE GENES AND USES THEREOF	Mukerji	2002	0		
961	chr22	49329113	49329243	3500382230	24		49329113	49329243	8421504	2	8,16	0,114	c	350038223000000010	18-42						Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors	Boyle	2013	0		
961	chr22	49329113	49329243	3500153386	24		49329113	49329243	8421504	2	8,16	0,114	c	350015338600000010	18-42						Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors	Boyle	2010	0		
961	chr22	49329113	49329243	3500094164	24		49329113	49329243	8421504	2	8,16	0,114	c	350009416400000010	18-42					Patent	Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors (Patent US:8455629)	Boyle	2013	0		
962	chr22	49438070	49485478	3500400478	45		49438070	49485478	8421504	2	23,22	0,47386	c	350040047800000166,350040047800000117,350040047800000116	0-23,0-22,0-21					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		WDR82,MIR135A1,GLYCTK
962	chr22	49438070	49485477	3500423784	44		49438070	49485477	8421504	2	23,21	0,47386	c	350042378400000039,350042378400000018	0-23,0-21						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		WDR82,MIR135A1,GLYCTK
962	chr22	49438070	49438095	3500013455	25		49438070	49438095	8421504	1	25	0	g	350001345500000117	23-48						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		RMST
962	chr22	49438070	49438093	3500287752	23		49438070	49438093	8421504	1	23	0	c,g	350028775200000012,350028775200000012	0-23,0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		MIR135A1
962	chr22	49485437	49485461	3500243673	24		49485437	49485461	8421504	1	24	0	g	350024367300000046,350024367300000027	0-24,0-24						TARGETING OF MIRNA PRECURSORS - UNIVERSITY OF DUNDEE	www.sumobrain.com	0	0		
962	chr22	49495070	49495096	3500045958	24		49495070	49495096	8421504	2	9,15	0,11	c	350004595800000011	2-26						Interaktion pathogener Neisserien mit zellul&#xe4;ren Rezeptoren	.uni-wuerzburg.de	0	0		
962	chr22	49527158	49529927	3500322039	125		49527158	49529927	8421504	5	22,42,20,20,21	0,57,844,946,2748	c,g	350032203900000016,350032203900000017,350032203900000015,350032203900000015,350032203900000004,350032203900000005,350032203900000003,350032203900000003	0-22,0-22,0-20,0-20,0-20,0-20,0-21,0-21			10.1128/CDLI.11.1.174-185.2004		Clinical and Diagnostic Laboratory Immunology	Mastitis Increases Mammary mRNA Abundance of &#x03b2;-Defensin 5, Toll-Like-Receptor 2 (TLR2), and TLR4 but Not TLR9 in Cattle	T.	2004	0		
962	chr22	49527252	49527276	3500304335	23		49527252	49527276	8421504	2	14,9	0,15	c	350030433500000515	18-41						Diagnosis and Treatment of Cancer Using Anti-EREG Antibody - Patent application	www.faqs.org	0	0		
962	chr22	49527754	49527814	3500412407	60		49527754	49527814	8421504	1	60	0	p	350041240700015003	0-60						Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies	Mudde	2008	0		TLR9
962	chr22	49527754	49527814	3500284007	60		49527754	49527814	8421504	1	60	0	p	350028400700015001	0-60						&#x7528;&#x4e8e;&#x53d8;&#x6001;&#x53cd;&#x5e94;&#x6cbb;&#x7597;&#x3001;&#x7ed3;&#x5408;tlr9&#x548c;cd32&#x4e14;&#x5305;&#x542b;t&#x7ec6;&#x80de;&#x8868;&#x4f4d;&#x7684;&#x53cc;&#x7279;&#x5f02;&#x6027;&#x5206;&#x5b50;	Ge Te Fu Li De *Xi Mu Le 	2009	0		TLR9
962	chr22	49527754	49527814	3500271468	60		49527754	49527814	8421504	1	60	0	p	350027146800015002	0-60						Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies	Ge Te Fu Li De *Xi Mu Le 	2009	0		TLR9
962	chr22	49527851	49528007	3500018219	44		49527851	49528007	8421504	2	22,22	0,134	c	350001821900000020,350001821900000021	0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
962	chr22	49527887	49527910	3500290734	23		49527887	49527910	8421504	1	23	0	c	350029073400000034	0-23		12829592			Blood	Toll-like receptors stimulate human neutrophil function.	Hayashi	2003	0		
962	chr22	49527950	49528471	3500086644	40		49527950	49528471	8421504	2	20,20	0,501	c,g	350008664400000008,350008664400000008,350008664400000009,350008664400000009	0-20,0-20,0-20,0-20			10.1111/j.1365-2567.2004.01781.x	1365-2567	Immunology	Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists - Werling - 2003 - Immunology - Wiley Online Library	Werling	2004	0		
962	chr22	49528400	49528569	3500291860	39		49528400	49528569	8421504	2	20,19	0,150	c,g	350029186000000018,350029186000000018,350029186000000019	0-20,0-20,0-19						Die Immunantwort boviner und capriner Euterepithelzellen auf verschiedene Mastitiserreger	b.uni-muenchen.de	0	0		
962	chr22	49529986	49530017	3500265690	27		49529986	49530017	8421504	3	17,5,5	0,20,26	c	350026569000000335	21-48						Polycystic kidney disease 12 gene and uses thereof	Harris	1998	0		
962	chr22	49530059	49530082	3500361960	23		49530059	49530082	8421504	1	23	0	c	350036196000000009	21-44						Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation	biomedcentral.com	0	0		
965	chr22	49818951	49818983	3500251013	26		49818951	49818983	8421504	3	12,8,6	0,16,26	c	350025101300000004	11-37		20367639	10.1111/j.1349-7006.2010.01533.x	1349-7006	Cancer Science	Subcellular distribution of S100A4 and its transcriptional regulation under hypoxic conditions in gastric cancer cell line BGC823 - Zhang - 2010 - Cancer Science - Wiley Online Library	Zhang	2010	0		
965	chr22	49820471	49820494	3500139966	23		49820471	49820494	8421504	1	23	0	c	350013996600000104	9-39						US Patent # 6,531,579. Fused polypeptides - Patents.com	www.patents.com	0	0		
966	chr22	49963659	49969054	3500263396	1704		49963659	49969054	8421504	23	21,44,67,30,33,168,42,45,183,105,30,24,60,84,45,135,86,112,66,30,72,69,153	0,27,297,370,445,2148,2319,2367,2427,2613,2724,2757,2784,2865,2952,3000,3138,4710,4975,5044,5092,5167,5242	p	350026339600015032,350026339600015031,350026339600015030,350026339600015029	0-168,0-705,0-462,0-405						Chimeric metabotropic glutamate receptors and uses thereof	Gupta	2007	0		GRM2
966	chr22	49964128	49969195	3500208450	288		49964128	49969195	8421504	5	9,87,48,48,96	0,1679,4365,4875,4971	p	350020845000015058,350020845000015057,350020845000015033,350020845000015022,350020845000015020,350020845000015019	0-48,0-48,0-48,0-48,0-48,0-48						GRM3 MUTATIONS AND USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF MELANOMA - Patent application	www.faqs.org	0	0		GRM2
966	chr22	49965885	49965912	3500458273	27		49965885	49965912	8421504	1	27	0	c	350045827300000194	6-33						US Patent # 6,031,003. Calcium receptor-active molecules - Patents.com	www.patents.com	0	0		
966	chr22	49965885	49965912	3500225844	27		49965885	49965912	8421504	1	27	0	c	350022584400000194	6-33						US Patent # 6,011,068. Calcium receptor-active molecules - Patents.com	www.patents.com	0	0		
966	chr22	49970145	49970172	3500272920	24		49970145	49970172	8421504	2	17,7	0,20	g	350027292000000131	0-33						Antibodies to CD40 - Patent application	www.faqs.org	0	0		
966	chr22	50007037	50007063	3500333965	23		50007037	50007063	8421504	2	7,16	0,10	g	350033396500000000	1-24						Animal interferons, processes involved in their production, compositions containing them, DNA sequences coding therefor and expression vehicles containing such sequences and cells transformed thereby	Capon	1983	0		
966	chr22	50053372	50053396	3500035992	23		50053372	50053396	8421504	2	10,13	0,11	g	350003599200000067	20-45						Fusion Proteins Between Plant Cell-Wall Degrading Enzymes, and Their Uses - Patent application	www.faqs.org	0	0		
968	chr22	50225154	50226680	3500258181	36		50225154	50226680	8421504	2	29,7	0,1519	c	350025818100000011	12-48						NEUROTROPHIC FACTOR MANF AND USES THEREOF - Patent application	www.faqs.org	0	0		
968	chr22	50266361	50266392	3500270200	30		50266361	50266392	8421504	2	5,25	0,6	g	350027020000000001	58-90						Virginia Tech : LIB 04232004 : FenauxPhDDiss	ww.coursehero.com	0	0		
968	chr22	50266361	50266392	3500088495	30		50266361	50266392	8421504	2	5,25	0,6	g	350008849500000048,350008849500000051	50-82,58-90						Genetic, antigenic and pathogenetic	lib.ugent.be	0	0		
969	chr22	50434415	50434555	3500459899	50		50434415	50434555	8421504	2	23,27	0,113	g	350045989900000033,350045989900000032	0-23,0-27						REASSESSMENT OF GENETIC DIVERSITY IN NATIVE TURKISH SHEEP BREEDS WITH LARGE NUMBERS OF MICROSATELLITE MARKERS AND MITOCHONDRIAL DNA (MTDNA) A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF NATURAL AND APPLIED SCIENCES OF MIDDLE EAST TECHNICAL UNIVERSITY BY FO	d.lib.metu.edu.tr	0	0		
969	chr22	50434415	50434555	3500250249	51		50434415	50434555	8421504	2	23,28	0,112	g	350025024900000009,350025024900000008	0-23,0-28						None	jstnar.iut.ac.ir	0	0		
969	chr22	50434415	50434555	3500024337	50		50434415	50434555	8421504	2	23,27	0,113	g	350002433700000011,350002433700000010	0-23,0-27						Genetic Diversity Analysis of the Gohilwari Breed of Indian Goat Capra hircus ) Using Microsatellite Markers	thescipub.com	0	0		
969	chr22	50434415	50434438	3500223039	23		50434415	50434438	8421504	1	23	0	g	350022303900000033	0-23		22423334	10.1002/ece3.97		Ecology and Evolution	Evaluation of experimental genetic management in reintroduced bighorn sheep	Zachary	2012	0		
970	chr22	50478176	50478289	3500088223	40		50478176	50478289	8421504	2	20,20	0,93	c	350008822300000010,350008822300000011	0-20,0-20						NUTRITIONAL REGULATION OF SERUM INSULIN-LIKE GROWTH FACTOR-I CONCENTRATION IN CATTLE	cholar.lib.vt.edu	0	0		
970	chr22	50478249	50478558	3500221463	43		50478249	50478558	8421504	2	22,21	0,288	c	350022146300000003,350022146300000004	0-22,0-21		16199887	10.1128/MCB.25.20.9115-9126.2005	0270-7306	Molecular and Cellular Biology	SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation	Tannahill	2005	6		CISH
970	chr22	50478251	50478540	3500433790	48		50478251	50478540	8421504	2	43,5	0,284	c	350043379000000110	0-48						Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression - Patent # 6020155 - PatentGenius	.patentgenius.com	0	0		
970	chr22	50479231	50479283	3500211535	52		50479231	50479283	8421504	1	52	0	c,g	350021153500000001,350021153500000000,350021153500000000	0-26,0-53,0-53						Mouse Cow	firstshow.com.au	0	0		
971	chr22	50694971	50705894	3500023842	43		50694971	50705894	8421504	2	22,21	0,10902	g	350002384200000029,350002384200000043	0-22,0-21						Calcium channel proteins	Lerman	2002	0		
972	chr22	50733466	50738126	3500280883	40		50733466	50738126	8421504	2	20,20	0,4640	c,g	350028088300000008,350028088300000009,350028088300000009	0-20,0-20,0-20			10.1111/j.1349-7006.2006.00253.x	1349-7006	Cancer Science	Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma - Zhang - 2006 - Cancer Science - Wiley Online Library	Zhang	2006	0		RASSF1
972	chr22	50746063	50746088	3500068521	24		50746063	50746088	8421504	2	11,13	0,12	g	350006852100000372	18-42						About ICRISAT	www.icrisat.org	0	0		
972	chr22	50748174	50750825	3500216740	82		50748174	50750825	8421504	4	20,21,21,20	0,255,445,2631	c,g	350021674000000000,350021674000000002,350021674000000002,350021674000000001,350021674000000003	0-20,0-21,0-21,0-21,0-20		11836391	10.1128/jvi.76.5.2141-2149.2002	0022-538X	Journal of Virology	Mechanism of Cell Entry and Transformation by Enzootic Nasal Tumor Virus	Dirks	2002	5		
972	chr22	50748174	50748640	3500325436	41		50748174	50748640	8421504	2	20,21	0,445	c,g	350032543600000002,350032543600000002,350032543600000003,350032543600000003	0-20,0-20,0-21,0-21		15788753	10.1095/biolreprod.105.039776	0006-3363	Biology of Reproduction	Sheep Endogenous Betaretroviruses (enJSRVs) and the Hyaluronidase 2 (HYAL2) Receptor in the Ovine Uterus and Conceptus	Dunlap	2005	4		
972	chr22	50748429	50750825	3500103423	62		50748429	50750825	8421504	3	21,21,20	0,190,2376	c,g	350010342300000002,350010342300000002,350010342300000001,350010342300000003,350010342300000003	0-21,0-21,0-21,0-20,0-20					Journal of Virology	Mechanism of Cell Entry and Transformation by Enzootic Nasal Tumor Virus	Clarissa	2002	0		
972	chr22	50749037	50749062	3500331407	25		50749037	50749062	8421504	1	25	0	c	350033140700000020	0-25						METHOD OF TREATING CANCER AND/OR CELLULAR PROLIFERATIVE CONDITIONS AND AGENTS TARGETING HYALURONAN ANABOLISM USEFUL FOR SAME	Brown	2011	0		
972	chr22	50790787	50790810	3500248703	23		50790787	50790810	8421504	1	23	0	c	350024870300000214	20-47						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
972	chr22	50824295	50824510	3500308562	44		50824295	50824510	8421504	2	23,21	0,194	c	350030856200000023,350030856200000022	0-23,0-21						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		GNAI2
972	chr22	50825936	50844378	3500046024	116		50825936	50844378	8421504	4	19,4,45,48	0,20,18346,18394	p,c	350004602400000075,350004602400015081	19-42,0-93						Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor - US Patent 7235648 Description	ww.patentstorm.us	0	0		GNAI2
972	chr22	50825941	50825977	3500124927	36		50825941	50825977	8421504	1	36	0	c,g	350012492700000029,350012492700000029,350012492700000050	20-56,20-56,10-35						Method for identifying inhibitors of G protein coupled receptor signaling - US Patent 7208279 Description	ww.patentstorm.us	0	0		GNAI2
972	chr22	50825943	50825968	3500253848	25		50825943	50825968	8421504	1	25	0	c	350025384800000048	10-35						G protein coupled receptor signaling modulation - Patent application	www.faqs.org	0	0		
121	chr22	50825944	50881768	3500147730	315		50825944	50881768	8421504	7	63,57,30,63,51,35,16	0,3891,3951,52647,53502,54582,55808	p	350014773000015088,350014773000015025,350014773000015093,350014773000015101,350014773000015107,350014773000015018,350014773000015022,350014773000015100,350014773000015095	0-66,0-90,0-66,0-51,0-45,102-150,39-84,0-45,0-48						Sequenceanalysis cDNAand DNA	www.pnas.org	0	0		
972	chr22	50825958	50825988	3500100903	30		50825958	50825988	8421504	1	30	0	c	350010090300000207	0-30						MINICELLS EXPRESSING ANTIBODIES OR DERIVATIVES THEREOF AND COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS - Patent application	www.faqs.org	0	0		
121	chr22	50825995	50881759	3500447577	495		50825995	50881759	8421504	11	90,111,24,16,74,10,35,45,45,38,7	0,550,746,860,1275,1394,3494,18272,53451,54528,55757	p	350044757700015021,350044757700015020,350044757700015017,350044757700015016,350044757700015015,350044757700015012,350044757700015011,350044757700015009,350044757700015001,350044757700015013,350044757700015002	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Human G-protein alpha I1 C351S GCTAGCGTTTAAACTTAAGCTTGGTACCACC ATG GGC TGC ACG CTG AGC GCC GAG GAC AAG GCG GCG GTG GAG CGG AGT AAG ATG ATC GAC CGC AAC CTC CGT GAG GAC GGC GAG AAG GCG GCG CGC GAG GTC AAG CTG CTG CTG CTC GGT GCT GGT GAA TCT GGT AAA AGT ACA 	www.cdna.org	0	0		
972	chr22	50826109	50826594	3500306408	42		50826109	50826594	8421504	2	20,22	0,463	c,g	350030640800000005,350030640800000002	0-20,0-22						Adenosine Induces Vasoconstriction through Gi-Dependent Activation of Phospholipase C in Isolated Perfused Afferent Arterioles of Mice	n.asnjournals.org	0	0		
972	chr22	50829967	50844261	3500203736	45		50829967	50844261	8421504	3	1,43,1	0,246,14293	c	350020373600000001	13-58						Anti-vegf Antibody Compositions And Methods 	.freshpatents.com	0	0		
972	chr22	50844333	50844378	3500287453	45		50844333	50844378	8421504	1	45	0	p	350028745300015065	0-45					Patent	Regulation of oxidative burst using LMWG-derived peptides and analogs (Patent US:6184203)	Bokoch	2001	0		GNAI2
972	chr22	50844333	50844378	3500169488	45		50844333	50844378	8421504	1	45	0	p	350016948800015049	0-45						Regulation of oxidative burst using lmwg-derived peptides and analogs	Bokoch	1995	0		GNAI2
973	chr22	50862951	50862974	3500218835	23		50862951	50862974	8421504	1	23	0	c	350021883500000005	0-23		18388187	10.1152/ajpgi.00578.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Functional characterization, localization, and molecular identification of rabbit intestinal N-amino acid transporter	Talukder	2008	0		
973	chr22	50878591	50880106	3500347034	717		50878591	50880106	8421504	5	188,154,130,129,116	0,310,786,1177,1399	p	350034703400015004	0-717						Binding domains directed against gpcr:g protein complexes and uses derived thereof	Steyaert	2012	0		GNAT1
973	chr22	50878591	50878666	3500003372	75		50878591	50878666	8421504	1	75	0	p	350000337200015074	0-75						pr&#xe9;sent&#xe9;e par Emilie HUET MOULARD DOCTEUR DE L&#x2019;UNIVERSITE JOSEPH FOURIER-GRENOBLE I	hives-ouvertes.fr	0	0		GNAT1
973	chr22	50878599	50878624	3500201598	25		50878599	50878624	8421504	1	25	0	c	350020159800000001	0-25						Method for identifying inhibitors of G protein coupled receptor signaling	Gilchrist	2001	0		
973	chr22	50878599	50878624	3500124927	25		50878599	50878624	8421504	1	25	0	c	350012492700000001	0-25						Method for identifying inhibitors of G protein coupled receptor signaling - US Patent 7208279 Description	ww.patentstorm.us	0	0		
973	chr22	50878609	50878702	3500351228	90		50878609	50878702	8421504	2	45,45	0,48	p	350035122800015029,350035122800015028	0-45,0-45						Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof - Patent application	www.faqs.org	0	0		GNAT1
973	chr22	50878657	50878702	3500147094	45		50878657	50878702	8421504	1	45	0	p	350014709400015023	0-45						Identification of bitter receptors for hydrolyzed soy protein - US Patent 7794959 Description	ww.patentstorm.us	0	0		GNAT2
973	chr22	50878681	50881849	3500153651	273		50878681	50881849	8421504	5	98,40,12,54,69	0,220,362,696,3099	p	350015365100015007,350015365100015009,350015365100015006	0-138,0-66,0-69						Methods in Molecular Biology Vol. 066 Epitope Mapping Protocols	www.scribd.com	0	0		GNAT1
973	chr22	50878699	50878765	3500027122	66		50878699	50878765	8421504	1	66	0	p	350002712200015017	0-66						 Assay For Measuring Enzyme Activity In Vivo 	www.docstoc.com	0	0		GNAT1
973	chr22	50879043	50881858	3500333014	213		50879043	50881858	8421504	5	12,48,31,26,96	0,334,823,947,2719	p,c	350033301400015095,350033301400015081,350033301400015092,350033301400000021,350033301400015085,350033301400015008,350033301400015084	0-48,0-48,0-48,0-20,0-48,0-48,0-48						Gustducin materials and methods	Margolskee	1995	0		
973	chr22	50880523	50881759	3500204636	45		50880523	50881759	8421504	2	38,7	0,1229	p	350020463600015002	0-45						Human G-protein alpha i2 C352I >KpnI GCTAGCGTTTAAACTTAAGCTTGGTACCACC ATG GGC TGC ACC GTG AGC GCC GAG GAC AAG GCG GCG GCC GAG CGC TCT AAG ATG ATC GAC AAG AAC CTG CGG GAG GAC GGA GAG AAG GCG GCG CGG GAG GTG AAG TTG CTG CTG TTG GGT GCT GGG GAG TCA GGG AAG AG	www.cdna.org	0	0		GNAS
973	chr22	50880523	50881759	3500199104	45		50880523	50881759	8421504	2	38,7	0,1229	p	350019910400015002	0-45						Human G-protein alpha i2 Q205L/D273N GCTAGCGTTTAAACTTAAGCTTGGTACCACC ATG GGC TGC ACC GTG AGC GCC GAG GAC AAG GCG GCG GCC GAG CGC TCT AAG ATG ATC GAC AAG AAC CTG CGG GAG GAC GGA GAG AAG GCG GCG CGG GAG GTG AAG TTG CTG CTG TTG GGT GCT GGG GAG TCA GGG AAG AG	www.cdna.org	0	0		GNAS
973	chr22	50943364	50965506	3500129973	2262		50943364	50965506	8421504	25	123,130,17,78,75,180,72,129,9,92,79,86,73,78,88,98,161,66,61,84,74,70,156,166,17	0,982,1190,1210,2307,2695,3663,3817,4722,6364,6661,7132,8085,8241,8487,9185,9731,10602,11174,12075,14633,15189,19021,19904,22125	p	350012997300015047,350012997300015044,350012997300015041,350012997300015038,350012997300015035,350012997300015029,350012997300015026,350012997300015023,350012997300015020,350012997300015017,350012997300015014,350012997300015011,350012997300015008,350012997300015005,350012997300015002	0-99,0-171,0-177,0-177,0-180,0-180,0-90,0-144,0-177,0-180,0-69,0-177,0-177,0-87,0-177						RBM10 Modulates Apoptosis and Influences TnF-&#x03b1; Gene expression	www.la-press.com	0	0		
973	chr22	50954030	50955466	3500451674	90		50954030	50955466	8421504	3	2,61,27	0,508,1409	p	350045167400015039	0-90						Arabidopsis VARIEGATED 3encodes a chloroplast- targeted, zinc-&#xfb01;nger protein required for chloroplast and palisade cell development	cs.biologists.org	0	0		RBM5
975	chr22	51134656	51134681	3500373371	24		51134656	51134681	8421504	2	5,19	0,6	g	350037337100000097	9-33						US Patent # 7,262,339. Tocopherol methyltransferase tMT2 and uses thereof - Patents.com	www.patents.com	0	0		
975	chr22	51149560	51149665	3500121860	40		51149560	51149665	8421504	2	20,20	0,85	c,g	350012186000000027,350012186000000027,350012186000000015,350012186000000015,350012186000000016	0-20,0-20,0-20,0-20,0-20		16207835	10.1095/biolreprod.105.046748	0006-3363	Biology of Reproduction	Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	Klein	2006	4		
975	chr22	51149560	51149665	3500049790	40		51149560	51149665	8421504	2	20,20	0,85	c,g	350004979000000027,350004979000000027,350004979000000015,350004979000000015,350004979000000016,350004979000000016	0-20,0-20,0-20,0-20,0-20,0-20						Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	ww.biolreprod.org	0	0		
975	chr22	51202675	51202698	3500347789	23		51202675	51202698	8421504	1	23	0	c	350034778900000001	9-32		19208622	10.1074/jbc.M900752200	0021-9258	Journal of Biological Chemistry	Characterization of a Selective Inhibitor of Inositol Hexakisphosphate Kinases	Padmanabhan	2009	5		IP6K1
975	chr22	51202675	51202698	3500266511	23		51202675	51202698	8421504	1	23	0	c,g	350026651100000001,350026651100000001	9-32,9-32		19208622	10.1074/jbc.M900752200		The Journal of Biological Chemistry	Characterization of a Selective Inhibitor of Inositol Hexakisphosphate Kinases: USE IN DEFINING BIOLOGICAL ROLES AND METABOLIC RELATIONSHIPS OF INOSITOL PYROPHOSPHATES*S&#x20de;	Usha	2009	0		IP6K1
975	chr22	51219092	51219120	3500302904	23		51219092	51219120	8421504	2	15,8	0,20	c	350030290400000034	0-23						MMB 260 Mobile Genetic Elements, Protocols and Genomic Applications	www.scribd.com	0	0		RNF123
975	chr22	51226259	51226283	3500236647	23		51226259	51226283	8421504	2	5,18	0,6	g	350023664700000044	11-36					Patent	Polyhydroxyalkanoate-containing structure and manufacturing method thereof (Patent US:6951745)	Honma	2005	0		
975	chr22	51235762	51238421	3500327284	96		51235762	51238421	8421504	3	48,47,1	0,2531,2658	p	350032728400015019,350032728400015071	0-48,0-48						 <HTML> <HEAD><TITLE>aa-aaa!a1/4a,aoae?ec1/2e3aae1a$?a1/2aaa3aa(r)ePS1/2e ae3 - c1e	www.j-tokkyo.com	0	0		
975	chr22	51235762	51238421	3500085712	96		51235762	51238421	8421504	3	48,47,1	0,2531,2658	p	350008571200015056,350008571200015081	0-48,0-48						Analogs of macrophage stimulating protein	Wahl	1996	0		
975	chr22	51236581	51237464	3500376632	288		51236581	51237464	8421504	6	48,29,67,16,32,96	0,96,295,410,512,787	p	350037663200015015,350037663200015016,350037663200015017,350037663200015019,350037663200015022,350037663200015023	0-48,0-48,0-48,0-48,0-48,0-48						Macrophage stimulating protein for the treatment of gastrointestinal disorders	Zhang	1997	0		
975	chr22	51236971	51236994	3500265596	23		51236971	51236994	8421504	1	23	0	c	350026559600000429	7-38						NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)	Andersen	2000	0		
975	chr22	51238470	51238517	3500199787	47		51238470	51238517	8421504	1	47	0	c	350019978700000108	1-48						Recombinant proteins derived from HGF and MSP	Medico	2000	0		
976	chr22	51296433	51296457	3500118118	24		51296433	51296457	8421504	1	24	0	g	350011811800000052	0-24						Method for preparing polypeptide specifically recognizing membrane protein	Tai	2010	0		
976	chr22	51339714	51339759	3500342863	45		51339714	51339759	8421504	1	45	0	p	350034286300015105	0-45							library.wiley.com	0	0		DAG1
977	chr22	51444148	51444211	3500144055	63		51444148	51444211	8421504	1	63	0	c,g	350014405500000128,350014405500000330,350014405500000328,350014405500000131,350014405500000130,350014405500000130	0-48,0-63,0-63,0-63,0-63,0-63						GENERATION AND REPRODUCTION OF DNA SEQUENCES AND ANALYSIS OF POLYMORPHISMS AND MUTATIONS BY USING ERROR-CORRECTING CODES - Patent application	www.faqs.org	0	0		
977	chr22	51444356	51444385	3500184607	24		51444356	51444385	8421504	2	6,18	0,11	c	350018460700000075	3-27						US Patent # 6,028,173. Human chromosome 16 genes, compositions, methods of making and using same - Patents.com	www.patents.com	0	0		
977	chr22	51491079	51491106	3500205002	27		51491079	51491106	8421504	1	27	0	c	350020500200000000	7-34		15191880	10.1152/ajpgi.00065.2004		American Journal of Physiology - Gastrointestinal and Liver Physiology	Epithelial cell spreading induced by hepatocyte growth factor influences paxillin protein synthesis and posttranslational modification	Hopkins	2004	0		RHOA
977	chr22	51491079	51491105	3500008823	26		51491079	51491105	8421504	1	26	0	c	350000882300000004	7-33			10.2353/ajpath.2007.060647		The American Journal of Pathology	Annexin 2 Regulates Intestinal Epithelial Cell Spreading and Wound Closure through Rho-Related Signaling	Brian	2007	0		RHOA
977	chr22	51491081	51500414	3500252632	579		51491081	51500414	8421504	4	156,121,131,171	0,4672,8526,9162	p	350025263200015006,350025263200015009	0-285,0-294						RhoA and Rnd1 in Xenopus development	ev.biologists.org	0	0		
977	chr22	51491081	51491108	3500152792	27		51491081	51491108	8421504	1	27	0	c	350015279200000000	11-38		15843433	10.1091/mbc.E04-10-0945	1059-1524	Molecular Biology of the Cell	Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines	Cardone	2005	5		
977	chr22	51491102	51499633	3500335720	225		51491102	51499633	8421504	5	114,27,39,19,26	0,4651,4681,4753,8505	p	350033572000015023,350033572000015006,350033572000015027	0-57,0-75,69-180						Characterization of two members of the rho gene family from the yeast Saccharomyces cerevisiae. - ResearchGate	.researchgate.net	0	0		
977	chr22	51491102	51495801	3500339749	40		51491102	51495801	8421504	2	20,20	0,4679	c,g	350033974900000000,350033974900000001,350033974900000001	0-20,0-20,0-20		15867248	10.1158/1078-0432.CCR-04-2026	1078-0432	Clinical Cancer Research	Antimetastatic Effect of Salvicine on Human Breast Cancer MDA-MB-435 Orthotopic Xenograft Is Closely Related to Rho-Dependent Pathway	Lang	2005	8		RHOA
977	chr22	51491102	51495801	3500183444	40		51491102	51495801	8421504	2	20,20	0,4679	c,g	350018344400000004,350018344400000005,350018344400000005	0-20,0-20,0-20			10.1111/j.1471-4159.2005.03256.x	1471-4159	Journal of Neurochemistry	Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg - Annabi - 2005 - Journal of Neurochemistry - Wiley Online Library	Annabi	2005	0		RHOA
977	chr22	51491102	51495801	3500149993	40		51491102	51495801	8421504	2	20,20	0,4679	c,g	350014999300000000,350014999300000001,350014999300000001	0-20,0-20,0-20		15867248	10.1158/1078-0432.CCR-04-2026	1078-0432	Clinical Cancer Research	Antimetastatic Effect of Salvicine on Human Breast Cancer MDA-MB-435 Orthotopic Xenograft Is Closely Related to Rho-Dependent Pathway	Lang	2005	8		RHOA
977	chr22	51491102	51495801	3500113875	40		51491102	51495801	8421504	2	20,20	0,4679	c,g	350011387500000000,350011387500000001,350011387500000001	0-20,0-20,0-20		12154059		0008-5472	Cancer Research	Activation of Small GTPase Rho Is Required for Autocrine Motility Factor Signaling	Tsutsumi	2002	8		RHOA
977	chr22	51491102	51495801	3500020902	40		51491102	51495801	8421504	2	20,20	0,4679	c,g	350002090200000002,350002090200000003,350002090200000003	0-20,0-20,0-20			10.1111/j.1349-7006.2006.00295.x	1349-7006	Cancer Science	Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: An important autocrine/paracrine factor in tumor progression - Kikuchi - 2006 - Cancer Science - Wiley Online Library	Kikuchi	2006	0		RHOA
977	chr22	51491117	51491216	3500441132	93		51491117	51491216	8421504	2	45,48	0,51	p	350044113200015022,350044113200015023,350044113200015012	0-45,3-48,0-48						US Patent # 6,277,564. Assays and reagents for identifying anti-fungal agents, and uses related thereto - Patents.com	ww.es.patents.com	0	0		
977	chr22	51491117	51491216	3500003558	93		51491117	51491216	8421504	2	45,48	0,51	p	350000355800015022,350000355800015012,350000355800015023	0-45,0-48,3-48						US Patent # 6,277,564. Assays and reagents for identifying anti-fungal agents, and uses related thereto - Patents.com	www.patents.com	0	0		
977	chr22	51491163	51500327	3500465499	42		51491163	51500327	8421504	2	22,20	0,9144	c	350046549900000000,350046549900000001	0-22,0-20						Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature	gi.physiology.org	0	0		
977	chr22	51491163	51500327	3500433499	42		51491163	51500327	8421504	2	22,20	0,9144	c,g	350043349900000000,350043349900000001,350043349900000001	0-22,0-20,0-20						Upregulation of rho A and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage	Yasushi	2009	0		GPX1,RHOA
977	chr22	51491168	51500414	3500009992	138		51491168	51500414	8421504	3	48,45,45	0,4612,9201	p	350000999200015046,350000999200015034,350000999200015048,350000999200015029	0-45,0-45,0-45,0-45						Assays and reagents for identifying anti-fungal agents, and uses related thereto	Berlin	1998	0		
977	chr22	51491168	51491216	3500098845	48		51491168	51491216	8421504	1	48	0	p	350009884500015006,350009884500015015	0-48,3-48						Assays and reagents for identifying anti-fungal agents, and uses related thereto	Berlin	1997	0		RHOB
977	chr22	51491195	51500405	3500211391	96		51491195	51500405	8421504	3	42,6,48	0,4558,9162	c	350021139100000103,350021139100000125	0-48,0-48						Cellular Rhogtpase Activation Assay 	.freshpatents.com	0	0		
977	chr22	51491198	51495849	3500201221	135		51491198	51495849	8421504	2	39,96	0,4555	p	350020122100015004,350020122100015005,350020122100015006	0-45,0-45,0-45						Human RhoB (3XHA) GCTAGCGTTTAAACTTAAGCTTGGTACCACC ATG TAC CCA TAC GAT GTT CCA GAT TAC GCT TAC CCA TAC GAT GTT CCA GAT TAC GCT TAC CCA TAC GAT GTT CCA GAT TAC GCT GAT GCG GCC ATC CGC AAG AAG CTG GTG GTG GTG GGC GAC GGC GCG TGT GGC AAG ACG TGC CTG CTG ATC G	www.cdna.org	0	0		
977	chr22	51491198	51495849	3500199809	135		51491198	51495849	8421504	2	39,96	0,4555	p	350019980900015004,350019980900015005,350019980900015006	0-45,0-45,0-45						Human RhoB G14V (3XHA) GCTAGCGTTTAAACTTAAGCTTGGTACCACC ATG TAC CCA TAC GAT GTT CCA GAT TAC GCT TAC CCA TAC GAT GTT CCA GAT TAC GCT TAC CCA TAC GAT GTT CCA GAT TAC GCT GAT GCG GCC ATC CGC AAG AAG CTG GTG GTG GTG GGC GAC G T C GCG TGT GGC AAG ACG TGC CTG CT	www.cdna.org	0	0		
977	chr22	51491198	51495759	3500448817	45		51491198	51495759	8421504	2	39,6	0,4555	p	350044881700015004	0-45						Human RhoB T19N (3XHA)	www.cdna.org	0	0		
977	chr22	51499699	51500273	3500444859	69		51499699	51500273	8421504	2	39,30	0,544	p	350044485900015002	3-72						Detection of Rho proteins	Cheng	2006	0		GPX1,RHOA
977	chr22	51500313	51500338	3500121113	25		51500313	51500338	8421504	1	25	0	c	350012111300000005,350012111300000004	0-25,0-25						PROTEIN PRENYLATION INHIBITORS REVEAL A NOVEL ROLE FOR RHOA AND RHOC IN TRAFFICKING OF G PROTEIN- COUPLED RECEPTORS THROUGH RECYCLING ENDOSOMES	artech.gatech.edu	0	0		
977	chr22	51500367	51500417	3500193782	50		51500367	51500417	8421504	1	50	0	c	350019378200000006,350019378200000000	8-58,8-58						CHIMERIC PEPTIDES FOR THE REGULATION OF GTPASES - Patent application	www.faqs.org	0	0		GPX1
977	chr22	51500367	51500417	3500120777	50		51500367	51500417	8421504	1	50	0	c	350012077700000000	8-58					Patent	Chimeric peptides for the regulation of GTPases (Patent US:8242246)	Zheng	2012	0		GPX1
977	chr22	51500367	51500417	3500115295	50		51500367	51500417	8421504	1	50	0	c	350011529500000000	8-58						Chimeric Peptides for the Regulation of GTPases	Zheng	2012	0		GPX1
977	chr22	51500367	51500417	3500113429	50		51500367	51500417	8421504	1	50	0	c	350011342900000000	8-58						Chimeric peptides for the regulation of GTPases	Zheng	2005	0		GPX1
977	chr22	51500367	51500417	3500061717	50		51500367	51500417	8421504	1	50	0	c	350006171700000000	8-58						Chimeric peptides for the regulation of gtpases	Williams	2005	0		GPX1
977	chr22	51500367	51500417	3500027280	50		51500367	51500417	8421504	1	50	0	c	350002728000000001	10-60			10.1111/j.1349-7006.2006.00242.x	1349-7006	Cancer Science	Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cancer cell invasion and metastasis - Kusama - 2006 - Cancer Science - Wiley Online Library	Kusama	2006	0		GPX1
977	chr22	51500478	51500503	3500424651	25		51500478	51500503	8421504	1	25	0	c	350042465100000008	0-25						Virology Journal	www.virologyj.com	0	0		
977	chr22	51502617	51502643	3500442334	24		51502617	51502643	8421504	2	5,19	0,7	c	350044233400000020	4-29						Methods and Compositions For Increasing the Nitrogen Storage Capacity of a Plant - Patent application	www.faqs.org	0	0		
977	chr22	51502617	51502643	3500110279	24		51502617	51502643	8421504	2	5,19	0,7	c	350011027900000020	4-29						Methods For Improving Plant Growth - Patent application	www.faqs.org	0	0		
977	chr22	51502872	51503538	3500186119	396		51502872	51503538	8421504	3	51,150,195	0,312,471	p	350018611900015001,350018611900015002	0-201,0-195						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		
977	chr22	51502872	51503538	3500095373	396		51502872	51503538	8421504	3	51,150,195	0,312,471	p	350009537300015001,350009537300015002	0-201,0-195						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		
977	chr22	51503271	51503295	3500118659	24		51503271	51503295	8421504	1	24	0	c	350011865900000002	0-24						Nonsense-mediated mrna decay - US Patent Application 20060154883 Description	ww.patentstorm.us	0	0		
977	chr22	51503501	51503525	3500340765	24		51503501	51503525	8421504	1	24	0	c	350034076500000009	0-24		21140382	10.1002/etc.423	1552-8618	Environmental Toxicology and Chemistry	The effects of environmental low-dose irradiation on tolerance to chemotherapeutic agents - Howell - 2011 - Environmental Toxicology and Chemistry - Wiley Online Library	Howell	2011	0		
978	chr22	51556578	51556605	3500141274	23		51556578	51556605	8421504	2	9,14	0,13	c	350014127400001263	0-23						 Isoforms Of Human Pregnancy 	www.docstoc.com	0	0		
978	chr22	51605641	51605667	3500386149	23		51605641	51605667	8421504	2	18,5	0,21	c	350038614900000089	4-27						Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon - US Patent 7105333 Description	ww.patentstorm.us	0	0		
978	chr22	51605641	51605667	3500337360	23		51605641	51605667	8421504	2	18,5	0,21	c	350033736000000305	7-30						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
978	chr22	51606583	51606612	3500084495	23		51606583	51606612	8421504	3	12,6,5	0,15,24	c	350008449500000045	8-31						Recombinant plant viral nucleic acids	Dawson	1994	0		
978	chr22	51619088	51619118	3500432629	26		51619088	51619118	8421504	3	5,14,7	0,7,23	g	350043262900000031	16-42						CANINE iPS CELLS AND METHOD OF PRODUCING SAME - Patent application	www.faqs.org	0	0		
978	chr22	51635737	51635907	3500337770	44		51635737	51635907	8421504	3	12,7,25	0,100,145	c	350033777000000030,350033777000000031	0-19,0-25						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
979	chr22	51642504	51645102	3500114630	73		51642504	51645102	8421504	2	47,26	0,2572	c	350011463000000319,350011463000000354	1-48,0-26						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
979	chr22	51661693	51667445	3500127983	146		51661693	51667445	8421504	8	28,25,11,25,2,15,13,27	0,1036,1273,2105,2470,2527,3469,5725	c	350012798300000091,350012798300000181,350012798300000291,350012798300000175,350012798300000114,350012798300000081	0-28,0-26,0-28,0-27,0-28,0-27						Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases	Greene	2011	0		
979	chr22	51662729	51664165	3500286841	63		51662729	51664165	8421504	4	25,11,25,2	0,237,1069,1434	c	350028684100000162,350028684100000263,350028684100000031	0-26,0-28,0-27						INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-TRNA SYNTHETASES - Patent application	www.faqs.org	0	0		
979	chr22	51665203	51665230	3500031500	23		51665203	51665230	8421504	2	9,14	0,13	c	350003150000000344	0-23						Vergleichende Genomanalyse und Evaluation von Stammtypisierungsmethoden	d-nb.info/1022029	0	0		
979	chr22	51679750	51679903	3500318543	153		51679750	51679903	8421504	1	153	0	p	350031854300015061	0-153						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		QRICH1
979	chr22	51712783	51712813	3500125482	30		51712783	51712813	8421504	1	30	0	c	350012548200000000	14-44						Method to identify specific inhibitors of IMP dehydrogenase - Patent # 6153398 - PatentGenius	.patentgenius.com	0	0		IMPDH2
979	chr22	51715088	51715114	3500193635	23		51715088	51715114	8421504	2	10,13	0,13	c	350019363500000287	0-23						Materials and methods for immunocontraception	Harris	1993	0		
979	chr22	51720882	51720905	3500439152	23		51720882	51720905	8421504	1	23	0	c	350043915200000247	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR191
979	chr22	51720882	51720905	3500277393	23		51720882	51720905	8421504	1	23	0	c,g	350027739300000032,350027739300000032	0-23,0-23						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		MIR191
979	chr22	51720882	51720905	3500131061	23		51720882	51720905	8421504	1	23	0	c,g	350013106100000056,350013106100000056	0-23,0-23						MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES - Patent application	www.faqs.org	0	0		MIR191
979	chr22	51721363	51721386	3500252752	23		51721363	51721386	8421504	1	23	0	c,g	350025275200000029,350025275200000029,350025275200000098,350025275200000098	0-23,0-23,0-23,0-23						MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY - Patent application	www.faqs.org	0	0		MIR191
979	chr22	51721363	51721386	3500205806	23		51721363	51721386	8421504	1	23	0	c,g	350020580600000029,350020580600000029	0-23,0-23						MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY	Wang	2010	0		MIR191
979	chr22	51721363	51721386	3500180208	23		51721363	51721386	8421504	1	23	0	c,g	350018020800001527,350018020800001527	0-23,0-23					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		MIR191
979	chr22	51721363	51721386	3500166534	23		51721363	51721386	8421504	1	23	0	c,g	350016653400001527,350016653400001527	0-23,0-23						METHODS FOR QUANTITATING SMALL RNA MOLECULES	Raymond	2007	0		MIR191
979	chr22	51721363	51721386	3500164893	23		51721363	51721386	8421504	1	23	0	c,g	350016489300001527,350016489300001527	0-23,0-23						Methods for quantitating small rna molecules	Raymond	2007	0		MIR191
979	chr22	51721363	51721386	3500114594	23		51721363	51721386	8421504	1	23	0	c,g	350011459400000899,350011459400000899,350011459400000472,350011459400000472	0-23,0-23,0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR191
979	chr22	51721363	51721386	3500031979	23		51721363	51721386	8421504	1	23	0	c,g	350003197900000387,350003197900000387	0-23,0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR191
979	chr22	51750559	51752088	3500121633	180		51750559	51752088	8421504	3	63,84,33	0,282,1496	p	350012163300015117	0-180						48 human secreted proteins	Komatsoulis	2000	0		ARIH2
979	chr22	51750559	51752088	3500063892	180		51750559	51752088	8421504	3	63,84,33	0,282,1496	p	350006389200015117	0-180						48 human secreted proteins	Komatsoulis	2002	0		ARIH2
979	chr22	51753779	51753824	3500466964	45		51753779	51753824	8421504	1	45	0	p	350046696400015002	0-45						Structure of the human Parkin ligase domain in an autoinhibited state	mrc-lmb.cam.ac.uk	0	0		ARIH2
979	chr22	51753836	51755988	3500306083	48		51753836	51755988	8421504	3	14,22,12	0,2028,2140	p	350030608300015022	0-48						Nature June 2 ,2011	www.calameo.com	0	0		ARIH2
980	chr22	51835235	51835262	3500223910	23		51835235	51835262	8421504	2	14,9	0,18	g	350022391000000038	19-47						ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS - Patent application	www.faqs.org	0	0		
980	chr22	51838774	51838843	3500408948	66		51838774	51838843	8421504	2	21,45	0,24	p	350040894800015016	27-93						 Stably Tethered Structures Of Defined Compositions With Multiple Functions Or Binding Specificities 	www.docstoc.com	0	0		
122	chr22	51838780	51908223	3500413096	1185		51838780	51908223	8421504	12	250,36,53,84,107,154,102,24,36,66,142,131	0,26646,40843,43334,48984,51925,58117,59260,59299,65791,68707,69312	p	350041309600015100,350041309600015101	0-810,0-375						Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)	Gilmore	2007	0		
980	chr22	51839020	51865461	3500114912	45		51839020	51865461	8421504	2	10,35	0,26406	p	350011491200015000	0-45						Detection of immunosuppressants	Friedman	1993	0		
981	chr22	51991770	51994575	3500162629	113		51991770	51994575	8421504	3	48,42,23	0,2545,2782	c	350016262900000017,350016262900000026,350016262900000064	0-48,6-48,12-35						Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor	Li	1998	0		
981	chr22	51994315	51994575	3500389612	65		51994315	51994575	8421504	2	42,23	0,237	c	350038961200000026,350038961200000064	6-48,12-35						Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor	Li	1999	0		
981	chr22	52003216	52003243	3500120768	23		52003216	52003243	8421504	2	8,15	0,12	g	350012076800000019	5-36						RESEARCH ARTICLE Open Access	itis-research.com	0	0		
982	chr22	52064514	52064543	3500143098	26		52064514	52064543	8421504	3	13,6,7	0,15,22	c	350014309800000488	17-45						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS - Patent application	www.faqs.org	0	0		
983	chr22	52218197	52218221	3500154402	23		52218197	52218221	8421504	2	11,12	0,12	g	350015440200000015	5-32						MUTATED STRUCTURAL PROTEIN OF A PARVOVIRUS	Lux	2008	0		
983	chr22	52240124	52240152	3500308897	24		52240124	52240152	8421504	3	5,5,14	0,6,14	g	350030889700000901	11-37						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		COL7A1
983	chr22	52247860	52248465	3500319942	40		52247860	52248465	8421504	2	20,20	0,585	g	350031994200000000,350031994200000001	0-20,0-20		22715415	10.1371/journal.pone.0038823		PLoS ONE	A COL7A1 Mutation Causes Dystrophic Epidermolysis Bullosa in Rotes H&#xf6;henvieh Cattle	Annie	2012	0		
983	chr22	52247860	52248465	3500101666	40		52247860	52248465	8421504	2	20,20	0,585	g	350010166600000000,350010166600000001	0-20,0-20		22715415	10.1371/journal.pone.0038823	1932-6203	PLOS ONE	PLOS ONE: A COL7A1 Mutation Causes Dystrophic Epidermolysis Bullosa in Rotes H&#xf6;henvieh Cattle	Menoud	2012	4		
983	chr22	52270490	52270517	3500448448	23		52270490	52270517	8421504	2	6,17	0,10	g	350044844800000017	9-32						Methods Of Treating Anemia Using Recombinant Adeno-associated Virus Virions 	.freshpatents.com	0	0		
122	chr22	52272689	52306424	3500256061	179		52272689	52306424	8421504	3	63,36,80	0,32133,33655	p,c,g	350025606100015003,350025606100000078,350025606100000081	36-99,0-36,0-80						Tesi doctoral: ESTUDI DEL PAPER DE LA FRUCTOSA-2,6-BISFOSFAT I LaENZIM FOSFOFRUCTO-2-QUINASA/FRUC	www.tdx.cat	0	0		
983	chr22	52278244	52278272	3500317439	28		52278244	52278272	8421504	1	28	0	c,g	350031743900000024,350031743900000024	0-28,0-28						Inducible phosphofructokinase and the warburg effect	Bucala	1999	0		
983	chr22	52278244	52278272	3500301745	28		52278244	52278272	8421504	1	28	0	c	350030174500000024	0-28					Patent	Inducible phosphofructokinase and the warburg effect (Patent EP:1042350)	Bucala	2008	0		PFKFB4
983	chr22	52278244	52278272	3500269693	28		52278244	52278272	8421504	1	28	0	c	350026969300000024	0-28						Inducible phosphofructokinase and the warburg effect	Bucala	1999	0		PFKFB4
983	chr22	52278244	52278272	3500261309	28		52278244	52278272	8421504	1	28	0	c	350026130900000024	0-28						Inducible phosphofructokinase and the warburg effect	Bucala	2000	0		PFKFB4
983	chr22	52278244	52278272	3500234031	28		52278244	52278272	8421504	1	28	0	c	350023403100000028	0-28						 Inducible Phosphofructokinase And The Warburg Effect 	www.docstoc.com	0	0		
983	chr22	52278244	52278272	3500115746	28		52278244	52278272	8421504	1	28	0	c	350011574600000016	0-28						Inducible phosphofructokinase and the warburg effect	Bucala	2003	0		PFKFB4
984	chr22	52364307	52412706	3500308897	39		52364307	52412706	8421504	3	15,5,19	0,16,48380	g	350030889700000656,350030889700000410,350030889700001032	21-41,2-21,2-21						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
984	chr22	52387522	52387547	3500267336	23		52387522	52387547	8421504	2	17,6	0,19	c	350026733600000011	12-35						Protein Glycosylation Modification In Methylotrophic Yeast 	.freshpatents.com	0	0		
984	chr22	52402591	52402616	3500440196	23		52402591	52402616	8421504	2	6,17	0,8	c	350044019600000025	0-23						Modified chitin binding domain and uses thereof	Xu	2005	0		
984	chr22	52402591	52402616	3500339139	23		52402591	52402616	8421504	2	6,17	0,8	c	350033913900000025	0-23						Modified chitin binding domain and uses thereof	Colussi	2006	0		
984	chr22	52402591	52402616	3500026566	23		52402591	52402616	8421504	2	6,17	0,8	c	350002656600000025	0-23						Modified chitin binding domain and uses thereof	osdir.com/patents	0	0		
984	chr22	52402591	52402616	3500016392	23		52402591	52402616	8421504	2	6,17	0,8	c	350001639200000025,350001639200000057	0-23,0-23						Modified Chitin Binding Domain And Uses Thereof 	.freshpatents.com	0	0		
984	chr22	52411578	52411695	3500200023	71		52411578	52411695	8421504	2	48,23	0,94	c	350020002300000023,350020002300000081	0-48,25-48						Human gene encoding 3&#x2032;-5&#x2032; exonuclease	Perrino	2000	0		
985	chr22	52551118	52558444	3500196971	531		52551118	52558444	8421504	5	99,54,72,108,198	0,6070,6708,6917,7128	p	350019697100015102,350019697100015095,350019697100015094,350019697100015093,350019697100015092	0-99,0-147,0-96,0-96,0-93						Fowlicidins and Methods of Their Use	Zhang	2006	0		
123	chr22	52551178	52651550	3500465634	1440		52551178	52651550	8421504	40	45,3,42,45,45,45,6,39,30,15,45,45,45,45,6,39,30,15,45,45,45,45,45,45,45,6,39,45,45,45,45,45,45,45,3,42,27,18,45,45	0,48,652,897,1709,6010,6058,6648,6690,6857,6875,7122,7170,12891,12939,13529,13571,13750,13768,13977,14025,44222,44318,64541,64637,64685,65281,65515,65724,90100,91384,92158,92206,98668,98716,99298,99343,99532,99553,100327	p	350046563400015241,350046563400015240,350046563400015239,350046563400015237,350046563400015219,350046563400015218,350046563400015217,350046563400015216,350046563400015210,350046563400015209,350046563400015193,350046563400015192,350046563400015191,350046563400015190,350046563400015188,350046563400015187,350046563400015211,350046563400015196,350046563400015207,350046563400015205,350046563400015204,350046563400015202,350046563400015200,350046563400015234,350046563400015230,350046563400015197,350046563400015184,350046563400015228,350046563400015227,350046563400015226,350046563400015225,350046563400015222	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION - Patent application	www.faqs.org	0	0		
123	chr22	52551178	52565296	3500042040	585		52551178	52565296	8421504	16	45,3,42,45,45,45,45,45,6,39,30,15,45,45,45,45	0,48,652,897,1709,7074,7170,12891,12939,13529,13571,13750,13768,13977,14025,14073	p	350004204000015095,350004204000015094,350004204000015092,350004204000015088,350004204000015090,350004204000015112,350004204000015085,350004204000015084,350004204000015083,350004204000015082,350004204000015080,350004204000015079,350004204000015078	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Antimicrobial Cathelicidin Peptides - Patent application	www.faqs.org	0	0		
123	chr22	52551872	52565347	3500011326	549		52551872	52565347	8421504	6	30,90,51,72,108,198	0,182,12200,12835,13056,13277	p	350001132600015051,350001132600015049,350001132600015025	0-120,0-213,0-216						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa h&#x1ecd;c: Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, fromCoturnix coturnix 	tailieu.vn/doc/ba	0	0		
985	chr22	52551883	52552830	3500013015	43		52551883	52552830	8421504	3	19,2,22	0,171,925	c	350001301500000001,350001301500000000	0-21,0-22		10417180		0019-9567	Infection and Immunity	Purification and Properties of Proline-Rich Antimicrobial Peptides from Sheep and Goat Leukocytes	Shamova	1999	4		
985	chr22	52552105	52552128	3500309144	23		52552105	52552128	8421504	1	23	0	c	350030914400000002	0-23						Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. - ResearchGate	.researchgate.net	0	0		CAMP
986	chr22	52564036	52651529	3500391307	1392		52564036	52651529	8421504	13	87,72,108,198,120,150,72,108,120,96,72,108,81	0,671,892,1113,31436,51683,52423,52639,52860,85765,86440,86674,87412	p	350039130700015040,350039130700015048,350039130700015038,350039130700015047,350039130700015039,350039130700015049	0-465,0-45,0-78,0-75,0-450,0-357						Targeted biocides	Bremel	2005	0		
986	chr22	52564036	52651529	3500294798	1470		52564036	52651529	8421504	14	87,72,108,198,78,150,72,108,120,120,96,72,108,81	0,671,892,1113,31478,51683,52423,52639,52860,79324,85765,86440,86674,87412	p	350029479800015041,350029479800015039,350029479800015040,350029479800015049,350029479800015048,350029479800015050	0-465,0-78,0-450,0-45,0-75,0-357						Targeted biocides	Bremel	2010	0		
986	chr22	52564036	52651529	3500260805	1395		52564036	52651529	8421504	14	87,72,108,123,75,150,72,108,123,120,96,72,108,81	0,671,892,1113,31481,51683,52423,52639,52860,79324,85765,86440,86674,87412	p	350026080500015044,350026080500015041,350026080500015042,350026080500015054,350026080500015053,350026080500015043,350026080500015056,350026080500015055	0-390,0-75,0-453,0-45,0-75,0-75,0-282,0-75						Innate Immune Receptor Directed Biocides	Bremel	2008	0		
986	chr22	52564036	52651529	3500141125	1395		52564036	52651529	8421504	14	87,72,108,123,75,150,72,108,123,120,96,72,108,81	0,671,892,1113,31481,51683,52423,52639,52860,79324,85765,86440,86674,87412	p	350014112500015044,350014112500015041,350014112500015042,350014112500015054,350014112500015043,350014112500015053,350014112500015056,350014112500015055	0-390,0-75,0-453,0-45,0-75,0-75,0-282,0-75						Antimicrobial Peptide Biocides	Bremel	2008	0		
986	chr22	52564036	52651529	3500115576	1344		52564036	52651529	8421504	14	87,72,108,135,63,150,72,108,135,57,96,72,108,81	0,671,892,1113,31493,51683,52423,52639,52860,79324,85765,86440,86674,87412	p	350011557600015044,350011557600015041,350011557600015043,350011557600015056,350011557600015042,350011557600015057,350011557600015059,350011557600015058	0-402,0-63,0-63,0-63,0-465,0-57,0-294,0-63						TARGETED BIOCIDES	Imboden	2009	0		
986	chr22	52564036	52565347	3500397089	465		52564036	52565347	8421504	4	87,72,108,198	0,671,892,1113	p	350039708900015040,350039708900015039	0-387,0-78						Immunoglobulin Directed Biocides	Bremel	2009	0		
986	chr22	52565217	52616528	3500342108	146		52565217	52616528	8421504	5	34,44,7,29,32	0,29678,40937,41253,51279	c,g	350034210800000012,350034210800000058,350034210800000063	0-34,84-237,0-32						Protegrins	Lehrer	1995	0		
986	chr22	52565217	52565251	3500261073	34		52565217	52565251	8421504	1	34	0	g	350026107300000021	0-34					Patent	Immunglobulins reactive with protegrins (Patent US:5708145)	Harwig	1998	0		
986	chr22	52593746	52593794	3500201038	48		52593746	52593794	8421504	1	48	0	p	350020103800015007	0-48						Antibacterial Peptide Protocols Methods in Molecular Biology Vol 78	www.scribd.com	0	0		
986	chr22	52593770	52593842	3500245270	72		52593770	52593842	8421504	1	72	0	p	350024527000015000	3-75						September | 2013 | Online Peptides Guide	rboxylic-acid.com	0	0		
986	chr22	52593822	52593849	3500264194	24		52593822	52593849	8421504	2	11,13	0,14	c	350026419400000000	9-33						PR39, a peptide regulator of angiogenesis	bidmc.harvard.edu	0	0		
986	chr22	52615719	52651649	3500397089	996		52615719	52651649	8421504	8	150,72,108,198,87,72,108,201	0,740,956,1177,34091,34757,34991,35729	p	350039708900015038,350039708900015037,350039708900015054,350039708900015053,350039708900015052,350039708900015051	0-450,0-78,0-234,0-78,0-78,0-78						Immunoglobulin Directed Biocides	Bremel	2009	0		
986	chr22	52615737	52615857	3500415555	120		52615737	52615857	8421504	1	120	0	p	350041555500015037	0-120						ANTIMICROBIAL AGENTS - LYSANDO Holding AG	www.sumobrain.com	0	0		
986	chr22	52615815	52616498	3500397807	90		52615815	52616498	8421504	3	45,6,39	0,48,644	p	350039780700015067,350039780700015066	0-45,0-45						ANTIMICROBIAL THERAPY - Patent application	www.faqs.org	0	0		
986	chr22	52616504	52616995	3500042040	90		52616504	52616995	8421504	3	27,18,45	0,171,446	p	350004204000015093,350004204000015089	0-45,0-45						Antimicrobial Cathelicidin Peptides - Patent application	www.faqs.org	0	0		
986	chr22	52641236	52649885	3500440614	165		52641236	52649885	8421504	2	81,84	0,8565	p	350044061400015024,350044061400015026	0-81,0-84						Combination adjuvant formulation - Patent application	www.faqs.org	0	0		
986	chr22	52641239	52641317	3500124685	78		52641239	52641317	8421504	1	78	0	p	350012468500015001	0-78						Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide	www.jleukbio.org	0	0		
986	chr22	52649764	52649787	3500354860	23		52649764	52649787	8421504	1	23	0	c,g	350035486000000016,350035486000000016	0-23,0-23						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system &#x2018;FocusField2-6GallupqPCRSet-upTool-001&#x2019; to attain consistently high fidelity qPCR reactions	uantification.com	0	0		
986	chr22	52649764	52649787	3500295231	23		52649764	52649787	8421504	1	23	0	c	350029523100000016	0-23						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system &#x2018;FocusField2-6GallupqPCRSet-upTool-001&#x2019; to attain consistently high fidelity qPCR reactions	quantification.de	0	0		
986	chr22	52649764	52649787	3500099621	23		52649764	52649787	8421504	1	23	0	c	350009962100000016	0-23						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet-upTool-001' to attain consistently high fidelity qPCR reactions.	.biomedsearch.com	0	0		
986	chr22	52649801	52649885	3500196971	84		52649801	52649885	8421504	1	84	0	p	350019697100015105	0-84						Fowlicidins and Methods of Their Use	Zhang	2006	0		
986	chr22	52649825	52649878	3500407610	39		52649825	52649878	8421504	2	20,19	0,34	c	350040761000000004,350040761000000007	0-20,6-25		8910461	10.1074/jbc.271.45.28375	0021-9258	Journal of Biological Chemistry	Biological Characterization of Two Novel Cathelicidin-derived Peptides and Identification of Structural Requirements for Their Antimicrobial and Cell Lytic Activities	Skerlavaj	1996	5		
986	chr22	52677231	52677294	3500393400	63		52677231	52677294	8421504	1	63	0	p	350039340000015005	0-63						METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS - Patent application	www.faqs.org	0	0		CDC25A
986	chr22	52677231	52677294	3500321498	63		52677231	52677294	8421504	1	63	0	p	350032149800015005	0-63						Methods and compositions related to wrapping of dehydrons	Bornmann	2008	0		CDC25A
986	chr22	52679950	52682222	3500452754	23		52679950	52682222	8421504	2	3,20	0,2252	c	350045275400000003	0-23		19737974	10.1158/1541-7786.MCR-09-0064	1541-7786	Molecular Cancer Research	Adaptor Protein Crk Induces Src-Dependent Activation of p38 MAPK in Regulation of Synovial Sarcoma Cell Proliferation	Watanabe	2009	4		
987	chr22	52690993	52693291	3500158166	44		52690993	52693291	8421504	2	22,22	0,2276	c,g	350015816600000002,350015816600000002,350015816600000003,350015816600000003	0-22,0-22,0-22,0-22						&#x9ec4;&#x725b;&#x3001;&#x7266;&#x725b;&#x548c;&#x728f;&#x725b;&#x777e;&#x4e38;&#x7ec4;&#x7ec7;&#x4e2d; Cdc2 Cdc25A &#x57fa;&#x56e0;	www.chinagene.cn	0	0		
988	chr22	52875847	52877318	3500121801	69		52875847	52877318	8421504	2	63,6	0,1465	p	350012180100015008	0-69						Distinct regional and subcellular localization of the actin-binding protein filamin A in the mature rat brain. - ResearchGate	.researchgate.net	0	0		MAP4
988	chr22	52889547	52889571	3500342196	24		52889547	52889571	8421504	1	24	0	c	350034219600000038	16-44						Methods and compositions for inhibiting CD14 mediated cell activation	Leturcq	1995	0		
990	chr22	53109548	53109575	3500308897	24		53109548	53109575	8421504	2	19,5	0,22	g	350030889700001235	18-42						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
123	chr22	53155469	53250039	3500131986	39251		53155469	53250039	8421504	17	1244,42,7,2593,23,5030,2365,6728,53,5752,4726,17,174,14,2496,7028,959	0,1245,1354,1488,4139,4163,9194,11560,18338,18686,24471,45247,62299,82101,82272,86582,93611	c,g	350013198600000023,350013198600000021,350013198600000020,350013198600000006,350013198600000051,350013198600000019,350013198600000050,350013198600000050,350013198600000049,350013198600000048,350013198600000017	0-1287,0-2600,0-5047,0-299,0-50,0-9090,0-70,0-70,0-70,0-70,0-22970						SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK - Patent application	www.faqs.org	0	0		
990	chr22	53166396	53166883	3500301078	42		53166396	53166883	8421504	3	13,8,21	0,392,466	c	350030107800000162,350030107800000161	0-21,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
123	chr22	53182753	53248875	3500374480	53		53182753	53248875	8421504	3	6,17,30	0,66005,66092	c	350037448000000001,350037448000000000	0-23,0-30		11358865	10.1101/gad.891301	0890-9369	Genes & Development	SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation	Matsuda	2001	12		SCAP
123	chr22	53182753	53248875	3500293395	53		53182753	53248875	8421504	3	6,17,30	0,66005,66092	c	350029339500000001,350029339500000000	0-23,0-30		11358865	10.1101/gad.891301	0890-9369	Genes & Development	SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation	Matsuda	2001	12		SCAP
123	chr22	53182753	53248875	3500202200	53		53182753	53248875	8421504	3	6,17,30	0,66005,66092	c	350020220000000001,350020220000000000	0-23,0-30			10.1101/gad.891301		Genes & Development	SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation	Morihiro	2001	0		
990	chr22	53187902	53187926	3500310997	24		53187902	53187926	8421504	1	24	0	c	350031099700000075	22-46						ISOLATION AND CHARACTERIZATION OF A NOVEL PYTHIUM OMEGA 3 DESATURASE WITH SPECIFICITY TO ALL OMEGA 6 FATTY ACIDS LONGER THAN 18 CARBON CHAINS - Patent application	www.faqs.org	0	0		
991	chr22	53216492	53219970	3500196971	516		53216492	53219970	8421504	4	180,102,93,141	0,874,2649,3337	p	350019697100015064,350019697100015065,350019697100015066,350019697100015067	0-90,0-96,0-99,0-231						Fowlicidins and Methods of Their Use	Zhang	2006	0		
991	chr22	53248851	53248876	3500220867	25		53248851	53248876	8421504	1	25	0	c,g	350022086700000000,350022086700000000	0-25,0-25						Screening for therapeutic agents being scap antagonists	GRAND-PERRET	2002	0		SCAP
991	chr22	53248851	53248876	3500038217	25		53248851	53248876	8421504	1	25	0	c	350003821700000013,350003821700000000	0-25,0-25						Methods of using SCAP antagonists - Patent # 6673555 - PatentGenius	.patentgenius.com	0	0		SCAP
991	chr22	53248851	53248876	3500034279	25		53248851	53248876	8421504	1	25	0	c	350003427900000000	0-25						Screening for therapeutic agents being scap antagonists	Grand-Perret	2001	0		SCAP
991	chr22	53308625	53308651	3500446401	24		53308625	53308651	8421504	2	12,12	0,14	g	350044640100000073	12-37						Human melanocyte stimulating hormone receptor polypeptide and DNA	Wikberg	1995	0		
994	chr22	53611265	53621012	3500005734	39		53611265	53621012	8421504	4	15,5,14,5	0,16,9727,9742	g	350000573400000071,350000573400000047	0-20,20-39						Apo-2 RECEPTOR	Adams	1998	0		
994	chr22	53679791	53699737	3500405823	511		53679791	53699737	8421504	10	69,42,81,13,62,77,38,48,45,36	0,697,842,971,1605,4034,4990,5260,9186,19910	p,c	350040582300000132,350040582300000131,350040582300000092,350040582300000130,350040582300000129,350040582300015015,350040582300000121,350040582300000018,350040582300000115,350040582300000113,350040582300000011,350040582300000105,350040582300000068	0-48,0-48,0-48,0-44,0-48,0-75,0-48,7-48,0-38,0-48,0-26,0-48,3-47						Parathyroid hormone receptor	www.devileye.net	0	0		
994	chr22	53679815	53700791	3500466700	254		53679815	53700791	8421504	8	45,3,53,8,36,79,3,27	0,673,5255,9199,19886,19924,20006,20949	c	350046670000000129,350046670000000011,350046670000000112,350046670000000068,350046670000000067	0-48,0-26,0-48,3-47,0-109						US Patent # 5,494,806. DNA and vectors encoding the parathyroid hormone receptor, transformed cells, and recombinant production of PTHR proteins and peptides - Patents.com	www.patents.com	0	0		
994	chr22	53679829	53679853	3500042604	24		53679829	53679853	8421504	1	24	0	c	350004260400000002	21-45						Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin.	.biomedsearch.com	0	0		PTH1R
994	chr22	53680497	53699808	3500337822	92		53680497	53699808	8421504	4	24,26,20,22	0,3385,4286,19289	c,g	350033782200000010,350033782200000010,350033782200000003,350033782200000006,350033782200000008,350033782200000008,350033782200000007,350033782200000007	0-20,0-20,0-23,0-26,0-20,0-20,0-22,0-22						Expression of PTHrP and the PTH/PTHrP receptor in growing red deer antler	PM	2004	0		
994	chr22	53680497	53680521	3500017446	24		53680497	53680521	8421504	1	24	0	c	350001744600000009	0-24						Methods and compositions for enhancing cartilage repair	Gazit	2002	0		
994	chr22	53680723	53681461	3500114931	111		53680723	53681461	8421504	3	52,5,54	0,673,684	p	350011493100015145,350011493100015144	0-57,0-54						Compounds with pth activity and recombinant dna vectors encoding same	Oldenburg	1996	0		PTH1R
994	chr22	53680756	53685018	3500188761	144		53680756	53685018	8421504	5	19,29,48,42,6	0,640,1042,4030,4256	p	350018876100015092,350018876100015086,350018876100015105	0-48,0-48,0-48						G-protein parathyroid hormone receptor HLTDG74	www.devileye.net	0	0		PTH1R
994	chr22	53680770	53683812	3500202548	74		53680770	53683812	8421504	5	5,22,7,13,27	0,626,1070,1415,3015	c	350020254800000002,350020254800000009,350020254800000003	0-27,0-20,0-27			10.1359/jbmr.1999.14.8.1345	1523-4681	Journal of Bone and Mineral Research	Further Characterization of Cells Expressing STRO-1 in Cultures of Adult Human Bone Marrow Stromal Cells - Stewart - 1999 - Journal of Bone and Mineral Research - Wiley Online Library	Stewart	1999	0		
994	chr22	53681804	53684828	3500202865	155		53681804	53684828	8421504	6	43,2,7,22,45,36	0,381,435,1969,2072,2988	c	350020286500000067,350020286500000157,350020286500000125,350020286500000148,350020286500000090,350020286500000001	0-45,0-29,0-45,12-48,12-42,9-39						Nucleic acids encoding PTH functional domain conjugate peptides - Patent # 7244834 - PatentGenius	.patentgenius.com	0	0		
994	chr22	53683661	53683687	3500145423	23		53683661	53683687	8421504	2	8,15	0,11	g	350014542300000019,350014542300000012	0-21,0-21						Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use	Sala-schaeffer	2007	0		
994	chr22	53684810	53689019	3500298113	41		53684810	53689019	8421504	3	18,3,20	0,202,4189	c,g	350029811300000031,350029811300000011,350029811300000030,350029811300000030,350029811300000010,350029811300000010	0-21,0-21,0-20,0-20,0-20,0-20						Method for preparing an organ for transplantation - Patent application	www.faqs.org	0	0		PTH1R
994	chr22	53699701	53699776	3500117439	75		53699701	53699776	8421504	1	75	0	p	350011743900015006	0-75						METHOD TO IDENTIFY LIGANDS FOR SIGMA-1 RECEPTORS - LABORATORIOS DEL DR. ESTEVE, S.A.	www.sumobrain.com	0	0		PTH1R
995	chr22	53817920	53817945	3500328917	25		53817920	53817945	8421504	1	25	0	c	350032891700000318	21-46						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
996	chr22	53957407	53957517	3500157219	42		53957407	53957517	8421504	2	21,21	0,89	c,g	350015721900000018,350015721900000018,350015721900000017,350015721900000017	0-21,0-21,0-21,0-21		18239051	10.1530/REP-07-0415	1470-1626	Reproduction	Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle	Mitko	2008	3		
996	chr22	53959386	53959491	3500159119	26		53959386	53959491	8421504	2	23,3	0,102	c	350015911900000018	0-26						Genes That Are Up- Or Down-regulated During Differentiation Of Human Embryonic Stem Cells 	.freshpatents.com	0	0		TDGF1
996	chr22	53959386	53959491	3500140581	26		53959386	53959491	8421504	2	23,3	0,102	c	350014058100000009	0-26			10.1002/dvdy.10430	1097-0177	Developmental Dynamics	Long-term culture of human embryonic stem cells in feeder-free conditions - Rosler - 2003 - Developmental Dynamics - Wiley Online Library	Rosler	2004	0		
996	chr22	53959386	53959491	3500014278	26		53959386	53959491	8421504	2	23,3	0,102	c	350001427800000005	0-26			10.1002/dvdy.10431	1097-0177	Developmental Dynamics	Properties of four human embryonic stem cell lines maintained in a feeder-free culture system - Carpenter - 2003 - Developmental Dynamics - Wiley Online Library	Carpenter	2004	0		
996	chr22	53990045	53990074	3500265508	23		53990045	53990074	8421504	3	11,5,7	0,12,22	g	350026550800000049	19-42						Polynucleotides and Uses Thereof	Bembridge	2010	0		
997	chr22	54024741	54024767	3500432195	23		54024741	54024767	8421504	2	17,6	0,20	c	350043219500000339,350043219500000305	4-27,26-48						 Compositions For Use In Recombinational Cloning Of Nucleic Acids 	www.docstoc.com	0	0		
997	chr22	54024741	54024767	3500284139	23		54024741	54024767	8421504	2	17,6	0,20	c	350028413900000345	4-27						Compositions for use in recombinational cloning of nucleic acids - US Patent 7670823 Description	ww.patentstorm.us	0	0		
997	chr22	54056176	54057208	3500042430	849		54056176	54057208	8421504	7	110,8,114,105,66,418,28	0,111,208,366,472,585,1004	c,g	350004243000000012,350004243000000016,350004243000000015,350004243000000025,350004243000000024,350004243000000028,350004243000000027,350004243000000033,350004243000000036,350004243000000039,350004243000000045,350004243000000048,350004243000000049,350004243000000052,350004243000000051,350004243000000054,350004243000000057,350004243000000061,350004243000000060,350004243000000063,350004243000000001,350004243000000065,350004243000000002	0-59,0-50,0-59,0-60,0-60,0-52,0-54,0-53,0-58,0-60,0-59,0-58,7-58,0-59,0-59,0-60,0-59,0-60,0-60,0-59,0-23,0-32,0-25						 <HTML> <TITLE>aa ieuee!1/4iie31/4iii i$?i e+-, iii(c)ee$?.aa </TITLE> <	www.ksast.org	0	0		
997	chr22	54056759	54090250	3500164847	2148		54056759	54090250	8421504	18	6,49,164,109,183,148,56,179,175,155,91,48,156,142,68,185,190,44	0,400,4191,7331,7736,8535,9626,15029,15635,16335,18446,20763,21434,23498,28398,30386,31701,33447	p,c,g	350016484700000003,350016484700000002,350016484700015002,350016484700015007,350016484700000001,350016484700000001,350016484700015009,350016484700015014,350016484700015020,350016484700015021,350016484700015023,350016484700015025,350016484700015026,350016484700015027,350016484700015029,350016484700015030,350016484700015031,350016484700015032,350016484700015033,350016484700015035,350016484700015036,350016484700015037,350016484700015038,350016484700015039	0-306,0-2141,0-48,0-48,0-20,0-20,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48						Sequences, transgenic products and processes thereof	ANISHA	2012	0		
997	chr22	54057044	54057150	3500425625	42		54057044	54057150	8421504	2	20,22	0,84	c,g	350042562500000004,350042562500000004,350042562500000005	0-20,0-20,0-22						Single nucleotide polymorphisms in immunity-related genes and their association with mastitis in Chilean dairy cattle. - ResearchGate	.researchgate.net	0	0		
997	chr22	54057095	54085219	3500286336	60		54057095	54085219	8421504	3	20,20,20	0,23206,28104	c,g	350028633600000000,350028633600000000,350028633600000003,350028633600000004	0-20,0-20,0-20,0-20						Two splice variants of the bovine lactoferrin gene identified in Staphylococcus aureus isolated from mastitis in dairy cattle	w.funpecrp.com.br	0	0		
997	chr22	54057132	54090420	3500438103	2338		54057132	54090420	8421504	18	76,156,7,109,183,148,56,179,175,155,91,48,156,142,68,185,190,214	0,3818,3975,6958,7363,8162,9253,14656,15262,15962,18073,20390,21061,23125,28025,30013,31328,33074	p,c	350043810300000012,350043810300015046,350043810300015047,350043810300015048,350043810300015049,350043810300015051,350043810300015052,350043810300015053,350043810300015054,350043810300015056,350043810300015057,350043810300015058,350043810300015059,350043810300015061,350043810300015062,350043810300015063,350043810300015066,350043810300015067,350043810300015068,350043810300015069,350043810300015071,350043810300015072,350043810300015073,350043810300015074,350043810300015076,350043810300015077,350043810300015078,350043810300015079,350043810300015081,350043810300015082,350043810300015083,350043810300015084,350043810300015086,350043810300015087,350043810300015088,350043810300015089	3-2343,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms	Conneely	2000	0		
997	chr22	54057157	54090242	3500284606	80		54057157	54090242	8421504	4	5,25,25,25	0,6,31321,33060	c,g	350028460600000029,350028460600000033,350028460600000032,350028460600000032,350028460600000030	10-40,13-38,10-35,10-35,14-37						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Identification of a Lactoferrin-derived Peptide Possessing Binding Activity to Hepatitis C Virus E2 Envelope Protein*	www.jbc.org	0	0		
997	chr22	54057164	54090241	3500332387	78		54057164	54090241	8421504	4	19,19,19,21	0,16024,21150,33056	c,g	350033238700000000,350033238700000009,350033238700000012,350033238700000012,350033238700000003,350033238700000003	9-28,9-28,9-28,9-28,10-31,10-31		11279204	10.1074/jbc.M101459200	0021-9258	Journal of Biological Chemistry	Inhibitory Effect of Bovine Milk Lactoferrin on the Interaction between a Streptococcal Surface Protein Antigen and Human Salivary Agglutinin	Mitoma	2001	5		
997	chr22	54057204	54064116	3500428460	153		54057204	54064116	8421504	5	4,76,41,6,26	0,3746,3862,3904,6886	c,g	350042846000000009,350042846000000011,350042846000000015,350042846000000018	0-41,0-39,0-41,0-32						Mass production method of lactoferrin polypeptide from yeast and useful microorganism thereof	Hong	2000	0		
997	chr22	54057204	54064116	3500325965	112		54057204	54064116	8421504	4	4,76,6,26	0,3746,3904,6886	c	350032596500000009,350032596500000011,350032596500000018	0-41,0-39,0-32						Mass production method of lactoferrin polypeptide from yeast and useful microorganism thereof	Hong	2000	0		
997	chr22	54060964	54090239	3500021434	49		54060964	54090239	8421504	2	24,25	0,29250	c,g	350002143400000001,350002143400000001,350002143400000002	0-24,0-24,8-33						JFS Vol 72 Is 02 MAR 2007 pp M067-M071 EXPRESSION AND PURIFICATION OF GOAT LACTOFERRIN FROM Pichia pastoris EXPRESSION SYSTEM.pdf	www.scribd.com	0	0		
997	chr22	54060964	54061108	3500151355	144		54060964	54061108	8421504	1	144	0	p	350015135500015005,350015135500015006,350015135500015007	0-48,0-48,0-48						Useful properties of human lactoferrin and variants thereof	Nuijens	1998	0		
997	chr22	54060979	54064542	3500135112	285		54060979	54064542	8421504	4	75,54,109,47	0,81,3111,3516	p	350013511200015224,350013511200015225	0-75,0-210						&#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x57f9;&#x8bad;&#x6559;&#x6750;	ibi.cqupt.edu.cn	0	0		
997	chr22	54061012	54061087	3500460529	75		54061012	54061087	8421504	1	75	0	p	350046052900015000	0-75						&#x4e3b;&#x9898;&#xff1a;Endothelial | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
997	chr22	54061012	54061087	3500397089	75		54061012	54061087	8421504	1	75	0	p	350039708900015022	0-75						Immunoglobulin Directed Biocides	Bremel	2009	0		
997	chr22	54061012	54061087	3500391307	75		54061012	54061087	8421504	1	75	0	p	350039130700015022	0-75						Targeted biocides	Bremel	2005	0		
997	chr22	54061012	54061087	3500294798	75		54061012	54061087	8421504	1	75	0	p	350029479800015023	0-75						Targeted biocides	Bremel	2010	0		
997	chr22	54061012	54061087	3500260805	75		54061012	54061087	8421504	1	75	0	p	350026080500015023	0-75						Innate Immune Receptor Directed Biocides	Bremel	2008	0		
997	chr22	54061012	54061087	3500179396	75		54061012	54061087	8421504	1	75	0	p	350017939600015001	0-75						&#x4e3b;&#x9898;&#xff1a;Angiogenesis | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
997	chr22	54061012	54061087	3500173658	75		54061012	54061087	8421504	1	75	0	p	350017365800015001	0-75						&#x4e3b;&#x9898;&#xff1a;angiogenesis | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
997	chr22	54061012	54061087	3500141125	75		54061012	54061087	8421504	1	75	0	p	350014112500015023	0-75						Antimicrobial Peptide Biocides	Bremel	2008	0		
997	chr22	54061012	54061075	3500115576	63		54061012	54061075	8421504	1	63	0	p	350011557600015022	0-63						TARGETED BIOCIDES	Imboden	2009	0		
997	chr22	54065305	54065329	3500197130	24		54065305	54065329	8421504	1	24	0	c	350019713000000013	0-24						Production of recombinant human lactoferrin	Conneely	1994	0		
997	chr22	54066453	54080437	3500343285	42		54066453	54080437	8421504	2	21,21	0,13963	g	350034328500000001,350034328500000005	0-21,0-21						SEQUENCE CHARACTERIZATION AND POLYMORPHISM DETECTION IN EXONS 6, 7 AND 13 OF THE BUBALINE LACTOFERRIN GENE	ibic.lib.ku.ac.th	0	0		
997	chr22	54072549	54073097	3500459826	23		54072549	54073097	8421504	2	20,3	0,545	c	350045982600000004	21-44						Changes in the Endometrial Transcriptome During the Bovine Estrous Cycle: Effect of Low Circulating Progesterone and Consequences for Conceptus Elongation	ww.biolreprod.org	0	0		
997	chr22	54075269	54088563	3500345230	66		54075269	54088563	8421504	2	23,43	0,13251	c	350034523000000048,350034523000000110,350034523000000063	25-48,0-43,0-40						Transgenic bovines and milk from transgenic bovines	Deboer	1995	0		
997	chr22	54078276	54088563	3500428753	109		54078276	54088563	8421504	4	42,11,13,43	0,2112,6881,10244	c	350042875300000036,350042875300000040,350042875300000047	0-42,12-36,0-43						 Cloning, Expression, And Uses Of Human Lactoferrin 	www.docstoc.com	0	0		
997	chr22	54078276	54078318	3500105240	42		54078276	54078318	8421504	1	42	0	c	350010524000000035	0-42						 Human Lactoferrin 	www.docstoc.com	0	0		
997	chr22	54078276	54078318	3500093048	42		54078276	54078318	8421504	1	42	0	c	350009304800000035	0-42						Human lactoferrin	Kruzel	2001	0		
997	chr22	54088539	54088562	3500440229	23		54088539	54088562	8421504	1	23	0	c	350044022900000000,350044022900000007	0-23,0-23						Recombinant lactoferrin, methods of production from plants and uses	Legrand	2000	0		
997	chr22	54088539	54088562	3500342237	23		54088539	54088562	8421504	1	23	0	c	350034223700000000	0-23						Recombinant lactoferrins, methods of production from plants and uses thereof	Legrand	2003	0		
997	chr22	54088539	54088562	3500235517	23		54088539	54088562	8421504	1	23	0	c	350023551700000000	0-23					Patent	Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations (Patent EP:0981617)	Bournat	2008	0		
997	chr22	54088539	54088562	3500033102	23		54088539	54088562	8421504	1	23	0	c	350003310200000000	0-23						Recombinant lactoferrins, methods of production from plants and uses thereof	Bournat	2003	0		
997	chr22	54097567	54097596	3500308897	24		54097567	54097596	8421504	2	9,15	0,14	g	350030889700001229	17-45						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
997	chr22	54102624	54102654	3500371735	30		54102624	54102654	8421504	1	30	0	c	350037173500000162	18-48						MAMMALIAN CHEMOKINE REAGENTS - Patent application	www.faqs.org	0	0		
997	chr22	54102954	54102977	3500033154	23		54102954	54102977	8421504	1	23	0	c	350003315400000024	10-33						Gpcrs as angiogenesis targets	Leung	2008	0		
998	chr22	54133589	54133613	3500316167	23		54133589	54133613	8421504	2	6,17	0,7	c	350031616700000011	25-48						en 1998	tionscanada.gc.ca	0	0		
998	chr22	54133884	54133907	3500352650	23		54133884	54133907	8421504	1	23	0	c	350035265000000403,350035265000000404	20-43,20-43						Dna Diagnostics Based On Mass Spectrometry 	.freshpatents.com	0	0		
998	chr22	54133884	54133907	3500128303	23		54133884	54133907	8421504	1	23	0	c	350012830300000362,350012830300000361	20-43,20-43						 DNA Diagnostics Based On Mass Spectrometry 	www.docstoc.com	0	0		
998	chr22	54133884	54133907	3500037197	23		54133884	54133907	8421504	1	23	0	c	350003719700000005	23-46		19380826	10.4049/jimmunol.0803013	0022-1767	The Journal of Immunology	Amyloid &#x03b2; Interaction with Receptor for Advanced Glycation End Products Up-Regulates Brain Endothelial CCR5 Expression and Promotes T Cells Crossing the Blood-Brain Barrier	Li	2009	6		
998	chr22	54133911	54133939	3500086122	28		54133911	54133939	8421504	1	28	0	c	350008612200000008	0-28						HIV coreceptor mutants	Landau	1997	0		
998	chr22	54133911	54133939	3500024187	28		54133911	54133939	8421504	1	28	0	c	350002418700000004	0-28						Hiv coreceptor mutants	Koup	1998	0		
998	chr22	54133911	54133936	3500202522	25		54133911	54133936	8421504	1	25	0	g	350020252200000007,350020252200000005	0-25,0-25			10.1128/CDLI.8.5.965-971.2001		Clinical and Diagnostic Laboratory Immunology	Chemokine Receptor CCR5 &#x0394;32 Genetic Analysis Using Multiple Specimen Types and the NucliSens Basic Kit	Suryakumari	2001	0		
998	chr22	54134075	54148478	3500086674	159		54134075	54148478	8421504	5	48,26,42,20,23	0,13695,13749,14260,14380	c	350008667400000014,350008667400000023,350008667400000022,350008667400000011,350008667400000009	0-48,22-48,0-42,27-47,0-23						Human g-protein chemokine receptor hdgnr10	Li	1996	0		
998	chr22	54134075	54148355	3500281438	65		54134075	54148355	8421504	2	45,20	0,14260	c	350028143800000014,350028143800000011	0-45,27-47						Human G-protein chemokine receptor (CCR5) HDGNR10 - Patent # 7160546 - PatentGenius	.patentgenius.com	0	0		
998	chr22	54134075	54147796	3500001653	74		54134075	54147796	8421504	2	48,26	0,13695	c	350000165300000014,350000165300000023	0-48,22-48						Human G-Protein chemokine receptor HDGNR10 (CCR5 receptor)	Li	1998	0		
998	chr22	54134115	54134159	3500173819	44		54134115	54134159	8421504	1	44	0	g	350017381900000033	0-44						MCP-1 receptor antibodies - Patent # 7105641 - PatentGenius	.patentgenius.com	0	0		
998	chr22	54134119	54134142	3500191686	23		54134119	54134142	8421504	1	23	0	g	350019168600000003	0-23		22952771	10.1371/journal.pone.0043815	1932-6203	PLOS ONE	PLOS ONE: Breast Milk from Tanzanian Women Has Divergent Effects on Cell-Free and Cell-Associated HIV-1 Infection In Vitro	Lyimo	2012	4		
998	chr22	54136254	54136278	3500205064	24		54136254	54136278	8421504	1	24	0	c	350020506400000031	0-24						Screening For Disease Susceptibility By Genotyping The Ccr5 And Ccr2 Genes 	.freshpatents.com	0	0		
998	chr22	54136254	54136278	3500012762	24		54136254	54136278	8421504	1	24	0	c	350001276200000031	0-24						Screening for disease susceptibility by genotyping the CCR5 and CCR2 genes	Ahuja	2008	0		
998	chr22	54239221	54239784	3500219356	104		54239221	54239784	8421504	3	21,48,35	0,336,528	p,c	350021935600000075,350021935600015050,350021935600000064	27-48,0-48,13-48						US Patent # 6,512,103. Mammalian chemokine reagents - Patents.com	www.patents.com	0	0		
998	chr22	54239221	54239784	3500164721	56		54239221	54239784	8421504	2	21,35	0,528	c	350016472100000076,350016472100000065	27-48,13-48						Mammalian chemokine ccf8 and chemokine receptor cckr3	Dairaghi	1997	0		
998	chr22	54239557	54239605	3500337883	48		54239557	54239605	8421504	1	48	0	p	350033788300015073	0-48						US Patent # 6,265,184. Polynucleotides encoding chemokine receptor 88C - Patents.com	www.patents.com	0	0		CCR1
998	chr22	54239752	54239781	3500281438	29		54239752	54239781	8421504	1	29	0	c	350028143800000010	16-45						Human G-protein chemokine receptor (CCR5) HDGNR10 - Patent # 7160546 - PatentGenius	.patentgenius.com	0	0		
998	chr22	54239752	54239781	3500001653	29		54239752	54239781	8421504	1	29	0	c	350000165300000010	19-48						Human G-Protein chemokine receptor HDGNR10 (CCR5 receptor)	Li	1998	0		
999	chr22	54307490	54307514	3500196470	23		54307490	54307514	8421504	2	14,9	0,15	c	350019647000000219	6-29						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
999	chr22	54332737	54332763	3500344311	26		54332737	54332763	8421504	1	26	0	c	350034431100000021	0-26						Immune Regulation in Mouse Models of Allergic Asthma	works.unsw.edu.au	0	0		CCR2
999	chr22	54333385	54333409	3500322635	24		54333385	54333409	8421504	1	24	0	c	350032263500000022	11-35						Antibodies to ccr2	A*La Ji Pa Er 	2011	0		
999	chr22	54333385	54333409	3500135720	24		54333385	54333409	8421504	1	24	0	c	350013572000000017,350013572000000090	11-35,11-35						ANTIBODIES TO CCR2 - Patent application	www.faqs.org	0	0		
999	chr22	54333385	54333409	3500101886	24		54333385	54333409	8421504	1	24	0	c	350010188600000011	11-35						Antibodies to ccr2	Gladue	2010	0		
1000	chr22	54423014	54423641	3500413440	40		54423014	54423641	8421504	2	20,20	0,607	c,g	350041344000000040,350041344000000040,350041344000000013,350041344000000041,350041344000000041	0-20,0-20,20-40,0-20,0-20						Embryo Implantation Inhibitor 	.freshpatents.com	0	0		
1001	chr22	54548218	54548243	3500358504	24		54548218	54548243	8421504	2	9,15	0,10	g	350035850400000106	0-46						Inducible herbicide resistance	Ryals	1997	0		
1001	chr22	54638665	54639586	3500212883	43		54638665	54639586	8421504	2	19,24	0,897	c	350021288300000021,350021288300000019	0-19,0-24						&#x4e3b;&#x9898;&#xff1a;transporter | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1002	chr22	54679813	54712476	3500191742	42		54679813	54712476	8421504	2	22,20	0,32643	c,g	350019174200000005,350019174200000000,350019174200000001	9-31,9-29,9-29		18299350	10.1083/jcb.200708109	0021-9525	The Journal of Cell Biology	Integration of Golgi trafficking and growth factor signaling by the lipid phosphatase SAC1	Blagoveshchenskaya	2008	10		
1002	chr22	54679813	54679837	3500357670	24		54679813	54679837	8421504	1	24	0	c	350035767000000009	10-34		18480408	10.1091/mbc.E07-12-1290	1059-1524	Molecular Biology of the Cell	The Sac1 Phosphoinositide Phosphatase Regulates Golgi Membrane Morphology and Mitotic Spindle Organization in Mammals	Liu	2008	5		
1003	chr22	54865184	54865209	3500113832	23		54865184	54865209	8421504	2	11,12	0,13	c	350011383200000019	8-35						TD-BM_2012	fr.scribd.com	0	0		
1004	chr22	54986376	54986404	3500140455	24		54986376	54986404	8421504	2	6,18	0,10	g	350014045500000082	1-25						TOOLS TO MEASURE SUSTAINABLE FORESTRY: ORGANELLE MARKERS IN CONIFERS FINAL REPORT - YEAR 1 (2002/3)	www.for.gov.bc.ca	0	0		
1004	chr22	55010838	55010862	3500441150	23		55010838	55010862	8421504	2	18,5	0,19	g	350044115000000003	2-25						Alpha-Amylase Variant With Altered Properties	Andersen	2008	0		
1004	chr22	55010838	55010862	3500013797	23		55010838	55010862	8421504	2	18,5	0,19	g	350001379700000006	2-25						Alpha-amylase Variant With Altered Properties 	.freshpatents.com	0	0		
1006	chr22	55294187	55297776	3500256587	140		55294187	55297776	8421504	4	26,21,8,85	0,89,347,3504	p,c,g	350025658700000072,350025658700000019,350025658700000097,350025658700015007	7-33,22-41,20-41,0-93						Polypeptides that bind Trail-R1 and Trail-R2	Bowdish	2010	0		
1006	chr22	55294187	55297776	3500198756	145		55294187	55297776	8421504	4	31,21,8,85	0,89,347,3504	p,c,g	350019875600000067,350019875600000032,350019875600000124,350019875600015012	13-50,22-41,20-41,0-93						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Le	2010	0		
1006	chr22	55294187	55297776	3500117727	145		55294187	55297776	8421504	4	31,21,8,85	0,89,347,3504	p,c,g	350011772700000067,350011772700000032,350011772700000032,350011772700000124,350011772700015010	13-50,22-41,22-41,20-41,0-93						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Holtet	2011	0		
1006	chr22	55294187	55294540	3500404999	37		55294187	55294540	8421504	2	31,6	0,347	g	350040499900000026	13-50						COMBINATORIAL LIBRARIES BASED ON C-TYPE LECTIN DOMAIN - ANPHORE, INC	www.sumobrain.com	0	0		
1006	chr22	55294187	55294540	3500241764	58		55294187	55294540	8421504	3	31,21,6	0,89,347	c,g	350024176400000060,350024176400000025,350024176400000117	13-50,22-41,20-41						Combinatorial Libraries Based on C-type Lectin-like Domain - Patent application	www.faqs.org	0	0		
1006	chr22	55294187	55294297	3500131005	47		55294187	55294297	8421504	2	26,21	0,89	c,g	350013100500000072,350013100500000121,350013100500000019,350013100500000097	7-33,22-41,22-41,20-41						Polypeptides that bind Trail-R1 and Trail-R2 - Patent application	www.faqs.org	0	0		
1006	chr22	55294190	55297776	3500095845	133		55294190	55297776	8421504	4	19,21,8,85	0,86,344,3501	p,c,g	350009584500000019,350009584500000019,350009584500000097,350009584500000097,350009584500015006	22-41,22-41,20-41,20-41,0-93						Polypeptides that Bind TRAIL-R1 and TRAIL-R2	Bowdish	2012	0		
1006	chr22	55294269	55297741	3500274071	85		55294269	55297741	8421504	3	29,28,28	0,35,3444	c,g	350027407100000281,350027407100000282,350027407100000352,350027407100000352,350027407100000275,350027407100000158,350027407100000295,350027407100000184,350027407100000184	1-30,17-46,18-37,18-37,0-26,1-29,1-29,17-45,17-45					Patent	Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains (Patent CN:100580084)	H*C*Se Ge Sen 	2010	0		
1006	chr22	55294274	55299830	3500266714	110		55294274	55299830	8421504	4	56,31,9,14	0,3436,3507,5542	c,g	350026671400000111,350026671400000203,350026671400000203,350026671400000214,350026671400000159,350026671400000080	0-47,12-31,12-31,0-26,17-48,5-28						Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains	M*Yi Ze Luo De Te 	2004	0		
1007	chr22	55370551	55370574	3500165384	23		55370551	55370574	8421504	1	23	0	c	350016538400000518	7-30						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		ZDHHC3
1007	chr22	55374936	55374966	3500179145	25		55374936	55374966	8421504	2	9,16	0,14	g	350017914500000175,350017914500000025	6-31,6-31						ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION - Patent application	www.faqs.org	0	0		
1007	chr22	55376576	55376669	3500043960	90		55376576	55376669	8421504	2	45,45	0,48	p	350004396000015009,350004396000015011	0-45,0-45						ALTERED ZDHHC8 EXPRESSION AS A MARKER OF INCREASED RISK OF SCHIZOPHRENIA - Patent application	www.faqs.org	0	0		ZDHHC7
1008	chr22	55448116	55451398	3500312701	96		55448116	55451398	8421504	2	48,48	0,3234	c	350031270100000065,350031270100000061	0-48,0-48						Novel peptides	Han Chuan Xian Zhi 	2002	0		
1008	chr22	55448116	55451398	3500067996	144		55448116	55451398	8421504	3	48,42,54	0,2984,3228	p,c	350006799600000063,350006799600000060,350006799600015148,350006799600000059	0-48,0-48,0-45,0-48						MODIFIED GHERLIN PEPTIDES - Patent application	www.faqs.org	0	0		
1008	chr22	55448116	55448188	3500230738	72		55448116	55448188	8421504	1	72	0	p	350023073800015008,350023073800015006,350023073800015007,350023073800015009	0-72,0-72,0-69,0-66						Mammalian obestatin receptors	Hsueh	2007	0		
1008	chr22	55451100	55451374	3500402185	72		55451100	55451374	8421504	2	42,30	0,244	p	350040218500015007,350040218500015008	0-72,0-72						Method for producing a modified peptide	Minamitake	2005	0		
1008	chr22	55451100	55451374	3500385616	72		55451100	55451374	8421504	2	42,30	0,244	p	350038561600015012,350038561600015013	0-72,0-72						SPINAL NERVE REPAIR PROMOTING THERAPEUTICS CONTAINING GHRELIN OR ITS DERIVATIVES OR SUBSTANCES THAT ACT ON GHS-R1a AS AN ACTIVE INGREDIENT	Hashimoto	2010	0		
1008	chr22	55451100	55451374	3500372907	72		55451100	55451374	8421504	2	42,30	0,244	p	350037290700015011,350037290700015012	0-72,0-72						THERAPEUTIC AGENT FOR SKIN OR SKIN REPAIR-PROMOTING AGENT COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT	Hayashi	2008	0		
1008	chr22	55451100	55451374	3500337201	72		55451100	55451374	8421504	2	42,30	0,244	p	350033720100015007,350033720100015008	0-72,0-72						Promoter of Regeneration of Pancreatic B Cell, and Promoter of Insulin Production in Pancreatic B Cell - Patent application	www.faqs.org	0	0		
1008	chr22	55451100	55451374	3500297140	72		55451100	55451374	8421504	2	42,30	0,244	p	350029714000015007,350029714000015006	0-72,0-72					Patent	&#x80f0;&#x817a;&#x03b2;&#x7ec6;&#x80de;&#x518d;&#x751f;&#x7684;&#x4fc3;&#x8fdb;&#x5242;&#x4ee5;&#x53ca;&#x5728;&#x80f0;&#x817a;&#x03b2;&#x7ec6;&#x80de;&#x4e2d;&#x751f;&#x4ea7;&#x80f0;&#x5c9b;&#x7d20;&#x7684;&#x4fc3;&#x8fdb;&#x5242; (Patent CN:101128213)	Han Chuan Xian Zhi 	2013	0		
1008	chr22	55451100	55451374	3500271414	72		55451100	55451374	8421504	2	42,30	0,244	p	350027141400015008,350027141400015007	0-72,0-72						Promoter of Regeneration of Pancreatic B Cell, and Promoter of Insulin Production in Pancreatic B Cell	Akamizu	2009	0		
1008	chr22	55451100	55451374	3500266801	72		55451100	55451374	8421504	2	42,30	0,244	p	350026680100015012,350026680100015014	0-72,0-72					Patent	Process for producing modified peptide (Patent CN:100491395)	Nan Zhu Yi Chun 	2009	0		
1008	chr22	55451100	55451374	3500265679	72		55451100	55451374	8421504	2	42,30	0,244	p	350026567900015015,350026567900015013	0-72,0-72						Process for producing modified peptide	Nan Zhu Yi Chun 	2005	0		
1008	chr22	55451100	55451374	3500250642	72		55451100	55451374	8421504	2	42,30	0,244	p	350025064200015007,350025064200015008	0-72,0-72					Patent	Method for treatment of hyperglycemia in a subject in need thereof (Patent US:7803768)	Akamizu	2010	0		
1008	chr22	55451100	55451374	3500247177	72		55451100	55451374	8421504	2	42,30	0,244	p	350024717700015014,350024717700015012	0-72,0-72					Patent	&#x80f0;&#x817a;&#x03b2;&#x7ec6;&#x80de;&#x518d;&#x751f;&#x7684;&#x4fc3;&#x8fdb;&#x5242;&#x4ee5;&#x53ca;&#x5728;&#x80f0;&#x817a;&#x03b2;&#x7ec6;&#x80de;&#x4e2d;&#x751f;&#x4ea7;&#x80f0;&#x5c9b;&#x7d20;&#x7684;&#x4fc3;&#x8fdb;&#x5242; Pancreatic &#x03b2; ce	Han Chuan Xian Zhi 	2013	0		
1008	chr22	55451100	55451374	3500146359	72		55451100	55451374	8421504	2	42,30	0,244	p	350014635900015006,350014635900015007	0-72,0-72					Patent	&#x4fee;&#x9970;&#x80bd;&#x7684;&#x5236;&#x9020;&#x65b9;&#x6cd5; (Patent CN:100491395)	Nan Zhu Yi Chun 	2009	0		
1008	chr22	55451100	55451374	3500051836	72		55451100	55451374	8421504	2	42,30	0,244	p	350005183600015008,350005183600015007	0-72,0-72						Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient - Patent application	www.faqs.org	0	0		
1008	chr22	55451100	55451374	3500023611	72		55451100	55451374	8421504	2	42,30	0,244	p	350002361100015045,350002361100015008,350002361100015007	0-54,0-72,0-72						Method for producing a modified peptide - Patent # 7138489 - PatentGenius	.patentgenius.com	0	0		
1008	chr22	55451100	55451374	3500019153	72		55451100	55451374	8421504	2	42,30	0,244	p	350001915300015007,350001915300015008	0-72,0-72					Patent	Method for producing a modified peptide (Patent US:7138489)	Makino	2006	0		
1008	chr22	55451100	55451374	3500008742	72		55451100	55451374	8421504	2	42,30	0,244	p	350000874200015012,350000874200015014	0-72,0-72						&#x7279;&#x8a31;&#x7b2c;4843827&#x53f7; &#x81b5;&#x81d3;&#x03b2;&#x7d30;&#x80de;&#x306e;&#x518d;&#x751f;&#x4fc3;&#x9032;&#x5264;&#x53ca;&#x3073;&#x81b5;&#x81d3;&#x03b2;&#x7d30;&#x80de;&#x306b;&#x304a;&#x3051;&#x308b;&#x30a4;&#x30f3;&#x30b9;&#x30ea;&#x30f3	astamuse.com	0	0		
1008	chr22	55451100	55451347	3500253335	45		55451100	55451347	8421504	2	42,3	0,244	p	350025333500015004	0-45						The structure and function of the human ghrelin receptor	theses.bham.ac.uk	0	0		
1008	chr22	55503066	55512456	3500140738	42		55503066	55512456	8421504	2	20,22	0,9368	c,g	350014073800000001,350014073800000001,350014073800000000	0-20,0-20,0-22		20489732	10.1038/cdd.2010.51	1350-9047	Cell Death & Differentiation	Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency	Mbaya	2010	9		ATP2B2
1008	chr22	55503216	55512403	3500013656	147		55503216	55512403	8421504	2	30,117	0,9070	p	350001365600015000	0-147						144-Calpain Methods and Protocols	www.scribd.com	0	0		ATP2B1
1008	chr22	55552868	55565402	3500123153	38		55552868	55565402	8421504	2	19,19	0,12515	c,g	350012315300000005,350012315300000002,350012315300000002	0-19,0-19,0-19		16763025	10.1523/JNEUROSCI.0447-06.2006	0270-6474	The Journal of Neuroscience	Splice-Site A Choice Targets Plasma-Membrane Ca2+-ATPase Isoform 2 to Hair Bundles	Hill	2006	7		
1009	chr22	55635235	55635263	3500008431	23		55635235	55635263	8421504	2	16,7	0,21	g	350000843100000060	5-34						Methods For The Diagnosis Of Fetal Abnormalities 	.freshpatents.com	0	0		
1009	chr22	55705506	55705533	3500428460	23		55705506	55705533	8421504	3	4,6,13	0,5,14	g	350042846000000017	12-35						Mass production method of lactoferrin polypeptide from yeast and useful microorganism thereof	Hong	2000	0		
1011	chr22	55964488	55964512	3500205116	23		55964488	55964512	8421504	2	7,16	0,8	g	350020511600000007	0-23						Small and intermediate conductance, calcium-activated potassium channels and uses thereof	Adelman	2005	0		
1012	chr22	56032649	56035584	3500139735	51		56032649	56035584	8421504	2	37,14	0,2921	p	350013973500015134,350013973500015070,350013973500015015	0-45,0-48,0-45						ANTIBODY AGAINST COLORECTAL CANCER MARKER - Patent application	www.faqs.org	0	0		SLC6A11
1013	chr22	56125740	56125768	3500090833	23		56125740	56125768	8421504	2	13,10	0,18	g	350009083300000020	21-44						Les transporteurs de peptides de	hives-ouvertes.fr	0	0		
1013	chr22	56226906	56229041	3500274995	111		56226906	56229041	8421504	4	17,37,42,15	0,449,1634,2120	p	350027499500015000,350027499500015001	0-54,0-57		8636119	10.1074/jbc.271.12.6917	0021-9258	Journal of Biological Chemistry	Polarized Expression of GABA Transporters in Madin-Darby Canine Kidney Cells and Cultured Hippocampal Neurons	Ahn	1996	5		SLC6A1
1014	chr22	56230948	56230976	3500440489	23		56230948	56230976	8421504	2	15,8	0,20	c	350044048900000148	20-43						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
1014	chr22	56238180	56238228	3500223020	48		56238180	56238228	8421504	1	48	0	p	350022302000015004	0-48						Only one of the charged amino acids located in the transmembrane alpha-helices of the gamma-aminobutyric acid transporter (subtype A) is essential for its activity. - ResearchGate	.researchgate.net	0	0		
1015	chr22	56458740	56461597	3500342421	2756		56458740	56461597	8421504	6	300,1344,114,465,367,166	0,360,1714,1831,2322,2691	p,c,g	350034242100000034,350034242100015062,350034242100000040,350034242100000046,350034242100000052,350034242100000058,350034242100000058,350034242100000070,350034242100000070,350034242100015072,350034242100000076,350034242100000076,350034242100000073,350034242100000073,350034242100000082,350034242100000082,350034242100000088,350034242100000088,350034242100015077,350034242100000100,350034242100000106,350034242100015082,350034242100000112,350034242100000112,350034242100000118,350034242100000118,350034242100000124,350034242100015087,350034242100000130,350034242100000136,350034242100000136,350034242100000142,350034242100000142,350034242100015092,350034242100000148,350034242100000148,350034242100000154,350034242100000154,350034242100000002,350034242100000160,350034242100000160,350034242100015097,350034242100000166,350034242100000166,350034242100000171,350034242100000178,350034242100000178,350034242100000183,350034242100000183,350034242100000187,350034242100000187,350034242100000191,350034242100000191,350034242100000195,350034242100000203,350034242100000203,350034242100000208,350034242100000208,350034242100000211,350034242100000214,350034242100000217,350034242100000220,350034242100000223,350034242100000223,350034242100000226,350034242100000229,350034242100000229,350034242100000232,350034242100000232,350034242100000235,350034242100000239,350034242100000239,350034242100000242,350034242100000245,350034242100000248,350034242100000251,350034242100000251,350034242100000254,350034242100000254,350034242100000257,350034242100000257,350034242100000260,350034242100000260,350034242100000263,350034242100000263,350034242100000266,350034242100000266	0-60,0-180,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-180,0-60,0-60,0-35,0-35,0-60,0-60,0-60,0-60,0-180,0-60,0-60,0-180,0-60,0-60,0-60,0-60,0-60,0-177,0-60,0-57,0-57,0-53,0-53,0-177,0-60,0-60,0-60,0-60,0-20,0-60,0-60,0-180,0-60,0-60,0-45,0-60,0-60,0-55,0-55,0-56,0-56,0-59,0-59,0-40,0-58,0-58,0-56,0-56,0-45,0-59,0-55,0-60,0-60,0-60,0-49,0-53,0-53,0-60,0-60,0-24,0-53,0-53,0-38,0-45,0-60,0-56,0-56,0-60,0-60,0-59,0-59,0-55,0-55,0-60,0-60,0-51,0-51						AUS DEM INSTITUT F&#xdc;R PHARMAKOLOGIE PHARMAZIE DER IER&#xc4;ZRZTLICHEN AKULT&#xc4;T	b.uni-muenchen.de	0	0		
1015	chr22	56459363	56460131	3500456196	46		56459363	56460131	8421504	2	23,23	0,745	c,g	350045619600000000,350045619600000000,350045619600000001	0-23,0-23,0-23			10.1167/iovs.05-1127	1552-5783	Investigative Ophthalmology & Visual Science	Histamine-Induced Phosphorylation of the Regulatory Light Chain of Myosin II Disrupts the Barrier Integrity of Corneal Endothelial Cells	Srinivas	2006	0		HRH1
1015	chr22	56459363	56460131	3500411036	46		56459363	56460131	8421504	2	23,23	0,745	c,g	350041103600000000,350041103600000001,350041103600000001	0-23,0-23,0-23						Histamine-Induced Phosphorylation of the Regulatory Light Chain of Myosin II Disrupts the Barrier Integrity of Corneal Endothelial Cells	www.iovs.org	0	0		
1015	chr22	56461284	56461309	3500134916	25		56461284	56461309	8421504	1	25	0	c,g	350013491600000059,350013491600000059	24-49,24-49						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
1020	chr22	57130019	57130045	3500112863	26		57130019	57130045	8421504	1	26	0	g	350011286300000043	3-29						Immunostimulatory oligodeoxynucleotides	Egyed	2003	0		
1022	chr22	57339177	57339203	3500278114	24		57339177	57339203	8421504	3	11,5,8	0,12,18	c	350027811400000172	0-36					Patent	Hog cholera virus vaccine and diagnostic (Patent US:5811103)	Meyers	1998	0		
1023	chr22	57428095	57430155	3500394704	40		57428095	57430155	8421504	2	20,20	0,2040	c,g	350039470400000021,350039470400000021,350039470400000020,350039470400000020	0-20,0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1023	chr22	57428095	57430155	3500292483	40		57428095	57430155	8421504	2	20,20	0,2040	c,g	350029248300000021,350029248300000021,350029248300000020,350029248300000020	0-20,0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1023	chr22	57466429	57466464	3500313402	35		57466429	57466464	8421504	1	35	0	c	350031340200000001	18-56		12110672	10.1074/jbc.M204265200	0021-9258	Journal of Biological Chemistry	Highly Purified Scavenger Receptor Class B, Type I Reconstituted into Phosphatidylcholine/Cholesterol Liposomes Mediates High Affinity High Density Lipoprotein Binding and Selective Lipid Uptake	Liu	2002	5		
1023	chr22	57466432	57471360	3500176147	1044		57466432	57471360	8421504	5	108,240,166,169,361	0,967,1325,2709,4567	p	350017614700015021	0-1044						Bioinformatics Notes site	iomath.med.uth.gr	0	0		
1023	chr22	57466432	57471360	3500121818	1044		57466432	57471360	8421504	5	108,240,166,169,361	0,967,1325,2709,4567	p	350012181800015001	0-1044						Lecture Notes: Language and Evolution	guistics.ucla.edu	0	0		
1023	chr22	57466432	57471360	3500080413	1044		57466432	57471360	8421504	5	108,240,166,169,361	0,967,1325,2709,4567	p	350008041300015002	0-1044						Lecture Notes - Language and Evolution	www.scribd.com	0	0		
1023	chr22	57466432	57466486	3500310016	54		57466432	57466486	8421504	1	54	0	p	350031001600015000	0-54						ScienceDirect.com - FEBS Letters - An improved rhodopsin/EGFP fusion protein for use in the generation of transgenic Xenopus laevis	sciencedirect.com	0	0		
1023	chr22	57466432	57466486	3500008001	54		57466432	57466486	8421504	1	54	0	p	350000800100015001	0-54						The quaternary structure of rhodopsin and its implications for rhodopsin function.	diss.fu-berlin.de	0	0		
1023	chr22	57466517	57467400	3500059136	24		57466517	57467400	8421504	2	23,1	0,882	c	350005913600000000	0-24						03149SuppText 	www.pnas.org	0	0		RHO
1023	chr22	57467408	57471252	3500453246	465		57467408	57471252	8421504	8	39,78,36,51,42,8,22,189	0,93,406,1756,1846,1894,3591,3655	p	350045324600015006,350045324600015000	12-552,0-114						Ashford University : ANT101 ANT101 : Developing and Limiting a Research Topic	ww.coursehero.com	0	0		
1023	chr22	57467408	57471252	3500453126	465		57467408	57471252	8421504	8	39,78,36,51,42,8,22,189	0,93,406,1756,1846,1894,3591,3655	p	350045312600015006,350045312600015000	12-552,0-114						Ashford University : ANT101 ANT101 : Evaluating Research Information	ww.coursehero.com	0	0		
1023	chr22	57467408	57471252	3500355216	465		57467408	57471252	8421504	8	39,78,36,51,42,8,22,189	0,93,406,1756,1846,1894,3591,3655	p	350035521600015006,350035521600015000	12-552,0-114						Ashford University : ANT101 ANT101 : Childhood Obesity Paper	ww.coursehero.com	0	0		
1023	chr22	57467408	57471252	3500235071	465		57467408	57471252	8421504	8	39,78,36,51,42,8,22,189	0,93,406,1756,1846,1894,3591,3655	p	350023507100015006,350023507100015000	12-552,0-114						Syracuse : GEO 273 : Harvey 2005_A Brief History of Neoliberalism 1	ww.coursehero.com	0	0		
1023	chr22	57467408	57471252	3500218822	465		57467408	57471252	8421504	8	39,78,36,51,42,8,22,189	0,93,406,1756,1846,1894,3591,3655	p	350021882200015006,350021882200015000	12-552,0-114						Ashford University : ANT101 ANT101 : Conducting Online Research	ww.coursehero.com	0	0		
1023	chr22	57467408	57471252	3500132313	465		57467408	57471252	8421504	8	39,78,36,51,42,8,22,189	0,93,406,1756,1846,1894,3591,3655	p	350013231300015006,350013231300015000	12-552,0-114						Ursinus : PSYCH 350 : Psych 350 Chapter 2 Notes	ww.coursehero.com	0	0		
1023	chr22	57467410	57467489	3500450082	59		57467410	57467489	8421504	2	20,39	0,40	c,g	350045008200000001,350045008200000012,350045008200000012,350045008200000000	0-20,0-19,0-19,0-20		12624187	10.1073/pnas.0630494100	0027-8424	Proceedings of the National Academy of Sciences	A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS	Ding	2003	10		
1023	chr22	57467450	57471300	3500109479	425		57467450	57471300	8421504	9	78,76,16,9,22,41,10,28,145	0,1730,1833,1850,3549,3611,3653,3664,3705	p,c	350010947900015052,350010947900000016,350010947900000015,350010947900000011,350010947900000010,350010947900015006	0-78,0-76,33-80,0-79,16-72,0-99						Cloning and Characterization of Rod Opsin cDNA From the Old World Monkey, Macaca fascicularis	www.iovs.org	0	0		
1023	chr22	57467579	57467763	3500070508	66		57467579	57467763	8421504	2	60,6	0,178	p	350007050800015015	0-66						Influencia de la movilidad de las h&#xe9;lices en la funci&#xf3;n de la bacteriorodopsina	www.tdx.cat	0	0		RHO
1023	chr22	57467610	57471210	3500301585	41		57467610	57471210	8421504	2	20,21	0,3579	c	350030158500000013,350030158500000012	0-20,0-21						GDNF Family Ligands Trigger Indirect Neuroprotective Signaling in Retinal Glial Cells - Keeping the Faith	pthefaith1296.com	0	0		RHO
1023	chr22	57467610	57471210	3500151975	41		57467610	57471210	8421504	2	20,21	0,3579	c	350015197500000013,350015197500000012	0-20,0-21			10.1128/MCB.26.7.2746-2757.2006		Molecular and Cellular Biology	GDNF Family Ligands Trigger Indirect Neuroprotective Signaling in Retinal Glial Cells	Stefanie	2006	0		RHO
1023	chr22	57469191	57469239	3500189807	48		57469191	57469239	8421504	1	48	0	c	350018980700000026	0-48						Diagnosis of hereditary retinal degenerative diseases	Dryja	1993	0		
1023	chr22	57469252	57469276	3500026011	24		57469252	57469276	8421504	1	24	0	c	350002601100000004	0-24						Cotylenin A inhibits cell proliferation and induces apoptosis and PAX6 mRNA transcripts in retinoblastoma cell lines	www.molvis.org	0	0		
1023	chr22	57469287	57471264	3500046143	96		57469287	57471264	8421504	3	23,25,48	0,1712,1929	c	350004614300000024,350004614300000019	0-48,0-48						US Patent # 5,498,521. Diagnosis of hereditary retinal degenerative diseases - Patents.com	www.patents.com	0	0		
1023	chr22	57469287	57471024	3500375653	48		57469287	57471024	8421504	2	23,25	0,1712	c	350037565300000012	0-48						US Patent # 5,262,529. Diagnosis of hereditary retinal degenerative diseases - Patents.com	www.patents.com	0	0		
1023	chr22	57471000	57471156	3500097226	156		57471000	57471156	8421504	1	156	0	p	350009722600015035	0-156						THESE	w2.vetagro-sup.fr	0	0		RHO
1023	chr22	57471255	57471360	3500446569	105		57471255	57471360	8421504	1	105	0	p	350044656900015018	0-105						IDENTIFICATION OF BITTER LIGANDS THAT SPECIFICALLY ACTIVATE HUMAN T2R RECEPTORS AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS	LI	2006	0		
1023	chr22	57471255	57471360	3500351228	105		57471255	57471360	8421504	1	105	0	p	350035122800015001,350035122800015006	0-105,0-45						Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof - Patent application	www.faqs.org	0	0		
1023	chr22	57471255	57471360	3500297589	105		57471255	57471360	8421504	1	105	0	p	350029758900015005	0-105					Patent	Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators (Patent US:7883856)	Li	2011	0		
1023	chr22	57471255	57471360	3500282079	105		57471255	57471360	8421504	1	105	0	p	350028207900015009	0-105						Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators	Li	2011	0		
1023	chr22	57471255	57471360	3500277218	105		57471255	57471360	8421504	1	105	0	p	350027721800015008	0-105						Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators	Li	2011	0		
1023	chr22	57471255	57471360	3500147094	105		57471255	57471360	8421504	1	105	0	p	350014709400015001	0-105						Identification of bitter receptors for hydrolyzed soy protein - US Patent 7794959 Description	ww.patentstorm.us	0	0		
1023	chr22	57471255	57471360	3500038696	105		57471255	57471360	8421504	1	105	0	p	350003869600015001	0-105						Compounds that inhibit (block) bitter taste in composition and use thereof	Li	2008	0		
1023	chr22	57471299	57471330	3500151293	31		57471299	57471330	8421504	1	31	0	c,g	350015129300000005,350015129300000005,350015129300000004,350015129300000004	77-108,77-108,0-31,0-31			10.1111/j.1471-4159.2006.03771.x	1471-4159	Journal of Neurochemistry	Characterization of an extended receptive ligand repertoire of the human olfactory receptor OR17-40 comprising structurally related compounds - Jacquier - 2006 - Journal of Neurochemistry - Wiley Online Library	Jacquier	2006	0		
1023	chr22	57471300	57471402	3500106275	102		57471300	57471402	8421504	1	102	0	c,g	350010627500000019,350010627500000019,350010627500000012,350010627500000011	0-42,0-42,0-42,4-64						Olfactory receptor expression libraries and methods of making and using them	Krautwurst	2000	0		
1023	chr22	57471300	57471402	3500024656	102		57471300	57471402	8421504	1	102	0	p,c,g	350002465600000050,350002465600000012,350002465600000012,350002465600000004,350002465600015211,350002465600000003	4-100,0-42,0-42,0-42,0-45,4-64						US Patent # 7,138,242. Olfactory receptor expression libraries and methods of making and using them - Patents.com	www.patents.com	0	0		
1023	chr22	57471300	57471360	3500342524	60		57471300	57471360	8421504	1	60	0	p	350034252400015000	0-60						Human T2R receptors recognizing a class of bitter molecules from coffee	Li	2007	0		RHO
1023	chr22	57471300	57471360	3500260056	60		57471300	57471360	8421504	1	60	0	p	350026005600015007	0-60						T2r taste receptors and genes encoding same	Adler	2001	0		
1023	chr22	57471300	57471360	3500241386	60		57471300	57471360	8421504	1	60	0	p	350024138600015004,350024138600015013	0-60,0-45						HUMAN T2R RECEPTORS FOR RANITIDINE, STRYCHNINE AND DENATONIUM AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS - Patent application	www.faqs.org	0	0		
1023	chr22	57471300	57471360	3500200233	60		57471300	57471360	8421504	1	60	0	p	350020023300015007	0-60						Human T2R63 receptor and related assays for identifying human bitter taste modulators	Adler	2006	0		RHO
1023	chr22	57471300	57471360	3500197359	60		57471300	57471360	8421504	1	60	0	p	350019735900015019	0-60						OLFACTORY RECEPTORS FOR ISOLVALERIC ACID AND RELATED MALODORANTS AND USE THEREOF IN ASSAYS FOR IDENTIFICATION OF BLOCKERS	Han	2007	0		RHO
1023	chr22	57471300	57471360	3500189369	60		57471300	57471360	8421504	1	60	0	p	350018936900015002	0-60						HUMAN T2R RECEPTORS RECOGNIZING A CLASS OF BITTER MOLECULES FROM COFFEE	Li	2011	0		RHO
1023	chr22	57471300	57471360	3500179490	60		57471300	57471360	8421504	1	60	0	p	350017949000015011	0-60						Human T2R54 taste receptor and related assays for identifying human bitter taste modulators	Adler	2006	0		RHO
1023	chr22	57471300	57471360	3500160717	60		57471300	57471360	8421504	1	60	0	p	350016071700015009	0-60						ISOLATED BITTER TASTE RECEPTOR POLYPEPTIDES - Patent application	www.faqs.org	0	0		RHO
1023	chr22	57471300	57471360	3500156430	60		57471300	57471360	8421504	1	60	0	p	350015643000015006	0-60						Use of specific T2R taste receptors to identify compounds that block bitter taste	Pronin	2002	0		RHO
1023	chr22	57471300	57471360	3500150387	60		57471300	57471360	8421504	1	60	0	p	350015038700015007	0-60						US Patent # 7,105,650. T2R taste receptors and genes encoding same - Patents.com	www.patents.com	0	0		RHO
1023	chr22	57471300	57471360	3500100614	60		57471300	57471360	8421504	1	60	0	p	350010061400015005	0-60						USE OF SPECIFIC T2R RECEPTORS TO IDENTIFY COMPOUNDS THAT BLOCK BITTER TASTE - Patent application	www.faqs.org	0	0		RHO
1023	chr22	57471300	57471360	3500098578	60		57471300	57471360	8421504	1	60	0	p	350009857800015007	0-60						T2r taste receptors and genes encoding same	Adler	2003	0		
1023	chr22	57471300	57471360	3500067342	60		57471300	57471360	8421504	1	60	0	p	350006734200015007	0-60						Use of specific t2r taste receptors to identify compounds that block bitter taste	Adler	2003	0		RHO
1023	chr22	57471300	57471360	3500015193	60		57471300	57471360	8421504	1	60	0	p	350001519300015000	0-60						Human t2r receptors recognizing a class of bitter molecules from coffee	Li	2011	0		RHO
1023	chr22	57471300	57471360	3500013131	60		57471300	57471360	8421504	1	60	0	c,g	350001313100000002,350001313100000002	12-72,12-72						Piezoelectric Biosensor Based on Olfactory Receptor Expressed in a Heterologous Cell System for Drug Discovery	www.hljbme.cn	0	0		
1023	chr22	57471300	57471360	3500000197	60		57471300	57471360	8421504	1	60	0	p	350000019700015000	0-60					Patent	Use of bitter taste receptor to screen for compounds that offset the bitter taste of chlorogenic lactone containing coffee compositions (Patent US:8318447)	Li	2012	0		RHO
1023	chr22	57471306	57471360	3500368827	54		57471306	57471360	8421504	1	54	0	p	350036882700015029	0-54						Application # 2003/0207337. Receptores olfativos de &#xe1;cido isovalerico y malodorants relacionados y uso en los ensayos para la identificaci&#xf3;n de los bloqueadores de malodor - Patents.com	es.patents.com	0	0		
1023	chr22	57471382	57471504	3500093704	39		57471382	57471504	8421504	2	19,20	0,102	g	350009370400000005,350009370400000007	0-19,0-20						Zinc-dedo de la mano de los dominios represor transcripcional KLF15 obligar&#xe1; a m&#xfa;ltiples sitios en rhodopsin y IRBP promotores incluido el CRS-1 y G-ricos elementos represor	viaclinica.com	0	0		
1023	chr22	57471383	57471406	3500170943	23		57471383	57471406	8421504	1	23	0	g	350017094300000001	7-30						Biotechniques - The International Journal for Life Science Method 	biotechniques.com	0	0		
1023	chr22	57471387	57471456	3500414914	48		57471387	57471456	8421504	2	28,20	0,49	g	350041491400000003,350041491400000006,350041491400000002	0-22,0-20,0-20		11006213		1552-5783	Investigative Ophthalmology & Visual Science	HRG4 (UNC119) Mutation Found in Cone&#x2013;Rod Dystrophy Causes Retinal Degeneration in a Transgenic Model	Kobayashi	2000	0		
1023	chr22	57471491	57471571	3500430116	51		57471491	57471571	8421504	2	20,31	0,49	g	350043011600000002,350043011600000001	0-20,0-31		18854042	10.1186/1471-2199-9-87	1471-2199	BMC Molecular Biology	FIZ1 is part of the regulatory protein complex on active photoreceptor-specific gene promoters in vivo	Mali	2008	3		
1023	chr22	57471521	57471550	3500242498	29		57471521	57471550	8421504	1	29	0	g	350024249800000000	0-29		15277472	10.1167/iovs.04-0072	1552-5783	Investigative Ophthalmology & Visual Science	Kr&#xfc;ppel-like Factor 15, a Zinc-Finger Transcriptional Regulator, Represses the Rhodopsin and Interphotoreceptor Retinoid-Binding Protein Promoters	Otteson	2004	0		
1023	chr22	57471535	57471571	3500208331	36		57471535	57471571	8421504	1	36	0	g	350020833100000004	0-36						CHX10TargetsaSubsetofPhotoreceptorGenes	hnres.utoronto.ca	0	0		
1023	chr22	57472338	57472364	3500008912	25		57472338	57472364	8421504	2	11,14	0,12	g	350000891200000003	0-25		16263331	10.1016/j.ymthe.2005.08.024	1525-0016	Molecular Therapy	Choroidal Neovascularization in Transgenic Mice Expressing Prokineticin 1: An Animal Model for Age-related Macular Degeneration	Tanaka	2006	7		
1023	chr22	57472609	57473639	3500350930	1023		57472609	57473639	8421504	5	34,649,196,138,6	0,35,685,882,1024	g	350035093000000006	0-1023						Mouse model for ocular neovascularization	www.devileye.net	0	0		
1024	chr22	57584103	57584140	3500189032	28		57584103	57584140	8421504	4	5,5,7,11	0,8,15,26	c	350018903200000004	1-30						Genes encoding melanocortin receptors	Yamada	1994	0		
1024	chr22	57585008	57585695	3500184589	43		57585008	57585695	8421504	2	22,21	0,666	c	350018458900000025,350018458900000026	0-22,0-21		19860831	10.1111/j.1742-4658.2009.07404.x	1742-4658	FEBS Journal	Fatty aldehyde dehydrogenase is up-regulated by polyunsaturated fatty acid via peroxisome proliferator-activated receptor &#x03b1; and suppresses polyunsaturated fatty acid-induced endoplasmic reticulum stress - Ashibe - 2009 - FEBS Journal - Wiley Online	Ashibe	2009	0		
1024	chr22	57585672	57585734	3500078659	46		57585672	57585734	8421504	2	23,23	0,39	c	350007865900000018,350007865900000019	0-23,0-23						SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY - Patent application	www.faqs.org	0	0		
1024	chr22	57585672	57585734	3500046939	46		57585672	57585734	8421504	2	23,23	0,39	c	350004693900000012,350004693900000013	0-23,0-23		20133924	10.1164/rccm.200912-1818OC		American Journal of Respiratory and Critical Care Medicine	Surfactant Protein-D Inhibits Lung Inflammation Caused by Ventilation in Premature Newborn Lambs	Atsuyasu	2010	0		
1024	chr22	57585698	57587570	3500214395	40		57585698	57587570	8421504	3	20,18,2	0,98,1870	c	350021439500000010,350021439500000011	0-20,0-20		9658135		0022-538X	Journal of Virology	CXCR4 Is Required by a Nonprimate Lentivirus: Heterologous Expression of Feline Immunodeficiency Virus in Human, Rodent, and Feline Cells	Poeschla	1998	5		RPL32
1024	chr22	57585719	57585784	3500430411	45		57585719	57585784	8421504	2	23,22	0,43	c	350043041100000002,350043041100000003	0-23,0-22						MULTI-COMPARTMENTAL MACROPHAGE DELIVERY	Amiji	2011	0		
1024	chr22	57585719	57585784	3500028966	45		57585719	57585784	8421504	2	23,22	0,43	c	350002896600000002,350002896600000003	0-23,0-22						MULTI-COMPARTMENTAL MACROPHAGE DELIVERY - Patent application	www.faqs.org	0	0		
1024	chr22	57585719	57585784	3500008382	45		57585719	57585784	8421504	2	23,22	0,43	c	350000838200000002,350000838200000003	0-23,0-22						Multi-compartmental macrophage delivery	Amiji	2011	0		
1024	chr22	57585799	57587577	3500163043	24		57585799	57587577	8421504	2	15,9	0,1769	c	350016304300000007	0-24		18250155	10.1128/MCB.00784-07	0270-7306	Molecular and Cellular Biology	Critical Role for Transcription Factor C/EBP-&#x03b2; in Regulating the Expression of Death-Associated Protein Kinase 1	Gade	2008	6		
1024	chr22	57585799	57587577	3500020831	24		57585799	57587577	8421504	2	15,9	0,1769	c	350002083100000009	0-24		19521987	10.1002/ijc.24493	1097-0215	International Journal of Cancer	Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells - Gade - 2009 - International Journal of Cancer - Wiley Online Library	Gade	2009	0		
1024	chr22	57585805	57587582	3500152337	23		57585805	57587582	8421504	2	9,14	0,1763	c	350015233700000003	4-27		23825951	10.1371/journal.ppat.1003460	1553-7374	PLOS Pathogens	PLOS Pathogens: Cellular RNA Binding Proteins NS1-BP and hnRNP K Regulate Influenza A Virus RNA Splicing	Tsai	2013	0		
1024	chr22	57591635	57591666	3500428330	26		57591635	57591666	8421504	4	4,4,5,13	0,5,10,18	g	350042833000000029	9-35						Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation	ev.biologists.org	0	0		
1025	chr22	57685915	57685941	3500089206	23		57685915	57685941	8421504	2	13,10	0,16	c	350008920600000000	3-26						Immunosuppressant binding antibodies and methods of obtaining and using same	Siegel	2009	0		
1025	chr22	57685915	57685941	3500031103	23		57685915	57685941	8421504	2	13,10	0,16	g	350003110300000014	11-34						TRAIL RECEPTOR-BINDING AGENTS AND USES OF THE SAME - Patent application	www.faqs.org	0	0		
1026	chr22	57847419	57876341	3500139609	357		57847419	57876341	8421504	13	29,21,8,47,19,66,25,5,6,39,25,20,47	0,12179,12500,12605,20520,20873,25099,25126,25757,25821,27031,28115,28875	c	350013960900000011,350013960900000016,350013960900000019,350013960900000028,350013960900000029,350013960900000031,350013960900000033,350013960900000036,350013960900000043	6-35,0-29,0-47,9-46,0-48,0-36,0-39,0-45,0-47						Detection method for c-raf-1 genes	Rapp	1993	0		
1026	chr22	57864387	57864432	3500372954	45		57864387	57864432	8421504	1	45	0	p	350037295400015003	0-45						Inhibition of intracellular signal transduction by 14-3-3-binding peptides	Muslin	1997	0		RAF1
1026	chr22	57867873	57867897	3500219117	24		57867873	57867897	8421504	1	24	0	c	350021911700000000	0-24		9625759	10.1084/jem.187.12.1995	0022-1007	The Journal of Experimental Medicine	Expression of Constitutively Active Raf-1 in the Mitochondria Restores Antiapoptotic and Leukemogenic Potential of a Transformation-deficient BCR/ABL Mutant	Salomoni	1998	14		RAF1
1026	chr22	57868340	57873201	3500288106	180		57868340	57873201	8421504	4	70,52,33,25	0,4124,4177,4836	p	350028810600015019,350028810600015027,350028810600015026	0-180,0-72,0-84						Duke : SCIENCE 111 : complete notes on Bioinformatics	ww.coursehero.com	0	0		
1026	chr22	57868340	57873201	3500204284	180		57868340	57873201	8421504	4	70,52,33,25	0,4124,4177,4836	p	350020428400015026,350020428400015014,350020428400015025	0-72,0-180,0-84						17727 Complete Notes on tics	www.scribd.com	0	0		RAF1
1026	chr22	57868340	57873201	3500185699	180		57868340	57873201	8421504	4	70,52,33,25	0,4124,4177,4836	p	350018569900015016,350018569900015028,350018569900015038	0-180,0-72,0-84						Introduction to Bioinformatics	www.koshika.co.in	0	0		
1026	chr22	57873330	57874450	3500295269	45		57873330	57874450	8421504	2	23,22	0,1098	p	350029526900015031	0-45						COMPOSITIONS AND METHODS FOR DETECTING NOONAN SYNDROME - Patent application	www.faqs.org	0	0		ARAF
1026	chr22	57875572	57875620	3500426490	48		57875572	57875620	8421504	1	48	0	p	350042649000015110	0-48						Signal Transduction Protein Tab2 	.freshpatents.com	0	0		RAF1
1026	chr22	57876279	57876550	3500394704	67		57876279	57876550	8421504	4	21,26,1,19	0,37,89,252	c,g	350039470400000003,350039470400000003,350039470400000005,350039470400000004	0-21,0-21,0-26,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1026	chr22	57876279	57876550	3500292483	67		57876279	57876550	8421504	4	21,26,1,19	0,37,89,252	c,g	350029248300000003,350029248300000003,350029248300000005,350029248300000005,350029248300000004	0-21,0-21,0-26,0-26,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1026	chr22	57876342	57876552	3500023591	48		57876342	57876552	8421504	2	27,21	0,189	c	350002359100000050	0-48						 Detection Method For C 	www.docstoc.com	0	0		
1027	chr22	57990565	57990595	3500366686	24		57990565	57990595	8421504	3	13,5,6	0,16,24	g	350036668600000002	0-24						STEC &#xfe8e;&#xfb95;&#xfef4;&#xfeb7; &#xfeaa;&#xfedf;&#xfeee;&#xfee3; &#xfef2;&#xfee0;&#xfb90;&#xfe8e;&#xfef4;&#xfeb7;&#xfeae;&#xfeb7;&#xfe8d; &#xfef1;&#xfeaf;&#xfe8e;&#xfeb3; &#xfe8d;&#xfeaa;&#xfe9f;	old.sbmu.ac.ir	0	0		
128	chr22	58046801	58119194	3500466835	1515		58046801	58119194	8421504	7	245,451,200,139,170,228,82	0,17857,29540,35215,43723,45665,72311	p	350046683500015049	0-1515						Ppar Active Compounds 	.freshpatents.com	0	0		
128	chr22	58046801	58119194	3500304394	1515		58046801	58119194	8421504	7	245,451,200,139,170,228,82	0,17857,29540,35215,43723,45665,72311	p	350030439400015049	0-1515						Ppar Active Compounds 	.freshpatents.com	0	0		
128	chr22	58046801	58119194	3500230399	1512		58046801	58119194	8421504	8	245,451,200,139,170,223,2,82	0,17857,29540,35215,43723,45665,45891,72311	p	350023039900015004,350023039900015005	0-1425,0-1506						Sirt1 modulation of adipogenesis and adipose function	Guarente	2005	0		
1027	chr22	58046801	58046864	3500237150	63		58046801	58046864	8421504	1	63	0	p	350023715000015008,350023715000015005	33-96,0-63		17101779	10.1128/MCB.00601-06	0270-7306	Molecular and Cellular Biology	Interaction with MEK Causes Nuclear Export and Downregulation of Peroxisome Proliferator-Activated Receptor &#x03b3;	Burgermeister	2007	6		PPARG
1027	chr22	58046877	58047026	3500281920	40		58046877	58047026	8421504	2	20,20	0,129	c,g	350028192000000029,350028192000000028,350028192000000028	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
1027	chr22	58046922	58046998	3500345859	62		58046922	58046998	8421504	3	19,24,19	0,20,57	c,g	350034585900000043,350034585900000044,350034585900000042,350034585900000042	0-19,0-24,0-19,0-19						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
1027	chr22	58047028	58064665	3500413254	25		58047028	58064665	8421504	2	18,7	0,17630	c	350041325400000002	0-25						Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes	www.ads.uga.edu	0	0		PPARG
1027	chr22	58047028	58064665	3500227525	25		58047028	58064665	8421504	2	18,7	0,17630	c	350022752500000018	0-25						REAL-TIME RT-PCR AND PROTEOMIC ANALYSIS OF ADIPOSE TISSUE FROM OB/OB MICE TREATED WITH LEPTIN WEI ZHANG	aeum.libs.uga.edu	0	0		PPARG
1027	chr22	58047031	58064668	3500331988	25		58047031	58064668	8421504	2	15,10	0,17627	c	350033198800000003	0-25						Regulation of adipogenesis by medium-chain fatty acids in the absence of hormonal cocktail	www.ads.uga.edu	0	0		PPARG
128	chr22	58047100	58119330	3500269838	83		58047100	58119330	8421504	4	19,22,21,21	0,43614,72053,72209	c,g	350026983800000006,350026983800000002,350026983800000008,350026983800000007	0-19,0-22,0-21,0-21						Hua et al. The peroxisome proliferators-ativated receptor gamma (PPARG) gene polymorphisms and associations with body measurements of cattle. Afr. J. Biotechnol. 2011	demicjournals.org	0	0		
128	chr22	58064658	58119114	3500424133	112		58064658	58119114	8421504	4	61,26,23,2	0,27891,28013,54454	c	350042413300000228,350042413300000284,350042413300000087,350042413300000260	0-46,0-48,6-32,23-48						Method of identifying PAX8-PPAR gamma-nucleic acid molecules - Patent # 6723506 - PatentGenius	.patentgenius.com	0	0		
128	chr22	58064658	58065025	3500274729	367		58064658	58065025	8421504	1	367	0	c	350027472900000023	8-375						Ex vivo Expansion and Differentiation of Mesenchymal Stem Cells from Goat Bone Marrow	www.mums.ac.ir	0	0		
1027	chr22	58064659	58064682	3500424598	23		58064659	58064682	8421504	1	23	0	c	350042459800000014	0-23							ww.jbiomedsci.com	0	0		
1027	chr22	58064659	58064682	3500006397	23		58064659	58064682	8421504	1	23	0	c	350000639700000013	0-23						Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulation	biomedcentral.com	0	0		
128	chr22	58064671	58119194	3500266208	1257		58064671	58119194	8421504	6	438,200,139,170,228,82	0,11670,17345,25853,27795,54441	p	350026620800015011	0-1257						Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders	Spiegelman	2011	0		
128	chr22	58064692	58090581	3500159789	90		58064692	58090581	8421504	2	45,45	0,25844	p	350015978900015037,350015978900015021	0-45,0-45						GENETIC MARKERS FOR WEIGHT MANAGEMENT AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		PPARD
128	chr22	58064692	58090581	3500044074	90		58064692	58090581	8421504	2	45,45	0,25844	p	350004407400015068,350004407400015052	0-45,0-45						METHODS AND COMPOSITIONS RELATED TO TR4 LIGAND - Patent application	www.faqs.org	0	0		PPARD
1027	chr22	58064696	58064719	3500102482	23		58064696	58064719	8421504	1	23	0	c	350010248200000002	20-43						One-Step Derivation of Mesenchymal Stem Cell (MSC)- Like Cells from Human Pluripotent Stem Cells on a Fibrillar Collagen Coating	commons.uconn.edu	0	0		PPARG
128	chr22	58064700	58092664	3500207079	56		58064700	58092664	8421504	2	29,27	0,27937	c	350020707900000018,350020707900000060,350020707900000009,350020707900000051	0-29,0-29,0-27,0-27						Human Peroxisome Proliferator Activated Receptor Gamma (ppargamma) Gene Regulatory Sequences And Uses Therefor 	.freshpatents.com	0	0		
1027	chr22	58064730	58064813	3500192765	45		58064730	58064813	8421504	2	24,21	0,62	c	350019276500000004,350019276500000009	0-24,0-21		16618765	10.1158/0008-5472.CAN-05-4277	0008-5472	Cancer Research	Ligand Activation of Peroxisome Proliferator&#x2013;Activated Receptor &#x03b2; Inhibits Colon Carcinogenesis	Marin	2006	8		
1027	chr22	58064734	58064809	3500255557	46		58064734	58064809	8421504	2	24,22	0,53	c	350025555700000005,350025555700000004	0-24,0-22						Carcinogenesis Advance Access published October 19, 2006	w.ifosprogram.com	0	0		PPARG
1027	chr22	58064734	58064809	3500095125	46		58064734	58064809	8421504	2	24,22	0,53	c	350009512500000005,350009512500000004	0-24,0-22						Complementary actions of docosahexaenoic acid and genistein on COX-2	www.docstoc.com	0	0		PPARG
128	chr22	58064744	58092526	3500387227	60		58064744	58092526	8421504	3	20,20,20	0,94,27762	c,g	350038722700000005,350038722700000005,350038722700000004,350038722700000004,350038722700000023	0-20,0-20,0-20,0-20,0-20		19596783	10.1128/MCB.01001-08	0270-7306	Molecular and Cellular Biology	The Multiple Endocrine Neoplasia Type 1 (MEN1) Tumor Suppressor Regulates Peroxisome Proliferator-Activated Receptor &#x03b3;-Dependent Adipocyte Differentiation	Dreijerink	2009	6		
128	chr22	58064744	58092526	3500385861	60		58064744	58092526	8421504	3	20,20,20	0,94,27762	c,g	350038586100000005,350038586100000005,350038586100000004,350038586100000004,350038586100000023	0-20,0-20,0-20,0-20,0-20		19596783	10.1128/MCB.01001-08	0270-7306	Molecular and Cellular Biology	The Multiple Endocrine Neoplasia Type 1 (MEN1) Tumor Suppressor Regulates Peroxisome Proliferator-Activated Receptor &#x03b3;-Dependent Adipocyte Differentiation	Dreijerink	2009	6		
128	chr22	58064744	58092526	3500370785	60		58064744	58092526	8421504	3	20,20,20	0,94,27762	c,g	350037078500000005,350037078500000004,350037078500000004,350037078500000023	0-20,0-20,0-20,0-20		19596783	10.1128/MCB.01001-08		Molecular and Cellular Biology	The Multiple Endocrine Neoplasia Type 1 (MEN1) Tumor Suppressor Regulates Peroxisome Proliferator-Activated Receptor &#x03b3;-Dependent Adipocyte Differentiation 	Koen	2009	0		
1027	chr22	58064746	58064838	3500315071	40		58064746	58064838	8421504	2	20,20	0,72	c,g	350031507100000025,350031507100000025,350031507100000024,350031507100000024	0-20,0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1027	chr22	58064747	58064865	3500459800	45		58064747	58064865	8421504	2	22,23	0,95	c	350045980000000027,350045980000000026	1-23,0-23						Isolation and characterization of canine adipose-derived mesenchymal stem cells | Vilma Yuzbasiyan-Gurkan - Academia.edu	www.academia.edu	0	0		
1027	chr22	58064747	58064865	3500001585	45		58064747	58064865	8421504	2	22,23	0,95	c	350000158500000027,350000158500000026	1-23,0-23						Isolation and Characterization of Canine Adipose&#x2013;Derived Mesenchymal Stem Cells	hemeng.queensu.ca	0	0		
128	chr22	58064751	58090631	3500367367	62		58064751	58090631	8421504	4	20,3,18,21	0,17401,25773,25859	c	350036736700000012,350036736700000005,350036736700000004	0-20,0-21,0-21		23598406	10.1038/cddis.2013.115	false	Cell Death & Disease	Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes	Rippo	2013	0		
128	chr22	58064751	58090631	3500080738	62		58064751	58090631	8421504	4	20,3,18,21	0,17401,25773,25859	c	350008073800000012,350008073800000005,350008073800000004	0-20,0-21,0-21		23598406	10.1038/cddis.2013.115		Cell Death & Disease	Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes	M	2013	0		
1027	chr22	58064773	58064797	3500459148	24		58064773	58064797	8421504	1	24	0	c,g	350045914800000003,350045914800000003	0-24,0-24						Mechanism of nicotine-induced pulmonary &#xfb01;broblast transdifferentiation	ng.physiology.org	0	0		
1027	chr22	58064773	58064797	3500289841	24		58064773	58064797	8421504	1	24	0	c	350028984100000007	0-24		18599738	10.1194/jlr.M700600-JLR200		Journal of Lipid Research	Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells	Jennifer	2008	0		
1027	chr22	58064773	58064797	3500218087	24		58064773	58064797	8421504	1	24	0	c	350021808700000003	0-24		15951329	10.1152/ajplung.00358.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation	Rehan	2005	0		
128	chr22	58064818	58076439	3500246269	40		58064818	58076439	8421504	2	20,20	0,11601	c,g	350024626900000001,350024626900000001,350024626900000000,350024626900000000	0-20,0-20,0-20,0-20						THE GROWTH AND DEVELPMENT OF MUSCLE 2	ertations.wsu.edu	0	0		
128	chr22	58064818	58065005	3500164990	39		58064818	58065005	8421504	3	14,5,20	0,15,167	c,g	350016499000000001,350016499000000000	0-19,0-20						 Effect of {beta}-carotene and retinoic acid on PPAR{gamma} expression during bovine white adipose tissue differentiation in vitro. -- Garc&#xed;a-Rojas et al. 22 (1): 1114.5 -- The FASEB Journal 	www.fasebj.org	0	0		
1027	chr22	58064837	58064860	3500360339	23		58064837	58064860	8421504	1	23	0	c	350036033900000000	0-23		16857792	10.1158/1078-0432.CCR-05-1833	1078-0432	Clinical Cancer Research	Peroxisome Proliferator-Activated Receptor &#x03b3; and Growth Inhibition by Its Ligands in Uterine Endometrial Carcinoma	Ota	2006	8		
1027	chr22	58064842	58064865	3500428967	23		58064842	58064865	8421504	1	23	0	c	350042896700000010	0-23						Effects of Donor Characteristics and Ex Vivo Expansion on Canine Mesenchymal Stem Cell Properties: Implications for MSC-Based Therapies	divet-america.com	0	0		
128	chr22	58064845	58065008	3500227451	44		58064845	58065008	8421504	2	24,20	0,143	c,g	350022745100000001,350022745100000000,350022745100000000	0-24,0-20,0-20		20844260	10.1152/ajpregu.00309.2010		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe	Mei	2010	0		
128	chr22	58064845	58065008	3500197640	43		58064845	58065008	8421504	3	19,4,20	0,20,143	c,g	350019764000000001,350019764000000000,350019764000000000	0-23,0-20,0-20		18372306	10.1113/jphysiol.2007.149633	0022-3751	The Journal of Physiology	AMP-activated protein kinase signalling pathways are down regulated and skeletal muscle development impaired in fetuses of obese, over-nourished sheep	Zhu	2008	5		
128	chr22	58064845	58065008	3500042434	44		58064845	58065008	8421504	2	24,20	0,143	c,g	350004243400000001,350004243400000000,350004243400000000	0-24,0-20,0-20		20844260	10.1152/ajpregu.00309.2010		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe	Zhu	2010	0		
128	chr22	58064874	58076521	3500232370	46		58064874	58076521	8421504	2	24,22	0,11625	c	350023237000000017,350023237000000016	19-43,0-22						<HTML><!-- InstanceBegin template="/Templates/index.dwt" codeOutsideHTMLIsLocked="false" --> <HEAD>	ock.colostate.edu	0	0		
1028	chr22	58064941	58064986	3500368446	45		58064941	58064986	8421504	1	45	0	p	350036844600015001	0-45						Emory : JUNE 16 : Liu.03.IntImm.15.861	ww.coursehero.com	0	0		PPARG
1028	chr22	58064970	58064993	3500094133	23		58064970	58064993	8421504	1	23	0	c	350009413300000004	16-39						Identification and Characterization of Aortic Valve Mesenchymal Progenitor Cells with Robust Osteogenic Calcification Potential	w.mie.utoronto.ca	0	0		
1028	chr22	58064973	58076400	3500409659	44		58064973	58076400	8421504	2	22,22	0,11405	c,g	350040965900000001,350040965900000001,350040965900000000	0-22,0-22,0-22						ScienceDirect.com - Veterinary Immunology and Immunopathology - Increased expression of the peroxisome proliferator-activated receptor &#x03b3; in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection	sciencedirect.com	0	0		
1028	chr22	58064973	58076400	3500073381	44		58064973	58076400	8421504	2	22,22	0,11405	c	350007338100000005,350007338100000004	0-22,0-22						Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs	ww.aseanfood.info	0	0		
1028	chr22	58065001	58076382	3500431450	42		58065001	58076382	8421504	2	21,21	0,11360	c	350043145000000005,350043145000000004	0-21,0-21						Supporting Information	www.pnas.org	0	0		PPARG
1028	chr22	58065068	58076377	3500416864	44		58065068	58076377	8421504	2	24,20	0,11289	c	350041686400000027,350041686400000026	0-24,0-20						Tendon Cell Behavior and Matrix Remodeling in Degenerative Tendinopathy	www.erasmusmc.nl	0	0		PPARG
1028	chr22	58065068	58076377	3500268955	44		58065068	58076377	8421504	2	24,20	0,11289	c	350026895500000027,350026895500000026	0-24,0-20						Tendon Cell Behavior and Matrix Remodeling in Degenerative Tendinopathy	repub.eur.nl	0	0		
1028	chr22	58065071	58065097	3500169766	26		58065071	58065097	8421504	1	26	0	c	350016976600000011	0-26		19670348	10.1002/term.198		Journal of tissue engineering and regenerative medicine	Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis	Teddi	2009	0		PPARG
1028	chr22	58076355	58082052	3500289617	40		58076355	58082052	8421504	2	20,20	0,5677	c	350028961700000005,350028961700000004	0-20,0-20		21734263	10.1095/biolreprod.111.090738	0006-3363	Biology of Reproduction	Bezafibrate Restores the Inhibition of FSH-Induced Follicular Development and Steroidogenesis by Tumor Necrosis Factor-Alpha Through Peroxisome Proliferator-Activated Receptor-Gamma Pathway in an In Vitro Mouse Preantral Follicle Culture	Hara	2011	4		
1028	chr22	58076355	58082052	3500072767	40		58076355	58082052	8421504	2	20,20	0,5677	c	350007276700000005,350007276700000004	0-20,0-20						Bezafibrate Restores the Inhibition of FSH-Induced Follicular Development and Steroidogenesis by Pathway in In Vitro Mouse Preantral Follicle Culture	ww.biolreprod.org	0	0		
1028	chr22	58076366	58076389	3500397617	23		58076366	58076389	8421504	1	23	0	c,g	350039761700000000,350039761700000000	0-23,0-23		19888469	10.1371/journal.pone.0007728		PLoS ONE	A Concerted Kinase Interplay Identifies PPAR&#x03b3; as a Molecular Target of Ghrelin Signaling in Macrophages	Annie	2009	0		PPARG
1028	chr22	58076371	58082020	3500334082	42		58076371	58082020	8421504	3	20,18,4	0,152,5645	c	350033408200000003,350033408200000002	0-20,0-22			10.1186/scrt230	1757-6512	Stem Cell Research & Therapy	Adipogenesis of adipose-derived stem cells may be regulated via the cytoskeleton at physiological oxygen levels in vitro	Schiller	2013	3		PPARG
1028	chr22	58076392	58076427	3500218146	35		58076392	58076427	8421504	1	35	0	c	350021814600000001	0-35						Impact of PPAR&#x03b3; overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays	g.library.pcc.edu	0	0		PPARG
1028	chr22	58076448	58082061	3500388345	40		58076448	58082061	8421504	2	20,20	0,5593	c,g	350038834500000006,350038834500000005,350038834500000005	0-20,0-20,0-20		17178811	10.2527/jas.2006-524	0021-8812	Journal of Animal Science	Transdifferentiation of porcine satellite cells to adipoblasts with ciglitizone	Singh	2007	2		
1028	chr22	58076448	58082061	3500314173	40		58076448	58082061	8421504	2	20,20	0,5593	c,g	350031417300000006,350031417300000005,350031417300000005	0-20,0-20,0-20		17178811	10.2527/jas.2006-524	0021-8812	Journal of Animal Science	Transdifferentiation of porcine satellite cells to adipoblasts with ciglitizone	Singh	2007	2		
1028	chr22	58076448	58082061	3500185231	40		58076448	58082061	8421504	2	20,20	0,5593	c,g	350018523100000006,350018523100000006,350018523100000005,350018523100000005	0-20,0-20,0-20,0-20						Transdifferentiation of porcine satellite cells to adipoblasts with ciglitizone	animalscience.org	0	0		
1028	chr22	58076487	58082030	3500450381	46		58076487	58082030	8421504	3	22,10,14	0,44,5529	c,g	350045038100000015,350045038100000015,350045038100000014	0-22,0-22,0-24						Gene expression patterns of bovine perimuscular preadipocytes during adipogenesis. - ResearchGate	.researchgate.net	0	0		PPARG
1028	chr22	58076525	58082023	3500123592	23		58076525	58082023	8421504	2	16,7	0,5491	c	350012359200000002	5-28						Insulin resistance curative and method of screening the same	Araki	2007	0		
1028	chr22	58076527	58082060	3500384416	47		58076527	58082060	8421504	3	14,12,21	0,5489,5512	c	350038441600000011,350038441600000010	0-26,0-21		21076077	10.1095/biolreprod.110.088005	0006-3363	Biology of Reproduction	PPARG Regulates Gonadotropin-Releasing Hormone Signaling in LbetaT2 Cells In Vitro and Pituitary Gonadotroph Function In Vivo in Mice	Sharma	2011	4		
1028	chr22	58076530	58119194	3500425715	630		58076530	58119194	8421504	5	11,139,170,228,82	0,5486,13994,15936,42582	p	350042571500015004	0-630						Introducci&#xf3;n a la programaci&#xf3;n en bioinform&#xe1;tica	ww.slideshare.net	0	0		
1028	chr22	58076538	58082038	3500463178	25		58076538	58082038	8421504	2	3,22	0,5478	c	350046317800000008	0-25						Bedeutung endogener Inhibitoren der NO-Synthase f&#xfc;r kardiovaskul&#xe4;re Erkrankungen und ihre pharmakologische Therapie	ie.uni-hamburg.de	0	0		
1028	chr22	58082049	58082079	3500451222	30		58082049	58082079	8421504	1	30	0	c	350045122200000014	0-30						Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses therefor	Auwerx	2006	0		
1028	chr22	58082081	58090560	3500191837	49		58082081	58090560	8421504	2	24,25	0,8454	c	350019183700000001,350019183700000000	0-24,0-25			10.1186/1476-511X-5-27	1476-511X	Lipids in Health and Disease	Is oxygen a key factor in the lipodystrophy phenotype?	Gentil	2006	2		PPARG
1028	chr22	58082091	58090560	3500331390	47		58082091	58090560	8421504	2	23,24	0,8445	c	350033139000000078,350033139000000077	0-23,0-24						Pharmacological and Toxicological Advances in PPAR-Related Medicines	loads.hindawi.com	0	0		
1028	chr22	58082140	58090557	3500072558	48		58082140	58090557	8421504	2	15,33	0,8384	p	350007255800015015	0-48						Human Single Nucleotide Polymorphisms Associated With Dose-dependent Weight Gain And Methods Of Use Thereof 	.freshpatents.com	0	0		PPARG
1028	chr22	58082140	58090557	3500052842	48		58082140	58090557	8421504	2	15,33	0,8384	p	350005284200015020	0-48						DMD #24695 A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor	aspetjournals.org	0	0		PPARG
1028	chr22	58082140	58090554	3500204768	45		58082140	58090554	8421504	2	15,30	0,8384	p	350020476800015008	0-45						Peroxisome proliferator-activated receptor alpha and disorders of lipid metabolism	Hudson	2000	0		PPARD
1028	chr22	58082140	58090554	3500080968	45		58082140	58090554	8421504	2	15,30	0,8384	p	350008096800015186	0-45						Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus - Patent application	www.faqs.org	0	0		NR1D2
1028	chr22	58082142	58090631	3500425023	40		58082142	58090631	8421504	3	13,6,21	0,8382,8468	c	350042502300000008,350042502300000029,350042502300000028	21-40,0-19,0-21						NON-TUMORIGENIC EXPANSION OF PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		PPARG
1028	chr22	58082142	58090631	3500415326	40		58082142	58090631	8421504	3	13,6,21	0,8382,8468	c,g	350041532600000003,350041532600000022,350041532600000021,350041532600000021	21-40,0-19,0-21,0-21						ESTABLISHED HUMAN BROWN ADIPOCYTE LINE AND METHOD FOR DIFFERENTIATION FROM AN HMADS CELL LINE - Patent application	www.faqs.org	0	0		PPARG
1028	chr22	58082143	58092482	3500099123	52		58082143	58092482	8421504	4	12,16,8,16	0,8381,8543,10323	c	350009912300000027,350009912300000009,350009912300000026	0-20,0-20,0-24						Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin	g.library.pcc.edu	0	0		PPARG
1028	chr22	58082152	58090631	3500461612	42		58082152	58090631	8421504	3	3,18,21	0,8372,8458	c	350046161200000006,350046161200000005	0-21,0-21						Inhibitors of the Arachidonic Acid Pathway and Peroxisome Proliferator&#x2013;Activated Receptor Ligands Have Superadditive Effects on Lung Cancer Growth Inhibition	.aacrjournals.org	0	0		PPARG
1028	chr22	58082152	58090631	3500273111	42		58082152	58090631	8421504	3	3,18,21	0,8372,8458	c	350027311100000002,350027311100000001	0-21,0-21		19298655	10.1186/bcr2240		Breast Cancer Research : BCR	Peroxisome proliferator-activated receptor-&#x03b3; protects ERBB2-positive breast cancer cells from palmitate toxicity	Antonis	2009	0		PPARG
1028	chr22	58082152	58090631	3500055676	42		58082152	58090631	8421504	3	3,18,21	0,8372,8458	c	350005567600000001,350005567600000000	0-21,0-21						PPARgamma in ERBB2-Positive Breast Cancer Cells : Materials and Methods	www.medscape.com	0	0		PPARG
1028	chr22	58082152	58090545	3500330549	24		58082152	58090545	8421504	2	3,21	0,8372	c	350033054900000000	0-24		17325128	10.1124/mol.107.034371	1521-0111 (Online)	Molecular Pharmacology	Mechanism of Thiazolidinedione-Dependent Cell Death in Jurkat T Cells	Soller	2007	0		PPARG
1028	chr22	58082152	58090545	3500285982	24		58082152	58090545	8421504	2	3,21	0,8372	c	350028598200000004	0-24						&#x4e3b;&#x9898;&#xff1a;Cell | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		PPARG
1028	chr22	58082152	58090545	3500179974	24		58082152	58090545	8421504	2	3,21	0,8372	c	350017997400000000	0-24						Mechanism of Thiazolidinedione-Dependent Cell Death in Jurkat T Cells 2007&#x5e74;&#x7b2c;69&#x5377;&#x7b2c;6&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		PPARG
1028	chr22	58090524	58090572	3500440617	48		58090524	58090572	8421504	1	48	0	p	350044061700015139	0-48						Human Mlr Single Nucleotide Polymorphisms Associated With Dose-dependent Congestive Heart Failure And Methods Of Use Thereof 	.freshpatents.com	0	0		PPARD
1028	chr22	58090528	58119194	3500352536	48		58090528	58119194	8421504	2	24,24	0,28642	c,g	350035253600000011,350035253600000011,350035253600000010	0-24,0-24,0-24		15034137	10.1091/mbc.E03-09-0657	1059-1524	Molecular Biology of the Cell	Inhibition of Adipogenesis by Ghrelin	Zhang	2004	5		PPARG
1028	chr22	58090528	58119194	3500060888	48		58090528	58119194	8421504	2	24,24	0,28642	c	350006088800000011,350006088800000010	0-24,0-24			10.1091/mbc.E03-09-0657		Molecular Biology of the Cell	Inhibition of Adipogenesis by Ghrelin	Weizhen	2004	0		PPARG
1028	chr22	58090600	58092692	3500311390	41		58090600	58092692	8421504	2	20,21	0,2071	c,g	350031139000000003,350031139000000003,350031139000000002	0-20,0-20,0-21						Angiogenesis and Morphometry of Bovine Placentas in Late Gestation from Embryos Produced In Vivo or In Vitro	ww.biolreprod.org	0	0		
1028	chr22	58090677	58092479	3500024984	30		58090677	58092479	8421504	2	17,13	0,1789	c	350002498400000004	100-130						Prostaglandin D2 synthase enzymes and PPARgamma are co-expressed in mouse 3T3-L1 adipocytes and human tissues. - ResearchGate	.researchgate.net	0	0		
1028	chr22	58092505	58119191	3500116618	41		58092505	58119191	8421504	2	21,20	0,26666	c	350011661800000001,350011661800000000	0-21,0-20		21339696	10.3858/emm.2011.43.3.021		Experimental & Molecular Medicine	Fibrin glue increases the cell survival and the transduced gene product secretion of the ceiling culture-derived adipocytes transplanted in mice	Yasuyuki	2011	0		
1028	chr22	58092671	58119113	3500425022	24		58092671	58119113	8421504	2	23,1	0,26441	c	350042502200000000	9-33					Patent	Function regulator for retinoid relative receptor (Patent US:7223791)	Kimura	2007	0		PPARG
1028	chr22	58092671	58119113	3500321929	24		58092671	58119113	8421504	2	23,1	0,26441	c	350032192900000000	9-33					Patent	Retinoid-related receptor function regulating agent (Patent US:6545009)	Sugiyama	2003	0		PPARG
1028	chr22	58092671	58119113	3500273861	24		58092671	58119113	8421504	2	23,1	0,26441	c	350027386100000000	9-33					Patent	Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity (Patent US:6251926)	Momose	2001	0		PPARG
1028	chr22	58092671	58119113	3500235175	24		58092671	58119113	8421504	2	23,1	0,26441	c	350023517500000001	0-24						BMC Cancer BioMed Central	biomedcentral.com	0	0		
1028	chr22	58092671	58119113	3500232105	24		58092671	58119113	8421504	2	23,1	0,26441	c	350023210500000001	0-24						BMC Cancer BioMed Central	pdocs.le-corp.net	0	0		
1028	chr22	58092671	58119113	3500225141	24		58092671	58119113	8421504	2	23,1	0,26441	c	350022514100000008	9-33						1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity	Maekawa	2003	0		PPARG
1028	chr22	58092671	58119113	3500219776	24		58092671	58119113	8421504	2	23,1	0,26441	c	350021977600000000	9-33					Patent	Function regulator for retinoid relative receptor (Patent US:7223791)	Kimura	2007	0		PPARG
1028	chr22	58092671	58119113	3500193845	24		58092671	58119113	8421504	2	23,1	0,26441	c	350019384500000008	9-33						1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity	Maekawa	2006	0		PPARG
1028	chr22	58092671	58119113	3500179448	24		58092671	58119113	8421504	2	23,1	0,26441	c	350017944800000001	0-24			10.1186/1471-2407-6-53	1471-2407	BMC Cancer	PPAR&#xce;&#xb3;-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma	Chaffer	2006	3		PPARG
1028	chr22	58092671	58119113	3500141286	24		58092671	58119113	8421504	2	23,1	0,26441	c	350014128600000000	9-33					Patent	Alkanoic acid derivatives process for their production and use thereof (Patent US:7238716)	Momose	2007	0		PPARG
1028	chr22	58092671	58119113	3500111532	24		58092671	58119113	8421504	2	23,1	0,26441	c	350011153200000000	9-33					Patent	Function regulator for retinoid relative receptor (Patent US:7223791)	Kimura	2007	0		PPARG
1028	chr22	58092671	58119113	3500050431	24		58092671	58119113	8421504	2	23,1	0,26441	c	350005043100000008,350005043100000000	9-33,9-33						ALKANOIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF	Momose	2001	0		PPARG
1028	chr22	58092671	58119113	3500048317	24		58092671	58119113	8421504	2	23,1	0,26441	c	350004831700000008	9-33					Patent	Furan or thiophene derivative and medicinal use thereof (Patent US:7553867)	Amano	2009	0		PPARG
1028	chr22	58092673	58119201	3500460001	46		58092673	58119201	8421504	3	21,3,22	0,26439,26506	c	350046000100000013,350046000100000012	0-24,0-22		17823662	10.1172/JCI31986	0021-9738	The Journal of Clinical Investigation	Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice	Nomiyama	2007	13		PPARG
1028	chr22	58092673	58119201	3500112114	46		58092673	58119201	8421504	3	21,3,22	0,26439,26506	c	350011211400000013,350011211400000012	0-24,0-22			10.1172/JCI31986		The Journal of Clinical Investigation	Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice	Takashi	2007	0		
1028	chr22	58092673	58119201	3500041106	46		58092673	58119201	8421504	3	21,3,22	0,26439,26506	c	350004110600000013,350004110600000012	0-24,0-22		17823662	10.1172/JCI31986	0021-9738	The Journal of Clinical Investigation	Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice	Nomiyama	2007	13		
1028	chr22	58092675	58119117	3500426753	24		58092675	58119117	8421504	2	19,5	0,26437	c	350042675300000004	0-24		15635089	10.1091/mbc.E04-10-0949	1059-1524	Molecular Biology of the Cell	Isolation and Transcription Profiling of Purified Uncultured Human Stromal Stem Cells: Alteration of Gene Expression after In Vitro Cell Culture	Boquest	2005	5		
1028	chr22	58092675	58119117	3500423532	24		58092675	58119117	8421504	2	19,5	0,26437	c	350042353200000004	0-24						Isolation and Transcription Pro&#xfb01;ling of Puri&#xfb01;ed Uncultured Human Stromal Stem Cells: Alteration of Gene Expression after In Vitro Cell Culture D	edivetarizona.com	0	0		
1028	chr22	58092675	58119117	3500070652	24		58092675	58119117	8421504	2	19,5	0,26437	c	350007065200000004	0-24			10.1091/mbc.E04-10-0949		Molecular Biology of the Cell	Isolation and Transcription Profiling of Purified Uncultured Human Stromal Stem Cells: Alteration of Gene Expression after In Vitro Cell Culture	Andrew	2005	0		
1028	chr22	58119137	58119243	3500463464	88		58119137	58119243	8421504	3	21,17,50	0,36,56	c	350046346400000019,350046346400000045	19-40,0-74						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
1028	chr22	58119138	58119239	3500455501	40		58119138	58119239	8421504	2	20,20	0,81	c,g	350045550100000008,350045550100000008,350045550100000007,350045550100000007	0-20,0-20,0-20,0-20						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
1028	chr22	58119138	58119239	3500301078	40		58119138	58119239	8421504	2	20,20	0,81	c,g	350030107800000056,350030107800000056,350030107800000055,350030107800000055	0-20,0-20,0-20,0-20						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
1028	chr22	58119217	58119306	3500221840	40		58119217	58119306	8421504	2	20,20	0,69	c,g	350022184000000004,350022184000000004,350022184000000003	0-20,0-20,0-20						Glucose-6-phosphate dehydrogenase and leptin are related to marbling differences J Anim Sci 2007.85:2882-2894.	ountaincattle.com	0	0		
1029	chr22	58263960	58263987	3500116359	23		58263960	58263987	8421504	2	14,9	0,18	g	350011635900000030	0-23						Integrated approach for generating multidomain protein therapeutics	Allan	2010	0		
1030	chr22	58419705	58419729	3500299746	23		58419705	58419729	8421504	2	19,4	0,20	g	350029974600000019	11-39						Streptomyces Protease	Jones	2010	0		
1032	chr22	58599485	58599516	3500113379	24		58599485	58599516	8421504	3	11,7,6	0,14,25	g	350011337900000130	1-27						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
1032	chr22	58609883	58617679	3500091230	315		58609883	58617679	8421504	9	45,45,41,4,45,45,29,16,45	0,96,4807,5590,5597,5693,5741,7732,7751	p	350009123000015049,350009123000015044,350009123000015035,350009123000015030,350009123000015022,350009123000015017,350009123000015053	0-45,0-45,0-45,0-45,0-45,0-45,0-45						Methods and Compositions Related to TR4 - Patent application	www.faqs.org	0	0		NR2C2
1032	chr22	58638479	58638503	3500418553	24		58638479	58638503	8421504	1	24	0	c,g	350041855300000028,350041855300000028	0-24,0-24						Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1. - ResearchGate	.researchgate.net	0	0		NR2C2
1033	chr22	58725808	58725837	3500276320	24		58725808	58725837	8421504	2	8,16	0,13	g	350027632000000030,350027632000000007	13-37,13-37						DNA-transfection system for the generation of infectious influenza virus - Patent application	www.faqs.org	0	0		
1033	chr22	58725808	58725837	3500068587	24		58725808	58725837	8421504	2	8,16	0,13	g	350006858700000014	13-37					Patent	Dna-transfection system for generation of infectious influenza virus (Patent CN:101580849)	E*Huo Fu Man 	2012	0		
1033	chr22	58725809	58725837	3500199205	23		58725809	58725837	8421504	2	7,16	0,12	g	350019920500000226	13-36						Influenza Therapeutic	Chen	2007	0		
1034	chr22	58925876	58925905	3500274418	25		58925876	58925905	8421504	3	7,13,5	0,8,24	g	350027441800000049	4-29						Hcv e1e2 vaccine compositions	M*Hao Dun 	2007	0		
1036	chr22	59219957	59219983	3500394930	26		59219957	59219983	8421504	1	26	0	c	350039493000000004	0-26						Modulation of activation&#x2010;associated host cell gene expression by the apicomplexan parasiteTheileria annulata | Zeeshan Durrani &#x0630;&#x0626;&#x0634;&#x0627;&#x0646; &#x062f;&#x0631;&#x0627;&#x0646;&#x0626; - Academia.edu	www.academia.edu	0	0		
1036	chr22	59234705	59240168	3500156335	90		59234705	59240168	8421504	2	45,45	0,5418	p	350015633500015022,350015633500015018	0-45,0-45						METHOD FOR PRODUCING A CELL CAPABLE OF HIGH-YIELD PRODUCTION OF HETEROPROTEINS - Patent application	www.faqs.org	0	0		
1037	chr22	59366393	59366417	3500360474	23		59366393	59366417	8421504	2	17,6	0,18	g	350036047400000036	11-34						Gene encoding for a transmembrane protein	Shimizu	2000	0		
1038	chr22	59424600	59424626	3500354111	23		59424600	59424626	8421504	2	11,12	0,14	g	350035411100000018,350035411100000020	9-32,10-33						The RssAB-FlhDC-ShlBA as a Dominant Pathogenesis Pathway in Serratia marcescens	search.cgu.edu.tw	0	0		
1038	chr22	59475009	59475033	3500332833	24		59475009	59475033	8421504	1	24	0	c	350033283300000068	24-48						Heat tolerant phytases	Loon	2000	0		
129	chr22	59588181	59651981	3500380369	1047		59588181	59651981	8421504	4	71,227,272,477	0,4637,21401,63323	p	350038036900015007	0-1047						KEGG T01001: 51384	www.genome.jp	0	0		WNT7A
129	chr22	59588181	59651981	3500022001	1047		59588181	59651981	8421504	4	71,227,272,477	0,4637,21401,63323	p	350002200100015001	0-1047						 Human Wnt7a Polypeptides 	www.docstoc.com	0	0		WNT7A
1039	chr22	59588193	59609602	3500138915	114		59588193	59609602	8421504	4	59,1,34,20	0,4625,4818,21389	p	350013891500015007,350013891500015032	0-60,0-54						Expression of multiple novel WnM/inM-related genes during fetal and adult mouse development	enesdev.cshlp.org	0	0		WNT7A
1039	chr22	59588200	59588224	3500355764	24		59588200	59588224	8421504	1	24	0	c	350035576400000043,350035576400000083	0-24,0-24						WNT PROTEINS AND DETECTION AND TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
1040	chr22	59651523	59651558	3500252803	35		59651523	59651558	8421504	1	35	0	c	350025280300000015	13-48						Wnt-7B-like polypeptides and nucleic acids encoding same	Vernet	2000	0		
1040	chr22	59651666	59651965	3500451109	42		59651666	59651965	8421504	2	21,21	0,278	c	350045110900000008,350045110900000009	0-21,0-21						Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas	Rhee	2002	0		WNT7A
1040	chr22	59651666	59651965	3500392487	42		59651666	59651965	8421504	2	21,21	0,278	c	350039248700000008,350039248700000009	0-21,0-21						Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas - Patent # 7682607 - PatentGenius	.patentgenius.com	0	0		WNT7A
1040	chr22	59651666	59651965	3500339762	42		59651666	59651965	8421504	2	21,21	0,278	c	350033976200000120,350033976200000121	0-21,0-21						Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas	Rhee	2002	0		WNT7A
1040	chr22	59651666	59651965	3500310758	42		59651666	59651965	8421504	2	21,21	0,278	c	350031075800000008,350031075800000009	0-21,0-21						Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas	Carson	2002	0		WNT7A
1040	chr22	59651911	59651934	3500360836	23		59651911	59651934	8421504	1	23	0	c	350036083600000007	19-42						Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic Leukemia and Oligonucleotides for Use in this Method	Bryja	2010	0		WNT5A
1040	chr22	59651915	59651938	3500217565	23		59651915	59651938	8421504	1	23	0	c	350021756500000009	0-23						Activation of the Canonical Wingless/T-Cell Factor Signaling Pathway Promotes Invasive Differentiation of Human Trophoblast 2006&#x5e74;&#x7b2c;168&#x5377;&#x7b2c;4&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1040	chr22	59767619	59767644	3500358635	23		59767619	59767644	8421504	2	8,15	0,10	g	350035863500000003	11-34						Down-Regulation of Type I Runx2 Mediated by Dexamethasone Is Required for 3T3-L1 Adipogenesis	.endojournals.org	0	0		
1043	chr22	60055842	60055865	3500101538	23		60055842	60055865	8421504	1	23	0	g	350010153800000472	1-25						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
1045	chr22	60367940	60367968	3500127308	24		60367940	60367968	8421504	2	13,11	0,17	g	350012730800000258	24-48						PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS - Patent application	www.faqs.org	0	0		
1047	chr22	60560223	60560247	3500399152	23		60560223	60560247	8421504	2	17,6	0,18	g	350039915200000076	18-41						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease - US Patent 6790612 Description	ww.patentstorm.us	0	0		
1047	chr22	60625423	60625483	3500375359	60		60625423	60625483	8421504	1	60	0	p	350037535900015000	0-60		12588852	10.1242/dev.00349	0950-1991	Development	The zinc-finger protein CNBP is required for forebrain formation in the mouse	Chen	2003	7		CNBP
1047	chr22	60626525	60626689	3500424538	45		60626525	60626689	8421504	2	44,1	0,163	p	350042453800015001	0-45		23642268	10.1186/1423-0127-20-27	1423-0127	Journal of Biomedical Science	Proteomic analyses and identification of arginine methylated proteins differentially recognized by autosera from anti-Sm positive SLE patients	Chang	2013	0		CNBP
130	chr22	60685927	60703348	3500385871	97		60685927	60703348	8421504	3	30,46,21	0,9559,17400	c,g	350038587100000000,350038587100000001,350038587100000002,350038587100000002,350038587100000003,350038587100000003	3-33,9-32,5-29,5-29,1-22,1-22		16940185	10.1128/MCB.01055-06	0270-7306	Molecular and Cellular Biology	Coatomer, the Coat Protein of COPI Transport Vesicles, Discriminates Endoplasmic Reticulum Residents from p24 Proteins	Bethune	2006	6		
130	chr22	60685927	60703348	3500020887	97		60685927	60703348	8421504	3	30,46,21	0,9559,17400	c,g	350002088700000000,350002088700000001,350002088700000002,350002088700000003,350002088700000003	3-33,9-32,5-29,1-22,1-22			10.1128/MCB.01055-06		Molecular and Cellular Biology	Coatomer, the Coat Protein of COPI Transport Vesicles, Discriminates Endoplasmic Reticulum Residents from p24 Proteins 	Julien	2006	0		
1048	chr22	60719302	60719328	3500195666	25		60719302	60719328	8421504	2	9,16	0,10	c	350019566600000051	6-44						Recombinational cloning using nucleic acids having recombination sites	Hartley	2001	0		
1048	chr22	60719302	60719328	3500008837	25		60719302	60719328	8421504	2	9,16	0,10	c	350000883700000095,350000883700000048	6-44,6-44						Recombinational cloning using nucleic acids having recombination sites	Hartley	1999	0		
1048	chr22	60728073	60728099	3500053431	24		60728073	60728099	8421504	2	5,19	0,7	g	350005343100000268	0-24					Patent	Binding agents which inhibit myostatin (Patent US:7928075)	Han	2011	0		
1048	chr22	60750297	60756911	3500376180	348		60750297	60756911	8421504	3	183,127,38	0,4340,6576	p	350037618000015030	18-366						Lung Cancer Diagnostic Assay - Patent application	www.faqs.org	0	0		RAB7A
1048	chr22	60750297	60756911	3500209076	348		60750297	60756911	8421504	3	183,127,38	0,4340,6576	p	350020907600015031	18-366						Lung Cancer Diagnostic Assay	Hirschowitz	2006	0		RAB7A
1048	chr22	60757287	60757316	3500118045	26		60757287	60757316	8421504	3	11,11,4	0,13,25	g	350011804500000082	4-30						Proteases and variants thereof - US Patent 7537922 Description	ww.patentstorm.us	0	0		
1050	chr22	60959760	60959785	3500112704	23		60959760	60959785	8421504	2	17,6	0,19	g	350011270400000137	25-48						COMPOSITIONS FOR CONTROLLING HAIR GROWTH - Patent application	www.faqs.org	0	0		
1050	chr22	60995908	60995936	3500354494	23		60995908	60995936	8421504	2	6,17	0,11	g	350035449400000258,350035449400000259	0-24,4-28						Modified cytosine deaminases - Patent application	www.faqs.org	0	0		
1050	chr22	61067182	61067213	3500459220	26		61067182	61067213	8421504	2	7,19	0,12	g	350045922000000269	14-41						 M. Tuberculosis Antigens 	www.docstoc.com	0	0		
1051	chr22	61105083	61105107	3500182346	24		61105083	61105107	8421504	1	24	0	c	350018234600000009	0-24						MYCN -< NME1	wanglab.ucsd.edu	0	0		RUVBL1
1051	chr22	61108565	61128305	3500387039	93		61108565	61128305	8421504	3	3,42,48	0,7343,19692	p	350038703900015002	30-123		19299493	10.1093/hmg/ddp134		Human Molecular Genetics	Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery	Mariangels	June	0		RUVBL1
1051	chr22	61143327	61143351	3500031192	24		61143327	61143351	8421504	1	24	0	c	350003119200000015	10-34						PRODUCTS AND METHODS FOR ENHANCED TRANSGENE EXPRESSION AND PROCESSING - Patent application	www.faqs.org	0	0		
1051	chr22	61143339	61145079	3500164379	360		61143339	61145079	8421504	3	175,77,108	0,1201,1632	p	350016437900015031	180-720						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		
1054	chr22	61485079	61485103	3500034782	23		61485079	61485103	8421504	2	12,11	0,13	g	350003478200000130	1-24						A PLANT CHITINASE GENE AND USE THEREOF - Danisco, A/s Mikkelsen Jorn Dalgaard Bojsen Kirsten Nielsen Klaus K.	www.sumobrain.com	0	0		
1054	chr22	61501980	61502097	3500463464	113		61501980	61502097	8421504	3	9,6,98	0,11,19	c	350046346400000012,350046346400000003	6-120,19-39						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
585	chr23	60141	60265	3500434928	76		60141	60265	8421504	2	55,21	0,103	g	350043492800000411,350043492800000267,350043492800000707,350043492800000609	0-56,0-51,0-21,0-21						Compositions, methods and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals - Patent application	www.faqs.org	0	0		
585	chr23	60141	60196	3500238669	55		60141	60196	8421504	1	55	0	g	350023866900000262,350023866900000080	0-51,0-21						Compositions, methods, and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals	Bates	2005	0		
585	chr23	101494	101522	3500063338	24		101494	101522	8421504	2	15,9	0,19	g	350006333800000195	0-24						Methods for producing polypeptides in protease-deficient mutants of trichoderma	A.Zhan 	2012	0		
593	chr23	1086619	1086643	3500416691	23		1086619	1086643	8421504	2	9,14	0,10	g	350041669100000006	0-23						US Patent # 6,335,424. ribG - Patents.com	www.patents.com	0	0		
74	chr23	1305558	1437264	3500110072	1332		1305558	1437264	8421504	7	223,179,244,116,221,122,227	0,94085,101657,115336,125088,127986,131479	p	350011007200015000	0-1332						KEGG T01001: 3062	www.genome.jp	0	0		HCRTR2
595	chr23	1433578	1433603	3500149069	25		1433578	1433603	8421504	1	25	0	c	350014906900000016	0-25		11282968	10.1101/gr.161001	1088-9051	Genome Research	Identification and Functional Analysis of Mutations in the Hypocretin (Orexin) Genes of Narcoleptic Canines	Hungs	2001	14		
595	chr23	1433578	1433603	3500052484	25		1433578	1433603	8421504	1	25	0	c	350005248400000016	0-25		11282968	10.1101/gr.161001	1088-9051	Genome Research	Identification and Functional Analysis of Mutations in the Hypocretin (Orexin) Genes of Narcoleptic Canines	Hungs	2001	14		
596	chr23	1559123	1559153	3500177869	27		1559123	1559153	8421504	2	11,16	0,14	g	350017786900000068	4-32						US Patent # 6,123,949. Recombinant fowlpox virus S-FPV-043 and uses thereof - Patents.com	www.patents.com	0	0		
598	chr23	1820184	1820210	3500301316	25		1820184	1820210	8421504	2	13,12	0,14	g	350030131600000013	0-28						Protective helicobacter antigens	Doidge	1996	0		
598	chr23	1820184	1820210	3500115313	25		1820184	1820210	8421504	2	13,12	0,14	g	350011531300000015	0-28						Protective helicobacter antigens	Doidge	1997	0		
74	chr23	1944924	1967763	3500447411	332		1944924	1967763	8421504	3	83,195,54	0,84,22785	g	350044741100000008,350044741100000007,350044741100000006,350044741100000005,350044741100000000	0-99,0-59,0-60,0-60,7-61						Osteoinductive compositions	Celeste	1990	0		
74	chr23	1944924	1967763	3500391943	433		1944924	1967763	8421504	4	83,195,101,54	0,84,4352,22785	g	350039194300000008,350039194300000007,350039194300000006,350039194300000005,350039194300000004,350039194300000003,350039194300000000	0-99,0-59,0-60,0-60,0-41,0-60,7-61						Osteoinductive compositions	Celeste	1991	0		
74	chr23	1944924	1967763	3500090126	433		1944924	1967763	8421504	4	83,195,101,54	0,84,4352,22785	g	350009012600000008,350009012600000007,350009012600000006,350009012600000005,350009012600000004,350009012600000003,350009012600000000	0-99,0-59,0-60,0-60,0-41,0-60,7-61						Osteoinductive compositions	Celeste	1990	0		
74	chr23	1944925	1967763	3500463073	331		1944925	1967763	8421504	3	82,195,54	0,83,22784	g	350046307300000008,350046307300000007,350046307300000006,350046307300000005,350046307300000000	0-98,0-59,0-60,0-60,7-61						 BMP 	www.docstoc.com	0	0		
74	chr23	1944925	1967763	3500323542	331		1944925	1967763	8421504	3	82,195,54	0,83,22784	g	350032354200000008,350032354200000007,350032354200000006,350032354200000005,350032354200000000	0-98,0-59,0-60,0-60,7-61						Bmp-5 derivatives	Celeste	1992	0		
599	chr23	1944925	1945077	3500362999	151		1944925	1945077	8421504	2	82,69	0,83	g	350036299900000009	0-151					Patent	Methods for producing BMP-7 proteins (Patent US:5366875)	Rosen	1994	0		
599	chr23	1944925	1945024	3500341511	98		1944925	1945024	8421504	2	82,16	0,83	g	350034151100000000	0-98						DNA sequences encoding BMP-7 proteins	Rosen	1989	0		
599	chr23	1944925	1945024	3500338138	98		1944925	1945024	8421504	2	82,16	0,83	g	350033813800000000	0-98						DNA sequences encoding BMP-7 proteins - US Patent 5141905 Description	ww.patentstorm.us	0	0		
599	chr23	1944925	1945024	3500200239	98		1944925	1945024	8421504	2	82,16	0,83	g	350020023900000000	0-98						DNA sequences encoding BMP-6 proteins	Wozney	1990	0		
600	chr23	2011246	2011409	3500096253	43		2011246	2011409	8421504	2	22,21	0,142	g	350009625300000001,350009625300000000	0-22,0-21						Revista Brasileira de Zootecnia	www.scielo.br	0	0		
600	chr23	2085020	2085046	3500135665	26		2085020	2085046	8421504	1	26	0	g	350013566500000006	0-42					Patent	Method of treating glaucoma comprising administering a composition comprising human BMP7 (Patent US:8063013)	Clark	2011	0		
602	chr23	2316495	2316831	3500128992	30		2316495	2316831	8421504	2	6,24	0,312	g	350012899200000059	0-30						Multiplexed assay and probes for identification of HPV types	Pourmand	2007	0		
608	chr23	3052132	3052157	3500070087	24		3052132	3052157	8421504	2	14,10	0,15	g	350007008700000026	0-24						Increased ethanol production from xylose - Patent #08071298	w.strutpatent.com	0	0		
608	chr23	3052132	3052157	3500030645	24		3052132	3052157	8421504	2	14,10	0,15	g	350003064500000026,350003064500000058	0-24,0-24						Increased Ethanol Production from Xylose - Patent application	www.faqs.org	0	0		
609	chr23	3200215	3200242	3500014455	23		3200215	3200242	8421504	2	7,16	0,11	g	350001445500000036	0-23						Methods for producing avian verotoxin antitoxin	Williams	1999	0		
621	chr23	4737288	4737312	3500374151	23		4737288	4737312	8421504	2	7,16	0,8	g	350037415100000171	1-24					Patent	Genetically engineered vaccine strain (Patent EP:0575491)	Cox	2003	0		
621	chr23	4737288	4737312	3500089835	23		4737288	4737312	8421504	2	7,16	0,8	g	350008983500000173	1-24						Genetically engineered vaccine strain	filed	2003	0		
633	chr23	6389724	6389754	3500430558	24		6389724	6389754	8421504	3	12,4,8	0,17,22	g	350043055800000009	1-28						Domain II Mutants Of Anthrax Lethal Factor	Duesbery	2005	0		
637	chr23	6820197	6820224	3500087648	23		6820197	6820224	8421504	2	7,16	0,11	c	350008764800000082	13-36						MOLECULAR CLONING AND SEQUENCING OF FISH MPR 300	d.inflibnet.ac.in	0	0		
637	chr23	6924244	6924272	3500029159	23		6924244	6924272	8421504	3	4,6,13	0,5,15	g	350002915900000022	14-39						Compositions for the prevention and treatment of verotoxin-induced disease	Williams	1997	0		
637	chr23	6924244	6924272	3500014455	23		6924244	6924272	8421504	3	4,6,13	0,5,15	g	350001445500000022	14-39						Methods for producing avian verotoxin antitoxin	Williams	1999	0		
637	chr23	6930393	6930422	3500003486	23		6930393	6930422	8421504	3	4,13,6	0,5,23	g	350000348600000115	19-42						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		
640	chr23	7209396	7209426	3500086911	24		7209396	7209426	8421504	3	5,13,6	0,8,24	g	350008691100000040	5-31						Response regulator - US Patent 6294652 Description	ww.patentstorm.us	0	0		
640	chr23	7222528	7222552	3500325133	24		7222528	7222552	8421504	1	24	0	g	350032513300000004	0-24		15561710	10.1074/jbc.M408531200	0021-9258	Journal of Biological Chemistry	Acceleration of Glutathione Efflux and Inhibition of &#x03b3;-Glutamyltranspeptidase Sensitize Metastatic B16 Melanoma Cells to Endothelium-induced Cytotoxicity	Benlloch	2005	5		GCLC
640	chr23	7222528	7222552	3500296080	24		7222528	7222552	8421504	1	24	0	g	350029608000000004	0-24						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> <!-- saved from url=(0046)http://www	www.uv.es/lopezr/	0	0		GCLC
640	chr23	7256291	7256314	3500456523	23		7256291	7256314	8421504	1	23	0	c	350045652300000002	19-42						THE ROLE OF NRF2 IN PREVENTING OXIDATIVE	holarworks.ku.edu	0	0		
641	chr23	7392923	7392950	3500431462	23		7392923	7392950	8421504	3	13,5,5	0,15,22	c	350043146200000296	6-29						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
641	chr23	7392923	7392950	3500110550	23		7392923	7392950	8421504	3	13,5,5	0,15,22	c	350011055000000286	6-29						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
641	chr23	7392923	7392950	3500031022	23		7392923	7392950	8421504	3	13,5,5	0,15,22	c	350003102200000286	6-29						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
641	chr23	7407545	7408663	3500375699	287		7407545	7408663	8421504	2	102,185	0,933	g	350037569900000008	0-287						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
641	chr23	7417980	7418008	3500264853	28		7417980	7418008	8421504	1	28	0	c	350026485300000029	0-28						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		PSMB9
641	chr23	7417980	7418008	3500205152	28		7417980	7418008	8421504	1	28	0	c	350020515200000029	0-28						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		PSMB9
642	chr23	7473268	7473291	3500029950	23		7473268	7473291	8421504	1	23	0	c	350002995000000671	0-23						ESCUELA SUPERIOR POLITECNICA DEL LITORAL Facultad de Ingenier&#xed;a Mec&#xe1;nica y Ciencias de la Producci&#xf3;n. Programa de Maestr&#xed;a en Biotecnolog&#xed;a Agr&#xed;cola	pace.espol.edu.ec	0	0		
642	chr23	7473271	7473402	3500166204	79		7473271	7473402	8421504	3	22,42,15	0,23,116	c	350016620400000027	0-145						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
642	chr23	7475921	7476101	3500429819	67		7475921	7476101	8421504	2	31,36	0,144	c	350042981900000258,350042981900000255	17-48,12-48						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
642	chr23	7490623	7490647	3500371190	24		7490623	7490647	8421504	1	24	0	c	350037119000000001	0-24						Review of microsatellites in ecology and parentage analysis of Norwegian beavers (Castor fiber based on cross-specific microsatellites	teora.hit.no	0	0		CYP24A1
642	chr23	7491139	7491163	3500346255	24		7491139	7491163	8421504	1	24	0	c	350034625500000018	24-48						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		
642	chr23	7585528	7585551	3500280145	23		7585528	7585551	8421504	1	23	0	c	350028014500000074	19-43						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2003	0		
642	chr23	7585869	7585892	3500044265	23		7585869	7585892	8421504	1	23	0	c	350004426500000001	5-28			10.1186/1472-6807-7-57		BMC Structural Biology	Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails	Hongda	2007	0		
642	chr23	7588858	7588884	3500060896	26		7588858	7588884	8421504	1	26	0	c	350006089600000204,350006089600000102	20-43,13-34						Polypeptides and polynucleotides from coagulase-negative staphylococci	Foster	1999	0		BRD2
642	chr23	7588858	7588884	3500028179	26		7588858	7588884	8421504	1	26	0	c,g	350002817900000210,350002817900000194,350002817900000194,350002817900000108	20-43,26-48,26-48,13-34						Polypeptides And Polynucleotides From Coagulase-negative Staphylococci 	.freshpatents.com	0	0		BRD2
643	chr23	7612834	7612863	3500307902	29		7612834	7612863	8421504	1	29	0	c	350030790200000131	6-35						Mhc complexes and uses thereof	Chavaillaz	1996	0		
643	chr23	7675410	7677391	3500362432	456		7675410	7677391	8421504	7	133,2,16,133,130,6,36	0,243,743,874,1219,1894,1945	p	350036243200015024,350036243200015016,350036243200015013	0-135,0-180,0-180						&#x5e73;&#x6210;&#xff11;&#xff15;&#x5e74;&#x5ea6; &#x5185;&#x5206;&#x6ccc;&#x652a;&#x4e71;&#x5316;&#x5b66;&#x7269;&#x8cea;&#x7b49;&#x306e;&#x4f5c;&#x7528; &#x30e1;&#x30ab;&#x30cb;&#x30ba;&#x30e0;&#x306e;&#x89e3;&#x660e;&#x7b49;&#x57fa;&#x790e;&#x7684;&#x78	www.env.go.jp	0	0		
643	chr23	7675431	7675455	3500365527	24		7675431	7675455	8421504	1	24	0	c	350036552700000009	0-24			10.1002/art.10106	1529-0131	Arthritis & Rheumatism	Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis - Stokes - 2002 - Arthritis & Rheumatism - Wiley Online Library	Stokes	2002	0		RXRB
643	chr23	7675452	7679828	3500111789	159		7675452	7679828	8421504	4	21,48,48,42	0,635,3691,4334	c	350011178900000031,350011178900000116,350011178900000101,350011178900000098	27-48,0-48,0-48,6-48						Retinoid receptor compositions and methods	Evans	1991	0		RXRB
643	chr23	7676110	7676133	3500377458	23		7676110	7676133	8421504	1	23	0	c	350037745800000002	17-40						Regulation of Mammary Gland Sensitivity to Thyroid Hormones During the Transition from Pregnancy to Lactation	ddr.nal.usda.gov	0	0		
643	chr23	7709355	7709589	3500105943	135		7709355	7709589	8421504	2	107,28	0,206	p	350010594300015087,350010594300015088,350010594300015089	0-45,0-45,0-45						Tumor necrosis factor receptor-associated factors	Goeddel	1997	0		
643	chr23	7709427	7711973	3500193670	40		7709427	7711973	8421504	2	20,20	0,2526	c	350019367000000098,350019367000000168	0-20,26-46						Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors - Patent application	www.faqs.org	0	0		
80	chr23	7712168	7742022	3500231380	42		7712168	7742022	8421504	2	22,20	0,29834	c	350023138000000009,350023138000000012	18-40,20-40						 SpringerImages - Bovine markers developed for RH mapping 	pringerimages.com	0	0		HCG25,RING1
644	chr23	7759633	7764209	3500170315	453		7759633	7764209	8421504	7	3,99,24,60,102,92,73	0,467,3915,3942,4089,4301,4503	p	350017031500015089,350017031500015091	0-210,0-243						Balding D. (2007) Handbook of Statistical Genetics	www.scribd.com	0	0		RPS18
644	chr23	7760179	7763552	3500323262	24		7760179	7763552	8421504	2	20,4	0,3369	c	350032326200000002	0-24		20471975	10.1016/j.yexmp.2010.05.002		Experimental and molecular pathology	Expression of Leukemia/Lymphoma-Related Factor (LRF/POKEMON) in Human Breast Carcinoma and Other Cancers	Anshu	2010	0		
644	chr23	7760191	7763768	3500400505	45		7760191	7763768	8421504	3	8,14,23	0,3357,3554	c,g	350040050500000012,350040050500000013,350040050500000013	0-22,0-23,0-23						Selection of reference genes for quantitative RT-PCR studies in striped dolphin (Stenella coeruleoalba) skin biopsies.	.biomedsearch.com	0	0		
644	chr23	7763568	7763760	3500363459	42		7763568	7763760	8421504	2	21,21	0,171	c,g	350036345900000004,350036345900000004,350036345900000005	0-21,0-21,0-21		21701420	10.1097/SHK.0b013e3182279868		Shock (Augusta, Ga.)	Non-hematopoietic TLR2 contributes to neutrophil and cardiac function impairment during polymicrobial sepsis	Lin	2011	0		RPS18
644	chr23	7763568	7763760	3500350885	42		7763568	7763760	8421504	2	21,21	0,171	c,g	350035088500000000,350035088500000000,350035088500000001,350035088500000001	0-21,0-21,0-21,0-21		16648192	10.1152/ajpheart.00112.2006		American Journal of Physiology - Heart and Circulatory Physiology	MyD88 and NOS2 are essential for Toll-like receptor 4-mediated survival effect in cardiomyocytes	Zhu	2006	0		RPS18
644	chr23	7763568	7763760	3500066868	42		7763568	7763760	8421504	2	21,21	0,171	c,g	350006686800000000,350006686800000000,350006686800000001,350006686800000001	0-21,0-21,0-21,0-21		16648192	10.1152/ajpheart.00112.2006		American Journal of Physiology - Heart and Circulatory Physiology	MyD88 and NOS2 are essential for Toll-like receptor 4-mediated survival effect in cardiomyocytes	Zhu	2006	0		RPS18
644	chr23	7763572	7763738	3500435393	44		7763572	7763738	8421504	3	22,6,16	0,57,150	c	350043539300000050,350043539300000051	0-22,0-22						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		RPS18
644	chr23	7763572	7763738	3500180860	44		7763572	7763738	8421504	3	22,6,16	0,57,150	c	350018086000000008,350018086000000009	0-22,0-22						Evidence That High Variation in Ovarian Reserves of Healthy Young Adults Has a Negative Impact on the Corpus Luteum and Endometrium During Estrous Cycles in Cattle	ww.biolreprod.org	0	0		RPS18
644	chr23	7763626	7763989	3500026836	40		7763626	7763989	8421504	3	9,11,20	0,96,343	c	350002683600000011,350002683600000012	0-20,0-20						Adipocyte-Derived Factors Potentiate Nutrient-Induced Production of Plasminogen Activator Inhibitor 1 by Macrophages	tm.sciencemag.org	0	0		RPS18
644	chr23	7763752	7764152	3500035193	120		7763752	7764152	8421504	3	60,44,16	0,230,384	p	350003519300015015,350003519300015017	0-60,0-60						Conserved Ribosomal Protein Sequences S5, S18, S27, S30 in the Pacific Oyster Crassostrea gigas and Crassostrea virginica	clib.kindai.ac.jp	0	0		RPS18
644	chr23	7764185	7764208	3500393382	23		7764185	7764208	8421504	1	23	0	c	350039338200000011	0-23		21669868	10.1074/jbc.M110.210443		The Journal of Biological Chemistry	Protein Kinase C&#x03b8; Is a Specific Target for Inhibition of the HIV Type 1 Replication in CD4+ T Lymphocytes	Maria	2011	0		OR7E156P
644	chr23	7764185	7764208	3500249433	23		7764185	7764208	8421504	1	23	0	c	350024943300000011	0-23						JBC Papers in Press. Published on June 13, 2011 as Manuscript M110.210443 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M110.210443 Role of PKC Theta in HIV-1 Replication	www.jbc.org	0	0		OR7E156P
644	chr23	7764185	7764208	3500016382	23		7764185	7764208	8421504	1	23	0	c	350001638200000011	0-23						Protein kinase C (PKC) theta (&#x03b8;) is a specific target for the inhibition of the human immunodeficiency virus type 1 (HIV-1) replication in CD4+ T lymphocytes | Francisco G&#xf3;mez-Esquer - Academia.edu	www.academia.edu	0	0		CBWD6
644	chr23	7764195	7764219	3500198723	24		7764195	7764219	8421504	1	24	0	c	350019872300000001	0-24						Technical note: Determination of cell-specific gene expression in bovine skeletal muscle tissue using laser microdissection and reverse-transcription quantitative polymerase chain reaction	animalscience.org	0	0		
644	chr23	7801134	7801204	3500175024	40		7801134	7801204	8421504	2	20,20	0,50	c,g	350017502400000010,350017502400000010,350017502400000011	0-20,0-20,0-20						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
644	chr23	7801587	7801613	3500452170	23		7801587	7801613	8421504	2	13,10	0,16	c	350045217000000014	12-35						US Patent # 6,706,509. Oncoprotein protein kinase - Patents.com	www.patents.com	0	0		
644	chr23	7801587	7801613	3500372660	23		7801587	7801613	8421504	2	13,10	0,16	c	350037266000000013	12-35						Oncoprotein protein kinase	Hibi	1995	0		
644	chr23	7801587	7801613	3500037915	23		7801587	7801613	8421504	2	13,10	0,16	c	350003791500000006,350003791500000013	12-35,12-35						ONCOPROTEIN PROTEIN KINASE ANTIBODY KIT - Patent application	www.faqs.org	0	0		
644	chr23	7802501	7803825	3500094668	246		7802501	7803825	8421504	4	8,115,75,48	0,323,1050,1276	p,c	350009466800000011,350009466800015018	0-123,0-123						Interphase-speci&#xfb01;c association of intrinsic centromere protein CENP-C with HDaxx, a death domain-binding protein implicated in Fas-mediated cell death	cs.biologists.org	0	0		
644	chr23	7803966	7803989	3500349494	23		7803966	7803989	8421504	1	23	0	c	350034949400000001,350034949400000000	0-23,0-23		18480747	10.1038/ki.2008.192	0085-2538	Kidney International	Induction of proapoptotic Daxx following ischemic acute kidney injury	Ma	2008	7		DAXX
645	chr23	7900543	7900603	3500195055	60		7900543	7900603	8421504	1	60	0	p	350019505500015002	0-60		23879974	10.1186/2050-6511-14-37	2050-6511	BMC Pharmacology and Toxicology	Polycomblike protein PHF1b: a transcriptional sensor for GABA receptor activity	Saha	2013	0		PHF1
645	chr23	7924765	7929778	3500391614	54		7924765	7929778	8421504	2	21,33	0,4980	p	350039161400015094,350039161400015067,350039161400015113,350039161400015131	81-135,0-54,87-141,6-60						Human monoclonal antibodies against human CXCR4 - US Patent 7138496 Description	ww.patentstorm.us	0	0		
645	chr23	7929088	7929139	3500009842	51		7929088	7929139	8421504	1	51	0	c	350000984200000053,350000984200000222	0-48,0-48						US Patent # 6,723,838. Signal transducing synaptic molecules and uses thereof - Patents.com	www.patents.com	0	0		
645	chr23	7929466	7929495	3500042473	29		7929466	7929495	8421504	1	29	0	c	350004247300000000	48-77						Doxycycline accelerates renal cyst growth and Wbrosis in the pcy mouse model of type 3 nephronophthisis, a form of recessive polycystic kidney disease	uni-regensburg.de	0	0		
645	chr23	7929467	7929496	3500202865	29		7929467	7929496	8421504	1	29	0	c	350020286500000005	9-38						Nucleic acids encoding PTH functional domain conjugate peptides - Patent # 7244834 - PatentGenius	.patentgenius.com	0	0		
645	chr23	7929745	7929985	3500200557	75		7929745	7929985	8421504	2	36,39	0,201	p	350020055700015016	6-96						NON-CYTOTOXIC FUSION PROTEINS COMPRISING EGF MUTEINS	Cossins	2009	0		
645	chr23	7929745	7929985	3500175204	75		7929745	7929985	8421504	2	36,39	0,201	p	350017520400015011	6-96						Non-cytotoxic fusion proteins comprising egf muteins	Cossins	2011	0		
645	chr23	7929745	7929973	3500444747	66		7929745	7929973	8421504	2	39,27	0,201	p	350044474700015023	15-81						NON-CYTOTOXIC PROTEIN CONJUGATES	Foster	2012	0		
645	chr23	7929745	7929973	3500423613	66		7929745	7929973	8421504	2	39,27	0,201	p	350042361300015015	15-81						Non-Cytotoxic Protein Conjugates	Foster	2008	0		
645	chr23	7929745	7929973	3500416678	66		7929745	7929973	8421504	2	39,27	0,201	p	350041667800015016	15-81					Patent	Non-cytotoxic protein conjugates (Patent US:8187834)	Foster	2012	0		
645	chr23	7929745	7929973	3500332622	66		7929745	7929973	8421504	2	39,27	0,201	p	350033262200015031	21-87						Agonist dr5 binding polypeptides	Cromie	2011	0		
645	chr23	7929745	7929973	3500247425	66		7929745	7929973	8421504	2	39,27	0,201	p	350024742500015142,350024742500015017,350024742500015151,350024742500015015,350024742500015083	159-219,213-276,156-216,210-273,216-276						Cxcr2 binding polypeptides	Bradley	2012	0		
645	chr23	7929745	7929973	3500213466	66		7929745	7929973	8421504	2	39,27	0,201	p	350021346600015015	15-81					Patent	Non-cytotoxic protein conjugates (Patent US:7658933)	Foster	2010	0		
645	chr23	7929745	7929973	3500182431	66		7929745	7929973	8421504	2	39,27	0,201	p	350018243100015015	15-81						Non-cytotoxic protein conjugates	Foster	2011	0		
645	chr23	7929745	7929973	3500008524	66		7929745	7929973	8421504	2	39,27	0,201	p	350000852400015019	15-81						NON-CYTOTOXIC PROTEIN CONJUGATES - Patent application	www.faqs.org	0	0		
645	chr23	7929757	7929985	3500227292	66		7929757	7929985	8421504	2	27,39	0,189	p	350022729200015065	81-147						 Streptavidin Expressed Gene Fusions And Methods Of Use Thereof 	www.docstoc.com	0	0		
645	chr23	7937352	7937376	3500441426	23		7937352	7937376	8421504	2	16,7	0,17	c	350044142600000002	0-23		16775306	10.1261/rna.90106	1355-8382	RNA	Arginine methylation regulates mitochondrial gene expression in Trypanosoma brucei through multiple effector proteins	Goulah	2006	5		
645	chr23	7937352	7937376	3500288445	23		7937352	7937376	8421504	2	16,7	0,17	c	350028844500000002	0-23			10.1261/rna.90106		RNA	Arginine methylation regulates mitochondrial gene expression in Trypanosoma brucei through multiple effector proteins	Christopher	2006	0		
645	chr23	7939779	7941162	3500093077	1383		7939779	7941162	8421504	1	1383	0	p	350009307700015000	0-1383						KEGG T01008: 539371	www.genome.jp	0	0		
646	chr23	8085039	8123782	3500152250	182		8085039	8123782	8421504	6	20,28,48,23,25,38	0,14438,29798,32966,33852,38705	c	350015225000000091,350015225000000099,350015225000000113,350015225000000126	0-48,0-48,0-48,0-38						Biosensors to measure InsP3 concentration in living cells - Patent application	www.faqs.org	0	0		
80	chr23	8112269	8146816	3500200974	40		8112269	8146816	8421504	3	21,10,9	0,33672,34538	c,g	350020097400000000,350020097400000000,350020097400000001	0-21,0-21,0-19			10.1111/j.1471-4159.2006.04245.x	1471-4159	Journal of Neurochemistry	Alcohol-induced blood&#x2013;brain barrier dysfunction is mediated via inositol 1,4,5-triphosphate receptor (IP3R)-gated intracellular calcium release - Haorah - 2006 - Journal of Neurochemistry - Wiley Online Library	Haorah	2007	0		
647	chr23	8150172	8151474	3500029380	28		8150172	8151474	8421504	2	17,11	0,1291	c	350002938000000005	28-56						The role of Akt2 and SGK1 in dendritic cells	.uni-tuebingen.de	0	0		ITPR3
647	chr23	8241697	8241722	3500025568	25		8241697	8241722	8421504	1	25	0	c	350002556800000207	9-36						US Patent # 7,105,305. Human platelet-derived growth factor receptors - Patents.com	www.patents.com	0	0		
650	chr23	8625975	8626038	3500353414	63		8625975	8626038	8421504	1	63	0	p	350035341400015001	0-63						HMGA binding nucleic acids	Jarosch	2006	0		HMGA1
650	chr23	8628989	8629018	3500408876	29		8628989	8629018	8421504	1	29	0	c	350040887600000013	0-29						 Microarray Analysis and RNA Silencing Link fra-1 to cd44 and c-met Expression in Mesothelioma1 	www.docstoc.com	0	0		HMGA1
651	chr23	8664192	8665729	3500207374	66		8664192	8665729	8421504	2	21,45	0,1492	p	350020737400015022	0-66						Biochemical and functional characterization of Nudix hydrolase enzymes with novel regulatory roles in Gram positive methylotrophic bacteria	tations.ub.rug.nl	0	0		HMGA1
652	chr23	8869993	8872435	3500075034	90		8869993	8872435	8421504	3	3,42,45	0,929,2397	p	350007503400015024,350007503400015031	0-45,0-45						AGENTS FOR PROPHYLAXIS OR TREATMENT OF NEUROLOGICAL RELATED DISEASES AND CONDITIONS - Patent application	www.faqs.org	0	0		PACSIN1
652	chr23	8881911	8888356	3500152602	63		8881911	8888356	8421504	3	21,21,21	0,6395,6424	c	350015260200000000,350015260200000002,350015260200000001	0-21,0-21,0-21		17483333	10.1158/0008-5472.CAN-06-3689	0008-5472	Cancer Research	Reduced PDEF Expression Increases Invasion and Expression of Mesenchymal Genes in Prostate Cancer Cells	Gu	2007	8		SPDEF
655	chr23	9177815	9177841	3500456123	26		9177815	9177841	8421504	1	26	0	c	350045612300000102	3-29						Expression cassettes for seed-preferential expression in plants - Patent application	www.faqs.org	0	0		
656	chr23	9369612	9369635	3500325127	23		9369612	9369635	8421504	1	23	0	c	350032512700000031	2-31						Method For Detecting Gene Specifying Allergic Predisposition 	.freshpatents.com	0	0		
657	chr23	9557960	9557983	3500290237	23		9557960	9557983	8421504	1	23	0	c	350029023700000000	1-24						Def-6,aGuanineNucleotideExchangeFactorforRac1, InteractswiththeSkeletalMuscleIntegrinChain andInfluencesMyoblastDifferentiation	www.jbc.org	0	0		
658	chr23	9665150	9677897	3500304394	1320		9665150	9677897	8421504	6	130,155,139,203,451,242	0,8540,9459,10814,11185,12505	p	350030439400015050	0-1320						Ppar Active Compounds 	.freshpatents.com	0	0		
658	chr23	9665193	9673691	3500345006	44		9665193	9673691	8421504	3	21,22,1	0,65,8497	c	350034500600000004,350034500600000005	0-21,0-23		19826104	10.1152/ajpendo.00505.2009		American Journal of Physiology - Endocrinology and Metabolism	Changed mitochondrial function by pre- and/or postpartum diet alterations in sheep	Jorgensen	2009	0		
658	chr23	9665193	9673691	3500258055	44		9665193	9673691	8421504	3	21,22,1	0,65,8497	c	350025805500000004,350025805500000005	0-21,0-23		19826104	10.1152/ajpendo.00505.2009		American Journal of Physiology - Endocrinology and Metabolism	Changed mitochondrial function by pre- and/or postpartum diet alterations in sheep	Jorgensen	2009	0		
658	chr23	9673711	9674669	3500281920	40		9673711	9674669	8421504	2	20,20	0,938	c,g	350028192000000030,350028192000000031,350028192000000031	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
658	chr23	9674672	9674700	3500157662	28		9674672	9674700	8421504	1	28	0	c	350015766200000005	0-28						Efecto de la atorvastatina sobre la expresi&#xf3;n vascular de los PPAR en conejos dislip&#xe9;micos | Cl&#xed;nica e Investigaci&#xf3;n en Arteriosclerosis	zl.elsevier.es	0	0		PPARD
658	chr23	9676068	9676135	3500004704	45		9676068	9676135	8421504	2	22,23	0,44	c	350000470400000004,350000470400000008	0-22,0-23						LIPOTOXICITY IN SMOOTH MUSCLE A Dissertation presented to the Faculty of the Graduate School	pace.umsystem.edu	0	0		
658	chr23	9676437	9676629	3500213123	96		9676437	9676629	8421504	2	48,48	0,144	c	350021312300000107,350021312300000110	0-48,0-48						PPAR active compounds - Patent application	www.faqs.org	0	0		
658	chr23	9676541	9676720	3500140729	40		9676541	9676720	8421504	2	20,20	0,159	c,g	350014072900000002,350014072900000003,350014072900000003	0-20,0-20,0-20		23304114	10.1155/2012/891841		PPAR Research	Effect of 2,4-Thiazolidinedione on Limousin Cattle Growth and on Muscle and Adipose Tissue Metabolism	M.	2012	0		
658	chr23	9676690	9677710	3500126453	46		9676690	9677710	8421504	2	24,22	0,998	c	350012645300000002,350012645300000001	0-24,0-22						Functional Characterization of Peroxisome Proliferator-Activated Receptor-bd Expression in Colon Cancer	www.cmtc.psu.edu	0	0		PPARD
658	chr23	9676690	9677710	3500072224	46		9676690	9677710	8421504	2	24,22	0,998	c	350007222400000002,350007222400000001	0-24,0-22		21400612	10.1002/mc.20757		Molecular carcinogenesis	Functional characterization of peroxisome proliferator-activated receptor-&#x03b2;/&#x03b4; expression in colon cancer	Jennifer	2011	0		
658	chr23	9676741	9676764	3500261436	23		9676741	9676764	8421504	1	23	0	c	350026143600000085	0-23						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
658	chr23	9676755	9677791	3500343864	46		9676755	9677791	8421504	2	23,23	0,1013	c,g	350034386400000009,350034386400000009,350034386400000010	0-23,0-23,0-23						NPG.nature.vol.431.Issue.7005.Sep	www.scribd.com	0	0		
658	chr23	9676755	9677791	3500329339	46		9676755	9677791	8421504	2	23,23	0,1013	c,g	350032933900000201,350032933900000201,350032933900000017,350032933900000017,350032933900000202,350032933900000018	0-23,0-23,0-23,0-23,0-23,0-23						US Patent # 8,389,207. Methods for identifying candidate fat-mobilizing agents - Patents.com	patents.com	0	0		
658	chr23	9676758	9676781	3500269402	23		9676758	9676781	8421504	1	23	0	c	350026940200000013	0-23						Compositions And Methods For Treating Obesity, Obesity Related Disorders And For Inhibiting The Infectivity Of Human Immunodeficiency Virus 	.freshpatents.com	0	0		
658	chr23	9677879	9677903	3500050968	24		9677879	9677903	8421504	1	24	0	c	350005096800000088,350005096800000024	0-24,23-45					Patent	Adipose-derived stem cells and lattices (Patent EP:1434855)	Hedrick	2012	0		
659	chr23	9716717	9717659	3500164379	267		9716717	9717659	8421504	2	94,173	0,769	p	350016437900015016	180-534						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPL10A
659	chr23	9717623	9717997	3500162540	69		9717623	9717997	8421504	2	36,33	0,341	p	350016254000015025	0-69						Evolution of Rhizaria: new insights from phylogenomic analysis of uncultivated protists	ww3.botany.ubc.ca	0	0		RPL10A
659	chr23	9761809	9762205	3500153718	24		9761809	9762205	8421504	3	5,9,10	0,8,386	c	350015371800000011	16-40						Parasitic helminth venom allergen antigen 5-like genes and proteins	Tripp	1995	0		
660	chr23	9861015	9916153	3500141636	704		9861015	9916153	8421504	15	32,96,3,72,93,3,35,48,24,41,7,53,84,55,58	0,86,230,2375,2468,6905,6921,9499,14113,14161,36006,36068,37067,37155,55080	p,c,g	350014163600000059,350014163600000057,350014163600000056,350014163600015078,350014163600015097,350014163600000022,350014163600000052,350014163600000051,350014163600000050,350014163600000048,350014163600000048,350014163600000045,350014163600000045,350014163600000044,350014163600000042,350014163600000011,350014163600000041,350014163600000040,350014163600000040,350014163600015068,350014163600000009,350014163600000039,350014163600000038,350014163600015089	6-38,0-48,0-48,0-48,0-48,27-48,0-48,0-48,0-35,0-48,0-48,24-48,24-48,0-48,0-41,0-36,0-48,0-48,0-48,0-48,18-48,0-44,0-48,0-48						NOVEL IMMUNOPHILINS AND CORRESPONDING NUCLEIC ACIDS - The Salk, Institute For Biological Studies Bourgeois Cohn Suzanne H.	www.sumobrain.com	0	0		FKBP5
660	chr23	9875166	9898110	3500231080	61		9875166	9898110	8421504	3	19,22,20	0,3646,22924	c,g	350023108000000007,350023108000000012,350023108000000006,350023108000000006	1-20,0-22,0-20,0-20						<article article-type="research-article" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http:/	elifesciences.org	0	0		
660	chr23	9878701	9878730	3500131433	29		9878701	9878730	8421504	1	29	0	g	350013143300000002	0-29		19282387	10.1210/en.2008-1181	0013-7227	Endocrinology	A Novel Androgen Receptor Amino Terminal Region Reveals Two Classes of Amino/Carboxyl Interaction-Deficient Variants with Divergent Capacity to Activate Responsive Sites in Chromatin	Need	2009	4		FKBP5
660	chr23	9898199	9916147	3500411740	78		9898199	9916147	8421504	2	26,52	0,17896	p	350041174000015048	0-78						Dissertation	thek.uni-halle.de	0	0		FKBP5
661	chr23	10024610	10024636	3500224750	24		10024610	10024636	8421504	2	19,5	0,21	g	350022475000000031	0-25						Methods for rapid identification of pathogens in humans and animals	Blyn	2012	0		
663	chr23	10280044	10351291	3500094823	431		10280044	10351291	8421504	13	23,48,8,40,9,39,73,23,25,23,9,79,32	0,27004,32541,45232,46143,46467,49097,49730,49777,63949,64020,66502,71215	c	350009482300000078,350009482300000008,350009482300000033,350009482300000060,350009482300000014,350009482300000065,350009482300000066,350009482300000043,350009482300000045,350009482300000046,350009482300000071	8-31,8-31,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Drug binding protein	J*C*L*Li 	1996	0		
663	chr23	10280044	10351291	3500037646	167		10280044	10351291	8421504	7	23,25,23,9,39,16,32	0,49777,63949,64020,66502,66565,71215	c	350003764600000004,350003764600000067,350003764600000031,350003764600000033,350003764600000059	8-31,8-31,0-48,0-48,0-48					Patent	Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein (Patent US:5777097)	Adams	1998	0		
663	chr23	10280044	10351267	3500246972	404		10280044	10351267	8421504	12	23,32,85,9,39,49,23,25,23,9,79,8	0,32517,45232,46143,46467,49121,49730,49777,63949,64020,66502,71215	c	350024697200000005,350024697200000065,350024697200000022,350024697200000047,350024697200000007,350024697200000009,350024697200000028,350024697200000053,350024697200000030,350024697200000032,350024697200000033	8-31,8-31,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Drug binding protein	Adams	1995	0		
663	chr23	10280044	10351267	3500192041	427		10280044	10351267	8421504	13	23,45,2,32,85,9,39,48,25,23,9,79,8	0,27028,32490,32517,45232,46143,46467,49121,49777,63949,64020,66502,71215	c	350019204100000004,350019204100000064,350019204100000044,350019204100000021,350019204100000046,350019204100000006,350019204100000003,350019204100000008,350019204100000027,350019204100000029,350019204100000031,350019204100000032	8-31,8-31,0-47,0-48,0-48,0-48,0-36,0-48,0-48,0-48,0-48,0-48						Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins	Lee	1997	0		
663	chr23	10280044	10346585	3500050029	215		10280044	10346585	8421504	8	23,32,16,48,25,23,9,39	0,32517,45232,45269,49777,63949,64020,66502	c	350005002900000004,350005002900000067,350005002900000024,350005002900000009,350005002900000003,350005002900000031,350005002900000033	8-31,8-31,0-48,0-48,0-36,0-48,0-48					Patent	Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins (Patent US:5871934)	Adams	1999	0		
663	chr23	10280044	10280067	3500060915	23		10280044	10280067	8421504	1	23	0	c	350006091500000004	8-31					Patent	Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins (Patent US:5955366)	Adams	1999	0		
663	chr23	10280046	10280073	3500316687	26		10280046	10280073	8421504	2	14,12	0,15	c	350031668700000000	0-26		20090955	10.1371/journal.pone.0008730		PLoS ONE	The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation	Azad	2010	0		MAPK14
663	chr23	10280046	10280071	3500209279	25		10280046	10280071	8421504	1	25	0	c,g	350020927900000006,350020927900000006	0-25,0-25						Coxsackievirus B3-induzierte Ver&#xe4;nderungen des Proteoms der Wirtszelle: Untersuchungen am Zellkulturmodell mit Hilfe der Zweidimensionalen Gelelektrophorese	sachsen-patent.de	0	0		MAPK14
663	chr23	10280048	10280074	3500401910	26		10280048	10280074	8421504	1	26	0	g	350040191000000000	36-62						Substituted 1,3-thiazole compounds, their production and use	Ohkawa	2001	0		MAPK14
663	chr23	10280048	10280074	3500277317	26		10280048	10280074	8421504	1	26	0	g	350027731700000004	36-62					Patent	5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung 5-pyridyl-1 ,3-azole derivatives, process for their production and their use (Patent DE:60033028)	KANZAKI	2007	0		MAPK14
663	chr23	10280048	10280074	3500273180	26		10280048	10280074	8421504	1	26	0	g	350027318000000018,350027318000000004	35-61,36-62						5-pyridyl-1,3-azole compounds, process for producing the same and use thereof	Da Chuan Zi Ji 	2002	0		MAPK14
663	chr23	10280048	10280074	3500265353	26		10280048	10280074	8421504	1	26	0	g	350026535300000004,350026535300000018	36-62,35-61					Patent	5-phridyl-1,3-azole compounds, process for producing the same and use thereof (Patent CN:1156471)	Da Chuan Zi Ji 	2004	0		MAPK14
663	chr23	10280048	10280074	3500079764	26		10280048	10280074	8421504	1	26	0	g	350007976400000002	36-62						5-pyridyl-1,3-azole compounds, process for producing the same and use thereof	Ohkawa	2006	0		MAPK14
663	chr23	10280048	10280074	3500064547	26		10280048	10280074	8421504	1	26	0	g	350006454700000002	36-62						5-pyridyl-1, 3-azole compounds, process for producing the same and use there of	Ohkawa	2009	0		MAPK14
663	chr23	10280048	10280074	3500064005	26		10280048	10280074	8421504	1	26	0	g	350006400500000002	36-62					Patent	5-pyridyl-1,3-azole compounds, process for producing the same and use thereof (Patent US:7101899)	Kanzaki	2006	0		MAPK14
663	chr23	10280048	10280074	3500038038	26		10280048	10280074	8421504	1	26	0	g	350003803800000002	36-62					Patent	5-pyridyl-1,3-azole compounds, process for producing the same and use thereof (Patent US:7276527)	Kanzaki	2007	0		MAPK14
663	chr23	10280048	10280074	3500013792	26		10280048	10280074	8421504	1	26	0	g	350001379200000000	36-62						Substituted 1,3-thiazole compounds, their production and use	Ohkawa	2002	0		MAPK14
663	chr23	10280049	10280075	3500339751	26		10280049	10280075	8421504	1	26	0	g	350033975100000000	31-57						Compositions and methods for purifying and crystallizing molecules of interest	Patchornik	2007	0		MAPK14
663	chr23	10280070	10352386	3500366304	543		10280070	10352386	8421504	16	45,45,45,41,4,45,45,9,30,6,39,54,45,45,31,14	0,26921,26969,32482,45206,45213,45261,45309,46096,46441,46450,49029,66506,71236,71332,72302	p	350036630400015026,350036630400015028,350036630400015029,350036630400015030,350036630400015031,350036630400015036,350036630400015038,350036630400015040	0-45,0-45,0-45,0-45,0-228,0-45,0-45,0-45						US Patent # 7,383,135. Methods of designing inhibitors for JNK kinases - Patents.com	www.patents.com	0	0		MAPK14
663	chr23	10280142	10329180	3500389014	192		10280142	10329180	8421504	6	20,28,48,17,31,48	0,26845,26921,32434,45134,48990	p	350038901400015015,350038901400015017,350038901400015019,350038901400015022	0-48,0-48,0-48,0-48						Max-interacting proteins and related molecules and methods	Brent	1995	0		MAPK14
663	chr23	10307077	10307103	3500183009	26		10307077	10307103	8421504	1	26	0	c,g	350018300900000001,350018300900000001,350018300900000000	0-21,0-21,0-21						Loss of p38 MAPK induces pleiotropic mitotic defects and massive cell death	cs.biologists.org	0	0		MAPK14
663	chr23	10307077	10307103	3500019304	26		10307077	10307103	8421504	1	26	0	c,g	350001930400000001,350001930400000001,350001930400000000,350001930400000000	0-21,0-21,0-21,0-21		21172807	10.1242/jcs.068254	0021-9533	Journal of Cell Science	Loss of p38&#x03b3; MAPK induces pleiotropic mitotic defects and massive cell death	Kukkonen-Macchi	2011	6		MAPK14
663	chr23	10329197	10329782	3500125070	25		10329197	10329782	8421504	2	17,8	0,577	c	350012507000000003	0-25		19687304	10.1128/MCB.00375-09		Molecular and Cellular Biology	TAK1-Mediated Serine/Threonine Phosphorylation of Epidermal Growth Factor Receptor via p38/Extracellular Signal-Regulated Kinase: NF-&#x03ba;B-Independent Survival Pathways in Tumor Necrosis Factor Alpha Signaling 	Miki	2009	0		MAPK14
663	chr23	10344064	10352535	3500124805	39		10344064	10352535	8421504	2	20,19	0,8452	c,g	350012480500000164,350012480500000077,350012480500000077	0-20,1-20,1-20						ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION - ISIS PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
663	chr23	10346576	10351305	3500185460	45		10346576	10351305	8421504	2	20,25	0,4704	c,g	350018546000000042,350018546000000042,350018546000000043	0-20,0-20,0-25						Supporting Information 	www.pnas.org	0	0		MAPK14
663	chr23	10346578	10346603	3500274721	25		10346578	10346603	8421504	1	25	0	c	350027472100000011,350027472100000012	0-25,0-25		19915702	10.4196/kjpp.2009.13.5.385		The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology	Downregulation of Angiotensin II-Induced 12-Lipoxygenase Expression and Cell Proliferation in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats by CCL5	Jung	2009	0		
663	chr23	10351336	10351399	3500423760	63		10351336	10351399	8421504	1	63	0	p	350042376000015008	0-63						Biological Sequence Similarity Matching Using Dynamic Programming	kopnicky.com	0	0		MAPK14
663	chr23	10352392	10352437	3500192057	45		10352392	10352437	8421504	1	45	0	p	350019205700015002	0-45		15837794	10.1074/jbc.M411657200	0021-9258	Journal of Biological Chemistry	Simultaneous Blockade of NF&#x03ba;B, JNK, and p38 MAPK by a Kinase-inactive Mutant of the Protein Kinase TAK1 Sensitizes Cells to Apoptosis and Affects a Distinct Spectrum of Tumor Necrosis Target Genes	Thiefes	2005	5		MAPK14
663	chr23	10352413	10352440	3500316687	26		10352413	10352440	8421504	2	13,13	0,14	c	350031668700000001	0-26		20090955	10.1371/journal.pone.0008730		PLoS ONE	The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation	Azad	2010	0		MAPK14
663	chr23	10352415	10352440	3500209279	25		10352415	10352440	8421504	1	25	0	c	350020927900000007	0-25						Coxsackievirus B3-induzierte Ver&#xe4;nderungen des Proteoms der Wirtszelle: Untersuchungen am Zellkulturmodell mit Hilfe der Zweidimensionalen Gelelektrophorese	sachsen-patent.de	0	0		MAPK14
663	chr23	10352416	10352441	3500339751	25		10352416	10352441	8421504	1	25	0	c	350033975100000001	8-33						Compositions and methods for purifying and crystallizing molecules of interest	Patchornik	2007	0		MAPK14
664	chr23	10370979	10373641	3500393782	39		10370979	10373641	8421504	2	19,20	0,2642	c	350039378200000014,350039378200000015	0-19,0-20						HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation	www.virologyj.com	0	0		MAPK13
664	chr23	10370979	10373641	3500340415	39		10370979	10373641	8421504	2	19,20	0,2642	c	350034041500000014,350034041500000015	0-19,0-20		21599968	10.1186/1743-422X-8-247	1743-422X	Virology Journal	HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation	RamArez-Salazar	2011	2		MAPK13
664	chr23	10370979	10373641	3500018494	39		10370979	10373641	8421504	2	19,20	0,2642	c	350001849400000014,350001849400000015	0-19,0-20						HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation	ww.inmegen.gob.mx	0	0		MAPK13
664	chr23	10435335	10435361	3500224148	23		10435335	10435361	8421504	3	6,5,12	0,8,14	g	350022414800000017	5-28						ComprehensiveandRapidReal-TimePCRAnalysisof 21FoodborneOutbreaks	loads.hindawi.com	0	0		
664	chr23	10435335	10435361	3500123419	23		10435335	10435361	8421504	3	6,5,12	0,8,14	g	350012341900000012	5-28						Life Science Journal, 2013;10(2) http://www.lifesciencesite	fesciencesite.com	0	0		
664	chr23	10439376	10439401	3500063186	24		10439376	10439401	8421504	2	19,5	0,20	c	350006318600000018	4-28						Research Paper Reduction in Tcf7l2 Expression Decreases Diabetic Susceptibility in Mice	www.ijbs.com	0	0		
664	chr23	10439376	10439401	3500024023	24		10439376	10439401	8421504	2	19,5	0,20	c,g	350002402300000018,350002402300000018	4-28,4-28						Reduction in Tcf7l2 Expression Decreases Diabetic Susceptibility in Mice	www.ijbs.com	0	0		
666	chr23	10708872	10708900	3500211749	23		10708872	10708900	8421504	2	14,9	0,19	g	350021174900000026	0-37					Patent	Bacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic form (Patent US:5977065)	Anlezark	1999	0		
666	chr23	10708872	10708900	3500191139	23		10708872	10708900	8421504	2	14,9	0,19	g	350019113900000026	0-37						Bacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic form	Anlezark	1998	0		
666	chr23	10717553	10717580	3500033254	23		10717553	10717580	8421504	2	15,8	0,19	c	350003325400000211	9-32						METHODS AND COMPOSITIONS FOR THE RESPONSE PREDICTION OF MALIG-NANT NEOPLASIA TO TREATMENT - BAYER HEALTHCARE AG	www.sumobrain.com	0	0		
666	chr23	10723762	10723828	3500176417	66		10723762	10723828	8421504	1	66	0	p	350017641700015005	0-66						InhibitionofCellMigrationbyAutophosphorylated MammalianSterile20-LikeKinase3(MST3)Involves PaxillinandProtein-tyrosinePhosphatase-PEST	www.ncku.edu.tw	0	0		STK38
666	chr23	10743281	10744852	3500438510	24		10743281	10744852	8421504	3	10,9,5	0,1554,1566	c	350043851000000002	12-36						Rhein induces apoptosis of HCT-116 human colon cancer cells via activation of the intrinsic apoptotic pathway	demicjournals.org	0	0		
666	chr23	10744883	10745871	3500230823	84		10744883	10745871	8421504	2	75,9	0,979	p	350023082300015001	0-84		16314523	10.1128/MCB.25.24.11019-11029.2005	0270-7306	Molecular and Cellular Biology	Regulation of NDR Protein Kinase by Hydrophobic Motif Phosphorylation Mediated by the Mammalian Ste20-Like Kinase MST3	Stegert	2005	6		STK38
666	chr23	10744887	10744934	3500429214	47		10744887	10744934	8421504	1	47	0	c	350042921400000004	0-47						Phosphorylated ndr kinase	Bichsel	2003	0		
668	chr23	10933930	10935701	3500038201	40		10933930	10935701	8421504	3	20,11,9	0,279,1762	c,g	350003820100000014,350003820100000014,350003820100000015	0-20,0-20,0-20		19114554	10.1128/MCB.01346-08	0270-7306	Molecular and Cellular Biology	TFIIB Recognition Elements Control the TFIIA-NC2 Axis in Transcriptional Regulation	Deng	2009	6		CDKN1A
668	chr23	10933931	10933954	3500329727	23		10933931	10933954	8421504	1	23	0	c,g	350032972700000005,350032972700000005	0-23,0-23						Inhibitory effect of BMP-2 on the proliferation of breast cancer cells	-publications.com	0	0		CDKN1A
668	chr23	10933931	10933954	3500133338	23		10933931	10933954	8421504	1	23	0	c,g	350013333800000015,350013333800000015	0-23,0-23						Induction of estrogen receptor &#x03b1;-36 expression by bone morphogenetic protein 2 in breast cancer cell lines	-publications.com	0	0		CDKN1A
668	chr23	10933931	10933954	3500076088	23		10933931	10933954	8421504	1	23	0	c,g	350007608800000001,350007608800000001	0-23,0-23		22690217	10.1155/2012/601682		Journal of Oncology	Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest	Suwit	2012	0		CDKN1A
668	chr23	10934189	10935727	3500021080	66		10934189	10935727	8421504	2	31,35	0,1503	p	350002108000015001	0-66		9305916	10.1074/jbc.272.39.24522	0021-9258	Journal of Biological Chemistry	The DNA Repair Endonuclease XPG Binds to Proliferating Cell Nuclear Antigen (PCNA) and Shares Sequence Elements with the PCNA-binding Regions of FEN-1 and Cyclin-dependent Kinase Inhibitor p21	Gary	1997	5		CDKN1A
668	chr23	10934195	10935731	3500236661	64		10934195	10935731	8421504	2	25,39	0,1497	c	350023666100000004	18-82					Patent	Multiparameter facs assays to detect alterations in cellular parameters (Patent EP:1071809)	Fisher	2003	0		
668	chr23	10934195	10935731	3500074000	64		10934195	10935731	8421504	2	25,39	0,1497	c	350007400000000007	18-82					Patent	Multiparameter FACS assays to detect alterations in cellular parameters and small molecule screening (Patent CN:100334227)	J*Fei She Er 	2007	0		
668	chr23	10934195	10935727	3500390179	60		10934195	10935727	8421504	2	25,35	0,1497	p	350039017900015001	0-60						Compounds for the treatment of inflammation and neutropenia	WITKO-SARSAT	2011	0		CDKN1A
668	chr23	10934195	10935727	3500331037	60		10934195	10935727	8421504	2	25,35	0,1497	p	350033103700015001	0-60						Compounds for the treatment of inflammation and neutropenia	WITKO-SARSAT	2013	0		CDKN1A
668	chr23	10934195	10935727	3500248969	60		10934195	10935727	8421504	2	25,35	0,1497	p	350024896900015000	0-60			10.1038/sj.onc.1209320		Oncogene	A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design	Emma	2006	0		CDKN1A
668	chr23	10934195	10935727	3500121299	60		10934195	10935727	8421504	2	25,35	0,1497	p	350012129900015001	0-60						Compounds for the treatment of inflammation and neutropenia	Witko-Sarsat	2013	0		CDKN1A
668	chr23	10934195	10935727	3500046797	60		10934195	10935727	8421504	2	25,35	0,1497	p	350004679700015000	0-60		20007687	10.1093/jxb/erp354		Journal of Experimental Botany	Identification and functional analysis of PCNA1 and PCNA-like1 genes of Phaseolus coccineus	Wojciech	2010	0		CDKN1A
668	chr23	10934199	10935695	3500457432	24		10934199	10935695	8421504	2	21,3	0,1493	c	350045743200000000	0-24		14729654	10.1158/0008-5472.CAN-03-2446	0008-5472	Cancer Research	Estrogen Receptor &#x03b2; Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest	Paruthiyil	2004	8		
668	chr23	10934203	10935745	3500409234	42		10934203	10935745	8421504	3	17,4,21	0,1489,1521	c	350040923400000000,350040923400000001	0-21,0-21						A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress	www.ejcho.info	0	0		CDKN1A
668	chr23	10934203	10935745	3500391018	42		10934203	10935745	8421504	3	17,4,21	0,1489,1521	c	350039101800000002,350039101800000003	0-21,0-21		22438557	10.1128/JVI.00070-12	0022-538X	Journal of Virology	Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Multifunctional Angiogenin To Utilize Its Antiapoptotic Functions	Paudel	2012	5		CDKN1A
668	chr23	10934203	10935745	3500300122	42		10934203	10935745	8421504	3	17,4,21	0,1489,1521	c	350030012200000002,350030012200000003	0-21,0-21		22438557	10.1128/JVI.00070-12		Journal of Virology	Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Multifunctional Angiogenin To Utilize Its Antiapoptotic Functions	Nitika	June	0		CDKN1A
668	chr23	10934211	10935711	3500366719	28		10934211	10935711	8421504	2	9,19	0,1481	c	350036671900000005	0-28		22025681	10.1128/MCB.05513-11	0270-7306	Molecular and Cellular Biology	Orphan Nuclear Receptor PNR/NR2E3 Stimulates p53 Functions by Enhancing p53 Acetylation	Wen	2012	6		CDKN1A
668	chr23	10934211	10935711	3500135085	28		10934211	10935711	8421504	2	9,19	0,1481	c	350013508500000005	0-28		22025681	10.1128/MCB.05513-11		Molecular and Cellular Biology	Orphan Nuclear Receptor PNR/NR2E3 Stimulates p53 Functions by Enhancing p53 Acetylation	Zhi	2012	0		CDKN1A
668	chr23	10937111	10937186	3500383646	47		10937111	10937186	8421504	2	22,25	0,50	c	350038364600000028,350038364600000029	0-22,0-25						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
669	chr23	11104133	11120456	3500456423	42		11104133	11120456	8421504	3	17,4,21	0,18,16302	g	350045642300000059,350045642300000118	7-28,4-25						Orpinomyces cellulases and coding sequences	Chen	1998	0		
669	chr23	11137950	11138046	3500229865	95		11137950	11138046	8421504	2	48,47	0,49	c	350022986500000168,350022986500000167	0-48,0-47						GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA - Patent application	www.faqs.org	0	0		
670	chr23	11231914	11242273	3500466452	558		11231914	11242273	8421504	8	42,145,60,52,58,78,107,16	0,1988,4578,6082,6440,6798,7281,10343	p	350046645200015056,350046645200015061,350046645200015060,350046645200015059,350046645200015058	0-366,0-129,0-138,0-135,0-144						Antibodies to HFXJW48 polypeptide	Ruben	2004	0		MTCH1
670	chr23	11231914	11242273	3500436879	534		11231914	11242273	8421504	10	42,87,46,60,32,8,58,78,107,16	0,1988,2087,4578,6082,6126,6440,6798,7281,10343	p	350043687900015059,350043687900015058,350043687900015057,350043687900015056	0-129,0-138,0-123,0-144						70 human secreted proteins	Ruben	2002	0		MTCH1
670	chr23	11265731	11265758	3500070288	23		11265731	11265758	8421504	2	16,7	0,20	c	350007028800000444	6-30						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
670	chr23	11265817	11265844	3500115982	23		11265817	11265844	8421504	3	5,14,4	0,8,23	c	350011598200000279	17-40						Human telomerase catalytic subunit: diagnostic and therapeutic methods	Cech	1997	0		
83	chr23	11265845	11291604	3500042549	1971		11265845	11291604	8421504	16	68,232,81,149,157,139,59,147,93,80,31,93,132,147,147,216	0,5388,8010,8769,10672,11031,11684,11976,13517,19319,19484,20140,20902,23760,25059,25543	c	350004254900000059	0-1971						ISOLATION OF THE T-COMPLEX DISTORTERS AND APPLICATIONS THEREOF - Patent application	www.faqs.org	0	0		
672	chr23	11425816	11429383	3500387355	67		11425816	11429383	8421504	3	25,21,21	0,3409,3546	c,g	350038735500000004,350038735500000004,350038735500000000,350038735500000001,350038735500000001	0-25,0-25,0-21,0-21,0-21		18426800	10.1074/jbc.M709479200		The Journal of Biological Chemistry	The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells	Marina	July	0		PIM1
672	chr23	11425816	11429383	3500231395	67		11425816	11429383	8421504	3	25,21,21	0,3409,3546	c,g	350023139500000004,350023139500000004,350023139500000000,350023139500000001	0-25,0-25,0-21,0-21		18426800	10.1074/jbc.M709479200	0021-9258	Journal of Biological Chemistry	The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells	Zemskova	2008	5		PIM1
672	chr23	11425861	11428557	3500187127	141		11425861	11428557	8421504	3	49,47,45	0,1616,2651	p,c	350018712700015123,350018712700015124,350018712700000144	0-48,0-48,0-45						Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof	Smith	1995	0		
672	chr23	11425897	11427509	3500087149	45		11425897	11427509	8421504	2	13,32	0,1580	p	350008714900015036	0-45						INHIBITION OF THE 44 KILODALTON ISOFORM OF PIM-1 KINASE RESTORES APOPTOSIS INDUCED BY CHEMOTHERAPEUTIC DRUGS IN CANCER CELLS - Patent application	www.faqs.org	0	0		PIM2
672	chr23	11429046	11429098	3500346026	52		11429046	11429098	8421504	1	52	0	c	350034602600000001,350034602600000000	6-58,5-57						Dysregulation of miR-15a and miR-214 in human pancreatic cancer	biomedcentral.com	0	0		PIM1
672	chr23	11429046	11429098	3500114623	52		11429046	11429098	8421504	1	52	0	c	350011462300000001,350011462300000000	6-58,5-57						Dysregulation of miR-15a and miR-214 in human pancreatic cancer	www.jhoonline.org	0	0		PIM1
672	chr23	11483569	11483593	3500058967	23		11483569	11483593	8421504	2	12,11	0,13	c	350005896700000017	0-23						COMPOSITIONS, METHODS AND USES - Patent application	www.faqs.org	0	0		
672	chr23	11483569	11483593	3500037080	23		11483569	11483593	8421504	2	12,11	0,13	c	350003708000000007	0-23						POLYPEPTIDE LIBRARIES WITH A PREDETERMINED SCAFFOLD - Patent application	www.faqs.org	0	0		
672	chr23	11533631	11533682	3500284337	51		11533631	11533682	8421504	1	51	0	p	350028433700015007	0-51						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		TBC1D22B
675	chr23	11876600	11876625	3500080900	23		11876600	11876625	8421504	2	15,8	0,17	g	350008090000000002	0-24						Impaired insulin secretion from the pancreatic islets of hypothyroidal growth-retarded mice	logy-journals.org	0	0		
675	chr23	11881164	11881190	3500461797	23		11881164	11881190	8421504	2	16,7	0,19	g	350046179700000016	15-40						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Protease Trafficking in Two Primitive Eukaryotes Is Mediated by a Prodomain Protein Motif*	www.gla.ac.uk	0	0		
676	chr23	12033976	12034002	3500309743	23		12033976	12034002	8421504	2	17,6	0,20	g	350030974300000008	5-28						US Patent # 5,834,598. Human growth hormone variants - Patents.com	www.patents.com	0	0		
676	chr23	12033976	12034002	3500201186	23		12033976	12034002	8421504	2	17,6	0,20	g	350020118600000009	5-28						Method of selection of proteolytic cleavage sites by directed evolution and phagemid display	Matthews	1995	0		
676	chr23	12033976	12034002	3500175874	23		12033976	12034002	8421504	2	17,6	0,20	g	350017587400000007	5-28					Patent	Human growth hormone variants (Patent US:5834598)	Lowman	1998	0		
677	chr23	12117424	12117532	3500246268	47		12117424	12117532	8421504	2	18,29	0,79	c	350024626800000477	8-55						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
677	chr23	12117498	12117523	3500339146	25		12117498	12117523	8421504	1	25	0	c	350033914600000004	0-25						Intracellular antigens for identifying fetal cells in maternal blood	Asgari	1996	0		ABCG1
677	chr23	12182667	12182694	3500131749	24		12182667	12182694	8421504	2	5,19	0,8	g	350013174900000039	10-35						UNIVERSIDADE FEDERAL DE MINAS GERAIS DEPARTAMENTO DE PARASITOLOGIA	cadigital.ufmg.br	0	0		
681	chr23	12703365	12703391	3500373645	23		12703365	12703391	8421504	2	6,17	0,9	g	350037364500000018	0-23						Caracteriza&#xe7;&#xe3;o genot&#xed;pica dos fatores de virul&#xea;ncia e seu regulador agr em cepas de Staphylococcus aureus	www.teses.usp.br	0	0		
683	chr23	12879650	12879673	3500236407	23		12879650	12879673	8421504	1	23	0	g	350023640700000040	1-24						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2001	0		
683	chr23	12929088	12929937	3500100552	25		12929088	12929937	8421504	2	9,16	0,833	c	350010055200000004	0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		
686	chr23	13243665	13243690	3500271817	24		13243665	13243690	8421504	2	13,11	0,14	g	350027181700000006	0-28			10.1083/jcb.200601036		The Journal of Cell Biology	The origin and maintenance of mammalian peroxisomes involves a de novo PEX16-dependent pathway from the ER	PeK.	2006	0		
689	chr23	13742721	13742749	3500164994	23		13742721	13742749	8421504	2	12,11	0,17	g	350016499400000069	9-32						HUMANIZED IMMUNOGLOBULIN LOCI	Buelow	2013	0		
692	chr23	14102884	14102912	3500165664	25		14102884	14102912	8421504	3	12,9,4	0,14,24	g	350016566400000147,350016566400000006	0-26,0-26						Cysteine-containing peptide tag for site-specific conjugation of proteins - Patent application	www.faqs.org	0	0		
694	chr23	14323013	14323144	3500148358	43		14323013	14323144	8421504	2	20,23	0,108	c,g	350014835800000000,350014835800000000	20-63,20-63		21255426	10.1186/1471-2156-12-11	1471-2156	BMC Genetics	Arachnomelia syndrome in Simmental cattle is caused by a homozygous 2-bp deletion in the molybdenum cofactor synthesis step 1 gene (MOCS1)	Buitkamp	2011	2		
696	chr23	14678701	14678727	3500341436	23		14678701	14678727	8421504	2	10,13	0,13	g	350034143600000039	8-32						PROBES AND METHODS FOR DETECTION OF PATHOGENS AND ANTIBIOTIC RESISTANCE	Haake	2007	0		
87	chr23	14804109	14845627	3500104945	343		14804109	14845627	8421504	9	48,40,48,4,44,47,38,48,26	0,188,330,618,40226,40463,41048,41374,41492	c	350010494500000049,350010494500000045,350010494500000042,350010494500000036,350010494500000031,350010494500000019,350010494500000012,350010494500000010	0-48,6-46,0-48,0-48,0-47,0-38,0-48,0-26						ANTIBODIES TO BRAIN SPECIFIC MEMBRANE PROTEIN - Patent application	www.faqs.org	0	0		
87	chr23	14804109	14845624	3500239221	150		14804109	14845624	8421504	4	41,45,41,23	0,330,40463,41492	c	350023922100000049,350023922100000042,350023922100000031,350023922100000010	1-42,0-45,0-41,0-23						US Patent # 7,344,838. Gene encoding brain specific membrane protein - Patents.com	www.patents.com	0	0		
703	chr23	15480795	15480821	3500023490	23		15480795	15480821	8421504	2	12,11	0,15	g	350002349000000015	0-23						Polynucleotides encoding cellulose synthase from pinus radiata and methods of use for regulating polysaccharides of a plant - Patent #08110726	w.strutpatent.com	0	0		
703	chr23	15501723	15501747	3500453252	24		15501723	15501747	8421504	1	24	0	c	350045325200000011	0-24		22530004	10.1371/journal.pone.0035302		PLoS ONE	Role of the CCAAT-Binding Protein NFY in SCA17 Pathogenesis	Li-Ching	2012	0		NFYA
703	chr23	15508992	15510721	3500428569	80		15508992	15510721	8421504	4	21,20,20,19	0,131,1668,1710	c,g	350042856900000001,350042856900000001,350042856900000004,350042856900000006,350042856900000006,350042856900000002,350042856900000002	0-21,0-21,0-20,0-20,0-20,0-19,0-19		21092319	10.1186/1471-2164-11-654		BMC Genomics	Bovine proteins containing poly-glutamine repeats are often polymorphic and enriched for components of transcriptional regulatory complexes	Vicki	2010	0		
703	chr23	15508992	15510721	3500069039	60		15508992	15510721	8421504	3	21,20,19	0,131,1710	c,g	350006903900000001,350006903900000004,350006903900000002	0-21,0-20,0-19		21092319	10.1186/1471-2164-11-654	1471-2164	BMC Genomics	Bovine proteins containing poly-glutamine repeats are often polymorphic and enriched for components of transcriptional regulatory complexes	Whan	2010	4		
703	chr23	15521729	15525308	3500308562	43		15521729	15525308	8421504	2	22,21	0,3558	c	350030856200000026,350030856200000027	0-22,0-21						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
703	chr23	15522819	15522843	3500362047	24		15522819	15522843	8421504	1	24	0	c	350036204700000007	0-24		18815279	10.1091/mbc.E08-03-0295	1059-1524	Molecular Biology of the Cell	Posttranslational Regulation of NF-YA Modulates NF-Y Transcriptional Activity	Manni	2008	5		NFYA
703	chr23	15525168	15525198	3500355861	30		15525168	15525198	8421504	1	30	0	c	350035586100000023	8-38			10.1042/BJ20070245		The Biochemical Journal	Identification of a responsible promoter region and a key transcription factor, CCAAT/enhancer-binding protein &#x03f5;, for up-regulation of PHGPx in HL60 cells stimulated with TNF&#x03b1;	Hiroyuki	2007	0		NFYA
703	chr23	15566612	15566641	3500308014	24		15566612	15566641	8421504	2	10,14	0,15	g	350030801400000050	1-25						Recombinant anti-cd4 antibodies for human therapy	Hanna	1997	0		
704	chr23	15640913	15640938	3500360747	23		15640913	15640938	8421504	2	17,6	0,19	g	350036074700000057	0-23						B-7 related nucleic acids and polypeptides useful for immunomodulation	Mikesell	2011	0		
704	chr23	15643845	15643908	3500198752	63		15643845	15643908	8421504	1	63	0	p	350019875200015020,350019875200015068	0-63,0-48						Inhibition of trem receptor signaling with peptide variants	Sigalov	2011	0		
706	chr23	15887023	15887050	3500400238	25		15887023	15887050	8421504	3	5,15,5	0,6,22	c	350040023800000020	18-43						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
706	chr23	15908220	15908245	3500021320	24		15908220	15908245	8421504	2	16,8	0,17	c	350002132000000040	11-35						Versatile Platform For Nanotechnology Based On Circular Permutations Of Chaperonin Protein 	.freshpatents.com	0	0		
706	chr23	15924057	15924084	3500242395	23		15924057	15924084	8421504	2	14,9	0,18	g	350024239500000114	0-23						Uses of myostatin antagonists	Han	2006	0		
707	chr23	16003083	16005981	3500002606	312		16003083	16005981	8421504	5	30,148,76,57,1	0,1024,1964,2751,2897	p	350000260600015007,350000260600015004	0-153,0-159						Untersuchung der Regulation und Interaktionen der Aktivierungsinduzierten Cytidindeaminase (AID) in humanen B-Lymphozyten	b.uni-muenchen.de	0	0		TFEB
707	chr23	16008506	16008710	3500267682	40		16008506	16008710	8421504	3	20,19,1	0,89,203	c	350026768200000013,350026768200000012	0-20,0-20		23381957	10.1002/emmm.201202046	1757-4684	EMBO Molecular Medicine	Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency - Pastore - 2013 - EMBO Molecular Medicine - Wiley Online Library	Pastore	2013	0		TFEB
707	chr23	16059385	16059433	3500403756	48		16059385	16059433	8421504	1	48	0	p	350040375600015115	0-48						Modified BACE - US Patent 7273743 Description	ww.patentstorm.us	0	0		PGCP1
707	chr23	16103795	16105056	3500452808	909		16103795	16105056	8421504	4	514,108,274,13	0,648,973,1248	p,c,g	350045280800000003,350045280800015007,350045280800015011,350045280800000004,350045280800000004,350045280800000014,350045280800000014,350045280800015018,350045280800000005,350045280800000015,350045280800000006,350045280800000007,350045280800000016,350045280800015019,350045280800000017,350045280800000017,350045280800015020	511-1523,0-120,0-120,0-120,0-120,0-101,0-101,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120						Modelos computacionais para identifica&#xe7;&#xe3;o de informa&#xe7;&#xe3;o gen&#xf4;mica associada &#xe0; resist&#xea;ncia ao carrapato bovino | Wagner Arbex - Academia.edu	www.academia.edu	0	0		
708	chr23	16198292	16198340	3500068396	48		16198292	16198340	8421504	1	48	0	c	350006839600000111	0-48						Trophinin and trophinin-assisting protein agonists, antibodies and antagonists	Fukuda	1996	0		
708	chr23	16202897	16202947	3500405213	50		16202897	16202947	8421504	1	50	0	c	350040521300000002	0-50		14603260	10.1038/sj.onc.1206872	0950-9232	Oncogene	PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression	Seminario	2003	6		CCND3
708	chr23	16203566	16207419	3500013836	40		16203566	16207419	8421504	2	20,20	0,3833	c,g	350001383600000003,350001383600000002,350001383600000002	0-20,0-20,0-20						El cadmio como disruptor endocrino. Estudios de la exposici&#xf3;n al cadmio sobre la adenohip&#xf3;fisis de rata	al.bl.fcen.uba.ar	0	0		
708	chr23	16207298	16207321	3500212717	23		16207298	16207321	8421504	1	23	0	c	350021271700000005,350021271700000010	5-28,5-28		15753390	10.1158/0008-5472.CAN-04-3196	0008-5472	Cancer Research	Real-time Detection of Gene Expression in Cancer Cells Using Molecular Beacon Imaging: New Strategies for Cancer Research	Peng	2005	8		
708	chr23	16207298	16207321	3500159303	23		16207298	16207321	8421504	1	23	0	c	350015930300000005	5-28						Real-time Detection of Gene Expression in Cancer Cells Using Molecular Beacon Imaging: New Strategies for Cancer Research	cular-beacons.org	0	0		
708	chr23	16207298	16207321	3500074525	23		16207298	16207321	8421504	1	23	0	c	350007452500000005	5-28						Methods and applications of molecular beacon imaging for cancer cell detection	Yang	2006	0		
708	chr23	16207314	16208395	3500006015	40		16207314	16208395	8421504	3	20,8,12	0,170,1069	c,g	350000601500000023,350000601500000023,350000601500000022	0-20,0-20,0-20						PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1. - ResearchGate	.researchgate.net	0	0		CCND3
710	chr23	16396660	16402829	3500269311	84		16396660	16402829	8421504	4	21,21,21,21	0,107,5651,6148	c,g	350026931100000000,350026931100000000,350026931100000001,350026931100000001,350026931100000002,350026931100000002,350026931100000003	0-21,0-21,0-21,0-21,0-21,0-21,0-21						Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model	www.pnas.org	0	0		
710	chr23	16402255	16402300	3500420904	45		16402255	16402300	8421504	1	45	0	p	350042090400015001	0-45		10037711	10.1074/jbc.274.10.6244	0021-9258	Journal of Biological Chemistry	Identification of a Domain in Guanylyl Cyclase-activating Protein 1 That Interacts with a Complex of Guanylyl Cyclase and Tubulin in Photoreceptors	Schrem	1999	5		GUCA1A
710	chr23	16403288	16403330	3500402253	42		16403288	16403330	8421504	1	42	0	c,g	350040225300000002,350040225300000002,350040225300000001	0-20,0-20,12-34		18541533	10.1074/jbc.M801899200	0021-9258	Journal of Biological Chemistry	Binding of Guanylyl Cyclase Activating Protein 1 (GCAP1) to Retinal Guanylyl Cyclase (RetGC1)	Peshenko	2008	5		
1	chr23	16767428	16864033	3500043928	1027		16767428	16864033	8421504	29	48,48,20,70,26,2,46,6,90,57,45,59,30,18,25,23,6,42,19,4,40,45,47,14,31,41,45,51,29	0,25607,33534,41288,43222,50560,50651,50745,53013,55757,58056,59063,59867,61476,61785,62963,63082,64971,67647,68084,70532,71811,71859,75113,75896,89305,91453,94346,96576	c	350004392800000130,350004392800000136,350004392800000255,350004392800000146,350004392800000147,350004392800000157,350004392800000159,350004392800000160,350004392800000275,350004392800000164,350004392800000279,350004392800000166,350004392800000281,350004392800000282,350004392800000170,350004392800000174,350004392800000177,350004392800000181,350004392800000185,350004392800000191,350004392800000192,350004392800000307,350004392800000076,350004392800000201,350004392800000224,350004392800000229,350004392800000235,350004392800000350,350004392800000239	0-48,0-48,27-47,0-48,0-48,0-48,0-48,0-48,0-23,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-23,0-40,0-45,3-45,3-44,7-31,0-45,0-41,0-45,0-45,0-45,0-29						HUMAN E3ALPHA UBIQUITIN LIGASE FAMILY - Patent application	www.faqs.org	0	0		
1	chr23	16767428	16861819	3500074260	1199		16767428	16861819	8421504	32	48,48,48,70,26,34,13,2,46,6,90,48,45,3,45,30,66,6,42,48,48,45,42,10,35,45,13,32,30,71,19,45	0,25607,33546,41288,43222,43296,43695,50560,50651,50745,53013,55757,58056,59063,59117,59867,61476,63082,64971,66568,68113,71811,71859,72906,75033,77560,81421,81846,85936,91453,92216,94346	c	350007426000000130,350007426000000136,350007426000000141,350007426000000146,350007426000000147,350007426000000149,350007426000000157,350007426000000159,350007426000000160,350007426000000164,350007426000000166,350007426000000168,350007426000000170,350007426000000171,350007426000000177,350007426000000179,350007426000000182,350007426000000191,350007426000000192,350007426000000199,350007426000000206,350007426000000212,350007426000000216,350007426000000229,350007426000000230,350007426000000235	0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,3-48,0-48,0-48,0-48,0-48,0-48,0-45,3-45,0-45,0-45,0-45,15-45,0-45,0-45,0-45						 Human E3.alpha. Ubiquitin Ligase Family 	www.docstoc.com	0	0		
713	chr23	16791093	16859663	3500123068	465		16791093	16859663	8421504	13	30,66,48,45,25,23,6,42,48,45,42,26,19	0,1924,9881,35452,38120,39298,39417,41306,42903,48146,48194,67833,68551	c	350012306800000135,350012306800000136,350012306800000141,350012306800000168,350012306800000174,350012306800000177,350012306800000179,350012306800000191,350012306800000192,350012306800000076,350012306800000230	0-48,0-48,0-48,3-48,0-48,0-48,0-48,0-45,3-45,7-31,0-45						Human E3&#x03b1; ubiquitin ligase family	Han	2000	0		
713	chr23	16798668	16864033	3500096506	599		16798668	16864033	8421504	17	48,48,2,46,23,45,3,47,48,48,48,45,47,31,11,30,29	0,12469,19320,19411,21824,26816,27823,27835,30254,35328,36873,40571,40619,54382,54667,54696,65336	c	350009650600000138,350009650600000150,350009650600000157,350009650600000275,350009650600000166,350009650600000282,350009650600000171,350009650600000179,350009650600000182,350009650600000191,350009650600000192,350009650600000307,350009650600000215,350009650600000216,350009650600000239	0-48,0-48,0-48,0-23,0-48,0-47,0-48,0-48,0-48,0-45,3-45,3-44,0-42,15-45,0-29						HUMAN E3ALPHA UBIQUITIN LIGASE FAMILY - Patent application	www.faqs.org	0	0		
713	chr23	16827315	16828919	3500434565	23		16827315	16828919	8421504	2	10,13	0,1591	c	350043456500000027	0-23						Human methionine aminopeptidase type 3	Sympson	2002	0		
713	chr23	16827315	16828919	3500059243	23		16827315	16828919	8421504	2	10,13	0,1591	c	350005924300000074,350005924300000027	0-23,0-23						Methionine aminopeptidase type 3	Aurora	2000	0		
713	chr23	16870708	16884399	3500092766	41		16870708	16884399	8421504	2	20,21	0,13670	c,g	350009276600000005,350009276600000001,350009276600000001	0-20,0-21,0-21		17591862	10.1167/iovs.07-0049	1552-5783	Investigative Ophthalmology & Visual Science	An Intramembrane Glutamic Acid Governs Peripherin/rds Function for Photoreceptor Disk Morphogenesis	Goldberg	2007	0		
713	chr23	16899882	16899907	3500233546	24		16899882	16899907	8421504	2	4,20	0,5	c	350023354600000023	7-36						Non-Natural Amino Acid Replication-Dependent Microorganisms and Vaccines - Patent application	www.faqs.org	0	0		
715	chr23	17073870	17074867	3500145718	39		17073870	17074867	8421504	3	19,19,1	0,847,996	c,g	350014571800000028,350014571800000029	0-19,0-20						Molecular markers of hepatocellular carcinoma and their applications	Avila	2007	0		GNMT
715	chr23	17075826	17075881	3500357772	39		17075826	17075881	8421504	2	29,10	0,45	c	350035777200000137	0-50						Functional Polymorphisms: Bovine Calpastatin Gene and Meat Tenderness	.nottingham.ac.uk	0	0		
715	chr23	17114424	17114559	3500356729	24		17114424	17114559	8421504	2	8,16	0,119	c	350035672900000004	0-24		20181665	10.1152/ajprenal.00708.2009		American Journal of Physiology - Renal Physiology	Acute regulation of renal Na+/H+ exchanger NHE3 by dopamine: role of protein phosphatase 2A	I.	2010	0		PPP2R5D
715	chr23	17119115	17119160	3500071005	45		17119115	17119160	8421504	1	45	0	p	350007100500015017	0-45						&#x767a;&#x73fe;&#x306b;&#x6027;&#x5dee;&#x306e;&#x3042;&#x308b;&#x907a;&#x4f1d;&#x5b50;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x30de;&#x30a6;&#x30b9;&#x304a;&#x3088;&#x3073;&#x30a6;&#x30b7;&#x80da;&#x306e;&#x6027;&#x5224;&#x5225;&#x6cd5; - &#x5bb6;&#x7	www.patentjp.com	0	0		MEA1
715	chr23	17130475	17130501	3500023147	23		17130475	17130501	8421504	3	4,14,5	0,5,21	c	350002314700000046	2-25						Method for recombinant production of biologically active polypeptides	Ishizaka	1996	0		
716	chr23	17219439	17219467	3500383728	23		17219439	17219467	8421504	3	5,13,5	0,8,23	c	350038372800000001	5-29						Method for reduction of transgene copy number	Kausch	2000	0		
716	chr23	17238960	17242990	3500288852	69		17238960	17242990	8421504	4	24,15,8,22	0,925,2662,4008	c,g	350028885200000000,350028885200000009,350028885200000010	0-24,0-23,0-22						Conditional Mutagenesis of the Murine Serum Response Factor Gene Blocks Cardiogenesis and the Transcription of Downstream Gene Targets--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x90	journal.9med.net	0	0		
716	chr23	17239813	17241643	3500455382	108		17239813	17241643	8421504	2	87,21	0,1809	p	350045538200015001	0-108						Berkeley : BIO 1a : Fischer_Lecture_Complete Edit	ww.coursehero.com	0	0		SRF
716	chr23	17239840	17241643	3500417432	81		17239840	17241643	8421504	2	60,21	0,1782	p	350041743200015001,350041743200015000	0-54,0-54			10.1073/pnas.0505338103		Proceedings of the National Academy of Sciences of the United States of America	Serum response factor MADS box serine -162 phosphorylation switches proliferation and myogenic gene programs	Dinakar	2006	0		SRF
716	chr23	17239840	17241631	3500082535	69		17239840	17241631	8421504	2	60,9	0,1782	p	350008253500015001,350008253500015000	0-54,0-66						Serum response factor MADS box serine-162 phosphorylation switches proliferation and myogenic gene programs	www.pnas.org	0	0		SRF
716	chr23	17239856	17239881	3500150459	25		17239856	17239881	8421504	1	25	0	c	350015045900000011	0-25		21258408	10.1038/onc.2010.616	0950-9232	Oncogene	Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer	Booy	2011	6		SRF
716	chr23	17239856	17239881	3500047302	25		17239856	17239881	8421504	1	25	0	c	350004730200000011	0-25		21258408	10.1038/onc.2010.616	0950-9232	Oncogene	Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer	Booy	2011	6		SRF
716	chr23	17239861	17241783	3500419944	40		17239861	17241783	8421504	2	20,20	0,1902	c,g	350041994400000030,350041994400000030,350041994400000031	0-20,0-20,0-20		17374850	10.1210/me.2006-0497	0888-8809	Molecular Endocrinology	Estrogen Receptors &#x03b1; and &#x03b2; Mediate Distinct Pathways of Vascular Gene Expression, Including Genes Involved in Mitochondrial Electron Transport and Generation of Reactive Oxygen Species	O'Lone	2007	5		SRF
716	chr23	17241639	17241668	3500311083	29		17241639	17241668	8421504	1	29	0	c	350031108300000006	0-29						Increased expression of alternatively spliced dominant-negative isoform of SRF in human failing hearts	rt.physiology.org	0	0		
716	chr23	17243083	17243106	3500073182	23		17243083	17243106	8421504	1	23	0	c	350007318200000010	0-23						Torella D. et al. miR-133 and vascular smooth muscle cells	s.ahajournals.org	0	0		
716	chr23	17243824	17244912	3500102520	54		17243824	17244912	8421504	2	43,11	0,1077	p	350010252000015014	0-54						Molecular switches ii	Choo	2001	0		SRF
716	chr23	17243824	17244912	3500037728	54		17243824	17244912	8421504	2	43,11	0,1077	p	350003772800015007	0-54						Compositions and methods for monitoring the modification of engineered binding partners	Colyer	2000	0		SRF
716	chr23	17243824	17244912	3500027122	54		17243824	17244912	8421504	2	43,11	0,1077	p	350002712200015015	0-54						 Assay For Measuring Enzyme Activity In Vivo 	www.docstoc.com	0	0		SRF
716	chr23	17243824	17244912	3500008425	54		17243824	17244912	8421504	2	43,11	0,1077	p	350000842500015010,350000842500015026	0-54,0-45						Methods of monitoring enzyme activity	Griffiths	2002	0		SRF
716	chr23	17245835	17245858	3500435393	23		17245835	17245858	8421504	1	23	0	c	350043539300000016	0-23						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		SRF
717	chr23	17366172	17366195	3500284394	23		17366172	17366195	8421504	1	23	0	g	350028439400000159	4-32						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2011	0		
717	chr23	17388707	17388736	3500438553	25		17388707	17388736	8421504	2	11,14	0,15	c	350043855300000280	12-37						Eph-related tyrosine kinases, nucleotide sequences and methods of use	Pasquale	1993	0		
717	chr23	17393253	17393280	3500093026	24		17393253	17393280	8421504	3	11,8,5	0,12,22	c	350009302600000095	0-28						METHOD FOR AMPLIFYING A FLAVIVIRUS cDNA IN A PROKARYOTIC CELL - Patent application	www.faqs.org	0	0		
719	chr23	17635890	17635920	3500256323	25		17635890	17635920	8421504	3	4,9,12	0,5,18	c	350025632300000152	15-47						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - US Patent 5627061 Description	ww.patentstorm.us	0	0		
719	chr23	17635890	17635920	3500210376	25		17635890	17635920	8421504	3	4,9,12	0,5,18	c	350021037600000157	15-47						US Patent # 6,248,876. Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patents.com	www.patents.com	0	0		
719	chr23	17635890	17635920	3500127679	25		17635890	17635920	8421504	3	4,9,12	0,5,18	c	350012767900000157	15-47						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
720	chr23	17775244	17791635	3500269496	40		17775244	17791635	8421504	2	20,20	0,16371	c,g	350026949600000014,350026949600000007,350026949600000007	0-20,0-20,0-20						RESEARCH ARTICLE Open Access HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo- resistance of invasive micropapillary carcinoma of the breast	biomedcentral.com	0	0		VEGFA
720	chr23	17775289	17783680	3500458951	42		17775289	17783680	8421504	2	22,20	0,8371	c,g	350045895100000007,350045895100000001	9-31,0-20		15342781	10.1091/mbc.E04-05-0374	1059-1524	Molecular Biology of the Cell	Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1&#x2013;independent Mechanism	Pore	2004	5		VEGFA
720	chr23	17775289	17783680	3500439642	42		17775289	17783680	8421504	2	22,20	0,8371	c,g	350043964200000007,350043964200000001	9-31,0-20						Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1-independent Mechanism | nabendu pore - Academia.edu	www.academia.edu	0	0		VEGFA
720	chr23	17775289	17783680	3500012356	42		17775289	17783680	8421504	2	22,20	0,8371	c,g	350001235600000007,350001235600000001	9-31,0-20						Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1-independent Mechanism | nabendu pore - Academia.edu	www.academia.edu	0	0		VEGFA
720	chr23	17775289	17783680	3500007695	42		17775289	17783680	8421504	2	22,20	0,8371	c,g	350000769500000007,350000769500000001	9-31,0-20						Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1-independent Mechanism | nabendu pore - Academia.edu	www.academia.edu	0	0		VEGFA
720	chr23	17775289	17775324	3500440012	35		17775289	17775324	8421504	1	35	0	g	350044001200000000	5-40		21169258	10.1158/1078-0432.CCR-10-0664	1078-0432	Clinical Cancer Research	A Hypoxia- and &#x03b1;-Fetoprotein&#x2013;Dependent Oncolytic Adenovirus Exhibits Specific Killing of Hepatocellular Carcinomas	Kwon	2010	8		
720	chr23	17775289	17775324	3500345319	35		17775289	17775324	8421504	1	35	0	g	350034531900000000	85-120		7641334	10.1161/01.RES.77.3.638	0009-7330	Circulation Research	Hypoxia Regulates Vascular Endothelial Growth Factor Gene Expression in Endothelial Cells	Liu	1995	9		VEGFA
720	chr23	17775289	17775324	3500220623	35		17775289	17775324	8421504	1	35	0	g	350022062300000017	0-35						An Algorithm for Identifying Novel Targets of Transcription Factor Families: Application to Hypoxia-inducible Factor 1 Targets	www.la-press.com	0	0		VEGFA
720	chr23	17775289	17775318	3500071673	27		17775289	17775318	8421504	2	5,22	0,7	g	350007167300000010	0-27						Diosgenin Induces Hypoxia-Inducible Factor-1 Activation and Angiogenesis through Estrogen Receptor-Related Phosphatidylinositol 3-kinase/Akt and p38 Mitogen-Activated Protein Kinase Pathways in Osteoblasts	aspetjournals.org	0	0		VEGFA
720	chr23	17775289	17775315	3500387115	26		17775289	17775315	8421504	1	26	0	g	350038711500000000	0-26						Berberine Inhibits HIF-1 Expression via Enhanced Proteolysis	aspetjournals.org	0	0		VEGFA
720	chr23	17775289	17775315	3500322645	26		17775289	17775315	8421504	1	26	0	g	350032264500000000	0-26		15322253		1521-0111 (Online)	Molecular Pharmacology	Berberine Inhibits HIF-1&#x03b1; Expression via Enhanced Proteolysis	Lin	2004	0		
720	chr23	17775290	17775323	3500238753	33		17775290	17775323	8421504	1	33	0	g	350023875300000001	0-33		22132102	10.1371/journal.pone.0027460		PLoS ONE	Assessment of Hypoxia Inducible Factor Levels in Cancer Cell Lines upon Hypoxic Induction Using a Novel Reporter Construct	Wenyu	2011	0		
720	chr23	17775291	17775314	3500365527	23		17775291	17775314	8421504	1	23	0	g	350036552700000024	0-23			10.1002/art.10106	1529-0131	Arthritis & Rheumatism	Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis - Stokes - 2002 - Arthritis & Rheumatism - Wiley Online Library	Stokes	2002	0		
720	chr23	17776859	17776884	3500259404	24		17776859	17776884	8421504	2	6,18	0,7	c	350025940400000190	20-44						Material and methods for treating or preventing HER-3 associated diseases - Patent application	www.faqs.org	0	0		
720	chr23	17780354	17791856	3500329425	57		17780354	17791856	8421504	3	25,3,29	0,3197,11473	c,g	350032942500000004,350032942500000005,350032942500000005	0-28,0-29,0-29		15901832	10.1091/mbc.E04-11-1029	1059-1524	Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Im	2005	5		
720	chr23	17780354	17791856	3500228083	57		17780354	17791856	8421504	3	25,3,29	0,3197,11473	c	350022808300000004,350022808300000005	0-28,0-29			10.1091/mbc.E04-11-1029		Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Eunok	2005	0		
720	chr23	17780354	17791856	3500078966	57		17780354	17791856	8421504	3	25,3,29	0,3197,11473	c,g	350007896600000004,350007896600000005,350007896600000005	0-28,0-29,0-29						Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells	w.molbiolcell.org	0	0		
720	chr23	17780370	17783592	3500385614	44		17780370	17783592	8421504	3	9,12,23	0,3181,3199	c,g	350038561400000000,350038561400000002	0-21,0-23		19506300	10.1182/blood-2009-01-199166		Blood	Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells	Esther	2009	0		
720	chr23	17780370	17783592	3500026318	44		17780370	17783592	8421504	3	9,12,23	0,3181,3199	c	350002631800000000,350002631800000002	0-21,0-23						Expressionofvascularendothelialgrowthfactoriscoordinatelyregulatedbythe activin-likekinasereceptors1and5inendothelialcells	tologylibrary.org	0	0		
720	chr23	17780373	17791706	3500038208	49		17780373	17791706	8421504	3	6,18,25	0,3178,11308	c	350003820800000002,350003820800000003	0-24,0-25		16227395	10.1158/1535-7163.MCT-05-0198	1535-7163	Molecular Cancer Therapeutics	Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1&#x03b1; and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells	Zhang	2005	5		VEGFA
720	chr23	17780374	17791706	3500453420	42		17780374	17791706	8421504	3	5,16,21	0,3177,11311	c	350045342000000003,350045342000000002	0-21,0-21		16951224	10.1158/1078-0432.CCR-05-2794	1078-0432	Clinical Cancer Research	Rac Activation Is Associated with Hepatocellular Carcinoma Metastasis by Up-regulation of Vascular Endothelial Growth Factor Expression	Lee	2006	8		VEGFA
720	chr23	17780374	17791706	3500400973	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350040097300000000,350040097300000001	0-23,0-25		10027945	10.1046/j.1523-1755.1999.0550031063.x	0085-2538	Kidney International	Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome	WEBB	1999	7		
720	chr23	17780374	17791706	3500385098	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350038509800000008,350038509800000009	0-23,0-25						Author's personal copy	ss.bjmu.edu.cn	0	0		VEGFA
720	chr23	17780374	17791706	3500357641	45		17780374	17791706	8421504	3	5,18,22	0,3177,11310	c	350035764100000002,350035764100000003	0-23,0-22						B2-MicroglobulinPromotestheGrowthofHumanRenalCell CarcinomathroughtheActivationoftheProteinKinaseA, CyclicAMP^ResponsiveElement-BindingProtein, andVascularEndothelialGrowthFactorAxis	.aacrjournals.org	0	0		VEGFA
720	chr23	17780374	17791706	3500351967	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350035196700000004,350035196700000005	0-23,0-25		22390300	10.1186/1471-2407-12-81	1471-2407	BMC Cancer	KAI1 suppresses HIF-1&#xce;&#xb1; and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer	Park	2012	3		
720	chr23	17780374	17791706	3500349510	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350034951000000001,350034951000000000	0-23,0-25		22458960	10.1111/j.1439-0531.2012.02019.x	1439-0531	Reproduction in Domestic Animals	Vascular Endothelial (VEGF) and Epithelial Growth Factor (EGF) as Well as Platelet-Activating Factor (PAF) and Receptors are Expressed in the Early Pregnant Canine Uterus - Sch&#xe4;fer-Somi - 2012 - Reproduction in Domestic Animals - Wiley Online Library	Schafer-Somi	2013	0		VEGFA
720	chr23	17780374	17791706	3500332969	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350033296900000004,350033296900000005	0-23,0-25						Vegfr-1 antibodies to treat breast cancer	Rafii	2004	0		VEGFA
720	chr23	17780374	17791706	3500311971	47		17780374	17791706	8421504	3	5,18,24	0,3177,11308	c	350031197100000032,350031197100000033	0-23,0-24						&#xb1b4;&#xb051;&#xc2e0;&#xbffd;&#xa65d;&#xa46c; Cbfa1 &#xa662;MDA-MB-231 &#xa8c5;&#xc0f9;&#xb2d3;&#xad4d;&#xa4a4; &#xb9ef;MMP-9 &#xb0f2;&#xa65d;&#xaaed;&#xb27b;&#xaaba;&#xbdd5;&#xb1b1;	ir.ym.edu.tw	0	0		VEGFA
720	chr23	17780374	17791706	3500274018	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350027401800000004,350027401800000005	0-23,0-25						Vegfr-1 antibodies to treat breast cancer	Rafii	2003	0		VEGFA
720	chr23	17780374	17791706	3500259968	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350025996800000004,350025996800000005	0-23,0-25						Vegfr-1 antibodies to treat breast cancer	Rafii	2003	0		VEGFA
720	chr23	17780374	17791706	3500237207	47		17780374	17791706	8421504	3	5,18,24	0,3177,11308	c	350023720700000000,350023720700000001	0-23,0-24						World J Gastroenterol	www.wjgnet.com	0	0		
720	chr23	17780374	17791706	3500232510	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350023251000000004,350023251000000005	0-23,0-25						Vegfr-1 antibodies to treat breast cancer	Rafii	2004	0		
720	chr23	17780374	17791706	3500192937	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350019293700000004,350019293700000005	0-23,0-25						Vegfr-1 antibodies to treat breast cancer	Wu	2004	0		VEGFA
720	chr23	17780374	17791706	3500151796	45		17780374	17791706	8421504	3	5,18,22	0,3177,11310	c	350015179600000006,350015179600000007	0-23,0-22		22389672	10.1371/journal.pone.0031655	1932-6203	PLOS ONE	PLOS ONE: A Garlic Derivative, S-allylcysteine (SAC), Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma	Ng	2012	4		VEGFA
720	chr23	17780374	17791706	3500132223	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350013222300000004,350013222300000005	0-23,0-25						VEGFR-1 ANTIBODIES TO TREAT BREAST CANCER - IMCLONE SYSTEMS INCORPORATED	www.sumobrain.com	0	0		VEGFA
720	chr23	17780374	17791706	3500101088	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350010108800000107,350010108800000004,350010108800000005,350010108800000108	0-23,0-23,0-25,0-25						Angiogenesis-modulating compositions and uses - Patent application	www.faqs.org	0	0		VEGFA
720	chr23	17780374	17791706	3500093417	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350009341700000004,350009341700000005	0-23,0-25						Angiogenesis-modulating compositions and uses	Ling	2010	0		VEGFA
720	chr23	17780374	17791706	3500090396	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350009039600000004,350009039600000005	0-23,0-25						Angiogenesis-modulating compositions and uses	Ling	2003	0		VEGFA
720	chr23	17780374	17791706	3500088659	48		17780374	17791706	8421504	3	5,18,25	0,3177,11307	c	350008865900000001,350008865900000000	0-23,0-25						ScienceDirect.com - FEBS Letters - Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16	sciencedirect.com	0	0		VEGFA
720	chr23	17780374	17791706	3500020093	45		17780374	17791706	8421504	3	5,18,22	0,3177,11310	c	350002009300000000,350002009300000001	0-23,0-22						SNS-032 Prevents Tumor Cell&#x2013;Induced Angiogenesis By Inhibiting Vascular Endothelial Growth Factor	www.neoplasia.com	0	0		VEGFA
720	chr23	17780374	17791705	3500264993	47		17780374	17791705	8421504	3	5,18,24	0,3177,11307	c	350026499300000004,350026499300000005	0-23,0-24						Angiogenesis-modulating compositions and uses	Ling	2003	0		VEGFA
720	chr23	17780374	17791705	3500162207	47		17780374	17791705	8421504	3	5,18,24	0,3177,11307	c	350016220700000004,350016220700000005	0-23,0-24						Angiogenesis-modulating compositions and uses	Ling	2001	0		
720	chr23	17780374	17789323	3500401377	45		17780374	17789323	8421504	4	5,18,14,8	0,3177,4684,8941	c	350040137700000000,350040137700000001	0-23,0-22		17388800	10.1111/j.1538-7836.2007.02431.x	1538-7836	Journal of Thrombosis and Haemostasis	Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms - GRANATA - 2007 - Journal of Thrombosis and Haemostasis - Wiley Online Library	GRANATA	2007	0		VEGFA
720	chr23	17780374	17783569	3500259978	23		17780374	17783569	8421504	2	5,18	0,3177	c	350025997800000002	25-48		16267257	10.1161/CIRCULATIONAHA.104.516898	0009-7322	Circulation	Id1 Gene Transfer Confers Angiogenic Property on Fully Differentiated Endothelial Cells and Contributes to Therapeutic Angiogenesis	Nishiyama	2005	15		
720	chr23	17780375	17789414	3500434391	40		17780375	17789414	8421504	3	4,16,20	0,3176,9019	c,g	350043439100000000,350043439100000001,350043439100000001	0-20,0-20,0-20		23922887	10.1371/journal.pone.0069994		PLoS ONE	TNF-&#x03b1; Decreases VEGF Secretion in Highly Polarized RPE Cells but Increases It in Non-Polarized RPE Cells Related to Crosstalk between JNK and NF-&#x03ba;B Pathways	Hiroto	2013	0		VEGFA
720	chr23	17780375	17789414	3500407899	70		17780375	17789414	8421504	4	4,16,30,20	0,3176,8970,9019	c,g	350040789900000001,350040789900000000,350040789900000002,350040789900000002	0-20,0-30,0-20,0-20		18840644	10.1530/REP-08-0117	1470-1626	Reproduction	Vascular supply as a discriminating factor for pig preantral follicle selection	Martelli	2009	3		VEGFA
720	chr23	17780375	17789414	3500224802	40		17780375	17789414	8421504	3	4,16,20	0,3176,9019	c,g	350022480200000000,350022480200000001,350022480200000001	0-20,0-20,0-20		23922887	10.1371/journal.pone.0069994	1932-6203	PLOS ONE	PLOS ONE: TNF-&#x03b1; Decreases VEGF Secretion in Highly Polarized RPE Cells but Increases It in Non-Polarized RPE Cells Related to Crosstalk between JNK and NF-&#x03ba;B Pathways	Terasaki	2013	4		VEGFA
720	chr23	17780375	17783621	3500237256	46		17780375	17783621	8421504	3	4,22,20	0,3176,3226	c,g	350023725600000020,350023725600000021,350023725600000021	0-26,0-20,0-20						TITLE: The Role of Neuropilin in Breast Cancer Metastasis PRINCIPAL INVESTIGATOR: Elizabeth A. Libscomb, Ph.D. Arthur M. Mercurio, Ph.D. CONTRACTING ORGANIZATION: Beth Israel Deaconess Medical Center Boston, Massachusetts 02215 REPORT DATE: June 2003 TYPE	handle.dtic.mil	0	0		VEGFA
720	chr23	17780375	17783571	3500457239	24		17780375	17783571	8421504	2	4,20	0,3176	c	350045723900000004	0-24						INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF	Fueyo	2009	0		VEGFA
720	chr23	17780375	17783571	3500125874	24		17780375	17783571	8421504	2	4,20	0,3176	c	350012587400000000	0-24		11830495	10.1182/blood.V99.4.1419	0006-4971	Blood	CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells	Tai	2002	10		
720	chr23	17780375	17783571	3500056928	24		17780375	17783571	8421504	2	4,20	0,3176	c	350005692800000015,350005692800000004	0-24,0-24						INFECTIVITY-ENHANCED CONDITIONALLY-REPLICATIVE ADENOVIRUS AND USES THEREOF - Patent application	www.faqs.org	0	0		
720	chr23	17780375	17783571	3500036353	24		17780375	17783571	8421504	2	4,20	0,3176	c	350003635300000028	0-24						www.stemcell8.c &#x2190;&#x70b9;&#x51fb;&#x8fdb;&#x5165;	rary.bjcancer.org	0	0		VEGFA
720	chr23	17780378	17789375	3500433630	41		17780378	17789375	8421504	3	1,20,20	0,3173,8977	c,g	350043363000000009,350043363000000010,350043363000000010	0-21,0-20,0-20						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation	Chang	2006	0		VEGFA
720	chr23	17780378	17789375	3500139519	41		17780378	17789375	8421504	3	1,20,20	0,3173,8977	c,g	350013951900000009,350013951900000010,350013951900000010	0-21,0-20,0-20						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation - US Patent 7435800 Description	ww.patentstorm.us	0	0		VEGFA
720	chr23	17783552	17783582	3500431310	30		17783552	17783582	8421504	1	30	0	c	350043131000000012	0-30						Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin	www.fasebj.org	0	0		
720	chr23	17783571	17791710	3500377396	129		17783571	17791710	8421504	2	69,60	0,8079	c,g	350037739600000001,350037739600000007,350037739600000007,350037739600000002,350037739600000002,350037739600000006,350037739600000006	0-39,0-57,0-57,10-37,10-37,0-60,0-60					Patent	Production of vascular endothelial cell growth factor (Patent US:5194596)	Abraham	1993	0		
720	chr23	17783571	17791710	3500350800	129		17783571	17791710	8421504	2	69,60	0,8079	c,g	350035080000000001,350035080000000002,350035080000000007,350035080000000007,350035080000000006,350035080000000006	0-39,10-37,0-57,0-57,0-60,0-60						Production of vascular endothelial cell growth factor	Tischer	1989	0		
720	chr23	17783583	17791710	3500385105	117		17783583	17791710	8421504	2	57,60	0,8067	c,g	350038510500000001,350038510500000001,350038510500000006,350038510500000006,350038510500000005,350038510500000005	10-37,10-37,0-57,0-57,0-60,0-60						 Production Of Vascular Endothelial Cell Growth Factor 	www.docstoc.com	0	0		
720	chr23	17783595	17791634	3500157158	199		17783595	17791634	8421504	6	30,27,35,58,26,23	0,126,1442,5720,5826,8016	c	350015715800000029,350015715800000032,350015715800000034,350015715800000035,350015715800000037	18-48,0-27,3-48,0-48,0-49						US Patent # 6,750,044. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids - Patents.com	www.patents.com	0	0		
720	chr23	17783602	17789415	3500198438	41		17783602	17789415	8421504	2	21,20	0,5793	c,g	350019843800000000,350019843800000001,350019843800000001	0-21,0-20,0-20		12124190	10.1152/ajpheart.00261.2002		American Journal of Physiology - Heart and Circulatory Physiology	Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats	Li	2002	0		VEGFA
720	chr23	17783603	17791634	3500426169	46		17783603	17791634	8421504	2	24,22	0,8009	c,g	350042616900000014,350042616900000015,350042616900000015	0-24,0-22,0-22						Estrogens Reduce the Expression of YKL-40 in the Retina: Implications for Eye and Joint Diseases	www.iovs.org	0	0		VEGFA
720	chr23	17783603	17783629	3500333221	26		17783603	17783629	8421504	1	26	0	c	350033322100000010	0-26						CLIC4 mediates TGF-&#xdf;1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer	-publications.com	0	0		VEGFA
720	chr23	17783603	17783629	3500280889	26		17783603	17783629	8421504	1	26	0	c	350028088900000009	0-26						Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro	www.fasebj.org	0	0		VEGFA
720	chr23	17783603	17783629	3500168712	26		17783603	17783629	8421504	1	26	0	c	350016871200000004	0-26		20533548	10.1002/ijc.25506	1097-0215	International Journal of Cancer	Micro-RNA-21 regulates TGF-&#x03b2;-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction - Yao - 2010 - International Journal of Cancer - Wiley Online Library	Yao	2011	0		
720	chr23	17783652	17783676	3500302272	24		17783652	17783676	8421504	1	24	0	c	350030227200000007	0-24						Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines	-publications.com	0	0		VEGFA
720	chr23	17783652	17783676	3500249852	24		17783652	17783676	8421504	1	24	0	c	350024985200000000	0-24						World J Gastroenterol	www.wjgnet.com	0	0		
720	chr23	17783652	17783676	3500086663	24		17783652	17783676	8421504	1	24	0	c	350008666300000010	0-24						Genetically engineered stem cells expressing cytosine deaminase and interferon-&#x03b2; migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects	-publications.com	0	0		
720	chr23	17783676	17783724	3500086404	48		17783676	17783724	8421504	1	48	0	p	350008640400015033	0-48						Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen	Buettner	1997	0		
720	chr23	17783706	17789355	3500245482	90		17783706	17789355	8421504	3	42,8,40	0,1358,5609	c	350024548200000139,350024548200000142	3-45,0-48						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
720	chr23	17783709	17783748	3500307736	39		17783709	17783748	8421504	1	39	0	c	350030773600000032	0-39						 Cysteine 	www.docstoc.com	0	0		
720	chr23	17783715	17791679	3500129294	40		17783715	17791679	8421504	2	20,20	0,7944	c,g	350012929400000014,350012929400000015,350012929400000015	0-20,0-20,0-20						Synthetic bone substitute engineered with amniotic epithelial cells enhances bone regeneration after maxillary sinus augmentation. - ResearchGate	.researchgate.net	0	0		
720	chr23	17785037	17791634	3500422965	94		17785037	17791634	8421504	4	35,10,26,23	0,4278,4384,6574	c	350042296500000034,350042296500000037	3-48,0-49						Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids	Keyt	1996	0		
720	chr23	17785037	17791633	3500218015	128		17785037	17791633	8421504	4	35,56,15,22	0,4278,4395,6574	c	350021801500000010,350021801500000011,350021801500000014	0-51,0-59,0-37						Synthesis of the human VEGF 165 gene based on overlap PCR and recombinant expression in stable transfected CHO cells	demicjournals.org	0	0		
720	chr23	17785037	17789331	3500267577	51		17785037	17789331	8421504	2	35,16	0,4278	c	350026757700000009	9-60						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS	Chen	2009	0		
720	chr23	17785057	17789385	3500244934	46		17785057	17789385	8421504	3	15,10,21	0,4258,4307	c,g	350024493400000146,350024493400000144,350024493400000144	0-25,0-21,0-21						Novel insulin/IGF/relaxin family polypeptides and dnas thereof	Yi Teng Kang Ming 	2005	0		VEGFA
720	chr23	17785059	17791627	3500229421	41		17785059	17791627	8421504	4	13,9,3,16	0,4256,4385,6552	c	350022942100000004,350022942100000005	0-22,0-19		17875711	10.1158/0008-5472.CAN-06-3612	0008-5472	Cancer Research	Semaphorin SEMA3F Affects Multiple Signaling Pathways in Lung Cancer Cells	Potiron	2007	8		VEGFA
720	chr23	17785059	17791622	3500200325	44		17785059	17791622	8421504	4	13,9,11,11	0,4256,4377,6552	c	350020032500000002,350020032500000003	0-22,0-22						VascularendothelialgrowthfactorA,secretedinresponse to transforming growth factor-b1 under hypoxic conditions, induces autocrine effects on migration of	www.asiaandro.com	0	0		VEGFA
720	chr23	17788166	17789348	3500338966	38		17788166	17789348	8421504	2	19,19	0,1163	c,g	350033896600000006,350033896600000007	0-19,0-19		18339878	10.1158/0008-5472.CAN-07-6011	0008-5472	Cancer Research	Diphenyl Difluoroketone: A Curcumin Derivative with Potent In vivo Anticancer Activity	Subramaniam	2008	8		VEGFA
720	chr23	17788166	17789348	3500205383	38		17788166	17789348	8421504	2	19,19	0,1163	c,g	350020538300000019,350020538300000041,350020538300000020,350020538300000042	0-19,0-19,0-19,0-19						Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same - Patent application	www.faqs.org	0	0		VEGFA
720	chr23	17788166	17789348	3500078841	38		17788166	17789348	8421504	2	19,19	0,1163	c,g	350007884100000006,350007884100000007	0-19,0-19						Diphenyl Difluoroketone: A Curcumin Derivative with Potent In vivo Anticancer Activity	.aacrjournals.org	0	0		VEGFA
720	chr23	17788166	17789348	3500070011	38		17788166	17789348	8421504	2	19,19	0,1163	c,g	350007001100000004,350007001100000005,350007001100000005	0-19,0-19,0-19		21347286	10.1371/journal.pone.0016958	1932-6203	PLOS ONE	PLOS ONE: RNA Binding Protein CUGBP2/CELF2 Mediates Curcumin-Induced Mitotic Catastrophe of Pancreatic Cancer Cells	Subramaniam	2011	4		VEGFA
720	chr23	17788168	17789351	3500279591	40		17788168	17789351	8421504	2	20,20	0,1163	c,g	350027959100000006,350027959100000007	0-20,0-20			10.1002/art.23061	1529-0131	Arthritis & Rheumatism	Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: Implications for progression to scarring in autoimmune-associated congenital heart block - Clancy - 2007 - Arthritis & Rheumatism - Wiley Online Library	Clancy	2007	0		VEGFA
720	chr23	17789316	17791633	3500207547	153		17789316	17791633	8421504	2	131,22	0,2295	p,c,g	350020754700000026,350020754700000026,350020754700015008,350020754700000006,350020754700015002,350020754700015004,350020754700000019,350020754700015013,350020754700000027,350020754700000027	0-131,0-131,0-45,0-19,0-72,0-63,8-27,0-45,0-22,0-22						Peptide antagonists of vascular endothelial growth factor	Klagsbrun	2000	0		VEGFA
720	chr23	17789316	17791630	3500131576	147		17789316	17791630	8421504	3	27,101,19	0,30,2295	p	350013157600015029,350013157600015034,350013157600015040	144-255,6-114,12-96						Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis - US Patent 7601341 Description	ww.patentstorm.us	0	0		
720	chr23	17789319	17789412	3500410189	90		17789319	17789412	8421504	2	45,45	0,48	p	350041018900015256,350041018900015257	0-45,0-45						Soluble inhibitors of vascular endothelial growth factor and use thereof - Patent application	www.faqs.org	0	0		VEGFA
720	chr23	17789329	17791616	3500415607	46		17789329	17791616	8421504	3	23,18,5	0,100,2282	c	350041560700000001,350041560700000000	0-23,0-23		18268046	10.2337/db07-0765	0012-1797	Diabetes	Selective Activation of Peroxisome Proliferator&#x2013;Activated Receptor (PPAR)&#x03b1; and PPAR&#x03b3; Induces Neoangiogenesis Through a Vascular Endothelial Growth Factor&#x2013;Dependent Mechanism	Biscetti	2008	8		VEGFA
720	chr23	17789332	17791676	3500094685	40		17789332	17791676	8421504	2	20,20	0,2324	c,g	350009468500000000,350009468500000001,350009468500000001	0-20,0-20,0-20						TREATMENT OF VASCULAR ABNORMALITIES USING NANOPARTICLES - Patent application	www.faqs.org	0	0		VEGFA
720	chr23	17789332	17791616	3500185201	46		17789332	17791616	8421504	3	22,19,5	0,96,2279	c	350018520100000009,350018520100000008	0-22,0-24						Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?	itis-research.com	0	0		VEGFA
720	chr23	17789332	17791616	3500088491	46		17789332	17791616	8421504	3	22,19,5	0,96,2279	c	350008849100000009,350008849100000008	0-22,0-24		22414623	10.1186/ar3774		Arthritis Research & Therapy	Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?	Joseph	2012	0		VEGFA
720	chr23	17789336	17791624	3500015644	40		17789336	17791624	8421504	3	21,6,13	0,105,2275	c	350001564400000006,350001564400000007	0-21,0-19					The American Journal of Pathology	N-Acetyl-Cysteine Promotes Angiostatin Production and Vascular Collapse in an Orthotopic Model of Breast Cancer	Anshu	2004	0		VEGFA
720	chr23	17789364	17791624	3500416192	44		17789364	17791624	8421504	3	22,9,13	0,74,2247	c,g	350041619200000014,350041619200000014,350041619200000015	0-22,0-22,0-22		16778100	10.1158/1078-0432.CCR-06-0054	1078-0432	Clinical Cancer Research	Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination	DiFeo	2006	8		VEGFA
720	chr23	17789364	17791624	3500277251	44		17789364	17791624	8421504	3	22,9,13	0,74,2247	c,g	350027725100000039,350027725100000039,350027725100000040	0-22,0-22,0-22						KLF6 ALTERNATIVE SPLICE FORMS AND A GERMLINE KLF6 DNA POLYMORPHISM ASSOCIATED WITH INCREASED CANCER RISK	Martignetti	2005	0		VEGFA
720	chr23	17789364	17791624	3500092683	44		17789364	17791624	8421504	3	22,9,13	0,74,2247	c,g	350009268300000039,350009268300000039,350009268300000091,350009268300000091,350009268300000040,350009268300000092	0-22,0-22,0-22,0-22,0-22,0-22						KLF6 ALTERNATIVE SPLICE FORMS AND A GERMLINE KLF6 DNA POLYMORPHISM ASSOCIATED WITH INCREASED CANCER RISK - Patent application	www.faqs.org	0	0		VEGFA
720	chr23	17789385	17791619	3500252687	43		17789385	17791619	8421504	3	20,15,8	0,47,2226	c	350025268700000000,350025268700000001	0-20,0-23						Inhibition of Angiogenesis and HIF-1aActivity by Antimycin A1	bpb.pharm.or.jp	0	0		VEGFA
720	chr23	17789428	17791616	3500324079	24		17789428	17791616	8421504	2	19,5	0,2183	c	350032407900000003	0-24						1-Page de Garde	.scd.uhp-nancy.fr	0	0		VEGFA
720	chr23	17789432	17791619	3500406092	23		17789432	17791619	8421504	2	15,8	0,2179	c	350040609200000001	0-23			10.1038/sj.onc.1203685	${footerJournalISSN}		Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis		2000	0		
720	chr23	17789436	17791630	3500393202	30		17789436	17791630	8421504	2	11,19	0,2175	c	350039320200000000	54-84						ScienceDirect.com - Cancer Cell - Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene	sciencedirect.com	0	0		VEGFA
720	chr23	17789439	17791633	3500127613	30		17789439	17791633	8421504	2	8,22	0,2172	c	350012761300000001	0-30			10.1046/j.1365-2567.2002.01395.x	1365-2567	Immunology	Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro - Matsuyama - 2002 - Immunology - Wiley Online Library	Matsuyama	2002	0		
720	chr23	17791615	17791638	3500409605	23		17791615	17791638	8421504	1	23	0	c,g	350040960500000001,350040960500000001	7-30,7-30						Le r&#xf4;le des r&#xe9;cepteurs &#xe0; VEGF dans la r&#xe9;gulation de l'angiogen&#xe8;se	doc.rero.ch	0	0		VEGFA
720	chr23	17791615	17791638	3500079611	23		17791615	17791638	8421504	1	23	0	c,g	350007961100000001,350007961100000001	7-30,7-30		11714897		1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro	Tille	2001	0		VEGFA
720	chr23	17791615	17791638	3500060313	23		17791615	17791638	8421504	1	23	0	c,g	350006031300000001,350006031300000001	7-30,7-30		11714897		1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro	Tille	2001	0		VEGFA
720	chr23	17791779	17791971	3500366972	40		17791779	17791971	8421504	2	20,20	0,172	c	350036697200000000,350036697200000001	0-20,0-20						ScienceDirect.com - Developmental Biology - Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: Evidence from knockout mice and growth factor administration	sciencedirect.com	0	0		
720	chr23	17791966	17791991	3500115995	24		17791966	17791991	8421504	2	20,4	0,21	c	350011599500000021	0-24						Effects of antagonists of luteinizing hormone- and growth hormone-releasing hormone on experimental benign prostatic hyperplasia and prostate cancer	aok.pte.hu/docs/p	0	0		VEGFA
722	chr23	18058892	18058917	3500373921	24		18058892	18058917	8421504	2	18,6	0,19	g	350037392100000000	5-29						Preparation process of a natural protein sweetener	Blade-Pique	1995	0		
723	chr23	18171013	18171037	3500382285	23		18171013	18171037	8421504	2	6,17	0,7	c	350038228500000048	2-25						Attenuated Chimeric Flavivirus Bearing Attenuated Japanese Encephalitis Virus Gene As Backbone 	.freshpatents.com	0	0		
723	chr23	18171013	18171037	3500226142	23		18171013	18171037	8421504	2	6,17	0,7	c	350022614200000003	2-25						Small Noncoding RNA Modulates Japanese Encephalitis Virus Replication and Translation in trans	www.virologyj.com	0	0		
724	chr23	18229745	18229770	3500315006	25		18229745	18229770	8421504	1	25	0	c	350031500600000000	0-25						MAMMALIAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS - GOVERNORS OF THE UNIVERSITY OF ALBERTA	www.sumobrain.com	0	0		SLC29A1
724	chr23	18232022	18232175	3500072968	48		18232022	18232175	8421504	2	20,28	0,125	c	350007296800000304	0-48						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
724	chr23	18247232	18252550	3500438785	48		18247232	18252550	8421504	3	4,20,24	0,1357,5294	c	350043878500000046,350043878500000026,350043878500000047,350043878500000027	9-33,9-33,9-32,8-32						Chaperone expression genomes	Belyaev	2007	0		
724	chr23	18247232	18252550	3500008269	48		18247232	18252550	8421504	3	4,20,24	0,1357,5294	c	350000826900000094,350000826900000075,350000826900000026,350000826900000046,350000826900000095,350000826900000076,350000826900000027,350000826900000047	9-33,9-33,9-33,9-33,9-32,8-32,8-32,9-32						Chaperone Expression Genomes 	.freshpatents.com	0	0		
724	chr23	18248589	18252547	3500410534	2163		18248589	18252547	8421504	12	147,207,160,83,42,309,166,191,148,269,334,107	0,443,746,1046,1138,1303,1962,2343,2634,2906,3424,3851	p	350041053400015181,350041053400015178,350041053400015186,350041053400015179,350041053400015187,350041053400015180,350041053400015189	0-198,0-198,0-393,0-393,9-1416,6-1569,0-1557						NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
724	chr23	18248589	18252535	3500131083	2160		18248589	18252535	8421504	11	147,207,160,134,309,166,191,148,269,334,95	0,443,746,1046,1303,1962,2343,2634,2906,3424,3851	p	350013108300015000	0-2160						KEGG T01001: 3326	www.genome.jp	0	0		HSP90AB1
724	chr23	18249077	18249104	3500437756	27		18249077	18249104	8421504	1	27	0	c	350043775600000008	1-28			10.1046/j.1432-1033.2002.03025.x	1432-1033	European Journal of Biochemistry	Differential regulation of telomerase activity by six telomerase subunits - Chang - 2002 - European Journal of Biochemistry - Wiley Online Library	Chang	2002	0		MEPE
724	chr23	18249101	18249155	3500107800	54		18249101	18249155	8421504	1	54	0	p	350010780000015002	0-54		16038408	10.1379/CSC-73R.1	1355-8145	Cell Stress & Chaperones	DNA sequence determinants of nuclear protein binding to the c-Ha-ras antioxidant/electrophile response element in vascular smooth muscle cells: identification of Nrf2 and heat shock protein 90&#x03b2; as heterocomplex components	KP	June	3		HSP90AB1
724	chr23	18249206	18249350	3500152771	48		18249206	18249350	8421504	2	33,15	0,129	p	350015277100015014	0-48						METHOD FOR CANCER DETECTION - Patent application	www.faqs.org	0	0		
724	chr23	18249221	18249377	3500260954	60		18249221	18249377	8421504	2	18,42	0,114	p	350026095400015030	0-60						ABREVIA&#xc7;&#xd5;ES	www.teses.usp.br	0	0		HSP90AB1
724	chr23	18250084	18250659	3500187783	225		18250084	18250659	8421504	2	117,108	0,467	p	350018778300015042	3-228						Oxford_SGC_Clones_web	www.docstoc.com	0	0		HSP90AA1
724	chr23	18250117	18251611	3500311730	180		18250117	18251611	8421504	5	42,3,30,42,63	0,81,434,823,1431	p	350031173000015067	0-180						The Lewisx glycan in mice	ie.uni-hamburg.de	0	0		
724	chr23	18250183	18250673	3500404944	40		18250183	18250673	8421504	3	18,2,20	0,368,470	c,g	350040494400000038,350040494400000039,350040494400000039	0-20,0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
724	chr23	18250198	18250571	3500090925	23		18250198	18250571	8421504	2	3,20	0,353	c	350009092500000021	25-48						Original article Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus- related disease	w.intmedpress.com	0	0		
724	chr23	18252490	18252547	3500411740	57		18252490	18252547	8421504	1	57	0	p	350041174000015090	0-57						Dissertation	thek.uni-halle.de	0	0		HSP90AB1
724	chr23	18299993	18300016	3500052099	23		18299993	18300016	8421504	1	23	0	c	350005209900000066	0-23						Card Domain Containing Polypeptides, Encoding Nucleic Acids, And Methods Of Use 	.freshpatents.com	0	0		
726	chr23	18528426	18528458	3500105055	28		18528426	18528458	8421504	3	7,8,13	0,10,19	g	350010505500000008	5-33						Substituted Quinobenzoxazine Analogs 	.freshpatents.com	0	0		
727	chr23	18681984	18682008	3500434667	23		18681984	18682008	8421504	2	14,9	0,15	g	350043466700000004	0-23					Patent	Expression of recombinant fusion proteins in attenuated bacteria (Patent US:6680182)	Khan	2004	0		
727	chr23	18681984	18682008	3500014097	23		18681984	18682008	8421504	2	14,9	0,15	g	350001409700000004	0-23						Expression of recombinant fusion proteins in attenuated bacteria	Khan	1995	0		
727	chr23	18734461	18734488	3500069587	23		18734461	18734488	8421504	3	5,13,5	0,8,22	g	350006958700000078	6-29					Patent	Probe system for performing hla dr typing and typing method using said probes (Patent CA:2091775)	Allibert	2003	0		
730	chr23	19099124	19099287	3500146128	46		19099124	19099287	8421504	3	11,11,24	0,13,139	g	350014612800000014,350014612800000015	0-22,0-24		22039299	10.4049/jimmunol.1101205		Journal of immunology (Baltimore, Md. : 1950)	TCF-1 Regulates Thymocyte Survival via a ROR&#x03b3;t-dependent Pathway	Ruiqing	2011	0		
730	chr23	19099246	19099269	3500323821	23		19099246	19099269	8421504	1	23	0	g	350032382100000001	0-23						Compositions and methods for inducing osteogenesis - US Patent 7273864 Description	ww.patentstorm.us	0	0		
730	chr23	19099272	19099334	3500449890	43		19099272	19099334	8421504	2	22,21	0,41	g	350044989000000000,350044989000000001	1-23,0-21						Effects of different serum conditions on osteogenic differentiation of human adipose stem cells in vitro. - ResearchGate	.researchgate.net	0	0		
731	chr23	19194382	19194405	3500271672	23		19194382	19194405	8421504	1	23	0	g	350027167200000005	0-23		16208410	10.1038/sj.leu.2403976	0887-6924	Leukemia	Human myeloma cells express the bone regulating gene Runx2&sol;Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients	Colla	2005	10		
731	chr23	19194382	19194405	3500157170	23		19194382	19194405	8421504	1	23	0	g	350015717000000000	0-23			10.1359/jbmr.2003.18.2.213	1523-4681	Journal of Bone and Mineral Research	Changes in Runx2/Cbfa1 Expression and Activity During Osteoblastic Differentiation of Human Bone Marrow Stromal Cells - Shui - 2003 - Journal of Bone and Mineral Research - Wiley Online Library	Shui	2003	0		
731	chr23	19203712	19203735	3500466092	23		19203712	19203735	8421504	1	23	0	g	350046609200000001	0-23		19088466	10.1159/000187633	1422-6421	Cells Tissues Organs	Cells Tissues Organs 2009, Vol. 190, No. 3 - Osteogenic and Adipogenic Cell Fractions Isolated from Postnatal Mouse Calvaria - FullText - Karger Publishers	Steenhuis	2008	0		RUNX2
731	chr23	19203712	19203735	3500044645	23		19203712	19203735	8421504	1	23	0	g	350004464500000001	0-23		19088466	10.1159/000187633		Cells, Tissues, Organs	Osteogenic and Adipogenic Cell Fractions Isolated from Postnatal Mouse Calvaria	P.	2009	0		RUNX2
731	chr23	19203712	19203735	3500021832	23		19203712	19203735	8421504	1	23	0	g	350002183200000001	0-23						Os teogenic and Adipogenic Cell Fractions Isolated from Postnatal Mouse Calvaria	www.karger.com	0	0		RUNX2
731	chr23	19246992	19247019	3500062787	24		19246992	19247019	8421504	2	14,10	0,17	g	350006278700000211	16-46						Polypeptides of Botryosphaeria Rhodina - Patent application	www.faqs.org	0	0		
732	chr23	19271803	19271970	3500238801	38		19271803	19271970	8421504	2	19,19	0,148	g	350023880100000009,350023880100000002	0-19,0-19		19383984	10.1074/jbc.M109.002378		The Journal of Biological Chemistry	Hyperglycemia Regulates RUNX2 Activation and Cellular Wound Healing through the Aldose Reductase Polyol Pathway	David	July	0		RUNX2
732	chr23	19327980	19328060	3500017696	41		19327980	19328060	8421504	2	21,20	0,60	g	350001769600000020,350001769600000021	0-21,0-20						Equine Veterinary Journal ISSN 0425-1644 DOI: 10.1111/j.2042-3306.2010.00353.x Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells	library.hverf.org	0	0		RUNX2
732	chr23	19327984	19328060	3500153089	41		19327984	19328060	8421504	2	21,20	0,56	g	350015308900000000,350015308900000001	0-21,0-20						Engineering bone tissue using human dental pulp stem cells and an osteogenic collagen-hydroxyapatite-poly(-lactide-co-{varepsilon}-caprolactone) scaffold. - ResearchGate	.researchgate.net	0	0		RUNX2
732	chr23	19327984	19328060	3500142558	41		19327984	19328060	8421504	2	21,20	0,56	g	350014255800000010,350014255800000011	0-21,0-20		23306704	10.1038/emm.2013.11		Experimental & Molecular Medicine	Regulation of osteogenic differentiation of human adipose-derived stem cells by controlling electromagnetic field conditions	Kyung	2013	0		RUNX2
732	chr23	19333779	19333803	3500109358	23		19333779	19333803	8421504	2	13,10	0,14	g	350010935800000011	7-30						Hepoxilins and modulators of ichthyin for treatment skin disorders	Fischer	2005	0		
735	chr23	19684774	19684802	3500123006	24		19684774	19684802	8421504	2	18,6	0,22	g	350012300600000002	10-36		20868491	10.1186/1750-2187-5-16	1750-2187	Journal of Molecular Signaling	Chaperones contribute to G protein coupled receptor oligomerization, but do not participate in assembly of the G protein with the receptor signaling complex	Hammad	2010	0		
737	chr23	19935746	19935778	3500360831	26		19935746	19935778	8421504	3	6,11,9	0,9,23	g	350036083100000017	3-31						Platelet-derived growth factor D, DNA coding therefor and uses thereof	Wu Er Fu *Ai Li Ke Song 	2001	0		
737	chr23	19973500	19973533	3500098032	33		19973500	19973533	8421504	1	33	0	c	350009803200000435	35-68						Compositions and methods for increasing bone mineralization	Brunkow	2000	0		
737	chr23	19982312	19982342	3500322582	25		19982312	19982342	8421504	2	13,12	0,18	g	350032258200000005	7-35			10.1111/j.1574-6968.2006.00135.x	1574-6968	FEMS Microbiology Letters	Genome mapping of Arcobacter butzleri - Stoeva - 2006 - FEMS Microbiology Letters - Wiley Online Library	Stoeva	2006	0		
740	chr23	20383737	20388778	3500388552	44		20383737	20388778	8421504	3	19,4,21	0,4956,5020	c	350038855200000005,350038855200000004	0-23,0-21						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
740	chr23	20383737	20388778	3500143254	44		20383737	20388778	8421504	3	19,4,21	0,4956,5020	c	350014325400000005,350014325400000004	0-23,0-21						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
741	chr23	20481990	20488387	3500385440	50		20481990	20488387	8421504	2	25,25	0,6372	c	350038544000000000,350038544000000001	0-25,0-25		17035241	10.1074/jbc.M605552200	0021-9258	Journal of Biological Chemistry	Mitochondrial Uncoupling Protein-4 Regulates Calcium Homeostasis and Sensitivity to Store Depletion-induced Apoptosis in Neural Cells	Chan	2006	5		
741	chr23	20512866	20550555	3500462791	1361		20512866	20550555	8421504	14	252,43,58,86,37,92,114,127,62,53,145,122,143,27	0,940,1031,5554,5688,7065,8417,9546,10359,12960,15004,15599,21434,37662	c,g	350046279100000133,350046279100000132,350046279100000132,350046279100000131,350046279100000101,350046279100000130,350046279100000129,350046279100000127,350046279100000126,350046279100000125,350046279100000123,350046279100000122,350046279100000121,350046279100000091,350046279100000120,350046279100000119,350046279100000118,350046279100000117,350046279100000087,350046279100000116,350046279100000115,350046279100000113,350046279100000112,350046279100000052,350046279100000111,350046279100000110,350046279100000080,350046279100000109,350046279100000108,350046279100000078,350046279100000107,350046279100000106,350046279100000105,350046279100000105	0-101,0-50,0-50,0-48,24-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,7-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,6-31,0-48,0-48,0-106,0-106					Patent	Antibodies specific for platelet-activating factor acetylhydrolase (Patent US:5847088)	Cousens	1998	0		
741	chr23	20512866	20550555	3500229418	1185		20512866	20550555	8421504	18	252,43,58,171,11,33,111,82,69,17,53,43,29,122,16,15,33,27	0,940,1031,5554,7065,7124,8417,9591,10359,12919,12960,15004,15120,15599,21434,21498,21544,37662	c,g	350022941800000132,350022941800000131,350022941800000131,350022941800000130,350022941800000129,350022941800000128,350022941800000126,350022941800000125,350022941800000124,350022941800000123,350022941800000122,350022941800000120,350022941800000119,350022941800000118,350022941800000116,350022941800000115,350022941800000114,350022941800000084,350022941800000112,350022941800000111,350022941800000079,350022941800000108,350022941800000107,350022941800000077,350022941800000106,350022941800000104,350022941800000104	0-101,0-50,0-50,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-47,0-48,0-48,6-31,0-48,0-75,0-75						Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic uses	Cousens	1998	0		
741	chr23	20512866	20550555	3500071969	1305		20512866	20550555	8421504	15	252,149,86,37,92,111,82,62,53,91,29,122,79,33,27	0,940,5554,5688,7065,8417,9591,10359,12960,15004,15120,15599,21434,21544,37662	c,g	350007196900000132,350007196900000131,350007196900000131,350007196900000130,350007196900000100,350007196900000129,350007196900000128,350007196900000127,350007196900000126,350007196900000125,350007196900000124,350007196900000122,350007196900000121,350007196900000121,350007196900000120,350007196900000090,350007196900000119,350007196900000118,350007196900000116,350007196900000115,350007196900000114,350007196900000114,350007196900000112,350007196900000013,350007196900000111,350007196900000052,350007196900000110,350007196900000079,350007196900000108,350007196900000107,350007196900000077,350007196900000106,350007196900000105,350007196900000105,350007196900000104,350007196900000104	0-101,0-50,0-50,0-48,24-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,22-48,0-48,0-48,0-48,0-47,0-48,0-48,6-31,0-48,0-48,0-48,0-75,0-75						Platelet-activating factor acetylhydrolase - Patent # 6045794 - PatentGenius	.patentgenius.com	0	0		
741	chr23	20512866	20550555	3500016424	1307		20512866	20550555	8421504	16	252,43,58,171,11,33,114,127,62,53,85,54,122,16,79,27	0,940,1031,5554,7065,7124,8417,9546,10359,12960,15004,15095,15599,21434,21498,37662	c,g	350001642400000135,350001642400000134,350001642400000134,350001642400000133,350001642400000132,350001642400000131,350001642400000129,350001642400000128,350001642400000127,350001642400000126,350001642400000125,350001642400000123,350001642400000122,350001642400000121,350001642400000120,350001642400000119,350001642400000089,350001642400000118,350001642400000117,350001642400000115,350001642400000114,350001642400000054,350001642400000112,350001642400000082,350001642400000111,350001642400000110,350001642400000080,350001642400000109,350001642400000107,350001642400000107	0-101,0-50,0-50,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,7-47,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,6-31,0-48,0-106,0-106						Antibodies specific for platelet-activating factor acetylhydrolase	Cousens	1995	0		
741	chr23	20513041	20528573	3500248944	219		20513041	20528573	8421504	9	24,9,39,40,27,8,29,18,25	0,6973,8242,9441,10226,12744,14945,15424,15507	c	350024894400000102,350024894400000092,350024894400000088,350024894400000124,350024894400000081,350024894400000079	24-48,0-48,7-47,0-35,0-47,6-31					Patent	Methods of detecting lesions in the platelet-activating factor acetylhydrolase gene (Patent US:5605801)	Cousens	1997	0		
741	chr23	20513041	20528573	3500247523	228		20513041	20528573	8421504	9	24,9,39,40,36,8,29,18,25	0,6973,8242,9441,10217,12744,14945,15424,15507	c	350024752300000102,350024752300000092,350024752300000088,350024752300000124,350024752300000081,350024752300000079	24-48,0-48,7-47,0-44,0-47,6-31					Patent	Methods of detecting platelet-activating factor acetylhydrolase using antibodies (Patent US:5698403)	Cousens	1997	0		
741	chr23	20513041	20528573	3500122587	184		20513041	20528573	8421504	7	24,9,39,40,29,18,25	0,6973,8242,9441,14945,15424,15507	c	350012258700000102,350012258700000092,350012258700000088,350012258700000081,350012258700000079	24-48,0-48,7-47,0-47,6-31					Patent	Platelet-activating factor acetylhydrolase (Patent US:5641669)	Cousens	1997	0		
742	chr23	20632099	20632129	3500045305	26		20632099	20632129	8421504	2	18,8	0,22	g	350004530500000420	17-48						ACTIVATING MUTATIONS OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA (PDGFRA) AS DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS - Patent application	www.faqs.org	0	0		
742	chr23	20707177	20707201	3500223565	24		20707177	20707201	8421504	1	24	0	c	350022356500000000	13-37					Patent	Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders (Patent US:8017313)	Adams	2011	0		
742	chr23	20707177	20707201	3500091873	24		20707177	20707201	8421504	1	24	0	c	350009187300000000	13-37						Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders	Adams	2007	0		
743	chr23	20802046	20802071	3500047977	23		20802046	20802071	8421504	2	14,9	0,16	c	350004797700000132	7-34						METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Patent application	www.faqs.org	0	0		
745	chr23	21011682	21011712	3500335848	25		21011682	21011712	8421504	3	8,5,12	0,11,18	g	350033584800000019	7-32						Fusion proteins comprising tumor necrosis factor receptor	Smith	1995	0		
745	chr23	21050812	21050835	3500373892	23		21050812	21050835	8421504	1	23	0	g	350037389200000006	7-30						Nucleotide sequence for the Avian Metapneumovirus (Colorado) attachment glycoprotein gene	Seal	2002	0		
745	chr23	21057259	21057282	3500217315	23		21057259	21057282	8421504	1	23	0	c	350021731500000076	1-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		
747	chr23	21342354	21342381	3500102554	27		21342354	21342381	8421504	1	27	0	c	350010255400000001	1-28						Regulation of human secretin receptor-like gpcr	Liou	2003	0		
747	chr23	21342354	21342381	3500089819	27		21342354	21342381	8421504	1	27	0	c,g	350008981900000001,350008981900000001	1-28,1-28						Regulation of human secretin receptor-like gpcr	Fujita	2004	0		
749	chr23	21526738	21526766	3500308235	25		21526738	21526766	8421504	3	4,11,10	0,5,18	g	350030823500000156	16-41					Patent	Recombinant infectious bovine rhinotracheitis virus (Patent US:5874279)	Cochran	1999	0		
749	chr23	21573751	21573776	3500467352	23		21573751	21573776	8421504	2	9,14	0,11	g	350046735200000087	24-48					Patent	Recombinant fowlpox virus S-FPV-043 and uses thereof (Patent US:6123949)	Cochran	2000	0		
756	chr23	22521394	22521756	3500463719	47		22521394	22521756	8421504	2	23,24	0,338	c	350046371900000045,350046371900000044	0-23,0-24			10.1111/j.1574-695X.2005.00035.x	1574-695X	FEMS Immunology & Medical Microbiology	Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and nontuberculous European wild boars naturally exposed to Mycobacterium bovis - Naranjo - 2006 - FEMS Immunology & Medical Microbiology - Wiley Online Libr	Naranjo	2006	0		
756	chr23	22521394	22521756	3500322660	47		22521394	22521756	8421504	2	23,24	0,338	c,g	350032266000000045,350032266000000045,350032266000000044,350032266000000044	0-23,0-23,0-24,0-24						Caracterizaci&#xf3;n gen&#xf3;mica y prote&#xf3;mica de la expresi&#xf3;n g&#xe9;nica diferencial en jabal&#xed;es infectados de forma natural con Mycobacterium bovis Identificaci&#xf3;n de biomarcadores asociados con la infecci&#xf3;n y la respuesta inmu	digital.csic.es	0	0		
757	chr23	22547688	22547716	3500237963	23		22547688	22547716	8421504	2	7,16	0,12	c	350023796300000148	3-26						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
757	chr23	22547688	22547716	3500060896	23		22547688	22547716	8421504	2	7,16	0,12	c	350006089600000148	3-26						Polypeptides and polynucleotides from coagulase-negative staphylococci	Foster	1999	0		
757	chr23	22547688	22547716	3500028179	23		22547688	22547716	8421504	2	7,16	0,12	c	350002817900000154	3-26						Polypeptides And Polynucleotides From Coagulase-negative Staphylococci 	.freshpatents.com	0	0		
757	chr23	22594823	22594853	3500214015	23		22594823	22594853	8421504	3	6,12,5	0,10,25	c	350021401500000007	15-38			10.1002/hep.21820	1527-3350	Hepatology	The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B&#x2013;dependent hepatotoxicity - Stout-Delgado - 2007 - Hepatology - Wiley Online Library	Stout-Delgado	2007	0		
757	chr23	22672049	22672076	3500131497	23		22672049	22672076	8421504	2	17,6	0,21	g	350013149700000013	9-35						SIGNALING FROM MATRIX ELASTICITY AND TGF- 1 TO CELLS OF THE CARDIAC VALVE	gradworks.umi.com	0	0		
758	chr23	22686824	22686849	3500323573	23		22686824	22686849	8421504	2	13,10	0,15	c	350032357300000004	8-31						Avertissement	www.sb-roscoff.fr	0	0		
758	chr23	22692048	22696645	3500427408	26		22692048	22696645	8421504	2	25,1	0,4596	c	350042740800000001,350042740800000011,350042740800000012	5-24,2-25,2-24		15994812	10.1128/JVI.79.14.9180-9191.2005	0022-538X	Journal of Virology	Regulation of Human Immunodeficiency Virus Type 1 Gene Expression by Clade-Specific Tat Proteins	Desfosses	2005	5		
758	chr23	22770744	22770767	3500097486	23		22770744	22770767	8421504	1	23	0	c	350009748600000016	23-46						Alterations in oxidative gene expression in equine skeletal muscle following exercise and training	cs.physiology.org	0	0		
759	chr23	22822455	22822484	3500141736	26		22822455	22822484	8421504	2	17,9	0,20	g	350014173600000120	5-31						US Patent # 6,497,882. Recombinant swinepox virus - Patents.com	www.patents.com	0	0		
765	chr23	23701420	23701446	3500075243	23		23701420	23701446	8421504	2	7,16	0,10	g	350007524300000176	3-33						Promoter variants for expressing genes in a fungal cell	Bi De *Na Mu 	2009	0		
766	chr23	23759468	23759492	3500322728	23		23759468	23759492	8421504	2	17,6	0,18	g	350032272800000000	0-23		21128305	10.1002/dvdy.22501	1097-0177	Developmental Dynamics	Fgfr1 and the IIIc isoform of Fgfr2 play critical roles in the metanephric mesenchyme mediating early inductive events in kidney development - Sims-Lucas - 2010 - Developmental Dynamics - Wiley Online Library	Sims-Lucas	2011	0		
766	chr23	23794264	23794291	3500133350	23		23794264	23794291	8421504	2	15,8	0,19	g	350013335000000278	0-28						Fen-1 endonucleases, mixtures and cleavage methods	Kaiser	1998	0		
768	chr23	24095308	24095331	3500062609	23		24095308	24095331	8421504	1	23	0	g	350006260900000034	11-41						Epithelial tissue targeting agent	Hein	1998	0		
770	chr23	24317389	24317414	3500203995	23		24317389	24317414	8421504	2	17,6	0,19	g	350020399500000003	0-23			10.1046/j.1432-1327.2001.02021.x	1432-1033	European Journal of Biochemistry	The rainbow trout (Oncorhynchus mykiss) Mx1 promoter - Collet - 2003 - European Journal of Biochemistry - Wiley Online Library	Collet	2001	0		
771	chr23	24425080	24425106	3500008872	23		24425080	24425106	8421504	3	7,5,11	0,9,15	g	350000887200000001	0-23						Methods and compositions for identifying bacteria associated with bacterial vaginosis	Fredricks	2006	0		
775	chr23	24932719	24972153	3500177333	49		24932719	24972153	8421504	2	29,20	0,39414	c,g	350017733300000003,350017733300000003,350017733300000004	16-45,16-45,20-40						Regulation of Mycobacterium-Specific Mononuclear Cell Responses by 25-Hydroxyvitamin D	aldc.nal.usda.gov	0	0		
775	chr23	24932759	24934307	3500449915	41		24932759	24934307	8421504	2	21,20	0,1528	c,g	350044991500000014,350044991500000014,350044991500000015,350044991500000015	0-21,0-21,0-20,0-20						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
775	chr23	24932890	24934261	3500362672	24		24932890	24934261	8421504	2	19,5	0,1366	c	350036267200000007	0-24			10.1002/art.22877	1529-0131	Arthritis & Rheumatism	T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro - Galdo - 2007 - Arthritis & Rheumatism - Wiley Online Library	Galdo	2007	0		
775	chr23	24932899	24934389	3500420158	39		24932899	24934389	8421504	3	10,9,20	0,1357,1470	c	350042015800000024,350042015800000010,350042015800000011,350042015800000025	0-19,0-19,0-20,0-20						Compound and method for treatment of chronic transplant rejection - Patent application	www.faqs.org	0	0		
775	chr23	24932899	24934389	3500329590	39		24932899	24934389	8421504	3	10,9,20	0,1357,1470	c,g	350032959000000000,350032959000000001	0-19,0-20		23648563	10.1038/labinvest.2013.67	0023-6837	Laboratory Investigation	The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response	Rodrigues-Diez	2013	4		
775	chr23	24932902	24934274	3500229646	25		24932902	24934274	8421504	2	7,18	0,1354	c	350022964600000007	0-25						Nucleic acids encoding anti-il-23 antibodies	Levin	2012	0		
775	chr23	24932902	24934274	3500094690	25		24932902	24934274	8421504	2	7,18	0,1354	c	350009469000000007	0-25						NUCLEIC ACIDS ENCODING ANTI-IL-23 ANTIBODIES - Patent application	www.faqs.org	0	0		
775	chr23	24973575	24973601	3500201852	24		24973575	24973601	8421504	2	8,16	0,10	c	350020185200000188	7-31						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
776	chr23	25035337	25036901	3500411214	40		25035337	25036901	8421504	3	20,16,4	0,526,1560	c	350041121400000027,350041121400000026	0-20,0-20		16199513	10.1073/pnas.0507479102	0027-8424	Proceedings of the National Academy of Sciences of the United States of America	The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation	Snyder	2005	10		MCM3
776	chr23	25035337	25036901	3500181102	40		25035337	25036901	8421504	3	20,16,4	0,526,1560	c	350018110200000027,350018110200000026	0-20,0-20						The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation. - ResearchGate	.researchgate.net	0	0		MCM3
776	chr23	25035337	25036901	3500019011	40		25035337	25036901	8421504	3	20,16,4	0,526,1560	c	350001901100000027,350001901100000026	0-20,0-20			10.1073/pnas.0507479102		Proceedings of the National Academy of Sciences of the United States of America	The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation	Marylynn	2005	0		MCM3
776	chr23	25035851	25035875	3500385556	24		25035851	25035875	8421504	1	24	0	c	350038555600000006	0-24						Affect Clinical Outcome in and Karin Jirstr&#xf6;m* Epithelial Ovarian Cancer *Center for Molecular Pathology, Department of Laboratory	www.transonc.com	0	0		
776	chr23	25151090	25151118	3500342699	26		25151090	25151118	8421504	2	5,21	0,7	c	350034269900000287	5-31						US Patent # 6,426,447. Plant seed oils - Patents.com	www.patents.com	0	0		
776	chr23	25151090	25151118	3500285997	26		25151090	25151118	8421504	2	5,21	0,7	c	350028599700000006	5-31					Patent	Jojoba wax biosynthesis gene (Patent US:5445947)	Lardizabal	1995	0		
776	chr23	25151090	25151118	3500008730	26		25151090	25151118	8421504	2	5,21	0,7	c	350000873000000004	5-31						Fatty acyl reductases	Metz	1992	0		
777	chr23	25193299	25193327	3500308897	23		25193299	25193327	8421504	3	6,6,11	0,10,17	c	350030889700000696	12-35						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
777	chr23	25218200	25218228	3500197497	25		25218200	25218228	8421504	2	5,20	0,8	c	350019749700000002	4-29		11568184	10.1074/jbc.M106861200	0021-9258	Journal of Biological Chemistry	Biochemical Activities Associated with Mouse Mcm2 Protein	Ishimi	2001	5		
97	chr23	25421743	25429196	3500062112	46		25421743	25429196	8421504	2	23,23	0,7430	c,g	350006211200000007,350006211200000006,350006211200000006	0-23,0-23,0-23						REPRODUCTION	uction-online.org	0	0		
97	chr23	25423437	25471765	3500256218	42		25423437	25471765	8421504	2	23,19	0,48309	c	350025621800000124,350025621800000123	0-23,0-19						REPRODUCTION	uction-online.org	0	0		
97	chr23	25425961	25471807	3500145630	46		25425961	25471807	8421504	2	22,24	0,45822	c,g	350014563000000034,350014563000000034,350014563000000035,350014563000000035	0-22,0-22,0-24,0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
779	chr23	25470353	25470377	3500250272	24		25470353	25470377	8421504	1	24	0	c	350025027200000000	0-24						ScienceDirect.com - Neurochemistry International - Tributyltin induces oxidative stress and neuronal injury by inhibiting glutathione S-transferase in rat organotypic hippocampal slice cultures	sciencedirect.com	0	0		
779	chr23	25471823	25473816	3500254537	43		25471823	25473816	8421504	3	2,20,21	0,1918,1972	c	350025453700000026,350025453700000010	0-22,20-41						Nuclear Factor (Erythroid 2-like) Factor 2 (Nrf2) as Cellular Protector in Bile Acid and Retinoid Toxicities	brary.utoronto.ca	0	0		
779	chr23	25556608	25556719	3500281920	39		25556608	25556719	8421504	2	19,20	0,91	c,g	350028192000000041,350028192000000040,350028192000000040	0-19,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
780	chr23	25560782	25561705	3500261436	44		25560782	25561705	8421504	2	24,20	0,903	c	350026143600000050,350026143600000049	0-24,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
780	chr23	25622303	25631331	3500308562	43		25622303	25631331	8421504	2	21,22	0,9006	c,g	350030856200000020,350030856200000020,350030856200000021,350030856200000021	0-21,0-21,0-22,0-22						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
780	chr23	25631374	25641037	3500114953	192		25631374	25641037	8421504	8	23,25,29,19,47,1,45,3	0,2040,3034,5631,5993,6707,7312,9660	c	350011495300000123,350011495300000128,350011495300000132,350011495300000136	0-48,0-48,0-48,0-48						NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
780	chr23	25634324	25634360	3500376741	36		25634324	25634360	8421504	1	36	0	c	350037674100000062	0-36					Patent	F-box genes and proteins (Patent US:6573094)	Harper	2003	0		
780	chr23	25634372	25637021	3500008503	81		25634372	25637021	8421504	2	65,16	0,2633	c	350000850300000049	0-81						F-box proteins and genes	Elledge	1999	0		
780	chr23	25634408	25638082	3500396061	96		25634408	25638082	8421504	4	29,19,47,1	0,2597,2959,3673	c	350039606100000125,350039606100000129	0-48,0-48						Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto	Reed	2000	0		
780	chr23	25634408	25638082	3500295516	96		25634408	25638082	8421504	4	29,19,47,1	0,2597,2959,3673	c	350029551600000125,350029551600000129	0-48,0-48						NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
780	chr23	25634408	25638082	3500096613	96		25634408	25638082	8421504	4	29,19,47,1	0,2597,2959,3673	c	350009661300000125,350009661300000129	0-48,0-48						US Patent # 6,638,734. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
780	chr23	25637027	25637072	3500251200	45		25637027	25637072	8421504	1	45	0	c	350025120000000130	0-45						Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof - US Patent 7504253 Description	ww.patentstorm.us	0	0		
780	chr23	25637367	25638082	3500347497	48		25637367	25638082	8421504	2	47,1	0,714	c	350034749700000129	0-48						Nucleic Acid Encoding Proteins Involved In Protein Degradation, Products And Methods Related Thereto 	.freshpatents.com	0	0		
780	chr23	25637370	25641037	3500014025	93		25637370	25641037	8421504	4	44,1,45,3	0,711,1316,3664	c	350001402500000129,350001402500000133	0-45,0-48						US Patent # 7,087,386. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
780	chr23	25658888	25658917	3500260488	25		25658888	25658917	8421504	3	4,7,14	0,5,15	c	350026048800000134	10-35						Hemoglobin receptors from neisseriae	Heffron	1996	0		
781	chr23	25755331	25755399	3500156475	66		25755331	25755399	8421504	3	21,24,21	0,22,47	c,g	350015647500000013,350015647500000014,350015647500000012,350015647500000012	0-21,0-24,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
782	chr23	25897290	25897317	3500246268	23		25897290	25897317	8421504	3	13,5,5	0,16,22	g	350024626800000526	10-35						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
97	chr23	26005174	26099488	3500409300	89		26005174	26099488	8421504	6	6,15,15,5,24,24	0,4160,22772,24483,52568,94290	c	350040930000000002,350040930000000007,350040930000000003,350040930000000006	3-24,0-20,0-24,0-24						Genomic analysis of Ovis aries Ovar) MHC class IIa loci	aldc.nal.usda.gov	0	0		
783	chr23	26040609	26040946	3500375699	337		26040609	26040946	8421504	1	337	0	c,g	350037569900000013,350037569900000013	30-369,30-369						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
97	chr23	26057735	26099462	3500307902	68		26057735	26099462	8421504	3	37,10,21	0,274,41706	c	350030790200000161,350030790200000086	0-47,0-21						Mhc complexes and uses thereof	Chavaillaz	1996	0		
783	chr23	26060477	26060501	3500467425	24		26060477	26060501	8421504	1	24	0	c	350046742500000003	0-24						Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction	j.ersjournals.com	0	0		
783	chr23	26060477	26060501	3500364422	24		26060477	26060501	8421504	1	24	0	c	350036442200000002	0-24		9593722	10.1074/jbc.273.22.13787	0021-9258	Journal of Biological Chemistry	Molecular Cloning of Platelet Factor XI, an Alternative Splicing Product of the Plasma Factor XI Gene	Hsu	1998	5		
784	chr23	26094448	26094633	3500353938	38		26094448	26094633	8421504	2	19,19	0,166	c,g	350035393800000176,350035393800000184,350035393800000184	5-24,0-19,0-19						DNA and RNA Profiling in Human Blood	www.bjcancer.org	0	0		TAP2
784	chr23	26094501	26094641	3500347203	46		26094501	26094641	8421504	2	19,27	0,113	c,g	350034720300000005,350034720300000005,350034720300000018	0-19,0-19,4-31						A New HLA-DRB1 Genotyping Method Using Single Nucleotide Polymorphism(SNP)Analysis with Multiplex Primer Extension Reactions and Its Application to Mixed Samples	b.okayama-u.ac.jp	0	0		
784	chr23	26094580	26094629	3500097499	49		26094580	26094629	8421504	1	49	0	c	350009749900000001	9-58						EvD VERANDERING 2011 08 23	upetd.up.ac.za	0	0		
784	chr23	26094598	26094635	3500340482	37		26094598	26094635	8421504	1	37	0	c	350034048200000102	2-39						Product and process for T cell regulation - Patent # 5820866 - PatentGenius	.patentgenius.com	0	0		
784	chr23	26094615	26094640	3500272276	25		26094615	26094640	8421504	1	25	0	c	350027227600000009	1-26						38084 016-Clinical Applications of Pcr	www.scribd.com	0	0		
784	chr23	26143953	26143977	3500135551	24		26143953	26143977	8421504	1	24	0	g	350013555100000000	0-24		22481880	10.1590/S1415-47572012005000013	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Molecular characterization of MHC-DRB cDNA in water buffalo (Bubalus bubalis)	Naskar	2012	1		
784	chr23	26148752	26148775	3500338834	23		26148752	26148775	8421504	1	23	0	c	350033883400000002	0-23						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
784	chr23	26148752	26148775	3500306609	23		26148752	26148775	8421504	1	23	0	c	350030660900000002	0-23						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
784	chr23	26149477	26149500	3500416548	23		26149477	26149500	8421504	1	23	0	c	350041654800000003	0-23						DETECCI&#xd3;N DE LOS POLIMORFISMOS DE 4 STRS EN LA REGI&#xd3;N BOLA Y AN`LISIS DE SU EFECTO SOBRE MASTITIS CL&#x02dd;NICA BOVINA EN LA RAZA HOLSTEIN	ncias.gov.co:8084	0	0		
784	chr23	26150790	26150816	3500328873	26		26150790	26150816	8421504	1	26	0	c	350032887300000150,350032887300000075	7-33,7-33						Nucleic acid detection	www.devileye.net	0	0		
784	chr23	26150790	26150816	3500154075	26		26150790	26150816	8421504	1	26	0	c	350015407500000719,350015407500000349	7-33,7-33						US Patent # 6,730,479. Detection of nucleic acid hybrids - Patents.com	www.patents.com	0	0		
784	chr23	26150790	26150816	3500058241	26		26150790	26150816	8421504	1	26	0	c	350005824100000337	7-33						Detection of nucleic acid hybrids	Shultz	2001	0		
784	chr23	26150801	26151740	3500438452	97		26150801	26151740	8421504	3	45,31,21	0,867,918	c,g	350043845200000016,350043845200000019,350043845200000017,350043845200000018,350043845200000018	0-30,5-27,0-31,15-36,15-36						Process for oxidation of steroids and genetically engineered cells used therein	Slijkhuis	1998	0		
784	chr23	26151406	26151435	3500231760	29		26151406	26151435	8421504	1	29	0	c	350023176000000017	0-29						Modified yeasts and uses thereof, in particular for producing steroid derivatives	Achstetter	2003	0		CYP21A2
784	chr23	26151406	26151435	3500075049	29		26151406	26151435	8421504	1	29	0	c	350007504900000009,350007504900000038	0-29,0-29						MODIFIED YEASTS AND USES THEREOF, IN PARTICULAR FOR PRODUCING STEROID DERIVATIVES - Patent application	www.faqs.org	0	0		CYP21A2
784	chr23	26151406	26151435	3500073524	29		26151406	26151435	8421504	1	29	0	c,g	350007352400000059,350007352400000059,350007352400000017	29-58,0-29,0-29					Patent	Modified yeasts and uses thereof, in particular for producing steroid derivatives (Patent EP:1313873)	Achstetter	2008	0		CYP21A2
784	chr23	26155648	26155958	3500089891	24		26155648	26155958	8421504	3	9,2,13	0,12,297	c	350008989100000005	9-33						The Role of Insulin and IGF2 Signalling on Metabolic Pathways in Prostate Cancer Progression	prints.qut.edu.au	0	0		
784	chr23	26158151	26210912	3500362403	103		26158151	26210912	8421504	7	6,15,22,6,14,20,20	0,146,382,42950,43229,43333,52741	c,g	350036240300000021,350036240300000020,350036240300000020,350036240300000033,350036240300000032,350036240300000032,350036240300000014,350036240300000014	0-21,0-22,0-22,0-20,0-20,0-20,0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
784	chr23	26169089	26169115	3500028148	23		26169089	26169115	8421504	2	8,15	0,11	g	350002814800000073	1-24					Patent	Dual variable domain immunoglobulin and uses thereof (Patent US:7612181)	Wu	2009	0		
784	chr23	26196242	26196265	3500381917	23		26196242	26196265	8421504	1	23	0	c	350038191700000004	5-28						ScienceDirect.com - Molecular Cell - NELF Interacts with CBC and Participates in 3&#x2032; End Processing of Replication-Dependent Histone mRNAs	sciencedirect.com	0	0		
784	chr23	26198787	26198887	3500207808	25		26198787	26198887	8421504	2	22,3	0,97	c	350020780800000021	22-47						Polypeptides Recognized by Anti-Trichinella Antibodies, and Uses Thereof - Patent application	www.faqs.org	0	0		
784	chr23	26199011	26199134	3500228821	24		26199011	26199134	8421504	2	6,18	0,105	c	350022882100000001	0-24		11804945	10.1095/biolreprod66.2.322	0006-3363	Biology of Reproduction	Ovarian Steroid-Regulated Synthesis and Secretion of Complement C3 and Factor B in Mouse Endometrium During the Natural Estrous Cycle and Pregnancy Period	Li	2002	4		
784	chr23	26204281	26204306	3500164756	23		26204281	26204306	8421504	2	10,13	0,12	g	350016475600000050	1-24						Compositions and methods for stimulating megakaryocyte growth and differentiation	Bartley	1997	0		
785	chr23	26253832	26253913	3500281528	81		26253832	26253913	8421504	1	81	0	p	350028152800015044	36-117						<Html><Title> Complet list of 2pfl hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
785	chr23	26253844	26253913	3500344270	69		26253844	26253913	8421504	1	69	0	p	350034427000015071,350034427000015038,350034427000015079	117-183,111-162,111-156						@IL23_3198:2:1:0:199/1 NCGGAACCGGGCGGAAACACCATCGTATGCCGTCTTC + &0;;;;:9:;:7;;;;;;;;;;;;;;;;;;;;;;;:8	rse.iop.kcl.ac.uk	0	0		
785	chr23	26253856	26253916	3500458997	60		26253856	26253916	8421504	1	60	0	p	350045899700015030	0-60						<Html><Title> Complet list of 1h18 hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
785	chr23	26253868	26253916	3500270720	48		26253868	26253916	8421504	1	48	0	p	350027072000015150	0-48						<Html><Title> Complet list of 1qt1 hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		SCAF1
785	chr23	26253877	26253903	3500380395	26		26253877	26253903	8421504	1	26	0	c	350038039500000023	28-54						Method and reagent for inhibiting HBV viral replication	Draper	2003	0		
785	chr23	26255273	26255296	3500207917	23		26255273	26255296	8421504	1	23	0	c	350020791700000021	7-30						US Patent # 7,208,310. Proteases - Patents.com	www.patents.com	0	0		
785	chr23	26255273	26255296	3500066984	23		26255273	26255296	8421504	1	23	0	c	350006698400000105,350006698400000155	7-30,7-30						Proteases - Patent application	www.faqs.org	0	0		
785	chr23	26255273	26255296	3500041857	23		26255273	26255296	8421504	1	23	0	c	350004185700000105,350004185700000155	7-30,7-30						Proteases - Patent application	www.faqs.org	0	0		
785	chr23	26259932	26262255	3500063417	321		26259932	26262255	8421504	9	45,14,13,48,93,29,16,45,18	0,48,1517,1548,1741,1885,2238,2257,2305	p	350006341700015217,350006341700015218,350006341700015219,350006341700015220,350006341700015222	0-72,0-48,0-45,0-48,0-108						Chromatin regulator genes - Patent # 7252968 - PatentGenius	.patentgenius.com	0	0		EHMT2
785	chr23	26269308	26275240	3500359288	82		26269308	26275240	8421504	3	32,3,47	0,313,5885	c	350035928800000024,350035928800000047	0-35,0-47						US Patent # 6,943,235. Transmembrane protein expressed in prostate cancer - Patents.com	www.patents.com	0	0		
785	chr23	26280366	26280605	3500424225	42		26280366	26280605	8421504	2	21,21	0,218	c,g	350042422500000022,350042422500000023,350042422500000023	0-21,0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
785	chr23	26302962	26305259	3500299530	2294		26302962	26305259	8421504	2	1487,807	0,1490	c,g	350029953000000019,350029953000000020,350029953000000020,350029953000000002,350029953000000002,350029953000000017,350029953000000017,350029953000000000,350029953000000000,350029953000000023,350029953000000022,350029953000000022,350029953000000004,350029953000000004	6-2083,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,833-1315,0-20,0-20,0-20,0-20						BOVINE POLYMORPHISMS AND METHODS OF PREDICTING BOVINE TRAITS - Patent application	www.faqs.org	0	0		
785	chr23	26302963	26302990	3500156823	27		26302963	26302990	8421504	1	27	0	c	350015682300000001	0-27		15827170	10.1128/JVI.79.9.5557-5567.2005	0022-538X	Journal of Virology	ATP&#x03b3;S Disrupts Human Immunodeficiency Virus Type 1 Virion Core Integrity	Gurer	2005	5		
785	chr23	26302963	26302987	3500000160	24		26302963	26302987	8421504	1	24	0	c	350000016000000003	9-33		14612530		0008-5472	Cancer Research	A Broadly Applicable, Personalized Heat Shock Protein-Mediated Oncolytic Tumor Vaccine	Huang	2003	8		
785	chr23	26302964	26307729	3500232473	86		26302964	26307729	8421504	2	26,60	0,4705	p,c	350023247300000001,350023247300000003,350023247300015006	1-27,21-45,0-60		23090015	10.1007/s12192-012-0376-9		Cell Stress & Chaperones	Identification and characterization of a 66&#x2013;68-kDa protein as a methotrexate-binding protein in murine leukemia L1210 cells	Tuoen	2013	0		
785	chr23	26302970	26302996	3500454390	26		26302970	26302996	8421504	1	26	0	c	350045439000000021	15-41						Holocarboxylase Synthetase Represses Long Terminal Repeats through Epigenetic Synergies between Biotin and Methyl Donors, and Activates Immune Response by Catalyzing Biotinylation of Heat Shock Protein 72	alcommons.unl.edu	0	0		
785	chr23	26303077	26304693	3500104165	561		26303077	26304693	8421504	8	159,108,45,48,45,63,45,48	0,201,633,693,813,1035,1221,1568	p	350010416500015201,350010416500015196,350010416500015195,350010416500015200,350010416500015193,350010416500015186,350010416500015184,350010416500015182,350010416500015180,350010416500015178,350010416500015173	0-78,0-81,0-63,0-60,0-48,0-45,0-48,0-45,0-63,0-45,0-48						The detection and role of human endogenous retroviruses in multiple sclerosis and other neurological diseases	penrepository.com	0	0		
785	chr23	26303086	26303968	3500328191	135		26303086	26303968	8421504	3	45,45,45	0,201,837	p	350032819100015017,350032819100015013,350032819100015009	0-45,0-45,0-45						 Expression System For Enhancing Solubility And Immunogeneicity Of Recombinant Proteins 	www.docstoc.com	0	0		
785	chr23	26303120	26304573	3500302104	41		26303120	26304573	8421504	2	21,20	0,1433	c,g	350030210400000019,350030210400000020	0-21,0-20						DELINEAMENTO IN SILICO E AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS	www.ufpel.tche.br	0	0		
785	chr23	26303120	26304573	3500238922	83		26303120	26304573	8421504	4	21,22,20,20	0,253,1026,1433	c,g	350023892200000009,350023892200000009,350023892200000008,350023892200000011,350023892200000011,350023892200000010	0-21,0-21,0-22,0-20,0-20,0-20						AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS E DE ESTRESSE OXIDATIVO EM O&#xd3;CITOS E TECIDOS REPRODUTIVOS EQ&#xdc;INOS KAEFER, Cristian *; BEGNINI, Karine; LEON, Priscila Marques Moura; CAMPOS, Vinicius; COLLARES, Tha&#xed;s; AMARAL, M.G.; DES	www.ufpel.edu.br	0	0		
785	chr23	26303120	26304573	3500003927	61		26303120	26304573	8421504	3	21,20,20	0,1026,1433	c,g	350000392700000009,350000392700000009,350000392700000011,350000392700000010	0-21,0-21,0-20,0-20						AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS E DE ESTRESSE OXIDATIVO EM O&#xd3;CITOS E TECIDOS REPRODUTIVOS EQ&#xdc;INOS KAEFER, Cristian *; BEGNINI, Karine; LEON, Priscila Marques Moura; CAMPOS, Vinicius; COLLARES, Tha&#xed;s; AMARAL, M.G.; DES	www.ufpel.tche.br	0	0		HSPA1A,SNORD48
785	chr23	26303126	26304145	3500302864	59		26303126	26304145	8421504	3	21,19,19	0,254,1000	c,g	350030286400000005,350030286400000001,350030286400000000	0-21,0-19,0-19						ShRNA-mediated gene silencing of heat shock protein 70 inhibits human colon cancer growth	-publications.com	0	0		HSPA1A,SNORD48
785	chr23	26303155	26303185	3500306233	30		26303155	26303185	8421504	1	30	0	c,g	350030623300000022,350030623300000022,350030623300000010	0-30,0-30,0-30						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
785	chr23	26303155	26303185	3500218393	30		26303155	26303185	8421504	1	30	0	c	350021839300000004	0-30						Nuclear Transfer Protocol Affects Messenger RNA Expression Patterns in Cloned Bovine Blastocysts	ww.biolreprod.org	0	0		
785	chr23	26303156	26303185	3500387417	29		26303156	26303185	8421504	1	29	0	c,g	350038741700000003,350038741700000003	0-29,0-29						Express&#xe3;o g&#xea;nica das c&#xe9;lulas do cumulus oophorus de bovinos ap&#xf3;s a vitrifica&#xe7;&#xe3;o*	www.ufrgs.br	0	0		
785	chr23	26303170	26303257	3500026769	48		26303170	26303257	8421504	2	24,24	0,63	c,g	350002676900000001,350002676900000000	0-24,0-24		20110459	10.1152/ajpgi.00234.2009		American Journal of Physiology - Gastrointestinal and Liver Physiology	Stress granule formation mediates the inhibition of colonic Hsp70 translation by interferon-&#x03b3; and tumor necrosis factor-&#x03b1;	Shien	2010	0		HSPA1A
785	chr23	26303223	26304855	3500015993	40		26303223	26304855	8421504	2	20,20	0,1612	c,g	350001599300000002,350001599300000002,350001599300000001,350001599300000001	0-20,0-20,0-20,0-20						Effects of fescue cultivar and heat shock protein haplotype on growth and fertility of crossbred beef heifers	asagnews.uark.edu	0	0		HSPA1A
785	chr23	26303248	26305207	3500446935	266		26303248	26305207	8421504	9	20,20,25,25,33,56,45,22,20	0,1587,1615,1663,1753,1787,1845,1891,1939	c,g	350044693500000006,350044693500000006,350044693500000005,350044693500000005,350044693500000014,350044693500000015,350044693500000008	0-20,0-20,0-20,0-20,9-346,14-370,0-24						Szent Istv&#xe1;n Egyetem &#xc1;llatorvos-tudom&#xe1;nyi Doktori Iskola	huveta.hu/bitstre	0	0		
785	chr23	26303299	26304606	3500136436	492		26303299	26304606	8421504	6	132,99,48,78,78,57	0,366,579,726,960,1250	p	350013643600015059,350013643600015047,350013643600015039,350013643600015031,350013643600015025,350013643600015010	0-132,0-99,0-48,0-78,0-78,0-57						Anu Thesis corrections 11oct	search.wmin.ac.uk	0	0		
785	chr23	26303373	26303577	3500392255	40		26303373	26303577	8421504	2	20,20	0,184	c,g	350039225500000023,350039225500000022	0-20,0-20						None	hives-ouvertes.fr	0	0		
785	chr23	26303381	26308766	3500409630	39		26303381	26308766	8421504	2	20,19	0,5366	c,g	350040963000000000,350040963000000001	0-20,0-19			10.1128/JVI.78.18.9697-9704.2004		Journal of Virology	Heat Shock Protein 70 Protects Cells from Cell Cycle Arrest and Apoptosis Induced by Human Immunodeficiency Virus Type 1 Viral Protein R	Sergey	2004	0		
785	chr23	26303382	26303405	3500264853	23		26303382	26303405	8421504	1	23	0	c	350026485300000033	0-23						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		
785	chr23	26303407	26304519	3500377554	41		26303407	26304519	8421504	2	21,20	0,1092	c	350037755400000001,350037755400000004	18-39,0-20						Method of screening a gene	Asai	2002	0		
785	chr23	26303446	26303491	3500298715	45		26303446	26303491	8421504	1	45	0	p	350029871500015011	0-45						CATECHOLAMINE REGULATED PROTEIN - Patent application	www.faqs.org	0	0		HSPA2
785	chr23	26303449	26304843	3500211515	432		26303449	26304843	8421504	8	48,48,48,48,48,48,48,96	0,249,336,393,624,729,816,1298	p	350021151500015138,350021151500015184,350021151500015124,350021151500015178,350021151500015112,350021151500015164,350021151500015104,350021151500015084,350021151500015082	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						IN VIVO CTL ELICITATION BY HEAT SHOCK PROTEIN FUSION PROTEINS MAPS TO A DISCRETE DOMAIN AND IS CD4+ T CELL-INDEPENDENT - Patent application	www.faqs.org	0	0		
785	chr23	26303863	26303908	3500405973	45		26303863	26303908	8421504	1	45	0	p	350040597300015044	3-48						Protein-Protein-Interaktion des kardialen Ankyrin-Repeat-Proteins, CARP, mit dem zytoplasmatischen -Aktin	ni-duesseldorf.de	0	0		SNORD48
785	chr23	26303957	26304202	3500395598	42		26303957	26304202	8421504	2	21,21	0,224	c,g	350039559800000005,350039559800000005,350039559800000004,350039559800000004	0-21,0-21,0-21,0-21						Consequences of physiological heat shock beginning at the zygote stage on embryonic development and expression of stress response genes in cattle	imal.ifas.ufl.edu	0	0		
785	chr23	26303957	26304202	3500286753	42		26303957	26304202	8421504	2	21,21	0,224	c,g	350028675300000003,350028675300000003,350028675300000002,350028675300000002	0-21,0-21,0-21,0-21						DEVELOPMENTAL ACQUISITION OF APOPTOSIS IN THE PREIMPLANTATION BOVINE EMBRYO: RETURNING TO THE BALANCE OF LIFE AND DEATH	imal.ifas.ufl.edu	0	0		HSPA1A,SNORD48
785	chr23	26303957	26304202	3500280109	42		26303957	26304202	8421504	2	21,21	0,224	c,g	350028010900000005,350028010900000005,350028010900000004,350028010900000004	0-21,0-21,0-21,0-21						Consequences of physiological heat shock beginning at the zygote stage on embryonic development and expression of stress response genes in cattle	imal.ifas.ufl.edu	0	0		
785	chr23	26303957	26304202	3500112748	42		26303957	26304202	8421504	2	21,21	0,224	c,g	350011274800000003,350011274800000003,350011274800000002,350011274800000002	0-21,0-21,0-21,0-21						DEVELOPMENTAL ACQUISITION OF APOPTOSIS IN THE PREIMPLANTATION BOVINE EMBRYO: RETURNING TO THE BALANCE OF LIFE AND DEATH	ww.animal.ufl.edu	0	0		
785	chr23	26304032	26304523	3500163373	42		26304032	26304523	8421504	2	20,22	0,469	c,g	350016337300000001,350016337300000001,350016337300000000	0-20,0-20,0-22						&#x718a;&#x672c;&#x5927;&#x5b66;&#x5b66;&#x8853;&#x30ea;&#x30dd;&#x30b8;&#x30c8;&#x30ea; Kumamoto University Repository System	.kumamoto-u.ac.jp	0	0		SNORD48
785	chr23	26304064	26308179	3500263247	135		26304064	26308179	8421504	3	45,45,45	0,291,4070	p	350026324700015092,350026324700015086,350026324700015094	0-45,0-45,0-45						Gene Expression Technique - Patent application	www.faqs.org	0	0		HSPA1L
785	chr23	26304103	26304157	3500195492	54		26304103	26304157	8421504	1	54	0	p	350019549200015029	0-54						HEPATITIS B VIRUS-BINDING POLYPEPTIDES AND METHODS OF USE THEREOF	Zimmerman	2008	0		HSPA1L
785	chr23	26304145	26304447	3500180812	41		26304145	26304447	8421504	2	21,20	0,282	c	350018081200000013,350018081200000012	0-21,0-20						ATF5 promotes cell survival through transcriptional activation of Hsp27 in H9c2 cells	H	2007	0		
785	chr23	26304181	26304232	3500144158	51		26304181	26304232	8421504	1	51	0	p	350014415800015065	3-54						TH&#xc8;SE DE DOCTORAT Influence des conditions environnementales sur le m&#xe9;tabolisme de Plasmodium falciparum	www.theses.fr	0	0		FCGR2A
785	chr23	26304248	26304271	3500033396	23		26304248	26304271	8421504	1	23	0	c,g	350003339600000001,350003339600000001	0-23,0-23		11358984		0741-5400	Journal of Leukocyte Biology	Effect of vibrational stress and spaceflight on regulation of heat shock proteins hsp70 and hsp27 in human lymphocytes (Jurkat)	Cubano	2001	5		HSPA1A
785	chr23	26304499	26305171	3500308041	65		26304499	26305171	8421504	3	20,20,25	0,300,647	c,g	350030804100000001,350030804100000001,350030804100000000,350030804100000006	0-20,0-20,0-20,8-33		20180806	10.1111/j.1349-7006.2010.01516.x	1349-7006	Cancer Science	Hyperthermia-associated carboplatin resistance: Differential role of p53, HSF1 and Hsp70 in hepatoma cells - Sharma - 2010 - Cancer Science - Wiley Online Library	Sharma	2010	0		
785	chr23	26304568	26304635	3500402065	40		26304568	26304635	8421504	2	21,19	0,48	c,g	350040206500000001,350040206500000001,350040206500000000	0-21,0-21,0-19		23638875	10.1111/aji.12131	1600-0897	American Journal of Reproductive Immunology	Heat Shock Induces Interferon-TAU Gene Expression by In Vitro-Produced Bovine Blastocysts - Hickman - 2013 - American Journal of Reproductive Immunology - Wiley Online Library	Hickman	2013	0		
785	chr23	26304580	26304605	3500463409	25		26304580	26304605	8421504	1	25	0	c	350046340900000000	0-25		21390211	10.1371/journal.pone.0016546		PLoS ONE	Heat Shock Protein 70 Inhibits the Activity of Influenza A Virus Ribonucleoprotein and Blocks the Replication of Virus In Vitro and In Vivo	Gang	2011	0		HSPA1A
785	chr23	26304582	26304962	3500308562	41		26304582	26304962	8421504	2	21,20	0,360	c	350030856200000017,350030856200000016	0-21,0-20						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
785	chr23	26304656	26304690	3500445200	34		26304656	26304690	8421504	1	34	0	c	350044520000000052	3-37						BMC Genomics BioMed Central	biomedcentral.com	0	0		
785	chr23	26304893	26305063	3500424395	138		26304893	26305063	8421504	6	25,13,5,15,30,50	0,26,40,71,89,120	c	350042439500000009	17-209						Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins	Coste	2000	0		
785	chr23	26305146	26305171	3500344906	25		26305146	26305171	8421504	1	25	0	g	350034490600000000	8-33		15972840	10.1152/ajpcell.00152.2005		American Journal of Physiology - Cell Physiology	Hypothermia enhances phosphorylation of I&#x03ba;B kinase and prolongs nuclear localization of NF-&#x03ba;B in lipopolysaccharide-activated macrophages	Fairchild	2005	0		
785	chr23	26305146	26305171	3500342597	25		26305146	26305171	8421504	1	25	0	g	350034259700000004	8-33						Methods in Molecular Biology Vol. 099 Stress Response.. Methods and Protocols	www.scribd.com	0	0		
785	chr23	26305146	26305171	3500158000	25		26305146	26305171	8421504	1	25	0	g	350015800000000000	8-33		11029298			American Journal of Physiology - Cell Physiolog	Phenylarsine oxide inhibits heat shock protein 70 induction in cultured guinea pig gastric mucosal cells	Rokutan	2000	0		
785	chr23	26305146	26305171	3500137117	25		26305146	26305171	8421504	1	25	0	g	350013711700000000	4-29						Report	www.edu.upmc.fr	0	0		HSPA1A
785	chr23	26305146	26305171	3500108213	25		26305146	26305171	8421504	1	25	0	g	350010821300000004	8-33						1 - Stephen M. Keyse - Stress Response	www.scribd.com	0	0		
785	chr23	26305146	26305171	3500068462	25		26305146	26305171	8421504	1	25	0	g	350006846200000000	8-33					Cell Stress & Chaperones	Fever and the heat shock response: distinct, partially overlapping processes	Jeffrey	2000	0		
785	chr23	26305146	26305171	3500017333	25		26305146	26305171	8421504	1	25	0	g	350001733300000000	8-33		11029298			American Journal of Physiology - Cell Physiolog	Phenylarsine oxide inhibits heat shock protein 70 induction in cultured guinea pig gastric mucosal cells	Rokutan	2000	0		
785	chr23	26305146	26305171	3500005915	25		26305146	26305171	8421504	1	25	0	g	350000591500000000	4-29						Report	.northwestern.edu	0	0		
785	chr23	26305148	26305171	3500035139	23		26305148	26305171	8421504	1	23	0	g	350003513900000000	0-23						ScienceDirect.com - Biochemical Pharmacology - Attenuation by glutathione of hsp72 gene expression induced by cadmium in cisplatin-resistant human ovarian cancer cells	sciencedirect.com	0	0		
785	chr23	26305150	26305180	3500138740	30		26305150	26305180	8421504	1	30	0	g	350013874000000000	0-30			10.1152/ajpgi.00307.2002		American Journal of Physiology - Gastrointestinal and Liver Physiology	Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-&#x03ba;B	Venkatraman	2003	0		
785	chr23	26305150	26305180	3500042666	30		26305150	26305180	8421504	1	30	0	g	350004266600000000	0-30			10.1152/ajpgi.00307.2002		American Journal of Physiology - Gastrointestinal and Liver Physiology	Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-&#x03ba;B	Venkatraman	2003	0		
785	chr23	26305155	26305178	3500246699	23		26305155	26305178	8421504	1	23	0	g	350024669900000049	0-23						RUSSIAN ACADEMY OF SCIENCES SIBERIAN BRANCH INSTITUTE OF CYTOLOGY AND GENETICS	www.bionet.nsc.ru	0	0		
785	chr23	26305155	26305178	3500217035	23		26305155	26305178	8421504	1	23	0	g	350021703500000019	0-23						Surface transfection and expression procedure	osdir.com/patents	0	0		
785	chr23	26305156	26305181	3500443251	25		26305156	26305181	8421504	1	25	0	g	350044325100000006	0-25						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Celastrols as Inducers of the Heat Shock Response and Cytoprotection*	.northwestern.edu	0	0		
785	chr23	26307261	26307405	3500446547	144		26307261	26307405	8421504	1	144	0	p	350044654700015008	6-150						BIOCHEMICAL CHARACTERIZATION OF PLASMODIUM FALCIPARUM HEAT SHOCK PROTEIN 70	eprints.ru.ac.za	0	0		
785	chr23	26307681	26307729	3500270521	48		26307681	26307729	8421504	1	48	0	p	350027052100015016	27-75						PROTE&#xd4;MICA DIFERENCIAL EM CLONES DE	www.tede.ufv.br	0	0		SNORD48
785	chr23	26307689	26307879	3500294910	40		26307689	26307879	8421504	2	20,20	0,170	c,g	350029491000000006,350029491000000007,350029491000000007	0-20,0-20,0-20						UNIVERSIDADE JOS&#xc9; DO ROS&#xc1;RIO VELLANO &#x2013; UNIFENAS TOCHIMARA APARECIDA MIYAUCHI	tede.unifenas.br	0	0		
785	chr23	26307843	26307903	3500443320	60		26307843	26307903	8421504	1	60	0	p	350044332000015030	45-105						Expression of Heat Shock Protein 70 in the Thermally Stressed Antarctic Clam Laternula Elliptica	www.jstor.org	0	0		HSPA8
785	chr23	26308742	26308765	3500205152	23		26308742	26308765	8421504	1	23	0	c	350020515200000033	0-23						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		
785	chr23	26308770	26308815	3500245937	45		26308770	26308815	8421504	1	45	0	p	350024593700015037	0-45						&#xc9;TUDE DE L&#x2019;IMPACT DES RADIONUCL&#xc9;IDES REJET&#xc9;S PAR LES INSTALLATIONS NUCL&#xc9;AIRES DU NORD COTENTIN SUR L&#x2019;HUITRE CREUSE Crassostrea gigas	www.irsn.fr	0	0		HSPA1L
786	chr23	26358187	26363272	3500325110	597		26358187	26363272	8421504	14	36,9,93,2,126,13,45,43,2,45,93,33,9,48	0,2454,2466,2562,2753,3035,3051,3099,3577,3582,3630,3726,5025,5037	p	350032511000015043,350032511000015044,350032511000015045,350032511000015046,350032511000015047,350032511000015048	0-90,0-48,0-45,0-48,0-48,0-318						 Methods Of Identifying Compounds That Modulate IL 	www.docstoc.com	0	0		CLIC1
786	chr23	26360718	26361006	3500256218	45		26360718	26361006	8421504	2	23,22	0,266	c	350025621800000119,350025621800000120	0-23,0-22						REPRODUCTION	uction-online.org	0	0		
786	chr23	26363353	26363376	3500369818	23		26363353	26363376	8421504	1	23	0	c	350036981800000003	7-30						Diarylsulfonylurea binding proteins	Dombroski	2000	0		
786	chr23	26365057	26366967	3500362636	717		26365057	26366967	8421504	5	297,100,74,120,126	0,411,636,874,1784	p	350036263600015051	0-720						Isolated human vCOL16A1 polypeptide and fragments thereof	Bejanin	2001	0		DDAH2
786	chr23	26365168	26366861	3500136457	43		26365168	26366861	8421504	3	20,3,20	0,880,1673	c	350013645700000002,350013645700000003	0-20,0-23		19820234	10.1074/jbc.M109.037036	0021-9258	Journal of Biological Chemistry	Role of Dimethylarginine Dimethylaminohydrolases in the Regulation of Endothelial Nitric Oxide Production	Pope	2009	5		
786	chr23	26410538	26410568	3500055849	25		26410538	26410568	8421504	2	11,14	0,16	c	350005584900000001	9-34						Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells	s.ulb.uni-bonn.de	0	0		
786	chr23	26410539	26415422	3500201278	294		26410539	26415422	8421504	6	90,48,60,3,45,48	0,96,2678,2744,3195,4835	p	350020127800015043,350020127800015042,350020127800015022,350020127800015019,350020127800015001	0-90,0-48,0-60,0-48,0-48						Intron retention and transcript chimerism conserved across mammals: Ly6g5b and Csnk2b-Ly6g5b as examples	biomedcentral.com	0	0		CSNK2B
786	chr23	26412320	26412347	3500276853	27		26412320	26412347	8421504	1	27	0	c	350027685300000005	0-27						Antiviral inhibition of casein kinase ii	Ramanathan	2008	0		CSNK2B
786	chr23	26412320	26412347	3500122700	27		26412320	26412347	8421504	1	27	0	c	350012270000000005	0-27						Antiviral inhibition of casein kinase ii	Ramanathan	2010	0		CSNK2B
786	chr23	26412322	26415422	3500122173	44		26412322	26415422	8421504	2	23,21	0,3079	c	350012217300000001,350012217300000000	9-32,14-35		12902976	10.1038/sj.onc.1206721	0950-9232	Oncogene	Modulation of human checkpoint kinase Chk1 by the regulatory &#x03b2;-subunit of protein kinase CK2	Guerra	2003	6		
786	chr23	26423112	26425893	3500165278	41		26423112	26425893	8421504	2	21,20	0,2761	c,g	350016527800000031,350016527800000125,350016527800000125	22-43,0-20,0-20						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
786	chr23	26424986	26425009	3500442694	23		26424986	26425009	8421504	1	23	0	c	350044269400000001	0-23						Epithelial-Restricted Gene Profile of Primary Cultures from Human Prostate Tumors: A Molecular Approach to Predict Clinical Behavior of Prostate Cancer	.aacrjournals.org	0	0		APOM
786	chr23	26437800	26438797	3500044949	140		26437800	26438797	8421504	4	3,54,60,23	0,111,377,974	p,c	350004494900015002,350004494900015001,350004494900000000	0-57,0-60,0-23			10.1128/MCB.25.23.10329-10337.2005		Molecular and Cellular Biology	The Reaper-Binding Protein Scythe Modulates Apoptosis and Proliferation during Mammalian Development	Fabienne	2005	0		BAG6
786	chr23	26438770	26438815	3500074180	45		26438770	26438815	8421504	1	45	0	p	350007418000015003	0-45			10.1128/MCB.00816-06		Molecular and Cellular Biology	Identification of Yin-Yang Regulators and a Phosphorylation Consensus for Male Germ Cell-Associated Kinase (MAK)-Related Kinase 	Zheng	2006	0		BAG6
787	chr23	26479563	26479587	3500362672	24		26479563	26479587	8421504	1	24	0	c	350036267200000002	24-48			10.1002/art.22877	1529-0131	Arthritis & Rheumatism	T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro - Galdo - 2007 - Arthritis & Rheumatism - Wiley Online Library	Galdo	2007	0		
787	chr23	26508081	26513610	3500383646	40		26508081	26513610	8421504	2	20,20	0,5509	g	350038364600000013,350038364600000011	0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
787	chr23	26510103	26513024	3500124247	120		26510103	26513024	8421504	6	20,20,20,20,20,20	0,460,648,911,1523,2901	c,g	350012424700000035,350012424700000033,350012424700000034,350012424700000032,350012424700000032,350012424700000031,350012424700000028	0-20,0-20,0-20,0-20,0-20,0-20,0-20						Flavia Aline Bressani Donatoni Prospec&#xe7;&#xe3;o de SNPs por eletroforese capilar e sua identifica&#xe7;&#xe3;o em genes candidatos relacionados &#xe0; resist&#xea;ncia de caprinos a nemat&#xf3;ides gastrintestinais	www.teses.usp.br	0	0		
787	chr23	26510301	26538860	3500288373	80		26510301	26538860	8421504	5	5,15,20,20,20	0,7,678,1019,28539	c,g	350028837300000554,350028837300000606,350028837300000606,350028837300000436,350028837300000338	0-20,0-20,0-20,0-20,0-20						ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-&#x03b1; (TNF-&#x03b1;) EXPRESSION	Baker	2000	0		
787	chr23	26510369	26510392	3500099916	23		26510369	26510392	8421504	1	23	0	c	350009991600000005	0-23						Cytokine gene expression during postnatal small intestinal development: regulation by glucocorticoids	gut.bmj.com	0	0		
787	chr23	26510451	26510509	3500442444	58		26510451	26510509	8421504	1	58	0	c	350044244400000010	4-62		20418359	10.1261/rna.2026310		RNA	A versatile ribosomal protein promoter-based reporter system for selective assessment of RNA stability and post-transcriptional control	Edward	June	0		
787	chr23	26510469	26510503	3500346224	34		26510469	26510503	8421504	1	34	0	c	350034622400000005	0-34						Gene	005.pasteur.ac.ir	0	0		
787	chr23	26510477	26510503	3500463748	26		26510477	26510503	8421504	1	26	0	c	350046374800000002	0-26		23951323	10.1371/journal.pone.0072426	1932-6203	PLOS ONE	PLOS ONE: A Novel High Throughput Biochemical Assay to Evaluate the HuR Protein-RNA Complex Formation	D'Agostino	2013	4		
787	chr23	26510477	26510503	3500150838	26		26510477	26510503	8421504	1	26	0	c	350015083800000011	0-26		23922739	10.1371/journal.pone.0069563	1932-6203	PLOS ONE	PLOS ONE: Autophagy Activation Clears ELAVL1/HuR-Mediated Accumulation of SQSTM1/p62 during Proteasomal Inhibition in Human Retinal Pigment Epithelial Cells	Viiri	2013	4		
787	chr23	26510511	26510644	3500280517	40		26510511	26510644	8421504	2	20,20	0,113	c,g	350028051700000024,350028051700000023,350028051700000023	0-20,0-20,0-20						Coxiella burnetii in pregnant goats	ive.library.uu.nl	0	0		
787	chr23	26510791	26511019	3500414028	40		26510791	26511019	8421504	2	20,20	0,208	c,g	350041402800000023,350041402800000022	0-20,0-20						Ganjam virus/Nairobi sheep disease virus induces a pro-inflammatory response in infected sheep	biomedcentral.com	0	0		
787	chr23	26510791	26511019	3500265224	40		26510791	26511019	8421504	2	20,20	0,208	c,g	350026522400000019,350026522400000018	0-20,0-20						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
787	chr23	26510960	26510989	3500270599	29		26510960	26510989	8421504	1	29	0	c	350027059900000004	7-36						Modified cytokines for use in cancer therapy	Corti	2001	0		
787	chr23	26510960	26510989	3500205959	29		26510960	26510989	8421504	1	29	0	c	350020595900000004	7-36						Modified cytokines for use in cancer therapy	Corti	2003	0		
787	chr23	26510960	26510989	3500096796	29		26510960	26510989	8421504	1	29	0	c	350009679600000020,350009679600000006	7-36,7-36						Modified cytokines for use in cancer therapy	A*Ke Er Di 	2006	0		
787	chr23	26510962	26512595	3500370126	558		26510962	26512595	8421504	4	422,48,49,39	0,737,969,1594	c	350037012600000025	0-558						Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease	Cantwell	1999	0		
787	chr23	26510962	26512595	3500227609	558		26510962	26512595	8421504	4	422,48,49,39	0,737,969,1594	c	350022760900000028	0-558						Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease	Tuo Ma Si *J*Ji Pu Si 	2000	0		
787	chr23	26510962	26512595	3500150471	558		26510962	26512595	8421504	4	422,48,49,39	0,737,969,1594	c	350015047100000024	0-558						Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease		1998	0		
787	chr23	26510962	26511271	3500245482	69		26510962	26511271	8421504	2	42,27	0,282	c	350024548200000220,350024548200000214	0-42,21-48						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
787	chr23	26510962	26510995	3500123989	33		26510962	26510995	8421504	1	33	0	c	350012398900000003	0-33		15784899	10.1099/vir.0.80531-0	0022-1317	Journal of General Virology	Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand	Matsuda	2005	3		
787	chr23	26510965	26511023	3500078659	43		26510965	26511023	8421504	2	22,21	0,37	c,g	350007865900000013,350007865900000012	0-22,0-21						SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY - Patent application	www.faqs.org	0	0		
787	chr23	26510965	26511023	3500046939	43		26510965	26511023	8421504	2	22,21	0,37	c,g	350004693900000007,350004693900000006	0-22,0-21		20133924	10.1164/rccm.200912-1818OC		American Journal of Respiratory and Critical Care Medicine	Surfactant Protein-D Inhibits Lung Inflammation Caused by Ventilation in Premature Newborn Lambs	Atsuyasu	2010	0		
787	chr23	26510968	26511161	3500383097	40		26510968	26511161	8421504	2	20,20	0,173	c,g	350038309700000007,350038309700000007,350038309700000006,350038309700000006	0-20,0-20,0-20,0-20						COMPOSITION COMPRISING S-ALLYLMERCAPTO-N-ACETYLCYSTEINE (ASSNAC) FOR UP-REGULATION OF CELLULAR GLUTATHIONE LEVEL	Savion	2008	0		
787	chr23	26510969	26511000	3500300376	31		26510969	26511000	8421504	1	31	0	c	350030037600000011	0-31		18435806	10.1111/j.1365-2249.2008.03647.x		Clinical and Experimental Immunology	Adrenomedullin suppresses tumour necrosis factor alpha-induced CXC chemokine ligand 10 production by human gingival fibroblasts	I	June	0		
787	chr23	26510969	26511000	3500299953	31		26510969	26511000	8421504	1	31	0	c	350029995300000002	0-31						20 December 1996 Volume 274 Number 5295 Breakthrough of the Y	ooks.gutenberg.cc	0	0		
787	chr23	26510969	26511000	3500206707	31		26510969	26511000	8421504	1	31	0	c	350020670700000001	0-31						Isolation of Human Conjunctival Mast Cells and Epithelial Cells: Tumor Necrosis Factor-a from Mast Cells Affects Intercellular Adhesion Molecul 1e Expression on Epithelial Cells	www.iovs.org	0	0		TNF
787	chr23	26510969	26511000	3500007965	31		26510969	26511000	8421504	1	31	0	c	350000796500000001	0-31		20463356	10.1095/biolreprod.109.082578	0006-3363	Biology of Reproduction	Tumor Necrosis Factor Stimulates Matrix Metalloproteinase 9 Secretion from Cultured Human Chorionic Trophoblast Cells Through TNF Receptor 1 Signaling to IKBKB-NFKB and MAPK1/3 Pathway	Li	2010	4		
787	chr23	26510969	26510999	3500288195	30		26510969	26510999	8421504	1	30	0	c	350028819500000019,350028819500000001	0-30,0-30						Inflammatory Mediator Antagonists 	.freshpatents.com	0	0		
787	chr23	26510969	26510999	3500059315	30		26510969	26510999	8421504	1	30	0	c	350005931500000001,350005931500000019	0-30,0-30						Oncostatin M antagonists	Life	1999	0		
787	chr23	26510969	26510999	3500052984	30		26510969	26510999	8421504	1	30	0	c	350005298400000001	0-30					Patent	Inflammatory mediator antagonists (Patent US:8003101)	Life	2011	0		
787	chr23	26510969	26510995	3500182644	26		26510969	26510995	8421504	1	26	0	c	350018264400000000	0-26						Comparison of SP-A and LPS effects on the THP-1 monocytic cell line	ng.physiology.org	0	0		TNF
787	chr23	26510972	26511936	3500355031	44		26510972	26511936	8421504	3	22,17,5	0,758,959	c	350035503100000011,350035503100000010	0-22,0-22						OKAMATSU-OGURA, Yuko; SOLIMAN, Mohamed; ABD Citation Journal of Veterinary Medical Science, 69(5): 509-514 Issue Date 2007-05	lib.hokudai.ac.jp	0	0		
787	chr23	26510972	26511936	3500349767	44		26510972	26511936	8421504	3	22,17,5	0,758,959	c,g	350034976700000015,350034976700000015,350034976700000014	0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
787	chr23	26510972	26510996	3500162844	24		26510972	26510996	8421504	1	24	0	c	350016284400000000	24-48		19180470	10.1002/eji.200838801	0014-2980	European journal of immunology	PI3K limits TNF-&#x03b1; production in CD16-activated monocytes	PR	2009	5		
787	chr23	26510974	26510998	3500397254	24		26510974	26510998	8421504	1	24	0	c	350039725400000005	20-44		19720839	10.1084/jem.20081761	0022-1007	The Journal of Experimental Medicine	Epstein-Barr virus (EBV)&#x2013;encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3	Iwakiri	2009	14		TNF
787	chr23	26510974	26510998	3500302092	24		26510974	26510998	8421504	1	24	0	c	350030209200000005	20-44		19720839	10.1084/jem.20081761	0022-1007	The Journal of Experimental Medicine	Epstein-Barr virus (EBV)&#x2013;encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3	Iwakiri	2009	14		
787	chr23	26510979	26511184	3500408020	41		26510979	26511184	8421504	2	22,19	0,186	c	350040802000000004,350040802000000003	18-40,0-19			10.1002/art.20776	1529-0131	Arthritis & Rheumatism	Role of interleukin-1 and tumor necrosis factor &#x03b1; in matrix degradation of human osteoarthritic cartilage - Kobayashi - 2005 - Arthritis & Rheumatism - Wiley Online Library	Kobayashi	2005	0		TNF
787	chr23	26511014	26511161	3500281920	40		26511014	26511161	8421504	2	20,20	0,127	c,g	350028192000000023,350028192000000023,350028192000000022	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
787	chr23	26511016	26511084	3500457560	41		26511016	26511084	8421504	2	19,22	0,46	c,g	350045756000000003,350045756000000003,350045756000000002	0-19,0-19,0-22						Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle	aldc.nal.usda.gov	0	0		
787	chr23	26511018	26511936	3500018812	57		26511018	26511936	8421504	3	26,26,5	0,703,913	c	350001881200000028,350001881200000014,350001881200000013,350001881200000027	3-29,8-34,7-36,0-31						 Use Of Recombinant Bovine CD14 In The Treatment And Prevention Of Coliform Mastitis In Dairy Cows 	www.docstoc.com	0	0		
787	chr23	26511018	26511934	3500120546	55		26511018	26511934	8421504	3	26,26,3	0,703,913	c	350012054600000014,350012054600000013	8-34,7-36						Use of recombinant bovine CD14 in the treatment and prevention of coliform mastitis in dairy cows	Wang	2002	0		
787	chr23	26511019	26511101	3500449915	41		26511019	26511101	8421504	2	20,21	0,61	c,g	350044991500000025,350044991500000025,350044991500000024	0-20,0-20,0-21						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
787	chr23	26511055	26511079	3500421622	24		26511055	26511079	8421504	1	24	0	c	350042162200000005	0-24		12734369		0022-1767	The Journal of Immunology	The Lymphotoxin &#x03b2; Receptor Is Critically Involved in Controlling Infections with the Intracellular Pathogens Mycobacterium tuberculosis and Listeria monocytogenes	Ehlers	2003	6		TNF
787	chr23	26511062	26511729	3500312145	40		26511062	26511729	8421504	2	20,20	0,647	c,g	350031214500000013,350031214500000013,350031214500000012,350031214500000012	0-20,0-20,0-20,0-20						Modulation of cytokine gene expression and secretion during the periparturient period in dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis	ddr.nal.usda.gov	0	0		
787	chr23	26511088	26511114	3500328036	26		26511088	26511114	8421504	1	26	0	c	350032803600000001	13-39						Tumor necrosis factor - Patent # 6686455 - PatentGenius	.patentgenius.com	0	0		
787	chr23	26511088	26511114	3500241223	26		26511088	26511114	8421504	1	26	0	c	350024122300000001	13-39						Tumor necrosis factor	www.devileye.net	0	0		
787	chr23	26511133	26511725	3500040185	41		26511133	26511725	8421504	2	21,20	0,572	c,g	350004018500000054,350004018500000054,350004018500000053,350004018500000053	0-21,0-21,0-20,0-20						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
787	chr23	26511141	26511956	3500275310	40		26511141	26511956	8421504	2	20,20	0,795	c,g	350027531000000019,350027531000000018,350027531000000018	0-20,0-20,0-20						The Bovine Mammary Glands Cytokines at the Periparturient Period	apps.kfu.edu.sa	0	0		
787	chr23	26511141	26511725	3500399883	40		26511141	26511725	8421504	2	20,20	0,564	c,g	350039988300000025,350039988300000024,350039988300000024	0-20,0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	bdtd.ufscar.br	0	0		
787	chr23	26511141	26511725	3500177864	40		26511141	26511725	8421504	2	20,20	0,564	c,g	350017786400000016,350017786400000016,350017786400000015,350017786400000015	0-20,0-20,0-20,0-20						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
787	chr23	26511141	26511725	3500164845	40		26511141	26511725	8421504	2	20,20	0,564	c,g	350016484500000025,350016484500000025,350016484500000024,350016484500000024	0-20,0-20,0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	ww.bdtd.ufscar.br	0	0		
787	chr23	26511141	26511725	3500136902	40		26511141	26511725	8421504	2	20,20	0,564	c,g	350013690200000011,350013690200000010,350013690200000010	0-20,0-20,0-20						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
787	chr23	26511192	26512613	3500253078	40		26511192	26512613	8421504	2	20,20	0,1401	c	350025307800000008,350025307800000040,350025307800000039	20-40,0-20,0-20						METHODS OF TREATING INFLAMMATORY CONDITIONS - Patent application	www.faqs.org	0	0		
787	chr23	26511240	26511710	3500291860	39		26511240	26511710	8421504	3	20,8,11	0,136,459	c,g	350029186000000001,350029186000000000	0-20,0-19						Die Immunantwort boviner und capriner Euterepithelzellen auf verschiedene Mastitiserreger	b.uni-muenchen.de	0	0		
787	chr23	26511287	26511710	3500362403	39		26511287	26511710	8421504	3	20,8,11	0,89,412	c,g	350036240300000085,350036240300000085,350036240300000084	0-20,0-20,0-19						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
787	chr23	26511324	26511742	3500453465	44		26511324	26511742	8421504	2	20,24	0,394	c,g	350045346500000011,350045346500000011,350045346500000010	0-20,0-20,0-24						Expression profile of genes associated with mastitis in dairy cattle	cnptia.embrapa.br	0	0		
787	chr23	26511324	26511742	3500137193	45		26511324	26511742	8421504	2	20,25	0,393	c	350013719300000003,350013719300000002	0-20,0-25						Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system	biomedcentral.com	0	0		
787	chr23	26511324	26511375	3500301078	51		26511324	26511375	8421504	1	51	0	c,g	350030107800000071,350030107800000071	2-53,2-53						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
787	chr23	26511371	26511713	3500296484	27		26511371	26511713	8421504	2	13,14	0,328	c	350029648400000005	0-27						Evaluation of cytokine expression by blood monocytes of lactating Holstein cows with or without postpartum uterine disease. - ResearchGate	.researchgate.net	0	0		
787	chr23	26511375	26511965	3500379004	44		26511375	26511965	8421504	3	9,13,22	0,324,568	c	350037900400000019,350037900400000018	0-22,0-22						Adaptation to High Grain Diets Proceeds Through Minimal Immune System Stimulation and Differences in Extracellular Matrix Protein Expression in A Model of Subacute Ruminal Acidosis in Non-lactating Dairy Cows	thescipub.com	0	0		
787	chr23	26511375	26511965	3500249098	44		26511375	26511965	8421504	3	9,13,22	0,324,568	c,g	350024909800000015,350024909800000014,350024909800000014	0-22,0-22,0-22						A CHARACTERIZATION OF INFLAMMATORY AND STRUCTURAL MARKERS WITHIN THE RUMEN EPITHELIUM DURING GRAIN-INDUCED RUMINAL ACIDOSIS IN	thescipub.com	0	0		
787	chr23	26511435	26511734	3500105262	38		26511435	26511734	8421504	2	19,19	0,280	c,g	350010526200000001,350010526200000000,350010526200000000	0-19,0-19,0-19						Polymorphism at the bovine tumor necrosis factor alpha locus and assignm ent to BTA 23	enomics.liv.ac.uk	0	0		
787	chr23	26511968	26512571	3500168145	24		26511968	26512571	8421504	2	9,15	0,588	c	350016814500000028	20-44						Characterization of insulin sensitivity and inflammation related factors in dairy cows receiving conjugated linoleic acids (CLA) or a control fat supplement during lactation	s.ulb.uni-bonn.de	0	0		
787	chr23	26512590	26512645	3500130944	38		26512590	26512645	8421504	2	19,19	0,36	c	350013094400000166,350013094400000164	0-19,0-19						RIBONUCLEIC ACIDS WITH NON-STANDARD BASES AND USES THEREOF - Patent application	www.faqs.org	0	0		
787	chr23	26512640	26512827	3500193113	41		26512640	26512827	8421504	2	20,21	0,166	c,g	350019311300000011,350019311300000011,350019311300000010	0-20,0-20,0-21		24086682	10.1371/journal.pone.0076036	1932-6203	PLOS ONE	PLOS ONE: Establishment and Evaluation of a Stable Cattle Type II Alveolar Epithelial Cell Line	Su	2013	4		
787	chr23	26512769	26527622	3500124685	43		26512769	26527622	8421504	2	20,23	0,14830	c	350012468500000025,350012468500000037	20-40,18-41						Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide	www.jleukbio.org	0	0		
787	chr23	26512999	26513026	3500028905	27		26512999	26513026	8421504	1	27	0	g	350002890500000005	0-27		12773519	10.1189/jlb.1202618	0741-5400	Journal of Leukocyte Biology	Histone acetylation and chromatin conformation are regulated separately at the TNF-&#x03b1; promoter in monocytes and macrophages	Lee	2003	5		
787	chr23	26513021	26513060	3500361339	39		26513021	26513060	8421504	1	39	0	g	350036133900000122	19-58						US Patent # 7,271,156. Immunostimulatory nucleic acids - Patents.com	www.patents.com	0	0		
787	chr23	26513021	26513060	3500111091	39		26513021	26513060	8421504	1	39	0	g	350011109100000125,350011109100000177,350011109100000176,350011109100000181,350011109100000182,350011109100000179	9-39,0-21,0-21,0-24,0-24,0-24						IMMUNOSTIMULATORY NUCLEIC ACIDS - Patent application	www.faqs.org	0	0		
787	chr23	26513021	26513051	3500237369	30		26513021	26513051	8421504	1	30	0	g	350023736900000165,350023736900000148,350023736900000115,350023736900000243	20-41,0-21,0-24,0-24						Methods for enhancing antibody-induced cell lysis and treating cancer	Weiner	2001	0		
787	chr23	26513021	26513051	3500091043	30		26513021	26513051	8421504	1	30	0	g	350009104300000144,350009104300000239,350009104300000111	0-21,0-24,0-24					Patent	Methods for enhancing antibody-induced cell lysis and treating cancer (Patent US:7534772)	Weiner	2009	0		
787	chr23	26514779	26514806	3500120743	27		26514779	26514806	8421504	1	27	0	c	350012074300000000	21-48						Peripheral and gastrointestinal immune systems of healthy cattle raised outdoors at pasture or indoors on a concentrate-based ration	biomedcentral.com	0	0		
787	chr23	26515694	26515718	3500406769	23		26515694	26515718	8421504	2	5,18	0,6	c	350040676900000000	0-23						Lymphotoxin DNA, lymphotoxin expression vector	Kakutani	1986	0		
787	chr23	26515694	26515718	3500092567	23		26515694	26515718	8421504	2	5,18	0,6	c	350009256700000000	0-23						US Patent # 4,988,624. Lymphotoxin DNA, lymphotoxin expression vector - Patents.com	www.patents.com	0	0		
787	chr23	26537888	26537936	3500335102	48		26537888	26537936	8421504	1	48	0	p	350033510200015140	0-48						BiochemicalCharacterizationandN-terminomicsAnalysisof Leukolysin,theMembrane-type6MatrixMetalloprotease (MMP25)	www.jbc.org	0	0		ATP6V1G2
787	chr23	26538295	26539053	3500321954	231		26538295	26539053	8421504	2	60,171	0,587	p	350032195400015000	0-231						Protein Page: NP_612139	ranetransport.org	0	0		
787	chr23	26543544	26552753	3500068530	1287		26543544	26552753	8421504	10	211,128,93,184,119,132,110,145,148,17	0,1421,1829,3760,5047,7398,8223,8434,8721,9192	c	350006853000000015	0-1287						Novel compositions and methods for cancer	Morris	2004	0		SNORD117,DDX39B
787	chr23	26543619	26543664	3500338243	45		26543619	26543664	8421504	1	45	0	p	350033824300015002	0-45		18411249	10.1242/jcs.021055	0021-9533	Journal of Cell Science	Binding of ATP to UAP56 is necessary for mRNA export	Kota	2008	6		DDX39B
787	chr23	26551825	26552045	3500347539	40		26551825	26552045	8421504	2	20,20	0,200	c,g	350034753900000000,350034753900000000,350034753900000005	0-20,0-20,0-20		21070294	10.1111/j.1365-2052.2010.02137.x	1365-2052	Animal Genetics	A conserved segmental duplication within ELA - Brinkmeyer-Langford - 2010 - Animal Genetics - Wiley Online Library	Brinkmeyer-Langford	2010	0		DDX39B
787	chr23	26551985	26552011	3500360658	26		26551985	26552011	8421504	1	26	0	c	350036065800000005	0-26						KIF14 MessengerRNAExpressionIsIndependentlyPrognostic forOutcomeinLungCancer	.aacrjournals.org	0	0		
98	chr23	26727524	26785169	3500264004	1058		26727524	26785169	8421504	8	23,50,270,273,276,113,48,5	0,26,371,837,56324,56716,57430,57640	c	350026400400000142	0-1089						Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus - Patent application	www.faqs.org	0	0		
788	chr23	26727945	26727990	3500086290	45		26727945	26727990	8421504	1	45	0	p	350008629000015018	0-45						Method for typing of HLA alleles	Canck	2000	0		HCG9
98	chr23	26727973	26752602	3500264004	142		26727973	26752602	8421504	7	20,21,21,21,19,19,21	0,101,133,167,446,24148,24608	c,g	350026400400000143,350026400400000144,350026400400000021,350026400400000169,350026400400000040,350026400400000040,350026400400000188,350026400400000188,350026400400000113,350026400400000113,350026400400000218,350026400400000218,350026400400000070,350026400400000070,350026400400000231,350026400400000083,350026400400000193,350026400400000045,350026400400000046,350026400400000194	0-20,0-20,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-21,0-19,0-19,0-19,0-19,0-19,0-19,0-21,0-21,0-20,0-20						Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus - Patent application	www.faqs.org	0	0		
788	chr23	26728134	26728378	3500024385	48		26728134	26728378	8421504	2	31,17	0,227	p	350002438500015015	0-48						Fusion Proteins, Uses Thereof And Processes For Producing Same 	.freshpatents.com	0	0		
788	chr23	26728137	26728378	3500018074	45		26728137	26728378	8421504	2	28,17	0,224	p	350001807400015037	0-45						Method For The Production Of High-level Soluble Human Recombinant Interferon Alpha In E. Coli And Vectors Useful For Such A Production 	.freshpatents.com	0	0		
790	chr23	26882546	26888899	3500113386	662		26882546	26888899	8421504	6	47,56,55,168,317,19	0,608,748,804,1739,6334	c,g	350011338600000084,350011338600000027,350011338600000043,350011338600000048,350011338600000053,350011338600000058,350011338600000063,350011338600000060,350011338600000008	37-84,0-56,0-111,0-112,0-97,0-107,0-113,0-67,4-23						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		
790	chr23	26883295	26884712	3500330278	72		26883295	26884712	8421504	2	50,22	0,1395	c,g	350033027800000018,350033027800000013,350033027800000013	0-50,0-22,0-22						METHOD FOR INDUCING PLURIPOTENCY IN HUMAN SOMATIC CELLS WITH PRDM14 OR NFRKB - AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH	www.sumobrain.com	0	0		
790	chr23	26883364	26883387	3500332775	23		26883364	26883387	8421504	1	23	0	g	350033277500000010	1-24		19158239	10.1128/JVI.01721-08	0022-538X	Journal of Virology	Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector	Gallaher	2009	5		
790	chr23	26884505	26884533	3500371297	28		26884505	26884533	8421504	1	28	0	g	350037129700000049	0-28		15988017	10.1128/MCB.25.14.6031-6046.2005	0270-7306	Molecular and Cellular Biology	Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells	Chew	2005	6		
790	chr23	26884708	26884732	3500409412	23		26884708	26884732	8421504	2	19,4	0,20	c	350040941200000002	0-23						Epigenetic Changes in the Hypothalamic Proopiomelanocortin and Glucocorticoid Receptor Genes in the Ovine Fetus after Periconceptional Undernutrition	.endojournals.org	0	0		
790	chr23	26884805	26887733	3500179889	46		26884805	26887733	8421504	3	20,13,13	0,195,2915	c	350017988900000003,350017988900000022	0-20,0-26						Research Paper Characterization of Bovine Induced Pluripotent Stem Cells by Lentiviral Transduction of Reprogramming Factor Fusion Proteins	www.ijbs.com	0	0		
790	chr23	26884806	26887840	3500151744	41		26884806	26887840	8421504	2	21,20	0,3014	c	350015174400000000,350015174400000001	0-21,0-20		21880014	10.1042/CBI20100720	1095-8355	Cell Biology International	Stemness characteristics and osteogenic potential of sheep amniotic epithelial cells	M	2012	0		
790	chr23	26885007	26888660	3500030307	40		26885007	26888660	8421504	3	6,14,20	0,2713,3633	c	350003030700000002,350003030700000003	0-20,0-20						NOVEL APPROACHES TO THE ISOLATION OF FARM ANIMAL EMBRYONIC STEM CELLS by Kwanta Thansa Thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy September 2009	.nottingham.ac.uk	0	0		
790	chr23	26885007	26888195	3500224138	40		26885007	26888195	8421504	3	6,14,20	0,2713,3168	c	350022413800000000,350022413800000001	0-20,0-20						Effects of ghrelin on developmental competence and gene expression of in&#xa0;vitro fertilized ovine embryos	ww.cas.zju.edu.cn	0	0		
790	chr23	26887726	26888886	3500321901	450		26887726	26888886	8421504	4	115,131,159,45	0,392,851,1115	p,c	350032190100015016,350032190100000019	0-450,18-40						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		POU5F1
790	chr23	26887726	26888886	3500283192	450		26887726	26888886	8421504	4	115,131,159,45	0,392,851,1115	p,c	350028319200015016,350028319200000019	0-450,18-40						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		POU5F1P4
790	chr23	26887726	26888886	3500282644	450		26887726	26888886	8421504	4	115,131,159,45	0,392,851,1115	p,c	350028264400015016,350028264400000019	0-450,18-40					Patent	Induced pluripotent stem cells produced using reprogramming factors and a rho kinase inhibitor or a histone deacetylase inhibitor (Patent US:8211697)	Ishikawa	2012	0		POU5F1
790	chr23	26887726	26888886	3500127647	450		26887726	26888886	8421504	4	115,131,159,45	0,392,851,1115	p,c	350012764700015016,350012764700000019	0-450,18-40						Multipotent/pluripotent cells and methods	Ishikawa	2009	0		POU5F1
790	chr23	26887735	26888895	3500385366	438		26887735	26888895	8421504	5	51,49,131,159,48	0,57,383,842,1112	p	350038536600015016	3-444						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		
790	chr23	26887758	26888890	3500312619	43		26887758	26888890	8421504	2	22,21	0,1111	c	350031261900000000,350031261900000001	0-22,0-21						Quality of embryonic bodies and seeding density effects on neural differentiation of mouse embryonic stem cells	J	2008	0		POU5F1
790	chr23	26887765	26888239	3500059113	42		26887765	26888239	8421504	2	21,21	0,453	c,g	350005911300000002,350005911300000002,350005911300000003,350005911300000003	0-21,0-21,0-21,0-21		22043807	10.1089/cell.2011.0021		Cellular Reprogramming	Efficient Production and Cellular Characterization of Sheep Androgenetic Embryos	Federica	2011	0		
790	chr23	26887768	26887791	3500276182	23		26887768	26887791	8421504	1	23	0	c	350027618200000000	0-23						METHODS OF ISOLATING AND USING STEM CELLS	Huang	2009	0		
790	chr23	26887797	26888603	3500435447	40		26887797	26888603	8421504	2	20,20	0,786	c	350043544700000006,350043544700000007	0-20,0-20						Effect of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate on in vitro developmental competence of bovine oocytes	health.huji.ac.il	0	0		
790	chr23	26887797	26888603	3500362883	40		26887797	26888603	8421504	2	20,20	0,786	c,g	350036288300000004,350036288300000005,350036288300000005	0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
790	chr23	26887798	26889033	3500432629	360		26887798	26889033	8421504	10	43,2,45,45,30,15,45,45,45,45	0,320,325,373,421,779,893,1046,1094,1190	p	350043262900015018,350043262900015020,350043262900015022,350043262900015024,350043262900015030,350043262900015032,350043262900015034,350043262900015038	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						CANINE iPS CELLS AND METHOD OF PRODUCING SAME - Patent application	www.faqs.org	0	0		
790	chr23	26887818	26888119	3500068995	24		26887818	26888119	8421504	2	23,1	0,300	c	350006899500000145	0-24						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
790	chr23	26887828	26888129	3500445636	24		26887828	26888129	8421504	2	13,11	0,290	c	350044563600000018	0-24		11124810	10.1101/gad.853700a	0890-9369	Genes & Development	Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses	Adelman	2000	12		
790	chr23	26887828	26888129	3500419057	24		26887828	26888129	8421504	2	13,11	0,290	c	350041905700000002	0-24			10.1634/stemcells.2004-0122	1549-4918	STEM CELLS	Derivation and Characterization of New Human Embryonic Stem Cell Lines: SNUhES1, SNUhES2, and SNUhES3 - Oh - 2005 - STEM CELLS - Wiley Online Library	Oh	2005	0		
790	chr23	26887828	26888129	3500410974	24		26887828	26888129	8421504	2	13,11	0,290	c	350041097400000007	0-24						ProgressionofProstateCancerfromaSubsetof p63-PositiveBasalEpithelialCellsinFG/Tag TransgenicMice	.aacrjournals.org	0	0		
790	chr23	26887828	26888129	3500380798	24		26887828	26888129	8421504	2	13,11	0,290	c	350038079800000010	0-24						Stem Cell 2011;2(1) http://www.sciencepub.net/stem	ww.sciencepub.net	0	0		
790	chr23	26887828	26888129	3500378874	24		26887828	26888129	8421504	2	13,11	0,290	c	350037887400000000	0-24		19194949	10.1002/btpr.57	1520-6033	Biotechnology Progress	Propagation of embryonic stem cells in stirred suspension without serum - Kehoe - 2008 - Biotechnology Progress - Wiley Online Library	Kehoe	2008	0		
790	chr23	26887828	26888129	3500270167	24		26887828	26888129	8421504	2	13,11	0,290	c	350027016700000001	0-24						Derivation, propagation and differentiation of human stem and progenitor cells	gupea.ub.gu.se	0	0		
790	chr23	26887828	26888129	3500250424	24		26887828	26888129	8421504	2	13,11	0,290	c	350025042400000000	0-24		18997114	10.1242/dev.023747	0950-1991	Development	The cytoplasm of mouse germinal vesicle stage oocytes can enhance somatic cell nuclear reprogramming	Bui	2008	7		
790	chr23	26887828	26888129	3500220080	24		26887828	26888129	8421504	2	13,11	0,290	c	350022008000000012	0-24						Method for inducing differentiation of embryonic stem cells	Inoue	2003	0		
790	chr23	26887828	26888129	3500192591	24		26887828	26888129	8421504	2	13,11	0,290	c	350019259100000016	0-24						Bone morphogenetic protein-4 enhances cardiomyocyte differentiation of cynomolgus monkey ESCs in knockout serum replacement medium. - ResearchGate	.researchgate.net	0	0		
790	chr23	26887828	26888129	3500162445	24		26887828	26888129	8421504	2	13,11	0,290	c	350016244500000006	0-24						Mouse Embryonic Stem Cell&#x2013;Derived Embryoid Bodies Generate Progenitors That Integrate Long Term into Renal Proximal Tubules In Vivo	n.asnjournals.org	0	0		
790	chr23	26887828	26888129	3500130519	24		26887828	26888129	8421504	2	13,11	0,290	c	350013051900000000	0-24						Scalable Production of Embryonic Stem Cell-Derived Cardiomyocytes	.ibme.utoronto.ca	0	0		
790	chr23	26887828	26888129	3500102679	24		26887828	26888129	8421504	2	13,11	0,290	c	350010267900000012	0-24		19433449	10.1128/MCB.00243-09	0270-7306	Molecular and Cellular Biology	CXXC Finger Protein 1 Contains Redundant Functional Domains That Support Embryonic Stem Cell Cytosine Methylation, Histone Methylation, and Differentiation	Tate	2009	6		
790	chr23	26887828	26888129	3500095956	24		26887828	26888129	8421504	2	13,11	0,290	c	350009595600000041,350009595600000008	0-24,0-24						Methods and Compositions Involving Developmental Decision Promoter Regions - Patent application	www.faqs.org	0	0		
790	chr23	26887828	26888129	3500051891	24		26887828	26888129	8421504	2	13,11	0,290	c	350005189100000004	0-24						Conferences, Proceedings, Journals, Open Access Journals, SCIRP	file.scirp.org	0	0		
790	chr23	26887828	26888129	3500042942	24		26887828	26888129	8421504	2	13,11	0,290	c	350004294200000000	0-24		18624284	10.1002/dvdy.21617		Developmental dynamics : an official publication of the American Association of Anatomists	Maintenance of undifferentiated mouse embryonic stem cells in suspension by the serum- and feeder-free defined culture condition	Yukiiko	2008	0		
790	chr23	26887828	26888129	3500031427	24		26887828	26888129	8421504	2	13,11	0,290	c	350003142700000006	0-24		18522852	10.1016/j.stem.2008.04.001		Cell stem cell	Caspase activity mediates the differentiation of embryonic stem cells	Jun	June	0		
790	chr23	26887828	26888129	3500001411	24		26887828	26888129	8421504	2	13,11	0,290	c	350000141100000008	0-24		18180327	10.1677/JOE-07-0452	0022-0795	Journal of Endocrinology	TSH stimulates adipogenesis in mouse embryonic stem cells	Lu	2008	4		
790	chr23	26887828	26888128	3500383573	23		26887828	26888128	8421504	2	13,10	0,290	c	350038357300000005	0-23						High sensitivity of embryonic stem cells to proteasome inhibitors correlates with low expression of heat shock protein and decrease of pluripotent cell marker expression	bmbreports.org	0	0		
790	chr23	26887830	26888873	3500328799	42		26887830	26888873	8421504	3	11,11,20	0,288,1023	c,g	350032879900000002,350032879900000032,350032879900000003,350032879900000003	0-22,0-22,0-20,0-20						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
790	chr23	26887830	26888873	3500100652	42		26887830	26888873	8421504	3	11,11,20	0,288,1023	c,g	350010065200000006,350010065200000007,350010065200000007	0-22,0-20,0-20						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
790	chr23	26887830	26888854	3500385770	42		26887830	26888854	8421504	4	11,11,7,13	0,288,899,1011	c	350038577000000000,350038577000000001	0-22,0-20		15229144	10.1095/biolreprod.104.029322	0006-3363	Biology of Reproduction	Pluripotent Lineage Definition in Bovine Embryos by Oct4 Transcript Localization	Kurosaka	2004	4		
790	chr23	26887830	26888854	3500270590	42		26887830	26888854	8421504	4	11,11,7,13	0,288,899,1011	c	350027059000000000,350027059000000001	0-22,0-20						CELL EXTRACT-BASED REPROGRAMMING OF SOMATIC CELLS	etd.lsu.edu	0	0		
790	chr23	26887830	26888854	3500028009	42		26887830	26888854	8421504	4	11,11,7,13	0,288,899,1011	c	350002800900000002,350002800900000003	0-22,0-20						Putative imprinted gene expression in uniparental bovine embryo models	library.uq.edu.au	0	0		
790	chr23	26887831	26888854	3500354445	41		26887831	26888854	8421504	4	10,11,7,13	0,287,898,1010	c	350035444500000000,350035444500000001	0-21,0-20						Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)	B	2007	0		
790	chr23	26887831	26888854	3500204982	41		26887831	26888854	8421504	4	10,11,7,13	0,287,898,1010	c	350020498200000001,350020498200000002	0-21,0-20						Derivation of buffalo embryonic stem-like cells from in vitro-produced blastocysts on homologous and heterologous feeder cells. - ResearchGate	.researchgate.net	0	0		
790	chr23	26887831	26888854	3500007780	41		26887831	26888854	8421504	4	10,11,7,13	0,287,898,1010	c	350000778000000000,350000778000000001	0-21,0-20						 ESTABLISHMENT OF EMBRYONIC STEM CELL LINES DERIVED FROM IN VITRO-PRODUCED BUFFALO (Bubalus bubalis) EMBRYOS -- Verma et al. 77 (1001): 186 -- Biology of Reproduction 	ww.biolreprod.org	0	0		
790	chr23	26887831	26888854	3500005763	41		26887831	26888854	8421504	4	10,11,7,13	0,287,898,1010	c	350000576300000005,350000576300000006	0-21,0-20						2005 ISSCR07Poster Sessions	www.scribd.com	0	0		
790	chr23	26888148	26888658	3500047878	40		26888148	26888658	8421504	2	20,20	0,490	c	350004787800000058,350004787800000059	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
790	chr23	26888176	26888201	3500456411	25		26888176	26888201	8421504	1	25	0	c	350045641100000005,350045641100000001	0-25,0-25						Two-stage culture protocol for isolating mesenchymal stem cells from amniotic fluid - US Patent 7101710 Description	ww.patentstorm.us	0	0		POU5F1B
790	chr23	26888176	26888201	3500432424	25		26888176	26888201	8421504	1	25	0	c	350043242400000003	0-25						In Vitro Generation of Hepatocytes from Human Embryonic Stem Cells	Mandal	2010	0		POU5F1P4
790	chr23	26888176	26888201	3500373327	25		26888176	26888201	8421504	1	25	0	c	350037332700000001	0-25						Two-stage culture protocol for isolating mesenchymal stem cells from amniotic fluid - US Patent 7101710 Claims	ww.patentstorm.us	0	0		POU5F1P4
790	chr23	26888176	26888201	3500356716	25		26888176	26888201	8421504	1	25	0	c	350035671600000003	0-25						Establishment Of A Human Embryonic Stem Cell Line Using Mammalian Cells 	.freshpatents.com	0	0		POU5F1
790	chr23	26888176	26888201	3500348411	25		26888176	26888201	8421504	1	25	0	c	350034841100000001	0-25						Two-stage culture protocol for isolating mesenchymal stem cells from amniotic fluid	Tsai	2004	0		POU5F1
790	chr23	26888176	26888201	3500304906	25		26888176	26888201	8421504	1	25	0	c	350030490600000003	0-25		16306422	10.1095/biolreprod.105.046029	0006-3363	Biology of Reproduction	Clonal Amniotic Fluid-Derived Stem Cells Express Characteristics of Both Mesenchymal and Neural Stem Cells	Tsai	2006	4		POU5F1P4
790	chr23	26888176	26888201	3500302103	25		26888176	26888201	8421504	1	25	0	c	350030210300000001	0-25		22393366	10.1371/journal.pone.0031645	1932-6203	PLOS ONE	PLOS ONE: Transcriptome and Network Changes in Climbers at Extreme Altitudes	Chen	2012	4		POU5F1
790	chr23	26888176	26888201	3500259383	25		26888176	26888201	8421504	1	25	0	c	350025938300000001	0-25						Human embryonic stem cell cultures, and compositions and methods for growing same	Cheng	2011	0		POU5F1P3
790	chr23	26888176	26888201	3500221726	25		26888176	26888201	8421504	1	25	0	c	350022172600000001	0-25		22393366	10.1371/journal.pone.0031645		PLoS ONE	Transcriptome and Network Changes in Climbers at Extreme Altitudes	Fang	2012	0		POU5F1
790	chr23	26888176	26888201	3500198523	25		26888176	26888201	8421504	1	25	0	c	350019852300000003,350019852300000043	0-25,0-25						Pluripotent Embryonic-like Stem Cells Derived From Corneal Limbus, Methods Of Isolation And Uses Thereof 	.freshpatents.com	0	0		POU5F1P4
790	chr23	26888176	26888201	3500189255	25		26888176	26888201	8421504	1	25	0	c	350018925500000001	0-25						Isolation and Differentiation of Human Mesenchymal Stem Cells Obtained from Second Trimester Amniotic Fluid; Experiments at Chang Gung Memorial Hospital	memo.cgu.edu.tw	0	0		POU5F1B
790	chr23	26888176	26888201	3500149628	25		26888176	26888201	8421504	1	25	0	c	350014962800000001	0-25			10.1634/stemcells.22-5-790	1549-4918	STEM CELLS	Derivation of Human Embryonic Stem Cells from Day-8 Blastocysts Recovered after Three-Step In Vitro Culture - Stojkovic - 2004 - STEM CELLS - Wiley Online Library	Stojkovic	2004	0		POU5F1B
790	chr23	26888176	26888201	3500130959	25		26888176	26888201	8421504	1	25	0	c	350013095900000001	0-25						Methods of derivation and propagation of undifferentiated human embryonic stem (hes) cells on feeder-free matrices and human feeder layers	Bongso	2003	0		POU5F1P3
790	chr23	26888176	26888201	3500051794	25		26888176	26888201	8421504	1	25	0	c	350005179400000019	0-25			10.1634/stemcells.21-6-624	1549-4918	STEM CELLS	Epithelial Colonies Cultured from Human Explanted Liver in Subacute Hepatic Failure Exhibit Hepatocyte, Biliary Epithelial, and Stem Cell Phenotypic Markers - Selden - 2003 - STEM CELLS - Wiley Online Library	Selden	2003	0		POU5F1P3
790	chr23	26888176	26888201	3500010184	25		26888176	26888201	8421504	1	25	0	c	350001018400000003	0-25						Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof	Totey	2009	0		POU5F1P4
790	chr23	26888176	26888201	3500005590	25		26888176	26888201	8421504	1	25	0	c	350000559000000001	0-25						Two-stage culture protocol for isolating mesenchymal stem cells from amniotic fluid	Tsai	2005	0		POU5F1P4
790	chr23	26888176	26888200	3500348371	24		26888176	26888200	8421504	1	24	0	c	350034837100000009	0-24						Lamin A/C Expression Is a Marker of Mouse and Human Embryonic Stem Cell Differentiation--&#x300a;&#x5e72;&#x7ec6;&#x80de;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		POU5F1
790	chr23	26888176	26888200	3500179928	24		26888176	26888200	8421504	1	24	0	c	350017992800000009	0-24			10.1634/stemcells.21-5-546	1549-4918	STEM CELLS	Comparative Evaluation of Various Human Feeders for Prolonged Undifferentiated Growth of Human Embryonic Stem Cells - Richards - 2003 - STEM CELLS - Wiley Online Library	Richards	2003	0		POU5F1P3
790	chr23	26888222	26888662	3500274287	42		26888222	26888662	8421504	2	22,20	0,420	c	350027428700000000,350027428700000031	0-22,0-20						Supporting Information - ID6 piPSC cells were seeded onto 12-well plates ( 10	www.pnas.org	0	0		
790	chr23	26888639	26888854	3500309581	40		26888639	26888854	8421504	3	20,7,13	0,90,202	c	350030958100000000,350030958100000001	0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Reproducci&#xf3;n		2011	0		
790	chr23	26888639	26888854	3500303705	40		26888639	26888854	8421504	3	20,7,13	0,90,202	c	350030370500000000,350030370500000001	0-20,0-20				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Reproducci&#xf3;n		2011	0		
790	chr23	26888683	26888856	3500009456	40		26888683	26888856	8421504	3	20,5,15	0,48,158	c	350000945600000014,350000945600000015	0-20,0-20						PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY	Fissore	2007	0		
790	chr23	26888872	26889045	3500323318	40		26888872	26889045	8421504	2	20,20	0,153	c,g	350032331800000002,350032331800000002,350032331800000003	0-20,0-20,0-20						Improved in vitro development of cloned bovine embryos using S-adenosylhomocysteine, a non-toxic epigenetic modifying reagent. - ResearchGate	.researchgate.net	0	0		
790	chr23	26888878	26889078	3500075257	39		26888878	26889078	8421504	2	19,20	0,180	c,g	350007525700000004,350007525700000004,350007525700000005	0-19,0-19,0-20						Isolation and Characterization of Porcine Visceral Endoderm Cell Lines Derived from in vivo 11-Day Blastocysts	www.jstor.org	0	0		
790	chr23	26888968	26888991	3500357319	23		26888968	26888991	8421504	1	23	0	c	350035731900000050	0-23						INDUCED PLURIPOTENT STEM CELLS DERIVED FROM HUMAN PANCREATIC BETA CELLS - Patent application	www.faqs.org	0	0		POU5F1P3
790	chr23	26888968	26888991	3500290644	23		26888968	26888991	8421504	1	23	0	c	350029064400000005	0-23						PLURIPOTENT CELL LINES AND METHODS OF USE THEREOF - PARKINSONS INSTITUTE	www.sumobrain.com	0	0		POU5F1P4
790	chr23	26888968	26888991	3500172381	23		26888968	26888991	8421504	1	23	0	c	350017238100000005	0-23						Pluripotent cell lines and methods of use thereof - Patent application	www.faqs.org	0	0		POU5F1B
790	chr23	26888968	26888991	3500026197	23		26888968	26888991	8421504	1	23	0	c	350002619700000005	0-23						Pluripotent cell lines and methods of use thereof	Reijo	2009	0		POU5F1B
790	chr23	26888973	26888997	3500141941	24		26888973	26888997	8421504	1	24	0	c,g	350014194100000017,350014194100000017	0-24,0-24						Isolation and Characterization of Equine Umbilical Cord Blood Derived Stem Cells	ufdc.ufl.edu	0	0		POU5F1
790	chr23	26889058	26889081	3500055849	23		26889058	26889081	8421504	1	23	0	c	350005584900000014	17-40						Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells	s.ulb.uni-bonn.de	0	0		
790	chr23	26893429	26893455	3500399520	23		26893429	26893455	8421504	2	11,12	0,14	c	350039952000000047	5-29						 Lysine 	www.docstoc.com	0	0		
790	chr23	26893429	26893455	3500052425	23		26893429	26893455	8421504	2	11,12	0,14	c	350005242500000060	5-29						Lysine-specific Porphyromonas gingivalis proteinase	Travis	1993	0		
790	chr23	26894200	26894228	3500102291	25		26894200	26894228	8421504	3	14,3,8	0,16,20	g	350010229100000358	9-34						Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods	Alvarez	2000	0		
790	chr23	26908875	26908920	3500466437	45		26908875	26908920	8421504	1	45	0	p	350046643700015014	0-45						COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING PSORIASIS - Patent application	www.faqs.org	0	0		
790	chr23	26908875	26908920	3500004183	45		26908875	26908920	8421504	1	45	0	p	350000418300015014	0-45						Compositions and methods for diagnosing or treating psoriasis - Patent application	www.faqs.org	0	0		
790	chr23	26926550	26926577	3500340941	24		26926550	26926577	8421504	2	8,16	0,11	c	350034094100000004	7-31		17000761	10.1128/MCB.02299-05	0270-7306	Molecular and Cellular Biology	The Microphthalmia-Associated Transcription Factor Mitf Interacts with &#x03b2;-Catenin To Determine Target Gene Expression	Schepsky	2006	6		
790	chr23	26926550	26926577	3500025776	24		26926550	26926577	8421504	2	8,16	0,11	c	350002577600000004	7-31			10.1128/MCB.02299-05		Molecular and Cellular Biology	The Microphthalmia-Associated Transcription Factor Mitf Interacts with &#x03b2;-Catenin To Determine Target Gene Expression 	Alexander	2006	0		
790	chr23	26957375	26957945	3500113156	41		26957375	26957945	8421504	2	21,20	0,550	c	350011315600000290,350011315600000272	0-21,0-20						M E T H O D S I N M O L E C U L A R M E D I C I N E Pediatric Hematology	dokteranakku.com	0	0		
790	chr23	26959452	26959478	3500395273	24		26959452	26959478	8421504	2	10,14	0,12	c	350039527300000263	24-48						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
790	chr23	26960810	26960838	3500130057	23		26960810	26960838	8421504	2	14,9	0,19	c	350013005700000424,350013005700000426	11-34,11-34						ABSTRACT BIRKENHEUER, ADAM JOSEPH. Canine Babesiosis: Epidemiological, Molecular and	tory.lib.ncsu.edu	0	0		
791	chr23	27075733	27076425	3500204691	40		27075733	27076425	8421504	2	20,20	0,672	c	350020469100000005,350020469100000004	0-20,0-20			10.1111/j.1349-7006.2007.00655.x	1349-7006	Cancer Science	Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer - Shimada - 2007 - Cancer Science - Wiley Online Library	Shimada	2008	0		DDR1
791	chr23	27077215	27077939	3500392871	49		27077215	27077939	8421504	2	26,23	0,701	c	350039287100000005,350039287100000004	0-26,16-39						UNIVERSITAT ROVIRA I VIRGILI EXPRESSIA DEL RECEPTOR DOMINI DISCOIDINA 1 (DDR1) EN CERVELL HUMA. REL	www.tdx.cat	0	0		
792	chr23	27186674	27186900	3500404944	40		27186674	27186900	8421504	2	20,20	0,206	c,g	350040494400000006,350040494400000006,350040494400000007,350040494400000007	0-20,0-20,0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
792	chr23	27188667	27188692	3500285009	25		27188667	27188692	8421504	1	25	0	c	350028500900000000	6-31						Campylobacter jejuni Survives within Epithelial Cells by Avoiding Delivery to Lysosomes	medicine.yale.edu	0	0		
792	chr23	27189875	27190036	3500066284	69		27189875	27190036	8421504	2	24,45	0,116	p	350006628400015082	0-69						I. BANDAS DIFERENCIALES SELECCIONADAS	www.tdx.cat	0	0		
792	chr23	27199986	27200138	3500411508	44		27199986	27200138	8421504	2	22,22	0,130	c	350041150800000009,350041150800000008	0-22,0-22			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Fol&#xed;culos ovarianos caprinos expressam diferentes n&#xed;veis de RNAm para subunidade &#xdf;A da inibina e ativina-A promove o crescimento de fol&#xed;culos secund&#xe1;rios in vitro	Leitao	2013	0		
792	chr23	27199992	27200016	3500118856	24		27199992	27200016	8421504	1	24	0	c	350011885600000008	0-24			10.1093/emboj/18.2.420	ERROR! NO ISSN	The EMBO Journal	Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation	Li	1999	0		TUBB4A
792	chr23	27200345	27201331	3500137241	144		27200345	27201331	8421504	3	45,54,45	0,528,941	p	350013724100015069,350013724100015067,350013724100015055	0-45,0-54,0-45						Improved cancer therapeutics	Lewensohn	2009	0		
792	chr23	27200396	27200606	3500229748	204		27200396	27200606	8421504	2	48,156	0,54	p	350022974800015003	0-207						mec-7 production of 15-protofilament microtubules in Caenorhabditis elegans	enesdev.cshlp.org	0	0		TUBB4B
792	chr23	27200486	27203152	3500426158	750		27200486	27203152	8421504	4	473,111,109,57	0,754,1122,2609	p	350042615800015064	57-807							foad2.unicaen.fr	0	0		TUBB
792	chr23	27200537	27201636	3500159212	87		27200537	27201636	8421504	3	54,5,28	0,809,1071	p	350015921200015012	0-87						Hypusination of eukaryotic initiation factor 5A(eIF5A): a novel therapeutic target in BCR-ABL&#x2013;positive leukemias identi&#xfb01;ed by a proteomics approach	tologylibrary.org	0	0		
792	chr23	27200723	27203152	3500330478	81		27200723	27203152	8421504	2	51,30	0,2399	p	350033047800015005	0-81						THE J B C Vol.271,No.44,IssueofNovember1,pp.27931&#x2013;27935,1996 &#xa9;1996byTheAmericanSocietyforBiochemistryandMolecularBiology,Inc. PrintedinU.S.A. -TubulinBindsSrcHomology2Domainsthrougha RegionDifferentfromtheTyrosine-phosphorylated Protein-recogn	www.jbc.org	0	0		TUBB6,AFG3L2
792	chr23	27201270	27201295	3500448445	25		27201270	27201295	8421504	1	25	0	c	350044844500000002	0-25						A novel inhibitor of hypoxia-inducible factor-1&#x03b1; P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells	biomedcentral.com	0	0		TUBB
792	chr23	27201322	27203137	3500392330	180		27201322	27203137	8421504	3	29,109,42	0,286,1773	p	350039233000015016	0-180						Planaria EST Database	an.bio.keio.ac.jp	0	0		TUBB
793	chr23	27281443	27281476	3500170371	33		27281443	27281476	8421504	1	33	0	c	350017037100000000	6-39						ScienceDirect.com - FEBS Letters - Purification and characterisation of p99, a nuclear modulator of protein phosphatase 1 activity	sciencedirect.com	0	0		PPP1R10
793	chr23	27285914	27285965	3500322289	51		27285914	27285965	8421504	1	51	0	p	350032228900015038,350032228900015045	0-51,0-45						Award Number: W81XWH-05-1-0233 TITLE: A Proteomic Approach to Identify Phosphorylation-Dependent Targets of BRCT PRINCIPAL INVESTIGATOR: Zhou Songyang, Ph.D. 9 TYPE OF REPORT: Final DISTRIBUTION STATEMENT: Approved for Public Release;	www.dtic.mil	0	0		PPP1R10
793	chr23	27304553	27304743	3500193860	29		27304553	27304743	8421504	2	5,24	0,166	c	350019386000000016	22-51						Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation	Kmiec	2003	0		
793	chr23	27304553	27304743	3500044153	29		27304553	27304743	8421504	2	5,24	0,166	c	350004415300000016	22-51						Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation	Kmiec	2004	0		
793	chr23	27378963	27378988	3500305954	23		27378963	27378988	8421504	2	18,5	0,20	g	350030595400000085	15-39					Patent	Bovine herpesvirus vaccine and method of using same (Patent US:5462734)	Israel	1995	0		
794	chr23	27464182	27464206	3500049938	24		27464182	27464206	8421504	1	24	0	c	350004993800000003,350004993800000010	0-24,0-24						IDENTIFICATION OF A NUCLEIC ACID MOLECULE - Patent application	www.faqs.org	0	0		HCG17
794	chr23	27465244	27504794	3500402823	89		27465244	27504794	8421504	4	21,29,20,19	0,122,618,39531	c,g	350040282300000165,350040282300000147,350040282300000221,350040282300000022,350040282300000113,350040282300000250,350040282300000058	0-21,0-19,0-19,0-19,0-20,0-19,0-19						 DNA Chip Based Genetic Typing 	www.docstoc.com	0	0		
99	chr23	27465415	27636290	3500264004	1235		27465415	27636290	8421504	16	19,32,11,14,50,10,14,35,60,5,279,55,276,41,58,276	0,19563,19772,20208,68017,68203,68224,68662,68699,68854,68875,113531,113703,170378,170425,170599	g	350026400400000211,350026400400000063,350026400400000141,350026400400000116,350026400400000117,350026400400000118,350026400400000119,350026400400000121,350026400400000120,350026400400000123,350026400400000122	0-19,0-19,588-1056,616-1086,588-1058,593-1063,614-1084,607-1077,607-1077,610-1077,610-1077						Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus - Patent application	www.faqs.org	0	0		
795	chr23	27533432	27580573	3500264004	885		27533432	27580573	8421504	10	44,7,96,279,46,11,46,55,276,25	0,45,645,858,44818,45026,45459,45514,45686,47116	g	350026400400000138,350026400400000137,350026400400000139,350026400400000134,350026400400000132,350026400400000133,350026400400000131,350026400400000114	472-936,616-1080,616-1078,610-1072,610-1072,593-1012,602-1064,0-25						Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus - Patent application	www.faqs.org	0	0		
795	chr23	27534505	27578291	3500074473	48		27534505	27578291	8421504	2	28,20	0,43766	c	350007447300000020,350007447300000003	9-37,11-31						METHODS OF SUPPRESSING IMMUNE RESPONSE BY GENE THERAPY	Barber	1994	0		
795	chr23	27579243	27579335	3500396950	43		27579243	27579335	8421504	2	21,22	0,70	c	350039695000000006,350039695000000007	0-21,0-22					Patent	Animal models for demyelination disorders (Patent US:8309790)	Lin	2012	0		
795	chr23	27579243	27579335	3500325944	43		27579243	27579335	8421504	2	21,22	0,70	c	350032594400000007,350032594400000008	0-21,0-22						Cell-based screen for agents useful for reducing neuronal demyelination or promoting neuronal remyelination	Popko	2006	0		
795	chr23	27579243	27579335	3500016531	43		27579243	27579335	8421504	2	21,22	0,70	c	350001653100000077,350001653100000006,350001653100000078,350001653100000007	0-21,0-21,0-22,0-22						Animal Models For Demyelination Disorders 	.freshpatents.com	0	0		
795	chr23	27580332	27580464	3500176064	68		27580332	27580464	8421504	2	22,46	0,86	c	350017606400000010,350017606400000008	18-40,0-46						Methods and reagents for HLA class I A locus DNA typing	Apple	1993	0		
795	chr23	27634976	27638433	3500264004	1040		27634976	27638433	8421504	9	5,48,33,105,276,276,120,113,64	0,170,357,817,1038,2337,2810,2967,3393	c,g	350026400400000125,350026400400000124,350026400400000115,350026400400000049,350026400400000049,350026400400000197,350026400400000197	0-1077,3-1059,0-29,0-19,0-19,0-19,0-19						Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus - Patent application	www.faqs.org	0	0		
795	chr23	27637424	27637806	3500402823	40		27637424	27637806	8421504	2	20,20	0,362	c	350040282300000049,350040282300000095,350040282300000279	0-20,0-20,0-20						 DNA Chip Based Genetic Typing 	www.docstoc.com	0	0		HCG9
795	chr23	27637811	27637848	3500341265	37		27637811	27637848	8421504	1	37	0	g	350034126500000003	37-74						Informe final* del Proyecto	ww.conabio.gob.mx	0	0		
795	chr23	27637961	27638006	3500252611	45		27637961	27638006	8421504	1	45	0	p	350025261100015097	0-45						Compositions and methods using recombinant MHC molecules for the treatment of stroke - Patent application	www.faqs.org	0	0		HCG9
795	chr23	27637961	27638006	3500099433	45		27637961	27638006	8421504	1	45	0	p	350009943300015055	0-45						Method for Typing HLA Alleles - Patent application	www.faqs.org	0	0		HCG9
795	chr23	27637961	27638006	3500086290	45		27637961	27638006	8421504	1	45	0	p	350008629000015050	0-45						Method for typing of HLA alleles	Canck	2000	0		HCG9
795	chr23	27637961	27638006	3500048313	45		27637961	27638006	8421504	1	45	0	p	350004831300015096	0-45						Recombinant MHC molecules useful for manipulation of antigen-specific T-cells - Patent application	www.faqs.org	0	0		HCG9
796	chr23	27698297	27698834	3500337770	41		27698297	27698834	8421504	3	8,13,20	0,444,517	c,g	350033777000000001,350033777000000000,350033777000000000	0-21,0-20,0-20						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
796	chr23	27698297	27698834	3500139803	41		27698297	27698834	8421504	3	8,13,20	0,444,517	c,g	350013980300000001,350013980300000000,350013980300000000	0-21,0-20,0-20						Conferences, Proceedings, Journals, Open Access Journals, SCIRP	file.scirp.org	0	0		
796	chr23	27735793	27737775	3500093559	23		27735793	27737775	8421504	4	3,5,13,2	0,1213,1223,1980	c	350009355900000020	15-38						Mammalian cytokines, related reagents and methods	B*Ao Pu Man 	2002	0		TRIM15
796	chr23	27737793	27737968	3500327558	38		27737793	27737968	8421504	4	7,11,5,15	0,16,135,160	g	350032755800000009	4-42						Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer - Patent application	www.faqs.org	0	0		
796	chr23	27747395	27747421	3500388711	23		27747395	27747421	8421504	2	6,17	0,9	c	350038871100000004,350038871100000002	15-38,15-37						Adipocyte complement related protein zacrp11	Feldhaus	2005	0		
797	chr23	27882639	27882708	3500409446	69		27882639	27882708	8421504	1	69	0	p	350040944600015003	0-69		21928277	10.1002/eji.201141863	1521-4141	European Journal of Immunology	Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34&#x2013;56 peptide in incomplete adjuvant - Jagessar - 2011 - European Journal of Immunology - Wiley Online Library	Jagessar	2012	0		MOG
797	chr23	27882642	27882705	3500466923	63		27882642	27882705	8421504	1	63	0	p	350046692300015000	0-63		23885286	10.1371/journal.pone.0066657	1932-6203	PLOS ONE	PLOS ONE: Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis	Lutz	2013	4		MOG
797	chr23	27882642	27882705	3500463659	63		27882642	27882705	8421504	1	63	0	p	350046365900015002	0-63						Inhibition of Nuclear Factor- B Enhances the Capacity of Immature Dendritic Cells to Induce Antigen-Specific Tolerance in Experimental Autoimmune Encephalomyelitis	aspetjournals.org	0	0		MOG
797	chr23	27882642	27882705	3500463504	63		27882642	27882705	8421504	1	63	0	p	350046350400015000	0-63						Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis	www.jimmunol.org	0	0		MOG
797	chr23	27882642	27882705	3500461364	63		27882642	27882705	8421504	1	63	0	p	350046136400015007	0-63						&#x81ea;&#x5df1;&#x514d;&#x75ab;&#x75be;&#x60a3;&#x306e;&#x6cbb;&#x7642;&#x7528;&#x306e;&#xff29;&#xff2c;&#x2212;&#xff11;&#xff12;&#x53c8;&#x306f;&#xff29;&#xff2c;&#x2212;&#xff12;&#xff13;&#x3092;&#x542b;&#x3080;&#x30ef;&#x30af;&#x30c1;&#x30f3; &#xff08;&#x516	astamuse.com	0	0		MOG
797	chr23	27882642	27882705	3500458068	63		27882642	27882705	8421504	1	63	0	p	350045806800015000	0-63		19411637	10.1182/blood-2008-12-192914		Blood	Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK	Wei	June	0		MOG
797	chr23	27882642	27882705	3500455398	63		27882642	27882705	8421504	1	63	0	p	350045539800015005	0-63						METHODS FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH FUNCTIONAL DISORDER OF REGULATORY T CELLS - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500451971	63		27882642	27882705	8421504	1	63	0	p	350045197100015000	0-63		11602620	10.1172/JCI13360	0021-9738	The Journal of Clinical Investigation	Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity	Slavin	2001	13		MOG
797	chr23	27882642	27882705	3500451889	63		27882642	27882705	8421504	1	63	0	p	350045188900015000	0-63			10.1111/j.1759-1961.2010.00016.x	1759-1961	Clinical and Experimental Neuroimmunology	Tumor necrosis factor-&#x03b1; promotes granulocyte-macrophage colony-stimulating factor-stimulated microglia to differentiate into competent dendritic cell-like antigen-presenting cells - Li - 2010 - Clinical and Experimental Neuroimmunology - Wiley Onli	Li	2011	0		MOG
797	chr23	27882642	27882705	3500447870	63		27882642	27882705	8421504	1	63	0	p	350044787000015000	0-63						Supporting Online Material for	ww.sciencemag.org	0	0		MOG
797	chr23	27882642	27882705	3500447116	63		27882642	27882705	8421504	1	63	0	p	350044711600015000	0-63						REGULATORY B CELLS AND THEIR USES - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500445846	63		27882642	27882705	8421504	1	63	0	p	350044584600015001	0-63						T-CELL RECEPTOR CDR3 SEQUENCE BUT NOT RECOGNITION CHARACTERISTICS DISTINGUISH AUTOREACTIVE EFFECTOR AND FOXP3 REGULATORY T-CELLS	etd.uthsc.edu	0	0		MOG
797	chr23	27882642	27882705	3500444360	63		27882642	27882705	8421504	1	63	0	p	350044436000015000	0-63						Journal of Neuroinflammation	oinflammation.com	0	0		MOG
797	chr23	27882642	27882705	3500439529	63		27882642	27882705	8421504	1	63	0	p	350043952900015001	0-63						&#x4e3b;&#x9898;&#xff1a;inhibitory | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		MOG
797	chr23	27882642	27882705	3500434237	63		27882642	27882705	8421504	1	63	0	p	350043423700015015	0-63						NPG.nature.vol.441.Issue.7090.May	www.scribd.com	0	0		MOG
797	chr23	27882642	27882705	3500427044	63		27882642	27882705	8421504	1	63	0	p	350042704400015034	0-63						Compositions and methods for binding sphingosine-1-phosphate	Sabbadini	2008	0		MOG
797	chr23	27882642	27882705	3500423239	63		27882642	27882705	8421504	1	63	0	p	350042323900015002	0-63		16597709	10.1124/jpet.106.103259	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Inhibition of Nuclear Factor-&#x03ba;B Enhances the Capacity of Immature Dendritic Cells to Induce Antigen-Specific Tolerance in Experimental Autoimmune Encephalomyelitis	Iruretagoyena	2006	0		MOG
797	chr23	27882642	27882705	3500417497	63		27882642	27882705	8421504	1	63	0	p	350041749700015000	0-63		21199897	10.4049/jimmunol.1003081	0022-1767	The Journal of Immunology	Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions	Joller	2011	6		MOG
797	chr23	27882642	27882705	3500416641	63		27882642	27882705	8421504	1	63	0	p	350041664100015000	0-63					The Journal of Experimental Medicine	Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis	Brian	2000	0		MOG
797	chr23	27882642	27882705	3500411133	63		27882642	27882705	8421504	1	63	0	p	350041113300015000	0-63			10.1172/JCI12976		Journal of Clinical Investigation	Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection	Christopher	2001	0		MOG
797	chr23	27882642	27882705	3500409426	63		27882642	27882705	8421504	1	63	0	p	350040942600015001	0-63		19188499	10.1084/jem.20081666	0022-1007	The Journal of Experimental Medicine	Down-regulation of Gfi-1 expression by TGF-&#x03b2; is important for differentiation of Th17 and CD103+ inducible regulatory T cells	Zhu	2009	14		MOG
797	chr23	27882642	27882705	3500405534	63		27882642	27882705	8421504	1	63	0	p	350040553400015000	0-63		18319343	10.1073/pnas.0709592105	0027-8424	Proceedings of the National Academy of Sciences	Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population	Wang	2008	10		MOG
797	chr23	27882642	27882705	3500404961	63		27882642	27882705	8421504	1	63	0	p	350040496100015001	0-63			10.1111/j.1476-5381.2009.00528.x	1476-5381	British Journal of Pharmacology	The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function - Ni - 2009 - British Journal of Pharmacology - Wile	Ni	2009	0		MOG
797	chr23	27882642	27882705	3500404686	63		27882642	27882705	8421504	1	63	0	p	350040468600015006	0-63						Suppression of experimental autoimmune encephalomyelitis by ghrelin. - ResearchGate	.researchgate.net	0	0		MOG
797	chr23	27882642	27882705	3500397440	63		27882642	27882705	8421504	1	63	0	p	350039744000015000	0-63		19188499	10.1084/jem.20081666		The Journal of Experimental Medicine	Down-regulation of Gfi-1 expression by TGF-&#x03b2; is important for differentiation of Th17 and CD103+ inducible regulatory T cells	Jinfang	2009	0		MOG
797	chr23	27882642	27882705	3500386431	63		27882642	27882705	8421504	1	63	0	p	350038643100015010	0-63						Interleukin-1 Conjugates and Uses Thereof	Bachmann	2012	0		MOG
797	chr23	27882642	27882705	3500385306	63		27882642	27882705	8421504	1	63	0	p	350038530600015001	0-63		21257712	10.1096/fj.10-177279	0892-6638	The FASEB Journal	Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation	Li	2011	6		MOG
797	chr23	27882642	27882705	3500382521	63		27882642	27882705	8421504	1	63	0	p	350038252100015003	0-63						Lymphoid Chemokines In The Diagnosis, Monitoring And Treatment Of Inflammatory Disease - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500377889	63		27882642	27882705	8421504	1	63	0	p	350037788900015000	0-63		20624940	10.4049/jimmunol.1001307	0022-1767	The Journal of Immunology	Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis	Matsushita	2010	6		MOG
797	chr23	27882642	27882705	3500375207	63		27882642	27882705	8421504	1	63	0	p	350037520700015000	0-63						Relevance of anti-myelin antibodies in Multiple Sclerosis	dspace.ubvu.vu.nl	0	0		MOG
797	chr23	27882642	27882705	3500364834	63		27882642	27882705	8421504	1	63	0	p	350036483400015000	0-63						Role of IFN- in induction of Foxp3 and conversion of CD4+ CD25--&#x300a;&#x4e34;&#x5e8a;&#x8c03;&#x67e5;&#x5b66;&#x62a5;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		MOG
797	chr23	27882642	27882705	3500363226	63		27882642	27882705	8421504	1	63	0	p	350036322600015000	0-63					Journal of immunology (Baltimore, Md. : 1950)	Retrogenic modeling of experimental allergic encephalomyelitis associates T-cell frequency but not T-cell receptor functional affinity with pathogenicity	Rajshekhar	July	0		MOG
797	chr23	27882642	27882705	3500363112	63		27882642	27882705	8421504	1	63	0	p	350036311200015004	0-63		20937706	10.1084/jem.20100876	0022-1007	The Journal of Experimental Medicine	Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis	Pareek	2010	14		MOG
797	chr23	27882642	27882705	3500360546	63		27882642	27882705	8421504	1	63	0	p	350036054600015001	0-63						Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response	www.jimmunol.org	0	0		MOG
797	chr23	27882642	27882705	3500358601	63		27882642	27882705	8421504	1	63	0	p	350035860100015005	0-63						Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population	www.pnas.org	0	0		MOG
797	chr23	27882642	27882705	3500351317	63		27882642	27882705	8421504	1	63	0	p	350035131700015000	0-63					Journal of immunology (Baltimore, Md. : 1950)	Combinations of CD45 Isoforms Are Crucial for Immune Function and Disease	Ritu	2006	0		MOG
797	chr23	27882642	27882705	3500343339	63		27882642	27882705	8421504	1	63	0	p	350034333900015001	0-63						DIAGNOSIS AND PROGNOSIS OF IMMUNE DISORDERS USING STAT4 EXPRESSION	Kaplan	2009	0		MOG
797	chr23	27882642	27882705	3500340739	63		27882642	27882705	8421504	1	63	0	p	350034073900015000	0-63		21078888	10.1084/jem.20100703		The Journal of Experimental Medicine	Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling	Shu	2010	0		MOG
797	chr23	27882642	27882705	3500340499	63		27882642	27882705	8421504	1	63	0	p	350034049900015000	0-63						&#x201c;Microglia derived from embryonic stem cells and its application in CNS diseases&#x201d; PhD thesis	s.ulb.uni-bonn.de	0	0		MOG
797	chr23	27882642	27882705	3500334764	63		27882642	27882705	8421504	1	63	0	p	350033476400015005	0-63						Interleukin-1 conjugates and uses thereof	Bachmann	2008	0		MOG
797	chr23	27882642	27882705	3500327236	63		27882642	27882705	8421504	1	63	0	p	350032723600015003	0-63					Patent	Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease (Patent US:7390884)	Bagaeva	2008	0		MOG
797	chr23	27882642	27882705	3500319397	63		27882642	27882705	8421504	1	63	0	p	350031939700015002	0-63						METHODS OF PREPARING A THERAPEUTIC FORMULATION COMPRISING GALECTIN-INDUCED TOLEROGENIC DENDRITIC CELLS - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500316847	63		27882642	27882705	8421504	1	63	0	p	350031684700015000	0-63			10.1172/JCI13360		Journal of Clinical Investigation	Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity	Anthony	2001	0		MOG
797	chr23	27882642	27882705	3500315463	63		27882642	27882705	8421504	1	63	0	p	350031546300015000	0-63		17182553		0022-1767	The Journal of Immunology	Th3 Cells in Peripheral Tolerance. I. Induction of Foxp3-Positive Regulatory T Cells by Th3 Cells Derived from TGF-&#x03b2; T Cell-Transgenic Mice	Carrier	2007	6		MOG
797	chr23	27882642	27882705	3500313633	63		27882642	27882705	8421504	1	63	0	p	350031363300015042	0-63						NPG.nature.vol.413.Issue.6855.Oct	www.scribd.com	0	0		MOG
797	chr23	27882642	27882705	3500311442	63		27882642	27882705	8421504	1	63	0	p	350031144200015000	0-63						Methods of treating inflammation - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500306819	63		27882642	27882705	8421504	1	63	0	p	350030681900015000	0-63						NeurobiologyofDisease CD200R1AgonistAttenuatesMechanismsofChronic DiseaseinaMurineModelofMultipleSclerosis	www.jneurosci.org	0	0		MOG
797	chr23	27882642	27882705	3500306791	63		27882642	27882705	8421504	1	63	0	p	350030679100015000	0-63		22733814	10.1074/jbc.M112.356584		The Journal of Biological Chemistry	The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis	Jie	2012	0		MOG
797	chr23	27882642	27882705	3500306568	63		27882642	27882705	8421504	1	63	0	p	350030656800015003	0-63						APTAMER AGAINST IL-17 AND USE THEREOF - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500299690	63		27882642	27882705	8421504	1	63	0	p	350029969000015000	0-63						Methods of Treating Inflammation - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500299448	63		27882642	27882705	8421504	1	63	0	p	350029944800015000	0-63		20548029	10.4049/jimmunol.0904100	0022-1767	The Journal of Immunology	Smad2 and Smad3 Are Redundantly Essential for the TGF-&#x03b2;&#x2013;Mediated Regulation of Regulatory T Plasticity and Th1 Development	Takimoto	2010	6		MOG
797	chr23	27882642	27882705	3500288723	63		27882642	27882705	8421504	1	63	0	p	350028872300015000	0-63		18566378		0022-1767	The Journal of Immunology	Retrogenic Modeling of Experimental Allergic Encephalomyelitis Associates T Cell Frequency but Not TCR Functional Affinity with Pathogenicity	Alli	2008	6		MOG
797	chr23	27882642	27882705	3500280538	63		27882642	27882705	8421504	1	63	0	p	350028053800015002	0-63						Estudo in vivo do papel das quimiocinas e dos receptores 1 2, no recrutamento de leuc&#xf3;citos na	cadigital.ufmg.br	0	0		MOG
797	chr23	27882642	27882705	3500278211	63		27882642	27882705	8421504	1	63	0	p	350027821100015003	0-63		20937706	10.1084/jem.20100876		The Journal of Experimental Medicine	Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis	Tej	2010	0		MOG
797	chr23	27882642	27882705	3500277596	63		27882642	27882705	8421504	1	63	0	p	350027759600015000	0-63						MHC class II&#x2013;restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell&#x2013;mediated autoimmunity	jem.rupress.org	0	0		MOG
797	chr23	27882642	27882705	3500273309	63		27882642	27882705	8421504	1	63	0	p	350027330900015001	0-63		21078888	10.1084/jem.20100703	0022-1007	The Journal of Experimental Medicine	Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling	Zhu	2010	14		MOG
797	chr23	27882642	27882705	3500270630	63		27882642	27882705	8421504	1	63	0	p	350027063000015000	0-63		19389933	10.2353/ajpath.2009.081084		The American Journal of Pathology	Synthetic Retinoid AM80 Inhibits Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis	Christian	June	0		MOG
797	chr23	27882642	27882705	3500263374	63		27882642	27882705	8421504	1	63	0	p	350026337400015003	0-63						Method for Treatment or Prevention of Disease Associated Wtih Functional Disorder of Regulatory T Cell - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500262815	63		27882642	27882705	8421504	1	63	0	p	350026281500015000	0-63						METHODS FOR MODULATING A POPULATION OF MYELOID-DERIVED SUPPRESSOR CELLS AND USES THEREOF - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500256582	63		27882642	27882705	8421504	1	63	0	p	350025658200015000	0-63		21239712	10.4049/jimmunol.1001345	0022-1767	The Journal of Immunology	CSF-1&#x2013;Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses	Kurotaki	2011	6		MOG
797	chr23	27882642	27882705	3500252611	63		27882642	27882705	8421504	1	63	0	p	350025261100015009	0-63						Compositions and methods using recombinant MHC molecules for the treatment of stroke - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500252371	63		27882642	27882705	8421504	1	63	0	p	350025237100015000	0-63						Unique B cell responses in B cell-dependent and B cell-independent EAE. | Kamaldeen Muili - Academia.edu	www.academia.edu	0	0		MOG
797	chr23	27882642	27882705	3500251837	63		27882642	27882705	8421504	1	63	0	p	350025183700015000	0-63			10.1172/JCI21846	0021-9738	The Journal of Clinical Investigation	EphB6-null mutation results in compromised T cell function	Luo	2004	13		MOG
797	chr23	27882642	27882705	3500250745	63		27882642	27882705	8421504	1	63	0	p	350025074500015004	0-63					Patent	Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases (Patent US:8449874)	Bachmann	2013	0		MOG
797	chr23	27882642	27882705	3500248871	63		27882642	27882705	8421504	1	63	0	p	350024887100015000	0-63		21317386	10.4049/jimmunol.1001322	0022-1767	The Journal of Immunology	Estriol Generates Tolerogenic Dendritic Cells In Vivo That Protect against Autoimmunity	Papenfuss	2011	6		MOG
797	chr23	27882642	27882705	3500248237	63		27882642	27882705	8421504	1	63	0	p	350024823700015000	0-63		19181483	10.1016/j.jaut.2008.12.004		Journal of autoimmunity	Deficiency of Thrombonspondin-1 Reduces Th17 Differentiation and Attenuates Experimental Autoimmune Encephalomyelitis	Kaiyong	2009	0		MOG
797	chr23	27882642	27882705	3500229978	63		27882642	27882705	8421504	1	63	0	p	350022997800015001	0-63		15289505	10.1084/jem.20040435	0022-1007	The Journal of Experimental Medicine	Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases	Xanthoulea	2004	14		MOG
797	chr23	27882642	27882705	3500229258	63		27882642	27882705	8421504	1	63	0	p	350022925800015002	0-63						Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells	jem.rupress.org	0	0		MOG
797	chr23	27882642	27882705	3500229175	63		27882642	27882705	8421504	1	63	0	p	350022917500015002	0-63		16597709	10.1124/jpet.106.103259	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Inhibition of Nuclear Factor-&#x03ba;B Enhances the Capacity of Immature Dendritic Cells to Induce Antigen-Specific Tolerance in Experimental Autoimmune Encephalomyelitis	Iruretagoyena	2006	0		MOG
797	chr23	27882642	27882705	3500224939	63		27882642	27882705	8421504	1	63	0	p	350022493900015004	0-63						Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease	Bagaeva	2006	0		MOG
797	chr23	27882642	27882705	3500221707	63		27882642	27882705	8421504	1	63	0	p	350022170700015001	0-63						Differential modulation of EAE by &#x03b1;9*- and &#x03b2;2*-nicotinic acetylcholine receptors. - ResearchGate	.researchgate.net	0	0		MOG
797	chr23	27882642	27882705	3500221660	63		27882642	27882705	8421504	1	63	0	p	350022166000015000	0-63						Fetuin-a As A Biomarker For Multiple Sclerosis 	.freshpatents.com	0	0		MOG
797	chr23	27882642	27882705	3500221457	63		27882642	27882705	8421504	1	63	0	p	350022145700015001	0-63						g The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease	.neuroimmunol.org	0	0		MOG
797	chr23	27882642	27882705	3500219569	63		27882642	27882705	8421504	1	63	0	p	350021956900015084	0-63						Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500219452	63		27882642	27882705	8421504	1	63	0	p	350021945200015000	0-63						Combinations of CD45 Isoforms Are Crucial for Immune Function and Disease	www.jimmunol.org	0	0		MOG
797	chr23	27882642	27882705	3500215883	63		27882642	27882705	8421504	1	63	0	p	350021588300015014	0-63						Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases	Mettens	2007	0		MOG
797	chr23	27882642	27882705	3500208939	63		27882642	27882705	8421504	1	63	0	p	350020893900015000	0-63		18056351		0022-1767	The Journal of Immunology	IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis	Kreymborg	2007	6		MOG
797	chr23	27882642	27882705	3500207538	63		27882642	27882705	8421504	1	63	0	p	350020753800015000	0-63						Animal model for identifying agents that inhibit or enhance CTLA4 signaling	Liu	2001	0		MOG
797	chr23	27882642	27882705	3500206831	63		27882642	27882705	8421504	1	63	0	p	350020683100015000	0-63						Involvement of Tissue Plasminogen Activator in Onset and Effector Phases of Experimental Allergic Encephalomyelitis	www.jneurosci.org	0	0		MOG
797	chr23	27882642	27882705	3500203444	63		27882642	27882705	8421504	1	63	0	p	350020344400015000	0-63		17372022		0022-1767	The Journal of Immunology	TGF-&#x03b2;1-Mediated Control of Central Nervous System Inflammation and Autoimmunity through the Inhibitory Receptor CD26	Preller	2007	6		MOG
797	chr23	27882642	27882705	3500202198	63		27882642	27882705	8421504	1	63	0	p	350020219800015009	0-63						&#x041a;&#x043e;&#x043d;&#x044a;&#x044e;&#x0433;&#x0430;&#x0442;&#x044b; &#x0438;&#x043d;&#x0442;&#x0435;&#x0440;&#x043b;&#x0435;&#x0439;&#x043a;&#x0438;&#x043d;&#x0430;-1 &#x0438; &#x0438;&#x0445; &#x043f;&#x0440;&#x0438;&#x043c;&#x0435;&#x043d;&#x0435;&	www.freepatent.ru	0	0		MOG
797	chr23	27882642	27882705	3500198937	63		27882642	27882705	8421504	1	63	0	p	350019893700015000	0-63						Diagnosis and prognosis of immune disorders using stat4 expression	Kaplan	2010	0		MOG
797	chr23	27882642	27882705	3500196316	63		27882642	27882705	8421504	1	63	0	p	350019631600015010	0-63						Recombinant MHC molecules useful for manipulation of antigen-specific T-cells	Offner	2009	0		MOG
797	chr23	27882642	27882705	3500196155	63		27882642	27882705	8421504	1	63	0	p	350019615500015000	0-63		21068410	10.4049/jimmunol.1000930	0022-1767	The Journal of Immunology	Oligodendrocyte-Specific FADD Deletion Protects Mice from Autoimmune-Mediated Demyelination	Guire	2010	6		MOG
797	chr23	27882642	27882705	3500190954	63		27882642	27882705	8421504	1	63	0	p	350019095400015000	0-63		18322180		0022-1767	The Journal of Immunology	Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-&#x03b3; on STAT3 and Smads	Tanaka	2008	6		MOG
797	chr23	27882642	27882705	3500190951	63		27882642	27882705	8421504	1	63	0	p	350019095100015003	0-63						Modulation of the Immune Response	Weiner	2008	0		MOG
797	chr23	27882642	27882705	3500184795	63		27882642	27882705	8421504	1	63	0	p	350018479500015000	0-63			10.1111/cen3.12005	1759-1961	Clinical and Experimental Neuroimmunology	Interleukin-27 promotes inflammatory and neuroprotective responses in microglia - Kawanokuchi - 2013 - Clinical and Experimental Neuroimmunology - Wiley Online Library	Kawanokuchi	2013	0		MOG
797	chr23	27882642	27882705	3500184629	63		27882642	27882705	8421504	1	63	0	p	350018462900015000	0-63		17947669		0022-1767	The Journal of Immunology	Anti-Inflammatory Properties and Regulatory Mechanism of a Novel Derivative of Artemisinin in Experimental Autoimmune Encephalomyelitis	Wang	2007	6		MOG
797	chr23	27882642	27882705	3500182363	63		27882642	27882705	8421504	1	63	0	p	350018236300015001	0-63		21078888	10.1084/jem.20100703	0022-1007	The Journal of Experimental Medicine	Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling	Zhu	2010	14		MOG
797	chr23	27882642	27882705	3500181268	63		27882642	27882705	8421504	1	63	0	p	350018126800015000	0-63		19050239		0022-1767	The Journal of Immunology	&#x03b3;-Aminobutyric Acid Transporter 1 Negatively Regulates T Cell-Mediated Immune Responses and Ameliorates Autoimmune Inflammation in the CNS	Wang	2008	6		MOG
797	chr23	27882642	27882705	3500180966	63		27882642	27882705	8421504	1	63	0	p	350018096600015009	0-63						Interleukin-1 Conjugates and Uses Thereof	Bachmann	2011	0		MOG
797	chr23	27882642	27882705	3500178872	63		27882642	27882705	8421504	1	63	0	p	350017887200015000	0-63						Th Cells in Peripheral Tolerance. I. Induction of Foxp-Positive Regulatory T Cells by Th Cells Derived from TGF- T Cell-Transgenic Mice--&#x300a;&#x514d;&#x75ab;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#	journal.9med.net	0	0		MOG
797	chr23	27882642	27882705	3500176393	63		27882642	27882705	8421504	1	63	0	p	350017639300015000	0-63		21804021	10.4049/jimmunol.1100333	0022-1767	The Journal of Immunology	Antiasthmatic Drugs Targeting the Cysteinyl Leukotriene Receptor 1 Alleviate Central Nervous System Inflammatory Cell Infiltration and Pathogenesis of Experimental Autoimmune Encephalomyelitis	Wang	2011	6		MOG
797	chr23	27882642	27882705	3500175965	63		27882642	27882705	8421504	1	63	0	p	350017596500015079	0-63						Antagonist anti-il-7 receptor antibodies and methods	Lin	2011	0		MOG
797	chr23	27882642	27882705	3500175316	63		27882642	27882705	8421504	1	63	0	p	350017531600015000	0-63		15294957		0022-1767	The Journal of Immunology	Estrogen Receptor &#x03b1; Signaling in Inflammatory Leukocytes Is Dispensable for 17&#x03b2;-Estradiol-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis	Garidou	2004	6		MOG
797	chr23	27882642	27882705	3500171976	63		27882642	27882705	8421504	1	63	0	p	350017197600015000	0-63			10.1371/journal.pone.0066772	1932-6203	PLOS ONE	PLOS ONE: CD8+ T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease	Tyler	2013	4		MOG
797	chr23	27882642	27882705	3500170258	63		27882642	27882705	8421504	1	63	0	p	350017025800015000	0-63		23011975	10.1002/eji.201242679	1521-4141	European Journal of Immunology	Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis - Wang - 2012 - European Journal of Immunology - Wiley Online Library	Wang	2013	0		MOG
797	chr23	27882642	27882705	3500169367	63		27882642	27882705	8421504	1	63	0	p	350016936700015044	0-63						DNA Vaccines, Methods and Protocols	www.scribd.com	0	0		MOG
797	chr23	27882642	27882705	3500165506	63		27882642	27882705	8421504	1	63	0	p	350016550600015012	0-63						THESE DE DOCTORAT DE L&#x2019;UNIVERSITE PIERRE ET MARIE CURIE	www.insermu698.fr	0	0		MOG
797	chr23	27882642	27882705	3500163533	63		27882642	27882705	8421504	1	63	0	p	350016353300015019	0-63						NPG.nature.vol.409.Issue.6816.Jan	www.scribd.com	0	0		MOG
797	chr23	27882642	27882705	3500159256	63		27882642	27882705	8421504	1	63	0	p	350015925600015017	0-63						MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500156891	63		27882642	27882705	8421504	1	63	0	p	350015689100015001	0-63						Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection	www.rsds.org	0	0		MOG
797	chr23	27882642	27882705	3500154964	63		27882642	27882705	8421504	1	63	0	p	350015496400015000	0-63						ScienceDirect.com - Immunity - T Cell Receptor CDR3 Sequence but Not Recognition Characteristics Distinguish Autoreactive Effector and Foxp3+ Regulatory T Cells	sciencedirect.com	0	0		MOG
797	chr23	27882642	27882705	3500151697	63		27882642	27882705	8421504	1	63	0	p	350015169700015000	0-63			10.1093/emboj/19.3.341		The EMBO Journal	Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination	Shin	2000	0		MOG
797	chr23	27882642	27882705	3500146611	63		27882642	27882705	8421504	1	63	0	p	350014661100015000	0-63		18974295	10.2353/ajpath.2008.080622		The American Journal of Pathology	NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora	Hiroaki	2008	0		MOG
797	chr23	27882642	27882705	3500142216	63		27882642	27882705	8421504	1	63	0	p	350014221600015001	0-63						A Suppressive Oligodeoxynucleotide Enhances the Ef&#xfb01;cacy of Myelin Cocktail/IL-4-Tolerizing DNA Vaccination and Treats Autoimmune Disease	nlab.stanford.edu	0	0		MOG
797	chr23	27882642	27882705	3500138141	63		27882642	27882705	8421504	1	63	0	p	350013814100015000	0-63						Down-regulation of Gfi -1 expression by TGF- is important for diff erentiation of Th17 and CD103 inducible regulatory T cells	jem.rupress.org	0	0		MOG
797	chr23	27882642	27882705	3500130475	63		27882642	27882705	8421504	1	63	0	p	350013047500015002	0-63						INDUCTION OF NEUROGENESIS AND STEM CELL THERAPY IN COMBINATION WITH COPOLYMER 1 - YEDA RESEARCH AND DEVELOPMENT CO. LTD.	www.sumobrain.com	0	0		MOG
797	chr23	27882642	27882705	3500130214	63		27882642	27882705	8421504	1	63	0	p	350013021400015002	0-63		21746882	10.1128/MCB.05020-11	0270-7306	Molecular and Cellular Biology	1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A	Joshi	2011	6		MOG
797	chr23	27882642	27882705	3500130207	63		27882642	27882705	8421504	1	63	0	p	350013020700015004	0-63		20937706	10.1084/jem.20100876	0022-1007	The Journal of Experimental Medicine	Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis	Pareek	2010	14		MOG
797	chr23	27882642	27882705	3500127649	63		27882642	27882705	8421504	1	63	0	p	350012764900015000	0-63		11544273	10.1172/JCI12976	0021-9738	The Journal of Clinical Investigation	Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection	Haskell	2001	13		MOG
797	chr23	27882642	27882705	3500119922	63		27882642	27882705	8421504	1	63	0	p	350011992200015088	0-63						COMPOSITIONS OF HSP60 PEPTIDES AND VIRAL ANTIGENS FOR VACCINATION AND DIAGNOSIS - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500119865	63		27882642	27882705	8421504	1	63	0	p	350011986500015002	0-63						REGULATORY B CELLS AND THEIR USES	Tedder	2009	0		MOG
797	chr23	27882642	27882705	3500118889	63		27882642	27882705	8421504	1	63	0	p	350011888900015004	0-63						Compositions and methods using recombinant MHC molecules for the treatment of stroke	Offner	2010	0		MOG
797	chr23	27882642	27882705	3500116340	63		27882642	27882705	8421504	1	63	0	p	350011634000015002	0-63		21807870	10.1084/jem.20110128	0022-1007	The Journal of Experimental Medicine	NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses	Hofmann	2011	14		MOG
797	chr23	27882642	27882705	3500112180	63		27882642	27882705	8421504	1	63	0	p	350011218000015000	0-63			10.1186/1471-2172-8-10		BMC Immunology	Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis	Madhuri	2007	0		MOG
797	chr23	27882642	27882705	3500108799	63		27882642	27882705	8421504	1	63	0	p	350010879900015000	0-63		22529957	10.1371/journal.pone.0034933		PLoS ONE	Tuftsin Promotes an Anti-Inflammatory Switch and Attenuates Symptoms in Experimental Autoimmune Encephalomyelitis	Muzhou	2012	0		MOG
797	chr23	27882642	27882705	3500107256	63		27882642	27882705	8421504	1	63	0	p	350010725600015003	0-63		18838544	10.1084/jem.20081212	0022-1007	The Journal of Experimental Medicine	CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming	Martin-Fontecha	2008	14		MOG
797	chr23	27882642	27882705	3500106218	63		27882642	27882705	8421504	1	63	0	p	350010621800015003	0-63		21987655	10.1084/jem.20100977	0022-1007	The Journal of Experimental Medicine	Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells	Ghoreschi	2011	14		MOG
797	chr23	27882642	27882705	3500102543	63		27882642	27882705	8421504	1	63	0	p	350010254300015001	0-63						Use of n-type calcium channel inhibitors in treating demyelinating diseases	Niidome	2004	0		MOG
797	chr23	27882642	27882705	3500098689	63		27882642	27882705	8421504	1	63	0	p	350009868900015001	0-63		21078888	10.1084/jem.20100703	0022-1007	The Journal of Experimental Medicine	Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling	Zhu	2010	14		MOG
797	chr23	27882642	27882705	3500096456	63		27882642	27882705	8421504	1	63	0	p	350009645600015000	0-63			10.1111/j.1476-5381.2009.00528.x		British Journal of Pharmacology	The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function	Jia	2009	0		MOG
797	chr23	27882642	27882705	3500096133	63		27882642	27882705	8421504	1	63	0	p	350009613300015004	0-63						Interleukin-1 Muteins Linked to Virus-Like Particles to Treat IL-1 Associated Diseases	Bachmann	2011	0		MOG
797	chr23	27882642	27882705	3500090951	63		27882642	27882705	8421504	1	63	0	p	350009095100015000	0-63		19411637	10.1182/blood-2008-12-192914	0006-4971	Blood	Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK	Jin	2009	10		MOG
797	chr23	27882642	27882705	3500090884	63		27882642	27882705	8421504	1	63	0	p	350009088400015000	0-63						Transgenic non-human Act1-deficient mammals and uses thereof	Li	2006	0		MOG
797	chr23	27882642	27882705	3500089838	63		27882642	27882705	8421504	1	63	0	p	350008983800015001	0-63		19234209	10.4049/jimmunol.0713169	0022-1767	The Journal of Immunology	Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response	Liston	2009	6		MOG
797	chr23	27882642	27882705	3500086543	63		27882642	27882705	8421504	1	63	0	p	350008654300015001	0-63		20696698	10.1084/jem.20092627	0022-1007	The Journal of Experimental Medicine	MHC class II&#x2013;restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell&#x2013;mediated autoimmunity	Irla	2010	14		MOG
797	chr23	27882642	27882705	3500086324	63		27882642	27882705	8421504	1	63	0	p	350008632400015000	0-63		12471103		0022-1767	The Journal of Immunology	The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease	Stuve	2002	6		MOG
797	chr23	27882642	27882705	3500084546	63		27882642	27882705	8421504	1	63	0	p	350008454600015000	0-63		23469037	10.1371/journal.pone.0057632		PLoS ONE	Functional Imaging of Rel Expression in Inflammatory Processes Using Bioluminescence Imaging System in Transgenic Mice	Xingyu	2013	0		MOG
797	chr23	27882642	27882705	3500079099	63		27882642	27882705	8421504	1	63	0	p	350007909900015004	0-63						Costimulatory Molecules and Uses Thereof - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500074110	63		27882642	27882705	8421504	1	63	0	p	350007411000015010	0-63						ANTIBODY RECOGNIZING C-DOMAIN OF MIDKINE - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500066265	63		27882642	27882705	8421504	1	63	0	p	350006626500015000	0-63			10.1084/jem.20050660		The Journal of Experimental Medicine	Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor	Yasuyuki	2005	0		MOG
797	chr23	27882642	27882705	3500063487	63		27882642	27882705	8421504	1	63	0	p	350006348700015076	0-63						METHODS FOR TREATING AUTOIMMUNE DISORDERS - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500063484	63		27882642	27882705	8421504	1	63	0	p	350006348400015006	0-63						&#x767d;&#x4ecb;&#x7d20;-1&#x5076;&#x8054;&#x7269;&#x53ca;&#x5176;&#x7528;&#x9014;	A*Di Suo Te 	2008	0		MOG
797	chr23	27882642	27882705	3500049914	63		27882642	27882705	8421504	1	63	0	p	350004991400015007	0-63						Use of statins and other immunomodulatory agents in the treatment of autoimmune disease	Steinman	2003	0		MOG
797	chr23	27882642	27882705	3500049808	63		27882642	27882705	8421504	1	63	0	p	350004980800015002	0-63						Compositions and Methods for Treating Neurodegenerating Diseases - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500048313	63		27882642	27882705	8421504	1	63	0	p	350004831300015009	0-63						Recombinant MHC molecules useful for manipulation of antigen-specific T-cells - Patent application	www.faqs.org	0	0		MOG
797	chr23	27882642	27882705	3500047281	63		27882642	27882705	8421504	1	63	0	p	350004728100015003	0-63						Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines	www.pnas.org	0	0		MOG
797	chr23	27882642	27882705	3500046993	63		27882642	27882705	8421504	1	63	0	p	350004699300015001	0-63		19136631	10.1073/pnas.0810769106	0027-8424	Proceedings of the National Academy of Sciences	CD40&#x2013;CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells	Iezzi	2009	10		MOG
797	chr23	27882642	27882705	3500028792	63		27882642	27882705	8421504	1	63	0	p	350002879200015000	0-63		20810983	10.4049/jimmunol.1001550		Journal of immunology (Baltimore, Md. : 1950)	Discrete TCR repertoires and CDR3 features distinguish effector and Foxp3+ regulatory T lymphocytes in MOG-EAE	Phuong	2010	0		MOG
797	chr23	27882642	27882705	3500027154	63		27882642	27882705	8421504	1	63	0	p	350002715400015000	0-63		17513712		0022-1767	The Journal of Immunology	Cutting Edge: CNS CD11c+ Cells from Mice with Encephalomyelitis Polarize Th17 cells and Support CD25+CD4+ T cell-Mediated Immunosuppression, Suggesting Dual Roles in the Disease Process	Deshpande	2007	6		MOG
797	chr23	27882642	27882705	3500018240	63		27882642	27882705	8421504	1	63	0	p	350001824000015000	0-63		20810983	10.4049/jimmunol.1001550	0022-1767	The Journal of Immunology	Discrete TCR Repertoires and CDR3 Features Distinguish Effector and Foxp3+ Regulatory T Lymphocytes in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Allergic Encephalomyelitis	Nguyen	2010	6		MOG
797	chr23	27882642	27882705	3500018085	63		27882642	27882705	8421504	1	63	0	p	350001808500015000	0-63						Cellular/Molecular MicroglialExpressionoftheB7FamilyMemberB7Homolog 1ConfersStrongImmuneInhibition:Implicationsfor ImmuneResponsesandAutoimmunityintheCNS	www.jneurosci.org	0	0		MOG
797	chr23	27882642	27882705	3500013073	63		27882642	27882705	8421504	1	63	0	p	350001307300015000	0-63		15696194	10.1172/JCI22982	0021-9738	The Journal of Clinical Investigation	The role of herpesvirus entry mediator as a negative regulator of T cell&#x2013;mediated responses	Wang	2005	13		MOG
797	chr23	27882642	27882705	3500012063	63		27882642	27882705	8421504	1	63	0	p	350001206300015017	0-63						Vaccine Comprising Il-12 Or Il-23 For Treatment Of Autoimmune Diseases 	.freshpatents.com	0	0		MOG
797	chr23	27882642	27882705	3500010910	63		27882642	27882705	8421504	1	63	0	p	350001091000015000	0-63						Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and In&#xfb02;ammatory Diseases	jem.rupress.org	0	0		MOG
797	chr23	27882642	27882705	3500006608	63		27882642	27882705	8421504	1	63	0	p	350000660800015000	0-63		19411637	10.1182/blood-2008-12-192914	0006-4971	Blood	Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK	Jin	2009	10		MOG
797	chr23	27882642	27882702	3500466395	60		27882642	27882702	8421504	1	60	0	p	350046639500015028	0-60						Methods of generating antigen-specific CD4+CD25+ regulatory T cells, compositions and methods of use	Buckner	2005	0		MOG
99	chr23	27905318	27932408	3500240668	3028		27905318	27932408	8421504	22	85,204,186,21,306,135,171,102,66,192,243,64,78,151,133,117,108,94,128,129,144,171	0,776,1739,3284,4672,8334,8848,10065,10595,11104,17319,18155,19672,21088,21684,23125,23344,23876,24643,25752,26070,26919	p	350024066800015047,350024066800015049	0-765,0-2532						Cell lines expressing gaba receptor and methods using them	Langer	2010	0		
99	chr23	27905318	27932408	3500131639	2883		27905318	27932408	8421504	22	85,204,186,21,161,135,171,102,66,192,243,64,78,151,133,117,108,94,128,129,144,171	0,776,1739,3284,4817,8334,8848,10065,10595,11104,17319,18155,19672,21088,21684,23125,23344,23876,24643,25752,26070,26919	p	350013163900015041,350013163900015043,350013163900015045,350013163900015044	0-2883,0-2697,0-1734,0-2793						Cell lines expressing gaba receptor and methods using them	Langer	2011	0		
797	chr23	27905394	27906172	3500196346	42		27905394	27906172	8421504	3	9,12,21	0,700,757	c,g	350019634600000011,350019634600000012,350019634600000012	0-21,0-21,0-21						Concerted Transcriptional Regulation by BRCA1 and COBRA1 in Breast Cancer Cells	www.ijbs.com	0	0		GABBR1
99	chr23	27916608	27922654	3500295037	23		27916608	27922654	8421504	2	6,17	0,6029	c	350029503700000010	0-23						Ein lokales GABAerges System in der Nebennierenrinde des Menschen und der Ratte	b.uni-muenchen.de	0	0		GABBR1
798	chr23	27922838	27922865	3500126685	24		27922838	27922865	8421504	2	11,13	0,14	c	350012668500000180	6-30						 DNA Sequences Encoding Polypeptides Having Beta 	www.docstoc.com	0	0		
798	chr23	27931388	27932279	3500380399	126		27931388	27932279	8421504	3	24,60,42	0,84,849	p,c	350038039900000001,350038039900015000	3-27,0-102						Truncated gabab receptor and methods of use thereof	Chung	2006	0		
798	chr23	27931472	27932279	3500312666	102		27931472	27932279	8421504	2	60,42	0,765	p	350031266600015001	0-102						Cross-Species and Multi-Species Display Systems - Patent application	www.faqs.org	0	0		GABBR1
798	chr23	27931472	27932279	3500293423	102		27931472	27932279	8421504	2	60,42	0,765	p	350029342300015000	0-102						Cross-species and multi-species display systems	Wang Kai Wen 	2009	0		GABBR1
798	chr23	27931472	27932279	3500120267	102		27931472	27932279	8421504	2	60,42	0,765	p	350012026700015001	0-102						Cross-species and multi-species display systems	Luo	2012	0		GABBR1
798	chr23	27931472	27932279	3500059039	102		27931472	27932279	8421504	2	60,42	0,765	p	350005903900015001	0-102						Cross-species and multi-species display systems	Luo	2012	0		GABBR1
798	chr23	27931481	27932279	3500009863	93		27931481	27932279	8421504	2	51,42	0,756	p,c	350000986300015037,350000986300015101,350000986300015004,350000986300015040,350000986300000033,350000986300000011	0-48,0-48,0-48,0-45,0-42,0-24						US Patent # 6,833,441. Compositions and methods for generating chimeric heteromultimers - Patents.com	www.patents.com	0	0		GABBR1
798	chr23	27931493	27932291	3500165172	93		27931493	27932291	8421504	2	39,54	0,744	p	350016517200015037	0-93						Die Rolle der 14-3-3-Proteine beim Vorw&#xe4;rtstransport von Kaliumkan&#xe4;len	uni-heidelberg.de	0	0		GABBR1
800	chr23	28227739	28227764	3500201388	23		28227739	28227764	8421504	2	14,9	0,16	g	350020138800000022,350020138800000144	0-24,0-24						Polypeptides And Antibodies 	.freshpatents.com	0	0		
801	chr23	28426388	28426416	3500105425	24		28426388	28426416	8421504	2	6,18	0,10	g	350010542500000019	15-39						Printable Version http://www.patentlens.net/daisy/promoters/ext/navaggregator/navaggr Promoters Used to Regulate Gene Expression	www.cambia.org.au	0	0		
804	chr23	28723438	28723463	3500125180	25		28723438	28723463	8421504	1	25	0	g	350012518000000000	0-25		22941645	10.1093/nar/gks798		Nucleic Acids Research	PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks	Jana	2012	0		NONO
806	chr23	29086196	29086256	3500414850	60		29086196	29086256	8421504	1	60	0	p	350041485000015034	0-60						Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. - ResearchGate	.researchgate.net	0	0		TRIM27
806	chr23	29086196	29086256	3500080266	60		29086196	29086256	8421504	1	60	0	p	350008026600015057	0-60						Genomicbinding-site cloningreveals anestrogen-responsive gene that encodes aRING fingerprotein	www.pnas.org	0	0		TRIM27
807	chr23	29098917	29099250	3500029726	270		29098917	29099250	8421504	6	45,45,45,45,45,45	0,48,96,192,240,288	p	350002972600015111,350002972600015112,350002972600015113,350002972600015115,350002972600015116,350002972600015117	0-45,0-45,0-45,0-45,0-45,0-45						NOVEL SNAKE TOXIN - Patent application	www.faqs.org	0	0		TRIM27
807	chr23	29205573	29205663	3500035977	89		29205573	29205663	8421504	2	73,16	0,74	g	350003597700000092,350003597700000094	10-114,10-114						t-RNA PRIMER, PRODUCTION AND USE FOR INHIBITING REVERSE TRANSCRIPTASE	Domdey	1999	0		
809	chr23	29426265	29426294	3500415826	24		29426265	29426294	8421504	2	13,11	0,18	c	350041582600000006	16-40						Methods - Investigation of PPAR delta as a pathogenic factor in psoriasis	diss.fu-berlin.de	0	0		
809	chr23	29456173	29456201	3500197770	23		29456173	29456201	8421504	3	4,6,13	0,5,15	g	350019777000000001	1-24		17085526	10.1152/ajplung.00135.2006		American Journal of Physiology - Lung Cellular and Molecular Physiology	Downregulation of PCNA potentiates p21-mediated growth inhibition in response to hyperoxia	Gehen	2007	0		
810	chr23	29574295	29574323	3500296662	23		29574295	29574323	8421504	3	11,6,6	0,14,22	g	350029666200000005	13-36						Immunocompromised ungulates	Ayares	2011	0		
813	chr23	29989685	29989710	3500133326	23		29989685	29989710	8421504	2	13,10	0,15	g	350013332600000054	0-23					Patent	Protein hydrolysates enriched in peptides having a carboxy terminal proline residue (Patent CN:100506981)	L*Yi Deng Si 	2009	0		
814	chr23	30023517	30023580	3500066566	63		30023517	30023580	8421504	1	63	0	p	350006656600015001	0-63						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		HIST1H2BN
814	chr23	30039285	30039311	3500349369	26		30039285	30039311	8421504	1	26	0	g	350034936900000011	0-26						Acyl-CoA:lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O palmitoylation to regulate mRNA synthesis	www.jbc.org	0	0		HIST2H3C
814	chr23	30043062	30043107	3500063454	45		30043062	30043107	8421504	1	45	0	p	350006345400015003	0-45						Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity	enesdev.cshlp.org	0	0		HIST1H2BM
814	chr23	30043098	30043161	3500454625	63		30043098	30043161	8421504	1	63	0	p	350045462500015001	0-63						3000151_DEFA4 103220-14-0;113255-28-0; 3000220_FOLH1 9074-87-7; 3000354_GDF1 138391-30-7; 3000355_GH	.biosemantics.org	0	0		MIR3143
814	chr23	30043098	30043161	3500414821	63		30043098	30043161	8421504	1	63	0	p	350041482100015120	0-63						Vivit Polypeptides, Therapeutic Agent Comprising The Same, And Method Of Screening For Anti-cancer Agent 	.freshpatents.com	0	0		
814	chr23	30043098	30043161	3500414025	63		30043098	30043161	8421504	1	63	0	p	350041402500015043,350041402500015072	0-63,0-63						Compositions and methods for promoting wound healing and tissue regeneration	Ghatnekar	2011	0		MIR3143
814	chr23	30043098	30043161	3500382571	63		30043098	30043161	8421504	1	63	0	p	350038257100015005	0-63						TTK as tumor marker and therapeutic target for lung cancer	Nakamura	2012	0		MIR3143
814	chr23	30043098	30043161	3500377058	63		30043098	30043161	8421504	1	63	0	p	350037705800015003	0-63						VIVIT POLYPEPTIDES, THERAPEUTIC AGENT COMPRISING THE SAME, AND METHOD OF SCREENING FOR ANTI-CANCER AGENT - Patent application	www.faqs.org	0	0		MIR3143
814	chr23	30043098	30043161	3500346493	63		30043098	30043161	8421504	1	63	0	p	350034649300015016	0-63						TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-ALPHA2 - Patent application	www.faqs.org	0	0		MIR3143
814	chr23	30043098	30043161	3500346273	63		30043098	30043161	8421504	1	63	0	p	350034627300015028	0-63						BLOCKADE OF TL1A-DR3 INTERACTIONS TO AMELIORATE T CELL MEDIATED DISEASE PATHOLOGY	Siegel	2008	0		MIR3143
814	chr23	30043098	30043161	3500337670	63		30043098	30043161	8421504	1	63	0	p	350033767000015005	0-63						METHOD FOR TREATING OR PREVENTING BLADDER CANCER USING THE DEPDC1 POLYPEPTIDE - ONCOTHERAPY SCIENCE, INC.	www.sumobrain.com	0	0		
814	chr23	30043098	30043161	3500332070	63		30043098	30043161	8421504	1	63	0	p	350033207000015109,350033207000015042	0-63,0-63						 Composition And Methods For Promoting Wound Healing And Tissue Regeneration 	www.docstoc.com	0	0		
814	chr23	30043098	30043161	3500318300	63		30043098	30043161	8421504	1	63	0	p	350031830000015059,350031830000015193,350031830000015138	0-63,0-48,0-63						COMPOSITIONS AND METHODS FOR MODULATING NOD-LIKE RECEPTOR ACTIVITY AND USES THEREOF - Patent application	www.faqs.org	0	0		
814	chr23	30043098	30043161	3500316176	63		30043098	30043161	8421504	1	63	0	p	350031617600015039,350031617600015005	0-63,0-54						Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex	Daigo	2008	0		MIR3143
814	chr23	30043098	30043161	3500306292	63		30043098	30043161	8421504	1	63	0	p	350030629200015000	0-63						Method for mass production of antimicrobial peptide	Kim	1999	0		MIR3143
814	chr23	30043098	30043161	3500259447	63		30043098	30043161	8421504	1	63	0	p	350025944700015031,350025944700015006	0-63,0-54						Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent	Inaki	2007	0		
814	chr23	30043098	30043161	3500257959	63		30043098	30043161	8421504	1	63	0	p	350025795900015107,350025795900015037	0-63,0-63						Composition and Methods for Promoting Wound Healing and tissue Regeneration	Ghatnekar	2008	0		MIR3143
814	chr23	30043098	30043161	3500230941	63		30043098	30043161	8421504	1	63	0	p	350023094100015002,350023094100015023	0-63,0-54						Treating or preventing cancers over-expressing reg4 or kiaa0101	Nakagawa	2008	0		
814	chr23	30043098	30043161	3500183031	63		30043098	30043161	8421504	1	63	0	p	350018303100015003	0-63						Screening method of anti-lung or esophageal cancer compounds	Daigo	2011	0		
814	chr23	30043110	30043161	3500426517	51		30043110	30043161	8421504	1	51	0	p	350042651700015118	0-51						Transport peptides such as C-terminal Erns peptide and analogues thereof	Langedijk	2002	0		MIR3143
814	chr23	30043287	30043332	3500337952	45		30043287	30043332	8421504	1	45	0	p	350033795200015072	0-45						New Fungal Production System - Patent application	www.faqs.org	0	0		HIST1H2AA
814	chr23	30043392	30043440	3500343021	48		30043392	30043440	8421504	1	48	0	p	350034302100015005,350034302100015026	0-48,0-48						AGENTS PROVIDING CONTROLS AND STANDARDS FOR IMMUNO-PRECIPITATION ASSAYS	Bernstein	2013	0		HIST1H3D
814	chr23	30046601	30046624	3500192319	23		30046601	30046624	8421504	1	23	0	g	350019231900000027	0-23		18237376	10.1186/1742-4690-5-9	1742-4690	Retrovirology	Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels	Bogenberger	2008	6		HIST2H3D
814	chr23	30083528	30083552	3500374355	23		30083528	30083552	8421504	2	11,12	0,12	g	350037435500000009	16-39						 Bacteriocins, Transport And Vector System And Method Of Use Thereof 	www.docstoc.com	0	0		
815	chr23	30274824	30274855	3500055299	27		30274824	30274855	8421504	3	6,16,5	0,8,26	c	350005529900000015	18-45						US Patent # 7,498,429. AHAS small subunit promoter - Patents.com	www.patents.com	0	0		
817	chr23	30469441	30469510	3500385351	69		30469441	30469510	8421504	1	69	0	p	350038535100015145	21-90						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZNF322
817	chr23	30469441	30469510	3500269504	69		30469441	30469510	8421504	1	69	0	p	350026950400015085	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZNF322
817	chr23	30469441	30469510	3500176901	69		30469441	30469510	8421504	1	69	0	p	350017690100015068	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZNF322
817	chr23	30469441	30469510	3500160097	69		30469441	30469510	8421504	1	69	0	p	350016009700015111	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZNF322
817	chr23	30469441	30469510	3500075471	69		30469441	30469510	8421504	1	69	0	p	350007547100015073	21-90						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZNF322
818	chr23	30578399	30578427	3500361350	27		30578399	30578427	8421504	2	9,18	0,10	c	350036135000000008	0-27						Nucleic acid accessible hybridization sites	Lyamichev	2001	0		
818	chr23	30578399	30578427	3500303116	27		30578399	30578427	8421504	2	9,18	0,10	c	350030311600000008	0-27						Nucleic acid accessible hybridization sites - US Patent 7060436 Description	ww.patentstorm.us	0	0		
818	chr23	30596615	30602891	3500203614	147		30596615	30602891	8421504	8	20,21,21,2,19,22,21,21	0,567,1129,1712,2117,4029,5697,6255	c,g	350020361400000012,350020361400000012,350020361400000008,350020361400000008,350020361400000006,350020361400000006,350020361400000007,350020361400000007,350020361400000005,350020361400000003,350020361400000004,350020361400000004,350020361400000009,350020361400000009,350020361400000002,350020361400000002	0-20,0-20,0-21,0-21,0-21,0-21,0-21,0-21,0-21,3-25,0-21,0-21,0-21,0-21,0-21,0-21		9461613	10.1074/jbc.273.7.4171	0021-9258	Journal of Biological Chemistry	Butyrophilin Is Expressed in Mammary Epithelial Cells from a Single-sized Messenger RNA as a Type I Membrane Glycoprotein	Banghart	1998	5		
818	chr23	30596859	30597097	3500016075	42		30596859	30597097	8421504	2	21,21	0,217	c,g	350001607500000139,350001607500000138,350001607500000138	0-21,0-21,0-21						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
818	chr23	30597272	30602757	3500197164	80		30597272	30602757	8421504	4	20,20,20,20	0,760,4908,5465	c,g	350019716400000004,350019716400000003,350019716400000002,350019716400000002,350019716400000001	0-20,0-20,0-20,0-20,0-20						AnnalsOfAnimalScience_2006_No1	www.scribd.com	0	0		
818	chr23	30597272	30602200	3500374871	60		30597272	30602200	8421504	3	20,20,20	0,760,4908	c,g	350037487100000003,350037487100000002,350037487100000001,350037487100000001	0-20,0-20,0-20,0-20						EFFECT OF POLYMORPHISM IN GENE BTN1A1 ON SOMATIC CELL COUNT IN MILK OF JERSEY COWS	al.pan.olsztyn.pl	0	0		
818	chr23	30597272	30602200	3500174592	60		30597272	30602200	8421504	3	20,20,20	0,760,4908	c	350017459200000004,350017459200000003,350017459200000002	0-20,0-20,0-20						ANNALS OF ANIMAL SCIENCE	www.biol.umk.pl	0	0		
818	chr23	30597948	30598281	3500029726	270		30597948	30598281	8421504	6	45,45,45,45,45,45	0,48,96,192,240,288	p	350002972600015126,350002972600015125,350002972600015124,350002972600015122,350002972600015121,350002972600015120	0-45,0-45,0-45,0-45,0-45,0-45						NOVEL SNAKE TOXIN - Patent application	www.faqs.org	0	0		
819	chr23	30772327	30789712	3500414085	109		30772327	30789712	8421504	3	20,20,69	0,13440,17316	p,c,g	350041408500000001,350041408500000002,350041408500015001	0-20,0-20,0-69						Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften an der Fakult&#xe4;t f&#xfc;r Biologie der Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen	b.uni-muenchen.de	0	0		HIST2H3C
819	chr23	30774128	30789709	3500285415	126		30774128	30789709	8421504	2	60,66	0,15515	p	350028541500015004,350028541500015002	0-60,0-66						DEPARTAMENTO DE LABORATORIO DE EPIGENATICA EPIGENETIC TRANSCRIPTIONAL REPRESSION OF TUMOR SUPPRESO	www.tdx.cat	0	0		
819	chr23	30785415	30785523	3500342139	108		30785415	30785523	8421504	1	108	0	p	350034213900015016	6-114						These Sandrine bis	esups.ups-tlse.fr	0	0		HIST1H2BH
819	chr23	30785418	30785463	3500063417	45		30785418	30785463	8421504	1	45	0	p	350006341700015230	0-45						Chromatin regulator genes - Patent # 7252968 - PatentGenius	.patentgenius.com	0	0		HIST3H3
819	chr23	30785418	30785463	3500062658	45		30785418	30785463	8421504	1	45	0	p	350006265800015004	0-45						ACTIVATION AND ACTIVATORS OF SIRT6 - Patent application	www.faqs.org	0	0		HIST3H3
819	chr23	30785442	30785493	3500174010	51		30785442	30785493	8421504	1	51	0	p	350017401000015002	0-51		15485804	10.1074/jbc.M409604200	0021-9258	Journal of Biological Chemistry	Substrate Specificity and Kinetic Mechanism of Mammalian G9a Histone H3 Methyltransferase	Patnaik	2004	5		HIST2H3C
819	chr23	30785442	30785490	3500425103	48		30785442	30785490	8421504	1	48	0	p	350042510300015006,350042510300015011	0-48,0-45			10.1111/j.1365-313X.2009.03861.x	1365-313X	The Plant Journal	Aurora1 phosphorylation activity on histone H3 and its cross-talk with other post-translational histone modifications in Arabidopsis - Demidov - 2009 - The Plant Journal - Wiley Online Library	Demidov	2009	0		HIST2H3C
819	chr23	30785640	30785718	3500338844	78		30785640	30785718	8421504	1	78	0	p	350033884400015011	0-78						NUCLEAR DIVISION OF Sarcocystis neurona	aeum.libs.uga.edu	0	0		HIST1H4A
819	chr23	30789643	30789700	3500112966	57		30789643	30789700	8421504	1	57	0	p	350011296600015000	0-57						Mutations in Saccharomyces cerevisiae Gene SIR2 Can Have Differential Effects on In Vivo Silencing Phenotypes and In Vitro Histone Deacetylation Activity	web.mit.edu	0	0		HIST2H3C
819	chr23	30789643	30789691	3500025867	48		30789643	30789691	8421504	1	48	0	p	350002586700015004	0-48		12486003	10.1093/emboj/cdf682	ERROR! NO ISSN	The EMBO Journal	In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation	Matsuyama	2002	0		HIST2H3C
819	chr23	30789812	30789872	3500174653	58		30789812	30789872	8421504	2	37,21	0,39	c	350017465300000009	0-59						Method for identifying and characterizing organisms	Jr	1984	0		
819	chr23	30789868	30789913	3500188111	45		30789868	30789913	8421504	1	45	0	p	350018811100015002	0-45						&#x4e3b;&#x9898;&#xff1a;Cells | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		HIST2H3C
820	chr23	30862767	30862875	3500430809	108		30862767	30862875	8421504	1	108	0	p	350043080900015051,350043080900015067	0-75,0-108						Patent Search: US Patent Number 8299236 - Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells	ww.archpatent.com	0	0		HIST1H2BC
820	chr23	30862767	30862875	3500208064	108		30862767	30862875	8421504	1	108	0	p	350020806400015042	0-108						COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY	Cui	2007	0		HIST1H2BC
820	chr23	30862767	30862875	3500188627	108		30862767	30862875	8421504	1	108	0	p	350018862700015059,350018862700015058	0-75,0-69						COMPOSITIONS AND METHODS FOR ENHANCING DELIVERY OF NUCLEIC ACIDS INTO CELLS AND FOR MODIFYING EXPRESSION OF TARGET GENES IN CELLS - Patent application	www.faqs.org	0	0		
820	chr23	30904300	30913964	3500394704	40		30904300	30913964	8421504	2	20,20	0,9644	c,g	350039470400000019,350039470400000018	0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
820	chr23	30904300	30913964	3500292483	40		30904300	30913964	8421504	2	20,20	0,9644	c,g	350029248300000019,350029248300000018,350029248300000018	0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
820	chr23	30913922	30914309	3500372576	291		30913922	30914309	8421504	3	81,51,159	0,87,228	p	350037257600015003,350037257600015002,350037257600015001,350037257600015004,350037257600015000	0-132,0-159,0-111,0-66,0-51						Histone h2a-derived peptides useful in gene delivery	Balicki	2001	0		HIST1H3H
820	chr23	30914201	30914255	3500030957	54		30914201	30914255	8421504	1	54	0	p	350003095700015008	0-54						Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex	Daigo	2007	0		HIST1H3H
821	chr23	30943373	30943400	3500392535	24		30943373	30943400	8421504	2	7,17	0,10	c	350039253500000007	15-41						Agonistic antibody directed against human thrombopoietin receptor	HAGIWARA	2008	0		
821	chr23	30943373	30943400	3500180724	24		30943373	30943400	8421504	2	7,17	0,10	c	350018072400000018	15-41						Agonist Antibody To Human Thrombopoietin Receptor 	.freshpatents.com	0	0		
821	chr23	30943373	30943400	3500137827	24		30943373	30943400	8421504	2	7,17	0,10	c	350013782700000018	15-41						Agonist antibody to human thrombopoietin receptor	Kai	2013	0		
821	chr23	30943373	30943400	3500044105	24		30943373	30943400	8421504	2	7,17	0,10	c	350004410500000020,350004410500000072	15-41,15-40						AGONIST ANTIBODY TO HUMAN THROMBOPOIETIN RECEPTOR - Patent application	www.faqs.org	0	0		
821	chr23	30943557	30943580	3500442861	23		30943557	30943580	8421504	1	23	0	c,g	350044286100000009,350044286100000009	0-23,0-23						REFERENCE MEASUREMENT SYSTEMS IN GENETIC TESTING: DEVELOPMENT OF DNA-BASED REFERENCE MATERIALS	.bibl.u-szeged.hu	0	0		
821	chr23	30954971	30954994	3500139219	23		30954971	30954994	8421504	1	23	0	c	350013921900000000	0-23		15840569	10.1074/jbc.M503676200	0021-9258	Journal of Biological Chemistry	Histone H1 Proteins Act As Receptors for the 987P Fimbriae of Enterotoxigenic Escherichia coli	Zhu	2005	5		
827	chr23	31758790	31758820	3500401291	25		31758790	31758820	8421504	3	12,7,6	0,16,24	g	350040129100000044	23-48						PORPHOBILINOGEN DEAMINASE GENE THERAPY - Patent application	www.faqs.org	0	0		
827	chr23	31809878	31836810	3500224553	99		31809878	31836810	8421504	3	20,22,57	0,20163,26875	g	350022455300000061,350022455300000128,350022455300000083,350022455300000143,350022455300000158	0-20,0-20,0-22,0-22,1-58						TEST FOR DETERMINING BLOOD TYPE IN THE CAT - Patent application	www.faqs.org	0	0		
829	chr23	32041390	32041414	3500161237	23		32041390	32041414	8421504	2	4,19	0,5	g	350016123700000038	3-26						US Patent # 6,683,165. Human gene relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
830	chr23	32145248	32149325	3500375699	157		32145248	32149325	8421504	3	30,75,52	0,31,4025	g	350037569900000033	11-168						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		ACOT13
831	chr23	32320413	32366289	3500068701	458		32320413	32366289	8421504	10	28,1,45,79,78,8,64,29,81,45	0,2552,2560,12627,24066,31272,34519,34589,39714,45831	p,c,g	350006870100000002,350006870100015007,350006870100000000,350006870100000000,350006870100015008,350006870100015009,350006870100000001,350006870100015001,350006870100015005,350006870100000003,350006870100000003,350006870100015006,350006870100015010	0-29,0-45,0-19,0-19,0-45,0-66,0-19,0-78,0-72,0-29,0-29,0-81,0-45					Patent	Glycosyl-phosphatidylinositol-specific phospholipase D (Patent US:5418147)	Huang	1995	0		
831	chr23	32366309	32366333	3500110636	23		32366309	32366333	8421504	2	12,11	0,13	c	350011063600000018	9-32						Protein expression system	Sgarlato	1999	0		
833	chr23	32581580	32581605	3500087139	25		32581580	32581605	8421504	1	25	0	g	350008713900000518	0-25						Full text of "Protocols_molecular_biology"	01.us.archive.org	0	0		
833	chr23	32608231	32608255	3500199770	24		32608231	32608255	8421504	1	24	0	c	350019977000000015	5-29						NUOVO PROTOCOLLO BASATO SULL&#x2019;ANALISI DEGLI SNPs APPLICATO ALLA TRACCIABILIT&#xc0; DELLA CARNE BOVINA	www.anabic.it	0	0		
835	chr23	32770528	32770553	3500360885	23		32770528	32770553	8421504	2	6,17	0,8	g	350036088500000141,350036088500000073	7-33,0-26						MEGANUCLEASE VARIANTS CLEAVING THE GENOME OF A PATHOGENIC NON-INTEGRATING VIRUS AND USES THEREOF	Choulika	2010	0		
837	chr23	33063826	33063852	3500139063	23		33063826	33063852	8421504	2	5,18	0,8	g	350013906300000010	0-23						Expression cassettes for seed-preferential expression in plants	Duwenig	2009	0		
839	chr23	33330494	33330522	3500301291	25		33330494	33330522	8421504	2	8,17	0,11	g	350030129100000009	0-25						REAGENTS AND METHODS FOR DETECTING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS - Genome, Institute Singapore OF.	www.sumobrain.com	0	0		
841	chr23	33590248	33590272	3500099527	23		33590248	33590272	8421504	2	4,19	0,5	g	350009952700000131	10-33						HIV envelopolype peptides	Berman	2001	0		
841	chr23	33642927	33643091	3500141583	40		33642927	33643091	8421504	2	20,20	0,144	g	350014158300000075,350014158300000074	0-20,0-20						Annealing control primer system for improving specificity of PCR amplification	www.seegene.com	0	0		
841	chr23	33662529	33662555	3500104992	23		33662529	33662555	8421504	2	7,16	0,10	g	350010499200000021	14-37						IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING - Patent application	www.faqs.org	0	0		
844	chr23	33975149	33976152	3500068065	62		33975149	33976152	8421504	3	22,20,20	0,945,983	c,g	350006806500000023,350006806500000005,350006806500000005,350006806500000004,350006806500000004	0-22,0-20,0-20,0-20,0-20						RESEARCH Open Access Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression	www.rbej.com	0	0		
844	chr23	33975149	33976114	3500020590	43		33975149	33976114	8421504	2	22,21	0,944	c	350002059000000016,350002059000000003	0-22,19-40						Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression. - ResearchGate	.researchgate.net	0	0		
844	chr23	33975285	33980027	3500237346	91		33975285	33980027	8421504	4	22,28,19,22	0,857,2757,4720	c,g	350023734600000004,350023734600000005,350023734600000006,350023734600000003,350023734600000003	0-22,0-28,0-19,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
846	chr23	34263040	34263086	3500237346	45		34263040	34263086	8421504	2	20,25	0,21	c,g	350023734600000007,350023734600000007,350023734600000008,350023734600000008	0-20,0-20,0-25,0-25						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
847	chr23	34471570	34471593	3500322635	23		34471570	34471593	8421504	1	23	0	g	350032263500000020	0-23						Antibodies to ccr2	A*La Ji Pa Er 	2011	0		
847	chr23	34471570	34471593	3500135720	23		34471570	34471593	8421504	1	23	0	g	350013572000000016,350013572000000089	0-23,0-23						ANTIBODIES TO CCR2 - Patent application	www.faqs.org	0	0		
848	chr23	34512527	34524903	3500068065	86		34512527	34524903	8421504	5	22,20,11,11,22	0,9149,9195,11190,12354	c,g	350006806500000020,350006806500000002,350006806500000002,350006806500000003,350006806500000021,350006806500000021	0-22,0-20,0-20,0-22,0-22,0-22						RESEARCH Open Access Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression	www.rbej.com	0	0		
848	chr23	34519447	34519798	3500169618	40		34519447	34519798	8421504	2	21,19	0,332	g	350016961800000003,350016961800000005	0-21,0-19		9508311		0095-1137	Journal of Clinical Microbiology	Detection of Cattle Naturally Infected with Anaplasma marginale in a Region of Endemicity by Nested PCR and a Competitive Enzyme-Linked Immunosorbent Assay Using Recombinant Major Surface Protein 5	Echaide	1998	4		
848	chr23	34519844	34519889	3500446771	45		34519844	34519889	8421504	1	45	0	p	350044677100015001	0-45						1 41 CCAACAGAGAGTCCTCACCCTGCGATCATTCCTCAATCCCC	www.docstoc.com	0	0		
848	chr23	34519854	34566483	3500336360	94		34519854	34566483	8421504	3	35,23,36	0,43842,46593	c	350033636000000015,350033636000000010,350033636000000009,350033636000000016,350033636000000008,350033636000000017	0-30,0-30,0-30,0-30,5-34,0-22						Zymogen activation system	Andrade-Gordon	2001	0		
848	chr23	34519854	34566483	3500202111	133		34519854	34566483	8421504	3	35,62,36	0,43803,46593	c	350020211100000061,350020211100000015,350020211100000010,350020211100000056,350020211100000038,350020211100000041,350020211100000040,350020211100000062,350020211100000016	0-30,0-28,1-29,0-30,4-99,4-99,4-99,0-30,0-30						Zymogen activation system - Patent # 6420157 - PatentGenius	.patentgenius.com	0	0		
848	chr23	34519854	34566483	3500102435	133		34519854	34566483	8421504	3	35,62,36	0,43803,46593	c,g	350010243500000062,350010243500000015,350010243500000057,350010243500000010,350010243500000041,350010243500000040,350010243500000038,350010243500000009,350010243500000056,350010243500000063,350010243500000016,350010243500000055,350010243500000008,350010243500000064,350010243500000017,350010243500000017	0-30,0-30,0-30,0-30,4-99,4-99,4-99,0-30,0-30,0-30,0-30,5-34,5-34,0-24,0-22,0-22						Zymogen activation system	Andrade-Gordon	2000	0		
848	chr23	34519854	34566483	3500093645	133		34519854	34566483	8421504	3	35,62,36	0,43803,46593	c	350009364500000061,350009364500000015,350009364500000056,350009364500000010,350009364500000038,350009364500000041,350009364500000040,350009364500000009,350009364500000055,350009364500000062,350009364500000016,350009364500000008,350009364500000054,350009364500000063,350009364500000017	0-30,0-30,0-30,0-30,4-99,4-99,4-99,0-30,0-30,0-30,0-30,5-34,5-34,0-24,0-22						Zymogen activation system	Andrade-Gordon	2002	0		
848	chr23	34519854	34566483	3500052462	133		34519854	34566483	8421504	3	35,62,36	0,43803,46593	c,g	350005246200000061,350005246200000061,350005246200000015,350005246200000015,350005246200000010,350005246200000056,350005246200000038,350005246200000041,350005246200000040,350005246200000062,350005246200000016,350005246200000008,350005246200000008,350005246200000054,350005246200000063,350005246200000063	0-30,0-30,0-28,0-28,0-28,0-30,4-99,4-99,4-99,0-30,0-30,3-32,3-32,5-34,0-24,0-24						Zymogen activation system - US Patent 6420157 Description	ww.patentstorm.us	0	0		
848	chr23	34519854	34566459	3500157878	65		34519854	34566459	8421504	3	35,18,12	0,43847,46593	c	350015787800000015,350015787800000010,350015787800000016	0-28,0-28,0-30					Patent	Zymogen activation system (Patent US:6420157)	Darrow	2002	0		
848	chr23	34519987	34521646	3500237346	52		34519987	34521646	8421504	3	30,1,21	0,33,1638	c,g	350023734600000002,350023734600000002,350023734600000001	0-30,0-30,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
848	chr23	34521676	34524904	3500020590	65		34521676	34524904	8421504	4	20,11,11,23	0,46,2041,3205	c,g	350002059000000001,350002059000000001,350002059000000002,350002059000000014	0-20,0-20,0-22,21-44						Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression. - ResearchGate	.researchgate.net	0	0		
848	chr23	34558060	34566480	3500126395	53		34558060	34566480	8421504	2	26,27	0,8393	c	350012639500000003,350012639500000002	16-42,9-36			10.1242/jcs.00047	0021-9533	Journal of Cell Science	Improperly folded green fluorescent protein is secreted via a non-classical pathway	Tanudji	2002	6		
848	chr23	34558060	34566475	3500175567	645		34558060	34566475	8421504	7	189,165,9,108,123,23,28	0,817,988,3025,5477,5636,8387	p	350017556700015033,350017556700015036,350017556700015039,350017556700015034	0-147,0-180,0-174,0-174						Methods in Molecular Biology Vol. 024 Computer Analysis of Sequence Data, Part1	www.scribd.com	0	0		
848	chr23	34558060	34566475	3500016261	495		34558060	34566475	8421504	4	189,114,164,28	0,817,5495,8387	p	350001626100015003	0-495						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> <HTML> <HEAD> <TITLE>Biochem	sor.chemi.muni.cz	0	0		
848	chr23	34558060	34563657	3500452698	513		34558060	34563657	8421504	12	117,69,18,30,30,21,45,9,96,12,18,48	0,120,817,847,880,925,952,3025,3037,5477,5528,5549	p	350045269800015092,350045269800015079	12-282,0-279						Fish_Physiology_1994_Vol_13_Molecular_Endocrinology_of_Fish | Nguyen Thanh Vu - Academia.edu	www.academia.edu	0	0		
848	chr23	34558060	34558086	3500452717	26		34558060	34558086	8421504	1	26	0	c	350045271700000003	16-42						The nonclassic secretion of thioredoxin is not sensitive to redox state	ll.physiology.org	0	0		
848	chr23	34558060	34558086	3500252650	26		34558060	34558086	8421504	1	26	0	c	350025265000000003	16-42						AD Award Number: DAMD17-01-1-0150 TITLE: The Non-Classical Secretion of Thioredoxin from Breast PRINCIPAL INVESTIGATOR: Steven L. Chuck, M.D. REPORT DATE: June 2 004	www.dtic.mil	0	0		
848	chr23	34558078	34563657	3500206656	417		34558078	34563657	8421504	10	51,90,24,21,45,45,12,36,45,48	0,54,147,799,823,871,967,3007,5483,5531	p	350020665600015060,350020665600015065,350020665600015064,350020665600015057,350020665600015053,350020665600015061	0-276,0-147,0-90,0-48,0-93,0-75						Use of anti-prolactin agents to treat proliferative conditions - Patent # 7115556 - PatentGenius	.patentgenius.com	0	0		
848	chr23	34558104	34563596	3500316258	44		34558104	34563596	8421504	2	22,22	0,5470	c	350031625800000001,350031625800000000	0-22,0-22		17785503	10.1152/ajpendo.00280.2007		American Journal of Physiology - Endocrinology and Metabolism	The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle	Erdmann	2007	0		
848	chr23	34558104	34563596	3500137385	44		34558104	34563596	8421504	2	22,22	0,5470	c	350013738500000001,350013738500000000	0-22,0-22		17785503	10.1152/ajpendo.00280.2007		American Journal of Physiology - Endocrinology and Metabolism	The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle	Erdmann	2007	0		
848	chr23	34558104	34563596	3500095051	44		34558104	34563596	8421504	2	22,22	0,5470	c	350009505100000001,350009505100000000	0-22,0-22						Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: evidence for autocrine effects	logy-journals.org	0	0		
848	chr23	34558104	34563596	3500010420	44		34558104	34563596	8421504	2	22,22	0,5470	c,g	350001042000000001,350001042000000001,350001042000000000,350001042000000000	0-22,0-22,0-22,0-22		17785503	10.1152/ajpendo.00280.2007		American Journal of Physiology - Endocrinology and Metabolism	The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle	Erdmann	2007	0		
848	chr23	34558104	34563596	3500007142	44		34558104	34563596	8421504	2	22,22	0,5470	c,g	350000714200000001,350000714200000001,350000714200000000,350000714200000000	0-22,0-22,0-22,0-22		17785503	10.1152/ajpendo.00280.2007		American Journal of Physiology - Endocrinology and Metabolism	The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle	Erdmann	2007	0		
848	chr23	34558242	34558871	3500326359	558		34558242	34558871	8421504	7	29,48,44,37,283,46,71	0,61,113,158,204,489,558	g	350032635900000001,350032635900000000	2-506,4-75						N6-Methyladenosine Residues an Intron-Specific Region Prolactin Pre-mRNA	mcb.asm.org	0	0		
848	chr23	34558818	34559112	3500362674	44		34558818	34559112	8421504	2	22,22	0,272	g	350036267400000001,350036267400000000	0-22,0-22			10.1111/j.1471-0307.2012.00875.x	1471-0307	International Journal of Dairy Technology	Prolactin gene polymorphism in Nili-Ravi buffaloes in relation to Sahiwal and Achai Cattle - ISHAQ - 2012 - International Journal of Dairy Technology - Wiley Online Library	ISHAQ	2013	0		
848	chr23	34558898	34559052	3500455388	46		34558898	34559052	8421504	2	24,22	0,132	c	350045538800000001,350045538800000000	0-24,2-24						&#x0421;&#x043f;&#x043e;&#x0441;&#x043e;&#x0431; &#x043e;&#x043f;&#x0440;&#x0435;&#x0434;&#x0435;&#x043b;&#x0435;&#x043d;&#x0438;&#x044f; &#x0433;&#x0435;&#x043d;&#x0435;&#x0442;&#x0438;&#x0447;&#x0435;&#x0441;&#x043a;&#x043e;&#x0433;&#x043e; &#x043f;&#x0	www.findpatent.ru	0	0		
848	chr23	34558898	34559052	3500438020	46		34558898	34559052	8421504	2	24,22	0,132	c	350043802000000005,350043802000000004	0-24,2-24						Serodiagnosis and molecular survey on leptospiral abortions in the dairy cattle of Tabriz	jvr.shirazu.ac.ir	0	0		
848	chr23	34558898	34559052	3500432996	46		34558898	34559052	8421504	2	24,22	0,132	c	350043299600000001,350043299600000000	0-24,2-24						Analysis of genetic variation at the prolactin-RsaI (PRL-RsaI) locus in Indian native cattle breeds (Bos indicus). - ResearchGate	.researchgate.net	0	0		
848	chr23	34558898	34559052	3500419099	46		34558898	34559052	8421504	2	24,22	0,132	c	350041909900000003,350041909900000002,350041909900000013	0-24,18-40,27-49						&#x0631;&#x062f; &#xfef2;&#xfef3;&#xfefc;&#xfeb3;&#x0648;&#xfeae;&#xfe91; &#x0648; &#xfef2;&#xfef3;&#xfe8e;&#xfef3;&#xfeae;&#xfe98;&#xfedb;&#xfe8e;&#xfe91;&#xfeee;&#xfee0;&#xfef4;&#xfb59;&#xfee4;&#xfedb; &#xfef2;&#xfedf;&#xfeee;&#xfedc;&#xfedf;&#xfeee;&#x	profdoc.um.ac.ir	0	0		
848	chr23	34558898	34559052	3500406028	46		34558898	34559052	8421504	2	24,22	0,132	c	350040602800000001,350040602800000000	0-24,2-24				1927-534X	International Journal of Molecular Zoology	Prolactin gene polymorphism and its associations with milk production traits in Frieswal cow	Bukhari	2013	0		
848	chr23	34558898	34559052	3500392209	46		34558898	34559052	8421504	2	24,22	0,132	c	350039220900000003,350039220900000002	0-24,2-24						&#x0418;&#x0417;&#x0414;&#x0410;&#x0422;&#x0415;&#x041b;&#x042c;&#x0421;&#x041a;&#x0418;&#x0419; &#x0414;&#x041e;&#x041c; &#x0410;&#x041a;&#x0410;&#x0414;&#x0415;&#x041c;&#x0418;&#x042f; &#x0415;&#x0421;&#x0422;&#x0415;&#x0421;&#x0422;&#x0412;&#x041e;&#x0	www.rae.ru/fs/pdf	0	0		
848	chr23	34558898	34559052	3500356296	46		34558898	34559052	8421504	2	24,22	0,132	c	350035629600000001,350035629600000000	0-24,2-24			10.5772/54756	978-953-51-0943-3		Prolactin	I.V.	2013	0		
848	chr23	34558898	34559052	3500331418	46		34558898	34559052	8421504	2	24,22	0,132	c,g	350033141800000004,350033141800000005,350033141800000005	0-24,2-24,2-24						m k Z j m d g Z b yf	csl.bas-net.by	0	0		
848	chr23	34558898	34559052	3500330018	46		34558898	34559052	8421504	2	24,22	0,132	c,g	350033001800000001,350033001800000000,350033001800000000	0-24,2-24,2-24				1794-4449	Revista Lasallista de Investigaci&#xf3;n	Revista Lasallista de Investigaci&#xf3;n - Efecto de la transici&#xf3;n adenina/guanina del gen de la prolactina bovina sobre caracter&#xed;sticas de importancia en producci&#xf3;n lechera	Echeverri	2010	0		
848	chr23	34558898	34559052	3500245680	46		34558898	34559052	8421504	2	24,22	0,132	c	350024568000000003,350024568000000002	0-24,2-24						Redalyc.KAPPA-CASEIN AND PRL-RSA I GENOTYPIC FREQUENCIES IN TWO RUSSIAN CATTLE BREEDS	redalyc.uaemex.mx	0	0		
848	chr23	34558898	34559052	3500235100	46		34558898	34559052	8421504	2	24,22	0,132	c	350023510000000001,350023510000000000	0-24,2-24						Associations between prolactin gene polymorphism and milk production in montebeliard cows	demicjournals.org	0	0		
848	chr23	34558898	34559052	3500195909	46		34558898	34559052	8421504	2	24,22	0,132	c	350019590900000001,350019590900000000	0-24,2-24						Genetic Analysis of Indian Cows	www.scribd.com	0	0		
848	chr23	34558898	34559052	3500164904	46		34558898	34559052	8421504	2	24,22	0,132	c,g	350016490400000001,350016490400000000,350016490400000000	0-24,2-24,2-24						Association of genetic variants of bovine prolactin with milk	www.docstoc.com	0	0		
848	chr23	34558898	34559052	3500097129	46		34558898	34559052	8421504	2	24,22	0,132	c	350009712900000003,350009712900000002,350009712900000013	0-24,18-40,27-49						&#x0631;&#x062f; &#xfef2;&#xfef3;&#xfefc;&#xfeb3;&#x0648;&#xfeae;&#xfe91; &#x0648; &#xfef2;&#xfef3;&#xfe8e;&#xfef3;&#xfeae;&#xfe98;&#xfedb;&#xfe8e;&#xfe91;&#xfeee;&#xfee0;&#xfef4;&#xfb59;&#xfee4;&#xfedb; &#xfef2;&#xfedf;&#xfeee;&#xfedc;&#xfedf;&#xfeee;&#x	pubj.ricest.ac.ir	0	0		
848	chr23	34563633	34566478	3500011545	40		34563633	34566478	8421504	2	20,20	0,2825	c,g	350001154500000007,350001154500000007,350001154500000006	0-20,0-20,10-30						ScienceDirect.com - Biophysical Journal - Green Fluorescent Protein as a Noninvasive Intracellular pH Indicator	sciencedirect.com	0	0		
848	chr23	34563648	34566475	3500356584	101		34563648	34566475	8421504	2	73,28	0,2799	p,g	350035658400015020,350035658400000011,350035658400015226,350035658400015009	0-96,23-96,0-45,0-84						RED-SHIFTED OPSIN MOLECULES AND USES THEREOF - Patent application	www.faqs.org	0	0		
848	chr23	34563648	34566475	3500161748	101		34563648	34566475	8421504	2	73,28	0,2799	p,g	350016174800000004,350016174800015004	23-96,0-84						Vol 463 7 January 2010 LETTERS	cneurobiology.org	0	0		
848	chr23	34563654	34566448	3500407219	66		34563654	34566448	8421504	2	65,1	0,2793	p	350040721900015000	30-96		20554759	10.1091/mbc.E10-03-0240	1059-1524	Molecular Biology of the Cell	Forced Homo- and Heterodimerization of All gp130-Type Receptor Complexes Leads to Constitutive Ligand-independent Signaling and Cytokine-independent Growth	Suthaus	2010	5		
848	chr23	34563657	34566475	3500461247	90		34563657	34566475	8421504	2	62,28	0,2790	p	350046124700015005,350046124700015073	0-90,0-48					Patent	Protese-activated receptor PAR4 (ZCHEMR2) (Patent US:6111075)	Foster	2000	0		
848	chr23	34563657	34566475	3500456553	90		34563657	34566475	8421504	2	62,28	0,2790	p	350045655300015001,350045655300015002	0-90,0-78		18587449	10.1038/bjp.2008.142	1476-5381	British Journal of Pharmacology	Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes - Liang - 2009 - British Journal of Pharmacology - Wiley Online Library	Liang	2008	0		
848	chr23	34563657	34566475	3500444606	90		34563657	34566475	8421504	2	62,28	0,2790	p	350044460600015001,350044460600015002	0-90,0-78		18587449	10.1038/bjp.2008.142		British Journal of Pharmacology	Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes	Y	June	0		
848	chr23	34563657	34566475	3500263505	90		34563657	34566475	8421504	2	62,28	0,2790	p	350026350500015000,350026350500015001,350026350500015173	30-120,30-111,0-45						Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection - Patent application	www.faqs.org	0	0		
848	chr23	34563657	34566475	3500205671	90		34563657	34566475	8421504	2	62,28	0,2790	p	350020567100015008	0-90						Protease-activated receptor PAR4 (ZCHEMR2)	Xu	1999	0		
848	chr23	34563657	34566475	3500055086	90		34563657	34566475	8421504	2	62,28	0,2790	p	350005508600015064,350005508600015007	9-60,0-90						US Patent # 7,084,253. Protease-activated receptor PAR4 (ZCHEMR2) - Patents.com	www.patents.com	0	0		
848	chr23	34563657	34563725	3500086756	68		34563657	34563725	8421504	1	68	0	g	350008675600000031	25-93						Suppression Of Postoperative Ileus 	.freshpatents.com	0	0		
848	chr23	34563657	34563681	3500216860	24		34563657	34563681	8421504	1	24	0	c	350021686000000010	0-24						ANTIBODIES TO CCR2 - PFIZER INC.	www.sumobrain.com	0	0		
848	chr23	34563657	34563681	3500101886	24		34563657	34563681	8421504	1	24	0	c	350010188600000010	0-24						Antibodies to ccr2	Gladue	2010	0		
848	chr23	34563666	34566475	3500275380	81		34563666	34566475	8421504	2	53,28	0,2781	p	350027538000015011	0-81						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
848	chr23	34563699	34566475	3500466340	48		34563699	34566475	8421504	2	20,28	0,2748	p	350046634000015073	0-48						Protease-activated receptor PAR4 ZCHEMR2	www.devileye.net	0	0		
848	chr23	34563699	34566475	3500166480	48		34563699	34566475	8421504	2	20,28	0,2748	p	350016648000015075	0-48						Protease-activated receptor PAR4 ZCHEMR2	Xu	2000	0		
848	chr23	34566529	34568712	3500299530	2183		34566529	34568712	8421504	1	2183	0	g	350029953000000030,350029953000000031,350029953000000009	26-2209,0-22,0-22						BOVINE POLYMORPHISMS AND METHODS OF PREDICTING BOVINE TRAITS - Patent application	www.faqs.org	0	0		
848	chr23	34566529	34567513	3500402520	981		34566529	34567513	8421504	3	590,57,334	0,591,650	g	350040252000000005,350040252000000003,350040252000000002,350040252000000001,350040252000000000	0-100,0-100,0-302,0-101,0-866						Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene	enesdev.cshlp.org	0	0		
848	chr23	34594990	34595017	3500282558	23		34594990	34595017	8421504	2	17,6	0,21	g	350028255800000000	5-28						Protofibril selective antibodies and the use thereof	Pettersson	2009	0		
848	chr23	34594990	34595017	3500233992	23		34594990	34595017	8421504	2	17,6	0,21	g	350023399200000000	5-28						Protofibril selective antibodies and the use thereof	Pettersson	2012	0		
851	chr23	34867424	34867451	3500105362	24		34867424	34867451	8421504	3	4,5,15	0,5,12	g	350010536200000059	1-25						Live attenuated vaccines	Browning	2010	0		
858	chr23	35876088	35876298	3500348080	165		35876088	35876298	8421504	2	60,105	0,105	p	350034808000015045,350034808000015047,350034808000015051	0-60,0-60,0-45						Compositions And Methods For The Therapy And Diagnosis Of Lung Cancer 	.freshpatents.com	0	0		
858	chr23	35876088	35876298	3500022835	165		35876088	35876298	8421504	2	60,105	0,105	p	350002283500015045,350002283500015047,350002283500015051	0-60,0-60,0-45						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER - Patent application	www.faqs.org	0	0		
858	chr23	35876088	35876148	3500112379	60		35876088	35876148	8421504	1	60	0	p	350011237900015017	0-60						Compositions and methods for the therapy and diagnosis of lung cancer	Bangur	2004	0		NRSN2
858	chr23	35876097	35876205	3500121763	108		35876097	35876205	8421504	1	108	0	p	350012176300015000	0-108						PCR Amplification of SRY-related Gene Sequences Reveals Evolutionary Conservation of the SRY-box Motif	genome.cshlp.org	0	0		LINC00340
858	chr23	35876145	35876247	3500329759	102		35876145	35876247	8421504	1	102	0	p	350032975900015001	0-102						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa hoc:"SRY-related genes in the genome of the rice &#xfb01;eld eel (Monopterus albus)" 	tailieu.vn/doc/ba	0	0		LINC00340
865	chr23	36825083	36825110	3500322636	23		36825083	36825110	8421504	2	15,8	0,19	g	350032263600000012,350032263600000007	17-45,11-39		21553115	10.1007/s10616-011-9357-6		Cytotechnology	A single plasmid transfection that offers a significant advantage associated with puromycin selection, fluorescence-assisted cell sorting, and doxycycline-inducible protein expression in mammalian cells	Takayuki	2011	0		
866	chr23	36880213	36887287	3500364541	40		36880213	36887287	8421504	3	20,19,1	0,3734,7073	c,g	350036454100000002,350036454100000002,350036454100000003	0-20,0-20,0-20		16909124	10.1038/sj.onc.1209817	0950-9232	Oncogene	Compensation and specificity of function within the E2F family	Kong	2006	6		E2F3
866	chr23	36880330	36887326	3500259965	40		36880330	36887326	8421504	2	19,21	0,6975	c,g	350025996500000005,350025996500000005,350025996500000004,350025996500000004	0-19,0-19,0-21,0-21		12682052	10.1074/jbc.M212612200	0021-9258	Journal of Biological Chemistry	Inhibition of E2F Abrogates the Development of Cardiac Myocyte Hypertrophy	Vara	2003	5		E2F3
866	chr23	36888819	36888966	3500352503	129		36888819	36888966	8421504	2	51,78	0,69	p	350035250300015015,350035250300015014	0-51,0-78						E2F AS A TARGET OF HORMONE REFRACTORY PROSTATE CANCER	Bertino	2011	0		E2F3
866	chr23	36889005	36890236	3500065187	24		36889005	36890236	8421504	2	20,4	0,1227	c	350006518700000014	18-42		16652153	10.1038/sj.onc.1209580	0950-9232	Oncogene	DNA-binding independent cell death from a minimal proapoptotic region of E2F-1	Bell	2006	6		
866	chr23	36960664	36960881	3500333637	40		36960664	36960881	8421504	2	20,20	0,197	c,g	350033363700000005,350033363700000005,350033363700000004	0-20,0-20,0-20		19917728	10.1128/MCB.00938-09	0270-7306	Molecular and Cellular Biology	E2F3 Is a Mediator of DNA Damage-Induced Apoptosis	Martinez	2010	6		E2F3
866	chr23	36960664	36960881	3500302284	40		36960664	36960881	8421504	2	20,20	0,197	c,g	350030228400000005,350030228400000005,350030228400000004,350030228400000004	0-20,0-20,0-20,0-20		19917728	10.1128/MCB.00938-09		Molecular and Cellular Biology	E2F3 Is a Mediator of DNA Damage-Induced Apoptosis 	Luis	2010	0		E2F3
866	chr23	36960804	36960864	3500213774	60		36960804	36960864	8421504	1	60	0	p	350021377400015002	0-60					Molecular and Cellular Biology	Identification of a Novel E2F3 Product Suggests a Mechanism for Determining Specificity of Repression by Rb Proteins	Gustavo	2000	0		E2F3
866	chr23	36960861	36960952	3500268189	39		36960861	36960952	8421504	2	19,20	0,71	c,g	350026818900000007,350026818900000006	0-19,0-20		20106982	10.1074/jbc.M109.091496		The Journal of Biological Chemistry	CDKN1C Negatively Regulates RNA Polymerase II C-terminal Domain Phosphorylation in an E2F1-dependent Manner	Yihong	2010	0		E2F3
868	chr23	37183413	37183438	3500299131	23		37183413	37183438	8421504	2	7,16	0,9	g	350029913100000012	2-25						Nucleic acids and proteins from streptococcus groups a & b	Telford	2001	0		
879	chr23	38579246	38579270	3500110587	23		38579246	38579270	8421504	2	5,18	0,6	c	350011058700000018	4-27					Patent	Human bikunin (Patent US:6583108)	Tamburini	2003	0		
880	chr23	38764501	38774280	3500282247	471		38764501	38774280	8421504	7	46,86,21,95,121,87,15	0,270,359,1826,2810,9674,9764	p	350028224700015002,350028224700015005,350028224700015004	0-471,0-378,0-390						Solution NMR structure of the N-terminal domain of the human DEK protein	tatic.msi.umn.edu	0	0		DEK
880	chr23	38764525	38766342	3500184556	66		38764525	38766342	8421504	4	22,2,27,15	0,246,329,1802	p	350018455600015001	0-66					Nucleic Acids Research	Transcriptional activation by AP-2&#x03b1; is modulated by the oncogene DEK	Monica	2003	0		DEK
880	chr23	38774346	38785770	3500023106	258		38774346	38785770	8421504	3	18,136,104	0,10850,11320	p	350002310600015046	0-258						NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS	Tainsky	2010	0		DEK
881	chr23	38840495	38854480	3500367715	468		38840495	38854480	8421504	6	65,93,133,53,75,49	0,1208,4287,8133,8833,13936	p	350036771500015014	0-468						Palaemonetes_pugio-Contig_560-v1 | MarineGenomics.org	arinegenomics.org	0	0		
881	chr23	38856574	38856652	3500223186	55		38856574	38856652	8421504	2	29,26	0,52	c	350022318600000019,350022318600000004	0-29,4-30						US Patent # 5,470,737. Stably-transformed cells expressing human thiopurine methyltransferase - Patents.com	www.patents.com	0	0		
881	chr23	38856574	38856652	3500013669	55		38856574	38856652	8421504	2	29,26	0,52	c	350001366900000019,350001366900000004	0-29,4-30						Stably-transformed cells expressing human thiopurine methyltransferase	Weinshilboum	1994	0		
883	chr23	39071485	39071511	3500206875	23		39071485	39071511	8421504	3	12,5,6	0,14,20	g	350020687500000040	4-30						Chimeric genes and methods for increasing the lysine and threonine content of the seeds of plants	Falco	2001	0		
884	chr23	39242713	39242739	3500414317	23		39242713	39242739	8421504	2	6,17	0,9	c	350041431700000122	8-35						US Patent # 7,408,100. Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene - Patents.com	www.patents.com	0	0		
889	chr23	39865288	39865317	3500020738	24		39865288	39865317	8421504	2	10,14	0,15	g	350002073800000018	0-24						Methods and compositions for protein expression and purification	Butt	2004	0		
889	chr23	39976293	39976320	3500245243	23		39976293	39976320	8421504	2	17,6	0,21	g	350024524300000159	20-43						Broad-spectrum delta-endotoxins	Gilmer	1999	0		
889	chr23	39976293	39976320	3500231031	23		39976293	39976320	8421504	2	17,6	0,21	g	350023103100000163	20-43						Broad-spectrum delta-endotoxins		1998	0		
892	chr23	40350107	40350131	3500399568	23		40350107	40350131	8421504	2	10,13	0,11	c	350039956800000067	0-23						Modified antibodies to prostate-specific membrane antigen and uses thereof	Bander	2002	0		
892	chr23	40350107	40350131	3500367555	23		40350107	40350131	8421504	2	10,13	0,11	c	350036755500000067	0-23						Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies	Bander	2003	0		
892	chr23	40350107	40350131	3500166660	23		40350107	40350131	8421504	2	10,13	0,11	c	350016666000000067	0-23						Modified antibodies to prostate-specific membrane antigen and uses thereof	Webb	2005	0		
893	chr23	40397550	40397577	3500359632	23		40397550	40397577	8421504	2	14,9	0,18	g	350035963200000002	3-26						Trypanosoma vivaxInfections: Pushing Ahead with Mouse Models for the Study of Nagana. I. Parasitological, Hematological and Pathological Parameters	www.pasteur.fr	0	0		
894	chr23	40560989	40561013	3500303497	24		40560989	40561013	8421504	1	24	0	c	350030349700000003	0-24						Supplemental Online Material Methods	dcentralcanada.ca	0	0		MYLIP
894	chr23	40560989	40561013	3500101724	24		40560989	40561013	8421504	1	24	0	c	350010172400000001	0-24						Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression	-publications.com	0	0		MYLIP
894	chr23	40578775	40578806	3500010815	27		40578775	40578806	8421504	3	7,8,12	0,10,19	g	350001081500000262	4-37						Polynucleotide encoding a propionibacterium linoleate isomerase and uses thereof	Rosson	2000	0		
897	chr23	41008338	41008365	3500164572	23		41008338	41008365	8421504	2	15,8	0,19	g	350016457200000001	19-44						Posttranscriptional Regulation of High-Affinity Sulfate Transporters in Arabidopsis by Sulfur Nutrition	www.jstor.org	0	0		
902	chr23	41576146	41576173	3500386203	23		41576146	41576173	8421504	3	5,12,6	0,8,21	g	350038620300000296	6-31						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
903	chr23	41787786	41787813	3500197427	24		41787786	41787813	8421504	2	7,17	0,10	g	350019742700000010,350019742700000009	0-24,0-24						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DT	www.plosone.org	0	0		
907	chr23	42217481	42222672	3500137193	40		42217481	42222672	8421504	2	20,20	0,5171	c	350013719300000013,350013719300000012	0-20,0-20						Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system	biomedcentral.com	0	0		
907	chr23	42217551	42219504	3500115369	31		42217551	42219504	8421504	2	8,23	0,1930	c	350011536900000018	13-44						Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds	Hauber	2001	0		
907	chr23	42219529	42219556	3500401170	23		42219529	42219556	8421504	2	13,10	0,17	g	350040117000000029	24-48						Polypeptide possessing protein disulfide isomerase activity gene encoding the same and process for producing the same	Yamada	1995	0		
907	chr23	42236410	42236439	3500386819	24		42236410	42236439	8421504	2	6,18	0,11	c	350038681900000180	6-30						Multi-functional chimeric hematopoietic receptor agonists	Feng	1998	0		
910	chr23	42682942	42682970	3500104717	25		42682942	42682970	8421504	2	6,19	0,9	g	350010471700000004	19-45						Optimierung einer Lipase aus Bacillus subtilis mit neuen Methoden der gerichteten Evolution	ni-duesseldorf.de	0	0		
911	chr23	42800168	42800216	3500314426	48		42800168	42800216	8421504	1	48	0	c	350031442600000031	0-48						TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER - Patent application	www.faqs.org	0	0		
919	chr23	43786299	43788756	3500063689	39		43786299	43788756	8421504	2	20,19	0,2438	c,g	350006368900000009,350006368900000008,350006368900000008	0-20,0-19,0-19						Prostaglandin F2tt Regulation of the Bovine Corpus Luteum Endothelin System: RESULTS | Methods of Treatment	-of-treatment.com	0	0		
919	chr23	43786461	43786620	3500017911	40		43786461	43786620	8421504	2	20,20	0,139	c,g	350001791100000005,350001791100000005,350001791100000004	0-20,0-20,0-20		18296510	10.1530/REP-07-0496	1470-1626	Reproduction	Prostaglandin F2&#x03b1; increases endothelial nitric oxide synthase in the periphery of the bovine corpus luteum: the possible regulation of blood flow at an early stage of luteolysis	Shirasuna	2008	3		
919	chr23	43786763	43792281	3500439208	42		43786763	43792281	8421504	2	22,20	0,5498	c,g	350043920800000002,350043920800000002,350043920800000000	0-22,0-22,0-20						Pulmonary Artery Adventitial Fibroblasts Cooperate with Vasa Vasorum Endothelial Cells to Regulate Vasa Vasorum Neovascularization 2006&#x5e74;&#x7b2c;168&#x5377;&#x7b2c;6&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
919	chr23	43786763	43792281	3500030860	42		43786763	43792281	8421504	2	22,20	0,5498	c,g	350003086000000002,350003086000000002,350003086000000000	0-22,0-22,0-20			10.2353/ajpath.2006.050754		The American Journal of Pathology	Pulmonary Artery Adventitial Fibroblasts Cooperate with Vasa Vasorum Endothelial Cells to Regulate Vasa Vasorum Neovascularization : A Process Mediated by Hypoxia and Endothelin-1	Neil	June	0		
919	chr23	43788827	43789006	3500049823	23		43788827	43789006	8421504	2	2,21	0,158	c	350004982300000000	1-24						Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase	ng.physiology.org	0	0		
919	chr23	43788828	43789009	3500343011	25		43788828	43789009	8421504	2	1,24	0,157	c	350034301100000008	8-33						COMPARATIVE MAPPING: HOMOLOGY WITHIN THE ORDER PERISSODACTYLA OF FOUR GENES LOCATED ON EQUUS CABALLUS CHROMOSOME 20	knowledge.uky.edu	0	0		EDN1
919	chr23	43790484	43790512	3500131006	28		43790484	43790512	8421504	1	28	0	c	350013100600000023	0-28						Role of Transcription Factors in the Pathomechanism of Cardiac Hypertrophy	phd.sote.hu	0	0		EDN1
919	chr23	43790497	43790557	3500384310	60		43790497	43790557	8421504	1	60	0	p	350038431000015060	0-60						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		EDN1
919	chr23	43792223	43792247	3500419992	24		43792223	43792247	8421504	1	24	0	c	350041999200000000	0-24		12618423	10.1152/ajplung.00215.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	Cyclooxygenase is regulated by ET-1 and MAPKs in peripheral lung microvascular smooth muscle cells	Chen	2003	0		EDN1
919	chr23	43792223	43792247	3500179763	24		43792223	43792247	8421504	1	24	0	c	350017976300000000	0-24		12618423	10.1152/ajplung.00215.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	Cyclooxygenase is regulated by ET-1 and MAPKs in peripheral lung microvascular smooth muscle cells	Chen	2003	0		EDN1
920	chr23	44027494	44027518	3500341139	24		44027494	44027518	8421504	1	24	0	g	350034113900000173	0-26						Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 - Patent application	www.faqs.org	0	0		
923	chr23	44422828	44422856	3500134395	23		44422828	44422856	8421504	2	16,7	0,21	g	350013439500000012	8-31						Polypeptides and polynucleotides from coagulase-negative staphylococci	Davis	2001	0		
923	chr23	44422828	44422856	3500028179	23		44422828	44422856	8421504	2	16,7	0,21	g	350002817900000243,350002817900000015,350002817900000247	8-31,8-31,8-31						Polypeptides And Polynucleotides From Coagulase-negative Staphylococci 	.freshpatents.com	0	0		
924	chr23	44512340	44512368	3500246693	23		44512340	44512368	8421504	2	7,16	0,12	g	350024669300000010	0-23						AdeIJK, a Resistance-Nodulation-Cell Division Pump Ef&#xfb02;uxing Multiple Antibiotics in Acinetobacter baumannii	aac.asm.org	0	0		
926	chr23	44802298	44802326	3500139055	23		44802298	44802326	8421504	2	8,15	0,13	g	350013905500000088	24-47					Patent	DNA encoding NV2 (long form) and carboxy truncated fragments thereof (Patent US:6146851)	Coyne	2000	0		
927	chr23	44851066	44851091	3500236344	25		44851066	44851091	8421504	1	25	0	c	350023634400000024	0-25						Double-muscling in mammals	Georges	2006	0		
928	chr23	45010340	45012812	3500156475	48		45010340	45012812	8421504	3	26,15,7	0,54,2465	c	350015647500000011,350015647500000009	0-26,0-22						REPRODUCTION	uction-online.org	0	0		
929	chr23	45144554	45144582	3500072920	25		45144554	45144582	8421504	3	7,6,12	0,9,16	c	350007292000000003	0-25						Transgenic microorganism provided with the ability to produce 1,3-butanediol, and usage therefor	Nakajima	2012	0		
930	chr23	45265290	45265313	3500016075	23		45265290	45265313	8421504	1	23	0	g	350001607500000022	0-23						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
930	chr23	45274894	45274917	3500188956	23		45274894	45274917	8421504	1	23	0	c	350018895600000003	18-41						Mucin biosynthesis in the bovine goblet cell induced by Cooperia oncophora infection. - ResearchGate	.researchgate.net	0	0		
930	chr23	45274894	45274917	3500053470	23		45274894	45274917	8421504	1	23	0	c	350005347000000004	18-41						Mucin biosynthesis in the bovine goblet cell induced by Cooperia oncophora infection	aldc.nal.usda.gov	0	0		
931	chr23	45383071	45399913	3500220883	116		45383071	45399913	8421504	5	29,28,7,23,29	0,4727,5115,8232,16813	c	350022088300000042,350022088300000044,350022088300000045,350022088300000043	0-29,0-28,0-30,0-29		16715130	10.1038/sj.onc.1209688	0950-9232	Oncogene	A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion	Takeuchi	2006	6		
931	chr23	45383071	45399913	3500006746	116		45383071	45399913	8421504	5	29,28,7,23,29	0,4727,5115,8232,16813	c	350000674600000042,350000674600000044,350000674600000045,350000674600000043	0-29,0-28,0-30,0-29		16715130	10.1038/sj.onc.1209688	0950-9232	Oncogene	A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion	Takeuchi	2006	6		
931	chr23	45383082	45399910	3500460806	46		45383082	45399910	8421504	2	20,26	0,16802	c	350046080600000000,350046080600000001	15-35,11-37			10.1359/jbmr.2004.19.2.245	1523-4681	Journal of Bone and Mineral Research	Negative Regulation of Chondrocyte Differentiation by Transcription Factor AP-2&#x03b1; - Huang - 2004 - Journal of Bone and Mineral Research - Wiley Online Library	Huang	2004	0		
931	chr23	45388153	45395641	3500391408	44		45388153	45395641	8421504	2	22,22	0,7466	c	350039140800000034,350039140800000092,350039140800000093	0-22,0-22,0-22						METHODS OF PREDICTING THERAPEUTIC EFFICACY OF CANCER THERAPY - Patent application	www.faqs.org	0	0		TFAP2A
931	chr23	45397630	45397654	3500342451	24		45397630	45397654	8421504	1	24	0	c	350034245100000004	24-48			10.1634/stemcells.2005-0038	1549-4918	STEM CELLS	Generation of Peripheral Sensory and Sympathetic Neurons and Neural Crest Cells from Human Embryonic Stem Cells - Pomp - 2005 - STEM CELLS - Wiley Online Library	Pomp	2005	0		TFAP2A
931	chr23	45397701	45399816	3500350912	40		45397701	45399816	8421504	2	20,20	0,2095	c,g	350035091200000002,350035091200000003,350035091200000003	0-20,0-20,0-20		18771418	10.1089/dna.2008.0766		DNA and Cell Biology	Regulation of the Mouse Treacher Collins Syndrome Homolog (Tcof1) Promoter Through Differential Repression of Constitutive Expression	Kathryn	2008	0		TFAP2A
931	chr23	45399658	45399829	3500351779	171		45399658	45399829	8421504	1	171	0	p	350035177900015010	171-342						DETERMINATION ET COMPARAISON DE NOEC &#xab; MATRICIELLES &#xbb; A L&#x2019;AIDE DE PUCES A ADN CHEZ DREISSENA POLYMORPHA ET MYTILUS EDULIS	ne-aval.crihan.fr	0	0		TFAP2A
931	chr23	45399882	45399910	3500350780	28		45399882	45399910	8421504	1	28	0	c	350035078000000003	0-28		21489314	10.1186/1471-2407-11-135	1471-2407	BMC Cancer	Increased expression of transcription factor TFAP2&#xce;&#xb1; correlates with chemosensitivity in advanced bladder cancer	Nordentoft	2011	3		
931	chr23	45399886	45399914	3500262540	28		45399886	45399914	8421504	1	28	0	c	350026254000000003	11-39		21940908	10.1093/carcin/bgr212		Carcinogenesis	Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells	PeB.	2011	0		TFAP2A
934	chr23	45767141	45767166	3500320705	23		45767141	45767166	8421504	2	11,12	0,13	g	350032070500000035	0-23						Fermentative glycerol-free ethanol production	An Dong Ni Si *J*A*Fan Ma Li Si 	2012	0		
934	chr23	45784026	45784051	3500238669	24		45784026	45784051	8421504	2	16,8	0,17	g	350023866900000313	13-37						Compositions, methods, and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals	Bates	2005	0		
944	chr23	47055019	47055042	3500335525	23		47055019	47055042	8421504	1	23	0	g	350033552500000018	1-24						Method of humanizing immune system molecules	H*C*Weng 	2005	0		
944	chr23	47055019	47055042	3500201243	23		47055019	47055042	8421504	1	23	0	g	350020124300000080,350020124300000012	1-24,1-24						COMPOSITIONS AND METHODS FOR TREATING COAGULATION RELATED DISORDERS - Patent application	www.faqs.org	0	0		
945	chr23	47230152	47230177	3500348581	23		47230152	47230177	8421504	2	5,18	0,7	c	350034858100000186	16-42						Use of Proteins as Demulsifying Agents - Patent application	www.faqs.org	0	0		
945	chr23	47230152	47230177	3500193766	23		47230152	47230177	8421504	2	5,18	0,7	c	350019376600000186	16-42						Use of Hydrophobin-Polypeptides and Conjugates From Hydrophobin-Polypeptides Having Active and Effect Agents and the Production Thereof and Use Thereof In the Cosmetic Industry - Patent application	www.faqs.org	0	0		
945	chr23	47244812	47244839	3500057001	24		47244812	47244839	8421504	2	9,15	0,12	g	350005700100000052,350005700100000129	4-26,26-48						Surface antigen	www.devileye.net	0	0		
946	chr23	47387502	47387550	3500259199	48		47387502	47387550	8421504	1	48	0	p	350025919900015012	0-48						Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in Endothelial Progenitor Cells	www.mcponline.org	0	0		TXNDC5
946	chr23	47392858	47392979	3500259232	121		47392858	47392979	8421504	1	121	0	c,g	350025923200000019,350025923200000019	0-122,0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
946	chr23	47392858	47392979	3500000589	121		47392858	47392979	8421504	1	121	0	c,g	350000058900000041,350000058900000041	0-122,0-122						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
946	chr23	47392981	47393007	3500154365	24		47392981	47393007	8421504	3	4,7,13	0,5,13	c	350015436500000034	7-35						Xenobiotic-metabolizing enzymes elevated in multiple mouse models of slow aging	lue.lib.umich.edu	0	0		
946	chr23	47394869	47404712	3500463073	631		47394869	47404712	8421504	7	178,108,49,50,108,30,108	0,246,504,1380,8917,9079,9735	g	350046307300000022,350046307300000020,350046307300000019,350046307300000017,350046307300000015,350046307300000014,350046307300000013,350046307300000011,350046307300000010,350046307300000009	0-178,0-54,0-54,5-54,4-54,0-54,0-54,24-54,0-54,0-54						 BMP 	www.docstoc.com	0	0		
946	chr23	47394869	47404712	3500362999	558		47394869	47404712	8421504	4	366,48,48,96	0,510,8953,9747	g	350036299900000023,350036299900000022,350036299900000021,350036299900000020,350036299900000018,350036299900000014,350036299900000010	0-218,0-52,0-48,0-48,0-48,0-48,0-117					Patent	Methods for producing BMP-7 proteins (Patent US:5366875)	Rosen	1994	0		
946	chr23	47394869	47404712	3500323542	812		47394869	47404712	8421504	5	375,87,50,192,108	0,471,1380,8917,9735	g	350032354200000022,350032354200000021,350032354200000020,350032354200000019,350032354200000018,350032354200000017,350032354200000015,350032354200000014,350032354200000013,350032354200000012,350032354200000011,350032354200000010,350032354200000009	0-188,0-58,0-54,0-54,0-54,0-54,4-54,0-54,0-54,0-54,24-54,0-54,0-54						Bmp-5 derivatives	Celeste	1992	0		
946	chr23	47394917	47403945	3500447411	172		47394917	47403945	8421504	6	20,42,30,21,26,33	0,435,480,1332,1356,8995	g	350044741100000027,350044741100000019,350044741100000018,350044741100000017,350044741100000015,350044741100000014,350044741100000012	0-20,0-21,0-21,0-30,0-21,4-30,0-33						Osteoinductive compositions	Celeste	1990	0		
946	chr23	47394917	47396270	3500090126	113		47394917	47396270	8421504	4	20,42,30,21	0,435,480,1332	g	350009012600000027,350009012600000019,350009012600000018,350009012600000017,350009012600000015	0-20,0-21,0-21,0-30,0-21						Osteoinductive compositions	Celeste	1990	0		
946	chr23	47395116	47432266	3500168337	751		47395116	47432266	8421504	6	128,111,77,199,147,89	0,224,1103,8663,9465,37061	g	350016833700000066,350016833700000071,350016833700000067,350016833700000068,350016833700000069,350016833700000070	8-407,0-752,42-440,92-491,126-524,54-422						Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		
946	chr23	47395130	47396299	3500391943	140		47395130	47396299	8421504	5	21,42,30,21,26	0,222,267,1119,1143	g	350039194300000021,350039194300000019,350039194300000018,350039194300000017,350039194300000015,350039194300000014	0-21,0-21,0-21,0-30,0-21,4-30						Osteoinductive compositions	Celeste	1991	0		
947	chr23	47554616	47554641	3500203533	25		47554616	47554641	8421504	1	25	0	g	350020353300000128	18-43						US Patent # 5,468,845. Antibodies to osteogenic proteins - Patents.com	www.patents.com	0	0		
947	chr23	47554803	47554847	3500391943	41		47554803	47554847	8421504	2	33,8	0,36	g	350039194300000074	4-45						Osteoinductive compositions	Celeste	1991	0		
950	chr23	47853044	47853069	3500133350	24		47853044	47853069	8421504	2	18,6	0,19	g	350013335000000221	16-40						Fen-1 endonucleases, mixtures and cleavage methods	Kaiser	1998	0		
953	chr23	48259936	48260180	3500166204	81		48259936	48260180	8421504	6	9,8,18,18,12,16	0,22,53,90,158,228	g	350016620400000052	202-319						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
954	chr23	48458423	48466946	3500392970	23		48458423	48466946	8421504	2	7,16	0,8507	c	350039297000000023	0-23						Probiotic Bacteria Enhance the Antibacterial Barrier of Enterocytes: Insights into Their Mechanism of Action	.uni-hohenheim.de	0	0		
957	chr23	48840052	48845999	3500367934	64		48840052	48845999	8421504	4	21,22,2,19	0,43,66,5928	c	350036793400000093,350036793400000095,350036793400000096	0-21,0-22,0-22						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
958	chr23	48942235	48945751	3500280926	261		48942235	48945751	8421504	2	119,142	0,3374	p	350028092600015001	0-261						Methods and compositions for soluble CPG15 - Patent application	www.faqs.org	0	0		NRN1
958	chr23	48945652	48945697	3500145705	45		48945652	48945697	8421504	1	45	0	p	350014570500015000	0-45		9122250		0027-8424	Proceedings of the National Academy of Sciences	Neuritin: A gene induced by neural activity and neurotrophins that&#x2009;promotes&#x2009;neuritogenesis	Naeve	1997	10		NRN1
964	chr23	49727087	49727116	3500425740	27		49727087	49727116	8421504	3	9,5,13	0,10,16	g	350042574000000090,350042574000000010	3-33,3-33						MN gene and protein - US Patent 7713704 Description	ww.patentstorm.us	0	0		
966	chr23	50025211	50025243	3500380283	26		50025211	50025243	8421504	4	6,4,4,12	0,10,15,20	c	350038028300000090	14-40						TARGETED THERAPEUTIC PROTEINS - Patent application	www.faqs.org	0	0		
966	chr23	50025211	50025243	3500265346	26		50025211	50025243	8421504	4	6,4,4,12	0,10,15,20	c	350026534600000083	14-40						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
966	chr23	50025211	50025243	3500160759	26		50025211	50025243	8421504	4	6,4,4,12	0,10,15,20	c	350016075900000083	14-40						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
966	chr23	50025211	50025243	3500125607	26		50025211	50025243	8421504	4	6,4,4,12	0,10,15,20	c	350012560700000082	14-40						Method for targeting lysosomal enzymes - Patent application	www.faqs.org	0	0		
966	chr23	50068987	50069016	3500067132	25		50068987	50069016	8421504	3	5,5,15	0,7,14	c	350006713200000002	0-25						Expression, purification and functional characterization of recombinant human acyl-CoA-binding protein (ACBP) from erythroid cells	www.actabp.pl	0	0		MPP1
968	chr23	50256102	50256133	3500099344	25		50256102	50256133	8421504	3	6,14,5	0,11,26	g	350009934400000077,350009934400000062	17-42,23-42						T cell epitopes of ryegrass pollen allergen	Griffith	1995	0		
121	chr23	50444649	50483668	3500334898	1335		50444649	50483668	8421504	4	57,109,111,1058	0,804,1183,37961	p	350033489800015000	0-1335						KEGG T01001: 347733	www.genome.jp	0	0		
969	chr23	50444664	50445861	3500392330	180		50444664	50445861	8421504	3	42,109,29	0,789,1168	p	350039233000015020	0-180						Planaria EST Database	an.bio.keio.ac.jp	0	0		TUBB2A
121	chr23	50445930	50482732	3500440817	135		50445930	50482732	8421504	2	13,122	0,36680	p	350044081700015014	0-135						Phakopsora pachyrhizi	www.tede.ufv.br	0	0		TUBB4B
121	chr23	50446376	50482845	3500105107	40		50446376	50482845	8421504	2	20,20	0,36449	c,g	350010510700000012,350010510700000013	0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		
121	chr23	50447250	50483290	3500123358	96		50447250	50483290	8421504	2	48,48	0,35992	c,g	350012335800000093,350012335800000086	0-48,0-48					Patent	53BP2 complexes (Patent US:5977311)	Nandabalan	1999	0		
970	chr23	50482704	50482845	3500412680	40		50482704	50482845	8421504	2	20,20	0,121	c	350041268000000012,350041268000000013	0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		
970	chr23	50482804	50483056	3500122305	108		50482804	50483056	8421504	2	33,75	0,177	p	350012230500015000	0-108		20388783	10.1158/0008-5472.CAN-09-2631		Cancer research	Proteomic Characterization of Novel Alternative Splice Variant Proteins in HER2/neu-induced Breast Cancers	Rajasree	2010	0		TUBB4B
970	chr23	50482991	50483014	3500310797	23		50482991	50483014	8421504	1	23	0	c	350031079700000079,350031079700000029	0-23,0-23						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS - Patent application	www.faqs.org	0	0		TUBB2A,TUBB3
970	chr23	50482991	50483014	3500003314	23		50482991	50483014	8421504	1	23	0	c	350000331400000029	0-23						Treatment of neurological disorders with haematopoietic growth factors	Schaebitz	2007	0		TUBB2A
970	chr23	50483601	50483624	3500425023	23		50483601	50483624	8421504	1	23	0	c	350042502300000025,350042502300000006	0-21,20-43						NON-TUMORIGENIC EXPANSION OF PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		TUBB2B
970	chr23	50483630	50483653	3500245307	23		50483630	50483653	8421504	1	23	0	c	350024530700000015	0-23						Induktion der Differenzierung von slender-Formen	.uni-tuebingen.de	0	0		
970	chr23	50484794	50484820	3500184837	24		50484794	50484820	8421504	3	14,3,7	0,15,19	c	350018483700000002	20-44						ALBUMIN VARIANTS - NOVOZYMES BIOPHARMA DK A/S	www.sumobrain.com	0	0		
970	chr23	50520698	50522106	3500175024	49		50520698	50522106	8421504	3	12,11,26	0,1330,1382	c	350017502400000027,350017502400000026	0-23,0-26						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
970	chr23	50579367	50579394	3500088774	25		50579367	50579394	8421504	2	7,18	0,9	c	350008877400000003	3-29		21517847	10.1111/j.1471-4159.2011.07282.x	1471-4159	Journal of Neurochemistry	NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted-In-Schizophrenia 1 (DISC1) - Namba - 2011 - Journal of Neurochemistry - Wiley Online Library	Namba	2011	0		
970	chr23	50579425	50583811	3500251195	60		50579425	50583811	8421504	2	50,10	0,4376	p	350025119500015002	0-60						Unexpectedgeneticandstructuralrelationshipsofa long-forgottenflavoenzymetoNAD(P)H:quinone reductase(DT-diaphorase)	www.pnas.org	0	0		
971	chr23	50689310	50689337	3500389752	24		50689310	50689337	8421504	2	18,6	0,21	c	350038975200000225	2-28						Double-stranded nucleic acid	Graham	2004	0		
971	chr23	50689310	50689337	3500218240	24		50689310	50689337	8421504	2	18,6	0,21	c	350021824000000453,350021824000000235	2-28,2-28						DOUBLE-STRANDED NUCLEIC ACID - Patent application	www.faqs.org	0	0		
971	chr23	50689415	50689441	3500289844	24		50689415	50689441	8421504	2	12,12	0,14	g	350028984400000006	5-35						Recombinant baculovirus insecticides - Patent # 6096304 - PatentGenius	.patentgenius.com	0	0		
971	chr23	50709830	50709863	3500348195	25		50709830	50709863	8421504	3	11,8,6	0,14,27	g	350034819500000063	0-27						 Nucleic Acid Probes For Detection And/or Quantitation Of Non 	www.docstoc.com	0	0		
971	chr23	50709830	50709863	3500329959	25		50709830	50709863	8421504	3	11,8,6	0,14,27	g	350032995900000130	0-27					Patent	Nucleic acid probes for detection and/or quantitation of non-viral organisms (Patent EP:0272009)	Hogan	2007	0		
971	chr23	50709830	50709863	3500301216	25		50709830	50709863	8421504	3	11,8,6	0,14,27	g	350030121600000063	0-27						US Patent # 5,547,842. Nucleic acid probes for detection and/or quantitation of non-viral organisms - Patents.com	www.patents.com	0	0		
971	chr23	50709830	50709863	3500199250	25		50709830	50709863	8421504	3	11,8,6	0,14,27	g	350019925000000059	0-27						Nucleic acid probes and methods for detecting Proteus mirabilis	Hogan	1995	0		
971	chr23	50709830	50709863	3500035630	25		50709830	50709863	8421504	3	11,8,6	0,14,27	g	350003563000000052	0-27						 Oligonucleotide Probes For The Detection And/or Quantitation Of Non 	www.docstoc.com	0	0		
971	chr23	50719612	50719636	3500057209	24		50719612	50719636	8421504	1	24	0	c	350005720900000001	0-24						The article title; Authors Affiliations: Running head Correspondence should be addressed to Yuji Naito	gi.physiology.org	0	0		
971	chr23	50722323	50722354	3500064429	31		50722323	50722354	8421504	1	31	0	c	350006442900000007	4-35						Human monocyte elastase inhibitor - US Patent 5663299 Description	ww.patentstorm.us	0	0		
972	chr23	50751778	50755798	3500233361	23		50751778	50755798	8421504	3	11,2,10	0,4003,4010	c	350023336100000185	10-44						TNF binding proteins - US Patent 7238776 Description	ww.patentstorm.us	0	0		
972	chr23	50812678	50812702	3500133170	23		50812678	50812702	8421504	2	6,17	0,7	g	350013317000000007	13-39		18669441	10.1261/rna.993608		RNA	A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication	Byung-Hak	2008	0		
976	chr23	51260171	51260202	3500446081	31		51260171	51260202	8421504	1	31	0	c	350044608100000070	1-32						Antibody Composition-Producing Cell - Patent application	www.faqs.org	0	0		
976	chr23	51260171	51260202	3500016481	31		51260171	51260202	8421504	1	31	0	c	350001648100000070	1-32						GLYCOENGINEERED, RECOMBINANT ANTIBODY - Patent application	www.faqs.org	0	0		
976	chr23	51260173	51260202	3500386326	29		51260173	51260202	8421504	1	29	0	c	350038632600000069	0-29						 Antibody Composition 	www.docstoc.com	0	0		
976	chr23	51260218	51261678	3500124002	48		51260218	51261678	8421504	2	43,5	0,1455	c	350012400200000016	0-48						PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION - Patent application	www.faqs.org	0	0		
976	chr23	51356101	51378098	3500124002	33		51356101	51378098	8421504	2	4,29	0,21968	c	350012400200000025	15-48						PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION - Patent application	www.faqs.org	0	0		
976	chr23	51356715	51356744	3500059269	25		51356715	51356744	8421504	2	13,12	0,17	g	350005926900000030	3-28						Protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof	Yamaguchi	2000	0		
976	chr23	51366753	51366779	3500066081	23		51366753	51366779	8421504	2	6,17	0,9	g	350006608100000045	22-45						US Patent # 7,235,712. Bacterial isolates of the genus Klebiella, and an isomaltulose synthase gene isolated therefrom - Patents.com	www.patents.com	0	0		
979	chr23	51756848	51756873	3500339481	23		51756848	51756873	8421504	2	7,16	0,9	g	350033948100000031,350033948100000030	0-23,9-30						Mutant Receptors And Their Use In A Nuclear Receptor-based Inducible Gene Expression System 	.freshpatents.com	0	0		
982	chr23	52113818	52114022	3500343734	25		52113818	52114022	8421504	4	6,6,2,11	0,9,17,193	c	350034373400000581	7-33					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
982	chr23	52113818	52114022	3500190760	25		52113818	52114022	8421504	4	6,6,2,11	0,9,17,193	c	350019076000000581	7-33						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
586	chr24	158786	163503	3500354385	46		158786	163503	8421504	3	21,14,11	0,93,4706	c	350035438500000003,350035438500000002	0-21,0-25						METHOD FOR DIAGNOSING AND MONITORING SCHIZOPHRENIA AND TAUOPATHIES	Gozes	2011	0		ADNP2
586	chr24	261373	261397	3500086618	24		261373	261397	8421504	1	24	0	c	350008661800000041	20-44						Identification of JAK/STAT pathway modulating genes by genome wide RNAi screening	Boutros	2006	0		
586	chr24	261374	261397	3500104992	23		261374	261397	8421504	1	23	0	c	350010499200000041	20-43						IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING - Patent application	www.faqs.org	0	0		
586	chr24	261374	261397	3500014152	23		261374	261397	8421504	1	23	0	c	350001415200000003	0-23						Materials and Methods Bacterial and eukaryotic cell growth conditions. Listeria monocytogenes	h.med.harvard.edu	0	0		
588	chr24	444608	444632	3500338425	23		444608	444632	8421504	2	11,12	0,12	g	350033842500000009	0-23						Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification	Rush	2009	0		
588	chr24	444608	444632	3500213482	23		444608	444632	8421504	2	11,12	0,12	g	350021348200000012	0-23					Patent	Aldehyde tags, uses thereof in site-specific protein modification (Patent US:8097701)	Bertozzi	2012	0		
588	chr24	444608	444632	3500180486	23		444608	444632	8421504	2	11,12	0,12	g	350018048600000010	0-23						Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification	Bertozzi	2008	0		
589	chr24	528244	528274	3500134317	25		528244	528274	8421504	2	12,13	0,17	g	350013431700000413,350013431700000197	0-25,11-36						Perhydrolase 	.freshpatents.com	0	0		
589	chr24	570846	571907	3500446285	44		570846	571907	8421504	2	10,34	0,1027	c	350044628500000088	0-44						NF-AT polynucleotides	Crabtree	1998	0		
589	chr24	574134	584856	3500152152	40		574134	584856	8421504	2	20,20	0,10702	c,g	350015215200000007,350015215200000007,350015215200000006,350015215200000006	0-20,0-20,0-20,0-20						Functional effect of mir-27b on myostatin expression: a relationship in piedmontese cattle with double-muscled phenotype	biomedcentral.com	0	0		
73	chr24	627799	673556	3500383915	38		627799	673556	8421504	4	12,7,12,7	0,14,45736,45750	g	350038391500000333,350038391500000092	0-19,0-19						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
589	chr24	630253	630281	3500365031	23		630253	630281	8421504	2	13,10	0,18	c	350036503100000193	11-34						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
589	chr24	630253	630281	3500326924	23		630253	630281	8421504	2	13,10	0,18	c	350032692400000193	11-34						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
590	chr24	672745	672771	3500254275	24		672745	672771	8421504	3	14,5,5	0,15,21	g	350025427500000002	0-26			10.1110/ps.072894407	1469-896X	Protein Science	A rapid and universal tandem-purification strategy for recombinant proteins - McCluskey - 2009 - Protein Science - Wiley Online Library	McCluskey	2007	0		
593	chr24	1056113	1056137	3500423725	23		1056113	1056137	8421504	2	5,18	0,6	g	350042372500000168	9-34					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
594	chr24	1188900	1188934	3500442426	26		1188900	1188934	8421504	3	11,8,7	0,14,27	g	350044242600000008	0-26						Gene encoding protein antigens of Plasmodium falciparum and uses therefor	Inselburg	1994	0		
594	chr24	1223080	1223108	3500252168	23		1223080	1223108	8421504	2	8,15	0,13	g	350025216800000079	2-39						PLANT OVEREXPRESSING ABSCISIC ACID TRANSPORTER PROTEIN AND METHOD FOR PRODUCING THE SAME - Patent application	www.faqs.org	0	0		
599	chr24	1846838	1846862	3500367604	24		1846838	1846862	8421504	1	24	0	c	350036760400000008	25-49						Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy - Patent application	www.faqs.org	0	0		
599	chr24	1856857	1856885	3500198677	23		1856857	1856885	8421504	2	17,6	0,22	c	350019867700000129	13-37						NOVEL CANCER-ASSOCIATED GENES - Patent application	www.faqs.org	0	0		GALR1
599	chr24	1856921	1856945	3500439046	24		1856921	1856945	8421504	1	24	0	c	350043904600000030	0-24						A METHOD OF TREATING DEPRESSION USING A GALR3 RECEPTOR ANTAGONIST	Bard	2001	0		
599	chr24	1856921	1856945	3500289930	24		1856921	1856945	8421504	1	24	0	c	350028993000000001	0-24					Patent	Method of preparing GALR2 receptors composition (Patent US:7060449)	Smith	2006	0		
599	chr24	1856921	1856945	3500288516	24		1856921	1856945	8421504	1	24	0	c	350028851600000001	0-24						Uses of galanin GALR2 receptors	Branchek	2003	0		
599	chr24	1856921	1856945	3500288508	24		1856921	1856945	8421504	1	24	0	c	350028850800000001	0-24						DNA encoding galanin GALR2 receptors and uses thereof	Branchek	2003	0		
599	chr24	1856921	1856945	3500288003	24		1856921	1856945	8421504	1	24	0	c	350028800300000001	0-24					Patent	DNA encoding galanin GALR2 receptors (Patent US:6790656)	Smith	2004	0		GALR1
599	chr24	1856921	1856945	3500234747	24		1856921	1856945	8421504	1	24	0	c	350023474700000030	0-24						Dna encoding galanin galr3 receptors and uses thereof	Bard	1999	0		
599	chr24	1856921	1856945	3500209712	24		1856921	1856945	8421504	1	24	0	c	350020971200000001	0-24						US Patent # 5,972,624. Method of identifying ligands which bind recombinant galanin receptor (GALR2) - Patents.com	www.patents.com	0	0		
599	chr24	1856921	1856945	3500188135	24		1856921	1856945	8421504	1	24	0	c	350018813500000030	0-24					Patent	DNA encoding galanin GALR3 receptors and uses thereof (Patent US:6287788)	Bard	2001	0		
599	chr24	1856921	1856945	3500172376	24		1856921	1856945	8421504	1	24	0	c	350017237600000001	0-24						Dna encoding galanin galr2 receptors and uses thereof	Branchek	1997	0		
599	chr24	1856921	1856945	3500101008	24		1856921	1856945	8421504	1	24	0	c	350010100800000030	0-24						US Patent # 6,329,197. DNA encoding galanin GALR3 receptors and uses thereof - Patents.com	www.patents.com	0	0		GALR1
599	chr24	1856921	1856945	3500077080	24		1856921	1856945	8421504	1	24	0	c	350007708000000030	0-24						Method of using cells expressing galanin receptor 3 (GALR3) - Patent # 7022489 - PatentGenius	.patentgenius.com	0	0		GALR1
599	chr24	1856921	1856945	3500008083	24		1856921	1856945	8421504	1	24	0	c	350000808300000001	0-24						Method of preparing GALR2 receptors composition	Smith	2002	0		GALR1
599	chr24	1856921	1856945	3500002871	24		1856921	1856945	8421504	1	24	0	c	350000287100000001	0-24					Patent	Method of identifying compounds that bind galanin receptor (GALR2) (Patent US:6586191)	Smith	2003	0		
599	chr24	1857029	1857419	3500156268	45		1857029	1857419	8421504	2	21,24	0,366	c,g	350015626800000001,350015626800000001,350015626800000000	9-30,9-30,0-24			10.1046/j.1471-4159.2001.00018.x	1471-4159	Journal of Neurochemistry	Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB-dependent mechanism - Zachariou - 2008 - Journal of Neurochemistry - Wiley Online Library	Zachariou	2001	0		
599	chr24	1857227	1857289	3500170203	42		1857227	1857289	8421504	2	23,19	0,43	c	350017020300000020,350017020300000019	0-23,0-19						9-Methyl- -carboline has restorative effects in an animal model of Parkinson&#x2019;s disease	.if-pan.krakow.pl	0	0		GALR1
600	chr24	1997471	2019698	3500466395	120		1997471	2019698	8421504	3	60,24,36	0,21221,22191	p	350046639500015022,350046639500015023	0-60,0-60						Methods of generating antigen-specific CD4+CD25+ regulatory T cells, compositions and methods of use	Buckner	2005	0		MBP
600	chr24	1997498	1997558	3500203667	60		1997498	1997558	8421504	1	60	0	p	350020366700015037	0-60						US Patent # 6,340,461. Superantigen based methods and compositions for treatment of diseases - Patents.com	www.patents.com	0	0		MBP
600	chr24	1997498	1997558	3500108742	60		1997498	1997558	8421504	1	60	0	p	350010874200015041	0-60						Superantigen based methods and compositions for treatment of diseases - US Patent 6340461 Description	ww.patentstorm.us	0	0		MBP
600	chr24	1997588	2018659	3500338715	75		1997588	2018659	8421504	2	24,51	0,21020	p	350033871500015008,350033871500015010	0-75,0-60						T cell receptor peptides as therapeutics for immune-related disease	Vandenbark	1993	0		
600	chr24	2018635	2018659	3500380174	24		2018635	2018659	8421504	1	24	0	c	350038017400000488	24-48						Goodpasture Antigen Binding Protein 	.freshpatents.com	0	0		
600	chr24	2018680	2019677	3500269997	51		2018680	2019677	8421504	2	36,15	0,982	p	350026999700015000	0-51						Method to produce recombinant MBP8298 and other polypeptides by nucleotide structure optimization	Zareie	2009	0		MBP
600	chr24	2018683	2028486	3500226426	138		2018683	2028486	8421504	4	33,27,42,36	0,979,5188,9767	p	350022642600015000,350022642600015001	0-60,0-78		20855882	10.4049/jimmunol.1000588	0022-1767	The Journal of Immunology	Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects	Correale	2010	6		MBP
600	chr24	2018683	2019680	3500430486	51		2018683	2019680	8421504	2	33,18	0,979	p	350043048600015003	0-51		15047612	10.2337/diabetes.53.4.971	0012-1797	Diabetes	Differential Recognition and Activation Thresholds in Human Autoreactive GAD-Specific T-Cells	Mallone	2004	8		MBP
600	chr24	2018683	2019680	3500214067	51		2018683	2019680	8421504	2	33,18	0,979	p	350021406700015002	0-51						Differential Recognition and Activation Thresholds in Human Autoreactive GAD-Speci&#xfb01;c T-Cells	munetolerance.org	0	0		MBP
600	chr24	2018683	2019674	3500268302	45		2018683	2019674	8421504	2	33,12	0,979	p	350026830200015000	0-45		10617620	10.1074/jbc.275.1.312	0021-9258	Journal of Biological Chemistry	Kinetics of T-cell Receptor Binding by Bivalent HLA-DR&#xb7;Peptide Complexes That Activate Antigen-specific Human T-cells	Appel	2000	5		MBP
600	chr24	2018683	2019674	3500049914	45		2018683	2019674	8421504	2	33,12	0,979	p	350004991400015011	0-45						Use of statins and other immunomodulatory agents in the treatment of autoimmune disease	Steinman	2003	0		MBP
600	chr24	2018686	2019686	3500344832	54		2018686	2019686	8421504	2	30,24	0,976	p	350034483200015004	0-54		20877010	10.1172/JCI43522	0021-9738	The Journal of Clinical Investigation	HLA-E&#x2013;restricted regulatory CD8+ T cells are involved in development and control of human autoimmune type 1 diabetes 	Jiang	2010	13		MBP
600	chr24	2018686	2019680	3500341995	48		2018686	2019680	8421504	2	30,18	0,976	p	350034199500015000	0-48						Fusion molecules and methods for treatment of immune diseases	Saxon	2011	0		MBP
600	chr24	2018686	2019680	3500288174	48		2018686	2019680	8421504	2	30,18	0,976	p	350028817400015001	0-48						Fusion molecules and methods for treatment of immune diseases	Saxon	2001	0		MBP
600	chr24	2018686	2019680	3500234827	48		2018686	2019680	8421504	2	30,18	0,976	p	350023482700015000	0-48						Fusion molecules and methods for treatment of immune diseases	Saxon	2011	0		MBP
600	chr24	2018686	2019680	3500195418	48		2018686	2019680	8421504	2	30,18	0,976	p	350019541800015003	0-48						FUSION MOLECULES AND METHODS FOR TREATMENT OF IMMUNE DISEASES	Saxon	2009	0		MBP
600	chr24	2018686	2019677	3500419842	45		2018686	2019677	8421504	2	30,15	0,976	p	350041984200015010	0-45						Charakterisierung einer hABL-spezifischen CD4+-T-Zellantwort und die Anwendung des AdEtOH als Katalysator der Peptidbeladung	diss.fu-berlin.de	0	0		MBP
600	chr24	2018686	2019677	3500282982	45		2018686	2019677	8421504	2	30,15	0,976	p	350028298200015010	0-45						Charakterisierung einer hABL-spezifischen CD4+-T-Zellantwort und die Anwendung des AdEtOH als Katalysator der Peptidbeladung	diss.fu-berlin.de	0	0		MBP
600	chr24	2018686	2019677	3500194975	45		2018686	2019677	8421504	2	30,15	0,976	p	350019497500015001	0-45		16210595		0022-1767	The Journal of Immunology	Conformational Variation of Surface Class II MHC Proteins during Myeloid Dendritic Cell Differentiation Accompanies Structural Changes in Lysosomal MIIC	Potolicchio	2005	6		MBP
600	chr24	2018686	2019677	3500110148	45		2018686	2019677	8421504	2	30,15	0,976	p	350011014800015002	0-45		17005558	10.1074/jbc.M606437200	0021-9258	Journal of Biological Chemistry	Small Organic Compounds Enhance Antigen Loading of Class II Major Histocompatibility Complex Proteins by Targeting the Polymorphic P1 Pocket	Hopner	2006	5		MBP
600	chr24	2018692	2019689	3500229104	51		2018692	2019689	8421504	2	24,27	0,970	p	350022910400015054,350022910400015060,350022910400015013,350022910400015006,350022910400015007,350022910400015017,350022910400015005,350022910400015150,350022910400015053	0-48,3-48,0-51,0-51,72-123,99-150,42-93,0-48,0-45						Method For Producing Catalytic Antibodies (variants), Antigens For Immunization And Nucleotide Sequence 	.freshpatents.com	0	0		MBP
600	chr24	2018695	2020078	3500218704	63		2018695	2020078	8421504	3	21,36,6	0,967,1377	p	350021870400015002	0-63		12933585	10.1182/blood-2003-03-0974	0006-4971	Blood	Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE	Theien	2003	10		MBP
600	chr24	2018701	2019698	3500444493	51		2018701	2019698	8421504	2	15,36	0,961	p	350044449300015002	0-51						Pyrrolopyrimidines for pharmaceutical compositions	Aktiengesellschaft	2006	0		MBP
600	chr24	2018701	2019698	3500421768	51		2018701	2019698	8421504	2	15,36	0,961	p	350042176800015001	0-51						Pyrrolopyrimidines for pharmaceutical compositions	Coulter	2009	0		MBP
600	chr24	2018701	2019698	3500267628	51		2018701	2019698	8421504	2	15,36	0,961	p	350026762800015003	0-51						THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - Patent application	www.faqs.org	0	0		MBP
600	chr24	2018701	2019698	3500199044	51		2018701	2019698	8421504	2	15,36	0,961	p	350019904400015005	0-51						THIENOPYRIMIDINES HAVING MNK1/MNK2 INHIBITING ACTIVITY FOR PHARMACEUTICAL COMPOSITIONS - Patent application	www.faqs.org	0	0		MBP
600	chr24	2018701	2019698	3500143524	51		2018701	2019698	8421504	2	15,36	0,961	p	350014352400015002	0-51						Thienopyrimidines treating inflammatory diseases	Aicher	2007	0		MBP
600	chr24	2019686	2023802	3500224979	54		2019686	2023802	8421504	3	12,33,9	0,386,4107	p	350022497900015003	0-54		15494416	10.1074/jbc.M405295200	0021-9258	Journal of Biological Chemistry	PRMT7, a New Protein Arginine Methyltransferase That Synthesizes Symmetric Dimethylarginine	Lee	2005	5		MBP
600	chr24	2019692	2023799	3500388488	45		2019692	2023799	8421504	3	6,33,6	0,380,4101	p	350038848800015009	0-45						<script language=javascript> function overCell(el) { el.style.background='#FCF7F2'; }	.chemicalbook.com	0	0		MBP
600	chr24	2019692	2023799	3500351418	45		2019692	2023799	8421504	3	6,33,6	0,380,4101	p	350035141800015006	0-45						<script language=javascript> function overCell(el) { el.style.background='#FCF7F2'; }	.chemicalbook.com	0	0		MBP
600	chr24	2019692	2023799	3500088912	45		2019692	2023799	8421504	3	6,33,6	0,380,4101	p	350008891200015009	0-45						 SIGMA&#x4ea7;&#x54c1;&#x76ee;&#x5f55;&#xff0c;&#x4e2d;&#x6587;&#x540d;&#x79f0;&#xff0c;CAS&#xff0c;&#x5206;&#x5b50;&#x5f0f;&#xff0c;&#x7532;&#x57fa;&#x7ea4;&#x7ef4;&#x7d20;,138169-43-4,C20H17N5O6S2,,102110-73-6,,,,,,69552-46-1,C21H34O4,,,,,78809-73-1,,&#x786	.chemicalbook.com	0	0		MBP
600	chr24	2026219	2026245	3500047637	23		2026219	2026245	8421504	2	12,11	0,15	g	350004763700000618	24-48						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
600	chr24	2028984	2029017	3500054944	27		2028984	2029017	8421504	3	4,6,17	0,5,16	c	350005494400000044	2-29						Steroid 5A-reductases	Andersson	1995	0		
602	chr24	2247315	2247343	3500218114	23		2247315	2247343	8421504	2	16,7	0,21	g	350021811400000093	14-37						US Patent # 5,498,831. Pea ADP-glucose pyrophosphorylase subunit genes and their uses - Patents.com	www.patents.com	0	0		
602	chr24	2347261	2347287	3500463327	23		2347261	2347287	8421504	3	11,5,7	0,12,19	g	350046332700000015,350046332700000039	20-43,20-43					Patent	Vaccins adn ameliores pour herpesvirus-1 bovin (Patent EP:1248650)	Audonnet	2006	0		
602	chr24	2347261	2347287	3500095783	23		2347261	2347287	8421504	3	11,5,7	0,12,19	g	350009578300000015	20-43						Vaccins adn ameliores pour animaux de rente	Audonnet	2002	0		
602	chr24	2347261	2347287	3500012787	23		2347261	2347287	8421504	3	11,5,7	0,12,19	g	350001278700000029	20-43						Improved DNA vaccines for production-type animals	J-C*F*Ao Duo Nai Te 	2003	0		
603	chr24	2384303	2384331	3500307902	25		2384303	2384331	8421504	2	14,11	0,17	g	350030790200000084	3-28						Mhc complexes and uses thereof	Chavaillaz	1996	0		
603	chr24	2471603	2471628	3500456730	25		2471603	2471628	8421504	1	25	0	g	350045673000000004	7-32						Viral Chemokine-antigen Fusion Proteins 	.freshpatents.com	0	0		
609	chr24	3252826	3252852	3500279437	23		3252826	3252852	8421504	2	7,16	0,10	c	350027943700000025	0-23						Interferon-gamma Inducing Polypeptide, Pharmaceutical Composition Thereof, Monoclonal Antibody Thereto, And Methods Of Use 	.freshpatents.com	0	0		
611	chr24	3464506	3464529	3500286808	23		3464506	3464529	8421504	1	23	0	g	350028680800000024	9-35						Corn Plants And Seed Enhanced For Asparagine And Protein 	.freshpatents.com	0	0		
613	chr24	3670495	3670519	3500330776	23		3670495	3670519	8421504	2	7,16	0,8	g	350033077600000015	3-26						Albumin Variants	Andersen	2012	0		
615	chr24	3955333	3992651	3500095434	48		3955333	3992651	8421504	2	23,25	0,37293	c,g	350009543400000016,350009543400000016,350009543400000017	0-23,0-23,0-25						BMC Genetics BioMed Central	biomedcentral.com	0	0		
615	chr24	3985203	3985231	3500312985	23		3985203	3985231	8421504	2	14,9	0,19	g	350031298500000274	16-39					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
617	chr24	4267566	4267591	3500361666	23		4267566	4267591	8421504	2	11,12	0,13	g	350036166600000338,350036166600000149	0-23,0-23						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
618	chr24	4337628	4337654	3500137915	24		4337628	4337654	8421504	2	9,15	0,11	g	350013791500000539	5-47						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
625	chr24	5268372	5268420	3500251406	48		5268372	5268420	8421504	1	48	0	p	350025140600015105	0-48					Patent	Human cDNAs and proteins and uses thereof (Patent US:7285631)	Bejanin	2007	0		CBLN2
625	chr24	5268372	5268420	3500054122	48		5268372	5268420	8421504	1	48	0	p	350005412200015099	0-48						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		CBLN2
626	chr24	5400919	5400948	3500018529	26		5400919	5400948	8421504	3	8,14,4	0,10,25	g	350001852900000119	3-29						***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Streptococcus pneumoniae antigens and vaccines	Choi	1997	0		
634	chr24	6544431	6544457	3500411223	23		6544431	6544457	8421504	2	13,10	0,16	g	350041122300000019	12-35						US Patent # 5,434,253. DNA encoding Helicobacter pylori recombinase - Patents.com	www.patents.com	0	0		
636	chr24	6779595	6779627	3500189735	25		6779595	6779627	8421504	3	11,3,11	0,15,21	g	350018973500000033	0-25						Method for Identifying, Marking and Treating Epithelial Lung Tumour Cells and Means for Carrying Out Said Method	Borlak	2006	0		
638	chr24	6973239	7023230	3500205714	40		6973239	7023230	8421504	3	6,14,20	0,11,49971	c,g	350020571400000244,350020571400000401	24-44,10-30						Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants - Patent application	www.faqs.org	0	0		
649	chr24	8437575	8437598	3500219109	23		8437575	8437598	8421504	1	23	0	g	350021910900000206	0-23						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		HNRNPL
651	chr24	8740061	8740084	3500210893	23		8740061	8740084	8421504	1	23	0	g	350021089300000028	1-24						Characterization of two chloroplast envelope membrane proteins	d-nb.info/1036101	0	0		
655	chr24	9227370	9227395	3500429156	25		9227370	9227395	8421504	1	25	0	g	350042915600000003	0-25						Liver related disease compositions and methods	Patil	2003	0		
657	chr24	9542762	9543539	3500415955	72		9542762	9543539	8421504	3	24,24,24	0,529,753	c,g	350041595500000002,350041595500000003,350041595500000004,350041595500000004	0-24,0-24,0-24,0-24						Letter The Heparan and Heparin Metabolism Pathway is Involved in Regulation of Fatty Acid Composition	www.ijbs.com	0	0		
657	chr24	9543561	9543585	3500288510	23		9543561	9543585	8421504	2	4,19	0,5	c	350028851000000004	1-25		21148107	10.1095/biolreprod.110.088831	0006-3363	Biology of Reproduction	Generation of Viable Male and Female Mice from Two Fathers	Deng	2011	4		
657	chr24	9543628	9543889	3500063345	261		9543628	9543889	8421504	1	261	0	c	350006334500000025,350006334500000003	0-261,0-261						Screening for Arthrogryposis Multiplex in Bovines - Patent application	www.faqs.org	0	0		
658	chr24	9569609	9569637	3500346203	23		9569609	9569637	8421504	2	11,12	0,16	g	350034620300000010	2-25						International Journal for Parasitology	005.pasteur.ac.ir	0	0		
666	chr24	10679956	10679982	3500327731	23		10679956	10679982	8421504	2	11,12	0,14	g	350032773100000123	0-23						Receptor for oncostatin m and leukemia inhibitory factor	Gearing	1995	0		
669	chr24	11049618	11049798	3500065941	180		11049618	11049798	8421504	1	180	0	p	350006594100015006	0-180						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH7
669	chr24	11063665	11063689	3500000852	24		11063665	11063689	8421504	1	24	0	c	350000085200000043	0-24						Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents	Brenner	2000	0		CDH7
669	chr24	11063716	11063742	3500098533	25		11063716	11063742	8421504	2	20,5	0,21	c	350009853300000058	9-35						DNA vaccine against feline immunodeficiency virus	Deng	2000	0		
676	chr24	12052105	12052129	3500223087	23		12052105	12052129	8421504	2	8,15	0,9	g	350022308700000010,350022308700000002	1-25,1-25						VIDO - Solutions Through Research	www.vido.org	0	0		
679	chr24	12345578	12345601	3500189823	23		12345578	12345601	8421504	1	23	0	g	350018982300000034	7-30						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
680	chr24	12533839	12533866	3500362049	23		12533839	12533866	8421504	2	11,12	0,15	g	350036204900000002,350036204900000001	0-23,22-45		21197589	10.1007/s12033-010-9367-1		Molecular Biotechnology	Ribosome Display Selection of a Murine IgG1 Fab Binding Affibody Molecule Allowing Species Selective Recovery Of Monoclonal Antibodies	Sebastian	July	0		
682	chr24	12732020	12732045	3500279741	25		12732020	12732045	8421504	1	25	0	c	350027974100000029	0-25						Mutations in the myostation gene cause double-muscling in mammals	Georges	1999	0		
682	chr24	12732628	12732679	3500368433	51		12732628	12732679	8421504	1	51	0	p	350036843300015005	0-51						Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression	Gerard	1991	0		SERPINB2
682	chr24	12732765	12733522	3500040185	40		12732765	12733522	8421504	3	20,4,16	0,198,741	c,g	350004018500000031,350004018500000031,350004018500000030	0-20,0-20,0-20						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
682	chr24	12738351	12738381	3500343319	30		12738351	12738381	8421504	1	30	0	c	350034331900000051	0-30						US Patent # 5,298,400. Polynucleotide constructs for secreted glycosylated plasminogen activator inhibitor-2 (PAI-2) - Patents.com	www.patents.com	0	0		
682	chr24	12738351	12738381	3500173240	30		12738351	12738381	8421504	1	30	0	c	350017324000000051	0-30						Polynucleotide constructs for secreted glycosylated plasminogen activator inhibitor-2 (PAI-2)	Whitfeld	1991	0		
693	chr24	14199732	14199757	3500240778	24		14199732	14199757	8421504	2	14,10	0,15	g	350024077800000015,350024077800000041	0-24,0-24						METHOD FOR THE PRODUCTION OF RECOMBINANT POLYOMAVIRAL VECTOR PARTICLES - AMARNA THERAPEUTICS B.V.	www.sumobrain.com	0	0		
693	chr24	14199732	14199757	3500208798	24		14199732	14199757	8421504	2	14,10	0,15	g	350020879800000005	0-24						METHOD FOR THE EXPRESSION OF A RECOMBINANT PROTEIN IN A MAMMALIAN CELL	Vries	2010	0		
694	chr24	14293311	14336308	3500152577	190		14293311	14336308	8421504	7	16,7,11,37,44,45,30	0,20623,20687,33740,33781,36578,42967	c	350015257700000101,350015257700000099,350015257700000098,350015257700000097,350015257700000094	6-29,0-48,0-44,0-45,18-48						US Patent # 7,422,849. Method for determining expression of a PI3 kinase gene - Patents.com	www.patents.com	0	0		
694	chr24	14327092	14336308	3500295373	74		14327092	14336308	8421504	2	44,30	0,9186	c,g	350029537300000108,350029537300000108,350029537300000104	0-44,0-44,18-48					Patent	Polypeptides having kinase activity, their preparation and use (Patent US:5824492)	Dhand	1998	0		
694	chr24	14327092	14327136	3500193936	44		14327092	14327136	8421504	1	44	0	c	350019393600000108	0-44						Polypeptides having kinase activity, their preparation and use	Hiles	1994	0		
694	chr24	14343612	14345188	3500434170	41		14343612	14345188	8421504	3	21,3,17	0,67,1559	c,g	350043417000000035,350043417000000035,350043417000000034	0-21,0-21,0-20						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
696	chr24	14679586	14679614	3500310582	25		14679586	14679614	8421504	3	16,5,4	0,18,24	g	350031058200000002	9-35		22492445	10.1128/AEM.07473-11	0099-2240	Applied and Environmental Microbiology	Catalytic Efficiency Diversification of Duplicate &#x03b2;-1,3-1,4-Glucanases from Neocallimastix patriciarum J11	Hung	2012	4		
698	chr24	14904660	14904689	3500387889	28		14904660	14904689	8421504	2	5,23	0,6	g	350038788900000003	0-31					Journal of Bacteriology	Intracellular Immunization of Prokaryotic Cells against a Bacteriotoxin	Patrick	1998	0		
722	chr24	18027571	18027595	3500037326	23		18027571	18027595	8421504	2	4,19	0,5	g	350003732600000089	0-24						MICROORGANISM EXPRESSING XYLOSE ISOMERASE - Patent application	www.faqs.org	0	0		
738	chr24	20121300	20121327	3500397944	23		20121300	20121327	8421504	2	10,13	0,14	g	350039794400000038	3-26						Antibodies	Cicortas	2013	0		
739	chr24	20229463	20229486	3500196141	23		20229463	20229486	8421504	1	23	0	c	350019614100000006	10-33		11158314	10.1128/MCB.21.4.1285-1296.2001	0270-7306	Molecular and Cellular Biology	The CELF Family of RNA Binding Proteins Is Implicated in Cell-Specific and Developmentally Regulated Alternative Splicing	Ladd	2001	6		CELF4
741	chr24	20517214	20517237	3500442201	23		20517214	20517237	8421504	1	23	0	g	350044220100000104	15-46						Amylase variants	Bisgard-frantzen	1996	0		
742	chr24	20587346	20587371	3500196141	25		20587346	20587371	8421504	1	25	0	c,g	350019614100000007,350019614100000007	12-37,12-37		11158314	10.1128/MCB.21.4.1285-1296.2001	0270-7306	Molecular and Cellular Biology	The CELF Family of RNA Binding Proteins Is Implicated in Cell-Specific and Developmentally Regulated Alternative Splicing	Ladd	2001	6		CELF4
749	chr24	21569961	21569987	3500340112	23		21569961	21569987	8421504	2	8,15	0,11	g	350034011200000048	0-32						PHAGE DISPLAY	Sidhu	2008	0		
749	chr24	21572727	21572754	3500400293	24		21572727	21572754	8421504	2	10,14	0,13	g	350040029300000020	0-24						Tesis Doctoral Sobre Virus	es.scribd.com	0	0		
751	chr24	21782036	21801410	3500316377	1332		21782036	21801410	8421504	9	3,129,52,170,219,106,378,81,194	0,3898,4030,5914,7123,13519,15992,17741,19180	p	350031637700015003,350031637700015001	786-2118,768-2100						Compositions Against Cancer Antigen LIV-1 and Uses Thereof - Patent application	www.faqs.org	0	0		
751	chr24	21798262	21798289	3500467616	27		21798262	21798289	8421504	1	27	0	c	350046761600000000	0-27						Untersuchungen zum Mechanismus der ER/Cytosol-Dislokation von Ricin A mittels Transposon-Mutagenese	b.uni-saarland.de	0	0		
751	chr24	21798262	21798289	3500432335	27		21798262	21798289	8421504	1	27	0	c	350043233500000112,350043233500000024	0-27,0-27						Recombinant dimeric envelope vaccine against flaviviral infection	Peters	1999	0		
751	chr24	21798262	21798289	3500339689	27		21798262	21798289	8421504	1	27	0	c	350033968900000027	19-46						Verso un vaccino autoadiuvante multivalente contro il virus del papilloma umano	ce-unipr.cilea.it	0	0		
751	chr24	21798262	21798289	3500216179	27		21798262	21798289	8421504	1	27	0	c	350021617900000004	0-27						Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells	ularsignaling.com	0	0		
751	chr24	21798262	21798286	3500443047	24		21798262	21798286	8421504	1	24	0	c	350044304700000003	1-25					Patent	Identification and engineering of antibodies with variant Fc regions and methods of using same (Patent US:7355008)	Gorlatov	2008	0		
751	chr24	21798262	21798286	3500288417	24		21798262	21798286	8421504	1	24	0	c	350028841700000000	10-34						Engineering Fc antibody regions to confer effector function	Stavenhagen	2009	0		
751	chr24	21798262	21798286	3500236968	24		21798262	21798286	8421504	1	24	0	c	350023696800000000	10-34						Engineering Fc Antibody Regions to Confer Effector Function	Koenig	2012	0		
751	chr24	21798262	21798286	3500188874	24		21798262	21798286	8421504	1	24	0	c	350018887400000041	18-42						ERYTHROCYTE-BINDING THERAPEUTICS	Hubbell	2012	0		
751	chr24	21798262	21798286	3500175109	24		21798262	21798286	8421504	1	24	0	c	350017510900000000	10-34					Patent	Identification and engineering of antibodies with variant Fc regions and methods of using same (Patent US:8003774)	Gorlatov	2011	0		
751	chr24	21798263	21798286	3500237599	23		21798263	21798286	8421504	1	23	0	c	350023759900000000	9-32						ISOLATED B7-H4 SPECIFIC COMPOSITIONS AND METHODS OF USE THEREOF - THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	www.sumobrain.com	0	0		
751	chr24	21798263	21798286	3500033049	23		21798263	21798286	8421504	1	23	0	c	350003304900000043,350003304900000023,350003304900000046	9-32,9-32,9-32						ANTI-TEM1 ANTIBODIES AND USES THEREOF - Patent application	www.faqs.org	0	0		
751	chr24	21886479	21886503	3500086931	23		21886479	21886503	8421504	2	13,10	0,14	g	350008693100000045	15-38						Hepatitis c assay utilizing recombinant antigens to ns1	Dailey	1993	0		
756	chr24	22489964	22489990	3500344997	23		22489964	22489990	8421504	2	5,18	0,8	c	350034499700000113	6-29						METHODS OF IDENTIFYING AGENTS THAT MODULATE METHYLATION OF VEGFR1 BY SMYD3 - Patent application	www.faqs.org	0	0		
757	chr24	22547702	22547728	3500240538	23		22547702	22547728	8421504	2	9,14	0,12	c	350024053800000011	0-23		16687512	10.1523/JNEUROSCI.4917-05.2006	0270-6474	The Journal of Neuroscience	Two mRNA-Binding Proteins Regulate the Distribution of Syntaxin mRNA in Aplysia Sensory Neurons	Liu	2006	7		
757	chr24	22648719	22648747	3500007239	23		22648719	22648747	8421504	2	16,7	0,21	g	350000723900000010	7-31						Multi plasmid system for the production of influenza virus	Hoffmann	2005	0		
757	chr24	22651869	22651910	3500402101	40		22651869	22651910	8421504	2	19,21	0,20	c	350040210100000005,350040210100000011	5-24,6-27		15113898	10.1128/JVI.78.10.5157-5169.2004	0022-538X	Journal of Virology	Effect of Extension of the Cytoplasmic Domain of Human Immunodeficiency Type 1 Virus Transmembrane Protein gp41 on Virus Replication	Chan	2004	5		
757	chr24	22651869	22651894	3500232997	25		22651869	22651894	8421504	1	25	0	c	350023299700000002	0-25						METHODS IN ENZYMOLOGY	.researchgate.net	0	0		
757	chr24	22651869	22651894	3500158657	25		22651869	22651894	8421504	1	25	0	c	350015865700000040	10-35						Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography	Ebersbach	2006	0		
757	chr24	22651869	22651894	3500027515	25		22651869	22651894	8421504	1	25	0	c	350002751500000001	14-39					Journal of Virology	Bamboo Mosaic Potexvirus Satellite RNA (satBaMV RNA)-Encoded P20 Protein Preferentially Binds to satBaMV RNA	Ming-Shiun	1999	0		
758	chr24	22722716	22722745	3500047898	24		22722716	22722745	8421504	2	15,9	0,20	g	350004789800000047	6-33					Patent	Target specific screening and its use for identifying target binders (Patent US:7056679)	Blume	2006	0		
760	chr24	22994923	22994952	3500368754	25		22994923	22994952	8421504	3	6,6,13	0,9,16	c	350036875400000007,350036875400000028	0-25,0-24						Methods of regulating differentiation in stem cells	Pebay	2003	0		
760	chr24	22994924	22994952	3500150912	24		22994924	22994952	8421504	3	5,6,13	0,8,15	c	350015091200000004	0-24						Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof	Miller	2004	0		LPAR3
760	chr24	22994924	22994952	3500096195	24		22994924	22994952	8421504	3	5,6,13	0,8,15	c	350009619500000004	0-24						Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents	Miller	2007	0		LPAR3
760	chr24	22994924	22994952	3500019638	24		22994924	22994952	8421504	3	5,6,13	0,8,15	c	350001963800000004	0-24						Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof	Dalton	2006	0		LPAR3
762	chr24	23277338	23277363	3500434325	23		23277338	23277363	8421504	2	16,7	0,18	g	350043432500000011	11-34						Estabilidad, plegamiento y asociaci&#xf3;n del dominio de dimerizaci&#xf3;n de la prote&#xed;na de la c&#xe1;psida del virus de la inmunodeficiencia humana	ibmc.umh.es	0	0		
768	chr24	24104786	24104809	3500028061	23		24104786	24104809	8421504	1	23	0	c	350002806100000233	17-40						Surface proteins of leptospira	www.devileye.net	0	0		
773	chr24	24677502	24677529	3500100734	24		24677502	24677529	8421504	2	8,16	0,11	g	350010073400000012	24-48						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
774	chr24	24795132	24795155	3500318229	23		24795132	24795155	8421504	1	23	0	g	350031822900000125	12-35						METHODS OF IDENTIFYING AND CREATING RUBISCO LARGE SUBUNIT VARIANTS WITH IMPROVED RUBISCO ACTIVITY, COMPOSITIONS AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
775	chr24	25027736	25027761	3500439152	24		25027736	25027761	8421504	2	11,13	0,12	g	350043915200000072	0-28						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		
782	chr24	25862195	25862219	3500168776	23		25862195	25862219	8421504	2	17,6	0,18	c	350016877600000164,350016877600000158,350016877600000166,350016877600000167,350016877600001216,350016877600001222,350016877600001224,350016877600001225	0-21,1-24,0-21,0-21,1-24,0-21,0-21,0-21						Micrornas (mirnas) For Plant Growth And Development 	.freshpatents.com	0	0		RNF138
782	chr24	25862200	25862226	3500095899	23		25862200	25862226	8421504	2	18,5	0,21	c	350009589900000004	0-23		16415021	10.1128/JVI.80.3.1440-1450.2006	0022-538X	Journal of Virology	Role of Helix P of the Human Cytomegalovirus DNA Polymerase in Resistance and Hypersusceptibility to the Antiviral Drug Foscarnet	Tchesnokov	2006	5		RNF138
785	chr24	26226029	26226053	3500306430	23		26226029	26226053	8421504	2	18,5	0,19	g	350030643000000155	7-30						Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars - Patent application	www.faqs.org	0	0		
785	chr24	26226029	26226053	3500189676	23		26226029	26226053	8421504	2	18,5	0,19	g	350018967600000155	7-30						 Transgenic Plants Containing Ligninase And Cellulase Which Degrade Lignin And Cellulose To Fermentab 	www.docstoc.com	0	0		
785	chr24	26228737	26293788	3500073907	1146		26228737	26293788	8421504	9	115,117,114,125,117,188,123,102,145	0,21231,31796,47723,53307,60792,63629,63993,64906	p	350007390700015000	0-1146						KEGG T01001: 9331	www.genome.jp	0	0		B4GALT6
785	chr24	26319933	26319978	3500150282	45		26319933	26319978	8421504	1	45	0	p	350015028200015029	0-45						Identification and Characterization of TTR genes of bat and fish	kb.psu.ac.th	0	0		
785	chr24	26321361	26321391	3500452225	25		26321361	26321391	8421504	2	15,10	0,20	c	350045222500000014	9-34						Multiple molecular effect pathways of an environmental ...	ww.slideshare.net	0	0		
785	chr24	26321361	26321391	3500308880	25		26321361	26321391	8421504	2	15,10	0,20	c	350030888000000014	9-34						Multiple molecular effect pathways of an environmental oestrogen in &#xfb01;sh	logy-journals.org	0	0		
786	chr24	26372751	26372775	3500171353	23		26372751	26372775	8421504	2	16,7	0,17	g	350017135300000001,350017135300000038	2-30,2-30						MODIFIED FAMILY 6 GLYCOSIDASES WITH ALTERED SUBSTRATE SPECIFICITY - Patent application	www.faqs.org	0	0		
786	chr24	26419956	26419982	3500218114	24		26419956	26419982	8421504	2	8,16	0,10	g	350021811400000094	2-26						US Patent # 5,498,831. Pea ADP-glucose pyrophosphorylase subunit genes and their uses - Patents.com	www.patents.com	0	0		
787	chr24	26533920	26573676	3500099949	3113		26533920	26573676	8421504	16	1017,209,73,134,80,195,140,260,186,135,167,145,156,132,36,48	0,3866,5826,6203,9016,9112,11979,14893,17863,18650,23889,26870,29096,30453,30843,39708	p	350009994900015000	0-3129						KEGG T01008: 281131	www.genome.jp	0	0		
787	chr24	26534024	26560836	3500045352	930		26534024	26560836	8421504	18	24,45,72,51,30,102,45,63,18,72,15,24,24,84,51,72,92,46	0,25,451,526,580,616,748,850,3762,3786,5744,5768,6099,9012,11879,14827,23860,26766	p	350004535200015108,350004535200015104,350004535200015103,350004535200015102,350004535200015100,350004535200015095,350004535200015093,350004535200015084,350004535200015078,350004535200015077,350004535200015064	0-69,0-153,15-117,0-45,9-90,0-72,0-63,0-84,3-54,0-72,0-138						Cloning and Sequence Analysis of Desmosomal Glycoproteins 2 and 3 (Desmocollins): Cadherin-like Desmosomal Adhesion Molecules with Heterogeneous Cytoplasmic Domains	jcb.rupress.org	0	0		
787	chr24	26534361	26564400	3500381146	111		26534361	26564400	8421504	3	57,27,27	0,28784,30012	p	350038114600015009,350038114600015011	0-57,0-54						Desmosomal Glycoprotein DGI, a Component of Intercellular Desmosome Junctions, is Related to the Cadherin Family of Cell Adhesion Molecules	www.jstor.org	0	0		DSG1
787	chr24	26557953	26560812	3500461966	45		26557953	26560812	8421504	2	23,22	0,2837	c	350046196600000011	0-45						Page de Garde	hives-ouvertes.fr	0	0		
98	chr24	26723237	26760681	3500045352	4012		26723237	26760681	8421504	123	50,85,17,30,72,6,11,65,35,5,145,48,23,9,19,9,9,7,63,36,145,167,20,12,10,56,12,74,22,5,47,123,132,14,28,9,85,216,113,62,25,2,27,48,5,12,63,13,93,25,14,14,8,75,28,3,52,16,8,26,30,7,5,6,39,47,13,9,5,32,13,9,16,37,12,25,15,11,14,20,86,13,7,77,15,5,7,13,37,9,3,11,7,13,24,13,42,48,11,13,78,19,9,55,59,17,43,20,6,12,6,20,13,9,8,48,7,16,24,23,9,8,31	0,109,226,247,305,2688,2695,2708,4637,4673,4692,6231,6282,6307,6318,6339,8048,8062,8093,8168,11902,13798,14395,14417,14433,14474,18486,18514,18592,18616,18625,20719,20850,21382,21398,21428,21440,29205,29758,29890,29976,31596,31601,31646,34266,34274,34288,34353,34371,35233,35260,35360,35392,35402,35483,35514,35520,35574,35598,35608,35635,35857,35867,35874,35884,35925,35974,35993,36003,36024,36063,36077,36088,36105,36143,36157,36184,36204,36237,36253,36281,36369,36384,36396,36475,36492,36499,36508,36523,36561,36572,36577,36590,36602,36621,36647,36667,36711,36761,36774,36788,36868,36892,36903,36960,37021,37042,37087,37109,37117,37131,37139,37161,37177,37188,37198,37247,37258,37284,37309,37392,37403,37413	p,c,g	350004535200000003,350004535200000003,350004535200000005,350004535200000005,350004535200000006,350004535200015043,350004535200015000,350004535200015048,350004535200000007,350004535200015001,350004535200000008,350004535200000008,350004535200015002,350004535200015050,350004535200000009,350004535200015004,350004535200000010,350004535200015007,350004535200000011,350004535200015008,350004535200000013,350004535200015009,350004535200000015,350004535200015061,350004535200000016,350004535200000016,350004535200015010,350004535200000017,350004535200000017,350004535200000019,350004535200015014,350004535200000020,350004535200015015,350004535200000021,350004535200015017,350004535200015018,350004535200000022,350004535200000022,350004535200000023,350004535200015020,350004535200015021,350004535200000024,350004535200000024,350004535200015023,350004535200000025,350004535200015076,350004535200015025,350004535200000026,350004535200000026,350004535200015026,350004535200015027,350004535200000027,350004535200000027,350004535200015082,350004535200015028,350004535200000028,350004535200000031,350004535200000031,350004535200015088,350004535200015091,350004535200000035,350004535200000035,350004535200015092,350004535200015037,350004535200000037,350004535200000037,350004535200000038,350004535200000039,350004535200015040,350004535200000040,350004535200000040,350004535200000041,350004535200000041,350004535200000044,350004535200000044,350004535200000045,350004535200000046,350004535200000047,350004535200000047,350004535200000050	0-50,0-50,0-85,0-85,4-157,0-69,3-69,0-69,0-91,0-75,4-81,4-81,0-75,0-183,0-83,0-63,8-85,0-63,0-27,0-99,4-48,0-99,17-89,0-168,4-75,4-75,0-51,0-93,0-93,0-66,0-66,7-80,0-72,0-80,0-60,0-99,0-95,0-95,4-94,0-63,0-51,0-89,0-89,0-69,0-93,0-66,0-51,0-95,0-95,0-45,0-99,0-80,0-80,0-117,0-63,0-91,0-62,0-62,0-54,0-48,0-91,0-91,0-48,0-78,0-85,0-85,0-53,0-89,0-63,0-91,0-91,0-64,0-64,68-202,68-202,0-175,0-854,2-142,2-142,0-48						Cloning and Sequence Analysis of Desmosomal Glycoproteins 2 and 3 (Desmocollins): Cadherin-like Desmosomal Adhesion Molecules with Heterogeneous Cytoplasmic Domains	jcb.rupress.org	0	0		
98	chr24	26723551	26758501	3500273926	2467		26723551	26758501	8421504	22	63,15,48,200,117,156,72,71,134,32,135,186,263,143,29,16,144,243,122,97,145,36	0,2374,2411,4323,5917,7734,11588,11662,13484,13619,14081,18172,20405,21068,28891,28946,28963,29444,31282,33925,34023,34914	p,c,g	350027392600015001,350027392600000002,350027392600000002,350027392600015002,350027392600015003,350027392600000003,350027392600000003,350027392600000004,350027392600015004,350027392600000005,350027392600000005,350027392600015005,350027392600000006,350027392600000006,350027392600015006,350027392600000007,350027392600000008,350027392600000008,350027392600015008,350027392600000009,350027392600000009,350027392600000010,350027392600000010,350027392600015010,350027392600000011,350027392600000012,350027392600000013,350027392600000013,350027392600015013,350027392600000014,350027392600000014,350027392600000015,350027392600000016,350027392600000016,350027392600015017,350027392600000017,350027392600015018,350027392600000018,350027392600000018,350027392600015021,350027392600015022,350027392600000019,350027392600000019,350027392600000020,350027392600015023,350027392600000021,350027392600000021,350027392600015024,350027392600000022,350027392600000023,350027392600000023,350027392600015027,350027392600000024,350027392600015029,350027392600000025,350027392600000026	3-81,0-100,0-100,0-99,0-99,0-86,0-86,0-100,0-102,0-100,0-100,0-84,0-98,0-98,0-96,0-98,0-100,0-100,0-78,0-100,0-100,0-99,0-99,0-63,0-100,0-100,0-100,0-100,0-99,0-100,0-100,0-100,0-100,0-100,0-102,0-89,0-69,4-88,4-88,15-63,0-99,0-100,0-100,0-99,0-57,0-100,0-100,0-81,0-100,0-100,0-100,0-78,0-99,0-102,0-100,0-20						Desmocollins Form a Distinct Subset of the Cadherin Family of Cell Adhesion Molecules	www.jstor.org	0	0		
789	chr24	26814678	26817376	3500306233	50		26814678	26817376	8421504	3	20,5,25	0,1652,2673	c,g	350030623300000002,350030623300000003,350030623300000003	0-25,0-25,0-25						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
789	chr24	26814678	26817376	3500218393	50		26814678	26817376	8421504	3	20,5,25	0,1652,2673	c,g	350021839300000010,350021839300000011,350021839300000011	0-25,0-25,0-25						Nuclear Transfer Protocol Affects Messenger RNA Expression Patterns in Cloned Bovine Blastocysts	ww.biolreprod.org	0	0		
789	chr24	26817392	26817468	3500009456	40		26817392	26817468	8421504	2	19,21	0,55	c	350000945600000004,350000945600000005	0-19,0-21						PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY	Fissore	2007	0		
803	chr24	28589639	28589666	3500012508	23		28589639	28589666	8421504	2	17,6	0,21	g	350001250800000023	8-31						Human antibodies derived from immunized xenomice - Patent application	www.faqs.org	0	0		
804	chr24	28804493	28804520	3500020614	24		28804493	28804520	8421504	3	13,5,6	0,15,21	g	350002061400000122	4-31						Biofuel production	Kashiyama	2011	0		
806	chr24	28998384	28998412	3500434325	24		28998384	28998412	8421504	2	6,18	0,10	g	350043432500000003	5-29						Estabilidad, plegamiento y asociaci&#xf3;n del dominio de dimerizaci&#xf3;n de la prote&#xed;na de la c&#xe1;psida del virus de la inmunodeficiencia humana	ibmc.umh.es	0	0		
809	chr24	29398393	29398416	3500428868	23		29398393	29398416	8421504	1	23	0	c	350042886800000015	8-31		19490362	10.1111/j.1471-4159.2009.06099.x	1471-4159	Journal of Neurochemistry	Tumor necrosis factor receptor-associated protein 1 regulates cell adhesion and synaptic morphology via modulation of N-cadherin expression - Kubota - 2009 - Journal of Neurochemistry - Wiley Online Library	Kubota	2009	0		
809	chr24	29400287	29400310	3500349626	23		29400287	29400310	8421504	1	23	0	g	350034962600000009	0-23						SET8 promotes epithelial&#x2013;mesenchymal transition and confers TWIST dual transcriptional activities	www.tmu.cn/pictur	0	0		
101	chr24	29577177	29645398	3500045352	636		29577177	29645398	8421504	12	60,102,29,16,60,33,36,24,66,18,129,63	0,26445,26634,28073,31191,31598,31634,34692,55461,55608,68017,68158	p	350004535200015045,350004535200015067,350004535200015073,350004535200015079,350004535200015080,350004535200015090,350004535200015096,350004535200015097	18-78,0-102,0-45,0-60,0-69,0-90,0-147,0-63						Cloning and Sequence Analysis of Desmosomal Glycoproteins 2 and 3 (Desmocollins): Cadherin-like Desmosomal Adhesion Molecules with Heterogeneous Cytoplasmic Domains	jcb.rupress.org	0	0		CDH2
810	chr24	29581430	29581455	3500368006	25		29581430	29581455	8421504	1	25	0	c	350036800600000007	0-25						The Open Biotechnology Journal, 2008, 2 121-132 121 Expansion of p75NTR/Oct4-Expressing Putative Stem Cells in HPV16- Transformed Precancerous Immortal Cell Lines under the Presence of and TNF	enthamscience.com	0	0		
810	chr24	29581476	29581502	3500347572	26		29581476	29581502	8421504	1	26	0	c	350034757200000041,350034757200000019	0-26,0-26						Method For Chondrocyte Expansion With Phenotype Retention 	.freshpatents.com	0	0		
810	chr24	29581476	29581502	3500205230	26		29581476	29581502	8421504	1	26	0	c	350020523000000019,350020523000000037	0-26,0-21						 Method For Chondrocyte Expansion With Phenotype Retention 	www.docstoc.com	0	0		
810	chr24	29581476	29581502	3500200862	26		29581476	29581502	8421504	1	26	0	c	350020086200000041,350020086200000019	0-26,0-26						Method for chondrocyte expansion with phenotype retention	Adkisson	2007	0		
810	chr24	29581537	29588418	3500467035	43		29581537	29588418	8421504	3	18,4,21	0,6736,6860	c	350046703500000006,350046703500000007	0-22,0-21						Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target	Wesley	2011	0		CDH2
810	chr24	29588324	29588372	3500419348	48		29588324	29588372	8421504	1	48	0	p	350041934800015004	0-48						Expression M-cadherin, cadherinmultigene skeletal muscle	www.pnas.org	0	0		CDH2
810	chr24	29591088	29608372	3500415714	49		29591088	29608372	8421504	2	21,28	0,17256	c	350041571400000009,350041571400000022	0-21,0-28						EpithelialtoMesenchymalTransition:ExpressionoftheRegulators Snail,Slug,andTwistinPancreaticCancer	.aacrjournals.org	0	0		CDH2
101	chr24	29600128	29645368	3500154332	144		29600128	29645368	8421504	4	48,45,3,48	0,11720,32510,45192	p	350015433200015189,350015433200015214,350015433200015221	0-48,0-48,0-48						HIGHLY EFFECTIVE ANTI-CADHERIN ANTIBODY FOR INDUCTION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN VIVO - Patent application	www.faqs.org	0	0		
810	chr24	29605381	29608321	3500319127	41		29605381	29608321	8421504	3	12,8,21	0,2835,2919	c	350031912700000042,350031912700000043	0-20,0-21						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
810	chr24	29608272	29608747	3500412024	40		29608272	29608747	8421504	3	20,19,1	0,159,474	c,g	350041202400000002,350041202400000002,350041202400000003	0-20,0-20,0-20			10.1038/am.2012.50	false	NPG Asia Materials	Configurable 2D and 3D spheroid tissue cultures on bioengineered surfaces with acquisition of epithelial&#x2013;mesenchymal transition characteristics	Kuo	2012	0		CDH2
810	chr24	29608278	29608445	3500029534	42		29608278	29608445	8421504	2	21,21	0,146	c,g	350002953400000002,350002953400000002,350002953400000003,350002953400000003	0-21,0-21,0-21,0-21		15355896	10.1158/1078-0432.CCR-03-0262	1078-0432	Clinical Cancer Research	N-Cadherin Is Regulated by Activin A and Associated with Tumor Aggressiveness in Esophageal Carcinoma	Yoshinaga	2004	8		CDH2
101	chr24	29611860	29632656	3500433197	51		29611860	29632656	8421504	2	33,18	0,20778	p	350043319700015001	0-51		11756478	10.1083/jcb.200108156	0021-9525	The Journal of Cell Biology	Requirement of the juxtamembrane domain of the cadherin cytoplasmic tail for morphogenetic cell rearrangement during myotome development	Horikawa	2001	10		CDH4
811	chr24	29632710	29645281	3500065941	180		29632710	29645281	8421504	2	93,87	0,12484	p	350006594100015002	0-180						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH2
811	chr24	29645252	29645275	3500121194	23		29645252	29645275	8421504	1	23	0	c	350012119400000003	0-23						available journal homepage:http://www.elsevier.com/locate/aob	cellbiosignal.jp	0	0		
811	chr24	29645281	29645344	3500381146	57		29645281	29645344	8421504	2	21,36	0,27	p	350038114600015070	0-57						Desmosomal Glycoprotein DGI, a Component of Intercellular Desmosome Junctions, is Related to the Cadherin Family of Cell Adhesion Molecules	www.jstor.org	0	0		CDH2
811	chr24	29645404	29646581	3500465380	41		29645404	29646581	8421504	2	21,20	0,1157	c	350046538000000000,350046538000000001	0-21,0-20						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	quantification.de	0	0		CDH2
811	chr24	29645404	29646581	3500011924	41		29645404	29646581	8421504	2	21,20	0,1157	c	350001192400000000,350001192400000001	0-21,0-20						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	qpcrupdate.net	0	0		CDH2
811	chr24	29645656	29645680	3500414172	24		29645656	29645680	8421504	1	24	0	c	350041417200000016,350041417200000007	0-24,0-24						Use of Compounds for Inducing Differentiation of Mesenchymal Stem Cells to Chondrocytes - Patent application	www.faqs.org	0	0		CDH2
811	chr24	29645783	29645807	3500118109	23		29645783	29645807	8421504	2	13,10	0,14	c	350011810900000011	7-30						THE INTERCALATED DISC PROTEIN mXIN&#x03b1;, IS CAPABLE OF INTERACTING WITH &#x03b2; CATENIN AND BUNDLING ACTIN FILAMENTS Sinn, Jenny L-C. Lin, and Jim J-C. Lin	www.jbc.org	0	0		
811	chr24	29645783	29645807	3500101238	23		29645783	29645807	8421504	2	13,10	0,14	c	350010123800000011	7-30						The Intercalated Disc Protein, mXin, Is Capable of Interacting with &#x03b2;-Catenin and Bundling Actin Filaments--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;	journal.9med.net	0	0		
814	chr24	30026875	30026903	3500201388	24		30026875	30026903	8421504	3	11,7,6	0,13,22	g	350020138800000074,350020138800000162	8-33,8-33						Polypeptides And Antibodies 	.freshpatents.com	0	0		
816	chr24	30356705	30356730	3500168556	24		30356705	30356730	8421504	2	9,15	0,10	g	350016855600000100	3-40						OMP85 Proteins of Neisseria Gonorrhoeae and Neisseria Meningitidis, Compositions Containing Same and Methods of Use Thereof - Patent application	www.faqs.org	0	0		
817	chr24	30533691	30534885	3500365167	41		30533691	30534885	8421504	2	20,21	0,1173	c	350036516700000004,350036516700000005	0-20,0-21		23942196	10.1038/srep01763	xxxx-xxxx	Scientific Reports	Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats	Sugimoto	2013	0		AQP4
817	chr24	30533691	30534885	3500178390	41		30533691	30534885	8421504	2	20,21	0,1173	c,g	350017839000000004,350017839000000005,350017839000000005	0-20,0-21,0-21		23942196	10.1038/srep01763	xxxx-xxxx	Scientific Reports	Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats	Sugimoto	2013	0		AQP4
818	chr24	30540535	30540559	3500293309	24		30540535	30540559	8421504	1	24	0	c	350029330900000002	0-24			10.1002/ijc.11176	1097-0215	International Journal of Cancer	Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines - Arnold - 2003 - International Journal of Cancer - Wiley Online Library	Arnold	2003	0		
818	chr24	30540535	30540559	3500230773	24		30540535	30540559	8421504	1	24	0	c	350023077300000016	0-24						ANNALES ACADEMIAE MEDICAE GEDANENSIS TOM XXXIX 2 0 0 9 SUPLEMENT 5	pbc.gda.pl/Conten	0	0		
818	chr24	30540536	30540559	3500388985	23		30540536	30540559	8421504	1	23	0	c	350038898500000016	0-23		21864295	10.1042/CBI20100851	1095-8355	Cell Biology International	Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma	Z	2012	0		
823	chr24	31214779	31214808	3500312985	24		31214779	31214808	8421504	2	10,14	0,15	g	350031298500000157	4-28					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
825	chr24	31494169	31504418	3500453732	114		31494169	31504418	8421504	2	28,86	0,10163	p	350045373200015006	0-114						intersex, a gene required for female sexual development in Drosophila, is expressed in both sexes and functions together with doublesexto regulate terminal differentiation	ev.biologists.org	0	0		SS18
827	chr24	31834240	31834268	3500135973	23		31834240	31834268	8421504	3	10,5,8	0,14,20	g	350013597300000224	21-44						CARRIER IMMUNOGLOBULINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
829	chr24	32004551	32004575	3500265438	24		32004551	32004575	8421504	1	24	0	g	350026543800000099	1-25						Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof	Frank	1998	0		
831	chr24	32294875	32294900	3500068521	23		32294875	32294900	8421504	3	6,13,4	0,7,21	c	350006852100000366	4-27						About ICRISAT	www.icrisat.org	0	0		
832	chr24	32397025	32397053	3500100734	26		32397025	32397053	8421504	3	8,14,4	0,9,24	g	350010073400000026	19-45						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
838	chr24	33205588	33223152	3500018529	41		33205588	33223152	8421504	4	7,15,5,14	0,9,17542,17550	g	350001852900000181,350001852900000278	4-26,23-42						***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Streptococcus pneumoniae antigens and vaccines	Choi	1997	0		
838	chr24	33284800	33284828	3500181891	23		33284800	33284828	8421504	2	14,9	0,19	g	350018189100000020	17-40			10.1111/j.1365-2958.2005.04618.x	1365-2958	Molecular Microbiology	Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK - Charlet - 2005 - Molecular Microbiology - Wiley Online Library	Charlet	2005	0		
843	chr24	33834978	33858478	3500099616	221		33834978	33858478	8421504	11	9,16,29,19,27,11,8,29,17,15,41	0,1220,6197,9183,9346,10181,10356,12949,18746,20082,23459	c	350009961600000032,350009961600000041,350009961600000045,350009961600000049,350009961600000068,350009961600000081	21-46,0-48,0-38,10-47,0-32,0-41						Genes for Niemann-Pick type C disease	Carstea	1999	0		
843	chr24	33851682	33851705	3500454678	23		33851682	33851705	8421504	1	23	0	c	350045467800000157	22-45						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2004	0		
843	chr24	33852280	33897356	3500155900	39		33852280	33897356	8421504	4	6,14,4,15	0,9,45056,45061	c	350015590000000616,350015590000000075	13-33,9-28						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
843	chr24	33912566	33912844	3500031998	41		33912566	33912844	8421504	2	20,21	0,257	c	350003199800000018,350003199800000017	0-20,0-21						REPRODUCTION	uction-online.org	0	0		
843	chr24	33912866	33912891	3500430320	25		33912866	33912891	8421504	1	25	0	c	350043032000000011	0-25						METHOD FOR EXAMINATION OF ACTION OF ANTI-CANCER AGENT UTILIZING SPLICING DEFECT AS MEASURE	Mizui	2008	0		RIOK3
851	chr24	34934355	34934417	3500225389	62		34934355	34934417	8421504	1	62	0	g	350022538900000053	58-123						Pegasoferae? - Genomewiki	nomewiki.ucsc.edu	0	0		
853	chr24	35166170	35166194	3500377038	23		35166170	35166194	8421504	2	19,4	0,20	g	350037703800000153	0-29						Trail receptor-binding agents and uses of the same	Jia	2007	0		
853	chr24	35219223	35219249	3500313829	23		35219223	35219249	8421504	2	7,16	0,10	g	350031382900000043	4-27						Libraries of recombinant chimeric proteins	Laban	2011	0		
853	chr24	35222553	35225894	3500423784	43		35222553	35225894	8421504	2	21,22	0,3319	c,g	350042378400000020,350042378400000020,350042378400000036	0-21,0-21,0-22						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIB1
853	chr24	35222553	35225894	3500400478	45		35222553	35225894	8421504	2	23,22	0,3319	c,g	350040047800000119,350040047800000119,350040047800000120,350040047800000120,350040047800000121,350040047800000121,350040047800000164	0-21,0-21,0-21,0-21,0-23,0-23,0-22					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		
853	chr24	35222553	35225892	3500355416	40		35222553	35225892	8421504	2	20,20	0,3319	c,g	350035541600000016,350035541600000016,350035541600000015,350035541600000045,350035541600000046	0-19,0-19,0-20,0-20,0-19						Rnai-mediated Inhibition Of Connexin 43 For Treatment Of Iop-related Conditions 	.freshpatents.com	0	0		MIB1
853	chr24	35222553	35222579	3500265008	26		35222553	35222579	8421504	1	26	0	c	350026500800000016	3-29						Cns targeting aav vectors and methods of use thereof	Gao	2013	0		MIB1
853	chr24	35222553	35222576	3500353647	23		35222553	35222576	8421504	1	23	0	c	350035364700000066	0-23						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		
853	chr24	35222553	35222576	3500351139	23		35222553	35222576	8421504	1	23	0	c,g	350035113900000066,350035113900000066,350035113900000184,350035113900000184,350035113900000183	0-23,0-23,0-19,0-19,0-22						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
853	chr24	35245226	35245255	3500383109	26		35245226	35245255	8421504	2	15,11	0,18	c	350038310900000004	10-36						Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis	www.cdfd.org.in	0	0		
853	chr24	35255132	35256450	3500044944	23		35255132	35256450	8421504	2	3,20	0,1298	c	350004494400000011	24-47						Supporting Information	www.pnas.org	0	0		
854	chr24	35283613	35283638	3500239678	24		35283613	35283638	8421504	2	5,19	0,6	g	350023967800000024	21-45						Streptomyces Avermitilis Gene Directing The Ratio of B2:B1 Avermectins - Patent application	www.faqs.org	0	0		
854	chr24	35374123	35381392	3500166180	48		35374123	35381392	8421504	3	24,10,14	0,3960,7255	c	350016618000000023,350016618000000022	9-33,9-33					Journal of Virology	Human Immunodeficiency Virus Type 1 Gag Polyprotein Multimerization Requires the Nucleocapsid Domain and RNA and Is Promoted by the Capsid-Dimer Interface and the Basic Region of Matrix Protein	Mark	1999	0		
854	chr24	35376409	35381398	3500164379	204		35376409	35381398	8421504	3	107,77,20	0,1607,4969	p	350016437900015046	174-378						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		
855	chr24	35444701	35444726	3500376130	24		35444701	35444726	8421504	2	11,13	0,12	g	350037613000000027	10-34						Replication competent hepatitis C virus and methods of use	Lemon	2004	0		
855	chr24	35444701	35444726	3500341280	24		35444701	35444726	8421504	2	11,13	0,12	g	350034128000000027	10-34						Replication competent hepatitus C virus and methods of use	Lemon	2002	0		
855	chr24	35444701	35444726	3500144356	24		35444701	35444726	8421504	2	11,13	0,12	g	350014435600000027,350014435600000093	10-34,10-34						Replication competent hepatitis C virus and methods of use - Patent application	www.faqs.org	0	0		
855	chr24	35518677	35518708	3500432119	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350043211900000005	0-32						PROCESS FOR PREPARING DIPEPTIDYL IV INHIBITORS AND INTERMEDIATES THEREFOR - BRISTOL-MYERS SQUIBB COMPANY	www.sumobrain.com	0	0		
855	chr24	35518677	35518708	3500411918	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350041191800000005	0-32					Patent	Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor (Patent US:8222009)	Cadin	2012	0		
855	chr24	35518677	35518708	3500388311	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350038831100000009,350038831100000005	0-32,0-32						METHODS AND COMPOUNDS FOR PRODUCING DIPEPTIDYL PEPTIDASE IV INHIBITORS AND INTERMEDIATES THEREOF - Patent application	www.faqs.org	0	0		
855	chr24	35518677	35518708	3500312345	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350031234500000005	0-32					Patent	Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor (Patent US:8222009)	Cadin	2012	0		
855	chr24	35518677	35518708	3500297355	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350029735500000007	0-32					Patent	Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor (Patent CN:1968925)	Mai Ke Er *Bo Li Di Nuo 	2013	0		
855	chr24	35518677	35518708	3500281378	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350028137800000005	0-32					Patent	Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof (Patent US:7420079)	Augeri	2008	0		
855	chr24	35518677	35518708	3500271105	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350027110500000005	0-32					Patent	Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor (Patent US:8361761)	Politino	2013	0		
855	chr24	35518677	35518708	3500260632	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350026063200000004	0-32					Patent	Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor (Patent US:7741082)	Cadin	2010	0		
855	chr24	35518677	35518708	3500258534	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350025853400000004	0-32						Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor	Politino	2005	0		
855	chr24	35518677	35518708	3500131311	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350013131100000006,350013131100000014	0-32,0-32						Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof	T*C*Wu 	2006	0		
855	chr24	35518677	35518708	3500126734	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350012673400000009,350012673400000005	0-32,0-32						Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor - Patent application	www.faqs.org	0	0		
855	chr24	35518677	35518708	3500117601	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350011760100000005	0-32						Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof	Vu	2005	0		
855	chr24	35518677	35518708	3500106243	26		35518677	35518708	8421504	3	6,7,13	0,7,18	g	350010624300000005	0-32						METHODS AND COMPOUNDS FOR PRODUCING DIPEPTIDYL PEPTIDASE IV INHIBITORS AND INTERMEDIATES THEREOF	Vu	2010	0		
858	chr24	35898414	35898444	3500228877	30		35898414	35898444	8421504	1	30	0	g	350022887700000004	0-30						Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways	ir.cmu.edu.tw	0	0		
859	chr24	35947252	35947278	3500404429	23		35947252	35947278	8421504	2	9,14	0,12	c	350040442900000014	0-23						CROWN CORK COMPRISING 27 GROOVES - Tapon Corona V, DE S. A. C.	www.sumobrain.com	0	0		
859	chr24	35947252	35947278	3500368545	23		35947252	35947278	8421504	2	9,14	0,12	c	350036854500000014	0-23						Prohormone convertase transformed cells	Gorman	1994	0		
859	chr24	35947252	35947278	3500162943	23		35947252	35947278	8421504	2	9,14	0,12	c	350016294300000005	0-23					Patent	Prohormone convertase transformed cells (Patent EP:0616645)	Gorman	2001	0		
859	chr24	35947252	35947278	3500050395	23		35947252	35947278	8421504	2	9,14	0,12	c	350005039500000014	0-23						Prohormone convertase transformed cells and polypeptide synthesis	Gorman	2001	0		
859	chr24	35947252	35947278	3500016486	23		35947252	35947278	8421504	2	9,14	0,12	c	350001648600000014	0-23						Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells	Gorman	1993	0		
859	chr24	35947252	35947278	3500009534	23		35947252	35947278	8421504	2	9,14	0,12	c	350000953400000014	0-23						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
859	chr24	35966206	35967567	3500249194	86		35966206	35967567	8421504	3	25,40,21	0,27,1340	c	350024919400000001,350024919400000002,350024919400000000	0-25,0-40,0-21						Linking Transcriptional Elongation and Messenger RNA Export to Metastatic Breast Cancers	.aacrjournals.org	0	0		THOC1
859	chr24	35975732	35975757	3500220182	23		35975732	35975757	8421504	3	7,12,4	0,8,21	c	350022018200000194	7-30						MICROORGANISMS FOR THE PRODUCTION OF METHYL ETHYL KETONE AND 2-BUTANOL - Patent application	www.faqs.org	0	0		
859	chr24	36011800	36039560	3500030963	82		36011800	36039560	8421504	3	22,30,30	0,27298,27730	c	350003096300000213,350003096300000215,350003096300000074,350003096300000056	8-30,8-30,15-45,0-30						Novel scavenger receptor	Ruo Gong Shen Long 	2008	0		
859	chr24	36012026	36039560	3500234195	49		36012026	36039560	8421504	2	19,30	0,27504	c	350023419500000120,350023419500000056	7-26,0-30					Patent	Novel scavenger receptor (Patent CN:101319010)	Ruo Gong Shen Long 	2013	0		
107	chr24	36013799	36050518	3500064229	211		36013799	36050518	8421504	7	37,5,20,36,23,89,1	0,8396,10902,25203,25387,27085,36718	c	350006422900000113,350006422900000103,350006422900000072,350006422900000164,350006422900000047,350006422900000046	6-48,0-20,12-48,0-23,0-42,0-48						Novel scavenger receptors	Ruo Gong Shen Long 	2005	0		
862	chr24	36333422	36333445	3500439032	23		36333422	36333445	8421504	1	23	0	c	350043903200000015	12-35		18411248	10.1242/jcs.021089	0021-9533	Journal of Cell Science	Organellar dynamics during the cell cycle of Toxoplasma gondii	Nishi	2008	6		
862	chr24	36363183	36389072	3500093266	2444		36363183	36389072	8421504	8	57,119,149,168,433,138,215,1165	0,1021,2596,8127,10755,16302,20360,24724	c,g	350009326600000324,350009326600000324,350009326600000052,350009326600000373,350009326600000323,350009326600000322,350009326600000325,350009326600000326,350009326600000327,350009326600000328,350009326600000090,350009326600000330,350009326600000335,350009326600000336,350009326600000337,350009326600000339,350009326600000340,350009326600000227,350009326600000342,350009326600000344,350009326600000235,350009326600000349,350009326600000350,350009326600000392,350009326600000364,350009326600000047,350009326600000353,350009326600000354	0-109,0-109,12-40,21-48,0-2431,0-2419,0-48,0-48,0-48,0-48,21-48,0-48,0-48,0-48,0-48,0-48,0-48,28-48,0-48,0-48,0-20,0-48,0-48,0-42,23-45,23-45,0-52,0-938						Methods and compositions for diagnosing and treating chromosome -18p related disorders	Chen	2000	0		
862	chr24	36400581	36400629	3500430509	48		36400581	36400629	8421504	1	48	0	p	350043050900015048	0-48						 DNA Encoding Neospora Dihydrofolate Reductase 	www.docstoc.com	0	0		TYMS
862	chr24	36402794	36405210	3500169933	135		36402794	36405210	8421504	2	66,69	0,2347	p	350016993300015118,350016993300015171	3-69,3-72						Virology Journal BioMed Central	www.virologyj.com	0	0		
862	chr24	36402806	36402854	3500182685	48		36402806	36402854	8421504	1	48	0	p	350018268500015001	0-48			10.1099/vir.0.80048-0	0022-1317	Journal of General Virology	Identification of the thymidylate synthase within the genome of white spot syndrome virus	Li	2004	3		TYMS
863	chr24	36440294	36440317	3500438553	23		36440294	36440317	8421504	1	23	0	c	350043855300000401	24-47						Eph-related tyrosine kinases, nucleotide sequences and methods of use	Pasquale	1993	0		
863	chr24	36450053	36456263	3500366935	51		36450053	36456263	8421504	2	20,31	0,6179	c,g	350036693500000009,350036693500000008,350036693500000008	16-36,12-43,12-43						THE J B C &#xa9; 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. The Tyrosine Kinase Hck Is an Inhibitor of HIV-1 Replication Counteracted by the Viral Vif Protein*	www.jbc.org	0	0		YES1
864	chr24	36582480	36582594	3500269878	114		36582480	36582594	8421504	1	114	0	p	350026987800015026,350026987800015027	0-114,0-81						ANALYSES OF cDNA AND RECOMBINANT PROTEIN FOR A POTENT VASOACTIVE PROTEIN IN SALIVA OF A BLOOD-FEEDING BLACK FLY, SIMULIUM VITTATUM	eb.biologists.org	0	0		ADCYAP1
864	chr24	36582480	36582594	3500193587	114		36582480	36582594	8421504	1	114	0	p	350019358700015005	0-114						Potassium channel mediated delivery of agents through the blood-brain barrier	Black	2005	0		ADCYAP1
864	chr24	36582480	36582594	3500183626	114		36582480	36582594	8421504	1	114	0	p	350018362600015008	0-114						Potassium channel mediated delivery of agents through the blood-brain barrier	Black	2004	0		ADCYAP1
864	chr24	36582480	36582594	3500101431	114		36582480	36582594	8421504	1	114	0	p	350010143100015010	0-114						Rationally designed antibodies	Bowdish	2005	0		ADCYAP1
864	chr24	36582480	36582594	3500054901	114		36582480	36582594	8421504	1	114	0	p	350005490100015001,350005490100015000,350005490100015003,350005490100015002	0-69,0-114,0-81,0-114					Patent	Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia (Patent US:7615219)	Freson	2009	0		ADCYAP1
864	chr24	36582480	36582588	3500038974	108		36582480	36582588	8421504	1	108	0	p	350003897400015022	0-108						Derwent GENESEQ Introduction	-international.de	0	0		ADCYAP1
864	chr24	36582480	36582561	3500333599	81		36582480	36582561	8421504	1	81	0	p	350033359900015001	0-81						Screening and treatment methods using IGS5 enzymes of the metalloprotease family	Deleersnijder	2007	0		ADCYAP1
864	chr24	36582531	36582576	3500271178	45		36582531	36582576	8421504	1	45	0	p	350027117800015002	0-45						Methods and Compositions Involving A1c Subunit of L-Type Calcium Channels in Smooth Muscle Cells - Patent application	www.faqs.org	0	0		ADCYAP1
864	chr24	36582543	36582594	3500340282	51		36582543	36582594	8421504	1	51	0	p	350034028200015003	0-51						FUNCTIONAL CHARACTERIZATION OF THREE G PROTEIN-COUPLED RECEPTORS CAENORHABDITIS ELEGANS	digilabglobal.com	0	0		ADCYAP1
864	chr24	36652411	36652437	3500327724	25		36652411	36652437	8421504	2	7,18	0,8	g	350032772400000052	15-40					Patent	Mutated thermostable nucleic acid polymerase enzyme from thermotoga maritima (Patent US:5420029)	Gelfand	1995	0		
865	chr24	36708405	36708429	3500220551	23		36708405	36708429	8421504	2	19,4	0,20	g	350022055100000204	8-31						Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same	Ye 	2009	0		
869	chr24	37232155	37232183	3500020971	23		37232155	37232183	8421504	2	13,10	0,18	g	350002097100000001	0-23		15485815	10.1074/jbc.M405331200	0021-9258	Journal of Biological Chemistry	Interleukin-10 Induces Uteroglobin-related Protein (UGRP) 1 Gene Expression in Lung Epithelial Cells through Homeodomain Transcription Factor T/EBP/NKX2.1	Srisodsai	2004	5		
869	chr24	37239028	37261644	3500243302	204		37239028	37261644	8421504	6	48,35,31,13,48,29	0,2761,4539,5623,6580,22587	c	350024330200000060,350024330200000065,350024330200000068,350024330200000072,350024330200000086	0-48,0-35,0-44,0-48,0-29						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX - Patent application	www.faqs.org	0	0		
869	chr24	37244748	37261089	3500022158	43		37244748	37261089	8421504	3	10,14,19	0,806,16322	c	350002215800000002,350002215800000025,350002215800000010	0-24,28-47,0-19						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX	Nakamura	2006	0		
874	chr24	37934172	37934198	3500225410	23		37934172	37934198	8421504	2	6,17	0,9	c	350022541000000255	11-34						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	osdir.com/patents	0	0		
874	chr24	37934172	37934198	3500152492	23		37934172	37934198	8421504	2	6,17	0,9	c	350015249200000381	10-33						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
875	chr24	38023735	38023758	3500309840	23		38023735	38023758	8421504	1	23	0	c	350030984000001130	16-39						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
878	chr24	38414829	38441220	3500453770	85		38414829	38441220	8421504	5	25,3,4,29,24	0,9978,20374,20381,26367	c	350045377000000000,350045377000000002,350045377000000003	2-27,0-36,10-34		17065553	10.1091/mbc.E06-08-0684	1059-1524	Molecular Biology of the Cell	Fibronectin Matrix Assembly Requires Distinct Contributions from Rho Kinases I and -II	Yoneda	2007	5		
878	chr24	38424720	38424748	3500370305	26		38424720	38424748	8421504	3	18,4,4	0,19,24	c	350037030500000433	18-44						 3 	www.docstoc.com	0	0		
878	chr24	38424720	38424748	3500166501	26		38424720	38424748	8421504	3	18,4,4	0,19,24	c	350016650100000444	18-44						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
878	chr24	38424809	38435233	3500149391	28		38424809	38435233	8421504	3	1,4,23	0,10394,10401	c	350014939100000000	2-30			10.1152/ajpcell.00631.2004		American Journal of Physiology - Cell Physiolog	Is myosin light-chain phosphorylation a regulatory signal for the osmotic activation of the Na+-K+-2Cl&#x2212; cotransporter?	Ciano-Oliveira	2005	0		
878	chr24	38440180	38440206	3500083825	23		38440180	38440206	8421504	2	8,15	0,11	c	350008382500000001	19-42						20060201 040	www.dtic.mil	0	0		
109	chr24	38528783	38536461	3500421308	45		38528783	38536461	8421504	2	19,26	0,7652	c,g	350042130800000000,350042130800000005	0-19,0-26			10.1167/iovs.07-0041	1552-5783	Investigative Ophthalmology & Visual Science	Linkage Mapping of Ovine Microphthalmia to Chromosome 23, the Sheep Orthologue of Human Chromosome 18	Tetens	2007	0		
109	chr24	38528783	38536461	3500310553	85		38528783	38536461	8421504	4	19,20,20,26	0,5238,6313,7652	c,g	350031055300000000,350031055300000002,350031055300000004,350031055300000005,350031055300000005	0-19,0-20,0-20,0-26,0-26			10.1167/iovs.07-0041	1552-5783	Investigative Ophthalmology & Visual Science	Linkage Mapping of Ovine Microphthalmia to Chromosome 23, the Sheep Orthologue of Human Chromosome 18	Tetens	2007	0		
109	chr24	38534021	38536461	3500302808	46		38534021	38536461	8421504	2	20,26	0,2414	c,g	350030280800000002,350030280800000005	0-20,0-26						Linkage Mapping of Ovine Microphthalmia to Chromosome 23, the Sheep Orthologue of Human Chromosome 18	www.iovs.org	0	0		
883	chr24	39130249	39130275	3500412261	24		39130249	39130275	8421504	2	13,11	0,15	g	350041226100000001	0-30						US Patent # 6,004,555. Methods for the specific coagulation of vasculature - Patents.com	www.patents.com	0	0		
890	chr24	40001895	40001921	3500083027	23		40001895	40001921	8421504	3	11,8,4	0,13,22	g	350008302700000155	25-48						Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group b streptococcus and further uses thereof	D*J*Lai Yin Ai De 	2005	0		
890	chr24	40001898	40001922	3500187571	23		40001898	40001922	8421504	2	7,16	0,8	g	350018757100000002	9-32		21541284	10.1371/journal.pone.0019265	1932-6203	PLOS ONE	PLOS ONE: Endophytic Bacteria in Toxic South African Plants: Identification, Phylogeny and Possible Involvement in Gousiekte	Verstraete	2011	4		
891	chr24	40112723	40112748	3500201280	23		40112723	40112748	8421504	2	7,16	0,9	g	350020128000000032	0-23						DNA encoding nestin protein	Mckay	1992	0		
891	chr24	40144779	40144803	3500338992	24		40144779	40144803	8421504	1	24	0	g	350033899200000013,350033899200000048	12-36,12-36						Antigen presenting system and methods for activation of T-cells	Cai	2002	0		
891	chr24	40144779	40144803	3500337527	24		40144779	40144803	8421504	1	24	0	g	350033752700000014	12-36						In vitro activation of cytotoxic t cells	Peterson	1993	0		
891	chr24	40144779	40144803	3500220319	24		40144779	40144803	8421504	1	24	0	g	350022031900000014	12-36						Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines	Peterson	1992	0		
893	chr24	40411361	40411387	3500399152	24		40411361	40411387	8421504	3	4,4,16	0,5,10	c	350039915200000031,350039915200000329	0-24,0-24						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease - US Patent 6790612 Description	ww.patentstorm.us	0	0		
893	chr24	40411361	40411387	3500261697	24		40411361	40411387	8421504	3	4,4,16	0,5,10	c	350026169700000031,350026169700000329	0-24,0-24						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease	Potts	2001	0		
896	chr24	40876545	40876568	3500379511	23		40876545	40876568	8421504	1	23	0	g	350037951100000026	0-23						Gammaretrovirus associated with cancer	Casey	2006	0		
899	chr24	41157437	41157466	3500228656	23		41157437	41157466	8421504	3	7,4,12	0,12,17	g	350022865600000017	0-23		18426905	10.1128/MCB.01914-07		Molecular and Cellular Biology	Downregulation of Vertebrate Tel (ETV6) and Drosophila Yan Is Facilitated by an Evolutionarily Conserved Mechanism of F-Box-Mediated Ubiquitination 	M.	July	0		
903	chr24	41717874	41717898	3500178185	24		41717874	41717898	8421504	1	24	0	g	350017818500000127	10-38						Fc-free antibodies comprising two fab fragments and methods of use	Bruenker	2013	0		
903	chr24	41773572	41773600	3500220714	24		41773572	41773600	8421504	2	14,10	0,18	g	350022071400000007	1-25						Terpenoid Biosynthesis	gradworks.umi.com	0	0		
906	chr24	42192574	42192602	3500069961	24		42192574	42192602	8421504	3	13,5,6	0,16,22	g	350006996100000026,350006996100000071	6-30,6-30						THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES - Patent application	www.faqs.org	0	0		
908	chr24	42338935	42338969	3500144802	28		42338935	42338969	8421504	3	11,11,6	0,14,28	g	350014480200000034,350014480200000030	3-32,4-32						Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies	Mudde	2007	0		
909	chr24	42534347	42534377	3500432400	24		42534347	42534377	8421504	3	4,7,13	0,5,17	c	350043240000000025	0-24						Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	Couture	2010	0		
909	chr24	42534449	42535723	3500083639	25		42534449	42535723	8421504	3	2,17,6	0,1249,1268	c	350008363900000171	10-35					Patent	Methods for screening for mutations at various positions in the introns and exons of the cystic fibrosis gene (Patent US:5981178)	Kerem	1999	0		
911	chr24	42743877	42743903	3500134343	23		42743877	42743903	8421504	3	6,4,13	0,8,13	c	350013434300000058	0-23						Assessing the complex nature of behavior: Sequence-based and transcriptomic analyses in a mouse model of extremes in trait anxiety	b.uni-muenchen.de	0	0		
911	chr24	42759382	42759436	3500113985	54		42759382	42759436	8421504	1	54	0	p	350011398500015000	0-54		21941513	10.3389/fphys.2011.00059	1664-042X	Frontiers in Physiology	 Frontiers | Glycosylation of Twisted Gastrulation is Required for BMP Binding and Activity during Craniofacial Development | Frontiers in Craniofacial Biology 	Billington	2011	0		TWSG1
916	chr24	43472676	43472704	3500101538	23		43472676	43472704	8421504	2	9,14	0,14	g	350010153800000546	1-24						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
917	chr24	43524305	43524332	3500265679	26		43524305	43524332	8421504	2	11,15	0,12	g	350026567900000008	0-26						Process for producing modified peptide	Nan Zhu Yi Chun 	2005	0		
917	chr24	43524305	43524332	3500023611	26		43524305	43524332	8421504	2	11,15	0,12	g	350002361100000004	0-26						Method for producing a modified peptide - Patent # 7138489 - PatentGenius	.patentgenius.com	0	0		
919	chr24	43870357	43870384	3500265596	26		43870357	43870384	8421504	2	21,5	0,22	c	350026559600000354	2-28						NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)	Andersen	2000	0		
114	chr24	43870646	43918008	3500101972	117		43870646	43918008	8421504	4	29,28,12,48	0,45426,45868,47314	c	350010197200000064,350010197200000007,350010197200000045,350010197200000051	0-29,0-29,7-47,0-48						G Proteins, Polynucleotides Encoding the Same and Utilization Thereof - Patent application	www.faqs.org	0	0		
919	chr24	43870646	43870675	3500120337	29		43870646	43870675	8421504	1	29	0	c	350012033700000007	0-29						G Proteins, Polynucleotides Encoding The Same And Utilization Thereof 	.freshpatents.com	0	0		
919	chr24	43908440	43908465	3500033147	25		43908440	43908465	8421504	1	25	0	c	350003314700000023	0-25					Patent	Double-muscling in mammals (Patent US:6103466)	Georges	2000	0		
920	chr24	43915212	43915238	3500304078	24		43915212	43915238	8421504	3	4,16,4	0,5,22	c	350030407800000066	5-29						Humanized Anti-ccr2 Antibodies And Methods Of Use Therefor 	.freshpatents.com	0	0		
920	chr24	43972610	43972636	3500272261	23		43972610	43972636	8421504	2	7,16	0,10	g	350027226100000029	0-23					Patent	Hefevarianten und verfahren zur herstellung von glykoprotein enthaltenden zuckerketten vom s&#xe4;ugetiertyp Containing Hefevarianten and process for the production of glycoprotein sugar chains from the mammal type (Patent DE:60032370)	Chiba	2007	0		
920	chr24	43982457	43986690	3500197718	80		43982457	43986690	8421504	4	20,20,20,20	0,41,996,4213	c,g	350019771800000007,350019771800000007,350019771800000003,350019771800000008,350019771800000004	0-20,0-20,0-20,0-20,0-20						Saturated fatty acids stimulate and insulin suppresses CIDE-A expression in bovine mammary epithelial cells q - ResearchGate	.researchgate.net	0	0		
920	chr24	44007615	44007640	3500378510	24		44007615	44007640	8421504	2	13,11	0,14	c	350037851000000096	15-39						P2x receptors (purinoceptor family)	Buell	1995	0		
921	chr24	44047893	44047920	3500365545	23		44047893	44047920	8421504	2	6,17	0,10	g	350036554500000001	12-38		17942558	10.1128/JVI.01788-07	0022-538X	Journal of Virology	Crystal Structure of the NS3 Protease-Helicase from Dengue Virus	Luo	2008	5		
922	chr24	44245327	44245355	3500370435	23		44245327	44245355	8421504	2	17,6	0,22	g	350037043500000782	0-25						Neisseria meningitidis antigens and compositions	Fraser	2008	0		
922	chr24	44245327	44245355	3500003517	23		44245327	44245355	8421504	2	17,6	0,22	g	350000351700000915	0-25						 Neisseria Meningitidis Antigens And Compositions 	www.docstoc.com	0	0		
922	chr24	44261999	44262024	3500338718	23		44261999	44262024	8421504	2	14,9	0,16	c	350033871800000082	12-35						US Patent # 6,824,781. Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist - Patents.com	www.patents.com	0	0		
923	chr24	44313983	44314049	3500044093	66		44313983	44314049	8421504	1	66	0	p	350004409300015025	0-66						A Fission-Yeast Gene Encoding a Protein with Features of Protein-Tyrosine- Phosphatases	www.jstor.org	0	0		PTPN2
923	chr24	44313998	44314046	3500382830	48		44313998	44314046	8421504	1	48	0	p	350038283000015047	0-48					Patent	Prosphatase binding assay (Patent US:6114132)	Desmarais	2000	0		PTPN2
923	chr24	44313998	44314046	3500019061	48		44313998	44314046	8421504	1	48	0	p	350001906100015042	0-48						US Patent # 6,348,572. Ligands for phosphatase binding assay - Patents.com	www.patents.com	0	0		PTPN2
923	chr24	44403782	44412988	3500264868	567		44403782	44412988	8421504	6	8,99,141,158,151,10	0,3846,5807,6649,8068,9196	p	350026486800015003,350026486800015002,350026486800015004	6-315,0-540,0-84						21 human secreted proteins	Baker	2002	0		
925	chr24	44686744	44686769	3500433279	23		44686744	44686769	8421504	2	7,16	0,9	c	350043327900000092	4-27						Transgenic plants presenting a modified inulin producing profile	Koops	2000	0		
926	chr24	44741275	44766285	3500002616	1089		44741275	44766285	8421504	5	360,180,180,21,348	0,537,24158,24413,24662	p,c	350000261600015207,350000261600015214,350000261600015185,350000261600015228,350000261600015169,350000261600000051,350000261600015145,350000261600015138	0-180,0-180,0-60,0-180,0-180,0-21,0-180,0-168						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	dare.ubn.kun.nl	0	0		
926	chr24	44741839	44741884	3500385413	45		44741839	44741884	8421504	1	45	0	p	350038541300015016	0-45						DNA molecules encoding the melanocortin 5 receptor protein from rhesus monkey	Fong	2001	0		
926	chr24	44742016	44765745	3500446401	80		44742016	44765745	8421504	2	32,48	0,23681	c	350044640100000078,350044640100000032	0-32,0-48						Human melanocyte stimulating hormone receptor polypeptide and DNA	Wikberg	1995	0		
926	chr24	44765309	44783851	3500430452	843		44765309	44783851	8421504	9	5,246,96,48,48,143,48,184,25	0,22,316,460,556,605,796,892,18517	c	350043045200000091,350043045200000090,350043045200000089,350043045200000088,350043045200000087,350043045200000085,350043045200000084,350043045200000082,350043045200000080,350043045200000059,350043045200000079,350043045200000078,350043045200000077,350043045200000075,350043045200000073,350043045200000072	0-65,0-42,0-48,0-48,0-48,0-48,0-48,0-48,0-48,21-47,0-47,0-48,0-48,0-48,0-48,7-168						Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals	Cone	1996	0		
926	chr24	44765309	44783851	3500029269	620		44765309	44783851	8421504	7	124,48,96,48,95,184,25	0,172,268,556,605,892,18517	c,g	350002926900000041,350002926900000041,350002926900000040,350002926900000038,350002926900000036,350002926900000036,350002926900000035,350002926900000030,350002926900000029,350002926900000028,350002926900000023,350002926900000022	0-75,0-75,0-49,0-48,10-58,10-58,0-48,0-48,0-47,0-48,0-48,7-168						DNA sequence encoding bovine and human adrenocorticotropic hormone receptors	Cone	1992	0		
926	chr24	44766038	44766061	3500338834	23		44766038	44766061	8421504	1	23	0	c	350033883400000005	20-43						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
926	chr24	44766038	44766061	3500306609	23		44766038	44766061	8421504	1	23	0	c	350030660900000005	20-43						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
933	chr24	45651710	45651738	3500111840	23		45651710	45651738	8421504	2	12,11	0,17	g	350011184000000083	0-24						Indoleamine 2,3-Dioxygenase-2 - Patent application	www.faqs.org	0	0		
935	chr24	45998329	45998353	3500434419	23		45998329	45998353	8421504	2	14,9	0,15	g	350043441900000008	8-31						Insights into the selenocysteine incorporation mechanism in mammals.	eses.u-strasbg.fr	0	0		
938	chr24	46296908	46296937	3500361666	23		46296908	46296937	8421504	3	7,4,12	0,12,17	g	350036166600000063,350036166600000253	0-24,0-24						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
940	chr24	46601453	46623533	3500425956	84		46601453	46623533	8421504	4	19,24,21,20	0,7326,14668,22060	c,g	350042595600000000,350042595600000000,350042595600000001,350042595600000003,350042595600000002,350042595600000002	0-19,0-19,0-24,0-21,0-20,0-20		15845882	10.1152/ajpregu.00127.2005		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	UT-B is expressed in bovine rumen: potential role in ruminal urea transport	Stewart	2005	0		
940	chr24	46601453	46623533	3500247687	84		46601453	46623533	8421504	4	19,24,21,20	0,7326,14668,22060	c,g	350024768700000000,350024768700000000,350024768700000001,350024768700000003,350024768700000002,350024768700000002	0-19,0-19,0-24,0-21,0-20,0-20		15845882	10.1152/ajpregu.00127.2005		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	UT-B is expressed in bovine rumen: potential role in ruminal urea transport	Stewart	2005	0		
940	chr24	46601453	46623533	3500234667	84		46601453	46623533	8421504	4	19,24,21,20	0,7326,14668,22060	c,g	350023466700000000,350023466700000000,350023466700000001,350023466700000003,350023466700000002,350023466700000002	0-19,0-19,0-24,0-21,0-20,0-20		15845882	10.1152/ajpregu.00127.2005		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	UT-B is expressed in bovine rumen: potential role in ruminal urea transport	Stewart	2005	0		
940	chr24	46613952	46614049	3500267670	40		46613952	46614049	8421504	2	20,20	0,77	c	350026767000000000,350026767000000001	0-20,0-20		19966167	10.2527/jas.2009-2218	0021-8812	Journal of Animal Science	Effects of partial ruminal defaunation on urea-nitrogen recycling, nitrogen metabolism, and microbial nitrogen supply in growing lambs fed low or high dietary crude protein concentrations	Kiran	2010	2		
940	chr24	46616462	46621399	3500353938	45		46616462	46621399	8421504	3	24,20,1	0,75,4936	c	350035393800000054,350035393800000030	0-24,0-21						DNA and RNA Profiling in Human Blood	www.bjcancer.org	0	0		
941	chr24	46737673	46737696	3500126821	23		46737673	46737696	8421504	1	23	0	c	350012682100000007	0-23		9973359		0021-9193	Journal of Bacteriology	Conversion of 3-Chlorocatechol by Various Catechol 2,3-Dioxygenases and Sequence Analysis of the Chlorocatechol Dioxygenase Region of Pseudomonas putida GJ31	Mars	1999	4		
943	chr24	46959755	46959782	3500446401	23		46959755	46959782	8421504	2	9,14	0,13	c	350044640100000079	9-40						Human melanocyte stimulating hormone receptor polypeptide and DNA	Wikberg	1995	0		
944	chr24	47063990	47065112	3500071382	42		47063990	47065112	8421504	2	22,20	0,1102	c	350007138200000015,350007138200000014	0-22,0-20						REPRODUCTION	uction-online.org	0	0		
944	chr24	47065081	47065326	3500379004	43		47065081	47065326	8421504	3	22,8,13	0,116,232	c,g	350037900400000001,350037900400000001,350037900400000000	0-22,0-22,0-21						Adaptation to High Grain Diets Proceeds Through Minimal Immune System Stimulation and Differences in Extracellular Matrix Protein Expression in A Model of Subacute Ruminal Acidosis in Non-lactating Dairy Cows	thescipub.com	0	0		
944	chr24	47065935	47067140	3500258364	120		47065935	47067140	8421504	3	60,19,41	0,941,1164	p	350025836400015031,350025836400015015	0-60,0-60						Czech Journal of FOOD SCIENCES	ecnostpotravin.cz	0	0		ATP5A1
944	chr24	47065935	47067140	3500114038	120		47065935	47067140	8421504	3	60,19,41	0,941,1164	p	350011403800015030,350011403800015014	0-60,0-60						Molecular Cloning and Characterisation of Alpha Subunit of H -ATPase in Lactobacillus casei Zhang	ulturejournals.cz	0	0		ATP5A1
944	chr24	47066055	47066106	3500027621	51		47066055	47066106	8421504	1	51	0	p	350002762100015027	0-51						TEREZA CRISTINA VIEIRA de REZENDE	itorio.bce.unb.br	0	0		ATP5A1
944	chr24	47066088	47066277	3500022688	90		47066088	47066277	8421504	2	69,21	0,168	p	350002268800015023	0-90						&#x30c6;&#x30f3;&#x30b5;&#x30a4;&#x306e;&#x7d30;&#x80de;&#x8cea;&#x96c4;&#x6027;&#x4e0d;&#x7a14;&#x6027;&#x306b;&#x304a;&#x3051;&#x308b;&#x30df;&#x30c8;&#x30b3;&#x30f3;&#x30c9;&#x30ea;&#x30a2;&#x907a; Issue Date http://hdl.handle.net/2115/12155	lib.hokudai.ac.jp	0	0		ATP5A1
944	chr24	47069470	47069518	3500405973	48		47069470	47069518	8421504	1	48	0	p	350040597300015056	3-51						Protein-Protein-Interaktion des kardialen Ankyrin-Repeat-Proteins, CARP, mit dem zytoplasmatischen -Aktin	ni-duesseldorf.de	0	0		ATP5A1
944	chr24	47107473	47107500	3500297423	25		47107473	47107500	8421504	2	8,17	0,10	g	350029742300000000	1-26		15689372	10.1242/dev.01668	0950-1991	Development	Mutations in half baked/E-cadherin block cell behaviors that are necessary for teleost epiboly	Kane	2005	7		
945	chr24	47212102	47212126	3500129307	23		47212102	47212126	8421504	2	11,12	0,12	g	350012930700000000	0-23						Afghans Kill 9 For Quran Flambe	forum.nin.com	0	0		
947	chr24	47475236	47475262	3500149799	25		47475236	47475262	8421504	2	5,20	0,6	g	350014979900000003	17-46						CHIMERIC FACTOR VII MOLECULES	Stafford	2010	0		
948	chr24	47673239	47673269	3500337360	24		47673239	47673269	8421504	3	12,8,4	0,17,26	g	350033736000000443	10-35						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
959	chr24	49049961	49099471	3500311758	1441		49049961	49099471	8421504	12	20,20,121,145,138,213,54,75,135,194,90,236	0,103,135,3319,3776,6270,7686,18864,21302,22453,23695,49274	p,c,g	350031175800000001,350031175800000001,350031175800000000,350031175800015004	0-21,0-21,0-20,0-1401						MADR2 tumour suppressor gene	Wrana	1996	0		
959	chr24	49050072	49050155	3500273558	78		49050072	49050155	8421504	4	11,15,25,27	0,14,30,56	c	350027355800000046,350027355800000047,350027355800000045	0-26,0-25,0-27						Compositions and methods for the diagnosis and treatment of tumor	Davis	2005	0		
959	chr24	49050072	49050155	3500271380	78		49050072	49050155	8421504	4	11,15,25,27	0,14,30,56	c	350027138000000041,350027138000000042,350027138000000040	0-26,0-25,0-27					Patent	Compositions and methods for the diagnosis and treatment of tumor (Patent EP:1546182)	Davis	2011	0		
959	chr24	49050072	49050155	3500244405	78		49050072	49050155	8421504	4	11,15,25,27	0,14,30,56	c	350024440500000046,350024440500000047,350024440500000045	0-26,0-25,0-27						Compositions and methods for the diagnosis and treatment of tumor	Davis	2004	0		
959	chr24	49050093	49050125	3500273385	32		49050093	49050125	8421504	1	32	0	c	350027338500000009	11-43					Nucleic Acids Research	Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes	Geon	2002	0		SMAD2
959	chr24	49050096	49099471	3500332365	1401		49050096	49099471	8421504	10	121,145,138,213,54,75,135,194,90,236	0,3184,3641,6135,7551,18729,21167,22318,23560,49139	p	350033236500015000	0-1401						KEGG T01001: 4087	www.genome.jp	0	0		SMAD2
959	chr24	49050211	49053775	3500418632	43		49050211	49053775	8421504	3	6,17,20	0,3069,3544	c	350041863200000023,350041863200000022	0-23,0-20			10.1038/onc.2013.67	0950-9232	Oncogene	Snail depletes the tumorigenic potential of glioblastoma	Savary	2013	6		
959	chr24	49050211	49053775	3500114503	43		49050211	49053775	8421504	3	6,17,20	0,3069,3544	c	350011450300000023,350011450300000022	0-23,0-20			10.1038/onc.2013.67	0950-9232	Oncogene	Snail depletes the tumorigenic potential of glioblastoma	Savary	2013	6		
959	chr24	49053788	49053811	3500327555	23		49053788	49053811	8421504	1	23	0	c,g	350032755500000000,350032755500000001,350032755500000001	0-21,0-21,0-21		17804408	10.1074/jbc.M706262200	0021-9258	Journal of Biological Chemistry	Expression and Regulation of the Osteoarthritis-associated Protein Asporin	Kou	2007	5		
959	chr24	49056347	49072524	3500266365	45		49056347	49072524	8421504	2	22,23	0,16154	c	350026636500000009,350026636500000008	0-22,0-23						HSV-1 infection suppresses TGF-&#x03b2;1 and SMAD3 expression in human corneal epithelial cells	www.molvis.org	0	0		
959	chr24	49062790	49062818	3500306374	23		49062790	49062818	8421504	2	7,16	0,12	g	350030637400000047	6-29						Coping with stress: anaerobic respiratory and oxidative stress tolerance mechanisms are critical for Neisseria gonorrhoeae biofilm formation	ir.uiowa.edu	0	0		
959	chr24	49072509	49072532	3500391143	23		49072509	49072532	8421504	1	23	0	c	350039114300000004	21-44		12639945	10.1210/en.2002-220978	0013-7227	Endocrinology	Activin Signaling through Type IB Activin Receptor Stimulates Aromatase Activity in the Ovarian Granulosa Cell-Like Human Granulosa (KGN) Cells	Mukasa	2003	4		SMAD2
959	chr24	49099394	49099441	3500225405	47		49099394	49099441	8421504	1	47	0	c	350022540500000004	20-67			10.1634/stemcells.2004-0341	1549-4918	STEM CELLS	Gene Expression Signatures of Seven Individual Human Embryonic Stem Cell Lines - Skottman - 2005 - STEM CELLS - Wiley Online Library	Skottman	2005	0		SMAD2
965	chr24	49830969	49830997	3500327991	24		49830969	49830997	8421504	2	11,13	0,15	g	350032799100000026	0-24						New antibiotic-sensitive lactic acid bacteria strains	Stroeman	2006	0		
965	chr24	49830969	49830997	3500263105	24		49830969	49830997	8421504	2	11,13	0,15	g	350026310500000026	0-24						New antibiotic-sensitive lactic acid bacteria strains	Stroeman	2006	0		
965	chr24	49830969	49830997	3500055007	24		49830969	49830997	8421504	2	11,13	0,15	g	350005500700000005	0-24						New antibiotic-sensitive lactic acid bacteria strains	Stroman	2012	0		
966	chr24	49957316	49983821	3500464025	43		49957316	49983821	8421504	2	21,22	0,26483	c	350046402500000003,350046402500000002	0-21,0-22							ingtechnology.com	0	0		SMAD7
966	chr24	49957325	49976700	3500434411	40		49957325	49976700	8421504	3	20,17,3	0,513,19372	c,g	350043441100000010,350043441100000010,350043441100000009	0-20,0-20,0-20		20668165	10.1091/mbc.E10-02-0117	1059-1524	Molecular Biology of the Cell	PDZRN3 Negatively Regulates BMP-2&#x2013;induced Osteoblast Differentiation through Inhibition of Wnt Signaling	Honda	2010	5		
966	chr24	49957325	49976700	3500066551	40		49957325	49976700	8421504	3	20,17,3	0,513,19372	c,g	350006655100000010,350006655100000010,350006655100000009	0-20,0-20,0-20		20668165	10.1091/mbc.E10-02-0117		Molecular Biology of the Cell	PDZRN3 Negatively Regulates BMP-2&#x2013;induced Osteoblast Differentiation through Inhibition of Wnt Signaling	Takeshi	2010	0		
966	chr24	49957341	49957532	3500241494	95		49957341	49957532	8421504	2	47,48	0,143	c	350024149400000093,350024149400000090	0-47,0-48						US Patent # 6,534,641. Compositions and methods for the treatment and diagnosis of cardiovascular disease - Patents.com	www.patents.com	0	0		
966	chr24	49957468	49957594	3500412680	40		49957468	49957594	8421504	2	20,20	0,106	c,g	350041268000000001,350041268000000001,350041268000000000,350041268000000000	0-20,0-20,0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		SMAD7
966	chr24	49957468	49957594	3500105107	40		49957468	49957594	8421504	2	20,20	0,106	c,g	350010510700000001,350010510700000001,350010510700000000,350010510700000000	0-20,0-20,0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		SMAD7
966	chr24	49957468	49957594	3500035761	40		49957468	49957594	8421504	2	20,20	0,106	c,g	350003576100000001,350003576100000001,350003576100000000,350003576100000000	0-20,0-20,0-20,0-20						Enhanced transforming growth factor- signaling and &#xfb01;brogenesis in ovine fetal skeletal muscle of obese dams at late gestation	do.physiology.org	0	0		SMAD7
966	chr24	49957487	49957781	3500414007	45		49957487	49957781	8421504	2	24,21	0,273	c	350041400700000003,350041400700000002	0-24,0-21		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		SMAD7
966	chr24	49957487	49957781	3500213699	45		49957487	49957781	8421504	2	24,21	0,273	c	350021369900000003,350021369900000002	0-24,0-21		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		SMAD7
966	chr24	49957487	49957781	3500207867	45		49957487	49957781	8421504	2	24,21	0,273	c	350020786700000003,350020786700000002	0-24,0-21		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		
966	chr24	49957487	49957781	3500179866	45		49957487	49957781	8421504	2	24,21	0,273	c	350017986600000003,350017986600000002	0-24,0-21		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		SMAD7
966	chr24	49957676	49983820	3500021769	129		49957676	49983820	8421504	3	48,47,34	0,25993,26110	c	350002176900000087,350002176900000071,350002176900000026	0-48,0-47,0-34						Compositions and methods for the treatment and diagnosis of cardiovascular disease	Falb	1997	0		
966	chr24	49957680	49983315	3500337761	40		49957680	49983315	8421504	2	20,20	0,25615	c,g	350033776100000003,350033776100000002,350033776100000002	0-20,0-20,0-20						TRANSGENIC USE OF SMAD7 TO SUPPRESS TGF&#x03b2; SIGNALING DURING MOUSE DEVELOPMENT	arworks.iupui.edu	0	0		SMAD7
966	chr24	49957680	49957705	3500456695	25		49957680	49957705	8421504	1	25	0	c,g	350045669500000014,350045669500000014	0-25,0-25						Identi&#xfb01;cationofBMP9andBMP10asfunctionalactivatorsoftheorphanactivin receptor-likekinase1(ALK1)inendothelialcells	tologylibrary.org	0	0		
966	chr24	49957685	49983231	3500342990	64		49957685	49983231	8421504	3	20,22,22	0,19030,25524	c,g	350034299000000004,350034299000000004,350034299000000013,350034299000000013,350034299000000012,350034299000000012	0-20,0-20,0-22,0-22,0-22,0-22		20386537	10.1038/labinvest.2010.78	0023-6837	Laboratory Investigation	Effects of Arkadia on airway remodeling through enhancing TGF-&#x03b2; signaling in allergic rats	Li	2010	4		SMAD7
966	chr24	49957685	49983231	3500309082	64		49957685	49983231	8421504	3	20,22,22	0,19030,25524	c,g	350030908200000004,350030908200000004,350030908200000013,350030908200000013,350030908200000012,350030908200000012	0-20,0-20,0-22,0-22,0-22,0-22		20386537	10.1038/labinvest.2010.78	0023-6837	Laboratory Investigation	Effects of Arkadia on airway remodeling through enhancing TGF-&#x03b2; signaling in allergic rats	Li	2010	4		SMAD7
966	chr24	49957797	49983324	3500447264	40		49957797	49983324	8421504	2	20,20	0,25507	c,g	350044726400000009,350044726400000009,350044726400000008,350044726400000008	0-20,0-20,0-20,0-20						USE OF MODIFIED CYCLOSPORINS - Patent application	www.faqs.org	0	0		SMAD7
966	chr24	49957829	49983230	3500129344	40		49957829	49983230	8421504	2	20,20	0,25381	c,g	350012934400000011,350012934400000010,350012934400000010	0-20,0-20,0-20						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		SMAD7
966	chr24	49957838	49976707	3500029338	27		49957838	49976707	8421504	2	17,10	0,18859	c	350002933800000031,350002933800000032	0-27,0-27		20659902	10.1074/jbc.M110.138370		The Journal of Biological Chemistry	Murine Protein Serine/Threonine Kinase 38 Stimulates TGF-&#x03b2; Signaling in a Kinase-dependent Manner via Direct Phosphorylation of Smad Proteins	Hyun-A	2010	0		
966	chr24	49976706	49976731	3500081338	25		49976706	49976731	8421504	1	25	0	c	350008133800000007	23-48						TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal	.ibme.utoronto.ca	0	0		SMAD7
966	chr24	49976715	49983231	3500452326	44		49976715	49983231	8421504	2	22,22	0,6494	c,g	350045232600000007,350045232600000007,350045232600000006,350045232600000006	0-22,0-22,0-22,0-22		18310502	10.1182/blood-2007-10-120337	0006-4971	Blood	Inhibition of endogenous TGF-&#x03b2; signaling enhances lymphangiogenesis	Oka	2008	10		SMAD7
966	chr24	49976731	49983246	3500343204	39		49976731	49983246	8421504	2	19,20	0,6495	c,g	350034320400000003,350034320400000003,350034320400000002,350034320400000002	0-19,0-19,0-20,0-20		22751114	10.1038/onc.2012.260	0950-9232	Oncogene	Targeting Stat3 and Smad7 to restore TGF-&#x03b2; cytostatic regulation of tumor cells in vitro and in vivo	Luwor	2012	6		SMAD7
966	chr24	49976731	49983246	3500209437	39		49976731	49983246	8421504	2	19,20	0,6495	c,g	350020943700000003,350020943700000003,350020943700000002,350020943700000002	0-19,0-19,0-20,0-20		22751114	10.1038/onc.2012.260	0950-9232	Oncogene	Targeting Stat3 and Smad7 to restore TGF-&#x03b2; cytostatic regulation of tumor cells in vitro and in vivo	Luwor	2012	6		SMAD7
966	chr24	49983317	49983817	3500075030	47		49983317	49983817	8421504	2	24,23	0,477	c,g	350007503000000013,350007503000000012,350007503000000012	0-24,0-23,0-23						Original Effects of Immobilized rhBMP-2/atelocollagen in vivo and in vitro	www.htbiol.gr.jp	0	0		SMAD7
967	chr24	50079618	50079645	3500229524	23		50079618	50079645	8421504	2	15,8	0,19	c	350022952400000078	1-24						Antibody combinations, and methods of making and using same	Vollmers	2009	0		
967	chr24	50146944	50146967	3500327497	23		50146944	50146967	8421504	1	23	0	c	350032749700000050	10-33						Methods for treating inflammatory disorders	Chuntharapai	1994	0		
967	chr24	50146944	50146967	3500277510	23		50146944	50146967	8421504	1	23	0	c	350027751000000293	1-24						Novel seven transmembrane receptors	Godiska	1994	0		
967	chr24	50161160	50161185	3500282252	23		50161160	50161185	8421504	2	15,8	0,17	c	350028225200000604	25-48						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
967	chr24	50161160	50161185	3500236407	23		50161160	50161185	8421504	2	15,8	0,17	c	350023640700000307	25-48						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2001	0		
969	chr24	50403500	50403526	3500286508	23		50403500	50403526	8421504	3	7,4,12	0,8,14	g	350028650800000078	0-23						METHODS AND COMPOSITIONS RELATED TO FATTY ALCOHOL BIOSYNTHETIC ENZYMES	Schirmer	2011	0		
976	chr24	51332152	51332175	3500445344	23		51332152	51332175	8421504	1	23	0	c	350044534400000009	10-33						Biomarkers - Patent application	www.faqs.org	0	0		
976	chr24	51370598	51377205	3500432295	144		51370598	51377205	8421504	3	48,14,82	0,96,6525	p	350043229500015173,350043229500015175,350043229500015176	0-48,0-48,0-48						Methods for detection of transition single-nucleotide polymorphisms - Patent # 6599700 - PatentGenius	.patentgenius.com	0	0		MBD1
976	chr24	51370649	51377205	3500330738	135		51370649	51377205	8421504	4	45,11,34,45	0,48,6474,6511	p	350033073800015175,350033073800015176,350033073800015177	0-45,0-45,0-45						NOVEL GENE ENCODING A DNA REPAIR ENZYME AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		MBD1
976	chr24	51379007	51379033	3500295865	24		51379007	51379033	8421504	2	15,9	0,17	c	350029586500000048	4-28						Protein scaffolds and uses therof	Stemmer	2006	0		
976	chr24	51379099	51379880	3500184849	144		51379099	51379880	8421504	3	6,69,69	0,89,712	p	350018484900015027	6-150						Pathogenesis of Rett syndrome and study of the role of MeCP2 protein in neuronal function	orio-aberto.up.pt	0	0		
976	chr24	51379212	51379816	3500412961	50		51379212	51379816	8421504	2	45,5	0,599	p,c	350041296100015164,350041296100000028	0-48,9-47						Nucleic acids encoding regulators of FGF-2 transcription (RFT) and variants thereof	Gage	1998	0		
977	chr24	51456572	51456600	3500018529	23		51456572	51456600	8421504	2	8,15	0,13	g	350001852900000242	3-36						***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Streptococcus pneumoniae antigens and vaccines	Choi	1997	0		
978	chr24	51576258	51576286	3500377977	25		51576258	51576286	8421504	2	7,18	0,10	g	350037797700000046	7-34						Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide	Malcolm	2000	0		
979	chr24	51662000	51662026	3500232700	23		51662000	51662026	8421504	2	11,12	0,14	g	350023270000000000	0-23		17307860	10.1128/JB.00044-07	0021-9193	Journal of Bacteriology	Role of PBP1 in Cell Division of Staphylococcus aureus	Pereira	2007	4		
979	chr24	51721972	51722020	3500420462	48		51721972	51722020	8421504	1	48	0	p	350042046200015008	3-51						Modified Proteins, Designer Toxins, And Methods Of Making Thereof 	.freshpatents.com	0	0		ME2
979	chr24	51721972	51722020	3500340504	48		51721972	51722020	8421504	1	48	0	p	350034050400015022	3-51					Patent	Modified proteins, designer toxins, and methods of making thereof (Patent US:7083957)	Rosenblum	2006	0		ME2
979	chr24	51721972	51722020	3500328606	48		51721972	51722020	8421504	1	48	0	p	350032860600015019,350032860600015045	3-51,0-48						Modified Proteins, Designer Toxins, and Methods of Making Thereof - Patent application	www.faqs.org	0	0		ME2
979	chr24	51721972	51722020	3500267342	48		51721972	51722020	8421504	1	48	0	p	350026734200015022	3-51					Patent	Modified proteins, designer toxins, and methods of making thereof (Patent US:7083957)	Rosenblum	2006	0		ME2
979	chr24	51729593	51729617	3500218185	24		51729593	51729617	8421504	1	24	0	c,g	350021818500000075,350021818500000075	14-41,14-41						Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
980	chr24	51776319	51782257	3500187783	225		51776319	51782257	8421504	2	151,74	0,5864	p	350018778300015048	0-225						Oxford_SGC_Clones_web	www.docstoc.com	0	0		ELAC1
980	chr24	51843482	51874275	3500180910	47		51843482	51874275	8421504	2	26,21	0,30772	c,g	350018091000000003,350018091000000004,350018091000000004	5-31,0-21,0-21		18997172	10.1182/blood-2008-05-160184		Blood	Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness	Jaroslav	2009	0		
980	chr24	51843485	51874275	3500179994	45		51843485	51874275	8421504	2	23,22	0,30768	c	350017999400000013,350017999400000014	9-32,8-30						Full text of "Protocols_molecular_biology"	archive.org	0	0		SMAD4
980	chr24	51843485	51874275	3500138720	45		51843485	51874275	8421504	2	23,22	0,30768	c	350013872000000011,350013872000000012	9-32,8-30						Tow hybrid systems - Methods and protocols	www.docstoc.com	0	0		SMAD4
980	chr24	51843523	51850084	3500393165	43		51843523	51850084	8421504	2	21,22	0,6539	c	350039316500000019,350039316500000020	0-21,0-22						Inhibin Resistance Is Associated with Aggressive Tumorigenicity of Ovarian Cancer Cells	.aacrjournals.org	0	0		SMAD4
980	chr24	51843524	51862949	3500065613	81		51843524	51862949	8421504	6	21,9,12,5,14,20	0,1711,6500,11754,17979,19405	c	350006561300000002,350006561300000005,350006561300000006,350006561300000008	0-21,0-21,0-19,0-20						Alterations in the Smad4 gene in hamster pancreatic duct adenocarcinomas and established cell lines	-publications.com	0	0		
980	chr24	51844782	51861522	3500465812	42		51844782	51861522	8421504	4	2,18,3,19	0,432,10498,16721	c	350046581200000004,350046581200000005	10-30,10-32		12393416	10.1182/blood-2002-05-1549	0006-4971	Blood	Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-&#x03b2; and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells	Cao	2003	10		
980	chr24	51844782	51861522	3500367541	42		51844782	51861522	8421504	4	2,18,3,19	0,432,10498,16721	c	350036754100000004,350036754100000005	10-30,10-32						Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF- and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells	tologylibrary.org	0	0		SMAD4
980	chr24	51844782	51861522	3500176276	42		51844782	51861522	8421504	4	2,18,3,19	0,432,10498,16721	c	350017627600000004,350017627600000005	10-30,10-32		12393416	10.1182/blood-2002-05-1549	0006-4971	Blood	Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-&#x03b2; and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells	Cao	2003	10		SMAD4
980	chr24	51850178	51874175	3500243418	43		51850178	51874175	8421504	2	22,21	0,23976	c,g	350024341800000004,350024341800000004,350024341800000005	0-22,0-22,0-21		19737884	10.1167/iovs.09-4073	1552-5783	Investigative Ophthalmology & Visual Science	Trichostatin A&#x2013;Induced TGF-&#x03b2; Type II Receptor Expression in Retinoblastoma Cell Lines	Kashiwagi	2010	0		SMAD4
980	chr24	51853497	51853522	3500004615	25		51853497	51853522	8421504	1	25	0	c	350000461500000015,350000461500000007	0-25,0-25						TREATMENT OF MITOCHONDRIA-RELATED DISEASES AND IMPROVEMENT OF AGE-RELATED METABOLIC DEFICITS - Patent application	www.faqs.org	0	0		
980	chr24	51855237	51855261	3500329727	24		51855237	51855261	8421504	1	24	0	c	350032972700000004	0-24						Inhibitory effect of BMP-2 on the proliferation of breast cancer cells	-publications.com	0	0		
980	chr24	51861505	51861530	3500228010	25		51861505	51861530	8421504	1	25	0	c	350022801000000031	0-25						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION	Hata	2009	0		SMAD4
980	chr24	51861505	51861530	3500125620	25		51861505	51861530	8421504	1	25	0	c	350012562000000031,350012562000000176	0-25,0-25						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION - Patent application	www.faqs.org	0	0		SMAD4
988	chr24	52922053	52922081	3500134170	24		52922053	52922081	8421504	3	5,12,7	0,6,21	g	350013417000000037	0-26						INHIBITING STAPHYLOCOCCUS EPIDERMIDIS INFECTIONS - Patent application	www.faqs.org	0	0		
992	chr24	53409549	53409582	3500295421	26		53409549	53409582	8421504	3	13,6,7	0,16,26	g	350029542100000109	10-36						Peptide vaccine for influenza virus	Aitio	2008	0		
997	chr24	54038100	54038126	3500335570	24		54038100	54038126	8421504	2	15,9	0,17	g	350033557000000093	0-24						Antibody Engineering	www.scribd.com	0	0		
1001	chr24	54608724	54608748	3500046125	23		54608724	54608748	8421504	2	14,9	0,15	g	350004612500000011	9-32						MUTANT ENZYMES - ISIS INNOVATION LIMITED	www.sumobrain.com	0	0		
1001	chr24	54623443	54623467	3500326797	24		54623443	54623467	8421504	1	24	0	g	350032679700000013	0-24					Patent	Glycyl tRNA synthetase polynucleotides of streptococcus (Patent US:5756330)	Lawlor	1998	0		
1002	chr24	54771444	54771469	3500414390	23		54771444	54771469	8421504	2	7,16	0,9	g	350041439000000002	0-23						Up-regulation of Fas Ligand Expression by Sirtuin 1 in both Flow-restricted Vessels and Serum-stimulated Vascular Smooth Muscle Cells	www.actacams.com	0	0		
1007	chr24	55364659	55364682	3500463051	23		55364659	55364682	8421504	1	23	0	c	350046305100000008	4-27						Occurrence of the invasion associated marker (iam) in Campylobacter jejuni isolated from cattle	ace.tennessee.edu	0	0		
1007	chr24	55364659	55364682	3500061723	23		55364659	55364682	8421504	1	23	0	c	350006172300000008	4-27						RESEARCH ARTICLE Open Access Occurrence of the invasion associated marker iam)inCampylobacter jejuni isolated from cattle	biomedcentral.com	0	0		
1010	chr24	55758048	55758073	3500390669	24		55758048	55758073	8421504	2	4,20	0,5	g	350039066900000032	12-36						Trefoil Factors and Methods of Treating Proliferation Disorders Using Same - Patent application	www.faqs.org	0	0		
1010	chr24	55779053	55779077	3500327539	23		55779053	55779077	8421504	2	10,13	0,11	g	350032753900000141,350032753900000083	10-33,22-45						Albumin-Fused Kunitz Domain Peptides - Patent application	www.faqs.org	0	0		
1011	chr24	55870290	55870318	3500311032	24		55870290	55870318	8421504	2	13,11	0,17	g	350031103200000019,350031103200000037	0-24,0-24						Anti-TNF Antibodies, Compositions, Methods and Uses - Patent application	www.faqs.org	0	0		
1011	chr24	55910523	55910551	3500201497	23		55910523	55910551	8421504	3	5,5,13	0,7,15	g	350020149700000004	5-28						Research Paper Differential Evolution of Duplicated Medakafish mitf Genes	www.ijbs.com	0	0		
1013	chr24	56138240	56138263	3500066729	23		56138240	56138263	8421504	1	23	0	g	350006672900000015	3-26		10762614			American Journal of Physiology - Gastrointestinal and Liver Physiology	Regulation of the human Na+-glucose cotransporter gene, SGLT1, by HNF-1 and Sp1	Martin	2000	0		
1014	chr24	56240738	56315808	3500014544	746		56240738	56315808	8421504	18	15,73,93,5,58,30,120,24,18,45,48,33,35,4,27,23,64,31	0,16,90,370,376,443,1228,1375,5020,6709,43877,44021,46995,49565,50748,70578,70603,75039	p,c	350001454400000026,350001454400015010,350001454400000024,350001454400000015	0-244,24-456,0-116,0-118						Cloning and sequence analysis of TFE, a helix-loop-helix transcription factor able to recognize the thyroglobulin gene promoter in vitro. - ResearchGate	.researchgate.net	0	0		
1014	chr24	56284788	56284811	3500141567	23		56284788	56284811	8421504	1	23	0	c	350014156700000009	0-23		14695187		0008-5472	Cancer Research	TIP49 Regulates &#x03b2;-Catenin-Mediated Neoplastic Transformation and T-Cell Factor Target Gene Induction via Effects on Chromatin Remodeling	Feng	2003	8		TCF4
1014	chr24	56290039	56290065	3500337319	24		56290039	56290065	8421504	3	4,5,15	0,5,11	g	350033731900000007	14-38						Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules	Drittanti	2004	0		
1014	chr24	56290364	56315805	3500248136	38		56290364	56315805	8421504	3	18,1,19	0,1107,25422	c	350024813600000007,350024813600000006	0-19,0-19		19295128	10.1242/jcs.028241	0021-9533	Journal of Cell Science	The class I bHLH factors E2-2A and E2-2B regulate EMT	Sobrado	2009	6		TCF4
1014	chr24	56290364	56315805	3500200189	38		56290364	56315805	8421504	3	18,1,19	0,1107,25422	c	350020018900000009,350020018900000008	0-19,0-19						The class I bHLH factors E2-2A and E2-2B regulate EMT. - ResearchGate	.researchgate.net	0	0		TCF4
1019	chr24	56898330	56898359	3500464311	24		56898330	56898359	8421504	2	13,11	0,18	g	350046431100000001	0-24						INSIGHTS INTO HEPATIC ALPHA-FETOPROTEIN GENE REGULATION DURING LIVER DEVELOPMENT AND DISEASE	knowledge.uky.edu	0	0		
1020	chr24	57142886	57142910	3500404264	23		57142886	57142910	8421504	2	8,15	0,9	g	350040426400000014	13-36					Patent	Gene manipulation and expression using genomic elements (Patent US:5578461)	Klapholz	1996	0		
1021	chr24	57220721	57220746	3500304527	25		57220721	57220746	8421504	1	25	0	g	350030452700000035	32-57						O by	tionscanada.gc.ca	0	0		
1025	chr24	57801856	57801882	3500252285	23		57801856	57801882	8421504	2	11,12	0,14	g	350025228500000067	3-26						HERPES SIMPLEX VIRUS MUTANT ICP0 - Patent application	www.faqs.org	0	0		
1028	chr24	58087537	58087561	3500351366	23		58087537	58087561	8421504	2	9,14	0,10	g	350035136600000058,350035136600000046	15-38,24-47						Calcium-binding photoprotein, gene encoding the same, and use thereof - Patent application	www.faqs.org	0	0		
1030	chr24	58453469	58456762	3500439896	42		58453469	58456762	8421504	2	22,20	0,3273	c,g	350043989600000000,350043989600000000,350043989600000001	0-22,0-22,0-20						Apoptosis Guide | papers about Apoptosis,Caspase-3/7 Inhibitor I,Cyclin D1 | Page 2	w.buysurvivin.com	0	0		ST8SIA3
1030	chr24	58453469	58456762	3500432694	42		58453469	58456762	8421504	2	22,20	0,3273	c,g	350043269400000000,350043269400000000,350043269400000001	0-22,0-22,0-20						Generic Peptides | Epigenetics Guide	ymosin-beta-4.com	0	0		ST8SIA3
1030	chr24	58453469	58456762	3500393398	42		58453469	58456762	8421504	2	22,20	0,3273	c,g	350039339800000000,350039339800000000,350039339800000001,350039339800000001	0-22,0-22,0-20,0-20						siRNA mediated MTf knockdown reduces | Online Peptides Guide	nhs-ss-biotin.com	0	0		ST8SIA3
1030	chr24	58453469	58456762	3500329739	42		58453469	58456762	8421504	2	22,20	0,3273	c,g	350032973900000000,350032973900000000,350032973900000001,350032973900000001	0-22,0-22,0-20,0-20						71989-28-1 | Online Peptides Guide	www.silodoxin.com	0	0		ST8SIA3
1030	chr24	58453469	58456762	3500234741	42		58453469	58456762	8421504	2	22,20	0,3273	c,g	350023474100000000,350023474100000000,350023474100000001	0-22,0-22,0-20						siRNA mediated MTf knockdown reduces | Online Peptides Guide	www.silodoxin.com	0	0		ST8SIA3
1030	chr24	58453469	58456762	3500033859	42		58453469	58456762	8421504	2	22,20	0,3273	c,g	350003385900000000,350003385900000000,350003385900000001,350003385900000001	0-22,0-22,0-20,0-20						admin | Online Cjc 1295 Peptide Guide	ymosin-beta-4.com	0	0		ST8SIA3
1035	chr24	59023935	59023963	3500414317	25		59023935	59023963	8421504	3	6,4,15	0,8,13	g	350041431700000176	2-27						US Patent # 7,408,100. Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene - Patents.com	www.patents.com	0	0		
1037	chr24	59280147	59280179	3500381969	27		59280147	59280179	8421504	3	7,15,5	0,11,27	g	350038196900000009	5-38						Expression-secretion vectors for the production of biologically active fv fragments	Anthony	1993	0		
1038	chr24	59476579	59476664	3500433622	71		59476579	59476664	8421504	2	36,35	0,50	c	350043362200000022,350043362200000000,350043362200000001,350043362200000002,350043362200000023	20-48,0-22,0-22,0-22,0-28		23200856	10.1016/j.celrep.2012.10.023	2211-1247	Cell Reports	Cell Reports - Specific miRNA Stabilization by Gld2-Catalyzed Monoadenylation	D'Ambrogio	2012	0		
1038	chr24	59476589	59476620	3500362629	31		59476589	59476620	8421504	1	31	0	c,g	350036262900000000,350036262900000001,350036262900000001,350036262900000002,350036262900000003	0-31,34-61,34-61,23-50,0-27		18665157	10.1038/mt.2008.159	1525-0016	Molecular Therapy	miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene Therapy	Suzuki	2008	7		
1038	chr24	59476591	59476615	3500353647	24		59476591	59476615	8421504	1	24	0	c	350035364700000068	20-44						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		MIR3591
1038	chr24	59476591	59476615	3500351139	24		59476591	59476615	8421504	1	24	0	c,g	350035113900000068,350035113900000068,350035113900000187,350035113900000187	20-44,20-44,0-22,0-22						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		MIR3591
1038	chr24	59476592	59476616	3500003710	24		59476592	59476616	8421504	1	24	0	c	350000371000000002	0-24						MicroRNAs in Development - Methods and Protocols	www.scribd.com	0	0		MIR3591
1038	chr24	59476593	59476651	3500010232	45		59476593	59476651	8421504	2	23,22	0,36	c	350001023200000014,350001023200000005,350001023200000015	0-23,0-23,0-22		21857646	10.1038/emboj.2011.301	ERROR! NO ISSN	The EMBO Journal	CAMTA1 is a novel tumour suppressor regulated by miR-9/9&ast; in glioblastoma stem cells	Schraivogel	2011	0		MIR3591
1038	chr24	59476593	59476618	3500226305	25		59476593	59476618	8421504	1	25	0	c	350022630500000000	0-25		23251659	10.1371/journal.pone.0051952	1932-6203	PLOS ONE	PLOS ONE: Specific Micro RNA-Regulated TetR-KRAB Transcriptional Control of Transgene Expression in Viral Vector-Transduced Cells	Pichard	2012	4		MIR3591
1038	chr24	59476593	59476617	3500215359	24		59476593	59476617	8421504	1	24	0	c	350021535900000009,350021535900000008,350021535900000010,350021535900000000,350021535900000007,350021535900000005,350021535900000004	0-23,0-23,0-23,0-22,0-23,0-23,0-24					Patent	Combination treatment for the treatment of hepatitis C virus infection (Patent US:8440637)	Elmen	2013	0		MIR3591
1038	chr24	59476593	59476617	3500104641	24		59476593	59476617	8421504	1	24	0	c	350010464100000008,350010464100000009,350010464100000010,350010464100000000,350010464100000007,350010464100000004,350010464100000005,350010464100000023	0-23,0-23,0-23,0-22,0-23,0-24,0-23,0-23						Combination Treatment For The Treatment of Hepatitis C Virus Infection - Patent application	www.faqs.org	0	0		MIR3591
1038	chr24	59476593	59476617	3500100057	24		59476593	59476617	8421504	1	24	0	c,g	350010005700000005,350010005700000004,350010005700000004,350010005700000007,350010005700000000,350010005700000000,350010005700000010,350010005700000009,350010005700000008	0-23,0-24,0-24,0-23,0-22,0-22,0-23,0-23,0-23						Combination Treatment For The Treatment of Hepatitis C Virus Infection	Elmen	2010	0		MIR3591
1038	chr24	59476593	59476616	3500447978	23		59476593	59476616	8421504	1	23	0	c	350044797800000010,350044797800000011	3-26,0-23						Improved Methods Controlling Gene Expression	Ren	2006	0		MIR3591
1038	chr24	59476593	59476616	3500436772	23		59476593	59476616	8421504	1	23	0	c	350043677200000000	0-23						Hepatitis C Virus Infects the Endothelial Cells of the Blood-Brain Barrier	www.natap.org	0	0		MIR3591
1038	chr24	59476593	59476616	3500428031	23		59476593	59476616	8421504	1	23	0	c	350042803100000011,350042803100000010,350042803100000008,350042803100000009	0-23,0-23,0-23,0-23						Pharmaceutical Composition 	.freshpatents.com	0	0		MIR3591
1038	chr24	59476593	59476616	3500423784	23		59476593	59476616	8421504	1	23	0	c	350042378400000026	0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR3591
1038	chr24	59476593	59476616	3500400478	23		59476593	59476616	8421504	1	23	0	c,g	350040047800000149,350040047800000149,350040047800000151,350040047800000151,350040047800000042,350040047800000042,350040047800000150,350040047800000150	0-23,0-23,0-22,0-22,0-23,0-23,0-22,0-22					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		MIR3591
1038	chr24	59476593	59476616	3500371873	23		59476593	59476616	8421504	1	23	0	c	350037187300000135	0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		MIR3591
1038	chr24	59476593	59476616	3500366537	23		59476593	59476616	8421504	1	23	0	c,g	350036653700000017,350036653700000017	0-23,0-23		19324960	10.1261/rna.1268209		RNA	Optimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virus	Duckhyang	2009	0		MIR3591
1038	chr24	59476593	59476616	3500357539	23		59476593	59476616	8421504	1	23	0	c	350035753900000150,350035753900000151,350035753900000042,350035753900000149	0-22,0-22,0-23,0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		MIR3591
1038	chr24	59476593	59476616	3500336067	23		59476593	59476616	8421504	1	23	0	c	350033606700000003,350033606700000002,350033606700000001,350033606700000000	0-23,0-23,0-23,0-23						Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides	ELMEN	2010	0		MIR3591
1038	chr24	59476593	59476616	3500304886	23		59476593	59476616	8421504	1	23	0	c	350030488600000111	0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		MIR3591
1038	chr24	59476593	59476616	3500277393	23		59476593	59476616	8421504	1	23	0	c	350027739300000004	0-23						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		MIR3591
1038	chr24	59476593	59476616	3500244257	23		59476593	59476616	8421504	1	23	0	c	350024425700000015	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR3591
1038	chr24	59476593	59476616	3500210973	23		59476593	59476616	8421504	1	23	0	c,g	350021097300000150,350021097300000150,350021097300000151,350021097300000151,350021097300000042,350021097300000149	0-22,0-22,0-22,0-22,0-23,0-23						Microrna molecules	Tuschl	2002	0		MIR3591
1038	chr24	59476593	59476616	3500185563	23		59476593	59476616	8421504	1	23	0	c	350018556300000002,350018556300000003,350018556300000000,350018556300000001	0-23,0-23,0-23,0-23						Pharmaceutical Composition	Elmen	2012	0		MIR3591
1038	chr24	59476593	59476616	3500131966	23		59476593	59476616	8421504	1	23	0	c	350013196600000015	0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR3591
1038	chr24	59476593	59476616	3500125321	23		59476593	59476616	8421504	1	23	0	c	350012532100000207,350012532100000195,350012532100000071,350012532100000171,350012532100000183	0-22,0-22,0-23,0-22,0-22						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
1038	chr24	59476593	59476616	3500110793	23		59476593	59476616	8421504	1	23	0	c	350011079300000002	0-23						Nucleic acid silencing agent-protein conjugates and use thereof for treating hcv-related disorders	Babcock	2009	0		MIR3591
1038	chr24	59476593	59476616	3500095645	23		59476593	59476616	8421504	1	23	0	c	350009564500000003,350009564500000002,350009564500000001,350009564500000000	0-23,0-23,0-23,0-23						Pharmaceutical Composition	Elmen	2010	0		MIR3591
1038	chr24	59476593	59476616	3500091544	23		59476593	59476616	8421504	1	23	0	c	350009154400000001,350009154400000008	0-23,0-23						Pharmaceutical composition comprising anti-mirna antisense oligonucleotides	Elmen	2007	0		MIR3591
1038	chr24	59476593	59476616	3500089055	23		59476593	59476616	8421504	1	23	0	c,g	350008905500000042,350008905500000031,350008905500000031,350008905500000003,350008905500000002,350008905500000001,350008905500000000	0-23,0-22,0-22,0-23,0-23,0-23,0-23						Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides	ELMEN	2010	0		MIR3591
1038	chr24	59476593	59476616	3500087450	23		59476593	59476616	8421504	1	23	0	c	350008745000000004,350008745000000001,350008745000000002,350008745000000003	0-23,0-23,0-23,0-23						Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides	Elmen	2012	0		MIR3591
1038	chr24	59476593	59476616	3500084107	23		59476593	59476616	8421504	1	23	0	c	350008410700000011,350008410700000010	0-23,3-26						Improved Methods Controlling Gene Expression	REN	2009	0		MIR3591
1038	chr24	59476593	59476616	3500079354	23		59476593	59476616	8421504	1	23	0	c	350007935400000018,350007935400000021	0-23,0-23						Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver	ylab.stanford.edu	0	0		MIR3591
1038	chr24	59476593	59476616	3500043594	23		59476593	59476616	8421504	1	23	0	c,g	350004359400000001,350004359400000001,350004359400000000,350004359400000000,350004359400000003,350004359400000003,350004359400000002,350004359400000002,350004359400000039,350004359400000039	0-23,0-23,0-23,0-23,0-23,0-23,0-23,0-23,0-23,0-23						Pharmaceutical Composition - Patent application	www.faqs.org	0	0		MIR3591
1040	chr24	59684314	59684341	3500218114	23		59684314	59684341	8421504	2	14,9	0,18	g	350021811400000006	3-40						US Patent # 5,498,831. Pea ADP-glucose pyrophosphorylase subunit genes and their uses - Patents.com	www.patents.com	0	0		
1042	chr24	59943094	59943120	3500326866	24		59943094	59943120	8421504	3	4,14,6	0,5,20	g	350032686600000025,350032686600000028	17-41,0-19						Method for detecting nucleic acid sequences using competitive amplification	Birkenmeyer	1996	0		
1043	chr24	60113793	60113819	3500144055	24		60113793	60113819	8421504	2	15,9	0,17	c	350014405500000396	20-44						GENERATION AND REPRODUCTION OF DNA SEQUENCES AND ANALYSIS OF POLYMORPHISMS AND MUTATIONS BY USING ERROR-CORRECTING CODES - Patent application	www.faqs.org	0	0		
1043	chr24	60149183	60149207	3500201280	23		60149183	60149207	8421504	2	4,19	0,5	g	350020128000000005	5-31						DNA encoding nestin protein	Mckay	1992	0		
1043	chr24	60158752	60158781	3500289512	29		60158752	60158781	8421504	1	29	0	g	350028951200000002,350028951200000004,350028951200000001	0-29,0-29,0-28						Molecular links among the causative genes for ocular malformation: Otx2 and Sox2 coregulate Raxexpression	www.pnas.org	0	0		
1045	chr24	60401209	60401236	3500218185	24		60401209	60401236	8421504	2	12,12	0,15	g	350021818500000074	9-33						Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
1052	chr24	61262748	61263555	3500308662	47		61262748	61263555	8421504	2	23,24	0,783	c	350030866200000098,350030866200000097	0-23,0-24						DNA	.lib.kobe-u.ac.jp	0	0		
1052	chr24	61262811	61262922	3500315071	40		61262811	61262922	8421504	2	20,20	0,91	c,g	350031507100000019,350031507100000018,350031507100000018	0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1052	chr24	61263135	61263761	3500430452	79		61263135	61263761	8421504	3	35,21,23	0,530,603	c	350043045200000045,350043045200000129,350043045200000076,350043045200000117	22-47,15-47,0-21,0-23						Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals	Cone	1996	0		
1052	chr24	61263138	61263692	3500043909	46		61263138	61263692	8421504	2	20,26	0,528	c,g	350004390900000011,350004390900000011,350004390900000012,350004390900000012,350004390900000009,350004390900000010	0-20,0-20,0-20,0-20,0-26,0-26		15470082	10.1124/mol.104.002857	1521-0111 (Online)	Molecular Pharmacology	Proteochemometric Mapping of the Interaction of Organic Compounds with Melanocortin Receptor Subtypes	Lapinsh	2005	0		
1052	chr24	61263447	61263494	3500236087	47		61263447	61263494	8421504	1	47	0	c	350023608700000074	0-47						Melanocortin receptor polypeptides MC-3, MC-4, and MC-5	Yamada	1996	0		
1052	chr24	61263447	61263494	3500208026	47		61263447	61263494	8421504	1	47	0	c	350020802600000074	0-47						Probes and methods for detecting melanocortin-5 receptor	Yamada	1997	0		
1052	chr24	61263548	61263701	3500097226	153		61263548	61263701	8421504	1	153	0	p	350009722600015031	0-153						THESE	w2.vetagro-sup.fr	0	0		MC4R
1052	chr24	61263665	61263697	3500029269	32		61263665	61263697	8421504	1	32	0	c	350002926900000026,350002926900000005	0-21,4-26						DNA sequence encoding bovine and human adrenocorticotropic hormone receptors	Cone	1992	0		
1052	chr24	61263740	61263776	3500163087	36		61263740	61263776	8421504	1	36	0	c	350016308700000038	0-36						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		MC4R
1057	chr24	61916198	61916223	3500405373	23		61916198	61916223	8421504	2	10,13	0,12	g	350040537300000117	1-24						Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection - US Patent 7410795 Description	ww.patentstorm.us	0	0		
1057	chr24	61922808	61922836	3500423989	23		61922808	61922836	8421504	2	10,13	0,15	g	350042398900000025	0-23						US Patent # 7,198,924. Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites - Patents.com	www.patents.com	0	0		
1057	chr24	61922808	61922836	3500393395	23		61922808	61922836	8421504	2	11,12	0,16	g	350039339500000010,350039339500000013	0-23,3-23						Recombinational cloning using engineered recombination sites - Patent # 6171861 - PatentGenius	.patentgenius.com	0	0		
1057	chr24	61922808	61922836	3500300168	23		61922808	61922836	8421504	2	11,12	0,16	g	350030016800000010,350030016800000013	0-23,3-23						Recombinational cloning using engineered recombination sites	Hartley	2011	0		
1057	chr24	61922808	61922836	3500292731	23		61922808	61922836	8421504	2	11,12	0,16	g	350029273100000010,350029273100000013	0-23,3-23					Patent	Chromosome-based platforms (Patent US:7521240)	Perkins	2009	0		
1057	chr24	61922808	61922836	3500281638	24		61922808	61922836	8421504	2	11,13	0,15	g	350028163800000010,350028163800000014,350028163800000013	0-23,0-23,3-23					Patent	Recombinational cloning using engineered recombination sites (Patent US:7304130)	Hartley	2007	0		
1057	chr24	61922808	61922836	3500260220	23		61922808	61922836	8421504	2	11,12	0,16	g	350026022000000019,350026022000000017	0-23,3-23						US Patent # 7,408,049. Recombinational cloning using nucleic acids having recombination sites - Patents.com	www.patents.com	0	0		
1057	chr24	61922808	61922836	3500195666	23		61922808	61922836	8421504	2	10,13	0,15	g	350019566600000018	0-23						Recombinational cloning using nucleic acids having recombination sites	Hartley	2001	0		
1057	chr24	61922808	61922836	3500149366	23		61922808	61922836	8421504	2	11,12	0,16	g	350014936600000024,350014936600000025	0-23,3-23						OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE	Corry	2008	0		
1057	chr24	61922808	61922836	3500092610	24		61922808	61922836	8421504	2	11,13	0,15	g	350009261000000010,350009261000000014,350009261000000013	0-23,0-23,3-23						Chromosome-based platforms	Perkins	2005	0		
1057	chr24	61922808	61922836	3500092586	23		61922808	61922836	8421504	2	11,12	0,16	g	350009258600000011,350009258600000015	0-23,3-23						Methods for assembling multiple expression constructs	Loyall	2005	0		
1057	chr24	61922808	61922836	3500048074	23		61922808	61922836	8421504	2	11,12	0,16	g	350004807400000019	0-23					Patent	Recombinational cloning using nucleic acids having recombination sites (Patent US:7714116)	Fox	2010	0		
1059	chr24	62147000	62157097	3500082944	90		62147000	62157097	8421504	3	45,18,27	0,48,10070	p	350008294400015069,350008294400015070	0-45,0-45						Cadherin-11 EC1 Domain Antagonists for Treating Inflammatory Joint Disorders - Patent application	www.faqs.org	0	0		CDH20
1059	chr24	62147045	62157097	3500180112	48		62147045	62157097	8421504	2	21,27	0,10025	p	350018011200015080	0-48						HUMANIZED ANTIBODIES TARGETING THE EC1 DOMAIN OF CADHERIN-11 AND RELATED COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		CDH20
1059	chr24	62147048	62157097	3500194270	45		62147048	62157097	8421504	2	18,27	0,10022	p	350019427000015082	0-45						CADHERIN-11 ANTAGONISTS AND METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISORDERS - Patent application	www.faqs.org	0	0		CDH20
1059	chr24	62157082	62157107	3500137915	24		62157082	62157107	8421504	2	7,17	0,8	g	350013791500000274	15-39						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1059	chr24	62200762	62200791	3500369652	24		62200762	62200791	8421504	2	9,15	0,14	c,g	350036965200000233,350036965200000233	16-48,16-48						<HTML> <HEAD> <TITLE>U.S. Patent: 5635617 - Methods and compositions comprising the agfA gene for	w.everypatent.com	0	0		
1059	chr24	62200762	62200791	3500187612	24		62200762	62200791	8421504	2	9,15	0,14	c,g	350018761200000233,350018761200000233	16-48,16-48						US Patent # 5,635,617. Methods and compositions comprising the agfA gene for detection of Salmonella - Patents.com	www.patents.com	0	0		
1063	chr24	62680422	62680454	3500238271	27		62680422	62680454	8421504	3	5,12,10	0,8,22	c	350023827100000023	21-48						Cdr-grafted anti-tissue factor antibodies and methods of use thereof	Joliffe	1998	0		
1063	chr24	62680422	62680454	3500147485	27		62680422	62680454	8421504	3	5,12,10	0,8,22	c	350014748500000085	21-48						Antigen Binding Proteins Capable Of Binding Thymic Stromal Lymphopoietin 	.freshpatents.com	0	0		
1063	chr24	62728959	62728992	3500403336	28		62728959	62728992	8421504	2	7,21	0,12	c	350040333600000323	0-30					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
1063	chr24	62728959	62728992	3500339718	28		62728959	62728992	8421504	2	7,21	0,12	c	350033971800000237	0-30						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1998	0		
1063	chr24	62728959	62728992	3500312985	28		62728959	62728992	8421504	2	7,21	0,12	c	350031298500000328	0-30					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
1063	chr24	62728959	62728992	3500199448	28		62728959	62728992	8421504	2	7,21	0,12	c	350019944800000235	0-30						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1996	0		
1063	chr24	62728959	62728992	3500126207	28		62728959	62728992	8421504	2	7,21	0,12	c	350012620700000323	0-30					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
1063	chr24	62728959	62728992	3500095165	28		62728959	62728992	8421504	2	7,21	0,12	c	350009516500000247	0-30						Chromosome 13-linked breast cancer susceptibility gene		1997	0		
1063	chr24	62728959	62728992	3500049566	28		62728959	62728992	8421504	2	7,21	0,12	c	350004956600000328	0-30					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
1067	chr24	63230488	63230513	3500100956	25		63230488	63230513	8421504	1	25	0	g	350010095600000005,350010095600000004	4-29,7-32			10.1074/jbc.M303718200		The Journal of biological chemistry	Critical Amino Acids in the Active Site of Meprin Metalloproteinases for Substrate and Peptide Bond Specificity	James	2003	0		
1069	chr24	63542864	63542892	3500232255	28		63542864	63542892	8421504	1	28	0	g	350023225500000003	9-37		23744359	10.1038/cddis.2013.193	false	Cell Death & Disease	miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer	Karaayvaz	2013	0		
1069	chr24	63542864	63542892	3500020800	28		63542864	63542892	8421504	1	28	0	g	350002080000000003	9-37		23744359	10.1038/cddis.2013.193	false	Cell Death & Disease	miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer	Karaayvaz	2013	0		
1069	chr24	63544489	63544516	3500403353	27		63544489	63544516	8421504	1	27	0	c	350040335300000030	0-27						Plasminogen activator inhibitor 1: mechanisms of its synergistic regulation by growth factors	ib.dr.iastate.edu	0	0		BCL2
1069	chr24	63544491	63544516	3500452288	25		63544491	63544516	8421504	1	25	0	c	350045228800000002	0-25		10644513			American Journal of Physiology - Cell Physiology	Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells	Ohigashi	2000	0		BCL2
1069	chr24	63544491	63544516	3500450308	25		63544491	63544516	8421504	1	25	0	c	350045030800000000	0-25						Methods of modulating cell death based on the Bit1/AES regulatory pathway	Jan	2003	0		BCL2
1069	chr24	63544491	63544516	3500445809	25		63544491	63544516	8421504	1	25	0	c	350044580900000007	0-25		20098578	10.4162/nrp.2009.3.4.265		Nutrition Research and Practice	Effects of &#x03b1;-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells	Mi	2009	0		BCL2
1069	chr24	63544491	63544516	3500429540	25		63544491	63544516	8421504	1	25	0	c	350042954000000000	0-25			10.1038/sj.onc.1204067	${footerJournalISSN}		Negative regulation of bcl-2 expression by p53 in hematopoietic cells		2001	0		BCL2
1069	chr24	63544491	63544516	3500232344	25		63544491	63544516	8421504	1	25	0	c	350023234400000007	0-25						Effects of &#x03b1;-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells	omolecular.com.br	0	0		BCL2
1069	chr24	63544491	63544516	3500162925	25		63544491	63544516	8421504	1	25	0	c	350016292500000000	0-25			10.1038/sj.onc.1204067	${footerJournalISSN}		Negative regulation of bcl-2 expression by p53 in hematopoietic cells		2001	0		BCL2
1069	chr24	63544491	63544516	3500010364	25		63544491	63544516	8421504	1	25	0	c	350001036400000015	0-25						Waltonitone induces human hepatocellular carcinoma cells apoptosis in vitro and in vivo	www.beyotime.com	0	0		BCL2
1069	chr24	63544501	63544542	3500004987	41		63544501	63544542	8421504	1	41	0	c	350000498700000017	77-118						THESE	esups.ups-tlse.fr	0	0		
1069	chr24	63544504	63544570	3500177194	66		63544504	63544570	8421504	1	66	0	p	350017719400015001	0-66						Protein Page: NP_000624	ranetransport.org	0	0		BCL2
1069	chr24	63544534	63544600	3500280211	66		63544534	63544600	8421504	1	66	0	p	350028021100015073	0-66						Compositions and methods for modulating nod-like receptor activity and uses thereof	Faustin	2011	0		BCL2
133	chr24	63544537	63749429	3500264792	222		63544537	63749429	8421504	2	87,135	0,204757	p	350026479200015004	0-222						CANCER THERAPY - Patent application	www.faqs.org	0	0		BCL2
1069	chr24	63544554	63544585	3500021791	31		63544554	63544585	8421504	1	31	0	c	350002179100000000	92-123						ISSUU - Gen-T n&#xba;4 by Javier Masoliver	issuu.com/euroesp	0	0		
1069	chr24	63544555	63544579	3500319232	24		63544555	63544579	8421504	1	24	0	c	350031923200000005	21-45						Citrullinated fibronectin inhibits apoptosis and promotes the secretion of pro-inflammatory cytokines in fibroblast-like synoviocytes in rheumatoid arthritis	itis-research.com	0	0		
1069	chr24	63544555	63544579	3500290112	24		63544555	63544579	8421504	1	24	0	c	350029011200000005	3-27		18356084	10.1016/j.immuni.2008.02.014		Immunity	Rapid culling of the CD4 repertoire in the transition from effector to memory	Matthew	2008	0		
1069	chr24	63544558	63544583	3500121617	25		63544558	63544583	8421504	1	25	0	c	350012161700000006	0-25			10.1093/emboj/21.1.103	ERROR! NO ISSN	The EMBO Journal	IL-7R&#x03b1; and E47: independent pathways required for development of multipotent lymphoid progenitors	Kee	2002	0		
1069	chr24	63544558	63544581	3500044165	23		63544558	63544581	8421504	1	23	0	c	350004416500000012	0-23						Involvement of GPR12 in the regulation of cell proliferation and survival	sat.ecnu.edu.cn	0	0		BCL2
1069	chr24	63544559	63544582	3500019970	23		63544559	63544582	8421504	1	23	0	c	350001997000000003	0-23		21862660	10.1124/jpet.111.179820	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	RETRACTION: Indole-3-Carbinol Enhances the Resolution of Rat Liver Fibrosis and Stimulates Hepatic Stellate Cell Apoptosis by Blocking the Inhibitor of &#x03ba;B Kinase &#x03b1;/Inhibitor of &#x03ba;B-&#x03b1;/Nuclear Factor-&#x03ba;B Pathway	Ping	2011	0		BCL2
1069	chr24	63544560	63544583	3500068586	23		63544560	63544583	8421504	1	23	0	c	350006858600000001	0-23		20876285	10.1093/carcin/bgq192		Carcinogenesis	Oncogenic HER2&#x0394;16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors	Diana	2010	0		
1069	chr24	63544561	63544585	3500458337	24		63544561	63544585	8421504	1	24	0	c	350045833700000007	0-24						Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells. - ResearchGate	.researchgate.net	0	0		
1069	chr24	63544561	63544585	3500437392	24		63544561	63544585	8421504	1	24	0	c	350043739200000001	0-24			10.1002/ijc.23154	1097-0215	International Journal of Cancer	p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: Antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action - Takahashi - 2007 - International Journal of Cancer - Wiley Online Library	Takahashi	2008	0		BCL2
1069	chr24	63544561	63544585	3500367041	24		63544561	63544585	8421504	1	24	0	c	350036704100000001	0-24						Arsenic-induced oxidative stress, apoptosis and alterations in testicular steroidogenesis and spermatogenesis in wistar rats: ameliorative effect of curcumin	earchjournals.org	0	0		BCL2
1069	chr24	63544561	63544585	3500349715	24		63544561	63544585	8421504	1	24	0	c,g	350034971500000001,350034971500000001	0-24,0-24		16299317	10.1128/IAI.73.12.8209-8218.2005	0019-9567	Infection and Immunity	Anaplasma phagocytophilum Delay of Neutrophil Apoptosis through the p38 Mitogen-Activated Protein Kinase Signal Pathway	Choi	2005	4		BCL2
1069	chr24	63544561	63544585	3500307366	24		63544561	63544585	8421504	1	24	0	c	350030736600000001	0-24						Anaplasma phagocytophilum Delay of Neutrophil Apoptosis through the p38 Mitogen-Activated Protein Kinase Signal Pathway	iai.asm.org	0	0		BCL2
1069	chr24	63544561	63544585	3500290742	24		63544561	63544585	8421504	1	24	0	c	350029074200000003	0-24						ScienceDirect.com - Phytomedicine - Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells	sciencedirect.com	0	0		BCL2
1069	chr24	63544561	63544585	3500271868	24		63544561	63544585	8421504	1	24	0	c	350027186800000003	0-24		20930561	10.1038/cdd.2010.74	1350-9047	Cell Death & Differentiation	A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2&#x2013;Beclin1 interaction at endoplasmic reticulum	Lian	2010	9		
1069	chr24	63544561	63544585	3500187432	24		63544561	63544585	8421504	1	24	0	c	350018743200000005	0-24		23593410	10.1371/journal.pone.0061132	1932-6203	PLOS ONE	PLOS ONE: PMS1077 Sensitizes TNF-&#x03b1; Induced Apoptosis in Human Prostate Cancer Cells by Blocking NF-&#x03ba;B Signaling Pathway	Shi	2013	4		BCL2
1069	chr24	63544561	63544585	3500116765	24		63544561	63544585	8421504	1	24	0	c	350011676500000001	0-24						p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: Antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action	laris.hoshi.ac.jp	0	0		
1069	chr24	63544562	63544585	3500467614	23		63544562	63544585	8421504	1	23	0	c	350046761400000003	0-23						Analyse de l&#x2019;expression de g&#xe8;nes indicateurs de la mort cellulaire dans la glande mammaire, un indice du potentiel de production de la glande mammaire.	www.journees3r.fr	0	0		BCL2
1069	chr24	63544562	63544585	3500236181	23		63544562	63544585	8421504	1	23	0	c	350023618100000002	0-23						0605_s3_article_14	www.jpp.krakow.pl	0	0		BCL2
1069	chr24	63544564	63544588	3500438885	24		63544564	63544588	8421504	1	24	0	c	350043888500000037	0-24						Intranasal Delivery Of Nucleic Acid Molecules 	.freshpatents.com	0	0		BCL2
1069	chr24	63544564	63544588	3500354168	24		63544564	63544588	8421504	1	24	0	c	350035416800000073,350035416800000037	0-24,0-24						INTRANASAL DELIVERY OF NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		BCL2
1069	chr24	63544564	63544588	3500103384	24		63544564	63544588	8421504	1	24	0	c	350010338400000037	0-24						Intranasal delivery of nucleic acid molecules	Lee	2005	0		BCL2
1069	chr24	63544572	63544596	3500181347	24		63544572	63544596	8421504	1	24	0	c	350018134700000009	0-24		20863366	10.1186/bcr2644		Breast Cancer Research : BCR	Silencing of the IKK&#x03b5; gene by siRNA inhibits invasiveness and growth of breast cancer cells	Bin	2010	0		
1069	chr24	63544572	63544596	3500039644	24		63544572	63544596	8421504	1	24	0	c	350003964400000006	0-24						Hedgehog-InducedSurvivalofB-CellChronicLymphocytic LeukemiaCellsinaStromalCellMicroenvironment: APotentialNewTherapeuticTarget	.aacrjournals.org	0	0		
133	chr24	63544597	63749831	3500018361	135		63544597	63749831	8421504	3	27,27,81	0,204697,205153	p	350001836100015017,350001836100015026,350001836100015016,350001836100015014	0-54,0-72,0-45,0-75						<HTML> <HEAD><TITLE>Table report for jbc 279/12</TITLE></HEAD> <BODY BGCOLOR=FFFFF8> <CENTER> <IM	ke.sciencemag.org	0	0		BCL2
133	chr24	63544603	63749576	3500164379	303		63544603	63749576	8421504	2	21,282	0,204691	p	350016437900015066	177-603						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		BCL2
133	chr24	63544612	63749306	3500020483	24		63544612	63749306	8421504	2	12,12	0,204682	c	350002048300000016	0-24		12451129		0270-6474	The Journal of Neuroscience	Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model	Ruscher	2002	7		BCL2
1071	chr24	63744157	63749360	3500405176	39		63744157	63749360	8421504	3	14,5,20	0,18,5183	c,g	350040517600000005,350040517600000000	0-19,0-20		19369421	10.1091/mbc.E08-10-1061	1059-1524	Molecular Biology of the Cell	Uncoupling Stress Granule Assembly and Translation Initiation Inhibition	Mokas	2009	5		HSPA1A
1071	chr24	63749324	63749549	3500425066	40		63749324	63749549	8421504	2	20,20	0,205	c,g	350042506600000005,350042506600000005,350042506600000004,350042506600000004	0-20,0-20,0-20,0-20						ScienceDirect.com - Carbohydrate Polymers - An exopolysaccharide from Trichoderma pseudokoningii and its apoptotic activity on human leukemia K562 cells	sciencedirect.com	0	0		BCL2
1071	chr24	63749324	63749549	3500062588	40		63749324	63749549	8421504	2	20,20	0,205	c,g	350006258800000003,350006258800000003,350006258800000002,350006258800000002	0-20,0-20,0-20,0-20						ANTITUMOUR EFFECT OF PLANT EXTRACTS AND THEIR CONSTITUENTS ON CANCER CELL LINES	.bibl.u-szeged.hu	0	0		BCL2
1071	chr24	63749324	63749549	3500021323	40		63749324	63749549	8421504	2	20,20	0,205	c,g	350002132300000004,350002132300000004,350002132300000003,350002132300000003	0-20,0-20,0-20,0-20		18798256	10.1002/ijc.23791	1097-0215	International Journal of Cancer	Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent - Mancini - 2008 - International Journal of Cancer - Wiley Online Library	Mancini	2008	0		BCL2
1071	chr24	63749324	63749484	3500388304	40		63749324	63749484	8421504	2	20,20	0,140	c	350038830400000013,350038830400000012	0-20,0-20						&#x4e3b;&#x9898;&#xff1a;hedgehog | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		BCL2
1071	chr24	63749324	63749484	3500361581	40		63749324	63749484	8421504	2	20,20	0,140	c	350036158100000013,350036158100000012	0-20,0-20						Hedgehog Signaling Promotes Medulloblastoma Survival via BclII 2007&#x5e74;&#x7b2c;169&#x5377;&#x7b2c;1&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		BCL2
1071	chr24	63749329	63749353	3500293793	24		63749329	63749353	8421504	1	24	0	c	350029379300000008	0-24						Gene silencing using mrna-cdna hybrids	Chuong	2002	0		BCL2
1071	chr24	63749329	63749353	3500254426	24		63749329	63749353	8421504	1	24	0	c	350025442600000008,350025442600000022	0-24,0-24						NOVEL RNA INTERFERENCE METHODS USING DNA-RNA DUPLEX CONSTRUCTS - Patent application	www.faqs.org	0	0		BCL2
1071	chr24	63749329	63749353	3500213322	24		63749329	63749353	8421504	1	24	0	c	350021332200000017,350021332200000008	0-24,0-24						Gene Silencing Using mRNA-cDNA Hybrids - Patent application	www.faqs.org	0	0		BCL2
1071	chr24	63749329	63749353	3500172912	24		63749329	63749353	8421504	1	24	0	c	350017291200000008	0-24						RNA interference methods using DNA-RNA duplex constructs	Ying	2010	0		BCL2
1071	chr24	63749329	63749353	3500070168	24		63749329	63749353	8421504	1	24	0	c	350007016800000008	0-24					Patent	RNA interference methods using DNA-RNA duplex constructs (Patent US:8372969)	Ying	2013	0		BCL2
1071	chr24	63749333	63749359	3500017630	26		63749333	63749359	8421504	1	26	0	c	350001763000000469,350001763000000199	0-26,0-26						RECURRENT GENE FUSIONS IN PROSTATE CANCER - Patent application	www.faqs.org	0	0		BCL2
1071	chr24	63749333	63749358	3500214281	25		63749333	63749358	8421504	1	25	0	c	350021428100000018	0-25		17634147	10.1186/bcr1743	1465-5411	Breast Cancer Research	The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells	Han	2007	0		BCL2
1071	chr24	63749339	63749789	3500453736	47		63749339	63749789	8421504	2	24,23	0,427	c	350045373600000001,350045373600000000	0-24,0-23		15026553		1535-7163	Molecular Cancer Therapeutics	Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells	Biswas	2004	5		BCL2
1071	chr24	63749343	63749550	3500452288	45		63749343	63749550	8421504	2	20,25	0,182	c	350045228800000001,350045228800000003	0-20,0-25		10644513			American Journal of Physiology - Cell Physiology	Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells	Ohigashi	2000	0		BCL2
1071	chr24	63749351	63749801	3500406531	95		63749351	63749801	8421504	2	48,47	0,403	c	350040653100000035,350040653100000026	0-48,0-47						 Regulation Of Bcl 	www.docstoc.com	0	0		
1071	chr24	63749353	63749412	3500139655	44		63749353	63749412	8421504	2	23,21	0,38	c,g	350013965500000002,350013965500000003,350013965500000003	0-23,0-21,0-21						Oligomeric compounds for the modulation of bcl-2	Frieden	2005	0		BCL2
1071	chr24	63749353	63749412	3500031168	43		63749353	63749412	8421504	2	22,21	0,38	c,g	350003116800000005,350003116800000003,350003116800000003	0-22,0-21,0-21		18349321	10.1182/blood-2007-10-117762	0006-4971	Blood	The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph&#x2212; acute lymphoblastic leukemia cells	Scuto	2008	10		BCL2
1071	chr24	63749359	63749386	3500245947	27		63749359	63749386	8421504	1	27	0	c	350024594700000006	0-27						B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells.	.biomedsearch.com	0	0		BCL2
1071	chr24	63749359	63749386	3500230751	27		63749359	63749386	8421504	1	27	0	c	350023075100000008	0-27		18575582	10.1371/journal.pone.0002478		PLoS ONE	B-MYB Is Essential for Normal Cell Cycle Progression and Chromosomal Stability of Embryonic Stem Cells	Kirill	2008	0		BCL2
1071	chr24	63749372	63749846	3500289662	315		63749372	63749846	8421504	4	63,42,81,129	0,96,153,345	p	350028966200015008,350028966200015005,350028966200015002	0-129,0-81,0-129						Expression galectin-3 modulates T-cell apoptosis	www.pnas.org	0	0		BCL2
1071	chr24	63749372	63749398	3500234365	26		63749372	63749398	8421504	1	26	0	c	350023436500000002	0-26						OF MEDICINAL MUSHROOMS	l.begellhouse.com	0	0		BCL2
1071	chr24	63749380	63749404	3500169844	24		63749380	63749404	8421504	1	24	0	c,g	350016984400000002,350016984400000002	0-24,0-24						SURGICAL ATTENUATION OF CONGENITAL PORTOSYSTEMIC SHUNTS IN DOGS	ive.library.uu.nl	0	0		BCL2
1071	chr24	63749382	63749586	3500036931	46		63749382	63749586	8421504	2	24,22	0,182	c	350003693100000005,350003693100000004	0-24,0-22						Maturation medium supplements affect transcript level of apoptosis and cell survival related genes in bovine blastocysts produced in vitro	www.ufpel.edu.br	0	0		
1071	chr24	63749391	63749546	3500337725	46		63749391	63749546	8421504	2	24,22	0,133	c,g	350033772500000005,350033772500000004,350033772500000004	0-24,0-22,0-22						Felipe Camargo Braga TESE	www.teses.usp.br	0	0		BCL2
1071	chr24	63749392	63749484	3500170470	41		63749392	63749484	8421504	2	21,20	0,72	c,g	350017047000000005,350017047000000005,350017047000000004	0-21,0-21,0-20						A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides. - ResearchGate	.researchgate.net	0	0		BCL2
1071	chr24	63749398	63749424	3500192942	26		63749398	63749424	8421504	1	26	0	c	350019294200000002	0-26						Antiproliferative and apoptotic effect of Astrodaucus orientalis (L.) drude on T47D human breast cancer cell line: Potential mechanisms of action - ResearchGate	.researchgate.net	0	0		BCL2
1071	chr24	63749406	63749430	3500314592	24		63749406	63749430	8421504	1	24	0	c	350031459200000002	0-24						The peroxisome proliferator-activated receptor &#xc1; ligands,	-publications.com	0	0		BCL2
1071	chr24	63749421	63749444	3500367782	23		63749421	63749444	8421504	1	23	0	c,g	350036778200000000,350036778200000000	0-23,0-23		17395704	10.1210/en.2006-1378	0013-7227	Endocrinology	Dehydroepiandrosterone Protects Vascular Endothelial Cells against Apoptosis through a G&#x03b1;i Protein-Dependent Activation of Phosphatidylinositol 3-Kinase/Akt and Regulation of Antiapoptotic Bcl-2 Expression	Liu	2007	4		
1071	chr24	63749448	63749548	3500380801	43		63749448	63749548	8421504	2	19,24	0,76	c,g	350038080100000004,350038080100000004,350038080100000005	0-19,0-19,0-24		15113961		0022-3166	The Journal of Nutrition	&#x03b2;-Sitosterol, &#x03b2;-Sitosterol Glucoside, and a Mixture of &#x03b2;-Sitosterol and &#x03b2;-Sitosterol Glucoside Modulate the Growth of Estrogen-Responsive Breast Cancer Cells In Vitro and in Ovariectomized Athymic Mice	Ju	2004	4		BCL2
1071	chr24	63749448	63749548	3500068650	43		63749448	63749548	8421504	2	19,24	0,76	c,g	350006865000000004,350006865000000004,350006865000000005	0-19,0-19,0-24		15113961		0022-3166	The Journal of Nutrition	&#x03b2;-Sitosterol, &#x03b2;-Sitosterol Glucoside, and a Mixture of &#x03b2;-Sitosterol and &#x03b2;-Sitosterol Glucoside Modulate the Growth of Estrogen-Responsive Breast Cancer Cells In Vitro and in Ovariectomized Athymic Mice	Ju	2004	4		BCL2
1071	chr24	63749463	63750047	3500038201	62		63749463	63750047	8421504	3	20,22,20	0,328,564	c,g	350003820100000018,350003820100000018,350003820100000003,350003820100000002	0-20,0-20,0-22,0-20		19114554	10.1128/MCB.01346-08	0270-7306	Molecular and Cellular Biology	TFIIB Recognition Elements Control the TFIIA-NC2 Axis in Transcriptional Regulation	Deng	2009	6		BCL2
1071	chr24	63749525	63749550	3500450308	25		63749525	63749550	8421504	1	25	0	c	350045030800000001	0-25						Methods of modulating cell death based on the Bit1/AES regulatory pathway	Jan	2003	0		BCL2
1071	chr24	63749525	63749550	3500445809	25		63749525	63749550	8421504	1	25	0	c	350044580900000006	0-25		20098578	10.4162/nrp.2009.3.4.265		Nutrition Research and Practice	Effects of &#x03b1;-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells	Mi	2009	0		BCL2
1071	chr24	63749525	63749550	3500429540	25		63749525	63749550	8421504	1	25	0	c	350042954000000001	0-25			10.1038/sj.onc.1204067	${footerJournalISSN}		Negative regulation of bcl-2 expression by p53 in hematopoietic cells		2001	0		BCL2
1071	chr24	63749525	63749550	3500391345	25		63749525	63749550	8421504	1	25	0	c	350039134500000012	0-25						View Online / Journal Homepage / Table of Contents for this issue Nanoscale C	www.howard.edu	0	0		BCL2
1071	chr24	63749525	63749550	3500232344	25		63749525	63749550	8421504	1	25	0	c	350023234400000006	0-25						Effects of &#x03b1;-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells	omolecular.com.br	0	0		BCL2
1071	chr24	63749525	63749550	3500162925	25		63749525	63749550	8421504	1	25	0	c	350016292500000001	0-25			10.1038/sj.onc.1204067	${footerJournalISSN}		Negative regulation of bcl-2 expression by p53 in hematopoietic cells		2001	0		BCL2
1071	chr24	63749525	63749550	3500010364	25		63749525	63749550	8421504	1	25	0	c	350001036400000014	0-25						Waltonitone induces human hepatocellular carcinoma cells apoptosis in vitro and in vivo	www.beyotime.com	0	0		BCL2
1071	chr24	63749759	63749837	3500118233	78		63749759	63749837	8421504	1	78	0	p	350011823300015000,350011823300015001	33-111,33-111		21233846	10.1038/cdd.2010.175	1350-9047	Cell Death & Differentiation	Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells	Trisciuoglio	2011	9		
1071	chr24	63749759	63749837	3500000257	78		63749759	63749837	8421504	1	78	0	p	350000025700015000,350000025700015001	33-111,33-111		21233846	10.1038/cdd.2010.175		Cell Death and Differentiation	Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells	D	June	0		
1071	chr24	63749771	63749819	3500105711	48		63749771	63749819	8421504	1	48	0	p	350010571100015127	0-48						BH3 interacting domain death agonist	Korsmeyer	1996	0		BCL2
1071	chr24	63759868	63759891	3500107060	23		63759868	63759891	8421504	1	23	0	g	350010706000000002	0-32						Interleukins-21 and 22	Ebner	2001	0		
1071	chr24	63793673	63793697	3500433932	24		63793673	63793697	8421504	1	24	0	c	350043393200000007	0-24						Distinct Subsets of Primary Effusion Lymphoma Can Be Identi&#xfb01;ed Based on Their Cellular Gene Expression Pro&#xfb01;le and Viral Association	jvi.asm.org	0	0		KDSR
1071	chr24	63793673	63793697	3500415993	24		63793673	63793697	8421504	1	24	0	c	350041599300000007	0-24			10.1128/JVI.79.2.1244-1251.2005		Journal of Virology	Distinct Subsets of Primary Effusion Lymphoma Can Be Identified Based on Their Cellular Gene Expression Profile and Viral Association	Wen	2005	0		KDSR
1072	chr24	63899778	63899803	3500312616	24		63899778	63899803	8421504	2	11,13	0,12	c	350031261600000229	11-35						METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Patent application	www.faqs.org	0	0		
1072	chr24	63899778	63899803	3500047977	24		63899778	63899803	8421504	2	11,13	0,12	c	350004797700000229	11-35						METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Patent application	www.faqs.org	0	0		
1075	chr24	64236095	64236121	3500271944	23		64236095	64236121	8421504	2	13,10	0,16	c	350027194400000047	25-48						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		
1075	chr24	64236095	64236121	3500237109	23		64236095	64236121	8421504	2	13,10	0,16	c	350023710900000047	25-48						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		
1075	chr24	64236095	64236121	3500210939	23		64236095	64236121	8421504	2	13,10	0,16	c	350021093900000088	25-48						Starchless variety of pisum sativum having elevated levels of sucrose	Webster	2000	0		
1075	chr24	64236095	64236121	3500187962	23		64236095	64236121	8421504	2	13,10	0,16	c	350018796200000088	25-48						 Starchless Variety Of Pisum Sativum Having Elevated Levels Of Sucrose 	www.docstoc.com	0	0		
1075	chr24	64320543	64320589	3500113861	46		64320543	64320589	8421504	1	46	0	c	350011386100000025	1-47						Megsin/Rage/Inos-Overexpressing Renal Disease Model Animals and Methods for Evaluating Compounds Using the Model Animals - Patent application	www.faqs.org	0	0		
1076	chr24	64385516	64396301	3500343319	101		64385516	64396301	8421504	3	34,28,39	0,6859,10746	c	350034331900000015,350034331900000025,350034331900000056	1-35,0-48,0-31						US Patent # 5,298,400. Polynucleotide constructs for secreted glycosylated plasminogen activator inhibitor-2 (PAI-2) - Patents.com	www.patents.com	0	0		
1076	chr24	64385587	64396282	3500173240	75		64385587	64396282	8421504	3	27,28,20	0,6788,10675	c	350017324000000016,350017324000000025	21-48,0-48						Polynucleotide constructs for secreted glycosylated plasminogen activator inhibitor-2 (PAI-2)	Whitfeld	1991	0		
1076	chr24	64397865	64397891	3500194446	26		64397865	64397891	8421504	1	26	0	c	350019444600000043,350019444600000019	15-41,0-20					Patent	Human monocyte elastase inhibitor antibodies (Patent US:5827672)	Remold-O'Donnell	1998	0		
1076	chr24	64397865	64397891	3500064429	26		64397865	64397891	8421504	1	26	0	c	350006442900000044	15-41						Human monocyte elastase inhibitor - US Patent 5663299 Description	ww.patentstorm.us	0	0		
1076	chr24	64427915	64428385	3500100734	43		64427915	64428385	8421504	2	20,23	0,447	c	350010073400000074,350010073400000429	12-34,10-33						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
589	chr25	579622	584260	3500065787	175		579622	584260	8421504	8	24,15,20,30,15,3,45,23	0,1802,1971,2042,2778,2937,3042,4615	c	350006578700000160,350006578700000119,350006578700000117,350006578700000113,350006578700000076	0-24,0-35,0-45,0-48,0-23						Genes and polypeptides relating to chronic myeloid leukemia	Zhong Cun You Fu 	2005	0		
589	chr25	579940	583306	3500037847	57		579940	583306	8421504	3	27,10,20	0,3333,3346	c	350003784700000114,350003784700000070	0-27,0-30					Patent	Genes and polypeptides relating to chronic myeloid leukemia (Patent CN:100434439)	Zhong Cun You Fu 	2008	0		
589	chr25	580036	580272	3500169957	69		580036	580272	8421504	2	12,57	0,179	p	350016995700015022	0-69						Targets for tumor growth inhibition - Patent #07781414	w.strutpatent.com	0	0		RHBDF2
589	chr25	580036	580272	3500151623	69		580036	580272	8421504	2	12,57	0,179	p	350015162300015025	0-69						TARGETS FOR TUMOR GROWTH INHIBITION	LU	2009	0		RHBDF2
589	chr25	580559	580658	3500081673	30		580559	580658	8421504	2	15,15	0,84	c	350008167300000458	15-45						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
590	chr25	657076	675248	3500391583	40		657076	675248	8421504	2	20,20	0,18152	c,g	350039158300000002,350039158300000003,350039158300000003	0-20,0-20,0-20						MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE - IMMUNIVEST CORPORATION	www.sumobrain.com	0	0		HBM,HBZ,HBA2
590	chr25	657076	675248	3500386225	40		657076	675248	8421504	2	20,20	0,18152	c,g	350038622500000011,350038622500000004,350038622500000012	0-20,20-40,0-20						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	S*M*Ao Ha La 	2005	0		HBM,HBZ,HBA1,HBA2
590	chr25	657076	675248	3500171619	40		657076	675248	8421504	2	20,20	0,18152	c,g	350017161900000002,350017161900000003	0-20,0-20						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2003	0		HBM,HBZ,HBA2
590	chr25	674621	675252	3500436935	426		674621	675252	8421504	3	95,205,126	0,196,505	p	350043693500015000,350043693500015001,350043693500015002,350043693500015003,350043693500015004	0-90,0-90,0-90,0-90,0-66						Translation (genetics) - The Full Wiki	w.thefullwiki.org	0	0		
590	chr25	674621	675252	3500432154	426		674621	675252	8421504	3	95,205,126	0,196,505	p	350043215400015000,350043215400015001,350043215400015002,350043215400015003,350043215400015004	0-90,0-90,0-90,0-90,0-66						Translation_(biology)	ww.chemeurope.com	0	0		
590	chr25	674621	675252	3500345195	414		674621	675252	8421504	7	87,5,82,87,30,57,66	0,90,196,281,371,505,565	p	350034519500015000,350034519500015001,350034519500015002,350034519500015003,350034519500015004	0-87,0-87,0-87,0-87,0-66						Translation (genetics)&#x3068;&#x306f; - goo Wikipedia (&#x30a6;&#x30a3;&#x30ad;&#x30da;&#x30c7;&#x30a3;&#x30a2;) 	wpedia.goo.ne.jp	0	0		
590	chr25	674621	675252	3500170672	426		674621	675252	8421504	3	95,205,126	0,196,505	p	350017067200015000,350017067200015001,350017067200015002,350017067200015003,350017067200015004	0-90,0-90,0-90,0-90,0-66						Translation (biology) - wikidoc	www.wikidoc.org	0	0		
590	chr25	674621	675252	3500060431	426		674621	675252	8421504	3	95,205,126	0,196,505	p	350006043100015000,350006043100015001,350006043100015002,350006043100015003,350006043100015004	0-90,0-90,0-90,0-90,0-66						Translation (biology) - The Full Wiki	w.thefullwiki.org	0	0		
590	chr25	674621	674666	3500143434	45		674621	674666	8421504	1	45	0	p	350014343400015001	0-45						Genetiske afstande og afstandsmatricer	teknologibogen.dk	0	0		
590	chr25	674622	675252	3500411568	123		674622	675252	8421504	2	57,66	0,564	p	350041156800015002,350041156800015001,350041156800015005	57-114,0-54,0-66						Nucleic Acids Research, 2006, Vol. 34, Web Server issue W385&#x2013;W388 doi:10.1093/nar/gkl252 Virtual Ribosome&#x2014;a comprehensive DNA translation tool with support for integration of sequence feature annotation	wiki.bio.dtu.dk	0	0		
590	chr25	674711	675252	3500223172	336		674711	675252	8421504	3	5,205,126	0,106,415	p	350022317200015000,350022317200015001,350022317200015002,350022317200015003	0-90,0-90,0-93,0-66						Biological Sciences 101 > Thoma > Notes > Genetic Code for Translation | StudyBlue	www.studyblue.com	0	0		
590	chr25	674842	675248	3500106806	40		674842	675248	8421504	2	20,20	0,386	c,g	350010680600000002,350010680600000003,350010680600000003	0-20,0-20,0-20						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2004	0		HBM,HBZ,HBA2
590	chr25	674842	675248	3500100860	40		674842	675248	8421504	2	20,20	0,386	c	350010086000000002,350010086000000003	0-20,0-20						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2004	0		HBM,HBZ,HBA2
590	chr25	674842	674880	3500203465	38		674842	674880	8421504	1	38	0	c	350020346500000023	0-38						Detection of human .alpha.-thalassemia mutations and their use as predictors of blood-related disorders - Patent # 5750345 - PatentGenius	.patentgenius.com	0	0		
590	chr25	674916	675332	3500375699	310		674916	675332	8421504	4	23,82,83,122	0,24,210,294	c,g	350037569900000016,350037569900000016	9-319,9-319						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
590	chr25	675002	681125	3500039690	44		675002	681125	8421504	3	20,5,19	0,124,6104	c	350003969000000001,350003969000000000	0-25,0-19		21958870	10.1016/j.ejphar.2011.09.024		European Journal of Pharmacology	C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells	Eleonora	2011	0		HBM,HBZ,HBA2
590	chr25	675171	675252	3500405341	81		675171	675252	8421504	1	81	0	p	350040534100015131	0-81						Wisconsin Package Program Manual	www.hsc.wvu.edu	0	0		
590	chr25	675195	675264	3500402065	66		675195	675264	8421504	3	20,23,23	0,22,46	c	350040206500000009,350040206500000011,350040206500000010	0-20,0-23,0-23		23638875	10.1111/aji.12131	1600-0897	American Journal of Reproductive Immunology	Heat Shock Induces Interferon-TAU Gene Expression by In Vitro-Produced Bovine Blastocysts - Hickman - 2013 - American Journal of Reproductive Immunology - Wiley Online Library	Hickman	2013	0		
590	chr25	675220	675252	3500047786	32		675220	675252	8421504	1	32	0	c	350004778600000003	0-32						Full text of "Annual report : National Cancer Institute (U.S.)"	archive.org	0	0		
590	chr25	675225	675256	3500461091	31		675225	675256	8421504	1	31	0	c	350046109100000013	44-75						Genetically fused globin-like polypeptides having hemoglobin-like activity	Hoffman	1995	0		HBA2
590	chr25	675225	675256	3500402965	31		675225	675256	8421504	1	31	0	c	350040296500000024	44-75					Patent	Hemoglobin-like protein comprising genetically fused globin-like polypeptides (Patent US:5844088)	Anderson	1998	0		HBA2
590	chr25	675225	675256	3500341383	31		675225	675256	8421504	1	31	0	c	350034138300000023	44-75						DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin	Hoffman	1991	0		HBA2
590	chr25	675225	675256	3500143633	31		675225	675256	8421504	1	31	0	c	350014363300000012	44-75					Patent	Co-expression of alpha and beta globins (Patent US:5798227)	Hoffman	1998	0		HBA2
590	chr25	675225	675256	3500086979	31		675225	675256	8421504	1	31	0	c	350008697900000023	44-75						DNA encoding fused alpha-beta globin pseuodimer and production of pseudotetrameric hemoglobin - US Patent 5801019 Description	ww.patentstorm.us	0	0		HBA2
590	chr25	675225	675256	3500081479	31		675225	675256	8421504	1	31	0	c	350008147900000023	44-75					Patent	DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin (Patent US:5545727)	Hoffman	1996	0		HBA2
590	chr25	675225	675256	3500074669	31		675225	675256	8421504	1	31	0	c	350007466900000023	44-75					Patent	DNA encoding fused alpha-beta globin pseuodimer and production of pseudotetrameric hemoglobin (Patent US:5801019)	Anderson	1998	0		HBA2
590	chr25	675225	675256	3500073710	31		675225	675256	8421504	1	31	0	c	350007371000000023	44-75					Patent	DNA encoding fused alpha-beta globin pseuodimer and production of pseudotetrameric hemoglobin (Patent US:5801019)	Anderson	1998	0		HBA2
590	chr25	675225	675256	3500068793	31		675225	675256	8421504	1	31	0	c	350006879300000011	44-75					Patent	DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin (Patent US:5744329)	Anderson	1998	0		HBA2
590	chr25	675225	675256	3500061865	31		675225	675256	8421504	1	31	0	c	350006186500000013	44-75					Patent	Genetically fused globin-like polypeptides having hemoglobin-like activity (Patent US:5844089)	Anderson	1998	0		HBA2
590	chr25	675225	675256	3500017629	31		675225	675256	8421504	1	31	0	c	350001762900000013	44-75						DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin	Hoffman	1995	0		HBA2
590	chr25	675231	675255	3500398357	24		675231	675255	8421504	1	24	0	c	350039835700000009,350039835700000046	10-32,0-24						Method for producing haemin proteins using plant cells, resulting proteins and products containing same	Baudino	1998	0		
590	chr25	681175	681203	3500451948	23		681175	681203	8421504	2	11,12	0,16	g	350045194800000363	12-35						CREATING POULTRY AND OTHER ANIMALS RESISTANT TO VIRAL DISEASE - Patent application	www.faqs.org	0	0		
590	chr25	770007	770045	3500293064	38		770007	770045	8421504	1	38	0	c	350029306400000159	0-38						Methods and Compositions for Modulating Apoptosis - Patent application	www.faqs.org	0	0		
592	chr25	1001505	1001535	3500106806	26		1001505	1001535	8421504	2	18,8	0,22	c	350010680600000012	19-45						Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample	Foulk	2004	0		
592	chr25	1033525	1033551	3500140718	23		1033525	1033551	8421504	2	11,12	0,14	g	350014071800000016	5-28						Binding peptides: methods for their generation and use	Roo	2006	0		
9	chr25	1043271	1092632	3500304200	43		1043271	1092632	8421504	5	17,5,6,11,4	0,18,48489,49345,49357	c	350030420000000294,350030420000000216,350030420000000217	16-38,0-21,0-21					Patent	Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use (Patent CN:1578678)	G*Gao 	2010	0		
593	chr25	1049193	1049218	3500119707	23		1049193	1049218	8421504	2	10,13	0,12	g	350011970700000001	0-23						Functional Association between Three Archaeal Aminoacyl-tRNA Synthetases--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
593	chr25	1111248	1111275	3500293314	27		1111248	1111275	8421504	1	27	0	c	350029331400000077	0-27					Patent	DNA coding for megakaryocyte potentiator (Patent US:5723318)	Hattori	1998	0		
593	chr25	1111248	1111275	3500273979	27		1111248	1111275	8421504	1	27	0	c	350027397900000069	0-27						DNA coding for megakaryocyte potentiator - Patent # 5723318 - PatentGenius	.patentgenius.com	0	0		
593	chr25	1127719	1127749	3500064429	26		1127719	1127749	8421504	2	19,7	0,23	c	350006442900000046	6-33						Human monocyte elastase inhibitor - US Patent 5663299 Description	ww.patentstorm.us	0	0		
594	chr25	1197590	1197733	3500149201	41		1197590	1197733	8421504	2	22,19	0,124	g	350014920100000005,350014920100000004	0-22,0-19						Bakht et al. Antimicrobial potentials of Eclipta alba by disc diffusion method. Afr. J. Biotechnol. 2011	demicjournals.org	0	0		
595	chr25	1317278	1317355	3500332640	49		1317278	1317355	8421504	2	23,26	0,51	g	350033264000000004,350033264000000005	0-23,0-26						Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion*	.endojournals.org	0	0		
595	chr25	1317278	1317301	3500254795	23		1317278	1317301	8421504	1	23	0	g	350025479500000004	0-23		16543371	10.1210/en.2005-1559	0013-7227	Endocrinology	Identification of the Somatostatin Receptor Subtypes (sst) Mediating the Divergent, Stimulatory/Inhibitory Actions of Somatostatin on Growth Hormone Secretion	Luque	2006	4		
596	chr25	1455279	1455386	3500342644	33		1455279	1455386	8421504	2	16,17	0,90	c	350034264400000002	1-34						Diverse stability and catalytic properties of human tryptase alpha and beta isoforms are mediated by residue differences at the S1 pocket. - ResearchGate	.researchgate.net	0	0		
596	chr25	1504561	1504609	3500058326	48		1504561	1504609	8421504	1	48	0	c	350005832600000058	0-48						Ubiquitin conjugating enzymes	Rolfe	1996	0		
596	chr25	1506431	1506479	3500444826	48		1506431	1506479	8421504	1	48	0	p	350044482600015000	3-51			10.1042/BJ20060861		Biochemical Journal	Ubc9 interacts with Lu/BCAM adhesion glycoproteins and regulates their stability at the membrane of polarized MDCK cells	EmmanuCollec	2007	0		UBE2I
596	chr25	1526561	1526599	3500246268	30		1526561	1526599	8421504	3	12,11,7	0,16,31	c	350024626800000147	5-38						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		ARTN
596	chr25	1529254	1529395	3500459355	63		1529254	1529395	8421504	2	38,25	0,116	p	350045935500015008	0-63					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6534300)	Canfield	2003	0		
596	chr25	1529254	1529395	3500388061	63		1529254	1529395	8421504	2	38,25	0,116	p	350038806100015008	0-63						US Patent # 7,371,366. GlcNAc phosphotransferase of the lysosomal targeting pathway - Patents.com	www.patents.com	0	0		
596	chr25	1529254	1529395	3500377888	63		1529254	1529395	8421504	2	38,25	0,116	p	350037788800015007	0-63					Patent	Lysosomal targeting pathway enzymes (Patent EP:1224266)	Canfield	2007	0		
596	chr25	1529254	1529395	3500326975	63		1529254	1529395	8421504	2	38,25	0,116	p	350032697500015015	0-63					Patent	Enzyme des auf die lysosomen gerichteten weges Enzymes of the pathway directed to the lysosomes (Patent DE:60036395)	William	2008	0		
596	chr25	1529254	1529395	3500285553	63		1529254	1529395	8421504	2	38,25	0,116	p	350028555300015011	0-63						LYSOSOMAL TARGETING PATHWAY ENZYMES - Canfield, William M.	www.sumobrain.com	0	0		
596	chr25	1529254	1529395	3500276287	63		1529254	1529395	8421504	2	38,25	0,116	p	350027628700015015	0-63					Patent	Enzyme des auf die lysosomen gerichteten weges Enzymes of the pathway directed to the lysosomes (Patent DE:60036395)	William	2008	0		
596	chr25	1529254	1529395	3500261187	63		1529254	1529395	8421504	2	38,25	0,116	p	350026118700015008	0-63					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:7371366)	Canfield	2008	0		
596	chr25	1529254	1529395	3500227303	63		1529254	1529395	8421504	2	38,25	0,116	p	350022730300015008	0-63					Patent	Methods of treating lysosomal storage diseases (Patent US:6537785)	Canfield	2003	0		
596	chr25	1529254	1529395	3500225243	63		1529254	1529395	8421504	2	38,25	0,116	p	350022524300015008	0-63					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6861242)	Canfield	2005	0		
596	chr25	1529254	1529395	3500220979	63		1529254	1529395	8421504	2	38,25	0,116	p	350022097900015008	0-63					Patent	GIcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:7067127)	Canfield	2006	0		
596	chr25	1529254	1529395	3500180443	63		1529254	1529395	8421504	2	38,25	0,116	p	350018044300015008	0-63					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
596	chr25	1529254	1529395	3500178080	63		1529254	1529395	8421504	2	38,25	0,116	p	350017808000015008	0-63					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
596	chr25	1529254	1529395	3500176191	63		1529254	1529395	8421504	2	38,25	0,116	p	350017619100015008	0-63					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6534300)	Canfield	2003	0		
596	chr25	1529254	1529395	3500129176	63		1529254	1529395	8421504	2	38,25	0,116	p	350012917600015008	0-63					Patent	Methods of treating lysosomal storage diseases (Patent US:6537785)	Canfield	2003	0		
596	chr25	1529254	1529395	3500053917	63		1529254	1529395	8421504	2	38,25	0,116	p	350005391700015008	0-63						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
596	chr25	1529254	1529395	3500030446	63		1529254	1529395	8421504	2	38,25	0,116	p	350003044600015008	0-63					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
596	chr25	1529254	1529392	3500422793	60		1529254	1529392	8421504	2	38,22	0,116	p	350042279300015001	0-60						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
596	chr25	1529254	1529392	3500324905	60		1529254	1529392	8421504	2	38,22	0,116	p	350032490500015006	0-60						Lysosomal targeting pathway enzymes	Canfield	2002	0		
596	chr25	1529254	1529392	3500280347	60		1529254	1529392	8421504	2	38,22	0,116	p	350028034700015006	0-60						Lysosomal targeting pathway enzymes	Canfield	2001	0		
596	chr25	1529254	1529392	3500245851	60		1529254	1529392	8421504	2	38,22	0,116	p	350024585100015001	0-60						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
596	chr25	1529254	1529392	3500161422	60		1529254	1529392	8421504	2	38,22	0,116	p	350016142200015006	0-60						Lysosomal targeting pathway enzymes	Canfield	2001	0		
598	chr25	1804530	1804553	3500464783	23		1804530	1804553	8421504	1	23	0	c	350046478300000141	8-31						BGS 4 - US Patent 7456256 Description	ww.patentstorm.us	0	0		
598	chr25	1807822	1807845	3500146291	23		1807822	1807845	8421504	1	23	0	c	350014629100000020	5-28						Enzymatically active recombinant human acetylcholinesterase and hosts and vectors for expression thereof - US Patent 5248604 Description	ww.patentstorm.us	0	0		
598	chr25	1809087	1809114	3500077530	27		1809087	1809114	8421504	1	27	0	c	350007753000000005	11-38		15911620	10.1074/jbc.M502318200	0021-9258	Journal of Biological Chemistry	Cross-talk between JIP3 and JIP1 during Glucose Deprivation	Song	2005	5		
598	chr25	1829050	1829161	3500248474	40		1829050	1829161	8421504	2	21,19	0,92	c,g	350024847400000017,350024847400000017,350024847400000016	0-21,0-21,0-19						REPRODUCTION	uction-online.org	0	0		
598	chr25	1829050	1829161	3500024081	40		1829050	1829161	8421504	2	21,19	0,92	c,g	350002408100000021,350002408100000021,350002408100000020	0-21,0-21,0-19						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
598	chr25	1829896	1830009	3500088223	40		1829896	1830009	8421504	2	20,20	0,93	c,g	350008822300000005,350008822300000005,350008822300000004	0-20,0-20,0-20						NUTRITIONAL REGULATION OF SERUM INSULIN-LIKE GROWTH FACTOR-I CONCENTRATION IN CATTLE	cholar.lib.vt.edu	0	0		
599	chr25	1844799	1844827	3500145481	23		1844799	1844827	8421504	2	14,9	0,19	c	350014548100000003	1-24						Human tumor necrosis factor receptor	Grant	2003	0		
600	chr25	1997831	2004006	3500423725	363		1997831	2004006	8421504	11	42,6,48,20,24,47,39,28,20,48,41	0,313,1260,1312,1522,1595,1928,3324,4472,6079,6134	c,g	350042372500000213,350042372500000207,350042372500000206,350042372500000204,350042372500000199,350042372500000196,350042372500000191,350042372500000190	0-48,0-48,0-44,0-47,9-48,0-48,0-48,0-41					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
600	chr25	1999091	2002323	3500184607	96		1999091	2002323	8421504	3	48,28,20	0,2064,3212	c	350018460700000199,350018460700000188	0-48,0-48						US Patent # 6,028,173. Human chromosome 16 genes, compositions, methods of making and using same - Patents.com	www.patents.com	0	0		
600	chr25	2010202	2010316	3500143487	114		2010202	2010316	8421504	1	114	0	p	350014348700015001	0-114		15073124	10.1158/1078-0432.CCR-03-0170	1078-0432	Clinical Cancer Research	Evidence for Prostate Cancer-Associated Diagnostic Marker-1	Ohkia	2004	8		RPS2
600	chr25	2010271	2010919	3500164379	306		2010271	2010919	8421504	3	57,174,75	0,143,573	p	350016437900015001	177-483						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		SNORA64,RPS2
600	chr25	2010893	2011821	3500436834	38		2010893	2011821	8421504	3	19,14,5	0,746,923	c,g	350043683400000416,350043683400000416,350043683400000413	0-19,0-19,0-19						Sirna Targeting Ribosomal Protein S2 (rps2) 	.freshpatents.com	0	0		TMSB10
600	chr25	2010913	2011641	3500351779	297		2010913	2011641	8421504	3	39,90,168	0,386,560	p	350035177900015002	171-588						DETERMINATION ET COMPARAISON DE NOEC &#xab; MATRICIELLES &#xbb; A L&#x2019;AIDE DE PUCES A ADN CHEZ DREISSENA POLYMORPHA ET MYTILUS EDULIS	ne-aval.crihan.fr	0	0		
600	chr25	2011350	2021061	3500036684	41		2011350	2021061	8421504	3	21,1,19	0,9584,9692	c	350003668400000277,350003668400000210	24-45,13-33						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
600	chr25	2023394	2023418	3500349145	24		2023394	2023418	8421504	1	24	0	c	350034914500000632	7-31						Novel Human Beta-2 Integrin Alpha Subunit 	.freshpatents.com	0	0		
600	chr25	2023394	2023418	3500247922	24		2023394	2023418	8421504	1	24	0	c	350024792200000632	7-31						Human B2 integrin alpha subunit antibodies	Gallatin	1996	0		
600	chr25	2023394	2023418	3500189016	24		2023394	2023418	8421504	1	24	0	c	350018901600000632	7-31						Methods of inhibiting locomotor damage following spinal cord injury with &#x03b1; D-specific antibodies	Gallatin	2000	0		
601	chr25	2105625	2105649	3500125991	23		2105625	2105649	8421504	2	6,17	0,7	c	350012599100000016	5-28						Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof - Patent application	www.faqs.org	0	0		
601	chr25	2137965	2137991	3500066683	23		2137965	2137991	8421504	2	5,18	0,8	g	350006668300000020	19-42						Bifunctional selectable fusion genes.	Lupton	1993	0		
601	chr25	2155466	2158873	3500022166	93		2155466	2158873	8421504	2	48,45	0,3362	g	350002216600000186,350002216600000150	68-116,71-116						Identification of polycystic kidney disease gene, diagnostics and treatment	Reeders	1995	0		
602	chr25	2253784	2253807	3500170682	23		2253784	2253807	8421504	1	23	0	c	350017068200000002	0-23						2012 Landes Bioscience. Do not distribute.	mcb.berkeley.edu	0	0		MLST8
602	chr25	2268271	2270579	3500359370	45		2268271	2270579	8421504	2	7,38	0,2270	p	350035937000015001	0-45		11283272	10.1128/MCB.21.8.2956-2966.2001	0270-7306	Molecular and Cellular Biology	Cyclin A Is a Mediator of p120 E4F -Dependent Cell Cycle Arrest in G1	Fajas	2001	6		E4F1
602	chr25	2268271	2270579	3500146141	45		2268271	2270579	8421504	2	7,38	0,2270	p	350014614100015000	0-45					Proceedings of the National Academy of Sciences of the United States of America	pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F	Lluis	July	0		E4F1
602	chr25	2300556	2300601	3500364042	45		2300556	2300601	8421504	1	45	0	p	350036404200015001	0-45		15684395	10.1128/MCB.25.4.1446-1457.2005	0270-7306	Molecular and Cellular Biology	Activation of Pre-mRNA Splicing by Human RNPS1 Is Regulated by CK2 Phosphorylation	Trembley	2005	6		RNPS1
602	chr25	2312160	2340535	3500423725	570		2312160	2340535	8421504	21	49,4,33,43,41,16,15,48,1,46,14,6,33,39,14,34,6,21,43,23,41	0,182,249,330,603,3285,3422,9105,13043,14029,15603,16097,18114,20420,20468,22140,22255,22503,22577,28280,28334	c	350042372500000328,350042372500000182,350042372500000326,350042372500000180,350042372500000178,350042372500000323,350042372500000312,350042372500000133,350042372500000126,350042372500000259,350042372500000255,350042372500000249,350042372500000248,350042372500000100,350042372500000098,350042372500000237,350042372500000090	0-41,0-48,0-21,0-33,0-48,0-48,0-31,0-48,0-47,0-20,15-48,9-48,0-48,0-27,0-43,12-35,0-41					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
602	chr25	2312409	2334780	3500184607	359		2312409	2334780	8421504	13	33,43,5,16,27,47,1,94,5,18,6,21,43	0,81,354,3036,3173,7136,12794,13780,15987,17859,22006,22254,22328	c	350018460700000172,350018460700000170,350018460700000158,350018460700000139,350018460700000118,350018460700000117,350018460700000102,350018460700000092,350018460700000090	0-33,0-48,0-43,0-47,0-47,0-48,0-23,0-27,0-43						US Patent # 6,028,173. Human chromosome 16 genes, compositions, methods of making and using same - Patents.com	www.patents.com	0	0		
603	chr25	2468862	2468887	3500007115	23		2468862	2468887	8421504	2	17,6	0,19	c	350000711500000111	17-41						DNA encoding mammalian phosphodiesterases	Beavo	1992	0		
603	chr25	2470370	2470398	3500365503	25		2470370	2470398	8421504	2	8,17	0,11	c	350036550300000000	7-32						World J Gastroenterol	www.wjgnet.com	0	0		
603	chr25	2486598	2486623	3500452310	23		2486598	2486623	8421504	2	7,16	0,9	c	350045231000000017	0-23						Methods and compositions for improving recombinant protein production - Patent application	www.faqs.org	0	0		
603	chr25	2486598	2486623	3500442555	23		2486598	2486623	8421504	2	7,16	0,9	c	350044255500000049	0-23						TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6	Sheppard	2007	0		
603	chr25	2486598	2486623	3500304335	23		2486598	2486623	8421504	2	7,16	0,9	c	350030433500000053,350030433500000444	0-23,5-26						Diagnosis and Treatment of Cancer Using Anti-EREG Antibody - Patent application	www.faqs.org	0	0		
603	chr25	2486598	2486623	3500287328	23		2486598	2486623	8421504	2	7,16	0,9	c	350028732800000213,350028732800000089	0-23,5-26						Concatameric immunoadhesion molecule - US Patent 7670602 Description	ww.patentstorm.us	0	0		
603	chr25	2486598	2486623	3500057287	23		2486598	2486623	8421504	2	7,16	0,9	c	350005728700000162	0-23						METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS - Patent application	www.faqs.org	0	0		
604	chr25	2492097	2492546	3500423725	136		2492097	2492546	8421504	5	48,15,32,7,34	0,49,135,317,415	c	350042372500000063,350042372500000064,350042372500000068	0-48,1-48,6-47					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
604	chr25	2492097	2492145	3500184607	48		2492097	2492145	8421504	1	48	0	c	350018460700000055	0-48						US Patent # 6,028,173. Human chromosome 16 genes, compositions, methods of making and using same - Patents.com	www.patents.com	0	0		
604	chr25	2492279	2492303	3500388290	24		2492279	2492303	8421504	1	24	0	c	350038829000000003	0-24		11356879		0270-6474	The Journal of Neuroscience	Widespread Expression of Netrin-1 by Neurons and Oligodendrocytes in the Adult Mammalian Spinal Cord	Manitt	2001	7		
604	chr25	2532340	2532409	3500284049	69		2532340	2532409	8421504	1	69	0	p	350028404900015005	0-69						Purified vacuolating toxin from helicobacter pylori and methods to use same	Blaser	1993	0		ATP6V0C
606	chr25	2853256	2853281	3500409453	24		2853256	2853281	8421504	2	8,16	0,9	g	350040945300000016	0-24						Optimization of lipase production in Burkholderia glumae; Optimierung der Lipaseproduktion in Burkholderia glumae	uhr-uni-bochum.de	0	0		
607	chr25	2947025	2947049	3500319986	24		2947025	2947049	8421504	1	24	0	g	350031998600000001	10-41		22226139	10.1186/1477-7819-10-3		World Journal of Surgical Oncology	In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line	Yue	2012	0		
607	chr25	2998661	2998685	3500364288	24		2998661	2998685	8421504	1	24	0	c	350036428800000045	22-46						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
607	chr25	3005161	3005189	3500459656	23		3005161	3005189	8421504	2	16,7	0,21	c	350045965600000005	5-35		21851590	10.1186/gb-2011-12-8-r78	1465-6906	Genome Biology	A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1	Blasius	2011	0		
607	chr25	3011783	3011810	3500423725	26		3011783	3011810	8421504	2	22,4	0,23	c	350042372500000080	8-34					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
608	chr25	3135338	3135366	3500300414	25		3135338	3135366	8421504	3	7,14,4	0,9,24	c	350030041400000001,350030041400000007	20-46,20-46						Host Cells and Methods for Producing Cinnamoyl Anthranilate and Analogs Thereof - Patent application	www.faqs.org	0	0		
609	chr25	3230187	3230216	3500446820	26		3230187	3230216	8421504	2	12,14	0,15	g	350044682000000007	0-26						Identifizierung einer Proteinkinase mit Calmodulin-&#xe4;hnlicher Dom&#xe4;ne bei Eimeria bovis und Studien zu ihrer Lokalisation im Parasiten	eb.uni-giessen.de	0	0		
610	chr25	3308224	3308250	3500112644	25		3308224	3308250	8421504	2	18,7	0,19	c	350011264400000131	6-31					Patent	Nucleic acids encoding a chloride channel protein (Patent US:6716603)	Holroyd	2004	0		
610	chr25	3308224	3308250	3500061374	25		3308224	3308250	8421504	2	18,7	0,19	c	350006137400000131	6-31						 Nucleic Acids Encoding A Chloride Channel Protein 	www.docstoc.com	0	0		
610	chr25	3310772	3310801	3500101661	25		3310772	3310801	8421504	3	11,9,5	0,12,24	c	350010166100000024	21-46						Feline immunodeficiency virus gene expression: analysis of the RNA splicing pattern and the monocistronic rev mRNA. - ResearchGate	.researchgate.net	0	0		
610	chr25	3311225	3311276	3500402790	51		3311225	3311276	8421504	1	51	0	p	350040279000015070	21-72						Toward a General Approach for RNA-Templated Hierarchical Assembly of Split-Proteins	.chem.arizona.edu	0	0		ZNF263
610	chr25	3311225	3311276	3500195492	51		3311225	3311276	8421504	1	51	0	p	350019549200015010	0-51						HEPATITIS B VIRUS-BINDING POLYPEPTIDES AND METHODS OF USE THEREOF	Zimmerman	2008	0		ZNF263
610	chr25	3311249	3311274	3500068396	25		3311249	3311274	8421504	1	25	0	c	350006839600000160	21-46						Trophinin and trophinin-assisting protein agonists, antibodies and antagonists	Fukuda	1996	0		
610	chr25	3311556	3311581	3500248703	25		3311556	3311581	8421504	1	25	0	c	350024870300000424	10-35						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
611	chr25	3458254	3458283	3500376415	25		3458254	3458283	8421504	2	9,16	0,13	c	350037641500000016	1-26						Transgenic animal with enhanced immune response and method for the preparation thereof	Bender	2008	0		
611	chr25	3458254	3458283	3500370589	25		3458254	3458283	8421504	2	9,16	0,13	c	350037058900000038,350037058900000104	1-26,1-26					Patent	Method using a transgenic animal with enhanced immune response (Patent EP:2097444)	BOSZE	2011	0		
611	chr25	3458254	3458283	3500333669	25		3458254	3458283	8421504	2	9,16	0,13	c	350033366900000933	1-26						Transgenic Animal With Enhanced Immune Response And Method For The Preparation Thereof 	.freshpatents.com	0	0		
611	chr25	3458254	3458283	3500253217	25		3458254	3458283	8421504	2	9,16	0,13	c	350025321700000038	1-26						Transgenic animal with enhanced immune response and method for the preparation thereof	Bosze	2010	0		
611	chr25	3458254	3458283	3500222782	25		3458254	3458283	8421504	2	9,16	0,13	c	350022278200000038	1-26						Transgenic Animal with Enhanced Immune Response and Method for the Preparation Thereof	Bosze	2013	0		
611	chr25	3458254	3458283	3500161111	25		3458254	3458283	8421504	2	9,16	0,13	c	350016111100000016	1-26						Transgenic animal with enhanced immune response and method for the preparation thereof	BOSZE	2009	0		
611	chr25	3458254	3458283	3500118217	25		3458254	3458283	8421504	2	9,16	0,13	c	350011821700000103,350011821700000038	1-26,1-26						TRANSGENIC ANIMAL WITH ENHANCED IMMUNE RESPONSE AND METHOD FOR THE PREPARATION THEREOF - Patent application	www.faqs.org	0	0		
612	chr25	3569322	3571633	3500258050	2200		3569322	3571633	8421504	3	1254,926,20	0,1342,2291	p,c,g	350025805000015001,350025805000000283,350025805000015051,350025805000000071,350025805000000071,350025805000000103,350025805000000103,350025805000000004,350025805000000004,350025805000015029,350025805000015044,350025805000000064,350025805000015052,350025805000000072,350025805000000072,350025805000015002,350025805000000107,350025805000000107,350025805000000006,350025805000000006,350025805000015030,350025805000000036,350025805000000036,350025805000015045,350025805000000065,350025805000000065,350025805000015053,350025805000000073,350025805000015003,350025805000000111,350025805000000008,350025805000000008,350025805000015031,350025805000000038,350025805000000038,350025805000015046,350025805000000066,350025805000000066,350025805000000074,350025805000000115,350025805000000119,350025805000000123,350025805000000127,350025805000000075,350025805000000131,350025805000000135,350025805000000135,350025805000015054,350025805000000076,350025805000000076,350025805000000040,350025805000015032,350025805000000010,350025805000000010,350025805000015047,350025805000000067,350025805000000067,350025805000000077,350025805000000139,350025805000000078,350025805000000143,350025805000000151,350025805000000042,350025805000000042,350025805000015048,350025805000000068,350025805000000068,350025805000015033,350025805000000012,350025805000000012,350025805000000284,350025805000000284,350025805000000155,350025805000000155,350025805000015057,350025805000000079,350025805000000079,350025805000015004,350025805000000044,350025805000000044,350025805000000045,350025805000015049,350025805000000069,350025805000015034,350025805000000014,350025805000000014,350025805000000285,350025805000000286,350025805000000080,350025805000000081,350025805000000181,350025805000000082,350025805000000082,350025805000015058,350025805000000046,350025805000000046,350025805000000185,350025805000000185,350025805000000016,350025805000000016,350025805000015035,350025805000000083,350025805000000083,350025805000015059,350025805000015005,350025805000000047,350025805000000047,350025805000000189,350025805000000018,350025805000000018,350025805000000085,350025805000000213,350025805000000213,350025805000000084,350025805000000048,350025805000000048,350025805000000070,350025805000000020,350025805000000020,350025805000015037,350025805000000086,350025805000000086,350025805000015061,350025805000000217,350025805000000050,350025805000000050,350025805000015038,350025805000000022,350025805000000022,350025805000000087,350025805000000052,350025805000000221,350025805000000088,350025805000000225,350025805000000089,350025805000000089,350025805000015063,350025805000015039,350025805000000024,350025805000000024,350025805000000229,350025805000000229,350025805000000054,350025805000000054,350025805000015007,350025805000000090,350025805000015064,350025805000000026,350025805000000026,350025805000015040,350025805000000233,350025805000000287,350025805000000056,350025805000000056,350025805000000091,350025805000015065,350025805000000028,350025805000000028,350025805000000029,350025805000000029,350025805000015041,350025805000000058,350025805000000237,350025805000000092,350025805000000241,350025805000000245,350025805000000249,350025805000000253,350025805000000003,350025805000000003,350025805000015009,350025805000000257,350025805000000257,350025805000000030,350025805000000030,350025805000015042,350025805000000093,350025805000000093,350025805000015067,350025805000000060,350025805000000060,350025805000000261,350025805000000032,350025805000000032,350025805000015043,350025805000000094,350025805000000095,350025805000000277,350025805000000277,350025805000000288	0-60,0-20,0-51,0-51,0-51,0-60,0-60,0-54,0-54,0-54,0-51,0-53,0-51,0-51,0-51,0-51,0-60,0-60,0-54,0-54,0-54,0-51,0-51,0-51,0-51,0-51,0-45,0-52,0-120,0-60,0-54,0-54,0-54,0-51,0-51,0-51,0-51,0-51,0-268,0-60,0-56,0-60,0-53,0-64,0-60,0-60,0-60,0-51,0-51,0-51,0-51,0-54,0-54,0-54,0-51,0-51,0-51,0-54,0-59,0-188,0-59,0-60,0-51,0-51,0-51,0-51,0-51,0-54,0-54,0-54,0-20,0-20,0-60,0-60,0-51,0-51,0-51,0-90,0-51,0-51,0-30,0-51,0-51,0-54,0-54,0-54,0-20,0-19,0-63,0-194,0-55,0-51,0-51,0-51,0-51,0-51,0-60,0-60,0-54,0-54,0-54,0-51,0-51,0-51,9-99,0-51,0-51,0-37,0-54,0-54,80-123,0-60,0-60,3-66,0-51,0-51,0-33,0-54,0-54,0-54,0-51,0-51,0-51,0-60,0-51,0-51,0-54,0-54,0-54,0-58,0-51,0-59,0-64,0-60,0-51,0-51,0-48,0-54,0-54,0-54,0-60,0-60,0-51,0-51,0-90,0-51,0-51,0-54,0-54,0-54,0-60,0-19,0-51,0-51,0-48,0-48,0-54,0-54,0-54,0-54,0-54,0-51,0-55,1-315,0-59,0-60,0-59,0-60,0-104,0-104,0-120,0-58,0-58,0-54,0-54,0-54,0-51,0-51,0-51,0-51,0-51,0-52,0-54,0-54,0-54,0-66,0-119,0-54,0-54,0-20						DNasa I EN EL CRISTALINO BOVINO	.bib.fcien.edu.uy	0	0		
612	chr25	3569322	3571582	3500234085	849		3569322	3571582	8421504	8	147,89,84,116,113,155,97,48	0,482,747,1075,1342,1544,1972,2212	p,c,g	350023408500015002,350023408500015130,350023408500015131,350023408500015004,350023408500015148,350023408500000049,350023408500000049,350023408500015003,350023408500015060,350023408500015098,350023408500015132,350023408500015282,350023408500015062,350023408500015100,350023408500000009,350023408500015133,350023408500015283,350023408500015011,350023408500015064,350023408500015102,350023408500015134,350023408500015284,350023408500015066,350023408500015104,350023408500015135,350023408500015285,350023408500015068,350023408500015106,350023408500000012,350023408500015136,350023408500015286,350023408500015022,350023408500015020,350023408500015071,350023408500015108,350023408500015137,350023408500015287,350023408500000014,350023408500015073,350023408500000032,350023408500015110,350023408500015138,350023408500015288,350023408500015076,350023408500015112,350023408500015139,350023408500015289,350023408500015029,350023408500015114,350023408500015290,350023408500015161,350023408500015158,350023408500015080,350023408500015116,350023408500015141,350023408500015291,350023408500015082,350023408500015118,350023408500015142,350023408500015292,350023408500015163,350023408500015084,350023408500015038,350023408500015120,350023408500015143,350023408500015293,350023408500015164,350023408500015086,350023408500015122,350023408500015144,350023408500015294,350023408500015253,350023408500015165,350023408500015088,350023408500015124,350023408500015145,350023408500015295,350023408500015090,350023408500015126,350023408500015047,350023408500015049,350023408500015296,350023408500015167,350023408500015092,350023408500015128	0-150,0-48,0-48,0-84,0-48,0-783,0-783,3-84,3-48,0-48,0-48,0-48,0-48,0-48,18-48,0-48,0-48,0-144,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,12-48,0-48,0-48,0-150,0-150,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-150,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-147,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-105,9-105,0-48,0-48,0-48,0-48						Compositions And Methods Of Using A Synthetic Dnase I 	.freshpatents.com	0	0		
612	chr25	3569322	3571582	3500106324	849		3569322	3571582	8421504	8	147,89,84,116,113,155,97,48	0,482,747,1075,1342,1544,1972,2212	p,c,g	350010632400015004,350010632400015134,350010632400000049,350010632400000049,350010632400015006,350010632400015005,350010632400015101,350010632400015135,350010632400015283,350010632400015065,350010632400015103,350010632400000009,350010632400015136,350010632400015013,350010632400015284,350010632400015067,350010632400015285,350010632400015069,350010632400015107,350010632400015138,350010632400015109,350010632400015139,350010632400015024,350010632400015022,350010632400015287,350010632400015074,350010632400015111,350010632400015140,350010632400015288,350010632400000014,350010632400000032,350010632400015076,350010632400015113,350010632400015141,350010632400015289,350010632400015079,350010632400015290,350010632400015031,350010632400015117,350010632400015143,350010632400015163,350010632400015160,350010632400015119,350010632400015144,350010632400015292,350010632400015085,350010632400015121,350010632400000018,350010632400015145,350010632400015293,350010632400015165,350010632400015040,350010632400015087,350010632400015123,350010632400015146,350010632400015294,350010632400015166,350010632400015089,350010632400015295,350010632400015091,350010632400015127,350010632400015148,350010632400015049,350010632400015129,350010632400015051,350010632400015297,350010632400015169,350010632400015095,350010632400015131	0-150,0-45,0-783,0-783,0-84,3-84,0-45,0-45,0-45,0-45,0-45,18-48,0-45,0-144,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-150,0-150,0-45,0-45,0-45,0-45,0-45,0-48,0-47,0-45,0-45,0-45,0-45,0-45,0-45,0-150,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,13-47,0-45,0-45,0-45,0-147,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-105,0-45,9-105,0-45,0-45,0-45,0-45						COMPOSITIONS AND METHODS OF USING A SYNTHETIC DNASE I - Patent application	www.faqs.org	0	0		
612	chr25	3569322	3571579	3500009290	846		3569322	3571579	8421504	8	147,89,84,116,113,155,97,45	0,482,747,1075,1342,1544,1972,2212	p	350000929000015004,350000929000015006,350000929000015005,350000929000015013,350000929000015022,350000929000015024,350000929000015031,350000929000015040,350000929000015049,350000929000015051	0-150,0-84,3-84,0-144,0-150,0-150,0-150,0-147,0-105,9-105						COMPOSITIONS AND METHODS OF USING A SYNTHETIC DNASE I	Latham	2011	0		
612	chr25	3569322	3571552	3500321561	729		3569322	3571552	8421504	10	45,99,89,84,116,113,78,45,42,18	0,48,482,747,1075,1342,1544,1640,2027,2212	p	350032156100015011,350032156100015000,350032156100015025,350032156100015012,350032156100015042,350032156100015026,350032156100015013,350032156100015001,350032156100015027,350032156100015014,350032156100015002,350032156100015043,350032156100015028,350032156100015003,350032156100015029,350032156100015016,350032156100015004,350032156100015005,350032156100015044,350032156100015017,350032156100015006,350032156100015031,350032156100015018,350032156100015048,350032156100015007,350032156100015035,350032156100015052	0-78,0-63,0-48,0-48,0-90,0-45,0-45,0-48,0-48,0-48,0-45,0-147,0-48,0-48,0-45,0-111,0-48,0-90,12-57,18-147,0-147,12-102,3-48,0-45,12-57,0-45,0-45						Recombinant bovine pancreatic desoxyribonuclease I with high specific activity - US Patent 7118901 Description	ww.patentstorm.us	0	0		
612	chr25	3569322	3571552	3500107953	729		3569322	3571552	8421504	10	45,99,89,84,116,113,78,45,42,18	0,48,482,747,1075,1342,1544,1640,2027,2212	p	350010795300015011,350010795300015000,350010795300015025,350010795300015012,350010795300015042,350010795300015026,350010795300015013,350010795300015001,350010795300015027,350010795300015014,350010795300015002,350010795300015043,350010795300015028,350010795300015003,350010795300015029,350010795300015016,350010795300015004,350010795300015005,350010795300015044,350010795300015017,350010795300015006,350010795300015031,350010795300015018,350010795300015048,350010795300015007,350010795300015035,350010795300015052	0-78,0-63,0-48,0-48,0-90,0-45,0-45,0-48,0-48,0-48,0-45,0-147,0-48,0-48,0-45,0-111,0-48,0-90,12-57,18-147,0-147,12-102,3-48,0-45,12-57,0-45,0-45						Recombinant bovine pancreatic desoxyribonuclease I with high specific activity - Patent # 7118901 - PatentGenius	.patentgenius.com	0	0		
612	chr25	3570941	3570976	3500225773	35		3570941	3570976	8421504	1	35	0	c	350022577300000009,350022577300000008	0-23,0-26			10.1110/ps.03438204		Protein Science : A Publication of the Protein Society	Biological functions of the disulfides in bovine pancreatic deoxyribonuclease	Wei-Jung	2004	0		
612	chr25	3570966	3570990	3500303833	24		3570966	3570990	8421504	1	24	0	c	350030383300000007,350030383300000008	0-24,0-24			10.1110/ps.20402	1469-896X	Protein Science	The distinctive functions of the two structural calcium atoms in bovine pancreatic deoxyribonuclease - Chen - 2009 - Protein Science - Wiley Online Library	Chen	2002	0		
612	chr25	3585401	3585430	3500346049	29		3585401	3585430	8421504	1	29	0	c	350034604900000056	15-44						Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis	Reed	1995	0		
612	chr25	3631274	3632971	3500335697	40		3631274	3632971	8421504	2	20,20	0,1677	c,g	350033569700000011,350033569700000010,350033569700000010	0-20,0-20,0-20						Down-regulation of Interferon Tau Gene Transcription With a Transcription Factor, EOMES. - ResearchGate	.researchgate.net	0	0		
612	chr25	3664509	3664956	3500110700	41		3664509	3664956	8421504	2	21,20	0,427	c,g	350011070000000004,350011070000000004,350011070000000009	0-21,0-21,0-20						by CBP-mediated histone 3 acetylation	www.jbc.org	0	0		CREBBP
613	chr25	3718571	3718599	3500142125	23		3718571	3718599	8421504	2	7,16	0,12	g	350014212500000043	2-25						US Patent # 6,537,748. Reagent for nucleic acid typing by primer extension - Patents.com	www.patents.com	0	0		
614	chr25	3874278	3874303	3500259903	25		3874278	3874303	8421504	1	25	0	c	350025990300000082	8-33						Vertebrate embryonic pattern-inducing hedgehog-like proteins	Ingham	1995	0		
615	chr25	3940984	3941011	3500150499	23		3940984	3941011	8421504	2	9,14	0,13	g	350015049900000001	1-25		22551203	10.1186/1476-069X-11-31	1476-069X	Environmental Health	Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line	Intarasunanont	2012	3		
615	chr25	3950885	3951743	3500000104	66		3950885	3951743	8421504	3	24,15,27	0,694,831	p	350000010400015206	114-180						Tarantulas and Social Spiders: A Tale of Sex and Silk	.nottingham.ac.uk	0	0		
615	chr25	4022250	4022276	3500400161	25		4022250	4022276	8421504	2	14,11	0,15	g	350040016100000012,350040016100000011	14-39,19-39					Patent	Antibody molecules which interact specifically with the active site or cleft of a target molecule (Patent EP:0937140)	Muyldermans	2007	0		
616	chr25	4102055	4102080	3500378306	23		4102055	4102080	8421504	2	8,15	0,10	c	350037830600000000	2-25						Respiratory Research BioMed Central	tory-research.com	0	0		
616	chr25	4109214	4114932	3500283153	129		4109214	4114932	8421504	3	42,84,3	0,909,5715	p	350028315300015022,350028315300015004	0-126,0-129						Antibodies to magmas and uses thereof	Jubinsky	2005	0		
616	chr25	4139493	4139517	3500374868	24		4139493	4139517	8421504	1	24	0	c,g	350037486800000077,350037486800000077	24-48,24-48						Compositions and methods for the treatment of tumor	Botstein	2000	0		
616	chr25	4139493	4139517	3500374128	24		4139493	4139517	8421504	1	24	0	c	350037412800000042	24-48						Compositions and methods for the treatment of tumor	Botstein	2000	0		
616	chr25	4139493	4139517	3500116822	24		4139493	4139517	8421504	1	24	0	c	350011682200000077,350011682200000182	24-48,24-48						Secreted And Transmembrane Polypeptides And Nucleic Acids Encoding The Same 	.freshpatents.com	0	0		
616	chr25	4139493	4139517	3500104360	24		4139493	4139517	8421504	1	24	0	c,g	350010436000000063,350010436000000063	24-48,24-48						Polypeptides and nucleic acids encoding the same	Baker	2001	0		
616	chr25	4139493	4139517	3500102405	24		4139493	4139517	8421504	1	24	0	c	350010240500000063	24-48						Polypeptides and nucleic acids encoding the same	Baker	2000	0		
616	chr25	4139493	4139517	3500034092	24		4139493	4139517	8421504	1	24	0	c	350003409200000182,350003409200000077	24-48,24-48						US Patent # 6,734,288. Antibodies against a secreted polypeptide that stimulates release of proteoglycans from cartilage - Patents.com	www.patents.com	0	0		
617	chr25	4204577	4209155	3500058528	60		4204577	4209155	8421504	2	40,20	0,4558	p	350005852800015000	0-60		19038220	10.1016/j.neuron.2008.09.025		Neuron	A Mammalian Homologue of Drosophila Tumorous Imaginal Discs, Tid1, Mediates Agrin Signaling at the Neuromuscular Junction	Jenny	2008	0		
617	chr25	4204600	4209146	3500304335	26		4204600	4209146	8421504	4	13,3,5,5	0,14,4535,4541	c	350030433500000456,350030433500000362,350030433500000068,350030433500000323	21-47,9-35,22-47,10-35						Diagnosis and Treatment of Cancer Using Anti-EREG Antibody - Patent application	www.faqs.org	0	0		
617	chr25	4204601	4209146	3500377046	25		4204601	4209146	8421504	4	12,3,5,5	0,13,4534,4540	c	350037704600000046	10-35						Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof - Patent application	www.faqs.org	0	0		
617	chr25	4204601	4209146	3500364155	25		4204601	4209146	8421504	4	12,3,5,5	0,13,4534,4540	c	350036415500000046	10-35						US Patent # 7,501,498. Alpha-fetoprotein Immu31 antibodies and fusion proteins - Patents.com	www.patents.com	0	0		
617	chr25	4204601	4209146	3500136352	25		4204601	4209146	8421504	4	12,3,5,5	0,13,4534,4540	c	350013635200000085	10-35						Mercury binding polypeptides and nucleotides coding therefor	Lopez	1995	0		
617	chr25	4260866	4260896	3500267336	27		4260866	4260896	8421504	3	16,7,4	0,18,26	c	350026733600000018	4-31						Protein Glycosylation Modification In Methylotrophic Yeast 	.freshpatents.com	0	0		
617	chr25	4260866	4260891	3500046125	23		4260866	4260891	8421504	2	16,7	0,18	c	350004612500000023	10-33						MUTANT ENZYMES - ISIS INNOVATION LIMITED	www.sumobrain.com	0	0		
617	chr25	4261022	4261053	3500421257	26		4261022	4261053	8421504	2	18,8	0,23	g	350042125700000029	1-42					Patent	Method of identifying binding molecules capable of neutralizing rabies virus (Patent EP:2314620)	Bakker	2013	0		
617	chr25	4261022	4261053	3500179612	26		4261022	4261053	8421504	2	18,8	0,23	g	350017961200000094	1-42						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2010	0		
617	chr25	4318811	4318879	3500456623	56		4318811	4318879	8421504	3	9,32,15	0,15,53	g	350045662300000009	28-96						Plant genes, the expression of which are altered by pathogen infection	Dangl	2003	0		
617	chr25	4318811	4318879	3500431501	56		4318811	4318879	8421504	3	9,32,15	0,15,53	g	350043150100000009	28-96						Plant genes, the expression of which are altered by pathogen infection	L	2002	0		
617	chr25	4318811	4318879	3500258223	56		4318811	4318879	8421504	3	9,32,15	0,15,53	g	350025822300000009	28-96						Plant genes, the expression of which are altered by pathogen infection	Dangl	2002	0		
618	chr25	4373535	4373562	3500164450	25		4373535	4373562	8421504	2	20,5	0,22	c	350016445000000048	0-25						COMPOUNDS USEFUL IN THE DIAGNOSIS AND TREATMENT OF MALARIA - Patent application	www.faqs.org	0	0		
618	chr25	4375716	4375740	3500370232	24		4375716	4375740	8421504	1	24	0	c	350037023200000129	0-24						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
618	chr25	4375716	4375740	3500187760	24		4375716	4375740	8421504	1	24	0	c	350018776000000111	0-24					Patent	Enzyme capable of degrading cellulose or hemicellulose (Patent US:5686593)	Hagen	1997	0		
618	chr25	4417696	4417726	3500325055	24		4417696	4417726	8421504	3	5,6,13	0,6,17	g	350032505500000004	0-24						A group of primer and the of domestic silkworm micro-sporozoon fast... - IP.com	ip.com/patfam/en/	0	0		
620	chr25	4672968	4673070	3500459355	99		4672968	4673070	8421504	2	63,36	0,66	p	350045935500015000	0-99					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6534300)	Canfield	2003	0		
620	chr25	4672968	4673070	3500422793	99		4672968	4673070	8421504	2	63,36	0,66	p	350042279300015007	0-99						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
620	chr25	4672968	4673070	3500388061	99		4672968	4673070	8421504	2	63,36	0,66	p	350038806100015000,350038806100015262	0-99,0-93						US Patent # 7,371,366. GlcNAc phosphotransferase of the lysosomal targeting pathway - Patents.com	www.patents.com	0	0		
620	chr25	4672968	4673070	3500377888	99		4672968	4673070	8421504	2	63,36	0,66	p	350037788800015000	0-99					Patent	Lysosomal targeting pathway enzymes (Patent EP:1224266)	Canfield	2007	0		
620	chr25	4672968	4673070	3500326975	99		4672968	4673070	8421504	2	63,36	0,66	p	350032697500015000	0-99					Patent	Enzyme des auf die lysosomen gerichteten weges Enzymes of the pathway directed to the lysosomes (Patent DE:60036395)	William	2008	0		
620	chr25	4672968	4673070	3500324905	99		4672968	4673070	8421504	2	63,36	0,66	p	350032490500015000	0-99						Lysosomal targeting pathway enzymes	Canfield	2002	0		
620	chr25	4672968	4673070	3500285553	99		4672968	4673070	8421504	2	63,36	0,66	p	350028555300015003	0-99						LYSOSOMAL TARGETING PATHWAY ENZYMES - Canfield, William M.	www.sumobrain.com	0	0		
620	chr25	4672968	4673070	3500280347	99		4672968	4673070	8421504	2	63,36	0,66	p	350028034700015000	0-99						Lysosomal targeting pathway enzymes	Canfield	2001	0		
620	chr25	4672968	4673070	3500276287	99		4672968	4673070	8421504	2	63,36	0,66	p	350027628700015000	0-99					Patent	Enzyme des auf die lysosomen gerichteten weges Enzymes of the pathway directed to the lysosomes (Patent DE:60036395)	William	2008	0		
620	chr25	4672968	4673070	3500261187	99		4672968	4673070	8421504	2	63,36	0,66	p	350026118700015000	0-99					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:7371366)	Canfield	2008	0		
620	chr25	4672968	4673070	3500245851	99		4672968	4673070	8421504	2	63,36	0,66	p	350024585100015007	0-99						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
620	chr25	4672968	4673070	3500227303	99		4672968	4673070	8421504	2	63,36	0,66	p	350022730300015000	0-99					Patent	Methods of treating lysosomal storage diseases (Patent US:6537785)	Canfield	2003	0		
620	chr25	4672968	4673070	3500225243	99		4672968	4673070	8421504	2	63,36	0,66	p	350022524300015000	0-99					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6861242)	Canfield	2005	0		
620	chr25	4672968	4673070	3500220979	99		4672968	4673070	8421504	2	63,36	0,66	p	350022097900015000	0-99					Patent	GIcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:7067127)	Canfield	2006	0		
620	chr25	4672968	4673070	3500180443	99		4672968	4673070	8421504	2	63,36	0,66	p	350018044300015000	0-99					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
620	chr25	4672968	4673070	3500178080	99		4672968	4673070	8421504	2	63,36	0,66	p	350017808000015000	0-99					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
620	chr25	4672968	4673070	3500176191	99		4672968	4673070	8421504	2	63,36	0,66	p	350017619100015000	0-99					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6534300)	Canfield	2003	0		
620	chr25	4672968	4673070	3500161422	99		4672968	4673070	8421504	2	63,36	0,66	p	350016142200015000	0-99						Lysosomal targeting pathway enzymes	Canfield	2001	0		
620	chr25	4672968	4673070	3500129176	99		4672968	4673070	8421504	2	63,36	0,66	p	350012917600015000	0-99					Patent	Methods of treating lysosomal storage diseases (Patent US:6537785)	Canfield	2003	0		
620	chr25	4672968	4673070	3500053917	99		4672968	4673070	8421504	2	63,36	0,66	p	350005391700015000	0-99						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
620	chr25	4672968	4673070	3500030446	99		4672968	4673070	8421504	2	63,36	0,66	p	350003044600015000	0-99					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
620	chr25	4672971	4673070	3500146929	96		4672971	4673070	8421504	2	60,36	0,63	p	350014692900015010	0-96					Patent	Enzyme des auf die lysosomen gerichteten weges (Patent DE:60036395)	William	2008	0		
621	chr25	4822584	4822612	3500325127	27		4822584	4822612	8421504	2	8,19	0,9	g	350032512700000108	3-35						Method For Detecting Gene Specifying Allergic Predisposition 	.freshpatents.com	0	0		
626	chr25	5411065	5411089	3500168811	23		5411065	5411089	8421504	2	7,16	0,8	g	350016881100000001	0-23						Method of treating brain tumors expressing tenascin	Bigner	1995	0		
630	chr25	5918864	5918893	3500306361	25		5918864	5918893	8421504	3	12,7,6	0,14,23	g	350030636100000699	22-47						PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use - Patent application	www.faqs.org	0	0		
631	chr25	6070844	6070872	3500420657	25		6070844	6070872	8421504	3	13,6,6	0,14,22	g	350042065700000206	18-48						Collection and Methods For Its Use - Patent application	www.faqs.org	0	0		
631	chr25	6092329	6092354	3500095165	23		6092329	6092354	8421504	2	12,11	0,14	g	350009516500000184	25-48						Chromosome 13-linked breast cancer susceptibility gene		1997	0		
631	chr25	6144629	6144652	3500095165	23		6144629	6144652	8421504	1	23	0	g	350009516500000088	12-35						Chromosome 13-linked breast cancer susceptibility gene		1997	0		
634	chr25	6478220	6478249	3500419621	24		6478220	6478249	8421504	3	5,5,14	0,7,15	g	350041962100000005	11-35						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
636	chr25	6706772	6706802	3500004227	27		6706772	6706802	8421504	2	12,15	0,15	g	350000422700000230	16-46						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
640	chr25	7302129	7302174	3500069549	45		7302129	7302174	8421504	1	45	0	p	350006954900015001	0-45		16260614	10.1128/MCB.25.22.10005-10016.2005	0270-7306	Molecular and Cellular Biology	Homologues of the Caenorhabditis elegans Fox-1 Protein Are Neuronal Splicing Regulators in Mammals	Underwood	2005	6		RBFOX1
640	chr25	7302129	7302174	3500047899	45		7302129	7302174	8421504	1	45	0	p	350004789900015000	0-45						Homologues of the Caenorhabditis elegans Fox-1 Protein Are Neuronal Splicing Regulators in Mammals&#x2020;	www.mimg.ucla.edu	0	0		RBFOX1
642	chr25	7504558	7504581	3500069549	23		7504558	7504581	8421504	1	23	0	c	350006954900000015,350006954900000014,350006954900000016	0-21,0-21,0-21		16260614	10.1128/MCB.25.22.10005-10016.2005	0270-7306	Molecular and Cellular Biology	Homologues of the Caenorhabditis elegans Fox-1 Protein Are Neuronal Splicing Regulators in Mammals	Underwood	2005	6		RBFOX1
642	chr25	7504558	7504581	3500047899	23		7504558	7504581	8421504	1	23	0	c	350004789900000013,350004789900000012,350004789900000014	0-21,0-21,0-21						Homologues of the Caenorhabditis elegans Fox-1 Protein Are Neuronal Splicing Regulators in Mammals&#x2020;	www.mimg.ucla.edu	0	0		RBFOX1
642	chr25	7528933	7528957	3500095243	23		7528933	7528957	8421504	2	18,5	0,19	g	350009524300000023	18-41						Eukaryotic layered vector initiation systems	Dubensky	2003	0		
646	chr25	8123925	8123953	3500396369	24		8123925	8123953	8421504	2	17,7	0,21	g	350039636900000029	0-24						 VMP 	www.docstoc.com	0	0		
648	chr25	8345178	8345205	3500131037	24		8345178	8345205	8421504	3	4,14,6	0,5,21	g	350013103700000042,350013103700000092	6-30,6-30						Defensin-antigen fusion proteins - US Patent 7754676 Description	ww.patentstorm.us	0	0		
648	chr25	8345178	8345205	3500031186	24		8345178	8345205	8421504	3	4,14,6	0,5,21	g	350003118600000042	6-30						Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection	Biragyn	2003	0		
653	chr25	8985563	8986333	3500166204	730		8985563	8986333	8421504	3	222,248,260	0,242,510	g	350016620400000102,350016620400000103,350016620400000104	0-222,0-248,0-260						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
662	chr25	10110918	10110946	3500340980	26		10110918	10110946	8421504	3	13,7,6	0,14,22	g	350034098000000000,350034098000000001	0-26,10-36						FUSION PROTEINS FOR DELIVERY OF ERYTHROPOIETIN TO THE CNS	Pardridge	2010	0		
662	chr25	10110918	10110946	3500309087	26		10110918	10110946	8421504	3	13,7,6	0,14,22	g	350030908700000007,350030908700000006	10-36,0-26						Fusion proteins for delivery of gdnf to the cns	Boado	2009	0		
662	chr25	10110918	10110946	3500300046	26		10110918	10110946	8421504	3	13,7,6	0,14,22	g	350030004600000024,350030004600000023	10-36,0-26						Fusion Proteins For Delivery Of Gdnf To The Cns 	.freshpatents.com	0	0		
662	chr25	10110918	10110946	3500030058	26		10110918	10110946	8421504	3	13,7,6	0,14,22	g	350003005800000000,350003005800000001,350003005800000028,350003005800000029	0-26,10-36,0-26,10-36						FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS - Patent application	www.faqs.org	0	0		
664	chr25	10461932	10461961	3500126207	24		10461932	10461961	8421504	2	13,11	0,18	g	350012620700000144	5-29					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
664	chr25	10461932	10461961	3500095165	24		10461932	10461961	8421504	2	13,11	0,18	g	350009516500000066	5-29						Chromosome 13-linked breast cancer susceptibility gene		1997	0		
664	chr25	10463526	10463557	3500235808	26		10463526	10463557	8421504	3	6,16,4	0,10,27	g	350023580800000011	0-26						ANTITUMOR EFFECT OF MUTANT BIK - Patent application	www.faqs.org	0	0		
664	chr25	10463526	10463557	3500036808	26		10463526	10463557	8421504	3	6,16,4	0,10,27	g	350003680800000003,350003680800000013	0-26,0-26						CANCER SPECIFIC PROMOTERS - Patent application	www.faqs.org	0	0		
666	chr25	10688754	10688783	3500423962	24		10688754	10688783	8421504	3	13,6,5	0,17,24	g	350042396200000080	22-46						US Patent # 7,034,105. FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy - Patents.com	www.patents.com	0	0		
669	chr25	11035525	11035573	3500004083	48		11035525	11035573	8421504	1	48	0	g	350000408300000322	0-48						Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins	Hancock	2001	0		
669	chr25	11036092	11036117	3500116395	25		11036092	11036117	8421504	1	25	0	g	350011639500000000	0-25		19911008	10.1038/cdd.2009.174	1350-9047	Cell Death & Differentiation	Pim-1 controls NF-&#x03ba;B signalling by stabilizing RelA&sol;p65	Nihira	2009	9		SOCS1
669	chr25	11044184	11077413	3500002829	2626		11044184	11077413	8421504	13	593,440,265,111,23,343,174,359,21,22,139,57,79	0,693,31611,31877,31989,32013,32362,32537,32897,32924,32949,33092,33150	g	350000282900000000,350000282900000002,350000282900000001	201-1234,0-1340,0-328						Sex- specific selection of sperm from transgenic animals	Forsberg	2002	0		
669	chr25	11057840	11057868	3500267044	23		11057840	11057868	8421504	2	16,7	0,21	c	350026704400000018	3-28						Investigations on the Regulation of 5-Lipoxygenase Gene Expression by DNA Methylation and Histone Deacetylation/Acetylation	.uni-frankfurt.de	0	0		
673	chr25	11607777	11608617	3500011923	69		11607777	11608617	8421504	2	10,59	0,781	p	350001192300015006	57-126						YOKOFAKUN: July 2010	baum.blogspot.com	0	0		
84	chr25	11662285	11669897	3500388350	121		11662285	11669897	8421504	5	25,22,23,21,30	0,143,682,829,7582	c,g	350038835000000048,350038835000000047,350038835000000047,350038835000000045,350038835000000045,350038835000000046,350038835000000043,350038835000000044,350038835000000044	0-25,0-22,0-22,0-23,0-23,0-21,0-27,0-20,0-20						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
84	chr25	11662285	11669897	3500027904	121		11662285	11669897	8421504	5	25,22,23,21,30	0,143,682,829,7582	c,g	350002790400000023,350002790400000022,350002790400000022,350002790400000020,350002790400000020,350002790400000021,350002790400000021,350002790400000018,350002790400000019,350002790400000019	0-25,0-22,0-22,0-23,0-23,0-21,0-21,0-27,0-20,0-20						 SpringerImages - primers sequences 	pringerimages.com	0	0		
674	chr25	11723919	11723952	3500344185	27		11723919	11723952	8421504	3	7,15,5	0,10,28	c	350034418500000163	15-48						Collagen Producing Plants And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
676	chr25	11934328	11934352	3500104347	24		11934328	11934352	8421504	1	24	0	g	350010434700000000	0-25		12920029	10.1182/blood-2003-04-1043	0006-4971	Blood	Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines	Chung	2003	10		
676	chr25	11969713	11969758	3500223129	45		11969713	11969758	8421504	1	45	0	p	350022312900015056	0-45						US Patent # 7,429,648. IREN protein, its preparation and use - Patents.com	www.patents.com	0	0		SNX29
678	chr25	12228380	12232633	3500256349	45		12228380	12232633	8421504	2	32,13	0,4240	p	350025634900015115	0-45						IREN PROTEIN, ITS PREPARATION AND USE - Patent application	www.faqs.org	0	0		SNX29
678	chr25	12232636	12232681	3500223129	45		12232636	12232681	8421504	1	45	0	p	350022312900015086	0-45						US Patent # 7,429,648. IREN protein, its preparation and use - Patents.com	www.patents.com	0	0		SNX29
681	chr25	12586555	12586579	3500203983	23		12586555	12586579	8421504	2	7,16	0,8	c	350020398300000000	10-33						MINIST&#xc9;RIO DA EDUCA&#xc7;&#xc3;O UNIVERSIDADE FEDERAL DE PELOTAS FACULDADE DE VETERIN&#xc1;RIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM VETERIN&#xc1;RIA &#x201c;ALTERA&#xc7;&#xd5;ES HEMATOL&#xd3;GICAS E HUMORAIS DE EQ&#xdc;INOS EXPOSTOS &#xc0; INF	www.ufpel.edu.br	0	0		
682	chr25	12743055	12756264	3500168776	61		12743055	12756264	8421504	6	13,6,5,4,14,19	0,16,9861,9868,9873,13190	g	350016877600001098,350016877600000040,350016877600001169,350016877600001170,350016877600000111,350016877600000112,350016877600000180,350016877600001238	5-24,5-24,0-23,0-23,0-23,0-23,0-19,0-19						Micrornas (mirnas) For Plant Growth And Development 	.freshpatents.com	0	0		
86	chr25	14281257	14312147	3500368736	44		14281257	14312147	8421504	2	25,19	0,30871	c,g	350036873600000012,350036873600000001,350036873600000001	0-25,0-19,0-19		16987998	10.1152/ajpcell.00449.2006		American Journal of Physiology - Cell Physiolog	Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters	Yoshida	2007	0		MKL2
86	chr25	14281257	14312147	3500130861	44		14281257	14312147	8421504	2	25,19	0,30871	c,g	350013086100000012,350013086100000001,350013086100000001	0-25,0-19,0-19		16987998	10.1152/ajpcell.00449.2006		American Journal of Physiology - Cell Physiolog	Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters	Yoshida	2007	0		MKL2
86	chr25	14281257	14312147	3500119465	44		14281257	14312147	8421504	2	25,19	0,30871	c,g	350011946500000012,350011946500000001,350011946500000001	0-25,0-19,0-19		16987998	10.1152/ajpcell.00449.2006	0363-6143	American Journal of Physiology - Cell Physiology	Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters	Yoshida	2007	4		MKL2
694	chr25	14332063	14332091	3500263420	25		14332063	14332091	8421504	2	20,5	0,23	c	350026342000000034	14-39						Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen - Patent application	www.faqs.org	0	0		
694	chr25	14388584	14393422	3500185291	170		14388584	14393422	8421504	2	83,87	0,4751	c	350018529100000045,350018529100000044,350018529100000101,350018529100000100	0-83,0-22,0-87,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR365A
694	chr25	14388584	14388667	3500433622	56		14388584	14388667	8421504	2	26,30	0,53	c	350043362200000034,350043362200000035	0-26,0-30		23200856	10.1016/j.celrep.2012.10.023	2211-1247	Cell Reports	Cell Reports - Specific miRNA Stabilization by Gld2-Catalyzed Monoadenylation	D'Ambrogio	2012	0		MIR365A
694	chr25	14388584	14388667	3500040785	83		14388584	14388667	8421504	1	83	0	c	350004078500000114,350004078500000082	0-83,0-22						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		MIR365A
694	chr25	14388597	14388656	3500254286	44		14388597	14388656	8421504	2	22,22	0,37	c	350025428600000013,350025428600000000	0-22,0-22						Mirnas dysregulated in triple-negative breast cancer	Richer	2011	0		MIR365A
694	chr25	14388597	14388656	3500171540	44		14388597	14388656	8421504	2	22,22	0,37	c,g	350017154000000013,350017154000000013,350017154000000000	0-22,0-22,0-22						MiRNAs dysregulated in triple-negative breast cancer	Richer	2010	0		MIR365A
694	chr25	14388597	14388656	3500003566	44		14388597	14388656	8421504	2	22,22	0,37	c	350000356600000013,350000356600000000	0-22,0-22						MIRNAS DYSREGULATED IN TRIPLE-NEGATIVE BREAST CANCER	Richer	2010	0		MIR365A
694	chr25	14388634	14388658	3500180208	24		14388634	14388658	8421504	1	24	0	c	350018020800001516	0-24					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		MIR365A
694	chr25	14388634	14388658	3500166534	24		14388634	14388658	8421504	1	24	0	c	350016653400001516	0-24						METHODS FOR QUANTITATING SMALL RNA MOLECULES	Raymond	2007	0		MIR365A
694	chr25	14388634	14388658	3500164893	24		14388634	14388658	8421504	1	24	0	c	350016489300001516	0-24						Methods for quantitating small rna molecules	Raymond	2007	0		MIR365A
694	chr25	14388634	14388658	3500035367	24		14388634	14388658	8421504	1	24	0	c	350003536700000004	0-24		19357368	10.1095/biolreprod.108.074005	0006-3363	Biology of Reproduction	Sexually Dimorphic MicroRNA Expression During Chicken Embryonic Gonadal Development	Bannister	2009	4		
694	chr25	14388634	14388658	3500022566	24		14388634	14388658	8421504	1	24	0	c	350002256600000004	0-24		19357368	10.1095/biolreprod.108.074005	0006-3363	Biology of Reproduction	Sexually Dimorphic MicroRNA Expression During Chicken Embryonic Gonadal Development	Bannister	2009	4		
695	chr25	14518034	14518057	3500017289	23		14518034	14518057	8421504	1	23	0	c	350001728900000007	0-23						Drug Discoveries Therapeutics	ddtjournal.com	0	0		
696	chr25	14646422	14663383	3500324182	80		14646422	14663383	8421504	3	5,15,60	0,15813,16901	c	350032418200000051	0-80						Cap-dependence of the Poly(A)-specific Ribonuclease PARN	thek.uni-halle.de	0	0		
697	chr25	14683904	14684260	3500427758	24		14683904	14684260	8421504	2	5,19	0,337	c	350042775800000002	9-33		22956911	10.1371/journal.pgen.1002901	1553-7404	PLOS Genetics	PLOS Genetics: The PARN Deadenylase Targets a Discrete Set of mRNAs for Decay and Regulates Cell Motility in Mouse Myoblasts	Lee	2012	0		
697	chr25	14718684	14720565	3500186243	24		14718684	14720565	8421504	2	14,10	0,1871	c	350018624300000025	0-24						&#xd3ec;&#xb3c4;&#xadfc; &#xc5d0;&#xd0c4;&#xc62c; &#xcd94;&#xcd9c;&#xbb3c;&#xc774; Hep G2 &#xc790;&#xc5f0;&#xc0ac;&#xc5d0; &#xbbf8;&#xce58;&#xb294; &#xd6a8;&#xacfc;	www.hantopic.com	0	0		
699	chr25	15072057	15072082	3500177869	24		15072057	15072082	8421504	2	5,19	0,6	g	350017786900000101	23-48						US Patent # 6,123,949. Recombinant fowlpox virus S-FPV-043 and uses thereof - Patents.com	www.patents.com	0	0		
700	chr25	15092953	15092982	3500236207	26		15092953	15092982	8421504	3	7,5,14	0,9,15	c	350023620700000013	0-26						Novel gene disruptions, compositions and methods relating thereto	Brennan	2007	0		
700	chr25	15092953	15092982	3500032360	26		15092953	15092982	8421504	3	7,5,14	0,9,15	c	350003236000000013	0-26						Novel gene disruptions, compositions and methods relating thereto	Brennan	2006	0		
700	chr25	15123612	15123639	3500058965	23		15123612	15123639	8421504	2	17,6	0,21	g	350005896500000007	3-27						The anti-anti-sigma factor BldG is involved in activation of the stress response sigma factor &#x03c3;(H) in Streptomyces coelicolor A3(2). - ResearchGate	.researchgate.net	0	0		
700	chr25	15198787	15198811	3500307534	23		15198787	15198811	8421504	2	15,8	0,16	c	350030753400000015	18-41						PUTATIVE TUMOR SUPPRESSOR MICRORNA-101 MODULATES THE CANCER EPIGENOME BY REPRESSING THE POLYCOMB GROUP PROTEIN EZH2 - Patent application	www.faqs.org	0	0		
701	chr25	15238564	15238590	3500054836	25		15238564	15238590	8421504	2	12,13	0,13	c	350005483600000057	8-47						Novel Compounds 	.freshpatents.com	0	0		
701	chr25	15238564	15238590	3500011853	25		15238564	15238590	8421504	2	12,13	0,13	c	350001185300000018	8-47						Proder P 1 Expressed In A Prokaryotic Cell 	.freshpatents.com	0	0		
701	chr25	15253248	15277933	3500197117	81		15253248	15277933	8421504	4	18,18,24,21	0,7419,20376,24664	p	350019711700015005	27-114						Nonneutral Mitochondrial DNA Variation in Humans and Chimpanzees	www.genetics.org	0	0		
701	chr25	15303933	15303960	3500026625	23		15303933	15303960	8421504	2	5,18	0,9	g	350002662500000000	22-45						Monoclonal antibody to human thrombopoietin	Eaton	1995	0		
701	chr25	15311825	15311850	3500400651	25		15311825	15311850	8421504	1	25	0	c	350040065100000005	0-25		10712248			American Journal of Physiology - Cell Physiolog	A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch	Dirksen	2000	0		
701	chr25	15311825	15311850	3500130855	25		15311825	15311850	8421504	1	25	0	c	350013085500000005	0-25		10712248			American Journal of Physiology - Cell Physiolog	A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch	Dirksen	2000	0		
87	chr25	15571630	15619009	3500287505	227		15571630	15619009	8421504	5	23,89,44,26,45	0,42014,42538,44954,47334	c,g	350028750500000075,350028750500000118,350028750500000117,350028750500000113,350028750500000211,350028750500000211,350028750500000111,350028750500000104	0-23,0-45,1-45,0-44,0-20,0-20,0-26,0-45						Methods for diagnosing Pseudoxanthoma elasticum	www.devileye.net	0	0		
703	chr25	15588299	15588329	3500141726	30		15588299	15588329	8421504	1	30	0	c	350014172600000001,350014172600000000	0-30,0-30						&#x6297;&#x30ac;&#x30f3;&#x5264;&#x6392;&#x51fa;&#x30bf;&#x30f3;&#x30d1;&#x30af;&#x8cea; MRPl&#x306e;&#x57fa;&#x8cea;&#x7279;&#x7570;&#x6027;&#x306e;&#x6c7a;&#x5b9a;&#x306b;&#x95a2;&#x4e0e;&#x3059;&#x308b;&#x90e8;&#x4f4d;&#x306e;&#x540c;&#x5b9a;	clib.kindai.ac.jp	0	0		ABCC1
703	chr25	15588362	15588385	3500308544	23		15588362	15588385	8421504	1	23	0	c	350030854400000000,350030854400000001	6-33,9-36		15674327	10.1038/sj.onc.1208401	0950-9232	Oncogene	Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 mediated cleavage of Raf-1	Cornelis	2005	6		
704	chr25	15598972	15598996	3500122691	24		15598972	15598996	8421504	1	24	0	g	350012269100000019	0-24		16415113	10.1124/dmd.105.007740	1521-009X (Online)	Drug Metabolism and Disposition	MUTATIONAL ANALYSIS OF POLAR AMINO ACID RESIDUES WITHIN PREDICTED TRANSMEMBRANE HELICES 10 AND 16 OF MULTIDRUG RESISTANCE PROTEIN 1 (ABCC1): EFFECT ON SUBSTRATE SPECIFICITY	Zhang	2006	0		ABCC1
704	chr25	15605927	15605951	3500126764	24		15605927	15605951	8421504	1	24	0	c	350012676400000002	22-46						Cerebrospinal Fluid Research BioMed Central	biomedcentral.com	0	0		ABCC1
704	chr25	15662713	15662737	3500325127	23		15662713	15662737	8421504	2	6,17	0,7	g	350032512700000135	14-37						Method For Detecting Gene Specifying Allergic Predisposition 	.freshpatents.com	0	0		
706	chr25	15970108	15970137	3500054339	25		15970108	15970137	8421504	2	20,5	0,24	g	350005433900000161	0-27						 Streptococcus Pneumoniae SP036 Polynucleotides 	www.docstoc.com	0	0		
710	chr25	16433125	16433156	3500389234	23		16433125	16433156	8421504	3	10,8,5	0,15,26	g	350038923400000084	4-27						High lysine fertile transgenic corn plants	Lundquist	1998	0		
710	chr25	16433125	16433156	3500043263	23		16433125	16433156	8421504	3	10,8,5	0,15,26	g	350004326300000084	4-27						Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof	Lundquist	1995	0		
712	chr25	16648897	16648924	3500244146	23		16648897	16648924	8421504	2	8,15	0,12	g	350024414600000046	13-36						Recombinant equine herpesviruses	Chiang	1997	0		
712	chr25	16664406	16664522	3500264039	114		16664406	16664522	8421504	2	59,55	0,61	g	350026403900000035,350026403900000038	24-83,2-57						Structure and Evolution of the Y-chromosomal and Mitochondrial DNA of cattle	ive.library.uu.nl	0	0		
714	chr25	16931654	16931693	3500354489	31		16931654	16931693	8421504	3	10,14,7	0,13,32	g	350035448900000123	0-38						Transgenic non-human animals capable of producing heterologous antibodies	Kay	1997	0		
714	chr25	16955014	16958385	3500233653	210		16955014	16958385	8421504	4	5,5,93,107	0,6,12,3264	g	350023365300000009	3-213						in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biological Engineering	dspace.mit.edu	0	0		
715	chr25	17100345	17100373	3500225722	23		17100345	17100373	8421504	2	13,10	0,18	g	350022572200000008	0-23						Compositions and methods for the treatment of tumors	Botstein	2000	0		
716	chr25	17181615	17181640	3500177982	23		17181615	17181640	8421504	2	15,8	0,17	g	350017798200000490	19-46						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		
716	chr25	17226116	17226139	3500027176	23		17226116	17226139	8421504	1	23	0	g	350002717600000013	1-24		21969865	10.1371/journal.pone.0024872		PLoS ONE	PlGF Repairs Myocardial Ischemia through Mechanisms of Angiogenesis, Cardioprotection and Recruitment of Myo-Angiogenic Competent Marrow Progenitors	Hiroto	2011	0		
716	chr25	17262766	17262791	3500304511	24		17262766	17262791	8421504	2	13,11	0,14	g	350030451100000100	0-26						&#x6297;&#x75c5;&#x690d;&#x7269; Disease-resistant plants	A*F*J*M*Fan Deng A Ke Wei Ken 	2008	0		
717	chr25	17425060	17425087	3500031175	24		17425060	17425087	8421504	2	11,13	0,14	g	350003117500000218	1-25						Prf protein and nucleic acid sequences: compositions and methods for plant pathogen resistance - Patent # 6245510 - PatentGenius	.patentgenius.com	0	0		
718	chr25	17538429	17538530	3500337770	40		17538429	17538530	8421504	2	20,20	0,81	c	350033777000000003,350033777000000002	0-20,0-20						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
718	chr25	17538429	17538530	3500139803	40		17538429	17538530	8421504	2	20,20	0,81	c	350013980300000003,350013980300000002	0-20,0-20						Conferences, Proceedings, Journals, Open Access Journals, SCIRP	file.scirp.org	0	0		
718	chr25	17538429	17538530	3500006584	40		17538429	17538530	8421504	2	20,20	0,81	c	350000658400000011,350000658400000010	0-20,0-20						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
718	chr25	17545129	17545174	3500184212	45		17545129	17545174	8421504	1	45	0	p	350018421200015002	3-48						&#x30e2;&#x30eb;&#x30d2;&#x30cd;&#x9577;&#x671f;&#x4f5c;&#x7528;&#x306b;&#x95a2;&#x308f;&#x308b;&#x65b0;&#x898f;&#x56e0;&#x5b50; addicsin &#x306e;&#x6a5f;&#x80fd;&#x89e3;&#x6790;	library.naist.jp	0	0		ARL6IP1
719	chr25	17609830	17609858	3500369652	23		17609830	17609858	8421504	2	16,7	0,21	c	350036965200000095	24-47						<HTML> <HEAD> <TITLE>U.S. Patent: 5635617 - Methods and compositions comprising the agfA gene for	w.everypatent.com	0	0		
719	chr25	17609830	17609858	3500187612	23		17609830	17609858	8421504	2	16,7	0,21	c	350018761200000095	24-47						US Patent # 5,635,617. Methods and compositions comprising the agfA gene for detection of Salmonella - Patents.com	www.patents.com	0	0		
11	chr25	17825654	17898204	3500054122	570		17825654	17898204	8421504	4	56,156,67,291	0,33862,35711,72259	p	350005412200015045,350005412200015043	0-279,0-291						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		SYT17
721	chr25	17861483	17898411	3500328917	83		17861483	17898411	8421504	3	3,39,41	0,36355,36887	c	350032891700000224,350032891700000213	0-42,0-41						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
722	chr25	18025294	18025317	3500181936	23		18025294	18025317	8421504	1	23	0	g	350018193600000011	16-39						ESTROGEN RECEPTOR GENES AND UTILIZATION THEREOF - Patent application	www.faqs.org	0	0		
725	chr25	18453894	18468023	3500396513	363		18453894	18468023	8421504	4	1,119,147,96	0,6741,13215,14033	p	350039651300015067	78-441						52 human secreted proteins	Baker	2002	0		KNOP1
725	chr25	18453894	18468023	3500024754	363		18453894	18468023	8421504	4	1,119,147,96	0,6741,13215,14033	p	350002475400015057	78-441						52 human secreted proteins	Baker	2002	0		KNOP1
726	chr25	18482533	18482561	3500017945	23		18482533	18482561	8421504	3	4,6,13	0,5,15	c	350001794500000002	12-35						Production of orthomyxoviruses in monkey kidney cells using protein-free media	Kistner	1997	0		
727	chr25	18671779	18671805	3500295899	24		18671779	18671805	8421504	2	18,6	0,20	g	350029589900000214	5-29						Polypeptides toxic to nematodes and methods of use	Salamone	2003	0		
728	chr25	18816379	18816427	3500010114	47		18816379	18816427	8421504	2	23,24	0,24	c,g	350001011400000036,350001011400000036,350001011400000034	0-23,0-23,0-24						Novel human G-protein coupled receptor, HGPRBMY8, expressed highly in brain	Battaglino	2003	0		
728	chr25	18858617	18858642	3500055538	25		18858617	18858642	8421504	1	25	0	c,g	350005553800000036,350005553800000036	0-25,0-25						G PROTEIN COUPLED RECEPTORS AND USES THEREOF - Patent application	www.faqs.org	0	0		
731	chr25	19180776	19199356	3500184228	2258		19180776	19199356	8421504	14	216,53,62,42,82,163,246,31,58,209,108,777,196,15	0,217,271,1410,2618,3287,6532,9056,9147,13121,14803,15005,16918,18565	c,g	350018422800000219,350018422800000219,350018422800000214,350018422800000209,350018422800000209,350018422800000204,350018422800000199,350018422800000194,350018422800000194,350018422800000189,350018422800000184,350018422800000179,350018422800000179,350018422800000174,350018422800000174,350018422800000169,350018422800000168,350018422800000164,350018422800000164,350018422800000159,350018422800000159,350018422800000154,350018422800000154,350018422800000149,350018422800000149,350018422800000139,350018422800000134,350018422800000134,350018422800000128,350018422800000129,350018422800000129,350018422800000124,350018422800000124,350018422800000119,350018422800000114,350018422800000114,350018422800000109,350018422800000109,350018422800000104,350018422800000104,350018422800000099,350018422800000099,350018422800000094,350018422800000094,350018422800000089,350018422800000089,350018422800000084,350018422800000084,350018422800000079,350018422800000079,350018422800000074,350018422800000074,350018422800000069,350018422800000069,350018422800000064,350018422800000064,350018422800000059,350018422800000059,350018422800000054,350018422800000054,350018422800000049,350018422800000049,350018422800000044,350018422800000039,350018422800000039,350018422800000034,350018422800000034,350018422800000031	0-59,0-59,0-60,0-60,0-60,0-58,0-59,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-37,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-54,0-54,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-59,0-59,0-59,0-59,0-51						IDENTIFICATION OF A MUTATION IN COL4A5 CAUSATIVE FOR X- LINKED ALPORT SYNDROME IN THE DOMESTIC DOG AND ANALYSIS OF GENE EXPRESSION IN THE KIDNEYS OF AFFECTED AND NONAFFECTED SIBLINGS	pository.tamu.edu	0	0		
731	chr25	19181056	19200969	3500329208	2455		19181056	19200969	8421504	11	53,42,1,670,84,27,315,488,627,112,36	0,1130,2338,14747,15418,16219,18203,18519,19018,19658,19877	p,c,g	350032920800015152,350032920800015151,350032920800000035,350032920800000025,350032920800000066,350032920800000040,350032920800000031,350032920800000072,350032920800000073	0-48,0-48,0-297,0-28,0-28,44-565,0-27,0-27,35-1630						Transgenic animals as urinary bioreactors for the production of polypeptide in the urine, recombinant DNA construct for kidney-specific expression, and method of using same - Patent # 6888047 - PatentGenius	.patentgenius.com	0	0		
731	chr25	19195818	19196065	3500180618	56		19195818	19196065	8421504	2	28,28	0,219	c	350018061800000026,350018061800000025	0-28,0-28						Transgenic animals as urinary bioreactors for the production of polypeptide in the urine, recombinant DNA construct for kidney-specific expression, and method of using same	Wu	2000	0		
731	chr25	19196021	19196048	3500295264	27		19196021	19196048	8421504	1	27	0	g	350029526400000005	0-27			10.1111/j.1600-0854.2006.00481.x	1600-0854	Traffic	Defective Intracellular Trafficking of Uromodulin Mutant Isoforms - Bernascone - 2006 - Traffic - Wiley Online Library	Bernascone	2006	0		
731	chr25	19208013	19208036	3500340922	23		19208013	19208036	8421504	1	23	0	c	350034092200000159,350034092200000463	0-20,1-20					Patent	Modulation of C-reactive protein expression (Patent US:7425545)	Crooke	2008	0		
735	chr25	19669825	19669852	3500374642	23		19669825	19669852	8421504	2	10,13	0,14	g	350037464200000009	1-24						DEPARTAMENT DE BIOQUIMICA	www.tdx.cat	0	0		
735	chr25	19776909	19776933	3500366733	23		19776909	19776933	8421504	2	12,11	0,13	g	350036673300000253	9-32						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
735	chr25	19782702	19784811	3500363465	40		19782702	19784811	8421504	3	4,16,20	0,1581,2089	c	350036346500000006,350036346500000000	0-20,0-20		18823379	10.1111/j.1349-7006.2008.00929.x	1349-7006	Cancer Science	DCUN1D3, a novel UVC-responsive gene that is involved in cell cycle progression and cell growth - Ma - 2008 - Cancer Science - Wiley Online Library	Ma	2008	0		DCUN1D3
738	chr25	20118508	20118536	3500414436	24		20118508	20118536	8421504	2	7,17	0,11	g	350041443600000007	2-26						High-Risk Human Papillomavirus Detection - Patent application	www.faqs.org	0	0		
739	chr25	20225692	20231061	3500366733	711		20225692	20231061	8421504	10	31,95,84,97,136,105,19,83,23,38	0,79,1180,1669,1840,3528,3978,4097,4348,5331	c,g	350036673300000345,350036673300000345,350036673300000343,350036673300000343,350036673300000342,350036673300000341,350036673300000340,350036673300000340,350036673300000339,350036673300000497,350036673300000485,350036673300000260,350036673300000338,350036673300000337,350036673300000337,350036673300000336,350036673300000335,350036673300000334,350036673300000334,350036673300000041,350036673300000178,350036673300000250,350036673300000177,350036673300000249,350036673300000175,350036673300000247,350036673300000243	0-31,0-31,0-48,0-48,0-48,0-117,0-48,0-48,0-48,1-33,4-35,25-44,0-48,0-48,0-48,0-48,0-48,14-51,14-51,7-48,6-48,0-48,17-48,21-48,0-23,9-32,0-38						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
739	chr25	20225692	20231061	3500193635	524		20225692	20231061	8421504	11	31,95,1,84,12,123,20,19,78,23,38	0,79,1180,1682,1840,1853,3528,3978,4097,4348,5331	c,g	350019363500000344,350019363500000344,350019363500000342,350019363500000341,350019363500000338,350019363500000337,350019363500000487,350019363500000476,350019363500000261,350019363500000336,350019363500000335,350019363500000334,350019363500000041,350019363500000177,350019363500000251,350019363500000176,350019363500000174,350019363500000248,350019363500000244	0-31,0-31,0-48,0-48,0-48,0-48,1-33,4-35,25-44,0-47,0-48,0-48,7-48,6-48,0-48,17-48,0-23,9-32,0-38						Materials and methods for immunocontraception	Harris	1993	0		
739	chr25	20229305	20229615	3500378665	40		20229305	20229615	8421504	2	20,20	0,290	c,g	350037866500000019,350037866500000019,350037866500000018	0-20,0-20,0-20						Specific maternal transcripts in bovine oocytes and cleavaged embryos: Identification with novel DDRT-PCR methods	www.seegene.com	0	0		
739	chr25	20229318	20229363	3500255959	45		20229318	20229363	8421504	1	45	0	p	350025595900015032	0-45						 <HTML> <HEAD><TITLE>aa3aueaea,-i1/4|i1/4oi1/4degi1/4aa3a1/4aaai1/4$?i1/4(r)i1/4!ea - c1ea13i1/4	www.j-tokkyo.com	0	0		
739	chr25	20229568	20232109	3500359799	83		20229568	20232109	8421504	4	20,20,22,21	0,538,2187,2520	c,g	350035979900000003,350035979900000002,350035979900000001,350035979900000000,350035979900000000	0-20,0-20,0-22,0-21,0-21						Sequencing primers and SNPs for rapidly evolving reproductive loci in endangered ibex and their kin (Bovidae, Capra spp.) - ResearchGate	.researchgate.net	0	0		
739	chr25	20229568	20232109	3500270029	82		20229568	20232109	8421504	4	20,20,21,21	0,538,2188,2520	c,g	350027002900000003,350027002900000002,350027002900000001,350027002900000001,350027002900000000,350027002900000000	0-20,0-20,0-21,0-21,0-21,0-21						Sequencing primers and SNPs for rapidly evolving reproductive loci in endangered ibex and their kin (Bovidae, Capra spp	taff.bucknell.edu	0	0		
739	chr25	20237429	20237456	3500096205	25		20237429	20237456	8421504	3	8,11,6	0,9,21	c	350009620500000042,350009620500000199	14-39,14-39						T Cell Adhesion Molecule and Antibody Thereto - Patent application	www.faqs.org	0	0		
739	chr25	20283987	20301944	3500049172	87		20283987	20301944	8421504	3	36,27,24	0,726,17933	p,c	350004917200015000,350004917200000000	0-63,0-24						 <HTML><HEAD><TITLE>Segovia, Mol Vis 1997; 3:9.</TITLE></HEAD> <BODY BGCOLOR="#FFFFFF"><	www.molvis.org	0	0		
740	chr25	20321900	20321927	3500415678	24		20321900	20321927	8421504	2	6,18	0,9	g	350041567800000015	4-28					Patent	Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same (Patent US:7846437)	Achen	2010	0		
740	chr25	20321900	20321927	3500233992	24		20321900	20321927	8421504	2	6,18	0,9	g	350023399200000003	4-28						Protofibril selective antibodies and the use thereof	Pettersson	2012	0		
740	chr25	20400591	20400617	3500126537	25		20400591	20400617	8421504	2	21,4	0,22	g	350012653700000000	0-27		18070983	10.1189/jlb.0607405	0741-5400	Journal of Leukocyte Biology	NF-&#x03ba;B-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells	Mahlknecht	2008	5		
746	chr25	21161445	21161469	3500371882	23		21161445	21161469	8421504	2	10,13	0,11	c	350037188200000013	1-24						One-step purification process for organophosphorus hydrolase enzyme	Rastogi	2000	0		
753	chr25	22039832	22039859	3500406521	24		22039832	22039859	8421504	2	6,18	0,9	g	350040652100000044	11-36						High molecular weight major outer membrane protein of moraxella	Sasaki	1998	0		
753	chr25	22086851	22086874	3500273225	23		22086851	22086874	8421504	1	23	0	g	350027322500000001	1-24						Overexpression of NAD kinase in recombinant Escherichia coli harboring the phbCAB operon improves poly(3-hydroxybutyrate) production	w.transgen.com.cn	0	0		
753	chr25	22130796	22131038	3500199933	44		22130796	22131038	8421504	2	21,23	0,219	c	350019993300000006,350019993300000007	0-21,0-23		17251323	10.1152/ajpcell.00369.2006		American Journal of Physiology - Cell Physiology	Glucocorticoids stimulate ENaC upregulation in bovine mammary epithelium	Quesnell	2007	0		
753	chr25	22130796	22131038	3500061173	44		22130796	22131038	8421504	2	21,23	0,219	c	350006117300000006,350006117300000007	0-21,0-23		17251323	10.1152/ajpcell.00369.2006		American Journal of Physiology - Cell Physiolog	Glucocorticoids stimulate ENaC upregulation in bovine mammary epithelium	Quesnell	2007	0		
755	chr25	22293135	22293165	3500345549	30		22293135	22293165	8421504	1	30	0	c	350034554900000003	0-30		11934701	10.1152/ajprenal.00268.2001		American Journal of Physiology - Renal Physiology	Genomic organization of the 5&#x2032; end of human &#x03b2;-ENaC and preliminary characterization of its promoter	Thomas	2002	0		
755	chr25	22293135	22293165	3500228003	30		22293135	22293165	8421504	1	30	0	c	350022800300000003	0-30		11934701	10.1152/ajprenal.00268.2001		American Journal of Physiology - Renal Physiology	Genomic organization of the 5&#x2032; end of human &#x03b2;-ENaC and preliminary characterization of its promoter	Thomas	2002	0		
755	chr25	22315361	22315384	3500024647	23		22315361	22315384	8421504	1	23	0	c	350002464700000000	0-23		23977235	10.1371/journal.pone.0072153	1932-6203	PLOS ONE	PLOS ONE: Reduced Expression of Enac in Placenta Tissues of Patients with Severe Preeclampsia Is Related to Compromised Trophoblastic Cell Migration and Invasion during Pregnancy	Wang	2013	4		
755	chr25	22367394	22367420	3500008403	23		22367394	22367420	8421504	2	17,6	0,20	g	350000840300000090,350000840300000213	7-30,7-30						HUMAN MONOCLONAL ANTIBODY NEUTRALIZING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND USE THEREOF - Patent application	www.faqs.org	0	0		
756	chr25	22430097	22430121	3500049949	23		22430097	22430121	8421504	2	18,5	0,19	c	350004994900000000	2-26		19211747	10.1128/JVI.02110-08		Journal of Virology	Identification of a Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Variant Resistant to Cold Inactivation 	Aemro	2009	0		
756	chr25	22498317	22498341	3500379040	24		22498317	22498341	8421504	1	24	0	c	350037904000000066,350037904000000061,350037904000000046,350037904000000044,350037904000000057,350037904000000049,350037904000000065	0-23,0-24,1-25,12-36,0-21,12-36,16-38						Nucleic acid aptamers	Giangrande	2011	0		
756	chr25	22498317	22498341	3500040019	24		22498317	22498341	8421504	1	24	0	c	350004001900000044,350004001900000046,350004001900000061,350004001900000057,350004001900000049,350004001900000065	12-36,1-25,0-24,0-21,12-36,16-38						NUCLEIC ACID APTAMERS - UNIVERSITY OF IOWA RESEARCH FOUNDATION	www.sumobrain.com	0	0		
756	chr25	22498317	22498340	3500081534	23		22498317	22498340	8421504	1	23	0	c	350008153400000000	0-23						Supplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION	www.jbc.org	0	0		
756	chr25	22499210	22499233	3500200608	23		22499210	22499233	8421504	1	23	0	c	350020060800000006	0-23						A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma	.aacrjournals.org	0	0		
756	chr25	22499210	22499233	3500042485	23		22499210	22499233	8421504	1	23	0	c	350004248500000006	0-23		22535157	10.1158/1078-0432.CCR-11-3058	1078-0432	Clinical Cancer Research	A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma	Shan	2012	8		
756	chr25	22500519	22500544	3500432343	25		22500519	22500544	8421504	1	25	0	c	350043234300000003,350043234300000002	0-25,0-25		22808196	10.1371/journal.pone.0040572	1932-6203	PLOS ONE	PLOS ONE: Increases in Mitochondrial DNA Content and 4977-bp Deletion upon ATM/Chk2 Checkpoint Activation in HeLa Cells	Niu	2012	4		PLK1
757	chr25	22568043	22568072	3500201383	24		22568043	22568072	8421504	3	12,5,7	0,15,22	c	350020138300000007	10-34						miR-32 and its target SLC45A3 regulate the lipid metabolism of oligodendrocytes and myelin. - ResearchGate	.researchgate.net	0	0		
94	chr25	22668440	23036245	3500262884	2019		22668440	23036245	8421504	17	173,32,83,112,129,157,135,97,147,174,92,63,139,81,108,141,156	0,1176,163491,197147,198639,256982,258571,270673,279892,312237,328372,330267,335759,340116,340481,346634,367649	p	350026288400015001	0-2019						KEGG T01001: 5578	www.genome.jp	0	0		PRKCB
94	chr25	22668440	23036245	3500165258	2019		22668440	23036245	8421504	17	173,32,83,112,129,157,135,97,147,174,92,63,139,81,108,141,156	0,1176,163491,197147,198639,256982,258571,270673,279892,312237,328372,330267,335759,340116,340481,346634,367649	p	350016525800015013	0-2019						T3DB: Showing Lead subacetate (T3D1331)	classic.t3db.org	0	0		
757	chr25	22668487	22668533	3500222581	46		22668487	22668533	8421504	1	46	0	c	350022258100000001	5-51			10.1016/j.prostaglandins.2005.12.002		Prostaglandins & other lipid mediators	Involvement of EP1 and EP2 receptors in the regulation of the Na,K-ATPase by prostaglandins in MDCK cells	Keikantse	2006	0		PRKCB
757	chr25	22668494	22668551	3500448373	36		22668494	22668551	8421504	2	9,27	0,30	g	350044837300000006	26-62		16849455		0022-1767	The Journal of Immunology	Phosphorylation of Nonmuscle Myosin Heavy Chain IIA on Ser1917 Is Mediated by Protein Kinase C&#x03b2;II and Coincides with the Onset of Stimulated Degranulation of RBL-2H3 Mast Cells	Ludowyke	2006	6		
757	chr25	22668494	22668548	3500390453	54		22668494	22668548	8421504	1	54	0	p	350039045300015001	0-54						Cytochrome P450 2J2 Is Highly Expressed in Hematologic Malignant Diseases and Promotes Tumor Cell Growth S	aspetjournals.org	0	0		PRKCB
757	chr25	22668494	22668548	3500029496	54		22668494	22668548	8421504	1	54	0	p	350002949600015000	0-54		16306123	10.1152/ajpcell.00602.2004		American Journal of Physiology - Cell Physiolog	Involvement of calmodulin and myosin light chain kinase in activation of mTRPC5 expressed in HEK cells	Kim	2006	0		PRKCB
757	chr25	22668494	22668548	3500000552	54		22668494	22668548	8421504	1	54	0	p	350000055200015001	0-54		10484327			American Journal of Physiology - Cell Physiology	Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway	Kobuchi	1999	0		PRKCB
757	chr25	22668519	22668560	3500303084	41		22668519	22668560	8421504	1	41	0	c	350030308400000021	7-48						Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof	Alvaro	1994	0		
757	chr25	22668573	22668597	3500198947	24		22668573	22668597	8421504	1	24	0	c	350019894700000001	0-24		23759514	10.1161/CIRCRESAHA.113.301074	0009-7330	Circulation Research	Induction of Vascular Insulin Resistance and Endothelin-1 Expression and Acceleration of Atherosclerosis by the Overexpression of Protein Kinase C-&#x03b2; Isoform in the Endothelium	Li	2013	9		PRKCA
759	chr25	22865635	22865680	3500303084	45		22865635	22865680	8421504	1	45	0	p	350030308400015097	0-45						Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof	Alvaro	1994	0		PRKCB
759	chr25	22885270	22885295	3500008216	25		22885270	22885295	8421504	1	25	0	g	350000821600000042,350000821600000045,350000821600000044,350000821600000049,350000821600000059,350000821600000051	13-33,13-35,13-34,13-36,14-38,12-37						Caracterizaci&#xf3;n estructural del polimorfismo del microsat&#xe9;lite MSTN01 del gen de miostatina bovina	.bnct.ipn.mx:8080	0	0		
759	chr25	22904014	22904040	3500431462	23		22904014	22904040	8421504	2	17,6	0,20	g	350043146200000089	4-28						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
759	chr25	22904014	22904040	3500031022	23		22904014	22904040	8421504	2	17,6	0,20	g	350003102200000089	4-28						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
760	chr25	22948422	22948449	3500275611	27		22948422	22948449	8421504	1	27	0	c	350027561100000000	0-27		7768933	10.1074/jbc.270.22.13326	0021-9258	Journal of Biological Chemistry	Regulation of Alternative Splicing of Protein Kinase C&#x03b2; by Insulin	Chalfant	1995	5		
760	chr25	22948422	22948445	3500318162	23		22948422	22948445	8421504	1	23	0	c	350031816200000000	0-23		19116344	10.1210/en.2008-0818	0013-7227	Endocrinology	Akt2 Regulation of Cdc2-Like Kinases (Clk/Sty), Serine/Arginine-Rich (SR) Protein Phosphorylation, and Insulin-Induced Alternative Splicing of PKC&#x03b2;II Messenger Ribonucleic Acid	Jiang	2009	4		PRKCB
760	chr25	22948422	22948445	3500170728	23		22948422	22948445	8421504	1	23	0	c	350017072800000000	0-23		19116344	10.1210/en.2008-0818		Endocrinology	Akt2 Regulation of Cdc2-Like Kinases (Clk/Sty), Serine/Arginine-Rich (SR) Protein Phosphorylation, and Insulin-Induced Alternative Splicing of PKC&#x03b2;II Messenger Ribonucleic Acid	Kun	2009	0		PRKCB
760	chr25	22962294	22962321	3500143676	24		22962294	22962321	8421504	3	8,5,11	0,10,16	g	350014367600000002	9-33		15047841	10.1128/JVI.78.8.4278-4288.2004	0022-538X	Journal of Virology	The Ribonucleotide Reductase R1 Homolog of Murine Cytomegalovirus Is Not a Functional Enzyme Subunit but Is Required for Pathogenesis	Lembo	2004	5		
760	chr25	23004260	23008595	3500366238	114		23004260	23008595	8421504	2	75,39	0,4296	p	350036623800015038	3-117						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		PRKCB
760	chr25	23015170	23036120	3500207695	45		23015170	23036120	8421504	2	23,22	0,20928	c,g	350020769500000004,350020769500000008,350020769500000008	0-23,0-22,0-22		14670960	10.1074/jbc.M312840200	0021-9258	Journal of Biological Chemistry	Bcr-Abl Regulates Protein Kinase C&#x03b9; (PKC&#x03b9;) Transcription via an Elk1 Site in the PKC&#x03b9; Promoter	Gustafson	2004	5		PRKCB
760	chr25	23036122	23036170	3500348183	48		23036122	23036170	8421504	1	48	0	p	350034818300015001	0-48						US Patent # 5,723,581. Murine and human box-dependent myc-interacting protein (Bin1) - Patents.com	www.patents.com	0	0		PRKCB
760	chr25	23036218	23036248	3500360967	30		23036218	23036248	8421504	1	30	0	c	350036096700000005	0-30		16299331	10.1128/IAI.73.12.8334-8344.2005	0019-9567	Infection and Immunity	Regulation of Impaired Protein Kinase C Signaling by Chemokines in Murine Macrophages during Visceral Leishmaniasis	Dey	2005	4		
766	chr25	23841056	23841081	3500442426	25		23841056	23841081	8421504	1	25	0	g	350044242600000148	95-120						Gene encoding protein antigens of Plasmodium falciparum and uses therefor	Inselburg	1994	0		
767	chr25	23951889	23951916	3500416974	23		23951889	23951916	8421504	2	10,13	0,14	g	350041697400000044	1-24						Curriculum Vitae Beth E. Zucconi Education	hsl.umaryland.edu	0	0		
769	chr25	24153420	24153450	3500059076	25		24153420	24153450	8421504	3	12,3,10	0,14,20	g	350005907600000133	17-42						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE	Frank-Kamenetsky	2009	0		
769	chr25	24153420	24153450	3500024490	25		24153420	24153450	8421504	3	12,3,10	0,14,20	g	350002449000000133	17-42						Compositions and methods for inhibiting expression of Nav1.8 gene	Sah	2006	0		
780	chr25	25578720	25578746	3500095449	24		25578720	25578746	8421504	2	11,13	0,13	g	350009544900002251	4-30						Expression Cassettes for Embryo-Specific Expression in Plants - Patent application	www.faqs.org	0	0		
780	chr25	25637974	25638001	3500352307	23		25637974	25638001	8421504	2	16,7	0,20	g	350035230700000026	9-32						Method Of Reverse Transcription 	.freshpatents.com	0	0		
783	chr25	26030139	26030169	3500014530	23		26030139	26030169	8421504	3	12,2,9	0,18,21	g	350001453000000039	2-25						METHODS AND COMPOSITIONS RELATING TO ZPA POLYPEPTIDES	Ashkenazi	2012	0		
786	chr25	26401902	26401930	3500225364	25		26401902	26401930	8421504	2	7,18	0,10	g	350022536400000009	0-25						Inhibitors Of Bacterial Type III Secretion System	Moir	2012	0		
786	chr25	26401902	26401930	3500214711	25		26401902	26401930	8421504	2	7,18	0,10	g	350021471100000003	0-25						PSM PEPTIDES AS VACCINE TARGETS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS	Otto	2009	0		
786	chr25	26401902	26401930	3500150020	25		26401902	26401930	8421504	2	7,18	0,10	g	350015002000000015,350015002000000005	0-25,0-25						DEVELOPMENT OF HIGH-THROUGHPUT GENE KNOCKOUT STRATEGIES IN FOR PRODUCTION OF ATTENUATED LINES genome, only a few genes	aeum.libs.uga.edu	0	0		
786	chr25	26401902	26401930	3500104114	25		26401902	26401930	8421504	2	7,18	0,10	g	350010411400000025,350010411400000011	0-25,0-25						ENGINEERED BIOLOGICAL PACEMAKERS - Patent application	www.faqs.org	0	0		
786	chr25	26401902	26401930	3500091159	25		26401902	26401930	8421504	2	7,18	0,10	g	350009115900000001	0-25						Colon cancer targets and uses thereof	Domon	2008	0		
786	chr25	26401902	26401930	3500052479	25		26401902	26401930	8421504	2	7,18	0,10	g	350005247900000003	0-25		21481190	10.1111/j.1742-4658.2011.08122.x	1742-4658	FEBS Journal	Expression analysis of the nucleocytoplasmic lectin &#x2018;Orysata&#x2019; from rice in Pichia&#xa0;pastoris - Al Atalah - 2011 - FEBS Journal - Wiley Online Library	Atalah	2011	0		
786	chr25	26401902	26401929	3500299566	24		26401902	26401929	8421504	2	7,17	0,10	g	350029956600000035,350029956600000017	0-24,0-24						PRLR-Specific Antibody and Uses Thereof - Patent application	www.faqs.org	0	0		
786	chr25	26401902	26401929	3500140713	24		26401902	26401929	8421504	2	7,17	0,10	g	350014071300000064,350014071300000060	0-24,0-24						Lehrstuhl f&#xfc;r Biochemische Pflanzenpathologie	d-nb.info/1037198	0	0		
788	chr25	26667293	26717249	3500462221	3483		26667293	26717249	8421504	10	27,88,139,161,152,157,100,79,50,2530	0,26061,28294,30226,32133,39496,43183,45247,46322,47426	p,c	350046222100000007,350046222100015152,350046222100015153,350046222100015154,350046222100015157,350046222100015159,350046222100015162,350046222100015163,350046222100015164,350046222100015166,350046222100015168,350046222100015169,350046222100015172,350046222100015173,350046222100015174,350046222100015176,350046222100015178,350046222100015179,350046222100015181,350046222100015182,350046222100015183,350046222100015184,350046222100015186,350046222100015187,350046222100015189,350046222100015191,350046222100015192,350046222100015193,350046222100015194,350046222100015196,350046222100015197,350046222100015198,350046222100015199	0-3483,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Antisense Respiratory Syncytial Virus Vaccine and Therapy - Patent application	www.faqs.org	0	0		
788	chr25	26714786	26714812	3500403998	26		26714786	26714812	8421504	1	26	0	c	350040399800000001	20-46		19386010	10.1111/j.1439-0396.2007.00780.x	1439-0396	Journal of Animal Physiology and Animal Nutrition	Use of gene profiling to evaluate the effects of a feed additive on immune function in periparturient dairy cattle - Wang - 2008 - Journal of Animal Physiology and Animal Nutrition - Wiley Online Library	Wang	2009	0		
788	chr25	26715206	26715371	3500274037	40		26715206	26715371	8421504	2	20,20	0,145	c,g	350027403700000086,350027403700000086,350027403700000087	0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
788	chr25	26716704	26717003	3500031022	38		26716704	26717003	8421504	3	6,13,19	0,9,280	c,g	350003102200000060,350003102200000103	21-40,22-41						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
789	chr25	26792239	26792269	3500179706	30		26792239	26792269	8421504	1	30	0	c	350017970600000033	12-42						METHODS AND COMPOSITIONS FOR MODULATING T HELPER (Th) CELL DEVELOPMENT AND FUNCTION - Patent application	www.faqs.org	0	0		
791	chr25	27072069	27072095	3500236647	26		27072069	27072095	8421504	1	26	0	g	350023664700000027	12-38					Patent	Polyhydroxyalkanoate-containing structure and manufacturing method thereof (Patent US:6951745)	Honma	2005	0		
797	chr25	27802177	27802267	3500126543	90		27802177	27802267	8421504	1	90	0	p	350012654300015004	0-90						BIOK&#xc9;MIA GYAKORLATI JEGYZET	elte-biokemia.hu	0	0		ATP2A3
797	chr25	27802327	27802908	3500410102	150		27802327	27802908	8421504	2	2,148	0,433	p	350041010200015005	0-150						THE JOURNAL OF No. pp. by Biology, U.S.A. Nucleotide Sequences of Avian Cardiac and Brain SR/ER ATPases and Functional Comparisons with Fast Twitch Ca2+-ATPase	www.jbc.org	0	0		
797	chr25	27815266	27820601	3500110543	1306		27815266	27820601	8421504	12	21,50,15,31,174,53,175,92,102,22,549,22	0,120,291,312,454,832,2983,3269,3606,4633,4699,5313	p,c,g	350011054300000131,350011054300000029,350011054300000082,350011054300000077,350011054300000071,350011054300000069,350011054300000067,350011054300000060,350011054300015161,350011054300000051,350011054300000104,350011054300015160,350011054300000058,350011054300015159,350011054300000050,350011054300000103	0-21,0-21,0-50,5-56,0-54,0-60,0-60,0-53,0-372,0-22,0-22,0-243,2-480,0-306,0-22,0-22						&#x010c;ESK&#xc1; ZEM&#x011a;D&#x011a;LSK&#xc1; UNIVERZITA V PRAZE Fakulta agrobiologie, potravinov&#xfd;ch a p&#x0159;&#xed;rodn&#xed;ch zdroj&#x016f;	w.agrobiologie.cz	0	0		
797	chr25	27816112	27816140	3500050546	28		27816112	27816140	8421504	1	28	0	c	350005054600000011	5-33		19372237	10.1210/me.2009-0011	0888-8809	Molecular Endocrinology	Nucleocytoplasmic Shuttling of the Adapter Protein SH2B1&#x03b2; (SH2-B&#x03b2;) Is Required for Nerve Growth Factor (NGF)-Dependent Neurite Outgrowth and Enhancement of Expression of a Subset of NGF-Responsive Genes	Maures	2009	5		
797	chr25	27831734	27831809	3500435181	75		27831734	27831809	8421504	1	75	0	p	350043518100015005	48-123						Jolly Thesis 1993 | Alain Dautant - Academia.edu	www.academia.edu	0	0		TUFM
797	chr25	27831734	27831800	3500205889	66		27831734	27831800	8421504	1	66	0	p	350020588900015100	33-99						A Brief Introduction to Multiple Sequence Analysis through GCG s SeqLab	bio.fsu.edu	0	0		TUFM
797	chr25	27831743	27831800	3500450263	57		27831743	27831800	8421504	1	57	0	p	350045026300015041	0-57						Structure-function studies of human cytosolic thymidine kinase	rudar.ruc.dk	0	0		TUFM
797	chr25	27831743	27831800	3500149900	57		27831743	27831800	8421504	1	57	0	p	350014990000015041	0-57						Structure-function studies of human cytosolic thymidine kinase Ph.D. Thesis Dvora Berenstein Departm	diggy.ruc.dk:8080	0	0		TUFM
797	chr25	27831764	27831809	3500314216	45		27831764	27831809	8421504	1	45	0	p	350031421600015054	0-45						Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor - Patent application	www.faqs.org	0	0		TUFM
797	chr25	27831767	27831812	3500034363	45		27831767	27831812	8421504	1	45	0	p	350003436300015012	0-45						The mob of Escherichia co/i required	c.sgmjournals.org	0	0		TUFM
797	chr25	27833151	27833897	3500278051	42		27833151	27833897	8421504	3	21,3,18	0,601,728	c,g	350027805100000000,350027805100000000,350027805100000001	0-21,0-21,0-21					Patent	Method to inhibit ischemia and reperfusion injury (Patent US:7615548)	Gottlieb	2009	0		TUFM
797	chr25	27833151	27833897	3500199270	42		27833151	27833897	8421504	3	21,3,18	0,601,728	c,g	350019927000000000,350019927000000000,350019927000000001	0-21,0-21,0-21						Method to inhibit ischemia and reperfusion injury	Gottlieb	2005	0		TUFM
797	chr25	27833151	27833897	3500158337	42		27833151	27833897	8421504	3	21,3,18	0,601,728	c,g	350015833700000000,350015833700000000,350015833700000001	0-21,0-21,0-21						METHOD TO INHIBIT ISCHEMIA AND REPERFUSION INJURY - Patent application	www.faqs.org	0	0		TUFM
797	chr25	27833151	27833897	3500111475	42		27833151	27833897	8421504	3	21,3,18	0,601,728	c,g	350011147500000000,350011147500000000,350011147500000001	0-21,0-21,0-21						Method to inhibit ischemia and reperfusion injury	Gottlieb	2003	0		TUFM
797	chr25	27833151	27833897	3500091954	42		27833151	27833897	8421504	3	21,3,18	0,601,728	c,g	350009195400000000,350009195400000000,350009195400000001	0-21,0-21,0-21						Method to inhibit ischemia and reperfusion injury	Gottlieb	2004	0		TUFM
797	chr25	27872665	27872692	3500170547	24		27872665	27872692	8421504	3	7,4,13	0,8,14	c	350017054700000021	9-33						Methods of preventing or treating brain ischemia or brain injury - US Patent 7202211 Description	ww.patentstorm.us	0	0		
797	chr25	27872725	27873250	3500280352	249		27872725	27873250	8421504	4	51,88,66,44	0,146,322,481	p	350028035200015012	0-249							y.engin.umich.edu	0	0		EIF3C
797	chr25	27872725	27873250	3500051404	249		27872725	27873250	8421504	4	51,88,66,44	0,146,322,481	p	350005140400015011	0-249						README for stand-alone BLAST (last updated 7/30/99) This document provides information on s	io.lundberg.gu.se	0	0		EIF3C
798	chr25	27987215	27987239	3500415955	24		27987215	27987239	8421504	1	24	0	c	350041595500000027	0-24						Letter The Heparan and Heparin Metabolism Pathway is Involved in Regulation of Fatty Acid Composition	www.ijbs.com	0	0		
798	chr25	27988480	27989079	3500077888	41		27988480	27989079	8421504	3	16,4,21	0,531,578	c	350007788800000049,350007788800000048	0-20,0-21						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
798	chr25	27998463	27999641	3500232494	38		27998463	27999641	8421504	2	19,19	0,1159	c,g	350023249400000003,350023249400000003,350023249400000004,350023249400000004	0-19,0-19,0-19,0-19		9915840	10.1074/jbc.274.5.3017	0021-9258	Journal of Biological Chemistry	Isolation, Cloning, and Characterization of a New Mammalian Coronin Family Member, Coroninse, Which Is Regulated within the Protein Kinase C Signaling Pathway	John	1999	5		CORO1A
798	chr25	27998463	27999641	3500010171	38		27998463	27999641	8421504	2	19,19	0,1159	c,g	350001017100000003,350001017100000003,350001017100000004,350001017100000004	0-19,0-19,0-19,0-19		9915840	10.1074/jbc.274.5.3017	0021-9258	Journal of Biological Chemistry	Isolation, Cloning, and Characterization of a New Mammalian Coronin Family Member, Coroninse, Which Is Regulated within the Protein Kinase C Signaling Pathway	John	1999	5		
798	chr25	27999061	28000233	3500424556	42		27999061	28000233	8421504	3	17,5,20	0,110,1152	c	350042455600000003,350042455600000002	0-22,0-20		19438603	10.1111/j.1365-2249.2009.03930.x	1365-2249	Clinical & Experimental Immunology	Tryptophan aspartate-containing coat protein (CORO1A) suppresses Toll-like receptor signalling in Mycobacterium leprae infection - Tanigawa - 2009 - Clinical & Experimental Immunology - Wiley Online Library	Tanigawa	2009	0		
798	chr25	27999061	28000233	3500322563	42		27999061	28000233	8421504	3	17,5,20	0,110,1152	c	350032256300000001,350032256300000000	0-22,0-20			10.1267/ahc.06010		Acta Histochemica et Cytochemica	Localization of CORO1A in the Macrophages Containing Mycobacterium leprae	Koichi	2006	0		CORO1A
798	chr25	28043209	28043243	3500158873	34		28043209	28043243	8421504	1	34	0	c	350015887300000008	30-64						METHOD FOR EXTRACTING QUANTITATIVE INFORMATION RELATING TO AN INFLUENCE ON A CELLULAR RESPONSE - Patent application	www.faqs.org	0	0		
798	chr25	28046805	28046850	3500327859	45		28046805	28046850	8421504	1	45	0	p	350032785900015000	0-45						Investigating the contribution of FGF receptors in breast tumorigenesis using models of mammary cancer	edoc.unibas.ch	0	0		MAPK3
798	chr25	28048183	28048370	3500187288	96		28048183	28048370	8421504	2	63,33	0,154	p	350018728800015001	0-96		21270289	10.1099/vir.0.028936-0	0022-1317	Journal of General Virology	Severe acute respiratory syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated signalling pathways	Li	2011	3		MAPK3
798	chr25	28048195	28048352	3500192350	66		28048195	28048352	8421504	2	51,15	0,142	p	350019235000015004	0-66						Molecular cloning and expression analysis of the Mitogen-activating protein kinase 1 (MAPK1) gene and protein during ovarian development of the giant tiger shrimp Penaeus monodon. - ResearchGate	.researchgate.net	0	0		
799	chr25	28063036	28064762	3500010868	44		28063036	28064762	8421504	3	22,9,13	0,676,1713	c,g	350001086800000018,350001086800000018,350001086800000019	0-22,0-22,0-22		19561075	10.1074/jbc.M109.007864	0021-9258	Journal of Biological Chemistry	Smad6 Inhibits the Transcriptional Activity of Tbx6 by Mediating Its Degradation	Chen	2009	5		
799	chr25	28063076	28063100	3500288332	24		28063076	28063100	8421504	1	24	0	c	350028833200000006	0-24						Method for generating primate cardiovascular progenitor cells for clinical and drug cells testing use from primate embryonic stem cells or embryonic-like state cells, and their applications	Costecalde	2013	0		TBX6
799	chr25	28063076	28063100	3500230360	24		28063076	28063100	8421504	1	24	0	c	350023036000000032,350023036000000006	0-24,0-24						METHOD FOR GENERATING PRIMATE CARDIOVASCULAR PROGENITOR CELLS FOR CLINICAL USE FROM PRIMATE EMBRYONIC STEM CELLS OR EMBRYONIC-LIKE STATE CELLS, AND THEIR APPLICATIONS - Patent application	www.faqs.org	0	0		TBX6
799	chr25	28063076	28063100	3500229357	24		28063076	28063100	8421504	1	24	0	c	350022935700000006	0-24						Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications	Larghero	2009	0		
799	chr25	28066242	28066270	3500369161	23		28066242	28066270	8421504	2	5,18	0,10	c	350036916100000099	0-23						Methods and compositions for phenotype identification based on nucleic acid methylation	Den	2004	0		
799	chr25	28066242	28066270	3500313277	23		28066242	28066270	8421504	2	5,18	0,10	c	350031327700000095,350031327700000175	0-23,0-23						Methods and compositions for phenotype identification based on nucleic acid methylation - US Patent 7608394 Description	ww.patentstorm.us	0	0		
799	chr25	28077488	28079368	3500203086	40		28077488	28079368	8421504	2	20,20	0,1860	c	350020308600000003,350020308600000002	0-20,0-20						Method for inhibiting tumor angiogenesis and tumor growth	Chun	2004	0		ALDOA
799	chr25	28077488	28079368	3500019022	40		28077488	28079368	8421504	2	20,20	0,1860	c	350001902200000013,350001902200000012	0-20,0-20			10.1046/j.1432-1327.2000.01453.x	1432-1033	European Journal of Biochemistry	Cadmium blocks hypoxia-inducible factor (HIF)-1-mediated response to hypoxia by stimulating the proteasome-dependent degradation of HIF-1&#x03b1; - Chun - 2001 - European Journal of Biochemistry - Wiley Online Library	Chun	2000	0		ALDOA
799	chr25	28079334	28079359	3500266997	25		28079334	28079359	8421504	1	25	0	c	350026699700000043	0-25						NPG.nature.vol.413.Issue.6851.Sep	www.scribd.com	0	0		
799	chr25	28079405	28079428	3500268847	23		28079405	28079428	8421504	1	23	0	c	350026884700000003	23-46						Transcriptomic analysis of the challenged gut barrier	edepot.wur.nl	0	0		ALDOA
799	chr25	28079437	28079585	3500232266	63		28079437	28079585	8421504	2	47,16	0,132	p	350023226600015000	0-63		19287488	10.1371/journal.pone.0004908		PLoS ONE	Interaction of the Coronavirus Infectious Bronchitis Virus Membrane Protein with &#x03b2;-Actin and Its Implication in Virion Assembly and Budding	Jibin	2009	0		ALDOA
799	chr25	28135550	28135578	3500359370	24		28135550	28135578	8421504	2	17,7	0,21	c	350035937000000013	0-24		11283272	10.1128/MCB.21.8.2956-2966.2001	0270-7306	Molecular and Cellular Biology	Cyclin A Is a Mediator of p120 E4F -Dependent Cell Cycle Arrest in G1	Fajas	2001	6		
799	chr25	28170760	28170934	3500286492	66		28170760	28170934	8421504	2	45,21	0,153	c	350028649200000018,350028649200000033,350028649200000001	3-48,0-21,0-21						INDUCTION OF APOPTOSIS AND CELL GROWTH INHIBITION BY PROTEIN 4.33 - Patent application	www.faqs.org	0	0		
801	chr25	28417565	28417671	3500240306	24		28417565	28417671	8421504	2	1,23	0,83	c	350024030600000002	0-24			10.1124/jpet.301.2.705	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	P2Y13: Identification and Characterization of a Novel G&#x03b1;i-Coupled ADP Receptor from Human and Mouse	Zhang	2002	0		CD2BP2
801	chr25	28422434	28422795	3500174556	23		28422434	28422795	8421504	3	8,4,11	0,345,350	c	350017455600000003	0-23						A-type lamins are essential for TGF- 1 induced PP2A to dephosphorylate transcription factors	arno.unimaas.nl	0	0		
802	chr25	28455873	28455903	3500246273	26		28455873	28455903	8421504	3	5,8,13	0,7,17	c	350024627300000064	9-35						Methods and compositions for treatment of diabetes and related disorders	Newgard	2007	0		
802	chr25	28486979	28487006	3500359363	23		28486979	28487006	8421504	2	17,6	0,21	c	350035936300000288	8-34						Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments 	.freshpatents.com	0	0		
802	chr25	28486979	28487006	3500054041	23		28486979	28487006	8421504	2	17,6	0,21	c	350005404100000289	8-34						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2012	0		
100	chr25	28530512	28578870	3500171178	3422		28530512	28578870	8421504	31	55,103,92,68,118,131,146,133,151,74,59,153,138,198,131,161,152,90,57,74,142,111,80,87,76,111,57,99,96,111,168	0,1753,2581,2775,8984,9226,10098,12039,12331,17547,17701,25749,27753,28552,28893,32397,32647,35456,38479,38630,39223,41486,41998,42183,43787,45394,45753,45905,46648,47588,48190	p	350017117800015025,350017117800015036,350017117800015037,350017117800015035,350017117800015047,350017117800015046,350017117800015045,350017117800015055,350017117800015056,350017117800015057,350017117800015065,350017117800015075,350017117800015085,350017117800015095,350017117800015096	0-441,0-447,0-447,0-447,0-450,0-450,0-450,0-450,3-450,3-450,0-450,0-450,0-444,0-363,0-363						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
802	chr25	28558354	28572094	3500451153	48		28558354	28572094	8421504	3	25,8,15	0,13716,13725	c	350045115300000001,350045115300000000	0-25,0-23			10.1186/1746-6148-1-4	1746-6148	BMC Veterinary Research	Molecular characterisation of the caprine (Capra hircus) lymphocyte function-associated antigen-1 alpha subunit-encoding cDNA	Fett	2005	2		
802	chr25	28562974	28562997	3500467548	23		28562974	28562997	8421504	1	23	0	c,g	350046754800000002,350046754800000002	21-44,21-44						Effects of Lipopolysaccharide and Mannheimia haemolytica Leukotoxin on Bovine Lung Microvascular Endothelial Cells and Alveolar Epithelial Cells	cvi.asm.org	0	0		
803	chr25	28659390	28659415	3500239371	23		28659390	28659415	8421504	2	7,16	0,9	g	350023937100000004	4-34						Transglutaminase gene of Streptoverticillium ladakanum and the transglutaminase encoded therefrom - US Patent 6660510 Description	ww.patentstorm.us	0	0		
803	chr25	28679415	28679478	3500228395	63		28679415	28679478	8421504	1	63	0	p	350022839500015136	66-129						<Html><Title> Complet list of 1hxt hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
803	chr25	28679426	28679474	3500120381	48		28679426	28679474	8421504	1	48	0	p	350012038100015105	162-210						<Html><Title> Complet list of 1mpf hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		FAM157B
803	chr25	28679430	28679478	3500108068	48		28679430	28679478	8421504	1	48	0	p	350010806800015137	72-120						Protein amf-1 to amf-10 and nucleic acids encoding the same	Burgess	2001	0		
803	chr25	28679442	28679668	3500321541	39		28679442	28679668	8421504	2	30,9	0,217	c	350032154100000004,350032154100000005	0-30,0-36						Co-expression of Ubiquitin gene and capsid protein gene enhances the potency of DNA immunization of PCV2 in mice - Springer	link.springer.com	0	0		
804	chr25	28771199	28771227	3500304335	23		28771199	28771227	8421504	2	16,7	0,21	c	350030433500000041,350030433500000608	14-37,2-25						Diagnosis and Treatment of Cancer Using Anti-EREG Antibody - Patent application	www.faqs.org	0	0		
804	chr25	28789361	28789406	3500363643	45		28789361	28789406	8421504	1	45	0	p	350036364300015147	0-45						Host Cell Protein Knock-Out Cells for Production of Therapeutic Proteins - Patent application	www.faqs.org	0	0		ZNF629
804	chr25	28789361	28789406	3500065053	45		28789361	28789406	8421504	1	45	0	p	350006505300015148	0-45						HOST CELL PROTEIN KNOCK-OUT CELLS FOR PRODUCTION OF THERAPEUTIC PROTEINS - Patent application	www.faqs.org	0	0		ZNF629
804	chr25	28789364	28789409	3500219065	45		28789364	28789409	8421504	1	45	0	p	350021906500015002	0-45						Methods and compositions for using zinc finger endonucleases to enhance homologous recombination - Patent application	www.faqs.org	0	0		ZNF629
804	chr25	28789364	28789409	3500188424	45		28789364	28789409	8421504	1	45	0	p	350018842400015002	0-45						Methods and compositions for using zinc finger endonucleases to enhance homologous recombination - Patent application	www.faqs.org	0	0		ZNF629
804	chr25	28789622	28790186	3500396461	54		28789622	28790186	8421504	2	33,21	0,543	p	350039646100015010	0-54						Artificial transcription factors	Iii	2006	0		ZNF629
804	chr25	28789622	28790186	3500382876	54		28789622	28790186	8421504	2	33,21	0,543	p	350038287600015010	0-54						Artificial transcription factors	Iii	2003	0		ZNF263
804	chr25	28789622	28790186	3500171197	54		28789622	28790186	8421504	2	33,21	0,543	p	350017119700015010	0-54						Artificial transcription factors	Iii	2005	0		ZNF263
805	chr25	28953707	28957718	3500036684	365		28953707	28957718	8421504	7	47,96,27,95,29,47,24	0,96,3450,3519,3718,3891,3987	c	350003668400000340,350003668400000342,350003668400000343,350003668400000531,350003668400000348,350003668400000349,350003668400000333,350003668400000352,350003668400000356,350003668400000358	0-47,0-48,0-48,0-27,0-48,0-47,9-29,19-48,0-47,0-24						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
806	chr25	28970682	28970838	3500389144	25		28970682	28970838	8421504	2	4,21	0,135	c	350038914400000034	0-34						Nucleotide sequences and process for amplifying and detection of hepatitis b virus	Spies	1995	0		
806	chr25	28970682	28970838	3500326753	25		28970682	28970838	8421504	2	4,21	0,135	c	350032675300000034	0-34						Nucleotide sequences and process for amplifying and detection of hepatitis b virus	Spies	1997	0		
806	chr25	28987213	28987891	3500428930	138		28987213	28987891	8421504	3	16,23,99	0,520,579	p	350042893000015071	0-174						50 human secreted proteins	George	2000	0		HSD3B7
806	chr25	28987213	28987891	3500102686	138		28987213	28987891	8421504	3	16,23,99	0,520,579	p	350010268600015071	0-174						50 human secreted proteins	Komatsoulis	2002	0		HSD3B7
806	chr25	28987213	28987891	3500000709	138		28987213	28987891	8421504	3	16,23,99	0,520,579	p	350000070900015071	0-174						50 human secreted proteins	Komatsoulis	2002	0		HSD3B7
806	chr25	28992510	28998939	3500176290	453		28992510	28998939	8421504	13	45,33,48,45,39,6,45,30,27,8,37,45,45	0,60,184,235,283,2182,2464,2512,2920,2986,5895,6084,6384	p	350017629000015243,350017629000015224,350017629000015241,350017629000015240,350017629000015239,350017629000015236,350017629000015235,350017629000015216,350017629000015233,350017629000015231,350017629000015229	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Protein involved in abscisic acid signalling	Blatt	2000	0		STX1A
806	chr25	28992814	28994697	3500247381	23		28992814	28994697	8421504	2	18,5	0,1878	c	350024738100000001	0-23		20186959	10.1002/ar.21106	1932-8494	The Anatomical Record	Immunohistochemical Localization of SNARE Proteins in Dental Pulp and Periodontal Ligament of the Rat Incisor - Honma - 2010 - The Anatomical Record - Wiley Online Library	Honma	2010	0		
806	chr25	29028411	29028436	3500318073	23		29028411	29028436	8421504	2	8,15	0,10	c	350031807300000020	2-25						RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK - Patent application	www.faqs.org	0	0		
806	chr25	29053864	29053890	3500097499	23		29053864	29053890	8421504	2	5,18	0,8	g	350009749900000004	4-27						EvD VERANDERING 2011 08 23	upetd.up.ac.za	0	0		
806	chr25	29081179	29081316	3500339239	48		29081179	29081316	8421504	2	29,19	0,118	p	350033923900015094	0-48						Plant pyruvate dehydrogenase kinase gene	Zou	2002	0		BCKDK
806	chr25	29081179	29081316	3500057447	48		29081179	29081316	8421504	2	29,19	0,118	p	350005744700015095	0-48						Plant pyruvate dehydrogenase kinase gene	www.devileye.net	0	0		BCKDK
806	chr25	29081989	29082353	3500455909	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350045590900000164,350045590900000164,350045590900000165	0-19,0-19,0-20						Methods for the diagnosis of fetal abnormalities	Kapur	2011	0		BCKDK
806	chr25	29081989	29082353	3500455233	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350045523300000059,350045523300000059,350045523300000060	0-19,0-19,0-20					Patent	Rare cell analysis using sample splitting and DNA tags (Patent US:8372584)	Shoemaker	2013	0		BCKDK
806	chr25	29081989	29082353	3500428698	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350042869800000153,350042869800000153,350042869800000154	0-19,0-19,0-20						Methods For The Diagnosis Of Fetal Abnormalities	Kapur	2011	0		BCKDK
806	chr25	29081989	29082353	3500421222	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350042122200000109,350042122200000109,350042122200000110	0-19,0-19,0-20						 Methods For The Diagnosis Of Fetal Abnormalities 	www.docstoc.com	0	0		BCKDK
806	chr25	29081989	29082353	3500403393	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350040339300000052,350040339300000052,350040339300000053	0-19,0-19,0-20						Devices and methods for enrichment and alteration of circulating tumor cells and other particles	Fuchs	2005	0		BCKDK
806	chr25	29081989	29082353	3500380244	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350038024400000059,350038024400000059,350038024400000103,350038024400000103,350038024400000104,350038024400000060	0-19,0-19,0-19,0-19,0-20,0-20						RARE CELL ANALYSIS USING SAMPLE SPLITTING AND DNA TAGS - Patent application	www.faqs.org	0	0		BCKDK
806	chr25	29081989	29082353	3500371836	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350037183600000066,350037183600000066,350037183600000067	0-19,0-19,0-20						Devices and method for detecting circulating tumor cells and other particles	Fuchs	2013	0		BCKDK
806	chr25	29081989	29082353	3500370275	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350037027500000164,350037027500000164,350037027500000165	0-19,0-19,0-20						Methods for the diagnosis of fetal abnormalities	Kapur	2011	0		BCKDK
806	chr25	29081989	29082353	3500343977	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350034397700000118,350034397700000118,350034397700000119	0-19,0-19,0-20						Methods for the Diagnosis of Fetal Abnormalities	Kapur	2007	0		BCKDK
806	chr25	29081989	29082353	3500307957	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350030795700000052,350030795700000052,350030795700000053	0-19,0-19,0-20						Devices and methods for enrichment and alteration of circulating tumor cells and other particles	Fuchs	2005	0		BCKDK
806	chr25	29081989	29082353	3500259498	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350025949800000095,350025949800000095,350025949800000096	0-19,0-19,0-20						DEVICES AND METHODS FOR ENRICHMENT AND ALTERATION OF CIRCULATING TUMOR CELLS AND OTHER PARTICLES - Patent application	www.faqs.org	0	0		BCKDK
806	chr25	29081989	29082353	3500248841	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350024884100000164,350024884100000164,350024884100000165	0-19,0-19,0-20						Methods for the diagnosis of fetal abnormalities	Kapur	2013	0		BCKDK
806	chr25	29081989	29082353	3500243705	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350024370500000043,350024370500000043,350024370500000087,350024370500000087,350024370500000044,350024370500000088	0-19,0-19,0-19,0-19,0-20,0-20						Devices And Methods For Enrichment And Alteration Of Circulating Tumor Cells And Other Particles 	.freshpatents.com	0	0		BCKDK
806	chr25	29081989	29082353	3500212956	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350021295600000118,350021295600000118,350021295600000119	0-19,0-19,0-20					Patent	Methods for the diagnosis of fetal abnormalities (Patent US:8137912)	Davis	2012	0		BCKDK
806	chr25	29081989	29082353	3500138952	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350013895200000043,350013895200000043,350013895200000087,350013895200000087,350013895200000044,350013895200000088	0-19,0-19,0-19,0-19,0-20,0-20						Devices And Methods For Enrichment And Alteration Of Circulating Tumor Cells And Other Particles 	.freshpatents.com	0	0		BCKDK
806	chr25	29081989	29082353	3500126592	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350012659200000103,350012659200000103,350012659200000059,350012659200000059,350012659200000104,350012659200000060	0-19,0-19,0-19,0-19,0-20,0-20						Rare cell analysis using sample splitting and DNA tags - Patent application	www.faqs.org	0	0		BCKDK
806	chr25	29081989	29082353	3500120364	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350012036400000103,350012036400000103,350012036400000059,350012036400000059,350012036400000060,350012036400000104	0-19,0-19,0-19,0-19,0-20,0-20						Rare Cell Analysis Using Sample Splitting And DNA Tags - Patent application	www.faqs.org	0	0		BCKDK
806	chr25	29081989	29082353	3500092730	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350009273000000043,350009273000000043,350009273000000087,350009273000000087,350009273000000044,350009273000000088	0-19,0-19,0-19,0-19,0-20,0-20						Devices And Methods For Enrichment And Alteration Of Circulating Tumor Cells And Other Particles 	.freshpatents.com	0	0		BCKDK
806	chr25	29081989	29082353	3500084564	39		29081989	29082353	8421504	2	19,20	0,344	c,g	350008456400000052,350008456400000052,350008456400000053	0-19,0-19,0-20						Devices and methods for enrichment and alteration of circulating tumor cells and other particles	Fuchs	2005	0		BCKDK
806	chr25	29086724	29090843	3500359260	267		29086724	29090843	8421504	3	66,54,147	0,3819,3972	p	350035926000015001	0-267						<HTML> <HEAD> </HEAD> <BODY> <FONT FACE="Sabon"><H1><P ALIGN="CENTER"> V22.0480.002 <P ALIGN="CENTE	www.settheory.com	0	0		KAT8
807	chr25	29136693	29136718	3500287481	23		29136693	29136718	8421504	2	5,18	0,7	c	350028748100000004	4-27		10523652		0270-7306	Molecular and Cellular Biology	Dual Transforming Activities of the FUS (TLS)-ERG Leukemia Fusion Protein Conferred by Two N-Terminal Domains of FUS (TLS)	Ichikawa	1999	6		
807	chr25	29140423	29142022	3500463381	45		29140423	29142022	8421504	3	1,23,21	0,569,1578	c,g	350046338100000004,350046338100000005,350046338100000005	20-44,0-21,0-21							odegeneration.com	0	0		
807	chr25	29140423	29142022	3500277798	45		29140423	29142022	8421504	3	1,23,21	0,569,1578	c	350027779800000004,350027779800000005	20-44,0-21						Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics	odegeneration.com	0	0		
807	chr25	29140423	29142022	3500007434	45		29140423	29142022	8421504	3	1,23,21	0,569,1578	c	350000743400000004,350000743400000005	20-44,0-21						Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics	biomedcentral.com	0	0		
807	chr25	29141996	29142021	3500243562	25		29141996	29142021	8421504	1	25	0	c	350024356200000006	23-48						The dual role of dexamethasone on anti-inflammation and outflow resistance demonstrated in cultured human trabecular meshwork cells	www.molvis.org	0	0		FUS
807	chr25	29194816	29194846	3500234760	26		29194816	29194846	8421504	2	10,16	0,14	g	350023476000000045	9-35						SACCHAROMYCES STRAIN WITH ABILITY TO GROW ON PENTOSE SUGARS UNDER ANAEROBIC CULTIVATION CONDITIONS - Patent application	www.faqs.org	0	0		
808	chr25	29320109	29341161	3500349145	417		29320109	29341161	8421504	16	32,28,34,21,5,21,26,39,65,25,26,20,21,26,12,16	0,4654,6850,7509,7556,9030,9106,9843,9915,12597,15737,18330,18560,20801,20867,21036	c,g	350034914500000510,350034914500000515,350034914500000090,350034914500000621,350034914500000265,350034914500000342,350034914500000344,350034914500000558,350034914500000559,350034914500000105,350034914500000569,350034914500000569,350034914500000114,350034914500000114,350034914500000577,350034914500000578,350034914500000578,350034914500000126,350034914500000129,350034914500000584,350034914500000584,350034914500000379	16-48,20-48,13-47,26-47,22-48,28-48,13-39,3-42,27-48,0-47,21-46,21-46,24-48,24-48,0-26,22-42,22-42,0-21,0-26,0-23,0-23,15-43						Novel Human Beta-2 Integrin Alpha Subunit 	.freshpatents.com	0	0		
808	chr25	29324763	29341161	3500247922	326		29324763	29341161	8421504	13	28,19,26,33,12,36,47,25,26,20,26,12,16	0,2855,4452,4714,4763,4933,5279,7943,11083,13676,16147,16213,16382	c	350024792200000513,350024792200000620,350024792200000346,350024792200000092,350024792200000093,350024792200000099,350024792200000108,350024792200000566,350024792200000574,350024792200000575,350024792200000123,350024792200000581,350024792200000380	20-48,29-48,13-39,0-33,0-48,0-47,24-48,21-46,0-26,22-42,0-26,0-23,15-43						Human B2 integrin alpha subunit antibodies	Gallatin	1996	0		
808	chr25	29324763	29338459	3500189016	95		29324763	29338459	8421504	3	28,47,20	0,5279,13676	c	350018901600000515,350018901600000105,350018901600000578	20-48,0-47,22-42						Methods of inhibiting locomotor damage following spinal cord injury with &#x03b1; D-specific antibodies	Gallatin	2000	0		
808	chr25	29344188	29344776	3500414143	343		29344188	29344776	8421504	4	116,137,75,15	0,213,496,573	p,c,g	350041414300000012,350041414300000017,350041414300015022,350041414300015025,350041414300015005,350041414300015019,350041414300015018,350041414300015024,350041414300015003,350041414300015014,350041414300000000	0-662,0-344,0-72,0-141,0-129,0-54,0-51,0-90,0-87,0-72,0-23						Deletion der Untereinheit VIa der Cytochrom c Oxidase in Hefe und heterologe Expression des entsprechenden Rindergens sowie Charakterisierung der Mutanten	ub.uni-marburg.de	0	0		
809	chr25	29378393	29387903	3500461549	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350046154900000000,350046154900000000,350046154900000004,350046154900000004,350046154900000003,350046154900000001,350046154900000007,350046154900000005	0-20,0-20,0-20,0-20,9-29,0-20,9-29,0-20						GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND USE THEREOF IN MEDICINES - Patent application	www.faqs.org	0	0		SLC5A2
809	chr25	29378393	29387903	3500451991	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350045199100000000,350045199100000000,350045199100000004,350045199100000004,350045199100000003,350045199100000001,350045199100000007,350045199100000005	0-20,0-20,0-20,0-20,9-29,0-20,9-29,0-20						Glucopyranosyloxypyrazole Derivatives And Medicinal Use Thereof 	.freshpatents.com	0	0		SLC5A2
809	chr25	29378393	29387903	3500448627	40		29378393	29387903	8421504	2	20,20	0,9490	c	350044862700000000,350044862700000001,350044862700000003	0-20,0-20,9-29					Patent	Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof (Patent US:7053060)	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500447276	40		29378393	29387903	8421504	2	20,20	0,9490	c	350044727600000000,350044727600000003,350044727600000001	0-20,9-29,0-20						Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives	Fujikura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500432554	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350043255400000001,350043255400000001,350043255400000005,350043255400000007,350043255400000002	0-20,0-20,0-20,9-29,0-20					Patent	Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor (Patent CN:100376592)	Yi Zuo Zhi Zheng Xing 	2008	0		SLC5A2
809	chr25	29378393	29387903	3500422876	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350042287600000000,350042287600000000,350042287600000001,350042287600000003	0-20,0-20,0-20,9-29					Patent	Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof (Patent US:7129381)	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500366723	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350036672300000000,350036672300000000,350036672300000002,350036672300000001,350036672300000003	0-20,0-20,9-29,0-20,9-29						Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof	Fujikura	2005	0		
809	chr25	29378393	29387903	3500357437	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350035743700000000,350035743700000000,350035743700000001,350035743700000003	0-20,0-20,0-20,9-29					Patent	Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives (Patent US:7465712)	Fujikura	2008	0		SLC5A2
809	chr25	29378393	29387903	3500353334	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350035333400000000,350035333400000000,350035333400000001,350035333400000003	0-20,0-20,0-20,9-29						Glucopyranosyloxypyrazole derivatives and use thereof in medicines	Fujikura	2008	0		SLC5A2
809	chr25	29378393	29387903	3500351061	40		29378393	29387903	8421504	2	20,20	0,9490	c	350035106100000000,350035106100000003,350035106100000001	0-20,9-29,0-20						Glucopyranosyloxypyrazole derivatives and use thereof in medicines	Fujikura	2003	0		SLC5A2
809	chr25	29378393	29387903	3500347469	40		29378393	29387903	8421504	2	20,20	0,9490	c	350034746900000000,350034746900000001,350034746900000003	0-20,0-20,9-29					Patent	Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives (Patent US:7045665)	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500341137	40		29378393	29387903	8421504	2	20,20	0,9490	c	350034113700000000,350034113700000003,350034113700000001	0-20,9-29,0-20					Patent	Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives (Patent US:7465712)	Fujikura	2008	0		SLC5A2
809	chr25	29378393	29387903	3500339893	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350033989300000000,350033989300000000,350033989300000003,350033989300000001	0-20,0-20,9-29,0-20						Glucopyranosyloxypyrazole derivatives and use thereof in medicines	Fujikura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500310562	40		29378393	29387903	8421504	2	20,20	0,9490	c	350031056200000000,350031056200000003,350031056200000001	0-20,9-29,0-20					Patent	Glucopyranosyloxypyrazole derivatives and medicinal use thereof (Patent US:7294618)	Fushimi	2007	0		SLC5A2
809	chr25	29378393	29387903	3500302939	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350030293900000000,350030293900000000,350030293900000001,350030293900000003	0-20,0-20,0-20,9-29					Patent	Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof (Patent US:7115575)	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500301824	40		29378393	29387903	8421504	2	20,20	0,9490	c	350030182400000000,350030182400000003,350030182400000001	0-20,9-29,0-20						Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof	Fujikura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500298673	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350029867300000000,350029867300000000,350029867300000001,350029867300000003,350029867300000004,350029867300000006	0-20,0-20,0-20,9-29,0-20,9-29						 Glucopyranosyloxybenzylbenzene Derivatives, Medicinal Compositions Containing The Same And Intermediates In The Production Thereof 	www.docstoc.com	0	0		SLC5A2
809	chr25	29378393	29387903	3500296844	40		29378393	29387903	8421504	2	20,20	0,9490	c	350029684400000000,350029684400000003,350029684400000001	0-20,9-29,0-20						Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof	Fujikura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500289248	40		29378393	29387903	8421504	2	20,20	0,9490	c	350028924800000000,350028924800000001,350028924800000003	0-20,0-20,9-29						Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof	Fujikura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500286850	40		29378393	29387903	8421504	2	20,20	0,9490	c	350028685000000000,350028685000000001,350028685000000003	0-20,0-20,9-29						Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof	Fujikura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500257097	40		29378393	29387903	8421504	2	20,20	0,9490	c	350025709700000000,350025709700000001,350025709700000003	0-20,0-20,9-29					Patent	Nitrogenous heterocyclic derivatives, medicinal compositions containing the same, medicinal uses thereof, and intermediates therefor (Patent US:7271153)	Nishimura	2007	0		SLC5A2
809	chr25	29378393	29387903	3500256458	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350025645800000000,350025645800000000,350025645800000001,350025645800000003	0-20,0-20,0-20,9-29						Nitrogenous heterocyclic derivative, medicinal composition containing the same, medical use thereof, and intermediate therefor	Nishimura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500248226	40		29378393	29387903	8421504	2	20,20	0,9490	c	350024822600000001,350024822600000004,350024822600000002	0-20,9-29,0-20					Patent	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same (Patent CN:1293087)	Teng Cang Xiu Ji 	2007	0		SLC5A2
809	chr25	29378393	29387903	3500246484	40		29378393	29387903	8421504	2	20,20	0,9490	c	350024648400000000,350024648400000003,350024648400000001	0-20,9-29,0-20					Patent	Crystals of glucopyranosyloxybenzyl benzene derivative (Patent US:7371730)	Isaji	2008	0		SLC5A2
809	chr25	29378393	29387903	3500240876	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350024087600000002,350024087600000002,350024087600000008,350024087600000004	0-20,0-20,9-29,0-20					Patent	Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung Glukopyranosyloxybenzylbenzolderivate and their medical use (Patent DE:60208351)	FUJIKURA	2006	0		SLC5A2
809	chr25	29378393	29387903	3500224216	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350022421600000000,350022421600000000,350022421600000001,350022421600000003	0-20,0-20,0-20,9-29					Patent	Glucopyranosyloxypyrazole derivatives and medicinal use thereof (Patent US:7087579)	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500210792	40		29378393	29387903	8421504	2	20,20	0,9490	c	350021079200000005,350021079200000001,350021079200000007,350021079200000011,350021079200000004,350021079200000002	0-20,0-20,0-20,9-29,9-29,0-20						Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor	Xi Cun Jun Yang 	2004	0		SLC5A2
809	chr25	29378393	29387903	3500150660	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350015066000000000,350015066000000000,350015066000000001,350015066000000003	0-20,0-20,0-20,9-29					Patent	Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof (Patent US:7541341)	Fujikura	2009	0		SLC5A2
809	chr25	29378393	29387903	3500131076	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350013107600000002,350013107600000000,350013107600000000,350013107600000003,350013107600000001	9-29,0-20,0-20,9-29,0-20						Crystals of glucopyranosyloxybenzyl benzene derivative	Isaji	2005	0		
809	chr25	29378393	29387903	3500121307	40		29378393	29387903	8421504	2	20,20	0,9490	c	350012130700000000,350012130700000001,350012130700000003	0-20,0-20,9-29						Glucopyranosyloxypyrazole derivatives and medicinal use thereof	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500101072	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350010107200000000,350010107200000000,350010107200000001,350010107200000003	0-20,0-20,0-20,9-29					Patent	Glycopyranosyloxypyrazole derivatives and medicinal use thereof (Patent EP:1364957)	Fujikura	2008	0		SLC5A2
809	chr25	29378393	29387903	3500081291	40		29378393	29387903	8421504	2	20,20	0,9490	c	350008129100000000,350008129100000001,350008129100000003	0-20,0-20,9-29						Glucopyranosyloxypyrazole derivatives and use thereof in medicines	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500079633	40		29378393	29387903	8421504	2	20,20	0,9490	c	350007963300000000,350007963300000003,350007963300000001	0-20,9-29,0-20					Patent	Glucopyranosyloxypyrazole derivatives and use thereof in medicines (Patent US:7429568)	Fujikura	2008	0		SLC5A2
809	chr25	29378393	29387903	3500053349	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350005334900000000,350005334900000000,350005334900000001,350005334900000003	0-20,0-20,0-20,9-29					Patent	Glucopyranosyloxypyrazole derivatives and use thereof in medicines (Patent US:7465713)	Fujikura	2008	0		SLC5A2
809	chr25	29378393	29387903	3500051858	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350005185800000000,350005185800000000,350005185800000003,350005185800000001	0-20,0-20,9-29,0-20					Patent	Glucopyranosyloxypyrazole derivatives and use thereof in medicines (Patent US:7393838)	Fujikura	2008	0		SLC5A2
809	chr25	29378393	29387903	3500048445	40		29378393	29387903	8421504	2	20,20	0,9490	c	350004844500000000,350004844500000003,350004844500000001	0-20,9-29,0-20						Glucopyranosyloxyprazole derivatives and use thereof in medicines	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500048371	40		29378393	29387903	8421504	2	20,20	0,9490	c	350004837100000000,350004837100000001,350004837100000003	0-20,0-20,9-29					Patent	Glucopyranosyloxypyrazole derivatives and use thereof in medicines (Patent US:7989424)	Fujikura	2011	0		SLC5A2
809	chr25	29378393	29387903	3500036782	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350003678200000000,350003678200000000,350003678200000003,350003678200000001	0-20,0-20,9-29,0-20						Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof	Fujikura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500033931	40		29378393	29387903	8421504	2	20,20	0,9490	c	350003393100000000,350003393100000001,350003393100000003	0-20,0-20,9-29					Patent	Glucopyranosyloxypyrazole derivatives and use thereof in medicines (Patent US:7084123)	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500031323	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350003132300000000,350003132300000000,350003132300000001,350003132300000003	0-20,0-20,0-20,9-29						Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same	Fujikura	2005	0		SLC5A2
809	chr25	29378393	29387903	3500028391	40		29378393	29387903	8421504	2	20,20	0,9490	c	350002839100000000,350002839100000001,350002839100000003	0-20,0-20,9-29					Patent	Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof (Patent US:7056892)	Fujikura	2006	0		SLC5A2
809	chr25	29378393	29387903	3500016775	40		29378393	29387903	8421504	2	20,20	0,9490	c,g	350001677500000000,350001677500000000,350001677500000003,350001677500000001	0-20,0-20,9-29,0-20						Glucopyranosyloxypyrazole derivatives and medicinal use thereof	Nishimura	2006	0		SLC5A2
809	chr25	29378393	29378416	3500455110	23		29378393	29378416	8421504	1	23	0	c	350045511000000002	11-34						Benzylphenyl glucopyranoside derivative	Abe	2009	0		
809	chr25	29379091	29386079	3500164699	252		29379091	29386079	8421504	6	48,62,27,47,48,20	0,124,4621,5533,6915,6968	p,c	350016469900015048,350016469900000277,350016469900000278,350016469900000332,350016469900000335,350016469900000297,350016469900000207,350016469900000061	0-45,5-48,0-35,0-27,0-47,0-48,0-20,0-20						MODULATION OF SGLT2 EXPRESSION - Patent application	www.faqs.org	0	0		
809	chr25	29385840	29386543	3500013832	172		29385840	29386543	8421504	6	31,17,22,60,6,36	0,158,287,421,584,667	c	350001383200000024,350001383200000027,350001383200000030	0-48,13-116,6-48						Nucleoside cotransporter protein cDNA	Wright	1992	0		SLC5A2
809	chr25	29387911	29387934	3500119526	23		29387911	29387934	8421504	1	23	0	c	350011952600000013	0-23						Authors: Chu Yan CHAN1,2, Jeremy A. GUGGENHEIM1, Chi Ho TO2	ll.physiology.org	0	0		
810	chr25	29561810	29561833	3500079392	23		29561810	29561833	8421504	1	23	0	c	350007939200000002	0-23		22783543	10.3389/fonc.2012.00065		Frontiers in Oncology	Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer	Jay	2012	0		
810	chr25	29565072	29565096	3500004670	24		29565072	29565096	8421504	1	24	0	c,g	350000467000000007,350000467000000007	0-24,0-24						Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. - ResearchGate	.researchgate.net	0	0		PSPH
810	chr25	29596989	29597013	3500236407	24		29596989	29597013	8421504	1	24	0	c	350023640700000167	18-42						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2001	0		
810	chr25	29599576	29599624	3500178142	48		29599576	29599624	8421504	1	48	0	p	350017814200015038	0-48						TaiLieu.VN: b&#xe1;o c&#xe1;o khoa h&#x1ecd;c: "Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells" 	tailieu.vn/doc/ba	0	0		CCT6A
810	chr25	29613571	29614122	3500389626	153		29613571	29614122	8421504	3	75,63,15	0,120,536	p	350038962600015007,350038962600015008	0-75,0-78						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		PHKG1
810	chr25	29613571	29614122	3500061337	123		29613571	29614122	8421504	3	75,33,15	0,150,536	p	350006133700015018,350006133700015137,350006133700015139	0-75,0-48,0-48						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		
811	chr25	29720120	29721595	3500418973	123		29720120	29721595	8421504	3	54,30,39	0,1301,1436	p	350041897300015109,350041897300015107,350041897300015123	0-54,0-69,0-63						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		ASL
811	chr25	29721604	29721922	3500431828	51		29721604	29721922	8421504	2	9,42	0,276	p	350043182800015001	6-57		19818875	10.1016/j.vph.2009.09.005		Vascular pharmacology	Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow	Shruti	2009	0		ASL
813	chr25	29927612	29973177	3500448596	49		29927612	29973177	8421504	3	17,6,26	0,45502,45539	c	350044859600000031,350044859600000032	0-23,0-26						METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES	Brys	2011	0		TPST1
813	chr25	29927612	29973177	3500399289	49		29927612	29973177	8421504	3	17,6,26	0,45502,45539	c	350039928900000031,350039928900000032	0-23,0-26						Methods For Identification, and Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases	Brys	2009	0		TPST1
813	chr25	29927612	29973177	3500235187	49		29927612	29973177	8421504	3	17,6,26	0,45502,45539	c	350023518700000031,350023518700000032	0-23,0-26					Patent	Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases (Patent US:7306923)	Brys	2007	0		TPST1
813	chr25	29927612	29973177	3500149044	49		29927612	29973177	8421504	3	17,6,26	0,45502,45539	c	350014904400000031,350014904400000032	0-23,0-26					Patent	Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases (Patent US:7919259)	Brys	2011	0		TPST1
814	chr25	30025409	30025434	3500305818	23		30025409	30025434	8421504	2	7,16	0,9	c	350030581800000026	23-46						RECOMBINANT SUPER-COMPOUND INTERFERON - Patent application	www.faqs.org	0	0		
814	chr25	30025409	30025434	3500276790	23		30025409	30025434	8421504	2	7,16	0,9	c	350027679000000026	23-46						RECOMBINANT SUPER-COMPOUND INTERFERON - Patent application	www.faqs.org	0	0		
814	chr25	30025409	30025434	3500138099	23		30025409	30025434	8421504	2	7,16	0,9	c	350013809900000026	23-46						RECOMBINANT SUPER-COMPOUND INTERFERON AND USES THEREOF - Patent application	www.faqs.org	0	0		
814	chr25	30025409	30025434	3500073015	23		30025409	30025434	8421504	2	7,16	0,9	c	350007301500000026	23-46						USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE - Patent application	www.faqs.org	0	0		
814	chr25	30025409	30025434	3500041968	23		30025409	30025434	8421504	2	7,16	0,9	c	350004196800000026	23-46						USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE - Patent application	www.faqs.org	0	0		
816	chr25	30386138	30386161	3500374909	23		30386138	30386161	8421504	1	23	0	g	350037490900000532	16-39						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
822	chr25	31087039	31087069	3500400080	24		31087039	31087069	8421504	3	4,6,14	0,5,16	g	350040008000000014	0-25						Methods and Nucleic Acids for Analyses of Colorectal Cell Proliferative Disorders	Lofton-Day	2008	0		
822	chr25	31087039	31087069	3500224267	24		31087039	31087069	8421504	3	4,6,14	0,5,16	g	350022426700000014	0-25						Methods And Nucleic Acids For Analyses Of Colorectal Cell Proliferative Disorders 	.freshpatents.com	0	0		
825	chr25	31567336	31567362	3500429312	23		31567336	31567362	8421504	2	6,17	0,9	g	350042931200000007	25-48					Patent	Linker and linked fusion polypeptides (Patent US:5990275)	Filpula	1999	0		
827	chr25	31719473	31719498	3500269449	23		31719473	31719498	8421504	2	5,18	0,7	g	350026944900000019	13-36						Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases - Patent application	www.faqs.org	0	0		
828	chr25	31916660	31916688	3500275484	23		31916660	31916688	8421504	2	10,13	0,15	g	350027548400000001	0-23						Molecular Motor KIF1C Is Not Essential for Mouse Survival and Motor-Dependent Retrograde Golgi Apparatus-to- Endoplasmic Reticulum Transport	mcb.asm.org	0	0		
829	chr25	31983487	31983512	3500301325	24		31983487	31983512	8421504	2	10,14	0,11	g	350030132500000011	0-25					Patent	Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment (Patent US:5595887)	Coolidge	1997	0		
829	chr25	31983487	31983512	3500168542	24		31983487	31983512	8421504	2	10,14	0,11	g	350016854200000007,350016854200000006	0-25,6-25						Purification directed cloning of peptides	Coolidge	1993	0		
830	chr25	32147650	32147676	3500465551	23		32147650	32147676	8421504	3	7,5,11	0,8,15	g	350046555100000136	0-23					Patent	Biological methods for preparing adipic acid (Patent US:8241879)	Picataggio	2012	0		
830	chr25	32147650	32147676	3500432081	23		32147650	32147676	8421504	3	7,5,11	0,8,15	g	350043208100000135	0-23						Biological methods for preparing adipic acid	Picataggio	2011	0		
830	chr25	32147650	32147676	3500225174	23		32147650	32147676	8421504	3	7,5,11	0,8,15	g	350022517400000135	0-23						Biological methods for preparing adipic acid	Beardslee	2012	0		
830	chr25	32147650	32147676	3500165695	23		32147650	32147676	8421504	3	7,5,11	0,8,15	g	350016569500000135	0-23						BIOLOGICAL METHODS FOR PREPARING ADIPIC ACID - Patent application	www.faqs.org	0	0		
830	chr25	32147650	32147676	3500105992	23		32147650	32147676	8421504	3	7,5,11	0,8,15	g	350010599200000136	0-23					Patent	Biological methods for preparing adipic acid (Patent US:8241879)	Picataggio	2012	0		
830	chr25	32147650	32147676	3500101720	23		32147650	32147676	8421504	3	7,5,11	0,8,15	g	350010172000000136	0-23						Biological methods for preparing adipic acid	Beardslee	2012	0		
830	chr25	32147650	32147676	3500084470	23		32147650	32147676	8421504	3	7,5,11	0,8,15	g	350008447000000134	0-23						Biological methods for preparing adipic acid	Picataggio	2013	0		
830	chr25	32147650	32147676	3500031956	23		32147650	32147676	8421504	3	7,5,11	0,8,15	g	350003195600000135	0-23						BIOLOGICAL METHODS FOR PREPARING ADIPIC ACID	Picataggio	2011	0		
832	chr25	32500122	32500145	3500351805	23		32500122	32500145	8421504	1	23	0	g	350035180500000048	14-39						Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2	Lemischka	1992	0		
833	chr25	32634270	32634297	3500043721	23		32634270	32634297	8421504	3	4,5,14	0,5,13	g	350004372100000448	0-23						NUCLEIC ACIDS CODING FOR ADHESION FACTOR OF GROUP B STREPTOCOCCUS, ADHESION FACTORS OF GROUP B STREPTOCOCCUS AND FURTHER USES THEREOF - Patent application	www.faqs.org	0	0		
840	chr25	33429215	33429241	3500199448	23		33429215	33429241	8421504	2	8,15	0,11	g	350019944800000194	12-48						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1996	0		
841	chr25	33555210	33555236	3500150231	23		33555210	33555236	8421504	3	11,6,6	0,13,20	g	350015023100000035	0-23						Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same	Nakanishi	2010	0		
846	chr25	34304228	34304264	3500244146	30		34304228	34304264	8421504	3	9,14,7	0,10,29	g	350024414600000012	8-48						Recombinant equine herpesviruses	Chiang	1997	0		
850	chr25	34814970	34815018	3500229299	48		34814970	34815018	8421504	1	48	0	p	350022929900015009	0-48						 UNIVERSIDAD AUTANOMA DE BARCELONA DEPARTAMENTO DE BIOLOGAA CELULAR, 	ddd.uab.cat	0	0		
850	chr25	34838129	34838152	3500404116	23		34838129	34838152	8421504	1	23	0	c	350040411600000026	9-32		15677713	10.1210/me.2004-0144	0888-8809	Molecular Endocrinology	An Upstream Initiator-Like Element Suppresses Transcription of the Rat Luteinizing Hormone Receptor Gene	Youn	2005	5		NCF1B
106	chr25	34974807	35046773	3500313903	266		34974807	35046773	8421504	5	38,58,80,5,85	0,39,98,69469,71881	p,g	350031390300000028,350031390300015005	0-178,0-90						Muscle transcription factors	Hardeman	2004	0		
852	chr25	35085063	35085089	3500382093	24		35085063	35085089	8421504	2	10,14	0,12	g	350038209300000055	0-24						US8236311B2	www.scribd.com	0	0		
853	chr25	35135242	35137976	3500447453	23		35135242	35137976	8421504	2	8,15	0,2719	c	350044745300000041	3-27		15140988	10.1128/JVI.78.11.5900-5912.2004	0022-538X	Journal of Virology	Processing of a Pestivirus Protein by a Cellular Protease Specific for Light Chain 3 of Microtubule-Associated Proteins	Fricke	2004	5		
853	chr25	35237881	35239167	3500462223	48		35237881	35239167	8421504	2	29,19	0,1267	p	350046222300015005	0-48					Patent	Thermophilic polymerase III holoenzyme (Patent US:6238905)	McHenry	2001	0		RFC2
854	chr25	35321003	35322778	3500190689	93		35321003	35322778	8421504	2	38,55	0,1720	p	350019068900015009	129-222						Bioinformatics: A Practical Guide to the Analysis of Genes and Proteins, Second Edition	www.zvlab.ru	0	0		LIMK1
854	chr25	35336241	35353546	3500329142	137		35336241	35353546	8421504	7	21,6,13,30,19,27,21	0,4028,4037,5759,7304,10678,17284	c,g	350032914200000006,350032914200000003,350032914200000005,350032914200000002,350032914200000020,350032914200000020,350032914200000019,350032914200000018	9-30,12-31,2-21,0-30,0-19,0-19,0-27,0-21		12626514	10.1074/jbc.M212715200	0021-9258	Journal of Biological Chemistry	Domains in Tropoelastin That Mediate Elastin Depositionin Vitro and in Vivo	Kozel	2003	5		
854	chr25	35343495	35348765	3500367790	195		35343495	35348765	8421504	3	18,2,175	0,4093,5095	p	350036779000015007	3-204						ELASTIN BASED GROWTH FACTOR DELIVERY PLATFORM FOR WOUND HEALING AND REGENERATION - Patent application	www.faqs.org	0	0		
854	chr25	35345321	35345348	3500197130	24		35345321	35345348	8421504	2	11,13	0,14	c	350019713000000003	0-27						Production of recombinant human lactoferrin	Conneely	1994	0		
854	chr25	35347588	35348678	3500213704	90		35347588	35348678	8421504	2	2,88	0,1002	p	350021370400015000,350021370400015003	9-90,0-90						Direct drug delivery system based on thermally responsive biopolymers	Setton	2011	0		
854	chr25	35347588	35348678	3500085034	90		35347588	35348678	8421504	2	2,88	0,1002	p	350008503400015003,350008503400015000	0-90,9-90						Direct drug delivery system based on thermally responsive biopolymers	Setton	2007	0		
854	chr25	35348594	35348672	3500373336	75		35348594	35348672	8421504	2	30,45	0,33	p	350037333600015116	72-147						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins - US Patent 7378506 Description	ww.patentstorm.us	0	0		
854	chr25	35355872	35367888	3500274307	40		35355872	35367888	8421504	2	20,20	0,11996	c,g	350027430700000005,350027430700000005,350027430700000004	0-20,0-20,0-20		10523620		0270-7306	Molecular and Cellular Biology	An Open Reading Frame Element Mediates Posttranscriptional Regulation of Tropoelastin and Responsiveness to Transforming Growth Factor &#x03b2;1	Zhang	1999	6		ELN
854	chr25	35363910	35363935	3500325127	24		35363910	35363935	8421504	2	17,7	0,18	g	350032512700000084	20-44						Method For Detecting Gene Specifying Allergic Predisposition 	.freshpatents.com	0	0		
854	chr25	35367962	35367987	3500188610	25		35367962	35367987	8421504	1	25	0	g	350018861000000009	0-25		12890646	10.1152/ajpcell.00173.2003		American Journal of Physiology - Cell Physiolog	Regulation of elastin gene transcription by interleukin-1&#x03b2;-induced C/EBP&#x03b2; isoforms	Kuang	2003	0		
854	chr25	35374209	35374237	3500177982	25		35374209	35374237	8421504	2	20,5	0,23	g	350017798200000039	15-40						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		
856	chr25	35567403	35567426	3500366512	23		35567403	35567426	8421504	1	23	0	g	350036651200000000	10-33		16103090	10.1158/0008-5472.CAN-05-1036	0008-5472	Cancer Research	Claudin-3 and Claudin-4 Expression in Ovarian Epithelial Cells Enhances Invasion and Is Associated with Increased Matrix Metalloproteinase-2 Activity	Agarwal	2005	8		
856	chr25	35567552	35567594	3500323255	42		35567552	35567594	8421504	1	42	0	c	350032325500000009	6-48						CLAUDIN-4 BINDING PEPTIDES, COMPOSITIONS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
856	chr25	35568134	35568162	3500347385	24		35568134	35568162	8421504	2	7,17	0,11	c	350034738500000008	11-35					Patent	Proteases (Patent US:8357408)	Lassen	2013	0		
856	chr25	35630389	35630598	3500122558	105		35630389	35630598	8421504	4	45,18,27,15	0,48,164,194	p	350012255800015141	0-105						US Patent # 7,399,607. Fluorescence polarization assays for determining clostridial toxin activity - Patents.com	www.patents.com	0	0		
856	chr25	35633866	35634371	3500117680	42		35633866	35634371	8421504	2	36,6	0,499	c	350011768000000001,350011768000000000	7-49,4-46		18003982	10.1091/mbc.E07-02-0148	1059-1524	Molecular Biology of the Cell	SNARE-catalyzed Fusion Events Are Regulated by Syntaxin1A&#x2013;Lipid Interactions	Lam	2008	5		
856	chr25	35635708	35635735	3500436243	26		35635708	35635735	8421504	2	21,5	0,22	c	350043624300000000	14-40		18346208	10.1111/j.1471-4159.2008.05338.x	1471-4159	Journal of Neurochemistry	Temporal and functional dynamics of the transcriptome during nerve growth factor-induced differentiation - Dijkmans - 2008 - Journal of Neurochemistry - Wiley Online Library	Dijkmans	2008	0		
856	chr25	35641961	35646594	3500196824	79		35641961	35646594	8421504	4	26,6,45,2	0,742,2084,4631	c	350019682400000034,350019682400000031	0-32,0-47						 Methods Of Determining SAM 	www.docstoc.com	0	0		
856	chr25	35641961	35642709	3500332335	32		35641961	35642709	8421504	2	26,6	0,742	c	350033233500000033	0-32						US Patent # 6,610,504. Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase - Patents.com	www.patents.com	0	0		
857	chr25	35697133	35705108	3500301078	96		35697133	35705108	8421504	4	26,20,24,26	0,207,7884,7949	c,g	350030107800000053,350030107800000054,350030107800000054,350030107800000149,350030107800000149,350030107800000150	0-26,0-20,0-20,0-24,0-24,0-26						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
857	chr25	35705082	35705109	3500463464	27		35705082	35705109	8421504	1	27	0	g	350046346400000018	23-50						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
857	chr25	35778309	35778360	3500194466	51		35778309	35778360	8421504	1	51	0	p	350019446600015012	0-51						Proteomic Analysis of Phosphorylated Nuclear Proteins Underscores Novel Roles for Rapid Actions of Retinoic Acid in the Regulation of mRNA Splicing and Translation	digital.csic.es	0	0		BAZ1B
858	chr25	35787229	35787283	3500012365	54		35787229	35787283	8421504	1	54	0	p	350001236500015000	0-54						Cell, Vol. 113, 905&#x2013;917, June 27, 2003, Copyright 2003 by Cell Press The Chromatin-Remodeling Complex WINAC Targets a Nuclear Receptor to Promoters and Is Impaired in Williams Syndrome	gs.washington.edu	0	0		BAZ1B
858	chr25	35793361	35793386	3500090423	23		35793361	35793386	8421504	3	7,12,4	0,8,21	g	350009042300000003	10-36						Methods for treating cancer using an immunotoxin	Paolo	2007	0		
858	chr25	35796547	35796570	3500229452	23		35796547	35796570	8421504	1	23	0	c	350022945200000025,350022945200000007	1-24,1-24						Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity	Albiston	2003	0		KIR3DL2
858	chr25	35796547	35796570	3500069836	23		35796547	35796570	8421504	1	23	0	c	350006983600000007	1-24						Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity	Albiston	2002	0		
858	chr25	35796564	35798823	3500212746	24		35796564	35798823	8421504	3	5,18,1	0,6,2258	c	350021274600000160,350021274600000165	1-26,1-26					Patent	Immunisation against chlamydia trachomatis (Patent CN:100515494)	G*La Di 	2009	0		
858	chr25	35800891	35800920	3500327109	28		35800891	35800920	8421504	2	23,5	0,24	c	350032710900000335	0-28						Invasive cleavage of nucleic acids	Brow	1999	0		
858	chr25	35800891	35800920	3500133350	28		35800891	35800920	8421504	2	23,5	0,24	c	350013335000000268	0-28						Fen-1 endonucleases, mixtures and cleavage methods	Kaiser	1998	0		
859	chr25	35956076	35956121	3500400489	45		35956076	35956121	8421504	1	45	0	c	350040048900000000	19-64		16027218	10.1083/jcb.200503106	0021-9525	The Journal of Cell Biology	Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors	Mills	2005	10		
860	chr25	36049819	36049845	3500428283	25		36049819	36049845	8421504	2	4,21	0,5	g	350042828300000018	15-40						HIGHLY EFFECTIVE ANTI-CADHERIN ANTIBODY FOR INDUCTION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN VIVO - Patent application	www.faqs.org	0	0		
860	chr25	36087841	36087868	3500400489	27		36087841	36087868	8421504	1	27	0	c	350040048900000002	9-36		16027218	10.1083/jcb.200503106	0021-9525	The Journal of Cell Biology	Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors	Mills	2005	10		HIP1
861	chr25	36269485	36276702	3500400089	134		36269485	36276702	8421504	4	48,5,40,41	0,2281,2683,7176	c	350040008900000118,350040008900000126,350040008900000145	0-48,0-45,0-41						 Aspergillus Ochraceus 11 Alpha Hydroxylase And Oxidoreductase 	www.docstoc.com	0	0		
861	chr25	36279078	36279196	3500344982	23		36279078	36279196	8421504	3	6,2,15	0,98,103	c	350034498200000004	11-34			10.1101/gad.996502		Genes & Development	The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-J&#x03ba; (CSL), the target of the Notch signaling pathway	Yuying	2002	0		
861	chr25	36279078	36279196	3500192001	23		36279078	36279196	8421504	3	6,2,15	0,98,103	c	350019200100000006	11-34		12154127	10.1101/gad.996502	0890-9369	Genes & Development	The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-J&#x03ba; (CSL), the target of the Notch signaling pathway	Liang	2002	12		
862	chr25	36319228	36319252	3500159378	23		36319228	36319252	8421504	2	9,14	0,10	c	350015937800000018	3-26						 Method Of Detection Of Herpes B Virus 	www.docstoc.com	0	0		
862	chr25	36319256	36322733	3500076453	99		36319256	36322733	8421504	2	66,33	0,3444	p	350007645300015006	0-99						COMPOSITIONS AND METHODS FOR MODIFYING A PREDETERMINED TARGET NUCLEIC ACID SEQUENCE - TARGETGENE BIOTECHNOLOGIES LTD	www.sumobrain.com	0	0		MDH2
862	chr25	36322639	36322965	3500229425	326		36322639	36322965	8421504	1	326	0	g	350022942500000055	0-326						JINKEE JUNG 2012	www.naqs.go.kr	0	0		
862	chr25	36324427	36324933	3500029357	45		36324427	36324933	8421504	2	28,17	0,489	p	350002935700015179	0-45						Polypeptides having C4 Dicarboxylic Acid Transporter Activity and Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		MDH2
862	chr25	36326545	36329768	3500006584	41		36326545	36329768	8421504	4	15,6,13,7	0,2227,2292,3216	c	350000658400000024,350000658400000025	0-21,0-20						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
862	chr25	36331591	36331809	3500047878	40		36331591	36331809	8421504	2	20,20	0,198	c,g	350004787800000022,350004787800000022,350004787800000023,350004787800000023	0-20,0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
863	chr25	36495917	36495942	3500264853	25		36495917	36495942	8421504	1	25	0	c	350026485300000036	0-25						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		HSPB1
863	chr25	36495917	36495942	3500205152	25		36495917	36495942	8421504	1	25	0	c	350020515200000036	0-25						HEAT STRESS INDUCES DOWNREGULATION OF HIPPOCAMPAL	etd.auburn.edu	0	0		HSPB1
863	chr25	36495950	36496781	3500294910	40		36495950	36496781	8421504	2	20,20	0,811	c,g	350029491000000012,350029491000000012,350029491000000013	0-20,0-20,0-20						UNIVERSIDADE JOS&#xc9; DO ROS&#xc1;RIO VELLANO &#x2013; UNIFENAS TOCHIMARA APARECIDA MIYAUCHI	tede.unifenas.br	0	0		
863	chr25	36495982	36496781	3500056162	40		36495982	36496781	8421504	3	10,10,20	0,597,779	c	350005616200000004,350005616200000005	0-20,0-20						Universidade de S&#xe3;o Paulo Escola Superior de Agricultura &#x201c;Luiz de Queiroz&#x201d;	www.teses.usp.br	0	0		
863	chr25	36496620	36496922	3500021577	40		36496620	36496922	8421504	3	20,11,9	0,281,293	c,g	350002157700000010,350002157700000010,350002157700000011	0-20,0-20,0-20						O-12	www.scribd.com	0	0		
863	chr25	36496623	36496738	3500279766	25		36496623	36496738	8421504	2	20,5	0,110	c	350027976600000005	18-43						Identi&#xfb01;cation of Differentially Expressed Genes in Individual Bovine Preimplantation Embryos Produced by Nuclear Transfer: Improper Reprogramming of Genes Required for Development	ww.biolreprod.org	0	0		
863	chr25	36496842	36496926	3500449335	41		36496842	36496926	8421504	3	19,12,10	0,61,74	c,g	350044933500000014,350044933500000014,350044933500000015	0-19,0-19,0-22						Significant role of &#x03bc;-calpain (CANP1) in proliferation/survival of bovine skeletal muscle satellite cells	link.springer.com	0	0		
863	chr25	36520538	36520583	3500418806	45		36520538	36520583	8421504	1	45	0	c	350041880600000003	0-45			10.1111/j.1742-4658.2005.04614.x	1742-4658	FEBS Journal	14-3-3 Proteins regulate glycogen synthase 3&#x03b2; phosphorylation and inhibit cardiomyocyte hypertrophy - Liao - 2005 - FEBS Journal - Wiley Online Library	Liao	2005	0		
863	chr25	36520588	36521234	3500337690	545		36520588	36521234	8421504	3	20,480,45	0,25,601	p,c	350033769000000004,350033769000015073,350033769000015201,350033769000015123,350033769000015138,350033769000015072,350033769000015137,350033769000015136,350033769000015071,350033769000015134,350033769000015166,350033769000015133,350033769000015070,350033769000015058,350033769000015052,350033769000015132,350033769000015042,350033769000015131,350033769000015129	6-26,0-120,0-45,0-45,0-45,0-120,0-45,0-45,0-120,0-45,0-45,0-45,0-120,0-48,0-45,0-45,0-45,0-45,0-45						14-3-3 Antagonists for the Prevention and Treatment of Arthritis - Patent application	www.faqs.org	0	0		
863	chr25	36520610	36520682	3500164379	72		36520610	36520682	8421504	1	72	0	p	350016437900015061	60-132						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		HSPB1
863	chr25	36520820	36520976	3500132981	66		36520820	36520976	8421504	2	15,51	0,105	p	350013298100015057	24-180						14-3-3 isoform specificity in barley	dare.ubvu.vu.nl	0	0		
863	chr25	36550234	36550263	3500004392	24		36550234	36550263	8421504	2	15,9	0,20	g	350000439200000292	0-30						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
864	chr25	36578608	36586335	3500366733	1045		36578608	36586335	8421504	11	48,48,141,119,76,110,82,24,60,112,225	0,96,192,2198,3156,3409,3614,3708,6383,6622,7502	c,g	350036673300000368,350036673300000368,350036673300000370,350036673300000372,350036673300000373,350036673300000374,350036673300000375,350036673300000375,350036673300000376,350036673300000314,350036673300000377,350036673300000378,350036673300000381,350036673300000381,350036673300000382,350036673300000383,350036673300000384,350036673300000323,350036673300000386,350036673300000386,350036673300000388,350036673300000388,350036673300000389,350036673300000389,350036673300000390,350036673300000391,350036673300000218,350036673300000392,350036673300000393,350036673300000394	124-172,124-172,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-32,0-48,0-48,0-48,0-48,0-48,0-48,0-48,6-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,1-38,0-48,0-48,0-49						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
864	chr25	36578800	36586335	3500193635	709		36578800	36586335	8421504	12	48,45,119,28,110,34,24,60,112,32,48,49	0,96,2006,2964,3217,3422,3516,6191,6430,7310,7390,7486	c	350019363500000370,350019363500000372,350019363500000373,350019363500000374,350019363500000314,350019363500000375,350019363500000379,350019363500000380,350019363500000381,350019363500000323,350019363500000384,350019363500000386,350019363500000387,350019363500000388,350019363500000390,350019363500000392	0-48,0-48,0-48,0-48,0-32,0-48,0-48,0-48,0-48,6-47,0-48,0-48,0-48,0-48,0-48,0-49						Materials and methods for immunocontraception	Harris	1993	0		
864	chr25	36581805	36582326	3500359799	79		36581805	36582326	8421504	4	19,19,19,22	0,158,299,499	c,g	350035979900000004,350035979900000006,350035979900000006,350035979900000005,350035979900000005,350035979900000007,350035979900000007	0-19,0-19,0-19,0-19,0-19,0-22,0-22						Sequencing primers and SNPs for rapidly evolving reproductive loci in endangered ibex and their kin (Bovidae, Capra spp.) - ResearchGate	.researchgate.net	0	0		
864	chr25	36581805	36582326	3500270029	79		36581805	36582326	8421504	4	19,19,19,22	0,158,299,499	c,g	350027002900000004,350027002900000006,350027002900000006,350027002900000005,350027002900000005,350027002900000007	0-19,0-19,0-19,0-19,0-19,0-22						Sequencing primers and SNPs for rapidly evolving reproductive loci in endangered ibex and their kin (Bovidae, Capra spp	taff.bucknell.edu	0	0		
864	chr25	36585338	36586154	3500411815	48		36585338	36586154	8421504	2	4,44	0,772	p	350041181500015002	0-48		11804956	10.1095/biolreprod66.2.407	0006-3363	Biology of Reproduction	Proteolytic Processing of Human Zona Pellucida Proteins	Kiefer	2002	4		POMZP3
864	chr25	36636582	36636606	3500431462	23		36636582	36636606	8421504	2	16,7	0,17	c	350043146200000759	10-33						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
864	chr25	36636582	36636606	3500110550	23		36636582	36636606	8421504	2	16,7	0,17	c	350011055000000750	10-33						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
864	chr25	36636582	36636606	3500031022	23		36636582	36636606	8421504	2	16,7	0,17	c	350003102200000750	10-33						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
864	chr25	36637422	36639562	3500033615	122		36637422	36639562	8421504	3	20,45,57	0,1224,2083	p,c,g	350003361500000000,350003361500015004,350003361500015000,350003361500000001,350003361500000001	0-20,0-45,0-57,0-20,0-20			10.1083/jcb.200204102		The Journal of Cell Biology	Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly	Fang-Ming	2002	0		
864	chr25	36637422	36639562	3500003191	122		36637422	36639562	8421504	3	20,45,57	0,1224,2083	p,c,g	350000319100000000,350000319100015009,350000319100015001,350000319100000001	0-20,0-45,0-57,0-20		12446744	10.1083/jcb.200204102	0021-9525	The Journal of Cell Biology	Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly	Deng	2002	10		
864	chr25	36655888	36655911	3500394547	23		36655888	36655911	8421504	1	23	0	c	350039454700000129	14-37						MODULATION OF TUDOR-SN EXPRESSION - Patent application	www.faqs.org	0	0		
865	chr25	36736519	36736567	3500036684	48		36736519	36736567	8421504	1	48	0	c	350003668400000334	0-48						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
866	chr25	36863760	36864032	3500214603	46		36863760	36864032	8421504	2	24,22	0,250	g	350021460300000013,350021460300000012	0-24,0-22						Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes. - ResearchGate	.researchgate.net	0	0		CUX1,SH2B2
866	chr25	36928809	36928837	3500043924	23		36928809	36928837	8421504	2	7,16	0,12	g	350004392400000283,350004392400000014	9-35,9-35						ANTIBODIES TO CD40 - Patent application	www.faqs.org	0	0		
867	chr25	37086083	37086114	3500264901	28		37086083	37086114	8421504	2	17,11	0,20	g	350026490100000039	9-37						Lipoprotein assays using antibodies to a pan native epitope and recombinant antigens	Curtiss	1993	0		
870	chr25	37369356	37369379	3500053111	23		37369356	37369379	8421504	1	23	0	g	350005311100000007,350005311100000006	5-33,9-37		18719602	10.1038/gene.2008.66	1466-4879	Genes and Immunity	Initial description of the human NLRP3 promoter	Anderson	2008	4		
870	chr25	37392055	37392083	3500095259	23		37392055	37392083	8421504	2	12,11	0,17	g	350009525900000003	0-23						Moraxella bovoculi sp. nov., isolated from calves with infectious bovine keratoconjunctivitis	s.sgmjournals.org	0	0		
871	chr25	37607564	37607592	3500457990	23		37607564	37607592	8421504	2	14,9	0,19	g	350045799000000088	4-35						US Patent # 7,217,554. Proteases and variants thereof - Patents.com	www.patents.com	0	0		
871	chr25	37613391	37613414	3500399973	23		37613391	37613414	8421504	1	23	0	c	350039997300000003	9-32		19203395	10.1186/1471-2199-10-9	1471-2199	BMC Molecular Biology	Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci	Chen	2009	3		
871	chr25	37615160	37616713	3500032348	40		37615160	37616713	8421504	4	13,7,7,13	0,575,1327,1540	c	350003234800000016,350003234800000017	0-20,0-20			10.1186/1471-2164-8-63		BMC Genomics	Target genes of myostatin loss-of-function in muscles of late bovine fetuses	Isabelle	2007	0		
872	chr25	37617808	37617923	3500252038	23		37617808	37617923	8421504	3	6,5,12	0,9,103	c	350025203800000234	4-27					Patent	Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium (Patent CN:1170938)	Zhao Cang Yang Zi 	2004	0		
872	chr25	37725011	37733316	3500183250	2501		37725011	37733316	8421504	50	20,58,55,55,55,55,55,56,55,56,54,55,55,60,54,58,57,58,58,58,56,60,57,59,58,57,107,26,13,55,23,45,13,35,45,42,20,22,45,45,45,45,45,45,17,31,141,47,55,60	0,25,88,147,207,267,327,387,447,507,568,627,687,746,809,866,927,986,1046,1106,1166,1224,1286,1345,1406,1466,1525,1638,2004,2022,3450,3658,3706,4827,4910,4958,5006,5650,5678,5774,6410,6458,6506,6554,6602,7268,7347,7491,8185,8245	c,g	350018325000000028,350018325000000027,350018325000000026,350018325000000025,350018325000000052,350018325000000050,350018325000000021,350018325000000100,350018325000000047,350018325000000018,350018325000000017,350018325000000016,350018325000000015,350018325000000013,350018325000000011,350018325000000010,350018325000000009,350018325000000008,350018325000000007,350018325000000005,350018325000000058,350018325000000004,350018325000000003,350018325000000002,350018325000000002	0-1496,0-46,0-39,0-46,0-42,19-42,0-45,11-45,6-42,0-45,0-42,0-42,0-45,0-45,0-45,0-45,0-45,0-45,0-48,0-45,0-47,0-48,0-45,0-162,0-162						US Patent # 7,057,086. Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors - Patents.com	www.patents.com	0	0		
872	chr25	37726352	37726387	3500200501	26		37726352	37726387	8421504	3	7,7,12	0,12,23	c	350020050100000010	0-27						Lectin compositions and methods for modulating an immune response to an antigen	Segal	2003	0		
872	chr25	37726352	37726387	3500196640	26		37726352	37726387	8421504	3	7,7,12	0,12,23	c	350019664000000010	0-27						Lectin compositions and methods for modulating an immune response to an antigen	Segal	2003	0		
872	chr25	37726624	37726658	3500419338	27		37726624	37726658	8421504	3	5,10,12	0,7,22	c	350041933800000087	10-38						US Patent # 6,063,597. Polypeptide compositions toxic to coleopteran insects - Patents.com	www.patents.com	0	0		
872	chr25	37726640	37727082	3500289620	102		37726640	37727082	8421504	2	35,67	0,375	p	350028962000015010	0-102						Crucial Residues Carboxy-terminal End of Inhibitor byPathogenic Mutants Impaired in Secretion Function	www.jci.org	0	0		SERPINE1
872	chr25	37727034	37729854	3500080964	45		37727034	37729854	8421504	3	23,6,16	0,1690,2804	c	350008096400000001,350008096400000000	0-23,0-22		20531292	10.1038/labinvest.2010.105	0023-6837	Laboratory Investigation	Reduced transforming growth factor-&#x03b2; receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis	Mamiya	2010	4		SERPINE1
872	chr25	37727043	37727088	3500368433	45		37727043	37727088	8421504	1	45	0	p	350036843300015003	0-45						Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression	Gerard	1991	0		SERPINE1
872	chr25	37728674	37732392	3500345870	40		37728674	37732392	8421504	2	20,20	0,3698	c	350034587000000000,350034587000000001	0-20,0-20		15201140	10.1152/ajpcell.00101.2004		American Journal of Physiology - Cell Physiology	Role of TGF-&#x03b2;1 and JNK signaling in capillary tube patterning	Bein	2004	0		
872	chr25	37728674	37732392	3500061918	40		37728674	37732392	8421504	2	20,20	0,3698	c	350006191800000000,350006191800000001	0-20,0-20		15201140	10.1152/ajpcell.00101.2004		American Journal of Physiology - Cell Physiolog	Role of TGF-&#x03b2;1 and JNK signaling in capillary tube patterning	Bein	2004	0		
872	chr25	37729994	37730849	3500040185	42		37729994	37730849	8421504	2	21,21	0,834	c,g	350004018500000029,350004018500000029,350004018500000028,350004018500000028	0-21,0-21,0-21,0-21						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
872	chr25	37730666	37730689	3500124282	23		37730666	37730689	8421504	1	23	0	c	350012428200000049	0-23						Me t h o d s in	torage.mjjw.co.uk	0	0		
872	chr25	37730774	37731577	3500190224	40		37730774	37731577	8421504	2	20,20	0,783	c	350019022400000010,350019022400000001,350019022400000000,350019022400000009	0-20,0-20,0-20,0-20						Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors - Patent application	www.faqs.org	0	0		SERPINE1
872	chr25	37730774	37731577	3500149965	40		37730774	37731577	8421504	2	20,20	0,783	c	350014996500000001,350014996500000000	0-20,0-20						Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors	Chang	2011	0		SERPINE1
872	chr25	37730774	37731577	3500044550	40		37730774	37731577	8421504	2	20,20	0,783	c	350004455000000001,350004455000000000	0-20,0-20		20061390	10.1074/jbc.M109.025684		The Journal of Biological Chemistry	SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of &#x03b2;-Catenin	Wenteh	2010	0		SERPINE1
872	chr25	37731445	37731493	3500029099	48		37731445	37731493	8421504	1	48	0	p	350002909900015053	0-48						Compositions And Methods For Targeting A Polypeptide To The Central Nervous System 	freshpatents.com	0	0		
872	chr25	37731445	37731490	3500074996	45		37731445	37731490	8421504	1	45	0	p	350007499600015053	0-45						COMPOSITIONS AND METHODS FOR TARGETING A POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM - Patent application	www.faqs.org	0	0		
873	chr25	37759138	37759165	3500190781	23		37759138	37759165	8421504	2	11,12	0,15	c	350019078100000005	13-36		21159870	10.1128/JVI.01796-10	0022-538X	Journal of Virology	Peroxiredoxin 1 Is Required for Efficient Transcription and Replication of Measles Virus	Watanabe	2011	5		
873	chr25	37873810	37873842	3500260285	32		37873810	37873842	8421504	1	32	0	c	350026028500000017	0-32						Molecularcloning G+C-rich	www.pnas.org	0	0		
873	chr25	37874005	37876191	3500146291	96		37874005	37876191	8421504	2	48,48	0,2138	c	350014629100000025,350014629100000031	0-48,0-48						Enzymatically active recombinant human acetylcholinesterase and hosts and vectors for expression thereof - US Patent 5248604 Description	ww.patentstorm.us	0	0		
873	chr25	37874116	37876259	3500152372	78		37874116	37876259	8421504	2	48,30	0,2113	c	350015237200000042,350015237200000001	0-48,0-30						Transgenic non-human animal assay system for anti-cholinesterase substances	Soreq	1995	0		
873	chr25	37874116	37874164	3500278603	48		37874116	37874164	8421504	1	48	0	c	350027860300000042	0-48						Transgenic non-human mammals producing a cholinesterase in their milk - US Patent 6987211 Description	ww.patentstorm.us	0	0		
873	chr25	37875222	37876260	3500279454	123		37875222	37876260	8421504	2	1,122	0,916	c	350027945400000002,350027945400000000	63-126,0-60						4Health Effects of Low-Level Exposure to Nerve Agents for Chemical Warfare Agents; Chemistry, Pharmacology, Toxicology, And Therapeutics, Second Edition	www.scribd.com	0	0		ACHE
873	chr25	37876188	37876233	3500406446	45		37876188	37876233	8421504	1	45	0	p	350040644600015007	0-45						ACETYLCHOLINESTERASE (ACHE)-DERIVED PEPTIDE AS AN INDUCER OF GRANULOCYTOPOIESIS, USES AND METHODS THEREOF - Patent application	www.faqs.org	0	0		ACHE
873	chr25	37876229	37876260	3500286966	31		37876229	37876260	8421504	1	31	0	c,g	350028696600000000,350028696600000000	36-67,36-67						05 DDT(IRDR)-11-00002-OA proof pp293-298	ww.ddtjournal.com	0	0		ACHE
873	chr25	37876229	37876259	3500203664	30		37876229	37876259	8421504	1	30	0	c	350020366400000003	0-30		9605686		0003-3022	Anesthesiology	 Acetylcholinesterase and Butyrylcholinesterase Are Expressed... : Anesthesiology 	Ummenhofer	1998	5		
873	chr25	37876236	37876260	3500188400	24		37876236	37876260	8421504	1	24	0	c	350018840000000000	24-48		10644632			American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Myotubes originating from single fast and slow satellite cells display similar patterns of AChE expression	Boudreau-Lariviere	2000	0		ACHE
873	chr25	37876236	37876260	3500029763	24		37876236	37876260	8421504	1	24	0	c	350002976300000000	24-48		10644632			American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Myotubes originating from single fast and slow satellite cells display similar patterns of AChE expression	Boudreau-Lariviere	2000	0		
874	chr25	37893290	37893466	3500055068	42		37893290	37893466	8421504	2	20,22	0,154	c	350005506800000071,350005506800000070	0-20,0-22						ELISA NAPOLITANO E FERREIRA	www.teses.usp.br	0	0		TRIP6
874	chr25	37918667	37934172	3500300582	2961		37918667	37934172	8421504	17	52,71,288,397,156,333,125,166,103,65,114,248,216,150,194,156,127	0,2605,2919,3932,5615,5952,6611,7420,8549,8873,9050,9280,12531,13043,13619,14014,15378	p	350030058200015034,350030058200015214	0-2961,0-45						Cancer treatment using humanized antibodies that bind to EphB4 - Patent application	www.faqs.org	0	0		EPHB4
874	chr25	37918712	37922770	3500376096	537		37918712	37922770	8421504	4	7,71,288,171	0,2560,2874,3887	p	350037609600015043,350037609600015049,350037609600015055,350037609600015061	0-150,0-141,0-132,0-114						Eph receptor ligands and methods of use	Pasquale	2010	0		EPHB4
874	chr25	37921296	37921798	3500104232	41		37921296	37921798	8421504	2	21,20	0,482	c,g	350010423200000480,350010423200000019	0-21,0-20						 Nucleic Acid Compounds For Inhibiting Angiogenesis And Tumor Growth 	www.docstoc.com	0	0		
874	chr25	37931322	37934094	3500381951	40		37931322	37934094	8421504	2	20,20	0,2752	c,g	350038195100000093,350038195100000093,350038195100000062	0-20,0-20,0-20						Nucleic acid compounds for inhibiting angiogenesis and tumor growth	Reddy	2005	0		
874	chr25	37981434	37981457	3500174472	23		37981434	37981457	8421504	1	23	0	c	350017447200000001	7-30						Eukaryotic cell-based gene interaction cloning	Tavernier	2000	0		EPO
874	chr25	37981434	37981457	3500143187	23		37981434	37981457	8421504	1	23	0	c	350014318700000022,350014318700000041	7-30,7-30						Eukaryotic cell-based gene interaction cloning	Ostade	2001	0		
874	chr25	37981434	37981457	3500075088	23		37981434	37981457	8421504	1	23	0	c	350007508800000001	7-30						Eukaryotic cell-based gene interaction cloning	Tavernier	2001	0		
874	chr25	37981437	37981472	3500071757	35		37981437	37981472	8421504	1	35	0	c	350007175700000003,350007175700000002	34-65,0-35		20924361	10.1038/mt.2010.215	1525-0016	Molecular Therapy	Prevention of Diabetic Neuropathy by Regulatable Expression of HSV-Mediated Erythropoietin	Wu	2010	7		
874	chr25	37981437	37981472	3500070308	35		37981437	37981472	8421504	1	35	0	c	350007030800000002,350007030800000003	0-35,34-65		20924361	10.1038/mt.2010.215	1525-0016	Molecular Therapy	Prevention of Diabetic Neuropathy by Regulatable Expression of HSV-Mediated Erythropoietin	Wu	2010	7		
874	chr25	37981438	37982594	3500092852	156		37981438	37982594	8421504	4	63,9,36,48	0,147,290,1108	p,c	350009285200015003,350009285200015009,350009285200000003,350009285200000010,350009285200015005	0-63,45-90,0-20,0-20,0-48						Canine erythropoietin gene and recombinant protein - Patent # RE40911 - PatentGenius	.patentgenius.com	0	0		
874	chr25	37981439	37982621	3500157797	98		37981439	37982621	8421504	2	32,66	0,1116	c	350015779700000258,350015779700000234,350015779700000240	0-32,0-48,0-48						 Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	www.docstoc.com	0	0		
874	chr25	37981439	37981464	3500232776	25		37981439	37981464	8421504	1	25	0	c	350023277600000001	12-37						Modified erythropoietin polypeptides and uses thereof for treatment	Guyon	2009	0		
874	chr25	37981439	37981464	3500004613	25		37981439	37981464	8421504	1	25	0	c	350000461300000001	12-37						Modified erythropoietin polypeptides and uses thereof - Patent application	www.faqs.org	0	0		
874	chr25	37981439	37981463	3500319267	24		37981439	37981463	8421504	1	24	0	c	350031926700000038	25-49						Methods and compositions for the prevention and treatment of anemia	Egrie	2007	0		
874	chr25	37981439	37981463	3500079851	24		37981439	37981463	8421504	1	24	0	c	350007985100000038,350007985100000056	25-49,25-49						Methods and compositions for the prevention and treatment of anemia - Patent application	www.faqs.org	0	0		
874	chr25	37981456	37982612	3500359970	133		37981456	37982612	8421504	2	60,73	0,1083	c,g	350035997000000242,350035997000000085,350035997000000235	0-60,0-51,0-60						MODIFIED ANIMAL ERYTHROPOIETIN POLYPEPTIDES AND THEIR USES - Patent application	www.faqs.org	0	0		
874	chr25	37981456	37982612	3500269619	144		37981456	37982612	8421504	3	60,11,73	0,709,1083	c,g	350026961900000233,350026961900000012,350026961900000076,350026961900000226	0-60,7-77,0-51,0-60						MODIFIED ANIMAL ERYTHROPOIETIN POLYPEPTIDES AND THEIR USES - Patent application	www.faqs.org	0	0		
874	chr25	37981456	37982612	3500026018	133		37981456	37982612	8421504	2	60,73	0,1083	c,g	350002601800000225,350002601800000068,350002601800000218	0-60,0-51,0-60						Modified Animal Erythropoietin Polypeptides And Their Uses 	.freshpatents.com	0	0		
874	chr25	37981506	37981732	3500261436	42		37981506	37981732	8421504	3	21,17,4	0,71,222	c,g	350026143600000036,350026143600000036,350026143600000035	0-21,0-21,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
874	chr25	37982869	37982896	3500198920	26		37982869	37982896	8421504	2	14,12	0,15	g	350019892000000004,350019892000000014,350019892000000013,350019892000000003	0-21,0-21,0-25,0-25						US Patent # 6,555,343. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same - Patents.com	www.patents.com	0	0		
874	chr25	38010071	38010098	3500013095	23		38010071	38010098	8421504	2	17,6	0,21	c	350001309500000695	4-27						Sequenciamento do Genoma Completo e Express&#xe3;o Heter&#xf3;loga da Capa Prot&#xe9;ica do Marafivirus Associado &#xe0; Morte S&#xfa;bita dos Citros	www.bdtd.ucb.br	0	0		
875	chr25	38018158	38019024	3500201814	52		38018158	38019024	8421504	2	28,24	0,842	c	350020181400000016,350020181400000010	13-41,9-33						PTX sensitive G proteins, the production and use thereof	Siffert	1999	0		
875	chr25	38019781	38020257	3500130533	150		38019781	38020257	8421504	3	54,39,57	0,169,419	p	350013053300015020	6-156						Cloning, tissue distribution and functional expression Victor Ruiz-Velasco 1,2	cs.physiology.org	0	0		GNB2
875	chr25	38057964	38057989	3500454678	24		38057964	38057989	8421504	2	9,15	0,10	c	350045467800000093	0-24						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2004	0		
875	chr25	38066108	38066964	3500461703	24		38066108	38066964	8421504	2	4,20	0,836	c	350046170300000000	14-38		12486138	10.1074/jbc.M210857200	0021-9258	Journal of Biological Chemistry	Low Resolution Structure Determination Shows Procollagen C-Proteinase Enhancer to be an Elongated Multidomain Glycoprotein	Bernocco	2003	5		
875	chr25	38066950	38066976	3500442517	23		38066950	38066976	8421504	2	10,13	0,13	c	350044251700000011	9-34						and	www.tipharma.com	0	0		
875	chr25	38067102	38067128	3500307135	26		38067102	38067128	8421504	1	26	0	c	350030713500000403,350030713500000013	17-43,17-43						NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - Patent application	www.faqs.org	0	0		CPEB3
876	chr25	38173233	38173259	3500407806	24		38173233	38173259	8421504	2	17,7	0,19	g	350040780600000123	8-38						METHOD RELATING TO SWEETNESS ENHANCEMENT - Patent application	www.faqs.org	0	0		
876	chr25	38182184	38182815	3500135939	192		38182184	38182815	8421504	2	39,153	0,478	p	350013593900015045,350013593900015043	0-192,0-192						Oreochromis_mossambicus-Contig_7-v1 | MarineGenomics.org	arinegenomics.org	0	0		TSC22D4
876	chr25	38182782	38182809	3500272859	25		38182782	38182809	8421504	3	16,5,4	0,17,23	c	350027285900000226	9-34						Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family		1996	0		
876	chr25	38182782	38182809	3500174807	25		38182782	38182809	8421504	3	16,5,4	0,17,23	c	350017480700000090	21-46						Nucleic acid transfer system	www.devileye.net	0	0		
876	chr25	38233856	38233895	3500065787	29		38233856	38233895	8421504	3	9,13,7	0,14,32	c	350006578700000074	19-48						Genes and polypeptides relating to chronic myeloid leukemia	Zhong Cun You Fu 	2005	0		
876	chr25	38251355	38251378	3500267789	23		38251355	38251378	8421504	1	23	0	c	350026778900000039	9-40						Human Transcriptome Subtraction by Using Short Sequence Tags To Search for Tumor Viruses in Conjunctival Carcinoma	virology.pitt.edu	0	0		
877	chr25	38304232	38308168	3500012655	24		38304232	38308168	8421504	2	20,4	0,3932	c	350001265500000003	1-36		22993150	10.1128/JVI.01418-12	0022-538X	Journal of Virology	Hepatitis C Virus Infection Suppresses GLUT2 Gene Expression via Downregulation of Hepatocyte Nuclear Factor 1&#x03b1;	Matsui	2012	5		
878	chr25	38452240	38452264	3500226848	24		38452240	38452264	8421504	1	24	0	c	350022684800000002	0-24		19671678	10.1158/1541-7786.MCR-08-0507	1541-7786	Molecular Cancer Research	miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1	Du	2009	4		MCM7
878	chr25	38452464	38452929	3500423784	66		38452464	38452929	8421504	3	21,23,22	0,202,443	c,g	350042378400000024,350042378400000024,350042378400000248,350042378400000248,350042378400000129,350042378400000129,350042378400000096,350042378400000096	0-21,0-21,0-23,0-23,0-22,0-22,0-22,0-22						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MCM7,MIR93
878	chr25	38452464	38452929	3500323428	66		38452464	38452929	8421504	3	21,23,22	0,202,443	c,g	350032342800000056,350032342800000056,350032342800000053,350032342800000053,350032342800000048	0-21,0-21,0-23,0-23,0-22						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		MCM7,MIR93
878	chr25	38452464	38452929	3500277393	43		38452464	38452929	8421504	2	21,22	0,443	c,g	350027739300000002,350027739300000002,350027739300000026,350027739300000026,350027739300000031,350027739300000031	0-21,0-21,0-21,0-21,0-22,0-22						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		MCM7,MIR93
878	chr25	38452464	38452929	3500244257	65		38452464	38452929	8421504	3	21,22,22	0,203,443	c,g	350024425700000011,350024425700000011,350024425700000006,350024425700000006,350024425700000090,350024425700000090	0-21,0-21,0-22,0-22,0-22,0-22						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MCM7,MIR93
878	chr25	38452464	38452929	3500131966	65		38452464	38452929	8421504	3	21,22,22	0,203,443	c,g	350013196600000011,350013196600000011,350013196600000006,350013196600000006,350013196600000090	0-21,0-21,0-22,0-22,0-22						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MCM7,MIR93
878	chr25	38452464	38452886	3500393603	63		38452464	38452886	8421504	3	21,23,19	0,202,403	c,g	350039360300000004,350039360300000004,350039360300000005,350039360300000005,350039360300000018	0-21,0-21,0-23,0-23,0-19						Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level	-publications.com	0	0		MCM7,MIR93
878	chr25	38452464	38452689	3500389139	45		38452464	38452689	8421504	2	22,23	0,202	c,g	350038913900000004,350038913900000004,350038913900000130,350038913900000130,350038913900000082,350038913900000082	22-44,22-44,22-44,22-44,22-44,22-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		MCM7,MIR93
878	chr25	38452464	38452689	3500306561	45		38452464	38452689	8421504	2	22,23	0,202	c,g	350030656100000004,350030656100000129,350030656100000129,350030656100000081,350030656100000081	22-44,22-44,22-44,22-44,22-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		MCM7,MIR93
878	chr25	38452464	38452689	3500257436	45		38452464	38452689	8421504	2	22,23	0,202	c,g	350025743600000004,350025743600000129,350025743600000129,350025743600000081,350025743600000081	22-44,22-44,22-44,22-44,22-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		MCM7,MIR93
878	chr25	38452464	38452689	3500232262	45		38452464	38452689	8421504	2	22,23	0,202	c,g	350023226200000004,350023226200000004,350023226200000129,350023226200000129,350023226200000081,350023226200000081	22-44,22-44,22-44,22-44,22-44,22-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
878	chr25	38452464	38452689	3500114594	44		38452464	38452689	8421504	2	21,23	0,202	c,g	350011459400000407,350011459400000407,350011459400000834,350011459400000834,350011459400000826,350011459400000826,350011459400000399,350011459400000399	0-21,0-21,0-21,0-21,0-23,0-23,0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MCM7,MIR93
878	chr25	38452464	38452689	3500031979	44		38452464	38452689	8421504	2	21,23	0,202	c,g	350003197900000322,350003197900000322,350003197900000314,350003197900000314	0-21,0-21,0-23,0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MCM7,MIR93
878	chr25	38452666	38452929	3500252752	45		38452666	38452929	8421504	2	23,22	0,241	c,g	350025275200000018,350025275200000018,350025275200000087,350025275200000087,350025275200000101,350025275200000032	0-23,0-23,0-23,0-23,0-22,0-22						MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY - Patent application	www.faqs.org	0	0		MCM7,MIR93
878	chr25	38452666	38452929	3500205806	45		38452666	38452929	8421504	2	23,22	0,241	c,g	350020580600000018,350020580600000018,350020580600000032,350020580600000032	0-23,0-23,0-22,0-22						MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY	Wang	2010	0		MCM7,MIR93
878	chr25	38452666	38452727	3500439152	45		38452666	38452727	8421504	2	23,22	0,39	c,g	350043915200000100,350043915200000100,350043915200000182	0-23,0-23,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR93
878	chr25	38452666	38452689	3500363855	23		38452666	38452689	8421504	1	23	0	c,g	350036385500000001,350036385500000001	0-23,0-23		20841420	10.1261/rna.2303610	1355-8382	RNA	Noncanonical cytoplasmic processing of viral microRNAs	Shapiro	2010	5		MIR93
878	chr25	38452861	38452929	3500338850	41		38452861	38452929	8421504	2	20,21	0,47	c,g	350033885000000006,350033885000000006,350033885000000007,350033885000000007	0-21,0-21,0-21,0-21		21372826	10.1038/aps.2010.220	1671-4083	Acta Pharmacologica Sinica	Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128	Wu	2011	2		MCM7,MIR93
878	chr25	38452905	38452930	3500306543	25		38452905	38452930	8421504	1	25	0	c	350030654300000015,350030654300000014	0-24,0-23		18694959	10.1128/MCB.00923-08		Molecular and Cellular Biology	Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells 	Li	2008	0		MCM7,MIR93
878	chr25	38454156	38455875	3500072968	427		38454156	38455875	8421504	8	95,48,13,115,12,3,89,52	0,412,464,560,751,1151,1253,1667	c	350007296800000300,350007296800000299,350007296800000295,350007296800000294,350007296800000293,350007296800000292,350007296800000289,350007296800000288,350007296800000287	0-47,0-48,0-48,0-44,0-48,0-48,0-48,0-48,0-48						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
878	chr25	38484982	38485051	3500385351	69		38484982	38485051	8421504	1	69	0	p	350038535100015176,350038535100015039	0-69,21-90						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZSCAN21
878	chr25	38484982	38485051	3500269504	69		38484982	38485051	8421504	1	69	0	p	350026950400015042	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZSCAN21
878	chr25	38484982	38485051	3500229015	69		38484982	38485051	8421504	1	69	0	p	350022901500015010	0-69						Figure S1 AB	genome.cshlp.org	0	0		ZSCAN21
878	chr25	38484982	38485051	3500176901	69		38484982	38485051	8421504	1	69	0	p	350017690100015025	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZSCAN21
878	chr25	38484982	38485051	3500160097	69		38484982	38485051	8421504	1	69	0	p	350016009700015040	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZSCAN21
878	chr25	38484982	38485051	3500105130	69		38484982	38485051	8421504	1	69	0	p	350010513000015004	0-69						Supplemental Figure 1	genome.cshlp.org	0	0		ZSCAN21
878	chr25	38484982	38485051	3500075471	69		38484982	38485051	8421504	1	69	0	p	350007547100015020,350007547100015088	21-90,0-69						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZSCAN21
878	chr25	38484982	38485051	3500074933	69		38484982	38485051	8421504	1	69	0	p	350007493300015051	0-69					Patent	Zink-Finger Dom&#xe4;nen und Verfahren zur Identifizierung derselben (Patent DE:60127819)	Hwang	2007	0		ZSCAN21
878	chr25	38484982	38485051	3500068714	69		38484982	38485051	8421504	1	69	0	p	350006871400015019	0-69					Patent	Zinc finger domains and methods of identifying same (Patent CN:1416467)	Quan Zhu Dao 	2012	0		ZSCAN21
878	chr25	38484994	38485051	3500238410	57		38484994	38485051	8421504	1	57	0	p	350023841000015032	0-57						Zinc finger domains and methods of identifying same	Hwang	2007	0		ZSCAN21
880	chr25	38696449	38696473	3500061916	24		38696449	38696473	8421504	1	24	0	c	350006191600000062,350006191600000004,350006191600000115,350006191600000104,350006191600000119,350006191600000016	7-31,7-31,7-31,7-31,7-30,7-27						Vaccine for House Dust Mite Allergen Using Naked DNA - Patent application	www.faqs.org	0	0		
880	chr25	38696450	38696473	3500314613	23		38696450	38696473	8421504	1	23	0	c	350031461300000118,350031461300000004	7-30,7-30						Vaccine for house dust mite allergen using naked DNA - US Patent 7439233 Description	ww.patentstorm.us	0	0		
880	chr25	38780028	38781628	3500003762	23		38780028	38781628	8421504	2	20,3	0,1597	c	350000376200000002	0-23						Novel Regulators of Pancreatic Cancer Cell Growth and Mobility	tampub.uta.fi	0	0		
882	chr25	39045765	39045843	3500337044	78		39045765	39045843	8421504	1	78	0	p	350033704400015001	15-93		11511539	10.1101/gad.906601	0890-9369	Genes & Development	Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation	Frank	2001	12		TRRAP
882	chr25	39045765	39045843	3500221242	78		39045765	39045843	8421504	1	78	0	p	350022124200015001	15-93		11511539	10.1101/gad.906601	0890-9369	Genes & Development	Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation	Frank	2001	12		TRRAP
882	chr25	39045768	39045796	3500238659	28		39045768	39045796	8421504	1	28	0	c	350023865900000000	0-28		16260778	10.1074/jbc.M510157200	0021-9258	Journal of Biological Chemistry	An hGCN5/TRRAP Histone Acetyltransferase Complex Co-activates BRCA1 Transactivation Function through Histone Modification	Oishi	2006	5		
883	chr25	39089581	39090040	3500206723	23		39089581	39090040	8421504	3	16,2,5	0,449,454	c	350020672300000035	3-26						MMB 292 DNA Viruses Methods and Protocols	www.scribd.com	0	0		
884	chr25	39206090	39206116	3500186557	23		39206090	39206116	8421504	2	11,12	0,14	g	350018655700000624,350018655700001518	0-23,0-23						Oligonucleotide for Detection of a Microorganism, Diagnostic Kits and Methods for Detection of Microorganisms Using the Oligonucleotide - Patent application	www.faqs.org	0	0		
888	chr25	39772149	39772224	3500035801	75		39772149	39772224	8421504	1	75	0	p	350003580100015041	96-171						Antibodies against human protein HUVDJ43	Moore	2002	0		CCZ1
888	chr25	39772149	39772215	3500182261	66		39772149	39772215	8421504	1	66	0	p	350018226100015062	96-162						49 human secreted proteins	Moore	2001	0		CCZ1
888	chr25	39824988	39825220	3500463575	48		39824988	39825220	8421504	2	38,10	0,222	p	350046357500015125	0-48						US Patent # 6,900,370. Method for generating hypermutable plants - Patents.com	www.patents.com	0	0		PMS2P5
888	chr25	39841085	39841114	3500458923	26		39841085	39841114	8421504	2	9,17	0,12	c	350045892300000080	10-36						US Patent # 6,475,782. Human platelet-derived growth factor receptor - Patents.com	www.patents.com	0	0		
888	chr25	39841085	39841114	3500025568	26		39841085	39841114	8421504	2	9,17	0,12	c	350002556800000185	9-35						US Patent # 7,105,305. Human platelet-derived growth factor receptors - Patents.com	www.patents.com	0	0		
888	chr25	39845663	39845689	3500425953	24		39845663	39845689	8421504	2	9,15	0,11	c	350042595300000150	20-44						Cleavage agents	www.devileye.net	0	0		
888	chr25	39845663	39845689	3500417793	24		39845663	39845689	8421504	2	9,15	0,11	c	350041779300000178	20-44						US Patent # 6,458,535. Detection of nucleic acids by multiple sequential invasive cleavages 02 - Patents.com	www.patents.com	0	0		
888	chr25	39845663	39845689	3500327109	24		39845663	39845689	8421504	2	9,15	0,11	c	350032710900000175	20-44						Invasive cleavage of nucleic acids	Brow	1999	0		
888	chr25	39845663	39845689	3500159977	24		39845663	39845689	8421504	2	9,15	0,11	c	350015997700000178	20-44						Detection of nucleic acids by multiple sequential invasive cleavages 02	Hall	1999	0		
888	chr25	39845663	39845689	3500152228	24		39845663	39845689	8421504	2	9,15	0,11	c	350015222800000183	20-44						Detection of nucleic acids by multiple sequential invasive cleavages	Hall	1997	0		
888	chr25	39845663	39845689	3500139533	24		39845663	39845689	8421504	2	9,15	0,11	c	350013953300000175	20-44						Invasive cleavage of nucleic acids	Brow	1997	0		
891	chr25	40121789	40121813	3500270031	23		40121789	40121813	8421504	2	4,19	0,5	c	350027003100000054	7-30						Method and product for regulating cell responsiveness to external signals	Johnson	1996	0		
891	chr25	40121789	40121813	3500234968	23		40121789	40121813	8421504	2	4,19	0,5	c	350023496800000054	7-30						Method and product for regulating cell responsiveness to external signals - Patent application	www.faqs.org	0	0		
891	chr25	40121884	40121912	3500422157	27		40121884	40121912	8421504	2	9,18	0,10	g	350042215700000000	35-62		21266780	10.1172/JCI43758		The Journal of Clinical Investigation	Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice	Omar	2011	0		
891	chr25	40133295	40133319	3500303532	24		40133295	40133319	8421504	1	24	0	c	350030353200000069	0-24						DEPARTAMENT DE GENATICA ESTUDIO DE FACTORES GENATICOS DE LOS SISTEMAS RELACIONADOS CON ESTRAS OX	www.tdx.cat	0	0		RAC1
891	chr25	40139170	40139290	3500306022	120		40139170	40139290	8421504	1	120	0	p	350030602200015102	0-120						What's new on STN International	biblio.bo.cnr.it	0	0		RAC1
891	chr25	40143323	40143347	3500120720	23		40143323	40143347	8421504	2	15,8	0,16	g	350012072000000109	13-40						Muscular Dystrophy	www.scribd.com	0	0		
891	chr25	40185519	40185549	3500406284	25		40185519	40185549	8421504	2	7,18	0,12	c	350040628400000141	9-34						Isolated ApoA-I gene regulatory sequence elements	Zannis	1993	0		HNF4A
893	chr25	40467237	40467265	3500241128	23		40467237	40467265	8421504	2	15,8	0,20	c	350024112800000096	5-28					Patent	Method for expression of heterologous proteins in yeast (Patent US:6083723)	Tekamp-Olson	2000	0		
893	chr25	40467237	40467265	3500155230	23		40467237	40467265	8421504	2	15,8	0,20	c	350015523000000162	2-25						 Microbially Expresses Xylanases And Their Use As Feed Additives And Other Uses 	www.docstoc.com	0	0		
893	chr25	40467237	40467265	3500043540	23		40467237	40467265	8421504	2	15,8	0,20	g	350004354000000108	2-25						US Patent # 6,987,212. Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use - Patents.com	www.patents.com	0	0		
893	chr25	40467237	40467265	3500014007	23		40467237	40467265	8421504	2	15,8	0,20	c	350001400700000137	5-28						Protease inhibitor peptides	White	1997	0		
894	chr25	40563429	40563474	3500306083	45		40563429	40563474	8421504	1	45	0	p	350030608300015026	0-45						Nature June 2 ,2011	www.calameo.com	0	0		RNF216
894	chr25	40563486	40563534	3500466964	48		40563486	40563534	8421504	1	48	0	p	350046696400015011	0-48						Structure of the human Parkin ligase domain in an autoinhibited state	mrc-lmb.cam.ac.uk	0	0		RNF216
894	chr25	40590573	40590598	3500004227	23		40590573	40590598	8421504	2	18,5	0,20	c	350000422700000600	10-33						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		FSCN1
895	chr25	40639861	40642176	3500203028	40		40639861	40642176	8421504	2	20,20	0,2295	g	350020302800000054,350020302800000033	0-20,0-20						DETERMINATION OF RENIN-PRORENIN RECEPTOR ACTIVITY	Funke-kaiser	2007	0		ACTB,RCAN2
895	chr25	40639861	40642176	3500136580	40		40639861	40642176	8421504	2	20,20	0,2295	g	350013658000000054,350013658000000033	0-20,0-20						DETERMINATION OF RENIN/PRORENIN RECEPTOR ACTIVITY - CHARITE - UNIVERSIT&#xc4;TSMEDIZIN BERLIN	www.sumobrain.com	0	0		ACTB
895	chr25	40640934	40641207	3500329982	40		40640934	40641207	8421504	2	20,20	0,253	c	350032998200000004,350032998200000005	0-20,0-20			10.1590/S1415-47572007000600029	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Expression of the CTCF gene in bovine oocytes and preimplantation embryos	Rios	2007	1		
895	chr25	40640948	40642129	3500467500	46		40640948	40642129	8421504	2	22,24	0,1157	c	350046750000000065,350046750000000057	0-22,0-24						Functional genomics in fish: towards undertanding	www.tdx.cat	0	0		
895	chr25	40640951	40642070	3500373325	41		40640951	40642070	8421504	2	20,21	0,1098	c,g	350037332500000000,350037332500000001,350037332500000001	0-20,0-21,0-21			10.1167/iovs.06-1023		Investigative ophthalmology & visual science	Thrombin Induces VEGF Expression in Human Retinal Pigment Epithelial Cells	Zong-Mei	June	0		ACTB
895	chr25	40640951	40642070	3500364850	41		40640951	40642070	8421504	2	20,21	0,1098	c,g	350036485000000002,350036485000000003,350036485000000003	0-20,0-21,0-21		18535203	10.1182/blood-2007-12-128967		Blood	Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-&#x03b3;	Raju	2008	0		ACTB
895	chr25	40640951	40641358	3500252820	40		40640951	40641358	8421504	2	20,20	0,387	c	350025282000000000,350025282000000001	0-20,0-20						Reproductive cancer diagnosis and therapy	Chopin	2004	0		
895	chr25	40641182	40641207	3500151026	25		40641182	40641207	8421504	1	25	0	c	350015102600000003	0-25		9570530		0022-1767	The Journal of Immunology	IL-12 Up-Regulates CD40 Ligand (CD154) Expression on Human T Cells	Peng	1998	6		
895	chr25	40641185	40641212	3500329425	27		40641185	40641212	8421504	1	27	0	c	350032942500000010	0-27		15901832	10.1091/mbc.E04-11-1029	1059-1524	Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Im	2005	5		ACTA1
895	chr25	40641185	40641212	3500228083	27		40641185	40641212	8421504	1	27	0	c	350022808300000010	0-27			10.1091/mbc.E04-11-1029		Molecular Biology of the Cell	Cathepsin B Regulates the Intrinsic Angiogenic Threshold of Endothelial Cells	Eunok	2005	0		ACTA1
895	chr25	40641185	40641212	3500078966	27		40641185	40641212	8421504	1	27	0	c	350007896600000010	0-27						Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells	w.molbiolcell.org	0	0		ACTC1
895	chr25	40641188	40641214	3500197303	26		40641188	40641214	8421504	1	26	0	c	350019730300000007	0-26		15039314	10.1128/IAI.72.4.1946-1955.2004	0019-9567	Infection and Immunity	N-Linked Glycosylation Is Required for C1 Inhibitor-Mediated Protection from Endotoxin Shock in Mice	Liu	2004	4		
895	chr25	40641190	40641219	3500355117	29		40641190	40641219	8421504	1	29	0	c	350035511700000016	0-29		18458092	10.2353/ajpath.2008.070429		The American Journal of Pathology	Endogenous Hydrogen Peroxide Regulates Glutathione Redox via Nuclear Factor Erythroid 2-Related Factor 2 Downstream of Phosphatidylinositol 3-Kinase during Muscle Differentiation	Yan	June	0		POTEG,POTEF
895	chr25	40641191	40642179	3500396446	40		40641191	40642179	8421504	2	20,20	0,968	c,g	350039644600000002,350039644600000003,350039644600000003	0-20,0-20,0-20						Cloning of mouse telomerase reverse transcriptase gene promoter and identification of proximal core promoter sequences essential for the expression of transgenes in cancer cells	-publications.com	0	0		
895	chr25	40641194	40641852	3500465773	40		40641194	40641852	8421504	2	20,20	0,638	c	350046577300000006,350046577300000007	0-20,0-20						Sonic Hedgehog Promotes Rod Photoreceptor Differentiation in Mammalian Retinal Cells In Vitro	ty.washington.edu	0	0		
895	chr25	40641194	40641852	3500458124	40		40641194	40641852	8421504	2	20,20	0,638	c	350045812400000002,350045812400000003	0-20,0-20		18055485	10.1677/JME-07-0036	0952-5041	Journal of Molecular Endocrinology	Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers	Nakamura	2007	3		
895	chr25	40641194	40641852	3500332037	40		40641194	40641852	8421504	2	20,20	0,638	c	350033203700000006,350033203700000007	0-20,0-20		9236238		0270-6474	The Journal of Neuroscience	Sonic Hedgehog Promotes Rod Photoreceptor Differentiation in Mammalian Retinal Cells In Vitro	Levine	1997	7		
895	chr25	40641194	40641852	3500317474	40		40641194	40641852	8421504	2	20,20	0,638	c	350031747400000006,350031747400000007	0-20,0-20						Sonic Hedgehog Promotes Rod Photoreceptor Differentiation in Mammalian Retinal Cells In Vitro	ty.washington.edu	0	0		
895	chr25	40641194	40641852	3500317161	40		40641194	40641852	8421504	2	20,20	0,638	c	350031716100000003,350031716100000004	0-20,0-20			10.1093/nar/gkh527		Nucleic Acids Research	DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene	Giuseppina	2004	0		
895	chr25	40641194	40641852	3500252540	40		40641194	40641852	8421504	2	20,20	0,638	c	350025254000000004,350025254000000005	0-20,0-20		17047050	10.1158/0008-5472.CAN-05-4302	0008-5472	Cancer Research	Connexins Act as Tumor Suppressors in Three-dimensional Mammary Cell Organoids by Regulating Differentiation and Angiogenesis	McLachlan	2006	8		ACTB
895	chr25	40641194	40641852	3500215772	40		40641194	40641852	8421504	2	20,20	0,638	c	350021577200000002,350021577200000003	0-20,0-20		18055485	10.1677/JME-07-0036	0952-5041	Journal of Molecular Endocrinology	Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers	Nakamura	2007	3		
895	chr25	40641194	40641852	3500203202	40		40641194	40641852	8421504	2	20,20	0,638	c	350020320200000013,350020320200000014	0-20,0-20		19783622	10.1124/mol.109.058024	1521-0111 (Online)	Molecular Pharmacology	Identification of Survival Genes in Human Glioblastoma Cells by Small Interfering RNA Screening	Thaker	2009	0		
895	chr25	40641194	40641852	3500202287	40		40641194	40641852	8421504	2	20,20	0,638	c	350020228700000007,350020228700000008	0-20,0-20		15087825		1073-2322	Shock	 Inhibition of Lipopolysaccharide-Induced Interferon Regulato... : Shock 	Dang	2004	3		
895	chr25	40641194	40641852	3500182723	40		40641194	40641852	8421504	2	20,20	0,638	c	350018272300000004,350018272300000005	0-20,0-20						Fatty Acid Derivatives of Catechins and Methods of Their use	Fereidoon	2013	0		
895	chr25	40641195	40642111	3500325264	54		40641195	40642111	8421504	2	27,27	0,889	g	350032526400000006,350032526400000007	0-27,0-27		17901226	10.1210/en.2007-1087	0013-7227	Endocrinology	Molecular Cloning and Characterization of Prostaglandin (PG) Transporter in Ovine Endometrium: Role for Multiple Cell Signaling Pathways in Transport of PGF2&#x03b1;	Banu	2008	4		
895	chr25	40641199	40641225	3500200036	26		40641199	40641225	8421504	1	26	0	c	350020003600000003	0-26		11679425	10.2337/diabetes.50.11.2481	0012-1797	Diabetes	Antecedent Hyperglycemia, Not Hyperlipidemia, Is Associated With Increased Islet Triacylglycerol Content and Decreased Insulin Gene mRNA Level in Zucker Diabetic Fatty Rats	Harmon	2001	8		POTEE
895	chr25	40641200	40642691	3500252042	60		40641200	40642691	8421504	3	20,20,20	0,1204,1471	c	350025204200000004,350025204200000006,350025204200000007	0-20,0-20,0-20		15653764	10.1152/ajpheart.00987.2004		American Journal of Physiology - Heart and Circulatory Physiology	Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors	Zhang	2005	0		
895	chr25	40641200	40641302	3500404944	40		40641200	40641302	8421504	2	20,20	0,82	c,g	350040494400000030,350040494400000031,350040494400000031	0-20,0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
895	chr25	40641203	40642759	3500351592	46		40641203	40642759	8421504	2	23,23	0,1533	c,g	350035159200000000,350035159200000000,350035159200000001	0-23,0-23,0-23						BMC Developmental Biology BioMed	biomedcentral.com	0	0		
895	chr25	40641203	40641232	3500338588	29		40641203	40641232	8421504	1	29	0	c	350033858800000047,350033858800000085	0-29,0-29						US Patent # 6,498,024. Subtractive amplification kit useful in the diagnosis of genetic disease mutation or variation - Patents.com	www.patents.com	0	0		POTEM
895	chr25	40641211	40641234	3500115089	23		40641211	40641234	8421504	1	23	0	c	350011508900000022	0-23		21423371	10.3389/fphys.2010.00129	1664-042X	Frontiers in Physiology	 Frontiers | Identification of Zebrafish Fxyd11a Protein that is Highly Expressed in Ion-Transporting Epithelium of the Gill and Skin and its Possible Role in Ion Homeostasis | Frontiers in Aquatic Physiology 	Saito	2010	0		
895	chr25	40641223	40641247	3500162718	24		40641223	40641247	8421504	1	24	0	c	350016271800000002	0-24						DEVICE AND METHOD FOR MANIPULATING DROPLETS USING GEL-STATE MEDIUM - Patent application	www.faqs.org	0	0		ACTB,TP53BP2
895	chr25	40641228	40641848	3500376749	42		40641228	40641848	8421504	2	21,21	0,599	c	350037674900000010,350037674900000011	0-21,0-21						The Expression of Sprouty1, an Inhibitor of Fibroblast Growth Factor Signal Transduction, Is Decreased in Human Prostate Cancer	www.dtic.mil	0	0		
895	chr25	40641233	40642079	3500404562	42		40641233	40642079	8421504	2	21,21	0,825	c,g	350040456200000010,350040456200000011	0-21,0-21						Angiogenesis, Metastasis, and the Cellular Microenvironment Molecular Cancer Research CADPE Inhibits PMA-Stimulated Gastric Carcinoma Cell Invasion and Matrix Metalloproteinase-9 Expression by FAK/MEK/ERK Mediated AP-1 Activation	.aacrjournals.org	0	0		
895	chr25	40641233	40642079	3500313397	42		40641233	40642079	8421504	2	21,21	0,825	c,g	350031339700000010,350031339700000011,350031339700000011	0-21,0-21,0-21		21047770	10.1158/1541-7786.MCR-10-0114	1541-7786	Molecular Cancer Research	CADPE Inhibits PMA-Stimulated Gastric Carcinoma Cell Invasion and Matrix Metalloproteinase-9 Expression by FAK/MEK/ERK&#x2013;Mediated AP-1 Activation	Han	2010	4		
895	chr25	40641233	40642079	3500210639	42		40641233	40642079	8421504	2	21,21	0,825	c,g	350021063900000004,350021063900000005	0-21,0-21						ScienceDirect.com - Biochemical and Biophysical Research Communications - Ascofuranone stimulates expression of adiponectin and peroxisome proliferator activated receptor through the modulation of mitogen activated protein kinase family members in 3T3-L1,	sciencedirect.com	0	0		
895	chr25	40641233	40642079	3500205756	42		40641233	40642079	8421504	2	21,21	0,825	c,g	350020575600000006,350020575600000007,350020575600000007	0-21,0-21,0-21						p53-Independent Induction of G Arrest and p21WAF1/CIP1 Expression by Ascofuranone, an Isoprenoid Antibiotic, through Downregulation of c-Myc	.aacrjournals.org	0	0		ACTG1
895	chr25	40641233	40642079	3500136694	42		40641233	40642079	8421504	2	21,21	0,825	c,g	350013669400000006,350013669400000007	0-21,0-21		20587660	10.1158/1535-7163.MCT-09-1159	1535-7163	Molecular Cancer Therapeutics	p53-Independent Induction of G1 Arrest and p21WAF1/CIP1 Expression by Ascofuranone, an Isoprenoid Antibiotic, through Downregulation of c-Myc	Jeong	2010	5		ACTG1
895	chr25	40641234	40641850	3500119829	47		40641234	40641850	8421504	2	23,24	0,592	c	350011982900000010,350011982900000011	0-23,0-24						Niacin Increases HDL Biogenesis by Enhancing DR4-dependent Transcription of ABCA1 and Lipidation of Apolipoprotein A-I in HepG2 Cells	www.jlr.org	0	0		
895	chr25	40641238	40641263	3500454041	25		40641238	40641263	8421504	1	25	0	c,g	350045404100000000,350045404100000000	0-25,0-25		20181667	10.1152/ajprenal.00529.2009		American Journal of Physiology - Renal Physiology	Upregulation of parathyroid VDR expression by extracellular calcium is mediated by ERK1/2-MAPK signaling pathway	Canadillas	2010	0		ACTB,ACTG1
895	chr25	40641238	40641263	3500353893	25		40641238	40641263	8421504	1	25	0	c	350035389300000000	0-25		20181667	10.1152/ajprenal.00529.2009		American Journal of Physiology - Renal Physiology	Upregulation of parathyroid VDR expression by extracellular calcium is mediated by ERK1/2-MAPK signaling pathway	Canadillas	2010	0		ACTB,ZP4
895	chr25	40641238	40641263	3500301925	25		40641238	40641263	8421504	1	25	0	c,g	350030192500000000,350030192500000000	0-25,0-25		15888568	10.1681/ASN.2004080657	1046-6673	Journal of the American Society of Nephrology	Calcium-Sensing Receptor Expression and Parathyroid Hormone Secretion in Hyperplastic Parathyroid Glands from Humans	Canadillas	2005	10		ACTB
895	chr25	40641238	40641263	3500236853	25		40641238	40641263	8421504	1	25	0	c,g	350023685300000000,350023685300000000	0-25,0-25		15888568	10.1681/ASN.2004080657	1046-6673	Journal of the American Society of Nephrology	Calcium-Sensing Receptor Expression and Parathyroid Hormone Secretion in Hyperplastic Parathyroid Glands from Humans	Canadillas	2005	10		ACTB,ZP4
895	chr25	40641239	40642358	3500406984	43		40641239	40642358	8421504	3	21,9,13	0,1008,1106	c	350040698400000051,350040698400000054	0-21,0-22						Detection of carcinoma metastases by nucleic acid amplification	Sobol	1995	0		ACTB
895	chr25	40641239	40642358	3500090507	43		40641239	40642358	8421504	3	21,9,13	0,1008,1106	c,g	350009050700000051,350009050700000051,350009050700000054	0-21,0-21,0-22					Patent	Detection of carcinoma metastases by nucleic acid amplification (Patent US:5543296)	Green	1996	0		ACTB
895	chr25	40641240	40641922	3500347722	39		40641240	40641922	8421504	2	20,19	0,663	c,g	350034772200000021,350034772200000022,350034772200000022	0-20,0-19,0-19		15087381	10.1158/0008-5472.CAN-03-3000	0008-5472	Cancer Research	Promoter Methylation Inhibits APC Gene Expression by Causing Changes in Chromatin Conformation and Interfering with the Binding of Transcription Factor CCAAT-Binding Factor	Deng	2004	8		ACTB
895	chr25	40641241	40642032	3500112484	40		40641241	40642032	8421504	2	20,20	0,771	c	350011248400000008,350011248400000009	0-20,0-20						Original article Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy	xa.yimg.com	0	0		
895	chr25	40641242	40642796	3500394731	42		40641242	40642796	8421504	2	21,21	0,1533	g	350039473100000000,350039473100000001	0-21,0-21			10.1111/j.1365-3024.2006.00928.x	1365-3024	Parasite Immunology	Haemonchus contortus intestine: a prominent source of mucosal antigens - JASMER - 2007 - Parasite Immunology - Wiley Online Library	JASMER	2007	0		
895	chr25	40641242	40642136	3500386207	43		40641242	40642136	8421504	2	23,20	0,874	c	350038620700000000,350038620700000007	0-23,0-20			10.1128/IAI.00622-06		Infection and Immunity	Autocrine Role for Interleukin-8 in Bartonella henselae-Induced Angiogenesis 	Amy	2006	0		
895	chr25	40641242	40642062	3500125239	43		40641242	40642062	8421504	2	23,20	0,800	c	350012523900000017,350012523900000018	0-23,0-20			10.1002/eji.200636999	1521-4141	European Journal of Immunology	Notch signaling is activated by TLR stimulation and regulates macrophage functions - Palaga - 2007 - European Journal of Immunology - Wiley Online Library	Palaga	2008	0		
895	chr25	40641242	40642036	3500101452	45		40641242	40642036	8421504	2	21,24	0,770	c	350010145200000010,350010145200000000,350010145200000011,350010145200000001	0-21,0-21,0-24,0-24						INHIBITION OF PACAP SIGNALLING FOR THE PREVENTION AND TREATMENT OF THROMBOCYTOPENIA - Patent application	www.faqs.org	0	0		
895	chr25	40641242	40642035	3500463087	44		40641242	40642035	8421504	2	21,23	0,770	g	350046308700000019,350046308700000020	0-21,0-23		19021771	10.1111/j.1742-4658.2008.06725.x	1742-4658	FEBS Journal	DNA-dependent protein kinase is involved in heat shock protein-mediated accumulation of hypoxia-inducible factor-1&#x03b1; in hypoxic preconditioned HepG2 cells - Kang - 2008 - FEBS Journal - Wiley Online Library	Kang	2008	0		ACTC1
895	chr25	40641242	40642035	3500358701	44		40641242	40642035	8421504	2	21,23	0,770	c	350035870100000024,350035870100000025	0-21,0-23		17569822	10.1124/jpet.107.124461	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Bcr-Abl-Independent Imatinib-Resistant K562 Cells Show Aberrant Protein Acetylation and Increased Sensitivity to Histone Deacetylase Inhibitors	Lee	2007	0		
895	chr25	40641242	40641267	3500325751	25		40641242	40641267	8421504	1	25	0	c	350032575100000000	0-25						N-cadherin in Osteolineage Cells is Not Required for Maintenance of Hematopoietic Stem Cells	tologylibrary.org	0	0		
895	chr25	40641242	40641267	3500213810	25		40641242	40641267	8421504	1	25	0	c	350021381000000003	0-25			10.1182/blood-2004-01-0272		Blood	G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow	Craig	2005	0		ACTG1
895	chr25	40641242	40641267	3500025738	25		40641242	40641267	8421504	1	25	0	c	350002573800000017	0-25						Knockdown of E2f1 by RNA interference impairs proliferation of rat cells in vitro. - ResearchGate	.researchgate.net	0	0		POTEM
895	chr25	40641242	40641265	3500299003	23		40641242	40641265	8421504	1	23	0	c	350029900300000003	0-23		17974967	10.1158/0008-5472.CAN-07-1204	0008-5472	Cancer Research	Manganese Superoxide Dismutase Enhances the Invasive and Migratory Activity of Tumor Cells	Connor	2007	8		ACTG1
895	chr25	40641242	40641265	3500118757	23		40641242	40641265	8421504	1	23	0	g	350011875700000004	0-23						Endothelial cell mediators of angiogenesis in Bartonella henselae infection	arcommons.usf.edu	0	0		ACTG1
895	chr25	40641243	40641274	3500421121	31		40641243	40641274	8421504	1	31	0	c	350042112100000024	29-60						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		ZP4
895	chr25	40641243	40641274	3500409810	31		40641243	40641274	8421504	1	31	0	c	350040981000000002	29-60						Estrous cycle-dependent changes of Fas expression in the bovine corpus luteum: influence of keratin 8/18 intermediate filaments and cytokines	www.rbej.com	0	0		ACTC1
895	chr25	40641243	40641274	3500055266	31		40641243	40641274	8421504	1	31	0	c	350005526600000002	29-60		23113883	10.1186/1477-7827-10-90	1477-7827	Reproductive Biology and Endocrinology	Estrous cycle-dependent changes of Fas expression in the bovine corpus luteum: influence of keratin 8/18 intermediate filaments and cytokines	Duncan	2012	2		POTEM
895	chr25	40641244	40641274	3500290087	30		40641244	40641274	8421504	1	30	0	c	350029008700000007	0-30		19656380	10.1186/1477-7827-7-80		Reproductive Biology and Endocrinology : RB&E	Transforming growth factor beta isoforms regulation of Akt activity and XIAP levels in rat endometrium during estrous cycle, in a model of pseudopregnancy and in cultured decidual cells	Pierre-Luc	2009	0		ACTC1
895	chr25	40641244	40641268	3500306438	24		40641244	40641268	8421504	1	24	0	c	350030643800000009	0-24						TheHistoneMethyltransferaseSETDB1andtheDNA MethyltransferaseDNMT3AInteractDirectlyandLocalize toPromotersSilencedinCancerCells S	www.jbc.org	0	0		ACTG1
895	chr25	40641244	40641268	3500021040	24		40641244	40641268	8421504	1	24	0	c	350002104000000002	0-24		20500517	10.1111/j.1349-7006.2010.01600.x	1349-7006	Cancer Science	Lentiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer - Liu - 2010 - Cancer Science - Wiley Online Library	Liu	2010	0		ACTB
895	chr25	40641244	40641267	3500304796	23		40641244	40641267	8421504	1	23	0	c	350030479600000004	0-23		10960347			American Journal of Physiology - Gastrointestinal and Liver Physiology	Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria	Ogawa	2000	0		ACTG1
895	chr25	40641246	40641876	3500361371	39		40641246	40641876	8421504	2	20,19	0,611	c	350036137100000012,350036137100000013	0-20,0-19		22340947	10.1186/2044-5040-2-4		Skeletal Muscle	Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation	Maura	2012	0		
895	chr25	40641252	40641352	3500231168	100		40641252	40641352	8421504	1	100	0	c	350023116800000004	0-100						Communication No. 31, Iesue OF 5, pp. 15868-15871,1988 1988 American Society for Biochemistry U:S.A	www.marietta.edu	0	0		
895	chr25	40641255	40641279	3500349350	24		40641255	40641279	8421504	1	24	0	g	350034935000000017	0-24		19357319	10.1124/jpet.109.153460	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Rab1 GTPase and Dimerization in the Cell Surface Expression of Angiotensin II Type 2 Receptor	Zhang	2009	0		ACTG1
895	chr25	40641258	40641949	3500092894	46		40641258	40641949	8421504	2	23,23	0,668	c	350009289400000004,350009289400000005	0-23,0-23						Effects of the monoamine oxidase inhibitors pargyline and tranylcypromine on cellular proliferation in human prostate cancer cells	-publications.com	0	0		POTEM
895	chr25	40641259	40642136	3500458941	42		40641259	40642136	8421504	2	21,21	0,856	c	350045894100000000,350045894100000001	0-21,0-21		20829890	10.1038/cgt.2010.49	0929-1903	Cancer Gene Therapy	Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a &#x03b2;-galactosidase-activatable prodrug seco-analog of duocarmycin SA	Seubert	2010	3		
895	chr25	40641264	40641287	3500457727	23		40641264	40641287	8421504	1	23	0	c	350045772700000000	0-23		19785658	10.1111/j.1476-5381.2009.00401.x	1476-5381	British Journal of Pharmacology	&#x03b1;-Fetoprotein as a modulator of the pro-inflammatory response of human keratinocytes - Potapovich - 2009 - British Journal of Pharmacology - Wiley Online Library	Potapovich	2009	0		POTEM
895	chr25	40641266	40641853	3500346927	45		40641266	40641853	8421504	2	23,22	0,565	c	350034692700000006,350034692700000007	0-23,0-22		19131542	10.1093/carcin/bgp009		Carcinogenesis	Grape seed extract inhibits VEGF expression via reducing HIF-1&#x03b1; protein expression	Jianming	2009	0		POTEE
895	chr25	40641266	40641853	3500335414	45		40641266	40641853	8421504	2	23,22	0,565	c	350033541400000006,350033541400000007	0-23,0-22		19250552	10.1186/1476-4598-8-11	1476-4598	Molecular Cancer	Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis	Zhang	2009	4		
895	chr25	40641266	40641289	3500106907	23		40641266	40641289	8421504	1	23	0	c	350010690700000000	20-43		22836867	10.1002/jbmr.1721	1523-4681	Journal of Bone and Mineral Research	Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro - Xiao - 2012 - Journal of Bone and Mineral Research - Wiley Online Library	Xiao	2013	0		ACTG1
895	chr25	40641267	40641887	3500333769	38		40641267	40641887	8421504	2	19,19	0,601	c,g	350033376900000010,350033376900000011,350033376900000011	0-19,0-19,0-19						Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells	www.jleukbio.org	0	0		
895	chr25	40641267	40641887	3500280392	38		40641267	40641887	8421504	2	19,19	0,601	c,g	350028039200000010,350028039200000011,350028039200000011	0-19,0-19,0-19						Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells	www.jleukbio.org	0	0		
895	chr25	40641267	40641353	3500178539	39		40641267	40641353	8421504	2	19,20	0,66	c	350017853900000005,350017853900000004	20-39,0-20						'EFEITO DO HORM&#xd4;NIO DO CRESCIMENTO RECOMBINANTE NA EXPRESS&#xc3;O G&#xca;NICA DE ENZIMAS REGULADORAS DA LIPOG&#xca;NESE EM ANIMAIS EM CRES	www.teses.usp.br	0	0		ACTG1
895	chr25	40641268	40641374	3500021615	40		40641268	40641374	8421504	2	20,20	0,86	c,g	350002161500000002,350002161500000002,350002161500000003	0-20,0-20,0-20		21473770	10.1186/1472-6750-11-33		BMC Biotechnology	A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogues	Nicklas	2011	0		
895	chr25	40641269	40642135	3500283483	40		40641269	40642135	8421504	2	20,20	0,846	c	350028348300000002,350028348300000003	0-20,0-20						THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 280, No. 1, Issue of January 7, pp. 476&#x2013;483, 2005 &#xa9; 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Prostaglandin E Regulates the Complement Inhibitor CD55/ D	www.jbc.org	0	0		
895	chr25	40641269	40642135	3500084653	40		40641269	40642135	8421504	2	20,20	0,846	c	350008465300000002,350008465300000003	0-20,0-20						Method for collecting and using nuclear mrna	Mitsuhashi	2002	0		
895	chr25	40641269	40641889	3500308390	48		40641269	40641889	8421504	2	24,24	0,596	c,g	350030839000000002,350030839000000002,350030839000000003	0-24,0-24,0-24						Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition	-publications.com	0	0		
895	chr25	40641272	40642094	3500347116	44		40641272	40642094	8421504	2	22,22	0,800	c,g	350034711600000015,350034711600000016,350034711600000016	0-22,0-22,0-22						Overexpression of IGF2R and IGF1R mRNA in	www.chinagene.cn	0	0		
895	chr25	40641272	40642094	3500191489	44		40641272	40642094	8421504	2	22,22	0,800	c,g	350019148900000002,350019148900000003,350019148900000003	0-22,0-22,0-22						RICARDO DE NARDI FONOFF	www.teses.usp.br	0	0		
895	chr25	40641299	40642479	3500404015	192		40641299	40642479	8421504	3	54,75,63	0,794,1117	p	350040401500015020,350040401500015022,350040401500015021	0-54,0-75,0-63			10.1111/j.1432-1033.2004.04004.x	1432-1033	European Journal of Biochemistry	Functional analyses of placental protein&#xa0;13/galectin-13 - Than - 2004 - European Journal of Biochemistry - Wiley Online Library	Than	2004	0		ACTG1
895	chr25	40641299	40641353	3500431918	54		40641299	40641353	8421504	1	54	0	p	350043191800015007	0-54						Riboproteomics of the Hepatitis C Virus Internal Ribosomal Entry Site	gs.washington.edu	0	0		ACTG1
895	chr25	40641299	40641353	3500248707	54		40641299	40641353	8421504	1	54	0	p	350024870700015086	0-54						Prot&#xe9;omique : maitrise de l'instrumentation, applications et &#xe9;tude des glycosylations	eses.u-strasbg.fr	0	0		ACTG1
895	chr25	40641299	40641350	3500316430	51		40641299	40641350	8421504	1	51	0	p	350031643000015002	0-51						Antigens for Vaccination Against and Detection of Mycoplasma Suis - Patent application	www.faqs.org	0	0		ACTG1
895	chr25	40641308	40642802	3500091635	55		40641308	40642802	8421504	2	22,33	0,1461	c	350009163500000002,350009163500000003	0-22,0-33		11451961	10.1074/jbc.M105135200	0021-9258	Journal of Biological Chemistry	Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate-dependent Surface Binding of Galectin-1 and Functional Divergence from Galectin-3	Kopitz	2001	5		
895	chr25	40641308	40642802	3500075617	41		40641308	40642802	8421504	2	22,19	0,1475	c	350007561700000002,350007561700000003	0-22,0-19		10666225		0006-4971	Blood	Aberrant expression of active leukotriene C4 synthase in CD16+ neutrophils from patients with chronic myeloid leukemia	Sjolinder	2000	10		
895	chr25	40641309	40642802	3500455647	42		40641309	40642802	8421504	2	21,21	0,1472	c	350045564700000000,350045564700000001	0-21,0-21		12839940		0008-5472	Cancer Research	Induction of Aromatase (CYP19) Expression in Breast Cancer Cells through a Nongenomic Action of Estrogen Receptor &#x03b1;	Kinoshita	2003	8		
895	chr25	40641310	40641999	3500126549	39		40641310	40641999	8421504	2	20,19	0,670	g	350012654900000005,350012654900000006	0-20,0-19			10.1093/emboj/cdg242	ERROR! NO ISSN	The EMBO Journal	Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1	Julien	2003	0		ACTB
895	chr25	40641315	40642005	3500226450	39		40641315	40642005	8421504	2	20,19	0,671	c	350022645000000009,350022645000000010	0-20,0-19		22446874	10.1158/1541-7786.MCR-11-0473	1541-7786	Molecular Cancer Research	Downregulation of Human Farnesoid X Receptor by miR-421 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells	Zhang	2012	4		
895	chr25	40641320	40641343	3500231750	23		40641320	40641343	8421504	1	23	0	c	350023175000000003	0-23						Nitricoxideinitiatesprogressionofhumanmelanoma viaafeedbackloopmediatedbyapurinic/apyrimidinic endonuclease-1/redoxfactor-1,whichisinhibited byresveratrol	.aacrjournals.org	0	0		
895	chr25	40641335	40641361	3500376052	26		40641335	40641361	8421504	1	26	0	g	350037605200000006	0-26						Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection	Arenzana-Seisdedos	1998	0		CCDC74A,POTEI
895	chr25	40641336	40642970	3500012652	41		40641336	40642970	8421504	2	22,19	0,1615	c	350001265200000007,350001265200000005	0-22,0-19						RELATED PEPTIDASE ACTIVATION ACTIVATED RECEPTOR FAMILY MEMBERS AND ASSOCIATION WITH PROSTATE CANCER	prints.qut.edu.au	0	0		
895	chr25	40641336	40641363	3500283519	27		40641336	40641363	8421504	1	27	0	c	350028351900000002	18-45						Effect of docosahexaenoic acid and arachidonic acid on the expression of adipocyte determination and differentiation-dependent factor 1 in differentiating porcine adipocytes	animalscience.org	0	0		
895	chr25	40641336	40641361	3500466087	25		40641336	40641361	8421504	1	25	0	c	350046608700000031	0-25						Soluble il-17rcx4 and methods of using in inflammation	Gao	2008	0		ACTB
895	chr25	40641336	40641361	3500430607	25		40641336	40641361	8421504	1	25	0	c	350043060700000001	0-25						Regulation of early peritoneal neutrophil migration by macrophage in&#xfb02;ammatory protein-2 and mast cells in experimental peritonitis	www.jleukbio.org	0	0		POTEF
895	chr25	40641336	40641361	3500423029	25		40641336	40641361	8421504	1	25	0	c	350042302900000009	0-25		18240266	10.1002/art.23163	1529-0131	Arthritis & Rheumatism	Effective treatment with oral administration of rebamipide in a mouse model of Sj&#xf6;gren's syndrome - Kohashi - 2008 - Arthritis & Rheumatism - Wiley Online Library	Kohashi	2008	0		ACTB
895	chr25	40641336	40641361	3500419481	25		40641336	40641361	8421504	1	25	0	c	350041948100000003	0-25		14726498	10.1189/jlb.0903442	0741-5400	Journal of Leukocyte Biology	Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene	Burnett	2004	5		ACTB
895	chr25	40641336	40641361	3500386834	25		40641336	40641361	8421504	1	25	0	c	350038683400000003	0-25		14726498	10.1189/jlb.0903442	0741-5400	Journal of Leukocyte Biology	Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene	Burnett	2004	5		POTEE
895	chr25	40641336	40641361	3500368063	25		40641336	40641361	8421504	1	25	0	c	350036806300000151,350036806300000034	0-25,0-25						SOLUBLE IL-17RA/RC FUSION PROTEINS AND RELATED METHODS - Patent application	www.faqs.org	0	0		ACTB
895	chr25	40641336	40641361	3500349123	25		40641336	40641361	8421504	1	25	0	c	350034912300000034	0-25						SOLUBLE IL-17RA/RC FUSION PROTEINS AND RELATED METHODS	Levin	2008	0		ACTB
895	chr25	40641336	40641361	3500315826	25		40641336	40641361	8421504	1	25	0	c	350031582600000034	0-25					Patent	Methods of treating inflammation using soluble IL-17RA/RC fusion proteins (Patent US:8242072)	Levin	2012	0		POTEF
895	chr25	40641336	40641361	3500298988	25		40641336	40641361	8421504	1	25	0	c	350029898800000015	0-25		9755091			American Journal of Physiology - Endocrinology and Metabolism	Intrinsic mineralization defect inHyp mouse osteoblasts	Xiao	1998	0		POTEF
895	chr25	40641336	40641361	3500290328	25		40641336	40641361	8421504	1	25	0	c	350029032800000010	0-25		19903769	10.1158/1541-7786.MCR-08-0325	1541-7786	Molecular Cancer Research	Critical Role of Endogenous Heme Oxygenase 1 as a Tuner of the Invasive Potential of Prostate Cancer Cells	Gueron	2009	4		ACTB
895	chr25	40641336	40641361	3500288440	25		40641336	40641361	8421504	1	25	0	c	350028844000000003	0-25						ScienceDirect.com - Lung Cancer - Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data	sciencedirect.com	0	0		ACTB
895	chr25	40641336	40641361	3500264182	25		40641336	40641361	8421504	1	25	0	c	350026418200000034	0-25						IL-17A and IL-17F Antagonists and Methods of Using the Same	Bilsborough	2007	0		POTEE
895	chr25	40641336	40641361	3500254942	25		40641336	40641361	8421504	1	25	0	c	350025494200000009	0-25		15673544	10.1189/jlb.1004567	0741-5400	Journal of Leukocyte Biology	Heterogeneity of functional responses in differentiated myeloid cell lines reveals EPRO cells as a valid model of murine neutrophil functional activation	Gaines	2005	5		ACTB
895	chr25	40641336	40641361	3500249440	25		40641336	40641361	8421504	1	25	0	c	350024944000000034	0-25						Soluble il-17ra/rc fusion proteins and related methods	Levin	2011	0		POTEF
895	chr25	40641336	40641361	3500249266	25		40641336	40641361	8421504	1	25	0	c	350024926600000034	0-25						Soluble il-17ra/rc fusion proteins and related methods	Levin	2012	0		POTEF
895	chr25	40641336	40641361	3500237458	25		40641336	40641361	8421504	1	25	0	c	350023745800000031	0-25						Soluble il-17ra/rc fusion proteins and related methods	Gao	2009	0		ACTB
895	chr25	40641336	40641361	3500218805	25		40641336	40641361	8421504	1	25	0	c	350021880500000033	0-25						Il-17a And Il-17f Antagonists And Methods Of Using The Same 	.freshpatents.com	0	0		POTEF
895	chr25	40641336	40641361	3500212967	25		40641336	40641361	8421504	1	25	0	c	350021296700000034	0-25						Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation	Presnell	2005	0		POTEF
895	chr25	40641336	40641361	3500181648	25		40641336	40641361	8421504	1	25	0	c	350018164800000034	0-25					Patent	Soluble IL-17RA/RC fusion proteins (Patent US:7790676)	Levin	2010	0		POTEE
895	chr25	40641336	40641361	3500167290	25		40641336	40641361	8421504	1	25	0	c	350016729000000151,350016729000000034	0-25,0-25						METHODS OF TREATING INFLAMMATION USING SOLUBLE IL-17RA/RC FUSION PROTEINS - Patent application	www.faqs.org	0	0		ACTB
895	chr25	40641336	40641361	3500142505	25		40641336	40641361	8421504	1	25	0	c	350014250500000034	0-25					Patent	Soluble IL-17RA/RC fusion proteins and related methods (Patent US:8084231)	Levin	2011	0		POTEF
895	chr25	40641336	40641361	3500129507	25		40641336	40641361	8421504	1	25	0	c	350012950700000010	0-25		19903769	10.1158/1541-7786.MCR-08-0325	1541-7786	Molecular Cancer Research	Critical Role of Endogenous Heme Oxygenase 1 as a Tuner of the Invasive Potential of Prostate Cancer Cells	Gueron	2009	4		POTEE
895	chr25	40641336	40641361	3500122687	25		40641336	40641361	8421504	1	25	0	c	350012268700000034	0-25						IL-17A and IL-17F Antagonists and Methods of Using the Same	Levin	2006	0		POTEE
895	chr25	40641336	40641361	3500091560	25		40641336	40641361	8421504	1	25	0	c	350009156000000151,350009156000000034	0-25,0-25						IL-17A AND IL-17F ANTAGONISTS AND METHODS OF USING THE SAME - Patent application	www.faqs.org	0	0		POTEE
895	chr25	40641336	40641361	3500091203	25		40641336	40641361	8421504	1	25	0	c	350009120300000034	0-25						Soluble il-17ra/rc fusion proteins and related methods	Levin	2008	0		POTEF
895	chr25	40641336	40641361	3500070060	25		40641336	40641361	8421504	1	25	0	c	350007006000000150,350007006000000034	0-25,0-25						 Soluble IL 	www.docstoc.com	0	0		POTEF
895	chr25	40641336	40641361	3500057073	25		40641336	40641361	8421504	1	25	0	c	350005707300000013	0-25						CriticalRoleofEndogenousHemeOxygenase1asaTuner oftheInvasivePotentialofProstateCancerCells	.aacrjournals.org	0	0		POTEF
895	chr25	40641336	40641361	3500041945	25		40641336	40641361	8421504	1	25	0	c	350004194500000034,350004194500000151	0-25,0-25						SOLUBLE IL-17RA/RC FUSION PROTEINS AND RELATED METHODS - Patent application	www.faqs.org	0	0		POTEE
895	chr25	40641336	40641361	3500012635	25		40641336	40641361	8421504	1	25	0	c	350001263500000015	0-25		9755091			American Journal of Physiology - Endocrinology and Metabolism	Intrinsic mineralization defect inHyp mouse osteoblasts	Xiao	1998	0		POTEF
895	chr25	40641336	40641360	3500458386	24		40641336	40641360	8421504	1	24	0	c	350045838600000007	0-24			10.1128/IAI.70.1.127-133.2002		Infection and Immunity	Staphylococcus aureus agr and sarA Functions Are Required for Invasive Infection but Not Inflammatory Responses in the Lung 	Geoffrey	2002	0		POTEE
895	chr25	40641336	40641360	3500400171	24		40641336	40641360	8421504	1	24	0	c	350040017100000007	0-24						Staphylococcus aureus agr and sarA Functions Are Required for Invasive Infection but Not In&#xfb02;ammatory Responses in the Lung	iai.asm.org	0	0		POTEF
895	chr25	40641336	40641360	3500193156	24		40641336	40641360	8421504	1	24	0	c	350019315600000007	0-24		11748173	10.1128/IAI.70.1.127-133.2002	0019-9567	Infection and Immunity	Staphylococcus aureus agr and sarA Functions Are Required for Invasive Infection but Not Inflammatory Responses in the Lung	Heyer	2002	4		
895	chr25	40641337	40641361	3500464489	24		40641337	40641361	8421504	1	24	0	c	350046448900000008	0-24		11719504	10.1074/jbc.M104957200	0021-9258	Journal of Biological Chemistry	Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-&#x03ba;B and Mitogen-activated Protein Kinase Signaling	Wei	2002	5		ACTB
895	chr25	40641337	40641361	3500455919	24		40641337	40641361	8421504	1	24	0	c	350045591900000007	0-24		11342573	10.1172/JCI10523	0021-9738	The Journal of Clinical Investigation	Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice	Imanishi	2001	13		ACTB
895	chr25	40641337	40641361	3500322770	24		40641337	40641361	8421504	1	24	0	c	350032277000000005	0-24		15731245	10.1128/JVI.79.6.3509-3516.2005	0022-538X	Journal of Virology	The Cytokine Osteopontin Modulates the Severity of Rotavirus Diarrhea	Rollo	2005	5		POTEE
895	chr25	40641337	40641361	3500063638	24		40641337	40641361	8421504	1	24	0	c	350006363800000007	0-24			10.1172/JCI10523		Journal of Clinical Investigation	Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice	Yasuo	2001	0		ACTB
895	chr25	40641342	40642516	3500151731	39		40641342	40642516	8421504	2	19,20	0,1154	c,g	350015173100000005,350015173100000006	0-19,0-20		23208499	10.1038/onc.2012.516	0950-9232	Oncogene	Long interspersed element-1 is differentially regulated by food-borne carcinogens via the aryl hydrocarbon receptor	Okudaira	2012	6		
895	chr25	40641351	40642123	3500390245	44		40641351	40642123	8421504	2	23,21	0,751	c	350039024500000004,350039024500000005	0-23,0-21		15355978	10.1074/jbc.M404655200	0021-9258	Journal of Biological Chemistry	Adenomatous Polyposis Coli Is Down-regulated by the Ubiquitin-Proteasome Pathway in a Process Facilitated by Axin	Choi	2004	5		
895	chr25	40641351	40642123	3500031195	44		40641351	40642123	8421504	2	23,21	0,751	c	350003119500000008,350003119500000009	0-23,0-21						Expression of Actin Isoforms in Human Auricular Cartilage	fb.cuni.cz/Data/f	0	0		
895	chr25	40641351	40641374	3500406604	23		40641351	40641374	8421504	1	23	0	c	350040660400000000	0-23					Patent	Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma (Patent US:7405192)	Clark	2008	0		POTEE
895	chr25	40641351	40641374	3500375142	23		40641351	40641374	8421504	1	23	0	c	350037514200000008	0-23		14600132	10.1136/jcp.56.11.854	1472-4146	Journal of Clinical Pathology	Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma	Sugimachi	2003	0		POTEM
895	chr25	40641351	40641374	3500319759	23		40641351	40641374	8421504	1	23	0	c	350031975900000004	0-23		10600897			American Journal of Physiology - Lung Cellular and Molecular Physiology	Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction	Wang	1999	0		
895	chr25	40641351	40641374	3500312664	23		40641351	40641374	8421504	1	23	0	c	350031266400000000	0-23					Patent	Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin (Patent US:7744873)	Clark	2010	0		
895	chr25	40641351	40641374	3500282153	23		40641351	40641374	8421504	1	23	0	c	350028215300000000	0-23						Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2008	0		POTEF
895	chr25	40641351	40641374	3500251903	23		40641351	40641374	8421504	1	23	0	c	350025190300000016	23-46						Role of Transforming Growth Factor-bin Transdifferentiation and Fibrosis of Lens Epithelial Cells	www.iovs.org	0	0		
895	chr25	40641351	40641374	3500233753	23		40641351	40641374	8421504	1	23	0	c	350023375300000002	0-23						Compositions and methods for increasing bone mineralization	Brunkow	2006	0		
895	chr25	40641351	40641374	3500225463	23		40641351	40641374	8421504	1	23	0	c	350022546300000000,350022546300000069	0-23,0-23						BONE MORPHOGENIC PROTEINS (BMP), BMP RECEPTORS AND BMP BINDING PROTEINS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF GLAUCOMA - Patent application	www.faqs.org	0	0		POTEF
895	chr25	40641351	40641374	3500211075	23		40641351	40641374	8421504	1	23	0	c	350021107500000000	0-23						BONE MORPHOGENIC PROTEINS (BMP), BMP RECEPTORS AND BMP BINDING PROTEINS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF GLAUCOMA	Clark	2008	0		
895	chr25	40641351	40641374	3500185939	23		40641351	40641374	8421504	1	23	0	c	350018593900000002	0-23					Patent	Polypeptides associated with alterations in bone density (Patent US:6489445)	Brunkow	2002	0		POTEE
895	chr25	40641351	40641374	3500181947	23		40641351	40641374	8421504	1	23	0	c	350018194700000002	0-23					Patent	Compositions and methods for increasing bone mineralization (Patent US:7572899)	Brunkow	2009	0		POTEE
895	chr25	40641351	40641374	3500144216	23		40641351	40641374	8421504	1	23	0	c	350014421600000000	0-23						Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2003	0		ACTA1
895	chr25	40641351	40641374	3500113986	23		40641351	40641374	8421504	1	23	0	c	350011398600000016	0-23						Methods for treating pulmonary fibrosis	Uhal	2003	0		
895	chr25	40641351	40641374	3500098032	23		40641351	40641374	8421504	1	23	0	c	350009803200001053,350009803200000002	0-23,0-23						Compositions and methods for increasing bone mineralization	Brunkow	2000	0		ACTA1
895	chr25	40641351	40641374	3500082936	23		40641351	40641374	8421504	1	23	0	c	350008293600000002	0-23						Compositions and methods for increasing bone mineralization	Brunkow	2003	0		
895	chr25	40641351	40641374	3500080849	23		40641351	40641374	8421504	1	23	0	c	350008084900000000	0-23					Patent	Knochen-morphogene proteine (bmp), bmp-rezeptoren und bmp-bindungsproteine und ihre verwendung bei der diagnose und behandlung des glaukoms Bone morphogenic proteins (BMP), BMP receptors, and BMP-binding proteins and their use in the diagnosis and treatme	CLARK	2007	0		ACTB
895	chr25	40641351	40641374	3500049485	23		40641351	40641374	8421504	1	23	0	c	350004948500000002	0-23					Patent	Polypeptides associated with alterations in bone density (Patent US:6489445)	Brunkow	2002	0		ACTA1
895	chr25	40641351	40641374	3500045045	23		40641351	40641374	8421504	1	23	0	c	350004504500000002	0-23						Compositions and Methods for Increasing Bone Mineralization	Brunkow	2013	0		
895	chr25	40641355	40641819	3500262431	24		40641355	40641819	8421504	2	22,2	0,462	c	350026243100000002	0-24						GSK3b mediates the induced expression of synaptic acetylcholinesterase during apoptosis	www.sibcb.ac.cn	0	0		
895	chr25	40641356	40642035	3500119769	42		40641356	40642035	8421504	2	21,21	0,658	c	350011976900000053,350011976900000054	0-21,0-21						Diagnostic methods and markers - Patent application	www.faqs.org	0	0		
895	chr25	40641356	40641822	3500024205	26		40641356	40641822	8421504	2	21,5	0,461	c	350002420500000006	0-26						Flores et al 2002 l arginina	ww.slideshare.net	0	0		
895	chr25	40641356	40641819	3500429981	23		40641356	40641819	8421504	2	21,2	0,461	c	350042998100000006	0-23		23951193	10.1371/journal.pone.0071572		PLoS ONE	Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion	Ilaria	2013	0		
895	chr25	40641362	40641825	3500259634	23		40641362	40641825	8421504	2	15,8	0,455	c	350025963400000004	1-24		21389127	10.1128/JVI.02399-10	0022-538X	Journal of Virology	A Respiratory Syncytial Virus Replicon That Is Noncytotoxic and Capable of Long-Term Foreign Gene Expression	Malykhina	2011	5		
895	chr25	40641370	40641833	3500308211	23		40641370	40641833	8421504	2	7,16	0,447	c	350030821100000008	0-23						Cardiac Transcriptome Analysis in Obesity-Related Hypertension	r.ahajournals.org	0	0		
895	chr25	40641595	40642134	3500085554	49		40641595	40642134	8421504	2	30,19	0,520	c,g	350008555400000021,350008555400000006,350008555400000012,350008555400000012,350008555400000027,350008555400000027	0-30,0-30,0-19,0-19,0-19,0-19						METHOD FOR INTRODUCING FOREIGN GENE INTO EARLY EMBRYO OF PRIMATE ANIMAL AND METHOD FOR PRODUCING TRANSGENIC PRIMATE ANIMAL COMPRISING SUCH METHOD - Patent application	www.faqs.org	0	0		ACTG1
895	chr25	40641823	40642061	3500186786	38		40641823	40642061	8421504	2	19,19	0,219	c,g	350018678600000004,350018678600000004,350018678600000005,350018678600000005	0-19,0-19,0-19,0-19		19741205	10.1095/biolreprod.109.078527	0006-3363	Biology of Reproduction	Characterization and Expression of the Nuclear Progestin Receptor in Zebrafish Gonads and Brain	Hanna	2010	4		
895	chr25	40641826	40642759	3500054202	46		40641826	40642759	8421504	2	23,23	0,910	c,g	350005420200000008,350005420200000009	0-23,0-23			10.1038/sj.emboj.7600549		The EMBO Journal	A type I DnaJ homolog, DjA1, regulates androgen receptor signaling and spermatogenesis	Kazutoyo	2005	0		POTEE
895	chr25	40641826	40642691	3500446659	40		40641826	40642691	8421504	2	20,20	0,845	c,g	350044665900000011,350044665900000012,350044665900000012	0-20,0-20,0-20			10.1242/jcs.01207	0021-9533	Journal of Cell Science	Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPAR&#x03b3;2	Tanabe	2004	6		
895	chr25	40641826	40642031	3500352313	42		40641826	40642031	8421504	2	21,21	0,184	c	350035231300000008,350035231300000009	0-21,0-21		20410161	10.1677/ERC-09-0269	1351-0088	Endocrine-Related Cancer	Suppression of MG132-mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells	Du	2010	4		POTEM
895	chr25	40641826	40642031	3500201951	42		40641826	40642031	8421504	2	21,21	0,184	c	350020195100000004,350020195100000005	0-21,0-21		23264393	10.1210/jc.2012-2679	0021-972X	Journal of Clinical Endocrinology & Metabolism	Beclin 1 Enhances Proteasome Inhibition-Mediated Cytotoxicity of Thyroid Cancer Cells in Macroautophagy-Independent Manner	Zhang	2013	6		POTEF
895	chr25	40641826	40642031	3500111658	42		40641826	40642031	8421504	2	21,21	0,184	c	350011165800000010,350011165800000011	0-21,0-21						Implication of Oxygen-Regulated Protein 150 (ORP150) in Apoptosis Induced by Proteasome Inhibitors in Human Thyroid Cancer Cells	.endojournals.org	0	0		
895	chr25	40641826	40642031	3500103033	42		40641826	40642031	8421504	2	21,21	0,184	c	350010303300000004,350010303300000005	0-21,0-21		21346076	10.1210/jc.2010-2642	0021-972X	Journal of Clinical Endocrinology & Metabolism	Proteasome Inhibition Induces a p38 MAPK Pathway-Dependent Antiapoptotic Program via Nrf2 in Thyroid Cancer Cells	Du	2011	6		POTEM
895	chr25	40641826	40642031	3500080671	42		40641826	40642031	8421504	2	21,21	0,184	c	350008067100000013,350008067100000014	0-21,0-21		21532751	10.1371/journal.pone.0018308		PLoS ONE	Activation of Multiple Apoptotic Pathways in Human Nasopharyngeal Carcinoma Cells by the Prenylated Isoflavone, Osajin	Tsung-Teng	2011	0		
895	chr25	40641826	40642031	3500036156	42		40641826	40642031	8421504	2	21,21	0,184	c	350003615600000013,350003615600000014	0-21,0-21						Activation of Multiple Apoptotic Pathways in Human Nasopharyngeal Carcinoma Cells by the Prenylated Isoflavone, Osajin	uphati.cmu.edu.tw	0	0		
895	chr25	40641826	40641849	3500149810	23		40641826	40641849	8421504	1	23	0	c	350014981000000005	0-23		15117948	10.1074/jbc.M403793200	0021-9258	Journal of Biological Chemistry	The SANT Domain of Human MI-ER1 Interacts with Sp1 to Interfere with GC Box Recognition and Repress Transcription from Its Own Promoter	Ding	2004	5		
895	chr25	40641826	40641849	3500123521	23		40641826	40641849	8421504	1	23	0	c	350012352100000005	0-23		20439987	10.1074/jbc.M109.083626		The Journal of Biological Chemistry	NF449 Is a Novel Inhibitor of Fibroblast Growth Factor Receptor 3 (FGFR3) Signaling Active in Chondrocytes and Multiple Myeloma Cells	PavKrejci	July	0		CCDC74A
895	chr25	40641827	40642865	3500203618	57		40641827	40642865	8421504	2	27,30	0,1008	c	350020361800000002,350020361800000003	0-27,0-30			10.1128/AAC.46.3.716-723.2002		Antimicrobial Agents and Chemotherapy	Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors	GabriBirkus	2002	0		
895	chr25	40641829	40642243	3500128868	42		40641829	40642243	8421504	2	21,21	0,393	c	350012886800000002,350012886800000003	0-21,0-21		16819515	10.1038/sj.onc.1209768	0950-9232	Oncogene	ErbB4 (JM-b&sol;CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein	Chen	2006	6		
895	chr25	40641829	40642138	3500147113	42		40641829	40642138	8421504	2	21,21	0,288	c	350014711300000006,350014711300000007	0-21,0-21						NeurobiologyofDisease EarlyandRapidEngraftmentofBoneMarrow-Derived MicrogliainScrapie	www.jneurosci.org	0	0		POTEE
895	chr25	40641830	40641855	3500199298	25		40641830	40641855	8421504	1	25	0	c	350019929800000011	1-26		15858217	10.1095/biolreprod.104.039313	0006-3363	Biology of Reproduction	Serotonin and Its Antidepressant-Sensitive Transport in Mouse Cumulus-Oocyte Complexes and Early Embryos	Amireault	2005	4		
895	chr25	40641832	40642357	3500368975	42		40641832	40642357	8421504	3	21,9,12	0,415,513	c	350036897500000024,350036897500000012	0-21,0-21						Nickel-Koordinationsstellen in einem T-Zellrezeptor/Peptid/MHC-Komplex	k.uni-freiburg.de	0	0		
895	chr25	40641832	40642209	3500176454	40		40641832	40642209	8421504	2	20,20	0,357	c	350017645400000004,350017645400000005	0-20,0-20						THE USE OF WNT5-A PEPTIDE DERIVATES FOR THE TREATMENT OF MELANOMA AND GASTRIC CANCER - FORSKARPATENT I SYD AB	www.sumobrain.com	0	0		
895	chr25	40641832	40642065	3500194692	40		40641832	40642065	8421504	2	20,20	0,213	c	350019469200000004,350019469200000003	0-20,0-20						A comparative study of the inhibitory effects of purine nucleotides and carboxyatractylate on the uncoupling protein-3 and adenine nucleotide translocase. - ResearchGate	.researchgate.net	0	0		
895	chr25	40641863	40642065	3500202631	40		40641863	40642065	8421504	2	20,20	0,182	c,g	350020263100000006,350020263100000006,350020263100000007	0-20,0-20,0-20						Ectodermal FGFs Induce Perinodular Inhibition of Limb Chondrogenesis in Vitro and in Vivo via FGF Receptor 2	www.nymc.edu	0	0		
895	chr25	40641866	40642062	3500252635	40		40641866	40642062	8421504	2	20,20	0,176	c,g	350025263500000010,350025263500000010,350025263500000011	0-20,0-20,0-20						Characterization of transgenic mice with the expression of phenylalanine hydroxylase and GTP cyclohydrolase I in the skin	www.cellntec.com	0	0		
895	chr25	40641901	40642734	3500466594	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350046659400000004,350046659400000004,350046659400000005	0-19,0-19,0-19						Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells	www.virologyj.com	0	0		
895	chr25	40641901	40642734	3500453430	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350045343000000008,350045343000000008,350045343000000009	0-19,0-19,0-19						BAFF, inhibitors thereof and their use in the modulation of B-cell response	Browning	2009	0		
895	chr25	40641901	40642734	3500448253	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350044825300000008,350044825300000008,350044825300000009	0-19,0-19,0-19						BAFF, inhibitors thereof and their use in the modulation of the B-cell response	Browning	2011	0		
895	chr25	40641901	40642734	3500441050	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350044105000000008,350044105000000008,350044105000000009	0-19,0-19,0-19						BAFF, inhibitors thereof and their use in the modulation of the B-cell response	Ambrose	2004	0		
895	chr25	40641901	40642734	3500436811	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350043681100000008,350043681100000008,350043681100000009	0-19,0-19,0-19						BAFF, inhibitors thereof and their use in the modulation of B-cell response	Browning	2001	0		
895	chr25	40641901	40642734	3500414621	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350041462100000004,350041462100000004,350041462100000005	0-19,0-19,0-19		18006782	10.1158/1078-0432.CCR-07-1909	1078-0432	Clinical Cancer Research	A Mycoplasma Peptide Elicits Heteroclitic CD4+ T Cell Responses against Tumor Antigen MAGE-A6	Vujanovic	2007	8		
895	chr25	40641901	40642734	3500402492	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350040249200000006,350040249200000006,350040249200000007	0-19,0-19,0-19		11818439		0741-5400	Journal of Leukocyte Biology	Myosin-V colocalizes with MHC class II in blood mononuclear cells and is up-regulated by T-lymphocyte activation	Bizario	2002	5		
895	chr25	40641901	40642734	3500392039	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350039203900000006,350039203900000006,350039203900000007	0-19,0-19,0-19		11316847		1046-6673	Journal of the American Society of Nephrology	Activated Coagulation Factor X: A Novel Mitogenic Stimulus for Human Mesangial Cells	MONNO	2001	10		
895	chr25	40641901	40642734	3500381453	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350038145300000004,350038145300000004,350038145300000005	0-19,0-19,0-19			10.1186/1743-422X-9-163		Virology Journal	Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells	Renxian	2012	0		
895	chr25	40641901	40642734	3500374947	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350037494700000002,350037494700000002,350037494700000003	0-19,0-19,0-19						Binding molecules for the treatment of myeloid cell malignancies	Oudenrijn	2012	0		
895	chr25	40641901	40642734	3500373967	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350037396700000028,350037396700000028,350037396700000029	0-19,0-19,0-19						CXCR6, a Newly Defined Biomarker of Tissue-Specific Stem Cell Asymmetric Self-Renewal, Identifies More Aggressive Human Melanoma Cancer Stem Cells	arxiv.org/pdf/130	0	0		ACTB
895	chr25	40641901	40642734	3500344074	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350034407400000008,350034407400000008,350034407400000009	0-19,0-19,0-19			10.1002/eji.200737210	1521-4141	European Journal of Immunology	Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner - Hardenberg - 2007 - European Journal of Immunology - Wiley Online Library	Hardenberg	2007	0		
895	chr25	40641901	40642734	3500334407	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350033440700000003,350033440700000003,350033440700000002	0-19,0-19,0-19		21957483	10.1371/journal.pone.0025247		PLoS ONE	The Pbx Interaction Motif of Hoxa1 Is Essential for Its Oncogenic Activity	Stephanie	2011	0		
895	chr25	40641901	40642734	3500328183	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350032818300000004,350032818300000004,350032818300000005	0-19,0-19,0-19						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
895	chr25	40641901	40642734	3500326968	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350032696800000002,350032696800000002,350032696800000003	0-19,0-19,0-19						Myeloid cell-specific lectin	Van	2011	0		
895	chr25	40641901	40642734	3500326223	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350032622300000008,350032622300000008,350032622300000009	0-19,0-19,0-19						BAFF, inhibitors thereof and their use in the modulation of the B-cell response	Browning	2011	0		
895	chr25	40641901	40642734	3500317035	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350031703500000009,350031703500000009,350031703500000010	0-19,0-19,0-19					Patent	An antibody specific for soluble BAFF for use in the treatment of cancer (Patent EP:1415659)	Browning	2012	0		
895	chr25	40641901	40642734	3500307619	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350030761900000016,350030761900000016,350030761900000017	0-19,0-19,0-19						BAFF, inhibitors thereof and their use in modulation of B-cell response	Jie Fu Li *Bu Lang Zhu 	2002	0		
895	chr25	40641901	40642734	3500301638	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350030163800000012,350030163800000012,350030163800000013	0-19,0-19,0-19					Patent	Baff, dessen inhibitoren und dessen verwendung zur modulierung der b-zell-antwort Baff, the inhibitors and their use for modulating the B-cell response (Patent DE:60004635)	Ambrose	2004	0		
895	chr25	40641901	40642734	3500300450	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350030045000000008,350030045000000008,350030045000000009	0-19,0-19,0-19					Patent	Baff, inhibitors thereof and their use in the modulation of the b-cell response (Patent EP:1146892)	Ambrose	2003	0		
895	chr25	40641901	40642734	3500287272	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350028727200000002,350028727200000002,350028727200000003	0-19,0-19,0-19		10815930		1078-0432	Clinical Cancer Research	Endoglin Is a Suitable Target for Efficient Imaging of Solid Tumors: In Vivo Evidence in a Canine Mammary Carcinoma Model	Fonsatti	2000	8		
895	chr25	40641901	40642734	3500285138	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350028513800000004,350028513800000004,350028513800000005	0-19,0-19,0-19						IMMUNOGENIC TUMOR ASSOCIATED STROMAL CELL ANTIGEN PEPTIDES AND METHODS OF THEIR USE - UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	www.sumobrain.com	0	0		
895	chr25	40641901	40642734	3500277781	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350027778100000022,350027778100000022,350027778100000008,350027778100000008,350027778100000023	0-19,0-19,0-19,0-19,0-19						BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders - Patent application	www.faqs.org	0	0		
895	chr25	40641901	40642734	3500274637	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350027463700000000,350027463700000000,350027463700000001	0-19,0-19,0-19						Expression of Foxp3, CD25 and IL-2 in the B16F10 cancer cell line and melanoma is correlated with tumor growth in mice	-publications.com	0	0		
895	chr25	40641901	40642734	3500267677	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350026767700000008,350026767700000008,350026767700000009	0-19,0-19,0-19					Patent	BAFF, inhibitors thereof and their use in the modulation of B-cell response (Patent US:6869605)	Browning	2005	0		
895	chr25	40641901	40642734	3500255813	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350025581300000008,350025581300000008,350025581300000009	0-19,0-19,0-19						BAFF, inhibitors thereof and their use in the modulation of the B-cell response	Browning	2011	0		
895	chr25	40641901	40642734	3500247165	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350024716500000008,350024716500000008,350024716500000009	0-19,0-19,0-19					Patent	BAFF, inhibitors thereof and their use in the modulation of B-cell response (Patent US:6869605)	Browning	2005	0		
895	chr25	40641901	40642734	3500247078	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350024707800000007,350024707800000007,350024707800000008	0-19,0-19,0-19						Vaccine adjuvants for immunotherapy of melanoma	Gajewski	1998	0		
895	chr25	40641901	40642734	3500242867	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350024286700000008,350024286700000008,350024286700000009	0-19,0-19,0-19						BAFF, inhibitors thereof and their use in the modulation of B-cell response	Ambrose	2002	0		ACTB
895	chr25	40641901	40642734	3500241207	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350024120700000008,350024120700000008,350024120700000009	0-19,0-19,0-19						Baff, inhibitors thereof and their use in the modulation of the b-cell response	Ambrose	2001	0		
895	chr25	40641901	40642734	3500232644	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350023264400000003,350023264400000003,350023264400000004	0-19,0-19,0-19		15664995	10.1074/jbc.M404260200	0021-9258	Journal of Biological Chemistry	Regulation of the Transcriptional Activity of the IRF7 Promoter by a Pathway Independent of Interferon Signaling	Ning	2005	5		
895	chr25	40641901	40642734	3500220879	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350022087900000006,350022087900000006,350022087900000007	0-19,0-19,0-19						Activated Coagulation Factor X: A Novel Mitogenic Stimulus for Human Mesangial Cells	n.asnjournals.org	0	0		
895	chr25	40641901	40642734	3500199907	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350019990700000008,350019990700000008,350019990700000009	0-19,0-19,0-19					Patent	BAFF, inhibitors thereof and their use in the modulation of B-cell response (Patent US:6869605)	Browning	2005	0		
895	chr25	40641901	40642734	3500194249	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350019424900000004,350019424900000004,350019424900000005	0-19,0-19,0-19		22897902	10.1186/1743-422X-9-163	1743-422X	Virology Journal	Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells	Tang	2012	2		
895	chr25	40641901	40642734	3500192371	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350019237100000011,350019237100000011,350019237100000012	0-19,0-19,0-19						PRIMARY AND METASTATIC UVEAL MELANOMA	repub.eur.nl	0	0		
895	chr25	40641901	40642734	3500183393	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350018339300000000,350018339300000000,350018339300000001	0-19,0-19,0-19						Expression of Foxp3, CD25 and IL-2 in the B16F10 cancer cell line and melanoma is correlated with tumor growth in mice	-publications.com	0	0		
895	chr25	40641901	40642734	3500155348	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350015534800000008,350015534800000008,350015534800000009	0-19,0-19,0-19						BMC Genomics BioMed Central	biomedcentral.com	0	0		
895	chr25	40641901	40642734	3500144217	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350014421700000002,350014421700000002,350014421700000003	0-19,0-19,0-19			10.1186/bcr1835		Breast Cancer Research : BCR	Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity	Maximino	2007	0		
895	chr25	40641901	40642734	3500119282	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350011928200000002,350011928200000002,350011928200000003	0-19,0-19,0-19						Open Access Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity	ncer-research.com	0	0		
895	chr25	40641901	40642734	3500106764	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350010676400000004,350010676400000004,350010676400000005	0-19,0-19,0-19						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
895	chr25	40641901	40642734	3500063237	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350006323700000006,350006323700000006,350006323700000007	0-19,0-19,0-19		11818439		0741-5400	Journal of Leukocyte Biology	Myosin-V colocalizes with MHC class II in blood mononuclear cells and is up-regulated by T-lymphocyte activation	Bizario	2002	5		
895	chr25	40641901	40642734	3500063001	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350006300100000040,350006300100000040,350006300100000016,350006300100000016,350006300100000041,350006300100000017	0-19,0-19,0-19,0-19,0-19,0-19					Patent	BAFF, inhibitors thereof and their use in modulation of B-cell response (Patent CN:100340292)	Jie Fu Li *Bu Lang Zhu 	2007	0		
895	chr25	40641901	40642734	3500053485	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350005348500000002,350005348500000002,350005348500000003	0-19,0-19,0-19						Binding molecules for the treatment of myeloid cell malignancies	Den	2009	0		ACTB
895	chr25	40641901	40642734	3500019973	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350001997300000009,350001997300000009,350001997300000010	0-19,0-19,0-19					Patent	An antibody specific for soluble BAFF for use in the treatment of cancer (Patent EP:1415659)	Browning	2011	0		
895	chr25	40641901	40642734	3500019597	38		40641901	40642734	8421504	2	19,19	0,814	c,g	350001959700000000,350001959700000000,350001959700000001	0-19,0-19,0-19			10.1002/art.22578	1529-0131	Arthritis & Rheumatism	Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus - Toukap - 2007 - Arthritis & Rheumatism - Wiley Online Library	Toukap	2007	0		
895	chr25	40641904	40641927	3500430222	23		40641904	40641927	8421504	1	23	0	c	350043022200000006	0-23		12904319	10.1095/biolreprod.103.019620	0006-3363	Biology of Reproduction	Bacterially-Induced Preterm Labor and Regulation of Prostaglandin-Metabolizing Enzyme Expression in Mice: The Role of Toll-Like Receptor 4	Wang	2003	4		ACTB
895	chr25	40641909	40641932	3500428383	23		40641909	40641932	8421504	1	23	0	c,g	350042838300000003,350042838300000003	0-23,0-23						Du C, Yang P, Zhang G, Hong C, Chen J, Dong X. Effect of Arsenic trioxide on EBV LMP1 mediated E-cadherin silencing in nasopharyngeal carcinoma. Head Neck Oncol. 2012 Sep 9;4(2):55.Head and Neck Oncology	lishinglondon.com	0	0		ACTB
895	chr25	40641921	40642809	3500172482	54		40641921	40642809	8421504	2	30,24	0,864	c,g	350017248200000006,350017248200000007,350017248200000007	0-30,6-30,6-30						Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses	Caputo	2004	0		
895	chr25	40641921	40642802	3500464628	60		40641921	40642802	8421504	2	30,30	0,851	c	350046462800000004,350046462800000005	0-30,0-30						In Vivo Distribution of Human Adipose-Derived Mesenchymal Stem Cells in Novel Xenotransplantation Models	edivetarizona.com	0	0		
895	chr25	40641921	40642802	3500462448	59		40641921	40642802	8421504	3	30,13,16	0,851,865	c	350046244800000002,350046244800000003	0-30,0-29						Glycyrrhetinic acid inhibits ICAM-1 expression via blocking JNK and NF-&#x03ba;B pathways in TNF-&#x03b1;-activated endothelial cells	ir.cmu.edu.tw	0	0		
895	chr25	40641921	40642802	3500461348	60		40641921	40642802	8421504	2	30,30	0,851	c	350046134800000004,350046134800000005	0-30,0-30						Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds. - ResearchGate	.researchgate.net	0	0		
895	chr25	40641921	40642802	3500461213	60		40641921	40642802	8421504	2	30,30	0,851	c	350046121300000006,350046121300000007	0-30,0-30		15254160	10.1128/JVI.78.15.7874-7882.2004	0022-538X	Journal of Virology	Adeno-Associated Virus Site-Specific Integration and AAVS1 Disruption	Hamilton	2004	5		
895	chr25	40641921	40642802	3500451373	60		40641921	40642802	8421504	2	30,30	0,851	c	350045137300000002,350045137300000003	0-30,0-30						Muscle actin isoforms are differentially expressed in human satellite cells isolated from donors of different ages	H	2007	0		
895	chr25	40641921	40642802	3500450725	60		40641921	40642802	8421504	2	30,30	0,851	c	350045072500000000,350045072500000001	0-30,0-30		11438536	10.1074/jbc.M104207200	0021-9258	Journal of Biological Chemistry	Characterization of Two Evolutionarily Conserved, Alternatively Spliced Nuclear Phosphoproteins, NFAR-1 and -2, That Function in mRNA Processing and Interact with the Double-stranded RNA-dependent Protein Kinase, PKR	Saunders	2001	5		
895	chr25	40641921	40642802	3500444209	59		40641921	40642802	8421504	3	30,13,16	0,851,865	c,g	350044420900000003,350044420900000004,350044420900000004	0-30,0-29,0-29						Cell culture HCT 116 and SW480 human colon carcinoma cells were cultured in DMEM | Wee1 Signaling	wee1signaling.com	0	0		
895	chr25	40641921	40642802	3500431181	59		40641921	40642802	8421504	3	30,13,16	0,851,865	c,g	350043118100000002,350043118100000003,350043118100000003	0-30,0-29,0-29		20418897	10.1038/aps.2010.34	1671-4083	Acta Pharmacologica Sinica	Glycyrrhetinic acid inhibits ICAM-1 expression via blocking JNK and NF-&#x03ba;B pathways in TNF-&#x03b1;-activated endothelial cells	Chang	2010	2		
895	chr25	40641921	40642802	3500414572	56		40641921	40642802	8421504	2	26,30	0,851	c	350041457200000016,350041457200000017	0-26,0-30						Dual Regulation of c-Myc by p300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription&#x2020;	mcb.asm.org	0	0		ACTB
895	chr25	40641921	40642802	3500409452	58		40641921	40642802	8421504	4	13,16,20,9	0,14,851,872	c,g	350040945200000004,350040945200000005	0-29,0-29			10.1002/1097-0142(20010401)91:7<1372::AID-CNCR1141>3.0.CO;2-E	1097-0142	Cancer	Granulocyte colony-stimulating factor (G-CSF) receptor gene expression of ovarian carcinoma does not correlate with G-CSF caused cell proliferation - Brandstetter - 2001 - Cancer - Wiley Online Library	Brandstetter	2001	0		
895	chr25	40641921	40642802	3500404770	60		40641921	40642802	8421504	2	30,30	0,851	c,g	350040477000000006,350040477000000007	0-30,0-30						Evaluation of the estrogenic activity of the constituents in the fruits of Vitex rotundifolia L. for the potential treatment of premenstrual syndrome	xa.yimg.com	0	0		ACTB
895	chr25	40641921	40642802	3500403228	60		40641921	40642802	8421504	2	30,30	0,851	c	350040322800000002,350040322800000003	0-30,0-30						Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. - ResearchGate	.researchgate.net	0	0		
895	chr25	40641921	40642802	3500396593	60		40641921	40642802	8421504	2	30,30	0,851	c	350039659300000007,350039659300000008	0-30,0-30		12167705	10.1128/MCB.22.17.6111-6121.2002	0270-7306	Molecular and Cellular Biology	Targeted Deletion of mNth1 Reveals a Novel DNA Repair Enzyme Activity	Ocampo	2002	6		POTEM
895	chr25	40641921	40642802	3500395463	59		40641921	40642802	8421504	3	30,20,9	0,851,872	c,g	350039546300000000,350039546300000001	0-30,0-29						Methods for enhancement of protective immune responses	Reed	1999	0		
895	chr25	40641921	40642802	3500394538	59		40641921	40642802	8421504	3	15,14,30	0,16,851	c,g	350039453800000007,350039453800000008,350039453800000008	0-29,0-30,0-30		18199619	10.2967/jnumed.107.042507	0161-5505	Journal of Nuclear Medicine	Development of a Dual-Luciferase Reporter System for In Vivo Visualization of MicroRNA Biogenesis and Posttranscriptional Regulation	Lee	2008	6		
895	chr25	40641921	40642802	3500390132	60		40641921	40642802	8421504	2	30,30	0,851	c	350039013200000012,350039013200000013	0-30,0-30						Funktion und Expression gastrointestinal und hepatisch exprimierter Organic Anion Transporting Polypeptides (OATP)	b.uni-erlangen.de	0	0		
895	chr25	40641921	40642802	3500370135	60		40641921	40642802	8421504	2	30,30	0,851	c	350037013500000004,350037013500000005	0-30,0-30		8969798	10.1161/01.STR.27.12.2304	0039-2499	Stroke	Regulation of Brain Capillary Endothelial Thrombomodulin mRNA Expression	Tran	1996	6		
895	chr25	40641921	40642802	3500367485	60		40641921	40642802	8421504	2	30,30	0,851	c	350036748500000002,350036748500000003	0-30,0-30		9609743			American Journal of Physiology - Lung Cellular and Molecular Physiology	Leukotriene B4 mediates histamine induction of NF-&#x03ba;B and IL-8 in human bronchial epithelial cells	Aoki	1998	0		
895	chr25	40641921	40642802	3500367383	60		40641921	40642802	8421504	2	30,30	0,851	c	350036738300000000,350036738300000001	0-30,0-30		19339556	10.1242/jcs.044123	0021-9533	Journal of Cell Science	Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells	Luxen	2009	6		
895	chr25	40641921	40642802	3500353318	60		40641921	40642802	8421504	2	30,30	0,851	c	350035331800000002,350035331800000003	0-30,0-30		12552083	10.1073/pnas.0337412100	0027-8424	Proceedings of the National Academy of Sciences	Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia	Comerford	2003	10		
895	chr25	40641921	40642802	3500345654	57		40641921	40642802	8421504	2	27,30	0,851	c	350034565400000009,350034565400000010	0-27,0-30		17483335	10.1158/0008-5472.CAN-06-3935	0008-5472	Cancer Research	Down-Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Results in Mesenchymal-to-Epithelial Transition of Human Lung Fibrosarcoma Cells	Funasaka	2007	8		POTEM
895	chr25	40641921	40642802	3500343374	60		40641921	40642802	8421504	2	30,30	0,851	c	350034337400000004,350034337400000005	0-30,0-30						Normalization of deranged signal transduction in lymphocytes of COPD patients by the novel calcium channel blocker H-DHPM. - ResearchGate	.researchgate.net	0	0		
895	chr25	40641921	40642802	3500336478	59		40641921	40642802	8421504	3	30,13,16	0,851,865	c	350033647800000002,350033647800000003	0-30,0-29						Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. - ResearchGate	.researchgate.net	0	0		
895	chr25	40641921	40642802	3500328974	60		40641921	40642802	8421504	2	30,30	0,851	c	350032897400000004,350032897400000005	0-30,0-30		23756845	10.1038/srep01972	xxxx-xxxx	Scientific Reports	Mahogunin ring finger-1 (MGRN1) Suppresses Chaperone-Associated Misfolded Protein Aggregation and Toxicity	Chhangani	2013	0		
895	chr25	40641921	40642802	3500325526	42		40641921	40642802	8421504	2	21,21	0,860	c	350032552600000006,350032552600000007	0-21,0-21						Funktionelle Charakterisierung p75TNF-Rezeptor-Isoformen	uni-regensburg.de	0	0		POTEF
895	chr25	40641921	40642802	3500309148	60		40641921	40642802	8421504	2	30,30	0,851	c	350030914800000000,350030914800000001	0-30,0-30						Establishment and characterization of a human adenoid cystic carcinoma cell line forming colonies cultured in collagen gel and transplantable in nude mice	-publications.com	0	0		
895	chr25	40641921	40642802	3500280010	60		40641921	40642802	8421504	2	30,30	0,851	c,g	350028001000000000,350028001000000001	0-30,0-30		11994503		0741-5400	Journal of Leukocyte Biology	Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28	Molinero	2002	5		POTEM
895	chr25	40641921	40642802	3500277049	60		40641921	40642802	8421504	2	30,30	0,851	c	350027704900000012,350027704900000013	0-30,0-30						Methods And Kits For Diagnosing And Treating B-cell Chronic Lymphocytic Leukemia 	.freshpatents.com	0	0		
895	chr25	40641921	40642802	3500275586	59		40641921	40642802	8421504	3	30,13,16	0,851,865	c	350027558600000002,350027558600000003	0-30,0-29		18381445	10.1158/0008-5472.CAN-07-5807	0008-5472	Cancer Research	Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2	Lin	2008	8		ACTB
895	chr25	40641921	40642802	3500272223	60		40641921	40642802	8421504	2	30,30	0,851	c	350027222300000002,350027222300000003	0-30,0-30					The American Journal of Pathology	Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis	Christoph	2003	0		
895	chr25	40641921	40642802	3500271994	60		40641921	40642802	8421504	2	30,30	0,851	c	350027199400000004,350027199400000005	0-30,0-30		12429721		0741-5400	Journal of Leukocyte Biology	TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE2 production in cells of the myeloid lineage	Secchiero	2002	5		
895	chr25	40641921	40642802	3500253085	60		40641921	40642802	8421504	2	30,30	0,851	c	350025308500000010,350025308500000011	0-30,0-30		14655726		1058-2916	ASAIO Journal	 Lentiviral Vector: A Useful Tool for Transduction of Human L... : ASAIO Journal 	Totsugawa	2003	1		
895	chr25	40641921	40642802	3500249125	60		40641921	40642802	8421504	2	30,30	0,851	c	350024912500000003,350024912500000004	0-30,0-30						Regulationsmechanismen	.uni-frankfurt.de	0	0		
895	chr25	40641921	40642802	3500248041	60		40641921	40642802	8421504	2	30,30	0,851	c	350024804100000004,350024804100000005	0-30,0-30		19100237	10.1016/j.abb.2008.11.027	0003-9861	Archives of biochemistry and biophysics	Nitric Oxide and Airway Epithelial Barrier Function: Regulation of Tight Junction Proteins and Epithelial Permeability	N	2009	3		
895	chr25	40641921	40642802	3500247270	60		40641921	40642802	8421504	2	30,30	0,851	c	350024727000000016,350024727000000017	0-30,0-30						METHOD OF INDUCING DIFFERENTIATION OF EMBRYO-STEM CELL INTO HEPATOCYTE AND HEPATOCYTE INDUCED BY THE METHOD	TANAKA	2006	0		
895	chr25	40641921	40642802	3500245824	60		40641921	40642802	8421504	2	30,30	0,851	c	350024582400000004,350024582400000005	0-30,0-30						Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles	Kelly	2001	0		
895	chr25	40641921	40642802	3500236532	60		40641921	40642802	8421504	2	30,30	0,851	c,g	350023653200000033,350023653200000034	0-30,0-30						Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis.	.biomedsearch.com	0	0		
895	chr25	40641921	40642802	3500234143	60		40641921	40642802	8421504	2	30,30	0,851	c	350023414300000010,350023414300000011	0-30,0-30						Tesis Doctoral Mecanismos moleculares que regulan la sensibilidad de c&#xe9;lulas tumorales de mama a la apoptosis por TRAIL	hera.ugr.es	0	0		POTEM
895	chr25	40641921	40642802	3500227358	59		40641921	40642802	8421504	3	30,13,16	0,851,865	c	350022735800000002,350022735800000003	0-30,0-29		15456896	10.1124/mol.104.005199	1521-0111 (Online)	Molecular Pharmacology	Induction of Cyclooxygenase-2 Overexpression in Human Gastric Epithelial Cells by Helicobacter pylori Involves TLR2/TLR9 and c-Src-Dependent Nuclear Factor-&#x03ba;B Activation	Chang	2004	0		
895	chr25	40641921	40642802	3500226975	56		40641921	40642802	8421504	2	28,28	0,853	c,g	350022697500000020,350022697500000021,350022697500000021	0-28,0-28,0-28						ScienceDirect.com - FEBS Letters - The effect of 2-deoxy-d-glucose on Werner syndrome RecQ helicase gene	sciencedirect.com	0	0		
895	chr25	40641921	40642802	3500225045	59		40641921	40642802	8421504	3	15,14,30	0,16,851	c	350022504500000011,350022504500000012	0-29,0-30		18703592	10.2967/jnumed.107.044461	0161-5505	Journal of Nuclear Medicine	Visualization of Hypoxia-Inducible Factor-1 Transcriptional Activation in C6 Glioma Using Luciferase and Sodium Iodide Symporter Genes	Yeom	2008	6		
895	chr25	40641921	40642802	3500222946	60		40641921	40642802	8421504	2	30,30	0,851	c	350022294600000004,350022294600000005	0-30,0-30		8969798	10.1161/01.STR.27.12.2304	0039-2499	Stroke	Regulation of Brain Capillary Endothelial Thrombomodulin mRNA Expression	Tran	1996	6		
895	chr25	40641921	40642802	3500222025	60		40641921	40642802	8421504	2	30,30	0,851	c	350022202500000000,350022202500000001	0-30,0-30						Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. - ResearchGate	.researchgate.net	0	0		
895	chr25	40641921	40642802	3500218903	60		40641921	40642802	8421504	2	30,30	0,851	c,g	350021890300000014,350021890300000015,350021890300000015	0-30,0-30,0-30					Patent	Spondyloarthropathies (Patent US:7371725)	Luyten	2008	0		ACTB
895	chr25	40641921	40642802	3500209593	59		40641921	40642802	8421504	3	30,20,9	0,851,872	c,g	350020959300000004,350020959300000005	0-30,0-29		20231411	10.1128/IAI.00118-10		Infection and Immunity	Bacteroides fragilis Enterotoxin Induces Human &#x03b2;-Defensin-2 Expression in Intestinal Epithelial Cells via a Mitogen-Activated Protein Kinase/I&#x03ba;B Kinase/NF-&#x03ba;B-Dependent Pathway 	Young	2010	0		ACTB
895	chr25	40641921	40642802	3500196853	60		40641921	40642802	8421504	2	30,30	0,851	c	350019685300000000,350019685300000001	0-30,0-30		12885939	10.1189/jlb.0103004	0741-5400	Journal of Leukocyte Biology	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-&#x03b1; promote the NF-&#x03ba;B-dependent maturation of normal and leukemic myeloid cells	Secchiero	2003	5		
895	chr25	40641921	40642802	3500194750	60		40641921	40642802	8421504	2	30,30	0,851	c	350019475000000012,350019475000000013	0-30,0-30						Methods And Kits For Diagnosing And Treating B-cell Chronic Lymphocytic Leukemia 	.freshpatents.com	0	0		
895	chr25	40641921	40642802	3500179149	60		40641921	40642802	8421504	2	30,30	0,851	c	350017914900000014,350017914900000015	0-30,0-30						ActivationofJNK-dependentPathwayIsRequiredforHIV ViralProteinR-inducedApoptosisinHumanMonocyticCells	www.jbc.org	0	0		
895	chr25	40641921	40642802	3500177637	60		40641921	40642802	8421504	2	30,30	0,851	c	350017763700000003,350017763700000002	0-30,0-30					The Journal of Experimental Medicine	Human Dendritic Cells Skew Isotype Switching of CD40-activated Naive B Cells towards IgA1 and IgA2	Jerome	June	0		
895	chr25	40641921	40642802	3500177368	60		40641921	40642802	8421504	2	30,30	0,851	c	350017736800000002,350017736800000003	0-30,0-30		22485170	10.1371/journal.pone.0034434	1932-6203	PLOS ONE	PLOS ONE: Modulation of Wnt5a Expression by Periodontopathic Bacteria	Nanbara	2012	4		
895	chr25	40641921	40642802	3500174211	60		40641921	40642802	8421504	2	30,30	0,851	c	350017421100000033,350017421100000016,350017421100000017,350017421100000034	0-30,0-30,0-30,0-30						Method of Inducing Differentiation of Embryo-Stem Cell Into Hepatocyte and Hepatocyte Induced by the Method - Patent application	www.faqs.org	0	0		
895	chr25	40641921	40642802	3500173321	59		40641921	40642802	8421504	3	30,13,16	0,851,865	c,g	350017332100000002,350017332100000003,350017332100000003	0-30,0-29,0-29		17145842	10.1158/1078-0432.CCR-06-1393	1078-0432	Clinical Cancer Research	A Novel Anticancer Effect of Thalidomide: Inhibition of Intercellular Adhesion Molecule-1&#x2013;Mediated Cell Invasion and Metastasis through Suppression of Nuclear Factor-&#x03ba;B	Lin	2006	8		
895	chr25	40641921	40642802	3500140568	60		40641921	40642802	8421504	2	30,30	0,851	c,g	350014056800000002,350014056800000003	0-30,0-30		19843975	10.1124/jpet.109.154518	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Influence of Cyclooxygenase Inhibitors on the Function of the Prostaglandin Transporter Organic Anion-Transporting Polypeptide 2A1 Expressed in Human Gastroduodenal Mucosa	Mandery	2010	0		
895	chr25	40641921	40642802	3500131013	60		40641921	40642802	8421504	2	30,30	0,851	c,g	350013101300000000,350013101300000001	0-30,0-30		12885939	10.1189/jlb.0103004	0741-5400	Journal of Leukocyte Biology	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-&#x03b1; promote the NF-&#x03ba;B-dependent maturation of normal and leukemic myeloid cells	Secchiero	2003	5		
895	chr25	40641921	40642802	3500116327	60		40641921	40642802	8421504	2	30,30	0,851	c	350011632700000004,350011632700000005	0-30,0-30		9028945		0006-4971	Blood	Thrombotic Thrombocytopenic Purpura and Sporadic Hemolytic-Uremic Syndrome Plasmas Induce Apoptosis in Restricted Lineages of Human Microvascular Endothelial Cells	Mitra	1997	10		
895	chr25	40641921	40642802	3500111962	60		40641921	40642802	8421504	2	30,30	0,851	c	350011196200000014,350011196200000015	0-30,0-30						Bmp inhibitors for the treatment of spondyloarthropathies	Lories	2004	0		
895	chr25	40641921	40642802	3500108733	60		40641921	40642802	8421504	2	30,30	0,851	c	350010873300000007,350010873300000008	0-30,0-30		17301127	10.1128/JVI.02448-06	0022-538X	Journal of Virology	Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its Promoter	Ho	2007	5		
895	chr25	40641921	40642802	3500100333	60		40641921	40642802	8421504	2	30,30	0,851	c	350010033300000000,350010033300000001	0-30,0-30						Calcium-mediated effects of coral and methods of use thereof	Vago	2009	0		
895	chr25	40641921	40642802	3500099798	60		40641921	40642802	8421504	2	30,30	0,851	c	350009979800000000,350009979800000001	0-30,0-30						CALCIUM-MEDIATED EFFECTS OF CORAL AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
895	chr25	40641921	40642802	3500097376	57		40641921	40642802	8421504	2	27,30	0,851	c,g	350009737600000002,350009737600000003	0-27,0-30						The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL	-publications.com	0	0		
895	chr25	40641921	40642802	3500091607	60		40641921	40642802	8421504	2	30,30	0,851	c	350009160700000002,350009160700000003	0-30,0-30		9609743			American Journal of Physiology - Lung Cellular and Molecular Physiology	Leukotriene B4 mediates histamine induction of NF-&#x03ba;B and IL-8 in human bronchial epithelial cells	Aoki	1998	0		
895	chr25	40641921	40642802	3500054464	60		40641921	40642802	8421504	2	30,30	0,851	c,g	350005446400000006,350005446400000007	0-30,0-30		15254160	10.1128/JVI.78.15.7874-7882.2004	0022-538X	Journal of Virology	Adeno-Associated Virus Site-Specific Integration and AAVS1 Disruption	Hamilton	2004	5		
895	chr25	40641921	40642802	3500054255	55		40641921	40642802	8421504	2	30,25	0,856	c,g	350005425500000002,350005425500000003	0-30,0-25		18315570	10.1111/j.1471-4159.2008.05318.x	1471-4159	Journal of Neurochemistry	IL-1&#x03b2; induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes - Wu - 2008 - Journal of Neurochemistry - Wiley Online Library	Wu	2008	0		
895	chr25	40641921	40642802	3500051813	60		40641921	40642802	8421504	2	30,30	0,851	c,g	350005181300000000,350005181300000001,350005181300000001	0-30,0-30,0-30		19087284	10.1186/bcr2211	1465-5411	Breast Cancer Research	Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide	Krishnamurthy	2008	0		POTEM
895	chr25	40641921	40642802	3500048734	57		40641921	40642802	8421504	2	27,30	0,851	c	350004873400000007,350004873400000008	0-27,0-30		19531650	10.1158/0008-5472.CAN-09-0488	0008-5472	Cancer Research	Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer	Funasaka	2009	8		ACTB
895	chr25	40641921	40642802	3500041088	55		40641921	40642802	8421504	2	30,25	0,856	c	350004108800000000,350004108800000001	0-30,0-25						ScienceDirect.com - Free Radical Biology and Medicine - Cigarette smoke extract induces cytosolic phospholipase A2 expression via NADPH oxidase, MAPKs, AP-1, and NF-&#x03ba;B in human tracheal smooth muscle cells	sciencedirect.com	0	0		
895	chr25	40641921	40642802	3500039534	60		40641921	40642802	8421504	2	30,30	0,851	c	350003953400000002,350003953400000003	0-30,0-30		14726529	10.1074/jbc.M310164200	0021-9258	Journal of Biological Chemistry	PI3K/Akt Is Required for Heat Shock Proteins to Protect Hypoxia-inducible Factor 1&#x03b1; from pVHL-independent Degradation	Zhou	2004	5		
895	chr25	40641921	40642802	3500022234	60		40641921	40642802	8421504	2	30,30	0,851	c	350002223400000250,350002223400000251	0-30,0-30						Treatment of cancer	Khachigian	2002	0		
895	chr25	40641921	40642802	3500008342	84		40641921	40642802	8421504	3	30,24,30	0,757,851	c,g	350000834200000002,350000834200000045,350000834200000003	0-30,0-24,0-30						Compositions comprising muscle progenitor cells and uses thereof	Bari	2003	0		
895	chr25	40641921	40642802	3500004188	60		40641921	40642802	8421504	2	30,30	0,851	c	350000418800000000,350000418800000001,350000418800000020	0-30,0-30,20-40						Gastroenterology	www.wjgnet.com	0	0		
895	chr25	40641921	40642802	3500003997	55		40641921	40642802	8421504	2	30,25	0,856	c	350000399700000002,350000399700000003	0-30,0-25		20649564	10.1111/j.1476-5381.2010.00858.x		British Journal of Pharmacology	IL-1&#x03b2; induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells	Ching-Yi	2010	0		POTEM
895	chr25	40641921	40642801	3500302058	48		40641921	40642801	8421504	2	24,24	0,856	c	350030205800000004,350030205800000005	0-24,0-24					Infection and Immunity	mkp-1 Encoding Mitogen-Activated Protein Kinase Phosphatase 1, a Verotoxin 1 Responsive Gene, Detected by Differential Display Reverse Transcription-PCR in Caco-2 Cells	Shihoko	2000	0		POTEM
895	chr25	40641921	40642801	3500212862	48		40641921	40642801	8421504	2	24,24	0,856	c	350021286200000002,350021286200000003	0-24,0-24		15096506	10.1074/jbc.M402725200	0021-9258	Journal of Biological Chemistry	Role of RhoA, mDia, and ROCK in Cell Shape-dependent Control of the Skp2-p27kip1 Pathway and the G1/S Transition	Mammoto	2004	5		
895	chr25	40641921	40642801	3500064200	59		40641921	40642801	8421504	2	30,29	0,851	c,g	350006420000000000,350006420000000001,350006420000000001	0-30,0-29,0-29			10.1016/j.exphem.2005.06.022		Experimental hematology	MMP-2 Is Required for Bone Marrow Stromal Cell Support of Chemotaxis	Suzanne	2005	0		
895	chr25	40641921	40642799	3500234662	46		40641921	40642799	8421504	2	24,22	0,856	c,g	350023466200000002,350023466200000003	0-24,0-22						THE J BIOLOGICAL C Vol. 279, No. 25, Issue of June 18, pp. 26323&#x2013;26330, 2004 &#xa9; 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Role of RhoA, mDia, and ROCK in Cell Shape-dependent Control of	drenshospital.org	0	0		
895	chr25	40641921	40641951	3500465934	30		40641921	40641951	8421504	1	30	0	c	350046593400000000	0-30						Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production	Reed	1995	0		POTEE,POTEH
895	chr25	40641921	40641951	3500458765	30		40641921	40641951	8421504	1	30	0	c	350045876500000000	0-30			10.1111/j.1471-4159.2004.02682.x	1471-4159	Journal of Neurochemistry	Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1&#x03b2;-induced matrix metalloproteinase-9 expression in rat brain astrocytes - Wu - 2004 - Journal of Neurochemistry - Wiley Online Library	Wu	2004	0		POTEF,POTEH
895	chr25	40641921	40641951	3500455052	30		40641921	40641951	8421504	1	30	0	c	350045505200000004	0-30						The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction	www.fasebj.org	0	0		ACTB
895	chr25	40641921	40641951	3500439041	30		40641921	40641951	8421504	1	30	0	c	350043904100000004	0-30		12506101	10.1167/iovs.02-0276	1552-5783	Investigative Ophthalmology & Visual Science	Potential Role of the Angiopoietin/Tie2 System in Ischemia-Induced Retinal Neovascularization	Takagi	2003	0		
895	chr25	40641921	40641951	3500434751	30		40641921	40641951	8421504	1	30	0	c	350043475100000002	0-30		16675562	10.1158/1078-0432.CCR-05-2721	1078-0432	Clinical Cancer Research	Sublethal Irradiation Induces Vascular Endothelial Growth Factor and Promotes Growth of Hepatoma Cells: Implications for Radiotherapy of Hepatocellular Carcinoma	Chung	2006	8		POTEE,POTEH
895	chr25	40641921	40641951	3500434452	30		40641921	40641951	8421504	1	30	0	c	350043445200000004	0-30		20231411	10.1128/IAI.00118-10	0019-9567	Infection and Immunity	Bacteroides fragilis Enterotoxin Induces Human &#x03b2;-Defensin-2 Expression in Intestinal Epithelial Cells via a Mitogen-Activated Protein Kinase/I&#x03ba;B Kinase/NF-&#x03ba;B-Dependent Pathway	Yoon	2010	4		POTEE,POTEM
895	chr25	40641921	40641951	3500405687	30		40641921	40641951	8421504	1	30	0	c	350040568700000005	0-30						The human paracellin-1 gene (hPCLN-1): renal epithelial cell-specific expression and regulation	al.physiology.org	0	0		POTEM
895	chr25	40641921	40641951	3500355382	30		40641921	40641951	8421504	1	30	0	c	350035538200000012	0-30						MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial Cells	ebm.sagepub.com	0	0		POTEF,POTEM
895	chr25	40641921	40641951	3500340900	30		40641921	40641951	8421504	1	30	0	c	350034090000000000	0-30		21391979	10.1111/j.1476-5381.2011.01312.x	1476-5381	British Journal of Pharmacology	Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases - Lin - 2011 - British Jou	Lin	2011	0		
895	chr25	40641921	40641951	3500339054	30		40641921	40641951	8421504	1	30	0	c	350033905400000001	0-30						A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10	www.fasebj.org	0	0		POTEF,FRMD5
895	chr25	40641921	40641951	3500331209	30		40641921	40641951	8421504	1	30	0	c	350033120900000002	0-30		11222368	10.1182/blood.V97.5.1258	0006-4971	Blood	Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA	Nathwani	2001	10		POTEE
895	chr25	40641921	40641951	3500327675	30		40641921	40641951	8421504	1	30	0	c	350032767500000002	0-30		18408758	10.1038/onc.2008.112	0950-9232	Oncogene	Regulation of IKK&#x03b2; by miR-199a affects NF-&#x03ba;B activity in ovarian cancer cells	Chen	2008	6		
895	chr25	40641921	40641951	3500319001	30		40641921	40641951	8421504	1	30	0	c	350031900100000002	0-30			10.1128/EC.00371-07	1535-9778	Eukaryotic Cell	Blastocystis ratti Contains Cysteine Proteases That Mediate Interleukin-8 Response from Human Intestinal Epithelial Cells in an NF-&#x03ba;B-Dependent Manner	Puthia	2008	4		POTEM
895	chr25	40641921	40641951	3500316858	30		40641921	40641951	8421504	1	30	0	c	350031685800000006	0-30		10339503		0006-4971	Blood	Expression and Functional Characterization of the &#x03b2;-Isoform of the Folate Receptor on CD34+ Cells	Reddy	1999	10		POTEE,POTEH
895	chr25	40641921	40641951	3500309032	30		40641921	40641951	8421504	1	30	0	c	350030903200000011	0-30						Analyse der Bartonella henselae-induzierten angiogenetischen Wirtszellantwort	.uni-tuebingen.de	0	0		POTEE,POTEH
895	chr25	40641921	40641951	3500307186	30		40641921	40641951	8421504	1	30	0	c	350030718600000008	0-30					The American Journal of Pathology	Vascular Endothelial Growth Factor Isoforms and Their Receptors Are Expressed in Human Osteoarthritic Cartilage	Hiroyuki	2003	0		POTEE
895	chr25	40641921	40641951	3500305982	30		40641921	40641951	8421504	1	30	0	c	350030598200000002	0-30		9763584		0006-4971	Blood	Role of CD28 in Acute Graft-Versus-Host Disease	Yu	1998	10		POTEM,POTEE
895	chr25	40641921	40641951	3500301281	30		40641921	40641951	8421504	1	30	0	c	350030128100000008	0-30		20980254	10.1074/jbc.M110.158857		The Journal of Biological Chemistry	Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells	Xiaohong	2011	0		POTEM
895	chr25	40641921	40641951	3500292773	30		40641921	40641951	8421504	1	30	0	c	350029277300000024	0-30						TESIS DOCTORAL CARACTERIZACI&#xd3;N DE LA APOPTOSIS INDUCIDA POR DROGAS INHIBIDORAS DE LA METILACI&#xd3;N DEL ADN EN C&#xc9;LULAS T LEUC&#xc9;MICAS	hera.ugr.es	0	0		POTEF
895	chr25	40641921	40641951	3500292684	30		40641921	40641951	8421504	1	30	0	c	350029268400000012	0-30						Methods and kits for diagnosing and treating b-Cell chronic lymphocytic leukemia (B-CLL)	Hertz	2008	0		POTEF
895	chr25	40641921	40641951	3500283354	30		40641921	40641951	8421504	1	30	0	c	350028335400000007	0-30		23509733	10.1155/2013/509714		BioMed Research International	RNase P-Associated External Guide Sequence Effectively Reduces the Expression of Human CC-Chemokine Receptor 5 and Inhibits the Infection of Human Immunodeficiency Virus 1	Wenbo	2013	0		ACTB
895	chr25	40641921	40641951	3500282552	30		40641921	40641951	8421504	1	30	0	c	350028255200000002	0-30						Molecular Characterization of the Immune Modulatory Function of Matrix Metalloproteinase-7, a Factor in the Tumour Micromilieu	d-nb.info/9849327	0	0		
895	chr25	40641921	40641951	3500273470	30		40641921	40641951	8421504	1	30	0	c	350027347000000002	0-30			10.1046/j.1365-2249.1999.00999.x		Clinical and Experimental Immunology	An African green monkey lacking peripheral CD4 lymphocytes that retains helper T cell activity and coexists with SIVagm	Y	1999	0		FRMD5
895	chr25	40641921	40641951	3500267182	30		40641921	40641951	8421504	1	30	0	c	350026718200000002	0-30		18408758	10.1038/onc.2008.112		Oncogene	Regulation of IKK&#x03b2; by miR-199a affects NF-&#x03ba;B activity in ovarian cancer cells	R	2008	0		POTEE
895	chr25	40641921	40641951	3500246801	30		40641921	40641951	8421504	1	30	0	c	350024680100000020	0-30						Tesis 15 diciembre	hera.ugr.es	0	0		
895	chr25	40641921	40641951	3500243770	30		40641921	40641951	8421504	1	30	0	c	350024377000000004	0-30			10.1084/jem.20022218		The Journal of Experimental Medicine	Prostaglandin D2 Reinforces Th2 Type Inflammatory Responses of Airways to Low-dose Antigen through Bronchial Expression of Macrophage-derived Chemokine	Kyoko	2003	0		POTEF
895	chr25	40641921	40641951	3500221107	30		40641921	40641951	8421504	1	30	0	c	350022110700000001	0-30						Insulin resistance due to lipid-induced signaling defects could be prevented by mahanine. - ResearchGate	.researchgate.net	0	0		POTEF
895	chr25	40641921	40641951	3500215351	30		40641921	40641951	8421504	1	30	0	c	350021535100000004	0-30		17704247	10.2967/jnumed.106.038612	0161-5505	Journal of Nuclear Medicine	Doxorubicin Enhances the Expression of Transgene Under Control of the CMV Promoter in Anaplastic Thyroid Carcinoma Cells	Kim	2007	6		POTEE
895	chr25	40641921	40641951	3500198371	30		40641921	40641951	8421504	1	30	0	c	350019837100000006	0-30		15254160	10.1128/JVI.78.15.7874-7882.2004	0022-538X	Journal of Virology	Adeno-Associated Virus Site-Specific Integration and AAVS1 Disruption	Hamilton	2004	5		POTEE
895	chr25	40641921	40641951	3500185364	30		40641921	40641951	8421504	1	30	0	c	350018536400000000	0-30		23902727	10.1186/1476-4598-12-84	1476-4598	Molecular Cancer	Characterization and identification of PARM-1 as a new potential oncogene	Charfi	2013	4		POTEM
895	chr25	40641921	40641951	3500183134	30		40641921	40641951	8421504	1	30	0	c	350018313400000002	0-30		21092238	10.1186/1423-0127-17-89	1423-0127	Journal of Biomedical Science	Conserved charged amino acid residues in the extracellular region of sodium/iodide symporter are critical for iodide transport activity	Li	2010	0		POTEE
895	chr25	40641921	40641951	3500175411	30		40641921	40641951	8421504	1	30	0	c	350017541100000000	0-30		20396564	10.4143/crt.2004.36.1.43		Cancer Research and Treatment : Official Journal of Korean Cancer Association	The Differential Gene Expression Profiles between Sensitive and Resistant Breast Cancer Cells to Adriamycin by cDNA Microarray	Myung-Ju	2004	0		POTEM
895	chr25	40641921	40641951	3500152631	29		40641921	40641951	8421504	2	15,14	0,16	c	350015263100000011	0-29						Visualization of Hypoxia-Inducible Factor-1 Transcriptional Activation in C6 Glioma Using Luciferase and Sodium Iodide Symporter Genes	m.snmjournals.org	0	0		POTEE
895	chr25	40641921	40641951	3500145511	30		40641921	40641951	8421504	1	30	0	c	350014551100000002	0-30		14673132	10.1210/me.2003-0215	0888-8809	Molecular Endocrinology	Agonist-Activated Glucocorticoid Receptor Inhibits Binding of Heat Shock Factor 1 to the Heat Shock Protein 70 Promoter in Vivo	Wadekar	2004	5		
895	chr25	40641921	40641951	3500143135	30		40641921	40641951	8421504	1	30	0	c	350014313500000003	0-30						Primary cultured hepatocytes of the bony &#xfb01;sh, Oreochromis mossambicus, the tilapia: a valid tool for physiological studies on IGF-I expression in liver	logy-journals.org	0	0		FRMD5
895	chr25	40641921	40641951	3500126892	30		40641921	40641951	8421504	1	30	0	c	350012689200000006	0-30		18708479	10.1677/JOE-08-0249	0022-0795	Journal of Endocrinology	Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter	Wu	2008	4		POTEM
895	chr25	40641921	40641951	3500126851	30		40641921	40641951	8421504	1	30	0	c	350012685100000004	0-30		18520705	10.1097/SHK.0b013e31817c0c69	1073-2322	Shock	 A Role for Il-18 in Human Neutrophil Apoptosis : Shock 	Hirata	2008	3		POTEM
895	chr25	40641921	40641951	3500125821	30		40641921	40641951	8421504	1	30	0	c	350012582100000000	0-30		21391979	10.1111/j.1476-5381.2011.01312.x		British Journal of Pharmacology	Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases	Wei-Ning	2011	0		ACTB
895	chr25	40641921	40641951	3500109582	30		40641921	40641951	8421504	1	30	0	c	350010958200000000	0-30		23902727	10.1186/1476-4598-12-84	1476-4598	Molecular Cancer	Characterization and identification of PARM-1 as a new potential oncogene	Charfi	2013	4		POTEE
895	chr25	40641921	40641951	3500107250	30		40641921	40641951	8421504	1	30	0	c	350010725000000002	0-30						Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA	eprints.ucl.ac.uk	0	0		POTEM
895	chr25	40641921	40641951	3500038986	30		40641921	40641951	8421504	1	30	0	c	350003898600000000	0-30						Methods for enhancement of protective immune responses	Reed	1996	0		
895	chr25	40641921	40641951	3500038017	30		40641921	40641951	8421504	1	30	0	c	350003801700000000	0-30		19087284	10.1186/bcr2211		Breast Cancer Research : BCR	Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide	Kannan	2008	0		ACTB
895	chr25	40641921	40641951	3500037768	30		40641921	40641951	8421504	1	30	0	c	350003776800000010	0-30						Tesis Doctoral Mecanismos moleculares que regulan la sensibilidad de c&#xe9;lulas tumorales de mama a la apoptosis por TRAIL	digibug.ugr.es	0	0		
895	chr25	40641921	40641951	3500033446	30		40641921	40641951	8421504	1	30	0	c	350003344600000005	0-30		20197310	10.1210/me.2009-0317		Molecular Endocrinology	Involvement of Estrogen Receptor Variant ER-&#x03b1;36, Not GPR30, in Nongenomic Estrogen Signaling	Lianguo	2010	0		POTEE
895	chr25	40641921	40641951	3500011380	30		40641921	40641951	8421504	1	30	0	c	350001138000000003	0-30						Detection of activation-induced cytidine deaminase in gastric epithelial cells infected with cag pathogenicity island-positive Helicobacter pylori : Protocol Exchange	www.nature.com	0	0		
895	chr25	40641921	40641951	3500000549	30		40641921	40641951	8421504	1	30	0	c	350000054900000006	0-30						The Pendrin Anion Exchanger Gene is Transcriptionally Regulated by Uroguanylin: A Novel Entero-Renal Link	al.physiology.org	0	0		
895	chr25	40641921	40641950	3500459983	29		40641921	40641950	8421504	1	29	0	c	350045998300000000	0-29		16760261	10.1152/ajpcell.00523.2005		American Journal of Physiology - Cell Physiolog	Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line	Zhang	2006	0		POTEE
895	chr25	40641921	40641950	3500421689	29		40641921	40641950	8421504	1	29	0	c	350042168900000010	0-29						Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer	www.wjgnet.com	0	0		ACTB
895	chr25	40641921	40641950	3500351454	29		40641921	40641950	8421504	1	29	0	c	350035145400000000	0-29		16760261	10.1152/ajpcell.00523.2005		American Journal of Physiology - Cell Physiology	Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line	Zhang	2006	0		ACTB
895	chr25	40641921	40641950	3500041892	29		40641921	40641950	8421504	1	29	0	c	350004189200000000	0-29		16760261	10.1152/ajpcell.00523.2005		American Journal of Physiology - Cell Physiolog	Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line	Zhang	2006	0		POTEE,POTEH
895	chr25	40641921	40641949	3500447573	28		40641921	40641949	8421504	1	28	0	c	350044757300000000	0-28		19900214	10.1111/j.1582-4934.2009.00964.x	1582-4934	Journal of Cellular and Molecular Medicine	Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1) - Rui - 2009 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Rui	2010	0		ACTB
895	chr25	40641921	40641948	3500323354	27		40641921	40641948	8421504	1	27	0	c	350032335400000024	0-27						Suppression of Hepatitis C Virus Genome Replication in Cells with RNA-Cleaving DNA Enzymes and Short-Hairpin RNA	pfjspark.maru.net	0	0		
895	chr25	40641921	40641945	3500439987	24		40641921	40641945	8421504	1	24	0	c	350043998700000008	0-24		19232089	10.1186/1756-9966-28-24	1756-9966	Journal of Experimental & Clinical Cancer Research	Expression and biological significance of c-FLIP in human hepatocellular carcinomas	Du	2009	2		POTEE
895	chr25	40641921	40641945	3500426224	24		40641921	40641945	8421504	1	24	0	c	350042622400000008	0-24						&#x4e3b;&#x9898;&#xff1a;Factor- | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		POTEE
895	chr25	40641922	40642802	3500358899	58		40641922	40642802	8421504	2	29,29	0,851	c	350035889900000010,350035889900000011	0-29,0-29		15525584	10.1677/joe.1.05788	0022-0795	Journal of Endocrinology	Hepatocyte growth factor regulates proliferation and differentiation of epithelial monolayers derived from islets of postnatal rat pancreas	Wang	2004	4		
895	chr25	40641926	40641949	3500176990	23		40641926	40641949	8421504	1	23	0	c	350017699000000016	23-46		23185455	10.1371/journal.pone.0049841		PLoS ONE	MCPIP1 Down-Regulates IL-2 Expression through an ARE-Independent Pathway	Min	2012	0		POTEF
895	chr25	40641927	40641951	3500314584	24		40641927	40641951	8421504	1	24	0	c	350031458400000022	0-24		20849415	10.1111/j.1742-4658.2010.07819.x	1742-4658	FEBS Journal	MBP-1 is efficiently encoded by an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover - Lung - 2010 - FEBS Journal - Wiley Online Library	Lung	2010	0		FRMD5,CCDC74A
895	chr25	40641929	40641954	3500300673	25		40641929	40641954	8421504	1	25	0	c	350030067300000005	0-25						Inhibition of NF&#x2212;&#x03ba;B and AP-1 activation by R- and S-flurbiprofen	www.fasebj.org	0	0		CCDC74A
895	chr25	40641929	40641954	3500218177	25		40641929	40641954	8421504	1	25	0	c	350021817700000005	0-25						SCREEN FOR INHIBITORS OF HIV REPLICATION - Patent application	www.faqs.org	0	0		POTEM
895	chr25	40641929	40641954	3500174430	25		40641929	40641954	8421504	1	25	0	c	350017443000000000	0-25						Nonylphenol induces apoptosis in rat testicular Sertoli cells via endoplasmic reticulum stress	www.beyotime.com	0	0		ACTB
895	chr25	40641929	40641954	3500030302	25		40641929	40641954	8421504	1	25	0	c	350003030200000009	0-25		23382463	10.1083/jcb.201204092	0021-9525	The Journal of Cell Biology	Myosin VI small insert isoform maintains exocytosis by tethering secretory granules to the cortical actin	Tomatis	2013	10		CCDC74A
895	chr25	40641932	40642044	3500245246	41		40641932	40642044	8421504	2	20,21	0,91	g	350024524600000002,350024524600000003	0-20,0-21		21430053	10.1128/JVI.00859-10		Journal of Virology	Inhibition of Bovine Viral Diarrhea Virus RNA Synthesis by Thiosemicarbazone Derived from 5,6-Dimethoxy-1-Indanone	Eliana	June	0		
895	chr25	40641954	40641984	3500078235	29		40641954	40641984	8421504	2	11,18	0,12	c	350007823500000003	0-29		23344235	10.1038/mtna.2012.35		Molecular Therapy. Nucleic Acids	Antisense 2&#x2032;-Deoxy, 2&#x2032;-Fluoroarabino Nucleic Acid (2&#x2032;F-ANA) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids	Naira	2012	0		ACTB
895	chr25	40641957	40642467	3500375699	421		40641957	40642467	8421504	2	299,122	0,388	c	350037569900000002	0-421						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
895	chr25	40641959	40641985	3500033966	25		40641959	40641985	8421504	2	6,19	0,7	c	350003396600000010	0-25		20978475	10.1038/mt.2010.226		Molecular Therapy	Biochemical Correction of X-CGD by a Novel Chimeric Promoter Regulating High Levels of Transgene Expression in Myeloid Cells	Giorgia	2011	0		
895	chr25	40641968	40642690	3500419159	39		40641968	40642690	8421504	2	20,19	0,703	c,g	350041915900000002,350041915900000003,350041915900000003	0-20,0-19,0-19		19693774	10.1002/jcb.22311		Journal of cellular biochemistry	Antitumor Activity of a Novel Antisense Oligonucleotide Against Akt1	Heejeong	2009	0		ACTB
895	chr25	40641968	40642690	3500380878	39		40641968	40642690	8421504	2	20,19	0,703	c,g	350038087800000047,350038087800000028,350038087800000029,350038087800000029,350038087800000048,350038087800000048	0-20,0-20,0-19,0-19,0-19,0-19					Patent	Use of antisense oligonucleotides to inhibit the expression of akt-1 (Patent EP:1546180)	Yoon	2013	0		
895	chr25	40641968	40642690	3500376217	39		40641968	40642690	8421504	2	20,19	0,703	c,g	350037621700000042,350037621700000043,350037621700000043	0-20,0-19,0-19						Use of antisense oligonucleotides to inhibit the expression of akt-1	Yoon	2004	0		ACTB
895	chr25	40641968	40642690	3500279796	39		40641968	40642690	8421504	2	20,19	0,703	c,g	350027979600000036,350027979600000037,350027979600000037	0-20,0-19,0-19					Patent	Use of antisense oligonucleotides to inhibit the expression of human Akt-1 (Patent US:7122527)	Ahn	2006	0		ACTB
895	chr25	40641968	40642690	3500261943	39		40641968	40642690	8421504	2	20,19	0,703	c,g	350026194300000002,350026194300000003,350026194300000003	0-20,0-19,0-19						RTICLE Journal of	tsouthwestern.edu	0	0		ACTB
895	chr25	40641968	40642690	3500257912	39		40641968	40642690	8421504	2	20,19	0,703	c,g	350025791200000042,350025791200000061,350025791200000043,350025791200000043,350025791200000062,350025791200000062	0-20,0-20,0-19,0-19,0-19,0-19						Use of antisense oligonucleotides to inhibit the expression of human Akt-1	Yoon	2004	0		
895	chr25	40641968	40642690	3500207206	39		40641968	40642690	8421504	2	20,19	0,703	c,g	350020720600000036,350020720600000036,350020720600000037,350020720600000037	0-20,0-20,0-19,0-19						Use of antisense oligonucleotides to inhibit the expression of human Akt-1	Yoon	2003	0		ACTB
895	chr25	40641968	40642690	3500177735	39		40641968	40642690	8421504	2	20,19	0,703	c,g	350017773500000053,350017773500000053,350017773500000054,350017773500000054	0-20,0-20,0-19,0-19					Patent	Use of antisense oligonucleotides to inhibit the expression of Akt-1 (Patent CN:100558740)	An Chang Hao 	2009	0		
895	chr25	40641969	40641994	3500168787	23		40641969	40641994	8421504	2	7,16	0,9	g	350016878700000003	0-24						ScienceDirect.com - FEBS Letters - TRPV1-null mice are protected from diet-induced obesity	sciencedirect.com	0	0		ACTB
895	chr25	40641969	40641994	3500022088	23		40641969	40641994	8421504	2	7,16	0,9	c	350002208800000003	0-24		18503767	10.1016/j.febslet.2008.05.021		FEBS letters	TRPV1-null mice are protected from diet-induced obesity	Arianne	June	0		
895	chr25	40641970	40642770	3500075811	46		40641970	40642770	8421504	2	23,23	0,777	c,g	350007581100000004,350007581100000005,350007581100000005	1-24,0-23,0-23						Respiratory Research BioMed Central	tory-research.com	0	0		
895	chr25	40641970	40642759	3500123252	49		40641970	40642759	8421504	2	22,27	0,762	c,g	350012325200000002,350012325200000002,350012325200000003	0-22,0-22,0-27						Biomechanical assessment of extracellular matrix in native and tissue engineered cartilage across length scales	edoc.unibas.ch	0	0		
895	chr25	40641970	40642691	3500420494	45		40641970	40642691	8421504	2	21,24	0,697	c,g	350042049400000001,350042049400000001,350042049400000002	0-21,0-21,0-24						Telomerase Activity and Expression of hTRT and hTR in Gastrointestinal Stromal Tumors in Comparison with Extragastrointestinal Sarcomas	.aacrjournals.org	0	0		
895	chr25	40641970	40642691	3500391127	45		40641970	40642691	8421504	2	21,24	0,697	c,g	350039112700000001,350039112700000001,350039112700000002	0-21,0-21,0-24		10815902		1078-0432	Clinical Cancer Research	Telomerase Activity and Expression of hTRT and hTR in Gastrointestinal Stromal Tumors in Comparison with Extragastrointestinal Sarcomas	Gunther	2000	8		
895	chr25	40641970	40641997	3500410417	27		40641970	40641997	8421504	1	27	0	c	350041041700000003	0-27		21054339	10.1111/j.1476-5381.2010.01101.x	1476-5381	British Journal of Pharmacology	Metformin inhibits P-glycoprotein expression via the NF-&#x03ba;B pathway and CRE transcriptional activity through AMPK activation - Kim - 2011 - British Journal of Pharmacology - Wiley Online Library	Kim	2011	0		ACTG1
895	chr25	40641970	40641993	3500456291	23		40641970	40641993	8421504	1	23	0	c	350045629100000007	0-23		19432902	10.1111/j.1349-7006.2009.01148.x	1349-7006	Cancer Science	Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway - He - 2009 - Cancer	He	2009	0		ACTG1
895	chr25	40641970	40641993	3500433246	23		40641970	40641993	8421504	1	23	0	g	350043324600000002	0-23		23429288	10.1038/cddis.2013.1	false	Cell Death & Disease	CUL1 promotes trophoblast cell invasion at the maternal&#x2013;fetal interface	Zhang	2013	0		
895	chr25	40641970	40641993	3500426268	23		40641970	40641993	8421504	1	23	0	g	350042626800000001	0-23		20969766	10.1186/1476-4598-9-280		Molecular Cancer	Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness	Srinivas	2010	0		
895	chr25	40641970	40641993	3500282482	23		40641970	40641993	8421504	1	23	0	c	350028248200000002	24-47						Prevention and therapy of type 2 diabetes by selective modulation of the human peroxisome proliferator-activated receptor gamma (PPAR&#x03b3;	diss.fu-berlin.de	0	0		
895	chr25	40641970	40641993	3500122861	23		40641970	40641993	8421504	1	23	0	c,g	350012286100000005,350012286100000005	0-23,0-23						Overexpression of peptide deformylase in breast, colon, and lung ca...	ww.slideshare.net	0	0		ACTG1
895	chr25	40641971	40642797	3500431004	50		40641971	40642797	8421504	2	25,25	0,801	c	350043100400000002,350043100400000003	0-25,0-25		14985364	10.1074/jbc.M401544200	0021-9258	Journal of Biological Chemistry	A Novel Angiotensin II Type 1 Receptor-associated Protein Induces Cellular Hypertrophy in Rat Vascular Smooth Muscle and Renal Proximal Tubular Cells	Guo	2004	5		ACTB
895	chr25	40641971	40642797	3500425167	50		40641971	40642797	8421504	2	25,25	0,801	c	350042516700000004,350042516700000005	0-25,0-25						B ASI CRE H Augmented regeneration of partial liver allograft induced by nuclear factor-kB decoy oligodeoxynucleotides-modified dendritic cells	www.wjgnet.com	0	0		ACTG1
895	chr25	40641971	40642797	3500302682	50		40641971	40642797	8421504	2	25,25	0,801	c	350030268200000006,350030268200000007	0-25,0-25						Triptolide Upregulates NGF Synthesis in Rat Astrocyte Cultures	nri.bjmu.edu.cn	0	0		ACTB
895	chr25	40641971	40641996	3500095087	25		40641971	40641996	8421504	1	25	0	c	350009508700000017	0-25						PU.l But Not Ets-2 Is Essential for Macrophage Development From Embryonic Stem Cells	tologylibrary.org	0	0		
895	chr25	40641973	40642759	3500347687	44		40641973	40642759	8421504	2	22,22	0,764	g	350034768700000002,350034768700000003	0-22,0-22						Spinner preparation machine and cavity resonator	Bach	2003	0		ACTB
895	chr25	40641973	40641996	3500081819	23		40641973	40641996	8421504	1	23	0	c	350008181900000002	19-42		19153068	10.1684/ejd.2008.0618	1167-1122	European Journal of Dermatology	John Libbey Eurotext : &#xc9;ditions m&#xe9;dicales et scientifiques France : revues, m&#xe9;dicales, scientifiques, m&#xe9;decine, sant&#xe9;, livres - Texte int&#xe9;gral de l'article	Zhang	2009	3		ACTB
895	chr25	40641974	40641998	3500354450	24		40641974	40641998	8421504	1	24	0	g	350035445000000009	0-24		9116296		0006-4971	Blood	Downregulation of RAR&#x03b1; in Mice by Antisense Transgene Leads to a Compensatory Increase in RAR&#x03b2; and RAR&#x03b3; and Development of Lymphoma	Manshouri	1997	10		PSMF1,ACTG1
895	chr25	40641982	40642802	3500222975	50		40641982	40642802	8421504	2	25,25	0,795	c	350022297500000002,350022297500000003	0-25,0-25						A novel tumor cell line cloned from mutated human embryonic bone marrow mesenchymal stem cells	-publications.com	0	0		
895	chr25	40641987	40642017	3500247338	30		40641987	40642017	8421504	1	30	0	c	350024733800000014	0-30						Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas	tologylibrary.org	0	0		ACTG1
895	chr25	40641993	40642023	3500211088	30		40641993	40642023	8421504	1	30	0	g	350021108800000004	0-30						Methods and Compositions Related to Inhibition of Ceramide Synthesis	Summers	2007	0		ACTB
895	chr25	40641995	40642021	3500460245	26		40641995	40642021	8421504	1	26	0	c	350046024500000014	0-26						DistinctEffectsofAnnexinA7andp53onArachidonate LipoxygenationinProstateCancerCellsInvolve 5-LipoxygenaseTranscription	.aacrjournals.org	0	0		ACTG1
895	chr25	40641999	40642023	3500330540	24		40641999	40642023	8421504	1	24	0	c	350033054000000024	0-24						METHODS FOR IMPROVING CARDIAC DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS - NOVARTIS AG	www.sumobrain.com	0	0		POTEM
895	chr25	40642000	40642023	3500390071	23		40642000	40642023	8421504	1	23	0	c	350039007100000005	0-23		20610602	10.1101/gr.105825.110	1088-9051	Genome Research	High-throughput profiling of amino acids in strains of the Saccharomyces cerevisiae deletion collection	Cooper	2010	14		CCDC74A
895	chr25	40642001	40642024	3500053272	23		40642001	40642024	8421504	1	23	0	c	350005327200000006	0-23						Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells	www.irme.org	0	0		
895	chr25	40642002	40642026	3500074215	24		40642002	40642026	8421504	1	24	0	c	350007421500000005	0-24			10.1111/j.1365-2567.2007.02578.x		Immunology	Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12	Ana	July	0		
895	chr25	40642002	40642026	3500062984	24		40642002	40642026	8421504	1	24	0	c	350006298400000020,350006298400000006	0-24,0-24						Treatment of cancer with aldose reductase inhibitors - Patent application	www.faqs.org	0	0		ACTB
895	chr25	40642003	40642797	3500021337	45		40642003	40642797	8421504	2	22,23	0,771	c,g	350002133700000018,350002133700000019	0-22,0-23						Overcoming multidrug resistance in human lung cancer with novel benzo[a]quinolizin-4-ones. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642012	40642038	3500209988	25		40642012	40642038	8421504	2	21,4	0,22	c	350020998800000000	0-25						Maruotti MRD 2012 - ResearchGate	.researchgate.net	0	0		
895	chr25	40642014	40642038	3500106329	24		40642014	40642038	8421504	1	24	0	c	350010632900000002	0-24		17409425	10.1158/0008-5472.CAN-06-3312	0008-5472	Cancer Research	Mutant V600E BRAF Increases Hypoxia Inducible Factor-1&#x03b1; Expression in Melanoma	Kumar	2007	8		ACTG2
895	chr25	40642019	40642109	3500261447	46		40642019	40642109	8421504	2	22,24	0,66	c	350026144700000000,350026144700000001	0-22,0-24						CRISTIANA LIBARDI MIRANDA	www.tede.ufv.br	0	0		
895	chr25	40642022	40642049	3500258471	27		40642022	40642049	8421504	1	27	0	c	350025847100000004	0-27						Virginia Tech : LIB 04212005 : Dissertation	ww.coursehero.com	0	0		
895	chr25	40642030	40642137	3500357902	39		40642030	40642137	8421504	2	19,20	0,87	c,g	350035790200000012,350035790200000012,350035790200000013	0-19,0-19,0-20						Identification of the ovine mannose receptor and its possible role in Visna/Maedi virus infection	inaryresearch.org	0	0		
895	chr25	40642030	40642137	3500159234	39		40642030	40642137	8421504	2	19,20	0,87	c,g	350015923400000000,350015923400000000,350015923400000001,350015923400000001	0-19,0-19,0-20,0-20						Trabajo Fin de Master . Olaia Urrutia Vera.	ica-e.unavarra.es	0	0		
895	chr25	40642031	40642092	3500243004	40		40642031	40642092	8421504	2	19,21	0,40	c,g	350024300400000003,350024300400000003,350024300400000004,350024300400000004	0-19,0-19,0-21,0-21						Effects of sex and age on the expression of stearoyl-CoA desaturase in bovine muscle and adipose tissue	www.vuzv.cz	0	0		
895	chr25	40642036	40642219	3500284321	44		40642036	40642219	8421504	2	19,25	0,158	c,g	350028432100000002,350028432100000002,350028432100000003	0-19,0-19,0-25		19625250	10.1074/jbc.M109.023010		The Journal of Biological Chemistry	Brain-derived Neurotrophic Factor Enhances the Basal Rate of Protein Synthesis by Increasing Active Eukaryotic Elongation Factor 2 Levels and Promoting Translation Elongation in Cortical Neurons	Nobuyuki	2009	0		
895	chr25	40642036	40642063	3500188498	27		40642036	40642063	8421504	1	27	0	c	350018849800000007	0-27		17438107	10.1158/1078-0432.CCR-06-2353	1078-0432	Clinical Cancer Research	The Human T-Box Mesodermal Transcription Factor Brachyury Is a Candidate Target for T-Cell&#x2013;Mediated Cancer Immunotherapy	Palena	2007	8		TNFRSF11A,ACTG1
895	chr25	40642036	40642059	3500223196	23		40642036	40642059	8421504	1	23	0	c	350022319600000006	0-23						Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. - ResearchGate	.researchgate.net	0	0		ACTG1
895	chr25	40642038	40642092	3500261436	39		40642038	40642092	8421504	2	19,20	0,34	c,g	350026143600000011,350026143600000012,350026143600000012	0-19,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
895	chr25	40642039	40642062	3500132933	23		40642039	40642062	8421504	1	23	0	c	350013293300000005	0-23						nchembio.1114-S1 - ResearchGate	.researchgate.net	0	0		ACTG1
895	chr25	40642041	40642758	3500432198	39		40642041	40642758	8421504	2	19,20	0,697	c,g	350043219800000004,350043219800000004,350043219800000005	0-19,0-19,0-20		19332490	10.1113/jphysiol.2009.172254	0022-3751	The Journal of Physiology	TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2009	5		
895	chr25	40642041	40642758	3500197829	39		40642041	40642758	8421504	2	19,20	0,697	c	350019782900000004,350019782900000005	0-19,0-20		20739625	10.1152/ajpcell.00548.2009		American Journal of Physiology - Cell Physiology	Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Ng	2010	0		
895	chr25	40642041	40642758	3500045843	39		40642041	40642758	8421504	2	19,20	0,697	c,g	350004584300000004,350004584300000004,350004584300000005	0-19,0-19,0-20		19332490	10.1113/jphysiol.2009.172254		The Journal of Physiology	TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells	Lih	June	0		
895	chr25	40642042	40642809	3500450668	41		40642042	40642809	8421504	2	20,21	0,746	c	350045066800000003,350045066800000006	0-20,21-42		20626554	10.1111/j.1471-4159.2010.06887.x	1471-4159	Journal of Neurochemistry	ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer&#x2019;s disease - Shen - 2010 - Journal of Neurochemistry - Wiley Online Library	Shen	2010	0		
895	chr25	40642042	40642809	3500082573	41		40642042	40642809	8421504	2	20,21	0,746	c,g	350008257300000000,350008257300000005,350008257300000005	0-20,0-21,0-21						Reactive Oxygen Species (ROS) up-regulates MMP-9 expression via MAPK-AP1 signaling	w.ruor.uottawa.ca	0	0		
895	chr25	40642042	40642759	3500021673	41		40642042	40642759	8421504	2	20,21	0,696	c,g	350002167300000010,350002167300000010,350002167300000011,350002167300000011	0-20,0-20,0-21,0-21						Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase	rt.physiology.org	0	0		ACTB
895	chr25	40642042	40642255	3500107990	41		40642042	40642255	8421504	2	20,21	0,192	c,g	350010799000000011,350010799000000012	0-20,0-21						Regulation of megakaryocytic differentiation of K562 cells by FosB, a member of the Fos family of AP1 transcription factors - ResearchGate	.researchgate.net	0	0		
895	chr25	40642042	40642186	3500086686	40		40642042	40642186	8421504	2	20,20	0,124	c	350008668600000028,350008668600000029	0-20,0-20		15485913	10.1128/MCB.24.21.9456-9469.2004	0270-7306	Molecular and Cellular Biology	Characterization of Stanniocalcin 2, a Novel Target of the Mammalian Unfolded Protein Response with Cytoprotective Properties	Ito	2004	6		
895	chr25	40642042	40642065	3500370943	23		40642042	40642065	8421504	1	23	0	c	350037094300000008	1-24						Enhanced CBir1-specific innate and adaptive immune responses in Crohn&#x2019;s disease - Keeping the Faith	pthefaith1296.com	0	0		GOLGA8A,ACTG1
895	chr25	40642043	40642764	3500208865	39		40642043	40642764	8421504	2	19,20	0,701	c,g	350020886500000007,350020886500000008,350020886500000008	0-19,0-20,0-20		23946657	10.4137/NMI.S6728		Nutrition and Metabolic Insights	Diets Enriched in Fish-Oil or Seal-Oil have Distinct Effects on Lipid Levels and Peroxidation in BioF1B Hamsters	Pratibha	2011	0		
895	chr25	40642043	40642077	3500422196	34		40642043	40642077	8421504	1	34	0	c,g	350042219600000008,350042219600000008	0-34,0-34		14973554	10.1038/sj.onc.1207247	0950-9232	Oncogene	EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma	Duxbury	2004	6		ACTB
895	chr25	40642043	40642067	3500436922	24		40642043	40642067	8421504	1	24	0	c	350043692200000026	24-48						Effects of sex steroids on indices of protein turnover in rainbow trout (Oncorhynchus mykiss) white muscle	aldc.nal.usda.gov	0	0		ACTG1
895	chr25	40642043	40642067	3500170805	24		40642043	40642067	8421504	1	24	0	c	350017080500000000	24-48						Beth M. Cleveland, Gregory M. Weber, Kenneth P. Blemings and Jeffrey T. Silverstein	ddr.nal.usda.gov	0	0		
895	chr25	40642045	40642176	3500448729	40		40642045	40642176	8421504	2	20,20	0,111	c	350044872900000047,350044872900000045	0-20,0-20		14630918	10.1074/jbc.M311862200	0021-9258	Journal of Biological Chemistry	Induction of CHOP Expression by Amino Acid Limitation Requires Both ATF4 Expression and ATF2 Phosphorylation	Averous	2004	5		ACTB,ACTG1
895	chr25	40642045	40642176	3500235108	40		40642045	40642176	8421504	2	20,20	0,111	c	350023510800000010,350023510800000008	0-20,0-20		19822663	10.1128/MCB.00489-09	0270-7306	Molecular and Cellular Biology	Identification of a Novel Amino Acid Response Pathway Triggering ATF2 Phosphorylation in Mammals	Chaveroux	2009	6		
895	chr25	40642045	40642176	3500024852	40		40642045	40642176	8421504	2	20,20	0,111	c	350002485200000010,350002485200000008	0-20,0-20		19822663	10.1128/MCB.00489-09		Molecular and Cellular Biology	Identification of a Novel Amino Acid Response Pathway Triggering ATF2 Phosphorylation in Mammals 	Cedric	2009	0		ACTG1
895	chr25	40642049	40642721	3500306881	40		40642049	40642721	8421504	2	20,20	0,652	c,g	350030688100000006,350030688100000006,350030688100000007	0-20,0-20,0-20		20529871	10.1074/jbc.M110.134544	0021-9258	Journal of Biological Chemistry	Inhibition of Golgi Apparatus Glycosylation Causes Endoplasmic Reticulum Stress and Decreased Protein Synthesis	Xu	2010	5		
895	chr25	40642049	40642079	3500467254	30		40642049	40642079	8421504	1	30	0	c,g	350046725400000011,350046725400000011	29-59,29-59						Gastroenterology World Journal of	www.wjgnet.com	0	0		ACTG1
895	chr25	40642049	40642079	3500443470	30		40642049	40642079	8421504	1	30	0	c,g	350044347000000011,350044347000000011	29-59,29-59						Gastroenterology World Journal of	www.wjgnet.com	0	0		ACTB,ACTG1
895	chr25	40642051	40642700	3500446330	40		40642051	40642700	8421504	2	20,20	0,629	c	350044633000000001,350044633000000021	0-20,0-20						Pim de Waard	arno.unimaas.nl	0	0		ACTG1
895	chr25	40642066	40642804	3500001887	44		40642066	40642804	8421504	2	21,23	0,715	c,g	350000188700000000,350000188700000001	0-21,0-23						Curcumin induces changes in expression of genes involved in cholesterol homeostasis	biodiversity.info	0	0		
895	chr25	40642066	40642433	3500179889	43		40642066	40642433	8421504	2	21,22	0,345	c,g	350017988900000026,350017988900000026,350017988900000027,350017988900000027	0-21,0-21,0-22,0-22						Research Paper Characterization of Bovine Induced Pluripotent Stem Cells by Lentiviral Transduction of Reprogramming Factor Fusion Proteins	www.ijbs.com	0	0		
895	chr25	40642066	40642433	3500165278	43		40642066	40642433	8421504	2	21,22	0,345	c,g	350016527800000203,350016527800000203,350016527800000204,350016527800000204	0-21,0-21,0-22,0-22						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
895	chr25	40642066	40642089	3500266423	23		40642066	40642089	8421504	1	23	0	c	350026642300000006	0-23						RESEARCH Open Access Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates	onal-medicine.com	0	0		POTEG,POTEE
895	chr25	40642066	40642089	3500263000	23		40642066	40642089	8421504	1	23	0	c	350026300000000033	21-44						015_PCR_Protocols_1st_Edition	x.llnw-trials.com	0	0		ACTG1
895	chr25	40642066	40642089	3500196586	23		40642066	40642089	8421504	1	23	0	c	350019658600000006	0-23		22704060	10.1186/1479-5876-10-122	1479-5876	Journal of Translational Medicine	Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates	Unzu	2012	3		POTEF,ACTG1
895	chr25	40642066	40642089	3500156302	23		40642066	40642089	8421504	1	23	0	c	350015630200000000	0-23		12444121		0022-1767	The Journal of Immunology	Kinetics of Gene Induction After Fc&#x03b5;RI Ligation of Atopic Monocytes Identified by Suppression Subtractive Hybridization	Bubnoff	2002	6		POTEF,ACTG1
895	chr25	40642066	40642089	3500023877	23		40642066	40642089	8421504	1	23	0	c	350002387700000033	21-44						015_PCR_Protocols_1st_Edition	www.docstoc.com	0	0		POTEG,POTEE
895	chr25	40642067	40642352	3500394139	40		40642067	40642352	8421504	3	20,13,7	0,176,278	c	350039413900000000,350039413900000001	0-20,0-20						ScienceDirect.com - Journal of the American College of Cardiology - High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life	sciencedirect.com	0	0		ACTB
895	chr25	40642071	40642664	3500165789	46		40642071	40642664	8421504	3	21,19,6	0,437,587	c,g	350016578900000012,350016578900000012,350016578900000007	0-21,0-21,0-25		18042303	10.1186/1471-2164-8-436	1471-2164	BMC Genomics	Characterization of Smoc-1 uncovers two transcript variants showing differential tissue and age specific expression in Bubalus bubalis	Srivastava	2007	4		
895	chr25	40642071	40642095	3500411508	24		40642071	40642095	8421504	1	24	0	c	350041150800000005	0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Fol&#xed;culos ovarianos caprinos expressam diferentes n&#xed;veis de RNAm para subunidade &#xdf;A da inibina e ativina-A promove o crescimento de fol&#xed;culos secund&#xe1;rios in vitro	Leitao	2013	0		
895	chr25	40642071	40642095	3500331184	24		40642071	40642095	8421504	1	24	0	c	350033118400000003	0-24						UNIVERSIDADE ESTADUAL DO CEAR&#xc1; PR&#xd3;-REITORIA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O E PESQUISA FACULDADE DE VETERIN&#xc1;RIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS VETERIN&#xc1;RIAS JULIANA JALES DE HOLLANDA CELESTINO EXX PPRREESSSS&#	cnptia.embrapa.br	0	0		
895	chr25	40642071	40642095	3500263461	24		40642071	40642095	8421504	1	24	0	c,g	350026346100000003,350026346100000003	0-24,0-24						Isolation and culture of Preantral Follicles	www.cbra.org.br	0	0		
895	chr25	40642071	40642095	3500205046	24		40642071	40642095	8421504	1	24	0	c	350020504600000002	24-48						Expression of protein and mRNA encoding Insulin Growth Factor-I (IGF-I) in goat ovarian follicles and the influence of IGF-I on in vitro development and survival of caprine preantral follicles	www.cbra.org.br	0	0		ACTG1
895	chr25	40642071	40642095	3500053285	24		40642071	40642095	8421504	1	24	0	c,g	350005328500000005,350005328500000005	0-24,0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Goat ovarian follicles express different levels of mRNA for inhibin-&#xdf;A subunit and activin-A stimulates secondary follicle growth in vitro	Leitao	2013	0		
895	chr25	40642071	40642095	3500053265	24		40642071	40642095	8421504	1	24	0	c,g	350005326500000001,350005326500000001	0-24,0-24						Levels of mRNA for BMP-7 in goat ovarian follicles and in vitro effects of BMP-7 on secondary follicle development	www.cbra.org.br	0	0		
895	chr25	40642073	40642253	3500332074	40		40642073	40642253	8421504	2	20,20	0,160	c,g	350033207400000004,350033207400000004,350033207400000005,350033207400000005	0-20,0-20,0-20,0-20						Estrogen augments shear stress-induced signaling and gene expression in osteoblast-like cells via estrogen receptor-mediated expression of beta1-integrin.	.biomedsearch.com	0	0		
895	chr25	40642073	40642253	3500116485	40		40642073	40642253	8421504	2	20,20	0,160	c,g	350011648500000002,350011648500000002,350011648500000003	0-20,0-20,0-20		19819988	10.1210/me.2009-0143	0888-8809	Molecular Endocrinology	BMP-4 Induction of Arrest and Differentiation of Osteoblast-Like Cells via p21CIP1 and p27KIP1 Regulation	Chang	2009	5		
895	chr25	40642081	40642107	3500305811	26		40642081	40642107	8421504	1	26	0	g	350030581100000048	26-52						Polymorphic microsatellite markers in the 100Graphicraft Limited, Hong Kong ornate dragon lizard, Ctenophorus ornatus	ww.chesapeake.org	0	0		
895	chr25	40642085	40642430	3500156424	39		40642085	40642430	8421504	2	20,19	0,326	c,g	350015642400000002,350015642400000003,350015642400000003	0-20,0-19,0-19		22321818	10.1186/1743-7075-9-10	1743-7075	Nutrition & Metabolism	Periodic 48 h feed withdrawal improves glucose tolerance in growing pigs by enhancing adipogenesis and lipogenesis	Mir	2012	3		
895	chr25	40642085	40642110	3500434117	25		40642085	40642110	8421504	1	25	0	g	350043411700000011	0-25						REPRODUCTION	uction-online.org	0	0		
895	chr25	40642093	40642445	3500113800	40		40642093	40642445	8421504	2	20,20	0,332	c	350011380000000004,350011380000000005	0-20,0-20						UNIVERSIDAD DE MURCIA	digitum.um.es	0	0		
895	chr25	40642101	40642125	3500156475	24		40642101	40642125	8421504	1	24	0	c	350015647500000002	0-24						REPRODUCTION	uction-online.org	0	0		
895	chr25	40642104	40642127	3500299455	23		40642104	40642127	8421504	1	23	0	c	350029945500000000	0-23						>	earningcenter.org	0	0		ACTG1
895	chr25	40642104	40642127	3500266398	23		40642104	40642127	8421504	1	23	0	c	350026639800000000	0-23						Entwicklung eines gewebenahen Konstruktes aus einer Matrix mit in vitro kultivierten Fibroblasten und Keratinozyten zum Ersatz der Oralmukosa unter Einsatz von Tissue Engineering	.uni-wuerzburg.de	0	0		
895	chr25	40642104	40642127	3500235327	23		40642104	40642127	8421504	1	23	0	c	350023532700000010	0-23						CHARAKTERISIERUNG VON HUMANEM HEADCASE (HECA) UND SEINEN ISOFORMEN IN NORMALEN KERATINOZYTEN UND IM ORALEN PLATTENEPITHELKARZINOM	uni-regensburg.de	0	0		MURC,ACTG1
895	chr25	40642114	40642254	3500346719	44		40642114	40642254	8421504	2	22,22	0,118	c	350034671900000002,350034671900000004	7-29,1-23						Methods For In Vitro Differentiation Of Th-17+cells 	.freshpatents.com	0	0		
895	chr25	40642115	40642524	3500048562	40		40642115	40642524	8421504	2	20,20	0,389	c,g	350004856200000010,350004856200000011,350004856200000011	0-20,0-20,0-20						Clinical and Experimental Immunology	005.pasteur.ac.ir	0	0		
895	chr25	40642115	40642357	3500348976	40		40642115	40642357	8421504	4	14,6,8,12	0,15,133,230	c	350034897600000042,350034897600000043	0-20,0-20						Methods comprising apoptosis inhibitors for the generation of transgenic pigs	Piedrahita	2001	0		ACTB
895	chr25	40642115	40642357	3500090639	40		40642115	40642357	8421504	4	14,6,8,12	0,15,133,230	c,g	350009063900000038,350009063900000038,350009063900000039	0-20,0-20,0-20						 Cells And Methods For The Generation Of Transgenic Pigs 	www.docstoc.com	0	0		ACTG1
895	chr25	40642115	40642357	3500054373	40		40642115	40642357	8421504	4	14,6,8,12	0,15,133,230	c,g	350005437300000042,350005437300000043	0-20,0-20					Patent	Methods comprising apoptosis inhibitors for the generation of transgenic pigs (Patent US:6369294)	Piedrahita	2002	0		
895	chr25	40642115	40642254	3500464111	40		40642115	40642254	8421504	2	20,20	0,119	c	350046411100000016,350046411100000017	0-20,0-20		23339444	10.1186/1752-0509-7-9		BMC Systems Biology	Signaling dynamics of palmitate-induced ER stress responses mediated by ATF4 in HepG2 cells	Hyunju	2013	0		
895	chr25	40642116	40642967	3500066090	40		40642116	40642967	8421504	2	20,20	0,831	c,g	350006609000000004,350006609000000005,350006609000000005	0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
895	chr25	40642116	40642438	3500426247	40		40642116	40642438	8421504	2	20,20	0,302	c,g	350042624700000012,350042624700000013,350042624700000013	0-20,0-20,0-20						Shedding of the Germinal Angiotensin I-Converting Enzyme (gACE) Involves a Serine Protease and Is Activated by Epididymal Fluid	ww.biolreprod.org	0	0		
895	chr25	40642116	40642438	3500422717	40		40642116	40642438	8421504	2	20,20	0,302	c,g	350042271700000006,350042271700000007,350042271700000007	0-20,0-20,0-20		16251497	10.1095/biolreprod.105.046847	0006-3363	Biology of Reproduction	An Epididymal Form of Cauxin, a Carboxylesterase-Like Enzyme, Is Present and Active in Mammalian Male Reproductive Fluids	Ecroyd	2006	4		
895	chr25	40642116	40642438	3500310121	40		40642116	40642438	8421504	2	20,20	0,302	c,g	350031012100000012,350031012100000013,350031012100000013	0-20,0-20,0-20		15987822	10.1095/biolreprod.105.042929	0006-3363	Biology of Reproduction	Shedding of the Germinal Angiotensin I-Converting Enzyme (gACE) Involves a Serine Protease and Is Activated by Epididymal Fluid	Thimon	2005	4		
895	chr25	40642116	40642438	3500272136	40		40642116	40642438	8421504	2	20,20	0,302	c,g	350027213600000008,350027213600000009,350027213600000009	0-20,0-20,0-20						Localization, Expression Change in PRRSV Infection and Association Analysis of the Porcine TAP1 Gene	www.ijbs.com	0	0		
895	chr25	40642116	40642438	3500146786	40		40642116	40642438	8421504	2	20,20	0,302	c,g	350014678600000008,350014678600000009,350014678600000009	0-20,0-20,0-20					International Journal of Biological Sciences	Localization, Expression Change in PRRSV Infection and Association Analysis of the Porcine TAP1 Gene - Scolaris	Sun	2011	0		
895	chr25	40642116	40642355	3500420428	40		40642116	40642355	8421504	3	20,10,10	0,130,229	c	350042042800000009,350042042800000011	0-20,0-20						Methods and systems for purifying, transferring, and/or manipulating nucleic acids	Armani	2011	0		
895	chr25	40642116	40642355	3500224468	40		40642116	40642355	8421504	3	20,10,10	0,130,229	c	350022446800000009,350022446800000021,350022446800000023,350022446800000011	0-20,0-20,0-20,0-20						METHODS AND SYSTEMS FOR PURIFYING, TRANSFERRING, AND/OR MANIPULATING NUCLEIC ACIDS - Patent application	www.faqs.org	0	0		ACTB
895	chr25	40642116	40642254	3500436763	40		40642116	40642254	8421504	2	20,20	0,118	c	350043676300000002,350043676300000004	0-20,0-20						Methods for in vitro differentiation of Th-17+cells	Manel	2009	0		
895	chr25	40642116	40642254	3500385340	40		40642116	40642254	8421504	2	20,20	0,118	c	350038534000000002,350038534000000004	0-20,0-20						METHODS FOR IN VITRO DIFFERENTIATION OF TH-17+ CELLS	Manel	2012	0		ACTG1
895	chr25	40642116	40642254	3500129446	39		40642116	40642254	8421504	2	20,19	0,119	c	350012944600000002,350012944600000003	0-20,0-19		18660423	10.1167/iovs.07-0456	1552-5783	Investigative Ophthalmology & Visual Science	Curcumin Modulates SDF-1&#x03b1;/CXCR4&#x2013;Induced Migration of Human Retinal Endothelial Cells (HRECs)	Sameermahmood	2008	0		ACTB
895	chr25	40642116	40642139	3500427251	23		40642116	40642139	8421504	1	23	0	c	350042725100000014	0-23		20805357	10.1128/MCB.00396-10	0270-7306	Molecular and Cellular Biology	The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression	Yu	2010	6		POTEE
895	chr25	40642117	40642757	3500000090	45		40642117	40642757	8421504	2	23,22	0,618	c	350000009000000002,350000009000000003	0-23,0-22		12016134	10.1152/ajpgi.00041.2001		American Journal of Physiology - Gastrointestinal and Liver Physiology	Analysis of human cellular retinol-binding protein II promoter during enterocyte differentiation	Zhang	2002	0		
895	chr25	40642117	40642140	3500425085	23		40642117	40642140	8421504	1	23	0	c	350042508500000003	0-23		16751365		0022-1767	The Journal of Immunology	Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU)	Jha	2006	6		ACTB
895	chr25	40642117	40642140	3500205115	23		40642117	40642140	8421504	1	23	0	c	350020511500000002	0-23		23894671	10.1371/journal.pone.0070554		PLoS ONE	Induction of Malignant Plasma Cell Proliferation by Eosinophils	Tina	2013	0		POTEE
895	chr25	40642153	40642756	3500168730	41		40642153	40642756	8421504	2	21,20	0,583	g	350016873000000018,350016873000000019	0-21,0-20		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		
895	chr25	40642153	40642756	3500117620	40		40642153	40642756	8421504	2	20,20	0,583	g	350011762000000008,350011762000000009	0-20,0-20						Vascular Endothelial Growth Factor Reduced and Connective Tissue Growth Factor Induced by Triamcinolone in ARPE19 Cells under Oxidative Stress	www.iovs.org	0	0		
895	chr25	40642156	40642424	3500155687	40		40642156	40642424	8421504	2	20,20	0,248	c,g	350015568700000012,350015568700000013,350015568700000013	0-20,0-20,0-20						Expression analysis of the steroidogenic acute regulatory protein (STAR) gene in developing porcine conceptuses. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642156	40642254	3500439816	40		40642156	40642254	8421504	2	20,20	0,78	c,g	350043981600000004,350043981600000004,350043981600000005,350043981600000005	0-20,0-20,0-20,0-20		21269472	10.1186/bcr2817	1465-5411	Breast Cancer Research	Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer	Li	2011	0		
895	chr25	40642156	40642254	3500269587	40		40642156	40642254	8421504	2	20,20	0,78	c,g	350026958700000004,350026958700000004,350026958700000005	0-20,0-20,0-20		21269472	10.1186/bcr2817		Breast Cancer Research : BCR	Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer	Yuqing	2011	0		
895	chr25	40642156	40642254	3500080508	40		40642156	40642254	8421504	2	20,20	0,78	c,g	350008050800000010,350008050800000010,350008050800000011	0-20,0-20,0-20		21119756	10.1007/s11568-010-9138-x		The HUGO Journal	Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development	Jianjun	2009	0		
895	chr25	40642156	40642254	3500003625	40		40642156	40642254	8421504	2	20,20	0,78	c	350000362500000010,350000362500000011	0-20,0-20						Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642157	40642884	3500182980	79		40642157	40642884	8421504	4	19,20,20,20	0,341,521,707	c	350018298000000043,350018298000000023,350018298000000022,350018298000000044	0-19,0-20,0-20,0-20						Cytokine mRNA quantification by real-time PCR. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642157	40642884	3500046740	39		40642157	40642884	8421504	2	19,20	0,707	c,g	350004674000000024,350004674000000024,350004674000000025	0-19,0-19,0-20		20123980	10.1128/MCB.01003-09		Molecular and Cellular Biology	Establishment of Extracellular Signal-Regulated Kinase 1/2 Bistability and Sustained Activation through Sprouty 2 and Its Relevance for Epithelial Function 	Weimin	2010	0		
895	chr25	40642157	40642503	3500110757	40		40642157	40642503	8421504	2	20,20	0,326	c,g	350011075700000017,350011075700000020	0-20,0-20						Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions	biomedcentral.com	0	0		ACTG2
895	chr25	40642160	40642184	3500113712	24		40642160	40642184	8421504	1	24	0	c	350011371200000006	0-24						&#x4e3b;&#x9898;&#xff1a;mRNA | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		ACTG1
895	chr25	40642162	40642185	3500087501	23		40642162	40642185	8421504	1	23	0	c	350008750100000003	0-23			10.1002/hep.21611	1527-3350	Hepatology	Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A - Christen - 2007 - Hepatology - Wiley Online Library	Christen	2007	0		ACTG1
895	chr25	40642164	40642809	3500051609	46		40642164	40642809	8421504	2	25,21	0,624	c,g	350005160900000009,350005160900000003,350005160900000003	8-33,12-33,12-33			10.1038/sj.onc.1202558	${footerJournalISSN}		Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis		1999	0		SPZ1
895	chr25	40642166	40642967	3500181873	60		40642166	40642967	8421504	4	20,16,4,20	0,345,492,781	c,g	350018187300000002,350018187300000001,350018187300000003,350018187300000003	0-20,0-20,0-20,0-20						Down-Regulation of -Actin Gene and Human Antigen R (HuR) in Human Keratoconus	www.iovs.org	0	0		
895	chr25	40642166	40642883	3500035805	40		40642166	40642883	8421504	2	20,20	0,697	c	350003580500000002,350003580500000003	0-20,0-20		17028267	10.1152/ajplung.00075.2006		American Journal of Physiology - Lung Cellular and Molecular Physiology	Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release	Mohammed	2007	0		
895	chr25	40642167	40642803	3500021374	40		40642167	40642803	8421504	2	20,20	0,616	c,g	350002137400000004,350002137400000005,350002137400000005	0-20,0-20,0-20		20523343	10.1038/aps.2010.49	1671-4083	Acta Pharmacologica Sinica	Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells	Zhao	2010	2		
895	chr25	40642189	40642214	3500264232	25		40642189	40642214	8421504	1	25	0	c	350026423200000011	0-25						Orphan Nuclear Receptor Small Heterodimer Partner Represses Hepatocyte Nuclear Factor 3/Foxa Transactivation via Inhibition of Its DNA Binding	.endojournals.org	0	0		
895	chr25	40642189	40642214	3500080644	25		40642189	40642214	8421504	1	25	0	c	350008064400000017	0-25						Orphan Nuclear Receptor Nur77 Induces Zinc Finger Protein GIOT-1 Gene Expression, and GIOT-1 Acts as a Novel Corepressor of Orphan Nuclear Receptor SF-1 via Recruitment of HDAC2--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#	journal.9med.net	0	0		
895	chr25	40642189	40642214	3500029548	25		40642189	40642214	8421504	1	25	0	c	350002954800000011	0-25		15358835	10.1210/me.2004-0211	0888-8809	Molecular Endocrinology	Orphan Nuclear Receptor Small Heterodimer Partner Represses Hepatocyte Nuclear Factor 3/Foxa Transactivation via Inhibition of Its DNA Binding	Kim	2004	5		
895	chr25	40642190	40642366	3500257699	39		40642190	40642366	8421504	2	20,19	0,157	c,g	350025769900000000,350025769900000001,350025769900000001	0-20,0-19,0-19						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
895	chr25	40642190	40642214	3500186485	24		40642190	40642214	8421504	1	24	0	c	350018648500000002	0-24						Methods For Modulating The Development Of Dopamine Neuron By The Dopamine D2 Receptor And Compositions Thereof - Patent application	www.faqs.org	0	0		
895	chr25	40642191	40642352	3500455759	43		40642191	40642352	8421504	3	20,16,7	0,49,154	c	350045575900000004,350045575900000006	0-20,0-23		20573995	10.1152/ajpcell.00441.2009		American Journal of Physiology - Cell Physiolog	RNA interference screen for RGS protein specificity at muscarinic and protease-activated receptors reveals bidirectional modulation of signaling	Laroche	2010	0		ACTB
895	chr25	40642192	40642242	3500256218	43		40642192	40642242	8421504	2	20,23	0,27	c,g	350025621800000093,350025621800000093,350025621800000095	0-20,0-20,0-23						REPRODUCTION	uction-online.org	0	0		
895	chr25	40642193	40642377	3500140406	40		40642193	40642377	8421504	2	20,20	0,164	c,g	350014040600000004,350014040600000005,350014040600000005	0-20,0-20,0-20						Suppression of ovarian secretions before puberty strongly affects mammogenesis in the goat. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642199	40642802	3500178991	52		40642199	40642802	8421504	3	25,22,5	0,573,598	c,g	350017899100000010,350017899100000005	0-25,0-27						METHODS AND COMPOUNDS FOR TREATING DISEASES CAUSED BY REACTIVE OXYGEN SPECIES - Patent application	www.faqs.org	0	0		ACTG1
895	chr25	40642199	40642225	3500448813	26		40642199	40642225	8421504	1	26	0	c	350044881300000002	8-34						Use of an internal standard in a closed one-tube RT-PCR for the detection of equine arteritis virus RNA with fluorescent probes*	www.vetres.org	0	0		ACTB
895	chr25	40642199	40642225	3500097713	26		40642199	40642225	8421504	1	26	0	c	350009771300000002	8-34						Use of an internal standard in a closed one-tube RT-PCR for the detection of equine arteritis virus RNA with fluorescent probes*	etres-archive.org	0	0		
895	chr25	40642199	40642224	3500451514	25		40642199	40642224	8421504	1	25	0	c	350045151400000003	0-25			10.1093/nar/gkg869		Nucleic Acids Research	DNA damage induces transcriptional activation of p73 by removing C-EBP&#x03b1; repression on E2F1	Mirko	2003	0		ACTG1
895	chr25	40642199	40642224	3500445866	25		40642199	40642224	8421504	1	25	0	c	350044586600000007	0-25		15548713	10.1158/0008-5472.CAN-04-1343	0008-5472	Cancer Research	Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4	Marchesi	2004	8		ACTG1
895	chr25	40642199	40642224	3500402387	25		40642199	40642224	8421504	1	25	0	c	350040238700000018	0-25						SIV infection decreases sympathetic innervation of primate lymph nodes: the role of neurotrophins. - ResearchGate	.researchgate.net	0	0		ACTG1
895	chr25	40642199	40642224	3500402368	25		40642199	40642224	8421504	1	25	0	c	350040236800000003	0-25					Patent	ABCA-1 elevating compounds (Patent US:6548548)	Campbell	2003	0		ACTG1
895	chr25	40642199	40642224	3500368467	25		40642199	40642224	8421504	1	25	0	c	350036846700000046	0-25						Regulation with binding cassette transporter protein abc1	Garvin	2002	0		ACTG1
895	chr25	40642199	40642224	3500326003	25		40642199	40642224	8421504	1	25	0	c	350032600300000003	0-25					Patent	ABCA-1 elevating compounds (Patent US:6919339)	Campbell	2005	0		ACTG1
895	chr25	40642199	40642224	3500282185	25		40642199	40642224	8421504	1	25	0	c	350028218500000001	0-25					Patent	Method for detecting the presence of a single target nucleic acid in a sample (Patent US:7972778)	Brown	2011	0		ACTG2
895	chr25	40642199	40642224	3500269960	25		40642199	40642224	8421504	1	25	0	c	350026996000000046	0-25						Atp binding cassette transporter protein abc1 popypeptides	Garvin	2000	0		ACTG1
895	chr25	40642199	40642224	3500263946	25		40642199	40642224	8421504	1	25	0	c	350026394600000004	0-25						Human T-Cell Leukemia Virus Type I-Infected Patients with Hashimoto&#x2019;s Thyroiditis and Graves&#x2019; Disease	.endojournals.org	0	0		ACTB,ACTG1
895	chr25	40642199	40642224	3500233309	25		40642199	40642224	8421504	1	25	0	c	350023330900000005	0-25						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DT	www.plosone.org	0	0		ACTG1
895	chr25	40642199	40642224	3500224743	25		40642199	40642224	8421504	1	25	0	c	350022474300000003	0-25		16269535	10.1124/mol.105.015404	1521-0111 (Online)	Molecular Pharmacology	Gene Transfer of Pro-opiomelanocortin Prohormone Suppressed the Growth and Metastasis of Melanoma: Involvement of &#x03b1;-Melanocyte-Stimulating Hormone-Mediated Inhibition of the Nuclear Factor &#x03ba;B/Cyclooxygenase-2 Pathway	Liu	2006	0		ACTB,ACTG1
895	chr25	40642199	40642224	3500224590	25		40642199	40642224	8421504	1	25	0	c	350022459000000003	0-25						ABCA-1 elevating compounds	Campbell	2002	0		ACTB,ACTG2
895	chr25	40642199	40642224	3500219355	25		40642199	40642224	8421504	1	25	0	c	350021935500000001	0-25						Microfluidic Devices and Methods of Using Same - Patent application	www.faqs.org	0	0		ACTG1
895	chr25	40642199	40642224	3500202862	25		40642199	40642224	8421504	1	25	0	c	350020286200000002	0-25		22659623	10.1038/aps.2012.36	1671-4083	Acta Pharmacologica Sinica	The mineralocorticoid receptor-p38MAPK-NF&#x03ba;B or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells	Zhu	2012	2		ACTG1
895	chr25	40642199	40642224	3500181734	25		40642199	40642224	8421504	1	25	0	c	350018173400000002	0-25						PKC412demonstratesJNK-dependentactivityagainsthuman multiplemyelomacells	tologylibrary.org	0	0		ACTG1
895	chr25	40642199	40642224	3500154174	25		40642199	40642224	8421504	1	25	0	c	350015417400000001	0-25						&#x4e3b;&#x9898;&#xff1a;HPV | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		ACTG1
895	chr25	40642199	40642224	3500138198	25		40642199	40642224	8421504	1	25	0	c	350013819800000006	0-25		18625884	10.1182/blood-2008-03-147850		Blood	A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration	Rieneke	2008	0		ACTG2
895	chr25	40642199	40642224	3500115913	25		40642199	40642224	8421504	1	25	0	c	350011591300000007	0-25						Crude biological derivatives competent for nucleic acid detection	Pasloske	2013	0		ACTG2
895	chr25	40642199	40642224	3500103197	25		40642199	40642224	8421504	1	25	0	c	350010319700000028	0-25						Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth 10.1016/S1535-6108(02)00097-1 : Cancer Cell | ScienceDirect.com	sciencedirect.com	0	0		ACTB,ACTG1
895	chr25	40642199	40642224	3500090989	25		40642199	40642224	8421504	1	25	0	c	350009098900000003	0-25						Abca-1 elevating compounds	Ibrahim	2005	0		ACTG1
895	chr25	40642199	40642224	3500086687	25		40642199	40642224	8421504	1	25	0	c	350008668700000001	0-25						Method and device for detecting the presence of a single target nucleic acid in a sample	Brown	2008	0		ACTG2
895	chr25	40642199	40642224	3500085836	25		40642199	40642224	8421504	1	25	0	c	350008583600000001	0-25						Method And Device For Detecting The Presence Of Target Nucleic Acids In A Sample, And Microfluidic Device For Use In Such Methods 	.freshpatents.com	0	0		ACTG1
895	chr25	40642199	40642224	3500044173	25		40642199	40642224	8421504	1	25	0	c	350004417300000003	0-25						Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis	Campbell	2003	0		ACTB
895	chr25	40642199	40642224	3500003989	25		40642199	40642224	8421504	1	25	0	c	350000398900000004	0-25						Evolution of the Pentraxin Family: The New Entry PTX4	www.jimmunol.org	0	0		ACTB,ACTG2
895	chr25	40642199	40642224	3500000348	25		40642199	40642224	8421504	1	25	0	c	350000034800000021	0-25		22202120	10.1128/IAI.06167-11	0019-9567	Infection and Immunity	Targeted Disruption of Toxoplasma gondii Serine Protease Inhibitor 1 Increases Bradyzoite Cyst Formation In Vitro and Parasite Tissue Burden in Mice	Pszenny	2012	4		ACTG1
895	chr25	40642200	40642224	3500226216	24		40642200	40642224	8421504	1	24	0	c	350022621600000003	0-24					Patent	PPAR-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants (Patent EP:2131829)	Baroni	2012	0		ACTB,ACTG2
895	chr25	40642201	40642433	3500018219	40		40642201	40642433	8421504	2	19,21	0,211	c,g	350001821900000002,350001821900000002,350001821900000003,350001821900000003	0-19,0-19,0-21,0-21						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
895	chr25	40642201	40642255	3500430626	39		40642201	40642255	8421504	2	20,19	0,35	c	350043062600000003,350043062600000005	5-25,0-19		21106720	10.1124/dmd.110.035188	1521-009X (Online)	Drug Metabolism and Disposition	Decreased Hepatic Breast Cancer Resistance Protein Expression and Function in Multidrug Resistance-Associated Protein 2-Deficient (TR&#x2212;) Rats	Yue	2011	0		
895	chr25	40642209	40642233	3500049740	24		40642209	40642233	8421504	1	24	0	c,g	350004974000000007,350004974000000007	0-24,0-24						MONITORAMENTO SOROL&#xd3;GICO E DA PRESEN&#xc7;A DO DNA PR&#xd3;-VIRAL DO LENTIV&#xcd;RUS CAPRINO (CAEV) NO SANGUE E S&#xca;MEN DE REPRODUTORES INFECTADOS	cnptia.embrapa.br	0	0		
895	chr25	40642210	40642730	3500231857	217		40642210	40642730	8421504	5	46,14,44,53,60	0,135,164,209,460	c	350023185700000088,350023185700000089,350023185700000090,350023185700000092	0-60,15-59,0-53,0-60						Toxicology and Applied Pharmacology	www.usask.ca	0	0		
895	chr25	40642210	40642237	3500349078	27		40642210	40642237	8421504	1	27	0	c	350034907800000015	0-27		18957126	10.1186/1742-4690-5-97	1742-4690	Retrovirology	Selective translational repression of HIV-1 RNA by Sam68DeltaC occurs by altering PABP1 binding to unspliced viral RNA	Marsh	2008	6		
895	chr25	40642223	40642369	3500396398	42		40642223	40642369	8421504	2	19,23	0,123	c,g	350039639800000003,350039639800000003,350039639800000005,350039639800000005	0-19,0-19,0-23,0-23						Original article Anti-bovine viral diarrhoea virus activity of novel diphenylmethane derivatives	w.intmedpress.com	0	0		
895	chr25	40642224	40642356	3500121316	41		40642224	40642356	8421504	3	18,12,11	0,20,121	c	350012131600000006	0-41						REPRODUCTION	uction-online.org	0	0		
895	chr25	40642228	40642254	3500288228	26		40642228	40642254	8421504	1	26	0	c	350028822800000015	0-26						mRNA and 18S&#x2013;RNA coapplication&#x2013;reverse transcription for quantitative gene expression analysis	uantification.com	0	0		
895	chr25	40642228	40642254	3500272882	26		40642228	40642254	8421504	1	26	0	c	350027288200000008	0-26						Novel Gene C17ORF37 in Prostate Cancer Progression and Metastasis	mmons.hsc.unt.edu	0	0		
895	chr25	40642231	40642799	3500460111	52		40642231	40642799	8421504	2	24,28	0,540	c	350046011100000018,350046011100000005,350046011100000003,350046011100000016,350046011100000012	0-24,0-24,0-24,0-24,12-40						METHOD OF MODULATING THE ACTIVITY OF FUNCTIONAL IMMUNE MOLECULES - Patent application	www.faqs.org	0	0		
895	chr25	40642231	40642799	3500430640	52		40642231	40642799	8421504	2	24,28	0,540	c	350043064000000016,350043064000000003,350043064000000018,350043064000000005,350043064000000011,350043064000000012	0-24,0-24,0-24,0-24,12-40,12-40						Method Of Modulating The Activity Of Functional Immune Molecules 	.freshpatents.com	0	0		
895	chr25	40642231	40642799	3500399445	52		40642231	40642799	8421504	2	24,28	0,540	c	350039944500000016,350039944500000003,350039944500000018,350039944500000005,350039944500000012,350039944500000011	0-24,0-24,0-24,0-24,12-40,12-40						Method Of Modulating The Activity Of Functional Immune Molecules 	.freshpatents.com	0	0		
895	chr25	40642231	40642799	3500386326	52		40642231	40642799	8421504	2	24,28	0,540	c	350038632600000003,350038632600000005,350038632600000023,350038632600000015,350038632600000014	0-24,0-24,0-19,7-35,12-40						 Antibody Composition 	www.docstoc.com	0	0		
895	chr25	40642231	40642769	3500371489	41		40642231	40642769	8421504	2	20,21	0,517	c,g	350037148900000012,350037148900000013,350037148900000013	0-20,0-21,0-21						Mammary Response to Exogenous Prolactin or Frequent Milking During Early Lactation in Dairy Cows	circlescience.biz	0	0		
895	chr25	40642231	40642769	3500099408	41		40642231	40642769	8421504	2	20,21	0,517	c,g	350009940800000006,350009940800000006,350009940800000007,350009940800000007	0-20,0-20,0-21,0-21						Exposure to Short Day Photoperiod During the Dry Period Enhances Mammary Growth in Dairy Cows	circlescience.biz	0	0		
895	chr25	40642231	40642346	3500289195	26		40642231	40642346	8421504	2	25,1	0,114	c	350028919500000006	0-26		21514442	10.1016/j.ajpath.2011.01.055		The American Journal of Pathology	Adipose Tissue-Derived Stem Cell in Vitro Differentiation in a Three-Dimensional Dental Bud Structure	Federico	2011	0		
895	chr25	40642231	40642255	3500460477	24		40642231	40642255	8421504	1	24	0	c	350046047700000005,350046047700000003	0-24,0-24						Method of modulating the activity of functional immune molecules to CD52	Hanai	2007	0		
895	chr25	40642231	40642255	3500419375	24		40642231	40642255	8421504	1	24	0	c	350041937500000013	0-24		17699847	10.1158/1078-0432.CCR-06-2723	1078-0432	Clinical Cancer Research	The Development and Characterization of a Human Midgut Carcinoid Cell Line	II	2007	8		
895	chr25	40642231	40642255	3500327438	24		40642231	40642255	8421504	1	24	0	c	350032743800000005,350032743800000003	0-24,0-24					Patent	Method of modulating the activity of functional immune molecules to CXCR4 protein (Patent US:7682611)	Hanai	2010	0		
895	chr25	40642231	40642255	3500290232	24		40642231	40642255	8421504	1	24	0	c	350029023200000003,350029023200000005	0-24,0-24					Patent	Method of enhancing of binding activity of antibody composition to Fc&#x03b3; receptor IIIa (Patent US:8313913)	Nakamura	2012	0		
895	chr25	40642231	40642255	3500264278	24		40642231	40642255	8421504	1	24	0	c	350026427800000003,350026427800000005	0-24,0-24					Patent	Cells with altered fucosylation and producing antibodies therefrom (Patent US:8367407)	Kanda	2013	0		
895	chr25	40642231	40642255	3500230524	24		40642231	40642255	8421504	1	24	0	c	350023052400000015	0-24		16798740	10.1074/jbc.M601209200	0021-9258	Journal of Biological Chemistry	Homophilic Interactions of Tetraspanin CD151 Up-regulate Motility and Matrix Metalloproteinase-9 Expression of Human Melanoma Cells through Adhesion-dependent c-Jun Activation Signaling Pathways	Hong	2006	5		
895	chr25	40642231	40642255	3500198866	24		40642231	40642255	8421504	1	24	0	c	350019886600000003,350019886600000005	0-24,0-24					Patent	Method of modulating the activity of functional immune molecules to GM2 (Patent US:7655228)	Hanai	2010	0		
895	chr25	40642231	40642255	3500196894	24		40642231	40642255	8421504	1	24	0	c	350019689400000003,350019689400000005	0-24,0-24					Patent	Method of modulating the activity of functional immune molecules (Patent US:7682610)	Hanai	2010	0		
895	chr25	40642231	40642255	3500189949	24		40642231	40642255	8421504	1	24	0	c	350018994900000003,350018994900000005	0-24,0-24						Method of modulating the activity of functional immune molecules	Hanai	2005	0		
895	chr25	40642231	40642255	3500154350	24		40642231	40642255	8421504	1	24	0	c	350015435000000005,350015435000000003	0-24,0-24						Methods for producing antibody compositions with increased ADCC	Hanai	2005	0		
895	chr25	40642231	40642255	3500024956	24		40642231	40642255	8421504	1	24	0	c	350002495600000007	0-24		12838318	10.1038/sj.bjc.6601015	0007-0920	British Journal of Cancer	Clinical significance of transmembrane 4 superfamily in colon cancer	Hashida	2003	5		
895	chr25	40642231	40642254	3500247431	23		40642231	40642254	8421504	1	23	0	c	350024743100000015	0-23						HE5/CD52 und die &#x03b1;1-3-Fucosyltransferasen des humanen Nebenhodens	ie.uni-hamburg.de	0	0		
895	chr25	40642234	40642969	3500261159	39		40642234	40642969	8421504	2	20,19	0,716	c,g	350026115900000007,350026115900000006,350026115900000006	0-20,0-19,0-19		18827818	10.1038/sj.bjc.6604688		British Journal of Cancer	NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer	D	2008	0		ACTB
895	chr25	40642234	40642969	3500107975	38		40642234	40642969	8421504	2	19,19	0,716	c,g	350010797500000002,350010797500000003,350010797500000003	0-19,0-19,0-19						Vaccine-mediated treatment of neurological disorders	During	2001	0		
895	chr25	40642234	40642969	3500100778	38		40642234	40642969	8421504	2	19,19	0,716	c,g	350010077800000002,350010077800000003,350010077800000003	0-19,0-19,0-19						Vaccine-mediated treatment of neurological disorders	During	2001	0		
895	chr25	40642234	40642967	3500251013	40		40642234	40642967	8421504	2	20,20	0,713	c,g	350025101300000002,350025101300000003,350025101300000003	0-20,0-20,0-20		20367639	10.1111/j.1349-7006.2010.01533.x	1349-7006	Cancer Science	Subcellular distribution of S100A4 and its transcriptional regulation under hypoxic conditions in gastric cancer cell line BGC823 - Zhang - 2010 - Cancer Science - Wiley Online Library	Zhang	2010	0		
895	chr25	40642234	40642967	3500021302	40		40642234	40642967	8421504	2	20,20	0,713	c,g	350002130200000006,350002130200000007,350002130200000007	0-20,0-20,0-20		19457162	10.1111/j.1471-4159.2009.06075.x	1471-4159	Journal of Neurochemistry	&#x03b1;-Synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP - Kim - 2009 - Journal of Neurochemistry - Wiley Online Library	Kim	2009	0		
895	chr25	40642234	40642765	3500155069	40		40642234	40642765	8421504	2	20,20	0,511	c,g	350015506900000002,350015506900000003,350015506900000003	0-20,0-20,0-20						Bilateral Inhibition of -Aminobutyric Acid Type A Receptor Function within the Basolateral Amygdala Blocked Propofol-induced Amnesia and Activity-regulated Cytoskeletal Protein Expression Inhibition in the Hippocampus	asic.shsmu.edu.cn	0	0		
895	chr25	40642234	40642698	3500422061	40		40642234	40642698	8421504	2	20,20	0,444	c	350042206100000000,350042206100000001	0-20,0-20		19305384	10.1038/modpathol.2009.39	0893-3952	Modern Pathology	Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks	Bertram	2009	5		ACTB
895	chr25	40642234	40642501	3500335697	40		40642234	40642501	8421504	2	20,20	0,247	c	350033569700000012,350033569700000013	0-20,0-20						Down-regulation of Interferon Tau Gene Transcription With a Transcription Factor, EOMES. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642234	40642501	3500319127	40		40642234	40642501	8421504	2	20,20	0,247	c	350031912700000044,350031912700000045	0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
895	chr25	40642234	40642501	3500303205	40		40642234	40642501	8421504	2	20,20	0,247	c	350030320500000007,350030320500000008	0-20,0-20		19105596	10.1089/dna.2008.0775		DNA and Cell Biology	Hydrogen Peroxide Decreases Endothelial Nitric Oxide Synthase Promoter Activity through the Inhibition of Sp1 Activity	Sanjiv	2009	0		
895	chr25	40642234	40642501	3500274037	60		40642234	40642501	8421504	3	20,20,20	0,170,247	c	350027403700000180,350027403700000178,350027403700000181	0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
895	chr25	40642234	40642501	3500021577	41		40642234	40642501	8421504	2	20,21	0,246	c	350002157700000016,350002157700000017	0-20,0-21						O-12	www.scribd.com	0	0		
895	chr25	40642238	40642443	3500158166	45		40642238	40642443	8421504	3	18,4,23	0,107,182	c	350015816600000004,350015816600000005	0-22,0-23						&#x9ec4;&#x725b;&#x3001;&#x7266;&#x725b;&#x548c;&#x728f;&#x725b;&#x777e;&#x4e38;&#x7ec4;&#x7ec7;&#x4e2d; Cdc2 Cdc25A &#x57fa;&#x56e0;	www.chinagene.cn	0	0		
895	chr25	40642240	40642356	3500209984	27		40642240	40642356	8421504	2	16,11	0,105	c	350020998400000008	0-27			10.1111/j.1742-4658.2005.05016.x	1742-4658	FEBS Journal	Signalling and regulation of collagen I synthesis by ET-1 and TGF-&#x03b2;1 - Horstmeyer - 2005 - FEBS Journal - Wiley Online Library	Horstmeyer	2005	0		
895	chr25	40642240	40642352	3500428047	23		40642240	40642352	8421504	2	16,7	0,105	c	350042804700000006	0-23		20573995	10.1152/ajpcell.00441.2009		American Journal of Physiology - Cell Physiolog	RNA interference screen for RGS protein specificity at muscarinic and protease-activated receptors reveals bidirectional modulation of signaling	Laroche	2010	0		
895	chr25	40642242	40642411	3500348308	41		40642242	40642411	8421504	3	14,7,20	0,103,149	c	350034830800000004,350034830800000003	0-21,0-20		22241994	10.1371/journal.ppat.1002468	1553-7374	PLOS Pathogens	PLOS Pathogens: Human Subtilase SKI-1/S1P Is a Master Regulator of the HCV Lifecycle and a Potential Host Cell Target for Developing Indirect-Acting Antiviral Agents	Olmstead	2012	0		
895	chr25	40642243	40642670	3500410537	44		40642243	40642670	8421504	4	13,11,8,12	0,102,276,415	c	350041053700000002,350041053700000000,350041053700000001	0-24,0-20,0-20						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
895	chr25	40642244	40642412	3500032460	47		40642244	40642412	8421504	3	12,13,22	0,101,146	c	350003246000000032,350003246000000031	0-25,0-22						Methods and materials for identifying the origin of a carcinoma of unknown primary origin	Wang	2012	0		ACTB
895	chr25	40642244	40642358	3500079640	25		40642244	40642358	8421504	2	12,13	0,101	c	350007964000000032	0-25						Methods and materials for identifying the origin of a carcinoma of unknown primary origin	Wang	2012	0		
895	chr25	40642244	40642358	3500062355	25		40642244	40642358	8421504	2	12,13	0,101	c	350006235500000052	0-25						Methods and Materials for Identifying the Origin of a Carcinoma of Unknown Primary Origin - Patent application	www.faqs.org	0	0		
895	chr25	40642244	40642357	3500100040	24		40642244	40642357	8421504	2	12,12	0,101	c	350010004000000005	17-41		11134254		1046-6673	Journal of the American Society of Nephrology	Induction of Metalloproteinases by Glomerular Mesangial Cells Stimulated by Proteins of the Extracellular Matrix	MARTIN	2001	10		
895	chr25	40642247	40642359	3500216718	23		40642247	40642359	8421504	2	9,14	0,98	c	350021671800000005	0-23						Surfactant replacement and open lung concept--comparison of two treatment strategies in an experimental model of neonatal ARDS. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642353	40642379	3500136055	26		40642353	40642379	8421504	1	26	0	c	350013605500000018	0-26						Effects of Mineralocorticoid and Glucocorticoid Agonists on Gene and Protein Expression, Structural Maturation and Compliance in the Ovine Preterm Fetal Lung	ufdc.ufl.edu	0	0		
895	chr25	40642358	40643025	3500411034	38		40642358	40643025	8421504	2	19,19	0,648	c,g	350041103400000002,350041103400000003,350041103400000003	0-19,0-19,0-19						Roles of prostaglandin F2alpha and hydrogen peroxide in the regulation of Copper/Zinc superoxide dismutase in bovine corpus luteum and luteal endothelial cells	www.rbej.com	0	0		
895	chr25	40642358	40643025	3500364935	38		40642358	40643025	8421504	2	19,19	0,648	c,g	350036493500000002,350036493500000002,350036493500000003,350036493500000003	0-19,0-19,0-19,0-19		23101731	10.1186/1477-7827-10-87	1477-7827	Reproductive Biology and Endocrinology	Roles of prostaglandin F2alpha and hydrogen peroxide in the regulation of Copper/Zinc superoxide dismutase in bovine corpus luteum and luteal endothelial cells	Vu	2012	2		
895	chr25	40642358	40642501	3500088096	39		40642358	40642501	8421504	2	20,19	0,124	c	350008809600000004,350008809600000005	0-20,0-19						Differential Neutrophil Function and Intracellular Signaling in Dairy Cows with Specific CXCR1 Genotypes	ace.tennessee.edu	0	0		
895	chr25	40642365	40642761	3500085185	41		40642365	40642761	8421504	2	21,20	0,376	c	350008518500000010,350008518500000011	0-21,0-20		21091668	10.1111/j.1365-2249.2010.04291.x	1365-2249	Clinical & Experimental Immunology	Toll-like receptor (TLR)-4 mediates anti-&#x03b2;2GPI/&#x03b2;2GPI-induced tissue factor expression in THP-1 cells - Zhou - 2010 - Clinical & Experimental Immunology - Wiley Online Library	Zhou	2011	0		
895	chr25	40642365	40642389	3500061821	24		40642365	40642389	8421504	1	24	0	c	350006182100000002	23-47						Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells - California Medical Marijuana Overnight Shipping | California Medical Marijuana Overnight Shipping	www.braatah.com	0	0		FXR1
895	chr25	40642367	40642391	3500128014	24		40642367	40642391	8421504	1	24	0	c	350012801400000003	0-24						DIAGNOSTIC AND THERAPEUTIC TARGET	Rabbani	2011	0		
895	chr25	40642370	40642395	3500388718	25		40642370	40642395	8421504	1	25	0	c	350038871800000021	0-25			10.1038/sj.bjp.0703688	1476-5381	British Journal of Pharmacology	The human prostanoid DP receptor stimulates mucin secretion in LS174T cells - Wright - 2009 - British Journal of Pharmacology - Wiley Online Library	Wright	2000	0		POTEE
895	chr25	40642375	40642678	3500347591	66		40642375	40642678	8421504	3	21,25,20	0,127,283	c,g	350034759100000015,350034759100000015,350034759100000001,350034759100000020,350034759100000020	0-21,0-21,18-63,0-20,0-20						A rapid real-time qRT-PCR assay for ovine -actin mRNA	quantification.de	0	0		
895	chr25	40642379	40642402	3500050483	23		40642379	40642402	8421504	1	23	0	c	350005048300000013	0-23						DETECTION OF CYTOMEGALOVIRUS DNA USING AMPLIFICATION FROM BLOOD SAMPLES	Baker	2011	0		
895	chr25	40642380	40642758	3500169068	40		40642380	40642758	8421504	2	20,20	0,358	c	350016906800000018,350016906800000019	0-20,0-20						Increased Expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis	www.virologyj.com	0	0		
895	chr25	40642383	40642412	3500386073	27		40642383	40642412	8421504	3	14,5,8	0,15,21	c,g	350038607300000005,350038607300000005	0-27,0-27						Method for specific detection of classical swine fever virus	Beer	2011	0		TMEM222,ACTG1
895	chr25	40642386	40642980	3500348380	42		40642386	40642980	8421504	2	21,21	0,573	c	350034838000000018,350034838000000019	0-21,0-21			10.1186/1475-2867-6-5		Cancer Cell International	Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells	Heather	2006	0		
895	chr25	40642386	40642980	3500337988	42		40642386	40642980	8421504	2	21,21	0,573	c,g	350033798800000018,350033798800000019,350033798800000019	0-21,0-21,0-21			10.1186/1475-2867-6-5	1475-2867	Cancer Cell International	Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells	Watt	2006	2		
895	chr25	40642386	40642410	3500449552	24		40642386	40642410	8421504	1	24	0	c	350044955200000010	0-24					International Journal of Biological Sciences	Characterization of transcriptional regulation of neurogranin by nitric oxide and the role of neurogranin in SNP-induced cell death: implication of neurogranin in an increased neuronal susceptibility to oxidative stress	Jingang	2007	0		ACTG1
895	chr25	40642386	40642410	3500252094	24		40642386	40642410	8421504	1	24	0	c	350025209400000010	0-24						Characterization of transcriptional regulation of neurogranin by nitric oxide and the role of neurogranin in SNP-induced cell death: implication of neurogranin in an increased neuronal susceptibility to oxidative stress	www.ijbs.com	0	0		ACTG1
895	chr25	40642387	40642803	3500430759	51		40642387	40642803	8421504	2	25,26	0,390	c	350043075900000002,350043075900000003	0-25,0-26		14644771	10.1152/ajpcell.00200.2003		American Journal of Physiology - Cell Physiolog	Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts	Wu	2004	0		
895	chr25	40642387	40642412	3500000467	25		40642387	40642412	8421504	1	25	0	c	350000046700000013	0-25		12620891	10.1152/ajpcell.00322.2002		American Journal of Physiology - Cell Physiology	Activation of gene expression in human neutrophils by high mobility group box 1 protein	Park	2003	0		TMEM222
895	chr25	40642389	40642412	3500249852	23		40642389	40642412	8421504	1	23	0	c	350024985200000003	0-23						World J Gastroenterol	www.wjgnet.com	0	0		ACTG1
895	chr25	40642389	40642412	3500213699	23		40642389	40642412	8421504	1	23	0	c	350021369900000008	0-23		15220111	10.1152/ajplung.00012.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Differential effects of TGF-&#x03b2;1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells	Sheares	2004	0		ACTG1
895	chr25	40642390	40642972	3500434065	44		40642390	40642972	8421504	2	22,22	0,560	c,g	350043406500000002,350043406500000003,350043406500000003	0-22,0-22,0-22						UNDER PEER REVIEW	sciencedomain.org	0	0		
895	chr25	40642390	40642972	3500334711	44		40642390	40642972	8421504	2	22,22	0,560	c	350033471100000011,350033471100000012	0-22,0-22						Compositions and methods for diagnosing and treating b-cll	Shachar	2010	0		
895	chr25	40642390	40642972	3500240959	44		40642390	40642972	8421504	2	22,22	0,560	c,g	350024095900000033,350024095900000011,350024095900000012,350024095900000012,350024095900000034,350024095900000034	0-22,0-22,0-22,0-22,0-22,0-22						COMPOSITIONS COMPRISING SOLUBLE CD84 OR ANTI-CD84 ANTIBODIES AND METHODS FOR DIAGNOSING AND TREATING B-CLL - Patent application	www.faqs.org	0	0		
895	chr25	40642399	40642422	3500271497	23		40642399	40642422	8421504	1	23	0	c	350027149700000016	0-23						PREVENTING OR REDUCING OXIDATIVE STRESS OR OXIDATIVE CELL INJURY - Patent application	www.faqs.org	0	0		
895	chr25	40642399	40642422	3500047565	23		40642399	40642422	8421504	1	23	0	c	350004756500000016	0-23						PREVENTING OR REDUCING OXIDATIVE STRESS OR OXIDATIVE CELL INJURY - Patent application	www.faqs.org	0	0		
895	chr25	40642404	40642691	3500453718	40		40642404	40642691	8421504	2	20,20	0,267	c,g	350045371800000006,350045371800000006,350045371800000007	0-20,0-20,0-20		15653764	10.1152/ajpheart.00987.2004		American Journal of Physiology - Heart and Circulatory Physiology	Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors	Zhang	2005	0		
895	chr25	40642404	40642691	3500242099	40		40642404	40642691	8421504	2	20,20	0,267	c	350024209900000002,350024209900000003	0-20,0-20		15894577	10.1152/ajpheart.00244.2005		American Journal of Physiology - Heart and Circulatory Physiology	Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction	Knudson	2005	0		
895	chr25	40642404	40642691	3500006879	40		40642404	40642691	8421504	2	20,20	0,267	c	350000687900000002,350000687900000003	0-20,0-20		15894577	10.1152/ajpheart.00244.2005		American Journal of Physiology - Heart and Circulatory Physiology	Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction	Knudson	2005	0		
895	chr25	40642405	40642980	3500451179	40		40642405	40642980	8421504	2	20,20	0,555	c,g	350045117900000091,350045117900000091,350045117900000024,350045117900000024,350045117900000092,350045117900000092,350045117900000025,350045117900000025	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						 Transgenic Animals And Uses Thereof 	www.docstoc.com	0	0		
895	chr25	40642405	40642980	3500319187	40		40642405	40642980	8421504	2	20,20	0,555	c,g	350031918700000024,350031918700000024,350031918700000025,350031918700000025	0-20,0-20,0-20,0-20						Transgenic animals and uses thereof	Robl	2005	0		
895	chr25	40642405	40642980	3500123062	40		40642405	40642980	8421504	2	20,20	0,555	c,g	350012306200000097,350012306200000097,350012306200000024,350012306200000024,350012306200000025,350012306200000025,350012306200000098,350012306200000098	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						TRANSGENIC ANIMALS AND USES THEREOF - Patent application	www.faqs.org	0	0		
895	chr25	40642406	40642877	3500445367	40		40642406	40642877	8421504	2	19,21	0,450	c,g	350044536700000002,350044536700000002,350044536700000003	0-19,0-19,0-21						&#x4e5d;&#x9f99;&#x7266;&#x725b;&#x8102;&#x80aa;&#x7ec6;&#x80de;&#x578b;&#x8102;&#x80aa;&#x9178;&#x7ed3;&#x5408;&#x86cb;&#x767d;&#x57fa;&#x56e0;(AFABP) &#x7684;&#x514b;&#x9686;&#x53ca;&#x5176;&#x8868;&#x8fbe;&#x8c31; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
895	chr25	40642407	40642745	3500131263	207		40642407	40642745	8421504	2	120,87	0,251	p	350013126300015002	0-207		12089209		0022-0949	Journal of Experimental Biology	Glutamine synthetase expression in liver, muscle, stomach and intestine of Bostrichthys sinensis in response to exposure to a high exogenous ammonia concentration	Anderson	2002	3		ACTG1
895	chr25	40642451	40642776	3500265301	41		40642451	40642776	8421504	2	21,20	0,305	c,g	350026530100000008,350026530100000009,350026530100000009	0-21,0-20,0-20		17569756	10.1210/en.2007-0327	0013-7227	Endocrinology	Exposure to Phytoestrogens in the Perinatal Period Affects Androgen Secretion by Testicular Leydig Cells in the Adult Rat	Akingbemi	2007	4		
895	chr25	40642451	40642776	3500230176	43		40642451	40642776	8421504	2	22,21	0,304	c,g	350023017600000004,350023017600000005,350023017600000005	0-22,0-21,0-21		16574770	10.1189/jlb.0805453	0741-5400	Journal of Leukocyte Biology	Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-&#x03ba;B (NF-&#x03ba;B), pyrrolidine dithiocarbamate	Kitamei	2006	5		
895	chr25	40642467	40642761	3500438162	177		40642467	40642761	8421504	3	63,23,91	0,155,203	g	350043816200000257,350043816200000305	4-291,4-291						SOMATIC HYPERMUTATION SYSTEMS - Patent application	www.faqs.org	0	0		
895	chr25	40642467	40642761	3500185088	177		40642467	40642761	8421504	3	63,23,91	0,155,203	g	350018508800000257	4-291						SOMATIC HYPERMUTATION SYSTEMS	Horlick	2011	0		
895	chr25	40642473	40642752	3500251703	39		40642473	40642752	8421504	3	20,11,8	0,259,271	c	350025170300000017,350025170300000025	0-20,0-19					Patent	Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases (Patent US:8114399)	Eriksson	2012	0		
895	chr25	40642473	40642752	3500075193	39		40642473	40642752	8421504	3	20,11,8	0,259,271	c	350007519300000017,350007519300000025	0-20,0-19						Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases	Eriksson	2013	0		ACTB
895	chr25	40642473	40642750	3500040860	40		40642473	40642750	8421504	2	20,20	0,257	c,g	350004086000000002,350004086000000003	0-20,0-20						Dehydroepiandrosterone Sulfotransferase Is a Target for Transcriptional Induction by the Vitamin D Receptor	aspetjournals.org	0	0		ACTG1
895	chr25	40642475	40642759	3500357547	46		40642475	40642759	8421504	2	23,23	0,261	c	350035754700000018,350035754700000019	0-23,0-23		18347022	10.1074/jbc.M709487200	0021-9258	Journal of Biological Chemistry	Characterization of an Orphan G Protein-coupled Receptor, GPR20, That Constitutively Activates Gi Proteins	Hase	2008	5		
895	chr25	40642482	40642505	3500242010	23		40642482	40642505	8421504	1	23	0	c	350024201000000019	0-23						Obesity related genes expressed at least in the hypotalamus, liver or pancreas	Collier	2004	0		
895	chr25	40642488	40642755	3500386210	45		40642488	40642755	8421504	2	20,25	0,242	c	350038621000000002,350038621000000003	5-25,0-25		18768663	10.1677/JME-08-0026		Journal of molecular endocrinology	Improvement of Sensitivity to Tamoxifen in ER-Positive and Herceptin-Resistant Breast Cancer Cells	Bin	2008	0		
895	chr25	40642488	40642755	3500305162	45		40642488	40642755	8421504	2	20,25	0,242	c,g	350030516200000000,350030516200000006,350030516200000001,350030516200000007	5-25,5-25,0-25,0-24					Patent	Gene overexpressed in cancer (Patent EP:1652923)	Aburatani	2011	0		
895	chr25	40642491	40643130	3500405418	42		40642491	40643130	8421504	2	20,22	0,617	c	350040541800000000,350040541800000001	0-20,0-22						Iranian J Parasitol	urnals.tums.ac.ir	0	0		ACTB
895	chr25	40642491	40643130	3500028407	42		40642491	40643130	8421504	2	20,22	0,617	c	350002840700000000,350002840700000001	0-20,0-22						Iranian J Parasitol	ijpa.tums.ac.ir	0	0		ACTB
895	chr25	40642498	40642884	3500005911	60		40642498	40642884	8421504	3	20,20,20	0,180,366	c	350000591100000014,350000591100000013,350000591100000020	0-20,0-20,0-20						Stem Cell Assays	.researchgate.net	0	0		
895	chr25	40642498	40642698	3500304715	40		40642498	40642698	8421504	2	20,20	0,180	c	350030471500000005,350030471500000004	0-20,0-20						Table of contents	eprints.nuim.ie	0	0		
895	chr25	40642498	40642698	3500025862	40		40642498	40642698	8421504	2	20,20	0,180	c	350002586200000023,350002586200000022	0-20,0-20						PII: S0022-1759(01)00489-6	ww.slideshare.net	0	0		
895	chr25	40642499	40642700	3500305090	39		40642499	40642700	8421504	2	19,20	0,181	c,g	350030509000000069,350030509000000069,350030509000000131	0-19,0-19,0-20						TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY - Patent application	www.faqs.org	0	0		
895	chr25	40642500	40642979	3500000001	41		40642500	40642979	8421504	2	21,20	0,459	c,g	350000000100000008,350000000100000008,350000000100000009,350000000100000009	0-21,0-21,0-20,0-20						Pharmacol ogical Sci ences 2012;16:1184-1191 Anti-inflammatoryeffectofsinomenineby inhibitionofpro-inflammatorymediatorsin PMAplusA23187-stimulatedHMC-1Cells	uropeanreview.org	0	0		
895	chr25	40642500	40642801	3500428878	42		40642500	40642801	8421504	2	21,21	0,280	c,g	350042887800000003,350042887800000004,350042887800000004	0-21,0-21,0-21		17363366	10.1074/jbc.M609725200	0021-9258	Journal of Biological Chemistry	Epigallocatechin Gallate, a Green Tea Polyphenol, Mediates NO-dependent Vasodilation Using Signaling Pathways in Vascular Endothelium Requiring Reactive Oxygen Species and Fyn	Kim	2007	5		
895	chr25	40642500	40642801	3500344333	41		40642500	40642801	8421504	3	21,12,8	0,280,293	c,g	350034433300000009,350034433300000010	0-21,0-20						Signal Transduction: Epigallocatechin Gallate (EGCG) Stimulates Autophagy in Vascular Endothelial Cells: A POTENTIAL ROLE FOR REDUCING LIPID ACCUMULATION Hae-Suk Kim, Vedrana Montana, Hyun-Ju	.si.mahidol.ac.th	0	0		
895	chr25	40642500	40642801	3500181589	41		40642500	40642801	8421504	3	21,12,8	0,280,293	c,g	350018158900000008,350018158900000008,350018158900000009	0-21,0-21,0-20						JBC Papers in Press. Published on June 10, 2013 as Manuscript M113.477505 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M113.477505	www.jbc.org	0	0		
895	chr25	40642502	40642965	3500223844	42		40642502	40642965	8421504	2	21,21	0,442	c,g	350022384400000002,350022384400000003	0-21,0-21						The prostate of cattle is | Epitope Tags/Tag Peptides Guide	eptor-peptide.com	0	0		
895	chr25	40642502	40642816	3500460246	48		40642502	40642816	8421504	2	24,24	0,290	c	350046024600000006,350046024600000007	0-24,0-24						Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability	rt.physiology.org	0	0		
895	chr25	40642502	40642816	3500000254	48		40642502	40642816	8421504	2	24,24	0,290	c,g	350000025400000006,350000025400000006,350000025400000007,350000025400000007	0-24,0-24,0-24,0-24		19429835	10.1152/ajpheart.00007.2009		American Journal of Physiology - Heart and Circulatory Physiology	Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability	Gao	2009	0		
895	chr25	40642502	40642700	3500366127	39		40642502	40642700	8421504	2	19,20	0,178	c	350036612700000002,350036612700000003	0-19,0-20		20029400	10.1038/pcan.2009.55		Prostate Cancer and Prostatic Diseases	Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation	X	2010	0		ACTB
895	chr25	40642502	40642700	3500192979	39		40642502	40642700	8421504	2	19,20	0,178	c	350019297900000011,350019297900000012	0-19,0-20		20675303	10.1677/JOE-10-0181		The Journal of endocrinology	Altered Renal FGF23-Mediated Activity Involving MAPK and Wnt: Effects of the Hyp Mutation	Emily	2010	0		
895	chr25	40642502	40642700	3500126598	39		40642502	40642700	8421504	2	19,20	0,178	c,g	350012659800000010,350012659800000010,350012659800000011	0-19,0-19,0-20						TC1(C8orf4) is upregulated by IL-1b/TNF-a and enhances proliferation of human follicular dendritic cells	cc.kangwon.ac.kr	0	0		ACTB
895	chr25	40642502	40642700	3500117034	39		40642502	40642700	8421504	2	19,20	0,178	c	350011703400000005,350011703400000006	0-19,0-20		22968430	10.4161/epi.22103		Epigenetics	miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues	Tatiana	2012	0		
895	chr25	40642502	40642699	3500358461	40		40642502	40642699	8421504	2	19,21	0,176	c,g	350035846100000002,350035846100000002,350035846100000003	0-19,0-19,0-21		22791947	10.3748/wjg.v18.i24.3112		World Journal of Gastroenterology : WJG	Decreased blood riboflavin levels are correlated with defective expression of RFT2 gene in gastric cancer	Maynur	June	0		
895	chr25	40642502	40642692	3500127561	39		40642502	40642692	8421504	2	19,20	0,170	c,g	350012756100000003,350012756100000004,350012756100000004	0-19,0-20,0-20		18316552	10.1158/1078-0432.CCR-07-1381	1078-0432	Clinical Cancer Research	Enhanced Expression of RAD51 Associating Protein-1 Is Involved in the Growth of Intrahepatic Cholangiocarcinoma Cells	Obama	2008	8		ACTB
895	chr25	40642502	40642661	3500274474	28		40642502	40642661	8421504	2	25,3	0,156	c	350027447400000007	0-28						Oxidative stress upregulates the ubiquitin proteasome pathway in retinal endothelial cells	www.molvis.org	0	0		ACTB
895	chr25	40642502	40642527	3500394813	25		40642502	40642527	8421504	1	25	0	g	350039481300000007	3-28						\\\\set{final} \\\\def\\<BR>uthor{Fernandes} \\\\def\\\\author{fernandes} \\\\def\\\\vol{12} \\\\def\\\\year{2006} \\\\def\\\\anum{17	www.molvis.org	0	0		ACTB
895	chr25	40642502	40642526	3500457384	24		40642502	40642526	8421504	1	24	0	c	350045738400000000	0-24						Detection of seven viruses and Mycoplasma in fetal bovine serum by real time PCR	rccp.udea.edu.co	0	0		ACTB
895	chr25	40642502	40642526	3500163284	24		40642502	40642526	8421504	1	24	0	c	350016328400000000	0-24				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Detection of seven viruses and Mycoplasma in fetal bovine serum by real time PCR	Cordero	2011	0		ACTB
895	chr25	40642502	40642526	3500100680	24		40642502	40642526	8421504	1	24	0	c	350010068000000000	0-24				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Detection of seven viruses and Mycoplasma in fetal bovine serum by real time PCR	Cordero	2011	0		ACTB
895	chr25	40642504	40642527	3500466199	23		40642504	40642527	8421504	1	23	0	c	350046619900000028,350046619900000006	0-23,0-23						Methods of Screening for Atherosclerosis - Patent application	www.faqs.org	0	0		ACTB
895	chr25	40642504	40642527	3500428688	23		40642504	40642527	8421504	1	23	0	c,g	350042868800000006,350042868800000006	0-23,0-23						Methods Of Screening For Atherosclerosis 	.freshpatents.com	0	0		
895	chr25	40642506	40642976	3500053379	47		40642506	40642976	8421504	3	21,5,21	0,152,449	c,g	350005337900000002,350005337900000010,350005337900000010	0-26,4-25,4-25						Shijie Huaren Xiaohua Zazhi	www.wjgnet.com	0	0		
895	chr25	40642506	40642738	3500348176	49		40642506	40642738	8421504	3	21,5,23	0,152,209	c	350034817600000000,350034817600000001	0-26,0-23						p16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642506	40642698	3500278884	40		40642506	40642698	8421504	2	20,20	0,172	c,g	350027888400000008,350027888400000008,350027888400000009	0-20,0-20,0-20		18542064	10.1038/sj.bjc.6604356	0007-0920	British Journal of Cancer	PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer	Wigfield	2008	5		ACTB
895	chr25	40642506	40642698	3500054024	40		40642506	40642698	8421504	2	20,20	0,172	c,g	350005402400000000,350005402400000000,350005402400000001	0-20,0-20,0-20						Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradation. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642506	40642663	3500465343	26		40642506	40642663	8421504	2	21,5	0,152	c	350046534300000002	0-26		23936312	10.1371/journal.pone.0068837		PLoS ONE	WT1 Promotes Cell Proliferation in Non-Small Cell Lung Cancer Cell Lines through Up-Regulating Cyclin D1 and p-pRb In Vitro and In Vivo	Caihua	2013	0		
895	chr25	40642506	40642663	3500401724	26		40642506	40642663	8421504	2	21,5	0,152	c	350040172400000003	0-26		16518414	10.1038/sj.onc.1209455	0950-9232	Oncogene	Antiapoptotic function of 17AA(&plus;)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway	Ito	2006	6		
895	chr25	40642506	40642663	3500398665	26		40642506	40642663	8421504	2	21,5	0,152	c	350039866500000002	0-26		23936312	10.1371/journal.pone.0068837	1932-6203	PLOS ONE	PLOS ONE: WT1 Promotes Cell Proliferation in Non-Small Cell Lung Cancer Cell Lines through Up-Regulating Cyclin D1 and p-pRb In Vitro and In Vivo	Xu	2013	4		
895	chr25	40642508	40642830	3500355754	49		40642508	40642830	8421504	3	19,6,24	0,150,298	c,g	350035575400000002,350035575400000003,350035575400000003	0-25,0-24,0-24						DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE	Khatib	2007	0		
895	chr25	40642508	40642830	3500180185	49		40642508	40642830	8421504	3	19,6,24	0,150,298	c,g	350018018500000002,350018018500000003,350018018500000003	0-25,0-24,0-24						DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE	Khatib	2010	0		
895	chr25	40642508	40642830	3500084821	49		40642508	40642830	8421504	3	19,6,24	0,150,298	c,g	350008482100000002,350008482100000003,350008482100000003	0-25,0-24,0-24						 DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE - Patent application	www.faqs.org	0	0		
895	chr25	40642508	40642830	3500001677	49		40642508	40642830	8421504	3	19,6,24	0,150,298	c,g	350000167700000002,350000167700000003,350000167700000003	0-25,0-24,0-24						Dairy Cattle Breeding For Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
895	chr25	40642508	40642770	3500186005	47		40642508	40642770	8421504	3	19,6,22	0,150,240	c,g	350018600500000011,350018600500000012,350018600500000012	0-25,0-22,0-22						UN IVERSITE PARIS -SUD	hives-ouvertes.fr	0	0		
895	chr25	40642508	40642770	3500182537	75		40642508	40642770	8421504	4	19,6,25,25	0,150,207,237	c	350018253700000007,350018253700000009,350018253700000008	0-25,0-25,0-25						Lengua Azul	www.oie.int	0	0		
895	chr25	40642508	40642770	3500105936	50		40642508	40642770	8421504	3	19,6,25	0,150,237	c	350010593600000010,350010593600000011	0-25,0-25						UNIVERSIDAD COMPLUTENSE DE MADRID	eprints.ucm.es	0	0		
895	chr25	40642508	40642770	3500081847	72		40642508	40642770	8421504	4	19,6,25,22	0,150,207,240	c,g	350008184700000014,350008184700000018,350008184700000015,350008184700000015	0-25,0-25,0-22,0-22		23110088	10.1371/journal.pone.0047666		PLoS ONE	IS-98-ST1 West Nile Virus Derived from an Infectious cDNA Clone Retains Neuroinvasiveness and Neurovirulence Properties of the Original Virus	Celine	2012	0		
895	chr25	40642508	40642768	3500012191	45		40642508	40642768	8421504	3	19,6,20	0,150,240	c,g	350001219100000003,350001219100000004,350001219100000004	0-25,0-20,0-20		21314967	10.1186/1297-9716-42-11	1297-9716	Veterinary Research	Pathogenicity of two recent Western Mediterranean West Nile virus isolates in a wild bird species indigenous to Southern Europe: the red-legged partridge	Sotelo	2011	0		POTEM
895	chr25	40642510	40642814	3500082790	44		40642510	40642814	8421504	3	17,6,21	0,148,283	c,g	350008279000000008,350008279000000009,350008279000000009	0-23,0-21,0-21						Ju et al. The polymorphisms of &#x03ba;-casein gene and their associations with milk production traits and expression analysis in Chinese Holstein cattle. Afr. J. Biotechnol. 2011	demicjournals.org	0	0		
895	chr25	40642514	40642694	3500088954	46		40642514	40642694	8421504	3	13,8,25	0,144,155	c	350008895400000000,350008895400000002	0-21,22-47						Brief note RNA interference: PCR strategies for the quanti&#xfb01;cation of stable degradation-fragments derived from siRNA-targeted mRNAs	quantification.de	0	0		
895	chr25	40642672	40642696	3500020093	24		40642672	40642696	8421504	1	24	0	c	350002009300000003	0-24						SNS-032 Prevents Tumor Cell&#x2013;Induced Angiogenesis By Inhibiting Vascular Endothelial Growth Factor	www.neoplasia.com	0	0		
895	chr25	40642678	40642856	3500326263	42		40642678	40642856	8421504	2	21,21	0,157	c,g	350032626300000003,350032626300000003,350032626300000002	0-21,0-21,0-21						SuppressionofG s SynthesisbySimvastatinTreatmentof VascularEndothelialCells	www.jbc.org	0	0		
895	chr25	40642678	40642809	3500028544	40		40642678	40642809	8421504	2	20,20	0,111	c,g	350002854400000002,350002854400000003,350002854400000003	0-20,0-20,0-20						Regulators for blood glucose level affect gene expression of aquaporin 3. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642680	40642761	3500430586	42		40642680	40642761	8421504	2	20,22	0,59	c	350043058600000034,350043058600000016	0-20,0-22						Fgf21 cis-element binding substance	Adachi	2011	0		
895	chr25	40642680	40642748	3500054392	61		40642680	40642748	8421504	3	20,21,20	0,24,48	c,g	350005439200000003,350005439200000005,350005439200000004	0-20,0-21,0-20		12393637	10.1182/blood-2002-01-0271	0006-4971	Blood	Low levels of ABCG2 expression in adult AML blast samples	Abbott	2002	10		
895	chr25	40642686	40642709	3500441760	23		40642686	40642709	8421504	1	23	0	c	350044176000000007	0-23						Endocrine therapy resistance can be associated with high estrogen receptor a (ERa) expression and reduced ERa phosphorylation in breast cancer models	logy-journals.org	0	0		ACTB
895	chr25	40642702	40642972	3500271543	40		40642702	40642972	8421504	2	20,20	0,250	c,g	350027154300000008,350027154300000008,350027154300000009	0-20,0-20,0-20						miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3&#xf0a2;-UTR Region of CyclinD1	www.mdpi.com	0	0		
895	chr25	40642702	40642972	3500078658	40		40642702	40642972	8421504	2	20,20	0,250	c,g	350007865800000006,350007865800000007	0-20,0-20						Effect of Regulation of HSV-tk Gene Expression and Tumor Killed Activity with a Single Tetracycline-regulatable Plasmid Vector on HeLa Cells	w.cjcu.jlu.edu.cn	0	0		
895	chr25	40642702	40642972	3500000453	40		40642702	40642972	8421504	2	20,20	0,250	c,g	350000045300000008,350000045300000009,350000045300000009	0-20,0-20,0-20						miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3&#xf0a2;-UTR Region of CyclinD1	www.mdpi.com	0	0		
895	chr25	40642706	40642731	3500277476	25		40642706	40642731	8421504	1	25	0	c	350027747600000001	19-44						Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer	www.mdpi.com	0	0		
895	chr25	40642712	40642973	3500457689	40		40642712	40642973	8421504	2	19,21	0,240	c	350045768900000008,350045768900000009	0-19,0-21					Journal of Clinical & Cellular Immunology	OMICS Publishing Group | Full-text | Assessment of Toll-like Receptors in the Ileum of Weanling Pigs - Responses to Feed Antibiotic Chlortetracycline and Gnotobiotic Conditions	Radhey	2012	0		SPZ1
895	chr25	40642712	40642973	3500436418	40		40642712	40642973	8421504	2	19,21	0,240	c	350043641800000008,350043641800000009	0-19,0-21						Clinical & Cellular George et al., Immunology	w.omicsonline.org	0	0		
895	chr25	40642712	40642973	3500401734	40		40642712	40642973	8421504	2	19,21	0,240	c	350040173400000008,350040173400000009	0-19,0-21					Journal of Clinical & Cellular Immunology	OMICS Publishing Group | Full-text | Assessment of Toll-like Receptors in the Ileum of Weanling Pigs - Responses to Feed Antibiotic Chlortetracycline and Gnotobiotic Conditions	Radhey	2012	0		
895	chr25	40642712	40642973	3500109803	40		40642712	40642973	8421504	2	19,21	0,240	c	350010980300000008,350010980300000009	0-19,0-21						Clinical & Cellular George et al., Immunology	w.omicsonline.org	0	0		
895	chr25	40642712	40642973	3500073590	40		40642712	40642973	8421504	2	19,21	0,240	c	350007359000000008,350007359000000009	0-19,0-21						Clinical & Cellular George et al., Immunology	cnptia.embrapa.br	0	0		
895	chr25	40642728	40642753	3500154698	25		40642728	40642753	8421504	1	25	0	c	350015469800000004	0-25		17470546	10.1128/IAI.00422-07	0019-9567	Infection and Immunity	Marginal Zone B-Cell Depletion Impairs Murine Host Defense against Borrelia burgdorferi Infection	Belperron	2007	4		POTEF
895	chr25	40642729	40642754	3500356570	25		40642729	40642754	8421504	1	25	0	g	350035657000000040	0-25						Mechanisms of Brain Ventricle Development	dspace.mit.edu	0	0		ACTB
895	chr25	40642730	40642813	3500025381	44		40642730	40642813	8421504	2	24,20	0,63	c,g	350002538100000004,350002538100000005,350002538100000005	0-24,0-20,0-20		15075359	10.1124/jpet.103.064329	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor	Brobst	2004	0		
895	chr25	40642732	40642761	3500328567	29		40642732	40642761	8421504	1	29	0	c,g	350032856700000010,350032856700000010	22-51,22-51						DOMAIN EXCHANGE BETWEEN HUMAN TOLL-LIKE RECEPTORS 1 AND 6 REVEALS A REGION REQUIRED FOR LIPOPEPTIDE DISCRIMINATION	www.jbc.org	0	0		
895	chr25	40642732	40642759	3500464942	27		40642732	40642759	8421504	1	27	0	c	350046494200000009	5-32		19657391	10.1371/journal.pone.0006535	1932-6203	PLOS ONE	PLOS ONE: Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice	Yadav	2009	4		SPZ1
895	chr25	40642732	40642759	3500464557	27		40642732	40642759	8421504	1	27	0	c	350046455700000001	5-32						World J Gastroenterol	www.wjgnet.com	0	0		SPZ1
895	chr25	40642732	40642759	3500371780	27		40642732	40642759	8421504	1	27	0	c	350037178000000003	5-32			10.1038/sj.onc.1203757	${footerJournalISSN}		Susceptibility to apoptosis is restored in human leukemia HCW-2 cells following induction and stabilization of the apoptotic effector Bak		2000	0		SPZ1
895	chr25	40642732	40642759	3500337781	27		40642732	40642759	8421504	1	27	0	c	350033778100000003	5-32			10.1074/jbc.M603414200		The Journal of biological chemistry	Cross-talk between Epidermal Growth Factor Receptor and Hypoxia-inducible Factor-1&#x03b1; Signal Pathways Increases Resistance to Apoptosis by Up-regulating Survivin Gene Expression	Xiang-Hong	2006	0		
895	chr25	40642732	40642759	3500214911	27		40642732	40642759	8421504	1	27	0	c,g	350021491100000004,350021491100000004	5-32,5-32						NOVEL TUMOR ANTIGENS ELICIT ANTI-TUMOR HUMORAL IMMUNE REACTIONS IN A SUBSET OF PATIENTS WITH POLYCYTHEMIA VERA	Yang	2007	0		SPZ1
895	chr25	40642732	40642759	3500207003	27		40642732	40642759	8421504	1	27	0	c	350020700300000005	5-32						Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy	www.jeccr.com	0	0		
895	chr25	40642732	40642759	3500187338	26		40642732	40642759	8421504	2	13,13	0,14	c	350018733800000042	5-31						Modulation of &#x03b2;-catenin/TCF-activated transcription	Kahn	2004	0		
895	chr25	40642732	40642759	3500109278	27		40642732	40642759	8421504	1	27	0	c	350010927800000003	5-32						ScienceDirect.com - FEBS Letters - Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect	sciencedirect.com	0	0		
895	chr25	40642732	40642759	3500050482	27		40642732	40642759	8421504	1	27	0	c	350005048200000002	5-32		20360133	10.1152/ajpgi.00528.2009		American Journal of Physiology - Gastrointestinal and Liver Physiology	Activation of transient receptor potential vanilloid subtype 1 increases secretion of the hypofunctional, transplanted submandibular gland	Zhang	2010	0		CCDC74A
895	chr25	40642735	40642759	3500315078	24		40642735	40642759	8421504	1	24	0	g	350031507800000003	0-24		19372484	10.2967/jnumed.108.058438	0161-5505	Journal of Nuclear Medicine	Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor	Johnson	2009	6		ACTG1
895	chr25	40642735	40642759	3500285194	24		40642735	40642759	8421504	1	24	0	c	350028519400000003	0-24						Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of F-FHBG PET Imaging in a Prostate Tumor	m.snmjournals.org	0	0		SPZ1
895	chr25	40642735	40642759	3500233394	24		40642735	40642759	8421504	1	24	0	c	350023339400000005	24-48						Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7	-publications.com	0	0		POTEE
895	chr25	40642735	40642758	3500345921	23		40642735	40642758	8421504	1	23	0	c	350034592100000006	20-43						Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes	www.bioteke.com	0	0		
895	chr25	40642736	40642760	3500123260	24		40642736	40642760	8421504	1	24	0	g	350012326000000003	22-46						Efeitos do resveratrol sobre as c&#xe9;lulas estreladas hep&#xe1;ticas.	www.lume.ufrgs.br	0	0		
895	chr25	40642736	40642759	3500429206	23		40642736	40642759	8421504	1	23	0	c,g	350042920600000010,350042920600000010	0-23,0-23		15728708	10.1152/ajpcell.00610.2004		American Journal of Physiology - Cell Physiolog	LPA2 receptor mediates mitogenic signals in human colon cancer cells	Yun	2005	0		POTEF
895	chr25	40642737	40642767	3500166179	30		40642737	40642767	8421504	1	30	0	c	350016617900000000	0-30						Nuclease protection assays	Kumar	1997	0		
895	chr25	40642739	40642799	3500315045	60		40642739	40642799	8421504	1	60	0	p	350031504500015012	0-60						Monozyt&#xe4;re Zellantwort gegen Aspergillus fumigatus	.uni-tuebingen.de	0	0		TMEM222
895	chr25	40642740	40642972	3500198702	40		40642740	40642972	8421504	2	20,20	0,212	c	350019870200000001,350019870200000007	0-20,0-20						Pharmacology Pharmacy and African Journal of	demicjournals.org	0	0		
895	chr25	40642740	40642967	3500059823	41		40642740	40642967	8421504	2	21,20	0,207	c,g	350005982300000002,350005982300000003,350005982300000003	0-21,0-20,0-20		17853924	10.1038/sj.cgt.7701086	0929-1903	Cancer Gene Therapy	An archaeal histone-like protein mediates efficient p53 gene transfer and facilitates its anti-cancer effect in vitro and in vivo	Li	2007	3		ACTB
895	chr25	40642740	40642765	3500000158	25		40642740	40642765	8421504	1	25	0	c	350000015800000025	0-25		17504977	10.1096/fj.06-7440com	0892-6638	The FASEB Journal	Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1&#x03b1;- and basic FGF-dependent pathway in muscle cells	Egger	2007	6		POTEE
895	chr25	40642743	40642767	3500391930	24		40642743	40642767	8421504	1	24	0	c	350039193000000023	24-48						Hepatoblast-Like Progenitor Cells Derived From Embryonic Stem Cells Can Repopulate Livers of Mice	library.ibp.ac.cn	0	0		POTEE
895	chr25	40642744	40642768	3500356386	24		40642744	40642768	8421504	1	24	0	c	350035638600000008	23-47						Research Paper &#x03b2;-Operated Growth Inhibition and Translineage Commitment into Smooth Muscle Cells of Periodontal Ligament-Derived Endothelial Progen- itor Cells through Smad- and p38 MAPK-Dependent Signals	www.ijbs.com	0	0		
895	chr25	40642745	40642984	3500315071	41		40642745	40642984	8421504	2	22,19	0,220	c,g	350031507100000054,350031507100000054,350031507100000055	0-22,0-22,0-19						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
895	chr25	40642746	40642770	3500447075	24		40642746	40642770	8421504	1	24	0	c	350044707500000001	0-24		16216911	10.1677/jme.1.01853	0952-5041	Journal of Molecular Endocrinology	Androgen metabolism via 17&#x03b2;-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme	Mindnich	2005	3		
895	chr25	40642746	40642770	3500343980	24		40642746	40642770	8421504	1	24	0	c	350034398000000007	0-24		18511484	10.1113/jphysiol.2008.153734		The Journal of Physiology	Initial segment Kv2.2 channels mediate a slow delayed rectifier and maintain high frequency action potential firing in medial nucleus of the trapezoid body neurons	Jamie	July	0		
895	chr25	40642747	40642770	3500458394	23		40642747	40642770	8421504	1	23	0	c	350045839400000005	0-23		19531238	10.1186/1465-9921-10-51	1465-9921	Respiratory Research	Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthma	Wu	2009	0		
895	chr25	40642748	40642771	3500320056	23		40642748	40642771	8421504	1	23	0	c	350032005600000000	24-47		19759828	10.1371/journal.pone.0006943	1932-6203	PLOS ONE	PLOS ONE: Earlier Onset of &#x03b4;-Retrovirus-Induced Leukemia after Splenectomy	Florins	2009	4		
895	chr25	40642750	40642773	3500251913	23		40642750	40642773	8421504	1	23	0	c,g	350025191300000003,350025191300000003	0-23,0-23		19074907	10.1158/0008-5472.CAN-08-1444	0008-5472	Cancer Research	Epithelial-Mesenchymal Transition Induced by Growth Suppressor p12CDK2-AP1 Promotes Tumor Cell Local Invasion but Suppresses Distant Colony Growth	Tsuji	2008	8		
895	chr25	40642750	40642773	3500247571	23		40642750	40642773	8421504	1	23	0	c,g	350024757100000003,350024757100000003	0-23,0-23		21989785	10.1002/cncr.26524	1097-0142	Cancer	HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection - Zhao - 2011 - Cancer - Wiley Online Library	Zhao	2012	0		
895	chr25	40642750	40642773	3500160929	23		40642750	40642773	8421504	1	23	0	c,g	350016092900000003,350016092900000003	0-23,0-23		23741443	10.1371/journal.pone.0065023		PLoS ONE	Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma	Lu	2013	0		
895	chr25	40642751	40642775	3500431336	24		40642751	40642775	8421504	1	24	0	c,g	350043133600000010,350043133600000010	0-24,0-24		20049711	10.1002/emmm.200900009	1757-4684	EMBO Molecular Medicine	Neutralization of IFN&#x03b3; defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice - Schmid - 2009 - EMBO Molecular Medicine - Wiley Online Library	Schmid	2009	0		
895	chr25	40642751	40642775	3500241987	23		40642751	40642775	8421504	2	9,14	0,10	c	350024198700000000	0-23		18316591	10.1158/0008-5472.CAN-07-3218	0008-5472	Cancer Research	A Novel Recurrent Chromosomal Inversion Implicates the Homeobox Gene Dlx5 in T-Cell Lymphomas from Lck-Akt2 Transgenic Mice	Tan	2008	8		
895	chr25	40642754	40642777	3500367466	23		40642754	40642777	8421504	1	23	0	c	350036746600000001	10-33						THE J B C &#xa9; 2002 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Several PATCHED1 Missense Mutations Display Activity in patched1-Deficient Fibroblasts*	med.stanford.edu	0	0		
895	chr25	40642754	40642777	3500338600	23		40642754	40642777	8421504	1	23	0	c	350033860000000002	19-42						NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression	rt.physiology.org	0	0		
895	chr25	40642760	40642783	3500177096	23		40642760	40642783	8421504	1	23	0	c,g	350017709600000036,350017709600000036	1-24,1-24						Specifically inhibiting liver cell cyp 2e1 shrna expression of the slow... - IP.com	ip.com/patfam/en/	0	0		ACTB
895	chr25	40642769	40642802	3500252826	33		40642769	40642802	8421504	1	33	0	c	350025282600000016	0-33						Die Rolle von Zinkionen in der Signaltransduktion von Monozyten	th.rwth-aachen.de	0	0		
895	chr25	40642769	40642802	3500182644	33		40642769	40642802	8421504	1	33	0	c	350018264400000003	0-33						Comparison of SP-A and LPS effects on the THP-1 monocytic cell line	ng.physiology.org	0	0		
895	chr25	40642769	40642802	3500085599	33		40642769	40642802	8421504	1	33	0	c,g	350008559900000009,350008559900000009	0-33,0-33						BCR/ABLinduces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1 , through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin	tologylibrary.org	0	0		
895	chr25	40642769	40642802	3500049872	33		40642769	40642802	8421504	1	33	0	c	350004987200000003	0-33		11274230		1046-6673	Journal of the American Society of Nephrology	CD40 Is Expressed on Human Peritoneal Mesothelial Cells and Upregulates the Production of Interleukin-15 and RANTES	BASOK	2001	10		
895	chr25	40642769	40642799	3500328408	30		40642769	40642799	8421504	1	30	0	c	350032840800000010	39-69						Methods and compounds for phototransfer	Lim	2009	0		SYN2,AMY2B
895	chr25	40642769	40642799	3500257495	30		40642769	40642799	8421504	1	30	0	c	350025749500000010	39-69						Methods and compounds for making arrays - Patent application	www.faqs.org	0	0		AMY2B
895	chr25	40642769	40642799	3500252067	30		40642769	40642799	8421504	1	30	0	c	350025206700000010	39-69						Methods for enriching subpopulations - Patent application	www.faqs.org	0	0		SYN2,AMY2B
895	chr25	40642769	40642799	3500153351	30		40642769	40642799	8421504	1	30	0	c	350015335100000010	39-69						Bead-ligand-nascent protein complexes	Lim	2008	0		ACTB
895	chr25	40642769	40642799	3500090280	30		40642769	40642799	8421504	1	30	0	c	350009028000000010	39-69						Bead-ligand-nascent protein complexes - Patent application	www.faqs.org	0	0		SYN2
895	chr25	40642769	40642799	3500059567	30		40642769	40642799	8421504	1	30	0	c	350005956700000010	39-69						Methods for controlling amplification - Patent application	www.faqs.org	0	0		
895	chr25	40642770	40642802	3500022922	32		40642770	40642802	8421504	1	32	0	c	350002292200000007	0-32		18701500	10.1158/0008-5472.CAN-07-6682		Cancer research	Leptin Enhances Cholangiocarcinoma Cell Growth	Giammarco	2008	0		
895	chr25	40642772	40642802	3500454199	30		40642772	40642802	8421504	1	30	0	c	350045419900000003	0-31		16732322	10.1038/sj.onc.1209697	0950-9232	Oncogene	Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, &#x03b1;25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5&#x2032;-flanking region	Wang	2006	6		SPZ1
895	chr25	40642772	40642802	3500391904	30		40642772	40642802	8421504	1	30	0	c	350039190400000002	0-30		18665237	10.1371/journal.pone.0002829		PLoS ONE	Human Microglial Cells Synthesize Albumin in Brain	Sung-Min	2008	0		
895	chr25	40642772	40642802	3500165160	30		40642772	40642802	8421504	1	30	0	g	350016516000000002	30-60						Die Rolle humaner NK-Zellen f&#xfc;r die Eradikation von Leuk&#xe4;mien in der HLA-haploidentischen Knochenmark- und Stammzelltransplantation	b.uni-muenchen.de	0	0		POTEF,POTEM
895	chr25	40642773	40642802	3500436797	29		40642773	40642802	8421504	1	29	0	c	350043679700000006	0-29		17210757	10.1677/joe.1.06881	0022-0795	Journal of Endocrinology	Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells	Vriese	2007	4		
895	chr25	40642773	40642802	3500330751	29		40642773	40642802	8421504	1	29	0	c	350033075100000006	0-29						Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells	logy-journals.org	0	0		
895	chr25	40642773	40642802	3500295086	29		40642773	40642802	8421504	1	29	0	g	350029508600000011	0-29						Nestin expression and clonal analysis of islet-derived epithelial monolayers: insight into nestin-expressing cell heterogeneity and differentiation potential	logy-journals.org	0	0		
895	chr25	40642773	40642802	3500168735	29		40642773	40642802	8421504	1	29	0	g	350016873500000003	0-29		23828577	10.1038/cddis.2013.244	false	Cell Death & Disease	TGF-&#x03b2;1 regulates cell fate during epithelial&#x2013;mesenchymal transition by upregulating survivin	Lee	2013	0		SPZ1
895	chr25	40642774	40642799	3500461636	25		40642774	40642799	8421504	1	25	0	c	350046163600000010	0-25						Biomarkers and targets for diagnosis, prognosis and management of prostate disease	An	2000	0		ACTG1,SPZ1
895	chr25	40642774	40642799	3500447989	25		40642774	40642799	8421504	1	25	0	c	350044798900000009	0-25						US Patent # 6,190,857. Diagnosis of disease state using MRNA profiles in peripheral leukocytes - Patents.com	www.patents.com	0	0		ACTG1
895	chr25	40642774	40642799	3500391245	25		40642774	40642799	8421504	1	25	0	c	350039124500000010	0-25						Biomarkers and targets for diagnosis, prognosis and management of prostate disease	An	1999	0		ACTG1,AMY2B
895	chr25	40642774	40642799	3500356347	25		40642774	40642799	8421504	1	25	0	c	350035634700000007	0-25					Patent	Biomarkers and targets for diagnosis, prognosis and management of prostate disease (Patent EP:1047793)	An	2006	0		AMY2B
895	chr25	40642774	40642799	3500340544	25		40642774	40642799	8421504	1	25	0	c	350034054400000010	0-25						US Patent # 5,972,615. Biomarkers and targets for diagnosis, prognosis and management of prostate disease - Patents.com	www.patents.com	0	0		ACTG1
895	chr25	40642774	40642799	3500334614	25		40642774	40642799	8421504	1	25	0	c	350033461400000007	0-25						US Patent # 5,882,864. Biomarkers and targets for diagnosis, prognosis and management of prostate disease - Patents.com	www.patents.com	0	0		ACTG1
895	chr25	40642774	40642799	3500270753	25		40642774	40642799	8421504	1	25	0	c	350027075300000010	0-25						Biomarkers and targets for diagnosis, prognosis and management of prostate disease	An	1998	0		
895	chr25	40642774	40642799	3500252210	25		40642774	40642799	8421504	1	25	0	c,g	350025221000000007,350025221000000007	0-25,0-25					Patent	Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer (Patent US:6218529)	An	2001	0		
895	chr25	40642774	40642799	3500177792	25		40642774	40642799	8421504	1	25	0	c	350017779200000010	0-25					Patent	Biomarkers for detection of prostate cancer (Patent US:5861248)	Russell	1999	0		ACTG1
895	chr25	40642774	40642799	3500108739	25		40642774	40642799	8421504	1	25	0	c	350010873900000007	0-25						Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer	An	2003	0		ACTG1,SPZ1
895	chr25	40642774	40642799	3500092992	25		40642774	40642799	8421504	1	25	0	c	350009299200000010	0-25					Patent	Biomarkers for the detection of prostate cancer (Patent US:6090559)	Russell	2000	0		
895	chr25	40642774	40642799	3500040982	25		40642774	40642799	8421504	1	25	0	c	350004098200000004	0-25					Patent	Biomarkers and targets for diagnosis, prognosis and management of prostate disease (Patent US:5882864)	An	1999	0		ACTG1,AMY2B
895	chr25	40642774	40642799	3500002159	25		40642774	40642799	8421504	1	25	0	c	350000215900000006	0-25						Diagnosis of disease state using mrna profiles	An	1998	0		ACTG1
895	chr25	40642774	40642798	3500429307	24		40642774	40642798	8421504	1	24	0	g	350042930700000009	0-24		20237295	10.4049/jimmunol.0902814	0022-1767	The Journal of Immunology	Lysophosphatidylcholine Increases Neutrophil Bactericidal Activity by Enhancement of Azurophil Granule-Phagosome Fusion via Glycine&#xb7;GlyR&#x03b1;2/TRPM2/p38 MAPK Signaling	Hong	2010	6		AMY2B
895	chr25	40642775	40642802	3500210821	27		40642775	40642802	8421504	1	27	0	c	350021082100000009	0-27						AVERTISSEMENT	.scd.uhp-nancy.fr	0	0		
895	chr25	40642777	40642803	3500431449	26		40642777	40642803	8421504	1	26	0	c	350043144900000005	0-26		16731755	10.1158/1535-7163.MCT-05-0490	1535-7163	Molecular Cancer Therapeutics	Green tea extract and (&#x2212;)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1&#x03b1; protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells	Zhang	2006	5		SPZ1
895	chr25	40642777	40642803	3500427388	26		40642777	40642803	8421504	1	26	0	c	350042738800000007	0-26		18248611	10.1111/j.1471-4159.2008.05276.x	1471-4159	Journal of Neurochemistry	Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia/reperfusion - Xing - 2008 - Journal of Neurochemistry - Wiley Online Library	Xing	2008	0		
895	chr25	40642777	40642803	3500285695	26		40642777	40642803	8421504	1	26	0	c	350028569500000003	0-26		14644771	10.1152/ajpcell.00200.2003		American Journal of Physiology - Cell Physiolog	Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts	Wu	2004	0		
895	chr25	40642777	40642803	3500265047	26		40642777	40642803	8421504	1	26	0	c	350026504700000014	0-26		21947283	10.1128/MCB.05646-11	0270-7306	Molecular and Cellular Biology	Survival and Differentiation of Mammary Epithelial Cells in Mammary Gland Development Require Nuclear Retention of Id2 Due to RANK Signaling	Kim	2011	6		
895	chr25	40642777	40642803	3500249674	26		40642777	40642803	8421504	1	26	0	c	350024967400000007	0-26					Patent	Cell culture system for synthesis of infectious hepatitis C virus (Patent US:7183095)	Dasgupta	2007	0		SPZ1
895	chr25	40642777	40642803	3500247851	26		40642777	40642803	8421504	1	26	0	c	350024785100000003	0-26		20300439	10.1155/2010/943516	1110-7243	BioMed Research International	Anti-Inflammatory Effects of <i>Inonotus obliquus</i> in Colitis Induced by Dextran Sodium Sulfate	Choi	2010	2		
895	chr25	40642777	40642803	3500226994	26		40642777	40642803	8421504	1	26	0	c	350022699400000013	0-26		16520738	10.1038/sj.bjp.0706718	1476-5381	British Journal of Pharmacology	Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-&#x03ba;B inactivation - Won - 2009 - British Journal of Pharmacology - Wiley Online Library	Won	2006	0		
895	chr25	40642777	40642803	3500203298	26		40642777	40642803	8421504	1	26	0	c	350020329800000030	0-26		18057259	10.1128/JVI.01650-07	0022-538X	Journal of Virology	Negative Feedback Regulation of RIG-I-Mediated Antiviral Signaling by Interferon-Induced ISG15 Conjugation	Kim	2008	5		
895	chr25	40642777	40642803	3500198848	26		40642777	40642803	8421504	1	26	0	c	350019884800000030	0-26			10.1128/JVI.01650-07		Journal of Virology	Negative Feedback Regulation of RIG-I-Mediated Antiviral Signaling by Interferon-Induced ISG15 Conjugation 	Min-Jung	2008	0		
895	chr25	40642777	40642803	3500063689	26		40642777	40642803	8421504	1	26	0	c	350006368900000001	0-26						Prostaglandin F2tt Regulation of the Bovine Corpus Luteum Endothelin System: RESULTS | Methods of Treatment	-of-treatment.com	0	0		
895	chr25	40642777	40642803	3500052338	26		40642777	40642803	8421504	1	26	0	c	350005233800000009	0-26		16940143	10.1128/IAI.00519-06	0019-9567	Infection and Immunity	The K1 Serotype Capsular Polysaccharide of Porphyromonas gingivalis Elicits Chemokine Production from Murine Macrophages That Facilitates Cell Migration	d'Empaire	2006	4		SPZ1
895	chr25	40642777	40642802	3500390024	25		40642777	40642802	8421504	1	25	0	c	350039002400000015	0-25					International Journal of Molecular Sciences	Modulation of Human Serotonin Transporter Expression by 5-HTTLPR in Colon Cells - Scolaris	Prasansuklab	2011	0		ACTA1
895	chr25	40642777	40642802	3500078551	25		40642777	40642802	8421504	1	25	0	g	350007855100000003	0-25						Decreased EGFR mRNA expression in response to antipsoriatic drug dithranol in vitro	demicjournals.org	0	0		
895	chr25	40642778	40642970	3500360592	44		40642778	40642970	8421504	2	22,22	0,170	c	350036059200000006,350036059200000007	0-22,0-22		22496243	10.1152/ajpcell.00080.2012		American Journal of Physiology - Cell Physiolog	Heme carrier protein 1 transports heme and is involved in heme-Fe metabolism	Le	2012	0		
895	chr25	40642778	40642970	3500114208	44		40642778	40642970	8421504	2	22,22	0,170	c,g	350011420800000006,350011420800000007,350011420800000007	0-22,0-22,0-22		22496243	10.1152/ajpcell.00080.2012		American Journal of Physiology - Cell Physiolog	Heme carrier protein 1 transports heme and is involved in heme-Fe metabolism	Le	2012	0		SPZ1
895	chr25	40642778	40642802	3500364719	24		40642778	40642802	8421504	1	24	0	c	350036471900000007	0-24						UNIVERSIT&#xc0; DEGLI STUDI DI ROMA TOR VERGATA	space.uniroma2.it	0	0		
895	chr25	40642778	40642801	3500150774	23		40642778	40642801	8421504	1	23	0	c,g	350015077400000016,350015077400000016	0-23,0-23		20406991	10.1158/0008-5472.CAN-09-2942	0008-5472	Cancer Research	Hypoxia Induces Trimethylated H3 Lysine 4 by Inhibition of JARID1A Demethylase	Zhou	2010	8		TMEM222
895	chr25	40642780	40642980	3500357857	41		40642780	40642980	8421504	2	19,22	0,178	c,g	350035785700000002,350035785700000002,350035785700000003	0-19,0-19,0-22		22929207	10.1186/1743-422X-9-176	1743-422X	Virology Journal	In vitro inhibition of transmissible gastroenteritis coronavirus replication in swine testicular cells by short hairpin RNAs targeting the ORF 7 gene	He	2012	2		SPZ1
895	chr25	40642780	40642980	3500049669	41		40642780	40642980	8421504	2	19,22	0,178	c,g	350004966900000002,350004966900000002,350004966900000003	0-19,0-19,0-22		22929207	10.1186/1743-422X-9-176		Virology Journal	In vitro inhibition of transmissible gastroenteritis coronavirus replication in swine testicular cells by short hairpin RNAs targeting the ORF 7 gene	Lei	2012	0		SPZ1
895	chr25	40642780	40642973	3500073381	43		40642780	40642973	8421504	2	22,21	0,172	c	350007338100000006,350007338100000007	0-22,0-21						Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs	ww.aseanfood.info	0	0		SPZ1
895	chr25	40642780	40642803	3500196482	23		40642780	40642803	8421504	1	23	0	c	350019648200000001	8-31						Cell stimulation with optically manipulated microsources	ophysics-tue.info	0	0		
895	chr25	40642781	40642973	3500393925	40		40642781	40642973	8421504	2	20,20	0,172	c,g	350039392500000000,350039392500000000,350039392500000001	0-20,0-20,0-20						Angelica sinensis suppresses human lung adenocarcinoma A549 cell metastasis by regulating MMPs/TIMPs and TGF- 1	-publications.com	0	0		
895	chr25	40642781	40642973	3500275427	40		40642781	40642973	8421504	2	20,20	0,172	c,g	350027542700000004,350027542700000005,350027542700000005	0-20,0-20,0-20						Sorafenib inhibits hypoxia-inducible factor-1 &#x03b1; synthesis: implications for anti- angiogenic activity in hepatocellular carcinoma	.aacrjournals.org	0	0		
895	chr25	40642785	40642809	3500092433	24		40642785	40642809	8421504	1	24	0	g	350009243300000003	6-30			10.1046/j.0022-3042.2001.00714.x	1471-4159	Journal of Neurochemistry	The &#x03b1;7 nicotinic receptors in human fetal brain and spinal cord - Falk - 2002 - Journal of Neurochemistry - Wiley Online Library	Falk	2002	0		
895	chr25	40642788	40642855	3500448302	44		40642788	40642855	8421504	2	23,21	0,46	c	350044830200000004,350044830200000005	0-23,0-21		24204395	10.1155/2013/548929	1741-427X	Evidence-Based Complementary and Alternative Medicine	Destruxin B Isolated from Entomopathogenic Fungus <i>Metarhizium anisopliae</i> Induces Apoptosis via a Bcl-2 Family-Dependent Mitochondrial Pathway in Human Nonsmall Cell Lung Cancer Cells	Wu	2013	5		
895	chr25	40642788	40642855	3500352144	44		40642788	40642855	8421504	2	23,21	0,46	c	350035214400000004,350035214400000005	0-23,0-21		24204395	10.1155/2013/548929	1741-427X	Evidence-Based Complementary and Alternative Medicine	Destruxin B Isolated from Entomopathogenic Fungus <i>Metarhizium anisopliae</i> Induces Apoptosis via a Bcl-2 Family-Dependent Mitochondrial Pathway in Human Nonsmall Cell Lung Cancer Cells	Wu	2013	5		
895	chr25	40642800	40642990	3500278885	42		40642800	40642990	8421504	2	21,21	0,169	c,g	350027888500000004,350027888500000004,350027888500000005,350027888500000005	0-21,0-21,0-21,0-21						Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642800	40642990	3500140766	42		40642800	40642990	8421504	2	21,21	0,169	c,g	350014076600000004,350014076600000004,350014076600000005,350014076600000005	0-21,0-21,0-21,0-21		23977311	10.1371/journal.pone.0072521		PLoS ONE	Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle	Maria	2013	0		
895	chr25	40642815	40642885	3500128937	43		40642815	40642885	8421504	3	15,7,21	0,17,49	c	350012893700000000,350012893700000001	0-22,0-21						The impact of reference gene selection in quantification of gene expression levels in guinea pig cervical tissues and cells	genomebiology.com	0	0		POTEE
895	chr25	40642817	40642972	3500225370	46		40642817	40642972	8421504	3	13,12,21	0,15,134	c,g	350022537000000008,350022537000000008,350022537000000009	0-25,0-25,0-21		16014382	10.1242/jcs.02448	0021-9533	Journal of Cell Science	Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation	He	2005	6		ACTB
895	chr25	40642817	40642972	3500210713	46		40642817	40642972	8421504	3	13,12,21	0,15,134	c	350021071300000008,350021071300000009	0-25,0-21		16014382	10.1242/jcs.02448	0021-9533	Journal of Cell Science	Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation	He	2005	6		ACTB
895	chr25	40642832	40642857	3500016716	25		40642832	40642857	8421504	1	25	0	c	350001671600000003	0-25		20036271	10.1016/j.taap.2009.12.014		Toxicology and applied pharmacology	Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure	Elena	2010	0		ACTB
895	chr25	40642833	40642857	3500198515	24		40642833	40642857	8421504	1	24	0	c,g	350019851500000011,350019851500000011	0-24,0-24						THE J B C Vol.271,No.50,IssueofDecember13,pp.32381&#x2013;32384,1996 &#xa9;1996byTheAmericanSocietyforBiochemistryandMolecularBiology,Inc. PrintedinU.S.A. NovelGroupVPhospholipaseA InvolvedinArachidonicAcid MobilizationinMurineP388D1 Macrophages*	cobra.ucsd.edu	0	0		ACTB
895	chr25	40642834	40642860	3500250921	26		40642834	40642860	8421504	1	26	0	c,g	350025092100000010,350025092100000010	0-26,0-26		20505765	10.1371/journal.pone.0010757		PLoS ONE	Immunological Basis for the Gender Differences in Murine Paracoccidioides brasiliensis Infection	Camila	2010	0		FRMD5,ACTB
895	chr25	40642835	40642865	3500061500	30		40642835	40642865	8421504	1	30	0	c	350006150000000003	0-30						Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors	aac.asm.org	0	0		ACTB
895	chr25	40642835	40642860	3500033962	25		40642835	40642860	8421504	1	25	0	c,g	350003396200000005,350003396200000005	0-25,0-25		22904072	10.1093/nar/gks779		Nucleic Acids Research	Rhythmic binding of Topoisomerase I impacts on the transcription of Bmal1 and circadian period	Yoshiaki	2012	0		ACTB
895	chr25	40642836	40642861	3500011891	25		40642836	40642861	8421504	1	25	0	c	350001189100000001	0-25						Conjugated linoleic acid isomers and their precursor fatty acids regulate peroxisome proliferator-activated receptor subtypes and major peroxisome proliferator responsive element-bearing target genes in HepG2 cell model	www.zju.edu.cn	0	0		ACTB
895	chr25	40642846	40642967	3500383646	40		40642846	40642967	8421504	2	20,20	0,101	c,g	350038364600000032,350038364600000032,350038364600000033,350038364600000033	0-20,0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		ACTB
895	chr25	40642851	40642966	3500322891	44		40642851	40642966	8421504	2	22,22	0,93	c	350032289100000004,350032289100000005	0-22,0-22		22222369	10.1016/j.bbrc.2011.12.095		Biochemical and Biophysical Research Communications	Nuclear localization of lymphocyte-specific protein tyrosine kinase (Lck) and its role in regulating LIM domain only 2 (Lmo2) gene	Srividya	2012	0		
895	chr25	40642854	40642877	3500145292	23		40642854	40642877	8421504	1	23	0	c	350014529200000009	0-23		22212866	10.1111/j.1742-7843.2011.00852.x	1742-7843	Basic & Clinical Pharmacology & Toxicology	Chronic Vitamin C Deficiency does not Accelerate Oxidative Stress in Ageing Brains of Guinea Pigs - Tveden-Nyborg - 2012 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library	Tveden-Nyborg	2012	0		ACTB
895	chr25	40642858	40642881	3500268241	23		40642858	40642881	8421504	1	23	0	c	350026824100000003	0-23		20046830	10.1371/journal.pone.0008531		PLoS ONE	Mechanisms of c-Myc Degradation by Nickel Compounds and Hypoxia	Qin	2009	0		ACTB
895	chr25	40642863	40642969	3500392623	40		40642863	40642969	8421504	2	20,20	0,86	c	350039262300000000,350039262300000001	0-20,0-20						CERIVASTATIN TO TREAT PULMONARY DISORDERS - Patent application	www.faqs.org	0	0		
895	chr25	40642863	40642967	3500446552	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350044655200000008,350044655200000009,350044655200000009	0-20,0-20,0-20			10.1371/journal.pmed.0020045	1549-1676	PLOS Medicine	PLOS Medicine: Multiple Metabolic Hits Converge on CD36 as Novel Mediator of Tubular Epithelial Apoptosis in Diabetic Nephropathy	Susztak	2005	0		
895	chr25	40642863	40642967	3500439839	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350043983900000002,350043983900000003,350043983900000003	0-20,0-20,0-20						&#x4e3b;&#x9898;&#xff1a;Growth | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		ACTB
895	chr25	40642863	40642967	3500438165	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350043816500000002,350043816500000003,350043816500000003	0-20,0-20,0-20		20962044	10.1210/me.2009-0448		Molecular Endocrinology	Cytokine and Progesterone Receptor Interplay in the Regulation of MUC1 Gene Expression	Neeraja	2010	0		
895	chr25	40642863	40642967	3500411091	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350041109100000002,350041109100000003,350041109100000003	0-20,0-20,0-20						PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. - ResearchGate	.researchgate.net	0	0		ACTB
895	chr25	40642863	40642967	3500391628	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350039162800000006,350039162800000007,350039162800000007	0-20,0-20,0-20						PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma	-publications.com	0	0		
895	chr25	40642863	40642967	3500339177	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350033917700000002,350033917700000003,350033917700000003	0-20,0-20,0-20						&#x4e3b;&#x9898;&#xff1a;cell | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		KDM4C
895	chr25	40642863	40642967	3500322980	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350032298000000000,350032298000000001,350032298000000001	0-20,0-20,0-20						AD (Leave blank)	handle.dtic.mil	0	0		
895	chr25	40642863	40642967	3500306476	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350030647600000002,350030647600000003,350030647600000003	0-20,0-20,0-20		15908458	10.1189/jlb.1004569	0741-5400	Journal of Leukocyte Biology	PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells	Baratelli	2005	5		TNFRSF11A
895	chr25	40642863	40642967	3500285982	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350028598200000002,350028598200000003,350028598200000003	0-20,0-20,0-20						&#x4e3b;&#x9898;&#xff1a;Cell | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
895	chr25	40642863	40642967	3500231469	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350023146900000004,350023146900000005,350023146900000005	0-20,0-20,0-20							ingtechnology.com	0	0		TNFRSF11A
895	chr25	40642863	40642967	3500190369	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350019036900000002,350019036900000003,350019036900000003	0-20,0-20,0-20						Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8.	.biomedsearch.com	0	0		ACTB
895	chr25	40642863	40642967	3500176941	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350017694100000002,350017694100000003,350017694100000003	0-20,0-20,0-20						KIP1 Up-Regulation and Nuclear Translocation in Association with Cell Growth Lung Cancer Cell Lines	aspetjournals.org	0	0		
895	chr25	40642863	40642967	3500173003	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350017300300000002,350017300300000003,350017300300000003	0-20,0-20,0-20						Cancer Cell International C BioMed Central	www.cancerci.com	0	0		
895	chr25	40642863	40642967	3500130562	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350013056200000004,350013056200000005,350013056200000005	0-20,0-20,0-20						&#x718a;&#x672c;&#x5927;&#x5b66;&#x5b66;&#x8853;&#x30ea;&#x30dd;&#x30b8;&#x30c8;&#x30ea; Kumamoto University Repository System	.kumamoto-u.ac.jp	0	0		
895	chr25	40642863	40642967	3500076691	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350007669100000002,350007669100000003,350007669100000003	0-20,0-20,0-20		22792519	10.5230/jgc.2012.12.2.73		Journal of Gastric Cancer	Amplification of the UQCRFS1 Gene in Gastric Cancers	Kyong	June	0		
895	chr25	40642863	40642967	3500036172	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350003617200000002,350003617200000003,350003617200000003	0-20,0-20,0-20						Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Up-Regulation and Nuclear Translocation in Association wit 2007&#x5e74;&#x7b2c;69&#x5377;&#x7b2c;8&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&	www.39kf.com	0	0		
895	chr25	40642863	40642967	3500017839	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350001783900000002,350001783900000003,350001783900000003	0-20,0-20,0-20						Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with Cell Growth Inhibition and G1/S Phase Arrest in Human Non-Small-Cell Lung Cancer Cell Lines--&#	journal.9med.net	0	0		ACTB
895	chr25	40642863	40642967	3500014212	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350001421200000002,350001421200000003,350001421200000003	0-20,0-20,0-20			10.1124/mol.107.034827	1521-0111 (Online)	Molecular Pharmacology	Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with Cell Growth Inhibition and G1/S Phase Arrest in Human Non-Small-Cell Lung Cancer Cell Lines	Ling	2007	0		ACTB
895	chr25	40642863	40642967	3500010064	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350001006400000008,350001006400000009,350001006400000009	0-20,0-20,0-20						Multiple Metabolic Hits Converge on CD36 as Novel Mediator of Tubular Epithelial Apoptosis in Diabetic Nephropathy	jdc.jefferson.edu	0	0		ACTB
895	chr25	40642863	40642967	3500004542	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350000454200000002,350000454200000003,350000454200000003	0-20,0-20,0-20		16707460	10.1158/0008-5472.CAN-05-3635	0008-5472	Cancer Research	Cyclooxygenase-2&#x2013;Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non&#x2013;Small Cell Lung Cancer	Dohadwala	2006	8		KDM4C
895	chr25	40642863	40642967	3500000595	40		40642863	40642967	8421504	2	20,20	0,84	c,g	350000059500000007,350000059500000006,350000059500000006	0-20,0-20,0-20		19789347	10.1158/0008-5472.CAN-09-0986	0008-5472	Cancer Research	An A13 Repeat within the 3&#x2032;-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression	Yuan	2009	8		
895	chr25	40642865	40642888	3500310730	23		40642865	40642888	8421504	1	23	0	c	350031073000000004	24-47						Expression of ABCB1, ABCC2 and ABCG2 in porcine tissues	ive.library.uu.nl	0	0		POTEE
895	chr25	40642933	40642956	3500264956	23		40642933	40642956	8421504	1	23	0	c,g	350026495600000003,350026495600000003	0-23,0-23		17532541	10.1016/j.ejcb.2007.03.008	0171-9335	European journal of cell biology	Procathepsin D secreted by HaCaT keratinocyte cells &#x2013; a novel regulator of keratinocyte growth	A	June	3		
895	chr25	40642933	40642956	3500211488	23		40642933	40642956	8421504	1	23	0	c	350021148800000003	0-23						Procathepsin D secreted by HaCaT keratinocyte cells &#x2013; A novel regulator of keratinocyte growth	glucan.us/eurocel	0	0		POTEH
895	chr25	40642945	40642968	3500466599	23		40642945	40642968	8421504	1	23	0	c,g	350046659900000003,350046659900000003	0-23,0-23		23940799	10.1371/journal.pone.0071983		PLoS ONE	Fisetin Inhibits Migration and Invasion of Human Cervical Cancer Cells by Down-Regulating Urokinase Plasminogen Activator Expression through Suppressing the p38 MAPK-Dependent NF-&#x03ba;B Signaling Pathway	Ruey-Hwang	2013	0		SYT8,SPZ1
895	chr25	40642945	40642968	3500037949	23		40642945	40642968	8421504	1	23	0	c,g	350003794900000013,350003794900000013	0-23,0-23		21216957	10.1074/jbc.M110.185124		The Journal of Biological Chemistry	EZH2 Regulates Neuronal Differentiation of Mesenchymal Stem Cells through PIP5K1C-dependent Calcium Signaling	Yung-Luen	2011	0		MURC,SPZ1
895	chr25	40642945	40642968	3500014183	23		40642945	40642968	8421504	1	23	0	c	350001418300000010	0-23		24073285	10.1371/journal.pone.0075884	1932-6203	PLOS ONE	PLOS ONE: Downregulation of DAB2IP Promotes Mesenchymal-To-Neuroepithelial Transition and Neuronal Differentiation of Human Mesenchymal Stem Cells	Chang	2013	4		ACTB,SPZ1
895	chr25	40642946	40642991	3500062291	41		40642946	40642991	8421504	2	20,21	0,24	c	350006229100000023,350006229100000025	0-20,0-21						Cop1 molecules and uses thereof	Dixit	2007	0		SPZ1
895	chr25	40642947	40643125	3500403780	40		40642947	40643125	8421504	2	20,20	0,158	c,g	350040378000000002,350040378000000002,350040378000000003	0-20,0-20,0-20						Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression. - ResearchGate	.researchgate.net	0	0		ACTB
895	chr25	40642947	40643125	3500088139	40		40642947	40643125	8421504	2	20,20	0,158	c,g	350008813900000004,350008813900000004,350008813900000005	0-20,0-20,0-20						Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cells	-publications.com	0	0		ACTB
895	chr25	40642947	40643125	3500086203	40		40642947	40643125	8421504	2	20,20	0,158	c,g	350008620300000004,350008620300000004,350008620300000005	0-20,0-20,0-20				2049-9450	Molecular and Clinical Oncology	Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cells	Cornelio	2013	0		ACTB
895	chr25	40642947	40643098	3500367367	43		40642947	40643098	8421504	2	20,23	0,128	c,g	350036736700000000,350036736700000000,350036736700000001	0-20,0-20,0-23		23598406	10.1038/cddis.2013.115	false	Cell Death & Disease	Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes	Rippo	2013	0		
895	chr25	40642947	40643098	3500080738	43		40642947	40643098	8421504	2	20,23	0,128	c,g	350008073800000000,350008073800000000,350008073800000001	0-20,0-20,0-23		23598406	10.1038/cddis.2013.115		Cell Death & Disease	Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes	M	2013	0		
895	chr25	40642947	40642971	3500343344	24		40642947	40642971	8421504	1	24	0	c,g	350034334400000007,350034334400000007	0-24,0-24						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose	www.medsci.org	0	0		ACTB,SPZ1
895	chr25	40642949	40642973	3500125719	24		40642949	40642973	8421504	1	24	0	c	350012571900000007	0-24						1,25-dihydroxyvitamin D inhibits renal interstitial myo&#xfb01;broblast activation by inducing hepatocyte growth factor expression	www.cmdrchina.org	0	0		SPZ1
895	chr25	40642950	40643097	3500462517	43		40642950	40643097	8421504	2	20,23	0,124	c	350046251700000000,350046251700000001	0-20,0-23			10.2353/ajpath.2007.060452		The American Journal of Pathology	Distinctive Epidermal Growth Factor Receptor/Extracellular Regulated Kinase-Independent and -Dependent Signaling Pathways in the Induction of Airway Mucin 5B and Mucin 5AC Expression by Phorbol 12-Myristate 13-Acetate	Daphne	2007	0		ACTB
895	chr25	40642950	40643097	3500446535	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350044653500000000,350044653500000000,350044653500000001	0-20,0-20,0-23						Hiv-1 Latency Model For High Throughput Screening 	.freshpatents.com	0	0		ACTB
895	chr25	40642950	40643097	3500444345	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350044434500000010,350044434500000010,350044434500000011	0-20,0-20,0-23						Effect of Costunolide and Dehydrocostus Lactone on Cell Cycle, Apoptosis, and ABC Transporter Expression in Human Soft Tissue Sarcoma Cells. - ResearchGate	.researchgate.net	0	0		SPZ1
895	chr25	40642950	40643097	3500434254	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350043425400000000,350043425400000000,350043425400000001	0-20,0-20,0-23						EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells. - ResearchGate	.researchgate.net	0	0		
895	chr25	40642950	40643097	3500431074	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350043107400000004,350043107400000004,350043107400000005	0-20,0-20,0-23						August | 2013 | Online Peptides Guide	www.amyloid.biz	0	0		
895	chr25	40642950	40643097	3500408931	43		40642950	40643097	8421504	2	20,23	0,124	c	350040893100000004,350040893100000005	0-20,0-23						hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics	al.physiology.org	0	0		SPZ1
895	chr25	40642950	40643097	3500391727	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350039172700000002,350039172700000002,350039172700000003	0-20,0-20,0-23			10.1016/j.febslet.2004.12.052		FEBS letters	Endogenous nitric oxide activation protects against cigarette smoking induced apoptosis in endothelial cells	Muthuswamy	2005	0		SPZ1
895	chr25	40642950	40643097	3500366812	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350036681200000004,350036681200000004,350036681200000005	0-20,0-20,0-23		18452581	10.1111/j.1538-7836.2008.03000.x	1538-7836	Journal of Thrombosis and Haemostasis	&#x03b2;2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain - YU - 2008 - Journal of Thrombosis and Haemostasis - Wiley Online Library	YU	2008	0		SPZ1
895	chr25	40642950	40643097	3500362537	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350036253700000000,350036253700000000,350036253700000001	0-20,0-20,0-23			10.1165/rcmb.2007-0145OC		American Journal of Respiratory Cell and Molecular Biology	PMA Stimulates MUC5B Gene Expression through an Sp1-Based Mechanism in Airway Epithelial Cells	Daphne	2007	0		ACTB
895	chr25	40642950	40643097	3500325683	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350032568300000004,350032568300000004,350032568300000005	0-20,0-20,0-23		18715936	10.1152/ajprenal.90405.2008		American Journal of Physiology - Renal Physiology	hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics	Wieser	2008	0		
895	chr25	40642950	40643097	3500315538	43		40642950	40643097	8421504	2	20,23	0,124	c	350031553800000000,350031553800000001	0-20,0-23			10.1016/j.thromres.2007.09.006		Thrombosis research	C-reactive protein increases plasminogen activator inhibitor&#x2013;1 expression in human endothelial cells	Changyi	2008	0		ACTB
895	chr25	40642950	40643097	3500285768	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350028576800000012,350028576800000012,350028576800000013	0-20,0-20,0-23		20048160	10.1074/jbc.M109.055087		The Journal of Biological Chemistry	Androgen Receptor-dependent Transactivation of Growth Arrest-specific Gene 6 Mediates Inhibitory Effects of Testosterone on Vascular Calcification	Bo-Kyung	2010	0		
895	chr25	40642950	40643097	3500266378	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350026637800000001,350026637800000001,350026637800000002	0-20,0-20,0-23		23197643	10.5966/sctm.2011-0007		Stem Cells Translational Medicine	Upregulating CXCR4 in Human Fetal Mesenchymal Stem Cells Enhances Engraftment and Bone Mechanics in a Mouse Model of Osteogenesis Imperfecta	Gemma	2012	0		
895	chr25	40642950	40643097	3500243960	43		40642950	40643097	8421504	2	20,23	0,124	c	350024396000000000,350024396000000001	0-20,0-23		22984580	10.1371/journal.pone.0044873		PLoS ONE	Systematic Analysis of Small RNAs Associated with Human Mitochondria by Deep Sequencing: Detailed Analysis of Mitochondrial Associated miRNA	Lakshmi	2012	0		ACTB
895	chr25	40642950	40643097	3500227370	43		40642950	40643097	8421504	2	20,23	0,124	c	350022737000000001,350022737000000002	0-20,0-23		23197643	10.5966/sctm.2011-0007	2157-6564	Stem Cells Translational Medicine	Upregulating CXCR4 in Human Fetal Mesenchymal Stem Cells Enhances Engraftment and Bone Mechanics in a Mouse Model of Osteogenesis Imperfecta	Jones	2012	0		SPZ1
895	chr25	40642950	40643097	3500205254	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350020525400000004,350020525400000004,350020525400000005	0-20,0-20,0-23		18715936	10.1152/ajprenal.90405.2008		American Journal of Physiology - Renal Physiology	hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics	Wieser	2008	0		
895	chr25	40642950	40643097	3500204618	43		40642950	40643097	8421504	2	20,23	0,124	c	350020461800000004,350020461800000005	0-20,0-23						hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics	al.physiology.org	0	0		SPZ1
895	chr25	40642950	40643097	3500199277	43		40642950	40643097	8421504	2	20,23	0,124	c	350019927700000004,350019927700000005	0-20,0-23		18715936	10.1152/ajprenal.90405.2008		American Journal of Physiology - Renal Physiology	hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics	Wieser	2008	0		ACTB
895	chr25	40642950	40643097	3500194180	43		40642950	40643097	8421504	2	20,23	0,124	c	350019418000000004,350019418000000005	0-20,0-23		18715936	10.1152/ajprenal.90405.2008		American Journal of Physiology - Renal Physiology	hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics	Wieser	2008	0		
895	chr25	40642950	40643097	3500157852	43		40642950	40643097	8421504	2	20,23	0,124	c	350015785200000004,350015785200000005	0-20,0-23						Matthias Wieser, Guido Stadler, Paul Jennings, Berthold Streubel, Walter Pfaller, Peter Ambros, Claus Riedl, Hermann Katinger, Johannes Grillari and Regina Grillari-Voglauer	www.evercyte.eu	0	0		
895	chr25	40642950	40643097	3500126139	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350012613900000000,350012613900000000,350012613900000001	0-20,0-20,0-23						HIV-1 LATENCY MODEL FOR HIGH THROUGHPUT SCREENING	Dougherty	2006	0		ACTB
895	chr25	40642950	40643097	3500102882	43		40642950	40643097	8421504	2	20,23	0,124	c	350010288200000002,350010288200000003	0-20,0-23		19194824	10.1080/07357900802254016		Cancer investigation	Thymosin beta 10 is Aberrantly Expressed in Pancreatic Cancer and Induces JNK Activation	Min	2009	0		SPZ1
895	chr25	40642950	40643097	3500081608	43		40642950	40643097	8421504	2	20,23	0,124	c	350008160800000000,350008160800000001	0-20,0-23						An hiv-1 latency model for high throughput screening	Dougherty	2008	0		CNR1,SPZ1
895	chr25	40642950	40643097	3500064984	43		40642950	40643097	8421504	2	20,23	0,124	c	350006498400000000,350006498400000001	0-20,0-23		18562542	10.1128/JVI.00108-08		Journal of Virology	Measles Virus Circumvents the Host Interferon Response by Different Actions of the C and V Proteins 	Yuichiro	2008	0		
895	chr25	40642950	40643097	3500045086	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350004508600000002,350004508600000002,350004508600000003	0-20,0-20,0-23						Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma	ecular-cancer.com	0	0		
895	chr25	40642950	40643097	3500021098	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350002109800000015,350002109800000015,350002109800000016	0-20,0-20,0-23						Aldehyde Dehydrogenase 1, a Potential Marker for Cancer Stem Cells in Human Sarcoma	.researchgate.net	0	0		
895	chr25	40642950	40643097	3500019941	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350001994100000008,350001994100000008,350001994100000009	0-20,0-20,0-23			10.1002/cncr.21862	1097-0142	Cancer	Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147 - Li - 2006 - Cancer - Wiley Online Library	Li	2006	0		SPZ1
895	chr25	40642950	40643097	3500010280	43		40642950	40643097	8421504	2	20,23	0,124	c,g	350001028000000017,350001028000000017,350001028000000018	0-20,0-20,0-23						Free Radical Biology & Medicine	libir.tmu.edu.tw	0	0		ACTB
895	chr25	40642984	40643328	3500173290	49		40642984	40643328	8421504	2	25,24	0,320	c	350017329000000002,350017329000000003	0-25,0-24		17449545	10.1152/ajpheart.01141.2006		American Journal of Physiology - Heart and Circulatory Physiology	Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities	Fukatsu	2007	0		
895	chr25	40642984	40643328	3500066975	49		40642984	40643328	8421504	2	25,24	0,320	c	350006697500000002,350006697500000003	0-25,0-24		17449545	10.1152/ajpheart.01141.2006		American Journal of Physiology - Heart and Circulatory Physiology	Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities	Fukatsu	2007	0		
895	chr25	40642984	40643009	3500409024	25		40642984	40643009	8421504	1	25	0	c,g	350040902400000004,350040902400000004	0-25,0-25			10.1124/jpet.106.111641	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	17&#x03b2;-Estradiol Antagonizes the Down-Regulation of Endothelial Nitric-Oxide Synthase and GTP Cyclohydrolase I by High Glucose: Relevance to Postmenopausal Diabetic Cardiovascular Disease	Miyazaki-Akita	2007	0		
895	chr25	40643074	40643097	3500195174	23		40643074	40643097	8421504	1	23	0	c	350019517400000001	0-23		19074877	10.1158/0008-5472.CAN-08-1839	0008-5472	Cancer Research	Hypoxia-Inducible Factor 1&#x03b1; Mediates Anoikis Resistance via Suppression of &#x03b1;5 Integrin	Rohwer	2008	8		
895	chr25	40643074	40643097	3500159555	23		40643074	40643097	8421504	1	23	0	c	350015955500000017	0-23						Simone Kaiser: Identification and Characterization of the Ion Channel TRPM8 in Prostate Cancer	edoc.hu-berlin.de	0	0		CNR1,ACTB
895	chr25	40643075	40643176	3500170945	44		40643075	40643176	8421504	2	23,21	0,80	c	350017094500000000,350017094500000001	0-23,0-21						Prolonged Postovulatory Proin&#xfb02;ammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis	.aacrjournals.org	0	0		KIAA1279
895	chr25	40643111	40643134	3500239775	23		40643111	40643134	8421504	1	23	0	c	350023977500000005	0-23						Genes and polypeptides relating to prostate cancers	Katagiri	2005	0		ACTB
895	chr25	40643111	40643134	3500237507	23		40643111	40643134	8421504	1	23	0	c	350023750700000003	0-23						Genes and polypeptides relating to human myeloid leukemia	Katagiri	2004	0		SPZ1
895	chr25	40643111	40643134	3500201448	23		40643111	40643134	8421504	1	23	0	c	350020144800000135,350020144800000647	0-23,0-23						METHOD OF DIAGNOSING BLADDER CANCER - Patent application	www.faqs.org	0	0		POTEG,ACTB
895	chr25	40643111	40643134	3500131160	23		40643111	40643134	8421504	1	23	0	c	350013116000000136	0-23						Method of diagnosing bladder cancer	Nakamura	2012	0		POTEF
895	chr25	40643111	40643134	3500084295	23		40643111	40643134	8421504	1	23	0	c	350008429500000039,350008429500000087	0-23,0-23					Patent	Genes and polypeptides relating to human pancreatic cancer (Patent CN:1703524)	Zhong Cun You Fu 	2010	0		POTEM
895	chr25	40643111	40643134	3500037834	23		40643111	40643134	8421504	1	23	0	c	350003783400000053,350003783400000023	0-23,0-23						GENES AND POLYPEPTIDES RELATING TO HUMAN PANCREATIC CANCERS - Patent application	www.faqs.org	0	0		SPZ1
895	chr25	40643111	40643134	3500031741	23		40643111	40643134	8421504	1	23	0	c	350003174100000135	0-23						METHOD OF DIAGNOSING BLADDER CANCER	Nakamura	2006	0		POTEM
895	chr25	40643289	40643312	3500128684	23		40643289	40643312	8421504	1	23	0	c	350012868400000018	0-23						Ubiquitin-proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase	cs.biologists.org	0	0		ACTB
895	chr25	40643291	40643391	3500466894	49		40643291	40643391	8421504	2	24,25	0,75	c,g	350046689400000000,350046689400000001,350046689400000001	0-24,0-25,0-25		21042291	10.1038/labinvest.2010.184	0023-6837	Laboratory Investigation	Evidence for enhanced tissue factor expression in age-related macular degeneration	Cho	2010	4		
895	chr25	40643291	40643391	3500290805	49		40643291	40643391	8421504	2	24,25	0,75	c	350029080500000000,350029080500000001	0-24,0-25		21042291	10.1038/labinvest.2010.184		Laboratory investigation; a journal of technical methods and pathology	Evidence for Enhanced Tissue Factor Expression in Age-related Macular Degeneration	Youngeun	2011	0		ACTB
895	chr25	40643291	40643391	3500283463	49		40643291	40643391	8421504	2	24,25	0,75	c	350028346300000000,350028346300000001	0-24,0-25		21042291	10.1038/labinvest.2010.184	0023-6837	Laboratory Investigation	Evidence for enhanced tissue factor expression in age-related macular degeneration	Cho	2010	4		ACTB
895	chr25	40643291	40643391	3500221168	49		40643291	40643391	8421504	2	24,25	0,75	c	350022116800000010,350022116800000011	0-24,0-25		20361964	10.1016/j.exer.2010.03.016		Experimental eye research	The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice	Xiaoguang	July	0		
895	chr25	40643291	40643391	3500199484	49		40643291	40643391	8421504	2	24,25	0,75	c	350019948400000000,350019948400000001	0-24,0-25		21042291	10.1038/labinvest.2010.184	0023-6837	Laboratory Investigation	Evidence for enhanced tissue factor expression in age-related macular degeneration	Cho	2010	4		ACTB
895	chr25	40643358	40643391	3500063045	33		40643358	40643391	8421504	1	33	0	c	350006304500000003	1-34		18006926	10.1158/1055-9965.EPI-06-0740	1055-9965	Cancer Epidemiology Biomarkers & Prevention	Galanin Is Up-Regulated in Colon Adenocarcinoma	Kim	2007	4		
895	chr25	40643366	40643390	3500399885	24		40643366	40643390	8421504	1	24	0	c	350039988500000004	0-24		20534813	10.1091/mbc.E10-01-0049	1059-1524	Molecular Biology of the Cell	Acid Activation of Trpv1 Leads to an Up-Regulation of Calcitonin Gene-related Peptide Expression in Dorsal Root Ganglion Neurons via the CaMK-CREB Cascade: A Potential Mechanism of Inflammatory Pain	Nakanishi	2010	5		ACTB
895	chr25	40643366	40643390	3500393965	24		40643366	40643390	8421504	1	24	0	c	350039396500000006	0-24						Resistance to telomerase inhibition by human squamous cell carcinoma cell lines	-publications.com	0	0		ACTB
895	chr25	40643366	40643390	3500385176	24		40643366	40643390	8421504	1	24	0	c,g	350038517600000003,350038517600000003	0-24,0-24		18443043	10.1128/MCB.01489-07		Molecular and Cellular Biology	Extracellular Signals Regulate Rapid Coactivator Recruitment at AP-1 Sites by Altered Phosphorylation of both CREB Binding Protein and c-jun 	Linh	July	0		RAPGEF6
895	chr25	40643366	40643390	3500194979	24		40643366	40643390	8421504	1	24	0	c	350019497900000003	0-24		17400812	10.1677/JOE-06-0029	0022-0795	Journal of Endocrinology	Coactivator-mediated estrogen response in human squamous cell carcinoma lines	Ku	2007	4		ACTB
895	chr25	40643366	40643390	3500186425	24		40643366	40643390	8421504	1	24	0	c	350018642500000003	0-24		18443043	10.1128/MCB.01489-07	0270-7306	Molecular and Cellular Biology	Extracellular Signals Regulate Rapid Coactivator Recruitment at AP-1 Sites by Altered Phosphorylation of both CREB Binding Protein and c-jun	Tsai	2008	6		
895	chr25	40643366	40643390	3500081218	24		40643366	40643390	8421504	1	24	0	c	350008121800000012	0-24						3780 Research Article	cs.biologists.org	0	0		ACTB
895	chr25	40643370	40643395	3500277668	25		40643370	40643395	8421504	1	25	0	c	350027766800000029	0-25						320-022125 FOCUS 25	ww.invitrogen.com	0	0		SPZ1,TP53BP2
895	chr25	40720133	40720158	3500135302	23		40720133	40720158	8421504	2	13,10	0,15	g	350013530200000053	7-30						Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays - Patent application	www.faqs.org	0	0		
895	chr25	40745056	40745081	3500349107	24		40745056	40745081	8421504	2	5,19	0,6	g	350034910700000020	8-32						Methods for determining tyrosine-DNA phosphodiesterase activity	Kan	2002	0		
896	chr25	40884030	40884057	3500031097	24		40884030	40884057	8421504	3	5,13,6	0,6,21	c	350003109700000001	6-30		21079797	10.1371/journal.pone.0013834		PLoS ONE	Anti-Tumor Effect in Human Lung Cancer by a Combination Treatment of Novel Histone Deacetylase Inhibitors: SL142 or SL325 and Retinoic Acids	Shaoteng	2010	0		
897	chr25	40990588	40990615	3500117717	26		40990588	40990615	8421504	2	13,13	0,14	c	350011771700000000	0-26						Protein tag-mediated conjugation of oligonucleotides to recombinant affinity binders for proximity ligation. - ResearchGate	.researchgate.net	0	0		
899	chr25	41208448	41208476	3500021212	23		41208448	41208476	8421504	2	13,10	0,18	g	350002121200000000	0-26			10.1111/j.1365-2958.2007.05638.x	1365-2958	Molecular Microbiology	OmpC and the &#x03c3;E regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82 - Rolhion - 2007 - Molecular Microbiology - Wiley Online Library	Rolhion	2007	0		
899	chr25	41286133	41286158	3500351507	23		41286133	41286158	8421504	2	8,15	0,10	g	350035150700000019	1-24						Journal of Virological Methods	005.pasteur.ac.ir	0	0		
900	chr25	41387770	41387796	3500121839	23		41387770	41387796	8421504	2	17,6	0,20	g	350012183900000167	0-25						DIRECTED EVOLUTION OF NOVEL BINDING PROTEINS	Ladner	2007	0		
901	chr25	41482365	41482388	3500332833	23		41482365	41482388	8421504	1	23	0	g	350033283300000158	13-48						Heat tolerant phytases	Loon	2000	0		
901	chr25	41537792	41537820	3500400238	23		41537792	41537820	8421504	2	13,10	0,18	g	350040023800000144	21-44						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
902	chr25	41657309	41657333	3500420424	23		41657309	41657333	8421504	2	17,6	0,18	g	350042042400000002	8-31						Yair Benita	.bivas-benita.org	0	0		
903	chr25	41758425	41758449	3500440276	23		41758425	41758449	8421504	2	17,6	0,18	g	350044027600000179	6-32					Patent	Kunitz domain peptides (Patent US:6989369)	Ladner	2006	0		
903	chr25	41758425	41758449	3500327539	23		41758425	41758449	8421504	2	17,6	0,18	g	350032753900000162	6-32						Albumin-Fused Kunitz Domain Peptides - Patent application	www.faqs.org	0	0		
907	chr25	42332235	42332376	3500318543	141		42332235	42332376	8421504	1	141	0	p	350031854300015043	0-141						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		CARD11
908	chr25	42357376	42358879	3500287183	66		42357376	42358879	8421504	2	6,60	0,1443	p	350028718300015003	3-69						PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. - ResearchGate	.researchgate.net	0	0		CARD11
908	chr25	42357376	42358879	3500071292	66		42357376	42358879	8421504	2	6,60	0,1443	p	350007129200015001	3-69		16301747	10.1084/jem.20051591	0022-1007	The Journal of Experimental Medicine	PKC&#x03b2; regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1	Shinohara	2005	14		CARD11
909	chr25	42511048	42511102	3500365756	54		42511048	42511102	8421504	1	54	0	c	350036575600000005	17-71		20958291	10.1111/j.1476-5381.2010.01082.x		British Journal of Pharmacology	Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via G&#x03b1;13 and &#x03b2;-arrestin-2	Laura	2011	0		
909	chr25	42511065	42511102	3500202278	37		42511065	42511102	8421504	1	37	0	c,g	350020227800000001,350020227800000001,350020227800000000	9-46,9-46,15-51		21901169	10.1177/1947601911419362		Genes & Cancer	Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene G&#x03b1;12 	Zachariah	2011	0		GNA12
909	chr25	42511066	42511100	3500408239	34		42511066	42511100	8421504	1	34	0	c,g	350040823900000021,350040823900000021	0-34,0-34						Method for identifying modulators of G protein coupled receptor signaling	Gilchrist	2003	0		GNA12
909	chr25	42511066	42511100	3500300392	34		42511066	42511100	8421504	1	34	0	c,g	350030039200000008,350030039200000017,350030039200000017	0-21,0-34,0-34						Method for identifying inhibitors of g protein coupled receptor signaling	Gilchrist	2002	0		GNA12
909	chr25	42511066	42511100	3500265391	34		42511066	42511100	8421504	1	34	0	c,g	350026539100000021,350026539100000021	0-34,0-34					Patent	Method for identifying modulators of G protein coupled receptor signaling (Patent US:7294472)	Gilchrist	2007	0		GNA12
909	chr25	42511066	42511100	3500124927	34		42511066	42511100	8421504	1	34	0	c,g	350012492700000022,350012492700000022	0-34,0-34						Method for identifying inhibitors of G protein coupled receptor signaling - US Patent 7208279 Description	ww.patentstorm.us	0	0		GNA12
909	chr25	42511071	42511099	3500439611	28		42511071	42511099	8421504	1	28	0	g	350043961100000201,350043961100000199	11-39,0-22						MINICELLS EXPRESSING ANTIBODIES OR DERIVATIVES THEREOF AND COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS	Sabbadini	2007	0		GNA12
909	chr25	42511071	42511099	3500365768	28		42511071	42511099	8421504	1	28	0	g	350036576800000103	11-39						Minicell compositions and methods	Berkley	2011	0		
909	chr25	42511078	42511103	3500197043	25		42511078	42511103	8421504	1	25	0	c	350019704300000009	9-34		12606754	10.1124/mol.63.3.478	1521-0111 (Online)	Molecular Pharmacology	Differential Requirement of G&#x03b1;12, G&#x03b1;13, G&#x03b1;q, and G&#x03b2;&#x03b3; for Endothelin-1-Induced c-Jun NH2-Terminal Kinase and Extracellular Signal-Regulated Kinase Activation	Arai	2003	0		
909	chr25	42551635	42551871	3500043838	25		42551635	42551871	8421504	4	14,4,2,5	0,18,228,231	c	350004383800000003	1-26		20166136	10.1002/pros.21132		The Prostate	Snail Transcription Factor Regulates Neuroendocrine Differentiation in LNCaP Prostate Cancer Cells	Danielle	June	0		
909	chr25	42556736	42556760	3500293106	23		42556736	42556760	8421504	2	9,14	0,10	c	350029310600000003	0-23		19420113	10.1152/ajprenal.00039.2009		American Journal of Physiology - Renal Physiology	Sp1 trans-activates the murine H+-K+-ATPase &#x03b1;2-subunit gene	Yu	2009	0		
909	chr25	42556736	42556760	3500097180	23		42556736	42556760	8421504	2	9,14	0,10	c	350009718000000002	0-23		19420113	10.1152/ajprenal.00039.2009		American Journal of Physiology - Renal Physiology	Sp1 trans-activates the murine H+-K+-ATPase &#x03b1;2-subunit gene	Zhiyuan	July	0		
910	chr25	42709361	42709851	3500233653	489		42709361	42709851	8421504	2	420,69	0,421	c	350023365300000010,350023365300000001	0-489,19-41						in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biological Engineering	dspace.mit.edu	0	0		
911	chr25	42753538	42753566	3500234636	23		42753538	42753566	8421504	2	13,10	0,18	g	350023463600000097	1-24						Recombinant anti-epidermal growth factor receptor antibody compositions	Ke Lao Si *Kai Fu De 	2010	0		
911	chr25	42773126	42784307	3500438386	61		42773126	42784307	8421504	3	19,6,36	0,10948,11145	c	350043838600000070,350043838600000034	20-39,0-42						US Patent # 6,316,225. Human Prt1-like subunit protein (hPrt1) polynucleotides - Patents.com	www.patents.com	0	0		
911	chr25	42773928	42773952	3500347340	23		42773928	42773952	8421504	2	18,5	0,19	c	350034734000000233	0-24						Human platelet-derived growth factor receptors	Williams	1995	0		
911	chr25	42773928	42773952	3500054009	23		42773928	42773952	8421504	2	18,5	0,19	c	350005400900000162	0-24						US Patent # 5,686,572. Domains of extracellular region of human platelet derived growth factor receptor polypeptides - Patents.com	www.patents.com	0	0		PIGU
912	chr25	42921419	42921444	3500304175	24		42921419	42921444	8421504	2	13,11	0,14	g	350030417500000005	0-24		11226178	10.1093/emboj/20.1.285	ERROR! NO ISSN	The EMBO Journal	The SurA periplasmic PPIase lacking its parvulin domains functions in vivo and has chaperone activity	Behrens	2001	0		
913	chr25	43109292	43109318	3500139688	23		43109292	43109318	8421504	2	18,5	0,21	c	350013968800000071	6-30						TRANSPORTER GENES OATP-B, C, D, AND E - Patent application	www.faqs.org	0	0		
914	chr25	43230435	43230461	3500334664	24		43230435	43230461	8421504	2	16,8	0,18	g	350033466400000092	10-34						Expression Cassettes for Seed-Preferential Expression in Plants - Patent application	www.faqs.org	0	0		
915	chr25	43276439	43276465	3500129188	24		43276439	43276465	8421504	2	15,9	0,17	g	350012918800000001	3-27		17541429	10.1038/sj.cdd.4402157	1350-9047	Cell Death & Differentiation	Positive regulation of ASK1-mediated c-Jun NH2-terminal kinase signaling pathway by the WD-repeat protein Gemin5	Kim	2007	9		
916	chr25	43388949	43388974	3500395280	23		43388949	43388974	8421504	2	17,6	0,19	c,g	350039528000000230,350039528000000230	23-48,23-48						Method of providing a hybrid polypeptide exhibiting an activity of interest - Patent # 6270968 - PatentGenius	.patentgenius.com	0	0		
917	chr25	43554648	43554671	3500434038	23		43554648	43554671	8421504	1	23	0	g	350043403800000000	8-32						Biofilm formation by Staphylococcus haemolyticus. - ResearchGate	.researchgate.net	0	0		
918	chr25	43691195	43691220	3500048321	23		43691195	43691220	8421504	2	16,7	0,18	c	350004832100000096	0-23						Hbm variants that modulate bone mass and lipid levels	Allen	2002	0		
919	chr25	43810941	43812790	3500365673	40		43810941	43812790	8421504	3	20,12,8	0,85,1841	c,g	350036567300000003,350036567300000003,350036567300000002	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
919	chr25	43810941	43812790	3500262357	40		43810941	43812790	8421504	3	20,12,8	0,85,1841	c,g	350026235700000003,350026235700000003,350026235700000002	0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
919	chr25	43812804	43812830	3500421437	25		43812804	43812830	8421504	2	17,8	0,18	c	350042143700000001	1-26						REGULATION OF PDGF CHAIN AND RECEPTOR EXPRESSION IN HUMAN MALIGNANT MESOTHELIOMA CELL LINES	repub.eur.nl	0	0		
919	chr25	43825315	43825355	3500048156	40		43825315	43825355	8421504	1	40	0	c	350004815600000025	8-48						Methods For Suppressing Tumor Proliferation - Patent application	www.faqs.org	0	0		
919	chr25	43874973	43875005	3500395463	25		43874973	43875005	8421504	3	14,3,8	0,17,24	g	350039546300000022	14-39						Methods for enhancement of protective immune responses	Reed	1999	0		
919	chr25	43883678	43883702	3500040355	23		43883678	43883702	8421504	2	11,12	0,12	g	350004035500000396,350004035500000435,350004035500000420,350004035500000411	7-30,7-39,7-30,7-39						RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)	Mcswiggen	2006	0		
919	chr25	43908750	43908775	3500126601	24		43908750	43908775	8421504	2	8,16	0,9	g	350012660100000071	6-33						Polypeptides Having Phytase Activity And Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
586	chr26	158027	158054	3500127263	25		158027	158054	8421504	3	5,5,15	0,6,12	g	350012726300000002	1-26						Trace Analysis With Nanomaterials	www.scribd.com	0	0		
587	chr26	273316	273340	3500039576	24		273316	273340	8421504	1	24	0	g	350003957600000215	0-24						METHOD FOR DIAGNOSING A PREDISPOSITION FOR BREAST AND OVARIAN CANCER - MYRIAD GENETICS, INC	www.sumobrain.com	0	0		
590	chr26	778887	778912	3500153821	23		778887	778912	8421504	3	5,6,12	0,6,13	g	350015382100000122	0-23						Neisserial antigens	Scarlato	1999	0		
73	chr26	786018	789623	3500214246	180		786018	789623	8421504	3	87,78,15	0,1496,3590	p	350021424600015063	0-180						Alignement multiple ClustalW	polytech.unice.fr	0	0		
592	chr26	926688	926711	3500337652	23		926688	926711	8421504	1	23	0	c	350033765200000021	1-24		16247451	10.1038/sj.onc.1209169	0950-9232	Oncogene	RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors	Morgan-Lappe	2005	6		
593	chr26	1163117	1163150	3500293493	25		1163117	1163150	8421504	3	8,12,5	0,13,28	g	350029349300000004	3-28					Patent	Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis (Patent EP:0711349)	Denoya	2003	0		
601	chr26	2107489	2107513	3500263287	23		2107489	2107513	8421504	2	17,6	0,18	g	350026328700000002	4-29		17099778	10.1172/JCI27702	0021-9738	The Journal of Clinical Investigation	TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling	Kuwahara	2006	13		
605	chr26	2715317	2715438	3500259232	121		2715317	2715438	8421504	1	121	0	g	350025923200000037	0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
605	chr26	2715317	2715438	3500000589	103		2715317	2715438	8421504	2	83,20	0,101	g	350000058900000063,350000058900000064	0-84,0-20						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
608	chr26	3059189	3059217	3500301186	24		3059189	3059217	8421504	3	12,8,4	0,15,24	g	350030118600000072,350030118600000020	0-24,0-24						PFU REPLICATION ACCESSORY FACTORS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
608	chr26	3059189	3059217	3500260579	24		3059189	3059217	8421504	3	12,8,4	0,15,24	g	350026057900000021	0-24						Pfu replication accessory factors and methods of use	Hogrefe	2004	0		
610	chr26	3366986	3367009	3500341507	23		3366986	3367009	8421504	1	23	0	g	350034150700000003	0-23		11121413	10.1074/jbc.M009378200	0021-9258	Journal of Biological Chemistry	Mutational and X-ray Crystallographic Analysis of the Interaction of Dihomo-&#x03b3;-linolenic Acid with Prostaglandin Endoperoxide H Synthases	Thuresson	2001	5		
612	chr26	3540710	3540733	3500227126	23		3540710	3540733	8421504	1	23	0	g	350022712600000168	11-34						Novel expressed sequence tag- simple sequence repeats (EST-SSR) markers characterized by new bioinformatic criteria reveal high genetic similarity in sugarcane ( Saccharum spp.) breeding lines	demicjournals.org	0	0		
620	chr26	4623659	4623693	3500113337	30		4623659	4623693	8421504	3	17,5,8	0,20,26	g	350011333700000015	9-39						 Expression Of Tetanus Toxin Fragment C 	www.docstoc.com	0	0		
629	chr26	5870658	5876053	3500112685	39		5870658	5876053	8421504	2	20,19	0,5376	c,g	350011268500000010,350011268500000011,350011268500000011	0-20,0-19,0-19						Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle	web1.sssup.it	0	0		
629	chr26	5877300	5879234	3500077888	42		5877300	5879234	8421504	3	15,6,21	0,1898,1913	c,g	350007788800000026,350007788800000027,350007788800000027	0-21,0-21,0-21						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
634	chr26	6506683	6506708	3500446649	24		6506683	6506708	8421504	2	19,5	0,20	g	350044664900000022	1-26						Chimeric sindbis-eastern equine encephalitis virus and uses thereof	Frolov	2006	0		
635	chr26	6591167	6591195	3500453101	24		6591167	6591195	8421504	2	14,10	0,18	c	350045310100000132	20-45						 Nucleotide Sequences Encoding Anthonomous Toxic Polypeptides From Bacillus Thuringiensis 	www.docstoc.com	0	0		
637	chr26	6832629	6832657	3500430375	24		6832629	6832657	8421504	2	7,17	0,11	g	350043037500000034	4-28						KERATINOCYTE GROWTH FACTOR-2	Ruben	1999	0		
637	chr26	6832629	6832657	3500391004	24		6832629	6832657	8421504	2	7,17	0,11	g	350039100400000178,350039100400000146,350039100400000133,350039100400000017,350039100400000025	4-28,6-28,14-36,6-28,4-28						Therapeutic uses of keratinocyte growth factor-2	Jimenez	1999	0		
637	chr26	6832629	6832657	3500224761	24		6832629	6832657	8421504	2	7,17	0,11	g	350022476100000031	4-28						 Keratinocyte Growth Factor 	www.docstoc.com	0	0		
637	chr26	6832629	6832657	3500034980	24		6832629	6832657	8421504	2	7,17	0,11	g	350003498000000025	4-28						Keratinocyte growth factor-2 - US Patent 6916786 Description	ww.patentstorm.us	0	0		
639	chr26	7129647	7129670	3500340272	23		7129647	7129670	8421504	1	23	0	c	350034027200000032	12-35						Reagents and methods for modulating dkk-mediated interactions	Allen	2002	0		
639	chr26	7129647	7129670	3500148665	23		7129647	7129670	8421504	1	23	0	c	350014866500000032	12-35						Reagents and method for modulating Dkk-mediated interactions	Allen	2007	0		
639	chr26	7129648	7129673	3500150531	25		7129648	7129673	8421504	1	25	0	c	350015053100000078,350015053100000029	13-38,13-38						US Patent # 6,344,541. DKR polypeptides - Patents.com	www.patents.com	0	0		
639	chr26	7129648	7129673	3500003896	25		7129648	7129673	8421504	1	25	0	c	350000389600000029	13-38						Novel dkr polypeptides	Bass	2000	0		
639	chr26	7129661	7131875	3500219109	117		7129661	7131875	8421504	3	48,21,48	0,469,2166	c	350021910900000281,350021910900000274,350021910900000267	0-48,13-34,0-48						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
639	chr26	7129661	7129709	3500288139	48		7129661	7129709	8421504	1	48	0	c	350028813900000281	0-48						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
639	chr26	7129682	7131728	3500302241	72		7129682	7131728	8421504	2	48,24	0,2022	c	350030224100000110,350030224100000099	0-48,24-48						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
639	chr26	7129686	7129835	3500366673	50		7129686	7129835	8421504	2	25,25	0,124	c	350036667300000069,350036667300000068	0-25,0-25			10.1111/j.1365-2141.2006.06442.x	1365-2141	British Journal of Haematology	Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines - Nygren - 2006 - British Journal of Haematology - Wiley Online Library	Nygren	2007	0		
639	chr26	7131340	7131363	3500115651	23		7131340	7131363	8421504	1	23	0	c,g	350011565100000011,350011565100000011	0-23,0-23		19520846	10.1074/jbc.M109.014332	0021-9258	Journal of Biological Chemistry	Requirement of Cell Cycle and Apoptosis Regulator 1 for Target Gene Activation by Wnt and &#x03b2;-Catenin and for Anchorage-independent Growth of Human Colon Carcinoma Cells	Ou	2009	5		DKK1
639	chr26	7131670	7131744	3500388552	42		7131670	7131744	8421504	2	21,21	0,53	c,g	350038855200000007,350038855200000006	0-21,0-21						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
639	chr26	7131670	7131744	3500143254	42		7131670	7131744	8421504	2	21,21	0,53	c,g	350014325400000007,350014325400000006	0-21,0-21						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
639	chr26	7131924	7132061	3500382906	40		7131924	7132061	8421504	2	20,20	0,117	c,g	350038290600000009,350038290600000008,350038290600000008	0-20,0-20,0-20						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
639	chr26	7131924	7132061	3500143893	40		7131924	7132061	8421504	2	20,20	0,117	c,g	350014389300000009,350014389300000008,350014389300000008	0-20,0-20,0-20						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
639	chr26	7182385	7182414	3500324390	29		7182385	7182414	8421504	1	29	0	c	350032439000000006	0-29			10.1046/j.1432-1033.2003.03574.x	1432-1033	European Journal of Biochemistry	Phosphorylation of NF-&#x03ba;B proteins by cyclic GMP-dependent kinase - He - 2003 - European Journal of Biochemistry - Wiley Online Library	He	2003	0		
640	chr26	7233586	7233609	3500299586	23		7233586	7233609	8421504	1	23	0	c	350029958600000116,350029958600000118	13-36,12-33						Permuted and nonpermuted luciferase biosensors	Binkowski	2011	0		
640	chr26	7324110	7324136	3500092809	23		7324110	7324136	8421504	2	14,9	0,17	g	350009280900000027	15-38						Therapeutic uses of inhibitors of RTP801	Feinstein	2006	0		
643	chr26	7613660	7730656	3500299586	24		7613660	7730656	8421504	2	16,8	0,116988	c	350029958600000117	12-36						Permuted and nonpermuted luciferase biosensors	Binkowski	2011	0		PRKG1
643	chr26	7613660	7730656	3500299586	24		7613660	7730656	8421504	2	16,8	0,116988	c	350029958600000115	16-40						Permuted and nonpermuted luciferase biosensors	Binkowski	2011	0		
646	chr26	8026740	8026768	3500156713	23		8026740	8026768	8421504	2	13,10	0,18	g	350015671300000008	0-23						Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents	Katz	1997	0		
646	chr26	8112168	8112196	3500168261	24		8112168	8112196	8421504	3	13,4,7	0,14,21	g	350016826100000134,350016826100000023	11-36,0-25						Modified Proteases - Patent application	www.faqs.org	0	0		
649	chr26	8501071	8501094	3500438309	23		8501071	8501094	8421504	1	23	0	c	350043830900000024	0-23						Protein kinase G-mediated stimulation of basal Leydig cell steroidogenesis	g.library.pcc.edu	0	0		PRKG1
652	chr26	8847329	8847583	3500363497	50		8847329	8847583	8421504	2	25,25	0,229	c	350036349700000001,350036349700000000	0-25,0-25			10.1038/sj.bjp.0707600	1476-5381	British Journal of Pharmacology	Role of cGMP-dependent protein kinase in development of tolerance to nitroglycerine in porcine coronary arteries - Dou - 2009 - British Journal of Pharmacology - Wiley Online Library	Dou	2008	0		
652	chr26	8847329	8847354	3500345297	25		8847329	8847354	8421504	1	25	0	c,g	350034529700000001,350034529700000001	0-25,0-25		12754191	10.1152/ajplung.00411.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	Effect of oxygen on cyclic GMP-dependent protein kinase-mediated relaxation in ovine fetal pulmonary arteries and veins	Gao	2003	0		PRKG1
652	chr26	8847329	8847354	3500234692	25		8847329	8847354	8421504	1	25	0	c	350023469200000001	0-25		14660486	10.1152/ajplung.00314.2003		American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs	Gao	2004	0		PRKG1
652	chr26	8847329	8847354	3500205463	25		8847329	8847354	8421504	1	25	0	c	350020546300000001	0-25		14660486	10.1152/ajplung.00314.2003		American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs	Gao	2004	0		PRKG1
652	chr26	8847542	8847565	3500082013	23		8847542	8847565	8421504	1	23	0	c	350008201300000000	0-23		19359370	10.1113/jphysiol.2009.170324		The Journal of Physiology	Regulation of epithelial sodium channels by cGMP/PKGII	Hong-Guang	June	0		PRKG1
652	chr26	8847543	8847566	3500340082	23		8847543	8847566	8421504	1	23	0	c	350034008200000002	0-23						Molecular Medicine	s.ahajournals.org	0	0		PRKG1
652	chr26	8847543	8847566	3500233952	23		8847543	8847566	8421504	1	23	0	c,g	350023395200000002,350023395200000002	0-23,0-23		17901360	10.1161/CIRCRESAHA.107.154351	0009-7330	Circulation Research	Rescue of cGMP Kinase I Knockout Mice by Smooth Muscle&#x2013;Specific Expression of Either Isozyme	Weber	2007	9		PRKG1
654	chr26	9134783	9134808	3500148394	23		9134783	9134808	8421504	3	4,4,15	0,5,10	g	350014839400000149,350014839400000324,350014839400000234	16-39,25-48,28-47						Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	.freshpatents.com	0	0		
654	chr26	9143694	9143723	3500403241	23		9143694	9143723	8421504	3	4,12,7	0,5,22	g	350040324100000038,350040324100000088	7-31,7-31						Vectors With Viral Insulators 	.freshpatents.com	0	0		
655	chr26	9272081	9272106	3500426560	25		9272081	9272106	8421504	1	25	0	c	350042656000000001,350042656000000002	0-25,0-25						Sphingolipid-modulatedExosomeSecretionPromotes ClearanceofAmyloid- byMicroglia	www.jbc.org	0	0		SGMS1
655	chr26	9272081	9272106	3500203953	25		9272081	9272106	8421504	1	25	0	c,g	350020395300000000,350020395300000000,350020395300000001,350020395300000001	0-25,0-25,0-25,0-25						The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M111.324616	www.jbc.org	0	0		SGMS1
655	chr26	9272081	9272106	3500018514	25		9272081	9272106	8421504	1	25	0	c	350001851400000001,350001851400000000	0-25,0-25		22303002	10.1074/jbc.M111.324616	0021-9258	Journal of Biological Chemistry	Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-&#x03b2; by Microglia	Yuyama	2012	5		SGMS1
661	chr26	10069267	10069291	3500099266	23		10069267	10069291	8421504	2	15,8	0,16	g	350009926600000026	0-23						Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas	haematologica.org	0	0		
661	chr26	10069423	10069480	3500153033	56		10069423	10069480	8421504	2	26,30	0,27	g	350015303300000000,350015303300000002	0-26,0-30						METHODS OF USING OLIGOMERIC COMPOUNDS COMPRISING 2'-SUBSTITUTED NUCLEOSIDES - ISIS PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
661	chr26	10069423	10069480	3500115526	56		10069423	10069480	8421504	2	26,30	0,27	g	350011552600000007,350011552600000009	0-26,0-30						Bis-modified Bicyclic Nucleic Acid Analogs 	.freshpatents.com	0	0		PTENP1
661	chr26	10069423	10069480	3500074117	56		10069423	10069480	8421504	2	26,30	0,27	g	350007411700000000,350007411700000002	0-26,0-30						Methods of using oligomeric compounds comprising 2'-substituted nucleosides	Prakash	2010	0		PTENP1
82	chr26	10069475	10098611	3500156457	101		10069475	10098611	8421504	4	22,22,29,28	0,79,28092,29108	g	350015645700000006,350015645700000007,350015645700000002,350015645700000003	0-22,0-22,8-37,12-40		23617834	10.1186/1476-4598-12-30	1476-4598	Molecular Cancer	MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells	Wu	2013	4		
661	chr26	10069564	10084423	3500258049	47		10069564	10084423	8421504	3	23,4,20	0,24,14839	g	350025804900000051,350025804900000028	80-107,0-20						Double stranded compositions comprising a 3'-endo modified strand for use in gene modulation	Baker	2007	0		
661	chr26	10069564	10069592	3500271422	27		10069564	10069592	8421504	2	23,4	0,24	g	350027142200000047	80-107					Patent	Double stranded compositions comprising a 3&#x2032;-endo modified strand for use in gene modulation (Patent US:7790691)	Baker	2010	0		
661	chr26	10069564	10069592	3500237007	27		10069564	10069592	8421504	2	23,4	0,24	g	350023700700000049	80-107						Double stranded compositions comprising a 3&#x2019;-endo modified strand for use in gene modulation	Baker	2004	0		
661	chr26	10069564	10069592	3500157875	27		10069564	10069592	8421504	2	23,4	0,24	g	350015787500000047	80-107						 Double Stranded Compositions Comprising A 3' 	www.docstoc.com	0	0		
661	chr26	10069564	10069592	3500074986	27		10069564	10069592	8421504	2	23,4	0,24	g	350007498600000010,350007498600000009,350007498600000113,350007498600000103	0-20,0-20,13-40,0-19						Compositions comprising alternating 2'-modified nucleosides for use in gene modulation	Allerson	2005	0		
661	chr26	10069564	10069592	3500067605	27		10069564	10069592	8421504	2	23,4	0,24	g	350006760500000010,350006760500000009,350006760500000113,350006760500000034,350006760500000103	0-20,0-20,13-40,0-20,0-19						Compositions comprising alternating 2'-modified nucleosides for use in gene modulation	Allerson	2008	0		
661	chr26	10084432	10084457	3500016556	25		10084432	10084457	8421504	1	25	0	g	350001655600000009	0-25		24198842	10.1155/2013/349067	1740-2522	Clinical and Developmental Immunology	Lymphoid Progenitor Cells from Childhood Acute Lymphoblastic Leukemia Are Functionally Deficient and Express High Levels of the Transcriptional Repressor Gfi-1	Purizaca	2013	2		PTEN
661	chr26	10084463	10092495	3500162538	44		10084463	10092495	8421504	2	22,22	0,8010	g	350016253800000006,350016253800000007	0-22,0-22		16518410	10.1038/sj.onc.1209460	0950-9232	Oncogene	Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-&#x03ba;B	Han	2006	6		PTENP1
661	chr26	10084484	10089944	3500308274	49		10084484	10089944	8421504	2	28,21	0,5439	g	350030827400000000,350030827400000001	0-28,0-21		16418168	10.1074/jbc.M511105200	0021-9258	Journal of Biological Chemistry	Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling	Shen	2006	5		PTEN
661	chr26	10089944	10089971	3500457353	27		10089944	10089971	8421504	1	27	0	g	350045735300000001	43-70						Model For Studying The Role Of Genes In Chemoresistance 	.freshpatents.com	0	0		
661	chr26	10089944	10089971	3500402732	27		10089944	10089971	8421504	1	27	0	g	350040273200000001	43-70						Model for studying the role of genes in tumor resistance to chemotherapy	De	2005	0		
661	chr26	10089944	10089971	3500131707	27		10089944	10089971	8421504	1	27	0	g	350013170700000001,350013170700000003	43-70,43-70						Model for studying the role of genes in chemoresistance - Patent application	www.faqs.org	0	0		
662	chr26	10095128	10095151	3500068430	23		10095128	10095151	8421504	1	23	0	g	350006843000000015	21-44						The Role Of Intracellular Signalling Pathways In Conferring Resistance To Endocrine Therapies In Breast Cancer	.era.lib.ed.ac.uk	0	0		PTEN
662	chr26	10095393	10098611	3500253626	42		10095393	10098611	8421504	2	21,21	0,3197	g	350025362600000017,350025362600000018	0-21,0-21						MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF	Olson	2009	0		PTEN
662	chr26	10095393	10098611	3500215065	42		10095393	10098611	8421504	2	21,21	0,3197	g	350021506500000017,350021506500000018	0-21,0-21						MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION	Olson	2011	0		PTEN
662	chr26	10095393	10098611	3500183142	42		10095393	10098611	8421504	2	21,21	0,3197	g	350018314200000017,350018314200000018	0-21,0-21					Patent	Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof (Patent US:7994150)	Olson	2011	0		
662	chr26	10098098	10098333	3500326771	44		10098098	10098333	8421504	3	21,15,8	0,211,227	g	350032677100000010,350032677100000011	0-21,0-23		18632660	10.1074/jbc.M804236200	0021-9258	Journal of Biological Chemistry	Adiponectin Blocks Interleukin-18-mediated Endothelial Cell Death via APPL1-dependent AMP-activated Protein Kinase (AMPK) Activation and IKK/NF-&#x03ba;B/PTEN Suppression	Chandrasekar	2008	5		PTEN
664	chr26	10431693	10431719	3500403336	25		10431693	10431719	8421504	2	15,10	0,16	c	350040333600000202	13-38					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
664	chr26	10431693	10431719	3500339718	25		10431693	10431719	8421504	2	15,10	0,16	c	350033971800000114	13-38						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1998	0		
664	chr26	10431693	10431719	3500199448	25		10431693	10431719	8421504	2	15,10	0,16	c	350019944800000114	13-38						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1996	0		
664	chr26	10431693	10431719	3500126207	25		10431693	10431719	8421504	2	15,10	0,16	c	350012620700000202	13-38					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
664	chr26	10431693	10431719	3500095165	25		10431693	10431719	8421504	2	15,10	0,16	c	350009516500000124	13-38						Chromosome 13-linked breast cancer susceptibility gene		1997	0		
664	chr26	10431693	10431719	3500070162	25		10431693	10431719	8421504	2	15,10	0,16	c	350007016200000205	13-38					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6124104)	Couch	2000	0		
664	chr26	10431693	10431719	3500049566	25		10431693	10431719	8421504	2	15,10	0,16	c	350004956600000205	13-38					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
10	chr26	10431799	10710013	3500266732	261		10431799	10710013	8421504	7	88,18,30,48,32,16,29	0,136,26739,63097,63193,267681,278185	c	350026673200000030,350026673200000029,350026673200000027,350026673200000022,350026673200000020,350026673200000012	0-40,0-48,0-48,0-48,0-48,0-29						DETECTION, ISOLATION AND USES OF RENALASE (MONOAMINE OXIDASE C) - Patent application	www.faqs.org	0	0		
664	chr26	10461398	10461427	3500068063	24		10461398	10461427	8421504	3	5,6,13	0,6,16	g	350006806300000090	14-40						MICROBIAL SYNTHESIS OF D-1,2,4-BUTANETRIOL - Patent application	www.faqs.org	0	0		
666	chr26	10698441	10698465	3500068173	23		10698441	10698465	8421504	2	4,19	0,5	g	350006817300000015	3-26						HUMANIZED ANTI-CD47 ANTIBODY - Patent application	www.faqs.org	0	0		
83	chr26	10878240	10889407	3500326696	1193		10878240	10889407	8421504	9	102,118,199,110,137,147,72,72,236	0,317,1183,2472,5421,7431,8763,9254,10931	p,c,g	350032669600015003,350032669600000000,350032669600015011,350032669600000055,350032669600015008,350032669600015007,350032669600000026,350032669600015133,350032669600015012,350032669600015135,350032669600015013,350032669600015139,350032669600015015,350032669600000027,350032669600015141,350032669600015016,350032669600015143,350032669600015017,350032669600015145,350032669600015018,350032669600015149,350032669600015020,350032669600015153,350032669600015022,350032669600015155,350032669600015023,350032669600015159,350032669600015025,350032669600015161,350032669600015026,350032669600015163,350032669600015027,350032669600015165,350032669600015028,350032669600015169,350032669600015030,350032669600000028,350032669600000028,350032669600015171,350032669600000013,350032669600000044,350032669600015032,350032669600015175,350032669600015033,350032669600000001,350032669600000011	0-1191,18-39,0-45,72-1206,72-1206,72-1206,72-250,0-45,0-45,0-45,0-45,0-45,0-45,0-730,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-206,0-206,0-45,0-21,0-21,0-45,0-45,0-45,19-40,11-32						Use of Esterase Genes as Selectable Markers for Transforming Plant Cells - Patent application	www.faqs.org	0	0		
83	chr26	10878240	10889407	3500182582	1193		10878240	10889407	8421504	9	102,118,199,110,137,147,72,72,236	0,317,1183,2472,5421,7431,8763,9254,10931	p,c,g	350018258200000000,350018258200015003,350018258200000026,350018258200015008,350018258200015007,350018258200000027,350018258200000028,350018258200000028,350018258200000013,350018258200000013,350018258200000001,350018258200000011	18-39,0-1191,72-250,72-1206,72-1206,0-730,0-206,0-206,0-21,0-21,19-40,11-32						Use of Esterase Genes as Selectable Markers for Transforming Plant Cells	Gabriel	2008	0		
83	chr26	10878240	10889407	3500066069	1193		10878240	10889407	8421504	9	102,118,199,110,137,147,72,72,236	0,317,1183,2472,5421,7431,8763,9254,10931	p,c,g	350006606900000000,350006606900015012,350006606900000026,350006606900015020,350006606900015017,350006606900000013,350006606900000013,350006606900000001,350006606900000015,350006606900000011	18-39,0-1191,72-1206,3-1137,72-1206,0-21,0-21,19-40,6-27,11-32						USE OF ESTERASE GENES AS SELECTABLE MARKERS FOR TRANSFORMING PLANT CELLS - INTEGRATED PLANT GENETCS, INC.	www.sumobrain.com	0	0		
83	chr26	10878240	10889407	3500006182	1193		10878240	10889407	8421504	9	102,118,199,110,137,147,72,72,236	0,317,1183,2472,5421,7431,8763,9254,10931	p,c,g	350000618200015007,350000618200000000,350000618200015012,350000618200015011,350000618200000026,350000618200000027,350000618200000028,350000618200000028,350000618200000013,350000618200000001,350000618200000011	0-1191,18-39,72-1206,72-1206,72-250,0-730,0-206,0-206,0-21,19-40,11-32						Use of Esterase Genes as Selectable Markers for Transforming Plant Cells	Gabriel	2007	0		
668	chr26	10879463	10889353	3500337447	199		10879463	10889353	8421504	9	33,23,41,4,12,8,3,39,36	0,70,1318,4198,6343,7540,7609,8031,9854	c	350033744700000030,350033744700000053,350033744700000078,350033744700000015,350033744700000035,350033744700000041,350033744700000090,350033744700000069,350033744700000024	14-47,18-41,24-47,0-40,3-47,27-47,0-42,23-48,0-32						Lipases preduodenales recombinantes et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations	Baudino	1996	0		
668	chr26	10951096	10951125	3500337447	29		10951096	10951125	8421504	1	29	0	c	350033744700000055	18-47						Lipases preduodenales recombinantes et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations	Baudino	1996	0		
669	chr26	11135203	11135228	3500272022	23		11135203	11135228	8421504	2	7,16	0,9	g	350027202200000035	2-25						Zinc finger protein derivatives and methods therefor	Carlos	2000	0		
670	chr26	11174931	11174955	3500131497	24		11174931	11174955	8421504	1	24	0	c	350013149700000000	21-45						SIGNALING FROM MATRIX ELASTICITY AND TGF- 1 TO CELLS OF THE CARDIAC VALVE	gradworks.umi.com	0	0		ACTA2
670	chr26	11174938	11174961	3500333221	23		11174938	11174961	8421504	1	23	0	c	350033322100000006	0-23						CLIC4 mediates TGF-&#xdf;1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer	-publications.com	0	0		ACTA2
670	chr26	11174938	11174961	3500168712	23		11174938	11174961	8421504	1	23	0	c	350016871200000000	0-23		20533548	10.1002/ijc.25506	1097-0215	International Journal of Cancer	Micro-RNA-21 regulates TGF-&#x03b2;-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction - Yao - 2010 - International Journal of Cancer - Wiley Online Library	Yao	2011	0		ACTA2
670	chr26	11174938	11174961	3500125762	23		11174938	11174961	8421504	1	23	0	c	350012576200000004	0-23						Molecular Cancer BioMed Central	ecular-cancer.com	0	0		ACTA2
670	chr26	11174938	11174961	3500031195	23		11174938	11174961	8421504	1	23	0	c	350003119500000002	0-23						Expression of Actin Isoforms in Human Auricular Cartilage	fb.cuni.cz/Data/f	0	0		ACTA2
670	chr26	11175051	11175074	3500146034	23		11175051	11175074	8421504	1	23	0	c	350014603400000017	0-23		19864562	10.1523/JNEUROSCI.2243-09.2009		The Journal of neuroscience : the official journal of the Society for Neuroscience	ENDOGENOUS BDNF IN THE DORSOLATERAL STRIATUM GATES ALCOHOL DRINKING	Jerome	2009	0		ACTC1
670	chr26	11175052	11188824	3500141136	1131		11175052	11188824	8421504	8	141,182,192,162,85,111,129,129	0,2752,4209,6192,6729,9119,12163,13643	p,c,g	350014113600015006,350014113600015007,350014113600000009,350014113600000009	0-1134,0-1134,0-20,0-20						BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS	DGaldo	2011	0		ACTA2
670	chr26	11175057	11175132	3500075257	40		11175057	11175132	8421504	2	19,21	0,54	c	350007525700000003,350007525700000022	0-19,0-21						Isolation and Characterization of Porcine Visceral Endoderm Cell Lines Derived from in vivo 11-Day Blastocysts	www.jstor.org	0	0		SPZ1
670	chr26	11175089	11175114	3500383499	25		11175089	11175114	8421504	1	25	0	c	350038349900000000	0-25						Nuclease protection assays	Kumar	2002	0		
670	chr26	11175089	11175112	3500309956	23		11175089	11175112	8421504	1	23	0	c	350030995600000016	0-23		20193040	10.1111/j.1471-4159.2010.06661.x	1471-4159	Journal of Neurochemistry	Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer&#x2019;s disease - Tian - 2010 - Journal of Neurochemistry - Wiley Online Library	Tian	2010	0		CCDC74A
670	chr26	11175092	11175116	3500315078	24		11175092	11175116	8421504	1	24	0	c	350031507800000003	0-24		19372484	10.2967/jnumed.108.058438	0161-5505	Journal of Nuclear Medicine	Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor	Johnson	2009	6		ACTG1
670	chr26	11175092	11175115	3500223196	23		11175092	11175115	8421504	1	23	0	c	350022319600000007	0-23						Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. - ResearchGate	.researchgate.net	0	0		CCDC74A
670	chr26	11175092	11175115	3500147411	23		11175092	11175115	8421504	1	23	0	c	350014741100000001	0-23		10666029			American Journal of Physiology - Cell Physiolog	Cyclic nucleotide-gated cation channels mediate sodium and calcium influx in rat colon	Qiu	2000	0		POTEE
670	chr26	11175092	11175115	3500143696	23		11175092	11175115	8421504	1	23	0	c	350014369600000010	0-23		15728708	10.1152/ajpcell.00610.2004		American Journal of Physiology - Cell Physiolog	LPA2 receptor mediates mitogenic signals in human colon cancer cells	Yun	2005	0		
670	chr26	11175093	11175117	3500464061	24		11175093	11175117	8421504	1	24	0	c	350046406100000009	0-24						Supplementary Information	www.nature.com	0	0		ACTG1
670	chr26	11175093	11175117	3500290037	24		11175093	11175117	8421504	1	24	0	c	350029003700000003	0-24		22762035	10.3980/j.issn.2222-3959.2012.02.02		International Journal of Ophthalmology	Age-related maculopathy susceptibility 2 participates in the phagocytosis functions of the retinal pigment epithelium	Yi-Ting	2012	0		COPS3,SPZ1
670	chr26	11175093	11175117	3500180330	24		11175093	11175117	8421504	1	24	0	c	350018033000000001	0-24		20610768	10.1152/ajpcell.00101.2010		American Journal of Physiology - Cell Physiolog	Vasoconstriction resulting from dynamic membrane trafficking of TRPM4 in vascular smooth muscle cells	Crnich	2010	0		POTEM
670	chr26	11175093	11175117	3500088133	24		11175093	11175117	8421504	1	24	0	c	350008813300000005	0-24		21378028	10.1152/ajplung.00119.2009		American Journal of Physiology - Lung Cellular and Molecular Physiology	Akt activation induces hypertrophy without contractile phenotypic maturation in airway smooth muscle	Lan	2011	0		SPZ1
670	chr26	11175096	11181332	3500461782	47		11175096	11181332	8421504	2	25,22	0,6214	c	350046178200000007,350046178200000006	0-25,0-22		20159943	10.1124/mol.109.061432	1521-0111 (Online)	Molecular Pharmacology	H2 Relaxin Is a Biased Ligand Relative to H3 Relaxin at the Relaxin Family Peptide Receptor 3 (RXFP3)	Westhuizen	2010	0		ACTG1
670	chr26	11175096	11181332	3500309350	47		11175096	11181332	8421504	2	25,22	0,6214	c	350030935000000007,350030935000000006	0-25,0-22			10.1038/sj.bjp.0704845	1476-5381	British Journal of Pharmacology	Characterization of the &#x03b2;-adrenoceptor subtype involved in mediation of glucose transport in L6 cells - Nevzorova - 2009 - British Journal of Pharmacology - Wiley Online Library	Nevzorova	2002	0		
670	chr26	11175098	11181292	3500353871	42		11175098	11181292	8421504	2	21,21	0,6173	c	350035387100000005,350035387100000004	0-21,0-21		14747372	10.1097/01.ASN.0000107560.80107.19	1046-6673	Journal of the American Society of Nephrology	Function and Localization of Urate Transporter 1 in Mouse Kidney	Hosoyamada	2004	10		POTEM
670	chr26	11175098	11181292	3500084678	42		11175098	11181292	8421504	2	21,21	0,6173	c	350008467800000005,350008467800000004	0-21,0-21						Function and Localization of Urate Transporter 1 in Mouse Kidney	n.asnjournals.org	0	0		POTEF
670	chr26	11175099	11175125	3500378282	26		11175099	11175125	8421504	1	26	0	c	350037828200000201,350037828200000085	0-26,0-26						METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA - Patent application	www.faqs.org	0	0		POTEF,FAM73A
670	chr26	11175100	11175169	3500260937	69		11175100	11175169	8421504	1	69	0	p	350026093700015005,350026093700015007	0-69,0-48						Use of neomycin for treating angiogenesis-related diseases - US Patent 6482802 Description	ww.patentstorm.us	0	0		ACTG2
670	chr26	11175103	11177850	3500307464	42		11175103	11177850	8421504	2	21,21	0,2726	c	350030746400000011,350030746400000010	0-21,0-21						Tanshinone IIA inhibits the dihydrotestosterone-induced secretion of lipids and activation of sterol regulatory element binding protein-1 in HaCaT cells	-publications.com	0	0		
670	chr26	11175106	11187278	3500138586	39		11175106	11187278	8421504	2	20,19	0,12153	c	350013858600000001,350013858600000000	0-20,0-19						Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1	jp.physoc.org	0	0		ACTA2
670	chr26	11175106	11175129	3500074215	23		11175106	11175129	8421504	1	23	0	c,g	350007421500000006,350007421500000006	0-23,0-23			10.1111/j.1365-2567.2007.02578.x		Immunology	Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12	Ana	July	0		POTEE
670	chr26	11175107	11175131	3500125659	24		11175107	11175131	8421504	1	24	0	c	350012565900000011	0-24						Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion	biomedcentral.com	0	0		ACTC1,POTEJ
670	chr26	11175109	11181296	3500439463	40		11175109	11181296	8421504	2	20,20	0,6167	g	350043946300000003,350043946300000002	0-20,0-20		22345865	10.4103/0253-7613.91862		Indian Journal of Pharmacology	Evaluation of anti-inflammatory effects of <i>Broussonetia papyrifera</i> stem bark	Wu	2012	0		
670	chr26	11175109	11181296	3500396777	40		11175109	11181296	8421504	2	20,20	0,6167	c	350039677700000001,350039677700000000	0-20,0-20						Extracts of polygonum multiflorum thunb., and preparation process and uses of the same - Patent application	www.faqs.org	0	0		POTEM
670	chr26	11175109	11181296	3500207327	40		11175109	11181296	8421504	2	20,20	0,6167	c	350020732700000004,350020732700000003	0-20,0-20			10.1038/sj.bjp.0704955		British Journal of Pharmacology	Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid	Ching-Wen	2002	0		POTEF
670	chr26	11175111	11177885	3500328765	40		11175111	11177885	8421504	2	20,20	0,2754	c	350032876500000042,350032876500000041	0-20,0-20						MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF - Patent application	www.faqs.org	0	0		
670	chr26	11175111	11177885	3500106840	40		11175111	11177885	8421504	2	20,20	0,2754	c	350010684000000000,350010684000000001	0-20,0-20						Anti-in&#xfb02;ammatory Activities of Aqueous Extract from Radix Ophiopogon japonicus and Its Two Constituents	bpb.pharm.or.jp	0	0		
670	chr26	11175111	11177885	3500071607	40		11175111	11177885	8421504	2	20,20	0,2754	c	350007160700000002,350007160700000003	0-20,0-20						World J Gastroenterol	www.wjgnet.com	0	0		
670	chr26	11175154	11175178	3500205833	24		11175154	11175178	8421504	1	24	0	c	350020583300000003	0-24		11566738	10.1095/biolreprod65.4.1156	0006-3363	Biology of Reproduction	Distribution Analysis of the Two Chicken Estrogen Receptor-Alpha Isoforms and Their Transcripts in the Hypothalamus and Anterior Pituitary Gland	Griffin	2001	4		
670	chr26	11175180	11177815	3500434117	24		11175180	11177815	8421504	2	13,11	0,2624	c	350043411700000012	0-24						REPRODUCTION	uction-online.org	0	0		
670	chr26	11175182	11177819	3500422477	26		11175182	11177819	8421504	2	11,15	0,2622	c	350042247700000001	0-26						Promoter of the human fatp5 gene and uses	Martin	2004	0		ACTA1
670	chr26	11175185	11177820	3500247571	24		11175185	11177820	8421504	2	8,16	0,2619	c	350024757100000002	0-24		21989785	10.1002/cncr.26524	1097-0142	Cancer	HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection - Zhao - 2011 - Cancer - Wiley Online Library	Zhao	2012	0		
670	chr26	11175185	11177820	3500160929	24		11175185	11177820	8421504	2	8,16	0,2619	c	350016092900000002	0-24		23741443	10.1371/journal.pone.0065023		PLoS ONE	Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma	Lu	2013	0		
670	chr26	11175187	11177821	3500286336	23		11175187	11177821	8421504	2	6,17	0,2617	c	350028633600000005	0-23						Two splice variants of the bovine lactoferrin gene identified in Staphylococcus aureus isolated from mastitis in dairy cattle	w.funpecrp.com.br	0	0		
670	chr26	11175190	11177825	3500411211	24		11175190	11177825	8421504	2	3,21	0,2614	c	350041121100000009	0-24		15768028	10.1038/nm1207	ERROR! NO ISSN	Nature Medicine	Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS	Raoul	2005	0		
670	chr26	11175190	11177825	3500388806	24		11175190	11177825	8421504	2	3,21	0,2614	c	350038880600000014	0-24						Keratinocyte growth factor and its receptor are involved in regulating early lung branching	ev.biologists.org	0	0		ACTA2
670	chr26	11175190	11177825	3500387033	24		11175190	11177825	8421504	2	3,21	0,2614	c	350038703300000007	0-24				1552-5783	Investigative Ophthalmology & Visual Science	Isolation and Characterization of Galectins in the Mammalian Retina	Uehara	2001	0		ACTA2
670	chr26	11175190	11177825	3500380509	24		11175190	11177825	8421504	2	3,21	0,2614	c	350038050900000015,350038050900000005	0-24,0-24						Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 - Patent application	www.faqs.org	0	0		
670	chr26	11175190	11177825	3500371451	24		11175190	11177825	8421504	2	3,21	0,2614	c	350037145100000003	0-24		18680601	10.1186/cc6977		Critical Care	Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release	Mian	2008	0		
670	chr26	11175190	11177825	3500364697	24		11175190	11177825	8421504	2	3,21	0,2614	c	350036469700000020	0-24						Expression of AP-1 family transcription factors in the amygdala during conditioned taste aversion learning: Role for Fra-2	houptlab.org	0	0		ACTA2
670	chr26	11175190	11177825	3500332391	24		11175190	11177825	8421504	2	3,21	0,2614	c	350033239100000003	0-24		12634350	10.1128/JVI.77.7.3898-3912.2003	0022-538X	Journal of Virology	Alpha Interferon Induces Distinct Translational Control Programs To Suppress Hepatitis C Virus RNA Replication	Wang	2003	5		
670	chr26	11175190	11177825	3500273052	24		11175190	11177825	8421504	2	3,21	0,2614	c	350027305200000005	0-24		17463047	10.1113/jphysiol.2007.128843	0022-3751	The Journal of Physiology	Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation	Subramanian	2007	5		
670	chr26	11175190	11177825	3500271825	24		11175190	11177825	8421504	2	3,21	0,2614	c	350027182500000005	0-24			10.1113/jphysiol.2007.128843		The Journal of Physiology	Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation	Veedamali	July	0		ACTA2
670	chr26	11175190	11177825	3500258944	24		11175190	11177825	8421504	2	3,21	0,2614	c	350025894400000007	0-24		12761250	10.1097/01.ASN.0000069223.98703.8E	1046-6673	Journal of the American Society of Nephrology	Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Renal Injury Induced by Protein-Overload Proteinuria	Shimizu	2003	10		
670	chr26	11175190	11177825	3500206989	24		11175190	11177825	8421504	2	3,21	0,2614	c	350020698900000001	0-24		10967095	10.1074/jbc.M003549200	0021-9258	Journal of Biological Chemistry	Leptin Regulates Prothyrotropin-releasing Hormone Biosynthesis	Nillni	2000	5		
670	chr26	11175190	11177825	3500188531	24		11175190	11177825	8421504	2	3,21	0,2614	c	350018853100000001	0-24		18003745	10.1152/ajpcell.00468.2007		American Journal of Physiology - Cell Physiolog	Apical membrane targeting and trafficking of the human proton-coupled transporter in polarized epithelia	Subramanian	2008	0		
670	chr26	11175190	11177825	3500155535	24		11175190	11177825	8421504	2	3,21	0,2614	c	350015553500000005	0-24		17135299	10.1152/ajpcell.00360.2006		American Journal of Physiology - Cell Physiolog	Regulation of the human biotin transporter hSMVT promoter by KLF-4 and AP-2: confirmation of promoter activity in vivo	Reidling	2007	0		
670	chr26	11175190	11177825	3500123041	24		11175190	11177825	8421504	2	3,21	0,2614	c	350012304100000003	0-24		12813157	10.1113/jphysiol.2002.037655	0022-3751	The Journal of Physiology	Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones	Wells	2003	5		
670	chr26	11175190	11177825	3500087932	24		11175190	11177825	8421504	2	3,21	0,2614	c	350008793200000006	0-24						Immortalized lines of endothelial brain cells and therapeutic application thereof	Chaverot	2001	0		ACTA2
670	chr26	11175190	11177825	3500062862	24		11175190	11177825	8421504	2	3,21	0,2614	c	350006286200000005,350006286200000019	0-24,0-24						Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis - Patent application	www.faqs.org	0	0		ACTG1
670	chr26	11175190	11177825	3500051243	24		11175190	11177825	8421504	2	3,21	0,2614	c	350005124300000003	0-24		15961565	10.1210/en.2004-1652	0013-7227	Endocrinology	Cultured Embryonic Hippocampal Neurons Deficient in Glucocorticoid (GC) Receptor: A Novel Model for Studying Nongenomic Effects of GC in the Neural System	Xiao	2005	4		
670	chr26	11175190	11177825	3500029635	24		11175190	11177825	8421504	2	3,21	0,2614	c	350002963500000013	24-48						&#x4e3b;&#x9898;&#xff1a;MCP-1 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
670	chr26	11175190	11177825	3500013478	24		11175190	11177825	8421504	2	3,21	0,2614	c	350001347800000004	0-24		18972601	10.3349/ymj.2008.49.5.804		Yonsei Medical Journal	The Expression of Adiponectin Receptors and the Effects of Adiponectin and Leptin on Airway Smooth Muscle Cells	Joo	2008	0		ACTA1
670	chr26	11175190	11177825	3500007374	24		11175190	11177825	8421504	2	3,21	0,2614	c	350000737400000005	0-24						8,9-Epoxyeicosatrienoic acid analog protects pulmonary artery smooth muscle cells from apoptosis via ROCK pathway	beyotime.com	0	0		
670	chr26	11175190	11177824	3500434391	23		11175190	11177824	8421504	2	3,20	0,2614	c	350043439100000002	0-23		23922887	10.1371/journal.pone.0069994		PLoS ONE	TNF-&#x03b1; Decreases VEGF Secretion in Highly Polarized RPE Cells but Increases It in Non-Polarized RPE Cells Related to Crosstalk between JNK and NF-&#x03ba;B Pathways	Hiroto	2013	0		
670	chr26	11177889	11177912	3500423471	23		11177889	11177912	8421504	1	23	0	c,g	350042347100000000,350042347100000000	1-24,1-24						Chinese Medicine BioMed Central	www.etcma.org	0	0		
670	chr26	11177889	11177912	3500357541	23		11177889	11177912	8421504	1	23	0	c	350035754100000000	1-24		18237412	10.1186/1749-8546-3-1	1749-8546	Chinese Medicine	Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats	Liu	2008	0		
670	chr26	11177889	11177912	3500227713	23		11177889	11177912	8421504	1	23	0	c	350022771300000000	1-24		18237412	10.1186/1749-8546-3-1		Chinese Medicine	Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats	Cheng	2008	0		
670	chr26	11177952	11187243	3500271974	44		11177952	11187243	8421504	2	20,24	0,9267	c	350027197400000008,350027197400000011	0-20,0-24						ScienceDirect.com - Fish & Shellfish Immunology - Identification and cloning of a transglutaminase from giant freshwater prawn, Macrobrachium rosenbergii, and its transcription during pathogen infection and moulting	sciencedirect.com	0	0		
670	chr26	11179332	11188800	3500430178	41		11179332	11188800	8421504	2	20,21	0,9447	c	350043017800000021,350043017800000016	0-20,0-21						A novel signaling pathway in mouse embryonic stem cells	ibg.uu.se/digital	0	0		
670	chr26	11179333	11179357	3500051594	24		11179333	11179357	8421504	1	24	0	c	350005159400000002	0-24		9357851			American Journal of Physiology - Lung Cellular and Molecular Physiology	Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells	Michael	1997	0		ACTG2
670	chr26	11179340	11179364	3500293498	24		11179340	11179364	8421504	1	24	0	c	350029349800000007	0-24		19517010	10.1371/journal.pone.0005876		PLoS ONE	Unconjugated Bilirubin Exposure Impairs Hippocampal Long-Term Synaptic Plasticity	Fang-Yu	2009	0		
670	chr26	11179344	11179383	3500417171	39		11179344	11179383	8421504	1	39	0	c	350041717100000079	0-39						UNIVERSIDAD COMPLUTENSE DE MADRID	www.elfoiegras.es	0	0		
670	chr26	11179427	11181833	3500231857	120		11179427	11181833	8421504	4	26,34,8,52	0,1817,1971,2354	p	350023185700015062,350023185700015059	0-60,0-60						Toxicology and Applied Pharmacology	www.usask.ca	0	0		ACTG2
670	chr26	11179433	11181299	3500395013	75		11179433	11181299	8421504	2	20,55	0,1811	p	350039501300015002	0-75						The role of actin isoforms in somatic embryogenesis in Norway spruce	biomedcentral.com	0	0		ACTG2
670	chr26	11181265	11181288	3500456419	23		11181265	11181288	8421504	1	23	0	c	350045641900000001	0-23		22052241	10.1038/gt.2011.166	0969-7128	Gene Therapy	Vector-mediated expression of erythropoietin improves functional outcome after cervical spinal cord contusion injury	Wang	2011	4		ACTA2
670	chr26	11181265	11181288	3500200124	23		11181265	11181288	8421504	1	23	0	c	350020012400000016	0-23		19074031	10.1523/JNEUROSCI.4099-08.2008	0270-6474	The Journal of Neuroscience	Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis	Vargas	2008	7		ACTA2
670	chr26	11181265	11181288	3500071757	23		11181265	11181288	8421504	1	23	0	c	350007175700000021	0-23		20924361	10.1038/mt.2010.215	1525-0016	Molecular Therapy	Prevention of Diabetic Neuropathy by Regulatable Expression of HSV-Mediated Erythropoietin	Wu	2010	7		ACTA2
670	chr26	11181265	11181288	3500070308	23		11181265	11181288	8421504	1	23	0	c	350007030800000021	0-23		20924361	10.1038/mt.2010.215	1525-0016	Molecular Therapy	Prevention of Diabetic Neuropathy by Regulatable Expression of HSV-Mediated Erythropoietin	Wu	2010	7		ACTA2
670	chr26	11181265	11181288	3500069213	23		11181265	11181288	8421504	1	23	0	c	350006921300000001	0-23		18033311	10.1038/sj.gt.3303054	0969-7128	Gene Therapy	HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor &#x03b1; in spinal cord microglia	Zhou	2007	4		ACTA2
670	chr26	11181267	11181292	3500065385	25		11181267	11181292	8421504	1	25	0	c	350006538500000004	0-25					International journal of oncology	Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote angiogenic process	Ravesanker	2007	0		ACTC1,ZP4
670	chr26	11181269	11181295	3500200456	26		11181269	11181295	8421504	1	26	0	c	350020045600000015	0-26		22072783	10.1128/JVI.06169-11	0022-538X	Journal of Virology	Epigenetic Changes Mediated by MicroRNA miR29 Activate Cyclooxygenase 2 and Lambda-1 Interferon Production during Viral Infection	Fang	2012	5		POTEE
670	chr26	11181271	11184276	3500160637	40		11181271	11184276	8421504	3	20,15,5	0,2983,3000	c,g	350016063700000011,350016063700000011,350016063700000010	0-20,0-20,0-20						Cellular/Molecular VasculatureGuidesMigratingNeuronalPrecursorsinthe AdultMammalianForebrainviaBrain-Derived NeurotrophicFactorSignaling	logie.univ-mrs.fr	0	0		
670	chr26	11181271	11184276	3500137544	40		11181271	11184276	8421504	3	20,15,5	0,2983,3000	g	350013754400000007,350013754400000006	0-20,0-20		17287525	10.1523/JNEUROSCI.4806-06.2007	0270-6474	The Journal of Neuroscience	Hypo-Osmolar Stress Induces p75NTR Expression by Activating Sp1-Dependent Transcription	Ramos	2007	7		
670	chr26	11181272	11181296	3500370943	24		11181272	11181296	8421504	1	24	0	c	350037094300000006	0-24						Enhanced CBir1-specific innate and adaptive immune responses in Crohn&#x2019;s disease - Keeping the Faith	pthefaith1296.com	0	0		
670	chr26	11181273	11181296	3500278746	23		11181273	11181296	8421504	1	23	0	c	350027874600000005	0-23		19967061	10.4196/kjpp.2008.12.5.231		The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology	Heparin Attenuates the Expression of TNF&#x03b1;-induced Cerebral Endothelial Cell Adhesion Molecule	Jeong	2008	0		ACTA2
670	chr26	11181273	11181296	3500176122	23		11181273	11181296	8421504	1	23	0	c	350017612200000005	0-23						Heparin Attenuates the Expression of TNFalpha-induced Cerebral Endothelial Cell Adhesion Molecule. - ResearchGate	.researchgate.net	0	0		ACTB
670	chr26	11181273	11181296	3500126722	23		11181273	11181296	8421504	1	23	0	c	350012672200000007	0-23		16609006	10.1158/1078-0432.CCR-05-2797	1078-0432	Clinical Cancer Research	Glycoprotein Nonmetastatic Melanoma Protein B, a Potential Molecular Therapeutic Target in Patients with Glioblastoma Multiforme	Kuan	2006	8		ACTG2
670	chr26	11181276	11187240	3500298443	40		11181276	11187240	8421504	2	20,20	0,5944	c	350029844300000003,350029844300000002	0-20,0-20						BMC Cancer BioMed Central	biomedcentral.com	0	0		ACTB
670	chr26	11181287	11188788	3500320459	45		11181287	11188788	8421504	2	22,23	0,7478	c	350032045900000009,350032045900000001	0-22,0-23						NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-&#x03b2;1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. - ResearchGate	.researchgate.net	0	0		
670	chr26	11181312	11181335	3500200410	23		11181312	11181335	8421504	1	23	0	c	350020041000000002	19-42		19153068	10.1684/ejd.2008.0618	1167-1122	European Journal of Dermatology	John Libbey Eurotext : &#xc9;ditions m&#xe9;dicales et scientifiques France : revues, m&#xe9;dicales, scientifiques, m&#xe9;decine, sant&#xe9;, livres - Texte int&#xe9;gral de l'article	Zhang	2009	3		CNR1,ACTG1
670	chr26	11181345	11181368	3500031675	23		11181345	11181368	8421504	1	23	0	c	350003167500000001	0-23		16675954	10.1038/sj.emboj.7601116	ERROR! NO ISSN	The EMBO Journal	TREK-1, a K&plus; channel involved in polymodal pain perception	Alloui	2006	0		
670	chr26	11181348	11181373	3500282297	25		11181348	11181373	8421504	1	25	0	c	350028229700000020	0-25						THERAPEUTIC GENE DELIVERY TO HUMAN PANCREATIC ISLETS FOR TREATMENT OF DIABETES AND THE EFFECT OF TFO ON LIVER FIBROSIS INDUCED BY BILE DUCT LIGATION	etd.uthsc.edu	0	0		
670	chr26	11181349	11181373	3500145966	24		11181349	11181373	8421504	1	24	0	c	350014596600000018	0-24						DEVELOPMENT AND EVALUATION OF NANO-SCALE SYSTEMS FOR TARGETED DELIVERY TO TREAT LIVER FIBROSIS	etd.uthsc.edu	0	0		
670	chr26	11181382	11187235	3500411589	40		11181382	11187235	8421504	2	20,20	0,5833	c	350041158900000007,350041158900000006	0-20,0-20		21984124	10.1002/path.2961	1096-9896	The Journal of Pathology	Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192 - Sun - 2011 - The Journal of Pathology - Wiley Online Library	Sun	2011	0		
670	chr26	11181382	11187235	3500223319	40		11181382	11187235	8421504	2	20,20	0,5833	c	350022331900000003,350022331900000002	0-20,0-20					The American Journal of Pathology	Ultrasound-Microbubble-Mediated Gene Transfer of Inducible Smad7 Blocks Transforming Growth Factor-&#x03b2; Signaling and Fibrosis in Rat Remnant Kidney	Chun-Cheng	2005	0		
670	chr26	11181382	11187235	3500213288	40		11181382	11187235	8421504	2	20,20	0,5833	c,g	350021328800000007,350021328800000006	0-20,0-20		21984124	10.1002/path.2961		The Journal of Pathology	Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192	Lin	2011	0		
670	chr26	11181382	11187235	3500200996	40		11181382	11187235	8421504	2	20,20	0,5833	c,g	350020099600000011,350020099600000010,350020099600000010	0-20,0-20,0-20					International Journal of Clinical and Experimental Pathology	Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells	Ahmad	2011	0		
670	chr26	11181382	11187235	3500055006	40		11181382	11187235	8421504	2	20,20	0,5833	c	350005500600000012,350005500600000011	0-20,0-20						THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF	Jin	2011	0		
670	chr26	11181382	11187235	3500055003	40		11181382	11187235	8421504	2	20,20	0,5833	c	350005500300000007,350005500300000006	0-20,0-20						Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. - ResearchGate	.researchgate.net	0	0		
670	chr26	11181398	11181818	3500241719	45		11181398	11181818	8421504	2	8,37	0,383	p	350024171900015089	0-45						RNAI FOR THE CONTROL OF INSECTS AND ARACHNIDS - Patent application	www.faqs.org	0	0		ACTG2
670	chr26	11181837	11184251	3500412920	41		11181837	11184251	8421504	2	21,20	0,2394	c	350041292000000007,350041292000000006	0-21,0-20		21832251	10.1152/ajpcell.00471.2010		American Journal of Physiology - Cell Physiolog	NF-&#x03ba;B plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells	Shimizu	2011	0		ACTA2
670	chr26	11181837	11184251	3500319766	41		11181837	11184251	8421504	2	21,20	0,2394	c,g	350031976600000003,350031976600000003,350031976600000002,350031976600000002	0-21,0-21,0-20,0-20		20720180	10.1152/ajpcell.00217.2010		American Journal of Physiology - Cell Physiolog	Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate	Shimizu	2010	0		ACTA2
670	chr26	11181837	11184251	3500306321	41		11181837	11184251	8421504	2	21,20	0,2394	c,g	350030632100000003,350030632100000002,350030632100000002	0-21,0-20,0-20						Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate	ll.physiology.org	0	0		ACTA2
670	chr26	11181837	11184251	3500147844	41		11181837	11184251	8421504	2	21,20	0,2394	c	350014784400000003,350014784400000002	0-21,0-20		20720180	10.1152/ajpcell.00217.2010		American Journal of Physiology - Cell Physiolog	Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate	Shimizu	2010	0		ACTA2
670	chr26	11184182	11184205	3500428383	23		11184182	11184205	8421504	1	23	0	g	350042838300000002	0-23						Du C, Yang P, Zhang G, Hong C, Chen J, Dong X. Effect of Arsenic trioxide on EBV LMP1 mediated E-cadherin silencing in nasopharyngeal carcinoma. Head Neck Oncol. 2012 Sep 9;4(2):55.Head and Neck Oncology	lishinglondon.com	0	0		
670	chr26	11184187	11184213	3500013787	26		11184187	11184213	8421504	1	26	0	c	350001378700000007	0-26		19369477	10.1128/CVI.00011-09	1556-6811	Clinical and Vaccine Immunology	Biologic and Immunologic Effects of Knockout of Human Cytomegalovirus pp65 Nuclear Localization Signal	Zaia	2009	3		ACTB
670	chr26	11184195	11184249	3500334309	54		11184195	11184249	8421504	1	54	0	p	350033430900015207	0-54						Proteomic Analyses of Thyroid Hormone-sensitive Tissues During Frog Tadpole Metamorphosis	rary.uvic.ca:8080	0	0		ACTG2
670	chr26	11184195	11184249	3500238558	54		11184195	11184249	8421504	1	54	0	p	350023855800015006	0-54					Patent	Recombinantly produced spider silk (Patent US:6268169)	Fahnestock	2001	0		ACTG2
670	chr26	11184231	11187244	3500450948	40		11184231	11187244	8421504	2	20,20	0,2993	c,g	350045094800000003,350045094800000003,350045094800000002	0-20,0-20,0-20						METHOD FOR FORMATION OF RENAL TUBULES	Zink	2009	0		
670	chr26	11184254	11184279	3500298114	25		11184254	11184279	8421504	1	25	0	c	350029811400000003	0-25						Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet &#x03b2;-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release	do.physiology.org	0	0		ACTA2
670	chr26	11184274	11187237	3500293281	30		11184274	11187237	8421504	2	8,22	0,2941	c	350029328100000003	0-30						Elsie Spell | Safety of Life and Health	fe-and-health.com	0	0		
670	chr26	11187216	11187241	3500228156	24		11187216	11187241	8421504	2	4,20	0,5	g	350022815600000001	5-29						Self-complementary primers used in LAMP gene amplification method	Iwaki	2008	0		
670	chr26	11187216	11187239	3500049859	23		11187216	11187239	8421504	1	23	0	c	350004985900000002	0-23						Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro	logy-journals.org	0	0		ZP4
670	chr26	11187219	11187243	3500336971	24		11187219	11187243	8421504	1	24	0	c	350033697100000009	0-24						Immune responses and gene expression in white shrimp, Litopenaeus vannamei, induced by Lactobacillus plantarum	rdms.npust.edu.tw	0	0		ACTA2
670	chr26	11187219	11187243	3500166978	24		11187219	11187243	8421504	1	24	0	c	350016697800000011	0-24						ScienceDirect.com - Fish & Shellfish Immunology - Effects of Bacillus subtilis on the growth performance, digestive enzymes, immune gene expression and disease resistance of white shrimp, Litopenaeus vannamei	sciencedirect.com	0	0		ACTG1
670	chr26	11187224	11187248	3500427977	24		11187224	11187248	8421504	1	24	0	c	350042797700000001	0-24						Human Intestinal V81 + T Lymphocytes Recognize Tumor Cells of Epithelial Origin By Markus J. Maeurer,*r Dina Martin,~ Wolfgang Walter,* Kaihong Liu,II Laurence Zitvogel,r Kathy Halusczcak,$ Hanna Kabinowichfi Rene Duquesnoy)l Walter Storkus,r and Michael 	jem.rupress.org	0	0		
670	chr26	11187235	11188698	3500349442	45		11187235	11188698	8421504	3	23,19,3	0,90,1460	c	350034944200000003,350034944200000002	0-23,0-22						REGULATION OF VOLTAGE-DEPENDENT CALCIUM CHANNELS IN NEONATAL PULMONARY ARTERIAL HYPERTENSION A dissertation submitted in partial fulfillment of the requirements for the degree of DINESH KUMAR HIRENALLUR SHANTHAPPA	gradworks.umi.com	0	0		
670	chr26	11187249	11188786	3500425506	46		11187249	11188786	8421504	2	24,22	0,1515	c	350042550600000023,350042550600000022	0-24,0-22						Snail and Slug Promote Epithelial-Mesenchymal Transition through -Catenin&#x2013;T-Cell Factor-4-dependent Expression of Transforming Growth Factor- 3	w.molbiolcell.org	0	0		ACTA2
670	chr26	11187249	11188786	3500006489	46		11187249	11188786	8421504	2	24,22	0,1515	c	350000648900000023,350000648900000022	0-24,0-22		18799618	10.1091/mbc.E08-05-0506		Molecular Biology of the Cell	Snail and Slug Promote Epithelial-Mesenchymal Transition through &#x03b2;-Catenin&#x2013;T-Cell Factor-4-dependent Expression of Transforming Growth Factor-&#x03b2;3	Damian	2008	0		ACTA2
670	chr26	11187253	11187277	3500340468	24		11187253	11187277	8421504	1	24	0	c	350034046800000021	0-24						zg0001050000c1 12/17/04 8:59 AM Page 1	005.pasteur.ac.ir	0	0		
670	chr26	11187259	11187284	3500460543	25		11187259	11187284	8421504	1	25	0	c	350046054300000001	0-25						Posttranslationally Modified Proteins as Mediators of Sustained Intestinal Inflammation 2006&#x5e74;&#x7b2c;168&#x5377;&#x7b2c;10&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
670	chr26	11187259	11187284	3500364018	25		11187259	11187284	8421504	1	25	0	c	350036401800000005	0-25		11723063	10.2337/diabetes.50.12.2792	0012-1797	Diabetes	Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-&#x03ba;B	Bierhaus	2001	8		POTEM
670	chr26	11187259	11187284	3500023246	25		11187259	11187284	8421504	1	25	0	c	350002324600000005	0-25						Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor- B	betesjournals.org	0	0		ACTA2
670	chr26	11187260	11187283	3500423133	23		11187260	11187283	8421504	1	23	0	c	350042313300000005	0-23		11489948	10.1084/jem.194.3.285	0022-1007	The Journal of Experimental Medicine	Point Mutation in Essential Genes with Loss or Mutation of the Second Allele	Beck-Engeser	2001	14		
670	chr26	11187296	11192329	3500299151	49		11187296	11192329	8421504	2	24,25	0,5008	c,g	350029915100000018,350029915100000015	0-24,0-25		20123992	10.1083/jcb.200906155		The Journal of Cell Biology	Fate-determining mechanisms in epithelial&#x2013;myofibroblast transition: major inhibitory role for Smad3	Andras	2010	0		ACTA2
670	chr26	11187296	11192329	3500176523	70		11187296	11192329	8421504	3	24,21,25	0,4954,5008	c,g	350017652300000018,350017652300000016,350017652300000015	0-24,0-21,0-25		20123992	10.1083/jcb.200906155	0021-9525	The Journal of Cell Biology	Fate-determining mechanisms in epithelial&#x2013;myofibroblast transition: major inhibitory role for Smad3	Masszi	2010	10		
670	chr26	11187300	11187323	3500409275	23		11187300	11187323	8421504	1	23	0	c	350040927500000005	0-23						PONTIF&#xcd;CIA UNIVERSIDADE CAT&#xd3;LICA DO RIO GRANDE DO SUL PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM BIOLOGIA CELULAR E MOLECULAR	tede.pucrs.br	0	0		
670	chr26	11187307	11187330	3500052215	23		11187307	11187330	8421504	1	23	0	c	350005221500000015	0-23						 <HTML> <HEAD> <TITLE> Transcriptional Programs following Genetic Alterations 	.aacrjournals.org	0	0		ACTA2
670	chr26	11188765	11188788	3500028051	23		11188765	11188788	8421504	1	23	0	c	350002805100000002	0-23						Research Paper Interaction of RAS Activation and Lipid Disorders Ac- celerates the Progression of Glomerulosclerosis	www.medsci.org	0	0		
670	chr26	11250396	11258821	3500409810	45		11250396	11258821	8421504	3	3,20,22	0,1273,8403	c	350040981000000000,350040981000000001	0-23,0-22						Estrous cycle-dependent changes of Fas expression in the bovine corpus luteum: influence of keratin 8/18 intermediate filaments and cytokines	www.rbej.com	0	0		
670	chr26	11250396	11258821	3500055266	45		11250396	11258821	8421504	3	3,20,22	0,1273,8403	c	350005526600000000,350005526600000001	0-23,0-22		23113883	10.1186/1477-7827-10-90	1477-7827	Reproductive Biology and Endocrinology	Estrous cycle-dependent changes of Fas expression in the bovine corpus luteum: influence of keratin 8/18 intermediate filaments and cytokines	Duncan	2012	2		
670	chr26	11250396	11254906	3500389718	47		11250396	11254906	8421504	3	3,20,24	0,1273,4486	c,g	350038971800000000,350038971800000001,350038971800000001	0-23,0-24,0-24						Safety of Life and Health	fe-and-health.com	0	0		
670	chr26	11250396	11254906	3500293281	47		11250396	11254906	8421504	3	3,20,24	0,1273,4486	c	350029328100000000,350029328100000001	0-23,0-24						Elsie Spell | Safety of Life and Health	fe-and-health.com	0	0		
670	chr26	11250398	11251733	3500264674	49		11250398	11251733	8421504	3	1,24,24	0,1271,1311	c	350026467400000006,350026467400000007	0-25,0-24						VITRIFICATION OF BOVINE OOCYTES	cholar.lib.vt.edu	0	0		
670	chr26	11251695	11251719	3500320534	24		11251695	11251719	8421504	1	24	0	c	350032053400000005	0-24		11535536	10.1182/blood.V98.6.1963	0006-4971	Blood	Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics	Joshi	2001	10		FAS
670	chr26	11251695	11251719	3500246178	24		11251695	11251719	8421504	1	24	0	c	350024617800000005	0-24		11535536	10.1182/blood.V98.6.1963	0006-4971	Blood	Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics	Joshi	2001	10		FAS
670	chr26	11251696	11251721	3500312138	25		11251696	11251721	8421504	1	25	0	c	350031213800000000	10-35		12944992	10.1038/sj.cgt.7700625	0929-1903	Cancer Gene Therapy	Enhancing antimelanoma immune responses through apoptosis	Bianco	2003	3		
670	chr26	11258690	11258738	3500365533	48		11258690	11258738	8421504	1	48	0	p	350036553300015092	0-48						Serine carboxypeptidase hx (SCPhx) and compositions thereof	Bejanin	2001	0		
670	chr26	11258690	11258738	3500185026	48		11258690	11258738	8421504	1	48	0	p	350018502600015093	0-48						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		
670	chr26	11259177	11259348	3500383646	40		11259177	11259348	8421504	2	20,20	0,151	c	350038364600000022,350038364600000023	0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
670	chr26	11259261	11259289	3500047604	23		11259261	11259289	8421504	2	10,13	0,15	c	350004760400000014,350004760400000043,350004760400000013,350004760400000044	11-34,11-34,11-34,11-34						VARIANTS OF PLASMINOGEN AND PLASMIN - Patent application	www.faqs.org	0	0		
670	chr26	11260000	11260030	3500380921	30		11260000	11260030	8421504	1	30	0	c,g	350038092100000008,350038092100000008	0-30,0-30						END OF PROJECT REPORT 5230 Animal Transport: Developing optimum animal handling procedures and effective transport strategies in the food production chain to improve animal welfare and food quality.	www.teagasc.ie	0	0		
671	chr26	11306456	11306764	3500375699	307		11306456	11306764	8421504	2	4,303	0,5	g	350037569900000040	12-321						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
672	chr26	11432029	11432119	3500158031	90		11432029	11432119	8421504	1	90	0	p	350015803100015027	0-90						Production of non-yeast sterols by yeast	Hohmann	2012	0		
672	chr26	11445903	11482303	3500041560	264		11445903	11482303	8421504	5	60,2,110,68,24	0,12212,14833,16058,36376	p,c,g	350004156000015015,350004156000000015,350004156000000015,350004156000015008,350004156000000008,350004156000000007,350004156000015007,350004156000000022,350004156000000006,350004156000015006,350004156000000020	0-60,9-60,9-60,0-60,0-60,0-61,0-60,0-23,0-60,0-60,0-24						Cloning, Phylogenetic Analysis and 3D Modeling of a Putative Lysosomal Acid Lipase from the Camel, Camelus dromedarius	www.mdpi.com	0	0		
672	chr26	11455791	11462107	3500368353	40		11455791	11462107	8421504	2	20,20	0,6296	c	350036835300000009,350036835300000005	0-20,0-21						Zielgerichtete Mutagenese der lysosomalen Lipase	ie.uni-hamburg.de	0	0		
672	chr26	11460746	11462058	3500116647	40		11460746	11462058	8421504	2	20,20	0,1292	c,g	350011664700000007,350011664700000006	0-20,0-20						Placental triglyceride accumulation in maternal type 1-diabetes is associated with increased endothelial and hormone sensitive lipase gene expression.	www.jlr.org	0	0		LIPA
672	chr26	11526238	11526329	3500317153	40		11526238	11526329	8421504	2	20,20	0,71	g	350031715300000036,350031715300000008,350031715300000037,350031715300000009	0-20,0-20,0-20,0-20						Markers for Viral Infections and Other Inflammatory Responses - Patent application	www.faqs.org	0	0		
674	chr26	11756355	11756378	3500439152	23		11756355	11756378	8421504	1	23	0	c	350043915200000190	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		
674	chr26	11756355	11756378	3500423784	23		11756355	11756378	8421504	1	23	0	c,g	350042378400000022,350042378400000025,350042378400000025	0-23,0-23,0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR103B1
674	chr26	11756355	11756378	3500323428	23		11756355	11756378	8421504	1	23	0	c	350032342800000055	0-23						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		
674	chr26	11756355	11756378	3500244257	23		11756355	11756378	8421504	1	23	0	c	350024425700000012,350024425700000009	0-23,0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR103B2,MIR103A2
674	chr26	11756355	11756378	3500131061	23		11756355	11756378	8421504	1	23	0	c	350013106100000047	0-23						MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES - Patent application	www.faqs.org	0	0		MIR103B1
674	chr26	11756355	11756378	3500119147	23		11756355	11756378	8421504	1	23	0	c	350011914700000017	0-23						(COX -2) regulation in colon cancer cells	rato.cib.unibo.it	0	0		MIR103B2,MIR103A2
674	chr26	11756355	11756378	3500114594	23		11756355	11756378	8421504	1	23	0	c	350011459400000404,350011459400000831,350011459400000835,350011459400000408	0-23,0-23,0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR103B1
674	chr26	11756355	11756378	3500031979	23		11756355	11756378	8421504	1	23	0	c	350003197900000323,350003197900000319	0-23,0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR103B2,MIR103A2
675	chr26	11867246	11872879	3500018039	40		11867246	11872879	8421504	2	20,20	0,5613	c	350001803900000004,350001803900000005	0-20,0-20		17030616	10.1128/MCB.01538-06	0270-7306	Molecular and Cellular Biology	HSP70 Induction by ING Proteins Sensitizes Cells to Tumor Necrosis Factor Alpha Receptor-Mediated Apoptosis	Feng	2006	6		KIF20B
675	chr26	11894318	11894342	3500317336	23		11894318	11894342	8421504	2	5,18	0,6	g	350031733600000016	23-46						Bifunctional molecules for inhibiting hiv entry	Jiang	2009	0		
675	chr26	11894318	11894342	3500235948	23		11894318	11894342	8421504	2	5,18	0,6	g	350023594800000312	21-44						Alvac canarypox virus recombinants comprising heterlogous inserts	Paoletti	1995	0		
84	chr26	11899645	11934256	3500201448	90		11899645	11934256	8421504	2	45,45	0,34566	c	350020144800000215,350020144800000247	0-45,0-45						METHOD OF DIAGNOSING BLADDER CANCER - Patent application	www.faqs.org	0	0		
675	chr26	11905341	11923170	3500359841	49		11905341	11923170	8421504	3	21,20,8	0,13906,17821	c	350035984100000012,350035984100000014	9-30,10-38						METHODS OF SCREENING FOR AGENTS THAT INHIBIT BINDING BETWEEN MPHOSPH1 AND PRC1 - ONCOTHERAPY SCIENCE, INC.	www.sumobrain.com	0	0		
683	chr26	12863046	12863069	3500288335	23		12863046	12863069	8421504	1	23	0	g	350028833500000186	5-33						Nematode Fatty Acid Desaturase-Like Sequences - Patent application	www.faqs.org	0	0		
684	chr26	13007058	13009797	3500205057	40		13007058	13009797	8421504	3	7,13,20	0,2483,2719	c	350020505700000001,350020505700000000	0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
684	chr26	13007058	13009797	3500137197	40		13007058	13009797	8421504	3	7,13,20	0,2483,2719	c	350013719700000001,350013719700000000	0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
684	chr26	13010069	13011610	3500450956	23		13010069	13011610	8421504	2	11,12	0,1529	c	350045095600000151	21-44						Analyse computationnelle des &#xe9;l&#xe9;ments cis-r&#xe9;gulateurs dans les g&#xe9;nomes des drosophiles et des mammif&#xe8;res | Marc Santolini - Academia.edu	www.academia.edu	0	0		
684	chr26	13011644	13013626	3500144261	40		13011644	13013626	8421504	3	20,19,1	0,1623,1981	c,g	350014426100000003,350014426100000003,350014426100000002	0-20,0-20,0-20						Gene expression profiling of bovine in vitro adipogenesis using a cDNA microarray	iotechnology.info	0	0		
684	chr26	13098204	13098227	3500148414	23		13098204	13098227	8421504	1	23	0	g	350014841400000427	0-23						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
687	chr26	13406054	13406080	3500279174	23		13406054	13406080	8421504	2	13,10	0,16	g	350027917400000061	1-24						DEPARTAMENTO DE BIOLOGAA, CULTIVO Y PATOLOGAA DE ESPECIES MARINAS ESTRATEGIAS DE ALIMENTACIAN Y 	www.tdx.cat	0	0		
687	chr26	13421459	13421485	3500247922	23		13421459	13421485	8421504	2	17,6	0,20	c	350024792200000435	19-42						Human B2 integrin alpha subunit antibodies	Gallatin	1996	0		
688	chr26	13599266	13599291	3500237963	24		13599266	13599291	8421504	2	9,15	0,10	g	350023796300000084	8-32						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
689	chr26	13660981	13661008	3500355785	23		13660981	13661008	8421504	2	9,14	0,13	g	350035578500000081	0-23						Use Of Histone Chaperone Activity Of Agrobacterium 6b Protein 	.freshpatents.com	0	0		
689	chr26	13734402	13734427	3500335341	23		13734402	13734427	8421504	2	10,13	0,12	c	350033534100000027	10-33					Patent	Polymer conjugates of interferon beta-1A and uses (Patent US:7446173)	Pepinsky	2008	0		
689	chr26	13734402	13734427	3500152141	23		13734402	13734427	8421504	2	10,13	0,12	c	350015214100000027	10-33						Polymer conjugates of interferon beta-1a and uses	Pepinsky	2007	0		
689	chr26	13734402	13734427	3500024742	23		13734402	13734427	8421504	2	10,13	0,12	c	350002474200000027	10-33						Polymer conjugates of interferon beta-1a and uses	Pepinsky	2004	0		
689	chr26	13735117	13736022	3500411827	95		13735117	13736022	8421504	3	48,28,19	0,772,886	c	350041182700000047,350041182700000031,350041182700000029	0-48,19-47,10-29						Protein targeting to glycogen	Brady	1999	0		
691	chr26	13917156	13917181	3500103009	24		13917156	13917181	8421504	2	15,9	0,16	g	350010300900000009	0-24		18786246	10.1186/1471-2164-9-408		BMC Genomics	Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation	Kyung	2008	0		
691	chr26	13982793	13982821	3500058103	24		13982793	13982821	8421504	2	14,10	0,18	g	350005810300000116	0-24						MITOCHONDRIAL MUTATIONS AND REARRANGEMENTS AS A DIAGNOSTIC TOOL FOR THE DETECTION OF SUN EXPOSURE, PROSTATE CANCER AND OTHER CANCERS - Patent application	www.faqs.org	0	0		
693	chr26	14183964	14267761	3500141587	663		14183964	14267761	8421504	7	71,115,96,89,139,56,97	0,9243,23220,43931,45745,76553,83700	p	350014158700015008,350014158700015009,350014158700015005,350014158700015034,350014158700015023,350014158700015020	0-282,0-282,24-252,0-87,0-57,0-99						comparative in Silico Analyses of Cpeb1&#x2013;4 with Functional predictions	www.la-press.com	0	0		
695	chr26	14457880	14518275	3500023334	828		14457880	14518275	8421504	19	23,18,48,48,10,38,50,92,1,62,34,63,15,78,96,7,41,60,44	0,678,12512,17861,26836,31582,33462,34418,34937,34968,35731,35831,36454,36487,54984,55110,58195,58284,60351	c	350002333400000197,350002333400000115,350002333400000110,350002333400000099,350002333400000096,350002333400000161,350002333400000095,350002333400000094,350002333400000158,350002333400000092,350002333400000157,350002333400000089,350002333400000154,350002333400000087,350002333400000152,350002333400000082,350002333400000147,350002333400000081,350002333400000145,350002333400000143,350002333400000077,350002333400000138	0-41,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,6-48,0-44						Proteins, Polynucleotides Encoding Them And Methods Of Using The Same 	.freshpatents.com	0	0		
695	chr26	14458223	14458254	3500029402	25		14458223	14458254	8421504	3	14,6,5	0,17,26	g	350002940200000014	1-26						NUCLEIC ACID PROMOTER - VTU HOLDING GMBH	www.sumobrain.com	0	0		
696	chr26	14591552	14629511	3500061628	398		14591552	14629511	8421504	12	33,12,35,12,48,48,36,12,48,44,30,40	0,249,312,434,1622,1718,4620,5232,16419,34985,35997,37919	c,g	350006162800000131,350006162800000133,350006162800000136,350006162800000138,350006162800000143,350006162800000159,350006162800000187,350006162800000190,350006162800000191,350006162800000191	0-45,0-47,0-48,0-48,0-48,0-48,0-44,0-45,0-25,0-25						Method For Diagnosing Non-small Cell Lung Cancer 	.freshpatents.com	0	0		
696	chr26	14591552	14629486	3500230031	329		14591552	14629486	8421504	11	33,12,35,12,48,48,36,12,48,30,15	0,249,312,434,447,1718,4620,5232,16419,35997,37919	c	350023003100000132,350023003100000134,350023003100000135,350023003100000139,350023003100000144,350023003100000160,350023003100000191	0-45,0-47,0-48,0-48,0-48,0-48,0-45						METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCER - Patent application	www.faqs.org	0	0		
696	chr26	14607992	14608017	3500081494	25		14607992	14608017	8421504	1	25	0	c	350008149400000006	0-25						Methods of treating, diagnosing or detecting cancer	Lai	2008	0		KIF11
696	chr26	14622504	14622528	3500230330	23		14622504	14622528	8421504	2	10,13	0,11	c	350023033000000356	12-35						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
698	chr26	14919047	14921594	3500360661	23		14919047	14921594	8421504	2	7,16	0,2531	c	350036066100000063	22-45						 Isoprenoid Biosynthesis 	www.docstoc.com	0	0		
699	chr26	14963055	14963084	3500285675	24		14963055	14963084	8421504	2	15,9	0,20	g	350028567500000015	3-36					Patent	Mutated thermostable nucleic acid polymerase enzyme from Thermus species Z05 (Patent US:5455170)	Abramson	1995	0		
699	chr26	14963055	14963084	3500145861	24		14963055	14963084	8421504	2	15,9	0,20	g	350014586100000107	3-36						PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME FROM THERMOSIPHO AFRICANUS - Cetus	www.sumobrain.com	0	0		
699	chr26	15031916	15031939	3500325563	23		15031916	15031939	8421504	1	23	0	g	350032556300000002	4-27						Retinoic acid metabolizing cytochrome P450	Wisniewski	2002	0		
699	chr26	15042049	15042073	3500458210	24		15042049	15042073	8421504	1	24	0	c	350045821000000018	0-24						MULTIPOTENT/PLURIPOTENT CELLS AND METHODS	Sakurada	2010	0		
699	chr26	15042049	15042073	3500375117	24		15042049	15042073	8421504	1	24	0	c	350037511700000044,350037511700000009	0-22,0-24						HUMAN PLURIPOTENT STEM CELLS INDUCED FROM UNDIFFERENTIATED STEM CELLS DERIVED FROM A HUMAN POSTNATAL TISSUE - Patent application	www.faqs.org	0	0		CYP26A1
699	chr26	15042049	15042073	3500321901	24		15042049	15042073	8421504	1	24	0	c	350032190100000018	0-24						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		
699	chr26	15042049	15042073	3500295400	24		15042049	15042073	8421504	1	24	0	c	350029540000000018	0-24						Multipotent/pluripotent cells and methods	Sakurada	2010	0		
699	chr26	15042049	15042073	3500283192	24		15042049	15042073	8421504	1	24	0	c	350028319200000018	0-24						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		
699	chr26	15042049	15042073	3500282644	24		15042049	15042073	8421504	1	24	0	c	350028264400000018	0-24					Patent	Induced pluripotent stem cells produced using reprogramming factors and a rho kinase inhibitor or a histone deacetylase inhibitor (Patent US:8211697)	Ishikawa	2012	0		
699	chr26	15042049	15042073	3500239675	24		15042049	15042073	8421504	1	24	0	c	350023967500000009	0-24						Human pluripotent stem cells induced from undifferentiated stem cells derived from a human postnatal tissue	Sakurada	2011	0		
699	chr26	15042049	15042073	3500216601	24		15042049	15042073	8421504	1	24	0	c	350021660100000052,350021660100000018	0-22,0-24						US Patent # 8,211,697. Induced pluripotent stem cells produced using reprogramming factors and a rho kinase inhibitor or a histone deacetylase inhibitor - Patents.com	patents.com	0	0		CYP26A1
699	chr26	15042049	15042073	3500171409	24		15042049	15042073	8421504	1	24	0	c	350017140900000009	0-24						Human pluripotent stem cells induced from undifferentiated stem cells derived from a human postnatal tissue	Ishikawa	2012	0		
699	chr26	15042049	15042073	3500127647	24		15042049	15042073	8421504	1	24	0	c	350012764700000018	0-24						Multipotent/pluripotent cells and methods	Ishikawa	2009	0		
699	chr26	15042049	15042073	3500036057	24		15042049	15042073	8421504	1	24	0	c	350003605700000018,350003605700000053	0-24,0-22						Multipotent/Pluripotent Cells and Methods - Patent application	www.faqs.org	0	0		CYP26A1
699	chr26	15042049	15042073	3500029588	24		15042049	15042073	8421504	1	24	0	c	350002958800000055,350002958800000018	0-22,0-24						MULTIPOTENT/PLURIPOTENT CELLS AND METHODS - Patent application	www.faqs.org	0	0		CYP26A1
699	chr26	15042049	15042073	3500025784	24		15042049	15042073	8421504	1	24	0	c	350002578400000018	0-24						Multipotent/Pluripotent Cells and Methods	Ishikawa	2009	0		
699	chr26	15042049	15042073	3500022727	24		15042049	15042073	8421504	1	24	0	c	350002272700000055,350002272700000018	0-22,0-24						MULTIPOTENT/PLURIPOTENT CELLS AND METHODS - Patent application	www.faqs.org	0	0		CYP26A1
699	chr26	15042049	15042073	3500013834	24		15042049	15042073	8421504	1	24	0	c	350001383400000009	0-24						HUMAN PLURIPOTENT STEM CELLS INDUCED FROM UNDIFFERENTIATED STEM CELLS DERIVED FROM A HUMAN POSTNATAL TISSUE	Sakurada	2007	0		
699	chr26	15042049	15042073	3500013444	24		15042049	15042073	8421504	1	24	0	c	350001344400000055,350001344400000018	0-22,0-24						Multipotent/pluripotent cells and methods - Patent application	www.faqs.org	0	0		CYP26A1
699	chr26	15042331	15042355	3500411682	24		15042331	15042355	8421504	1	24	0	c	350041168200000002	23-47						Role of the 26S proteasome and Posttranslational Modifications in Regulating the Expression of Retinoic Acid-Responsive Genes	w.ruor.uottawa.ca	0	0		CYP26A1
699	chr26	15042424	15044742	3500356848	334		15042424	15044742	8421504	9	48,39,26,48,40,48,4,33,48	0,126,328,973,1681,1770,2184,2189,2270	c	350035684800000117,350035684800000042,350035684800000122,350035684800000048,350035684800000050,350035684800000052,350035684800000055,350035684800000057	0-48,9-48,0-26,0-48,7-47,0-48,11-48,0-48						P450rai-2 (p450 Cytochrome 26b), Encoding Nucleic Acid Molecules And Methods And Uses Thereof 	.freshpatents.com	0	0		
699	chr26	15042550	15044742	3500189250	212		15042550	15044742	8421504	6	39,40,48,4,33,48	0,1555,1644,2058,2063,2144	c	350018925000000042,350018925000000050,350018925000000052,350018925000000055,350018925000000057	9-48,7-47,0-48,11-48,0-48						P450RAI-2 (P450 CYTOCHROME 26B), ENCODING NUCLEIC ACID MOLECULES AND METHODS AND USES THEREOF - Patent application	www.faqs.org	0	0		
701	chr26	15251547	15254440	3500384679	29		15251547	15254440	8421504	4	9,4,3,13	0,13,2873,2880	c	350038467900000074	3-48						Methods for the generation of primordial germ cells and transgenic animal species	Piedrahita	1998	0		
701	chr26	15317865	15317910	3500041644	45		15317865	15317910	8421504	1	45	0	p	350004164400015041	0-45						ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLIN - Patent application	www.faqs.org	0	0		MYOF
702	chr26	15361674	15361700	3500169933	23		15361674	15361700	8421504	2	13,10	0,16	g	350016993300000060	8-31						Virology Journal BioMed Central	www.virologyj.com	0	0		
702	chr26	15361674	15361700	3500107680	23		15361674	15361700	8421504	2	13,10	0,16	g	350010768000000016	8-31						CODEHOP-mediated PCR &#x2013; A powerful technique for the identification and characterization of viral genomes - Springer	link.springer.com	0	0		
703	chr26	15468271	15470886	3500109425	60		15468271	15470886	8421504	3	6,33,21	0,1902,2594	c	350010942500000050	0-60						Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer	Afar	2002	0		
703	chr26	15526686	15530455	3500018521	40		15526686	15530455	8421504	2	20,20	0,3749	c,g	350001852100000001,350001852100000001,350001852100000000	0-20,0-20,0-20						REGULATION OF RETINOL BINDING PROTEIN 4 EXPRESSION AND ITS RELATION TO ADIPOGENESIS IN BOVINE ADIPOCYTES	thescipub.com	0	0		
703	chr26	15526767	15526794	3500465455	23		15526767	15526794	8421504	2	16,7	0,20	c	350046545500000081	0-23						Antibody Gene Transfer and Recombinant AAV Therefor - Patent application	www.faqs.org	0	0		
703	chr26	15526773	15530622	3500111639	40		15526773	15530622	8421504	2	20,20	0,3829	c,g	350011163900000005,350011163900000005,350011163900000004	0-20,0-20,0-20						Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin	-publications.com	0	0		RBP4
703	chr26	15526844	15530097	3500413563	45		15526844	15530097	8421504	2	5,40	0,3213	p	350041356300015007	0-45						Treatment of hyperproliferative diseases	Ward	2002	0		RBP4
703	chr26	15526844	15530097	3500273599	45		15526844	15530097	8421504	2	5,40	0,3213	p	350027359900015007	0-45						Treatment of hyperproliferative diseases	Ward	2002	0		RBP4
703	chr26	15530398	15530595	3500211111	102		15530398	15530595	8421504	2	72,30	0,167	p	350021111100015002	0-102						ncbi&#x4f7f;&#x7528;&#x6280;&#x5de7; spss&#x4f7f;&#x7528;&#x6307;&#x5357; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		RBP4
703	chr26	15530425	15530589	3500455073	69		15530425	15530589	8421504	2	45,24	0,140	p	350045507300015004	0-69						TaiLieu.VN: SO S&#xc1;NH C&#xc1;C TR&#xcc;NH T&#x1ef0; SINH H&#x1ecc;C B&#x1eb0;NG BLAST V&#xc0; CLUTALX 	tailieu.vn/doc/so	0	0		RBP4
703	chr26	15530425	15530589	3500374430	69		15530425	15530589	8421504	2	45,24	0,140	p	350037443000015003	0-69						BLAST	www.csus.edu	0	0		RBP4
703	chr26	15530425	15530589	3500217555	69		15530425	15530589	8421504	2	45,24	0,140	p	350021755500015001	0-69						Biology 4900	www.docstoc.com	0	0		RBP4
703	chr26	15530425	15530589	3500138377	69		15530425	15530589	8421504	2	45,24	0,140	p	350013837700015002	0-69						&#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x7b2c;4&#x8bb2;-&#x5e8f;&#x5217;&#x76f8;&#x4f3c;&#x6027;&#x641c;&#x7d22; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		RBP4
703	chr26	15530596	15530912	3500091202	40		15530596	15530912	8421504	3	20,9,11	0,89,305	c	350009120200000001,350009120200000000	0-20,0-20						Alterations in systemic concentrations of progesterone during the early luteal phase affect RBP4 expression in the bovine uterus. - ResearchGate	.researchgate.net	0	0		
703	chr26	15542554	15542577	3500335263	23		15542554	15542577	8421504	1	23	0	g	350033526300000122	17-42						Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof	Chandrashekar	1999	0		
703	chr26	15574122	15585793	3500245742	23		15574122	15585793	8421504	3	10,1,12	0,14,11659	c	350024574200000006	2-25						SUBTRACTIVE TRANSGENICS - Patent application	www.faqs.org	0	0		
705	chr26	15746296	15746322	3500287505	23		15746296	15746322	8421504	2	16,7	0,19	c	350028750500000158	11-34						Methods for diagnosing Pseudoxanthoma elasticum	www.devileye.net	0	0		
705	chr26	15772378	15772412	3500099159	24		15772378	15772412	8421504	3	6,6,12	0,11,22	g	350009915900000055	7-33						Streptococcus pneumoniae proteins and nucleic acids	Masignani	2011	0		
709	chr26	16280266	16280289	3500467403	23		16280266	16280289	8421504	1	23	0	c	350046740300000008	0-23						&#x4e3b;&#x9898;&#xff1a;Adrenergic | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		PLCE1
711	chr26	16578716	16586282	3500077888	48		16578716	16586282	8421504	3	25,4,19	0,28,7547	c	350007788800000022,350007788800000023	0-25,0-23						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
711	chr26	16586742	16589599	3500112685	66		16586742	16589599	8421504	2	7,59	0,2798	p,c	350011268500015003,350011268500015002,350011268500000006	0-66,0-66,0-20						Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle	web1.sssup.it	0	0		CYP2C8
711	chr26	16619375	16619400	3500085216	25		16619375	16619400	8421504	1	25	0	c	350008521600000073	0-25						Cloning, expression and diagnosis of human cytochrome p450 2c19: the principal determinant of s-mephenytoin metabolism	De	1995	0		
712	chr26	16680764	16680793	3500085216	29		16680764	16680793	8421504	1	29	0	c	350008521600000053	0-29						Cloning, expression and diagnosis of human cytochrome p450 2c19: the principal determinant of s-mephenytoin metabolism	De	1995	0		
712	chr26	16705901	16705946	3500426529	45		16705901	16705946	8421504	1	45	0	p	350042652900015000	0-45						&#x30b5;&#x30eb;&#x306e;&#x65b0;&#x898f;&#x85ac;&#x7269;&#x4ee3;&#x8b1d;&#x9175;&#x7d20; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; 2012055274&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		
714	chr26	17018979	17026062	3500066892	25		17018979	17026062	8421504	2	8,17	0,7066	c	350006689200000004	1-26		10497139		1521-009X (Online)	Drug Metabolism and Disposition	Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib	Paulson	1999	0		
717	chr26	17335450	17349684	3500111618	23		17335450	17349684	8421504	2	18,5	0,14229	c	350011161800000150	0-23						Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression	005.pasteur.ac.ir	0	0		
720	chr26	17787783	17787821	3500433362	36		17787783	17787821	8421504	2	16,20	0,18	c	350043336200000001	2-40		21325440	10.1124/jpet.111.179994	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	The Expression Level of Ecto-NTP Diphosphohydrolase1/CD39 Modulates Exocytotic and Ischemic Release of Neurotransmitters in a Cellular Model of Sympathetic Neurons	Corti	2011	0		
722	chr26	17984885	17999247	3500310233	1116		17984885	17999247	8421504	5	69,211,299,128,409	0,5089,12773,13192,13953	p	350031023300015000	0-1116						DNASU | CCNJ&#xa0;(Homo sapiens) in pLX304 (Gateway V5-tagged lentiviral expression vector) 	dnasu.org/DNASU/G	0	0		
722	chr26	18052545	18052571	3500016811	23		18052545	18052571	8421504	2	5,18	0,8	g	350001681100000006	1-24						The integral inner membrane component XcpS of the Pseudomonas aeruginosa type II secretion system: Freya Senf	ive.library.uu.nl	0	0		
723	chr26	18136035	18136061	3500459021	23		18136035	18136061	8421504	2	11,12	0,14	g	350045902100000793	11-34						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
725	chr26	18436294	18471714	3500430220	1311		18436294	18471714	8421504	14	65,70,40,32,61,69,140,131,95,167,132,78,161,70	0,3742,3990,4481,4567,7484,10388,19191,20849,25759,28108,31298,32388,35350	p	350043022000015229,350043022000015226,350043022000015222,350043022000015220,350043022000015218,350043022000015214,350043022000015211,350043022000015209	36-171,0-165,0-180,0-180,0-180,0-177,0-180,0-168						49 human secreted proteins	A	2000	0		TM9SF3
726	chr26	18484565	18484622	3500317862	57		18484565	18484622	8421504	1	57	0	p	350031786200015003	0-57						Molecular cloning and characterization of human age-related NADH oxidase (arNOX) proteins as members of the TM9 superfamily of transmembrane proteins	www.scirp.org	0	0		TM9SF3
726	chr26	18484565	18484622	3500298774	57		18484565	18484622	8421504	1	57	0	p	350029877400015003	0-57						Molecular cloning and characterization of human age-related NADH oxidase (arNOX) proteins as members of the TM9 superfamily of transmembrane proteins	www.scirp.org	0	0		TM9SF3
727	chr26	18617913	18617941	3500247665	24		18617913	18617941	8421504	2	13,11	0,17	g	350024766500000099	0-24					Patent	Method for modifying chromosomes (Patent US:8124406)	Hanaoka	2012	0		
728	chr26	18815404	18817095	3500076526	462		18815404	18817095	8421504	6	36,63,153,57,123,30	0,1214,1280,1466,1535,1661	p	350007652600015044,350007652600015046,350007652600015048,350007652600015050	0-174,0-51,0-171,0-153						41 human secreted proteins	Komatsoulis	2001	0		
729	chr26	18880721	18880994	3500415375	231		18880721	18880994	8421504	2	48,183	0,90	p	350041537500015020,350041537500015009,350041537500015031	0-48,0-60,0-180						Zebra&#xfb01;sh tinman homolog demarcates the heart &#xfb01;eld and initiates myocardial differentiation	ev.biologists.org	0	0		
730	chr26	19029688	19029718	3500176877	23		19029688	19029718	8421504	3	5,12,6	0,7,24	g	350017687700000022	15-38						Wnt/ &#x03b2;-Catenin-Zielgene in der Maus-Entwicklung	k.uni-freiburg.de	0	0		
731	chr26	19150325	19150351	3500137655	24		19150325	19150351	8421504	3	4,11,9	0,5,17	g	350013765500000028	7-31					Patent	Hepadnavirus receptor (Patent US:5929220)	Li	1999	0		
733	chr26	19446201	19446226	3500016751	23		19446201	19446226	8421504	2	7,16	0,9	g	350001675100000126	10-33						Entomopoxvirus spheroidin gene sequences	Moyer	1992	0		
735	chr26	19727205	19727232	3500379151	25		19727205	19727232	8421504	2	11,14	0,13	g	350037915100000007	14-45			10.1128/JVI.77.9.5178-5191.2003		Journal of Virology	Characterization of the Minimal DNA Binding Domain of the Human Papillomavirus E1 Helicase: Fluorescence Anisotropy Studies and Characterization of a Dimerization-Defective Mutant Protein	S.	2003	0		
736	chr26	19819354	19819381	3500462459	24		19819354	19819381	8421504	2	10,14	0,13	g	350046245900000062	13-37						CYTOLETHAL DISTENDING TOXINS AND DETECTION OF CAMPYLOBACTER BACTERIA USING THE SAME AS A TARGET - Patent application	www.faqs.org	0	0		
737	chr26	19942951	19942974	3500246463	23		19942951	19942974	8421504	1	23	0	c	350024646300000024	0-23						Modulation of Gene Expression Using Oligomers That Target Gene Regions Downstream of 3' Untranslated Regions	Corey	2010	0		PYROXD2
737	chr26	19991034	19991063	3500160005	26		19991034	19991063	8421504	2	15,11	0,18	g	350016000500000025	9-37						Original article Microsatellite loci in Japanese quail and cross-species ampli&#xfb01;cation in chicken and guinea fowl	biomedcentral.com	0	0		
740	chr26	20320355	20320383	3500260488	24		20320355	20320383	8421504	3	5,6,13	0,7,15	g	350026048800000096	24-48						Hemoglobin receptors from neisseriae	Heffron	1996	0		
740	chr26	20418803	20420740	3500458997	35		20418803	20420740	8421504	2	2,33	0,1904	p	350045899700015052	75-167						<Html><Title> Complet list of 1h18 hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
741	chr26	20506650	20506980	3500337812	330		20506650	20506980	8421504	1	330	0	p	350033781200015027	0-330						Wnt antagonists and methods of treatment and screening	Satyal	2011	0		SFRP5
741	chr26	20506650	20506980	3500039991	330		20506650	20506980	8421504	1	330	0	p	350003999100015029	0-330						WNT ANTAGONISTS AND METHODS OF TREATMENT AND SCREENING - ONCOMED PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		SFRP5
741	chr26	20506818	20506866	3500200120	48		20506818	20506866	8421504	1	48	0	p	350020012000015007	0-48						Diagnostics And Therapeutics For Glaucoma 	.freshpatents.com	0	0		SFRP5
741	chr26	20506818	20506866	3500164073	48		20506818	20506866	8421504	1	48	0	p	350016407300015007	0-48						Diagnostics and therapeutics for glaucoma - US Patent 7033755 Description	ww.patentstorm.us	0	0		SFRP5
741	chr26	20506850	20506874	3500189431	23		20506850	20506874	8421504	2	4,19	0,5	c	350018943100000538	0-23						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
741	chr26	20508722	20510283	3500219009	48		20508722	20510283	8421504	2	24,24	0,1537	c	350021900900000036,350021900900000037	0-24,0-24						Concurrent epigenetic silencing of wnt/&#xfffd;-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia	biomedcentral.com	0	0		SFRP5
741	chr26	20553814	20553839	3500168145	25		20553814	20553839	8421504	1	25	0	c	350016814500000005	20-45						Characterization of insulin sensitivity and inflammation related factors in dairy cows receiving conjugated linoleic acids (CLA) or a control fat supplement during lactation	s.ulb.uni-bonn.de	0	0		
742	chr26	20580062	20580090	3500130848	26		20580062	20580090	8421504	2	9,17	0,11	c	350013084800000221	22-48						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
742	chr26	20580062	20580090	3500008756	26		20580062	20580090	8421504	2	9,17	0,11	c	350000875600000221	22-48						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
743	chr26	20749735	20751495	3500307359	444		20749735	20751495	8421504	7	12,57,99,85,47,45,99	0,135,338,440,854,1327,1661	p	350030735900015114,350030735900015116,350030735900015120	0-168,0-132,0-144						48 human secreted proteins	Komatsoulis	2000	0		MMS19
743	chr26	20755686	20756780	3500043960	90		20755686	20756780	8421504	4	45,8,29,8	0,48,665,1086	p	350004396000015028,350004396000015027	0-45,0-45						ALTERED ZDHHC8 EXPRESSION AS A MARKER OF INCREASED RISK OF SCHIZOPHRENIA - Patent application	www.faqs.org	0	0		ZDHHC16
743	chr26	20770896	20776463	3500407027	750		20770896	20776463	8421504	5	167,58,111,275,139	0,1067,1137,1749,5428	p	350040702700015022,350040702700015018,350040702700015014,350040702700015010,350040702700015006,350040702700015002	0-63,0-162,0-129,0-174,0-93,0-129						Burkholderia Pseudomallei	st.bic.nus.edu.sg	0	0		
743	chr26	20770896	20776463	3500171597	762		20770896	20776463	8421504	4	167,181,275,139	0,1067,1749,5428	p	350017159700015000	0-762						KEGG T01001: 5223	www.genome.jp	0	0		
743	chr26	20772879	20772905	3500058427	26		20772879	20772905	8421504	1	26	0	c	350005842700000114	0-26						Methods of identifying compounds that modulate protein activity	Berghs	2005	0		
743	chr26	20810205	20810401	3500242423	23		20810205	20810401	8421504	3	3,9,11	0,173,185	c	350024242300000039	13-36					Patent	A novel protein, a genes encoding therefor and a method of using the same (Patent CN:100545263)	Gao Cang You Guang 	2009	0		
745	chr26	21010922	21010951	3500268904	25		21010922	21010951	8421504	3	4,7,14	0,5,15	g	350026890400000000	5-30						Zerumbone Induces Heme Oxygenase-1 Expression in Mouse Skin and Cultured Murine Epidermal Cells through Activation of Nrf2	.aacrjournals.org	0	0		
746	chr26	21207509	21207533	3500000954	24		21207509	21207533	8421504	1	24	0	g	350000095400000005,350000095400000006	5-29,0-24						Hepatocyte Nuclear Factor (HNF) 1 and HNF4 Mediate Hepatic Multidrug Resistance Protein 2 Up-Regulation during Hepatitis C Virus Gene Expression 2006&#x5e74;&#x7b2c;68&#x5377;&#x7b2c;8&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c	www.39kf.com	0	0		
747	chr26	21294496	21294541	3500079754	45		21294496	21294541	8421504	1	45	0	p	350007975400015009	0-45						Heparanase Specific Molecular Probes And Their Use In Research And Medical Applications 	.freshpatents.com	0	0		DNMBP
747	chr26	21321982	21322010	3500346476	27		21321982	21322010	8421504	2	22,5	0,23	g	350034647600000010,350034647600000009	32-59,32-59						BMC Bioinformatics BioMed Central	biomedcentral.com	0	0		
93	chr26	21488633	21504507	3500149440	38		21488633	21504507	8421504	2	19,19	0,15855	c,g	350014944000000001,350014944000000001,350014944000000000	0-19,0-19,0-19						SPFH1 and SPFH2 mediate the ubiquitination and degradation of inositol 1,4,5-trisphosphate receptors in muscarinic receptor-expressing HeLa cells. - ResearchGate	.researchgate.net	0	0		ERLIN1
749	chr26	21531800	21532582	3500237196	33		21531800	21532582	8421504	3	25,2,6	0,28,776	c	350023719600000002	5-39		20720575	10.1038/gt.2010.110		Gene therapy	Inhibition of the IKK/NF-&#x03ba;B Pathway by AAV Gene Transfer Improves Muscle Regeneration in Older mdx Mice	Ying	2010	0		
749	chr26	21534912	21534998	3500175024	43		21534912	21534998	8421504	2	20,23	0,63	c,g	350017502400000021,350017502400000021,350017502400000020	0-20,0-20,1-24						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
749	chr26	21560987	21561011	3500454678	24		21560987	21561011	8421504	1	24	0	c	350045467800000022,350045467800000023	22-46,0-23						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2004	0		
749	chr26	21560988	21561011	3500048665	23		21560988	21561011	8421504	1	23	0	c	350004866500000064	0-23						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2005	0		
749	chr26	21560996	21562181	3500240665	90		21560996	21562181	8421504	4	19,26,12,33	0,614,1000,1152	p	350024066500015016,350024066500015011	0-45,0-45						Inhibition of cancer metastasis - Patent application	www.faqs.org	0	0		
749	chr26	21565779	21565813	3500140968	33		21565779	21565813	8421504	2	18,15	0,19	c	350014096800000002	0-33						Antisense modulation of cd44 expression	Bennett	2000	0		
749	chr26	21575529	21575594	3500084244	59		21575529	21575594	8421504	2	12,47	0,18	c	350008424400000023	0-62						Comparative analysis of transposed element insertion within human and mouse genomes reveals Alu's unique role in shaping the human transcriptome Noa Sela Wagenblatt	www.tau.ac.il	0	0		
751	chr26	21849166	21849190	3500244842	24		21849166	21849190	8421504	1	24	0	c	350024484200000000	0-24						Supporting Information 	www.pnas.org	0	0		HIF1AN
752	chr26	21920103	21920133	3500137915	30		21920103	21920133	8421504	1	30	0	g	350013791500000601	2-39						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
754	chr26	22262742	22262769	3500113379	23		22262742	22262769	8421504	3	5,12,6	0,7,21	g	350011337900000050	7-30						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
755	chr26	22402965	22405113	3500376059	84		22402965	22405113	8421504	2	52,32	0,2116	p	350037605900015018	0-84		8600458			Nucleic Acids Research	Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA.	Shen	1996	0		TLX1NB,TLX1
94	chr26	22670646	22745700	3500036459	1293		22670646	22745700	8421504	30	45,27,18,45,45,93,45,45,45,45,8,37,24,36,45,45,26,19,45,45,78,51,9,107,67,41,19,57,36,45	0,48,17898,17919,53162,53210,53306,58967,59036,59084,59132,64095,64168,64839,64878,64926,65546,67193,67215,67263,67311,67392,67929,67941,69255,69325,70768,70790,74970,75009	p,c	350003645900015005,350003645900015006,350003645900015007,350003645900015009,350003645900015010,350003645900015045,350003645900015011,350003645900000020,350003645900015012,350003645900015048,350003645900015015,350003645900015016,350003645900015017,350003645900015053,350003645900015019,350003645900015020,350003645900015021,350003645900015024,350003645900015025,350003645900015026,350003645900015027,350003645900015062,350003645900015063,350003645900015029,350003645900015030,350003645900015065,350003645900015031,350003645900015066,350003645900015032,350003645900015067,350003645900015068,350003645900015034,350003645900015035,350003645900015070,350003645900015036,350003645900015037	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-21,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						METHODS TO IDENTIFY COMPOUNDS USEFUL FOR TUMOR SENSITIZATION TO DNA DAMAGE - Patent application	www.faqs.org	0	0		
759	chr26	22878387	22878419	3500220927	27		22878387	22878419	8421504	4	5,13,4,5	0,7,21,27	g	350022092700000017	1-28						Supporting Information 	www.pnas.org	0	0		
760	chr26	22950323	22950515	3500445910	192		22950323	22950515	8421504	1	192	0	p	350044591000015154,350044591000015153,350044591000015152,350044591000015151	0-48,0-48,0-48,0-48						Human Fgf-23 Gene And Gene Expression Products 	.freshpatents.com	0	0		FGF8
760	chr26	22950371	22954936	3500082590	43		22950371	22954936	8421504	2	21,22	0,4543	c,g	350008259000000013,350008259000000013,350008259000000012	0-21,0-21,0-22						The pure anti-androgen bicalutamide inhibits cyclin A expression both in androgen-dependent and -independent cell lines	-publications.com	0	0		FGF8
760	chr26	22950407	22951503	3500142509	120		22950407	22951503	8421504	3	30,45,45	0,33,1051	p	350014250900015135,350014250900015133	45-120,0-45						Fibroblast growth factor (FGF23) polypeptides - US Patent 7745406 Description	ww.patentstorm.us	0	0		FGF8
760	chr26	22950440	22951503	3500213723	90		22950440	22951503	8421504	2	45,45	0,1018	p	350021372300015172,350021372300015168	0-45,0-45						Methods of Diagnosing Hypophosphatemic Disorders - Patent application	www.faqs.org	0	0		FGF8
760	chr26	22950548	22950572	3500008335	24		22950548	22950572	8421504	1	24	0	c	350000833500000045	0-24						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
760	chr26	22978635	22991812	3500184501	642		22978635	22991812	8421504	11	90,75,14,55,69,48,39,86,98,52,16	0,162,243,1113,2382,2484,7595,7640,9262,9791,13161	p	350018450100015042,350018450100015028,350018450100015015,350018450100015008	0-90,0-144,0-198,0-210						Enterococcus faecium	.javeriana.edu.co	0	0		MGEA5
761	chr26	23158100	23158339	3500409160	40		23158100	23158339	8421504	2	20,20	0,219	c,g	350040916000000038,350040916000000039,350040916000000039	0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
761	chr26	23162008	23162053	3500235660	45		23162008	23162053	8421504	1	45	0	p	350023566000015004	111-156						Characterization and Expression of Two cDNAs Encoding Carbonic Anhydrase in Arabidopsis thaliana	www.jstor.org	0	0		
761	chr26	23162010	23163151	3500458997	63		23162010	23163151	8421504	2	18,45	0,1096	p	350045899700015050	15-78						<Html><Title> Complet list of 1h18 hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
761	chr26	23162041	23163188	3500436089	174		23162041	23163188	8421504	2	53,121	0,1026	p	350043608900015002	0-174						CREB/NRF-1 binding domain associated with cytochrome ACCEPTED	mcb.asm.org	0	0		
762	chr26	23312141	23312167	3500065320	24		23312141	23312167	8421504	3	4,16,4	0,5,22	c	350006532000000004	6-30						Studies Enabling a Faster Directed Evolution	uhr-uni-bochum.de	0	0		
764	chr26	23505575	23505806	3500007545	56		23505575	23505806	8421504	2	20,36	0,195	g	350000754500000002,350000754500000000,350000754500000003	0-20,6-25,0-20						Identification of novel putative regulators of the major apoptotic nuclease DNA Fragmentation Factor	www.actabp.pl	0	0		
765	chr26	23598364	23598391	3500118777	24		23598364	23598391	8421504	3	12,6,6	0,13,21	g	350011877700000000	5-29						Viable Bacteria Present within Oral Squamous Cell Carcinoma Tissue	jcm.asm.org	0	0		
765	chr26	23617057	23622740	3500427173	1833		23617057	23622740	8421504	23	34,82,41,56,42,152,106,100,105,86,139,129,101,6,114,40,20,90,103,47,45,70,125	0,375,591,891,948,1069,1485,1739,2098,2304,2468,2842,3098,3990,4087,4261,4454,4534,4739,4976,5083,5258,5558	p,c,g	350042717300000018,350042717300000018,350042717300015014,350042717300015015,350042717300000022,350042717300000000,350042717300000000,350042717300015017,350042717300000023,350042717300015018,350042717300000024,350042717300015019,350042717300000026,350042717300015020,350042717300000027,350042717300015021,350042717300015023,350042717300000003,350042717300015024,350042717300015025,350042717300000031,350042717300000032,350042717300015027,350042717300000033,350042717300015028,350042717300000034,350042717300015029,350042717300000035,350042717300015030,350042717300000036,350042717300015031,350042717300000037,350042717300000038,350042717300015033,350042717300000039,350042717300000006,350042717300015040,350042717300015041,350042717300015043,350042717300015045,350042717300015046,350042717300015047,350042717300015048,350042717300015050,350042717300000056,350042717300015051,350042717300000057,350042717300015052,350042717300015053	26-60,26-60,0-60,0-60,0-59,0-20,0-20,0-60,0-60,0-60,0-50,0-60,0-60,0-60,0-60,0-60,0-60,0-31,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-59,0-60,9-65,0-60,0-60,0-60,0-21,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-29,0-60,0-60						CLONING AND EXPRESSION OF EQUINE NF- B2	pository.tamu.edu	0	0		
765	chr26	23618791	23619181	3500383646	40		23618791	23619181	8421504	2	20,20	0,370	c,g	350038364600000018,350038364600000018,350038364600000019	0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
765	chr26	23619371	23619588	3500232777	45		23619371	23619588	8421504	2	23,22	0,195	c,g	350023277700000056,350023277700000057,350023277700000057	0-23,0-22,0-22						1 abstract title	tory.lib.ncsu.edu	0	0		
765	chr26	23623630	23629407	3500083374	40		23623630	23629407	8421504	3	6,13,21	0,8,5756	c,g	350008337400000030,350008337400000111	10-29,4-26					Patent	Compositions and methods relating to STOP-1 (Patent US:7799899)	Ackerly	2010	0		
765	chr26	23641770	23641800	3500347059	26		23641770	23641800	8421504	3	8,12,6	0,10,24	c	350034705900000159	19-45					Patent	Process for producing 7-aminocephem compound or salts thereof (Patent US:5677141)	Aramori	1997	0		
765	chr26	23654777	23654851	3500040785	73		23654777	23654851	8421504	2	44,29	0,45	c	350004078500000108,350004078500000081	0-73,0-22						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		CUEDC2
95	chr26	23704776	23799833	3500248008	1296		23704776	23799833	8421504	10	182,135,137,143,86,73,154,112,135,139	0,4855,36590,72544,73564,73903,77031,78991,93248,94918	p	350024800800015000	0-1296						KEGG T01001: 51684	www.genome.jp	0	0		ACTR1A,SUFU
766	chr26	23777380	23783831	3500065643	40		23777380	23783831	8421504	2	20,20	0,6431	c	350006564300000006,350006564300000007	0-20,0-20						Enhancement of GLI1-transcriptional activity by &#xdf;-catenin in human cancer cells	-publications.com	0	0		
766	chr26	23778710	23781869	3500039644	40		23778710	23781869	8421504	2	20,20	0,3139	c,g	350003964400000008,350003964400000008,350003964400000009,350003964400000009	0-20,0-20,0-20,0-20						Hedgehog-InducedSurvivalofB-CellChronicLymphocytic LeukemiaCellsinaStromalCellMicroenvironment: APotentialNewTherapeuticTarget	.aacrjournals.org	0	0		SUFU
766	chr26	23783832	23783855	3500352019	23		23783832	23783855	8421504	1	23	0	c	350035201900000057	0-23						Etude des propri&#xe9;t&#xe9;s h&#xe9;mato-supportives in vitro des cellules souches m&#xe9;senchymateuses	bictel.ulg.ac.be	0	0		
766	chr26	23837212	23837237	3500111234	24		23837212	23837237	8421504	2	16,8	0,17	c	350011123400000134	6-30						Znf206: A Novel Regulator Of Embryonic Stem Cell Self-renewal And Pluripotency 	.freshpatents.com	0	0		
767	chr26	23944322	23944635	3500055961	40		23944322	23944635	8421504	2	20,20	0,293	g	350005596100000001,350005596100000000	0-20,0-20		20699380	10.1530/REP-10-0214	1470-1626	Reproduction	Evidence that high variation in antral follicle count during follicular waves is linked to alterations in ovarian androgen production in cattle	Mossa	2010	3		
769	chr26	24244087	24246020	3500303537	25		24244087	24246020	8421504	2	2,23	0,1910	c	350030353700000009	1-26						ScienceDirect.com - Biochimica et Biophysica Acta (BBA) - Molecular Cell Research - Knockdown of cytosolic 5&#x2032;-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells	sciencedirect.com	0	0		
770	chr26	24281750	24281782	3500090833	28		24281750	24281782	8421504	2	18,10	0,22	c	350009083300000024	17-45						Les transporteurs de peptides de	hives-ouvertes.fr	0	0		
771	chr26	24379647	24379670	3500310739	23		24379647	24379670	8421504	1	23	0	c	350031073900000002	2-25						&#x4e3b;&#x9898;&#xff1a;involved | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
771	chr26	24494268	24495586	3500438337	25		24494268	24495586	8421504	2	12,13	0,1305	c	350043833700000005	0-25						Target Genes of Neuron-Restrictive Silencer Factor Are Abnormally Up-Regulated in Human Myotilinopathy 2007&#x5e74;&#x7b2c;169&#x5377;&#x7b2c;10&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
773	chr26	24748863	24748888	3500308226	23		24748863	24748888	8421504	3	6,12,5	0,7,20	g	350030822600000034	13-39		11861841	10.1128/JVI.76.6.2739-2752.2002	0022-538X	Journal of Virology	Specific Inactivation of Inhibitory Sequences in the 5&#x2032; End of the Human Papillomavirus Type 16 L1 Open Reading Frame Results in Production of High Levels of L1 Protein in Human Epithelial Cells	Collier	2002	5		
773	chr26	24755045	24755070	3500085287	25		24755045	24755070	8421504	1	25	0	c,g	350008528700000008,350008528700000008	0-25,0-25						Methods and compositions for the diagnosis, prognosis, and treatment of cancer	Neuman	2003	0		NEURL
773	chr26	24755560	24755585	3500308331	24		24755560	24755585	8421504	2	5,19	0,6	c	350030833100000291	14-38						Recombinant neu differentiation factors		1995	0		
774	chr26	24827259	24827286	3500139986	23		24827259	24827286	8421504	2	8,15	0,12	g	350013998600000006,350013998600000087	0-23,0-23						Apoptosis inducing molecule II and methods of use	Ebner	2000	0		
774	chr26	24827259	24827286	3500073508	23		24827259	24827286	8421504	2	8,15	0,12	g	350007350800000006	0-23						Apoptosis inducing molecule ii and methods of use	Ebner	1999	0		
776	chr26	25109939	25109967	3500274681	23		25109939	25109967	8421504	2	16,7	0,21	g	350027468100000078	7-30						Cystic fibrosis gene mutations - Patent # 8338578 - PatentGenius	.patentgenius.com	0	0		
777	chr26	25175253	25175279	3500380085	23		25175253	25175279	8421504	2	16,7	0,19	g	350038008500000004	13-37						Vaccines against chlamydia infection	Brazer	2008	0		
778	chr26	25361837	25361863	3500393412	24		25361837	25361863	8421504	2	6,18	0,8	g	350039341200000010	0-24						Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform	Gerngross	2007	0		
778	chr26	25361837	25361863	3500010992	24		25361837	25361863	8421504	2	6,18	0,8	g	350001099200000010	0-24						Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform	Gerngross	2005	0		
779	chr26	25476376	25476402	3500279355	23		25476376	25476402	8421504	2	7,16	0,10	g	350027935500000004	14-37						US Patent # 5,516,674. Insecticide resistance associated cytochrome 450 - Patents.com	www.patents.com	0	0		
780	chr26	25587735	25587860	3500373947	44		25587735	25587860	8421504	2	22,22	0,103	g	350037394700000192,350037394700000193	0-22,0-22						Udder Health Characteristics	Lund	2007	0		
784	chr26	26153714	26153737	3500089885	23		26153714	26153737	8421504	1	23	0	g	350008988500000021	0-23		11566755	10.1095/biolreprod65.4.1289	0006-3363	Biology of Reproduction	Identification of a Novel Retrovirus Expressed in Rat Sertoli Cells and Granulosa Cells	Anway	2001	4		
790	chr26	26900800	26900828	3500225844	24		26900800	26900828	8421504	2	11,13	0,15	g	350022584400000135	6-48						US Patent # 6,011,068. Calcium receptor-active molecules - Patents.com	www.patents.com	0	0		
796	chr26	27732384	27732411	3500068155	23		27732384	27732411	8421504	2	14,9	0,18	g	350006815500000235	0-23						AMPLIFICATION DYNAMICS OF PRIMATE RETROTRANSPOSONS	etd.lsu.edu	0	0		
800	chr26	28239819	28239844	3500341533	24		28239819	28239844	8421504	2	20,4	0,21	g	350034153300000052	15-42						Microbial system for formaldehyde sensing and remediation	Donohue	1998	0		
808	chr26	29284925	29284949	3500374909	24		29284925	29284949	8421504	1	24	0	g	350037490900000281	11-35						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
819	chr26	30747069	30748334	3500230330	23		30747069	30748334	8421504	2	14,9	0,1256	c	350023033000000387,350023033000000266	4-27,10-33						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
819	chr26	30788504	30788532	3500408735	25		30788504	30788532	8421504	2	17,8	0,20	c	350040873500000144	1-26						METHODS AND MEANS FOR REGULATING GENE EXPRESSION	Den	2004	0		
821	chr26	31024999	31025027	3500412090	24		31024999	31025027	8421504	3	6,14,4	0,9,24	g	350041209000000026	0-24						Polymer conjugates of interferon beta- 1a and their uses	Brickelmaier	2000	0		
102	chr26	31136310	31207681	3500389014	141		31136310	31207681	8421504	5	2,30,16,45,48	0,25863,63672,63736,71323	p	350038901400015006,350038901400015008,350038901400015014	0-48,0-45,0-48						Max-interacting proteins and related molecules and methods	Brent	1995	0		MXI1
102	chr26	31136310	31207681	3500385283	141		31136310	31207681	8421504	5	2,30,16,45,48	0,25863,63672,63736,71323	p	350038528300015006,350038528300015008,350038528300015014	0-48,0-45,0-48						Max-interacting proteins and related molecules and methods	Brent	2001	0		MXI1
102	chr26	31136310	31207681	3500161515	141		31136310	31207681	8421504	5	2,30,16,45,48	0,25863,63672,63736,71323	p	350016151500015006,350016151500015008,350016151500015014	0-48,0-45,0-48						Max-interacting proteins and related molecules and methods	Brent	1994	0		MXI1
826	chr26	31589328	31589359	3500233964	26		31589328	31589359	8421504	2	16,10	0,21	g	350023396400000056	9-35						Bacteria mediated gene silencing	Fruehauf	2009	0		
826	chr26	31611428	31611451	3500109358	23		31611428	31611451	8421504	1	23	0	g	350010935800000033	10-39						Hepoxilins and modulators of ichthyin for treatment skin disorders	Fischer	2005	0		
827	chr26	31805809	31807480	3500404944	40		31805809	31807480	8421504	3	20,15,5	0,82,1666	c	350040494400000022,350040494400000023	0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		PDCD4
827	chr26	31812495	31815735	3500249929	48		31812495	31815735	8421504	2	24,24	0,3216	c,g	350024992900000000,350024992900000000,350024992900000001	0-24,0-24,0-24						miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma	-publications.com	0	0		PDCD4
827	chr26	31815720	31815746	3500387984	26		31815720	31815746	8421504	1	26	0	c	350038798400000001	5-31		20357187	10.1152/ajpcell.00413.2009		American Journal of Physiology - Cell Physiology	An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular disease	Xiaojun	June	0		PDCD4
827	chr26	31815720	31815746	3500278633	26		31815720	31815746	8421504	1	26	0	c	350027863300000001	5-31		19336275	10.1016/j.yjmcc.2009.01.008		Journal of molecular and cellular cardiology	MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4	Yunhui	July	0		PDCD4
827	chr26	31815720	31815746	3500264128	26		31815720	31815746	8421504	1	26	0	c	350026412800000001	5-31		19158092	10.1074/jbc.M806920200	0021-9258	Journal of Biological Chemistry	Involvement of MicroRNAs in Hydrogen Peroxide-mediated Gene Regulation and Cellular Injury Response in Vascular Smooth Muscle Cells	Lin	2009	5		PDCD4
827	chr26	31815720	31815746	3500213219	26		31815720	31815746	8421504	1	26	0	c	350021321900000001	5-31						MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. - ResearchGate	.researchgate.net	0	0		PDCD4
827	chr26	31815720	31815746	3500125773	26		31815720	31815746	8421504	1	26	0	c	350012577300000001	5-31		20357187	10.1152/ajpcell.00413.2009		American Journal of Physiology - Cell Physiolog	An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular disease	Liu	2010	0		PDCD4
827	chr26	31834947	31834977	3500429819	26		31834947	31834977	8421504	2	13,13	0,17	g	350042981900000221	12-38						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
828	chr26	31865912	31865937	3500198599	23		31865912	31865937	8421504	2	6,17	0,8	c	350019859900000010	9-33						A case of a shiga toxin producing Escherichia coli. - ResearchGate	.researchgate.net	0	0		
828	chr26	31930648	31930676	3500161043	24		31930648	31930676	8421504	3	14,3,7	0,17,21	c	350016104300000246	9-33						PRODUCTION OF SIALYLATED N-GLYCANS IN LOWER EUKARYOTES - Patent application	www.faqs.org	0	0		
828	chr26	31952932	31952957	3500327446	25		31952932	31952957	8421504	1	25	0	g	350032744600000027	11-36						NOVEL ULTRASENSITIVE CELL BASED SENSORS AND USES THEREOF	Paz-rojas	2010	0		ADRA2A
832	chr26	32474397	32475194	3500062112	46		32474397	32475194	8421504	2	23,23	0,774	g	350006211200000000,350006211200000001	0-23,0-23						REPRODUCTION	uction-online.org	0	0		
833	chr26	32508374	32508402	3500421858	24		32508374	32508402	8421504	2	12,12	0,16	g	350042185800000045	0-27						Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof	Ichtchenko	2006	0		
836	chr26	32923668	32923696	3500373623	24		32923668	32923696	8421504	3	4,6,14	0,5,14	g	350037362300000066	23-47						US Patent # 6,905,857. RAD51 polypeptides - Patents.com	www.patents.com	0	0		
838	chr26	33183824	33184533	3500301078	49		33183824	33184533	8421504	2	26,23	0,686	c	350030107800000044,350030107800000043	0-26,0-23						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
838	chr26	33183824	33183850	3500052685	26		33183824	33183850	8421504	1	26	0	c	350005268500000001	23-49						Effects of the peroxisome proliferator-activated receptor-[alpha] agonists clofibrate and fish oil on hepatic fatty acid metabolism in weaned dairy calves | Massimo Bionaz - Academia.edu	www.academia.edu	0	0		
838	chr26	33186968	33216357	3500328810	47		33186968	33216357	8421504	3	7,14,26	0,994,29363	c,g	350032881000000022,350032881000000036	0-21,13-39						Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereof	Farrelly	2002	0		
839	chr26	33315697	33315907	3500300104	69		33315697	33315907	8421504	2	62,7	0,203	p	350030010400015001	0-69		20142329	10.1242/dmm.004135		Disease Models & Mechanisms	Deficient forward transduction and enhanced reverse transduction in the alpha tectorin C1509G human hearing loss mutation	Anping	2010	0		
839	chr26	33400003	33400029	3500403336	23		33400003	33400029	8421504	3	14,4,5	0,15,21	g	350040333600000311	10-33					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
840	chr26	33431306	33432457	3500210802	40		33431306	33432457	8421504	2	20,20	0,1131	c	350021080200000020,350021080200000021	0-20,0-20			10.1002/ejlt.201100343	1438-9312	European Journal of Lipid Science and Technology	Fish-meal diet enriched with omega-3 PUFA and treatment of canine chronic enteropathies - Ontsouka - 2012 - European Journal of Lipid Science and Technology - Wiley Online Library	Ontsouka	2012	0		
840	chr26	33434248	33434964	3500225389	716		33434248	33434964	8421504	1	716	0	g	350022538900000028	0-716						Pegasoferae? - Genomewiki	nomewiki.ucsc.edu	0	0		
840	chr26	33463859	33465101	3500043960	90		33463859	33465101	8421504	3	45,37,8	0,48,1234	p	350004396000015016,350004396000015015	0-45,0-45						ALTERED ZDHHC8 EXPRESSION AS A MARKER OF INCREASED RISK OF SCHIZOPHRENIA - Patent application	www.faqs.org	0	0		ZDHHC6
840	chr26	33495202	33495226	3500403401	23		33495202	33495226	8421504	2	16,7	0,17	g	350040340100000024	8-36					Patent	Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity (Patent US:5529926)	Maat	1996	0		
840	chr26	33544649	33544674	3500254382	23		33544649	33544674	8421504	2	5,18	0,7	g	350025438200000017	1-24		18567802	10.1158/1541-7786.MCR-07-2217	1541-7786	Molecular Cancer Research	The RNA Exosome Component hRrp6 Is a Target for 5-Fluorouracil in Human Cells	Kammler	2008	4		
841	chr26	33577381	33577405	3500061543	23		33577381	33577405	8421504	2	17,6	0,18	g	350006154300000069	0-23					Patent	Sequences for detection and identification of methicillin-resistant staphyloccocus aureus (Patent EP:1397510)	Huletsky	2009	0		
842	chr26	33737187	33737212	3500429620	25		33737187	33737212	8421504	1	25	0	g	350042962000000079	36-61						Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof	Luke	2006	0		VTI1A
843	chr26	33820287	33859712	3500308897	40		33820287	33859712	8421504	4	7,14,14,5	0,10,39403,39420	g	350030889700000726,350030889700000463	23-44,5-24						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
844	chr26	34031902	34032141	3500223039	40		34031902	34032141	8421504	2	20,20	0,219	g	350022303900000007,350022303900000006	0-20,0-20		22423334	10.1002/ece3.97		Ecology and Evolution	Evaluation of experimental genetic management in reintroduced bighorn sheep	Zachary	2012	0		
845	chr26	34175865	34187277	3500061483	47		34175865	34187277	8421504	2	23,24	0,11388	c,g	350006148300000002,350006148300000003	0-23,0-24			10.1152/ajpcell.00417.2001		American Journal of Physiology - Cell Physiolog	Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and &#x03b2;-catenin	Venkiteswaran	2002	0		
845	chr26	34175865	34175888	3500369666	23		34175865	34175888	8421504	1	23	0	c	350036966600000002	0-23			10.1152/ajpcell.00417.2001		American Journal of Physiology - Cell Physiolog	Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and &#x03b2;-catenin	Venkiteswaran	2002	0		TCF7L2
848	chr26	34588249	34588291	3500042046	42		34588249	34588291	8421504	1	42	0	c	350004204600000058	6-48						METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS INVOLVING HIGHER MOLECULAR WEIGHT HYALURONAN - Patent application	www.faqs.org	0	0		
848	chr26	34591766	34591790	3500463784	24		34591766	34591790	8421504	1	24	0	c	350046378400000010	9-33					Patent	Modified plasmin precursors with resistance to inhibitors of plasmin (Patent US:5932213)	Dawson	1999	0		
848	chr26	34591766	34591790	3500395462	24		34591766	34591790	8421504	1	24	0	c	350039546200000066	24-48					Patent	Activatable fibrinolytic and anti-thrombotic proteins (Patent US:5637492)	Dawson	1997	0		
848	chr26	34597785	34597809	3500119980	23		34597785	34597809	8421504	2	15,8	0,16	c	350011998000000039	4-33						Binding Molecules Capable Of Neutralizing Rabies Virus And Uses Thereof 	.freshpatents.com	0	0		
849	chr26	34641418	34641443	3500308897	23		34641418	34641443	8421504	2	5,18	0,7	g	350030889700000420,350030889700000651	10-34,1-25						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
849	chr26	34719592	34719693	3500404944	40		34719592	34719693	8421504	2	20,20	0,81	g	350040494400000014,350040494400000015	0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
852	chr26	35048979	35049074	3500345859	40		35048979	35049074	8421504	2	19,21	0,74	c	350034585900000002,350034585900000003	0-19,0-21						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		NHLRC2
852	chr26	35048979	35049074	3500243216	40		35048979	35049074	8421504	2	19,21	0,74	c	350024321600000000,350024321600000001	0-19,0-21						EFFECT OF ZILPATEROL HYDROCHLORIDE AND STEROID IMPLANTATION ON YEARLING STEER FEEDLOT PERFORMANCE, CARCASS CHARACTERISTICS, AND SKELETAL MUSCLE GENE EXPRESSION TIMOTHY JOHN BAXA B.S., Kansas State University, 2004 A THESIS	krex.k-state.edu	0	0		NHLRC2
852	chr26	35048979	35049074	3500093083	67		35048979	35049074	8421504	3	19,27,21	0,21,74	c	350009308300000000,350009308300000002,350009308300000001	0-19,0-27,0-21						messenger ribonucleic acid abundance in finishing steers1	animalscience.org	0	0		
852	chr26	35049031	35049079	3500262838	48		35049031	35049079	8421504	1	48	0	p	350026283800015015	0-48						&#x03b2;&#x30a2;&#x30c9;&#x30ec;&#x30ca;&#x30ea;&#x30f3;&#x53d7;&#x5bb9;&#x4f53;&#x30ad;&#x30ca;&#x30fc;&#x30bc;&#xff11;&#x306e;&#x5408;&#x6210;&#x57fa;&#x8cea;&#x3001;&#x3053;&#x308c;&#x3092;&#x30b3;&#x30fc;&#x30c9;&#x3059;&#x308b;&#xff24;&#xff2e;&#xff21	www.patentjp.com	0	0		NHLRC2
852	chr26	35049152	35049417	3500245790	44		35049152	35049417	8421504	2	20,24	0,241	c,g	350024579000000000,350024579000000001	0-20,0-24					Patent	Immortalized cell lines from human adipose tissue, process for preparing same and applications thereof (Patent US:6071747)	Strosberg	2000	0		NHLRC2,TDRD1
852	chr26	35049152	35049417	3500189549	44		35049152	35049417	8421504	2	20,24	0,241	c	350018954900000000,350018954900000001	0-20,0-24						Immortalized cell lines from human adipose tissue, process for preparing same and applications thereof	Strosberg	1998	0		NHLRC2,TDRD1
852	chr26	35049152	35049417	3500125715	44		35049152	35049417	8421504	2	20,24	0,241	c	350012571500000000,350012571500000001	0-20,0-24						Immortalized cell lines from human adipose tissue, process for preparing same and applications thereof - Patent # 6071747 - PatentGenius	.patentgenius.com	0	0		NHLRC2,TDRD1
852	chr26	35049152	35049417	3500017026	44		35049152	35049417	8421504	2	20,24	0,241	c,g	350001702600000000,350001702600000001	0-20,0-24						Human immortalized brown adipocytes express functional &#x03b2;-adrenoceptor coupled to lipolysis	cs.biologists.org	0	0		NHLRC2,TDRD1
852	chr26	35049523	35049546	3500098065	23		35049523	35049546	8421504	1	23	0	c	350009806500000010	0-23						Human CD4 CD25 and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop	tologylibrary.org	0	0		TDRD1
852	chr26	35049649	35049672	3500133907	23		35049649	35049672	8421504	1	23	0	c	350013390700000002	0-23						The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells	-publications.com	0	0		
852	chr26	35049722	35049766	3500287103	44		35049722	35049766	8421504	1	44	0	c	350028710300000100,350028710300000099,350028710300000095	0-44,0-44,0-23						Single Nucleotide Polymorphisms Associated With Dose-dependent Edema And Methods Of Use Thereof 	.freshpatents.com	0	0		
852	chr26	35055147	35094910	3500130848	39		35055147	35094910	8421504	2	19,20	0,39743	g	350013084800000736,350013084800000605	29-48,18-38						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
861	chr26	36249658	36249684	3500213171	23		36249658	36249684	8421504	2	8,15	0,11	g	350021317100000002	8-31		11160323		0022-1767	The Journal of Immunology	Mycoplasma fermentans Lipoprotein M161Ag-Induced Cell Activation Is Mediated by Toll-Like Receptor 2: Role of N-Terminal Hydrophobic Portion in its Multiple Functions	Nishiguchi	2001	6		
108	chr26	36810358	36838357	3500462880	40		36810358	36838357	8421504	2	21,19	0,27980	g	350046288000000075,350046288000000140	16-37,1-20						cAMP- und cGMP-bindende Tandem-GAF-Dom&#xa8;anen: Biochemische Untersuchungen mit einer cyanobakteriellen Adenylatcyclase	.uni-tuebingen.de	0	0		
108	chr26	36949092	37181266	3500433860	1359		36949092	37181266	8421504	13	15,75,24,54,182,135,110,337,15,13,65,294,40	0,1007,1085,2038,29799,33781,36723,70210,163573,229667,229686,231007,232134	p	350043386000015028	0-1362						Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa	Campochiaro	2011	0		
108	chr26	36950111	37019496	3500085073	144		36950111	37019496	8421504	3	48,48,48	0,35708,69337	c	350008507300000236,350008507300000204,350008507300000052	0-48,0-48,0-48						Glial Cell Line-derived Neurotrophic Factor Receptor 	freshpatents.com	0	0		
867	chr26	37033873	37033898	3500113312	25		37033873	37033898	8421504	1	25	0	g	350011331200000060	19-44						 Response Regulator 	www.docstoc.com	0	0		
868	chr26	37112673	37178799	3500446518	47		37112673	37178799	8421504	2	7,40	0,66086	c	350044651800000012	0-47						METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-GFRA1 ANTIBODIES - Patent application	www.faqs.org	0	0		
868	chr26	37180248	37181270	3500268406	45		37180248	37181270	8421504	2	20,25	0,997	c	350026840600000021,350026840600000006	0-20,11-36		19188437	10.1128/MCB.01484-08	0270-7306	Molecular and Cellular Biology	Ape1/Ref-1 Induces Glial Cell-Derived Neurotropic Factor (GDNF) Responsiveness by Upregulating GDNF Receptor &#x03b1;1 Expression	Kim	2009	6		
868	chr26	37180253	37180285	3500422142	32		37180253	37180285	8421504	1	32	0	c	350042214200000011	7-39						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
872	chr26	37620888	37620916	3500462459	24		37620888	37620916	8421504	2	7,17	0,11	g	350046245900000042	10-35						CYTOLETHAL DISTENDING TOXINS AND DETECTION OF CAMPYLOBACTER BACTERIA USING THE SAME AS A TARGET - Patent application	www.faqs.org	0	0		
873	chr26	37825068	37825093	3500115879	23		37825068	37825093	8421504	2	10,13	0,12	g	350011587900000052	24-47						Recombinant fowlpox virus s-fpv-043 and uses thereof	Cochran	1994	0		
874	chr26	37951722	37955128	3500413185	258		37951722	37955128	8421504	3	48,188,22	0,2041,3384	p	350041318500015000	0-258						Function and Evolution of highly conserved head genes in the red flour beetle Tribolium castaneum	uni-goettingen.de	0	0		VAX2
875	chr26	38032584	38032611	3500455446	24		38032584	38032611	8421504	2	9,15	0,12	g	350045544600000119	0-24						IDENTIFICATION AND VERIFICATION OF METHYLATION MARKER SEQUENCES - Patent application	www.faqs.org	0	0		
875	chr26	38032584	38032611	3500443598	24		38032584	38032611	8421504	2	9,15	0,12	g	350044359800000002	0-24						Role of DNA Methylation in Cell Cycle Arrest Induced by Cr (VI) in Two Cell Lines. - ResearchGate	.researchgate.net	0	0		
875	chr26	38046510	38084977	3500440812	137		38046510	38084977	8421504	5	26,41,30,14,26	0,12247,13473,13609,38441	c,g	350044081200000041,350044081200000052,350044081200000056,350044081200000071	0-26,0-41,0-44,0-26						Vesicle membrane transport proteins	Edwards	1993	0		
875	chr26	38079113	38084977	3500366969	74		38079113	38084977	8421504	3	27,21,26	0,5754,5838	c	350036696900000107,350036696900000071	0-48,0-26						US Patent # 5,688,936. Vesicle membrane transport proteins - Patents.com	www.patents.com	0	0		
875	chr26	38079113	38084977	3500185198	74		38079113	38084977	8421504	3	27,21,26	0,5754,5838	c	350018519800000107,350018519800000071	0-48,0-26						 Vesicle Membrane Transport Proteins 	www.docstoc.com	0	0		
875	chr26	38096900	38096925	3500453579	23		38096900	38096925	8421504	2	5,18	0,7	c	350045357900000014	15-38						Methods and materials relating to novel CD39-like polypeptides	Ford	2002	0		PDZD8
881	chr26	38913847	38913871	3500279401	24		38913847	38913871	8421504	1	24	0	g	350027940100000156	4-42						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1992	0		
884	chr26	39289174	39289203	3500110319	23		39289174	39289203	8421504	3	12,6,5	0,15,24	g	350011031900000038	0-23						Regulation der Phosphatmangelgene von Corynebacterium glutamicum durch das Zweikomponenten-System PhoRS	ni-duesseldorf.de	0	0		
887	chr26	39689616	39689652	3500030322	36		39689616	39689652	8421504	1	36	0	g	350003032200000159,350003032200000088,350003032200000104	21-63,34-76,37-79						SYSTEM FOR TRANSFORMATION OF THE CHLOROPLAST GENOME OF SCENEDESMUS SP. AND DUNALIELLA SP. - Patent application	www.faqs.org	0	0		
888	chr26	39784181	39784218	3500166204	32		39784181	39784218	8421504	2	23,9	0,28	c	350016620400000068	128-161						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
889	chr26	39873368	39874438	3500439824	63		39873368	39874438	8421504	2	40,23	0,1047	p	350043982400015010	9-72						METHOD OF CONFERRING MULTIPLE STRESS TOLERANCE AND EARLY FLOWERING IN PLANTS	Kav	2007	0		PRDX3
889	chr26	39909264	39909289	3500210755	23		39909264	39909289	8421504	2	12,11	0,14	g	350021075500000057	0-24						Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1	Cregg	1999	0		
891	chr26	40140593	40148255	3500197663	40		40140593	40148255	8421504	2	20,20	0,7642	c	350019766300000002,350019766300000003	0-20,0-20		18723764	10.1152/ajpheart.00564.2008		American Journal of Physiology - Heart and Circulatory Physiology	Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances &#x03b1;1D-adrenergic receptor constriction	Heather	2008	0		GRK5
892	chr26	40355610	40355681	3500388552	39		40355610	40355681	8421504	2	20,19	0,52	c,g	350038855200000002,350038855200000002,350038855200000003,350038855200000003	0-20,0-20,0-19,0-19						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
892	chr26	40355610	40355681	3500143254	39		40355610	40355681	8421504	2	20,19	0,52	c,g	350014325400000002,350014325400000002,350014325400000003,350014325400000003	0-20,0-20,0-19,0-19						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
893	chr26	40373967	40373992	3500125116	25		40373967	40373992	8421504	1	25	0	c	350012511600000003	0-25		16788006	10.1152/physiolgenomics.00001.2006	1094-8341	Physiological Genomics	Differential expression profiling of the blind subterranean mole rat Spalax ehrenbergi superspecies: bioprospecting for hypoxia tolerance	Avivi	2006	3		
893	chr26	40378110	40378138	3500195592	24		40378110	40378138	8421504	3	12,4,8	0,13,20	c	350019559200000002	1-26						Flea protease proteins, nucleic acid molecules, and uses thereof	Grieve	1995	0		
894	chr26	40539598	40539624	3500387329	23		40539598	40539624	8421504	2	5,18	0,8	c	350038732900000002,350038732900000022	0-23,0-23						Methods For Regulating The Growth And/Or Survival Of Tumor Cells And Stem Cells By Modulating The Expression Or Function Of The Transcription Factor ATF5 - Patent application	www.faqs.org	0	0		
894	chr26	40539598	40539624	3500063166	23		40539598	40539624	8421504	2	5,18	0,8	c	350006316600000002,350006316600000022	0-23,0-23						METHODS FOR REGULATING THE GROWTH AND/OR SURVIVAL OF TUMOR CELLS AND STEM CELLS BY MODULATING THE EXPRESSION OR FUNCTION OF THE TRANSCRIPTION FACTORS ATF5 - Patent application	www.faqs.org	0	0		
895	chr26	40655439	40655467	3500455207	24		40655439	40655467	8421504	2	12,12	0,16	g	350045520700000041	0-24						Prostate Cancer Methods and Protocols	www.docstoc.com	0	0		
898	chr26	41101568	41101595	3500068199	24		41101568	41101595	8421504	2	8,16	0,11	g	350006819900000253	5-29						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
899	chr26	41236111	41236224	3500373947	42		41236111	41236224	8421504	2	22,20	0,93	g	350037394700000199,350037394700000198	0-22,0-20						Udder Health Characteristics	Lund	2007	0		
901	chr26	41478054	41478183	3500124751	126		41478054	41478183	8421504	2	15,111	0,18	p	350012475100015054	0-126						Spine construct record	spine.nesg.org	0	0		
901	chr26	41478199	41478227	3500350348	23		41478199	41478227	8421504	2	7,16	0,12	c	350035034800000241	4-27						US Patent # 6,004,924. Protein sequences of serrate gene products - Patents.com	www.patents.com	0	0		
902	chr26	41618605	41618633	3500302946	23		41618605	41618633	8421504	2	15,8	0,20	g	350030294600000007	1-24						articles Initial sequencing and analysis of the human genome	www.ndsu.edu	0	0		
906	chr26	42140889	42172750	3500337247	1287		42140889	42172750	8421504	13	162,106,138,71,123,191,31,74,73,43,137,81,57	0,3143,4909,6327,6957,15331,16860,16897,19006,19085,21967,31717,31804	p	350033724700015018,350033724700015016,350033724700015054,350033724700015053,350033724700015052,350033724700015050	0-822,0-822,0-357,0-444,0-330,0-141						Biomarkers for circulating tumor cells	Garcia-Blanco	2011	0		
906	chr26	42141034	42144043	3500224824	28		42141034	42144043	8421504	2	17,11	0,2998	c	350022482400000009	7-35						June | 2013 | Epitope Tags/Tag Peptides Guide	www.gap-1-13.com	0	0		
906	chr26	42144068	42144113	3500339899	45		42144068	42144113	8421504	1	45	0	p	350033989900015139	0-45						INHIBITING BINDING OF FGF23 TO THE BINARY FGFR-KLOTHO COMPLEX FOR THE TREATMENT OF HYPOPHOSPHATEMIA - Patent application	www.faqs.org	0	0		FGFR2
906	chr26	42144073	42144097	3500257834	24		42144073	42144097	8421504	1	24	0	c	350025783400000025	0-24						Novel bone mass increasing agent	Yasuda	2010	0		
906	chr26	42145806	42147266	3500309390	180		42145806	42147266	8421504	2	130,50	0,1410	p	350030939000015016	0-180						Isolation and developmental expression of the amphibian homolog of the fibroblast growth factor receptor 3. - ResearchGate	.researchgate.net	0	0		FGFR1
906	chr26	42145929	42160013	3500230885	192		42145929	42160013	8421504	5	7,71,15,54,45	0,1287,1917,11851,14039	p	350023088500015093,350023088500015041,350023088500015092,350023088500015033,350023088500015084,350023088500015081	0-45,0-45,0-45,0-45,0-45,0-45						 Fibroblast growth factor receptors Patent (Patent # 6,344,546 issued February 5, 2002) - Justia Patents Database 	atents.justia.com	0	0		
906	chr26	42147223	42156400	3500116987	40		42147223	42156400	8421504	2	20,20	0,9157	c,g	350011698700000009,350011698700000009,350011698700000008,350011698700000008	0-20,0-20,0-20,0-20						Analysis of Gene Transcription in Bovine Nuclear Transfer Embryos: RESULTS | Medicine Healthiest	ne-healthiest.com	0	0		
906	chr26	42147251	42194697	3500203766	276		42147251	42194697	8421504	8	30,3,18,24,21,78,47,55	0,33,595,637,15736,25334,30548,47391	p	350020376600015019,350020376600015012,350020376600015007	0-84,3-102,0-102						K-sam, anamplifiedgenein stomach	www.pnas.org	0	0		
906	chr26	42147943	42156280	3500009456	45		42147943	42156280	8421504	2	22,23	0,8314	c	350000945600000006,350000945600000007	0-22,0-23						PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY	Fissore	2007	0		
906	chr26	42169833	42169859	3500000746	23		42169833	42169859	8421504	3	14,4,5	0,15,21	g	350000074600000002	5-28		10982359	10.1128/JVI.74.19.9125-9133.2000	0022-538X	Journal of Virology	Full-Length GB Virus C (Hepatitis G Virus) RNA Transcripts Are Infectious in Primary CD4-Positive T Cells	Xiang	2000	5		
906	chr26	42172603	42174845	3500461974	42		42172603	42174845	8421504	2	21,21	0,2221	c,g	350046197400000005,350046197400000005,350046197400000004	0-21,0-21,0-21		19009564	10.1002/mc.20494		Molecular carcinogenesis	Resident Hepatocyte Fibroblast Growth Factor Receptor 4 Limits Hepatocarcinogenesis	Xinqiang	June	0		
906	chr26	42174857	42174882	3500092953	25		42174857	42174882	8421504	1	25	0	g	350009295300000002,350009295300000003	0-25,0-25						Fibroblast growth factor receptor 3 effects on proliferation and telomerase activity in sheep growth plate chondrocytes	www.jasbsci.com	0	0		FGFR1
906	chr26	42176394	42176542	3500233309	58		42176394	42176542	8421504	2	20,38	0,110	c,g	350023330900000001,350023330900000001,350023330900000009,350023330900000000,350023330900000000	0-20,0-20,0-28,0-20,0-20						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DT	www.plosone.org	0	0		FGFR2
906	chr26	42176400	42176504	3500035336	40		42176400	42176504	8421504	2	20,20	0,84	c	350003533600000003,350003533600000002	0-20,0-20		10819782	10.1095/biolreprod62.6.1772	0006-3363	Biology of Reproduction	Keratinocyte Growth Factor: Expression by Endometrial Epithelia of the Porcine Uterus	Ka	2000	4		FGFR2
906	chr26	42176530	42177667	3500137981	24		42176530	42177667	8421504	2	12,12	0,1125	c	350013798100000002	0-24						Ligand-binding domains of fibroblast growth factor receptors and chimeric proteins containing these domains	Givol	1993	0		
906	chr26	42177817	42177840	3500017446	23		42177817	42177840	8421504	1	23	0	c	350001744600000013	0-23						Methods and compositions for enhancing cartilage repair	Gazit	2002	0		
113	chr26	42194722	42207186	3500461928	44		42194722	42207186	8421504	2	23,21	0,12443	c,g	350046192800000007,350046192800000006,350046192800000006	0-23,0-21,0-21		16288035	10.1158/0008-5472.CAN-05-1718	0008-5472	Cancer Research	Alternative Splicing of Fibroblast Growth Factor Receptor 3 Produces a Secreted Isoform That Inhibits Fibroblast Growth Factor&#x2013;Induced Proliferation and Is Repressed in Urothelial Carcinoma Cell Lines	Tomlinson	2005	8		FGFR2
113	chr26	42194722	42207186	3500339192	44		42194722	42207186	8421504	2	23,21	0,12443	c,g	350033919200000007,350033919200000006,350033919200000006	0-23,0-21,0-21		16288035	10.1158/0008-5472.CAN-05-1718	0008-5472	Cancer Research	Alternative Splicing of Fibroblast Growth Factor Receptor 3 Produces a Secreted Isoform That Inhibits Fibroblast Growth Factor&#x2013;Induced Proliferation and Is Repressed in Urothelial Carcinoma Cell Lines	Tomlinson	2005	8		FGFR2
906	chr26	42194724	42194750	3500166588	26		42194724	42194750	8421504	1	26	0	c,g	350016658800000003,350016658800000003	24-50,24-50						Fetal pulmonary cells and uses thereof	Lelkes	2007	0		
907	chr26	42207247	42207295	3500425336	48		42207247	42207295	8421504	1	48	0	p	350042533600015004	0-48						NPG.nature.vol.407.Issue.6807.Oct	www.scribd.com	0	0		FGFR2
907	chr26	42242509	42242534	3500431542	25		42242509	42242534	8421504	1	25	0	c	350043154200000023	32-57						US Patent # 4,973,551. Vector for the expression of fusion proteins and protein immunogens - Patents.com	www.patents.com	0	0		TNRC6B
908	chr26	42408374	42408401	3500006522	24		42408374	42408401	8421504	3	12,4,8	0,13,19	g	350000652200000055	20-48						FLAVIVIRUS NS1 SUBUNIT VACCINE - Patent application	www.faqs.org	0	0		
912	chr26	42873160	42873191	3500114494	25		42873160	42873191	8421504	3	11,5,9	0,15,22	g	350011449400000002	11-36						Molecular Medicine	s.ahajournals.org	0	0		
912	chr26	42922833	42922858	3500427776	25		42922833	42922858	8421504	1	25	0	c	350042777600000001	0-25		19786618	10.1182/blood-2009-03-213058	0006-4971	Blood	TAPP2 links phosphoinositide 3-kinase signaling to B-cell adhesion through interaction with the cytoskeletal protein utrophin: expression of a novel cell adhesion-promoting complex in B-cell leukemia	Costantini	2009	10		PLEKHA1
912	chr26	42949798	42949822	3500368596	24		42949798	42949822	8421504	1	24	0	c	350036859600000023	19-43						Diagnosis and treatment of age related macular degeneration	Dewan	2008	0		
912	chr26	42949798	42949822	3500143222	24		42949798	42949822	8421504	1	24	0	c	350014322200000023	19-43						Diagnosis and Treatment of Age Related Macular Degeneration	Hoh	2007	0		
913	chr26	43005957	43028532	3500106195	147		43005957	43028532	8421504	4	45,18,33,51	0,19880,20917,22524	p	350010619500015006,350010619500015015,350010619500015045,350010619500015016,350010619500015046	0-45,0-45,0-45,0-45,0-45						METHOD OF DETECTING OCULAR DISEASES AND PATHOLOGIC CONDITIONS AND TREATMENT OF SAME - Patent application	www.faqs.org	0	0		HTRA3
913	chr26	43033602	43033625	3500364288	23		43033602	43033625	8421504	1	23	0	c	350036428800000006	21-44						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
913	chr26	43033705	43033736	3500343734	28		43033705	43033736	8421504	2	14,14	0,17	c	350034373400000515	16-44					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
913	chr26	43033705	43033736	3500190760	28		43033705	43033736	8421504	2	14,14	0,17	c	350019076000000515	16-44						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
916	chr26	43439693	43443483	3500188807	1257		43439693	43443483	8421504	3	941,183,133	0,1536,3657	p	350018880700015000	0-1257						KEGG T01058: 100058131	www.genome.jp	0	0		IKZF5
916	chr26	43439693	43443483	3500008371	1257		43439693	43443483	8421504	3	941,183,133	0,1536,3657	p	350000837100015000	0-1257						KEGG T01007: 611212	www.genome.jp	0	0		IKZF5
917	chr26	43600848	43603411	3500338844	48		43600848	43603411	8421504	2	9,39	0,2524	p	350033884400015054	0-48						NUCLEAR DIVISION OF Sarcocystis neurona	aeum.libs.uga.edu	0	0		BUB3
920	chr26	43948198	43948223	3500052549	23		43948198	43948223	8421504	3	6,13,4	0,7,21	g	350005254900000420	18-44						 Compositions Against SARS 	www.docstoc.com	0	0		
920	chr26	43958178	43958203	3500428254	23		43958178	43958203	8421504	2	5,18	0,7	g	350042825400000016	4-27						Method for selective inactivation of viral replication	Miles	2000	0		
920	chr26	44039346	44039370	3500103209	24		44039346	44039370	8421504	1	24	0	g	350010320900000226	21-45						Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity - US Patent 7211424 Description	ww.patentstorm.us	0	0		
921	chr26	44145164	44145192	3500052554	24		44145164	44145192	8421504	2	11,13	0,15	g	350005255400000041	0-24						Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS	Fu	2007	0		
922	chr26	44214552	44214577	3500430989	24		44214552	44214577	8421504	2	20,4	0,21	g	350043098900000704	21-45						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
115	chr26	44536959	44566772	3500233653	627		44536959	44566772	8421504	9	43,124,23,157,157,74,40,5,4	0,1967,2092,8474,26297,29687,29762,29803,29809	g	350023365300000012	5-632						in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biological Engineering	dspace.mit.edu	0	0		
926	chr26	44818865	44818890	3500074474	23		44818865	44818890	8421504	2	7,16	0,9	g	350007447400000125,350007447400000123	7-30,12-35						Combination therapy for conditions leading to bone loss	Boyle	2001	0		
928	chr26	44981479	44981527	3500264954	48		44981479	44981527	8421504	1	48	0	p	350026495400015042	39-87						A Forms 1-Lactam Precursor oL-Aminoadipic Acid, Is Located Cluster	digital.csic.es	0	0		
929	chr26	45125256	45125284	3500341442	23		45125256	45125284	8421504	2	6,17	0,11	g	350034144200000035	0-23						Methods for analyzing animal products	Andersson	2004	0		
929	chr26	45208663	45208689	3500024322	25		45208663	45208689	8421504	2	15,10	0,16	g	350002432200000224	18-43						US Patent # 7,132,257. Production or aromatic carotenoids in gram negative bacteria - Patents.com	www.patents.com	0	0		
930	chr26	45249089	45249117	3500160309	24		45249089	45249117	8421504	2	12,12	0,16	g	350016030900000084	0-24						A gene from Solanum bulbocastanum conferring resistance to Phytophthora infestans	Allefs	2011	0		
930	chr26	45272369	45272393	3500233903	23		45272369	45272393	8421504	2	9,14	0,10	g	350023390300000125	20-44						VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS - Patent application	www.faqs.org	0	0		
931	chr26	45479161	45479184	3500059527	23		45479161	45479184	8421504	1	23	0	c	350005952700000000	0-23		17538025	10.1091/mbc.E06-09-0869	1059-1524	Molecular Biology of the Cell	Evidence that Mono-ADP-Ribosylation of CtBP1/BARS Regulates Lipid Storage	Bartz	2007	5		CTBP2
932	chr26	45563595	45563632	3500351577	37		45563595	45563632	8421504	1	37	0	g	350035157700000000	64-101						2012 Penstate Nutrition Workshop Proceedings	www.scribd.com	0	0		
932	chr26	45563595	45563632	3500120184	37		45563595	45563632	8421504	1	37	0	g	350012018400000000	64-101						NORTHEAST DAIRY PRODUCERS ASSOCIATION CONFERENCE	ansci.cornell.edu	0	0		
937	chr26	46267213	46267238	3500344020	25		46267213	46267238	8421504	1	25	0	c	350034402000000019	0-25						Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene. - ResearchGate	.researchgate.net	0	0		
939	chr26	46454700	46457892	3500378665	40		46454700	46457892	8421504	2	20,20	0,3172	c,g	350037866500000010,350037866500000010,350037866500000011,350037866500000011	0-20,0-20,0-20,0-20						Specific maternal transcripts in bovine oocytes and cleavaged embryos: Identification with novel DDRT-PCR methods	www.seegene.com	0	0		
940	chr26	46552190	46552213	3500144974	23		46552190	46552213	8421504	1	23	0	c	350014497400000002	0-23						Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo)	biomedcentral.com	0	0		
940	chr26	46580677	46594070	3500440364	27		46580677	46594070	8421504	2	2,25	0,13368	c	350044036400000050	0-27						Secreted and transmembrane polypeptides and nucleic acids encoding the same	Ashkenazi	2001	0		
940	chr26	46580677	46594070	3500202825	27		46580677	46594070	8421504	2	2,25	0,13368	c	350020282500000048	0-27						Secreted and transmembrane polypeptides and nucleic acids encoding the same	Ashkenazi	2001	0		
940	chr26	46580677	46594070	3500060131	27		46580677	46594070	8421504	2	2,25	0,13368	c	350006013100000046	0-27						Secreted and transmembrane polypeptides and nucleic acids encoding the same	osdir.com/patents	0	0		
942	chr26	46882709	46882737	3500247570	23		46882709	46882737	8421504	2	6,17	0,11	g	350024757000000191,350024757000000190	15-37,15-34						INFLUENZA VACCINE - Patent application	www.faqs.org	0	0		
943	chr26	46928855	46928880	3500427722	24		46928855	46928880	8421504	2	11,13	0,12	g	350042772200000013	21-45						THE JOURNAL OF CHEMISTRY Vol. No. 29, Issue of October 15, Inc. in U.S.A. Nitrilase from Rhodococcus rhodochrous J1	www.jbc.org	0	0		
944	chr26	47108985	47109011	3500224153	25		47108985	47109011	8421504	2	6,19	0,7	g	350022415300000012	3-29						Baculovirus-Based Vaccines - Patent application	www.faqs.org	0	0		
944	chr26	47177073	47177101	3500217472	23		47177073	47177101	8421504	2	12,11	0,17	g	350021747200000036	3-26						US Patent # 5,795,760. Purified Myceliophthora laccases and nucleic acids encoding same - Patents.com	www.patents.com	0	0		
947	chr26	47565008	47565034	3500317272	23		47565008	47565034	8421504	2	5,18	0,8	g	350031727200000057	23-46						Antibodies	Kavlie	2011	0		
951	chr26	48015023	48032141	3500308897	42		48015023	48032141	8421504	3	6,15,21	0,10,17097	g	350030889700000865,350030889700000668,350030889700001028	12-33,9-30,10-31						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
957	chr26	48859664	48859688	3500280721	23		48859664	48859688	8421504	2	6,17	0,7	g	350028072100000029	21-47						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
959	chr26	49039540	49039566	3500237963	25		49039540	49039566	8421504	2	8,17	0,9	g	350023796300000044	0-25						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
959	chr26	49111292	49111316	3500341162	23		49111292	49111316	8421504	2	4,19	0,5	g	350034116200000613,350034116200000403	13-36,0-23						Perhydrolase	Amin	2004	0		
960	chr26	49218117	49218140	3500225849	23		49218117	49218140	8421504	1	23	0	g	350022584900000002	10-36						A new tick-borne encephalitis-like virus infecting New England deer ticks, Ixodes dammini. - ResearchGate	.researchgate.net	0	0		
960	chr26	49231451	49231619	3500458003	40		49231451	49231619	8421504	2	20,20	0,148	g	350045800300000008,350045800300000009	0-20,0-20			10.1111/j.1752-4571.2010.00142.x		Evolutionary Applications	Broad and fine-scale genetic analysis of white-tailed deer populations: estimating the relative risk of chronic wasting disease spread	Catherine	2011	0		
960	chr26	49231451	49231619	3500412553	40		49231451	49231619	8421504	2	20,20	0,148	g	350041255300000008,350041255300000009	0-20,0-20			10.1111/j.1752-4571.2010.00142.x	1752-4571	Evolutionary Applications	Broad and fine-scale genetic analysis of white-tailed deer populations: estimating the relative risk of chronic wasting disease spread - Cullingham - 2010 - Evolutionary Applications - Wiley Online Library	Cullingham	2011	5		
961	chr26	49325170	49325201	3500451407	26		49325170	49325201	8421504	2	7,19	0,12	g	350045140700000033	22-48						Dye compositions containing purified polyporus laccases and nucleic acids encoding same	Yaver	1995	0		
962	chr26	49487145	49487168	3500026054	23		49487145	49487168	8421504	1	23	0	g	350002605400000024	25-48						US Patent # 5,436,392. Transgenic plants expressing M. sexta protease inhibitor - Patents.com	www.patents.com	0	0		
965	chr26	49831853	49831881	3500317364	24		49831853	49831881	8421504	2	18,6	0,22	g	350031736400000041	4-28						Flax seed specific promoters - US Patent 7642346 Description	ww.patentstorm.us	0	0		
967	chr26	50170414	50170443	3500341278	23		50170414	50170443	8421504	3	12,5,6	0,13,23	g	350034127800000098	12-35						Method of distinguishing an IBRV-vaccinated bovine from a bovine infected with a wild type virus	Cochran	1996	0		
967	chr26	50170414	50170443	3500308235	23		50170414	50170443	8421504	3	12,5,6	0,13,23	g	350030823500000120	12-35					Patent	Recombinant infectious bovine rhinotracheitis virus (Patent US:5874279)	Cochran	1999	0		
968	chr26	50276883	50287477	3500290029	312		50276883	50287477	8421504	6	20,58,53,40,93,48	0,2117,3451,5710,5857,10546	p	350029002900015034	69-381							rcebioscience.com	0	0		GLRX3
968	chr26	50282793	50287474	3500175024	43		50282793	50287474	8421504	2	19,24	0,4657	c	350017502400000031,350017502400000030	0-19,0-24						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
972	chr26	50799988	50800013	3500323345	25		50799988	50800013	8421504	1	25	0	c	350032334500000003	20-45						Gene expression in bovine rumen epithelium during weaning identifies molecular regulators of rumen development and growth	aldc.nal.usda.gov	0	0		
973	chr26	50870250	50870276	3500269550	24		50870250	50870276	8421504	2	5,19	0,7	g	350026955000000192,350026955000000197	8-33,8-33						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
973	chr26	50881169	50881193	3500092036	23		50881169	50881193	8421504	2	17,6	0,18	g	350009203600000113	10-35					Patent	Recombinant bone morphogenetic protein heterodimers (Patent US:5866364)	Israel	1999	0		
975	chr26	51245011	51245043	3500229301	27		51245011	51245043	8421504	3	7,7,13	0,10,19	g	350022930100000079	21-48						Inducible Gene Expression - Patent application	www.faqs.org	0	0		
977	chr26	51443288	51443314	3500038254	23		51443288	51443314	8421504	2	14,9	0,17	g	350003825400000048	0-25						Polyhydroxyalkanoate-containing Structure And Manufacturing Method Thereof 	.freshpatents.com	0	0		
979	chr26	51701069	51701098	3500316341	24		51701069	51701098	8421504	2	7,17	0,12	g	350031634100000193	1-25						Durham E-Theses Glutathione transferases in maize (zea mays)	etheses.dur.ac.uk	0	0		
979	chr26	51773169	51773193	3500104401	24		51773169	51773193	8421504	1	24	0	c	350010440100000350	15-39						3-HYDROXYPROPIONIC ACID AND OTHER ORGANIC COMPOUNDS - Patent application	www.faqs.org	0	0		
980	chr26	51811870	51812228	3500337770	39		51811870	51812228	8421504	2	20,19	0,339	c,g	350033777000000005,350033777000000005,350033777000000004	0-20,0-20,0-19						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
980	chr26	51811870	51812228	3500139803	39		51811870	51812228	8421504	2	20,19	0,339	c,g	350013980300000005,350013980300000005,350013980300000004,350013980300000004	0-20,0-20,0-19,0-19						Conferences, Proceedings, Journals, Open Access Journals, SCIRP	file.scirp.org	0	0		
980	chr26	51811870	51812228	3500006584	39		51811870	51812228	8421504	2	20,19	0,339	c,g	350000658400000013,350000658400000013,350000658400000012,350000658400000012	0-20,0-20,0-19,0-19						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
980	chr26	51819192	51819462	3500151065	249		51819192	51819462	8421504	2	135,114	0,156	p	350015106500015036,350015106500015035,350015106500015019	0-135,0-135,0-114						CHARACTERIZATION OF SHADOO AND DPPX: TWO PROTEINS OF POTENTIAL RELEVANCE TO PRION BIOLOGY	brary.utoronto.ca	0	0		
593	chr27	1124481	1124505	3500231114	23		1124481	1124505	8421504	2	14,9	0,15	c	350023111400000007	7-30						Stereoselective reduction of substituted acetophenone	Chu	2002	0		
608	chr27	3099496	3099519	3500314221	23		3099496	3099519	8421504	1	23	0	g	350031422100000005	0-23						Use of ectoenzymes and secreted enzymes to monitor cellular proliferation	Zyskind	2000	0		
611	chr27	3453027	3453051	3500348778	23		3453027	3453051	8421504	2	16,7	0,17	g	350034877800000026	0-23						Analysis of imprinted gene expression in normal fertilized and uniparental preimplantation porcine embryos. - ResearchGate	.researchgate.net	0	0		
614	chr27	3859951	3859982	3500332845	26		3859951	3859982	8421504	3	9,5,12	0,11,19	g	350033284500000009,350033284500000023	4-35,4-35						Method of Detecting Target Substances - Patent application	www.faqs.org	0	0		
615	chr27	4046378	4046406	3500267446	23		4046378	4046406	8421504	2	14,9	0,19	g	350026744600000043	0-23						Systematics, Genetics and Conservation of Golden Trout BY DISSERTATION in	e-lab.ucdavis.edu	0	0		
625	chr27	5302710	5302741	3500382810	24		5302710	5302741	8421504	3	12,6,6	0,15,25	g	350038281000000025	0-24						Polypeptide having enhanced effector function	Tsuji	2010	0		
625	chr27	5302710	5302741	3500292089	24		5302710	5302741	8421504	3	12,6,6	0,15,25	g	350029208900000025,350029208900000062	0-24,0-24						MUTANT POLYPEPTIDE HAVING EFFECTOR FUNCTION - Patent application	www.faqs.org	0	0		
625	chr27	5302710	5302741	3500130953	24		5302710	5302741	8421504	3	12,6,6	0,15,25	g	350013095300000011	6-30						HUMAN MONOCLONAL ANTIBODIES AND METHODS FOR PRODUCING THE SAME - Patent application	www.faqs.org	0	0		
625	chr27	5302710	5302741	3500074570	24		5302710	5302741	8421504	3	12,6,6	0,15,25	g	350007457000000117,350007457000000025	0-24,0-24						POLYPEPTIDE HAVING ENHANCED EFFECTOR FUNCTION - Patent application	www.faqs.org	0	0		
628	chr27	5651704	5651761	3500243792	57		5651704	5651761	8421504	1	57	0	p	350024379200015005	0-57						Novel haptotactic peptides	Gorodetsky	2002	0		ANGPT2
628	chr27	5651848	5678226	3500440472	53		5651848	5678226	8421504	3	14,12,27	0,2773,26351	c	350044047200000001,350044047200000005,350044047200000004	0-26,0-27,0-27						ROLE OF SHEAR STRESS IN ANGIOPOIETIN-2-DEPENDENT NEOVASCULARIZATION: IMPLICATIONS IN OCCLUSIVE VASCULAR DISEASE AND ATHEROSCLEROSIS	artech.gatech.edu	0	0		ANGPT2
628	chr27	5668334	5668363	3500165384	29		5668334	5668363	8421504	1	29	0	c	350016538400000900	12-41						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
628	chr27	5668414	5668438	3500306106	23		5668414	5668438	8421504	2	8,15	0,9	c	350030610600000003	22-45						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		
628	chr27	5668414	5668438	3500054314	23		5668414	5668438	8421504	2	8,15	0,9	c	350005431400000003	22-45						Xenopus Cdc6 Performs Separate Functions in Initiating DNA Replication	w.molbiolcell.org	0	0		
628	chr27	5708248	5708278	3500456272	25		5708248	5708278	8421504	3	11,9,5	0,15,25	c	350045627200000065	19-44						Novel fetal genes - Patent application	www.faqs.org	0	0		
629	chr27	5857208	5857234	3500088021	23		5857208	5857234	8421504	3	5,13,5	0,7,21	g	350008802100000131	20-44						Control of fruit ripening and senescence in plants - US Patent 5512466 Description	ww.patentstorm.us	0	0		
632	chr27	6183497	6186815	3500266706	3264		6183497	6186815	8421504	9	866,513,328,321,60,5,488,196,487	0,874,1388,1756,2078,2139,2145,2634,2831	c,g	350026670600000013,350026670600000019,350026670600000012,350026670600000012,350026670600000011,350026670600000004,350026670600000010,350026670600000009,350026670600000003,350026670600000016,350026670600000014,350026670600000005	19-328,0-48,0-114,0-114,0-24,0-53,0-48,0-48,0-44,0-1494,0-1547,0-20						Novel tracheal antimicrobial peptides	Bevins	1994	0		
632	chr27	6183497	6185326	3500265948	309		6183497	6185326	8421504	2	236,73	0,1756	c,g	350026594800000006,350026594800000005,350026594800000005,350026594800000004,350026594800000003	19-328,0-114,0-114,0-53,0-44						Production and use of tracheal antimicrobial peptides	Bevins	1993	0		
632	chr27	6183498	6185317	3500384273	293		6183498	6185317	8421504	3	237,2,54	0,251,1765	c,g	350038427300000012,350038427300000011,350038427300000006,350038427300000004,350038427300000004,350038427300000005,350038427300000003,350038427300000009,350038427300000008	0-101,0-48,0-48,0-53,0-53,0-48,0-44,6-48,28-82					Patent	Tracheal antimicrobial peptides, dna sequences and methods for the production and use thereof (Patent US:5202420)	Bevins	1993	0		
632	chr27	6183498	6185317	3500287242	299		6183498	6185317	8421504	3	237,4,58	0,251,1761	p,c,g	350028724200000005,350028724200000004,350028724200000004,350028724200015007,350028724200015006,350028724200015001,350028724200015005,350028724200015004,350028724200000003	0-98,0-117,0-117,0-114,0-45,0-114,0-66,0-78,18-102						Tracheal Antimicrobial Peptide, A Cysteine-Rich Peptide from Mammalian Tracheal Mucosa: Peptide Isolation and Cloning of a cDNA	www.jstor.org	0	0		
632	chr27	6183498	6185284	3500388565	38		6183498	6185284	8421504	2	19,19	0,1767	c	350038856500000001,350038856500000000	1-20,0-19					Infection and Immunity	Differential Expression of Caprine &#x03b2;-Defensins in Digestive and Respiratory Tissues	Chengquan	1999	0		
632	chr27	6183498	6183751	3500427057	239		6183498	6183751	8421504	2	237,2	0,251	c,g	350042705700000012,350042705700000011,350042705700000004,350042705700000004,350042705700000005,350042705700000003,350042705700000009	0-101,0-48,0-53,0-53,0-48,0-44,6-48						Tracheal antimicrobial peptides, DNA sequences and methods for the production and use thereof	Zasloff	1990	0		
632	chr27	6183525	6186815	3500449392	3276		6183525	6186815	8421504	8	838,513,689,60,5,488,196,487	0,846,1360,2050,2111,2117,2606,2803	c,g	350044939200000013,350044939200000020,350044939200000012,350044939200000012,350044939200000011,350044939200000004,350044939200000010,350044939200000003,350044939200000017,350044939200000016,350044939200000015,350044939200000005	28-300,0-48,0-114,0-114,0-24,0-53,0-48,0-44,0-1494,0-53,0-1547,0-20						US Patent # 5,432,270. DNA encoding tracheal antimicrobial peptides - Patents.com	www.patents.com	0	0		
632	chr27	6183561	6183624	3500199033	52		6183561	6183624	8421504	2	23,29	0,34	c	350019903300000001,350019903300000000	0-23,0-29		12704177	10.1128/IAI.71.5.2950-2955.2003	0019-9567	Infection and Immunity	Coordinated Expression of Tracheal Antimicrobial Peptide and Inflammatory-Response Elements in the Lungs of Neonatal Calves with Acute Bacterial Pneumonia	Caverly	2003	4		
632	chr27	6183577	6185280	3500358194	40		6183577	6185280	8421504	2	20,20	0,1683	c,g	350035819400000001,350035819400000001,350035819400000000	0-20,0-20,0-20		17158892	10.1128/IAI.00686-06	0019-9567	Infection and Immunity	Effect of Corticosteroids and Neuropeptides on the Expression of Defensins in Bovine Tracheal Epithelial Cells	Mitchell	2007	4		
632	chr27	6183596	6183623	3500461592	27		6183596	6183623	8421504	1	27	0	c	350046159200000001	10-37						METHODS OF TREATING LUNG INFECTIONS WITH HUMAN TRACHEAL ANTIMICROBIAL PEPTIDE (hTAP)	Delannoy	1998	0		
632	chr27	6183596	6183623	3500404304	27		6183596	6183623	8421504	1	27	0	c	350040430400000001	10-37						METHODS OF TREATING LUNG INFECTIONS WITH HUMAN TRACHEAL ANTIMICROBIAL PEPTIDE (hTAP) - JOHNS HOPKINS UNIVERSITY	www.sumobrain.com	0	0		
632	chr27	6183599	6183713	3500415555	114		6183599	6183713	8421504	1	114	0	p	350041555500015029	0-114						ANTIMICROBIAL AGENTS - LYSANDO Holding AG	www.sumobrain.com	0	0		
632	chr27	6183608	6183713	3500354416	105		6183608	6183713	8421504	1	105	0	p	350035441600015001	0-105						Studie van het celdoodproces in Candida albicans	lib.ugent.be	0	0		
632	chr27	6183695	6185311	3500460350	93		6183695	6185311	8421504	3	40,2,51	0,54,1565	p	350046035000015008	0-93						 Antimicrobial Peptide 	www.docstoc.com	0	0		
632	chr27	6183728	6185311	3500115576	63		6183728	6185311	8421504	3	7,4,52	0,21,1531	p	350011557600015000	0-63						TARGETED BIOCIDES	Imboden	2009	0		
632	chr27	6185260	6185311	3500011040	50		6185260	6185311	8421504	2	27,23	0,28	c	350001104000000006	0-50						US Patent # 5,550,109. Inducible defensin peptide from mammalian epithelia - Patents.com	www.patents.com	0	0		
632	chr27	6185643	6185673	3500189718	30		6185643	6185673	8421504	1	30	0	g	350018971800000002	0-30		10603376	10.1128/IAI.68.1.113-119.2000	0019-9567	Infection and Immunity	Transcriptional Regulation of &#x03b2;-Defensin Gene Expression in Tracheal Epithelial Cells	Diamond	2000	4		
632	chr27	6193882	6193949	3500401616	38		6193882	6193949	8421504	3	5,14,19	0,6,48	c	350040161600000005,350040161600000004	0-19,0-19						Human Beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions. - ResearchGate	.researchgate.net	0	0		DEFB103A
632	chr27	6194698	6194727	3500259309	24		6194698	6194727	8421504	2	17,7	0,22	c	350025930900000008	1-25						Tagging of Endogenous Genes in a Toxoplasma gondii Strain Lacking Ku80	ec.asm.org/conten	0	0		
632	chr27	6240248	6240272	3500307903	23		6240248	6240272	8421504	2	8,15	0,9	g	350030790300000000	2-36						Modified gene-silencing nucleic acid molecules and uses thereof	Both	2006	0		
634	chr27	6444588	6446102	3500388565	26		6444588	6446102	8421504	2	17,9	0,1505	c	350038856500000002	0-26					Infection and Immunity	Differential Expression of Caprine &#x03b2;-Defensins in Digestive and Respiratory Tissues	Chengquan	1999	0		
634	chr27	6446101	6446221	3500397089	120		6446101	6446221	8421504	1	120	0	p	350039708900015103	0-120						Immunoglobulin Directed Biocides	Bremel	2009	0		
634	chr27	6446101	6446221	3500391307	120		6446101	6446221	8421504	1	120	0	p	350039130700015097	0-120						Targeted biocides	Bremel	2005	0		
634	chr27	6446101	6446221	3500294798	120		6446101	6446221	8421504	1	120	0	p	350029479800015097	0-120						Targeted biocides	Bremel	2010	0		
634	chr27	6446101	6446221	3500260805	120		6446101	6446221	8421504	1	120	0	p	350026080500015108	0-120						Innate Immune Receptor Directed Biocides	Bremel	2008	0		
634	chr27	6446101	6446221	3500141125	120		6446101	6446221	8421504	1	120	0	p	350014112500015108	0-120						Antimicrobial Peptide Biocides	Bremel	2008	0		
634	chr27	6446101	6446221	3500115576	120		6446101	6446221	8421504	1	120	0	p	350011557600015128,350011557600015129	0-63,0-57						TARGETED BIOCIDES	Imboden	2009	0		
636	chr27	6751339	6751390	3500011040	47		6751339	6751390	8421504	2	24,23	0,28	c	350001104000000001	0-52						US Patent # 5,550,109. Inducible defensin peptide from mammalian epithelia - Patents.com	www.patents.com	0	0		
636	chr27	6751368	6752984	3500172641	145		6751368	6752984	8421504	2	29,116	0,1500	c	350017264100000005	41-186						Identification and sequence analysis of two antimicrobial peptides in Egyptian native and crossbred frisian cattle	www.acgssr.org	0	0		
636	chr27	6752876	6752999	3500397089	123		6752876	6752999	8421504	1	123	0	p	350039708900015101	0-123						Immunoglobulin Directed Biocides	Bremel	2009	0		
636	chr27	6752876	6752999	3500391307	123		6752876	6752999	8421504	1	123	0	p	350039130700015095	0-123						Targeted biocides	Bremel	2005	0		
636	chr27	6752876	6752999	3500294798	123		6752876	6752999	8421504	1	123	0	p	350029479800015095	0-123						Targeted biocides	Bremel	2010	0		
636	chr27	6752876	6752999	3500260805	123		6752876	6752999	8421504	1	123	0	p	350026080500015106	0-123						Innate Immune Receptor Directed Biocides	Bremel	2008	0		
636	chr27	6752876	6752999	3500141125	123		6752876	6752999	8421504	1	123	0	p	350014112500015106	0-123						Antimicrobial Peptide Biocides	Bremel	2008	0		
636	chr27	6752876	6752999	3500115576	123		6752876	6752999	8421504	1	123	0	p	350011557600015124,350011557600015125,350011557600015123	0-63,0-60,9-57						TARGETED BIOCIDES	Imboden	2009	0		
636	chr27	6752999	6753022	3500322039	23		6752999	6753022	8421504	1	23	0	c	350032203900000006	0-23			10.1128/CDLI.11.1.174-185.2004		Clinical and Diagnostic Laboratory Immunology	Mastitis Increases Mammary mRNA Abundance of &#x03b2;-Defensin 5, Toll-Like-Receptor 2 (TLR2), and TLR4 but Not TLR9 in Cattle	T.	2004	0		
636	chr27	6753028	6753051	3500402635	23		6753028	6753051	8421504	1	23	0	c	350040263500000003	1-24		15674371	10.1038/sj.gene.6364153	1466-4879	Genes and Immunity	Variability and evolution of bovine &#x03b2;-defensin genes	Luenser	2004	4		
638	chr27	7001265	7001296	3500367454	26		7001265	7001296	8421504	2	6,20	0,11	c	350036745400000009	10-38						Antibodies that bind OV064 and methods of use therefor	Veiby	2006	0		
640	chr27	7234309	7271759	3500322650	98		7234309	7271759	8421504	3	20,20,58	0,1659,37392	c	350032265000000001,350032265000000000,350032265000000004	0-20,0-20,0-58						A note on the organization and expression of &#x03b2;-defensin genes in Polish goats. - ResearchGate	.researchgate.net	0	0		
640	chr27	7234376	7271759	3500397089	336		7234376	7271759	8421504	4	128,58,92,58	0,1585,35744,37325	p	350039708900015097,350039708900015098,350039708900015137,350039708900015001,350039708900015000	0-120,0-120,0-72,0-75,0-75						Immunoglobulin Directed Biocides	Bremel	2009	0		
640	chr27	7234376	7271759	3500391307	336		7234376	7271759	8421504	5	128,58,72,20,58	0,1585,35702,35816,37325	p	350039130700015091,350039130700015092,350039130700015132,350039130700015002,350039130700015000	0-120,0-120,0-72,0-72,0-78						Targeted biocides	Bremel	2005	0		
640	chr27	7234376	7271759	3500294798	378		7234376	7271759	8421504	4	128,58,134,58	0,1585,35702,37325	p	350029479800015091,350029479800015092,350029479800015132,350029479800015002,350029479800015001,350029479800015000	0-120,0-120,0-72,0-72,0-45,0-75						Targeted biocides	Bremel	2010	0		
640	chr27	7234376	7271759	3500260805	372		7234376	7271759	8421504	4	128,58,128,58	0,1585,35708,37325	p	350026080500015102,350026080500015103,350026080500015141,350026080500015002,350026080500015001,350026080500015000	0-120,0-120,0-72,0-66,0-45,0-75						Innate Immune Receptor Directed Biocides	Bremel	2008	0		
640	chr27	7234376	7271759	3500141125	372		7234376	7271759	8421504	4	128,58,128,58	0,1585,35708,37325	p	350014112500015103,350014112500015102,350014112500015141,350014112500015002,350014112500015001,350014112500015000	0-120,0-120,0-72,0-66,0-45,0-75						Antimicrobial Peptide Biocides	Bremel	2008	0		
640	chr27	7234376	7271759	3500115576	303		7234376	7271759	8421504	3	120,125,58	0,35711,37325	p	350011557600015119,350011557600015126,350011557600015116,350011557600015002,350011557600015001,350011557600015169	0-57,0-63,0-63,0-63,0-57,0-63						TARGETED BIOCIDES	Imboden	2009	0		
640	chr27	7235968	7271763	3500381758	345		7235968	7271763	8421504	4	51,73,159,62	0,34008,34085,35733	p,c,g	350038175800000004,350038175800000001,350038175800000008,350038175800000006,350038175800000006,350038175800000007,350038175800000007,350038175800015002,350038175800015000,350038175800015001,350038175800015004,350038175800000000	0-50,0-52,19-317,0-127,0-127,0-133,0-133,0-132,0-126,0-192,126-318,0-48						US Patent # 5,656,738. Inducible defensin peptide from mammalian epithelia - Patents.com	www.patents.com	0	0		
640	chr27	7269976	7271763	3500011040	294		7269976	7271763	8421504	3	73,159,62	0,77,1725	p,c,g	350001104000000010,350001104000000008,350001104000000008,350001104000000009,350001104000000009,350001104000015002,350001104000015000,350001104000015007,350001104000015005,350001104000000000	19-317,0-127,0-127,0-133,0-133,0-132,0-192,126-318,0-126,0-48						US Patent # 5,550,109. Inducible defensin peptide from mammalian epithelia - Patents.com	www.patents.com	0	0		
640	chr27	7270078	7271759	3500256076	192		7270078	7271759	8421504	2	134,58	0,1623	p,c	350025607600015005,350025607600015000,350025607600015013,350025607600015012,350025607600015009,350025607600000000,350025607600000001,350025607600000004	0-132,0-126,126-318,0-192,9-189,0-48,0-52,0-51						Inducible defensin peptide from mammalian epithelia	Schonwetter	1995	0		
640	chr27	7270126	7270174	3500427057	48		7270126	7270174	8421504	1	48	0	c	350042705700000010	0-48						Tracheal antimicrobial peptides, DNA sequences and methods for the production and use thereof	Zasloff	1990	0		
640	chr27	7270126	7270174	3500384273	48		7270126	7270174	8421504	1	48	0	c	350038427300000010	0-48					Patent	Tracheal antimicrobial peptides, dna sequences and methods for the production and use thereof (Patent US:5202420)	Bevins	1993	0		
640	chr27	7270129	7270174	3500460350	45		7270129	7270174	8421504	1	45	0	p	350046035000015009	0-45						 Antimicrobial Peptide 	www.docstoc.com	0	0		
640	chr27	7270144	7271759	3500449392	83		7270144	7271759	8421504	2	29,54	0,1561	c	350044939200000009,350044939200000007,350044939200000008	0-29,0-54,0-54						US Patent # 5,432,270. DNA encoding tracheal antimicrobial peptides - Patents.com	www.patents.com	0	0		
640	chr27	7271705	7271759	3500266706	54		7271705	7271759	8421504	1	54	0	p,c	350026670600000007,350026670600000008,350026670600015007	0-54,0-54,0-45						Novel tracheal antimicrobial peptides	Bevins	1994	0		
640	chr27	7271705	7271759	3500189718	54		7271705	7271759	8421504	1	54	0	c	350018971800000000	0-54		10603376	10.1128/IAI.68.1.113-119.2000	0019-9567	Infection and Immunity	Transcriptional Regulation of &#x03b2;-Defensin Gene Expression in Tracheal Epithelial Cells	Diamond	2000	4		
641	chr27	7429127	7429153	3500404304	26		7429127	7429153	8421504	1	26	0	c	350040430400000000	10-36						METHODS OF TREATING LUNG INFECTIONS WITH HUMAN TRACHEAL ANTIMICROBIAL PEPTIDE (hTAP) - JOHNS HOPKINS UNIVERSITY	www.sumobrain.com	0	0		
641	chr27	7429135	7430767	3500145236	42		7429135	7430767	8421504	2	20,22	0,1610	c	350014523600000012,350014523600000013	0-20,0-22		17170087	10.1677/jme.1.02131	0952-5041	Journal of Molecular Endocrinology	DNA-remethylation around a STAT5-binding enhancer in the &#x03b1;S1-casein promoter is associated with abrupt shutdown of &#x03b1;S1-casein synthesis during acute mastitis	Vanselow	2006	3		
641	chr27	7429162	7430674	3500172641	39		7429162	7430674	8421504	2	28,11	0,1501	c	350017264100000004	134-173						Identification and sequence analysis of two antimicrobial peptides in Egyptian native and crossbred frisian cattle	www.acgssr.org	0	0		
641	chr27	7430863	7430892	3500322650	29		7430863	7430892	8421504	1	29	0	c	350032265000000008	12-41						A note on the organization and expression of &#x03b2;-defensin genes in Polish goats. - ResearchGate	.researchgate.net	0	0		
641	chr27	7469289	7469315	3500461592	26		7469289	7469315	8421504	1	26	0	c	350046159200000000	10-36						METHODS OF TREATING LUNG INFECTIONS WITH HUMAN TRACHEAL ANTIMICROBIAL PEPTIDE (hTAP)	Delannoy	1998	0		
641	chr27	7469294	7470908	3500115576	126		7469294	7470908	8421504	3	58,5,63	0,1543,1551	p	350011557600015167,350011557600015122	0-63,0-63						TARGETED BIOCIDES	Imboden	2009	0		
641	chr27	7469297	7470941	3500417810	42		7469297	7470941	8421504	2	20,22	0,1622	c	350041781000000012,350041781000000013	0-20,0-22						DNA-remethylation around a STAT5-binding enhancer in the aS1-casein promoter is associated with abrupt shutdown of aS1-casein synthesis during acute mastitis	logy-journals.org	0	0		
641	chr27	7470845	7470965	3500397089	120		7470845	7470965	8421504	1	120	0	p	350039708900015100	0-120						Immunoglobulin Directed Biocides	Bremel	2009	0		
641	chr27	7470845	7470965	3500391307	120		7470845	7470965	8421504	1	120	0	p	350039130700015094	0-120						Targeted biocides	Bremel	2005	0		
641	chr27	7470845	7470965	3500294798	120		7470845	7470965	8421504	1	120	0	p	350029479800015094	0-120						Targeted biocides	Bremel	2010	0		
641	chr27	7470845	7470965	3500260805	120		7470845	7470965	8421504	1	120	0	p	350026080500015105	0-120						Innate Immune Receptor Directed Biocides	Bremel	2008	0		
641	chr27	7470845	7470965	3500141125	120		7470845	7470965	8421504	1	120	0	p	350014112500015105	0-120						Antimicrobial Peptide Biocides	Bremel	2008	0		
641	chr27	7470997	7471020	3500323538	23		7470997	7471020	8421504	1	23	0	c	350032353800000003	1-24		15674371	10.1038/sj.gene.6364153	1466-4879	Genes and Immunity	Variability and evolution of bovine &#x03b2;-defensin genes	Luenser	2004	4		
642	chr27	7595940	7595967	3500322650	27		7595940	7595967	8421504	1	27	0	g	350032265000000006	55-82						A note on the organization and expression of &#x03b2;-defensin genes in Polish goats. - ResearchGate	.researchgate.net	0	0		
645	chr27	7931345	7938285	3500197449	23		7931345	7938285	8421504	2	11,12	0,6928	c	350019744900000013	22-45		21539888	10.1016/j.mce.2011.04.008		Molecular and cellular endocrinology	Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers	Craig	June	0		
647	chr27	8129625	8129650	3500416780	23		8129625	8129650	8421504	3	14,5,4	0,15,21	g	350041678000000096	11-34						Gamma-iterferon-leukotoxin gene fusions and uses thereof	Potter	1991	0		
647	chr27	8129625	8129650	3500013181	23		8129625	8129650	8421504	3	14,5,4	0,15,21	g	350001318100000028	11-34						 GnRH 	www.docstoc.com	0	0		
650	chr27	8594010	8594035	3500208905	25		8594010	8594035	8421504	1	25	0	c	350020890500000003	21-46			10.1111/j.1442-2042.2004.00961.x	1442-2042	International Journal of Urology	Comparison of two in vivo models for prostate cancer: Orthotopic and intratesticular inoculation of LNCaP or PC-3 cells - KOSHIDA - 2004 - International Journal of Urology - Wiley Online Library	KOSHIDA	2004	0		VEGFC
650	chr27	8594012	8594035	3500041768	23		8594012	8594035	8421504	1	23	0	c	350004176800000001	0-23			10.1002/ijc.1379	1097-0215	International Journal of Cancer	Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas - Kitadai - 2001 - International Journal of Cancer - Wiley Online Library	Kitadai	2001	0		VEGFC
650	chr27	8594220	8621974	3500438157	539		8594220	8621974	8421504	11	50,22,8,48,66,116,18,48,29,59,75	0,83,2955,3134,3212,11519,25677,25776,25839,27564,27679	p,c	350043815700000048,350043815700000076,350043815700000103,350043815700000042,350043815700000097,350043815700000040,350043815700000093,350043815700000092,350043815700000035,350043815700000034,350043815700000060,350043815700000030,350043815700000029,350043815700015024,350043815700000027,350043815700015053,350043815700015154,350043815700000083	0-44,27-48,9-39,0-48,0-48,0-48,0-20,1-48,0-48,0-48,0-48,0-48,8-48,0-45,0-48,0-45,0-45,18-44						Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof	Alitalo	1999	0		
650	chr27	8594220	8621959	3500376390	258		8594220	8621959	8421504	7	44,22,8,48,86,24,26	0,83,2955,3212,11519,25857,27713	c,g	350037639000000048,350037639000000103,350037639000000097,350037639000000093,350037639000000092,350037639000000035,350037639000000130,350037639000000083	0-44,9-39,0-48,0-20,1-48,0-48,0-24,18-44						Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof - Patent application	www.faqs.org	0	0		
650	chr27	8594220	8621947	3500240613	426		8594220	8621947	8421504	9	44,48,48,78,18,48,75,19,48	0,3134,3230,11557,25677,25743,25793,27564,27679	c	350024061300000031,350024061300000025,350024061300000023,350024061300000018,350024061300000017,350024061300000015,350024061300000014,350024061300000013,350024061300000010	0-44,0-48,0-48,0-48,0-48,0-48,0-46,0-48,0-48						AUTOLOGOUS LYMPH NODE TRANSFER IN COMBINATION WITH VEGF-C OR VEGF-D GROWTH FACTOR THERAPY TO TREAT SECONDARY LYMPHEDEMA AND TO IMPROVE RECONSTRUCTIVE SURGERY - Patent application	www.faqs.org	0	0		
650	chr27	8594220	8621947	3500157422	259		8594220	8621947	8421504	6	44,48,75,4,40,48	0,11557,25793,27564,27583,27679	c	350015742200000074,350015742200000061,350015742200000057,350015742200000091,350015742200000055,350015742200000053	0-44,0-48,0-46,0-48,8-48,0-48						US Patent # 6,403,088. Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3) - Patents.com	www.patents.com	0	0		
650	chr27	8594220	8621824	3500192168	309		8594220	8621824	8421504	7	44,48,105,18,46,8,40	0,3230,11530,25677,25793,25860,27564	c	350019216800000100,350019216800000092,350019216800000057,350019216800000087,350019216800000086,350019216800000083,350019216800000051	0-44,0-48,0-48,0-48,0-48,0-46,0-48						US Patent # 6,245,530. Receptor ligand - Patents.com	www.patents.com	0	0		
650	chr27	8594220	8621824	3500007607	188		8594220	8621824	8421504	4	44,96,8,40	0,11530,25860,27564	c,g	350000760700000100,350000760700000057,350000760700000087,350000760700000056,350000760700000051	0-44,0-48,0-48,0-48,0-48						Receptor ligand	Alitalo	1996	0		
650	chr27	8594220	8620059	3500038401	155		8594220	8620059	8421504	3	44,48,63	0,11557,25776	c	350003840100000083,350003840100000070,350003840100000101,350003840100000066	0-44,0-48,0-48,0-46						US Patent # 6,645,933. Receptor ligand VEGF-C - Patents.com	www.patents.com	0	0		
650	chr27	8594220	8620044	3500405555	236		8594220	8620044	8421504	5	44,48,78,18,48	0,3230,11557,25677,25776	c	350040555500000083,350040555500000075,350040555500000070,350040555500000069,350040555500000101	0-44,0-48,0-48,0-48,0-48						Receptor ligand VEGF-C	Alitalo	1996	0		
650	chr27	8594303	8621974	3500104816	333		8594303	8621974	8421504	7	22,8,48,86,75,19,75	0,2872,3129,11436,25710,27481,27596	p,c	350010481600000103,350010481600000097,350010481600015167,350010481600000093,350010481600000092,350010481600000035,350010481600000031,350010481600000030,350010481600015023,350010481600000027,350010481600015054,350010481600015180,350010481600015153,350010481600000083	9-39,0-48,0-45,0-20,1-48,0-48,0-46,0-48,0-45,0-48,0-48,0-45,0-45,18-44						VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) PROTEIN AND GENE, MUTANTS THEREOF, AND USES THEREOF - Patent application	www.faqs.org	0	0		
650	chr27	8594303	8621959	3500235906	380		8594303	8621959	8421504	8	22,8,66,116,18,48,11,91	0,2872,3129,11436,25594,25693,27552,27565	p,c	350023590600000104,350023590600000098,350023590600000041,350023590600000094,350023590600000093,350023590600000036,350023590600000035,350023590600000061,350023590600000000,350023590600015021,350023590600015156,350023590600015053,350023590600000084	9-39,0-48,0-48,0-20,1-48,0-48,0-48,0-48,74-163,0-48,0-45,0-48,18-44						Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof	Alitalo	1999	0		
650	chr27	8597193	8621914	3500191872	239		8597193	8621914	8421504	7	26,42,43,29,13,40,46	0,8584,22820,22866,24591,24610,24675	c	350019187200000050,350019187200000064,350019187200000060,350019187200000059,350019187200000058,350019187200000032	0-26,0-42,0-43,0-42,5-45,0-46						US Patent # 7,153,942. Vascular endothelial growth factor 2 - Patents.com	www.patents.com	0	0		
650	chr27	8597354	8621950	3500443593	291		8597354	8621950	8421504	7	42,42,43,29,13,40,82	0,8423,22659,22705,24430,24449,24514	p,c	350044359300000070,350044359300000063,350044359300000059,350044359300000058,350044359300000057,350044359300000032,350044359300015040	0-42,0-42,0-43,0-42,8-48,0-46,0-45						US Patent # 7,186,688. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2 - Patents.com	www.patents.com	0	0		
650	chr27	8597354	8621914	3500081784	315		8597354	8621914	8421504	7	62,48,78,18,29,34,46	0,96,8423,22543,22705,24430,24514	c	350008178400000049,350008178400000025,350008178400000047,350008178400000042,350008178400000018,350008178400000041,350008178400000037,350008178400000013,350008178400000011	0-48,1-48,0-48,0-48,0-48,0-48,0-48,0-48,0-46						US Patent # 5,932,540. Vascular endothelial growth factor 2 - Patents.com	www.patents.com	0	0		
650	chr27	8597354	8597498	3500452900	96		8597354	8597498	8421504	2	48,48	0,96	c	350045290000000106,350045290000000104	0-48,0-48						Vascular endothelial growth factor 2 - Patent application	www.faqs.org	0	0		
650	chr27	8597369	8619915	3500266338	191		8597369	8619915	8421504	4	47,48,78,18	0,81,8408,22528	c	350026633800000047,350026633800000069,350026633800000064,350026633800000063	1-48,0-48,0-48,0-48						US Patent # 6,734,285. Vascular endothelial growth factor 2 proteins and compositions - Patents.com	www.patents.com	0	0		
650	chr27	8597369	8597416	3500213514	47		8597369	8597416	8421504	1	47	0	c	350021351400000021	1-48						MODULATION OF VEGF-C/VEGFR-3 INTERACTIONS IN THE TREATMENT OF RHEUMATOID ARTHRITIS - Patent application	www.faqs.org	0	0		
650	chr27	8597423	8597498	3500172765	75		8597423	8597498	8421504	1	75	0	p	350017276500015008	15-90						Avian VEGF-C: cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors	ev.biologists.org	0	0		
650	chr27	8597450	8621803	3500353443	190		8597450	8621803	8421504	4	48,48,75,19	0,8327,22563,24334	c	350035344300000016,350035344300000011,350035344300000007,350035344300000006	0-48,0-48,0-46,0-48						Polynucleotides encoding vascular endothelial growth factor 2	Hu	1997	0		
650	chr27	8597450	8621803	3500069301	286		8597450	8621803	8421504	6	48,78,18,48,75,19	0,8327,22447,22513,22563,24334	c	350006930100000023,350006930100000018,350006930100000017,350006930100000015,350006930100000014,350006930100000013	0-48,0-48,0-48,0-48,0-46,0-48						Use of VEGF-C or VEGF-D in Reconstructive Surgery - Patent application	www.faqs.org	0	0		
650	chr27	8605777	8621914	3500130054	128		8605777	8621914	8421504	3	42,40,46	0,16026,16091	c	350013005400000099,350013005400000093,350013005400000068	0-42,5-45,0-46						US Patent # 7,208,582. Vascular endothelial growth factor 2 - Patents.com	www.patents.com	0	0		
650	chr27	8605777	8621843	3500452046	82		8605777	8621843	8421504	2	42,40	0,16026	c	350045204600000099,350045204600000093	0-42,5-45						US Patent # 7,402,312. Antibodies to vascular endothelial growth factor 2 (VEGF-2) - Patents.com	www.patents.com	0	0		
650	chr27	8605794	8619910	3500264552	49		8605794	8619910	8421504	3	24,12,13	0,49,14103	c	350026455200000001,350026455200000000	0-24,0-25		22825326	10.4161/cbt.21187		Cancer Biology & Therapy	Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice	Maria	2012	0		VEGFC
650	chr27	8619961	8620087	3500266059	62		8619961	8620087	8421504	2	26,36	0,90	c	350026605900000023,350026605900000029,350026605900000020	9-35,2-38,0-24						Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins - US Patent 7566566 Description	ww.patentstorm.us	0	0		
650	chr27	8620051	8620087	3500390693	36		8620051	8620087	8421504	1	36	0	c	350039069300000029	2-38						Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins - Patent application	www.faqs.org	0	0		
650	chr27	8620074	8621914	3500320855	94		8620074	8621914	8421504	3	14,34,46	0,1710,1794	c	350032085500000034,350032085500000032	0-48,0-46						VASCULAR ENDOTHELIAL GROWTH FACTOR-2 - Patent application	www.faqs.org	0	0		
651	chr27	8679125	8679173	3500438157	48		8679125	8679173	8421504	1	48	0	c	350043815700000023	0-48						Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof	Alitalo	1999	0		
651	chr27	8679160	8679185	3500096682	25		8679160	8679185	8421504	1	25	0	c	350009668200000023	10-35						Vascular endothelial growth factor 2	Rosen	2012	0		
651	chr27	8741536	8741561	3500258001	23		8741536	8741561	8421504	2	7,16	0,9	g	350025800100000173	0-23						PROTEASE VARIANTS - Patent application	www.faqs.org	0	0		
656	chr27	9322946	9322974	3500149404	23		9322946	9322974	8421504	2	6,17	0,11	c	350014940400000048	10-33						Use Of Stomatin (STM1) Polynucleotides For Achieving A Pathogen Resistance In Plants - Patent application	www.faqs.org	0	0		
667	chr27	10761305	10761331	3500348580	23		10761305	10761331	8421504	3	5,6,12	0,7,14	g	350034858000000333	1-24						US Patent # 7,226,755. HPTPbeta as a target in treatment of angiogenesis mediated disorders - Patents.com	www.patents.com	0	0		
668	chr27	10968380	10968404	3500458527	23		10968380	10968404	8421504	2	4,19	0,5	g	350045852700000004	2-25		21317927	10.1038/onc.2011.15	0950-9232	Oncogene	MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4	Schramedei	2011	6		
682	chr27	12797758	12797786	3500331383	24		12797758	12797786	8421504	2	6,18	0,10	g	350033138300000032,350033138300000007	1-26,1-26						PROCESS FOR PRODUCING GLUTAMATE DERIVATIVES - Patent application	www.faqs.org	0	0		
682	chr27	12797758	12797786	3500307346	24		12797758	12797786	8421504	2	6,18	0,10	g	350030734600000007	1-26						Process for producing glutamic acid derivatives	Sugiyama	2011	0		
682	chr27	12797758	12797786	3500279987	24		12797758	12797786	8421504	2	6,18	0,10	g	350027998700000007	1-26						Process of producing glutamate derivatives - Patent # 7297800 - PatentGenius	.patentgenius.com	0	0		
682	chr27	12797758	12797786	3500248359	24		12797758	12797786	8421504	2	6,18	0,10	g	350024835900000007	1-26					Patent	Process for producing glutamic acid derivatives (Patent EP:1445323)	Sugiyama	2011	0		
684	chr27	13076347	13076374	3500200695	24		13076347	13076374	8421504	2	8,16	0,11	g	350020069500000016	8-32						Regulation of angiogenesis with zinc finger proteins	Rebar	2001	0		
685	chr27	13126580	13126605	3500031145	23		13126580	13126605	8421504	3	11,6,6	0,12,19	g	350003114500000009	20-46					Protein Science : A Publication of the Protein Society	Properties of Bacillus cereus hemolysin II: A heptameric transmembrane pore	George	July	0		
689	chr27	13742385	13742412	3500332026	23		13742385	13742412	8421504	3	11,4,8	0,14,19	g	350033202600000762,350033202600000016	0-23,0-23						Methods for Detecting Epigenetic Modifications - Patent application	www.faqs.org	0	0		
689	chr27	13742385	13742412	3500013036	23		13742385	13742412	8421504	3	11,4,8	0,14,19	g	350001303600000058	0-23						Methods For Detecting Epigenetic Modifications 	.freshpatents.com	0	0		
693	chr27	14246860	14246884	3500451741	23		14246860	14246884	8421504	2	15,8	0,16	g	350045174100000065	0-23						US Patent # 7,291,334. Antibodies to novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections - Patents.com	www.patents.com	0	0		
696	chr27	14644610	14644634	3500258818	23		14644610	14644634	8421504	2	12,11	0,13	g	350025881800000058,350025881800000265	0-23,0-23						METHODS AND MATERIALS RELATED TO HAIR PIGMENTATION AND CANCER - Patent application	www.faqs.org	0	0		
700	chr27	15114442	15114468	3500465589	23		15114442	15114468	8421504	2	6,17	0,9	g	350046558900000005,350046558900000004	1-25,9-33					Patent	Multifunctional cytokines (Patent US:7534585)	Paul	2009	0		
700	chr27	15114442	15114468	3500148962	23		15114442	15114468	8421504	2	6,17	0,9	g	350014896200000002,350014896200000003	9-33,1-25						Multifunctional cytokines	Paul	2004	0		
701	chr27	15277910	15277935	3500328029	24		15277910	15277935	8421504	2	14,10	0,15	g	350032802900000009	5-29						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation 	www.jbc.org	0	0		
701	chr27	15277910	15277935	3500156403	24		15277910	15277935	8421504	2	14,10	0,15	g	350015640300000009	5-29						The AF-1 domain of NOR-1/NR4A3 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-Mercaptopurine.	www.jbc.org	0	0		
702	chr27	15348917	15348942	3500241434	23		15348917	15348942	8421504	2	10,13	0,12	g	350024143400000353	3-26						GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME	Schellenberger	2010	0		
702	chr27	15459820	15459886	3500232699	66		15459820	15459886	8421504	1	66	0	p	350023269900015003	0-66			10.1128/MCB.22.3.835-848.2002		Molecular and Cellular Biology	Role of the Sin3-Histone Deacetylase Complex in Growth Regulation by the Candidate Tumor Suppressor p33ING1	A.	2002	0		ING2
704	chr27	15705520	15705548	3500042870	23		15705520	15705548	8421504	2	9,14	0,14	g	350004287000000059	9-34						Thermophilic polymerase iii holoenzyme	Mchenry	2001	0		
707	chr27	16055747	16057609	3500319127	40		16055747	16057609	8421504	2	20,20	0,1842	c	350031912700000019,350031912700000018	0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
709	chr27	16311856	16318173	3500304637	51		16311856	16318173	8421504	2	25,26	0,6291	c	350030463700000000,350030463700000004	11-36,0-26		17020986	10.1158/1078-0432.CCR-06-0725	1078-0432	Clinical Cancer Research	Overexpression of Caspase-3s Splice Variant in Locally Advanced Breast Carcinoma Is Associated with Poor Response to Neoadjuvant Chemotherapy	Vegran	2006	8		
709	chr27	16311876	16313415	3500441253	40		16311876	16313415	8421504	2	21,19	0,1520	c,g	350044125300000000,350044125300000000,350044125300000001,350044125300000001	0-21,0-21,0-19,0-19						1. INTRODU&#xc7;&#xc3;O	www.ufpel.tche.br	0	0		
709	chr27	16318174	16318603	3500049463	47		16318174	16318603	8421504	3	12,11,24	0,355,405	c	350004946300000004,350004946300000005	0-23,0-24			10.1590/S0102-09352010000200003	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Apoptosis and expression of Bcl-2 and caspases 3 and 8 in placenta of cows at different pregnancy stages	Meca	2010	0		
709	chr27	16318543	16318566	3500021577	23		16318543	16318566	8421504	1	23	0	c,g	350002157700000004,350002157700000004	0-23,0-23						O-12	www.scribd.com	0	0		CASP3
709	chr27	16318568	16320022	3500389774	40		16318568	16320022	8421504	2	20,20	0,1434	c,g	350038977400000006,350038977400000007,350038977400000007	0-20,0-20,0-20						mRNA and microRNA quality control for RT-qPCR analysis	uantification.com	0	0		
709	chr27	16318568	16320022	3500107315	40		16318568	16320022	8421504	2	20,20	0,1434	c,g	350010731500000006,350010731500000007,350010731500000007	0-20,0-20,0-20						mRNA and microRNA quality control for RT-qPCR analysis	uantification.net	0	0		
709	chr27	16318588	16320054	3500108530	40		16318588	16320054	8421504	2	20,20	0,1446	c,g	350010853000000004,350010853000000005,350010853000000005	0-20,0-20,0-20						7,8-Dihydroxycoumarin inhibits A549 human lung adenocarcinoma cell proliferation by inducing apoptosis via suppression of Akt/NF-&#x03ba;B signaling	-publications.com	0	0		
709	chr27	16318639	16319955	3500227525	26		16318639	16319955	8421504	2	11,15	0,1301	c	350022752500000029	0-26						REAL-TIME RT-PCR AND PROTEOMIC ANALYSIS OF ADIPOSE TISSUE FROM OB/OB MICE TREATED WITH LEPTIN WEI ZHANG	aeum.libs.uga.edu	0	0		
709	chr27	16320065	16320161	3500239005	96		16320065	16320161	8421504	1	96	0	p	350023900500015017	0-96						ABSTRACT	tory.lib.ncsu.edu	0	0		
709	chr27	16320141	16320168	3500327446	26		16320141	16320168	8421504	2	22,4	0,23	c	350032744600000001	12-38						NOVEL ULTRASENSITIVE CELL BASED SENSORS AND USES THEREOF	Paz-rojas	2010	0		
709	chr27	16321976	16322002	3500295556	23		16321976	16322002	8421504	2	8,15	0,11	c	350029555600000062	5-37						Seed plants exhibiting early reproductive development and methods of making same	Weigel	1997	0		
709	chr27	16321976	16322002	3500121284	23		16321976	16322002	8421504	2	8,15	0,11	c	350012128400000062	5-37						Seed plants exhibiting inducible early reproductive development and methods of making same	Yanofsky	1999	0		
88	chr27	16345226	16389144	3500095434	47		16345226	16389144	8421504	2	25,22	0,43896	c,g	350009543400000023,350009543400000022,350009543400000022	0-25,0-22,0-22						BMC Genetics BioMed Central	biomedcentral.com	0	0		
709	chr27	16345525	16346129	3500301078	47		16345525	16346129	8421504	3	15,10,22	0,368,582	c	350030107800000032,350030107800000031	0-25,0-22						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
88	chr27	16360827	16409755	3500216025	68		16360827	16409755	8421504	4	24,24,12,8	0,9271,28329,48920	c	350021602500000008	0-108						Association of an ACSL1 gene variant with polyunsaturated fatty acids in bovine skeletal muscle. - ResearchGate	.researchgate.net	0	0		
709	chr27	16363347	16367227	3500331390	44		16363347	16367227	8421504	3	6,17,21	0,903,3859	c	350033139000000066,350033139000000065	0-23,0-21						Pharmacological and Toxicological Advances in PPAR-Related Medicines	loads.hindawi.com	0	0		
709	chr27	16364706	16364734	3500344462	25		16364706	16364734	8421504	2	16,9	0,19	g	350034446200000009	7-32						&#x02d9;& &#x02d8;	data.epo.org	0	0		
710	chr27	16426759	16426789	3500080694	26		16426759	16426789	8421504	2	18,8	0,22	g	350008069400000194	11-40						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
711	chr27	16556434	16556457	3500393748	23		16556434	16556457	8421504	1	23	0	g	350039374800000013	0-23						Human umbilical cord-derived mesenchymal stromal cells promote sensory recovery in a spinal cord injury rat model	www.scirp.org	0	0		HELT
711	chr27	16556434	16556457	3500195883	23		16556434	16556457	8421504	1	23	0	g	350019588300000013	0-23						Human umbilical cord-derived mesenchymal stromal cells promote sensory recovery in a spinal cord injury rat model	www.scirp.org	0	0		HELT
712	chr27	16658424	16660577	3500252626	183		16658424	16660577	8421504	5	48,39,1,47,48	0,57,480,986,2105	c	350025262600000015,350025262600000016,350025262600000025,350025262600000030	0-48,9-48,0-48,0-48						Mouse lacking heart-muscle adenine nucleotide translocator protein and methods	Wallace	1997	0		
712	chr27	16658424	16660577	3500068260	137		16658424	16660577	8421504	3	48,41,48	0,198,2105	c	350006826000000015,350006826000000019,350006826000000030	0-48,6-47,0-48						Mouse lacking heart-muscle adenine nucleotide translocator protein and methods	Graham	1998	0		
712	chr27	16658459	16658484	3500448606	25		16658459	16658484	8421504	1	25	0	c	350044860600000026	0-25		20504995	10.1093/hmg/ddq214		Human Molecular Genetics	The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis	Greta	2010	0		SLC25A4
712	chr27	16658543	16658586	3500400388	41		16658543	16658586	8421504	2	20,21	0,22	c	350040038800000011,350040038800000009	0-20,0-21			10.1111/j.1742-4658.2007.05810.x	1742-4658	FEBS Journal	Identification of substrates for transglutaminase in Physarum polycephalum, an acellular slime mold, upon cellular mechanical damage - Wada - 2007 - FEBS Journal - Wiley Online Library	Wada	2007	0		SLC25A4
713	chr27	16826624	16826650	3500288304	23		16826624	16826650	8421504	2	16,7	0,19	c	350028830400000018	13-36						Stable polyvalent antibody	Nobuaki	2011	0		
713	chr27	16826844	16826874	3500434630	25		16826844	16826874	8421504	2	18,7	0,23	g	350043463000000007	0-29						&#x4e3b;&#x984c;&#xff1a;&#x8461;&#x8404;&#x7403;&#x83cc; | &#x91ab;&#x6e90;&#x4e16;&#x754c;	big5.39kf.com	0	0		
713	chr27	16826844	16826874	3500298679	25		16826844	16826874	8421504	2	18,7	0,23	g	350029867900000007	0-29						&#x4e3b;&#x984c;&#xff1a;RPLA | &#x91ab;&#x6e90;&#x4e16;&#x754c;	big5.39kf.com	0	0		
713	chr27	16826844	16826874	3500209467	25		16826844	16826874	8421504	2	18,7	0,23	g	350020946700000007	0-29						Detec&#xe7;&#xe3;o de genes toxig&#xea;nicos em amostras de Staphylococcus spp. isoladas de queijos de coalho	www.scielo.br	0	0		
713	chr27	16826844	16826874	3500013163	25		16826844	16826874	8421504	2	18,7	0,23	g	350001316300000007	0-29			10.1016/j.femsle.2005.04.007	1574-6968	FEMS Microbiology Letters	Comprehensive analysis of classical and newly described staphylococcal superantigenic toxin genes in Staphylococcus aureus isolates - Omoe - 2006 - FEMS Microbiology Letters - Wiley Online Library	Omoe	2005	0		
714	chr27	17028679	17028709	3500036684	26		17028679	17028709	8421504	3	6,7,13	0,8,17	c	350003668400000198	11-40						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
714	chr27	17028679	17028709	3500003486	26		17028679	17028709	8421504	3	6,7,13	0,8,17	c	350000348600000425	11-40						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		
714	chr27	17028679	17028708	3500235753	25		17028679	17028708	8421504	3	6,7,12	0,8,17	c	350023575300000095	0-28						Protein Fragment Complementation Assays For High-throughput And High-content Screening 	.freshpatents.com	0	0		
717	chr27	17322450	17365327	3500021662	40		17322450	17365327	8421504	4	7,13,6,14	0,9,42853,42863	g	350002166200000174,350002166200000284	24-44,0-21						FLAVIVIRUS IMMUNOGENS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
717	chr27	17345853	17345876	3500396965	23		17345853	17345876	8421504	1	23	0	c	350039696500000008	0-23					Journal of immunology (Baltimore, Md. : 1950)	Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF	Weifeng	July	0		
717	chr27	17345853	17345876	3500028329	23		17345853	17345876	8421504	1	23	0	c	350002832900000008	0-23		18566393		0022-1767	The Journal of Immunology	Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF	Xu	2008	6		
717	chr27	17351938	17352133	3500018219	44		17351938	17352133	8421504	2	22,22	0,173	c	350001821900000008,350001821900000009	0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
717	chr27	17352183	17353510	3500086644	40		17352183	17353510	8421504	2	20,20	0,1307	c,g	350008664400000004,350008664400000005,350008664400000005	0-20,0-20,0-20			10.1111/j.1365-2567.2004.01781.x	1365-2567	Immunology	Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists - Werling - 2003 - Immunology - Wiley Online Library	Werling	2004	0		
717	chr27	17353479	17353503	3500195493	24		17353479	17353503	8421504	1	24	0	c	350019549300000003	16-41						FUNCTIONAL TOLL-LIKE RECEPTORS (TLR) ON MELANOCYTES AND MELANOMA CELLS AND USES THEREOF	Hoon	2008	0		
717	chr27	17353496	17353569	3500256733	71		17353496	17353569	8421504	3	21,27,23	0,22,50	c,g	350025673300000009,350025673300000011,350025673300000010,350025673300000010	0-21,0-27,0-23,0-23						Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q)	www.ijbs.org	0	0		
718	chr27	17448730	17448755	3500114630	23		17448730	17448755	8421504	3	11,5,7	0,12,18	c	350011463000000381	0-23						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
718	chr27	17450788	17450814	3500386149	26		17450788	17450814	8421504	1	26	0	c	350038614900000067	15-41						Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon - US Patent 7105333 Description	ww.patentstorm.us	0	0		KLKB1
718	chr27	17450791	17450814	3500121586	23		17450791	17450814	8421504	1	23	0	c	350012158600000132	21-44						Nucleic acids encoding endotheliases, endotheliases and uses thereof - US Patent 7276364 Description	ww.patentstorm.us	0	0		
718	chr27	17468850	17469581	3500362821	23		17468850	17469581	8421504	2	1,22	0,709	c	350036282100000000	18-41		9632702	10.1074/jbc.273.26.16382	0021-9258	Journal of Biological Chemistry	A Binding Site for Heparin in the Apple 3 Domain of Factor XI	Ho	1998	5		
718	chr27	17471997	17472021	3500313060	24		17471997	17472021	8421504	1	24	0	c	350031306000000030	0-24						Gene specific universal mammalian sequence-tagged sites	Brewer	1997	0		
718	chr27	17472240	17472263	3500199202	23		17472240	17472263	8421504	1	23	0	c	350019920200000001	0-23						Pedigree Analysis of Factor XI Deficiency in Japanese Black Cattle - &#x8c46;&#x4e01;&#x7f51;	docin.com/p-11290	0	0		
718	chr27	17476687	17476932	3500348821	40		17476687	17476932	8421504	2	20,20	0,225	c,g	350034882100000008,350034882100000009,350034882100000009	0-20,0-20,0-20						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa h&#x1ecd;c: "Screening for bovine leukocyte adhesion deficiency, deficiency of uridine monophosphate synthase, complex vertebral malformation, bovine citrullinaemia, and factor XI deficiency in Holstein cows reared in Tu	tailieu.vn/doc/ba	0	0		
718	chr27	17476687	17476932	3500042463	91		17476687	17476932	8421504	4	20,5,46,20	0,127,134,225	c,g	350004246300000002,350004246300000004,350004246300000004,350004246300000003,350004246300000003	0-20,0-51,0-51,0-20,0-20						Study of factor XI deficiency in Khuzestan cattle population of Iran	demicjournals.org	0	0		
718	chr27	17476814	17476932	3500366211	71		17476814	17476932	8421504	3	5,46,20	0,7,98	c,g	350036621100000004,350036621100000004,350036621100000003,350036621100000003	0-51,0-51,0-20,0-20						Study of factor XI deficiency in Khuzestan cattle population of Iran - ResearchGate	.researchgate.net	0	0		
718	chr27	17478414	17478438	3500269812	23		17478414	17478438	8421504	2	6,17	0,7	c	350026981200000005	13-36						A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer.	www.mimg.ucla.edu	0	0		
718	chr27	17479156	17479181	3500318806	25		17479156	17479181	8421504	1	25	0	c	350031880600000004	0-25						METHOD FOR DETECTING ORAL SQUAMOUS-CELL CARCINOMA	Inazawa	2009	0		
718	chr27	17479156	17479181	3500052792	25		17479156	17479181	8421504	1	25	0	c	350005279200000004	0-25						METHOD FOR DETECTING ORAL SQUAMOUS-CELL CARCINOMA - Patent application	www.faqs.org	0	0		
718	chr27	17546611	17546640	3500378054	25		17546611	17546640	8421504	2	6,19	0,10	g	350037805400000108	20-45					Patent	17Q-linked breast and ovarian cancer susceptibility gene (Patent US:5747282)	Futreal	1998	0		
718	chr27	17551171	17551368	3500427541	44		17551171	17551368	8421504	2	23,21	0,176	g	350042754100000004,350042754100000011	0-24,0-21		19814723	10.1111/j.1476-5381.2009.00453.x	1476-5381	British Journal of Pharmacology	The end of a myth: cloning and characterization of the ovine melatonin MT2 receptor - Cog&#xe9; - 2009 - British Journal of Pharmacology - Wiley Online Library	Coge	2009	0		
719	chr27	17649661	17649689	3500344082	23		17649661	17649689	8421504	2	9,14	0,14	g	350034408200000084	14-45						US Patent # 6,265,639. Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use - Patents.com	www.patents.com	0	0		
720	chr27	17728047	17728073	3500328917	23		17728047	17728073	8421504	3	5,14,4	0,7,22	c	350032891700000122	15-38						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
721	chr27	17849659	17849683	3500189864	23		17849659	17849683	8421504	2	16,7	0,17	g	350018986400000005	0-23						Presence of Double-Stranded RNAs in Human and Calf Isolates of Cryptosporidium parvum	www.jstor.org	0	0		
735	chr27	19767274	19767302	3500377977	23		19767274	19767302	8421504	2	16,7	0,21	g	350037797700000275	8-31						Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide	Malcolm	2000	0		
742	chr27	20645450	20646746	3500337770	52		20645450	20646746	8421504	3	29,6,17	0,71,1279	c	350033777000000024,350033777000000025	0-29,0-23						Effect of exogenous somatotropin and staged ovariectomy on mRNA expression of select ECM-related proteins in mammary tissue of prepubertal Holstein calves	www.scirp.org	0	0		
742	chr27	20652031	20652055	3500309405	24		20652031	20652055	8421504	1	24	0	c	350030940500000000,350030940500000002	10-34,10-32		21829175	10.1038/mt.2011.153	1525-0016	Molecular Therapy	AAV6-mediated Systemic shRNA Delivery Reverses Disease in a Mouse Model of Facioscapulohumeral Muscular Dystrophy	Bortolanza	2011	7		
742	chr27	20653328	20653353	3500283211	24		20653328	20653353	8421504	2	7,17	0,8	c	350028321100000018	11-35						CYTOKINE THAT INDUCES APOPTOSIS - IMMUNEX CORPORATION.	www.sumobrain.com	0	0		
742	chr27	20653328	20653353	3500181583	24		20653328	20653353	8421504	2	7,17	0,8	c	350018158300000017	11-35					Patent	DNA encoding a cytokine that induces apoptosis (Patent US:5763223)	Goodwin	1998	0		
742	chr27	20653329	20653353	3500205952	23		20653329	20653353	8421504	2	6,17	0,7	c	350020595200000064	0-23						Use of Trail Polypeptides to Treat Cancer - Patent application	www.faqs.org	0	0		
742	chr27	20704199	20704342	3500435447	40		20704199	20704342	8421504	2	20,20	0,123	c,g	350043544700000004,350043544700000004,350043544700000005	0-20,0-20,0-20						Effect of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate on in vitro developmental competence of bovine oocytes	health.huji.ac.il	0	0		
747	chr27	21347744	21347773	3500358221	23		21347744	21347773	8421504	3	6,12,5	0,11,24	g	350035822100000001	21-45						Stabilized polypeptide compositions	Glaser	2007	0		
747	chr27	21347744	21347773	3500343478	23		21347744	21347773	8421504	3	6,12,5	0,11,24	g	350034347800000001	21-45						Stabilized polypeptide compositions	Glaser	2007	0		
748	chr27	21442138	21442162	3500001633	23		21442138	21442162	8421504	2	8,15	0,9	g	350000163300000002	0-23						Cloned streptococcal genes encoding protein g and their use to construct recombinant microorganisms to produce protein g.	R	1989	0		
749	chr27	21559056	21559082	3500202865	24		21559056	21559082	8421504	2	11,13	0,13	c	350020286500000124	8-32						Nucleic acids encoding PTH functional domain conjugate peptides - Patent # 7244834 - PatentGenius	.patentgenius.com	0	0		
753	chr27	22033033	22039138	3500432527	46		22033033	22039138	8421504	2	21,25	0,6080	c	350043252700000015,350043252700000002,350043252700000009	17-38,17-38,0-25						 Fibroblast Growth Factor And Nucleic Acids Encoding Same 	www.docstoc.com	0	0		
755	chr27	22364402	22364430	3500300029	24		22364402	22364430	8421504	2	17,7	0,21	g	350030002900000022	24-48						Chilling-resistant plants and their production - US Patent 5516667 Description	ww.patentstorm.us	0	0		
758	chr27	22711466	22727704	3500252867	71		22711466	22727704	8421504	5	1,11,15,24,20	0,8792,8804,15997,16218	c	350025286700000001,350025286700000000,350025286700000002	8-35,5-29,0-20						Method of using a scavenger receptor in the treatment of atherosclerosis	Bisgaier	2001	0		
758	chr27	22711466	22727704	3500194302	71		22711466	22727704	8421504	5	1,11,15,24,20	0,8792,8804,15997,16218	c	350019430200000001,350019430200000000,350019430200000002	8-35,5-29,0-20						Method of using a scavenger receptor in the treatment of atherosclerosis	Bisgaier	2001	0		
758	chr27	22711466	22727704	3500132340	71		22711466	22727704	8421504	5	1,11,15,24,20	0,8792,8804,15997,16218	c	350013234000000001,350013234000000000,350013234000000002	8-35,5-29,0-20						Method of using a scavenger receptor in the treatment of atherosclerosis	Bisgaier	1997	0		
95	chr27	23124779	23212741	3500002196	39		23124779	23212741	8421504	2	6,33	0,87929	c	350000219600000098	9-48						Prostate/colon tumor suppressor gene located on human chromosome 8	Bookstein	1995	0		
766	chr27	23752813	23752843	3500070204	25		23752813	23752843	8421504	3	8,13,4	0,12,26	g	350007020400000012,350007020400000004	6-31,7-28						Modified virus having an altered tropism	BOULANGER	2003	0		
768	chr27	24111794	24111867	3500269499	73		24111794	24111867	8421504	1	73	0	c	350026949900000096,350026949900000016,350026949900000037	0-73,22-67,0-23						MICRORNA AND METHODS FOR INHIBITING SAME - Patent application	www.faqs.org	0	0		
770	chr27	24300986	24301012	3500001633	23		24300986	24301012	8421504	2	11,12	0,14	g	350000163300000032	11-34						Cloned streptococcal genes encoding protein g and their use to construct recombinant microorganisms to produce protein g.	R	1989	0		
780	chr27	25562401	25562426	3500185167	23		25562401	25562426	8421504	2	11,12	0,13	g	350018516700000001	4-27						Detection of multiple mycoplasma infection in cell cultures by PCR	w.bjournal.com.br	0	0		
781	chr27	25750674	25750697	3500009976	23		25750674	25750697	8421504	1	23	0	c	350000997600000000	1-24		18829524	10.1158/0008-5472.CAN-08-2042		Cancer research	Mutations in DLC-1's (deleted in liver cancer 1) focal adhesion targeting region attenuate their expression and function	Yi-Chun	2008	0		
784	chr27	26123581	26123614	3500452929	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350045292900000022,350045292900000011	0-31,0-31					Patent	Compositions of aminoacyl-TRNA synthetase and uses thereof (Patent US:7736872)	Cho	2010	0		
784	chr27	26123581	26123614	3500347463	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350034746300000022,350034746300000011	0-31,0-31					Patent	Compositions of tRNA and uses thereof (Patent US:7632823)	Tian	2009	0		
784	chr27	26123581	26123614	3500299813	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350029981300000022	0-31						Compositions of tRNA and Uses Thereof	Tian	2010	0		
784	chr27	26123581	26123614	3500294825	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350029482500000022	0-31					Patent	Compositions of aminoacyl-tRNA synthetase and uses thereof (Patent US:7883866)	Cho	2011	0		
784	chr27	26123581	26123614	3500294161	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350029416100000022	0-31					Patent	Compositions of aminoacyl-tRNA synthetase and uses thereof (Patent US:7829310)	Cho	2010	0		
784	chr27	26123581	26123614	3500287629	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350028762900000022	0-31					Patent	Compositions of aminoacyl-TRNA synthetase and uses thereof (Patent US:7736872)	Cho	2010	0		
784	chr27	26123581	26123614	3500283860	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350028386000000022	0-31					Patent	Compositions of aminoacyl-tRNA synthetase and uses thereof (Patent US:7838265)	Cho	2010	0		
784	chr27	26123581	26123614	3500282560	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350028256000000022	0-31					Patent	Compositions of aminoacyl-tRNA synthetase and uses thereof (Patent US:7858344)	Cho	2010	0		
784	chr27	26123581	26123614	3500179081	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350017908100000022	0-31						Compositions of aminoacyl-tRNA synthetase and uses thereof - Patent application	www.faqs.org	0	0		
784	chr27	26123581	26123614	3500139018	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350013901800000022	0-31						Compositions of aminoacyl-tRNA synthetase and uses thereof	Cho	2009	0		
784	chr27	26123581	26123614	3500043683	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350004368300000022	0-31					Patent	Compositions of tRNA and uses thereof (Patent US:7632823)	Tian	2009	0		
784	chr27	26123581	26123614	3500037101	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350003710100000022	0-31						Compositions of tRNA and uses thereof	Tian	2008	0		
784	chr27	26123581	26123614	3500029196	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350002919600000022	0-31					Patent	Compositions of aminoacyl-tRNA synthetase and uses thereof (Patent US:7846689)	Cho	2010	0		
784	chr27	26123581	26123614	3500027910	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350002791000000022	0-31						Compositions of Aminoacyl-tRNA Synthetase and Uses Thereof	Cho	2010	0		
784	chr27	26123581	26123614	3500020130	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350002013000000022	0-31						Compositions of Aminoacyl-tRNA Synthetase and Uses Thereof	Cho	2010	0		
784	chr27	26123581	26123614	3500017119	27		26123581	26123614	8421504	3	16,6,5	0,19,28	g	350001711900000022	0-31						Compositions of Aminoacyl-tRNA Synthetase and Uses Thereof	Cho	2010	0		
787	chr27	26577957	26577982	3500102211	23		26577957	26577982	8421504	2	6,17	0,8	g	350010221100000121	3-26						Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) - US Patent 7264802 Description	ww.patentstorm.us	0	0		
791	chr27	27104794	27104819	3500227126	23		27104794	27104819	8421504	2	7,16	0,9	g	350022712600000204	19-42						Novel expressed sequence tag- simple sequence repeats (EST-SSR) markers characterized by new bioinformatic criteria reveal high genetic similarity in sugarcane ( Saccharum spp.) breeding lines	demicjournals.org	0	0		
792	chr27	27219881	27219911	3500006313	23		27219881	27219911	8421504	3	5,12,6	0,8,24	g	350000631300000456	0-24						METHODS FOR SELECTIVE ERADICATION OF METASTASIZING CANCER CELLS EX VIVO USING MULTIDOMAIN BIOTAGS - Patent application	www.faqs.org	0	0		
794	chr27	27440883	27440943	3500391427	60		27440883	27440943	8421504	1	60	0	p	350039142700015007	0-60						Assays - Patent application	www.faqs.org	0	0		TNKS2
794	chr27	27440883	27440928	3500289333	45		27440883	27440928	8421504	1	45	0	p	350028933300015001	0-45						Assays 	.freshpatents.com	0	0		TNKS
794	chr27	27440883	27440928	3500208501	45		27440883	27440928	8421504	1	45	0	p	350020850100015009	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		TNKS
794	chr27	27440883	27440928	3500189065	45		27440883	27440928	8421504	1	45	0	p	350018906500015011	0-45						Assays	Schofield	2005	0		TNKS
794	chr27	27447366	27447390	3500266670	23		27447366	27447390	8421504	2	4,19	0,5	c	350026667000000002	16-39		15254236	10.1128/MCB.24.15.6690-6700.2004	0270-7306	Molecular and Cellular Biology	Rap1 Regulates the Formation of E-Cadherin-Based Cell-Cell Contacts	Hogan	2004	6		
794	chr27	27447366	27447390	3500195954	23		27447366	27447390	8421504	2	4,19	0,5	c	350019595400000002	16-39		15254236	10.1128/MCB.24.15.6690-6700.2004	0270-7306	Molecular and Cellular Biology	Rap1 Regulates the Formation of E-Cadherin-Based Cell-Cell Contacts	Hogan	2004	6		
794	chr27	27447434	27469081	3500448107	921		27447434	27469081	8421504	9	40,83,121,98,75,106,187,157,54	0,1033,7714,9518,11438,12200,12850,14860,21593	p	350044810700015015,350044810700015021,350044810700015026,350044810700015031	0-135,0-288,0-261,0-240						PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression	cs.biologists.org	0	0		TNKS
794	chr27	27459634	27469111	3500296333	354		27459634	27469111	8421504	4	106,59,105,84	0,650,2712,9393	p	350029633300015043,350029633300015053,350029633300015059	0-165,0-99,0-90						Molekulare Klonierung und Charakterisierung neuer ADP-Ribosyltransferasen bei Homo sapiens und Salmonella typhimurium	ub.uni-hamburg.de	0	0		TNKS
794	chr27	27469066	27469111	3500269547	45		27469066	27469111	8421504	1	45	0	p	350026954700015091	0-45						VERTEBRATE TANKYRASE DOMAIN STRUCTURE AND STERILE ALPHA MOTIF (SAM) MEDIATED MULTIMERIZATION	www.biochemj.org	0	0		TNKS
794	chr27	27494918	27494942	3500342160	24		27494918	27494942	8421504	1	24	0	c	350034216000000044	21-45						US Patent # 5,714,594. cDNA cloning and expression of human liver estrogen sulfotransferase - Patents.com	www.patents.com	0	0		
794	chr27	27494918	27494942	3500199879	24		27494918	27494942	8421504	1	24	0	c	350019987900000014	21-45						The high bone mass gene of 11q13.3	Carulli	2008	0		
794	chr27	27494918	27494942	3500161522	24		27494918	27494942	8421504	1	24	0	c	350016152200000017	21-45						THE HIGH BONE MASS GENE OF 11q13.3	Carulli	2001	0		
794	chr27	27494918	27494942	3500091142	24		27494918	27494942	8421504	1	24	0	c	350009114200000096	21-45						Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors - Patent application	www.faqs.org	0	0		
794	chr27	27494918	27494942	3500068827	24		27494918	27494942	8421504	1	24	0	c	350006882700000309	21-45					Patent	High bone mass gene of 1.1q13.3 (Patent US:6780609)	Carulli	2004	0		
794	chr27	27495415	27495438	3500246066	23		27495415	27495438	8421504	1	23	0	c	350024606600000003	9-32						ModulationofReplicativeSenescenceofDiploidHumanCells byNuclearERKSignaling S	www.jbc.org	0	0		
794	chr27	27495628	27496594	3500299297	270		27495628	27496594	8421504	6	45,45,45,45,45,45	0,48,96,825,873,921	p	350029929700015113,350029929700015112,350029929700015110,350029929700015107,350029929700015106,350029929700015105	0-45,0-45,0-45,0-45,0-45,0-45						Phosphatases which activate map kinase pathways - Patent application	www.faqs.org	0	0		
794	chr27	27507492	27507518	3500415770	24		27507492	27507518	8421504	2	5,19	0,7	c	350041577000000000	2-28						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
794	chr27	27507492	27507518	3500160005	24		27507492	27507518	8421504	2	5,19	0,7	c,g	350016000500000027,350016000500000027	2-28,2-28						Original article Microsatellite loci in Japanese quail and cross-species ampli&#xfb01;cation in chicken and guinea fowl	biomedcentral.com	0	0		
797	chr27	27913515	27913541	3500098120	24		27913515	27913541	8421504	2	17,7	0,19	g	350009812000000107	0-24						PRODUCTION OF PROANTHOCYANIDINS TO IMPROVE FORAGE QUALITY - Patent application	www.faqs.org	0	0		
799	chr27	28101749	28110082	3500048645	177		28101749	28110082	8421504	3	10,76,91	0,5963,8242	p	350004864500015097	39-216						Secreted protein HFEAF41	Brewer	2002	0		
799	chr27	28111370	28111400	3500145039	24		28111370	28111400	8421504	3	8,4,12	0,9,18	c	350014503900000072	7-32						A novel haemopoietin receptor	Hilton	1997	0		
800	chr27	28209031	28218046	3500375250	1308		28209031	28218046	8421504	3	964,225,119	0,4740,8896	p,c,g	350037525000000053,350037525000000075,350037525000015072,350037525000000074,350037525000000074,350037525000015071,350037525000000073,350037525000000073,350037525000000098,350037525000015070,350037525000000072,350037525000000072,350037525000000071,350037525000000071,350037525000015067,350037525000000070,350037525000000070,350037525000000069,350037525000000069,350037525000015065,350037525000000068,350037525000000068,350037525000015064,350037525000000067,350037525000000067,350037525000015063,350037525000000066,350037525000000066,350037525000000091,350037525000015062,350037525000000065,350037525000000065,350037525000015061,350037525000000064,350037525000000064,350037525000015060,350037525000000063,350037525000000063,350037525000015059,350037525000015058,350037525000000062,350037525000000062,350037525000000061,350037525000000061,350037525000015057,350037525000000060,350037525000000060,350037525000015056,350037525000015055,350037525000000059,350037525000000052,350037525000015054,350037525000000058,350037525000000058,350037525000000057,350037525000000057,350037525000015053,350037525000015052,350037525000000056,350037525000000056,350037525000000055,350037525000000051,350037525000015051,350037525000000054,350037525000000054,350037525000015050	0-963,0-48,0-60,0-60,0-60,0-60,0-60,0-60,0-55,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,10-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-225,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-120,0-60,0-60,0-60,0-60						Ghrelin o-acyltransferase (GOAT) biochemical assay	Brown	2007	0		
800	chr27	28209031	28218046	3500121445	1308		28209031	28218046	8421504	3	964,225,119	0,4740,8896	p,c,g	350012144500000053,350012144500000053,350012144500000137,350012144500000137,350012144500000136,350012144500000136,350012144500000075,350012144500015252,350012144500015072,350012144500000074,350012144500000074,350012144500015251,350012144500015071,350012144500000073,350012144500000073,350012144500000098,350012144500015249,350012144500015070,350012144500000072,350012144500000072,350012144500015248,350012144500000071,350012144500000071,350012144500015246,350012144500015067,350012144500000070,350012144500000070,350012144500015245,350012144500015065,350012144500000069,350012144500000069,350012144500015244,350012144500015064,350012144500000068,350012144500000068,350012144500015243,350012144500015063,350012144500000067,350012144500000067,350012144500015242,350012144500015062,350012144500000091,350012144500000066,350012144500000066,350012144500015241,350012144500015061,350012144500000065,350012144500000065,350012144500015239,350012144500015060,350012144500000064,350012144500000064,350012144500015238,350012144500015059,350012144500000063,350012144500000063,350012144500015237,350012144500015058,350012144500000062,350012144500000062,350012144500015236,350012144500000061,350012144500000061,350012144500015057,350012144500015234,350012144500015056,350012144500000060,350012144500000060,350012144500015233,350012144500015055,350012144500000059,350012144500000135,350012144500000052,350012144500015232,350012144500015054,350012144500000058,350012144500000058,350012144500015231,350012144500015053,350012144500000057,350012144500000057,350012144500015229,350012144500000056,350012144500000056,350012144500015052,350012144500015228,350012144500015051,350012144500000134,350012144500000051,350012144500000055,350012144500015227,350012144500015050,350012144500000054,350012144500000054	0-963,0-963,0-1308,0-1308,0-963,0-963,0-48,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-55,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,10-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-225,0-225,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-60,0-60,0-45,0-60,0-120,0-120,0-60,0-45,0-60,0-60,0-60						GHRELIN O-ACYLTRANSFERASE (GOAT) BIOCHEMICAL ASSAY - Patent application	www.faqs.org	0	0		
800	chr27	28209171	28209197	3500250061	23		28209171	28209197	8421504	2	16,7	0,19	c	350025006100000322	1-24						Anti-alpha(v)beta(6) antibodies and uses thereof - Patent application	www.faqs.org	0	0		
804	chr27	28779995	28784892	3500313903	23		28779995	28784892	8421504	3	8,3,12	0,4881,4885	c	350031390300000007	0-23						Muscle transcription factors	Hardeman	2004	0		
804	chr27	28803140	28803166	3500069972	25		28803140	28803166	8421504	2	4,21	0,5	c	350006997200000046	5-30						METHODS AND COMPOSITIONS FOR GENOMIC MODIFICATION - Patent application	www.faqs.org	0	0		
804	chr27	28812325	28814111	3500167875	40		28812325	28814111	8421504	2	20,20	0,1766	c	350016787500000001,350016787500000000	0-20,0-20						Supplemental Experimental procedures Cell culture Generation of stable Jurkat cells expressing shRNA targeting PP2Ac beta isoform	www.jbc.org	0	0		PPP2CB
807	chr27	29102448	29140612	3500415563	77		29102448	29140612	8421504	4	12,36,12,17	0,4655,37218,38147	c	350041556300000511,350041556300000289	0-48,0-29						Gene products related to werner's syndrome	Fu	2000	0		
807	chr27	29102448	29139649	3500014443	124		29102448	29139649	8421504	4	12,36,48,28	0,4655,4739,37173	c	350001444300000357,350001444300000359,350001444300000218	0-48,0-48,3-31						Genes and gene products related to Werner's syndrome - US Patent 6090620 Description	ww.patentstorm.us	0	0		
807	chr27	29107187	29139649	3500048116	101		29107187	29139649	8421504	4	48,19,9,25	0,30338,32376,32437	c	350004811600000500,350004811600000276,350004811600000278	0-48,16-44,0-25						 Antibodies Against Gene Products Related To Werner's Syndrome 	www.docstoc.com	0	0		
807	chr27	29139666	29147136	3500000908	118		29139666	29147136	8421504	4	12,17,48,41	0,929,3731,7429	c	350000090800000219,350000090800000224,350000090800000226	0-29,0-48,3-44						Genes and gene products related to Werner's syndrome	Fu	1996	0		
808	chr27	29324254	29324284	3500245018	25		29324254	29324284	8421504	2	7,18	0,12	g	350024501800000031	1-26						Identification and Functional Analysis of Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Target Genes	b.uni-muenchen.de	0	0		
809	chr27	29416358	29416494	3500155339	88		29416358	29416494	8421504	2	40,48	0,88	g	350015533900000004,350015533900000169	0-68,0-48						Process for preparing glial mitogenic factors	Goodearl	1995	0		
809	chr27	29416358	29416398	3500249298	40		29416358	29416398	8421504	1	40	0	g	350024929800000004	0-68						Glial mitogenic factors, their preparation and use	Chen	1994	0		
809	chr27	29416358	29416398	3500166350	40		29416358	29416398	8421504	1	40	0	g	350016635000000004	0-68						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
809	chr27	29416366	29416508	3500021084	105		29416366	29416508	8421504	2	43,62	0,80	g	350002108400000019,350002108400000350,350002108400000168,350002108400000113,350002108400000021	0-43,0-23,0-48,0-48,0-46						US Patent # 5,621,081. Glial mitogenic factors - Patents.com	www.patents.com	0	0		
809	chr27	29416375	29416398	3500261711	23		29416375	29416398	8421504	1	23	0	g	350026171100000307,350026171100000004	0-23,0-23						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
809	chr27	29416375	29416398	3500007738	23		29416375	29416398	8421504	1	23	0	g	350000773800000004	0-23						Methods for treating multiple sclerosis with GGF-related polypeptides	Goodearl	1996	0		
809	chr27	29416446	29416494	3500446349	48		29416446	29416494	8421504	1	48	0	g	350044634900000168	0-48						Glial mitogenic factors	www.devileye.net	0	0		
809	chr27	29416483	29416508	3500159407	25		29416483	29416508	8421504	1	25	0	g	350015940700000283	0-25						Glial mitogenic factors, their preparation and use	Goodearl	1995	0		WRN
810	chr27	29505409	29530136	3500146696	40		29505409	29530136	8421504	3	20,7,13	0,24703,24714	g	350014669600000006,350014669600000001	9-30,6-26						Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration	www.pnas.org	0	0		
813	chr27	29915958	29915987	3500343734	24		29915958	29915987	8421504	2	16,8	0,21	g	350034373400000169	22-46					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
815	chr27	30157033	30157059	3500332838	23		30157033	30157059	8421504	3	13,5,5	0,14,21	g	350033283800000029	17-40						Nucleotide sequences of soybean acyl-acp thioesterase genes	Hitz	1992	0		
816	chr27	30303283	30303547	3500446349	215		30303283	30303547	8421504	3	15,163,37	0,16,227	g	350044634900000161,350044634900000163	295-473,0-37						Glial mitogenic factors	www.devileye.net	0	0		
816	chr27	30303283	30303547	3500021084	263		30303283	30303547	8421504	2	15,248	0,16	g	350002108400000161,350002108400000162,350002108400000220,350002108400000163	295-473,0-48,0-37,0-37						US Patent # 5,621,081. Glial mitogenic factors - Patents.com	www.patents.com	0	0		
816	chr27	30303283	30303546	3500022936	203		30303283	30303546	8421504	5	15,50,56,52,30	0,16,70,130,233	g	350002293600000121,350002293600000176,350002293600000123	71-239,281-443,0-30						US Patent # 7,094,749. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
816	chr27	30303283	30303465	3500328336	181		30303283	30303465	8421504	2	15,166	0,16	g	350032833600000223,350032833600000166	295-476,295-473						US Patent # 5,854,220. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
816	chr27	30303283	30303465	3500261711	181		30303283	30303465	8421504	2	15,166	0,16	g	350026171100000121,350026171100000176	76-254,295-476						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
816	chr27	30303283	30303465	3500166350	181		30303283	30303465	8421504	2	15,166	0,16	g	350016635000000162,350016635000000107	295-476,76-254						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
816	chr27	30303283	30303465	3500159407	181		30303283	30303465	8421504	2	15,166	0,16	g	350015940700000161,350015940700000109	295-476,64-244						Glial mitogenic factors, their preparation and use	Goodearl	1995	0		
816	chr27	30303283	30303462	3500155339	178		30303283	30303462	8421504	2	15,163	0,16	g	350015533900000162	295-473						Process for preparing glial mitogenic factors	Goodearl	1995	0		
816	chr27	30303283	30303462	3500081476	178		30303283	30303462	8421504	2	15,163	0,16	g	350008147600000169	295-473						US Patent # 5,602,096. Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis - Patents.com	www.patents.com	0	0		
816	chr27	30303290	30303465	3500185781	166		30303290	30303465	8421504	4	8,50,56,52	0,9,63,123	g	350018578100000121,350018578100000176	74-235,281-443						US Patent # 7,192,915. Methods for treating multiple sclerosis with GGF-related polypeptides - Patents.com	www.patents.com	0	0		
12	chr27	30358239	30515851	3500159407	873		30358239	30515851	8421504	7	179,122,130,68,94,5,275	0,10390,144869,156584,157236,157331,157337	g	350015940700000089	256-1129						Glial mitogenic factors, their preparation and use	Goodearl	1995	0		
12	chr27	30358239	30515618	3500166350	640		30358239	30515618	8421504	7	179,122,130,68,94,5,42	0,10390,144869,156584,157236,157331,157337	g	350016635000000179	239-880						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
816	chr27	30358239	30378205	3500021084	644		30358239	30378205	8421504	3	179,417,48	0,10308,19918	g	350002108400000114,350002108400000170,350002108400000104,350002108400000106,350002108400000115,350002108400000171,350002108400000222,350002108400000116,350002108400000172,350002108400000223,350002108400000173,350002108400000177,350002108400000069,350002108400000070,350002108400000224,350002108400000174,350002108400000254,350002108400000118,350002108400000103,350002108400000071,350002108400000225,350002108400000178,350002108400000101,350002108400000097,350002108400000175,350002108400000255,350002108400000119,350002108400000100,350002108400000099,350002108400000072,350002108400000226,350002108400000179,350002108400000176,350002108400000120,350002108400000073,350002108400000180,350002108400000121,350002108400000074,350002108400000181,350002108400000122,350002108400000107,350002108400000105,350002108400000075,350002108400000182,350002108400000076,350002108400000227,350002108400000183	9-48,0-48,8-33,11-36,0-48,0-48,0-48,0-48,0-48,0-48,0-34,0-110,0-53,0-48,22-48,0-46,0-49,0-48,13-35,0-48,0-48,0-48,13-37,12-38,0-48,0-48,0-48,13-37,11-37,0-48,0-48,0-48,0-28,0-48,0-48,0-48,0-42,0-48,0-48,0-58,15-39,15-39,0-48,0-115,0-48,0-48,0-47						US Patent # 5,621,081. Glial mitogenic factors - Patents.com	www.patents.com	0	0		
816	chr27	30358239	30368964	3500261711	426		30358239	30368964	8421504	5	33,57,113,48,175	0,39,10308,10484,10550	g	350026171100000075,350026171100000199,350026171100000130,350026171100000136,350026171100000050,350026171100000182,350026171100000081,350026171100000135,350026171100000055,350026171100000140,350026171100000083,350026171100000141	15-48,0-48,0-48,0-113,0-21,19-48,0-48,0-24,0-30,0-55,0-58,0-105						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
816	chr27	30358240	30368964	3500159407	595		30358240	30368964	8421504	2	178,417	0,10307	g	350015940700000117,350015940700000061,350015940700000121,350015940700000125,350015940700000088,350015940700000126	0-178,0-417,0-113,0-55,0-58,0-105						Glial mitogenic factors, their preparation and use	Goodearl	1995	0		
816	chr27	30358278	30368964	3500446349	331		30358278	30368964	8421504	4	48,110,28,145	0,10269,10445,10541	g	350044634900000115,350044634900000177,350044634900000069,350044634900000176,350044634900000122,350044634900000182	0-48,0-110,0-53,0-28,0-58,0-115						Glial mitogenic factors	www.devileye.net	0	0		
816	chr27	30358278	30368964	3500155339	303		30358278	30368964	8421504	3	48,110,145	0,10269,10541	g	350015533900000116,350015533900000178,350015533900000070,350015533900000123,350015533900000183	0-48,0-110,0-53,0-58,0-115						Process for preparing glial mitogenic factors	Goodearl	1995	0		
816	chr27	30368547	30368964	3500328336	255		30368547	30368964	8421504	2	110,145	0,272	g	350032833600000182,350032833600000075,350032833600000128,350032833600000187	0-110,0-53,0-58,0-115						US Patent # 5,854,220. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
816	chr27	30368547	30368964	3500166350	417		30368547	30368964	8421504	1	417	0	g	350016635000000044,350016635000000122,350016635000000126,350016635000000069,350016635000000127	0-417,0-113,0-55,0-58,0-105						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
816	chr27	30368547	30368964	3500081476	255		30368547	30368964	8421504	2	110,145	0,272	g	350008147600000185,350008147600000077,350008147600000130,350008147600000190	0-110,0-53,0-58,0-115						US Patent # 5,602,096. Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis - Patents.com	www.patents.com	0	0		
816	chr27	30368550	30368964	3500185781	257		30368550	30368964	8421504	4	57,48,52,100	0,62,257,314	g	350018578100000136,350018578100000140,350018578100000141	0-105,0-52,0-100						US Patent # 7,192,915. Methods for treating multiple sclerosis with GGF-related polypeptides - Patents.com	www.patents.com	0	0		
816	chr27	30368550	30368964	3500022936	278		30368550	30368964	8421504	4	57,69,52,100	0,62,257,314	g	350002293600000136,350002293600000065,350002293600000203,350002293600000140,350002293600000141	0-105,10-32,0-45,0-52,0-100						US Patent # 7,094,749. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
816	chr27	30368633	30368656	3500006876	23		30368633	30368656	8421504	1	23	0	g	350000687600000000	0-23			10.1371/journal.pmed.0040237	1549-1676	PLOS Medicine	PLOS Medicine: Surfactant Maturation Is Not Delayed in Human Fetuses with Diaphragmatic Hernia	Boucherat	2007	0		NRG1
817	chr27	30411912	30411940	3500420391	23		30411912	30411940	8421504	2	8,15	0,13	g	350042039100000020	0-25		16543367	10.1210/en.2005-1222	0013-7227	Endocrinology	Identification of a Functional AP1 Element in the Rat Vasopressin Gene Promoter	Yoshida	2006	4		
817	chr27	30435245	30435276	3500463625	28		30435245	30435276	8421504	3	19,5,4	0,21,27	g	350046362500000025	10-38						Methods and compositions for polypeptide engineering	Patten	2009	0		
817	chr27	30503107	30536195	3500021084	1969		30503107	30536195	8421504	14	123,37,21,96,443,65,127,63,90,89,145,142,402,126	0,11716,11762,12372,12469,23965,25579,28364,29449,29569,31794,32358,32530,32962	g	350002108400000135,350002108400000256,350002108400000229,350002108400000320,350002108400000257,350002108400000136,350002108400000230,350002108400000321,350002108400000137,350002108400000259,350002108400000187,350002108400000031,350002108400000232,350002108400000251,350002108400000140,350002108400000035,350002108400000313,350002108400000252,350002108400000141,350002108400000159,350002108400000234,350002108400000253,350002108400000160,350002108400000192,350002108400000261,350002108400000194,350002108400000263,350002108400000195,350002108400000264,350002108400000196,350002108400000198,350002108400000267,350002108400000268,350002108400000200,350002108400000269,350002108400000202,350002108400000271,350002108400000203,350002108400000272,350002108400000273,350002108400000324,350002108400000274,350002108400000325,350002108400000204,350002108400000276,350002108400000205,350002108400000277,350002108400000206,350002108400000279,350002108400000208,350002108400000280,350002108400000209,350002108400000281,350002108400000210,350002108400000282,350002108400000283,350002108400000211,350002108400000284,350002108400000212,350002108400000285,350002108400000213,350002108400000286,350002108400000214,350002108400000288,350002108400000216,350002108400000289,350002108400000217	21-48,24-48,7-48,0-47,0-48,0-48,0-48,0-48,0-48,11-48,0-21,0-48,0-48,0-48,0-51,0-36,0-27,0-54,0-303,0-53,0-443,0-252,0-233,1-48,0-48,8-48,0-48,0-48,0-48,0-39,3-48,0-48,6-48,0-48,0-48,0-48,0-48,0-41,20-48,0-48,0-48,0-48,0-47,0-46,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-118,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-50,0-76,0-58						US Patent # 5,621,081. Glial mitogenic factors - Patents.com	www.patents.com	0	0		
817	chr27	30503107	30536193	3500446349	1012		30503107	30536193	8421504	9	27,37,81,443,48,48,96,126,106	0,11716,12387,12469,25589,32434,32530,32644,32980	g	350044634900000135,350044634900000259,350044634900000251,350044634900000252,350044634900000141,350044634900000159,350044634900000234,350044634900000253,350044634900000160,350044634900000263,350044634900000277,350044634900000279,350044634900000280,350044634900000210,350044634900000283,350044634900000216,350044634900000289	21-48,11-48,0-48,0-54,0-303,0-53,0-443,0-252,0-233,0-48,0-48,0-48,0-48,0-118,0-48,0-50,0-76						Glial mitogenic factors	www.devileye.net	0	0		
817	chr27	30514824	30536117	3500022936	899		30514824	30536117	8421504	14	45,34,310,58,59,15,45,45,48,42,45,66,45,42	0,717,752,1064,1124,1185,13875,17759,17852,20675,20720,20816,20933,21251	g	350002293600000144,350002293600000101,350002293600000118,350002293600000119,350002293600000212,350002293600000193,350002293600000222,350002293600000157,350002293600000159,350002293600000235,350002293600000236,350002293600000238,350002293600000165,350002293600000167,350002293600000247	0-45,0-304,0-43,0-240,0-209,0-346,0-45,0-45,0-48,0-42,0-45,0-45,0-48,0-45,0-42						US Patent # 7,094,749. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
817	chr27	30515509	30515548	3500156499	39		30515509	30515548	8421504	1	39	0	g	350015649900000146	0-39						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
817	chr27	30515524	30515548	3500006876	24		30515524	30515548	8421504	1	24	0	g	350000687600000001	0-24			10.1371/journal.pmed.0040237	1549-1676	PLOS Medicine	PLOS Medicine: Surfactant Maturation Is Not Delayed in Human Fetuses with Diaphragmatic Hernia	Boucherat	2007	0		NRG1
817	chr27	30515536	30536193	3500261711	749		30515536	30536193	8421504	8	33,5,443,48,48,48,48,76	0,34,40,11553,13160,20122,20218,20581	g	350026171100000101,350026171100000210,350026171100000192,350026171100000119,350026171100000212,350026171100000220,350026171100000222,350026171100000165,350026171100000167,350026171100000248	0-313,0-54,0-433,0-243,0-223,0-48,0-48,0-48,0-48,0-76						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
817	chr27	30515536	30536193	3500166350	557		30515536	30536193	8421504	4	33,5,443,76	0,34,40,20581	g	350016635000000087,350016635000000178,350016635000000105,350016635000000180,350016635000000216	0-313,0-433,0-243,0-223,0-76						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
817	chr27	30515541	30535706	3500185781	662		30515541	30535706	8421504	9	34,310,58,59,15,48,45,45,48	0,35,347,407,468,17135,19415,20003,20117	g	350018578100000101,350018578100000118,350018578100000192,350018578100000119,350018578100000211,350018578100000159,350018578100000280,350018578100000235,350018578100000165	0-304,0-43,0-419,0-240,0-209,0-48,0-45,0-45,0-48						US Patent # 7,192,915. Methods for treating multiple sclerosis with GGF-related polypeptides - Patents.com	www.patents.com	0	0		
817	chr27	30515542	30536193	3500328336	677		30515542	30536193	8421504	5	27,5,443,96,106	0,28,34,20209,20545	g	350032833600000257,350032833600000147,350032833600000164,350032833600000239,350032833600000258,350032833600000165,350032833600000215,350032833600000221,350032833600000294	0-54,0-303,0-58,0-433,0-252,0-234,0-118,0-50,0-76						US Patent # 5,854,220. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
817	chr27	30515542	30536193	3500159407	551		30515542	30536193	8421504	4	27,5,443,76	0,28,34,20575	g	350015940700000195,350015940700000177,350015940700000107,350015940700000197,350015940700000233	0-54,0-433,0-243,0-223,0-76						Glial mitogenic factors, their preparation and use	Goodearl	1995	0		
817	chr27	30515542	30536193	3500155339	773		30515542	30536193	8421504	7	33,326,116,48,48,96,106	0,34,361,19999,20143,20209,20545	g	350015533900000253,350015533900000142,350015533900000160,350015533900000235,350015533900000254,350015533900000161,350015533900000278,350015533900000281,350015533900000211,350015533900000217,350015533900000290	0-54,0-303,0-62,0-442,0-251,0-223,0-48,0-48,0-118,0-50,0-76						Process for preparing glial mitogenic factors	Goodearl	1995	0		
817	chr27	30515542	30536193	3500081476	677		30515542	30536193	8421504	5	33,326,116,96,106	0,34,361,20209,20545	g	350008147600000260,350008147600000149,350008147600000167,350008147600000242,350008147600000261,350008147600000168,350008147600000218,350008147600000224,350008147600000297	0-54,0-303,0-62,0-442,0-251,0-223,0-118,0-50,0-76						US Patent # 5,602,096. Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis - Patents.com	www.patents.com	0	0		
818	chr27	30604784	30604810	3500193391	24		30604784	30604810	8421504	2	12,12	0,14	g	350019339100000005	0-24						US Patent # 6,297,037. Oxidatively stable alpha-amylase - Patents.com	www.patents.com	0	0		
822	chr27	31126795	31127002	3500431485	207		31126795	31127002	8421504	1	207	0	g	350043148500000013,350043148500000010,350043148500000006,350043148500000007	12-141,4-143,1-196,0-55						Nucleic acid encoding a fragment of bovine luteinizing hormone/chorionic gonadotropin receptor	Saxena	1993	0		
822	chr27	31126795	31127002	3500194396	207		31126795	31127002	8421504	1	207	0	g	350019439600000013,350019439600000010,350019439600000006,350019439600000007	12-141,4-143,1-196,0-55						hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine	Saxena	2003	0		
823	chr27	31222245	31222271	3500346364	23		31222245	31222271	8421504	2	17,6	0,20	c	350034636400000036	4-28						CARACTERIZACI&#xd3;N DE GENES DE LA SUBFAMILIA DE TRANSPORTADORES ABCG DE LEISHMANIA INFANTUM	hera.ugr.es	0	0		
825	chr27	31503082	31503110	3500337474	27		31503082	31503110	8421504	2	4,23	0,5	g	350033747400000001	9-36						Reversible Acyl-Homoserine Lactone Binding to Puri&#xfb01;ed Vibrio &#xfb01;scheri LuxR Protein	jb.asm.org/conten	0	0		
825	chr27	31503082	31503110	3500269243	27		31503082	31503110	8421504	2	4,23	0,5	g	350026924300000001	9-36			10.1128/JB.186.3.631-637.2004		Journal of Bacteriology	Reversible Acyl-Homoserine Lactone Binding to Purified Vibrio fischeri LuxR Protein	M.	2004	0		
825	chr27	31503082	31503110	3500047643	27		31503082	31503110	8421504	2	4,23	0,5	g	350004764300000001	9-36						Reversible Acyl-Homoserine Lactone Binding to Puri&#xfb01;ed Vibrio &#xfb01;scheri LuxR Protein	.bio.davidson.edu	0	0		
825	chr27	31546425	31546456	3500064414	26		31546425	31546456	8421504	2	7,19	0,12	g	350006441400000001	0-29		19767430	10.1128/JB.00618-09	0021-9193	Journal of Bacteriology	&#x03c3;X Is Involved in Controlling Bacillus subtilis Biofilm Architecture through the AbrB Homologue Abh	Murray	2009	4		
831	chr27	32317286	32317314	3500183368	23		32317286	32317314	8421504	2	15,8	0,20	g	350018336800000035	3-41						Recombinant antibodies specific for a growth factor receptor	Wels	1994	0		
836	chr27	32985135	32985163	3500041159	23		32985135	32985163	8421504	2	14,9	0,19	g	350004115900000042	9-42						Diversity and Abundance of Sulfur-Oxidizing Bacteria in Wadden Sea Sediments Revealed by DsrAB Phylogeny and dsrAB-Targeted Real-Time PCR	www.marmic.mpg.de	0	0		
839	chr27	33315412	33315436	3500317364	23		33315412	33315436	8421504	2	7,16	0,8	g	350031736400000095	3-26						Flax seed specific promoters - US Patent 7642346 Description	ww.patentstorm.us	0	0		
849	chr27	34703030	34703057	3500287328	23		34703030	34703057	8421504	3	12,6,5	0,15,22	g	350028732800000128	0-24						Concatameric immunoadhesion molecule - US Patent 7670602 Description	ww.patentstorm.us	0	0		
852	chr27	35080283	35098242	3500146501	41		35080283	35098242	8421504	4	21,12,4,4	0,17937,17950,17955	g	350014650100000545,350014650100000043	2-23,0-20					Patent	GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants (Patent CN:1665934)	D*E*A*Fu Luo La Ke 	2010	0		
853	chr27	35129903	35129927	3500113619	24		35129903	35129927	8421504	1	24	0	g	350011361900000015	0-24						Comparative mapping of bovine chromosome 27 with human chromosome 8 near a dairy form QTL in cattle	nces.missouri.edu	0	0		
853	chr27	35191228	35217943	3500441689	41		35191228	35217943	8421504	2	21,20	0,26695	c	350044168900000002,350044168900000003	0-21,1-21						Patent Search: US Patent Number 8168602 - Compositions, kits and methods for identification, assessment, prevention and therapy of cancer	ww.archpatent.com	0	0		
853	chr27	35215574	35218260	3500221823	1959		35215574	35218260	8421504	2	657,1302	0,1384	c,g	350022182300000022,350022182300000022,350022182300000021,350022182300000021,350022182300000020,350022182300000039,350022182300000019,350022182300000019,350022182300000018,350022182300000017,350022182300000015,350022182300000015,350022182300000013,350022182300000013,350022182300000012,350022182300000010,350022182300000010,350022182300000009,350022182300000009,350022182300000008,350022182300000007,350022182300000006,350022182300000005,350022182300000004,350022182300000004,350022182300000003,350022182300000002	0-588,0-588,0-56,0-56,0-48,0-1200,0-117,0-117,0-48,0-48,0-117,0-117,0-117,0-117,0-48,0-48,0-48,0-184,0-184,0-48,0-48,0-48,0-48,0-119,0-119,0-48,0-166					Patent	Nucleotide sequences coding for the bovine &#x03b2;.sub.3 -adrenergic receptor (AR&#x03b2;.sub.3) and their applications (Patent US:5656440)	Kapoor	1997	0		
853	chr27	35215792	35215820	3500068102	23		35215792	35215820	8421504	2	8,15	0,13	c	350006810200000232	7-33						 Codon 	www.docstoc.com	0	0		
853	chr27	35217924	35217996	3500077698	41		35217924	35217996	8421504	2	21,20	0,52	c,g	350007769800000003,350007769800000003,350007769800000002,350007769800000002	0-21,0-21,0-20,0-20						Physiology and Endocrinology: Endocrinology/Metabolic Physiology	www.jtmtg.org	0	0		ADRB3
853	chr27	35217939	35217964	3500154817	25		35217939	35217964	8421504	1	25	0	c	350015481700000024	0-25						Methods and materials for determining pain sensitivity and predicting and treating related disorders	Diatchenko	2007	0		
853	chr27	35217958	35218008	3500236659	40		35217958	35218008	8421504	2	20,20	0,30	c,g	350023665900000031,350023665900000003,350023665900000048,350023665900000048	0-20,0-20,0-19,0-19						Primer set for amplification of obesity gene, reagent for amplification of obesity gene comprising the primer set, and use of the primer set	Hirai	2009	0		ADRB3
854	chr27	35274641	35274692	3500426076	51		35274641	35274692	8421504	1	51	0	p	350042607600015000	0-51						The Nematode Eukaryotic Translation Initiation Factor 4E/G Complex Works with a trans-Spliced Leader Stem-Loop To Enable Ef&#xfb01;cient Translation of Trimethylguanosine-Capped RNAs &#x2020;	140.226.65.22	0	0		EIF4EBP1
854	chr27	35274641	35274692	3500324803	51		35274641	35274692	8421504	1	51	0	p	350032480300015000	12-63						StructuralInsightsintoParasiteeIF4EBindingSpecificity	140.226.65.22	0	0		EIF4EBP1
854	chr27	35274641	35274692	3500293384	51		35274641	35274692	8421504	1	51	0	p	350029338400015001	0-51		20154140	10.1128/MCB.01437-09		Molecular and Cellular Biology	The Nematode Eukaryotic Translation Initiation Factor 4E/G Complex Works with a trans-Spliced Leader Stem-Loop To Enable Efficient Translation of Trimethylguanosine-Capped RNAs 	Adam	2010	0		EIF4EBP1
854	chr27	35274641	35274692	3500273057	51		35274641	35274692	8421504	1	51	0	p	350027305700015001	12-63		19710013	10.1074/jbc.M109.049858		The Journal of Biological Chemistry	Structural Insights into Parasite eIF4E Binding Specificity for m7G and m2,2,7G mRNA Caps	Weizhi	2009	0		EIF4EBP1
854	chr27	35274641	35274692	3500127834	51		35274641	35274692	8421504	1	51	0	p	350012783400015001	0-51		20154140	10.1128/MCB.01437-09	0270-7306	Molecular and Cellular Biology	The Nematode Eukaryotic Translation Initiation Factor 4E/G Complex Works with a trans-Spliced Leader Stem-Loop To Enable Efficient Translation of Trimethylguanosine-Capped RNAs	Wallace	2010	6		EIF4EBP1
854	chr27	35274641	35274692	3500050966	51		35274641	35274692	8421504	1	51	0	p	350005096600015001	12-63						JBC Papers in Press. Published on August 26, 2009 as Manuscript M109.049858 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M109.049858	140.226.65.22	0	0		EIF4EBP1
854	chr27	35274650	35277086	3500448729	44		35274650	35277086	8421504	2	21,23	0,2413	c	350044872900000025,350044872900000026	0-21,0-23		14630918	10.1074/jbc.M311862200	0021-9258	Journal of Biological Chemistry	Induction of CHOP Expression by Amino Acid Limitation Requires Both ATF4 Expression and ATF2 Phosphorylation	Averous	2004	5		EIF4EBP1
854	chr27	35296291	35297346	3500413479	57		35296291	35297346	8421504	2	30,27	0,1028	p	350041347900015001	3-60						Molecular Cell, Vol. 13, 587&#x2013;597, February 27, 2004, Copyright 2004 by Cell Press Menin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus	.researchgate.net	0	0		ASH2L
854	chr27	35322720	35322983	3500405697	44		35322720	35322983	8421504	2	22,22	0,241	c	350040569700000007,350040569700000006	0-22,0-22						Intrafollicular Steroids and Anti-Mu&#xa8;llerian Hormone During Normal and Cystic Ovarian Follicular Development in the Cow	ww.biolreprod.org	0	0		
854	chr27	35322720	35322983	3500016549	44		35322720	35322983	8421504	2	22,22	0,241	c	350001654900000007,350001654900000006	0-22,0-22		18448844	10.1095/biolreprod.107.065847	0006-3363	Biology of Reproduction	Intrafollicular Steroids and Anti-M&#xfc;llerian Hormone During Normal and Cystic Ovarian Follicular Development in the Cow	Monniaux	2008	4		
854	chr27	35323892	35325201	3500319611	41		35323892	35325201	8421504	2	19,22	0,1287	c,g	350031961100000007,350031961100000007,350031961100000006	0-19,0-19,0-22						Medicine Chest - About your prescription and over-the-counter medicines, herbs and supplements - Part 6	medicinechest.com	0	0		
854	chr27	35324154	35324357	3500335613	40		35324154	35324357	8421504	2	20,20	0,183	c,g	350033561300000001,350033561300000001,350033561300000000	0-20,0-20,0-20						ScienceDirect.com - Molecular and Cellular Endocrinology - Luteinizing hormone (LH) regulates production of androstenedione and progesterone via control of histone acetylation of StAR and CYP17 promoters in ovarian theca cells	sciencedirect.com	0	0		
854	chr27	35324364	35325970	3500126808	40		35324364	35325970	8421504	2	20,20	0,1586	c	350012680800000015,350012680800000014	0-20,0-20						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
854	chr27	35325150	35325173	3500306609	23		35325150	35325173	8421504	1	23	0	c	350030660900000003	23-46						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
854	chr27	35325151	35326127	3500273108	46		35325151	35326127	8421504	2	22,24	0,952	c	350027310800000024,350027310800000023	0-22,0-24		19179481	10.1210/me.2008-0296		Molecular Endocrinology	cAMP-Dependent Posttranscriptional Regulation of Steroidogenic Acute Regulatory (STAR) Protein by the Zinc Finger Protein ZFP36L1/TIS11b	Haichuan	2009	0		
854	chr27	35326089	35326112	3500062112	23		35326089	35326112	8421504	1	23	0	c	350006211200000004	0-23						REPRODUCTION	uction-online.org	0	0		
854	chr27	35326099	35326278	3500180860	40		35326099	35326278	8421504	2	20,20	0,159	c	350018086000000005,350018086000000004	0-20,0-20						Evidence That High Variation in Ovarian Reserves of Healthy Young Adults Has a Negative Impact on the Corpus Luteum and Endometrium During Estrous Cycles in Cattle	ww.biolreprod.org	0	0		
854	chr27	35326104	35326127	3500259875	23		35326104	35326127	8421504	1	23	0	c	350025987500000008	19-42						REGULATING MECHANISMS OF GONADAL AND PITUITARY TUMORIGENESIS IN MICE PRODUCING HUMAN CHORIONIC GONADOTROPIN	www.doria.fi	0	0		
854	chr27	35328299	35328716	3500375528	38		35328299	35328716	8421504	3	19,2,17	0,126,400	c,g	350037552800000001,350037552800000001,350037552800000000	0-19,0-19,0-19						LH-induced ERK Activation Differently Modulates Progesterone and Androstenedione Production in Bovine Theca Cells.	.endojournals.org	0	0		
854	chr27	35328299	35328716	3500075026	38		35328299	35328716	8421504	3	19,2,17	0,126,400	c	350007502600000003,350007502600000002	0-19,0-19		19917087	10.1186/1757-2215-2-17		Journal of Ovarian Research	Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells	Shin	2009	0		
854	chr27	35368853	35368876	3500148414	23		35368853	35368876	8421504	1	23	0	g	350014841400000566	8-31						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
854	chr27	35371842	35371867	3500135121	25		35371842	35371867	8421504	1	25	0	g	350013512100000050	0-25						Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus - US Patent 7833758 Description	ww.patentstorm.us	0	0		
854	chr27	35381044	35381478	3500027423	24		35381044	35381478	8421504	2	14,10	0,424	c	350002742300000005	0-24		23646287	10.7717/peerj.68	2167-8359	PeerJ	Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice [PeerJ]	Fleming	2013	0		
855	chr27	35441831	35441858	3500451187	23		35441831	35441858	8421504	2	11,12	0,15	c	350045118700000041	0-23						Sequences for Differential Diagnostic of Ehrlichia Ruminantium and Use Thereof - Patent application	www.faqs.org	0	0		
856	chr27	35558163	35562400	3500094640	63		35558163	35562400	8421504	4	21,21,15,6	0,2760,4019,4231	c	350009464000000234,350009464000000209,350009464000000241,350009464000000218	0-21,0-20,0-21,1-22						SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION	Natt	2010	0		
856	chr27	35558163	35560944	3500292931	42		35558163	35560944	8421504	2	21,21	0,2760	c	350029293100000234,350029293100000241	0-21,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent EP:2135950)	NATT	2012	0		
856	chr27	35558163	35560944	3500083334	42		35558163	35560944	8421504	2	21,21	0,2760	c	350008333400000234,350008333400000241	0-21,0-21					Patent	Short interfering ribonucleic acid (siRNA) with improved pharmacological properties (Patent US:8084600)	Billy	2011	0		
856	chr27	35558852	35558912	3500353736	60		35558852	35558912	8421504	1	60	0	p	350035373600015022	0-60						Two Additional Protein-Tyrosine Kinases Expressed in Human Lung: Fourth Member of the Fibroblast Growth Factor Receptor Family and an Intracellular Protein-Tyrosine Kinase	www.jstor.org	0	0		FGFR1
856	chr27	35559021	35562444	3500325527	785		35559021	35562444	8421504	12	5,106,138,71,57,63,54,38,111,82,10,50	0,186,459,802,1026,1086,1736,1889,2437,3054,3166,3373	p,c	350032552700000082,350032552700015032,350032552700015030,350032552700015028,350032552700015026,350032552700015024,350032552700015018,350032552700015017,350032552700015015,350032552700015013	12-34,0-120,0-60,0-120,0-60,0-117,0-81,0-60,0-90,0-60						Compounds and methods for development of RET modulators	Ibrahim	2006	0		
856	chr27	35559021	35562444	3500234586	785		35559021	35562444	8421504	12	5,106,138,71,57,63,54,38,111,82,10,50	0,186,459,802,1026,1086,1736,1889,2437,3054,3166,3373	p,c	350023458600000082,350023458600015027,350023458600015025,350023458600015023,350023458600015021,350023458600015015,350023458600015014,350023458600015029,350023458600015012	12-34,0-135,0-180,0-60,0-117,0-81,0-150,0-120,0-60						Compounds and methods for development of Ret modulators	Artis	2007	0		FGFR1
856	chr27	35559021	35562444	3500052584	785		35559021	35562444	8421504	12	5,106,138,71,57,63,54,38,111,82,10,50	0,186,459,802,1026,1086,1736,1889,2437,3054,3166,3373	p,c	350005258400000082,350005258400015027,350005258400015025,350005258400015023,350005258400015021,350005258400015015,350005258400015014,350005258400015029,350005258400015012	12-34,0-135,0-180,0-60,0-117,0-81,0-150,0-120,0-60						Compounds and methods for development of Ret modulators	Artis	2007	0		FGFR1
856	chr27	35559213	35562435	3500102578	897		35559213	35562435	8421504	8	100,138,71,123,191,111,122,41	0,267,610,834,1544,2245,2862,3181	p	350010257800015003	0-897						Remote homologues and kinases and methods of detection	Grigoriev	2003	0		FGFR1
856	chr27	35559243	35559288	3500263670	45		35559243	35559288	8421504	1	45	0	p	350026367000015139	0-45						INHIBITING BINDING OF FGF23 TO THE BINARY FGFR-KLOTHO COMPLEX FOR THE TREATMENT OF HYPOPHOSPHATEMIA - Patent application	www.faqs.org	0	0		FGFR2
856	chr27	35559884	35560064	3500094913	27		35559884	35560064	8421504	2	10,17	0,163	c	350009491300000053	0-27						Gene Expression Markers For Response To Egfr Inhibitor Drugs 	.freshpatents.com	0	0		
856	chr27	35562459	35562504	3500130441	45		35562459	35562504	8421504	1	45	0	p	350013044100015002	0-45		21765395	10.1038/emboj.2011.234	ERROR! NO ISSN	The EMBO Journal	Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function	Persaud	2011	0		FGFR1
856	chr27	35565543	35565595	3500014561	41		35565543	35565595	8421504	2	20,21	0,31	c	350001456100000015,350001456100000014	0-20,0-21						Immortalization of swine umbilical vein endothelial cells (SUVECs) with the simian virus 40 large-T antigen. - ResearchGate	.researchgate.net	0	0		
856	chr27	35567998	35571011	3500173089	90		35567998	35571011	8421504	2	45,45	0,2968	p	350017308900015078,350017308900015077	0-45,0-45						ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME	Ashkenazi	2010	0		FGFR1
856	chr27	35569186	35573010	3500352177	137		35569186	35573010	8421504	4	18,24,48,47	0,1699,3728,3777	c	350035217700000235,350035217700000226,350035217700000225	6-48,0-48,0-47						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
856	chr27	35571056	35572830	3500244396	153		35571056	35572830	8421504	3	2,84,67	0,268,1707	p	350024439600015002	0-153						FGFR-FC FUSION PROTEIN AND USE THEREOF - YANTAI RC BIOTECHNOLOGIES, LTD.	www.sumobrain.com	0	0		
858	chr27	35818260	35818290	3500074294	24		35818260	35818290	8421504	3	4,13,7	0,5,23	g	350007429400000014,350007429400000003	5-31,5-31						Chimeric Papillomavirus-like Particles 	.freshpatents.com	0	0		
861	chr27	36180139	36180163	3500153276	23		36180139	36180163	8421504	2	17,6	0,18	g	350015327600000141	10-33						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
862	chr27	36310134	36311732	3500122117	35		36310134	36311732	8421504	2	20,15	0,1583	c	350012211700000225	9-44						METHODS FOR TREATING PATHOLOGICAL NEOVASCULARIZATION - Patent application	www.faqs.org	0	0		
862	chr27	36310145	36311731	3500057195	23		36310145	36311731	8421504	2	9,14	0,1572	c	350005719500000011	10-33						Molecularand morphological aspects	n.library.ethz.ch	0	0		
862	chr27	36427544	36427569	3500408792	24		36427544	36427569	8421504	2	8,16	0,9	c	350040879200000059	21-45						Engulfment gene and uses thereof	Liu	1998	0		
868	chr27	37184174	37187375	3500362403	40		37184174	37187375	8421504	4	2,15,3,20	0,713,3111,3181	c	350036240300000054,350036240300000055	0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
868	chr27	37191180	37191207	3500320193	23		37191180	37191207	8421504	2	10,13	0,14	c	350032019300000014	1-24						RAS P21-interacting protein (RGL) and its RAS interacting domain (RID) - Patent # 5955354 - PatentGenius	.patentgenius.com	0	0		
869	chr27	37239557	37239582	3500374909	23		37239557	37239582	8421504	3	4,15,4	0,5,21	g	350037490900000012,350037490900000902	7-30,7-30						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
874	chr27	37972740	37972769	3500328855	24		37972740	37972769	8421504	2	14,10	0,19	g	350032885500000241	9-33						Polynucleotide encoding cytokine receptor zcytor17 multimer - US Patent 7494804 Description	ww.patentstorm.us	0	0		
874	chr27	37972740	37972769	3500110636	24		37972740	37972769	8421504	2	14,10	0,19	g	350011063600000041	0-24						Protein expression system	Sgarlato	1999	0		
878	chr27	38425901	38425927	3500183262	23		38425901	38425927	8421504	2	16,7	0,19	c	350018326200000015	9-32		12406221	10.1046/j.1365-2958.2002.03162.x	1365-2958	Molecular Microbiology	Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis - Larsen - 2002 - Molecular Microbiology - Wiley Online Library	Larsen	2002	0		
878	chr27	38428341	38462850	3500270595	40		38428341	38462850	8421504	2	20,20	0,34489	c,g	350027059500000001,350027059500000000,350027059500000000	0-20,0-20,0-20						RESEARCH ARTICLE Open Access Secreted frizzled-related protein 4 expression is	biomedcentral.com	0	0		SFRP1
878	chr27	38428450	38462836	3500431806	42		38428450	38462836	8421504	3	20,15,7	0,57,34379	c	350043180600000009,350043180600000008	0-20,0-22						Effects of EpCAM overexpression on human breast cancer cell lines. - ResearchGate	.researchgate.net	0	0		
878	chr27	38428450	38462836	3500126048	42		38428450	38462836	8421504	3	20,15,7	0,57,34379	c	350012604800000009,350012604800000008	0-20,0-22						Effects of EpCAM overexpression on human breast cancer cell lines	biomedcentral.com	0	0		SFRP1
878	chr27	38428457	38468193	3500122320	41		38428457	38468193	8421504	2	21,20	0,39716	c,g	350012232000000006,350012232000000007,350012232000000001,350012232000000001	2-21,0-21,0-20,0-20						Secreted Frizzled-Related Protein 1 Modulates Glucocorticoid Attenuation of Osteogenic Activities and Bone Mass	.endojournals.org	0	0		SFRP1
878	chr27	38428502	38462834	3500467582	25		38428502	38462834	8421504	2	20,5	0,34327	c	350046758200000018	19-44						Gene array identification of Ipf1/Pdx1-/- regulated genes in pancreatic progenitor cells. - ResearchGate	.researchgate.net	0	0		
878	chr27	38428513	38468066	3500366673	40		38428513	38468066	8421504	3	9,11,20	0,34316,39533	c,g	350036667300000061,350036667300000060,350036667300000060	0-20,0-20,0-20			10.1111/j.1365-2141.2006.06442.x	1365-2141	British Journal of Haematology	Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines - Nygren - 2006 - British Journal of Haematology - Wiley Online Library	Nygren	2007	0		SFRP1
878	chr27	38468222	38468289	3500465081	39		38468222	38468289	8421504	2	20,19	0,48	c,g	350046508100000003,350046508100000002,350046508100000002	0-20,0-19,0-19		20049321	10.1371/journal.pone.0008558	1932-6203	PLOS ONE	PLOS ONE: Differential Impact of Tumor Suppressor Pathways on DNA Damage Response and Therapy-Induced Transformation in a Mouse Primary Cell Model	McClendon	2010	4		
880	chr27	38747963	38748457	3500301078	41		38747963	38748457	8421504	2	20,21	0,473	c,g	350030107800000105,350030107800000105,350030107800000106,350030107800000106	0-20,0-20,0-21,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
882	chr27	38952297	38952321	3500068547	23		38952297	38952321	8421504	2	14,9	0,15	g	350006854700000481	0-23						HUMAN ERYTHROVIRUS - Patent application	www.faqs.org	0	0		
882	chr27	39020485	39020511	3500334356	24		39020485	39020511	8421504	2	10,14	0,12	g	350033435600000033	6-30						Soluble recombinant botulinum toxin proteins	Williams	2006	0		
884	chr27	39272306	39272939	3500401651	58		39272306	39272939	8421504	2	31,27	0,606	c	350040165100000282,350040165100000218	17-48,21-48					Patent	Tissue plasminogen activator (Patent US:5840533)	Hayashi	1998	0		
885	chr27	39343182	39343205	3500293999	23		39343182	39343205	8421504	1	23	0	c	350029399900000000	10-33					Patent	6-azaindole compound (Patent US:7608627)	Horiguchi	2009	0		IKBKB
885	chr27	39343182	39343205	3500282507	23		39343182	39343205	8421504	1	23	0	c	350028250700000000	10-33						6-Azaindole Compound	Horiguchi	2008	0		IKBKB
885	chr27	39374429	39378288	3500264759	44		39374429	39378288	8421504	3	12,12,20	0,1049,3839	c,g	350026475900000002,350026475900000003,350026475900000003	0-24,0-20,0-20						Synergetic downregulation of 67&#xfffd;kDa laminin receptor by the green tea (Camellia sinensis) secondary plant compound epigallocatechin gallate: a new gateway in metastasis prevention?	biomedcentral.com	0	0		
885	chr27	39375496	39378250	3500287183	96		39375496	39378250	8421504	2	72,24	0,2730	p	350028718300015004	0-96						PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. - ResearchGate	.researchgate.net	0	0		IKBKB
885	chr27	39375496	39378250	3500071292	96		39375496	39378250	8421504	2	72,24	0,2730	p	350007129200015002	0-96		16301747	10.1084/jem.20051591	0022-1007	The Journal of Experimental Medicine	PKC&#x03b2; regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1	Shinohara	2005	14		IKBKB
885	chr27	39385490	39385514	3500124685	24		39385490	39385514	8421504	1	24	0	g	350012468500000039	17-41						Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide	www.jleukbio.org	0	0		
885	chr27	39388448	39390171	3500206492	24		39388448	39390171	8421504	2	18,6	0,1717	c	350020649200000000	11-35						Methods of labeling transiently expressed proteins in large-scale eukaryotic cell cultures	Zhong	2007	0		IKBKB
885	chr27	39407543	39432136	3500345294	1005		39407543	39432136	8421504	14	61,58,67,75,59,50,52,55,73,71,87,65,140,92	0,376,3276,6654,7338,9147,11661,13494,13646,15728,16757,22672,23434,24501	p	350034529400015005,350034529400015007,350034529400015009,350034529400015011,350034529400015013,350034529400015015	0-180,0-180,0-180,0-180,0-174,0-111						Characterization and functional study of DNA polymerase beta during zebrafish development	iris.lib.neu.edu	0	0		POLB
885	chr27	39407570	39432136	3500358804	978		39407570	39432136	8421504	14	34,58,67,75,59,50,52,55,73,71,87,65,140,92	0,349,3249,6627,7311,9120,11634,13467,13619,15701,16730,22645,23407,24474	p	350035880400015005	0-978						3JPS - JenaLib	ib.fli-leibniz.de	0	0		POLB
885	chr27	39407921	39407951	3500072202	30		39407921	39407951	8421504	1	30	0	c	350007220200000000	0-30		18650495	10.1095/biolreprod.108.069104		Biology of Reproduction	Mutagenesis Is Elevated in Male Germ Cells Obtained from DNA Polymerase-beta Heterozygous Mice	Diwi	2008	0		
885	chr27	39414218	39414908	3500291432	81		39414218	39414908	8421504	2	54,27	0,663	p	350029143200015006,350029143200015008	0-81,45-102						&#xa9; 2008 Melissa Liz Armas	ges.uflib.ufl.edu	0	0		POLB
885	chr27	39419379	39419488	3500024826	62		39419379	39419488	8421504	3	22,20,20	0,31,89	g	350002482600000159,350002482600000157,350002482600000158	0-22,0-20,0-20						Udder Health Characteristics 	.freshpatents.com	0	0		
886	chr27	39455238	39457323	3500224737	236		39455238	39457323	8421504	3	138,53,45	0,962,2040	p,c	350022473700000004,350022473700000020,350022473700000021,350022473700000022,350022473700015018,350022473700000023,350022473700015019	0-23,0-59,0-60,0-60,0-60,0-57,0-54						Lokalisation und Relevanz von Porin Subtypen im bovinen Hoden	eb.uni-giessen.de	0	0		
886	chr27	39457402	39457468	3500229755	66		39457402	39457468	8421504	1	66	0	p	350022975500015000	0-66		9228078	10.1074/jbc.272.30.18966	0021-9258	Journal of Biological Chemistry	The Murine Voltage-dependent Anion Channel Gene Family	Sampson	1997	5		VDAC3
886	chr27	39459044	39460624	3500241494	68		39459044	39460624	8421504	3	6,58,4	0,1098,1576	c	350024149400000111,350024149400000112	0-48,0-20						US Patent # 6,534,641. Compositions and methods for the treatment and diagnosis of cardiovascular disease - Patents.com	www.patents.com	0	0		
886	chr27	39467689	39477534	3500116399	48		39467689	39477534	8421504	2	36,12	0,9833	p	350011639900015002	0-48		11356966	10.1128/JVI.75.12.5584-5592.2001	0022-538X	Journal of Virology	Transmembrane Topology of PiT-2, a Phosphate Transporter-Retrovirus Receptor	Salaun	2001	5		SLC20A2
886	chr27	39488111	39488139	3500408348	23		39488111	39488139	8421504	2	14,9	0,19	c	350040834800000101	11-48						Methods and systems for producing recombinant viral antigens	Zebedee	1997	0		
887	chr27	39595801	39595831	3500236784	25		39595801	39595831	8421504	2	17,8	0,22	c	350023678400000034	23-48						Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites	Tian Gui 	2006	0		
888	chr27	39761477	39761502	3500407663	25		39761477	39761502	8421504	1	25	0	c	350040766300000043	12-37						Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation	AMALRIC	2005	0		
888	chr27	39761477	39761502	3500348009	25		39761477	39761502	8421504	1	25	0	c	350034800900000018,350034800900000123	12-37,12-37						NOVEL DEATH ASSOCIATED PROTEINS, AND THAP1 AND PAR4 PATHWAYS IN APOPTOSIS CONTROL - Patent application	www.faqs.org	0	0		
888	chr27	39761477	39761502	3500046680	25		39761477	39761502	8421504	1	25	0	c	350004668000000003	12-37		12717420	10.1038/sj.onc.1206271	0950-9232	Oncogene	THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies	Roussigne	2003	6		
888	chr27	39762590	39766823	3500298132	35		39762590	39766823	8421504	2	30,5	0,4228	c	350029813200000078,350029813200000032,350029813200000033,350029813200000077	4-39,0-35,4-39,0-35						NUCLEIC ACIDS, METHODS AND KITS FOR THE DIAGNOSIS OF DYT6 PRIMARY TORSION DYSTONIA - Patent application	www.faqs.org	0	0		
888	chr27	39832296	39835698	3500013408	23		39832296	39835698	8421504	3	1,12,10	0,3375,3392	c	350001340800000000	10-33		21665951	10.1074/jbc.M111.249656		The Journal of Biological Chemistry	Identification and Functional Characterization of Kir2.6 Mutations Associated with Non-familial Hypokalemic Periodic Paralysis	Chih-Jen	2011	0		
889	chr27	39928047	39931407	3500467612	48		39928047	39931407	8421504	2	38,10	0,3350	p	350046761200015003	0-48					Patent	Method for identifying farnesyl transferase inhibitors (Patent US:8003342)	Brown	2011	0		FNTA
889	chr27	39928047	39931407	3500375216	48		39928047	39931407	8421504	2	38,10	0,3350	p	350037521600015010	0-48					Patent	Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase (Patent EP:0528820)	Brown	1996	0		FNTA
889	chr27	39928047	39931407	3500100513	48		39928047	39931407	8421504	2	38,10	0,3350	p	350010051300015010	0-48					Patent	Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase (Patent EP:0528820)	Brown	2001	0		FNTA
890	chr27	40017112	40017137	3500239599	23		40017112	40017137	8421504	2	16,7	0,18	g	350023959900000148	25-48						F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy	Qia Li *A Li Ta Luo 	2002	0		
894	chr27	40565719	40565746	3500223862	23		40565719	40565746	8421504	2	9,14	0,13	g	350022386200000003	0-23						Isolated DNA sequences and polypeptides inducing multiple resistance of plants to phytopathogens and pests	Dzhavakhia	2004	0		
894	chr27	40587078	40587102	3500381545	23		40587078	40587102	8421504	2	7,16	0,8	g	350038154500000020	0-23						Molecular mechanisms of multi-drug resistance induced by EvgA/EvgS, a two-component signal transduction system in Escherichia coli	clib.kindai.ac.jp	0	0		
895	chr27	40696350	40696377	3500175562	23		40696350	40696377	8421504	2	9,14	0,13	g	350017556200000003	10-33						Generation and characterization of rat and mouse monoclonal antibodies specific for MeCP2 and their use in X-inactivation studies. - ResearchGate	.researchgate.net	0	0		
902	chr27	41554202	41554530	3500164626	50		41554202	41554530	8421504	2	5,45	0,283	c	350016462600000043	0-50						Promotion or inhibition of angiogenesis and cardiovascularization	Ashkenazi	2000	0		
903	chr27	41765633	41765658	3500135471	23		41765633	41765658	8421504	2	17,6	0,19	g	350013547100000012	17-40		16923907	10.1128/JB.00249-06	0021-9193	Journal of Bacteriology	Bacillus subtilis Aconitase Is Required for Efficient Late-Sporulation Gene Expression	Serio	2006	4		
905	chr27	41986335	41986359	3500347010	23		41986335	41986359	8421504	2	6,17	0,7	g	350034701000000000	3-26		18461053	10.1038/mt.2008.92		Molecular therapy : the journal of the American Society of Gene Therapy	Novel Dual Inhibitory Function Aptamer&#x2013;siRNA Delivery System for HIV-1 Therapy	Jiehua	2008	0		
905	chr27	42040598	42040621	3500008756	23		42040598	42040621	8421504	1	23	0	g	350000875600000192	0-32						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
908	chr27	42354414	42354438	3500252738	23		42354414	42354438	8421504	2	16,7	0,17	g	350025273800000001	6-29						Inhibitors of MshC and Homologs Thereof, and Methods of Identifying Same - Patent application	www.faqs.org	0	0		
908	chr27	42354414	42354438	3500017912	23		42354414	42354438	8421504	2	16,7	0,17	g	350001791200000001	6-29						Inhibitors of MshC and Homologs Thereof, and Methods of Identifying Same	Fahey	2007	0		
908	chr27	42457727	42457754	3500367761	23		42457727	42457754	8421504	3	6,12,5	0,8,22	g	350036776100000021	20-44						NOVEL FUSION PROTEINS AND USE THEREOF FOR PREPARING HEPATITIS C VACCINES - Patent application	www.faqs.org	0	0		
911	chr27	42815138	42815171	3500261809	27		42815138	42815171	8421504	3	6,8,13	0,11,20	g	350026180900000018	11-41						Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system - US Patent 7473423 Description	ww.patentstorm.us	0	0		
917	chr27	43633676	43633699	3500308662	23		43633676	43633699	8421504	1	23	0	g	350030866200000112	0-23						DNA	.lib.kobe-u.ac.jp	0	0		
922	chr27	44213318	44213343	3500340964	23		44213318	44213343	8421504	2	6,17	0,8	g	350034096400000001	0-23						Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury	al.physiology.org	0	0		
922	chr27	44213318	44213343	3500194265	23		44213318	44213343	8421504	2	6,17	0,8	g	350019426500000001	0-23		18614620	10.1152/ajprenal.90255.2008		American Journal of Physiology - Renal Physiology	Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury	Yeboah	2008	0		
923	chr27	44314704	44314730	3500327077	23		44314704	44314730	8421504	2	15,8	0,18	g	350032707700000019,350032707700000018,350032707700000028	9-32,10-32,0-23						2-branched nucleosides and flaviviridae mutation	Bichko	2005	0		
932	chr27	45575011	45575036	3500376618	23		45575011	45575036	8421504	2	10,13	0,12	g	350037661800000021,350037661800000036	18-41,18-41						MODULAR VECTOR SYSTEMS - Patent application	www.faqs.org	0	0		
932	chr27	45575011	45575036	3500204632	23		45575011	45575036	8421504	2	10,13	0,12	g	350020463200000021	18-41						Modular vector systems	Jarrell	2003	0		
934	chr27	45823105	45823334	3500460141	40		45823105	45823334	8421504	2	20,20	0,209	g	350046014100000009,350046014100000008	0-20,0-20						Author's personal copy	www.dsa.unipd.it	0	0		
934	chr27	45823105	45823334	3500024826	40		45823105	45823334	8421504	2	20,20	0,209	g	350002482600000162,350002482600000161	0-20,0-20						Udder Health Characteristics 	.freshpatents.com	0	0		
934	chr27	45823246	45823364	3500419411	116		45823246	45823364	8421504	2	30,86	0,32	g	350041941100000024,350041941100000021	0-56,0-60						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		
935	chr27	45926947	45927205	3500376180	258		45926947	45927205	8421504	1	258	0	p	350037618000015004,350037618000015005,350037618000015006	0-78,0-78,0-102						Lung Cancer Diagnostic Assay - Patent application	www.faqs.org	0	0		RPL15
935	chr27	45926947	45927205	3500209076	258		45926947	45927205	8421504	1	258	0	p	350020907600015005,350020907600015006,350020907600015007	0-78,0-78,0-102						Lung Cancer Diagnostic Assay	Hirschowitz	2006	0		RPL15
935	chr27	45927124	45927189	3500134803	44		45927124	45927189	8421504	2	23,21	0,44	c,g	350013480300000036,350013480300000036,350013480300000037,350013480300000037	0-23,0-23,0-21,0-21						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		RPL15
935	chr27	45928573	45928600	3500086323	23		45928573	45928600	8421504	2	8,15	0,12	c	350008632300000115	0-26						MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCINE AND RELATED COMPOUNDS, AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
935	chr27	45928573	45928600	3500042925	23		45928573	45928600	8421504	2	8,15	0,12	c	350004292500000115	0-26						MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCINE AND RELATED COMPOUNDS, AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
949	chr27	47773156	47773180	3500105414	23		47773156	47773180	8421504	2	15,8	0,16	g	350010541400000247,350010541400000314,350010541400000246	0-20,0-20,0-20						Compositions And Methods Comprising Variant Microbial Proteases - Patent application	www.faqs.org	0	0		
949	chr27	47822514	47822548	3500368073	34		47822514	47822548	8421504	1	34	0	g	350036807300000010,350036807300000011,350036807300000012	6-29,6-34,6-40						Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor	Evans	1994	0		
949	chr27	47822514	47822548	3500208017	34		47822514	47822548	8421504	1	34	0	g	350020801700000012,350020801700000011	6-40,6-34					Patent	Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor (Patent US:7119077)	Evans	2006	0		
949	chr27	47822514	47822548	3500200948	34		47822514	47822548	8421504	1	34	0	g	350020094800000007,350020094800000006,350020094800000008	6-34,6-29,6-40						Response element compositions and assays employing same	Sucov	2002	0		
949	chr27	47822514	47822548	3500200792	34		47822514	47822548	8421504	1	34	0	g	350020079200000011,350020079200000010,350020079200000012	6-34,6-29,6-40					Patent	Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor (Patent US:6281330)	Evans	2001	0		
949	chr27	47822514	47822548	3500166091	34		47822514	47822548	8421504	1	34	0	g	350016609100000011,350016609100000012	6-34,6-40						Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor	Evans	2000	0		
949	chr27	47822514	47822541	3500307339	27		47822514	47822541	8421504	1	27	0	g	350030733900000000	0-27		12527889	10.1038/sj.onc.1206100	0950-9232	Oncogene	Fusion proteins of retinoid receptors antagonize TGF-&#x03b2;-induced growth inhibition of lung epithelial cells	La	2003	6		
949	chr27	47822515	47822538	3500300785	23		47822515	47822538	8421504	1	23	0	g	350030078500000001,350030078500000000	0-23,0-23						Maternal smoking and the retinoid pathway in the developing lung	tory-research.com	0	0		RARB
949	chr27	47822515	47822538	3500180219	23		47822515	47822538	8421504	1	23	0	g	350018021900000001,350018021900000000	0-23,0-23		22651576	10.1186/1465-9921-13-42	1465-9921	Respiratory Research	Maternal smoking and the retinoid pathway in the developing lung	Manoli	2012	0		
949	chr27	47822515	47822538	3500157716	23		47822515	47822538	8421504	1	23	0	g	350015771600000001,350015771600000000	0-23,0-23		22651576	10.1186/1465-9921-13-42	1465-9921	Respiratory Research	Maternal smoking and the retinoid pathway in the developing lung	Manoli	2012	0		
950	chr27	47851330	47851361	3500252340	23		47851330	47851361	8421504	3	6,5,12	0,11,19	g	350025234000000057	6-29						Protein Scaffolds And Uses Thereof 	.freshpatents.com	0	0		
950	chr27	47897156	47897901	3500329390	745		47897156	47897901	8421504	1	745	0	g	350032939000000001	7-753						NCBI GenBank | DN542070 | 1390717 MARC 7BOV Bos taurus cDNA 3', mRNA sequence.	www.metalife.com	0	0		
587	chr28	291258	291282	3500426004	23		291258	291282	8421504	2	4,19	0,5	g	350042600400000008	6-34						Parasitic helminth PLA2 proteins	Grieve	1995	0		
588	chr28	427542	427787	3500146047	40		427542	427787	8421504	2	20,20	0,225	c	350014604700000001,350014604700000000	0-20,0-20						PASTURE-FEEDING OF CHAROLAIS STEERS INFLUENCES SKELETAL MUSCLE METABOLISM AND GENE EXPRESSION	www.jpp.krakow.pl	0	0		
588	chr28	427542	427787	3500053255	40		427542	427787	8421504	2	20,20	0,225	c,g	350005325500000001,350005325500000000,350005325500000000	0-20,0-20,0-20						1009_S3_article_10	www.jpp.krakow.pl	0	0		
588	chr28	427776	427809	3500352907	33		427776	427809	8421504	1	33	0	g	350035290700000015	0-33						Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1	Dong	1995	0		
588	chr28	427776	427806	3500426224	30		427776	427806	8421504	1	30	0	g	350042622400000009	0-30						&#x4e3b;&#x9898;&#xff1a;Factor- | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		SPZ1
588	chr28	427776	427806	3500405687	29		427776	427806	8421504	2	11,18	0,12	g	350040568700000006	0-29						The human paracellin-1 gene (hPCLN-1): renal epithelial cell-specific expression and regulation	al.physiology.org	0	0		
588	chr28	427776	427806	3500351454	30		427776	427806	8421504	1	30	0	g	350035145400000001	0-30		16760261	10.1152/ajpcell.00523.2005		American Journal of Physiology - Cell Physiology	Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line	Zhang	2006	0		SPZ1
588	chr28	427776	427806	3500243770	29		427776	427806	8421504	2	11,18	0,12	g	350024377000000005	0-29			10.1084/jem.20022218		The Journal of Experimental Medicine	Prostaglandin D2 Reinforces Th2 Type Inflammatory Responses of Airways to Low-dose Antigen through Bronchial Expression of Macrophage-derived Chemokine	Kyoko	2003	0		ACTB,SPZ1
588	chr28	427776	427806	3500185364	30		427776	427806	8421504	1	30	0	g	350018536400000001	0-30		23902727	10.1186/1476-4598-12-84	1476-4598	Molecular Cancer	Characterization and identification of PARM-1 as a new potential oncogene	Charfi	2013	4		
588	chr28	427776	427806	3500165160	30		427776	427806	8421504	1	30	0	c	350016516000000002	30-60						Die Rolle humaner NK-Zellen f&#xfc;r die Eradikation von Leuk&#xe4;mien in der HLA-haploidentischen Knochenmark- und Stammzelltransplantation	b.uni-muenchen.de	0	0		POTEF,POTEM
588	chr28	427776	427806	3500109582	30		427776	427806	8421504	1	30	0	g	350010958200000001	0-30		23902727	10.1186/1476-4598-12-84	1476-4598	Molecular Cancer	Characterization and identification of PARM-1 as a new potential oncogene	Charfi	2013	4		
588	chr28	427776	427806	3500041892	30		427776	427806	8421504	1	30	0	g	350004189200000001	0-30		16760261	10.1152/ajpcell.00523.2005		American Journal of Physiology - Cell Physiolog	Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line	Zhang	2006	0		SPZ1
588	chr28	427776	427806	3500033446	30		427776	427806	8421504	1	30	0	g	350003344600000006	0-30		20197310	10.1210/me.2009-0317		Molecular Endocrinology	Involvement of Estrogen Receptor Variant ER-&#x03b1;36, Not GPR30, in Nongenomic Estrogen Signaling	Lianguo	2010	0		
588	chr28	427776	427805	3500291352	29		427776	427805	8421504	1	29	0	g	350029135200000003	0-29		23828577	10.1038/cddis.2013.244	false	Cell Death & Disease	TGF-&#x03b2;1 regulates cell fate during epithelial&#x2013;mesenchymal transition by upregulating survivin	Lee	2013	0		SPZ1
588	chr28	427776	427805	3500045467	29		427776	427805	8421504	1	29	0	g	350004546700000003	0-29						Smad3RegulatesRhoSignalingviaNET1intheTransforming GrowthFactor- -inducedEpithelial-MesenchymalTransition ofHumanRetinalPigmentEpithelialCells	www.jbc.org	0	0		
588	chr28	427776	427802	3500062926	26		427776	427802	8421504	1	26	0	g	350006292600000062	0-26						Genetic and Epigenetic Alterations In the Diagnosis and Treatment of Cancer - Patent application	www.faqs.org	0	0		
588	chr28	427776	427800	3500351094	24		427776	427800	8421504	1	24	0	g	350035109400000003	0-24						Metastasis associated protein1/Histone Deacetylase 4-Nucleosome Remodeling and Deacetylase Complex Regulates PTEN Expression and Function | Neil Sahni - Academia.edu	www.academia.edu	0	0		SPZ1
588	chr28	427777	427801	3500357936	24		427777	427801	8421504	1	24	0	c	350035793600000009	2-26						Development/Plasticity/Repair Neuron-SpecificEffectsofInterleukin-1 AreMediatedbya NovelIsoformoftheIL-1ReceptorAccessoryProtein	www.jneurosci.org	0	0		
588	chr28	427779	428947	3500464768	41		427779	428947	8421504	2	21,20	0,1148	c,g	350046476800000004,350046476800000013,350046476800000013	0-21,0-20,0-20						E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16 &#x2013; Positive Oropharyngeal Cancer Cells	ww.oralcancer.org	0	0		SPZ1
588	chr28	427779	427809	3500328408	30		427779	427809	8421504	1	30	0	g	350032840800000010	39-69						Methods and compounds for phototransfer	Lim	2009	0		SYN2,AMY2B
588	chr28	427779	427809	3500257495	30		427779	427809	8421504	1	30	0	g	350025749500000010	39-69						Methods and compounds for making arrays - Patent application	www.faqs.org	0	0		AMY2B
588	chr28	427779	427809	3500252067	30		427779	427809	8421504	1	30	0	g	350025206700000010	39-69						Methods for enriching subpopulations - Patent application	www.faqs.org	0	0		SYN2,AMY2B
588	chr28	427779	427809	3500153351	30		427779	427809	8421504	1	30	0	g	350015335100000010	39-69						Bead-ligand-nascent protein complexes	Lim	2008	0		ACTB
588	chr28	427779	427809	3500090280	30		427779	427809	8421504	1	30	0	g	350009028000000010	39-69						Bead-ligand-nascent protein complexes - Patent application	www.faqs.org	0	0		SYN2
588	chr28	427779	427809	3500059567	30		427779	427809	8421504	1	30	0	g	350005956700000010	39-69						Methods for controlling amplification - Patent application	www.faqs.org	0	0		
588	chr28	427779	427806	3500323354	27		427779	427806	8421504	1	27	0	g	350032335400000025	0-28						Suppression of Hepatitis C Virus Genome Replication in Cells with RNA-Cleaving DNA Enzymes and Short-Hairpin RNA	pfjspark.maru.net	0	0		ACTG1
588	chr28	427779	427804	3500447989	25		427779	427804	8421504	1	25	0	g	350044798900000009	0-25						US Patent # 6,190,857. Diagnosis of disease state using MRNA profiles in peripheral leukocytes - Patents.com	www.patents.com	0	0		ACTG1
588	chr28	427779	427804	3500314584	24		427779	427804	8421504	2	6,18	0,7	g	350031458400000023	0-24		20849415	10.1111/j.1742-4658.2010.07819.x	1742-4658	FEBS Journal	MBP-1 is efficiently encoded by an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover - Lung - 2010 - FEBS Journal - Wiley Online Library	Lung	2010	0		ACTG1
588	chr28	427779	427804	3500108739	25		427779	427804	8421504	1	25	0	g	350010873900000007	0-25						Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer	An	2003	0		ACTG1,SPZ1
588	chr28	427781	427836	3500288852	41		427781	427836	8421504	2	19,22	0,33	c,g	350028885200000034,350028885200000032	0-19,0-22						Conditional Mutagenesis of the Murine Serum Response Factor Gene Blocks Cardiogenesis and the Transcription of Downstream Gene Targets--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x90	journal.9med.net	0	0		
588	chr28	427809	429045	3500060977	152		427809	429045	8421504	2	51,101	0,1135	c	350006097700000047,350006097700000032,350006097700000031	0-51,0-51,0-50						Studies on molecular mechanisms underlying high pressure adaptation of &#x03b1;-actin from deep-sea fish	w.fra.affrc.go.jp	0	0		
588	chr28	427818	428923	3500253008	540		427818	428923	8421504	5	102,78,116,162,82	0,188,541,758,1023	p	350025300800015010,350025300800015006,350025300800015004	0-180,0-180,0-180						Slide 1	ai.stanford.edu	0	0		
588	chr28	427822	428625	3500417171	500		427822	428625	8421504	5	23,54,182,192,49	0,44,184,461,754	p,c	350041717100000133,350041717100000130,350041717100000012,350041717100015056,350041717100015055,350041717100015054,350041717100000078,350041717100015053	0-21,0-21,0-22,0-120,0-120,0-120,0-50,0-120						UNIVERSIDAD COMPLUTENSE DE MADRID	www.elfoiegras.es	0	0		
588	chr28	427838	427863	3500320056	25		427838	427863	8421504	1	25	0	g	350032005600000002	0-25		19759828	10.1371/journal.pone.0006943	1932-6203	PLOS ONE	PLOS ONE: Earlier Onset of &#x03b4;-Retrovirus-Induced Leukemia after Splenectomy	Florins	2009	4		CCDC74A,ACTA1
588	chr28	427912	428024	3500460589	26		427912	428024	8421504	2	8,18	0,94	c	350046058900000024	4-30						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Soreq	2010	0		
588	chr28	427912	428024	3500371873	26		427912	428024	8421504	2	8,18	0,94	c	350037187300000067,350037187300000024	4-30,4-30						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		ACTA1
588	chr28	427912	428024	3500304886	26		427912	428024	8421504	2	8,18	0,94	c	350030488600000043,350030488600000024	4-30,4-30						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		
588	chr28	427912	428024	3500256738	26		427912	428024	8421504	2	8,18	0,94	c	350025673800000024	4-30						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2007	0		
588	chr28	427912	428024	3500141326	26		427912	428024	8421504	2	8,18	0,94	c	350014132600000055	4-30						 Estrategias para la diferenciaciA3n in vitro de cA(c)lulas ES de ratA3n a cA(c)lulas acinares pancreA!	www.tdx.cat	0	0		ACTG1
588	chr28	427912	428022	3500251913	24		427912	428022	8421504	2	8,16	0,94	c	350025191300000002	0-24		19074907	10.1158/0008-5472.CAN-08-1444	0008-5472	Cancer Research	Epithelial-Mesenchymal Transition Induced by Growth Suppressor p12CDK2-AP1 Promotes Tumor Cell Local Invasion but Suppresses Distant Colony Growth	Tsuji	2008	8		
588	chr28	427913	428022	3500064690	23		427913	428022	8421504	2	7,16	0,93	c	350006469000000001	0-23		18598677	10.1016/j.brainres.2008.06.013		Brain research	Functional response to SDF1&#x03b1; through over-expression of CXCR4 on adult subventricular zone progenitor cells	Xian	2008	0		ACTA2
588	chr28	427915	428024	3500348778	23		427915	428024	8421504	2	5,18	0,91	c	350034877800000023	0-23						Analysis of imprinted gene expression in normal fertilized and uniparental preimplantation porcine embryos. - ResearchGate	.researchgate.net	0	0		ACTA1
588	chr28	427917	429061	3500020524	43		427917	429061	8421504	3	3,21,19	0,89,1125	c,g	350002052400000013,350002052400000012	0-24,5-24		17938256	10.1096/fj.07-9239com	0892-6638	The FASEB Journal	Phospholipase C-&#x03b4;1 is an essential molecule downstream of Foxn1, the gene responsible for the nude mutation, in normal hair development	Nakamura	2008	6		ACTG1
588	chr28	427917	428027	3500464712	24		427917	428027	8421504	2	3,21	0,89	c	350046471200000003	0-24		19536110	10.1038/npp.2009.64	0893-133X	Neuropsychopharmacology	Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation	Wu	2009	8		
588	chr28	427917	428027	3500439681	24		427917	428027	8421504	2	3,21	0,89	c	350043968100000007	0-24			10.1186/1750-2187-1-7	1750-2187	Journal of Molecular Signaling	Agonist mediated internalization of M2 mAChR is &#xce;&#xb2;-arrestin-dependent	Jones	2006	0		
588	chr28	427917	428027	3500435082	24		427917	428027	8421504	2	3,21	0,89	c	350043508200000035	0-24						Biochemical and Biophysical Research Communications	teca.cinvestav.mx	0	0		
588	chr28	427917	428027	3500429053	24		427917	428027	8421504	2	3,21	0,89	c	350042905300000005	0-24		17135299	10.1152/ajpcell.00360.2006		American Journal of Physiology - Cell Physiolog	Regulation of the human biotin transporter hSMVT promoter by KLF-4 and AP-2: confirmation of promoter activity in vivo	Reidling	2007	0		
588	chr28	427917	428027	3500417414	24		427917	428027	8421504	2	3,21	0,89	c	350041741400000003	0-24		22170341	10.1038/gt.2011.197	0969-7128	Gene Therapy	Bacterial magnetic particles as a novel and efficient gene vaccine delivery system	Tang	2011	4		
588	chr28	427917	428027	3500286677	24		427917	428027	8421504	2	3,21	0,89	c	350028667700000007	0-24						Apical membrane targeting and trafficking of the human proton-coupled transporter in polarized epithelia	g.library.pcc.edu	0	0		
588	chr28	427917	428027	3500224552	24		427917	428027	8421504	2	3,21	0,89	c	350022455200000003	0-24		22170341	10.1038/gt.2011.197	0969-7128	Gene Therapy	Bacterial magnetic particles as a novel and efficient gene vaccine delivery system	Tang	2011	4		
588	chr28	427917	428027	3500119312	24		427917	428027	8421504	2	3,21	0,89	c	350011931200000005	0-24		10362637			American Journal of Physiology - Gastrointestinal and Liver Physiology	Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury	Jones	1999	0		
588	chr28	427917	428027	3500064597	24		427917	428027	8421504	2	3,21	0,89	c	350006459700000007	0-24						THE ROLE OF BETA-ARRESTIN IN REGULATING THE MUSCARINIC ACETYLCHOLINE TYPE II RECEPTOR	artech.gatech.edu	0	0		ACTA2
588	chr28	427918	428332	3500329131	39		427918	428332	8421504	3	2,17,20	0,88,394	c	350032913100000003,350032913100000002	1-20,0-20						Embryogenesis of the murine endocrine pancreas; early expression of pancreatic polypeptide gene	ev.biologists.org	0	0		
588	chr28	428036	428600	3500419090	46		428036	428600	8421504	2	24,22	0,542	c	350041909000000048,350041909000000047	0-24,0-22						International Journal for Parasitology	005.pasteur.ac.ir	0	0		
588	chr28	428070	428094	3500447055	24		428070	428094	8421504	1	24	0	c	350044705500000017	1-25		20228833	10.1038/cmi.2010.6	1672-7681	Cellular & Molecular Immunology	Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNF&agr; response and p53 activity	Li	2010	3		
588	chr28	428070	428094	3500315291	24		428070	428094	8421504	1	24	0	c	350031529100000008	1-25						Silencing of the human TERT gene by RNAi inhibits A549 lung adenocarcinoma cell growth in vitro and in vivo	-publications.com	0	0		ACTG1
588	chr28	428070	428094	3500282361	24		428070	428094	8421504	1	24	0	c	350028236100000005	1-25			10.1046/j.1365-2567.2004.01905.x	1365-2567	Immunology	Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis - Roy - 2004 - Immunology - Wiley Online Library	Roy	2004	0		
588	chr28	428070	428094	3500199325	24		428070	428094	8421504	1	24	0	c	350019932500000005	1-25		16804107	10.1152/ajprenal.00014.2006		American Journal of Physiology - Renal Physiology	Molecular cloning and functional characterization of novel zinc transporter rZip10 (Slc39a10) involved in zinc uptake across rat renal brush-border membrane	Kaler	2007	0		ACTG2
588	chr28	428070	428094	3500006542	24		428070	428094	8421504	1	24	0	c	350000654200000001	0-24						Pegylated Arginine Deiminase (ADI-SS PEG20,000 mw) Inhibits Human Melanomas and Hepatocellula - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		SPZ1
588	chr28	428071	428095	3500364184	24		428071	428095	8421504	1	24	0	c	350036418400000001	0-24						Human Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation Potential - Springer	rd.springer.com	0	0		ACTG1
588	chr28	428071	428095	3500337719	24		428071	428095	8421504	1	24	0	c	350033771900000001	0-24		19182209	10.1182/blood-2008-08-174797		Blood	Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells	Claudia	2009	0		CCDC74A
588	chr28	428071	428095	3500323944	24		428071	428095	8421504	1	24	0	c	350032394400000006	0-24						Adipose vs Bone Marrow | Stem Cell Treatments	orldstemcells.com	0	0		EP300,SPZ1
588	chr28	428071	428095	3500276758	24		428071	428095	8421504	1	24	0	c	350027675800000014	0-24						Suppression of Androgen Receptor Transactivation and Prostate Cancer Cell Growth by Heterogeneous Nuclear Ribonucleoprotein A1 via Interaction with Androgen Receptor Coregulator ARA54	rmc.rochester.edu	0	0		SPZ1
588	chr28	428071	428095	3500259930	24		428071	428095	8421504	1	24	0	c	350025993000000003	0-24						ERAP75FunctionsasaCoactivatortoEnhance EstrogenReceptor aTransactivation inProstateStromalCells	rmc.rochester.edu	0	0		ACTG1
588	chr28	428071	428095	3500196365	24		428071	428095	8421504	1	24	0	c	350019636500000003	0-24		15048090	10.1038/sj.onc.1207435	0950-9232	Oncogene	RRR-&#x03b1;-tocopheryl succinate inhibits human prostate cancer cell invasiveness	Zhang	2004	6		POTEE,EP300
588	chr28	428071	428095	3500007851	24		428071	428095	8421504	1	24	0	c	350000785100000007	0-24		19118046	10.1158/1078-0432.CCR-08-0910	1078-0432	Clinical Cancer Research	RRR-&#x03b1;-Vitamin E Succinate Potentiates the Antitumor Effect of Calcitriol in Prostate Cancer without Overt Side Effects	Yin	2009	8		POTEE
588	chr28	428071	428094	3500466726	23		428071	428094	8421504	1	23	0	c	350046672600000008	0-23						Identification of a new tumor suppressor gene located at chromosome 8p21.3&#x0152;22	www.jan-galle.de	0	0		CCDC74A
588	chr28	428091	428161	3500079955	46		428091	428161	8421504	2	22,24	0,46	c,g	350007995500000009,350007995500000009,350007995500000008	0-22,0-22,0-24						METHODS AND COMPOSITIONS FOR INDUCING PHYSIOLOGICAL HYPERTROPHY - Patent application	www.faqs.org	0	0		
588	chr28	428141	428173	3500208541	32		428141	428173	8421504	1	32	0	c	350020854100000000	31-63		16311515	10.1038/sj.cdd.4401789	1350-9047	Cell Death & Differentiation	Apoptosis and differentiation commitment: novel insights revealed by gene profiling studies in mouse embryonic stem cells	Duval	2005	9		
588	chr28	428141	428173	3500040762	32		428141	428173	8421504	1	32	0	c	350004076200000000	31-63		16311515	10.1038/sj.cdd.4401789	1350-9047	Cell Death & Differentiation	Apoptosis and differentiation commitment: novel insights revealed by gene profiling studies in mouse embryonic stem cells	Duval	2005	9		
588	chr28	428148	428171	3500425902	23		428148	428171	8421504	1	23	0	c	350042590200000000	0-23						N&#xb0; d&#xb6;ordre THESE	ai.u-bordeaux1.fr	0	0		
588	chr28	428411	428434	3500291341	23		428411	428434	8421504	1	23	0	c,g	350029134100000005,350029134100000005	0-23,0-23						UNIVERSIT&#xc0; DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
588	chr28	428435	428461	3500404008	26		428435	428461	8421504	1	26	0	c	350040400800000003	0-26		17194746	10.1210/en.2006-1193	0013-7227	Endocrinology	Development of Primordial Follicles in the Hamster: Role of Estradiol-17&#x03b2;	Wang	2007	4		CCDC74A
588	chr28	428439	428462	3500184773	23		428439	428462	8421504	1	23	0	c	350018477300000048	0-23		21285411	10.1126/scisignal.2001249		Science signaling	METABOLISM Wnt Signaling Regulates Hepatic Metabolism	Hongjun		0		POTEM
588	chr28	428439	428462	3500030307	23		428439	428462	8421504	1	23	0	c	350003030700000030	0-23						NOVEL APPROACHES TO THE ISOLATION OF FARM ANIMAL EMBRYONIC STEM CELLS by Kwanta Thansa Thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy September 2009	.nottingham.ac.uk	0	0		POTEF
588	chr28	428686	428711	3500062993	25		428686	428711	8421504	1	25	0	c	350006299300000002	0-25						Oxygen-regulated expression of the erythropoietin gene in a human renal cell line REPC	tologylibrary.org	0	0		ACTB
588	chr28	428905	428930	3500070419	25		428905	428930	8421504	1	25	0	g	350007041900000008	0-25		18724390	10.1038/onc.2008.264	0950-9232	Oncogene	Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration	Wu	2008	6		SYN2
588	chr28	428905	428929	3500169664	24		428905	428929	8421504	1	24	0	g	350016966400000002	0-24		23887392	10.1038/srep02292	xxxx-xxxx	Scientific Reports	Development associated profiling of chitinase and microRNA of Helicoverpa armigera identified chitinase repressive microRNA	Agrawal	2013	0		POTEF
588	chr28	428909	428933	3500282991	24		428909	428933	8421504	1	24	0	c	350028299100000007	0-24		22928018	10.1371/journal.pone.0043696		PLoS ONE	Siderocalin/Lcn2/NGAL/24p3 Does Not Drive Apoptosis Through Gentisic Acid Mediated Iron Withdrawal in Hematopoietic Cell Lines	Colin	2012	0		CCDC74A
588	chr28	428911	428934	3500182926	23		428911	428934	8421504	1	23	0	c	350018292600000015	0-23		21411528	10.1128/JVI.02154-10		Journal of Virology	Cardiomyopathy Syndrome of Atlantic Salmon (Salmo salar L.) Is Caused by a Double-Stranded RNA Virus of the Totiviridae Family	Oyvind	June	0		KDM4C,POTEF
588	chr28	428914	428938	3500287474	24		428914	428938	8421504	1	24	0	c,g	350028747400000004,350028747400000004	0-24,0-24		19952113	10.1158/1541-7786.MCR-08-0501	1541-7786	Molecular Cancer Research	Dysregulation of Platelet-Derived Growth Factor &#x03b2;-Receptor Expression by &#x0394;Np73 in Neuroblastoma	Wetterskog	2009	4		POTEF
588	chr28	428916	428941	3500410275	25		428916	428941	8421504	1	25	0	c	350041027500000005	0-25						Berberine Decreased N-acetylation of 2-Aminofluorene through Inhibition of N-acetyltransferase Gene Expression in Human Leukemia HL-60 Cells	b1.fyh.doh.gov.tw	0	0		ACTC1
588	chr28	428916	428941	3500391221	25		428916	428941	8421504	1	25	0	c	350039122100000013	0-26		18768984	10.1128/JVI.00506-08		Journal of Virology	Mutations at Alternative 5&#x2032; Splice Sites of M1 mRNA Negatively Affect Influenza A Virus Viability and Growth Rate 	Chiayn	2008	0		
588	chr28	428916	428941	3500318637	25		428916	428941	8421504	1	25	0	c	350031863700000003	0-25						Neutralization of flt3 ligand as a leukemia therapy	Levis	2011	0		POTEM
588	chr28	428916	428941	3500283161	25		428916	428941	8421504	1	25	0	c	350028316100000005	0-25			10.1083/jcb.200606145		The Journal of Cell Biology	Human SHPRH suppresses genomic instability through proliferating cell nuclear antigen polyubiquitination	Akira	2006	0		ACTA1
588	chr28	428916	428941	3500156287	25		428916	428941	8421504	1	25	0	c	350015628700000008	0-25						GAMMA SECRETASE INHIBITOR FOR TREATMENT OF HERPESVIRUS INFECTION	Robertson	2012	0		CCDC74A
588	chr28	428916	428941	3500148804	25		428916	428941	8421504	1	25	0	c	350014880400000000	102-127						Combined effects of TGF&#x03b2;1 and BMP2 in serum-free chondrogenic differentiation of mesenchymal stem cells induced hyaline-like cartilage formation | Rufaihah Abdul Jalil - Academia.edu	www.academia.edu	0	0		POTEF,GOLGA8A
588	chr28	428916	428941	3500086803	25		428916	428941	8421504	1	25	0	c	350008680300000006,350008680300000005	21-46,21-46						&#xb2c4;&#xa440;&#xb3b9; &#xab65;&#xa8a5;	ir.cmu.edu.tw	0	0		POTEF,SYN2
588	chr28	428917	428947	3500456080	30		428917	428947	8421504	1	30	0	c	350045608000000003	0-30		12538732	10.1097/01.ASN.0000042169.23931.73	1046-6673	Journal of the American Society of Nephrology	Bacterial CpG-DNA Aggravates Immune Complex Glomerulonephritis: Role of TLR9-Mediated Expression of Chemokines and Chemokine Receptors	Anders	2003	10		
588	chr28	428917	428947	3500237549	30		428917	428947	8421504	1	30	0	c	350023754900000005	0-30						Bacterial CpG-DNA Aggravates Immune Complex Glomerulonephritis: Role of TLR9-Mediated Expression of Chemokines and Chemokine Receptors	n.asnjournals.org	0	0		
588	chr28	428917	428947	3500175733	30		428917	428947	8421504	1	30	0	c	350017573300000002	0-30			10.1634/stemcells.2007-0653	1549-4918	STEM CELLS	Adipose-Derived Stem Cells Are a Source for Cell Therapy of the Corneal Stroma - Arnalich-Montiel - 2007 - STEM CELLS - Wiley Online Library	Arnalich-Montiel	2008	0		POTEF
588	chr28	428919	428943	3500077960	24		428919	428943	8421504	1	24	0	c	350007796000000004	0-24		21188139	10.1371/journal.pone.0015073	1932-6203	PLOS ONE	PLOS ONE: The Effect of DNA-Dependent Protein Kinase on Adeno-Associated Virus Replication	Choi	2010	4		POTEF
588	chr28	428923	429029	3500210668	39		428923	429029	8421504	2	19,20	0,86	c,g	350021066800000007,350021066800000007,350021066800000006	0-19,0-19,0-20						ENDOTHELIN B RECEPTOR BLOCKER INHIBITS HIGH GLUCOSE-INDUCED SYNTHESIS OF FIBRONECTIN IN HUMAN PERITONEAL MESOTHELIAL CELLS	pdiconnect.com	0	0		
588	chr28	429014	429037	3500386671	23		429014	429037	8421504	1	23	0	g	350038667100000006	0-23			10.1186/1479-0556-5-10		Genetic Vaccines and Therapy	HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo	Blanca	2007	0		POTEF,ACTG1
588	chr28	429024	429049	3500070169	24		429024	429049	8421504	2	12,12	0,13	g	350007016900000033	0-24						Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides	Gursel	2005	0		FRMD5
588	chr28	429029	429060	3500421121	31		429029	429060	8421504	1	31	0	g	350042112100000024	29-60						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		ZP4
588	chr28	429029	429060	3500409810	31		429029	429060	8421504	1	31	0	g	350040981000000002	29-60						Estrous cycle-dependent changes of Fas expression in the bovine corpus luteum: influence of keratin 8/18 intermediate filaments and cytokines	www.rbej.com	0	0		ACTC1
588	chr28	429029	429060	3500055266	31		429029	429060	8421504	1	31	0	g	350005526600000002	29-60		23113883	10.1186/1477-7827-10-90	1477-7827	Reproductive Biology and Endocrinology	Estrous cycle-dependent changes of Fas expression in the bovine corpus luteum: influence of keratin 8/18 intermediate filaments and cytokines	Duncan	2012	2		POTEM
588	chr28	429041	429065	3500336971	24		429041	429065	8421504	1	24	0	g	350033697100000009	0-24						Immune responses and gene expression in white shrimp, Litopenaeus vannamei, induced by Lactobacillus plantarum	rdms.npust.edu.tw	0	0		ACTA2
588	chr28	429148	429301	3500106263	48		429148	429301	8421504	2	18,30	0,123	p	350010626300015073	0-48						Protein modification method	Sato	1995	0		ACTG1
590	chr28	776780	776804	3500460464	23		776780	776804	8421504	2	13,10	0,14	g	350046046400000005	1-24						The Acyl-Acyl Carrier Protein Synthetase from Synechocystis sp. PCC6803 mediates Fatty Acid Import | Patrick Fink - Academia.edu	www.academia.edu	0	0		
592	chr28	929783	929810	3500295818	24		929783	929810	8421504	2	7,17	0,10	c	350029581800000001	6-36		19279666	10.1038/emboj.2009.49		The EMBO Journal	Coordination of dual incision and repair synthesis in human nucleotide excision repair	Lidija	2009	0		
598	chr28	1801007	1801036	3500061111	24		1801007	1801036	8421504	2	8,16	0,13	g	350006111100000009,350006111100000027	1-26,1-26						Novel Herbicide Resistance Genes - Patent application	www.faqs.org	0	0		
599	chr28	1899365	1899393	3500157069	25		1899365	1899393	8421504	2	16,9	0,19	g	350015706900000059	5-31						US Patent # 6,545,137. Receptor - Patents.com	www.patents.com	0	0		
599	chr28	1899365	1899393	3500025771	25		1899365	1899393	8421504	2	16,9	0,19	g	350002577100000059,350002577100000537	5-31,2-28						US Patent # 7,244,577. Method of screening for modulator of LRP5 activity - Patents.com	www.patents.com	0	0		
602	chr28	2342221	2342247	3500399667	26		2342221	2342247	8421504	1	26	0	c	350039966700000006	9-35						ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES	Clausen	2007	0		GALNT2
602	chr28	2342221	2342247	3500265908	26		2342221	2342247	8421504	1	26	0	c	350026590800000093,350026590800000006	9-35,9-35						Isolated Lectin Polypeptides Consisting Of Truncated Mammalian Udp-galnac:polypeptide N- Acetylgalactosaminyltransferases 	.freshpatents.com	0	0		
604	chr28	2580119	2580150	3500017979	26		2580119	2580150	8421504	3	15,3,8	0,19,23	g	350001797900000375	0-26						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
605	chr28	2704728	2704757	3500147499	23		2704728	2704757	8421504	3	4,6,13	0,5,16	g	350014749900000001	0-23					Patent	Genes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors (Patent US:5486602)	Gething	1996	0		
605	chr28	2731800	2731827	3500008756	23		2731800	2731827	8421504	3	11,5,7	0,14,20	g	350000875600000591	0-23						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
610	chr28	3312614	3312642	3500326993	25		3312614	3312642	8421504	3	14,6,5	0,16,23	g	350032699300000115	22-48						Nucleic Acid, Polypeptide and Its Use - Patent application	www.faqs.org	0	0		
616	chr28	4127807	4127831	3500199785	23		4127807	4127831	8421504	2	10,13	0,11	g	350019978500000131	0-23						Method For Identifying Progressive Rod-cone Degeneration In Dogs 	.freshpatents.com	0	0		
621	chr28	4795167	4795212	3500094837	45		4795167	4795212	8421504	1	45	0	c	350009483700000049	0-45						DISSERTATION submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences	uni-heidelberg.de	0	0		
622	chr28	4857407	4857434	3500366604	27		4857407	4857434	8421504	1	27	0	c	350036660400000001	0-27		9362344			American Journal of Physiology - Renal Physiology	Cloning and localization of a double-pore K channel, KCNK1: exclusive expression in distal nephron segments	Orias	1997	0		
622	chr28	4857407	4857434	3500179026	27		4857407	4857434	8421504	1	27	0	c	350017902600000001	0-27		9362344			American Journal of Physiology - Renal Physiology	Cloning and localization of a double-pore K channel, KCNK1: exclusive expression in distal nephron segments	Orias	1997	0		
633	chr28	6366755	6378669	3500402846	38		6366755	6378669	8421504	2	6,32	0,11882	c	350040284600000026,350040284600000027	23-61,0-38						Understanding ER-to-Mitochondria Trafficking of Proteins Using Human Cytomegalovirus UL37 Proteins	td.gelman.gwu.edu	0	0		
635	chr28	6582279	6582305	3500008545	23		6582279	6582305	8421504	2	17,6	0,20	g	350000854500000030,350000854500000020	0-23,0-23						ADAPTIVE MUTATIONS ALLOW ESTABLISHMENT OF JFH1-BASED CELL CULTURE SYSTEMS FOR HEPATITIS C VIRUS GENOTYPE 4A	Scheel	2008	0		
636	chr28	6780942	6780973	3500116881	25		6780942	6780973	8421504	3	15,3,7	0,19,24	c	350011688100000006,350011688100000046	10-35,10-35						CHIMERIC NON-HUMAN ANIMAL - Patent application	www.faqs.org	0	0		
638	chr28	6991359	6991385	3500103472	24		6991359	6991385	8421504	2	7,17	0,9	g	350010347200000011,350010347200000012	0-24,3-27						Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer - Patent #07491802	w.strutpatent.com	0	0		
9	chr28	7324189	7353411	3500448596	44		7324189	7353411	8421504	3	19,3,22	0,24107,29200	c	350044859600000025,350044859600000026	0-22,0-22						METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES	Brys	2011	0		GPR137B
9	chr28	7324189	7353411	3500400072	44		7324189	7353411	8421504	3	19,3,22	0,24107,29200	c	350040007200000025,350040007200000026	0-22,0-22						Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases	Brys	2006	0		
9	chr28	7324189	7353411	3500399289	44		7324189	7353411	8421504	3	19,3,22	0,24107,29200	c	350039928900000025,350039928900000026	0-22,0-22						Methods For Identification, and Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases	Brys	2009	0		
9	chr28	7324189	7353411	3500235187	44		7324189	7353411	8421504	3	19,3,22	0,24107,29200	c,g	350023518700000025,350023518700000026,350023518700000026	0-22,0-22,0-22					Patent	Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases (Patent US:7306923)	Brys	2007	0		
9	chr28	7324189	7353411	3500149044	44		7324189	7353411	8421504	3	19,3,22	0,24107,29200	c,g	350014904400000025,350014904400000026,350014904400000026	0-22,0-22,0-22					Patent	Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases (Patent US:7919259)	Brys	2011	0		
645	chr28	7889252	7889275	3500108622	23		7889252	7889275	8421504	1	23	0	c	350010862200000366	13-36						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
80	chr28	7968812	8078215	3500085562	822		7968812	8078215	8421504	25	42,51,36,30,53,12,32,6,27,11,26,48,47,41,6,42,63,20,48,47,35,20,38,36,5	0,87,7504,7552,10217,10275,12274,16148,16157,16953,16965,20384,31139,72533,72581,73611,73701,76798,85790,104125,105902,105989,108605,108692,109398	c	350008556200000106,350008556200000027,350008556200000108,350008556200000029,350008556200000111,350008556200000031,350008556200000032,350008556200000037,350008556200000038,350008556200000121,350008556200000049,350008556200000146,350008556200000147,350008556200000149,350008556200000069,350008556200000074,350008556200000084,350008556200000088,350008556200000170,350008556200000092,350008556200000094,350008556200000175	6-48,9-48,0-48,12-48,0-48,0-47,4-48,0-47,0-26,0-48,1-48,0-41,0-48,0-48,0-47,0-48,0-47,0-35,27-47,9-47,0-41,0-29						Methods and compositions for assaying analytes	Yuan	1999	0		
645	chr28	7979087	7985800	3500343655	45		7979087	7985800	8421504	3	12,12,21	0,1999,6692	c	350034365500000001,350034365500000007	0-24,0-21			10.1002/hep.20168	1527-3350	Hepatology	Hepatic transmethylation reactions in micropigs with alcoholic liver disease - Villanueva - 2004 - Hepatology - Wiley Online Library	Villanueva	2004	0		
646	chr28	8046788	8046851	3500402379	63		8046788	8046851	8421504	1	63	0	p	350040237900015113	87-150						AEROBIC MICROBIAL DEGRADATION OF CHLOROMETHANE	www.egbeck.de	0	0		MTR
646	chr28	8068559	8068585	3500296302	26		8068559	8068585	8421504	1	26	0	c	350029630200000000	0-26		21206701	10.4103/0971-6866.73405		Indian Journal of Human Genetics	Methionine synthase polymorphisms (MTR 2756 A>G and MTR 2758 C>G) frequencies and distribution in the Jordanian population and their correlation with neural tube defects in the population of the northern part of Jordan	Helmi	2010	0		
653	chr28	8971768	8971796	3500210728	23		8971768	8971796	8421504	3	4,12,7	0,5,21	g	350021072800000003	2-25						Method for producing the Nla III restriction endonuclease and methylase	Morgan	1990	0		
655	chr28	9178258	9182653	3500366733	679		9178258	9182653	8421504	11	141,106,39,9,48,137,55,28,20,30,66	0,342,1646,1991,2048,2266,2589,2692,3745,3813,4329	c,g	350036673300000366,350036673300000366,350036673300000365,350036673300000364,350036673300000363,350036673300000362,350036673300000360,350036673300000358,350036673300000355,350036673300000354,350036673300000353,350036673300000352,350036673300000350,350036673300000348,350036673300000347	0-55,0-55,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
655	chr28	9178258	9182653	3500193635	679		9178258	9182653	8421504	11	141,106,39,9,48,137,55,28,20,30,66	0,342,1646,1991,2048,2266,2589,2692,3745,3813,4329	c,g	350019363500000365,350019363500000365,350019363500000364,350019363500000363,350019363500000362,350019363500000361,350019363500000359,350019363500000357,350019363500000354,350019363500000353,350019363500000352,350019363500000351,350019363500000349,350019363500000347,350019363500000346	0-55,0-55,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Materials and methods for immunocontraception	Harris	1993	0		
655	chr28	9183576	9183600	3500261697	23		9183576	9183600	8421504	2	11,12	0,12	c	350026169700000078	11-48						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease	Potts	2001	0		
657	chr28	9566122	9566146	3500363214	23		9566122	9566146	8421504	2	4,19	0,5	g	350036321400000020	3-26						Plasmodium falciparum Enzymes Involved in Redox Balancing of Nicotinamide Nucleotides	ibrary.drexel.edu	0	0		
666	chr28	10645328	10645353	3500345519	23		10645328	10645353	8421504	2	6,17	0,8	g	350034551900000033	10-33						Intermediates And Enzymes Of The Non-mevalonate Isoprenoid Pathway 	.freshpatents.com	0	0		
666	chr28	10645328	10645353	3500313889	23		10645328	10645353	8421504	2	6,17	0,8	g	350031388900000033	10-33						INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY - Bacher, Adelbert	www.sumobrain.com	0	0		
666	chr28	10645328	10645353	3500161755	23		10645328	10645353	8421504	2	6,17	0,8	g	350016175500000033,350016175500000073	10-33,10-33						Intermediates and enzymes of the non-mevalonate isoprenoid pathway - Patent application	www.faqs.org	0	0		
666	chr28	10645328	10645353	3500154987	23		10645328	10645353	8421504	2	6,17	0,8	g	350015498700000033	10-33						Intermediates and enzymes of the non-mevalonate isoprenoid pathway	Bacher	2002	0		
666	chr28	10696781	10696804	3500203377	23		10696781	10696804	8421504	1	23	0	c	350020337700000009	0-23		18521086	10.1038/onc.2008.151	0950-9232	Oncogene	Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-&#x03b1; transactivation	Talukder	2008	6		
671	chr28	11321631	11321660	3500383915	26		11321631	11321660	8421504	2	18,8	0,21	g	350038391500000266	0-26						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
671	chr28	11344790	11345424	3500444770	43		11344790	11345424	8421504	2	22,21	0,613	c	350044477000000005,350044477000000006	0-22,0-21						Impaired gastric acid secretion in gastrin-deficient mice	gi.physiology.org	0	0		CHRM3
671	chr28	11345410	11346287	3500378152	91		11345410	11346287	8421504	3	23,23,45	0,131,832	p,c	350037815200000001,350037815200000002,350037815200015005,350037815200000003	8-31,8-32,0-45,0-21				0798-0469	Revista de la Facultad de Medicina	Revista de la Facultad de Medicina - Clonamiento Molecular de las Asas Intracelulares de los receptores Muscar&#xed;nicos M2 y M3 implicadas en la interacci&#xf3;n con Prote&#xed;nas G en el M&#xfa;sculo Liso Traqueal de Bovino	Bruges	2002	0		
671	chr28	11345549	11345597	3500230939	48		11345549	11345597	8421504	1	48	0	p	350023093900015017	0-48						Identification Of Ligands By Selective Amplification Of Cells Transfected With Receptors 	.freshpatents.com	0	0		CHRM3
671	chr28	11345552	11345597	3500322678	45		11345552	11345597	8421504	1	45	0	p	350032267800015017	0-45						US Patent # 7,425,420. Identification of ligands by selective amplification of cells transfected with a 5HT2A receptor - Patents.com	www.patents.com	0	0		CHRM3
671	chr28	11345552	11345597	3500188848	45		11345552	11345597	8421504	1	45	0	p	350018884800015020	0-45						IDENTIFICATION OF LIGANDS BY SELECTIVE AMPLIFICATION OF CELLS TRANSFECTED WITH RECEPTORS - Patent application	www.faqs.org	0	0		CHRM3
671	chr28	11346380	11346537	3500420363	40		11346380	11346537	8421504	2	20,20	0,137	c,g	350042036300000022,350042036300000022,350042036300000023	0-20,0-20,0-20						Jennifer Bohls thesis Final edits July 8	hsl.umaryland.edu	0	0		CHRM3
671	chr28	11378038	11378064	3500213165	23		11378038	11378064	8421504	2	13,10	0,16	g	350021316500000018	0-23						COMPOSITIONS AND METHODS FOR REGULATING POLYSACCHARIDES OF A PLANT CELL - Patent application	www.faqs.org	0	0		
675	chr28	11856882	11856906	3500271816	23		11856882	11856906	8421504	2	5,18	0,6	g	350027181600000001	13-36						ScienceDirect.com - Immunobiology - Engagement of heterogeneous nuclear ribonucleoprotein M with listeriolysin O induces type I interferon expression and restricts Listeria monocytogenes growth in host cells	sciencedirect.com	0	0		
677	chr28	12150371	12150396	3500052549	23		12150371	12150396	8421504	2	12,11	0,14	c	350005254900000444	10-34						 Compositions Against SARS 	www.docstoc.com	0	0		
677	chr28	12159224	12159249	3500360215	25		12159224	12159249	8421504	1	25	0	c	350036021500000005	19-44					Patent	Compounds and methods for development of Ret modulators (Patent US:8067434)	Artis	2011	0		
677	chr28	12159224	12159249	3500325527	25		12159224	12159249	8421504	1	25	0	c	350032552700000005	19-44						Compounds and methods for development of RET modulators	Ibrahim	2006	0		
677	chr28	12159224	12159249	3500052438	25		12159224	12159249	8421504	1	25	0	c	350005243800000005	19-44					Patent	Compounds and methods for development of Ret modulators (Patent US:8067434)	Artis	2011	0		
677	chr28	12163354	12164972	3500406372	225		12163354	12164972	8421504	7	52,5,57,21,39,27,24	0,1246,1254,1398,1422,1546,1594	p	350040637200015012	0-240						Compounds and methods for development of ret modulators	Ibrahim	2005	0		
677	chr28	12163399	12164638	3500084824	45		12163399	12164638	8421504	2	7,38	0,1201	p	350008482400015109	0-45						OVER-EXPRESSION AND MUTATION OF A TYROSINE KINASE RECEPTOR FGFR4 IN TUMORS - Patent application	www.faqs.org	0	0		RET
677	chr28	12164975	12167150	3500004352	63		12164975	12167150	8421504	2	45,18	0,2157	p	350000435200015007	0-63						Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity. - ResearchGate	.researchgate.net	0	0		RET
677	chr28	12167174	12168482	3500324787	60		12167174	12168482	8421504	2	29,31	0,1277	p	350032478700015046	0-60						ppendix 1	tations.ub.rug.nl	0	0		
677	chr28	12167174	12168482	3500043024	60		12167174	12168482	8421504	2	29,31	0,1277	p	350004302400015046	0-60						The RET gene and its associated diseases	tations.ub.rug.nl	0	0		
677	chr28	12167189	12168482	3500229609	45		12167189	12168482	8421504	2	14,31	0,1262	p	350022960900015105	0-45						ANTITUMOR AGENT FOR THYROID CANCER - Patent application	www.faqs.org	0	0		
677	chr28	12167189	12168482	3500132191	45		12167189	12168482	8421504	2	14,31	0,1262	p	350013219100015060	0-45						METHOD FOR EVALUATING PATIENTS FOR TREATMENT WITH DRUGS TARGETING RET RECEPTOR TYROSINE KINASE - Patent application	www.faqs.org	0	0		
677	chr28	12171351	12171375	3500027759	24		12171351	12171375	8421504	1	24	0	c	350002775900000001	8-32		16849418	10.1210/jc.2005-2845	0021-972X	Journal of Clinical Endocrinology & Metabolism	An Orally Administered Multitarget Tyrosine Kinase Inhibitor, SU11248, Is a Novel Potent Inhibitor of Thyroid Oncogenic RET/Papillary Thyroid Cancer Kinases	Kim	2006	6		RET
678	chr28	12248500	12248560	3500224129	60		12248500	12248560	8421504	1	60	0	p	350022412900015012	0-60						Homo sapiens RasGEF domain family, member 1A (RASGEF1A), mRNA. , NM_145313.1 - GenScript	www.genscript.com	0	0		
678	chr28	12273769	12273796	3500430989	23		12273769	12273796	8421504	2	15,8	0,19	g	350043098900000495	7-37						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
679	chr28	12359473	12359498	3500141019	24		12359473	12359498	8421504	2	4,20	0,5	g	350014101900000010	4-30						Obligate Biotroph Uromyces fabae and Analysis of Expression Patterns of Host and Pathogen Invertases in the Course of Infection	b.uni-konstanz.de	0	0		
680	chr28	12457787	12457832	3500079754	45		12457787	12457832	8421504	1	45	0	p	350007975400015207	0-45						Heparanase Specific Molecular Probes And Their Use In Research And Medical Applications 	.freshpatents.com	0	0		HNRNPF
680	chr28	12461531	12461557	3500439461	25		12461531	12461557	8421504	2	19,6	0,20	c	350043946100000026	12-37						Method of inhibiting prostaglandin synthesis in a human host	Young	1995	0		
680	chr28	12461531	12461557	3500412505	25		12461531	12461557	8421504	2	19,6	0,20	c	350041250500000025	12-37						US Patent # 5,837,479. Screening assays for inhibitors of mammalian prostaglandin H synthase-2 - Patents.com	www.patents.com	0	0		
680	chr28	12461531	12461557	3500380718	25		12461531	12461557	8421504	2	19,6	0,20	c	350038071800000026	12-37						Mammalian prostaglandin h synthase-2	O'Banion	1996	0		
680	chr28	12461533	12461557	3500340990	23		12461533	12461557	8421504	2	17,6	0,18	c	350034099000000004	1-24		16861639	10.1128/IAI.01938-05	0019-9567	Infection and Immunity	Signal Transduction, Gene Transcription, and Cytokine Production Triggered in Macrophages by Exposure to Trypanosome DNA	Harris	2006	4		
680	chr28	12461533	12461557	3500278074	23		12461533	12461557	8421504	2	17,6	0,18	c	350027807400000004	1-24		16861639	10.1128/IAI.01938-05	0019-9567	Infection and Immunity	Signal Transduction, Gene Transcription, and Cytokine Production Triggered in Macrophages by Exposure to Trypanosome DNA	Harris	2006	4		
680	chr28	12495415	12495443	3500299253	24		12495415	12495443	8421504	2	18,6	0,22	g	350029925300000003	22-46		22438533	10.1128/JVI.06597-11	0022-538X	Journal of Virology	HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors	Boyer	2012	5		
683	chr28	12935372	12935398	3500085444	24		12935372	12935398	8421504	2	17,7	0,19	g	350008544400000004	9-33						Vaccins vivants recombines et adjuves	Audonnet	2000	0		
688	chr28	13570115	13570142	3500314365	24		13570115	13570142	8421504	3	5,4,15	0,7,12	g	350031436500000000	15-39						Nucleic acid probes for detection and/or quantitation of non-viral organisms	Hogan	1988	0		
688	chr28	13577855	13577882	3500047637	23		13577855	13577882	8421504	2	17,6	0,21	g	350004763700000544	12-37						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
695	chr28	14439532	14459062	3500163290	40		14439532	14459062	8421504	2	20,20	0,19510	c,g	350016329000000005,350016329000000005,350016329000000004	0-20,0-20,0-20						Research Paper Functional genomics analysis of low concentration of ethanol in human hepatocellular carcinoma (HepG2) cells. Role of genes involved in transcriptional and translational processes	www.medsci.org	0	0		ANK3
695	chr28	14461969	14462046	3500069611	40		14461969	14462046	8421504	2	20,20	0,57	c,g	350006961100000025,350006961100000025,350006961100000024,350006961100000024	0-20,0-20,0-20,0-20						Trabecular Meshwork Stem Cells	Du	2012	0		ANK3
695	chr28	14461969	14462046	3500053949	40		14461969	14462046	8421504	2	20,20	0,57	c,g	350005394900000025,350005394900000025,350005394900000024,350005394900000024	0-20,0-20,0-20,0-20						Trabecular Meshwork Stem Cells	Du	2012	0		ANK3
698	chr28	14910939	14910965	3500272162	24		14910939	14910965	8421504	2	15,9	0,17	g	350027216200000013	14-39						Isociatrate dehydrogenase and uses therof - Patent application	www.faqs.org	0	0		
700	chr28	15098631	15098657	3500160249	23		15098631	15098657	8421504	2	7,16	0,10	g	350016024900000242	9-32						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN - Patent application	www.faqs.org	0	0		
701	chr28	15274722	15274751	3500241875	25		15274722	15274751	8421504	2	6,19	0,10	g	350024187500000227	10-35					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
701	chr28	15274722	15274751	3500070088	25		15274722	15274751	8421504	2	6,19	0,10	g	350007008800000227	10-35						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
701	chr28	15318930	15329933	3500118294	68		15318930	15329933	8421504	3	20,24,24	0,9164,10979	c,g	350011829400000010,350011829400000019,350011829400000020	0-20,0-24,0-24		21930790	10.1128/MCB.05574-11	0270-7306	Molecular and Cellular Biology	TopBP1 Mediates Mutant p53 Gain of Function through NF-Y and p63/p73	Liu	2011	6		
701	chr28	15321491	15332363	3500351139	426		15321491	15332363	8421504	7	37,118,26,5,2,139,99	0,2341,8189,8220,8336,8339,10773	c	350035113900000095	0-563						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		CDK1
701	chr28	15321491	15332360	3500034953	627		15321491	15332360	8421504	11	37,68,17,94,90,6,105,53,37,24,96	0,2341,2481,3284,6478,6643,8061,8172,8336,8454,10773	p	350003495300015032,350003495300015044,350003495300015045,350003495300015061,350003495300015072,350003495300015073,350003495300015088	0-105,0-48,3-66,0-90,0-111,0-90,0-120						Proc. Nati. Acad. Sci. USA	www.pnas.org	0	0		CDK1
701	chr28	15321491	15332360	3500002923	891		15321491	15332360	8421504	7	37,157,124,171,164,142,96	0,2341,3284,6478,8061,8336,10773	p	350000292300015000,350000292300015001	0-891,0-720						Methods, Compositions and Kits for Use in Prognosis, Characterization and Treatment of Cancer	Lin	2006	0		
701	chr28	15321491	15327999	3500074445	336		15321491	15327999	8421504	6	37,11,30,104,124,30	0,2341,2358,2394,3284,6478	p	350007444500015001	0-342						Methods, compositions and kits for use in prognosis, characterization and treatment of cancer	Lin	2007	0		
701	chr28	15323908	15328112	3500202321	41		15323908	15328112	8421504	2	21,20	0,4184	c	350020232100000022,350020232100000023	0-21,0-20						PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling	biomedcentral.com	0	0		CDK1
701	chr28	15323919	15323942	3500344084	23		15323919	15323942	8421504	1	23	0	c	350034408400000002,350034408400000003	0-21,0-21		20808790	10.1371/journal.pone.0012341	1932-6203	PLOS ONE	PLOS ONE: Cyclin B1/Cdk1 Phosphorylation of Mitochondrial p53 Induces Anti-Apoptotic Response	Nantajit	2010	4		CDK1
701	chr28	15324788	15329639	3500130364	41		15324788	15329639	8421504	2	20,21	0,4830	c,g	350013036400000002,350013036400000002,350013036400000003	0-20,0-20,0-21						ScienceDirect.com - Cancer Letters - Kaempferol-7-O-&#x03b2;-d-glucoside (KG) isolated from Smilax china L. rhizome induces G2/M phase arrest and apoptosis on HeLa cells in a p53-independent manner	sciencedirect.com	0	0		CDK1
701	chr28	15324859	15329622	3500158166	40		15324859	15329622	8421504	2	19,21	0,4742	c	350015816600000000,350015816600000001	0-19,0-21						&#x9ec4;&#x725b;&#x3001;&#x7266;&#x725b;&#x548c;&#x728f;&#x725b;&#x777e;&#x4e38;&#x7ec4;&#x7ec7;&#x4e2d; Cdc2 Cdc25A &#x57fa;&#x56e0;	www.chinagene.cn	0	0		
701	chr28	15324893	15332360	3500276688	579		15324893	15332360	8421504	5	6,171,164,142,96	0,3076,4659,4934,7371	p	350027668800015034,350027668800015035	318-504,180-1128						MOLECULAR GENETIC TECHNIQUES AND GENOMICS	cencia.izt.uam.mx	0	0		CDK1
701	chr28	15328122	15329942	3500310260	96		15328122	15329942	8421504	3	18,30,48	0,1430,1772	p	350031026000015056,350031026000015078	0-48,0-48						Interaction trap system for isolating novel proteins	Brent	1994	0		CDK1
701	chr28	15329678	15332373	3500237078	40		15329678	15332373	8421504	2	20,20	0,2675	c,g	350023707800000000,350023707800000001,350023707800000001	0-20,0-20,0-20		20463006	10.1124/jpet.109.165415	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	MJ-29 Inhibits Tubulin Polymerization, Induces Mitotic Arrest, and Triggers Apoptosis via Cyclin-Dependent Kinase 1-Mediated Bcl-2 Phosphorylation in Human Leukemia U937 Cells	Yang	2010	0		CDK1
701	chr28	15329709	15332310	3500009081	40		15329709	15332310	8421504	3	7,13,20	0,118,2581	c	350000908100000010,350000908100000011	0-20,0-20						Prostate Cancer Treatment With Glycogen Synthase Kinase-3beta Inhibitors 	.freshpatents.com	0	0		CDK1
701	chr28	15329709	15332310	3500006015	40		15329709	15332310	8421504	3	7,13,20	0,118,2581	c	350000601500000000,350000601500000001	0-20,0-20						PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1. - ResearchGate	.researchgate.net	0	0		CDK1
701	chr28	15329858	15332294	3500423707	77		15329858	15332294	8421504	3	26,26,25	0,50,2411	c	350042370700000000,350042370700000002,350042370700000001	0-26,0-26,0-25			10.1111/j.1365-2141.2004.05344.x	1365-2141	British Journal of Haematology	Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia - Dickinson - 2005 - British Journal of Haematology - Wiley Online Library	Dickinson	2005	0		CDK1
701	chr28	15329858	15329942	3500307465	74		15329858	15329942	8421504	3	24,28,22	0,32,62	c	350030746500000003,350030746500000040,350030746500000005,350030746500000042,350030746500000004,350030746500000041	0-24,0-24,0-28,0-28,0-22,0-22						CRUDE BIOLOGICAL DERIVATIVES COMPETENT FOR NUCLEIC ACID DETECTION - Patent application	www.faqs.org	0	0		
701	chr28	15329914	15332315	3500028888	41		15329914	15332315	8421504	2	21,20	0,2381	c	350002888800000004,350002888800000005	0-21,0-20		18566237	10.1158/1535-7163.MCT-08-0193	1535-7163	Molecular Cancer Therapeutics	Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid	Domhan	2008	5		CDK1
701	chr28	15329920	15332393	3500047878	40		15329920	15332393	8421504	2	20,20	0,2453	c,g	350004787800000020,350004787800000020,350004787800000021,350004787800000021	0-20,0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
701	chr28	15329949	15332334	3500388350	45		15329949	15332334	8421504	2	20,25	0,2360	c,g	350038835000000062,350038835000000062,350038835000000063,350038835000000063	0-20,0-20,0-25,0-25						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
701	chr28	15329949	15332334	3500357446	45		15329949	15332334	8421504	2	20,25	0,2360	c,g	350035744600000009,350035744600000010,350035744600000010	0-20,0-25,0-25						Spatio-Temporal Expression Patterns of Aurora Kinases A, B, and C and Cytoplasmic Polyadenylation-Element-Binding Protein in Bovine Oocytes During Meiotic Maturation	ww.biolreprod.org	0	0		
701	chr28	15329949	15332334	3500027904	45		15329949	15332334	8421504	2	20,25	0,2360	c	350002790400000037,350002790400000038	0-20,0-25						 SpringerImages - primers sequences 	pringerimages.com	0	0		
701	chr28	15332272	15332323	3500103064	50		15332272	15332323	8421504	2	23,27	0,24	c	350010306400000006,350010306400000008	0-23,0-27					The American Journal of Pathology	Insulin-Like Growth Factor-Binding Protein 3 Expression Increases during Immortalization of Cervical Keratinocytes by Human Papillomavirus Type 16 E6 and E7 Proteins	Allison	2002	0		CDK1
703	chr28	15486526	15486549	3500070088	23		15486526	15486549	8421504	1	23	0	g	350007008800000406	12-35						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
710	chr28	16492306	16492332	3500081021	25		16492306	16492332	8421504	2	6,19	0,7	g	350008102100000097	3-28						A method for detection of alterations in the dna mismatch repair pathway	Fishel	1995	0		
722	chr28	18012238	18012263	3500195624	25		18012238	18012263	8421504	1	25	0	g	350019562400000021	8-33						Rational directed protein evolution using two-dimensional rational mutagenesis scanning	Drittanti	2006	0		
723	chr28	18165998	18166484	3500465380	46		18165998	18166484	8421504	2	26,20	0,466	c	350046538000000005,350046538000000004	8-34,0-20						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	quantification.de	0	0		
723	chr28	18165998	18166484	3500011924	46		18165998	18166484	8421504	2	26,20	0,466	c,g	350001192400000005,350001192400000005,350001192400000004	8-34,8-34,0-20						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	qpcrupdate.net	0	0		
726	chr28	18493493	18581132	3500388628	525		18493493	18581132	8421504	8	32,73,45,26,121,114,12,102	0,48749,75424,75475,78774,79072,87516,87537	p	350038862800015069,350038862800015071,350038862800015073,350038862800015075,350038862800015072	0-63,0-51,0-51,0-447,0-51						123 human secreted proteins	Brewer	1999	0		REEP3
726	chr28	18493493	18581132	3500163563	525		18493493	18581132	8421504	8	32,73,45,26,121,114,12,102	0,48749,75424,75475,78774,79072,87516,87537	p	350016356300015069,350016356300015071,350016356300015073,350016356300015075,350016356300015072	0-63,0-51,0-51,0-447,0-51						123 human secreted proteins	Brewer	2000	0		REEP3
726	chr28	18542255	18572642	3500374916	95		18542255	18572642	8421504	2	48,47	0,30340	c	350037491600000055,350037491600000061	0-48,0-47						Autism Genes And Regulated Secretion 	.freshpatents.com	0	0		
731	chr28	19164111	19164138	3500337630	23		19164111	19164138	8421504	2	10,13	0,14	g	350033763000000018,350033763000000003	13-36,12-33		18641141	10.1128/JB.00467-08	0021-9193	Journal of Bacteriology	Impassable YscP Substrates and Their Impact on the Yersinia enterocolitica Type III Secretion Pathway	Riordan	2008	4		
746	chr28	21217172	21217374	3500337980	51		21217172	21217374	8421504	2	27,24	0,178	g	350033798000000061	5-208						GENERATION AND CHARACTERIZATION OF ANTI-NOTCH ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC USE - Patent application	www.faqs.org	0	0		
746	chr28	21217350	21217376	3500013789	26		21217350	21217376	8421504	1	26	0	g	350001378900000201	114-140						Methods for using canine immunoglobulin variable domains and caninized antibodies	Krah	2002	0		
750	chr28	21675317	21675346	3500108622	26		21675317	21675346	8421504	3	5,13,8	0,6,21	g	350010862200000310	0-26						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
755	chr28	22351336	22351361	3500465169	23		22351336	22351361	8421504	3	7,12,4	0,8,21	g	350046516900000095	12-37						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
762	chr28	23244780	23244805	3500433412	25		23244780	23244805	8421504	1	25	0	c	350043341200000040	17-42						NOVEL $g(a)-CATENIN EXPRESSED IN HEART AND TESTIS - Vlaams, Interuniversitair Instituut Voor Biotechnologie Vzw	www.sumobrain.com	0	0		
764	chr28	23558862	23562684	3500361312	43		23558862	23562684	8421504	2	22,21	0,3801	c,g	350036131200000051,350036131200000052,350036131200000052	0-22,0-21,0-21						Tumour associated antigens	Banham	2004	0		SIRT1
764	chr28	23558929	23559835	3500454426	31		23558929	23559835	8421504	2	12,19	0,887	c	350045442600000010,350045442600000011	10-41,0-29		18687677	10.1074/jbc.M805711200		The Journal of Biological Chemistry	SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1: POSSIBLE ROLE IN AMP-ACTIVATED PROTEIN KINASE ACTIVATION*S&#x20de;	Fan	2008	0		
764	chr28	23566176	23566199	3500387324	23		23566176	23566199	8421504	1	23	0	c	350038732400000064	23-46						Recombinant fowlpox vaccine for protection against Marek's disease - US Patent 5369025 Description	ww.patentstorm.us	0	0		
764	chr28	23566241	23566361	3500106980	43		23566241	23566361	8421504	2	21,22	0,98	c,g	350010698000000000,350010698000000000,350010698000000001	0-21,0-21,0-22						Differential gene expression of bovine intramuscular and subcutaneous preadipocytes during differentiation*	www.ighz.edu.pl	0	0		
764	chr28	23566423	23566448	3500103540	25		23566423	23566448	8421504	1	25	0	c	350010354000000003	11-36						Terri,2007	www.scribd.com	0	0		SIRT1
766	chr28	23761951	23761977	3500220271	23		23761951	23761977	8421504	2	6,17	0,9	g	350022027100000014	3-26						Cell Individuality in Adhesin Expression of Candida glabrata	.nottingham.ac.uk	0	0		
767	chr28	23926802	23928276	3500130191	42		23926802	23928276	8421504	2	23,19	0,1455	c,g	350013019100000180,350013019100000181,350013019100000181	0-23,0-19,0-19						Function of Splicing factor Tra2-beta1 in Alternative Splicing and Translation	b.uni-erlangen.de	0	0		HNRNPH3
767	chr28	23931943	23931975	3500033164	27		23931943	23931975	8421504	2	10,17	0,15	c	350003316400000011	13-40		20089835	10.1091/mbc.E09-09-0814	1059-1524	Molecular Biology of the Cell	Role of the Second Cysteine-rich Domain and Pro275 in Protein Kinase D2 Interaction with ADP-Ribosylation Factor 1, Trans-Golgi Network Recruitment, and Protein Transport	Pusapati	2010	5		
768	chr28	24002894	24002917	3500201852	23		24002894	24002917	8421504	1	23	0	c	350020185200000080	2-44						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
768	chr28	24039349	24044112	3500244017	23		24039349	24044112	8421504	2	6,17	0,4746	c	350024401700000034,350024401700000032	0-21,0-20						Regions of papilloma virus e1 helicase involved in e1 oligomerization	Archambault	2000	0		
768	chr28	24039349	24044112	3500193739	23		24039349	24044112	8421504	2	6,17	0,4746	c	350019373900000034,350019373900000032	0-21,0-20						Regions of papilloma virus E1 helicase involved in E1 oligomerization	Archambault	2005	0		SLC25A16
768	chr28	24056372	24056407	3500089026	30		24056372	24056407	8421504	2	7,23	0,12	c	350008902600000025	15-47						Recombinant equine herpesviruses	Cochran	1994	0		
768	chr28	24076881	24076906	3500399857	23		24076881	24076906	8421504	2	10,13	0,12	g	350039985700000081	24-47						 Glycosyltransferases For Biosynthesis Of Oligosaccharides, And Genes Encoding Them 	www.docstoc.com	0	0		
770	chr28	24251896	24257122	3500275789	26		24251896	24257122	8421504	3	13,1,12	0,14,5214	c	350027578900000003	14-40						Methods and compounds for the diagnosis and treatment of	Coverley	2012	0		
770	chr28	24335856	24335881	3500153072	23		24335856	24335881	8421504	2	18,5	0,20	c	350015307200000015	11-34		20179150	10.1261/rna.2007310	1355-8382	RNA	Genetic identification of potential RNA-binding regions in a group II intron-encoded reverse transcriptase	Gu	2010	5		
773	chr28	24730751	24730774	3500220169	23		24730751	24730774	8421504	1	23	0	g	350022016900000004	0-41		18694522	10.1186/1756-9966-27-27	1756-9966	Journal of Experimental & Clinical Cancer Research	siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells	Hao	2008	2		
96	chr28	24870830	24922117	3500208379	2690		24870830	24922117	8421504	17	165,149,120,96,100,184,156,234,305,149,120,96,100,184,156,234,142	0,12168,17984,20089,20779,20991,27541,30417,33407,34612,35067,36862,38761,43737,45991,49316,51145	p	350020837900015004	61-2751						Alinhamento de sequ&#xea;ncias	2.bioqmed.ufrj.br	0	0		
96	chr28	24870830	24922117	3500100732	2690		24870830	24922117	8421504	17	165,149,120,96,100,184,156,234,305,149,120,96,100,184,156,234,142	0,12168,17984,20089,20779,20991,27541,30417,33407,34612,35067,36862,38761,43737,45991,49316,51145	p	350010073200015000	61-2751						Biologia Molecular, revis&#xe3;o do conte&#xfa;do	2.bioqmed.ufrj.br	0	0		
775	chr28	24904273	24904298	3500026051	23		24904273	24904298	8421504	2	9,14	0,11	c	350002605100000004	2-25		23762395	10.1371/journal.pone.0065556	1932-6203	PLOS ONE	PLOS ONE: AIB1 Cooperates with ER&#x03b1; to Promote Epithelial Mesenchymal Transition in Breast Cancer through SNAI1 Activation	Wang	2013	4		
775	chr28	24916867	24916891	3500295949	24		24916867	24916891	8421504	1	24	0	c	350029594900000059	18-42						Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness	path.slu.edu	0	0		
775	chr28	24925231	24928734	3500318824	42		24925231	24928734	8421504	3	19,8,15	0,20,3488	c	350031882400000006,350031882400000007	28-47,0-23						Hemokinin-1 Gene Expression Is Upregulated in Microglia Activated by Lipopolysaccharide through NF-&#x03ba;B and p38 MAPK Signaling Pathways - Keeping the Faith	pthefaith1296.com	0	0		
775	chr28	24935752	24935821	3500430436	69		24935752	24935821	8421504	1	69	0	p	350043043600015011	0-69						Synthetic Hyperglycosylated, And Hyperglycosylated Protease-resistant Polypeptide Variants, Oral Formulations And Methods Of Using The Same 	.freshpatents.com	0	0		TACR2
775	chr28	24935752	24935821	3500285885	69		24935752	24935821	8421504	1	69	0	p	350028588500015011	0-69						<HTML> <HEAD><META HTTP-EQUIV='Expires' CONTENT='Tue, 01 Jan 1980 1:00:00 GMT'><META HTTP-EQUIV='	bd.patent.su	0	0		TACR2
775	chr28	24935752	24935821	3500270565	69		24935752	24935821	8421504	1	69	0	p	350027056500015011	0-69						SYNTHETIC HYPERGLYCOSYLATED, PROTEASE-RESISTANT POLYPEPTIDE VARIANTS, ORAL FORMULATIONS AND METHODS OF USING THE SAME - Patent application	www.faqs.org	0	0		TACR2
775	chr28	24935752	24935821	3500233849	69		24935752	24935821	8421504	1	69	0	p	350023384900015015	0-69						Hyperglycosylated polypeptide variants and methods of use	Blatt	2006	0		TACR2
775	chr28	24935752	24935821	3500193559	69		24935752	24935821	8421504	1	69	0	p	350019355900015013	0-69						Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same	Hong	2006	0		TACR2
776	chr28	25063381	25063405	3500383241	24		25063381	25063405	8421504	1	24	0	g	350038324100000000	0-24						Nature.October.2.2008	www.docstoc.com	0	0		NEUROG3
776	chr28	25064277	25064303	3500125982	26		25064277	25064303	8421504	1	26	0	g	350012598200000009	5-31		11334435	10.2337/diabetes.50.5.928	0012-1797	Diabetes	Regulation of the Pancreatic Pro-Endocrine Gene Neurogenin3	Lee	2001	8		
776	chr28	25117979	25118009	3500332026	27		25117979	25118009	8421504	2	12,15	0,15	g	350033202600000189	11-38						Methods for Detecting Epigenetic Modifications - Patent application	www.faqs.org	0	0		
778	chr28	25333617	25333644	3500409992	24		25333617	25333644	8421504	2	9,15	0,12	g	350040999200000011	12-36					Patent	Methods of producing recombinant insulin from novel fused proteins (Patent US:6841361)	Oka	2005	0		
779	chr28	25547333	25547357	3500164761	24		25547333	25547357	8421504	1	24	0	g	350016476100000002	0-24			10.1182/blood-2003-10-3458		Blood	The hydroxyurea-induced small GTP-binding protein SAR modulates &#x03b3;-globin gene expression in human erythroid cells	Delia	2005	0		
781	chr28	25772308	25792736	3500343565	360		25772308	25792736	8421504	3	145,186,29	0,19248,20399	p	350034356500015007,350034356500015024,350034356500015023	0-174,0-186,0-186						C&#xe9;line Brochier 04.91.1.64.75 Celine.brochier@up.univ-mrs.fr http://http://194.57.197.233:800/	.igmors.u-psud.fr	0	0		EIF4EBP2
781	chr28	25772311	25792715	3500073111	258		25772311	25792715	8421504	5	48,46,20,136,8	0,96,19235,19295,20396	c,g	350007311100000347,350007311100000349,350007311100000038,350007311100000351,350007311100000352,350007311100000353	0-48,0-48,0-20,0-48,0-48,0-48						MODULATION OF EIF4E-BP2 EXPRESSION - Patent application	www.faqs.org	0	0		
781	chr28	25772362	25792739	3500045715	137		25772362	25792739	8421504	4	45,20,48,24	0,19184,19244,20353	c,g	350004571500000346,350004571500000038,350004571500000349,350004571500000366	0-45,0-20,0-48,0-24						Modulation of eIF4E-BP2 expression - US Patent 7468431 Description	ww.patentstorm.us	0	0		
781	chr28	25792712	25792739	3500385256	27		25792712	25792739	8421504	1	27	0	c	350038525600000368	0-27						MODULATION OF EIF4E-BP2 EXPRESSION - Patent application	www.faqs.org	0	0		
781	chr28	25802515	25804886	3500106460	71		25802515	25804886	8421504	2	23,48	0,2323	c	350010646000000023,350010646000000008	15-38,0-48						Bone morphogenetic protein-16 (bmp-16) compositions	Celeste	1999	0		
781	chr28	25804838	25804886	3500219605	48		25804838	25804886	8421504	1	48	0	c	350021960500000008	0-48					Patent	Nucleic acids encoding bone morphogenic protein-16 (BMP-16) (Patent US:5965403)	Celeste	1999	0		
783	chr28	25960950	25962379	3500399012	40		25960950	25962379	8421504	2	20,20	0,1409	c,g	350039901200000008,350039901200000008,350039901200000007,350039901200000007	0-20,0-20,0-20,0-20		15294977		0022-1767	The Journal of Immunology	Characterization of Bovine Homologues of Granulysin and NK-lysin	Endsley	2004	6		
783	chr28	25997413	25997436	3500196852	23		25997413	25997436	8421504	1	23	0	g	350019685200000111,350019685200000043	2-39,11-48						TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF OPTIC NEURITIS - Patent application	www.faqs.org	0	0		
784	chr28	26192225	26200043	3500104818	44		26192225	26200043	8421504	2	25,19	0,7799	c	350010481800000088,350010481800000141	19-44,7-26						COMPOSITIONS AND METHODS FOR PROTECTION AGAINST CARDIAC AND/OR CENTRAL NERVOUS SYSTEM TISSUE INJURY BY INHIBITING SPHINGOSINE-1-PHOSPHATE LYASE - Patent application	www.faqs.org	0	0		
785	chr28	26277960	26277984	3500423257	23		26277960	26277984	8421504	2	13,10	0,14	g	350042325700000051	12-42						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
787	chr28	26584400	26584426	3500326924	23		26584400	26584426	8421504	3	5,4,14	0,7,12	g	350032692400000472	1-24						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
788	chr28	26689064	26689095	3500075814	27		26689064	26689095	8421504	3	4,14,9	0,5,22	g	350007581400000013	4-31						Methods and nucleic acids for analyses of cellular proliferative disorders	Distler	2009	0		
788	chr28	26689349	26689374	3500061438	24		26689349	26689374	8421504	2	12,12	0,13	g	350006143800000030	10-34						Method for detection of metastatic prostate cancer	Klee	1998	0		
789	chr28	26779003	26779035	3500108622	26		26779003	26779035	8421504	3	8,13,5	0,12,27	g	350010862200000082	3-29						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
790	chr28	26906233	26906257	3500430509	23		26906233	26906257	8421504	2	8,15	0,9	g	350043050900000007	21-44						 DNA Encoding Neospora Dihydrofolate Reductase 	www.docstoc.com	0	0		
790	chr28	26996780	26996807	3500179898	23		26996780	26996807	8421504	2	12,11	0,16	g	350017989800000014	0-23						Journal of Microbiological Methods	005.pasteur.ac.ir	0	0		
791	chr28	27037423	27037451	3500130848	25		27037423	27037451	8421504	2	12,13	0,15	g	350013084800000369	8-44						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
792	chr28	27143773	27148629	3500065941	180		27143773	27148629	8421504	2	108,72	0,4784	p	350006594100015019	0-180						Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts	.uni-tuebingen.de	0	0		CDH23
792	chr28	27178429	27178783	3500375699	353		27178429	27178783	8421504	2	13,340	0,14	g	350037569900000041	0-354						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
792	chr28	27239652	27239678	3500075252	26		27239652	27239678	8421504	1	26	0	c	350007525200000100	14-40						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
792	chr28	27239789	27240181	3500441527	66		27239789	27240181	8421504	2	12,54	0,338	p	350044152700015009	0-66						Methods of alleviating neuropathic pain	O'brien	2003	0		
792	chr28	27240133	27240178	3500156211	45		27240133	27240178	8421504	1	45	0	p	350015621100015015	0-45						&#x0421;&#x043f;&#x043e;&#x0441;&#x043e;&#x0431; &#x0432;&#x043e;&#x0437;&#x0434;&#x0435;&#x0439;&#x0441;&#x0442;&#x0432;&#x0438;&#x044f; &#x043d;&#x0430; &#x043d;&#x0435;&#x0439;&#x0440;&#x043e;&#x0434;&#x0435;&#x0433;&#x0435;&#x043d;&#x0435;&#x0440;&#x0	www.findpatent.ru	0	0		
793	chr28	27285959	27285983	3500338086	23		27285959	27285983	8421504	2	18,5	0,19	g	350033808600000000	3-26					Patent	Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification (Patent US:6114115)	Robert	2000	0		
793	chr28	27311532	27311556	3500351016	23		27311532	27311556	8421504	2	11,12	0,12	g	350035101600000047	0-23						Nematode-extracted anticoagulant protein	www.devileye.net	0	0		
793	chr28	27368798	27369500	3500058923	144		27368798	27369500	8421504	3	48,48,48	0,447,654	p	350005892300015065,350005892300015069,350005892300015073	0-48,0-48,0-48						US Patent # 6,933,142. HEC-G1CNAC6ST - Patents.com	www.patents.com	0	0		CHST3
793	chr28	27369128	27369783	3500233653	654		27369128	27369783	8421504	2	18,636	0,19	c	350023365300000008,350023365300000002	7-663,18-38						in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biological Engineering	dspace.mit.edu	0	0		
794	chr28	27418588	27418616	3500287505	25		27418588	27418616	8421504	3	6,4,15	0,8,13	c	350028750500000156	8-34						Methods for diagnosing Pseudoxanthoma elasticum	www.devileye.net	0	0		
794	chr28	27420949	27420977	3500282773	28		27420949	27420977	8421504	1	28	0	c	350028277300000454,350028277300000169	0-28,0-28						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT - Patent application	www.faqs.org	0	0		
794	chr28	27424556	27424685	3500295686	69		27424556	27424685	8421504	2	36,33	0,96	p	350029568600015007	0-69						Struktur-Funktions-Beziehungen	ebdoc.sub.gwdg.de	0	0		SPOCK2
795	chr28	27596489	27598261	3500092809	138		27596489	27598261	8421504	6	21,26,22,26,20,23	0,157,600,870,1179,1749	c	350009280900000097,350009280900000010,350009280900000151,350009280900000090,350009280900000084,350009280900000011,350009280900000033,350009280900000018,350009280900000019,350009280900000165	17-38,0-20,21-42,19-38,18-38,0-19,0-22,0-26,0-20,19-42						Therapeutic uses of inhibitors of RTP801	Feinstein	2006	0		
795	chr28	27596489	27598248	3500440656	182		27596489	27598248	8421504	8	21,20,27,22,26,20,27,19	0,135,156,600,870,1179,1697,1740	c	350044065600000097,350044065600000009,350044065600000152,350044065600000010,350044065600000151,350044065600000090,350044065600000084,350044065600000011,350044065600000033,350044065600000018,350044065600000019,350044065600000155,350044065600000096,350044065600000103,350044065600000099,350044065600000069	17-38,0-20,21-42,0-20,21-42,19-38,18-38,0-19,0-22,0-26,0-20,21-42,19-38,19-38,18-38,19-38						Therapeutic uses of inhibitors of RTP801	Feinstein	2005	0		
795	chr28	27596489	27598248	3500246296	137		27596489	27598248	8421504	6	21,22,22,26,27,19	0,157,600,870,1697,1740	c,g	350024629600000097,350024629600000010,350024629600000151,350024629600000033,350024629600000018,350024629600000155,350024629600000096,350024629600000103,350024629600000099,350024629600000069,350024629600000069	17-38,0-20,21-42,0-22,0-26,21-42,19-38,19-38,18-38,19-38,19-38						Methods of treating eye diseases in diabetic patients	Feinstein	2011	0		
795	chr28	27596489	27598248	3500157867	223		27596489	27598248	8421504	10	21,19,26,20,22,19,26,20,24,26	0,134,157,552,600,818,870,1179,1697,1733	c,g	350015786700000104,350015786700000015,350015786700000017,350015786700000158,350015786700000097,350015786700000088,350015786700000018,350015786700000083,350015786700000054,350015786700000040,350015786700000024,350015786700000025,350015786700000026,350015786700000026,350015786700000162,350015786700000103,350015786700000110,350015786700000154,350015786700000076	17-38,0-19,0-20,21-42,19-38,19-38,0-19,19-38,0-19,0-22,0-19,0-26,0-20,0-20,21-42,19-38,19-38,21-42,19-38					Patent	Therapeutic uses of inhibitors of RTP801 (Patent US:8309532)	Feinstein	2012	0		
795	chr28	27596489	27598213	3500314588	137		27596489	27598213	8421504	6	21,20,21,22,26,27	0,157,552,600,870,1697	c,g	350031458800000122,350031458800000042,350031458800000170,350031458800000061,350031458800000049,350031458800000180,350031458800000180,350031458800000121,350031458800000121,350031458800000124,350031458800000124	17-38,0-20,21-42,0-22,0-26,21-42,21-42,19-38,19-38,18-38,18-38						Therapeutic uses of inhibitors of RTP801	filed	2011	0		
795	chr28	27596489	27597992	3500250136	154		27596489	27597992	8421504	7	21,27,19,22,26,20,19	0,157,552,600,870,1179,1484	c	350025013600000109,350025013600000022,350025013600000093,350025013600000096,350025013600000160,350025013600000088,350025013600000045,350025013600000030,350025013600000031,350025013600000032	17-38,0-20,19-38,18-38,21-42,19-38,0-22,0-26,0-20,0-19						Therapeutic uses of inhibitors of RTP801	Feinstein	2011	0		
795	chr28	27596646	27598248	3500271179	65		27596646	27598248	8421504	3	27,19,19	0,1327,1583	c	350027117900000042,350027117900000043,350027117900000044,350027117900000051,350027117900000094	0-20,0-19,0-19,0-19,19-38						Therapeutic uses of inhibitors of RTP801	The	2005	0		
795	chr28	27597116	27598188	3500186308	41		27597116	27598188	8421504	2	19,22	0,1050	c	350018630800000028,350018630800000032	20-39,0-22						EFFECTS OF GROWTH HORMONE AND INSULIN-LIKE GROWTH FACTOR-I ON MILK PROTEIN GENE EXPRESSION AND NUTRIENT UPTAKE AND CELL PROLIFERATION IN CLONAL BOVINE MAMMARY EPITHELIAL CELLS	cholar.lib.vt.edu	0	0		
795	chr28	27597146	27597235	3500034683	39		27597146	27597235	8421504	2	20,19	0,70	c,g	350003468300000002,350003468300000002,350003468300000001	0-20,0-20,0-19		23144934	10.1371/journal.pone.0048700		PLoS ONE	Micro-RNA30c Negatively Regulates REDD1 Expression in Human Hematopoietic and Osteoblast Cells after Gamma-Irradiation	Xiang	2012	0		DDIT4
795	chr28	27598195	27598220	3500436097	25		27598195	27598220	8421504	1	25	0	c	350043609700000005	0-25						Identification of candidate genes for congenital splay leg in piglets by al- ternative analysis of DNA microarray data	www.ijbs.com	0	0		
796	chr28	27676061	27702205	3500430220	252		27676061	27702205	8421504	4	158,22,62,10	0,1111,1139,26134	p	350043022000015204,350043022000015201,350043022000015203,350043022000015202	0-78,9-177,0-177,0-168						49 human secreted proteins	A	2000	0		MICU1
796	chr28	27729879	27729906	3500326638	23		27729879	27729906	8421504	2	6,17	0,10	g	350032663800000000,350032663800000006	12-35,12-35						DETECTING CYP24 EXPRESSION LEVEL AS A MARKER FOR PREDISPOSITION TO CANCER - Patent application	www.faqs.org	0	0		
800	chr28	28189680	28189706	3500160732	23		28189680	28189706	8421504	2	14,9	0,17	g	350016073200000034	0-23						Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions - Patent application	www.faqs.org	0	0		
800	chr28	28192374	28197510	3500107629	75		28192374	28197510	8421504	2	1,74	0,5062	p	350010762900015011	0-75						Serine proteases	Ni	2000	0		OIT3
801	chr28	28344206	28345718	3500466715	48		28344206	28345718	8421504	2	23,25	0,1487	p	350046671500015011	6-54						Novel lysyl hydroxylase isoforms	herkules.oulu.fi	0	0		P4HA1
801	chr28	28414132	28414164	3500369719	32		28414132	28414164	8421504	1	32	0	c	350036971900000018	12-44						Expression system for producing collagen - Patent application	www.faqs.org	0	0		
803	chr28	28662368	28674567	3500179291	53		28662368	28674567	8421504	3	24,3,26	0,2733,12173	c	350017929100000002,350017929100000000	4-31,5-31						Expression and localization of annexin VII (synexin) in muscle cells	cs.biologists.org	0	0		ANXA7
100	chr28	28698537	28744337	3500351863	1575		28698537	28744337	8421504	14	176,30,98,85,78,126,95,78,140,146,112,125,201,85	0,1586,6428,7264,14526,21863,24727,24927,25112,25517,27303,30244,31067,45715	p	350035186300015002	0-1575						KEGG T01001: 11261	www.genome.jp	0	0		
100	chr28	28698537	28744337	3500195956	1575		28698537	28744337	8421504	14	176,30,98,85,78,126,95,78,140,146,112,125,201,85	0,1586,6428,7264,14526,21863,24727,24927,25112,25517,27303,30244,31067,45715	p	350019595600015000	0-1575						KEGG T01001: 5532	www.genome.jp	0	0		
100	chr28	28698579	28723487	3500132428	61		28698579	28723487	8421504	3	20,21,20	0,108,24888	c,g	350013242800000005,350013242800000005,350013242800000004,350013242800000004,350013242800000006,350013242800000006	0-20,0-20,0-21,0-21,0-20,0-20		17303652	10.1152/ajpcell.00139.2005		American Journal of Physiology - Cell Physiolog	Nuclear translocation of calcineurin A&#x03b2; but not calcineurin A&#x03b1; by platelet-derived growth factor in rat aortic smooth muscle	Jabr	2007	0		PPP3CB
100	chr28	28698579	28723487	3500072502	61		28698579	28723487	8421504	3	20,21,20	0,108,24888	c,g	350007250200000005,350007250200000005,350007250200000004,350007250200000004,350007250200000006,350007250200000006	0-20,0-20,0-21,0-21,0-20,0-20						Nuclear translocation of calcineurin A but not calcineurin A by platelet-derived growth factor in rat aortic smooth muscle	ll.physiology.org	0	0		PPP3CB
100	chr28	28698579	28723487	3500047858	61		28698579	28723487	8421504	3	20,21,20	0,108,24888	c,g	350004785800000005,350004785800000005,350004785800000004,350004785800000004,350004785800000006,350004785800000006	0-20,0-20,0-21,0-21,0-20,0-20						Nuclear translocation of calcineurin A&#x03b2; but not calcineurin A &#x03b1; by platelet-derived growth factor in rat aortic smooth muscle	ll.physiology.org	0	0		PPP3CB
100	chr28	28698579	28723487	3500042034	61		28698579	28723487	8421504	3	20,21,20	0,108,24888	c,g	350004203400000005,350004203400000005,350004203400000004,350004203400000004,350004203400000006,350004203400000006	0-20,0-20,0-21,0-21,0-20,0-20		17303652	10.1152/ajpcell.00139.2005		American Journal of Physiology - Cell Physiolog	Nuclear translocation of calcineurin A&#x03b2; but not calcineurin A&#x03b1; by platelet-derived growth factor in rat aortic smooth muscle	Jabr	2007	0		PPP3CB
803	chr28	28704167	28704426	3500367934	207		28704167	28704426	8421504	4	29,44,92,42	0,31,83,217	g	350036793400000224,350036793400000221,350036793400000220	0-174,0-21,0-21						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
804	chr28	28705062	28705872	3500389626	72		28705062	28705872	8421504	2	1,71	0,739	p	350038962600015006	0-72						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		PPP3CA
804	chr28	28720425	28723310	3500052832	147		28720425	28723310	8421504	2	101,46	0,2839	p	350005283200015152	3-150						NOTES ON SELECTED SOFTBERRY PRODUCTS	ux1.softberry.com	0	0		PPP3CB
804	chr28	28720477	28720517	3500101606	40		28720477	28720517	8421504	1	40	0	c	350010160600000042	1-41						Modulators of anchoring protein function	Coghlan	1996	0		
804	chr28	28723265	28723340	3500435033	75		28723265	28723340	8421504	1	75	0	p	350043503300015000	0-75						Cell, Vol. 66, 907-615, August 23, 1991, Copyright 0 1991 by Cell Press Calcineurin Is a Common Target of Cyclophilin-Cyclosporin A and FKBP-FK506 Complexes	.researchgate.net	0	0		PPP3CB
804	chr28	28723265	28723340	3500185263	75		28723265	28723340	8421504	1	75	0	p	350018526300015000	0-75						Cell, Vol. 66, 907-615, August 23, 1991, Copyright 0 1991 by Cell Press Calcineurin Is a Common Target of Cyclophilin-Cyclosporin A and FKBP-FK506 Complexes	roadinstitute.org	0	0		PPP3CB
804	chr28	28723265	28723340	3500114912	75		28723265	28723340	8421504	1	75	0	p	350011491200015001	0-75						Detection of immunosuppressants	Friedman	1993	0		PPP3CB
804	chr28	28723358	28723523	3500097653	60		28723358	28723523	8421504	2	1,59	0,106	p	350009765300015000	0-60					The Journal of Cell Biology	Matching of Calcineurin Activity to Upstream Effectors Is Critical for Skeletal Muscle Fiber Growth	Shannon	2000	0		PPP3CB
804	chr28	28724060	28725862	3500282713	132		28724060	28725862	8421504	4	30,24,56,22	0,33,84,1780	p	350028271300015013,350028271300015007	0-54,0-78						THE BIOLOGICAL CHEMISTRY JOGRNAL 268, Vol. No. OF by U.S.A. in Expression, Purification, Crystallization, and Biochemical a Recombinant Protein Phosphatase* Characterization of	www.jbc.org	0	0		PPP3CB
804	chr28	28724084	28725891	3500305914	40		28724084	28725891	8421504	2	20,20	0,1787	c,g	350030591400000009,350030591400000009,350030591400000008,350030591400000008	0-20,0-20,0-20,0-20		19156133	10.1038/mt.2008.298		Molecular Therapy: the Journal of the American Society of Gene Therapy	Asymmetric Shorter-duplex siRNA Structures Trigger Efficient Gene Silencing With Reduced Nonspecific Effects	Chan	2009	0		PPP3CB
804	chr28	28724084	28725891	3500154570	40		28724084	28725891	8421504	2	20,20	0,1787	c	350015457000000009,350015457000000008	0-20,0-20		19156133	10.1038/mt.2008.298	1525-0016	Molecular Therapy	Asymmetric Shorter-duplex siRNA Structures Trigger Efficient Gene Silencing With Reduced Nonspecific Effects	Chang	2009	7		PPP3CB
804	chr28	28812535	28812563	3500070437	24		28812535	28812563	8421504	3	12,5,7	0,15,21	g	350007043700000003	0-24						VACCINES FOR CHLAMYDIA - UNIVERSITEIT GENT	www.sumobrain.com	0	0		
806	chr28	28980802	28980847	3500310408	45		28980802	28980847	8421504	1	45	0	p	350031040800015000	0-45						Calcium/calmodulin-dependent protein kinase II- isoform regulation of vascular smooth muscle cell proliferation	ll.physiology.org	0	0		CAMK2G
806	chr28	28980802	28980847	3500239923	45		28980802	28980847	8421504	1	45	0	p	350023992300015000	0-45		17267544	10.1152/ajpcell.00606.2006		American Journal of Physiology - Cell Physiolog	Calcium/calmodulin-dependent protein kinase II-&#x03b4; isoform regulation of vascular smooth muscle cell proliferation	House	2007	0		CAMK2G
806	chr28	28980802	28980847	3500061795	45		28980802	28980847	8421504	1	45	0	p	350006179500015000	0-45						Calcium/calmodulin-dependent protein kinase II- isoform regulation of vascular smooth muscle cell proliferation	ll.physiology.org	0	0		CAMK2G
806	chr28	29068416	29068441	3500058609	25		29068416	29068441	8421504	1	25	0	c	350005860900000023	23-48						Supporting Information	www.pnas.org	0	0		PLAU
806	chr28	29069034	29071448	3500345870	40		29069034	29071448	8421504	2	20,20	0,2394	c,g	350034587000000003,350034587000000002,350034587000000002	0-20,0-20,0-20		15201140	10.1152/ajpcell.00101.2004		American Journal of Physiology - Cell Physiology	Role of TGF-&#x03b2;1 and JNK signaling in capillary tube patterning	Bein	2004	0		
806	chr28	29069034	29071448	3500061918	40		29069034	29071448	8421504	2	20,20	0,2394	c	350006191800000003,350006191800000002	0-20,0-20		15201140	10.1152/ajpcell.00101.2004		American Journal of Physiology - Cell Physiolog	Role of TGF-&#x03b2;1 and JNK signaling in capillary tube patterning	Bein	2004	0		
100	chr28	29149855	29260302	3500281866	3198		29149855	29260302	8421504	22	168,71,151,109,123,161,91,148,154,176,191,200,129,150,109,303,125,171,15,204,105,144	0,42171,68188,68519,70923,72459,80564,81630,85183,86031,88278,89700,91176,95190,96879,98097,99872,101695,105166,107183,107792,110303	p	350028186600015000	0-3198						KEGG T01001: 7414	www.genome.jp	0	0		VCL
807	chr28	29192156	29192181	3500448021	23		29192156	29192181	8421504	2	17,6	0,19	g	350044802100000000	0-23		19785743	10.1186/1741-7007-7-63	1741-7007	BMC Biology	c-Myc affects mRNA translation, cell proliferation and progenitor cell function in the mammary gland	Stoelzle	2009	6		
808	chr28	29260729	29260753	3500256113	23		29260729	29260753	8421504	2	13,10	0,14	c	350025611300000004	21-44						Toxicology and Applied Pharmacology	og.catholic.ac.kr	0	0		
808	chr28	29262109	29262134	3500092476	25		29262109	29262134	8421504	1	25	0	c	350009247600000003	1-26						Mechanismen der Mastzellaktivierung durch gram-negative Bakterien und Bakterienprodukte aus der Darmflora	.uni-hohenheim.de	0	0		
810	chr28	29494319	29494347	3500351366	23		29494319	29494347	8421504	3	4,6,13	0,5,15	g	350035136600000100	11-37						Calcium-binding photoprotein, gene encoding the same, and use thereof - Patent application	www.faqs.org	0	0		
811	chr28	29667711	29667737	3500363265	24		29667711	29667737	8421504	2	7,17	0,9	g	350036326500000005	0-24						Antitumor effect of humanized anti&#x2013;interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation	Mareina	2009	0		
815	chr28	30201384	30201409	3500399531	23		30201384	30201409	8421504	2	14,9	0,16	g	350039953100000568	22-45						 Methods Of Modulating And Identifying Agents That Modulate Intracellular Calcium 	www.docstoc.com	0	0		
815	chr28	30224084	30237738	3500224737	1054		30224084	30237738	8421504	9	31,69,50,153,53,228,151,58,261	0,1102,1980,5809,6058,7138,8320,12100,13393	p,c,g	350022473700015020,350022473700000024,350022473700015021,350022473700015022,350022473700000026,350022473700015023,350022473700000027,350022473700000027,350022473700000028,350022473700000028,350022473700015024,350022473700000029,350022473700015025,350022473700000030,350022473700000030,350022473700000031,350022473700015026,350022473700000032,350022473700000032,350022473700015027,350022473700000033,350022473700000034,350022473700000034,350022473700015028,350022473700000016,350022473700000035,350022473700015016,350022473700000017,350022473700000036,350022473700015029,350022473700015017,350022473700000018,350022473700015030,350022473700000037,350022473700000019	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,3-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-217						Lokalisation und Relevanz von Porin Subtypen im bovinen Hoden	eb.uni-giessen.de	0	0		
815	chr28	30231270	30231346	3500121965	46		30231270	30231346	8421504	2	24,22	0,54	c	350012196500000004,350012196500000005	0-24,0-22						Establishment of a continuous untransfected human corneal endothelial cell line and its biocompatibility to denuded amniotic membrane.	.biomedsearch.com	0	0		VDAC2,ACTR2
815	chr28	30232431	30232471	3500075252	40		30232431	30232471	8421504	1	40	0	c	350007525200000300	0-40						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
825	chr28	31556078	31556104	3500430558	23		31556078	31556104	8421504	2	17,6	0,20	g	350043055800000018	1-24						Domain II Mutants Of Anthrax Lethal Factor	Duesbery	2005	0		
828	chr28	31968129	31968377	3500291395	49		31968129	31968377	8421504	2	25,24	0,224	c	350029139500000001,350029139500000000	0-25,0-24		19640305	10.1186/1471-2407-9-258		BMC Cancer	Role of KCNMA1 gene in breast cancer invasion and metastasis to brain	Divya	2009	0		KCNMA1
828	chr28	31968440	31968464	3500069972	24		31968440	31968464	8421504	1	24	0	c	350006997200000045	10-34						METHODS AND COMPOSITIONS FOR GENOMIC MODIFICATION - Patent application	www.faqs.org	0	0		
828	chr28	31970300	31970324	3500090770	24		31970300	31970324	8421504	1	24	0	c	350009077000000008	25-49						Neuron, volume 59 Supplemental Data Posttranscriptional Regulation of BK Channel Splice Variant Stability by miR-9 Underlies Neuroadaptation to Alcohol	download.cell.com	0	0		KCNMA1
828	chr28	31970449	31973031	3500346063	41		31970449	31973031	8421504	2	20,21	0,2561	c,g	350034606300000001,350034606300000000,350034606300000000	0-20,0-21,0-21		17164406	10.1124/mol.106.028290	1521-0111 (Online)	Molecular Pharmacology	The Antiestrogen Tamoxifen Activates BK Channels and Stimulates Proliferation of MCF-7 Breast Cancer Cells	Coiret	2007	0		KCNMA1
828	chr28	31970449	31973031	3500180690	41		31970449	31973031	8421504	2	20,21	0,2561	c,g	350018069000000001,350018069000000000,350018069000000000	0-20,0-21,0-21						The Antiestrogen Tamoxifen Activates BK Channels and Stimulates Proliferation of MCF-7 Breast Cancer Cells 2007&#x5e74;&#x7b2c;69&#x5377;&#x7b2c;3&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
828	chr28	31970449	31973031	3500132384	41		31970449	31973031	8421504	2	20,21	0,2561	c,g	350013238400000005,350013238400000004,350013238400000004	0-20,0-21,0-21						&#x4e3b;&#x984c;&#xff1a;MCF-7 | &#x91ab;&#x6e90;&#x4e16;&#x754c;	big5.39kf.com	0	0		KCNMA1
828	chr28	31970449	31973031	3500060211	41		31970449	31973031	8421504	2	20,21	0,2561	c,g	350006021100000001,350006021100000000,350006021100000000	0-20,0-21,0-21		17164406	10.1124/mol.106.028290	1521-0111 (Online)	Molecular Pharmacology	The Antiestrogen Tamoxifen Activates BK Channels and Stimulates Proliferation of MCF-7 Breast Cancer Cells	Coiret	2007	0		KCNMA1
828	chr28	31970529	31970559	3500465913	30		31970529	31970559	8421504	1	30	0	c,g	350046591300000020,350046591300000020	0-30,0-30						Regulation des BK-Kanals durch die Proteinkinase C	ie.uni-hamburg.de	0	0		
829	chr28	32026588	32026616	3500017616	24		32026588	32026616	8421504	3	14,5,5	0,17,23	g	350001761600000014	16-40						Killer cell Immunoglobulin-like Receptor (KIR) polymorphism in Haematopoietic Stem Cell Transplantation (HSCT)	ive.library.uu.nl	0	0		
829	chr28	32035316	32044392	3500319705	43		32035316	32044392	8421504	2	20,23	0,9053	c	350031970500000003,350031970500000002	0-20,0-23		12882761	10.1152/ajplung.00091.2003		American Journal of Physiology - Lung Cellular and Molecular Physiology	Chronic intrauterine pulmonary hypertension compromises fetal pulmonary artery smooth muscle cell O2 sensing	Linden	2003	0		KCNMA1
829	chr28	32035316	32044392	3500306118	43		32035316	32044392	8421504	2	20,23	0,9053	c	350030611800000003,350030611800000002	0-20,0-23		12882761	10.1152/ajplung.00091.2003		American Journal of Physiology - Lung Cellular and Molecular Physiology	Chronic intrauterine pulmonary hypertension compromises fetal pulmonary artery smooth muscle cell O2 sensing	Linden	2003	0		KCNMA1
829	chr28	32035368	32035452	3500128210	81		32035368	32035452	8421504	2	48,33	0,51	p	350012821000015014	0-81						Cell, Volume 135	download.cell.com	0	0		KCNMA1
829	chr28	32044430	32044454	3500279357	24		32044430	32044454	8421504	1	24	0	c	350027935700000008	0-24		20479001	10.1074/jbc.M110.139758		The Journal of Biological Chemistry	Membrane Trafficking of Large Conductance Calcium-activated Potassium Channels Is Regulated by Alternative Splicing of a Transplantable, Acidic Trafficking Motif in the RCK1-RCK2 Linker	Lie	July	0		KCNMA1
103	chr28	32044456	32122196	3500465913	151		32044456	32122196	8421504	6	7,16,26,32,23,47	0,17990,18007,18051,68073,77693	c,g	350046591300000014,350046591300000015,350046591300000015,350046591300000010,350046591300000012,350046591300000012,350046591300000007,350046591300000005,350046591300000005,350046591300000009,350046591300000009,350046591300000006,350046591300000006	0-23,0-26,0-26,0-31,0-25,0-25,0-26,0-19,0-19,0-20,0-20,0-27,0-27						Regulation des BK-Kanals durch die Proteinkinase C	ie.uni-hamburg.de	0	0		
829	chr28	32105070	32112491	3500003299	75		32105070	32112491	8421504	2	49,26	0,7395	p,c	350000329900015003,350000329900000018	0-69,0-22						&#x4e3b;&#x984c;&#xff1a;Monoxide | &#x91ab;&#x6e90;&#x4e16;&#x754c;	big5.39kf.com	0	0		KCNMA1
829	chr28	32112484	32112510	3500090770	26		32112484	32112510	8421504	1	26	0	c,g	350009077000000002,350009077000000002	25-51,25-51						Neuron, volume 59 Supplemental Data Posttranscriptional Regulation of BK Channel Splice Variant Stability by miR-9 Underlies Neuroadaptation to Alcohol	download.cell.com	0	0		
830	chr28	32122200	32140820	3500158547	34		32122200	32140820	8421504	2	18,16	0,18604	c	350015854700000003	4-38						BK Channel Interactome with cover figure | Thandavam Kathiresan - Academia.edu	www.academia.edu	0	0		KCNMA1
830	chr28	32192166	32210733	3500465913	25		32192166	32210733	8421504	2	16,9	0,18558	c	350046591300000001	0-25						Regulation des BK-Kanals durch die Proteinkinase C	ie.uni-hamburg.de	0	0		
830	chr28	32210724	32212538	3500121025	39		32210724	32212538	8421504	2	19,20	0,1794	c,g	350012102500000003,350012102500000003,350012102500000002	0-19,0-19,0-20			10.1016/j.eururo.2006.11.028		European urology	Diabetes-Induced Changes in the Alternative Splicing of the Slo Gene in Corporal Tissue	Kelvin	2007	0		KCNMA1
830	chr28	32210768	32212506	3500154352	150		32210768	32212506	8421504	2	48,102	0,1636	p	350015435200015010	0-150						NPG.nature.vol.417.Issue.6888.May	www.scribd.com	0	0		KCNMA1
830	chr28	32210794	32212406	3500090770	24		32210794	32212406	8421504	2	22,2	0,1610	c	350009077000000001	0-24						Neuron, volume 59 Supplemental Data Posttranscriptional Regulation of BK Channel Splice Variant Stability by miR-9 Underlies Neuroadaptation to Alcohol	download.cell.com	0	0		KCNMA1
830	chr28	32212416	32212533	3500192418	117		32212416	32212533	8421504	1	117	0	p	350019241800015006	0-117						vom Fachbereich Biologie der Technischen Universit&#xe4;t Darmstadt zur Erlangung des akademischen Grades eines Doctor rerum naturalium genehmigte Dissertation von	b.tu-darmstadt.de	0	0		KCNMA1
832	chr28	32422719	32422746	3500080545	26		32422719	32422746	8421504	2	4,22	0,5	g	350008054500000004	15-41						Phosphorus-32 labeling of antibodies for cancer therapy	Griffiths	1997	0		
834	chr28	32708009	32708044	3500003299	35		32708009	32708044	8421504	1	35	0	c	350000329900000026,350000329900000024	2-27,0-25						&#x4e3b;&#x984c;&#xff1a;Monoxide | &#x91ab;&#x6e90;&#x4e16;&#x754c;	big5.39kf.com	0	0		KCNMA1
834	chr28	32708147	32708176	3500295532	29		32708147	32708176	8421504	1	29	0	c	350029553200000002	56-85						Transcription factor Islet-Brain 1 (IB1)	Waeber	1997	0		
835	chr28	32870978	32871002	3500044813	23		32870978	32871002	8421504	2	14,9	0,15	c	350004481300000007	0-25			10.1534/genetics.106.061184		Genetics	Trans-Kingdom Transposition of the Maize Dissociation Element	Alexander	2006	0		
835	chr28	32874978	32876149	3500318543	174		32874978	32876149	8421504	2	70,104	0,1067	p	350031854300015052	0-174						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		DLG5
835	chr28	32885713	32885744	3500334700	31		32885713	32885744	8421504	1	31	0	c	350033470000000228	0-31						'cause 'cause IN 257 'd 'd MD 11481 'd 'd NNP 2166 'em 'em NNP 15 'em 'em PRP 586 'll 'll MD 13	cs.cmu.edu/afs/cs	0	0		DLG5
836	chr28	32951105	32951128	3500108605	23		32951105	32951128	8421504	1	23	0	g	350010860500000074	20-43						Production of apomictic seed	De	1999	0		
836	chr28	32967145	32967178	3500231235	28		32967145	32967178	8421504	3	6,9,13	0,10,20	g	350023123500000005	4-34					Patent	Targeted proteolysis by recruitment to ubiquitin protein ligases (Patent US:7223556)	Zhou	2007	0		
837	chr28	33055170	33055244	3500245646	44		33055170	33055244	8421504	2	24,20	0,54	c	350024564600000047,350024564600000046	0-24,0-20						Wound Healing Profile	Kemp	2005	0		RPS24
837	chr28	33055177	33056052	3500020831	52		33055177	33056052	8421504	2	26,26	0,849	c	350002083100000010,350002083100000011	0-26,0-26		19521987	10.1002/ijc.24493	1097-0215	International Journal of Cancer	Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells - Gade - 2009 - International Journal of Cancer - Wiley Online Library	Gade	2009	0		RPS24
837	chr28	33056005	33056059	3500410834	54		33056005	33056059	8421504	1	54	0	p	350041083400015003	0-54		18697920	10.1261/rna.1132008	1355-8382	RNA	The role of human ribosomal proteins in the maturation of rRNA and ribosome production	Robledo	2008	5		RPS24
837	chr28	33056005	33056059	3500182164	54		33056005	33056059	8421504	1	54	0	p	350018216400015003	0-54		18697920	10.1261/rna.1132008	1355-8382	RNA	The role of human ribosomal proteins in the maturation of rRNA and ribosome production	Robledo	2008	5		RPS24
837	chr28	33056005	33056059	3500103090	54		33056005	33056059	8421504	1	54	0	p	350010309000015004	0-54						The role of human ribosomal proteins in the maturation of rRNA and ribosome production	journal.cshlp.org	0	0		RPS24
837	chr28	33058303	33058745	3500375699	88		33058303	33058745	8421504	3	4,5,79	0,357,363	c	350037569900000039	62-150						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
837	chr28	33089169	33089192	3500437909	23		33089169	33089192	8421504	1	23	0	g	350043790900000011	5-28						Methods and Compositions for Ultra-High Throughput Screening of Natural Products	Baltz	2005	0		
838	chr28	33249562	33249590	3500062787	23		33249562	33249590	8421504	2	8,15	0,13	g	350006278700000189	0-29						Polypeptides of Botryosphaeria Rhodina - Patent application	www.faqs.org	0	0		
839	chr28	33365134	33365162	3500347416	23		33365134	33365162	8421504	2	13,10	0,18	g	350034741600000409	1-24						 Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
839	chr28	33365134	33365162	3500283618	23		33365134	33365162	8421504	2	13,10	0,18	g	350028361800000409	1-24						Toxin peptide therapeutic agents	Sullivan	2007	0		
840	chr28	33533927	33533955	3500326853	23		33533927	33533955	8421504	2	7,16	0,12	g	350032685300000008	12-38						IMMUNOGLOBULINS COMPRISING PREDOMINANTLY A GlCNACMAN5GLCNAC2 GLYCOFORM	Gerngross	2007	0		
844	chr28	34044064	34044096	3500165260	27		34044064	34044096	8421504	2	7,20	0,12	g	350016526000000049	3-45						Transgenic chickens with an inactivated endogenous gene locus - Patent application	www.faqs.org	0	0		
845	chr28	34136627	34149833	3500326993	41		34136627	34149833	8421504	4	20,13,4,4	0,13183,13197,13202	g	350032699300000104,350032699300000013	25-45,11-32						Nucleic Acid, Polypeptide and Its Use - Patent application	www.faqs.org	0	0		
845	chr28	34171013	34171041	3500195767	23		34171013	34171041	8421504	2	8,15	0,13	g	350019576700000324	0-23						Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules - Patent application	www.faqs.org	0	0		
845	chr28	34181105	34181131	3500081476	23		34181105	34181131	8421504	2	18,5	0,21	g	350008147600000015	12-35						US Patent # 5,602,096. Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis - Patents.com	www.patents.com	0	0		
850	chr28	34815442	34815465	3500418269	23		34815442	34815465	8421504	1	23	0	g	350041826900000021	0-23						Generation of a Species-Specific DNA Sequence Library of British Mammals	jncc.defra.gov.uk	0	0		
850	chr28	34816472	34816508	3500303644	31		34816472	34816508	8421504	2	22,9	0,27	g	350030364400000013,350030364400000012	18-49,18-49						ENTRE CHIEN ET LOUP : DE LA CROTTE A L&#x2019;ADN	.univ-toulouse.fr	0	0		
850	chr28	34841731	34841757	3500377495	23		34841731	34841757	8421504	2	17,6	0,20	c	350037749500000035	11-37						Methods and compositions for the prevention and treatment of anemia	Browne	2003	0		
106	chr28	34843081	34888348	3500156700	871		34843081	34888348	8421504	15	96,20,11,86,97,92,13,83,49,47,96,141,19,1,20	0,123,2019,4458,4848,5248,5343,5727,6494,8999,9094,9238,41949,42583,45247	p,c	350015670000015002,350015670000015003,350015670000015023,350015670000015004,350015670000015024,350015670000015005,350015670000015026,350015670000015007,350015670000015027,350015670000015008,350015670000015009,350015670000015029,350015670000015030,350015670000015011,350015670000015031,350015670000015014,350015670000015015,350015670000015016,350015670000015017,350015670000015019,350015670000015020,350015670000015021,350015670000000000,350015670000000001	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-20,0-20						Recombinant conglutinin and producing method thereof - Patent # 6979727 - PatentGenius	.patentgenius.com	0	0		
850	chr28	34849542	34849623	3500404999	81		34849542	34849623	8421504	1	81	0	p	350040499900015034	0-81						COMBINATORIAL LIBRARIES BASED ON C-TYPE LECTIN DOMAIN - ANPHORE, INC	www.sumobrain.com	0	0		
850	chr28	34849542	34849623	3500256587	81		34849542	34849623	8421504	1	81	0	p	350025658700015044	0-81						Polypeptides that bind Trail-R1 and Trail-R2	Bowdish	2010	0		
850	chr28	34849542	34849623	3500198756	81		34849542	34849623	8421504	1	81	0	p	350019875600015050	0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Le	2010	0		
850	chr28	34849542	34849623	3500117727	81		34849542	34849623	8421504	1	81	0	p	350011772700015048	0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Holtet	2011	0		
850	chr28	34849542	34849623	3500095845	81		34849542	34849623	8421504	1	81	0	p	350009584500015044	0-81						Polypeptides that Bind TRAIL-R1 and TRAIL-R2	Bowdish	2012	0		
850	chr28	34852274	34852376	3500457503	102		34852274	34852376	8421504	1	102	0	p	350045750300015035	0-102						Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains	Etzerodt	2007	0		
850	chr28	34852274	34852376	3500366958	102		34852274	34852376	8421504	1	102	0	p	350036695800015035	0-102					Patent	Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains (Patent US:8017559)	Etzerodt	2011	0		
850	chr28	34852274	34852376	3500266768	102		34852274	34852376	8421504	1	102	0	p	350026676800015035	0-102						Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains	Etzerodt	2007	0		
851	chr28	34885016	34885043	3500325139	23		34885016	34885043	8421504	2	9,14	0,13	c	350032513900000007	14-37						HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4	logy-journals.org	0	0		
851	chr28	34979675	34979702	3500163097	23		34979675	34979702	8421504	2	12,11	0,16	c	350016309700000053,350016309700000002	0-23,0-23						METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS - Patent application	www.faqs.org	0	0		
851	chr28	34986986	34987067	3500404999	81		34986986	34987067	8421504	1	81	0	p	350040499900015032	0-81						COMBINATORIAL LIBRARIES BASED ON C-TYPE LECTIN DOMAIN - ANPHORE, INC	www.sumobrain.com	0	0		
851	chr28	34986986	34987067	3500256587	81		34986986	34987067	8421504	1	81	0	p	350025658700015042	0-81						Polypeptides that bind Trail-R1 and Trail-R2	Bowdish	2010	0		
851	chr28	34986986	34987067	3500198756	81		34986986	34987067	8421504	1	81	0	p	350019875600015048	0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Le	2010	0		
851	chr28	34986986	34987067	3500117727	81		34986986	34987067	8421504	1	81	0	p	350011772700015046	0-81						HSP70-Based Treatment for Autoimmune Diseases and Cancer	Holtet	2011	0		
851	chr28	34986986	34987067	3500095845	81		34986986	34987067	8421504	1	81	0	p	350009584500015042	0-81						Polypeptides that Bind TRAIL-R1 and TRAIL-R2	Bowdish	2012	0		
106	chr28	34989267	35021239	3500305779	63		34989267	35021239	8421504	3	20,22,21	0,31923,31951	c,g	350030577900000007,350030577900000004,350030577900000004,350030577900000005,350030577900000005	0-20,0-22,0-22,0-21,0-21						Differential Expression of Ovine Innate Immune Genes by Preterm and Neonatal Lung Epithelia Infected with Respiratory Syncytial Virus	ddr.nal.usda.gov	0	0		
852	chr28	35007863	35007935	3500457503	72		35007863	35007935	8421504	1	72	0	p	350045750300015077,350045750300015076,350045750300015075,350045750300015074,350045750300015073,350045750300015072,350045750300015071,350045750300015070,350045750300015068,350045750300015079	0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72						Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains	Etzerodt	2007	0		
852	chr28	35007863	35007935	3500366958	72		35007863	35007935	8421504	1	72	0	p	350036695800015076,350036695800015077,350036695800015074,350036695800015075,350036695800015072,350036695800015073,350036695800015070,350036695800015071,350036695800015068,350036695800015079	0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72					Patent	Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains (Patent US:8017559)	Etzerodt	2011	0		
852	chr28	35007863	35007935	3500266768	72		35007863	35007935	8421504	1	72	0	p	350026676800015072,350026676800015073,350026676800015070,350026676800015071,350026676800015076,350026676800015077,350026676800015074,350026676800015075,350026676800015068,350026676800015079,350026676800015085	0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-72,0-66						Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains	Etzerodt	2007	0		
852	chr28	35020741	35020786	3500441916	45		35020741	35020786	8421504	1	45	0	p	350044191600015081	0-45						Novel Collectin - Patent application	www.faqs.org	0	0		
852	chr28	35021163	35021190	3500324524	23		35021163	35021190	8421504	2	6,17	0,10	c	350032452400000074	12-35						Exploring Functionality-Intestinal Bifidobacteria	www.scribd.com	0	0		
852	chr28	35021190	35021239	3500354860	43		35021190	35021239	8421504	2	22,21	0,28	c	350035486000000007,350035486000000008	0-22,0-21						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system &#x2018;FocusField2-6GallupqPCRSet-upTool-001&#x2019; to attain consistently high fidelity qPCR reactions	uantification.com	0	0		
852	chr28	35021190	35021239	3500295231	43		35021190	35021239	8421504	2	22,21	0,28	c	350029523100000007,350029523100000008	0-22,0-21						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system &#x2018;FocusField2-6GallupqPCRSet-upTool-001&#x2019; to attain consistently high fidelity qPCR reactions	quantification.de	0	0		
852	chr28	35021190	35021239	3500117275	43		35021190	35021239	8421504	2	22,21	0,28	c	350011727500000001,350011727500000002	0-22,0-21			10.1128/CDLI.11.3.599-607.2004		Clinical and Diagnostic Laboratory Immunology	Enhanced Surfactant Protein and Defensin mRNA Levels and Reduced Viral Replication during Parainfluenza Virus Type 3 Pneumonia in Neonatal Lambs	Branka	2004	0		
852	chr28	35021190	35021239	3500099621	43		35021190	35021239	8421504	2	22,21	0,28	c	350009962100000007,350009962100000008	0-22,0-21						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet-upTool-001' to attain consistently high fidelity qPCR reactions.	.biomedsearch.com	0	0		
853	chr28	35197477	35200294	3500188832	135		35197477	35200294	8421504	3	1,92,42	0,2039,2775	p	350018883200015003	0-135						scientificreport	formatica.upf.edu	0	0		
106	chr28	35255404	35285431	3500336961	810		35255404	35285431	8421504	8	81,51,147,171,126,45,120,69	0,19825,21634,23292,25594,26984,28759,29958	p	350033696100015038	0-810						97 human secreted proteins	Brewer	2001	0		
854	chr28	35285976	35286001	3500381794	25		35285976	35286001	8421504	1	25	0	c	350038179400000002	1-26						Receptor family profiling	Coull	2009	0		
854	chr28	35285976	35286001	3500315372	25		35285976	35286001	8421504	1	25	0	c	350031537200000111,350031537200000002	1-26,1-26						RECEPTOR FAMILY PROFILING - Patent application	www.faqs.org	0	0		
854	chr28	35285976	35286001	3500312823	25		35285976	35286001	8421504	1	25	0	c	350031282300000028,350031282300000002	1-26,1-26						Detection Assays and Use Thereof - Patent application	www.faqs.org	0	0		
854	chr28	35285976	35286001	3500107253	25		35285976	35286001	8421504	1	25	0	c	350010725300000002	1-26						Receptor family profiling	Landsman	2010	0		
854	chr28	35285976	35286001	3500099918	25		35285976	35286001	8421504	1	25	0	c	350009991800000002,350009991800000088	1-26,1-26					Patent	Receptor family profiling (Patent EP:2064348)	Coull	2012	0		
854	chr28	35285976	35286001	3500099437	25		35285976	35286001	8421504	1	25	0	c	350009943700000309	1-26						Receptor Family Profiling 	.freshpatents.com	0	0		
13	chr28	36343496	36868650	3500164837	634		36343496	36868650	8421504	10	94,90,90,90,45,90,45,45,19,26	0,132,225,360,495,585,720,810,951,525128	p,c,g	350016483700000004,350016483700015096,350016483700015013,350016483700015066,350016483700000007,350016483700015099,350016483700015020,350016483700015021,350016483700015026,350016483700015174,350016483700015101,350016483700015036,350016483700015040,350016483700015045	0-100,0-45,0-45,0-45,0-70,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		NRG3
862	chr28	36344390	36344438	3500179398	48		36344390	36344438	8421504	1	48	0	p	350017939800015054	135-183						Princeton : COMPUTER S 207 : algorithms, 4th edition (robert sedgewick and kevin wayne princeton university, 2011)	ww.coursehero.com	0	0		BMP2K
13	chr28	36344453	37285467	3500211233	174		36344453	37285467	8421504	3	13,130,31	0,524171,940983	p	350021123300015123,350021123300015096,350021123300015098,350021123300015057,350021123300015102,350021123300015059	0-45,0-45,0-45,0-45,0-45,0-45						US Patent # 6,252,051. ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor - Patents.com	www.patents.com	0	0		NRG3
13	chr28	36344453	36868701	3500316673	90		36344453	36868701	8421504	2	13,77	0,524171	p	350031667300015125,350031667300015075,350031667300015095	0-45,0-45,0-45						Erbb4 receptor-specific neuregulin, related ligands and uses thereof	Godowski	1999	0		NRG3
13	chr28	36344456	36868662	3500298293	48		36344456	36868662	8421504	2	10,38	0,524168	p	350029829300015008	0-48						Heregulin-like factor	Hijazi	1998	0		NRG3
865	chr28	36824095	36824122	3500044397	24		36824095	36824122	8421504	2	12,12	0,15	g	350004439700000009	22-46			10.1093/emboj/20.24.7271		The EMBO Journal	A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69	PeLischka	2001	0		
108	chr28	36868746	37450410	3500211233	84		36868746	37450410	8421504	3	8,74,2	0,416690,581662	p	350021123300015125,350021123300015097	0-45,0-45						US Patent # 6,252,051. ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor - Patents.com	www.patents.com	0	0		NRG3
108	chr28	37285471	37559880	3500316673	296		37285471	37559880	8421504	4	39,27,103,127	0,164937,267224,274282	c	350031667300000000	0-296						Erbb4 receptor-specific neuregulin, related ligands and uses thereof	Godowski	1999	0		NRG3
108	chr28	37285471	37559880	3500211233	296		37285471	37559880	8421504	4	39,27,103,127	0,164937,267224,274282	c	350021123300000000	0-296						US Patent # 6,252,051. ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor - Patents.com	www.patents.com	0	0		NRG3
108	chr28	37285471	37559880	3500164837	293		37285471	37559880	8421504	6	39,27,14,72,14,127	0,164937,267224,267239,267313,274282	c	350016483700000000	0-293						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
108	chr28	37285473	37450416	3500164837	45		37285473	37450416	8421504	2	37,8	0,164935	p	350016483700015116	0-45						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		NRG3
108	chr28	37450418	37552764	3500130871	55		37450418	37552764	8421504	3	17,18,20	0,102277,102326	c,g	350013087100000019,350013087100000008,350013087100000008,350013087100000020,350013087100000020	7-42,0-20,0-20,0-20,0-20						Heregulin-like Factor - Patent application	www.faqs.org	0	0		
108	chr28	37450418	37552764	3500050392	55		37450418	37552764	8421504	3	17,18,20	0,102277,102326	c,g	350005039200000005,350005039200000008,350005039200000008	7-42,0-20,0-20						Heregulin-like factor	Young	2006	0		NRG3
108	chr28	37450418	37552711	3500298293	33		37450418	37552711	8421504	2	17,16	0,102277	c	350029829300000032	9-42						Heregulin-like factor	Hijazi	1998	0		NRG3
108	chr28	37450418	37552711	3500130871	33		37450418	37552711	8421504	2	17,16	0,102277	c	350013087100000017	9-42						Heregulin-like Factor - Patent application	www.faqs.org	0	0		
108	chr28	37450418	37552711	3500050392	33		37450418	37552711	8421504	2	17,16	0,102277	c	350005039200000003	9-42						Heregulin-like factor	Young	2006	0		NRG3
108	chr28	37450433	37552721	3500326716	28		37450433	37552721	8421504	2	2,26	0,102262	c	350032671600000005	12-40			10.1038/sj.onc.1205960	${footerJournalISSN}		Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation		2002	0		NRG3
871	chr28	37559800	37599174	3500164837	295		37559800	37599174	8421504	4	43,5,215,32	0,39018,39126,39342	c	350016483700000001,350016483700000021	1-44,0-252						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
872	chr28	37663254	37663282	3500358508	24		37663254	37663282	8421504	2	6,18	0,10	g	350035850800000019	0-24						DIVERSIDADE GEN&#xc9;TICA, ANCESTRALIDADE INDIVIDUAL E MISCIGENA&#xc7;&#xc3;O NAS RA&#xc7;AS BOVINAS NO BRASIL COM BASE EM MICROSSAT&#xc9;LITES E HAPL&#xd3;TIPOS DE DNA MITOCONDRIAL: SUBS&#xcd;DIOS PARA A CONSERVA&#xc7;&#xc3;O	itorio.bce.unb.br	0	0		
872	chr28	37663254	37663282	3500336592	24		37663254	37663282	8421504	2	6,18	0,10	g	350033659200000019	0-24						DIVERSIDADE GEN&#xc9;TICA, ANCESTRALIDADE INDIVIDUAL E MISCIGENA&#xc7;&#xc3;O NAS RA&#xc7;AS BOVINAS NO BRASIL COM BASE EM MICROSSAT&#xc9;LITES E HAPL&#xd3;TIPOS DE DNA MITOCONDRIAL: SUBS&#xcd;DIOS PARA A CONSERVA&#xc7;&#xc3;O	epositorio.unb.br	0	0		
875	chr28	38100083	38100107	3500154779	23		38100083	38100107	8421504	2	10,13	0,11	g	350015477900000007	0-23						Recombinant co-expression system of protein disulfide isomerase gene, yeast receptor protein ERD2 gene and a foreign product polypeptide gene, and a process for producing the foreign polypeptide using such system	Hayano	1992	0		
878	chr28	38465109	38465132	3500289524	23		38465109	38465132	8421504	1	23	0	g	350028952400000000	0-23						&#x5229;&#x7528;MTDNA D-LOOP &#x533a;&#x7814;&#x7a76;&#x4e2d;&#x56fd;10 &#x4e2a;&#x7ef5;&#x7f8a;&#x54c1;&#x79cd;&#x7684;&#x9057;&#x4f20;&#x591a;&#x6837;&#x6027;&#x4e0e;&#x8d77;&#x6e90; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
879	chr28	38586412	38586444	3500430989	25		38586412	38586444	8421504	3	14,6,5	0,18,27	g	350043098900000259	20-46						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
879	chr28	38586412	38586444	3500070288	25		38586412	38586444	8421504	3	14,6,5	0,18,27	g	350007028800000263	20-46						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
881	chr28	38797316	38797341	3500241923	23		38797316	38797341	8421504	2	6,17	0,8	g	350024192300000013	0-23						Methods of preparing a targeting vector and uses thereof	Morrison	2003	0		
881	chr28	38797652	38797679	3500426490	23		38797652	38797679	8421504	2	7,16	0,11	c	350042649000000046	2-25						Signal Transduction Protein Tab2 	.freshpatents.com	0	0		
881	chr28	38899228	38899252	3500390759	23		38899228	38899252	8421504	2	19,4	0,20	g	350039075900000005	5-29					Patent	Multivalent antigen-binding proteins (Patent EP:1027439)	FRENKEN	2010	0		
881	chr28	38899228	38899252	3500199393	23		38899228	38899252	8421504	2	19,4	0,20	g	350019939300000029,350019939300000203,350019939300000201	5-29,5-29,9-33						Multivalent antigen-binding proteins	Frenken	2000	0		
884	chr28	39231016	39231041	3500265263	24		39231016	39231041	8421504	2	9,15	0,10	g	350026526300000053	5-29						RECOMBINANT ANTIGENS OF HUMAN CYTOMEGALOVIRUS (HCMV) - Patent application	www.faqs.org	0	0		
891	chr28	40160792	40160818	3500081476	23		40160792	40160818	8421504	2	16,7	0,19	g	350008147600000125	18-41						US Patent # 5,602,096. Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis - Patents.com	www.patents.com	0	0		
892	chr28	40330840	40330867	3500121309	23		40330840	40330867	8421504	3	6,4,13	0,9,14	g	350012130900000007	0-23						Comprehensive phenotyping of two mouse mutants reveals a potential novel role of G protein-coupled receptor 30	edoc.hu-berlin.de	0	0		
895	chr28	40726636	40726663	3500423725	24		40726636	40726663	8421504	2	19,5	0,22	g	350042372500000075	3-27					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
896	chr28	40805714	40805809	3500340968	95		40805714	40805809	8421504	1	95	0	c	350034096800000087,350034096800000090	0-95,0-23						TARGETS FOR USE IN DIAGNOSIS, PROGNOSIS AND THERAPY OF CANCER - Patent application	www.faqs.org	0	0		GRID1
896	chr28	40805714	40805809	3500166301	95		40805714	40805809	8421504	1	95	0	c	350016630100000087,350016630100000090	0-95,0-23						Targets For Use In Diagnosis, Prognosis And Therapy Of Cancer - Patent application	www.faqs.org	0	0		GRID1
896	chr28	40805767	40805790	3500423784	23		40805767	40805790	8421504	1	23	0	c	350042378400000123	0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		GRID1
896	chr28	40805767	40805790	3500114594	23		40805767	40805790	8421504	1	23	0	c	350011459400000464,350011459400000891	0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		GRID1
896	chr28	40805767	40805790	3500031979	23		40805767	40805790	8421504	1	23	0	c	350003197900000379	0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		GRID1
898	chr28	41121811	41126630	3500381578	876		41121811	41126630	8421504	6	143,172,165,108,181,107	0,803,1414,2449,3379,4712	c,g	350038157800000000,350038157800000000,350038157800000002,350038157800000003,350038157800000003,350038157800000005,350038157800000004,350038157800000006,350038157800000007,350038157800000007,350038157800000009,350038157800000009,350038157800000011,350038157800000011,350038157800000031,350038157800000031,350038157800000013,350038157800000013,350038157800000033,350038157800000033,350038157800000015,350038157800000015,350038157800000014,350038157800000035,350038157800000035,350038157800000034,350038157800000017,350038157800000016,350038157800000037,350038157800000037,350038157800000036,350038157800000019,350038157800000018,350038157800000039,350038157800000038,350038157800000020,350038157800000021,350038157800000021,350038157800000041,350038157800000041,350038157800000023,350038157800000023,350038157800000043,350038157800000043,350038157800000025,350038157800000045,350038157800000027,350038157800000027,350038157800000047,350038157800000047	0-60,0-60,0-60,0-60,0-60,0-60,1-60,0-60,0-60,0-60,0-60,0-60,0-58,0-58,0-59,0-59,0-59,0-59,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-59,0-59						PowerPoint Presentation	www.kean.edu	0	0		
898	chr28	41124365	41125215	3500112397	23		41124365	41125215	8421504	3	3,14,6	0,825,844	c	350011239700000068	4-29						US Patent # 7,427,596. Variants of vascular endothelial cell growth factor, their uses, and processes for their production - Patents.com	www.patents.com	0	0		
899	chr28	41227989	41228024	3500179101	31		41227989	41228024	8421504	2	13,18	0,17	g	350017910100000039	9-46						Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
900	chr28	41318252	41347056	3500361277	1596		41318252	41347056	8421504	12	67,163,103,97,97,3,145,193,298,176,131,123	0,4374,6278,12532,12795,12896,16742,21119,23672,27278,28463,28681	p	350036127700015006,350036127700015011	0-1596,0-1596						BONE MORPHOGENETIC PROTEIN RECEPTOR BINDING AGENTS AND METHODS OF THEIR USE	Chartier-courtaud	2011	0		BMPR1A
900	chr28	41318253	41318278	3500458204	25		41318253	41318278	8421504	1	25	0	c	350045820400000012	0-25		18233958	10.1111/j.1365-2443.2007.01158.x	1365-2443	Genes to Cells	Reduced BMP4 abundance in Gata2 hypomorphic mutant mice result in uropathies resembling human CAKUT - Hoshino - 2008 - Genes to Cells - Wiley Online Library	Hoshino	2008	0		
900	chr28	41324530	41324553	3500401126	23		41324530	41324553	8421504	1	23	0	c	350040112600000008	22-45						Platelet-Rich Plasma Promotes the Proliferation of Human Muscle Derived Progenitor Cells and Maintains Their Stemness	olarship.pitt.edu	0	0		BMPR1A
900	chr28	41330800	41330881	3500309958	40		41330800	41330881	8421504	2	20,20	0,61	c,g	350030995800000012,350030995800000012,350030995800000013	0-20,0-20,0-20						BMP-2/6 Heterodimer Is More Effective than BMP-2 or BMP-6 Homodimers as Inductor of Differentiation of Human Embryonic Stem Cells	www.salk.edu	0	0		
900	chr28	41330835	41345690	3500463793	942		41330835	41345690	8421504	7	46,97,3,145,193,298,160	0,212,313,4159,8536,11089,14695	p	350046379300015001	0-942						<HTML> <HEAD> <META http-equiv="content-type" content="text/html; charset=UTF-8"> <TITLE>KF0397	ry.ddbj.nig.ac.jp	0	0		BMPR1A
900	chr28	41331078	41335028	3500217315	48		41331078	41335028	8421504	2	24,24	0,3926	c	350021731500000023,350021731500000024	0-24,0-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		
900	chr28	41339386	41339418	3500098010	32		41339386	41339418	8421504	1	32	0	c,g	350009801000000002,350009801000000002	30-62,30-62						Aus der Klinik f&#xfc;r Gastroenterologie mit Sektionen Infektiologie und Tropenmedizin	ub.uni-hamburg.de	0	0		
900	chr28	41341948	41341972	3500461854	24		41341948	41341972	8421504	1	24	0	c	350046185400000001	22-46		20587070	10.1186/1756-9966-29-85	1756-9966	Journal of Experimental & Clinical Cancer Research	Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients	Ma	2010	2		
900	chr28	41341948	41341972	3500332399	24		41341948	41341972	8421504	1	24	0	c	350033239900000001	22-46		20587070	10.1186/1756-9966-29-85	1756-9966	Journal of Experimental & Clinical Cancer Research	Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients	Ma	2010	2		BMPR1A
900	chr28	41341948	41341972	3500307052	24		41341948	41341972	8421504	1	24	0	c	350030705200000001	22-46						Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients	www.jeccr.com	0	0		
900	chr28	41342122	41342152	3500205595	30		41342122	41342152	8421504	1	30	0	c	350020559500000010	0-30		14742427	10.1074/jbc.M313938200	0021-9258	Journal of Biological Chemistry	Pre-B Cell Leukemia Transcription Factor (PBX) Proteins Are Important Mediators for Retinoic Acid-dependent Endodermal and Neuronal Differentiation of Mouse Embryonal Carcinoma P19 Cells	Qin	2004	5		
900	chr28	41345558	41345669	3500099578	99		41345558	41345669	8421504	2	48,51	0,60	p	350009957800015005,350009957800015012	6-54,0-51						TransformingGrowthFactor&#xc3;&#x0178;TypeIReceptorKinaseMutantAssociatedwith MetastaticBreastCancer1	.aacrjournals.org	0	0		BMPR1A
900	chr28	41345678	41346997	3500424225	42		41345678	41346997	8421504	2	21,21	0,1298	c,g	350042422500000006,350042422500000006,350042422500000007,350042422500000007	0-21,0-21,0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
900	chr28	41346803	41346980	3500053265	42		41346803	41346980	8421504	2	20,22	0,155	c,g	350005326500000006,350005326500000006,350005326500000007,350005326500000007	0-20,0-20,0-22,0-22						Levels of mRNA for BMP-7 in goat ovarian follicles and in vitro effects of BMP-7 on secondary follicle development	www.cbra.org.br	0	0		BMPR1B
112	chr28	41415653	41454343	3500388329	1634		41415653	41454343	8421504	17	9,122,64,5,92,124,81,138,138,180,95,64,56,81,332,12,41	0,18,1340,1519,5015,6201,6935,7264,9185,11388,17661,23358,24306,24886,38233,38585,38649	p,c,g	350038832900000132,350038832900000130,350038832900000185,350038832900000185,350038832900000126,350038832900000126,350038832900000183,350038832900000184,350038832900000122,350038832900000122,350038832900000182,350038832900000181,350038832900000119,350038832900000118,350038832900000118,350038832900000179,350038832900000179,350038832900000114,350038832900000114,350038832900000177,350038832900000111,350038832900000110,350038832900000175,350038832900000108,350038832900000106,350038832900000173,350038832900000173,350038832900000102,350038832900015041,350038832900015040,350038832900015042,350038832900000172,350038832900000171,350038832900000171,350038832900000098,350038832900000169,350038832900000094,350038832900000094,350038832900000167,350038832900000167,350038832900000168,350038832900000090,350038832900015038,350038832900000165,350038832900015039,350038832900000003,350038832900000086,350038832900000163,350038832900000164,350038832900000082,350038832900000085,350038832900000085,350038832900000161,350038832900000081,350038832900000078,350038832900015033,350038832900000159,350038832900000160,350038832900000160,350038832900000074,350038832900000075,350038832900000157,350038832900000158,350038832900000070,350038832900000155,350038832900000155,350038832900000156,350038832900000066,350038832900015031,350038832900015029,350038832900015032,350038832900000137,350038832900000137,350038832900000154,350038832900000061,350038832900000147,350038832900000152,350038832900000153,350038832900000058,350038832900000056,350038832900000057,350038832900000150,350038832900000151,350038832900000051,350038832900000053,350038832900000054,350038832900015025,350038832900000148,350038832900000149,350038832900000048,350038832900000047,350038832900000046,350038832900000136,350038832900000136,350038832900000001,350038832900000043,350038832900000042,350038832900000041,350038832900000041,350038832900000146,350038832900000145,350038832900000145,350038832900000040,350038832900000036,350038832900000036,350038832900000037,350038832900015024,350038832900015023,350038832900015022,350038832900015021,350038832900000144,350038832900000144,350038832900000143,350038832900000033,350038832900000033,350038832900000031,350038832900000141,350038832900000141,350038832900000029,350038832900000027,350038832900000026,350038832900000026,350038832900000140,350038832900000135,350038832900000135,350038832900000021,350038832900000021,350038832900000022,350038832900000139,350038832900000134	0-53,0-34,0-60,0-60,0-60,0-60,0-59,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-180,0-180,0-180,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-53,0-60,0-180,0-60,0-174,0-22,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-180,0-60,0-60,0-60,0-60,0-60,0-60,0-59,0-60,0-60,0-60,3-60,0-59,0-180,0-180,0-177,0-59,0-59,12-59,0-60,0-60,0-60,0-59,0-60,0-60,0-60,0-60,0-59,0-60,0-60,7-48,0-180,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-21,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-147,0-180,0-180,0-180,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-31,0-60,0-60,0-60,0-60,0-60,0-60,9-60						UNIVERSIDADE DO ESTADO DE SANTA CATARINA UDESC CENTRO DE CI&#xca;NCIAS AGROVETERIN&#xc1;RIAS CAV MESTRADO EM CI&#xca;NCIA ANIMAL SANDRA REGINA DE MELLO CLONAGEM DO cDNA E SEQUENCIAMENTO PARCIAL DO GENE QUE CODIFICA A ENZIMA GLUTAMATO DESIDROGENASE HEP&#xc	imal.cav.udesc.br	0	0		
901	chr28	41420674	41423019	3500337968	174		41420674	41423019	8421504	3	48,63,63	0,1932,2282	p	350033796800015046,350033796800015045,350033796800015042,350033796800015040	0-48,0-63,0-48,0-63						THE DISCOVERY AND FUNCTIONAL STUDIES OF TWO DIPHTHAMIDE BIOSYNTHETIC GENES	mmons.cornell.edu	0	0		
901	chr28	41420674	41423019	3500021643	174		41420674	41423019	8421504	3	48,63,63	0,1932,2282	p	350002164300015046,350002164300015045,350002164300015042,350002164300015040	0-48,0-63,0-48,0-63						THE DISCOVERY AND FUNCTIONAL STUDIES OF TWO DIPHTHAMIDE BIOSYNTHETIC GENES	brary.cornell.edu	0	0		
901	chr28	41420674	41422669	3500249757	111		41420674	41422669	8421504	2	48,63	0,1932	p	350024975700015032,350024975700015029	0-48,0-63						Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase	ww.sciencemag.org	0	0		GLUD1
901	chr28	41424913	41427062	3500188060	84		41424913	41427062	8421504	2	63,21	0,2128	p	350018806000015017	0-84						AnExaminationbySite-DirectedMutagenesisofPutative KeyResiduesintheDeterminationofCoenzymeSpeci&#xfb01;cityin ClostridialNAD -DependentGlutamateDehydrogenase	loads.hindawi.com	0	0		GLUD1
901	chr28	41453993	41454093	3500424712	40		41453993	41454093	8421504	2	20,20	0,80	c,g	350042471200000013,350042471200000013,350042471200000012	0-20,0-20,0-20		16687569	10.1091/mbc.E06-03-0247	1059-1524	Molecular Biology of the Cell	Ongoing U snRNP Biogenesis Is Required for the Integrity of Cajal Bodies	Lemm	2006	5		FAM35A
901	chr28	41453993	41454093	3500134872	40		41453993	41454093	8421504	2	20,20	0,80	c,g	350013487200000013,350013487200000013,350013487200000012	0-20,0-20,0-20			10.1091/mbc.E06-03-0247		Molecular Biology of the Cell	Ongoing U snRNP Biogenesis Is Required for the Integrity of Cajal Bodies	Ira	July	0		GLUD2
902	chr28	41671998	41672046	3500219194	48		41671998	41672046	8421504	1	48	0	c	350021919400000032	0-48						DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof	Bard	1997	0		
903	chr28	41720329	41720358	3500452256	29		41720329	41720358	8421504	1	29	0	c	350045225600000100,350045225600000187	0-20,0-29						 Modified Annexin Proteins And Methods For Their Use In Organ Transplantation 	www.docstoc.com	0	0		
905	chr28	42003980	42004154	3500225389	174		42003980	42004154	8421504	1	174	0	c,g	350022538900000055,350022538900000055,350022538900000056	0-174,0-174,0-173						Pegasoferae? - Genomewiki	nomewiki.ucsc.edu	0	0		
905	chr28	42004199	42004268	3500433844	69		42004199	42004268	8421504	1	69	0	p	350043384400015004	0-69						Amelioration of experimental autoimmune uveitis by leflunomide in lewis rats. - ResearchGate	.researchgate.net	0	0		
905	chr28	42012807	42012855	3500230176	48		42012807	42012855	8421504	1	48	0	p	350023017600015000	0-48		16574770	10.1189/jlb.0805453	0741-5400	Journal of Leukocyte Biology	Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-&#x03ba;B (NF-&#x03ba;B), pyrrolidine dithiocarbamate	Kitamei	2006	5		
905	chr28	42012886	42012912	3500317354	26		42012886	42012912	8421504	1	26	0	c	350031735400000000	0-26		21120359	10.1590/S0074-02762010000700009	0074-0276	Mem&#xf3;rias do Instituto Oswaldo Cruz	Mem&#xf3;rias do Instituto Oswaldo Cruz - Alternative PCR protocol using a single primer set for assessing DNA quality in several tissues from a large variety of mammalian species living in areas endemic for leishmaniasis	Ferreira	2010	2		
905	chr28	42021619	42021780	3500342586	65		42021619	42021780	8421504	2	24,41	0,120	c	350034258600000029,350034258600000026	0-24,7-48						Bmp-9 compositions	Celeste	1993	0		
905	chr28	42021619	42021780	3500262519	65		42021619	42021780	8421504	2	24,41	0,120	c	350026251900000085,350026251900000082	0-24,7-48						BMP-9 compositions	www.devileye.net	0	0		
905	chr28	42021622	42021742	3500337121	120		42021622	42021742	8421504	1	120	0	p	350033712100015057	15-135						Designer osteogenic proteins	Berasi	2012	0		GDF2
905	chr28	42022508	42022531	3500289438	23		42022508	42022531	8421504	1	23	0	c	350028943800000013	24-47						CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)	Basler	1994	0		
905	chr28	42038139	42040547	3500430647	411		42038139	42040547	8421504	2	186,225	0,2183	p	350043064700015013,350043064700015056,350043064700015047,350043064700015009,350043064700015010,350043064700015046,350043064700015054,350043064700015045,350043064700015052,350043064700015042,350043064700015006,350043064700015007,350043064700015005,350043064700015051,350043064700015040,350043064700015017,350043064700015039	0-51,0-45,0-45,0-180,0-180,0-48,0-45,0-45,0-45,0-45,0-177,0-180,0-180,0-45,0-45,0-75,0-45						Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		
905	chr28	42038166	42040548	3500168337	298		42038166	42040548	8421504	6	45,45,45,45,93,25	0,48,96,2189,2237,2357	p,c	350016833700015077,350016833700015076,350016833700015075,350016833700015073,350016833700015072,350016833700000062,350016833700015071,350016833700000060	0-45,0-45,0-45,0-45,0-45,6-27,0-45,5-30						Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		
905	chr28	42063324	42063350	3500260091	23		42063324	42063350	8421504	2	16,7	0,19	g	350026009100000014	9-36					Patent	Tapetum-specific promoters from Brassicaceae spp (Patent US:5723754)	Draper	1998	0		
906	chr28	42130868	42130892	3500008674	23		42130868	42130892	8421504	2	4,19	0,5	g	350000867400000180,350000867400000057	1-24,1-24						 Polyhydroxyalkanoate 	www.docstoc.com	0	0		
909	chr28	42537415	42537439	3500004723	24		42537415	42537439	8421504	1	24	0	c	350000472300000000,350000472300000001	0-24,0-24						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2002 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Paclitaxel-resistant Human Ovarian Cancer Cells Undergo c-Jun 2-terminal Kinase-mediated Apoptosis in Response to Noscap	medicorcancer.com	0	0		MAPK8
909	chr28	42537418	42537443	3500442572	25		42537418	42537443	8421504	1	25	0	c	350044257200000000	0-25						Supporting Information 	www.pnas.org	0	0		
909	chr28	42537421	42568370	3500027619	64		42537421	42568370	8421504	2	34,30	0,30919	c	350002761900000000,350002761900000001	8-42,0-30						Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity	www.whitelabs.org	0	0		MAPK8
909	chr28	42537466	42558781	3500452170	413		42537466	42558781	8421504	9	48,63,63,48,95,22,26,3,45	0,6361,9697,14916,20135,20279,20606,20728,21270	p,c	350045217000015070,350045217000000043,350045217000015072,350045217000015053,350045217000015076,350045217000015083,350045217000015061,350045217000000056,350045217000015063,350045217000000061	0-48,0-44,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48						US Patent # 6,706,509. Oncoprotein protein kinase - Patents.com	www.patents.com	0	0		
909	chr28	42543827	42568263	3500029292	290		42543827	42568263	8421504	10	44,40,8,47,22,26,3,45,1,54	0,8603,12365,13822,13918,14245,14367,14909,18209,24382	p,c	350002929200000043,350002929200015113,350002929200000056,350002929200000058,350002929200000061,350002929200000064	0-44,0-48,0-47,0-48,0-48,0-55						US Patent # 6,863,888. Oncoprotein protein kinase - Patents.com	www.patents.com	0	0		
909	chr28	42543899	42558125	3500279089	63		42543899	42558125	8421504	3	21,21,21	0,13782,14205	c,g	350027908900000002,350027908900000003,350027908900000003,350027908900000001,350027908900000001	0-21,0-21,0-21,0-21,0-21						The JNK/AP-1 pathway upregulates expression of the recycling endosome rab11a gene in B cells transformed by Theileria	theileria.org	0	0		
909	chr28	42546948	42546972	3500121245	23		42546948	42546972	8421504	2	6,17	0,7	g	350012124500000095	12-40						Coleopteran-resistant transgenic plants and methods of their production using modified Bacillus thuringiensis Cry3Bb nucleic acids	English	1999	0		
909	chr28	42547162	42547187	3500361592	25		42547162	42547187	8421504	1	25	0	c	350036159200000000	0-25						 Assessing Mitochondrial Redox Status by Flow Cytometric Methods: Vascular Response to Fluid Shear Stress - Current Protocols 	rentprotocols.com	0	0		
909	chr28	42547211	42547236	3500358184	25		42547211	42547236	8421504	1	25	0	c	350035818400000002,350035818400000003	0-22,0-22		20028971	10.1074/jbc.M109.038570		The Journal of Biological Chemistry	c-Jun N-terminal Kinase Enhances MST1-mediated Pro-apoptotic Signaling through Phosphorylation at Serine 82	Wenzhi	2010	0		MAPK9
909	chr28	42555761	42568219	3500351243	80		42555761	42568219	8421504	4	20,20,20,20	0,72,2965,12438	g	350035124300000035,350035124300000171,350035124300000172,350035124300000036,350035124300000041,350035124300000177,350035124300000045,350035124300000181	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						ANTISENSE INHIBITION VIA RNASE H-INDEPENDENT REDUCTION IN MRNA - Patent application	www.faqs.org	0	0		
909	chr28	42556225	42557589	3500053557	44		42556225	42557589	8421504	2	39,5	0,1359	c	350005355700000182,350005355700000180	0-44,0-44						COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS - Patent application	www.faqs.org	0	0		
909	chr28	42558769	42568254	3500272048	45		42558769	42568254	8421504	2	23,22	0,9463	c	350027204800000005,350027204800000015	0-23,0-22		18524773	10.1074/jbc.M709892200	0021-9258	Journal of Biological Chemistry	FoxM1 Regulates Transcription of JNK1 to Promote the G1/S Transition and Tumor Cell Invasiveness	Wang	2008	5		MAPK8
909	chr28	42562000	42568223	3500299297	51		42562000	42568223	8421504	2	37,14	0,6209	p	350029929700015004	3-54						Phosphatases which activate map kinase pathways - Patent application	www.faqs.org	0	0		MAPK8
909	chr28	42597913	42597941	3500241703	24		42597913	42597941	8421504	2	12,12	0,16	g	350024170300000005	3-28						Method of treating cell damage or depletion	Clark	1995	0		
910	chr28	42633705	42633731	3500202471	24		42633705	42633731	8421504	2	13,11	0,15	g	350020247100000018	15-41						US Patent # 6,737,519. Human genes relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
912	chr28	42904855	42904880	3500449380	24		42904855	42904880	8421504	2	18,6	0,19	c	350044938000000105	8-32						Anti-hiv Antibody 	freshpatents.com	0	0		
912	chr28	42905988	42906018	3500032434	25		42905988	42906018	8421504	3	7,13,5	0,11,25	g	350003243400000012	3-28						Method for selecting and producing vaccine components and vaccines based thereon	Leenhouts	2004	0		
913	chr28	43035161	43035185	3500044261	23		43035161	43035185	8421504	2	4,19	0,5	c	350004426100000013	3-26					Patent	Plant ubiquitin promoter system (Patent US:6054574)	Christensen	2000	0		
914	chr28	43232689	43232717	3500390652	23		43232689	43232717	8421504	2	10,13	0,15	g	350039065200000011	0-23						Chinese hamster apoptosis-related genes	Wong	2011	0		
917	chr28	43594817	43594841	3500093009	23		43594817	43594841	8421504	2	10,13	0,11	g	350009300900000031	1-24						Mechanisms and enzymes involved in SARS coronavirus genome expression	r.sgmjournals.org	0	0		
918	chr28	43655549	43676748	3500392695	47		43655549	43676748	8421504	2	24,23	0,21176	c,g	350039269500000003,350039269500000002,350039269500000002	0-26,0-23,0-23		11581270	10.1074/jbc.M107888200	0021-9258	Journal of Biological Chemistry	The Cockayne Syndrome Group B Gene Product Is Involved in General Genome Base Excision Repair of 8-Hydroxyguanine in DNA	Tuo	2001	5		ERCC6
918	chr28	43655549	43676748	3500266571	47		43655549	43676748	8421504	2	24,23	0,21176	c,g	350026657100000004,350026657100000003,350026657100000003	0-26,0-23,0-23					Molecular Biology of the Cell	The ATPase Domain but Not the Acidic Region of Cockayne Syndrome Group B Gene Product Is Essential for DNA Repair	Robert	1999	0		
918	chr28	43676640	43676672	3500380511	25		43676640	43676672	8421504	3	5,12,8	0,8,24	c	350038051100000001	1-26						Supplementary Materials for	ww.sciencemag.org	0	0		
918	chr28	43702636	43702664	3500370067	25		43702636	43702664	8421504	3	16,4,5	0,17,23	c	350037006700000041	0-25						SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 - Patent application	www.faqs.org	0	0		
918	chr28	43702636	43702664	3500145475	25		43702636	43702664	8421504	3	16,4,5	0,17,23	c	350014547500000040	0-25						Selective and potent peptide inhibitors of kv1.3	Arora	2012	0		
919	chr28	43878332	43878365	3500262611	26		43878332	43878365	8421504	3	6,6,14	0,10,19	c	350026261100000065	7-33						ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO - Patent application	www.faqs.org	0	0		
919	chr28	43878332	43878365	3500144411	26		43878332	43878365	8421504	3	6,6,14	0,10,19	c	350014441100000052	7-33						Tumor-Targeting Monoclonal Antibodies to FZD10 and Uses Thereof - Patent application	www.faqs.org	0	0		
920	chr28	43927642	43927687	3500448147	45		43927642	43927687	8421504	1	45	0	p	350044814700015001	0-45			10.1016/j.yexcr.2007.03.043		Experimental cell research	Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity	Ralph	2007	0		PARG
920	chr28	44022210	44023501	3500390575	78		44022210	44023501	8421504	2	55,23	0,1268	c,g	350039057500000002,350039057500000002,350039057500000001,350039057500000004,350039057500000004	16-35,16-35,0-43,13-36,13-36		11053413	10.1074/jbc.M007269200	0021-9258	Journal of Biological Chemistry	Caspase-3-mediated Processing of Poly(ADP-ribose) Glycohydrolase during Apoptosis	Affar	2001	5		
921	chr28	44127803	44137924	3500373689	459		44127803	44137924	8421504	4	138,63,174,84	0,5744,7647,10037	p	350037368900015055	0-459						Identification and characterization of Risp: a new nucleocytoplasmic shuttle protein interacting with the HIV-1 Rev protein	b.uni-muenchen.de	0	0		
921	chr28	44146414	44146446	3500098032	29		44146414	44146446	8421504	3	16,5,8	0,18,24	c	350009803200000608	3-33						Compositions and methods for increasing bone mineralization	Brunkow	2000	0		
923	chr28	44351393	44351416	3500292953	23		44351393	44351416	8421504	1	23	0	c	350029295300000036,350029295300000004	13-46,13-46						CYCLODIPEPTIDE SYNTHETASE AND ITS USE FOR SYNTHESIS OF CYCLO(Tyr-Xaa) CYCLODIPEPTIDES - Patent application	www.faqs.org	0	0		
923	chr28	44385200	44399273	3500349521	60		44385200	44399273	8421504	2	49,11	0,14062	p	350034952100015012	0-60						S E N S E M Y A > .Doc > Page : 1 > Fichiers-Doc.COM	fichiersdoc.com	0	0		ALOX5
923	chr28	44401397	44401420	3500328784	23		44401397	44401420	8421504	1	23	0	c	350032878400000018	8-32						Human erythroid p55 nucleic acids	Chishti	1992	0		
923	chr28	44407865	44407890	3500191511	25		44407865	44407890	8421504	1	25	0	c	350019151100000000	9-34						Overexpression of 5-Lipoxygenase Increases the Neuronal Vulnerability of PC12 Cells to A	kushi.pharm.or.jp	0	0		ALOX5
925	chr28	44666495	44671908	3500366168	273		44666495	44671908	8421504	4	101,52,102,18	0,685,1005,5395	p	350036616800015000	0-273						POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-KB PATHWAY - BRISTOL-MYERS SQUIBB COMPANY	www.sumobrain.com	0	0		RASSF4
925	chr28	44686184	44686209	3500311491	25		44686184	44686209	8421504	1	25	0	c	350031149100000081	14-39						Polynucleotides and polypeptides associated with the NF-kB pathway	Carman	2003	0		
928	chr28	45086043	45086071	3500035992	26		45086043	45086071	8421504	3	5,5,16	0,6,12	g	350003599200000054	13-42						Fusion Proteins Between Plant Cell-Wall Degrading Enzymes, and Their Uses - Patent application	www.faqs.org	0	0		
929	chr28	45100131	45102705	3500407924	201		45100131	45102705	8421504	2	116,85	0,2489	p	350040792400015016	3-204						Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells	Casanova	2012	0		CXCL12
929	chr28	45100131	45102675	3500327008	171		45100131	45102675	8421504	2	116,55	0,2489	p	350032700800015025,350032700800015026	3-87,0-87						Methods and reagents for efficient and targeted delivery of therapeutic molecules to cxcr4 cells	Casanova	2012	0		CXCL12
929	chr28	45100139	45102672	3500361371	41		45100139	45102672	8421504	2	21,20	0,2513	c,g	350036137100000004,350036137100000005,350036137100000005	0-21,0-20,0-20		22340947	10.1186/2044-5040-2-4		Skeletal Muscle	Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation	Maura	2012	0		
929	chr28	45100139	45102672	3500167716	41		45100139	45102672	8421504	2	21,20	0,2513	c,g	350016771600000004,350016771600000005,350016771600000005	0-21,0-20,0-20						Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation	musclejournal.com	0	0		
929	chr28	45100139	45102672	3500050904	41		45100139	45102672	8421504	2	21,20	0,2513	c,g	350005090400000004,350005090400000005,350005090400000005	0-21,0-20,0-20		22340947	10.1186/2044-5040-2-4	2044-5040	Skeletal Muscle	Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation	Parker	2012	0		
929	chr28	45100143	45100169	3500344791	26		45100143	45100169	8421504	1	26	0	c	350034479100000029,350034479100000079	0-26,0-26						Morphogen Compositions And Use Thereof To Treat Wounds 	.freshpatents.com	0	0		CXCL12
929	chr28	45100158	45103577	3500274037	40		45100158	45103577	8421504	2	20,20	0,3399	c,g	350027403700000033,350027403700000033,350027403700000034,350027403700000034	0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
929	chr28	45100158	45102661	3500432118	40		45100158	45102661	8421504	2	20,20	0,2483	c,g	350043211800000002,350043211800000002,350043211800000003	0-20,0-20,0-20						The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep. - ResearchGate	.researchgate.net	0	0		
929	chr28	45100158	45102661	3500027225	40		45100158	45102661	8421504	2	20,20	0,2483	c,g	350002722500000002,350002722500000002,350002722500000003,350002722500000003	0-20,0-20,0-20,0-20		22053725	10.1186/1477-7827-9-148	1477-7827	Reproductive Biology and Endocrinology	The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep	Ashley	2011	2		
929	chr28	45100158	45100242	3500365673	40		45100158	45100242	8421504	2	20,20	0,64	c,g	350036567300000004,350036567300000004,350036567300000005	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
929	chr28	45100158	45100242	3500262357	40		45100158	45100242	8421504	2	20,20	0,64	c,g	350026235700000004,350026235700000004,350026235700000005,350026235700000005	0-20,0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
929	chr28	45100206	45100232	3500090446	26		45100206	45100232	8421504	1	26	0	c	350009044600000019	20-46						Kaposi sarcoma herpesvirus microRNA function in lymphatic endothelial cells	scovery.ucl.ac.uk	0	0		CXCL12
929	chr28	45102643	45102667	3500167412	24		45102643	45102667	8421504	1	24	0	c	350016741200000041	22-46						The Molecular Mechanisms Utilised by Mesenchymal Stem Cells in Migration to Acute Myocardial Infarction Katarina Kollar	prints.qut.edu.au	0	0		
929	chr28	45102684	45102712	3500336766	28		45102684	45102712	8421504	1	28	0	c	350033676600000001	0-28		18648536	10.1371/journal.pone.0002543	1932-6203	PLOS ONE	PLOS ONE: The CXCL12&#x03b3; Chemokine Displays Unprecedented Structural and Functional Properties that Make It a Paradigm of Chemoattractant Proteins	Rueda	2008	4		
929	chr28	45102684	45102708	3500211380	24		45102684	45102708	8421504	1	24	0	c	350021138000000001	12-36						Biotechniques - The International Journal for Life Science Method 	biotechniques.com	0	0		CXCL12
931	chr28	45456015	45456038	3500147485	23		45456015	45456038	8421504	1	23	0	g	350014748500000001,350014748500000555,350014748500000019	8-31,2-25,5-28						Antigen Binding Proteins Capable Of Binding Thymic Stromal Lymphopoietin 	.freshpatents.com	0	0		
932	chr28	45542453	45542485	3500147445	28		45542453	45542485	8421504	3	4,17,7	0,5,25	g	350014744500000020	1-36						Ig genes specific oligonucleotides and uses thereof - Patent application	www.faqs.org	0	0		
933	chr28	45710484	45710512	3500101538	23		45710484	45710512	8421504	3	13,4,6	0,14,22	g	350010153800001718	0-23						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
934	chr28	45760504	45787162	3500249598	174		45760504	45787162	8421504	7	23,24,25,25,25,27,25	0,14204,17778,22441,24551,24848,26633	c,g	350024959800000011,350024959800000010,350024959800000007,350024959800000006,350024959800000004,350024959800000003,350024959800000002	0-23,1-25,25-50,0-25,0-25,23-50,1-26						Polymorphisms In Mitochondrial Transcription Factor A (tfam) Gene And Their Associations With Carcass Traits 	.freshpatents.com	0	0		
934	chr28	45760504	45785759	3500433539	96		45760504	45785759	8421504	4	23,23,25,25	0,14204,18145,25230	c,g	350043353900000019,350043353900000018,350043353900000012,350043353900000004,350043353900000004	0-23,0-23,0-25,0-25,0-25						Polymorphisms in mitochondrial transcription factor A ("TFAM") gene and their associations with carcass traits	Woodward	2006	0		
934	chr28	45760504	45785759	3500344696	95		45760504	45785759	8421504	4	23,23,24,25	0,14204,24850,25230	c,g	350034469600000019,350034469600000018,350034469600000005,350034469600000004,350034469600000004	0-23,0-23,0-24,0-25,0-25						Polymorphisms in mitochondrial transcription factor A (&#x201c;TFAM&#x201d;) gene and their associations with measures of marbling and subcutaneous fat depth in beef cattle	Jiang	2006	0		
934	chr28	45760504	45785759	3500235840	71		45760504	45785759	8421504	3	23,23,25	0,14204,25230	c,g	350023584000000017,350023584000000016,350023584000000002,350023584000000002	0-23,0-23,0-25,0-25						Means within a column with | Online Peptides Guide	tor-1-alpha-1.com	0	0		
934	chr28	45778494	45782798	3500221109	40		45778494	45782798	8421504	2	20,20	0,4284	c,g	350022110900000006,350022110900000006,350022110900000005	0-20,0-20,0-20						Embryonic quality and survival	ive.library.uu.nl	0	0		
934	chr28	45789962	45789985	3500187565	23		45789962	45789985	8421504	1	23	0	g	350018756500000001	5-35						Inhibition Of Metallo-Beta-Lactamase By Rna	Shaw	2005	0		
934	chr28	45862598	45862626	3500453754	24		45862598	45862626	8421504	3	7,13,4	0,10,24	c	350045375400000064	11-35						 Protein Showing Enhanced Expression In Cancer Cells 	www.docstoc.com	0	0		
934	chr28	45862598	45862626	3500012683	24		45862598	45862626	8421504	3	7,13,4	0,10,24	c	350001268300000038	11-35						 Methods To Inhibit Growth Of Prostate Cancer Cells 	www.docstoc.com	0	0		
934	chr28	45869340	45869365	3500241434	23		45869340	45869365	8421504	3	4,4,15	0,5,10	c	350024143400001260	9-32						GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME	Schellenberger	2010	0		
73	chr29	21879	156583	3500427859	434		21879	156583	8421504	22	11,6,16,19,12,17,18,11,17,11,14,12,21,64,13,30,38,49,7,15,20,13	0,18,1196,1414,1484,1497,3552,3786,3904,4031,4461,4594,5789,5967,6292,132860,133054,133362,133570,134446,134574,134691	g	350042785900000000	10-540						ScienceDirect.com - Genomics - Comparative genomic organization of the human and bovine PRNP locus	sciencedirect.com	0	0		
586	chr29	199706	199737	3500344705	25		199706	199737	8421504	3	8,5,12	0,11,19	c	350034470500000048	11-36						APJ ligand polypeptides	Hinuma	1999	0		
587	chr29	266277	266302	3500413332	25		266277	266302	8421504	1	25	0	c	350041333200000005	0-25		20685892	10.3945/jn.109.117531		The Journal of Nutrition	Identification of Zyklopen, a New Member of the Vertebrate Multicopper Ferroxidase Family, and Characterization in Rodents and Human Cells	Huijun	2010	0		
587	chr29	266277	266302	3500393559	25		266277	266302	8421504	1	25	0	c	350039355900000005	0-25		20685892	10.3945/jn.109.117531	0022-3166	The Journal of Nutrition	Identification of Zyklopen, a New Member of the Vertebrate Multicopper Ferroxidase Family, and Characterization in Rodents and Human Cells	Chen	2010	4		
589	chr29	630763	630791	3500357772	28		630763	630791	8421504	1	28	0	c	350035777200000152	21-49						Functional Polymorphisms: Bovine Calpastatin Gene and Meat Tenderness	.nottingham.ac.uk	0	0		
589	chr29	630879	630906	3500264039	27		630879	630906	8421504	1	27	0	c	350026403900000013	0-27						Structure and Evolution of the Y-chromosomal and Mitochondrial DNA of cattle	ive.library.uu.nl	0	0		
590	chr29	665211	665239	3500035423	25		665211	665239	8421504	3	5,5,15	0,6,13	g	350003542300000009	1-26		11069618	10.1046/j.1523-1747.2000.00131.x	0022-202X	Journal of Investigative Dermatology	Human Peptidylarginine Deiminase Type III: Molecular Cloning and Nucleotide Sequence of the cDNA, Properties of the Recombinant Enzyme, and Immunohistochemical Localization in Human Skin	Kanno	2000	6		
590	chr29	695654	695686	3500062301	25		695654	695686	8421504	3	11,3,11	0,15,21	g	350006230100000031	0-25						Immunotoxicology of titanium dioxide and hydroxylated fullerenes engineered nanoparticles in fish models	ib.dr.iastate.edu	0	0		
593	chr29	1049895	1049923	3500135942	24		1049895	1049923	8421504	2	13,11	0,17	g	350013594200000005	0-27						Hepatocyte Growth Factor (HGF) Binding Proteins	Breault	2010	0		
74	chr29	1560637	1575533	3500427541	91		1560637	1575533	8421504	5	23,1,24,19,24	0,24,14015,14491,14872	c,g	350042754100000003,350042754100000002,350042754100000006,350042754100000013,350042754100000013,350042754100000007	0-23,0-25,0-25,0-19,0-19,0-24		19814723	10.1111/j.1476-5381.2009.00453.x	1476-5381	British Journal of Pharmacology	The end of a myth: cloning and characterization of the ovine melatonin MT2 receptor - Cog&#xe9; - 2009 - British Journal of Pharmacology - Wiley Online Library	Coge	2009	0		
597	chr29	1574711	1575398	3500234055	162		1574711	1575398	8421504	2	84,78	0,609	p	350023405500015123,350023405500015081	0-84,6-84						Cloning and retinal expression of melatonin receptors in the European sea bass, Dicentrarchus labrax	chimer.ifremer.fr	0	0		
598	chr29	1760907	1760935	3500425388	28		1760907	1760935	8421504	1	28	0	g	350042538800000143	0-28						Taninos condensados en leguminosas del g&#xe9;nero Lotus : Estudio de sus	ri.agro.uba.ar	0	0		
599	chr29	1846544	1846571	3500437151	23		1846544	1846571	8421504	2	8,15	0,12	c	350043715100000027	7-30						NATRIURETIC PEPTIDE RELATED FRAGMENT IN CARDIOVASCULAR DISEASE - Patent application	www.faqs.org	0	0		ETNK1
599	chr29	1865296	1865324	3500243179	23		1865296	1865324	8421504	2	10,13	0,15	g	350024317900000042	0-23						Neural regeneration peptides and methods for their use in treatment of brain damage - US Patent 7563862 Description	ww.patentstorm.us	0	0		
599	chr29	1912209	1912239	3500323425	24		1912209	1912239	8421504	3	6,13,5	0,10,25	g	350032342500000000	11-38						E.coli host cells with modified phos/psts periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs	Humphreys	2004	0		
600	chr29	2055691	2055719	3500252038	25		2055691	2055719	8421504	2	20,5	0,23	g	350025203800000219	7-34					Patent	Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium (Patent CN:1170938)	Zhao Cang Yang Zi 	2004	0		
600	chr29	2055691	2055719	3500096256	25		2055691	2055719	8421504	2	20,5	0,23	g	350009625600000179	7-34						Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium	Zhao Cang Yang Zi 	2001	0		
602	chr29	2239984	2240010	3500317022	23		2239984	2240010	8421504	2	13,10	0,16	g	350031702200000033	0-23						Martin-Luther-Universit&#xe4;t Halle-Wittenberg	d-nb.info/1024873	0	0		
604	chr29	2527287	2527313	3500427395	23		2527287	2527313	8421504	2	8,15	0,11	g	350042739500000003	2-25						Polymerase chain reaction for the diagnosis of bovine genital campylobacteriosis	www.scielo.br	0	0		
604	chr29	2527287	2527313	3500006730	23		2527287	2527313	8421504	2	8,15	0,11	g	350000673000000003	2-25		16162226	10.1111/j.1365-2672.2005.02680.x	1365-2672	Journal of Applied Microbiology	A multiplex polymerase chain reaction to detect and differentiate Campylobacter fetus subspecies fetus and Campylobacter fetus -species venerealis: use on UK isolates of C. fetus and other Campylobacter spp. - Willoughby - 2005 - Journal of Applied Microb	Willoughby	2005	0		
615	chr29	4000665	4000691	3500023119	23		4000665	4000691	8421504	2	13,10	0,16	g	350002311900000042	3-38						MuO-conopeptides and their use as local anesthetics	Olivera	2004	0		
618	chr29	4417710	4426256	3500309840	50		4417710	4426256	8421504	4	13,6,18,13	0,16,8512,8533	g	350030984000000037,350030984000001044	29-48,0-34						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
619	chr29	4497894	4514299	3500309840	40		4497894	4514299	8421504	3	21,16,3	0,16384,16402	g	350030984000000526,350030984000000497	6-30,11-30						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
625	chr29	5315451	5315744	3500169014	90		5315451	5315744	8421504	2	45,45	0,248	p	350016901400015027,350016901400015024	0-45,0-45						Pharmaceutical Composition, Composition for Screening Therapeutics Preventing and Treating Beta Amyloid Accumulation in Brain Comprising Gcp II (Glutamate Carboxypeptidase II) as an Active Ingredient and Method for Screening Using the Same - Patent applic	www.faqs.org	0	0		NAALAD2
625	chr29	5315451	5315744	3500121710	90		5315451	5315744	8421504	2	45,45	0,248	p	350012171000015076,350012171000015073	0-45,0-45						METHOD FOR TREATING SOLID TUMORS - Patent application	www.faqs.org	0	0		NAALAD2
625	chr29	5315451	5315744	3500052642	90		5315451	5315744	8421504	2	45,45	0,248	p	350005264200015053,350005264200015050	0-45,0-45						Prostate-specific membrane antigen and uses thereof - Patent application	www.faqs.org	0	0		NAALAD2
626	chr29	5386736	5403122	3500388350	71		5386736	5403122	8421504	3	27,21,23	0,12317,16363	c,g	350038835000000050,350038835000000049,350038835000000049,350038835000000051,350038835000000051	0-27,0-21,0-21,0-23,0-23						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
626	chr29	5399053	5403122	3500027904	44		5399053	5403122	8421504	2	21,23	0,4046	c,g	350002790400000024,350002790400000026,350002790400000026	0-21,0-23,0-23						 SpringerImages - primers sequences 	pringerimages.com	0	0		
630	chr29	5920439	5977296	3500370353	137		5920439	5977296	8421504	5	31,17,41,45,3	0,2375,21075,44645,56854	p,c	350037035300000057,350037035300000040,350037035300015024	0-48,7-48,0-48						Prostate-specific membrane antigen	Fair	1995	0		
630	chr29	5940293	5991496	3500298438	43		5940293	5991496	8421504	4	1,21,5,16	0,1191,48424,51187	c	350029843800000004,350029843800000008	0-22,0-21						CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY	Kufer	2011	0		
630	chr29	5945645	5945693	3500151848	48		5945645	5945693	8421504	1	48	0	p	350015184800015005	0-48						PrecursorofBrain-derivedNeurotrophicFactor(proBDNF) FormsaComplexwithHuntingtin-associatedProtein-1 (HAP1)andSortilinThatModulatesproBDNFTrafficking, Degradation,andProcessing	www.jbc.org	0	0		FOLH1
630	chr29	5965021	5977296	3500055561	105		5965021	5977296	8421504	4	42,45,15,3	0,45,93,12272	p	350005556100015031	0-105						Prostate-specific membrane antigen and uses thereof - Patent # 7037647 - PatentGenius	.patentgenius.com	0	0		
631	chr29	6146626	6147466	3500097633	43		6146626	6147466	8421504	2	20,23	0,817	g	350009763300000017,350009763300000008	0-20,0-23						Regulation of NAD(P)H oxidase growth and transcription in melanoma cells	Kennedy	2002	0		NOX4
631	chr29	6147443	6147466	3500173132	23		6147443	6147466	8421504	1	23	0	g	350017313200000010	0-23		12686516	10.1152/ajpcell.00525.2002		American Journal of Physiology - Cell Physiolog	NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells	Brar	2003	0		NOX4
632	chr29	6223605	6223680	3500103872	67		6223605	6223680	8421504	3	21,24,22	0,27,53	g	350010387200000003,350010387200000004,350010387200000005	0-21,0-24,0-22						Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: Implication of NADPH oxidase	ww.uphs.upenn.edu	0	0		
634	chr29	6435904	6546296	3500413148	2053		6435904	6546296	8421504	5	625,182,148,217,881	0,17254,64381,99763,109511	p,c,g	350041314800000034,350041314800000118,350041314800000118,350041314800000119,350041314800000115,350041314800000115,350041314800000114,350041314800000114,350041314800000137,350041314800000137,350041314800015099,350041314800015031,350041314800000033,350041314800000033,350041314800000136,350041314800000136,350041314800015030,350041314800000032,350041314800000032,350041314800015029,350041314800000031,350041314800015098,350041314800015028,350041314800000030,350041314800015027,350041314800000029,350041314800000029,350041314800015026,350041314800000028,350041314800000028,350041314800015097,350041314800015025,350041314800000027,350041314800000027,350041314800015024,350041314800000026,350041314800015023,350041314800000025,350041314800015022,350041314800000024,350041314800015096,350041314800015021,350041314800000023,350041314800000023,350041314800015020,350041314800000022,350041314800000022,350041314800000021,350041314800000021,350041314800015019,350041314800015095,350041314800000020,350041314800015018,350041314800000019,350041314800000019,350041314800015017,350041314800000018,350041314800000018,350041314800015016,350041314800015094,350041314800015015,350041314800000017,350041314800000017,350041314800015014,350041314800000016,350041314800000016,350041314800000015,350041314800000015,350041314800015013,350041314800000014,350041314800015012,350041314800015093,350041314800015011,350041314800000013,350041314800000013,350041314800015010,350041314800000012,350041314800000012,350041314800015009,350041314800000011,350041314800000011,350041314800015092,350041314800015008,350041314800000010,350041314800015007,350041314800000009,350041314800000009,350041314800000008,350041314800000008,350041314800015006,350041314800015091,350041314800015005,350041314800000007,350041314800000007,350041314800015004,350041314800000006,350041314800000006,350041314800015003,350041314800000005,350041314800000005,350041314800000004,350041314800000117,350041314800000116,350041314800000116	0-419,0-30,0-30,0-31,0-25,0-25,0-27,0-27,0-20,0-20,0-150,0-54,0-54,0-54,0-21,0-21,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-55,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,2-70,0-28,1-29,1-29						G&#xe9;n&#xe9;tique de la coloration de la robe chez les bovins : Contribution &#xe0; l&#x2019;&#xe9;tude du r&#xf4;le des g&#xe8;nes de la famille tyrosinase	cations.unilim.fr	0	0		
634	chr29	6436190	6436215	3500258554	24		6436190	6436215	8421504	2	12,12	0,13	c	350025855400000712	16-40						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
634	chr29	6535675	6535746	3500329835	71		6535675	6535746	8421504	1	71	0	c	350032983500000083,350032983500000044	0-47,0-48						US Patent # 5,679,511. CDNA clones for a regulatory protein in the melanin-production pathway - Patents.com	www.patents.com	0	0		
634	chr29	6545421	6545446	3500214021	25		6545421	6545446	8421504	1	25	0	c	350021402100000004	0-25		12692260		1541-7786	Molecular Cancer Research	Induction of &#x201c;Antigen Silencing&#x201d; in Melanomas by Oncostatin M: Down-Modulation of Melanocyte Antigen Expression1 1 International Cancer Research Fellowship and Phase I SBIR Grant 1R43CA086153 to CytoCure LLC, Paul J. Durda PI.	Durda	2003	4		
636	chr29	6787743	6787768	3500155900	24		6787743	6787768	8421504	2	20,4	0,21	g	350015590000000433	16-48						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
638	chr29	7059831	7059857	3500154834	23		7059831	7059857	8421504	3	6,5,12	0,8,14	g	350015483400000025	16-39						Transferrin receptor antibodies	Mather	2005	0		
642	chr29	7491293	7491317	3500297881	24		7491293	7491317	8421504	1	24	0	g	350029788100000040	1-25						Translocation dependent complementation for drug screening	Dahl	2003	0		
642	chr29	7585881	7586125	3500235713	44		7585881	7586125	8421504	2	22,22	0,222	c,g	350023571300000020,350023571300000020,350023571300000021,350023571300000021	0-22,0-22,0-22,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
80	chr29	7672697	7737874	3500413148	332		7672697	7737874	8421504	4	115,55,81,81	0,25291,25399,65096	g	350041314800000098,350041314800000099,350041314800000104,350041314800000106,350041314800000107,350041314800000108	0-61,0-54,0-55,0-54,0-54,0-54						G&#xe9;n&#xe9;tique de la coloration de la robe chez les bovins : Contribution &#xe0; l&#x2019;&#xe9;tude du r&#xf4;le des g&#xe8;nes de la famille tyrosinase	cations.unilim.fr	0	0		
651	chr29	8663268	8663293	3500167920	23		8663268	8663293	8421504	2	10,13	0,12	g	350016792000000005	0-23						The Dissertation Committee for Stephen Charles Stout Certifies that this is the approved version of the following dissertation: Physiological and Bioinformatic Studies on Polarity Development Ceratopteris richardii Spores	es.lib.utexas.edu	0	0		
652	chr29	8868449	8871139	3500398855	40		8868449	8871139	8421504	3	9,11,20	0,2503,2670	c,g	350039885500000009,350039885500000010,350039885500000010	0-20,0-20,0-20						CROSSTALK BETWEEN INSULIN AND WNT SIGNALING PATHWAYS	brary.utoronto.ca	0	0		FZD4
654	chr29	9058555	9058587	3500258078	25		9058555	9058587	8421504	3	12,8,5	0,17,27	c	350025807800000122	8-34						Nematode PAN and ZP Receptor-Like Sequences - Patent application	www.faqs.org	0	0		
658	chr29	9568388	9568411	3500401421	23		9568388	9568411	8421504	1	23	0	g	350040142100000011	0-23						Xin. mRNA expression of iron metabolism relation genes in macrophages by infection with Salmonella typhimurium. Afr. J. Microbiol. Res. 2011	demicjournals.org	0	0		
658	chr29	9576365	9606689	3500296148	1308		9576365	9606689	8421504	15	124,74,120,36,18,85,134,92,82,126,66,93,30,114,114	0,395,1214,1337,11245,11266,13311,15201,17704,18406,19850,23550,25306,25345,30210	p	350029614800015052,350029614800015049,350029614800015044,350029614800015046,350029614800015045,350029614800015041,350029614800015038,350029614800015035,350029614800015032	0-84,0-234,9-54,0-54,0-102,0-165,0-225,0-216,0-228						The Polycomb group in Caenorhabditis elegansand maternal control of germline development	ev.biologists.org	0	0		EED
658	chr29	9596253	9601740	3500330297	47		9596253	9601740	8421504	2	27,20	0,5467	c,g	350033029700000003,350033029700000003,350033029700000004,350033029700000004	23-50,23-50,0-20,0-20				1470-1626		Polycomb gene expression and histone H3 lysine 27 trimethylation changes during bovine preimplantation development 	uction-online.org	0	3		
658	chr29	9652415	9652439	3500023334	24		9652415	9652439	8421504	1	24	0	g	350002333400000107	15-39						Proteins, Polynucleotides Encoding Them And Methods Of Using The Same 	.freshpatents.com	0	0		
658	chr29	9675366	9675397	3500261310	24		9675366	9675397	8421504	3	5,6,13	0,7,18	g	350026131000000016	9-33						Taci-immunoglobulin fusion proteins	Gross	2010	0		
658	chr29	9675366	9675397	3500211099	24		9675366	9675397	8421504	3	5,6,13	0,7,18	g	350021109900000016	9-33						TACI-immunoglobulin fusion proteins	Rixon	2005	0		
659	chr29	9716033	9716057	3500167742	24		9716033	9716057	8421504	1	24	0	g	350016774200000144	8-33						By Jonathan Seaman	www.rhizobium.net	0	0		
660	chr29	9861215	9861239	3500165664	23		9861215	9861239	8421504	2	17,6	0,18	g	350016566400000132	11-38						Cysteine-containing peptide tag for site-specific conjugation of proteins - Patent application	www.faqs.org	0	0		
660	chr29	9884040	9906283	3500183887	42		9884040	9906283	8421504	2	21,21	0,22222	c	350018388700000003,350018388700000002	0-21,0-21		22952941	10.1371/journal.pone.0044252	1932-6203	PLOS ONE	PLOS ONE: The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation	Scotland	2012	4		PICALM
660	chr29	9930537	9930564	3500386203	25		9930537	9930564	8421504	2	10,15	0,12	c	350038620300000271	20-46						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
662	chr29	10130954	10130983	3500019454	24		10130954	10130983	8421504	2	11,13	0,16	g	350001945400000075	0-24						Introduction to Computational Molecular Biology - Carlos Setubal, Joao Meidanis	www.scribd.com	0	0		
665	chr29	10614042	10614070	3500323015	25		10614042	10614070	8421504	2	10,15	0,13	g	350032301500000027	20-45						US Patent # 5,998,191. High specificity homocysteine assays for biological samples - Patents.com	www.patents.com	0	0		
666	chr29	10637410	10637563	3500024337	40		10637410	10637563	8421504	2	20,20	0,133	g	350002433700000020,350002433700000021	0-20,0-20						Genetic Diversity Analysis of the Gohilwari Breed of Indian Goat Capra hircus ) Using Microsatellite Markers	thescipub.com	0	0		
667	chr29	10832162	10832189	3500101538	24		10832162	10832189	8421504	2	7,17	0,10	g	350010153800000314	1-27						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
669	chr29	11136443	11136469	3500309840	23		11136443	11136469	8421504	2	6,17	0,9	g	350030984000000758	0-25						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
670	chr29	11236367	11236396	3500443003	24		11236367	11236396	8421504	3	6,5,13	0,9,16	g	350044300300000025	10-34						Pasteurella vaccine - Patent # 5369019 - PatentGenius	.patentgenius.com	0	0		
672	chr29	11493449	11493478	3500114536	24		11493449	11493478	8421504	3	7,13,4	0,11,25	g	350011453600000074,350011453600000328	5-30,5-30						HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF - Patent application	www.faqs.org	0	0		
683	chr29	12959692	12959716	3500074983	23		12959692	12959716	8421504	2	6,17	0,7	c	350007498300000152	9-35						Alpha-amylase mutants with altered properties - US Patent 7713723 Description	ww.patentstorm.us	0	0		
685	chr29	13154388	13154411	3500200817	23		13154388	13154411	8421504	1	23	0	g	350020081700000277	5-28						 Use Of Multiple Recombination Sites With Unique Specificity In Recombinational Cloning 	www.docstoc.com	0	0		
685	chr29	13221001	13221868	3500162254	40		13221001	13221868	8421504	2	20,20	0,847	g	350016225400000002,350016225400000000	0-20,0-20					Patent	Pigs and pig cells having an inactivated &#x03b1; 1,3-galactosyl transferase gene (Patent US:6849448)	Crawford	2005	0		
689	chr29	13648562	13648591	3500227650	25		13648562	13648591	8421504	3	7,14,4	0,10,25	g	350022765000000028	1-27						Detection of acid-resistant micro-organisms in a stool	Cullmann	2000	0		
691	chr29	13913338	13913361	3500082390	23		13913338	13913361	8421504	1	23	0	g	350008239000000059	0-23						US Patent # 7,411,057. Nucleic acids encoding human monoclonal antibodies to CTLA-4 - Patents.com	www.patents.com	0	0		
709	chr29	16290108	16290137	3500243407	24		16290108	16290137	8421504	3	6,5,13	0,8,16	g	350024340700000038	12-36						Method of assaying Neutrokine-&#x03b1; mRNA level	Yu	1999	0		
710	chr29	16464414	16464438	3500354301	23		16464414	16464438	8421504	2	7,16	0,8	g	350035430100000004	19-42						World J Gastroenterol	www.wjgnet.com	0	0		
711	chr29	16640707	16640732	3500044252	23		16640707	16640732	8421504	2	8,15	0,10	g	350004425200000006	12-35						Construction of an infectious cDNA clone of foot-and-mouth disease virus type O BFS 1860 and its use in the preparation of candidate 1 vaccine	www.ias.ac.in	0	0		
719	chr29	17646576	17646603	3500255062	23		17646576	17646603	8421504	3	4,6,13	0,5,14	g	350025506200000033	8-33						TNF-&#x03b1; binding molecules - US Patent 7101978 Description	ww.patentstorm.us	0	0		
721	chr29	17853431	17853454	3500062329	23		17853431	17853454	8421504	1	23	0	g	350006232900000780,350006232900000232	4-27,2-25						ISOLATION OF UNKNOWN REARRANGED T-CELL RECEPTORS FROM SINGLE CELLS - Patent application	www.faqs.org	0	0		
722	chr29	18053780	18053812	3500047637	26		18053780	18053812	8421504	3	13,9,4	0,18,28	g	350004763700000502	20-46						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
722	chr29	18084620	18084654	3500130848	30		18084620	18084654	8421504	2	22,8	0,26	g	350013084800000480	6-48						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
723	chr29	18176450	18176480	3500304335	23		18176450	18176480	8421504	3	11,6,6	0,15,24	g	350030433500000346	0-23						Diagnosis and Treatment of Cancer Using Anti-EREG Antibody - Patent application	www.faqs.org	0	0		
724	chr29	18239281	18255311	3500289217	3430		18239281	18255311	8421504	5	25,1290,39,1400,676	0,12479,13789,13948,15354	p,c,g	350028921700000037,350028921700000026,350028921700000029,350028921700000000,350028921700000000,350028921700000059,350028921700000059,350028921700000030,350028921700000036,350028921700015007,350028921700000052,350028921700000053,350028921700000050,350028921700000051,350028921700000058,350028921700000041,350028921700000045,350028921700000046,350028921700000007,350028921700000062,350028921700000031,350028921700000032,350028921700000027,350028921700000033,350028921700000005,350028921700000060,350028921700015008,350028921700000009,350028921700000064,350028921700015009,350028921700000001,350028921700000078,350028921700000038,350028921700000034	0-830,0-1290,0-500,0-21,0-21,0-21,0-21,0-85,0-254,0-45,0-25,0-25,0-30,0-30,0-30,0-30,0-26,0-26,0-21,0-21,0-690,0-740,0-1440,0-700,0-21,0-21,0-45,0-21,0-21,0-45,0-22,0-22,0-675,0-225						JY-1 Regulation Of Granulosa Cell Function And Early Embryonic Development In Cattle - Patent application	www.faqs.org	0	0		
724	chr29	18252256	18253956	3500435393	42		18252256	18253956	8421504	2	21,21	0,1679	c,g	350043539300000038,350043539300000038,350043539300000039,350043539300000039	0-21,0-21,0-21,0-21						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
724	chr29	18253914	18255267	3500269943	88		18253914	18255267	8421504	4	20,20,25,23	0,379,727,1330	c	350026994300000002,350026994300000003,350026994300000000,350026994300000001,350026994300000004,350026994300000005	0-20,0-20,0-20,0-25,0-25,0-23						Sitio Argentino de Producci&#xf3;n Animal	ion-animal.com.ar	0	0		
725	chr29	18411164	18411195	3500145423	24		18411164	18411195	8421504	3	13,5,6	0,15,25	c	350014542300000021	0-24						Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use	Sala-schaeffer	2007	0		
728	chr29	18866377	18866511	3500172791	45		18866377	18866511	8421504	2	23,22	0,112	c,g	350017279100000023,350017279100000023,350017279100000022	0-23,0-23,0-22		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
728	chr29	18866377	18866511	3500120290	45		18866377	18866511	8421504	2	23,22	0,112	c	350012029000000023,350012029000000022	0-23,0-22						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
728	chr29	18866377	18866511	3500048191	45		18866377	18866511	8421504	2	23,22	0,112	c	350004819100000023,350004819100000022	0-23,0-22		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
728	chr29	18866665	18866816	3500301078	47		18866665	18866816	8421504	2	23,24	0,127	c	350030107800000062,350030107800000061	0-23,0-24						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
728	chr29	18866665	18866772	3500463464	107		18866665	18866772	8421504	1	107	0	c	350046346400000049,350046346400000023	11-119,24-47						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
728	chr29	18871340	18872069	3500238125	72		18871340	18872069	8421504	3	23,21,28	0,516,701	c,g	350023812500000004,350023812500000002,350023812500000003,350023812500000006	0-23,0-21,0-23,1-25						 The Polymorphisms of Goat THRSP Gene Associated with Ecological Factors in Chinese Indigenous Goat Breeds with Different Lipogenesis Ability	scialert.net	0	0		
728	chr29	18871812	18871921	3500319126	80		18871812	18871921	8421504	2	20,60	0,49	p,c	350031912600000000,350031912600000001,350031912600000002,350031912600015001	20-40,0-60,0-58,0-54						&#x4e94;&#x79cd;&#x725b;THRSP&#x57fa;&#x56e0;&#x90e8;&#x5206;&#x7b2c;&#x4e00;&#x5916;&#x663e;&#x5b50;&#x5e8f;&#x5217;	www.casb.org.cn	0	0		
731	chr29	19227310	19227339	3500081318	24		19227310	19227339	8421504	3	11,8,5	0,14,24	g	350008131800000055	7-31						Nucleotide sequences of soybean acyl-acp thioesterase genes.	Hitz	1993	0		
733	chr29	19469029	19469058	3500333706	24		19469029	19469058	8421504	2	6,18	0,11	g	350033370600000016	4-32						Doctorate Program in Molecular Oncology and Endocrinology	ww.fedoa.unina.it	0	0		
733	chr29	19490565	19490610	3500143843	45		19490565	19490610	8421504	1	45	0	p	350014384300015032	3-48						Quantitative Analyse von T-Zell Stimulation und Costimulation durch zellul&#xe4;re Mikrosysteme	.uni-tuebingen.de	0	0		PAK1
733	chr29	19505210	19514401	3500367854	201		19505210	19514401	8421504	3	45,148,8	0,3655,9183	p	350036785400015002	0-201						USE OF PAK INHIBITOR FOR THE TREATMENT OF A JOINT DISEASE - Patent application	www.faqs.org	0	0		
733	chr29	19505210	19514401	3500208579	201		19505210	19514401	8421504	3	45,148,8	0,3655,9183	p	350020857900015000	0-201						Use of PAK inhibitor for the treatment of a joint disease	Barradeau	2004	0		
733	chr29	19508912	19508936	3500448691	24		19508912	19508936	8421504	1	24	0	c,g	350044869100000001,350044869100000001	0-24,0-24						Article	jcb.rupress.org	0	0		PAK1
733	chr29	19523340	19529639	3500073579	63		19523340	19529639	8421504	2	42,21	0,6278	p	350007357900015118,350007357900015108,350007357900015140,350007357900015102	0-45,0-45,0-45,0-45						Compositons, methods and kits for real-time nucleic acid analysis in live cells - Patent application	www.faqs.org	0	0		PAK1
733	chr29	19523343	19529633	3500006484	54		19523343	19529633	8421504	2	39,15	0,6275	p	350000648400015002	0-54						MMB 189 GTPase Protocols	www.scribd.com	0	0		PAK1
734	chr29	19564992	19565037	3500410081	45		19564992	19565037	8421504	1	45	0	p	350041008100015041	0-45						Method to determine inhibition of PAK3 activation of Raf-1	Marshall	1998	0		PAK1
734	chr29	19569432	19569455	3500360289	23		19569432	19569455	8421504	1	23	0	c	350036028900000004	17-40		11733498	10.1074/jbc.M110000200	0021-9258	Journal of Biological Chemistry	Interaction between Active Pak1 and Raf-1 Is Necessary for Phosphorylation and Activation of Raf-1	Zang	2002	5		
739	chr29	20194310	20194339	3500463341	25		20194310	20194339	8421504	2	7,18	0,11	g	350046334100000002	8-33						International Journal of Food Microbiology	ww.fp7-pilgrim.eu	0	0		
748	chr29	21387231	21387257	3500130848	24		21387231	21387257	8421504	2	15,9	0,17	g	350013084800000774	15-39						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
749	chr29	21611993	21612019	3500465948	24		21611993	21612019	8421504	2	6,18	0,8	g	350046594800000077	24-48						&#x6d17;&#x6da4;&#x5242;&#x7ec4;&#x5408;&#x7269; Detergent compositions	K*Ji Bu Sen 	2006	0		
750	chr29	21675621	21675644	3500317386	23		21675621	21675644	8421504	1	23	0	g	350031738600000000	1-24						'club dues invoice excel' cmyk to rgb in excel	hehelmgallery.com	0	0		
750	chr29	21675770	21675793	3500260984	23		21675770	21675793	8421504	1	23	0	g	350026098400000007	0-23						Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans	jp.physoc.org	0	0		
750	chr29	21675862	21676314	3500390202	40		21675862	21676314	8421504	2	20,20	0,432	g	350039020200000005,350039020200000006	0-20,0-20						The RhoA Activator GEF-H1/Lfc Is a Transforming Growth Factor- Target Gene and Effector That Regulates -Smooth Muscle Actin Expression and Cell Migration	w.molbiolcell.org	0	0		GAPDH
750	chr29	21676291	21676314	3500047825	23		21676291	21676314	8421504	1	23	0	g	350004782500000000	18-41						Development of IL-17-mediated Delayed-Type Hypersensitivity Is Not Affected by Down-Regulation of IL-25 Expression	ai.jsaweb.jp	0	0		GAPDH
757	chr29	22605500	22605533	3500057001	24		22605500	22605533	8421504	3	6,11,7	0,10,26	g	350005700100000334	5-32						Surface antigen	www.devileye.net	0	0		
759	chr29	22914328	22914352	3500182034	23		22914328	22914352	8421504	2	11,12	0,12	g	350018203400000015	9-32						-Proximal Hot Spot for an Inducible Positive-to-Negative-Strand Template Switch by Coronavirus RNA-Dependent RNA Polymerase	jvi.asm.org	0	0		
760	chr29	22963115	22963142	3500333793	24		22963115	22963142	8421504	2	6,18	0,9	g	350033379300000014	9-33						&#x514d;&#x75ab;&#x539f;&#x6027;&#x7ec4;&#x5408;&#x7269; Immunogenic compositions	P.De Nei Er 	2013	0		
760	chr29	23014103	23014126	3500240560	23		23014103	23014126	8421504	1	23	0	g	350024056000000000	1-24						Polypeptide-RasGTP enzyme activated protein 9.57 and polynucleotide for coding it	Mao Yu Min 	2001	0		
760	chr29	23064877	23064904	3500167501	23		23064877	23064904	8421504	2	15,8	0,19	g	350016750100000018	25-48						2-deoxyglucose-6-phosphate (2-dog-6-p) phosphatase dna sequences as selection markers in plants	Ebneth	1998	0		
764	chr29	23466312	23476444	3500205199	40		23466312	23476444	8421504	2	20,20	0,10112	c,g	350020519900000005,350020519900000005,350020519900000007,350020519900000006,350020519900000006	0-20,0-20,0-20,0-20,0-20		12444014	10.1152/ajpgi.00333.2002		American Journal of Physiology - Gastrointestinal and Liver Physiology	Characterization of vesicular glutamate transporter in pancreatic &#x03b1;- and &#x03b2;-cells and its regulation by glucose	Bai	2003	0		SLC17A6
764	chr29	23466312	23476444	3500132482	40		23466312	23476444	8421504	2	20,20	0,10112	c,g	350013248200000007,350013248200000005,350013248200000005,350013248200000006	0-20,0-20,0-20,0-20		12444014	10.1152/ajpgi.00333.2002		American Journal of Physiology - Gastrointestinal and Liver Physiology	Characterization of vesicular glutamate transporter in pancreatic &#x03b1;- and &#x03b2;-cells and its regulation by glucose	Bai	2003	0		SLC17A6
764	chr29	23466626	23476519	3500287061	64		23466626	23476519	8421504	4	14,7,22,21	0,789,884,9872	c	350028706100000036,350028706100000034,350028706100000026	21-42,0-22,0-21						Vglut-specific dsrna compounds	Bahrenberg	2005	0		
764	chr29	23468797	23472428	3500044051	24		23468797	23472428	8421504	4	4,14,1,5	0,5,3622,3626	c	350004405100000014	18-42						Mutation associated with epilepsy - US Patent 7157569 Description	ww.patentstorm.us	0	0		
767	chr29	23944756	23944782	3500240785	23		23944756	23944782	8421504	2	10,13	0,13	g	350024078500000006	6-30						Turkey herpesvirus vectored recombinant containing avian influenza genes	Esaki	2007	0		
770	chr29	24287168	24287201	3500234051	27		24287168	24287201	8421504	3	16,4,7	0,17,26	g	350023405100000194	7-38						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		
770	chr29	24300994	24301020	3500044085	23		24300994	24301020	8421504	2	17,6	0,20	g	350004408500000002	7-30		19109502	10.1523/JNEUROSCI.2216-08.2008	0270-6474	The Journal of Neuroscience	Signaling through cGMP-Dependent Protein Kinase I in the Amygdala Is Critical for Auditory-Cued Fear Memory and Long-Term Potentiation	Paul	2008	7		
778	chr29	25389371	25389396	3500367325	23		25389371	25389396	8421504	3	4,4,15	0,5,10	g	350036732500000126	1-24						Nov-x proteins and nucleic acids encoding same	Ii	2002	0		
779	chr29	25459422	25459448	3500376811	26		25459422	25459448	8421504	1	26	0	c	350037681100000005	8-34		16648481	10.1128/MCB.26.10.3864-3874.2006	0270-7306	Molecular and Cellular Biology	Protein Methyltransferase 2 Inhibits NF-&#x03ba;B Function and Promotes Apoptosis	Ganesh	2006	6		
779	chr29	25459473	25473649	3500357329	66		25459473	25473649	8421504	2	59,7	0,14169	p	350035732900015001	0-66			10.1042/BJ20040373		Biochemical Journal	Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5)	Stephane	2005	0		PRMT3
780	chr29	25584585	25584608	3500016075	23		25584585	25584608	8421504	1	23	0	c	350001607500000042	0-23						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
780	chr29	25584888	25584911	3500223042	23		25584888	25584911	8421504	1	23	0	c	350022304200000017	15-38						NOVEL ANTIBODIES - GLAXO GROUP LIMITED	www.sumobrain.com	0	0		
781	chr29	25777626	25777649	3500395209	23		25777626	25777649	8421504	1	23	0	c,g	350039520900000034,350039520900000155	3-26,0-20						Cytokinin Oxidase Sequences and Methods of Use - Patent application	www.faqs.org	0	0		
782	chr29	25825313	25825339	3500193761	24		25825313	25825339	8421504	2	16,8	0,18	g	350019376100000000	0-24						Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS	www.fasebj.org	0	0		
784	chr29	26149446	26149476	3500240738	27		26149446	26149476	8421504	2	14,13	0,17	g	350024073800000072	20-47						Antibodies Against Protective Antigen - Patent application	www.faqs.org	0	0		
786	chr29	26354067	26354091	3500390290	23		26354067	26354091	8421504	2	6,17	0,7	g	350039029000000052	0-26					Patent	Trail&#x53d7;&#x4f53;2&#x591a;&#x80bd;&#x548c;&#x6297;&#x4f53; Trail receptor 2 polypeptides and antibodies (Patent CN:101300273)	B*Ge Li Ni Ya Ke 	2013	0		
789	chr29	26759118	26774060	3500316414	296		26759118	26774060	8421504	3	29,140,127	0,10443,14815	p,c,g	350031641400000007,350031641400015004,350031641400000010,350031641400000010,350031641400015008,350031641400000022,350031641400000022,350031641400000027,350031641400000027,350031641400000001,350031641400000001,350031641400000000,350031641400000000,350031641400015009,350031641400015000,350031641400015003,350031641400015002,350031641400015010,350031641400000011,350031641400000002,350031641400000005,350031641400015001,350031641400000025,350031641400000025,350031641400000024,350031641400000030,350031641400000016,350031641400000016,350031641400000014,350031641400000015,350031641400000032,350031641400000031,350031641400000031,350031641400000020	1-60,0-180,0-60,0-60,0-171,0-60,0-60,0-61,0-61,0-60,0-60,0-21,0-21,0-126,0-60,0-126,0-126,0-126,0-60,0-60,0-60,0-57,0-60,0-60,0-60,0-47,0-60,0-60,0-59,0-55,0-28,0-27,0-27,0-49						Characterization and sequence analysis of cysteine and glycine-rich protein 3 in Egyptian native cattle and river native buffalo cDNA sequences	www.ajol.info	0	0		
789	chr29	26769691	26773947	3500303665	23		26769691	26773947	8421504	3	10,7,6	0,4242,4250	c	350030366500000044	0-23						US Patent # 7,745,130. Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof - Patents.com	patents.com	0	0		
789	chr29	26769691	26773947	3500281500	23		26769691	26773947	8421504	3	10,7,6	0,4242,4250	c	350028150000000048	0-23						Hepatitis B Viral Variants With Reduced Susceptibility To Nucleoside Analogs And Uses Thereof - Patent application	www.faqs.org	0	0		
789	chr29	26789124	26789152	3500206786	26		26789124	26789152	8421504	3	6,6,14	0,7,14	c	350020678600000003,350020678600000030	0-28,0-28						Electrocatalytic Nucleic Acid Hybridization Detection 	.freshpatents.com	0	0		
789	chr29	26816509	26816536	3500313011	23		26816509	26816536	8421504	3	6,6,11	0,9,16	g	350031301100000037	9-32						CYTOLETHAL DISTENDING TOXINS AND DETECTION OF CAMPYLOBACTER BACTERIA USING THE SAME AS A TARGET - Patent application	www.faqs.org	0	0		
791	chr29	27098878	27098911	3500257349	30		27098878	27098911	8421504	3	15,7,8	0,17,25	c	350025734900000150	3-39					Patent	Muteins of tear lipocalin (Patent CN:1871256)	A*Si Ke La 	2010	0		
791	chr29	27101951	27107566	3500187783	207		27101951	27107566	8421504	3	72,85,50	0,2657,5565	p	350018778300015055	27-234						Oxford_SGC_Clones_web	www.docstoc.com	0	0		PTPN5
791	chr29	27130409	27130434	3500397795	25		27130409	27130434	8421504	1	25	0	c	350039779500000007	22-47						Desarrollo de un multiplex de microsat&#xe9;lites para diagn&#xf3;stico de paternidad en ovinos Corriedale del Uruguay	cionbovina.com.ar	0	0		
791	chr29	27130409	27130434	3500369164	25		27130409	27130434	8421504	1	25	0	c	350036916400000007	22-47						Desarrollo de un multiplex de microsat&#xe9;lites para diagn&#xf3;stico de paternidad en ovinos Corriedale del Uruguay	duccionbovina.com	0	0		
791	chr29	27130409	27130434	3500236994	25		27130409	27130434	8421504	1	25	0	c	350023699400000007	22-47						Desarrollo de un multiplex de microsat&#xe9;lites para diagn&#xf3;stico de paternidad en ovinos Corriedale del Uruguay	ion-animal.com.ar	0	0		
791	chr29	27130409	27130434	3500070613	25		27130409	27130434	8421504	1	25	0	c	350007061300000007	22-47						Desarrollo de un multiplex de microsat&#xe9;lites para diagn&#xf3;stico de paternidad en ovinos Corriedale del Uruguay	www.scielo.edu.uy	0	0		
792	chr29	27153513	27153548	3500309840	26		27153513	27153548	8421504	3	7,13,6	0,12,29	g	350030984000000982	16-43						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
792	chr29	27182919	27182942	3500161043	23		27182919	27182942	8421504	1	23	0	c	350016104300000327	10-33						PRODUCTION OF SIALYLATED N-GLYCANS IN LOWER EUKARYOTES - Patent application	www.faqs.org	0	0		
792	chr29	27261308	27261336	3500252796	25		27261308	27261336	8421504	2	8,17	0,11	g	350025279600000139	1-39						METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF RSV INFECTION	Vaishnaw	2008	0		
793	chr29	27300826	27318421	3500251659	429		27300826	27318421	8421504	6	48,85,66,8,153,69	0,4902,7174,10726,10737,17526	p	350025165900015028,350025165900015020,350025165900015021,350025165900015022	36-462,0-171,0-60,0-129						UNIVERSIDAD DE GRANADA	hera.ugr.es	0	0		TSG101,UEVLD
793	chr29	27300844	27342282	3500131592	43		27300844	27342282	8421504	2	22,21	0,41417	c	350013159200000011,350013159200000002	0-22,0-21		22832105	10.1016/j.celrep.2011.10.004	2211-1247	Cell Reports	Cell Reports - An Essential Role of Hrs/Vps27 in Endosomal Cholesterol Trafficking	Du	2012	0		
793	chr29	27300844	27342282	3500029938	43		27300844	27342282	8421504	2	22,21	0,41417	c	350002993800000011,350002993800000002	0-22,0-21		22832105	10.1016/j.celrep.2011.10.004	2211-1247	Cell Reports	Cell Reports - An Essential Role of Hrs/Vps27 in Endosomal Cholesterol Trafficking	Du	2012	0		TSG101,UEVLD
793	chr29	27340454	27340481	3500202481	27		27340454	27340481	8421504	1	27	0	c	350020248100000031	11-38		22348143	10.1371/journal.pone.0032030		PLoS ONE	Tumor Susceptibility Gene 101 (TSG101) Is a Novel Binding-Partner for the Class II Rab11-FIPs	Conor	2012	0		
793	chr29	27342359	27342384	3500196470	24		27342359	27342384	8421504	2	20,4	0,21	c	350019647000000036	12-36						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
793	chr29	27363321	27372371	3500407568	26		27363321	27372371	8421504	4	4,7,4,11	0,5,15,9039	c	350040756800000019	4-35						Co-suppressed glutamine synthetase2 gene modifies nitrogen metabolism and plant growth in rice	scichina.com:8080	0	0		
99	chr29	27372443	27397704	3500083506	191		27372443	27397704	8421504	6	15,20,12,80,16,48	0,1330,1351,24426,25149,25213	p,c	350008350600000036,350008350600000044,350008350600015016,350008350600015014,350008350600015012	113-183,113-183,0-48,0-48,0-48					Patent	Method of controlling ethanol production (Patent CN:100526466)	Jin Zhi Xiao Fu 	2009	0		
794	chr29	27394103	27405986	3500299530	1770		27394103	27405986	8421504	9	778,124,118,174,174,118,150,85,49	0,1357,2728,3489,4325,5440,7040,10332,11834	c,g	350029953000000024,350029953000000006,350029953000000006,350029953000000005,350029953000000005	0-1770,0-20,0-20,0-20,0-20						BOVINE POLYMORPHISMS AND METHODS OF PREDICTING BOVINE TRAITS - Patent application	www.faqs.org	0	0		
794	chr29	27394328	27394351	3500364288	23		27394328	27394351	8421504	1	23	0	c	350036428800000009	21-44						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
794	chr29	27395460	27395483	3500463987	23		27395460	27395483	8421504	1	23	0	c	350046398700000032,350046398700000028	0-23,0-22						Effets d'une d&#xe9;nutrition maternelle pr&#xe9;natale sur la r&#xe9;gulation de l'hom&#xe9;ostasie &#xe9;nerg&#xe9;tique chez la descendance m&#xe2;le adulte : focus sur l'hypothalamus et le tissu adipeux	eo.univ-lille1.fr	0	0		
794	chr29	27395480	27395503	3500330881	23		27395480	27395503	8421504	1	23	0	c	350033088100000009	22-45						[tel-00624381, v1] D&#xe9;terminants mitochondriaux de l'oxydation des acides gras : modulation par l'entra&#xee;nement, l'hypoxie et un agoniste PPAR-*	hives-ouvertes.fr	0	0		
794	chr29	27395496	27399622	3500268527	210		27395496	27399622	8421504	4	60,83,7,60	0,3023,4047,4066	p	350026852700015043,350026852700015032,350026852700015036	0-60,12-102,0-60						Lactate Dehydrogenase (LDH) Gene Duplication During Chordate Evolution: The cDNA Sequence of the LDH of the Tunicate StyeZa plicata	brary.arizona.edu	0	0		LDHA,LDHC
794	chr29	27395560	27399580	3500019022	40		27395560	27399580	8421504	2	20,20	0,4000	c	350001902200000015,350001902200000014	0-20,0-20			10.1046/j.1432-1327.2000.01453.x	1432-1033	European Journal of Biochemistry	Cadmium blocks hypoxia-inducible factor (HIF)-1-mediated response to hypoxia by stimulating the proteasome-dependent degradation of HIF-1&#x03b1; - Chun - 2001 - European Journal of Biochemistry - Wiley Online Library	Chun	2000	0		LDHA
794	chr29	27396869	27398459	3500080397	135		27396869	27398459	8421504	4	45,45,14,31	0,739,883,1559	p	350008039700015071,350008039700015070,350008039700015053	0-45,0-45,0-45						MODIFIED MICROORGANISM FOR HIGHLY EFFICIENT PRODUCTION OF LACTIC ACID - Patent application	www.faqs.org	0	0		
794	chr29	27396869	27397704	3500243269	144		27396869	27397704	8421504	3	80,16,48	0,723,787	p	350024326900015008,350024326900015007,350024326900015006	0-48,0-48,0-48					Patent	&#x63a7;&#x5236;&#x4e59;&#x9187;&#x4ea7;&#x751f;&#x7684;&#x65b9;&#x6cd5; (Patent CN:100526466)	Jin Zhi Xiao Fu 	2009	0		
794	chr29	27397593	27397749	3500389774	39		27397593	27397749	8421504	2	19,20	0,136	c	350038977400000005,350038977400000004	0-19,0-20						mRNA and microRNA quality control for RT-qPCR analysis	uantification.com	0	0		
794	chr29	27397593	27397749	3500107315	39		27397593	27397749	8421504	2	19,20	0,136	c	350010731500000005,350010731500000004	0-19,0-20						mRNA and microRNA quality control for RT-qPCR analysis	uantification.net	0	0		
794	chr29	27399577	27399646	3500423840	69		27399577	27399646	8421504	1	69	0	p	350042384000015007	0-69						Determination of the DNA and Amino Acid Sequences of the Lactate Dehydrogenase Gene from Plasmodium falciparumStrains K1 and PFFCBR: A Route to the Design of New Antimalarials	ls.tubitak.gov.tr	0	0		
794	chr29	27399643	27401203	3500339302	78		27399643	27401203	8421504	2	18,60	0,1500	p	350033930200015063	0-78						Multiple Sequence Alignment	www.cs.uml.edu	0	0		
794	chr29	27399643	27401203	3500326081	78		27399643	27401203	8421504	2	18,60	0,1500	p	350032608100015020	0-78						Overview of the Bernoulli Sampler	web.ccv.brown.edu	0	0		
794	chr29	27399643	27401203	3500036433	78		27399643	27401203	8421504	2	18,60	0,1500	p	350003643300015020	0-78						Overview of the Gibbs Motif Sampler	web.ccv.brown.edu	0	0		
794	chr29	27405954	27426166	3500138868	40		27405954	27426166	8421504	4	6,15,5,14	0,11,20192,20198	c,g	350013886800000281,350013886800000358	18-39,0-19						 Transgenic Animal Model Of Bone Mass Modulation 	www.docstoc.com	0	0		
794	chr29	27445964	27446962	3500057031	23		27445964	27446962	8421504	3	8,2,13	0,982,985	c	350005703100000008	1-29						OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof	Judd	2001	0		
794	chr29	27517935	27518564	3500281920	40		27517935	27518564	8421504	2	20,20	0,609	c,g	350028192000000001,350028192000000000,350028192000000000	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
99	chr29	27518470	27563721	3500291860	39		27518470	27563721	8421504	2	20,19	0,45232	c,g	350029186000000002,350029186000000003,350029186000000003	0-20,0-19,0-19						Die Immunantwort boviner und capriner Euterepithelzellen auf verschiedene Mastitiserreger	b.uni-muenchen.de	0	0		
99	chr29	27518500	27563717	3500172791	40		27518500	27563717	8421504	2	20,20	0,45197	c,g	350017279100000002,350017279100000002,350017279100000003	0-20,0-20,0-20		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
795	chr29	27563052	27563076	3500333001	24		27563052	27563076	8421504	1	24	0	c	350033300100000002	0-24						 Identification in milk of a serum amyloid A peptide chemoattractant for B lymphoblasts - Engormix 	en.engormix.com	0	0		
795	chr29	27563052	27563076	3500172673	24		27563052	27563076	8421504	1	24	0	c	350017267300000002	0-24		19166592	10.1186/1471-2172-10-4	1471-2172	BMC Immunology	Identification in milk of a serum amyloid A peptide chemoattractant for B lymphoblasts	Rodriguez	2009	3		
796	chr29	27691274	27691302	3500427186	24		27691274	27691302	8421504	2	10,14	0,14	c	350042718600000111	12-36						PREDICTOR SETS FOR TYROSINE KINASE PATHWAYS - BRISTOL-MYERS SQUIBB COMPANY	www.sumobrain.com	0	0		
797	chr29	27879030	27879058	3500395209	23		27879030	27879058	8421504	3	13,5,5	0,16,23	g	350039520900000308	4-27						Cytokinin Oxidase Sequences and Methods of Use - Patent application	www.faqs.org	0	0		
797	chr29	27905753	27905777	3500187053	23		27905753	27905777	8421504	2	9,14	0,10	g	350018705300000025	4-46						Production of Bacillus entomotoxins in methylotrophic yeast	Sreekrishna	1994	0		
799	chr29	28161116	28161147	3500238285	24		28161116	28161147	8421504	3	6,5,13	0,10,18	g	350023828500000034	14-38					Patent	Hepatitis C virus epitopes (Patent US:5436318)	Kim	1995	0		
802	chr29	28463065	28463110	3500240631	45		28463065	28463110	8421504	1	45	0	p	350024063100015058	87-132						G-protein coupled receptors and nucleic acids encoding same	Casman	2002	0		OR8U8
807	chr29	29145022	29183482	3500309840	40		29145022	29183482	8421504	3	20,15,5	0,38437,38455	g	350030984000000567,350030984000000764	0-20,28-48						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
808	chr29	29276213	29276237	3500092685	23		29276213	29276237	8421504	2	13,10	0,14	g	350009268500000231	21-45						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
809	chr29	29412472	29412623	3500228810	39		29412472	29412623	8421504	2	19,20	0,131	c,g	350022881000000012,350022881000000012,350022881000000013	0-19,0-19,0-20						Expression analysis of regulatory MicroRNA in bovine cumulus oocyte complex and preimplantation embryos	s.ulb.uni-bonn.de	0	0		
809	chr29	29427442	29427469	3500340198	24		29427442	29427469	8421504	2	8,16	0,11	c	350034019800000475	7-40						Genetically engineered vaccine strain	Cox	1993	0		
809	chr29	29440246	29441069	3500273330	72		29440246	29441069	8421504	4	11,10,18,33	0,753,769,790	p	350027333000015031	0-72						43 human secreted proteins	Komatsoulis	2001	0		
810	chr29	29542590	29542638	3500402297	48		29542590	29542638	8421504	1	48	0	p	350040229700015026	0-48						cat&#xe1;logo promega	www.scribd.com	0	0		NRGN
810	chr29	29542590	29542638	3500225018	48		29542590	29542638	8421504	1	48	0	p	350022501800015003	0-48		11884555	10.1128/JVI.76.7.3301-3308.2002	0022-538X	Journal of Virology	The RNA Binding Domain of the Hantaan Virus N Protein Maps to a Central, Conserved Region	Xu	2002	5		NRGN
810	chr29	29542590	29542638	3500200064	48		29542590	29542638	8421504	1	48	0	p	350020006400015002	0-48		15972818	10.1074/jbc.M504533200	0021-9258	Journal of Biological Chemistry	Identification and Characterization of Human Archaemetzincin-1 and -2, Two Novel Members of a Family of Metalloproteases Widely Distributed in Archaea	Diaz-Perales	2005	5		NRGN
810	chr29	29542590	29542638	3500140921	48		29542590	29542638	8421504	1	48	0	p	350014092100015001	0-48			10.1038/sj.jid.5701103		The Journal of investigative dermatology	Multiple PKC&#x03b4; Tyrosine Residues Are Required for PKC&#x03b4;-Dependent Activation of Involucrin Expression&#x2014;a Key Role of PKC&#x03b4;-Y311	Ling	2008	0		NRGN
810	chr29	29542590	29542638	3500121046	48		29542590	29542638	8421504	1	48	0	p	350012104600015004	0-48						Target activated nucleic acid biosensor and methods of using same	Stanton	2001	0		NRGN
810	chr29	29542590	29542638	3500063578	48		29542590	29542638	8421504	1	48	0	p	350006357800015000	0-48		17943181	10.1038/sj.jid.5701103	0022-202X	Journal of Investigative Dermatology	Multiple PKC&#x03b4; Tyrosine Residues Are Required for PKC&#x03b4;-Dependent Activation of Involucrin Expression&#x2014;a Key Role of PKC&#x03b4;-Y311	Zhu	2007	6		NRGN
810	chr29	29542590	29542638	3500047003	48		29542590	29542638	8421504	1	48	0	p	350004700300015008	0-48						Emerald Luc -pELuc&#x30d9;&#x30af;&#x30bf;&#x30fc;&#x30b7;&#x30ea;&#x30fc;&#x30ba;-	www.toyobo.co.jp	0	0		NRGN
810	chr29	29542590	29542638	3500040310	48		29542590	29542638	8421504	1	48	0	p	350004031000015008	0-48						TARGET ACTIVATED NUCLEIC ACID BIOSENSOR AND METHODS OF USING SAME - ARCHEMIX CORPORATION	www.sumobrain.com	0	0		NRGN
810	chr29	29542590	29542638	3500032902	48		29542590	29542638	8421504	1	48	0	p	350003290200015002	0-48						BIOCHIP FOR THE DETECTION OF PHOSPHORYLATION AND THE DETECTION METHOD USING THE SAME - Patent application	www.faqs.org	0	0		NRGN
810	chr29	29594420	29594445	3500044157	23		29594420	29594445	8421504	2	18,5	0,20	g	350004415700000015	1-24						METHODS FOR PRODUCING AN IMMUNE RESPONSE TO TUBERCULOSIS - Patent application	www.faqs.org	0	0		
811	chr29	29749945	29753138	3500318380	73		29749945	29753138	8421504	3	32,19,22	0,3011,3171	c	350031838000000084,350031838000000075	0-32,0-41						Imaging, diagnosis and treatment of disease - US Patent 7740830 Description	ww.patentstorm.us	0	0		
812	chr29	29836266	29836295	3500465890	24		29836266	29836295	8421504	2	10,14	0,15	g	350046589000000004	10-34						MUTANT ALPHA-AMYLASES - Patent application	www.faqs.org	0	0		
813	chr29	29904386	29904411	3500106940	23		29904386	29904411	8421504	2	7,16	0,9	g	350010694000000084	5-28						Detection Of Target Molecules With Labeled Nucleic Acid Detection Molecules 	.freshpatents.com	0	0		
815	chr29	30274384	30274409	3500227937	23		30274384	30274409	8421504	2	9,14	0,11	g	350022793700000301,350022793700000302	0-23,14-36						POLYMORPHISMS IN GENES AFFECTING CNS DISORDERS AND USES THEREOF - Patent application	www.faqs.org	0	0		
816	chr29	30386368	30386395	3500070060	23		30386368	30386395	8421504	2	8,15	0,12	c	350007006000000114	11-34						 Soluble IL 	www.docstoc.com	0	0		
816	chr29	30396966	30399785	3500298220	98		30396966	30399785	8421504	4	30,40,7,21	0,839,1436,2798	c	350029822000000040,350029822000000027,350029822000000009,350029822000000005	0-30,1-48,28-49,28-49						Novel apoptosis gene EI24, compositions, and methods of use - Patent application	www.faqs.org	0	0		
817	chr29	30438154	30438198	3500411537	44		30438154	30438198	8421504	1	44	0	c	350041153700000013	0-44						Inhibitors of checkpoint kinases - US Patent 7550477 Description	ww.patentstorm.us	0	0		
817	chr29	30441397	30441420	3500173743	23		30441397	30441420	8421504	1	23	0	c	350017374300000009	0-23			10.1177/1947601910395578		Genes & Cancer	The ETS Gene ETV4 Is Required for Anchorage-Independent Growth and a Cell Proliferation Gene Expression Program in PC3 Prostate Cells	PeC.	2010	0		
817	chr29	30447898	30447938	3500407364	40		30447898	30447938	8421504	1	40	0	c	350040736400000011	0-40						Inhibitors of checkpoint kinases	Arrington	2007	0		
817	chr29	30454397	30454429	3500099984	32		30454397	30454429	8421504	1	32	0	c	350009998400000002	0-33						Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods	Carr	1999	0		
818	chr29	30652941	30652967	3500231114	24		30652941	30652967	8421504	2	7,17	0,9	c	350023111400000010	1-28						Stereoselective reduction of substituted acetophenone	Chu	2002	0		
818	chr29	30652941	30652967	3500098376	24		30652941	30652967	8421504	2	7,17	0,9	c	350009837600000010	1-28						 Stereoselective Reduction Of Substituted Acetophenone 	www.docstoc.com	0	0		
818	chr29	30653002	30653027	3500265273	23		30653002	30653027	8421504	2	9,14	0,11	c	350026527300000163	9-32					Patent	Ordered molecular presentation of antigens, method of preparation and use (Patent CN:100534529)	F*Heng Nei Ke 	2009	0		
818	chr29	30653701	30653728	3500350773	24		30653701	30653728	8421504	2	8,16	0,11	g	350035077300000001	0-24		17505005	10.1158/1078-0432.CCR-06-2575	1078-0432	Clinical Cancer Research	Capsaicin Is a Novel Blocker of Constitutive and Interleukin-6&#x2013;Inducible STAT3 Activation	Bhutani	2007	8		
818	chr29	30653701	30653728	3500250336	24		30653701	30653728	8421504	2	8,16	0,11	g	350025033600000001	0-24		19147543	10.1158/1541-7786.MCR-08-0154		Molecular cancer research : MCR	Boswellic Acid Blocks STAT3 Signaling, Proliferation, and Survival of Multiple Myeloma via the Protein Tyrosine Phosphatase SHP-1	Ajaikumar	2009	0		
818	chr29	30653701	30653728	3500241061	24		30653701	30653728	8421504	2	8,16	0,11	g	350024106100000001	0-24		20068065	10.1158/1541-7786.MCR-09-0257	1541-7786	Molecular Cancer Research	5-Hydroxy-2-Methyl-1,4-Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in Chemosensitization	Sandur	2010	4		
818	chr29	30653701	30653728	3500238027	24		30653701	30653728	8421504	2	8,16	0,11	g	350023802700000001	0-24						Signaling and Regulation Molecular Cancer 5-Hydroxy-2-Methyl-1,4-Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in Chemosensitization	.aacrjournals.org	0	0		
818	chr29	30653701	30653728	3500044408	24		30653701	30653728	8421504	2	8,16	0,11	g	350004440800000001	0-24						Butein Suppresses Constitutive and Inducible Signal Transducer and Activator of Transcription (STAT) 3 Activation and STAT3-Regulated Gene Products through the Induction of a Protein Tyrosine Phosphatase SHP-1	aspetjournals.org	0	0		
821	chr29	31056567	31062778	3500131986	6211		31056567	31062778	8421504	1	6211	0	c,g	350013198600000030,350013198600000077,350013198600000015,350013198600000075,350013198600000074,350013198600000073,350013198600000014,350013198600000072	0-6211,0-141,0-300,0-60,0-40,0-141,0-300,0-80						SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK - Patent application	www.faqs.org	0	0		
822	chr29	31087827	31088008	3500022796	40		31087827	31088008	8421504	2	20,20	0,161	c	350002279600000020,350002279600000021	0-20,0-20						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
822	chr29	31177755	31177780	3500033449	25		31177755	31177780	8421504	1	25	0	c	350003344900000010	25-50						Supporting Information	www.pnas.org	0	0		ST3GAL4
822	chr29	31177876	31177899	3500301860	23		31177876	31177899	8421504	1	23	0	c	350030186000000005	0-23						Neuroblastoma cells can be classified according to glycosphingolipid expression profiles identified by liquid chromatography-tandem mass spectrometry	-publications.com	0	0		
824	chr29	31334104	31334132	3500385626	23		31334104	31334132	8421504	2	9,14	0,14	g	350038562600000008	0-23					Patent	Methods for promoting growth using porcine growth hormone analogs (Patent US:5356877)	Souza	1994	0		
824	chr29	31334104	31334132	3500382538	23		31334104	31334132	8421504	2	9,14	0,14	g	350038253800000012	0-23					Patent	Porcine growth hormone analogs encoding dna (Patent US:5104806)	Souza	1992	0		
824	chr29	31334104	31334132	3500158512	23		31334104	31334132	8421504	2	9,14	0,14	g	350015851200000008	0-23						Methods for promoting growth using porcine growth hormone analogs	Souza	1993	0		
824	chr29	31334104	31334132	3500078523	23		31334104	31334132	8421504	2	9,14	0,14	g	350007852300000012	0-23						Porcine growth hormone analogs	Lai Wen Si *M*Suo Sa 	1988	0		
824	chr29	31334104	31334132	3500047867	23		31334104	31334132	8421504	2	9,14	0,14	g	350004786700000016	0-23					Patent	&#x732a;&#x751f;&#x957f;&#x6fc0;&#x7d20;&#x7c7b;&#x4f3c;&#x7269; Porcine growth hormone analogs (Patent CN:1033759)	Lai Wen Si *M*Suo Sa 	1997	0		
826	chr29	31679220	31679247	3500171548	24		31679220	31679247	8421504	3	8,12,4	0,10,23	g	350017154800000004	3-27						An&#xe1;lise in silico de regi&#xf5;es promotoras de genes de Xylella fastidiosa	www.teses.usp.br	0	0		
826	chr29	31692660	31692693	3500091560	26		31692660	31692693	8421504	3	14,5,7	0,16,26	g	350009156000000057	0-26						IL-17A AND IL-17F ANTAGONISTS AND METHODS OF USING THE SAME - Patent application	www.faqs.org	0	0		
827	chr29	31730656	31730681	3500442456	23		31730656	31730681	8421504	2	18,5	0,20	g	350044245600000149	15-38						DNA expression systems based on alphaviruses	Garoff	2000	0		
834	chr29	32669170	32669201	3500023260	28		32669170	32669201	8421504	2	13,15	0,16	g	350002326000000014	3-31						Engineered Microorganisms For Producing N-butanol And Related Methods 	.freshpatents.com	0	0		
834	chr29	32725834	32725858	3500252902	23		32725834	32725858	8421504	2	13,10	0,14	g	350025290200000015	0-24						Biosensors, method for obtaining the same and uses thereof	Renard	2010	0		
835	chr29	32875038	32875068	3500114519	25		32875038	32875068	8421504	3	7,4,14	0,8,16	g	350011451900000004	18-44						CHLAMYDIA POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF - Patent application	www.faqs.org	0	0		
838	chr29	33192750	33192778	3500252890	24		33192750	33192778	8421504	2	8,16	0,12	g	350025289000000829	7-31						Neisseria meningitidis antigens and compositions	Fraser	2012	0		
838	chr29	33208127	33208151	3500003625	23		33208127	33208151	8421504	2	6,17	0,7	g	350000362500000003	2-26						Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development. - ResearchGate	.researchgate.net	0	0		
839	chr29	33307103	33378025	3500295452	1152		33307103	33378025	8421504	8	75,86,261,249,78,201,120,82	0,1897,22134,27032,28451,32197,34663,70840	p	350029545200015031,350029545200015030	0-75,0-1077						Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer	Fritz	2011	0		
839	chr29	33307214	33307307	3500062254	90		33307214	33307307	8421504	2	45,45	0,48	p	350006225400015073,350006225400015072	0-45,0-45						ETS2 AND MESP1 GENERATE CARDIAC PROGENITORS FROM FIBROBLASTS - Patent application	www.faqs.org	0	0		ETS1
839	chr29	33307286	33309075	3500186119	138		33307286	33309075	8421504	2	30,108	0,1681	p	350018611900015104	0-138						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		ETS1
839	chr29	33307286	33309075	3500095373	138		33307286	33309075	8421504	2	30,108	0,1681	p	350009537300015104	0-138						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		ETS1
839	chr29	33378002	33378025	3500436713	23		33378002	33378025	8421504	1	23	0	c,g	350043671300000000,350043671300000000	5-28,5-28			10.1046/j.1432-1327.2001.02219.x	1432-1033	European Journal of Biochemistry	Ets1 is a common element in directing transcription of the &#x03b1; and &#x03b2; genes of human protein kinase CK2 - Krehan - 2001 - European Journal of Biochemistry - Wiley Online Library	Krehan	2001	0		ETS1
104	chr29	33410114	33431830	3500309840	39		33410114	33431830	8421504	3	19,13,7	0,21695,21709	g	350030984000000109,350030984000000792	6-25,0-20						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
840	chr29	33479872	33479905	3500302241	30		33479872	33479905	8421504	2	15,15	0,18	g	350030224100000223	6-38						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
841	chr29	33667496	33670227	3500442049	24		33667496	33670227	8421504	2	2,22	0,2709	c	350044204900000015,350044204900000047	1-25,1-25						Diagnostics And Therapeutics For Diseases Associated With Endothelial Differentiation, Sphingolipid G-protein-coupled Receptor 6(edg6) 	.freshpatents.com	0	0		
841	chr29	33667496	33670227	3500324100	24		33667496	33670227	8421504	2	2,22	0,2709	c	350032410000000003	1-25		11551897	10.1074/jbc.C100343200	0021-9258	Journal of Biological Chemistry	Interleukin-6 Regulation of the Human DNA Methyltransferase (HDNMT) Gene in Human Erythroleukemia Cells	Hodge	2001	5		
841	chr29	33671515	33671653	3500095373	138		33671515	33671653	8421504	1	138	0	p	350009537300015103	0-138						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		ERG
847	chr29	34355079	34355594	3500080418	57		34355079	34355594	8421504	3	8,13,36	0,460,479	p	350008041800015058	0-60						Methods and compositions for predicting response to eribulin	AGOULNIK	2012	0		
848	chr29	34501114	34501142	3500310044	23		34501114	34501142	8421504	3	6,5,12	0,10,16	g	350031004400000201	10-33						Gene Differentially Expressed In Breast And Bladder Cancer And Encoded Polypeptides 	.freshpatents.com	0	0		
848	chr29	34501114	34501142	3500243470	23		34501114	34501142	8421504	3	6,5,12	0,10,16	g	350024347000000261	10-33						Gene differentially expressed in breast and bladder cancer and encoded polypeptides	M*Zuo De Er 	2005	0		
852	chr29	35032230	35032256	3500254445	23		35032230	35032256	8421504	3	12,6,5	0,14,21	g	350025444500000011	21-46					Patent	Quantitative microarray hybridizaton assays (Patent US:6004755)	Wang	1999	0		
856	chr29	35593098	35593122	3500309524	23		35593098	35593122	8421504	2	10,13	0,11	g	350030952400000001	1-25						Introduction and Review Of Literature	a.inflibnet.ac.in	0	0		
856	chr29	35593098	35593122	3500282580	23		35593098	35593122	8421504	2	10,13	0,11	g	350028258000000006	1-25						DOKAZOVANJE OKU&#x0162;B S &#x010c;LOVE&#x0160;KIMI PAPILOMAVIRUSI V ARHIVSKIH TKIVNIH VZORCIH PLO&#x0160;&#x010c;ATOCELI&#x010c;NEGA KARCINOMA USTNE VOTLINE IN USTNEGA DELA &#x0162;RELA	nica.bf.uni-lj.si	0	0		
856	chr29	35593098	35593122	3500243178	23		35593098	35593122	8421504	2	10,13	0,11	g	350024317800000011,350024317800000010	1-25,1-21						Virus detection method, primers therefor and screening kit	Hart	2002	0		
857	chr29	35752948	35752972	3500262060	23		35752948	35752972	8421504	2	14,9	0,15	g	350026206000000032	7-35						Methods and compositions for expressing negative-sense viral RNA in canine cells	G*Kan Bao 	2009	0		
858	chr29	35893216	35893239	3500203465	23		35893216	35893239	8421504	1	23	0	g	350020346500000041	0-25						Detection of human .alpha.-thalassemia mutations and their use as predictors of blood-related disorders - Patent # 5750345 - PatentGenius	.patentgenius.com	0	0		
858	chr29	35893216	35893239	3500103146	23		35893216	35893239	8421504	1	23	0	g	350010314600000090	0-25						Methods and compounds for curing diseases caused by mutations	Cole-Strauss	1997	0		
859	chr29	36029694	36029877	3500458003	46		36029694	36029877	8421504	2	22,24	0,159	c	350045800300000014,350045800300000015	0-22,0-24			10.1111/j.1752-4571.2010.00142.x		Evolutionary Applications	Broad and fine-scale genetic analysis of white-tailed deer populations: estimating the relative risk of chronic wasting disease spread	Catherine	2011	0		
859	chr29	36029694	36029877	3500412553	46		36029694	36029877	8421504	2	22,24	0,159	c,g	350041255300000014,350041255300000014,350041255300000015,350041255300000015	0-22,0-22,0-24,0-24			10.1111/j.1752-4571.2010.00142.x	1752-4571	Evolutionary Applications	Broad and fine-scale genetic analysis of white-tailed deer populations: estimating the relative risk of chronic wasting disease spread - Cullingham - 2010 - Evolutionary Applications - Wiley Online Library	Cullingham	2011	5		
859	chr29	36029694	36029877	3500015140	49		36029694	36029877	8421504	2	25,24	0,159	c	350001514000000004,350001514000000005	0-25,0-24						Development of Microsatellite DNA Markers for the Automated Genetic Characterization of White-Tailed Deer Populations	www.jstor.org	0	0		
860	chr29	36107875	36107901	3500170763	23		36107875	36107901	8421504	3	12,4,7	0,13,19	g	350017076300000002	0-23					Patent	Truncated keratinocyte growth factor (KGF) having increased biological activity (Patent US:7084119)	Gospodarowicz	2006	0		
862	chr29	36409188	36427857	3500309840	41		36409188	36427857	8421504	4	5,16,5,15	0,7,18648,18654	g	350030984000000762,350030984000000252	4-25,21-41						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
863	chr29	36546717	36546747	3500459021	24		36546717	36546747	8421504	3	7,3,14	0,12,16	g	350045902100000211,350045902100000455,350045902100000527,350045902100000112	22-45,1-25,13-37,10-34						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
866	chr29	36857318	36905062	3500114897	41		36857318	36905062	8421504	3	7,15,19	0,8,47725	g	350011489700000163,350011489700000136	0-26,29-48						COLLAGEN PRODUCING PLANTS AND METHODS OF GENERATING AND USING SAME - Patent application	www.faqs.org	0	0		
867	chr29	37031620	37031646	3500282773	23		37031620	37031646	8421504	2	13,10	0,16	g	350028277300000537,350028277300000253	0-25,0-25						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT - Patent application	www.faqs.org	0	0		
867	chr29	37073239	37073269	3500219861	25		37073239	37073269	8421504	3	14,7,4	0,18,26	g	350021986100000098	11-39						Preliminary linkage map of the Turkey (Meleagris gallopavo) based on microsatellite markers	dmoosemedia.co.uk	0	0		
872	chr29	37636896	37636921	3500004457	24		37636896	37636921	8421504	2	12,12	0,13	g	350000445700000028	21-45						Amidase from variovorax - Patent # 7070963 - PatentGenius	.patentgenius.com	0	0		
873	chr29	37767405	37767434	3500095659	23		37767405	37767434	8421504	3	5,7,11	0,8,18	g	350009565900000010	10-33						High Copy Display of Large Proteins on Phage for Functional Selections	www.chem.uci.edu	0	0		
874	chr29	37880797	37882568	3500424375	85		37880797	37882568	8421504	2	40,45	0,1726	c	350042437500000009,350042437500000018	0-40,0-45						MT-SP1 polynucleotides and polypeptides - Patent # 7227009 - PatentGenius	.patentgenius.com	0	0		
874	chr29	37882460	37882484	3500337360	24		37882460	37882484	8421504	1	24	0	c	350033736000000058	24-48						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - Patent application	www.faqs.org	0	0		
874	chr29	37882538	37882573	3500404568	35		37882538	37882573	8421504	1	35	0	c	350040456800000060	0-35						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - US Patent 7700341 Description	ww.patentstorm.us	0	0		
874	chr29	37882538	37882573	3500129128	35		37882538	37882573	8421504	1	35	0	c	350012912800000043	0-35						Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon - US Patent 7172892 Description	ww.patentstorm.us	0	0		
874	chr29	37882538	37882573	3500126554	35		37882538	37882573	8421504	1	35	0	c	350012655400000010	0-35						MATRIPTASE, A SERINE PROTEASE AND ITS APPLICATIONS - Patent application	www.faqs.org	0	0		
874	chr29	37886817	37886862	3500386149	45		37886817	37886862	8421504	1	45	0	c	350038614900000047	0-45						Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon - US Patent 7105333 Description	ww.patentstorm.us	0	0		
874	chr29	37902185	37902211	3500384749	23		37902185	37902211	8421504	3	7,4,12	0,9,14	g	350038474900000250	3-26						5' to 3' exonuclease mutations of thermostable DNA polymerases - Patent # 5795762 - PatentGenius	.patentgenius.com	0	0		
876	chr29	38151257	38151282	3500260964	24		38151257	38151282	8421504	2	5,19	0,6	g	350026096400000139	3-27						NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM FORAXELLA CATARRHALIS - Patent application	www.faqs.org	0	0		
877	chr29	38345922	38345948	3500440946	23		38345922	38345948	8421504	2	8,15	0,11	g	350044094600000012	1-24					Patent	Heterodimer complex of RXR and NURR1 or NGFI-B (Patent US:6458926)	Evans	2002	0		
878	chr29	38484045	38484073	3500187053	24		38484045	38484073	8421504	2	17,7	0,21	g	350018705300000046	22-46						Production of Bacillus entomotoxins in methylotrophic yeast	Sreekrishna	1994	0		
879	chr29	38597604	38597631	3500313213	23		38597604	38597631	8421504	2	8,15	0,12	g	350031321300000006	0-23						PAX6 expression identifies progenitor cells for corneal keratocytes	www.fasebj.org	0	0		
879	chr29	38601713	38641080	3500309840	41		38601713	38641080	8421504	3	22,14,5	0,39347,39362	c,g	350030984000000691,350030984000000790,350030984000000790	1-23,10-29,10-29						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
879	chr29	38616376	38616744	3500251519	42		38616376	38616744	8421504	2	21,21	0,347	c,g	350025151900000010,350025151900000010,350025151900000011,350025151900000011	0-21,0-21,0-21,0-21		15956356	10.1677/jme.1.01799	0952-5041	Journal of Molecular Endocrinology	Gene expression profiling of bovine endometrium during the oestrous cycle: detection of molecular pathways involved in functional changes	Bauersachs	2005	3		
880	chr29	38772930	38773984	3500352210	72		38772930	38773984	8421504	2	39,33	0,1021	p	350035221000015010	45-117						Proteomic analysis of porcine alveolar macrophages infected with porcine circovirus type 2. - ResearchGate	.researchgate.net	0	0		
882	chr29	38985299	38985365	3500225389	66		38985299	38985365	8421504	1	66	0	c,g	350022538900000039,350022538900000039	0-66,0-66						Pegasoferae? - Genomewiki	nomewiki.ucsc.edu	0	0		
882	chr29	39012524	39012549	3500252890	23		39012524	39012549	8421504	3	4,4,15	0,5,10	g	350025289000000579	3-26						Neisseria meningitidis antigens and compositions	Fraser	2012	0		
883	chr29	39097594	39127154	3500191478	2579		39097594	39127154	8421504	24	85,154,118,119,194,117,49,16,27,47,96,299,7,31,8,219,99,142,117,194,119,118,142,62	0,1161,1868,2089,3418,4721,6414,6464,6481,6509,6640,8141,20145,20154,20186,20195,22117,22301,24167,25351,26738,26956,28036,29498	c	350019147800000020,350019147800000012,350019147800000023	7-1328,0-1258,9-1119						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
883	chr29	39097594	39127154	3500155081	2579		39097594	39127154	8421504	24	85,154,118,119,194,117,49,16,27,47,96,299,7,31,8,219,99,142,117,194,119,118,142,62	0,1161,1868,2089,3418,4721,6414,6464,6481,6509,6640,8141,20145,20154,20186,20195,22117,22301,24167,25351,26738,26956,28036,29498	c	350015508100000020,350015508100000012,350015508100000023	7-1328,0-1258,9-1119						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
883	chr29	39097594	39127154	3500121131	2579		39097594	39127154	8421504	24	85,154,118,119,194,117,49,16,27,47,96,299,7,31,8,219,99,142,117,194,119,118,142,62	0,1161,1868,2089,3418,4721,6414,6464,6481,6509,6640,8141,20145,20154,20186,20195,22117,22301,24167,25351,26738,26956,28036,29498	c	350012113100000020,350012113100000012,350012113100000023,350012113100000033,350012113100000010,350012113100000032,350012113100000009,350012113100000030,350012113100000007	7-1328,0-1258,9-1119,0-22,0-22,0-22,0-22,0-21,0-21						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
883	chr29	39101198	39127483	3500037189	380		39101198	39127483	8421504	8	8,14,12,12,14,12,24,284	0,1117,1222,2810,20666,21747,23182,26001	c,g	350003718900000007,350003718900000008,350003718900000004,350003718900000003,350003718900000027,350003718900000019,350003718900000015	0-22,0-24,0-26,0-24,0-99,0-94,0-91						BMC Genomics BioMed Central	biomedcentral.com	0	0		
883	chr29	39101198	39124404	3500285874	96		39101198	39124404	8421504	7	8,14,12,12,14,12,24	0,1117,1222,2810,20666,21747,23182	c	350028587400000004,350028587400000005,350028587400000001,350028587400000000	0-22,0-24,0-26,0-24					BMC Genomics	Characterization of the bovine pregnancy-associated glycoprotein gene family &#x2013; analysis of gene sequences, regulatory regions within the promoter and expression of selected genes - Scolaris	Telugu	2009	0		
883	chr29	39121846	39127145	3500148891	64		39121846	39127145	8421504	3	22,22,20	0,2790,5279	c	350014889100000010,350014889100000009,350014889100000007,350014889100000003	0-22,0-22,0-21,9-29						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS	Roberts	2010	0		
884	chr29	39201775	39211939	3500191478	1117		39201775	39211939	8421504	10	53,131,10,118,119,194,117,142,99,134	0,2387,2519,3493,3748,5232,6370,7995,8222,10030	c	350019147800000003,350019147800000026,350019147800000022	9-29,9-29,0-1117						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
884	chr29	39201775	39211939	3500155081	1117		39201775	39211939	8421504	10	53,131,10,118,119,194,117,142,99,134	0,2387,2519,3493,3748,5232,6370,7995,8222,10030	c	350015508100000022	0-1117						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
884	chr29	39201775	39211939	3500121131	1117		39201775	39211939	8421504	10	53,131,10,118,119,194,117,142,99,134	0,2387,2519,3493,3748,5232,6370,7995,8222,10030	c	350012113100000022	0-1117						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
884	chr29	39205570	39208155	3500285874	46		39205570	39208155	8421504	3	24,12,10	0,1619,2575	c	350028587400000008,350028587400000009	0-24,0-22					BMC Genomics	Characterization of the bovine pregnancy-associated glycoprotein gene family &#x2013; analysis of gene sequences, regulatory regions within the promoter and expression of selected genes - Scolaris	Telugu	2009	0		
884	chr29	39205570	39208155	3500037189	46		39205570	39208155	8421504	3	24,12,10	0,1619,2575	c	350003718900000011,350003718900000012	0-24,0-22						BMC Genomics BioMed Central	biomedcentral.com	0	0		
110	chr29	39333292	39649537	3500191478	2341		39333292	39649537	8421504	22	91,66,142,71,24,87,49,111,194,81,37,118,151,82,150,99,142,194,119,118,151,64	0,94,163,1989,2064,2174,2267,3827,4880,6270,6352,6487,7593,8824,35973,66975,67161,239931,241311,241528,242623,316181	c	350019147800000015,350019147800000027,350019147800000004,350019147800000017	0-1317,40-69,40-69,30-1067						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
110	chr29	39333292	39649537	3500155081	2341		39333292	39649537	8421504	22	91,66,142,71,24,87,49,111,194,81,37,118,151,82,150,99,142,194,119,118,151,64	0,94,163,1989,2064,2174,2267,3827,4880,6270,6352,6487,7593,8824,35973,66975,67161,239931,241311,241528,242623,316181	c	350015508100000015,350015508100000027,350015508100000004,350015508100000017	0-1317,40-69,40-69,30-1067						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
110	chr29	39333292	39649537	3500121131	2341		39333292	39649537	8421504	22	91,66,142,71,24,87,49,111,194,81,37,118,151,82,150,99,142,194,119,118,151,64	0,94,163,1989,2064,2174,2267,3827,4880,6270,6352,6487,7593,8824,35973,66975,67161,239931,241311,241528,242623,316181	c	350012113100000015,350012113100000027,350012113100000004,350012113100000031,350012113100000008,350012113100000017	0-1317,40-69,40-69,0-20,0-20,30-1067						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
885	chr29	39333450	39369285	3500064013	49		39333450	39369285	8421504	3	2,27,20	0,5,35815	c	350006401300000004,350006401300000006	40-69,9-29						Early pregnancy diagnosis using PAGs(Pregnancy-associated Glycoproteins)	Roberts	2011	0		
885	chr29	39333450	39338206	3500148891	49		39333450	39338206	8421504	3	2,27,20	0,5,4736	c	350014889100000004,350014889100000008	40-69,0-20						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS	Roberts	2010	0		
110	chr29	39369265	39649537	3500191478	1154		39369265	39649537	8421504	9	150,99,142,117,194,119,118,151,64	0,31002,31188,202920,203958,205338,205555,206650,280208	c	350019147800000034	0-1154						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
110	chr29	39369265	39649537	3500155081	1154		39369265	39649537	8421504	9	150,99,142,117,194,119,118,151,64	0,31002,31188,202920,203958,205338,205555,206650,280208	c	350015508100000034	0-1154						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
110	chr29	39369265	39649537	3500121131	1154		39369265	39649537	8421504	9	150,99,142,117,194,119,118,151,64	0,31002,31188,202920,203958,205338,205555,206650,280208	c	350012113100000034	0-1154						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
885	chr29	39398424	39407440	3500191478	1157		39398424	39407440	8421504	9	153,99,142,117,194,119,118,151,64	0,1843,2029,3840,4893,6415,6632,7728,8952	g	350019147800000039	1-1158						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
885	chr29	39398424	39407440	3500155081	1157		39398424	39407440	8421504	9	153,99,142,117,194,119,118,151,64	0,1843,2029,3840,4893,6415,6632,7728,8952	g	350015508100000039	1-1158						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
885	chr29	39398424	39407440	3500121131	1157		39398424	39407440	8421504	9	153,99,142,117,194,119,118,151,64	0,1843,2029,3840,4893,6415,6632,7728,8952	g	350012113100000039	1-1158						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
886	chr29	39572270	39573257	3500064013	43		39572270	39573257	8421504	2	23,20	0,967	c	350006401300000010,350006401300000008	0-23,0-20						Early pregnancy diagnosis using PAGs(Pregnancy-associated Glycoproteins)	Roberts	2011	0		
13	chr29	39640675	39919948	3500191478	1140		39640675	39919948	8421504	9	150,99,139,117,194,119,118,151,53	0,228741,272586,274264,275301,276687,276905,277996,279220	c	350019147800000037	11-1154						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
13	chr29	39640675	39919948	3500155081	1140		39640675	39919948	8421504	9	150,99,139,117,194,119,118,151,53	0,228741,272586,274264,275301,276687,276905,277996,279220	c	350015508100000037	11-1154						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
13	chr29	39640675	39919948	3500121131	1140		39640675	39919948	8421504	9	150,99,139,117,194,119,118,151,53	0,228741,272586,274264,275301,276687,276905,277996,279220	c	350012113100000037	11-1154						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
887	chr29	39684616	39693489	3500191478	1154		39684616	39693489	8421504	9	150,99,142,117,194,119,118,151,64	0,1842,2028,3840,4882,6275,6492,7582,8809	g	350019147800000036	0-1154						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
887	chr29	39684616	39693489	3500155081	1154		39684616	39693489	8421504	9	150,99,142,117,194,119,118,151,64	0,1842,2028,3840,4882,6275,6492,7582,8809	g	350015508100000036	0-1154						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
887	chr29	39684616	39693489	3500121131	1154		39684616	39693489	8421504	9	150,99,142,117,194,119,118,151,64	0,1842,2028,3840,4882,6275,6492,7582,8809	g	350012113100000036	0-1154						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
888	chr29	39818609	39826580	3500191478	1344		39818609	39826580	8421504	11	114,100,81,137,99,142,117,194,119,118,123	0,116,218,306,2134,2320,4114,5157,6531,6748,7848	c	350019147800000014	0-1359						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
888	chr29	39818609	39826580	3500155081	1344		39818609	39826580	8421504	11	114,100,81,137,99,142,117,194,119,118,123	0,116,218,306,2134,2320,4114,5157,6531,6748,7848	c	350015508100000014	0-1359						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
888	chr29	39818609	39826580	3500121131	1344		39818609	39826580	8421504	11	114,100,81,137,99,142,117,194,119,118,123	0,116,218,306,2134,2320,4114,5157,6531,6748,7848	c	350012113100000014	0-1359						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
888	chr29	39826528	39827770	3500037189	35		39826528	39827770	8421504	2	6,29	0,1213	c	350003718900000028	22-57						BMC Genomics BioMed Central	biomedcentral.com	0	0		
111	chr29	39963183	40018168	3500191478	2440		39963183	40018168	8421504	19	150,99,142,117,194,119,118,151,53,113,181,99,142,117,194,119,118,151,63	0,1849,2035,3856,4894,6277,6494,7586,9074,45908,46031,47895,48081,49922,50972,52362,52580,53673,54922	c,g	350019147800000041,350019147800000043,350019147800000042,350019147800000042	11-1154,0-113,6-1190,6-1190						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
111	chr29	39963183	40018168	3500155081	2440		39963183	40018168	8421504	19	150,99,142,117,194,119,118,151,53,113,181,99,142,117,194,119,118,151,63	0,1849,2035,3856,4894,6277,6494,7586,9074,45908,46031,47895,48081,49922,50972,52362,52580,53673,54922	c,g	350015508100000041,350015508100000043,350015508100000042,350015508100000042	11-1154,0-113,6-1190,6-1190						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
111	chr29	39963183	40018168	3500121131	2440		39963183	40018168	8421504	19	150,99,142,117,194,119,118,151,53,113,181,99,142,117,194,119,118,151,63	0,1849,2035,3856,4894,6277,6494,7586,9074,45908,46031,47895,48081,49922,50972,52362,52580,53673,54922	c,g	350012113100000041,350012113100000043,350012113100000042,350012113100000042	11-1154,0-113,6-1190,6-1190						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
891	chr29	40138420	40147749	3500191478	1295		40138420	40147749	8421504	10	70,212,99,142,117,194,119,118,151,73	0,71,2005,2191,4279,5320,6710,6927,8029,9256	c	350019147800000011	0-1295						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
891	chr29	40138420	40147749	3500155081	1295		40138420	40147749	8421504	10	70,212,99,142,117,194,119,118,151,73	0,71,2005,2191,4279,5320,6710,6927,8029,9256	c	350015508100000011	0-1295						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
891	chr29	40138420	40147749	3500121131	1295		40138420	40147749	8421504	10	70,212,99,142,117,194,119,118,151,73	0,71,2005,2191,4279,5320,6710,6927,8029,9256	c	350012113100000011	0-1295						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
891	chr29	40140449	40145217	3500068065	63		40140449	40145217	8421504	3	21,22,20	0,4706,4748	c,g	350006806500000025,350006806500000007,350006806500000006,350006806500000006	0-21,0-22,0-20,0-20						RESEARCH Open Access Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression	www.rbej.com	0	0		
891	chr29	40145429	40147740	3500220133	101		40145429	40147740	8421504	3	36,9,56	0,1020,2255	p,c	350022013300015003,350022013300015000,350022013300000000	0-45,0-45,0-19		22567354	10.4061/2011/436138		Genetics Research International	Characterization and In Silico Analysis of Pregnancy-Associated Glycoprotein-1 Gene of Buffalo (Bubalus bubalis)	Jerome	2011	0		
891	chr29	40218239	40227239	3500191478	1143		40218239	40227239	8421504	9	150,99,142,117,194,119,118,151,53	0,1831,2017,3854,4898,6286,6503,7597,8947	c	350019147800000040	11-1154						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
891	chr29	40218239	40227239	3500155081	1143		40218239	40227239	8421504	9	150,99,142,117,194,119,118,151,53	0,1831,2017,3854,4898,6286,6503,7597,8947	c	350015508100000040	11-1154						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
891	chr29	40218239	40227239	3500121131	1143		40218239	40227239	8421504	9	150,99,142,117,194,119,118,151,53	0,1831,2017,3854,4898,6286,6503,7597,8947	c	350012113100000040	11-1154						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
894	chr29	40581132	40583675	3500191478	523		40581132	40583675	8421504	4	143,99,197,84	0,226,2257,2459	c	350019147800000021	754-1280						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
894	chr29	40581132	40583675	3500155081	523		40581132	40583675	8421504	4	143,99,197,84	0,226,2257,2459	c	350015508100000021	754-1280						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
894	chr29	40581132	40583675	3500121131	523		40581132	40583675	8421504	4	143,99,197,84	0,226,2257,2459	c	350012113100000021	754-1280						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
894	chr29	40581265	40583395	3500285874	44		40581265	40583395	8421504	4	10,10,18,6	0,93,174,2124	c	350028587400000006,350028587400000007	0-20,0-24					BMC Genomics	Characterization of the bovine pregnancy-associated glycoprotein gene family &#x2013; analysis of gene sequences, regulatory regions within the promoter and expression of selected genes - Scolaris	Telugu	2009	0		
894	chr29	40581265	40583395	3500037189	44		40581265	40583395	8421504	4	10,10,18,6	0,93,174,2124	c	350003718900000009,350003718900000010	0-20,0-24						BMC Genomics BioMed Central	biomedcentral.com	0	0		
894	chr29	40583524	40583548	3500063369	24		40583524	40583548	8421504	1	24	0	c	350006336900000005	0-24		10819764	10.1095/biolreprod62.6.1624	0006-3363	Biology of Reproduction	Pregnancy-Associated Bovine and Ovine Glycoproteins Exhibit Spatially and Temporally Distinct Expression Patterns During Pregnancy	Green	2000	4		
895	chr29	40636434	40645749	3500191478	1295		40636434	40645749	8421504	13	13,56,148,118,119,194,117,142,99,253,8,5,23	0,14,1138,2559,2775,4090,5196,6983,7212,9023,9277,9286,9292	c	350019147800000016	0-1295						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
895	chr29	40636434	40645749	3500155081	1295		40636434	40645749	8421504	13	13,56,148,118,119,194,117,142,99,253,8,5,23	0,14,1138,2559,2775,4090,5196,6983,7212,9023,9277,9286,9292	c	350015508100000016	0-1295						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
895	chr29	40636434	40645749	3500121131	1295		40636434	40645749	8421504	13	13,56,148,118,119,194,117,142,99,253,8,5,23	0,14,1138,2559,2775,4090,5196,6983,7212,9023,9277,9286,9292	c	350012113100000016	0-1295						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
895	chr29	40706592	40715557	3500191478	1255		40706592	40715557	8421504	11	46,151,118,119,190,6,117,142,99,211,56	0,1121,2251,2467,3783,3974,4899,6678,6907,8697,8909	g	350019147800000013	0-1256						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
895	chr29	40706592	40715557	3500155081	1255		40706592	40715557	8421504	11	46,151,118,119,190,6,117,142,99,211,56	0,1121,2251,2467,3783,3974,4899,6678,6907,8697,8909	g	350015508100000013	0-1256						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
895	chr29	40706592	40715557	3500121131	1255		40706592	40715557	8421504	11	46,151,118,119,190,6,117,142,99,211,56	0,1121,2251,2467,3783,3974,4899,6678,6907,8697,8909	g	350012113100000013	0-1256						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
895	chr29	40724019	40724045	3500190800	24		40724019	40724045	8421504	2	19,5	0,21	g	350019080000000018	11-36						Recombinant IgG expression in mammalian cells	etc.tu-bs.de:8080	0	0		
899	chr29	41188862	41199072	3500191478	1317		41188862	41199072	8421504	9	63,151,118,119,200,117,145,99,305	0,1154,2302,2510,3870,4986,6862,7094,9905	c	350019147800000018	23-1340						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
899	chr29	41188862	41199072	3500155081	1317		41188862	41199072	8421504	9	63,151,118,119,200,117,145,99,305	0,1154,2302,2510,3870,4986,6862,7094,9905	c	350015508100000018	23-1340						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
899	chr29	41188862	41199072	3500121131	1317		41188862	41199072	8421504	9	63,151,118,119,200,117,145,99,305	0,1154,2302,2510,3870,4986,6862,7094,9905	c	350012113100000018	23-1340						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
899	chr29	41195851	41198779	3500285874	43		41195851	41198779	8421504	4	18,3,10,12	0,105,194,2916	c	350028587400000002,350028587400000003	0-21,0-22					BMC Genomics	Characterization of the bovine pregnancy-associated glycoprotein gene family &#x2013; analysis of gene sequences, regulatory regions within the promoter and expression of selected genes - Scolaris	Telugu	2009	0		
899	chr29	41195851	41198779	3500037189	43		41195851	41198779	8421504	4	18,3,10,12	0,105,194,2916	c	350003718900000005,350003718900000006	0-21,0-22						BMC Genomics BioMed Central	biomedcentral.com	0	0		
899	chr29	41224100	41227758	3500238389	183		41224100	41227758	8421504	4	33,105,1,44	0,2408,2525,3614	p	350023838900015018,350023838900015019	0-138,0-45						Structure ofthe humanrenin gene	www.pnas.org	0	0		
899	chr29	41228804	41228829	3500195071	23		41228804	41228829	8421504	2	9,14	0,11	g	350019507100000091	3-26						NEUTRALIZING ANTI-CCL20 ANTIBODIES - Patent application	www.faqs.org	0	0		
900	chr29	41292699	41292722	3500356169	23		41292699	41292722	8421504	1	23	0	g	350035616900000004	3-26						THE NEW ROLE OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9: A CONNECTION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, APOLIPOPROTEIN B, and AUTOPHAGY	s.library.tmc.edu	0	0		
901	chr29	41473739	41473765	3500347059	23		41473739	41473765	8421504	3	13,5,5	0,14,21	g	350034705900000060	0-25					Patent	Process for producing 7-aminocephem compound or salts thereof (Patent US:5677141)	Aramori	1997	0		
902	chr29	41645949	41645976	3500199811	23		41645949	41645976	8421504	2	7,16	0,11	g	350019981100000002	1-24		9882362		0022-538X	Journal of Virology	Evidence that the Human Foamy Virus Genome Is DNA	Yu	1999	5		
903	chr29	41700757	41700829	3500227738	72		41700757	41700829	8421504	1	72	0	p	350022773800015000	0-72						FEN-1 Nuclease in Genome Stability By Xin Xie Doug Brutlag&#x2019;s Introsem	m118.stanford.edu	0	0		FEN1
112	chr29	41807890	41813682	3500190549	90		41807890	41813682	8421504	4	15,30,21,24	0,134,215,5768	p	350019054900015011,350019054900015013	0-45,0-45						Transgenic fish with increased unsaturated fatty acid content - Patent application	www.faqs.org	0	0		FADS2
904	chr29	41830921	41831048	3500281920	40		41830921	41831048	8421504	2	20,20	0,107	c,g	350028192000000038,350028192000000038,350028192000000039	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
904	chr29	41861546	41861570	3500106407	23		41861546	41861570	8421504	2	4,19	0,5	c	350010640700000072	10-33						IRAP gene as treatment for arthritis	Glorioso	1995	0		
904	chr29	41876063	41876093	3500291921	25		41876063	41876093	8421504	2	12,13	0,17	g	350029192100000005	0-25						DOWN-REGULATION OF MORTALIN BY siRNA - Patent application	www.faqs.org	0	0		
904	chr29	41917498	41919386	3500430446	40		41917498	41919386	8421504	2	20,20	0,1868	c,g	350043044600000002,350043044600000003,350043044600000003	0-20,0-20,0-20						DPOFA, a Cl-/HCO3- exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	biomedcentral.com	0	0		
904	chr29	41917498	41919386	3500198876	40		41917498	41919386	8421504	2	20,20	0,1868	c,g	350019887600000002,350019887600000003,350019887600000003	0-20,0-20,0-20		22085910	10.1186/1471-2415-11-33	1471-2415	BMC Ophthalmology	DPOFA, a Cl-/HCO3 - exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	Iserovich	2011	1		
904	chr29	41919949	41919973	3500418514	24		41919949	41919973	8421504	1	24	0	c	350041851400000044	14-38						Human platelet-derived growth factor receptor extracellular domain antibodies	Wolf	1995	0		
904	chr29	41919949	41919973	3500347340	24		41919949	41919973	8421504	1	24	0	c	350034734000000230	14-38						Human platelet-derived growth factor receptors	Williams	1995	0		
904	chr29	41921826	41922198	3500289661	51		41921826	41922198	8421504	3	13,13,25	0,302,347	c	350028966100000017,350028966100000016	0-26,0-25						KUOPION YLIOPISTON JULKAISUJA G. - A.I. VIRTANEN -INSTITUUTTI 63 KUOPIO UNIVERSITY PUBLICATIONS G. A.I. VIRTANEN INSTITUTE FOR MOLECULAR SCIENCES 63	blications.uef.fi	0	0		FTH1
904	chr29	41922173	41922198	3500458327	25		41922173	41922198	8421504	1	25	0	c	350045832700000006	0-25						HBx modulates iron regulatory protein 1-mediated iron metabolism via reactive oxygen species. - ResearchGate	.researchgate.net	0	0		
904	chr29	41922243	41922266	3500095683	23		41922243	41922266	8421504	1	23	0	c	350009568300000013	1-24		20385107	10.1016/j.bcp.2010.04.008		Biochemical pharmacology	FERRITIN H INDUCTION BY HISTONE DEACETYLASE INHIBITORS	Wei	2010	0		
907	chr29	42226655	42226678	3500182494	23		42226655	42226678	8421504	1	23	0	g	350018249400000024	2-31						Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products	Barbas	2000	0		
907	chr29	42251904	42251931	3500257654	23		42251904	42251931	8421504	2	16,7	0,20	g	350025765400000027	0-23						Black Aspergillus species: implications for ochratoxin A in Australian grapes and wine	s.adelaide.edu.au	0	0		
908	chr29	42409874	42415789	3500381115	60		42409874	42415789	8421504	3	28,5,27	0,2540,5888	p	350038111500015000	0-60		12533507	10.1101/gad.1040803	0890-9369	Genes & Development	Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA	Pestova	2003	12		EEF1G
908	chr29	42433209	42433233	3500137915	23		42433209	42433233	8421504	2	19,4	0,20	c	350013791500000192	17-41						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		MTA2
908	chr29	42438499	42439323	3500394155	66		42438499	42439323	8421504	2	13,53	0,771	p	350039415500015004	3-69						Serologische Identifikation von Pankreaskarzinom-spezifischen Antigenen	b.uni-saarland.de	0	0		MTA2
908	chr29	42451316	42451373	3500296606	57		42451316	42451373	8421504	1	57	0	p	350029660600015000	0-57		21994382	10.1523/JNEUROSCI.3516-11.2011		The Journal of neuroscience : the official journal of the Society for Neuroscience	Membrane attachment is key to protecting transducin GTPase activating complex from intracellular proteolysis in photoreceptors	Sidney	2011	0		
908	chr29	42451316	42451373	3500156276	57		42451316	42451373	8421504	1	57	0	p	350015627600015004	0-57		21994382	10.1523/JNEUROSCI.3516-11.2011	0270-6474	The Journal of Neuroscience	Membrane Attachment Is Key to Protecting Transducin GTPase-Activating Complex from Intracellular Proteolysis in Photoreceptors	III	2011	7		
908	chr29	42452193	42456393	3500386161	1005		42452193	42456393	8421504	5	96,291,361,175,82	0,673,1120,2808,4118	p	350038616100015000	0-1005						KEGG T01008: 404162	www.genome.jp	0	0		B3GAT3,ROM1
909	chr29	42518694	42519155	3500434299	192		42518694	42519155	8421504	2	99,93	0,368	p	350043429900015051,350043429900015052,350043429900015053,350043429900015054	0-48,0-48,0-48,0-48						Zebrafish Heterotrimer G-protein Gamma 2 Subunit (gng2) 	.freshpatents.com	0	0		GNG3
909	chr29	42519167	42519191	3500120337	24		42519167	42519191	8421504	1	24	0	c	350012033700000021	0-24						G Proteins, Polynucleotides Encoding The Same And Utilization Thereof 	.freshpatents.com	0	0		GNG3
909	chr29	42534206	42534269	3500310861	63		42534206	42534269	8421504	1	63	0	p	350031086100015032	90-153						<Html><Title> Complet list of 1zwm hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
909	chr29	42584827	42586675	3500115572	24		42584827	42586675	8421504	4	6,5,10,3	0,10,16,1845	c	350011557200000191	10-37						METHOD FOR PRODUCING SCYLLO-INOSITOL - Patent application	www.faqs.org	0	0		
909	chr29	42596621	42596818	3500244412	23		42596621	42596818	8421504	2	12,11	0,186	c	350024441200000026	6-33						Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain - Patent # 7238354 - PatentGenius	.patentgenius.com	0	0		
910	chr29	42639826	42639856	3500414194	25		42639826	42639856	8421504	2	17,8	0,22	c	350041419400000027	9-34						Cells & vertebrates for enhanced somatic hypermutation and class switch recombination	Lee	2012	0		
910	chr29	42641118	42641287	3500031564	169		42641118	42641287	8421504	1	169	0	c	350003156400000000,350003156400000055	19-188,0-169						METHODS OF DETECTING LUNG CANCER	Michot	2012	0		
910	chr29	42641118	42641141	3500422443	23		42641118	42641141	8421504	1	23	0	c	350042244300000000	0-23		18756266	10.1038/emboj.2008.172	ERROR! NO ISSN	The EMBO Journal	Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells	Ferretti	2008	0		
910	chr29	42641118	42641141	3500340011	23		42641118	42641141	8421504	1	23	0	c	350034001100000014	0-23		23071155	10.1083/jcb.201203134	0021-9525	The Journal of Cell Biology	miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration	Amelio	2012	10		
910	chr29	42641118	42641141	3500116416	23		42641118	42641141	8421504	1	23	0	c	350011641600000000	0-23						The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells	www.pnas.org	0	0		
910	chr29	42641163	42641196	3500214855	33		42641163	42641196	8421504	1	33	0	c	350021485500000002	0-33		11134342	10.1128/MCB.21.2.548-561.2001	0270-7306	Molecular and Cellular Biology	The RNase P Associated with HeLa Cell Mitochondria Contains an Essential RNA Component Identical in Sequence to That of the Nuclear RNase P	Puranam	2001	6		
910	chr29	42641207	42641235	3500199074	28		42641207	42641235	8421504	1	28	0	c	350019907400000002	0-28						&#x77f3;&#x8721;&#x5207;&#x7247;&#x539f;&#x4f4d;&#x6742;&#x4ea4; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
910	chr29	42641255	42641280	3500367418	25		42641255	42641280	8421504	1	25	0	c	350036741800000001	0-25		22252314	10.1128/MCB.05788-11	0270-7306	Molecular and Cellular Biology	A Quantitative High-Throughput In Vitro Splicing Assay Identifies Inhibitors of Spliceosome Catalysis	Berg	2012	6		
910	chr29	42685477	42685518	3500190264	41		42685477	42685518	8421504	1	41	0	c	350019026400000135	0-41						NOVEL ANTI-CD98 ANTIBODY - Patent application	www.faqs.org	0	0		
910	chr29	42691043	42691067	3500292309	24		42691043	42691067	8421504	1	24	0	c	350029230900000011	9-33						Tat-031 And Methods Of Assessing And Treating Cancer 	.freshpatents.com	0	0		
910	chr29	42714508	42715688	3500460081	603		42714508	42715688	8421504	7	99,84,87,81,75,84,93	0,102,610,760,883,988,1087	p	350046008100015040,350046008100015035,350046008100015030,350046008100015025,350046008100015020,350046008100015015,350046008100015010	0-99,0-84,0-87,0-81,0-75,0-84,0-93						Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor	Kapeller-libermann	2006	0		
910	chr29	42715091	42715139	3500322678	48		42715091	42715139	8421504	1	48	0	p	350032267800015016	0-48						US Patent # 7,425,420. Identification of ligands by selective amplification of cells transfected with a 5HT2A receptor - Patents.com	www.patents.com	0	0		CHRM1
910	chr29	42715094	42715142	3500230939	48		42715094	42715142	8421504	1	48	0	p	350023093900015016	0-48						Identification Of Ligands By Selective Amplification Of Cells Transfected With Receptors 	.freshpatents.com	0	0		CHRM1
910	chr29	42715094	42715139	3500188848	45		42715094	42715139	8421504	1	45	0	p	350018884800015019	0-45						IDENTIFICATION OF LIGANDS BY SELECTIVE AMPLIFICATION OF CELLS TRANSFECTED WITH RECEPTORS - Patent application	www.faqs.org	0	0		CHRM1
911	chr29	42783814	42785527	3500001569	46		42783814	42785527	8421504	2	26,20	0,1693	c	350000156900000020	2-48						Gene encoding organic anion transporter	Cihlar	1999	0		
914	chr29	43180629	43180654	3500134916	25		43180629	43180654	8421504	1	25	0	c	350013491600000032	11-36						Item 3.2 of the Provisional Agenda COMMISSION ON GENETIC RESOURCES FOR FOOD AND AGRICULTURE INTERGOVERNMENTAL TECHNICAL WORKING GROUP ON ANIMAL GENETIC RESOURCES FOR FOOD AND AGRICULTURE	www.fao.org	0	0		
916	chr29	43446804	43446828	3500224180	24		43446804	43446828	8421504	1	24	0	c	350022418000000004	0-24						H-REV0- Stimulates Growth in Non-Small Cell Lung Carcinomas via the Activation of Mitogenic Signaling 2006&#x5e74;&#x7b2c;168&#x5377;&#x7b2c;10&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
916	chr29	43476897	43477041	3500376368	144		43476897	43477041	8421504	1	144	0	p	350037636800015052	0-144						148 human secreted proteins	Brewer	1999	0		ATL3
917	chr29	43524156	43524180	3500041283	24		43524156	43524180	8421504	1	24	0	c	350004128300000002	0-24						Reticulon3Bindsthe2CProteinofEnterovirus71and IsRequiredforViralReplication	www.jbc.org	0	0		ATL3
917	chr29	43596468	43596493	3500240561	23		43596468	43596493	8421504	2	7,16	0,9	g	350024056100000102	1-25						MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR - Patent application	www.faqs.org	0	0		
917	chr29	43645861	43645885	3500442260	23		43645861	43645885	8421504	2	15,8	0,16	g	350044226000000004	15-39						METHOD FOR THE PRODUCTION OF ERYTHROPOIETIN - GENETICS INSTITUTE, INC	www.sumobrain.com	0	0		
919	chr29	43785335	43791021	3500147922	747		43785335	43791021	8421504	10	78,54,49,66,71,6,45,237,120,21	0,317,3270,3641,3796,4049,4061,4781,5448,5665	p	350014792200015003,350014792200015007,350014792200015011,350014792200015015,350014792200015018	0-165,0-159,0-165,0-165,0-93						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
919	chr29	43790185	43790266	3500366238	81		43790185	43790266	8421504	1	81	0	p	350036623800015026	0-81						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		MARK2
919	chr29	43791212	43791290	3500068159	78		43791212	43791290	8421504	1	78	0	p	350006815900015009	0-78						INAUGURAL - DISSERTATION	uni-heidelberg.de	0	0		MARK2
919	chr29	43890989	43892382	3500384752	129		43890989	43892382	8421504	2	81,48	0,1345	p	350038475200015017	0-129						48 human secreted proteins	Komatsoulis	2002	0		
919	chr29	43890989	43892382	3500375425	129		43890989	43892382	8421504	2	81,48	0,1345	p	350037542500015017	0-129						48 human secreted proteins	Komatsoulis	2000	0		
919	chr29	43891027	43892337	3500367934	46		43891027	43892337	8421504	2	43,3	0,1307	c	350036793400000461	0-46						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
919	chr29	43900574	43904533	3500324450	51		43900574	43904533	8421504	2	15,36	0,3923	p	350032445000015004	0-51		19383985	10.1074/jbc.M109.007484		The Journal of Biological Chemistry	OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1 (OTUB1) Deubiquitinates Estrogen Receptor (ER) &#x03b1; and Affects ER&#x03b1; Transcriptional Activity	Vladimir	June	0		OTUB1
921	chr29	44093543	44094707	3500411740	57		44093543	44094707	8421504	2	30,27	0,1137	p	350041174000015023	0-57						Dissertation	thek.uni-halle.de	0	0		STIP1
921	chr29	44116352	44118965	3500179772	372		44116352	44118965	8421504	8	51,27,30,75,30,66,24,69	0,196,998,1181,1391,1765,1834,2544	p	350017977200015027,350017977200015026,350017977200015023,350017977200015024,350017977200015025	0-72,0-78,0-105,0-120,0-69						Antibodies to secreted protein HEMCM42	Ruben	2002	0		FERMT3
921	chr29	44116352	44118965	3500010113	387		44116352	44118965	8421504	7	51,27,30,75,42,93,69	0,196,998,1181,1379,1765,2544	p	350001011300015026,350001011300015023,350001011300015024,350001011300015025	0-78,0-105,0-135,0-69						32 Human Secreted Proteins	Ruben	2007	0		FERMT3
921	chr29	44119567	44119592	3500179117	23		44119567	44119592	8421504	2	8,15	0,10	c	350017911700000005	0-23					Patent	Production of vanillin (Patent US:6664088)	Narbad	2003	0		
921	chr29	44119567	44119592	3500159227	23		44119567	44119592	8421504	2	8,15	0,10	c	350015922700000012	0-23						Production of vanillin	Gasson	1997	0		
921	chr29	44119585	44119611	3500374909	24		44119585	44119611	8421504	2	19,5	0,21	c	350037490900000511	21-45						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
921	chr29	44120607	44120631	3500062355	23		44120607	44120631	8421504	2	19,4	0,20	c	350006235500000038	9-32						Methods and Materials for Identifying the Origin of a Carcinoma of Unknown Primary Origin - Patent application	www.faqs.org	0	0		
921	chr29	44130341	44131063	3500123507	44		44130341	44131063	8421504	4	12,10,15,7	0,353,535,715	c	350012350700000003,350012350700000004	0-22,0-22		15529014	10.1097/01.WCB.0000134477.38980.38	0271-678X	Journal of Cerebral Blood Flow & Metabolism	Increased Severity of Cerebral Ischemic Injury in Vascular Endothelial Growth Factor-B&#x2013;Deficient Mice	Sun	2004	5		
921	chr29	44130345	44130709	3500324005	23		44130345	44130709	8421504	2	8,15	0,349	c	350032400500000005	0-23						ScienceDirect.com - Developmental Biology - FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate	sciencedirect.com	0	0		
921	chr29	44130807	44130852	3500223423	45		44130807	44130852	8421504	1	45	0	p	350022342300015010	0-45						ISOLATED VEGF-C AND VEGF-D PEPTIDES AND USES THEREOF - VEGENICS LIMITED	www.sumobrain.com	0	0		VEGFB
921	chr29	44130807	44130852	3500188730	45		44130807	44130852	8421504	1	45	0	p	350018873000015009	0-45						ISOLATED VEGF-C AND VEGF-D PEPTIDES AND USES THEREOF - Patent application	www.faqs.org	0	0		VEGFB
921	chr29	44136744	44136792	3500219021	48		44136744	44136792	8421504	1	48	0	c	350021902100000007	0-48						FKBP-13, an FK506-binding immunophilin	Burakoff	1992	0		
115	chr29	44164086	44175159	3500389069	41		44164086	44175159	8421504	2	19,22	0,11051	c	350038906900000005,350038906900000004	9-28,9-31		15857576	10.1038/sj.cr.7290290	1001-0602	Cell Research	The crystal structure of the non-liganded 14-3-3&#x03c3; protein: insights into determinants of isoform specific ligand binding and dimerization	BENZINGER	2005	8		BAD,GPR137
921	chr29	44164788	44164839	3500266784	51		44164788	44164839	8421504	1	51	0	p	350026678400015000	0-51						Supplemental Material and Methods Peptide sequence information for binding studies and compound synthesis Pharmacokinetics and hematology studies	.aacrjournals.org	0	0		BAD
921	chr29	44164788	44164839	3500177194	51		44164788	44164839	8421504	1	51	0	p	350017719400015005	0-51						Protein Page: NP_000624	ranetransport.org	0	0		BAD
921	chr29	44164788	44164839	3500159812	51		44164788	44164839	8421504	1	51	0	p	350015981200015005	0-51						Protein Page: NP_620118	ranetransport.org	0	0		BAD
922	chr29	44175136	44175160	3500319811	24		44175136	44175160	8421504	1	24	0	c	350031981100000000	7-31		22011203	10.1089/cbr.2011.1018		Cancer Biotherapy & Radiopharmaceuticals	Overexpression of Bcl-2&#x2013;Associated Death Inhibits A549 Cell Growth In Vitro and In Vivo	Na	2012	0		
922	chr29	44195200	44200878	3500402627	164		44195200	44200878	8421504	6	39,25,29,19,21,31	0,264,294,3978,5578,5647	c,g	350040262700000007,350040262700000008,350040262700000024,350040262700000025,350040262700000021,350040262700000040,350040262700000040,350040262700000020,350040262700000041,350040262700000041	6-30,9-37,5-30,0-29,10-29,0-21,0-21,4-30,0-19,0-19						Method of using estrogen-related receptor alpha (ERR&#x03b1;) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERR&#x03b1; as a therapeutic target for the treatment of breast cancer	Mertz	2002	0		
922	chr29	44195211	44200878	3500136544	153		44195211	44200878	8421504	6	28,25,29,19,21,31	0,253,283,3967,5567,5636	c,g	350013654400000008,350013654400000024,350013654400000025,350013654400000021,350013654400000040,350013654400000020,350013654400000041,350013654400000041	9-37,5-30,0-29,10-29,0-21,4-30,0-19,0-19						Method of using estrogen-related receptor alpha (ERRalpha) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRalpha as a therapeutic target for the treatment of breast cancer	Mertz	2002	0		
922	chr29	44195461	44200856	3500102390	90		44195461	44200856	8421504	2	45,45	0,5350	p	350010239000015008,350010239000015027	0-45,0-45						 <HTML> <HEAD><TITLE>aedege|ec1/2e3a - c1ei1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4 | j-tokkyo</TITLE> <M	www.j-tokkyo.com	0	0		ESRRG
922	chr29	44198851	44200862	3500185455	591		44198851	44200862	8421504	5	93,133,104,87,174	0,834,1065,1172,1837	p	350018545500015016,350018545500015040,350018545500015060,350018545500015098	0-93,0-237,0-87,0-174						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers_ Sources	www.docstoc.com	0	0		ESRRA
922	chr29	44198851	44200862	3500111757	420		44198851	44200862	8421504	4	93,66,87,174	0,1103,1172,1837	p	350011175700015024,350011175700015049,350011175700015071,350011175700015108	0-93,0-66,0-87,0-174						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers, Sources	www.scribd.com	0	0		ESRRA
922	chr29	44199243	44200745	3500093095	462		44199243	44200745	8421504	11	7,41,45,28,65,45,45,45,10,83,48	0,407,451,547,673,789,837,885,933,1368,1454	p	350009309500015110,350009309500015112,350009309500015113,350009309500015115	0-93,0-45,0-48,0-276						Method for identifying antagonist compounds of the estrogen-related receptor 3 (ERR3) by using the x-ray structural coordinates of the ligand binding domain - Patent # 7279325 - PatentGenius	.patentgenius.com	0	0		
922	chr29	44199664	44200868	3500356489	651		44199664	44200868	8421504	4	154,270,20,207	0,252,947,997	p	350035648900015063,350035648900015083	0-348,0-336					Patent	Polynucleotide encoding insect ecdysone receptor (Patent US:6245531)	Hogness	2001	0		
922	chr29	44201624	44201649	3500464289	25		44201624	44201649	8421504	1	25	0	c	350046428900000045	0-25						High bone mass gene of 11q13.3	Carulli	2000	0		TRMT112
922	chr29	44201624	44201649	3500361009	25		44201624	44201649	8421504	1	25	0	c	350036100900000052	0-25						Transgenic Animal Model Of Bone Mass Modulation 	.freshpatents.com	0	0		TRMT112
922	chr29	44201624	44201649	3500189896	25		44201624	44201649	8421504	1	25	0	c	350018989600000045	0-25						High bone mass gene of 11q13.3	Carulli	2003	0		TRMT112
922	chr29	44201624	44201649	3500138868	25		44201624	44201649	8421504	1	25	0	c	350013886800000052	0-25						 Transgenic Animal Model Of Bone Mass Modulation 	www.docstoc.com	0	0		
922	chr29	44201624	44201649	3500068827	25		44201624	44201649	8421504	1	25	0	c	350006882700000045	0-25					Patent	High bone mass gene of 1.1q13.3 (Patent US:6780609)	Carulli	2004	0		TRMT112
922	chr29	44237591	44250623	3500295452	2313		44237591	44250623	8421504	18	55,72,219,116,108,81,104,151,165,129,134,94,174,31,164,160,164,192	0,159,906,1201,2117,2431,2585,2782,5649,8791,9082,9297,11358,11612,11644,12080,12424,12840	p	350029545200015029	0-2316						Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer	Fritz	2011	0		
922	chr29	44237594	44250524	3500257178	2199		44237594	44250524	8421504	20	52,72,219,116,108,81,104,151,165,129,134,64,24,147,21,31,164,160,164,93	0,156,903,1198,2114,2428,2582,2779,5646,8788,9079,9294,9364,11355,11508,11609,11641,12077,12421,12837	p	350025717800015008,350025717800015043,350025717800015038,350025717800015005,350025717800015023,350025717800015046	9-2199,0-2043,0-2040,0-2118,0-1713,0-1413						Polypeptides, polynucleotides and uses thereof	Alessi	2001	0		
922	chr29	44237639	44250491	3500247142	2133		44237639	44250491	8421504	18	7,72,219,116,108,81,104,151,165,129,134,94,174,31,164,160,164,60	0,111,858,1153,2069,2383,2537,2734,5601,8743,9034,9249,11310,11564,11596,12032,12376,12792	p	350024714200015003	0-2139					Patent	Polypeptides, polynucleotides and uses thereof (Patent US:7122360)	Alessi	2006	0		
922	chr29	44240037	44246394	3500399057	54		44240037	44246394	8421504	3	36,6,12	0,3362,6345	p	350039905700015025	0-54						Method for designing pdk1 modulators	ALESSI	2005	0		
922	chr29	44274620	44274646	3500321761	23		44274620	44274646	8421504	3	4,14,5	0,5,21	g	350032176100000005	4-27						Stimulation Of The Synthesis And Of The Activity Of An Isoform Of Lysyl Oxidase-like Loxl For Stimulating The Formation Of Elastic Fibers. 	.freshpatents.com	0	0		
922	chr29	44274620	44274646	3500096057	23		44274620	44274646	8421504	3	4,14,5	0,5,21	g	350009605700000005	4-27						Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers. - Patent application	www.faqs.org	0	0		
924	chr29	44461321	44461471	3500380957	150		44461321	44461471	8421504	1	150	0	p	350038095700015015	0-150						beta-Neurexin 1 ( -NRXN1 &#x0e17;&#x0e35;&#x0e48;&#x0e40;&#x0e1b;&#xf712;&#x0e19;&#x0e2d;&#x0e2d;&#x0e17; &#x0e34;&#x0e0b;&#x0e36;&#x0e21;&#x0e2a;&#x0e40;&#x0e1b;&#x0e04;&#x0e15;&#x0e23; &#x0e31;&#x0e21; Mutation Screening of the beta-Neurexin 1 (&#x03b2;	kb.psu.ac.th	0	0		NRXN2
924	chr29	44473833	44473857	3500258554	23		44473833	44473857	8421504	2	13,10	0,14	c	350025855400000371	3-29						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
924	chr29	44503583	44503607	3500365320	24		44503583	44503607	8421504	1	24	0	c	350036532000000002	0-24		17035546	10.1523/JNEUROSCI.1913-06.2006	0270-6474	The Journal of Neuroscience	Important Contribution of &#x03b1;-Neurexins to Ca2+-Triggered Exocytosis of Secretory Granules	Dudanova	2006	7		
924	chr29	44545122	44545150	3500395209	25		44545122	44545150	8421504	3	6,13,6	0,7,22	g	350039520900000096	6-31						Cytokinin Oxidase Sequences and Methods of Use - Patent application	www.faqs.org	0	0		
115	chr29	44559281	44571588	3500102602	1827		44559281	44571588	8421504	15	59,177,37,142,116,123,78,282,117,174,151,132,63,103,73	0,942,1632,1950,5349,5801,6119,7137,8899,9176,9532,10450,10904,11495,12234	p,c,g	350010260200000010,350010260200000007,350010260200000009,350010260200000009,350010260200000008,350010260200015005,350010260200015015,350010260200015003,350010260200015000	0-1827,0-1827,0-1827,0-1827,0-1827,0-69,0-129,0-129,0-72						CalDAG-GEF1 Gene Mutations Associated with Thrombopathy - Patent application	www.faqs.org	0	0		
925	chr29	44566553	44568888	3500026406	270		44566553	44568888	8421504	4	69,90,39,72	0,1654,1904,2263	p	350002640600015004,350002640600015003,350002640600015002	0-69,0-129,0-72						Journal of Laboratory and Clinical Medicine	lib.ajaums.ac.ir	0	0		RASGRP2
925	chr29	44579074	44586695	3500199211	200		44579074	44586695	8421504	4	20,9,102,69	0,6297,6392,7552	p,c	350019921100000020,350019921100015005	0-20,0-180						Etude des voies metaboliques des sucres chez l'huitre creuse crassostrea gigas. Implication dans les mortalites estivales.	chimer.ifremer.fr	0	0		
925	chr29	44580883	44580906	3500008756	23		44580883	44580906	8421504	1	23	0	c	350000875600000863	0-23						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		PYGB
925	chr29	44596884	44596959	3500078731	45		44596884	44596959	8421504	2	22,23	0,52	c,g	350007873100000018,350007873100000018,350007873100000017	0-22,0-22,0-23						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		
925	chr29	44597853	44604053	3500383984	126		44597853	44604053	8421504	3	16,62,48	0,211,6152	p	350038398400015132,350038398400015130	0-78,0-48						Inaugural-Dissertation	uni-heidelberg.de	0	0		SF1
925	chr29	44630917	44653070	3500361009	43		44630917	44653070	8421504	3	24,7,12	0,22131,22141	c	350036100900000113,350036100900000145	0-24,8-27						Transgenic Animal Model Of Bone Mass Modulation 	.freshpatents.com	0	0		MAP4K2,SF1
925	chr29	44630917	44630941	3500464289	24		44630917	44630941	8421504	1	24	0	c	350046428900000106	0-24						High bone mass gene of 11q13.3	Carulli	2000	0		
925	chr29	44631669	44636746	3500059132	1812		44631669	44636746	8421504	10	105,357,165,136,137,88,41,129,209,445	0,123,678,1302,1851,2662,2824,3156,3490,4632	p	350005913200015006,350005913200015005	0-105,0-1722						MEN1 GENE FOR DIAGNOSIS AND TREATMENT OF DIABETES	Hua	2008	0		MEN1
925	chr29	44631669	44631726	3500413479	57		44631669	44631726	8421504	1	57	0	p	350041347900015000	3-60						Molecular Cell, Vol. 13, 587&#x2013;597, February 27, 2004, Copyright 2004 by Cell Press Menin Associates with a Trithorax Family Histone Methyltransferase Complex and with the Hoxc8 Locus	.researchgate.net	0	0		MEN1
925	chr29	44636310	44636334	3500425658	24		44636310	44636334	8421504	1	24	0	c	350042565800000028	0-24						minimal stimulation protocol: Topics by Science.gov	www.science.gov	0	0		MEN1
925	chr29	44636310	44636334	3500241545	24		44636310	44636334	8421504	1	24	0	c	350024154500000028	0-24						vascular setting protocol: Topics by Science.gov	www.science.gov	0	0		MEN1
925	chr29	44636310	44636334	3500005771	24		44636310	44636334	8421504	1	24	0	c	350000577100000028	0-24						efficient arq protocols: Topics by Science.gov	www.science.gov	0	0		MEN1
925	chr29	44666424	44666484	3500389641	60		44666424	44666484	8421504	1	60	0	p	350038964100015006	0-60						Myotonic dystrophy	Korneluk	1993	0		CDC42BPG
925	chr29	44676751	44676796	3500463907	45		44676751	44676796	8421504	1	45	0	p	350046390700015000	0-45		22456504	10.1091/mbc.E11-10-0881	1059-1524	Molecular Biology of the Cell	cPLA2&#x03b1; and EHD1 interact and regulate the vesiculation of cholesterol-rich, GPI-anchored, protein-containing endosomes	Cai	2012	5		EHD1
925	chr29	44676751	44676796	3500322135	45		44676751	44676796	8421504	1	45	0	p	350032213500015000	0-45						802 Research Article	cs.biologists.org	0	0		EHD1
925	chr29	44676772	44676967	3500262495	195		44676772	44676967	8421504	1	195	0	p	350026249500015022,350026249500015025	0-195,0-195						est_a_palmata1012 | MarineGenomics.org	arinegenomics.org	0	0		EHD1
926	chr29	44740247	44740354	3500390562	45		44740247	44740354	8421504	2	26,19	0,88	c,g	350039056200000010,350039056200000009,350039056200000009	12-38,15-34,15-34						Construction of HCC-targeting artificial miRNAs using natural miRNA precursors	-publications.com	0	0		
926	chr29	44740313	44740540	3500257436	44		44740313	44740540	8421504	2	22,22	0,205	c	350025743600000027,350025743600000030	22-44,22-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
926	chr29	44740314	44740540	3500244257	43		44740314	44740540	8421504	2	21,22	0,204	c,g	350024425700000055,350024425700000055,350024425700000056,350024425700000056	0-21,0-21,0-22,0-22						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		ATG2A
926	chr29	44740314	44740343	3500206818	26		44740314	44740343	8421504	2	21,5	0,24	c	350020681800000037,350020681800000046,350020681800000038,350020681800000033	0-21,0-21,0-26,0-21						Method For Producing Novel Hipsc By Means Of Sirna Introduction	Miura	2011	0		
926	chr29	44740518	44775471	3500114594	43		44740518	44775471	8421504	2	22,21	0,34932	g	350011459400000857,350011459400000430,350011459400000889,350011459400000462	0-22,0-22,0-21,0-21						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		
926	chr29	44743443	44743469	3500070288	25		44743443	44743469	8421504	2	13,12	0,14	c	350007028800000636	12-37						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
926	chr29	44748898	44748922	3500369490	23		44748898	44748922	8421504	2	10,13	0,11	c	350036949000000036	23-48						Novel variants of apolipoprotein a-i	Assmann	1998	0		
926	chr29	44756115	44756141	3500354208	23		44756115	44756141	8421504	2	12,11	0,15	g	350035420800000018	6-29						Small interference RNA gene therapy	Chang	2004	0		
926	chr29	44780686	44780714	3500457733	28		44780686	44780714	8421504	1	28	0	c	350045773300000009	0-28						Beta-like glycoprotein hormone polypeptide and heterodimer	Paszty	2008	0		GPHA2
926	chr29	44780686	44780714	3500399303	28		44780686	44780714	8421504	1	28	0	c	350039930300000009	0-28						Beta-like glycoprotein hormone polypeptide and heterodimer	Paszty	2008	0		GPHA2
926	chr29	44780686	44780714	3500392935	28		44780686	44780714	8421504	1	28	0	c	350039293500000009	0-28						Beta-like glycoprotein hormone polypeptide and heterodimer	Cao	2003	0		GPHA2
926	chr29	44780686	44780714	3500367634	28		44780686	44780714	8421504	1	28	0	c	350036763400000009	0-28						Beta-like glycoprotein hormone polypeptide and heterodimer	Paszty	2003	0		GPHA2
926	chr29	44780686	44780714	3500337138	28		44780686	44780714	8421504	1	28	0	c	350033713800000009	0-28					Patent	&#x03b2;-like glycoprotein hormone polypeptide and heterodimer (Patent US:7910709)	Paszty	2011	0		GPHA2
926	chr29	44780686	44780714	3500320173	28		44780686	44780714	8421504	1	28	0	c	350032017300000009	0-28					Patent	Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof (Patent US:8278422)	Paszty	2012	0		GPHA2
926	chr29	44780686	44780714	3500305942	28		44780686	44780714	8421504	1	28	0	c	350030594200000009	0-28					Patent	Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof (Patent US:8278422)	Paszty	2012	0		GPHA2
926	chr29	44780686	44780714	3500147605	28		44780686	44780714	8421504	1	28	0	c	350014760500000009	0-28					Patent	Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof (Patent US:7883868)	Paszty	2011	0		GPHA2
926	chr29	44780686	44780714	3500139351	28		44780686	44780714	8421504	1	28	0	c	350013935100000009	0-28						Beta-like glycoprotein hormone polypeptide and heterodimer	Paszty	2008	0		GPHA2
926	chr29	44781079	44781269	3500282816	30		44781079	44781269	8421504	2	5,25	0,165	c	350028281600000011	5-35						Glycoprotein hormone family member	Cao	2000	0		
927	chr29	44878103	44893837	3500186773	2232		44878103	44893837	8421504	18	184,93,88,171,82,91,92,68,64,86,120,86,105,284,123,122,173,200	0,497,696,858,1112,1931,2117,2434,2587,2733,4735,4995,6119,6308,14561,15072,15276,15534	p	350018677300015000	0-2232						KEGG T01008: 506692	www.genome.jp	0	0		
927	chr29	44922903	44922929	3500167899	24		44922903	44922929	8421504	2	19,5	0,21	c	350016789900000002	12-39			10.1111/j.1574-6968.1999.tb13467.x	1574-6968	FEMS Microbiology Letters	Cloning and characterization in Escherichia coli of the gene encoding the principal sigma factor of an extreme thermophile, Thermus thermophilus - Nishiyama - 2006 - FEMS Microbiology Letters - Wiley Online Library	Nishiyama	1999	0		
927	chr29	44939004	44943408	3500432096	163		44939004	44943408	8421504	4	62,20,57,24	0,444,3195,4380	p,c,g	350043209600000000,350043209600015000,350043209600015001,350043209600000001,350043209600000001	6-31,0-69,0-57,6-30,6-30			10.1046/j.0014-2956.2001.02646.x	1432-1033	European Journal of Biochemistry	Cloning and expression of sterol &#x0394;14-reductase from bovine liver - Roberti - 2003 - European Journal of Biochemistry - Wiley Online Library	Roberti	2002	0		
927	chr29	44944671	44944694	3500396579	23		44944671	44944694	8421504	1	23	0	c	350039657900000016	1-33						Recombinant rna 3'-terminal phosphate cyclases and production methods thereof	Filipowicz	1997	0		
927	chr29	44947729	44947999	3500122703	105		44947729	44947999	8421504	2	51,54	0,216	p	350012270300015005,350012270300015003	0-54,0-54						Natural Peptides with Potential Applications in Drug Development, Diagnosis, and/or Biotechnology	loads.hindawi.com	0	0		FAU
115	chr29	44956723	44958572	3500059392	191		44956723	44958572	8421504	6	48,21,26,48,17,31	0,240,333,597,1379,1818	c	350005939200000035,350005939200000032,350005939200000028,350005939200000025	0-48,0-47,0-48,0-48						Method Of Suppressing Cancer 	.freshpatents.com	0	0		
928	chr29	44958102	44958572	3500310407	48		44958102	44958572	8421504	2	17,31	0,439	c	350031040700000025	0-48						Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer - Patent application	www.faqs.org	0	0		
928	chr29	44958756	44958782	3500430989	23		44958756	44958782	8421504	2	17,6	0,20	c	350043098900000506,350043098900000507	12-35,21-44						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
928	chr29	45021087	45047771	3500242384	14504		45021087	45047771	8421504	208	60,55,118,55,56,55,55,55,56,54,56,55,55,55,56,55,60,356,59,177,60,57,57,177,58,57,56,56,55,55,56,55,54,56,54,57,53,57,55,55,57,6,51,57,57,55,56,55,55,54,235,296,57,57,55,54,56,57,54,56,55,55,55,55,116,55,54,58,57,57,115,56,55,55,55,55,60,110,52,178,57,57,56,55,57,35,60,55,57,57,54,237,55,56,55,55,55,55,56,55,58,58,58,58,58,60,56,59,60,55,59,58,57,58,58,58,58,57,57,57,55,58,52,56,55,53,57,55,56,56,54,55,57,55,57,57,57,55,56,55,55,54,56,56,54,55,56,55,56,56,56,57,57,237,55,49,59,55,55,55,56,55,54,56,57,115,57,55,57,55,57,56,53,56,55,56,56,54,55,57,57,54,62,53,56,59,55,55,55,56,55,55,114,57,55,57,279,790,57,55,115,56,55,55,55,55,56,183	0,65,123,245,304,365,425,485,545,605,664,725,785,845,904,965,1022,1084,1442,1503,1682,1744,1803,1862,2042,2103,2163,2224,2285,2345,2404,2465,2525,2584,2645,2703,2765,2823,2885,2945,3003,3063,3070,3124,3184,3246,3305,3366,3426,3486,3545,3785,4084,4144,4205,4265,4324,4385,4447,4505,4566,4626,4686,4746,4805,4926,4986,5043,5104,5164,5226,5346,5406,5466,5526,5586,5646,5711,5826,5883,6163,6223,6283,6344,6403,6465,17736,17801,17859,17919,17981,18039,18281,18340,18401,18461,18521,18581,18640,18701,18758,18818,18878,18938,18998,19058,19120,19178,19239,19301,19358,19419,19479,19538,19598,19658,19718,19779,19839,19899,19961,20021,20084,20140,20201,20261,20319,20381,20440,20501,20562,20621,20681,20741,20799,20859,20919,20981,21040,21101,21161,21221,21280,21340,21401,21460,21520,21581,21640,21701,21760,21819,21879,21940,22181,22240,22297,22361,22421,22481,22540,22601,22661,22720,22779,22839,22959,23021,23078,23139,23199,23261,23322,23380,23440,23500,23561,23622,23681,23739,23799,23859,23916,23983,24040,24097,24161,24221,24281,24340,24401,24461,24521,24639,24701,24759,24819,25106,25899,25961,26021,26140,26201,26261,26321,26381,26440,26501	p,c,g	350024238400000049,350024238400000046,350024238400015003,350024238400000050,350024238400015004,350024238400015006,350024238400015007,350024238400000016,350024238400015008,350024238400000051,350024238400000014,350024238400015009,350024238400000063,350024238400000063,350024238400000018,350024238400000017,350024238400000017,350024238400000069,350024238400000052,350024238400000064,350024238400000065,350024238400015010,350024238400000071,350024238400000070,350024238400000021,350024238400000068,350024238400015014,350024238400000023,350024238400000072,350024238400000072,350024238400015016,350024238400000053,350024238400000057,350024238400000057,350024238400000047,350024238400000108,350024238400000003,350024238400015019,350024238400000074,350024238400000024,350024238400000054,350024238400000028,350024238400000079,350024238400000079,350024238400015026,350024238400015029,350024238400000005,350024238400000005,350024238400000109,350024238400000006,350024238400000110,350024238400000083,350024238400000058,350024238400000058,350024238400000048,350024238400000055,350024238400000085,350024238400000087,350024238400000095,350024238400015036,350024238400000097,350024238400000008,350024238400000059,350024238400000056,350024238400000060,350024238400015039,350024238400000098,350024238400000040,350024238400000009,350024238400000105,350024238400000105,350024238400000045	0-1063,1-947,0-69,0-388,0-48,0-48,0-48,0-21,0-45,0-388,20-40,0-147,0-20,0-20,0-20,0-19,0-19,0-21,0-3430,0-19,0-20,0-108,0-20,0-21,21-42,0-20,0-45,20-40,0-20,0-20,0-45,0-644,0-50,0-50,0-610,11-30,11-30,0-45,0-24,21-45,0-4260,0-21,0-20,0-20,0-45,0-45,11-30,11-30,6-25,8-30,8-30,0-20,0-20,0-20,0-669,0-2592,0-20,0-20,0-20,0-45,0-20,0-20,0-172,0-1453,0-574,0-45,0-19,20-39,0-19,0-20,0-20,0-20						Single nucleotide polymorphism markers in the bovine gene to identify meat tenderness - US Patent 7238479 Description	ww.patentstorm.us	0	0		
928	chr29	45021286	45047583	3500394979	60		45021286	45047583	8421504	3	21,19,20	0,158,26277	c,g	350039497900000003,350039497900000003,350039497900000004,350039497900000001	0-21,0-21,0-19,0-20		15583037		0021-8812	Journal of Animal Science	Assessment of single nucleotide polymorphisms in genes residing on chromosomes 14 and 29 for association with carcass composition traits in Bos indicus cattle	Casas	2005	2		
928	chr29	45022312	45047661	3500434741	365		45022312	45047661	8421504	16	27,21,20,20,21,19,24,21,46,21,27,20,20,19,20,19	0,333,546,746,2705,4515,4738,17023,20889,21440,21805,23648,23857,24581,25296,25330	c,g	350043474100000013,350043474100000012,350043474100000016,350043474100000014,350043474100000018,350043474100000017,350043474100000017,350043474100000021,350043474100000003,350043474100000003,350043474100000024,350043474100000028,350043474100000005,350043474100000005,350043474100000006,350043474100000006,350043474100000030,350043474100000034,350043474100000035,350043474100000033,350043474100000008,350043474100000010,350043474100000040,350043474100000009,350043474100000045,350043474100000042	17-38,19-39,0-21,20-40,0-20,0-19,0-19,21-42,11-30,11-30,21-45,0-21,11-30,11-30,8-30,8-30,18-38,0-21,0-21,17-38,0-20,0-20,20-39,0-19,0-20,17-36						Single nucleotide polymorphism markers in the bovine CAPN1 gene to identify meat tenderness	Smith	2003	0		
928	chr29	45022645	45047628	3500246934	186		45022645	45047628	8421504	9	21,20,20,21,20,24,21,19,20	0,213,413,2372,3686,4405,16690,24248,24963	c,g	350024693400000005,350024693400000003,350024693400000007,350024693400000006,350024693400000006,350024693400000010,350024693400000012,350024693400000013,350024693400000017,350024693400000029,350024693400000034	0-21,20-40,0-20,0-19,0-19,21-42,20-40,21-45,0-21,20-39,0-20						Evaluation of single-nucleotide polymorphisms in CAPN1 for association with meat tenderness in cattle	www.ars.usda.gov	0	0		
928	chr29	45024690	45045356	3500056162	39		45024690	45045356	8421504	2	20,19	0,20647	c,g	350005616200000001,350005616200000020	0-20,0-19						Universidade de S&#xe3;o Paulo Escola Superior de Agricultura &#x201c;Luiz de Queiroz&#x201d;	www.teses.usp.br	0	0		
928	chr29	45026342	45043770	3500163366	80		45026342	45043770	8421504	4	20,20,20,20	0,434,711,17408	c,g	350016336600000000,350016336600000002,350016336600000001,350016336600000004	0-20,0-20,0-20,0-20						J Anim Sci 2004. 82:3474-3481. The online version of this article, along with updated information and services, is located on the World Wide Web at: http://jas.fass.org/cgi/content/full/82/12/3474	www.nbcec.org	0	0		
928	chr29	45026759	45045356	3500012705	58		45026759	45045356	8421504	3	20,19,19	0,46,18578	c,g	350001270500000000,350001270500000001,350001270500000001,350001270500000004	0-20,0-19,0-19,0-19						Parra-Bracamonte GM et al. Marcadores gen&#xe9;ticos en ganado Charolais 257 Art&#xed;culos originales	alnet.unirioja.es	0	0		
928	chr29	45026759	45043349	3500290147	72		45026759	45043349	8421504	4	20,14,19,19	0,29,46,16571	g	350029014700000000,350029014700000001,350029014700000002	0-20,0-33,0-19						UNIVERSIDADE DE S&#xc3;O PAULO FACULDADE DE ZOOTENIA E ENGENHARIA DE ALIMENTOS	www.teses.usp.br	0	0		
928	chr29	45026826	45043239	3500355197	41		45026826	45043239	8421504	2	20,21	0,16392	c,g	350035519700000001,350035519700000002,350035519700000002	0-20,0-21,0-21						Associa&#xe7;&#xe3;o de polimorfismos no gene da &#xb5;-calpa&#xed;na com a maciez da carne em animais da ra&#xe7;a Nelore	cnptia.embrapa.br	0	0		
928	chr29	45045196	45045968	3500378421	60		45045196	45045968	8421504	3	3,33,24	0,419,748	p	350037842100015242	0-60						University of Southampton Research Repository ePrints Soton	rints.soton.ac.uk	0	0		CAPN1
928	chr29	45045368	45045451	3500432578	39		45045368	45045451	8421504	2	17,22	0,61	g	350043257800000000	134-173				0021-8812		A new single nucleotide polymorphism in CAPN1 extends the current tenderness marker test to include cattle of Bos indicus, Bos taurus, and crossbred descent 	animalscience.org	0	2		
928	chr29	45045663	45047605	3500021577	60		45045663	45047605	8421504	4	21,9,23,7	0,263,1525,1935	c	350002157700000000,350002157700000001	0-30,0-30						O-12	www.scribd.com	0	0		
930	chr29	45339074	45339176	3500188849	102		45339074	45339176	8421504	1	102	0	g	350018884900000006	0-102						Evolution of the Long Non-coding RNAs MALAT1 and MEN&#x03b2;/&#x03b5; - ResearchGate	.researchgate.net	0	0		
931	chr29	45375137	45375162	3500109131	24		45375137	45375162	8421504	2	17,7	0,18	g	350010913100000114	17-41						Recombinant DNA constructs and methods for controlling gene expression	Huang	2007	0		
931	chr29	45386230	45402244	3500422438	145		45386230	45402244	8421504	5	26,44,3,33,39	0,29,3250,10981,15975	c	350042243800000060,350042243800000059,350042243800000030,350042243800000009	0-47,22-48,15-48,9-48						Methods and compositions for multiple gene transfer into bone cells	Bonadio	1994	0		LTBP3
931	chr29	45386230	45402244	3500225737	223		45386230	45402244	8421504	8	26,44,3,44,33,28,6,39	0,29,3250,10934,10981,11572,11601,15975	c	350022573700000057,350022573700000056,350022573700000028,350022573700000027,350022573700000025,350022573700000006	0-47,22-48,3-47,15-48,4-38,9-48					Patent	Methods and compositions for multiple gene transfer into bone cells (Patent US:5942496)	Bonadio	1999	0		
931	chr29	45386230	45402244	3500188667	145		45386230	45402244	8421504	5	26,44,3,33,39	0,29,3250,10981,15975	c	350018866700000060,350018866700000059,350018866700000030,350018866700000009	0-47,22-48,15-48,9-48						 Methods And Compositions For Multiple Gene Transfer Into Bone Cells 	www.docstoc.com	0	0		
931	chr29	45402316	45402341	3500431542	25		45402316	45402341	8421504	1	25	0	c	350043154200000016	32-57						US Patent # 4,973,551. Vector for the expression of fusion proteins and protein immunogens - Patents.com	www.patents.com	0	0		LTBP3
931	chr29	45434142	45434168	3500341162	23		45434142	45434168	8421504	2	15,8	0,18	g	350034116200000646	11-34						Perhydrolase	Amin	2004	0		
931	chr29	45434142	45434168	3500134317	23		45434142	45434168	8421504	2	15,8	0,18	c	350013431700000646	12-35						Perhydrolase 	.freshpatents.com	0	0		
931	chr29	45451579	45451608	3500356813	24		45451579	45451608	8421504	3	12,6,6	0,14,23	g	350035681300000003	24-48						US Patent # 5,928,922. .alpha.2 subunit of prolyl-4-hydroxylase, nucleic acid sequences encoding such subunit and methods for producing the same - Patents.com	www.patents.com	0	0		
931	chr29	45455857	45456090	3500033060	45		45455857	45456090	8421504	2	31,14	0,219	p	350003306000015042	27-72						Molecular Cloning of a Novel Receptor Tyrosine Kinase Gene, STK, Derived From Enriched Hematopoietic Stem Cells	tologylibrary.org	0	0		MAP3K10
931	chr29	45456150	45456198	3500426490	48		45456150	45456198	8421504	1	48	0	p	350042649000015106	0-48						Signal Transduction Protein Tab2 	.freshpatents.com	0	0		MAP3K11
932	chr29	45483961	45483990	3500143054	24		45483961	45483990	8421504	2	8,16	0,13	g	350014305400000001	0-24		17395767	10.1124/jpet.106.118018	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Beryllium Induces Premature Senescence in Human Fibroblasts	Coates	2007	0		
932	chr29	45499262	45499293	3500355861	31		45499262	45499293	8421504	1	31	0	c	350035586100000043	6-37			10.1042/BJ20070245		The Biochemical Journal	Identification of a responsible promoter region and a key transcription factor, CCAAT/enhancer-binding protein &#x03f5;, for up-regulation of PHGPx in HL60 cells stimulated with TNF&#x03b1;	Hiroyuki	2007	0		
932	chr29	45499262	45499289	3500002507	27		45499262	45499289	8421504	1	27	0	c	350000250700000001	10-37						Involvement of nuclear factor-kappa B on corticosterone- induced rat Leydig cell apoptosis	www.asiaandro.com	0	0		
932	chr29	45499418	45499441	3500439875	23		45499418	45499441	8421504	1	23	0	g	350043987500000014	0-23						NFkB-p65 Dependent Transcriptional Regulation of Glycosyltransferases in Human Colon Adenocarcinoma HT-29 by Stimulation with Tumor Necrosis Factor a	bpb.pharm.or.jp	0	0		
932	chr29	45499418	45499441	3500326771	23		45499418	45499441	8421504	1	23	0	g	350032677100000009	0-23		18632660	10.1074/jbc.M804236200	0021-9258	Journal of Biological Chemistry	Adiponectin Blocks Interleukin-18-mediated Endothelial Cell Death via APPL1-dependent AMP-activated Protein Kinase (AMPK) Activation and IKK/NF-&#x03ba;B/PTEN Suppression	Chandrasekar	2008	5		RELA
932	chr29	45500807	45503491	3500328049	42		45500807	45503491	8421504	2	21,21	0,2663	c	350032804900000005,350032804900000004	0-21,0-21		20504934	10.1128/JVI.00416-10	0022-538X	Journal of Virology	Phorbol Ester-Induced Human Cytomegalovirus Major Immediate-Early (MIE) Enhancer Activation through PKC-Delta, CREB, and NF-&#x03ba;B Desilences MIE Gene Expression in Quiescently Infected Human Pluripotent NTera2 Cells	Liu	2010	5		RELA
932	chr29	45500812	45500863	3500300562	51		45500812	45500863	8421504	1	51	0	p	350030056200015043	0-51						Method of identifying transmembrane protein-interacting compounds	George	2005	0		RELA
932	chr29	45500812	45500863	3500289629	51		45500812	45500863	8421504	1	51	0	p	350028962900015045	0-51						METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - Patent application	www.faqs.org	0	0		RELA
932	chr29	45500812	45500863	3500127324	51		45500812	45500863	8421504	1	51	0	p	350012732400015043	0-51						Method of Identifying Transmembrane Protein-Interacting Compounds	O'Dowd	2013	0		RELA
932	chr29	45500812	45500863	3500126126	51		45500812	45500863	8421504	1	51	0	p	350012612600015044	0-51						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2010	0		RELA
932	chr29	45500812	45500863	3500090706	51		45500812	45500863	8421504	1	51	0	p	350009070600015035	0-51						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2011	0		RELA
932	chr29	45500812	45500863	3500083847	51		45500812	45500863	8421504	1	51	0	p	350008384700015043	0-51						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2003	0		RELA
932	chr29	45500812	45500863	3500043017	51		45500812	45500863	8421504	1	51	0	p	350004301700015046	0-51						METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - Patent application	www.faqs.org	0	0		RELA
932	chr29	45500833	45502987	3500425813	45		45500833	45502987	8421504	2	38,7	0,2147	p	350042581300015000	3-48		19095969	10.1161/STROKEAHA.108.520262	0039-2499	Stroke	Edaravone, a Free Radical Scavenger, Inhibits MMP-9&#x2013;Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator	Yagi	2009	6		RELA
932	chr29	45500833	45502987	3500182832	45		45500833	45502987	8421504	2	38,7	0,2147	p	350018283200015000	3-48		19095969	10.1161/STROKEAHA.108.520262	0039-2499	Stroke	Edaravone, a Free Radical Scavenger, Inhibits MMP-9&#x2013;Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator	Yagi	2009	6		RELA
932	chr29	45500833	45502987	3500151057	45		45500833	45502987	8421504	2	38,7	0,2147	p	350015105700015000	3-48			10.1038/sj.bjp.0701652	1476-5381	British Journal of Pharmacology	Modulation of transcription factor NF-&#x03ba;B by enantiomers of the nonsteroidal drug ibuprofen - Scheuren - 2009 - British Journal of Pharmacology - Wiley Online Library	Scheuren	1998	0		RELA
932	chr29	45503011	45503499	3500136867	270		45503011	45503499	8421504	3	150,26,94	0,156,394	p	350013686700015007,350013686700015031,350013686700015003,350013686700015019	0-138,0-93,0-120,0-78						Regulation of pyruvate dehydrogenase kinase 4 (PDK4) through protein-protein interaction and its role in apoptosis	dspace.wits.ac.za	0	0		RELA
932	chr29	45503477	45503500	3500113264	23		45503477	45503500	8421504	1	23	0	c	350011326400000004	0-23			10.1002/art.20601	1529-0131	Arthritis & Rheumatism	Role of NF-&#x03ba;B transcription factors in antiinflammatory and proinflammatory actions of mechanical signals - Agarwal - 2004 - Arthritis & Rheumatism - Wiley Online Library	Agarwal	2004	0		RELA
932	chr29	45504912	45505932	3500260968	42		45504912	45505932	8421504	2	22,20	0,1000	c,g	350026096800000025,350026096800000025,350026096800000024,350026096800000024	0-22,0-22,0-20,0-20						Mar&#xed;a Eugenia Meneses &#xc1;lvarez	helvia.uco.es	0	0		RELA
932	chr29	45504960	45505935	3500393522	40		45504960	45505935	8421504	2	21,19	0,956	c,g	350039352200000011,350039352200000010,350039352200000010	0-21,0-19,0-19		20844082	10.1091/mbc.E10-04-0312		Molecular Biology of the Cell	Adenomatous Polyposis Coli and Hypoxia-inducible Factor-1&#x03b1; Have an Antagonistic Connection	Ian	2010	0		RELA
932	chr29	45506235	45506280	3500032470	45		45506235	45506280	8421504	1	45	0	p	350003247000015006	0-45						COMPOSITIONS AND METHODS FOR MODULATING C-REL-DEPENDENT CYTOKINE PRODUCTION - Patent application	www.faqs.org	0	0		RELA
932	chr29	45546477	45546522	3500385418	45		45546477	45546522	8421504	1	45	0	p	350038541800015000	0-45		22348108	10.1371/journal.pone.0031569		PLoS ONE	Stress-Induced Cell-Cycle Activation in Tip60 Haploinsufficient Adult Cardiomyocytes	Joseph	2012	0		KAT5
932	chr29	45546483	45553466	3500242417	168		45546483	45553466	8421504	5	49,11,18,45,45	0,376,1432,1796,6938	p	350024241700015000,350024241700015001,350024241700015002	0-60,0-63,0-45			10.1038/sj.embor.embor861		EMBO Reports	MYC recruits the TIP60 histone acetyltransferase complex to chromatin	Scott	June	0		KAT5,RNASEH2C
932	chr29	45546483	45553466	3500049660	168		45546483	45553466	8421504	5	49,11,18,45,45	0,376,1432,1796,6938	p	350004966000015000,350004966000015001,350004966000015002	0-60,0-63,0-45		12776177	10.1038/sj.embor.embor861	ERROR! NO ISSN	EMBO reports	MYC recruits the TIP60 histone acetyltransferase complex to chromatin	Frank	2003	0		KAT5,RNASEH2C
932	chr29	45546884	45553242	3500281203	116		45546884	45553242	8421504	4	20,16,29,51	0,4107,5992,6307	p,c	350028120300000000,350028120300015003,350028120300015004	0-20,6-51,0-51		17709392	10.1128/MCB.00579-07	0270-7306	Molecular and Cellular Biology	DNA Damage-Dependent Acetylation and Ubiquitination of H2AX Enhances Chromatin Dynamics	Ikura	2007	6		KAT5,RNASEH2C
932	chr29	45546884	45553242	3500184023	116		45546884	45553242	8421504	4	20,16,29,51	0,4107,5992,6307	p,c,g	350018402300000000,350018402300000000,350018402300015003,350018402300015004	0-20,0-20,6-51,0-51			10.1128/MCB.00579-07		Molecular and Cellular Biology	DNA Damage-Dependent Acetylation and Ubiquitination of H2AX Enhances Chromatin Dynamics 	Tsuyoshi	2007	0		KAT5,RNASEH2C
932	chr29	45550940	45552881	3500006289	72		45550940	45552881	8421504	2	67,5	0,1936	p	350000628900015003	0-72						Yeast silencing genes proteins and methods - Patent # 5989897 - PatentGenius	.patentgenius.com	0	0		KAT5,RNASEH2C
932	chr29	45554018	45554044	3500210266	25		45554018	45554044	8421504	2	4,21	0,5	c	350021026600000042	5-30						US Patent # 5,780,266. Feline infectious peritonitis virus diagnostic tools - Patents.com	www.patents.com	0	0		
932	chr29	45576498	45576543	3500444754	45		45576498	45576543	8421504	1	45	0	p	350044475400015000	0-45			10.1073/pnas.092137099		Proceedings of the National Academy of Sciences of the United States of America	The LEF1/&#x03b2;-catenin complex activates movo1, a mouse homolog of Drosophila ovo required for epidermal appendage differentiation	Baoan	2002	0		OVOL1
933	chr29	45677724	45680538	3500292002	52		45677724	45680538	8421504	3	26,23,3	0,944,2811	c	350029200200000001,350029200200000003,350029200200000000,350029200200000002	0-26,0-26,0-26,0-26					Patent	Cofilin for promoting the proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells (Patent EP:1459758)	Miura	2009	0		
933	chr29	45677727	45680538	3500207985	498		45677727	45680538	8421504	4	110,77,308,3	0,313,656,2808	p	350020798500015003	0-498						ACCELERATED EXTENSION OF AXONS	Butler	2011	0		CFL1
933	chr29	45677727	45678590	3500091015	91		45677727	45678590	8421504	4	21,25,25,20	0,85,743,843	c	350009101500000001,350009101500000020,350009101500000021,350009101500000002	8-29,0-25,0-25,0-20						Co&#xfb01;lin 1-Mediated Biphasic F-Actin Dynamics of Neuronal Cells Affect Herpes Simplex Virus 1 Infection and Replication	jvi.asm.org	0	0		CFL1
933	chr29	45677745	45680538	3500165478	432		45677745	45680538	8421504	4	92,52,285,3	0,295,661,2790	p,c	350016547800015015,350016547800015014,350016547800015013,350016547800015011,350016547800015010,350016547800015009,350016547800015008,350016547800015007,350016547800015000,350016547800000002	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45						Compositions And Methods For Detecting And Treating Hiv Infections 	.freshpatents.com	0	0		
933	chr29	45678601	45678655	3500032960	54		45678601	45678655	8421504	1	54	0	p	350003296000015000	0-54		22855535	10.1091/mbc.E12-01-0053	1059-1524	Molecular Biology of the Cell	Novel PKC&#x03b1;-mediated phosphorylation site(s) on cofilin and their potential role in terminating histamine release	Sakuma	2012	5		CFL1
933	chr29	45678601	45678655	3500003911	54		45678601	45678655	8421504	1	54	0	p	350000391100015000	0-54		22855535	10.1091/mbc.E12-01-0053	1059-1524	Molecular Biology of the Cell	Novel PKC&#x03b1;-mediated phosphorylation site(s) on cofilin and their potential role in terminating histamine release	Sakuma	2012	5		CFL1
933	chr29	45678637	45678691	3500408788	54		45678637	45678691	8421504	1	54	0	p	350040878800015004	0-54						Flightless I is a focal adhesion-associated actin-capping protein that regulates cell migration	www.fasebj.org	0	0		CFL1
933	chr29	45678677	45680547	3500174032	23		45678677	45680547	8421504	3	14,3,6	0,1858,1864	c	350017403200000000	4-27		21355047	10.1093/hmg/ddr075		Human Molecular Genetics	Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease	Lise	2011	0		CFL1
933	chr29	45705168	45705247	3500435393	43		45705168	45705247	8421504	2	20,23	0,56	c,g	350043539300000008,350043539300000008,350043539300000009	0-20,0-20,0-23						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
933	chr29	45711698	45711724	3500193635	23		45711698	45711724	8421504	2	16,7	0,19	c	350019363500000367	25-48						Materials and methods for immunocontraception	Harris	1993	0		
934	chr29	45778951	45778978	3500305954	25		45778951	45778978	8421504	3	5,7,13	0,6,14	g	350030595400000045	7-35					Patent	Bovine herpesvirus vaccine and method of using same (Patent US:5462734)	Israel	1995	0		
934	chr29	45805498	45806074	3500188892	26		45805498	45806074	8421504	2	8,18	0,558	c	350018889200000082	16-42						METHOD FOR MODIFYING THE ATP/ADP RATIO IN CELLS - Patent application	www.faqs.org	0	0		
934	chr29	45857284	45857335	3500120381	51		45857284	45857335	8421504	1	51	0	p	350012038100015089	102-153						<Html><Title> Complet list of 1mpf hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
936	chr29	46076949	46079685	3500271050	59		46076949	46079685	8421504	2	29,30	0,2706	c	350027105000000110,350027105000000088	12-41,18-48						Cloning by complementation and related processes	Colicelli	1991	0		
936	chr29	46091533	46091557	3500334303	24		46091533	46091557	8421504	1	24	0	c	350033430300000011	21-47						Dna encoding a human 5-ht1e receptor and uses thereof	Branchek	1993	0		
936	chr29	46104187	46104221	3500454249	27		46104187	46104221	8421504	3	16,6,5	0,21,29	c	350045424900000062	21-48					Patent	Prosthetic devices having enhanced osteogenic properties (Patent US:5344654)	Kuberasampath	1994	0		
936	chr29	46104187	46104221	3500422167	27		46104187	46104221	8421504	3	16,6,5	0,21,29	c	350042216700000293	21-48					Patent	Osteogenic proteins (Patent US:5266683)	Kuberasampath	1993	0		
936	chr29	46104187	46104221	3500008143	27		46104187	46104221	8421504	3	16,6,5	0,21,29	c	350000814300000062	21-48						 Prosthetic Devices Having Enhanced Osteogenic Properties 	www.docstoc.com	0	0		
937	chr29	46156937	46158361	3500015581	96		46156937	46158361	8421504	2	48,48	0,1376	g	350001558100000083,350001558100000091	0-48,0-48						Transcription Activation Complex And Utilization Thereof 	.freshpatents.com	0	0		
938	chr29	46303054	46303079	3500408278	23		46303054	46303079	8421504	2	10,13	0,12	c	350040827800000006	3-27			10.1093/emboj/cdf445		The EMBO Journal	A mitochondrial specific stress response in mammalian cells	Quan	2002	0		
938	chr29	46303054	46303079	3500125275	23		46303054	46303079	8421504	2	10,13	0,12	c	350012527500000006	3-27		12198143	10.1093/emboj/cdf445	ERROR! NO ISSN	The EMBO Journal	A mitochondrial specific stress response in mammalian cells	Zhao	2002	0		
938	chr29	46309311	46309335	3500286401	23		46309311	46309335	8421504	2	19,4	0,20	c	350028640100000086	16-39						Characterization of the equine skeletal muscle transcriptome identifies novel functional responses to exercise training	biomedcentral.com	0	0		
938	chr29	46314645	46315135	3500418698	45		46314645	46315135	8421504	2	22,23	0,467	c	350041869800000002,350041869800000003	0-22,0-23						Universidade de Bras&#xed;lia Faculdade de Medicina Programa de P&#xf3;s Gradua&#xe7;&#xe3;o em Patologia Molecular	epositorio.unb.br	0	0		ACTN3
938	chr29	46317424	46398492	3500138868	65		46317424	46398492	8421504	3	20,22,23	0,45744,81045	c	350013886800000009,350013886800000173,350013886800000056,350013886800000055	0-20,0-22,0-23,0-23						 Transgenic Animal Model Of Bone Mass Modulation 	www.docstoc.com	0	0		
938	chr29	46317424	46398492	3500068827	65		46317424	46398492	8421504	3	20,22,23	0,45744,81045	c	350006882700000002,350006882700000166,350006882700000049,350006882700000048	0-20,0-22,0-23,0-23					Patent	High bone mass gene of 1.1q13.3 (Patent US:6780609)	Carulli	2004	0		
938	chr29	46317424	46363190	3500003080	42		46317424	46363190	8421504	2	20,22	0,45744	c	350000308000000002,350000308000000170	0-20,0-22						US Patent # 7,285,400. High bone mass gene of 11q13.3 - Patents.com	www.patents.com	0	0		
938	chr29	46354141	46354168	3500167840	23		46354141	46354168	8421504	2	7,16	0,11	g	350016784000000108	16-39						Entwicklung von Real-Time PCR Nachweissystemen f&#xfc;r getr&#xe4;nkerelevante Hefen	opus4.kobv.de	0	0		
938	chr29	46363168	46398492	3500464289	45		46363168	46398492	8421504	2	22,23	0,35301	c	350046428900000166,350046428900000049,350046428900000048	0-22,0-23,0-23						High bone mass gene of 11q13.3	Carulli	2000	0		
939	chr29	46442028	46442051	3500005314	23		46442028	46442051	8421504	1	23	0	g	350000531400000348	1-27						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
940	chr29	46584056	46584081	3500007563	23		46584056	46584081	8421504	3	4,13,6	0,5,19	c	350000756300000123	13-38						Fused	Sauvage	1998	0		
940	chr29	46584706	46584730	3500412853	24		46584706	46584730	8421504	1	24	0	c,g	350041285300000000,350041285300000000	0-24,0-24						Effects of non-esteri&#xfb01;ed fatty acids on the gluconeogenesis in bovine hepatocytes	www.dairy973.com	0	0		
940	chr29	46584706	46584730	3500191310	24		46584706	46584730	8421504	1	24	0	c,g	350019131000000000,350019131000000000	0-24,0-24						Effects of non-esterified fatty acids on the gluconeogenesis in bovine hepatocytes. - ResearchGate	.researchgate.net	0	0		
940	chr29	46591778	46594083	3500464481	1695		46591778	46594083	8421504	3	1139,424,132	0,1746,2173	p	350046448100015011	0-1695						Antibodies to HBIMF63 polypeptide - US Patent 7381800 Description	ww.patentstorm.us	0	0		LRFN4
940	chr29	46603884	46603908	3500433268	24		46603884	46603908	8421504	1	24	0	c	350043326800000000	0-24		18060064	10.1371/journal.pone.0001270	1932-6203	PLOS ONE	PLOS ONE: Expression of Pyruvate Carboxylase mRNA Variants in Liver of Dairy Cattle at Calving	Agca	2007	4		
940	chr29	46603884	46603908	3500273722	24		46603884	46603908	8421504	1	24	0	c,g	350027372200000000,350027372200000000	0-24,0-24			10.1371/journal.pone.0001270		PLoS ONE	Expression of Pyruvate Carboxylase mRNA Variants in Liver of Dairy Cattle at Calving	Cansu	2007	0		
117	chr29	46923656	46925201	3500348183	23		46923656	46925201	8421504	4	6,4,11,2	0,9,14,1543	c	350034818300000014	21-45						US Patent # 5,723,581. Murine and human box-dependent myc-interacting protein (Bin1) - Patents.com	www.patents.com	0	0		
943	chr29	46929082	46929106	3500044536	24		46929082	46929106	8421504	1	24	0	c	350004453600000004	0-24			10.1124/jpet.106.116921	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells	Salim	2007	0		ADRBK1
943	chr29	46929953	46931154	3500276535	588		46929953	46931154	8421504	5	9,163,137,114,165	0,234,552,789,1036	p,c	350027653500000002,350027653500015002,350027653500015003,350027653500015004,350027653500015006,350027653500015007,350027653500015008,350027653500015009,350027653500015011,350027653500015012	3-591,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Method of inhibiting smooth muscle cell proliferation	Koch	1999	0		
943	chr29	46930531	46930768	3500197663	40		46930531	46930768	8421504	2	20,20	0,217	c,g	350019766300000000,350019766300000000,350019766300000001	0-20,0-20,0-20		18723764	10.1152/ajpheart.00564.2008		American Journal of Physiology - Heart and Circulatory Physiology	Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances &#x03b1;1D-adrenergic receptor constriction	Heather	2008	0		ADRBK1
943	chr29	46946476	46946503	3500221210	23		46946476	46946503	8421504	2	7,16	0,11	c	350022121000000003	12-35		21182589	10.1111/j.1742-4658.2010.07970.x	1742-4658	FEBS Journal	P25&#x03b1;&#x200a;/&#x200a;TPPP expression increases plasma membrane presentation of the dopamine transporter and enhances cellular sensitivity to dopamine toxicity - Fjorback - 2010 - FEBS Journal - Wiley Online Library	Fjorback	2011	0		
944	chr29	47057481	47057950	3500193889	23		47057481	47057950	8421504	2	1,22	0,447	c	350019388900000003	0-23		18316588	10.1158/0008-5472.CAN-07-2304	0008-5472	Cancer Research	Rad9 Has a Functional Role in Human Prostate Carcinogenesis	Zhu	2008	8		
944	chr29	47058167	47058191	3500070475	24		47058167	47058191	8421504	1	24	0	c	350007047500000010	8-32						Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1	library.ibp.ac.cn	0	0		
944	chr29	47061259	47061600	3500128180	48		47061259	47061600	8421504	2	18,30	0,311	p	350012818000015023	0-48						PEPTIDES AND PROTEINS INTERACTING WITH THE ANDROGEN RECEPTOR	repub.eur.nl	0	0		RAD9A
944	chr29	47062303	47062327	3500134683	24		47062303	47062327	8421504	1	24	0	c	350013468300000001	0-24		10336542		1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	The Protein Phosphatase Inhibitor Cantharidin Alters Vascular Endothelial Cell Permeability	Knapp	1999	0		PPP1CA
944	chr29	47062685	47062709	3500464289	24		47062685	47062709	8421504	1	24	0	c	350046428900000007	0-24						High bone mass gene of 11q13.3	Carulli	2000	0		
944	chr29	47062685	47062709	3500408649	24		47062685	47062709	8421504	1	24	0	c	350040864900000101	0-24						HBM variants that modulate bone mass and lipid levels	Allen	2008	0		
944	chr29	47062685	47062709	3500138868	24		47062685	47062709	8421504	1	24	0	c	350013886800000014	0-24						 Transgenic Animal Model Of Bone Mass Modulation 	www.docstoc.com	0	0		
944	chr29	47063936	47063959	3500320400	23		47063936	47063959	8421504	1	23	0	c,g	350032040000000022,350032040000000001	0-21,0-21						Compositions and methods for the treatment of krabbe and other neurodegenerative diseases	Bongarzone	2012	0		PPP1CA
944	chr29	47139750	47139828	3500411740	78		47139750	47139828	8421504	1	78	0	p	350041174000015051	0-78						Dissertation	thek.uni-halle.de	0	0		AIP
944	chr29	47142264	47142414	3500185803	150		47142264	47142414	8421504	1	150	0	p	350018580300015009	0-150						UNIVERSIT&#xc0; DEGLI STUDI DI PADOVA DIPARTIMENTO DI SCIENZE MEDICO-DIAGNOSTICHE E TERAPIE SPECIALI	arch.cab.unipd.it	0	0		
944	chr29	47171062	47171085	3500403171	23		47171062	47171085	8421504	1	23	0	c	350040317100000000	3-26		10625670	10.1074/jbc.275.2.1247	0021-9258	Journal of Biological Chemistry	Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin	Haeseleer	2000	5		
944	chr29	47171062	47171085	3500301352	23		47171062	47171085	8421504	1	23	0	c	350030135200000000	3-26					The Journal of biological chemistry	Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin	Francoise	2000	0		
944	chr29	47181408	47181433	3500363484	24		47181408	47181433	8421504	2	10,14	0,11	g	350036348400000028	12-36						Preparation of thaumatin sweeteners	Uriach-marsal	1995	0		
944	chr29	47181408	47181433	3500243276	24		47181408	47181433	8421504	2	10,14	0,11	g	350024327600000028	12-36					Patent	Preparation of thaumatin sweeteners (Patent US:5932438)	Blade-Pique	1999	0		
945	chr29	47212183	47212206	3500221815	23		47212183	47212206	8421504	1	23	0	c	350022181500000029	22-45						Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin	-publications.com	0	0		
945	chr29	47212858	47213718	3500077888	43		47212858	47213718	8421504	3	19,5,19	0,807,841	c	350007788800000040,350007788800000041	0-24,0-19						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
945	chr29	47232426	47238394	3500272231	1503		47232426	47238394	8421504	12	130,83,171,184,190,213,167,82,146,84,39,14	0,1208,1647,2538,3491,4421,4758,5228,5564,5822,5909,5954	p,c,g	350027223100000002,350027223100015021,350027223100015009,350027223100000004,350027223100000004,350027223100015010,350027223100000006,350027223100000006,350027223100015023,350027223100015011,350027223100000007,350027223100015012,350027223100000008,350027223100015025,350027223100015013,350027223100000009,350027223100000009,350027223100015026,350027223100015014,350027223100000010,350027223100000010,350027223100015015,350027223100000011,350027223100000011,350027223100015028,350027223100015016,350027223100000012,350027223100000012,350027223100000013,350027223100000013,350027223100015030,350027223100000014,350027223100000014,350027223100015018,350027223100015031,350027223100015033,350027223100000015,350027223100000015,350027223100015019,350027223100000016,350027223100000016	20-120,0-198,0-120,0-118,0-118,0-96,0-120,0-120,0-204,0-105,0-112,0-99,0-120,0-183,0-81,0-120,0-120,0-201,0-60,0-118,0-118,0-105,0-119,0-119,0-207,0-78,0-120,0-120,0-120,0-120,0-93,0-118,0-118,0-75,3-93,0-165,0-120,0-120,0-60,3-87,3-87						cDNA-Derived Amino Acid Sequence of the NADH-Binding 51-kDa Subunit of the Bovine Respiratory NADH Dehydrogenase Reveals Striking Similarities to a Bacterial NAD+-Reducing Hydrogenase	www.jstor.org	0	0		
945	chr29	47232526	47238290	3500452190	1027		47232526	47238290	8421504	16	30,83,7,45,29,184,132,97,167,54,6,7,84,4,56,42	0,1108,1547,1641,1689,2438,3391,4437,4658,5128,5194,5203,5464,5549,5554,5722	p,c,g	350045219000015011,350045219000015025,350045219000015015,350045219000015026,350045219000015017,350045219000000013,350045219000000013,350045219000015029,350045219000015020,350045219000015031,350045219000000011,350045219000015023	0-120,0-150,9-114,0-189,0-120,0-120,0-120,0-207,0-117,0-183,0-134,0-96						cDNA-derivedaminoacid NADH-binding of NADH to a NAD+-reducing	www.pnas.org	0	0		
945	chr29	47232553	47237252	3500234051	139		47232553	47237252	8421504	4	3,45,43,48	0,1081,1535,4651	c	350023405100000172,350023405100000174,350023405100000190	0-48,5-48,0-48						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		
945	chr29	47236013	47236067	3500209861	54		47236013	47236067	8421504	1	54	0	p	350020986100015024	0-54						METHOD OF EXPRESSING dsRNA IN PLANTS TO INHIBIT INSECT PESTS - DNA PLANT TECHNOLOGY CORPORATION	www.sumobrain.com	0	0		NDUFV1
945	chr29	47242234	47242262	3500003914	24		47242234	47242262	8421504	2	18,6	0,22	g	350000391400000000	3-28						Dominant-negative Effects of COL7A1 Mutations Can be Rescued by Controlled Overexpression of Normal Collagen VII - Keeping the Faith	pthefaith1296.com	0	0		
945	chr29	47291029	47291053	3500464289	24		47291029	47291053	8421504	1	24	0	c	350046428900000252	0-24						High bone mass gene of 11q13.3	Carulli	2000	0		UNC93B1
945	chr29	47291029	47291053	3500408649	24		47291029	47291053	8421504	1	24	0	c	350040864900000345	0-24						HBM variants that modulate bone mass and lipid levels	Allen	2008	0		UNC93B1
945	chr29	47291029	47291053	3500361009	24		47291029	47291053	8421504	1	24	0	c	350036100900000259	0-24						Transgenic Animal Model Of Bone Mass Modulation 	.freshpatents.com	0	0		UNC93B1
945	chr29	47291029	47291053	3500189896	24		47291029	47291053	8421504	1	24	0	c	350018989600000252	0-24						High bone mass gene of 11q13.3	Carulli	2003	0		UNC93B1
945	chr29	47291029	47291053	3500138868	24		47291029	47291053	8421504	1	24	0	c	350013886800000259	0-24						 Transgenic Animal Model Of Bone Mass Modulation 	www.docstoc.com	0	0		UNC93B1
945	chr29	47291029	47291053	3500003080	24		47291029	47291053	8421504	1	24	0	c	350000308000000971,350000308000000256	0-24,0-24						US Patent # 7,285,400. High bone mass gene of 11q13.3 - Patents.com	www.patents.com	0	0		UNC93B1
945	chr29	47301759	47301783	3500201203	24		47301759	47301783	8421504	1	24	0	g	350020120300000015,350020120300000019	4-33,7-33						Construction of thermostable mutants of a low molecular mass xylanase	Campbell	1993	0		
945	chr29	47316199	47316546	3500446436	45		47316199	47316546	8421504	2	13,32	0,315	p	350044643600015039	0-45						METHODS OF PRODUCING GABA - Patent application	www.faqs.org	0	0		ALDH3B1
946	chr29	47425082	47425108	3500424373	23		47425082	47425108	8421504	2	10,13	0,13	g	350042437300000013	12-36		9528783		0270-7306	Molecular and Cellular Biology	Interleukin-6-Specific Activation of the C/EBP&#x03b4; Gene in Hepatocytes Is Mediated by Stat3 and Sp1	Cantwell	1998	6		
947	chr29	47462497	47508708	3500235183	184		47462497	47508708	8421504	3	41,95,48	0,8496,46163	g	350023518300000087,350023518300000091,350023518300000092,350023518300000145	0-41,0-48,0-47,0-48						The high bone mass gene of 11q13.3	J*P*Qia Lu Li 	2003	0		
949	chr29	47727143	47727167	3500005314	23		47727143	47727167	8421504	2	16,7	0,17	g	350000531400000146	2-25						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
949	chr29	47727880	47733124	3500434023	369		47727880	47733124	8421504	5	81,55,87,78,68	0,958,3738,4094,5176	p	350043402300015050,350043402300015011	0-369,0-87						Method for Inducing Mammary Epithelial Cell Differentiation	Ormandy	2003	0		
949	chr29	47727880	47733124	3500383722	369		47727880	47733124	8421504	5	81,55,87,78,68	0,958,3738,4094,5176	p	350038372200015051,350038372200015010	0-369,0-87						Method for inducing mammary epithelial cell differentiation	Ormandy	2004	0		
949	chr29	47727931	47733091	3500280350	225		47727931	47733091	8421504	8	30,15,37,8,45,45,10,35	0,907,925,3687,3698,4063,4111,5125	p	350028035000015170,350028035000015181,350028035000015182,350028035000015184,350028035000015185	0-45,0-45,0-45,0-45,0-45						EXPRESSION OF NEUROPEPTIDES IN MAMMALIAN CELLS - Patent application	www.faqs.org	0	0		
949	chr29	47728847	47731663	3500389033	82		47728847	47731663	8421504	4	20,22,20,20	0,441,935,2796	c,g	350038903300000002,350038903300000006,350038903300000005,350038903300000007,350038903300000003,350038903300000003	0-20,0-20,0-20,0-20,0-20,0-20						Isolation, mapping and association study with carcass and feed covertion ratio trait of the bovine GAD and GAL genes	www.ajol.info	0	0		
949	chr29	47728849	47731622	3500121316	44		47728849	47731622	8421504	3	20,20,4	0,28,2769	c,g	350012131600000007,350012131600000001	0-47,0-20						REPRODUCTION	uction-online.org	0	0		
949	chr29	47820587	47820611	3500261436	23		47820587	47820611	8421504	2	19,4	0,20	g	350026143600000031	1-24						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		CPT1A
951	chr29	48006479	48006502	3500285671	23		48006479	48006502	8421504	1	23	0	g	350028567100000079	23-46						PREPARATION OF EPSILON-CAPROLACTAM FROM (Z)-6,7-DIHYDRO-1H-AZEPIN-2(5H)-ONE - Patent application	www.faqs.org	0	0		
951	chr29	48012717	48012743	3500066984	23		48012717	48012743	8421504	2	10,13	0,13	g	350006698400000106	0-23						Proteases - Patent application	www.faqs.org	0	0		
951	chr29	48081794	48081817	3500234120	23		48081794	48081817	8421504	1	23	0	g	350023412000000002	0-23		10710519		1040-0605	American Journal of Physiology - Lung Cellular and Molecular Physiology	Identification of functional TTF-1 and Sp1/Sp3 sites in the upstream promoter region of rabbit SP-B gene	Margana	2000	4		
955	chr29	48549652	48552954	3500315633	59		48549652	48552954	8421504	3	19,20,20	0,2539,3282	c,g	350031563300000008,350031563300000005,350031563300000015,350031563300000015	5-24,0-20,0-20,0-20						Cyclin D1 Is Transcriptionally Down-Regulated by ZO-2 via an E Box and the Transcription Factor c-Myc	w.molbiolcell.org	0	0		
955	chr29	48550050	48550117	3500038248	63		48550050	48550117	8421504	3	20,33,10	0,21,57	g	350003824800000002	0-71		11410592	10.1074/jbc.M103339200	0021-9258	Journal of Biological Chemistry	Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer Elements	Castro-Rivera	2001	5		
955	chr29	48550154	48550181	3500032915	27		48550154	48550181	8421504	1	27	0	g	350003291500000002	0-27		11739801	10.1091/mbc.12.12.4066	1059-1524	Molecular Biology of the Cell	Transcriptional Activation of Cyclin D1 Promoter by FAK Contributes to Cell Cycle Progression	Zhao	2001	5		CCND1
955	chr29	48550170	48552220	3500447794	40		48550170	48552220	8421504	2	20,20	0,2030	c,g	350044779400000000,350044779400000001,350044779400000001	0-20,0-20,0-20						Fluorescent regulators of rassf1a expression and human cancer cell proliferation	Brown	2010	0		CCND1
955	chr29	48550170	48552220	3500052640	40		48550170	48552220	8421504	2	20,20	0,2030	c,g	350005264000000000,350005264000000010,350005264000000001,350005264000000001,350005264000000011,350005264000000011	0-20,0-20,0-20,0-20,0-20,0-20						CANCER THERAPY - Patent application	www.faqs.org	0	0		CCND1
955	chr29	48550435	48552160	3500040099	41		48550435	48552160	8421504	3	21,12,8	0,133,1717	c,g	350004009900000004,350004009900000004,350004009900000005	0-21,0-21,0-20		16705171	10.1128/MCB.01612-05	0270-7306	Molecular and Cellular Biology	Focal Adhesion Kinase Controls Cellular Levels of p27/Kip1 and p21/Cip1 through Skp2-Dependent and -Independent Mechanisms	Bryant	2006	6		
955	chr29	48550437	48552246	3500006489	40		48550437	48552246	8421504	2	20,20	0,1789	c,g	350000648900000024,350000648900000024,350000648900000025,350000648900000025	0-20,0-20,0-20,0-20		18799618	10.1091/mbc.E08-05-0506		Molecular Biology of the Cell	Snail and Slug Promote Epithelial-Mesenchymal Transition through &#x03b2;-Catenin&#x2013;T-Cell Factor-4-dependent Expression of Transforming Growth Factor-&#x03b2;3	Damian	2008	0		CCND1
955	chr29	48550490	48550553	3500328122	60		48550490	48550553	8421504	2	24,36	0,27	p	350032812200015008	27-87						Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase.	mcb.asm.org	0	0		
955	chr29	48550499	48550523	3500169384	24		48550499	48550523	8421504	1	24	0	c	350016938400000002	0-24		19874313	10.1111/j.1349-7006.2009.01413.x	1349-7006	Cancer Science	Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia - Mart&#xed;n - 2009 - Cancer Science - Wiley Online Library	Martin	2010	0		
955	chr29	48550522	48550546	3500358191	24		48550522	48550546	8421504	1	24	0	c	350035819100000001	0-24		20876745	10.1158/1535-7163.MCT-10-0352	1535-7163	Molecular Cancer Therapeutics	Efficacy of the Multi-Kinase Inhibitor Enzastaurin Is Dependent on Cellular Signaling Context	Kuo	2010	5		CCND1
955	chr29	48550543	48552300	3500382251	43		48550543	48552300	8421504	2	20,23	0,1734	c	350038225100000008,350038225100000009	0-20,0-23						Supplemental Figure legends	.aacrjournals.org	0	0		CCND1
955	chr29	48550556	48552337	3500176408	45		48550556	48552337	8421504	2	23,22	0,1759	c	350017640800000013,350017640800000002	0-23,0-22		18632669	10.1074/jbc.M800325200	0021-9258	Journal of Biological Chemistry	Silencing Mediator for Retinoid and Thyroid Hormone Receptor and Nuclear Receptor Corepressor Attenuate Transcriptional Activation by the &#x03b2;-Catenin-TCF4 Complex	Song	2008	5		CCND1
955	chr29	48550568	48559416	3500233103	47		48550568	48559416	8421504	3	12,11,24	0,1584,8824	c	350023310300000020,350023310300000021	0-23,0-24						Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells	-publications.com	0	0		
955	chr29	48550568	48552163	3500138061	23		48550568	48552163	8421504	2	12,11	0,1584	c	350013806100000005	0-23						Anti-proliferative effect of ginseng saponins on human prostate cancer cell line	eanimal.snu.ac.kr	0	0		
955	chr29	48550569	48552165	3500333920	24		48550569	48552165	8421504	2	11,13	0,1583	c	350033392000000014	0-24		18987336	10.1091/mbc.E08-08-0792	1059-1524	Molecular Biology of the Cell	PCAF Acetylates &#x03b2;-Catenin and Improves Its Stability	Ge	2009	5		
955	chr29	48550569	48552165	3500306674	24		48550569	48552165	8421504	2	11,13	0,1583	c	350030667400000014	0-24						PCAF Acetylates &#x03b2;-Catenin and Improves Its Stability - Keeping the Faith	pthefaith1296.com	0	0		CCND1
955	chr29	48550575	48552253	3500240762	41		48550575	48552253	8421504	3	5,17,19	0,1577,1659	c,g	350024076200000008,350024076200000009,350024076200000009	0-22,0-19,0-19		19470727	10.1158/1078-0432.CCR-08-3155	1078-0432	Clinical Cancer Research	FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma	Nucera	2009	8		CCND1
955	chr29	48550575	48552253	3500037777	41		48550575	48552253	8421504	3	5,17,19	0,1577,1659	c,g	350003777700000015,350003777700000016,350003777700000016	0-22,0-19,0-19		17591692	10.1128/MCB.00237-07	0270-7306	Molecular and Cellular Biology	The Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Corepressor Is Required for Full Estrogen Receptor &#x03b1; Transcriptional Activity	Peterson	2007	6		CCND1
955	chr29	48552188	48553018	3500403161	39		48552188	48553018	8421504	2	20,19	0,811	c,g	350040316100000057,350040316100000056,350040316100000056	0-20,0-19,0-19						Inhibitors for growth hormone and related hormones, and methods of use thereof	Lobie	2010	0		CCND1
955	chr29	48552188	48553018	3500390028	39		48552188	48553018	8421504	2	20,19	0,811	c,g	350039002800000057,350039002800000057,350039002800000127,350039002800000127,350039002800000056,350039002800000056,350039002800000126,350039002800000126	0-20,0-20,0-20,0-20,0-19,0-19,0-19,0-19						INHIBITORS FOR GROWTH HORMONE AND RELATED HORMONES, AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		CCND1
955	chr29	48552188	48553018	3500031849	39		48552188	48553018	8421504	2	20,19	0,811	c,g	350003184900000057,350003184900000056,350003184900000056	0-20,0-19,0-19						INHIBITORS FOR GROWTH HORMONE AND RELATED HORMONES, AND METHODS OF USE THEREOF	Lobie	2008	0		CCND1
955	chr29	48552188	48553018	3500002351	39		48552188	48553018	8421504	2	20,19	0,811	c,g	350000235100000047,350000235100000046,350000235100000046	0-20,0-19,0-19						POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF	Dongxu	2008	0		CCND1
955	chr29	48552191	48552954	3500456168	40		48552191	48552954	8421504	2	20,20	0,743	c	350045616800000005,350045616800000017	0-20,0-20			10.1091/mbc.E07-02-0109		Molecular Biology of the Cell	Cyclin D1 Is Transcriptionally Down-Regulated by ZO-2 via an E Box and the Transcription Factor c-Myc	Miriam	2007	0		CCND1
955	chr29	48552272	48552917	3500396734	44		48552272	48552917	8421504	2	22,22	0,623	c	350039673400000002,350039673400000003	0-22,0-22						Increase of the therapeutic effect on non-small-cell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-xL in vitro	-publications.com	0	0		CCND1
955	chr29	48559635	48559659	3500386453	24		48559635	48559659	8421504	1	24	0	c	350038645300000021	16-40						Modulation of growth factors and cell cycle regulatory molecules in experimental cardiomyopathy	theses.ulb.ac.be	0	0		
956	chr29	48661116	48662064	3500116987	40		48661116	48662064	8421504	2	20,20	0,928	c	350011698700000007,350011698700000006	0-20,0-20						Analysis of Gene Transcription in Bovine Nuclear Transfer Embryos: RESULTS | Medicine Healthiest	ne-healthiest.com	0	0		FGF4
956	chr29	48662761	48662784	3500451592	23		48662761	48662784	8421504	1	23	0	c	350045159200000001	0-23						Fibroblast Growth Factor-Like Polypeptides	Thomason	2010	0		FGF6
956	chr29	48662761	48662784	3500404591	23		48662761	48662784	8421504	1	23	0	c	350040459100000006,350040459100000001	0-23,0-23						US Patent # 7,320,796. Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family - Patents.com	www.patents.com	0	0		FGF6
956	chr29	48662761	48662784	3500305528	23		48662761	48662784	8421504	1	23	0	c	350030552800000001	0-23						Fibroblast Growth Factor-Like Polypeptides	Thomason	2009	0		FGF6
956	chr29	48662761	48662784	3500254166	23		48662761	48662784	8421504	1	23	0	c	350025416600000007,350025416600000001	0-23,0-23						Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family - Patent application	www.faqs.org	0	0		FGF4
956	chr29	48662761	48662784	3500060961	23		48662761	48662784	8421504	1	23	0	c	350006096100000053,350006096100000001	0-23,0-23						Fibroblast Growth Factor-Like Polypeptides - Patent application	www.faqs.org	0	0		FGF4
956	chr29	48662761	48662784	3500029280	23		48662761	48662784	8421504	1	23	0	c	350002928000000045	0-23						Fibroblast Growth Factor-like Polypeptides 	.freshpatents.com	0	0		FGF6
956	chr29	48705067	48705095	3500309646	23		48705067	48705095	8421504	2	15,8	0,20	g	350030964600000011	0-23			10.1093/nar/gkm609		Nucleic Acids Research	Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter	Alan	2007	0		
957	chr29	48819334	48819363	3500068995	24		48819334	48819363	8421504	3	5,5,14	0,8,15	g	350006899500000521	9-33						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
958	chr29	48969035	48969059	3500111057	24		48969035	48969059	8421504	1	24	0	g	350011105700000008	0-24						TMEM16A alternative splicing coordination in breast cancer	biomedcentral.com	0	0		
959	chr29	49033066	49033091	3500280518	24		49033066	49033091	8421504	2	7,17	0,8	c	350028051800000026	0-24						Novel Hansenula Polymorpha Gene Coding for Alpha 1,6-Mannosyltransferase and Process for the Production of Recombinant Glycoproteins with Hansenula Polymorpha Mutant Strain Deficient in the Same Gene - Patent application	www.faqs.org	0	0		
960	chr29	49157142	49157165	3500464289	23		49157142	49157165	8421504	1	23	0	c	350046428900000059	23-46						High bone mass gene of 11q13.3	Carulli	2000	0		
960	chr29	49157142	49157165	3500138868	23		49157142	49157165	8421504	1	23	0	c	350013886800000066	23-46						 Transgenic Animal Model Of Bone Mass Modulation 	www.docstoc.com	0	0		
960	chr29	49157142	49157165	3500068827	23		49157142	49157165	8421504	1	23	0	c	350006882700000059	23-46					Patent	High bone mass gene of 1.1q13.3 (Patent US:6780609)	Carulli	2004	0		
960	chr29	49157142	49157165	3500003080	23		49157142	49157165	8421504	1	23	0	c	350000308000000060	23-46						US Patent # 7,285,400. High bone mass gene of 11q13.3 - Patents.com	www.patents.com	0	0		
960	chr29	49190169	49190192	3500396759	23		49190169	49190192	8421504	1	23	0	c	350039675900000016	25-48						Mechanisms of Chlamydia trachomatis Entry into Nonphagocytic Cells	ww.hybiskelab.org	0	0		
960	chr29	49281057	49281086	3500162126	24		49281057	49281086	8421504	2	11,13	0,16	g	350016212600000010	3-27						Growth hormone fusion proteins	Francis	1990	0		
965	chr29	49934773	49934796	3500229006	23		49934773	49934796	8421504	1	23	0	g	350022900600000008	0-23						Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts	biomedcentral.com	0	0		POTEF,POTEM
969	chr29	50362012	50362036	3500394411	24		50362012	50362036	8421504	1	24	0	c	350039441100002525	0-24						OSK1 peptide analogs and pharmaceutical compositions - Patent application	www.faqs.org	0	0		
969	chr29	50362013	50362036	3500275614	23		50362013	50362036	8421504	1	23	0	c	350027561400000671	0-23						Toxin peptide therapeutic agents	Sullivan	2006	0		XPNPEP1
969	chr29	50400491	50402799	3500143138	67		50400491	50402799	8421504	3	24,21,22	0,927,2286	c,g	350014313800000013,350014313800000004,350014313800000005	0-24,0-21,0-22						RESEARCH Open Access KCNQ1OT1 CDKN1C H19 PLAGL1 KvDMR1 and H19/IGF2 imprinting control regions	ww.jbiomedsci.com	0	0		
969	chr29	50401375	50401401	3500456704	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350045670400000043	6-30						Detection of nucleic acid sequences by invader-directed cleavage	Brow	1996	0		
969	chr29	50401375	50401401	3500425953	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350042595300000063	6-30						Cleavage agents	www.devileye.net	0	0		
969	chr29	50401375	50401401	3500417793	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350041779300000070	6-30						US Patent # 6,458,535. Detection of nucleic acids by multiple sequential invasive cleavages 02 - Patents.com	www.patents.com	0	0		
969	chr29	50401375	50401401	3500405778	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350040577800000065	6-30						 Detection Of Target Sequences By Cleavage Of Non 	www.docstoc.com	0	0		
969	chr29	50401375	50401401	3500401479	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350040147900000065	6-30						Methods and compositions for characterizing nucleic acids	Dahlberg	2000	0		
969	chr29	50401375	50401401	3500401260	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350040126000000065	6-30						Rapid detection and identification of pathogens	Brow	1995	0		
969	chr29	50401375	50401401	3500351696	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350035169600000079	6-30						US Patent # 6,372,424. Rapid detection and identification of pathogens - Patents.com	www.patents.com	0	0		
969	chr29	50401375	50401401	3500327109	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350032710900000066	6-30						Invasive cleavage of nucleic acids	Brow	1999	0		
969	chr29	50401375	50401401	3500299105	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350029910500000067	6-30						DETECTION OF NUCEIC ACIDS BY MULTIPLE SEQUENTIAL INVASIVE CLEAVAGES - Patent application	www.faqs.org	0	0		
969	chr29	50401375	50401401	3500258699	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350025869900000066	6-30						Systems for the detection of target sequences	Dahlberg	2001	0		
969	chr29	50401375	50401401	3500228725	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350022872500000043	6-30						Nucleic acid detection assays	www.devileye.net	0	0		
969	chr29	50401375	50401401	3500205290	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350020529000000042	6-30						Detection of nucleic acid sequences by invader-directed cleavage	Brow	1999	0		
969	chr29	50401375	50401401	3500174014	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350017401400000065	6-30						 Rapid Detection And Identification Of Pathogens 	www.docstoc.com	0	0		
969	chr29	50401375	50401401	3500159977	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350015997700000070	6-30						Detection of nucleic acids by multiple sequential invasive cleavages 02	Hall	1999	0		
969	chr29	50401375	50401401	3500152228	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350015222800000073	6-30						Detection of nucleic acids by multiple sequential invasive cleavages	Hall	1997	0		
969	chr29	50401375	50401401	3500139533	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350013953300000066	6-30						Invasive cleavage of nucleic acids	Brow	1997	0		
969	chr29	50401375	50401401	3500133350	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350013335000000073	6-30						Fen-1 endonucleases, mixtures and cleavage methods	Kaiser	1998	0		
969	chr29	50401375	50401401	3500126449	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350012644900000063	6-30						 Cleavage Of Nucleic Acids 	www.docstoc.com	0	0		
969	chr29	50401375	50401401	3500125749	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350012574900000066	6-30						 Systems For The Detection Of Target Sequences 	www.docstoc.com	0	0		
969	chr29	50401375	50401401	3500016165	24		50401375	50401401	8421504	3	4,15,5	0,5,21	c	350001616500000041	6-30						 Detection Of Nucleic Acid Sequences By Invader 	www.docstoc.com	0	0		
121	chr29	50432066	50501306	3500381625	45		50432066	50501306	8421504	2	12,33	0,69207	p	350038162500015193	0-45						KVLQT1&#x2014;a long QT syndrome gene	Keating	2000	0		KCNQ1DN,KCNQ1
970	chr29	50503095	50503119	3500086426	24		50503095	50503119	8421504	1	24	0	c	350008642600000008	14-38		12021266	10.1074/jbc.M112375200	0021-9258	Journal of Biological Chemistry	Defective Human Ether-&#xe0;-go-go-related Gene Trafficking Linked to an Endoplasmic Reticulum Retention Signal in the C Terminus	Kupershmidt	2002	5		
970	chr29	50592977	50593001	3500204459	23		50592977	50593001	8421504	2	6,17	0,7	g	350020445900000001	15-38						Tumor Cell-specific Transcription of a Murine Histocompatibility Class Ib Gene	.iiarjournals.org	0	0		
970	chr29	50593141	50593164	3500143138	23		50593141	50593164	8421504	1	23	0	g	350014313800000002	0-23						RESEARCH Open Access KCNQ1OT1 CDKN1C H19 PLAGL1 KvDMR1 and H19/IGF2 imprinting control regions	ww.jbiomedsci.com	0	0		
121	chr29	50706404	50812085	3500205101	102		50706404	50812085	8421504	4	36,21,28,17	0,303,49073,105664	p	350020510100015023,350020510100015065,350020510100015157	0-45,0-45,0-45						Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene	Keating	1999	0		
971	chr29	50706404	50715947	3500338672	111		50706404	50715947	8421504	4	36,27,13,35	0,303,8968,9508	p,c	350033867200015023,350033867200015160,350033867200015065,350033867200015245,350033867200000184	0-48,0-48,0-48,0-48,0-48						KVLQT1--a long qt syndrome gene	www.devileye.net	0	0		
971	chr29	50706404	50706716	3500381625	45		50706404	50706716	8421504	2	36,9	0,303	p	350038162500015023	0-45						KVLQT1&#x2014;a long QT syndrome gene	Keating	2000	0		KCNQ2
971	chr29	50706416	50706731	3500343942	48		50706416	50706731	8421504	2	24,24	0,291	p	350034394200015023	0-48						Polymorphisms associated with ion-channel disease - US Patent Application 20050089905 Description	ww.patentstorm.us	0	0		KCNQ5
971	chr29	50706719	50716433	3500329173	87		50706719	50716433	8421504	3	42,32,13	0,9240,9701	c	350032917300000046,350032917300000038	0-42,0-45						Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene - US Patent 7247436 Description	ww.patentstorm.us	0	0		
971	chr29	50706785	50714568	3500202391	45		50706785	50714568	8421504	2	33,12	0,7771	p	350020239100015005	0-45						Human potassium channel genes	Miller	2002	0		KCNQ1
971	chr29	50706785	50714568	3500128285	45		50706785	50714568	8421504	2	33,12	0,7771	p	350012828500015005	0-45						Human Potassium Channel Genes	Miller	2009	0		KCNQ1
971	chr29	50714692	50715308	3500349831	25		50714692	50715308	8421504	2	5,20	0,596	c	350034983100000001,350034983100000000	0-25,0-21						Single base extension	Herron	2004	0		KCNQ1
972	chr29	50755477	50812088	3500338672	48		50755477	50812088	8421504	2	28,20	0,56591	p	350033867200015166	0-48						KVLQT1--a long qt syndrome gene	www.devileye.net	0	0		KCNQ1
972	chr29	50755477	50812085	3500381625	45		50755477	50812085	8421504	2	28,17	0,56591	p	350038162500015164	0-45						KVLQT1&#x2014;a long QT syndrome gene	Keating	2000	0		KCNQ1
972	chr29	50755483	50812094	3500338672	48		50755483	50812094	8421504	2	22,26	0,56585	p	350033867200015203	0-48						KVLQT1--a long qt syndrome gene	www.devileye.net	0	0		KCNQ1
972	chr29	50755483	50812091	3500381625	45		50755483	50812091	8421504	2	22,23	0,56585	p	350038162500015201	0-45						KVLQT1&#x2014;a long QT syndrome gene	Keating	2000	0		KCNQ1
972	chr29	50755495	50812137	3500381625	79		50755495	50812137	8421504	2	10,69	0,56573	p,c	350038162500015009,350038162500000177	0-45,5-48						KVLQT1&#x2014;a long QT syndrome gene	Keating	2000	0		
972	chr29	50755495	50812137	3500338672	79		50755495	50812137	8421504	2	10,69	0,56573	p,c	350033867200015009,350033867200000177	0-48,5-48						KVLQT1--a long qt syndrome gene	www.devileye.net	0	0		
972	chr29	50755495	50812106	3500329173	48		50755495	50812106	8421504	2	10,38	0,56573	p	350032917300015009	0-48						Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene - US Patent 7247436 Description	ww.patentstorm.us	0	0		KCNQ1
972	chr29	50755495	50812103	3500205101	45		50755495	50812103	8421504	2	10,35	0,56573	p	350020510100015009	0-45						Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene	Keating	1999	0		KCNQ1
973	chr29	50974357	50974388	3500234051	25		50974357	50974388	8421504	3	13,5,7	0,14,24	c	350023405100000307	10-38						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		
973	chr29	50974619	50974642	3500364288	23		50974619	50974642	8421504	1	23	0	c	350036428800000001	21-44						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
974	chr29	51049347	51049485	3500361354	57		51049347	51049485	8421504	2	48,9	0,129	p	350036135400015000	0-57						PRENATAL DIAGNOSIS 25 DOI: Pre- and postnatal diagnosis of tyrosine hydroxylase de&#xfb01;ciency	www.biopku.org	0	0		
974	chr29	51050811	51069227	3500014234	115		51050811	51069227	8421504	2	22,93	0,18323	c,g	350001423400000120,350001423400000048,350001423400000154,350001423400000153,350001423400000085,350001423400000005	0-22,0-19,0-94,0-94,0-19,0-19						Selecting Animals For Desired Genotypic Or Potential Phenotypic Properties 	.freshpatents.com	0	0		
974	chr29	51050811	51069185	3500416002	42		51050811	51069185	8421504	2	23,19	0,18355	c,g	350041600200000059,350041600200000010	0-23,0-19						Selecting animals for desired genotypic or potential phenotypic properties	Andersson	2010	0		
974	chr29	51050842	51051924	3500212595	38		51050842	51051924	8421504	2	19,19	0,1063	c,g	350021259500000012,350021259500000013,350021259500000013	0-19,0-19,0-19		16943556	10.1523/JNEUROSCI.2828-06.2006	0270-6474	The Journal of Neuroscience	Involvement of Protein Kinase C-&#x03b5; in Activity-Dependent Potentiation of Large Dense-Core Vesicle Exocytosis in Chromaffin Cells	Park	2006	7		
974	chr29	51051871	51051905	3500426063	25		51051871	51051905	8421504	3	6,7,12	0,10,22	c	350042606300000016	17-43						Herbicide-tolerant plants expressing carbamate hydrolase	Pohlenz	1990	0		
974	chr29	51051871	51051905	3500258868	25		51051871	51051905	8421504	3	6,7,12	0,10,22	c	350025886800000016	17-43						US Patent # 5,347,076. Herbicide-tolerant plants expressing carbamate hydrolase - Patents.com	www.patents.com	0	0		
974	chr29	51054119	51054606	3500356043	108		51054119	51054606	8421504	2	5,103	0,384	c,g	350035604300000001,350035604300000002,350035604300000002	0-80,0-43,0-43						Process of Making Transgenic Mammals That Produce Exogenous Proteins in Milk and Transgenic Mammals Produced Thereby	A.	2008	0		
974	chr29	51054119	51054606	3500161305	108		51054119	51054606	8421504	2	5,103	0,384	c,g	350016130500000001,350016130500000012,350016130500000002,350016130500000002,350016130500000013,350016130500000013	0-80,0-80,0-43,0-43,0-43,0-43						Process for Producing Exogenous Protein in the Milk of Transgenic Mammals and a Process For Purifying Proteins Therefrom - Patent application	www.faqs.org	0	0		
974	chr29	51054445	51055236	3500232263	315		51054445	51055236	8421504	2	187,128	0,663	p	350023226300015030,350023226300015035,350023226300015125,350023226300015132,350023226300015209,350023226300015013,350023226300015034,350023226300015036,350023226300015037,350023226300015029	0-171,0-171,0-90,3-162,36-189,63-207,0-144,0-144,0-63,0-63					Patent	&#x5728;&#x690d;&#x7269;&#x4e2d;&#x751f;&#x4ea7;&#x80f0;&#x5c9b;&#x7d20;&#x7684;&#x65b9;&#x6cd5; (Patent CN:1836047)	Ji Jie Si *Fan Lu Yi Jie En 	2010	0		
974	chr29	51054445	51055236	3500180042	315		51054445	51055236	8421504	2	187,128	0,663	p	350018004200015010,350018004200015038	0-315,0-96						Svar pAY= Multiple Alignment A,velse --------------------------------- Af: Rasmus Wernersson (v18013)	www.cbs.dtu.dk	0	0		
974	chr29	51054445	51055236	3500113242	315		51054445	51055236	8421504	2	187,128	0,663	p	350011324200015010,350011324200015038	0-315,0-96						Svar p&#xe5; Multiple Alignment &#xf8;velse ---------------------------------	www.cbs.dtu.dk	0	0		
974	chr29	51054445	51055236	3500108196	315		51054445	51055236	8421504	2	187,128	0,663	p	350010819600015013	0-315						Dados estat&#xed;sticos sobre a vida biol&#xf3;gica	www2.ee.ufpe.br	0	0		
974	chr29	51054499	51055236	3500210720	252		51054499	51055236	8421504	3	108,16,128	0,117,609	p	350021072000015019,350021072000015091,350021072000015020,350021072000015014	3-207,0-90,0-144,0-60						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
974	chr29	51054517	51055239	3500009534	105		51054517	51055239	8421504	2	84,21	0,701	p,c	350000953400015133,350000953400000015	0-84,9-30						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
974	chr29	51054517	51055236	3500431650	153		51054517	51055236	8421504	2	90,63	0,656	p	350043165000015004	0-153						Algorithmes de comparaison de s&#xe9;quences	www.lifl.fr	0	0		
974	chr29	51054517	51055236	3500394978	153		51054517	51055236	8421504	2	90,63	0,656	p	350039497800015006	0-153						Comparaisondes&#xb6;equences	lifl.fr/~touzet/S	0	0		
974	chr29	51054517	51055236	3500371611	153		51054517	51055236	8421504	2	90,63	0,656	p	350037161100015010,350037161100015009	0-90,0-63						Therapeutic agents comprising elastin-like peptides	Chilkoti	2009	0		
974	chr29	51054517	51055236	3500360142	153		51054517	51055236	8421504	2	90,63	0,656	p	350036014200015004,350036014200015002,350036014200015001	0-81,0-90,0-63						 Projet en "masterpro" CCI an 2007	fo.univ-angers.fr	0	0		
974	chr29	51054517	51055236	3500305180	153		51054517	51055236	8421504	2	90,63	0,656	p	350030518000015004	0-153						Algorithmes de comparaison de s&#xe9;quences	www.lifl.fr	0	0		
974	chr29	51054517	51055236	3500232100	153		51054517	51055236	8421504	2	90,63	0,656	p	350023210000015013,350023210000015014	0-90,0-63						Substrate assisted catalysis	Carter	1988	0		
974	chr29	51054517	51055236	3500166876	153		51054517	51055236	8421504	2	90,63	0,656	p	350016687600015010,350016687600015009	0-90,0-63						THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES - Patent application	www.faqs.org	0	0		
974	chr29	51054517	51055236	3500070074	153		51054517	51055236	8421504	2	90,63	0,656	p	350007007400015017	0-153						Introduction &#xe0; la bio-informatique	www.lifl.fr	0	0		
974	chr29	51054517	51055236	3500060811	153		51054517	51055236	8421504	2	90,63	0,656	p	350006081100015000	612-765						Carl Herrmann - Bioinformatique Appliqu&#xe9;e - L2 SV	logie.univ-mrs.fr	0	0		TH
974	chr29	51054517	51055236	3500029373	129		51054517	51055236	8421504	3	69,15,45	0,656,674	p	350002937300015000,350002937300015002	0-69,0-60						ATGGGCATTGTCGAACAGTGTTGCGCCAGCGTCTGTTCCCTCTATCAATTAGAGAATTACTGCAATTAG CGCGGTCGCAGACAAGGGAGAT AGTTAATCTCTTAATGAC GTTAATC anticodogener Strang &#xdc;bung Proteinsynthese	www.wilke-j.de	0	0		
974	chr29	51054517	51055236	3500029002	153		51054517	51055236	8421504	2	90,63	0,656	p	350002900200015008	0-153						Introduction &#xe0; la bio-informatique	www.lifl.fr	0	0		
974	chr29	51054517	51055236	3500027446	153		51054517	51055236	8421504	2	90,63	0,656	p	350002744600015001,350002744600015000	3-93,3-66						Estructura de Las Proteinas 1	www.scribd.com	0	0		
974	chr29	51054517	51054607	3500390577	90		51054517	51054607	8421504	1	90	0	p	350039057700015018,350039057700015010,350039057700015012	63-153,63-150,63-144					Patent	Zusammensetzungen und verfahren zur behandlung von diabetes Compositions and methods for treatment of diabetes (Patent DE:60223058)	TCHELINGERIAN	2008	0		
974	chr29	51054517	51054607	3500371971	90		51054517	51054607	8421504	1	90	0	p	350037197100015009,350037197100015005,350037197100015006	63-153,63-150,63-144					Patent	Compositions and methods of treating diabetes (Patent EP:1427758)	TCHELINGERIAN	2007	0		
974	chr29	51054517	51054607	3500356316	90		51054517	51054607	8421504	1	90	0	p	350035631600015010,350035631600015006,350035631600015007	63-153,63-150,63-144						Insulin conjugates and methods of use thereof	Tchelingerian	2002	0		
974	chr29	51054517	51054607	3500270953	90		51054517	51054607	8421504	1	90	0	p	350027095300015001	0-90						Adding bioinformatics to AP Bio | Gas station without pumps	mps.wordpress.com	0	0		
974	chr29	51054517	51054607	3500172887	90		51054517	51054607	8421504	1	90	0	p	350017288700015005,350017288700015004,350017288700015008	63-144,63-150,63-153					Patent	Insulin conjugates and methods of use thereof (Patent US:7049286)	Tchelingerian	2006	0		
974	chr29	51054517	51054607	3500097998	90		51054517	51054607	8421504	1	90	0	p	350009799800015008	63-153						Insulin conjugates and methods of use thereof	Tchelingerian	2006	0		
974	chr29	51054517	51054607	3500097385	90		51054517	51054607	8421504	1	90	0	p	350009738500015008,350009738500015004,350009738500015005	63-153,63-150,63-144					Patent	Insulin conjugates and methods of use thereof (Patent US:7112562)	Tchelingerian	2006	0		
974	chr29	51054517	51054607	3500069754	90		51054517	51054607	8421504	1	90	0	p	350006975400015010,350006975400015007,350006975400015006	63-153,63-144,63-150					Patent	Zusammensetzungen und verfahren zur behandlung von diabetes (Patent DE:60223058)	TCHELINGERIAN	2008	0		
974	chr29	51054517	51054604	3500427779	87		51054517	51054604	8421504	1	87	0	p	350042777900015004,350042777900015012,350042777900015011	63-150,63-150,87-153						Estudio de la endocitosis y se&#xf1;alizaci&#xf3;n mitog&#xe9;nica y metab&#xf3;lica de las dos variantes de splicing del receptor de insulina	al.bl.fcen.uba.ar	0	0		TH
974	chr29	51054517	51054604	3500093358	87		51054517	51054604	8421504	1	87	0	p	350009335800015001	168-255						2116315 . T3	www.oepm.es	0	0		
974	chr29	51054517	51054601	3500117840	84		51054517	51054601	8421504	1	84	0	p	350011784000015012	0-84						KEGG T01001: 3643	www.genome.jp	0	0		
974	chr29	51054517	51054595	3500230041	78		51054517	51054595	8421504	1	78	0	p	350023004100015006	0-78						K. S. VISHWANATHA	ir.cftri.com	0	0		TH
974	chr29	51054517	51054592	3500353990	75		51054517	51054592	8421504	1	75	0	p	350035399000015009	0-75						Use of aspartic proteases in cosmetics and therapeutics	Bernard	2003	0		TH
974	chr29	51054517	51054562	3500452346	45		51054517	51054562	8421504	1	45	0	p	350045234600015008	0-45						Cd127 Expression Inversely Correlates With Foxp3 And Suppressive Function Of Cd4+ Tregs 	.freshpatents.com	0	0		TH
974	chr29	51054520	51054607	3500054758	87		51054520	51054607	8421504	1	87	0	p	350005475800015005	12-99						P1-C03 - Macromol&#xe9;culas. Estructura, forma e informaci&#xf3;n	it.scribd.com	0	0		
974	chr29	51054526	51054607	3500067760	81		51054526	51054607	8421504	1	81	0	p	350006776000015001,350006776000015009	9-72,0-48						 Insulin Derivatives 	www.docstoc.com	0	0		TH
974	chr29	51054535	51055236	3500113483	213		51054535	51055236	8421504	2	90,123	0,578	p	350011348300015004,350011348300015006,350011348300015008	0-90,0-69,0-54						PPT &#x2013; The Darwinian Genome: Genetic and Molecular Evidence for Evolution PowerPoint presentation | free to view 	www.powershow.com	0	0		
974	chr29	51054535	51055233	3500191814	72		51054535	51055233	8421504	2	36,36	0,662	p	350019181400015006	24-96						Vi Sinh Vat Hoc (duoc si)	vi.scribd.com	0	0		TH
974	chr29	51054535	51054592	3500460494	57		51054535	51054592	8421504	1	57	0	p	350046049400015009	0-57						USC : BIO 320 : Moore_ _Biochemistry_for_Dummies__Wiley__2008_	ww.coursehero.com	0	0		TH
974	chr29	51054535	51054592	3500227989	57		51054535	51054592	8421504	1	57	0	p	350022798900015011	48-105						Full text of "atlases of olateb2.co.cc"	archive.org	0	0		TH
974	chr29	51054541	51054586	3500466395	45		51054541	51054586	8421504	1	45	0	p	350046639500015008	0-45						Methods of generating antigen-specific CD4+CD25+ regulatory T cells, compositions and methods of use	Buckner	2005	0		TH
974	chr29	51054541	51054586	3500441456	45		51054541	51054586	8421504	1	45	0	p	350044145600015009	0-45						Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease	Jiang	2009	0		TH
974	chr29	51054541	51054586	3500326074	45		51054541	51054586	8421504	1	45	0	p	350032607400015007	0-45						Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease - Patent application	www.faqs.org	0	0		TH
974	chr29	51054541	51054586	3500200218	45		51054541	51054586	8421504	1	45	0	p	350020021800015000	0-45		19680229	10.1038/emboj.2009.212		The EMBO Journal	Thymus-specific deletion of insulin induces autoimmune diabetes	Yong	2009	0		TH
974	chr29	51054541	51054586	3500024567	45		51054541	51054586	8421504	1	45	0	p	350002456700015000	0-45		19680229	10.1038/emboj.2009.212	ERROR! NO ISSN	The EMBO Journal	Thymus-specific deletion of insulin induces autoimmune diabetes	Fan	2009	0		TH
974	chr29	51054584	51055220	3500315071	40		51054584	51055220	8421504	2	20,20	0,616	c,g	350031507100000038,350031507100000038,350031507100000039,350031507100000039	0-20,0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
974	chr29	51054619	51055152	3500451662	57		51054619	51055152	8421504	2	13,44	0,489	p	350045166200015006	51-108						Deletion of a highly conserved tetrapeptide sequence of the proinsulin connecting peptide (C-peptide) inhibits proinsulin to insulin conversion by transfected pituitary corticotroph (AtT20) cells. - ResearchGate	.researchgate.net	0	0		
974	chr29	51055173	51055236	3500017103	63		51055173	51055236	8421504	1	63	0	p	350001710300015011,350001710300015012	0-63,0-63						The Foundations of Biochemistry	bib.tiera.ru	0	0		
974	chr29	51055209	51079693	3500082184	219		51055209	51079693	8421504	3	27,85,107	0,22842,24377	p,c	350008218400000019,350008218400015013	1-28,0-192					Patent	Vector for expression and secretion of polypeptide microorganism transformed by the vector and production of polypeptide with the same microorganism (Patent US:5545564)	Kajifusa	1996	0		
974	chr29	51055210	51055234	3500020431	24		51055210	51055234	8421504	1	24	0	c	350002043100000006	0-24		16024779	10.1128/MCB.25.15.6404-6414.2005	0270-7306	Molecular and Cellular Biology	JMJD2A Is a Novel N-CoR-Interacting Protein and Is Involved in Repression of the Human Transcription Factor Achaete Scute-Like Homologue 2 (ASCL2/Hash2)	Zhang	2005	6		
974	chr29	51055212	51055240	3500408857	28		51055212	51055240	8421504	1	28	0	c	350040885700000030	6-34					Patent	Method for increased expression of low molecular weight recombinant polypeptides (Patent US:5378613)	Belagaje	1995	0		
974	chr29	51055212	51055239	3500419030	27		51055212	51055239	8421504	1	27	0	c	350041903000000019,350041903000000031	0-27,0-27						Methods of producing recombinant insulin from novel fused proteins - Patent # 6841361 - PatentGenius	.patentgenius.com	0	0		
974	chr29	51055212	51055239	3500409992	27		51055212	51055239	8421504	1	27	0	c	350040999200000019	0-27					Patent	Methods of producing recombinant insulin from novel fused proteins (Patent US:6841361)	Oka	2005	0		
974	chr29	51055212	51055239	3500332470	27		51055212	51055239	8421504	1	27	0	c	350033247000000043	0-27						Fused protein containing insulin precursor of overexpression and secretion type, DNA encoding the same and method of producing insulin	Zuo Teng Jing Zhi 	2009	0		
974	chr29	51055212	51055239	3500275583	27		51055212	51055239	8421504	1	27	0	c	350027558300000022	0-27						Fusion protein containing highly-expressed and secreted insulin precursor, dna encoding same, and method of producing insulin	Endo	2010	0		
974	chr29	51055212	51055239	3500213034	27		51055212	51055239	8421504	1	27	0	c	350021303400000058,350021303400000023	0-27,0-27						Process for producing recombinant insulain from novel fused protein	Gang Zhou Zuo 	2002	0		
974	chr29	51055212	51055237	3500415695	25		51055212	51055237	8421504	1	25	0	c	350041569500000001,350041569500000002	23-48,0-25		16107864	10.1038/sj.gt.3302578	0969-7128	Gene Therapy	DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice	Chang	2005	4		
974	chr29	51055212	51055237	3500378017	25		51055212	51055237	8421504	1	25	0	c	350037801700000001,350037801700000002	23-48,0-25		16107864	10.1038/sj.gt.3302578	0969-7128	Gene Therapy	DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice	Chang	2005	4		TH
974	chr29	51055212	51055237	3500157391	25		51055212	51055237	8421504	1	25	0	c	350015739100000001,350015739100000002	23-48,0-25			10.1038/sj.gt.3302578		Gene therapy	DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice.	Chang	2005	0		
974	chr29	51055212	51055235	3500096317	23		51055212	51055235	8421504	1	23	0	c	350009631700000003	0-23		17579214	10.1210/me.2007-0077	0888-8809	Molecular Endocrinology	Regulated Autophagy Controls Hormone Content in Secretory-Deficient Pancreatic Endocrine &#x03b2;-Cells	Marsh	2007	5		TH
974	chr29	51055214	51055238	3500135205	24		51055214	51055238	8421504	1	24	0	c	350013520500000012	19-43						Universit&#xe0; degli Studi di Trieste	enstarts.units.it	0	0		TH
974	chr29	51055217	51055240	3500189198	23		51055217	51055240	8421504	1	23	0	c	350018919800000001	7-30						ISOLATED PEPTIDES AND USES THEREOF	Peakman	2008	0		
974	chr29	51063909	51064252	3500024644	343		51063909	51064252	8421504	1	343	0	g	350002464400000004,350002464400000008,350002464400000011,350002464400000014,350002464400000017,350002464400000020	0-52,0-55,0-59,0-59,0-59,0-59						Influence of assisted reproductive technologies on imprinting centers and functional characterization of conserved elements in Beckwith Wiedemann Syndrome (BWS) region	b.uni-saarland.de	0	0		
974	chr29	51064459	51064643	3500292247	40		51064459	51064643	8421504	2	20,20	0,164	g	350029224700000000,350029224700000001	0-20,0-20						An association of C/T polymorphism in exon 2 of the bovine insulin-like growth factor 2 gene with meat production traits in Polish Holstein-Friesian cattle	ulturejournals.cz	0	0		
974	chr29	51069166	51078108	3500338309	79		51069166	51078108	8421504	2	19,60	0,8882	c,g	350033830900000023,350033830900000053,350033830900000014,350033830900000014	0-19,0-60,0-22,0-22						Variabilita DNA gen&#x016f; MYF6 IGF2 a ACSL4 u prasat	phd.af.mendelu.cz	0	0		
974	chr29	51069166	51069189	3500401676	23		51069166	51069189	8421504	1	23	0	g	350040167600000013	0-23						Mendel University of Agriculture and Forestry in Brno	phd.af.mendelu.cz	0	0		
974	chr29	51077813	51077841	3500326853	23		51077813	51077841	8421504	2	9,14	0,14	g	350032685300000023	12-35						IMMUNOGLOBULINS COMPRISING PREDOMINANTLY A GlCNACMAN5GLCNAC2 GLYCOFORM	Gerngross	2007	0		
974	chr29	51078011	51079612	3500299869	40		51078011	51079612	8421504	2	21,19	0,1582	c,g	350029986900000004,350029986900000004,350029986900000005,350029986900000005	0-21,0-21,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
974	chr29	51078028	51080286	3500347116	82		51078028	51080286	8421504	4	21,21,20,20	0,1564,2173,2238	c,g	350034711600000003,350034711600000003,350034711600000004,350034711600000004,350034711600000019,350034711600000017,350034711600000017	0-21,0-21,0-21,0-21,0-20,0-20,0-20						Overexpression of IGF2R and IGF1R mRNA in	www.chinagene.cn	0	0		
974	chr29	51078028	51079613	3500159827	42		51078028	51079613	8421504	2	21,21	0,1564	c,g	350015982700000000,350015982700000000,350015982700000001,350015982700000001	0-21,0-21,0-21,0-21						Microarray Analysis on the Differences in Gene Expression Related t	docsdrive.com	0	0		
974	chr29	51078051	51079702	3500357165	201		51078051	51079702	8421504	2	85,116	0,1535	p	350035716500015039,350035716500015040	3-204,3-204						Novel Antibodies Against Igf-ir 	.freshpatents.com	0	0		IGF2
974	chr29	51078051	51079702	3500223042	201		51078051	51079702	8421504	2	85,116	0,1535	p	350022304200015036,350022304200015037	3-204,3-204						NOVEL ANTIBODIES - GLAXO GROUP LIMITED	www.sumobrain.com	0	0		IGF2
974	chr29	51078051	51079681	3500198050	180		51078051	51079681	8421504	2	85,95	0,1535	p,c	350019805000000017,350019805000000008,350019805000015019	0-99,0-33,0-90						Process of purifying antler-derived bone growth factors	Mundy	1994	0		
974	chr29	51078051	51079600	3500392622	99		51078051	51079600	8421504	2	85,14	0,1535	c	350039262200000014,350039262200000008	0-99,0-32						Novel antler-derived bone growth factors	Arnett	1993	0		
974	chr29	51078051	51079600	3500054149	99		51078051	51079600	8421504	2	85,14	0,1535	c	350005414900000017,350005414900000008	0-99,0-27					Patent	Process of purifying antler-derived bone growth factors (Patent US:5408041)	Arnett	1995	0		
974	chr29	51078051	51078105	3500389394	51		51078051	51078105	8421504	2	24,27	0,27	p	350038939400015000	0-51					Patent	Process for the production and refolding of unfused IGF-II protein in E. coli (Patent US:5708148)	Marki	1998	0		IGF2
974	chr29	51078051	51078105	3500263484	51		51078051	51078105	8421504	2	24,27	0,27	p	350026348400015000	0-51					Patent	Process for the production of unfused igf-ii protein in e. coli (Patent US:5210028)	Marki	1993	0		IGF2
974	chr29	51078051	51078105	3500248108	51		51078051	51078105	8421504	2	24,27	0,27	p	350024810800015000	0-51						Novel process for the production of unfused protein in E. coli	Marki	1991	0		IGF2
974	chr29	51078059	51080297	3500331267	400		51078059	51080297	8421504	6	77,149,14,77,60,23	0,1527,1980,2074,2154,2215	c,g	350033126700000005,350033126700000006,350033126700000007,350033126700000009,350033126700000010,350033126700000003,350033126700000003	0-80,0-80,0-80,0-77,0-60,0-23,0-23						&#x4e1c;&#x5317;&#x9a6c;&#x9e7f;&#x9e7f;&#x8338;&#x8f6f;&#x9aa8;&#x7ec4;&#x7ec7;cDNA&#x6587;&#x5e93;&#x6784;&#x5efa; &#x53ca;IGF2&#x57fa;&#x56e0;&#x514b;&#x9686;&#x4e0e;&#x7ed3;&#x6784;&#x5206;&#x6790;	.chinaagrisci.com	0	0		
974	chr29	51078096	51080199	3500099408	40		51078096	51080199	8421504	2	20,20	0,2083	c	350009940800000002,350009940800000003	0-20,0-20						Exposure to Short Day Photoperiod During the Dry Period Enhances Mammary Growth in Dairy Cows	circlescience.biz	0	0		
974	chr29	51078096	51079712	3500362403	40		51078096	51079712	8421504	2	20,20	0,1596	c,g	350036240300000064,350036240300000065,350036240300000065	0-20,0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		IGF2
974	chr29	51078117	51080074	3500335386	41		51078117	51080074	8421504	3	19,1,21	0,1469,1936	c,g	350033538600000002,350033538600000003,350033538600000003	0-20,0-21,0-21			10.5402/2013/470328		ISRN Genetics	Hypermethylation of <i>INS</i> Promoter in the Developing Liver of Cattle	Lisowski	2013	0		IGF2
974	chr29	51078117	51080074	3500141821	41		51078117	51080074	8421504	3	19,1,21	0,1469,1936	c,g	350014182100000004,350014182100000005,350014182100000005	0-20,0-21,0-21						The mRNA expression of the members of the IGF-system in bovine corpus luteum during induced luteolysis	quantification.de	0	0		IGF2
974	chr29	51078117	51080074	3500036931	41		51078117	51080074	8421504	3	19,1,21	0,1469,1936	c,g	350003693100000012,350003693100000013,350003693100000013	0-20,0-21,0-21						Maturation medium supplements affect transcript level of apoptosis and cell survival related genes in bovine blastocysts produced in vitro	www.ufpel.edu.br	0	0		IGF2
974	chr29	51078117	51079590	3500380283	23		51078117	51079590	8421504	2	19,4	0,1469	c	350038028300000091	15-38						TARGETED THERAPEUTIC PROTEINS - Patent application	www.faqs.org	0	0		
974	chr29	51078117	51079590	3500265346	23		51078117	51079590	8421504	2	19,4	0,1469	c	350026534600000084	15-38						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
974	chr29	51078117	51079590	3500160759	23		51078117	51079590	8421504	2	19,4	0,1469	c	350016075900000084,350016075900000010	15-38,11-30						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
974	chr29	51078117	51079590	3500125607	23		51078117	51079590	8421504	2	19,4	0,1469	c	350012560700000083	15-38						Method for targeting lysosomal enzymes - Patent application	www.faqs.org	0	0		
974	chr29	51078124	51079684	3500315971	42		51078124	51079684	8421504	3	12,9,21	0,1462,1539	c	350031597100000004,350031597100000005	0-21,0-21						REPRODUCTION	uction-online.org	0	0		
974	chr29	51078124	51079684	3500248474	42		51078124	51079684	8421504	3	12,9,21	0,1462,1539	c	350024847400000002,350024847400000003	0-21,0-21						REPRODUCTION	uction-online.org	0	0		
974	chr29	51078124	51079684	3500024081	42		51078124	51079684	8421504	3	12,9,21	0,1462,1539	c	350002408100000004,350002408100000005	0-21,0-21						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
974	chr29	51079167	51079190	3500180208	23		51079167	51079190	8421504	1	23	0	c	350018020800001558	0-23					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		IGF2
974	chr29	51079167	51079190	3500166534	23		51079167	51079190	8421504	1	23	0	c	350016653400001558	0-23						METHODS FOR QUANTITATING SMALL RNA MOLECULES	Raymond	2007	0		IGF2
974	chr29	51079167	51079190	3500164893	23		51079167	51079190	8421504	1	23	0	c	350016489300001558	0-23						Methods for quantitating small rna molecules	Raymond	2007	0		IGF2
974	chr29	51079612	51079711	3500319017	99		51079612	51079711	8421504	1	99	0	p	350031901700015020,350031901700015005	0-99,0-99						Alignements multiples Recherche de motifs, signatures & profils	logie.univ-mrs.fr	0	0		IGF2
974	chr29	51080161	51080208	3500332754	40		51080161	51080208	8421504	2	20,20	0,27	c,g	350033275400000006,350033275400000006,350033275400000002,350033275400000002	0-20,0-20,0-20,0-20						Serum Hormones, Follicular Fluid Steroids, Insulin-LikeGrowth Factors an d Their Binding Proteins, and Ovarian IGF mRNA in Sheep with Different O vulation Rates	nimal-science.org	0	0		
15	chr29	51099340	51394277	3500166204	232		51099340	51394277	8421504	13	30,24,18,21,13,7,25,11,11,21,36,11,4	0,41,131,155,204,186575,294558,294587,294670,294697,294766,294921,294933	g	350016620400000111	144-534						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
975	chr29	51119902	51119926	3500196715	23		51119902	51119926	8421504	2	7,16	0,8	g	350019671500000002	0-25						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa h&#x1ecd;c: Expression studies of the core+1 protein of the hepatitis C virus 1a in mammalian cells 	tailieu.vn/doc/ba	0	0		
975	chr29	51172523	51173511	3500143138	50		51172523	51173511	8421504	2	28,22	0,966	c,g	350014313800000000,350014313800000000,350014313800000001,350014313800000001	0-28,0-28,0-23,0-23						RESEARCH Open Access KCNQ1OT1 CDKN1C H19 PLAGL1 KvDMR1 and H19/IGF2 imprinting control regions	ww.jbiomedsci.com	0	0		
975	chr29	51173048	51173239	3500345464	41		51173048	51173239	8421504	2	20,21	0,170	c,g	350034546400000000,350034546400000000,350034546400000001	0-20,0-20,0-21		15240429	10.1095/biolreprod.104.031807	0006-3363	Biology of Reproduction	Genomic Imprinting of H19 in Naturally Reproduced and Cloned Cattle	Zhang	2004	4		
975	chr29	51173048	51173239	3500066967	41		51173048	51173239	8421504	2	20,21	0,170	c,g	350006696700000000,350006696700000000,350006696700000001,350006696700000001	0-20,0-20,0-21,0-21		15240429	10.1095/biolreprod.104.031807	0006-3363	Biology of Reproduction	Genomic Imprinting of H19 in Naturally Reproduced and Cloned Cattle	Zhang	2004	4		
976	chr29	51258749	51258777	3500036492	27		51258749	51258777	8421504	2	23,4	0,24	c	350003649200000060	5-32						UNIVERSIDAD DE SALAMANCA	gredos.usal.es	0	0		
976	chr29	51305748	51307603	3500200471	357		51305748	51307603	8421504	6	93,177,15,27,44,1	0,204,656,992,1110,1854	p	350020047100015036,350020047100015034,350020047100015030	0-105,0-180,0-72						Cardiac Troponin C methods - The structure and conformational 	www.docstoc.com	0	0		
976	chr29	51373342	51373367	3500297881	24		51373342	51373367	8421504	2	12,12	0,13	g	350029788100000024	10-43						Translocation dependent complementation for drug screening	Dahl	2003	0		
976	chr29	51374950	51376825	3500442358	48		51374950	51376825	8421504	2	24,24	0,1851	c,g	350044235800000002,350044235800000003,350044235800000003	0-24,0-24,0-24		21631942	10.1186/1750-1326-6-37		Molecular Neurodegeneration	Reduction of mutant huntingtin accumulation and toxicity by lysosomal cathepsins D and B in neurons	Qiuli	2011	0		CTSD
976	chr29	51374950	51376825	3500204338	48		51374950	51376825	8421504	2	24,24	0,1851	c,g	350020433800000002,350020433800000003,350020433800000003	0-24,0-24,0-24		21631942	10.1186/1750-1326-6-37	1750-1326	Molecular Neurodegeneration	Reduction of mutant huntingtin accumulation and toxicity by lysosomal cathepsins D and B in neurons	Liang	2011	4		CTSD
15	chr29	51377352	51381398	3500055315	330		51377352	51381398	8421504	6	48,45,51,54,9,123	0,1396,3128,3597,3832,3923	p	350005531500015032,350005531500015045,350005531500015046,350005531500015061,350005531500015074	0-48,0-45,0-51,0-54,0-132						UNIVERSIDADE DE S&#xc3;O PAULO INSTITUTO DE QU&#xcd;MICA DEPARTAMENTO DE BIOQU&#xcd;MICA &#x201c;FISIOLOGIA MOLECULAR DIGESTIVA DE Musca domestica MARCELO HENRIQUE PETERES PADILHA TESE DE DOUTORADO DR. WALTER RIBEIRO TERRA ORIENTADOR	www.teses.usp.br	0	0		
976	chr29	51378660	51378691	3500248813	24		51378660	51378691	8421504	3	12,6,6	0,15,25	c	350024881300000027	11-37						Compositions and method for deimmunization of proteins	Cantor	2012	0		
978	chr29	51543673	51543700	3500383862	27		51543673	51543700	8421504	1	27	0	c	350038386200000014	0-27						METHOD FOR ASSAYING ACTION OF ANTITUMOR AGENT USING SPLICING DEFECTS AS INDEX	Mizui	2008	0		NUP54
978	chr29	51543673	51543700	3500259963	27		51543673	51543700	8421504	1	27	0	c	350025996300000014	0-27						Method for examination of action of anti-cancer agent utilizing splicing defect as measure	Hata	2009	0		NUP54
978	chr29	51592445	51592474	3500139257	24		51592445	51592474	8421504	2	8,16	0,13	g	350013925700000001	0-25		16254373	10.1128/JVI.79.22.14392-14403.2005	0022-538X	Journal of Virology	Genomic Analysis of Anti-Hepatitis B Virus (HBV) Activity by Small Interfering RNA and Lamivudine in Stable HBV-Producing Cells	Guo	2005	5		
591	chr3	789307	792305	3500122415	45		789307	792305	8421504	2	18,27	0,2971	p	350012241500015012	0-45						Chimeric Infectious Dna Clones, Chimeric Porcine Circoviruses And Uses Thereof 	.freshpatents.com	0	0		TBX19
592	chr3	922020	922049	3500445384	24		922020	922049	8421504	3	14,5,5	0,16,24	g	350044538400000007	0-24		15691950	10.1128/AEM.71.2.930-939.2005	0099-2240	Applied and Environmental Microbiology	Genomic and Phylogenetic Characterization of Luminous Bacteria Symbiotic with the Deep-Sea Fish Chlorophthalmus albatrossis (Aulopiformes: Chlorophthalmidae)	Dunlap	2005	4		
595	chr3	1334812	1334838	3500099527	25		1334812	1334838	8421504	2	9,16	0,10	c	350009952700000089	15-40						HIV envelopolype peptides	Berman	2001	0		
596	chr3	1469238	1469274	3500225990	35		1469238	1469274	8421504	2	9,26	0,10	c	350022599000000017	14-49						Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same	Mehraban	2001	0		
596	chr3	1469240	1469274	3500116123	33		1469240	1469274	8421504	2	7,26	0,8	c	350011612300000063	0-33						DIFFERENTIALLY EXPRESSED GENES INVOLVED IN ANGIOGENESIS, THE POLYPEPTIDES ENCODED THEREBY, AND METHODS OF USING THE SAME - Patent application	www.faqs.org	0	0		
598	chr3	1811488	1811551	3500197347	63		1811488	1811551	8421504	1	63	0	p	350019734700015008	0-63						Means for the identification compounds capable of inhibiting karap-transduced signals	Vivier	2003	0		CD247
598	chr3	1811531	1814000	3500274037	40		1811531	1814000	8421504	2	20,20	0,2449	c	350027403700000006,350027403700000007	0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
598	chr3	1812743	1812773	3500059779	30		1812743	1812773	8421504	1	30	0	c	350005977900000040	4-34						CE7-specific chimeric T cell receptor - Patent # 7265209 - PatentGenius	.patentgenius.com	0	0		
598	chr3	1817122	1817146	3500311561	24		1817122	1817146	8421504	1	24	0	c	350031156100000004	6-30						The Adaptor Protein SAP Directly Associates with CD3&#x03b6; Chain and Regulates T Cell Receptor Signaling - Keeping the Faith	pthefaith1296.com	0	0		
598	chr3	1817122	1817146	3500253364	24		1817122	1817146	8421504	1	24	0	c	350025336400000004	6-30						The Adaptor Protein SAP Directly Associates with CD3&#x03b6; Chain and Regulates T Cell Receptor Signaling - Keeping the Faith	pthefaith1296.com	0	0		
598	chr3	1817122	1817146	3500169003	24		1817122	1817146	8421504	1	24	0	c	350016900300000004	6-30		22912825	10.1371/journal.pone.0043200		PLoS ONE	The Adaptor Protein SAP Directly Associates with CD3&#x03b6; Chain and Regulates T Cell Receptor Signaling	Richard	2012	0		
598	chr3	1817920	1818018	3500317153	40		1817920	1818018	8421504	2	20,20	0,78	c,g	350031715300000050,350031715300000050,350031715300000022,350031715300000022,350031715300000051,350031715300000051,350031715300000023,350031715300000023	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						Markers for Viral Infections and Other Inflammatory Responses - Patent application	www.faqs.org	0	0		
599	chr3	1873692	1915960	3500079191	40		1873692	1915960	8421504	3	20,11,9	0,12664,42259	c	350007919100000002,350007919100000001	0-20,0-20		11103783		0008-5472	Cancer Research	Activation of the Transcription Factor Oct-1 in Response to DNA Damage	Zhao	2000	8		POU2F1
603	chr3	2460150	2460181	3500339819	24		2460150	2460181	8421504	3	5,6,13	0,8,18	g	350033981900000043	24-48						 Antibodies Recognizing Tie Receptor Tyrosine Kinase And Uses Thereof 	www.docstoc.com	0	0		
603	chr3	2486813	2486837	3500127308	23		2486813	2486837	8421504	2	9,14	0,10	g	350012730800000128	4-27						PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS - Patent application	www.faqs.org	0	0		
604	chr3	2500961	2500988	3500019590	23		2500961	2500988	8421504	2	8,15	0,12	g	350001959000000023	7-30						Functional genomics of the horn fly, Haematobia irritans (Linnaeus, 1758). - ResearchGate	.researchgate.net	0	0		
610	chr3	3376315	3376341	3500336859	25		3376315	3376341	8421504	2	13,12	0,14	g	350033685900000016	7-34						Methods and compositions for polypeptide engineering	Patten	2005	0		
610	chr3	3376315	3376341	3500137585	25		3376315	3376341	8421504	2	13,12	0,14	g	350013758500000016	7-34						Methods and compositions for polypeptide engineering	Patten	2006	0		
610	chr3	3376315	3376341	3500134057	25		3376315	3376341	8421504	2	13,12	0,14	g	350013405700000016	7-34					Patent	Methods and compositions for polypeptide engineering (Patent US:7776598)	Patten	2010	0		
610	chr3	3376315	3376341	3500128024	25		3376315	3376341	8421504	2	13,12	0,14	g	350012802400000016	7-34						Methods and compositions for polypeptide engineering	Patten	2006	0		
610	chr3	3376315	3376341	3500115500	25		3376315	3376341	8421504	2	13,12	0,14	g	350011550000000016	7-34					Patent	Methods and compositions for polypeptide engineering (Patent US:7776598)	Patten	2010	0		
610	chr3	3376315	3376341	3500045144	25		3376315	3376341	8421504	2	13,12	0,14	g	350004514400000016	7-34						Methods and compositions for polypeptide engineering	Patten	2012	0		
611	chr3	3428387	3520504	3500320726	635		3428387	3520504	8421504	7	153,117,32,300,4,23,6	0,91625,91743,91776,92082,92087,92111	c	350032072600000001	15-657						Hematopoietic regulatory factors and methods of use thereof	Gold	2001	0		
611	chr3	3513126	3535247	3500004130	43		3513126	3535247	8421504	3	21,15,7	0,22097,22114	g	350000413000000048,350000413000000102	12-33,21-48						Alpha-Amylase Variants - Patent application	www.faqs.org	0	0		
615	chr3	3955466	3955514	3500072968	48		3955466	3955514	8421504	1	48	0	c	350007296800000352	0-48						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
615	chr3	4059673	4059701	3500004130	25		4059673	4059701	8421504	3	6,6,13	0,8,15	g	350000413000000104	9-36						Alpha-Amylase Variants - Patent application	www.faqs.org	0	0		
617	chr3	4261878	4273211	3500052316	40		4261878	4273211	8421504	3	20,10,10	0,2589,11323	c,g	350005231600000012,350005231600000012,350005231600000013	0-20,0-20,0-20						DMD29025 TITLE: Gene Regulation of CYP4F11 in Human Keratinocyte HaCaT Cells AUTHORS: Ying Wang, Jordan C. Bell, Diane S. Keeney, and Henry W. Strobel	aspetjournals.org	0	0		RXRG
617	chr3	4261895	4283433	3500360339	42		4261895	4283433	8421504	2	22,20	0,21518	c	350036033900000006,350036033900000003	0-22,0-20		16857792	10.1158/1078-0432.CCR-05-1833	1078-0432	Clinical Cancer Research	Peroxisome Proliferator-Activated Receptor &#x03b3; and Growth Inhibition by Its Ligands in Uterine Endometrial Carcinoma	Ota	2006	8		RXRG
617	chr3	4261981	4264386	3500362432	126		4261981	4264386	8421504	2	37,89	0,2316	p	350036243200015007	54-180						&#x5e73;&#x6210;&#xff11;&#xff15;&#x5e74;&#x5ea6; &#x5185;&#x5206;&#x6ccc;&#x652a;&#x4e71;&#x5316;&#x5b66;&#x7269;&#x8cea;&#x7b49;&#x306e;&#x4f5c;&#x7528; &#x30e1;&#x30ab;&#x30cb;&#x30ba;&#x30e0;&#x306e;&#x89e3;&#x660e;&#x7b49;&#x57fa;&#x790e;&#x7684;&#x78	www.env.go.jp	0	0		RXRG
617	chr3	4261990	4264350	3500224604	81		4261990	4264350	8421504	2	28,53	0,2307	p	350022460400015000	0-81						&#x5e73;&#x6210;&#xff11;&#xff14;&#x5e74;&#x5ea6; &#x5185;&#x5206;&#x6ccc;&#x652a;&#x4e71;&#x5316;&#x5b66;&#x7269;&#x8cea;&#x7b49;&#x306e;&#x4f5c;&#x7528; &#x30e1;&#x30ab;&#x30cb;&#x30ba;&#x30e0;&#x306e;&#x89e3;&#x660e;&#x7b49;&#x57fa;&#x790e;&#x7684;&#x78	www.env.go.jp	0	0		RXRB
617	chr3	4273270	4273512	3500281920	40		4273270	4273512	8421504	2	20,20	0,222	c,g	350028192000000032,350028192000000032,350028192000000033,350028192000000033	0-20,0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
617	chr3	4274981	4276301	3500180995	24		4274981	4276301	8421504	2	20,4	0,1316	c	350018099500000006	0-24		12354931	10.1136/mp.55.5.294	1472-4154	Molecular Pathology	Further evidence to support the melanocytic origin of MDA-MB-435	Ellison	2002	0		
617	chr3	4274981	4276301	3500128235	24		4274981	4276301	8421504	2	20,4	0,1316	c	350012823500000006	0-24		12354931	10.1136/mp.55.5.294	1472-4154	Molecular Pathology	Further evidence to support the melanocytic origin of MDA-MB-435	Ellison	2002	0		
618	chr3	4359549	4359572	3500147447	23		4359549	4359572	8421504	1	23	0	g	350014744700000020	19-47						Cyclodipeptide Synthetase and its use for Synthesis of Cyclo(Tyr-Xaa) Cyclodipeptides - Patent application	www.faqs.org	0	0		
618	chr3	4383250	4383276	3500393280	23		4383250	4383276	8421504	2	18,5	0,21	g	350039328000000049	16-39						DNA encoding &#x0b32-1,3-glucanases - US Patent 5847258 Description	ww.patentstorm.us	0	0		
618	chr3	4383250	4383276	3500358504	23		4383250	4383276	8421504	2	18,5	0,21	g	350035850400000053	16-39						Inducible herbicide resistance	Ryals	1997	0		
622	chr3	4923142	4923184	3500131966	42		4923142	4923184	8421504	1	42	0	c	350013196600000255,350013196600000256,350013196600000253	0-42,1-42,0-42						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
622	chr3	4923164	4923230	3500321118	40		4923164	4923230	8421504	2	20,20	0,46	c,g	350032111800000015,350032111800000015,350032111800000014,350032111800000014	0-20,0-20,0-20,0-20						G&#xfb01;1integratesprogenitorversusgranulocytictranscriptionalprogramming	tologylibrary.org	0	0		PBX1
622	chr3	4923164	4923230	3500145457	40		4923164	4923230	8421504	2	20,20	0,46	c,g	350014545700000015,350014545700000015,350014545700000014,350014545700000014	0-20,0-20,0-20,0-20		19346496	10.1182/blood-2008-09-179747		Blood	Gfi1 integrates progenitor versus granulocytic transcriptional programming	Shane	2009	0		PBX1
622	chr3	4923315	4923344	3500182611	26		4923315	4923344	8421504	2	6,20	0,9	c	350018261100000013	22-48		18480829	10.1038/gene.2008.33	1466-4879	Genes and Immunity	Prep1&sol;Pbx2 complexes regulate CCL2 expression through the &#x2212;2578 guanine polymorphism	Wright	2008	4		PBX1
622	chr3	4923329	4953666	3500172558	50		4923329	4953666	8421504	2	25,25	0,30312	c	350017255800000021,350017255800000019	0-25,0-25		12609849	10.1182/blood-2002-02-0380	0006-4971	Blood	Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 gene	Okada	2003	10		PBX1
622	chr3	4953623	4953671	3500388138	47		4953623	4953671	8421504	2	24,23	0,25	c,g	350038813800000009,350038813800000009,350038813800000010,350038813800000010	0-24,0-24,0-23,0-23		14701735	10.1128/MCB.24.2.617-628.2004	0270-7306	Molecular and Cellular Biology	Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization	Zeisig	2004	6		PBX1
622	chr3	4953623	4953671	3500337593	47		4953623	4953671	8421504	2	24,23	0,25	c	350033759300000009,350033759300000010	0-24,0-23		14701735	10.1128/MCB.24.2.617-628.2004	0270-7306	Molecular and Cellular Biology	Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization	Zeisig	2004	6		PBX1
622	chr3	4953623	4953671	3500308944	47		4953623	4953671	8421504	2	24,23	0,25	c,g	350030894400000009,350030894400000009,350030894400000010	0-24,0-24,0-23			10.1128/MCB.24.2.617-628.2004		Molecular and Cellular Biology	Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization	Bernd	2004	0		PBX1
77	chr3	4953644	5215764	3500331910	1041		4953644	5215764	8421504	8	44,1,159,136,191,245,74,191	0,1363,8574,13820,21215,27755,258596,261929	p	350033191000015000	0-1041						KEGG T01001: 5087	www.genome.jp	0	0		
622	chr3	4962275	4974864	3500265271	243		4962275	4974864	8421504	3	102,136,5	0,5189,12584	p	350026527100015012,350026527100015005	3-246,3-246						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> <!--Converted with LaTeX2HTML 2002-2	www.eead.csic.es	0	0		
622	chr3	4969229	4969255	3500343043	24		4969229	4969255	8421504	3	4,16,4	0,5,22	g	350034304300000035	15-39						New aspects of N-form dependent growth retardation as found in physiological and microarray studies on seedlings of	w.zbm.uni-kiel.de	0	0		
623	chr3	5003103	5003126	3500174638	23		5003103	5003126	8421504	1	23	0	g	350017463800000124,350017463800000126	25-48,23-44						US Patent # 8,318,908. Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof - Patents.com	patents.com	0	0		
623	chr3	5003103	5003126	3500083027	23		5003103	5003126	8421504	1	23	0	g	350008302700000250,350008302700000252	25-48,27-48						Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group b streptococcus and further uses thereof	D*J*Lai Yin Ai De 	2005	0		
623	chr3	5003103	5003126	3500043721	23		5003103	5003126	8421504	1	23	0	g	350004372100000125,350004372100000127	25-48,27-48						NUCLEIC ACIDS CODING FOR ADHESION FACTOR OF GROUP B STREPTOCOCCUS, ADHESION FACTORS OF GROUP B STREPTOCOCCUS AND FURTHER USES THEREOF - Patent application	www.faqs.org	0	0		
631	chr3	6114332	6114355	3500074983	23		6114332	6114355	8421504	1	23	0	g	350007498300000183	8-33						Alpha-amylase mutants with altered properties - US Patent 7713723 Description	ww.patentstorm.us	0	0		
635	chr3	6605308	6605333	3500448902	24		6605308	6605333	8421504	2	10,14	0,11	g	350044890200000026	4-29						STRUCTURE,FUNCTION,ANDINHIBITIONOFENOYL REDUCTASES	pository.tamu.edu	0	0		
636	chr3	6753059	6775095	3500243302	274		6753059	6775095	8421504	7	48,39,9,48,44,65,21	0,1126,2081,4247,11340,21001,22015	c	350024330200000118,350024330200000114,350024330200000109,350024330200000102,350024330200000099,350024330200000098	0-48,0-48,0-48,0-44,0-44,6-48						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX - Patent application	www.faqs.org	0	0		
637	chr3	6920838	6920864	3500312357	23		6920838	6920864	8421504	3	4,5,14	0,5,12	g	350031235700000085,350031235700000343	1-24,1-24						Artificial Plant Minichromosomes - Patent application	www.faqs.org	0	0		
637	chr3	6920838	6920864	3500073963	23		6920838	6920864	8421504	3	4,5,14	0,5,12	g	350007396300000085	1-24						Artificial Plant Minichromosomes - Patent application	www.faqs.org	0	0		
640	chr3	7212889	7234036	3500062112	43		7212889	7234036	8421504	2	21,22	0,21125	c,g	350006211200000003,350006211200000003,350006211200000002	0-21,0-21,0-22						REPRODUCTION	uction-online.org	0	0		
640	chr3	7219134	7219158	3500230957	23		7219134	7219158	8421504	2	12,11	0,13	c	350023095700000116	2-25						Streptococcus antigens	Hamel	2001	0		
640	chr3	7262282	7264260	3500366238	105		7262282	7264260	8421504	3	30,12,63	0,1900,1915	p	350036623800015011	0-105						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		DDR2
640	chr3	7298643	7298666	3500081373	23		7298643	7298666	8421504	1	23	0	c	350008137300000018	0-23		10906192	10.1128/JVI.74.16.7391-7399.2000	0022-538X	Journal of Virology	Upregulation of Tyrosine Kinase TKT by the Epstein-Barr Virus Transactivator Zta	Lu	2000	5		
641	chr3	7359472	7359497	3500405373	23		7359472	7359497	8421504	2	5,18	0,7	g	350040537300000229	1-24						Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection - US Patent 7410795 Description	ww.patentstorm.us	0	0		
641	chr3	7359472	7359497	3500312260	23		7359472	7359497	8421504	2	5,18	0,7	g	350031226000000222	1-24						CODON-OPTIMIZED POLYNUCLEOTIDE-BASED VACCINES AGAINST HUMAN CYTOMEGALOVIRUS INFECTION - Patent application	www.faqs.org	0	0		
642	chr3	7509040	7509065	3500064474	25		7509040	7509065	8421504	1	25	0	g	350006447400000002	63-88						Combinatorial libraries of monomer domains	Kolkman	2005	0		
642	chr3	7518279	7518306	3500156475	27		7518279	7518306	8421504	1	27	0	g	350015647500000041	0-27						REPRODUCTION	uction-online.org	0	0		
642	chr3	7562682	7562705	3500024797	23		7562682	7562705	8421504	1	23	0	c	350002479700000005	0-46		23665877	10.1534/g3.113.005819		G3: Genes|Genomes|Genetics	Sequence-Based Mapping of the Polyploid Wheat Genome	Cyrille	July	0		UHMK1
648	chr3	8268022	8268046	3500446862	23		8268022	8268046	8421504	2	8,15	0,9	g	350044686200000027	1-24						DNA Methylation Protocols	lib.fk.uwks.ac.id	0	0		
648	chr3	8268022	8268046	3500445731	23		8268022	8268046	8421504	2	8,15	0,9	g	350044573100000005	1-24						&#x4e3b;&#x9898;&#xff1a;Genome-Wide | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
648	chr3	8268022	8268046	3500346805	23		8268022	8268046	8421504	2	8,15	0,9	g	350034680500000008	1-24						Methylated CpG Island Amplification-&#x5b9e;&#x9a8c;-&#x751f;&#x7269;&#x8c37; 	www.bioon.com	0	0		
648	chr3	8268022	8268046	3500229941	23		8268022	8268046	8421504	2	8,15	0,9	g	350022994100000006	1-24						Methylated CpG island amplification (MCA)	Issa	1999	0		
648	chr3	8268022	8268046	3500092521	23		8268022	8268046	8421504	2	8,15	0,9	g	350009252100000003,350009252100000002	1-24,1-24			10.1111/j.1365-2443.2004.00804.x	1365-2443	Genes to Cells	High-throughput screening of genome fragments bound to differentially acetylated histones - Kaneda - 2004 - Genes to Cells - Wiley Online Library	Kaneda	2004	0		
651	chr3	8698267	8706989	3500284887	8722		8698267	8706989	8421504	1	8722	0	p,g	350028488700000003,350028488700015002	2-8724,0-750						VIOLIN: Vaccine Investigation and Online Information Network	www.violinet.org	0	0		
651	chr3	8756738	8756765	3500246407	23		8756738	8756765	8421504	3	13,4,6	0,14,21	g	350024640700000007	0-23					Patent	Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism (Patent US:8076098)	Belgore	2011	0		
651	chr3	8756738	8756765	3500213674	23		8756738	8756765	8421504	3	13,4,6	0,14,21	g	350021367400000007	0-23						Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM	Belgore	2012	0		
651	chr3	8756738	8756765	3500096065	23		8756738	8756765	8421504	3	13,4,6	0,14,21	g	350009606500000007	0-23						Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM - Patent application	www.faqs.org	0	0		
651	chr3	8756738	8756765	3500055531	23		8756738	8756765	8421504	3	13,4,6	0,14,21	g	350005553100000007	0-23						Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism	Belgore	2003	0		
652	chr3	8894130	8894154	3500364288	24		8894130	8894154	8421504	1	24	0	c	350036428800000025	24-48						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
652	chr3	8894445	8900987	3500375699	345		8894445	8900987	8421504	2	258,87	0,6455	c	350037569900000015	0-345						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
653	chr3	8930316	8930341	3500160898	25		8930316	8930341	8421504	1	25	0	g	350016089800000001	100-125						ESTUDIO DE LA V&#xcd;A DE SE&#xd1;ALIZACI&#xd3;N DE NRG1typeIII EN EL DESARROLLO DE LA NEUROPAT&#xcd;A DIAB&#xc9;TICA	ddd.uab.cat	0	0		
653	chr3	8931572	8931595	3500133203	23		8931572	8931595	8421504	1	23	0	c	350013320300000189	0-23						[tel-00521428, v1] &#xc9;tude des voies de conduction cardiaque : identification des g&#xe8;nes sp&#xe9;cifiquement exprim&#xe9;s et impliqu&#xe9;s dans des troubles de conduction	hives-ouvertes.fr	0	0		MPZ
653	chr3	8932104	8932133	3500342180	24		8932104	8932133	8421504	2	18,6	0,23	c	350034218000000077,350034218000000021	14-38,14-38						US Patent # 6,700,040. Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector - Patents.com	www.patents.com	0	0		
653	chr3	8932104	8932133	3500191708	24		8932104	8932133	8421504	2	18,6	0,23	c	350019170800000021,350019170800000078	14-38,14-38						US Patent # 7,498,480. Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector - Patents.com	www.patents.com	0	0		
653	chr3	9011483	9016748	3500360915	111		9011483	9016748	8421504	5	20,20,20,25,26	0,47,117,5213,5239	c,g	350036091500000003,350036091500000005,350036091500000004,350036091500000004,350036091500000006	0-20,0-20,0-20,0-20,6-57						Characterization of Ovine Nectin-4, a Novel Peste des Petits Ruminants Virus Receptor	alcommons.unl.edu	0	0		
653	chr3	9011483	9016748	3500035381	111		9011483	9016748	8421504	5	20,20,20,25,26	0,47,117,5213,5239	c,g	350003538100000003,350003538100000005,350003538100000004,350003538100000004,350003538100000006	0-20,0-20,0-20,0-20,6-57						1 Characterization of ovine Nectin-4, a novel peste des petits ruminants virus (PPRV) receptor	jvi.asm.org	0	0		
653	chr3	9037733	9037799	3500453075	66		9037733	9037799	8421504	1	66	0	p	350045307500015000	0-66			10.1093/emboj/20.17.5022	ERROR! NO ISSN	The EMBO Journal	The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression	Galibert	2001	0		USF1
653	chr3	9037811	9038086	3500075995	25		9037811	9038086	8421504	2	10,15	0,260	c	350007599500000020	0-25		18458078	10.1074/jbc.M802332200	0021-9258	Journal of Biological Chemistry	Tip60 Is Regulated by Circadian Transcription Factor Clock and Is Involved in Cisplatin Resistance	Miyamoto	2008	5		USF1
653	chr3	9038331	9038568	3500102409	90		9038331	9038568	8421504	3	31,5,54	0,175,183	p	350010240900015102	3-93						Methods and compositions for regulating gene expression in plant cells - US Patent 7517689 Description	ww.patentstorm.us	0	0		USF1
653	chr3	9039879	9039914	3500188830	33		9039879	9039914	8421504	2	15,18	0,17	c	350018883000000038	0-33						FRIEDRICH-SCHILLER-UNIVERSITAT JENA BIOLOGISCH-PHARMAZEUTISCHE FAKULTAT Experimentelle Unter	.db-thueringen.de	0	0		
654	chr3	9079997	9080021	3500263420	23		9079997	9080021	8421504	2	19,4	0,20	c	350026342000000032	25-48						Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen - Patent application	www.faqs.org	0	0		
654	chr3	9119455	9120620	3500077888	24		9119455	9120620	8421504	2	8,16	0,1149	c	350007788800000050	0-24						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
654	chr3	9121639	9121666	3500024557	27		9121639	9121666	8421504	1	27	0	c	350002455700000036	0-27						Doctorat ParisTech T H &#xc8; S E	hives-ouvertes.fr	0	0		
654	chr3	9123060	9123095	3500286941	35		9123060	9123095	8421504	1	35	0	c	350028694100000001	9-44		20966044	10.1124/dmd.110.034504	1521-009X (Online)	Drug Metabolism and Disposition	Cigarette Smoke Extract Induces CYP2B6 through Constitutive Androstane Receptor in Hepatocytes	Washio	2011	0		
654	chr3	9123068	9123093	3500224012	25		9123068	9123093	8421504	1	25	0	c	350022401200000006	17-42						Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity	Collins	2004	0		
654	chr3	9129987	9130032	3500012817	45		9129987	9130032	8421504	1	45	0	p	350001281700015017,350001281700015018	0-45,0-45						IDENTIFICATIOND&#x2019;EPITOPESTCD4+ D&#x2019;ANTIGENESTUMORAUX	hives-ouvertes.fr	0	0		
654	chr3	9130499	9130550	3500450373	51		9130499	9130550	8421504	1	51	0	p	350045037300015000	0-51						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
654	chr3	9133808	9134478	3500370083	87		9133808	9134478	8421504	3	48,21,18	0,213,652	p	350037008300015047	0-87						METHODS AND COMPOSITIONS TARGETING VIRAL AND CELLULAR ITAM MOTIFS, AND USE OF SAME IN IDENTIFYING COMPOUNDS WITH THERAPEUTIC ACTIVITY - Patent application	www.faqs.org	0	0		
654	chr3	9134655	9134742	3500301416	87		9134655	9134742	8421504	1	87	0	p	350030141600015008	0-87						IgE, Mast Cells and the Allergic Response	www.scribd.com	0	0		FCER1G
654	chr3	9134664	9134727	3500197347	63		9134664	9134727	8421504	1	63	0	p	350019734700015007	0-63						Means for the identification compounds capable of inhibiting karap-transduced signals	Vivier	2003	0		FCER1G
654	chr3	9134710	9134745	3500461323	35		9134710	9134745	8421504	1	35	0	c	350046132300000000	0-35		14722612	10.1172/JCI19639	0021-9738	The Journal of Clinical Investigation	Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses	Yamaguchi	2004	13		FCER1G
654	chr3	9151049	9151072	3500092988	23		9151049	9151072	8421504	1	23	0	c	350009298800000053,350009298800000003	4-27,4-27						Insulin-producing Bone Marrow Derived Cells And Methods Of Generating And Using Same 	.freshpatents.com	0	0		
654	chr3	9152542	9152565	3500331821	23		9152542	9152565	8421504	1	23	0	c	350033182100000009	0-23						Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma	.aacrjournals.org	0	0		
654	chr3	9152763	9152835	3500182158	43		9152763	9152835	8421504	2	20,23	0,49	c,g	350018215800000008,350018215800000008,350018215800000009,350018215800000009	0-20,0-20,0-23,0-23						METHODS AND USES OF HYPOXIC COMPARTMENT CELLS - Patent application	www.faqs.org	0	0		
654	chr3	9153822	9154715	3500083194	40		9153822	9154715	8421504	3	20,19,1	0,121,892	c,g	350008319400000009,350008319400000009,350008319400000010	0-20,0-20,0-20						Role of infrapatellar fat pad in knee osteoarthritis	www.tipharma.com	0	0		
654	chr3	9154896	9154919	3500022584	23		9154896	9154919	8421504	1	23	0	g	350002258400000008	0-23						DISCRIMINATION OF MENISCAL CELL PHENOTYPES USING GENE EXPRESSION PROFILES	ww.ecmjournal.org	0	0		
655	chr3	9180807	9181073	3500448596	43		9180807	9181073	8421504	3	13,7,23	0,194,243	c	350044859600000022,350044859600000021	0-20,0-23						METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES	Brys	2011	0		USP21
655	chr3	9180807	9181073	3500400072	43		9180807	9181073	8421504	3	13,7,23	0,194,243	c	350040007200000022,350040007200000021	0-20,0-23						Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases	Brys	2006	0		USP21
655	chr3	9180807	9181073	3500399289	43		9180807	9181073	8421504	3	13,7,23	0,194,243	c	350039928900000022,350039928900000021	0-20,0-23						Methods For Identification, and Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases	Brys	2009	0		USP21
655	chr3	9180807	9181073	3500235187	43		9180807	9181073	8421504	3	13,7,23	0,194,243	c	350023518700000022,350023518700000021	0-20,0-23					Patent	Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases (Patent US:7306923)	Brys	2007	0		USP21
655	chr3	9180807	9181073	3500149044	43		9180807	9181073	8421504	3	13,7,23	0,194,243	c	350014904400000022,350014904400000021	0-20,0-23					Patent	Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases (Patent US:7919259)	Brys	2011	0		USP21
655	chr3	9254836	9254860	3500030891	23		9254836	9254860	8421504	2	18,5	0,19	g	350003089100000036,350003089100000213	0-23,0-23						HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR AND HUMAN CELL MEDICINE COMPRISING SAME - Patent application	www.faqs.org	0	0		
656	chr3	9329162	9329219	3500388628	57		9329162	9329219	8421504	1	57	0	p	350038862800015018	0-57						123 human secreted proteins	Brewer	1999	0		ITLN2
656	chr3	9329162	9329219	3500163563	57		9329162	9329219	8421504	1	57	0	p	350016356300015018	0-57						123 human secreted proteins	Brewer	2000	0		ITLN2
656	chr3	9330155	9330181	3500155689	26		9330155	9330181	8421504	1	26	0	c	350015568900000027	21-47						Antibodies Against Inducible Th2 Cell Factors 	.freshpatents.com	0	0		
657	chr3	9486942	9486965	3500098477	23		9486942	9486965	8421504	1	23	0	c	350009847700000016	18-41						COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS - Patent application	www.faqs.org	0	0		
658	chr3	9680109	9680133	3500125168	24		9680109	9680133	8421504	1	24	0	c	350012516800000001	0-24		21371505	10.1016/j.jviromet.2011.02.024		Journal of Virological Methods	Monkey CV1 cell line expressing the sheep&#x2013;goat SLAM protein: A highly sensitive cell line for the isolation of peste des petits ruminants virus from pathological specimens	Caroline	2011	0		
658	chr3	9698029	9698061	3500349986	32		9698029	9698061	8421504	1	32	0	c	350034998600000120,350034998600000181	8-40,0-31						Mammalian cell surface antigens	Aversa	1995	0		
660	chr3	9890629	9890655	3500434038	25		9890629	9890655	8421504	2	18,7	0,19	c	350043403800000007	14-43						Biofilm formation by Staphylococcus haemolyticus. - ResearchGate	.researchgate.net	0	0		
661	chr3	10007666	10007711	3500431779	45		10007666	10007711	8421504	1	45	0	p	350043177900015001	0-45		23722234	10.1074/mcp.O112.021022		Molecular & Cellular Proteomics : MCP	The Human PDZome: A Gateway to PSD95-Disc Large-Zonula Occludens (PDZ)-mediated Functions	Edwige	2013	0		VANGL2
661	chr3	10007666	10007711	3500232293	45		10007666	10007711	8421504	1	45	0	p	350023229300015001	0-45		23722234	10.1074/mcp.O112.021022	1535-9476	Molecular & Cellular Proteomics	The Human PDZome: A Gateway to PSD95-Disc Large-Zonula Occludens (PDZ)-mediated Functions	Belotti	2013	7		VANGL2
661	chr3	10078529	10078552	3500274287	23		10078529	10078552	8421504	1	23	0	g	350027428700000030	1-24						Supporting Information - ID6 piPSC cells were seeded onto 12-well plates ( 10	www.pnas.org	0	0		
661	chr3	10084095	10084846	3500252627	96		10084095	10084846	8421504	2	63,33	0,718	p	350025262700015001	90-186						aph-2encodes a novel extracellular protein required for GLP-1-mediated signaling	ev.biologists.org	0	0		NCSTN
82	chr3	10092108	10135490	3500004570	3663		10092108	10135490	8421504	33	40,114,74,81,77,110,110,100,136,83,151,67,76,83,140,86,139,163,147,190,96,89,124,90,110,78,69,137,187,111,162,195,48	0,5221,5520,8799,10353,11164,15483,17163,18109,19538,24917,26007,27019,28998,30152,31004,31204,34329,34593,35479,35791,37039,37517,38525,38781,39700,39944,40529,40897,41173,41821,42883,43334	p	350000457000015042,350000457000015043,350000457000015044,350000457000015045,350000457000015046,350000457000015047,350000457000015048,350000457000015049,350000457000015050,350000457000015051,350000457000015052,350000457000015053,350000457000015054,350000457000015055,350000457000015056,350000457000015057,350000457000015058,350000457000015059,350000457000015060,350000457000015061,350000457000015062,350000457000015063,350000457000015064,350000457000015065,350000457000015066	0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-90						Tesi doctoral presentada per En/Na Soraya RUIZ PAZ amb el tAtol "TrA!fico intracelular y activac	www.tdx.cat	0	0		COPA,NCSTN
82	chr3	10092108	10097364	3500384310	75		10092108	10097364	8421504	2	40,35	0,5221	p	350038431000015143	0-75						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		COPA,NCSTN
662	chr3	10117014	10117042	3500165096	23		10117014	10117042	8421504	2	13,10	0,18	g	350016509600000016	2-39						BMC Cancer BioMed Central	biomedcentral.com	0	0		
662	chr3	10203631	10203654	3500465169	23		10203631	10203654	8421504	1	23	0	c	350046516900000154	4-32						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
662	chr3	10204123	10205843	3500174228	46		10204123	10205843	8421504	2	24,22	0,1698	c	350017422800000004,350017422800000006	18-42,0-22		19103758	10.1128/MCB.01660-08	0270-7306	Molecular and Cellular Biology	PTEN Loss Promotes Mitochondrially Dependent Type II Fas-Induced Apoptosis via PEA-15	Peacock	2009	6		
662	chr3	10204447	10205980	3500341372	180		10204447	10205980	8421504	5	20,25,45,45,45	0,1364,1392,1440,1488	p	350034137200015047,350034137200015043,350034137200015041,350034137200015046	0-45,0-45,0-45,0-45						Methods and reagents for modulating apoptosis	Shore	1999	0		PEA15
663	chr3	10236031	10236054	3500445913	23		10236031	10236054	8421504	1	23	0	g	350044591300000004	2-25		19321007	10.1186/1471-2164-10-131	1471-2164	BMC Genomics	Snapshot of iron response in Shewanella oneidensis by gene network reconstruction	Yang	2009	4		
663	chr3	10238275	10239931	3500170738	51		10238275	10239931	8421504	2	32,19	0,1637	p	350017073800015009	0-51						Evidence for an apical Na&#x2013;Cl cotransporter involved in ion uptake in a teleost fish	www.bio.umass.edu	0	0		
663	chr3	10238278	10239931	3500123139	48		10238278	10239931	8421504	2	29,19	0,1634	p	350012313900015003	0-48			10.1242/jeb.00773	0022-0949	Journal of Experimental Biology	A facilitative urea transporter is localized in the renal collecting tubule of the dogfish Triakis scyllia	Hyodo	2004	3		ATP12A
663	chr3	10238278	10239931	3500122366	48		10238278	10239931	8421504	2	29,19	0,1634	p	350012236600015003	0-48			10.1242/jeb.00773	0022-0949	Journal of Experimental Biology	A facilitative urea transporter is localized in the renal collecting tubule of the dogfish Triakis scyllia	Hyodo	2004	3		ATP12A
663	chr3	10270175	10270201	3500093706	24		10270175	10270201	8421504	2	16,8	0,18	g	350009370600000120	0-25						An in vivo Approach to Elucidating the Function of Mitochondrial Porin by the Characterisation of Neurospora crassa Strains Deficient in Porin	.lib.umanitoba.ca	0	0		
663	chr3	10276030	10276056	3500386767	23		10276030	10276056	8421504	2	10,13	0,13	c	350038676700000110,350038676700000109	0-23,0-23						Polypeptides toxic to nematodes, and methods of use	Salamone	2005	0		
663	chr3	10276030	10276056	3500295899	23		10276030	10276056	8421504	2	10,13	0,13	c	350029589900000109,350029589900000108	0-23,0-23						Polypeptides toxic to nematodes and methods of use	Salamone	2003	0		ATP1A4
663	chr3	10276949	10280199	3500233231	96		10276949	10280199	8421504	2	36,60	0,3190	p	350023323100015026	0-96						Structure of a Plasmodium yoelii gene-encoded protein homologous to the Ca	cs.biologists.org	0	0		ATP1A3
663	chr3	10286384	10286708	3500050799	75		10286384	10286708	8421504	2	12,63	0,261	p	350005079900015004	0-75		10753953	10.1074/jbc.275.15.11383	0021-9258	Journal of Biological Chemistry	Sodium Channel &#x03b2; Subunits Mediate Homophilic Cell Adhesion and Recruit Ankyrin to Points of Cell-Cell Contact	Malhotra	2000	5		ATP1A3
663	chr3	10286394	10286668	3500302945	25		10286394	10286668	8421504	2	2,23	0,251	c	350030294500000001	0-25						Eur. J. Biochem. 267, 2071&#x2013;2078 (2000) FEBS 2000	www.utoledo.edu	0	0		
663	chr3	10286394	10286668	3500182578	25		10286394	10286668	8421504	2	2,23	0,251	c	350018257800000001	0-25			10.1046/j.1432-1327.2000.01211.x	1432-1033	European Journal of Biochemistry	Effect of streptozotocin-induced diabetes on rat liver Na+/K+-ATPase - Sennoune - 2001 - European Journal of Biochemistry - Wiley Online Library	Sennoune	2000	0		ATP1A1
663	chr3	10289401	10289461	3500321751	60		10289401	10289461	8421504	1	60	0	p	350032175100015000	0-60		12805306		0270-6474	The Journal of Neuroscience	Degeneration of the Amygdala/Piriform Cortex and Enhanced Fear/Anxiety Behaviors in Sodium Pump &#x03b1;2 Subunit (Atp1a2)-Deficient Mice	Ikeda	2003	7		ATP1A2
663	chr3	10293126	10293154	3500363336	28		10293126	10293154	8421504	1	28	0	g	350036333600000015	23-51						UNIVERSIDADE FEDERAL DA PARA&#xcd;BA UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO UNIVERSIDADE FEDERAL DO CEAR&#xc1; PROGRAMA DE DOUTORADO INTEGRADO EM ZOOTECNIA	www.cca.ufpb.br	0	0		
663	chr3	10293126	10293154	3500259506	28		10293126	10293154	8421504	1	28	0	g	350025950600000000	22-50						PARTE I &#x2013; REVIS&#xc3;O BIBLIOGR&#xc1;FICA 1 &#x2013; INTRODU&#xc7;&#xc3;O	ecadigital.ipb.pt	0	0		
663	chr3	10293126	10293154	3500231057	28		10293126	10293154	8421504	1	28	0	g	350023105700000015	23-51						S Chapter1 General introduction	upetd.up.ac.za	0	0		
663	chr3	10293126	10293154	3500222801	28		10293126	10293154	8421504	1	28	0	g	350022280100000002	23-51						Preliminary comparative RH mapping between river buffalo chromosome 6 (BBU6) and bovine chromosome 3 (BTA3) - ResearchGate	.researchgate.net	0	0		
663	chr3	10293126	10293154	3500070560	28		10293126	10293154	8421504	1	28	0	g	350007056000000002	23-51						Preliminary radiation hybrid map for river buffalo chromosome 6 and comparison to bovine chromosome 3	ticabovina.com.br	0	0		
663	chr3	10329587	10333683	3500057829	1179		10329587	10333683	8421504	3	84,245,850	0,120,3246	p	350005782900015003	0-1179						KEGG T01001: 3760	www.genome.jp	0	0		
663	chr3	10329938	10332867	3500432158	48		10329938	10332867	8421504	2	14,34	0,2895	p	350043215800015019	0-48						Diagnostic And Therapeutic Use Of Kcnj6 For Alzheimer's Disease 	.freshpatents.com	0	0		KCNJ5
663	chr3	10332961	10332997	3500435622	36		10332961	10332997	8421504	1	36	0	c	350043562200000019	5-41						DNA encoding ATP-sensitive potassium channel genes	Adelman	1995	0		
664	chr3	10375026	10375071	3500202391	45		10375026	10375071	8421504	1	45	0	p	350020239100015012	0-45						Human potassium channel genes	Miller	2002	0		PIGM
664	chr3	10375155	10375200	3500003266	45		10375155	10375200	8421504	1	45	0	p	350000326600015003	0-45						Loss of Function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits - Patent application	www.faqs.org	0	0		KCNJ15
664	chr3	10387555	10387587	3500401025	32		10387555	10387587	8421504	1	32	0	c	350040102500000004	32-64						Identification of Short Interspersed Elements (SINEs) in Iranian River Buffalo	www.eaap.org	0	0		
665	chr3	10493191	10493231	3500316325	40		10493191	10493231	8421504	1	40	0	c	350031632500000025	0-40						Novel Gene Disruptions, Composition and Methods Relating Thereto - Patent application	www.faqs.org	0	0		
665	chr3	10493191	10493231	3500117412	40		10493191	10493231	8421504	1	40	0	c	350011741200000025	0-40						Novel Gene Disruptions, Composition And Methods Relating Thereto 	.freshpatents.com	0	0		
665	chr3	10545103	10545127	3500124400	23		10545103	10545127	8421504	2	19,4	0,20	g	350012440000000035	12-37						Tese Eder Jorge de Oliveira	www.teses.usp.br	0	0		
665	chr3	10576509	10576537	3500115779	26		10576509	10576537	8421504	3	4,5,17	0,5,11	g	350011577900000005	1-27						Full-length human cdnas encoding potentially secreted proteins	Bejanin	2001	0		
666	chr3	10623133	10623158	3500403557	23		10623133	10623158	8421504	2	17,6	0,19	g	350040355700000021	18-41						CANINE TRANSIENT RECEPTOR POTENTIAL V2 (CTRPV2) AND METHODS OF SCREENING FOR TRPV2 CHANNEL MODULATORS - Patent application	www.faqs.org	0	0		
666	chr3	10654862	10655894	3500353739	73		10654862	10655894	8421504	2	45,28	0,1004	p,c	350035373900015003,350035373900000000	0-45,9-37						VHZ FOR DIAGNOSIS AND TREATMENT OF CANCER	Zeng	2008	0		DUSP23
666	chr3	10654946	10654971	3500002708	25		10654946	10654971	8421504	1	25	0	c,g	350000270800000024,350000270800000024	0-25,0-25						Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23	Feder	2007	0		
666	chr3	10655792	10655821	3500284856	29		10655792	10655821	8421504	1	29	0	c	350028485600000006	14-43						Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof - Patent # 7153678 - PatentGenius	.patentgenius.com	0	0		
666	chr3	10725709	10725773	3500095378	52		10725709	10725773	8421504	2	27,25	0,39	c	350009537800000021,350009537800000023,350009537800000022,350009537800000024	9-36,8-35,0-25,5-24						Mutant protein and methods and materials for making and using it	Potempa	1999	0		
666	chr3	10726037	10726061	3500458079	24		10726037	10726061	8421504	1	24	0	c	350045807900000022	1-25						Dihydrocapsaicin Attenuates Plaque Formation through a PPAR&#x03b3;/LXR&#x03b1; Pathway in apoE(-/-) Mice Fed a High-Fat/High-Cholesterol Diet. - ResearchGate	.researchgate.net	0	0		
666	chr3	10727506	10728726	3500006671	40		10727506	10728726	8421504	2	20,20	0,1200	c	350000667100000022,350000667100000026	0-20,0-20						Identification of genetic variants in differentially expressed sequences in cattle of different metabolic type &#x2013; potential genetic markers of nutrient utilization	bn-dummerstorf.de	0	0		
667	chr3	10869123	10869848	3500373769	615		10869123	10869848	8421504	2	608,7	0,718	p	350037376900015010	0-615						Treatment and diagnostic methods for fibrosis related disorders	Surowy	2009	0		
667	chr3	10869123	10869848	3500069856	615		10869123	10869848	8421504	2	608,7	0,718	p	350006985600015005,350006985600015045,350006985600015044,350006985600015042,350006985600015041,350006985600015040,350006985600015039,350006985600015037,350006985600015036,350006985600015035	0-615,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Treatment and diagnostic methods for fibrosis related disorders - Patent application	www.faqs.org	0	0		
667	chr3	10869611	10869637	3500375473	24		10869611	10869637	8421504	2	13,11	0,15	c	350037547300000132	0-24						Molecular Identification of Fungi	dlx.bookos.org	0	0		
667	chr3	10869611	10869637	3500354454	24		10869611	10869637	8421504	2	13,11	0,15	c	350035445400000132	0-24						Molecular Identification of Fungi	ggene.cn/uploads/	0	0		
667	chr3	10869611	10869637	3500043729	24		10869611	10869637	8421504	2	13,11	0,15	c	350004372900000132	0-24						Molecular Identi&#xfb01;cation of Fungi	dlx.bookos.org	0	0		
670	chr3	11166576	11166600	3500386819	24		11166576	11166600	8421504	1	24	0	c	350038681900000165,350038681900000171	6-26,12-32						Multi-functional chimeric hematopoietic receptor agonists	Feng	1998	0		
671	chr3	11272360	11272388	3500378074	28		11272360	11272388	8421504	1	28	0	c	350037807400000005	11-39						Modulators of cell adhesion molecules and use thereof	Ballivet	2008	0		CADM3
671	chr3	11276708	11302848	3500066613	138		11276708	11302848	8421504	3	48,25,65	0,5236,26075	c	350006661300000082,350006661300000092,350006661300000064,350006661300000062,350006661300000091	0-48,0-47,27-48,0-22,5-48						Antagonists and agonists of ldcam and methods of use	Galibert	2005	0		
671	chr3	11401632	11401656	3500037261	23		11401632	11401656	8421504	2	8,15	0,9	g	350003726100000146	1-24						ANTIBODIES TO IL-6 AND USE THEREOF - Patent application	www.faqs.org	0	0		
672	chr3	11460371	11461497	3500362403	40		11460371	11461497	8421504	2	20,20	0,1106	g	350036240300000056,350036240300000057	0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
675	chr3	11804609	11804635	3500413740	24		11804609	11804635	8421504	2	15,9	0,17	c	350041374000000042	8-40						DNA sequence encoding N-acetyl-galactosamine-transferase	www.devileye.net	0	0		
676	chr3	11992962	11992988	3500177324	23		11992962	11992988	8421504	3	14,4,5	0,15,21	g	350017732400000089	15-38						Methods Of Use For Hsv-1 And Hsv-2 Vaccines 	.freshpatents.com	0	0		
84	chr3	12431309	12460902	3500003568	81		12431309	12460902	8421504	3	27,27,27	0,252,29566	c,g	350000356800000018,350000356800000017,350000356800000008,350000356800000008	0-27,0-27,0-27,0-27		16585584		0022-1767	The Journal of Immunology	The Bovine CD1 Family Contains Group 1 CD1 Proteins, but No Functional CD1d	Rhijn	2006	6		
681	chr3	12614998	12615025	3500003568	27		12614998	12615025	8421504	1	27	0	g	350000356800000003	0-27		16585584		0022-1767	The Journal of Immunology	The Bovine CD1 Family Contains Group 1 CD1 Proteins, but No Functional CD1d	Rhijn	2006	6		
686	chr3	13276679	13276703	3500240561	23		13276679	13276703	8421504	2	12,11	0,13	g	350024056100000021	10-33						MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR - Patent application	www.faqs.org	0	0		
687	chr3	13378354	13378381	3500201864	23		13378354	13378381	8421504	2	16,7	0,20	g	350020186400000651	5-31						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
691	chr3	13940749	13940778	3500186736	26		13940749	13940778	8421504	3	5,6,15	0,7,14	g	350018673600000124	7-36						Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist - Patent application	www.faqs.org	0	0		
692	chr3	14071554	14071579	3500108636	23		14071554	14071579	8421504	2	15,8	0,17	g	350010863600000211	5-28						CLOSTRIDIUM BOTULINUM C3 EXOTRANSFERASE COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING - Patent application	www.faqs.org	0	0		
694	chr3	14344125	14344151	3500306361	24		14344125	14344151	8421504	2	16,8	0,18	g	350030636100000198	9-38						PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use - Patent application	www.faqs.org	0	0		
695	chr3	14525878	14525904	3500085562	23		14525878	14525904	8421504	2	14,9	0,17	g	350008556200000467	19-42						Methods and compositions for assaying analytes	Yuan	1999	0		
696	chr3	14626982	14627009	3500008756	23		14626982	14627009	8421504	3	5,13,5	0,7,22	g	350000875600000427	5-28						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
698	chr3	14920106	14920247	3500186119	141		14920106	14920247	8421504	1	141	0	p	350018611900015106	0-141						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		ETV3
698	chr3	14941601	14941629	3500115879	24		14941601	14941629	8421504	2	6,18	0,10	g	350011587900000067	0-24						Recombinant fowlpox virus s-fpv-043 and uses thereof	Cochran	1994	0		
699	chr3	14954033	14954174	3500095373	141		14954033	14954174	8421504	1	141	0	p	350009537300015106	0-141						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		ETV3
699	chr3	14993588	14993615	3500186995	23		14993588	14993615	8421504	2	15,8	0,19	g	350018699500000003	14-37						INTEGRATED MICROFLUIDIC AND SOLID STATE PYROSEQUENCING SYSTEMS	Goel	2011	0		
699	chr3	15010784	15010810	3500403762	23		15010784	15010810	8421504	3	14,5,4	0,16,22	g	350040376200000007	7-30						Efficient expression screening of human membrane proteins in transiently transfected Human Embryonic Kidney 293S cells	mpec.ucsf.edu	0	0		
700	chr3	15124340	15124366	3500307135	23		15124340	15124366	8421504	2	16,7	0,19	c	350030713500000377	2-25						NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - Patent application	www.faqs.org	0	0		
700	chr3	15186647	15186674	3500430470	23		15186647	15186674	8421504	2	8,15	0,12	c	350043047000000015	0-23						Production Process for Fine Chemicals Using Microorganisms with Reduced Isocitrate Dehydrogenase Activity - Patent application	www.faqs.org	0	0		
700	chr3	15192813	15193167	3500432124	90		15192813	15193167	8421504	2	45,45	0,309	p	350043212400015076,350043212400015079	0-45,0-45						US Patent # 6,340,674. Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides - Patents.com	www.patents.com	0	0		INSRR
700	chr3	15193116	15193179	3500071841	63		15193116	15193179	8421504	1	63	0	p	350007184100015009,350007184100015006	0-63,9-54						UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CI&#xca;NCIAS B&#xc1;SICAS DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS BIOL&#xd3;GICAS: FISIOLOGIA	www.lume.ufrgs.br	0	0		INSRR
700	chr3	15193489	15193552	3500004352	63		15193489	15193552	8421504	1	63	0	p	350000435200015006	0-63						Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity. - ResearchGate	.researchgate.net	0	0		IGF1R
701	chr3	15210876	15210901	3500419950	25		15210876	15210901	8421504	1	25	0	g	350041995000000002,350041995000000003	9-34,0-25						Issue Date 2009-07	lib.hokudai.ac.jp	0	0		
701	chr3	15227310	15227338	3500186750	24		15227310	15227338	8421504	2	7,17	0,11	g	350018675000000073	7-31						Brian Golding and Dick Morton	www.cs.ukzn.ac.za	0	0		
701	chr3	15311433	15316399	3500125691	42		15311433	15316399	8421504	2	21,21	0,4945	c	350012569100000006,350012569100000007	0-21,0-21		15448016	10.1158/1078-0432.CCR-04-0655	1078-0432	Clinical Cancer Research	Identification of the Fenretinide Metabolite 4-Oxo-Fenretinide Present in Human Plasma and Formed in Human Ovarian Carcinoma Cells through Induction of Cytochrome P450 26A1	Villani	2004	8		CRABP2
701	chr3	15315877	15316365	3500291273	26		15315877	15316365	8421504	2	12,14	0,474	c	350029127300000001	0-26						STUDY Improvement of Naturally Aged Skin With Vitamin A (Retinol)	lifecellcream.com	0	0		
702	chr3	15379432	15381240	3500301077	23		15379432	15381240	8421504	2	8,15	0,1793	c	350030107700000014	18-41						Trabajo Fin de M&#xe1;ster	zaguan.unizar.es	0	0		
702	chr3	15381636	15381659	3500405050	23		15381636	15381659	8421504	1	23	0	c	350040505000000002	0-23		22190725	10.1128/JVI.05663-11	0022-538X	Journal of Virology	Borna Disease Virus Infects Human Neural Progenitor Cells and Impairs Neurogenesis	Brnic	2012	5		
702	chr3	15381961	15381984	3500122088	23		15381961	15381984	8421504	1	23	0	c	350012208800000025	0-23		15084470	10.1242/dev.01065	0950-1991	Development	Development of primitive and definitive hematopoiesis from nonhuman primate embryonic stem cells in vitro	Umeda	2004	7		NES
702	chr3	15381962	15381986	3500442774	24		15381962	15381986	8421504	1	24	0	c	350044277400000018	22-46						Reprogramming of somatic cells: a tool for modelling neurodegenerative diseases	works.unsw.edu.au	0	0		
702	chr3	15381962	15381986	3500313105	24		15381962	15381986	8421504	1	24	0	c	350031310500000005	0-24		20808872	10.1371/journal.pone.0012297		PLoS ONE	A Combined Epigenetic and Non-Genetic Approach for Reprogramming Human Somatic Cells	Jinnuo	2010	0		NES
702	chr3	15381962	15381986	3500276552	24		15381962	15381986	8421504	1	24	0	c	350027655200000029,350027655200000065	0-24,0-24						Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof - Patent application	www.faqs.org	0	0		NES
702	chr3	15381962	15381986	3500185091	24		15381962	15381986	8421504	1	24	0	c	350018509100000002	23-47						Growth and Differentiation of Embryoid Bodies Derived from Human Embryonic Stem Cells: Effect of Glucose and Basic Fibroblast Growth Factor	ww.biolreprod.org	0	0		
702	chr3	15381962	15381986	3500003835	24		15381962	15381986	8421504	1	24	0	c	350000383500000003	0-24		19281762	10.1016/j.diff.2008.09.005		Differentiation; research in biological diversity	Differentiation and Regenerative Capacities of Human Odontoma-Derived Mesenchymal Cells	Jin-Seon	2009	0		NES
702	chr3	15394693	15394719	3500003052	23		15394693	15394719	8421504	3	5,11,7	0,6,19	c	350000305200000000	21-44			10.1128/JVI.79.4.2614-2619.2005		Journal of Virology	Inhibition of Virus DNA Replication by Artificial Zinc Finger Proteins	Takashi	2005	0		
702	chr3	15425803	15426784	3500434555	279		15425803	15426784	8421504	3	141,89,49	0,706,932	p	350043455500015003,350043455500015002	0-141,0-138						31 human secreted proteins	Ni	2001	0		HAPLN2
702	chr3	15426431	15426458	3500400238	24		15426431	15426458	8421504	2	9,15	0,12	c	350040023800000044	9-33						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
703	chr3	15509021	15509045	3500063853	23		15509021	15509045	8421504	2	17,6	0,18	c	350006385300000008	5-28						Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth	Furukawa	2004	0		
704	chr3	15608145	15609891	3500311219	118		15608145	15609891	8421504	4	39,34,23,22	0,88,1587,1724	c	350031121900000527,350031121900000529,350031121900000545	9-48,1-35,0-45						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
704	chr3	15610856	15610884	3500184569	23		15610856	15610884	8421504	2	8,15	0,13	c	350018456900000001	7-30						Induction of porcine host defense Peptide gene expression by short-chain Fatty acids and their analogs. - ResearchGate	.researchgate.net	0	0		
704	chr3	15622825	15626820	3500360395	180		15622825	15626820	8421504	4	90,18,58,14	0,692,2754,3981	p	350036039500015003,350036039500015011	0-108,0-72						Tel1ATM and Rad3ATR kinases promote Ccq1-Est1 interaction to maintain telomeres in fission yeast	www.uic.edu	0	0		SMG5
704	chr3	15638548	15652765	3500339288	61		15638548	15652765	8421504	3	20,20,21	0,12302,14196	c	350033928800000331,350033928800000106,350033928800000205	0-20,20-40,0-21						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		
704	chr3	15652432	15652459	3500150683	27		15652432	15652459	8421504	1	27	0	c	350015068300000009	0-27						Intracellular Vitamin D Binding Proteins: Novel Facilitators of Vitamin D-Directed Transactivation	.endojournals.org	0	0		BGLAP
704	chr3	15652474	15653278	3500257699	40		15652474	15653278	8421504	3	20,18,2	0,531,802	c,g	350025769900000028,350025769900000028,350025769900000027	0-20,0-20,0-20						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
704	chr3	15652484	15653352	3500373489	41		15652484	15653352	8421504	2	20,21	0,847	c	350037348900000005,350037348900000004	0-20,0-21			10.1186/ar1991		Arthritis Research & Therapy	Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary	Ilse-GerlinSunk	2006	0		
704	chr3	15652484	15653352	3500001250	41		15652484	15653352	8421504	2	20,21	0,847	c,g	350000125000000005,350000125000000004,350000125000000004	0-20,0-21,0-21		16831232	10.1186/ar1991	1478-6354	Arthritis Research & Therapy	Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary	Sunk	2006	4		
704	chr3	15652504	15653347	3500129294	41		15652504	15653347	8421504	2	20,21	0,822	c,g	350012929400000005,350012929400000005,350012929400000004	0-20,0-20,0-21						Synthetic bone substitute engineered with amniotic epithelial cells enhances bone regeneration after maxillary sinus augmentation. - ResearchGate	.researchgate.net	0	0		
704	chr3	15662377	15662403	3500429256	24		15662377	15662403	8421504	2	19,5	0,21	g	350042925600000020	13-39						Maltose-1-phosphate-producing Enzyme 	.freshpatents.com	0	0		
705	chr3	15745629	15746426	3500376584	221		15745629	15746426	8421504	4	113,36,63,9	0,502,547,788	p,c	350037658400000003,350037658400015025,350037658400015022	7-57,0-66,0-141						&#x201c;EFECTOS BIOL&#xd3;GICOS Y CARACTERIZACI&#xd3;N DE DIANAS DE LA PROSTAGLANDINA A : INTERACCIONES CON PROTE&#xcd;NAS DE FILAMENTOS INTERMEDIOS&#x201d;.	digital.csic.es	0	0		
705	chr3	15746242	15748997	3500459152	38		15746242	15748997	8421504	3	9,10,19	0,115,2736	c	350045915200000003,350045915200000002	0-19,0-19						Hb-egf-bound protein complex	Minamino	2010	0		LMNA
705	chr3	15746242	15748997	3500448477	38		15746242	15748997	8421504	3	9,10,19	0,115,2736	c,g	350044847700000003,350044847700000002,350044847700000002	0-19,0-19,0-19						Hb-egf-bound protein complex	Minamino	2010	0		
705	chr3	15747212	15747235	3500380714	23		15747212	15747235	8421504	1	23	0	g	350038071400000000	0-23						Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety	Manoharan	2006	0		LMNA
705	chr3	15747212	15747235	3500246121	23		15747212	15747235	8421504	1	23	0	c	350024612100000040,350024612100000000	0-23,0-23						SINGLE-STRANDED AND DOUBLE-STRANDED OLIGONUCLEOTIDES COMPRISING A 2-ARYLPROPYL MOIETY - Patent application	www.faqs.org	0	0		KRT71
705	chr3	15747212	15747235	3500132886	23		15747212	15747235	8421504	1	23	0	c	350013288600000135,350013288600000001	0-23,0-23						MODIFIED iRNA AGENTS - Patent application	www.faqs.org	0	0		LMNB2
705	chr3	15747238	15749062	3500260900	45		15747238	15749062	8421504	2	23,22	0,1802	c,g	350026090000000003,350026090000000003,350026090000000002,350026090000000002	0-23,0-23,0-22,0-22			10.1371/journal.ppat.0020105		PLoS Pathogens	Changes in the Expression of Human Cell Division Autoantigen-1 Influence Toxoplasma gondii Growth and Development	Jay	2006	0		LMNA
705	chr3	15747238	15749062	3500237985	45		15747238	15749062	8421504	2	23,22	0,1802	c	350023798500000003,350023798500000002	0-23,0-22			10.1371/journal.ppat.0020105	1553-7374	PLOS Pathogens	PLOS Pathogens: Changes in the Expression of Human Cell Division Autoantigen-1 Influence Toxoplasma gondii Growth and Development	Radke	2006	0		LMNA
705	chr3	15748630	15748997	3500181164	41		15748630	15748997	8421504	2	21,20	0,347	c	350018116400000000,350018116400000001	0-21,0-20		19084037	10.1016/j.jconrel.2008.10.020		Journal of controlled release : official journal of the Controlled Release Society	Polymersome delivery of siRNA and antisense oligonucleotides	Younghoon	2009	0		LMNA
705	chr3	15748975	15748999	3500322844	24		15748975	15748999	8421504	1	24	0	c	350032284400000022,350032284400000023	0-22,0-23						Molecular Determinants for the Tissue Specificity of SERMs &#x2014; Supplemental Data 	ww.sciencemag.org	0	0		LMNA
705	chr3	15748975	15748999	3500220493	24		15748975	15748999	8421504	1	24	0	c	350022049300000002,350022049300000003	0-22,0-23		15659654	10.1091/mbc.E04-08-0654	1059-1524	Molecular Biology of the Cell	Transcriptional Regulation by a DNA-associated Form of Cyclin D1	Bienvenu	2005	5		LMNA
705	chr3	15748976	15748999	3500461784	23		15748976	15748999	8421504	1	23	0	c	350046178400000000	0-23						Newly identified cholinephosphotransferases and ethanolaminephosphotransferases	Huitema	2005	0		LMNA
705	chr3	15748976	15748999	3500442671	23		15748976	15748999	8421504	1	23	0	c	350044267100000000	0-23						Newly Identified Cholinephosphotransferases And Ethanolaminephosphotransferases 	.freshpatents.com	0	0		LMNA
705	chr3	15748976	15748999	3500310584	23		15748976	15748999	8421504	1	23	0	c	350031058400000000,350031058400000007,350031058400000002	0-23,0-22,0-21						Novel active nucleic acid complexes for rna interference and the use thereof for inhibiting protein expression	Adib	2005	0		LMNA
705	chr3	15748976	15748999	3500252772	23		15748976	15748999	8421504	1	23	0	c	350025277200000003	0-23						The QIAGEN Transfection Resource Book Second Edition	ric.postech.ac.kr	0	0		LMNA
705	chr3	15748976	15748999	3500068865	23		15748976	15748999	8421504	1	23	0	c	350006886500000003	0-23						The QIAGEN Transfection Resource Book Second Edition	www.ff.ul.pt	0	0		LMNA
705	chr3	15748978	15750555	3500088954	66		15748978	15750555	8421504	3	21,25,20	0,67,1557	c	350008895400000003,350008895400000004	0-21,0-45						Brief note RNA interference: PCR strategies for the quanti&#xfb01;cation of stable degradation-fragments derived from siRNA-targeted mRNAs	quantification.de	0	0		
705	chr3	15797274	15797301	3500319425	27		15797274	15797301	8421504	1	27	0	c	350031942500000007,350031942500000056	11-38,11-38						TUMOR ANTIGEN BFY3 FOR PREVENTION AND/OR TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
706	chr3	15899209	15899241	3500401291	25		15899209	15899241	8421504	3	12,6,7	0,16,25	g	350040129100000007	0-25						PORPHOBILINOGEN DEAMINASE GENE THERAPY - Patent application	www.faqs.org	0	0		
706	chr3	15919269	15919407	3500336961	138		15919269	15919407	8421504	1	138	0	p	350033696100015124	0-138						97 human secreted proteins	Brewer	2001	0		RXFP4
706	chr3	15973872	15973901	3500155608	25		15973872	15973901	8421504	2	14,11	0,18	c	350015560800000151	20-45						Borrelia burdorferi Osp A and B proteins and immunogenic peptides	Barbour	1995	0		
706	chr3	15977633	15988101	3500131354	188		15977633	15988101	8421504	3	48,44,96	0,10280,10372	p,c	350013135400000073,350013135400000059,350013135400015089,350013135400000056	0-48,0-44,0-48,0-48						Parkin interacting polypeptides and methods of use - Patent application	www.faqs.org	0	0		
708	chr3	16156717	16164916	3500282054	234		16156717	16164916	8421504	5	19,115,20,47,33	0,920,4733,8118,8166	c	350028205400000031,350028205400000030,350028205400000029,350028205400000027,350028205400000017,350028205400000016	0-38,0-48,0-48,28-48,1-48,15-48					Patent	Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins (Patent US:6160106)	Kimchi	2000	0		
708	chr3	16157656	16164913	3500294513	251		16157656	16164913	8421504	4	99,65,39,48	0,3749,6066,7209	c	350029451300000068,350029451300000067,350029451300000066,350029451300000017,350029451300000065,350029451300000022,350029451300000020	0-48,0-48,0-48,0-48,28-48,9-48,0-48						NOVEL DEATH DOMAIN PROTEINS - Patent application	www.faqs.org	0	0		
708	chr3	16162771	16162795	3500070288	23		16162771	16162795	8421504	2	8,15	0,9	c	350007028800000180	0-23						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
709	chr3	16258475	16258504	3500433937	24		16258475	16258504	8421504	2	11,13	0,16	c	350043393700000001	22-46						Truncated TrkB-T1 regulates the morphology of neocortical layer I astrocytes in adult rat brain slices. - ResearchGate	.researchgate.net	0	0		
710	chr3	16415953	16415977	3500401695	24		16415953	16415977	8421504	1	24	0	g	350040169500000001	24-48						Geranylgeranyl diphosphate synthase as a novel cancer therapeutic target	ir.uiowa.edu	0	0		
710	chr3	16514598	16514627	3500097699	25		16514598	16514627	8421504	3	15,4,6	0,16,23	c	350009769900000074	23-48						/tardir/tiffs/a391939	www.dtic.mil	0	0		
88	chr3	16514952	16516608	3500249481	363		16514952	16516608	8421504	3	20,165,178	0,483,1478	p	350024948100015007,350024948100015018	0-183,0-180						Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. - ResearchGate	.researchgate.net	0	0		HCN3
711	chr3	16515508	16518348	3500284445	141		16515508	16518348	8421504	2	60,81	0,2759	p	350028444500015009,350028444500015004	0-60,0-81						Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1	Folander	2004	0		POLRMT,HCN2
711	chr3	16539325	16539459	3500089848	25		16539325	16539459	8421504	2	2,23	0,111	c	350008984800000002	0-25		18171723	10.1152/ajpcell.00493.2007		American Journal of Physiology - Cell Physiolog	Nonredundant function of secretory carrier membrane protein isoforms in dense core vesicle exocytosis	Liao	2008	0		
711	chr3	16550153	16554865	3500360551	56		16550153	16554865	8421504	4	27,1,23,5	0,360,4682,4707	c	350036055100000002,350036055100000003	19-47,13-41						Method For Producing Glycoprotein Having Mannose Residue As Non-reducing End Of Sugar Chain 	.freshpatents.com	0	0		
711	chr3	16550153	16554865	3500155106	56		16550153	16554865	8421504	4	27,1,23,5	0,360,4682,4707	c,g	350015510600000026,350015510600000027,350015510600000027	19-47,13-41,13-41						NOVEL EXPRESSION VECTOR - Patent application	www.faqs.org	0	0		
711	chr3	16550153	16554865	3500100292	56		16550153	16554865	8421504	4	27,1,23,5	0,360,4682,4707	c	350010029200000002,350010029200000010,350010029200000011,350010029200000003	19-47,19-47,13-41,13-41						METHOD FOR PRODUCING GLYCOPROTEIN HAVING MANNOSE RESIDUE AS NON-REDUCING END OF SUGAR CHAIN - Patent application	www.faqs.org	0	0		
711	chr3	16550153	16554856	3500258273	48		16550153	16554856	8421504	2	25,23	0,4680	c,g	350025827300000005,350025827300000006,350025827300000006	9-34,10-33,10-33						Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, &#x03b2;-glucocerebrosidase	w.molbiolcell.org	0	0		GBAP1
711	chr3	16550153	16554856	3500219199	48		16550153	16554856	8421504	2	25,23	0,4680	c,g	350021919900000008,350021919900000009,350021919900000009	9-34,10-33,10-33		22337770	10.1091/mbc.E11-06-0553	1059-1524	Molecular Biology of the Cell	Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, &#x03b2;-glucocerebrosidase	Jovic	2012	5		GBAP1,GBA
711	chr3	16552153	16554595	3500411767	97		16552153	16554595	8421504	3	34,15,48	0,263,2394	c	350041176700000137,350041176700000104,350041176700000151	7-48,0-44,0-48						Recombinant adeno-associated virus virions for the treatment of lysosomal disorders	Podsakoff	2000	0		
711	chr3	16571713	16571809	3500040785	96		16571713	16571809	8421504	1	96	0	c,g	350004078500000059,350004078500000080,350004078500000080	0-96,0-22,0-22						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		MIR92B
711	chr3	16574564	16575532	3500163898	612		16574564	16575532	8421504	7	21,128,212,8,62,161,20	0,29,217,457,466,549,948	c,g	350016389800000000,350016389800000000,350016389800000006,350016389800000006,350016389800000008,350016389800000018,350016389800000028,350016389800000009,350016389800000011,350016389800000026,350016389800000026,350016389800000021,350016389800000019,350016389800000010,350016389800000001,350016389800000001,350016389800000007,350016389800000007	0-21,0-21,0-21,0-21,10-150,12-460,0-75,0-359,12-135,0-66,0-66,3-63,4-50,0-30,0-20,0-20,0-20,0-20						Universidade de S&#xaa;o Paulo Faculdade de Medicina de Ribeir&#xaa;o Preto Departamento de Gen&#xd8;tica	www.teses.usp.br	0	0		
711	chr3	16575964	16575988	3500001280	23		16575964	16575988	8421504	2	19,4	0,20	c	350000128000000034	17-40						MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom	Kufe	2005	0		
711	chr3	16575996	16576190	3500315315	78		16575996	16576190	8421504	2	23,55	0,139	p	350031531500015002	0-78			10.1111/j.1742-4658.2005.04711.x	1742-4658	FEBS Journal	The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane-tethered mucins - Palmai-Pallag - 2005 - FEBS Journal - Wiley Online Library	Palmai-Pallag	2005	0		
711	chr3	16576513	16576536	3500053470	23		16576513	16576536	8421504	1	23	0	c	350005347000000007	15-38						Mucin biosynthesis in the bovine goblet cell induced by Cooperia oncophora infection	aldc.nal.usda.gov	0	0		
711	chr3	16579612	16579638	3500048680	23		16579612	16579638	8421504	2	15,8	0,18	c	350004868000000076	10-33						Novel Stra6 Polypeptides - Patent application	www.faqs.org	0	0		
711	chr3	16608663	16608726	3500233649	50		16608663	16608726	8421504	2	27,23	0,40	g	350023364900000326	87-149					Patent	Method of screening compounds that inhibit the biosynthesis of GPI in malaria parasites (Patent CN:100504392)	Zhong Ben He Xiao 	2009	0		
711	chr3	16615256	16615279	3500329586	23		16615256	16615279	8421504	1	23	0	c	350032958600000022	0-23						Eck receptor ligands	Bartley	1994	0		
711	chr3	16619070	16619094	3500148290	24		16619070	16619094	8421504	1	24	0	c	350014829000000006	0-24						Hypoxia-inducibleTranscriptionFactor-2 inEndothelial CellsRegulatesTumorNeovascularizationthrough ActivationofEphrinA1	www.jbc.org	0	0		EFNA1
711	chr3	16623040	16623066	3500115879	23		16623040	16623066	8421504	2	5,18	0,8	g	350011587900000116	10-33						Recombinant fowlpox virus s-fpv-043 and uses thereof	Cochran	1994	0		
712	chr3	16659840	16680804	3500114805	191		16659840	16680804	8421504	3	48,96,47	0,793,20917	c	350011480500000011,350011480500000008,350011480500000007,350011480500000020	0-48,0-48,0-48,0-47						US Patent # 5,516,658. DNA encoding cytokines that bind the cell surface receptor hek - Patents.com	www.patents.com	0	0		
712	chr3	16660636	16660705	3500330320	54		16660636	16660705	8421504	2	27,27	0,42	p	350033032000015047	15-75						Structure, Function & Control of the EphA3 Receptor Tyrosine Kinase	.swinburne.edu.au	0	0		EFNA3
712	chr3	16679120	16679149	3500011328	24		16679120	16679149	8421504	2	18,6	0,23	c	350001132800000424	16-40						US Patent # 7,119,183. Rapid immunoselection cloning method - Patents.com	www.patents.com	0	0		
712	chr3	16684890	16694683	3500036532	2391		16684890	16694683	8421504	27	40,125,72,27,24,70,139,28,39,78,202,32,270,93,175,149,85,170,69,66,39,130,77,79,14,20,79	0,139,522,1011,1059,1710,2157,2428,2462,2966,3301,3589,3624,4024,4360,4610,5195,5423,5669,5820,6675,6738,6960,7212,7725,8511,9714	p	350003653200015123,350003653200015118,350003653200015113,350003653200015112,350003653200015108,350003653200015103,350003653200015098,350003653200015093,350003653200015092,350003653200015083,350003653200015078,350003653200015073,350003653200015068,350003653200015063,350003653200015058,350003653200015053,350003653200015048,350003653200015043,350003653200015033	0-114,0-150,0-111,0-69,0-150,0-144,0-150,0-57,0-90,0-150,0-150,0-150,0-150,0-150,0-150,0-126,0-150,0-150,0-99						ENFERMEDAD RENAL QU&#xcd;STICA MEDULAR (MCKD): ESTUDIO MOLECULAR Y B&#xda;SQUEDA DE GENES CANDIDATOS.	dspace.usc.es	0	0		
712	chr3	16690102	16690125	3500175283	23		16690102	16690125	8421504	1	23	0	c	350017528300000011,350017528300000001	0-23,0-23						ADAM-15 ANTIBODIES AND IMMUNOGENIC PEPTIDES - Patent application	www.faqs.org	0	0		
712	chr3	16693767	16693793	3500445631	23		16693767	16693793	8421504	2	17,6	0,20	g	350044563100000019	3-30						Igm Production By Transformed Cells And Methods Of Quantifying Said Igm Production 	.freshpatents.com	0	0		
712	chr3	16729741	16730180	3500385351	75		16729741	16730180	8421504	2	34,41	0,398	p	350038535100015137	15-90						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZBTB7B
712	chr3	16729741	16730180	3500075471	75		16729741	16730180	8421504	2	34,41	0,398	p	350007547100015069	15-90						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZBTB7B
712	chr3	16729741	16730174	3500269504	69		16729741	16730174	8421504	2	34,35	0,398	p	350026950400015082	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZBTB7B
712	chr3	16729741	16730174	3500176901	69		16729741	16730174	8421504	2	34,35	0,398	p	350017690100015065	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZBTB7B
712	chr3	16729741	16730174	3500160097	69		16729741	16730174	8421504	2	34,35	0,398	p	350016009700015103	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZBTB7B
712	chr3	16761715	16765094	3500346840	48		16761715	16765094	8421504	2	24,24	0,3355	c	350034684000000001,350034684000000000	0-24,0-24		9774639		0270-7306	Molecular and Cellular Biology	Ectopic Expression of cdc2/cdc28 Kinase Subunit Homo sapiens 1 Uncouples Cyclin B Metabolism from the Mitotic Spindle Cell Cycle Checkpoint	Hixon	1998	6		
712	chr3	16762514	16765073	3500426290	48		16762514	16765073	8421504	2	1,47	0,2512	p	350042629000015008	0-48						Methods to identify compounds useful for the treatment of proliferative and differentiative disorders	Pagano	2008	0		
712	chr3	16765071	16765096	3500351173	25		16765071	16765096	8421504	1	25	0	c	350035117300000000,350035117300000020	5-30,5-30						Aberrant expression of CKS1 and CKS2 and uses thereof - Patent application	www.faqs.org	0	0		
712	chr3	16765071	16765096	3500223659	25		16765071	16765096	8421504	1	25	0	c	350022365900000000	5-30		18498131	10.1002/ijc.23548	1097-0215	International Journal of Cancer	Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death - Lan - 2008 - International Journal of Cancer - Wiley Online Library	Lan	2008	0		
712	chr3	16768787	16768952	3500420646	39		16768787	16768952	8421504	2	20,19	0,146	c,g	350042064600000002,350042064600000002,350042064600000003	0-20,0-20,0-19		23109234	10.1002/mrd.22128	1098-2795	Molecular Reproduction and Development	Elevated p66Shc is associated with intracellular redox imbalance in developmentally compromised bovine embryos - Bain - 2012 - Molecular Reproduction and Development - Wiley Online Library	Bain	2013	0		
712	chr3	16769075	16774451	3500197574	45		16769075	16774451	8421504	2	21,24	0,5352	c	350019757400000051,350019757400000052	0-21,7-31						Identification, Function and clinical Relevance of mouse myeloid leukemia Genes	repub.eur.nl	0	0		
712	chr3	16773340	16773364	3500208520	24		16773340	16773364	8421504	1	24	0	c	350020852000000006	15-39						Emission ratiometric indicators of phosphorylation	Ting	2004	0		
712	chr3	16773340	16773364	3500131283	24		16773340	16773364	8421504	1	24	0	c	350013128300000008	15-39						Emission ratiometric indicators of phosphorylation by c-kinase	Newton	2005	0		
712	chr3	16773340	16773364	3500060411	24		16773340	16773364	8421504	1	24	0	c	350006041100000006	15-39						Emission ratiometric indicators of phosphorylation	Tsien	2001	0		
712	chr3	16773397	16773490	3500043803	72		16773397	16773490	8421504	3	21,24,27	0,36,66	p	350004380300015004	0-72						Genexpression des Adaptorproteins Shc bei Patienten mit Juveniler Myelomonozyt&#xe4;rer Leuk&#xe4;mie (JMML)	k.uni-freiburg.de	0	0		
712	chr3	16773469	16773494	3500149704	23		16773469	16773494	8421504	3	4,14,5	0,5,20	c	350014970400000055	7-30						METHOD OF DIAGNOSIS/PROGNOSIS OF HUMAN CHRONIC LYMPHOCYTIC LEUKEMIA COMPRISING THE PROFILING OF LPL/ADAM GENES - Patent application	www.faqs.org	0	0		
712	chr3	16773501	16774655	3500181711	39		16773501	16774655	8421504	3	1,19,19	0,820,1135	c,g	350018171100000007,350018171100000006,350018171100000006	0-20,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
712	chr3	16773501	16774655	3500133737	39		16773501	16774655	8421504	3	1,19,19	0,820,1135	c,g	350013373700000007,350013373700000006,350013373700000006	0-20,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
712	chr3	16774321	16774447	3500273330	126		16774321	16774447	8421504	1	126	0	p	350027333000015149,350027333000015148,350027333000015150	0-126,12-135,12-135						43 human secreted proteins	Komatsoulis	2001	0		SHC1
1	chr3	16776693	16778837	3500025345	192		16776693	16778837	8421504	4	49,47,48,48	0,520,1712,2096	c	350002534500000031,350002534500000032,350002534500000044,350002534500000052	0-48,0-48,0-48,0-48						Pygopus In Diagnosis And Treatment Of Cancer 	.freshpatents.com	0	0		
713	chr3	16777949	16777973	3500389158	23		16777949	16777973	8421504	2	14,9	0,15	c	350038915800000000	0-23		16609037	10.1158/1078-0432.CCR-05-2433	1078-0432	Clinical Cancer Research	Antisense Suppression of Pygopus2 Results in Growth Arrest of Epithelial Ovarian Cancer	Popadiuk	2006	8		PYGO2
713	chr3	16805840	16805864	3500137789	23		16805840	16805864	8421504	2	16,7	0,17	g	350013778900000001	7-30			10.1182/blood-2005-01-0440		Blood	A critical role for 14-3-3&#x03b6; protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications	Kesheng	2005	0		
89	chr3	17033804	17040814	3500017321	45		17033804	17040814	8421504	2	21,24	0,6986	g	350001732100000003,350001732100000001,350001732100000005	0-21,0-21,0-21		11245600			American Journal of Physiology - Cell Physiolog	Cloning and functional expression of a liver isoform of the small conductance Ca2+-activated K+ channel SK3	Barfod	2001	0		KCNN3
715	chr3	17155698	17155727	3500040195	24		17155698	17155727	8421504	2	7,17	0,12	c	350004019500000013	19-45						Recombinant BCG Vaccine - Patent application	www.faqs.org	0	0		
715	chr3	17157208	17157662	3500155925	41		17157208	17157662	8421504	2	17,24	0,430	c,g	350015592500000001,350015592500000002,350015592500000005,350015592500000006	0-40,0-40,0-21,17-38						Defining the Putative Inhibitory Site for a Selective Negative Allosteric Modulator of Human &#x03b1;4&#x03b2;2 Neuronal Nicotinic Receptors. - ResearchGate	.researchgate.net	0	0		
715	chr3	17157208	17157662	3500154171	40		17157208	17157662	8421504	2	17,23	0,431	c	350015417100000004	0-40			10.1021/cn300035f		ACS Chemical Neuroscience	Defining the Putative Inhibitory Site for a Selective Negative Allosteric Modulator of Human &#x03b1;4&#x03b2;2 Neuronal Nicotinic Receptors	Brandon	2012	0		
716	chr3	17172004	17179863	3500111863	164		17172004	17179863	8421504	6	22,20,45,24,30,23	0,202,5611,6572,6874,7836	p,c,g	350011186300000008,350011186300000002,350011186300000005,350011186300000005,350011186300000011,350011186300000011,350011186300015044,350011186300015065,350011186300015032,350011186300000003,350011186300000009	11-33,11-33,0-20,0-20,0-20,0-20,0-45,0-45,0-45,13-36,13-36						METHODS AND COMPOSITIONS FOR REGULATION OF STEM CELL SURVIVAL, PROLIFERATION, AND DIFFERENTIATION BY PROTEIN UBIQUITINATION - Patent application	www.faqs.org	0	0		
716	chr3	17236126	17236154	3500115533	23		17236126	17236154	8421504	2	10,13	0,15	c	350011553300000017	12-46						flt3-L mutants and method of use	Graddis	1998	0		
716	chr3	17282541	17297883	3500440172	45		17282541	17297883	8421504	3	13,6,26	0,1342,15316	c	350044017200000023,350044017200000018	0-19,10-36						 Cynomolgus Gp80 Receptor And Uses Thereof 	www.docstoc.com	0	0		
716	chr3	17298004	17298346	3500301078	61		17298004	17298346	8421504	2	14,47	0,295	c	350030107800000067	4-65						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
717	chr3	17366674	17366698	3500407090	23		17366674	17366698	8421504	2	12,11	0,13	c	350040709000000392	0-23						HIV envelope polypeptides and vaccine	Berman	1997	0		
718	chr3	17468262	17468286	3500174742	24		17468262	17468286	8421504	1	24	0	c	350017474200000000	0-24		22897929	10.1186/1756-3305-5-176	1756-3305	Parasites & Vectors	Characterization and evaluation of a Sarcoptes scabiei allergen as a candidate vaccine	Zhang	2012	3		TPM4
718	chr3	17468262	17468286	3500094467	24		17468262	17468286	8421504	1	24	0	c	350009446700000000	0-24		22897929	10.1186/1756-3305-5-176	1756-3305	Parasites & Vectors	Characterization and evaluation of a Sarcoptes scabiei allergen as a candidate vaccine	Zhang	2012	3		TPM3
718	chr3	17469084	17480694	3500319008	150		17469084	17480694	8421504	2	30,120	0,11490	p	350031900800015007,350031900800015033	0-150,0-90						Cell surface tropomyosin as a target of angiogenesis inhibition	Donate	2005	0		
718	chr3	17480581	17482403	3500216735	40		17480581	17482403	8421504	2	20,20	0,1802	c	350021673500000010,350021673500000011	0-20,0-20		19339625	10.1523/JNEUROSCI.0126-09.2009	0270-6474	The Journal of Neuroscience	A SnoN&#x2013;Ccd1 Pathway Promotes Axonal Morphogenesis in the Mammalian Brain	Ikeuchi	2009	7		TPM3
718	chr3	17486079	17486107	3500438028	23		17486079	17486107	8421504	3	11,8,4	0,15,24	g	350043802800000211,350043802800000277	0-23,11-34						 Personal Care Compositions Comprising Modified Variant Bowman Birk Protease Inhibitors 	www.docstoc.com	0	0		
718	chr3	17486079	17486107	3500408538	23		17486079	17486107	8421504	3	11,8,4	0,15,24	g	350040853800000276,350040853800000210	11-34,0-23						 Modified Variant Bowman Birk Protease Inhibitors 	www.docstoc.com	0	0		
718	chr3	17486079	17486107	3500346666	23		17486079	17486107	8421504	3	11,8,4	0,15,24	g	350034666600000208,350034666600000274	0-23,11-34						Modified Variant Bowman Birk Protease Inhibitors - Patent application	www.faqs.org	0	0		
718	chr3	17486079	17486107	3500246658	23		17486079	17486107	8421504	3	11,8,4	0,15,24	g	350024665800000210,350024665800000276	0-23,11-34						PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS - Patent application	www.faqs.org	0	0		
718	chr3	17486079	17486107	3500217561	23		17486079	17486107	8421504	3	11,8,4	0,15,24	g	350021756100000276,350021756100000210	11-34,0-23						Modified Variant Bowman Birk Protease Inhibitors	Amin	2011	0		
719	chr3	17611536	17613115	3500327553	42		17611536	17613115	8421504	2	19,23	0,1556	c	350032755300000008,350032755300000009	0-19,0-23						Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells. - ResearchGate	.researchgate.net	0	0		JTB
719	chr3	17625411	17625585	3500148659	174		17625411	17625585	8421504	1	174	0	p	350014865900015074	0-174						50 human secreted proteins	Komatsoulis	2002	0		CRTC2
719	chr3	17625411	17625585	3500068672	174		17625411	17625585	8421504	1	174	0	p	350006867200015074	0-174						50 human secreted proteins	Komatsoulis	2000	0		CRTC2
719	chr3	17627247	17627273	3500224286	26		17627247	17627273	8421504	1	26	0	c	350022428600000000	13-39		19509226	10.1158/0008-5472.CAN-09-0108	0008-5472	Cancer Research	Subcellular Localization of Cyclic AMP-Responsive Element Binding Protein-Regulated Transcription Coactivator 2 Provides a Link between Obesity and Breast Cancer in Postmenopausal Women	Brown	2009	8		
719	chr3	17632757	17632878	3500449217	40		17632757	17632878	8421504	2	20,20	0,101	c,g	350044921700000008,350044921700000008,350044921700000009	0-20,0-20,0-20		20819186	10.1111/j.1755-148X.2010.00760.x	1755-148X	Pigment Cell & Melanoma Research	Downregulation of SIK2 expression promotes the melanogenic program in mice - Horike - 2010 - Pigment Cell & Melanoma Research - Wiley Online Library	Horike	2010	0		CRTC2
720	chr3	17769118	17771153	3500244690	78		17769118	17771153	8421504	4	19,20,20,19	0,62,704,2016	g	350024469000000024,350024469000000030,350024469000000028,350024469000000027	0-19,0-20,0-20,0-19						Isolation, mapping and identi&#xfb01; cation of SNPs for four genes (ACP6 CGN ANXA9 SLC27A3) from a bovine QTL region on BTA3	.researchgate.net	0	0		
721	chr3	17850412	17861811	3500437151	635		17850412	17861811	8421504	17	20,6,90,51,76,7,45,24,41,89,48,6,35,27,21,25,24	0,57,215,2701,2954,3114,3218,4631,4661,5087,5331,5686,5693,6432,7511,9126,11375	c,g	350043715100000001,350043715100000001,350043715100000100,350043715100000100,350043715100000152,350043715100000086,350043715100000151,350043715100000062,350043715100000132,350043715100000060,350043715100000130,350043715100000059,350043715100000129,350043715100000102,350043715100000005,350043715100000073,350043715100000052,350043715100000051,350043715100000048,350043715100000047,350043715100000045,350043715100000043,350043715100000039,350043715100000033,350043715100000033,350043715100000023,350043715100000023	9-29,9-29,9-29,9-29,0-48,0-48,0-48,0-48,0-48,0-48,0-48,20-48,23-47,12-32,12-32,3-48,5-29,6-47,0-41,0-48,0-48,0-41,0-48,19-44,19-44,7-31,7-31						NATRIURETIC PEPTIDE RELATED FRAGMENT IN CARDIOVASCULAR DISEASE - Patent application	www.faqs.org	0	0		
721	chr3	17850439	17862976	3500318004	563		17850439	17862976	8421504	13	36,9,92,4,39,21,12,124,68,45,41,24,48	0,188,1662,1985,2121,2653,2710,2879,3087,4633,5060,11348,12489	p,c	350031800400000071,350031800400015126,350031800400015218,350031800400015124,350031800400015176,350031800400015148,350031800400015206,350031800400015116,350031800400015172,350031800400015142,350031800400015112,350031800400015170,350031800400015193,350031800400000142,350031800400000130,350031800400015134,350031800400000076,350031800400015188,350031800400015108,350031800400015168,350031800400000129,350031800400000005,350031800400000102,350031800400015183,350031800400015106,350031800400015167,350031800400015092,350031800400000048,350031800400000023,350031800400000013	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-48,0-48,0-45,0-48,0-45,0-45,0-45,0-47,12-32,12-32,0-45,0-45,0-45,0-45,0-41,7-31,0-48						NATRIURETIC PEPTIDE RELATED FRAGMENT IN CARDIOVASCULAR DISEASE - Patent application	www.faqs.org	0	0		
721	chr3	17859484	17859508	3500451535	24		17859484	17859508	8421504	1	24	0	c	350045153500000001	0-24				0798-0469	Revista de la Facultad de Medicina	Revista de la Facultad de Medicina - Presencia de Guanilil Ciclasas sensibles a los P&#xe9;ptidos Natriur&#xe9;ticos Anp y Cnp en el M&#xfa;sculo Liso Traqueal de Bovino	Borges	2002	0		
721	chr3	17886694	17886730	3500065038	36		17886694	17886730	8421504	1	36	0	c	350006503800000003	9-45		21146485	10.1016/j.ab.2010.12.007		Analytical biochemistry	Identification of cyclophilin-40 interacting proteins reveals potential cellular function of cyclophilin-40	Miki	2011	0		
721	chr3	17888533	17888853	3500169677	57		17888533	17888853	8421504	2	10,47	0,273	p	350016967700015000	0-57						extension by binding to Snapin and Snap25	mcb.asm.org	0	0		SNAPIN
721	chr3	17888533	17888853	3500156202	57		17888533	17888853	8421504	2	10,47	0,273	p	350015620200015002	0-57		21986494	10.1128/MCB.05593-11	0270-7306	Molecular and Cellular Biology	Type VI Adenylyl Cyclase Regulates Neurite Extension by Binding to Snapin and Snap25	Wu	2011	6		SNAPIN
721	chr3	17916964	17918301	3500378421	75		17916964	17918301	8421504	2	36,39	0,1298	p	350037842100015241	0-75						University of Southampton Research Repository ePrints Soton	rints.soton.ac.uk	0	0		S100A1
721	chr3	17933365	17933389	3500369391	23		17933365	17933389	8421504	2	19,4	0,20	c	350036939100000000	11-34						Truncated Sequences of Influenza A Virus Subtype H5 Haemagglutinin for Vaccination and Diagnostic Purposes	d-nb.info/1020088	0	0		
722	chr3	17989743	17991049	3500256292	303		17989743	17991049	8421504	2	141,162	0,1144	p,c	350025629200015000,350025629200000000	60-363,0-22						Manoj Reddy Medapati	.lib.umanitoba.ca	0	0		
722	chr3	17989743	17991049	3500015056	303		17989743	17991049	8421504	2	141,162	0,1144	p	350001505600015008	0-303						Therapeutic compositions and methods for treating diseases that involve angiogenesis	Semov	2005	0		S100A4
722	chr3	17989744	17989813	3500388552	40		17989744	17989813	8421504	2	19,21	0,48	c,g	350038855200000020,350038855200000020,350038855200000021,350038855200000021	0-19,0-19,0-21,0-21						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
722	chr3	17989744	17989813	3500143254	40		17989744	17989813	8421504	2	19,21	0,48	c,g	350014325400000020,350014325400000020,350014325400000021,350014325400000021	0-19,0-19,0-21,0-21						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
722	chr3	17989781	17990901	3500187025	43		17989781	17990901	8421504	3	22,7,14	0,96,1106	c,g	350018702500000002,350018702500000003	0-22,0-21		20492652	10.1186/ar3031	1478-6354	Arthritis Research & Therapy	Physiological tonicity improves human chondrogenic marker expression through nuclear factor of activated T-cells 5 in vitro	Windt	2010	4		S100A4
722	chr3	17989805	17990952	3500365673	39		17989805	17990952	8421504	2	19,20	0,1127	c,g	350036567300000008,350036567300000008,350036567300000009,350036567300000009	0-19,0-19,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
722	chr3	17989805	17990952	3500262357	39		17989805	17990952	8421504	2	19,20	0,1127	c,g	350026235700000008,350026235700000008,350026235700000009	0-19,0-19,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
722	chr3	17989809	17989836	3500324888	27		17989809	17989836	8421504	1	27	0	c	350032488800000000	0-27		11106237		1078-0432	Clinical Cancer Research	Inverse Expression of S100A4 and E-Cadherin Is Associated with Metastatic Potential in Gastric Cancer	Yonemura	2000	8		S100A4
722	chr3	18083975	18084002	3500032429	24		18083975	18084002	8421504	2	11,13	0,14	g	350003242900000024	0-24						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2012	0		
724	chr3	18249665	18249978	3500172791	40		18249665	18249978	8421504	2	20,20	0,293	c,g	350017279100000006,350017279100000006,350017279100000007,350017279100000007	0-20,0-20,0-20,0-20		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
724	chr3	18249665	18249978	3500120290	40		18249665	18249978	8421504	2	20,20	0,293	c,g	350012029000000006,350012029000000006,350012029000000007,350012029000000007	0-20,0-20,0-20,0-20						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
724	chr3	18249665	18249978	3500048191	40		18249665	18249978	8421504	2	20,20	0,293	c,g	350004819100000006,350004819100000006,350004819100000007,350004819100000007	0-20,0-20,0-20,0-20		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
724	chr3	18249911	18280669	3500324511	44		18249911	18280669	8421504	2	21,23	0,30735	c	350032451100000015,350032451100000029	21-42,0-23						Genome-wide Transcriptome Analysis of Laminar Tissue During the Early Stages of Experimentally Induced Equine Laminitis	pository.tamu.edu	0	0		
724	chr3	18266033	18280670	3500247762	413		18266033	18280670	8421504	5	30,135,138,90,20	0,581,1174,1328,14617	p,c,g	350024776200000008,350024776200015000,350024776200000010,350024776200000010,350024776200015006,350024776200000012,350024776200000003,350024776200000003,350024776200000013,350024776200015007,350024776200000015,350024776200000015,350024776200000002	0-30,0-153,0-48,0-48,0-93,0-48,0-20,0-20,0-48,0-60,0-90,0-90,0-20						DNA encoding novel calcium-binding proteins	Hitomi	1995	0		
724	chr3	18266033	18267451	3500174206	393		18266033	18267451	8421504	4	30,135,138,90	0,581,1174,1328	p,c,g	350017420600000008,350017420600015000,350017420600000009,350017420600000002,350017420600000010,350017420600000010,350017420600015006,350017420600000012,350017420600000003,350017420600000003,350017420600000013,350017420600015007,350017420600000015,350017420600000015	0-30,0-153,0-48,0-20,0-48,0-48,0-93,0-48,0-20,0-20,0-48,0-60,0-90,0-90					Patent	DNA encoding novel calcium-binding proteins (Patent US:5976832)	Hitomi	1999	0		
724	chr3	18266582	18267413	3500027894	65		18266582	18267413	8421504	4	21,19,5,20	0,747,767,811	c,g	350002789400000000,350002789400000000,350002789400000002,350002789400000003,350002789400000003	0-21,0-21,8-32,7-27,7-27						Phagocyte-specific S100 proteins in the local response to the Echinococcus granulosus larva. - ResearchGate	.researchgate.net	0	0		
724	chr3	18266611	18267457	3500325999	377		18266611	18267457	8421504	7	138,142,50,10,10,19,8	0,596,744,796,807,818,838	p,c	350032599900000004,350032599900015014,350032599900015015,350032599900015016,350032599900015069,350032599900015018,350032599900015019,350032599900015071,350032599900015073,350032599900015021,350032599900015022,350032599900015020	0-378,0-87,0-90,15-105,0-45,0-90,15-105,0-45,0-45,0-90,15-105,6-60						Methods for treating inflammation - Patent application	www.faqs.org	0	0		
724	chr3	18266614	18267342	3500319890	270		18266614	18267342	8421504	2	135,135	0,593	p	350031989000015016,350031989000015015,350031989000015014,350031989000015019,350031989000015018,350031989000015022,350031989000015021,350031989000015020	0-90,0-90,0-87,0-90,0-90,0-90,0-90,6-60						Methods for treating inflammation	Stern	2001	0		
724	chr3	18266614	18267342	3500225860	270		18266614	18267342	8421504	2	135,135	0,593	p	350022586000015014,350022586000015013,350022586000015016,350022586000015018,350022586000015017	108-198,0-87,0-90,0-90,6-60						Methods For Treating Inflammation 	.freshpatents.com	0	0		
724	chr3	18267302	18267354	3500288419	50		18267302	18267354	8421504	2	45,5	0,47	c	350028841900000008,350028841900000009	20-40,36-69						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
724	chr3	18280647	18280670	3500449315	23		18280647	18280670	8421504	1	23	0	c	350044931500000123	16-39						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
730	chr3	19025410	19025436	3500227126	24		19025410	19025436	8421504	2	14,10	0,16	g	350022712600000137	0-30						Novel expressed sequence tag- simple sequence repeats (EST-SSR) markers characterized by new bioinformatic criteria reveal high genetic similarity in sugarcane ( Saccharum spp.) breeding lines	demicjournals.org	0	0		
731	chr3	19165193	19165220	3500078927	23		19165193	19165220	8421504	3	6,12,5	0,7,22	g	350007892700000017	4-27						Oligonucleotide Analogs Having Cationic Intersubunit Linkages 	.freshpatents.com	0	0		
735	chr3	19669169	19669194	3500467352	24		19669169	19669194	8421504	2	12,12	0,13	g	350046735200000143	21-48					Patent	Recombinant fowlpox virus S-FPV-043 and uses thereof (Patent US:6123949)	Cochran	2000	0		
735	chr3	19669169	19669194	3500454505	24		19669169	19669194	8421504	2	12,12	0,13	g	350045450500000158	21-48					Patent	Recombinant fowlpox viruses and uses thereof (Patent US:6001369)	Cochran	1999	0		
735	chr3	19669169	19669194	3500428877	24		19669169	19669194	8421504	2	12,12	0,13	g	350042887700000147	21-48						Recombinant fowlpox viruses and uses thereof	Cochran	1994	0		
735	chr3	19669169	19669194	3500408690	24		19669169	19669194	8421504	2	12,12	0,13	g	350040869000000158	21-48						 Recombinant Fowlpox Viruses And Uses Thereof 	www.docstoc.com	0	0		
735	chr3	19669169	19669194	3500395930	24		19669169	19669194	8421504	2	12,12	0,13	g	350039593000000240	21-48						Recombinant infectious laryngotracheitis virus and uses thereof	Cochran	1995	0		
735	chr3	19669169	19669194	3500395029	24		19669169	19669194	8421504	2	12,12	0,13	g	350039502900000240	18-45						 Recombinant Infectious Laryngotracheitis Virus And Uses Thereof 	www.docstoc.com	0	0		
735	chr3	19669169	19669194	3500282511	24		19669169	19669194	8421504	2	12,12	0,13	g	350028251100000158	21-48						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
735	chr3	19669169	19669194	3500263349	24		19669169	19669194	8421504	2	12,12	0,13	g	350026334900000158	21-48						Recombinant fowlpox viruses and uses thereof	Cochran	1998	0		
735	chr3	19669169	19669194	3500197547	24		19669169	19669194	8421504	2	12,12	0,13	g	350019754700000147	21-48						Recombinant fowlpox virus s-fpv-043 and uses thereof		1994	0		
735	chr3	19669169	19669194	3500195146	24		19669169	19669194	8421504	2	12,12	0,13	g	350019514600000143	21-48						Recombinant fowlpox virus S-FPV-043 and uses thereof	Cochran	1995	0		
735	chr3	19669169	19669194	3500180733	24		19669169	19669194	8421504	2	12,12	0,13	g	350018073300000147	21-48						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
735	chr3	19669169	19669194	3500179670	24		19669169	19669194	8421504	2	12,12	0,13	g	350017967000000158	21-48						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
735	chr3	19669169	19669194	3500177869	24		19669169	19669194	8421504	2	12,12	0,13	g	350017786900000143	21-48						US Patent # 6,123,949. Recombinant fowlpox virus S-FPV-043 and uses thereof - Patents.com	www.patents.com	0	0		
735	chr3	19669169	19669194	3500115879	24		19669169	19669194	8421504	2	12,12	0,13	g	350011587900000147	21-48						Recombinant fowlpox virus s-fpv-043 and uses thereof	Cochran	1994	0		
737	chr3	20038724	20039748	3500263376	23		20038724	20039748	8421504	2	13,10	0,1014	c	350026337600000026	0-23		17192283	10.1152/ajpcell.00439.2006		American Journal of Physiology - Cell Physiolog	Identification of a novel interaction between the Ca2+-binding protein S100A11 and the Ca2+- and phospholipid-binding protein annexin A6	Chang	2007	0		S100A11
738	chr3	20069207	20079808	3500303218	44		20069207	20079808	8421504	3	8,15,21	0,6981,10580	c,g	350030321800000000,350030321800000001,350030321800000001	0-23,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
738	chr3	20076191	20079857	3500222007	309		20076191	20079857	8421504	2	150,159	0,3507	p	350022200700015039	93-402						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		
738	chr3	20076191	20079857	3500203017	309		20076191	20079857	8421504	2	150,159	0,3507	p	350020301700015038	93-402						Human cDNAs and proteins and uses thereof	Bejanin	2001	0		
738	chr3	20076278	20079857	3500227271	222		20076278	20079857	8421504	2	63,159	0,3420	p	350022727100015049	0-222						Human cdnas and proteins and uses thereof	Bejanin	2002	0		S100A10
738	chr3	20079728	20079794	3500242547	66		20079728	20079794	8421504	1	66	0	p	350024254700015003	0-66						13 human colon and colon cancer associated proteins	Birse	2001	0		S100A10
738	chr3	20079946	20080078	3500071382	44		20079946	20080078	8421504	2	22,22	0,110	c,g	350007138200000004,350007138200000004,350007138200000005	0-22,0-22,0-22						REPRODUCTION	uction-online.org	0	0		
738	chr3	20125329	20125356	3500304970	24		20125329	20125356	8421504	2	12,12	0,15	g	350030497000000018	7-34						Nucleic acid amplification method: ramification-extension amplification method (ram)		1998	0		
739	chr3	20217414	20217439	3500252796	24		20217414	20217439	8421504	2	13,11	0,14	g	350025279600000113	0-42						METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF RSV INFECTION	Vaishnaw	2008	0		
739	chr3	20217414	20217439	3500179508	24		20217414	20217439	8421504	2	13,11	0,14	g	350017950800000116	0-42						Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules - Patent application	www.faqs.org	0	0		
739	chr3	20217414	20217439	3500147965	24		20217414	20217439	8421504	2	13,11	0,14	g	350014796500000113	0-42						Methods and compositions for prevention or treatment of RSV infection (&#x043f;&#x0430;&#x0442;&#x0435;&#x043d;&#x0442; US &#x2116; 8410073)	www.freepatent.ru	0	0		
739	chr3	20262084	20279937	3500371315	2051		20262084	20279937	8421504	9	4,52,432,229,82,220,430,19,583	0,5,58,491,721,14002,14224,14655,17270	c,g	350037131500000008,350037131500000006,350037131500000009,350037131500000007,350037131500000002	0-801,0-20,10-682,346-931,0-26						Dna markers for marbling	Barendse	2004	0		
739	chr3	20275753	20276064	3500257083	27		20275753	20276064	8421504	2	3,24	0,287	c	350025708300000011	0-27		23861783	10.1371/journal.pone.0067693		PLoS ONE	Lipocalin-2 Expressed in Innate Immune Cells Is an Endogenous Inhibitor of Inflammation in Murine Nephrotoxic Serum Nephritis	K	2013	0		
739	chr3	20275753	20276064	3500213826	27		20275753	20276064	8421504	2	3,24	0,287	c	350021382600000015	0-27						THELPER CELL TYPE 17 LINEAGE-SPECIFIC ADJUVANTS, COMPOSITIONS AND METHODS - MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY	www.sumobrain.com	0	0		
739	chr3	20275753	20276064	3500196109	27		20275753	20276064	8421504	2	3,24	0,287	c	350019610900000011	0-27		23861783	10.1371/journal.pone.0067693	1932-6203	PLOS ONE	PLOS ONE: Lipocalin-2 Expressed in Innate Immune Cells Is an Endogenous Inhibitor of Inflammation in Murine Nephrotoxic Serum Nephritis	Eller	2013	4		
739	chr3	20289330	20289362	3500461121	32		20289330	20289362	8421504	1	32	0	g	350046112100000016,350046112100000017,350046112100000035,350046112100000036	56-88,0-32,56-88,0-32						Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination - Patent application	www.faqs.org	0	0		
740	chr3	20317210	20317236	3500092388	23		20317210	20317236	8421504	3	12,4,7	0,13,19	c	350009238800000003	10-33						InhibitorofNrf2(INrf2orKeap1)ProteinDegradesBcl-xLvia PhosphoglycerateMutase5andControlsCellular Apoptosis S	www.jbc.org	0	0		
740	chr3	20336294	20336320	3500128270	26		20336294	20336320	8421504	1	26	0	c	350012827000000012	15-47		16024810	10.1128/MCB.25.15.6772-6788.2005	0270-7306	Molecular and Cellular Biology	Components of the ESCRT Pathway, DFG16, and YGR122w Are Required for Rim101 To Act as a Corepressor with Nrg1 at the Negative Regulatory Element of the DIT1 Gene of Saccharomyces cerevisiae	Rothfels	2005	6		
740	chr3	20336294	20336320	3500039123	26		20336294	20336320	8421504	1	26	0	c	350003912300000012	15-47		16024810	10.1128/MCB.25.15.6772-6788.2005	0270-7306	Molecular and Cellular Biology	Components of the ESCRT Pathway, DFG16, and YGR122w Are Required for Rim101 To Act as a Corepressor with Nrg1 at the Negative Regulatory Element of the DIT1 Gene of Saccharomyces cerevisiae	Rothfels	2005	6		
740	chr3	20388494	20388526	3500155952	28		20388494	20388526	8421504	3	18,5,5	0,21,27	c	350015595200000012	0-30						Developmental Expression in Leishmania donovani: Cloning Amastigote-Stage- Specific Gene	mcb.asm.org	0	0		
741	chr3	20473272	20473302	3500396961	25		20473272	20473302	8421504	3	5,5,15	0,7,15	g	350039696100000005	0-25						A Protective Domain of Heat-Shock Protein 60 from Histoplasma capsulatum	www.jstor.org	0	0		
741	chr3	20528827	20528852	3500343361	25		20528827	20528852	8421504	1	25	0	g	350034336100000002	21-46						Pericyte-Like Progenitors Show High Immaturity and Engraftment Potential as Compared with Mesenchymal Stem Cells. - ResearchGate	.researchgate.net	0	0		CNN3
741	chr3	20560041	20560070	3500288304	24		20560041	20560070	8421504	2	8,16	0,13	c	350028830400000014	7-31						Stable polyvalent antibody	Nobuaki	2011	0		
742	chr3	20672800	20672824	3500099187	23		20672800	20672824	8421504	2	16,7	0,17	c	350009918700000106	12-35						GENETIC SUSCEPTIBILITY VARIANTS ASSOCIATED WITH CARDIOVASCULAR DISEASE	Helgadottir	2008	0		
743	chr3	20796784	20811841	3500449759	85		20796784	20811841	8421504	4	19,36,12,18	0,13601,14306,15039	p,c	350044975900000002,350044975900015003	7-26,0-66		9218477	10.1074/jbc.272.29.18358	0021-9258	Journal of Biological Chemistry	Isolation and Molecular Cloning of Wortmannin-sensitive Bovine Type III Phosphatidylinositol 4-Kinases	Balla	1997	5		
743	chr3	20797492	20817112	3500255107	42		20797492	20817112	8421504	2	20,22	0,19598	c,g	350025510700000000,350025510700000001	6-26,8-30		10799551	10.1074/jbc.275.19.14642	0021-9258	Journal of Biological Chemistry	Characterization of Recombinant Phosphatidylinositol 4-Kinase &#x03b2; Reveals Auto- and Heterophosphorylation of the Enzyme	Zhao	2000	5		
743	chr3	20798349	20798398	3500229564	49		20798349	20798398	8421504	1	49	0	c	350022956400000000,350022956400000001	21-70,17-66						Entwicklung von molekularen Werkzeugen zur Untersuchung einer Funktion der Proteinkinase D in der Organisation des Golgi Komplexes	.uni-stuttgart.de	0	0		PI4KB
744	chr3	20864663	20865945	3500363464	327		20864663	20865945	8421504	3	150,68,109	0,1021,1173	p	350036346400015019,350036346400015138,350036346400015137	0-327,0-150,63-150						Anticancer fusion protein	Pieczykolan	2013	0		PSMD4
744	chr3	20864663	20865945	3500181216	327		20864663	20865945	8421504	3	150,68,109	0,1021,1173	p	350018121600015020,350018121600015139,350018121600015138	0-327,0-150,63-150						ANTICANCER FUSION PROTEIN - ADAMED SP. Z O.O.	www.sumobrain.com	0	0		PSMD4
744	chr3	20866636	20869205	3500231053	435		20866636	20869205	8421504	13	45,45,15,69,3,45,15,18,45,6,39,45,45	0,48,96,117,400,406,454,711,744,792,1172,1214,2524	p	350023105300015049,350023105300015048,350023105300015047,350023105300015046,350023105300015045,350023105300015043	0-105,0-150,0-45,0-45,0-45,0-45						Assays for modulators of parkin activity using S5a as a parkin substrate - US Patent 7790365 Description	ww.patentstorm.us	0	0		
744	chr3	20962704	20962794	3500160538	90		20962704	20962794	8421504	1	90	0	p	350016053800015005	0-90						TIPE2, a Negative Regulator of Innate and Adaptive Immunity that Maintains Immune Homeostasis	download.cell.com	0	0		LYSMD1
745	chr3	21045810	21046033	3500424225	42		21045810	21046033	8421504	2	21,21	0,202	c,g	350042422500000011,350042422500000010,350042422500000010	0-21,0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
745	chr3	21065001	21065025	3500210939	24		21065001	21065025	8421504	1	24	0	c	350021093900000146	16-40						Starchless variety of pisum sativum having elevated levels of sucrose	Webster	2000	0		
745	chr3	21065001	21065025	3500187962	24		21065001	21065025	8421504	1	24	0	c	350018796200000146	16-40						 Starchless Variety Of Pisum Sativum Having Elevated Levels Of Sucrose 	www.docstoc.com	0	0		
745	chr3	21092461	21093693	3500244690	58		21092461	21093693	8421504	3	19,20,19	0,926,1213	c,g	350024469000000020,350024469000000018,350024469000000018,350024469000000016,350024469000000016	0-19,0-20,0-20,0-19,0-19						Isolation, mapping and identi&#xfb01; cation of SNPs for four genes (ACP6 CGN ANXA9 SLC27A3) from a bovine QTL region on BTA3	.researchgate.net	0	0		
746	chr3	21106669	21108517	3500352172	101		21106669	21108517	8421504	6	2,19,24,24,29,3	0,209,960,1529,1638,1845	c	350035217200000029,350035217200000004,350035217200000027,350035217200000033	16-37,8-32,0-24,13-48						AcylChainSpecificityofCeramideSynthasesIsDetermined withinaRegionof150ResiduesintheTram-Lag-CLN8(TLC) Domain	www.jbc.org	0	0		
746	chr3	21110148	21114324	3500063417	306		21110148	21114324	8421504	8	36,39,34,11,48,71,22,45	0,39,81,290,304,3514,4106,4131	p	350006341700015229,350006341700015228,350006341700015225,350006341700015224	0-120,0-48,0-48,0-90						Chromatin regulator genes - Patent # 7252968 - PatentGenius	.patentgenius.com	0	0		SETDB1
747	chr3	21246815	21254945	3500254665	69		21246815	21254945	8421504	3	23,45,1	0,3406,8129	p	350025466500015067	0-69						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		ARNT
747	chr3	21250264	21275846	3500099796	300		21250264	21275846	8421504	8	2,45,13,60,60,55,5,60	0,4680,7404,9629,14599,18026,19416,25522	p,c	350009979600000165,350009979600015050,350009979600015052,350009979600015059,350009979600015062,350009979600015069	0-60,0-60,0-60,0-60,0-60,0-60						&#x201c;Clonagem e Express&#xe3;o do Fator 1 Humano Induz&#xed;vel por Hip&#xf3;xia (HIF-1) na Levedura Saccharomyces cerevisiae&#x201d;.	bdtd.bce.unb.br	0	0		
747	chr3	21250264	21257681	3500020367	60		21250264	21257681	8421504	3	2,45,13	0,4680,7404	p	350002036700015050	0-60						&#x201c;Clonagem e Express&#xe3;o do Fator 1 Humano Induz&#xed;vel por Hip&#xf3;xia (HIF-1) na Levedura Saccharomyces cerevisiae&#x201d;.	itorio.bce.unb.br	0	0		
747	chr3	21254948	21257687	3500166513	60		21254948	21257687	8421504	2	41,19	0,2720	c	350016651300000159	0-60						Isolation and Functional Characterization of a Dioxin-Inducible CYP1A Regulatory Region From Zebrafish ( Gary T. ZeRuth A dissertation submitted in partial fulfillment	gradworks.umi.com	0	0		
747	chr3	21263493	21270458	3500357244	42		21263493	21270458	8421504	3	21,17,4	0,6247,6961	c,g	350035724400000005,350035724400000005,350035724400000004	0-21,0-21,0-21		14726445	10.1210/en.2003-1254	0013-7227	Endocrinology	Constitutive Expression of CYP1A1 in Bovine Cumulus Oocyte-Complexes in Vitro: Mechanisms and Biological Implications	Pocar	2004	4		
747	chr3	21264870	21268270	3500451950	44		21264870	21268270	8421504	3	22,11,11	0,2962,3389	c	350045195000000004,350045195000000005	0-22,0-22						Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells	shsmu-path.com.cn	0	0		ARNT
747	chr3	21264870	21268270	3500280601	44		21264870	21268270	8421504	3	22,11,11	0,2962,3389	c	350028060100000004,350028060100000005	0-22,0-22						Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells	shsmu-path.com.cn	0	0		ARNT
747	chr3	21278707	21279760	3500446652	43		21278707	21279760	8421504	2	21,22	0,1031	c,g	350044665200000004,350044665200000005,350044665200000005	0-21,0-22,0-22		17616719	10.1530/REP-06-0246	1470-1626	Reproduction	Regulation of aryl hydrocarbon receptor activity in porcine cumulus&#x2013;oocyte complexes in physiological and toxicological conditions: the role of follicular fluid	Nestler	2007	3		
747	chr3	21287542	21297924	3500271690	359		21287542	21297924	8421504	9	63,63,18,30,48,47,39,6,45	0,565,661,764,2659,2755,2821,7626,10337	p,c	350027169000000003,350027169000015054,350027169000000005,350027169000015056,350027169000000007,350027169000000011,350027169000000013,350027169000015063,350027169000000022	0-48,0-45,0-48,0-48,0-48,0-48,0-47,0-45,0-45						Human Osteoclast Derived Cathepsin - Patent application	www.faqs.org	0	0		
747	chr3	21288200	21295620	3500100450	96		21288200	21295620	8421504	4	21,27,34,14	0,106,7100,7406	c	350010045000000007,350010045000000018	0-48,0-48						Cathepsin o2 protease	Bromme	1997	0		
747	chr3	21288319	21324005	3500435393	45		21288319	21324005	8421504	2	24,21	0,35665	c,g	350043539300000047,350043539300000044,350043539300000044	0-24,0-21,0-21						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
747	chr3	21288362	21290224	3500024851	40		21288362	21290224	8421504	2	20,20	0,1842	c	350002485100000000,350002485100000001	0-20,0-20		23951042	10.1371/journal.pone.0070925		PLoS ONE	Cathepsin K Is Present in Invasive Oral Tongue Squamous Cell Carcinoma In Vivo and In Vitro	Carolina	2013	0		CTSK
747	chr3	21288447	21290216	3500382830	48		21288447	21290216	8421504	2	15,33	0,1736	p	350038283000015081	0-48					Patent	Prosphatase binding assay (Patent US:6114132)	Desmarais	2000	0		
747	chr3	21290188	21290211	3500426288	23		21290188	21290211	8421504	1	23	0	c	350042628800000028	0-23						Entwicklung muriner cDNA-Arrays zur Bestimmung der Proteinase-Expression arthritischer Fibroblasten im Modell der Antigen-induzierten Arthritis	.db-thueringen.de	0	0		
747	chr3	21298198	21298492	3500303839	294		21298198	21298492	8421504	1	294	0	c	350030383900000004	0-295						ASSESSMENT OF MYCOBACTERIUM INFECTION - THE UNVERSITY OF SYDNEY	www.sumobrain.com	0	0		
747	chr3	21318318	21319172	3500345074	27		21318318	21319172	8421504	2	19,8	0,846	c	350034507400000002	0-27						Localization of Cysteine Protease Cathepsin S to the Surface of Vascular Smooth Muscle Cells by Association with Integrin &#xdf; 2006&#x5e74;&#x7b2c;168&#x5377;&#x7b2c;2&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
747	chr3	21319157	21319181	3500454678	24		21319157	21319181	8421504	1	24	0	g	350045467800000268	0-24						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2004	0		
747	chr3	21322704	21323958	3500463719	23		21322704	21323958	8421504	2	1,22	0,1232	c	350046371900000034	6-29			10.1111/j.1574-695X.2005.00035.x	1574-695X	FEMS Immunology & Medical Microbiology	Genes differentially expressed in oropharyngeal tonsils and mandibular lymph nodes of tuberculous and nontuberculous European wild boars naturally exposed to Mycobacterium bovis - Naranjo - 2006 - FEMS Immunology & Medical Microbiology - Wiley Online Libr	Naranjo	2006	0		
747	chr3	21322704	21323958	3500322660	23		21322704	21323958	8421504	2	1,22	0,1232	c	350032266000000034	6-29						Caracterizaci&#xf3;n gen&#xf3;mica y prote&#xf3;mica de la expresi&#xf3;n g&#xe9;nica diferencial en jabal&#xed;es infectados de forma natural con Mycobacterium bovis Identificaci&#xf3;n de biomarcadores asociados con la infecci&#xf3;n y la respuesta inmu	digital.csic.es	0	0		
748	chr3	21462517	21463225	3500054480	44		21462517	21463225	8421504	3	20,4,20	0,339,688	c	350005448000000004,350005448000000005	0-20,0-24		23788110	10.1038/cgt.2013.35	0929-1903	Cancer Gene Therapy	Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy	Karlsson	2013	3		MCL1
748	chr3	21462853	21466711	3500198976	90		21462853	21466711	8421504	5	7,15,21,22,25	0,352,518,1221,3833	c	350019897600000004,350019897600000005,350019897600000000,350019897600000001	0-22,0-21,0-22,5-30		18292181	10.1152/ajpgi.00602.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2	Subramaniam	2008	0		MCL1
748	chr3	21463244	21463268	3500320087	24		21463244	21463268	8421504	1	24	0	c	350032008700000002	0-24		16439548	10.1128/JVI.80.4.1922-1938.2006	0022-538X	Journal of Virology	Insights into Gene Expression Changes Impacting B-Cell Transformation: Cross-Species Microarray Analysis of Bovine Leukemia Virus Tax-Responsive Genes in Ovine B Cells	Klener	2006	5		
748	chr3	21463293	21464107	3500222078	43		21463293	21464107	8421504	2	19,24	0,790	c	350022207800000004,350022207800000002	20-39,9-33			10.1128/MCB.25.8.3117-3126.2005		Molecular and Cellular Biology	Stabilization and Enhancement of the Antiapoptotic Activity of Mcl-1 by TCTP	Hsuan	2005	0		
748	chr3	21463299	21463352	3500021508	52		21463299	21463352	8421504	2	22,30	0,23	c	350002150800000001,350002150800000000	0-22,0-30						The Three-Substituted Indolinone Cyclin-Dependent Kinase 2 Inhibitor 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) Kill 2006&#x5e74;&#x7b2c;68&#x5377;&#x7b2c;8&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&	www.39kf.com	0	0		MCL1
748	chr3	21463335	21463417	3500175024	47		21463335	21463417	8421504	2	22,25	0,57	c	350017502400000022,350017502400000023	0-22,0-25						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
748	chr3	21463992	21464058	3500355231	40		21463992	21464058	8421504	2	20,20	0,46	c,g	350035523100000004,350035523100000004,350035523100000005	0-20,0-20,0-20		23716557	10.3324/haematol.2012.080424		Haematologica	Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis	Fukun	2013	0		
748	chr3	21463992	21464058	3500293020	40		21463992	21464058	8421504	2	20,20	0,46	c,g	350029302000000004,350029302000000005,350029302000000005	0-20,0-20,0-20						Hematopoiesis & Hematopoietic Stem Cells ARTICLES Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis	haematologica.org	0	0		
748	chr3	21463992	21464058	3500024053	40		21463992	21464058	8421504	2	20,20	0,46	c	350002405300000004,350002405300000005	0-20,0-20		23716557	10.3324/haematol.2012.080424	0390-6078	Haematologica	Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis	Guo	2013	6		
748	chr3	21464083	21464107	3500449646	24		21464083	21464107	8421504	1	24	0	c	350044964600000001	0-24						Science.Magazine.5712.2005-02-18	www.scribd.com	0	0		MCL1
748	chr3	21464083	21464107	3500414328	24		21464083	21464107	8421504	1	24	0	c	350041432800000009	0-24						&#x4e3b;&#x9898;&#xff1a;pre | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		MCL1
748	chr3	21464083	21464107	3500401751	24		21464083	21464107	8421504	1	24	0	c	350040175100000001	0-24		17475833		0022-1767	The Journal of Immunology	Unrestrained Glycogen Synthase Kinase-3&#x03b2; Activity Leads to Activated T Cell Death and Can Be Inhibited by Natural Adjuvant	Sengupta	2007	6		MCL1
748	chr3	21464083	21464107	3500344366	24		21464083	21464107	8421504	1	24	0	c	350034436600000002	0-24						Science.Magazine.5712.2005-02-18	www.scribd.com	0	0		MCL1
748	chr3	21464083	21464107	3500293845	24		21464083	21464107	8421504	1	24	0	c	350029384500000009	0-24		15728238	10.1084/jem.20041924	0022-1007	The Journal of Experimental Medicine	The BCL2A1 gene as a pre&#x2013;T cell receptor&#x2013;induced regulator of thymocyte survival	Mandal	2005	14		MCL1
748	chr3	21464083	21464107	3500237492	24		21464083	21464107	8421504	1	24	0	c	350023749200000002	9-33						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		MCL1
748	chr3	21464083	21464107	3500205124	24		21464083	21464107	8421504	1	24	0	c	350020512400000009	0-24						&#x4e3b;&#x9898;&#xff1a;BCL2 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		MCL1
748	chr3	21464083	21464107	3500017269	24		21464083	21464107	8421504	1	24	0	c	350001726900000009	0-24						&#x4e3b;&#x9898;&#xff1a;BCL2 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		MCL1
750	chr3	21671842	21671866	3500226848	24		21671842	21671866	8421504	1	24	0	c	350022684800000001	1-25		19671678	10.1158/1541-7786.MCR-08-0507	1541-7786	Molecular Cancer Research	miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1	Du	2009	4		
750	chr3	21707898	21707925	3500373892	23		21707898	21707925	8421504	2	12,11	0,16	c	350037389200000015	9-35						Nucleotide sequence for the Avian Metapneumovirus (Colorado) attachment glycoprotein gene	Seal	2002	0		
750	chr3	21709928	21709961	3500442868	24		21709928	21709961	8421504	3	6,12,6	0,10,27	c	350044286800000000	4-31						US Patent # 5,378,822. Nucleic acids encoding murine and human Ah receptors - Patents.com	www.patents.com	0	0		
750	chr3	21709928	21709961	3500008139	24		21709928	21709961	8421504	3	6,12,6	0,10,27	c	350000813900000000	4-31						Nucleic acids encoding murine and human Ah receptors	Bradfield	1993	0		
750	chr3	21711186	21715162	3500336961	93		21711186	21715162	8421504	5	23,22,26,21,1	0,663,817,1795,3975	p	350033696100015035,350033696100015033	0-45,0-48						97 human secreted proteins	Brewer	2001	0		CA14
750	chr3	21746035	21746080	3500440852	45		21746035	21746080	8421504	1	45	0	p	350044085200015005	0-45						DEVELOPMENT OF MONOCLONAL OLIGOBODIES AND CHEMICALLY SYNTHESIZED OLIGOBODIES	nabuenosaires.com	0	0		ANP32E
751	chr3	21808819	21808845	3500395273	24		21808819	21808845	8421504	2	5,19	0,7	c	350039527300000046	20-45						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
753	chr3	22058891	22058939	3500194466	48		22058891	22058939	8421504	1	48	0	p	350019446600015016	0-48						Proteomic Analysis of Phosphorylated Nuclear Proteins Underscores Novel Roles for Rapid Actions of Retinoic Acid in the Regulation of mRNA Splicing and Translation	digital.csic.es	0	0		HIST2H3C
753	chr3	22058957	22059011	3500445336	54		22058957	22059011	8421504	1	54	0	p	350044533600015001	0-54						BREAST CANCER-ASSOCIATED GENE, MELK, AND ITS INTERACTIONS WITH BCL-G - ONCOTHERAPY SCIENCE, INC.	www.sumobrain.com	0	0		HIST1H2BM
753	chr3	22059386	22059728	3500320902	342		22059386	22059728	8421504	1	342	0	p	350032090200015035,350032090200015036	0-168,0-174						Method for manufacturing a modified peptide	Bauer	2009	0		HIST1H2BK
753	chr3	22059389	22059452	3500342139	63		22059389	22059452	8421504	1	63	0	p	350034213900015019	0-63						These Sandrine bis	esups.ups-tlse.fr	0	0		HIST1H2BK
753	chr3	22059485	22059530	3500266806	45		22059485	22059530	8421504	1	45	0	p	350026680600015002	0-45						Supporting Online Material for	ww.sciencemag.org	0	0		HIST1H2BB
753	chr3	22059630	22059653	3500310981	23		22059630	22059653	8421504	1	23	0	c	350031098100000007,350031098100000005	0-23,0-21						Co-Culture of Spermatogonial Stem Cells with Sertoli Cells in the Presence of Testosterone and FSH Improved Differentiation via Up-Regulation of Post Meiotic Genes	acta.tums.ac.ir	0	0		HIST1H1E
753	chr3	22061591	22061615	3500369652	23		22061591	22061615	8421504	2	17,6	0,18	c	350036965200000134	25-48						<HTML> <HEAD> <TITLE>U.S. Patent: 5635617 - Methods and compositions comprising the agfA gene for	w.everypatent.com	0	0		
753	chr3	22091827	22091850	3500134460	23		22091827	22091850	8421504	1	23	0	c	350013446000000005,350013446000000007	0-21,0-23						Co-Culture of Spermatogonial Stem Cells with Sertoli Cells in the Presence of Testosterone and FSH Improved Differentiation via Up-Regulation of Post Meiotic Genes	urnals.tums.ac.ir	0	0		
754	chr3	22173272	22173392	3500087532	102		22173272	22173392	8421504	2	51,51	0,69	p	350008753200015002,350008753200015000,350008753200015003	0-51,3-51,0-51						IdentificationofSmallMoleculeInhibitorsofJumonjiAT-rich InteractiveDomain1B(JARID1B)HistoneDemethylasebya SensitiveHighThroughputScreen S	medicine.yale.edu	0	0		HIST1H4A
754	chr3	22173287	22173335	3500459444	48		22173287	22173335	8421504	1	48	0	p	350045944400015015	0-48						Inhibition Of Gasc1 	.freshpatents.com	0	0		HIST1H4A
754	chr3	22173314	22173359	3500099386	45		22173314	22173359	8421504	1	45	0	p	350009938600015022	0-45						Assay for Monitoring Activity of Jmjd6	Schofield	2009	0		HIST1H4A
754	chr3	22173419	22173446	3500255702	27		22173419	22173446	8421504	1	27	0	c	350025570200000014	0-27						Transcriptional activation of histone H4 &#x03b2; during the mitotic clonal expansion of 3T3-L1 adipocyte differentiation	w.molbiolcell.org	0	0		
754	chr3	22199085	22199125	3500104176	40		22199085	22199125	8421504	1	40	0	c	350010417600000057	9-49						Non-human primate fc receptors and methods of use	Namenuk	2004	0		
754	chr3	22199085	22199125	3500101956	40		22199085	22199125	8421504	1	40	0	c	350010195600000057	9-49						Non-human primate fc receptors and methods of use	Namenuk	2006	0		
754	chr3	22200999	22201023	3500374088	24		22200999	22201023	8421504	1	24	0	c	350037408800000002	0-24		16552040	10.1128/IAI.74.4.2115-2120.2006	0019-9567	Infection and Immunity	Genetic Resistance to Brucella abortus in the Water Buffalo (Bubalus bubalis)	Borriello	2006	4		
754	chr3	22200999	22201023	3500015801	24		22200999	22201023	8421504	1	24	0	c,g	350001580100000002,350001580100000002	0-24,0-24			10.1128/IAI.74.4.2115-2120.2006		Infection and Immunity	Genetic Resistance to Brucella abortus in the Water Buffalo (Bubalus bubalis) 	Giorgia	2006	0		
759	chr3	22857581	22857605	3500074983	23		22857581	22857605	8421504	2	8,15	0,9	g	350007498300000217	0-23						Alpha-amylase mutants with altered properties - US Patent 7713723 Description	ww.patentstorm.us	0	0		
760	chr3	23046270	23048485	3500416925	132		23046270	23048485	8421504	4	19,24,57,32	0,773,1827,2183	p,c	350041692500000004,350041692500000015,350041692500015002,350041692500000013	9-28,0-24,0-57,8-40						Methods and composition to regulate iron metabolism	Babitt	2012	0		HFE2
760	chr3	23046270	23048485	3500277508	154		23046270	23048485	8421504	5	19,22,24,57,32	0,547,773,1827,2183	p,c	350027750800000004,350027750800000014,350027750800000015,350027750800015000,350027750800000013	9-28,19-41,0-24,0-57,8-40						Use of modulators of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism	Lin	2007	0		
760	chr3	23046270	23048485	3500147478	132		23046270	23048485	8421504	4	19,24,57,32	0,773,1827,2183	p,c,g	350014747800000004,350014747800000004,350014747800000015,350014747800015000,350014747800000013	9-28,9-28,0-24,0-57,8-40						Use of modulatirs of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism	Babitt	2006	0		HFE2
760	chr3	23046270	23048485	3500101449	132		23046270	23048485	8421504	4	19,24,57,32	0,773,1827,2183	p,c	350010144900000004,350010144900000015,350010144900015001,350010144900000013	9-28,0-24,0-57,8-40						Methods and Compositions to Regulate Iron Metabolism	Lin	2008	0		
760	chr3	23046969	23047017	3500241857	48		23046969	23047017	8421504	1	48	0	p	350024185700015036	0-48						Competitive Regulation Of Hepcidin Mrna By Soluble And Cell-associated Hemojuvelin 	.freshpatents.com	0	0		
760	chr3	23048019	23048067	3500007682	48		23048019	23048067	8421504	1	48	0	c	350000768200000087	0-48						Binding Domains of Proteins of the Repulsive Guidance Molecule (RGM) Protein Family and Functional Fragments Thereof, and Their Use - Patent application	www.faqs.org	0	0		
760	chr3	23048453	23048485	3500111697	32		23048453	23048485	8421504	1	32	0	c	350011169700000013,350011169700000039	8-40,8-40						Methods and Compositions to Regulate Iron Metabolism - Patent application	www.faqs.org	0	0		
760	chr3	23048453	23048485	3500003748	32		23048453	23048485	8421504	1	32	0	c	350000374800000013,350000374800000045	8-40,8-40						HEMOJUVELIN FUSION PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
761	chr3	23098432	23098457	3500421898	25		23098432	23098457	8421504	1	25	0	c	350042189800000082	0-25						LAFORA'S DISEASE GENE - Patent application	www.faqs.org	0	0		
761	chr3	23190954	23192578	3500290590	195		23190954	23192578	8421504	3	15,161,19	0,149,1605	p	350029059000015038	0-195						The Drosophila trithorax group gene tonalli(tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING &#xfb01;nger protein	ev.biologists.org	0	0		PIAS3
761	chr3	23192425	23192452	3500004521	26		23192425	23192452	8421504	2	21,5	0,22	c	350000452100000181	0-35						US Patent # 6,680,209. Human antibodies as diagnostic reagents - Patents.com	www.patents.com	0	0		
762	chr3	23204754	23206779	3500279951	23		23204754	23206779	8421504	3	8,7,8	0,9,2017	c	350027995100000044	7-44						Recombinant hexose oxidase - Patent application	www.faqs.org	0	0		
762	chr3	23204754	23206779	3500201862	23		23204754	23206779	8421504	3	8,7,8	0,9,2017	c	350020186200000044	7-44					Patent	Recombinant hexose oxidase, a method of producing same and use of such enzyme (Patent US:7544795)	Stougaard	2009	0		
762	chr3	23204754	23206779	3500067200	23		23204754	23206779	8421504	3	8,7,8	0,9,2017	c	350006720000000044	7-44						Recombinant hexose oxidase, a method of producing same and use of such enzyme - Patent application	www.faqs.org	0	0		
762	chr3	23204754	23206779	3500013363	23		23204754	23206779	8421504	3	8,7,8	0,9,2017	c	350001336300000044	7-44						Recombinant hexose oxidase, a method of producing same and use of such enzyme	Stougaard	2004	0		
762	chr3	23212871	23212898	3500382900	25		23212871	23212898	8421504	3	4,13,8	0,5,19	c	350038290000000010	4-29					Patent	Methods for modulating transcription from the amyloid &#x03b2;-protein precursor (APP) promoter (Patent US:5643726)	Kovacs	1997	0		
762	chr3	23212871	23212898	3500380736	25		23212871	23212898	8421504	3	4,13,8	0,5,19	c	350038073600000023	4-29						Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter	KOVACS	1997	0		
762	chr3	23212871	23212898	3500294547	25		23212871	23212898	8421504	3	4,13,8	0,5,19	c	350029454700000010	4-29					Patent	Methods for modulating transcription from the amyloid &#x03b2;-protein precursor (APP) promoter (Patent US:5643726)	Kovacs	1997	0		
762	chr3	23212871	23212898	3500080131	25		23212871	23212898	8421504	3	4,13,8	0,5,19	c	350008013100000023	4-29						METHODS FOR MODULATING TRANSCRIPTION FROM THE AMYLOID &#x03b2;-PROTEIN PRECURSOR (APP) PROMOTER	Kovacs	1996	0		
762	chr3	23212871	23212898	3500011575	25		23212871	23212898	8421504	3	4,13,8	0,5,19	c	350001157500000023	4-29						Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter	M	2001	0		
763	chr3	23373763	23373790	3500181413	27		23373763	23373790	8421504	1	27	0	c	350018141300000019	0-27						METHOD AND MEANS FOR REDUCING CHEMOTHERAPEUTIC DRUG RESISTANCE IN-SITU WITHIN NEOPLASMS OF EPITHELIAL CELL ORIGIN - BETH ISRAEL DEACONESS MEDICAL CENTER, INC.	www.sumobrain.com	0	0		
765	chr3	23596799	23596859	3500194161	60		23596799	23596859	8421504	1	60	0	p	350019416100015012,350019416100015043	0-60,0-48						Recombinant lysophosphatidic acid phosphatase	www.devileye.net	0	0		
765	chr3	23632162	23632206	3500212912	38		23632162	23632206	8421504	2	19,19	0,25	c,g	350021291200000002,350021291200000001,350021291200000001	0-19,0-19,0-19		20089928	10.1152/ajpcell.00406.2009		American Journal of Physiology - Cell Physiolog	Regulation of gap junction coupling in bovine ciliary epithelium	Wang	2010	0		
765	chr3	23632549	23632597	3500376693	48		23632549	23632597	8421504	1	48	0	p	350037669300015038	0-48						Improved medical devices	Becker	2009	0		
765	chr3	23632549	23632597	3500371641	48		23632549	23632597	8421504	1	48	0	p	350037164100015041	0-48						Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions	Duft	2009	0		
765	chr3	23632549	23632597	3500369797	48		23632549	23632597	8421504	1	48	0	p	350036979700015040	0-48						Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions	Becker	2009	0		
765	chr3	23632549	23632597	3500346472	48		23632549	23632597	8421504	1	48	0	p	350034647200015078	0-48						WOUND HEALING COMPOSITIONS AND TREATMENTS	Mori	2009	0		
765	chr3	23632549	23632597	3500143816	48		23632549	23632597	8421504	1	48	0	p	350014381600015039	0-48						Improved methods and compositions for wound healing	Green	2008	0		
765	chr3	23632549	23632597	3500074141	48		23632549	23632597	8421504	1	48	0	p	350007414100015039	0-48						Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions	Duft	2009	0		
765	chr3	23632549	23632597	3500023472	48		23632549	23632597	8421504	1	48	0	p	350002347200015079	0-48						TREATMENT OF SURGICAL ADHESIONS	Duft	2008	0		
765	chr3	23632549	23632597	3500015607	48		23632549	23632597	8421504	1	48	0	p	350001560700015076	0-48						METHODS AND COMPOSITIONS FOR WOUND HEALING	Green	2012	0		
765	chr3	23633023	23633092	3500422615	69		23633023	23633092	8421504	1	69	0	p	350042261500015042	0-69						TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES - FIRSTSTRING RESEARCH, INC.	www.sumobrain.com	0	0		GJA5
765	chr3	23633023	23633092	3500414025	69		23633023	23633092	8421504	1	69	0	p	350041402500015106	0-69						Compositions and methods for promoting wound healing and tissue regeneration	Ghatnekar	2011	0		GJA5
765	chr3	23633023	23633092	3500374795	69		23633023	23633092	8421504	1	69	0	p	350037479500015095	0-69						COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION	Gourdie	2007	0		GJA5
765	chr3	23633023	23633092	3500332070	69		23633023	23633092	8421504	1	69	0	p	350033207000015100	0-69						 Composition And Methods For Promoting Wound Healing And Tissue Regeneration 	www.docstoc.com	0	0		GJA5
765	chr3	23633023	23633092	3500257959	69		23633023	23633092	8421504	1	69	0	p	350025795900015098	0-69						Composition and Methods for Promoting Wound Healing and tissue Regeneration	Ghatnekar	2008	0		GJA5
765	chr3	23633023	23633092	3500254081	69		23633023	23633092	8421504	1	69	0	p	350025408100015092	0-69						Compositions and methods for promoting wound healing and tissue regeneration	Gourdie	2009	0		GJA5
765	chr3	23633023	23633092	3500248458	69		23633023	23633092	8421504	1	69	0	p	350024845800015092	0-69					Patent	Compositions and methods for promoting wound healing and tissue regeneration (Patent US:7888319)	Ghatnekar	2011	0		GJA5
765	chr3	23633023	23633092	3500226091	69		23633023	23633092	8421504	1	69	0	p	350022609100015108	0-69						Compositions and methods for promoting wound healing and tissue regeneration	Gourdie	2011	0		GJA5
765	chr3	23633023	23633092	3500103084	69		23633023	23633092	8421504	1	69	0	p	350010308400015109	0-69						ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION - Patent application	www.faqs.org	0	0		GJA5
765	chr3	23633023	23633092	3500096913	69		23633023	23633092	8421504	1	69	0	p	350009691300015098	0-69					Patent	Composition and methods for promoting wound healing and tissue regeneration (Patent US:7786074)	Ghatnekar	2010	0		GJA5
765	chr3	23633023	23633092	3500079904	69		23633023	23633092	8421504	1	69	0	p	350007990400015093	0-69						COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION - Patent application	www.faqs.org	0	0		GJA5
765	chr3	23684745	23684772	3500073963	23		23684745	23684772	8421504	3	12,6,5	0,13,22	g	350007396300000099	0-23						Artificial Plant Minichromosomes - Patent application	www.faqs.org	0	0		
765	chr3	23700398	23700441	3500333552	43		23700398	23700441	8421504	1	43	0	g	350033355200000001,350033355200000002	0-24,0-19						Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets	Hakonarson	2009	0		BCL9
766	chr3	23734183	23734210	3500122711	24		23734183	23734210	8421504	2	16,8	0,19	g	350012271100000092	9-33						Humanized antibodies that recognize beta amyloid peptide - US Patent 7790856 Description	ww.patentstorm.us	0	0		
766	chr3	23734183	23734210	3500021871	24		23734183	23734210	8421504	2	16,8	0,19	g	350002187100000009	9-33						ANTI-TSG101 ANTIBODIES AND THEIR USES FOR TREATMENT OF VIRAL INFECTIONS - Patent application	www.faqs.org	0	0		
766	chr3	23734184	23734210	3500388470	23		23734184	23734210	8421504	2	15,8	0,18	g	350038847000000002	0-23					Patent	Humanized antibodies that recognize beta amyloid peptide (Patent US:7625560)	Basi	2009	0		
766	chr3	23734184	23734210	3500218934	23		23734184	23734210	8421504	2	15,8	0,18	g	350021893400000020	0-23					Patent	Biological products (Patent US:7012135)	Athwal	2006	0		
766	chr3	23734184	23734210	3500144205	23		23734184	23734210	8421504	2	15,8	0,18	g	350014420500000000	0-23						Diagnostic antibody assay	Demuth	2012	0		
766	chr3	23734184	23734210	3500138456	23		23734184	23734210	8421504	2	15,8	0,18	g	350013845600000004	0-23						AUTOREACTIVE B CELL DEVELOPMENT IN THE PERIPHERY By	ry.vanderbilt.edu	0	0		
766	chr3	23734184	23734210	3500074570	23		23734184	23734210	8421504	2	15,8	0,18	g	350007457000000000,350007457000000104	0-23,0-23						POLYPEPTIDE HAVING ENHANCED EFFECTOR FUNCTION - Patent application	www.faqs.org	0	0		
766	chr3	23734184	23734210	3500032455	23		23734184	23734210	8421504	2	15,8	0,18	g	350003245500000032	0-23						ANTI-AMYLOID BETA ANTIBODIES CONJUGATED TO SIALIC ACID-CONTAINING MOLECULES	Benz	2010	0		
766	chr3	23734184	23734210	3500003792	23		23734184	23734210	8421504	2	15,8	0,18	g	350000379200000012,350000379200000103	0-23,0-23						Anti-IGF-IR antibodies and their applications	Goetsch	2003	0		
768	chr3	24090566	24091183	3500354224	23		24090566	24091183	8421504	3	2,3,18	0,594,599	c	350035422400000032	0-24						Methods, compositions, and kits for detection of microRNA	Mullinax	2006	0		
768	chr3	24090566	24091183	3500012895	23		24090566	24091183	8421504	3	2,3,18	0,594,599	c	350001289500000032,350001289500000075	0-24,0-24						Methods, Compositions, And Kits For Detection Of Microrna 	.freshpatents.com	0	0		
774	chr3	24840631	24840679	3500072968	48		24840631	24840679	8421504	1	48	0	c	350007296800000260	0-48						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
774	chr3	24846435	24846464	3500311269	27		24846435	24846464	8421504	2	14,13	0,16	c	350031126900000012	7-34					Patent	Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used (Patent CN:100572556)	Si Di Na *Luo Te 	2009	0		
778	chr3	25314082	25314112	3500335406	30		25314082	25314112	8421504	1	30	0	c	350033540600000050	0-30						HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS	Kato	1998	0		
778	chr3	25419902	25419942	3500376053	40		25419902	25419942	8421504	1	40	0	c	350037605300000000	5-45		11567059		0270-6474	The Journal of Neuroscience	3-Phosphoglycerate Dehydrogenase, a Key Enzyme forl-Serine Biosynthesis, Is Preferentially Expressed in the Radial Glia/Astrocyte Lineage and Olfactory Ensheathing Glia in the Mouse Brain	Yamasaki	2001	7		
779	chr3	25502651	25502674	3500230330	23		25502651	25502674	8421504	1	23	0	g	350023033000000146	0-27						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
779	chr3	25531116	25531356	3500085562	73		25531116	25531356	8421504	2	25,48	0,192	c,g	350008556200000581,350008556200000581,350008556200000577	23-48,23-48,0-48						Methods and compositions for assaying analytes	Yuan	1999	0		
779	chr3	25531501	25531636	3500126808	42		25531501	25531636	8421504	2	21,21	0,114	c,g	350012680800000011,350012680800000011,350012680800000010,350012680800000010	0-21,0-21,0-21,0-21						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
779	chr3	25531644	25540035	3500033775	88		25531644	25540035	8421504	5	20,15,9,24,20	0,56,3578,3682,8371	c,g	350003377500000009,350003377500000007,350003377500000006,350003377500000008,350003377500000008	0-20,0-24,0-24,0-20,0-20		19747959	10.1016/j.mce.2009.09.004		Molecular and cellular endocrinology	Progesterone Regulation of Primordial Follicle Assembly In Bovine Fetal Ovaries	Eric	2009	0		
779	chr3	25531645	25535352	3500062286	40		25531645	25535352	8421504	2	19,21	0,3686	c,g	350006228600000007,350006228600000007,350006228600000006	0-19,0-19,0-21						Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells	logy-journals.org	0	0		
779	chr3	25531646	25531669	3500401331	23		25531646	25531669	8421504	1	23	0	c	350040133100000008	20-43						Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesis	.researchgate.net	0	0		
779	chr3	25531646	25531669	3500221075	23		25531646	25531669	8421504	1	23	0	c	350022107500000005	20-43						Effect of the metabolic environment at key stages of follicle development in cattle: focus on steroid biosynthesis. - ResearchGate	.researchgate.net	0	0		
779	chr3	25531649	25531673	3500338834	24		25531649	25531673	8421504	1	24	0	c	350033883400000004	20-44						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
779	chr3	25531708	25535239	3500095130	24		25531708	25535239	8421504	2	7,17	0,3514	c	350009513000000007	0-24		17916626	10.1210/en.2007-1123	0013-7227	Endocrinology	Evidence that Androgens Regulate Early Developmental Events, Prior to Sexual Differentiation	Goldman-Johnson	2008	4		HSD3B2
779	chr3	25535326	25540035	3500180860	40		25535326	25540035	8421504	2	20,20	0,4689	c,g	350018086000000001,350018086000000001,350018086000000000,350018086000000000	0-20,0-20,0-20,0-20						Evidence That High Variation in Ovarian Reserves of Healthy Young Adults Has a Negative Impact on the Corpus Luteum and Endometrium During Estrous Cycles in Cattle	ww.biolreprod.org	0	0		
779	chr3	25540058	25540136	3500339302	78		25540058	25540136	8421504	1	78	0	p	350033930200015064	0-78						Multiple Sequence Alignment	www.cs.uml.edu	0	0		
779	chr3	25540058	25540136	3500326081	78		25540058	25540136	8421504	1	78	0	p	350032608100015021	0-78						Overview of the Bernoulli Sampler	web.ccv.brown.edu	0	0		
779	chr3	25540058	25540136	3500036433	78		25540058	25540136	8421504	1	78	0	p	350003643300015021	0-78						Overview of the Gibbs Motif Sampler	web.ccv.brown.edu	0	0		
781	chr3	25748101	25748126	3500019989	24		25748101	25748126	8421504	2	10,14	0,11	g	350001998900000575	12-36						Genexpressions-Profil einer dysmyelinisierenden Doppel knock out-Mausmutante (mbp-/- plp-/-) und Rescue-Versuch des normalen Ph&#xe4;notyps	www.uni-koeln.de	0	0		
781	chr3	25752184	25752211	3500241875	24		25752184	25752211	8421504	2	16,8	0,19	g	350024187500000220	9-33					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
781	chr3	25752184	25752211	3500019915	24		25752184	25752211	8421504	2	16,8	0,19	g	350001991500000220	9-33						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
782	chr3	25899367	25913359	3500306769	48		25899367	25913359	8421504	2	38,10	0,13982	p	350030676900015036,350030676900015013	3-48,0-48						Method For Site-Specifically Introducing Non-Natural Amino Acid Into Protien Using Mitochondrial Protein and Method For Effectively Preparing Trna - Patent application	www.faqs.org	0	0		WARS2
783	chr3	26038110	26081749	3500114740	264		26038110	26081749	8421504	3	105,156,3	0,1290,43636	p	350011474000015019	0-264						A novel family of T-box genes in urodele amphibian limb development and regeneration: candidate genes involved in vertebrate forelimb/hindlimb patterning	ev.biologists.org	0	0		
784	chr3	26090310	26090336	3500213741	24		26090310	26090336	8421504	2	7,17	0,9	g	350021374100000000	10-34						Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence	Cochran	1988	0		
791	chr3	27073116	27073141	3500037063	23		27073116	27073141	8421504	2	8,15	0,10	g	350003706300000084,350003706300000015	10-34,10-34						PRODUCTION OF VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS IN OILSEED PLANTS - Patent application	www.faqs.org	0	0		
795	chr3	27538744	27538771	3500258554	25		27538744	27538771	8421504	2	11,14	0,13	g	350025855400000586,350025855400000810	15-41,24-48						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
796	chr3	27736904	27736928	3500218609	23		27736904	27736928	8421504	2	15,8	0,16	g	350021860900000048	20-43						Methods of construction biodiverse gene fragment libraries	Hopkins	2010	0		
803	chr3	28642692	28643075	3500391924	52		28642692	28643075	8421504	2	26,26	0,357	c	350039192400000227,350039192400000222,350039192400000344	18-44,19-45,16-42						Tetravalent etanercept - US Patent 7229962 Description	ww.patentstorm.us	0	0		
803	chr3	28642692	28643075	3500287328	52		28642692	28643075	8421504	2	26,26	0,357	c	350028732800000227,350028732800000222	18-44,16-42						Concatameric immunoadhesion molecule - US Patent 7670602 Description	ww.patentstorm.us	0	0		
803	chr3	28643037	28643062	3500230394	23		28643037	28643062	8421504	3	14,5,4	0,15,21	c	350023039400000124	9-32						COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES - Patent application	www.faqs.org	0	0		
803	chr3	28701779	28701806	3500137915	23		28701779	28701806	8421504	2	12,11	0,16	g	350013791500000119	22-45						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
807	chr3	29135523	29135549	3500315079	26		29135523	29135549	8421504	1	26	0	c	350031507900000001	0-26						Generation of pig primary fibroblast cells harboring MC R N-ethyl-N-nitrosourea mutagenesis: A gene-driven, nontransgenic approach to pig improvement	www.scirp.org	0	0		
807	chr3	29135523	29135549	3500274044	26		29135523	29135549	8421504	1	26	0	c	350027404400000001	0-26						Generation of pig primary fibroblast cells harboring MC R N-ethyl-N-nitrosourea mutagenesis: A gene-driven, nontransgenic approach to pig improvement	www.scirp.org	0	0		
807	chr3	29135523	29135549	3500106202	26		29135523	29135549	8421504	1	26	0	c	350010620200000001	0-26						Conferences, Proceedings, Journals, Open Access Journals, SCIRP	file.scirp.org	0	0		
807	chr3	29136281	29138473	3500010617	41		29136281	29138473	8421504	2	20,21	0,2171	c,g	350001061700000007,350001061700000007,350001061700000006	0-20,0-20,0-21						Revista Brasileira de Zootecnia	www.scielo.br	0	0		
807	chr3	29136286	29136337	3500136055	50		29136286	29136337	8421504	2	21,29	0,22	c	350013605500000005,350013605500000016	22-43,0-29						Effects of Mineralocorticoid and Glucocorticoid Agonists on Gene and Protein Expression, Structural Maturation and Compliance in the Ovine Preterm Fetal Lung	ufdc.ufl.edu	0	0		
807	chr3	29136315	29140570	3500317497	46		29136315	29140570	8421504	3	22,6,18	0,3085,4237	c	350031749700000013,350031749700000012	0-22,0-24						Fasting-induced changes in ECL cell gene expression	cs.physiology.org	0	0		
807	chr3	29136323	29139334	3500181711	43		29136323	29139334	8421504	2	21,22	0,2989	c	350018171100000035,350018171100000034	0-21,0-22						REPRODUCTION	uction-online.org	0	0		
807	chr3	29139022	29139354	3500303218	40		29139022	29139354	8421504	2	20,20	0,312	c	350030321800000007,350030321800000006	0-20,0-20						REPRODUCTION	uction-online.org	0	0		
807	chr3	29139041	29139097	3500136133	42		29139041	29139097	8421504	2	22,20	0,36	c,g	350013613300000002,350013613300000000,350013613300000000	0-22,0-20,0-20						-K -ATPase in adult rat pump activity in postinfarction myocytes	www.jappl.org	0	0		
807	chr3	29155244	29155271	3500292851	24		29155244	29155271	8421504	2	5,19	0,8	g	350029285100000013	0-25						Recombinant microorganisms expressing an oligosaccharide receptor mimic	Paton	2005	0		
807	chr3	29155244	29155271	3500283350	24		29155244	29155271	8421504	2	5,19	0,8	g	350028335000000013	0-25					Patent	Recombinant microorganisms expressing an oligosaccharide receptor mimic (Patent US:6833130)	Paton	2004	0		
807	chr3	29155244	29155271	3500141100	24		29155244	29155271	8421504	2	5,19	0,8	g	350014110000000012	0-25						Recombinant microorganisms expressing an oligosaccharide receptor mimic	Paton	2000	0		
812	chr3	29776916	29777090	3500409304	174		29776916	29777090	8421504	1	174	0	p	350040930400015013,350040930400015012	0-174,0-174						Thylacine 1is expressed segmentally within the paraxial mesoderm of the Xenopusembryo and interacts with the Notch pathway	ev.biologists.org	0	0		NHLH2
813	chr3	29922817	29922847	3500031103	27		29922817	29922847	8421504	3	18,5,4	0,20,26	c	350003110300000257	19-48						TRAIL RECEPTOR-BINDING AGENTS AND USES OF THE SAME - Patent application	www.faqs.org	0	0		
815	chr3	30174386	30174413	3500103866	25		30174386	30174413	8421504	2	19,6	0,21	g	350010386600000021	4-29						Method, device and kit for determining conditions related to a dysfunction of the renal proximal tubule	Devuyst	2008	0		
816	chr3	30304047	30304086	3500255432	39		30304047	30304086	8421504	1	39	0	c,g	350025543200000000,350025543200000008,350025543200000003,350025543200000004,350025543200000004	0-26,0-28,0-26,1-21,1-21					Patent	Vectors for expression of NGF in eukaryotic cells (Patent US:5457034)	Callegaro	1995	0		
816	chr3	30304054	30304081	3500313675	27		30304054	30304081	8421504	1	27	0	c	350031367500000092,350031367500000034	21-48,21-48						 Envelope Gene 	www.docstoc.com	0	0		
816	chr3	30304057	30304582	3500032379	148		30304057	30304582	8421504	3	53,48,47	0,237,478	p,c	350003237900000008,350003237900000035,350003237900015089,350003237900000018	0-45,0-44,0-48,1-48						Human Therapeutic Cells Secreting Nerve Growth Factor - Patent application	www.faqs.org	0	0		
816	chr3	30304057	30304568	3500446610	55		30304057	30304568	8421504	2	27,28	0,483	c,g	350044661000000003,350044661000000002,350044661000000002,350044661000000005,350044661000000005,350044661000000006	0-27,12-35,12-35,0-21,0-21,0-28					Patent	Process of making human nerve growth factor (Patent US:5272063)	Baecker	1993	0		
816	chr3	30304057	30304568	3500401303	55		30304057	30304568	8421504	2	27,28	0,483	c,g	350040130300000003,350040130300000002,350040130300000005,350040130300000005,350040130300000006	0-27,12-35,0-21,0-21,0-28						Process of making human nerve growth factor	Chan	1989	0		
816	chr3	30304057	30304084	3500313643	27		30304057	30304084	8421504	1	27	0	c	350031364300000000,350031364300000001	14-37,0-27						Method for producing human nerve growth factor-2	Igarashi	1992	0		
816	chr3	30304066	30304765	3500186499	93		30304066	30304765	8421504	3	44,22,27	0,288,672	c	350018649900000465,350018649900000471,350018649900000479	0-44,0-22,0-27						Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity. - Patent application	www.faqs.org	0	0		
816	chr3	30304174	30304768	3500287420	41		30304174	30304768	8421504	2	20,21	0,573	c	350028742000000000,350028742000000001	0-20,0-21						European Journal of Pharmacology	005.pasteur.ac.ir	0	0		NGF
816	chr3	30304174	30304198	3500009749	24		30304174	30304198	8421504	1	24	0	c	350000974900000001	0-24						Chinese Medical Journal: a peer reviewed, open access journal, published semimonthly by the Chinese Medical Association	www.cmj.org	0	0		NGF
816	chr3	30304396	30304551	3500263073	45		30304396	30304551	8421504	2	20,25	0,130	c,g	350026307300000003,350026307300000003,350026307300000005	0-20,0-20,1-26						Methods for treating bone cancer by administering a nerve growth factor antagonist antibody	Shelton	2012	0		NGF
816	chr3	30304420	30304765	3500283855	345		30304420	30304765	8421504	1	345	0	p	350028385500015027	51-396					Patent	Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups (Patent US:7744912)	Hubbell	2010	0		NGF
816	chr3	30304468	30304621	3500191435	153		30304468	30304621	8421504	1	153	0	p	350019143500015002	162-315		14759811	10.1016/j.ymthe.2003.11.005	1525-0016	Molecular Therapy	Nerve Growth Factor Receptor-Mediated Gene Transfer	Ma	2004	7		NGF
816	chr3	30304535	30304574	3500231606	39		30304535	30304574	8421504	1	39	0	c	350023160600000002	0-39		10594731	10.1046/j.1523-1747.1999.00773.x	0022-202X	Journal of Investigative Dermatology	Nerve Growth Factor Protects Human Keratinocytes from Ultraviolet-B-Induced Apoptosis	Marconi	1999	6		
816	chr3	30304537	30304585	3500407720	48		30304537	30304585	8421504	1	48	0	c	350040772000000065	0-48						US Patent # 5,935,824. Protein expression system - Patents.com	www.patents.com	0	0		
816	chr3	30304549	30304576	3500202461	27		30304549	30304576	8421504	1	27	0	c	350020246100000006	0-27		22409996	10.1186/ar3771		Arthritis Research & Therapy	Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate	Cecile	2012	0		NGF
817	chr3	30539174	30539197	3500403968	23		30539174	30539197	8421504	1	23	0	g	350040396800000003	7-30						Therapeutic methods and compositions	Smith	2012	0		
818	chr3	30593290	30594143	3500211629	414		30593290	30594143	8421504	2	252,162	0,691	p	350021162900015034,350021162900015017,350021162900015009	0-57,0-180,0-180						&#x4e21;&#x751f;&#x985e;&#x7532;&#x72b6;&#x817a;&#x523a;&#x6fc0;&#x30db;&#x30eb;&#x30e2;&#x30f3;&#x306e; &#x5206;&#x6ccc;&#x8abf;&#x7bc0;&#x6a5f;&#x69cb;&#x306b;&#x95a2;&#x3059;&#x308b;&#x7814;&#x7a76;	.wul.waseda.ac.jp	0	0		
820	chr3	30879686	30885018	3500452772	45		30879686	30885018	8421504	2	22,23	0,5309	c	350045277200000013,350045277200000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Nguyen	2001	0		
820	chr3	30879686	30885018	3500381792	45		30879686	30885018	8421504	2	22,23	0,5309	c,g	350038179200000013,350038179200000013,350038179200000014	16-38,16-38,9-32						Inhibitors of prenyl-protein transferases	Stump	2002	0		NRAS
820	chr3	30879686	30885018	3500368564	45		30879686	30885018	8421504	2	22,23	0,5309	c	350036856400000013,350036856400000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Ciccarone	2000	0		NRAS
820	chr3	30879686	30885018	3500356779	45		30879686	30885018	8421504	2	22,23	0,5309	c	350035677900000007,350035677900000008	16-38,9-32						Inhibitors of prenyl-protein transferase	Graham	1999	0		NRAS
820	chr3	30879686	30885018	3500333272	45		30879686	30885018	8421504	2	22,23	0,5309	c	350033327200000013,350033327200000014	16-38,9-32						Inhibitors of prenyl-protein transferase	William	2000	0		NRAS
820	chr3	30879686	30885018	3500331838	45		30879686	30885018	8421504	2	22,23	0,5309	c	350033183800000013,350033183800000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Hartman	2000	0		NRAS
820	chr3	30879686	30885018	3500318323	45		30879686	30885018	8421504	2	22,23	0,5309	c	350031832300000020,350031832300000007,350031832300000008,350031832300000021	16-38,16-38,9-32,9-32					Patent	Inhibitors of prenyl-protein transferase (Patent US:6127390)	deSolms	2000	0		
820	chr3	30879686	30885018	3500317274	45		30879686	30885018	8421504	2	22,23	0,5309	c,g	350031727400000007,350031727400000007,350031727400000008	16-38,16-38,9-32					Patent	Inhibitors of farnesyl-protein transferase (Patent US:5977134)	Ciccarone	1999	0		
820	chr3	30879686	30885018	3500314144	45		30879686	30885018	8421504	2	22,23	0,5309	c	350031414400000013,350031414400000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Stump	2002	0		
820	chr3	30879686	30885018	3500294312	45		30879686	30885018	8421504	2	22,23	0,5309	c	350029431200000007,350029431200000019,350029431200000008	16-38,0-22,9-32					Patent	Inhibitors of farnesyl-protein transferase (Patent US:6015817)	Halczenko	2000	0		NRAS
820	chr3	30879686	30885018	3500289096	45		30879686	30885018	8421504	2	22,23	0,5309	c	350028909600000013,350028909600000014	16-38,9-32						INHIBITORS OF PRENYL-PROTEIN TRANSFERASE - MERCK & CO., INC.	www.sumobrain.com	0	0		NRAS
820	chr3	30879686	30885018	3500272814	45		30879686	30885018	8421504	2	22,23	0,5309	c	350027281400000012,350027281400000013	16-38,9-32						Inhibitors of prenyl-protein transferase	Hartman	2000	0		NRAS
820	chr3	30879686	30885018	3500269191	45		30879686	30885018	8421504	2	22,23	0,5309	c	350026919100000013,350026919100000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Dinsmore	2001	0		NRAS
820	chr3	30879686	30885018	3500264949	45		30879686	30885018	8421504	2	22,23	0,5309	c	350026494900000013,350026494900000014	16-38,9-32						Inhibitors of prenyl-protein transferase	William	2002	0		
820	chr3	30879686	30885018	3500259939	45		30879686	30885018	8421504	2	22,23	0,5309	c	350025993900000013,350025993900000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Anthony	2000	0		NRAS
820	chr3	30879686	30885018	3500253343	45		30879686	30885018	8421504	2	22,23	0,5309	c	350025334300000013,350025334300000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Bell	2005	0		NRAS
820	chr3	30879686	30885018	3500243501	45		30879686	30885018	8421504	2	22,23	0,5309	c	350024350100000013,350024350100000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Desolms	2001	0		
820	chr3	30879686	30885018	3500230182	45		30879686	30885018	8421504	2	22,23	0,5309	c	350023018200000007,350023018200000008	16-38,9-32						Inhibitors of farnesyl-protein transferase	Ciccarone	2001	0		NRAS
820	chr3	30879686	30885018	3500182487	45		30879686	30885018	8421504	2	22,23	0,5309	c	350018248700000013,350018248700000014	16-38,9-32					Patent	Inhibitors of prenyl-protein transferase (Patent US:6358956)	Hartman	2002	0		
820	chr3	30879686	30885018	3500145850	45		30879686	30885018	8421504	2	22,23	0,5309	c	350014585000000007,350014585000000008	10-32,9-32						Inhibitors of farnesyl-protein transferase	Halczenko	1999	0		
820	chr3	30879686	30885018	3500142333	45		30879686	30885018	8421504	2	22,23	0,5309	c	350014233300000013,350014233300000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Desolms	2001	0		NRAS
820	chr3	30879686	30885018	3500131992	45		30879686	30885018	8421504	2	22,23	0,5309	c	350013199200000013,350013199200000014	16-38,9-32					Patent	Inhibitors of prenyl-protein transferase (Patent US:6316436)	deSolms	2001	0		
820	chr3	30879686	30885018	3500131280	45		30879686	30885018	8421504	2	22,23	0,5309	c	350013128000000013,350013128000000014	16-38,9-32					Patent	Inhibitors of prenyl-protein transferase (Patent US:6410534)	Dinsmore	2002	0		NRAS
820	chr3	30879686	30885018	3500114484	45		30879686	30885018	8421504	2	22,23	0,5309	c	350011448400000013,350011448400000014	16-38,9-32					Patent	Inhibitors of prenyl-protein transferase (Patent US:6380228)	Stump	2002	0		NRAS
820	chr3	30879686	30885018	3500092255	45		30879686	30885018	8421504	2	22,23	0,5309	c	350009225500000013,350009225500000014	16-38,9-32					Patent	Inhibitors of prenyl-protein transferase (Patent US:6358985)	Anthony	2002	0		NRAS
820	chr3	30879686	30885018	3500090200	45		30879686	30885018	8421504	2	22,23	0,5309	c	350009020000000007,350009020000000008	16-38,9-32						Inhibitors of farnesyl-protein transferase	Desolms	2000	0		NRAS
820	chr3	30879686	30885018	3500089179	45		30879686	30885018	8421504	2	22,23	0,5309	c	350008917900000013,350008917900000014	16-38,9-32						Prenyl-protein transferase inhibitors	Dinsmore	2001	0		NRAS
820	chr3	30879686	30885018	3500088249	45		30879686	30885018	8421504	2	22,23	0,5309	c	350008824900000013,350008824900000014	16-38,9-32						Inhibitors of prenyl-protein transferase	Bergman	2005	0		NRAS
820	chr3	30879686	30885018	3500085674	45		30879686	30885018	8421504	2	22,23	0,5309	c,g	350008567400000013,350008567400000013,350008567400000014	16-38,16-38,9-32					Patent	Inhibitors of prenyl-protein transferase (Patent US:6376496)	Hartman	2002	0		
820	chr3	30879686	30885018	3500034151	45		30879686	30885018	8421504	2	22,23	0,5309	c	350003415100000013,350003415100000014	16-38,9-32						A METHOD OF TREATING ENDOMETRIOSIS - MERCK & CO., INC.	www.sumobrain.com	0	0		NRAS
820	chr3	30879686	30885018	3500033373	45		30879686	30885018	8421504	2	22,23	0,5309	c	350003337300000007,350003337300000008	16-38,9-32						Inhibitors of prenyl-protein transferase	Desolms	2000	0		
820	chr3	30879686	30885018	3500031614	45		30879686	30885018	8421504	2	22,23	0,5309	c	350003161400000013,350003161400000014	16-38,9-32						A method of treating cancer	Graham	2000	0		NRAS
820	chr3	30879686	30885018	3500028334	45		30879686	30885018	8421504	2	22,23	0,5309	c	350002833400000013,350002833400000014	16-38,9-32					Patent	Inhibitors of prenyl-protein transferase (Patent US:6562823)	Dinsmore	2003	0		
820	chr3	30879686	30885018	3500018213	45		30879686	30885018	8421504	2	22,23	0,5309	c	350001821300000018,350001821300000019	16-38,9-32						Method of treating cancer	Defeo-jones	2002	0		NRAS
820	chr3	30879686	30885018	3500001821	45		30879686	30885018	8421504	2	22,23	0,5309	c	350000182100000032,350000182100000013,350000182100000014,350000182100000033	16-38,16-38,9-32,9-32						Inhibitors of prenyl-protein transferase	Desolms	1999	0		
820	chr3	30879686	30879797	3500456396	77		30879686	30879797	8421504	3	51,6,20	0,53,91	c,g	350045639600000003,350045639600000003,350045639600000000,350045639600000000,350045639600000002,350045639600000001	0-57,0-57,0-20,0-20,0-20,0-20						Electronically-solid-phase assay biomolecules	Mandecki	2001	0		NRAS
820	chr3	30879686	30879745	3500388702	57		30879686	30879745	8421504	2	51,6	0,53	c,g	350038870200000003,350038870200000003	0-57,0-57						Electronically-solid-phase assay biomolecules	Mandecki	1998	0		
820	chr3	30879686	30879745	3500377497	57		30879686	30879745	8421504	2	51,6	0,53	c,g	350037749700000003,350037749700000003	0-57,0-57						Electronically-solid-phase assay biomolecules	Mandecki	1997	0		
820	chr3	30879686	30879734	3500373093	48		30879686	30879734	8421504	1	48	0	p	350037309300015045	0-48						Noey2 gene compositions and methods of use	Robert	1998	0		KRAS
820	chr3	30879686	30879710	3500311280	24		30879686	30879710	8421504	1	24	0	c	350031128000000011	0-24						Supplemental materials and methods	tologylibrary.org	0	0		NRAS
820	chr3	30879688	30879806	3500460558	39		30879688	30879806	8421504	2	20,19	0,99	c,g	350046055800000002,350046055800000002,350046055800000003	0-20,0-20,0-19		12907632		0008-5472	Cancer Research	High Prevalence of BRAF Gene Mutation in Papillary Thyroid Carcinomas and Thyroid Tumor Cell Lines	Xu	2003	8		NRAS
820	chr3	30879688	30879791	3500156942	43		30879688	30879791	8421504	2	23,20	0,83	c,g	350015694200000005,350015694200000006,350015694200000006	0-23,0-20,0-20						Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. - ResearchGate	.researchgate.net	0	0		
820	chr3	30879734	30884070	3500286722	237		30879734	30884070	8421504	4	63,126,2,46	0,2155,2332,4290	p	350028672200015003,350028672200015004,350028672200015005,350028672200015006,350028672200015008	0-48,0-48,0-48,0-45,0-48						METHOD OF TREATMENT WITH BRAF INHIBITOR - Patent application	www.faqs.org	0	0		
820	chr3	30879789	30879812	3500445106	23		30879789	30879812	8421504	1	23	0	g	350044510600000001	0-23		12446472		0009-9147	Clinical Chemistry	Pyrosequencing as an Alternative to Single-Strand Conformation Polymorphism Analysis for Detection of N-ras Mutations in Human Melanoma Metastases	Sivertsson	2002	8		
820	chr3	30881924	30882004	3500400177	47		30881924	30882004	8421504	2	26,21	0,59	c,g	350040017700000002,350040017700000003,350040017700000003	0-26,0-21,0-21						Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters. - ResearchGate	.researchgate.net	0	0		NRAS
820	chr3	30881958	30884984	3500063399	360		30881958	30884984	8421504	3	110,160,90	0,2066,2936	p	350006339900015012,350006339900015007,350006339900015024	0-180,0-180,0-180						Patr&#xed;cia Ribeiro Biomarcadores moleculares em peixes expostos a Nogueira compostos xenobi&#xf3;ticos Molecular biomarkers in fish exposed to xenobiotics	ria.ua.pt/bitstre	0	0		NRAS
820	chr3	30882063	30884064	3500382888	45		30882063	30884064	8421504	2	5,40	0,1961	p	350038288800015001	0-45						Phenotypic Reversion Of Pancreatic Carcinoma Cells 	.freshpatents.com	0	0		HRAS
820	chr3	30884966	30885011	3500009992	45		30884966	30885011	8421504	1	45	0	p	350000999200015031	0-45						Assays and reagents for identifying anti-fungal agents, and uses related thereto	Berlin	1998	0		NRAS
821	chr3	30977396	30977421	3500399978	23		30977396	30977421	8421504	2	5,18	0,7	c	350039997800000025,350039997800000054	13-36,13-36						Collagen-binding proteins from streptococcus pyogenes	www.devileye.net	0	0		
102	chr3	31164339	31202253	3500219482	45		31164339	31202253	8421504	2	41,4	0,37910	p	350021948200015082	0-45						P53 MODULATOR AND CANCER TARGET - Patent application	www.faqs.org	0	0		TRIM33
823	chr3	31311379	31311403	3500251744	23		31311379	31311403	8421504	2	9,14	0,10	g	350025174400000001	12-35						DNA methylation patterns in tissues from mid-gestation bovine foetuses produced by somatic cell nuclear transfer show subtle abnormalities in nuclear reprogramming	biomedcentral.com	0	0		
824	chr3	31368540	31368565	3500108622	24		31368540	31368565	8421504	2	4,20	0,5	g	350010862200000369	7-31						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
826	chr3	31652280	31653808	3500457611	41		31652280	31653808	8421504	2	21,20	0,1508	c,g	350045761100000009,350045761100000006,350045761100000006	0-21,0-20,0-20						OLFML3 Expression is Decreased during Prenatal Muscle Development and Regulated by MicroRNA-155 in Pigs	www.ijbs.com	0	0		OLFML3
826	chr3	31652280	31653808	3500315004	41		31652280	31653808	8421504	2	21,20	0,1508	c,g	350031500400000009,350031500400000006,350031500400000006	0-21,0-20,0-20						Research Paper OLFML3 Expression is Decreased during Prenatal Muscle Development and Regulated by MicroRNA-155 in Pigs	www.ijbs.com	0	0		OLFML3
826	chr3	31661444	31699909	3500322270	3132		31661444	31699909	8421504	17	486,131,242,207,183,143,135,3,92,226,162,183,87,120,3,1,728	0,1583,3728,5606,6289,6871,9605,10684,10714,15385,16402,16932,18060,18845,28172,28295,37737	p	350032227000015069	0-3132						Novel human proteins, polynucleotides encoding them and methods of using the same	Spytek	2002	0		
834	chr3	32669990	32676851	3500321053	49		32669990	32676851	8421504	2	25,24	0,6837	c,g	350032105300000000,350032105300000000,350032105300000001,350032105300000001	0-25,0-25,1-25,1-25		16857719	10.1113/expphysiol.2006.033837	0958-0670	Experimental Physiology	Monocarboxylate transporter 1 (MCT1) mediates transport of short-chain fatty acids in bovine caecum	Kirat	2006	3		SLC16A1,AKR7A2P1
834	chr3	32669990	32676851	3500068681	49		32669990	32676851	8421504	2	25,24	0,6837	c,g	350006868100000000,350006868100000001,350006868100000001	0-25,1-25,1-25			10.1113/expphysiol.2006.033837	1469-445X	Experimental Physiology	Monocarboxylate transporter 1 (MCT1) mediates transport of short-chain fatty acids in bovine caecum - Kirat - 2006 - Experimental Physiology - Wiley Online Library	Kirat	2006	0		SLC16A1,AKR7A2P1
834	chr3	32674843	32674866	3500454173	23		32674843	32674866	8421504	1	23	0	c	350045417300000000	0-23		16901943	10.1113/jphysiol.2006.115931	0022-3751	The Journal of Physiology	Monocarboxylate transporter 1 (MCT1) plays a direct role in short-chain fatty acids absorption in caprine rumen	Kirat	2006	5		
834	chr3	32676198	32676221	3500056603	23		32676198	32676221	8421504	1	23	0	c	350005660300000001	0-23						ScienceDirect.com - The Veterinary Journal - Monocarboxylate transporter 1 gene expression in the ovine gastrointestinal tract	sciencedirect.com	0	0		
836	chr3	32972317	32972346	3500305758	26		32972317	32972346	8421504	2	8,18	0,11	g	350030575800000005	0-26			10.1111/j.1574-6968.2004.tb09685.x	1574-6968	FEMS Microbiology Letters	Mutational analyses of the thermostable NAD+-dependent DNA ligase from Thermus filiformis - Jeon - 2006 - FEMS Microbiology Letters - Wiley Online Library	Jeon	2004	0		
836	chr3	32995788	32995818	3500270006	30		32995788	32995818	8421504	1	30	0	c	350027000600000016	12-42		15831458	10.1128/MCB.25.9.3519-3534.2005	0270-7306	Molecular and Cellular Biology	The Pleckstrin Homology Domain-Containing Protein CKIP-1 Is Involved in Regulation of Cell Morphology and the Actin Cytoskeleton and Interaction with Actin Capping Protein	Canton	2005	6		
837	chr3	33127779	33133003	3500216650	38		33127779	33133003	8421504	2	19,19	0,5205	c,g	350021665000000007,350021665000000007,350021665000000006	0-19,0-19,0-19			10.1002/dvdy.10315	1097-0177	Developmental Dynamics	Characterization of Wnt signaling components and activation of the Wnt canonical pathway in the murine retina - Liu - 2003 - Developmental Dynamics - Wiley Online Library	Liu	2003	0		
838	chr3	33171149	33171175	3500435248	23		33171149	33171175	8421504	2	9,14	0,12	c	350043524800000005	0-23						Identification Of Oligonucleotides For The Capture, Detection And Quantitation Of West Nile Virus 	.freshpatents.com	0	0		
838	chr3	33171149	33171175	3500208479	23		33171149	33171175	8421504	2	9,14	0,12	c	350020847900000005	0-23						Identification Of Oligonucleotides For The Capture, Detection And Quantitation Of West Nile Virus 	.freshpatents.com	0	0		
838	chr3	33171149	33171175	3500135121	23		33171149	33171175	8421504	2	9,14	0,12	c	350013512100000005	0-23						Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus - US Patent 7833758 Description	ww.patentstorm.us	0	0		
105	chr3	33646843	33912744	3500110814	1965		33646843	33912744	8421504	7	1106,163,102,90,57,248,199	0,252376,261077,261510,263105,264540,265702	p	350011081400015000	0-1965						KEGG T01001: 3752	www.genome.jp	0	0		KCND3
841	chr3	33646938	33646962	3500375438	24		33646938	33646962	8421504	1	24	0	c	350037543800000001	0-24						NeurobiologyofDisease ReducedExpressionofA-TypePotassiumChannels inPrimarySensoryNeuronsInduces MechanicalHypersensitivity	bml.ym.edu.tw	0	0		KCND3
841	chr3	33646938	33646962	3500308928	24		33646938	33646962	8421504	1	24	0	c	350030892800000001	0-24		17855600	10.1523/JNEUROSCI.0604-07.2007	0270-6474	The Journal of Neuroscience	Reduced Expression of A-Type Potassium Channels in Primary Sensory Neurons Induces Mechanical Hypersensitivity	Chien	2007	7		KCND3
105	chr3	33647936	33909980	3500222539	40		33647936	33909980	8421504	3	13,7,20	0,251283,262024	c,g	350022253900000003,350022253900000004,350022253900000004	20-40,0-20,0-20		20370806	10.1111/j.1755-5949.2010.00133.x	1755-5949	CNS Neuroscience & Therapeutics	Effects of Acetazolamide on Transient K+ Currents and Action Potentials in Nodose Ganglion Neurons of Adult Rats - Matsumoto - 2010 - CNS Neuroscience & Therapeutics - Wiley Online Library	Matsumoto	2011	0		
844	chr3	33974025	33974299	3500320074	38		33974025	33974299	8421504	2	19,19	0,255	c,g	350032007400000005,350032007400000004,350032007400000004	0-19,0-19,0-19						RAS FAMILY MEMBERS Dissertation Submitted to the Faculty of the in partial fulfillment of the requirements	ry.vanderbilt.edu	0	0		RAP1A
844	chr3	33977380	33990350	3500432038	495		33977380	33990350	8421504	5	84,144,141,57,69	0,6014,8058,10856,12901	p	350043203800015001,350043203800015003	0-495,0-54						Mutant Smg p21 protein with GTP binding activity	Takai	1992	0		RAP1A
844	chr3	33977434	33992247	3500116014	44		33977434	33992247	8421504	2	20,24	0,14789	c,g	350011601400000005,350011601400000004,350011601400000004	0-20,0-24,0-24						Role of SPA-1inPhenotypesof Chronic Myelogenous	www.docstoc.com	0	0		RAP1A
844	chr3	33990342	33992210	3500155523	25		33990342	33992210	8421504	2	8,17	0,1851	c	350015552300000014	0-25		17724123	10.1083/jcb.200610073	0021-9525	The Journal of Cell Biology	Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes, leading to sustained activation of Rap1 and ERK and neurite outgrowth	Hisata	2007	10		
844	chr3	33992223	33992248	3500411517	25		33992223	33992248	8421504	1	25	0	c	350041151700000001	0-25						The M-Ras-RA-GEF-2-Rap1 Pathway Mediates Tumor Necrosis Factor- &#x2013;dependent Regulation of Integrin Activation in Splenocytes	w.molbiolcell.org	0	0		RAP1A
844	chr3	33992223	33992248	3500407530	25		33992223	33992248	8421504	1	25	0	c	350040753000000001	0-25		17538012	10.1091/mbc.E07-03-0250	1059-1524	Molecular Biology of the Cell	The M-Ras-RA-GEF-2-Rap1 Pathway Mediates Tumor Necrosis Factor-&#x03b1;&#x2013;dependent Regulation of Integrin Activation in Splenocytes	Yoshikawa	2007	5		RAP1A
845	chr3	34197710	34197812	3500222505	41		34197710	34197812	8421504	2	21,20	0,82	c,g	350022250500000002,350022250500000002,350022250500000003,350022250500000003	0-21,0-21,0-20,0-20						Adenosine A1 Receptors Promote Vasa Vasorum Endothelial Cell Barrier Integrity via Gi and Akt-Dependent Actin Cytoskeleton Remodeling. - ResearchGate	.researchgate.net	0	0		
846	chr3	34230649	34237307	3500435181	237		34230649	34237307	8421504	5	45,15,102,15,60	0,2475,6086,6532,6598	p	350043518100015054,350043518100015037,350043518100015028	0-60,0-117,0-60						Jolly Thesis 1993 | Alain Dautant - Academia.edu	www.academia.edu	0	0		
846	chr3	34237193	34240187	3500409160	40		34237193	34240187	8421504	3	20,16,4	0,136,2990	c	350040916000000023,350040916000000022	0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
846	chr3	34276306	34276357	3500465087	39		34276306	34276357	8421504	2	19,20	0,31	c,g	350046508700000012,350046508700000012,350046508700000013,350046508700000013	0-19,0-19,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
846	chr3	34285686	34285709	3500222801	23		34285686	34285709	8421504	1	23	0	c	350022280100000013	21-44						Preliminary comparative RH mapping between river buffalo chromosome 6 (BBU6) and bovine chromosome 3 (BTA3) - ResearchGate	.researchgate.net	0	0		
846	chr3	34285686	34285709	3500070560	23		34285686	34285709	8421504	1	23	0	c	350007056000000013	21-44						Preliminary radiation hybrid map for river buffalo chromosome 6 and comparison to bovine chromosome 3	ticabovina.com.br	0	0		
105	chr3	34464193	34482135	3500144585	1146		34464193	34482135	8421504	11	120,120,186,124,125,6,151,57,202,30,25	0,207,1067,1536,2087,5930,5945,7068,15310,16053,17917	p	350014458500015011,350014458500015017	0-681,0-465						Palaemonetes_pugio-Contig_381-v1 | MarineGenomics.org	arinegenomics.org	0	0		
848	chr3	34556628	34557654	3500205057	42		34556628	34557654	8421504	2	22,20	0,1006	g	350020505700000007,350020505700000006	0-22,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
849	chr3	34627712	34649283	3500434555	705		34627712	34649283	8421504	6	117,126,159,132,85,86	0,807,1427,2090,9175,21485	p	350043455500015031,350043455500015037,350043455500015036,350043455500015035,350043455500015034,350043455500015033,350043455500015032	0-702,0-144,0-111,0-114,0-114,0-114,0-108						31 human secreted proteins	Ni	2001	0		CEPT1
849	chr3	34636900	34636925	3500246164	25		34636900	34636925	8421504	1	25	0	c	350024616400000001	0-25						Identification of a Physiologically Relevant Endogenous Ligand for PPAR&#x03b1; in Liver	iencias.uchile.cl	0	0		CEPT1
849	chr3	34672743	34672806	3500429996	63		34672743	34672806	8421504	1	63	0	p	350042999600015001	0-63					Patent	5' ESTs for secreted proteins expressed in various tissues (Patent EP:1378571)	Duclert	2011	0		DRAM2
849	chr3	34672743	34672806	3500409040	63		34672743	34672806	8421504	1	63	0	p	350040904000015002	0-63					Patent	5' ests f&#xfc;r sekretierte proteine die im gehirn expremiert werden 5 'ests for secreted proteins that are expressed in the brain (Patent DE:69834190)	Duclert	2007	0		DRAM2
849	chr3	34672743	34672806	3500319328	63		34672743	34672806	8421504	1	63	0	p	350031932800015006	0-63						EXTENDED cDNAs FOR SECRETED PROTEINS	Bougueleret	2000	0		DRAM2
849	chr3	34672743	34672806	3500257421	63		34672743	34672806	8421504	1	63	0	p	350025742100015001	0-63					Patent	5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES (Patent EP:1000149)	Duclert	2007	0		DRAM2
849	chr3	34672743	34672806	3500110945	63		34672743	34672806	8421504	1	63	0	p	350011094500015001	0-63					Patent	5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN (Patent EP:1000150)	Duclert	2006	0		DRAM2
849	chr3	34672743	34672806	3500109417	63		34672743	34672806	8421504	1	63	0	p	350010941700015006	0-63						EXTENDED cDNAs FOR SECRETED PROTEINS	Bougueleret	1999	0		DRAM2
849	chr3	34672743	34672806	3500088517	63		34672743	34672806	8421504	1	63	0	p	350008851700015009	0-63						Cdnas encoding secreted proteins	Bougueleret	1999	0		DRAM2
851	chr3	34964142	34964180	3500011328	38		34964142	34964180	8421504	1	38	0	c	350001132800000490	0-38						US Patent # 7,119,183. Rapid immunoselection cloning method - Patents.com	www.patents.com	0	0		
855	chr3	35393136	35393160	3500137760	24		35393136	35393160	8421504	1	24	0	g	350013776000000028	24-48						A novel voltage-gated potassium channel gene	Chandy	1995	0		
855	chr3	35414053	35424654	3500102231	43		35414053	35424654	8421504	3	19,10,14	0,7646,10587	c,g	350010223100000003,350010223100000003,350010223100000001	0-19,0-19,3-27						Recombinant Lamb Chymosin as an Alternative Coagulating Enzyme in	www.docstoc.com	0	0		
855	chr3	35414056	35424651	3500292678	1092		35414056	35424651	8421504	9	136,98,145,114,200,119,118,151,11	0,847,1560,3027,3721,5438,6624,7502,10584	p	350029267800015007,350029267800015006,350029267800015005,350029267800015004,350029267800015003,350029267800015002,350029267800015001,350029267800015000	0-45,0-243,255-408,0-150,0-150,0-156,72-222,303-525						&#x041f;&#x0420;&#x0418;&#x041e;&#x0420;&#x0418;&#x0422;&#x0415;&#x0422;&#x041d;&#x042b;&#x0419; &#x041d;&#x0410;&#x0426;&#x0418;&#x041e;&#x041d;&#x0410;&#x041b;&#x042c;&#x041d;&#x042b;&#x0419; &#x041f;&#x0420;&#x041e;&#x0415;&#x041a;&#x0422; &#x041e;&#x0	web-local.rudn.ru	0	0		
855	chr3	35414056	35421591	3500238389	930		35414056	35421591	8421504	12	90,40,98,45,97,101,1,200,119,1,105,33	0,96,847,1560,1608,3027,3140,3721,5438,6624,6637,7502	p	350023838900015039,350023838900015038,350023838900015027,350023838900015026,350023838900015011,350023838900015010	0-90,0-183,0-198,0-135,0-186,0-138						Structure ofthe humanrenin gene	www.pnas.org	0	0		
855	chr3	35414065	35424702	3500126991	1134		35414065	35424702	8421504	9	127,98,145,114,200,119,118,151,62	0,838,1551,3018,3712,5429,6615,7493,10575	p,c,g	350012699100000022,350012699100000022,350012699100015042,350012699100015039,350012699100000021,350012699100000021,350012699100000020,350012699100015036,350012699100015034,350012699100000019,350012699100015032,350012699100000037,350012699100000037,350012699100000018,350012699100015029,350012699100000017,350012699100000017,350012699100015051,350012699100015027,350012699100000016,350012699100000052,350012699100000015,350012699100000015,350012699100015024,350012699100000014,350012699100015021,350012699100015018,350012699100000013,350012699100000013,350012699100015015,350012699100000012,350012699100000012,350012699100015012,350012699100000048,350012699100000011,350012699100000030,350012699100000030,350012699100015009,350012699100000010,350012699100000010,350012699100000028,350012699100000009,350012699100015006,350012699100015003,350012699100000008,350012699100000008,350012699100000027,350012699100000027,350012699100000007,350012699100015000,350012699100015048,350012699100000025,350012699100000025,350012699100000024,350012699100015046,350012699100015045	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-54,0-54,0-60,0-60,0-63,0-63,0-63,0-63,0-63,0-48						Processes for producing pre-prorennin, prorennin and rennin	Alford	1989	0		
855	chr3	35414065	35424654	3500348397	846		35414065	35424654	8421504	9	96,81,145,114,140,48,96,112,14	0,855,1551,3018,3712,5465,6628,7532,10575	c,g	350034839700000077,350034839700000076,350034839700000074,350034839700000073,350034839700000072,350034839700000071,350034839700000070,350034839700000069,350034839700000068,350034839700000067,350034839700000066,350034839700000065,350034839700000062,350034839700000060,350034839700000059,350034839700000059,350034839700000057,350034839700000056,350034839700000055	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,18-48						Preparation of heterologous proteins on oil bodies	Moloney	2001	0		
855	chr3	35414065	35424654	3500260674	990		35414065	35424654	8421504	10	127,98,111,100,200,119,61,9,151,14	0,838,1551,3032,3712,5429,6615,6724,7493,10575	c,g	350026067400000080,350026067400000080,350026067400000079,350026067400000078,350026067400000077,350026067400000076,350026067400000075,350026067400000074,350026067400000072,350026067400000071,350026067400000071,350026067400000070,350026067400000069,350026067400000069,350026067400000068,350026067400000068,350026067400000067,350026067400000066,350026067400000065,350026067400000064,350026067400000063,350026067400000061,350026067400000060,350026067400000059,350026067400000058	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,18-48						Preparation of thioredoxin and thioredoxin reductase proteins on oil bodies	Moloney	2001	0		
855	chr3	35414071	35424654	3500036303	1080		35414071	35424654	8421504	9	121,98,145,114,200,119,118,151,14	0,832,1545,3012,3706,5423,6609,7487,10569	p,c,g	350003630300015017,350003630300000035,350003630300000035,350003630300015016,350003630300000033,350003630300000033,350003630300000031,350003630300015015,350003630300000029,350003630300015014,350003630300000027,350003630300000027,350003630300015013,350003630300000025,350003630300000023,350003630300000021,350003630300015011,350003630300015010,350003630300000019,350003630300000019,350003630300000017,350003630300000017,350003630300015009,350003630300000015,350003630300000015,350003630300015008,350003630300000013,350003630300015007,350003630300000011,350003630300000011,350003630300015006,350003630300000009,350003630300015005,350003630300000007,350003630300015004,350003630300000005,350003630300015003,350003630300000003,350003630300000003,350003630300015002,350003630300000001,350003630300015001	0-60,0-60,0-60,0-63,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,6-66						Produ&#xe7;&#xe3;o de quimosina B de Bos taurus em Pichia pastoris	bdtd.bce.unb.br	0	0		
855	chr3	35414074	35421699	3500418009	904		35414074	35421699	8421504	18	45,22,71,23,18,45,28,65,26,48,45,45,15,33,119,67,48,141	0,96,829,904,1542,1566,1659,3009,3096,3705,3756,3804,3852,3870,5420,6606,6676,7484	p,c	350041800900015036,350041800900000023,350041800900015032,350041800900000021,350041800900000045,350041800900015077,350041800900015030,350041800900000019,350041800900015056,350041800900015074,350041800900015053,350041800900000040,350041800900015073,350041800900000038,350041800900000014,350041800900000037,350041800900015017,350041800900015085,350041800900015047,350041800900015016,350041800900015015,350041800900015046,350041800900015084,350041800900015068,350041800900015067,350041800900015011,350041800900015066,350041800900015083,350041800900015045,350041800900015010,350041800900015007,350041800900015064,350041800900015043,350041800900000027,350041800900015005,350041800900015062,350041800900015002	0-45,6-44,0-45,0-23,0-20,0-45,0-45,0-41,0-45,0-45,0-45,0-41,0-45,0-26,0-26,15-42,0-45,0-105,12-102,0-45,0-45,0-150,0-150,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Commercial production of chymosin in plants - Patent # 7390936 - PatentGenius	.patentgenius.com	0	0		
855	chr3	35414113	35420738	3500185259	543		35414113	35420738	8421504	15	45,45,34,11,45,52,41,45,45,45,12,33,35,10,45	0,807,1614,2970,2984,3032,3664,3708,3756,3804,3852,5381,5465,6567,6580	p	350018525900015013,350018525900015011,350018525900015007,350018525900015006,350018525900015004,350018525900015003	0-45,0-45,0-318,0-45,0-45,0-45						 Method Of Producing An Aspartic Protease In A Recombinant Host Organism 	www.docstoc.com	0	0		
855	chr3	35417164	35419606	3500361848	345		35417164	35419606	8421504	3	33,200,112	0,613,2330	c,g	350036184800000018,350036184800000018,350036184800000017,350036184800000017,350036184800000016,350036184800000016,350036184800000015,350036184800000015,350036184800000014,350036184800000014,350036184800000013,350036184800000013,350036184800000012,350036184800000012,350036184800000011,350036184800000011,350036184800000010,350036184800000010	0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69,0-69						&#x5fae;&#x5c0f;&#x6bdb;&#x9709;&#x51dd;&#x4e73;&#x9176;&#x57fa;&#x56e0;&#x7684;&#x514b;&#x9686;&#x4e0e;&#x8868;&#x8fbe; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
855	chr3	35421609	35424654	3500232263	114		35421609	35424654	8421504	2	100,14	0,3031	p	350023226300015012,350023226300015207,350023226300015011	0-63,3-117,156-207					Patent	&#x5728;&#x690d;&#x7269;&#x4e2d;&#x751f;&#x4ea7;&#x80f0;&#x5c9b;&#x7d20;&#x7684;&#x65b9;&#x6cd5; (Patent CN:1836047)	Ji Jie Si *Fan Lu Yi Jie En 	2010	0		
855	chr3	35421609	35421681	3500210720	72		35421609	35421681	8421504	1	72	0	p	350021072000015147	0-72						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
855	chr3	35424678	35424702	3500380641	24		35424678	35424702	8421504	1	24	0	c,g	350038064100000000,350038064100000000	0-24,0-24						Use of active recombinant chymosin	Ageitos	2009	0		
857	chr3	35672794	35673441	3500128308	40		35672794	35673441	8421504	3	5,15,20	0,8,627	c,g	350012830800000002,350012830800000004,350012830800000004	0-20,0-20,0-20						Molecular identification of Kvasubunits that contribute to the oxygen-sensitive K current of chemoreceptor cells of the rabbit carotid body	jp.physoc.org	0	0		KCNC3
857	chr3	35673324	35673347	3500158521	23		35673324	35673347	8421504	1	23	0	c	350015852100000006	22-45		19955484	10.1152/ajpcell.00251.2009		American journal of physiology Cell physiology	Electrophysiological properties of human induced pluripotent stem cells.	Jiang	2010	0		KCNC4
857	chr3	35685079	35685136	3500342863	57		35685079	35685136	8421504	1	57	0	p	350034286300015053	0-57							library.wiley.com	0	0		KCNC4
857	chr3	35685570	35685594	3500375438	24		35685570	35685594	8421504	1	24	0	c	350037543800000000	0-24						NeurobiologyofDisease ReducedExpressionofA-TypePotassiumChannels inPrimarySensoryNeuronsInduces MechanicalHypersensitivity	bml.ym.edu.tw	0	0		KCNC4
857	chr3	35685570	35685594	3500308928	24		35685570	35685594	8421504	1	24	0	c	350030892800000000	0-24		17855600	10.1523/JNEUROSCI.0604-07.2007	0270-6474	The Journal of Neuroscience	Reduced Expression of A-Type Potassium Channels in Primary Sensory Neurons Induces Mechanical Hypersensitivity	Chien	2007	7		KCNC4
858	chr3	35844314	35852881	3500231766	1236		35844314	35852881	8421504	12	245,205,105,67,101,127,98,75,72,64,66,11	0,1409,2225,2881,3689,3998,5305,5598,6162,7330,7499,8556	p	350023176600015006	9-1245						29 human secreted proteins	Birse	2001	0		STRIP1
859	chr3	35962323	35962348	3500108622	23		35962323	35962348	8421504	2	5,18	0,7	g	350010862200000374	10-34						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
859	chr3	35966018	35966042	3500222801	24		35966018	35966042	8421504	1	24	0	c	350022280100000015	16-40						Preliminary comparative RH mapping between river buffalo chromosome 6 (BBU6) and bovine chromosome 3 (BTA3) - ResearchGate	.researchgate.net	0	0		
859	chr3	35966018	35966042	3500070560	24		35966018	35966042	8421504	1	24	0	c	350007056000000015	16-40						Preliminary radiation hybrid map for river buffalo chromosome 6 and comparison to bovine chromosome 3	ticabovina.com.br	0	0		
859	chr3	35966022	35972477	3500466907	123		35966022	35972477	8421504	3	41,48,34	0,2198,6421	c	350046690700000052,350046690700000032,350046690700000068,350046690700000029	0-41,0-48,3-48,0-34						Multifunctional M-CSF proteins and genes encoding therefor - US Patent 5567611 Description	ww.patentstorm.us	0	0		
859	chr3	35966112	35972573	3500139055	74		35966112	35972573	8421504	2	26,48	0,6413	c	350013905500000097,350013905500000007	0-26,0-48					Patent	DNA encoding NV2 (long form) and carboxy truncated fragments thereof (Patent US:6146851)	Coyne	2000	0		
859	chr3	35966750	35968316	3500410278	75		35966750	35968316	8421504	2	30,45	0,1521	c	350041027800000045,350041027800000038	0-30,0-45					Patent	Multifunctional M-CSF proteins and genes encoding therefor (Patent US:6022953)	Larrick	2000	0		
859	chr3	35966928	35968268	3500178474	92		35966928	35968268	8421504	2	47,45	0,1295	c	350017847400000062,350017847400000060	0-47,3-48					Patent	Peptide and protein fusions to thioredoxin and thioredoxin-like molecules (Patent US:5270181)	LaVallie	1993	0		
859	chr3	35966928	35967009	3500186944	81		35966928	35967009	8421504	1	81	0	c,g	350018694400000062,350018694400000061	0-47,12-46						 Peptide And Protein Fusions To Thioredoxin And Thioredoxin 	www.docstoc.com	0	0		
859	chr3	35966957	35966985	3500324612	24		35966957	35966985	8421504	2	17,7	0,21	c	350032461200000001	3-28						&#x7b2c;&#x516d;&#x7ae0;&#x7b2c;&#x516d;&#x7ae0;&#x7b2c;&#x516d;&#x7ae0;&#x7b2c;&#x516d;&#x7ae0; &#x5206;&#x5b50;&#x8fdb;&#x5316;&#x4e0e;&#x57fa;&#x56e0;&#x7ec4;&#x6f14;&#x5316;&#x7684; &#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x7814;&#x7a76; &#xff08;&#xf	ww.coe.pku.edu.cn	0	0		
859	chr3	35966957	35966985	3500043918	24		35966957	35966985	8421504	2	17,7	0,21	c	350004391800000005	3-28						&#x7b2c;&#x4e94;&#x7ae0;&#x7b2c;&#x4e94;&#x7ae0;&#x7b2c;&#x4e94;&#x7ae0;&#x7b2c;&#x4e94;&#x7ae0; &#x57fa;&#x5b66;&#x7684;&#x57fa;&#x56e0;&#x7ec4;&#x5b66;&#x7684; &#x751f;&#x7269;&#x4fe1;&#x606f;&#x5b66;&#x7814;&#x7a76; &#xff08;&#xff08;Part IIPart II	ww.coe.pku.edu.cn	0	0		
859	chr3	35966975	35972576	3500245451	140		35966975	35972576	8421504	4	32,15,45,48	0,1232,1248,5553	c	350024545100000061,350024545100000060,350024545100000055	1-48,3-48,0-48					Patent	Peptide and protein fusions to thioredoxin and thioredoxin-like molecules (Patent US:5292646)	LaVallie	1994	0		
859	chr3	35966975	35968268	3500087097	92		35966975	35968268	8421504	3	32,15,45	0,1232,1248	c	350008709700000061,350008709700000060	1-48,3-48					Patent	Peptide and protein fusions to thioredoxin and thioredoxin-like molecules (Patent US:5292646)	LaVallie	1994	0		
859	chr3	35968223	35972576	3500245482	93		35968223	35972576	8421504	2	45,48	0,4305	c	350024548200000165,350024548200000160	3-48,0-48						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
859	chr3	35968224	35968248	3500067250	24		35968224	35968248	8421504	1	24	0	c	350006725000000005	1-25		19427849	10.1016/j.yexcr.2009.05.002		Experimental cell research	Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation	Kader	2009	0		CSF1
859	chr3	35968343	35974160	3500136244	110		35968343	35974160	8421504	7	12,9,22,24,22,12,9	0,4077,4118,4141,4168,4236,5808	c	350013624400000010,350013624400000004,350013624400000005,350013624400000003,350013624400000009	0-21,0-22,0-24,0-22,0-21						ScienceDirect.com - Theriogenology - Gene expression of leukemia inhibitory factor (LIF) and macrophage colony stimulating factor (M-CSF) in bovine endometrium during early pregnancy	sciencedirect.com	0	0		
859	chr3	35972448	35972591	3500362403	40		35972448	35972591	8421504	2	20,20	0,123	c,g	350036240300000047,350036240300000046,350036240300000046	0-20,0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
860	chr3	36131266	36131290	3500440698	24		36131266	36131290	8421504	1	24	0	c	350044069800000023	24-48						Inhibitors of Dkk-1	Prockop	2007	0		
860	chr3	36131266	36131290	3500347249	24		36131266	36131290	8421504	1	24	0	c	350034724900000023	24-48						Inhibitors of Dkk-1	Prockop	2004	0		GSTM3
860	chr3	36131266	36131290	3500207603	24		36131266	36131290	8421504	1	24	0	c	350020760300000023,350020760300000053	24-48,0-24						Inhibitors Of Dkk-1 	.freshpatents.com	0	0		
860	chr3	36144354	36144381	3500354368	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350035436800000032	0-23					Patent	Method of humanizing immune system molecules (Patent CN:100584946)	H*C*Weng 	2010	0		
860	chr3	36144354	36144381	3500337167	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350033716700000019	0-23						Method of humanizing immune system molecules	Mosquera	2005	0		
860	chr3	36144354	36144381	3500335525	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350033552500000037	0-23						Method of humanizing immune system molecules	H*C*Weng 	2005	0		
860	chr3	36144354	36144381	3500292099	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350029209900000043	0-23						Antibodies for inhibiting blood coagulation and methods of use thereof	Jiao	2006	0		
860	chr3	36144354	36144381	3500241794	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350024179400000019	0-23						Compositions and methods for treating coagulation related disorders	Jiao	2005	0		
860	chr3	36144354	36144381	3500201243	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350020124300000019,350020124300000087	0-23,0-23						COMPOSITIONS AND METHODS FOR TREATING COAGULATION RELATED DISORDERS - Patent application	www.faqs.org	0	0		
860	chr3	36144354	36144381	3500138484	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350013848400000035	0-23						Antibodies for inhibiting blood coagulation and methods of use thereof	Jiao	2009	0		
860	chr3	36144354	36144381	3500075549	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350007554900000068,350007554900000013	0-23,0-23						USE OF ANTI-TISSUE FACTOR ANTIBODIES FOR TREATING THROMBOSES - Patent application	www.faqs.org	0	0		
860	chr3	36144354	36144381	3500072583	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350007258300000035,350007258300000103	0-23,0-23						ANTIBODIES FOR INHIBITING BLOOD COAGULATION AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
860	chr3	36144354	36144381	3500065734	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350006573400000019	0-23						Compositions and methods for treating coagulation related disorders	Jiao	2006	0		
860	chr3	36144354	36144381	3500043661	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350004366100000053	0-23						Antibodies for inhibiting blood coagulation and methods of use thereof	Jiao Jian An 	2005	0		
860	chr3	36144354	36144381	3500013245	23		36144354	36144381	8421504	3	5,7,11	0,7,16	c	350001324500000013	0-23						Use Of Anti-tissue Factor Antibodies For Treating Thromboses 	.freshpatents.com	0	0		
860	chr3	36161628	36162035	3500461945	102		36161628	36162035	8421504	2	66,36	0,371	p	350046194500015000	0-102						Data Interoperability - the vision of seamless data-sharing in 	www.docstoc.com	0	0		GSTM1
860	chr3	36161628	36162035	3500221245	102		36161628	36162035	8421504	2	66,36	0,371	p	350022124500015000	0-102						PPT &#x2013; Russ Miller PowerPoint presentation | free to download 	www.powershow.com	0	0		GSTM1
860	chr3	36161628	36162035	3500186998	102		36161628	36162035	8421504	2	66,36	0,371	p	350018699800015002	0-102						Moores Law, Management of Information Systems	www.docstoc.com	0	0		GSTM1
860	chr3	36161628	36162035	3500004878	102		36161628	36162035	8421504	2	66,36	0,371	p	350000487800015000	0-102						Open Analytics Environment	ww.slideshare.net	0	0		GSTM1
860	chr3	36167652	36175434	3500077888	43		36167652	36175434	8421504	3	19,4,20	0,7702,7762	c,g	350007788800000039,350007788800000038,350007788800000038	0-23,0-20,0-20						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
861	chr3	36235430	36235454	3500096737	23		36235430	36235454	8421504	2	5,18	0,6	g	350009673700000161	1-24						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
861	chr3	36235430	36235454	3500094640	23		36235430	36235454	8421504	2	5,18	0,6	c	350009464000000161	1-24						SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION	Natt	2010	0		
861	chr3	36235430	36235454	3500085091	23		36235430	36235454	8421504	2	5,18	0,6	c	350008509100000161	1-24						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
861	chr3	36240669	36241979	3500330892	180		36240669	36241979	8421504	4	3,65,76,36	0,302,796,1274	p	350033089200015028,350033089200015029	0-180,0-60						A Web-based Tool for Visual Identification of Novel Genes	w.cs.virginia.edu	0	0		
861	chr3	36298570	36298594	3500429007	23		36298570	36298594	8421504	2	17,6	0,18	c	350042900700000033	0-24						Assay method for screening for inhibitors of proTNF conversion	Halenbeck	1995	0		
861	chr3	36298570	36298594	3500399779	23		36298570	36298594	8421504	2	17,6	0,18	c	350039977900000035	0-24						Compositions for the inhibition of tnf formation and uses thereof	Halenback	1995	0		
861	chr3	36300121	36300145	3500237963	23		36300121	36300145	8421504	2	4,19	0,5	c	350023796300000110	20-45						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
862	chr3	36313753	36313801	3500333014	48		36313753	36313801	8421504	1	48	0	p	350033301400015074	0-48						Gustducin materials and methods	Margolskee	1995	0		GNAT2
862	chr3	36315929	36315986	3500147730	57		36315929	36315986	8421504	1	57	0	p	350014773000015029	0-57						Sequenceanalysis cDNAand DNA	www.pnas.org	0	0		
862	chr3	36316010	36316055	3500290055	45		36316010	36316055	8421504	1	45	0	p	350029005500015012	54-99						Inhibitory of cDNA acid	www.pnas.org	0	0		
862	chr3	36322437	36322463	3500433472	26		36322437	36322463	8421504	1	26	0	c	350043347200000000	0-26						NeurobiologyofDisease TraffickingofMembrane-AssociatedProteinstoCone PhotoreceptorOuterSegmentsRequirestheChromophore 11-cis-Retinal	macology.case.edu	0	0		GNAT2
862	chr3	36322458	36322533	3500156701	75		36322458	36322533	8421504	1	75	0	p	350015670100015074	0-75						pr&#xe9;sent&#xe9;e par Emilie HUET MOULARD DOCTEUR DE L&#x2019;UNIVERSITE JOSEPH FOURIER-GRENOBLE I	hives-ouvertes.fr	0	0		GNAT2
862	chr3	36322467	36322515	3500068645	48		36322467	36322515	8421504	1	48	0	p	350006864500015016	0-48						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		GNAT2
862	chr3	36332147	36332180	3500408239	33		36332147	36332180	8421504	1	33	0	c	350040823900000004	0-33						Method for identifying modulators of G protein coupled receptor signaling	Gilchrist	2003	0		GNAI3
862	chr3	36332147	36332180	3500392754	33		36332147	36332180	8421504	1	33	0	c	350039275400000003	0-33						Method for identifying modulators of g protein coupled receptor signaling	Gilchrist	2006	0		GNAI3
862	chr3	36332147	36332180	3500300392	33		36332147	36332180	8421504	1	33	0	c	350030039200000002	0-33						Method for identifying inhibitors of g protein coupled receptor signaling	Gilchrist	2002	0		GNAI3
862	chr3	36332147	36332180	3500265391	33		36332147	36332180	8421504	1	33	0	c	350026539100000004	0-33					Patent	Method for identifying modulators of G protein coupled receptor signaling (Patent US:7294472)	Gilchrist	2007	0		GNAI3
862	chr3	36332147	36332180	3500253848	33		36332147	36332180	8421504	1	33	0	c	350025384800000004	0-33						G protein coupled receptor signaling modulation - Patent application	www.faqs.org	0	0		GNAI3
862	chr3	36332147	36332180	3500124927	33		36332147	36332180	8421504	1	33	0	c	350012492700000037,350012492700000004	0-33,0-25						Method for identifying inhibitors of G protein coupled receptor signaling - US Patent 7208279 Description	ww.patentstorm.us	0	0		GNAI3
862	chr3	36332155	36332180	3500201598	25		36332155	36332180	8421504	1	25	0	c	350020159800000004	0-25						Method for identifying inhibitors of G protein coupled receptor signaling	Gilchrist	2001	0		GNAI3
862	chr3	36332177	36347745	3500406268	285		36332177	36347745	8421504	7	96,24,24,48,48,10,35	0,4603,5199,5271,8518,15402,15533	p	350040626800015137,350040626800015121,350040626800015136,350040626800015120,350040626800015115,350040626800015131,350040626800015112,350040626800015110,350040626800015128,350040626800015099	0-48,0-45,0-48,0-45,0-45,0-48,0-48,0-45,0-48,0-45						 <HTML> <HEAD><TITLE>i1/4PSi1/4i1/4degi1/4!i1/4!i1/4PSi1/4Y=i1/4i1/4i1/4i1/4i1/4i1/4i1/4a<<a-3/4aaaaa!a3aa(r)a1a-a	www.j-tokkyo.com	0	0		MIR197,GNAT2,GNAI3
862	chr3	36340691	36343082	3500080434	84		36340691	36343082	8421504	4	25,29,22,8	0,41,73,2383	c	350008043400000031,350008043400000032,350008043400000030	0-25,0-29,0-30						Method for counteracting a pathologic change in the beta-adrenergic pathway	Higgins	2004	0		
862	chr3	36347715	36375160	3500345036	45		36347715	36375160	8421504	2	38,7	0,27438	p	350034503600015002	0-45						Human G-protein alpha i2 C352G GCTAGCGTTTAAACTTAAGCTTGGTACCACC ATG GGC TGC ACC GTG AGC GCC GAG GAC AAG GCG GCG GCC GAG CGC TCT AAG ATG ATC GAC AAG AAC CTG CGG GAG GAC GGA GAG AAG GCG GCG CGG GAG GTG AAG TTG CTG CTG TTG GGT GCT GGG GAG TCA GGG AAG AGC ACC 	www.cdna.org	0	0		GNAT2
862	chr3	36347744	36375169	3500466037	25		36347744	36375169	8421504	2	9,16	0,27409	c	350046603700000072	12-37						US Patent # 6,255,059. Methods for identifying G protein coupled receptor effectors - Patents.com	www.patents.com	0	0		
862	chr3	36347744	36375169	3500213320	25		36347744	36375169	8421504	2	9,16	0,27409	c	350021332000000027,350021332000000052	12-37,0-21					Patent	Recombinant yeast cells for identifying receptor effectors (Patent US:6159705)	Fuernkranz	2000	0		GNAI3,GPR61
862	chr3	36347744	36375169	3500152838	25		36347744	36375169	8421504	2	9,16	0,27409	c	350015283800000078	12-37						US Patent # 5,876,951. Yeast cells engineered to produce pheromone system protein surrogates and uses therefor - Patents.com	www.patents.com	0	0		
862	chr3	36347744	36375169	3500121688	25		36347744	36375169	8421504	2	9,16	0,27409	c	350012168800000011	12-37						Yeast cells expressing modified G proteins and methods of use therefor	Fowlkes	1997	0		
862	chr3	36347744	36375169	3500096140	25		36347744	36375169	8421504	2	9,16	0,27409	c	350009614000000078	12-37						Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor	Fowlkes	1994	0		
862	chr3	36347744	36375169	3500046024	25		36347744	36375169	8421504	2	9,16	0,27409	c	350004602400000077,350004602400000137	12-37,12-37						Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor - US Patent 7235648 Description	ww.patentstorm.us	0	0		
862	chr3	36347744	36375169	3500011685	25		36347744	36375169	8421504	2	9,16	0,27409	c	350001168500000030	12-37						Recombinant yeast cells for identifying receptor effectors	Trueheart	1997	0		
862	chr3	36379861	36379894	3500318937	33		36379861	36379894	8421504	1	33	0	c	350031893700000002	0-33						Regulation of human serotonin-like g protein-coupled receptor	Ramakrishnan	2001	0		
862	chr3	36388293	36388321	3500045397	24		36388293	36388321	8421504	2	7,17	0,11	g	350004539700000053	14-41						ABSTRACT	drum.lib.umd.edu	0	0		
863	chr3	36444909	36444932	3500424106	23		36444909	36444932	8421504	1	23	0	c	350042410600000224	0-23						PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
863	chr3	36447759	36456815	3500228107	216		36447759	36456815	8421504	7	18,84,21,6,15,48,24	0,21,1592,8792,8801,8819,9032	p	350022810700015059,350022810700015057	0-102,0-114						Human polynucleotides and polypeptides encoded thereby	Burgess	2002	0		
863	chr3	36488865	36502408	3500360721	426		36488865	36502408	8421504	9	29,55,60,1,68,69,12,59,73	0,4926,9263,9365,11578,12572,12668,12821,13470	p	350036072100015012,350036072100015013,350036072100015014,350036072100015015	6-90,0-60,0-138,0-144						BMC Biochemistry BioMed Central	biomedcentral.com	0	0		PSMA5
864	chr3	36569110	36569143	3500021720	28		36569110	36569143	8421504	3	11,13,4	0,15,29	g	350002172000000005	0-28						Tuberculosis in African lions | DANIEL AYUKO - Academia.edu	www.academia.edu	0	0		
864	chr3	36621368	36621393	3500001277	23		36621368	36621393	8421504	2	13,10	0,15	c	350000127700000003,350000127700000046	1-24,1-24						OLIGONUCLEOTIDE PROBE RETRIEVAL ASSAY FOR DNA TRANSACTIONS IN MAMMALIAN CELLS - Patent application	www.faqs.org	0	0		
864	chr3	36633884	36633918	3500305210	29		36633884	36633918	8421504	2	6,23	0,11	c	350030521000000028	5-34						METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-CDH3 ANTIBODIES - Patent application	www.faqs.org	0	0		
864	chr3	36681213	36681238	3500252890	24		36681213	36681238	8421504	2	10,14	0,11	g	350025289000000301	11-35						Neisseria meningitidis antigens and compositions	Fraser	2012	0		
866	chr3	36942216	36951344	3500217120	55		36942216	36951344	8421504	2	21,34	0,9094	c	350021712000000000,350021712000000008	0-21,10-44		22252550	10.1038/ncomms1634	2041-1733	Nature Communications	ABL1 regulates spindle orientation in adherent cells and mammalian skin	Matsumura	2012	0		GPSM2
867	chr3	37053267	37090236	3500092288	689		37053267	37090236	8421504	16	22,12,48,48,2,89,78,66,39,91,14,45,3,48,36,48	0,23,875,12060,12156,13141,14207,15065,21686,22757,27420,27530,30975,31026,35376,36921	c	350009228800000036,350009228800000035,350009228800000028,350009228800000026,350009228800000025,350009228800000023,350009228800000022,350009228800000021,350009228800000015,350009228800000014,350009228800000013,350009228800000010,350009228800000008,350009228800000005,350009228800000002	13-48,0-48,0-48,0-48,5-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,12-48,0-48					Patent	Platelet secretory transport protein (Patent US:5939540)	Reed	1999	0		
867	chr3	37072828	37089518	3500433033	111		37072828	37089518	8421504	4	34,14,44,19	0,2039,15833,16671	p	350043303300015002,350043303300015001	3-51,0-63		12649283	10.1074/jbc.M212465200	0021-9258	Journal of Biological Chemistry	Munc18-Syntaxin Complexes and Exocytosis in Human Platelets	Houng	2003	5		STXBP3
868	chr3	37173108	37173136	3500448882	23		37173108	37173136	8421504	3	7,5,11	0,11,17	g	350044888200000024	0-23						Peer-Reviewed Journal Tracking and Analyzing Disease Trends pages 701&#x2013;874	wwwnc.cdc.gov	0	0		
869	chr3	37255622	37255650	3500008756	25		37255622	37255650	8421504	3	5,16,4	0,7,24	g	350000875600000253	14-39						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
880	chr3	38750781	38750807	3500293102	23		38750781	38750807	8421504	2	5,18	0,8	g	350029310200000006	6-29		11325958	10.1074/jbc.M009003200	0021-9258	Journal of Biological Chemistry	Characterization of an N-system Amino Acid Transporter Expressed in Retina and Its Involvement in Glutamine Transport	Gu	2001	5		
882	chr3	38993605	38993633	3500392138	24		38993605	38993633	8421504	2	8,16	0,12	g	350039213800000279	20-44						Designer ligands of tgf-beta superfamily	Choe	2010	0		
883	chr3	39167261	39167291	3500251744	23		39167261	39167291	8421504	3	6,5,12	0,11,18	g	350025174400000005	17-40						DNA methylation patterns in tissues from mid-gestation bovine foetuses produced by somatic cell nuclear transfer show subtle abnormalities in nuclear reprogramming	biomedcentral.com	0	0		
912	chr3	42862652	42862677	3500392358	23		42862652	42862677	8421504	2	6,17	0,8	g	350039235800000108	3-26						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
912	chr3	42862652	42862677	3500004392	23		42862652	42862677	8421504	2	6,17	0,8	g	350000439200000108	3-26						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
913	chr3	43010245	43010983	3500323963	23		43010245	43010983	8421504	4	6,4,7,6	0,11,16,732	c	350032396300000006	9-32						High throughput screening assay for detecting a dna sequence	Harvey	2006	0		
913	chr3	43010245	43010983	3500271035	23		43010245	43010983	8421504	4	6,4,7,6	0,11,16,732	c	350027103500000006	9-32						High throughput screening assay for detecting a dna sequence	Harvey	2003	0		
913	chr3	43010245	43010983	3500158092	23		43010245	43010983	8421504	4	6,4,7,6	0,11,16,732	c	350015809200000006	9-32						High throughput screening assay for detecting a dna sequence	Harvey	2005	0		
913	chr3	43010245	43010983	3500069702	23		43010245	43010983	8421504	4	6,4,7,6	0,11,16,732	c	350006970200000007	0-23						 High Throughput Screening Assay For Detecting A DNA Sequence 	www.docstoc.com	0	0		
913	chr3	43010245	43010983	3500028142	23		43010245	43010983	8421504	4	6,4,7,6	0,11,16,732	c	350002814200000017,350002814200000006	9-32,9-32						Dna Sequence Detection Of Nucleated Red Blood Cells 	.freshpatents.com	0	0		
913	chr3	43010245	43010983	3500017134	23		43010245	43010983	8421504	4	6,4,7,6	0,11,16,732	c	350001713400000007	0-23					Patent	High throughput screening assay for detecting a DNA sequence (Patent US:7122309)	Harvey	2006	0		
913	chr3	43055045	43060213	3500376465	24		43055045	43060213	8421504	2	23,1	0,5167	c	350037646500000001	0-24						An skipping mutation Vcollagen gene (COL5A1) in Ehlers-Danlos syndrome	jmg.bmj.com	0	0		COL11A1
914	chr3	43150794	43150819	3500126483	24		43150794	43150819	8421504	2	10,14	0,11	g	350012648300000383	5-29						MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - Patent application	www.faqs.org	0	0		
914	chr3	43155934	43157781	3500102621	144		43155934	43157781	8421504	3	6,69,69	0,1706,1778	p	350010262100015006	3-147						ORIGINAL ARTICLE A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the pro&#x03b1;1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases	jmg.bmj.com	0	0		COL11A1
926	chr3	44719420	44720422	3500193512	238		44719420	44720422	8421504	5	87,28,36,42,45	0,585,717,765,957	p,c	350019351200000058,350019351200000156,350019351200000003,350019351200000057,350019351200000046,350019351200000043,350019351200000042,350019351200015055	0-45,11-32,11-32,6-48,8-36,12-48,6-48,0-45						Methods for detecting compounds which modulate the activity of an LPA receptor	Erickson	1998	0		
926	chr3	44719708	44719732	3500442049	24		44719708	44719732	8421504	1	24	0	c	350044204900000032,350044204900000000	0-24,0-24						Diagnostics And Therapeutics For Diseases Associated With Endothelial Differentiation, Sphingolipid G-protein-coupled Receptor 6(edg6) 	.freshpatents.com	0	0		S1PR1
926	chr3	44719744	44719774	3500205314	30		44719744	44719774	8421504	1	30	0	c	350020531400000001	0-30		18590333	10.1021/cb800051m	1554-8929	ACS chemical biology	Ligand-binding pocket shape differences between S1P1 and S1P3 determine efficiency of chemical probe identification by uHTS	SC	2008	6		S1PR1
926	chr3	44719851	44720422	3500205797	92		44719851	44720422	8421504	5	23,24,22,13,10	0,231,475,547,561	c,g	350020579700000004,350020579700000000,350020579700000001,350020579700000006,350020579700000012	0-23,0-24,0-24,0-22,1-24						CANIS SPHINGOSINE 1-PHOSPHATE RECEPTOR ISOFORM 1 - MERCK & CO., INC.	www.sumobrain.com	0	0		
926	chr3	44720033	44720056	3500297120	23		44720033	44720056	8421504	1	23	0	c	350029712000000001	0-23						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		
926	chr3	44720103	44720214	3500006584	88		44720103	44720214	8421504	3	55,13,20	0,56,91	c,g	350000658400000033,350000658400000001,350000658400000001,350000658400000000,350000658400000000	53-122,0-22,0-22,0-20,0-20						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
926	chr3	44720297	44720342	3500271972	44		44720297	44720342	8421504	2	22,22	0,23	c	350027197200000002,350027197200000041,350027197200000000,350027197200000039	0-22,0-22,0-22,0-22						Novel Use Of Edg Receptors 	.freshpatents.com	0	0		S1PR1
926	chr3	44720999	44721054	3500011051	54		44720999	44721054	8421504	2	11,43	0,12	g	350001105100000052	0-57						Genetic test for the identification of carriers of complex vertebral malformations in cattle - Patent # 7094544 - PatentGenius	.patentgenius.com	0	0		
926	chr3	44724410	44724447	3500119952	37		44724410	44724447	8421504	1	37	0	g	350011995200000000	0-37						&#x30a6;&#x30b7;&#x8102;&#x80aa;&#x4ea4;&#x96d1;&#x5f62;&#x6210;&#x306b;&#x95a2;&#x308f;&#x308b;&#x4e00;&#x5869;&#x57fa;&#x591a;&#x578b;&#x304a;&#x3088;&#x3073;&#x305d;&#x306e;&#x5229;&#x7528; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; 2009065861&#xff09;&#x	astamuse.com	0	0		
930	chr3	45239050	45239119	3500199028	69		45239050	45239119	8421504	1	69	0	p	350019902800015014	0-69						Membrane-bound cytokine compositions and methods of modulating an immune response using same	Hoo	2001	0		VCAM1
930	chr3	45239087	45239112	3500026712	25		45239087	45239112	8421504	1	25	0	c	350002671200000013	21-46						Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier	oinflammation.com	0	0		VCAM1
930	chr3	45245757	45245781	3500186797	24		45245757	45245781	8421504	1	24	0	c	350018679700000002	0-24		11916938	10.2337/diabetes.51.4.1146	0012-1797	Diabetes	Flux Through the Hexosamine Pathway Is a Determinant of Nuclear Factor &#x03ba;B&#x2013; Dependent Promoter Activation	James	2002	8		
930	chr3	45245787	45245812	3500076582	25		45245787	45245812	8421504	1	25	0	c	350007658200000007	0-25						Development of a New Biomechanical ex vivo Perfusion System	gupea.ub.gu.se	0	0		
930	chr3	45253361	45255739	3500274037	40		45253361	45255739	8421504	2	20,20	0,2358	c,g	350027403700000131,350027403700000131,350027403700000130,350027403700000130	0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
930	chr3	45253381	45255620	3500366041	51		45253381	45255620	8421504	3	19,17,15	0,51,2224	c,g	350036604100000005,350036604100000004	0-19,0-32		18245814	10.2353/ajpath.2008.070312		The American Journal of Pathology	Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells	Yoichi	2008	0		
930	chr3	45253381	45255620	3500325952	51		45253381	45255620	8421504	3	19,17,15	0,51,2224	c,g	350032595200000005,350032595200000004	0-19,0-32						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		
930	chr3	45255719	45289644	3500383097	40		45255719	45289644	8421504	2	20,20	0,33905	c,g	350038309700000010,350038309700000011	0-20,0-20						COMPOSITION COMPRISING S-ALLYLMERCAPTO-N-ACETYLCYSTEINE (ASSNAC) FOR UP-REGULATION OF CELLULAR GLUTATHIONE LEVEL	Savion	2008	0		
930	chr3	45255739	45255762	3500279888	23		45255739	45255762	8421504	1	23	0	c	350027988800000005	0-23		11093771	10.1124/mol.58.6.1333	1521-0111 (Online)	Molecular Pharmacology	Decoy Oligodeoxynucleotide Characterization of Transcription Factors Controlling Endothelin-B Receptor Expression in Vascular Smooth Muscle Cells	Wagner	2000	0		VCAM1
930	chr3	45259050	45259076	3500008756	23		45259050	45259076	8421504	2	6,17	0,9	g	350000875600000897	20-44						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
930	chr3	45260243	45260874	3500399193	48		45260243	45260874	8421504	3	26,2,20	0,75,611	c	350039919300000009,350039919300000008	0-26,0-22		22235260	10.1371/journal.pone.0029054		PLoS ONE	Rapid Accumulation of Polymorphonuclear Neutrophils in the Corpus luteum during Prostaglandin F2&#x03b1;-Induced Luteolysis in the Cow	Koumei	2012	0		
930	chr3	45261071	45261095	3500321377	24		45261071	45261095	8421504	1	24	0	g	350032137700000001	0-24						Methods of modulating NF-kB transcription factor - Patent # 6545027 - PatentGenius	.patentgenius.com	0	0		VCAM1
930	chr3	45279489	45289705	3500174216	48		45279489	45289705	8421504	2	24,24	0,10192	c	350017421600000000,350017421600000002	8-32,9-33		16943205	10.1074/jbc.M600943200	0021-9258	Journal of Biological Chemistry	Differential Engagement of Modules 1 and 4 of Vascular Cell Adhesion Molecule-1 (CD106) by Integrins &#x03b1;4&#x03b2;1 (CD49d/29) and &#x03b1;M&#x03b2;2 (CD11b/18) of Eosinophils	Barthel	2006	5		VCAM1
930	chr3	45279490	45279513	3500221031	23		45279490	45279513	8421504	1	23	0	c	350022103100000001	16-39						NEW USE OF SIXTH IMMUNOGLOBULIN-LIKE DOMAIN OF VCAM-1 - SNU R&DB FOUNDATION	www.sumobrain.com	0	0		
930	chr3	45283377	45283401	3500009428	24		45283377	45283401	8421504	1	24	0	c	350000942800000002	0-24		11916938	10.2337/diabetes.51.4.1146	0012-1797	Diabetes	Flux Through the Hexosamine Pathway Is a Determinant of Nuclear Factor &#x03ba;B&#x2013; Dependent Promoter Activation	James	2002	8		
930	chr3	45295623	45295646	3500321182	23		45295623	45295646	8421504	1	23	0	c	350032118200000009	0-23						On the pathophysiological significance of CD154/CD40- mediated leukocyte-endothelial cell interaction	uni-goettingen.de	0	0		
930	chr3	45300097	45300933	3500005411	48		45300097	45300933	8421504	3	26,2,20	0,75,816	c	350000541100000009,350000541100000008	0-26,0-22						Rapid accumulation of polymorphonuclear neutrophils in the Corpus luteum during prostaglandin F(2&#x03b1;)-induced luteolysis in the cow. - ResearchGate	.researchgate.net	0	0		
933	chr3	45723878	45723926	3500436803	48		45723878	45723926	8421504	1	48	0	p	350043680300015018	0-48						Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis	Gershwin	2004	0		DBT
116	chr3	45743037	45754128	3500396579	137		45743037	45754128	8421504	4	48,3,39,47	0,4682,7716,11044	c,g	350039657900000017,350039657900000022,350039657900000028	0-48,6-48,0-47						Recombinant rna 3'-terminal phosphate cyclases and production methods thereof	Filipowicz	1997	0		
934	chr3	45804176	45804206	3500402127	29		45804176	45804206	8421504	2	24,5	0,25	c	350040212700000040	15-47						R-SPONDIN COMPOSITIONS AND METHODS OF USE THEREOF	Christiano	2009	0		
934	chr3	45805357	45805387	3500100734	25		45805357	45805387	8421504	2	6,19	0,11	c	350010073400000096	17-42						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
934	chr3	45839581	45839607	3500353564	23		45839581	45839607	8421504	2	9,14	0,12	c	350035356400000627	2-25						Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof	Begovich	2004	0		
934	chr3	45863768	45863792	3500322097	24		45863768	45863792	8421504	1	24	0	c	350032209700000444	24-48						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
934	chr3	45863768	45863792	3500309840	24		45863768	45863792	8421504	1	24	0	c	350030984000000444	24-48						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
934	chr3	45863768	45863792	3500065112	24		45863768	45863792	8421504	1	24	0	c	350006511200000412	24-48					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
934	chr3	45863768	45863792	3500011388	24		45863768	45863792	8421504	1	24	0	c	350001138800000427	24-48						Vaccine and antitoxin for the treatment of C. difficile disease	Kink	1997	0		
934	chr3	45863768	45863792	3500004227	24		45863768	45863792	8421504	1	24	0	c	350000422700000448	24-48						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
935	chr3	45951129	45966785	3500011051	1200		45951129	45966785	8421504	17	23,15,58,58,61,52,49,66,55,3,52,55,174,123,155,86,115	0,523,540,600,660,723,780,6216,6287,6347,7989,8046,9041,11190,11386,15452,15541	p,c,g	350001105100000019,350001105100000050,350001105100000049,350001105100015012,350001105100015010,350001105100015006,350001105100000033,350001105100000061,350001105100000032,350001105100000060,350001105100000031,350001105100000059,350001105100000030,350001105100000063,350001105100000036,350001105100000018,350001105100015005,350001105100015004,350001105100015003,350001105100015002,350001105100015000	0-23,0-23,0-1132,0-45,0-45,0-147,0-26,0-26,0-24,0-24,0-30,0-70,0-45,0-21,0-21,0-20,0-147,0-48,0-48,0-45,0-90						Genetic test for the identification of carriers of complex vertebral malformations in cattle - Patent # 7094544 - PatentGenius	.patentgenius.com	0	0		
935	chr3	45959234	45962322	3500262719	178		45959234	45962322	8421504	3	3,172,3	0,938,3085	c	350026271900000000	60-356				2228-6705	&#x0645;&#x062c;&#x0644;&#x0647; &#x0628;&#x06cc;&#x0648;&#x062a;&#x06a9;&#x0646;&#x0648;&#x0644;&#x0648;&#x0698;&#x06cc; &#x06a9;&#x0634;&#x0627;&#x0648;&#x0631;&#x0632;&#x06cc;	&#x0645;&#x0637;&#x0627;&#x0644;&#x0639;&#x0647; &#x0628;&#x06cc;&#x0645;&#x0627;&#x0631;&#x06cc; &#x0698;&#x0646;&#x062a;&#x06cc;&#x06a9;&#x06cc; &#x067e;&#x06cc;&#x0686;&#x06cc;&#x062f;&#x06af;&#x06cc; &#x0633;&#x062a;&#x0648;&#x0646; &#x0641;&#x0642;&#		2011	0		
935	chr3	45960253	45960310	3500147857	56		45960253	45960310	8421504	2	18,38	0,19	c,g	350014785700000003,350014785700000003	0-56,0-56						Molecular diagnosis and control strategies for the relevant genetic diseases of cattle	ntiae.cigb.edu.cu	0	0		
935	chr3	45960272	45960295	3500448444	23		45960272	45960295	8421504	1	23	0	c	350044844400000000	0-23						A method for detecting complex vertebral malformation in Holstein calves using polymerase chain reaction-primer introduced restriction analysis. - ResearchGate	.researchgate.net	0	0		
935	chr3	45960289	45962322	3500314956	58		45960289	45962322	8421504	2	55,3	0,2030	c	350031495600000012	60-118						Jeld 1 Shomareh 1 Mojaleh-4	.joagribiotech.ir	0	0		
935	chr3	45960313	45960337	3500348821	24		45960313	45960337	8421504	1	24	0	c,g	350034882100000004,350034882100000004	0-24,0-24						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa h&#x1ecd;c: "Screening for bovine leukocyte adhesion deficiency, deficiency of uridine monophosphate synthase, complex vertebral malformation, bovine citrullinaemia, and factor XI deficiency in Holstein cows reared in Tu	tailieu.vn/doc/ba	0	0		
936	chr3	46056044	46056069	3500402055	23		46056044	46056069	8421504	3	12,6,5	0,13,20	g	350040205500000414,350040205500000149	5-28,5-28						Methods And Kits For Detecting Mutations 	.freshpatents.com	0	0		
938	chr3	46293544	46293572	3500165384	23		46293544	46293572	8421504	2	13,10	0,18	g	350016538400000877	13-36						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
945	chr3	47265877	47265902	3500252890	24		47265877	47265902	8421504	2	10,14	0,11	g	350025289000000574	10-34						Neisseria meningitidis antigens and compositions	Fraser	2012	0		
946	chr3	47422070	47422096	3500010729	24		47422070	47422096	8421504	2	13,11	0,15	g	350001072900000000	1-29						SELECTIVE RESTRICTION FRAGMENT AMPLIFICATION: FINGERPRINTING - Patent application	www.faqs.org	0	0		
947	chr3	47457707	47457733	3500203200	23		47457707	47457733	8421504	2	9,14	0,12	g	350020320000000019	1-24		18778501	10.1590/S1677-55382008000400012	1677-5538	International braz j urol	International braz j urol - In vitro evidence for a new therapeutic approach in renal cell carcinoma	Pittoggi	2008	1		
950	chr3	47909635	47909666	3500445485	25		47909635	47909666	8421504	3	6,6,13	0,11,18	g	350044548500000010	16-41						Trigonopsis transformant producing D-amino acid oxidase	Furuya	1993	0		
950	chr3	47929855	47929878	3500447367	23		47929855	47929878	8421504	1	23	0	c	350044736700000017,350044736700000023,350044736700000031	0-23,0-23,0-23						MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY	Yu	2009	0		
950	chr3	47929855	47929878	3500176000	23		47929855	47929878	8421504	1	23	0	c,g	350017600000000017,350017600000000062,350017600000000031,350017600000000023,350017600000000084,350017600000000084	0-23,0-23,0-23,0-23,0-22,0-22						MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY - Patent application	www.faqs.org	0	0		MIR137HG
950	chr3	47929855	47929878	3500114594	23		47929855	47929878	8421504	1	23	0	c	350011459400000416,350011459400000843	0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR137HG
950	chr3	47929855	47929878	3500031979	23		47929855	47929878	8421504	1	23	0	c,g	350003197900000331,350003197900000331	0-23,0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		
951	chr3	48083039	48083067	3500437159	25		48083039	48083067	8421504	3	15,3,7	0,16,21	g	350043715900000008	6-31						US Patent # 6,107,462. Genes and proteins controlling cholesterol synthesis - Patents.com	www.patents.com	0	0		
953	chr3	48362750	48362779	3500115572	24		48362750	48362779	8421504	3	13,6,5	0,16,24	g	350011557200000000	1-25						METHOD FOR PRODUCING SCYLLO-INOSITOL - Patent application	www.faqs.org	0	0		
954	chr3	48476092	48476115	3500082784	23		48476092	48476115	8421504	1	23	0	g	350008278400000037	3-27					Patent	Treatment of cellulosic material and enzymes useful therein (Patent CN:101384713)	Ya Li *Wei He Man Pei Lei 	2013	0		
955	chr3	48582944	48624998	3500333669	27		48582944	48624998	8421504	4	8,7,7,5	0,42030,42040,42049	c	350033366900000419	3-30						Transgenic Animal With Enhanced Immune Response And Method For The Preparation Thereof 	.freshpatents.com	0	0		
955	chr3	48624297	48624323	3500022512	23		48624297	48624323	8421504	2	15,8	0,18	g	350002251200000002	0-23		18215300	10.1186/1471-2180-8-15	1471-2180	BMC Microbiology	The surface protein Shr of Streptococcus pyogenes binds heme and transfers it to the streptococcal heme-binding protein Shp	Zhu	2008	3		
119	chr3	48844295	48912993	3500234320	45		48844295	48912993	8421504	2	25,20	0,68678	p	350023432000015048	0-45						DPYD GENE VARIANTS AND USE THEREOF - Patent application	www.faqs.org	0	0		DPYD
958	chr3	48931267	48931293	3500391478	25		48931267	48931293	8421504	2	16,9	0,17	g	350039147800000218,350039147800000217,350039147800000216	8-33,8-33,8-33						dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION - Patent application	www.faqs.org	0	0		
960	chr3	49179044	49179067	3500241875	23		49179044	49179067	8421504	1	23	0	g	350024187500000376	18-42					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
961	chr3	49351544	49351567	3500232484	23		49351544	49351567	8421504	1	23	0	g	350023248400000012	9-32						Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated - Patent # 8524491 - PatentGenius	.patentgenius.com	0	0		
962	chr3	49455014	49498255	3500160794	162		49455014	49498255	8421504	5	39,17,76,22,8	0,48,16320,41544,43233	p,c	350016079400000003,350016079400015009,350016079400000000	0-60,0-90,0-57			10.1046/j.1432-1033.2002.02942.x	1432-1033	European Journal of Biochemistry	Importin &#x03b1; binds to an unusual bipartite nuclear localization signal in the heterogeneous ribonucleoprotein type&#xa0;I - Romanelli - 2002 - European Journal of Biochemistry - Wiley Online Library	Romanelli	2002	0		PTBP2
963	chr3	49583948	49583981	3500213847	25		49583948	49583981	8421504	3	9,11,5	0,12,28	g	350021384700000000	0-25						&#x0421;&#x043f;&#x043e;&#x0441;&#x043e;&#x0431; &#x0432;&#x044b;&#x044f;&#x0432;&#x043b;&#x0435;&#x043d;&#x0438;&#x044f; &#x0432;&#x0430;&#x0440;&#x0438;&#x0430;&#x043d;&#x0442;&#x0430; &#x0432;* &#x0431;&#x0435;&#x0442;&#x0430;-&#x043b;&#x0430;&#x043a;&	www.freepatent.ru	0	0		
965	chr3	49807394	49807418	3500155900	24		49807394	49807418	8421504	1	24	0	g	350015590000000205	18-47						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
972	chr3	50791866	50791890	3500008756	23		50791866	50791890	8421504	2	18,5	0,19	g	350000875600000237	3-27						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
974	chr3	51068812	51068882	3500011051	65		51068812	51068882	8421504	2	60,5	0,65	g	350001105100000051	0-65						Genetic test for the identification of carriers of complex vertebral malformations in cattle - Patent # 7094544 - PatentGenius	.patentgenius.com	0	0		
978	chr3	51563922	51563950	3500396579	25		51563922	51563950	8421504	2	5,20	0,8	g	350039657900000062	23-48						Recombinant rna 3'-terminal phosphate cyclases and production methods thereof	Filipowicz	1997	0		
980	chr3	51782046	51791934	3500355056	46		51782046	51791934	8421504	2	22,24	0,9864	c,g	350035505600000003,350035505600000002,350035505600000002,350035505600000000,350035505600000000	6-28,5-29,5-29,6-26,6-26						REAGENT FOR MEASURING CLOTTING TIME AND METHOD FOR MANUFACTURING THE REAGENT	Okuda	2007	0		
980	chr3	51782046	51791933	3500130739	45		51782046	51791933	8421504	2	22,23	0,9864	c,g	350013073900000001,350013073900000000,350013073900000000	0-22,0-23,0-23						ScienceDirect.com - Thrombosis Research - Properties of a recombinant bovine tissue factor expressed by Silkworm pupae and its performance as an Owren-type prothrombin time reagent for warfarin monitoring	sciencedirect.com	0	0		
980	chr3	51783276	51790686	3500409598	48		51783276	51790686	8421504	2	24,24	0,7386	c	350040959800000005,350040959800000004	0-24,0-24		11581405	10.1128/JVI.75.21.10372-10382.2001	0022-538X	Journal of Virology	African Swine Fever Virus Infection of Porcine Aortic Endothelial Cells Leads to Inhibition of Inflammatory Responses, Activation of the Thrombotic State, and Apoptosis	Vallee	2001	5		F3
980	chr3	51784152	51784192	3500068478	39		51784152	51784192	8421504	2	4,35	0,5	c,g	350006847800000014,350006847800000014	72-111,72-111					Patent	Human mutant tissue factor compositions useful as tissue factor antagonists (Patent US:5726147)	Edgington	1998	0		
980	chr3	51790663	51790689	3500408017	26		51790663	51790689	8421504	1	26	0	c	350040801700000008	0-26		20307321	10.1186/1743-8977-7-6	1743-8977	Particle and Fibre Toxicology	Ultrafine particles from diesel vehicle emissions at different driving cycles induce differential vascular pro-inflammatory responses: Implication of chemical components and NF-&#xce;&#xba;B signaling	Li	2010	7		
980	chr3	51790663	51790689	3500363674	26		51790663	51790689	8421504	1	26	0	c	350036367400000008	0-26						&#x4e3b;&#x9898;&#xff1a;Growth | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
980	chr3	51811186	51811215	3500403380	24		51811186	51811215	8421504	2	7,17	0,12	g	350040338000000014	8-32		9852042	10.1074/jbc.273.51.33915	0021-9258	Journal of Biological Chemistry	A Mutational Analysis of the Baculovirus Inhibitor of Apoptosis Op-IAP	Vucic	1998	5		
980	chr3	51852310	51852341	3500334171	24		51852310	51852341	8421504	3	6,5,13	0,10,18	g	350033417100000006	14-38						75 Contents Volume II	www.oie.int	0	0		
981	chr3	51921922	51921952	3500442165	30		51921922	51921952	8421504	1	30	0	g	350044216500000014	66-96						US Patent # 5,589,363. DNA encoding tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders - Patents.com	www.patents.com	0	0		
981	chr3	51921922	51921952	3500118976	30		51921922	51921952	8421504	1	30	0	g	350011897600000014	66-96						US Patent # 5,739,101. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders - Patents.com	www.patents.com	0	0		
981	chr3	51963013	51963040	3500454505	24		51963013	51963040	8421504	2	9,15	0,12	c	350045450500000071	0-24					Patent	Recombinant fowlpox viruses and uses thereof (Patent US:6001369)	Cochran	1999	0		
981	chr3	51963013	51963040	3500408690	24		51963013	51963040	8421504	2	9,15	0,12	c	350040869000000071	0-24						 Recombinant Fowlpox Viruses And Uses Thereof 	www.docstoc.com	0	0		
981	chr3	51963013	51963040	3500353284	24		51963013	51963040	8421504	2	9,15	0,12	c	350035328400000099	9-33						Recombinant swinepox virus	Cochran	1993	0		
981	chr3	51963013	51963040	3500282511	24		51963013	51963040	8421504	2	9,15	0,12	c	350028251100000071	0-24						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
981	chr3	51963013	51963040	3500263349	24		51963013	51963040	8421504	2	9,15	0,12	c	350026334900000071	0-24						Recombinant fowlpox viruses and uses thereof	Cochran	1998	0		
981	chr3	51963013	51963040	3500180733	24		51963013	51963040	8421504	2	9,15	0,12	c	350018073300000059	0-24						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
981	chr3	51963013	51963040	3500179670	24		51963013	51963040	8421504	2	9,15	0,12	c	350017967000000071	0-24						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
981	chr3	51963013	51963040	3500141736	24		51963013	51963040	8421504	2	9,15	0,12	c	350014173600000169	9-33						US Patent # 6,497,882. Recombinant swinepox virus - Patents.com	www.patents.com	0	0		
981	chr3	51963013	51963040	3500115879	24		51963013	51963040	8421504	2	9,15	0,12	c	350011587900000059	0-24						Recombinant fowlpox virus s-fpv-043 and uses thereof	Cochran	1994	0		
982	chr3	52067301	52067327	3500107865	24		52067301	52067327	8421504	2	12,12	0,14	g	350010786500000019,350010786500000556	10-34,10-34						Anti-Cd14 Antibody Fusion Protein - Patent application	www.faqs.org	0	0		
983	chr3	52216058	52216081	3500343734	23		52216058	52216081	8421504	1	23	0	c	350034373400000134	19-42					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
983	chr3	52216058	52216081	3500190760	23		52216058	52216081	8421504	1	23	0	c	350019076000000134	19-42						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		NPR3
985	chr3	52441635	52441660	3500253256	23		52441635	52441660	8421504	3	14,4,5	0,15,20	c	350025325600002569	5-30						 Methods Of Using Conjugated Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
985	chr3	52491495	52491518	3500166547	23		52491495	52491518	8421504	1	23	0	c	350016654700000028	19-42						Human tumor necrosis factor receptor-like proteins TR11, TR11SV1, and TR11SV2	Ni	1998	0		
985	chr3	52552701	52555446	3500399283	43		52552701	52555446	8421504	3	22,12,9	0,179,2736	c	350039928300000004,350039928300000005	0-22,0-21		23826868	10.1186/1472-6882-13-159	1472-6882	BMC Complementary and Alternative Medicine	Protective effect of AVS073, a polyherbal formula, against UVA-induced melanogenesis through a redox mechanism involving glutathione-related antioxidant defense	Panich	2013	2		GCLM
985	chr3	52552701	52555446	3500049757	43		52552701	52555446	8421504	3	22,12,9	0,179,2736	c	350004975700000002,350004975700000003	0-22,0-21		16452219	10.1158/0008-5472.CAN-05-3462	0008-5472	Cancer Research	Inhibition of Glutamate Cysteine Ligase Activity Sensitizes Human Breast Cancer Cells to the Toxicity of 2-Deoxy-d-Glucose	Andringa	2006	8		GCLM
985	chr3	52552733	52555440	3500303532	46		52552733	52555440	8421504	3	24,19,3	0,140,2704	c	350030353200000083,350030353200000029	0-24,0-22						DEPARTAMENT DE GENATICA ESTUDIO DE FACTORES GENATICOS DE LOS SISTEMAS RELACIONADOS CON ESTRAS OX	www.tdx.cat	0	0		GCLM
985	chr3	52555495	52555521	3500221815	26		52555495	52555521	8421504	1	26	0	c	350022181500000031	0-26						Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin	-publications.com	0	0		
985	chr3	52555542	52559717	3500211913	25		52555542	52559717	8421504	2	10,15	0,4160	c	350021191300000006	0-25						FXR Activation by Chenodeoxycholic Acid Induces Detoxifying Enzymes through AMPK and ERK1/2-mediated Phosphorylation of C/EBP&#x03b2;	aspetjournals.org	0	0		
985	chr3	52555542	52559717	3500035622	25		52555542	52559717	8421504	2	10,15	0,4160	c	350003562200000006	0-25		21596890	10.1124/dmd.111.038414	1521-009X (Online)	Drug Metabolism and Disposition	Farnesoid X Receptor Activation by Chenodeoxycholic Acid Induces Detoxifying Enzymes through AMP-Activated Protein Kinase and Extracellular Signal-Regulated Kinase 1/2-Mediated Phosphorylation of CCAAT/Enhancer Binding Protein &#x03b2;	Noh	2011	0		
988	chr3	52867944	52867968	3500178740	23		52867944	52867968	8421504	2	10,13	0,11	g	350017874000000003	0-23						Platypus TCR&#xb5; Provides Insight into the Origins and Evolution of a Uniquely Mammalian TCR Locus	vetmed.tamu.edu	0	0		
989	chr3	52961585	53001985	3500081673	120		52961585	53001985	8421504	3	30,45,45	0,4366,40355	g	350008167300000030,350008167300000023,350008167300000013	0-30,0-45,0-45						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
991	chr3	53292095	53300419	3500081673	45		53292095	53300419	8421504	2	17,28	0,8296	c	350008167300000003	0-45						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
993	chr3	53514319	53514346	3500045026	24		53514319	53514346	8421504	3	14,5,5	0,16,22	g	350004502600000082	22-47						Modified HIV-1 Envelope Proteins - Patent application	www.faqs.org	0	0		
124	chr3	53515658	53643569	3500292734	1233		53515658	53643569	8421504	5	45,135,108,177,768	0,86786,120266,126042,127143	p	350029273400015001	15-1248						29 human secreted proteins	Komatsoulis	2001	0		FAM69A
124	chr3	53515658	53643569	3500265377	1233		53515658	53643569	8421504	5	45,135,108,177,768	0,86786,120266,126042,127143	p	350026537700015001	15-1248						29 human secreted proteins	Komatsoulis	2002	0		FAM69A
996	chr3	53974598	53974658	3500156599	60		53974598	53974658	8421504	1	60	0	p	350015659900015000	0-60		17909014	10.1158/0008-5472.CAN-07-2987	0008-5472	Cancer Research	The Ajuba LIM Domain Protein Is a Corepressor for SNAG Domain&#x2013;Mediated Repression and Participates in Nucleocytoplasmic Shuttling	Ayyanathan	2007	8		GFI1
996	chr3	53977285	53977308	3500373979	23		53977285	53977308	8421504	1	23	0	c	350037397900000056	25-48						Herpes simplex type 1 protease mutants and vectors	Register	1996	0		
996	chr3	53977285	53977308	3500354881	23		53977285	53977308	8421504	1	23	0	c	350035488100000056	25-48						Herpes simplex type 1 protease mutants and vectors	Register	1998	0		
996	chr3	53977285	53977308	3500200529	23		53977285	53977308	8421504	1	23	0	c	350020052900000053	25-48						Method of making herpes simplex type 1 mutants and mutants so produced	Register	1995	0		
996	chr3	53977285	53977308	3500183025	23		53977285	53977308	8421504	1	23	0	c	350018302500000032	25-48						US Patent # 5,478,727. Methods and compositions for the preparation and use of a herpes protease - Patents.com	www.patents.com	0	0		
1000	chr3	54444507	54444539	3500089192	30		54444507	54444539	8421504	2	24,6	0,26	c	350008919200000032	12-42						 Recombinant Soluble Epoxide Hydrolase 	www.docstoc.com	0	0		
1000	chr3	54493803	54493829	3500339702	23		54493803	54493829	8421504	2	15,8	0,18	g	350033970200000055	9-40						Streptococcus pneumoniae proteins and nucleic acids	Masignani	2002	0		
1001	chr3	54653158	54653185	3500081874	25		54653158	54653185	8421504	2	20,5	0,22	g	350008187400000034	0-27						Method of introducing modifications into a gene	Wirak	1999	0		
1003	chr3	54870298	54870327	3500431083	24		54870298	54870327	8421504	2	7,17	0,12	g	350043108300000015	8-36						Investigations of self-incompatibility (SI) in perennial ryegrass (Lolium perenne L.)	theses.bham.ac.uk	0	0		
1004	chr3	54950801	54950824	3500358328	23		54950801	54950824	8421504	1	23	0	c	350035832800000008,350035832800000009	0-21,0-21		21790909	10.1111/j.1365-2443.2011.01535.x	1365-2443	Genes to Cells	Efficient expression and purification of human replication fork-stabilizing factor, Claspin, from mammalian cells: DNA-binding activity and novel protein interactions - Uno - 2011 - Genes to Cells - Wiley Online Library	Uno	2011	0		CDC7
1004	chr3	54950803	54958726	3500442347	42		54950803	54958726	8421504	2	21,21	0,7902	c	350044234700000003,350044234700000002	0-21,0-21			10.1091/mbc.E06-03-0241		Molecular Biology of the Cell	Essential Role of Phosphorylation of MCM2 by Cdc7/Dbf4 in the Initiation of DNA Replication in Mammalian Cells	Toshiya	2006	0		CDC7
1004	chr3	54950803	54958726	3500407627	42		54950803	54958726	8421504	2	21,21	0,7902	c	350040762700000003,350040762700000002	0-21,0-21		16899510	10.1091/mbc.E06-03-0241	1059-1524	Molecular Biology of the Cell	Essential Role of Phosphorylation of MCM2 by Cdc7/Dbf4 in the Initiation of DNA Replication in Mammalian Cells	Tsuji	2006	5		CDC7
1004	chr3	54950803	54958726	3500217769	42		54950803	54958726	8421504	2	21,21	0,7902	c	350021776900000003,350021776900000002	0-21,0-21						Essential Role of Phosphorylation of MCM2 by Cdc7/Dbf4 in the Initiation of DNA Replication in Mammalian Cells D	w.molbiolcell.org	0	0		CDC7
1006	chr3	55267071	55267095	3500045028	24		55267071	55267095	8421504	1	24	0	g	350004502800000041	3-27					Patent	Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants (Patent US:5559223)	Falco	1996	0		
1011	chr3	55912494	55912519	3500008756	25		55912494	55912519	8421504	1	25	0	g	350000875600000609	6-34						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
1017	chr3	56635589	56635613	3500350682	24		56635589	56635613	8421504	1	24	0	g	350035068200000192	5-29						17Q-linked breast and ovarian cancer susceptibility gene	Skolnick	1995	0		
1019	chr3	57004360	57004388	3500293010	25		57004360	57004388	8421504	2	12,13	0,15	g	350029301000000000	0-25		15547049	10.1124/dmd.104.002220	1521-009X (Online)	Drug Metabolism and Disposition	SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT	Sung	2005	0		
1021	chr3	57159693	57159720	3500204816	23		57159693	57159720	8421504	2	11,12	0,15	c	350020481600000010	3-26						Cationic polyelectrolytes in biomolecule purification and analysis	Ness	2003	0		
1021	chr3	57203949	57203972	3500322095	23		57203949	57203972	8421504	1	23	0	c	350032209500000230	0-23						Immunostimulatory sequence oligonucleotides and methods of using the same	Dina	2004	0		GBP1
1021	chr3	57203949	57203972	3500172906	23		57203949	57203972	8421504	1	23	0	c	350017290600000455	0-23					Patent	Immunostimulatory sequence oligonucleotides and methods of using the same (Patent CN:101693890)	D*Di Na 	2012	0		GBP1
1021	chr3	57203949	57203972	3500147417	23		57203949	57203972	8421504	1	23	0	c	350014741700000439	0-23					Patent	Immunostimulatory sequence oligonucleotides and methods of using the same (Patent CN:100546998)	D*Di Na 	2009	0		GBP1
1022	chr3	57311256	57311301	3500051177	45		57311256	57311301	8421504	1	45	0	p	350005117700015245	0-45						Guanylate-binding protein	www.devileye.net	0	0		
1027	chr3	58033284	58033314	3500279346	25		58033284	58033314	8421504	3	13,4,8	0,14,22	g	350027934600000013	0-25			10.1002/ijc.21371	1097-0215	International Journal of Cancer	Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization - Yang - 2005 - International Journal of Cancer - Wiley Online Library	Yang	2006	0		
1028	chr3	58135242	58139761	3500461145	111		58135242	58139761	8421504	2	72,39	0,4480	p	350046114500015004,350046114500015008	3-117,0-45						PYRROLO-PYRIDINE KINASE MODULATIORS - Patent application	www.faqs.org	0	0		PKN2
1028	chr3	58135242	58139761	3500402297	111		58135242	58139761	8421504	2	72,39	0,4480	p	350040229700015021	3-117						cat&#xe1;logo promega	www.scribd.com	0	0		PKN2
1028	chr3	58135242	58139761	3500361537	111		58135242	58139761	8421504	2	72,39	0,4480	p	350036153700015002	3-117						Pyrrolo-pyridine Kinase Modulators 	.freshpatents.com	0	0		PKN2
1028	chr3	58135242	58139761	3500281780	111		58135242	58139761	8421504	2	72,39	0,4480	p	350028178000015021	3-117						TETRACYCLIC IMIDAZOLE ANALOGS - Patent application	www.faqs.org	0	0		PKN2
1028	chr3	58135242	58139761	3500276748	111		58135242	58139761	8421504	2	72,39	0,4480	p	350027674800015001	3-117						Pyrazolothiazole Protein Kinase Modulators	Bounaud	2007	0		PKN2
1028	chr3	58135242	58139761	3500275190	111		58135242	58139761	8421504	2	72,39	0,4480	p	350027519000015002	3-117						Pyrrolo-pyridine kinase modulators	Arnold	2008	0		PKN2
1028	chr3	58135242	58139761	3500272592	111		58135242	58139761	8421504	2	72,39	0,4480	p	350027259200015005	3-117						Fused Ring Heterocycle Kinase Modulators 	.freshpatents.com	0	0		PKN2
1028	chr3	58135242	58139761	3500252849	111		58135242	58139761	8421504	2	72,39	0,4480	p	350025284900015002	3-117						Pyrrolo-pyridine kinase modulators	Arnold	2006	0		PKN2
1028	chr3	58135242	58139761	3500245781	111		58135242	58139761	8421504	2	72,39	0,4480	p	350024578100015005	3-117					Patent	Fused ring heterocycle kinase modulators (Patent US:7829558)	Arnold	2010	0		PKN2
1028	chr3	58135242	58139761	3500245133	111		58135242	58139761	8421504	2	72,39	0,4480	p	350024513300015003,350024513300015006	3-117,0-48						Pyrrolo-pyridine Kinase Modulators 	.freshpatents.com	0	0		PKN2
1028	chr3	58135242	58139761	3500240919	111		58135242	58139761	8421504	2	72,39	0,4480	p	350024091900015002	3-117						Pyrrolo-pyridine Kinase Modulators 	.freshpatents.com	0	0		PKN2
1028	chr3	58135242	58139761	3500239298	111		58135242	58139761	8421504	2	72,39	0,4480	p	350023929800015031	3-117					Patent	Method for designing pdk1 modulators (Patent EP:1513947)	ALESSI	2007	0		PKN2
1028	chr3	58135242	58139761	3500237506	111		58135242	58139761	8421504	2	72,39	0,4480	p	350023750600015000	3-117						Pyrazolothiazole protein kinase modulators	Bounaud	2008	0		PKN2
1028	chr3	58135242	58139761	3500234108	111		58135242	58139761	8421504	2	72,39	0,4480	p	350023410800015040	3-117					Patent	Verfahren zur entwicklung von pdk1-modulatoren Process for development of PDK1 modulators (Patent DE:60313967)	ALESSI	2008	0		PKN2
1028	chr3	58135242	58139761	3500218866	111		58135242	58139761	8421504	2	72,39	0,4480	p	350021886600015023	3-117						Human Ribosomal Dna (rdna) And Ribosomal Rna (rrna) Nucleic Acids And Uses Thereof 	.freshpatents.com	0	0		PKN2
1028	chr3	58135242	58139761	3500218676	111		58135242	58139761	8421504	2	72,39	0,4480	p	350021867600015005	3-117						Fused ring heterocycle kinase modulators	Arnold	2009	0		PKN2
1028	chr3	58135242	58139761	3500213571	111		58135242	58139761	8421504	2	72,39	0,4480	p	350021357100015005	3-117					Patent	Fused ring heterocycle kinase modulators (Patent US:7452993)	Arnold	2008	0		PKN2
1028	chr3	58135242	58139761	3500184563	111		58135242	58139761	8421504	2	72,39	0,4480	p	350018456300015004,350018456300015008	3-117,0-45						PYRROLO-PYRIDINE KINASE MODULATORS - Patent application	www.faqs.org	0	0		PKN2
1028	chr3	58135242	58139761	3500155278	111		58135242	58139761	8421504	2	72,39	0,4480	p	350015527800015005	3-117						Fused ring heterocycle kinase modulators	Arnold	2010	0		PKN2
1028	chr3	58135242	58139761	3500137442	111		58135242	58139761	8421504	2	72,39	0,4480	p	350013744200015002	3-117						3,5-DIPHENYL-SUBSTITUTED PYRROLO[2,3b]PYRIDINES USEFUL AS KINASE INHIBITORS	Arnold	2010	0		PKN2
1028	chr3	58135242	58139761	3500080587	111		58135242	58139761	8421504	2	72,39	0,4480	p	350008058700015032	3-117						Pyridinone analogs as cell proliferation inhibitors	Pierre	2007	0		PKN2
1028	chr3	58135242	58139761	3500079349	111		58135242	58139761	8421504	2	72,39	0,4480	p	350007934900015004,350007934900015008	3-117,0-45						PYRROLO-PYRIDINE KINASE MODULATORS - Patent application	www.faqs.org	0	0		PKN2
1028	chr3	58135242	58139761	3500076541	111		58135242	58139761	8421504	2	72,39	0,4480	p	350007654100015021	3-117						Tetracyclic imidazole analogs	Whitten	2008	0		PKN2
1028	chr3	58135242	58139761	3500064396	111		58135242	58139761	8421504	2	72,39	0,4480	p	350006439600015028	3-117						Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide	Nagasawa	2007	0		PKN2
1028	chr3	58135242	58139761	3500043781	111		58135242	58139761	8421504	2	72,39	0,4480	p	350004378100015030	3-117					Patent	Verfahren zur entwicklung von pdk1-modulatoren (Patent DE:60313967)	ALESSI	2008	0		PKN2
1028	chr3	58135242	58139761	3500026662	111		58135242	58139761	8421504	2	72,39	0,4480	p	350002666200015038	3-117						HUMAN RIBOSOMAL DNA(rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF - CYLENE PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		PKN2
1028	chr3	58135242	58139761	3500017012	111		58135242	58139761	8421504	2	72,39	0,4480	p	350001701200015003	3-117						Fused Ring Heterocycle Kinase Modulators 	.freshpatents.com	0	0		PKN2
1028	chr3	58135242	58135314	3500287967	72		58135242	58135314	8421504	1	72	0	p	350028796700015010	0-72						In vivo role of the phosphate groove of PDK1 de&#xfb01;ned by knockin mutation	cs.biologists.org	0	0		PKN2
1028	chr3	58135242	58135314	3500287896	72		58135242	58135314	8421504	1	72	0	p	350028789600015000	0-72						The Arabidopsis Protein Kinase PTI1-2 Is Activated by Convergent Phosphatidic Acid and Oxidative Stress Signaling Pathways Downstream of PDK1 and OXI1--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x52	journal.9med.net	0	0		PKN2
1028	chr3	58135254	58139761	3500221555	99		58135254	58139761	8421504	2	60,39	0,4468	p	350022155500015006	3-105						Cancer associated protein kinases and their uses	Yoganathan	2010	0		PKN2
1028	chr3	58135254	58139761	3500049849	99		58135254	58139761	8421504	2	60,39	0,4468	p	350004984900015008	3-105						Cancer associated protein kinases and their uses	Delaney	2004	0		PKN2
1028	chr3	58135257	58139761	3500399057	54		58135257	58139761	8421504	2	18,36	0,4468	p	350039905700015018	0-54						Method for designing pdk1 modulators	ALESSI	2005	0		
1028	chr3	58135586	58139782	3500318889	231		58135586	58139782	8421504	6	24,57,48,12,30,60	0,492,552,4058,4103,4136	p	350031888900015011,350031888900015010	0-141,0-90						Gene amplification and overexpression in cancer	Yang	2004	0		PKN2
1031	chr3	58586450	58586478	3500327027	24		58586450	58586478	8421504	3	11,5,8	0,14,20	g	350032702700000003	0-24						bFGF mutein and its production	Fujishima	1992	0		
1037	chr3	59346116	59346140	3500461774	23		59346116	59346140	8421504	2	7,16	0,8	g	350046177400000001	0-23						Enhanced Bystander Cytotoxicity of P450 Gene-directed Enzyme Prodrug Therapy by Expression of the Antiapoptotic Factor p35	people.bu.edu	0	0		
1037	chr3	59346116	59346140	3500381737	23		59346116	59346140	8421504	2	7,16	0,8	g	350038173700000001	0-23						Method of using anti-apoptotic factors in gene expression	Schwartz	2003	0		
1038	chr3	59419519	59419543	3500073664	23		59419519	59419543	8421504	2	18,5	0,19	g	350007366400000074	13-37						Lepidopteran-active bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use - Patent application	www.faqs.org	0	0		
1039	chr3	59608665	59608693	3500115879	24		59608665	59608693	8421504	3	14,3,7	0,16,21	g	350011587900000109	4-28						Recombinant fowlpox virus s-fpv-043 and uses thereof	Cochran	1994	0		
1039	chr3	59624742	59624801	3500178306	59		59624742	59624801	8421504	1	59	0	g	350017830600000007,350017830600000008,350017830600000002,350017830600000009,350017830600000000	0-59,0-59,0-59,0-59,0-59						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: "Measuring the accuracy of genome-size multiple alignments" 	tailieu.vn/doc/ba	0	0		LMO4
1041	chr3	59801251	59801274	3500077080	23		59801251	59801274	8421504	1	23	0	g	350007708000000052	0-26						Method of using cells expressing galanin receptor 3 (GALR3) - Patent # 7022489 - PatentGenius	.patentgenius.com	0	0		
1041	chr3	59844487	59844512	3500451862	25		59844487	59844512	8421504	1	25	0	c	350045186200000010	20-45						Supporting Information	www.pnas.org	0	0		LMO4
1045	chr3	60299433	60334783	3500455587	141		60299433	60334783	8421504	4	6,64,20,51	0,17815,32496,35299	c	350045558700000016,350045558700000042,350045558700000020,350045558700000032	0-48,0-48,0-48,0-48						MAMMALIAN SELENOPROTEIN DIFFERENTIALLY EXPRESSED IN TUMOR CELLS - Patent application	www.faqs.org	0	0		
130	chr3	60522478	60592312	3500180764	3340		60522478	60592312	8421504	23	23,20,17,30,99,24,239,451,240,171,271,225,101,178,225,228,181,109,148,141,181,26,12	0,72,45559,45577,45608,45716,45741,45983,51407,52166,52931,53319,53900,55647,59741,60768,63007,66369,67244,67585,68749,69795,69822	c	350018076400000016,350018076400000014,350018076400000000,350018076400000018,350018076400000008,350018076400000001,350018076400000004,350018076400000017,350018076400000005,350018076400000012,350018076400000010,350018076400000011,350018076400000009,350018076400000013,350018076400000032	0-23,0-20,2-3313,12-32,0-335,0-26,0-19,9-32,0-28,0-23,0-20,0-20,0-24,0-23,0-22						Nucleotide sequences encoding mammalian calcium activated chloride channel-adhesion molecules - Patent # 6692939 - PatentGenius	.patentgenius.com	0	0		
1048	chr3	60706737	60734273	3500061374	192		60706737	60734273	8421504	7	54,26,15,24,29,29,15	0,3181,3963,5370,15080,25121,27521	c,g	350006137400000182,350006137400000005,350006137400000188,350006137400000166,350006137400000159,350006137400000141,350006137400000135	0-36,0-21,0-21,7-48,0-24,18-47,4-48						 Nucleic Acids Encoding A Chloride Channel Protein 	www.docstoc.com	0	0		
1048	chr3	60706737	60727217	3500112644	127		60706737	60727217	8421504	6	36,26,15,24,24,2	0,3181,3963,5370,15088,20478	c	350011264400000182,350011264400000166,350011264400000159,350011264400000021	0-36,7-48,0-24,22-48					Patent	Nucleic acids encoding a chloride channel protein (Patent US:6716603)	Holroyd	2004	0		
1049	chr3	60860194	60860222	3500068199	23		60860194	60860222	8421504	2	9,14	0,14	g	350006819900000454	5-37						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
1049	chr3	60860194	60860222	3500019915	23		60860194	60860222	8421504	2	9,14	0,14	g	350001991500000454	5-37						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
1053	chr3	61443436	61443465	3500259295	26		61443436	61443465	8421504	2	9,17	0,12	g	350025929500000043	17-45						Novel Phage Display Technologies - Patent application	www.faqs.org	0	0		
1055	chr3	61679605	61679681	3500435659	51		61679605	61679681	8421504	2	22,29	0,47	c	350043565900000053,350043565900000052	0-22,0-29						 Proteins And Nucleic Acids Encoding Same 	www.docstoc.com	0	0		
1055	chr3	61680142	61680973	3500200138	101		61680142	61680973	8421504	3	33,35,33	0,55,798	c	350020013800000068,350020013800000067,350020013800000029	0-33,0-35,0-33						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1055	chr3	61680197	61681690	3500010057	258		61680197	61681690	8421504	6	35,48,48,41,38,48	0,131,437,906,1008,1445	c	350001005700000064,350001005700000061,350001005700000057,350001005700000025,350001005700000048,350001005700000046	0-35,0-48,0-48,0-41,0-38,0-48						CYR61 COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		
1055	chr3	61680328	61681243	3500051726	86		61680328	61681243	8421504	2	48,38	0,877	c	350005172600000049,350005172600000036	0-48,0-38						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1055	chr3	61680421	61680583	3500444681	48		61680421	61680583	8421504	2	21,27	0,135	c	350044468100000021	0-48						Connective Tissue Growth Factor-2 - Patent application	www.faqs.org	0	0		
1055	chr3	61681164	61681187	3500372406	23		61681164	61681187	8421504	1	23	0	c	350037240600000001	10-33						Cyr61 mediates the expression of VEGF, v -integrin, and -actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells--&#x300a;&#x5e94;&#x7528;&#x751f;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x6	journal.9med.net	0	0		CYR61
1055	chr3	61681164	61681187	3500055244	23		61681164	61681187	8421504	1	23	0	c	350005524400000001	10-33			10.1152/japplphysiol.01093.2004	8750-7587	Journal of Applied Physiology	Cyr61 mediates the expression of VEGF, &#x03b1;v-integrin, and &#x03b1;-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells	Zhou	2005	4		CYR61
16	chr3	61818494	61944413	3500136457	40		61818494	61944413	8421504	3	10,10,20	0,116053,125899	c,g	350013645700000000,350013645700000001	0-20,0-20		19820234	10.1074/jbc.M109.037036	0021-9258	Journal of Biological Chemistry	Role of Dimethylarginine Dimethylaminohydrolases in the Regulation of Endothelial Nitric Oxide Production	Pope	2009	5		
1057	chr3	61968834	61968860	3500073664	24		61968834	61968860	8421504	3	4,13,7	0,5,19	g	350007366400000429	7-31						Lepidopteran-active bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use - Patent application	www.faqs.org	0	0		
1057	chr3	61983092	61983117	3500096045	24		61983092	61983117	8421504	2	4,20	0,5	g	350009604500000042	4-31					Patent	Oligonucleotides for the detection of salmonella (Patent US:5824795)	Fellous	1998	0		
1059	chr3	62161516	62161541	3500442426	24		62161516	62161541	8421504	2	15,9	0,16	c	350044242600000134	24-48						Gene encoding protein antigens of Plasmodium falciparum and uses therefor	Inselburg	1994	0		
1059	chr3	62162043	62164123	3500379004	50		62162043	62164123	8421504	2	25,25	0,2055	c,g	350037900400000003,350037900400000002,350037900400000002	0-25,0-25,0-25						Adaptation to High Grain Diets Proceeds Through Minimal Immune System Stimulation and Differences in Extracellular Matrix Protein Expression in A Model of Subacute Ruminal Acidosis in Non-lactating Dairy Cows	thescipub.com	0	0		
1059	chr3	62162043	62164123	3500249098	50		62162043	62164123	8421504	2	25,25	0,2055	c	350024909800000001,350024909800000000	0-25,0-25						A CHARACTERIZATION OF INFLAMMATORY AND STRUCTURAL MARKERS WITHIN THE RUMEN EPITHELIUM DURING GRAIN-INDUCED RUMINAL ACIDOSIS IN	thescipub.com	0	0		
1059	chr3	62164212	62171723	3500318543	138		62164212	62171723	8421504	2	81,57	0,7454	p	350031854300015053	0-138						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		BCL10
1059	chr3	62164245	62164269	3500379360	24		62164245	62164269	8421504	1	24	0	c	350037936000000022	0-24		22860069	10.1371/journal.pone.0042159	1932-6203	PLOS ONE	PLOS ONE: ARID3B Induces Tumor Necrosis Factor Alpha Mediated Apoptosis While a Novel ARID3B Splice Form Does Not Induce Cell Death	Joseph	2012	4		BCL10
1059	chr3	62164245	62164269	3500146943	24		62164245	62164269	8421504	1	24	0	c	350014694300000022	0-24		22860069	10.1371/journal.pone.0042159		PLoS ONE	ARID3B Induces Tumor Necrosis Factor Alpha Mediated Apoptosis While a Novel ARID3B Splice Form Does Not Induce Cell Death	Stancy	2012	0		BCL10
1059	chr3	62220171	62220196	3500241349	23		62220171	62220196	8421504	2	5,18	0,7	c	350024134900000020	3-26						Comparisons of the Complete Genomes of Asian, African and European Isolates of a Recent Foot-and-Mouth Disease Virus Type O Pandemic Strain (PanAsia)	www.fao.org	0	0		
132	chr3	62378913	62428814	3500339976	44		62378913	62428814	8421504	4	15,7,13,9	0,8121,40366,49892	c	350033997600000005,350033997600000002	0-22,0-22						Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release	cdb.lsa.umich.edu	0	0		MCOLN3
132	chr3	62378913	62428814	3500126733	44		62378913	62428814	8421504	4	15,7,13,9	0,8121,40366,49892	c	350012673300000005,350012673300000002	0-22,0-22		22415822	10.1038/ncomms1735		Nature Communications	Lipid Storage Disorders Block Lysosomal Trafficking By Inhibiting TRP Channel and Calcium Release	D	2011	0		MCOLN3,MCOLN2
1061	chr3	62520714	62520738	3500459775	24		62520714	62520738	8421504	1	24	0	c	350045977500000012,350045977500000004	0-24,0-24						THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF - Patent application	www.faqs.org	0	0		LPAR3
1061	chr3	62520714	62520738	3500403018	24		62520714	62520738	8421504	1	24	0	c	350040301800000004	0-24					Patent	Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof (Patent US:7307093)	Dalton	2007	0		LPAR3
1061	chr3	62520714	62520738	3500380968	24		62520714	62520738	8421504	1	24	0	c	350038096800000004	0-24						Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents	Dalton	2008	0		LPAR3
1061	chr3	62520714	62520738	3500282748	24		62520714	62520738	8421504	1	24	0	c	350028274800000022	0-24						Methods of regulating differentiation in stem cells	Pebay	2003	0		LPAR3
1061	chr3	62520714	62520738	3500248769	24		62520714	62520738	8421504	1	24	0	c	350024876900000009	0-24						Methods of regulating differentiation in stem cells	Pebay	2005	0		LPAR3
1061	chr3	62520714	62520738	3500172729	24		62520714	62520738	8421504	1	24	0	c	350017272900000028	0-24					Patent	Methods of regulating differentiation in stem cells (Patent US:7413903)	Pebay	2008	0		LPAR3
1061	chr3	62521000	62521023	3500094442	23		62521000	62521023	8421504	1	23	0	c	350009444200000008	0-23		22359668	10.1371/journal.pone.0032185	1932-6203	PLOS ONE	PLOS ONE: Targeting Lysophosphatidic Acid Signaling Retards Culture-Associated Senescence of Human Marrow Stromal Cells	Kanehira	2012	4		LPAR3
1061	chr3	62521011	62521034	3500199490	23		62521011	62521034	8421504	1	23	0	c	350019949000000004	0-23		18925509	10.1080/09537100802220468		Platelets	Lysophosphatidic Acid-Induced Platelet Shape Change Revealed Through LPA1&#x2013;5 Receptor-selective Probes and Albumin	A.L.	2008	0		LPAR3
132	chr3	62521023	62574342	3500440659	23		62521023	62574342	8421504	2	20,3	0,53316	c	350044065900000031	0-23		21314984	10.1186/1476-4598-10-18		Molecular Cancer	Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis	Song	2011	0		
132	chr3	62521023	62574342	3500401749	23		62521023	62574342	8421504	2	20,3	0,53316	c	350040174900000031	0-23						Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis	ecular-cancer.com	0	0		
1062	chr3	62574469	62574493	3500459775	24		62574469	62574493	8421504	1	24	0	c	350045977500000005,350045977500000013	0-24,0-24						THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF - Patent application	www.faqs.org	0	0		
1062	chr3	62574469	62574493	3500380968	24		62574469	62574493	8421504	1	24	0	c	350038096800000005	0-24						Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents	Dalton	2008	0		
1062	chr3	62574469	62574493	3500248769	24		62574469	62574493	8421504	1	24	0	c	350024876900000032	0-24						Methods of regulating differentiation in stem cells	Pebay	2005	0		LPAR3
1062	chr3	62574469	62574493	3500191701	24		62574469	62574493	8421504	1	24	0	g	350019170100000015	0-24						Methods of regulating differentiation in stem cells	Pebay	2004	0		
1062	chr3	62574469	62574493	3500096195	24		62574469	62574493	8421504	1	24	0	g	350009619500000005	0-24						Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents	Miller	2007	0		LPAR3
1062	chr3	62574469	62574493	3500019638	24		62574469	62574493	8421504	1	24	0	g	350001963800000005	0-24						Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof	Dalton	2006	0		LPAR3
1064	chr3	62805118	62805145	3500388239	26		62805118	62805145	8421504	2	22,4	0,23	g	350038823900000043	0-30						NANBV diagnostics and vaccines	Chien	1995	0		
1066	chr3	63124208	63128364	3500434299	192		63124208	63128364	8421504	2	81,111	0,4045	p	350043429900015074,350043429900015075,350043429900015076,350043429900015078	0-48,0-48,0-48,0-48						Zebrafish Heterotrimer G-protein Gamma 2 Subunit (gng2) 	.freshpatents.com	0	0		GNG5
1066	chr3	63134841	63134869	3500202695	24		63134841	63134869	8421504	3	6,13,5	0,7,23	g	350020269500000102	8-32						Chimeric genes and methods for increasing the lysine and threonine content of the seeds of plants	Falco	1997	0		
1067	chr3	63214885	63214911	3500464979	23		63214885	63214911	8421504	2	7,16	0,10	c	350046497900000142	25-48						Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses - Patent # 6051375 - PatentGenius	.patentgenius.com	0	0		
1067	chr3	63214885	63214911	3500198559	23		63214885	63214911	8421504	2	7,16	0,10	c	350019855900000142	25-48						Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses - Patent # 6015565 - PatentGenius	.patentgenius.com	0	0		
1067	chr3	63214885	63214911	3500161722	23		63214885	63214911	8421504	2	7,16	0,10	c	350016172200000145	25-48						Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses	Rose	1999	0		
1067	chr3	63246391	63268067	3500348888	164		63246391	63268067	8421504	5	48,13,35,48,20	0,2359,15379,17423,21656	p,c	350034888800015019,350034888800015031,350034888800015067,350034888800000001	0-48,0-48,0-48,20-40						Urate Oxidase 	.freshpatents.com	0	0		
1067	chr3	63246394	63246439	3500275335	45		63246394	63246439	8421504	1	45	0	p	350027533500015101	0-45						Variant Form of Urate Oxidase and Use Thereof - Patent application	www.faqs.org	0	0		
1067	chr3	63246394	63246439	3500095137	45		63246394	63246439	8421504	1	45	0	p	350009513700015101	0-45						Variant Forms of Urate Oxidase and Use Thereof - Patent application	www.faqs.org	0	0		
1067	chr3	63248540	63268048	3500085562	90		63248540	63268048	8421504	3	39,9,42	0,144,19466	c	350008556200000799,350008556200000810	0-48,0-42						Methods and compositions for assaying analytes	Yuan	1999	0		
1067	chr3	63248750	63261805	3500201728	48		63248750	63261805	8421504	2	13,35	0,13020	p	350020172800015031	0-48						(19) &#xb300;&#xd55c;&#xbbfc;&#xad6d;&#xd2b9;&#xd5c8;&#xccad;(KR) (12) &#xacf5;&#xac1c;&#xd2b9;&#xd5c8;&#xacf5;&#xbcf4;(A)	kpat.kipris.or.kr	0	0		
1067	chr3	63266016	63268067	3500044711	62		63266016	63268067	8421504	3	18,24,20	0,1975,2031	c	350004471100000040,350004471100000001	0-42,20-40						 Urate Oxidase 	www.docstoc.com	0	0		
1067	chr3	63273654	63273679	3500380836	24		63273654	63273679	8421504	2	18,6	0,19	g	350038083600000307	3-27						US Patent # 7,186,541. 3-hydroxypropionic acid and other organic compounds - Patents.com	www.patents.com	0	0		
1067	chr3	63273654	63273679	3500166501	24		63273654	63273679	8421504	2	18,6	0,19	g	350016650100000307	3-27						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
1069	chr3	63469550	63483689	3500288106	75		63469550	63483689	8421504	2	45,30	0,14109	p	350028810600015042	9-84						Duke : SCIENCE 111 : complete notes on Bioinformatics	ww.coursehero.com	0	0		PRKACB
1069	chr3	63469550	63483689	3500185699	75		63469550	63483689	8421504	2	45,30	0,14109	p	350018569900015044	9-84						Introduction to Bioinformatics	www.koshika.co.in	0	0		PRKACB
1070	chr3	63575170	63575201	3500222808	31		63575170	63575201	8421504	1	31	0	c,g	350022280800000000,350022280800000000	10-41,10-41		12438317	10.1074/jbc.M211078200	0021-9258	Journal of Biological Chemistry	Cell Cycle-dependent Regulation of Pyrimidine Biosynthesis	Sigoillot	2003	5		PRKACB
1071	chr3	63743913	63743937	3500039581	23		63743913	63743937	8421504	2	9,14	0,10	g	350003958100000007	1-24					Nucleic Acids Research	PNRC2 is a 16 kDa coactivator that interacts with nuclear receptors through an SH3-binding motif	Dujin	2001	0		
1076	chr3	64435178	64435204	3500252890	23		64435178	64435204	8421504	3	5,12,6	0,7,20	g	350025289000000193	5-29						Neisseria meningitidis antigens and compositions	Fraser	2012	0		CHD6
1081	chr3	65048828	65048854	3500405694	23		65048828	65048854	8421504	2	16,7	0,19	g	350040569400000007	8-36						Novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1	Feder	2001	0		
1081	chr3	65048828	65048854	3500218936	23		65048828	65048854	8421504	2	16,7	0,19	g	350021893600000000	8-36						Nucleic acids, proteins, and antibodies	Ebner	2002	0		
136	chr3	66251951	66371952	3500382800	2262		66251951	66371952	8421504	11	39,206,126,184,39,186,104,294,801,110,173	0,1116,1575,13572,16609,17471,18490,19131,25754,32193,119828	c	350038280000000062	0-2262						Novel proteins and nucleic acids encoding same	Anderson	2003	0		
1090	chr3	66271157	66271287	3500272471	51		66271157	66271287	8421504	2	26,25	0,105	c	350027247100000003,350027247100000002	0-26,0-25						Lectomedin materials and methods	Douangpanya	2000	0		
1090	chr3	66271262	66271287	3500240709	25		66271262	66271287	8421504	1	25	0	c	350024070900000002	0-25						Lectomedin materials and methods	Hayflick	2000	0		
1098	chr3	67272465	67272492	3500339718	23		67272465	67272492	8421504	2	13,10	0,17	g	350033971800000175	24-48						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1998	0		
1101	chr3	67724617	67724641	3500096793	24		67724617	67724641	8421504	1	24	0	g	350009679300000008	5-29						Production of antibodies in plants with plus -sense single -stranded viral rna vectors	Giritch	2006	0		
1103	chr3	67932937	67932970	3500045028	29		67932937	67932970	8421504	3	6,17,6	0,7,27	g	350004502800000074,350004502800000091	14-43,4-27					Patent	Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants (Patent US:5559223)	Falco	1996	0		
1105	chr3	68205887	68205912	3500126397	23		68205887	68205912	8421504	2	14,9	0,16	g	350012639700000000	19-42						Hypertension, Cardiac Hypertrophy, and Impaired Vascular Relaxation Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin are Associated with Increased Superoxide	ddr.nal.usda.gov	0	0		
1112	chr3	69179674	69179698	3500104098	23		69179674	69179698	8421504	2	17,6	0,18	g	350010409800000261	23-47						METHOD OF DETECTING HUMAN PAPILLOMA VIRUS BY USING NUCLEIC ACID AMPLIFICATION METHOD AND NUCLEIC ACID CHAIN-IMMOBILIZED CARRIER - Patent application	www.faqs.org	0	0		
1113	chr3	69281951	69281976	3500045026	23		69281951	69281976	8421504	2	8,15	0,10	g	350004502600000052	1-24						Modified HIV-1 Envelope Proteins - Patent application	www.faqs.org	0	0		
139	chr3	69632765	69771738	3500300648	297		69632765	69771738	8421504	12	10,27,19,29,26,48,41,13,17,44,8,15	0,1361,1492,75728,91258,103191,106149,106197,106213,106470,137606,138958	c	350030064800000108,350030064800000017,350030064800000030,350030064800000040,350030064800000045,350030064800000194,350030064800000049,350030064800000149	0-37,0-48,22-48,0-48,0-41,15-48,0-44,0-23						Methods and targets for identifying compounds for regulating angiogenesis - Patent application	www.faqs.org	0	0		
1116	chr3	69634227	69634259	3500115116	26		69634227	69634259	8421504	3	13,5,8	0,17,24	c	350011511600000471	11-38						Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use	J*M*Wei Er Sen 	2005	0		
139	chr3	69634248	69771793	3500081673	473		69634248	69771793	8421504	14	28,17,27,2,13,32,90,69,45,36,6,67,14,27	0,74245,87118,87935,89840,93433,93539,101708,101810,101864,104845,104980,136039,137518	c,g	350008167300000271,350008167300000276,350008167300000287,350008167300000334,350008167300000290,350008167300000335,350008167300000291,350008167300000340,350008167300000341,350008167300000298,350008167300000299,350008167300000380,350008167300000306,350008167300000354	0-45,0-29,0-45,20-45,0-44,1-45,0-32,21-45,0-45,0-45,9-45,0-80,0-44,18-45						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
1119	chr3	70103573	70104239	3500263236	40		70103573	70104239	8421504	2	20,20	0,646	c,g	350026323600000002,350026323600000002,350026323600000003	0-20,0-20,26-46		22262696	10.1095/biolreprod.111.094870	0006-3363	Biology of Reproduction	Patterns of Gene Expression in the Bovine Corpus Luteum Following Repeated Intrauterine Infusions of Low Doses of Prostaglandin F2alpha	Atli	2012	4		
1119	chr3	70103701	70104110	3500010569	41		70103701	70104110	8421504	2	20,21	0,388	c,g	350001056900000007,350001056900000002,350001056900000002	0-20,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
1119	chr3	70103975	70104176	3500287387	40		70103975	70104176	8421504	2	20,20	0,181	c,g	350028738700000000,350028738700000000,350028738700000001	0-20,0-20,0-20		21693577	10.1242/jcs.084558	0021-9533	Journal of Cell Science	TGFB1 disrupts the angiogenic potential of microvascular endothelial cells of the corpus luteum	Maroni	2011	6		
1119	chr3	70103975	70104176	3500249458	40		70103975	70104176	8421504	2	20,20	0,181	c	350024945800000000,350024945800000001	0-20,0-20		21693577	10.1242/jcs.084558	0021-9533	Journal of Cell Science	TGFB1 disrupts the angiogenic potential of microvascular endothelial cells of the corpus luteum	Maroni	2011	6		
1119	chr3	70103975	70104176	3500247796	40		70103975	70104176	8421504	2	20,20	0,181	c,g	350024779600000000,350024779600000000,350024779600000001	0-20,0-20,0-20						TGFB1 disrupts the angiogenic potential of microvascular endothelial cells of the corpus luteum	cs.biologists.org	0	0		
1119	chr3	70104206	70104229	3500326220	23		70104206	70104229	8421504	1	23	0	c	350032622000000008	0-23						Human prostaglandin receptors and methods of use thereof	Jonsson	2000	0		
1120	chr3	70164115	70165023	3500010569	86		70164115	70165023	8421504	4	20,21,24,21	0,200,747,887	c,g	350001056900000005,350001056900000005,350001056900000006,350001056900000006,350001056900000004,350001056900000008	0-20,0-20,0-21,0-21,0-24,0-21						REPRODUCTION	uction-online.org	0	0		
1124	chr3	70672931	70679094	3500104569	40		70672931	70679094	8421504	3	13,7,20	0,6048,6143	c	350010456900000013,350010456900000012	0-20,0-20						ANTI-NEOPLASTIC COMPOSITIONS COMPRISING EXTRACTS OF BLACK COHOSH - Patent application	www.faqs.org	0	0		
1124	chr3	70672931	70679094	3500035926	40		70672931	70679094	8421504	3	13,7,20	0,6048,6143	c,g	350003592600000013,350003592600000012,350003592600000012	0-20,0-20,0-20						Anti-neoplastic compositions comprising extracts of black cohosh - Patent application	www.faqs.org	0	0		DNAJB4
1124	chr3	70704132	70704156	3500110550	23		70704132	70704156	8421504	2	8,15	0,9	g	350011055000000767	20-43						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
1124	chr3	70759815	70759860	3500023707	45		70759815	70759860	8421504	1	45	0	p	350002370700015008	0-45						[PDF-Version] DISSERTATION	edoc.hu-berlin.de	0	0		FUBP1
1124	chr3	70761305	70761328	3500270988	23		70761305	70761328	8421504	1	23	0	c	350027098800000021	5-31						Stable expression of triple helical proteins	Galanis	1998	0		
1124	chr3	70778106	70778142	3500461407	35		70778106	70778142	8421504	2	21,14	0,22	c	350046140700000060	46-81						Compositions and methods for determining canine gender - Patent # 7300752 - PatentGenius	.patentgenius.com	0	0		
1126	chr3	70994406	70995603	3500132998	75		70994406	70995603	8421504	3	1,23,51	0,1120,1146	p	350013299800015061	12-87						Generierung muriner monoklonaler Antik&#xf6;rper -Fragmente gegen des Tenascin C	b.uni-muenchen.de	0	0		USP33
1134	chr3	72033352	72033375	3500045075	23		72033352	72033375	8421504	1	23	0	g	350004507500000086	2-25						Gene therapy for cystic fibrosis - US Patent 6093567 Description	ww.patentstorm.us	0	0		
1136	chr3	72252758	72295722	3500199661	43		72252758	72295722	8421504	4	10,12,12,9	0,11,42942,42955	g	350019966100000023,350019966100000086	14-36,0-21						Promoters for regulated gene expression	Kim	2001	0		
1137	chr3	72467975	72468002	3500155900	25		72467975	72468002	8421504	2	20,5	0,22	g	350015590000000303	14-40						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
1138	chr3	72507569	72507593	3500353024	23		72507569	72507593	8421504	2	18,5	0,19	g	350035302400000076,350035302400000060	2-25,2-25						Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein	Graf	2005	0		
1140	chr3	72861523	72861553	3500068199	25		72861523	72861553	8421504	2	12,13	0,17	g	350006819900000639	1-40						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
1140	chr3	72861523	72861553	3500019915	25		72861523	72861553	8421504	2	12,13	0,17	g	350001991500000639,350001991500000637	1-40,3-36						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
1143	chr3	73204694	73204718	3500429690	23		73204694	73204718	8421504	2	8,15	0,9	g	350042969000000001,350042969000000119	1-24,1-24						IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND USES THEREOF - Patent application	www.faqs.org	0	0		
1143	chr3	73213064	73213092	3500297276	24		73213064	73213092	8421504	2	13,11	0,17	c	350029727600000004	0-24						Assay For Bipolar Affective Disorder	Schofield	2004	0		
1143	chr3	73256301	73267262	3500454660	44		73256301	73267262	8421504	2	22,22	0,10939	c	350045466000000002,350045466000000024,350045466000000001,350045466000000023	0-22,0-22,0-22,0-22						&#xff32;&#xff2f;&#xff32;&#x03b1;&#xc758; &#xd65c;&#xc131;&#xc790;&#xb85c;&#xc11c;&#xc758; &#xc2e0;&#xaddc;&#xd55c; &#xff54;&#xff48;&#xff49;&#xff4f;&#xff55;&#xff52;&#xff45;&#xff41; &#xc720;&#xb3c4;&#xccb4; &#xbc0f; &#xc774;&#xb97c; &#xd568;&#xc720;&#xd558;	ip.com/patfam/ko/	0	0		ACADM
1143	chr3	73257817	73257857	3500121983	40		73257817	73257857	8421504	1	40	0	c	350012198300000002,350012198300000004	0-20,0-20		9550560		0009-9147	Clinical Chemistry	Molecular diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by oligonucleotide ligation assay	Romppanen	1998	8		ACADM
1144	chr3	73274493	73274516	3500124495	23		73274493	73274516	8421504	1	23	0	g	350012449500000006	1-24						The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. - ResearchGate	.researchgate.net	0	0		ACADM
1148	chr3	73806144	73806169	3500460467	24		73806144	73806169	8421504	2	17,7	0,18	g	350046046700000301	5-32						 Neutrophil Inhibitors 	www.docstoc.com	0	0		
1148	chr3	73863375	73863402	3500082848	25		73863375	73863402	8421504	2	14,11	0,16	g	350008284800000059	15-40						A STUDY OF THE BETA-2 TOXIN GENE AND THE BETA-2 TOXIN IN CLOSTRIDIUM PERFRINGENS STRAINS ISOLATED FROM HUMAN SOURCES	arworks.iupui.edu	0	0		
1149	chr3	73932165	73932191	3500427313	25		73932165	73932191	8421504	2	14,11	0,15	g	350042731300000011	1-26						Molecular Cloning and Functional Analysis of the Duck TLR4 Gene	www.mdpi.com	0	0		
1150	chr3	74165967	74165992	3500393129	25		74165967	74165992	8421504	1	25	0	c	350039312900000008	11-36						Identi&#xfb01;cation of a novel protein that regulates mitochondrial fusion by modulating mitofusin (Mfn) protein function	cs.biologists.org	0	0		
1153	chr3	74468867	74474936	3500414903	70		74468867	74474936	8421504	2	46,24	0,6045	g	350041490300000095,350041490300000132,350041490300000054	1-47,12-36,12-36						Novel Human Leucine-rich Repeat Domain Containing Protein Hllrcr-1 	.freshpatents.com	0	0		
1155	chr3	74775836	74775862	3500167309	24		74775836	74775862	8421504	2	19,5	0,21	c	350016730900000146	15-39						METHOD FOR MEASURING BETA-GLUCAN, AND BETA-GLUCAN-BINDING PROTEIN FOR USE IN THE METHOD - Patent application	www.faqs.org	0	0		
1155	chr3	74776649	74776676	3500299953	25		74776649	74776676	8421504	3	4,12,9	0,5,18	c	350029995300000022	1-26						20 December 1996 Volume 274 Number 5295 Breakthrough of the Y	ooks.gutenberg.cc	0	0		
1155	chr3	74805576	74805600	3500425870	23		74805576	74805600	8421504	2	13,10	0,14	c	350042587000000079	0-23							w.bhdsyndrome.org	0	0		
1155	chr3	74805576	74805600	3500419949	23		74805576	74805600	8421504	2	13,10	0,14	c	350041994900000079	0-23							w.bhdsyndrome.org	0	0		
1155	chr3	74805576	74805600	3500007309	23		74805576	74805600	8421504	2	13,10	0,14	c	350000730900000176	0-23						Immunoblot - Birt-Hogg-Dub&#xe9; Syndrome	www.docstoc.com	0	0		
1166	chr3	76240725	76240758	3500013455	32		76240725	76240758	8421504	2	14,18	0,15	g	350001345500000181	0-35						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		
1172	chr3	77051469	77051497	3500254292	23		77051469	77051497	8421504	2	16,7	0,21	g	350025429200000076	0-23					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent US:7579446)	Bakker	2009	0		
147	chr3	77608974	78048494	3500382095	337		77608974	78048494	8421504	3	269,47,21	0,439432,439499	c	350038209500000031,350038209500000032	0-316,0-21						Proteins and nucleic acids encoding same	Boldog	2003	0		NEGR1
18	chr3	77609067	78673658	3500293780	1062		77609067	78673658	8421504	7	176,233,126,132,121,152,122	0,439339,607134,686760,798834,822479,1064469	p	350029378000015102	0-1062					Patent	Nucleic acid encoding a NOVX13 polypeptide (Patent US:7122345)	Padigaru	2006	0		NEGR1
18	chr3	77609067	78673646	3500357092	1050		77609067	78673646	8421504	7	176,233,126,132,121,152,110	0,439339,607134,686760,798834,822479,1064469	p	350035709200015033	0-1050					Patent	Proteins and nucleic acids encoding same (Patent US:7276593)	Vernet	2007	0		NEGR1
18	chr3	77609067	78673646	3500357092	1050		77609067	78673646	8421504	7	176,233,126,132,121,152,110	0,439339,607134,686760,798834,822479,1064469	p	350035709200015032	0-1050					Patent	Proteins and nucleic acids encoding same (Patent US:7276593)	Vernet	2007	0		NEGR1
18	chr3	77609067	78673646	3500127615	1050		77609067	78673646	8421504	7	176,233,126,132,121,152,110	0,439339,607134,686760,798834,822479,1064469	p	350012761500015052	0-1050						 Proteins And Nucleic Acids Encoding Same 	www.docstoc.com	0	0		NEGR1
1178	chr3	77763099	77763123	3500085219	23		77763099	77763123	8421504	2	19,4	0,20	g	350008521900000016	3-26						Bedeutung der myokardialen Tissue Factor-Expression f&#xfc;r die myokardiale Struktur und Thrombogenit&#xe4;t bei der inflammatorischen Kardiomyopathie.	diss.fu-berlin.de	0	0		
147	chr3	78216242	78295913	3500293780	171		78216242	78295913	8421504	2	85,86	0,79585	p	350029378000015108	0-171					Patent	Nucleic acid encoding a NOVX13 polypeptide (Patent US:7122345)	Padigaru	2006	0		NEGR1
1183	chr3	78407924	78431694	3500293780	246		78407924	78431694	8421504	2	98,148	0,23622	p	350029378000015104,350029378000015106	0-180,0-66					Patent	Nucleic acid encoding a NOVX13 polypeptide (Patent US:7122345)	Padigaru	2006	0		NEGR1
1183	chr3	78444947	78444974	3500437227	24		78444947	78444974	8421504	2	19,5	0,22	g	350043722700000004	6-30						CHAPTER II Topology of LcnD, a protein implicated in the transport of bacteriocins from Lactococcus lactis	tations.ub.rug.nl	0	0		
1185	chr3	78673590	78673650	3500127615	49		78673590	78673650	8421504	2	22,27	0,33	c	350012761500000106,350012761500000107	0-22,0-27						 Proteins And Nucleic Acids Encoding Same 	www.docstoc.com	0	0		
1187	chr3	78967635	78973883	3500209147	42		78967635	78973883	8421504	3	21,7,14	0,1172,6234	c	350020914700000022,350020914700000023	0-21,0-21						Selection of New Appropriate Reference Genes for RT-qPCR Analysis via Transcriptome Sequencing of Cynomolgus Monkeys (Macaca fascicularis). - ResearchGate	.researchgate.net	0	0		ZRANB2
1187	chr3	78978429	78978452	3500400478	23		78978429	78978452	8421504	1	23	0	c	350040047800000194	0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		
1187	chr3	78978429	78978452	3500357539	23		78978429	78978452	8421504	1	23	0	c	350035753900000194	0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		MIR186
1187	chr3	78978429	78978452	3500244257	23		78978429	78978452	8421504	1	23	0	c	350024425700000050	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR186
1187	chr3	78978429	78978452	3500210973	23		78978429	78978452	8421504	1	23	0	c	350021097300000194	0-23						Microrna molecules	Tuschl	2002	0		
1187	chr3	78978429	78978452	3500131966	23		78978429	78978452	8421504	1	23	0	c	350013196600000050	0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
1187	chr3	79004555	79004840	3500196081	90		79004555	79004840	8421504	2	45,45	0,240	p	350019608100015024,350019608100015039	0-45,0-45						Methods and compositions for high yield production of eukaryotic proteins	Breyer	1999	0		
1187	chr3	79004555	79004840	3500107341	93		79004555	79004840	8421504	2	45,48	0,237	p	350010734100015025,350010734100015040	3-48,0-48						 Methods And Compositions For High Yield Production Of Eukaryotic Proteins 	www.docstoc.com	0	0		
148	chr3	79004756	79046479	3500154551	126		79004756	79046479	8421504	6	20,20,20,24,21,21	0,219,35785,36012,41670,41702	c,g	350015455100000002,350015455100000002,350015455100000003,350015455100000004,350015455100000007,350015455100000006,350015455100000005,350015455100000005	0-20,0-20,0-20,0-20,0-24,0-21,0-21,0-21		11299240			American Journal of Physiology - Heart and Circulatory Physiology	Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus	Bouayad	2001	0		
1192	chr3	79610872	79638848	3500212632	1041		79610872	79638848	8421504	10	24,139,154,78,58,132,110,96,82,168	0,310,11524,12786,13320,16326,18872,22037,23873,27808	p	350021263200015001	0-1215						BMDB: Showing 2-Ketobutyric acid (BMDB00005)	www.cowmetdb.ca	0	0		
1193	chr3	79776321	79776344	3500085562	23		79776321	79776344	8421504	1	23	0	c	350008556200000151	24-47						Methods and compositions for assaying analytes	Yuan	1999	0		
1198	chr3	80351620	80351643	3500007191	23		80351620	80351643	8421504	1	23	0	g	350000719100000120	1-24						Non-anaphylactogenic IgE fusion proteins	Morsey	2005	0		
1201	chr3	80741955	80742093	3500024337	40		80741955	80742093	8421504	2	20,20	0,118	g	350002433700000006,350002433700000007	0-20,0-20						Genetic Diversity Analysis of the Gohilwari Breed of Indian Goat Capra hircus ) Using Microsatellite Markers	thescipub.com	0	0		
1201	chr3	80757290	80757316	3500428877	23		80757290	80757316	8421504	2	17,6	0,20	g	350042887700000041	25-48						Recombinant fowlpox viruses and uses thereof	Cochran	1994	0		
1202	chr3	80885131	80885156	3500395713	23		80885131	80885156	8421504	2	6,17	0,8	g	350039571300000003	0-24						Bacillus megaterium	d-nb.info/9834731	0	0		
1202	chr3	80885131	80885156	3500341779	23		80885131	80885156	8421504	2	6,17	0,8	g	350034177900000003	0-24						Bacillus megaterium	etc.tu-bs.de:8080	0	0		
1202	chr3	80885131	80885156	3500281112	23		80885131	80885156	8421504	2	6,17	0,8	g	350028111200000003	0-24						Bacillus megaterium	b1lp1.rz.tu-bs.de	0	0		
1202	chr3	80885131	80885156	3500029756	23		80885131	80885156	8421504	2	6,17	0,8	g	350002975600000003	0-24						Bacillus megaterium	etc.tu-bs.de:8080	0	0		
1204	chr3	81164819	81164851	3500248094	26		81164819	81164851	8421504	3	7,5,14	0,10,18	g	350024809400000386,350024809400001667	20-46,0-24						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
1204	chr3	81234795	81234819	3500229650	23		81234795	81234819	8421504	2	8,15	0,9	g	350022965000000010	9-32						Alpha-amylase mutants	Svendsen	2012	0		
1204	chr3	81234795	81234819	3500206599	23		81234795	81234819	8421504	2	8,15	0,9	g	350020659900000008	9-32					Patent	Alpha-amylase variants (Patent US:8124395)	Andersen	2012	0		
1206	chr3	81417119	81417143	3500465169	24		81417119	81417143	8421504	1	24	0	g	350046516900000079	0-48						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
1207	chr3	81548687	81548715	3500009171	24		81548687	81548715	8421504	2	15,9	0,19	g	350000917100000125	0-26						Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor	Paoletti	1995	0		
1208	chr3	81701794	81721825	3500160662	1426		81701794	81721825	8421504	17	11,83,151,108,142,148,82,133,102,37,9,48,12,43,95,112,110	0,1133,2418,4038,4249,8911,10443,10763,11000,11103,11815,11897,18099,18171,18312,18516,19921	p,c,g	350016066200015000,350016066200015002,350016066200015004,350016066200015006,350016066200000010,350016066200015008,350016066200015010,350016066200000011,350016066200015012,350016066200000000,350016066200015014,350016066200000001,350016066200015015,350016066200000015,350016066200000015,350016066200015016,350016066200015036,350016066200015017,350016066200000016,350016066200015018,350016066200000018,350016066200015019,350016066200015020,350016066200000020,350016066200015022,350016066200000022,350016066200015025,350016066200000026,350016066200015027,350016066200015028,350016066200015029,350016066200015030,350016066200015031,350016066200000030,350016066200000031,350016066200015032	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-26,0-60,0-25,0-60,0-60,0-60,0-60,0-57,0-60,0-60,0-60,0-59,0-60,0-60,0-60,0-60,1-47,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						Congenital stationary night blindness in the dog: common muta- tion in the RPE65 gene indicates founder effect	www.molvis.org	0	0		RPE65
1208	chr3	81721846	81721869	3500432491	23		81721846	81721869	8421504	1	23	0	c	350043249100000009	13-36		18195010	10.1074/jbc.M708982200	0021-9258	Journal of Biological Chemistry	Metabolic Basis of Visual Cycle Inhibition by Retinoid and Nonretinoid Compounds in the Vertebrate Retina	Golczak	2008	5		
1208	chr3	81721846	81721869	3500108901	23		81721846	81721869	8421504	1	23	0	c	350010890100000010	13-36						MetabolicBasisofVisualCycleInhibitionbyRetinoidand NonretinoidCompoundsintheVertebrateRetina	macology.case.edu	0	0		
1211	chr3	82054639	82059488	3500349544	44		82054639	82059488	8421504	3	22,8,14	0,2543,4835	c	350034954400000052,350034954400000054	0-22,0-22		18302287	10.1002/hep.22084	1527-3350	Hepatology	Wnt2 acts as a cell type&#x2013;specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway - Klein - 2007 - Hepatology - Wiley Online Library	Klein	2008	0		
1211	chr3	82085895	82085949	3500012189	54		82085895	82085949	8421504	1	54	0	p	350001218900015000	0-54		20652957	10.1002/dvdy.22369	1097-0177	Developmental Dynamics	Expression of GPR177 (Wntless/Evi/Sprinter), a highly conserved Wnt-transport protein, in rat tissues, zebrafish embryos, and cultured human cells - Jin - 2010 - Developmental Dynamics - Wiley Online Library	Jin	2010	0		WLS
1213	chr3	82338183	82338207	3500253256	23		82338183	82338207	8421504	2	14,9	0,15	g	350025325600002449	8-31						 Methods Of Using Conjugated Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
1213	chr3	82367686	82367716	3500357543	23		82367686	82367716	8421504	3	5,12,6	0,8,24	g	350035754300000007	16-39						Aberrant TGF- 1 signaling contributes to the development of primary biliary cirrhosis in murine model	www.wjgnet.com	0	0		
1213	chr3	82430796	82430819	3500299342	23		82430796	82430819	8421504	1	23	0	g	350029934200000014	1-25						Proteins With Repetitive Bacterial-ig-like (big) Domains Present In Leptospira Species 	.freshpatents.com	0	0		
1215	chr3	82659242	82659620	3500215294	43		82659242	82659620	8421504	2	23,20	0,358	c,g	350021529400000005,350021529400000004,350021529400000004	0-23,0-20,0-20			10.1089/aid.2005.21.273		AIDS research and human retroviruses	Human T Lymphotropic Virus Type 1 Accessory Protein p12I Modulates Calcium-Mediated Cellular Gene Expression and Enhances p300 Expression in T Lymphocytes	AMRITHRAJ	2005	0		GADD45A
1215	chr3	82659411	82659435	3500279875	24		82659411	82659435	8421504	1	24	0	c	350027987500000005	0-24		18505818	10.1128/MCB.01747-07	0270-7306	Molecular and Cellular Biology	Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4	Li	2008	6		
1215	chr3	82659490	82659616	3500430306	42		82659490	82659616	8421504	2	21,21	0,105	c,g	350043030600000010,350043030600000009,350043030600000009	0-21,0-21,0-21		20562210	10.1158/1078-0432.CCR-10-0964	1078-0432	Clinical Cancer Research	Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-l-Carnitine	Pisano	2010	8		GADD45A
1215	chr3	82659490	82659616	3500224952	42		82659490	82659616	8421504	2	21,21	0,105	c,g	350022495200000010,350022495200000009,350022495200000009	0-21,0-21,0-21						Research Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-L-Carnitine Abstract	.aacrjournals.org	0	0		GADD45A
1215	chr3	82659490	82659616	3500043829	42		82659490	82659616	8421504	2	21,21	0,105	c,g	350004382900000010,350004382900000009,350004382900000009	0-21,0-21,0-21		20562210	10.1158/1078-0432.CCR-10-0964	1078-0432	Clinical Cancer Research	Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-l-Carnitine	Pisano	2010	8		GADD45A
1215	chr3	82659564	82659694	3500408876	67		82659564	82659694	8421504	3	24,23,20	0,82,110	c,g	350040887600000011,350040887600000010,350040887600000010,350040887600000009	0-24,0-23,0-23,0-20						 Microarray Analysis and RNA Silencing Link fra-1 to cd44 and c-met Expression in Mesothelioma1 	www.docstoc.com	0	0		GADD45A
1215	chr3	82659607	82661933	3500188719	500		82659607	82661933	8421504	4	116,238,102,44	0,1175,1659,2282	p,c,g	350018871900000002,350018871900015001,350018871900015008,350018871900015009,350018871900015016,350018871900015002,350018871900015017,350018871900015003,350018871900015010,350018871900015005,350018871900015004,350018871900015006,350018871900015015,350018871900015007,350018871900015012,350018871900000001,350018871900000001	0-24,0-495,0-78,0-81,0-108,0-138,0-123,0-114,0-51,0-63,0-78,0-63,0-45,0-78,0-48,10-31,10-31						Methods for identifying inhibitors of GADD45 polypeptide activity and inhibitors of such activity	Wang	2003	0		
1215	chr3	82659609	82661933	3500437202	45		82659609	82661933	8421504	2	24,21	0,2303	c,g	350043720200000001,350043720200000001,350043720200000000	11-35,11-35,11-32		12833139	10.1038/sj.onc.1206599	0950-9232	Oncogene	Role of Gadd45&#x03b1; in the density-dependent G1 arrest induced by p27Kip1	Zhang	2003	6		GADD45A
1215	chr3	82659612	82661933	3500048822	495		82659612	82661933	8421504	4	111,238,102,44	0,1170,1654,2277	p	350004882200015044,350004882200015051	0-495,0-495						Le coin du Bioinformaticien	ntunis.tripod.com	0	0		
1215	chr3	82659612	82661915	3500032295	471		82659612	82661915	8421504	5	111,238,80,16,26	0,1170,1654,1740,2277	p,c	350003229500015083,350003229500015036,350003229500000014,350003229500015032,350003229500015002,350003229500015100,350003229500015000,350003229500015009,350003229500000006,350003229500000005	0-132,0-405,0-45,0-108,30-138,0-93,0-108,0-78,0-42,0-42						US Patent # 7,438,892. Method of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity - Patents.com	www.patents.com	0	0		
1215	chr3	82659661	82661893	3500176387	40		82659661	82661893	8421504	3	20,16,4	0,1691,2228	c	350017638700000005,350017638700000004	0-20,0-20		19376846	10.1093/carcin/bgp088		Carcinogenesis	Alterations of histone modifications by cobalt compounds	Qin	July	0		GADD45A
1215	chr3	82659663	82659687	3500261816	24		82659663	82659687	8421504	1	24	0	c	350026181600000001	0-24		21785564	10.1155/2011/692846	1110-7243	BioMed Research International	Synergic Effect of Genistein and Daidzein on UVB-Induced DNA Damage: An Effective Photoprotective Combination	Iovine	2011	2		GADD45A
1215	chr3	82661006	82661275	3500365209	23		82661006	82661275	8421504	2	14,9	0,260	c	350036520900000004	0-23						Proibitina e a resposta a mecanismos de estresse em melanoma e sua rela&#xe7;&#xe3;o com a via E2F1	www.teses.usp.br	0	0		
1215	chr3	82661351	82661940	3500349798	39		82661351	82661940	8421504	3	17,3,19	0,538,570	c,g	350034979800000017,350034979800000016,350034979800000016	0-20,0-19,0-19		22438963	10.1371/journal.pone.0033609	1932-6203	PLOS ONE	PLOS ONE: TWEAK Affects Keratinocyte G2/M Growth Arrest and Induces Apoptosis through the Translocation of the AIF Protein to the Nucleus	Alaoui	2012	4		GADD45A
1215	chr3	82661358	82661903	3500215302	24		82661358	82661903	8421504	2	10,14	0,531	c	350021530200000016	0-24		19147553	10.1158/0008-5472.CAN-08-1856	0008-5472	Cancer Research	Reversal of P-glycoprotein&#x2013;Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3	Michaelis	2009	8		GADD45A
1216	chr3	82781490	82781517	3500424461	26		82781490	82781517	8421504	2	9,17	0,10	g	350042446100000001	1-27		19807062	10.1021/bi9013165		Biochemistry	The ATP-dependent amide ligases DdaG and DdaF assemble the fumaramoyl-dipeptide scaffold of the dapdiamide antibiotics	Marie	2009	0		
1217	chr3	82930494	82934631	3500020009	40		82930494	82934631	8421504	2	20,20	0,4117	c	350002000900000008,350002000900000009	0-20,0-20		19535458	10.1091/mbc.E08-08-0845	1059-1524	Molecular Biology of the Cell	Novel Roles of Hakai in Cell Proliferation and Oncogenesis	Figueroa	2009	5		SERBP1
1217	chr3	82930539	82930587	3500431918	48		82930539	82930587	8421504	1	48	0	p	350043191800015022	0-48						Riboproteomics of the Hepatitis C Virus Internal Ribosomal Entry Site	gs.washington.edu	0	0		SERBP1
1217	chr3	82930586	82944454	3500431986	42		82930586	82944454	8421504	2	21,21	0,13847	c	350043198600000018,350043198600000019	0-21,0-21						Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. - ResearchGate	.researchgate.net	0	0		SERBP1
1217	chr3	82930586	82944454	3500417061	42		82930586	82944454	8421504	2	21,21	0,13847	c	350041706100000018,350041706100000019	0-21,0-21						Gene Cloning of Immunogenic Antigens Overexpressed in Pancreatic Canc&#xef;#%	.kumamoto-u.ac.jp	0	0		
1217	chr3	82944446	82944473	3500454707	27		82944446	82944473	8421504	1	27	0	c,g	350045470700000030,350045470700000030	0-27,0-27						Methods and kits for investigating cancer	Munnes	2008	0		FRAS1
1217	chr3	82944446	82944473	3500400698	27		82944446	82944473	8421504	1	27	0	c,g	350040069800000030,350040069800000030	0-27,0-27						Methods and kits for investigating cancer	Munnes	2008	0		SERBP1
1217	chr3	82962365	82962389	3500009791	24		82962365	82962389	8421504	1	24	0	c	350000979100000007	0-24						Dna Marker For Meat Tenderness In Cattle 	.freshpatents.com	0	0		
1218	chr3	82994007	83020176	3500347624	40		82994007	83020176	8421504	3	19,11,10	0,24529,26159	c,g	350034762400000011,350034762400000011,350034762400000010	0-19,0-19,0-21		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		
1218	chr3	83028995	83029024	3500325127	29		83028995	83029024	8421504	1	29	0	c	350032512700000019	6-35						Method For Detecting Gene Specifying Allergic Predisposition 	.freshpatents.com	0	0		
1218	chr3	83093926	83093949	3500148414	23		83093926	83093949	8421504	1	23	0	g	350014841400000471	0-31						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
1224	chr3	83774890	83774915	3500328768	24		83774890	83774915	8421504	2	16,8	0,17	g	350032876800000047	1-25						Alternative methods for the biosynthesis of gaba	Turano	2009	0		
1225	chr3	83918552	83918578	3500431462	24		83918552	83918578	8421504	2	15,9	0,17	g	350043146200000439	11-35						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
153	chr3	83976608	84018865	3500271050	322		83976608	84018865	8421504	10	44,2,36,48,2,46,18,30,54,42	0,198,3148,4090,4443,6715,9097,9258,16838,42215	c	350027105000000241,350027105000000237,350027105000000232,350027105000000033,350027105000000222,350027105000000215,350027105000000214	0-44,0-38,0-48,0-48,0-48,0-48,0-48						Cloning by complementation and related processes	Colicelli	1991	0		
153	chr3	83976685	84019055	3500253350	79		83976685	84019055	8421504	2	48,31	0,42339	c,g	350025335000000035,350025335000000002	0-48,11-42					Patent	Polynucleotides encoding human brain phosphodiesterase (Patent US:5932477)	Livi	1999	0		
1225	chr3	83976685	83976733	3500111473	48		83976685	83976733	8421504	1	48	0	c	350011147300000037	0-48						Human brain phosphodiesterase	Livi	1994	0		
1225	chr3	83976685	83976733	3500096830	48		83976685	83976733	8421504	1	48	0	c	350009683000000036	0-48						Human brain phosphodiesterase	Livi	1998	0		
153	chr3	83976772	84117441	3500435413	646		83976772	84117441	8421504	16	36,84,84,36,42,33,55,2,100,3,60,7,41,3,33,27	0,2984,3083,3881,3962,4126,4164,4279,6551,8786,8804,42104,42123,126039,140478,140642	p,c	350043541300015071,350043541300015070,350043541300000023,350043541300015021,350043541300015068,350043541300015020,350043541300015066,350043541300015018,350043541300015015,350043541300015062,350043541300015013,350043541300000063,350043541300015086	0-60,0-60,0-61,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,10-61,0-60						PDE4B inhibitors	Ibrahim	2005	0		
153	chr3	83976772	84117441	3500403003	646		83976772	84117441	8421504	16	36,84,84,36,42,33,55,2,100,3,60,7,41,3,33,27	0,2984,3083,3881,3962,4126,4164,4279,6551,8786,8804,42104,42123,126039,140478,140642	p,c	350040300300015066,350040300300015065,350040300300000019,350040300300015016,350040300300015063,350040300300015015,350040300300015061,350040300300015013,350040300300015010,350040300300015057,350040300300015008,350040300300000059,350040300300015081	0-60,0-60,0-61,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,10-61,0-60						 PDE4B Inhibitors 	www.docstoc.com	0	0		
1225	chr3	83976787	83981051	3500456905	144		83976787	83981051	8421504	3	21,60,63	0,2969,4201	p	350045690500015023,350045690500015046,350045690500015038,350045690500015014	0-48,0-48,0-48,0-48						PDE4B INHIBITORS AND USES THEREFOR - Patent application	www.faqs.org	0	0		PDE4A
153	chr3	83979780	84102814	3500462693	481		83979780	84102814	8421504	13	60,39,36,42,33,55,2,100,3,60,7,41,3	0,120,873,954,1118,1156,1271,3543,5778,5796,39096,39115,123031	p,c	350046269300015064,350046269300000020,350046269300015062,350046269300015015,350046269300015060,350046269300015013,350046269300015010,350046269300015056,350046269300015008,350046269300000060	0-60,0-61,0-60,0-60,0-60,0-60,0-60,0-60,0-60,10-61						Bicyclic heteroaryl pde4b inhibitors	Ibrahim	2006	0		
1225	chr3	83981009	83983360	3500173558	81		83981009	83983360	8421504	2	44,37	0,2314	p	350017355800015007	0-81						CRYSTAL OF PDE5, ITS CRYSTAL STRUCTURE AND ITS USE IN DRUG DESIGN - PFIZER LIMITED	www.sumobrain.com	0	0		PDE4B
1225	chr3	83981009	83983360	3500042418	81		83981009	83983360	8421504	2	44,37	0,2314	p	350004241800015000	0-81						Crystal structure of phosphodiesterase 5 and use thereof	Brown	2003	0		PDE4A
1225	chr3	83985930	83993450	3500274533	41		83985930	83993450	8421504	2	21,20	0,7500	c	350027453300000001,350027453300000004	0-21,20-40						Phosphodiesterase 4 regulates the migration of B16-F10 melanoma cells	-publications.com	0	0		PDE4B
1226	chr3	84018898	84102814	3500284029	41		84018898	84102814	8421504	2	38,3	0,83913	c	350028402900000008	7-48					Patent	Human brain phosphodiesterase (Patent US:6150150)	Livi	2000	0		
1229	chr3	84512360	84516991	3500271050	89		84512360	84516991	8421504	2	80,9	0,4622	c	350027105000000201,350027105000000200	0-41,0-48						Cloning by complementation and related processes	Colicelli	1991	0		
1232	chr3	84913091	84914931	3500022313	210		84913091	84914931	8421504	2	111,99	0,1741	p	350002231300015059	204-414						The characterisation of trypanosomal type 1 DnaJ-like proteins | Michael Ludewig - Academia.edu	www.academia.edu	0	0		DNAJC6
1232	chr3	84914910	84914936	3500438994	26		84914910	84914936	8421504	1	26	0	c	350043899400000001	10-36						letters to nature	ystal.harvard.edu	0	0		
1232	chr3	84914910	84914936	3500358923	26		84914910	84914936	8421504	1	26	0	c,g	350035892300000001,350035892300000001	10-36,10-36						letters to nature	www.med.nyu.edu	0	0		
1232	chr3	84916465	84916495	3500329088	24		84916465	84916495	8421504	3	6,4,14	0,11,16	c	350032908800000115	21-45						Expression cassettes for seed-preferential expression in plants - US Patent 7790873 Description	ww.patentstorm.us	0	0		
1233	chr3	84988618	84988641	3500238669	23		84988618	84988641	8421504	1	23	0	g	350023866900000055	0-23						Compositions, methods, and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals	Bates	2005	0		
154	chr3	85027269	85075814	3500321684	660		85027269	85075814	8421504	22	30,30,30,30,30,30,33,27,30,30,30,30,30,30,32,28,30,30,30,30,32,28	0,31,2448,2479,5196,5227,9803,9837,19521,19552,24942,24973,33491,33522,43338,43371,46997,47028,47792,47823,48484,48517	g	350032168400000000,350032168400000001,350032168400000002,350032168400000004,350032168400000009,350032168400000010,350032168400000013,350032168400000016,350032168400000017,350032168400000018,350032168400000019	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						EVALUATION OF SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH FERTILITY AND PRODUCTION TRAITS IN HOLSTEIN AND MULTI-GENERATIONAL ANGUS FEMALES	etd.lsu.edu	0	0		
1233	chr3	85032817	85035440	3500168145	25		85032817	85035440	8421504	2	9,16	0,2607	c	350016814500000024	23-48						Characterization of insulin sensitivity and inflammation related factors in dairy cows receiving conjugated linoleic acids (CLA) or a control fat supplement during lactation	s.ulb.uni-bonn.de	0	0		
154	chr3	85060604	85104161	3500173591	205		85060604	85104161	8421504	6	31,47,45,3,48,31	0,10753,29501,42793,42844,43526	c	350017359100000112,350017359100000118,350017359100000150,350017359100000152,350017359100000166	0-31,1-48,0-48,0-48,7-38						 Methods Of Using The OB Receptor Antibodies To Treat Bodyweight Disorders 	www.docstoc.com	0	0		
154	chr3	85060616	85085685	3500374303	111		85060616	85085685	8421504	4	19,44,4,44	0,10848,23300,25025	c	350037430300000027,350037430300000035,350037430300000056	0-19,0-44,0-48						Antibodies specific for Hu-B1.219, a novel hematopoietin receptor	Snodgrass	1996	0		
1234	chr3	85071543	85071727	3500152653	25		85071543	85071727	8421504	2	6,19	0,165	c	350015265300000000	11-36						Leptin binding domain compositions and methods thereto	Gertler	2004	0		LEPR
1234	chr3	85074699	85077095	3500202035	23		85074699	85077095	8421504	2	22,1	0,2395	c	350020203500000014	0-23						Estudo de caracteriza&#xe7;&#xe3;o e associa&#xe7;&#xe3;o de marcadores moleculares rel...	ww.slideshare.net	0	0		LEPR
1234	chr3	85074699	85077095	3500055131	23		85074699	85077095	8421504	2	22,1	0,2395	c	350005513100000014	0-23						Silva,RCG Disserta&#xe7;&#xe3;o Mestrado	pt.scribd.com	0	0		LEPR
1234	chr3	85103517	85103828	3500205679	44		85103517	85103828	8421504	2	22,22	0,289	c,g	350020567900000014,350020567900000015,350020567900000015,350020567900000011	0-22,0-22,0-22,22-44						TABLE OF CONTENTS October, 2012	www.engii.org	0	0		
1234	chr3	85103517	85103828	3500155802	44		85103517	85103828	8421504	2	22,22	0,289	c	350015580200000000,350015580200000001	0-22,0-22		16322546	10.1530/rep.1.00557	1470-1626	Reproduction	The ovarian expression of mRNAs for aromatase, IGF-I receptor, IGF-binding protein-2, -4 and -5, leptin and leptin receptor in cycling ewes after three days of leptin infusion	Munoz-Gutierrez	2005	3		
1234	chr3	85103517	85103828	3500054995	44		85103517	85103828	8421504	2	22,22	0,289	c	350005499500000005,350005499500000006	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
1234	chr3	85103526	85103906	3500410800	50		85103526	85103906	8421504	2	25,25	0,355	c	350041080000000000,350041080000000001	0-25,0-25						Asociaci&#xf3;n entre receptores de leptina en test&#xed;culo, niveles de leptina y testosterona en terneros p&#xfa;beres	unicordoba.edu.co	0	0		
1234	chr3	85103526	85103906	3500389949	50		85103526	85103906	8421504	2	25,25	0,355	c	350038994900000000,350038994900000001	0-25,0-25		11349006	10.1161/hh0901.090975	0009-7330	Circulation Research	Leptin Enhances the Calcification of Vascular Cells	Parhami	2001	9		
1234	chr3	85103526	85103906	3500361461	50		85103526	85103906	8421504	2	25,25	0,355	c,g	350036146100000000,350036146100000000,350036146100000001	0-25,0-25,0-25		11349006	10.1161/hh0901.090975	0009-7330	Circulation Research	Leptin Enhances the Calcification of Vascular Cells	Parhami	2001	9		
1234	chr3	85103526	85103906	3500286666	50		85103526	85103906	8421504	2	25,25	0,355	c	350028666600000000,350028666600000001	0-25,0-25						Artery Wall as a Target of Leptin	s.ahajournals.org	0	0		
1234	chr3	85103526	85103906	3500244511	50		85103526	85103906	8421504	2	25,25	0,355	c,g	350024451100000000,350024451100000000,350024451100000001,350024451100000001	0-25,0-25,0-25,0-25						None	unicordoba.edu.co	0	0		
1234	chr3	85103526	85103906	3500162030	50		85103526	85103906	8421504	2	25,25	0,355	c	350016203000000000,350016203000000001	0-25,0-25						RNA EXTRACTION AND LEPTIN RECEPTOR MRNA DETECTION IN BULL EJACULATED SPERMATOZOA	www.sid.ir/en/VEW	0	0		
1234	chr3	85103526	85103906	3500092675	50		85103526	85103906	8421504	2	25,25	0,355	c	350009267500000000,350009267500000001	0-25,0-25				0122-0268	Revista MVZ C&#xf3;rdoba	Revista MVZ C&#xf3;rdoba - Asociaci&#xf3;n entre receptores de leptina en test&#xed;culo, niveles de leptina y testosterona en terneros p&#xfa;beres	Ruiz-Cortes	2010	0		
1234	chr3	85103528	85103816	3500355031	45		85103528	85103816	8421504	2	23,22	0,266	c	350035503100000000,350035503100000001	0-23,0-22						OKAMATSU-OGURA, Yuko; SOLIMAN, Mohamed; ABD Citation Journal of Veterinary Medical Science, 69(5): 509-514 Issue Date 2007-05	lib.hokudai.ac.jp	0	0		
1234	chr3	85103528	85103816	3500192148	45		85103528	85103816	8421504	2	23,22	0,266	c,g	350019214800000000,350019214800000000,350019214800000001,350019214800000001	0-23,0-23,0-22,0-22						Effects of leptin and tumor necrosis factor-alpha on degranulation and superoxide production of polymorphonuclear neutrophils from Holstein cows. - ResearchGate	.researchgate.net	0	0		
1234	chr3	85103753	85103890	3500315071	40		85103753	85103890	8421504	2	20,20	0,117	c	350031507100000046,350031507100000047	0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1234	chr3	85103907	85103932	3500165694	25		85103907	85103932	8421504	1	25	0	c	350016569400000013	0-25						ANNALS OF ANIMAL SCIENCE	ww.izoo.krakow.pl	0	0		
1235	chr3	85209570	85209598	3500065112	23		85209570	85209598	8421504	2	11,12	0,16	g	350006511200000052	13-46					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
1235	chr3	85232029	85232054	3500060896	24		85232029	85232054	8421504	2	5,19	0,6	g	350006089600000136	13-37						Polypeptides and polynucleotides from coagulase-negative staphylococci	Foster	1999	0		
1235	chr3	85309110	85309133	3500268814	23		85309110	85309133	8421504	1	23	0	g	350026881400000003	8-31		23096363	10.4067/S0716-97602012000200011	0716-9760	Biological Research	Biological Research - Structurally conserved C-RFa revealed prolactin releasing activity in vitro and gene expression changes in pituitary of seasonally acclimatized carp	Romero	2012	1		
1236	chr3	85386811	85386886	3500180989	75		85386811	85386886	8421504	1	75	0	c	350018098900000000	0-75						COMBINATION TREATMENT OF CANCER	Yu	2011	0		AK4
1236	chr3	85386855	85386881	3500177892	26		85386855	85386881	8421504	1	26	0	g	350017789200000020	24-50						Supporting Information	www.pnas.org	0	0		AK4
1236	chr3	85386862	85386885	3500025704	23		85386862	85386885	8421504	1	23	0	c	350002570400000015	20-43						METHODS FOR QUANTIFYING MICRORNA PRECURSORS	Schmittigen	2006	0		AK4
1238	chr3	85625830	85628190	3500381544	63		85625830	85628190	8421504	2	15,48	0,2312	p	350038154400015000	0-63						US Patent # 5,843,697. Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein - Patents.com	www.patents.com	0	0		JAK1
1238	chr3	85625830	85628190	3500104462	63		85625830	85628190	8421504	2	15,48	0,2312	p	350010446200015000	0-63		9030561	10.1074/jbc.272.8.4993	0021-9258	Journal of Biological Chemistry	Chimeric Erythropoietin-Interferon &#x03b3; Receptors Reveal Differences in Functional Architecture of Intracellular Domains for Signal Transduction	Muthukumaran	1997	5		JAK1
1246	chr3	86748427	86748450	3500358504	23		86748427	86748450	8421504	1	23	0	g	350035850400000137	11-43						Inducible herbicide resistance	Ryals	1997	0		
1247	chr3	86813570	86813596	3500089515	24		86813570	86813596	8421504	2	11,13	0,13	g	350008951500000010	11-35						INAUGURAL-DISSERTATION zur Erlangung der Doktorw&#xfc;rde der Naturwissenschaftlich-Mathematischen Gesamtfakult&#xe4;t der Ruprecht-Karls-Universit&#xe4;t Heidelberg	uni-heidelberg.de	0	0		
1248	chr3	87012958	87012984	3500110329	23		87012958	87012984	8421504	2	18,5	0,21	g	350011032900000604	21-44						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
19	chr3	87028856	87040322	3500210939	51		87028856	87040322	8421504	2	26,25	0,11441	p	350021093900015243,350021093900015269,350021093900015122	0-45,0-45,0-45						Starchless variety of pisum sativum having elevated levels of sucrose	Webster	2000	0		PGM1
19	chr3	87028856	87040322	3500187962	51		87028856	87040322	8421504	2	26,25	0,11441	p	350018796200015243,350018796200015270,350018796200015122	0-48,0-48,3-48						 Starchless Variety Of Pisum Sativum Having Elevated Levels Of Sucrose 	www.docstoc.com	0	0		PGM1
1248	chr3	87028857	87028880	3500271944	23		87028857	87028880	8421504	1	23	0	c	350027194400000146	0-23						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		PGM1
1248	chr3	87028857	87028880	3500237109	23		87028857	87028880	8421504	1	23	0	c	350023710900000146	0-23						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		PGM1
1248	chr3	87029518	87029542	3500346666	23		87029518	87029542	8421504	2	5,18	0,6	g	350034666600000922,350034666600000527	19-44,19-44						Modified Variant Bowman Birk Protease Inhibitors - Patent application	www.faqs.org	0	0		
1253	chr3	87678766	87678793	3500310625	25		87678766	87678793	8421504	2	17,8	0,19	g	350031062500000004	13-38						DNA encoding structural protein-1 of infectious Salmon Anaemia virus and uses thereof	Biering	2000	0		
1255	chr3	87887944	87887974	3500065112	24		87887944	87887974	8421504	3	12,5,7	0,14,23	g	350006511200000213	1-25					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
1255	chr3	87905778	87905806	3500253347	23		87905778	87905806	8421504	2	11,12	0,16	g	350025334700000061	10-33						US Patent # 6,136,310. Recombinant anti-CD4 antibodies for human therapy - Patents.com	www.patents.com	0	0		
157	chr3	88142081	88214556	3500231766	1302		88142081	88214556	8421504	10	165,120,77,79,57,70,331,234,84,85	0,24929,30723,31460,36501,42538,44707,47403,59540,72390	p	350023176600015023	0-1302						29 human secreted proteins	Birse	2001	0		ATG4C
1259	chr3	88350010	88350034	3500348397	23		88350010	88350034	8421504	2	6,17	0,7	c	350034839700000027,350034839700000146	0-23,21-44						Preparation of heterologous proteins on oil bodies	Moloney	2001	0		
1259	chr3	88453004	88453036	3500107005	25		88453004	88453036	8421504	3	13,6,6	0,15,26	g	350010700500000002	0-26						Development and Evaluation of a Multitarget Real-Time Taqman Reverse Transcription-PCR Assay for Detection of the Severe Acute Respiratory Syndrome-Associated Coronavirus and Surveillance for an Apparently Related Coronavirus Found in Masked Palm Civets	jcm.asm.org	0	0		
1259	chr3	88469462	88469488	3500158750	23		88469462	88469488	8421504	2	9,14	0,12	c	350015875000000078	15-38						Method of treating dopaminergic and gaba-nergic disorders	Miao	1999	0		
1260	chr3	88510172	88510200	3500152135	23		88510172	88510200	8421504	2	12,11	0,17	c	350015213500000067	22-45						DNA encoding Fas ligand	Nagata	1994	0		
1264	chr3	89053420	89076911	3500053228	40		89053420	89076911	8421504	2	20,20	0,23471	c	350005322800000007,350005322800000006	0-20,0-20						The human G Protein-Coupled Receptor GPR30: interaction partners and expression analysis in endothelial cells	edoc.hu-berlin.de	0	0		INADL
1267	chr3	89422078	89435766	3500241839	42		89422078	89435766	8421504	2	21,21	0,13667	c	350024183900000024	0-42						 Compositions And Methods For Delivery Of Genetic Material 	www.docstoc.com	0	0		
1268	chr3	89581711	89581734	3500308662	23		89581711	89581734	8421504	1	23	0	g	350030866200000016	0-23						DNA	.lib.kobe-u.ac.jp	0	0		
1269	chr3	89756087	89756112	3500018095	25		89756087	89756112	8421504	1	25	0	c	350001809500000011	0-25		12955085	10.1038/sj.onc.1206884	0950-9232	Oncogene	The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy	Johansson	2003	6		NFIA
1274	chr3	90353845	90353868	3500180208	23		90353845	90353868	8421504	1	23	0	g	350018020800000116,350018020800000191,350018020800000079	5-27,5-26,5-26					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		
1279	chr3	91031381	91031409	3500059891	23		91031381	91031409	8421504	2	9,14	0,14	g	350005989100000006	1-24			10.1038/sj.onc.1204740	${footerJournalISSN}		Nrh, a human homologue of Nr-13 associates with Bcl-Xs and is an inhibitor of apoptosis		2001	0		
1282	chr3	91411850	91416192	3500112685	359		91411850	91416192	8421504	3	135,177,47	0,1548,4295	p,c,g	350011268500000042,350011268500015011,350011268500000044,350011268500000044,350011268500000046,350011268500015015,350011268500000048,350011268500000048,350011268500000050,350011268500000052	1-60,3-180,0-60,0-60,0-60,0-180,0-60,0-60,0-60,0-60						Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle	web1.sssup.it	0	0		
1288	chr3	92256475	92256502	3500065112	24		92256475	92256502	8421504	2	6,18	0,9	g	350006511200000279	4-28					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
1290	chr3	92480975	92481003	3500116257	24		92480975	92481003	8421504	3	13,7,4	0,16,24	g	350011625700000118	21-45						SAM-6 VARIANTS, TARGET AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1292	chr3	92701342	92702496	3500094172	45		92701342	92702496	8421504	2	25,20	0,1134	c,g	350009417200000028,350009417200000000	0-25,10-30						JNK1-dependentPUMAExpressionContributesto HepatocyteLipoapoptosis S	www.jbc.org	0	0		MYSM1
1292	chr3	92702455	92702479	3500016159	24		92702455	92702479	8421504	1	24	0	c	350001615900000002	0-24						Catechins inhibit angiotensin II-induced vascular smooth muscle 	www.docstoc.com	0	0		MYSM1
1292	chr3	92702473	92703481	3500465855	50		92702473	92703481	8421504	2	25,25	0,983	c	350046585500000000,350046585500000001	10-35,11-36		17672916	10.1186/1471-2407-7-145	1471-2407	BMC Cancer	Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model	Zhang	2007	3		MYSM1
1292	chr3	92702473	92703481	3500450949	44		92702473	92703481	8421504	2	21,23	0,985	c,g	350045094900000002,350045094900000002,350045094900000003	0-21,0-21,0-23						Compositions and methods for enhancing polynucleotide amplification reactions	Chakrabarti	2002	0		MYSM1
1292	chr3	92702473	92703481	3500193114	44		92702473	92703481	8421504	2	21,23	0,985	c	350019311400000002,350019311400000003	0-21,0-23						Chemical PCR: Compositions for enhancing polynucleotide amplification reactions	Chakrabarti	2004	0		MYSM1
1292	chr3	92702473	92703481	3500126216	42		92702473	92703481	8421504	2	21,21	0,987	c	350012621600000002,350012621600000003	9-30,9-30		15592508	10.1038/sj.onc.1208297	0950-9232	Oncogene	HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein	Matsumoto	2004	6		MYSM1
1292	chr3	92702473	92703451	3500452170	209		92702473	92703451	8421504	7	21,21,38,48,4,29,48	0,29,198,342,404,504,930	c,g	350045217000000010,350045217000000002,350045217000000003,350045217000000003,350045217000000011,350045217000000011,350045217000000022,350045217000000015,350045217000000025,350045217000000028,350045217000000037	14-35,14-35,13-34,13-34,13-34,13-34,0-38,10-30,0-48,14-47,0-48						US Patent # 6,706,509. Oncoprotein protein kinase - Patents.com	www.patents.com	0	0		
1292	chr3	92702473	92702709	3500036430	47		92702473	92702709	8421504	2	24,23	0,213	c	350003643000000006,350003643000000007	10-34,16-39					Patent	JNK inhibitor (Patent US:7199124)	Kawamoto	2007	0		
1292	chr3	92702473	92702497	3500223692	24		92702473	92702497	8421504	1	24	0	c	350022369200000001	0-24						&#x4e3b;&#x9898;&#xff1a;C-JUN | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		MYSM1
1292	chr3	92702473	92702497	3500024418	24		92702473	92702497	8421504	1	24	0	c,g	350002441800000000,350002441800000000	0-24,0-24			10.1038/sj.bjp.0702039	1476-5381	British Journal of Pharmacology	Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-&#x03ba;B-signaling pathways - Kleinert - 2009 - British Journal of Pharmacology - Wiley Online Library	Kleinert	1998	0		MYSM1
1292	chr3	92702477	92703987	3500464960	40		92702477	92703987	8421504	2	20,20	0,1490	c	350046496000000012,350046496000000006	0-20,0-20		17510634	10.1038/sj.emboj.7601712	ERROR! NO ISSN	The EMBO Journal	Staufen1 regulates diverse classes of mammalian transcripts	Kim	2007	0		MYSM1
1292	chr3	92702477	92702594	3500386061	69		92702477	92702594	8421504	3	22,25,22	0,23,95	c,g	350038606100000016,350038606100000016,350038606100000018,350038606100000017	0-22,0-22,0-25,0-22						Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells	-publications.com	0	0		MYSM1
1292	chr3	92702478	92702523	3500246999	44		92702478	92702523	8421504	2	21,23	0,22	c,g	350024699900000003,350024699900000005,350024699900000005	0-21,0-23,0-23						Volume 13 Number 24 June 28, 2007	www.wjgnet.com	0	0		MYSM1
1292	chr3	92702478	92702523	3500001139	44		92702478	92702523	8421504	2	21,23	0,22	c,g	350000113900000003,350000113900000005,350000113900000005	0-21,0-23,0-23						Phase 1 Human Trial of Autologous Bone Marrow-Hematopoietic Stem Cell Transplantation In Patients With Decompensated Cirrhosis | Seyed Mahmoud Hashemi - Academia.edu	www.academia.edu	0	0		MYSM1
1292	chr3	92702479	92702504	3500085914	25		92702479	92702504	8421504	1	25	0	c	350008591400000011	0-25						Epstein-Barr Virus Latent Membrane Protein 2A Promotes Invasion of Nasopharyngeal Carcinoma Cells through ERK/Fra-1-Mediated Induction of Matrix Metalloproteinase 9	jvi.asm.org	0	0		MYSM1
1292	chr3	92702479	92702504	3500028458	25		92702479	92702504	8421504	1	25	0	c	350002845800000016	0-25		17363454	10.1210/en.2007-0215	0013-7227	Endocrinology	Overexpression of &#x03b3;-Glutamyltransferase in Transgenic Mice Accelerates Bone Resorption and Causes Osteoporosis	Hiramatsu	2007	4		
1292	chr3	92702487	92703477	3500150614	62		92702487	92703477	8421504	3	22,20,20	0,499,970	c	350015061400000005,350015061400000001,350015061400000006	0-22,0-20,0-20		16676006	10.1038/sj.cdd.4401946	1350-9047	Cell Death & Differentiation	c-Jun promotes cellular survival by suppression of PTEN	Hettinger	2006	9		
1292	chr3	92702487	92702517	3500074637	30		92702487	92702517	8421504	1	30	0	c	350007463700000016,350007463700000006	0-30,0-30						Combination Treatment of Cancer With Cetuximab and Tetrac - Patent application	www.faqs.org	0	0		MYSM1
1292	chr3	92702487	92702517	3500038784	30		92702487	92702517	8421504	1	30	0	c	350003878400000008	0-30		17550983	10.1124/mol.107.036541	1521-0111 (Online)	Molecular Pharmacology	Stromal Cell-Derived Factor-1 Induces Matrix Metalloprotease-13 Expression in Human Chondrocytes	Chiu	2007	0		MYSM1
1292	chr3	92702487	92702510	3500208288	23		92702487	92702510	8421504	1	23	0	c	350020828800000029	0-23		19773752	10.1038/sj.bjc.6605307	0007-0920	British Journal of Cancer	Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells	Ueno	2009	5		MYSM1
1292	chr3	92702491	92702999	3500181235	40		92702491	92702999	8421504	2	20,20	0,488	c,g	350018123500000007,350018123500000007,350018123500000008	0-20,0-20,0-20						Copper is Required for Retinoic Acid Receptor- Dependent Transcription and Neuronal Differentiation in P19 Embryonal Carcinoma Cells	jhs.pharm.or.jp	0	0		
1292	chr3	92702502	92703451	3500372660	188		92702502	92703451	8421504	5	21,24,66,29,48	0,49,313,475,901	c,g	350037266000000003,350037266000000003,350037266000000010,350037266000000010,350037266000000018,350037266000000024,350037266000000025,350037266000000027,350037266000000036	13-34,13-34,13-34,13-34,24-48,0-48,0-21,14-47,0-48						Oncoprotein protein kinase	Hibi	1995	0		
1292	chr3	92702502	92703451	3500037915	202		92702502	92703451	8421504	5	21,38,66,29,48	0,169,313,475,901	c,g	350003791500000010,350003791500000010,350003791500000003,350003791500000003,350003791500000021,350003791500000021,350003791500000014,350003791500000007,350003791500000024,350003791500000024,350003791500000025,350003791500000027,350003791500000036	13-34,13-34,13-34,13-34,0-38,0-38,10-30,10-30,0-48,0-48,0-21,14-47,0-48						ONCOPROTEIN PROTEIN KINASE ANTIBODY KIT - Patent application	www.faqs.org	0	0		
1292	chr3	92702502	92703006	3500029292	68		92702502	92703006	8421504	3	21,18,29	0,361,475	c	350002929200000003,350002929200000011,350002929200000026,350002929200000028	13-34,13-34,0-21,14-47						US Patent # 6,863,888. Oncoprotein protein kinase - Patents.com	www.patents.com	0	0		
1292	chr3	92702507	92702859	3500134458	44		92702507	92702859	8421504	2	22,22	0,330	c,g	350013445800000000,350013445800000000,350013445800000001,350013445800000001	0-22,0-22,0-22,0-22						tyrosine Monocyte Ras	www.pnas.org	0	0		MYSM1
1292	chr3	92702517	92702540	3500467492	23		92702517	92702540	8421504	1	23	0	c	350046749200000013	0-26						Generation and Characterization of p38 (MAPK11) Gene-Targeted Mice	mcb.asm.org	0	0		
1292	chr3	92702542	92702629	3500399055	87		92702542	92702629	8421504	1	87	0	p	350039905500015022	0-87						Cell-permeable peptide inhibitors of the JNK signal transduction pathway	Bonny	2009	0		
1292	chr3	92702542	92702629	3500323422	87		92702542	92702629	8421504	1	87	0	p	350032342200015023	0-87						Cell-permeable peptide inhibitors of the JNK signal transduction pathway	Bonny	2007	0		
1292	chr3	92702542	92702629	3500312239	87		92702542	92702629	8421504	1	87	0	p	350031223900015023	0-87						Cell-permeable peptide inhibitors of the JNK signal transduction pathway	Bonny	2008	0		
1292	chr3	92702542	92702629	3500310202	87		92702542	92702629	8421504	1	87	0	p	350031020200015024	0-87					Patent	Cell-permeable peptide inhibitors of the JNK signal transduction pathway (Patent EP:1776958)	Bonny	2008	0		
1292	chr3	92702542	92702629	3500309409	87		92702542	92702629	8421504	1	87	0	p	350030940900015023	0-87					Patent	Cell-permeable peptide inhibitors of the jnk signal transduction pathway (Patent EP:1511507)	Bonny	2007	0		
1292	chr3	92702542	92702629	3500112441	87		92702542	92702629	8421504	1	87	0	p	350011244100015111	0-87						Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases	Abadie	2012	0		
1292	chr3	92702542	92702629	3500063794	87		92702542	92702629	8421504	1	87	0	p	350006379400015026,350006379400015053	0-87,0-48						CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY - Patent application	www.faqs.org	0	0		
1292	chr3	92702545	92702569	3500321365	24		92702545	92702569	8421504	1	24	0	c	350032136500000009	0-24						Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration	.aacrjournals.org	0	0		
1292	chr3	92702545	92702569	3500007490	24		92702545	92702569	8421504	1	24	0	c	350000749000000009	0-24		17308082	10.1158/0008-5472.CAN-06-0850	0008-5472	Cancer Research	Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration	Bailly-Maitre	2007	8		
1292	chr3	92702662	92703430	3500206988	54		92702662	92703430	8421504	2	27,27	0,741	c	350020698800000009,350020698800000011	7-34,0-27		17636030	10.1128/MCB.00613-07	0270-7306	Molecular and Cellular Biology	Amino Acid Residues Required for Physical and Cooperative Transcriptional Interaction of STAT3 and AP-1 Proteins c-Jun and c-Fos	Ginsberg	2007	6		
1292	chr3	92703172	92703409	3500191222	237		92703172	92703409	8421504	1	237	0	p	350019122200015022	0-237						Basic leucine zipper transcription factor Hac1 binds DNA in two distinct modes as revealed by microfluidic analyses	alterlab.ucsf.edu	0	0		MYSM1
1292	chr3	92703199	92703352	3500252570	153		92703199	92703352	8421504	1	153	0	p	350025257000015000	0-153						JunB differs from c-Jun in its DNA- binding and dlmenzatlon domains, and represses c-Jun by formation of inactive heterodimers	enesdev.cshlp.org	0	0		MYSM1
1292	chr3	92703214	92703310	3500127746	87		92703214	92703310	8421504	2	39,48	0,48	p	350012774600015030	3-90						Transcriptional Repression by Member ofthe bZIP Family of Transcription	mcb.asm.org	0	0		
1292	chr3	92703222	92703245	3500305224	23		92703222	92703245	8421504	1	23	0	c	350030522400000012	0-23			10.1128/MCB.24.10.4128-4137.2004		Molecular and Cellular Biology	Glucose Utilization Is Essential for Hypoxia-Inducible Factor 1&#x03b1;-Dependent Phosphorylation of c-Jun	Keith	2004	0		MYSM1
1292	chr3	92703238	92703322	3500345251	84		92703238	92703322	8421504	1	84	0	p	350034525100015036	0-84						MEMBRANE RESIDENT PEPTIDE IN ANTI-CANCER PEPTIDES CAUSES TUMOR CELL NECROSIS RATHER THAN APOPTOSIS OF CANCER CELLS	Pincus	2009	0		MYSM1
1292	chr3	92703238	92703319	3500382888	81		92703238	92703319	8421504	1	81	0	p	350038288800015027	0-81						Phenotypic Reversion Of Pancreatic Carcinoma Cells 	.freshpatents.com	0	0		MYSM1
1292	chr3	92703244	92703367	3500022027	123		92703244	92703367	8421504	1	123	0	p	350002202700015001	0-123						&#x7b2c;5&#x56de;&#x30ce;&#x30a2;&#x30a8;&#x30a2;&#x30f1;&#x30d3;&#x30a7;&#x30dc;&#x30c4;&#x30a1;&#x30ad;&#x30b7;&#x30a0;&#x30e9;&#x30b2;&#x30e8;&#x30b8;&#x30de; &#x30a0;&#x30e7;&#x30a2;&#x30f1;&#x30df;&#x30f1;&#x30c6;&#x30a0;&#x30e9;&#x30b2;&#x30e8;&#x30	fo.sfc.keio.ac.jp	0	0		MYSM1
1292	chr3	92703244	92703340	3500102409	90		92703244	92703340	8421504	2	45,45	0,51	p	350010240900015105	0-93						Methods and compositions for regulating gene expression in plant cells - US Patent 7517689 Description	ww.patentstorm.us	0	0		MYSM1
1292	chr3	92703247	92703313	3500210745	66		92703247	92703313	8421504	1	66	0	p	350021074500015006	0-66						The Switch between Latency and Replication of Epstein-Barr Virus	www.jstor.org	0	0		MYSM1
1292	chr3	92703256	92703307	3500254665	51		92703256	92703307	8421504	1	51	0	p	350025466500015062	0-51						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		MYSM1
1292	chr3	92703310	92703433	3500383796	123		92703310	92703433	8421504	1	123	0	p	350038379600015000	9-132						Molecular Antigen Array	Renner	2011	0		MYSM1
1292	chr3	92703310	92703433	3500374171	123		92703310	92703433	8421504	1	123	0	p	350037417100015000	9-132						Molecular antigen array	Renner	2011	0		MYSM1
1292	chr3	92703310	92703433	3500370493	123		92703310	92703433	8421504	1	123	0	p	350037049300015028	9-132						Molecular antigen array	Renner	2002	0		MYSM1
1292	chr3	92703310	92703433	3500369777	123		92703310	92703433	8421504	1	123	0	p	350036977700015000	9-132						Ordered molecular presentation of antigens, method of preparation and use	Bachmann	2001	0		MYSM1
1292	chr3	92703310	92703433	3500289431	123		92703310	92703433	8421504	1	123	0	p	350028943100015002	9-132						ordered molecualr presentation of antigens, method of preparation and use	W*A*Lun Na 	2002	0		MYSM1
1292	chr3	92703310	92703433	3500287603	123		92703310	92703433	8421504	1	123	0	p	350028760300015008	9-132					Patent	Molecular antigen array (Patent US:7320793)	Renner	2008	0		MYSM1
1292	chr3	92703310	92703433	3500279893	123		92703310	92703433	8421504	1	123	0	p	350027989300015009	9-132					Patent	Molecular antigen array presenting amyloid beta (Patent EP:1353691)	Renner	2009	0		MYSM1
1292	chr3	92703310	92703433	3500271723	123		92703310	92703433	8421504	1	123	0	p	350027172300015006	9-132						Molecular antigen array	Wo Er Fu Gang *A*Lun Na 	2004	0		MYSM1
1292	chr3	92703310	92703433	3500260645	123		92703310	92703433	8421504	1	123	0	p	350026064500015010	9-132						Molecular antigen arrary	Renner	2008	0		MYSM1
1292	chr3	92703310	92703433	3500259268	111		92703310	92703433	8421504	4	15,30,27,39	0,21,54,84	p	350025926800015015	9-120						Molecular antigen array	Bachmann	2003	0		
1292	chr3	92703310	92703433	3500244984	123		92703310	92703433	8421504	1	123	0	p	350024498400015002	9-132						Ordered molecular presentation of antigens, method of preparation and use	W*A*Lun Na 	2005	0		MYSM1
1292	chr3	92703310	92703433	3500219378	123		92703310	92703433	8421504	1	123	0	p	350021937800015000	9-132					Patent	Ordered molecular presentation of antigens, method of preparation and use (Patent US:7229624)	Renner	2007	0		MYSM1
1292	chr3	92703310	92703433	3500154312	123		92703310	92703433	8421504	1	123	0	p	350015431200015035	9-132						Molecular antigen array	Bachmann	2003	0		MYSM1
1292	chr3	92703310	92703433	3500143718	123		92703310	92703433	8421504	1	123	0	p	350014371800015005	9-132						Molecular antigen array presenting amyloid beta	Bachmann	2003	0		MYSM1
1292	chr3	92703310	92703433	3500108031	123		92703310	92703433	8421504	1	123	0	p	350010803100015002	9-132						COMPOSITIONS FOR INDUCING SELF-SPECIFIC ANTI-IgE ANTIBODIES AND USES THEREOF	Bachmann	2002	0		MYSM1
1292	chr3	92703310	92703433	3500096921	123		92703310	92703433	8421504	1	123	0	p	350009692100015010	9-132						Molecular antigen array	Bachmann	2003	0		MYSM1
1292	chr3	92703310	92703433	3500095833	123		92703310	92703433	8421504	1	123	0	p	350009583300015015	9-132					Patent	Molecular antigen array (Patent US:7264810)	Renner	2007	0		MYSM1
1292	chr3	92703310	92703433	3500089496	123		92703310	92703433	8421504	1	123	0	p	350008949600015005	9-132						Molecular antigen array presenting amyloid beta	Renner	2002	0		MYSM1
1292	chr3	92703310	92703433	3500079495	123		92703310	92703433	8421504	1	123	0	p	350007949500015001	9-132						&#x6297;&#x539f;&#x7684;&#x6709;&#x5e8f;&#x5206;&#x5b50;&#x5448;&#x9012;&#xff0c;&#x5236;&#x5907;&#x53ca;&#x4f7f;&#x7528;&#x7684;&#x65b9;&#x6cd5;	W*A*Lun Na 	2005	0		MYSM1
1292	chr3	92703310	92703433	3500020039	123		92703310	92703433	8421504	1	123	0	p	350002003900015015	9-132						Molecular antigen array	Renner	2002	0		MYSM1
1292	chr3	92703310	92703430	3500276554	120		92703310	92703430	8421504	1	120	0	p	350027655400015011	0-120						ISOLATED HIGH AFFINITY ENTITIES WITH T-CELL RECEPTOR LIKE SPECIFICITY TOWARDS NATIVE COMPLEXES OF MHC CLASS II AND GLUTAMIC ACID DECARBOXYLASE (GAD) AUTOANTIGENIC PEPTIDES	Reiter	2011	0		MYSM1
1292	chr3	92703310	92703430	3500032428	120		92703310	92703430	8421504	1	120	0	p	350003242800015010	0-120						Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides	Dahan	2012	0		MYSM1
1292	chr3	92703310	92703427	3500074119	117		92703310	92703427	8421504	1	117	0	p	350007411900015003,350007411900015001,350007411900015005,350007411900015006	0-117,0-87,0-84,0-84						Surface display of recombinant proteins in lower eukaryotes	Zha	2009	0		MYSM1
1292	chr3	92703310	92703427	3500070627	117		92703310	92703427	8421504	1	117	0	p	350007062700015000	0-117						Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem Cells	w.molbiolcell.org	0	0		MYSM1
1292	chr3	92703310	92703427	3500051366	117		92703310	92703427	8421504	1	117	0	p	350005136600015000	0-117		16624864	10.1091/mbc.E05-12-1129	1059-1524	Molecular Biology of the Cell	Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem Cells	Stuhlmann-Laeisz	2006	5		MYSM1
1292	chr3	92703310	92703421	3500438749	111		92703310	92703421	8421504	1	111	0	p	350043874900015001	0-111						Tethering Small Molecules to a Phage Display Library: Discovery of a Selective Bivalent Inhibitor of Protein Kinase A Supporting Information	cbc.arizona.edu	0	0		MYSM1
1292	chr3	92703310	92703421	3500320745	111		92703310	92703421	8421504	1	111	0	p	350032074500015016,350032074500015018,350032074500015020	3-114,3-57,0-54						Article Title: Corresponding author: Authors: Supplementary Information Guide	nic-chemistry.com	0	0		MYSM1
1292	chr3	92703310	92703421	3500275153	111		92703310	92703421	8421504	1	111	0	p	350027515300015001	0-111						Tethering Small Molecules to a Phage Display Library: Discovery of a Selective Bivalent Inhibitor of Protein Kinase A Supporting Information	.chem.arizona.edu	0	0		MYSM1
1292	chr3	92703311	92703431	3500437328	72		92703311	92703431	8421504	2	47,25	0,95	c	350043732800000082,350043732800000084	1-48,0-25					Patent	Zinc finger protein derivatives and methods therefor (Patent US:6790941)	Carlos	2004	0		MYSM1
1292	chr3	92703311	92703431	3500201637	72		92703311	92703431	8421504	2	47,25	0,95	c	350020163700000081,350020163700000083	1-48,0-25						Zinc finger protein derivatives and methods therefor	Barbas	1997	0		
1292	chr3	92703313	92703409	3500362031	96		92703313	92703409	8421504	1	96	0	p	350036203100015014	0-96						Totally synthetic affinity reagents	Fowlkes	1996	0		MYSM1
1292	chr3	92703313	92703409	3500307462	96		92703313	92703409	8421504	1	96	0	p	350030746200015013	0-96						Totally synthetic affinity reagents	Fowlkes	1994	0		MYSM1
1292	chr3	92703313	92703397	3500462351	84		92703313	92703397	8421504	1	84	0	p	350046235100015011	0-84						3335532 Protein Engineering Protocols	www.scribd.com	0	0		MYSM1
1292	chr3	92703313	92703397	3500359706	84		92703313	92703397	8421504	1	84	0	p	350035970600015000	0-84						Selectional and Mutational Scope of Peptides Sequestering the Jun Fos Coiled-Coil Domain	h.uni-freiburg.de	0	0		MYSM1
1292	chr3	92703313	92703397	3500315260	84		92703313	92703397	8421504	1	84	0	p	350031526000015000	0-84						ScienceDirect.com - Journal of Molecular Biology - Selectional and Mutational Scope of Peptides Sequestering the Jun&#x2013;Fos Coiled-Coil Domain	sciencedirect.com	0	0		MYSM1
1292	chr3	92703313	92703397	3500148060	84		92703313	92703397	8421504	1	84	0	p	350014806000015016,350014806000015144	0-84,0-45						MULTIMERIC PROTEINS AND METHODS OF MAKING AND USING SAME - Patent application	www.faqs.org	0	0		MYSM1
1292	chr3	92703322	92703415	3500000694	90		92703322	92703415	8421504	2	45,45	0,48	p	350000069400015031,350000069400015032	0-45,0-45						Rationally designed antibodies - Patent application	www.faqs.org	0	0		MYSM1
1292	chr3	92703325	92703355	3500372015	30		92703325	92703355	8421504	1	30	0	c	350037201500000521	0-30						Method for selective oligonucleotide modification	Mitsch	2011	0		
1292	chr3	92703330	92703431	3500181734	50		92703330	92703431	8421504	2	25,25	0,76	c	350018173400000004,350018173400000005	0-25,0-25						PKC412demonstratesJNK-dependentactivityagainsthuman multiplemyelomacells	tologylibrary.org	0	0		MYSM1
1292	chr3	92703333	92703357	3500455599	24		92703333	92703357	8421504	1	24	0	c,g	350045559900000004,350045559900000004	0-24,0-24		19730727	10.1371/journal.pone.0006905		PLoS ONE	DR*W201/P65 Tetramer Visualization of Epitope-Specific CD4 T-Cell during M. tuberculosis Infection and Its Resting Memory Pool after BCG Vaccination	Huiyong	2009	0		
1292	chr3	92703399	92703423	3500121853	24		92703399	92703423	8421504	1	24	0	c	350012185300000001	19-43		19779561	10.1371/journal.ppat.1000595	1553-7374	PLOS Pathogens	PLOS Pathogens: Selective Inhibition of Type III Secretion Activated Signaling by the Salmonella Effector AvrA	Du	2009	0		
1292	chr3	92703431	92703817	3500460481	61		92703431	92703817	8421504	2	30,31	0,355	c	350046048100000014,350046048100000015	0-30,0-31		19584293	10.1158/0008-5472.CAN-08-3820	0008-5472	Cancer Research	Computational Identification of a p38SAPK-Regulated Transcription Factor Network Required for Tumor Cell Quiescence	Adam	2009	8		MYSM1
1292	chr3	92703431	92703813	3500412427	57		92703431	92703813	8421504	2	30,27	0,355	c,g	350041242700000002,350041242700000003,350041242700000003	0-30,3-30,3-30		11504688			American Journal of Physiology - Lung Cellular and Molecular Physiology	AP-1-dependent induction of plasminogen activator inhibitor-1 by nickel does not require reactive oxygen	Andrew	2001	0		MYSM1
1292	chr3	92703431	92703813	3500172871	57		92703431	92703813	8421504	2	30,27	0,355	c	350017287100000002,350017287100000003	0-30,3-30		11504688			American Journal of Physiology - Lung Cellular and Molecular Physiology	AP-1-dependent induction of plasminogen activator inhibitor-1 by nickel does not require reactive oxygen	Andrew	2001	0		MYSM1
1292	chr3	92703457	92703482	3500179994	25		92703457	92703482	8421504	1	25	0	c	350017999400000016	8-33						Full text of "Protocols_molecular_biology"	archive.org	0	0		
1292	chr3	92703457	92703482	3500138720	25		92703457	92703482	8421504	1	25	0	c	350013872000000014	8-33						Tow hybrid systems - Methods and protocols	www.docstoc.com	0	0		
1293	chr3	92799138	92799161	3500065112	23		92799138	92799161	8421504	1	23	0	g	350006511200000352	0-23					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
1297	chr3	93409154	93409178	3500454493	23		93409154	93409178	8421504	2	8,15	0,9	g	350045449300000007	11-34						Biosynthetic Polypeptide Fusion Inhibitors - Patent application	www.faqs.org	0	0		
1297	chr3	93409154	93409178	3500419700	23		93409154	93409178	8421504	2	8,15	0,9	g	350041970000000012	10-33						In vivo incorporation of unnatural amino acids	Anderson	2007	0		
1297	chr3	93409154	93409178	3500093587	23		93409154	93409178	8421504	2	8,15	0,9	g	350009358700000012	0-23						US Patent # 7,368,275. In vivo incorporation of unnatural amino acids - Patents.com	www.patents.com	0	0		
1303	chr3	94237147	94237171	3500244884	24		94237147	94237171	8421504	1	24	0	g	350024488400000008	0-24		19855901	10.1590/S0100-879X2009001100004	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Dengue virus-induced regulation of the host cell translational machinery	Villas-Boas	2009	1		DDX47
1307	chr3	94718982	94719007	3500134270	23		94718982	94719007	8421504	2	14,9	0,16	c	350013427000000170,350013427000000206,350013427000000256	2-23,2-23,2-23					Patent	Antibody against human parathormone related peptides (Patent CN:100335501)	Zuo Teng Gong 	2007	0		
1308	chr3	94786318	94787358	3500022178	682		94786318	94787358	8421504	4	395,52,178,57	0,396,449,983	c,g	350002217800000122,350002217800000122,350002217800000118,350002217800000114,350002217800000110,350002217800000065,350002217800000061,350002217800000057,350002217800000053,350002217800000047,350002217800000042,350002217800000038,350002217800000010	0-56,0-56,0-53,0-50,0-57,0-60,0-60,0-59,0-52,0-60,0-59,0-59,0-57						Polymorphic sites in the 5&#xb4;-region of the porcine C8A gene	bn-dummerstorf.de	0	0		
1309	chr3	94971882	94971945	3500463464	63		94971882	94971945	8421504	1	63	0	g	350046346400000069	18-83						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
163	chr3	94972935	95044769	3500206905	1656		94972935	95044769	8421504	9	236,127,505,225,88,145,94,142,94	0,1494,3512,12568,14185,16299,17021,29762,71740	p	350020690500015001	0-1656						KEGG T01001: 5562	www.genome.jp	0	0		PRKAA2
163	chr3	94972935	95044769	3500206364	1656		94972935	95044769	8421504	9	236,127,505,225,88,145,94,142,94	0,1494,3512,12568,14185,16299,17021,29762,71740	p	350020636400015000	0-1656						KEGG T01001: 5563	www.genome.jp	0	0		PRKAA2
163	chr3	94972935	95044769	3500064585	1644		94972935	95044769	8421504	11	225,5,127,505,225,88,67,72,94,142,94	0,231,1494,3512,12568,14185,16299,16372,17021,29762,71740	p	350006458500015082	0-1650						Ampk pathway components	Apfeld	2004	0		PRKAA2
163	chr3	94972935	95044769	3500064585	1641		94972935	95044769	8421504	12	225,5,127,505,194,28,88,67,72,94,142,94	0,231,1494,3512,12568,12765,14185,16299,16372,17021,29762,71740	p	350006458500015081	0-1647						Ampk pathway components	Apfeld	2004	0		
163	chr3	94972935	95044769	3500002525	1656		94972935	95044769	8421504	9	236,127,505,225,88,145,94,142,94	0,1494,3512,12568,14185,16299,17021,29762,71740	p	350000252500015000	0-1656						KEGG T01002: 108079	www.genome.jp	0	0		PRKAA2
163	chr3	94985607	95044769	3500131072	684		94985607	95044769	8421504	6	121,88,145,94,142,94	0,1513,3627,4349,17090,59068	p	350013107200015077	0-684						AMPK PATHWAY COMPONENTS - ELIXIR PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1309	chr3	94985691	94989259	3500456790	150		94985691	94989259	8421504	3	37,88,25	0,1429,3543	p	350045679000015007	0-150						Insulin receptor, AMPK and CPT-2: Crystallization experiments a nd structural characterization of three proteins relevant to diabetes mellitus	s.ub.uni-koeln.de	0	0		
1310	chr3	95044721	95044766	3500028463	45		95044721	95044766	8421504	1	45	0	p	350002846300015001	0-45		16638825	10.1152/ajpendo.00073.2006		American Journal of Physiology - Endocrinology and Metabolism	Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase &#x03b3;3-subunit differentially regulates glycogen accumulation	Yu	2006	0		PRKAA1
1310	chr3	95044745	95044769	3500382394	24		95044745	95044769	8421504	1	24	0	c	350038239400000000	8-32		18940938	10.1152/ajpendo.90690.2008		American Journal of Physiology - Endocrinology and Metabolism	&#x03b1;2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise	Miura	2009	0		
1310	chr3	95044745	95044769	3500199558	24		95044745	95044769	8421504	1	24	0	c	350019955800000000	8-32		18940938	10.1152/ajpendo.90690.2008		American Journal of Physiology - Endocrinology and Metabolism	&#x03b1;2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise	Miura	2009	0		
1310	chr3	95044745	95044769	3500143635	24		95044745	95044769	8421504	1	24	0	c	350014363500000000	8-32						1 Yuko Kai,1 Yasutomi Kamei,1,3 4 Mark A. Febbraio,4 Takashi Kadowaki,2,5 and Osamu Ezaki1	do.physiology.org	0	0		
1310	chr3	95044745	95044769	3500062734	24		95044745	95044769	8421504	1	24	0	c	350006273400000000	8-32		18940938	10.1152/ajpendo.90690.2008		American Journal of Physiology - Endocrinology and Metabolism	&#x03b1;2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise	Miura	2009	0		
1311	chr3	95234741	95234767	3500009109	23		95234741	95234767	8421504	2	11,12	0,14	g	350000910900000011	21-44						Plant desaturases--compositions and uses	Thompson	1995	0		
1319	chr3	96319927	96319952	3500065110	24		96319927	96319952	8421504	2	15,9	0,16	g	350006511000000020,350006511000000031	15-34,10-34					Patent	Method, tools and kits for the detection of members of the staphylococcus genus (Patent CA:2789369)	Bergeron	2013	0		
1320	chr3	96391210	96391241	3500199461	26		96391210	96391241	8421504	3	6,5,15	0,9,16	g	350019946100000064	0-26						Live attenuated vaccines based on cp45 HPIV-3 strain and method to ensure attenuation in such vaccines	Belshe	1997	0		
1320	chr3	96399736	96399772	3500112085	36		96399736	96399772	8421504	1	36	0	g	350011208500000005	26-62		12456664	10.1093/emboj/cdf656	ERROR! NO ISSN	The EMBO Journal	Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases	Suzuki	2002	0		
1324	chr3	96935968	96973826	3500244830	39		96935968	96973826	8421504	2	20,19	0,37839	g	350024483000000293,350024483000000294,350024483000000406	0-20,0-20,5-24						METHODS FOR LOWERING SERUM CHOLESTROL IN A SUBJECT USING INHIBITION OF PCSK9 - ALNYLAM PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1325	chr3	97074377	97074401	3500465667	24		97074377	97074401	8421504	1	24	0	c	350046566700000045	0-24						Compositions And Methods For Modulating Pgc-1beta To Treat Lipid-related Diseases And Disorders 	.freshpatents.com	0	0		
1325	chr3	97074377	97074401	3500434910	24		97074377	97074401	8421504	1	24	0	c	350043491000000045	0-24						Compositions and Methods For Modulating Pgc-1Beta to Treat Lipid-Related Diseases and Disorders - Patent application	www.faqs.org	0	0		
1325	chr3	97074377	97074401	3500306103	24		97074377	97074401	8421504	1	24	0	c	350030610300000027	0-24						COMPOSITIONS AND METHODS FOR MODULATING PGC-1&#x03b2; TO TREAT LIPID-RELATED DISEASES AND DISORDERS	Lin	2006	0		
1325	chr3	97074619	97074643	3500046604	24		97074619	97074643	8421504	1	24	0	c	350004660400000004	0-24						REPRODUCTION	uction-online.org	0	0		
1326	chr3	97144354	97144388	3500187712	27		97144354	97144388	8421504	3	6,14,7	0,9,27	c	350018771200000038	10-37						Method of measuring plasma membrane targeting of GLUT4	Bogan	2001	0		
1327	chr3	97312791	97312816	3500180416	23		97312791	97312816	8421504	2	10,13	0,12	g	350018041600000013	16-39						RECOMBINANT VSV FOR THE TREATMENT OF TUMOR CELLS - Patent application	www.faqs.org	0	0		
1327	chr3	97334027	97334183	3500388065	97		97334027	97334183	8421504	2	47,50	0,106	c	350038806500000002,350038806500000003,350038806500000008,350038806500000009	0-47,14-47,0-37,0-50						A 1.3 kb Satellite DNA from Bubalus bubalis not Conserved Evolutionarily is Transcribed	.znaturforsch.com	0	0		
1327	chr3	97334927	97334962	3500072931	35		97334927	97334962	8421504	1	35	0	c	350007293100000021	39-74						Method of Preparing DNA Fragments and Applications Thereof - Patent application	www.faqs.org	0	0		
20	chr3	97472392	97636756	3500459941	1080		97472392	97636756	8421504	19	1,55,73,62,85,87,3,60,67,77,65,49,36,55,71,79,29,102,24	0,2,1058,1354,4173,116733,138872,139757,143900,144083,152849,153541,154202,154756,156132,162961,163251,163393,164340	p	350045994100015000	0-1080						KEGG T01003: 84354	www.genome.jp	0	0		
1329	chr3	97612189	97628546	3500447679	40		97612189	97628546	8421504	2	20,20	0,16337	c	350044767900000021,350044767900000022	0-20,0-20						HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR AND HUMAN CELL MEDICINE COMPRISING SAME	Kakeda	2007	0		
1329	chr3	97612189	97628546	3500336461	40		97612189	97628546	8421504	2	20,20	0,16337	c	350033646100000021,350033646100000022	0-20,0-20						SureChem - Document - European Applications - Patent No. 2048229 - "HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR, AND HUMAN CELL PHARMACEUTICAL COMPRISING HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR" - Description	www.surechem.org	0	0		
1329	chr3	97612189	97628546	3500030891	40		97612189	97628546	8421504	2	20,20	0,16337	c,g	350003089100000021,350003089100000021,350003089100000200,350003089100000200,350003089100000201,350003089100000022	0-20,0-20,0-20,0-20,0-20,0-20						HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR AND HUMAN CELL MEDICINE COMPRISING SAME - Patent application	www.faqs.org	0	0		
1329	chr3	97636161	97636187	3500328844	23		97636161	97636187	8421504	2	11,12	0,14	g	350032884400000000	0-23						Genotyping of Pseudohermaphrodite Polar Bears in Nunavut and Advances in DNA Sexing Techniques	www.jstor.org	0	0		
1330	chr3	97703617	97703641	3500287327	23		97703617	97703641	8421504	2	17,6	0,18	g	350028732700000106	6-33						Postpartum Cells Derived From Umbilical Cord Tissue, And Methods Of Making And Using The Same 	.freshpatents.com	0	0		
1335	chr3	98373182	98373206	3500277828	23		98373182	98373206	8421504	2	10,13	0,11	g	350027782800000000	0-24		21402899	10.4049/jimmunol.1002631		Journal of immunology (Baltimore, Md. : 1950)	INTERFERON-ALPHA MEDIATES THE DEVELOPMENT OF AUTOIMMUNITY BOTH BY DIRECT TISSUE TOXICITY AND THROUGH IMMUNE-CELL RECRUITMENT MECHANISMS	Nagako	2011	0		
1336	chr3	98440374	98440398	3500384026	23		98440374	98440398	8421504	2	10,13	0,11	g	350038402600000059	25-48						 Biotechnological Method Of Producing Biotin 	www.docstoc.com	0	0		
1336	chr3	98440374	98440398	3500335231	23		98440374	98440398	8421504	2	10,13	0,11	g	350033523100000059	25-48						Biotechnological method of producing biotin - Patent # 6083712 - PatentGenius	.patentgenius.com	0	0		
167	chr3	98690057	98765404	3500270141	270		98690057	98765404	8421504	13	22,24,23,21,19,6,15,21,25,23,24,23,24	0,904,34810,52849,52914,52965,56140,64145,67294,72287,74691,74794,75323	c,g	350027014100000021,350027014100000021,350027014100000022,350027014100000022,350027014100000023,350027014100000002,350027014100000002,350027014100000001,350027014100000000,350027014100000025,350027014100000025,350027014100000027,350027014100000003,350027014100000019,350027014100000004,350027014100000020	0-22,0-22,0-24,0-24,0-23,0-21,0-21,0-19,0-21,0-21,0-21,0-25,0-23,0-24,0-23,0-24		17108332	10.1095/biolreprod.106.057216	0006-3363	Biology of Reproduction	Low-Density Lipoprotein Receptor-Related Protein 8 (LRP8) Is Upregulated in Granulosa Cells of Bovine Dominant Follicle: Molecular Characterization and Spatio-Temporal Expression Studies	Fayad	2007	4		
1338	chr3	98732506	98732530	3500236370	23		98732506	98732530	8421504	2	8,15	0,9	g	350023637000000035,350023637000000131	1-24,1-23						CYTOKINE PRODUCTION REGULATOR GENE AND USE THEREOF - Patent application	www.faqs.org	0	0		
1338	chr3	98764752	98764775	3500429506	23		98764752	98764775	8421504	1	23	0	c	350042950600000008	0-23						 Compound And Method For Regulating Plasminogen Activation And Cell Migration 	www.docstoc.com	0	0		
1338	chr3	98764752	98764775	3500060134	23		98764752	98764775	8421504	1	23	0	c	350006013400000008,350006013400000026	0-23,0-23						Compound And Method For Regulating Plasminogen Activation And Cell Migration 	.freshpatents.com	0	0		
1338	chr3	98772921	98781945	3500290439	438		98772921	98781945	8421504	5	88,59,111,83,97	0,2994,5408,7754,8927	c	350029043900000025,350029043900000016,350029043900000017,350029043900000018,350029043900000019,350029043900000021,350029043900000022	0-438,6-48,0-48,0-48,0-44,0-48,0-48					Patent	Conservin compositions (Patent US:6031076)	Falb	2000	0		
1338	chr3	98772921	98781927	3500326939	420		98772921	98781927	8421504	5	88,59,111,83,79	0,2994,5408,7754,8927	c	350032693900000025,350032693900000018,350032693900000019,350032693900000020,350032693900000021	0-420,0-48,0-44,0-48,0-48						US Patent # 5,807,708. Conservin nucleic acid molecules and compositions - Patents.com	www.patents.com	0	0		
1338	chr3	98803118	98805388	3500115238	63		98803118	98805388	8421504	3	20,21,22	0,2147,2248	c	350011523800000025,350011523800000033,350011523800000032	0-20,0-21,0-22						INDUCTION OF APOPTOSIS AND INHIBITION OF CELL PROLIFERATION THROUGH MODULATION OF CARNITINE PALMITOYLTRANSFERASE 1C ACTIVITY - Patent application	www.faqs.org	0	0		CPT2
1339	chr3	98937673	98937713	3500374932	40		98937673	98937713	8421504	1	40	0	c	350037493200000037	0-40						Compositions and methods for the treatment of immune related diseases	Ashkenazi	2000	0		
1342	chr3	99233492	99233729	3500068521	24		99233492	99233729	8421504	3	8,4,12	0,216,225	c	350006852100000212	19-43						About ICRISAT	www.icrisat.org	0	0		
1345	chr3	99693505	99693532	3500381630	25		99693505	99693532	8421504	2	19,6	0,21	c	350038163000000100,350038163000000066	0-24,0-24						Tuberculosis nucleic acids, polypeptides and immunogenic compositions	Roth	2005	0		
1345	chr3	99693505	99693532	3500352646	25		99693505	99693532	8421504	2	19,6	0,21	c	350035264600000100,350035264600000066	0-24,0-24						Tuberculosis nucleic acids, polypeptides and immunogenic compositions	Roth	2005	0		
1345	chr3	99693505	99693532	3500344831	25		99693505	99693532	8421504	2	19,6	0,21	c	350034483100000177,350034483100000100,350034483100000066	0-24,0-24,0-24						 Tuberculosis Nucleic Acids, Polypeptides And Immunogenic Compositions 	www.docstoc.com	0	0		
1345	chr3	99693505	99693531	3500006837	24		99693505	99693531	8421504	2	19,5	0,21	c	350000683700000100	0-24						Tuberculosis nucleic acids, polypeptides and immunogenic compositions	Roth	2010	0		
1346	chr3	99746697	99746721	3500300648	24		99746697	99746721	8421504	1	24	0	c	350030064800000284	16-40						Methods and targets for identifying compounds for regulating angiogenesis - Patent application	www.faqs.org	0	0		
1348	chr3	100064720	100064743	3500189431	23		100064720	100064743	8421504	1	23	0	c	350018943100000259	3-26						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1348	chr3	100115486	100117547	3500445993	25		100115486	100117547	8421504	3	14,1,10	0,2049,2051	c	350044599300000000	8-33						IMPROVED PAIRWISE ALIGNMENT OF GENOMIC DNA	www.bx.psu.edu	0	0		
1349	chr3	100192593	100192619	3500272824	26		100192593	100192619	8421504	1	26	0	c	350027282400000008	0-26						Identification and Functional Analysis of Candidate Genes Regulating Mesenchymal Stem Cell Self-Renewal and Multipotency--&#x300a;&#x5e72;&#x7ec6;&#x80de;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&	journal.9med.net	0	0		
1349	chr3	100192593	100192619	3500005224	26		100192593	100192619	8421504	1	26	0	c	350000522400000008	0-26						Identification and Functional Analysis of Candidate Genes Regulating Mesenchymal - &#x300a;stemcells&#x300b;&#x5e72;&#x7ec6;&#x80de;&#x5b66;&#x6742;&#x5fd7; &#x5e72;&#x7ec6;&#x80de;&#x4e4b;&#x5bb6; - &#x4e2d;&#x56fd;&#x5e72;&#x7ec6;&#x80de;&#x7814;&#x7a76	www.stemcell8.cn	0	0		
1350	chr3	100272784	100272829	3500281528	45		100272784	100272829	8421504	1	45	0	p	350028152800015121	9-54						<Html><Title> Complet list of 2pfl hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		HRC
1350	chr3	100342746	100343800	3500344705	24		100342746	100343800	8421504	2	15,9	0,1045	c	350034470500000107	16-40						APJ ligand polypeptides	Hinuma	1999	0		
1350	chr3	100348670	100348696	3500110329	23		100348670	100348696	8421504	2	12,11	0,15	c	350011032900000568	21-44						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
1352	chr3	100547788	100547817	3500280721	25		100547788	100547817	8421504	2	10,15	0,14	g	350028072100000056	2-27						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1355	chr3	101041352	101046674	3500115779	99		101041352	101046674	8421504	2	80,19	0,5303	p	350011577900015033,350011577900015034	0-66,0-66						Full-length human cdnas encoding potentially secreted proteins	Bejanin	2001	0		RNF11
1355	chr3	101041352	101041418	3500336681	66		101041352	101041418	8421504	1	66	0	p	350033668100015031	0-66						FULL-LENGTH HUMAN CDNAS ENCODING POTENTIALLY SECRETED PROTEINS - GENSET S.A.	www.sumobrain.com	0	0		RNF11
1357	chr3	101189375	101189558	3500239315	40		101189375	101189558	8421504	2	20,20	0,163	c	350023931500000014,350023931500000013	0-20,0-20						RhoARegulatesG -SProgressionofGastricCancerCells byModulationofMultipleINK4FamilyTumorSuppressors	.aacrjournals.org	0	0		
1357	chr3	101189415	101189478	3500040223	63		101189415	101189478	8421504	1	63	0	p	350004022300015004	0-63						Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells - Patent application	www.faqs.org	0	0		CDKN2C
1357	chr3	101189542	101193192	3500459319	74		101189542	101193192	8421504	5	6,12,27,8,21	0,8,3428,3619,3629	c	350045931900000015,350045931900000007	0-45,0-29						Growth suppression by p18, a p16/w/;4/ a's - and p 141wI 4n/ TSe-related CDK6 inhibitor, correlates with wild-type pRb function	enesdev.cshlp.org	0	0		
1357	chr3	101257034	101257082	3500234051	48		101257034	101257082	8421504	1	48	0	c	350023405100000129	0-48						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		FAF1
1358	chr3	101346684	101346732	3500234051	48		101346684	101346732	8421504	1	48	0	c	350023405100000134	0-48						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		
169	chr3	101399283	101655659	3500234051	619		101399283	101655659	8421504	15	53,43,6,42,47,37,11,5,82,57,48,43,89,12,44	0,26538,73222,127916,148383,148431,149405,149464,150613,165444,165549,190374,194523,237463,256332	c	350023405100000138,350023405100000139,350023405100000143,350023405100000146,350023405100000147,350023405100000149,350023405100000150,350023405100000151,350023405100000153,350023405100000156,350023405100000157,350023405100000158,350023405100000163	0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-44						Host cell specific binding molecules capable of neutralizing viruses and uses thereof - Patent application	www.faqs.org	0	0		
1361	chr3	101720007	101720032	3500407668	24		101720007	101720032	8421504	2	12,12	0,13	c	350040766800000013	24-48						Spliced Variants Of Lgr6 	.freshpatents.com	0	0		
1362	chr3	101931095	101931123	3500336712	28		101931095	101931123	8421504	1	28	0	c	350033671200000013	6-34		16508003	10.1128/MCB.26.6.2273-2285.2006	0270-7306	Molecular and Cellular Biology	CARM1 Regulates Proliferation of PC12 Cells by Methylating HuD	Fujiwara	2006	6		
1365	chr3	102259410	102259439	3500197962	23		102259410	102259439	8421504	3	11,5,7	0,13,22	g	350019796200000018	0-24						Real-time multiplex PCR assays for reliable detection of Clostridium perfringens toxin genes in animal isolates	xa.yimg.com	0	0		
1368	chr3	102673656	102673680	3500409155	24		102673656	102673680	8421504	1	24	0	g	350040915500000012	2-26						Composition and method for detecting mutagens	Thomas	2000	0		
1373	chr3	103409501	103409525	3500065112	23		103409501	103409525	8421504	2	15,8	0,16	g	350006511200000164	18-48					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
1374	chr3	103439896	103439919	3500248094	23		103439896	103439919	8421504	1	23	0	g	350024809400001862	1-24						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
1374	chr3	103447344	103447371	3500285671	24		103447344	103447371	8421504	2	18,6	0,21	g	350028567100000029	0-24						PREPARATION OF EPSILON-CAPROLACTAM FROM (Z)-6,7-DIHYDRO-1H-AZEPIN-2(5H)-ONE - Patent application	www.faqs.org	0	0		
1374	chr3	103493217	103493242	3500283291	23		103493217	103493242	8421504	2	9,14	0,11	g	350028329100000102	0-23						Apo-2 RECEPTOR	Adams	1998	0		
1374	chr3	103493217	103493242	3500089910	23		103493217	103493242	8421504	2	9,14	0,11	g	350008991000000102	0-23						US Patent # 6,342,369. Apo-2-receptor - Patents.com	www.patents.com	0	0		
1377	chr3	103938988	103939033	3500035173	45		103938988	103939033	8421504	1	45	0	p	350003517300015024	0-45						 <HTML> <HEAD><TITLE>aai1/43i1/4SSi1/4!i1/4'aaC/aadegaaaC/a1/4a?a1/4aaa3aa(r)c"e - c1e	www.j-tokkyo.com	0	0		SLC5A10
1378	chr3	103957110	103957135	3500007443	23		103957110	103957135	8421504	3	13,6,4	0,14,21	g	350000744300000009	7-30						 Spatiotemporal Control of Gene Expression in Mammalian Cells and in Mice Using the LightOn System - Current Protocols 	rentprotocols.com	0	0		
1379	chr3	104195698	104195721	3500260905	23		104195698	104195721	8421504	1	23	0	g	350026090500000014	4-35					Patent	Therapeutic human anti-IL-1R1 monoclonal antibody (Patent CN:100471871)	A*Wei Te 	2009	0		
1381	chr3	104411289	104411321	3500133326	32		104411289	104411321	8421504	1	32	0	g	350013332600000025	65-104					Patent	Protein hydrolysates enriched in peptides having a carboxy terminal proline residue (Patent CN:100506981)	L*Yi Deng Si 	2009	0		
1382	chr3	104587360	104587384	3500176399	23		104587360	104587384	8421504	2	19,4	0,20	g	350017639900000005	1-24			10.1104/pp.106.085829		Plant Physiology	Species Having C4 Single-Cell-Type Photosynthesis in the Chenopodiaceae Family Evolved a Photosynthetic Phosphoenolpyruvate Carboxylase Like That of Kranz-Type C4 Species	Maria	2006	0		
1383	chr3	104675806	104675833	3500175193	25		104675806	104675833	8421504	3	6,14,5	0,7,22	g	350017519300000036	12-37						CHARACTERIZATION OF PROTEIN SECRETION IN MYCOBACTERIUM LEPRAE USING PHOA FUSIONS IN AND	etd.lsu.edu	0	0		
1384	chr3	104798914	104798939	3500380836	24		104798914	104798939	8421504	2	14,10	0,15	c	350038083600000123	21-45						US Patent # 7,186,541. 3-hydroxypropionic acid and other organic compounds - Patents.com	www.patents.com	0	0		
1384	chr3	104798914	104798939	3500370305	24		104798914	104798939	8421504	2	14,10	0,15	c	350037030500000117	21-45						 3 	www.docstoc.com	0	0		
1384	chr3	104798914	104798939	3500312386	24		104798914	104798939	8421504	2	14,10	0,15	c	350031238600000114	24-48						ALANINE 2, 3-AMINOMUTASE - Patent application	www.faqs.org	0	0		
1384	chr3	104798914	104798939	3500166501	24		104798914	104798939	8421504	2	14,10	0,15	c	350016650100000123	21-45						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
1384	chr3	104798914	104798939	3500104401	24		104798914	104798939	8421504	2	14,10	0,15	c	350010440100000123	24-48						3-HYDROXYPROPIONIC ACID AND OTHER ORGANIC COMPOUNDS - Patent application	www.faqs.org	0	0		
1384	chr3	104798914	104798939	3500070165	24		104798914	104798939	8421504	2	14,10	0,15	c	350007016500000114	21-45						US Patent # 7,309,597. Alanine 2,3-Aminomutase - Patents.com	www.patents.com	0	0		
1384	chr3	104798914	104798939	3500031391	24		104798914	104798939	8421504	2	14,10	0,15	c	350003139100000049	24-48						METHOD FOR PRODUCTION OF POLYLACTATE USING RECOMBINANT MICROORGANISM - Patent application	www.faqs.org	0	0		
1384	chr3	104799170	104799322	3500427946	40		104799170	104799322	8421504	2	20,20	0,132	c,g	350042794600000004,350042794600000001	0-20,20-40						Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia	www.molvis.org	0	0		
1385	chr3	104888375	104888401	3500370015	25		104888375	104888401	8421504	2	14,11	0,15	g	350037001500000001	6-33						PhosphorylationandProcessingoftheQuorum- SensingMoleculeAutoinducer-2inEntericBacteria	.researchgate.net	0	0		
1385	chr3	104907799	104907822	3500028061	23		104907799	104907822	8421504	1	23	0	c	350002806100000242	13-36						Surface proteins of leptospira	www.devileye.net	0	0		
1385	chr3	104948867	104948897	3500039368	29		104948867	104948897	8421504	2	17,12	0,18	g	350003936800000014	0-29						Lineage-restricted regulation of the murine SCL/TAL-1 promoter. - ResearchGate	.researchgate.net	0	0		
1385	chr3	104948892	104948915	3500393746	23		104948892	104948915	8421504	1	23	0	g	350039374600000015	0-23		18443038	10.1128/MCB.00071-08	0270-7306	Molecular and Cellular Biology	A T-to-G Transversion at Nucleotide &#x2212;567 Upstream of HBG2 in a GATA-1 Binding Motif Is Associated with Elevated Hemoglobin F	Chen	2008	6		
1385	chr3	104957390	104962407	3500165100	41		104957390	104962407	8421504	2	21,20	0,4997	c,g	350016510000000027,350016510000000011,350016510000000011,350016510000000028,350016510000000028	0-21,20-40,20-40,0-19,0-19						METHODS FOR PRODUCING ENUCLEATED ERYTHROID CELLS DERIVED FROM PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		TAL1
1385	chr3	104962447	104962470	3500176414	23		104962447	104962470	8421504	1	23	0	c	350017641400000007	22-45						AMNIOTIC FLUID STEM CELLS AND KIDNEY REGENERATION	arch.cab.unipd.it	0	0		
1386	chr3	104992237	104992261	3500370435	23		104992237	104992261	8421504	2	7,16	0,8	g	350037043500000457	16-39						Neisseria meningitidis antigens and compositions	Fraser	2008	0		
1387	chr3	105188586	105188616	3500156532	25		105188586	105188616	8421504	3	5,8,12	0,7,18	g	350015653200000036	14-39						 Cephalosporin Acetylhydrolase Gene And Protein Encoded By Said Gene 	www.docstoc.com	0	0		
1388	chr3	105261147	105263539	3500197610	71		105261147	105263539	8421504	2	21,50	0,2342	c	350019761000000003,350019761000000009	0-21,7-57		11113117	10.1074/jbc.M006584200	0021-9258	Journal of Biological Chemistry	Cloning and Expression of a Pig Liver Taurochenodeoxycholic Acid 6&#x03b1;-Hydroxylase (CYP4A21)	Lundell	2001	5		
1388	chr3	105263368	105270061	3500077888	39		105263368	105270061	8421504	4	3,17,6,13	0,87,4147,6680	c	350007788800000002,350007788800000063	0-20,0-19						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1388	chr3	105359814	105359839	3500266002	23		105359814	105359839	8421504	3	5,12,6	0,6,19	g	350026600200000491	10-33						Treatment of Cellulosic Material and Enzymes Useful Therein - Patent application	www.faqs.org	0	0		
1389	chr3	105473372	105473400	3500461394	23		105473372	105473400	8421504	3	6,11,6	0,7,22	c	350046139400000033	10-35						Genome-wide analysis of nutrient starvation responses of	uni-greifswald.de	0	0		
1389	chr3	105483882	105486338	3500321823	25		105483882	105486338	8421504	2	21,4	0,2452	c	350032182300000001	0-25						Inhibition of Mammalian Target of Rapamycin Induces Phosphatidylinositol 3-Kinase-Dependent and Mnk-Mediated Eukaryotic Translation Initiation Factor 4E Phosphorylation	mcb.asm.org	0	0		MKNK1
1389	chr3	105483882	105486338	3500285804	25		105483882	105486338	8421504	2	21,4	0,2452	c	350028580400000001	0-25		17724079	10.1128/MCB.00760-07	0270-7306	Molecular and Cellular Biology	Inhibition of Mammalian Target of Rapamycin Induces Phosphatidylinositol 3-Kinase-Dependent and Mnk-Mediated Eukaryotic Translation Initiation Factor 4E Phosphorylation	Wang	2007	6		MKNK1
1389	chr3	105483882	105486338	3500095775	25		105483882	105486338	8421504	2	21,4	0,2452	c	350009577500000001	0-25		17724079	10.1128/MCB.00760-07	0270-7306	Molecular and Cellular Biology	Inhibition of Mammalian Target of Rapamycin Induces Phosphatidylinositol 3-Kinase-Dependent and Mnk-Mediated Eukaryotic Translation Initiation Factor 4E Phosphorylation	Wang	2007	6		MKNK1
1389	chr3	105499410	105499438	3500096485	24		105499410	105499438	8421504	2	13,11	0,17	g	350009648500000167	9-33						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
1390	chr3	105556851	105557178	3500302727	72		105556851	105557178	8421504	2	33,39	0,288	p	350030272700015002	0-72						Methods and reagents for regulating telomere length and telomerase activity	Adams	1998	0		DMBX1
1391	chr3	105657043	105658925	3500278885	40		105657043	105658925	8421504	3	18,2,20	0,278,1862	c,g	350027888500000001,350027888500000000,350027888500000000	0-20,0-20,0-20						Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle. - ResearchGate	.researchgate.net	0	0		
1391	chr3	105657043	105658925	3500140766	40		105657043	105658925	8421504	3	18,2,20	0,278,1862	c	350014076600000001,350014076600000000	0-20,0-20		23977311	10.1371/journal.pone.0072521		PLoS ONE	Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle	Maria	2013	0		
1391	chr3	105657405	105658888	3500463464	62		105657405	105658888	8421504	3	16,39,7	0,1434,1476	c	350046346400000011,350046346400000002	4-73,21-45						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
21	chr3	105900334	105997859	3500453701	1383		105900334	105997859	8421504	10	106,109,99,181,126,143,177,75,171,196	0,60395,62397,70110,71067,79081,83365,89500,90046,97329	p	350045370100015004	0-1383						KEGG T01002: 18706	www.genome.jp	0	0		TSPAN1,PIK3R3
21	chr3	105900334	105997859	3500346688	1383		105900334	105997859	8421504	10	106,109,99,181,126,143,177,75,171,196	0,60395,62397,70110,71067,79081,83365,89500,90046,97329	p	350034668800015000	0-1383						KEGG T01001: 8503	www.genome.jp	0	0		TSPAN1,PIK3R3
21	chr3	105900334	105997859	3500285121	1383		105900334	105997859	8421504	10	106,109,99,181,126,143,177,75,171,196	0,60395,62397,70110,71067,79081,83365,89500,90046,97329	p	350028512100015000	0-1383						KEGG T01005: 456565	www.genome.jp	0	0		TSPAN1,PIK3R3
21	chr3	105900334	105997859	3500149165	1383		105900334	105997859	8421504	10	106,109,99,181,126,143,177,75,171,196	0,60395,62397,70110,71067,79081,83365,89500,90046,97329	p	350014916500015007	0-1383						KEGG T01001: 23533	www.genome.jp	0	0		TSPAN1,PIK3R3
1393	chr3	105962816	105970475	3500322942	45		105962816	105970475	8421504	2	14,31	0,7628	p	350032294200015063	0-45						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		PIK3R3
1393	chr3	105962816	105970475	3500075196	45		105962816	105970475	8421504	2	14,31	0,7628	p	350007519600015069	0-45						USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS	Dunnington	1997	0		PIK3R3
1393	chr3	105979432	105979456	3500383016	23		105979432	105979456	8421504	2	5,18	0,6	c	350038301600000004	0-23		23092334	10.1186/1471-2091-13-22		BMC Biochemistry	Phosphatase of regenerating liver-3 directly interacts with integrin &#x03b2;1 and regulates its phosphorylation at tyrosine 783	Wei	2012	0		
1393	chr3	105979432	105979456	3500270412	23		105979432	105979456	8421504	2	5,18	0,6	c	350027041200000004	0-23						Phosphatase of regenerating liver-3 directly interacts with integrin &#xfffd;1 and regulates its phosphorylation at tyrosine 783	biomedcentral.com	0	0		
1393	chr3	105990491	105990515	3500353377	24		105990491	105990515	8421504	1	24	0	c	350035337700000111	5-29						Compositions and methods for producing bioactive fusion proteins - Patent application	www.faqs.org	0	0		
1395	chr3	106265654	106265681	3500019011	24		106265654	106265681	8421504	3	13,3,8	0,14,19	g	350001901100000030	0-24			10.1073/pnas.0507479102		Proceedings of the National Academy of Sciences of the United States of America	The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation	Marylynn	2005	0		
1397	chr3	106455706	106461787	3500086256	975		106455706	106461787	8421504	8	63,87,73,200,196,152,120,84	0,684,910,1231,1765,2563,2885,5997	p	350008625600015006	0-975						Alcohol dehydrogenases (adh) useful for fermentive production of lower alkyl alcohols	Gude	2011	0		
1397	chr3	106455709	106461787	3500291387	927		106455709	106461787	8421504	9	54,57,73,200,162,25,152,120,84	0,711,907,1228,1762,1933,2560,2882,5994	p	350029138700015018,350029138700015017,350029138700015016	0-54,0-492,0-381						ALCOHOL DEHYDROGENASES (ADH) USEFUL FOR FERMENTIVE PRODUCTION OF LOWER ALKYL ALCOHOLS - BUTAMAX(TM) ADVANCED BIOFUELS LLC	www.sumobrain.com	0	0		
1397	chr3	106455709	106461787	3500135742	927		106455709	106461787	8421504	9	54,57,73,200,162,25,152,120,84	0,711,907,1228,1762,1933,2560,2882,5994	p	350013574200015016,350013574200015015,350013574200015014	0-54,0-492,0-381						Alcohol dehydrogenases (adh) useful for fermentive production of lower alkyl alcohols	Gude	2012	0		
1397	chr3	106467154	106467180	3500431462	23		106467154	106467180	8421504	2	16,7	0,19	g	350043146200000838	8-38						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
1397	chr3	106503756	106505557	3500116069	45		106503756	106505557	8421504	2	22,23	0,1778	c,g	350011606900000016,350011606900000017,350011606900000017	0-22,0-23,0-23		23132798	10.1167/iovs.12-10165	1552-5783	Investigative Ophthalmology & Visual Science	Metallothionein-III Deficiency Exacerbates Light-Induced Retinal Degeneration	Tsuruma	2012	0		PRDX1
1397	chr3	106505557	106515356	3500047475	65		106505557	106515356	8421504	3	21,20,24	0,794,9775	c,g	350004747500000002,350004747500000006,350004747500000006,350004747500000007	0-21,0-20,0-20,0-24						THE ROLE OF PEROXIREDOXINS AS MECHANOSENSITIVE ANTIOXIDANTS IN ENDOTHELIAL CELLS	artech.gatech.edu	0	0		PRDX1
1397	chr3	106505592	106506802	3500047878	40		106505592	106506802	8421504	3	2,18,20	0,727,1190	c	350004787800000042,350004787800000043	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1397	chr3	106515333	106515507	3500388350	42		106515333	106515507	8421504	2	23,19	0,155	c	350038835000000064,350038835000000065	0-23,0-19						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
1397	chr3	106515333	106515507	3500027904	42		106515333	106515507	8421504	2	23,19	0,155	c	350002790400000039,350002790400000040	0-23,0-19						 SpringerImages - primers sequences 	pringerimages.com	0	0		
1397	chr3	106515354	106515383	3500029341	29		106515354	106515383	8421504	1	29	0	c	350002934100000003	6-35		21159870	10.1128/JVI.01796-10		Journal of Virology	Peroxiredoxin 1 Is Required for Efficient Transcription and Replication of Measles Virus 	Akira	2011	0		
1398	chr3	106650566	106650592	3500219861	23		106650566	106650592	8421504	2	16,7	0,19	c	350021986100000036	0-23						Preliminary linkage map of the Turkey (Meleagris gallopavo) based on microsatellite markers	dmoosemedia.co.uk	0	0		
1398	chr3	106651392	106651417	3500124002	23		106651392	106651417	8421504	2	15,8	0,17	c	350012400200000012	9-32						PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION - Patent application	www.faqs.org	0	0		
1400	chr3	106932044	106932119	3500376180	75		106932044	106932119	8421504	1	75	0	p	350037618000015033	0-75						Lung Cancer Diagnostic Assay - Patent application	www.faqs.org	0	0		UROD
1400	chr3	106932044	106932119	3500209076	75		106932044	106932119	8421504	1	75	0	p	350020907600015034	0-75						Lung Cancer Diagnostic Assay	Hirschowitz	2006	0		UROD
1400	chr3	106944322	106944345	3500340200	23		106944322	106944345	8421504	1	23	0	c	350034020000000020	20-43					Patent	Calcium receptor-active molecules (Patent US:6031003)	Balandrin	2000	0		
1400	chr3	106944322	106944345	3500225844	23		106944322	106944345	8421504	1	23	0	c	350022584400000020	20-43						US Patent # 6,011,068. Calcium receptor-active molecules - Patents.com	www.patents.com	0	0		
1402	chr3	107105556	107106576	3500428541	40		107105556	107106576	8421504	3	20,19,1	0,876,1019	c	350042854100000045,350042854100000044	0-20,0-20						Developmental Regulation and In Vitro Culture Effects on Expression of DNA Repair and Cell Cycle Checkpoint Control Genes in Rhesus Monkey Oocytes and Embryos1	ww.biolreprod.org	0	0		PLK3,TCTEX1D4
1402	chr3	107124438	107124844	3500068155	24		107124438	107124844	8421504	3	9,13,2	0,10,404	c	350006815500000054	16-40						AMPLIFICATION DYNAMICS OF PRIMATE RETROTRANSPOSONS	etd.lsu.edu	0	0		
1402	chr3	107130081	107130440	3500164379	144		107130081	107130440	8421504	2	57,87	0,272	p	350016437900015004	144-288						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		SNORD38A
1402	chr3	107147556	107147918	3500432308	30		107147556	107147918	8421504	2	25,5	0,357	c	350043230800000007	0-30		20368358	10.1128/MCB.00098-10	0270-7306	Molecular and Cellular Biology	Functional and Spatial Regulation of Mitotic Centromere- Associated Kinesin by Cyclin-Dependent Kinase 1	Sanhaji	2010	6		
1402	chr3	107147556	107147918	3500398183	30		107147556	107147918	8421504	2	25,5	0,357	c	350039818300000007	0-30		20368358	10.1128/MCB.00098-10		Molecular and Cellular Biology	Functional and Spatial Regulation of Mitotic Centromere- Associated Kinesin by Cyclin-Dependent Kinase 1 	Mourad	June	0		
1402	chr3	107155049	107159856	3500034285	93		107155049	107159856	8421504	3	36,14,43	0,4749,4764	c,g	350003428500000009,350003428500000003	24-60,1-58						Identification and Partial Characterization of Mitotic Centromere-associated Kinesin, a Kinesin-related Protein That Associates with Centromeres during Mitosis	jcb.rupress.org	0	0		
1406	chr3	107612845	107615660	3500425953	24		107612845	107615660	8421504	3	7,1,16	0,11,2799	c	350042595300000121	3-27						Cleavage agents	www.devileye.net	0	0		
1406	chr3	107612845	107615660	3500417793	24		107612845	107615660	8421504	3	7,1,16	0,11,2799	c	350041779300000146	3-27						US Patent # 6,458,535. Detection of nucleic acids by multiple sequential invasive cleavages 02 - Patents.com	www.patents.com	0	0		
1406	chr3	107612845	107615660	3500327109	24		107612845	107615660	8421504	3	7,1,16	0,11,2799	c	350032710900000143	3-27						Invasive cleavage of nucleic acids	Brow	1999	0		
1406	chr3	107612845	107615660	3500159977	24		107612845	107615660	8421504	3	7,1,16	0,11,2799	c	350015997700000146	3-27						Detection of nucleic acids by multiple sequential invasive cleavages 02	Hall	1999	0		
1406	chr3	107612845	107615660	3500152228	24		107612845	107615660	8421504	3	7,1,16	0,11,2799	c	350015222800000151	3-27						Detection of nucleic acids by multiple sequential invasive cleavages	Hall	1997	0		
1406	chr3	107612845	107615660	3500139533	24		107612845	107615660	8421504	3	7,1,16	0,11,2799	c	350013953300000143	3-27						Invasive cleavage of nucleic acids	Brow	1997	0		
1406	chr3	107612845	107615660	3500133350	24		107612845	107615660	8421504	3	7,1,16	0,11,2799	c	350013335000000181	3-27						Fen-1 endonucleases, mixtures and cleavage methods	Kaiser	1998	0		
1408	chr3	107964503	107965025	3500347554	44		107964503	107965025	8421504	2	24,20	0,502	c	350034755400000003,350034755400000002	0-24,0-20						US Patent # 7,019,024. Pharmaceutical for treatment of neurological and neuropsychiatric disorders - Patents.com	www.patents.com	0	0		
1408	chr3	107964503	107965025	3500299734	44		107964503	107965025	8421504	2	24,20	0,502	c	350029973400000003,350029973400000002	0-24,0-20						Pharmaceutical For Treatment Of Neurological And Neuropsychiatric Disorders 	.freshpatents.com	0	0		
1408	chr3	107965213	107965239	3500070597	26		107965213	107965239	8421504	1	26	0	c	350007059700000229	0-26						VARIANTS AND EXONS OF THE GLYT1 TRANSPORTER - Patent application	www.faqs.org	0	0		
1408	chr3	107985857	107985889	3500300591	25		107985857	107985889	8421504	3	6,5,14	0,10,18	g	350030059100000073	19-47						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
176	chr3	108204059	108267273	3500162260	23		108204059	108267273	8421504	2	12,11	0,63203	c	350016226000000002	2-25		19131698			Journal of Microbiology and Biotechnology	Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression.	Jeong	2008	0		
1411	chr3	108300004	108333137	3500459444	849		108300004	108333137	8421504	10	72,99,59,118,9,138,104,50,194,6	0,355,11009,11517,27379,28085,28603,29414,31552,33127	p	350045944400015002,350045944400015001,350045944400015000	0-171,0-177,0-501						Inhibition Of Gasc1 	.freshpatents.com	0	0		KDM4A
1411	chr3	108335779	108336535	3500089590	105		108335779	108336535	8421504	3	24,36,45	0,663,711	p	350008959000015014,350008959000015013	0-60,0-45						TH&#xe9;SE pr&#x017d;sent&#x017d;e par	www.hal.inserm.fr	0	0		KDM4A
1411	chr3	108371228	108371258	3500328316	25		108371228	108371258	8421504	2	15,10	0,20	c	350032831600000022	0-25						Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins - Patent application	www.faqs.org	0	0		
176	chr3	108371599	108440023	3500276455	5694		108371599	108440023	8421504	31	66,136,155,126,127,179,286,155,120,176,124,98,116,155,219,94,254,98,579,118,194,306,145,137,582,270,111,189,142,146,91	0,416,631,1034,1341,1681,1962,2323,2757,3602,3922,7066,10945,13582,14013,14786,14976,15391,16163,16821,21224,22096,25838,26424,26775,28872,38574,47114,59201,59528,68333	p	350027645500015000	0-5721						KEGG T01001: 5792	www.genome.jp	0	0		PTPRF
1411	chr3	108372139	108372242	3500186204	24		108372139	108372242	8421504	2	12,12	0,91	c	350018620400000124	2-26						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
1411	chr3	108372301	108374032	3500205994	192		108372301	108374032	8421504	3	75,7,110	0,1539,1621	p	350020599400015005,350020599400015016	0-75,0-117						Characterizing the cancer genome in lung adenocarcinoma	roadinstitute.org	0	0		PTPRF
1411	chr3	108373681	108378740	3500365548	573		108373681	108378740	8421504	15	45,36,45,33,33,21,45,9,36,36,89,52,21,24,48	0,276,315,363,675,714,738,786,1520,1559,1607,1840,1943,4984,5011	p	350036554800015037,350036554800015033,350036554800015032,350036554800015031,350036554800015030,350036554800015029,350036554800015027	0-45,0-147,0-147,0-48,0-48,0-45,0-93						US Patent # 7,214,487. Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates - Patents.com	www.patents.com	0	0		
1413	chr3	108610579	108610604	3500440434	25		108610579	108610604	8421504	1	25	0	c	350044043400000018	0-25						Novel -Adrenergic Receptor Signaling Pathways: Secreted Factors and Interactions with the Extracellular Matrix S	aspetjournals.org	0	0		
1413	chr3	108629922	108629945	3500434109	23		108629922	108629945	8421504	1	23	0	c	350043410900000003	0-23			10.1634/stemcells.2006-0701	1549-4918	STEM CELLS	Thrombopoietin Enhances Generation of CD34+ Cells from Human Embryonic Stem Cells - Srivastava - 2007 - STEM CELLS - Wiley Online Library	Srivastava	2007	0		
1413	chr3	108631422	108631446	3500245296	24		108631422	108631446	8421504	1	24	0	c	350024529600000000	0-24					Patent	&#x4e9a;&#x4e59;&#x57fa;&#x80bc;&#x9170;&#x80fa;&#x7c7b;&#x884d;&#x751f;&#x7269;&#x3001;&#x5176;&#x5236;&#x5907;&#x65b9;&#x6cd5;&#x53ca;&#x5176;&#x5728;&#x533b;&#x836f;&#x4e0a;&#x7684;&#x5e94;&#x7528; Ethylidene hydrazine amide derivatives, their preparat	Deng Bing Chu 	2013	0		
1413	chr3	108631422	108631446	3500136686	24		108631422	108631446	8421504	1	24	0	c	350013668600000000	0-24					Patent	Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof (Patent CN:101679286)	Lu He Jun 	2011	0		
1413	chr3	108631439	108631469	3500208252	30		108631439	108631469	8421504	1	30	0	c	350020825200000036	0-30						Subtractive amplification kit useful in the diagnosis of genetic disease mutation or variation	Malek	1999	0		
176	chr3	108649854	108663847	3500339819	342		108649854	108663847	8421504	11	33,15,38,10,47,48,40,17,16,30,48	0,1508,4847,5046,9250,9298,10080,12758,13565,13629,13945	c	350033981900000073,350033981900000058,350033981900000042,350033981900000041,350033981900000032,350033981900000025,350033981900000023,350033981900000021	0-48,0-48,1-48,0-48,7-47,0-33,18-48,0-48						 Antibodies Recognizing Tie Receptor Tyrosine Kinase And Uses Thereof 	www.docstoc.com	0	0		
1413	chr3	108651782	108653150	3500366238	99		108651782	108653150	8421504	4	4,38,30,27	0,1160,1201,1341	p	350036623800015035	0-99						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		TIE1
1413	chr3	108653171	108653194	3500420477	23		108653171	108653194	8421504	1	23	0	c	350042047700000387	0-23						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
1413	chr3	108653171	108653194	3500032480	23		108653171	108653194	8421504	1	23	0	c	350003248000000391	0-23						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments - US Patent 7964349 Description	ww.patentstorm.us	0	0		
1413	chr3	108653171	108653194	3500017979	23		108653171	108653194	8421504	1	23	0	c	350001797900000387	0-23						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		TIE1
1413	chr3	108654236	108654694	3500453109	40		108654236	108654694	8421504	2	20,20	0,438	c	350045310900000027,350045310900000026	0-20,0-20						Expression von lokalen Regulationsfaktoren im Ovar des Schweins	b.uni-muenchen.de	0	0		TIE1
1414	chr3	108669072	108669098	3500455588	23		108669072	108669098	8421504	3	4,5,14	0,5,12	c,g	350045558800000000,350045558800000000	13-36,13-36		21693026	10.1186/1471-2407-11-261		BMC Cancer	Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo	Longjiang	2011	0		
1414	chr3	108669072	108669098	3500445342	23		108669072	108669098	8421504	3	4,5,14	0,5,12	c	350044534200000000	13-36		21693026	10.1186/1471-2407-11-261	1471-2407	BMC Cancer	Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo	Yang	2011	3		
1414	chr3	108691167	108691191	3500026606	24		108691167	108691191	8421504	1	24	0	g	350002660600000006	0-24						Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A). - ResearchGate	.researchgate.net	0	0		HPRT1
1415	chr3	108882074	108882101	3500156631	23		108882074	108882101	8421504	2	12,11	0,16	g	350015663100000046	10-33						US Patent # 7,037,667. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer - Patents.com	www.patents.com	0	0		
1418	chr3	109278919	109278989	3500441394	42		109278919	109278989	8421504	2	21,21	0,49	c,g	350044139400000004,350044139400000004,350044139400000005	0-21,0-21,0-21						Adenovirus Type 36 Enhances Glucose Uptake: Research Design and Methods	www.medscape.com	0	0		SLC2A1
1418	chr3	109278919	109278989	3500383043	42		109278919	109278989	8421504	2	21,21	0,49	c,g	350038304300000004,350038304300000004,350038304300000005	0-21,0-21,0-21		18420488	10.2337/db07-1313	0012-1797	Diabetes	Human Adenovirus Type 36 Enhances Glucose Uptake in Diabetic and Nondiabetic Human Skeletal Muscle Cells Independent of Insulin Signaling	Wang	2008	8		SLC2A1
1418	chr3	109278919	109278989	3500133212	42		109278919	109278989	8421504	2	21,21	0,49	c,g	350013321200000004,350013321200000004,350013321200000005	0-21,0-21,0-21		18420488	10.2337/db07-1313	0012-1797	Diabetes	Human Adenovirus Type 36 Enhances Glucose Uptake in Diabetic and Nondiabetic Human Skeletal Muscle Cells Independent of Insulin Signaling	Wang	2008	8		SLC2A1
1418	chr3	109279022	109283473	3500332880	89		109279022	109283473	8421504	2	26,63	0,4388	p,c	350033288000000001,350033288000015003	0-26,0-63						GLUT1 transporters expressed in cancer cells	Gangakhedkar	2006	0		SLC2A1
1418	chr3	109279022	109279048	3500252651	26		109279022	109279048	8421504	1	26	0	g	350025265100000001	0-26						Glut3 transporters expressed in cancer cells	Zerangue	2006	0		SLC2A1
1418	chr3	109279029	109279052	3500129199	23		109279029	109279052	8421504	1	23	0	c	350012919900000044	0-23						Gene Expression Profiling in a Renal Cell Carcinoma Cell Line: Dissecting VHL and Hypoxia-Dependent Pathways	.aacrjournals.org	0	0		SLC2A1
1418	chr3	109279029	109279052	3500126010	23		109279029	109279052	8421504	1	23	0	c,g	350012601000000008,350012601000000008	0-23,0-23		12692265		1541-7786	Molecular Cancer Research	Gene Expression Profiling in a Renal Cell Carcinoma Cell Line: Dissecting VHL and Hypoxia-Dependent Pathways	Jiang	2003	4		SLC2A1
1418	chr3	109279121	109281491	3500119526	41		109279121	109281491	8421504	2	20,21	0,2349	c,g	350011952600000000,350011952600000000,350011952600000001,350011952600000001	0-20,0-20,0-21,0-21						Authors: Chu Yan CHAN1,2, Jeremy A. GUGGENHEIM1, Chi Ho TO2	ll.physiology.org	0	0		
1418	chr3	109280194	109280460	3500035162	40		109280194	109280460	8421504	2	20,20	0,246	c,g	350003516200000003,350003516200000003,350003516200000004	0-20,0-20,0-20						The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS). - ResearchGate	.researchgate.net	0	0		
1418	chr3	109280199	109282727	3500181711	40		109280199	109282727	8421504	2	20,20	0,2508	c,g	350018171100000019,350018171100000020,350018171100000020	0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
1418	chr3	109280199	109282727	3500163467	40		109280199	109282727	8421504	2	20,20	0,2508	c,g	350016346700000000,350016346700000001,350016346700000001	0-20,0-20,0-20						Entwicklungsspezifische Expression und m&#xf6;gliche funktionelle Bedeutung der Glukosetransporterisoformen in Pr&#xe4;implantationsembryonen des Rindes	ebdoc.sub.gwdg.de	0	0		
1418	chr3	109280269	109280417	3500407545	60		109280269	109280417	8421504	4	20,18,3,19	0,21,125,129	c,g	350040754500000000,350040754500000000,350040754500000002,350040754500000001,350040754500000001	0-20,0-20,0-21,0-19,0-19		14695907	10.1095/biolreprod.103.023853	0006-3363	Biology of Reproduction	Maternal Growth Hormone Treatment from Day 35 to 80 of Gestation Alters Nutrient Partitioning in Favor of Uteroplacental Growth in the Overnourished Adolescent Sheep	Wallace	2004	4		
1418	chr3	109280276	109280413	3500299869	39		109280276	109280413	8421504	2	20,19	0,118	c,g	350029986900000008,350029986900000008,350029986900000009,350029986900000009	0-20,0-20,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
1418	chr3	109280534	109282816	3500080968	90		109280534	109282816	8421504	2	45,45	0,2237	p	350008096800015113,350008096800015120	0-45,0-45						Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus - Patent application	www.faqs.org	0	0		SLC2A1
1418	chr3	109283311	109283395	3500230702	43		109283311	109283395	8421504	2	22,21	0,63	c,g	350023070200000000,350023070200000000,350023070200000001,350023070200000001	0-22,0-22,0-21,0-21						Effect of glucose availability on glucose transport in bovine mammary epithelial cells	cience.zju.edu.cn	0	0		
1418	chr3	109283383	109283473	3500297230	90		109283383	109283473	8421504	1	90	0	p	350029723000015002	0-90						and the Glut1 Glucose Transporter. Bandyopadhyay G*, Sajan MP*, Kanoh Y*, Standaert ML*, Burke RT**, Jr., Quon M**, J. A. Haley Veterans' Hospital Research Service, and	www.jbc.org	0	0		SLC2A1
1418	chr3	109283396	109283574	3500009456	42		109283396	109283574	8421504	2	20,22	0,156	c,g	350000945600000010,350000945600000010,350000945600000011,350000945600000011	0-20,0-20,0-22,0-22						PHOSPHOLIPASE C ZETA MEDIATED OOCYTE ACTIVATION, COMPOSITIONS FOR USE THEREIN, AND ASSAYS FOR DETECTING AND IDENTIFYING AGENTS FOR TREATING MALE INFERTILITY	Fissore	2007	0		
1418	chr3	109283425	109283473	3500326335	48		109283425	109283473	8421504	1	48	0	p	350032633500015006	0-48						Award Number: W81XWH-06-1-0423 PRINCIPAL INVESTIGATOR: Christian Daniel Young CONTRACTING ORGANIZATION: University of Colorado TYPE OF REPORT: Annual Summary DISTRIBUTION STATEMENT: Approved for Public Release;	handle.dtic.mil	0	0		SLC2A1
1418	chr3	109283425	109283473	3500246182	48		109283425	109283473	8421504	1	48	0	p	350024618200015005	0-48						AD Award Number: W81XWH-06-1-0423 The Role of Akt and its Substrates in Resistance of Breast Cancer to PRINCIPAL INVESTIGATOR: CONTRACTING ORGANIZATION: University of Colorado Health Sciences Center	www.dtic.mil	0	0		SLC2A1
1418	chr3	109283435	109283763	3500218393	60		109283435	109283763	8421504	2	30,30	0,298	c	350021839300000002,350021839300000003	0-30,0-30						Nuclear Transfer Protocol Affects Messenger RNA Expression Patterns in Cloned Bovine Blastocysts	ww.biolreprod.org	0	0		
1418	chr3	109283437	109283763	3500306233	58		109283437	109283763	8421504	2	28,30	0,296	c,g	350030623300000006,350030623300000015,350030623300000007	0-28,28-58,0-28						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
1418	chr3	109283514	109283625	3500294910	44		109283514	109283625	8421504	2	22,22	0,89	c	350029491000000010,350029491000000011	0-22,0-22						UNIVERSIDADE JOS&#xc9; DO ROS&#xc1;RIO VELLANO &#x2013; UNIFENAS TOCHIMARA APARECIDA MIYAUCHI	tede.unifenas.br	0	0		
1418	chr3	109283733	109283763	3500138064	30		109283733	109283763	8421504	1	30	0	g	350013806400000001	30-60						Improvement of the Developmental Capacity of Oocytes from Prepubertal Cattle by Intraovarian Insulin-Like Growth Factor-I Application	ww.biolreprod.org	0	0		
1419	chr3	109340124	109340150	3500066984	24		109340124	109340150	8421504	2	12,12	0,14	c	350006698400000038	0-24						Proteases - Patent application	www.faqs.org	0	0		
1419	chr3	109340124	109340150	3500041857	24		109340124	109340150	8421504	2	12,12	0,14	c	350004185700000038	0-24						Proteases - Patent application	www.faqs.org	0	0		
1419	chr3	109340209	109340237	3500106629	26		109340209	109340237	8421504	3	5,9,12	0,6,16	c	350010662900000029	5-31						UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL CENTRO DE BIOTECNOLOGIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM BIOLOGIA CELULAR E MOLECULAR	www.lume.ufrgs.br	0	0		
1419	chr3	109356355	109356380	3500376873	23		109356355	109356380	8421504	2	12,11	0,14	g	350037687300000061	0-23						Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis	Belli	1999	0		
1419	chr3	109356355	109356380	3500105054	23		109356355	109356380	8421504	2	12,11	0,14	g	350010505400000061	0-23					Patent	Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis (Patent US:6451592)	Thomas	2002	0		
1419	chr3	109431762	109431786	3500026302	24		109431762	109431786	8421504	1	24	0	g	350002630200000117	5-43						ACKNOWLEDGMENTS	curis.ku.dk	0	0		
1420	chr3	109483275	109483301	3500370404	23		109483275	109483301	8421504	3	13,5,5	0,14,21	g	350037040400000036	4-27						Substance Specific To Human Pd-1 	.freshpatents.com	0	0		
1420	chr3	109483275	109483301	3500107865	23		109483275	109483301	8421504	3	13,5,5	0,14,21	g	350010786500000520	25-48						Anti-Cd14 Antibody Fusion Protein - Patent application	www.faqs.org	0	0		
1420	chr3	109498056	109517249	3500271050	654		109498056	109517249	8421504	15	18,32,96,34,14,21,171,35,12,30,18,32,16,48,77	0,896,984,1128,4629,4691,4827,5095,5427,5487,8235,18148,18907,18972,19116	c,g	350027105000000338,350027105000000336,350027105000000335,350027105000000335,350027105000000333,350027105000000331,350027105000000330,350027105000000329,350027105000000328,350027105000000325,350027105000000323,350027105000000321,350027105000000319,350027105000000316,350027105000000315	0-50,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,16-45						Cloning by complementation and related processes	Colicelli	1991	0		
1420	chr3	109499019	109499064	3500396373	45		109499019	109499064	8421504	1	45	0	p	350039637300015001	3-48		18809583	10.1128/MCB.00244-08	0270-7306	Molecular and Cellular Biology	Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1	Chattopadhyay	2008	6		YBX1
1420	chr3	109499019	109499064	3500343918	45		109499019	109499064	8421504	1	45	0	p	350034391800015001	3-48		18809583	10.1128/MCB.00244-08		Molecular and Cellular Biology	Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1 	Ranajoy	2008	0		YBX1
1420	chr3	109499027	109516971	3500114154	59		109499027	109516971	8421504	4	19,21,11,8	0,7274,17198,17936	c	350011415400000001,350011415400000000,350011415400000002	0-19,0-21,0-19		18945760	10.1128/JVI.01719-08	0022-538X	Journal of Virology	Control of the Papillomavirus Early-to-Late Switch by Differentially Expressed SRp20	Jia	2009	5		YBX1
1420	chr3	109499042	109516225	3500209575	48		109499042	109516225	8421504	2	24,24	0,17159	c,g	350020957500000038,350020957500000037,350020957500000037	0-24,0-24,0-24			10.1093/emboj/cdg067		The EMBO Journal	Identification of YB-1 as a regulator of PTP1B expression: implications for regulation of insulin and cytokine signaling	Toshiyuki	2003	0		YBX1
1420	chr3	109499113	109503538	3500180705	47		109499113	109503538	8421504	2	22,25	0,4400	c	350018070500000001,350018070500000000	0-22,0-25		20649952	10.1186/1471-2407-10-388	1471-2407	BMC Cancer	p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance	Yang	2010	3		YBX1
1420	chr3	109499172	109502894	3500465042	40		109499172	109502894	8421504	3	20,9,11	0,3587,3711	c,g	350046504200000003,350046504200000003,350046504200000002	0-20,0-20,0-20		20838384	10.1038/onc.2010.366	0950-9232	Oncogene	Suppression of Her2&sol;neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1	Kalra	2010	6		YBX1
1420	chr3	109499172	109502894	3500034936	40		109499172	109502894	8421504	3	20,9,11	0,3587,3711	c,g	350003493600000003,350003493600000003,350003493600000002	0-20,0-20,0-20		20838384	10.1038/onc.2010.366	0950-9232	Oncogene	Suppression of Her2&sol;neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1	Kalra	2010	6		YBX1
1420	chr3	109503145	109503518	3500402403	76		109503145	109503518	8421504	2	41,35	0,338	c,g	350040240300000026,350040240300000107,350040240300000105,350040240300000105	0-76,0-23,0-25,0-25						Gene Expression Markers for Response to EGFR Inhibitor Drugs	Agus	2008	0		YBX1
1420	chr3	109516233	109517131	3500462002	45		109516233	109517131	8421504	3	3,16,26	0,730,872	c	350046200200000010,350046200200000000	9-28,9-35		22855482	10.1128/JVI.00453-12	0022-538X	Journal of Virology	YB-1 Functions as a Porter To Lead Influenza Virus Ribonucleoprotein Complexes to Microtubules	Kawaguchi	2012	5		
1420	chr3	109516233	109517131	3500230158	45		109516233	109517131	8421504	3	3,16,26	0,730,872	c	350023015800000010,350023015800000000	9-28,9-35		22855482	10.1128/JVI.00453-12	0022-538X	Journal of Virology	YB-1 Functions as a Porter To Lead Influenza Virus Ribonucleoprotein Complexes to Microtubules	Kawaguchi	2012	5		
1420	chr3	109532479	109532507	3500384026	23		109532479	109532507	8421504	2	11,12	0,16	g	350038402600000000	2-25						 Biotechnological Method Of Producing Biotin 	www.docstoc.com	0	0		
1420	chr3	109532479	109532507	3500335231	23		109532479	109532507	8421504	2	11,12	0,16	g	350033523100000000	2-25						Biotechnological method of producing biotin - Patent # 6083712 - PatentGenius	.patentgenius.com	0	0		
1420	chr3	109534753	109534779	3500099159	23		109534753	109534779	8421504	2	15,8	0,18	g	350009915900000063	11-41						Streptococcus pneumoniae proteins and nucleic acids	Masignani	2011	0		
1420	chr3	109541849	109542851	3500144405	165		109541849	109542851	8421504	5	43,2,31,24,65	0,304,318,621,937	p	350014440500015029	0-165						Characterisation of heterogeneous nuclear ribonucleoprotein G (hnRNP G) and its role in splice site selection.	b.uni-erlangen.de	0	0		PPIH
1420	chr3	109542799	109543252	3500423250	41		109542799	109543252	8421504	2	21,20	0,433	c	350042325000000011,350042325000000010	0-21,0-20		18316553	10.1158/1078-0432.CCR-07-1755	1078-0432	Clinical Cancer Research	hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer	Camps	2008	8		PPIH
1424	chr3	110032190	110032216	3500131554	23		110032190	110032216	8421504	2	16,7	0,19	g	350013155400000086,350013155400000085	0-23,0-23						Full text of "Identification and characterization of cDNA clones for chromoplast-associated proteins in tomato fruit"	www.archive.org	0	0		
1428	chr3	110537380	110537406	3500362588	23		110537380	110537406	8421504	2	5,18	0,8	g	350036258800000018	10-33						GENETIC DIVERSITY ANALYSIS IN SORGHUM GERMPLASM COLLECTIONS FROM EASTERN AFRICA AS ESTIMATED BY MORPHO-AGRONOMICAL AND SSR MARKERS	etd.uovs.ac.za	0	0		
1428	chr3	110613745	110613771	3500225844	23		110613745	110613771	8421504	2	5,18	0,8	g	350022584400000279	13-37						US Patent # 6,011,068. Calcium receptor-active molecules - Patents.com	www.patents.com	0	0		
1429	chr3	110696364	110696427	3500409531	63		110696364	110696427	8421504	1	63	0	p	350040953100015000	0-63						DNA coding for a human vasoconstrictive peptide and use thereof	Kosaka	1992	0		EDN2
1429	chr3	110696364	110696427	3500108812	63		110696364	110696427	8421504	1	63	0	p	350010881200015000	0-63						DNA coding for a human vasoconstrictive peptide and use thereof	Kosaka	1992	0		EDN2
1429	chr3	110696405	110698006	3500047577	39		110696405	110698006	8421504	2	20,19	0,1582	c,g	350004757700000006,350004757700000006,350004757700000007	0-20,0-20,0-19		20176726	10.1210/en.2009-0767	0013-7227	Endocrinology	Induction of Endothelin-2 Expression by Luteinizing Hormone and Hypoxia: Possible Role in Bovine Corpus Luteum Formation	Klipper	2010	4		
1431	chr3	110973350	110973378	3500300591	25		110973350	110973378	8421504	2	12,13	0,15	g	350030059100000270	11-38						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
1433	chr3	111217003	111217028	3500110329	23		111217003	111217028	8421504	2	13,10	0,15	g	350011032900000825	14-37						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
1433	chr3	111228801	111228825	3500341953	23		111228801	111228825	8421504	2	9,14	0,10	c	350034195300000112	5-28						Thymidine kinase mutants	www.devileye.net	0	0		
1433	chr3	111228801	111228825	3500059779	23		111228801	111228825	8421504	2	9,14	0,10	c	350005977900000076	11-34						CE7-specific chimeric T cell receptor - Patent # 7265209 - PatentGenius	.patentgenius.com	0	0		
1435	chr3	111487738	111490957	3500185291	181		111487738	111490957	8421504	2	89,92	0,3127	c	350018529100000091,350018529100000090,350018529100000095,350018529100000094	0-89,0-23,0-92,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		LINC00472
1435	chr3	111487786	111487814	3500351139	28		111487786	111487814	8421504	1	28	0	c	350035113900000028,350035113900000145	10-38,10-38						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
1435	chr3	111487788	111487811	3500450448	23		111487788	111487811	8421504	1	23	0	c	350045044800000019	0-23						Compositions And Methods For Inhibiting Or Reversing Fibrotic Disorders 	.freshpatents.com	0	0		NFYC
1435	chr3	111487788	111487811	3500400478	23		111487788	111487811	8421504	1	23	0	c	350040047800000144	0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		MIR30C2
1435	chr3	111487788	111487811	3500287752	23		111487788	111487811	8421504	1	23	0	c	350028775200000052	0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		
1435	chr3	111487788	111487811	3500013455	23		111487788	111487811	8421504	1	23	0	c	350001345500000286	0-23						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		
1435	chr3	111490917	111490941	3500389139	24		111490917	111490941	8421504	1	24	0	c	350038913900000068	20-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		
1435	chr3	111490917	111490941	3500306561	24		111490917	111490941	8421504	1	24	0	c	350030656100000067	20-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		LINC00472
1435	chr3	111490917	111490941	3500257436	24		111490917	111490941	8421504	1	24	0	c	350025743600000067	20-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		LINC00472
1435	chr3	111490917	111490941	3500232262	24		111490917	111490941	8421504	1	24	0	c	350023226200000067	20-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		LINC00472
1437	chr3	111770362	111770386	3500277894	24		111770362	111770386	8421504	1	24	0	g	350027789400000166	12-36						MODIFICATION OF MYD88 SPLICING USING MODIFIED OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		
1439	chr3	111938630	111938662	3500342160	26		111938630	111938662	8421504	3	6,6,14	0,11,18	c	350034216000000026	9-38						US Patent # 5,714,594. cDNA cloning and expression of human liver estrogen sulfotransferase - Patents.com	www.patents.com	0	0		
1439	chr3	111993510	111994001	3500175005	40		111993510	111994001	8421504	2	20,20	0,471	g	350017500500000009,350017500500000010	0-20,0-20						FarnesoidXReceptor,throughtheBindingwith SteroidogenicFactor1-responsiveElement,Inhibits AromataseExpressioninTumorLeydigCells S	www.jbc.org	0	0		RPL19
1440	chr3	112140040	112140091	3500139520	51		112140040	112140091	8421504	1	51	0	p	350013952000015011	3-54						MOLECULAR AND CELL BIOLOGY OF INFANTILE (CLN1) AND VARIANT LATE INFANTILE (CLN5) NEURONAL CEROID LIPOFUSCINOSES	hesis.helsinki.fi	0	0		PPT1
1441	chr3	112252220	112252243	3500101289	23		112252220	112252243	8421504	1	23	0	g	350010128900000047	12-36						NOVEL SURFACE ANTIGEN - Patent application	www.faqs.org	0	0		
1441	chr3	112311632	112311655	3500446687	23		112311632	112311655	8421504	1	23	0	g	350044668700000006	17-41						Characterization and Safety Assessment of Bioengineered Limbal Epithelium	www.e-mjm.org	0	0		
1442	chr3	112369377	112369408	3500199255	24		112369377	112369408	8421504	3	5,6,13	0,7,18	c	350019925500000053	8-33						Recombinant pneumocystis carinii aminoacyl tRNA synthetase genes, tester strains and assays	Whoriskey	1995	0		
1442	chr3	112396118	112410185	3500092036	234		112396118	112410185	8421504	6	42,23,25,15,81,48	0,138,591,9533,10030,14019	c	350009203600000167,350009203600000170,350009203600000179,350009203600000180,350009203600000183	7-49,0-48,0-48,0-48,0-48					Patent	Recombinant bone morphogenetic protein heterodimers (Patent US:5866364)	Israel	1999	0		
1442	chr3	112396118	112406229	3500320185	90		112396118	112406229	8421504	2	42,48	0,10063	c	350032018500000169,350032018500000182	7-49,0-48						Recombinant bone morphogenetic protein heterodimers	Israel	1992	0		
1442	chr3	112396265	112406253	3500422167	166		112396265	112406253	8421504	5	14,43,29,26,54	0,444,8425,8467,9934	c	350042216700000273,350042216700000300,350042216700000303,350042216700000304,350042216700000310,350042216700000024	3-48,0-48,18-47,12-38,11-59,0-27					Patent	Osteogenic proteins (Patent US:5266683)	Kuberasampath	1993	0		
1442	chr3	112396816	112396839	3500203533	23		112396816	112396839	8421504	1	23	0	c	350020353300000284	25-48						US Patent # 5,468,845. Antibodies to osteogenic proteins - Patents.com	www.patents.com	0	0		
1442	chr3	112400174	112400203	3500218461	24		112400174	112400203	8421504	2	7,17	0,12	c	350021846100000028	0-27						Mapping of catalytically important residues in the rat L-histidine decarboxylase enzyme using bioinformatic and site-directed mutagenesis approaches	w.asp.uma.es:8080	0	0		
1442	chr3	112404732	112406253	3500008143	53		112404732	112406253	8421504	2	26,27	0,1494	c	350000814300000073,350000814300000024	12-38,0-27						 Prosthetic Devices Having Enhanced Osteogenic Properties 	www.docstoc.com	0	0		
1442	chr3	112404840	112410179	3500316601	192		112404840	112410179	8421504	5	43,26,42,27,54	0,746,784,1308,5285	p	350031660100015003,350031660100015002,350031660100015001	0-69,0-69,0-54						PROTEINAS DE INDUCCION OSEA Y CARTILAGINOSA.(ES2168091)	ww.espatentes.com	0	0		
1442	chr3	112405567	112410218	3500189969	436		112405567	112410218	8421504	3	99,161,176	0,531,4475	p,c,g	350018996900000022,350018996900000002,350018996900000005,350018996900000027,350018996900015024,350018996900015023,350018996900000018,350018996900000001,350018996900000001,350018996900000025,350018996900000019,350018996900015019,350018996900015020,350018996900000014,350018996900000000,350018996900000003,350018996900015017,350018996900000015,350018996900015014,350018996900000013	0-51,1-72,1-72,0-29,3-336,0-48,0-56,0-111,0-111,0-30,0-48,0-48,0-48,0-53,0-147,0-147,0-48,0-48,0-75,0-30						Bone and cartilage inductive proteins	Hewick	1994	0		
1442	chr3	112405591	112405633	3500392138	42		112405591	112405633	8421504	1	42	0	c	350039213800000297	0-42						Designer ligands of tgf-beta superfamily	Choe	2010	0		
1442	chr3	112405651	112406181	3500334789	48		112405651	112406181	8421504	2	15,33	0,497	c	350033478900000184	0-48						Recombinant bone morphogenetic protein heterodimers, compositions and methods of use	Israel	1994	0		
1442	chr3	112410194	112410218	3500168337	24		112410194	112410218	8421504	1	24	0	c	350016833700000017	6-30						Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		
1442	chr3	112410194	112410218	3500126350	24		112410194	112410218	8421504	1	24	0	c	350012635000000014	6-30						Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof	Birr	2006	0		
1443	chr3	112486051	112486077	3500358645	24		112486051	112486077	8421504	2	10,14	0,12	c	350035864500000010	1-25						Supporting Information	www.pnas.org	0	0		
1443	chr3	112540323	112542742	3500135406	40		112540323	112542742	8421504	2	20,20	0,2399	c	350013540600000035,350013540600000036	0-20,0-20						The interaction between the Wnt and Notch-pathways in colorectal cancer development John Gr&#xfc;nberg	www.ifm.liu.se	0	0		
1443	chr3	112547010	112547034	3500328917	23		112547010	112547034	8421504	2	6,17	0,7	c,g	350032891700000346,350032891700000346	18-41,18-41						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
1444	chr3	112659999	112660024	3500068521	23		112659999	112660024	8421504	2	5,18	0,7	c	350006852100000432	12-35						About ICRISAT	www.icrisat.org	0	0		
1444	chr3	112676338	112676365	3500403401	24		112676338	112676365	8421504	2	17,7	0,20	c	350040340100000007	9-33					Patent	Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity (Patent US:5529926)	Maat	1996	0		
1446	chr3	112867084	112867107	3500445631	23		112867084	112867107	8421504	1	23	0	g	350044563100000106	17-43						Igm Production By Transformed Cells And Methods Of Quantifying Said Igm Production 	.freshpatents.com	0	0		
1447	chr3	113057529	113066546	3500059784	577		113057529	113066546	8421504	5	8,72,135,141,221	0,667,2053,4501,8796	p,c,g	350005978400000001,350005978400000018,350005978400000019,350005978400015020,350005978400000022,350005978400015018,350005978400015016,350005978400015014,350005978400000024,350005978400000003,350005978400015024,350005978400015011,350005978400015009,350005978400015023,350005978400015022,350005978400015005,350005978400015003,350005978400015001,350005978400000002,350005978400000002,350005978400000023,350005978400000023,350005978400000021	0-21,0-576,0-576,0-48,0-21,0-48,0-48,0-48,0-22,0-22,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-20,0-20,0-20,0-20,3-25						Novel Muscle Growth Regulator 	.freshpatents.com	0	0		
1447	chr3	113066424	113066451	3500350348	24		113066424	113066451	8421504	3	14,6,4	0,16,23	c	350035034800000255	20-44						US Patent # 6,004,924. Protein sequences of serrate gene products - Patents.com	www.patents.com	0	0		
1448	chr3	113181494	113186839	3500463336	46		113181494	113186839	8421504	3	13,9,24	0,3703,5321	c	350046333600000004,350046333600000005	0-22,0-24						Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention	.aacrjournals.org	0	0		MYCBP
1448	chr3	113181494	113186839	3500241392	47		113181494	113186839	8421504	3	13,10,24	0,3703,5321	c	350024139200000004,350024139200000003	0-23,0-24		20948428	10.1097/CAD.0b013e3283409673	0959-4973	Anti-Cancer Drugs	 Ursolic acid induces HL60 monocytic differentiation and upre... : Anti-Cancer Drugs 	Zhang	2011	2		MYCBP
1451	chr3	113586076	113586102	3500011328	24		113586076	113586102	8421504	2	7,17	0,9	g	350001132800000185	8-32						US Patent # 7,119,183. Rapid immunoselection cloning method - Patents.com	www.patents.com	0	0		
1451	chr3	113587247	113587271	3500068166	23		113587247	113587271	8421504	2	17,6	0,18	g	350006816600000152	20-43						Attenuated SP12 mutants as antigen carriers - US Patent 7700104 Description	ww.patentstorm.us	0	0		
1452	chr3	113699058	113699084	3500225443	24		113699058	113699084	8421504	2	14,10	0,16	g	350022544300000026	1-37						Chromosome-based platforms	Fleming	2012	0		
1452	chr3	113699058	113699084	3500093665	24		113699058	113699084	8421504	2	14,10	0,16	g	350009366500000026	1-37						Chromosome-based platforms	Perkins	2006	0		
1453	chr3	113868500	113868526	3500384749	23		113868500	113868526	8421504	2	12,11	0,15	g	350038474900000260	11-39						5' to 3' exonuclease mutations of thermostable DNA polymerases - Patent # 5795762 - PatentGenius	.patentgenius.com	0	0		
1455	chr3	114118932	114119366	3500200016	182		114118932	114119366	8421504	3	23,24,135	0,254,299	p,c,g	350020001600000001,350020001600000007,350020001600015005,350020001600000009,350020001600015006,350020001600015007	48-115,0-24,0-45,0-45,3-48,3-51						Expression of transcription regulating genes in human preimplantation embryos | daniel rappolee - Academia.edu	www.academia.edu	0	0		UTP11L
1455	chr3	114118935	114119407	3500024412	46		114118935	114119407	8421504	2	22,24	0,448	c,g	350002441200000006,350002441200000007,350002441200000007	0-22,0-24,0-24		9889200	10.1093/emboj/18.2.444	ERROR! NO ISSN	The EMBO Journal	A role for the POU-III transcription factor Brn-4 in the regulation of striatal neuron precursor differentiation	Shimazaki	1999	0		UTP11L
1455	chr3	114119225	114119279	3500350371	54		114119225	114119279	8421504	1	54	0	p	350035037100015010	0-54						Supporting Information	www.pnas.org	0	0		UTP11L
1455	chr3	114119261	114119378	3500244493	63		114119261	114119378	8421504	2	15,48	0,69	p	350024449300015012	3-105						Identification comS, a srfA the in Bacillus subtilis	www.pnas.org	0	0		
1455	chr3	114162274	114162297	3500084279	23		114162274	114162297	8421504	1	23	0	c	350008427900000022	0-23						High throughput directed evolution by rational mutagenesis	Drittanti	2003	0		
1456	chr3	114164014	114164042	3500321429	23		114164014	114164042	8421504	3	13,5,5	0,16,23	c,g	350032142900000017,350032142900000017	2-25,2-25		17079310	10.1128/JVI.01759-06	0022-538X	Journal of Virology	Evidence for Persistent, Occult Infection in Neonatal Macaques following Perinatal Transmission of Simian-Human Immunodeficiency Virus SF162P3	Jayaraman	2007	5		
1456	chr3	114164014	114164042	3500222220	23		114164014	114164042	8421504	3	13,5,5	0,16,23	c,g	350022222000000017,350022222000000017	2-25,2-25			10.1128/JVI.01759-06		Journal of Virology	Evidence for Persistent, Occult Infection in Neonatal Macaques following Perinatal Transmission of Simian-Human Immunodeficiency Virus SF162P3 	Pushpa	2007	0		
1456	chr3	114294420	114294447	3500232484	26		114294420	114294447	8421504	2	18,8	0,19	c	350023248400000067	11-37						Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated - Patent # 8524491 - PatentGenius	.patentgenius.com	0	0		
1456	chr3	114294420	114294447	3500065454	26		114294420	114294447	8421504	2	18,8	0,19	c	350006545400000204	11-37						Methods and materials for characterizing and modulating interaction between heregulin and HER3 - US Patent 7314916 Description	ww.patentstorm.us	0	0		
1457	chr3	114349575	114358054	3500371228	945		114349575	114358054	8421504	5	63,87,588,154,53	0,765,855,7665,8426	p	350037122800015015,350037122800015021,350037122800015025	30-972,0-180,0-177						Novel proteins and nucleic acids encoding same	Burgess	2001	0		
1457	chr3	114350412	114350808	3500376096	396		114350412	114350808	8421504	1	396	0	p	350037609600015021,350037609600015030,350037609600015039	0-141,0-150,0-105						Eph receptor ligands and methods of use	Pasquale	2010	0		
1457	chr3	114399130	114410302	3500421823	69		114399130	114410302	8421504	2	33,36	0,11136	c	350042182300000063,350042182300000052	14-47,2-38						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX - Patent application	www.faqs.org	0	0		
1457	chr3	114417836	114417876	3500321684	39		114417836	114417876	8421504	2	10,29	0,11	c	350032168400000015	1-40						EVALUATION OF SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH FERTILITY AND PRODUCTION TRAITS IN HOLSTEIN AND MULTI-GENERATIONAL ANGUS FEMALES	etd.lsu.edu	0	0		
1457	chr3	114419110	114419133	3500084824	23		114419110	114419133	8421504	1	23	0	c	350008482400000144,350008482400000050	0-23,0-23						OVER-EXPRESSION AND MUTATION OF A TYROSINE KINASE RECEPTOR FGFR4 IN TUMORS - Patent application	www.faqs.org	0	0		
1457	chr3	114419110	114419133	3500004338	23		114419110	114419133	8421504	1	23	0	c	350000433800000035	0-23						Over-expression And Mutation Of A Tyrosine Kinase Receptor Fgfr4 In Tumors 	.freshpatents.com	0	0		
1458	chr3	114490417	114500948	3500086063	149		114490417	114500948	8421504	4	43,24,34,48	0,52,10415,10483	c	350008606300000112,350008606300000343,350008606300000148,350008606300000413,350008606300000150	0-43,2-26,28-48,7-41,0-48						Gastrointestinal proliferative foctor and uses thereof - Patent application	www.faqs.org	0	0		
1458	chr3	114490469	114503107	3500184404	143		114490469	114503107	8421504	4	24,46,48,25	0,10363,10410,12613	c	350018440400000343,350018440400000165,350018440400000114,350018440400000413,350018440400000115,350018440400000418	2-26,13-47,1-47,7-41,0-48,10-35						Gastrointestinal proliferative factor and uses thereof - Patent application	www.faqs.org	0	0		
1458	chr3	114500930	114503129	3500059116	192		114500930	114503129	8421504	2	79,113	0,2086	p	350005911600015001	546-738						Mouse Cristin/R-spondin family proteins are novel ligands for the Frizzled8 and LRP6 receptors and activate -catenin-dependent gene expression	www.jbc.org	0	0		
1458	chr3	114501005	114503081	3500293908	69		114501005	114503081	8421504	2	4,65	0,2011	c	350029390800000235,350029390800000238	0-35,0-34						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	hera.ugr.es	0	0		
1458	chr3	114501005	114503081	3500192823	69		114501005	114503081	8421504	2	4,65	0,2011	c	350019282300000235,350019282300000238	0-35,0-34						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	digibug.ugr.es	0	0		
1458	chr3	114503081	114503132	3500263968	51		114503081	114503132	8421504	1	51	0	p	350026396800015137	0-51						Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides - US Patent 7411052 Description	ww.patentstorm.us	0	0		
1458	chr3	114552080	114552108	3500199176	24		114552080	114552108	8421504	3	11,8,5	0,13,23	g	350019917600000023	23-48						HEPATITIS C VIRUS CODON OPTIMIZED NON-STRUCTURAL NS3/4A FUSION GENE - Patent application	www.faqs.org	0	0		
1459	chr3	114620429	114620453	3500176990	24		114620429	114620453	8421504	1	24	0	c	350017699000000014	24-48		23185455	10.1371/journal.pone.0049841		PLoS ONE	MCPIP1 Down-Regulates IL-2 Expression through an ARE-Independent Pathway	Min	2012	0		
1459	chr3	114672897	114672926	3500186557	23		114672897	114672926	8421504	3	6,5,12	0,11,17	g	350018655700000561	0-23						Oligonucleotide for Detection of a Microorganism, Diagnostic Kits and Methods for Detection of Microorganisms Using the Oligonucleotide - Patent application	www.faqs.org	0	0		
1464	chr3	115251184	115251207	3500037971	23		115251184	115251207	8421504	1	23	0	g	350003797100000156	15-45						Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor - Patent application	www.faqs.org	0	0		
1464	chr3	115300540	115300567	3500304200	24		115300540	115300567	8421504	2	15,9	0,18	g	350030420000000303	0-24					Patent	Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use (Patent CN:1578678)	G*Gao 	2010	0		
1464	chr3	115312209	115312237	3500081673	23		115312209	115312237	8421504	3	13,5,5	0,15,23	g	350008167300000411	20-43						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
1467	chr3	115667825	115670153	3500447347	42		115667825	115670153	8421504	2	21,21	0,2307	c,g	350044734700000002,350044734700000002,350044734700000003	0-21,0-21,0-21						Characterization of Differentiation of Bovine Mammary Epithelial Cells	commons.uconn.edu	0	0		
1468	chr3	115745679	115747951	3500037586	156		115745679	115747951	8421504	3	7,86,63	0,1834,2209	p	350003758600015004	9-165						Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies	Ni	2001	0		STK40
1468	chr3	115751068	115756430	3500316425	43		115751068	115756430	8421504	2	21,22	0,5340	c	350031642500000002,350031642500000003	0-21,0-22		20179198	10.1158/0008-5472.CAN-09-3875	0008-5472	Cancer Research	Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers	Creighton	2010	8		STK40
1468	chr3	115788152	115788203	3500245940	51		115788152	115788203	8421504	1	51	0	p	350024594000015056	0-51						Secreted protein HCEJQ69	Brewer	2003	0		SH3D21
1468	chr3	115788152	115788203	3500182039	51		115788152	115788203	8421504	1	51	0	p	350018203900015013	0-51						Secreted protein HCEJQ69	Brewer	2003	0		SH3D21
1469	chr3	115896525	115896553	3500070999	23		115896525	115896553	8421504	2	10,13	0,15	g	350007099900000009	18-41						International Sorghum and Millets Newsletter	oar.icrisat.org	0	0		
1469	chr3	115906324	115906354	3500304944	25		115906324	115906354	8421504	2	18,7	0,23	g	350030494400000278	1-26						Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto - Patent application	www.faqs.org	0	0		
1469	chr3	115926770	115926794	3500399153	23		115926770	115926794	8421504	2	4,19	0,5	c	350039915300000118	15-38						 Method Of Diagnosing Esophageal Cancer 	www.docstoc.com	0	0		
1469	chr3	115926770	115926794	3500288139	23		115926770	115926794	8421504	2	4,19	0,5	c	350028813900000122	18-41						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
1469	chr3	115926770	115926794	3500219109	23		115926770	115926794	8421504	2	4,19	0,5	c	350021910900000122	18-41						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
1469	chr3	115952231	115953566	3500000104	72		115952231	115953566	8421504	2	24,48	0,1287	p	350000010400015193	66-138						Tarantulas and Social Spiders: A Tale of Sex and Silk	.nottingham.ac.uk	0	0		
1469	chr3	115965589	115965612	3500339288	23		115965589	115965612	8421504	1	23	0	c	350033928800000402	0-23						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		TEKT2
1469	chr3	115991243	115995258	3500008270	45		115991243	115995258	8421504	2	9,36	0,3979	p	350000827000015201	0-45						VIRUS INDUCED GENE SILENCING (VIGS) FOR FUNCTIONAL ANALYSIS OF GENES IN COTTON - Patent application	www.faqs.org	0	0		AGO2
1470	chr3	116021447	116021798	3500042587	51		116021447	116021798	8421504	2	3,48	0,303	p	350004258700015056	0-51						Materials and methods DNA constructs and site-directed mutagenesis Human Cell Culture and transfection	a-torlab.cshl.edu	0	0		AGO3
1470	chr3	116059130	116059153	3500069843	23		116059130	116059153	8421504	1	23	0	c	350006984300000004	0-23						microRNA expression profiling of pediatric acute myeloid leukemia patient samples and global identification of Argonaute protein-associated RNAs in respective cell line models	ni-duesseldorf.de	0	0		AGO3
1470	chr3	116119485	116120579	3500405955	45		116119485	116120579	8421504	3	23,4,18	0,455,1076	c	350040595500000039,350040595500000038	0-23,0-22		16943360	10.1095/biolreprod.106.056499	0006-3363	Biology of Reproduction	A Restricted Role for Sperm-Borne MicroRNAs in Mammalian Fertilization	Amanai	2006	4		
1471	chr3	116135038	116139902	3500402790	222		116135038	116139902	8421504	4	87,48,37,50	0,4005,4116,4814	p	350040279000015024,350040279000015017,350040279000015023,350040279000015015,350040279000015021	0-60,0-75,0-75,0-75,0-75						Toward a General Approach for RNA-Templated Hierarchical Assembly of Split-Proteins	.chem.arizona.edu	0	0		
1471	chr3	116244392	116244418	3500065112	24		116244392	116244418	8421504	2	9,15	0,11	g	350006511200000192	13-37					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		CHP2
22	chr3	116378351	116403219	3500153573	40		116378351	116403219	8421504	3	8,12,20	0,24731,24848	c	350015357300000008,350015357300000009	0-20,0-20						Pulmonary haptoglobin and CD163 are functional immunoregulatory elements in the human lung. - ResearchGate	.researchgate.net	0	0		PSMB2
1476	chr3	116838902	116838947	3500424538	45		116838902	116838947	8421504	1	45	0	p	350042453800015000	0-45		23642268	10.1186/1423-0127-20-27	1423-0127	Journal of Biomedical Science	Proteomic analyses and identification of arginine methylated proteins differentially recognized by autosera from anti-Sm positive SLE patients	Chang	2013	0		SFPQ
1476	chr3	116838968	116839025	3500072708	57		116838968	116839025	8421504	1	57	0	p	350007270800015003	3-60						PSPC1, NONO, and SFPQ Are Expressed in Mouse Sertoli Cells and May Function as	ww.biolreprod.org	0	0		SFPQ
1476	chr3	116839005	116839028	3500438824	23		116839005	116839028	8421504	1	23	0	c	350043882400000018	17-40		23175834	10.1523/JNEUROSCI.2636-12.2012	0270-6474	The Journal of Neuroscience	A Polymorphic Microsatellite Repeat within the ECE-1c Promoter Is Involved in Transcriptional Start Site Determination, Human Evolution, and Alzheimer's Disease	Li	2012	7		
1477	chr3	116948534	116948558	3500130848	23		116948534	116948558	8421504	2	9,14	0,10	c	350013084800000911	15-38						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
1477	chr3	116948534	116948558	3500008756	23		116948534	116948558	8421504	2	9,14	0,10	c	350000875600000911	15-38						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
1478	chr3	117067017	117067040	3500356618	23		117067017	117067040	8421504	1	23	0	c,g	350035661800000000,350035661800000000	0-23,0-23		22761992	10.1038/srep00484	xxxx-xxxx	Scientific Reports	Synthesis of two SAPAP3 isoforms from a single mRNA is mediated via alternative translational initiation	Chua	2012	0		DLGAP3
1478	chr3	117144300	117144328	3500343285	23		117144300	117144328	8421504	2	15,8	0,20	g	350034328500000004	0-23						SEQUENCE CHARACTERIZATION AND POLYMORPHISM DETECTION IN EXONS 6, 7 AND 13 OF THE BUBALINE LACTOFERRIN GENE	ibic.lib.ku.ac.th	0	0		
1479	chr3	117206090	117206118	3500329088	24		117206090	117206118	8421504	3	11,5,8	0,12,20	c	350032908800000098	17-41						Expression cassettes for seed-preferential expression in plants - US Patent 7790873 Description	ww.patentstorm.us	0	0		
1484	chr3	117860129	117860446	3500166204	283		117860129	117860446	8421504	7	11,4,11,83,73,18,83	0,12,19,31,115,189,234	g	350016620400000048	0-312						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1486	chr3	118133650	118133674	3500143808	23		118133650	118133674	8421504	2	17,6	0,18	g	350014380800000012	21-44						E6AP antisense constructs and methods of use	Beer-romero	1995	0		
1487	chr3	118276382	118276405	3500360910	23		118276382	118276405	8421504	1	23	0	g	350036091000000004	7-30						US Patent # 5,831,064. Kaposi's sarcoma-associated herpes virus (KSHV) interferon consensus sequence binding protein (ICSBP) and uses thereof - Patents.com	www.patents.com	0	0		
1487	chr3	118353040	118353064	3500037834	23		118353040	118353064	8421504	2	8,15	0,9	g	350003783400000026	1-24						GENES AND POLYPEPTIDES RELATING TO HUMAN PANCREATIC CANCERS - Patent application	www.faqs.org	0	0		
1489	chr3	118554104	118554275	3500228180	68		118554104	118554275	8421504	2	7,61	0,110	g	350022818000000169	0-68						Polypeptides and nucleic acids encoding same	Fernandes	2001	0		
1490	chr3	118670999	118671024	3500116822	23		118670999	118671024	8421504	2	16,7	0,18	g	350011682200000012,350011682200000105	1-24,1-24						Secreted And Transmembrane Polypeptides And Nucleic Acids Encoding The Same 	.freshpatents.com	0	0		
1490	chr3	118670999	118671024	3500104360	23		118670999	118671024	8421504	2	16,7	0,18	g	350010436000000014	1-24						Polypeptides and nucleic acids encoding the same	Baker	2001	0		
1490	chr3	118670999	118671024	3500102405	23		118670999	118671024	8421504	2	16,7	0,18	g	350010240500000014	1-24						Polypeptides and nucleic acids encoding the same	Baker	2000	0		
1491	chr3	118812829	118812853	3500059999	24		118812829	118812853	8421504	1	24	0	c	350005999900000002	12-36		20670374	10.1111/j.1471-4159.2010.06930.x	1471-4159	Journal of Neurochemistry	GIGYF2 is present in endosomal compartments in the mammalian brains and enhances IGF-1-induced ERK1/2 activation - Higashi - 2010 - Journal of Neurochemistry - Wiley Online Library	Higashi	2010	0		
1491	chr3	118867344	118867371	3500318712	24		118867344	118867371	8421504	2	12,12	0,15	c	350031871200000000	0-24						Repair and regeneration of ocular tissue using postpartum umbilical cord-derived cells	Mistry	2011	0		
1491	chr3	118872566	118872590	3500408981	24		118872566	118872590	8421504	1	24	0	c	350040898100000013	11-35						4 Materials and Methods	diss.fu-berlin.de	0	0		
1492	chr3	118908110	118910430	3500310861	48		118908110	118910430	8421504	2	45,3	0,2317	p	350031086100015024	3-51						<Html><Title> Complet list of 1zwm hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		
1493	chr3	119118167	119118195	3500156776	24		119118167	119118195	8421504	3	4,5,15	0,5,13	g	350015677600000050	24-48						MAGE-A3 PEPTIDES PRESENTED BY HLA-DR1 MOLECULES - Patent application	www.faqs.org	0	0		
1495	chr3	119351714	119380227	3500128647	551		119351714	119380227	8421504	17	23,4,20,44,21,19,30,24,54,65,138,28,14,44,4,16,3	0,4486,6844,10448,12110,12161,13331,14327,14357,16315,18752,20964,23826,25675,25727,28379,28510	p,c,g	350012864700000012,350012864700000032,350012864700000027,350012864700000019,350012864700015014,350012864700015015,350012864700015016,350012864700000015,350012864700000015,350012864700015017,350012864700015018,350012864700015019,350012864700015021,350012864700000025,350012864700000031,350012864700000009	8-31,0-24,0-65,0-19,0-54,0-54,0-51,0-20,0-20,0-60,0-60,0-60,0-54,6-28,0-21,12-35						Arrestin hetero/oge Expression/l Mutagenese und biophy,sikalische Untersuchungen	z-juelich.de:8080	0	0		
1495	chr3	119370578	119372706	3500104165	54		119370578	119372706	8421504	2	26,28	0,2100	p	350010416500015066	0-54						The detection and role of human endogenous retroviruses in multiple sclerosis and other neurological diseases	penrepository.com	0	0		
1496	chr3	119426238	119426262	3500370232	23		119426238	119426262	8421504	2	5,18	0,6	g	350037023200000104	9-34						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
187	chr3	119626408	119743417	3500077888	83		119626408	119743417	8421504	5	20,9,19,19,16	0,668,110425,110477,116993	c,g	350007788800000010,350007788800000010,350007788800000033,350007788800000030,350007788800000030,350007788800000031,350007788800000031	0-20,0-20,0-25,0-19,0-19,0-19,0-19						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1498	chr3	119736479	119736505	3500214027	26		119736479	119736505	8421504	1	26	0	c	350021402700000002	4-30		15932951	10.1124/dmd.105.005157	1521-009X (Online)	Drug Metabolism and Disposition	EXPRESSION OF HUMAN PHASE II ENZYMES IN CHIMERIC MICE WITH HUMANIZED LIVER	Katoh	2005	0		
1498	chr3	119737084	119737107	3500347090	23		119737084	119737107	8421504	1	23	0	c	350034709000000002	0-23		16135700	10.1124/jpet.105.090795	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Differential UGT1A1 Induction by Chrysin in Primary Human Hepatocytes and HepG2 Cells	Smith	2005	0		
1498	chr3	119737084	119737107	3500237576	23		119737084	119737107	8421504	1	23	0	c	350023757600000002	0-23		16135700	10.1124/jpet.105.090795	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Differential UGT1A1 Induction by Chrysin in Primary Human Hepatocytes and HepG2 Cells	Smith	2005	0		
1498	chr3	119746395	119746440	3500069335	45		119746395	119746440	8421504	1	45	0	p	350006933500015038	0-45						AVERTISSEMENT	.scd.uhp-nancy.fr	0	0		
187	chr3	119910652	119988931	3500100439	445		119910652	119988931	8421504	11	55,3,3,17,101,60,60,17,43,52,34	0,61,3897,3954,9238,20016,29102,55141,56426,58543,78245	p,c,g	350010043900000002,350010043900015003,350010043900000005,350010043900000020,350010043900000023,350010043900000045,350010043900000050,350010043900000055,350010043900000055	1-62,0-60,0-60,0-60,0-60,0-60,0-52,0-34,0-34						Canine cold-and menthol-sensitive receptor 1	Flores	2005	0		
187	chr3	119910652	119988931	3500099501	445		119910652	119988931	8421504	11	55,3,3,17,101,60,60,17,43,52,34	0,61,3897,3954,9238,20016,29102,55141,56426,58543,78245	p,c,g	350009950100000002,350009950100015003,350009950100000005,350009950100000019,350009950100000022,350009950100000044,350009950100000049,350009950100000054,350009950100000054	1-62,0-60,0-60,0-60,0-60,0-60,0-52,0-34,0-34						Canine cold- and menthol-sensitive receptor 1	Flores	2005	0		
1500	chr3	119951301	119951329	3500159555	28		119951301	119951329	8421504	1	28	0	c,g	350015955500000003,350015955500000003	0-28,0-28						Simone Kaiser: Identification and Characterization of the Ion Channel TRPM8 in Prostate Cancer	edoc.hu-berlin.de	0	0		
1500	chr3	119952245	119952268	3500015213	23		119952245	119952268	8421504	1	23	0	c	350001521300000046	19-42						P53 binding T cell receptor molecules - Patent # 7456263 - PatentGenius	.patentgenius.com	0	0		
1500	chr3	119969153	119969176	3500191855	23		119969153	119969176	8421504	1	23	0	c	350019185500000000	0-23			10.1113/jphysiol.2005.086546	0022-3751	The Journal of Physiology	The contribution of TRPM8 channels to cold sensing in mammalian neurones	Pena	2005	5		TRPM8
1500	chr3	119996732	119996756	3500348878	24		119996732	119996756	8421504	1	24	0	c	350034887800000015	1-25						Metabolic Method To Identify Compounds	Schilling	2008	0		
1500	chr3	119996732	119996756	3500276787	24		119996732	119996756	8421504	1	24	0	c	350027678700000015	1-25						Metabolic method to identify flavours and/or fragrances	Schilling	2006	0		
1500	chr3	119996732	119996756	3500111486	24		119996732	119996756	8421504	1	24	0	c	350011148600000015	1-25						Metabolic method to identify flavours and/or fragrances	Schilling	2007	0		
1500	chr3	119996738	119996761	3500409323	23		119996738	119996761	8421504	1	23	0	g	350040932300000005	0-23		15911692	10.1124/mol.105.012146	1521-0111 (Online)	Molecular Pharmacology	Conservation of Functional and Pharmacological Properties in the Distantly Related Temperature Sensors TRPV1 and TRPM8	Weil	2005	0		SNORA31
1500	chr3	119996738	119996761	3500208923	23		119996738	119996761	8421504	1	23	0	g	350020892300000005	0-23						Conservation of Functional and Pharmacological Properties in the Distantly Related Temperature Sensors TRPV1 and TRPM8--&#x300a;&#x5206;&#x5b50;&#x836f;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x	journal.9med.net	0	0		
1503	chr3	120431354	120431380	3500347059	24		120431354	120431380	8421504	2	19,5	0,21	g	350034705900000064	24-48					Patent	Process for producing 7-aminocephem compound or salts thereof (Patent US:5677141)	Aramori	1997	0		
1503	chr3	120445910	120445933	3500440489	23		120445910	120445933	8421504	1	23	0	c	350044048900000193	4-27						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
1505	chr3	120641422	120641450	3500426503	25		120641422	120641450	8421504	3	6,15,4	0,8,24	g	350042650300000022	11-36						Expression profile of components of the acetylcholine-system in rat testicular tissue and function in non-germ cell populations	eb.uni-giessen.de	0	0		
1511	chr3	121499457	121499492	3500068199	26		121499457	121499492	8421504	3	7,13,6	0,12,29	g	350006819900000568	4-31						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
1513	chr3	121715652	121715679	3500346733	24		121715652	121715679	8421504	2	15,9	0,18	g	350034673300000087	13-39						Tissue specific transcriptional regulatory element	Breitman	1992	0		
1516	chr3	122081874	122081901	3500379838	25		122081874	122081901	8421504	3	13,6,6	0,14,21	g	350037983800000048	9-34						Preventive And Therapeutic Vaccine For Huntington's Disease - Patent application	www.faqs.org	0	0		
1516	chr3	122128779	122128884	3500003595	105		122128779	122128884	8421504	1	105	0	p	350000359500015001,350000359500015007	0-105,0-102						Analyse der Expression des proliferationsassoziierten Proteins P8 in Betazellen des endokrinen Pankreas	.uni-wuerzburg.de	0	0		AGAP3
1517	chr3	122265753	122265779	3500419977	23		122265753	122265779	8421504	3	4,13,6	0,5,20	g	350041997700000000	15-38		22686419	10.1186/1423-0127-19-57	1423-0127	Journal of Biomedical Science	Epigeneitc silencing of ribosomal RNA genes by Mybbp1a	Tan	2012	0		
1519	chr3	122538739	122538764	3500363399	25		122538739	122538764	8421504	1	25	0	c	350036339900000000	14-39					Neoplasia (New York, N.Y.)	Imaging Ligand-Dependent Activation of CXCR7	Kathryn	2009	0		
1519	chr3	122539366	122539390	3500120545	23		122539366	122539390	8421504	2	14,9	0,15	c	350012054500000180	17-40						DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS	St.	2007	0		
1519	chr3	122539580	122539730	3500256306	40		122539580	122539730	8421504	2	20,20	0,130	c	350025630600000004,350025630600000005	0-20,0-20		22152016	10.1186/bcr3074		Breast Cancer Research : BCR	Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis	Lorena	2011	0		
1519	chr3	122539626	122539827	3500325807	201		122539626	122539827	8421504	1	201	0	p	350032580700015008	0-201						Reagents that bind ccx-ckr2	Howard	2008	0		
1519	chr3	122539626	122539827	3500095884	201		122539626	122539827	8421504	1	201	0	p	350009588400015008	0-201						Reagents that bind ccx-ckr2	Howard	2006	0		
1524	chr3	123135653	123135679	3500358730	23		123135653	123135679	8421504	2	18,5	0,21	g	350035873000000027,350035873000000067	2-27,2-27						Building IP: Patent Application re "Methods and Compositions of the HPRT Locus" | SGMO Message Board Posts	vestorvillage.com	0	0		
1527	chr3	123512169	123512193	3500292021	23		123512169	123512193	8421504	2	18,5	0,19	c	350029202100000009	17-40					Patent	ARF-p19, a novel regulator of the mammalian cell cycle (Patent US:5723313)	Quelle	1998	0		
1527	chr3	123512169	123512193	3500006943	23		123512169	123512193	8421504	2	18,5	0,19	c	350000694300000011	17-40						ARF-P19, a novel regulator of the mammalian cell cycle	Sherr	1998	0		
1527	chr3	123538287	123539068	3500375967	309		123538287	123539068	8421504	2	100,209	0,572	p,c,g	350037596700015010,350037596700000029,350037596700000029,350037596700000008,350037596700000059,350037596700000033,350037596700000033,350037596700015003,350037596700015002,350037596700015005,350037596700000058,350037596700000035,350037596700015006,350037596700000057,350037596700000036,350037596700000036,350037596700000048,350037596700000046,350037596700000046,350037596700000044,350037596700000044,350037596700000030,350037596700000042,350037596700000042,350037596700000040,350037596700000040,350037596700015012,350037596700000031,350037596700000031,350037596700015013,350037596700000032,350037596700000032,350037596700000009	0-48,0-120,0-120,10-32,0-27,0-60,0-60,0-93,0-93,0-69,0-28,0-20,0-60,0-20,0-27,0-27,0-36,0-33,0-33,0-30,0-30,0-40,0-23,0-23,0-20,0-20,0-48,0-50,0-50,0-48,0-54,0-54,0-24						Ligand polypeptides for the g-protein-coupled receptor protein, their production and use	Fujii	1997	0		
1527	chr3	123538287	123539068	3500088269	139		123538287	123539068	8421504	4	22,34,59,24	0,66,572,757	p,c,g	350008826900000008,350008826900015004,350008826900015007,350008826900000009	10-32,0-93,0-45,0-24					Patent	Polypeptides, their production and use (Patent US:6794491)	Hinuma	2004	0		
1527	chr3	123538287	123539068	3500021968	284		123538287	123539068	8421504	4	100,65,50,69	0,572,652,712	p,c,g	350002196800000016,350002196800015018,350002196800000114,350002196800000058,350002196800000058,350002196800000112,350002196800015004,350002196800000062,350002196800000062,350002196800015010,350002196800000111,350002196800015012,350002196800000070,350002196800000110,350002196800000071,350002196800000095,350002196800000085,350002196800000087,350002196800000075,350002196800000075,350002196800000083,350002196800000083,350002196800000060,350002196800000061,350002196800000061,350002196800000017	10-32,0-45,10-32,0-120,0-120,0-27,0-93,0-60,0-60,0-69,0-28,0-60,0-20,0-20,0-27,0-36,0-30,0-33,0-20,0-20,0-23,0-23,0-50,0-54,0-54,0-24						Ligand polypeptides for the G-protein-coupled receptor protein, their production and use	Ri Zhao Zhou Si 	1999	0		
1527	chr3	123538287	123539053	3500365204	294		123538287	123539053	8421504	2	100,194	0,572	p,c,g	350036520400000034,350036520400000034,350036520400015014,350036520400000008,350036520400015016,350036520400015004,350036520400015026,350036520400000038,350036520400000038,350036520400015035,350036520400015018,350036520400015009,350036520400015030,350036520400000040,350036520400000063,350036520400015036,350036520400015034,350036520400000035,350036520400000045,350036520400000045,350036520400000047,350036520400000047,350036520400015020,350036520400000036,350036520400000036,350036520400015021,350036520400015023,350036520400000037,350036520400000037	0-120,0-120,0-48,10-32,0-48,0-93,0-48,0-60,0-60,0-45,0-48,0-60,0-48,0-20,0-20,0-48,0-45,0-40,0-20,0-20,0-23,0-23,0-48,0-50,0-50,0-48,0-48,0-54,0-54						PROLACTIN SECRETION MODULATOR - TAKEDA CHEMICAL INDUSTRIES, LTD.	www.sumobrain.com	0	0		
1527	chr3	123538287	123538918	3500288951	115		123538287	123538918	8421504	3	22,34,59	0,66,572	p,c	350028895100000008,350028895100015002,350028895100015005,350028895100000037,350028895100000029,350028895100000036	10-32,0-93,0-69,0-28,0-20,0-20					Patent	Ligand polypeptides for the pituitary g-protein-coupled receptor protein, their production and use (Patent EP:0870020)	Fujii	2006	0		PRLH
1527	chr3	123538386	123538918	3500419077	60		123538386	123538918	8421504	2	1,59	0,473	p	350041907700015020	0-60						Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity	www.pnas.org	0	0		PRLH
1527	chr3	123538386	123538918	3500268814	60		123538386	123538918	8421504	2	1,59	0,473	p	350026881400015001	0-60		23096363	10.4067/S0716-97602012000200011	0716-9760	Biological Research	Biological Research - Structurally conserved C-RFa revealed prolactin releasing activity in vitro and gene expression changes in pituitary of seasonally acclimatized carp	Romero	2012	1		PRLH
1529	chr3	123737423	123761523	3500006313	42		123737423	123761523	8421504	4	9,13,14,6	0,12,24076,24094	g	350000631300000002,350000631300000064	1-23,10-30						METHODS FOR SELECTIVE ERADICATION OF METASTASIZING CANCER CELLS EX VIVO USING MULTIDOMAIN BIOTAGS - Patent application	www.faqs.org	0	0		
191	chr3	123853723	123884898	3500333181	23		123853723	123884898	8421504	2	8,15	0,31160	c	350033318100000004	0-23						Pharmacological and Kinetic Characterization of Adrenomedullin 1 and Calcitonin Gene-Related Peptide 1 Receptor Reporter Cell Lines S	aspetjournals.org	0	0		
1531	chr3	124039815	124039850	3500173250	31		124039815	124039850	8421504	3	9,4,18	0,12,17	g	350017325000000246,350017325000000239	3-34,6-28						Engineered Listeria and methods of use thereof	Dubensky	2006	0		
1531	chr3	124082823	124082847	3500445420	23		124082823	124082847	8421504	2	13,10	0,14	c	350044542000000009	0-23			10.1093/emboj/20.9.2160	ERROR! NO ISSN	The EMBO Journal	Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1	Leung-Hagesteijn	2001	0		
1531	chr3	124121517	124121545	3500114875	24		124121517	124121545	8421504	2	10,14	0,14	c	350011487500000004,350011487500000005	0-34,0-34		17065448	10.1523/JNEUROSCI.1358-06.2006	0270-6474	The Journal of Neuroscience	Hes6 Inhibits Astrocyte Differentiation and Promotes Neurogenesis through Different Mechanisms	Jhas	2006	7		
1532	chr3	124158955	124158978	3500286401	23		124158955	124158978	8421504	1	23	0	c	350028640100000092	1-24						Characterization of the equine skeletal muscle transcriptome identifies novel functional responses to exercise training	biomedcentral.com	0	0		
1534	chr3	124454334	124454363	3500455772	24		124454334	124454363	8421504	2	17,7	0,22	g	350045577200000006	0-24					Patent	Process for the production of infectious negative-strand RNA viruses (Patent EP:0780475)	Billeter	2006	0		
1534	chr3	124454334	124454363	3500379992	24		124454334	124454363	8421504	2	17,7	0,22	g	350037999200000006	0-24						cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS	Billeter	1997	0		
1535	chr3	124551213	124551240	3500251913	27		124551213	124551240	8421504	1	27	0	g	350025191300000019,350025191300000018	0-27,0-25		19074907	10.1158/0008-5472.CAN-08-1444	0008-5472	Cancer Research	Epithelial-Mesenchymal Transition Induced by Growth Suppressor p12CDK2-AP1 Promotes Tumor Cell Local Invasion but Suppresses Distant Colony Growth	Tsuji	2008	8		
1537	chr3	124889319	124889349	3500310954	25		124889319	124889349	8421504	2	17,8	0,22	g	350031095400000027	0-25						Novel peptides comprising repetitive units of amino acids and DNA sequences encoding the same - Patent application	www.faqs.org	0	0		
1538	chr3	125042063	125042091	3500454832	23		125042063	125042091	8421504	2	6,17	0,11	g	350045483200000039	6-29						Systematic evolution of ligands by exponential enrichment: tissue selex	Heilig	2002	0		
1538	chr3	125042063	125042091	3500406595	23		125042063	125042091	8421504	2	6,17	0,11	g	350040659500000039	6-29						 Systematic Evolution Of Ligands By Exponential Enrichment: Tissue SELEX 	www.docstoc.com	0	0		
1542	chr3	125531363	125531391	3500136890	26		125531363	125531391	8421504	2	5,21	0,7	c,g	350013689000000005,350013689000000005	4-30,4-30		19942931	10.1038/cdd.2009.167	1350-9047	Cell Death & Differentiation	Mtd&sol;Bok takes a swing: proapoptotic Mtd&sol;Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia	Ray	2009	9		
1542	chr3	125534212	125541591	3500049463	49		125534212	125541591	8421504	2	24,25	0,7354	c,g	350004946300000000,350004946300000000,350004946300000001	0-24,0-24,0-25			10.1590/S0102-09352010000200003	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Apoptosis and expression of Bcl-2 and caspases 3 and 8 in placenta of cows at different pregnancy stages	Meca	2010	0		
1542	chr3	125542502	125542574	3500138361	72		125542502	125542574	8421504	1	72	0	p	350013836100015001	0-72						Bcl-2-like polynucleotides, polypeptides, and antibodies	Duan	2001	0		BOK
1543	chr3	125657811	125657834	3500227613	23		125657811	125657834	8421504	1	23	0	g	350022761300000211	14-40						IMMUNODOMINANT MYCOBACTERIUM TUBERCULOSIS PEPTIDES FROM CELL WALL PROTEINS FOR EARLY DIAGNOSIS AND IMMUNIZATION - Patent application	www.faqs.org	0	0		
1543	chr3	125657971	125664339	3500447453	109		125657971	125664339	8421504	6	1,44,19,4,21,20	0,365,1607,3790,3951,6348	p,c,g	350044745300015004,350044745300000015,350044745300000016,350044745300000016,350044745300000005	0-45,0-23,0-21,0-21,9-29		15140988	10.1128/JVI.78.11.5900-5912.2004	0022-538X	Journal of Virology	Processing of a Pestivirus Protein by a Cellular Protease Specific for Light Chain 3 of Microtubule-Associated Proteins	Fricke	2004	5		
1543	chr3	125662580	125662606	3500101184	24		125662580	125662606	8421504	2	13,11	0,15	c	350010118400000044	0-24					Patent	METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE (Patent EP:1076097)	Ohsuye	2008	0		
1543	chr3	125690422	125694699	3500009342	93		125690422	125694699	8421504	3	33,12,48	0,1281,4229	p	350000934200015008,350000934200015015	0-45,0-48						HERPES SIMPLEX VIRUSES AND METHODS OF VIRAL REPLICATION - Patent application	www.faqs.org	0	0		ING5
1544	chr3	125740719	125740742	3500279845	23		125740719	125740742	8421504	1	23	0	g	350027984500000063	0-28						GUANOSINE TRIPHOSPHATE (GTP)-BINDING PROTEIN-COUPLED RECEPTOR PROTEIN, BG37 - Patent application	www.faqs.org	0	0		
1545	chr3	125900932	125900958	3500225213	24		125900932	125900958	8421504	2	5,19	0,7	g	350022521300000018	20-46					Patent	Cortistatin: nucleic acids that encode these neuropeptides (Patent US:6074872)	Lecea	2000	0		
1546	chr3	126044538	126044567	3500255012	24		126044538	126044567	8421504	3	4,14,6	0,5,23	g	350025501200000173	13-38						Omega-amino carboxylic acids, omega-amino carboxylic acid esters, or recombinant cells which produce lactams thereof	A*Qia Lao 	2009	0		
1547	chr3	126157011	126157041	3500328917	24		126157011	126157041	8421504	3	5,5,14	0,8,16	g	350032891700000018	11-35						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
1548	chr3	126301931	126301954	3500440739	23		126301931	126301954	8421504	1	23	0	c	350044073900000159,350044073900000047	13-36,19-41						5' to 3' exonuclease mutations of thermostable DNA polymerases	Abramson	1993	0		
1548	chr3	126301931	126301954	3500384749	23		126301931	126301954	8421504	1	23	0	c	350038474900000157,350038474900000053	13-36,19-41						5' to 3' exonuclease mutations of thermostable DNA polymerases - Patent # 5795762 - PatentGenius	.patentgenius.com	0	0		
1548	chr3	126301931	126301954	3500321554	23		126301931	126301954	8421504	1	23	0	c	350032155400000047,350032155400000155	19-41,13-36						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1993	0		
1548	chr3	126301931	126301954	3500279401	23		126301931	126301954	8421504	1	23	0	c	350027940100000155,350027940100000047	13-36,19-41						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1992	0		
1549	chr3	126436080	126436106	3500053741	23		126436080	126436106	8421504	3	6,5,12	0,7,14	g	350005374100000000	21-44						Vascular remodeling in pulmonary hypertension	arno.unimaas.nl	0	0		
1549	chr3	126475443	126475470	3500199176	24		126475443	126475470	8421504	2	19,5	0,22	g	350019917600000053	3-27						HEPATITIS C VIRUS CODON OPTIMIZED NON-STRUCTURAL NS3/4A FUSION GENE - Patent application	www.faqs.org	0	0		
1552	chr3	126771945	126771973	3500370232	23		126771945	126771973	8421504	3	7,5,11	0,11,17	g	350037023200000084	25-48						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
1552	chr3	126823660	126823683	3500244830	23		126823660	126823683	8421504	1	23	0	g	350024483000000397	0-34						METHODS FOR LOWERING SERUM CHOLESTROL IN A SUBJECT USING INHIBITION OF PCSK9 - ALNYLAM PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
594	chr4	1219672	1219696	3500113105	23		1219672	1219696	8421504	2	4,19	0,5	g	350011310500000000	7-30		9786922	10.1074/jbc.273.44.29135	0021-9258	Journal of Biological Chemistry	Anchor Structure of Staphylococcal Surface Proteins	Navarre	1998	5		
602	chr4	2251270	2251295	3500085878	25		2251270	2251295	8421504	1	25	0	g	350008587800000084	12-37						Method for modifying chromosomes	Hanaoka	2011	0		
619	chr4	4556032	4556056	3500284078	23		4556032	4556056	8421504	2	10,13	0,11	g	350028407800000006	0-23						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
619	chr4	4556032	4556056	3500268568	23		4556032	4556056	8421504	2	10,13	0,11	g	350026856800000006	0-23						Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-Cadherin	www.mdpi.com	0	0		
619	chr4	4556032	4556056	3500146447	23		4556032	4556056	8421504	2	10,13	0,11	g	350014644700000006	0-23						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
623	chr4	4998263	4998291	3500108433	24		4998263	4998291	8421504	2	6,18	0,10	g	350010843300000076	5-29					Patent	Secreted factors (Patent US:6800455)	Stanton	2004	0		
623	chr4	5012700	5012724	3500073470	23		5012700	5012724	8421504	2	9,14	0,10	g	350007347000000092	8-32						COMBINATION METHODS OF INHIBITING TUMOR GROWTH WITH A VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTAGONIST - Patent application	www.faqs.org	0	0		
624	chr4	5237125	5237148	3500360452	23		5237125	5237148	8421504	1	23	0	c	350036045200000026	0-23		8626808	10.1074/jbc.271.8.4528	0021-9258	Journal of Biological Chemistry	Tissue-specific Expression of the Nonneuronal Promoter of the Aromatic L-Amino Acid Decarboxylase Gene Is Regulated by Hepatocyte Nuclear Factor 1	Aguanno	1996	5		DDC
625	chr4	5302528	5302560	3500271222	26		5302528	5302560	8421504	3	4,7,15	0,5,17	g	350027122200000128	10-37						Oligonucleotides complementary to mycobacterial nucleic acids	Liu	1993	0		
625	chr4	5358749	5358781	3500113379	26		5358749	5358781	8421504	3	12,6,8	0,15,24	g	350011337900000016	21-47						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
626	chr4	5476852	5476927	3500214246	75		5476852	5476927	8421504	1	75	0	p	350021424600015018,350021424600015053	0-75,0-57						Alignement multiple ClustalW	polytech.unice.fr	0	0		IKZF1
626	chr4	5476858	5476906	3500244161	48		5476858	5476906	8421504	1	48	0	p	350024416100015012	0-48						Helene Touzet	www.lifl.fr	0	0		IKZF1
626	chr4	5494881	5494950	3500385351	69		5494881	5494950	8421504	1	69	0	p	350038535100015188,350038535100015053	0-69,21-90						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		IKZF1
626	chr4	5494881	5494950	3500238410	69		5494881	5494950	8421504	1	69	0	p	350023841000015056	0-69						Zinc finger domains and methods of identifying same	Hwang	2007	0		IKZF1
626	chr4	5494881	5494950	3500176901	69		5494881	5494950	8421504	1	69	0	p	350017690100015049	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		IKZF1
626	chr4	5494881	5494950	3500160097	69		5494881	5494950	8421504	1	69	0	p	350016009700015052	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		IKZF1
626	chr4	5494881	5494950	3500081197	69		5494881	5494950	8421504	1	69	0	p	350008119700015146	0-69					Patent	Zink-Finger Dom&#xe4;nen und Verfahren zur Identifizierung derselben Zinc finger domains and the same method for identifying (Patent DE:60127819)	Hwang	2007	0		IKZF1
626	chr4	5494881	5494950	3500068714	69		5494881	5494950	8421504	1	69	0	p	350006871400015067	0-69					Patent	Zinc finger domains and methods of identifying same (Patent CN:1416467)	Quan Zhu Dao 	2012	0		IKZF1
627	chr4	5543624	5543656	3500343738	27		5543624	5543656	8421504	4	4,4,12,7	0,5,10,25	g	350034373800000035	8-35			10.1111/j.1742-4658.2005.04890.x	1742-4658	FEBS Journal	15-Deoxy &#x0394;12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor &#x03b3; in human erythroleukemia cells - Coyle - 2005 - FEBS Journal - Wiley Onlin	Coyle	2005	0		
632	chr4	6165927	6165952	3500106418	24		6165927	6165952	8421504	2	4,20	0,5	g	350010641800000011	5-29						Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids	Hildinger	2001	0		
642	chr4	7548440	7549452	3500349544	44		7548440	7549452	8421504	2	22,22	0,990	c	350034954400000009,350034954400000003	0-22,0-22		18302287	10.1002/hep.22084	1527-3350	Hepatology	Wnt2 acts as a cell type&#x2013;specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway - Klein - 2007 - Hepatology - Wiley Online Library	Klein	2008	0		
646	chr4	8052420	8052446	3500185070	23		8052420	8052446	8421504	2	6,17	0,9	g	350018507000000363	7-30						Neisserial Antigens 	.freshpatents.com	0	0		
80	chr4	8095620	8134827	3500364476	144		8095620	8134827	8421504	2	64,80	0,39127	p	350036447600015047,350036447600015044,350036447600015086	0-48,0-48,0-48						Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof - Patent # 6900042 - PatentGenius	.patentgenius.com	0	0		CDK14
652	chr4	8885656	8885683	3500061628	26		8885656	8885683	8421504	2	4,22	0,5	g	350006162800000155	21-47						Method For Diagnosing Non-small Cell Lung Cancer 	.freshpatents.com	0	0		
657	chr4	9463128	9463727	3500047878	40		9463128	9463727	8421504	2	20,20	0,579	c,g	350004787800000033,350004787800000033,350004787800000032,350004787800000032	0-20,0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
658	chr4	9643166	9643191	3500131528	23		9643166	9643191	8421504	2	7,16	0,9	g	350013152800000004	0-23						Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation	biomedcentral.com	0	0		
659	chr4	9705324	9710181	3500306083	48		9705324	9710181	8421504	2	24,24	0,4833	p	350030608300015024	0-48						Nature June 2 ,2011	www.calameo.com	0	0		ANKIB1
659	chr4	9710193	9710238	3500466964	45		9710193	9710238	8421504	1	45	0	p	350046696400015006	0-45						Structure of the human Parkin ligase domain in an autoinhibited state	mrc-lmb.cam.ac.uk	0	0		ANKIB1
660	chr4	9830601	9839152	3500114661	23		9830601	9839152	8421504	2	17,6	0,8545	c	350011466100000011	0-23						Dynamic and Functional Assembly of the AAA Peroxins, Pex1p and Pex6p, and Their Membrane Receptor Pex26p--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&	journal.9med.net	0	0		
82	chr4	9940757	10187712	3500369536	978		9940757	10187712	8421504	7	144,136,51,110,168,136,233	0,6294,11366,69996,132267,182909,246722	p	350036953600015000	0-978						KEGG T01001: 1021	www.genome.jp	0	0		CDK6
82	chr4	9940757	10187712	3500097339	978		9940757	10187712	8421504	7	144,136,51,110,168,136,233	0,6294,11366,69996,132267,182909,246722	p	350009733900015001	0-978						KEGG T01001: 1019	www.genome.jp	0	0		CDK6
660	chr4	9947141	9947165	3500011784	24		9947141	9947165	8421504	1	24	0	c	350001178400000011	0-24					International Journal of Molecular Sciences	Lewis y Regulate Cell Cycle Related Factors in Ovarian Carcinoma Cell RMG-I in Vitro via ERK and Akt Signaling Pathways - Scolaris	Liu	2012	0		CDK6
661	chr4	10073081	10073106	3500405955	25		10073081	10073106	8421504	1	25	0	c	350040595500000034	0-25		16943360	10.1095/biolreprod.106.056499	0006-3363	Biology of Reproduction	A Restricted Role for Sperm-Borne MicroRNAs in Mammalian Fertilization	Amanai	2006	4		
662	chr4	10187520	10187565	3500110315	45		10187520	10187565	8421504	1	45	0	p	350011031500015042	0-45						TARGETING CDK4 AND CDK6 IN CANCER THERAPY - Patent application	www.faqs.org	0	0		CDK6
662	chr4	10187626	10187649	3500051318	23		10187626	10187649	8421504	1	23	0	c	350005131800000000	0-23						ORIGINAL ARTICLE Survey of the Human Pancreatic -Cell G1/S Proteome Reveals a Potential Therapeutic Role for Cdk-6 and 1 in Enhancing Human -Cell Replication and Function In Vivo	betesjournals.org	0	0		
667	chr4	10802815	10813931	3500274037	60		10802815	10813931	8421504	3	20,20,20	0,2364,11096	c,g	350027403700000027,350027403700000027,350027403700000026,350027403700000026,350027403700000025,350027403700000025	0-20,0-20,0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
670	chr4	11194417	11194441	3500217315	24		11194417	11194441	8421504	1	24	0	c	350021731500000073	0-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		
670	chr4	11197248	11197534	3500328917	33		11197248	11197534	8421504	2	30,3	0,283	c	350032891700000238	1-34						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
670	chr4	11218448	11224752	3500218890	49		11218448	11224752	8421504	2	24,25	0,6279	c,g	350021889000000072,350021889000000073,350021889000000073	24-48,13-38,13-38						Method for linking sequences of interest	Andersen	2007	0		
670	chr4	11218448	11224752	3500175657	49		11218448	11224752	8421504	2	24,25	0,6279	c	350017565700000052,350017565700000053	24-48,13-38						Method for Linking Sequences of Interest	Andersen	2010	0		GNGT1
670	chr4	11218448	11224752	3500140018	49		11218448	11224752	8421504	2	24,25	0,6279	c	350014001800000170,350014001800000172	24-48,13-38						Method for linking sequences of interest	M*B*Ao Lie Ke Xi Wei Qi 	2006	0		GNGT1
670	chr4	11218448	11224752	3500095670	49		11218448	11224752	8421504	2	24,25	0,6279	c	350009567000000072,350009567000000073	24-48,13-38					Patent	Method for linking sequences of interest (Patent US:7749697)	Andersen	2010	0		
670	chr4	11218448	11224752	3500086850	49		11218448	11224752	8421504	2	24,25	0,6279	c	350008685000000139,350008685000000033,350008685000000140,350008685000000034	24-48,24-48,13-38,13-38					Patent	Method for linking sequences of interest (Patent EP:1921144)	Andersen	2011	0		GNGT1
674	chr4	11773602	11774071	3500267902	69		11773602	11774071	8421504	3	5,44,20	0,6,449	c,g	350026790200000035,350026790200000004,350026790200000004	0-49,0-20,0-20		21746880	10.1128/MCB.05263-11	0270-7306	Molecular and Cellular Biology	A Novel Role of Vimentin Filaments: Binding and Stabilization of Collagen mRNAs	Challa	2011	6		
674	chr4	11773609	11773632	3500192133	23		11773609	11773632	8421504	1	23	0	g	350019213300000001	0-23		24058639	10.1371/journal.pone.0074930		PLoS ONE	Fli1 Represses Transcription of the Human &#x03b1;2(I) Collagen Gene by Recruitment of the HDAC1/p300 Complex	YoshihiAsano	2013	0		COL1A2
674	chr4	11773889	11774080	3500372160	44		11773889	11774080	8421504	2	22,22	0,169	g	350037216000000000,350037216000000002	0-22,0-22		21266484	10.1093/nar/gkq1357		Nucleic Acids Research	A high-throughput DNA methylation analysis of a single cell	Kantlehner	2011	0		COL1A2
84	chr4	11774004	11810148	3500331878	52		11774004	11810148	8421504	2	26,26	0,36118	c	350033187800000002,350033187800000003	11-37,4-30						Methods of producing proteins having triple-helix structure	KASE	2007	0		
84	chr4	11774004	11810146	3500400553	76		11774004	11810146	8421504	3	27,21,28	0,28832,36114	c	350040055300000024,350040055300000104,350040055300000147,350040055300000075,350040055300000025,350040055300000105	10-37,10-37,0-21,0-21,16-44,16-44						TRANSFORMANT WHICH PRODUCES GLYCINE REPEAT SEQUENCE PROTEIN - Patent application	www.faqs.org	0	0		COL1A2
674	chr4	11774005	11784686	3500220839	48		11774005	11784686	8421504	3	24,6,18	0,10208,10663	c	350022083900000000,350022083900000001	0-24,0-24						METHOD FOR PREPARATION OF CARTILAGE CELL - Patent application	www.faqs.org	0	0		
674	chr4	11774005	11784686	3500200098	48		11774005	11784686	8421504	3	24,6,18	0,10208,10663	c,g	350020009800000000,350020009800000000,350020009800000001	0-24,0-24,0-24						METHOD FOR PREPARATION OF CARTILAGE CELL	Taniguchi	2008	0		
674	chr4	11784715	11786864	3500465085	40		11784715	11786864	8421504	3	7,13,20	0,540,2129	c	350046508500000003,350046508500000004	0-20,0-20			10.1002/art.22300	1529-0131	Arthritis & Rheumatism	Isolation and chondroinduction of a dermis-isolated, aggrecan-sensitive subpopulation with high chondrogenic potential - Deng - 2006 - Arthritis & Rheumatism - Wiley Online Library	Deng	2007	0		
674	chr4	11784715	11786864	3500096061	40		11784715	11786864	8421504	3	7,13,20	0,540,2129	c,g	350009606100000015,350009606100000003,350009606100000004,350009606100000004,350009606100000016,350009606100000016	0-20,0-20,0-20,0-20,0-20,0-20						Dermis-Derived Cells for Tissue Engineering Applications - Patent application	www.faqs.org	0	0		
674	chr4	11784715	11785291	3500463365	43		11784715	11785291	8421504	2	7,36	0,540	c	350046336500000000	0-61						 SpringerImages - Primer and probe sequences of desired genes 	pringerimages.com	0	0		
84	chr4	11792900	11797471	3500301021	60		11792900	11797471	8421504	2	27,33	0,4538	p	350030102100015034	0-60						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/l	grenada.lumc.nl	0	0		
674	chr4	11793682	11793706	3500407417	24		11793682	11793706	8421504	1	24	0	c	350040741700000061	16-43						Method For Producing Carotenoids Or Their Precursors Using Genetically Modified Organisms Of The Blakeslea Genus, Carotenoids Or Their Precursors Produced By Said Method And Use Thereof 	.freshpatents.com	0	0		
675	chr4	11802785	11804618	3500207027	39		11802785	11804618	8421504	3	19,11,9	0,1148,1824	c	350020702700000002,350020702700000003	0-19,0-20						Keratocyte behavior in three-dimensional photopolymerizable poly(ethylene glycol) hydrogels	pkinsmedicine.org	0	0		
675	chr4	11806171	11807627	3500087263	40		11806171	11807627	8421504	2	20,20	0,1436	c,g	350008726300000012,350008726300000013,350008726300000013	0-20,0-20,0-20						Identification of genes having a role in the presentation of diabetic nephropathy	Brady	2000	0		COL1A2
675	chr4	11806731	11807568	3500236138	69		11806731	11807568	8421504	3	19,14,36	0,141,801	p	350023613800015008	0-93						Structural elements of mussel byssus	eb.biologists.org	0	0		COL1A2
675	chr4	11807732	11808213	3500282907	64		11807732	11808213	8421504	3	19,35,10	0,22,471	c,g	350028290700000006,350028290700000006,350028290700000026,350028290700000007	0-19,0-19,0-20,0-25						ABSTRACT Title of Document: ENGINEERING ZONAL CARTILAGE THROUGH UTILIZATION OF A MESENCHYMAL STEM CELL POPULATION Articular	drum.lib.umd.edu	0	0		
675	chr4	11808223	11808246	3500166424	23		11808223	11808246	8421504	1	23	0	c	350016642400000005	0-23						Hirosaki University Repository for Academic Resources	.hirosaki-u.ac.jp	0	0		COL1A2
675	chr4	11808331	11809094	3500018210	44		11808331	11809094	8421504	2	22,22	0,741	c	350001821000000000,350001821000000001	0-22,0-22		21800203	10.1007/s10439-011-0365-7		Annals of biomedical engineering	Fiber Stretch and Reorientation Modulates Mesenchymal Stem Cell Morphology and Fibrous Gene Expression on Oriented Nanofibrous Microenvironments	Su-Jin	2011	0		
675	chr4	11809072	11809096	3500022584	24		11809072	11809096	8421504	1	24	0	c	350002258400000001	20-44						DISCRIMINATION OF MENISCAL CELL PHENOTYPES USING GENE EXPRESSION PROFILES	ww.ecmjournal.org	0	0		
675	chr4	11809113	11809233	3500414945	42		11809113	11809233	8421504	2	20,22	0,98	c,g	350041494500000002,350041494500000002,350041494500000003	0-20,0-20,0-22						Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: Influence of collagen type II extracellular matrix on MSC chondrogenesis	prints.ugd.edu.mk	0	0		
675	chr4	11809129	11809153	3500427186	24		11809129	11809153	8421504	1	24	0	c	350042718600000113	18-42						PREDICTOR SETS FOR TYROSINE KINASE PATHWAYS - BRISTOL-MYERS SQUIBB COMPANY	www.sumobrain.com	0	0		
675	chr4	11810509	11810538	3500261298	29		11810509	11810538	8421504	1	29	0	c	350026129800000000,350026129800000001,350026129800000002	5-34,5-25,5-34		20338660	10.1016/j.jhep.2009.12.025		Journal of hepatology	Let-7g targets collagen type I &#x03b1;2 and inhibits cell migration in hepatocellular carcinoma	Junfang	2010	0		
675	chr4	11921907	11921933	3500423492	26		11921907	11921933	8421504	1	26	0	g	350042349200000006,350042349200000007	0-26,0-26			10.1046/j.1365-2958.2001.02651.x	1365-2958	Molecular Microbiology	Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide - Janbon - 2008 - Molecular Microbiology - Wiley Online Library	Janbon	2001	0		CASD1
676	chr4	11997755	11997783	3500015754	23		11997755	11997783	8421504	2	11,12	0,16	g	350001575400000043	0-23						Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions - Patent application	www.faqs.org	0	0		
676	chr4	12002947	12016837	3500028009	40		12002947	12016837	8421504	2	20,20	0,13870	c,g	350002800900000033,350002800900000033,350002800900000032,350002800900000032	0-20,0-20,0-20,0-20						Putative imprinted gene expression in uniparental bovine embryo models	library.uq.edu.au	0	0		
677	chr4	12065428	12066020	3500037451	52		12065428	12066020	8421504	2	26,26	0,566	c	350003745100000012,350003745100000013	0-26,0-26						Comparative genomic imprinting a	www.docstoc.com	0	0		
677	chr4	12067164	12067188	3500023269	24		12067164	12067188	8421504	1	24	0	c	350002326900000025	0-24						Full text of "RNA fen li yu jian ding shi yan zhi nan RNA yan jiu fang fa"	archive.org	0	0		
677	chr4	12068720	12068746	3500396503	25		12068720	12068746	8421504	2	9,16	0,10	c	350039650300000201,350039650300000067	9-36,9-36						Novel Ifngamma-like Polypeptides 	.freshpatents.com	0	0		
84	chr4	12376223	12534314	3500102248	1362		12376223	12534314	8421504	29	22,65,53,43,59,64,69,84,15,33,21,30,30,54,51,68,4,78,9,30,24,112,44,57,48,120,24,3,48	0,5225,5293,26717,26763,62321,62388,86707,86794,86830,100356,100380,102991,103030,103087,103153,104664,104671,104752,105705,105738,105765,129737,129787,129847,155993,156923,158037,158043	p	350010224800015024,350010224800015025,350010224800015026	0-603,0-105,0-672						Novel human proteins, polynucleotides encoding them and methods of using the same	Anderson	2002	0		
680	chr4	12544183	12544284	3500261436	39		12544183	12544284	8421504	2	19,20	0,81	c,g	350026143600000080,350026143600000080,350026143600000079,350026143600000079	0-19,0-19,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
681	chr4	12601397	12601425	3500440696	28		12601397	12601425	8421504	1	28	0	c	350044069600000000	0-28						PON3 and uses thereof	Draganov	2003	0		PON1
681	chr4	12601397	12601425	3500204494	28		12601397	12601425	8421504	1	28	0	c	350020449400000000	0-28					Patent	PON3 and uses thereof (Patent US:6573370)	Du	2003	0		PON1
681	chr4	12658613	12658641	3500316461	24		12658613	12658641	8421504	2	6,18	0,10	g	350031646100000048	6-32						Cytokine that induces apoptosis	Goodwin	1997	0		HHIPL2
681	chr4	12674630	12674657	3500061629	24		12674630	12674657	8421504	2	16,8	0,19	c	350006162900000026	11-35						Zein-based Peptide Tags For The Expression And Purification Of Bioactive Peptides 	.freshpatents.com	0	0		
682	chr4	12752308	12763589	3500037451	63		12752308	12763589	8421504	3	22,21,20	0,10918,11261	c,g	350003745100000016,350003745100000014,350003745100000017,350003745100000017	0-22,0-21,0-20,0-20						Comparative genomic imprinting a	www.docstoc.com	0	0		
683	chr4	12883562	12883682	3500248474	43		12883562	12883682	8421504	2	22,21	0,99	c,g	350024847400000043,350024847400000043,350024847400000042,350024847400000042	0-22,0-22,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
683	chr4	12883978	12884073	3500388552	46		12883978	12884073	8421504	2	25,21	0,74	c,g	350038855200000015,350038855200000014	0-25,0-21						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
683	chr4	12883978	12884003	3500143254	25		12883978	12884003	8421504	1	25	0	c	350014325400000015	0-25						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
683	chr4	12891527	12891551	3500131497	24		12891527	12891551	8421504	1	24	0	c	350013149700000016	18-42						SIGNALING FROM MATRIX ELASTICITY AND TGF- 1 TO CELLS OF THE CARDIAC VALVE	gradworks.umi.com	0	0		
683	chr4	12892039	12892371	3500410461	44		12892039	12892371	8421504	2	23,21	0,311	c,g	350041046100000011,350041046100000010,350041046100000010	0-23,0-21,0-21		21449913	10.1111/j.1476-5381.2011.01384.x	1476-5381	British Journal of Pharmacology	The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor &#x03b1; protein - Fiori - 2011 - British Journal of Pharmacology - Wiley Online Library	Fiori	2011	0		PDK4
683	chr4	12892060	12896057	3500457931	40		12892060	12896057	8421504	2	20,20	0,3977	c,g	350045793100000010,350045793100000009,350045793100000009	0-20,0-20,0-20						Hypoxia Induces PDK4 Gene Expression through Induction of the Orphan Nuclear Receptor ERR	plaza.snu.ac.kr	0	0		
683	chr4	12893259	12894893	3500139036	25		12893259	12894893	8421504	2	19,6	0,1628	c	350013903600000014	18-43						A Kruppel-like transcriptional factor KLF 15 Mediates Fasting-Induced	www.jbc.org	0	0		
684	chr4	13063019	13106896	3500017457	119		13063019	13106896	8421504	2	2,117	0,43760	c	350001745700000014	4-123						Cytoplasmic Dynein Heavy Chain 1 Genes, Expression Products, Non-human Animal Model Uses In Human Neurological Diseases 	.freshpatents.com	0	0		
685	chr4	13116196	13118998	3500116960	66		13116196	13118998	8421504	2	52,14	0,2788	p	350011696000015010	0-66		23115187	10.1523/JNEUROSCI.5599-11.2012	0270-6474	The Journal of Neuroscience	Trk Activation of the ERK1/2 Kinase Pathway Stimulates Intermediate Chain Phosphorylation and Recruits Cytoplasmic Dynein to Signaling Endosomes for Retrograde Axonal Transport	Mitchell	2012	7		
685	chr4	13118998	13119049	3500373705	51		13118998	13119049	8421504	1	51	0	p	350037370500015000	0-51						Phosphorylation regulates targeting of cytoplasmic dynein to kinetochores during mitosis	jcb.rupress.org	0	0		DYNC1I1
85	chr4	13158051	13287287	3500246327	23		13158051	13287287	8421504	2	3,20	0,129216	c	350024632700000002	0-23						Induction of adipose-derived stem cell into motoneuron-like cells using selegiline as preinducer	uploadtak.com	0	0		
687	chr4	13419043	13419097	3500195705	52		13419043	13419097	8421504	2	47,5	0,49	c,g	350019570500000034,350019570500000034	0-52,0-52						Homology of the 74-kD cytoplasmic dynein subunit with a flagellar dynein polypeptide suggests an intracellular targeting function. - ResearchGate	.researchgate.net	0	0		
688	chr4	13552863	13552891	3500394579	23		13552863	13552891	8421504	2	6,17	0,11	g	350039457900000040	25-48						HEPATITIS C VIRUS VACCINE - Patent application	www.faqs.org	0	0		
692	chr4	14061041	14085698	3500360158	210		14061041	14085698	8421504	3	40,94,76	0,4451,24581	p	350036015800015004,350036015800015003	0-210,0-210						Bioinformatics	theory.bio.uu.nl	0	0		SHFM1
692	chr4	14061041	14085698	3500193221	210		14061041	14085698	8421504	3	40,94,76	0,4451,24581	p	350019322100015004,350019322100015003	0-210,0-210						Bioinformatics	rmatics.bio.uu.nl	0	0		SHFM1
694	chr4	14400132	14414210	3500020523	116		14400132	14414210	8421504	6	19,16,16,21,21,23	0,3848,3866,4126,4176,14055	c,g	350002052300000038,350002052300000033,350002052300000015,350002052300000034,350002052300000041	0-19,12-45,0-21,0-21,0-23						8. Nature Neuroscience August 2009	www.scribd.com	0	0		
694	chr4	14410251	14414288	3500270745	40		14410251	14414288	8421504	2	20,20	0,4017	c,g	350027074500000003,350027074500000003,350027074500000002	0-20,0-20,0-20		21441981	10.3389/fnana.2011.00010	1662-5129	Frontiers in Neuroanatomy	 Frontiers | Topography of Somatostatin Gene Expression Relative to Molecular Progenitor Domains during Ontogeny of the Mouse Hypothalamus | Frontiers in Neuroanatomy 	Morales-Delgado	2011	3		
694	chr4	14410251	14414288	3500197048	40		14410251	14414288	8421504	2	20,20	0,4017	c,g	350019704800000003,350019704800000003,350019704800000002	0-20,0-20,0-20						Topography of Somatostatin Gene Expression Relative to Molecular Progenitor Domains during Ontogeny of the Mouse Hypothalamus. - ResearchGate	.researchgate.net	0	0		
694	chr4	14410733	14410757	3500157538	23		14410733	14410757	8421504	2	19,4	0,20	c	350015753800000057	0-24						Proteases and variants thereof | Seedbuzz	www.seedbuzz.com	0	0		
694	chr4	14411960	14413895	3500241987	25		14411960	14413895	8421504	2	13,12	0,1923	c	350024198700000001	0-25		18316591	10.1158/0008-5472.CAN-07-3218	0008-5472	Cancer Research	A Novel Recurrent Chromosomal Inversion Implicates the Homeobox Gene Dlx5 in T-Cell Lymphomas from Lck-Akt2 Transgenic Mice	Tan	2008	8		
694	chr4	14414091	14414115	3500424047	24		14414091	14414115	8421504	1	24	0	c,g	350042404700000010,350042404700000010	0-24,0-24			10.1042/BJ20120172		Biochemical Journal	Dedifferentiated follicular granulosa cells derived from pig ovary can transdifferentiate into osteoblasts	Yoshinao	2012	0		
694	chr4	14414246	14414269	3500224574	23		14414246	14414269	8421504	1	23	0	c	350022457400000032	0-24						Anti-MPL Antibodies	Tsunoda	2010	0		
694	chr4	14414246	14414269	3500114454	23		14414246	14414269	8421504	1	23	0	c	350011445400000032	0-24						Anti-mpl antibody	Tsunoda	2004	0		
696	chr4	14601908	14601932	3500104392	23		14601908	14601932	8421504	2	17,6	0,18	g	350010439200000078	0-28						&#x30b9;&#x30da;&#x30eb;&#x30df;&#x30b8;&#x30f3;&#x8f38;&#x9001;&#x7cfb;&#x306e;&#x89e3;&#x660e;&#x3068;&#x30b4;&#x30eb;&#x30b8;&#x4f53;&#x306b;&#x5bfe;&#x3059;&#x308b;&#x30dd;&#x30ea;&#x30a2;&#x30df;&#x30f3;&#x306e;&#x5f79;&#x5272;	ane.ll.chiba-u.jp	0	0		
696	chr4	14632653	14632682	3500348013	25		14632653	14632682	8421504	3	4,9,12	0,5,17	g	350034801300000034	6-31						Modified Anti-cd52 Antibody 	.freshpatents.com	0	0		
699	chr4	15019052	15019112	3500269671	41		15019052	15019112	8421504	2	21,20	0,40	c,g	350026967100000004,350026967100000011,350026967100000011	0-21,0-20,0-20						Microarray analysis in caudal medulla of cattle orally challenged with bovine spongiform encephalopathy	w.funpecrp.com.br	0	0		
699	chr4	15019153	15026528	3500067881	261		15019153	15026528	8421504	6	6,97,45,24,54,35	0,1027,1574,2091,3676,7340	p	350006788100015018,350006788100015012	0-261,0-213						Human tachykinins and their precursors	Harmar	1987	0		
699	chr4	15020229	15020261	3500116379	32		15020229	15020261	8421504	1	32	0	c	350011637900000001	0-32		15623814	10.1210/jc.2004-1512	0021-972X	Journal of Clinical Endocrinology & Metabolism	Placental Expression of Substance P and Vasoactive Intestinal Peptide: Evidence for a Local Effect on Hormone Release	Marzioni	2005	6		TAC1
700	chr4	15142207	15142234	3500234918	23		15142207	15142234	8421504	3	12,5,6	0,15,21	c	350023491800000198	15-38						Methods and compositions for detecting sars virus and other infectious agents	Cheng	2005	0		
700	chr4	15146965	15146990	3500462979	25		15146965	15146990	8421504	1	25	0	c	350046297900000001	0-25			10.1111/j.1365-2141.2005.05694.x	1365-2141	British Journal of Haematology	Selective apoptosis of natural killer-cell tumours by l-asparaginase - Ando - 2005 - British Journal of Haematology - Wiley Online Library	Ando	2005	0		
700	chr4	15152927	15152972	3500128591	45		15152927	15152972	8421504	1	45	0	p	350012859100015002	3-48						Nucleotide Sequence of Escherichia coli amB and Deduced Amino Acid Sequence of Asparagine Synthetase B*	www.jbc.org	0	0		
703	chr4	15507129	15507158	3500380174	24		15507129	15507158	8421504	2	11,13	0,16	g	350038017400000462	22-47						Goodpasture Antigen Binding Protein 	.freshpatents.com	0	0		
706	chr4	15967407	15967430	3500058326	23		15967407	15967430	8421504	1	23	0	g	350005832600000159	4-27						Ubiquitin conjugating enzymes	Rolfe	1996	0		
712	chr4	16720174	16720203	3500454948	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350045494800000002	13-36						 Anti 	www.docstoc.com	0	0		
712	chr4	16720174	16720203	3500421945	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350042194500000002	13-36					Patent	Anti-VEGF antibodies (Patent EP:1787999)	Baca	2010	0		
712	chr4	16720174	16720203	3500367549	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350036754900000002	13-36						Anti-vegf Antibodies 	.freshpatents.com	0	0		
712	chr4	16720174	16720203	3500312622	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350031262200000002	13-36					Patent	Anti-VEGF antibodies (Patent EP:1787999)	Baca	2010	0		
712	chr4	16720174	16720203	3500297747	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350029774700000002	13-36					Patent	Anti-VEGF antibodies (Patent US:7060269)	Baca	2006	0		
712	chr4	16720174	16720203	3500296684	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350029668400000002	13-36					Patent	Anti-VEGF antibodies (Patent US:7060269)	Baca	2006	0		
712	chr4	16720174	16720203	3500044476	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350004447600000002	13-36					Patent	Anti-VEGF antibodies (Patent US:7060269)	Baca	2006	0		
712	chr4	16720174	16720203	3500016676	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350001667600000002	13-36						ANTI-VEGF ANTIBODIES	Baca	2010	0		
712	chr4	16720174	16720203	3500013665	23		16720174	16720203	8421504	3	12,6,5	0,16,24	g	350001366500000001	13-36						ANTI-VEGF ANTIBODIES	Baca	2006	0		
714	chr4	16953968	16954439	3500287361	441		16953968	16954439	8421504	2	360,81	0,390	p	350028736100015072,350028736100015071,350028736100015070,350028736100015074,350028736100015075,350028736100015073,350028736100015078	0-177,0-180,18-177,0-162,0-177,0-180,0-81						50 human secreted proteins	Komatsoulis	2001	0		NXPH1
714	chr4	16953968	16954439	3500274890	441		16953968	16954439	8421504	2	360,81	0,390	p	350027489000015072,350027489000015071,350027489000015070,350027489000015075,350027489000015074,350027489000015073,350027489000015078	0-177,0-180,18-177,0-177,0-162,0-180,0-81						50 human secreted proteins	Komatsoulis	2000	0		
724	chr4	18231335	18231358	3500456059	23		18231335	18231358	8421504	1	23	0	g	350045605900000006	0-23		18363651	10.1111/j.1472-765X.2008.02353.x	1472-765X	Letters in Applied Microbiology	High resolution genotyping of Bacillus anthracis outbreak strains using four highly mutable single nucleotide repeat markers - Kenefic - 2008 - Letters in Applied Microbiology - Wiley Online Library	Kenefic	2008	0		
726	chr4	18499950	18499976	3500427948	23		18499950	18499976	8421504	2	5,18	0,8	g	350042794800000026	4-28						ScienceDirect.com - Cell Reports - TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases	sciencedirect.com	0	0		
729	chr4	18965990	18966013	3500405434	23		18965990	18966013	8421504	1	23	0	g	350040543400000073	1-24						Use of intronic RNA to measure gene expression - US Patent 7767391 Description	ww.patentstorm.us	0	0		
731	chr4	19174468	19174493	3500246214	24		19174468	19174493	8421504	2	13,11	0,14	g	350024621400000000	1-25						Poly(ADP-Ribose) Polymerase-1 Could Facilitate the Religation of Topoisomerase I-linked DNA Inhibited by Camptothecin	.aacrjournals.org	0	0		
733	chr4	19421241	19421271	3500176414	24		19421241	19421271	8421504	3	7,6,11	0,10,19	g	350017641400000026	8-33						AMNIOTIC FLUID STEM CELLS AND KIDNEY REGENERATION	arch.cab.unipd.it	0	0		
734	chr4	19582390	19582417	3500020039	24		19582390	19582417	8421504	2	11,13	0,14	g	350002003900000092	18-42						Molecular antigen array	Renner	2002	0		
744	chr4	20967054	20967089	3500022178	34		20967054	20967089	8421504	2	25,9	0,26	g	350002217800000034	21-60						Polymorphic sites in the 5&#xb4;-region of the porcine C8A gene	bn-dummerstorf.de	0	0		
746	chr4	21143792	21143822	3500073269	30		21143792	21143822	8421504	1	30	0	c	350007326900000007	0-30		15342343	10.1152/ajpcell.00397.2004		American Journal of Physiology - Cell Physiolog	Barrier role of actin filaments in regulated mucin secretion from airway goblet cells	Ehre	2005	0		SCIN
746	chr4	21143792	21143822	3500042329	30		21143792	21143822	8421504	1	30	0	c	350004232900000007	0-30						Barrier role of actin &#xfb01;laments in regulated mucin secretion from airway goblet cells	ll.physiology.org	0	0		
746	chr4	21143792	21143822	3500012827	30		21143792	21143822	8421504	1	30	0	c	350001282700000007	0-30		15342343	10.1152/ajpcell.00397.2004		American Journal of Physiology - Cell Physiology	Barrier role of actin filaments in regulated mucin secretion from airway goblet cells	Ehre	2005	0		SCIN
748	chr4	21383716	21383742	3500113280	24		21383716	21383742	8421504	2	18,6	0,20	g	350011328000000010	15-39						Glutathione S-transferase Sequence Variants 	.freshpatents.com	0	0		
757	chr4	22663705	22663729	3500275560	23		22663705	22663729	8421504	2	13,10	0,14	g	350027556000000010	0-24						Dual oxidases as mitogenic and endocrine regulators	Lambeth	2001	0		
758	chr4	22750716	22798829	3500212227	74		22750716	22798829	8421504	4	24,26,3,21	0,38615,38649,48092	c	350021222700000035,350021222700000033,350021222700000032	0-24,0-26,0-24						Transgenic animals comprising gene fusions - Patent application	www.faqs.org	0	0		
758	chr4	22750716	22750751	3500367930	35		22750716	22750751	8421504	1	35	0	c	350036793000000220,350036793000000005,350036793000000062,350036793000000367	0-24,0-24,0-27,0-27						Recurrent gene fusions in prostate cancer - Patent application	www.faqs.org	0	0		
758	chr4	22800242	22800272	3500314078	26		22800242	22800272	8421504	3	7,4,15	0,10,15	c	350031407800000082	19-46						Thrombin-inhibitory protein from assassin bugs - US Patent 5523287 Description	ww.patentstorm.us	0	0		ETV1
11	chr4	23003882	23801346	3500226062	2394		23003882	23801346	8421504	28	111,61,5,78,23,196,91,65,161,90,86,75,74,117,36,3,90,117,89,118,120,75,50,141,154,21,77,70	0,33469,37421,37435,37519,204011,214453,376538,486438,494075,496472,527500,531081,540055,549672,579420,579429,593245,593444,596625,608550,613355,617883,639548,659420,676224,679801,797394	p,c,g	350022606200000119,350022606200000119,350022606200015014	0-19,0-19,0-2403						Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases	Brys	2007	0		DGKB
11	chr4	23003882	23801346	3500108932	2394		23003882	23801346	8421504	28	111,61,5,78,23,196,91,65,161,90,86,75,74,117,36,3,90,117,89,118,120,75,50,141,154,21,77,70	0,33469,37421,37435,37519,204011,214453,376538,486438,494075,496472,527500,531081,540055,549672,579420,579429,593245,593444,596625,608550,613355,617883,639548,659420,676224,679801,797394	p,c,g	350010893200000119,350010893200000119,350010893200015014	0-19,0-19,0-2403						Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases	Brys	2006	0		DGKB
762	chr4	23274303	23274329	3500361347	23		23274303	23274329	8421504	2	9,14	0,12	g	350036134700000005	0-23			10.1128/AEM.71.1.123-130.2005		Applied and Environmental Microbiology	Seasonal Change in Bacterial Flora and Biomass in Mountain Snow from the Tateyama Mountains, Japan, Analyzed by 16S rRNA Gene Sequencing and Real-Time PCR	Takahiro	2005	0		
764	chr4	23490344	23531430	3500116515	39		23490344	23531430	8421504	2	19,20	0,41066	c,g	350011651500000030,350011651500000030,350011651500000418,350011651500000418,350011651500000029,350011651500000029,350011651500000417,350011651500000417	0-19,0-19,0-19,0-19,0-20,0-20,0-19,0-19						METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS - Patent application	www.faqs.org	0	0		DGKB
764	chr4	23535027	23543951	3500005911	23		23535027	23543951	8421504	3	8,1,14	0,9,8910	c	350000591100000035	17-40						Stem Cell Assays	.researchgate.net	0	0		
765	chr4	23617259	23617283	3500129802	24		23617259	23617283	8421504	1	24	0	c	350012980200000003	0-24						Phosphatidic acid is required for the constitutive ruffling and macropinocytosis of phagocytes	w.molbiolcell.org	0	0		
765	chr4	23677939	23677965	3500028050	23		23677939	23677965	8421504	2	12,11	0,15	g	350002805000000491	26-49						Stress response and virulence in Salmonella Typhimurium: a genomics approach	edepot.wur.nl	0	0		
766	chr4	23801325	23801348	3500378114	23		23801325	23801348	8421504	1	23	0	c	350037811400000010	7-30		20657643	10.1371/journal.pone.0011602	1932-6203	PLOS ONE	PLOS ONE: Essential Role of Neuron-Enriched Diacylglycerol Kinase (DGK), DGK&#x03b2; in Neurite Spine Formation, Contributing to Cognitive Function	Shirai	2010	4		DGKB
766	chr4	23801325	23801348	3500106886	23		23801325	23801348	8421504	1	23	0	c	350010688600000010	7-30		20657643	10.1371/journal.pone.0011602		PLoS ONE	Essential Role of Neuron-Enriched Diacylglycerol Kinase (DGK), DGK&#x03b2; in Neurite Spine Formation, Contributing to Cognitive Function	Yasuhito	2010	0		DGKB
772	chr4	24570330	24570353	3500258869	23		24570330	24570353	8421504	1	23	0	g	350025886900000067,350025886900000015,350025886900000066,350025886900000016	2-25,2-25,2-25,2-25						Gemini virus vectors for gene expression in plants - Patent # 6392121 - PatentGenius	.patentgenius.com	0	0		
772	chr4	24570330	24570353	3500058109	23		24570330	24570353	8421504	1	23	0	g	350005810900000015,350005810900000016	2-25,2-25					Patent	Gemini virus vectors for gene expression in plants (Patent US:6392121)	Mason	2002	0		
773	chr4	24714692	24769089	3500015716	24		24714692	24769089	8421504	2	20,4	0,54393	c	350001571600000016	16-40						-Carotene and angiogenesis*	media.iupac.org	0	0		MEOX2
773	chr4	24769403	24769427	3500036033	24		24769403	24769427	8421504	1	24	0	c	350003603300000001	0-24					Patent	Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis (Patent US:5851521)	Branellec	1998	0		MEOX2
773	chr4	24769403	24769427	3500031396	24		24769403	24769427	8421504	1	24	0	c	350003139600000001	0-24					Patent	Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis (Patent US:RE37933)	Branellec	2002	0		
773	chr4	24769482	24769631	3500122810	149		24769482	24769631	8421504	1	149	0	c	350012281000000036,350012281000000004,350012281000000035,350012281000000034	0-48,12-32,0-48,0-53						Growth arrest homebox gene	Gorski	1994	0		
97	chr4	25395584	25437996	3500406455	44		25395584	25437996	8421504	4	16,6,6,16	0,19,42387,42396	g	350040645500000038,350040645500000037	1-23,8-30						&#x9ad8;&#x3044;&#x30a8;&#x30cd;&#x30eb;&#x30ae;&#x30fc;&#x79fb;&#x52d5;&#x52b9;&#x7387;&#x3092;&#x6709;&#x3059;&#x308b;&#xff22;&#xff32;&#xff25;&#xff34;&#x767a;&#x73fe;&#x7cfb; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; 2008283959&#xff09;&#xff5c;&#x30a2;&#x	astamuse.com	0	0		
781	chr4	25733297	25733321	3500324039	24		25733297	25733321	8421504	1	24	0	c	350032403900000128	1-25						INHIBITORS OF SIDEROPHORE BIOSYNTHESIS IN FUNGI - Austria, Wirtschaftsservice Gesellschaft Mbh	www.sumobrain.com	0	0		
781	chr4	25733297	25733321	3500208791	24		25733297	25733321	8421504	1	24	0	c	350020879100000128	1-25						Inhibitors Of Siderophore Biosynthesis In Fungi 	.freshpatents.com	0	0		
781	chr4	25733297	25733321	3500008646	24		25733297	25733321	8421504	1	24	0	c	350000864600000128	1-25						Inhibitors of Siderophore Biosynthesis in Fungi	Haas	2005	0		
782	chr4	25929004	25929028	3500389534	23		25929004	25929028	8421504	2	7,16	0,8	g	350038953400000010	0-23					Patent	Dns oder gene, die an der parkinsonschen krankheit beteiligt sind Dns or genes, which are involved in Parkinson's disease (Patent DE:69929417)	Mizuno	2006	0		
783	chr4	26070014	26070179	3500335406	47		26070014	26070179	8421504	2	28,19	0,146	c	350033540600000191	1-48						HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS	Kato	1998	0		
784	chr4	26120360	26120391	3500070088	27		26120360	26120391	8421504	3	16,7,4	0,19,27	g	350007008800000492	2-29						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
786	chr4	26387984	26388011	3500073470	25		26387984	26388011	8421504	3	12,9,4	0,13,23	g	350007347000000019	20-45						COMBINATION METHODS OF INHIBITING TUMOR GROWTH WITH A VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTAGONIST - Patent application	www.faqs.org	0	0		
788	chr4	26701649	26701673	3500236868	24		26701649	26701673	8421504	1	24	0	c	350023686800000000	0-24						The Zebrafish (Danio rerio) Aryl Hydrocarbon Receptor Type 1 Is a Novel Vertebrate Receptor	t.oregonstate.edu	0	0		
788	chr4	26703579	26705532	3500024557	46		26703579	26705532	8421504	3	24,4,18	0,93,1935	c	350002455700000033,350002455700000034	0-24,0-22						Doctorat ParisTech T H &#xc8; S E	hives-ouvertes.fr	0	0		AHR
788	chr4	26703643	26705607	3500442868	78		26703643	26705607	8421504	2	30,48	0,1916	c	350044286800000091,350044286800000093	18-48,0-48						US Patent # 5,378,822. Nucleic acids encoding murine and human Ah receptors - Patents.com	www.patents.com	0	0		
788	chr4	26705532	26707373	3500303038	357		26705532	26707373	8421504	3	185,110,62	0,868,1779	p	350030303800015006,350030303800015007	0-180,0-177						Canine dioxin/aryl hydrocarbon receptor sequences	Gu	2003	0		
788	chr4	26705547	26705607	3500008139	60		26705547	26705607	8421504	1	60	0	c,g	350000813900000038,350000813900000093,350000813900000093	0-23,0-48,0-48						Nucleic acids encoding murine and human Ah receptors	Bradfield	1993	0		
788	chr4	26705559	26705607	3500190761	48		26705559	26705607	8421504	1	48	0	c	350019076100000102	0-48						Biological assay for detecting agonists to the Ah receptor - Patent # 5650283 - PatentGenius	.patentgenius.com	0	0		
788	chr4	26705579	26705602	3500459257	23		26705579	26705602	8421504	1	23	0	c	350045925700000000,350045925700000001	6-29,13-35		17200336	10.1158/1078-0432.CCR-06-1166	1078-0432	Clinical Cancer Research	Requirement of Aryl Hydrocarbon Receptor Overexpression for CYP1B1 Up-Regulation and Cell Growth in Human Lung Adenocarcinomas	Chang	2007	8		AHR
788	chr4	26705579	26705602	3500281218	23		26705579	26705602	8421504	1	23	0	c	350028121800000000,350028121800000001	6-29,13-35		17200336	10.1158/1078-0432.CCR-06-1166	1078-0432	Clinical Cancer Research	Requirement of Aryl Hydrocarbon Receptor Overexpression for CYP1B1 Up-Regulation and Cell Growth in Human Lung Adenocarcinomas	Chang	2007	8		AHR
788	chr4	26707324	26710619	3500446652	44		26707324	26710619	8421504	2	22,22	0,3273	c,g	350044665200000002,350044665200000002,350044665200000003	0-22,0-22,0-22		17616719	10.1530/REP-06-0246	1470-1626	Reproduction	Regulation of aryl hydrocarbon receptor activity in porcine cumulus&#x2013;oocyte complexes in physiological and toxicological conditions: the role of follicular fluid	Nestler	2007	3		
788	chr4	26707324	26710619	3500357244	44		26707324	26710619	8421504	2	22,22	0,3273	c,g	350035724400000002,350035724400000002,350035724400000003	0-22,0-22,0-22		14726445	10.1210/en.2003-1254	0013-7227	Endocrinology	Constitutive Expression of CYP1A1 in Bovine Cumulus Oocyte-Complexes in Vitro: Mechanisms and Biological Implications	Pocar	2004	4		
788	chr4	26714756	26714785	3500423944	29		26714756	26714785	8421504	1	29	0	c	350042394400000001	31-60		19917880	10.1124/mol.109.059675	1521-0111 (Online)	Molecular Pharmacology	Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4	Barhoover	2010	0		AHR
795	chr4	27617343	27617368	3500380174	24		27617343	27617368	8421504	2	9,15	0,10	g	350038017400000069	0-24						Goodpasture Antigen Binding Protein 	.freshpatents.com	0	0		
799	chr4	28098684	28098709	3500337509	25		28098684	28098709	8421504	1	25	0	g	350033750900000009	0-25		19109424	10.1091/mbc.E08-07-0759	1059-1524	Molecular Biology of the Cell	A Histone Deacetylase 4/Myogenin Positive Feedback Loop Coordinates Denervation-dependent Gene Induction and Suppression	Tang	2009	5		HDAC9
803	chr4	28644774	28644797	3500465506	23		28644774	28644797	8421504	1	23	0	g	350046550600000006	4-27		18289379			Journal of Molecular Signaling	 Dramatic inhibition of osteoclast sealing ring formation and bone resorption in vitro by a WASP-peptide containing pTyr294 amino acid.(Research article)(Wiskott Aldrich Syndrome protein) - Journal of Molecular Signaling | HighBeam Research 	Ma	2008	0		
803	chr4	28650330	28651256	3500415714	39		28650330	28651256	8421504	2	19,20	0,906	c	350041571400000006,350041571400000018	0-19,0-20						EpithelialtoMesenchymalTransition:ExpressionoftheRegulators Snail,Slug,andTwistinPancreaticCancer	.aacrjournals.org	0	0		
803	chr4	28650362	28651180	3500396187	63		28650362	28651180	8421504	3	20,23,20	0,39,798	c,g	350039618700000015,350039618700000015,350039618700000011,350039618700000014,350039618700000014	0-20,0-20,0-23,0-20,0-20						Research Paper TWIST Represses Estrogen Receptor-alpha Expression by Recruiting the NuRD Protein Complex in Breast Cancer Cells	www.ijbs.com	0	0		TWIST1
803	chr4	28650362	28651180	3500239969	63		28650362	28651180	8421504	3	20,23,20	0,39,798	c,g	350023996900000015,350023996900000015,350023996900000011,350023996900000014,350023996900000014	0-20,0-20,0-23,0-20,0-20						TWIST Represses Estrogen Receptor-alpha Expression by Recruiting the NuRD Protein Complex in Breast Cancer Cells	www.ijbs.com	0	0		TWIST1
803	chr4	28650437	28651034	3500069168	45		28650437	28651034	8421504	3	25,11,9	0,50,588	c	350006916800000010,350006916800000009	0-26,5-25		21697088	10.1074/jbc.M111.220376	0021-9258	Journal of Biological Chemistry	Enhanced Epithelial-Mesenchymal Transition-like Phenotype in N-Acetylglucosaminyltransferase V Transgenic Mouse Skin Promotes Wound Healing	Terao	2011	5		TWIST1
803	chr4	28650438	28651117	3500266010	40		28650438	28651117	8421504	2	20,20	0,659	c,g	350026601000000009,350026601000000008,350026601000000008	0-20,0-20,0-20		21738704	10.1371/journal.pone.0021548		PLoS ONE	Epithelial to Mesenchymal Transition by TGF&#x03b2;-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line	Giuseppe	2011	0		TWIST1
803	chr4	28650438	28651117	3500218886	40		28650438	28651117	8421504	2	20,20	0,659	c,g	350021888600000009,350021888600000008,350021888600000008	0-20,0-20,0-20						Epithelial to Mesenchymal Transition by TGFb-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line	.biomedsearch.com	0	0		TWIST1
803	chr4	28650446	28650472	3500467254	26		28650446	28650472	8421504	1	26	0	c,g	350046725400000009,350046725400000009	0-26,0-26						Gastroenterology World Journal of	www.wjgnet.com	0	0		TWIST1
803	chr4	28650446	28650472	3500443470	26		28650446	28650472	8421504	1	26	0	c,g	350044347000000009,350044347000000009	0-26,0-26						Gastroenterology World Journal of	www.wjgnet.com	0	0		TWIST1
803	chr4	28650461	28651385	3500365527	83		28650461	28651385	8421504	3	24,24,35	0,680,889	c	350036552700000015,350036552700000013,350036552700000012,350036552700000014	0-24,0-24,0-24,0-20			10.1002/art.10106	1529-0131	Arthritis & Rheumatism	Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis - Stokes - 2002 - Arthritis & Rheumatism - Wiley Online Library	Stokes	2002	0		
803	chr4	28650461	28650485	3500050973	24		28650461	28650485	8421504	1	24	0	c	350005097300000001	0-24						Twist expression promotes migration and invasion in hepatocellular carcinoma. - ResearchGate	.researchgate.net	0	0		
803	chr4	28650473	28651221	3500316174	51		28650473	28651221	8421504	3	25,1,25	0,552,723	c,g	350031617400000025,350031617400000004,350031617400000024,350031617400000024	0-26,25-51,0-25,0-25						CELL MASS CAPABLE OF SERVING AS A PRIMITIVE ORGAN-LIKE STRUCTURE COMPRISED OF A PLURALITY OF CELL TYPES OF SOMATIC ORIGIN - Patent application	www.faqs.org	0	0		TWIST1
803	chr4	28651067	28651673	3500226814	109		28651067	28651673	8421504	3	25,60,24	0,270,582	p,c	350022681400000001,350022681400015000,350022681400000000	1-26,0-60,7-31					Neoplasia (New York, N.Y.)	TWIST is Expressed in Human Gliomas and Promotes Invasion	Maria	2005	0		TWIST1
803	chr4	28651159	28651210	3500455206	42		28651159	28651210	8421504	2	20,22	0,29	c,g	350045520600000005,350045520600000005,350045520600000004	0-20,0-20,0-22						Supplementary Figures and Tables	.aacrjournals.org	0	0		
803	chr4	28651159	28651210	3500143396	42		28651159	28651210	8421504	2	20,22	0,29	c,g	350014339600000005,350014339600000005,350014339600000013,350014339600000013,350014339600000004,350014339600000012	0-20,0-20,0-20,0-20,0-22,0-22						Devices and methods of cell capture and analysis - Patent application	www.faqs.org	0	0		
803	chr4	28651161	28651373	3500457385	46		28651161	28651373	8421504	2	23,23	0,189	c	350045738500000003,350045738500000002	0-23,0-23		19609939	10.1002/stem.181	1549-4918	STEM CELLS	TWIST Family of Basic Helix-Loop-Helix Transcription Factors Mediate Human Mesenchymal Stem Cell Growth and Commitment - Isenmann - 2009 - STEM CELLS - Wiley Online Library	Isenmann	2009	0		
803	chr4	28652089	28652196	3500237114	66		28652089	28652196	8421504	2	42,24	0,83	g	350023711400000006,350023711400000016,350023711400000005	9-32,0-25,9-33		18353781	10.1074/jbc.M707429200		The Journal of Biological Chemistry	Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function	George	2008	0		
803	chr4	28686909	28686968	3500438916	59		28686909	28686968	8421504	1	59	0	g	350043891600000113	0-59						DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Nato3 - Patent application	www.faqs.org	0	0		
804	chr4	28793406	28793432	3500009794	23		28793406	28793432	8421504	2	5,18	0,8	g	350000979400000001	0-23		21820995	10.1016/j.ajpath.2011.06.029		The American Journal of Pathology	Interferon-&#x03b3; Influences the Composition of Leukocytic Infiltrates in Murine Lyme Carditis	Gregory	2011	0		
808	chr4	29316222	29316249	3500390844	27		29316222	29316249	8421504	1	27	0	c	350039084400000006	60-87						Dna molecules, preparation thereof and use thereof in gene therapy	Cameron	1998	0		
808	chr4	29316222	29316249	3500237096	27		29316222	29316249	8421504	1	27	0	c	350023709600000005,350023709600000004	88-114,60-87					Patent	Dna molecules, preparation thereof and use thereof in gene therapy (Patent EP:0815214)	Cameron	2007	0		
811	chr4	29623051	29623078	3500441591	24		29623051	29623078	8421504	2	9,15	0,12	g	350044159100000028,350044159100000175	5-29,5-29						Porphyromonas gingivalis polypeptides and nucleotides - Patent application	www.faqs.org	0	0		
811	chr4	29623051	29623078	3500438192	24		29623051	29623078	8421504	2	9,15	0,12	g	350043819200000030	5-29						Porphorymonas gingivalis polypeptides and nucleotides	Ross	2006	0		
811	chr4	29698635	29698663	3500177982	27		29698635	29698663	8421504	2	21,6	0,22	g	350017798200000737	1-39						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		
813	chr4	29946566	29946598	3500109650	32		29946566	29946598	8421504	1	32	0	g	350010965000000009	15-47		20519498	10.1074/jbc.M110.113977	0021-9258	Journal of Biological Chemistry	Transcription of the Transforming Growth Factor &#x03b2; Activating Integrin &#x03b2;8 Subunit Is Regulated by SP3, AP-1, and the p38 Pathway	Markovics	2010	5		
101	chr4	29982196	30038933	3500455424	624		29982196	30038933	8421504	19	28,34,54,39,8,24,38,53,39,18,21,35,38,75,2,24,38,20,36	0,11057,20258,20351,20459,21805,21845,22571,39305,39368,45555,48380,48458,48693,51205,56389,56449,56671,56701	c	350045542400000072,350045542400000077,350045542400000018,350045542400000080,350045542400000082,350045542400000023,350045542400000086,350045542400000028,350045542400000090,350045542400000096,350045542400000036,350045542400000101,350045542400000103,350045542400000109,350045542400000110,350045542400000129,350045542400000121,350045542400000124,350045542400000125	0-28,5-39,0-39,0-39,0-39,6-38,0-38,0-39,0-38,0-39,0-39,0-35,0-38,1-39,0-39,0-24,0-38,9-29,0-36						Beta-8 integrin subunit antibodies	Moyle	1995	0		
101	chr4	29982196	30038933	3500450362	817		29982196	30038933	8421504	21	28,34,54,39,39,8,24,38,39,39,39,18,21,35,38,29,75,2,116,39,63	0,11057,20258,20336,20390,20459,21805,21845,22571,35980,39305,39368,45555,48380,48458,48614,48693,51205,56371,56623,56674	p,c	350045036200000072,350045036200000077,350045036200000018,350045036200000080,350045036200000020,350045036200000083,350045036200000023,350045036200000086,350045036200000028,350045036200000033,350045036200000096,350045036200000036,350045036200000101,350045036200000103,350045036200000107,350045036200000109,350045036200000110,350045036200000119,350045036200000120,350045036200000121,350045036200000123,350045036200015001,350045036200000125	0-28,5-39,0-39,0-39,0-39,0-39,6-38,0-38,0-39,0-39,0-39,0-39,0-35,0-38,0-29,1-39,0-39,0-39,0-39,0-38,0-39,0-60,0-36						US Patent # 5,635,601. Beta-8 integrin subunit antibodies - Patents.com	www.patents.com	0	0		
814	chr4	30038635	30038933	3500393364	49		30038635	30038933	8421504	2	25,24	0,274	c	350039336400000026,350039336400000027	8-33,9-33						Inhibitors of beta integrin-g protein alpha subunit binding interactions	Du	2013	0		
814	chr4	30038635	30038933	3500139288	49		30038635	30038933	8421504	2	25,24	0,274	c,g	350013928800000028,350013928800000028,350013928800000029,350013928800000029	8-33,8-33,9-33,9-33						Inhibitors of beta integrin-g protein alpha subunit binding interactions	Du	2013	0		ITGB8
814	chr4	30038834	30038930	3500032843	96		30038834	30038930	8421504	1	96	0	p	350003284300015000	0-96		15576410	10.1242/dev.01551	0950-1991	Development	Selective ablation of &#x03b1;v integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death	McCarty	2005	7		ITGB8
819	chr4	30729303	30729333	3500061628	25		30729303	30729333	8421504	3	6,14,5	0,9,25	g	350006162800000346	21-46						Method For Diagnosing Non-small Cell Lung Cancer 	.freshpatents.com	0	0		
820	chr4	30922829	30922857	3500281500	23		30922829	30922857	8421504	2	14,9	0,19	g	350028150000000037	5-28						Hepatitis B Viral Variants With Reduced Susceptibility To Nucleoside Analogs And Uses Thereof - Patent application	www.faqs.org	0	0		
821	chr4	30960373	30960399	3500070288	24		30960373	30960399	8421504	2	13,11	0,15	g	350007028800000732	1-26						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
821	chr4	30993198	30993223	3500178993	23		30993198	30993223	8421504	3	4,6,13	0,5,12	g	350017899300000004,350017899300000003	0-23,7-30						www.biochemj	.glycobiochem.com	0	0		
828	chr4	31863322	31863356	3500282634	30		31863322	31863356	8421504	2	6,24	0,10	g	350028263400000145	17-47						Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy - Patent application	www.faqs.org	0	0		
828	chr4	31970266	31970289	3500131986	23		31970266	31970289	8421504	1	23	0	g	350013198600000055	5-30						SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK - Patent application	www.faqs.org	0	0		
831	chr4	32349169	32349197	3500035977	23		32349169	32349197	8421504	2	16,7	0,21	g	350003597700000014	0-26						t-RNA PRIMER, PRODUCTION AND USE FOR INHIBITING REVERSE TRANSCRIPTASE	Domdey	1999	0		
832	chr4	32396218	32396243	3500114581	25		32396218	32396243	8421504	1	25	0	g	350011458100000000	0-25		18854426	10.1152/ajpendo.90543.2008		American Journal of Physiology - Endocrinology and Metabolism	Pycnogenol, an extract from French maritime pine, suppresses Toll-like receptor 4-mediated expression of adipose differentiation-related protein in macrophages	Gu	2008	0		
832	chr4	32396219	32396243	3500013373	24		32396219	32396243	8421504	1	24	0	g	350001337300000835	0-24						 Immunostimulatory Nucleic Acids 	www.docstoc.com	0	0		
832	chr4	32396574	32396647	3500256733	69		32396574	32396647	8421504	3	21,23,25	0,23,48	c,g	350025673300000006,350025673300000006,350025673300000008,350025673300000007	0-21,0-21,0-23,0-25						Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q)	www.ijbs.org	0	0		
832	chr4	32396574	32396647	3500197219	46		32396574	32396647	8421504	2	21,25	0,48	c	350019721900000006,350019721900000007	0-21,0-25		19553336	10.1128/JVI.00626-09	0022-538X	Journal of Virology	Bluetongue Virus Targets Conventional Dendritic Cells in Skin Lymph	Hemati	2009	5		
832	chr4	32396574	32396647	3500117118	46		32396574	32396647	8421504	2	21,25	0,48	c,g	350011711800000006,350011711800000006,350011711800000007	0-21,0-21,0-25		19553336	10.1128/JVI.00626-09		Journal of Virology	Bluetongue Virus Targets Conventional Dendritic Cells in Skin Lymph 	Behzad	2009	0		
832	chr4	32396576	32398753	3500116987	40		32396576	32398753	8421504	2	20,20	0,2157	c,g	350011698700000002,350011698700000002,350011698700000003,350011698700000003	0-20,0-20,0-20,0-20						Analysis of Gene Transcription in Bovine Nuclear Transfer Embryos: RESULTS | Medicine Healthiest	ne-healthiest.com	0	0		
832	chr4	32396642	32397874	3500008614	43		32396642	32397874	8421504	2	21,22	0,1210	c	350000861400000000,350000861400000001	0-21,0-22						HYDROGEL-FORMING POLYMER, AND PREPARATION PROCESS AND USES THEREOF	Lai	2012	0		
832	chr4	32396677	32398748	3500167455	240		32396677	32398748	8421504	3	57,114,69	0,1158,2002	p	350016745500015064,350016745500015065,350016745500015066,350016745500015067,350016745500015068	0-48,0-48,0-48,0-48,0-48						Cytokine-like Proteins 	.freshpatents.com	0	0		
832	chr4	32397857	32397926	3500365673	40		32397857	32397926	8421504	2	20,20	0,49	c,g	350036567300000018,350036567300000019,350036567300000019	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
832	chr4	32397857	32397926	3500262357	40		32397857	32397926	8421504	2	20,20	0,49	c,g	350026235700000018,350026235700000019,350026235700000019	0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
832	chr4	32397858	32398776	3500275310	40		32397858	32398776	8421504	2	20,20	0,898	c	350027531000000008,350027531000000009	0-20,0-20						The Bovine Mammary Glands Cytokines at the Periparturient Period	apps.kfu.edu.sa	0	0		
832	chr4	32397870	32400129	3500120546	65		32397870	32400129	8421504	3	19,22,24	0,872,2235	c,g	350012054600000006,350012054600000009,350012054600000009,350012054600000004	10-29,8-30,8-30,0-24						Use of recombinant bovine CD14 in the treatment and prevention of coliform mastitis in dairy cows	Wang	2002	0		
832	chr4	32397870	32400129	3500018812	65		32397870	32400129	8421504	3	19,22,24	0,872,2235	c	350001881200000024,350001881200000006,350001881200000009,350001881200000023,350001881200000004,350001881200000022	10-29,10-29,8-30,8-30,0-24,0-24						 Use Of Recombinant Bovine CD14 In The Treatment And Prevention Of Coliform Mastitis In Dairy Cows 	www.docstoc.com	0	0		
832	chr4	32397872	32397896	3500453465	24		32397872	32397896	8421504	1	24	0	c	350045346500000004	0-24						Expression profile of genes associated with mastitis in dairy cattle	cnptia.embrapa.br	0	0		
832	chr4	32397891	32398821	3500291860	44		32397891	32398821	8421504	2	23,21	0,909	c,g	350029186000000006,350029186000000006,350029186000000007,350029186000000007	0-23,0-23,0-21,0-21						Die Immunantwort boviner und capriner Euterepithelzellen auf verschiedene Mastitiserreger	b.uni-muenchen.de	0	0		
832	chr4	32397913	32397938	3500135226	25		32397913	32397938	8421504	1	25	0	c	350013522600000000	0-25						Validation of Quantitative Polymerase Chain Reaction Assays	www.scribd.com	0	0		IL6
832	chr4	32398702	32400126	3500137193	40		32398702	32400126	8421504	2	20,20	0,1404	c	350013719300000004,350013719300000005	0-20,0-20						Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system	biomedcentral.com	0	0		
832	chr4	32400145	32400171	3500349534	26		32400145	32400171	8421504	1	26	0	c	350034953400000004	19-45			10.1046/j.1365-3083.2001.00994.x	1365-3083	Scandinavian Journal of Immunology	Morphologic and Functional Changes in Bovine Monocytes Infected In vitro with the Bovine Leukaemia Virus - Altreuther - 2002 - Scandinavian Journal of Immunology - Wiley Online Library	Altreuther	2001	0		
832	chr4	32400258	32400321	3500449915	41		32400258	32400321	8421504	2	21,20	0,43	c	350044991500000004,350044991500000005	1-22,0-20						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
832	chr4	32400277	32400301	3500296484	24		32400277	32400301	8421504	1	24	0	c	350029648400000002	0-24						Evaluation of cytokine expression by blood monocytes of lactating Holstein cows with or without postpartum uterine disease. - ResearchGate	.researchgate.net	0	0		
832	chr4	32495525	32495548	3500281031	23		32495525	32495548	8421504	1	23	0	g	350028103100000001	0-23		20388795	10.1158/0008-5472.CAN-09-3690	0008-5472	Cancer Research	5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell&#x2013;Dependent Antitumor Immunity	Vincent	2010	8		HNRNPH2
833	chr4	32508741	32508767	3500023276	23		32508741	32508767	8421504	2	10,13	0,13	g	350002327600000014	1-24		20488889	10.1093/brain/awq107		Brain	Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition	Govindaiah	2010	0		
834	chr4	32763662	32764362	3500255592	700		32763662	32764362	8421504	1	700	0	g	350025559200000001	8-708						NCBI GenBank | DN529206 | 1317840 MARC 7BOV Bos taurus cDNA 3', mRNA sequence.	www.metalife.com	0	0		
835	chr4	32853109	32853136	3500203588	23		32853109	32853136	8421504	3	7,4,12	0,8,15	c	350020358800000039	0-23						US Patent # 7,442,777. Cytotoxicity mediation of cells evidencing surface expression of CD63 - Patents.com	www.patents.com	0	0		
104	chr4	32904800	33046679	3500432547	1737		32904800	33046679	8421504	15	96,114,132,75,117,126,136,123,135,282,64,52,49,61,175	0,384,1188,3974,7548,15296,16982,19259,20650,24163,36447,36604,101935,140432,141704	p	350043254700015002	0-1737						Use of IMP3 as a Prognostic Marker for Cancer	Jiang	2007	0		SNORD65,IGF2BP3
104	chr4	32904800	33046679	3500412380	1737		32904800	33046679	8421504	15	96,114,132,75,117,126,136,123,135,282,64,52,49,61,175	0,384,1188,3974,7548,15296,16982,19259,20650,24163,36447,36604,101935,140432,141704	p	350041238000015000	0-1737						Use of IMP3 as a Prognostic Marker for Cancer - Patent application	www.faqs.org	0	0		SNORD65,IGF2BP3
104	chr4	32904800	33046679	3500395070	1737		32904800	33046679	8421504	15	96,114,132,75,117,126,136,123,135,282,64,52,49,61,175	0,384,1188,3974,7548,15296,16982,19259,20650,24163,36447,36604,101935,140432,141704	p	350039507000015002	0-1737						USE OF IMP3 AS A PROGNOSTIC MARKER FOR CANCER	Jiang	2012	0		SNORD65,IGF2BP3
104	chr4	32904800	33046679	3500315303	1737		32904800	33046679	8421504	15	96,114,132,75,117,126,136,123,135,282,64,52,49,61,175	0,384,1188,3974,7548,15296,16982,19259,20650,24163,36447,36604,101935,140432,141704	p	350031530300015001	0-1737						USE OF IMP3 AS A PROGNOSTIC MARKER FOR CANCER	Jiang	2010	0		SNORD65,IGF2BP3
104	chr4	32904800	33046679	3500219437	1737		32904800	33046679	8421504	15	96,114,132,75,117,126,136,123,135,282,64,52,49,61,175	0,384,1188,3974,7548,15296,16982,19259,20650,24163,36447,36604,101935,140432,141704	p	350021943700015001	0-1737						Use of IMP3 as a Prognostic Marker for Cancer	Jiang	2010	0		SNORD65,IGF2BP3
836	chr4	32905208	32929022	3500148535	540		32905208	32929022	8421504	8	90,54,48,90,43,101,55,59	0,780,3593,7140,16667,18851,20322,23755	p	350014853500015075,350014853500015074,350014853500015073,350014853500015072,350014853500015071,350014853500015070,350014853500015069,350014853500015068,350014853500015056,350014853500015066,350014853500015053,350014853500015019	0-48,0-48,0-48,0-45,0-48,3-48,0-48,0-48,0-48,0-45,0-48,0-48						c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence	Ross	1999	0		
836	chr4	32905289	33006777	3500412380	180		32905289	33006777	8421504	6	9,36,45,45,3,42	0,699,738,3488,36164,101446	p	350041238000015032,350041238000015031,350041238000015029,350041238000015006	0-45,0-45,0-45,0-45						Use of IMP3 as a Prognostic Marker for Cancer - Patent application	www.faqs.org	0	0		
836	chr4	32908792	32921902	3500247743	120		32908792	32921902	8421504	3	57,3,60	0,3556,13050	p	350024774300015004,350024774300015020	0-60,0-60						Compositions and methods for the therapy and diagnosis of lung cancer	Foy	2003	0		IGF2BP3
836	chr4	32920162	32920186	3500179145	23		32920162	32920186	8421504	2	14,9	0,15	c	350017914500000174	8-32						ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION - Patent application	www.faqs.org	0	0		
837	chr4	33041433	33041457	3500318229	23		33041433	33041457	8421504	2	19,4	0,20	g	350031822900000074	20-43						METHODS OF IDENTIFYING AND CREATING RUBISCO LARGE SUBUNIT VARIANTS WITH IMPROVED RUBISCO ACTIVITY, COMPOSITIONS AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
837	chr4	33045245	33046667	3500145932	42		33045245	33046667	8421504	2	20,22	0,1400	c,g	350014593200000003,350014593200000003,350014593200000002,350014593200000002	0-20,0-20,0-22,0-22						Gene Regulation and Systems Biology	www.la-press.com	0	0		IGF2BP3
837	chr4	33046644	33046679	3500442882	35		33046644	33046679	8421504	1	35	0	c,g	350044288200000013,350044288200000013,350044288200000025,350044288200000023	0-32,0-32,11-35,15-36						Compositions and methods for the therapy and diagnosis of lung cancer	Cai	2009	0		IGF2BP3
837	chr4	33046650	33046679	3500323428	29		33046650	33046679	8421504	1	29	0	c,g	350032342800000008,350032342800000008	10-39,10-39						METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES - ROCKEFELLER UNIVERSITY	www.sumobrain.com	0	0		IGF2BP3
837	chr4	33046654	33046679	3500353343	25		33046654	33046679	8421504	1	25	0	c	350035334300000023	12-37		22266872	10.1038/onc.2011.620	0950-9232	Oncogene	Regulation of IMP3 by EGFR signaling and repression by ER&#x03b2;: implications for triple-negative breast cancer	Samanta	2012	6		IGF2BP3
837	chr4	33046655	33046683	3500401848	28		33046655	33046683	8421504	1	28	0	c	350040184800000000	0-28						Role of insulin-like growth factor-II mRNA-binding protein-3 in invadopodia formation and the growth of oral squamous cell carcinoma in athymic nude mice. - ResearchGate	.researchgate.net	0	0		IGF2BP3
837	chr4	33046655	33046679	3500404324	24		33046655	33046679	8421504	1	24	0	g	350040432400000025	11-35						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER - Patent application	www.faqs.org	0	0		
837	chr4	33046655	33046679	3500196583	24		33046655	33046679	8421504	1	24	0	c,g	350019658300000025,350019658300000025	11-35,11-35						Compositions and methods for the therapy and diagnosis of lung cancer	Wang	2006	0		
837	chr4	33046655	33046679	3500024144	24		33046655	33046679	8421504	1	24	0	c	350002414400000025	11-35						 Methods For The Detection Of Cervical Cancer 	www.docstoc.com	0	0		
837	chr4	33077985	33080947	3500130191	63		33077985	33080947	8421504	3	20,23,20	0,1871,2942	c,g	350013019100000097,350013019100000097,350013019100000107,350013019100000096	0-20,0-20,0-23,0-20						Function of Splicing factor Tra2-beta1 in Alternative Splicing and Translation	b.uni-erlangen.de	0	0		
838	chr4	33245292	33245332	3500056775	40		33245292	33245332	8421504	1	40	0	c	350005677500000025	5-45						Screen for CDC7 inhibitors	Amidon	2002	0		
838	chr4	33245292	33245332	3500019267	40		33245292	33245332	8421504	1	40	0	c	350001926700000025	5-45						Screen for CDC7 inhibitors	www.devileye.net	0	0		
838	chr4	33250171	33250196	3500066528	23		33250171	33250196	8421504	2	6,17	0,8	c	350006652800000016	7-34						Staphylococcus aureus Pseudomonas aeruginosa Strains Isolated from Clinical Infections	www.mdpi.com	0	0		
838	chr4	33267734	33267767	3500213139	26		33267734	33267767	8421504	3	13,8,5	0,18,28	g	350021313900000030	13-39						Production of trehalose in plants	Hoekema	1995	0		
840	chr4	33491503	33491526	3500145627	23		33491503	33491526	8421504	1	23	0	g	350014562700000059	0-23						Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications	Brinkmann	2005	0		
845	chr4	34093852	34093960	3500235713	44		34093852	34093960	8421504	2	20,24	0,84	g	350023571300000004,350023571300000005	0-20,0-24						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
846	chr4	34319769	34320842	3500063349	48		34319769	34320842	8421504	2	23,25	0,1048	p	350006334900015088	0-48						 <HTML> <HEAD><TITLE>a,aa1/2c1cdegceoa1/4aa(r)a1/2?c"ae3 - c1ei1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4i1/4	www.j-tokkyo.com	0	0		KIAA1324L
105	chr4	34335874	34361087	3500208450	47		34335874	34361087	8421504	3	4,17,26	0,5,25187	c	350020845000000024,350020845000000017,350020845000000019	25-46,21-42,0-21						GRM3 MUTATIONS AND USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF MELANOMA - Patent application	www.faqs.org	0	0		
105	chr4	34335876	34360802	3500273293	52		34335876	34360802	8421504	2	20,32	0,24894	c	350027329300000005,350027329300000015,350027329300000014	10-30,8-40,0-32						Heterooligomeric serotonin/glutamate receptor complex	Gingrich	2009	0		
105	chr4	34335879	34436842	3500464043	2637		34335879	34436842	8421504	5	71,175,1067,856,468	0,14571,24791,77650,100495	p	350046404300015152	0-2637						Novel proteins and nucleic acids encoding same	Gerlach	2001	0		GRM3
105	chr4	34335879	34436842	3500445735	2637		34335879	34436842	8421504	5	71,175,1067,856,468	0,14571,24791,77650,100495	p	350044573500015000	0-2637						KEGG T01001: 2913	www.genome.jp	0	0		GRM3
105	chr4	34335879	34436842	3500333043	2637		34335879	34436842	8421504	5	71,175,1067,856,468	0,14571,24791,77650,100495	p	350033304300015000	0-2637						KEGG T01001: 2913	www.genome.jp	0	0		GRM3
105	chr4	34335879	34436842	3500186961	2637		34335879	34436842	8421504	5	71,175,1067,856,468	0,14571,24791,77650,100495	p	350018696100015156	0-2637						Proteins and nucleic acids encoding same	Gerlach	2001	0		GRM3
847	chr4	34360682	34436563	3500173626	249		34360682	34436563	8421504	4	48,51,99,51	0,53490,53592,75830	p	350017362600015047,350017362600015013,350017362600015011,350017362600015010,350017362600015006	0-48,0-51,0-48,0-51,0-51						Sequence Range: 1 to 2747 >HindIII >KpnI >BamHI CATGCATGCAGCGTTTACTTAAGCTTGGTACCGAGCTCGGATCCACTAGT >EcoRI >BstXI| CCAGTGTGGTGGAATTCACCATGAAGATGTTGACAAGACTGCAAGTTCTT METABOTROPIC GLUTAMATE > ACCTTAGCTTTGTTTTCAAAGGGATTTTTACTCTCTTTAGGGGACCATAA CTTTCTAAGGAGAG	www.cdna.org	0	0		
847	chr4	34361244	34361267	3500343669	23		34361244	34361267	8421504	1	23	0	c,g	350034366900000034,350034366900000034	0-23,0-23						Gastroenterology (February 2005)	005.pasteur.ac.ir	0	0		GRM3
847	chr4	34413642	34413671	3500385809	29		34413642	34413671	8421504	1	29	0	c	350038580900000541	12-41						Novel family of pheromone receptors	Buck	1999	0		
847	chr4	34413782	34436761	3500263396	960		34413782	34436761	8421504	5	258,180,138,345,39	0,261,465,22592,22940	p	350026339600015024,350026339600015003,350026339600015014,350026339600015002,350026339600015023,350026339600015011,350026339600015022	0-435,0-396,0-285,0-480,0-210,87-315,36-159						Chimeric metabotropic glutamate receptors and uses thereof	Gupta	2007	0		GRM3
848	chr4	34532651	34532680	3500002434	24		34532651	34532680	8421504	2	9,15	0,14	g	350000243400000002	0-24						Method for the Production of Glutaconate	Zelder	2010	0		
863	chr4	36509543	36509566	3500078141	23		36509543	36509566	8421504	1	23	0	g	350007814100000003	0-23		19238208	10.1371/journal.pone.0004571		PLoS ONE	Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome	Barbara	2009	0		
864	chr4	36647163	36647191	3500428665	23		36647163	36647191	8421504	2	6,17	0,11	g	350042866500000000	0-23			10.3347/kjp.2002.40.1.33		The Korean Journal of Parasitology	Identification of newly isolated Babesia parasites from cattle in Korea by using the Bo-RBC-SCID mice	Shin-Hyeong	2002	0		
868	chr4	37183991	37184015	3500369652	23		37183991	37184015	8421504	2	8,15	0,9	g	350036965200000092	9-48						<HTML> <HEAD> <TITLE>U.S. Patent: 5635617 - Methods and compositions comprising the agfA gene for	w.everypatent.com	0	0		
880	chr4	38792486	38792514	3500164756	23		38792486	38792514	8421504	2	7,16	0,12	g	350016475600000053	15-38						Compositions and methods for stimulating megakaryocyte growth and differentiation	Bartley	1997	0		
882	chr4	38985529	38985556	3500003517	24		38985529	38985556	8421504	2	11,13	0,14	g	350000351700000117	0-24						 Neisseria Meningitidis Antigens And Compositions 	www.docstoc.com	0	0		
110	chr4	39122688	39258737	3500004246	233		39122688	39258737	8421504	5	48,41,82,14,48	0,54,113348,135938,136001	c	350000424600000388,350000424600000389,350000424600000390,350000424600000391,350000424600000393	0-48,6-48,0-48,0-47,0-48						Assays for agonists and antagonists of recombinant human calcium channels	Harpold	1991	0		
110	chr4	39122776	39236052	3500449456	23		39122776	39236052	8421504	2	7,16	0,113260	c	350044945600000001	0-23						A NEW CLASS OF &agr 2&dgr CALCIUM CHANNEL SUBUNITS - NEUROMED TECHNOLOGIES, INC.	www.sumobrain.com	0	0		CACNA2D1
110	chr4	39538430	39663408	3500004246	1125		39538430	39663408	8421504	30	48,8,40,15,33,30,8,64,50,24,18,78,54,42,6,62,28,35,13,37,1,77,63,52,4,44,47,30,66,48	0,14615,16868,20426,55020,55149,61261,75985,76673,77899,77971,83128,85450,91821,93242,96367,102614,104653,111714,111775,112975,112986,114798,115529,115629,116535,118146,120010,120546,124930	c	350000424600000399,350000424600000403,350000424600000406,350000424600000409,350000424600000412,350000424600000413,350000424600000414,350000424600000416,350000424600000417,350000424600000420,350000424600000421,350000424600000424,350000424600000425,350000424600000428,350000424600000430,350000424600000431,350000424600000432,350000424600000433,350000424600000434,350000424600000436,350000424600000438,350000424600000441,350000424600000442,350000424600000450	0-48,0-48,0-48,0-38,6-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-38,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48						Assays for agonists and antagonists of recombinant human calcium channels	Harpold	1991	0		
886	chr4	39558795	39558820	3500158521	25		39558795	39558820	8421504	1	25	0	c	350015852100000001	25-50		19955484	10.1152/ajpcell.00251.2009		American journal of physiology Cell physiology	Electrophysiological properties of human induced pluripotent stem cells.	Jiang	2010	0		CACNA2D1
887	chr4	39599749	39599775	3500399153	25		39599749	39599775	8421504	2	17,8	0,18	c	350039915300000085,350039915300000083	22-47,20-45						 Method Of Diagnosing Esophageal Cancer 	www.docstoc.com	0	0		
887	chr4	39599749	39599775	3500293286	25		39599749	39599775	8421504	2	17,8	0,18	c	350029328600000067	22-47					Patent	Method of prognosing cancers (Patent EP:2295602)	Nakamura	2012	0		
887	chr4	39599749	39599775	3500288139	25		39599749	39599775	8421504	2	17,8	0,18	c	350028813900000089,350028813900000060	22-47,0-20						METHOD OF DIAGNOSING ESOPHAGEAL CANCER - Patent application	www.faqs.org	0	0		
887	chr4	39653228	39653252	3500000979	24		39653228	39653252	8421504	1	24	0	c,g	350000097900000009,350000097900000009	0-24,0-24						Cell line for the expression of an &#x03b1;2&#x03b4;2 calcium channel subunit and methods of use	Su	2001	0		CACNA2D1
887	chr4	39683368	39683393	3500305030	24		39683368	39683393	8421504	2	20,4	0,21	c	350030503000000202	13-37						Biological methods for preparing a fatty dicarboxylic acid	Beardslee	2013	0		
887	chr4	39683690	39683713	3500342384	23		39683690	39683713	8421504	1	23	0	c	350034238400000438,350034238400000437	18-41,18-41						Compositions and methods for inhibiting expression of a gene from the JC virus	Tan	2007	0		
887	chr4	39683690	39683713	3500323036	23		39683690	39683713	8421504	1	23	0	c	350032303600000436,350032303600000437	18-41,18-41						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF A GENE FROM THE JC VIRUS - Patent application	www.faqs.org	0	0		
889	chr4	39901700	39901726	3500297690	24		39901700	39901726	8421504	3	12,7,5	0,13,21	g	350029769000000093	20-44						US Patent # 5,556,781. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
890	chr4	40049799	40049823	3500289121	24		40049799	40049823	8421504	1	24	0	c	350028912100000013	0-24						Methods and compositions for the treatment of cirrhosis and liver fibrosis	FORTES	2012	0		
890	chr4	40049799	40049823	3500257142	24		40049799	40049823	8421504	1	24	0	c	350025714200000013	0-24						Methods and compositions for the treatment of cirrhosis and liver fibrosis	Alonso	2012	0		
890	chr4	40049803	40063651	3500199787	170		40049803	40063651	8421504	5	40,2,32,48,48	0,3969,9462,9726,13800	c	350019978700000054,350019978700000063,350019978700000066,350019978700000068	6-48,0-32,0-48,0-48						Recombinant proteins derived from HGF and MSP	Medico	2000	0		
890	chr4	40058405	40058444	3500158342	39		40058405	40058444	8421504	1	39	0	c	350015834200000001,350015834200000002	0-39,1-40						Hepatocyte growth factor is a preferred in vitrosubstrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers	craiklab.ucsf.edu	0	0		
890	chr4	40058448	40059234	3500169844	48		40058448	40059234	8421504	3	24,21,3	0,71,783	c	350016984400000014,350016984400000015	0-24,0-24						SURGICAL ATTENUATION OF CONGENITAL PORTOSYSTEMIC SHUNTS IN DOGS	ive.library.uu.nl	0	0		
890	chr4	40058448	40058482	3500234912	34		40058448	40058482	8421504	1	34	0	c	350023491200000059	0-34					Patent	Hepatocyte growth factor (HGF) binding proteins (Patent US:8268315)	Han	2012	0		
890	chr4	40058448	40058482	3500146001	34		40058448	40058482	8421504	1	34	0	c	350014600100000059	0-34						Hepatocyte Growth Factor (HGF) Binding Proteins	Breault	2011	0		
890	chr4	40063645	40063696	3500191479	41		40063645	40063696	8421504	2	20,21	0,30	c,g	350019147900000014,350019147900000015,350019147900000015	0-20,0-21,0-21						 <HTML> <HEAD> <TITLE> The Gene Expression Program of Prostate Fibroblast Sene	.aacrjournals.org	0	0		HGF
898	chr4	41121795	41143796	3500402387	45		41121795	41143796	8421504	2	22,23	0,21978	c,g	350040238700000013,350040238700000013,350040238700000014,350040238700000014	0-22,0-22,0-23,0-23						SIV infection decreases sympathetic innervation of primate lymph nodes: the role of neurotrophins. - ResearchGate	.researchgate.net	0	0		SEMA3C
898	chr4	41121795	41143796	3500040498	45		41121795	41143796	8421504	2	22,23	0,21978	c	350004049800000012,350004049800000013	0-22,0-23			10.1016/j.bbi.2007.07.008		Brain, behavior, and immunity	SIV infection decreases sympathetic innervation of primate lymph nodes: The role of neurotrophins	Erica	2008	0		SEMA3C
898	chr4	41129895	41129927	3500196910	24		41129895	41129927	8421504	3	11,6,7	0,16,25	g	350019691000000019	0-24						Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same	Farmer	2002	0		
898	chr4	41139479	41139502	3500442645	23		41139479	41139502	8421504	1	23	0	c	350044264500000035	0-23		19091861	10.1128/JVI.01871-08	0022-538X	Journal of Virology	Gene Regulation and Functional Alterations Induced by Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORFK13/vFLIP in Endothelial Cells	Sakakibara	2009	5		SEMA3C
900	chr4	41393318	41393344	3500273964	25		41393318	41393344	8421504	2	1,24	0,2	c	350027396400000002	0-25						REPRODUCTION	uction-online.org	0	0		
902	chr4	41551980	41552006	3500336909	24		41551980	41552006	8421504	2	5,19	0,7	g	350033690900000005	4-29						Mikrobiologische herstellung von 3-hydroxypropions&#xe4;ure	Buchholz	2008	0		
902	chr4	41568842	41574692	3500053805	42		41568842	41574692	8421504	3	21,4,17	0,2063,5833	c,g	350005380500000014,350005380500000014,350005380500000015	0-21,0-21,0-21						DIFFERENTIAL ANALYSIS OF GENE EXPRESSION DURING IN VITRO ADIPOGENESIS IN CATTLE	brary.okstate.edu	0	0		
902	chr4	41570903	41575875	3500301078	72		41570903	41575875	8421504	5	6,16,17,12,21	0,3772,3825,4881,4951	c	350030107800000113,350030107800000114,350030107800000037,350030107800000038	0-22,0-22,0-24,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
902	chr4	41575875	41575901	3500344082	23		41575875	41575901	8421504	2	18,5	0,21	c	350034408200000178	25-48						US Patent # 6,265,639. Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use - Patents.com	www.patents.com	0	0		
902	chr4	41583861	41583984	3500281920	41		41583861	41583984	8421504	2	19,22	0,101	c,g	350028192000000010,350028192000000010,350028192000000011,350028192000000011	0-19,0-19,0-22,0-22						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
902	chr4	41651345	41651386	3500442822	41		41651345	41651386	8421504	1	41	0	c	350044282200000002	0-41						US Patent # 5,817,759. Gustducin polypeptides and fragments - Patents.com	www.patents.com	0	0		
902	chr4	41651345	41651386	3500333014	41		41651345	41651386	8421504	1	41	0	c	350033301400000012	0-41						Gustducin materials and methods	Margolskee	1995	0		
905	chr4	42035807	42035835	3500289667	23		42035807	42035835	8421504	2	11,12	0,16	c	350028966700000000,350028966700000011	7-30,7-30						Secreted Luciferase Fluorescent Protein Conjugate Nucleic Acid Construct and Uses Thereof - Patent application	www.faqs.org	0	0		
113	chr4	42036627	42139286	3500033112	1071		42036627	42139286	8421504	8	188,154,130,129,158,142,43,127	0,9434,10627,18298,21817,32478,32717,102532	p	350003311200015027	90-1161						Fluorescent Assay Technologies for G-protein Interactions	y.adelaide.edu.au	0	0		
905	chr4	42036627	42036678	3500383952	51		42036627	42036678	8421504	1	51	0	p	350038395200015056	0-51						Yeast cells expressing modified g proteins and methods of use therefor	Benegal	2000	0		GNAI2
905	chr4	42069150	42069237	3500098797	72		42069150	42069237	8421504	2	30,42	0,45	p	350009879700015050	0-81						G&#x03b1;12 and G&#x03b1;13 Subunits Define a Fourth Class of G Protein &#x03b1; Subunits	www.jstor.org	0	0		GNAI1
113	chr4	42069234	42139259	3500096140	156		42069234	42139259	8421504	3	13,43,100	0,110,69925	p	350009614000015034	0-156						Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor	Fowlkes	1994	0		GNAI1
907	chr4	42302528	42302553	3500309840	24		42302528	42302553	8421504	2	16,8	0,17	g	350030984000000100	19-43						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
907	chr4	42302528	42302553	3500065112	24		42302528	42302553	8421504	2	16,8	0,17	g	350006511200000079	19-43					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
907	chr4	42302528	42302553	3500063056	24		42302528	42302553	8421504	2	16,8	0,17	g	350006305600000083	19-43						Vaccine and antitoxin for treatment and prevention of c. difficile disease	Firca	1999	0		
909	chr4	42567251	42567276	3500394579	23		42567251	42567276	8421504	2	9,14	0,11	g	350039457900000030	16-39						HEPATITIS C VIRUS VACCINE - Patent application	www.faqs.org	0	0		
910	chr4	42613395	42613419	3500466773	23		42613395	42613419	8421504	2	15,8	0,16	g	350046677300000084	22-45						PROTEASES AND VARIANTS THEREOF - Patent application	www.faqs.org	0	0		
916	chr4	43404641	43404666	3500404023	23		43404641	43404666	8421504	2	9,14	0,11	g	350040402300000019	13-36						Cellulase variants	K*V*An De Sen 	1999	0		
916	chr4	43404641	43404666	3500213321	23		43404641	43404666	8421504	2	9,14	0,11	g	350021332100000013	13-36					Patent	Cellulase variants (Patent CN:101085985)	B*Da Mu Jia De 	2012	0		
924	chr4	44498157	44498182	3500156570	23		44498157	44498182	8421504	2	6,17	0,8	g	350015657000000055,350015657000000009	22-45,22-45						Genetically Engineered Clostridial Genes, Proteins Encoded By The Engineered Genes, And Uses Thereof 	.freshpatents.com	0	0		
927	chr4	44893890	44894486	3500466707	60		44893890	44894486	8421504	2	59,1	0,595	p	350046670700015006,350046670700015054	0-60,0-45						US Patent # 6,887,705. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPs) - Patents.com	www.patents.com	0	0		PTPN12
927	chr4	44893890	44894486	3500450152	60		44893890	44894486	8421504	2	59,1	0,595	p	350045015200015006	0-60						US Patent # 6,040,437. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPS) - Patents.com	www.patents.com	0	0		PTPN12
927	chr4	44893890	44894486	3500250528	60		44893890	44894486	8421504	2	59,1	0,595	p	350025052800015008	0-60						US Patent # 6,111,073. Tyrosine phosphorylated cleavage furrow-associated proteins (PSTPIPs) - Patents.com	www.patents.com	0	0		PTPN12
927	chr4	44893890	44894486	3500025751	60		44893890	44894486	8421504	2	59,1	0,595	p	350002575100015002	0-60					The Journal of Cell Biology	PSTPIP: A Tyrosine Phosphorylated Cleavage Furrow&#x2013;associated Protein that Is a Substrate for a PEST Tyrosine Phosphatase 	Susan	1997	0		PTPN12
929	chr4	45184375	45184401	3500342147	24		45184375	45184401	8421504	2	11,13	0,13	g	350034214700000015	8-34						TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling--&#x300a;&#x4e34;&#x5e8a;&#x8c03;&#x67e5;&#x5b66;&#x62a5;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
929	chr4	45196062	45196088	3500073146	23		45196062	45196088	8421504	2	16,7	0,19	g	350007314600000058	17-40						S-ADENOSYL-L-METHIONINE SYNTHETASE PROMOTER AND ITS USE IN EXPRESSION OF TRANSGENIC GENES IN PLANTS - Patent application	www.faqs.org	0	0		
929	chr4	45208991	45209051	3500201764	60		45208991	45209051	8421504	1	60	0	p	350020176400015009	3-63						NOVEL REGULATORY PROTEINS AND INHIBITORS	Greengard	2012	0		GSAP
929	chr4	45208991	45209051	3500019882	60		45208991	45209051	8421504	1	60	0	p	350001988200015000	3-63						Gamma-secretase activating protein is a therapeutic target for Alzheimer&#x2019;s disease	www.scribd.com	0	0		GSAP
116	chr4	45219668	45219922	3500375699	254		45219668	45219922	8421504	1	254	0	g	350037569900000044	0-254						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
930	chr4	45277560	45277588	3500309840	23		45277560	45277588	8421504	3	6,13,4	0,10,24	g	350030984000000694	3-28						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
930	chr4	45340837	45340863	3500159886	23		45340837	45340863	8421504	2	6,17	0,9	c	350015988600000137	5-28						 Methods Of Screening For Compounds That Regulate The Level Of Nramp 	www.docstoc.com	0	0		
933	chr4	45734110	45742809	3500278885	40		45734110	45742809	8421504	2	20,20	0,8679	c,g	350027888500000003,350027888500000003,350027888500000002	0-20,0-20,0-20						Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle. - ResearchGate	.researchgate.net	0	0		
933	chr4	45734110	45742809	3500140766	40		45734110	45742809	8421504	2	20,20	0,8679	c,g	350014076600000003,350014076600000003,350014076600000002	0-20,0-20,0-20		23977311	10.1371/journal.pone.0072521		PLoS ONE	Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle	Maria	2013	0		
934	chr4	45839291	45839320	3500313011	24		45839291	45839320	8421504	2	14,10	0,19	c	350031301100000044	12-36						CYTOLETHAL DISTENDING TOXINS AND DETECTION OF CAMPYLOBACTER BACTERIA USING THE SAME AS A TARGET - Patent application	www.faqs.org	0	0		
934	chr4	45844737	45868415	3500300713	47		45844737	45868415	8421504	2	23,24	0,23654	c	350030071300000011,350030071300000010	0-23,0-24						Pan Arab Journal of Oncology	amaac.org/images/	0	0		DNAJC2
934	chr4	45866944	45866971	3500260488	23		45866944	45866971	8421504	2	11,12	0,15	g	350026048800000099	6-39						Hemoglobin receptors from neisseriae	Heffron	1996	0		
935	chr4	45897328	45899327	3500197291	168		45897328	45899327	8421504	3	38,55,75	0,1255,1924	p	350019729100015096	0-168						The Molecular Characterization and Expression of New Human SLC26 Anion Transporters	helda.helsinki.fi	0	0		
935	chr4	45962329	45962360	3500355848	31		45962329	45962360	8421504	1	31	0	c	350035584800000002	0-31		17687039	10.1523/JNEUROSCI.5041-06.2007	0270-6474	The Journal of Neuroscience	Kinetic Properties of Cl&#x2212; Uptake Mediated by Na+-Dependent K+-2Cl&#x2212; Cotransport in Immature Rat Neocortical Neurons	Achilles	2007	7		
935	chr4	45999106	45999129	3500098694	23		45999106	45999129	8421504	1	23	0	c	350009869400000002	0-23						Use of reelin, gas6, and protein s in the treatment of neural disorders	Bertilsson	2003	0		RELN
936	chr4	46115835	46115861	3500309840	23		46115835	46115861	8421504	2	9,14	0,12	g	350030984000000940	1-24						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
937	chr4	46162276	46168200	3500270141	45		46162276	46168200	8421504	3	22,1,22	0,5173,5902	c	350027014100000010,350027014100000009	0-23,0-22		17108332	10.1095/biolreprod.106.057216	0006-3363	Biology of Reproduction	Low-Density Lipoprotein Receptor-Related Protein 8 (LRP8) Is Upregulated in Granulosa Cells of Bovine Dominant Follicle: Molecular Characterization and Spatio-Temporal Expression Studies	Fayad	2007	4		
938	chr4	46295246	46318574	3500388552	50		46295246	46318574	8421504	2	26,24	0,23304	c,g	350038855200000019,350038855200000019,350038855200000018,350038855200000018	0-26,0-26,0-24,0-24						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
938	chr4	46295246	46318574	3500143254	50		46295246	46318574	8421504	2	26,24	0,23304	c,g	350014325400000019,350014325400000019,350014325400000018,350014325400000018	0-26,0-26,0-24,0-24						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
940	chr4	46541568	46541593	3500251483	25		46541568	46541593	8421504	1	25	0	c	350025148300000024	0-25						Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells	Bertilsson	2002	0		RELN
940	chr4	46541568	46541593	3500098694	25		46541568	46541593	8421504	1	25	0	c	350009869400000024	0-25						Use of reelin, gas6, and protein s in the treatment of neural disorders	Bertilsson	2003	0		RELN
943	chr4	47003934	47003959	3500070288	24		47003934	47003959	8421504	2	16,8	0,17	g	350007028800000700	2-26						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
946	chr4	47365413	47365436	3500025873	23		47365413	47365436	8421504	1	23	0	g	350002587300000322	10-38						US Patent # 6,593,293. Lepidopteran-active Bacillus thuringiensis .delta.-endotoxin compositions and methods of use - Patents.com	www.patents.com	0	0		
949	chr4	47771873	47771896	3500426133	23		47771873	47771896	8421504	1	23	0	g	350042613300000020	0-23						Genomic Characterization of Porcine Rotaviruses in Italy	cvi.asm.org	0	0		
949	chr4	47789434	47789794	3500375699	360		47789434	47789794	8421504	1	360	0	g	350037569900000026	0-361						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
950	chr4	47841776	47878219	3500048564	45		47841776	47878219	8421504	3	20,18,7	0,35127,36436	c,g	350004856400000000,350004856400000000,350004856400000003	0-20,0-20,0-25						MIXED LINEAGE LEUKEMIA 5 ISOFORM IS A POTENTIAL BIOMARKER AND THERAPEUTIC TARGET FOR HPV-ASSOCIATED CERVICAL CANCER - NATIONAL UNIVERSITY OF SINGAPORE	www.sumobrain.com	0	0		
951	chr4	48083952	48083977	3500462669	24		48083952	48083977	8421504	2	8,16	0,9	g	350046266900000035	11-38						US Patent # 6,146,863. Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase - Patents.com	www.patents.com	0	0		
952	chr4	48176588	48176613	3500421313	23		48176588	48176613	8421504	2	12,11	0,14	c	350042131300000003	5-39						High-performance Metagenomic Data Clustering and Assembly	graphanalysis.org	0	0		
953	chr4	48300218	48300246	3500269550	23		48300218	48300246	8421504	2	15,8	0,20	g	350026955000000098	2-28						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
953	chr4	48318859	48318887	3500105905	24		48318859	48318887	8421504	2	15,9	0,19	c	350010590500000020	11-35						Method for Expression and Accumulation of Peptide in Plant - Patent application	www.faqs.org	0	0		ATXN7L1
958	chr4	48915706	48915735	3500119662	26		48915706	48915735	8421504	2	5,21	0,8	c	350011966200000003	15-41						Journal of Inflammation BioMed Central	biomedcentral.com	0	0		
958	chr4	48915714	48920918	3500205721	81		48915714	48920918	8421504	2	21,60	0,5144	p,c	350020572100000003,350020572100015000	0-21,3-63						Biochemical Genetics, Volume43, Number3-4, 2005&#x5e74;4&#x6708;, &#x6750;&#x6599;4 - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		NAMPT
958	chr4	48934432	48939464	3500211738	38		48934432	48939464	8421504	2	19,19	0,5013	c,g	350021173800000001,350021173800000001,350021173800000000,350021173800000000	0-19,0-19,0-19,0-19		19478080	10.1074/jbc.M109.016469	0021-9258	Journal of Biological Chemistry	Enzymes in the NAD+ Salvage Pathway Regulate SIRT1 Activity at Target Gene Promoters	Zhang	2009	5		
961	chr4	49293592	49293616	3500055138	23		49293592	49293616	8421504	2	4,19	0,5	g	350005513800000000	0-24						SureChem - Document - European Granted - Patent No. 0721013 - "New staphylokinase derivatives" - Description	www.surechem.org	0	0		
963	chr4	49591255	49591280	3500271179	23		49591255	49591280	8421504	2	8,15	0,10	g	350027117900000076	2-25						Therapeutic uses of inhibitors of RTP801	The	2005	0		
963	chr4	49614155	49614184	3500335399	29		49614155	49614184	8421504	1	29	0	c	350033539900000003	9-38						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	Fowler	2012	0		PIK3CG
963	chr4	49614155	49614184	3500307977	29		49614155	49614184	8421504	1	29	0	c	350030797700000003	9-38						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	Fowler	2013	0		
963	chr4	49614155	49614184	3500306413	29		49614155	49614184	8421504	1	29	0	c	350030641300000003	9-38						Quinazolinones as Inhibitors of Human Phosphatidylinositol 3-Kinase Delta	Fowler	2008	0		PIK3CG
963	chr4	49614155	49614184	3500299796	29		49614155	49614184	8421504	1	29	0	c	350029979600000003	9-38						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	Fowler	2010	0		
963	chr4	49614155	49614184	3500189971	29		49614155	49614184	8421504	1	29	0	c	350018997100000003	9-38						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	Fowler	2010	0		PIK3CG
963	chr4	49614155	49614184	3500176911	29		49614155	49614184	8421504	1	29	0	c	350017691100000003	9-38					Patent	Inhibitors of human phosphatidyl-inositol 3-kinase delta (Patent US:6949535)	Sadhu	2005	0		PIK3CG
963	chr4	49614155	49614184	3500173904	29		49614155	49614184	8421504	1	29	0	c	350017390400000003	9-38						Inhibitors of human phosphatidylinositol 3-kinase delta	Sadhu	2010	0		PIK3CG
963	chr4	49614155	49614184	3500127478	29		49614155	49614184	8421504	1	29	0	c	350012747800000003	9-38					Patent	Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (Patent US:8207153)	Fowler	2012	0		
963	chr4	49614155	49614184	3500120979	29		49614155	49614184	8421504	1	29	0	c	350012097900000003	9-38					Patent	Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (Patent US:7932260)	Fowler	2011	0		
963	chr4	49614155	49614184	3500111188	29		49614155	49614184	8421504	1	29	0	c	350011118800000003,350011118800000074	9-38,9-37						INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA - Patent application	www.faqs.org	0	0		PIK3CG
963	chr4	49614155	49614184	3500051994	29		49614155	49614184	8421504	1	29	0	c	350005199400000003	9-38						INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA	Sadhu	2009	0		
963	chr4	49614155	49614184	3500018554	29		49614155	49614184	8421504	1	29	0	c	350001855400000003	9-38						Quinazolinones as Inhibitors of Human Phosphatidylinositol 3-Kinase Delta	Fowler	2005	0		
963	chr4	49614155	49614183	3500396234	28		49614155	49614183	8421504	1	28	0	c	350039623400000003	9-37						Inhibitors of human phosphatidyl-inositol 3-kinase delta	Farouz	2009	0		
963	chr4	49614155	49614183	3500297309	28		49614155	49614183	8421504	1	28	0	c	350029730900000005	9-37					Patent	Inhibitors of human phosphatidyl-inositol 3-kinase delta (Patent CN:1606444)	A*Ao Li Fu 	2010	0		
963	chr4	49614155	49614183	3500278290	28		49614155	49614183	8421504	1	28	0	c	350027829000000005	9-37					Patent	Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta (Patent CN:101031569)	A*R*Ao Li Fu 	2011	0		
963	chr4	49614155	49614183	3500263537	28		49614155	49614183	8421504	1	28	0	c	350026353700000006	9-37						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	A*R*Ao Li Fu 	2011	0		
963	chr4	49614155	49614183	3500166986	28		49614155	49614183	8421504	1	28	0	c	350016698600000002	9-37						Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	Fowler	2013	0		
963	chr4	49614155	49614183	3500083335	28		49614155	49614183	8421504	1	28	0	c	350008333500000004,350008333500000075	9-37,9-37					Patent	Inhibitors of human phosphatidylinositol 3-kinase delta (Patent US:6667300)	Sadhu	2003	0		PIK3CG
963	chr4	49635058	49635082	3500271107	23		49635058	49635082	8421504	2	16,7	0,17	c	350027110700000055	1-24						Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis - Patent application	www.faqs.org	0	0		
120	chr4	49839750	49942239	3500111111	1254		49839750	49942239	8421504	11	307,36,53,84,107,154,102,75,66,139,131	0,25988,63795,72035,87587,90863,95766,97454,99876,100070,102358	p	350011111100015030	0-1254						Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity	Chang	2012	0		PRKAR2B
965	chr4	49839753	49839885	3500446950	132		49839753	49839885	8421504	1	132	0	p	350044695000015025,350044695000015112,350044695000015113	0-132,0-45,0-48						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells - Patent application	www.faqs.org	0	0		PRKAR2B
965	chr4	49839753	49839885	3500430125	132		49839753	49839885	8421504	1	132	0	p	350043012500015029	0-132						Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer	Gold	2012	0		PRKAR2B
965	chr4	49839753	49839885	3500427070	132		49839753	49839885	8421504	1	132	0	p	350042707000015054	0-132						Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases	Chang	2011	0		PRKAR2B
965	chr4	49839753	49839885	3500404766	132		49839753	49839885	8421504	1	132	0	p	350040476600015035	0-132						FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death	Alinari	2013	0		PRKAR2B
965	chr4	49839753	49839885	3500382936	132		49839753	49839885	8421504	1	132	0	p	350038293600015030,350038293600015191	0-132,0-45						Detection of Early-Stage Pancreatic Adenocarcinoma - Patent application	www.faqs.org	0	0		PRKAR2B
965	chr4	49839753	49839885	3500377644	132		49839753	49839885	8421504	1	132	0	p	350037764400015047	0-132						Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma	Burton	2012	0		PRKAR2B
965	chr4	49839753	49839885	3500304681	132		49839753	49839885	8421504	1	132	0	p	350030468100015031,350030468100015187	0-132,0-45						Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer - Patent application	www.faqs.org	0	0		PRKAR2B
965	chr4	49839753	49839885	3500289124	132		49839753	49839885	8421504	1	132	0	p	350028912400015021	0-132						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells	Chang	2011	0		PRKAR2B
965	chr4	49839753	49839885	3500249189	132		49839753	49839885	8421504	1	132	0	p	350024918900015026,350024918900015105	0-132,0-45						Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity - Patent application	www.faqs.org	0	0		PRKAR2B
965	chr4	49839753	49839885	3500240466	132		49839753	49839885	8421504	1	132	0	p	350024046600015037,350024046600015074	0-132,0-45						FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death - Patent application	www.faqs.org	0	0		PRKAR2B
965	chr4	49839753	49839885	3500221336	132		49839753	49839885	8421504	1	132	0	p	350022133600015046	0-132						COMBINATION THERAPY WITH ANTI-CD74 ANTIBODIES PROVIDES ENHANCED TOXICITY TO MALIGNANCIES, AUTOIMMUNE DISEASE AND OTHER DISEASES - IMMUNOMEDICS, INC.	www.sumobrain.com	0	0		PRKAR2B
965	chr4	49839753	49839885	3500196739	132		49839753	49839885	8421504	1	132	0	p	350019673900015027	0-132						Anti-HLA-DR Antibodies Suppress Allogeneic and Xenogeneic Immune Responses to Organ Transplants	Sawada	2012	0		PRKAR2B
965	chr4	49839753	49839885	3500165028	132		49839753	49839885	8421504	1	132	0	p	350016502800015015	0-132						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting	Mcbride	2012	0		PRKAR2B
965	chr4	49839753	49839885	3500147691	132		49839753	49839885	8421504	1	132	0	p	350014769100015045	0-132						Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases	Chang	2011	0		PRKAR2B
965	chr4	49839753	49839885	3500100255	132		49839753	49839885	8421504	1	132	0	p	350010025500015018	0-132						Dock-and-lock (dnl) complexes for delivery of interference rna	Chang	2012	0		PRKAR2B
965	chr4	49839753	49839885	3500096413	132		49839753	49839885	8421504	1	132	0	p	350009641300015018,350009641300015117,350009641300015119	0-132,0-48,0-48						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting - Patent application	www.faqs.org	0	0		PRKAR2B
965	chr4	49839753	49839885	3500089169	132		49839753	49839885	8421504	1	132	0	p	350008916900015026,350008916900015111	0-132,0-45						Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells - Patent application	www.faqs.org	0	0		PRKAR2B
965	chr4	49839753	49839885	3500080236	132		49839753	49839885	8421504	1	132	0	p	350008023600015043	0-132						Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases	Chang	2011	0		PRKAR2B
965	chr4	49839753	49839885	3500036974	132		49839753	49839885	8421504	1	132	0	p	350003697400015018	0-132						Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting - Patent application	www.faqs.org	0	0		PRKAR2B
120	chr4	49927346	49942179	3500173556	348		49927346	49942179	8421504	7	90,18,66,63,27,13,71	0,3403,8170,9870,12280,12600,14762	p	350017355600015022,350017355600015029,350017355600015019,350017355600015027	0-90,0-84,0-90,0-84						EpacisaRap1guanine- nucleotide-exchangefactor directlyactivatedby cyclicAMP	mcr.umcutrecht.nl	0	0		PRKAR2B
966	chr4	49942160	49942228	3500299586	52		49942160	49942228	8421504	2	26,26	0,42	c	350029958600000092,350029958600000093,350029958600000023	21-47,0-26,13-39						Permuted and nonpermuted luciferase biosensors	Binkowski	2011	0		
966	chr4	49968978	49979402	3500397283	67		49968978	49979402	8421504	3	24,24,19	0,3017,10405	c	350039728300000001,350039728300000002,350039728300000000	0-24,0-24,0-19		16495219	10.1074/jbc.M513378200	0021-9258	Journal of Biological Chemistry	Suppression of Wnt Signaling by the Green Tea Compound (&#x2013;)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells	Kim	2006	5		HBP1
966	chr4	49968978	49979402	3500181115	67		49968978	49979402	8421504	3	24,24,19	0,3017,10405	c	350018111500000001,350018111500000002,350018111500000000	0-24,0-24,0-19		16495219	10.1074/jbc.M513378200	0021-9258	Journal of Biological Chemistry	Suppression of Wnt Signaling by the Green Tea Compound (&#x2013;)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells	Kim	2006	5		HBP1
966	chr4	49968978	49972019	3500358017	48		49968978	49972019	8421504	2	24,24	0,3017	c	350035801700000004,350035801700000005	0-24,0-24		21967847	10.1093/nar/gkr818		Nucleic Acids Research	The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression	Weibin	2012	0		HBP1
966	chr4	49968978	49972019	3500232368	48		49968978	49972019	8421504	2	24,24	0,3017	c	350023236800000011,350023236800000012	0-24,0-24		23249948	10.1128/MCB.00637-12		Molecular and Cellular Biology	HBP1-Mediated Transcriptional Regulation of DNA Methyltransferase 1 and Its Impact on Cell Senescence	Kewu	2013	0		HBP1
966	chr4	49969537	49972806	3500290029	411		49969537	49972806	8421504	4	37,113,157,104	0,125,2337,3165	p	350029002900015036	69-480							rcebioscience.com	0	0		HBP1
970	chr4	50466842	50466865	3500252168	23		50466842	50466865	8421504	1	23	0	c	350025216800000021	11-40						PLANT OVEREXPRESSING ABSCISIC ACID TRANSPORTER PROTEIN AND METHOD FOR PRODUCING THE SAME - Patent application	www.faqs.org	0	0		
970	chr4	50468941	50468973	3500299205	32		50468941	50468973	8421504	1	32	0	c	350029920500000000	9-41		12372813	10.1152/ajpcell.00115.2002		American Journal of Physiology - Cell Physiolog	The functional and physical relationship between the DRA bicarbonate transporter and carbonic anhydrase II	Sterling	2002	0		SLC26A3
971	chr4	50721513	50724301	3500203394	48		50721513	50724301	8421504	2	24,24	0,2764	c,g	350020339400000045,350020339400000044,350020339400000044	0-24,0-24,0-24						Human Embryonic Stem Cells: The Practical Handbook	www.scribd.com	0	0		
972	chr4	50726995	50727019	3500114630	24		50726995	50727019	8421504	1	24	0	c	350011463000000294	21-45						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
972	chr4	50727109	50731955	3500283855	51		50727109	50731955	8421504	2	41,10	0,4836	p	350028385500015011	0-51					Patent	Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups (Patent US:7744912)	Hubbell	2010	0		LAMB1
972	chr4	50727109	50731955	3500013096	51		50727109	50731955	8421504	2	41,10	0,4836	p	350001309600015012,350001309600015032	0-51,0-45						 Biomaterials Formed By Nucleophilic Addition Reaction To Conjugated Unsaturated Groups 	www.docstoc.com	0	0		LAMB1
972	chr4	50732273	50743988	3500249098	46		50732273	50743988	8421504	3	15,9,22	0,8212,11693	c,g	350024909800000013,350024909800000012,350024909800000012	0-24,0-22,0-22						A CHARACTERIZATION OF INFLAMMATORY AND STRUCTURAL MARKERS WITHIN THE RUMEN EPITHELIUM DURING GRAIN-INDUCED RUMINAL ACIDOSIS IN	thescipub.com	0	0		LAMB1
973	chr4	50935427	50935472	3500062902	45		50935427	50935472	8421504	1	45	0	p	350006290200015015	15-60						neuer Funktionen der	ub.uni-hamburg.de	0	0		NRCAM
973	chr4	50968940	50968965	3500072968	24		50968940	50968965	8421504	2	18,6	0,19	c	350007296800000211	24-48						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
977	chr4	51418048	51418108	3500405634	60		51418048	51418108	8421504	1	60	0	p	350040563400015000	0-60						Method for diagnosing polycystic kidney disease	Walz	2011	0		SFRP4
977	chr4	51418048	51418108	3500362926	60		51418048	51418108	8421504	1	60	0	p	350036292600015004	0-60						METHOD FOR DIAGNOSING POLYCYSTIC KIDNEY DISEASE	Walz	2007	0		SFRP4
977	chr4	51418048	51418108	3500252830	60		51418048	51418108	8421504	1	60	0	p	350025283000015000	0-60					Patent	Method for diagnosing polycystic kidney disease (Patent EP:1974210)	Walz	2010	0		SFRP4
977	chr4	51418048	51418108	3500099865	60		51418048	51418108	8421504	1	60	0	p	350009986500015000	0-60						Method for diagnosing polycystic kidney disease	Walz	2008	0		SFRP4
977	chr4	51418048	51418108	3500043934	60		51418048	51418108	8421504	1	60	0	p	350004393400015000	0-60					Patent	Method for diagnosing polycystic kidney disease (Patent EP:1974210)	Walz	2010	0		SFRP4
977	chr4	51427152	51427491	3500337812	336		51427152	51427491	8421504	2	297,39	0,300	p	350033781200015026	0-336						Wnt antagonists and methods of treatment and screening	Satyal	2011	0		SFRP4
977	chr4	51427152	51427491	3500039991	336		51427152	51427491	8421504	2	297,39	0,300	p	350003999100015028	0-336						WNT ANTAGONISTS AND METHODS OF TREATMENT AND SCREENING - ONCOMED PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		SFRP4
977	chr4	51427219	51427462	3500366673	43		51427219	51427462	8421504	2	22,21	0,222	c,g	350036667300000067,350036667300000066,350036667300000066	0-22,0-21,0-21			10.1111/j.1365-2141.2006.06442.x	1365-2141	British Journal of Haematology	Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines - Nygren - 2006 - British Journal of Haematology - Wiley Online Library	Nygren	2007	0		SFRP4
979	chr4	51770205	51770228	3500012101	23		51770205	51770228	8421504	1	23	0	g	350001210100000058	21-44						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		
980	chr4	51829788	51829814	3500113403	26		51829788	51829814	8421504	1	26	0	g	350011340300000003	2-28		17234682	10.1189/jlb.0506331	0741-5400	Journal of Leukocyte Biology	Massive, sustained &#x03b3;&#x03b4; T cell migration from the bovine skin in vivo	Rhijn	2007	5		
983	chr4	52231035	52247358	3500414565	94		52231035	52247358	8421504	2	30,64	0,16259	g	350041456500000787,350041456500000676,350041456500000666,350041456500000660,350041456500000671,350041456500000655,350041456500000668,350041456500000657,350041456500000659,350041456500000663	41-71,0-48,67-117,0-48,0-64,0-50,0-51,0-50,7-45,7-51						Analyzing Comparative Sequence Data to Understand Genome Function and Evolution	gradworks.umi.com	0	0		
983	chr4	52235313	52235338	3500259074	25		52235313	52235338	8421504	1	25	0	g	350025907400000161	0-25						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
15	chr4	52425372	52611004	3500111044	259		52425372	52611004	8421504	10	40,4,41,42,3,41,15,25,19,29	0,1708,2351,45584,61355,89308,154414,155534,179208,185603	c	350011104400000157,350011104400000150,350011104400000136,350011104400000106,350011104400000078,350011104400000066	0-40,0-45,0-45,0-41,7-47,0-48						TDP-43-STORING CELL MODEL - Patent application	www.faqs.org	0	0		
984	chr4	52426991	52427749	3500034129	46		52426991	52427749	8421504	2	22,24	0,734	c	350003412900000018,350003412900000019,350003412900000012	0-22,23-45,19-43		11022033	10.1074/jbc.M003672200	0021-9258	Journal of Biological Chemistry	Localization of Sequences within the C-terminal Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Which Impact Maturation and Stability	Gentzsch	2001	5		
984	chr4	52427035	52427059	3500259074	24		52427035	52427059	8421504	1	24	0	c	350025907400000170	21-45						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		CFTR
15	chr4	52427072	52438882	3500039054	80		52427072	52438882	8421504	3	12,28,40	0,651,11770	c	350003905400000056,350003905400000053	0-40,0-40						Use Of Wavelet Packet Transforms to Develop an David L. Walker	olar.wvu.edu:8881	0	0		
15	chr4	52427075	52663565	3500306898	664		52427075	52663565	8421504	20	9,20,48,24,24,48,47,41,46,87,11,48,24,24,48,15,32,31,17,20	0,648,43752,43899,59652,62087,87215,87605,87889,89446,93139,119571,131325,149634,159169,177509,183900,183980,229237,236470	c,g	350030689800000112,350030689800000101,350030689800000098,350030689800000095,350030689800000077,350030689800000069,350030689800000063,350030689800000062,350030689800000061,350030689800000058,350030689800000049,350030689800000032,350030689800000029,350030689800000027,350030689800000011	0-29,0-48,0-48,0-48,0-47,3-44,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-20						Cystic fibrosis gene	www.devileye.net	0	0		
15	chr4	52427075	52656329	3500121469	220		52427075	52656329	8421504	8	9,20,48,47,37,11,31,17	0,648,59676,87215,89496,93139,183980,229237	c	350012146900000112,350012146900000097,350012146900000077,350012146900000061,350012146900000027	0-29,0-48,0-47,0-48,0-48						Cystic fibrosis gene	Tsui	1995	0		
15	chr4	52427075	52656329	3500045075	950		52427075	52656329	8421504	25	9,20,48,24,72,96,8,40,47,41,46,87,11,29,60,24,24,42,48,31,48,15,32,31,17	0,648,43752,43899,59652,62087,69023,71971,87215,87605,87889,89446,93139,93205,119559,131325,149634,149706,154696,159062,159169,177509,183900,183980,229237	c	350004507500000095,350004507500000084,350004507500000081,350004507500000080,350004507500000078,350004507500000077,350004507500000069,350004507500000060,350004507500000052,350004507500000046,350004507500000045,350004507500000044,350004507500000042,350004507500000041,350004507500000032,350004507500000030,350004507500000020,350004507500000005,350004507500000015,350004507500000012,350004507500000010	0-29,0-48,0-48,0-48,0-48,0-48,0-48,0-47,3-44,0-48,0-48,0-48,0-41,0-48,0-48,6-48,0-48,0-31,0-48,0-47,0-48						Gene therapy for cystic fibrosis - US Patent 6093567 Description	ww.patentstorm.us	0	0		
15	chr4	52427075	52586292	3500173367	567		52427075	52586292	8421504	16	9,20,48,48,47,41,85,11,29,12,24,24,42,48,31,48	0,648,59676,62135,87215,87605,89448,93139,93205,119559,131325,149634,149706,154696,159062,159169	c	350017336700000093,350017336700000078,350017336700000075,350017336700000058,350017336700000050,350017336700000043,350017336700000042,350017336700000040,350017336700000030,350017336700000028,350017336700000019,350017336700000005,350017336700000014	0-29,0-48,0-48,0-47,3-44,0-48,0-48,0-41,0-48,6-48,0-48,0-31,0-48						 Adenovirus Vector For Gene Therapy 	www.docstoc.com	0	0		
15	chr4	52427075	52586168	3500325090	347		52427075	52586168	8421504	11	9,20,24,72,47,37,11,24,24,48,31	0,648,43899,59652,87215,89496,93139,131325,149634,154696,159062	c	350032509000000093,350032509000000079,350032509000000078,350032509000000058,350032509000000042,350032509000000030,350032509000000019,350032509000000005	0-29,0-48,0-48,0-47,0-48,0-48,0-48,0-31						Adenoviral vectors for gene therapy containing deletions in the adenoviral genome	Gregory	1997	0		
15	chr4	52427075	52576733	3500317121	309		52427075	52576733	8421504	11	9,20,24,24,47,41,37,11,48,24,24	0,648,43899,59652,87215,87605,89496,93139,119571,131325,149634	c	350031712100000093,350031712100000079,350031712100000058,350031712100000050,350031712100000042,350031712100000039,350031712100000030	0-29,0-48,0-47,3-44,0-48,0-48,0-48						US Patent # 5,670,488. Adenovirus vector for gene therapy - Patents.com	www.patents.com	0	0		
15	chr4	52427836	52656326	3500083639	275		52427836	52656326	8421504	8	47,44,48,15,25,48,34,14	0,61471,84447,151950,153070,158261,183216,228476	c	350008363900000173,350008363900000156,350008363900000143,350008363900000105,350008363900000099,350008363900000091	1-48,0-44,0-48,7-47,0-48,0-48					Patent	Methods for screening for mutations at various positions in the introns and exons of the cystic fibrosis gene (Patent US:5981178)	Kerem	1999	0		
15	chr4	52427894	52656326	3500430011	314		52427894	52656326	8421504	14	2,36,28,16,20,28,40,8,15,25,19,29,34,14	0,10933,58906,61249,61457,62602,88674,92320,151892,153012,176686,183081,183158,228418	c	350043001100000171,350043001100000159,350043001100000154,350043001100000124,350043001100000104,350043001100000092,350043001100000090	0-38,0-44,0-48,0-48,7-47,0-48,0-48						Introns and exons of the cystic fibrosis gene and mutations thereof	Tsui	1992	0		
123	chr4	52438821	52611102	3500206075	116		52438821	52611102	8421504	6	20,25,6,15,23,27	0,47901,112890,112897,147237,172254	g	350020607500000055,350020607500000048,350020607500000026,350020607500000014,350020607500000009	3-23,0-25,1-22,0-23,0-27						CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MUTATIONS	Hantash	2010	0		
123	chr4	52438821	52586081	3500016509	137		52438821	52586081	8421504	7	20,25,25,6,15,23,23	0,47901,50541,112890,112897,140957,147237	c,g	350001650900000091,350001650900000085,350001650900000082,350001650900000063,350001650900000056,350001650900000051	3-23,0-25,0-25,1-22,18-41,0-23						Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations 	.freshpatents.com	0	0		
985	chr4	52438842	52438865	3500368098	23		52438842	52438865	8421504	1	23	0	c	350036809800000002	0-23						Replication deficient recombinant adenovirus vector	www.devileye.net	0	0		CFTR
985	chr4	52451914	52470752	3500379875	51		52451914	52470752	8421504	2	45,6	0,18832	p	350037987500015007	0-51						Protein Kinase CK2, Cystic Fibrosis Transmembrane Conductance Regulator, and the F508 Mutation--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x	journal.9med.net	0	0		CFTR
985	chr4	52451914	52470752	3500199794	51		52451914	52470752	8421504	2	45,6	0,18832	p	350019979400015007	0-51		17289674	10.1074/jbc.M610956200	0021-9258	Journal of Biological Chemistry	Protein Kinase CK2, Cystic Fibrosis Transmembrane Conductance Regulator, and the &#x0394;F508 Mutation	Treharne	2007	5		CFTR
985	chr4	52470927	52551821	3500414565	211		52470927	52551821	8421504	7	40,29,39,25,25,27,26	0,43466,43661,43737,43786,43820,80868	c,g	350041456500000596,350041456500000557,350041456500000476,350041456500000476,350041456500000479,350041456500000479,350041456500000437,350041456500000418,350041456500000440,350041456500000436,350041456500000396,350041456500000353,350041456500000354,350041456500000312,350041456500000317,350041456500000299,350041456500000271,350041456500000256	0-24,0-25,0-29,0-29,1-29,1-29,0-39,5-27,6-25,0-22,0-25,0-25,0-25,0-27,0-23,0-20,0-26,10-29						Analyzing Comparative Sequence Data to Understand Genome Function and Evolution	gradworks.umi.com	0	0		
985	chr4	52489191	52489241	3500450183	49		52489191	52489241	8421504	2	17,32	0,18	c	350045018300000055	0-49						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
985	chr4	52489209	52489249	3500137403	40		52489209	52489249	8421504	1	40	0	c	350013740300000001	0-40						Gene expression profiling	Chowdhury	2004	0		
985	chr4	52499754	52512250	3500303994	24		52499754	52512250	8421504	2	21,3	0,12493	c	350030399400000001	5-29		11504700			American Journal of Physiology - Lung Cellular and Molecular Physiology	Expression of CFTR and Cl&#x2212; conductances in cells of pulmonary neuroepithelial bodies	Yeger	2001	0		
985	chr4	52499754	52512250	3500186462	24		52499754	52512250	8421504	2	21,3	0,12493	c	350018646200000001	5-29		11504700			American Journal of Physiology - Lung Cellular and Molecular Physiology	Expression of CFTR and Cl&#x2212; conductances in cells of pulmonary neuroepithelial bodies	Yeger	2001	0		
985	chr4	52520240	52520270	3500337543	30		52520240	52520270	8421504	1	30	0	g	350033754300000072,350033754300000068	15-44,15-45						Process for allele discrimination utilizing primer extension	Abarzua	2001	0		
985	chr4	52520246	52520273	3500146585	27		52520246	52520273	8421504	1	27	0	c	350014658500000025,350014658500000024,350014658500000023	1-25,0-25,0-25					Patent	Method for analyzing the nucleotide sequence of a polynucleotide by oligonucleotide extension on an array (Patent US:6294336)	Boyce-Jacino	2001	0		
985	chr4	52520247	52546698	3500058241	47		52520247	52546698	8421504	2	20,27	0,26424	c,g	350005824100000326,350005824100000326,350005824100000197	0-20,0-20,0-27						Detection of nucleic acid hybrids	Shultz	2001	0		
985	chr4	52546642	52558355	3500414004	40		52546642	52558355	8421504	2	19,21	0,11692	c	350041400400000003,350041400400000002	0-19,0-21			10.1152/ajplung.00445.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	NHE-RF1 protein rescues &#x0394;F508-CFTR function	Bossard	2007	0		CFTR
985	chr4	52546642	52558355	3500061140	40		52546642	52558355	8421504	2	19,21	0,11692	c	350006114000000003,350006114000000002	0-19,0-21			10.1152/ajplung.00445.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	NHE-RF1 protein rescues &#x0394;F508-CFTR function	Bossard	2007	0		CFTR
985	chr4	52546642	52558355	3500028120	40		52546642	52558355	8421504	2	19,21	0,11692	c,g	350002812000000003,350002812000000003,350002812000000002,350002812000000002	0-19,0-19,0-21,0-21			10.1152/ajplung.00445.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	NHE-RF1 protein rescues &#x0394;F508-CFTR function	Bossard	2007	0		CFTR
985	chr4	52546642	52558355	3500018492	40		52546642	52558355	8421504	2	19,21	0,11692	c	350001849200000003,350001849200000002	0-19,0-21			10.1152/ajplung.00445.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	NHE-RF1 protein rescues &#x0394;F508-CFTR function	Bossard	2007	0		CFTR
985	chr4	52546668	52546697	3500348251	29		52546668	52546697	8421504	1	29	0	c	350034825100000008,350034825100000007,350034825100000019	1-28,0-28,0-24						DNA DIAGNOSTICS BASED ON MASS SPECTROMETRY	Koster	1999	0		CFTR
985	chr4	52546668	52546697	3500272332	29		52546668	52546697	8421504	1	29	0	c	350027233200000003,350027233200000002,350027233200000014	1-28,0-28,0-24					Patent	DNA diagnostics based on mass spectrometry (Patent US:6300076)	Koster	2001	0		CFTR
985	chr4	52546668	52546696	3500128303	28		52546668	52546696	8421504	1	28	0	c,g	350012830300000134,350012830300000008,350012830300000218	1-28,1-28,0-21						 DNA Diagnostics Based On Mass Spectrometry 	www.docstoc.com	0	0		
985	chr4	52546668	52546695	3500425166	27		52546668	52546695	8421504	1	27	0	c	350042516600000003	1-28						US Patent # 6,428,955. DNA diagnostics based on mass spectrometry - Patents.com	www.patents.com	0	0		
985	chr4	52546668	52546695	3500403475	27		52546668	52546695	8421504	1	27	0	c	350040347500000008	1-28					Patent	DNA diagnostics based on mass spectrometry (Patent US:7198893)	Koster	2007	0		
985	chr4	52546671	52546718	3500453187	47		52546671	52546718	8421504	1	47	0	c	350045318700000031	0-47						Detection of nucleic acid hybrids	www.devileye.net	0	0		
985	chr4	52546671	52546696	3500453382	25		52546671	52546696	8421504	1	25	0	c,g	350045338200000001,350045338200000001,350045338200000000	0-23,0-23,0-25					Patent	Enzymatic ligation of 3'amino-substituted oligonucleotides (Patent US:5593826)	Fung	1997	0		CFTR
985	chr4	52546671	52546696	3500229464	25		52546671	52546696	8421504	1	25	0	c	350022946400000001,350022946400000000	0-23,0-25						Enzymatic ligation of 3'amino-substituted oligonucleotides	Fung	1993	0		CFTR
985	chr4	52546671	52546695	3500370587	24		52546671	52546695	8421504	1	24	0	c	350037058700000002	0-24						DNA diagnostics based on mass spectrometry	KOSTER	2003	0		CFTR
985	chr4	52546672	52546699	3500341129	27		52546672	52546699	8421504	1	27	0	c	350034112900000012	17-44						Rapid and sensitive detection of molecules	Straus	2002	0		
985	chr4	52546673	52546715	3500266876	42		52546673	52546715	8421504	1	42	0	c	350026687600000023	0-42						Biology book genetics	www.scribd.com	0	0		CFTR
985	chr4	52546677	52547146	3500133223	31		52546677	52547146	8421504	2	26,5	0,464	g	350013322300000091	0-31						PRIMERS FOR MELTING ANALYSIS - Patent application	www.faqs.org	0	0		
985	chr4	52546679	52551813	3500265471	44		52546679	52551813	8421504	2	23,21	0,5113	c	350026547100000002,350026547100000003	0-23,0-21			10.1038/sj.gt.3301307	${footerJournalISSN}		Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing		2000	0		
123	chr4	52546748	52576735	3500115666	48		52546748	52576735	8421504	2	24,24	0,29963	c	350011566600000001,350011566600000000	0-24,0-24		17667945	10.1038/sj.mt.6300277	1525-0016	Molecular Therapy	Biological Differences in rAAV Transduction of Airway Epithelia in Humans and in Old World Non-human Primates	Liu	2007	7		
123	chr4	52546748	52576735	3500004604	48		52546748	52576735	8421504	2	24,24	0,29963	c	350000460400000001,350000460400000000	0-24,0-24		17667945	10.1038/sj.mt.6300277	1525-0016	Molecular Therapy	Biological Differences in rAAV Transduction of Airway Epithelia in Humans and in Old World Non-human Primates	Liu	2007	7		CFTR
985	chr4	52546748	52546789	3500361443	41		52546748	52546789	8421504	1	41	0	c	350036144300000025	7-48						Building IP: Patent Application re "METHODS AND COMPOSITIONS FOR ALTERATION OF A CYSTIC FIBROSIS TRA | SGMO Message Board Posts	vestorvillage.com	0	0		
123	chr4	52551711	52579801	3500349105	44		52551711	52579801	8421504	3	6,15,23	0,7,28067	c,g	350034910500000026,350034910500000119,350034910500000112	1-22,1-22,18-41						CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MUTATIONS - Patent application	www.faqs.org	0	0		
986	chr4	52576709	52576732	3500396198	23		52576709	52576732	8421504	1	23	0	c	350039619800000011	0-23						Gene therapy by small fragment homologous replacement - Patent # 7217571 - PatentGenius	.patentgenius.com	0	0		
986	chr4	52576859	52576899	3500016056	40		52576859	52576899	8421504	1	40	0	c	350001605600000025	0-40					Patent	Template-dependent ligation with PNA-DNA chimeric probes (Patent US:6297016)	Egholm	2001	0		
986	chr4	52581758	52581782	3500368098	24		52581758	52581782	8421504	1	24	0	c,g	350036809800000001,350036809800000001	0-24,0-24						Replication deficient recombinant adenovirus vector	www.devileye.net	0	0		CFTR
986	chr4	52581774	52581798	3500109164	24		52581774	52581798	8421504	1	24	0	c	350010916400000018	0-24						Episomal expression cassettes for gene therapy	Chow	1998	0		
986	chr4	52604562	52604592	3500414565	30		52604562	52604592	8421504	1	30	0	c	350041456500000187,350041456500000173	0-30,0-30						Analyzing Comparative Sequence Data to Understand Genome Function and Evolution	gradworks.umi.com	0	0		
986	chr4	52604601	52604625	3500274681	24		52604601	52604625	8421504	1	24	0	g	350027468100000049,350027468100000083	19-43,14-38						Cystic fibrosis gene mutations - Patent # 8338578 - PatentGenius	.patentgenius.com	0	0		
986	chr4	52611042	52656348	3500191795	69		52611042	52656348	8421504	4	20,14,16,19	0,30,45270,45287	c,g	350019179500000008,350019179500000009,350019179500000007,350019179500000007	0-20,0-30,0-19,0-19		21512505	10.1038/gt.2011.55	0969-7128	Gene Therapy	Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung	McLachlan	2011	4		
986	chr4	52615100	52615125	3500180039	25		52615100	52615125	8421504	1	25	0	g	350018003900000019	0-25						Nucleic Acid Size Detection Method 	.freshpatents.com	0	0		
986	chr4	52656312	52656336	3500378872	23		52656312	52656336	8421504	2	11,12	0,12	c	350037887200000001	0-23						Phylogenetic Analysis of Cystic Fibrosis Transmembrane Conductance Regulator Gene in Mammalian Species Argues for the Development of a Rabbit Model for Cystic Fibrosis	brary.arizona.edu	0	0		
986	chr4	52656333	52656370	3500137298	37		52656333	52656370	8421504	1	37	0	c	350013729800000001	6-43						STABLE PROPAGATION OF MODIFIED FULL LENGTH CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN cDNA IN HETEROLOGOUS SYSTEMS	Rommens	1992	0		
986	chr4	52656335	52656365	3500345679	30		52656335	52656365	8421504	1	30	0	c,g	350034567900000055,350034567900000055,350034567900000068,350034567900000068	21-51,21-51,0-24,0-24						Minus strand rna virus vector carrying gene modified in high mutation region	You	2004	0		CFTR
986	chr4	52656335	52656365	3500121023	30		52656335	52656365	8421504	1	30	0	c,g	350012102300000000,350012102300000000	21-51,21-51						CFTRtranfer	www.docstoc.com	0	0		CFTR
986	chr4	52656340	52656367	3500427982	27		52656340	52656367	8421504	1	27	0	c	350042798200000000	8-35		17898794	10.1038/sj.gt.3303032	0969-7128	Gene Therapy	Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein	Ban	2007	4		
986	chr4	52656347	52656371	3500401977	24		52656347	52656371	8421504	1	24	0	c,g	350040197700000000,350040197700000000	6-30,6-30						<?xml version="1.0"?> <ART xmlns="http://highwire.org/sgml/arthw" VERSION="4.2.34HW" DOI="10.1074/jb	ke.sciencemag.org	0	0		CFTR
986	chr4	52656347	52656371	3500401680	24		52656347	52656371	8421504	1	24	0	c,g	350040168000000000,350040168000000000	6-30,6-30		16954204	10.1074/jbc.M607085200	0021-9258	Journal of Biological Chemistry	Derlin-1 Promotes the Efficient Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and CFTR Folding Mutants	Sun	2006	5		CFTR
987	chr4	52701432	52701456	3500333277	24		52701432	52701456	8421504	1	24	0	c	350033327700000007	0-24						Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency type 1 subtype C LTR - Keeping the Faith	pthefaith1296.com	0	0		CEBPB
987	chr4	52701918	52711937	3500414565	50		52701918	52711937	8421504	2	26,24	0,9995	c	350041456500000030,350041456500000028,350041456500000066	0-26,0-26,0-24						Analyzing Comparative Sequence Data to Understand Genome Function and Evolution	gradworks.umi.com	0	0		
987	chr4	52755177	52755201	3500259074	24		52755177	52755201	8421504	1	24	0	c	350025907400000164	1-25						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
988	chr4	52906499	52906526	3500460182	23		52906499	52906526	8421504	3	12,6,5	0,15,22	g	350046018200000020	0-24						Chimeric Promoter Molecules For Gene Expression In Prokaryotes 	.freshpatents.com	0	0		
991	chr4	53252664	53252698	3500405434	34		53252664	53252698	8421504	1	34	0	g	350040543400000026	71-105						Use of intronic RNA to measure gene expression - US Patent 7767391 Description	ww.patentstorm.us	0	0		
992	chr4	53370543	53381316	3500365379	43		53370543	53381316	8421504	2	20,23	0,10750	c	350036537900000003,350036537900000002	0-20,0-23			10.1128/MCB.25.21.9632-9645.2005		Molecular and Cellular Biology	Met/Hepatocyte Growth Factor Receptor Ubiquitination Suppresses Transformation and Is Required for Hrs Phosphorylation	Jasmine	2005	0		MET
992	chr4	53388364	53388388	3500402191	24		53388364	53388388	8421504	1	24	0	c	350040219100000002,350040219100000000	15-39,15-39						Compounds And Methods Of Use 	.freshpatents.com	0	0		
992	chr4	53388364	53388388	3500395307	24		53388364	53388388	8421504	1	24	0	c	350039530700000000	15-39						Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer	Bauer	2005	0		MET
992	chr4	53388364	53388388	3500258400	24		53388364	53388388	8421504	1	24	0	c	350025840000000000	15-39						Fused heterocyclic derivatives and methods of use	Albrecht	2011	0		MET
992	chr4	53388364	53388388	3500255906	24		53388364	53388388	8421504	1	24	0	c,g	350025590600000000,350025590600000000	15-39,15-39					Patent	Substituted heterocycles and methods of use (Patent US:7652009)	Bellon	2010	0		
992	chr4	53388364	53388388	3500247663	24		53388364	53388388	8421504	1	24	0	c	350024766300000000	15-39						Bis-aryl kinase inhibitors and method	Kim	2007	0		MET
992	chr4	53388364	53388388	3500207121	24		53388364	53388388	8421504	1	24	0	c	350020712100000000	15-39						Compounds and methods of use	Kim	2005	0		MET
992	chr4	53388364	53388388	3500101592	24		53388364	53388388	8421504	1	24	0	c	350010159200000000	15-39						Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer	Kim	2007	0		MET
992	chr4	53388364	53388388	3500096884	24		53388364	53388388	8421504	1	24	0	c	350009688400000000	15-39					Patent	Bis-aryl kinase inhibitors and method (Patent US:8017601)	Kim	2011	0		
992	chr4	53388364	53388388	3500025075	24		53388364	53388388	8421504	1	24	0	c	350002507500000000	15-39					Patent	Substituted amide derivatives as protein kinase inhibitors (Patent EP:1881976)	Bauer	2012	0		MET
992	chr4	53388526	53391727	3500081269	25		53388526	53391727	8421504	2	5,20	0,3181	c	350008126900000005	0-25		15870272	10.1128/MCB.25.10.3982-3996.2005	0270-7306	Molecular and Cellular Biology	Negative Feedback Regulation of Met-Dependent Invasive Growth by Notch	Stella	2005	6		MET
992	chr4	53391721	53405357	3500016890	305		53391721	53405357	8421504	4	20,144,100,41	0,8864,12537,13595	p,c,g	350001689000000003,350001689000000003,350001689000015001,350001689000000002	0-20,0-20,0-285,0-22						Biomarker and Method for Predicting Sensitivity to MET Inhibitors	VanWoude	2011	0		MET
992	chr4	53391721	53404264	3500407121	42		53391721	53404264	8421504	3	20,16,6	0,8992,12537	c,g	350040712100000001,350040712100000001,350040712100000000	0-20,0-20,0-22						HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro	tologylibrary.org	0	0		MET
992	chr4	53391769	53393463	3500227457	48		53391769	53393463	8421504	2	24,24	0,1670	c	350022745700000003,350022745700000002	0-24,0-24						Interlobular and intralobular mammary stroma: genotype may not reflect phenotype. - ResearchGate	.researchgate.net	0	0		MET
992	chr4	53392100	53400719	3500328139	40		53392100	53400719	8421504	2	20,20	0,8599	c,g	350032813900000035,350032813900000036,350032813900000030	0-20,0-19,0-20						siRNA for inhibition of c-Met expression and anticancer composition containing the same	Kim	2009	0		
992	chr4	53392102	53392132	3500212943	30		53392102	53392132	8421504	1	30	0	c	350021294300000000	15-45						NOVEL COMPOUNDS - Patent application	www.faqs.org	0	0		MET
992	chr4	53392102	53392132	3500140149	30		53392102	53392132	8421504	1	30	0	c	350014014900000000	15-45						Novel compounds	Hamajima	2010	0		MET
992	chr4	53408186	53408213	3500036938	24		53408186	53408213	8421504	2	18,6	0,21	c	350003693800000015	2-26						In vivo and in vitro knockdown of FREP2 gene expression in the snail Biomphalaria glabrata	courses.umass.edu	0	0		
992	chr4	53413283	53414334	3500259529	23		53413283	53414334	8421504	2	9,14	0,1037	c	350025952900000069	0-23						Methods for production of receptor and ligand isoforms	Jin	2006	0		
992	chr4	53451705	53451790	3500414565	64		53451705	53451790	8421504	2	45,19	0,66	c	350041456500000870,350041456500000857,350041456500000861,350041456500000859,350041456500000867,350041456500000832	0-45,0-27,0-27,0-27,0-27,0-19						Analyzing Comparative Sequence Data to Understand Genome Function and Evolution	gradworks.umi.com	0	0		
992	chr4	53451766	53452710	3500304449	49		53451766	53452710	8421504	2	22,27	0,917	c	350030444900000057,350030444900000124	18-40,0-27						C-MET MUTATIONS AND USES THEREOF - Patent application	www.faqs.org	0	0		
992	chr4	53451812	53452711	3500162293	54		53451812	53452711	8421504	2	23,31	0,868	c	350016229300000296,350016229300000056,350016229300000295	0-23,0-23,6-37						BISPECIFIC SINGLE CHAIN ANTIBODIES WITH SPECIFICITY FOR HIGH MOLECULAR WEIGHT TARGET ANTIGENS - Patent application	www.faqs.org	0	0		
992	chr4	53452327	53452470	3500263558	49		53452327	53452470	8421504	2	24,25	0,118	c	350026355800000151,350026355800000022,350026355800000093	0-24,24-49,0-24						Method for Predicting Responsiveness to Drugs - Patent application	www.faqs.org	0	0		
992	chr4	53452443	53452466	3500116246	23		53452443	53452466	8421504	1	23	0	c	350011624600000006	17-40		19097049	10.1002/dvdy.21833	1097-0177	Developmental Dynamics	Analysis of human muscle stem cells reveals a differentiation-resistant progenitor cell population expressing Pax7 capable of self-renewal - Pawlikowski - 2008 - Developmental Dynamics - Wiley Online Library	Pawlikowski	2009	0		MET
992	chr4	53452443	53452466	3500021888	23		53452443	53452466	8421504	1	23	0	c	350002188800000006	17-40		19097049	10.1002/dvdy.21833		Developmental dynamics : an official publication of the American Association of Anatomists	Analysis of human muscle stem cells reveals a differentiation-resistant progenitor cell population expressing Pax7 capable of self-renewal	Bradley	2009	0		MET
992	chr4	53452680	53452711	3500042099	31		53452680	53452711	8421504	1	31	0	c	350004209900000097	6-37						CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY - Patent application	www.faqs.org	0	0		
993	chr4	53581164	53581226	3500211437	57		53581164	53581226	8421504	2	50,7	0,55	g	350021143700000011	0-57						Orthologous Repeats and Mammalian Phylogenetic Inference	cseweb.ucsd.edu	0	0		
994	chr4	53613705	53613813	3500461947	40		53613705	53613813	8421504	2	20,20	0,88	c	350046194700000001,350046194700000000	0-20,0-20						Heat stress abatement during the dry period influences metabolic gene expression and improves immune status in the transition period of dairy cows	ddr.nal.usda.gov	0	0		
994	chr4	53613705	53613813	3500367267	40		53613705	53613813	8421504	2	20,20	0,88	c	350036726700000001,350036726700000000	0-20,0-20						Heat stress abatement during the dry period influences metabolic gene expression and improves immune status in the transition period of dairy cows	aldc.nal.usda.gov	0	0		
994	chr4	53614735	53646868	3500265002	45		53614735	53646868	8421504	2	21,24	0,32109	c	350026500200000009,350026500200000004	0-21,0-24						Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin	cs.biologists.org	0	0		CAV1
994	chr4	53614794	53646847	3500355494	41		53614794	53646847	8421504	2	21,20	0,32033	c,g	350035549400000001,350035549400000001,350035549400000000	0-21,0-21,0-20		11861755		0021-9533	Journal of Cell Science	Sites of Ca2+ wave initiation move with caveolae to the trailing edge of migrating cells	Isshiki	2002	6		
994	chr4	53614797	53614824	3500396759	27		53614797	53614824	8421504	1	27	0	c	350039675900000011	21-48						Mechanisms of Chlamydia trachomatis Entry into Nonphagocytic Cells	ww.hybiskelab.org	0	0		CAV1
994	chr4	53614797	53614824	3500085607	27		53614797	53614824	8421504	1	27	0	c	350008560700000001	0-27						EffectofanangiotensinIItype1receptorblocker oncaveolin-1expressioninprostatecancercells	www.termedia.pl	0	0		
994	chr4	53614814	53646868	3500186171	50		53614814	53646868	8421504	2	26,24	0,32030	c	350018617100000002,350018617100000001	0-26,0-24						Caveolin-1 Regulates Proliferation and Osteogenic Differentiation of Human Mesenchymal Stem Cells | Natasha Baker - Academia.edu	www.academia.edu	0	0		CAV1
994	chr4	53614882	53614969	3500449446	87		53614882	53614969	8421504	1	87	0	p	350044944600015001,350044944600015000	0-87,0-60		20729193	10.1074/jbc.M110.153569	0021-9258	Journal of Biological Chemistry	The Role of Proline in the Membrane Re-entrant Helix of Caveolin-1	Aoki	2010	5		CAV1
994	chr4	53614945	53615005	3500444542	60		53614945	53615005	8421504	1	60	0	p	350044454200015009	0-60						&#x4e3b;&#x9898;&#xff1a;Regulates | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		CAV1
994	chr4	53614945	53615005	3500412288	60		53614945	53615005	8421504	1	60	0	p	350041228800015000	0-60		18717816	10.1111/j.1471-4159.2008.05630.x	1471-4159	Journal of Neurochemistry	Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells - Shen - 2008 - Journal of Neurochemistry - Wiley Online Library	Shen	2008	0		CAV1
994	chr4	53614945	53615005	3500124891	60		53614945	53615005	8421504	1	60	0	p	350012489100015002	0-60		16822931	10.1124/mol.105.021741	1521-0111 (Online)	Molecular Pharmacology	Caveolin-1 Regulates Store-Operated Ca2+ Influx by Binding of Its Scaffolding Domain to Transient Receptor Potential Channel-1 in Endothelial Cells	Kwiatek	2006	0		CAV1
994	chr4	53614945	53615005	3500113737	60		53614945	53615005	8421504	1	60	0	p	350011373700015000	0-60						&#x4e3b;&#x9898;&#xff1a;CD40 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		CAV1
994	chr4	53614966	53646752	3500185009	40		53614966	53646752	8421504	3	20,3,17	0,84,31769	c	350018500900000021,350018500900000020	0-20,0-20			10.1186/bcr3459	1465-5411	Breast Cancer Research	Evidence for a multipotent mammary progenitor with pregnancy-specific activity	Kaanta	2013	0		
994	chr4	53614966	53646752	3500155529	40		53614966	53646752	8421504	3	20,3,17	0,84,31769	c	350015552900000021,350015552900000020	0-20,0-20						Evidence for a multipotent mammary progenitor with pregnancy-specific activity	ncer-research.com	0	0		
994	chr4	53614967	53646736	3500038184	43		53614967	53646736	8421504	3	19,23,1	0,63,31768	c	350003818400000023,350003818400000024	0-19,0-24						Mechanisms Regulating Osteoblast Response to Surface Microtopography and Vitamin D	artech.gatech.edu	0	0		CAV1
994	chr4	53614996	53646854	3500440042	40		53614996	53646854	8421504	2	20,20	0,31838	c,g	350044004200000001,350044004200000000,350044004200000000	0-20,0-20,0-20		20959538	10.1152/ajpendo.00498.2010		American Journal of Physiology - Endocrinology and Metabolism	Caveolin-1 is required for vascular endothelial insulin uptake	Wang	2011	0		
994	chr4	53614996	53646854	3500344523	40		53614996	53646854	8421504	2	20,20	0,31838	c,g	350034452300000001,350034452300000000,350034452300000000	0-20,0-20,0-20		20959538	10.1152/ajpendo.00498.2010		American Journal of Physiology - Endocrinology and Metabolism	Caveolin-1 is required for vascular endothelial insulin uptake	Hong	2011	0		
994	chr4	53614996	53646854	3500179955	40		53614996	53646854	8421504	2	20,20	0,31838	c,g	350017995500000001,350017995500000001,350017995500000000,350017995500000000	0-20,0-20,0-20,0-20		20959538	10.1152/ajpendo.00498.2010		American Journal of Physiology - Endocrinology and Metabolism	Caveolin-1 is required for vascular endothelial insulin uptake	Wang	2011	0		
994	chr4	53615016	53648431	3500443672	60		53615016	53648431	8421504	3	20,20,20	0,31722,33395	c,g	350044367200000003,350044367200000002,350044367200000002,350044367200000000,350044367200000000	0-20,0-20,0-20,0-20,0-20		21467199	10.1210/en.2010-1015	0013-7227	Endocrinology	Uterine Cysts in Female Mice Deficient for Caveolin-1 and Insulin-Like 3 Receptor RXFP2	Li	2011	4		
994	chr4	53615016	53615044	3500259074	28		53615016	53615044	8421504	1	28	0	c	350025907400000119	17-45						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
994	chr4	53615022	53646822	3500268003	42		53615022	53646822	8421504	2	21,21	0,31779	c,g	350026800300000001,350026800300000001,350026800300000000,350026800300000000	0-21,0-21,0-21,0-21						Moderate Caveolin-1 Downregulation Prevents NADPH OxidaseDependent Cells	ww.uphs.upenn.edu	0	0		CAV1
994	chr4	53646793	53648365	3500270230	42		53646793	53648365	8421504	3	21,3,18	0,104,1554	c,g	350027023000000005,350027023000000005,350027023000000004	0-21,0-21,0-21		19521982	10.1002/ijc.24451		International journal of cancer. Journal international du cancer	Caveolin-1 tumor-promoting role in human melanoma	Federica	2009	0		
994	chr4	53646793	53648365	3500203999	42		53646793	53648365	8421504	3	21,3,18	0,104,1554	c,g	350020399900000005,350020399900000005,350020399900000004	0-21,0-21,0-21		19521982	10.1002/ijc.24451	1097-0215	International Journal of Cancer	Caveolin-1 tumor-promoting role in human melanoma - Felicetti - 2009 - International Journal of Cancer - Wiley Online Library	Felicetti	2009	0		
994	chr4	53646803	53646826	3500414565	23		53646803	53646826	8421504	1	23	0	c,g	350041456500000134,350041456500000134,350041456500000152,350041456500000149,350041456500000141,350041456500000142,350041456500000143,350041456500000145	0-21,0-21,0-21,2-21,26-45,0-21,0-21,0-21						Analyzing Comparative Sequence Data to Understand Genome Function and Evolution	gradworks.umi.com	0	0		CAV1
994	chr4	53646844	53646868	3500182947	24		53646844	53646868	8421504	1	24	0	c	350018294700000004	0-24		19244345	10.1091/mbc.E08-09-0939	1059-1524	Molecular Biology of the Cell	Caveolin-1&#x2013;mediated Suppression of Cyclooxygenase-2 via a &#x03b2;-catenin-Tcf/Lef&#x2013;dependent Transcriptional Mechanism Reduced Prostaglandin E2 Production and Survivin Expression	Rodriguez	2009	5		CAV1
994	chr4	53646844	53646868	3500163364	24		53646844	53646868	8421504	1	24	0	c	350016336400000002	0-24			10.1128/MCB.01991-06		Molecular and Cellular Biology	E-Cadherin Is Required for Caveolin-1-Mediated Down-Regulation of the Inhibitor of Apoptosis Protein Survivin via Reduced &#x03b2;-Catenin-Tcf/Lef-Dependent Transcription 	Vicente	2007	0		CAV1
994	chr4	53646879	53648377	3500416903	51		53646879	53648377	8421504	2	21,30	0,1468	p	350041690300015000	0-51		19628671	10.1681/ASN.2008111190		Journal of the American Society of Nephrology : JASN	Decreased Nitric Oxide Bioavailability in a Mouse Model of Fabry Disease	Liming	2009	0		CAV1
994	chr4	53646879	53648377	3500199936	51		53646879	53648377	8421504	2	21,30	0,1468	p	350019993600015001	0-51		19628671	10.1681/ASN.2008111190	1046-6673	Journal of the American Society of Nephrology	Decreased Nitric Oxide Bioavailability in a Mouse Model of Fabry Disease	Shu	2009	10		CAV1
994	chr4	53670525	53670548	3500360446	23		53670525	53670548	8421504	1	23	0	c	350036044600000010	20-43						Effects of Gravitational Mechanical Unloading in Endothelial Cells: Association between Caveolins, Inflammation and Adhesion Molecules	bofcellgrowth.com	0	0		CAV2
994	chr4	53670525	53670548	3500204761	23		53670525	53670548	8421504	1	23	0	c	350020476100000010	20-43						Effects of Gravitational Mechanical Unloading in Endothelial Cells: Association between Caveolins, Inflammation and Adhesion Molecules	hesfulfordlab.com	0	0		CAV2
994	chr4	53670557	53675683	3500258791	40		53670557	53675683	8421504	2	19,21	0,5105	c,g	350025879100000007,350025879100000007,350025879100000002	0-19,0-19,0-21						Regulation of cancer cell proliferation by caveolin-2 down-regulation and re-expression	-publications.com	0	0		
995	chr4	53800145	53800171	3500380203	25		53800145	53800171	8421504	2	10,15	0,11	g	350038020300000022	1-26						Packaging cells for recombinant adenovirus	Havenga	2006	0		
996	chr4	53904434	53904466	3500035992	25		53904434	53904466	8421504	3	6,13,6	0,10,26	g	350003599200000068	20-48						Fusion Proteins Between Plant Cell-Wall Degrading Enzymes, and Their Uses - Patent application	www.faqs.org	0	0		
999	chr4	54314596	54321693	3500454707	27		54314596	54321693	8421504	2	15,12	0,7085	c	350045470700000054	0-27						Methods and kits for investigating cancer	Munnes	2008	0		TFEC
999	chr4	54314596	54321693	3500400698	27		54314596	54321693	8421504	2	15,12	0,7085	c	350040069800000054	0-27						Methods and kits for investigating cancer	Munnes	2008	0		TFEC
1006	chr4	55229420	55229449	3500016592	24		55229420	55229449	8421504	2	12,12	0,17	g	350001659200000021	10-34						Supplementary materials and methods	prints.ibb.waw.pl	0	0		
1007	chr4	55361328	55361352	3500013163	23		55361328	55361352	8421504	2	4,19	0,5	g	350001316300000015	0-23			10.1016/j.femsle.2005.04.007	1574-6968	FEMS Microbiology Letters	Comprehensive analysis of classical and newly described staphylococcal superantigenic toxin genes in Staphylococcus aureus isolates - Omoe - 2006 - FEMS Microbiology Letters - Wiley Online Library	Omoe	2005	0		
126	chr4	55595919	55900448	3500064060	2235		55595919	55900448	8421504	17	142,164,70,122,102,77,202,84,88,105,214,163,231,138,75,90,168	0,33332,34238,35603,38111,38352,39500,43829,45542,53519,55411,73098,74725,76065,142125,193758,304361	p	350006406000015000	0-2235						KEGG T01008: 505502	www.genome.jp	0	0		
126	chr4	55595967	55900358	3500121446	510		55595967	55900358	8421504	16	30,30,28,2,30,29,31,30,60,28,2,62,88,24,6,30	0,33370,34232,35555,38093,38352,39452,39603,45509,53548,55363,55515,73050,74884,76017,304361	p	350012144600015009,350012144600015006	0-900,90-300						NPG.nature.vol.418.Issue.6900.Aug	www.scribd.com	0	0		FOXP2
1009	chr4	55606881	55606907	3500070288	23		55606881	55606907	8421504	3	5,5,13	0,6,13	g	350007028800001028	5-29						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
1009	chr4	55670716	55670788	3500459705	72		55670716	55670788	8421504	1	72	0	p	350045970500015007	51-123						Prologue 1: Overview of the Biological Sciences	.bio.davidson.edu	0	0		
1010	chr4	55789712	55789737	3500316714	25		55789712	55789737	8421504	1	25	0	c	350031671400000000,350031671400000001	0-25,0-25						Behavioral/Cognitive Foxp2MediatesSexDifferencesinUltrasonicVocalization byRatPupsandDirectsOrderofMaternalRetrieval	www.jneurosci.org	0	0		FOXP2
1011	chr4	55849360	55849383	3500315363	23		55849360	55849383	8421504	1	23	0	g	350031536300000133,350031536300000069	2-25,2-25						Molecular signature and assay for fluoroquinoline resistance in bacillus anthracis - Patent application	www.faqs.org	0	0		
1011	chr4	55914369	55914397	3500201864	23		55914369	55914397	8421504	2	12,11	0,17	g	350020186400000374	7-45						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1011	chr4	55914369	55914397	3500005314	23		55914369	55914397	8421504	2	12,11	0,17	g	350000531400000378	4-42						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
1013	chr4	56196047	56196327	3500422344	40		56196047	56196327	8421504	2	20,20	0,260	g	350042234400000003,350042234400000002	0-20,0-20		20861313	10.1091/mbc.E10-02-0112	1059-1524	Molecular Biology of the Cell	STAT1 Is Required for Redifferentiation during Madin-Darby Canine Kidney Tubulogenesis	Kim	2010	5		
1013	chr4	56196073	56196277	3500316245	40		56196073	56196277	8421504	2	20,20	0,184	g	350031624500000006,350031624500000005	0-20,0-20						Effective inhibition of specific gene by adeno- associated virus (AAV)-mediated expression of small interfering RNA	www.ajol.info	0	0		GAPDH
1013	chr4	56196540	56196564	3500431331	24		56196540	56196564	8421504	1	24	0	g	350043133100000003	0-24		15175554		0160-2446	Journal of Cardiovascular Pharmacology	 Roles of NF-&#x03ba;B and SP-1 in Oxidative Stress-Mediated Inducti... : Journal of Cardiovascular Pharmacology 	Jianru	2004	2		
1015	chr4	56418499	56418527	3500318806	24		56418499	56418527	8421504	2	11,13	0,15	c	350031880600000000	0-24						METHOD FOR DETECTING ORAL SQUAMOUS-CELL CARCINOMA	Inazawa	2009	0		
1021	chr4	57232996	57234139	3500429177	50		57232996	57234139	8421504	2	25,25	0,1118	c	350042917700000009,350042917700000002,350042917700000003	9-33,9-34,10-35					Patent	Polynucleotides encoding SRE B2 receptor (Patent US:6555344)	Matsumoto	2003	0		GPR85
1021	chr4	57232996	57234139	3500423486	50		57232996	57234139	8421504	2	25,25	0,1118	c,g	350042348600000002,350042348600000009,350042348600000003,350042348600000003	9-34,9-33,10-35,10-35					Patent	Novel g protein-coupled receptor proteins (Patent EP:1067183)	KAMOHARA	2006	0		GPR85
1021	chr4	57232996	57234139	3500390057	50		57232996	57234139	8421504	2	25,25	0,1118	c	350039005700000002,350039005700000009,350039005700000003	9-34,9-33,10-35						Novel g protein-coupled receptor proteins	KOBAYASHI	2001	0		GPR85
1021	chr4	57232996	57234139	3500322144	50		57232996	57234139	8421504	2	25,25	0,1118	c	350032214400000002,350032214400000009,350032214400000003	9-34,9-33,10-35						Novel G protein-coupled receptor proteins	Jun	2008	0		GPR85
1021	chr4	57232996	57234139	3500292615	673		57232996	57234139	8421504	6	25,144,192,95,192,25	0,148,340,580,916,1118	c	350029261500000002,350029261500000009,350029261500000086,350029261500000093,350029261500000040,350029261500000041,350029261500000125,350029261500000042,350029261500000126,350029261500000044,350029261500000129,350029261500000045,350029261500000046,350029261500000047,350029261500000049,350029261500000133,350029261500000134,350029261500000140,350029261500000056,350029261500000057,350029261500000058,350029261500000059,350029261500000003,350029261500000087	9-34,9-33,9-34,9-33,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-47,0-48,0-48,0-48,0-48,0-48,10-35,10-35					Patent	Polynucleotides encoding SREB3 receptor (Patent US:6808899)	Matsumoto	2004	0		
1021	chr4	57232996	57234139	3500292471	50		57232996	57234139	8421504	2	25,25	0,1118	c	350029247100000002,350029247100000009,350029247100000003	9-34,9-33,10-35					Patent	Polynucleotides encoding SRE B2 receptor (Patent US:6555344)	Matsumoto	2003	0		GPR85
1021	chr4	57232996	57234139	3500261325	50		57232996	57234139	8421504	2	25,25	0,1118	c	350026132500000009,350026132500000002,350026132500000003	9-33,9-34,10-35						Novel G protein-coupled receptor proteins	Kamohara	2006	0		GPR85
1021	chr4	57232996	57234139	3500235274	50		57232996	57234139	8421504	2	25,25	0,1118	c	350023527400000002,350023527400000009,350023527400000015,350023527400000022,350023527400000003,350023527400000016	9-34,9-33,9-34,9-33,10-35,10-35					Patent	Novel G protein-coupled receptor proteins (Patent EP:1690939)	Kamohara	2008	0		GPR85
1021	chr4	57232996	57234139	3500234670	50		57232996	57234139	8421504	2	25,25	0,1118	c,g	350023467000000004,350023467000000004,350023467000000018,350023467000000018,350023467000000005,350023467000000005,350023467000000020	9-34,9-34,9-33,9-33,10-35,10-35,10-35					Patent	Neue, an ein g-protein gekoppelte rezeptorproteine New, coupled to a G-protein receptor proteins (Patent DE:69931360)	KAMOHARA	2007	0		GPR85
1021	chr4	57232996	57234139	3500229468	50		57232996	57234139	8421504	2	25,25	0,1118	c	350022946800000018,350022946800000004,350022946800000020,350022946800000005	9-33,9-34,10-35,10-35					Patent	Neue G Protein-gekoppelte Rezeptorproteine New G protein-coupled receptor proteins (Patent DE:69938015)	Kamohara	2009	0		GPR85
1021	chr4	57232996	57234139	3500198123	50		57232996	57234139	8421504	2	25,25	0,1118	c	350019812300000009,350019812300000002,350019812300000003	9-33,9-34,10-35					Patent	Polynucleotides encoding SREB1 receptor (Patent US:7341849)	Matsumoto	2008	0		GPR85
1021	chr4	57232996	57234139	3500155086	50		57232996	57234139	8421504	2	25,25	0,1118	c	350015508600000009,350015508600000002,350015508600000003	9-33,9-34,10-35						Polynucleotides encoding SREB2 receptor	Kamohara	2003	0		GPR85
1021	chr4	57233075	57233138	3500163087	63		57233075	57233138	8421504	1	63	0	p,c	350016308700015025,350016308700000022	0-63,0-36						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		GPR85
1021	chr4	57233528	57233598	3500196806	43		57233528	57233598	8421504	2	21,22	0,48	c	350019680600000007,350019680600000008	0-21,0-22						Polynucleotides and polypeptides associated with the NF-kappaB pathway	Nadler	2004	0		GPR85
1023	chr4	57529946	57529974	3500406917	23		57529946	57529974	8421504	2	15,8	0,20	c	350040691700000018	2-25						Endothelin B1, (ETB1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof	Shyamala	1993	0		
1025	chr4	57775426	57775453	3500210973	23		57775426	57775453	8421504	2	10,13	0,14	g	350021097300000194	0-23						Microrna molecules	Tuschl	2002	0		
1025	chr4	57775426	57775453	3500131966	23		57775426	57775453	8421504	2	10,13	0,14	g	350013196600000050	0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
1025	chr4	57800115	57800140	3500365031	24		57800115	57800140	8421504	2	10,14	0,11	c	350036503100000578	20-44						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
1025	chr4	57800115	57800140	3500326924	24		57800115	57800140	8421504	2	10,14	0,11	c	350032692400000577,350032692400000578	20-44,20-44						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
1027	chr4	57959332	57959356	3500263568	24		57959332	57959356	8421504	1	24	0	c	350026356800000055	0-24						Genomic characterization of remission in juvenile idiopathic arthritis	itis-research.com	0	0		ZNF277
1028	chr4	58107091	58107114	3500025873	23		58107091	58107114	8421504	1	23	0	g	350002587300000470	13-36						US Patent # 6,593,293. Lepidopteran-active Bacillus thuringiensis .delta.-endotoxin compositions and methods of use - Patents.com	www.patents.com	0	0		
1029	chr4	58248578	58248603	3500114536	23		58248578	58248603	8421504	2	13,10	0,15	g	350011453600000007	11-36						HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF - Patent application	www.faqs.org	0	0		
1032	chr4	58719251	58719280	3500139083	29		58719251	58719280	8421504	1	29	0	g	350013908300000016	23-52						SUSTAINED POLYPEPTIDE EXPRESSION FROM SYNTHETIC, MODIFIED RNAS AND USES THEREOF - Patent application	www.faqs.org	0	0		POU5F1
1033	chr4	58827928	58827954	3500126207	23		58827928	58827954	8421504	2	13,10	0,16	g	350012620700000098	0-23					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
1038	chr4	59503674	59503701	3500092680	25		59503674	59503701	8421504	3	12,6,7	0,13,20	g	350009268000000012	8-36						US Patent # 5,591,605. Plant structural gene expression - Patents.com	www.patents.com	0	0		
1045	chr4	60356633	60356657	3500322795	23		60356633	60356657	8421504	2	19,4	0,20	g	350032279500000212	19-42						Method of Diagnosis/Prognosis of Human Chronic Lymphocytic Leukemia Comprising the Profiling of Lpl/Adam Genes - Patent application	www.faqs.org	0	0		
1053	chr4	61397763	61401395	3500309883	261		61397763	61401395	8421504	3	80,61,120	0,3439,3512	p	350030988300015023,350030988300015024	0-141,0-120						THAP1, UN REGULATEUR CLE DE LA PROLIFERATION DES CELLULES ENDOTHELIALES : RELATIONS STRUCTURE/FONCTION ET GENES CIBLES	esups.ups-tlse.fr	0	0		
1056	chr4	61757009	61757038	3500278114	24		61757009	61757038	8421504	2	11,13	0,16	g	350027811400000268	13-37					Patent	Hog cholera virus vaccine and diagnostic (Patent US:5811103)	Meyers	1998	0		
1056	chr4	61769892	61769919	3500311943	24		61769892	61769919	8421504	2	5,19	0,8	g	350031194300000005	7-32						DEPARTAMENTO DE PRODUCCI&#xd3;N ANIMAL	helvia.uco.es	0	0		
1057	chr4	61944904	61944927	3500316254	23		61944904	61944927	8421504	1	23	0	g	350031625400000197,350031625400000057,350031625400000175,350031625400000035	11-35,11-35,0-23,0-23						Gene Synthesis Kit 	.freshpatents.com	0	0		
1060	chr4	62263285	62263311	3500068547	23		62263285	62263311	8421504	2	13,10	0,16	g	350006854700000404,350006854700000101	7-30,7-30						HUMAN ERYTHROVIRUS - Patent application	www.faqs.org	0	0		
1060	chr4	62299861	62299886	3500460405	25		62299861	62299886	8421504	1	25	0	c	350046040500000008	0-25						Elmo1 inhibits ubiquitylation of Dock180	cs.biologists.org	0	0		ELMO1
1060	chr4	62307769	62317932	3500121633	108		62307769	62317932	8421504	2	1,107	0,10056	p	350012163300015178	0-108						48 human secreted proteins	Komatsoulis	2000	0		ELMO1
1060	chr4	62307769	62317932	3500063892	108		62307769	62317932	8421504	2	1,107	0,10056	p	350006389200015178	0-108						48 human secreted proteins	Komatsoulis	2002	0		ELMO1
1060	chr4	62339499	62339523	3500078663	24		62339499	62339523	8421504	1	24	0	c	350007866300000001	1-25		17021600	10.1038/sj.ki.5001939	0085-2538	Kidney International	ELMO1 increases expression of extracellular matrix proteins and inhibits cell adhesion to ECMs	Shimazaki	2006	7		ELMO1
1063	chr4	62682150	62682179	3500070088	27		62682150	62682179	8421504	2	10,17	0,12	g	350007008800000505	1-28						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
1066	chr4	63165178	63172106	3500019989	41		63165178	63172106	8421504	2	21,20	0,6908	c	350001998900000220,350001998900000219	0-21,0-20						Genexpressions-Profil einer dysmyelinisierenden Doppel knock out-Mausmutante (mbp-/- plp-/-) und Rescue-Versuch des normalen Ph&#xe4;notyps	www.uni-koeln.de	0	0		
1066	chr4	63165282	63166459	3500042600	40		63165282	63166459	8421504	2	20,20	0,1157	c,g	350004260000000001,350004260000000001,350004260000000000	0-20,0-20,0-20		23118862	10.1371/journal.pone.0046889		PLoS ONE	Matrix Stiffness Regulates Endothelial Cell Proliferation through Septin 9	Yi-Ting	2012	0		SEPT7
1070	chr4	63635316	63635341	3500224727	24		63635316	63635341	8421504	2	18,6	0,19	c	350022472700000000	9-37		11279245	10.1074/jbc.M101470200	0021-9258	Journal of Biological Chemistry	A Complex of the Bacteriophage T7 Primase-Helicase and DNA Polymerase Directs Primer Utilization	Kato	2001	5		
1072	chr4	63850375	63850404	3500241928	25		63850375	63850404	8421504	2	12,13	0,16	g	350024192800000113	3-28						THERAPEUTIC AND DIAGNOSTIC AGENTS CAPABLE OF MODULATING CELLULAR RESPONSIVENESS TO CYTOKINES - THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH	www.sumobrain.com	0	0		
1073	chr4	64073121	64073145	3500371703	24		64073121	64073145	8421504	1	24	0	c	350037170300000005	0-24						G protein coupled receptors	An	2002	0		
1073	chr4	64073199	64079172	3500024643	48		64073199	64079172	8421504	4	13,7,16,12	0,1074,1239,5961	c	350002464300000000,350002464300000004	0-20,2-30						GPRA and the asthma locus on chromosome 7p14-p15	hesis.helsinki.fi	0	0		
1074	chr4	64104889	64105039	3500397967	135		64104889	64105039	8421504	5	27,27,15,30,36	0,30,60,78,114	p	350039796700015027	0-138						G protein-coupled receptors	Hiebsch	2002	0		
1075	chr4	64300257	64300359	3500166204	102		64300257	64300359	8421504	1	102	0	g	350016620400000031	0-102						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1077	chr4	64616159	64616183	3500445239	24		64616159	64616183	8421504	1	24	0	c	350044523900000014	23-47						Robert W. Li, Matthew J. Meyer, Curtis. P. Van Tassell, Tad S. Sonstegard, Erin E. Connor, Michael E. Van Amburgh, Yves R. Boisclair and Anthony V. Capuco Physiol Genomics 27:42-53, 2006. First published Jun 20, 2006; This article cites 42 articles, 25 of	ddr.nal.usda.gov	0	0		
1079	chr4	64837316	64837343	3500108153	23		64837316	64837343	8421504	2	6,17	0,10	g	350010815300000053	9-35					Patent	Insect-resistant transgenic plants and methods for improving delta-endotoxin activity against insects (Patent EP:1801220)	Brussock	2012	0		
1079	chr4	64837316	64837343	3500047291	23		64837316	64837343	8421504	2	6,17	0,10	g	350004729100000053	9-35						Methods for improving the activity of &#x03b4;-endotoxins against insect pests - US Patent 6077824 Description	ww.patentstorm.us	0	0		
1080	chr4	64893327	64893351	3500361399	23		64893327	64893351	8421504	2	10,13	0,11	g	350036139900000000	1-24		22082027	10.1186/1756-0500-4-494	1756-0500	BMC Research Notes	Expression of human protein S100A7 (psoriasin), preparation of antibody and application to human larynx squamous cell carcinoma	Barbieri	2011	0		
1080	chr4	64893327	64893351	3500250433	23		64893327	64893351	8421504	2	10,13	0,11	g	350025043300000000	1-24					BMC Research Notes	Expression of human protein S100A7 (psoriasin), preparation of antibody and application to human larynx squamous cell carcinoma - Scolaris	Barbieri	2011	0		
1080	chr4	64893327	64893351	3500228429	23		64893327	64893351	8421504	2	10,13	0,11	g	350022842900000000	1-24						Expression of human protein S100A7 (psoriasin), preparation of antibody and application to human larynx squamous cell carcinoma	biomedcentral.com	0	0		
1081	chr4	65023890	65023916	3500382093	24		65023890	65023916	8421504	2	9,15	0,11	g	350038209300000116	0-24						US8236311B2	www.scribd.com	0	0		
1081	chr4	65096380	65096407	3500321242	24		65096380	65096407	8421504	2	12,12	0,15	g	350032124200000027,350032124200000104	10-40,10-40						RABIES VACCINE - Patent application	www.faqs.org	0	0		
1089	chr4	66078101	66078126	3500282773	23		66078101	66078126	8421504	2	8,15	0,10	g	350028277300000147,350028277300000432	5-28,5-28						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT - Patent application	www.faqs.org	0	0		
1092	chr4	66510703	66510734	3500221916	25		66510703	66510734	8421504	3	14,4,7	0,19,24	g	350022191600000097	8-33						VECTORS AND YEAST STRAINS FOR PROTEIN PRODUCTION	Choi	2009	0		
1097	chr4	67170825	67170848	3500146321	23		67170825	67170848	8421504	1	23	0	g	350014632100000002	0-24						Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use - US Patent 7056714 Description	ww.patentstorm.us	0	0		
1097	chr4	67203505	67205967	3500085287	52		67203505	67205967	8421504	2	26,26	0,2436	c,g	350008528700000011,350008528700000012	0-26,0-26						Methods and compositions for the diagnosis, prognosis, and treatment of cancer	Neuman	2003	0		NEUROD6
1098	chr4	67308350	67308375	3500281360	23		67308350	67308375	8421504	2	7,16	0,9	g	350028136000000016	5-28		19488069	10.1038/cr.2009.64	1001-0602	Cell Research	A unique sequence in the N-terminal regulatory region controls the nuclear localization of KLF8 by cooperating with the C-terminal zinc-fingers	Mehta	2009	8		
1099	chr4	67392575	67450447	3500136477	2620		67392575	67450447	8421504	30	14,308,28,47,32,8,14,15,18,43,21,36,271,42,130,1,91,70,61,154,133,98,110,42,21,108,106,139,428,31	0,30,339,368,416,449,554,569,585,604,649,671,709,2484,3956,7443,14933,19189,19804,20296,21356,21943,22675,25217,26499,28562,44329,46177,57412,57841	c	350013647700000016	0-2714						US Patent # 5,973,117. PACAP receptor protein, method for preparing said protein, and use thereof - Patents.com	www.patents.com	0	0		
1099	chr4	67393369	67438854	3500136477	1539		67393369	67438854	8421504	16	186,42,130,84,92,70,61,154,133,98,110,42,21,108,106,102	0,1690,3162,6649,14138,18395,19010,19502,20562,21149,21881,24423,25705,27768,43535,45383	c,g	350013647700000007,350013647700000007,350013647700000008	0-1523,0-1523,0-1440						US Patent # 5,973,117. PACAP receptor protein, method for preparing said protein, and use thereof - Patents.com	www.patents.com	0	0		
1099	chr4	67395613	67395644	3500065112	24		67395613	67395644	8421504	3	13,6,5	0,17,26	g	350006511200000228	12-38					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
1100	chr4	67519512	67520403	3500173631	25		67519512	67520403	8421504	2	23,2	0,889	c	350017363100000006	0-25						Somatostatin Receptor Subtype Speci&#xfb01;city in Human Fetal Pituitary Cultures	www.jci.org	0	0		
1100	chr4	67520437	67520464	3500100039	27		67520437	67520464	8421504	1	27	0	c	350010003900000063	0-27						Renoprotection by growth hormone-releasing hormone and agonists - Patent application	www.faqs.org	0	0		
1100	chr4	67552363	67552390	3500120768	27		67552363	67552390	8421504	1	27	0	c	350012076800000020	19-46						RESEARCH ARTICLE Open Access	itis-research.com	0	0		
1100	chr4	67553926	67566232	3500430568	120		67553926	67566232	8421504	2	96,24	0,12282	c	350043056800000037,350043056800000036,350043056800000003	0-48,0-48,6-30						Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)	Agre	1995	0		
1100	chr4	67553931	67553954	3500380796	23		67553931	67553954	8421504	1	23	0	c,g	350038079600000009,350038079600000009	0-23,0-23						Tissue engineered construct for supplementing or replacing a damaged organ	Atala	2006	0		GHRHR
1100	chr4	67553931	67553954	3500368395	23		67553931	67553954	8421504	1	23	0	c,g	350036839500000010,350036839500000010	0-23,0-23						Methods and compositions for cell therapy - Patent application	www.faqs.org	0	0		GHRHR
1100	chr4	67553931	67553954	3500278279	23		67553931	67553954	8421504	1	23	0	c,g	350027827900000010,350027827900000010	0-23,0-23						Methods And Compositions For Cell Therapy 	.freshpatents.com	0	0		GHRHR
1100	chr4	67553931	67553954	3500229454	23		67553931	67553954	8421504	1	23	0	c,g	350022945400000010,350022945400000010	0-23,0-23						Methods and compositions for cell therapy	Cibelli	2002	0		GHRHR
1100	chr4	67553931	67553954	3500208031	23		67553931	67553954	8421504	1	23	0	c,g	350020803100000008,350020803100000008	0-23,0-23						Generation of histocompatible tissues using nuclear transplantation	Lanza	2003	0		GHRHR
1100	chr4	67553931	67553954	3500207328	23		67553931	67553954	8421504	1	23	0	c,g	350020732800000009,350020732800000009	0-23,0-23						Tissue engineered construct for supplementing or replacing a damaged organ	Atala	2003	0		GHRHR
1100	chr4	67553974	67554022	3500134080	48		67553974	67554022	8421504	1	48	0	c	350013408000000035	0-48						Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)	Agre	1995	0		
1100	chr4	67565877	67565901	3500136055	24		67565877	67565901	8421504	1	24	0	c	350013605500000011	0-24						Effects of Mineralocorticoid and Glucocorticoid Agonists on Gene and Protein Expression, Structural Maturation and Compliance in the Ovine Preterm Fetal Lung	ufdc.ufl.edu	0	0		
1100	chr4	67614424	67614452	3500063769	24		67614424	67614452	8421504	2	8,16	0,12	g	350006376900000000	4-28			10.1128/JVI.77.12.6731-6742.2003		Journal of Virology	Structure-Function Analysis of Herpes Simplex Virus Type 1 gD and gH-gL: Clues from gDgH Chimeras	Tina	June	0		
1102	chr4	67795260	67796949	3500195875	123		67795260	67796949	8421504	3	45,36,42	0,48,1647	p	350019587500015154,350019587500015133	0-120,0-48						US Patent # 7,358,225. Cloning and recombinant production of CRF receptor(s) - Patents.com	www.patents.com	0	0		
1102	chr4	67799856	67808931	3500095184	221		67799856	67808931	8421504	7	48,23,21,45,3,24,57	0,620,2049,7370,7832,7850,9018	c	350009518400000057,350009518400000059,350009518400000026,350009518400000066,350009518400000028	0-48,0-44,0-48,0-48,0-48						ISOLATED SOLUBLE CORTICOTROPIN RELEASING FACTOR RECEPTOR TYPE 2 (SCRFR2) - Patent application	www.faqs.org	0	0		
1102	chr4	67801938	67801962	3500204384	24		67801938	67801962	8421504	1	24	0	c	350020438400000003	0-24						Corticotropin-Releasing Factor (CRF) and the Urocortins Differentially Regulate Catecholamine Secretion in Human and Rat Adrenals, in a CRF Receptor Type-Specific Manner	.endojournals.org	0	0		CRHR2
1102	chr4	67845952	67866447	3500370516	85		67845952	67866447	8421504	3	38,19,28	0,70,20467	c,g	350037051600000031,350037051600000031,350037051600000026,350037051600000073,350037051600000056	0-29,0-29,0-29,9-28,0-28						INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLYCYL-TRNA SYNTHETASES - Patent application	www.faqs.org	0	0		
1102	chr4	67848356	67863199	3500427030	24		67848356	67863199	8421504	2	2,22	0,14821	c	350042703000000038,350042703000000065,350042703000000118	7-26,7-26,7-26						Detection Of Nucleic Acid Differences Using Endonuclease Cleavage/ligase Resealing Reactions And Capillary Electrophoresis Or Microarrays 	.freshpatents.com	0	0		
1102	chr4	67848356	67863199	3500164893	23		67848356	67863199	8421504	3	2,11,10	0,14821,14833	c	350016489300000046,350016489300000171	7-26,7-26						Methods for quantitating small rna molecules	Raymond	2007	0		
1103	chr4	68004279	68005758	3500349767	44		68004279	68005758	8421504	2	22,22	0,1457	c,g	350034976700000006,350034976700000007,350034976700000007	0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
1103	chr4	68005660	68005683	3500337002	23		68005660	68005683	8421504	1	23	0	c	350033700200000001	0-23		20384614	10.1111/j.1398-9995.2009.02315.x	1398-9995	Allergy	Nod1, Nod2 and Nalp3 receptors, new potential targets in treatment of allergic rhinitis? - Bogefors - 2010 - Allergy - Wiley Online Library	Bogefors	2010	0		NOD1
1106	chr4	68390106	68390129	3500068954	23		68390106	68390129	8421504	1	23	0	c	350006895400000010	6-30		11278953	10.1074/jbc.M011643200	0021-9258	Journal of Biological Chemistry	The Tumor Suppressor Protein p53 Requires a Cofactor to Activate Transcriptionally the Human BAX Promoter	Thornborrow	2001	5		
1107	chr4	68548652	68548679	3500270883	23		68548652	68548679	8421504	2	10,13	0,14	c	350027088300000005	4-27					Patent	Rapidly degraded reporter fusion proteins (Patent EP:1558729)	Almond	2009	0		
1108	chr4	68587306	68627497	3500062793	224		68587306	68627497	8421504	6	15,33,47,48,48,33	0,18429,18510,25623,37579,40158	c	350006279300000096,350006279300000098,350006279300000102,350006279300000113,350006279300000223,350006279300000062	0-48,0-47,0-48,0-48,5-38,5-38						GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS - Patent application	www.faqs.org	0	0		
1108	chr4	68627464	68627497	3500394794	33		68627464	68627497	8421504	1	33	0	c	350039479400000062,350039479400000012	5-38,7-36						Genes and polypeptides relating to human colon cancers	Furukawa	2005	0		
1108	chr4	68627464	68627497	3500212214	33		68627464	68627497	8421504	1	33	0	c	350021221400000062,350021221400000012	5-38,7-36						Genes and polypeptides relating to human colon cancers	Furukawa	2003	0		SCRN1
1108	chr4	68627464	68627497	3500058493	33		68627464	68627497	8421504	1	33	0	c	350005849300000012,350005849300000062	7-36,5-38						Genes and polypeptides relating to human colon cancers	Nakamura	2009	0		
1108	chr4	68627464	68627497	3500026288	33		68627464	68627497	8421504	1	33	0	c	350002628800000012,350002628800000062	7-36,5-38						CXADRL1 polypeptides relating to human cancers	Nakamura	2008	0		
1108	chr4	68627464	68627496	3500211755	32		68627464	68627496	8421504	1	32	0	c	350021175500000061,350021175500000012	5-37,7-36						Genes and polypeptides relating to human colon cancers	Nakamura	2010	0		
1108	chr4	68629698	68629724	3500264716	26		68629698	68629724	8421504	1	26	0	c	350026471600000010	0-26						Methods of diagnosis and treatment of metabolic disorders - Patent application	www.faqs.org	0	0		
1108	chr4	68630877	68630905	3500241781	25		68630877	68630905	8421504	2	11,14	0,14	c	350024178100000164	9-34						Immunostimulatory nucleic acids	osdir.com/patents	0	0		
1109	chr4	68791950	68791976	3500073303	23		68791950	68791976	8421504	2	14,9	0,17	g	350007330300000011,350007330300000015,350007330300000055,350007330300000046,350007330300000038,350007330300000009,350007330300000032,350007330300000035,350007330300000036	11-34,5-28,11-34,5-28,11-34,21-44,21-44,11-34,11-34						Rapid subcloning using site-specific recombination - Patent application	www.faqs.org	0	0		
1113	chr4	69209296	69209322	3500454061	23		69209296	69209322	8421504	2	10,13	0,13	g	350045406100000041	22-45						PIROPLASMID VACCINE - Patent application	www.faqs.org	0	0		
1113	chr4	69221818	69221846	3500460452	26		69221818	69221846	8421504	2	18,8	0,20	g	350046045200000007	15-42						Nucleic Acid - Patent application	www.faqs.org	0	0		
1114	chr4	69337249	69337272	3500281451	23		69337249	69337272	8421504	1	23	0	g	350028145100000049	2-25						DETECTION OF GENETICALLY MODIFIED POTATOES BY THE POLYMERASE CHAIN REACTION	d.lib.metu.edu.tr	0	0		
1117	chr4	69824860	69824885	3500013235	23		69824860	69824885	8421504	2	14,9	0,16	g	350001323500000008	0-23						Interleukin-6 antagonists	Gillies	2007	0		
1119	chr4	70002018	70002044	3500369845	24		70002018	70002044	8421504	2	10,14	0,12	g	350036984500000075	12-36						LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof - Patent application	www.faqs.org	0	0		
1122	chr4	70420839	70420863	3500242489	23		70420839	70420863	8421504	2	5,18	0,6	g	350024248900000001,350024248900000000	0-27,5-32						Small-Molecule Control of Kinesin-5 Proteins	cholar.lib.vt.edu	0	0		
1124	chr4	70722425	70722449	3500171549	24		70722425	70722449	8421504	1	24	0	c,g	350017154900000000,350017154900000000	0-24,0-24		18284611	10.1111/j.1471-4159.2008.05298.x	1471-4159	Journal of Neurochemistry	Expression of 3-hydroxyisobutyrate dehydrogenase in cultured neural cells - Mur&#xed;n - 2008 - Journal of Neurochemistry - Wiley Online Library	Murin	2008	0		
1124	chr4	70732659	70732684	3500309840	24		70732659	70732684	8421504	2	19,5	0,20	g	350030984000000965	0-35						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1124	chr4	70742339	70742364	3500113337	24		70742339	70742364	8421504	2	5,19	0,6	g	350011333700000031	0-29						 Expression Of Tetanus Toxin Fragment C 	www.docstoc.com	0	0		
1126	chr4	70967265	70967291	3500166346	25		70967265	70967291	8421504	2	10,15	0,11	g	350016634600000000	0-25						Membrane proteins and peptides of haemophilus influenzae type B	Munson	1993	0		
1126	chr4	70967265	70967291	3500138680	25		70967265	70967291	8421504	2	10,15	0,11	g	350013868000000000	0-25						Membrane proteins and peptides of haemophilus influenzae type b	Munson	1990	0		
1126	chr4	71008598	71008624	3500242313	24		71008598	71008624	8421504	2	13,11	0,15	g	350024231300000002	0-25						In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs - Springer	link.springer.com	0	0		
1127	chr4	71080632	71080865	3500011362	40		71080632	71080865	8421504	2	20,20	0,213	g	350001136200000000,350001136200000001	0-20,0-20			10.1371/journal.pgen.0020119	1553-7404	PLOS Genetics	PLOS Genetics: Anatomic Demarcation by Positional Variation in Fibroblast Gene Expression Programs	Rinn	2006	0		
1127	chr4	71094805	71094830	3500321290	25		71094805	71094830	8421504	1	25	0	g	350032129000000000,350032129000000001	0-25,10-31						ScienceDirect.com - Mechanisms of Development - Microarray analysis of novel cell lines representing two stages of metanephric mesenchyme differentiation	sciencedirect.com	0	0		
1127	chr4	71095209	71111361	3500125321	40		71095209	71111361	8421504	2	19,21	0,16131	c,g	350012532100000213,350012532100000075	0-19,0-21						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
1127	chr4	71105817	71105847	3500426392	30		71105817	71105847	8421504	1	30	0	g	350042639200000002	0-30		19017365	10.1111/j.1582-4934.2008.00574.x	1582-4934	Journal of Cellular and Molecular Medicine	WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type - Andikyan - 2008 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Andikyan	2009	0		HOXA10
1127	chr4	71106045	71106124	3500436295	79		71106045	71106124	8421504	1	79	0	g	350043629500000000,350043629500000001,350043629500000006,350043629500000007	0-50,6-52,0-36,24-56						Positive selection vector for the bacteriophage P1 cloning system	Pierce	1991	0		
1127	chr4	71106045	71106069	3500112915	24		71106045	71106069	8421504	1	24	0	g	350011291500000019	0-24			10.1242/dev.01268		Development (Cambridge, England)	Ribosomal protein L24 defect in Belly spot and tail (Bst), a mouse Minute	Edward	2004	0		
1127	chr4	71106082	71106123	3500219670	41		71106082	71106123	8421504	1	41	0	g	350021967000000009	0-41		17283059	10.1128/MCB.01609-06	0270-7306	Molecular and Cellular Biology	Bmp2 Transcription in Osteoblast Progenitors Is Regulated by a Distant 3&#x2032; Enhancer Located 156.3 Kilobases from the Promoter	Chandler	2007	6		
1127	chr4	71106082	71106123	3500147152	41		71106082	71106123	8421504	1	41	0	g	350014715200000009	0-41			10.1128/MCB.01609-06		Molecular and Cellular Biology	Bmp2 Transcription in Osteoblast Progenitors Is Regulated by a Distant 3&#x2032; Enhancer Located 156.3 Kilobases from the Promoter 	Ronald	2007	0		
1127	chr4	71106082	71106123	3500013233	41		71106082	71106123	8421504	1	41	0	g	350001323300000009	0-41		17283059	10.1128/MCB.01609-06	0270-7306	Molecular and Cellular Biology	Bmp2 Transcription in Osteoblast Progenitors Is Regulated by a Distant 3&#x2032; Enhancer Located 156.3 Kilobases from the Promoter	Chandler	2007	6		
1127	chr4	71106083	71106113	3500345629	30		71106083	71106113	8421504	1	30	0	g	350034562900000002	0-30						Method of cell growth inhibition with agnoprotein	Khalili	2003	0		
1127	chr4	71106083	71106113	3500209350	30		71106083	71106113	8421504	1	30	0	g	350020935000000000	0-30		16940540	10.1128/JVI.02138-05	0022-538X	Journal of Virology	Cross-Interaction between JC Virus Agnoprotein and Human Immunodeficiency Virus Type 1 (HIV-1) Tat Modulates Transcription of the HIV-1 Long Terminal Repeat in Glial Cells	Kaniowska	2006	5		
1127	chr4	71106085	71106114	3500161534	29		71106085	71106114	8421504	1	29	0	g	350016153400000010	0-29						A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)	Antoniou	2000	0		
1127	chr4	71106085	71106114	3500029287	29		71106085	71106114	8421504	1	29	0	g	350002928700000003	1-37		15987734	10.1091/mbc.E05-05-0472	1059-1524	Molecular Biology of the Cell	The Terminal Phase of Cytokinesis in the Caenorhabditis elegans Early Embryo Requires Protein Glycosylation	Wang	2005	5		
1127	chr4	71106086	71106117	3500453324	31		71106086	71106117	8421504	1	31	0	g	350045332400000000	6-42						BMC Cancer BioMed Central	biomedcentral.com	0	0		
1127	chr4	71106086	71106117	3500402609	31		71106086	71106117	8421504	1	31	0	g	350040260900000011	5-41						USE OF HIGHLY PARALLEL SNP GENOTYPING FOR FETAL DIAGNOSIS	Stoughton	2007	0		
1127	chr4	71106086	71106117	3500394476	31		71106086	71106117	8421504	1	31	0	g	350039447600000019,350039447600000011	5-40,5-41						USE OF HIGHLY PARALLEL SNP GENOTYPING FOR FETAL DIAGNOSIS - Patent application	www.faqs.org	0	0		
1127	chr4	71106086	71106117	3500356609	31		71106086	71106117	8421504	1	31	0	g	350035660900000000	6-42		16737555	10.1186/gb-2006-7-5-r42	1465-6906	Genome Biology	PI3K signaling and miRNA expression during the response of quiescent human fibroblasts to distinct proliferative stimuli	Gu	2006	0		
1127	chr4	71106086	71106117	3500345162	31		71106086	71106117	8421504	1	31	0	g	350034516200000000	6-42		18959781	10.1186/1471-2407-8-313	1471-2407	BMC Cancer	Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures	Daigeler	2008	3		
1127	chr4	71106086	71106117	3500116312	31		71106086	71106117	8421504	1	31	0	g	350011631200000011,350011631200000019	5-41,5-40						FETAL ANEUPLOIDY DETECTION BY SEQUENCING - Patent application	www.faqs.org	0	0		
1127	chr4	71106086	71106117	3500012353	31		71106086	71106117	8421504	1	31	0	g	350001235300000000	6-42		18959781	10.1186/1471-2407-8-313		BMC Cancer	Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures	Daigeler	2008	0		
1127	chr4	71106086	71106114	3500438512	28		71106086	71106114	8421504	1	28	0	g	350043851200000106,350043851200000107	16-44,1-29						Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening	Capon	2004	0		
1127	chr4	71106086	71106114	3500384144	28		71106086	71106114	8421504	1	28	0	g	350038414400000250,350038414400000146,350038414400000145,350038414400000012	16-44,1-29,16-44,18-38						US Patent # 6,242,187. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening - Patents.com	www.patents.com	0	0		
1127	chr4	71106086	71106114	3500303208	28		71106086	71106114	8421504	1	28	0	g	350030320800000107,350030320800000106,350030320800000205,350030320800000206	1-29,16-44,12-40,0-25						Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening - US Patent 7279279 Description	ww.patentstorm.us	0	0		
1127	chr4	71106086	71106114	3500300803	28		71106086	71106114	8421504	1	28	0	g	350030080300000000	7-35					Journal of Virology	Replication and Packaging of Transmissible Gastroenteritis Coronavirus-Derived Synthetic Minigenomes	Ander	1999	0		
1127	chr4	71106086	71106112	3500370243	26		71106086	71106112	8421504	1	26	0	g	350037024300000064	10-36						CELL CULTURE SYSTEM OF A HEPATITIS C GENOTYPE 3A AND 2A CHIMERA - Patent application	www.faqs.org	0	0		
1127	chr4	71106086	71106111	3500085416	24		71106086	71106111	8421504	2	7,17	0,8	g	350008541600000005	2-26						Retroviral vector particles produced in a baculovirus expression system	Jones	1998	0		
1127	chr4	71106086	71106109	3500000008	23		71106086	71106109	8421504	1	23	0	g	350000000800000006,350000000800000000	4-27,4-27						Swine vesicular disease virus expression vectors	Hwong	2000	0		
1127	chr4	71106087	71106112	3500040923	24		71106087	71106112	8421504	2	6,18	0,7	g	350004092300000017	2-26						Infectious bovine viral diarrhea virus clone	osdir.com/patents	0	0		
1127	chr4	71106087	71106112	3500017615	24		71106087	71106112	8421504	2	6,18	0,7	g	350001761500000017	2-26						Infectious bovine viral diarrhea virus clone	Elbers	2002	0		
1127	chr4	71106088	71106115	3500102698	27		71106088	71106115	8421504	1	27	0	g	350010269800000000	0-27		8626610	10.1074/jbc.271.17.10379	0021-9258	Journal of Biological Chemistry	Regulated Cleavage of Sterol Regulatory Element Binding Proteins Requires Sequences on Both Sides of the Endoplasmic Reticulum Membrane	Hua	1996	5		
1127	chr4	71106088	71106114	3500309863	25		71106088	71106114	8421504	2	4,21	0,5	g	350030986300000005	21-46						H 4: BETEKINT&#xc9;S A SZERIN PROTE&#xc1;Z AKTIV&#xc1;CI&#xd3; &#xc9;S KATAL&#xcd;ZIS MOLEKUL&#xc1;RIS VIL&#xc1;G&#xc1;BA	teo.elte.hu	0	0		
1127	chr4	71106089	71106113	3500334054	24		71106089	71106113	8421504	1	24	0	g	350033405400000015	0-24						Ribosome complexes as selection particles for in vitro display and evolution of proteins	Taussig	1999	0		
1127	chr4	71106089	71106113	3500197244	24		71106089	71106113	8421504	1	24	0	g	350019724400000030,350019724400000010	0-24,0-19						US Patent # 7,442,787. Polynucleotide - Patents.com	www.patents.com	0	0		
1127	chr4	71106090	71106118	3500294427	28		71106090	71106118	8421504	1	28	0	g	350029442700000003,350029442700000001,350029442700000002	0-27,6-30,22-45						Vectors for cloning	Lubys	2009	0		
1127	chr4	71106090	71106114	3500365620	24		71106090	71106114	8421504	1	24	0	g	350036562000000010	0-24						Splice variants of nuclear dot protein Sp100	cs.biologists.org	0	0		
1127	chr4	71106090	71106114	3500254000	24		71106090	71106114	8421504	1	24	0	g	350025400000000000	0-24						Use of pi3k inibitors for the treatment of obesity, steatosis and ageing	Bischoff	2012	0		
1127	chr4	71106091	71106117	3500225263	26		71106091	71106117	8421504	1	26	0	g	350022526300000002	0-26						Transcriptional reprogramming of somatic cell nuclei during preimplantation development of cloned bovine embryos. - ResearchGate	.researchgate.net	0	0		
1127	chr4	71106091	71106116	3500249193	25		71106091	71106116	8421504	1	25	0	g	350024919300000011	24-49						Arginine/Serine-rich Protein Interaction Domain-dependent Modulation of a Tau Exon 10 Splicing Enhancer--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#	journal.9med.net	0	0		
1127	chr4	71106091	71106114	3500330854	23		71106091	71106114	8421504	1	23	0	g	350033085400000016	3-26						An improved method for recovering rabies virus from cloned cDNA - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
1127	chr4	71106091	71106114	3500303632	23		71106091	71106114	8421504	1	23	0	g	350030363200000081,350030363200000117,350030363200000033,350030363200000008,350030363200000084,350030363200000144,350030363200000145	1-24,0-21,0-21,0-21,0-21,5-26,0-19						METHODS AND COMPOSITIONS FOR FULL-LENGTH cDNA CLONING	Chenchik	1997	0		
1127	chr4	71106092	71106117	3500056259	25		71106092	71106117	8421504	1	25	0	g	350005625900000004,350005625900000005	1-26,9-31						A respiratory syncytial virus with a genomic deficiency complemented in trans	Luytjes	2012	0		
1127	chr4	71106092	71106117	3500028274	25		71106092	71106117	8421504	1	25	0	g	350002827400000038	2-27					Patent	Abspaltbare, nicht-fl&#xfc;chtige molek&#xfc;le zur massenmarkierung Removable, nonvolatile molecules for mass marker (Patent DE:69735445)	BECKER	2006	0		
1127	chr4	71106092	71106116	3500110077	24		71106092	71106116	8421504	1	24	0	g	350011007700000044,350011007700000006,350011007700000023,350011007700000004	3-25,0-22,3-25,11-33						Novel dna capable of being amplified by pcr with high selectivity and high efficiency	Hirao	2009	0		
1127	chr4	71106092	71106115	3500422304	23		71106092	71106115	8421504	1	23	0	g	350042230400000001	0-23					Journal of Virology	Anti-Rex Aptamers as Mimics of the Rex-Binding Element	Scott	June	0		
1127	chr4	71106092	71106115	3500366772	23		71106092	71106115	8421504	1	23	0	g	350036677200000016,350036677200000008	0-23,0-23						METHODS AND COMPOSITIONS RELATED TO IDENTIFYING PROTEIN-PROTEIN INTERACTIONS - Patent application	www.faqs.org	0	0		
1127	chr4	71106093	71106124	3500085397	28		71106093	71106124	8421504	2	21,7	0,24	g	350008539700000009	5-34						FIBROBLAST GROWTH FACTOR-19	Botstein	1998	0		
1127	chr4	71106093	71106124	3500007262	28		71106093	71106124	8421504	2	21,7	0,24	g	350000726200000015,350000726200000003	5-34,5-34						FGF-19 NUCLEIC ACIDS - Patent application	www.faqs.org	0	0		
1127	chr4	71106093	71106119	3500462748	26		71106093	71106119	8421504	1	26	0	g	350046274800000000	4-30			10.1046/j.1365-2672.2003.02106.x	1365-2672	Journal of Applied Microbiology	Nucleic acid sequence based amplification for the rapid and sensitive detection of Salmonella enterica from foods - D'Souza - 2003 - Journal of Applied Microbiology - Wiley Online Library	D'Souza	2003	0		
1127	chr4	71106093	71106119	3500234129	26		71106093	71106119	8421504	1	26	0	g	350023412900000003,350023412900000037,350023412900000025	0-24,0-26,0-25						Surviving the Enterohepatic Tract	repub.eur.nl	0	0		
1127	chr4	71106093	71106118	3500466428	25		71106093	71106118	8421504	1	25	0	g	350046642800000021,350046642800000003	10-35,10-35						SIMPLE CATALYTIC DNA BIOSENSORS FOR IONS BASED ON COLOR CHANGES	LU	2003	0		
1127	chr4	71106093	71106118	3500133146	25		71106093	71106118	8421504	1	25	0	g	350013314600000022,350013314600000028,350013314600000008,350013314600000024,350013314600000003	10-35,6-31,5-30,7-32,10-32						US Patent # 7,192,708. Nucleic acid enzyme biosensors for ions - Patents.com	www.patents.com	0	0		
1127	chr4	71106093	71106118	3500119175	25		71106093	71106118	8421504	1	25	0	g	350011917500000022	6-31						 Nucleic Acid Enzyme Biosensors For Ions 	www.docstoc.com	0	0		
1127	chr4	71106093	71106118	3500078345	25		71106093	71106118	8421504	1	25	0	g	350007834500000004	6-31		15385409	10.1095/biolreprod.104.035451	0006-3363	Biology of Reproduction	CDC6 Requirement for Spindle Formation During Maturation of Mouse Oocytes	Anger	2005	4		
1127	chr4	71106093	71106118	3500060330	25		71106093	71106118	8421504	1	25	0	g	350006033000000039,350006033000000036,350006033000000034	1-25,0-23,0-24						015 PCR Protocols 1st Edition	www.scribd.com	0	0		
1127	chr4	71106093	71106118	3500055303	25		71106093	71106118	8421504	1	25	0	g	350005530300000061,350005530300000014,350005530300000004	10-35,10-35,10-35						Enzymatic DNA molecules that contain modified nucleotides	Barbas	1999	0		
1127	chr4	71106093	71106118	3500050782	25		71106093	71106118	8421504	1	25	0	g	350005078200000010,350005078200000006	6-30,0-20						Esterases For Monitoring Protein Biosynthesis In Vitro 	.freshpatents.com	0	0		
1127	chr4	71106093	71106117	3500431968	24		71106093	71106117	8421504	1	24	0	g	350043196800000001,350043196800000000	4-28,4-28					Patent	Use of RNA polymerase to improve nucleic acid amplification process (Patent US:6025134)	Sooknanan	2000	0		
1127	chr4	71106093	71106117	3500425991	24		71106093	71106117	8421504	1	24	0	g	350042599100000000	8-32		23804758	10.1093/nar/gkt565		Nucleic Acids Research	miR-195 competes with HuR to modulate stim1 mRNA stability and regulate cell migration	Ran	2013	0		
1127	chr4	71106093	71106117	3500423237	24		71106093	71106117	8421504	1	24	0	g	350042323700000000	8-32			10.1128/MCB.22.10.3425-3436.2002		Molecular and Cellular Biology	AMP-Activated Kinase Regulates Cytoplasmic HuR	Wengong	2002	0		
1127	chr4	71106093	71106117	3500391581	24		71106093	71106117	8421504	1	24	0	g	350039158100000000	8-32		12832484	10.1128/MCB.23.14.4991-5004.2003	0270-7306	Molecular and Cellular Biology	Role of HuR in Skeletal Myogenesis through Coordinate Regulation of Muscle Differentiation Genes	Figueroa	2003	6		
1127	chr4	71106093	71106117	3500374631	24		71106093	71106117	8421504	1	24	0	g	350037463100000001	4-28						Real-Time Nucleic Acid Sequence-Based Ampli&#xfb01;cation Assay for Detection of Hepatitis A Virus	www.che.udel.edu	0	0		
1127	chr4	71106093	71106117	3500348253	24		71106093	71106117	8421504	1	24	0	g	350034825300000014	8-32		18562690	10.1091/mbc.E08-02-0175		Molecular Biology of the Cell	JunD Represses Transcription and Translation of the Tight Junction Protein Zona Occludens-1 Modulating Intestinal Epithelial Barrier Function	Jie	2008	0		
1127	chr4	71106093	71106117	3500340647	24		71106093	71106117	8421504	1	24	0	g	350034064700000000	4-28						Rapid detection of enteroviruses in environmental samples by NASBA	John	2002	0		
1127	chr4	71106093	71106117	3500339171	24		71106093	71106117	8421504	1	24	0	g	350033917100000001	8-32		21737690	10.1091/mbc.E11-01-0069	1059-1524	Molecular Biology of the Cell	Regulation of cyclin-dependent kinase 4 translation through CUG-binding protein 1 and microRNA-222 by polyamines	Xiao	2011	5		
1127	chr4	71106093	71106117	3500339058	24		71106093	71106117	8421504	1	24	0	g	350033905800000010	8-32		20498276	10.1128/MCB.00169-10	0270-7306	Molecular and Cellular Biology	HuR Uses AUF1 as a Cofactor To Promote p16INK4 mRNA Decay	Chang	2010	6		
1127	chr4	71106093	71106117	3500317072	24		71106093	71106117	8421504	1	24	0	g	350031707200000286,350031707200000043	5-29,0-23						STRUCTURE AND USE OF 5'PHOSPHATE OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		
1127	chr4	71106093	71106117	3500312335	24		71106093	71106117	8421504	1	24	0	g	350031233500000003	8-32			10.1093/emboj/19.10.2340		The EMBO Journal	HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation	Wengong	2000	0		
1127	chr4	71106093	71106117	3500312171	24		71106093	71106117	8421504	1	24	0	g	350031217100000010	8-32		21859890	10.1128/MCB.05955-11	0270-7306	Molecular and Cellular Biology	Competitive Regulation of Nucleolin Expression by HuR and miR-494	Tominaga	2011	6		
1127	chr4	71106093	71106117	3500310490	24		71106093	71106117	8421504	1	24	0	g	350031049000000001	5-29		18272663	10.1152/ajpregu.00753.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	PACAP is expressed in sympathoexcitatory bulbospinal C1 neurons of the brain stem and increases sympathetic nerve activity in vivo	Farnham	2008	0		
1127	chr4	71106093	71106117	3500301026	24		71106093	71106117	8421504	1	24	0	g	350030102600000014,350030102600000012	0-24,0-23		14679237	10.1128/JB.186.1.179-191.2004	0021-9193	Journal of Bacteriology	Fine-Tuning in Regulation of Clp Protein Content in Bacillus subtilis	Gerth	2004	4		
1127	chr4	71106093	71106117	3500260639	24		71106093	71106117	8421504	1	24	0	g	350026063900000041	8-32		17620417	10.1128/MCB.00500-07	0270-7306	Molecular and Cellular Biology	Analysis of Turnover and Translation Regulatory RNA-Binding Protein Expression through Binding to Cognate mRNAs	Jr.	2007	6		
1127	chr4	71106093	71106117	3500225967	24		71106093	71106117	8421504	1	24	0	g	350022596700000036,350022596700000020,350022596700000297,350022596700000150,350022596700000033	0-23,5-24,0-23,5-24,5-24						Carbon Catabolism in Bacillus subtilis	uni-goettingen.de	0	0		
1127	chr4	71106093	71106117	3500210721	24		71106093	71106117	8421504	1	24	0	g	350021072100000000	4-28						Integrated Microfluidic tmRNA Purification and Real-Time NASBA Device for Molecular Diagnostics | Justin O'Grady - Academia.edu	www.academia.edu	0	0		
1127	chr4	71106093	71106117	3500204039	24		71106093	71106117	8421504	1	24	0	g	350020403900000001	8-32		20007147	10.1093/nar/gkp1114		Nucleic Acids Research	Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence	Jie	2010	0		
1127	chr4	71106093	71106117	3500200683	24		71106093	71106117	8421504	1	24	0	g	350020068300000001	8-32						Impact Journals presents	impactaging.com	0	0		
1127	chr4	71106093	71106117	3500194919	24		71106093	71106117	8421504	1	24	0	g	350019491900000014	8-32		18562690	10.1091/mbc.E08-02-0175	1059-1524	Molecular Biology of the Cell	JunD Represses Transcription and Translation of the Tight Junction Protein Zona Occludens-1 Modulating Intestinal Epithelial Barrier Function	Chen	2008	5		
1127	chr4	71106093	71106117	3500190006	24		71106093	71106117	8421504	1	24	0	g	350019000600000001	0-24		16339943	10.1099/mic.0.28188-0	1350-0872	Microbiology	Differential regulation of urease activity in Helicobacter hepaticus and Helicobacter pylori	Belzer	2005	3		
1127	chr4	71106093	71106117	3500176990	24		71106093	71106117	8421504	1	24	0	g	350017699000000019	8-32		23185455	10.1371/journal.pone.0049841		PLoS ONE	MCPIP1 Down-Regulates IL-2 Expression through an ARE-Independent Pathway	Min	2012	0		
1127	chr4	71106093	71106117	3500160251	24		71106093	71106117	8421504	1	24	0	g	350016025100000007	8-32		18678645	10.1128/MCB.00142-08	0270-7306	Molecular and Cellular Biology	CSIG Inhibits PTEN Translation in Replicative Senescence	Ma	2008	6		
1127	chr4	71106093	71106117	3500149466	24		71106093	71106117	8421504	1	24	0	g	350014946600000004	8-32		14517280	10.1128/MCB.23.20.7083-7095.2003	0270-7306	Molecular and Cellular Biology	Influence of the RNA-Binding Protein HuR in pVHL-Regulated p53 Expression in Renal Carcinoma Cells	Galban	2003	6		
1127	chr4	71106093	71106117	3500149292	24		71106093	71106117	8421504	1	24	0	g	350014929200000000	0-24						Plasmalemmal Vesicle Associated Protein-1Is a Novel Marker Implicatedin Brain Tumor Angiogenesis	.aacrjournals.org	0	0		
1127	chr4	71106093	71106117	3500139730	24		71106093	71106117	8421504	1	24	0	g	350013973000000000	8-32		19033365	10.1093/nar/gkn929		Nucleic Acids Research	Identification of a signature motif in target mRNAs of RNA-binding protein AUF1	Krystyna	2009	0		
1127	chr4	71106093	71106117	3500138786	24		71106093	71106117	8421504	1	24	0	g	350013878600000011	0-24						Inverse nickel-responsive regulation of two urease enzymes in the gastric pathogen Helicobacter mustelae	www.ifr.ac.uk	0	0		
1127	chr4	71106093	71106117	3500128275	24		71106093	71106117	8421504	1	24	0	g	350012827500000008	8-32		23301007	10.1371/journal.pone.0052954	1932-6203	PLOS ONE	PLOS ONE: Quinacrine Impairs Enterovirus 71 RNA Replication by Preventing Binding of Polypyrimidine-Tract Binding Protein with Internal Ribosome Entry Sites	Wang	2013	4		
1127	chr4	71106093	71106117	3500118683	24		71106093	71106117	8421504	1	24	0	g	350011868300000003	8-32		23155001	10.1091/mbc.E12-07-0531	1059-1524	Molecular Biology of the Cell	Competitive binding of CUGBP1 and HuR to occludin mRNA controls its translation and modulates epithelial barrier function	Yu	2013	5		
1127	chr4	71106093	71106117	3500114457	24		71106093	71106117	8421504	1	24	0	g	350011445700000007	8-32		10629032	10.1128/MCB.20.3.760-769.2000	0270-7306	Molecular and Cellular Biology	HuR Regulates p21 mRNA Stabilization by UV Light	Wang	2000	6		
1127	chr4	71106093	71106117	3500112045	24		71106093	71106117	8421504	1	24	0	g	350011204500000008	8-32		23301007	10.1371/journal.pone.0052954		PLoS ONE	Quinacrine Impairs Enterovirus 71 RNA Replication by Preventing Binding of Polypyrimidine-Tract Binding Protein with Internal Ribosome Entry Sites	Jianmin	2013	0		
1127	chr4	71106093	71106117	3500108265	24		71106093	71106117	8421504	1	24	0	g	350010826500000030,350010826500000019	5-29,0-20						molecular Analysis of cancer	www.docstoc.com	0	0		
1127	chr4	71106093	71106117	3500107756	24		71106093	71106117	8421504	1	24	0	g	350010775600000015	0-24						BMC Biotechnology BioMed Central	www.telebitcom.de	0	0		
1127	chr4	71106093	71106117	3500100779	24		71106093	71106117	8421504	1	24	0	g	350010077900000002	8-32						THE JOURNAL OF BIOLOGICAL CHEMISTRY Printed in U.S.A. Prostaglandin A -mediated Stabilization of p21 mRNA through an ERK-dependent Pathway Requiring the RNA-binding Protein HuR*	age.bjmu.edu.cn	0	0		
1127	chr4	71106093	71106117	3500087608	24		71106093	71106117	8421504	1	24	0	g	350008760800000009,350008760800000000,350008760800000001	4-28,4-28,0-23						Terminal repeat amplification method	Malek	1996	0		
1127	chr4	71106093	71106117	3500069290	24		71106093	71106117	8421504	1	24	0	g	350006929000000000,350006929000000001	4-28,4-28						Use of rna polymerase to improve nucleic acid amplification process	Sooknanan	1997	0		
1127	chr4	71106093	71106117	3500050942	24		71106093	71106117	8421504	1	24	0	g	350005094200000085,350005094200000086,350005094200000079,350005094200000078,350005094200000074,350005094200000073,350005094200000157	4-25,4-26,4-26,4-26,4-26,4-28,4-26						Nucleic Acid Sequences That Can Be Used As Primers And Probes In The Amplification And Detection Of Sars Coronavirus 	.freshpatents.com	0	0		
1127	chr4	71106093	71106117	3500040130	24		71106093	71106117	8421504	1	24	0	g	350004013000000007	8-32		20805360	10.1128/MCB.00807-10	0270-7306	Molecular and Cellular Biology	Polyamines Regulate the Stability of JunD mRNA by Modulating the Competitive Binding of Its 3&#x2032; Untranslated Region to HuR and AUF1	Zou	2010	6		
1127	chr4	71106093	71106117	3500038032	24		71106093	71106117	8421504	1	24	0	g	350003803200000028	8-32						Role of the MID1/&#x03b1;4 protein complex in Huntington&#x2019;s disease	diss.fu-berlin.de	0	0		
1127	chr4	71106093	71106117	3500033209	24		71106093	71106117	8421504	1	24	0	g	350003320900000007	8-32					Molecular and Cellular Biology	HuR Regulates p21 mRNA Stabilization by UV Light	Wengong	2000	0		
1127	chr4	71106093	71106116	3500454830	23		71106093	71106116	8421504	1	23	0	g	350045483000000002	5-28		15917345	10.1095/biolreprod.105.041624	0006-3363	Biology of Reproduction	Pituitary Adenylate Cyclase Activating Polypeptide Messenger RNA in the Paraventricular Nucleus and Anterior Pituitary During the Rat Estrous Cycle	Joseph	2005	4		
1127	chr4	71106093	71106116	3500404915	23		71106093	71106116	8421504	1	23	0	g	350040491500000004,350040491500000002	9-31,0-22						Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. - ResearchGate	.researchgate.net	0	0		
1127	chr4	71106093	71106116	3500399438	23		71106093	71106116	8421504	1	23	0	g	350039943800000000,350039943800000002	4-27,4-27						 Enhanced Nucleic Acid Amplification Process 	www.docstoc.com	0	0		
1127	chr4	71106093	71106116	3500384133	23		71106093	71106116	8421504	1	23	0	g	350038413300000091	8-31						Aptamers as agonists - Patent application	www.faqs.org	0	0		
1127	chr4	71106093	71106116	3500351307	23		71106093	71106116	8421504	1	23	0	g	350035130700000052	5-28						Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease - Patent # 6312890 - PatentGenius	.patentgenius.com	0	0		
1127	chr4	71106093	71106116	3500242196	23		71106093	71106116	8421504	1	23	0	g	350024219600000029	5-28		11870074	10.1095/biolreprod66.3.675	0006-3363	Biology of Reproduction	Sp1 and Egr1 Regulate Transcription of the Dmrt1 Gene in Sertoli Cells	Lei	2002	4		
1127	chr4	71106093	71106116	3500213978	23		71106093	71106116	8421504	1	23	0	g	350021397800000137	2-25						In Vitro Selection of RNA Aptamers to Clinically Applicable Small- Molecule Ligands	brary.caltech.edu	0	0		
1127	chr4	71106093	71106116	3500198167	23		71106093	71106116	8421504	1	23	0	g	350019816700000001	4-27					Patent	Enhanced nucleic acid amplification process (Patent US:5130238)	Davey	1992	0		
1127	chr4	71106093	71106116	3500164803	23		71106093	71106116	8421504	1	23	0	g	350016480300000033,350016480300000094	4-27,4-27						Lateral Flow Assay Device And Method 	.freshpatents.com	0	0		
1127	chr4	71106093	71106116	3500145410	23		71106093	71106116	8421504	1	23	0	g	350014541000000004	2-25		22233578	10.1038/mt.2011.277		Molecular Therapy	A General RNA Motif for Cellular Transfection	Maria	2012	0		
1127	chr4	71106093	71106116	3500112772	23		71106093	71106116	8421504	1	23	0	g	350011277200000016	9-32						DEVICE FOR DECELERATING THE ROTATION OF A HINGE IN PARTICULAR FOR FURNITURE AND A HINGE PARTICULARLY FOR FURNITURE HAVING SAID DECELERATION DEVICE - Patent application	www.faqs.org	0	0		
1127	chr4	71106093	71106116	3500111445	23		71106093	71106116	8421504	1	23	0	g	350011144500000009	5-28			10.1128/MCB.21.20.6748-6757.2001		Molecular and Cellular Biology	Role of p14ARF in Replicative and Induced Senescence of Human Fibroblasts	Wenyi	2001	0		
1127	chr4	71106093	71106116	3500086878	23		71106093	71106116	8421504	1	23	0	g	350008687800000012	5-28		10454564		0270-7306	Molecular and Cellular Biology	Identification of cis andtrans Elements Involved in the Cell Cycle Regulation of Multiple Genes in Crithidia fasciculata	Mahmood	1999	6		
1127	chr4	71106093	71106116	3500013184	23		71106093	71106116	8421504	1	23	0	g	350001318400000008	2-25					Patent	Selection method for cell internalizing nucleic acids (Patent CN:101680037)	An De Lu *D*Ai Lin Dun 	2012	0		
1127	chr4	71106093	71106116	3500007671	23		71106093	71106116	8421504	1	23	0	g	350000767100000010	2-25						Selection method for cell internalizing nucleic acids	An De Lu *D*Ai Lin Dun 	2010	0		
1127	chr4	71106093	71106116	3500002541	23		71106093	71106116	8421504	1	23	0	g	350000254100000036	0-23						ScienceDirect.com - Mechanisms of Development - ESC, ESCL and their roles in Polycomb Group mechanisms	sciencedirect.com	0	0		
1127	chr4	71106094	71106123	3500374272	27		71106094	71106123	8421504	2	22,5	0,24	g	350037427200000003	0-27						IDENTIFICA&#xc7;&#xc3;O E CARACTERIZA&#xc7;&#xc3;O DE UMA PROTE&#xcd;NA COM MOTIVOS	bdtd.bce.unb.br	0	0		
1127	chr4	71106094	71106123	3500324249	28		71106094	71106123	8421504	2	22,6	0,23	g	350032424900000017,350032424900000047,350032424900000013,350032424900000092	0-33,0-22,0-20,0-21						HIGH-AFFINITY OLIGONUCLEOTIDE LIGANDS TO GROWTH FACTORS - NEXSTAR PHARMACEUTICALS, INC	www.sumobrain.com	0	0		
1127	chr4	71106094	71106123	3500111462	28		71106094	71106123	8421504	2	22,6	0,23	g	350011146200000022,350011146200000024	5-25,5-35						Novel gaba b? receptor dna sequences	Bonner	2000	0		
1127	chr4	71106094	71106122	3500145861	28		71106094	71106122	8421504	1	28	0	g	350014586100000131,350014586100000132	14-37,0-22						PURIFIED THERMOSTABLE NUCLEIC ACID POLYMERASE ENZYME FROM THERMOSIPHO AFRICANUS - Cetus	www.sumobrain.com	0	0		
1127	chr4	71106094	71106122	3500073071	27		71106094	71106122	8421504	2	20,7	0,21	g	350007307100000057,350007307100000049,350007307100000053,350007307100000045	0-20,0-24,0-25,0-20		22273551	10.1186/1471-213X-12-6	1471-213X	BMC Developmental Biology	Transcriptional signature of accessory cells in the lateral line, using the Tnk1bp1:EGFP transgenic zebrafish line	Behra	2012	3		
1127	chr4	71106094	71106122	3500009954	28		71106094	71106122	8421504	1	28	0	g	350000995400000047,350000995400000044,350000995400000048,350000995400000014,350000995400000016,350000995400000012	0-23,4-27,0-28,0-20,0-20,0-24						Caract&#xe9;risation mol&#xe9;culaire des R&#xe9;cepteurs Venus Kinase: &#xe9;tude ... - TechyLib	techylib.com	0	0		
1127	chr4	71106094	71106121	3500448166	27		71106094	71106121	8421504	1	27	0	g	350044816600000012,350044816600000013	3-32,0-29						Modified ribozymes	Eckstein	1995	0		
1127	chr4	71106094	71106121	3500384318	26		71106094	71106121	8421504	2	20,6	0,21	g	350038431800000007,350038431800000009	0-20,0-32						APPLICATION OF MOLECULAR GENOMICS IN ADDRESSING QUESTIONS ON TERMITE BIOLOGY	www.icup.org.uk	0	0		
1127	chr4	71106094	71106121	3500069082	27		71106094	71106121	8421504	1	27	0	g	350006908200000000,350006908200000002	0-20,0-27						The head-regeneration transcriptome of the planarian Schmidtea mediterranea	genomebiology.com	0	0		
1127	chr4	71106094	71106121	3500002262	27		71106094	71106121	8421504	1	27	0	g	350000226200000002,350000226200000003,350000226200000000,350000226200000001	1-24,1-24,1-28,1-25		19429919	10.1074/mcp.M800559-MCP200	1535-9476	Molecular & Cellular Proteomics	Systems-wide Analysis of a Phosphatase Knock-down by Quantitative Proteomics and Phosphoproteomics	Hilger	2009	7		
1127	chr4	71106094	71106119	3500433830	25		71106094	71106119	8421504	1	25	0	g	350043383000000000	13-38						Noval Compounds From Natural Products in the New Millennium E-book	www.scribd.com	0	0		
1127	chr4	71106094	71106119	3500306604	25		71106094	71106119	8421504	1	25	0	g	350030660400000096,350030660400000007,350030660400000092,350030660400000009,350030660400000015,350030660400000011,350030660400000013	4-27,4-27,4-27,4-29,4-28,4-28,4-28						COMPOSITIONS, KITS AND RELATED METHODS FOR THE DETECTION AND/OR MONITORING OF LISTERIA - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106118	3500452019	24		71106094	71106118	8421504	1	24	0	g	350045201900000001	6-30						Vectors For Cloning 	.freshpatents.com	0	0		
1127	chr4	71106094	71106118	3500404002	24		71106094	71106118	8421504	1	24	0	g	350040400200000009	1-25		21844892	10.1038/cr.2011.136	1001-0602	Cell Research	Transduction of the Hedgehog signal through the dimerization of Fused and the nuclear translocation of Cubitus interruptus	Zhang	2011	8		
1127	chr4	71106094	71106118	3500397261	24		71106094	71106118	8421504	1	24	0	g	350039726100000002,350039726100000003,350039726100000000,350039726100000001	1-24,1-24,1-24,1-25			10.1128/MCB.25.14.5947-5954.2005		Molecular and Cellular Biology	The MRG Domain Mediates the Functional Integration of MSL3 into the Dosage Compensation Complex	Violette	July	0		
1127	chr4	71106094	71106118	3500366505	24		71106094	71106118	8421504	1	24	0	g	350036650500000001	6-30						Vectors for cloning	Lubys	2008	0		
1127	chr4	71106094	71106118	3500364059	24		71106094	71106118	8421504	1	24	0	g	350036405900000001,350036405900000000	0-24,0-23			10.1111/j.1440-169X.2007.00957.x	1440-169X	Development, Growth & Differentiation	Cloning of a novel protease required for the molting of Locusta migratoria manilensis - Wei - 2007 - Development, Growth & Differentiation - Wiley Online Library	Wei	2007	0		
1127	chr4	71106094	71106118	3500299583	24		71106094	71106118	8421504	1	24	0	g	350029958300000092,350029958300000098,350029958300000103	4-27,4-27,4-28						COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF CHLAMYDOPHILA PNEUMONIAE IN A TEST SAMPLE - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106118	3500286733	24		71106094	71106118	8421504	1	24	0	g	350028673300000000,350028673300000134	4-27,3-27						COMPOSITIONS, KITS AND RELATED METHODS FOR THE DETECTION AND/OR MONITORING OF SALMONELLA - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106118	3500267647	24		71106094	71106118	8421504	1	24	0	g	350026764700000007	0-24						METHODS AND COMPOSITIONS FOR TUMOR VACCINATION AND THERAPY - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106118	3500188050	24		71106094	71106118	8421504	1	24	0	g	350018805000000000	6-30		20920187	10.1186/1756-0500-3-244	1756-0500	BMC Research Notes	Selective amplification of Brucella melitensis mRNA from a mixed host-pathogen total RNA	Rossetti	2010	0		
1127	chr4	71106094	71106118	3500117311	24		71106094	71106118	8421504	1	24	0	g	350011731100000016	0-24						CHIMERIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106118	3500117113	24		71106094	71106118	8421504	1	24	0	g	350011711300000003	10-34		19861584	10.1152/ajpendo.00380.2009		American Journal of Physiology - Endocrinology and Metabolism	Interactions between neurotensin and GnRH neurons in the positive feedback control of GnRH/LH secretion in the mouse	Dungan	2010	0		
1127	chr4	71106094	71106118	3500097317	24		71106094	71106118	8421504	1	24	0	g	350009731700000001	0-24			10.1186/1471-2121-7-7		BMC Cell Biology	D-MEKK1, the Drosophila orthologue of mammalian MEKK4/MTK1, and Hemipterous/D-MKK7 mediate the activation of D-JNK by cadmium and arsenite in Schneider cells	Olga	2006	0		
1127	chr4	71106094	71106118	3500064094	24		71106094	71106118	8421504	1	24	0	g	350006409400000003	0-24		12944990	10.1038/sj.cgt.7700623	0929-1903	Cancer Gene Therapy	E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes	Kim	2003	3		
1127	chr4	71106094	71106118	3500050941	24		71106094	71106118	8421504	1	24	0	g	350005094100000016	0-24						The nucleoporin Seh1 forms a complex with Mio and serves an essential tissue-specific function in Drosophila oogenesis	ev.biologists.org	0	0		
1127	chr4	71106094	71106117	3500449086	23		71106094	71106117	8421504	1	23	0	g	350044908600000032	0-23						CD	itc.u-tokyo.ac.jp	0	0		
1127	chr4	71106094	71106117	3500447806	23		71106094	71106117	8421504	1	23	0	g	350044780600000000	4-27			10.1186/1471-2202-8-100		BMC Neuroscience	Analysis of gene expression during neurite outgrowth and regeneration	Moriah	2007	0		
1127	chr4	71106094	71106117	3500447497	23		71106094	71106117	8421504	1	23	0	g	350044749700000000	0-23		19883761	10.1016/j.ibmb.2009.10.008		Insect biochemistry and molecular biology	Molecular Genetic Analysis of Midgut Serine Proteases in Aedes aegypti Mosquitoes	Jun	2009	0		
1127	chr4	71106094	71106117	3500439064	23		71106094	71106117	8421504	1	23	0	g	350043906400000000	0-23						Podoviriedae bacteriophage having killing activity specific to staphylococcus aureus - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500433603	23		71106094	71106117	8421504	1	23	0	g	350043360300000002	0-23		15975913	10.1091/mbc.E04-10-0938	1059-1524	Molecular Biology of the Cell	dGRASP Localization and Function in the Early Exocytic Pathway in Drosophila S2 Cells	Kondylis	2005	5		
1127	chr4	71106094	71106117	3500430820	23		71106094	71106117	8421504	1	23	0	g	350043082000000002	3-26						Amino acids as modulators of endothelium-derived nitric oxide	al.physiology.org	0	0		
1127	chr4	71106094	71106117	3500426319	23		71106094	71106117	8421504	1	23	0	g	350042631900000001	0-23						Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in David G. Wang, Science www.sciencemag.org (this information is current as of October 29, 2007 )	seerx.ist.psu.edu	0	0		
1127	chr4	71106094	71106117	3500418963	23		71106094	71106117	8421504	1	23	0	g	350041896300000001	0-23		21050473	10.1186/1477-7827-8-134	1477-7827	Reproductive Biology and Endocrinology	Expression of genes related to the hypothalamic-pituitary-adrenal axis in murine fetal lungs in late gestation	Simard	2010	2		
1127	chr4	71106094	71106117	3500416772	23		71106094	71106117	8421504	1	23	0	g	350041677200000041,350041677200000040,350041677200000009,350041677200000052,350041677200000047,350041677200000046,350041677200000005,350041677200000007,350041677200000012,350041677200000013,350041677200000010,350041677200000024,350041677200000003,350041677200000053,350041677200000022	0-20,0-20,4-27,0-20,0-20,0-20,4-27,4-24,0-21,0-20,0-20,0-23,4-27,0-20,0-20						Supplemental Data Identification of SUMO-Dependent Chromatin-Associated Transcriptional Repression Components by a Genome-wide RNA Interference Screen	mt.uni-marburg.de	0	0		
1127	chr4	71106094	71106117	3500414912	23		71106094	71106117	8421504	1	23	0	g	350041491200000002	0-23		21447833	10.1182/blood-2010-12-325332	0006-4971	Blood	TIP110/p110nrb/SART3/p110 regulation of hematopoiesis through CMYC	Liu	2011	10		
1127	chr4	71106094	71106117	3500411596	23		71106094	71106117	8421504	1	23	0	g	350041159600000003	0-23						Bartonella quintana in Cynomolgus Monkey (Macaca fascicularis) - Vol. 11 No. 12 - December 2005 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
1127	chr4	71106094	71106117	3500403582	23		71106094	71106117	8421504	1	23	0	g	350040358200000005	10-33		22185205	10.1186/1746-4811-7-47	1746-4811	Plant Methods	Reverse protection assay: a tool to analyze transcriptional rates from individual promoters	Zubo	2011	3		
1127	chr4	71106094	71106117	3500400585	23		71106094	71106117	8421504	1	23	0	g	350040058500000002	7-30		16115915	10.1158/1078-0432.CCR-04-2274	1078-0432	Clinical Cancer Research	WOX1 Is Essential for UVB Irradiation&#x2013;Induced Apoptosis and Down-Regulated via Translational Blockade in UVB-Induced Cutaneous Squamous Cell Carcinoma In vivo	Lai	2005	8		
1127	chr4	71106094	71106117	3500400469	23		71106094	71106117	8421504	1	23	0	g	350040046900000001	0-23						ARF6 AS A NEW TARGET FOR TREATING ALZHEIMER'S DISEASE - VIB VZW	www.sumobrain.com	0	0		
1127	chr4	71106094	71106117	3500399531	23		71106094	71106117	8421504	1	23	0	g	350039953100000000,350039953100000275	4-27,4-27						 Methods Of Modulating And Identifying Agents That Modulate Intracellular Calcium 	www.docstoc.com	0	0		
1127	chr4	71106094	71106117	3500396306	23		71106094	71106117	8421504	1	23	0	g	350039630600000056	0-23						Identification et caract&#xe9;risation fonctionnelle de deux g&#xe8;nes r&#xe9;gulateurs du m&#xe9;tabolisme des compos&#xe9;s ph&#xe9;noliques de la baie de raisin	mm.u-bordeaux1.fr	0	0		
1127	chr4	71106094	71106117	3500393745	23		71106094	71106117	8421504	1	23	0	g	350039374500000015	0-23						a Sterol Demethylase-Related cyp51A cyp51B Aspergillus fumigatus Aspergillus	jcm.asm.org	0	0		
1127	chr4	71106094	71106117	3500391387	23		71106094	71106117	8421504	1	23	0	g	350039138700000002	3-26						Comparative sequence analysis processes and systems	Ke Li Si Di Ya Nei *Huo Ni Shi 	2010	0		
1127	chr4	71106094	71106117	3500391052	23		71106094	71106117	8421504	1	23	0	g	350039105200000010	0-23						Nf-hev compositions and methods of use	Luc	2004	0		
1127	chr4	71106094	71106117	3500388987	23		71106094	71106117	8421504	1	23	0	g	350038898700000092,350038898700000100,350038898700000102	4-27,4-27,4-27						Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample	Cunningham	2007	0		
1127	chr4	71106094	71106117	3500386882	23		71106094	71106117	8421504	1	23	0	g	350038688200000013,350038688200000011,350038688200000004	29-49,26-49,0-20						Method of amplifying an RNA target sequence using an RNA polymerase functioning preferably on RNA template - Patent # 6828127 - PatentGenius	.patentgenius.com	0	0		
1127	chr4	71106094	71106117	3500385927	23		71106094	71106117	8421504	1	23	0	g	350038592700000000	0-23						An RNA Interference Screen Identi&#xfb01;es a Novel Regulator of Target of Rapamycin That Mediates Hypoxia Suppression of Translation in Drosophila	w.molbiolcell.org	0	0		
1127	chr4	71106094	71106117	3500385133	23		71106094	71106117	8421504	1	23	0	g	350038513300000028	4-27					Patent	Method for obtaining and initiating amplification of a target nucleic acid sequence (Patent US:8058006)	Jonas	2011	0		
1127	chr4	71106094	71106117	3500384360	23		71106094	71106117	8421504	1	23	0	g	350038436000000003	0-23						Isothermal amplification of dna	Richardson	2001	0		
1127	chr4	71106094	71106117	3500382175	23		71106094	71106117	8421504	1	23	0	g	350038217500000000	3-26		16687650	10.1095/biolreprod.105.049502	0006-3363	Biology of Reproduction	Gene Expression Profiling of Mouse Embryonic Stem Cell Subpopulations	Furusawa	2006	4		
1127	chr4	71106094	71106117	3500381546	23		71106094	71106117	8421504	1	23	0	g	350038154600000000	13-36						Cloning and expression of activation induced cytidine deaminase from Bos taurus. - ResearchGate	.researchgate.net	0	0		
1127	chr4	71106094	71106117	3500373693	23		71106094	71106117	8421504	1	23	0	g	350037369300000048	0-23						Chromosomal expression of heterologous genes in bacterial cells	Mascarenhas	1996	0		
1127	chr4	71106094	71106117	3500371182	23		71106094	71106117	8421504	1	23	0	g	350037118200000002	1-24			10.1091/mbc.E03-05-0342		Molecular Biology of the Cell	The Drosophila Kinesin-like Protein KLP67A Is Essential for Mitotic and Male Meiotic Spindle Assembly	Rita	2004	0		
1127	chr4	71106094	71106117	3500366651	23		71106094	71106117	8421504	1	23	0	g	350036665100000025,350036665100000063	12-35,12-35					Patent	Gene for a heat resistant enzyme of the amino acid biosynthetic pathway derived from thermophilic Coryneform bacteria (Patent EP:1712632)	Akiyoshi	2009	0		
1127	chr4	71106094	71106117	3500348620	23		71106094	71106117	8421504	1	23	0	g	350034862000000098,350034862000000045	0-23,0-20						Nucleotide sequences for gene regulation and methods of use thereof	Kurachi	1999	0		
1127	chr4	71106094	71106117	3500345597	23		71106094	71106117	8421504	1	23	0	g	350034559700000029,350034559700000028	4-27,4-27						METHOD FOR OBTAINING AND INITIATING AMPLIFICATION OF A TARGET NUCLEIC ACID SEQUENCE	Jonas	2007	0		
1127	chr4	71106094	71106117	3500342948	23		71106094	71106117	8421504	1	23	0	g	350034294800000003	0-23		11971983	10.1128/MCB.22.10.3527-3536.2002	0270-7306	Molecular and Cellular Biology	Tyrosine Phosphorylation Regulates Alpha II Spectrin Cleavage by Calpain	Nicolas	2002	6		
1127	chr4	71106094	71106117	3500341591	23		71106094	71106117	8421504	1	23	0	g	350034159100000000	4-27		19056684	10.1091/mbc.E08-06-0639	1059-1524	Molecular Biology of the Cell	Stwl Modifies Chromatin Compaction and Is Required to Maintain DNA Integrity in the Presence of Perturbed DNA Replication	Yi	2009	5		
1127	chr4	71106094	71106117	3500340956	23		71106094	71106117	8421504	1	23	0	g	350034095600000002,350034095600000019	0-23,0-23						EXPRESSION OF APOAI AND VARIANTS THEREOF USING SPLICEOSOME MEDIATED RNA TRANS-SPLICING - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500323906	23		71106094	71106117	8421504	1	23	0	g	350032390600000001	0-23					Journal of Clinical Microbiology	Identification of a Granulocytic Ehrlichia Strain Isolated from a Horse in Switzerland and Comparison with Other Rickettsiae of the Ehrlichia phagocytophila Genogroup	Nicola	July	0		
1127	chr4	71106094	71106117	3500321132	23		71106094	71106117	8421504	1	23	0	g	350032113200000007	0-23						Insect pest control method	Teruyuki	2012	0		
1127	chr4	71106094	71106117	3500312336	23		71106094	71106117	8421504	1	23	0	g	350031233600000011,350031233600000003	0-23,0-23						Compositions And Methods For Reversing Or Preventing Resistance Of A Cancer Cell To A Cytotoxic Agent - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500311781	23		71106094	71106117	8421504	1	23	0	g	350031178100000001,350031178100000000	0-23,0-21			10.1091/mbc.E06-07-0587		Molecular Biology of the Cell	Mad2-independent Spindle Assembly Checkpoint Activation and Controlled Metaphase&#x2013;Anaphase Transition in Drosophila S2 Cells	Bernardo	2007	0		
1127	chr4	71106094	71106117	3500309068	23		71106094	71106117	8421504	1	23	0	g	350030906800000003	0-23			10.3201/eid1112.030045		Emerging Infectious Diseases	Bartonella quintana in Cynomolgus Monkey (Macaca fascicularis)	Laurie	2005	0		
1127	chr4	71106094	71106117	3500300654	23		71106094	71106117	8421504	1	23	0	g	350030065400000009,350030065400000004	0-23,0-23						Method of rapidly producing vaccines for animals	Bartholomay	2012	0		
1127	chr4	71106094	71106117	3500299570	23		71106094	71106117	8421504	1	23	0	g	350029957000000000,350029957000000041	0-23,0-23						 Podoviriedae Bacteriophage Having Killing Activity Specific To Staphylococcus Aureus 	www.docstoc.com	0	0		
1127	chr4	71106094	71106117	3500297566	23		71106094	71106117	8421504	1	23	0	g	350029756600000003	0-23			10.1128/MCB.22.10.3527-3536.2002		Molecular and Cellular Biology	Tyrosine Phosphorylation Regulates Alpha II Spectrin Cleavage by Calpain	Gael	2002	0		
1127	chr4	71106094	71106117	3500294580	23		71106094	71106117	8421504	1	23	0	g	350029458000000003	0-23						Use of cathepsin inhibitors for reversing or preventing resistance of a cancer cell to a cytotoxic agent	Rebbaa	2006	0		
1127	chr4	71106094	71106117	3500284970	23		71106094	71106117	8421504	1	23	0	g	350028497000000003	0-23						Isothermal amplification of DNA	Tabor	2003	0		
1127	chr4	71106094	71106117	3500280324	23		71106094	71106117	8421504	1	23	0	g	350028032400000001	0-23						C&#xc1;SSIA ARANTES DE LIMA	w.bdtd.unifesp.br	0	0		
1127	chr4	71106094	71106117	3500273486	23		71106094	71106117	8421504	1	23	0	g	350027348600000146,350027348600000147,350027348600000024,350027348600000025	2-23,2-25,2-23,2-25						Single-Point Genome Signature Tags - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500272832	23		71106094	71106117	8421504	1	23	0	g	350027283200000028	4-27						Method for obtaining and initiating amplification of a target nucleic acid sequence	Jonas	2009	0		
1127	chr4	71106094	71106117	3500269763	23		71106094	71106117	8421504	1	23	0	g	350026976300000006	10-33						 Consensus Configurational Bias Monte Carlo Method And System For Pharmacophore Structure Determination 	www.docstoc.com	0	0		
1127	chr4	71106094	71106117	3500261134	23		71106094	71106117	8421504	1	23	0	g	350026113400000002,350026113400000001	0-20,0-20						None	www.msk.or.kr	0	0		
1127	chr4	71106094	71106117	3500260256	23		71106094	71106117	8421504	1	23	0	g	350026025600000001	0-23						molecular biology ENZYMES	www.enzymes.at	0	0		
1127	chr4	71106094	71106117	3500259515	23		71106094	71106117	8421504	1	23	0	g	350025951500000042,350025951500000095	0-20,0-23						US Patent # 7,341,871. Nucleotide sequences for gene regulation and methods of use thereof - Patents.com	www.patents.com	0	0		
1127	chr4	71106094	71106117	3500255631	23		71106094	71106117	8421504	1	23	0	g	350025563100000007	4-27						Polynucleotides and polypeptides associated with the nf-kb pathway	Carman	2004	0		
1127	chr4	71106094	71106117	3500253705	23		71106094	71106117	8421504	1	23	0	g	350025370500000001	0-23		12958243	10.1128/JCM.41.9.4172-4177.2003	0095-1137	Journal of Clinical Microbiology	Development and Evaluation of a Seminested PCR for Detection and Differentiation of Babesia gibsoni (Asian Genotype) and B. canis DNA in Canine Blood Samples	Birkenheuer	2003	4		
1127	chr4	71106094	71106117	3500253072	23		71106094	71106117	8421504	1	23	0	g	350025307200000000	0-23						Antimicrobial protein derived from podoviriedae bacteriophage specific to staphylococcus aureus - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500249179	23		71106094	71106117	8421504	1	23	0	g	350024917900000002	9-32						Method for generating proteins	Behar	2012	0		
1127	chr4	71106094	71106117	3500248255	23		71106094	71106117	8421504	1	23	0	g	350024825500000000	0-23						Developmental control of nuclear morphogenesis and anchoring by charleston, identi&#xfb01;ed in a functional genomic screen of Drosophila cellularisation	ev.biologists.org	0	0		
1127	chr4	71106094	71106117	3500241749	23		71106094	71106117	8421504	1	23	0	g	350024174900000000	3-26		16687650	10.1095/biolreprod.105.049502	0006-3363	Biology of Reproduction	Gene Expression Profiling of Mouse Embryonic Stem Cell Subpopulations	Furusawa	2006	4		
1127	chr4	71106094	71106117	3500233739	23		71106094	71106117	8421504	1	23	0	g	350023373900000000	0-23						Methods and compositions of amplifying rna	Che	2002	0		
1127	chr4	71106094	71106117	3500232051	23		71106094	71106117	8421504	1	23	0	g	350023205100000037	3-26						G protein-coupled receptors	Lind	2006	0		
1127	chr4	71106094	71106117	3500228345	23		71106094	71106117	8421504	1	23	0	g	350022834500000001	0-23						UV AND COLD TEMPRATURE EFFECTS ON MESSENGER RNA INTEGRITY FROM HUMAN SALIVA A DISSERTATION SUBMITTED TO THE GRADUATE SCHOOL IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE DOCTORATE OF EDUCATION IN SCIENCE BY SAMILA CHARKHEZARRIN ADVISOR DR. JOH	alscholar.bsu.edu	0	0		
1127	chr4	71106094	71106117	3500223789	23		71106094	71106117	8421504	1	23	0	g	350022378900000000	0-23		18653470	10.1091/mbc.E08-03-0265	1059-1524	Molecular Biology of the Cell	An RNA Interference Screen Identifies a Novel Regulator of Target of Rapamycin That Mediates Hypoxia Suppression of Translation in Drosophila S2 Cells	Lee	2008	5		
1127	chr4	71106094	71106117	3500221996	23		71106094	71106117	8421504	1	23	0	g	350022199600000000	4-27			10.1128/MCB.23.24.9117-9126.2003		Molecular and Cellular Biology	Signaling from Akt to FRAP/TOR Targets both 4E-BP and S6K in Drosophila melanogaster	Mathieu	2003	0		
1127	chr4	71106094	71106117	3500208151	23		71106094	71106117	8421504	1	23	0	g	350020815100000011	0-23						Rab35 regulates Arf6 activity through centaurin 2/ACAP2 during neurite outgrowth	cs.biologists.org	0	0		
1127	chr4	71106094	71106117	3500204873	23		71106094	71106117	8421504	1	23	0	g	350020487300000048,350020487300000044	1-24,7-30						US Patent # 7,056,672. Method of identifying an open reading frame using a nucleic acid molecule encoding multiple start codons and histidine tags - Patents.com	www.patents.com	0	0		
1127	chr4	71106094	71106117	3500202587	23		71106094	71106117	8421504	1	23	0	g	350020258700000030	0-23						World Journal of Gastroenterology	www.wjgnet.com	0	0		
1127	chr4	71106094	71106117	3500202509	23		71106094	71106117	8421504	1	23	0	g	350020250900000010	3-26						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
1127	chr4	71106094	71106117	3500201864	23		71106094	71106117	8421504	1	23	0	g	350020186400000711,350020186400000020	12-35,12-35						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1127	chr4	71106094	71106117	3500201083	23		71106094	71106117	8421504	1	23	0	g	350020108300000025	6-29						Species-Dependent Posttranscriptional Regulation of NOS1 by FMRP in the Developing Cerebral Cortex | Kenneth Kwan - Academia.edu	www.academia.edu	0	0		
1127	chr4	71106094	71106117	3500197585	23		71106094	71106117	8421504	1	23	0	g	350019758500000009	12-35						Molecular cloning, overexpression and enzymatic characterization of glycosyl hydrolase family 16 beta-agarase from marine bacterium Saccharophagus sp. AG21 in Escherichia coli. - ResearchGate	.researchgate.net	0	0		
1127	chr4	71106094	71106117	3500196806	23		71106094	71106117	8421504	1	23	0	g	350019680600000107	4-27						Polynucleotides and polypeptides associated with the NF-kappaB pathway	Nadler	2004	0		
1127	chr4	71106094	71106117	3500188634	23		71106094	71106117	8421504	1	23	0	g	350018863400000004,350018863400000005,350018863400000002,350018863400000003	0-23,0-23,0-23,0-23			10.1016/j.ydbio.2007.03.012		Developmental biology	Distinct mechanisms for mRNA localization during embryonic axis specification in the wasp Nasonia	Eugenia	June	0		
1127	chr4	71106094	71106117	3500179201	23		71106094	71106117	8421504	1	23	0	g	350017920100000014	0-23						Discovery of an alternate metabolic pathway for urea synthesis in adult Aedes aegyptimosquitoes	ochem.arizona.edu	0	0		
1127	chr4	71106094	71106117	3500173718	23		71106094	71106117	8421504	1	23	0	g	350017371800000002	3-26						Amino acids as modulators of endothelium-derived nitric oxide	al.physiology.org	0	0		
1127	chr4	71106094	71106117	3500168828	23		71106094	71106117	8421504	1	23	0	g	350016882800000007	0-23						IMMUNOCONTRACEPTIVE COMPOSITIONS CONTAINING SPERM ANTIGENS, AND METHODS OF USE - ZYGAM, INC.	www.sumobrain.com	0	0		
1127	chr4	71106094	71106117	3500168337	23		71106094	71106117	8421504	1	23	0	g	350016833700000047,350016833700000013,350016833700000009	0-23,0-20,0-23						Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500161607	23		71106094	71106117	8421504	1	23	0	g	350016160700000025,350016160700000018,350016160700000021	0-23,0-22,0-21		22801366	10.1128/MCB.00232-12	0270-7306	Molecular and Cellular Biology	High-Resolution Protein Interaction Map of the Drosophila melanogaster p38 Mitogen-Activated Protein Kinases Reveals Limited Functional Redundancy	Belozerov	2012	6		
1127	chr4	71106094	71106117	3500160854	23		71106094	71106117	8421504	1	23	0	g	350016085400000011,350016085400000010	2-25,7-28						Method for extracting quantitative information relating to interactions between cellular components	Bjorn	2001	0		
1127	chr4	71106094	71106117	3500160100	23		71106094	71106117	8421504	1	23	0	g	350016010000000003	0-23						Isothermal amplification of dna	Richardson	2000	0		
1127	chr4	71106094	71106117	3500157774	23		71106094	71106117	8421504	1	23	0	g	350015777400000000	0-23						Antimicrobial protein derived from podoviriedae bacteriophage specific to staphylococcus aureus	Yoon	2009	0		
1127	chr4	71106094	71106117	3500148980	23		71106094	71106117	8421504	1	23	0	g	350014898000000025	12-35						Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium	Hirano	2000	0		
1127	chr4	71106094	71106117	3500147790	23		71106094	71106117	8421504	1	23	0	g	350014779000000000	0-23		16421189	10.1242/dev.02251	0950-1991	Development	Developmental control of nuclear morphogenesis and anchoring by charleston, identified in a functional genomic screen of Drosophila cellularisation	Pilot	2006	7		
1127	chr4	71106094	71106117	3500141185	23		71106094	71106117	8421504	1	23	0	g	350014118500000000	6-29		18298834	10.1186/1471-2164-9-94		BMC Genomics	Microarray analysis of defined Mycobacterium tuberculosis populations using RNA amplification strategies	Simon	2008	0		
1127	chr4	71106094	71106117	3500138257	23		71106094	71106117	8421504	1	23	0	g	350013825700000000,350013825700000278	4-27,4-27						METHODS OF MODULATING AND IDENTIFYING AGENTS THAT MODULATE INTRACELLULAR CALCIUM - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500130386	23		71106094	71106117	8421504	1	23	0	g	350013038600000011	0-23						Rab35 regulates Arf6 activity through centaurin- 2 (ACAP2) during neurite outgrowth	cs.biologists.org	0	0		
1127	chr4	71106094	71106117	3500130040	23		71106094	71106117	8421504	1	23	0	g	350013004000000002	2-25						Gene discovery in genetically labeled single dopaminergic neurons of the retina	www.pnas.org	0	0		
1127	chr4	71106094	71106117	3500126483	23		71106094	71106117	8421504	1	23	0	g	350012648300000143,350012648300000142,350012648300000141,350012648300000135,350012648300000132,350012648300000133,350012648300000933,350012648300000134,350012648300000139,350012648300000140	0-23,0-23,0-23,9-29,0-23,5-28,0-23,0-19,0-23,1-23						MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500126350	23		71106094	71106117	8421504	1	23	0	g	350012635000000009	0-23						Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof	Birr	2006	0		
1127	chr4	71106094	71106117	3500119030	23		71106094	71106117	8421504	1	23	0	g	350011903000000002	3-26		21199324	10.1111/j.1582-4934.2010.01246.x	1582-4934	Journal of Cellular and Molecular Medicine	Caveolin-1 is required for contractile phenotype expression by airway smooth muscle cells - Gosens - 2011 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Gosens	2011	0		
1127	chr4	71106094	71106117	3500118263	23		71106094	71106117	8421504	1	23	0	g	350011826300000092,350011826300000102	4-27,4-27						Compositions and methods for determining the presence of Chlamydophila pneumoniae in a test sample	Cunningham	2006	0		
1127	chr4	71106094	71106117	3500115012	23		71106094	71106117	8421504	1	23	0	g	350011501200000002,350011501200000003	0-23,0-20		21561986	10.1242/dev.061770	0950-1991	Development	Drosophila Smt3 negatively regulates JNK signaling through sequestering Hipk in the nucleus	Huang	2011	7		
1127	chr4	71106094	71106117	3500112157	23		71106094	71106117	8421504	1	23	0	g	350011215700000000	4-27		11865064	10.1128/MCB.22.6.1868-1880.2002	0270-7306	Molecular and Cellular Biology	Control of DNA Replication and Chromosome Ploidy by Geminin and Cyclin A	Mihaylov	2002	6		
1127	chr4	71106094	71106117	3500108283	23		71106094	71106117	8421504	1	23	0	g	350010828300000001	0-23		22189268	10.1038/ejhg.2011.223		European Journal of Human Genetics	Splicing analysis of unclassified variants in COL2A1 and COL11A1 identifies deep intronic pathogenic mutations	Allan	2012	0		
1127	chr4	71106094	71106117	3500101718	23		71106094	71106117	8421504	1	23	0	g	350010171800000000	20-43						Methods for the treatment of chronic pain anc compositions therefor	Buxton	2003	0		
1127	chr4	71106094	71106117	3500096173	23		71106094	71106117	8421504	1	23	0	g	350009617300000000	0-23						Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus	Yoon	2009	0		
1127	chr4	71106094	71106117	3500089886	23		71106094	71106117	8421504	1	23	0	g	350008988600000125,350008988600000045	0-23,0-23						METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ANIMALS - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500079459	23		71106094	71106117	8421504	1	23	0	g	350007945900000006,350007945900000032	0-23,0-23						Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500073682	23		71106094	71106117	8421504	1	23	0	g	350007368200000001	0-23						Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome	cmgm.stanford.edu	0	0		
1127	chr4	71106094	71106117	3500073309	23		71106094	71106117	8421504	1	23	0	g	350007330900000001	0-23		12958243	10.1128/JCM.41.9.4172-4177.2003	0095-1137	Journal of Clinical Microbiology	Development and Evaluation of a Seminested PCR for Detection and Differentiation of Babesia gibsoni (Asian Genotype) and B. canis DNA in Canine Blood Samples	Birkenheuer	2003	4		
1127	chr4	71106094	71106117	3500069315	23		71106094	71106117	8421504	1	23	0	g	350006931500000051	0-23						Hybrid winter oilseed rape and methods for producing same	G*De Bo Te 	2003	0		
1127	chr4	71106094	71106117	3500069052	23		71106094	71106117	8421504	1	23	0	g	350006905200000062	0-23					Patent	Hybrid winter oilseed rape and methods for producing same (Patent CN:1219065)	G*De Bo Te 	2005	0		
1127	chr4	71106094	71106117	3500066394	23		71106094	71106117	8421504	1	23	0	g	350006639400000006,350006639400000229	0-23,23-46					Patent	Hybrid winter oilseed rape and methods for producing same (Patent CN:1690211)	G*De Bo Te 	2010	0		
1127	chr4	71106094	71106117	3500061601	23		71106094	71106117	8421504	1	23	0	g	350006160100000058	0-23						Hybrid winter oilseed rape and methods for producing same	G*De Bo Te 	2005	0		
1127	chr4	71106094	71106117	3500053061	23		71106094	71106117	8421504	1	23	0	g	350005306100000090	4-27					Patent	Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to Mycoplasma pneumoniae nucleic acid (Patent US:5656427)	Endozo	1997	0		
1127	chr4	71106094	71106117	3500051881	23		71106094	71106117	8421504	1	23	0	g	350005188100000001,350005188100000003	0-23,0-23			10.1111/j.1349-7006.2006.00292.x	1349-7006	Cancer Science	Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNA - Cho - 2006 - Cancer Science - Wiley Online Library	Cho	2006	0		
1127	chr4	71106094	71106117	3500051260	23		71106094	71106117	8421504	1	23	0	g	350005126000000002	0-23						Bacteriophage or lytic protein derived from the bacteriophage which effective for the treatment of staphylococcus aureus biofilm - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500045528	23		71106094	71106117	8421504	1	23	0	g	350004552800000020	3-26						Means for amplifying nucleic acid sequences	Mullis	1992	0		
1127	chr4	71106094	71106117	3500031232	23		71106094	71106117	8421504	1	23	0	g	350003123200000000	4-27						Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use	Roos	2004	0		
1127	chr4	71106094	71106117	3500030191	23		71106094	71106117	8421504	1	23	0	g	350003019100000003	0-23						Continuous in vitro evolution	Coia	1999	0		
1127	chr4	71106094	71106117	3500024748	23		71106094	71106117	8421504	1	23	0	g	350002474800000010	1-24			10.1091/mbc.E06-03-0229		Molecular Biology of the Cell	A Novel Function of 14-3-3 Protein: 14-3-3&#x03b6; Is a Heat-Shock&#x2013;related Molecular Chaperone That Dissolves Thermal-aggregated Proteins	Mihiro	2006	0		
1127	chr4	71106094	71106117	3500020771	23		71106094	71106117	8421504	1	23	0	g	350002077100000092,350002077100000102,350002077100000100	4-27,4-27,4-27					Patent	Compositions and methods for determining the presence of Chlamydophila pneumoniae in a test sample (Patent US:7498137)	Cunningham	2009	0		
1127	chr4	71106094	71106117	3500018434	23		71106094	71106117	8421504	1	23	0	g	350001843400000003	0-23						Bartonella quintana in Cynomolgus Monkey (Macaca fascicularis) - Vol. 11 No. 12 - December 2005 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
1127	chr4	71106094	71106117	3500018246	23		71106094	71106117	8421504	1	23	0	g	350001824600000004	0-23						Methods and compositions to protect aquatic invertebrates from disease	Bartholomay	2012	0		
1127	chr4	71106094	71106117	3500017668	23		71106094	71106117	8421504	1	23	0	g	350001766800000003	0-23						Bartonella quintana in Cynomolgus Monkey (Macaca fascicularis) - Vol. 11 No. 12 - December 2005 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
1127	chr4	71106094	71106117	3500013834	23		71106094	71106117	8421504	1	23	0	g	350001383400000025	3-26						HUMAN PLURIPOTENT STEM CELLS INDUCED FROM UNDIFFERENTIATED STEM CELLS DERIVED FROM A HUMAN POSTNATAL TISSUE	Sakurada	2007	0		
1127	chr4	71106094	71106117	3500013193	23		71106094	71106117	8421504	1	23	0	g	350001319300000065,350001319300000008	9-32,9-32						VARIABLE DOMAINS OF CAMELID HEAVY-CHAIN ANTIBODIES DIRECTED AGAINST GLIAL FIBRILLARY ACIDIC PROTEINS - Patent application	www.faqs.org	0	0		
1127	chr4	71106094	71106117	3500012563	23		71106094	71106117	8421504	1	23	0	g	350001256300000045	0-23						METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ANIMALS	Fahrenkrug	2009	0		
1127	chr4	71106094	71106117	3500011248	23		71106094	71106117	8421504	1	23	0	g	350001124800000000	4-27		14645523	10.1128/MCB.23.24.9117-9126.2003	0270-7306	Molecular and Cellular Biology	Signaling from Akt to FRAP/TOR Targets both 4E-BP and S6K in Drosophila melanogaster	Miron	2003	6		
1127	chr4	71106094	71106117	3500006356	23		71106094	71106117	8421504	1	23	0	g	350000635600000015	8-31						Alternatively spliced isoform of calcium channel, voltage dependent, alpha-II subunit (CACNA1I)	Armour	2005	0		
1127	chr4	71106098	71106124	3500377977	23		71106098	71106124	8421504	2	16,7	0,19	g	350037797700000055	4-36						Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide	Malcolm	2000	0		
1127	chr4	71108915	71108940	3500061343	25		71108915	71108940	8421504	1	25	0	c	350006134300000001	0-25		16985261	10.1152/ajpendo.00167.2006		American Journal of Physiology - Endocrinology and Metabolism	Regulation of HOXA10 expression by phytoestrogens	Akbas	2007	0		HOXA10
1127	chr4	71109001	71171638	3500239314	92		71109001	71171638	8421504	3	45,25,22	0,29887,62615	p,c	350023931400015039,350023931400000027,350023931400000019	0-45,0-25,0-22						Characterization of the Hox patterning genes in acoel flatworms	www.tdx.cat	0	0		
1127	chr4	71110275	71110308	3500040785	30		71110275	71110308	8421504	2	6,24	0,9	g	350004078500000139,350004078500000019	12-42,12-42						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		
1127	chr4	71111326	71111410	3500185291	84		71111326	71111410	8421504	1	84	0	c,g	350018529100000051,350018529100000051,350018529100000050	0-84,0-84,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR196B
1127	chr4	71111340	71111363	3500439152	23		71111340	71111363	8421504	1	23	0	c	350043915200000213	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		HOXB8
1127	chr4	71115907	71115932	3500441461	25		71115907	71115932	8421504	1	25	0	c	350044146100000000	0-25		18337761	10.1038/leu.2008.57	0887-6924	Leukemia	HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia	Whelan	2008	10		
1127	chr4	71117313	71117344	3500128025	26		71117313	71117344	8421504	2	19,7	0,24	c	350012802500000016	4-30		15894583	10.1189/jlb.0904515	0741-5400	Journal of Leukocyte Biology	Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation	Iida	2005	5		
1127	chr4	71117316	71117344	3500377488	23		71117316	71117344	8421504	2	16,7	0,21	c	350037748800000001	3-26		22633751	10.1016/j.bcmd.2012.05.003		Blood cells, molecules & diseases	Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia	Miao	2012	0		
1127	chr4	71118033	71118056	3500295969	23		71118033	71118056	8421504	1	23	0	c	350029596900000001	0-23			10.1634/stemcells.2006-0233	1549-4918	STEM CELLS	An Epidermal Neural Crest Stem Cell (EPI-NCSC) Molecular Signature - Hu - 2006 - STEM CELLS - Wiley Online Library	Hu	2006	0		HOXA9
1127	chr4	71137269	71137648	3500321101	42		71137269	71137648	8421504	2	21,21	0,358	c,g	350032110100000001,350032110100000001,350032110100000002,350032110100000002	0-21,0-21,0-21,0-21		12163409		0950-1991	Development	Hoxa5 overexpression correlates with IGFBP1 upregulation and postnatal dwarfism: evidence for an interaction between Hoxa5 and Forkhead box transcription factors	Foucher	2002	7		HOXA5
1127	chr4	71137767	71138870	3500394833	39		71137767	71138870	8421504	3	4,16,19	0,5,1084	c,g	350039483300000032,350039483300000033,350039483300000033	0-20,0-19,0-19						Compositions And Methods For Diagnosis And Treatment Of Tumors 	.freshpatents.com	0	0		HOXA5
1127	chr4	71139169	71139740	3500203093	123		71139169	71139740	8421504	5	24,26,25,23,25	0,75,125,314,546	c	350020309300000006,350020309300000007,350020309300000012,350020309300000014,350020309300000013	0-24,0-26,0-25,0-23,0-25		22876840	10.1186/1471-2407-12-348		BMC Cancer	MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5	Xiang-hua	2012	0		
1127	chr4	71139244	71139270	3500205830	26		71139244	71139270	8421504	1	26	0	c	350020583000000012	0-26		17804711	10.1158/0008-5472.CAN-07-1405	0008-5472	Cancer Research	HOXA5 Acts Directly Downstream of Retinoic Acid Receptor &#x03b2; and Contributes to Retinoic Acid&#x2013;Induced Apoptosis and Growth Inhibition	Chen	2007	8		
1127	chr4	71150739	71151354	3500376059	63		71150739	71151354	8421504	2	37,26	0,589	p	350037605900015015	0-63		8600458			Nucleic Acids Research	Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA.	Shen	1996	0		HOXA4
1127	chr4	71171690	71171713	3500128123	23		71171690	71171713	8421504	1	23	0	c	350012812300000007	1-24		16352531	10.1128/JVI.80.1.62-72.2006	0022-538X	Journal of Virology	Anti-CD45RO Suppresses Human Immunodeficiency Virus Type 1 Replication in Microglia: Role of Hck Tyrosine Kinase and Implications for AIDS Dementia	Kim	2006	5		
1128	chr4	71172787	71172811	3500380700	23		71172787	71172811	8421504	2	15,8	0,16	c	350038070000000005	0-24						Methods for producing sialyloligosaccharides in a dairy source	Barker	1999	0		
1128	chr4	71172787	71172811	3500066633	23		71172787	71172811	8421504	2	15,8	0,16	c	350006663300000005	0-24						Methods for producing sialyloligosaccharides in a dairy source	Pelletier	2001	0		
1128	chr4	71178053	71178078	3500336997	25		71178053	71178078	8421504	1	25	0	c	350033699700000010,350033699700000011	0-25,17-42		21324897	10.1074/jbc.M110.176099	0021-9258	Journal of Biological Chemistry	A Runx2/miR-3960/miR-2861 Regulatory Feedback Loop during Mouse Osteoblast Differentiation	Hu	2011	5		
1133	chr4	71856583	71897739	3500049649	23		71856583	71897739	8421504	2	9,14	0,41142	c	350004964900000005	0-29		18931185	10.3382/ps.2008-00114	0032-5791	Poultry Science	MicroRNA Expression in Chicken Embryos	Hicks	2008	2		
1133	chr4	71937511	71937535	3500189921	24		71937511	71937535	8421504	1	24	0	g	350018992100000055	0-24						METHOD FOR IDENTIFICATION OF T-LYMPHOCYTE ANTIGENS	Brown	2009	0		
1134	chr4	71961276	71967840	3500384302	55		71961276	71967840	8421504	3	17,10,28	0,18,6536	c,g	350038430200000011,350038430200000015	0-27,0-28						Polynucleotide comprising ubiquitous chromatin opening element (UCDE)	Mai Ke Er *An Dong Ni Wu 	2002	0		
1134	chr4	71961276	71967840	3500237715	55		71961276	71967840	8421504	3	17,10,28	0,18,6536	c,g	350023771500000011,350023771500000015	0-27,0-28					Patent	Polynucleotide comprising ubiquitous chromatin opening element (UCDE) (Patent CN:100365127)	Luo Bo Te *Ke Long Bi 	2008	0		HNRNPA2B1
1134	chr4	71961276	71967840	3500235669	80		71961276	71967840	8421504	4	17,10,25,28	0,18,464,6536	c,g	350023566900000006,350023566900000007,350023566900000008	0-27,0-25,0-28					Patent	A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) (Patent EP:1098986)	ANTONIOU	2011	0		
1134	chr4	71961276	71967840	3500161534	80		71961276	71967840	8421504	4	17,10,25,28	0,18,464,6536	c,g	350016153400000006,350016153400000007,350016153400000008	0-27,0-25,0-28						A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)	Antoniou	2000	0		
1134	chr4	71961276	71961304	3500393081	27		71961276	71961304	8421504	2	17,10	0,18	g	350039308100000006	0-27						A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)	Antoniou	2011	0		
1134	chr4	71961276	71961304	3500197244	27		71961276	71961304	8421504	2	17,10	0,18	g	350019724400000006,350019724400000026	0-27,0-27						US Patent # 7,442,787. Polynucleotide - Patents.com	www.patents.com	0	0		
1134	chr4	71961276	71961304	3500126985	27		71961276	71961304	8421504	2	17,10	0,18	g	350012698500000006	0-27						POLYNUCLEOTIDE	Antoniou	2008	0		
1134	chr4	71961704	71965481	3500367930	76		71961704	71965481	8421504	3	20,27,29	0,3539,3748	c,g	350036793000000364,350036793000000364,350036793000000059,350036793000000059,350036793000000384,350036793000000081,350036793000000082,350036793000000385	0-20,0-20,0-20,0-20,0-27,0-27,0-29,0-29						Recurrent gene fusions in prostate cancer - Patent application	www.faqs.org	0	0		CBX3,HNRNPA2B1
1134	chr4	71961704	71965481	3500017630	76		71961704	71965481	8421504	3	20,27,29	0,3539,3748	c,g	350001763000000383,350001763000000383,350001763000000065,350001763000000065,350001763000000403,350001763000000087,350001763000000404,350001763000000088	0-20,0-20,0-20,0-20,0-27,0-27,0-29,0-29						RECURRENT GENE FUSIONS IN PROSTATE CANCER - Patent application	www.faqs.org	0	0		CBX3,HNRNPA2B1
1134	chr4	71961738	71970035	3500171948	99		71961738	71970035	8421504	7	6,13,20,5,15,20,20	0,2712,6080,6115,6715,8203,8277	c,g	350017194800000002,350017194800000016,350017194800000017,350017194800000019,350017194800000019,350017194800000018	10-29,0-20,0-20,0-20,0-20,0-20		20946641	10.1186/1471-2164-11-565		BMC Genomics	Expression proteomics of UPF1 knockdown in HeLa cells reveals autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting in nonsense-mediated mRNA decay	Nicholas	2010	0		
1134	chr4	71961738	71968509	3500027167	846		71961738	71968509	8421504	10	6,72,27,147,211,95,48,61,123,56	0,2712,2796,2982,3345,3694,3894,5693,5997,6715	p	350002716700015138,350002716700015139,350002716700015140,350002716700015141,350002716700015142,350002716700015144,350002716700015145,350002716700015146	0-78,0-60,0-150,0-150,0-120,0-48,0-120,0-120						Neela Devi Sing RAMBARUTH	search.wmin.ac.uk	0	0		CBX3,HNRNPA2B1
1134	chr4	71961738	71967415	3500287808	764		71961738	71967415	8421504	8	6,111,147,211,102,81,63,43	0,2712,2982,3345,3694,3871,4442,5634	p,c	350028780800000022,350028780800015035	0-764,0-141						An epithelial protein and dna thereof for use in early cancer detection	Mulshine	1997	0		
1134	chr4	71961738	71967415	3500076998	764		71961738	71967415	8421504	8	6,111,147,211,102,81,63,43	0,2712,2982,3345,3694,3871,4442,5634	p,c	350007699800000030,350007699800015018	0-764,0-144						Epithelial protein and DNA thereof for use in early cancer detection - Patent # 5994062 - PatentGenius	.patentgenius.com	0	0		
1134	chr4	71961738	71964747	3500023185	144		71961738	71964747	8421504	3	6,111,27	0,2712,2982	p	350002318500015025	0-144						Methods for diagnosing cancer or precancer based upon hnRNP protein expression	Mulshine	2000	0		
1134	chr4	71965678	71969094	3500185350	38		71965678	71969094	8421504	3	12,7,19	0,502,3397	c,g	350018535000000004,350018535000000002	0-19,0-19						Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS	.researchgate.net	0	0		HNRNPA2B1
1134	chr4	71965678	71966227	3500129396	38		71965678	71966227	8421504	3	12,7,19	0,502,530	c	350012939600000006,350012939600000003	0-19,21-40						Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS - ResearchGate	.researchgate.net	0	0		HNRNPA2B1
1135	chr4	72168597	72168626	3500085091	24		72168597	72168626	8421504	2	18,6	0,23	g	350008509100000202	9-33						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
1135	chr4	72174794	72174862	3500185291	68		72174794	72174862	8421504	1	68	0	c,g	350018529100000031,350018529100000030,350018529100000030	0-68,0-22,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		NFE2L3
1135	chr4	72174830	72174862	3500014651	32		72174830	72174862	8421504	1	32	0	c	350001465100000008,350001465100000007	0-32,0-19		18367714	10.1261/rna.972008	1355-8382	RNA	miR-148 targets human DNMT3b protein coding region	Duursma	2008	5		NFE2L3
1135	chr4	72174837	72174861	3500438376	24		72174837	72174861	8421504	1	24	0	c	350043837600000008,350043837600000005	2-26,0-22		18268015	10.1074/jbc.M709382200	0021-9258	Journal of Biological Chemistry	Post-transcriptional Regulation of Human Pregnane X Receptor by Micro-RNA Affects the Expression of Cytochrome P450 3A4	Takagi	2008	5		
1141	chr4	72921083	72924447	3500120520	599		72921083	72924447	8421504	3	149,401,49	0,1576,3315	p,c,g	350012052000000019,350012052000015025,350012052000000034,350012052000000034,350012052000015026,350012052000000006,350012052000000030,350012052000015027,350012052000015008,350012052000015028,350012052000015029,350012052000000009,350012052000000007,350012052000000031,350012052000015030,350012052000000069,350012052000000069,350012052000015093	0-20,0-90,0-544,0-544,0-48,0-27,0-23,0-45,0-60,0-48,0-48,0-27,0-27,0-23,0-273,0-79,0-79,0-81						 RFRP 	www.docstoc.com	0	0		
1141	chr4	72921097	72924435	3500298256	450		72921097	72924435	8421504	12	45,45,39,6,45,45,45,45,45,45,8,37	0,48,96,1562,1571,1667,1715,1763,1811,1907,1955,3301	p	350029825600015033,350029825600015034,350029825600015035,350029825600015036,350029825600015038,350029825600015039,350029825600015040,350029825600015041,350029825600015043,350029825600015044	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						 <HTML> <HEAD><TITLE>aedege|i1/4SSec1/2e3aa+-a1/21aa!a>>aa?a1/4ec1/2e3aaaa(r)i1/4$?i1/4(r)i1/4!aaa	www.j-tokkyo.com	0	0		
1141	chr4	72922692	72922797	3500403600	105		72922692	72922797	8421504	1	105	0	p	350040360000015010	0-105			10.1046/j.1432-1033.2002.03351.x	1432-1033	European Journal of Biochemistry	Novel fish hypothalamic neuropeptide - Sawada - 2002 - European Journal of Biochemistry - Wiley Online Library	Sawada	2002	0		
1141	chr4	72991143	72991566	3500368174	312		72991143	72991566	8421504	2	166,146	0,277	p	350036817400015004,350036817400015001,350036817400015002	0-312,0-120,0-120						Analyse_sequences	www.docstoc.com	0	0		
1141	chr4	72991143	72991554	3500414143	300		72991143	72991554	8421504	2	166,134	0,277	p	350041414300015008,350041414300015011	0-150,0-150						Deletion der Untereinheit VIa der Cytochrom c Oxidase in Hefe und heterologe Expression des entsprechenden Rindergens sowie Charakterisierung der Mutanten	ub.uni-marburg.de	0	0		
1141	chr4	72991143	72991230	3500325015	87		72991143	72991230	8421504	1	87	0	p	350032501500015006	0-87						METHOD AND SYSTEM FOR PURIFYING AND QUANTITATING PROTEINS USING HEME FUSION TAGS	Bren	2011	0		
1141	chr4	72991143	72991230	3500198633	87		72991143	72991230	8421504	1	87	0	p	350019863300015004,350019863300015024	0-87,0-45						METHOD AND SYSTEM FOR PURIFYING AND QUANTITATING PROTEINS USING HEME FUSION TAGS - Patent application	www.faqs.org	0	0		
1141	chr4	72991545	72991569	3500434570	24		72991545	72991569	8421504	1	24	0	c	350043457000000001	9-33		11602721	10.1128/JVI.75.22.10800-10807.2001	0022-538X	Journal of Virology	Overexpression of Cytochrome c by a Recombinant Rabies Virus Attenuates Pathogenicity and Enhances Antiviral Immunity	Pulmanausahakul	2001	5		
1144	chr4	73357193	73357218	3500369652	23		73357193	73357218	8421504	2	5,18	0,7	g	350036965200000177	1-24						<HTML> <HEAD> <TITLE>U.S. Patent: 5635617 - Methods and compositions comprising the agfA gene for	w.everypatent.com	0	0		
143	chr4	73525373	73532327	3500352268	82		73525373	73532327	8421504	4	21,21,20,20	0,1094,2073,6934	g	350035226800000015,350035226800000014,350035226800000011,350035226800000001	0-21,0-21,0-20,0-20						 SpringerImages - The sequences of the oligonuclotides and the size of the corresponding PCR products used for sequencing of different regions of the bovine NPY gene 	pringerimages.com	0	0		
1145	chr4	73526323	73526349	3500170203	25		73526323	73526349	8421504	2	9,16	0,10	c	350017020300000036	0-25						9-Methyl- -carboline has restorative effects in an animal model of Parkinson&#x2019;s disease	.if-pan.krakow.pl	0	0		NPY
143	chr4	73526347	73532066	3500105382	291		73526347	73532066	8421504	3	22,81,188	0,1812,5531	p	350010538200015000	0-291						KEGG T01008: 504216	www.genome.jp	0	0		
143	chr4	73528174	73531915	3500315071	40		73528174	73531915	8421504	2	20,20	0,3721	c,g	350031507100000003,350031507100000002,350031507100000002	0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
143	chr4	73528236	73531982	3500400043	108		73528236	73531982	8421504	2	4,104	0,3642	p	350040004300015000	0-108						Neuropeptide Y receptor Y2 site-directed mutagenesis	www.ibg.uu.se	0	0		NPY
143	chr4	73528236	73531982	3500355648	108		73528236	73531982	8421504	2	4,104	0,3642	p	350035564800015061	0-108						DISTRIBUTION, ISOLATION AND POTENTIAL FUNCTIONS OF NEUROPEPTIDE F IN THE EASTERN SUBTERRANEAN TERMITE, Reticulitermes flavipes	aeum.libs.uga.edu	0	0		
143	chr4	73528236	73531982	3500323576	108		73528236	73531982	8421504	2	4,104	0,3642	p	350032357600015004	0-108						Adaptogens stimulate neuropeptide Y and Hsp72 expression and release in neuroglia cells	www.www-com.es	0	0		NPY
143	chr4	73528236	73531982	3500227155	108		73528236	73531982	8421504	2	4,104	0,3642	p	350022715500015001	0-108		22347152	10.3389/fnins.2012.00006	1662-453X	Frontiers in Neuroscience	 Frontiers | Adaptogens Stimulate Neuropeptide Y and Hsp72 Expression and Release in Neuroglia Cells | Frontiers in Neuroendocrine Science 	Panossian	2012	0		NPY
143	chr4	73528236	73531982	3500120665	108		73528236	73531982	8421504	2	4,104	0,3642	p	350012066500015015,350012066500015014	0-102,0-108						Synergic action of a prolyl protease and tripeptidyl proteases	Monod	2011	0		NPY
143	chr4	73528236	73531919	3500422771	45		73528236	73531919	8421504	2	4,41	0,3642	p	350042277100015001	0-45						None	www.epa.ee/ep/EPt	0	0		NPY
143	chr4	73528236	73531919	3500040279	45		73528236	73531919	8421504	2	4,41	0,3642	p	350004027900015022	0-45						Untersuchungen zur Regulation der Kohlenmonoxid-bedingten Stimulation der Erythropoetinsekretion bei der Ratte	.uni-tuebingen.de	0	0		NPY
1146	chr4	73531881	73531942	3500269671	41		73531881	73531942	8421504	2	21,20	0,41	c,g	350026967100000005,350026967100000005,350026967100000003,350026967100000003	0-21,0-21,0-20,0-20						Microarray analysis in caudal medulla of cattle orally challenged with bovine spongiform encephalopathy	w.funpecrp.com.br	0	0		
1146	chr4	73531922	73531982	3500384310	60		73531922	73531982	8421504	1	60	0	p	350038431000015098	0-60						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		NPY
1150	chr4	74063600	74063628	3500449315	24		74063600	74063628	8421504	2	15,9	0,19	g	350044931500000139	0-27						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
1150	chr4	74063600	74063628	3500080694	24		74063600	74063628	8421504	2	15,9	0,19	g	350008069400000116	0-27						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
1164	chr4	75925520	75925544	3500392358	23		75925520	75925544	8421504	2	6,17	0,7	g	350039235800000049	1-24						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
1166	chr4	76205082	76205106	3500434899	23		76205082	76205106	8421504	2	9,14	0,10	g	350043489900000007	9-32						LACTOCOCCUS LACTIS&#x201d; PRODUCTORES DE pediocina PA-1_2001	es.scribd.com	0	0		
1166	chr4	76259002	76263217	3500328316	212		76259002	76263217	8421504	6	87,4,48,1,24,48	0,88,95,241,2983,4167	c	350032831600000037,350032831600000036,350032831600000035,350032831600000074,350032831600000024	0-47,4-48,0-48,0-25,0-48						Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins - Patent application	www.faqs.org	0	0		
1166	chr4	76259002	76263073	3500447882	235		76259002	76263073	8421504	6	87,4,48,3,45,48	0,88,95,239,2983,4023	p,c	350044788200000051,350044788200000050,350044788200000049,350044788200015047,350044788200000041	0-47,4-48,0-48,0-48,0-48						Novel Serpentine Transmembrane Antigens Expressed In Human Cancers And Uses Thereof 	.freshpatents.com	0	0		
1166	chr4	76259002	76259049	3500017621	47		76259002	76259049	8421504	1	47	0	c	350001762100000037	0-47						Antibodies And Molecules Derived Therefrom That Bind To Steap-1 Proteins 	.freshpatents.com	0	0		
1166	chr4	76259192	76263224	3500268398	131		76259192	76263224	8421504	5	5,47,53,2,24	0,2793,2905,3761,4008	c	350026839800000038,350026839800000042,350026839800000009	0-60,0-47,0-24						Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer	Challita-Eid	2003	0		STEAP1B
1166	chr4	76259192	76262955	3500316335	60		76259192	76262955	8421504	3	5,53,2	0,2905,3761	c	350031633500000038	0-60						Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer	Challita-Eid	2003	0		
1166	chr4	76259196	76263088	3500142263	240		76259196	76263088	8421504	3	48,114,78	0,2789,3814	p	350014226300015030	0-240						[tel-00157749, v1] Etude de 2 g&#xe8;nes cibles de la prot&#xe9;ine P53 : siah (seven in absentia human homologue) et tsap6 (tumor suppressor activated pathway 6)	hives-ouvertes.fr	0	0		
1166	chr4	76263200	76263224	3500431631	24		76263200	76263224	8421504	1	24	0	c	350043163100000010	0-24						Antibodies and molecules derived therefrom that bind to STEAP-1 proteins	Jakobovits	2004	0		
1166	chr4	76263200	76263224	3500326478	24		76263200	76263224	8421504	1	24	0	c	350032647800000010	0-24						Antibodies and molecules derived therefrom that bind to steap-1 proteins	Jakobovits	2005	0		
1166	chr4	76263202	76263247	3500448005	45		76263202	76263247	8421504	1	45	0	p	350044800500015189	0-45						Use of MVA to treat prostate cancer	Delcayre	2010	0		STEAP1
1166	chr4	76263202	76263247	3500286885	45		76263202	76263247	8421504	1	45	0	p	350028688500015005	0-45						Dna Vaccine Enhancement With Mhc Class Ii Activators 	.freshpatents.com	0	0		STEAP1B
1166	chr4	76265780	76265825	3500236789	45		76265780	76265825	8421504	1	45	0	p	350023678900015000	0-45						Novel serpentine transmembrane antigens expressed in human cancers and uses thereof	Hubert	2006	0		STEAP1
1166	chr4	76265780	76265825	3500228503	45		76265780	76265825	8421504	1	45	0	p	350022850300015001	0-45						Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof	Afar	2001	0		STEAP1
1166	chr4	76265780	76265825	3500117223	45		76265780	76265825	8421504	1	45	0	p	350011722300015000	0-45						Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof	Afar	2006	0		STEAP1
1166	chr4	76265798	76265846	3500080865	48		76265798	76265846	8421504	1	48	0	c	350008086500000041	0-48						Antibodies and molecules derived therefrom that bind to STEAP-1 proteins - Patent application	www.faqs.org	0	0		
1166	chr4	76270912	76270936	3500388377	23		76270912	76270936	8421504	2	10,13	0,11	g	350038837700000006	0-23						Detection and Differentiation of Cryptosporidium spp. in Human Clinical Samples by Use of Real-Time PCR	jcm.asm.org	0	0		
1168	chr4	76415417	76427958	3500309840	43		76415417	76427958	8421504	4	15,6,17,5	0,18,12517,12536	c,g	350030984000000936,350030984000000490	4-25,17-39						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1168	chr4	76418704	76427606	3500447882	266		76418704	76427606	8421504	5	40,9,135,48,34	0,3579,6468,8772,8868	c	350044788200000065,350044788200000081,350044788200000082,350044788200000083,350044788200000085,350044788200000087	8-48,0-48,0-48,0-48,0-48,0-34						Novel Serpentine Transmembrane Antigens Expressed In Human Cancers And Uses Thereof 	.freshpatents.com	0	0		
1168	chr4	76422157	76427506	3500142263	240		76422157	76427506	8421504	3	78,114,48	0,3066,5301	p	350014226300015031	0-240						[tel-00157749, v1] Etude de 2 g&#xe8;nes cibles de la prot&#xe9;ine P53 : siah (seven in absentia human homologue) et tsap6 (tumor suppressor activated pathway 6)	hives-ouvertes.fr	0	0		STEAP2
1169	chr4	76553061	76553084	3500259074	23		76553061	76553084	8421504	1	23	0	c	350025907400000045	22-45						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
1169	chr4	76579138	76579167	3500068521	23		76579138	76579167	8421504	3	13,6,4	0,18,25	g	350006852100000433	0-24						About ICRISAT	www.icrisat.org	0	0		
1169	chr4	76630353	76630377	3500319167	24		76630353	76630377	8421504	1	24	0	g	350031916700000037	9-34						Rat PEG-3 promoter	www.devileye.net	0	0		
1170	chr4	76735104	76735130	3500147765	25		76735104	76735130	8421504	2	6,19	0,7	g	350014776500000001,350014776500000002	4-29,10-35		21543742	10.1152/ajpcell.00005.2011		American Journal of Physiology - Cell Physiolog	An intramolecular transport metabolon: fusion of carbonic anhydrase II to the COOH terminus of the Cl&#x2212;/HCO3&#x2212; exchanger, AE1	Sowah	2011	0		
1170	chr4	76773024	76773049	3500061574	23		76773024	76773049	8421504	3	5,11,7	0,6,18	g	350006157400000007	15-38						ANALISI DELL&#x2019;ESPRESSIONE GENICA: VALUTAZIONE DELLA QUALITA&#x2019; DELL&#x2019;OOCITA E DELL&#x2019;EMBRIONE PRE-IMPIANTO DI OVINO SVILUPPATO IN VITRO.	eprints.uniss.it	0	0		
1170	chr4	76790912	76790937	3500341278	24		76790912	76790937	8421504	2	10,14	0,11	g	350034127800000011	0-24						Method of distinguishing an IBRV-vaccinated bovine from a bovine infected with a wild type virus	Cochran	1996	0		
1175	chr4	77410455	77410481	3500036684	24		77410455	77410481	8421504	2	17,7	0,19	g	350003668400000291	6-30						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1177	chr4	77695755	77695787	3500206374	29		77695755	77695787	8421504	4	13,4,7,5	0,14,19,27	g	350020637400000001	0-31		10768937	10.1128/IAI.68.5.2503-2512.2000	0019-9567	Infection and Immunity	Tetanus Toxin Fragment C Expressed in LiveSalmonella Vaccines Enhances Antibody Responses to Its Fusion Partner Schistosoma haematobium GlutathioneS-Transferase	Lee	2000	4		
1182	chr4	78338842	78339033	3500315971	68		78338842	78339033	8421504	2	45,23	0,168	c	350031597100000044,350031597100000045,350031597100000012	0-45,0-45,0-23						REPRODUCTION	uction-online.org	0	0		
1182	chr4	78338919	78340530	3500418951	42		78338919	78340530	8421504	2	21,21	0,1590	c,g	350041895100000000,350041895100000000,350041895100000001	0-21,0-21,0-21						Insulin-like growth factor (IGF) system in the oocyte and somatic cells of bovine preantral follicles	uction-online.org	0	0		
1182	chr4	78338971	78340483	3500123810	48		78338971	78340483	8421504	2	24,24	0,1488	c	350012381000000022,350012381000000023	0-24,0-24						Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer	mcb.asm.org	0	0		IGFBP3
1182	chr4	78338996	78340480	3500112892	46		78338996	78340480	8421504	2	24,22	0,1462	c	350011289200000010,350011289200000024,350011289200000025,350011289200000011	0-24,0-24,0-22,0-22						Genes relating to gastric cancer metastasis - Patent application	www.faqs.org	0	0		IGFBP3
1182	chr4	78339004	78340491	3500088223	41		78339004	78340491	8421504	2	20,21	0,1466	c	350008822300000002,350008822300000003	0-20,0-21						NUTRITIONAL REGULATION OF SERUM INSULIN-LIKE GROWTH FACTOR-I CONCENTRATION IN CATTLE	cholar.lib.vt.edu	0	0		
1182	chr4	78339018	78340480	3500422131	42		78339018	78340480	8421504	2	21,21	0,1441	c	350042213100000004,350042213100000005	9-30,10-31						Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs	logy-journals.org	0	0		
1182	chr4	78339022	78340486	3500071105	43		78339022	78340486	8421504	2	22,21	0,1443	c,g	350007110500000002,350007110500000003	0-22,0-21						REPRODUCTION	uction-online.org	0	0		
1182	chr4	78340459	78340483	3500124682	24		78340459	78340483	8421504	1	24	0	c	350012468200000023	0-24		19289498	10.1128/MCB.01140-08	0270-7306	Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer	Liu	2009	6		
1182	chr4	78342244	78342271	3500285794	27		78342244	78342271	8421504	1	27	0	c	350028579400000004	0-27						The effects of growth hormone on primary bovine mammary cell models	mmons.calpoly.edu	0	0		
1182	chr4	78342244	78342271	3500126808	27		78342244	78342271	8421504	1	27	0	c	350012680800000024	0-27						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
147	chr4	78440367	78524318	3500083481	101		78440367	78524318	8421504	6	21,18,12,28,16,6	0,32892,33066,41672,83928,83945	c,g	350008348100000005,350008348100000003,350008348100000001,350008348100000002,350008348100000000	12-33,15-45,11-39,6-28,7-29					Proceedings of the National Academy of Sciences of the United States of America	Regions on adenylyl cyclase that are necessary for inhibition of activity by &#x03b2;&#x03b3; and Gi&#x03b1; subunits of heterotrimeric G proteins	Claus	1999	0		
1183	chr4	78444675	78452294	3500181907	46		78444675	78452294	8421504	2	23,23	0,7596	c,g	350018190700000001,350018190700000000,350018190700000000	0-23,0-23,0-23		9675008	10.1095/biolreprod59.1.169	0006-3363	Biology of Reproduction	Adenylyl Cyclase Messenger Ribonucleic Acid in Myometrium: Splice Variant of Type IV	Emala	1998	4		
1183	chr4	78473271	78482001	3500251710	41		78473271	78482001	8421504	4	6,13,19,3	0,162,7028,8727	c	350025171000000003,350025171000000002	10-29,10-32		16275644	10.1074/jbc.M511045200	0021-9258	Journal of Biological Chemistry	G&#x03b2;&#x03b3; Activation Site in Adenylyl Cyclase Type II	Diel	2006	5		
1183	chr4	78480207	78480291	3500389626	84		78480207	78480291	8421504	1	84	0	p	350038962600015013	0-84						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		ADCY1
1183	chr4	78480207	78480291	3500061337	84		78480207	78480291	8421504	1	84	0	p	350006133700015023,350006133700015146	0-84,0-48						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		ADCY1
1184	chr4	78538517	78538961	3500092873	46		78538517	78538961	8421504	2	22,24	0,420	c,g	350009287300000007,350009287300000007,350009287300000006	0-22,0-22,0-24		10347206	10.1074/jbc.274.23.16444	0021-9258	Journal of Biological Chemistry	Stimulation of cAMP Synthesis by Gi-coupled Receptors upon Ablation of Distinct G&#x03b1;i Protein Expression	Liu	1999	5		
1185	chr4	78738487	78738510	3500066133	23		78738487	78738510	8421504	1	23	0	g	350006613300000010	3-36					Patent	Nukleins&#xe4;uresequenzen f&#xfc;r proteine, die an der tocopherolbiosynthese beteiligt sind Nucleic acid sequences for proteins that are involved in tocopherol biosynthesis (Patent DE:60025713)	LASSNER	2006	0		
1185	chr4	78738487	78738510	3500022505	23		78738487	78738510	8421504	1	23	0	g	350002250500000089,350002250500000005	3-36,3-36						US Patent # 7,420,101. Nucleic acid sequences to proteins involved in tocopherol synthesis - Patents.com	www.patents.com	0	0		
1186	chr4	78793727	78793755	3500065916	24		78793727	78793755	8421504	3	13,7,4	0,16,24	c	350006591600000013	6-30						Collectins in innate immune defense of pigs and chickens	ive.library.uu.nl	0	0		
1186	chr4	78845835	78845911	3500239265	76		78845835	78845911	8421504	1	76	0	c	350023926500000008	0-76						Molecular Diagnosis in Bladder Cancer	repub.eur.nl	0	0		CCM2
1187	chr4	78931093	78931138	3500408263	45		78931093	78931138	8421504	1	45	0	c	350040826300000051	0-45						Methods for identifying compounds that bind to PUR protein	Johnson	1995	0		
1187	chr4	78932115	78932141	3500430989	23		78932115	78932141	8421504	2	11,12	0,14	c	350043098900000300	9-32						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
1187	chr4	78932115	78932141	3500070288	23		78932115	78932141	8421504	2	11,12	0,14	c	350007028800000304	9-32						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
1187	chr4	78932974	78933002	3500232088	24		78932974	78933002	8421504	2	14,10	0,18	c	350023208800000000	1-27					Patent	Pectate lyase signal sequence (Patent US:5846818)	Better	1998	0		
1187	chr4	78932974	78933002	3500210887	24		78932974	78933002	8421504	2	14,10	0,18	c	350021088700000000	1-27						Pectate lyase signal sequence	Robinson	1995	0		
1187	chr4	78974400	78978092	3500330718	359		78974400	78978092	8421504	5	24,144,89,31,71	0,539,1169,1356,3621	p,c,g	350033071800000005,350033071800015016,350033071800015015,350033071800015014,350033071800000074,350033071800000074,350033071800000011,350033071800000010,350033071800000072,350033071800000004	10-34,0-126,0-126,0-75,11-30,11-30,0-21,18-39,0-21,13-35						Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same	Luban	2012	0		
1187	chr4	78974400	78974427	3500278578	27		78974400	78974427	8421504	1	27	0	c	350027857800000019	0-27						ScienceDirect.com - Developmental & Comparative Immunology - Characterization of porcine CD205	sciencedirect.com	0	0		VAT1L
1187	chr4	78974402	78974427	3500189555	25		78974402	78974427	8421504	1	25	0	c	350018955500000008	10-35		19193229	10.1186/1742-4690-6-11		Retrovirology	HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome	Lyubov	2009	0		LINC00623
1187	chr4	78974402	78974427	3500189225	25		78974402	78974427	8421504	1	25	0	c	350018922500000008	10-35		19193229	10.1186/1742-4690-6-11	1742-4690	Retrovirology	HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome	Zaitseva	2009	6		LINC00623,VAT1L
1187	chr4	78974408	78974468	3500027398	40		78974408	78974468	8421504	2	21,19	0,41	c	350002739800000019,350002739800000018	0-21,0-19						ADIPOSE TISSUE-SPECIFIC EXPRESSION OF LIPOGENIC GENES IN DIFFERENT CATTLE BREEDS: RELATIONSHIP TO FATTY ACID COMPOSITION	www.vuzv.cz	0	0		
1187	chr4	78974425	78975000	3500368978	46		78974425	78975000	8421504	2	23,23	0,552	c	350036897800000048,350036897800000047	0-23,0-23						The C-type Lectin Receptors Dectin-1, MR, and SIGNR3 Contribute Both Positively and Negatively to the Macrophage Response to Leishmania infantum. | Geanncarlo Lugo - Academia.edu	www.academia.edu	0	0		
1187	chr4	78974427	78975080	3500120855	40		78974427	78975080	8421504	2	20,20	0,633	c	350012085500000003,350012085500000002	0-20,0-20		18162520	10.1210/en.2007-1425	0013-7227	Endocrinology	Kisspeptin Is Present in Ovine Hypophysial Portal Blood But Does Not Increase during the Preovulatory Luteinizing Hormone Surge: Evidence that Gonadotropes Are Not Direct Targets of Kisspeptin in Vivo	Smith	2008	4		PPIA
1187	chr4	78974428	78974982	3500427868	41		78974428	78974982	8421504	2	21,20	0,534	c	350042786800000005,350042786800000004	0-21,0-20						N&#xb0; d&#x2019;ordre 171 - 2007 Ann&#xe9;e 2007 THESE	hal.inria.fr	0	0		LINC00623,MIR548O2
1187	chr4	78974432	78975770	3500292654	48		78974432	78975770	8421504	3	24,10,14	0,1216,1324	c	350029265400000007,350029265400000006	0-24,0-24						Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein and Peroxisome Proliferator-activated Receptor--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&	journal.9med.net	0	0		
1187	chr4	78974432	78975770	3500190969	48		78974432	78975770	8421504	3	24,10,14	0,1216,1324	c	350019096900000005,350019096900000004	0-24,0-24						Disruption of the Phosphatidylserine Decarboxylase Gene in Mice Causes Embryonic Lethality and Mitochondrial Defects--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e	journal.9med.net	0	0		
1187	chr4	78974432	78975641	3500425118	45		78974432	78975641	8421504	2	22,23	0,1186	c	350042511800000001,350042511800000000	0-22,0-23						Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism. - ResearchGate	.researchgate.net	0	0		TVP23C
1187	chr4	78974432	78975641	3500298278	45		78974432	78975641	8421504	2	22,23	0,1186	c	350029827800000001,350029827800000000	0-22,0-23		18552160	10.1152/ajpheart.00387.2008		American Journal of Physiology - Heart and Circulatory Physiology	Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts	Augustus	2008	0		NBPF14
1187	chr4	78974433	78974460	3500142009	27		78974433	78974460	8421504	1	27	0	c	350014200900000000	0-27						AN ABSTRACT OF THE DISSERTATION OF	y.oregonstate.edu	0	0		PFN2
1187	chr4	78974433	78974456	3500091747	23		78974433	78974456	8421504	1	23	0	c	350009174700000007	0-23		17395701	10.1210/en.2006-1500	0013-7227	Endocrinology	Ectopic Expression of Myostatin Induces Atrophy of Adult Skeletal Muscle by Decreasing Muscle Gene Expression	Durieux	2007	4		PPIA
1187	chr4	78974435	78975000	3500198317	40		78974435	78975000	8421504	2	20,20	0,545	c	350019831700000008,350019831700000007	0-20,0-20		20955597	10.1186/1471-2407-10-562	1471-2407	BMC Cancer	Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis	Reeves	2010	3		
1187	chr4	78974436	78978078	3500341721	40		78974436	78978078	8421504	2	20,20	0,3622	c	350034172100000003,350034172100000002	0-20,0-20		16672357	10.1530/rep.1.00657	1470-1626	Reproduction	Modulation of peroxisome proliferator-activated receptor &#x03b4; and &#x03b3; transcripts in swine endometrial tissue during early gestation	Lord	2006	3		
1187	chr4	78974438	78974911	3500017707	40		78974438	78974911	8421504	3	20,19,1	0,79,472	c	350001770700000015,350001770700000014	0-20,0-20		19759244	10.3945/jn.109.108845	0022-3166	The Journal of Nutrition	Maternal Milk, but Not Formula, Regulates the Immune Response to &#x03b2;-Lactoglobulin in Allergy-Prone Rat Pups	Tooley	2009	4		
1187	chr4	78974445	78975653	3500269923	40		78974445	78975653	8421504	2	20,20	0,1188	c,g	350026992300000009,350026992300000029,350026992300000008,350026992300000008,350026992300000028,350026992300000028	0-20,0-20,0-20,0-20,0-20,0-20						Morphine and Morphine Precursors - Patent application	www.faqs.org	0	0		PPIA
1187	chr4	78974445	78975653	3500078972	40		78974445	78975653	8421504	2	20,20	0,1188	c	350007897200000029,350007897200000009,350007897200000028,350007897200000008	0-20,0-20,0-20,0-20						MORPHINE AND MORPHINE PRECURSORS - Patent application	www.faqs.org	0	0		PPIA
1187	chr4	78974467	78974917	3500016688	45		78974467	78974917	8421504	3	25,13,7	0,56,443	c	350001668800000007,350001668800000009	0-25,11-31						N&#xb0; d'ordre THESE	mm.u-bordeaux1.fr	0	0		PPIA
1187	chr4	78974474	78974959	3500018207	41		78974474	78974959	8421504	2	21,20	0,465	c	350001820700000007,350001820700000008	0-21,0-20		11788655	10.1210/jc.87.1.255	0021-972X	Journal of Clinical Endocrinology & Metabolism	Down-Regulation of Insulin Receptor Substrates (IRS)-1 and IRS-2 and Src Homologous and Collagen-Like Protein Shc Gene Expression by Insulin in Skeletal Muscle Is Not Associated with Insulin Resistance or Type 2 Diabetes	Huang	2002	6		
1187	chr4	78974476	78974984	3500272991	40		78974476	78974984	8421504	2	20,20	0,488	c	350027299100000001,350027299100000000	0-20,0-20		21730049	10.1074/jbc.M111.244715		The Journal of Biological Chemistry	Gain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen Receptor	Qiang	2011	0		
1187	chr4	78974480	78974504	3500211816	24		78974480	78974504	8421504	1	24	0	c	350021181600000008	0-24		18039850	10.1128/MCB.02078-06	0270-7306	Molecular and Cellular Biology	Double-Stranded RNA-Binding Protein Regulates Vascular Endothelial Growth Factor mRNA Stability, Translation, and Breast Cancer Angiogenesis	Vumbaca	2008	6		PPIA
1187	chr4	78974480	78974504	3500118396	24		78974480	78974504	8421504	1	24	0	c	350011839600000002	0-24		16369494	10.1038/sj.onc.1209273	0950-9232	Oncogene	Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation	Munoz-Najar	2005	6		PPIA
1187	chr4	78974521	78974918	3500209439	23		78974521	78974918	8421504	2	15,8	0,389	c	350020943900000002	1-24							s.whiterose.ac.uk	0	0		
1187	chr4	78974525	78975582	3500068124	46		78974525	78975582	8421504	4	11,9,13,13	0,385,545,1044	c	350006812400000030,350006812400000011	0-20,0-26						METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2	Pinto	2010	0		
1187	chr4	78974525	78975582	3500054724	46		78974525	78975582	8421504	4	11,9,13,13	0,385,545,1044	c	350005472400000062,350005472400000030,350005472400000011,350005472400000046	0-20,0-20,0-26,0-26						METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2 - Patent application	www.faqs.org	0	0		
1187	chr4	78974527	78974991	3500434431	40		78974527	78974991	8421504	3	9,12,19	0,383,445	c	350043443100000011,350043443100000010	0-21,0-19						Journal of Translational Medicine	onal-medicine.com	0	0		
1187	chr4	78974532	78978090	3500409099	260		78974532	78978090	8421504	4	4,173,63,20	0,378,1037,3538	p,c,g	350040909900015027,350040909900015026,350040909900015025,350040909900015024,350040909900015023,350040909900000039,350040909900000039,350040909900000007,350040909900000007	0-48,0-48,0-48,0-48,0-48,0-20,0-20,0-20,0-20						Polynucleotide Encoding A Trim-cyp Polypeptide, Compositions Thereof, And Methods Of Using Same 	.freshpatents.com	0	0		PPIAP30
1187	chr4	78974533	78974996	3500361854	40		78974533	78974996	8421504	3	3,17,20	0,377,443	c	350036185400000018,350036185400000017	0-20,0-20						Neuroprotective compositions and methods	Lipton	2007	0		
1187	chr4	78974533	78974996	3500119984	40		78974533	78974996	8421504	3	3,17,20	0,377,443	c	350011998400000018,350011998400000045,350011998400000017,350011998400000044	0-20,0-20,0-20,0-20						Neuroprotective Compositions and Methods - Patent application	www.faqs.org	0	0		
1187	chr4	78974535	78974957	3500447808	48		78974535	78974957	8421504	2	1,47	0,375	p	350044780800015194	0-48						Tyrosine-containing cyclophilin and related methods	Carlow	2000	0		
1187	chr4	78974912	78978090	3500422362	360		78974912	78978090	8421504	4	171,89,31,69	0,657,844,3109	p	350042236200015009,350042236200015007	0-180,0-180						Symbiodinium. Corals are the most widely	y.oregonstate.edu	0	0		PPIA
1187	chr4	78974916	78978024	3500346041	42		78974916	78978024	8421504	3	20,19,3	0,852,3105	c	350034604100000040,350034604100000008	0-20,0-22						CMKLR regulation of adipogenesis and adipocyte metabolic function	Sinal	2007	0		ATG10
1187	chr4	78974927	78975065	3500234934	41		78974927	78975065	8421504	2	20,21	0,117	c,g	350023493400000006,350023493400000006,350023493400000005	0-20,0-20,0-21			10.4081/ijas.2012.e79	1828-051X	Italian Journal of Animal Science	Effect of dietary polyunsaturated fatty acids on Stearoyl CoA-Desaturase gene expression in intramuscular lipids of lamb	Conte	2012	0		
1187	chr4	78974964	78974991	3500220783	27		78974964	78974991	8421504	1	27	0	c	350022078300000007	0-27						Cell Adhesion Molecule Expression in Cultured Human Iris Endothelial Cells	www.iovs.org	0	0		PPIA
1187	chr4	78974964	78974991	3500108029	27		78974964	78974991	8421504	1	27	0	c	350010802900000007	0-27		11687530		1552-5783	Investigative Ophthalmology & Visual Science	Cell Adhesion Molecule Expression in Cultured Human Iris Endothelial Cells	Silverman	2001	0		LINC00623
1187	chr4	78974965	78978083	3500437092	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350043709200000122,350043709200000227,350043709200000121,350043709200000226	0-20,0-20,0-20,0-20						Ee3-protein Family And Corresponding Dna Sequence 	.freshpatents.com	0	0		
1187	chr4	78974965	78978083	3500436669	40		78974965	78978083	8421504	2	20,20	0,3098	c	350043666900000005,350043666900000004	0-20,0-20						Methods of treating neurological conditions with hematopoietic growth factors	Schaebitz	2004	0		
1187	chr4	78974965	78978083	3500428656	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350042865600000122,350042865600000121	0-20,0-20						Ee3-protein family and corresponding dna sequence	Schneider	2002	0		
1187	chr4	78974965	78978083	3500404405	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350040440500000003,350040440500000003,350040440500000002	0-20,0-20,0-20						Neuronal serine threonine protein kinase	Eisenhardt	2008	0		
1187	chr4	78974965	78978083	3500395763	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350039576300000005,350039576300000004	0-20,0-20						Treatment of neurological disorders with haematopoietic growth factors	Schneider	2011	0		
1187	chr4	78974965	78978083	3500390379	40		78974965	78978083	8421504	2	20,20	0,3098	c	350039037900000005,350039037900000004	0-20,0-20						Methods of treating neurological conditions with hematopoeitic growth factors	Gassler	2005	0		
1187	chr4	78974965	78978083	3500383877	40		78974965	78978083	8421504	2	20,20	0,3098	c	350038387700000005,350038387700000047,350038387700000004,350038387700000046	0-20,0-20,0-20,0-20					Patent	G-csf for use in the treatment of amyotrophic lateral sclerosis (Patent EP:1581249)	Gassler	2009	0		PPIA
1187	chr4	78974965	78978083	3500369296	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350036929600000005,350036929600000004,350036929600000004	0-20,0-20,0-20						Treatment of neurological disorders with hematopoeitic growth factors	Schaebitz	2006	0		
1187	chr4	78974965	78978083	3500339523	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350033952300000005,350033952300000004	0-20,0-20						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPEITIC GROWTH FACTORS	Schaebitz	2007	0		
1187	chr4	78974965	78978083	3500330835	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350033083500000005,350033083500000005,350033083500000054,350033083500000054,350033083500000004,350033083500000004,350033083500000053,350033083500000053	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20					Patent	Treatment of neurological disorders with haematopoietic growth factors (Patent EP:1765381)	Gassler	2010	0		
1187	chr4	78974965	78978083	3500310797	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350031079700000005,350031079700000057,350031079700000004,350031079700000056	0-20,0-20,0-20,0-20						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS - Patent application	www.faqs.org	0	0		PPIA
1187	chr4	78974965	78978083	3500258255	40		78974965	78978083	8421504	2	20,20	0,3098	c	350025825500000007,350025825500000006	0-20,0-20						Method of identifying a modulator of a voltage-gated sodium channel using cells expressing Nav1.8 and p11	Okuse	2002	0		
1187	chr4	78974965	78978083	3500241756	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350024175600000005,350024175600000004,350024175600000004	0-20,0-20,0-20						GCSF for use in treating a neurological disease with pathophysiological mechanisms involving ischemia or hypoxia	Schneider	2011	0		
1187	chr4	78974965	78978083	3500225225	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350022522500000032,350022522500000031,350022522500000031	0-20,0-20,0-20						Materials and Methods Relating to Cell Based Therapies - Patent application	www.faqs.org	0	0		
1187	chr4	78974965	78978083	3500185268	41		78974965	78978083	8421504	2	20,21	0,3097	c,g	350018526800000005,350018526800000005,350018526800000004,350018526800000004	0-20,0-20,0-21,0-21						Amygdalin Induces Apoptosis through Regulation of Bax and Bcl-2 Expressions in Human DU145 and LNCaP Prostate Cancer Cells	paignfortruth.com	0	0		
1187	chr4	78974965	78978083	3500175311	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350017531100000005,350017531100000004	0-20,0-20						Methods Of Treating Neurological Conditions With Hematopoeitic Growth Factors 	.freshpatents.com	0	0		TMPRSS15
1187	chr4	78974965	78978083	3500148684	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350014868400000005,350014868400000004	0-20,0-20						Treatment of neurological disorders with haematopoietic growth factors	Schneider	2011	0		
1187	chr4	78974965	78978083	3500139277	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350013927700000005,350013927700000004	0-20,0-20						Methods Of Treating Neurological Conditions With Hematopoeitic Growth Factors 	.freshpatents.com	0	0		
1187	chr4	78974965	78978083	3500044055	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350004405500000057,350004405500000005,350004405500000004,350004405500000004,350004405500000056,350004405500000056	0-20,0-20,0-20,0-20,0-20,0-20						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS - Patent application	www.faqs.org	0	0		
1187	chr4	78974965	78978083	3500003314	40		78974965	78978083	8421504	2	20,20	0,3098	c,g	350000331400000005,350000331400000004,350000331400000004	0-20,0-20,0-20						Treatment of neurological disorders with haematopoietic growth factors	Schaebitz	2007	0		
1187	chr4	78974965	78975607	3500299869	48		78974965	78975607	8421504	2	24,24	0,618	c	350029986900000015,350029986900000014	0-24,0-24						REPRODUCTION	uction-online.org	0	0		LINC00623
1187	chr4	78974966	78975071	3500310279	41		78974966	78975071	8421504	2	21,20	0,85	c	350031027900000031,350031027900000030	0-21,0-20						Identification of testosterone-/androgen receptor-regulated genes in mouse Sertoli cells	www.asiaandro.com	0	0		LINC00623
1187	chr4	78974966	78975071	3500024103	41		78974966	78975071	8421504	2	21,20	0,85	c	350002410300000009,350002410300000008	0-21,0-20		10330085	10.1095/biolreprod60.6.1304	0006-3363	Biology of Reproduction	Expression and Action of Transforming Growth Factor Beta (TGF&#x03b2;1, TGF&#x03b2;2, and TGF&#x03b2;3) during Embryonic Rat Testis Development	Cupp	1999	4		LINC00623
1187	chr4	78974966	78975071	3500013254	41		78974966	78975071	8421504	2	21,20	0,85	c	350001325400000009,350001325400000008	0-21,0-20						Expression and Action of Transforming Growth Factor Beta (TGFb1, TGFb2, and TGFb3) during Embryonic Rat Testis Development 1	ww.biolreprod.org	0	0		
1187	chr4	78974966	78974999	3500459046	33		78974966	78974999	8421504	1	33	0	c	350045904600000003	0-33		12193416	10.1095/biolreprod.101.002527	0006-3363	Biology of Reproduction	Growth and Differentiation Factor-9 Stimulates Progression of Early Primary but Not Primordial Rat Ovarian Follicle Development	Nilsson	2002	4		PPIAP30
1187	chr4	78974966	78974999	3500423401	33		78974966	78974999	8421504	1	33	0	c	350042340100000007	0-33						Thecal Cell-Granulosa Cell Interactions Involve a Positive Feedback Loop among Keratinocyte Growth Factor, Hepatocyte Growth Factor, and Kit Ligand during Ovarian Follicular Development*	.endojournals.org	0	0		PPIAL4G
1187	chr4	78974972	78975001	3500348040	29		78974972	78975001	8421504	1	29	0	c	350034804000000003	24-53						Generation and Characterization of the Cation-Chloride Cotransporter KCC2 Hypomorphic Mouse	hesis.helsinki.fi	0	0		GCNT1
1187	chr4	78974973	78975572	3500143947	39		78974973	78975572	8421504	3	20,16,3	0,94,596	c	350014394700000012,350014394700000011	0-20,0-19		9843713			American Journal of Physiology - Cell Physiolog	Zinc deficiency decreases plasma level and hepatic mRNA abundance of apolipoprotein A-I in rats and hamsters	Wu	1998	0		
1187	chr4	78974973	78975572	3500110548	39		78974973	78975572	8421504	3	20,16,3	0,94,596	c	350011054800000012,350011054800000011	0-20,0-19		9843713			American Journal of Physiology - Cell Physiolog	Zinc deficiency decreases plasma level and hepatic mRNA abundance of apolipoprotein A-I in rats and hamsters	Wu	1998	0		PPIA
1187	chr4	78974978	78975584	3500140406	44		78974978	78975584	8421504	3	21,8,15	0,97,591	c	350014040600000009,350014040600000008	0-21,0-23						Suppression of ovarian secretions before puberty strongly affects mammogenesis in the goat. - ResearchGate	.researchgate.net	0	0		
1187	chr4	78975055	78975618	3500436744	46		78975055	78975618	8421504	2	20,26	0,537	c	350043674400000003,350043674400000002	0-20,0-26		18304981	10.1530/REP-08-0014	1470-1626	Reproduction	Relaxin (RLX) and estrogen affect estrogen receptor &#x03b1;, vascular endothelial growth factor, and RLX receptor expression in the neonatal porcine uterus and cervix	Yan	2008	3		LINC00623
1187	chr4	78975065	78978090	3500251829	40		78975065	78978090	8421504	3	18,2,20	0,504,3005	c	350025182900000004,350025182900000003	0-20,0-20		9609733			American Journal of Physiology - Lung Cellular and Molecular Physiology	Transcriptional regulation of tropoelastin expression in rat lung fibroblasts: changes with age and hyperoxia	Bruce	1998	0		
1187	chr4	78975065	78978090	3500066738	40		78975065	78978090	8421504	3	18,2,20	0,504,3005	c	350006673800000004,350006673800000003	0-20,0-20		9609733			American Journal of Physiology - Lung Cellular and Molecular Physiology	Transcriptional regulation of tropoelastin expression in rat lung fibroblasts: changes with age and hyperoxia	Bruce	1998	0		
1187	chr4	78975065	78978090	3500060767	40		78975065	78978090	8421504	3	18,2,20	0,504,3005	c,g	350006076700000004,350006076700000003,350006076700000003	0-20,0-20,0-20		9609733			American Journal of Physiology - Lung Cellular and Molecular Physiology	Transcriptional regulation of tropoelastin expression in rat lung fibroblasts: changes with age and hyperoxia	Bruce	1998	0		
1187	chr4	78975066	78978090	3500431618	39		78975066	78978090	8421504	3	17,2,20	0,503,3004	c,g	350043161800000005,350043161800000004,350043161800000004	0-19,0-20,0-20		8626576	10.1074/jbc.271.17.10154	0021-9258	Journal of Biological Chemistry	Neurotrophin-3 Increases Intracellular Calcium in a Rat Insulin-secreting Cell Line through Its Action on a Functional TrkC Receptor	Tazi	1996	5		
1187	chr4	78975066	78978090	3500201694	39		78975066	78978090	8421504	3	17,2,20	0,503,3004	c	350020169400000004,350020169400000005	0-19,0-20						The Role of Interferon Regulatory Factor-1 and Interferon Regulatory Factor-2 in IFN-&#x03b3; Growth Inhibition of Human Breast Carcinoma Cell Lines	lue.lib.umich.edu	0	0		
1187	chr4	78975066	78978090	3500050087	50		78975066	78978090	8421504	3	17,8,25	0,503,2999	c,g	350005008700000001,350005008700000000,350005008700000000	0-25,0-25,0-25		15485486	10.1111/j.1471-4159.2004.02771.x	1471-4159	Journal of Neurochemistry	Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease - Angulo - 2004 - Journal of Neurochemistry - Wiley Online Library	Angulo	2004	0		PPIA
1187	chr4	78975066	78978090	3500032577	38		78975066	78978090	8421504	3	17,2,19	0,503,3005	c	350003257700000011,350003257700000010	0-19,0-19		19228956	10.1523/JNEUROSCI.2621-08.2009	0270-6474	The Journal of Neuroscience	STAT5 Mediates Antiapoptotic Effects of Methylprednisolone on Oligodendrocytes	Xu	2009	7		
1187	chr4	78975066	78975642	3500021354	49		78975066	78975642	8421504	3	17,6,26	0,503,550	c	350002135400000013,350002135400000012	0-23,0-26		22520557	10.1111/j.1464-410X.2012.11144.x	1464-410X	BJU International	Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro - Latil - 2012 - BJU International - Wiley Online Library	Latil	2012	0		
1187	chr4	78975070	78975581	3500401184	25		78975070	78975581	8421504	2	13,12	0,499	c	350040118400000002	0-25		10232684		1046-6673	Journal of the American Society of Nephrology	Temporal Changes in mRNA Expression for Bikunin in the Kidneys of Rats during Calcium Oxalate Nephrolithiasis	IIDA	1999	10		
1187	chr4	78975070	78975581	3500039096	25		78975070	78975581	8421504	2	13,12	0,499	c	350003909600000002	0-25						Temporal Changes in mRNA Expression for Bikunin in the Kidneys of Rats during Calcium Oxalate Nephrolithiasis	n.asnjournals.org	0	0		
1187	chr4	78975075	78975584	3500021577	23		78975075	78975584	8421504	2	8,15	0,494	c	350002157700000014	0-23						O-12	www.scribd.com	0	0		
1187	chr4	78975584	78975609	3500421411	25		78975584	78975609	8421504	1	25	0	c	350042141100000005	0-25						Hypoxia, oxidative stress, and benzo[a]pyrene induced carcinogenesis	arno.unimaas.nl	0	0		
1187	chr4	78975602	78978091	3500310852	56		78975602	78978091	8421504	2	30,26	0,2463	c	350031085200000009,350031085200000008	0-30,0-26						Novel Partners of SPAG11B Isoform D in the Human Male Reproductive Tract	ww.biolreprod.org	0	0		PPIA
1187	chr4	78975602	78978091	3500042564	56		78975602	78978091	8421504	2	30,26	0,2463	c	350004256400000009,350004256400000008	0-30,0-26		19535787	10.1095/biolreprod.109.077545	0006-3363	Biology of Reproduction	Novel Partners of SPAG11B Isoform D in the Human Male Reproductive Tract	Radhakrishnan	2009	4		
1187	chr4	78975602	78975627	3500407389	25		78975602	78975627	8421504	1	25	0	c	350040738900000034	0-25						Journal of Virological Methods	005.pasteur.ac.ir	0	0		PPIAP30
1187	chr4	78975603	78975626	3500244452	23		78975603	78975626	8421504	1	23	0	c	350024445200000004	0-23		16227615	10.1128/MCB.25.21.9687-9699.2005	0270-7306	Molecular and Cellular Biology	Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1)	Yi	2005	6		NBPF15,TMPRSS15
1187	chr4	78975621	78978090	3500215424	42		78975621	78978090	8421504	2	23,19	0,2450	c	350021542400000010,350021542400000009	0-23,0-19			10.1101/gr.5532707		Genome Research	Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing	Bin	2007	0		
1187	chr4	78975622	78978090	3500210293	48		78975622	78978090	8421504	2	24,24	0,2444	c	350021029300000013,350021029300000012	0-24,0-24						Epigenetic effects of prenatal stress on 11&#x03b2;-hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. - ResearchGate	.researchgate.net	0	0		PPIA
1187	chr4	78975633	78978081	3500446042	40		78975633	78978081	8421504	2	20,20	0,2428	c,g	350044604200000013,350044604200000013,350044604200000012,350044604200000012	0-20,0-20,0-20,0-20		19011236	10.1074/jbc.M808184200	0021-9258	Journal of Biological Chemistry	Promoter Cloning and Characterization of the Anti-vascular Proliferation Gene, R-ras	Xu	2009	5		
1187	chr4	78975633	78978081	3500402309	40		78975633	78978081	8421504	2	20,20	0,2428	c,g	350040230900000018,350040230900000018,350040230900000017,350040230900000017	0-20,0-20,0-20,0-20						Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof	Davis	2008	0		
1187	chr4	78975633	78978081	3500379793	40		78975633	78978081	8421504	2	20,20	0,2428	c,g	350037979300000018,350037979300000037,350037979300000017,350037979300000017,350037979300000036,350037979300000036	0-20,0-20,0-20,0-20,0-20,0-20						Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof - Patent application	www.faqs.org	0	0		
1187	chr4	78975633	78978081	3500320004	63		78975633	78978081	8421504	3	20,23,20	0,127,2428	c,g	350032000400000005,350032000400000016,350032000400000004	0-20,0-23,0-20						Wisconsin : BIOCHEM 911 : Adachi	ww.coursehero.com	0	0		
1187	chr4	78975633	78978081	3500224815	40		78975633	78978081	8421504	2	20,20	0,2428	c,g	350022481500000018,350022481500000017	0-20,0-20						Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof	Mousa	2007	0		
1187	chr4	78975633	78978079	3500269611	42		78975633	78978079	8421504	2	21,21	0,2425	c	350026961100000003,350026961100000002	0-21,0-21		11788351	10.1152/ajpcell.00295.2001		American Journal of Physiology - Cell Physiolog	Peroxynitrite increases iNOS through NF-&#x03ba;B and decreases prostacyclin synthase in endothelial cells	Cooke	2002	0		
1187	chr4	78975633	78978079	3500153776	42		78975633	78978079	8421504	2	21,21	0,2425	c	350015377600000007,350015377600000006	0-21,0-21						<?xml version="1.0"?> <ART xmlns="http://highwire.org/sgml/arthw" VERSION="4.2.33HW" DOI="10.1074/jb	ke.sciencemag.org	0	0		
1187	chr4	78975637	78975758	3500092433	23		78975637	78975758	8421504	2	21,2	0,119	c	350009243300000004	0-23			10.1046/j.0022-3042.2001.00714.x	1471-4159	Journal of Neurochemistry	The &#x03b1;7 nicotinic receptors in human fetal brain and spinal cord - Falk - 2002 - Journal of Neurochemistry - Wiley Online Library	Falk	2002	0		
1187	chr4	78975656	78978090	3500414873	43		78975656	78978090	8421504	3	2,22,19	0,100,2415	c	350041487300000007,350041487300000006	0-24,0-19		21878906	10.1038/ncomms1463	2041-1733	Nature Communications	Blimp1 regulates the transition of neonatal to adult intestinal epithelium	Muncan	2011	0		
1187	chr4	78975656	78978090	3500247620	43		78975656	78978090	8421504	3	2,22,19	0,100,2415	c	350024762000000048,350024762000000047	0-24,0-19						Gastroenterology	005.pasteur.ac.ir	0	0		
1187	chr4	78975656	78978090	3500038158	43		78975656	78978090	8421504	3	2,22,19	0,100,2415	c	350003815800000007,350003815800000006	0-24,0-19		21878906	10.1038/ncomms1463		Nature Communications	Blimp1 regulates the transition of neonatal to adult intestinal epithelium	Vanesa		0		
1187	chr4	78975657	78978036	3500406785	47		78975657	78978036	8421504	3	1,31,15	0,99,2364	c	350040678500000010,350040678500000004,350040678500000011,350040678500000005	0-23,0-23,0-24,0-24						Tissue Factor Production Inhibitor - Patent application	www.faqs.org	0	0		
1187	chr4	78975657	78978036	3500256046	47		78975657	78978036	8421504	3	1,31,15	0,99,2364	c	350025604600000004,350025604600000005	0-23,0-24						Tissue Factor Production Inhibitor	Terasaka	2008	0		
1187	chr4	78975657	78975778	3500208668	23		78975657	78975778	8421504	2	1,22	0,99	c	350020866800000002	0-23		21072052	10.1038/cdd.2010.136	1350-9047	Cell Death & Differentiation	Retinoids enhance glucocorticoid-induced apoptosis of T cells by facilitating glucocorticoid receptor-mediated transcription	Toth	2010	9		
1187	chr4	78975657	78975778	3500183012	23		78975657	78975778	8421504	2	1,22	0,99	c	350018301200000002	0-23		21072052	10.1038/cdd.2010.136	1350-9047	Cell Death & Differentiation	Retinoids enhance glucocorticoid-induced apoptosis of T cells by facilitating glucocorticoid receptor-mediated transcription	Toth	2010	9		
1187	chr4	78975657	78975778	3500063103	23		78975657	78975778	8421504	2	1,22	0,99	c	350006310300000002	0-23						Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes	biomedcentral.com	0	0		
1187	chr4	78975757	78978090	3500256433	40		78975757	78978090	8421504	2	21,19	0,2314	c	350025643300000007,350025643300000006	4-25,0-19			10.1128/MCB.25.23.10379-10390.2005		Molecular and Cellular Biology	RBP-J&#x03ba;/SHARP Recruits CtIP/CtBP Corepressors To Silence Notch Target Genes	Franz	2005	0		
1187	chr4	78975757	78978090	3500051574	40		78975757	78978090	8421504	2	21,19	0,2314	c	350005157400000010,350005157400000009	4-25,0-19		22421968	10.1038/cdd.2012.30	1350-9047	Cell Death & Differentiation	TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death	Seillier	2012	9		
1187	chr4	78975760	78975784	3500292648	24		78975760	78975784	8421504	1	24	0	c	350029264800000004	0-24						NeurobiologyofDisease Presenilin-1RegulatesNeuralProgenitorCellDifferentiation intheAdultBrain	w.anatomy.uic.edu	0	0		HNRNPH2
1187	chr4	78975760	78975783	3500399827	23		78975760	78975783	8421504	1	23	0	c	350039982700000003	0-23						Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity	www.pnas.org	0	0		HNRNPH2
1187	chr4	78975760	78975783	3500392816	23		78975760	78975783	8421504	1	23	0	c	350039281600000004	0-23						Sulfonylureas and Glinides Exhibit Peroxisome Proliferator- Activated Receptor Activity: A Combined Virtual Screening and Biological Assay Approach	aspetjournals.org	0	0		HNRNPH2
1187	chr4	78975760	78975783	3500240211	23		78975760	78975783	8421504	1	23	0	c	350024021100000004	0-23						Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor Activity: A Combined Virtual Screening and Biological Assay Approach 2007&#x5e74;&#x7b2c;69&#x5377;&#x7b2c;2&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x75	www.39kf.com	0	0		ZNF217,HNRNPH2
1187	chr4	78975760	78975783	3500204496	23		78975760	78975783	8421504	1	23	0	c	350020449600000007	0-23						INSIGHTS INTO THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY ARTERY DISEASE: STUDIES FROM GENE TARGETED MICE LACKING THE HIGH DENSITY LIPOPROTEIN RECEPTOR, SR-BI	mmons.mcmaster.ca	0	0		HNRNPH2
1187	chr4	78975760	78975783	3500052436	23		78975760	78975783	8421504	1	23	0	c	350005243600000008	0-23						Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. 4 Nicole de Wit , Muriel Derrien , Hanneke Bosch-Vermeulen , Els Oosterink , Shohreh 5 Keshtkar ,	gi.physiology.org	0	0		
1187	chr4	78975767	78978083	3500304938	39		78975767	78978083	8421504	2	20,19	0,2297	c	350030493800000008,350030493800000007	0-20,0-19						immunomodulatory	n.library.ethz.ch	0	0		
1187	chr4	78975770	78978087	3500201584	44		78975770	78978087	8421504	3	17,6,21	0,2251,2296	c,g	350020158400000009,350020158400000008,350020158400000008	0-23,0-21,0-21		20607591	10.1007/s11010-010-0533-3		Molecular and cellular biochemistry	Fatty acids regulate CREBh via transcriptional mechanisms that are dependent on proteasome activity and insulin	CL	2010	0		
1187	chr4	78975772	78978032	3500352019	26		78975772	78978032	8421504	2	15,11	0,2249	c	350035201900000059	0-26						Etude des propri&#xe9;t&#xe9;s h&#xe9;mato-supportives in vitro des cellules souches m&#xe9;senchymateuses	bictel.ulg.ac.be	0	0		
1187	chr4	78975778	78978081	3500059243	44		78975778	78978081	8421504	3	9,15,20	0,2243,2283	c,g	350005924300000079,350005924300000032,350005924300000030,350005924300000077	0-24,0-24,0-20,0-20						Methionine aminopeptidase type 3	Aurora	2000	0		PPIA
1187	chr4	78975778	78978036	3500442535	24		78975778	78978036	8421504	2	9,15	0,2243	c	350044253500000002	0-24		21124855	10.1371/journal.pone.0014081	1932-6203	PLOS ONE	PLOS ONE: Molecular and Functional Characterization of Hv1 Proton Channel in Human Granulocytes	Petheo	2010	4		PPIA
1187	chr4	78975778	78978036	3500347647	24		78975778	78978036	8421504	2	9,15	0,2243	c	350034764700000003	0-24		22157720	10.1038/labinvest.2011.168		Laboratory Investigation; a Journal of Technical Methods and Pathology	Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells	Ioannis	2012	0		PPIA
1187	chr4	78975778	78978035	3500048411	23		78975778	78978035	8421504	2	9,14	0,2243	c	350004841100000002	0-23		16272563	10.1074/jbc.M508307200	0021-9258	Journal of Biological Chemistry	Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic &#x03b2; Cell Growth and Function	Park	2006	5		PPIA
1187	chr4	78975778	78978035	3500010762	23		78975778	78978035	8421504	2	9,14	0,2243	c	350001076200000002	0-23		16272563	10.1074/jbc.M508307200	0021-9258	Journal of Biological Chemistry	Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic &#x03b2; Cell Growth and Function	Park	2006	5		PPIA
1187	chr4	78975785	78978087	3500172455	43		78975785	78978087	8421504	3	2,20,21	0,2236,2281	c	350017245500000017,350017245500000016	0-22,0-21						Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation	hives-ouvertes.fr	0	0		
1187	chr4	78978061	78978091	3500283033	30		78978061	78978091	8421504	1	30	0	c	350028303300000001	0-30		11246869	10.2337/diabetes.50.3.502	0012-1797	Diabetes	Characterization of the Mouse Islet-Specific Glucose-6-Phosphatase Catalytic Subunit&#x2013;Related Protein Gene Promoter by In Situ Footprinting	Bischof	2001	8		ATG10,PPIA
1187	chr4	78978063	78978090	3500232007	27		78978063	78978090	8421504	1	27	0	g	350023200700000000	6-33		21245143	10.1074/jbc.C110.181347		The Journal of Biological Chemistry	Cyclophilin A (CyPA) Induces Chemotaxis Independent of Its Peptidylprolyl Cis-Trans Isomerase Activity: DIRECT BINDING BETWEEN CyPA AND THE ECTODOMAIN OF CD147*	Fei	2011	0		PPIA
1187	chr4	78978065	78978089	3500264880	24		78978065	78978089	8421504	1	24	0	c	350026488000000006	0-24						BMC Neuroscience BioMed Central	biomedcentral.com	0	0		PPIA
1187	chr4	78978066	78978090	3500403028	24		78978066	78978090	8421504	1	24	0	c	350040302800000002	6-30						Transduced PEP-1-Grb7 fusion protein suppressed LPS-induced COX-2 expression. - ResearchGate	.researchgate.net	0	0		PPIAP30
1187	chr4	78978069	78978092	3500164699	23		78978069	78978092	8421504	1	23	0	c	350016469900000620	0-23						MODULATION OF SGLT2 EXPRESSION - Patent application	www.faqs.org	0	0		PPIA
1188	chr4	79038892	79038920	3500259989	25		79038892	79038920	8421504	2	17,8	0,20	c	350025998900000031	8-33						Genetic factors affecting the omega-3 and omega-6 fatty acid variation in egg yolk	s.ulb.uni-bonn.de	0	0		
1188	chr4	79038947	79076898	3500268809	1209		79038947	79076898	8421504	9	3,180,91,147,155,116,103,192,222	0,3597,4157,4751,5037,8174,21510,23567,37729	p	350026880900015000	0-1209						KEGG T01001: 4967	www.genome.jp	0	0		OGDH
1188	chr4	79111279	79111303	3500349145	24		79111279	79111303	8421504	1	24	0	c	350034914500000373	17-41						Novel Human Beta-2 Integrin Alpha Subunit 	.freshpatents.com	0	0		
1188	chr4	79111279	79111303	3500247922	24		79111279	79111303	8421504	1	24	0	c	350024792200000374	17-41						Human B2 integrin alpha subunit antibodies	Gallatin	1996	0		
148	chr4	79270273	79360355	3500390910	1626		79270273	79360355	8421504	20	65,95,60,55,66,73,103,84,95,123,84,43,75,38,72,45,49,76,95,230	0,33554,50805,56582,60782,66141,69438,69632,70408,70666,71270,72140,73102,78152,78346,79900,81570,89237,89440,89852	p	350039091000015001	0-1998						KEGG T01001: 815	www.genome.jp	0	0		
1190	chr4	79341567	79342440	3500183591	87		79341567	79342440	8421504	2	60,27	0,846	p	350018359100015004	282-369						Methods in Molecular Biology Vol. 088 Protein Targeting Protocols	www.scribd.com	0	0		CAMK2B
1190	chr4	79392693	79427538	3500029105	1365		79392693	79427538	8421504	11	45,163,155,120,96,100,184,37,89,234,142	0,26295,27004,28233,29937,30239,32328,33430,33497,34219,34703	p	350002910500015003,350002910500015004	0-900,0-465						Bioinformatica 06-10-2011-p2 introduction	ww.slideshare.net	0	0		
1190	chr4	79392693	79427538	3500024993	1395		79392693	79427538	8421504	10	45,163,155,120,96,100,184,156,234,142	0,26295,27004,28233,29937,30239,32328,33430,34219,34703	p	350002499300015000	0-1395						KEGG T01001: 2645	www.genome.jp	0	0		
1190	chr4	79392693	79419849	3500158145	360		79392693	79419849	8421504	3	45,163,152	0,26295,27004	p	350015814500015012	0-360						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose	.csfmetabolome.ca	0	0		
1190	chr4	79419730	79419772	3500422979	42		79419730	79419772	8421504	1	42	0	c	350042297900000034	0-42						Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification	Wagner	1995	0		
1190	chr4	79419730	79419772	3500338086	42		79419730	79419772	8421504	1	42	0	c	350033808600000034	0-42					Patent	Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification (Patent US:6114115)	Robert	2000	0		
1190	chr4	79419730	79419772	3500189557	42		79419730	79419772	8421504	1	42	0	c	350018955700000032	0-42						US Patent # 6,120,992. Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human - Patents.com	www.patents.com	0	0		
1190	chr4	79419730	79419772	3500109729	42		79419730	79419772	8421504	1	42	0	c	350010972900000033	0-42						Methods for detection of a triplet repeat block and a functional mismatch binding protein in a biological fluid sample - Patent # 6329147 - PatentGenius	.patentgenius.com	0	0		
1190	chr4	79426190	79427544	3500374866	471		79426190	79427544	8421504	3	89,234,148	0,722,1206	p	350037486600015002	0-471						Code Snippet | Bioinformatics.be	bioinformatics.be	0	0		GCK
1190	chr4	79426190	79427544	3500018178	471		79426190	79427544	8421504	3	89,234,148	0,722,1206	p	350001817800015001	0-471						admin | Bioinformatics.be | Page 6	bioinformatics.be	0	0		GCK
1190	chr4	79427466	79427493	3500220172	27		79427466	79427493	8421504	1	27	0	c	350022017200000001	0-27		22291974	10.1371/journal.pone.0030518		PLoS ONE	Functional Characterization of MODY2 Mutations Highlights the Importance of the Fine-Tuning of Glucokinase and Its Role in Glucose Sensing	Carmen-Maria	2012	0		
1191	chr4	79446564	79446589	3500104661	25		79446564	79446589	8421504	1	25	0	c	350010466100000004	0-25		11595739	10.1074/jbc.M106990200	0021-9258	Journal of Biological Chemistry	Mediation of Proliferating Cell Nuclear Antigen (PCNA)-dependent DNA Replication through a Conserved p21Cip1-like PCNA-binding Motif Present in the Third Subunit of Human DNA Polymerase &#x03b4;	Ducoux	2001	5		POLD2
1191	chr4	79446565	79446588	3500326942	23		79446565	79446588	8421504	1	23	0	c	350032694200000002	7-30					Nucleic Acids Research	Identification of delta helicase as the bovine homolog of HUPF1: demonstration of an interaction with the third subunit of DNA polymerase delta	L.	2002	0		
1191	chr4	79453918	79457478	3500292291	256		79453918	79457478	8421504	6	48,30,48,42,41,47	0,1019,1163,1507,1745,3513	c	350029229100000070,350029229100000058,350029229100000055,350029229100000052,350029229100000049,350029229100000033	0-48,18-48,0-48,6-48,6-47,0-47						Aortic Carboxypeptidase-like Polypeptide 	.freshpatents.com	0	0		
1191	chr4	79456107	79456130	3500016813	23		79456107	79456130	8421504	1	23	0	c	350001681300000031	0-23						 Hepadnavirus Receptor 	www.docstoc.com	0	0		
1191	chr4	79539052	79558584	3500460946	336		79539052	79558584	8421504	8	45,45,45,40,5,45,45,66	0,48,96,192,4505,12515,16280,19466	p,c,g	350046094600015126,350046094600015125,350046094600015124,350046094600015122,350046094600015120,350046094600015118,350046094600000018,350046094600000018,350046094600000001,350046094600000001,350046094600015117	0-45,0-45,0-45,0-45,0-45,0-45,0-21,0-21,0-21,0-21,0-45						USE OF BILIVERDIN REDUCTASE (BVR) AND BVR PEPTIDE FRAGMENTS TO TREAT CORONARY DISORDERS - Patent application	www.faqs.org	0	0		
148	chr4	79558587	79573122	3500350986	48		79558587	79573122	8421504	2	36,12	0,14523	p	350035098600015037	0-48						Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions	Maines	2002	0		
1194	chr4	79933501	79933529	3500055561	27		79933501	79933529	8421504	2	4,23	0,5	g	350005556100000178	29-56						Prostate-specific membrane antigen and uses thereof - Patent # 7037647 - PatentGenius	.patentgenius.com	0	0		
1194	chr4	79939095	79939121	3500335263	23		79939095	79939121	8421504	2	13,10	0,16	g	350033526300000083	6-42						Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof	Chandrashekar	1999	0		
1198	chr4	80390956	80400859	3500027167	678		80390956	80400859	8421504	8	41,77,122,122,82,74,58,102	0,3583,4217,5701,6563,8113,9659,9801	p	350002716700015087,350002716700015088,350002716700015089,350002716700015090,350002716700015091,350002716700015092	0-150,0-90,0-48,0-150,0-150,0-90						Neela Devi Sing RAMBARUTH	search.wmin.ac.uk	0	0		PSMA2
1198	chr4	80396774	80400769	3500269923	42		80396774	80400769	8421504	4	5,15,10,12	0,745,3889,3983	c	350026992300000035,350026992300000036,350026992300000013	0-20,0-22,20-42						Morphine and Morphine Precursors - Patent application	www.faqs.org	0	0		
1198	chr4	80396774	80400769	3500078972	42		80396774	80400769	8421504	4	5,15,10,12	0,745,3889,3983	c	350007897200000035,350007897200000036,350007897200000013	0-20,0-22,20-40						MORPHINE AND MORPHINE PRECURSORS - Patent application	www.faqs.org	0	0		
1198	chr4	80397550	80397573	3500432185	23		80397550	80397573	8421504	1	23	0	c	350043218500000019	21-44						ScienceDirect.com - Genomics - Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis	sciencedirect.com	0	0		PSMA2
1199	chr4	80562270	80562295	3500221779	23		80562270	80562295	8421504	2	15,8	0,17	g	350022177900000003	0-23						Fish & Shell&#xfb01;sh Immunology	ur.lib.ntu.edu.tw	0	0		
1202	chr4	80954745	80954771	3500012257	23		80954745	80954771	8421504	2	17,6	0,20	g	350001225700000005	1-24		10586026		0022-1767	The Journal of Immunology	Characterization of Paired Ig-Like Receptors in Rats	Glynn	1999	6		
1204	chr4	81136876	81136903	3500121878	26		81136876	81136903	8421504	2	6,20	0,7	g	350012187800000036	3-33						Plant fatty acid synthases	www.devileye.net	0	0		
1204	chr4	81136876	81136903	3500109714	26		81136876	81136903	8421504	2	6,20	0,7	g	350010971400000036	3-33						Plant fatty acid synthases	Knauf	1991	0		
1204	chr4	81158488	81158516	3500092685	23		81158488	81158516	8421504	2	15,8	0,20	g	350009268500000278	25-48						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
1206	chr4	81438360	81444325	3500440223	60		81438360	81444325	8421504	3	20,20,20	0,2807,5945	g	350044022300000004,350044022300000007,350044022300000003	0-20,0-20,0-20		19019083	10.1111/j.1742-4658.2008.06762.x	1742-4658	FEBS Journal	A &#x03d5;C31 integrase-mediated integration hotspot in favor of transgene expression exists in the bovine genome - Ou - 2008 - FEBS Journal - Wiley Online Library	Ou	2009	0		
1207	chr4	81627265	81627293	3500032470	23		81627265	81627293	8421504	2	10,13	0,15	c	350003247000000014,350003247000000035	1-24,1-24						COMPOSITIONS AND METHODS FOR MODULATING C-REL-DEPENDENT CYTOKINE PRODUCTION - Patent application	www.faqs.org	0	0		
1207	chr4	81627485	81627767	3500214955	50		81627485	81627767	8421504	2	25,25	0,257	c,g	350021495500000000,350021495500000001,350021495500000001	0-25,0-25,0-25				1552-5783	Investigative Ophthalmology & Visual Science	Differential Effect of Activin A and BMP-7 on Myofibroblast Differentiation and the Role of the Smad Signaling Pathway	You	2002	0		
1207	chr4	81627846	81638458	3500212126	60		81627846	81638458	8421504	3	20,20,20	0,10436,10592	c,g	350021212600000000,350021212600000000,350021212600000001,350021212600000002,350021212600000002	0-20,0-20,0-20,0-20,0-20						The activin-follistatin system and in vitro early follicle development in goats	logy-journals.org	0	0		
1207	chr4	81637702	81637725	3500382508	23		81637702	81637725	8421504	1	23	0	c,g	350038250800000000,350038250800000000,350038250800000001,350038250800000001	0-23,0-23,0-22,0-22					Patent	Recombinant inhibin (Patent CA:1341619)	De	2011	0		
1207	chr4	81637907	81638031	3500411508	48		81637907	81638031	8421504	2	24,24	0,100	c	350041150800000000,350041150800000001	0-24,0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Fol&#xed;culos ovarianos caprinos expressam diferentes n&#xed;veis de RNAm para subunidade &#xdf;A da inibina e ativina-A promove o crescimento de fol&#xed;culos secund&#xe1;rios in vitro	Leitao	2013	0		
1207	chr4	81637907	81638031	3500053285	48		81637907	81638031	8421504	2	24,24	0,100	c,g	350005328500000000,350005328500000001,350005328500000001	0-24,0-24,0-24			10.1590/S0103-84782012005000140	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Goat ovarian follicles express different levels of mRNA for inhibin-&#xdf;A subunit and activin-A stimulates secondary follicle growth in vitro	Leitao	2013	0		
1207	chr4	81638092	81638301	3500118600	40		81638092	81638301	8421504	2	20,20	0,189	c	350011860000000004,350011860000000005	0-20,0-20						Immunohistochemical studies on buffalo adenohypophysis Attia et al. Immunohistochemical, cellular localization and ex- Animal species in this issue pression of inhibin hormone in the buffalo ( Camelus dromedarius Buba- One-humped camel ( lus bubalis) aden	www.vetanat.com	0	0		
1207	chr4	81638144	81638207	3500435393	41		81638144	81638207	8421504	2	21,20	0,43	c,g	350043539300000028,350043539300000029,350043539300000029	0-21,0-20,0-20						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
1207	chr4	81638249	81638513	3500063913	264		81638249	81638513	8421504	1	264	0	p	350006391300015047	0-264						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		INHBA
1207	chr4	81638252	81638537	3500037926	225		81638252	81638537	8421504	5	45,45,45,45,45	0,48,96,192,240	p	350003792600015235,350003792600015236,350003792600015237,350003792600015239,350003792600015240	0-45,0-45,0-45,0-45,0-45						Polynucleotides Encoding Growth Differentiation Factor-8 - Patent application	www.faqs.org	0	0		INHBA
1207	chr4	81638291	81638557	3500392138	122		81638291	81638557	8421504	4	24,26,47,25	0,108,165,241	c	350039213800000015,350039213800000089,350039213800000061,350039213800000164,350039213800000054,350039213800000416	12-36,12-36,11-37,50-97,6-37,0-25						Designer ligands of tgf-beta superfamily	Choe	2010	0		
1207	chr4	81638387	81638634	3500145630	48		81638387	81638634	8421504	2	24,24	0,223	c,g	350014563000000024,350014563000000024,350014563000000025	0-24,0-24,0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1207	chr4	81638399	81638465	3500232100	66		81638399	81638465	8421504	1	66	0	p	350023210000015008	0-66						Substrate assisted catalysis	Carter	1988	0		INHBA
1207	chr4	81638450	81638510	3500203533	60		81638450	81638510	8421504	1	60	0	p	350020353300015023	0-60						US Patent # 5,468,845. Antibodies to osteogenic proteins - Patents.com	www.patents.com	0	0		INHBA
1207	chr4	81638503	81638616	3500251519	39		81638503	81638616	8421504	2	19,20	0,93	c,g	350025151900000006,350025151900000006,350025151900000022,350025151900000022,350025151900000007	0-19,0-19,0-19,0-19,0-20		15956356	10.1677/jme.1.01799	0952-5041	Journal of Molecular Endocrinology	Gene expression profiling of bovine endometrium during the oestrous cycle: detection of molecular pathways involved in functional changes	Bauersachs	2005	3		
1208	chr4	81786133	81786157	3500385528	23		81786133	81786157	8421504	2	8,15	0,9	g	350038552800000001	3-26						INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR	Schwender	1997	0		
1209	chr4	81833411	81833435	3500176290	23		81833411	81833435	8421504	2	7,16	0,8	g	350017629000000008	12-40						Protein involved in abscisic acid signalling	Blatt	2000	0		
1214	chr4	82458287	82458315	3500262004	23		82458287	82458315	8421504	2	13,10	0,18	g	350026200400000080	22-45					Patent	Glyphosate tolerant plants (Patent US:5463175)	Barry	1995	0		
1214	chr4	82458287	82458315	3500256535	23		82458287	82458315	8421504	2	13,10	0,18	g	350025653500000116	22-45						Glyphosate tolerant plants	Barry	1992	0		
1214	chr4	82458287	82458315	3500192741	23		82458287	82458315	8421504	2	13,10	0,18	g	350019274100000080	22-45						Glyphosate tolerant plants	www.devileye.net	0	0		
1214	chr4	82458287	82458315	3500190153	23		82458287	82458315	8421504	2	13,10	0,18	g	350019015300000080	22-45						Glyphosate tolerant plants	Barry	1995	0		
1214	chr4	82575002	82575025	3500416384	23		82575002	82575025	8421504	1	23	0	c	350041638400000006	0-23						Grape seed proanthocyanidin rescues rats from steatosis - A comparative and combination study with metformin	loads.hindawi.com	0	0		
1220	chr4	83305322	83305350	3500152492	24		83305322	83305350	8421504	2	8,16	0,12	g	350015249200000339	1-33						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
1220	chr4	83344280	83344310	3500206260	27		83344280	83344310	8421504	2	17,10	0,20	c	350020626000000001	4-31						Durham E-Theses Copper and zinc ligands of pisum sativum and expression of psMT( A)	etheses.dur.ac.uk	0	0		
1221	chr4	83379981	83448978	3500034953	804		83379981	83448978	8421504	11	111,4,117,50,19,89,174,60,45,26,109	0,114,693,9929,9988,10099,25247,66839,66920,66971,68888	p	350003495300015081,350003495300015080,350003495300015068,350003495300015067,350003495300015056,350003495300015040,350003495300015039,350003495300015027,350003495300015026	0-111,0-81,0-90,0-108,0-90,0-84,0-60,0-45,0-135						Proc. Nati. Acad. Sci. USA	www.pnas.org	0	0		
1221	chr4	83380039	83390147	3500152372	60		83380039	83390147	8421504	2	30,30	0,10078	c	350015237200000008,350015237200000007	0-30,0-30						Transgenic non-human animal assay system for anti-cholinesterase substances	Soreq	1995	0		CDK13
1222	chr4	83606933	83606960	3500160528	23		83606933	83606960	8421504	2	16,7	0,20	g	350016052800000262,350016052800000327	10-33,22-45						Anthrax toxin fusion proteins and uses thereof	Arora	1994	0		
1222	chr4	83609369	83619496	3500439629	48		83609369	83619496	8421504	2	25,23	0,10104	c	350043962900000001,350043962900000000	10-35,13-36		16103060	10.1158/0008-5472.CAN-04-1957	0008-5472	Cancer Research	RalA and RalB: Antagonistic Relatives in Cancer Cell Migration	Oxford	2005	8		RALA
1222	chr4	83609369	83609398	3500096744	29		83609369	83609398	8421504	1	29	0	c	350009674400000005,350009674400000003,350009674400000001	9-38,9-38,9-38			10.1128/MCB.00057-07		Molecular and Cellular Biology	Geranylgeranyltransferase I Inhibitors Target RalB To Inhibit Anchorage-Dependent Growth and Induce Apoptosis and RalA To Inhibit Anchorage-Independent Growth 	SamuC.	2007	0		
1222	chr4	83609369	83609398	3500059335	29		83609369	83609398	8421504	1	29	0	c	350005933500000003,350005933500000001,350005933500000005	9-38,9-38,9-38		17875936	10.1128/MCB.00057-07	0270-7306	Molecular and Cellular Biology	Geranylgeranyltransferase I Inhibitors Target RalB To Inhibit Anchorage-Dependent Growth and Induce Apoptosis and RalA To Inhibit Anchorage-Independent Growth	Falsetti	2007	6		RALA
1222	chr4	83617140	83619496	3500219377	180		83617140	83619496	8421504	2	66,114	0,2242	p	350021937700015126	0-180						PPT &#x2013; Bioinformatics Tools for Sequences and Structures Tim Stevens, 29th January 2008 Department of Bioch PowerPoint presentation | free to view 	www.powershow.com	0	0		RALA
1224	chr4	83803483	83803507	3500167483	23		83803483	83803507	8421504	2	5,18	0,6	g	350016748300000006	10-33		16368963	10.1128/IAI.74.1.108-117.2006	0019-9567	Infection and Immunity	The Brucella suis Type IV Secretion System Assembles in the Cell Envelope of the Heterologous Host Agrobacterium tumefaciens and Increases IncQ Plasmid pLS1 Recipient Competence	Carle	2006	4		
1226	chr4	84067405	84067431	3500091444	23		84067405	84067431	8421504	2	6,17	0,9	g	350009144400000026	23-46						PROTEINACEOUS COMPOUNDS - Patent application	www.faqs.org	0	0		
1227	chr4	84152968	84152999	3500119046	29		84152968	84152999	8421504	2	19,10	0,21	g	350011904600000236	20-49					Patent	Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence (Patent US:5833975)	Cox	1998	0		
1227	chr4	84259535	84259562	3500442456	23		84259535	84259562	8421504	2	15,8	0,19	c	350044245600000074	2-37						DNA expression systems based on alphaviruses	Garoff	2000	0		
1229	chr4	84413137	84413166	3500256323	26		84413137	84413166	8421504	2	21,5	0,24	g	350025632300000145	9-37						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - US Patent 5627061 Description	ww.patentstorm.us	0	0		
1232	chr4	84824071	84824102	3500420477	28		84824071	84824102	8421504	2	10,18	0,13	g	350042047700000209	11-39						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
1233	chr4	84938463	84938492	3500220349	29		84938463	84938492	8421504	1	29	0	c	350022034900000002	7-36		11877424	10.1074/jbc.M111101200	0021-9258	Journal of Biological Chemistry	Dynamin Is a Minibrain Kinase/Dual Specificity Yak1-related Kinase 1A Substrate	Chen-Hwang	2002	5		AMPH
1235	chr4	85250698	85250721	3500332706	23		85250698	85250721	8421504	1	23	0	g	350033270600000007	0-23						T cell immunodominant Anaplasma marginale	www.jleukbio.org	0	0		
1235	chr4	85252501	85252603	3500317153	40		85252501	85252603	8421504	2	20,20	0,82	g	350031715300000020,350031715300000048,350031715300000021,350031715300000049	0-20,0-20,0-20,0-20						Markers for Viral Infections and Other Inflammatory Responses - Patent application	www.faqs.org	0	0		
1249	chr4	87039025	87039053	3500330733	25		87039025	87039053	8421504	2	11,14	0,14	g	350033073300000014	0-25							noemata.net	0	0		
1250	chr4	87259826	87259859	3500248879	27		87259826	87259859	8421504	3	15,4,8	0,20,25	g	350024887900000016	10-37						Protease Inhibition 	.freshpatents.com	0	0		
1255	chr4	87826090	87830249	3500062860	105		87826090	87830249	8421504	2	42,63	0,4096	p	350006286000015016	3-108						Tm4sf receptors	Fan	2000	0		TSPAN12
1261	chr4	88619147	88619177	3500304866	23		88619147	88619177	8421504	3	6,5,12	0,11,18	g	350030486600000064	14-38						Methods For Identifying Modulators Of Kinesin Activity 	.freshpatents.com	0	0		
1263	chr4	88907750	88907775	3500030519	23		88907750	88907775	8421504	3	14,4,5	0,15,20	c	350003051900000169	10-33						Nematode-extracted serine protease inhibitors and anticoagulant proteins - Patent application	www.faqs.org	0	0		PTPRZ1
1263	chr4	88907771	88907798	3500236871	24		88907771	88907798	8421504	2	16,8	0,19	c	350023687100000036	12-36						Methods and compositions involving endopeptidases PepO2 and PepO3 - US Patent 7741438 Description	ww.patentstorm.us	0	0		
1264	chr4	89014716	89017421	3500233269	23		89014716	89017421	8421504	2	8,15	0,2690	c	350023326900000002	26-49						Author's personal copy	ss.bjmu.edu.cn	0	0		PTPRZ1
1264	chr4	89023706	89023897	3500326125	24		89023706	89023897	8421504	2	13,11	0,180	c	350032612500000005	0-24						Use of biomolecular targets in the treatment and visualization of brain tumors	Chin	2002	0		
1264	chr4	89023706	89023897	3500098327	24		89023706	89023897	8421504	2	13,11	0,180	c	350009832700000005	0-24						Use of protein biomolecular targets in the treatment and visualization of brain tumors	Mueller	2003	0		
1264	chr4	89027940	89043404	3500298543	40		89027940	89043404	8421504	2	19,21	0,15443	c,g	350029854300000003,350029854300000003,350029854300000001	0-19,0-19,0-21		23170925	10.1186/1471-2407-12-537	1471-2407	BMC Cancer	PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma	Makinoshima	2012	3		PTPRZ1
1264	chr4	89031838	89033438	3500136297	48		89031838	89033438	8421504	2	23,25	0,1575	p	350013629700015206	99-147						Novel proteins and nucleic acids encoding same	Ellerman	2002	0		PTPRZ1
1268	chr4	89644543	89644585	3500224317	42		89644543	89644585	8421504	1	42	0	c	350022431700000044	0-42					Patent	Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration (Patent US:7767786)	Sieg	2010	0		
1269	chr4	89778548	89778571	3500113379	23		89778548	89778571	8421504	1	23	0	g	350011337900000096	8-47						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
1269	chr4	89778548	89778571	3500062787	23		89778548	89778571	8421504	1	23	0	g	350006278700000096	8-47						Polypeptides of Botryosphaeria Rhodina - Patent application	www.faqs.org	0	0		
1271	chr4	89946833	89946875	3500449936	42		89946833	89946875	8421504	1	42	0	c	350044993600000021	0-42						Major taste loss in carnivorous mammals	www.pnas.org	0	0		
1271	chr4	89946833	89946875	3500425014	42		89946833	89946875	8421504	1	42	0	c	350042501400000021	0-42						Major taste loss in carnivorous mammals	www.pnas.org	0	0		
1271	chr4	90036751	90036778	3500394860	23		90036751	90036778	8421504	2	9,14	0,13	c	350039486000000033	19-48						METHODS AND COMPOSITIONS FOR TREATING TULAREMIA - Patent application	www.faqs.org	0	0		SLC13A1
1275	chr4	90442837	90442864	3500108244	24		90442837	90442864	8421504	3	14,5,5	0,15,22	g	350010824400000003	6-30						Materials and methods relating to proteins that interact with casein kinase i	Demaggio	1996	0		
1275	chr4	90454657	90455119	3500268985	48		90454657	90455119	8421504	2	24,24	0,438	c,g	350026898500000002,350026898500000003,350026898500000003	0-24,0-24,0-24		16424087	10.1152/ajpregu.00239.2005		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle	McDaneld	2006	0		
1275	chr4	90454657	90455119	3500000782	48		90454657	90455119	8421504	2	24,24	0,438	c	350000078200000002,350000078200000003	0-24,0-24		16424087	10.1152/ajpregu.00239.2005		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle	McDaneld	2006	0		
1275	chr4	90458184	90458208	3500325589	23		90458184	90458208	8421504	2	12,11	0,13	g	350032558900000038	8-35						ATLASTIN - Patent application	www.faqs.org	0	0		
1275	chr4	90509206	90509233	3500432864	27		90509206	90509233	8421504	1	27	0	c	350043286400000018	0-27						57278535 Pcr Technology	www.scribd.com	0	0		
1275	chr4	90509209	90512122	3500080177	102		90509209	90512122	8421504	2	59,43	0,2870	p	350008017700015008	0-102						Regulatory Mimicry in Listeria monocytogenes Actin-Based Motility	www.med.yale.edu	0	0		WASL
1275	chr4	90519585	90519618	3500177982	27		90519585	90519618	8421504	3	15,8,4	0,20,29	c	350017798200000106	1-31						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		
1275	chr4	90528823	90541696	3500418652	63		90528823	90541696	8421504	3	11,24,28	0,9464,12845	p	350041865200015001	0-63		15102814	10.1128/IAI.72.5.3011-3021.2004	0019-9567	Infection and Immunity	Cdc42 and the Actin-Related Protein/Neural Wiskott-Aldrich Syndrome Protein Network Mediate Cellular Invasion by Cryptosporidium parvum	Chen	2004	4		WASL
1276	chr4	90588062	90588085	3500015113	23		90588062	90588085	8421504	1	23	0	c	350001511300000000	10-33						Tao Wang, Rachel A Cleary, Ruping Wang, and Dale D. Tang1	www.jbc.org	0	0		WASL
1283	chr4	91510495	91510522	3500271519	24		91510495	91510522	8421504	2	12,12	0,15	g	350027151900000059	0-24						Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used	Jalava	2004	0		
1284	chr4	91653154	91653199	3500218622	42		91653154	91653199	8421504	2	23,19	0,26	c,g	350021862200000012,350021862200000010,350021862200000010	0-23,0-19,0-19						Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder	www.med.nyu.edu	0	0		GPR37
1290	chr4	92438034	92438062	3500264979	23		92438034	92438062	8421504	2	15,8	0,20	g	350026497900000006	6-29		19279104	10.1128/JVI.00097-09		Journal of Virology	The LMP1 Promoter Can Be Transactivated Directly by NF-&#x03ba;B 	Constantinos	2009	0		
1297	chr4	93348099	93348132	3500327502	33		93348099	93348132	8421504	1	33	0	c,g	350032750200000055,350032750200000055	1-34,1-34						Identification of novel polymorphic sites in the human mglur8 gene and uses thereof	Conn	2003	0		
1298	chr4	93463858	93464296	3500343669	46		93463858	93464296	8421504	2	21,25	0,413	c	350034366900000044,350034366900000043	0-21,0-25						Gastroenterology (February 2005)	005.pasteur.ac.ir	0	0		GRM8
1298	chr4	93464346	93464374	3500102487	23		93464346	93464374	8421504	2	9,14	0,14	c	350010248700000081	0-23						Syndecan enhancer element and syndecan stimulation of cellular differentiation	Jalkanen	1996	0		
1299	chr4	93688453	93688477	3500222543	24		93688453	93688477	8421504	1	24	0	c	350022254300000011	0-24						US Patent # 6,051,688. Isolated human metabotropic glutamate receptor Mglur-8 - Patents.com	www.patents.com	0	0		GRM8
1299	chr4	93688453	93688477	3500185503	24		93688453	93688477	8421504	1	24	0	c	350018550300000010	0-24						Human metabotropic glutamate receptor	www.devileye.net	0	0		GRM8
1299	chr4	93688453	93688477	3500123563	24		93688453	93688477	8421504	1	24	0	c	350012356300000010	0-24					Patent	Human metabotropic glutamate receptor (Patent US:6084084)	Fuller	2000	0		GRM8
1299	chr4	93688453	93688477	3500121039	24		93688453	93688477	8421504	1	24	0	c	350012103900000011	0-24					Patent	Human metabotropic glutamate receptor (Patent US:6077675)	Fuller	2000	0		GRM8
1299	chr4	93688453	93688477	3500078205	24		93688453	93688477	8421504	1	24	0	c	350007820500000011	0-24						Novel human metabotropic glutamate receptor	Fuller	1998	0		GRM8
1300	chr4	93790427	93790451	3500465169	23		93790427	93790451	8421504	2	15,8	0,16	g	350046516900000221	19-48						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
1300	chr4	93790427	93790451	3500092685	23		93790427	93790451	8421504	2	15,8	0,16	g	350009268500000221	19-48						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
162	chr4	93837636	94190671	3500222543	864		93837636	94190671	8421504	10	48,38,58,49,136,7,162,174,96,96	0,96,1711,1817,2335,210540,210595,352573,352795,352939	p	350022254300015022,350022254300015020,350022254300015019,350022254300015017,350022254300015016,350022254300015015,350022254300015014,350022254300015012,350022254300015011,350022254300015010,350022254300015009,350022254300015008,350022254300015007,350022254300015006,350022254300015004,350022254300015003,350022254300015002,350022254300015001	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						US Patent # 6,051,688. Isolated human metabotropic glutamate receptor Mglur-8 - Patents.com	www.patents.com	0	0		GRM8,MIR592
1306	chr4	94540876	94540917	3500330733	41		94540876	94540917	8421504	1	41	0	c	350033073300000039	0-41							noemata.net	0	0		
1306	chr4	94540876	94540913	3500111646	37		94540876	94540913	8421504	1	37	0	c	350011164600000003	20-57		15988002	10.1128/MCB.25.14.5846-5858.2005	0270-7306	Molecular and Cellular Biology	GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells	Ge	2005	6		
1306	chr4	94540893	94540918	3500418620	24		94540893	94540918	8421504	2	7,17	0,8	c	350041862000000000	8-32			10.1093/emboj/17.15.4491	ERROR! NO ISSN	The EMBO Journal	Importin &#x03b2;, transportin, RanBP5 and RanBP7 mediate nuclear import of ribosomal proteins in mammalian cells	Jakel	1998	0		
1306	chr4	94545922	94545947	3500407650	23		94545922	94545947	8421504	2	8,15	0,10	c	350040765000000022,350040765000000008	19-42,19-42						METHODS FOR TARGETING MODIFIED RAAV VECTORS TO MAMMALIAN CELLS - Patent application	www.faqs.org	0	0		IFT122
1306	chr4	94545922	94545947	3500306690	23		94545922	94545947	8421504	2	8,15	0,10	c	350030669000000008	19-42						Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus&#x2020;	jvi.asm.org	0	0		IFT122
1306	chr4	94545922	94545947	3500221385	23		94545922	94545947	8421504	2	8,15	0,10	c	350022138500000008,350022138500000022	19-42,19-42						rAAV EXPRESSION SYSTEMS AND COMPOSITIONS - Patent application	www.faqs.org	0	0		
1306	chr4	94545922	94545947	3500192768	23		94545922	94545947	8421504	2	8,15	0,10	c	350019276800000022,350019276800000008	19-42,19-42						rAAV Expression Systems and Methods of Use - Patent application	www.faqs.org	0	0		IFT122
1306	chr4	94545922	94545947	3500020322	23		94545922	94545947	8421504	2	8,15	0,10	c	350002032200000008	19-42						rAAV Expression Systems and Methods of Use	Warrington	2009	0		IFT122
1306	chr4	94548237	94551274	3500393275	102		94548237	94551274	8421504	4	29,6,23,44	0,1845,2484,2993	c	350039327500000014,350039327500000019,350039327500000023	11-40,4-33,0-44						Polypeptide-human actin-binding protein 54 and a polynucleotide encoding the same - US Patent 7273724 Description	ww.patentstorm.us	0	0		
163	chr4	94635024	94925863	3500394547	398		94635024	94925863	8421504	12	55,79,10,7,41,48,8,40,28,17,45,20	0,3435,6169,6323,7083,7858,194565,212472,234452,290741,290761,290819	p,c,g	350039454700000097,350039454700000098,350039454700000099,350039454700000103,350039454700000106,350039454700000121,350039454700015036,350039454700015037,350039454700000046,350039454700000046,350039454700000082,350039454700000082,350039454700000022,350039454700000058	0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-45,0-20,0-20,0-20,0-20,0-20,0-20						MODULATION OF TUDOR-SN EXPRESSION - Patent application	www.faqs.org	0	0		
1307	chr4	94673600	94673629	3500242892	25		94673600	94673629	8421504	3	12,8,5	0,13,24	g	350024289200000006	0-25						Therapeutic approaches for treating cmt and related disorders	Cohen	2010	0		
1309	chr4	94925791	94925863	3500354966	40		94925791	94925863	8421504	2	20,20	0,52	c	350035496600000049,350035496600000085,350035496600000025,350035496600000061	0-20,0-20,0-20,0-20						Modulation Of Tudor-sn Expression 	.freshpatents.com	0	0		SND1
1309	chr4	95016841	95016864	3500251828	23		95016841	95016864	8421504	1	23	0	g	350025182800000191	19-42						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
1309	chr4	95016841	95016864	3500013299	23		95016841	95016864	8421504	1	23	0	g	350001329900000231	16-39						Human Antibodies As Detection Reagents 	.freshpatents.com	0	0		
163	chr4	95023730	95032074	3500394547	89		95023730	95032074	8421504	4	34,8,21,26	0,3585,8188,8318	c	350039454700000134,350039454700000146	6-48,0-47						MODULATION OF TUDOR-SN EXPRESSION - Patent application	www.faqs.org	0	0		
1310	chr4	95152983	95153011	3500412562	28		95152983	95153011	8421504	1	28	0	g	350041256200000010	14-42						A Splicing Enhancer in the E4 Coding Region of Human Papillomavirus Type 16 Is Required for Early mRNA Splicing and Polyadenylation as Well as Inhibition of Premature Late Gene Expression	jvi.asm.org	0	0		
1311	chr4	95172021	95187358	3500121582	3513		95172021	95187358	8421504	6	397,25,970,402,1252,467	0,398,424,1395,1798,14870	c,g	350012158200000025,350012158200000024,350012158200000023,350012158200000022,350012158200000028,350012158200000000,350012158200000027,350012158200000026,350012158200000038,350012158200000006,350012158200000039,350012158200000007	0-3052,0-3052,0-3052,0-3052,0-25,0-25,0-467,0-467,0-23,0-23,0-22,0-22						LEPTIN PROMOTER POLYMORPHISMS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1311	chr4	95172188	95187358	3500055131	46		95172188	95187358	8421504	2	25,21	0,15149	g	350005513100000006,350005513100000003	0-25,0-21						Silva,RCG Disserta&#xe7;&#xe3;o Mestrado	pt.scribd.com	0	0		
1311	chr4	95172188	95187231	3500346703	71		95172188	95187231	8421504	3	25,24,22	0,14966,15021	c,g	350034670300000001,350034670300000025,350034670300000028,350034670300000007,350034670300000008	0-25,25-50,0-24,0-23,0-22						Leptin and Growth Hormone Receptor Gene Markers Associated with Rearing, Carcass Traits and Productive Life in Cattle	Woodward	2007	0		
1311	chr4	95172188	95187231	3500271388	70		95172188	95187231	8421504	3	25,23,22	0,14966,15021	c,g	350027138800000000,350027138800000006,350027138800000006,350027138800000007	0-25,0-23,0-23,0-22						LEPTIN PROMOTER POLYMORPHISMS AND USES THEREOF	Moore	2008	0		
1311	chr4	95174066	95187358	3500202035	41		95174066	95187358	8421504	2	20,21	0,13271	g	350020203500000011,350020203500000003	0-20,0-21						Estudo de caracteriza&#xe7;&#xe3;o e associa&#xe7;&#xe3;o de marcadores moleculares rel...	ww.slideshare.net	0	0		
1311	chr4	95174981	95175045	3500256175	47		95174981	95175045	8421504	3	33,7,7	0,42,57	g	350025617500000036	9-60					Patent	Modulators of ob gene and screening methods therefor (Patent US:6068976)	Auwerx	2000	0		
1311	chr4	95179744	95187145	3500234746	60		95179744	95187145	8421504	3	19,19,22	0,117,7379	c,g	350023474600000001,350023474600000000,350023474600000002,350023474600000002	0-19,0-19,0-22,0-22						Leptin gene polymorphisms and beef longissimus muscle association in Hart&#xf3;n Del Valle and Blanco Orejinegro cattle	ftp.sunet.se	0	0		
1311	chr4	95179861	95187145	3500355968	40		95179861	95187145	8421504	2	19,21	0,7263	c,g	350035596800000002,350035596800000000,350035596800000000	0-19,0-21,0-21						FRECUENCIA DE LOS MARCADORES DEL GEN LEPTINA EN RAZAS BOVINAS CRIOLLAS Y COLOMBIANAS: I. ROMOSINUANO, CHINO	vistas.luz.edu.ve	0	0		
1311	chr4	95179861	95187145	3500211299	41		95179861	95187145	8421504	2	19,22	0,7262	c,g	350021129900000002,350021129900000000,350021129900000000	0-19,0-22,0-22				0798-2259	Revista Cient&#xed;fica	Revista Cient&#xed;fica - Marcadores del GEN Leptina en bovinos cruzados con Angus, ceb&#xfa;, romosinuano y blanco orejinegro	Ceron-Munoz	2009	0		
1311	chr4	95179861	95187145	3500169466	41		95179861	95187145	8421504	2	19,22	0,7262	c,g	350016946600000002,350016946600000000,350016946600000000	0-19,0-22,0-22				0798-2259	Revista Cient&#xed;fica	Revista Cient&#xed;fica - Leptin Gene Markers in Crossbred cattle with Angus, Zebu, Romosinuano and Blanco Orejinegro	Ceron-Munoz	2009	0		
1311	chr4	95179861	95187145	3500010344	41		95179861	95187145	8421504	2	19,22	0,7262	c,g	350001034400000002,350001034400000000,350001034400000000	0-19,0-22,0-22						MARCADORES DEL GEN LEPTINA EN BOVINOS CRUZADOS CON ANGUS, CEB&#xda;, ROMOSINUANO Y BLANCO OREJINEGRO	www.scielo.org.ve	0	0		
1311	chr4	95186855	95189151	3500165694	101		95186855	95189151	8421504	4	23,23,23,32	0,288,2068,2264	c,g	350016569400000002,350016569400000003,350016569400000008,350016569400000007,350016569400000009	0-23,0-23,0-23,0-24,0-22						ANNALS OF ANIMAL SCIENCE	ww.izoo.krakow.pl	0	0		
1311	chr4	95187007	95189381	3500245748	953		95187007	95189381	8421504	2	596,357	0,2017	p,g	350024574800000000,350024574800000001,350024574800015004	0-596,0-596,0-501						Systems and Methods for Improving Protein and Milk Production of Dairy Herds	Marquess	2009	0		
1311	chr4	95187007	95189381	3500088916	953		95187007	95189381	8421504	2	596,357	0,2017	p,g	350008891600000008,350008891600000009,350008891600000000,350008891600000001,350008891600015002,350008891600015003,350008891600015005,350008891600015006,350008891600015007,350008891600015008,350008891600015009,350008891600015010,350008891600015011	0-596,0-596,0-596,0-596,0-501,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Systems and Methods for Improving Protein and Milk Production of Dairy Herds - Patent application	www.faqs.org	0	0		
1311	chr4	95187041	95187224	3500370604	81		95187041	95187224	8421504	3	28,27,26	0,128,157	c,g	350037060400000006,350037060400000004,350037060400000005	0-28,0-27,0-26						MARCADORES MOLECULARES ASOCIADOS AL VETEADO DE LA CARNE EN BOVINOS CRIOLLOS URUGUAYOS	ion-animal.com.ar	0	0		
1311	chr4	95187066	95189721	3500171470	182		95187066	95189721	8421504	9	20,24,20,20,19,19,20,20,20	0,190,1101,1126,1408,1436,1751,1955,2635	c,g	350017147000000004,350017147000000005,350017147000000006,350017147000000012,350017147000000011,350017147000000014,350017147000000013,350017147000000015,350017147000000017,350017147000000021	0-20,0-20,0-20,0-20,0-20,0-19,0-19,0-20,0-20,0-20						Molecular characterization of leptin (obese) gene in domesticated Yak (Bos grunniens	demicjournals.org	0	0		
1311	chr4	95187103	95187127	3500256118	24		95187103	95187127	8421504	1	24	0	c	350025611800000045	9-33					Patent	Mammalian ob polypeptides capable of modulating body weight, corresponding nucleic acids, and diagnostic and therapeutic uses thereof (Patent US:5935810)	Burley	1999	0		
1311	chr4	95187123	95189381	3500155802	38		95187123	95189381	8421504	2	19,19	0,2239	c,g	350015580200000002,350015580200000002,350015580200000003	0-19,0-19,0-19		16322546	10.1530/rep.1.00557	1470-1626	Reproduction	The ovarian expression of mRNAs for aromatase, IGF-I receptor, IGF-binding protein-2, -4 and -5, leptin and leptin receptor in cycling ewes after three days of leptin infusion	Munoz-Gutierrez	2005	3		
1311	chr4	95187123	95189381	3500054995	38		95187123	95189381	8421504	2	19,19	0,2239	c,g	350005499500000007,350005499500000007,350005499500000008	0-19,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
1311	chr4	95187123	95188839	3500017322	60		95187123	95188839	8421504	3	21,20,19	0,114,1697	c,g	350001732200000000,350001732200000000,350001732200000004,350001732200000004,350001732200000002	0-21,0-21,0-20,0-20,0-19						Associations between Leptin Gene Polymorphisms and Somatic Cell Count in Milk of Jersey Cows	actavet.vfu.cz	0	0		
1311	chr4	95187123	95187217	3500262266	41		95187123	95187217	8421504	2	22,19	0,75	c,g	350026226600000002,350026226600000002,350026226600000003,350026226600000003	0-22,0-22,0-19,0-19						RESUMOS EXPANDIDOS 128 RESUMOS SIMPLES 157 RESUMOS DE PROJETOS 162	vistas.unoeste.br	0	0		
1311	chr4	95187154	95189035	3500301078	42		95187154	95189035	8421504	3	22,9,11	0,104,1870	c	350030107800000045,350030107800000046	0-22,0-20						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
1311	chr4	95187167	95189046	3500106980	46		95187167	95189046	8421504	3	23,1,22	0,99,1857	c,g	350010698000000006,350010698000000006,350010698000000007	0-23,0-23,0-23						Differential gene expression of bovine intramuscular and subcutaneous preadipocytes during differentiation*	www.ighz.edu.pl	0	0		
1311	chr4	95187169	95187224	3500425687	53		95187169	95187224	8421504	2	27,26	0,29	c	350042568700000006,350042568700000007	0-27,0-26						Effect of leptin gene polymorphisms on growth, slaughter and meat quality traits of grazing Brangus steers. - ResearchGate	.researchgate.net	0	0		
1311	chr4	95187186	95189381	3500190703	435		95187186	95189381	8421504	3	81,39,315	0,1838,1880	p,c	350019070300015012,350019070300000023,350019070300000019,350019070300000018,350019070300000021,350019070300015039,350019070300015045,350019070300000035,350019070300000034,350019070300000011,350019070300000010,350019070300015022,350019070300015031,350019070300015054,350019070300015029,350019070300015042,350019070300015034,350019070300015043	0-93,0-398,6-404,6-404,6-404,0-72,0-45,15-44,0-29,15-44,0-29,0-45,0-48,0-90,0-135,0-45,0-117,0-81						Leptin antagonists - Patent # 7307142 - PatentGenius	.patentgenius.com	0	0		
1311	chr4	95187187	95189384	3500408611	437		95187187	95189384	8421504	3	80,276,81	0,1837,2116	p,c,g	350040861100000002,350040861100015006,350040861100000003,350040861100000003,350040861100000001	1-22,3-453,0-20,0-20,11-31						UNIVERSITATEA DE &#x015e;TIIN &#x0142;E AGRICOLE &#x015e;I MEDICIN &#x0102; VETERINAR &#x0102; &#x015e; &#x0102; FACULTATEA DE ZOOTEHNIE &#x015e;I BIOTEHNOLOGII Ing. Socol Claudia Terezia	www.usamvcluj.ro	0	0		
1311	chr4	95187199	95187227	3500069005	28		95187199	95187227	8421504	1	28	0	c	350006900500000046	0-28						Method for genome editing	Cui	2012	0		
1311	chr4	95187201	95189084	3500322447	84		95187201	95189084	8421504	2	36,48	0,1835	p,c	350032244700000090,350032244700015110,350032244700015105	6-42,0-48,0-45						US Patent # 7,544,492. OB polypeptides, modified forms and derivatives - Patents.com	patents.com	0	0		
1311	chr4	95187206	95187249	3500272204	43		95187206	95187249	8421504	1	43	0	c	350027220400000014,350027220400000015,350027220400000007,350027220400000006	0-43,0-43,0-43,0-43					Patent	Novel leptin antagonist (Patent EP:1508575)	Peelman	2007	0		
1311	chr4	95187206	95187249	3500230822	43		95187206	95187249	8421504	1	43	0	c	350023082200000018,350023082200000019	0-43,0-43						Leptin antagonist - Patent # 7423113 - PatentGenius	.patentgenius.com	0	0		
1311	chr4	95187211	95187234	3500064373	23		95187211	95187234	8421504	1	23	0	c	350006437300000008	0-23						Placental angiogenesis and angiogenesis related risk factors in severe pre-eclampsia	herkules.oulu.fi	0	0		LEP
1311	chr4	95187218	95187243	3500435629	25		95187218	95187243	8421504	1	25	0	c	350043562900000005	0-25						&#x30ab;&#x30eb;&#x30b7;&#x30a6;&#x30e0;&#x62ee;&#x6297;&#x85ac;&#x30a2;&#x30bc;&#x30eb;&#x30cb;&#x30b8;&#x30d4;&#x30f3;&#x306e;3T3-L1 &#x8102;&#x80aa;&#x7d30;&#x80de;&#x306b;&#x304a;&#x3051;&#x308b;&#x30a4;&#x30f3;&#x30b9;&#x30ea;&#x30f3;&#x611f;&#x53d7;	www.docin.com	0	0		
1311	chr4	95187218	95187241	3500125473	23		95187218	95187241	8421504	1	23	0	c	350012547300000008	0-23						&#x8840;&#x7ba1;&#x5185;&#x76ae;&#x7d30;&#x80de;PDK1&#x30b7;&#x30b0;&#x30ca;&#x30eb;&#x306e;&#x751f;&#x7406;&#x7684;&#x5f79;&#x5272;&#x306e;&#x89e3;&#x660e; &#x301c;&#x8840;&#x7ba1;&#x5185;&#x76ae;&#x7d30;&#x80de;&#x7279;&#x7570;&#x7684;PDK1&#x6b20;&#x640	.kawasaki-m.ac.jp	0	0		LEP
1311	chr4	95187228	95187251	3500050297	23		95187228	95187251	8421504	1	23	0	c	350005029700000000	0-23						Diet-induced obesity in gravid rats engenders early hyperadiposity in the offspring. - ResearchGate	.researchgate.net	0	0		LEP
1311	chr4	95187238	95187262	3500171116	24		95187238	95187262	8421504	1	24	0	c	350017111600000020	0-24						Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells	www.iovs.org	0	0		
1311	chr4	95187239	95189205	3500129021	40		95187239	95189205	8421504	2	21,19	0,1947	c	350012902100000006,350012902100000007	0-21,0-19						Early pregnancy alters the metabolic responses to restricted nutrition in sheep. - ResearchGate	.researchgate.net	0	0		
1311	chr4	95187242	95187266	3500459800	24		95187242	95187266	8421504	1	24	0	c	350045980000000035	0-24						Isolation and characterization of canine adipose-derived mesenchymal stem cells | Vilma Yuzbasiyan-Gurkan - Academia.edu	www.academia.edu	0	0		
1311	chr4	95187242	95187266	3500001585	24		95187242	95187266	8421504	1	24	0	c	350000158500000035	0-24						Isolation and Characterization of Canine Adipose&#x2013;Derived Mesenchymal Stem Cells	hemeng.queensu.ca	0	0		
1311	chr4	95187255	95189214	3500035162	39		95187255	95189214	8421504	3	12,8,19	0,1769,1940	c	350003516200000007,350003516200000008	0-20,0-19						The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS). - ResearchGate	.researchgate.net	0	0		
1311	chr4	95187287	95189475	3500344409	39		95187287	95189475	8421504	2	19,20	0,2168	c,g	350034440900000001,350034440900000003,350034440900000003	0-19,0-20,0-20						DNA Polymorphisms in River Buffalo Leptin Gene - ResearchGate	.researchgate.net	0	0		
1311	chr4	95188354	95188378	3500438345	24		95188354	95188378	8421504	1	24	0	g	350043834500000001	0-24						Polymorphism Within the Intron Region of the Bovine Leptin Gene in Iranian Sarabi Cattle ( Iranian Bos taurus ) | Arash Javanmard - Academia.edu	www.academia.edu	0	0		
1311	chr4	95188354	95188378	3500400554	24		95188354	95188378	8421504	1	24	0	g	350040055400000003	0-24						Comparison of DNA Polymorphism of Bovine Pituitary-Specific Transcription Factor and Leptin Gene Between Iranian Bos indicus and Bos taurus Cattle &#x2026; | Arash Javanmard - Academia.edu	www.academia.edu	0	0		
1311	chr4	95188354	95188378	3500396813	24		95188354	95188378	8421504	1	24	0	g	350039681300000001	0-24						Genetic Polymorphism at the Leptin Gene in Iranian Holstein Cattle by PCR-RFLP	dwelljournals.com	0	0		
1311	chr4	95188354	95188378	3500342611	24		95188354	95188378	8421504	1	24	0	g	350034261100000001	0-24						None	www.jkmt.ir	0	0		
1311	chr4	95188354	95188378	3500321244	24		95188354	95188378	8421504	1	24	0	g	350032124400000001	0-24						FAKULTA BIOTECHNOL&#xd3;GIE A POTRAVIN&#xc1;RSTVA	kfzfbp.uniag.sk	0	0		
1311	chr4	95188820	95189150	3500051356	39		95188820	95189150	8421504	2	20,19	0,311	c,g	350005135600000000,350005135600000001,350005135600000001	0-20,0-19,0-19						association of polymorphisms of leptin gene with body weight and	www.docstoc.com	0	0		
1311	chr4	95189033	95189084	3500382776	51		95189033	95189084	8421504	1	51	0	p	350038277600015122,350038277600015124	0-48,0-48						 OB Polypeptides, Modified Forms And Derivatives 	www.docstoc.com	0	0		
1311	chr4	95189033	95189084	3500128790	51		95189033	95189084	8421504	1	51	0	p	350012879000015136,350012879000015141	0-48,0-48						US Patent # 6,309,853. Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof - Patents.com	www.patents.com	0	0		
1311	chr4	95189034	95189083	3500017328	49		95189034	95189083	8421504	1	49	0	c	350001732800000015,350001732800000016,350001732800000013	0-29,15-44,9-29					Patent	Leptin antagonists (Patent US:7307142)	Callebaut	2007	0		
1311	chr4	95189034	95189063	3500412498	29		95189034	95189063	8421504	1	29	0	c	350041249800000011,350041249800000010,350041249800000026,350041249800000027	15-44,0-29,0-29,15-44					Patent	Leptin antagonists (Patent EP:1814986)	Callebaut	2011	0		
1311	chr4	95189034	95189063	3500228383	29		95189034	95189063	8421504	1	29	0	c	350022838300000011,350022838300000010	15-44,0-29						Leptin antagonists	Callebaut	2006	0		
1311	chr4	95189036	95189084	3500404347	48		95189036	95189084	8421504	1	48	0	p	350040434700015009	0-48						OB fusion protein compositions and methods - US Patent 7112659 Description	ww.patentstorm.us	0	0		
1311	chr4	95189074	95189123	3500090886	48		95189074	95189123	8421504	2	21,27	0,22	c	350009088600000000,350009088600000002	0-21,0-27		16687645	10.1095/biolreprod.106.052605	0006-3363	Biology of Reproduction	Late but Not Early Gestational Maternal Growth Hormone Treatment Increases Fetal Adiposity in Overnourished Adolescent Sheep	Wallace	2006	4		
1311	chr4	95189096	95189119	3500448494	23		95189096	95189119	8421504	1	23	0	c	350044849400000035	18-41						Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof	Friedman	2000	0		
1311	chr4	95189127	95189151	3500009455	24		95189127	95189151	8421504	1	24	0	c	350000945500000001	0-24		18367502	10.1530/REP-07-0304	1470-1626	Reproduction	Leptin and leptin receptor in pig spermatozoa: evidence of their involvement in sperm capacitation and survival	Aquila	2008	3		
1311	chr4	95189319	95189347	3500108268	23		95189319	95189347	8421504	2	17,6	0,22	c	350010826800000205	7-30						COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE - Patent application	www.faqs.org	0	0		
1311	chr4	95189319	95189347	3500006449	23		95189319	95189347	8421504	2	17,6	0,22	c	350000644900000205	7-30						COMBINATION OF BLyS AND/OR APRIL INHIBITION AND IMMUNNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE DISEASE - Patent application	www.faqs.org	0	0		
1311	chr4	95189780	95189804	3500126483	23		95189780	95189804	8421504	2	15,8	0,16	c,g	350012648300000321,350012648300000321	4-30,4-30						MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - Patent application	www.faqs.org	0	0		
1311	chr4	95189973	95190001	3500430284	25		95189973	95190001	8421504	2	8,17	0,11	c	350043028400000012	20-45						FULL BIBLIOGRAPHIC DETAILS: File ID 92958 Type Dissertation	dare.uva.nl	0	0		
1312	chr4	95311389	95311413	3500271774	24		95311389	95311413	8421504	1	24	0	c	350027177400000000	0-24		12944494	10.1128/MCB.23.18.6702-6712.2003	0270-7306	Molecular and Cellular Biology	Targeted Disruption of the Inosine 5&#x2032;-Monophosphate Dehydrogenase Type I Gene in Mice	Gu	2003	6		
1313	chr4	95464739	95464787	3500453246	48		95464739	95464787	8421504	1	48	0	p	350045324600015007	0-48						Ashford University : ANT101 ANT101 : Developing and Limiting a Research Topic	ww.coursehero.com	0	0		CALU
1313	chr4	95464739	95464787	3500453126	48		95464739	95464787	8421504	1	48	0	p	350045312600015007	0-48						Ashford University : ANT101 ANT101 : Evaluating Research Information	ww.coursehero.com	0	0		CALU
1313	chr4	95464739	95464787	3500355216	48		95464739	95464787	8421504	1	48	0	p	350035521600015007	0-48						Ashford University : ANT101 ANT101 : Childhood Obesity Paper	ww.coursehero.com	0	0		CALU
1313	chr4	95464739	95464787	3500235071	48		95464739	95464787	8421504	1	48	0	p	350023507100015007	0-48						Syracuse : GEO 273 : Harvey 2005_A Brief History of Neoliberalism 1	ww.coursehero.com	0	0		CALU
1313	chr4	95464739	95464787	3500218822	48		95464739	95464787	8421504	1	48	0	p	350021882200015007	0-48						Ashford University : ANT101 ANT101 : Conducting Online Research	ww.coursehero.com	0	0		CALU
1313	chr4	95464790	95476215	3500335406	80		95464790	95476215	8421504	3	48,10,22	0,9568,11403	c	350033540600000025,350033540600000037	0-48,6-38						HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS	Kato	1998	0		
1313	chr4	95464796	95470114	3500112553	126		95464796	95470114	8421504	2	45,81	0,5237	p	350011255300015001,350011255300015002	0-45,0-81						ScienceDirect.com - FEBS Letters - Crocalbin: a new calcium-binding protein that is also a binding protein for crotoxin, a neurotoxic phospholipase A2	sciencedirect.com	0	0		CALU
1313	chr4	95473980	95474004	3500234859	24		95473980	95474004	8421504	1	24	0	c	350023485900000005	0-24						Proteomics characterisation of the secretome from rat pancreatic stellate cells with ATP-binding cassette transporters (ABCG2) and NCAM phenotype	loads.hindawi.com	0	0		CALU
1314	chr4	95557197	95557242	3500335102	45		95557197	95557242	8421504	1	45	0	p	350033510200015124	0-45						BiochemicalCharacterizationandN-terminomicsAnalysisof Leukolysin,theMembrane-type6MatrixMetalloprotease (MMP25)	www.jbc.org	0	0		FLNB
1314	chr4	95560082	95560107	3500222462	23		95560082	95560107	8421504	2	11,12	0,13	c	350022246200000001	0-23		23902739	10.1186/1476-4598-12-85	1476-4598	Molecular Cancer	PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling	Conley-LaComb	2013	4		
1314	chr4	95638785	95638809	3500357726	24		95638785	95638809	8421504	1	24	0	c	350035772600000024	0-24						IRF-5 HAPLOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUS - REGENTS OF THE UNIVERSITY OF MINNESOTA	www.sumobrain.com	0	0		
1314	chr4	95638788	95639818	3500207362	43		95638788	95639818	8421504	3	21,6,16	0,1007,1014	c	350020736200000141,350020736200000143	0-22,19-41						Irf-5 Haplotypes In Systemic Lupus Erythematosus 	.freshpatents.com	0	0		
1314	chr4	95670080	95672782	3500181931	25		95670080	95672782	8421504	3	3,9,13	0,2678,2689	c	350018193100000000	9-34			10.1046/j.1365-2958.2001.02394.x	1365-2958	Molecular Microbiology	MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis - Stahl - 2001 - Molecular Microbiology - Wiley Online Library	Stahl	2001	0		
1315	chr4	95694608	95694634	3500114630	25		95694608	95694634	8421504	2	18,7	0,19	c	350011463000000185	0-27						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
1315	chr4	95697533	95723643	3500118985	60		95697533	95723643	8421504	2	48,12	0,26098	p	350011898500015051	0-60						Sara Catarina Tim&#xf3;teo O S istema D ois -H&#xed;brido de L evedura para Santos Domingues Confirma&#xe7;&#xe3;o da S inaliza&#xe7;&#xe3;o de APP T ipo -Notch T he U se of Yeast Two -Hybrid Sy stem to Support the Notch -Like Signalling of A PP	ria.ua.pt/bitstre	0	0		
1315	chr4	95766746	95766776	3500235523	27		95766746	95766776	8421504	3	7,12,8	0,8,22	g	350023552300000043,350023552300000122,350023552300000031,350023552300000023,350023552300000124,350023552300000035,350023552300000027,350023552300000069,350023552300000075,350023552300000067,350023552300000077,350023552300000071,350023552300000073	3-22,3-22,3-22,3-22,3-38,3-22,3-22,3-22,3-22,3-22,3-22,3-22,3-22						METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - Patent application	www.faqs.org	0	0		
1316	chr4	95823833	95823857	3500283035	23		95823833	95823857	8421504	2	7,16	0,8	c	350028303500000008	0-23		21929751	10.1186/1477-3155-9-40	1477-3155	Journal of Nanobiotechnology	Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism	Sureban	2011	0		
1316	chr4	95823833	95823857	3500186048	23		95823833	95823857	8421504	2	7,16	0,8	c	350018604800000008	0-23		21929751	10.1186/1477-3155-9-40		Journal of Nanobiotechnology	Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism	Sripathi	2011	0		
1316	chr4	95823833	95823857	3500110272	23		95823833	95823857	8421504	2	7,16	0,8	c	350011027200000045,350011027200000121	0-23,0-23						COMPOSITIONS USEFUL FOR CANCER DETECTION AND TREATMENT, A CANCER STEM CELL MODEL, AND METHODS OF PRODUCTION AND USE THEREOF - Patent application	www.faqs.org	0	0		
1316	chr4	95861395	95861419	3500224087	24		95861395	95861419	8421504	1	24	0	c	350022408700000010	0-24						Hedgehog inhibitor assay	Toftgard	2008	0		
1316	chr4	95861395	95861419	3500096739	24		95861395	95861419	8421504	1	24	0	c	350009673900000014	0-24						Hedgehog inhibitor assay	Lauth	2012	0		
1316	chr4	95864136	95865991	3500152081	45		95864136	95865991	8421504	2	22,23	0,1832	c,g	350015208100000006,350015208100000006,350015208100000007,350015208100000007	0-22,0-22,0-23,0-23						Sonic hedgehog signaling promotes growth of oral squamous cell carcinoma cells associated with bone destruction	ww.sdclucknow.com	0	0		SMO
1316	chr4	95865968	95865992	3500315249	24		95865968	95865992	8421504	1	24	0	c	350031524900000002	21-45						Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells	-publications.com	0	0		
1316	chr4	95865968	95865992	3500267434	24		95865968	95865992	8421504	1	24	0	c	350026743400000002	21-45		14733907			Biochemical and Biophysical Research Communications	A role of activated Sonic hedgehog signaling for the cellular proliferation of oral squamous cell carcinoma cell line.	Nishimaki	2004	0		
1316	chr4	95866560	95866584	3500114441	24		95866560	95866584	8421504	1	24	0	c	350011444100000003	0-24		21189326	10.1158/0008-5472.CAN-10-2993	0008-5472	Cancer Research	TGF-&#x03b2; Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling	Johnson	2011	8		SMO
1316	chr4	95866630	95866656	3500363288	26		95866630	95866656	8421504	1	26	0	c	350036328800000034	0-26						Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling	Sauvage	2006	0		SMO
1318	chr4	96091286	96091310	3500370008	23		96091286	96091310	8421504	2	8,15	0,9	g	350037000800000016	9-33						Monomeric streptavidin muteins - Patent application	www.faqs.org	0	0		
1319	chr4	96233240	96233270	3500319848	28		96233240	96233270	8421504	2	6,22	0,8	c	350031984800000008,350031984800000006	2-30,6-33						Diseases associated with altered mitochondrial function	Anderson	2001	0		
1319	chr4	96233240	96233270	3500023223	28		96233240	96233270	8421504	2	6,22	0,8	c	350002322300000008	2-30						Modulation of mitochondrial mass and function for the treatment of diseases and for target and drug discovery	Anderson	2001	0		
1319	chr4	96246944	96259186	3500203232	26		96246944	96259186	8421504	2	15,11	0,12231	c	350020323200000010	0-26						Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity. - ResearchGate	.researchgate.net	0	0		
1319	chr4	96273683	96275597	3500409160	40		96273683	96275597	8421504	2	20,20	0,1894	c,g	350040916000000031,350040916000000031,350040916000000030,350040916000000030	0-20,0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
1319	chr4	96328749	96333535	3500304886	44		96328749	96333535	8421504	2	21,23	0,4763	c,g	350030488600000125,350030488600000125,350030488600000078,350030488600000078	0-21,0-21,0-23,0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		MIR183,MIR182
1319	chr4	96328749	96333535	3500125321	89		96328749	96333535	8421504	4	21,22,23,23	0,43,4540,4763	c,g	350012532100000109,350012532100000109,350012532100000108,350012532100000063,350012532100000048	0-21,0-21,0-22,0-23,0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIR183,MIR182
1319	chr4	96328789	96333496	3500439152	47		96328789	96333496	8421504	2	25,22	0,4685	c,g	350043915200000142,350043915200000091,350043915200000091	0-25,0-22,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR183,MIR182
1319	chr4	96328789	96328814	3500363476	25		96328789	96328814	8421504	1	25	0	c	350036347600000019	0-25						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - Patent application	www.faqs.org	0	0		MIR182
1319	chr4	96328789	96328814	3500307429	25		96328789	96328814	8421504	1	25	0	c	350030742900000019	0-25						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - YEDA RESEARCH AND DEVELOPMENT CO. LTD.	www.sumobrain.com	0	0		MIR182
1319	chr4	96328790	96328814	3500337119	24		96328790	96328814	8421504	1	24	0	c	350033711900000007	0-24						COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MELANOMA - Patent application	www.faqs.org	0	0		
1319	chr4	96328790	96328814	3500291981	24		96328790	96328814	8421504	1	24	0	c	350029198100000000	0-24						MIR-182 IN THE DIAGNOSIS AND TREATMENT OF CANCER	Chowdhury	2011	0		
1319	chr4	96328790	96328814	3500233367	24		96328790	96328814	8421504	1	24	0	c	350023336700000002	0-24						High-Resolution Pro&#xfb01;ling and Analysis of Viral and Host Small RNAs during Human Cytomegalovirus Infection	yeolab.ucsd.edu	0	0		MIR182
1319	chr4	96328790	96328814	3500162985	24		96328790	96328814	8421504	1	24	0	c	350016298500000011	0-24		22325466	10.1111/j.1742-4658.2012.08519.x	1742-4658	FEBS Journal	MicroRNA-182 targets cAMP-responsive element-binding protein&#xa0;1 and suppresses cell growth in human gastric adenocarcinoma - Kong - 2012 - FEBS Journal - Wiley Online Library	Kong	2012	0		MIR182
1319	chr4	96328792	96333535	3500423784	45		96328792	96333535	8421504	2	22,23	0,4720	c	350042378400000064,350042378400000065	0-22,0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR183,MIR182
1319	chr4	96328792	96333535	3500400478	45		96328792	96333535	8421504	2	22,23	0,4720	c	350040047800000189,350040047800000190	0-22,0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		MIR183,MIR182
1319	chr4	96328792	96333535	3500389139	66		96328792	96333535	8421504	3	22,22,22	0,4498,4721	c	350038913900000016,350038913900000084,350038913900000017	22-44,22-44,22-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		
1319	chr4	96328792	96333535	3500357539	45		96328792	96333535	8421504	2	22,23	0,4720	c,g	350035753900000189,350035753900000189,350035753900000190	0-22,0-22,0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		MIR183,MIR182
1319	chr4	96328792	96333535	3500306561	66		96328792	96333535	8421504	3	22,22,22	0,4498,4721	c	350030656100000016,350030656100000083,350030656100000017	22-44,22-44,22-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
1319	chr4	96328792	96333535	3500257436	66		96328792	96333535	8421504	3	22,22,22	0,4498,4721	c	350025743600000016,350025743600000083,350025743600000017	22-44,22-44,22-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
1319	chr4	96328792	96333535	3500232262	66		96328792	96333535	8421504	3	22,22,22	0,4498,4721	c,g	350023226200000016,350023226200000083,350023226200000083,350023226200000017	22-44,22-44,0-22,22-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
1319	chr4	96328792	96333535	3500210973	45		96328792	96333535	8421504	2	22,23	0,4720	c	350021097300000189,350021097300000190	0-22,0-23						Microrna molecules	Tuschl	2002	0		MIR183,MIR182
1319	chr4	96333242	96333320	3500185291	78		96333242	96333320	8421504	1	78	0	c	350018529100000119,350018529100000118	0-78,0-23						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR183
1319	chr4	96333247	96333312	3500147254	45		96333247	96333312	8421504	2	22,23	0,42	c	350014725400000000,350014725400000016	0-22,0-23						hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas	-publications.com	0	0		MIR183
1319	chr4	96333288	96333313	3500013455	25		96333288	96333313	8421504	1	25	0	c	350001345500000074	20-45						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		
1319	chr4	96333289	96333312	3500065300	23		96333289	96333312	8421504	1	23	0	c	350006530000000005	0-23						Die Funktion von microRNAs bei der Entstehung und Verarbeitung von Schmerzen	.uni-frankfurt.de	0	0		MIR183
1319	chr4	96333511	96333536	3500343205	25		96333511	96333536	8421504	1	25	0	c	350034320500000001	0-25						The miR-183/Taok1 Target Pair Is Implicated in Cochlear Responses to Acoustic Trauma. - ResearchGate	.researchgate.net	0	0		MIR183
1319	chr4	96333511	96333536	3500192658	25		96333511	96333536	8421504	1	25	0	c	350019265800000001	0-25		23472202	10.1371/journal.pone.0058471	1932-6203	PLOS ONE	PLOS ONE: The miR-183/Taok1 Target Pair Is Implicated in Cochlear Responses to Acoustic Trauma	Patel	2013	4		MIR183
1319	chr4	96333512	96333535	3500287752	23		96333512	96333535	8421504	1	23	0	c	350028775200000028	0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		MIR183
1319	chr4	96333512	96333535	3500244257	23		96333512	96333535	8421504	1	23	0	c	350024425700000047	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR183
1319	chr4	96333512	96333535	3500131966	23		96333512	96333535	8421504	1	23	0	c	350013196600000047	0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR183
1319	chr4	96333512	96333535	3500105686	23		96333512	96333535	8421504	1	23	0	c	350010568600000015,350010568600000001	0-23,0-22						miR-183&#x5728;&#x809d;&#x764c;&#x7ec6;&#x80de;&#x4e2d;&#x7684;&#x529f;&#x80fd;&#x53ca;&#x4eba;&#x5de5;miRNA&#x7c07;&#x8868;&#x8fbe;&#x8f7d;&#x4f53;&#x7684;&#x6784;&#x5efa;&#x7814;&#x7a76; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		MIR183
1320	chr4	96388489	96429578	3500044671	127		96388489	96429578	8421504	6	5,33,18,12,4,55	0,4362,21668,21687,40257,41034	c	350004467100000009,350004467100000012	0-64,0-63						A human ubiquitin-conjugating enzyme homologous to yeast UBC8. - ResearchGate	.researchgate.net	0	0		
1322	chr4	96726292	96726322	3500194623	25		96726292	96726322	8421504	4	5,4,11,5	0,6,11,25	c	350019462300000010	13-38						Regulation of Phospholipase C and Plasma Membrane Phosphatidylinositol 4,5-bisphosphate in Insulin-Secreting Cells	u.diva-portal.org	0	0		
165	chr4	96844864	96869317	3500097991	56		96844864	96869317	8421504	4	18,3,1,34	0,592,22827,24419	c	350009799100000023,350009799100000064	27-48,9-44						Therapy	Blumenkopf	1995	0		
1324	chr4	96863452	96864139	3500093196	234		96863452	96864139	8421504	2	78,156	0,531	p	350009319600015001	0-234						PANDIT - PF02244	www.ebi.ac.uk	0	0		
1324	chr4	96864166	96869462	3500138028	912		96864166	96869462	8421504	9	51,102,102,111,33,49,200,85,179	0,296,1133,1431,2128,2170,2728,3441,5117	p	350013802800015013,350013802800015021,350013802800015029,350013802800015038,350013802800015046	0-201,0-198,0-198,0-171,0-144						UNIVERSITAT AUTANOMA DE BARCELONA Departament de BioquAmica i Biologia Molecul	ddd.uab.cat	0	0		
1324	chr4	96864537	96869384	3500065768	438		96864537	96869384	8421504	12	27,18,45,45,45,37,2,90,18,18,48,45	0,762,783,1123,1757,1811,2357,2362,2458,2482,2503,4802	p	350006576800015109,350006576800015110,350006576800015113,350006576800015114,350006576800015115,350006576800015119	0-45,0-45,0-90,0-150,0-66,0-45						Baboon TAFI polypeptides - US Patent 7189829 Description	ww.patentstorm.us	0	0		
1324	chr4	96867691	96869452	3500042999	75		96867691	96869452	8421504	3	1,34,40	0,1592,1721	c	350004299900000064,350004299900000041	9-44,1-41					Patent	Cell-targeting molecule comprising a mutant human carboxypeptidase A (Patent US:6140100)	Blumenkopf	2000	0		
1324	chr4	96890532	96890559	3500278276	25		96890532	96890559	8421504	2	5,20	0,7	c	350027827600000015	7-32						UNIVERSITY OF HA.WAI UBRARY	.manoa.hawaii.edu	0	0		
165	chr4	96985104	96996651	3500460691	1005		96985104	96996651	8421504	12	26,155,80,78,137,59,41,71,102,77,64,115	0,3210,5164,5652,5853,6122,7274,7830,8150,9574,10484,11432	p	350046069100015017	0-1005						Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph	Cotsarelis	2011	0		
1324	chr4	96985110	96991002	3500028009	41		96985110	96991002	8421504	2	20,21	0,5871	c,g	350002800900000022,350002800900000022,350002800900000023,350002800900000023	0-20,0-20,0-21,0-21						Putative imprinted gene expression in uniparental bovine embryo models	library.uq.edu.au	0	0		
1324	chr4	96989127	96989185	3500439152	45		96989127	96989185	8421504	2	23,22	0,36	c	350043915200000143,350043915200000226	0-23,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR335
1324	chr4	96989127	96989158	3500460589	30		96989127	96989158	8421504	2	26,4	0,27	g	350046058900000013	86-116						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Soreq	2010	0		
1324	chr4	96989127	96989158	3500371873	30		96989127	96989158	8421504	2	26,4	0,27	c,g	350037187300000013,350037187300000143	86-116,0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		
1324	chr4	96989127	96989158	3500304886	30		96989127	96989158	8421504	2	26,4	0,27	c,g	350030488600000119,350030488600000119,350030488600000013	0-23,0-23,86-116						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		
1324	chr4	96989127	96989158	3500256738	30		96989127	96989158	8421504	2	26,4	0,27	g	350025673800000013	86-116						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2007	0		
1324	chr4	96989127	96989158	3500246068	30		96989127	96989158	8421504	2	26,4	0,27	g	350024606800000013	86-116						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2008	0		
1324	chr4	96989127	96989158	3500208886	30		96989127	96989158	8421504	2	26,4	0,27	g	350020888600000013	86-116						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL	Soreq	2008	0		
1324	chr4	96989127	96989150	3500423784	23		96989127	96989150	8421504	1	23	0	c,g	350042378400000119,350042378400000119	0-23,0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR335
1324	chr4	96989127	96989150	3500271171	23		96989127	96989150	8421504	1	23	0	c,g	350027117100000018,350027117100000018,350027117100000036,350027117100000036	0-23,0-23,0-23,0-23						Method for Categorizing Samples Containing Spermatozoa by Molecular Profiling - Patent application	www.faqs.org	0	0		MIR335
1324	chr4	96989127	96989150	3500107408	23		96989127	96989150	8421504	1	23	0	c	350010740800000017,350010740800000016	12-35,12-35						Compositions and methods relating to mir-31	Weinberg	2011	0		MIR335
1325	chr4	96995638	96996546	3500399156	24		96995638	96996546	8421504	2	14,10	0,898	c	350039915600000007	24-48						Senescence is accelerated through donor cell specificity in cloned pigs	-publications.com	0	0		MEST
1325	chr4	96998035	96998318	3500303839	281		96998035	96998318	8421504	2	46,235	0,48	c	350030383900000001	311-592						ASSESSMENT OF MYCOBACTERIUM INFECTION - THE UNVERSITY OF SYDNEY	www.sumobrain.com	0	0		
1325	chr4	97049667	97049694	3500150447	23		97049667	97049694	8421504	2	17,6	0,21	c	350015044700000010	0-24						Method For Sorting Antifungal Molecules Acting On The Glucanosyltransferase Activity 	.freshpatents.com	0	0		
1327	chr4	97322181	97322746	3500139175	87		97322181	97322746	8421504	2	6,81	0,484	g	350013917500000009	6-93						Functional characterisation of microRNA-containing Argonaute Protein complexes	b.uni-muenchen.de	0	0		
1327	chr4	97322290	97322354	3500337119	64		97322290	97322354	8421504	1	64	0	c,g	350033711900000015,350033711900000015,350033711900000008	0-64,0-64,0-22						COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MELANOMA - Patent application	www.faqs.org	0	0		MIR29B1
1327	chr4	97322290	97322354	3500185291	64		97322290	97322354	8421504	1	64	0	c,g	350018529100000085,350018529100000085,350018529100000084,350018529100000084	0-64,0-64,0-22,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR29B1
1327	chr4	97322291	97322696	3500363476	45		97322291	97322696	8421504	2	22,23	0,382	c	350036347600000026,350036347600000025	0-22,0-23						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - Patent application	www.faqs.org	0	0		MIR29B1
1327	chr4	97322291	97322696	3500261674	43		97322291	97322696	8421504	2	22,21	0,384	c	350026167400000006,350026167400000007	20-42,23-44		23764849	10.1038/cddis.2013.184	false	Cell Death & Disease	miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development	Wei	2013	0		
1327	chr4	97322291	97322696	3500195089	43		97322291	97322696	8421504	2	22,21	0,384	c	350019508900000006,350019508900000007	20-42,23-44		23764849	10.1038/cddis.2013.184	false	Cell Death & Disease	miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development	Wei	2013	0		
1327	chr4	97322292	97322696	3500450448	45		97322292	97322696	8421504	2	21,24	0,380	c,g	350045044800000000,350045044800000000,350045044800000017,350045044800000017,350045044800000023,350045044800000023,350045044800000061,350045044800000040,350045044800000055,350045044800000028,350045044800000036,350045044800000059	0-21,0-21,0-21,0-21,0-19,0-19,0-23,0-23,0-23,0-23,0-22,0-22						Compositions And Methods For Inhibiting Or Reversing Fibrotic Disorders 	.freshpatents.com	0	0		
1327	chr4	97322292	97322696	3500357539	45		97322292	97322696	8421504	2	22,23	0,381	c,g	350035753900000032,350035753900000032,350035753900000101,350035753900000101,350035753900000139	0-22,0-22,0-22,0-22,0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		
1327	chr4	97322292	97322696	3500244257	44		97322292	97322696	8421504	2	21,23	0,381	c,g	350024425700000096,350024425700000096,350024425700000097,350024425700000098	0-21,0-21,0-23,0-20						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR29B1
1327	chr4	97322292	97322696	3500131966	44		97322292	97322696	8421504	2	21,23	0,381	c,g	350013196600000096,350013196600000096,350013196600000097,350013196600000098	0-21,0-21,0-23,0-20						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
1327	chr4	97322664	97322746	3500184233	82		97322664	97322746	8421504	1	82	0	g	350018423300000000	0-82						Use of miR-29 for Cell protection	Deshmukh	2011	0		MIR29B1
1327	chr4	97322673	97322696	3500371873	23		97322673	97322696	8421504	1	23	0	c	350037187300000081	0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		
1327	chr4	97322673	97322696	3500304886	23		97322673	97322696	8421504	1	23	0	c	350030488600000057	0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		
1336	chr4	98474675	98474704	3500292413	23		98474675	98474704	8421504	3	11,6,6	0,13,23	g	350029241300000015	11-34						TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling 2006&#x5e74;&#x7b2c;116&#x5377;&#x7b2c;12&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1336	chr4	98519744	98519771	3500214542	26		98519744	98519771	8421504	2	21,5	0,22	g	350021454200000007,350021454200000005	0-25,1-25						Adipogenic adenoviruses as a biomarker for disease	Atkinson	2009	0		
1336	chr4	98519744	98519770	3500108373	25		98519744	98519770	8421504	2	21,4	0,22	g	350010837300000007	0-25						Adipogenic adenoviruses as a biomarker for disease	Atkinson	2008	0		
1336	chr4	98519746	98519771	3500265443	24		98519746	98519771	8421504	2	19,5	0,20	g	350026544300000005	1-25						Adipogenic adenoviruses as a biomarker for disease	Atkinson	2007	0		
1336	chr4	98519746	98519771	3500188383	24		98519746	98519771	8421504	2	19,5	0,20	g	350018838300000005	1-25						ADIPOGENIC ADENOVIRUSES AS A BIOMARKER FOR DISEASE	Atkinson	2008	0		
1339	chr4	98928059	98928090	3500378617	28		98928059	98928090	8421504	2	18,10	0,21	c	350037861700000034	8-36						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins	Kieliszewski	2003	0		
1339	chr4	98928059	98928090	3500373336	28		98928059	98928090	8421504	2	18,10	0,21	c	350037333600000034	8-36						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins - US Patent 7378506 Description	ww.patentstorm.us	0	0		
1339	chr4	98928059	98928090	3500098931	28		98928059	98928090	8421504	2	18,10	0,21	c	350009893100000034	8-36					Patent	Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins (Patent US:7378506)	Kieliszewski	2008	0		
1340	chr4	99054515	99054544	3500392286	25		99054515	99054544	8421504	3	6,14,5	0,7,24	g	350039228600000000,350039228600000001	7-38,1-32		14570882	10.1074/jbc.M309891200	0021-9258	Journal of Biological Chemistry	Molecular Basis of the Amylose-like Polymer Formation Catalyzed by Neisseria polysaccharea Amylosucrase	Albenne	2004	5		
1342	chr4	99261170	99261196	3500013095	25		99261170	99261196	8421504	2	16,9	0,17	g	350001309500000296	0-25						Sequenciamento do Genoma Completo e Express&#xe3;o Heter&#xf3;loga da Capa Prot&#xe9;ica do Marafivirus Associado &#xe0; Morte S&#xfa;bita dos Citros	www.bdtd.ucb.br	0	0		
1342	chr4	99331649	99331680	3500434184	24		99331649	99331680	8421504	3	11,8,5	0,16,26	g	350043418400000104	0-24						US Patent # 6,902,922. Subtilisin variants - Patents.com	www.patents.com	0	0		
1343	chr4	99387142	99387166	3500214539	23		99387142	99387166	8421504	2	4,19	0,5	g	350021453900000000	0-24		20410313	10.1099/vir.0.020255-0	0022-1317	Journal of General Virology	High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages	Wu	2010	3		
1349	chr4	100227810	100227835	3500131252	23		100227810	100227835	8421504	3	13,6,4	0,14,21	g	350013125200000000	0-26		19542509	10.2527/jas.2008-1446	0021-8812	Journal of Animal Science	Effects of dietary changes and yeast culture (Saccharomyces cerevisiae) on rumen microbial fermentation of Holstein heifers	Moya	2009	2		
1352	chr4	100536454	100536478	3500013299	23		100536454	100536478	8421504	2	14,9	0,15	g	350001329900000305	6-29						Human Antibodies As Detection Reagents 	.freshpatents.com	0	0		
1356	chr4	101115236	101115262	3500251793	24		101115236	101115262	8421504	2	17,7	0,19	g	350025179300000003	11-35						Downregulation of Soluble Guanylyl Cyclase in Young and Aging Spontaneously Hypertensive Rats	s.ahajournals.org	0	0		
1356	chr4	101124131	101128138	3500181711	39		101124131	101128138	8421504	2	19,20	0,3987	c	350018171100000025,350018171100000024	0-19,0-20						REPRODUCTION	uction-online.org	0	0		
1356	chr4	101124131	101128138	3500133737	39		101124131	101128138	8421504	2	19,20	0,3987	c	350013373700000012,350013373700000011	0-19,0-20						REPRODUCTION	uction-online.org	0	0		
1356	chr4	101148130	101148155	3500104998	23		101148130	101148155	8421504	3	11,8,4	0,12,21	g	350010499800000129	4-27						Indoleamine 2,3-Dioxygenase-2 - Patent application	www.faqs.org	0	0		
1360	chr4	101708098	101708128	3500019404	25		101708098	101708128	8421504	2	14,11	0,19	g	350001940400000065	0-25						Plasmid maintenance system for antigen delivery	Galen	1999	0		
1361	chr4	101735512	101735563	3500389626	51		101735512	101735563	8421504	1	51	0	p	350038962600015003	0-51						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		CALD1
1361	chr4	101735512	101735563	3500061337	51		101735512	101735563	8421504	1	51	0	p	350006133700015131,350006133700015015	0-48,0-51						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		CALD1
1362	chr4	101946006	101946035	3500424192	25		101946006	101946035	8421504	2	6,19	0,10	c	350042419200000001	17-42						HEAT SHOCK PROTEIN 70B&#x2019; (HSP70B&#x2019;) EXPRESSION AND RELEASE IN RESPONSE TO HUMAN OXIDIZED LDL IMMUNE COMPLEXES IN MACROPHAGES 1, Farzan Soodavar1 2 3,4 1	www.jbc.org	0	0		
1362	chr4	101946006	101946035	3500280889	25		101946006	101946035	8421504	2	6,19	0,10	c	350028088900000003	17-42						Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro	www.fasebj.org	0	0		
1366	chr4	102370340	102371482	3500408002	24		102370340	102371482	8421504	3	13,2,9	0,1126,1133	c	350040800200000114	4-28						Actin-binding polypeptides and nucleic acids encoding the same	Luna	1997	0		
1366	chr4	102448229	102448256	3500117311	23		102448229	102448256	8421504	3	6,11,6	0,8,21	c	350011731100000001	5-29						CHIMERIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1366	chr4	102477764	102477791	3500281273	24		102477764	102477791	8421504	2	6,18	0,9	g	350028127300000001	13-39						Gentechnische herstellung von neukombinierten plasmiden fuer die produktion von humanem adrenocorticotropen horman (acth) und davon abgeleiteten derivaten durch enzymatische spaltung primaer synthetisierter fusionsproteine Genetic production of recombined	Boidol	1989	0		
1368	chr4	102666562	102666588	3500151037	23		102666562	102666588	8421504	2	10,13	0,13	g	350015103700000104	19-42						Acylated insulin	Havelund	1997	0		
1368	chr4	102705331	102705657	3500375699	325		102705331	102705657	8421504	2	20,305	0,21	g	350037569900000042	0-325						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1368	chr4	102731896	102732785	3500391427	60		102731896	102732785	8421504	2	12,48	0,841	p	350039142700015010	0-60						Assays - Patent application	www.faqs.org	0	0		LUZP6
1368	chr4	102732740	102732785	3500208501	45		102732740	102732785	8421504	1	45	0	p	350020850100015012	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		LUZP6
1368	chr4	102732740	102732785	3500189065	45		102732740	102732785	8421504	1	45	0	p	350018906500015014	0-45						Assays	Schofield	2005	0		LUZP6
1369	chr4	102798404	102798427	3500009502	23		102798404	102798427	8421504	1	23	0	g	350000950200000018	3-27						Nucleic acids and methods for environmental monitoring	Berghof	2011	0		
1371	chr4	103110077	103110101	3500292035	23		103110077	103110101	8421504	2	4,19	0,5	g	350029203500000070	0-23					Patent	Complementing cell lines (Patent CA:2428739)	Vogels	2010	0		
1372	chr4	103185205	103185229	3500155898	23		103185205	103185229	8421504	2	19,4	0,20	g	350015589800000237	11-39						Heparin-binding growth factors for gene therapy and anterior eye disorders	Sosnowski	1995	0		
1375	chr4	103624616	103624675	3500176000	42		103624616	103624675	8421504	2	20,22	0,37	c,g	350017600000000053,350017600000000053,350017600000000060,350017600000000060,350017600000000082	0-20,0-20,0-20,0-20,0-22						MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY - Patent application	www.faqs.org	0	0		
1376	chr4	103740861	103740886	3500327446	25		103740861	103740886	8421504	1	25	0	c	350032744600000040	9-34						NOVEL ULTRASENSITIVE CELL BASED SENSORS AND USES THEREOF	Paz-rojas	2010	0		MIR490
1376	chr4	103741258	103742067	3500440085	44		103741258	103742067	8421504	2	22,22	0,787	c,g	350044008500000000,350044008500000001,350044008500000001	0-22,0-22,0-22		10712263			American Journal of Physiology - Gastrointestinal and Liver Physiology	Coupling of M2 muscarinic receptors to ERK MAP kinases and caldesmon phosphorylation in colonic smooth muscle	Cook	2000	0		MIR490
1376	chr4	103741258	103742067	3500193210	44		103741258	103742067	8421504	2	22,22	0,787	c,g	350019321000000000,350019321000000001,350019321000000001	0-22,0-22,0-22		10712263			American Journal of Physiology - Gastrointestinal and Liver Physiology	Coupling of M2 muscarinic receptors to ERK MAP kinases and caldesmon phosphorylation in colonic smooth muscle	Cook	2000	0		MIR490
1376	chr4	103741322	103741533	3500343895	40		103741322	103741533	8421504	2	20,20	0,191	c,g	350034389500000000,350034389500000000,350034389500000001	0-20,0-20,0-20		23490231	10.1111/jcmm.12038	1582-4934	Journal of Cellular and Molecular Medicine	M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells - Ferretti - 2013 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Ferretti	2013	0		MIR490
1376	chr4	103741357	103741954	3500274997	98		103741357	103741954	8421504	2	66,32	0,565	p,c	350027499700015002,350027499700000001	0-66,20-52						Parathyroid Ca2+-conducting currents are modulated by muscarinic receptor agonists and antagonists	g.library.pcc.edu	0	0		
1376	chr4	103741357	103741586	3500069492	95		103741357	103741586	8421504	2	75,20	0,209	p,c,g	350006949200015003,350006949200000007,350006949200000007	0-75,0-20,0-20						Autoimmunity in complex regional pain syndrome	eb.uni-giessen.de	0	0		MIR490
1376	chr4	103741450	103742057	3500378152	45		103741450	103742057	8421504	2	23,22	0,585	c	350037815200000004,350037815200000005	9-32,7-29				0798-0469	Revista de la Facultad de Medicina	Revista de la Facultad de Medicina - Clonamiento Molecular de las Asas Intracelulares de los receptores Muscar&#xed;nicos M2 y M3 implicadas en la interacci&#xf3;n con Prote&#xed;nas G en el M&#xfa;sculo Liso Traqueal de Bovino	Bruges	2002	0		
1376	chr4	103741468	103741516	3500230939	48		103741468	103741516	8421504	1	48	0	p	350023093900015015	0-48						Identification Of Ligands By Selective Amplification Of Cells Transfected With Receptors 	.freshpatents.com	0	0		MIR490
1376	chr4	103741471	103741516	3500188848	45		103741471	103741516	8421504	1	45	0	p	350018884800015018	0-45						IDENTIFICATION OF LIGANDS BY SELECTIVE AMPLIFICATION OF CELLS TRANSFECTED WITH RECEPTORS - Patent application	www.faqs.org	0	0		MIR490
1376	chr4	103741712	103742047	3500060203	40		103741712	103742047	8421504	2	21,19	0,316	c,g	350006020300000008,350006020300000008,350006020300000005	0-22,0-22,0-19		8663391	10.1074/jbc.271.29.17476	0021-9258	Journal of Biological Chemistry	Identification and Molecular Characterization of a m5 Muscarinic Receptor in A2058 Human Melanoma Cells	Kohn	1996	5		MIR490
1377	chr4	103874244	103901135	3500354612	504		103874244	103901135	8421504	4	53,162,174,115	0,22796,25497,26776	p,c,g	350035461200015035,350035461200015033,350035461200015049,350035461200000009,350035461200015041,350035461200015031,350035461200015026,350035461200015029,350035461200015040,350035461200015050,350035461200000008,350035461200000008	0-78,0-138,0-75,0-19,0-102,0-141,0-348,0-129,0-81,0-63,0-19,0-19						UNIVERSITE PARIS 12 &#x2013;VAL DE MARNE &#xc9;COLE DOCTORALE SCIENCES DE LA VIE ET DE LA SANTE	doxa.u-pec.fr	0	0		PTN
1377	chr4	103897063	103897087	3500108068	24		103897063	103897087	8421504	1	24	0	c	350010806800000249	0-24						Protein amf-1 to amf-10 and nucleic acids encoding the same	Burgess	2001	0		
1377	chr4	103897192	103899782	3500172455	45		103897192	103899782	8421504	3	10,12,23	0,2549,2567	c	350017245500000015,350017245500000014	0-22,0-23						Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation	hives-ouvertes.fr	0	0		
1379	chr4	104199345	104199374	3500382910	24		104199345	104199374	8421504	2	9,15	0,14	g	350038291000000193	0-28					Patent	DNA expression systems based on alphaviruses (Patent US:5739026)	Garoff	1998	0		
1381	chr4	104427655	104427680	3500186557	23		104427655	104427680	8421504	2	5,18	0,7	g	350018655700001419	5-28						Oligonucleotide for Detection of a Microorganism, Diagnostic Kits and Methods for Detection of Microorganisms Using the Oligonucleotide - Patent application	www.faqs.org	0	0		
1382	chr4	104482243	104482271	3500091444	25		104482243	104482271	8421504	2	14,11	0,17	g	350009144400000044	1-26						PROTEINACEOUS COMPOUNDS - Patent application	www.faqs.org	0	0		
1383	chr4	104604944	104621147	3500191222	258		104604944	104621147	8421504	4	7,69,59,123	0,12849,14652,16080	p	350019122200015009	0-258						Basic leucine zipper transcription factor Hac1 binds DNA in two distinct modes as revealed by microfluidic analyses	alterlab.ucsf.edu	0	0		CREB3L2
1389	chr4	105438694	105438731	3500300591	32		105438694	105438731	8421504	3	15,6,11	0,18,26	g	350030059100000834	0-36						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
1396	chr4	106420180	106420203	3500437082	23		106420180	106420203	8421504	1	23	0	g	350043708200000045	14-37						US Patent # 7,186,551. 3'-phosphoadenosine -5'-phosphosulfate synthetase 2 (PAPSS2) sequence variants - Patents.com	www.patents.com	0	0		
1397	chr4	106471541	106471585	3500367934	44		106471541	106471585	8421504	1	44	0	c	350036793400000112,350036793400000113	0-22,0-22						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		TBXAS1
1399	chr4	106706782	106706808	3500274523	23		106706782	106706808	8421504	2	18,5	0,21	g	350027452300000012	17-40						Chromosome 17q25 genes, RHBDF2 and CYGB in ovarian cancer	-publications.com	0	0		
1400	chr4	106899595	106899619	3500147329	24		106899595	106899619	8421504	1	24	0	c	350014732900000015	0-24						Nonneutral Evolution of the Transcribed Pseudogene Makorin1-p1 in Mice	www.umich.edu	0	0		
1400	chr4	106915359	106915407	3500120381	48		106915359	106915407	8421504	1	48	0	p	350012038100015080	105-153						<Html><Title> Complet list of 1mpf hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		BRD3
1402	chr4	107128022	107128139	3500160938	39		107128022	107128139	8421504	2	19,20	0,97	g	350016093800000071,350016093800000070	0-19,0-20						Utility Of Ret Mutant In Diagnosis And Treatment Of Melanoma 	.freshpatents.com	0	0		BRAF
1402	chr4	107128022	107128139	3500013021	39		107128022	107128139	8421504	2	19,20	0,97	g	350001302100000038,350001302100000017,350001302100000016,350001302100000037	0-19,0-19,0-20,0-20						UTILITY OF RET MUTANT IN DIAGNOSIS AND TREATMENT OF MELANOMA - Patent application	www.faqs.org	0	0		BRAF
1402	chr4	107128124	107128154	3500076643	30		107128124	107128154	8421504	1	30	0	g	350007664300000064	26-56						Diagnostic test for susceptibility to b-raf kinase inhibitors	L*Wu 	2009	0		
1402	chr4	107128199	107128222	3500443579	23		107128199	107128222	8421504	1	23	0	g	350044357900000009	0-23						Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation. - ResearchGate	.researchgate.net	0	0		
1402	chr4	107128199	107128222	3500388819	23		107128199	107128222	8421504	1	23	0	g	350038881900000000	0-23						UNIVERSIDAD DE GRANADA DEPARTAMENTO DE FISIOLOG&#xcd;A	hera.ugr.es	0	0		
1403	chr4	107240920	107240948	3500430558	23		107240920	107240948	8421504	2	13,10	0,18	g	350043055800000066	0-29						Domain II Mutants Of Anthrax Lethal Factor	Duesbery	2005	0		
1407	chr4	107780382	107780407	3500106839	25		107780382	107780407	8421504	1	25	0	g	350010683900000084	17-42						Plant having improved tolerance to various environmental stresses, method of constructing the same and polyamine metabolism-relating enzyme gene - US Patent 7238861 Description	ww.patentstorm.us	0	0		
1409	chr4	108117696	108117738	3500449936	42		108117696	108117738	8421504	1	42	0	c	350044993600000013	0-42						Major taste loss in carnivorous mammals	www.pnas.org	0	0		
1409	chr4	108117696	108117738	3500425014	42		108117696	108117738	8421504	1	42	0	c	350042501400000013	0-42						Major taste loss in carnivorous mammals	www.pnas.org	0	0		
1411	chr4	108304999	108313991	3500444428	63		108304999	108313991	8421504	3	36,14,13	0,7978,8979	c	350044442800000037,350044442800000031	0-36,0-27						MAMMALIAN CELL MEMBRANE PROTEINS; RELATED REAGENTS - Patent application	www.faqs.org	0	0		
1411	chr4	108304999	108313991	3500406253	63		108304999	108313991	8421504	3	36,14,13	0,7978,8979	c	350040625300000037,350040625300000031	0-36,0-27						MAMMALIAN CELL MEMBRANE PROTEINS; RELATED REAGENTS - Patent application	www.faqs.org	0	0		
1411	chr4	108304999	108313991	3500233350	63		108304999	108313991	8421504	3	36,14,13	0,7978,8979	c	350023335000000037,350023335000000031	0-36,0-27						Mammalian cell membrane proteins; related reagents	Bakker	2000	0		
1411	chr4	108304999	108313991	3500015008	63		108304999	108313991	8421504	3	36,14,13	0,7978,8979	c	350001500800000037,350001500800000031	0-36,0-27						MDL-1 polypeptides	Bakker	2004	0		
1411	chr4	108304999	108305035	3500106013	36		108304999	108305035	8421504	1	36	0	c	350010601300000037	0-36						Nucleic acids encoding mammalian cell membrane protein MDL-1 - Patent # 6416973 - PatentGenius	.patentgenius.com	0	0		
1413	chr4	108646207	108649026	3500273603	687		108646207	108649026	8421504	4	147,137,254,149	0,681,1504,2670	p	350027360300015027,350027360300015013,350027360300015055,350027360300015041,350027360300015026,350027360300015012,350027360300015054,350027360300015040,350027360300015025,350027360300015011,350027360300015053,350027360300015039,350027360300015024,350027360300015010,350027360300015052,350027360300015038,350027360300015023,350027360300015009,350027360300015051,350027360300015037,350027360300015022,350027360300015008,350027360300015050,350027360300015036,350027360300015021,350027360300015007,350027360300015049,350027360300015035,350027360300015020,350027360300015006,350027360300015048,350027360300015034,350027360300015019,350027360300015005,350027360300015047,350027360300015033,350027360300015018,350027360300015004,350027360300015046,350027360300015032,350027360300015017,350027360300015003,350027360300015045,350027360300015031,350027360300015016,350027360300015002,350027360300015044,350027360300015030,350027360300015015,350027360300015001,350027360300015043,350027360300015029,350027360300015014,350027360300015042	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,6-51,3-48						&#x30a6;&#x30b7;&#x30c8;&#x30ea;&#x30d7;&#x30b7;&#x30f3;&#x304a;&#x3088;&#x3073;&#x30c8;&#x30ea;&#x30d7;&#x30b7;&#x30ce;&#x30fc;&#x30b2;&#x30f3;&#x306e;&#x767a;&#x73fe;&#x30d9;&#x30af;&#x30bf;&#x30fc;&#x306a;&#x3089;&#x3073;&#x306b;&#x8a72;&#x30d9;&#x30af	www.patentjp.com	0	0		
1413	chr4	108646318	108646906	3500278687	54		108646318	108646906	8421504	2	36,18	0,570	p	350027868700015016	0-54						Molecular Cloning and Characterization of Esterase-6, a Serine Hydrolase of Drosophila	www.jstor.org	0	0		
1413	chr4	108646330	108646909	3500292389	45		108646330	108646909	8421504	2	24,21	0,558	p	350029238900015075	0-45						B b G Comparing Sequences	www.dartmouth.edu	0	0		
1413	chr4	108646343	108646901	3500404568	24		108646343	108646901	8421504	2	11,13	0,545	c	350040456800000094	5-29						Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon - US Patent 7700341 Description	ww.patentstorm.us	0	0		
1413	chr4	108647805	108647874	3500423760	69		108647805	108647874	8421504	1	69	0	p	350042376000015006	0-69						Biological Sequence Similarity Matching Using Dynamic Programming	kopnicky.com	0	0		
1415	chr4	108799404	108799431	3500072761	27		108799404	108799431	8421504	1	27	0	g	350007276100000003	0-27						&#x4e3b;&#x9898;&#xff1a;CML | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1415	chr4	108827017	108827044	3500416294	27		108827017	108827044	8421504	1	27	0	g	350041629400000052	0-27						Mig-7 As A Specific Anticancer Target 	.freshpatents.com	0	0		TRB
1415	chr4	108827017	108827044	3500156776	27		108827017	108827044	8421504	1	27	0	g	350015677600000007,350015677600000021	0-27,0-27						MAGE-A3 PEPTIDES PRESENTED BY HLA-DR1 MOLECULES - Patent application	www.faqs.org	0	0		TRB
1419	chr4	109403778	109407488	3500346135	741		109403778	109407488	8421504	5	40,160,254,137,150	0,1025,2556,3187,3560	p,c,g	350034613500000024,350034613500000010,350034613500000010,350034613500000000,350034613500015041,350034613500000001,350034613500015042,350034613500015043,350034613500000002,350034613500000002,350034613500000003,350034613500000003,350034613500015045,350034613500015046,350034613500000004,350034613500000005,350034613500000006,350034613500000007,350034613500000007,350034613500015052,350034613500015053,350034613500000008	0-741,3-23,3-23,3-58,0-45,0-100,0-45,0-45,0-100,0-100,0-100,0-100,0-45,0-45,0-100,0-94,0-100,0-100,0-100,0-45,0-45,0-100						TREATMENT SOLUTION, METHOD FOR PRETREATMENT, METHOD FOR ACQUIRING INFORMATION AND METHOD FOR DETECTION - Patent application	www.faqs.org	0	0		
1419	chr4	109403778	109407344	3500275568	405		109403778	109407344	8421504	7	40,8,108,60,46,137,6	0,1025,1057,2611,2764,3187,3560	p	350027556800015014,350027556800015015,350027556800015022,350027556800015030,350027556800015038,350027556800015044	0-48,0-54,0-54,0-60,9-150,0-48						Characterization of the specificity of human neutrophil elastase for Shigella flexneri virulence factors	edoc.hu-berlin.de	0	0		
1419	chr4	109407386	109407461	3500292389	75		109407386	109407461	8421504	1	75	0	p	350029238900015039	0-75						B b G Comparing Sequences	www.dartmouth.edu	0	0		
1419	chr4	109419365	109420623	3500399368	93		109419365	109420623	8421504	2	45,48	0,1210	p	350039936800015070,350039936800015078,350039936800015131	0-45,0-45,0-45						HBV EPITOPE REACTIVE EXOGENOUS T CELL RECEPTOR (TCR) AND USES THEREOF - Patent application	www.faqs.org	0	0		
1419	chr4	109419368	109419584	3500264765	90		109419368	109419584	8421504	2	45,45	0,171	p	350026476500015086,350026476500015042	0-45,3-48						Single Chain Recombinant T Cell Receptors 	.freshpatents.com	0	0		
1419	chr4	109419368	109419413	3500195676	45		109419368	109419413	8421504	1	45	0	p	350019567600015066	0-45						Soluble Bifunctional Proteins - Patent application	www.faqs.org	0	0		
1419	chr4	109419397	109419422	3500203667	25		109419397	109419422	8421504	1	25	0	c	350020366700000009	18-43						US Patent # 6,340,461. Superantigen based methods and compositions for treatment of diseases - Patents.com	www.patents.com	0	0		
1419	chr4	109419397	109419422	3500108742	25		109419397	109419422	8421504	1	25	0	c	350010874200000009	18-43						Superantigen based methods and compositions for treatment of diseases - US Patent 6340461 Description	ww.patentstorm.us	0	0		
1419	chr4	109419569	109420592	3500332706	40		109419569	109420592	8421504	2	20,20	0,1003	c,g	350033270600000013,350033270600000012,350033270600000012	0-20,0-20,0-20						T cell immunodominant Anaplasma marginale	www.jleukbio.org	0	0		
1419	chr4	109420524	109420590	3500225202	66		109420524	109420590	8421504	1	66	0	p	350022520200015012	0-66						GenerationofdualTcellreceptor(TCR)Tcells byTCRgenetransfer foradoptiveTcelltherapy	edoc.hu-berlin.de	0	0		
1419	chr4	109420587	109420960	3500151937	48		109420587	109420960	8421504	2	36,12	0,361	p	350015193700015058	0-48						T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1419	chr4	109420613	109420962	3500264643	24		109420613	109420962	8421504	2	10,14	0,335	c	350026464300000007	0-24		19468063	10.1084/jem.20082480	0022-1007	The Journal of Experimental Medicine	CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids	Rhijn	2009	14		
1419	chr4	109420613	109420962	3500199520	24		109420613	109420962	8421504	2	10,14	0,335	c	350019952000000007	0-24						The Journal of Experimental Medicine	www.life.umd.edu	0	0		
1419	chr4	109437454	109437481	3500327395	24		109437454	109437481	8421504	2	8,16	0,11	g	350032739500000138	2-26						Vaccine For Periodontal Disease - Patent application	www.faqs.org	0	0		
1419	chr4	109440883	109440906	3500308662	23		109440883	109440906	8421504	1	23	0	g	350030866200000018	0-23						DNA	.lib.kobe-u.ac.jp	0	0		
1420	chr4	109447015	109447044	3500112146	24		109447015	109447044	8421504	2	18,6	0,23	g	350011214600000119	0-24						Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use	Anderson	2002	0		
1420	chr4	109517000	109517972	3500462106	67		109517000	109517972	8421504	3	20,24,23	0,381,949	c	350046210600000007,350046210600000001,350046210600000008,350046210600000002,350046210600000000	0-20,0-20,0-24,0-24,0-23						 Vitamin D 	www.docstoc.com	0	0		TRPV6
1420	chr4	109517000	109517972	3500318257	67		109517000	109517972	8421504	3	20,24,23	0,381,949	c	350031825700000001,350031825700000007,350031825700000008,350031825700000002,350031825700000000,350031825700000006	0-20,0-20,0-24,0-24,0-23,0-23						VITAMIN-D-LIKE COMPOUNDS - Patent application	www.faqs.org	0	0		
1420	chr4	109520688	109521608	3500077120	41		109520688	109521608	8421504	2	20,21	0,899	c,g	350007712000000001,350007712000000001,350007712000000000,350007712000000000	0-20,0-20,0-21,0-21						TRPV6 and Calbindin-D9k-expression and localization in the bovine uterus and placenta during pregnancy	www.rbej.com	0	0		
1421	chr4	109589326	109589357	3500144493	26		109589326	109589357	8421504	2	7,19	0,12	g	350014449300000082	0-26						Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase - US Patent 7033807 Description	ww.patentstorm.us	0	0		
1425	chr4	110123412	110123435	3500305678	23		110123412	110123435	8421504	1	23	0	c	350030567800000007	0-23						Journal of Cancer Science & Therapy Open Access	faculty.unlv.edu	0	0		
1425	chr4	110221508	110223077	3500183213	45		110221508	110223077	8421504	2	4,41	0,1528	p	350018321300015058	0-45						Power point file - PPSK - USM	www.docstoc.com	0	0		
1425	chr4	110223553	110230328	3500438553	43		110223553	110230328	8421504	2	21,22	0,6753	c,g	350043855300000274,350043855300000004	25-46,20-42						Eph-related tyrosine kinases, nucleotide sequences and methods of use	Pasquale	1993	0		
178	chr4	110223597	110236296	3500426947	190		110223597	110236296	8421504	8	38,3,27,26,20,28,11,37	0,208,5362,5651,6872,11596,11644,12662	c	350042694700000054,350042694700000020,350042694700000014,350042694700000009,350042694700000007,350042694700000006	0-41,21-48,21-47,0-20,20-48,0-48						A novel receptor-type tyrosine kinase and use thereof	Boyd	1997	0		
1428	chr4	110550202	110550228	3500039132	23		110550202	110550228	8421504	2	16,7	0,19	c	350003913200000030	0-23						Funktionelle Charakterisierung zweier Levamisolrezeptor-assoziierter Proteine in C. elegans &#x2013; NRA-2 und NRA-4	.uni-frankfurt.de	0	0		
1430	chr4	110787771	110787801	3500214252	24		110787771	110787801	8421504	3	5,8,11	0,6,19	g	350021425200000074	15-43						Human serum albumin expression construct	www.devileye.net	0	0		
1430	chr4	110846393	110846421	3500322097	24		110846393	110846421	8421504	3	6,14,4	0,9,24	g	350032209700000520	2-26						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
1430	chr4	110860131	110860157	3500021221	23		110860131	110860157	8421504	2	16,7	0,19	g	350002122100000082	1-24						US Patent # 5,880,334. DNA encoding phosphoenolpyruvate carboxykinase, recombinant vector and transformed plant containing the same - Patents.com	www.patents.com	0	0		
1436	chr4	111542570	111542596	3500420381	23		111542570	111542596	8421504	2	5,18	0,8	g	350042038100000043	1-24						Albumin Variants	Andersen	2012	0		
1467	chr4	115645694	115647656	3500235713	44		115645694	115647656	8421504	2	22,22	0,1940	c,g	350023571300000024,350023571300000024,350023571300000025,350023571300000025	0-22,0-22,0-22,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
1467	chr4	115658378	115658447	3500445452	69		115658378	115658447	8421504	1	69	0	p	350044545200015002	3-72		18678709	10.1083/jcb.200802146		The Journal of Cell Biology	Ku80 removal from DNA through double strand break&#x2013;induced ubiquitylation	Lisa	2008	0		CUL1
1467	chr4	115658378	115658447	3500209696	69		115658378	115658447	8421504	1	69	0	p	350020969600015003	3-72		18678709	10.1083/jcb.200802146	0021-9525	The Journal of Cell Biology	Ku80 removal from DNA through double strand break&#x2013;induced ubiquitylation	Postow	2008	10		CUL1
1467	chr4	115664265	115664288	3500390684	23		115664265	115664288	8421504	1	23	0	c	350039068400000162,350039068400000003	0-23,0-23						Compositions and methods for immortalizing cells and screening for anti-cancer agents - Patent application	www.faqs.org	0	0		EZH2
1467	chr4	115664265	115664288	3500189649	23		115664265	115664288	8421504	1	23	0	c	350018964900000003	0-23						Compositions and methods for immortalizing cells and screening for anti-cancer agents	Tsichlis	2010	0		EZH2,SETD4
1467	chr4	115666666	115666694	3500313640	28		115666666	115666694	8421504	1	28	0	c	350031364000000000	0-28		19969553	10.1093/carcin/bgp305		Carcinogenesis	Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells	Manjari	2010	0		
1467	chr4	115666666	115666694	3500292755	28		115666666	115666694	8421504	1	28	0	c	350029275500000000	0-28						Anagh Carcinogenesis 2010 | Anagh Sahasrabuddhe - Academia.edu	www.academia.edu	0	0		
1467	chr4	115670985	115697156	3500203239	1440		115670985	115697156	8421504	11	30,170,241,92,179,103,141,121,117,129,117	0,549,1365,2978,7793,8515,9567,10470,14009,25367,26054	p	350020323900015005	0-1440						INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF - EPIZYME, INC.	www.sumobrain.com	0	0		
1469	chr4	115869269	115880070	3500293064	71		115869269	115880070	8421504	2	48,23	0,10778	c	350029306400000203,350029306400000173	0-48,6-29						Methods and Compositions for Modulating Apoptosis - Patent application	www.faqs.org	0	0		
1469	chr4	115876210	115876708	3500353734	69		115876210	115876708	8421504	2	46,23	0,475	p	350035373400015008	72-141						The Protein Disulfide Isomerase gene family in bread wheat (T. aestivum L.) | Arun Prabhu Dhanapal - Academia.edu	www.academia.edu	0	0		PDIA4
1469	chr4	115876239	115876693	3500328917	25		115876239	115876693	8421504	2	17,8	0,446	c	350032891700000445	9-34						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
1469	chr4	115880072	115880097	3500445688	25		115880072	115880097	8421504	1	25	0	c	350044568800000070	0-28						 Herpes Simplex Virus Mutant ICP0 Protein 	www.docstoc.com	0	0		
1470	chr4	116103916	116125372	3500068396	144		116103916	116125372	8421504	3	48,48,48	0,192,21408	c	350006839600000166,350006839600000162,350006839600000135	0-48,0-48,0-48						Trophinin and trophinin-assisting protein agonists, antibodies and antagonists	Fukuda	1996	0		
1472	chr4	116342756	116342784	3500321554	24		116342756	116342784	8421504	3	14,5,5	0,17,23	c	350032155400000204	23-47						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1993	0		
1472	chr4	116342756	116342784	3500279401	24		116342756	116342784	8421504	3	14,5,5	0,17,23	c	350027940100000204	23-47						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1992	0		
1472	chr4	116379991	116380020	3500184607	28		116379991	116380020	8421504	2	15,13	0,16	c	350018460700000182	12-40						US Patent # 6,028,173. Human chromosome 16 genes, compositions, methods of making and using same - Patents.com	www.patents.com	0	0		
1473	chr4	116419716	116421789	3500276164	58		116419716	116421789	8421504	3	19,20,19	0,268,2054	c,g	350027616400000003,350027616400000002,350027616400000000,350027616400000000	0-19,0-20,0-19,0-19						Song et al. Identification of SNPs in chemerin gene and association with carcass and meat quality traits of Qinchuan Cattle. Afr. J. Biotechnol.	demicjournals.org	0	0		
1473	chr4	116419897	116421718	3500354917	315		116419897	116421718	8421504	10	45,9,36,45,9,36,18,27,45,45	0,48,237,276,324,1356,1443,1698,1728,1776	p	350035491700015176,350035491700015175,350035491700015174,350035491700015173,350035491700015172,350035491700015171,350035491700015170	0-45,0-45,0-45,0-45,0-45,0-45,0-45						Lafora's Disease Gene 	.freshpatents.com	0	0		
1473	chr4	116419897	116421718	3500111696	315		116419897	116421718	8421504	10	45,9,36,45,9,36,18,27,45,45	0,48,237,276,324,1356,1443,1698,1728,1776	p	350011169600015226,350011169600015225,350011169600015224,350011169600015223,350011169600015222,350011169600015221,350011169600015220	0-45,0-45,0-45,0-45,0-45,0-45,0-45						COMPOSITIONS AND METHODS COMPRISING A LIGAND OF CHEMERINR - Patent application	www.faqs.org	0	0		
1473	chr4	116420145	116421341	3500455501	39		116420145	116421341	8421504	2	20,19	0,1177	c,g	350045550100000004,350045550100000004,350045550100000003	0-20,0-20,0-19						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
1473	chr4	116454097	116455356	3500024022	89		116454097	116455356	8421504	3	23,51,15	0,1187,1244	p,c	350002402200000020,350002402200015020	25-48,0-66						RIP60 nucleic acid and polypeptide sequences and uses therefor	Heintz	2000	0		
1474	chr4	116564497	116564524	3500245468	26		116564497	116564524	8421504	2	5,21	0,6	g	350024546800000361	1-29						Inhibition Of Cancer Metastasis 	.freshpatents.com	0	0		
184	chr4	117170251	117184409	3500382780	100		117170251	117184409	8421504	5	20,20,20,20,20	0,2178,6168,9151,14138	c,g	350038278000000001,350038278000000000,350038278000000005,350038278000000005,350038278000000004,350038278000000003	0-20,0-20,0-20,0-20,0-20,0-20		18184764	10.1152/ajpregu.00521.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Erg K+ channels modulate contractile activity in the bovine epididymal duct	Mewe	2008	0		
184	chr4	117170251	117184409	3500057255	100		117170251	117184409	8421504	5	20,20,20,20,20	0,2178,6168,9151,14138	c,g	350005725500000001,350005725500000000,350005725500000005,350005725500000005,350005725500000004,350005725500000003	0-20,0-20,0-20,0-20,0-20,0-20		18184764	10.1152/ajpregu.00521.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Erg K+ channels modulate contractile activity in the bovine epididymal duct	Mewe	2008	0		
1478	chr4	117175016	117177264	3500147613	65		117175016	117177264	8421504	2	20,45	0,2203	c,g	350014761300000028,350014761300000086,350014761300000021	0-20,0-45,0-25						Long QT syndrome genes	Keating	1995	0		
1478	chr4	117175752	117176189	3500154352	150		117175752	117176189	8421504	2	50,100	0,337	p	350015435200015012	0-150						NPG.nature.vol.417.Issue.6888.May	www.scribd.com	0	0		KCNH2
1478	chr4	117176099	117176216	3500192418	117		117176099	117176216	8421504	1	117	0	p	350019241800015017	0-117						vom Fachbereich Biologie der Technischen Universit&#xe4;t Darmstadt zur Erlangung des akademischen Grades eines Doctor rerum naturalium genehmigte Dissertation von	b.tu-darmstadt.de	0	0		KCNH7
1478	chr4	117176147	117176195	3500202391	48		117176147	117176195	8421504	1	48	0	p	350020239100015014	0-48						Human potassium channel genes	Miller	2002	0		KCNH7
1478	chr4	117176147	117176195	3500128285	48		117176147	117176195	8421504	1	48	0	p	350012828500015014	0-48						Human Potassium Channel Genes	Miller	2009	0		KCNH7
1479	chr4	117180992	117195312	3500106462	38		117180992	117195312	8421504	2	19,19	0,14301	g	350010646200000055,350010646200000057	4-23,2-21						METHODS AND SYSTEMS FOR PHYLOGENETIC ANALYSIS - Patent application	www.faqs.org	0	0		
1479	chr4	117218789	117218864	3500405013	75		117218789	117218864	8421504	1	75	0	p	350040501300015001	0-75						endothelialnitric oxide Mutagenesis palmitoylation motif dual identifies targeting	www.pnas.org	0	0		NOS3
1479	chr4	117220277	117223475	3500374164	53		117220277	117223475	8421504	3	27,15,11	0,3171,3187	c,g	350037416400000000,350037416400000000,350037416400000001,350037416400000001	0-27,0-27,0-26,0-26		9815072		0363-6135	American Journal of Physiology - Heart and Circulatory Physiology	Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension	Black	1998	4		
1479	chr4	117220277	117220304	3500325210	27		117220277	117220304	8421504	1	27	0	c	350032521000000000	0-27		9612300			American Journal of Physiology - Lung Cellular and Molecular Physiology	Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide	Sheehy	1998	0		
1479	chr4	117220291	117236574	3500367637	204		117220291	117236574	8421504	7	73,34,7,14,19,37,20	0,818,922,2206,5174,9018,16263	p,c	350036763700000005,350036763700015001,350036763700000006,350036763700000016,350036763700000018,350036763700000007,350036763700000013,350036763700000015,350036763700000001,350036763700000002,350036763700000003	8-30,0-60,1-21,0-35,0-34,0-21,2-21,0-22,0-19,17-38,1-21						Src Kinase Activates Endothelial Nitric-oxide Synthase by Phosphorylating Tyr-83--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
1479	chr4	117220304	117236574	3500427801	191		117220304	117236574	8421504	7	60,34,7,14,19,37,20	0,805,909,2193,5161,9005,16250	p,c,g	350042780100015000,350042780100000006,350042780100000016,350042780100000018,350042780100000007,350042780100000013,350042780100000015,350042780100000001,350042780100000001,350042780100000002,350042780100000003,350042780100000003	0-60,1-21,0-35,0-34,0-21,2-21,0-22,0-19,0-19,17-38,1-21,1-21						SrcKinaseActivatesEndothelialNitric-oxideSynthaseby PhosphorylatingTyr-83	www.jbc.org	0	0		
1479	chr4	117220786	117222557	3500463390	40		117220786	117222557	8421504	2	20,20	0,1751	c,g	350046339000000000,350046339000000000,350046339000000002,350046339000000002,350046339000000003,350046339000000003,350046339000000005,350046339000000005	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						Time and dose effect of transdermal nicotine on endothelial function	rt.physiology.org	0	0		
1479	chr4	117222533	117225281	3500001935	63		117222533	117225281	8421504	3	21,21,21	0,2025,2727	c,g	350000193500000000,350000193500000001,350000193500000001,350000193500000005	0-21,0-21,0-21,0-21		10666099			American Journal of Physiology - Heart and Circulatory Physiology	Quantification of eNOS mRNA in the canine cardiac vasculature by competitive PCR	Fulton	2000	0		NOS1
1479	chr4	117223704	117223731	3500173290	27		117223704	117223731	8421504	1	27	0	c	350017329000000000	0-27		17449545	10.1152/ajpheart.01141.2006		American Journal of Physiology - Heart and Circulatory Physiology	Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities	Fukatsu	2007	0		
1479	chr4	117223704	117223731	3500066975	27		117223704	117223731	8421504	1	27	0	c	350006697500000000	0-27		17449545	10.1152/ajpheart.01141.2006		American Journal of Physiology - Heart and Circulatory Physiology	Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities	Fukatsu	2007	0		
1479	chr4	117223723	117225122	3500017911	40		117223723	117225122	8421504	3	20,12,8	0,893,1391	c,g	350001791100000000,350001791100000000,350001791100000001	0-20,0-20,0-20		18296510	10.1530/REP-07-0496	1470-1626	Reproduction	Prostaglandin F2&#x03b1; increases endothelial nitric oxide synthase in the periphery of the bovine corpus luteum: the possible regulation of blood flow at an early stage of luteolysis	Shirasuna	2008	3		
1479	chr4	117223765	117225280	3500339349	64		117223765	117225280	8421504	3	20,24,20	0,770,1495	c,g	350033934900000000,350033934900000000,350033934900000004,350033934900000004,350033934900000001,350033934900000001	0-20,0-20,0-24,0-24,0-20,0-20		11290515			American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction	Bove	2001	0		
1479	chr4	117223765	117225280	3500280427	64		117223765	117225280	8421504	3	20,24,20	0,770,1495	c,g	350028042700000000,350028042700000000,350028042700000004,350028042700000001,350028042700000001	0-20,0-20,0-24,0-20,0-20		11290515			American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction	Bove	2001	0		
1479	chr4	117223765	117225280	3500042373	64		117223765	117225280	8421504	3	20,24,20	0,770,1495	c,g	350004237300000000,350004237300000000,350004237300000004,350004237300000001,350004237300000001	0-20,0-20,0-24,0-20,0-20		11290515			American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction	Bove	2001	0		
1479	chr4	117223808	117236832	3500263272	85		117223808	117236832	8421504	4	20,21,22,22	0,1356,12887,13002	c,g	350026327200000012,350026327200000012,350026327200000013,350026327200000013,350026327200000004,350026327200000005,350026327200000005	0-20,0-20,0-21,0-21,0-22,0-22,0-22						Nitric oxide synthase (NOS) genes expression in catlle in vitro produced embryos	s.ulb.uni-bonn.de	0	0		
1479	chr4	117225114	117225671	3500156266	60		117225114	117225671	8421504	3	30,29,1	0,349,556	c	350015626600000002,350015626600000003	0-30,0-30		10764687	10.1161/01.ATV.20.4.1155	1079-5642	Arteriosclerosis, Thrombosis, and Vascular Biology	Hypoxia Induces Transcription of the Plasminogen Activator Inhibitor-1 Gene Through Genistein-Sensitive Tyrosine Kinase Pathways in Vascular Endothelial Cells	Uchiyama	2000	6		
1479	chr4	117225295	117225687	3500389840	43		117225295	117225687	8421504	4	14,5,7,17	0,123,190,375	c	350038984000000004,350038984000000005	0-19,0-24		16935840	10.1210/en.2005-1548	0013-7227	Endocrinology	Hormonal and Spatial Regulation of Nitric Oxide Synthases (NOS) (Neuronal NOS, Inducible NOS, and Endothelial NOS) in the Oviducts	Lapointe	2006	4		
1479	chr4	117225454	117236984	3500121208	71		117225454	117236984	8421504	3	21,28,22	0,11464,11508	c,g	350012120800000000,350012120800000006,350012120800000007,350012120800000007	0-21,0-28,0-22,0-22						Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy	Lorenz	2004	0		NOS3
1479	chr4	117225454	117225479	3500368414	25		117225454	117225479	8421504	1	25	0	c	350036841400000006	0-25					The American Journal of Pathology	Nitric Oxide Inhibits HIV Tat-Induced NF-&#x03ba;B Activation	Fei	July	0		NOS3
1479	chr4	117225455	117234737	3500278596	39		117225455	117234737	8421504	2	20,19	0,9263	c	350027859600000000,350027859600000004	0-20,0-19		11401942	10.1161/01.CIR.103.23.2839	0009-7322	Circulation	Dysfunctional Regulation of Endothelial Nitric Oxide Synthase (eNOS) Expression in Response to Exercise in Mice Lacking One eNOS Gene	Kojda	2001	15		NOS3
1479	chr4	117225459	117225483	3500425501	24		117225459	117225483	8421504	1	24	0	c	350042550100000016	0-24						DEPARTAMENT DE FISIOLOGIA EFECTOS ANTICANCEROSOS DE POLIFENOLES NATURALES: PETEROSTILBENO Y QUERCET	www.tdx.cat	0	0		NOS3
1479	chr4	117225459	117225483	3500379221	24		117225459	117225483	8421504	1	24	0	c	350037922100000016	0-24						EFECTOS ANTICANCEROSOS DE POLIFENOLES NATURALES: PETEROSTILBENO Y QUERCETINA	www.tdx.cat	0	0		NOS3
1479	chr4	117225475	117225698	3500018838	45		117225475	117225698	8421504	2	17,28	0,195	p	350001883800015001	0-45			10.1111/j.1742-4658.2006.05193.x	1742-4658	FEBS Journal	Binding and activation of nitric oxide synthase isozymes by calmodulin EF hand pairs - Spratt - 2006 - FEBS Journal - Wiley Online Library	Spratt	2006	0		NOS3
1479	chr4	117225675	117225698	3500196485	23		117225675	117225698	8421504	1	23	0	c	350019648500000008	0-23		21383501	10.1172/JCI42040		The Journal of Clinical Investigation	Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress&#x2013;specific manner	KVin	2011	0		
1479	chr4	117226160	117228829	3500100552	25		117226160	117228829	8421504	2	10,15	0,2654	c	350010055200000012	0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		
1479	chr4	117229359	117232918	3500198652	49		117229359	117232918	8421504	3	19,6,24	0,20,3535	c,g	350019865200000004,350019865200000004,350019865200000005	7-32,7-32,9-33		10409306			American Journal of Physiology - Renal Physiology	Nitric oxide synthase in the JGA of the SHR: expression and role in tubuloglomerular feedback	Welch	1999	0		
1479	chr4	117231551	117232208	3500287220	42		117231551	117232208	8421504	2	21,21	0,636	c	350028722000000000,350028722000000001	0-21,0-21						&#xc9;tude de la surexpression in vivo de la monoxyde d'azote synthase endoth&#xe9;liale chez le rat ur&#xe9;mique : effets sur la dysfonction endoth&#xe9;liale en insuffisance r&#xe9;nale	de.bibl.ulaval.ca	0	0		
1479	chr4	117231551	117232208	3500196187	42		117231551	117232208	8421504	2	21,21	0,636	c,g	350019618700000000,350019618700000001,350019618700000001	0-21,0-21,0-21						&#xc9;tude de la surexpression in vivo de la monoxyde d'azote synthase endoth&#xe9;liale chez le rat ur&#xe9;mique : effets sur la dysfonction endoth&#xe9;liale en insuffisance r&#xe9;nale	theses.ulaval.ca	0	0		
1479	chr4	117232105	117236489	3500457109	70		117232105	117236489	8421504	3	24,23,23	0,4109,4361	c,g	350045710900000000,350045710900000002,350045710900000003,350045710900000003	0-24,0-23,0-23,0-23		18624772	10.1111/j.1582-4934.2008.00416.x		Journal of Cellular and Molecular Medicine	Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase	Yunzhou	2009	0		
1479	chr4	117232105	117236489	3500133486	70		117232105	117236489	8421504	3	24,23,23	0,4109,4361	c,g	350013348600000000,350013348600000000,350013348600000002,350013348600000002,350013348600000003,350013348600000003	0-24,0-24,0-23,0-23,0-23,0-23		18624772	10.1111/j.1582-4934.2008.00416.x	1582-4934	Journal of Cellular and Molecular Medicine	Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase - Dong - 2008 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Dong	2009	0		
1479	chr4	117232970	117233677	3500225890	42		117232970	117233677	8421504	3	20,2,20	0,321,687	c	350022589000000000,350022589000000001	0-22,0-20		20881096	10.1152/ajpregu.00123.2010		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Long-term exposure to high-altitude chronic hypoxia during gestation induces neonatal pulmonary hypertension at sea level	Emilio	2010	0		
1479	chr4	117232970	117233677	3500022360	42		117232970	117233677	8421504	3	20,2,20	0,321,687	c,g	350002236000000000,350002236000000001,350002236000000001	0-22,0-20,0-20		20881096	10.1152/ajpregu.00123.2010		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Long-term exposure to high-altitude chronic hypoxia during gestation induces neonatal pulmonary hypertension at sea level	Herrera	2010	0		
1479	chr4	117232971	117233678	3500189128	40		117232971	117233678	8421504	3	19,1,20	0,320,687	c,g	350018912800000002,350018912800000003,350018912800000003	0-20,0-20,0-20		16868034	10.1124/jpet.106.108803	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Fibroblast Growth Factor-2 Mediates Angiotensin-Converting Enzyme Inhibitor-Induced Angiogenesis in Coronary Endothelium	Donnini	2006	0		
1479	chr4	117233307	117233433	3500339921	39		117233307	117233433	8421504	2	19,20	0,106	c,g	350033992100000002,350033992100000002,350033992100000003,350033992100000003	0-19,0-19,0-20,0-20		16461547	10.1677/joe.1.06526	0022-0795	Journal of Endocrinology	Region-specific expression of nitric oxide synthases in the bovine oviduct during the oestrous cycle and in vitro	Ulbrich	2006	4		NOS3
1479	chr4	117233307	117233433	3500312388	39		117233307	117233433	8421504	2	19,20	0,106	c,g	350031238800000002,350031238800000002,350031238800000003,350031238800000003	0-19,0-19,0-20,0-20						Region-speci&#xfb01;c expression of nitric oxide synthases in the bovine oviduct during the oestrous cycle and in vitro	logy-journals.org	0	0		NOS3
1479	chr4	117233658	117234832	3500188576	40		117233658	117234832	8421504	2	20,20	0,1154	c,g	350018857600000004,350018857600000004,350018857600000005,350018857600000005	0-20,0-20,0-20,0-20		16569760	10.1152/ajpendo.00007.2006		American Journal of Physiology - Endocrinology and Metabolism	Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+	O'Kane	2006	0		
1479	chr4	117233699	117234742	3500454738	25		117233699	117234742	8421504	2	1,24	0,1019	c	350045473800000000	0-25						UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS	Endres	1999	0		NOS3
1479	chr4	117233699	117234742	3500416580	25		117233699	117234742	8421504	2	1,24	0,1019	c	350041658000000000	0-25					The American Journal of Pathology	Endothelial Nitric Oxide Synthase Gene-Deficient Mice Demonstrate Marked Retardation in Postnatal Bone Formation, Reduced Bone Volume, and Defects in Osteoblast Maturation and Activity	Jose	2001	0		
1479	chr4	117233699	117234742	3500398511	25		117233699	117234742	8421504	2	1,24	0,1019	c	350039851100000000	0-25		17557122	10.1172/JCI29877	0021-9738	The Journal of Clinical Investigation	The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo	Atochin	2007	13		
1479	chr4	117233699	117234742	3500259259	25		117233699	117234742	8421504	2	1,24	0,1019	c	350025925900000000	0-25						 Upregulation Of Type III Endothelial Cell Nitric Oxide Synthase By HMG 	www.docstoc.com	0	0		NOS3
1479	chr4	117233699	117234742	3500259040	25		117233699	117234742	8421504	2	1,24	0,1019	c	350025904000000000	0-25						UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS	Endres	2000	0		NOS3
1479	chr4	117233699	117234742	3500181141	25		117233699	117234742	8421504	2	1,24	0,1019	c	350018114100000000	0-25					Patent	Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors (Patent US:6180597)	Liao	2001	0		
1479	chr4	117233699	117234742	3500002000	25		117233699	117234742	8421504	2	1,24	0,1019	c	350000200000000000	0-25						Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors	Liao	1998	0		
1479	chr4	117234764	117235627	3500372029	84		117234764	117235627	8421504	2	76,8	0,855	p	350037202900015131	0-84						 Assessing Brain Aneurysms 	www.docstoc.com	0	0		
1479	chr4	117234812	117235685	3500116635	44		117234812	117235685	8421504	2	22,22	0,851	c,g	350011663500000000,350011663500000000,350011663500000001,350011663500000001	0-22,0-22,0-22,0-22		18714308	10.1038/mt.2008.165	1525-0016	Molecular Therapy	Gene-eluting Stents: Adenovirus-mediated Delivery of eNOS to the Blood Vessel Wall Accelerates Re-endothelialization and Inhibits Restenosis	Sharif	2008	7		NOS3
1479	chr4	117236186	117236431	3500032199	40		117236186	117236431	8421504	3	20,1,19	0,106,226	c,g	350003219900000006,350003219900000006,350003219900000007	0-20,0-20,0-20		19141072	10.1111/j.1471-4159.2008.05862.x	1471-4159	Journal of Neurochemistry	Signaling mechanisms of interferon gamma induced apoptosis in chromaffin cells: involvement of nNOS, iNOS, and NF&#x03ba;B - P&#xe9;rez-Rodr&#xed;guez - 2008 - Journal of Neurochemistry - Wiley Online Library	Perez-Rodriguez	2009	0		
1479	chr4	117236419	117236961	3500273456	43		117236419	117236961	8421504	2	20,23	0,519	c	350027345600000000,350027345600000001	8-28,6-29		11591621	10.1161/hc3901.095769	0009-7322	Circulation	Regulation of Endothelial Nitric Oxide Synthase Expression in the Vascular Wall and in Mononuclear Cells From Hypercholesterolemic Rabbits	Jimenez	2001	15		
1479	chr4	117236419	117236961	3500205602	43		117236419	117236961	8421504	2	20,23	0,519	c	350020560200000000,350020560200000001	8-28,6-29				1885-5857	Revista Espa&#xf1;ola de Cardiolog&#xed;a	Effect of HMG-CoA Reductase Inhibition on Endothelial Dysfunction-Inducing Protein in Hypercholesterolemic Rabbits	Jimenez	2002	0		
1479	chr4	117236431	117236461	3500297390	29		117236431	117236461	8421504	2	25,4	0,26	c	350029739000000010	0-29			10.1634/stemcells.22-3-385	1549-4918	STEM CELLS	Derivation of Endothelial Cells from CD34&#x2212; Umbilical Cord Blood - Murga - 2004 - STEM CELLS - Wiley Online Library	Murga	2004	0		
1479	chr4	117236448	117236472	3500116480	24		117236448	117236472	8421504	1	24	0	c	350011648000000007	8-32						Supporting Information 	www.pnas.org	0	0		ATG9B,NOS3
1479	chr4	117236475	117236508	3500087465	28		117236475	117236508	8421504	2	13,15	0,18	c	350008746500000000	0-32		11839759	10.1074/jbc.M200258200	0021-9258	Journal of Biological Chemistry	Disabling a C-terminal Autoinhibitory Control Element in Endothelial Nitric-oxide Synthase by Phosphorylation Provides a Molecular Explanation for Activation of Vascular NO Synthesis by Diverse Physiological Stimuli	Lane	2002	5		
1479	chr4	117236575	117236929	3500467067	77		117236575	117236929	8421504	2	42,35	0,319	c	350046706700000002,350046706700000000,350046706700000001	1-43,0-35,0-35		10506483	10.1161/01.RES.85.7.588	0009-7330	Circulation Research	Posttranscriptional Regulation of Endothelial Nitric Oxide Synthase During Cell Growth	Searles	1999	9		
1479	chr4	117236765	117236788	3500245482	23		117236765	117236788	8421504	1	23	0	c	350024548200000218	21-44						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
1479	chr4	117236938	117236961	3500151024	23		117236938	117236961	8421504	1	23	0	c	350015102400000001	6-29				1885-5857	Revista Espa&#xf1;ola de Cardiolog&#xed;a	Effect of HMG-CoA Reductase Inhibition on Endothelial Dysfunction-Inducing Protein in Hypercholesterolemic Rabbits	Jimenez	2002	0		
1479	chr4	117236938	117236961	3500096418	23		117236938	117236961	8421504	1	23	0	c	350009641800000001	6-29		11004215		1046-6673	Journal of the American Society of Nephrology	Expression of Endothelial Nitric Oxide Synthase in Human Peritoneal Tissue	ARRIERO	2000	10		
1479	chr4	117270581	117270606	3500344570	23		117270581	117270606	8421504	3	4,14,5	0,5,20	c	350034457000000173	25-48						Antibodies Directed to HER-3 and Uses Thereof - Patent application	www.faqs.org	0	0		
1479	chr4	117276010	117276033	3500316755	23		117276010	117276033	8421504	1	23	0	c	350031675500000004	0-23					Patent	Thiazolyl urea compounds and methods of uses (Patent US:6645990)	Askew	2003	0		
1479	chr4	117276010	117276033	3500009222	23		117276010	117276033	8421504	1	23	0	c	350000922200000004	0-23						Urea compounds and methods of uses	Santora	2001	0		
1479	chr4	117279585	117284892	3500204449	83		117279585	117284892	8421504	4	21,22,20,20	0,3029,3394,5287	c,g	350020444900000004,350020444900000003,350020444900000006,350020444900000006,350020444900000000,350020444900000000,350020444900000001,350020444900000001	0-21,0-20,0-21,0-21,0-20,0-20,0-20,0-20		20507629	10.1186/1471-2164-11-337	1471-2164	BMC Genomics	A deletion mutation in bovine SLC4A2 is associated with osteopetrosis in Red Angus cattle	Meyers	2010	4		
1479	chr4	117291234	117292198	3500430446	39		117291234	117292198	8421504	2	20,19	0,945	c	350043044600000018,350043044600000019	0-20,0-19						DPOFA, a Cl-/HCO3- exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	biomedcentral.com	0	0		
1479	chr4	117291234	117292198	3500198876	39		117291234	117292198	8421504	2	20,19	0,945	c,g	350019887600000018,350019887600000018,350019887600000019	0-20,0-20,0-19		22085910	10.1186/1471-2415-11-33	1471-2415	BMC Ophthalmology	DPOFA, a Cl-/HCO3 - exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	Iserovich	2011	1		
1479	chr4	117291925	117291952	3500068459	24		117291925	117291952	8421504	2	18,6	0,21	c	350006845900000007	14-38						NANOSCALE ARCHITECTURE	tations.ub.rug.nl	0	0		
1479	chr4	117293242	117293266	3500187344	23		117293242	117293266	8421504	2	14,9	0,15	c	350018734400000006	1-24						Cytosine Methylation Represses Glutathione S-Transferase P1 (GSTP1) Gene Expression in Human Prostate Cancer Cells	.aacrjournals.org	0	0		
1479	chr4	117298544	117298571	3500189677	24		117298544	117298571	8421504	2	12,12	0,15	c	350018967700000017	12-42						US Patent # 7,067,118. Methods of using mutant flt3-ligand polypeptides to induce cellular expansion - Patents.com	www.patents.com	0	0		
1481	chr4	117442704	117443440	3500383096	24		117442704	117443440	8421504	2	16,8	0,728	c	350038309600000118,350038309600000012	2-26,15-34						Rho target protein kinase p160	Narumiya	1996	0		
1481	chr4	117464073	117468061	3500370207	216		117464073	117468061	8421504	6	42,28,38,25,42,41	0,182,935,1964,3809,3947	c	350037020700000033,350037020700000022,350037020700000043,350037020700000050,350037020700000074,350037020700000077	6-48,0-28,0-38,0-25,6-48,0-41						Chondroitin Sulfate Synthesis Promoter 	.freshpatents.com	0	0		
1481	chr4	117465009	117465046	3500286478	37		117465009	117465046	8421504	1	37	0	c	350028647800000046	0-37						Compositions and methods for the treatment of tumour	Ashkenazi	2002	0		
1481	chr4	117465009	117465046	3500114329	37		117465009	117465046	8421504	1	37	0	c	350011432900000044	0-37						Compositions and methods for the treatment of tumor	Ashkenazi	2002	0		
1481	chr4	117465009	117465046	3500098526	37		117465009	117465046	8421504	1	37	0	c	350009852600000046	0-37						Compositions and methods for the treatment of tumor	Ashkenazi	2001	0		
1481	chr4	117465010	117465046	3500289472	36		117465010	117465046	8421504	1	36	0	c	350028947200000044	0-36					Patent	Compositions and methods for the diagnosis of tumours (Patent EP:1626084)	Ashkenazi	2009	0		
1481	chr4	117471960	117472821	3500234474	25		117471960	117472821	8421504	2	9,16	0,845	c	350023447400000034	0-25		19996304	10.1158/1541-7786.MCR-09-0119	1541-7786	Molecular Cancer Research	Inhibition of Expression of the Chromatin Remodeling Gene, SNF2L, Selectively Leads to DNA Damage, Growth Inhibition, and Cancer Cell Death	Ye	2009	4		
185	chr4	117684113	117716547	3500434170	38		117684113	117716547	8421504	3	17,2,19	0,32376,32415	c	350043417000000037,350043417000000036	0-19,0-19						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
1483	chr4	117831870	117831895	3500314534	25		117831870	117831895	8421504	1	25	0	g	350031453400000028	9-34						CELL VISUAL CHARACTERISTIC-MODIFYING SEQUENCES - FLORIGENE LTD	www.sumobrain.com	0	0		
1486	chr4	118177878	118177901	3500265908	23		118177878	118177901	8421504	1	23	0	g	350026590800000111	8-31						Isolated Lectin Polypeptides Consisting Of Truncated Mammalian Udp-galnac:polypeptide N- Acetylgalactosaminyltransferases 	.freshpatents.com	0	0		
1488	chr4	118421157	118421181	3500343008	23		118421157	118421181	8421504	2	6,17	0,7	g	350034300800000056	5-28						Hemoglobin A1c Determination Method, Enzyme To Be Used Therefor, And Production Method Thereof 	.freshpatents.com	0	0		
1488	chr4	118455165	118455189	3500009269	23		118455165	118455189	8421504	2	18,5	0,19	g	350000926900000023	10-39					Patent	Method for expression of heterologous proteins in yeast (Patent US:6017731)	Merryweather	2000	0		
1489	chr4	118496610	118496638	3500190800	24		118496610	118496638	8421504	2	10,14	0,14	g	350019080000000022	10-34						Recombinant IgG expression in mammalian cells	etc.tu-bs.de:8080	0	0		
1489	chr4	118496610	118496638	3500116460	24		118496610	118496638	8421504	2	10,14	0,14	g	350011646000000022	10-34						Recombinant IgG expression in mammalian cells	etc.tu-bs.de:8080	0	0		
1489	chr4	118583545	118583578	3500429819	25		118583545	118583578	8421504	3	13,7,5	0,18,28	g	350042981900000184	0-25						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
1489	chr4	118583545	118583578	3500272641	25		118583545	118583578	8421504	3	13,7,5	0,18,28	g	350027264100000102	9-34						DNA Vaccine Enhancement with MHC Class II Activators - Patent application	www.faqs.org	0	0		
1492	chr4	118912948	118912981	3500088733	26		118912948	118912981	8421504	3	13,6,7	0,18,26	g	350008873300000012	0-26		18033315	10.1038/sj.leu.2405043	0887-6924	Leukemia	Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F	Shide	2007	10		
1498	chr4	119683873	119683897	3500392541	23		119683873	119683897	8421504	2	13,10	0,14	g	350039254100000006	3-26						Engineered Bacteriophages As Adjuvants For Antimicrobial Agents And Compositions And Methods Of Use Thereof 	.freshpatents.com	0	0		
1501	chr4	120127858	120127885	3500086674	24		120127858	120127885	8421504	2	12,12	0,15	c	350008667400000019	7-31						Human g-protein chemokine receptor hdgnr10	Li	1996	0		
1501	chr4	120127858	120127885	3500001653	24		120127858	120127885	8421504	2	12,12	0,15	c	350000165300000019	7-31						Human G-Protein chemokine receptor HDGNR10 (CCR5 receptor)	Li	1998	0		
1503	chr4	120375367	120375392	3500404502	23		120375367	120375392	8421504	3	4,6,13	0,5,12	g	350040450200000084	0-23						Osteoprotegerin	Boyle	2011	0		
1503	chr4	120375367	120375392	3500254750	23		120375367	120375392	8421504	3	4,6,13	0,5,12	g	350025475000000136	0-23						Osteoprotegerin	Boyle	1997	0		
1503	chr4	120375367	120375392	3500074474	23		120375367	120375392	8421504	3	4,6,13	0,5,12	g	350007447400000140	0-23						Combination therapy for conditions leading to bone loss	Boyle	2001	0		
1503	chr4	120430616	120430645	3500009943	23		120430616	120430645	8421504	3	6,12,5	0,9,24	g	350000994300000019	10-34						IceA gene and related methods	Miller	1998	0		
1506	chr4	120726294	120738130	3500131986	11836		120726294	120738130	8421504	1	11836	0	c,g	350013198600000024,350013198600000052,350013198600000007,350013198600000053,350013198600000054,350013198600000054,350013198600000056,350013198600000008,350013198600000057,350013198600000058,350013198600000009,350013198600000059,350013198600000060,350013198600000060,350013198600000010,350013198600000010,350013198600000061,350013198600000061,350013198600000062,350013198600000062	0-11836,0-80,0-300,0-60,0-100,0-100,0-80,0-130,0-36,0-60,0-150,0-81,0-60,0-60,0-301,0-301,0-70,0-70,0-151,0-151						SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK - Patent application	www.faqs.org	0	0		
1506	chr4	120730906	120737127	3500187080	210		120730906	120737127	8421504	3	83,100,27	0,621,6194	p	350018708000015026	0-210						186 human secreted proteins	Bednarik	2003	0		INSIG1
1506	chr4	120730906	120737127	3500053947	210		120730906	120737127	8421504	3	83,100,27	0,621,6194	p	350005394700015026	0-210						186 human secreted proteins	Bednarik	2003	0		INSIG1
1507	chr4	120869314	120869340	3500104444	23		120869314	120869340	8421504	2	18,5	0,21	g	350010444400000067	14-38						Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof	Dewhurst	2007	0		
1507	chr4	120943170	120956544	3500248841	42		120943170	120956544	8421504	3	11,11,20	0,14,13354	g	350024884100000064,350024884100000008,350024884100000010	0-23,3-23,15-35						Methods for the diagnosis of fetal abnormalities	Kapur	2013	0		
1508	chr4	121003892	121003920	3500292291	23		121003892	121003920	8421504	2	6,17	0,11	g	350029229100000029	12-35						Aortic Carboxypeptidase-like Polypeptide 	.freshpatents.com	0	0		
1508	chr4	121056540	121056566	3500074658	24		121056540	121056566	8421504	3	7,4,13	0,8,13	g	350007465800000004	7-36						&#x041f;&#x043e;&#x043b;&#x0438;&#x043c;&#x043e;&#x0440;&#x0444;&#x0438;&#x0437;&#x043c; &#x0414;&#x041d;&#x041a; &#x043c;&#x0438;&#x043a;&#x043e;&#x0431;&#x0430;&#x043a;&#x0442;&#x0435;&#x0440;&#x0438;&#x0439;, &#x0432;&#x044b;&#x0437;&#x044b;&#x0432;&#x	docs.podelise.ru	0	0		
1508	chr4	121061975	121062005	3500023225	24		121061975	121062005	8421504	3	12,8,4	0,17,26	g	350002322500000016	9-33						INTEREST FROM EXTREMOPHILIC ORGANISMS	ww.fedoa.unina.it	0	0		
1509	chr4	121176048	121176071	3500391778	23		121176048	121176071	8421504	1	23	0	g	350039177800000091	8-35						Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof	Halbur	1996	0		
1509	chr4	121179740	121179768	3500197092	24		121179740	121179768	8421504	3	5,15,4	0,8,24	g	350019709200000035	14-38						Cephalosporin C acylase	www.devileye.net	0	0		
1510	chr4	121346898	121346928	3500405159	25		121346898	121346928	8421504	2	13,12	0,18	g	350040515900000233	0-25						PATHOGEN AND SUBSTANCE TRAPS - VECOY NANOMEDICINES LTD.	www.sumobrain.com	0	0		
1511	chr4	121382038	121382063	3500330774	24		121382038	121382063	8421504	2	9,15	0,10	g	350033077400000011	4-28					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5871998)	Kirnbauer	1999	0		
1511	chr4	121382038	121382063	3500092529	24		121382038	121382063	8421504	2	9,15	0,10	g	350009252900000011	4-28					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5756284)	Kirnbauer	1998	0		
1512	chr4	121531792	121531817	3500032694	23		121531792	121531817	8421504	3	6,13,4	0,7,21	g	350003269400000008	3-26						a knock-out mice and Pura DNA unwinding activity	b.uni-muenchen.de	0	0		
1512	chr4	121577746	121577772	3500420208	24		121577746	121577772	8421504	2	6,18	0,8	g	350042020800000036	8-33						Lyophilized Therapeutic Peptibody Formulations 	.freshpatents.com	0	0		
1513	chr4	121644569	121644599	3500053431	24		121644569	121644599	8421504	3	12,6,6	0,17,24	g	350005343100000741	0-24					Patent	Binding agents which inhibit myostatin (Patent US:7928075)	Han	2011	0		
1513	chr4	121747934	121747960	3500011464	23		121747934	121747960	8421504	2	8,15	0,11	c	350001146400000014	4-27			10.1046/j.1432-1327.1999.00427.x	1432-1033	European Journal of Biochemistry	Site-directed removal of N-glycosylation sites in human gastric lipase - Wicker-Planquart - 2001 - European Journal of Biochemistry - Wiley Online Library	Wicker-Planquart	1999	0		
1513	chr4	121758438	121758464	3500294115	23		121758438	121758464	8421504	2	14,9	0,17	c	350029411500000097	21-44						ANTI-HDLK-1 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO - Patent application	www.faqs.org	0	0		
1514	chr4	121828100	121828125	3500343734	24		121828100	121828125	8421504	2	16,8	0,17	c	350034373400000379,350034373400000457	11-35,23-47					Patent	Transferrin receptor antibodies (Patent US:6008326)	Chong	1999	0		
1514	chr4	121828100	121828125	3500190760	24		121828100	121828125	8421504	2	16,8	0,17	c	350019076000000457,350019076000000379	23-47,11-35						Transferrin receptor genes - Patent # 6015688 - PatentGenius	.patentgenius.com	0	0		
1514	chr4	121857424	121857499	3500376368	75		121857424	121857499	8421504	1	75	0	p	350037636800015072	0-75						148 human secreted proteins	Brewer	1999	0		LMBR1
1514	chr4	121858457	121858480	3500067216	23		121858457	121858480	8421504	1	23	0	g	350006721600000044	1-26						DNA Vaccines Encoding Antigen Linked to a Domain That Binds CD40 - Patent application	www.faqs.org	0	0		
1515	chr4	121931889	121931912	3500400238	23		121931889	121931912	8421504	1	23	0	c	350040023800000293	21-44						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1515	chr4	121984467	121984493	3500152492	25		121984467	121984493	8421504	2	14,11	0,15	g	350015249200000293	3-28						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
1517	chr4	122215494	122215518	3500287824	23		122215494	122215518	8421504	2	8,15	0,9	c	350028782400000240	20-48						Improved isoprenoid production	Ai Lun *Bei Li 	2005	0		
1518	chr4	122296541	122297006	3500386303	69		122296541	122297006	8421504	2	11,58	0,407	p	350038630300015005	0-69						MEANS AND METHODS FOR COUNTERACTING PROTEIN AGGREGATION	Kampinga	2008	0		
1519	chr4	122424463	122424490	3500127679	24		122424463	122424490	8421504	2	8,16	0,11	g	350012767900000156	2-33						Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases - Patent application	www.faqs.org	0	0		
1529	chr4	123745540	123745569	3500067285	25		123745540	123745569	8421504	2	8,17	0,12	g	350006728500000075	5-30						Dissertation zur Erlangung des Doktorgrades der Fakult&#xe4;t f&#xfc;r Chemie und Pharmazie der Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen	b.uni-muenchen.de	0	0		
594	chr5	1210534	1211721	3500397484	49		1210534	1211721	8421504	2	25,24	0,1163	c	350039748400000116,350039748400000114	0-25,6-30					Patent	Non-endogenous, constitutively activated human G protein-coupled receptors (Patent CN:1329511)	Duo Mi Ni Ke *P*Bi Yi 	2007	0		LGR5
594	chr5	1215766	1215915	3500110272	48		1215766	1215915	8421504	2	24,24	0,125	c	350011027200000078,350011027200000144,350011027200000145,350011027200000079	0-24,0-24,0-24,0-24						COMPOSITIONS USEFUL FOR CANCER DETECTION AND TREATMENT, A CANCER STEM CELL MODEL, AND METHODS OF PRODUCTION AND USE THEREOF - Patent application	www.faqs.org	0	0		LGR5
596	chr5	1541537	1541567	3500428253	23		1541537	1541567	8421504	3	5,12,6	0,8,24	g	350042825300000000	5-28						Vaccine composition comprising an inactivated chikungunya virus strain	Ella	2012	0		
598	chr5	1822788	1822813	3500402343	23		1822788	1822813	8421504	3	5,4,14	0,6,11	g	350040234300000007	0-23						Severe Dengue Epidemics in Sri Lanka, 2003&#x2013;2006 - Vol. 15 No. 2 - February 2009 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
599	chr5	1852143	1852171	3500081835	24		1852143	1852171	8421504	2	17,7	0,21	g	350008183500000010	0-24						LABELED ENZYME COMPOSITIONS, METHODS AND SYSTEMS - Patent application	www.faqs.org	0	0		
604	chr5	2559014	2559110	3500373947	42		2559014	2559110	8421504	2	20,22	0,74	g	350037394700000031,350037394700000030	0-20,0-22						Udder Health Characteristics	Lund	2007	0		
607	chr5	2986095	2986122	3500215323	23		2986095	2986122	8421504	2	12,11	0,16	g	350021532300000000	0-34		20562109	10.1074/jbc.M109.092486	0021-9258	Journal of Biological Chemistry	Ero1&#x03b1; Is Expressed on Blood Platelets in Association with Protein-disulfide Isomerase and Contributes to Redox-controlled Remodeling of &#x03b1;IIb&#x03b2;3	Swiatkowska	2010	5		
616	chr5	4074432	4074461	3500462501	24		4074432	4074461	8421504	2	11,13	0,16	g	350046250100000061	10-34						FAKULT&#xc4;T F&#xdc;R CHEMIE UND HARMAZIE	b.uni-muenchen.de	0	0		
618	chr5	4360983	4361007	3500063056	23		4360983	4361007	8421504	2	16,7	0,17	g	350006305600000127	4-27						Vaccine and antitoxin for treatment and prevention of c. difficile disease	Firca	1999	0		
636	chr5	6694997	6702322	3500245940	324		6694997	6702322	8421504	6	84,63,94,23,12,48	0,1331,3911,4888,6307,7277	p	350024594000015074,350024594000015076	0-264,0-60						Secreted protein HCEJQ69	Brewer	2003	0		ZDHHC17
636	chr5	6698944	6699920	3500043960	90		6698944	6699920	8421504	3	45,10,35	0,48,941	p	350004396000015018,350004396000015019	0-45,0-45						ALTERED ZDHHC8 EXPRESSION AS A MARKER OF INCREASED RISK OF SCHIZOPHRENIA - Patent application	www.faqs.org	0	0		ZDHHC17
636	chr5	6714042	6722158	3500396089	462		6714042	6722158	8421504	5	62,94,75,128,103	0,675,1415,5227,8013	p	350039608900015000	0-462						<HTML><HEAD> <!-- automatically generated by Darwin prepared on Fri Sep 2 16:43:11 MEST 2005 runnin	atics-recipes.com	0	0		CSRP2
636	chr5	6714042	6722158	3500368407	462		6714042	6722158	8421504	5	62,94,75,128,103	0,675,1415,5227,8013	p	350036840700015000	0-462						<HTML><HEAD> <!-- automatically generated by Darwin prepared on Fri Sep 2 16:43:11 MEST 2005 runnin	w.bio-recipes.org	0	0		CSRP2
636	chr5	6714042	6722158	3500149827	462		6714042	6722158	8421504	5	62,94,75,128,103	0,675,1415,5227,8013	p	350014982700015000	0-462						<HTML><HEAD> <!-- automatically generated by Darwin prepared on Fri Sep 2 16:43:11 MEST 2005 runnin	ww.biorecipes.com	0	0		CSRP2
636	chr5	6719344	6719370	3500300046	23		6719344	6719370	8421504	2	18,5	0,21	c	350030004600000015	16-41						Fusion Proteins For Delivery Of Gdnf To The Cns 	.freshpatents.com	0	0		
637	chr5	6858260	6858287	3500405373	23		6858260	6858287	8421504	2	13,10	0,17	g	350040537300000287	11-34						Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection - US Patent 7410795 Description	ww.patentstorm.us	0	0		
641	chr5	7368158	7368181	3500434768	23		7368158	7368181	8421504	1	23	0	g	350043476800000003	8-31		9786920	10.1074/jbc.273.44.29118	0021-9258	Journal of Biological Chemistry	Differential Regulation of Multiple Glucose Transporter Genes in Leishmania mexicana	Burchmore	1998	5		PGPEP1
641	chr5	7368158	7368181	3500428254	23		7368158	7368181	8421504	1	23	0	g	350042825400000021	11-34						Method for selective inactivation of viral replication	Miles	2000	0		
641	chr5	7368158	7368181	3500422362	23		7368158	7368181	8421504	1	23	0	g	350042236200000000	1-24						Symbiodinium. Corals are the most widely	y.oregonstate.edu	0	0		
645	chr5	7913736	7913759	3500091189	23		7913736	7913759	8421504	1	23	0	g	350009118900000004	8-33						Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains	Sasaki	1989	0		
645	chr5	7952425	7952451	3500193866	26		7952425	7952451	8421504	1	26	0	c	350019386600000040	84-110						Team:Stockholm/Planning - 2010.igem.org	2010.igem.org	0	0		
647	chr5	8147290	8147316	3500278467	23		8147290	8147316	8421504	3	6,5,12	0,8,14	g	350027846700000000	18-43						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2006	0		
647	chr5	8177839	8177862	3500456727	23		8177839	8177862	8421504	1	23	0	c	350045672700000110	0-25					Patent	Recombinant plant expressing non-competitively binding insecticidal crystal proteins (Patent US:5866784)	Botterman	1999	0		
647	chr5	8177839	8177862	3500376795	23		8177839	8177862	8421504	1	23	0	c	350037679500000111	0-25						Recombinant plant expressing non-competitively binding insecticidal crystal proteins	Mellaert	1995	0		
656	chr5	9353499	9411472	3500131354	68		9353499	9411472	8421504	3	20,43,5	0,48,57968	c	350013135400000028,350013135400000029	0-20,0-48						Parkin interacting polypeptides and methods of use - Patent application	www.faqs.org	0	0		
10	chr5	9353541	10988529	3500257087	1146		9353541	10988529	8421504	8	49,185,123,168,168,118,134,201	0,57926,64509,68874,72157,1528653,1629085,1634787	p	350025708700015021	0-1146						Chimeric GFP-aequorin as bioluminescent Ca&plus &plus reporters at the single cell level	Baubet	2001	0		SYT1
10	chr5	9353541	10988529	3500019661	1146		9353541	10988529	8421504	8	49,185,123,168,168,118,134,201	0,57926,64509,68874,72157,1528653,1629085,1634787	p	350001966100015022	0-1146						Chimeric GFP-aequorin as bioluminescent Ca+at the single cell level	Baubet	2002	0		SYT1
10	chr5	9353541	10988520	3500295344	1083		9353541	10988520	8421504	17	49,59,111,3,105,12,93,69,42,108,6,102,10,98,30,78,108	0,57926,57991,58108,64509,64620,68874,68973,72157,72205,72319,1528653,1528761,1629085,1629189,1634787,1634871	p	350029534400015021	0-1083						Chimeric GFP-aequorin as bioluminescent Ca++reporters at the single cell level	osdir.com/patents	0	0		SYT1
10	chr5	9425851	10882227	3500131354	48		9425851	10882227	8421504	2	15,33	0,1456343	c	350013135400000043	0-48						Parkin interacting polypeptides and methods of use - Patent application	www.faqs.org	0	0		SYT1
659	chr5	9731056	9731083	3500363671	23		9731056	9731083	8421504	3	5,4,14	0,8,13	g	350036367100000005	22-45						PLAG GENE FAMILY AND TUMORIGENESIS - Vlaams, Interuniversitair Instituut Voor Biotechnologie	www.sumobrain.com	0	0		
661	chr5	9999873	10004611	3500347624	50		9999873	10004611	8421504	2	29,21	0,4717	c	350034762400000018,350034762400000016	0-29,0-21		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		
661	chr5	9999920	10063657	3500319213	4296		9999920	10063657	8421504	21	143,138,90,138,33,315,42,315,315,93,318,309,315,315,315,93,318,309,22,287,73	0,3118,4129,4604,5288,5575,5978,12451,13879,14270,23343,23754,29524,40053,41514,41905,50451,50862,58319,58353,63664	p,c	350031921300015019,350031921300015010,350031921300015018,350031921300015017,350031921300015008,350031921300015007,350031921300015009,350031921300015006,350031921300015005,350031921300000008,350031921300015000,350031921300000002	0-249,0-234,0-480,0-477,0-480,0-480,0-480,0-480,0-480,0-20,0-468,0-25						BMC Genomics BioMed Central	biomedcentral.com	0	0		
661	chr5	10023717	10023743	3500349986	23		10023717	10023743	8421504	2	10,13	0,13	c	350034998600000205	0-23						Mammalian cell surface antigens	Aversa	1995	0		
662	chr5	10156399	10161217	3500332175	705		10156399	10161217	8421504	7	199,158,78,31,71,144,24	0,455,927,1502,1877,2134,4794	p	350033217500015004,350033217500015003,350033217500015001	0-165,0-270,0-270						Editorial Manager(tm) for Molecular Cell Manuscript Draft Manuscript Number: MC-D-06-00911R2 Title: Recognition of a functional peroxisome type 1 target by the dynamic import receptor Pex5p Article Type: Research Manuscript Section/Category: Corresponding	w.embl-hamburg.de	0	0		PEX5
662	chr5	10161265	10169568	3500446127	96		10161265	10169568	8421504	2	48,48	0,8255	p	350044612700015001,350044612700015000	0-48,0-48		21525035	10.1242/jcs.079368	0021-9533	Journal of Cell Science	PEX14 is required for microtubule-based peroxisome motility in human cells	Bharti	2011	6		PEX5
663	chr5	10230439	10233616	3500246332	41		10230439	10233616	8421504	3	14,6,21	0,3140,3156	c	350024633200000004,350024633200000005	0-20,0-21						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		
664	chr5	10361381	10361438	3500369924	57		10361381	10361438	8421504	1	57	0	p	350036992400015017	0-57						KOMPLEMENT KONTROLL MODULOK VIZSG&#xc1;LATA NMR-SPEKTROSZK&#xd3;PI&#xc1;VAL	teo.elte.hu	0	0		
664	chr5	10364488	10384958	3500121860	59		10364488	10384958	8421504	3	19,20,20	0,99,20450	c,g	350012186000000001,350012186000000001,350012186000000002,350012186000000002,350012186000000003,350012186000000003,350012186000000022,350012186000000022	0-19,0-19,0-20,0-20,0-20,0-20,0-20,0-20		16207835	10.1095/biolreprod.105.046748	0006-3363	Biology of Reproduction	Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	Klein	2006	4		
664	chr5	10364488	10384958	3500049790	59		10364488	10384958	8421504	3	19,20,20	0,99,20450	c,g	350004979000000001,350004979000000001,350004979000000002,350004979000000002,350004979000000022,350004979000000022,350004979000000003,350004979000000003	0-19,0-19,0-20,0-20,0-20,0-20,0-20,0-20						Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	ww.biolreprod.org	0	0		
664	chr5	10476747	10480915	3500184286	41		10476747	10480915	8421504	2	20,21	0,4147	c	350018428600000034,350018428600000035	15-35,10-31						[tel-00555532, v1] Etude des int&#xe9;ractions prot&#xe9;ine-prot&#xe9;ine par double hybride bact&#xe9;rien : applications en agro-alimentaire et en sant&#xe9;.	hives-ouvertes.fr	0	0		
664	chr5	10480889	10480912	3500050271	23		10480889	10480912	8421504	1	23	0	c	350005027100000047,350005027100000133	9-32,9-32						GENES AND POLYPEPTIDES RELATING TO BREAST CANCERS - Patent application	www.faqs.org	0	0		
664	chr5	10482382	10482827	3500377404	44		10482382	10482827	8421504	2	22,22	0,423	c,g	350037740400000009,350037740400000003,350037740400000005,350037740400000005,350037740400000004,350037740400000004	0-22,0-22,0-22,0-22,0-22,0-22						METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME - Patent application	www.faqs.org	0	0		
664	chr5	10482382	10482827	3500363476	45		10482382	10482827	8421504	2	22,23	0,422	c,g	350036347600000005,350036347600000003,350036347600000003	0-22,0-23,0-23						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - Patent application	www.faqs.org	0	0		MIR141
664	chr5	10482382	10482827	3500244257	44		10482382	10482827	8421504	2	22,22	0,423	c,g	350024425700000027,350024425700000070,350024425700000070	0-22,0-22,0-22						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR141
664	chr5	10482382	10482827	3500205029	44		10482382	10482827	8421504	2	22,22	0,423	c,g	350020502900000009,350020502900000003,350020502900000004,350020502900000004,350020502900000005,350020502900000005	0-22,0-22,0-22,0-22,0-22,0-22						METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME	Khew-goodall	2007	0		MIR141
664	chr5	10482382	10482827	3500131966	44		10482382	10482827	8421504	2	22,22	0,423	c,g	350013196600000027,350013196600000070,350013196600000070	0-22,0-22,0-22						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
664	chr5	10482382	10482827	3500131061	45		10482382	10482827	8421504	2	22,23	0,422	c,g	350013106100000025,350013106100000064,350013106100000064	0-22,0-23,0-23						MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES - Patent application	www.faqs.org	0	0		MIR141
664	chr5	10482382	10482827	3500031979	45		10482382	10482827	8421504	2	22,23	0,422	c,g	350003197900000333,350003197900000354,350003197900000354	0-22,0-23,0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR141
664	chr5	10482803	10482827	3500362752	24		10482803	10482827	8421504	1	24	0	c,g	350036275200000113,350036275200000113	12-36,12-36						Method for inhibiting function of micro-rna	Iba	2011	0		MIR141
664	chr5	10482804	10482827	3500254286	23		10482804	10482827	8421504	1	23	0	c,g	350025428600000005,350025428600000005	0-23,0-23						Mirnas dysregulated in triple-negative breast cancer	Richer	2011	0		MIR141
664	chr5	10482804	10482827	3500251585	23		10482804	10482827	8421504	1	23	0	c,g	350025158500000001,350025158500000001	0-23,0-23						miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression	.aacrjournals.org	0	0		MIR141
664	chr5	10482804	10482827	3500171540	23		10482804	10482827	8421504	1	23	0	c,g	350017154000000005,350017154000000005	0-23,0-23						MiRNAs dysregulated in triple-negative breast cancer	Richer	2010	0		MIR141
664	chr5	10482804	10482827	3500003566	23		10482804	10482827	8421504	1	23	0	c,g	350000356600000005,350000356600000005	0-23,0-23						MIRNAS DYSREGULATED IN TRIPLE-NEGATIVE BREAST CANCER	Richer	2010	0		MIR141
665	chr5	10491687	10495425	3500336346	38		10491687	10495425	8421504	3	19,7,12	0,3635,3726	c,g	350033634600000011,350033634600000011,350033634600000010	0-19,0-19,0-19						DNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation	.springerplus.com	0	0		PTPN6
665	chr5	10491687	10495425	3500238848	38		10491687	10495425	8421504	3	19,7,12	0,3635,3726	c,g	350023884800000011,350023884800000011,350023884800000010	0-19,0-19,0-19						DNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation - Springer	link.springer.com	0	0		PTPN6
665	chr5	10491687	10495425	3500198082	38		10491687	10495425	8421504	3	19,7,12	0,3635,3726	c,g	350019808200000011,350019808200000011,350019808200000010	0-19,0-19,0-19		24010046	10.1186/2193-1801-2-392	2193-1801	SpringerPlus	DNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation	FernA!ndez-Nestosa	2013	0		PTPN6
665	chr5	10494857	10495319	3500359428	138		10494857	10495319	8421504	3	45,45,48	0,96,414	p	350035942800015025,350035942800015023,350035942800015020	0-45,0-45,0-48						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		PTPN6
665	chr5	10494857	10495319	3500322942	138		10494857	10495319	8421504	3	45,45,48	0,96,414	p	350032294200015025,350032294200015023,350032294200015020	0-45,0-45,0-48						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		PTPN6
665	chr5	10494857	10495319	3500075196	138		10494857	10495319	8421504	3	45,45,48	0,96,414	p	350007519600015030,350007519600015028,350007519600015025	0-45,0-45,0-48						USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS	Dunnington	1997	0		PTPN6
665	chr5	10494953	10495319	3500335247	93		10494953	10495319	8421504	2	45,48	0,318	p	350033524700015022,350033524700015019	0-45,0-48						Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection	Dunnington	1997	0		PTPN6
665	chr5	10503944	10503983	3500044070	39		10503944	10503983	8421504	1	39	0	c	350004407000000019,350004407000000005,350004407000000014	12-51,12-51,0-24						Multivalent rna nanoparticles for delivery of active agents to a cell - Patent application	www.faqs.org	0	0		
665	chr5	10508720	10509395	3500087477	57		10508720	10509395	8421504	2	21,36	0,639	p	350008747700015001	93-150						Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders	Chen	2003	0		
665	chr5	10510338	10510368	3500174068	30		10510338	10510368	8421504	1	30	0	c	350017406800000024	40-70						Full text of "Human Type 5, tartrate-resistant acid phosphatase : purification, characterization and molecular cloning"	archive.org	0	0		
665	chr5	10564129	10566975	3500372281	744		10564129	10566975	8421504	7	116,88,86,133,85,124,112	0,247,718,1078,1289,1489,2734	p	350037228100015011	0-744						12.2. Problems and exercises	elte.prompt.hu	0	0		TPI1,USP5
665	chr5	10564129	10566975	3500182600	744		10564129	10566975	8421504	7	116,88,86,133,85,124,112	0,247,718,1078,1289,1489,2734	p	350018260000015010,350018260000015007,350018260000015014,350018260000015013	0-744,0-744,0-177,0-180						Alignment09Apr14 print [&#x4e92;&#x63db;&#x30e2;&#x30fc;&#x30c9;]	isw3.naist.jp	0	0		
665	chr5	10564172	10565325	3500151965	47		10564172	10565325	8421504	2	24,23	0,1130	c	350015196500000001,350015196500000000	0-24,0-23						US Patent # 6,642,024. Guanylate-binding protein - Patents.com	www.patents.com	0	0		TPI1
665	chr5	10586602	10586627	3500121684	25		10586602	10586627	8421504	1	25	0	c	350012168400000001	0-25		11978662	10.2337/diabetes.51.5.1601	0012-1797	Diabetes	Effect of the (C825T) G&#x03b2;3 Polymorphism on Adrenoceptor-Mediated Lipolysis in Human Fat Cells	Ryden	2002	8		
665	chr5	10586606	10586635	3500110993	29		10586606	10586635	8421504	1	29	0	c	350011099300000012	10-39						Functional expression of heterologous adenylyl cyclase	Broach	1997	0		GNB3
665	chr5	10587682	10590079	3500201814	220		10587682	10590079	8421504	4	35,41,96,48	0,1465,1943,2349	p,c	350020181400000013,350020181400000012,350020181400000008,350020181400015012,350020181400000004	0-35,0-41,0-48,0-48,0-48						PTX sensitive G proteins, the production and use thereof	Siffert	1999	0		
665	chr5	10591590	10591617	3500307779	24		10591590	10591617	8421504	2	12,12	0,15	g	350030777900000002	8-32		20500693	10.1111/j.1365-3083.2010.02395.x	1365-3083	Scandinavian Journal of Immunology	Identification of the Amino Acid Sequence Motif for Conventional PKC-Mediated Regulation of NKp46 Surface Expression - Kim - 2010 - Scandinavian Journal of Immunology - Wiley Online Library	Kim	2010	0		
666	chr5	10617038	10617062	3500248946	24		10617038	10617062	8421504	1	24	0	c	350024894600000003	0-24						Mousemacrophages containatruncated CD4transcript	www.jleukbio.org	0	0		CD4
666	chr5	10649801	10649832	3500038331	28		10649801	10649832	8421504	2	11,17	0,14	c	350003833100000008	2-30		18614798	10.1091/mbc.E07-12-1223	1059-1524	Molecular Biology of the Cell	Phosphatidylinositol (4,5)-bisphosphate Modulates Nox5 Localization via an N-Terminal Polybasic Region	Kawahara	2008	5		
666	chr5	10741119	10747652	3500070288	27		10741119	10747652	8421504	2	22,5	0,6528	c	350007028800000509,350007028800000514	28-47,0-19						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
667	chr5	10748863	10748886	3500077080	23		10748863	10748886	8421504	1	23	0	c	350007708000000079	19-42						Method of using cells expressing galanin receptor 3 (GALR3) - Patent # 7022489 - PatentGenius	.patentgenius.com	0	0		
667	chr5	10767611	10767881	3500322289	57		10767611	10767881	8421504	2	14,43	0,227	p	350032228900015009	0-60						Award Number: W81XWH-05-1-0233 TITLE: A Proteomic Approach to Identify Phosphorylation-Dependent Targets of BRCT PRINCIPAL INVESTIGATOR: Zhou Songyang, Ph.D. 9 TYPE OF REPORT: Final DISTRIBUTION STATEMENT: Approved for Public Release;	www.dtic.mil	0	0		ING4
667	chr5	10808524	10808623	3500375099	99		10808524	10808623	8421504	1	99	0	p	350037509900015007	0-99						A plant cyclin dependent kinase-like protein, its interactors and uses thereof	De	2003	0		CHD4
667	chr5	10811571	10811599	3500036421	24		10811571	10811599	8421504	3	5,14,5	0,6,23	c	350003642100000331	21-45						ANTI-EPHA2 ANTIBODY - Patent application	www.faqs.org	0	0		
667	chr5	10811572	10811601	3500398895	25		10811572	10811601	8421504	3	4,14,7	0,5,22	c	350039889500000001	7-32						Anti-CD38 antibodies for the treatment of cancer	Park	2007	0		
667	chr5	10811572	10811601	3500259812	25		10811572	10811601	8421504	3	4,14,7	0,5,22	c	350025981200000001	7-32					Patent	Anti-CD38 antibodies for the treatment of cancer (Patent US:8153765)	Bartle	2012	0		
667	chr5	10811572	10811601	3500111698	25		10811572	10811601	8421504	3	4,14,7	0,5,22	c	350011169800000148	7-32						NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
667	chr5	10811653	10811756	3500391633	23		10811653	10811756	8421504	3	2,7,14	0,81,89	c	350039163300000022	0-24						Methods for producing an immune response to tuberculosis	Lewinsohn	2011	0		
667	chr5	10811653	10811756	3500272874	23		10811653	10811756	8421504	3	2,7,14	0,81,89	c	350027287400000022	0-24					Patent	Methods for producing an immune response to tuberculosis (Patent US:8101192)	Lewinsohn	2012	0		
667	chr5	10811653	10811756	3500267466	23		10811653	10811756	8421504	3	2,7,14	0,81,89	c	350026746600000022	0-24						Methods for producing an immune response to tuberculosis	Lewinsohn	2012	0		
667	chr5	10811653	10811756	3500122099	23		10811653	10811756	8421504	3	2,7,14	0,81,89	c	350012209900000022	0-24					Patent	Methods for producing an immune response to tuberculosis (Patent US:8440206)	Lewinsohn	2013	0		
667	chr5	10811653	10811756	3500069749	23		10811653	10811756	8421504	3	2,7,14	0,81,89	c	350006974900000022	0-24						Methods for detecting a mycobacterium tuberculosis infection	Lewinsohn	2013	0		
667	chr5	10812558	10814927	3500299630	201		10812558	10814927	8421504	3	96,54,51	0,592,2318	p	350029963000015056,350029963000015052,350029963000015055,350029963000015053	0-57,0-45,3-57,3-54						ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis	icine.bjmu.edu.cn	0	0		
667	chr5	10812558	10814927	3500216346	201		10812558	10814927	8421504	3	96,54,51	0,592,2318	p	350021634600015056,350021634600015052,350021634600015055,350021634600015053	0-57,0-45,3-57,3-54						ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis	icine.bjmu.edu.cn	0	0		
667	chr5	10829752	10829812	3500308897	44		10829752	10829812	8421504	4	4,25,10,5	0,5,43,55	c	350030889700000772,350030889700000343	76-120,16-60						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
667	chr5	10830759	10831059	3500264201	27		10830759	10831059	8421504	3	6,15,6	0,11,294	c	350026420100000001	3-32					Patent	Modified Morbillivirus V proteins (Patent US:6664066)	Parks	2003	0		
667	chr5	10847238	10847546	3500004994	23		10847238	10847546	8421504	2	3,20	0,288	c	350000499400000013	12-40						Methods and reagents for targeting organic compounds to selected cellular locations - Patent # 7045305 - PatentGenius	.patentgenius.com	0	0		
667	chr5	10853122	10853936	3500150786	40		10853122	10853936	8421504	2	20,20	0,794	g	350015078600000001,350015078600000000	0-20,0-20		23394073	10.1186/1756-9966-32-8	1756-9966	Journal of Experimental & Clinical Cancer Research	Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma	Wang	2013	2		GAPDH
667	chr5	10853122	10853936	3500150640	40		10853122	10853936	8421504	2	20,20	0,794	g	350015064000000010,350015064000000009	0-20,0-20						Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. - ResearchGate	.researchgate.net	0	0		GAPDH
667	chr5	10853122	10853936	3500032252	40		10853122	10853936	8421504	2	20,20	0,794	g	350003225200000003,350003225200000002	0-20,0-20		23892317	10.1038/srep02293	xxxx-xxxx	Scientific Reports	Capturing intercellular sugar-mediated ligand-receptor recognitions via a simple yet highly biospecific interfacial system	Li	2013	0		GAPDH
667	chr5	10853123	10853146	3500206935	23		10853123	10853146	8421504	1	23	0	g	350020693500000003	0-23						Cyclooxygenase-2/prostaglandin E2 accelerates the	gi.physiology.org	0	0		GAPDH
667	chr5	10853123	10853146	3500088953	23		10853123	10853146	8421504	1	23	0	g	350008895300000003	0-23		17673547	10.1152/ajpgi.00131.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors	Hatazawa	2007	0		GAPDH
667	chr5	10853123	10853146	3500037424	23		10853123	10853146	8421504	1	23	0	g	350003742400000003	0-23		17673547	10.1152/ajpgi.00131.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors	Hatazawa	2007	0		GAPDH
667	chr5	10853127	10853924	3500006299	45		10853127	10853924	8421504	2	24,21	0,776	g	350000629900000005,350000629900000004	0-24,0-21		9700083			American Journal of Physiology - Lung Cellular and Molecular Physiology	Retinoic acid-receptor activation of SP-B gene transcription in respiratory epithelial cells	Yan	1998	0		GAPDH
667	chr5	10853128	10854834	3500293281	41		10853128	10854834	8421504	2	20,21	0,1685	g	350029328100000005,350029328100000004	0-20,0-21						Elsie Spell | Safety of Life and Health	fe-and-health.com	0	0		
667	chr5	10853131	10853709	3500018416	40		10853131	10853709	8421504	2	20,20	0,558	g	350001841600000009,350001841600000008	0-20,0-20		12456808	10.1210/me.2001-0330	0888-8809	Molecular Endocrinology	Loss of Interleukin 6 Results in Delayed Mammary Gland Involution: A Possible Role for Mitogen-Activated Protein Kinase and Not Signal Transducer and Activator of Transcription 3	Zhao	2002	5		GAPDH
667	chr5	10853131	10853520	3500073842	40		10853131	10853520	8421504	2	20,20	0,369	g	350007384200000054,350007384200000053	0-20,0-20						Comparison of human and mouse AKR1C enzymes: implications for modeling human cancer	theses.bham.ac.uk	0	0		GAPDH
667	chr5	10853277	10853678	3500362883	48		10853277	10853678	8421504	2	24,24	0,377	g	350036288300000007,350036288300000006	0-24,0-24						REPRODUCTION	uction-online.org	0	0		
667	chr5	10853284	10853308	3500396701	24		10853284	10853308	8421504	1	24	0	g	350039670100000006	0-24		23977392	10.1371/journal.pone.0073709		PLoS ONE	Increased Plin2 Expression in Human Skeletal Muscle Is Associated with Sarcopenia and Muscle Weakness	Maria	2013	0		GAPDH
667	chr5	10853306	10854413	3500137385	40		10853306	10854413	8421504	2	20,20	0,1087	g	350013738500000003,350013738500000002	0-20,0-20		17785503	10.1152/ajpendo.00280.2007		American Journal of Physiology - Endocrinology and Metabolism	The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle	Erdmann	2007	0		
667	chr5	10853325	10853521	3500167223	43		10853325	10853521	8421504	2	22,21	0,175	g	350016722300000013,350016722300000012	0-22,0-21						Molecular characterization of the encoding regions and tissue expression analyses for three novel buffalo AKT genes AKT1 AKT2 and AKT3	ls.tubitak.gov.tr	0	0		
667	chr5	10853326	10853658	3500141385	44		10853326	10853658	8421504	2	23,21	0,311	g	350014138500000003,350014138500000002	0-23,0-21		11320249	10.1073/pnas.091577598	0027-8424	Proceedings of the National Academy of Sciences	Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola M&#xe9;rino ewes	Mulsant	2001	10		
667	chr5	10853497	10854209	3500004330	39		10853497	10854209	8421504	2	19,20	0,692	g	350000433000000006,350000433000000005	0-19,0-20			10.1111/j.1471-4159.2006.03852.x	1471-4159	Journal of Neurochemistry	Biochemical and biological characterization of a neuroendocrine-associated phosphatase - Wang - 2006 - Journal of Neurochemistry - Wiley Online Library	Wang	2006	0		GAPDH
667	chr5	10853503	10853528	3500361526	25		10853503	10853528	8421504	1	25	0	g	350036152600000004	0-25		15494465	10.1210/jc.2004-0277	0021-972X	Journal of Clinical Endocrinology & Metabolism	Mechanical Stretch Up-Regulates the Human Oxytocin Receptor in Primary Human Uterine Myocytes	Terzidou	2005	6		
667	chr5	10853658	10853681	3500206937	23		10853658	10853681	8421504	1	23	0	g	350020693700000027	0-23						terms and conditions of use	.era.lib.ed.ac.uk	0	0		
667	chr5	10853663	10853927	3500394704	40		10853663	10853927	8421504	2	20,20	0,244	g	350039470400000010,350039470400000009	0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
667	chr5	10853689	10853713	3500407152	24		10853689	10853713	8421504	1	24	0	g	350040715200000008	0-29					Patent	Oligomeric compounds for the modulation HIF-1&#x03b1; expression (Patent US:7737264)	Thrue	2010	0		
667	chr5	10853901	10853924	3500211710	23		10853901	10853924	8421504	1	23	0	g	350021171000000013	0-23						Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth 2003&#x5e74;&#x7b2c;162&#x5377;&#x7b2c;2&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		GAPDH,PPP5D1
667	chr5	10854132	10854361	3500360299	48		10854132	10854361	8421504	2	24,24	0,205	g	350036029900000009,350036029900000008	0-24,0-24						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	ijpr.sbmu.ac.ir	0	0		
667	chr5	10854137	10854348	3500399883	42		10854137	10854348	8421504	2	19,23	0,188	g	350039988300000001,350039988300000000	0-19,0-23						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	bdtd.ufscar.br	0	0		
667	chr5	10854137	10854348	3500358194	42		10854137	10854348	8421504	2	19,23	0,188	g	350035819400000007,350035819400000006	0-19,0-23		17158892	10.1128/IAI.00686-06	0019-9567	Infection and Immunity	Effect of Corticosteroids and Neuropeptides on the Expression of Defensins in Bovine Tracheal Epithelial Cells	Mitchell	2007	4		
667	chr5	10854137	10854348	3500337725	42		10854137	10854348	8421504	2	19,23	0,188	g	350033772500000001,350033772500000000	0-19,0-23						Felipe Camargo Braga TESE	www.teses.usp.br	0	0		
667	chr5	10854137	10854348	3500315071	42		10854137	10854348	8421504	2	19,23	0,188	g	350031507100000057,350031507100000056	0-19,0-23						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
667	chr5	10854137	10854348	3500205057	42		10854137	10854348	8421504	2	19,23	0,188	g	350020505700000029,350020505700000028	0-19,0-23						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
667	chr5	10854137	10854348	3500177864	42		10854137	10854348	8421504	2	19,23	0,188	g	350017786400000028,350017786400000027	0-19,0-23						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
667	chr5	10854137	10854348	3500137197	42		10854137	10854348	8421504	2	19,23	0,188	g	350013719700000029,350013719700000028	0-19,0-23						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
667	chr5	10854146	10856842	3500430446	40		10854146	10856842	8421504	2	20,20	0,2676	g	350043044600000031,350043044600000030	0-20,0-20						DPOFA, a Cl-/HCO3- exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	biomedcentral.com	0	0		
667	chr5	10854146	10854591	3500300182	40		10854146	10854591	8421504	2	20,20	0,425	g	350030018200000002,350030018200000001	0-20,0-20						Mechanisms underlying the synergistic enhancement of self-assembled neocartilage treated with chondroitinase-ABC and TGF-&#x03b2;1	w.bme.ucdavis.edu	0	0		
667	chr5	10854571	10854797	3500032199	41		10854571	10854797	8421504	2	20,21	0,205	g	350003219900000003,350003219900000002	0-20,0-21		19141072	10.1111/j.1471-4159.2008.05862.x	1471-4159	Journal of Neurochemistry	Signaling mechanisms of interferon gamma induced apoptosis in chromaffin cells: involvement of nNOS, iNOS, and NF&#x03ba;B - P&#xe9;rez-Rodr&#xed;guez - 2008 - Journal of Neurochemistry - Wiley Online Library	Perez-Rodriguez	2009	0		
667	chr5	10854956	10856843	3500233221	42		10854956	10856843	8421504	2	20,22	0,1865	g	350023322100000007,350023322100000006	0-20,0-22		24019931	10.1371/journal.pone.0073636	1932-6203	PLOS ONE	PLOS ONE: SGO1 Maintains Bovine Meiotic and Mitotic Centromeric Cohesions of Sister Chromatids and Directly Affects Embryo Development	Yin	2013	4		
667	chr5	10854956	10856843	3500193113	42		10854956	10856843	8421504	2	20,22	0,1865	g	350019311300000009,350019311300000008	0-20,0-22		24086682	10.1371/journal.pone.0076036	1932-6203	PLOS ONE	PLOS ONE: Establishment and Evaluation of a Stable Cattle Type II Alveolar Epithelial Cell Line	Su	2013	4		
667	chr5	10854966	10857182	3500079109	39		10854966	10857182	8421504	2	19,20	0,2196	g	350007910900000003,350007910900000002	0-19,0-20						Metalloproteinase Research	www.jbc.org	0	0		
668	chr5	10882227	10982637	3500131354	96		10882227	10982637	8421504	2	85,11	0,100399	c	350013135400000044,350013135400000045	0-48,0-48						Parkin interacting polypeptides and methods of use - Patent application	www.faqs.org	0	0		
668	chr5	10982637	10982733	3500131354	96		10982637	10982733	8421504	1	96	0	c	350013135400000046,350013135400000047	0-48,0-48						Parkin interacting polypeptides and methods of use - Patent application	www.faqs.org	0	0		
668	chr5	10982664	10988517	3500257087	225		10982664	10988517	8421504	5	45,45,45,45,45	0,48,5664,5712,5808	p	350025708700015179,350025708700015180,350025708700015181,350025708700015182,350025708700015184	0-45,0-45,0-45,0-45,0-45						Chimeric GFP-aequorin as bioluminescent Ca&plus &plus reporters at the single cell level	Baubet	2001	0		SYT1
668	chr5	10988430	10988493	3500413019	63		10988430	10988493	8421504	1	63	0	p	350041301900015000,350041301900015001	3-66,3-51					Proceedings of the National Academy of Sciences of the United States of America	Role of the conserved WHXL motif in the C terminus of synaptotagmin in synaptic vesicle docking	Mitsunori	2000	0		SYT1
669	chr5	11019373	11019401	3500217581	23		11019373	11019401	8421504	2	12,11	0,17	g	350021758100000060	16-39					Patent	Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods (Patent US:5604116)	Abrams	1997	0		
671	chr5	11324353	11324379	3500405557	24		11324353	11324379	8421504	3	15,4,5	0,16,21	g	350040555700000023	0-24						Abstracts of Oak Ridge Posters	www.clinchem.org	0	0		
671	chr5	11345293	11347840	3500446238	76		11345293	11347840	8421504	5	17,8,16,10,25	0,1133,1192,2509,2522	c	350044623800000006,350044623800000007,350044623800000005	0-25,0-26,0-25		15234908	10.1152/ajplung.00398.2003		American Journal of Physiology - Lung Cellular and Molecular Physiology	Role of CPI-17 in the regulation of endothelial cytoskeleton	Kolosova	2004	0		PPP1R12A
671	chr5	11347904	11352699	3500391427	60		11347904	11352699	8421504	2	43,17	0,4778	p	350039142700015011	0-60						Assays - Patent application	www.faqs.org	0	0		PPP1R12A
671	chr5	11347919	11352699	3500208501	45		11347919	11352699	8421504	2	28,17	0,4763	p	350020850100015013	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		PPP1R12A
671	chr5	11347919	11352699	3500189065	45		11347919	11352699	8421504	2	28,17	0,4763	p	350018906500015015	0-45						Assays	Schofield	2005	0		PPP1R12A
672	chr5	11412852	11412879	3500193135	24		11412852	11412879	8421504	2	19,5	0,22	g	350019313500000071,350019313500000029	6-30,6-30						Recombinant RSV Virus Expression Systems And Vaccines - Patent application	www.faqs.org	0	0		
676	chr5	12030054	12037668	3500424106	144		12030054	12037668	8421504	3	54,70,20	0,2717,7594	c,g	350042410600000052,350042410600000380,350042410600000380,350042410600000053	0-72,0-24,0-24,0-72						PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
678	chr5	12196213	12213159	3500424106	144		12196213	12213159	8421504	2	137,7	0,16939	c	350042410600000109	0-144						PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
678	chr5	12229424	12229451	3500095794	27		12229424	12229451	8421504	1	27	0	g	350009579400000008	0-27		16951257	10.1101/gad.382806	0890-9369	Genes & Development	A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb	Bajard	2006	12		
678	chr5	12287387	12288219	3500338309	169		12287387	12288219	8421504	4	6,60,43,60	0,394,581,772	c,g	350033830900000040,350033830900000047,350033830900000050,350033830900000006	0-60,0-60,13-56,0-20						Variabilita DNA gen&#x016f; MYF6 IGF2 a ACSL4 u prasat	phd.af.mendelu.cz	0	0		
678	chr5	12296301	12296936	3500032348	43		12296301	12296936	8421504	2	22,21	0,614	c,g	350003234800000010,350003234800000010,350003234800000011,350003234800000011	0-22,0-22,0-21,0-21			10.1186/1471-2164-8-63		BMC Genomics	Target genes of myostatin loss-of-function in muscles of late bovine fetuses	Isabelle	2007	0		
678	chr5	12296716	12296742	3500357396	26		12296716	12296742	8421504	1	26	0	c	350035739600000003	0-26						Early myotome speci&#xfb01;cation regulates PDGFA expression and axial skeleton development	ev.biologists.org	0	0		
678	chr5	12296828	12298353	3500257699	39		12296828	12298353	8421504	2	20,19	0,1506	c,g	350025769900000025,350025769900000026,350025769900000026	0-20,0-19,0-19						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
678	chr5	12297209	12298400	3500242241	42		12297209	12298400	8421504	2	20,22	0,1169	c,g	350024224100000002,350024224100000005,350024224100000003	0-20,20-42,0-22						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
678	chr5	12298732	12298756	3500261872	24		12298732	12298756	8421504	1	24	0	c	350026187200000000	23-47						RegioNes deL CRoMosoMA 5 AsoCiAdAs A CARACteR&#xcd;stiCAs de CReCiMieNto eN gANAdo CRioLLo RoMosiNUANo	www.scielo.org.co	0	0		MYF5
679	chr5	12336265	12336864	3500382374	596		12336265	12336864	8421504	4	247,72,35,242	0,248,321,357	g	350038237400000009	29-680						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
679	chr5	12336265	12336864	3500221817	596		12336265	12336864	8421504	4	247,72,35,242	0,248,321,357	g	350022181700000009	29-680					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
679	chr5	12336265	12336864	3500101798	590		12336265	12336864	8421504	5	247,72,35,128,108	0,248,321,357,491	g	350010179800000012	29-680						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
680	chr5	12464342	12464365	3500307094	23		12464342	12464365	8421504	1	23	0	c	350030709400000007	0-23		11104771	10.1074/jbc.M009334200	0021-9258	Journal of Biological Chemistry	Contrasting Localizations of MALS/LIN-7 PDZ Proteins in Brain and Molecular Compensation in Knockout Mice	Misawa	2001	5		
680	chr5	12465146	12465169	3500308662	23		12465146	12465169	8421504	1	23	0	g	350030866200000024	0-23						DNA	.lib.kobe-u.ac.jp	0	0		
685	chr5	13222215	13222238	3500161408	23		13222215	13222238	8421504	1	23	0	g	350016140800000003	1-25			10.1111/j.1742-4658.2007.06087.x	1742-4658	FEBS Journal	A comparative study of type&#xa0;I and type&#xa0;II tryparedoxin peroxidases in Leishmania major - K&#xf6;nig - 2007 - FEBS Journal - Wiley Online Library	Konig	2007	0		
686	chr5	13268170	13268202	3500454505	30		13268170	13268202	8421504	3	9,8,13	0,10,19	g	350045450500000031	1-31					Patent	Recombinant fowlpox viruses and uses thereof (Patent US:6001369)	Cochran	1999	0		
688	chr5	13595349	13595377	3500405663	23		13595349	13595377	8421504	2	12,11	0,17	g	350040566300000021	10-33						US Patent # 6,512,097. High affinity human antibodies to tumor antigens - Patents.com	www.patents.com	0	0		
691	chr5	13934695	13934725	3500306055	27		13934695	13934725	8421504	2	12,15	0,15	g	350030605500000089,350030605500000174,350030605500000090,350030605500000175	0-31,0-31,0-31,0-31					Patent	Anticorps anti-igf-ir et leurs applications (Patent EP:1461359)	Corvaia	2007	0		
691	chr5	13934695	13934725	3500003792	27		13934695	13934725	8421504	2	12,15	0,15	g	350000379200000089,350000379200000173,350000379200000090,350000379200000172	0-31,0-31,0-31,0-31						Anti-IGF-IR antibodies and their applications	Goetsch	2003	0		
694	chr5	14360247	14360271	3500112397	23		14360247	14360271	8421504	2	8,15	0,9	g	350011239700000091	0-23						US Patent # 7,427,596. Variants of vascular endothelial cell growth factor, their uses, and processes for their production - Patents.com	www.patents.com	0	0		
694	chr5	14416184	14416211	3500292931	24		14416184	14416211	8421504	2	19,5	0,22	g	350029293100000338	0-29					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent EP:2135950)	NATT	2012	0		
696	chr5	14677473	14677500	3500324039	23		14677473	14677500	8421504	2	14,9	0,18	g	350032403900000003,350032403900000005	0-23,0-21						INHIBITORS OF SIDEROPHORE BIOSYNTHESIS IN FUNGI - Austria, Wirtschaftsservice Gesellschaft Mbh	www.sumobrain.com	0	0		
696	chr5	14677473	14677500	3500208791	23		14677473	14677500	8421504	2	14,9	0,18	g	350020879100000003,350020879100000005	0-23,0-21						Inhibitors Of Siderophore Biosynthesis In Fungi 	.freshpatents.com	0	0		
696	chr5	14677473	14677500	3500008646	23		14677473	14677500	8421504	2	14,9	0,18	g	350000864600000003,350000864600000005	0-23,0-21						Inhibitors of Siderophore Biosynthesis in Fungi	Haas	2005	0		
696	chr5	14678687	14678713	3500383915	24		14678687	14678713	8421504	3	4,4,16	0,5,10	g	350038391500000384,350038391500000385	3-25,3-27						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
713	chr5	16783664	16783691	3500253862	23		16783664	16783691	8421504	3	5,5,13	0,8,14	g	350025386200000075	1-26						Virus assay method	Fan	1998	0		
714	chr5	16980288	16980313	3500309311	24		16980288	16980313	8421504	2	4,20	0,5	c	350030931100000012	10-34						The17-ResidueTransmembraneDomainof&#xdf;-Galactoside a2,6-SialyltransferaseIsSufficientforGolgiRetention	jcb.rupress.org	0	0		
714	chr5	17034870	17034893	3500320247	23		17034870	17034893	8421504	1	23	0	g	350032024700000093	14-37						Oligonucleotide modulation of protein kinase c	Bennett	1996	0		
714	chr5	17034870	17034893	3500250374	23		17034870	17034893	8421504	1	23	0	g	350025037400000005	14-37		10982336	10.1128/JVI.74.19.8930-8937.2000	0022-538X	Journal of Virology	3&#x2032;-End Formation of Baculovirus Late RNAs	Jin	2000	5		RNF152
714	chr5	17034870	17034893	3500107878	23		17034870	17034893	8421504	1	23	0	g	350010787800000012	14-37						Screening assay for identifying human purinoreceptor ligands	Burgard	1999	0		RNF152
714	chr5	17034870	17034893	3500012509	23		17034870	17034893	8421504	1	23	0	g	350001250900000005	14-37		14973148	10.1152/ajpcell.00061.2003		American Journal of Physiology - Cell Physiology	OKP cells express the Na-dicarboxylate cotransporter NaDC-1	Aruga	2004	0		
716	chr5	17223612	17223673	3500463210	48		17223612	17223673	8421504	2	21,27	0,34	c	350046321000000004,350046321000000005	0-21,0-27		12393715	10.1182/blood-2002-03-0711	0006-4971	Blood	Identification of a novel class of human adherent CD34&#x2212; stem cells that give rise to SCID-repopulating cells	Kuci	2003	10		
716	chr5	17223612	17223673	3500412028	48		17223612	17223673	8421504	2	21,27	0,34	c	350041202800000004,350041202800000005	0-21,0-27		12393715	10.1182/blood-2002-03-0711	0006-4971	Blood	Identification of a novel class of human adherent CD34&#x2212; stem cells that give rise to SCID-repopulating cells	Kuci	2003	10		
720	chr5	17816246	17824559	3500018308	72		17816246	17824559	8421504	3	25,23,24	0,1840,8289	c	350001830800000007,350001830800000000,350001830800000003,350001830800000001	6-30,0-25,5-28,0-24		9530155			American Journal of Physiology - Gastrointestinal and Liver Physiology	DNA methylation contributes to expression of the human neurotensin/neuromedin N gene	Dong	1998	0		
720	chr5	17816246	17816271	3500353385	25		17816246	17816271	8421504	1	25	0	c	350035338500000000	0-25		11093935			American Journal of Physiology - Gastrointestinal and Liver Physiology	Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers	Dong	2000	0		NTS
720	chr5	17816246	17816271	3500062021	25		17816246	17816271	8421504	1	25	0	c	350006202100000000	0-25		11093935			American Journal of Physiology - Gastrointestinal and Liver Physiology	Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers	Dong	2000	0		NTS
721	chr5	17827170	17827193	3500219201	23		17827170	17827193	8421504	1	23	0	c	350021920100000062	22-45						Somatostatin, cortistatin, ghrelin and their receptors: From an endocrine system to a pleiotropic system of patho- physiologic relevance	helvia.uco.es	0	0		
725	chr5	18359959	18359982	3500084244	23		18359959	18359982	8421504	1	23	0	g	350008424400000040	11-34						Comparative analysis of transposed element insertion within human and mouse genomes reveals Alu's unique role in shaping the human transcriptome Noa Sela Wagenblatt	www.tau.ac.il	0	0		
731	chr5	19252714	19252746	3500418203	26		19252714	19252746	8421504	3	13,5,8	0,14,24	g	350041820300000060	17-45						Biofuel Production 	.freshpatents.com	0	0		
731	chr5	19252714	19252746	3500257879	26		19252714	19252746	8421504	3	13,5,8	0,14,24	g	350025787900000060	17-45						Biofuel Production 	freshpatents.com	0	0		
742	chr5	20612094	20626338	3500108101	132		20612094	20626338	8421504	4	30,54,43,5	0,46,3978,14239	c	350010810100000140,350010810100000141,350010810100000112,350010810100000098,350010810100000084	2-32,0-48,0-48,0-48,0-43						US Patent # 6,841,147. Stem cell factor compositions - Patents.com	www.patents.com	0	0		
742	chr5	20612095	20628473	3500101830	540		20612095	20628473	8421504	16	45,45,45,27,18,45,43,2,45,31,14,45,45,45,17,28	0,48,96,144,3079,3100,3196,3936,3941,3989,14238,14255,14303,15295,15343,16350	p	350010183000015065,350010183000015066,350010183000015067,350010183000015068,350010183000015069,350010183000015071,350010183000015072,350010183000015073,350010183000015074,350010183000015075,350010183000015076,350010183000015077	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						 <HTML> <HEAD><TITLE>a|a*c+-aeY=i1/2i1/4i1/4<<i1/2i1/2a?a3aa-e3aa<<a-3/4aaaC/aa-aa1/4aa<<ae	www.j-tokkyo.com	0	0		
742	chr5	20612108	20615275	3500274037	40		20612108	20615275	8421504	2	20,20	0,3147	c,g	350027403700000023,350027403700000023,350027403700000020	0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
742	chr5	20612113	20612255	3500331184	48		20612113	20612255	8421504	2	24,24	0,118	c	350033118400000004,350033118400000005	0-24,0-24						UNIVERSIDADE ESTADUAL DO CEAR&#xc1; PR&#xd3;-REITORIA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O E PESQUISA FACULDADE DE VETERIN&#xc1;RIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS VETERIN&#xc1;RIAS JULIANA JALES DE HOLLANDA CELESTINO EXX PPRREESSSS&#	cnptia.embrapa.br	0	0		
742	chr5	20612127	20612169	3500245482	42		20612127	20612169	8421504	1	42	0	c	350024548200000276	5-47						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
742	chr5	20612157	20626432	3500459046	72		20612157	20626432	8421504	2	42,30	0,14245	c	350045904600000000,350045904600000001	0-42,0-30		12193416	10.1095/biolreprod.101.002527	0006-3363	Biology of Reproduction	Growth and Differentiation Factor-9 Stimulates Progression of Early Primary but Not Primordial Rat Ovarian Follicle Development	Nilsson	2002	4		
742	chr5	20612157	20626432	3500423401	72		20612157	20626432	8421504	2	42,30	0,14245	c	350042340100000004,350042340100000005	0-42,0-30						Thecal Cell-Granulosa Cell Interactions Involve a Positive Feedback Loop among Keratinocyte Growth Factor, Hepatocyte Growth Factor, and Kit Ligand during Ovarian Follicular Development*	.endojournals.org	0	0		
742	chr5	20612157	20626432	3500297499	72		20612157	20626432	8421504	2	42,30	0,14245	c	350029749900000000,350029749900000001	0-42,0-30						Growth and Differentiation Factor-9 Stimulates Progression of Early Primary but Not Primordial Rat Ovarian Follicle Development1	ww.biolreprod.org	0	0		
742	chr5	20615309	20616066	3500085396	60		20615309	20616066	8421504	2	25,35	0,722	c	350008539600000124	0-60						Recombinant production of authentic human proteins using human cell expression systems	Chen	2009	0		
742	chr5	20615327	20628492	3500205201	148		20615327	20628492	8421504	5	7,84,8,2,47	0,704,11006,12126,13118	c	350020520100000105,350020520100000106,350020520100000092,350020520100000156,350020520100000178	0-48,0-48,0-43,0-39,0-49						Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides	Zsebo	1995	0		
742	chr5	20616039	20616087	3500204190	48		20616039	20616087	8421504	1	48	0	c,g	350020419000000042,350020419000000042	0-48,0-48						US Patent # 5,525,708. Covalent dimer of kit ligand - Patents.com	www.patents.com	0	0		
742	chr5	20616072	20628492	3500203133	97		20616072	20628492	8421504	4	43,5,2,47	0,10261,11381,12373	c	350020313300000106,350020313300000092,350020313300000178	0-48,0-43,0-49						Method of preparing human stem cell factor polypeptide	Zsebo	2000	0		
742	chr5	20616084	20628470	3500146612	64		20616084	20628470	8421504	3	19,20,25	0,11351,12361	p,c,g	350014661200000001,350014661200000001,350014661200000004,350014661200000004,350014661200015008	0-19,0-19,0-19,0-19,0-45						Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor - US Patent 6248326 Description	ww.patentstorm.us	0	0		KITLG
743	chr5	20822666	20836872	3500101830	135		20822666	20836872	8421504	4	45,12,33,45	0,48,14125,14161	p	350010183000015064,350010183000015063,350010183000015062	0-45,0-45,0-45						 <HTML> <HEAD><TITLE>a|a*c+-aeY=i1/2i1/4i1/4<<i1/2i1/2a?a3aa-e3aa<<a-3/4aaaC/aa-aa1/4aa<<ae	www.j-tokkyo.com	0	0		KITLG
743	chr5	20822678	20822726	3500205201	48		20822678	20822726	8421504	1	48	0	c	350020520100000097	0-48						Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides	Zsebo	1995	0		
743	chr5	20832446	20832471	3500015771	24		20832446	20832471	8421504	2	20,4	0,21	g	350001577100000007,350001577100000003	6-31,6-31						SALMONELLA ENTERICA PRESENTING C. JEJUNI N-GLYCAN OR DERIVATIVES THEREOF - Patent application	www.faqs.org	0	0		
743	chr5	20836851	20836887	3500204190	36		20836851	20836887	8421504	1	36	0	c	350020419000000001	0-36						US Patent # 5,525,708. Covalent dimer of kit ligand - Patents.com	www.patents.com	0	0		
747	chr5	21304154	21304178	3500246549	23		21304154	21304178	8421504	2	12,11	0,13	g	350024654900000153	9-48						Haemophilus influenzae type IV pili - Patent application	www.faqs.org	0	0		
749	chr5	21513070	21513096	3500295746	25		21513070	21513096	8421504	2	9,16	0,10	g	350029574600000010	2-27		11514451		0016-6731	Genetics	The cyclope Gene of Drosophila Encodes a Cytochrome c Oxidase Subunit VIc Homolog	Szuplewski	2001	4		
751	chr5	21837371	21837433	3500444068	62		21837371	21837433	8421504	1	62	0	g	350044406800000001,350044406800000003	4-66,22-84						 STAR: ultrafast universal RNA-seq aligner - Page 3 - SEQanswers	seqanswers.com	0	0		
751	chr5	21837446	21838266	3500004143	41		21837446	21838266	8421504	2	21,20	0,800	c,g	350000414300000003,350000414300000002	0-21,0-20		18542059	10.1038/onc.2008.182	0950-9232	Oncogene	Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice	Hasegawa	2008	6		
751	chr5	21838233	21841007	3500370645	52		21838233	21841007	8421504	2	25,27	0,2747	c	350037064500000007,350037064500000006	17-42,10-37						The Role of Cellular Micro-RNAs in Epstein-Barr Virus Induced Cellular Transformation and Oncogenesis	theses.bham.ac.uk	0	0		DUSP6
751	chr5	21838433	21839702	3500180819	40		21838433	21839702	8421504	2	20,20	0,1249	c,g	350018081900000001,350018081900000001,350018081900000000	0-20,0-20,0-20		16551863	10.1158/1078-0432.CCR-05-1729	1078-0432	Clinical Cancer Research	Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivo	Ouyang	2006	8		DUSP6
751	chr5	21839604	21839628	3500287081	24		21839604	21839628	8421504	1	24	0	c	350028708100000014	24-48						Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia	tologylibrary.org	0	0		
751	chr5	21840691	21840717	3500150285	26		21840691	21840717	8421504	1	26	0	c	350015028500000000	0-26						 Methods Utilizing Target Genes Related To Immune 	www.docstoc.com	0	0		
751	chr5	21841612	21841642	3500361430	30		21841612	21841642	8421504	1	30	0	g	350036143000000004,350036143000000000,350036143000000003	0-27,0-25,0-27		18321244	10.1042/BJ20071512		Biochemical Journal	Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter	Maria	June	0		DUSP6
753	chr5	22101354	22109950	3500367264	48		22101354	22109950	8421504	3	24,16,8	0,258,8588	c	350036726400000005,350036726400000004	0-24,0-24		12181175	10.1152/ajpgi.00269.2001		American Journal of Physiology - Gastrointestinal and Liver Physiology	Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell lines	Fleet	2002	0		ATP2B1
753	chr5	22101354	22109950	3500138424	48		22101354	22109950	8421504	3	24,16,8	0,258,8588	c,g	350013842400000005,350013842400000005,350013842400000004	0-24,0-24,0-24		12181175	10.1152/ajpgi.00269.2001		American Journal of Physiology - Gastrointestinal and Liver Physiology	Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell lines	Fleet	2002	0		
753	chr5	22101354	22109950	3500036012	48		22101354	22109950	8421504	3	24,16,8	0,258,8588	c	350003601200000005,350003601200000004	0-24,0-24						Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell lines	gi.physiology.org	0	0		ATP2B1
753	chr5	22101598	22110059	3500156963	147		22101598	22110059	8421504	2	30,117	0,8344	p	350015696300015001	0-147						0946.Calpain Methods and Protocols	www.scribd.com	0	0		ATP2B2
753	chr5	22109948	22109996	3500061337	48		22109948	22109996	8421504	1	48	0	p	350006133700015141	0-48						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		ATP2B3
753	chr5	22115110	22115136	3500401449	24		22115110	22115136	8421504	2	11,13	0,13	g	350040144900000002	0-24		9858504	10.1095/biolreprod60.1.183	0006-3363	Biology of Reproduction	Induction of Matrix Metalloproteinases and Collagenolysis in Chick Embryonic Membranes before Hatching	Lei	1999	4		
753	chr5	22139880	22139903	3500369442	23		22139880	22139903	8421504	1	23	0	c	350036944200000006	13-36						PMCA AS A REGULATOR OF CALCIUM/CALMODULIN-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS	penrepository.com	0	0		ATP2B1
759	chr5	22852553	22852577	3500454505	24		22852553	22852577	8421504	1	24	0	g	350045450500000023	0-45					Patent	Recombinant fowlpox viruses and uses thereof (Patent US:6001369)	Cochran	1999	0		
763	chr5	23446774	23446799	3500216463	23		23446774	23446799	8421504	2	6,17	0,8	g	350021646300000064	0-23						Bacterial genomics and its applications in molecular epidemiology of Salmonella enterica	works.unsw.edu.au	0	0		
764	chr5	23511647	23511674	3500196890	25		23511647	23511674	8421504	2	9,16	0,11	c	350019689000000001	0-25						50 human secreted proteins	George	2000	0		
765	chr5	23608677	23654200	3500207027	64		23608677	23654200	8421504	3	23,21,20	0,5103,45503	c,g	350020702700000009,350020702700000008,350020702700000010,350020702700000010	0-23,0-21,0-20,0-20						Keratocyte behavior in three-dimensional photopolymerizable poly(ethylene glycol) hydrogels	pkinsmedicine.org	0	0		
765	chr5	23613551	23613772	3500444204	40		23613551	23613772	8421504	2	20,20	0,201	c	350044420400000005,350044420400000004	0-20,0-20						Modulation of keratocyte phenotype by collagen fibril nanoarchitecture in membranes for corneal repair	.johnshopkins.edu	0	0		
765	chr5	23614111	23654467	3500286026	80		23614111	23654467	8421504	3	28,27,25	0,36853,40331	c	350028602600000017,350028602600000019,350028602600000018	0-28,0-27,0-25						Analysis of transcriptional regulation of the small leucine rich proteoglycans	www.molvis.org	0	0		
95	chr5	23694075	23728278	3500105644	67		23694075	23728278	8421504	3	25,22,20	0,4472,34183	c,g	350010564400000002,350010564400000000,350010564400000000,350010564400000001	0-25,0-22,0-22,4-24						Characterization of decorin mRNA in pregnant intrauterine tissues of the ewe and regulation by steroids	ll.physiology.org	0	0		
765	chr5	23694146	23694170	3500180889	24		23694146	23694170	8421504	1	24	0	c	350018088900000013	24-48						Mechanoactive Tenogenic Differentiation of Human Mesenchymal Stem Cells	ncedbiomatrix.com	0	0		
765	chr5	23694269	23698537	3500161109	26		23694269	23698537	8421504	2	19,7	0,4261	c	350016110900000009	0-26						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		DCN
765	chr5	23702534	23702557	3500122889	23		23702534	23702557	8421504	1	23	0	c	350012288900000039,350012288900000015	0-23,0-23						Methods And Compositions Targeting Tyrosine Kinases For The Diagnosis And Treatment Of Osteoarthritis 	.freshpatents.com	0	0		DCN
765	chr5	23702591	23709370	3500358136	40		23702591	23709370	8421504	2	20,20	0,6759	c	350035813600000006,350035813600000007	0-20,0-20						Untersuchungen zur gef&#xe4;&#xdf;protektiven Wirkung von Iloprost an humanen Gef&#xe4;&#xdf;muskelzellen	ni-duesseldorf.de	0	0		DCN
765	chr5	23702591	23709370	3500110311	40		23702591	23709370	8421504	2	20,20	0,6759	c	350011031100000006,350011031100000007	0-20,0-20						Untersuchungen zur gef&#xe4;&#xdf;protektiven Wirkung von Iloprost an humanen Gef&#xe4;&#xdf;muskelzellen	ni-duesseldorf.de	0	0		DCN
773	chr5	24755498	24755523	3500292395	24		24755498	24755523	8421504	2	6,18	0,7	c	350029239500000012	4-31						METHODS OF USING HUMANIZED ANTIBODIES AND COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE - Patent application	www.faqs.org	0	0		
773	chr5	24755498	24755523	3500276774	24		24755498	24755523	8421504	2	6,18	0,7	c	350027677400000012	4-31						COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND CONDITIONS - Patent application	www.faqs.org	0	0		
773	chr5	24755789	24757244	3500251406	501		24755789	24757244	8421504	3	279,74,148	0,288,1307	p	350025140600015093,350025140600015095,350025140600015094	0-501,0-108,0-186					Patent	Human cDNAs and proteins and uses thereof (Patent US:7285631)	Bejanin	2007	0		BTG1
773	chr5	24755789	24757244	3500054122	510		24755789	24757244	8421504	2	362,148	0,1307	p	350005412200015089,350005412200015090	0-510,0-477						Human Cdnas And Proteins And Uses Thereof 	.freshpatents.com	0	0		BTG1
773	chr5	24755855	24755915	3500196806	43		24755855	24755915	8421504	2	22,21	0,39	c	350019680600000014,350019680600000013	0-22,0-21						Polynucleotides and polypeptides associated with the NF-kappaB pathway	Nadler	2004	0		
779	chr5	25525808	25525831	3500063056	23		25525808	25525831	8421504	1	23	0	g	350006305600000038	0-23						Vaccine and antitoxin for treatment and prevention of c. difficile disease	Firca	1999	0		
783	chr5	25963825	25966775	3500291450	180		25963825	25966775	8421504	4	30,45,88,17	0,861,2660,2933	p	350029145000015008	0-180						BMC Biochemistry BioMed Central	biomedcentral.com	0	0		
783	chr5	25976765	26016945	3500287310	1084		25976765	26016945	8421504	26	58,20,30,8,58,34,22,25,31,7,14,11,19,52,58,56,53,21,33,39,56,54,20,247,28,30	0,60,81,119,129,189,225,252,278,321,331,349,361,386,443,506,567,624,647,701,1550,1611,1670,1872,40117,40150	p,c	350028731000000012,350028731000015216,350028731000015215,350028731000015214,350028731000015213,350028731000015212	20-1112,0-48,0-48,0-45,0-48,0-90						 Assays For Identifying Ubiquitin Agents And For Identifying Agents That Modify The Activity Of Ubiquitin Agents 	www.docstoc.com	0	0		
783	chr5	25976997	25977287	3500281203	42		25976997	25977287	8421504	2	21,21	0,269	c	350028120300000004,350028120300000003	0-21,0-21		17709392	10.1128/MCB.00579-07	0270-7306	Molecular and Cellular Biology	DNA Damage-Dependent Acetylation and Ubiquitination of H2AX Enhances Chromatin Dynamics	Ikura	2007	6		UBE2N
783	chr5	25976997	25977287	3500184023	42		25976997	25977287	8421504	2	21,21	0,269	c	350018402300000004,350018402300000003	0-21,0-21			10.1128/MCB.00579-07		Molecular and Cellular Biology	DNA Damage-Dependent Acetylation and Ubiquitination of H2AX Enhances Chromatin Dynamics 	Tsuyoshi	2007	0		UBE2N
783	chr5	25977144	25978345	3500046604	44		25977144	25978345	8421504	2	22,22	0,1179	c	350004660400000001,350004660400000000	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
783	chr5	25978423	26016888	3500093942	225		25978423	26016888	8421504	5	32,7,18,162,6	0,214,224,299,38459	p	350009394200015011,350009394200015005	0-57,12-180						Bioinformatica e Progetto Genoma Umano	www.unibas.it	0	0		MRPL42,UBE2N
784	chr5	26130949	26132623	3500261436	49		26130949	26132623	8421504	3	17,6,26	0,1613,1648	c	350026143600000099,350026143600000100	0-23,0-26						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
784	chr5	26132707	26132836	3500088223	40		26132707	26132836	8421504	2	20,20	0,109	c,g	350008822300000008,350008822300000008,350008822300000009,350008822300000009	0-20,0-20,0-20,0-20						NUTRITIONAL REGULATION OF SERUM INSULIN-LIKE GROWTH FACTOR-I CONCENTRATION IN CATTLE	cholar.lib.vt.edu	0	0		
784	chr5	26132959	26133355	3500371489	40		26132959	26133355	8421504	2	20,20	0,376	c,g	350037148900000003,350037148900000004,350037148900000004	0-20,0-20,0-20						Mammary Response to Exogenous Prolactin or Frequent Milking During Early Lactation in Dairy Cows	circlescience.biz	0	0		
788	chr5	26708254	26708281	3500278603	23		26708254	26708281	8421504	3	13,5,5	0,15,22	g	350027860300000050	16-39						Transgenic non-human mammals producing a cholinesterase in their milk - US Patent 6987211 Description	ww.patentstorm.us	0	0		
792	chr5	27195481	27195509	3500270833	25		27195481	27195509	8421504	2	9,16	0,12	g	350027083300000013	0-29						Altered polypeptides, immunoconjugates thereof, and methods related thereto	Lugovskoy	2008	0		
792	chr5	27209673	27209699	3500363471	23		27209673	27209699	8421504	3	13,5,5	0,15,21	g	350036347100000043	10-33						Syst&#xe8;me de s&#xe9;cr&#xe9;tion de type IV et prot&#xe9;ines &#xe0; domaines ankyrines dans les interactions Wolbachia-arthropodes	.univ-poitiers.fr	0	0		
792	chr5	27219380	27219406	3500348374	24		27219380	27219406	8421504	2	6,18	0,8	g	350034837400000018	6-32		20545850	10.1111/j.1365-2958.2010.07230.x	1365-2958	Molecular Microbiology	Screening Leishmania donovani-specific genes required for visceral infection - Zhang - 2010 - Molecular Microbiology - Wiley Online Library	Zhang	2010	0		
793	chr5	27353792	27353817	3500318414	23		27353792	27353817	8421504	3	7,11,5	0,8,20	g	350031841400000013	15-40			10.1111/j.1742-4658.2006.05613.x	1742-4658	FEBS Journal	Protein disulfide isomerase family proteins involved in soybean protein biogenesis - Wadahama - 2006 - FEBS Journal - Wiley Online Library	Wadahama	2007	0		
794	chr5	27484484	27484512	3500363671	23		27484484	27484512	8421504	3	5,11,7	0,6,21	g	350036367100000037	17-40						PLAG GENE FAMILY AND TUMORIGENESIS - Vlaams, Interuniversitair Instituut Voor Biotechnologie	www.sumobrain.com	0	0		
795	chr5	27563925	27563985	3500254665	60		27563925	27563985	8421504	1	60	0	p	350025466500015049	0-60						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		NR2C1
795	chr5	27563964	27564024	3500145287	60		27563964	27564024	8421504	1	60	0	p	350014528700015001	0-60						Dna binding proteins including androgen receptor	Chang	1992	0		NR2C1
796	chr5	27726900	27726924	3500231031	23		27726900	27726924	8421504	2	7,16	0,8	g	350023103100000151	15-44						Broad-spectrum delta-endotoxins		1998	0		
797	chr5	27845253	27845282	3500006718	29		27845253	27845282	8421504	1	29	0	c	350000671800000240,350000671800000239	14-43,14-43						CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME - Patent application	www.faqs.org	0	0		
797	chr5	27848832	27848866	3500059243	34		27848832	27848866	8421504	1	34	0	c	350005924300000064,350005924300000017	0-34,0-34						Methionine aminopeptidase type 3	Aurora	2000	0		
797	chr5	27912716	27912925	3500373947	42		27912716	27912925	8421504	2	20,22	0,187	g	350037394700000042,350037394700000043	0-20,0-22						Udder Health Characteristics	Lund	2007	0		
800	chr5	28273149	28273179	3500354019	25		28273149	28273179	8421504	2	13,12	0,18	c	350035401900000056	19-44						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
12	chr5	28309296	28334583	3500007115	1171		28309296	28334583	8421504	23	25,32,39,48,86,58,48,7,41,7,126,101,141,57,31,62,3,19,29,37,11,64,99	0,456,534,1325,1801,2181,2589,2679,3735,3830,3953,4161,4676,7105,7589,7800,7863,7964,9114,9191,24978,25037,25188	c,g	350000711500000123,350000711500000121,350000711500000119,350000711500000117,350000711500000116,350000711500000115,350000711500000113,350000711500000084,350000711500000109,350000711500000081,350000711500000108,350000711500000080,350000711500000107,350000711500000106,350000711500000105,350000711500000104,350000711500000103,350000711500000102,350000711500000101,350000711500000098,350000711500000097,350000711500000094,350000711500000092,350000711500000090,350000711500000126,350000711500000089	15-72,9-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,5-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,11-34,0-116						DNA encoding mammalian phosphodiesterases	Beavo	1992	0		
801	chr5	28311919	28313978	3500252826	46		28311919	28313978	8421504	3	23,17,6	0,1622,2053	c	350025282600000004,350025282600000003	0-23,0-23						Die Rolle von Zinkionen in der Signaltransduktion von Monozyten	th.rwth-aachen.de	0	0		PDE1B
801	chr5	28404589	28404612	3500416294	23		28404589	28404612	8421504	1	23	0	g	350041629400000014	16-39						Mig-7 As A Specific Anticancer Target 	.freshpatents.com	0	0		
802	chr5	28455049	28455160	3500159663	111		28455049	28455160	8421504	1	111	0	c,g	350015966300000004,350015966300000005,350015966300000007,350015966300000000,350015966300000000,350015966300000001,350015966300000001	2-58,2-38,0-31,0-52,0-52,0-52,0-52		12939287	10.1167/iovs.03-0191	1552-5783	Investigative Ophthalmology & Visual Science	Regulation of the Integrin Subunit &#x03b1;5 Gene Promoter by the Transcription Factors Sp1/Sp3 Is Influenced by the Cell Density in Rabbit Corneal Epithelial Cells	Gingras	2003	0		
802	chr5	28455103	28474973	3500033126	94		28455103	28474973	8421504	2	70,24	0,19846	c,g	350003312600000005,350003312600000001,350003312600000001,350003312600000008,350003312600000008,350003312600000004,350003312600000020	0-51,0-52,0-52,2-26,2-26,3-32,0-24		18775869	10.1167/iovs.08-2059	1552-5783	Investigative Ophthalmology & Visual Science	Differential Binding of the Transcription Factors Sp1, AP-1, and NFI to the Promoter of the Human &#x03b1;5 Integrin Gene Dictates Its Transcriptional Activity	Gingras	2009	0		ITGA5
802	chr5	28455129	28455153	3500410288	24		28455129	28455153	8421504	1	24	0	c,g	350041028800000012,350041028800000012	2-26,2-26			10.1167/iovs.07-0016	1552-5783	Investigative Ophthalmology & Visual Science	Laminin Reduces Expression of the Human &#x03b1;6 Integrin Subunit Gene by Altering the Level of the Transcription Factors Sp1 and Sp3	Gaudreault	2007	0		ITGA5
802	chr5	28455301	28455346	3500436553	45		28455301	28455346	8421504	1	45	0	p	350043655300015053	81-126					Patent	A tumor suppressor designated ts10q23.3 (Patent CA:2301199)	Steck	2013	0		
802	chr5	28463343	28463628	3500122758	40		28463343	28463628	8421504	2	20,20	0,265	c,g	350012275800000006,350012275800000006,350012275800000007	0-20,0-20,0-20						a Accelerates Monocyte to Endothelial Transdifferentiation in Tumors by the Induction of Integrin a Expression and Adhesion to Fibronectin	.aacrjournals.org	0	0		
802	chr5	28468985	28469030	3500391361	45		28468985	28469030	8421504	1	45	0	p	350039136100015116	0-45						Transcriptomic and Proteomic Approaches to the Discovery of New Markers of Pathology	n.library.ethz.ch	0	0		ITGA5
802	chr5	28470326	28474205	3500413440	40		28470326	28474205	8421504	2	20,20	0,3859	c	350041344000000042,350041344000000043	0-20,0-20						Embryo Implantation Inhibitor 	.freshpatents.com	0	0		
802	chr5	28470942	28472647	3500319127	40		28470942	28472647	8421504	2	20,20	0,1685	c	350031912700000028,350031912700000029	0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
802	chr5	28474913	28474973	3500435682	60		28474913	28474973	8421504	1	60	0	p	350043568200015003	0-60						Integrin-linked kinase and its uses	Dedhar	2007	0		ITGA5
802	chr5	28474913	28474973	3500431731	60		28474913	28474973	8421504	1	60	0	p	350043173100015001,350043173100015135	0-60,0-48						Integrin-linked kinase and its uses	Dedhar	2000	0		ITGA5
802	chr5	28474913	28474973	3500242249	60		28474913	28474973	8421504	1	60	0	p	350024224900015000	0-60						Integrin-linked kinase and its uses	Dedhar	2008	0		ITGA5
802	chr5	28474913	28474973	3500172573	60		28474913	28474973	8421504	1	60	0	p	350017257300015000	0-60						US Patent # 6,013,782. Integrin-linked kinase and its uses - Patents.com	www.patents.com	0	0		ITGA5
802	chr5	28474913	28474973	3500155840	60		28474913	28474973	8421504	1	60	0	p	350015584000015000	0-60						US Patent # 6,001,622. Integrin-linked kinase and its use - Patents.com	www.patents.com	0	0		ITGA5
802	chr5	28503295	28503318	3500450007	23		28503295	28503318	8421504	1	23	0	c,g	350045000700000002,350045000700000002	0-23,0-23						Medium-Chain Fatty Acids as Ligands for Orphan G Protein-Coupled Receptor GPR84	www.scribd.com	0	0		
802	chr5	28503905	28503933	3500394547	24		28503905	28503933	8421504	2	18,6	0,22	c	350039454700000105	22-46						MODULATION OF TUDOR-SN EXPRESSION - Patent application	www.faqs.org	0	0		
802	chr5	28517561	28523767	3500148302	453		28517561	28523767	8421504	7	39,52,78,56,92,82,54	0,1273,1483,2858,4060,4790,6152	p	350014830200015068,350014830200015069	0-453,0-453						Rubus_Contig312 (contig) Rubus sp. | GDR	www.rosaceae.org	0	0		COPZ1
803	chr5	28580388	28583133	3500225370	41		28580388	28583133	8421504	2	22,19	0,2726	c	350022537000000001,350022537000000012	0-22,0-19		16014382	10.1242/jcs.02448	0021-9533	Journal of Cell Science	Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation	He	2005	6		HNRNPA1
803	chr5	28581251	28584729	3500463168	957		28581251	28584729	8421504	9	53,156,75,93,93,211,147,117,12	0,293,1351,1664,1846,2033,2381,2800,3466	p	350046316800015020	0-1113						Mastering Perl for Bioinformatics	www.scribd.com	0	0		
803	chr5	28581296	28581689	3500348108	43		28581296	28581689	8421504	3	8,13,22	0,248,371	c	350034810800000005,350034810800000004	0-21,12-34						-Catenin Can Be Transported into the Nucleus in a Ran-unassisted Manner	w.molbiolcell.org	0	0		
803	chr5	28581296	28581674	3500455148	138		28581296	28581674	8421504	2	8,130	0,248	p	350045514800015003,350045514800015004	18-132,0-78						DIPLOMARBEIT	thes.univie.ac.at	0	0		
803	chr5	28581296	28581662	3500415354	126		28581296	28581662	8421504	2	8,118	0,248	p	350041535400015003	0-126		18448520	10.1128/JVI.02406-07	0022-538X	Journal of Virology	Severe Acute Respiratory Syndrome Coronavirus Protein 6 Accelerates Murine Hepatitis Virus Infections by More than One Mechanism	Hussain	2008	5		
803	chr5	28581296	28581650	3500373689	114		28581296	28581650	8421504	2	8,106	0,248	p	350037368900015007,350037368900015019	0-114,0-51						Identification and characterization of Risp: a new nucleocytoplasmic shuttle protein interacting with the HIV-1 Rev protein	b.uni-muenchen.de	0	0		HNRNPA1
803	chr5	28581296	28581650	3500352871	114		28581296	28581650	8421504	2	8,106	0,248	p	350035287100015002	0-114		15037768	10.1261/rna.5224304	1355-8382	RNA	Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR	REBANE	2004	5		
803	chr5	28581296	28581650	3500278989	114		28581296	28581650	8421504	2	8,106	0,248	p	350027898900015002	0-114		15037768	10.1261/rna.5224304	1355-8382	RNA	Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR	REBANE	2004	5		HNRNPA1
803	chr5	28581296	28581650	3500228010	114		28581296	28581650	8421504	2	8,106	0,248	p	350022801000015008	0-114						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION	Hata	2009	0		HNRNPA1
803	chr5	28581296	28581650	3500225482	114		28581296	28581650	8421504	2	8,106	0,248	p	350022548200015002,350022548200015006,350022548200015005	0-114,0-48,0-45						DISPLAY OF ANTIBODY FRAGMENTS ON VIRUS-LIKE PARTICLES OF RNA BACTERIOPHAGES - Patent application	www.faqs.org	0	0		HNRNPA1
803	chr5	28581296	28581650	3500125620	114		28581296	28581650	8421504	2	8,106	0,248	p	350012562000015006,350012562000015016	0-114,0-45						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION - Patent application	www.faqs.org	0	0		HNRNPA1
803	chr5	28581296	28581650	3500109265	114		28581296	28581650	8421504	2	8,106	0,248	p	350010926500015006	0-114						Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations	Ciolina	1999	0		
803	chr5	28581299	28581662	3500134824	123		28581299	28581662	8421504	2	5,118	0,245	p	350013482400015069	3-126						Improved pharmaceutical compositions for gene therapy	Craig	1998	0		HNRNPA1
803	chr5	28581569	28584732	3500416974	882		28581569	28584732	8421504	8	131,75,93,93,211,147,117,15	0,1033,1346,1528,1715,2063,2482,3148	p	350041697400015018,350041697400015015,350041697400015012,350041697400015009,350041697400015006,350041697400015003	0-132,0-150,0-150,0-150,0-150,0-150						Curriculum Vitae Beth E. Zucconi Education	hsl.umaryland.edu	0	0		HNRNPA1
803	chr5	28581596	28581641	3500409413	45		28581596	28581641	8421504	1	45	0	p	350040941300015002	0-45						Display of antibody fragments on virus-like particles of rna bacteriophages	Peabody	2011	0		HNRNPA1
803	chr5	28581596	28581641	3500388190	45		28581596	28581641	8421504	1	45	0	p	350038819000015002	0-45						DISPLAY OF ANTIBODY FRAGMENTS ON VIRUS-LIKE PARTICLES OF RNA BACTERIOPHAGES - STC.UNM	www.sumobrain.com	0	0		HNRNPA1
803	chr5	28581599	28581683	3500019553	84		28581599	28581683	8421504	1	84	0	p	350001955300015002	0-84		20818336	10.1038/emboj.2010.216		The EMBO Journal	An actin-regulated importin &#x03b1;/&#x03b2;-dependent extended bipartite NLS directs nuclear import of MRTF-A	Rafal	2010	0		HNRNPA1
803	chr5	28581611	28581656	3500254665	45		28581611	28581656	8421504	1	45	0	p	350025466500015038	0-45						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		HNRNPA1
803	chr5	28583632	28584141	3500306497	186		28583632	28584141	8421504	2	96,90	0,419	p	350030649700015034,350030649700015031	0-96,0-90						Dynamite: A Flexible Code Generating Language for Dynamic Programming Methods Used in Sequence Comaprison.	www.aaai.org	0	0		HNRNPA1
803	chr5	28585425	28585451	3500218185	24		28585425	28585451	8421504	2	5,19	0,7	c	350021818500000164	18-42						Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		HNRNPA1
803	chr5	28585425	28585451	3500173025	24		28585425	28585451	8421504	2	5,19	0,7	c	350017302500000323	18-42						Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same	Wu Wen Ping 	2006	0		HNRNPA1
803	chr5	28602237	28611806	3500412009	43		28602237	28611806	8421504	2	21,22	0,9547	c	350041200900000000,350041200900000001	9-30,7-29		15220403	10.1128/JVI.78.14.7299-7310.2004	0022-538X	Journal of Virology	Accumulation of Heterochromatin Components on the Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus Mediated by the Latency-Associated Nuclear Antigen	Sakakibara	2004	5		CBX5
803	chr5	28602237	28611806	3500035733	43		28602237	28611806	8421504	2	21,22	0,9547	c	350003573300000000,350003573300000001	9-30,7-29			10.1128/JVI.78.14.7299-7310.2004		Journal of Virology	Accumulation of Heterochromatin Components on the Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus Mediated by the Latency-Associated Nuclear Antigen	Shuhei	July	0		CBX5
803	chr5	28602237	28611804	3500195870	41		28602237	28611804	8421504	2	21,20	0,9547	c,g	350019587000000000,350019587000000001,350019587000000001	9-30,0-20,0-20						Accumulation of Heterochromatin Components on the Terminal Repeat Sequence of Kaposi&#x2019;s Sarcoma-Associated Herpesvirus Mediated by the Latency-Associated Nuclear Antigen	jvi.asm.org	0	0		
803	chr5	28602238	28602263	3500239274	25		28602238	28602263	8421504	1	25	0	c	350023927400000002	20-45		20590528	10.1042/BC20100033		Biology of the Cell	Bimolecular fluorescence complementation analysis of eukaryotic fusion products	Ho-Pi		0		CBX5
803	chr5	28602288	28602319	3500279236	31		28602288	28602319	8421504	1	31	0	c	350027923600000031	0-31						Molecular Determinants for Targeting Heterochromatin Protein 1-Mediated Gene Silencing: Direct Chromoshadow Domain&#x2013;KAP-1 Corepressor Interaction Is Essential	mcb.asm.org	0	0		
803	chr5	28602373	28606549	3500238212	40		28602373	28606549	8421504	2	2,38	0,4138	c,g	350023821200000016,350023821200000015,350023821200000015	0-21,0-21,0-21		19468068	10.1083/jcb.200810084		The Journal of Cell Biology	Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins	Wei-Qin	June	0		CBX5
804	chr5	28778020	28778045	3500309840	24		28778020	28778045	8421504	2	12,12	0,13	c	350030984000000884,350030984000000806	3-27,3-27						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
804	chr5	28778020	28778045	3500119454	24		28778020	28778045	8421504	2	12,12	0,13	c	350011945400000809	3-27						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
804	chr5	28778020	28778045	3500004227	24		28778020	28778045	8421504	2	12,12	0,13	c	350000422700000809,350000422700000887	3-27,3-27						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
804	chr5	28778772	28780036	3500201172	780		28778772	28780036	8421504	2	341,439	0,825	p	350020117200015004,350020117200015003,350020117200015002,350020117200015001,350020117200015000	0-60,0-180,0-180,0-180,0-180						Cancer biomarkers	Morgan	2010	0		
804	chr5	28778772	28780036	3500011693	780		28778772	28780036	8421504	2	341,439	0,825	p	350001169300015004,350001169300015003,350001169300015002,350001169300015001,350001169300015000	0-60,0-180,0-180,0-180,0-180					Patent	Cancer biomarkers (Patent US:8460882)	Pandha	2013	0		HOXC4
804	chr5	28778883	28779063	3500222737	180		28778883	28779063	8421504	1	180	0	p	350022273700015009	0-180						Detecting elementswiththemodelgenome Japanese fish, Fugu	www.pnas.org	0	0		HOXC4
804	chr5	28778910	28778961	3500299792	51		28778910	28778961	8421504	1	51	0	p	350029979200015009,350029979200015010,350029979200015012,350029979200015006	18-69,114-162,114-162,0-48						Control of gene expression using a complex of an oligonucleotide and a regulatory peptide	Ali	2003	0		
804	chr5	28778910	28778961	3500178179	51		28778910	28778961	8421504	1	51	0	p	350017817900015007,350017817900015008,350017817900015010,350017817900015004	18-69,114-162,114-162,0-48						Control Of Gene Expression Using A Complex Of An Oligonucleotide And A Regulatory Peptide 	.freshpatents.com	0	0		
804	chr5	28778913	28778964	3500366297	51		28778913	28778964	8421504	1	51	0	p	350036629700015013,350036629700015007,350036629700015005,350036629700015004,350036629700015017	0-51,0-51,0-51,0-51,0-45						Modulation of TRIP-Br function and method of treating proliferative disorders - Patent # 7223733 - PatentGenius	.patentgenius.com	0	0		
804	chr5	28778913	28778961	3500444542	48		28778913	28778961	8421504	1	48	0	p	350044454200015011	0-48						&#x4e3b;&#x9898;&#xff1a;Regulates | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		HOXC6
804	chr5	28778913	28778961	3500443721	48		28778913	28778961	8421504	1	48	0	p	350044372100015004	0-48						Controlling gene expressions in plastids	Muhlbauer	2004	0		HOXB5
804	chr5	28778913	28778961	3500443094	48		28778913	28778961	8421504	1	48	0	p	350044309400015009	0-48					Patent	Hemangio-colony forming cells (Patent US:8017393)	Lanza	2011	0		HOXC6
804	chr5	28778913	28778961	3500440875	48		28778913	28778961	8421504	1	48	0	p	350044087500015001	0-48						Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	ecular-cancer.com	0	0		HOXC6
804	chr5	28778913	28778961	3500440222	48		28778913	28778961	8421504	1	48	0	p	350044022200015006	0-48						HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS	Lanza	2009	0		HOXB5
804	chr5	28778913	28778961	3500425641	48		28778913	28778961	8421504	1	48	0	p	350042564100015001	0-48						Oligonucleotide Compositions with Enhanced Efficiency	Woolf	2010	0		HOXC6
804	chr5	28778913	28778961	3500423289	48		28778913	28778961	8421504	1	48	0	p	350042328900015000	0-48		12902516		0022-1767	The Journal of Immunology	Intracellular Domain of Brain Endothelial Intercellular Adhesion Molecule-1 Is Essential for T Lymphocyte-Mediated Signaling and Migration	Greenwood	2003	6		HOXC6
804	chr5	28778913	28778961	3500422475	48		28778913	28778961	8421504	1	48	0	p	350042247500015000	0-48						PYRROLIDINYL GROUPS FOR ATTACHING CONJUGATES TO OLIGOMERIC COMPOUNDS - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500422214	48		28778913	28778961	8421504	1	48	0	p	350042221400015005,350042221400015014	3-51,3-51						ENTZ&#xdc;NDUNGSHEMMENDE VERBINDUNGEN UND IHRE VERWENDUNG - Dokument DE60123041T2	www.patent-de.com	0	0		HOXC6
804	chr5	28778913	28778961	3500416811	48		28778913	28778961	8421504	1	48	0	p	350041681100015001	0-48						Methods for the Delivery of Oligomeric Compounds - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500415188	48		28778913	28778961	8421504	1	48	0	p	350041518800015006	0-48						Synthetic Lipid Rafts and Methods of Use	Khan	2007	0		HOXC6
804	chr5	28778913	28778961	3500414821	48		28778913	28778961	8421504	1	48	0	p	350041482100015118	0-48						Vivit Polypeptides, Therapeutic Agent Comprising The Same, And Method Of Screening For Anti-cancer Agent 	.freshpatents.com	0	0		HOXC6
804	chr5	28778913	28778961	3500414025	48		28778913	28778961	8421504	1	48	0	p	350041402500015040,350041402500015068	0-48,0-48						Compositions and methods for promoting wound healing and tissue regeneration	Ghatnekar	2011	0		HOXB5
804	chr5	28778913	28778961	3500410569	48		28778913	28778961	8421504	1	48	0	p	350041056900015003	0-48						Secretion System and Methods for its Use	Mougous	2012	0		HOXC6
804	chr5	28778913	28778961	3500405690	48		28778913	28778961	8421504	1	48	0	p	350040569000015008,350040569000015009	0-48,0-48						COMPLEX FOR TRANSFERRING AN ANIONIC SUBSTANCE INTO A CELL - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500400715	48		28778913	28778961	8421504	1	48	0	p	350040071500015005	0-48					Patent	Therapeutic compositions (Patent US:8110674)	Manoharan	2012	0		HOXC6
804	chr5	28778913	28778961	3500400594	48		28778913	28778961	8421504	1	48	0	p	350040059400015001	0-48		17363608	10.1158/0008-5472.CAN-06-4082	0008-5472	Cancer Research	Caveolin-1&#x2013;Deficient Mice Have Increased Tumor Microvascular Permeability, Angiogenesis, and Growth	Lin	2007	8		HOXC6
804	chr5	28778913	28778961	3500399022	48		28778913	28778961	8421504	1	48	0	p	350039902200015000	0-48						Method for preventing or treating memory impairment and pharmaceutical compositions useful therefore	Fischer	2013	0		HOXC6
804	chr5	28778913	28778961	3500390436	48		28778913	28778961	8421504	1	48	0	p	350039043600015002,350039043600015000	3-51,3-51						Anti-inflammatory compounds and uses thereof	Ghosh	2002	0		HOXC6
804	chr5	28778913	28778961	3500388449	48		28778913	28778961	8421504	1	48	0	p	350038844900015005	3-51					Patent	Entz&#xfc;ndungshemmende verbindungen und ihre verwendung (Patent DE:60123041)	GHOSH	2007	0		HOXC6
804	chr5	28778913	28778961	3500383186	48		28778913	28778961	8421504	1	48	0	p	350038318600015007	0-48						Methods of Rejuvenating Cells In Vitro and In Vivo - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500382571	48		28778913	28778961	8421504	1	48	0	p	350038257100015003	0-48						TTK as tumor marker and therapeutic target for lung cancer	Nakamura	2012	0		HOXB5
804	chr5	28778913	28778961	3500381193	48		28778913	28778961	8421504	1	48	0	p	350038119300015005	0-48						Methods and compositions for delivering polynucleotides	Khan	2009	0		HOXC6
804	chr5	28778913	28778961	3500377058	48		28778913	28778961	8421504	1	48	0	p	350037705800015026	0-48						VIVIT POLYPEPTIDES, THERAPEUTIC AGENT COMPRISING THE SAME, AND METHOD OF SCREENING FOR ANTI-CANCER AGENT - Patent application	www.faqs.org	0	0		HOXB5
804	chr5	28778913	28778961	3500368674	48		28778913	28778961	8421504	1	48	0	p	350036867400015022	0-48						Fusion protein for use as vector	Hwu	2002	0		HOXC6
804	chr5	28778913	28778961	3500368538	48		28778913	28778961	8421504	1	48	0	p	350036853800015020,350036853800015052,350036853800015051	36-84,0-48,39-87						Inhibitors of the interaction between P53 and MDM2	Lane	1997	0		HOXC6
804	chr5	28778913	28778961	3500360151	48		28778913	28778961	8421504	1	48	0	p	350036015100015007	0-48						Toxin compounds with enhanced membrane translocation characteristics	Fernandez-salas	2004	0		HOXC6
804	chr5	28778913	28778961	3500352610	48		28778913	28778961	8421504	1	48	0	p	350035261000015005	0-48						Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. - ResearchGate	.researchgate.net	0	0		HOXC6
804	chr5	28778913	28778961	3500346772	48		28778913	28778961	8421504	1	48	0	p	350034677200015018	3-51						PEPTIDES AND APTAMERS FOR TARGETING OF NEURON OR NERVES	Tsien	2010	0		HOXC6
804	chr5	28778913	28778961	3500346493	48		28778913	28778961	8421504	1	48	0	p	350034649300015012	0-48						TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-ALPHA2 - Patent application	www.faqs.org	0	0		HOXB5
804	chr5	28778913	28778961	3500346275	48		28778913	28778961	8421504	1	48	0	p	350034627500015000	0-48		12788645	10.1016/S1525-0016(03)00130-8	1525-0016	Molecular Therapy	A Novel TAT&#x2013;Mitochondrial Signal Sequence Fusion Protein is Processed, Stays in Mitochondria, and Crosses the Placenta	Gaizo	2003	7		HOXB5
804	chr5	28778913	28778961	3500346273	48		28778913	28778961	8421504	1	48	0	p	350034627300015025	0-48						BLOCKADE OF TL1A-DR3 INTERACTIONS TO AMELIORATE T CELL MEDIATED DISEASE PATHOLOGY	Siegel	2008	0		HOXB5
804	chr5	28778913	28778961	3500341491	48		28778913	28778961	8421504	1	48	0	p	350034149100015003	0-48						Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring	Bao	2003	0		HOXB5
804	chr5	28778913	28778961	3500339578	48		28778913	28778961	8421504	1	48	0	p	350033957800015003	0-48						COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500337670	48		28778913	28778961	8421504	1	48	0	p	350033767000015003	0-48						METHOD FOR TREATING OR PREVENTING BLADDER CANCER USING THE DEPDC1 POLYPEPTIDE - ONCOTHERAPY SCIENCE, INC.	www.sumobrain.com	0	0		HOXC6
804	chr5	28778913	28778961	3500332070	48		28778913	28778961	8421504	1	48	0	p	350033207000015070,350033207000015088,350033207000015107	0-48,0-48,0-48						 Composition And Methods For Promoting Wound Healing And Tissue Regeneration 	www.docstoc.com	0	0		HOXC6
804	chr5	28778913	28778961	3500321661	48		28778913	28778961	8421504	1	48	0	p	350032166100015005	0-48						Therapeutic Compositions	Manoharan	2010	0		HOXB5
804	chr5	28778913	28778961	3500318300	48		28778913	28778961	8421504	1	48	0	p	350031830000015053	0-48						COMPOSITIONS AND METHODS FOR MODULATING NOD-LIKE RECEPTOR ACTIVITY AND USES THEREOF - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500316176	48		28778913	28778961	8421504	1	48	0	p	350031617600015035	0-48						Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex	Daigo	2008	0		HOXB5
804	chr5	28778913	28778961	3500315135	48		28778913	28778961	8421504	1	48	0	p	350031513500015035	0-48						Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders	Bedi	2009	0		HOXB5
804	chr5	28778913	28778961	3500315070	48		28778913	28778961	8421504	1	48	0	p	350031507000015012	0-48						2-F MODIFIED RNA INTERFERENCE AGENTS - ALNYLAM PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		HOXB5
804	chr5	28778913	28778961	3500313912	48		28778913	28778961	8421504	1	48	0	p	350031391200015005	0-48						Synthetic lipid rafts and methods of use	Khan	2007	0		HOXC6
804	chr5	28778913	28778961	3500306786	48		28778913	28778961	8421504	1	48	0	p	350030678600015017	0-48						Cell-killing molecules and methods of use thereof	Larrick	2004	0		HOXB5
804	chr5	28778913	28778961	3500306510	48		28778913	28778961	8421504	1	48	0	p	350030651000015002	0-48						Application # 2012/0136042. CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES - Patents.com	patents.com	0	0		HOXB5
804	chr5	28778913	28778961	3500301507	48		28778913	28778961	8421504	1	48	0	p	350030150700015009	0-48						Hemangio-colony forming cells	Lanza	2008	0		HOXC6
804	chr5	28778913	28778961	3500295035	48		28778913	28778961	8421504	1	48	0	p	350029503500015000,350029503500015002	0-48,0-48						TheApolipoproteinE-MimeticPeptideCOG112Inhibits BSignaling,ProinflammatoryCytokineExpression,and DiseaseActivityinMurineModelsofColitis S	www.jbc.org	0	0		HOXB5
804	chr5	28778913	28778961	3500276741	48		28778913	28778961	8421504	1	48	0	p	350027674100015008	0-48						CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES	Manoharan	2012	0		HOXC6
804	chr5	28778913	28778961	3500275686	48		28778913	28778961	8421504	1	48	0	p	350027568600015000	0-48		22676333	10.1186/1756-0500-5-268	1756-0500	BMC Research Notes	Ribozyme-mediated gene knock down strategy to dissect the consequences of PDGF stimulation in vascular smooth muscle cells	Lande	2012	0		HOXC6
804	chr5	28778913	28778961	3500273506	48		28778913	28778961	8421504	1	48	0	p	350027350600015000	36-84						 <HTML> <HEAD><TITLE>ae1a$?aaC/aaa|a$?a<<a1aa-a?a1/4aa3aa(r)a1/2ePS1/2ae1ae3 - c1ei1/4	www.j-tokkyo.com	0	0		HOXB5
804	chr5	28778913	28778961	3500268198	48		28778913	28778961	8421504	1	48	0	p	350026819800015058	0-48						INHIBITORS OF PROTEIN KINASE C ISOFORMS AND USES THEREOF - Patent application	www.faqs.org	0	0		HOXB5
804	chr5	28778913	28778961	3500259447	48		28778913	28778961	8421504	1	48	0	p	350025944700015003	0-48						Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent	Inaki	2007	0		HOXC6
804	chr5	28778913	28778961	3500257959	48		28778913	28778961	8421504	1	48	0	p	350025795900015085,350025795900015105,350025795900015065	0-48,0-48,0-48						Composition and Methods for Promoting Wound Healing and tissue Regeneration	Ghatnekar	2008	0		HOXB5
804	chr5	28778913	28778961	3500257921	48		28778913	28778961	8421504	1	48	0	p	350025792100015002	3-51		14560006	10.1128/MCB.23.21.7600-7610.2003	0270-7306	Molecular and Cellular Biology	Fibroblast Growth Factor 2-Mediated Translational Control of IAPs Blocks Mitochondrial Release of Smac/DIABLO and Apoptosis in Small Cell Lung Cancer Cells	Pardo	2003	6		HOXB5
804	chr5	28778913	28778961	3500257622	48		28778913	28778961	8421504	1	48	0	p	350025762200015001	0-48		18160487	10.1152/ajpcell.00360.2007		American Journal of Physiology - Cell Physiolog	Role of PKC-&#x03b4; on substance P-induced chemokine synthesis in pancreatic acinar cells	Ramnath	2008	0		HOXB5
804	chr5	28778913	28778961	3500254638	48		28778913	28778961	8421504	1	48	0	p	350025463800015002	0-48						Secretion System and Methods for its Use - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500230941	48		28778913	28778961	8421504	1	48	0	p	350023094100015000	0-48						Treating or preventing cancers over-expressing reg4 or kiaa0101	Nakagawa	2008	0		HOXC6
804	chr5	28778913	28778961	3500218975	48		28778913	28778961	8421504	1	48	0	p	350021897500015003	0-48					Patent	Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring (Patent US:7459145)	Bao	2008	0		HOXC6
804	chr5	28778913	28778961	3500218826	48		28778913	28778961	8421504	1	48	0	p	350021882600015073	0-48						Targeted immunogens	Barber	2003	0		HOXC6
804	chr5	28778913	28778961	3500215589	48		28778913	28778961	8421504	1	48	0	p	350021558900015000	0-48		19961612	10.1186/1742-4690-6-112	1742-4690	Retrovirology	Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal	Levin	2009	6		HOXB5
804	chr5	28778913	28778961	3500214662	48		28778913	28778961	8421504	1	48	0	p	350021466200015001	0-48						Controlling gene expression in plastids	Muehlbauer	2005	0		HOXC6
804	chr5	28778913	28778961	3500209792	48		28778913	28778961	8421504	1	48	0	p	350020979200015030	0-48						Compositions and methods of use of targeting peptides against placenta and adipose tissues	osdir.com/patents	0	0		HOXC6
804	chr5	28778913	28778961	3500206127	48		28778913	28778961	8421504	1	48	0	p	350020612700015001	0-48		18160487	10.1152/ajpcell.00360.2007		American Journal of Physiology - Cell Physiology	Role of PKC-&#x03b4; on substance P-induced chemokine synthesis in pancreatic acinar cells	Ramnath	2008	0		HOXC6
804	chr5	28778913	28778961	3500201468	48		28778913	28778961	8421504	1	48	0	p	350020146800015016	0-48						Immunogenic Polypeptides and Monoclonal Antibodies	Ochs	2012	0		HOXB5
804	chr5	28778913	28778961	3500200898	48		28778913	28778961	8421504	1	48	0	p	350020089800015009	0-48						Lipid formulation	Chen	2010	0		HOXC6
804	chr5	28778913	28778961	3500200892	48		28778913	28778961	8421504	1	48	0	p	350020089200015004	0-48						Fusion proteins for the treatment of CNS	Gruskin	2004	0		HOXC6
804	chr5	28778913	28778961	3500200713	48		28778913	28778961	8421504	1	48	0	p	350020071300015012,350020071300015015,350020071300015009,350020071300015010	0-48,0-48,0-48,0-48						Disheveled pdz modulators	Costa	2010	0		
804	chr5	28778913	28778961	3500199113	48		28778913	28778961	8421504	1	48	0	p	350019911300015000,350019911300015001	9-57,9-57		17347452	10.1152/ajpgi.00273.2006		American Journal of Physiology - Gastrointestinal and Liver Physiology	Ethanol induced NF-&#x03ba;B activation protects against cell injury in cultured rat gastric mucosal epithelium	Mustonen	2007	0		HOXC6
804	chr5	28778913	28778961	3500190261	48		28778913	28778961	8421504	1	48	0	p	350019026100015001	0-48		22913813	10.1186/1476-4598-11-59	1476-4598	Molecular Cancer	Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	Horibe	2012	4		HOXC6
804	chr5	28778913	28778961	3500183031	48		28778913	28778961	8421504	1	48	0	p	350018303100015000	0-48						Screening method of anti-lung or esophageal cancer compounds	Daigo	2011	0		HOXC6
804	chr5	28778913	28778961	3500179659	48		28778913	28778961	8421504	1	48	0	p	350017965900015002	0-48						Factor	Maden	2007	0		HOXC6
804	chr5	28778913	28778961	3500168461	48		28778913	28778961	8421504	1	48	0	p	350016846100015000	0-48						Peptides targeted to protein kinase C isoforms and uses thereof	Phipps	2011	0		HOXC6
804	chr5	28778913	28778961	3500165478	48		28778913	28778961	8421504	1	48	0	p	350016547800015005	0-48						Compositions And Methods For Detecting And Treating Hiv Infections 	.freshpatents.com	0	0		HOXC6
804	chr5	28778913	28778961	3500158535	48		28778913	28778961	8421504	1	48	0	p	350015853500015002	0-48						Pharmaceutical composition for treating autoimmune, allergic and inflammatory diseases and delivery method thereof	Lee	2008	0		HOXB5
804	chr5	28778913	28778961	3500157203	48		28778913	28778961	8421504	1	48	0	p	350015720300015004	0-48						Perde1588292657	www.scribd.com	0	0		HOXB5
804	chr5	28778913	28778961	3500132886	48		28778913	28778961	8421504	1	48	0	p	350013288600015006	0-48						MODIFIED iRNA AGENTS - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500132386	48		28778913	28778961	8421504	1	48	0	p	350013238600015006,350013238600015020,350013238600015011	0-48,0-48,0-48						&#x6563;&#x4e71;&#x86cb;&#x767d;pdz&#x8c03;&#x8282;&#x5242;	Zhang Ying Nan 	2009	0		
804	chr5	28778913	28778961	3500130575	48		28778913	28778961	8421504	1	48	0	p	350013057500015008	0-48						IMMUNOGENIC POLYPEPTIDES AND MONOCLONAL ANTIBODIES - Sanofi Pasteur Limited	www.sumobrain.com	0	0		HOXC6
804	chr5	28778913	28778961	3500127054	48		28778913	28778961	8421504	1	48	0	p	350012705400015005	0-48						Therapeutic compositions	Manoharan	2013	0		HOXC6
804	chr5	28778913	28778961	3500116776	48		28778913	28778961	8421504	1	48	0	p	350011677600015000,350011677600015001	0-48,0-48		20427663	10.1523/JNEUROSCI.5094-09.2010	0270-6474	The Journal of Neuroscience	Dysregulation of Dopamine Transporters via Dopamine D2 Autoreceptors Triggers Anomalous Dopamine Efflux Associated with Attention-Deficit Hyperactivity Disorder	Bowton	2010	7		HOXC6
804	chr5	28778913	28778961	3500110086	48		28778913	28778961	8421504	1	48	0	p	350011008600015000	0-48					Patent	Pna conjugate for the treatment of diseases associated with hiv (Patent EP:1404373)	Braun	2008	0		HOXC6
804	chr5	28778913	28778961	3500109228	48		28778913	28778961	8421504	1	48	0	p	350010922800015008,350010922800015009	0-48,63-111		12138200	10.1128/MCB.22.16.5897-5911.2002	0270-7306	Molecular and Cellular Biology	Site-Directed Perturbation of Protein Kinase C- Integrin Interaction Blocks Carcinoma Cell Chemotaxis	Parsons	2002	6		HOXC6
804	chr5	28778913	28778961	3500108397	48		28778913	28778961	8421504	1	48	0	p	350010839700015005	0-48						Methods and compositions for delivering polynucleotides	Khan	2006	0		HOXB5
804	chr5	28778913	28778961	3500106573	48		28778913	28778961	8421504	1	48	0	p	350010657300015000	0-48						Enhanced efficiency of induced pluripotent stem cell generation - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500106421	48		28778913	28778961	8421504	1	48	0	p	350010642100015093,350010642100015100	3-51,0-48						ISOZYME-SPECIFIC ANTAGONISTS OF PROTEIN KINASE C - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500096451	48		28778913	28778961	8421504	1	48	0	p	350009645100015001	0-48					Patent	Aptamer therapeutics useful in the treatment of complement-related disorders (Patent US:7803931)	Benedict	2010	0		HOXC6
804	chr5	28778913	28778961	3500096113	48		28778913	28778961	8421504	1	48	0	p	350009611300015006	0-48						ALGAL TRANSFORMATION SYSTEMS, COMPOSITIONS AND METHODS	Macmillan	2012	0		HOXC6
804	chr5	28778913	28778961	3500084148	48		28778913	28778961	8421504	1	48	0	p	350008414800015002	0-48						COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778913	28778961	3500079348	48		28778913	28778961	8421504	1	48	0	p	350007934800015019,350007934800015016	0-48,0-48						&#x9776;&#x5411;&#x7ebf;&#x7c92;&#x4f53;&#x7684;&#x6297;&#x80bf;&#x7624;&#x5242;	Jiang Bing Xian 	2010	0		HOXB5
804	chr5	28778913	28778961	3500065094	48		28778913	28778961	8421504	1	48	0	p	350006509400015000	0-48			10.1083/jcb.200211081		The Journal of Cell Biology	An essential role for hGle1 nucleocytoplasmic shuttling in mRNA export	Frederic	2003	0		HOXC6
804	chr5	28778913	28778961	3500065002	48		28778913	28778961	8421504	1	48	0	p	350006500200015001	0-48						Use of cytidine deaminase-related agents to promote demethylation and cell reprogramming	Blau	2011	0		HOXC6
804	chr5	28778913	28778961	3500061397	48		28778913	28778961	8421504	1	48	0	p	350006139700015018	0-48						Interaction between the vhl tumour suppressor and hypoxia inducible factor, and assay methods relating thereto	Maxwell	2000	0		HOXB5
804	chr5	28778913	28778961	3500059982	48		28778913	28778961	8421504	1	48	0	p	350005998200015001	0-48		15637154	10.1073/pnas.0407224102	0027-8424	Proceedings of the National Academy of Sciences of the United States of America	Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides	Bernatchez	2005	10		HOXC6
804	chr5	28778913	28778961	3500051201	48		28778913	28778961	8421504	1	48	0	p	350005120100015003	0-48						PROMOTION OF PEROXISOMAL CATALASE FUNCTION IN CELLS	Terlecky	2003	0		HOXC6
804	chr5	28778913	28778961	3500051060	48		28778913	28778961	8421504	1	48	0	p	350005106000015000	0-48					Patent	Method for detecting proteinaceous inhibitors of protein-protein or DNA-protein interactions (Patent US:6610495)	Watt	2003	0		HOXC6
804	chr5	28778913	28778961	3500044825	48		28778913	28778961	8421504	1	48	0	p	350004482500015004	0-48						Double-stranded oligonucleotides	Woolf	2003	0		HOXB5
804	chr5	28778913	28778961	3500042770	48		28778913	28778961	8421504	1	48	0	p	350004277000015091,350004277000015098	3-51,0-48						Isozyme-specific antagonists of protein kinase C - Patent application	www.faqs.org	0	0		HOXB5
804	chr5	28778913	28778961	3500029444	48		28778913	28778961	8421504	1	48	0	p	350002944400015006	39-87						&#x7528;&#x4e8e;&#x9012;&#x9001;&#x6cbb;&#x7597;&#x5242;&#x7684;&#x65b0;&#x578b;&#x8102;&#x8d28;&#x548c;&#x7ec4;&#x5408;&#x7269;	Kai Lan Tuo Ta Ti Er *G*La Ji Fu 	2011	0		HOXC6
804	chr5	28778913	28778961	3500029112	48		28778913	28778961	8421504	1	48	0	p	350002911200015000	0-48						Peptides targeted to protein kinase c isoforms and uses thereof	Phipps	2010	0		HOXC6
804	chr5	28778913	28778961	3500022904	48		28778913	28778961	8421504	1	48	0	p	350002290400015003	0-48						Assays and methods for determining activity of a therapeutic agent in a subject	Sah	2012	0		HOXB5
804	chr5	28778913	28778961	3500010947	48		28778913	28778961	8421504	1	48	0	p	350001094700015230,350001094700015229,350001094700015231,350001094700015232	3-51,3-51,0-45,0-45						Anti-inflammatory compounds and uses thereof - Patent # 7049395 - PatentGenius	.patentgenius.com	0	0		HOXC6
804	chr5	28778913	28778961	3500009611	48		28778913	28778961	8421504	1	48	0	p	350000961100015006	0-48						LIGAND-CONJUGATED MONOMERS	Manoharan	2012	0		HOXC6
804	chr5	28778913	28778961	3500009575	48		28778913	28778961	8421504	1	48	0	p	350000957500015005	0-48						PNA conjugate for the treatment of diseases associated with HIV	Braun	2002	0		HOXC6
804	chr5	28778913	28778961	3500008929	48		28778913	28778961	8421504	1	48	0	p	350000892900015006	0-48						iRNA conjugates	Manoharan	2004	0		HOXB5
804	chr5	28778913	28778961	3500008841	48		28778913	28778961	8421504	1	48	0	p	350000884100015000	24-72		18283311	10.1038/sj.bjc.6604268	0007-0920	British Journal of Cancer	Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis	Bilim	2008	5		HOXB5
804	chr5	28778913	28778961	3500008686	48		28778913	28778961	8421504	1	48	0	p	350000868600015019	3-51						Peptides and aptamers for targeting of neuron or nerves	Tsien	2010	0		HOXB5
804	chr5	28778913	28778961	3500003096	48		28778913	28778961	8421504	1	48	0	p	350000309600015019	0-48						TREATMENT OF DISEASE CONDITIONS VIA ADMINISTRATION OF DNA REPAIR ENZYME - UNIVERSITY OF SOUTH ALABAMA	www.sumobrain.com	0	0		HOXC6
804	chr5	28778913	28778958	3500178016	45		28778913	28778958	8421504	1	45	0	p	350017801600015003	3-48						RGD-independentCellAdhesionviaaTissue Transglutaminase-FibronectinMatrixPromotesFibronectin FibrilDepositionandRequiresSyndecan-4/2and IntegrinCo-signaling S	www.jbc.org	0	0		HOXC6
804	chr5	28778913	28778958	3500107575	45		28778913	28778958	8421504	1	45	0	p	350010757500015002	3-48						The Importance of the Tissue Transglutaminase-Fibronectin Heterocomplex in the RGD-independent Cell Adhesion and Fibronectin Matrix Deposition	rints.aston.ac.uk	0	0		HOXC6
804	chr5	28778913	28778958	3500102585	45		28778913	28778958	8421504	1	45	0	p	350010258500015047	0-45						EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS AND USES THEREOF - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28778914	28778958	3500419804	44		28778914	28778958	8421504	1	44	0	c	350041980400000002	0-44						Developmental and spatial patterns of expression of the mouse homeobox gene, Hox2	ev.biologists.org	0	0		
804	chr5	28778916	28778961	3500270939	45		28778916	28778961	8421504	1	45	0	p	350027093900015000	0-45						Methods of constructing and screening diverse expression libraries - Patent application	www.faqs.org	0	0		HOXC6
804	chr5	28779087	28779634	3500376059	63		28779087	28779634	8421504	2	26,37	0,510	p	350037605900015016	0-63		8600458			Nucleic Acids Research	Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA.	Shen	1996	0		HOXC4
804	chr5	28779624	28779649	3500313609	25		28779624	28779649	8421504	1	25	0	c	350031360900000007	0-25						Az antitest diverzifik&#xe1;ci&#xf3;t meghat&#xe1;roz&#xf3; folyamatok, valamint egy autoantitestek &#xe1;ltal medi&#xe1;lt neuromuszkul&#xe1;ris betegs&#xe9;g, a myasthenia gravis immunol&#xf3;giai &#xe9;s genetikai h&#xe1;tter&#xe9;nek vizsg&#xe1;lata	phd.sote.hu	0	0		HOXC4
804	chr5	28821728	28821752	3500350070	24		28821728	28821752	8421504	1	24	0	g	350035007000000000	0-24						Ksi&#x0119;&#x017c;niczki i ich Pere&#x0142;ki. Z &#x017c;ycia transwestyt&#xf3;w - Op. cit.,	opcit.pl/teksty/k	0	0		HOXC8
805	chr5	28841196	28841222	3500351139	26		28841196	28841222	8421504	1	26	0	c	350035113900000030,350035113900000147	10-36,10-36						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
805	chr5	28841196	28841219	3500439152	23		28841196	28841219	8421504	1	23	0	g	350043915200000213	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		HOXB8
805	chr5	28847645	28847670	3500325139	25		28847645	28847670	8421504	1	25	0	g	350032513900000033	0-25						HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4	logy-journals.org	0	0		
805	chr5	28849450	28849473	3500216021	23		28849450	28849473	8421504	1	23	0	g	350021602100000002	5-31						PPrevalence of aerobactin and adhesin genes in revalence of aerobactin and adhesin genes in EEscherichia colischerichia coli iisolates from blood of bacteremic severely ill neonatal calvessolates from blood of bacteremic severely ill neonatal calves	www.vef.unizg.hr	0	0		
805	chr5	28876176	28876201	3500402599	25		28876176	28876201	8421504	1	25	0	c	350040259900000017	0-25						Noncoding RNA synthesis and loss of Polycomb group repression accompanies the colinear activation of the human HOXA cluster	journal.cshlp.org	0	0		
805	chr5	28878119	28878143	3500326672	24		28878119	28878143	8421504	1	24	0	g	350032667200000290	0-24						Purification, Characterization and Reconstitution of a Ubiquitin E3 Ligase - Patent application	www.faqs.org	0	0		
805	chr5	28887215	28887380	3500168379	165		28887215	28887380	8421504	1	165	0	p	350016837900015006,350016837900015007,350016837900015008,350016837900015012	6-171,6-171,6-171,6-72						Science- Amores et al. 	ww.sciencemag.org	0	0		HOXC13
805	chr5	28899260	28899283	3500444508	23		28899260	28899283	8421504	1	23	0	g	350044450800000088	0-23						Purification, Characterization And Reconstitution Of A Ubiquitin E3 Ligase 	.freshpatents.com	0	0		
807	chr5	29202644	29202675	3500278580	23		29202644	29202675	8421504	3	12,6,5	0,17,26	g	350027858000000032	9-32						Nouveau anticorps anti-GF-IR et leurs applications	Corvaia	2007	0		
807	chr5	29202644	29202675	3500003792	23		29202644	29202675	8421504	3	12,6,5	0,17,26	g	350000379200000032,350000379200000116	9-32,9-32						Anti-IGF-IR antibodies and their applications	Goetsch	2003	0		
809	chr5	29400920	29402285	3500148060	93		29400920	29402285	8421504	2	57,36	0,1329	p	350014806000015013,350014806000015079,350014806000015080	0-84,0-45,0-45						MULTIMERIC PROTEINS AND METHODS OF MAKING AND USING SAME - Patent application	www.faqs.org	0	0		ATF7
809	chr5	29415693	29415747	3500395589	54		29415693	29415747	8421504	1	54	0	p	350039558900015000	0-54						DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof	Gerald	2004	0		
809	chr5	29415693	29415747	3500317071	54		29415693	29415747	8421504	1	54	0	p	350031707100015001	0-54						Neuropeptide sf receptor assays, compounds and therapeutic methods	Bailey	2002	0		
809	chr5	29415693	29415747	3500272517	54		29415693	29415747	8421504	1	54	0	p	350027251700015003,350027251700015001	0-51,0-54						Neuropeptide sf receptor assays, compounds and therapeutic methods	Bailey	2001	0		
809	chr5	29415693	29415747	3500262753	54		29415693	29415747	8421504	1	54	0	p	350026275300015000	0-54					Patent	Methods of identifying agonists and antagonists of mammalian NPFF receptor (Patent US:7041461)	Gerald	2006	0		
809	chr5	29415693	29415747	3500225253	54		29415693	29415747	8421504	1	54	0	p	350022525300015000	0-54					Patent	DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof (Patent US:6709831)	Gerald	2004	0		
809	chr5	29415693	29415747	3500211747	54		29415693	29415747	8421504	1	54	0	p	350021174700015000	0-54						DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof	Bonini	2002	0		
809	chr5	29415693	29415747	3500175726	54		29415693	29415747	8421504	1	54	0	p	350017572600015000	0-54					Patent	DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof (Patent US:6262246)	Gerald	2001	0		
809	chr5	29415693	29415747	3500004373	54		29415693	29415747	8421504	1	54	0	p	350000437300015001	0-54						Identifizierung von Liganden des G-Protein gekoppelten Rezeptors Mas und Mas-Sequenz-&#xe4;hnlicher Rezeptoren	diss.fu-berlin.de	0	0		
809	chr5	29415693	29415741	3500072894	48		29415693	29415741	8421504	1	48	0	p	350007289400015001	0-48						7tm receptor hlwar77	Robert	2000	0		
809	chr5	29415730	29415756	3500402675	26		29415730	29415756	8421504	1	26	0	c	350040267500000001	8-34			10.1046/j.1432-1033.2003.03816.x	1432-1033	European Journal of Biochemistry	Identification of proNeuropeptide FFA peptides processed in neuronal and non-neuronal cells and in nervous tissue - Bonnard - 2003 - European Journal of Biochemistry - Wiley Online Library	Bonnard	2003	0		
809	chr5	29419641	29419692	3500362195	51		29419641	29419692	8421504	1	51	0	p	350036219500015027	0-51						Cloning and structural and expressional characterization of BcpLH gene preferentially expressed in folding leaf of Chinese cabbage	scichina.com:8082	0	0		TARBP2
809	chr5	29444724	29444772	3500211829	47		29444724	29444772	8421504	2	37,10	0,38	c	350021182900000007,350021182900000006	0-48,0-47		12414943	10.1128/JVI.76.23.12008-12022.2002	0022-538X	Journal of Virology	Distinct Poly(rC) Binding Protein KH Domain Determinants for Poliovirus Translation Initiation and Viral RNA Replication	Walter	2002	5		PCBP2
809	chr5	29456338	29457656	3500448129	65		29456338	29457656	8421504	4	1,21,21,22	0,532,1269,1296	c	350044812900000022,350044812900000016,350044812900000021	0-22,0-21,0-22		15933215	10.1124/mol.105.012245	1521-0111 (Online)	Molecular Pharmacology	Poly(C) Binding Protein Family Is a Transcription Factor in &#x03bc;-Opioid Receptor Gene Expression	Kim	2005	0		PCBP2
810	chr5	29507359	29540495	3500045288	51		29507359	29540495	8421504	3	26,17,8	0,32135,33128	c	350004528800000001,350004528800000000	4-30,5-30						ScienceDirect.com - FEBS Letters - O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1	sciencedirect.com	0	0		SP1
810	chr5	29507425	29539509	3500149810	53		29507425	29539509	8421504	2	25,28	0,32056	c	350014981000000001,350014981000000000	0-25,0-28		15117948	10.1074/jbc.M403793200	0021-9258	Journal of Biological Chemistry	The SANT Domain of Human MI-ER1 Interacts with Sp1 to Interfere with GC Box Recognition and Repress Transcription from Its Own Promoter	Ding	2004	5		
810	chr5	29507434	29507458	3500128481	24		29507434	29507458	8421504	1	24	0	c	350012848100000011,350012848100000024	11-35,11-35						Uses of diphenyl/diphenylamine carboxylic acids - Patent application	www.faqs.org	0	0		
810	chr5	29507437	29507466	3500293387	29		29507437	29507466	8421504	1	29	0	c	350029338700000006	34-63		19077666	10.1097/FPC.0b013e328318b21a		Pharmacogenetics and genomics	Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity	Rungnapa	2009	0		SP1
810	chr5	29507650	29508174	3500404900	126		29507650	29508174	8421504	2	98,28	0,496	p,c	350040490000015009,350040490000015007,350040490000000014	6-132,6-132,13-33					Patent	Cells for drug discovery (Patent US:6989269)	Case	2006	0		SP1
810	chr5	29507650	29508174	3500210174	126		29507650	29508174	8421504	2	98,28	0,496	p,c	350021017400015013,350021017400015015,350021017400000014	6-132,6-132,13-33						Cells for drug discovery	Case	2003	0		SP1
810	chr5	29507650	29508174	3500043010	126		29507650	29508174	8421504	2	98,28	0,496	p,c	350004301000015009,350004301000015006,350004301000015012,350004301000000013	6-132,6-132,0-102,13-33					Patent	Modulation of endogenous gene expression in cells (Patent US:7220719)	Case	2007	0		SP1
810	chr5	29507653	29508333	3500183663	282		29507653	29508333	8421504	2	95,187	0,493	p	350018366300015008	0-282						Dimerizing peptides	Wang	2000	0		SP1
810	chr5	29507653	29508333	3500160663	282		29507653	29508333	8421504	2	95,187	0,493	p	350016066300015005	0-282						Iterative optimization in the design of binding proteins	Eisenberg	2002	0		SP1
810	chr5	29507654	29508333	3500289135	41		29507654	29508333	8421504	2	20,21	0,658	c,g	350028913500000007,350028913500000006	13-33,18-39						Regulation of endogenous gene expression in cells using zinc finger proteins	Case	2003	0		
810	chr5	29507654	29508333	3500288478	41		29507654	29508333	8421504	2	20,21	0,658	c,g	350028847800000013,350028847800000013,350028847800000012	13-33,13-33,18-39						Regulation of endogenous gene expression in cells using zinc finger proteins	Cox	2005	0		
810	chr5	29507654	29508333	3500084051	41		29507654	29508333	8421504	2	20,21	0,658	c,g	350008405100000013,350008405100000012	13-33,18-39						Cells expressing zinc finger protein for drug discovery	Case	2001	0		
810	chr5	29507654	29508249	3500282393	106		29507654	29508249	8421504	4	20,41,4,41	0,53,492,554	p,c	350028239300000049,350028239300000014,350028239300015047,350028239300000058	13-33,13-33,0-45,0-41						Regulation of endogenous gene expression in cells using zinc finger proteins	Cox	2000	0		SP1
810	chr5	29507654	29508249	3500147998	109		29507654	29508249	8421504	4	20,41,7,41	0,53,492,554	p,c	350014799800000014,350014799800000048,350014799800015031,350014799800000057	13-33,13-33,0-48,0-41						Regulation Of Endogenous Gene Expression In Cells Using Zinc Finger Proteins 	.freshpatents.com	0	0		SP1
810	chr5	29507656	29507743	3500387469	87		29507656	29507743	8421504	1	87	0	p	350038746900015004	0-87						Biological sequence analysis	stat.berkeley.edu	0	0		SP1
810	chr5	29507668	29507737	3500229015	69		29507668	29507737	8421504	1	69	0	p	350022901500015065	0-69						Figure S1 AB	genome.cshlp.org	0	0		SP1
810	chr5	29507668	29507737	3500105130	69		29507668	29507737	8421504	1	69	0	p	350010513000015060	0-69						Supplemental Figure 1	genome.cshlp.org	0	0		SP1
810	chr5	29508150	29508225	3500442935	75		29508150	29508225	8421504	1	75	0	p	350044293500015001	3-78						Journal of Nanobiotechnology BioMed Central	biotechnology.com	0	0		SP1
810	chr5	29508150	29508225	3500201349	75		29508150	29508225	8421504	1	75	0	p	350020134900015001	3-78						Journal of Nanobiotechnology BioMed Central	biomedcentral.com	0	0		SP1
810	chr5	29508150	29508225	3500148251	75		29508150	29508225	8421504	1	75	0	p	350014825100015001	3-78		15985184	10.1186/1477-3155-3-5	1477-3155	Journal of Nanobiotechnology	Chemically synthesized zinc finger molecules as nano-addressable probes for double-stranded DNAs	Nickisch-Rosenegk	2005	0		SP1
810	chr5	29508216	29511140	3500208064	168		29508216	29511140	8421504	2	130,38	0,2886	p	350020806400015025	0-168						COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY	Cui	2007	0		SP1
810	chr5	29508216	29511140	3500100022	168		29508216	29511140	8421504	2	130,38	0,2886	p	350010002200015068	0-168						Peptide-dicer substrate rna conjugates as delivery vehicles for sirna	Ahmadian	2007	0		SP1
810	chr5	29508321	29511122	3500117015	45		29508321	29511122	8421504	2	25,20	0,2781	p	350011701500015000	0-45			10.1038/sj.onc.1205914	${footerJournalISSN}		Human Dbf4/ASK promoter is activated through the Sp1 and MluI cell-cycle box (MCB) transcription elements		2002	0		SP1
810	chr5	29511259	29537548	3500100552	25		29511259	29537548	8421504	2	12,13	0,26276	c	350010055200000020	0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		SP1
810	chr5	29537770	29538799	3500381781	525		29537770	29538799	8421504	5	99,93,45,84,204	0,165,261,693,825	p	350038178100015008,350038178100015006,350038178100015003,350038178100015001	0-99,0-138,0-84,0-204		10733580	10.1128/MCB.20.8.2774-2782.2000	0270-7306	Molecular and Cellular Biology	Conservation of Glutamine-Rich Transactivation Function between Yeast and Humans	Escher	2000	6		SP1
810	chr5	29537770	29538799	3500376924	525		29537770	29538799	8421504	5	99,93,45,84,204	0,165,261,693,825	p	350037692400015008,350037692400015006,350037692400015003,350037692400015001	0-99,0-138,0-84,0-204		10733580	10.1128/MCB.20.8.2774-2782.2000	0270-7306	Molecular and Cellular Biology	Conservation of Glutamine-Rich Transactivation Function between Yeast and Humans	Escher	2000	6		SP1
810	chr5	29537815	29537896	3500132566	67		29537815	29537896	8421504	3	21,24,22	0,34,59	c,g	350013256600000004,350013256600000005,350013256600000003,350013256600000003	0-21,0-24,0-22,0-22		16260592	10.1128/MCB.25.22.9741-9752.2005	0270-7306	Molecular and Cellular Biology	Interleukin-21 Receptor Gene Induction in Human T Cells Is Mediated by T-Cell Receptor-Induced Sp1 Activity	Wu	2005	6		SP1
810	chr5	29537815	29537896	3500045726	67		29537815	29537896	8421504	3	21,24,22	0,34,59	c	350004572600000004,350004572600000005,350004572600000003	0-21,0-24,0-22			10.1128/MCB.25.22.9741-9752.2005		Molecular and Cellular Biology	Interleukin-21 Receptor Gene Induction in Human T Cells Is Mediated by T-Cell Receptor-Induced Sp1 Activity	Zheng	2005	0		SP1
810	chr5	29538189	29538629	3500334508	40		29538189	29538629	8421504	2	20,20	0,420	c	350033450800000008,350033450800000007	0-20,0-20						The Sp1 and CBF/NF-Y Transcription Factors Cooperatively Regulate the Mouse Pro-&#x03b1;3(V) Collagen Gene (Col5a3) in Osteoblastic Cells	b.okayama-u.ac.jp	0	0		SP1
810	chr5	29538697	29538721	3500267062	24		29538697	29538721	8421504	1	24	0	c,g	350026706200000023,350026706200000023,350026706200000022,350026706200000022	0-24,0-24,0-24,0-24		12665574	10.1128/MCB.23.8.2720-2732.2003	0270-7306	Molecular and Cellular Biology	A Nucleoprotein Complex Containing Sp1, C/EBP&#x03b2;, and HMGI-Y Controls Human Insulin Receptor Gene Transcription	Foti	2003	6		SP1
810	chr5	29538923	29538947	3500191782	24		29538923	29538947	8421504	1	24	0	c	350019178200000020	8-32		18682402	10.1074/jbc.M802477200		The Journal of Biological Chemistry	Proto-oncogene FBI-1 (Pokemon) and SREBP-1 Synergistically Activate Transcription of Fatty-acid Synthase Gene (FASN)	Won-Il	2008	0		
810	chr5	29538990	29540491	3500350912	40		29538990	29540491	8421504	3	20,16,4	0,505,1497	c,g	350035091200000032,350035091200000032,350035091200000031	0-20,0-20,0-20		18771418	10.1089/dna.2008.0766		DNA and Cell Biology	Regulation of the Mouse Treacher Collins Syndrome Homolog (Tcof1) Promoter Through Differential Repression of Constitutive Expression	Kathryn	2008	0		SP1
810	chr5	29538990	29539051	3500459066	40		29538990	29539051	8421504	2	20,20	0,41	c	350045906600000000,350045906600000001	0-20,10-30		18417714	10.1095/biolreprod.107.067082	0006-3363	Biology of Reproduction	Expression Patterns of SP1 and SP3 During Mouse Spermatogenesis: SP1 Down-Regulation Correlates with Two Successive Promoter Changes and Translationally Compromised Transcripts	Ma	2008	4		
810	chr5	29538990	29539051	3500285322	40		29538990	29539051	8421504	2	20,20	0,41	c	350028532200000000,350028532200000001	0-20,10-30		18417714	10.1095/biolreprod.107.067082		Biology of reproduction	Expression Patterns of SP1 and SP3 During Mouse Spermatogenesis: SP1 Down-Regulation Correlates with Two Successive Promoter Changes and Translationally Compromised Transcripts1	Wenli	2008	0		
810	chr5	29539473	29539497	3500446473	24		29539473	29539497	8421504	1	24	0	c	350044647300000021	11-35		16467376	10.1091/mbc.E05-11-1063	1059-1524	Molecular Biology of the Cell	Sp2 Localizes to Subnuclear Foci Associated with the Nuclear Matrix	Moorefield	2006	5		SP1
810	chr5	29539491	29540496	3500128753	29		29539491	29540496	8421504	2	20,9	0,996	c	350012875300000000	7-36						activated by phosphatidylserine, DAG or phorbol esters, but insensitive to Ca	www.jbc.org	0	0		
810	chr5	29586875	29587063	3500280434	39		29586875	29587063	8421504	2	20,19	0,169	c,g	350028043400000002,350028043400000002,350028043400000003	0-20,0-20,0-19						COMPARATIVE OSTEOGENESIS OF EQUINE MESENCHYMAL STEM CELLS ISOLATED FROM BONE MARROW, ADIPOSE TISSUE AND SYNOVIUM BY ANTONELLA LIZA PANTALEONI ANDRIETTI THESIS	eals.illinois.edu	0	0		
810	chr5	29587562	29587589	3500076380	27		29587562	29587589	8421504	1	27	0	c	350007638000000057	0-27						Regulation of endogenous gene expression in cells using zinc finger proteins - US Patent 6824978 Description	ww.patentstorm.us	0	0		
810	chr5	29587562	29587589	3500021801	27		29587562	29587589	8421504	1	27	0	c	350002180100000057,350002180100000028	0-27,0-24						Regulation of endogenous gene expression in cells using zinc finger proteins	Cox	1999	0		
810	chr5	29587565	29587589	3500282393	24		29587565	29587589	8421504	1	24	0	c	350028239300000029	0-24						Regulation of endogenous gene expression in cells using zinc finger proteins	Cox	2000	0		
811	chr5	29653366	29655394	3500107989	1455		29653366	29655394	8421504	2	1368,87	0,1941	p	350010798900015055	69-1524					Patent	Protein HLQDR48 (Patent US:6569992)	Lafleur	2003	0		
811	chr5	29673783	29688898	3500380663	1263		29673783	29688898	8421504	12	108,73,26,111,142,161,177,114,79,92,58,122	0,111,11303,11341,11662,12445,12796,13358,13484,14182,14283,14993	p	350038066300015009,350038066300015012,350038066300015015,350038066300015018,350038066300015021,350038066300015024,350038066300015027,350038066300015030	0-108,0-99,0-180,0-180,0-180,0-165,0-171,0-180							eb.usherbrooke.ca	0	0		
811	chr5	29685161	29685184	3500121176	23		29685161	29685184	8421504	1	23	0	c	350012117600000009	0-23						Therapeutic combinations of RAR antagonists and RXR agonists and use thereof - Patent # 6653322 - PatentGenius	.patentgenius.com	0	0		RARG
811	chr5	29685188	29685211	3500326390	23		29685188	29685211	8421504	1	23	0	c	350032639000000003	0-23		20807888	10.1182/blood-2010-01-264432	0006-4971	Blood	BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia	Yamamoto	2010	10		RARG
811	chr5	29685478	29685577	3500111757	96		29685478	29685577	8421504	2	78,18	0,81	p	350011175700015018	0-96						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers, Sources	www.scribd.com	0	0		
811	chr5	29686367	29688862	3500126804	40		29686367	29688862	8421504	2	20,20	0,2475	c	350012680400000004,350012680400000005	0-20,0-20		14715861	10.1210/jc.2003-030770	0021-972X	Journal of Clinical Endocrinology & Metabolism	Retinoic Acid and Retinoid X Receptors Are Differentially Expressed in Thyroid Cancer and Thyroid Carcinoma Cell Lines and Predict Response to Treatment with Retinoids	Haugen	2004	6		RARG
811	chr5	29686378	29686593	3500016688	25		29686378	29686593	8421504	2	11,14	0,201	c	350001668800000012	0-25						N&#xb0; d'ordre THESE	mm.u-bordeaux1.fr	0	0		RARG
811	chr5	29686708	29687146	3500200513	53		29686708	29687146	8421504	2	48,5	0,433	c	350020051300000021	27-80						 Genes And Genetic Markers For Improved Reproductive Traits In Animals 	www.docstoc.com	0	0		
811	chr5	29686708	29687146	3500147561	53		29686708	29687146	8421504	2	48,5	0,433	c	350014756100000021	27-80						Genes and genetic markers for improved reproductive traits in animals - Patent # 5939264 - PatentGenius	.patentgenius.com	0	0		
811	chr5	29688064	29688929	3500176157	848		29688064	29688929	8421504	14	133,201,11,43,44,4,14,41,36,137,9,5,6,164	0,134,336,348,392,437,443,458,501,538,676,686,694,701	g	350017615700000026,350017615700000014	23-872,23-872						Assessing lipid metabolism	Barendse	1999	0		
811	chr5	29689105	29690061	3500266782	48		29689105	29690061	8421504	2	25,23	0,933	c	350026678200000001,350026678200000002	9-34,11-34		19782699	10.1016/j.mad.2009.09.002		Mechanisms of ageing and development	Alterations in microRNA Expression in Stress-induced Cellular Senescence	Guorong	2009	0		
811	chr5	29710280	29710306	3500253052	23		29710280	29710306	8421504	2	16,7	0,19	c	350025305200000007	10-33					Proceedings of the National Academy of Sciences of the United States of America	The poly(A)-limiting element is a conserved cis-acting sequence that regulates poly(A) tail length on nuclear pre-mRNAs	Haidong	1999	0		ZNF740
811	chr5	29710280	29710306	3500058932	23		29710280	29710306	8421504	2	16,7	0,19	c	350005893200000007	10-33		10430875	10.1073/pnas.96.16.8943	0027-8424	Proceedings of the National Academy of Sciences	The poly(A)-limiting element is a conserved cis-acting sequence that regulates poly(A) tail length on nuclear pre-mRNAs	Gu	1999	10		ZNF740
812	chr5	29787006	29787031	3500357525	25		29787006	29787031	8421504	1	25	0	c	350035752500000015	0-25						AmpliTaq and AmpliTaq Gold DNA Polymerase The Most Referenced Brand of DNA Polymerase in the World	ls.invitrogen.com	0	0		SOAT2
812	chr5	29787006	29787031	3500249072	25		29787006	29787031	8421504	1	25	0	c,g	350024907200000015,350024907200000015	0-25,0-25						AmpliTaq and AmpliTaq Gold DNA Polymerase The Most Referenced Brand of DNA Polymerase in the World	etechnologies.com	0	0		SOAT2
812	chr5	29787006	29787031	3500088814	25		29787006	29787031	8421504	1	25	0	c,g	350008881400000008,350008881400000008	0-25,0-25						AmpliTaq and AmpliTaq Gold DNA Polymerase	etechnologies.com	0	0		SOAT2
812	chr5	29799136	29801527	3500315971	89		29799136	29801527	8421504	4	45,21,22,1	0,316,393,2390	c,g	350031597100000051,350031597100000050,350031597100000019,350031597100000019,350031597100000018	0-45,0-45,0-21,0-21,0-23						REPRODUCTION	uction-online.org	0	0		
812	chr5	29799452	29801527	3500248474	44		29799452	29801527	8421504	3	21,22,1	0,77,2074	c,g	350024847400000015,350024847400000015,350024847400000014	0-21,0-21,0-23						REPRODUCTION	uction-online.org	0	0		
812	chr5	29799452	29801527	3500024081	44		29799452	29801527	8421504	3	21,22,1	0,77,2074	c,g	350002408100000019,350002408100000019,350002408100000018	0-21,0-21,0-23						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
812	chr5	29828130	29828155	3500020589	23		29828130	29828155	8421504	2	15,8	0,17	g	350002058900000030	6-29						Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof	Brams	1996	0		CYP27B1
812	chr5	29847600	29847645	3500385072	45		29847600	29847645	8421504	1	45	0	p	350038507200015070	0-45						Analysis of FOXO transcriptional networks	ive.library.uu.nl	0	0		EIF4B
812	chr5	29856881	29859839	3500394182	48		29856881	29859839	8421504	2	24,24	0,2934	c,g	350039418200000017,350039418200000017,350039418200000016	0-24,0-24,0-24		19855901	10.1590/S0100-879X2009001100004	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Dengue virus-induced regulation of the host cell translational machinery	Villas-Boas	2009	1		EIF4B
812	chr5	29856881	29859839	3500244884	48		29856881	29859839	8421504	2	24,24	0,2934	c,g	350024488400000017,350024488400000017,350024488400000016	0-24,0-24,0-24		19855901	10.1590/S0100-879X2009001100004	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Dengue virus-induced regulation of the host cell translational machinery	Villas-Boas	2009	1		
813	chr5	29918341	29918717	3500047878	40		29918341	29918717	8421504	2	20,20	0,356	c,g	350004787800000003,350004787800000003,350004787800000002	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
813	chr5	29918462	29918792	3500449710	38		29918462	29918792	8421504	2	19,19	0,311	c,g	350044971000000001,350044971000000001,350044971000000000,350044971000000000	0-19,0-19,0-19,0-19						186 LASER CAPTURE MICRODISSECTION FOR GENE EXPRESSION ANALYSIS OF INNER CELL MASS AND TROPHOBLAST FROM BOVINE BLASTOCYSTS. - ResearchGate	.researchgate.net	0	0		
813	chr5	29918497	29919687	3500337096	40		29918497	29919687	8421504	3	12,8,20	0,198,1170	c,g	350033709600000009,350033709600000008,350033709600000008	0-20,0-20,0-20						DeAnza College : HTEC 50 : Molecular signature detection of circulating tumor cells	ww.coursehero.com	0	0		
813	chr5	29919012	29919035	3500141941	23		29919012	29919035	8421504	1	23	0	c	350014194100000012	0-23						Isolation and Characterization of Equine Umbilical Cord Blood Derived Stem Cells	ufdc.ufl.edu	0	0		
813	chr5	29919012	29919035	3500124981	23		29919012	29919035	8421504	1	23	0	c	350012498100000012	0-23			10.1002/jcp.21312	1097-4652	Journal of Cellular Physiology	Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types - Reed - 2007 - Journal of Cellular Physiology - Wiley Online Library	Reed	2008	0		
814	chr5	30018713	30018776	3500065419	63		30018713	30018776	8421504	1	63	0	p	350006541900015017	0-63						The Genetic Basis of Weber-Cockayne Epidermolysis Bullosa Simplex	www.jstor.org	0	0		KRT6C
814	chr5	30138162	30138187	3500172455	25		30138162	30138187	8421504	1	25	0	c	350017245500000012	0-25						Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation	hives-ouvertes.fr	0	0		KRT16P1
815	chr5	30181395	30181418	3500189702	23		30181395	30181418	8421504	1	23	0	c	350018970200000019	10-33						US Patent # 5,851,797. Tie ligand-3, methods of making and uses thereof - Patents.com	www.patents.com	0	0		
815	chr5	30181395	30181418	3500149367	23		30181395	30181418	8421504	1	23	0	c	350014936700000092	1-24						Method For Treating Ischemic Diseases 	freshpatents.com	0	0		
815	chr5	30196951	30196974	3500380714	23		30196951	30196974	8421504	1	23	0	c	350038071400000000	0-23						Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety	Manoharan	2006	0		LMNA
101	chr5	30228653	30280474	3500233276	1781		30228653	30280474	8421504	20	28,91,118,10,60,40,51,144,36,33,103,370,2,60,20,34,81,332,4,164	0,15611,15704,15824,15850,15913,15957,16108,16253,21032,35228,35341,35793,36231,36422,36592,36630,51319,51652,51657	c,g	350023327600000083,350023327600000090,350023327600000091,350023327600000108,350023327600000092,350023327600000109,350023327600000093,350023327600000112,350023327600000117,350023327600000098,350023327600000118,350023327600000008,350023327600000032,350023327600000033,350023327600000044,350023327600000039,350023327600000042,350023327600000079,350023327600000003,350023327600000030,350023327600000110,350023327600000031,350023327600000116	14-42,0-60,0-58,43-98,7-297,30-82,2-57,0-50,0-50,0-120,0-207,0-33,0-100,0-370,1-84,0-60,0-20,0-34,3-24,0-120,0-221,0-370,49-99						LA FAMILIA DE GENES DE LA QUERATINA 6: CARACTERIZACION Y REGULACION	emigracion.ucm.es	0	0		
815	chr5	30229781	30249023	3500459722	50		30229781	30249023	8421504	3	12,13,25	0,621,19217	c	350045972200000004,350045972200000014	0-25,0-25		18637117	10.1111/j.1742-4658.2008.06567.x	1742-4658	FEBS Journal	Truncated P-cadherin is produced in oral squamous cell carcinoma - Bauer - 2008 - FEBS Journal - Wiley Online Library	Bauer	2008	0		
101	chr5	30244264	30280474	3500425986	1763		30244264	30280474	8421504	20	91,118,10,60,40,51,144,36,370,2,70,33,103,60,20,34,21,332,4,164	0,93,213,239,302,346,497,642,760,1212,2134,5421,19617,20620,20811,20981,21052,35708,36041,36046	c,g	350042598600000090,350042598600000091,350042598600000108,350042598600000092,350042598600000109,350042598600000093,350042598600000112,350042598600000117,350042598600000098,350042598600000118,350042598600000033,350042598600000044,350042598600000008,350042598600000032,350042598600000039,350042598600000042,350042598600000079,350042598600000003,350042598600000030,350042598600000110,350042598600000031,350042598600000116	0-60,0-58,43-98,7-297,30-82,2-57,0-50,0-50,0-120,0-207,0-370,1-73,0-33,0-100,0-60,0-20,0-34,3-24,0-120,0-221,0-370,49-99						LA FAMILIA DE GENES DE LA QUERATINA 6: CARACTERIZACION Y REGULACION	biblioteca.ucm.es	0	0		
816	chr5	30329277	30329337	3500451274	60		30329277	30329337	8421504	1	60	0	p	350045127400015005	0-60						cDNA II Da: Analysis differences II	www.pnas.org	0	0		
816	chr5	30329821	30329846	3500076448	24		30329821	30329846	8421504	2	14,10	0,15	c	350007644800000126,350007644800000471,350007644800000128,350007644800000129,350007644800000472,350007644800000473	0-21,0-21,0-19,0-21,0-19,0-21						ASSAY FOR THE DETECTION OF FACTORS THAT MODULATE THE EXPRESSION OF INAGP - Patent application	www.faqs.org	0	0		
816	chr5	30329885	30329925	3500249061	40		30329885	30329925	8421504	1	40	0	c	350024906100000002	0-40						Nucleotide sequence polymorphisms in the promoter region of bovine growth hormone receptor gene ( have no effect on its expression level in liver*	www.ighz.edu.pl	0	0		
816	chr5	30367194	30368462	3500461645	63		30367194	30368462	8421504	2	45,18	0,1250	p	350046164500015011	0-63					Patent	Peptide capable d'alterer la polymerisation de la tubuline et son utilisation pour inhiber la proliferation cellulaire (Patent EP:1742964)	Bocquet	2011	0		KRT71
816	chr5	30385388	30385502	3500065419	105		30385388	30385502	8421504	2	42,63	0,51	p	350006541900015021	0-105						The Genetic Basis of Weber-Cockayne Epidermolysis Bullosa Simplex	www.jstor.org	0	0		
816	chr5	30397598	30397621	3500292673	23		30397598	30397621	8421504	1	23	0	c	350029267300000006,350029267300000005,350029267300000009	4-25,1-24,4-25						Chicken genome mapping	edepot.wur.nl	0	0		
817	chr5	30528286	30528311	3500094094	25		30528286	30528311	8421504	1	25	0	g	350009409400000000	0-25						Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo	-publications.com	0	0		
817	chr5	30533798	30533843	3500023334	45		30533798	30533843	8421504	1	45	0	c	350002333400000363	3-48						Proteins, Polynucleotides Encoding Them And Methods Of Using The Same 	.freshpatents.com	0	0		
818	chr5	30589827	30598077	3500349090	23		30589827	30598077	8421504	2	8,15	0,8235	c	350034909000000021	10-34						DNA for expression of bovine growth hormone	Boer	1993	0		
818	chr5	30600531	30600559	3500157623	23		30600531	30600559	8421504	2	11,12	0,16	c	350015762300000005	10-33		15385642	10.1124/mol.66.4.921	1521-0111 (Online)	Molecular Pharmacology	Raf Kinase Activation of Adenylyl Cyclases: Isoform-Selective Regulation	Ding	2004	0		
818	chr5	30669011	30669038	3500024197	27		30669011	30669038	8421504	1	27	0	g	350002419700000001	46-73						Cytochrome c Release and Apoptosis Induced by Mitochondrial Targeting of Nuclear Orphan Receptor TR3	ww.sciencemag.org	0	0		
102	chr5	30669210	30672404	3500263236	40		30669210	30672404	8421504	4	9,11,4,16	0,1906,2863,3178	c	350026323600000001,350026323600000000	26-46,0-20		22262696	10.1095/biolreprod.111.094870	0006-3363	Biology of Reproduction	Patterns of Gene Expression in the Bovine Corpus Luteum Following Repeated Intrauterine Infusions of Low Doses of Prostaglandin F2alpha	Atli	2012	4		
102	chr5	30669210	30671210	3500261436	41		30669210	30671210	8421504	3	9,12,20	0,1906,1980	c,g	350026143600000074,350026143600000073,350026143600000073	0-21,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
819	chr5	30672056	30672391	3500064784	24		30672056	30672391	8421504	2	21,3	0,332	c	350006478400000001	0-24		22761936	10.1371/journal.pone.0039950		PLoS ONE	Orphan Nuclear Receptor Nur77 Regulates Androgen Receptor Gene Expression in Mouse Ovary	Anyi	2012	0		NR4A1
819	chr5	30672412	30672437	3500123324	25		30672412	30672437	8421504	1	25	0	c	350012332400000013	0-25						Subhajit Dasgupta, Avik Roy, Malabendu Jana, Dean M. Hartley, and Kalipada Pahan Division of Neuroscience, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612	aspetjournals.org	0	0		PPARD
819	chr5	30690208	30690233	3500451973	23		30690208	30690233	8421504	2	8,15	0,10	g	350045197300000003	0-23		20554879	10.1523/JNEUROSCI.1594-10.2010	0270-6474	The Journal of Neuroscience	Oxytocin-Induced Analgesia and Scratching Are Mediated by the Vasopressin-1A Receptor in the Mouse	Schorscher-Petcu	2010	7		
819	chr5	30790286	30790337	3500099578	51		30790286	30790337	8421504	1	51	0	p	350009957800015011	0-51						TransformingGrowthFactor&#xc3;&#x0178;TypeIReceptorKinaseMutantAssociatedwith MetastaticBreastCancer1	.aacrjournals.org	0	0		ACVRL1
819	chr5	30791315	30791784	3500252871	177		30791315	30791784	8421504	5	108,15,29,7,18	0,111,129,441,451	p	350025287100015011	0-177						Method and composition for modulating bone growth	Agius	2002	0		
819	chr5	30794051	30794075	3500032339	24		30794051	30794075	8421504	1	24	0	g	350003233900000004	0-24						Shortened Alk1 Regulatory Fragment - Patent application	www.faqs.org	0	0		ACVRL1
820	chr5	30896524	30896549	3500095218	23		30896524	30896549	8421504	2	10,13	0,12	c	350009521800000072	11-34						Compositions for saccharification of cellulosic material - Patent application	www.faqs.org	0	0		SCN8A
820	chr5	30921433	30921493	3500447272	60		30921433	30921493	8421504	1	60	0	p	350044727200015001	0-60			10.1083/jcb.200109026		The Journal of Cell Biology	Ankyrin-G coordinates assembly of the spectrin-based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at Purkinje neuron initial segments	Scott	2001	0		SCN8A
820	chr5	30921682	30924603	3500126493	78		30921682	30924603	8421504	3	33,3,42	0,36,2879	p	350012649300015136	0-78						 Screen For Sodium Channel Modulators 	www.docstoc.com	0	0		SCN3A
102	chr5	30921694	30935500	3500108932	411		30921694	30935500	8421504	5	24,219,66,39,63	0,2870,3158,5117,13743	p	350010893200015076,350010893200015075,350010893200015073,350010893200015069	0-66,0-180,0-105,6-69						Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases	Brys	2006	0		
102	chr5	30921712	31015188	3500344931	234		30921712	31015188	8421504	7	9,36,48,48,9,39,45	0,2849,3032,5165,42754,44017,93431	p	350034493100015060,350034493100015056,350034493100015051,350034493100015028,350034493100015003	3-48,0-48,0-48,0-48,3-48						Diagnostic And Therapeutic Use Of A Voltage-gated Ion Channel Scn2a For Neurodegenerative Diseases 	.freshpatents.com	0	0		
823	chr5	31226670	31226698	3500378708	24		31226670	31226698	8421504	2	16,8	0,20	g	350037870800000001	0-24						Bacillus thuringiensis isolates and toxins	Michaels	1995	0		
823	chr5	31226670	31226698	3500284964	24		31226670	31226698	8421504	2	16,8	0,20	g	350028496400000001	0-24						US Patent # 5,436,002. Bacillus thuringiensisisolate PS201T6 toxin - Patents.com	www.patents.com	0	0		
823	chr5	31238383	31238408	3500008258	24		31238383	31238408	8421504	2	9,15	0,10	c	350000825800000114	2-26						Polypeptides having L-asparaginase activity	Ario	1997	0		
823	chr5	31251882	31262583	3500368747	243		31251882	31262583	8421504	7	46,28,36,38,7,47,41	0,1092,1229,1289,4777,4812,10660	c	350036874700000067,350036874700000108,350036874700000111,350036874700000072,350036874700000114,350036874700000086	0-48,0-47,5-48,3-48,1-48,0-41						GENE AND POLYPEPTIDE RELATING TO BREAST CANCER - Patent application	www.faqs.org	0	0		
824	chr5	31404645	31404671	3500183223	26		31404645	31404671	8421504	1	26	0	c,g	350018322300000007,350018322300000007,350018322300000005,350018322300000005	6-32,6-32,6-32,6-32		19751393	10.1111/j.1365-2443.2009.01344.x	1365-2443	Genes to Cells	Transactivation activity of LBP-1 proteins and their dimerization in living cells - Katsura - 2009 - Genes to Cells - Wiley Online Library	Katsura	2009	0		
12	chr5	31404648	31549841	3500104186	1239		31404648	31549841	8421504	14	122,152,77,106,107,153,111,89,1,57,37,143,52,32	0,129243,129954,130920,132848,133996,134859,136655,138632,141949,142033,142509,144282,145161	p	350010418600015001,350010418600015002	0-1020,0-267						Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression - Patent application	www.faqs.org	0	0		
825	chr5	31541330	31543734	3500170700	153		31541330	31543734	8421504	3	62,49,42	0,1950,2362	p	350017070000015003,350017070000015001,350017070000015002	6-66,0-105,0-81						Phosphorylation by Cyclin C/Cyclin-Dependent Kinase 2 following Mitogenic Stimulation of Murine Fibroblasts Inhibits Transcriptional Activity of LSF during G Progression	mcb.asm.org	0	0		TFCP2
826	chr5	31624687	31636603	3500058897	141		31624687	31636603	8421504	6	24,29,43,21,6,18	0,8610,10144,10239,10284,11898	c	350005889700000165,350005889700000099,350005889700000103,350005889700000194,350005889700000195	24-48,15-44,4-47,27-48,24-48						Methods of screening for compounds that regulate the level of Nramp	Gros	2000	0		
826	chr5	31631111	31633326	3500159886	77		31631111	31633326	8421504	2	48,29	0,2186	c	350015988600000252,350015988600000099	0-48,15-44						 Methods Of Screening For Compounds That Regulate The Level Of Nramp 	www.docstoc.com	0	0		
827	chr5	31744195	31754350	3500159886	66		31744195	31754350	8421504	3	20,21,25	0,2888,10130	c	350015988600000165,350015988600000082,350015988600000103	24-44,27-48,22-47						 Methods Of Screening For Compounds That Regulate The Level Of Nramp 	www.docstoc.com	0	0		
829	chr5	32044509	32044533	3500159083	24		32044509	32044533	8421504	1	24	0	c	350015908300000003	5-29						Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma	files.chuv.ch	0	0		ATF1
829	chr5	32044509	32044533	3500154557	24		32044509	32044533	8421504	1	24	0	c	350015455700000003	5-29		16849546	10.1158/0008-5472.CAN-05-3979	0008-5472	Cancer Research	Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma	Riggi	2006	8		
829	chr5	32044509	32044533	3500058407	24		32044509	32044533	8421504	1	24	0	c	350005840700000003	5-29		16849546	10.1158/0008-5472.CAN-05-3979	0008-5472	Cancer Research	Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma	Riggi	2006	8		
829	chr5	32044521	32044614	3500148060	93		32044521	32044614	8421504	1	93	0	p	350014806000015147,350014806000015017,350014806000015146	0-45,0-84,0-45						MULTIMERIC PROTEINS AND METHODS OF MAKING AND USING SAME - Patent application	www.faqs.org	0	0		
830	chr5	32133497	32133523	3500441142	23		32133497	32133523	8421504	3	5,12,6	0,7,20	g	350044114200000000	12-35						SU PPLEMENTARY INFORMATION	rano.stanford.edu	0	0		
830	chr5	32167817	32167844	3500462669	24		32167817	32167844	8421504	2	14,10	0,17	g	350046266900000015	10-35						US Patent # 6,146,863. Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase - Patents.com	www.patents.com	0	0		
831	chr5	32327421	32327448	3500383543	24		32327421	32327448	8421504	3	4,15,5	0,5,22	g	350038354300000040	18-42						Genes that encode a surface protein of p. carinii	Angus	1994	0		
832	chr5	32381829	32381852	3500226926	23		32381829	32381852	8421504	1	23	0	g	350022692600000004	5-28						Cellular protein TDP-43 and regulation of HIV-1 gene expression - US Patent 5688511 Description	ww.patentstorm.us	0	0		
832	chr5	32385222	32385245	3500339689	23		32385222	32385245	8421504	1	23	0	c	350033968900000026	20-43						Verso un vaccino autoadiuvante multivalente contro il virus del papilloma umano	ce-unipr.cilea.it	0	0		
832	chr5	32385226	32385249	3500398947	23		32385226	32385249	8421504	1	23	0	c	350039894700000000	13-36		22375000	10.1074/jbc.M111.314617		The Journal of Biological Chemistry	GRK2 Protein-mediated Transphosphorylation Contributes to Loss of Function of &#x03bc;-Opioid Receptors Induced by Neuropeptide FF (NPFF2) Receptors	LionMouledous	2012	0		
832	chr5	32442409	32442434	3500211761	24		32442409	32442434	8421504	2	15,9	0,16	g	350021176100000035	0-24						Small Interfering Rnas Targeting Feline Herpes Virus 	.freshpatents.com	0	0		
834	chr5	32692692	32701117	3500352172	55		32692692	32701117	8421504	3	18,7,30	0,1766,8395	c	350035217200000014,350035217200000003	15-40,8-38						AcylChainSpecificityofCeramideSynthasesIsDetermined withinaRegionof150ResiduesintheTram-Lag-CLN8(TLC) Domain	www.jbc.org	0	0		
834	chr5	32739026	32745895	3500320950	225		32739026	32745895	8421504	4	28,17,132,48	0,1409,6018,6821	p	350032095000015061,350032095000015036,350032095000015037	0-45,0-180,0-75						Diversity. and specialization of mammalian SWI/SNF complexes	enesdev.cshlp.org	0	0		SMARCD1
834	chr5	32744492	32744516	3500234474	24		32744492	32744516	8421504	1	24	0	c	350023447400000032	24-48		19996304	10.1158/1541-7786.MCR-09-0119	1541-7786	Molecular Cancer Research	Inhibition of Expression of the Chromatin Remodeling Gene, SNF2L, Selectively Leads to DNA Damage, Growth Inhibition, and Cancer Cell Death	Ye	2009	4		SMARCD1
835	chr5	32834893	32848468	3500365167	62		32834893	32848468	8421504	3	20,21,21	0,12268,13554	c,g	350036516700000009,350036516700000007,350036516700000006,350036516700000006	0-20,0-21,0-21,0-21		23942196	10.1038/srep01763	xxxx-xxxx	Scientific Reports	Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats	Sugimoto	2013	0		
835	chr5	32834893	32848468	3500178390	62		32834893	32848468	8421504	3	20,21,21	0,12268,13554	c,g	350017839000000009,350017839000000007,350017839000000006,350017839000000006	0-20,0-21,0-21,0-21		23942196	10.1038/srep01763	xxxx-xxxx	Scientific Reports	Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats	Sugimoto	2013	0		
835	chr5	32846768	32847129	3500205057	42		32846768	32847129	8421504	3	20,9,13	0,48,348	c,g	350020505700000003,350020505700000003,350020505700000002	0-20,0-20,0-22						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
835	chr5	32846768	32847129	3500137197	42		32846768	32847129	8421504	3	20,9,13	0,48,348	c,g	350013719700000003,350013719700000003,350013719700000002	0-20,0-20,0-22						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
835	chr5	32847176	32847200	3500188558	24		32847176	32847200	8421504	1	24	0	c	350018855800000000	0-24			10.1167/iovs.04-1148	1552-5783	Investigative Ophthalmology & Visual Science	Gene Expression Profile Studies of Human Keratoconus Cornea for NEIBank: A Novel Cornea-Expressed Gene and the Absence of Transcripts for Aquaporin 5	Rabinowitz	2005	0		AQP5
835	chr5	32848687	32848711	3500265423	24		32848687	32848711	8421504	1	24	0	c	350026542300000001	0-24		18423983	10.1016/j.canlet.2008.01.029		Cancer letters	Overexpression of AQP5, a putative oncogene, promotes cell growth and transformation	Janghee	June	0		
835	chr5	32862519	32862585	3500450874	66		32862519	32862585	8421504	1	66	0	p	350045087400015001	3-69						&#x4e3b;&#x9898;&#xff1a;expression | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		AQP2
835	chr5	32862519	32862585	3500450696	66		32862519	32862585	8421504	1	66	0	p	350045069600015001	3-69						&#x4e3b;&#x984c;&#xff1a;expression | &#x91ab;&#x6e90;&#x4e16;&#x754c;	big5.39kf.com	0	0		AQP2
835	chr5	32862519	32862585	3500419513	66		32862519	32862585	8421504	1	66	0	p	350041951300015000	3-69		18480184	10.1152/ajprenal.00006.2008		American Journal of Physiology - Renal Physiology	A novel method of ligand peptidomics to identify peptide ligands binding to AQP2-expressing plasma membranes and intracellular vesicles of rat kidney	Lee	2008	0		AQP2
835	chr5	32862519	32862585	3500263942	66		32862519	32862585	8421504	1	66	0	p	350026394200015000	3-69		18480184	10.1152/ajprenal.00006.2008		American Journal of Physiology - Renal Physiology	A novel method of ligand peptidomics to identify peptide ligands binding to AQP2-expressing plasma membranes and intracellular vesicles of rat kidney	Lee	2008	0		AQP2
835	chr5	32862519	32862567	3500174125	48		32862519	32862567	8421504	1	48	0	p	350017412500015001	0-48						&#x4e3b;&#x9898;&#xff1a;Proteins | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
835	chr5	32862519	32862564	3500413086	45		32862519	32862564	8421504	1	45	0	p	350041308600015003	3-48		18322017	10.1152/ajprenal.00613.2007		American Journal of Physiology - Renal Physiology	Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins	Wagner	2008	0		
835	chr5	32862519	32862564	3500120679	45		32862519	32862564	8421504	1	45	0	p	350012067900015003	3-48		18322017	10.1152/ajprenal.00613.2007		American Journal of Physiology - Renal Physiology	Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins	Wagner	2008	0		
835	chr5	32862519	32862564	3500006267	45		32862519	32862564	8421504	1	45	0	p	350000626700015003	3-48		18322017	10.1152/ajprenal.00613.2007		American Journal of Physiology - Renal Physiology	Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins	Wagner	2008	0		
835	chr5	32862693	32863367	3500208975	36		32862693	32863367	8421504	2	33,3	0,671	c	350020897500000015	0-36						US Patent # 5,661,003. Water channel - Patents.com	www.patents.com	0	0		
835	chr5	32867063	32867162	3500372686	99		32867063	32867162	8421504	1	99	0	p	350037268600015004	0-99						Molecular evolution and phylogeny Version 1.3	pingpong.ki.se	0	0		
835	chr5	32867216	32867390	3500437641	174		32867216	32867390	8421504	1	174	0	p	350043764100015082	0-174						Eduardo Campos dos Santos Uma introdu&#xe7;&#xe3;o &#xe0; Bioinform&#xe1;tica atrav&#xe9;s da an&#xe1;lise de algumas ferramentas de software de seq&#xfc;&#xea;ncias	www.ginux.ufla.br	0	0		
835	chr5	32867279	32867302	3500431462	23		32867279	32867302	8421504	1	23	0	c	350043146200000469	15-38						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
835	chr5	32867279	32867302	3500110550	23		32867279	32867302	8421504	1	23	0	c	350011055000000459	15-38						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
835	chr5	32867279	32867302	3500031022	23		32867279	32867302	8421504	1	23	0	c	350003102200000459	15-38						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
836	chr5	32935723	32973586	3500242436	180		32935723	32973586	8421504	3	27,54,99	0,1657,37764	p	350024243600015047	0-180						Novel polypeptides and nucleic acids encoding same	Burgess	2002	0		FAIM2
836	chr5	33004113	33004137	3500153276	23		33004113	33004137	8421504	2	15,8	0,16	c	350015327600000333	19-42						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
837	chr5	33049449	33049472	3500257166	23		33049449	33049472	8421504	1	23	0	c	350025716600000333	1-26						Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes - Patent application	www.faqs.org	0	0		
837	chr5	33071441	33071466	3500006718	25		33071441	33071466	8421504	1	25	0	c	350000671800000159	3-28						CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME - Patent application	www.faqs.org	0	0		
837	chr5	33114299	33114326	3500270031	23		33114299	33114326	8421504	3	5,4,14	0,8,13	g	350027003100000036	23-46						Method and product for regulating cell responsiveness to external signals	Johnson	1996	0		
838	chr5	33223561	33224165	3500002653	93		33223561	33224165	8421504	3	10,38,45	0,518,559	p	350000265300015026	0-93						 MEKK1 	www.docstoc.com	0	0		
838	chr5	33223817	33223841	3500414482	24		33223817	33223841	8421504	1	24	0	g	350041448200000001	0-24		19187526	10.1186/1471-2121-10-9	1471-2121	BMC Cell Biology	MCRS2 represses the transactivation activities of Nrf1	Wu	2009	3		
838	chr5	33226701	33227101	3500452588	42		33226701	33227101	8421504	2	22,20	0,380	c	350045258800000000,350045258800000001	0-22,0-20		19549253	10.1111/j.1349-7006.2009.01223.x	1349-7006	Cancer Science	Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1&#x2013;cyclin-dependent kinase 4&#x2013;p21 pathway - Shi - 2009 - Cancer Science - Wiley Online Library	Shi	2009	0		MCRS1
838	chr5	33231970	33231994	3500186547	24		33231970	33231994	8421504	1	24	0	c	350018654700000274	2-47						Polycystic kidney disease gene and protein	Klinger	1996	0		
838	chr5	33239628	33239656	3500353345	23		33239628	33239656	8421504	3	13,3,7	0,14,21	g	350035334500000067,350035334500000027	10-33,10-33						Protein scaffolds and uses thereof - Patent application	www.faqs.org	0	0		
838	chr5	33240384	33250144	3500369026	122		33240384	33250144	8421504	5	20,28,26,25,23	0,301,364,5155,9737	p,c	350036902600015035,350036902600000003,350036902600000017,350036902600000011,350036902600000019,350036902600000000,350036902600000014	0-48,0-26,0-26,0-25,0-25,0-23,0-23						Human Elk, a voltage-gated potassium channel subunit	Jegla	2002	0		
840	chr5	33492228	33493797	3500101334	48		33492228	33493797	8421504	3	11,13,24	0,295,1545	c	350010133400000053,350010133400000052	0-24,0-24						Neural crest development in a human embryonic stem cell-based model system	s.ulb.uni-bonn.de	0	0		PRPH
840	chr5	33494638	33494698	3500371765	60		33494638	33494698	8421504	1	60	0	p	350037176500015071	0-60						Peripherin And Neurofilament Light Protein Splice Variants In Amyotrophic Lateral Sclerosis (als) 	.freshpatents.com	0	0		DES
840	chr5	33513394	33525687	3500191479	40		33513394	33525687	8421504	2	20,20	0,12273	c,g	350019147900000004,350019147900000005	0-20,0-20						 <HTML> <HEAD> <TITLE> The Gene Expression Program of Prostate Fibroblast Sene	.aacrjournals.org	0	0		
840	chr5	33525644	33526062	3500131157	39		33525644	33526062	8421504	2	19,20	0,398	c	350013115700000007,350013115700000006	0-19,0-20		20237268	10.1523/JNEUROSCI.6421-09.2010		The Journal of neuroscience : the official journal of the Society for Neuroscience	SERTAD1 PLAYS AN ESSENTIAL ROLE IN DEVELOPMENTAL AND PATHOLOGICAL NEURON DEATH	Subhas	2010	0		
840	chr5	33525671	33525794	3500100654	40		33525671	33525794	8421504	2	19,21	0,102	c	350010065400000037,350010065400000035	0-19,0-21						Screening Method For Anti-diabetic Compounds 	.freshpatents.com	0	0		TUBA1A
840	chr5	33525764	33525790	3500454086	26		33525764	33525790	8421504	1	26	0	c	350045408600000005	0-26		19258514	10.1158/0008-5472.CAN-08-2308	0008-5472	Cancer Research	Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation	Mukhopadhyay	2009	8		TUBA1C
840	chr5	33525811	33526090	3500068121	42		33525811	33526090	8421504	2	21,21	0,258	c	350006812100000002,350006812100000000	0-21,0-21						Analyse einzelner disseminierter Mammakarzinomzellen durch SSH: Identifizierung eines differentiell exprimierten ERV9-LTR Transkripes	b.uni-muenchen.de	0	0		TUBA1C
840	chr5	33526271	33526296	3500141126	25		33526271	33526296	8421504	1	25	0	c	350014112600000011	0-25		10660558	10.1074/jbc.275.6.4013	0021-9258	Journal of Biological Chemistry	Role of Niemann-Pick Type C1 Protein in Intracellular Trafficking of Low Density Lipoprotein-derived Cholesterol	Cruz	2000	5		
840	chr5	33528402	33528724	3500380160	180		33528402	33528724	8421504	2	134,46	0,276	p	350038016000015003	0-180						SNP report 	.cerealsdb.uk.net	0	0		
840	chr5	33528419	33528696	3500189520	42		33528419	33528696	8421504	3	21,3,18	0,114,259	c	350018952000000005,350018952000000004	0-21,0-21						Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines	isma.viamedica.pl	0	0		TUBA1C
840	chr5	33528421	33528505	3500254340	44		33528421	33528505	8421504	2	22,22	0,62	c	350025434000000035,350025434000000034	0-22,0-22		22347457	10.1371/journal.pone.0031286		PLoS ONE	Caffeic Acid Phenethyl Ester Causes p21Cip1 Induction, Akt Signaling Reduction, and Growth Inhibition in PC-3 Human Prostate Cancer Cells	Hui-Ping	2012	0		
840	chr5	33528446	33528472	3500072776	26		33528446	33528472	8421504	1	26	0	c	350007277600000056	0-26						Methods for detecting target nucleic acids using coupled ligation and amplification	Wenz	2006	0		
841	chr5	33616767	33619198	3500151699	39		33616767	33619198	8421504	4	1,14,4,20	0,2035,2050,2411	c,g	350015169900000002,350015169900000003,350015169900000003	0-19,0-20,0-20			10.1046/j.1471-4159.2001.00475.x	1471-4159	Journal of Neurochemistry	Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells - Butler - 2001 - Journal of Neurochemistry - Wiley Online Library	Butler	2001	0		
841	chr5	33619182	33619208	3500072776	26		33619182	33619208	8421504	1	26	0	c	350007277600000054	26-52						Methods for detecting target nucleic acids using coupled ligation and amplification	Wenz	2006	0		TUBA1A,CHORDC1
841	chr5	33619202	33661310	3500174956	44		33619202	33661310	8421504	2	23,21	0,42087	c,g	350017495600000004,350017495600000003	0-23,0-21		18239070	10.1210/en.2007-1059		Endocrinology	The Antiinflammatory Cytokine Interleukin-1 Receptor Antagonist Protects from High-Fat Diet-Induced Hyperglycemia	Nadine	2008	0		
841	chr5	33619202	33619225	3500423947	23		33619202	33619225	8421504	1	23	0	c	350042394700000001	21-44		24024120	10.1016/j.molmet.2012.08.006		Molecular Metabolism	TOSO promotes &#x03b2;-cell proliferation and protects from apoptosis	G.	2012	0		
841	chr5	33619865	33662478	3500121557	48		33619865	33662478	8421504	2	23,25	0,42588	c	350012155700000030,350012155700000031	0-23,0-25						Reduced complexity nucleic acid targets and methods of using same	Mcclelland	1999	0		TUBA1A
841	chr5	33619869	33620233	3500152218	41		33619869	33620233	8421504	2	21,20	0,344	c	350015221800000007,350015221800000008	0-21,1-21		23657814	10.1091/mbc.E13-01-0017		Molecular Biology of the Cell	Transforming growth factor-&#x03b2;1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199&#x2013;dependent posttranscriptional mechanism	Ognoon	July	0		TUBA1A
841	chr5	33620200	33620226	3500032898	26		33620200	33620226	8421504	1	26	0	c	350003289800000007	0-26			10.1128/JVI.78.6.2819-2830.2004		Journal of Virology	Retinoid-Dependent Restriction of Human Immunodeficiency Virus Type 1 Replication in Monocytes/Macrophages	Timothy	2004	0		TUBA1A
841	chr5	33620229	33620339	3500170351	42		33620229	33620339	8421504	2	21,21	0,89	c,g	350017035100000004,350017035100000005,350017035100000005	0-21,0-21,0-21		21150911	10.1038/npp.2010.214	0893-133X	Neuropsychopharmacology	Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation	Zoppi	2010	8		
841	chr5	33620302	33620623	3500098406	45		33620302	33620623	8421504	2	20,25	0,296	c	350009840600000002,350009840600000003	0-20,0-25		14583436	10.1152/ajprenal.00254.2003		American Journal of Physiology - Renal Physiology	Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma	Turcotte	2004	0		
841	chr5	33620360	33620667	3500442102	40		33620360	33620667	8421504	2	20,20	0,287	c	350044210200000044,350044210200000045	0-20,0-20		17908930	10.1101/gad.437807	0890-9369	Genes & Development	Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis	Larrivee	2007	12		TUBA1A
841	chr5	33620360	33620667	3500383300	40		33620360	33620667	8421504	2	20,20	0,287	c	350038330000000044,350038330000000045	0-20,0-20						Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis	enesdev.cshlp.org	0	0		
841	chr5	33620599	33620830	3500247908	44		33620599	33620830	8421504	2	23,21	0,210	c	350024790800000003,350024790800000002	0-23,0-21						Genes and polypeptides relating to human pancreatic cancers	Nakamura	2006	0		
841	chr5	33620599	33620622	3500065157	23		33620599	33620622	8421504	1	23	0	c	350006515700000009	0-23						C2orf18 as target gene for cancer therapy and diagnosis	Nakamura	2009	0		
841	chr5	33620809	33663080	3500084295	44		33620809	33663080	8421504	2	21,23	0,42248	c,g	350008429500000004,350008429500000004,350008429500000070,350008429500000006,350008429500000071	0-21,0-21,0-21,0-23,23-46					Patent	Genes and polypeptides relating to human pancreatic cancer (Patent CN:1703524)	Zhong Cun You Fu 	2010	0		
841	chr5	33659827	33659850	3500231330	23		33659827	33659850	8421504	1	23	0	c,g	350023133000000006,350023133000000006	0-23,0-23		20889969	10.1074/jbc.M110.146290	0021-9258	Journal of Biological Chemistry	Cobra CRISP Functions as an Inflammatory Modulator via a Novel Zn2+- and Heparan Sulfate-dependent Transcriptional Regulation of Endothelial Cell Adhesion Molecules	Wang	2010	5		TUBA1B
841	chr5	33661280	33661439	3500230459	43		33661280	33661439	8421504	2	21,22	0,137	c	350023045900000002,350023045900000003	0-21,0-22						ATP-binding Cassette Transporter G2 Activity in the Bovine Spermatozoa is modulated along the Epididymal Duct and at Ejaculation	ww.biolreprod.org	0	0		
841	chr5	33661385	33662610	3500405973	258		33661385	33662610	8421504	2	60,198	0,1027	p	350040597300015026,350040597300015030,350040597300015036,350040597300015035,350040597300015027	0-60,3-48,3-48,3-69,3-54						Protein-Protein-Interaktion des kardialen Ankyrin-Repeat-Proteins, CARP, mit dem zytoplasmatischen -Aktin	ni-duesseldorf.de	0	0		TUBA1B,TUBA1A
841	chr5	33661385	33662562	3500391361	168		33661385	33662562	8421504	4	60,34,11,63	0,72,249,1114	p	350039136100015156,350039136100015163,350039136100015147	0-60,0-45,0-63						Transcriptomic and Proteomic Approaches to the Discovery of New Markers of Pathology	n.library.ethz.ch	0	0		TUBA1B,TUBA1A
841	chr5	33661413	33662391	3500219092	45		33661413	33662391	8421504	2	22,23	0,955	c	350021909200000002,350021909200000003	0-22,0-23						RIC-3 Enhances Functional Expression of Multiple Nicotinic Acetylcholine Receptor Subtypes in Mammalian Cells 2006&#x5e74;&#x7b2c;68&#x5377;&#x7b2c;5&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		TUBA1B,TUBA1A
841	chr5	33661413	33662391	3500039177	45		33661413	33662391	8421504	2	22,23	0,955	c	350003917700000002,350003917700000003	0-22,0-23		16120769	10.1124/mol.105.017459	1521-0111 (Online)	Molecular Pharmacology	RIC-3 Enhances Functional Expression of Multiple Nicotinic Acetylcholine Receptor Subtypes in Mammalian Cells	Lansdell	2005	0		
841	chr5	33661421	33661469	3500315045	48		33661421	33661469	8421504	1	48	0	p	350031504500015011	0-48						Monozyt&#xe4;re Zellantwort gegen Aspergillus fumigatus	.uni-tuebingen.de	0	0		TUBA3E
841	chr5	33662654	33662777	3500215582	40		33662654	33662777	8421504	2	21,19	0,104	c	350021558200000035,350021558200000037	0-21,0-19						Screening Method For Anti-diabetic Compounds 	.freshpatents.com	0	0		TUBA1A
841	chr5	33663057	33663080	3500306187	23		33663057	33663080	8421504	1	23	0	c	350030618700000036,350030618700000008	0-23,0-23						PANCREATIC CANCER RELATED GENE TTLL4 - Patent application	www.faqs.org	0	0		
841	chr5	33663057	33663080	3500279235	23		33663057	33663080	8421504	1	23	0	c	350027923500000007	0-23						SureChem - Document - WO/PCT - Patent No. 2008020596 - "TREATING OR PREVENTING CANCERS OVER-EXPRESSING REG4 OR KIAA0101" - Description	www.surechem.org	0	0		TUBA1A
841	chr5	33663057	33663080	3500247076	23		33663057	33663080	8421504	1	23	0	c	350024707600000003	0-23						Genes and polypeptides relating to human pancreatic cancers	Katagiri	2005	0		
841	chr5	33663057	33663080	3500230941	23		33663057	33663080	8421504	1	23	0	c	350023094100000007	0-23						Treating or preventing cancers over-expressing reg4 or kiaa0101	Nakagawa	2008	0		
841	chr5	33663057	33663080	3500211421	23		33663057	33663080	8421504	1	23	0	c	350021142100000003	0-23					Patent	Genes and polypeptides relating to human pancreatic cancers (Patent US:7601826)	Nakamura	2009	0		TUBA1A
841	chr5	33663057	33663080	3500086559	23		33663057	33663080	8421504	1	23	0	c	350008655900000027,350008655900000003	0-23,0-23					Patent	Genes and polypeptides relating to human pancreatic cancers (Patent EP:1556518)	Nakamura	2008	0		TUBA1A
842	chr5	33773652	33773971	3500353380	51		33773652	33773971	8421504	2	33,18	0,301	p,c	350035338000015008,350035338000000004	0-51,0-23						AMP activated protein kinase	Kemp	1998	0		PRKAG1
842	chr5	33787914	33787949	3500325351	35		33787914	33787949	8421504	1	35	0	g	350032535100000010	0-35						Identi&#xfb01;cation of an evolutionarily conserved 110 base-pair cis-acting regulatory sequence that governs Wnt-1expression in the murine neural plate	ev.biologists.org	0	0		WNT1
842	chr5	33793491	33793517	3500148394	26		33793491	33793517	8421504	1	26	0	c	350014839400000153	22-48						Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	.freshpatents.com	0	0		
842	chr5	33794958	33794981	3500069173	23		33794958	33794981	8421504	1	23	0	c,g	350006917300000018,350006917300000018	0-23,0-23						JNK is required for lineage -specific differentiation, but not for stem cell self -renewal	mcb.asm.org	0	0		WNT1
842	chr5	33795157	33795180	3500033607	23		33795157	33795180	8421504	1	23	0	c	350003360700000001	0-23						Role of Wnt/GSK3beta/beta-catenin signaling pathway in cardiac and pulmonary vascular remodeling	eb.uni-giessen.de	0	0		
842	chr5	33802217	33802280	3500463464	61		33802217	33802280	8421504	2	5,56	0,7	g	350046346400000050	7-68						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
843	chr5	33829237	33830164	3500070724	121		33829237	33830164	8421504	2	109,12	0,915	c	350007072400000011	0-121						Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes	Dayn	1998	0		ARF3
843	chr5	33829237	33830164	3500013377	121		33829237	33830164	8421504	2	109,12	0,915	c	350001337700000011	0-121						Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes	Holzmayer	1998	0		ARF3
843	chr5	33829238	33830164	3500086392	120		33829238	33830164	8421504	2	108,12	0,914	c	350008639200000011	0-120					Patent	Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes (Patent US:6071743)	Dayn	2000	0		ARF3
843	chr5	33883880	33889886	3500252632	696		33883880	33889886	8421504	5	120,88,110,135,243	0,881,3496,4683,5763	p	350025263200015001,350025263200015003,350025263200015005	0-285,0-285,0-126						RhoA and Rnd1 in Xenopus development	ev.biologists.org	0	0		RND1
843	chr5	33883880	33889880	3500264769	684		33883880	33889880	8421504	6	27,87,88,110,135,237	0,33,881,3496,4683,5763	p	350026476900015128	0-687						Compositions and methods for treating and diagnosing irritable bowel syndrome	Pasricha	2005	0		RND1
843	chr5	33890414	33890661	3500424225	42		33890414	33890661	8421504	2	21,21	0,226	c	350042422500000012,350042422500000013	0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
843	chr5	33902823	33902848	3500403336	25		33902823	33902848	8421504	1	25	0	c,g	350040333600000298,350040333600000298	26-51,26-51					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
843	chr5	33902823	33902848	3500199448	25		33902823	33902848	8421504	1	25	0	c,g	350019944800000210,350019944800000210	26-51,26-51						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1996	0		
843	chr5	33902823	33902848	3500126207	25		33902823	33902848	8421504	1	25	0	c,g	350012620700000298,350012620700000298	26-51,26-51					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:5837492)	Couch	1998	0		
843	chr5	33910780	33910804	3500077003	23		33910780	33910804	8421504	2	17,6	0,18	c	350007700300000010	9-32						GHGKHKNK Octapeptide (P-5m) Inhibits Metastasis of HCCLM3 Cell Lines via Regulation of MMP-2 Expression in in Vitro and in Vivo Studies	www.mdpi.com	0	0		
843	chr5	33911215	33919022	3500328440	1428		33911215	33919022	8421504	15	192,99,150,33,60,152,110,59,81,20,65,116,123,123,45	0,195,744,992,1028,1295,1750,2027,2286,2564,2782,3148,3705,4019,7762	p	350032844000015025,350032844000015013	0-1416,0-1410						Methods for identifying ion channel modulators	Friden	2004	0		
843	chr5	33913268	33913516	3500359236	48		33913268	33913516	8421504	2	33,15	0,233	p	350035923600015019	0-48						STUDI SUL MECCANISMO DI AZIONE DEL FARMACO ANTIPARASSITARIO PRAZIQUANTEL	padis.uniroma1.it	0	0		CACNB2
843	chr5	33914998	33919025	3500255562	46		33914998	33919025	8421504	2	24,22	0,4005	c,g	350025556200000005,350025556200000004,350025556200000004	0-24,0-22,0-22		19996312	10.1074/jbc.M109.044271		The Journal of Biological Chemistry	Reciprocal Interactions Regulate Targeting of Calcium Channel &#x03b2; Subunits and Membrane Expression of &#x03b1;1 Subunits in Cultured Hippocampal Neurons	Gerald	2010	0		CACNB3
844	chr5	33952779	33965960	3500167164	3492		33952779	33965960	8421504	22	285,567,150,122,112,128,159,142,129,26,148,98,88,117,159,179,36,130,264,205,125,123	0,291,4332,4876,5087,5522,6157,6390,6641,7043,7301,7645,7917,8153,8536,8962,10111,10229,10674,11699,12708,13058	p	350016716400015004	0-3504						KEGG T01001: 107	www.genome.jp	0	0		
844	chr5	34049062	34049233	3500309375	171		34049062	34049233	8421504	1	171	0	p	350030937500015001,350030937500015002	0-132,0-63		20926576	10.1128/JVI.00943-10		Journal of Virology	Human T-Lymphotropic Virus Type 1 Tax Protein Complexes with P-TEFb and Competes for Brd4 and 7SK snRNP/HEXIM1 Binding 	Won-Kyung	2010	0		CCNT1
846	chr5	34306959	34309600	3500378204	1632		34306959	34309600	8421504	22	809,28,41,39,40,40,39,41,40,39,42,38,41,40,40,40,41,38,41,40,55,20	0,1042,1090,1151,1210,1270,1330,1389,1450,1510,1569,1632,1690,1751,1811,1871,1931,1992,2050,2111,2171,2621	c,g	350037820400000024,350037820400000012,350037820400000017,350037820400000000,350037820400000030,350037820400000011,350037820400000021,350037820400000021,350037820400000034	0-1640,21-70,0-50,0-69,0-21,21-43,0-20,0-20,0-20						Patent EP0555435A4 - Google Patents	T	1995	0		
846	chr5	34306959	34309600	3500365123	2021		34306959	34309600	8421504	4	809,591,601,20	0,1042,1634,2621	g	350036512300000013,350036512300000029,350036512300000002,350036512300000006	0-2044,0-69,0-21,0-20						Transgenic non-human mammals comprising a bovine 5' flanking regulatory sequence - Patent # 5850000 - PatentGenius	.patentgenius.com	0	0		
846	chr5	34306959	34309600	3500096651	2021		34306959	34309600	8421504	4	809,591,601,20	0,1042,1634,2621	c,g	350009665100000007,350009665100000002,350009665100000023,350009665100000016,350009665100000001,350009665100000004,350009665100000004,350009665100000020	0-2044,21-70,0-69,0-21,21-43,0-20,0-20,0-20					Patent	Transgenic mice producing bovine &#x03b1;-lactalbumin in their milk (Patent US:5530177)	Bleck	1996	0		
846	chr5	34306959	34309184	3500334502	1735		34306959	34309184	8421504	12	809,589,88,21,6,20,31,35,7,55,20,54	0,1042,1632,1737,1761,1793,1862,1895,1934,1949,2010,2171	g	350033450200000045,350033450200000044,350033450200000048,350033450200000047,350033450200000038	0-1801,2670-6764,0-2319,0-1797,0-1796						 Expression Vectors 	www.docstoc.com	0	0		
846	chr5	34306959	34309184	3500087055	1760		34306959	34309184	8421504	14	809,591,86,21,6,20,31,35,7,55,10,7,26,56	0,1042,1634,1737,1761,1793,1862,1895,1934,1949,2010,2047,2056,2169	g	350008705500000031,350008705500000032,350008705500000022,350008705500000029,350008705500000028	0-1904,0-2458,0-1904,0-3743,2839-7252						Host Cells Containing Multiple Integrating Vectors - Patent application	www.faqs.org	0	0		
846	chr5	34308431	34309101	3500465634	666		34308431	34309101	8421504	2	422,244	0,426	g	350046563400000012	0-706						METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION - Patent application	www.faqs.org	0	0		
846	chr5	34308703	34310809	3500186308	197		34308703	34310809	8421504	3	177,5,15	0,1582,2091	c,g	350018630800000023,350018630800000004	0-177,20-40						EFFECTS OF GROWTH HORMONE AND INSULIN-LIKE GROWTH FACTOR-I ON MILK PROTEIN GENE EXPRESSION AND NUTRIENT UPTAKE AND CELL PROLIFERATION IN CLONAL BOVINE MAMMARY EPITHELIAL CELLS	cholar.lib.vt.edu	0	0		
846	chr5	34309077	34309741	3500161305	65		34309077	34309741	8421504	3	21,23,21	0,43,643	c,g	350016130500000006,350016130500000008,350016130500000009,350016130500000009	0-21,0-23,0-21,0-21						Process for Producing Exogenous Protein in the Milk of Transgenic Mammals and a Process For Purifying Proteins Therefrom - Patent application	www.faqs.org	0	0		
846	chr5	34309120	34311453	3500402183	2158		34309120	34311453	8421504	40	11,55,57,55,54,57,54,58,56,55,59,56,56,53,54,57,55,55,55,55,57,54,56,54,57,57,57,55,56,54,55,56,55,55,53,58,55,54,56,37	0,16,76,136,196,254,316,373,434,493,552,616,677,738,796,854,916,976,1036,1096,1155,1217,1276,1337,1394,1454,1514,1576,1636,1697,1755,1815,1876,1936,1996,2053,2116,2176,2235,2296	c,g	350040218300000002,350040218300000003,350040218300000003,350040218300000000,350040218300000000,350040218300000004,350040218300000004,350040218300000001,350040218300000001	3420-5576,0-25,0-25,0-25,0-25,0-25,0-25,0-25,0-25						 Retrovirus 	www.docstoc.com	0	0		
846	chr5	34309120	34309741	3500356043	44		34309120	34309741	8421504	2	23,21	0,600	c	350035604300000008,350035604300000009	0-23,0-21						Process of Making Transgenic Mammals That Produce Exogenous Proteins in Milk and Transgenic Mammals Produced Thereby	A.	2008	0		
846	chr5	34309128	34310852	3500157424	426		34309128	34310852	8421504	4	133,159,76,58	0,454,1086,1666	p,c,g	350015742400015013,350015742400015005,350015742400000000,350015742400015006,350015742400015007,350015742400015008,350015742400015009,350015742400015010,350015742400015014,350015742400015011,350015742400015012,350015742400000001,350015742400000001	0-291,0-57,15-36,0-60,0-60,0-60,0-60,0-60,0-105,0-60,0-57,36-64,36-64						DISSERTATION	thes.univie.ac.at	0	0		
846	chr5	34309128	34309185	3500434332	57		34309128	34309185	8421504	1	57	0	c,g	350043433200000000,350043433200000000	0-57,0-57						Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance. - ResearchGate	.researchgate.net	0	0		
846	chr5	34309128	34309185	3500399608	57		34309128	34309185	8421504	1	57	0	p,c,g	350039960800000000,350039960800000000,350039960800015003	0-50,0-50,0-57						Decorin compositions and use thereof	Bleck	2012	0		
846	chr5	34309128	34309185	3500265864	57		34309128	34309185	8421504	1	57	0	p,c,g	350026586400015004,350026586400000000,350026586400000000,350026586400000011,350026586400000011	0-57,0-50,0-50,0-56,0-56						DECORIN COMPOSITIONS AND USE THEREOF - Patent application	www.faqs.org	0	0		
846	chr5	34309128	34309185	3500120053	57		34309128	34309185	8421504	1	57	0	p,c,g	350012005300015005,350012005300000000,350012005300000000	0-57,0-50,0-50						DECORIN COMPOSITIONS AND USE THEREOF	Bleck	2012	0		
846	chr5	34309142	34309710	3500398906	41		34309142	34309710	8421504	2	21,20	0,548	c,g	350039890600000008,350039890600000009,350039890600000009	0-21,0-20,0-20						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
846	chr5	34309144	34309590	3500124900	40		34309144	34309590	8421504	3	20,12,8	0,105,438	c	350012490000000015,350012490000000016	0-20,0-20						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
846	chr5	34309185	34310843	3500418941	180		34309185	34310843	8421504	4	76,44,11,49	0,397,1094,1609	p	350041894100015058,350041894100015059,350041894100015063	0-60,0-60,0-60						TEJFEH&#xc9;RJE GENETIKAI VIZSG&#xc1;LATOK HAZAI SZARVASMARHA FAJT&#xc1;KBAN	www.szie.hu	0	0		
846	chr5	34309227	34310813	3500371489	40		34309227	34310813	8421504	3	20,1,19	0,1062,1567	c,g	350037148900000010,350037148900000010,350037148900000011	0-20,0-20,0-20						Mammary Response to Exogenous Prolactin or Frequent Milking During Early Lactation in Dairy Cows	circlescience.biz	0	0		
846	chr5	34309228	34310854	3500207785	50		34309228	34310854	8421504	2	25,25	0,1601	c	350020778500000000,350020778500000001	0-25,0-25					Patent	Retrovirus-based genomic screening (Patent US:7384738)	Bleck	2008	0		
846	chr5	34309228	34310854	3500177197	50		34309228	34310854	8421504	2	25,25	0,1601	c,g	350017719700000000,350017719700000000,350017719700000001,350017719700000001	0-25,0-25,0-25,0-25						Retrovirus-based genomic screening	Bremel	2003	0		
846	chr5	34310837	34311055	3500228344	46		34310837	34311055	8421504	2	23,23	0,195	c,g	350022834400000006,350022834400000007,350022834400000007	0-23,0-23,0-23						GEN&#xd4;MICA COMPARATIVA COMO FERRAMENTA PARA O ESTUDO DE GENES RELACIONADOS COM PRODU&#xc7;&#xc3;O DE LEITE NO GENOMA DO B&#xda;FALO DE RIO COMPARATIVE GENOMICSAS A TOOL FOR STUDINGGENES RELATED WITH MILK PRODUCTION IN RIVER BUFFALO	prope.unesp.br	0	0		
847	chr5	34408808	34408833	3500340426	24		34408808	34408833	8421504	2	4,20	0,5	g	350034042600000016	13-37						Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector	Roberts	2003	0		
849	chr5	34733627	34733654	3500062787	23		34733627	34733654	8421504	2	15,8	0,19	g	350006278700000198	15-40						Polypeptides of Botryosphaeria Rhodina - Patent application	www.faqs.org	0	0		
850	chr5	34786749	34786773	3500361723	23		34786749	34786773	8421504	2	8,15	0,9	g	350036172300000058	15-42						FERMENTATIVE GLYCEROL-FREE ETHANOL PRODUCTION - Patent application	www.faqs.org	0	0		
853	chr5	35254182	35254208	3500405373	25		35254182	35254208	8421504	2	4,21	0,5	c	350040537300000087	0-25						Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection - US Patent 7410795 Description	ww.patentstorm.us	0	0		
853	chr5	35254182	35254208	3500068102	25		35254182	35254208	8421504	2	4,21	0,5	c	350006810200000087	0-25						 Codon 	www.docstoc.com	0	0		
853	chr5	35254791	35258162	3500163467	510		35254791	35258162	8421504	6	135,88,71,150,64,2	0,224,639,1766,2739,3369	p,c,g	350016346700015030,350016346700000032,350016346700015029,350016346700015028,350016346700000033,350016346700000033	0-150,0-20,0-180,0-180,0-20,0-20						Entwicklungsspezifische Expression und m&#xf6;gliche funktionelle Bedeutung der Glukosetransporterisoformen in Pr&#xe4;implantationsembryonen des Rindes	ebdoc.sub.gwdg.de	0	0		
853	chr5	35254812	35254869	3500247257	57		35254812	35254869	8421504	1	57	0	p	350024725700015003	0-57						Supplementary Materials for	grtc.ucsd.edu	0	0		PFKM
854	chr5	35271848	35271899	3500081803	51		35271848	35271899	8421504	1	51	0	p	350008180300015003	0-51						data=readDNAStringSet(file="data.txt") data # A DNAStringSet instance of length - Pastebin.com	pastebin.com	0	0		
854	chr5	35271848	35271899	3500027127	51		35271848	35271899	8421504	1	51	0	p	350002712700015001	0-51						sequence - R: How to use output of 'translate' function to write a table? - Stack Overflow	stackoverflow.com	0	0		
854	chr5	35299211	35345108	3500197246	46		35299211	35345108	8421504	3	4,20,22	0,1908,45875	c	350019724600000000,350019724600000001	0-24,0-22		15105549	10.1099/vir.0.19610-0	0022-1317	Journal of General Virology	Characterization of human herpesvirus 6 variant B immediate-early 1 protein modifications by small ubiquitin-related modifiers	Gravel	2004	3		
854	chr5	35302519	35307792	3500320661	45		35302519	35307792	8421504	2	24,21	0,5252	c,g	350032066100000004,350032066100000005,350032066100000005	0-24,0-21,0-21					Patent	SENP1 as a marker for cancer (Patent US:7939251)	Holcomb	2011	0		SENP1
854	chr5	35302519	35307792	3500254401	45		35302519	35307792	8421504	2	24,21	0,5252	c,g	350025440100000004,350025440100000005,350025440100000005	0-24,0-21,0-21					Patent	SENP1 as a marker for cancer (Patent US:7776539)	Holcomb	2010	0		SENP1
854	chr5	35302519	35307792	3500253781	45		35302519	35307792	8421504	2	24,21	0,5252	c,g	350025378100000004,350025378100000005,350025378100000005	0-24,0-21,0-21						SENP1 as a marker for cancer	Holcomb	2006	0		SENP1
854	chr5	35302519	35307792	3500245710	45		35302519	35307792	8421504	2	24,21	0,5252	c,g	350024571000000004,350024571000000005,350024571000000005	0-24,0-21,0-21						SENP1 as a marker for cancer	Holcomb	2009	0		SENP1
854	chr5	35302519	35307792	3500221999	45		35302519	35307792	8421504	2	24,21	0,5252	c,g	350022199900000016,350022199900000004,350022199900000017,350022199900000017,350022199900000005,350022199900000005	0-24,0-24,0-21,0-21,0-21,0-21					Patent	Senp1 as a marker for cancer (Patent EP:1761640)	Higuchi	2010	0		SENP1
854	chr5	35302519	35307792	3500108449	45		35302519	35307792	8421504	2	24,21	0,5252	c,g	350010844900000004,350010844900000005,350010844900000005	0-24,0-21,0-21					Patent	Senp1 as a marker for cancer (Patent CA:2564484)	Holcomb	2013	0		SENP1
854	chr5	35302519	35307792	3500100429	45		35302519	35307792	8421504	2	24,21	0,5252	c,g	350010042900000016,350010042900000004,350010042900000017,350010042900000017,350010042900000005,350010042900000005	0-24,0-24,0-21,0-21,0-21,0-21					Patent	SENP1 as a marker for cancer (Patent EP:2258876)	Schoenbrunner	2012	0		SENP1
854	chr5	35302519	35307792	3500084167	45		35302519	35307792	8421504	2	24,21	0,5252	c,g	350008416700000004,350008416700000005,350008416700000005	0-24,0-21,0-21						SENP1 as a marker for cancer	Holcomb	2008	0		SENP1
854	chr5	35302519	35302543	3500357890	24		35302519	35302543	8421504	1	24	0	c	350035789000000004,350035789000000019	0-24,0-24						SENP1 as a marker for cancer - Patent application	www.faqs.org	0	0		
854	chr5	35307686	35320394	3500175845	61		35307686	35320394	8421504	4	19,23,13,6	0,57,12607,12702	c,g	350017584500000000,350017584500000000,350017584500000001,350017584500000004	0-19,0-19,0-23,0-19						Down-regulation of SENP1 Expression Increases Apoptosis of Burkitt Lymphoma Cells	.apocpcontrol.org	0	0		SENP1
854	chr5	35387762	35387785	3500313228	23		35387762	35387785	8421504	1	23	0	c	350031322800000001	0-23		16766717	10.1124/mol.106.024398	1521-0111 (Online)	Molecular Pharmacology	A Molecular Mechanism of Pyruvate Protection against Cytotoxicity of Reactive Oxygen Species in Osteoblasts	Hinoi	2006	0		
854	chr5	35387908	35387931	3500001250	23		35387908	35387931	8421504	1	23	0	g	350000125000000002	0-23		16831232	10.1186/ar1991	1478-6354	Arthritis Research & Therapy	Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary	Sunk	2006	4		
106	chr5	35387971	35394004	3500456458	35		35387971	35394004	8421504	3	12,12,11	0,4348,6022	c	350045645800000002,350045645800000001	1-24,0-24						AlternativelySplicedType11ProcollagenmRNAsDefine DistinctPopulationsofCellsduringVertebral Development: DifferentialExpressionoftheAmino-Propeptide	jcb.rupress.org	0	0		
106	chr5	35387971	35394004	3500341716	23		35387971	35394004	8421504	2	12,11	0,6022	c	350034171600000001	0-23						HUMAN ARTICULAR CHONDROCYTES CULTURED IN ALGINATE BEADS MAINTAIN THEIR GENE EXPRESSION	ecmjournal.org	0	0		COL2A1
106	chr5	35387971	35394004	3500242861	35		35387971	35394004	8421504	3	12,12,11	0,4348,6022	c	350024286100000001,350024286100000000	1-24,0-24						Assays for cartilage synthesis in osteoarthritis based on detection of type IIA procollagen/propeptide	Sandell	1996	0		COL2A1
106	chr5	35387971	35394004	3500128152	23		35387971	35394004	8421504	2	12,11	0,6022	c	350012815200000000	0-23			10.1002/art.21535	1529-0131	Arthritis & Rheumatism	Collagen and proteoglycan turnover in focally damaged human ankle cartilage: Evidence for a generalized response and active matrix remodeling across the entire joint surface - Aurich - 2005 - Arthritis & Rheumatism - Wiley Online Library	Aurich	2006	0		COL2A1
106	chr5	35387971	35392331	3500134848	24		35387971	35392331	8421504	2	12,12	0,4348	c	350013484800000000	0-24						Assays for cartilage synthesis in osteoarthritis based on detection of type IIA procollagen/propeptide - Patent # 5780240 - PatentGenius	.patentgenius.com	0	0		
855	chr5	35392349	35392432	3500303113	49		35392349	35392432	8421504	2	29,20	0,63	c	350030311300000005,350030311300000004	0-29,0-20			10.1634/stemcells.2007-0300	1549-4918	STEM CELLS	Chondrogenic Potential of Human Adult Mesenchymal Stem Cells Is Independent of Age or Osteoarthritis Etiology - Scharstuhl - 2007 - STEM CELLS - Wiley Online Library	Scharstuhl	2007	0		COL2A1
855	chr5	35392349	35392432	3500080452	49		35392349	35392432	8421504	2	29,20	0,63	c,g	350008045200000004,350008045200000005,350008045200000005	0-29,0-20,0-20						Rheological and biological properties of a hydrogel support for cells intended for intervertebral disc repair	biomedcentral.com	0	0		COL2A1
855	chr5	35392406	35417012	3500118026	40		35392406	35417012	8421504	2	20,20	0,24586	c	350011802600000010,350011802600000008	0-20,0-20						SCD T 2010 0057 FRANCIN2	.scd.uhp-nancy.fr	0	0		COL1A2,COL2A1
855	chr5	35393995	35394227	3500394044	26		35393995	35394227	8421504	2	15,11	0,221	c	350039404400000005	9-35						Type IIA Procollagen Containing the Cysteine-rich Amino Propeptide Is Deposited in the Extracellular Matrix of Prechondrogenic Tissue and Binds to TGF- b 1 and BMP-2	jcb.rupress.org	0	0		
855	chr5	35393995	35394227	3500004256	26		35393995	35394227	8421504	2	15,11	0,221	c	350000425600000005	9-35		10085302	10.1083/jcb.144.5.1069	0021-9525	The Journal of Cell Biology	Type IIA Procollagen Containing the Cysteine-rich Amino Propeptide Is Deposited in the Extracellular Matrix of Prechondrogenic Tissue and Binds to TGF-&#x03b2;1 and BMP-2	Zhu	1999	10		
855	chr5	35394515	35415835	3500142096	84		35394515	35415835	8421504	4	22,20,20,22	0,187,13612,21298	c	350014209600000072,350014209600000058,350014209600000101,350014209600000113	0-22,0-20,0-20,0-22						A candidate gene association study of cryptorchidism and scrotal hernia using canine and porcine models	ib.dr.iastate.edu	0	0		
855	chr5	35394750	35395817	3500370070	96		35394750	35395817	8421504	2	33,63	0,1004	p	350037007000015006,350037007000015010	0-45,45-96						Mutated recombinant collagens	Berg	1996	0		
855	chr5	35394750	35395766	3500374678	45		35394750	35395766	8421504	2	33,12	0,1004	p	350037467800015004	0-45						Mutated recombinant collagens	Berg	1994	0		COL2A1
855	chr5	35394780	35396654	3500347362	43		35394780	35396654	8421504	3	3,18,22	0,974,1852	c	350034736200000012,350034736200000013	0-21,0-22						Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells. - ResearchGate	.researchgate.net	0	0		
855	chr5	35394780	35396654	3500258444	43		35394780	35396654	8421504	3	3,18,22	0,974,1852	c	350025844400000012,350025844400000013	0-21,0-22						Vol 10 No 4Research article Open Access Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells	biomedcentral.com	0	0		
855	chr5	35394780	35396654	3500050405	43		35394780	35396654	8421504	3	3,18,22	0,974,1852	c	350005040500000018,350005040500000019	0-21,0-22		18978407	10.2106/JBJS.H.00049	0021-9355	The Journal of Bone & Joint Surgery	 The Journal of Bone & Joint Surgery | Differentiation Potential of Multipotent Progenitor Cells Derived from War-Traumatized Muscle Tissue 	Nesti	2008	3		
855	chr5	35395759	35396635	3500448138	44		35395759	35396635	8421504	2	22,22	0,854	c	350044813800000004,350044813800000005	0-22,0-22		19762915	10.1074/jbc.M109.056838	0021-9258	Journal of Biological Chemistry	Oxidative Stress Inhibits Insulin-like Growth Factor-I Induction of Chondrocyte Proteoglycan Synthesis through Differential Regulation of Phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK Signaling Pathways	Yin	2009	5		COL2A1
855	chr5	35395759	35396635	3500349205	44		35395759	35396635	8421504	2	22,22	0,854	c	350034920500000012,350034920500000013	0-22,0-22		19790046	10.1002/art.24846	1529-0131	Arthritis & Rheumatism	The melanocortin system in articular chondrocytes: Melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of &#x03b1;-melanocyte&#x2013;stimulating hormone on proinflammatory cytokines and extracellular matrix component	Grassel	2009	0		
855	chr5	35395759	35396635	3500268546	44		35395759	35396635	8421504	2	22,22	0,854	c	350026854600000002,350026854600000003	0-22,0-22						Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9)	cs.biologists.org	0	0		COL2A1
855	chr5	35395759	35396635	3500129888	44		35395759	35396635	8421504	2	22,22	0,854	c	350012988800000004,350012988800000005	0-22,0-22						OxidativeStressInhibitsInsulin-likeGrowthFactor-I InductionofChondrocyteProteoglycanSynthesisthrough DifferentialRegulationofPhosphatidylinositol3-Kinase-Akt andMEK-ERKMAPKSignalingPathways	www.jbc.org	0	0		
855	chr5	35395759	35396635	3500001923	44		35395759	35396635	8421504	2	22,22	0,854	c	350000192300000004,350000192300000005	0-22,0-22		19762915	10.1074/jbc.M109.056838		The Journal of Biological Chemistry	Oxidative Stress Inhibits Insulin-like Growth Factor-I Induction of Chondrocyte Proteoglycan Synthesis through Differential Regulation of Phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK Signaling Pathways	Weihong	2009	0		COL2A1
855	chr5	35404522	35404773	3500019982	78		35404522	35404773	8421504	2	33,45	0,206	p	350001998200015000	0-78						Redirection of T Cell Effector Function In Vivo and Enhanced Collagen-Induced Arthritis Mediated by an IL-2R /IL-4R Chimeric Cytokine Receptor Transgene	ww.decal-bone.com	0	0		COL2A1
855	chr5	35404537	35404773	3500343340	63		35404537	35404773	8421504	2	18,45	0,191	p	350034334000015004	0-63						HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis	Luthra	1995	0		COL2A1
855	chr5	35404737	35404770	3500293380	33		35404737	35404770	8421504	1	33	0	c,g	350029338000000001,350029338000000001	0-33,0-33		11859151		0022-1767	The Journal of Immunology	A Single-Chain Class II MHC-IgG3 Fusion Protein Inhibits Autoimmune Arthritis by Induction of Antigen-Specific Hyporesponsiveness	Zuo	2002	6		
855	chr5	35404744	35404767	3500154878	23		35404744	35404767	8421504	1	23	0	c	350015487800000004	0-23						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
855	chr5	35405110	35405137	3500304078	23		35405110	35405137	8421504	3	5,6,12	0,7,15	c	350030407800000018	4-27						Humanized Anti-ccr2 Antibodies And Methods Of Use Therefor 	.freshpatents.com	0	0		
855	chr5	35407510	35408685	3500278506	45		35407510	35408685	8421504	2	24,21	0,1154	c,g	350027850600000004,350027850600000005,350027850600000005	0-24,0-21,0-21						Cytotherapy	www.makna.org.my	0	0		COL2A1
855	chr5	35407902	35414598	3500466395	105		35407902	35414598	8421504	4	12,39,39,15	0,195,6358,6681	p	350046639500015033,350046639500015034	0-51,0-54						Methods of generating antigen-specific CD4+CD25+ regulatory T cells, compositions and methods of use	Buckner	2005	0		COL2A1
855	chr5	35412887	35412932	3500280081	45		35412887	35412932	8421504	1	45	0	p	350028008100015065	0-45						Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance - Patent application	www.faqs.org	0	0		COL2A1
855	chr5	35415814	35416407	3500059389	40		35415814	35416407	8421504	2	20,20	0,573	c	350005938900000017,350005938900000018	0-20,0-20						Application of IL-4 Transgene Expression in a Chondrocyte-Based 3D Model of Inflammatory Arthritis	diss.fu-berlin.de	0	0		COL2A1
855	chr5	35415814	35416404	3500459800	41		35415814	35416404	8421504	2	21,20	0,570	c	350045980000000016,350045980000000017	0-21,0-20						Isolation and characterization of canine adipose-derived mesenchymal stem cells | Vilma Yuzbasiyan-Gurkan - Academia.edu	www.academia.edu	0	0		COL2A1
855	chr5	35415814	35416404	3500428967	41		35415814	35416404	8421504	2	21,20	0,570	c,g	350042896700000004,350042896700000005	0-21,0-20						Effects of Donor Characteristics and Ex Vivo Expansion on Canine Mesenchymal Stem Cell Properties: Implications for MSC-Based Therapies	divet-america.com	0	0		COL2A1
855	chr5	35415814	35416404	3500001585	41		35415814	35416404	8421504	2	21,20	0,570	c	350000158500000016,350000158500000017	0-21,0-20						Isolation and Characterization of Canine Adipose&#x2013;Derived Mesenchymal Stem Cells	hemeng.queensu.ca	0	0		COL2A1
855	chr5	35415824	35416284	3500347572	26		35415824	35416284	8421504	3	19,3,4	0,452,456	c	350034757200000032,350034757200000010	0-26,0-26						Method For Chondrocyte Expansion With Phenotype Retention 	.freshpatents.com	0	0		
855	chr5	35415831	35417642	3500194602	39		35415831	35417642	8421504	3	12,7,20	0,445,1791	c,g	350019460200000002,350019460200000003,350019460200000003	0-19,0-20,0-20						In vitro chondrocyte differentiation using costochondral chondrocytes as a source of primary rat chondrocyte cultures: An improved isolation and cryopreservation method	www.cof.org.cn	0	0		
855	chr5	35415841	35416425	3500274729	151		35415841	35416425	8421504	2	2,149	0,435	c	350027472900000020,350027472900000003	0-151,0-20						Ex vivo Expansion and Differentiation of Mesenchymal Stem Cells from Goat Bone Marrow	www.mums.ac.ir	0	0		
855	chr5	35416311	35417535	3500211132	40		35416311	35417535	8421504	2	20,20	0,1204	c,g	350021113200000000,350021113200000001,350021113200000001	0-20,0-20,0-20			10.1007/s10561-005-5810-0		Cell and tissue banking	Phenotypic analysis of bovine chondrocytes cultured in 3D collagen sponges: effect of serum substitutes	Karen	2005	0		
855	chr5	35416387	35416909	3500102451	48		35416387	35416909	8421504	2	24,24	0,498	c	350010245100000029,350010245100000028	0-24,0-24		19180509	10.1002/art.24258	1529-0131	Arthritis & Rheumatism	Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis - Li - 2009 - Arthritis & Rheumatism - Wiley Online Library	Li	2009	0		COL2A1
855	chr5	35416395	35417828	3500254194	40		35416395	35417828	8421504	2	20,20	0,1413	c	350025419400000000,350025419400000001	0-20,0-20						Method of inducing the differentiation of amnion-origin cells and utilization of the same	HARA	2007	0		COL2A1
855	chr5	35416395	35417828	3500134000	40		35416395	35417828	8421504	2	20,20	0,1413	c	350013400000000000,350013400000000001	0-20,0-20						Method Of Inducing The Differentiation Of Amnion-Derived Cells And Utilization Of The Same	Hara	2007	0		COL2A1
855	chr5	35416446	35417509	3500412394	39		35416446	35417509	8421504	4	18,1,18,2	0,348,573,1061	c	350041239400000002,350041239400000003	0-19,0-20						HYDROGELS BASED ON POLYMERS OF DEXTRAN TYRAMINE AND TYRAMINE CONJUGATES OF NATURAL POLYMERS - Patent application	www.faqs.org	0	0		
855	chr5	35416452	35416973	3500220011	41		35416452	35416973	8421504	3	12,9,20	0,342,501	c	350022001100000005,350022001100000006	0-21,0-20			10.1083/jcb.200106040		The Journal of Cell Biology	Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival	Bill	2001	0		
855	chr5	35416796	35416820	3500141941	24		35416796	35416820	8421504	1	24	0	c	350014194100000002,350014194100000221	0-24,0-22						Isolation and Characterization of Equine Umbilical Cord Blood Derived Stem Cells	ufdc.ufl.edu	0	0		COL2A1
855	chr5	35416796	35416820	3500124981	24		35416796	35416820	8421504	1	24	0	c	350012498100000002	0-24			10.1002/jcp.21312	1097-4652	Journal of Cellular Physiology	Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types - Reed - 2007 - Journal of Cellular Physiology - Wiley Online Library	Reed	2008	0		
855	chr5	35416798	35417524	3500206635	48		35416798	35417524	8421504	3	24,7,17	0,232,709	c,g	350020663500000008,350020663500000008,350020663500000009	0-24,0-24,0-24						COMPOSITION FOR MANUFACTURING A SCAFFOLD FOR TISSUE ENGINEERING, AND A METHOD OF MAKING IT - NANYANG TECHNOLOGICAL UNIVERSITY	www.sumobrain.com	0	0		
855	chr5	35416807	35416830	3500463365	23		35416807	35416830	8421504	1	23	0	c	350046336500000002	0-23						 SpringerImages - Primer and probe sequences of desired genes 	pringerimages.com	0	0		
855	chr5	35416815	35417699	3500199206	48		35416815	35417699	8421504	2	24,24	0,860	c	350019920600000012,350019920600000013,350019920600000002	0-24,0-24,24-48						Novel Herbal Composition 	.freshpatents.com	0	0		COL2A1
855	chr5	35416815	35417699	3500099979	48		35416815	35417699	8421504	2	24,24	0,860	c	350009997900000002,350009997900000003	0-24,0-24		14734521	10.1084/jem.20031677	0022-1007	The Journal of Experimental Medicine	Medullary Epithelial Cells of the Human Thymus Express a Highly Diverse Selection of Tissue-specific Genes Colocalized in Chromosomal Clusters	Gotter	2004	14		COL2A1
855	chr5	35416815	35417699	3500099954	48		35416815	35417699	8421504	2	24,24	0,860	c	350009995400000002,350009995400000003	0-24,0-24						Medullary Epithelial Cells of the Human Thymus Express a Highly Diverse Selection of Tissue-speci&#xfb01;c Genes Colocalized in Chromosomal Clusters	jem.rupress.org	0	0		COL2A1
855	chr5	35416815	35417699	3500089289	48		35416815	35417699	8421504	2	24,24	0,860	c	350008928900000002,350008928900000003	0-24,0-24		21434846	10.3109/17453674.2011.566153		Acta Orthopaedica	Stem/progenitor cells in closed suction drainage fluid after hip arthroplasty	Satoshi	2011	0		
855	chr5	35416849	35416902	3500202396	45		35416849	35416902	8421504	2	21,24	0,29	c	350020239600000029,350020239600000028	0-21,0-24						Supporting Information	www.pnas.org	0	0		COL1A1
855	chr5	35416878	35416901	3500022437	23		35416878	35416901	8421504	1	23	0	c,g	350002243700000001,350002243700000001	0-23,0-23						ONLINE MATERIALS AND METHODS	b.ahajournals.org	0	0		COL2A1
855	chr5	35416880	35417738	3500105237	44		35416880	35417738	8421504	2	22,22	0,836	c,g	350010523700000018,350010523700000019	0-22,0-22						Cell Communication and Signaling BioMed	.biosignaling.com	0	0		COL2A1
855	chr5	35416880	35417738	3500090229	44		35416880	35417738	8421504	2	22,22	0,836	c,g	350009022900000017,350009022900000017,350009022900000054,350009022900000054,350009022900000055,350009022900000018	0-22,0-22,0-22,0-22,0-22,0-22						REISHI-MEDIATED ENHANCEMENT OF HUMAN TISSUE PROGENITOR CELL ADHESION AND DIFFERENTIATION - Patent application	www.faqs.org	0	0		COL2A1
855	chr5	35416919	35416944	3500284424	25		35416919	35416944	8421504	1	25	0	c	350028442400000010	0-25						Msx2StimulatesChondrocyteMaturationbyControlling IhhExpression	www.jbc.org	0	0		COL2A1
855	chr5	35416941	35417535	3500182158	44		35416941	35417535	8421504	2	22,22	0,572	c,g	350018215800000002,350018215800000003,350018215800000003	0-22,0-22,0-22						METHODS AND USES OF HYPOXIC COMPARTMENT CELLS - Patent application	www.faqs.org	0	0		
855	chr5	35417019	35417516	3500118159	27		35417019	35417516	8421504	2	18,9	0,488	c	350011815900000009	1-28						The Role of Nitric Oxide in Chondrocyte Models of Osteoarthritis	b.uni-konstanz.de	0	0		
855	chr5	35417031	35417651	3500102621	147		35417031	35417651	8421504	3	6,72,69	0,476,551	p	350010262100015002	0-147						ORIGINAL ARTICLE A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the pro&#x03b1;1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases	jmg.bmj.com	0	0		COL2A1
855	chr5	35417034	35417636	3500263468	42		35417034	35417636	8421504	3	3,18,21	0,473,581	c	350026346800000001,350026346800000003	0-21,0-21		16204335	10.1152/ajpendo.00363.2005		American Journal of Physiology - Endocrinology and Metabolism	Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5	Kiepe	2006	0		
855	chr5	35417509	35417883	3500014646	72		35417509	35417883	8421504	3	24,24,24	0,306,350	c,g	350001464600000000,350001464600000004,350001464600000004,350001464600000006,350001464600000002,350001464600000005,350001464600000001	0-24,0-19,0-19,0-24,0-24,0-24,0-24						Method of culturing human chondrocytes - Patent # 7189567 - PatentGenius	.patentgenius.com	0	0		COL2A1
855	chr5	35417509	35417883	3500009783	72		35417509	35417883	8421504	3	24,24,24	0,306,350	c	350000978300000000,350000978300000002,350000978300000001	0-24,0-24,0-24						Method of culturing human chondrocytes	Yanaga	2001	0		COL2A1
855	chr5	35417572	35417911	3500220839	44		35417572	35417911	8421504	2	22,22	0,317	c,g	350022083900000002,350022083900000002,350022083900000003,350022083900000003	0-22,0-22,0-22,0-22						METHOD FOR PREPARATION OF CARTILAGE CELL - Patent application	www.faqs.org	0	0		
855	chr5	35417572	35417911	3500200098	44		35417572	35417911	8421504	2	22,22	0,317	c,g	350020009800000002,350020009800000002,350020009800000003	0-22,0-22,0-22						METHOD FOR PREPARATION OF CARTILAGE CELL	Taniguchi	2008	0		COL2A1
855	chr5	35417585	35418051	3500271324	41		35417585	35418051	8421504	2	21,20	0,446	c	350027132400000002,350027132400000003	0-21,0-20						Transforming Growth Factor (TGF)--activated Kinase 1 Mimics and Mediates TGF--induced Stimulation of Type II Collagen Synthesis in Chondrocytes Independent of Col2a1 Transcription and Smad3 Signaling--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x674	journal.9med.net	0	0		
855	chr5	35417625	35417650	3500018937	25		35417625	35417650	8421504	1	25	0	c	350001893700000002	0-25						Physical Properties and Biocompatibility of Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) Blended with Poly(3-hydroxybutyrate-co-4-hydroxybutyrate)	mrc.stu.edu.cn	0	0		COL2A1
855	chr5	35417675	35417699	3500021756	24		35417675	35417699	8421504	1	24	0	c	350002175600000002	24-48						Novel herbal composition	Liu	2005	0		COL2A1
855	chr5	35417678	35417825	3500414945	40		35417678	35417825	8421504	2	20,20	0,127	c,g	350041494500000004,350041494500000004,350041494500000005	0-20,0-20,0-20						Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: Influence of collagen type II extracellular matrix on MSC chondrogenesis	prints.ugd.edu.mk	0	0		
855	chr5	35417817	35417875	3500374887	51		35417817	35417875	8421504	3	21,4,26	0,22,32	c	350037488700000020,350037488700000005,350037488700000019	0-25,0-25,2-28						SUBSTRATE FOR CARTILAGE CULTIVATION USING ARTIFICIAL COLLAGEN, AND METHOD FOR CARTILAGE REGENERATION TREATMENT USING THE SUBSTRATE - Patent application	www.faqs.org	0	0		
855	chr5	35417817	35417875	3500220522	51		35417817	35417875	8421504	3	21,4,26	0,22,32	c,g	350022052200000010,350022052200000010,350022052200000008	0-25,0-25,2-28						Culture substrate for cartilage comprising artificial collagen, and cartilage regeneration therapy method using the culture substrate	Suzuki	2010	0		
855	chr5	35417996	35418019	3500424598	23		35417996	35418019	8421504	1	23	0	c	350042459800000017	0-23							ww.jbiomedsci.com	0	0		COL2A1
855	chr5	35417996	35418019	3500006397	23		35417996	35418019	8421504	1	23	0	c	350000639700000016	0-23						Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulation	biomedcentral.com	0	0		
855	chr5	35437405	35437432	3500159378	23		35437405	35437432	8421504	3	5,13,5	0,8,22	g	350015937800000040	8-33						 Method Of Detection Of Herpes B Virus 	www.docstoc.com	0	0		
106	chr5	35512784	35522165	3500021751	45		35512784	35522165	8421504	2	29,16	0,9365	p	350002175100015003	0-45						Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same	Dedhar	1995	0		VDR
106	chr5	35512799	35529572	3500399861	138		35512799	35529572	8421504	4	14,31,40,53	0,9350,9441,16720	p	350039986100015026,350039986100015028	0-45,0-93						COINCIDENCE DETECTION	Parker	2011	0		VDR
856	chr5	35522171	35542831	3500111757	213		35522171	35542831	8421504	3	96,46,71	0,19046,20589	p	350011175700015020,350011175700015083,350011175700015128	0-96,0-117,0-135						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers, Sources	www.scribd.com	0	0		VDR
856	chr5	35522260	35529525	3500236853	26		35522260	35529525	8421504	2	20,6	0,7259	c	350023685300000001	23-49		15888568	10.1681/ASN.2004080657	1046-6673	Journal of the American Society of Nephrology	Calcium-Sensing Receptor Expression and Parathyroid Hormone Secretion in Hyperplastic Parathyroid Glands from Humans	Canadillas	2005	10		
856	chr5	35522260	35529524	3500353893	25		35522260	35529524	8421504	2	20,5	0,7259	c	350035389300000001	23-48		20181667	10.1152/ajprenal.00529.2009		American Journal of Physiology - Renal Physiology	Upregulation of parathyroid VDR expression by extracellular calcium is mediated by ERK1/2-MAPK signaling pathway	Canadillas	2010	0		
856	chr5	35532867	35540886	3500368446	144		35532867	35540886	8421504	2	62,82	0,7937	p	350036844600015000	0-144						Emory : JUNE 16 : Liu.03.IntImm.15.861	ww.coursehero.com	0	0		VDR
856	chr5	35542995	35543020	3500430215	25		35542995	35543020	8421504	1	25	0	c	350043021500000001	0-25		14507914	10.1074/jbc.M308448200	0021-9258	Journal of Biological Chemistry	Direct Transcriptional Regulation of RelB by 1&#x03b1;,25-Dihydroxyvitamin D3 and Its Analogs	Dong	2003	5		
856	chr5	35542997	35543020	3500416163	23		35542997	35543020	8421504	1	23	0	c	350041616300000003	10-33		19622632	10.1242/jcs.049619	0021-9533	Journal of Cell Science	Regulation of VDR by &#x0394;Np63&#x03b1; is associated with inhibition of cell invasion	Kommagani	2009	6		
856	chr5	35542997	35543020	3500358318	23		35542997	35543020	8421504	1	23	0	c	350035831800000003	10-33		19622632	10.1242/jcs.049619		Journal of Cell Science	Regulation of VDR by &#x0394;Np63&#x03b1; is associated with inhibition of cell invasion	Ramakrishna	2009	0		
856	chr5	35589793	35589821	3500332742	25		35589793	35589821	8421504	3	12,5,8	0,13,20	c	350033274200000056	0-25						Method of treating cell damage or depletion	Williams	1994	0		
856	chr5	35603066	35603096	3500158219	29		35603066	35603096	8421504	2	5,24	0,6	c,g	350015821900000038,350015821900000038	17-46,17-46						OLIGONUCLEOTIDE-, PROTEIN AND/OR PEPTIDE-POLYMER CONJUGATES - Patent application	www.faqs.org	0	0		
856	chr5	35605995	35606066	3500357152	46		35605995	35606066	8421504	2	24,22	0,49	c	350035715200000011,350035715200000019	0-24,0-22						ABSTRACT Document: IDENTIFICATION AND CHARACTERIZATION OF HRG-1 HEME TRANSPORTERS IN EUKARYOTES of Animal and Avian sciences & Molecular and	drum.lib.umd.edu	0	0		
856	chr5	35640970	35641084	3500193635	23		35640970	35641084	8421504	3	8,4,11	0,12,103	c	350019363500000371	12-35						Materials and methods for immunocontraception	Harris	1993	0		
13	chr5	35642818	35654315	3500282634	157		35642818	35654315	8421504	7	29,27,5,25,29,30,12	0,2222,2328,10626,10976,11011,11485	c	350028263400000019,350028263400000193,350028263400000163,350028263400000033,350028263400000184,350028263400000054,350028263400000055	18-47,0-20,18-48,12-44,0-48,0-48,6-48						Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy - Patent application	www.faqs.org	0	0		
863	chr5	36456625	36456651	3500446848	24		36456625	36456651	8421504	3	6,6,12	0,7,14	g	350044684800000009	2-26						THE THAI JOURNAL OF VETERINARY MEDICINE	w.vet.chula.ac.th	0	0		
867	chr5	36981214	36981239	3500359620	25		36981214	36981239	8421504	1	25	0	g	350035962000000007	0-25			10.1042/BJ20051867		Biochemical Journal	Characterization of the amino acid response element within the human sodium-coupled neutral amino acid transporter 2 (SNAT2) System A transporter gene	Stela S.	2006	0		
867	chr5	37027202	37027227	3500037256	23		37027202	37027227	8421504	2	9,14	0,11	g	350003725600000000	10-33						Method for treating neurological disorders	Benowitz	2006	0		
868	chr5	37203151	37203179	3500063079	24		37203151	37203179	8421504	3	6,13,5	0,7,23	g	350006307900000005	13-41						E..	m.hms.harvard.edu	0	0		
874	chr5	37883080	37883106	3500031188	24		37883080	37883106	8421504	3	11,9,4	0,12,22	g	350003118800000003	0-24					Patent	Production of antibodies in plants with plus-sense single-stranded viral rna vectors (Patent EP:1844152)	Giritch	2012	0		
881	chr5	38897664	38897687	3500219376	23		38897664	38897687	8421504	1	23	0	c	350021937600000046	21-44						TECHNIQUE FOR REGULATING REGENRATION OF TISSUE OR FAULTY OR ABNORMAL PART IN ORGAN USING NELL-1 - Patent application	www.faqs.org	0	0		
881	chr5	38923340	38923364	3500241875	23		38923340	38923364	8421504	2	11,12	0,12	g	350024187500000535	0-29					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
883	chr5	39154418	39154446	3500063033	23		39154418	39154446	8421504	3	6,5,12	0,8,16	g	350006303300000057	4-27						UNIVERSIDAD COMPLUTENSE DE MADRID	eprints.ucm.es	0	0		
886	chr5	39529724	39529757	3500013181	28		39529724	39529757	8421504	3	12,12,4	0,16,29	g	350001318100000035	20-48						 GnRH 	www.docstoc.com	0	0		
888	chr5	39794126	39794153	3500099619	27		39794126	39794153	8421504	1	27	0	c	350009961900000002	0-27						cDNA databases for analysis of hematopoietic tissue	Westbrook	2002	0		
888	chr5	39794126	39794153	3500033523	27		39794126	39794153	8421504	1	27	0	c	350003352300000002	0-27						Highly abundant genes in the transcriptosome of human and baboon CD34 antigen-positive bone marrow cells	w.bioengr.uic.edu	0	0		TWF1
888	chr5	39833203	39833229	3500302345	26		39833203	39833229	8421504	1	26	0	c	350030234500000028	0-26						Irak-related interventions and diagnosis	Holvoet	2012	0		
888	chr5	39838102	39842361	3500294513	120		39838102	39842361	8421504	3	48,31,41	0,1553,4218	c	350029451300000084,350029451300000076,350029451300000027	0-48,0-48,0-48						NOVEL DEATH DOMAIN PROTEINS - Patent application	www.faqs.org	0	0		
890	chr5	40104794	40104817	3500308247	23		40104794	40104817	8421504	1	23	0	c	350030824700000019	0-23		10082527		0270-7306	Molecular and Cellular Biology	Multiple Layers of Cooperativity Regulate Enhanceosome-Responsive RNA Polymerase II Transcription Complex Assembly	Ellwood	1999	6		
890	chr5	40104794	40104817	3500300475	23		40104794	40104817	8421504	1	23	0	c	350030047500000113	16-39						MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCINE AND RELATED COMPOUNDS, AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
890	chr5	40104794	40104817	3500124165	23		40104794	40104817	8421504	1	23	0	c	350012416500000001	0-23		9632787		0270-7306	Molecular and Cellular Biology	DA-Complex Assembly Activity Required for VP16C Transcriptional Activation	Kobayashi	1998	6		
890	chr5	40104794	40104817	3500086323	23		40104794	40104817	8421504	1	23	0	c	350008632300000113	16-39						MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCINE AND RELATED COMPOUNDS, AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
890	chr5	40104794	40104817	3500067301	23		40104794	40104817	8421504	1	23	0	c	350006730100000113	16-39						MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL AND RELATED METHODS - Patent application	www.faqs.org	0	0		
890	chr5	40104794	40104817	3500042925	23		40104794	40104817	8421504	1	23	0	c	350004292500000113	16-39						MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL, 4-HYDROXYBUTANAL, 4-HYDROXYBUTYRYL-COA, PUTRESCINE AND RELATED COMPOUNDS, AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
890	chr5	40104794	40104817	3500024946	23		40104794	40104817	8421504	1	23	0	c	350002494600000008	0-23						METHODS IN ENZYMOLOGY	lib.fk.uwks.ac.id	0	0		
890	chr5	40104794	40104817	3500020410	23		40104794	40104817	8421504	1	23	0	c	350002041000000006	1-24						Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the p - Patent # 6316004 - PatentGenius	.patentgenius.com	0	0		
891	chr5	40143983	40144007	3500465208	24		40143983	40144007	8421504	1	24	0	c	350046520800000000	0-24		18454205	10.1371/journal.pgen.1000003	1553-7404	PLOS Genetics	PLOS Genetics: The Secreted Metalloprotease ADAMTS20 Is Required for Melanoblast Survival	Silver	2008	0		
891	chr5	40143983	40144007	3500412880	24		40143983	40144007	8421504	1	24	0	c	350041288000000000	0-24						The secreted metalloprotease ADAMTS20 is required for melanoblast survival.	.biomedsearch.com	0	0		
897	chr5	40898038	40898066	3500396843	24		40898038	40898066	8421504	2	17,7	0,21	g	350039684300000009	3-27						Promoters for regulated gene expression	Bruice	2001	0		
898	chr5	41055965	41055990	3500084495	24		41055965	41055990	8421504	2	18,6	0,19	g	350008449500000082	16-40						Recombinant plant viral nucleic acids	Dawson	1994	0		
899	chr5	41263873	41263902	3500013267	24		41263873	41263902	8421504	3	7,13,4	0,11,25	g	350001326700000100	2-27						Diagnostic for metastatic prostate cancer	Wu	2000	0		
900	chr5	41346671	41346697	3500388162	26		41346671	41346697	8421504	1	26	0	c	350038816200000017	5-31						ScienceDirect.com - FEBS Letters - Mouse Prickle1 and Prickle2 are expressed in postmitotic neurons and promote neurite outgrowth	sciencedirect.com	0	0		
901	chr5	41427488	41458331	3500383915	41		41427488	41458331	8421504	5	4,16,4,6,11	0,5,30816,30821,30832	g	350038391500000823,350038391500001032	0-20,1-22						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
902	chr5	41554753	41554801	3500313062	48		41554753	41554801	8421504	1	48	0	p	350031306200015007	3-51			10.1261/rna.7320604		RNA	The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome	CINDY	June	0		ZCRB1
908	chr5	42456298	42456323	3500400031	23		42456298	42456323	8421504	3	14,5,4	0,15,21	c	350040003100000008	1-24						VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents | David Stojdl - Academia.edu	www.academia.edu	0	0		
908	chr5	42456298	42456323	3500389589	23		42456298	42456323	8421504	3	14,5,4	0,15,21	c	350038958900000008	1-24						Mutant vesicular stomatitis viruses and use thereof	Bell	2009	0		
908	chr5	42456298	42456323	3500316837	23		42456298	42456323	8421504	3	14,5,4	0,15,21	c	350031683700000021,350031683700000008	1-24,1-24					Patent	Mutant vesicular stomatitis viruses and use thereof (Patent EP:2039773)	Bell	2011	0		
908	chr5	42456298	42456323	3500304051	23		42456298	42456323	8421504	3	14,5,4	0,15,21	c	350030405100000016	1-24					Patent	Mutant vesicular stomatitis viruses and use thereof (Patent CN:1788088)	Da Wei *F*Shi Tuo Yi De Er 	2012	0		
908	chr5	42456298	42456323	3500301887	23		42456298	42456323	8421504	3	14,5,4	0,15,21	c	350030188700000054,350030188700000014	1-24,1-24						Mutant vesicular stomatitis viruses and use thereof	Yue Han *C*Bei Er 	2006	0		
908	chr5	42456298	42456323	3500301439	23		42456298	42456323	8421504	3	14,5,4	0,15,21	c	350030143900000008	1-24						Mutant vesicular stomatitis viruses and use thereof	Bell	2005	0		
908	chr5	42456298	42456323	3500175663	23		42456298	42456323	8421504	3	14,5,4	0,15,21	c	350017566300000010	1-24						VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents	ww.med.uottawa.ca	0	0		
908	chr5	42456298	42456323	3500112374	23		42456298	42456323	8421504	3	14,5,4	0,15,21	c	350011237400000008,350011237400000026	1-24,1-24						MUTANT VIRUSES AND USES THEREOF - Patent application	www.faqs.org	0	0		
910	chr5	42673355	42673386	3500320272	26		42673355	42673386	8421504	3	7,3,16	0,11,15	g	350032027200000036	0-28					Patent	Polynucleotide constructs and uses thereof (Patent EP:1115877)	Binley	2009	0		
910	chr5	42673355	42673386	3500301453	26		42673355	42673386	8421504	3	7,3,16	0,11,15	g	350030145300000100	0-28						Enhanced prodrug activation	I*J*Si Te La Te Fu De 	2002	0		
910	chr5	42673355	42673386	3500278462	26		42673355	42673386	8421504	3	7,3,16	0,11,15	g	350027846200000061	0-28						Enhanced prodrug activation	Griffiths	1999	0		
910	chr5	42673355	42673386	3500174781	26		42673355	42673386	8421504	3	7,3,16	0,11,15	g	350017478100000013	0-28						Retroviral vectors	Carroll	2003	0		
914	chr5	43136964	43136989	3500396978	23		43136964	43136989	8421504	2	18,5	0,20	g	350039697800000005	3-26						Pcsk9 antagonists	D*Yue Wei 	2012	0		
114	chr5	43243318	43292173	3500256454	558		43243318	43292173	8421504	10	72,65,4,111,60,110,88,21,10,17	0,75,24803,24813,44695,44758,45178,45272,45296,48838	p	350025645400015054	0-561						Prostate specific genes and the use thereof in design or therapeutics	Gately	2003	0		
915	chr5	43300996	43315490	3500311730	126		43300996	43315490	8421504	3	57,38,31	0,12199,14463	p	350031173000015068,350031173000015069	0-57,183-252						The Lewisx glycan in mice	ie.uni-hamburg.de	0	0		CNTN1
917	chr5	43547245	43547278	3500013095	24		43547245	43547278	8421504	3	11,6,7	0,15,26	g	350001309500000667	10-37						Sequenciamento do Genoma Completo e Express&#xe3;o Heter&#xf3;loga da Capa Prot&#xe9;ica do Marafivirus Associado &#xe0; Morte S&#xfa;bita dos Citros	www.bdtd.ucb.br	0	0		
917	chr5	43632639	43632663	3500401471	24		43632639	43632663	8421504	1	24	0	g	350040147100000001	0-24		15340121	10.1152/physiolgenomics.00161.2004	1094-8341	Physiological Genomics	The gene encoding mouse Muc19: cDNA, genomic organization and relationship to Smgc	Culp	2004	3		
918	chr5	43756068	43756095	3500176702	23		43756068	43756095	8421504	3	13,5,5	0,16,22	g	350017670200000010	0-23		17259627	10.1099/mic.0.29259-0	1350-0872	Microbiology	Identification of amino acid residues of Salmonella SlyA that are critical for transcriptional regulation	Okada	2007	3		
919	chr5	43832632	43832683	3500255303	51		43832632	43832683	8421504	1	51	0	p	350025530300015000	3-54						[peer-00479223, v1] Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease	peer.ccsd.cnrs.fr	0	0		LRRK2
919	chr5	43832638	43832683	3500069365	45		43832638	43832683	8421504	1	45	0	p	350006936500015020	3-48						METHODS - MEDICAL RESEARCH COUNCIL	www.sumobrain.com	0	0		LRRK2
919	chr5	43835567	43835621	3500026667	54		43835567	43835621	8421504	1	54	0	p	350002666700015008	0-54						Molecular role of Leucine-rich repeat kinase2 (LRRK2) in Parkinson&#x2019;s disease models	uhr-uni-bochum.de	0	0		LRRK2
921	chr5	44137048	44137078	3500308014	25		44137048	44137078	8421504	2	12,13	0,17	g	350030801400000028	15-40						Recombinant anti-cd4 antibodies for human therapy	Hanna	1997	0		
925	chr5	44652283	44652311	3500306832	23		44652283	44652311	8421504	3	5,13,5	0,7,23	g	350030683200000015,350030683200000004,350030683200000005,350030683200000016	4-27,4-27,6-29,7-30						CRYSTAL STRUCTURE OF GLUTAMINYL CYCLASE - Patent application	www.faqs.org	0	0		
931	chr5	45405580	45405611	3500127746	23		45405580	45405611	8421504	3	11,7,5	0,16,26	g	350012774600000001	0-23						Transcriptional Repression by Member ofthe bZIP Family of Transcription	mcb.asm.org	0	0		
937	chr5	46139521	46212504	3500191346	193		46139521	46212504	8421504	7	23,36,12,26,7,41,48	0,47500,50463,58199,58227,71527,72935	c	350019134600000161,350019134600000166,350019134600000172,350019134600000174,350019134600000176	10-33,0-48,12-45,0-41,0-48						Nucleotide sequences for novel protein tyrosine phosphatases	Gonez	1996	0		
937	chr5	46139583	46186904	3500005424	45		46139583	46186904	8421504	2	11,34	0,47287	p	350000542400015001	0-45		11983687	10.1074/jbc.M111683200	0021-9258	Journal of Biological Chemistry	Striatal Enriched Phosphatase 61 Dephosphorylates Fyn at Phosphotyrosine 420	Nguyen	2002	5		PTPRR
937	chr5	46194194	46194222	3500161755	23		46194194	46194222	8421504	2	16,7	0,21	g	350016175500000007,350016175500000047	9-33,9-33						Intermediates and enzymes of the non-mevalonate isoprenoid pathway - Patent application	www.faqs.org	0	0		
937	chr5	46240881	46240904	3500435354	23		46240881	46240904	8421504	1	23	0	c	350043535400000052	11-40						Novel Wheat Allergens - Patent application	www.faqs.org	0	0		
938	chr5	46290002	46348462	3500348580	263		46290002	46348462	8421504	12	8,26,20,16,29,44,10,32,2,40,33,3	0,1585,5332,6728,21643,34704,34842,35826,52704,54045,55899,58457	c	350034858000000019,350034858000000030,350034858000000055,350034858000000078,350034858000000081,350034858000000107,350034858000000114	8-42,5-41,0-29,0-44,0-42,0-42,6-42						US Patent # 7,226,755. HPTPbeta as a target in treatment of angiogenesis mediated disorders - Patents.com	www.patents.com	0	0		
938	chr5	46301965	46362799	3500186204	327		46301965	46362799	8421504	10	32,29,48,48,45,48,4,22,6,45	0,4128,4179,9659,28271,29042,29135,31686,31711,60789	c	350018620400000419,350018620400000423,350018620400000045,350018620400000434,350018620400000090,350018620400000135,350018620400000097,350018620400000129	15-47,15-44,0-48,0-48,0-45,0-48,0-32,0-45						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
938	chr5	46311624	46351268	3500150372	124		46311624	46351268	8421504	3	48,48,28	0,19383,39616	c	350015037200000434,350015037200000135,350015037200000122	0-48,0-48,17-45						Hptpbeta As A Target In Treatment Of Angiogenesis Mediated Disorders 	.freshpatents.com	0	0		
938	chr5	46333863	46351256	3500205994	192		46333863	46351256	8421504	3	32,85,75	0,5371,17318	p	350020599400015021,350020599400015010	0-117,0-75						Characterizing the cancer genome in lung adenocarcinoma	roadinstitute.org	0	0		PTPRB
938	chr5	46334884	46334912	3500403401	23		46334884	46334912	8421504	2	11,12	0,16	g	350040340100000019	11-45					Patent	Cloning and expression of DNA encoding a ripening form of a polypeptide having sulfhydryl oxidase activity (Patent US:5529926)	Maat	1996	0		
938	chr5	46344382	46345898	3500187783	201		46344382	46345898	8421504	3	69,91,41	0,671,1475	p	350018778300015054	27-228						Oxford_SGC_Clones_web	www.docstoc.com	0	0		PTPRB
939	chr5	46496948	46502216	3500447618	294		46496948	46502216	8421504	6	52,71,13,86,65,7	0,1767,3850,5007,5099,5261	p	350044761800015027,350044761800015026,350044761800015025,350044761800015024	0-123,0-117,0-72,0-156					Patent	Antibodies to HASAV70 polypeptide (Patent US:7169565)	Ruben	2007	0		CNOT2
939	chr5	46496948	46502216	3500439093	300		46496948	46502216	8421504	5	52,71,13,157,7	0,1767,3850,5007,5261	p	350043909300015027,350043909300015026,350043909300015025,350043909300015024	0-123,0-117,0-72,0-159						Secreted protein HFEAF41	Brewer	2003	0		CNOT2
939	chr5	46496948	46502216	3500064227	300		46496948	46502216	8421504	5	52,71,13,157,7	0,1767,3850,5007,5261	p	350006422700015027,350006422700015026,350006422700015025,350006422700015024	0-123,0-117,0-72,0-159						Secreted protein HFEAF41	Brewer	2003	0		CNOT2
939	chr5	46496948	46502216	3500048645	300		46496948	46502216	8421504	5	52,71,13,157,7	0,1767,3850,5007,5261	p	350004864500015027,350004864500015026,350004864500015025,350004864500015024	0-120,0-111,0-72,0-162						Secreted protein HFEAF41	Brewer	2002	0		CNOT2
939	chr5	46496948	46502216	3500032881	297		46496948	46502216	8421504	6	52,71,13,80,74,7	0,1767,3850,5007,5090,5261	p	350003288100015027,350003288100015026,350003288100015025,350003288100015024	0-123,0-117,0-72,0-156						87 human secreted proteins	Brewer	2003	0		CNOT2
939	chr5	46496948	46502216	3500029713	294		46496948	46502216	8421504	6	52,71,13,86,65,7	0,1767,3850,5007,5099,5261	p	350002971300015027,350002971300015026,350002971300015025,350002971300015024	0-123,0-117,0-72,0-156						87 human secreted proteins	Young	2005	0		CNOT2
939	chr5	46496969	46502216	3500080223	276		46496969	46502216	8421504	6	31,71,13,59,95,7	0,1746,3829,4986,5048,5240	p	350008022300015026,350008022300015025,350008022300015024	0-102,45-117,0-102						87 Human Secreted Proteins	Young	2007	0		CNOT2
939	chr5	46502006	46502030	3500155594	24		46502006	46502030	8421504	1	24	0	c	350015559400000001	24-48		22367759	10.1002/stem.1070	1549-4918	STEM CELLS	Cnot1, Cnot2, and Cnot3 Maintain Mouse and Human ESC Identity and Inhibit Extraembryonic Differentiation - Zheng - 2012 - STEM CELLS - Wiley Online Library	Zheng	2012	0		
945	chr5	47262107	47277591	3500320902	1251		47262107	47277591	8421504	15	28,142,100,104,129,120,103,50,127,15,77,112,66,75,3	0,4105,5085,5450,5737,6304,8972,9858,11515,12619,12763,13657,14500,14670,15481	p	350032090200015114,350032090200015113,350032090200015112,350032090200015111	0-726,0-177,0-171,0-177						Method for manufacturing a modified peptide	Bauer	2009	0		CCT2
945	chr5	47275870	47277591	3500027167	150		47275870	47277591	8421504	4	6,66,75,3	0,737,907,1718	p	350002716700015147	0-150						Neela Devi Sing RAMBARUTH	search.wmin.ac.uk	0	0		
946	chr5	47322087	47322113	3500126483	24		47322087	47322113	8421504	2	11,13	0,13	g	350012648300000097	0-24						MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - Patent application	www.faqs.org	0	0		
947	chr5	47515842	47517595	3500362160	23		47515842	47517595	8421504	2	11,12	0,1741	c	350036216000000010	21-44						Understanding intestinal lipopolysaccharide permeability and associated inflammation	ib.dr.iastate.edu	0	0		
949	chr5	47770689	47793387	3500336164	515		47770689	47793387	8421504	3	41,446,28	0,17074,22670	c,g	350033616400000008,350033616400000013,350033616400000013,350033616400000003	0-41,0-446,0-446,23-51						US Patent # 5,422,108. Protection of plants against plant pathogens - Patents.com	www.patents.com	0	0		
949	chr5	47787763	47793387	3500154326	531		47787763	47793387	8421504	2	503,28	0,5596	c,g	350015432600000013,350015432600000013,350015432600000012,350015432600000003	0-446,0-446,0-57,23-51						Protection of plants against plant pathogens	Mirkov	1991	0		
949	chr5	47788242	47793392	3500100486	41		47788242	47793392	8421504	2	19,22	0,5128	c	350010048600000024,350010048600000023	11-30,12-34						Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector	Holzberg	2003	0		
949	chr5	47793338	47793392	3500255475	54		47793338	47793392	8421504	1	54	0	p	350025547500015013	0-54						Fibroblast growth factor 21 variants	Dickinson	2013	0		
950	chr5	47845674	47852113	3500336164	191		47845674	47852113	8421504	5	47,20,28,41,55	0,3154,4968,5092,6384	c,g	350033616400000012,350033616400000012,350033616400000009,350033616400000006,350033616400000005	10-57,10-57,0-48,0-48,0-48						US Patent # 5,422,108. Protection of plants against plant pathogens - Patents.com	www.patents.com	0	0		
950	chr5	47845731	47852161	3500154326	329		47845731	47852161	8421504	6	40,8,20,28,130,103	0,3041,3097,4911,4946,6327	c	350015432600000011,350015432600000009,350015432600000008,350015432600000007,350015432600000006,350015432600000005,350015432600000004	0-48,0-48,0-41,0-48,0-48,0-48,0-48						Protection of plants against plant pathogens	Mirkov	1991	0		
950	chr5	47935081	47935126	3500336905	45		47935081	47935126	8421504	1	45	0	p	350033690500015034	3-48						Human lysozyme gene, its encoding polypeptide and the method preparing for them	Yu	2001	0		
950	chr5	47936827	47936874	3500336164	47		47936827	47936874	8421504	1	47	0	c	350033616400000004	1-48						US Patent # 5,422,108. Protection of plants against plant pathogens - Patents.com	www.patents.com	0	0		
951	chr5	47991546	47994305	3500379780	240		47991546	47994305	8421504	4	48,48,96,48	0,2471,2567,2711	c	350037978000000081,350037978000000077,350037978000000075,350037978000000074,350037978000000072	0-48,0-48,0-48,0-48,0-48						AMELIORATING AGENT FOR INSULIN RESISTANCE - Patent application	www.faqs.org	0	0		
953	chr5	48291289	48291312	3500337147	23		48291289	48291312	8421504	1	23	0	c	350033714700000014	6-29		10713175	10.1128/MCB.20.7.2517-2528.2000	0270-7306	Molecular and Cellular Biology	Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex	Weber	2000	6		
953	chr5	48295674	48295702	3500342985	28		48295674	48295702	8421504	1	28	0	c	350034298500000027,350034298500000008	0-28,0-28						US Patent # 6,383,752. Pseudo-cyclic oligonucleobases - Patents.com	patents.com	0	0		
953	chr5	48300451	48305810	3500123810	45		48300451	48305810	8421504	2	20,25	0,5334	c,g	350012381000000018,350012381000000009	0-20,0-25						Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer	mcb.asm.org	0	0		MDM2
953	chr5	48302661	48306186	3500110757	45		48302661	48306186	8421504	3	23,20,2	0,2791,3523	c	350011075700000013,350011075700000001	0-23,11-33						Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions	biomedcentral.com	0	0		
953	chr5	48302672	48305389	3500155980	23		48302672	48305389	8421504	2	21,2	0,2715	c	350015598000000009	17-40						New perspectives on Rett syndrome: the role of MECP2 gene in cellular senescence and neural differentiation	www3.unisi.it	0	0		MDM2
953	chr5	48305390	48305420	3500121461	30		48305390	48305420	8421504	1	30	0	c,g	350012146100000007,350012146100000007	0-30,0-30						 Polynucleotides Encoding Soluble, Stable Forms Of Human Double Minute 2 Polypeptides 	www.docstoc.com	0	0		
953	chr5	48305400	48305424	3500329899	24		48305400	48305424	8421504	1	24	0	c	350032989900000467	1-25						Antisense modulation of human mdm2 expression - Patent # 6184212 - PatentGenius	.patentgenius.com	0	0		
953	chr5	48305400	48305424	3500204777	24		48305400	48305424	8421504	1	24	0	c	350020477700000467	1-25						Antisense modulation of human mdm2 expression	Miraglia	1999	0		
953	chr5	48305409	48305433	3500229356	24		48305409	48305433	8421504	1	24	0	c	350022935600000015	0-24						p53 Protocols	blogsua.com	0	0		
954	chr5	48445596	48448042	3500169824	87		48445596	48448042	8421504	3	66,14,7	0,562,2439	c	350016982400000091,350016982400000096,350016982400000009	0-44,0-40,0-21						MDM2 splice variants Cellular localization and expression in a transgenic mouse model	thek.uni-halle.de	0	0		
954	chr5	48445596	48445632	3500313730	36		48445596	48445632	8421504	1	36	0	c	350031373000000023	12-48						E3 LIGASE INHIBITORS - Patent application	www.faqs.org	0	0		
954	chr5	48445596	48445620	3500375038	24		48445596	48445620	8421504	1	24	0	c	350037503800000002	0-24		11331603	10.1101/gad.886901	0890-9369	Genes & Development	ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage	Maya	2001	12		MDM2
954	chr5	48445599	48445623	3500023622	24		48445599	48445623	8421504	1	24	0	c	350002362200000011	11-35			10.1128/MCB.01352-06		Molecular and Cellular Biology	CSK Controls Retinoic Acid Receptor (RAR) Signaling: a RAR-c-SRC Signaling Axis Is Required for Neuritogenic Differentiation 	Nandini	June	0		MDM2
954	chr5	48445668	48445749	3500117791	78		48445668	48445749	8421504	2	21,57	0,24	p	350011779100015004	0-78						Characterization of the Ubiquitin/Nedd8 E3 Ligase Activity of the Mdm2/MdmX complex	www.uni-koeln.de	0	0		
956	chr5	48679471	48687877	3500446165	47		48679471	48687877	8421504	3	5,16,26	0,2114,8380	c,g	350044616500000012,350044616500000011,350044616500000011	9-30,6-32,6-32		20170508	10.1186/1471-2148-10-55	1471-2148	BMC Evolutionary Biology	Retrotransposition and mutation events yield Rap1 GTPases with differential signalling capacity	Zemojtel	2010	4		
960	chr5	49222957	49223176	3500440887	219		49222957	49223176	8421504	1	219	0	g	350044088700000007	0-219						Method for screening compounds for anti-inflammatory activity - Patent # 6864061 - PatentGenius	.patentgenius.com	0	0		
960	chr5	49223282	49227416	3500274525	95		49223282	49227416	8421504	4	24,20,23,28	0,56,84,4106	c,g	350027452500000000,350027452500000000,350027452500000002,350027452500000001,350027452500000006,350027452500000005	0-24,0-24,0-20,0-23,0-20,0-23						DIAGNOSTIC TOOLS AND GENETIC SUSCEPTIBILITY FACTORS ASSOCIATED WITH BOVINE PARATUBERCULOSIS INFECTION	ges.uflib.ufl.edu	0	0		
960	chr5	49223294	49224616	3500414028	40		49223294	49224616	8421504	2	20,20	0,1302	c,g	350041402800000026,350041402800000027,350041402800000027	0-20,0-20,0-20						Ganjam virus/Nairobi sheep disease virus induces a pro-inflammatory response in infected sheep	biomedcentral.com	0	0		
960	chr5	49223319	49223343	3500464427	24		49223319	49223343	8421504	1	24	0	c	350046442700000000	12-36						Expression of bioactive recombinant bovine interferon-gamma using baculovirus. - ResearchGate	.researchgate.net	0	0		
960	chr5	49223343	49227420	3500439378	40		49223343	49227420	8421504	2	20,20	0,4057	c	350043937800000008,350043937800000009	0-20,0-20		15150340	10.1099/jmm.0.45530-0	0022-2615	Journal of Medical Microbiology	Phenotypic and functional characterization of intraepithelial lymphocytes in a bovine ligated intestinal loop model of enterohaemorrhagic Escherichia coli infection	Menge	2004	3		
960	chr5	49223343	49227420	3500408450	40		49223343	49227420	8421504	2	20,20	0,4057	c,g	350040845000000009,350040845000000010,350040845000000010	0-20,0-20,0-20						Phenotypic and functional characterization of intraepithelial lymphocytes in a bovine ligated intestinal loop model of enterohaemorrhagic Escherichia coliinfection	m.sgmjournals.org	0	0		
960	chr5	49223349	49224599	3500291341	45		49223349	49224599	8421504	3	19,7,19	0,77,1231	c,g	350029134100000002,350029134100000003	0-19,0-26						UNIVERSIT&#xc0; DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
960	chr5	49223382	49227454	3500331365	60		49223382	49227454	8421504	2	31,29	0,4043	c	350033136500000000,350033136500000001	0-31,0-29		15659710	10.1095/biolreprod.104.032953	0006-3363	Biology of Reproduction	Cooperative Expression of Monocyte Chemoattractant Protein 1 Within the Bovine Corpus Luteum: Evidence of Immune Cell-Endothelial Cell Interactions in a Coculture System	Liptak	2005	4		
960	chr5	49223382	49227454	3500072444	60		49223382	49227454	8421504	2	31,29	0,4043	c	350007244400000004,350007244400000005	0-31,0-29		10906073	10.1095/biolreprod63.2.619	0006-3363	Biology of Reproduction	Production, Purification, and Carboxy-Terminal Sequencing of Bioactive Recombinant Bovine Interferon-Stimulated Gene Product 17	Pru	2000	4		
960	chr5	49223388	49227483	3500183553	46		49223388	49227483	8421504	2	25,21	0,4074	c	350018355300000001,350018355300000000	0-25,0-21						The development of an interferon-gamma (IFN&#x03b3;) assay for the diagnosis of tuberculosis in African elephants (Loxodonta africana	upetd.up.ac.za	0	0		
960	chr5	49224589	49227462	3500416780	385		49224589	49227462	8421504	3	60,183,142	0,155,2731	c	350041678000000132,350041678000000133,350041678000000134,350041678000000135,350041678000000136,350041678000000137,350041678000000138,350041678000000139	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-49						Gamma-iterferon-leukotoxin gene fusions and uses thereof	Potter	1991	0		
960	chr5	49224589	49224900	3500275310	40		49224589	49224900	8421504	2	20,20	0,291	c,g	350027531000000016,350027531000000016,350027531000000017	0-20,0-20,0-20						The Bovine Mammary Glands Cytokines at the Periparturient Period	apps.kfu.edu.sa	0	0		
960	chr5	49224599	49224625	3500394731	26		49224599	49224625	8421504	1	26	0	c	350039473100000004	0-26			10.1111/j.1365-3024.2006.00928.x	1365-3024	Parasite Immunology	Haemonchus contortus intestine: a prominent source of mucosal antigens - JASMER - 2007 - Parasite Immunology - Wiley Online Library	JASMER	2007	0		
960	chr5	49224602	49227327	3500265224	40		49224602	49227327	8421504	3	20,13,7	0,312,2718	c	350026522400000016,350026522400000017	0-20,0-20						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
960	chr5	49224603	49227478	3500347624	40		49224603	49227478	8421504	2	20,20	0,2855	c,g	350034762400000004,350034762400000004,350034762400000005	0-20,0-20,0-20		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		
960	chr5	49224625	49224828	3500280517	40		49224625	49224828	8421504	2	20,20	0,183	c,g	350028051700000029,350028051700000030,350028051700000030	0-20,0-20,0-20						Coxiella burnetii in pregnant goats	ive.library.uu.nl	0	0		
960	chr5	49224628	49227484	3500464000	44		49224628	49227484	8421504	3	21,1,22	0,116,2834	c	350046400000000006,350046400000000007	0-22,0-22			10.1046/j.1365-2567.2000.00124.x	1365-2567	Immunology	T helper 1-type cytokine transcription in peripheral blood mononuclear cells of pseudorabies virus (Suid herpesvirus 1)-primed swine indicates efficient immunization - Fischer - 2008 - Immunology - Wiley Online Library	Fischer	2000	0		
960	chr5	49224634	49224694	3500320149	60		49224634	49224694	8421504	1	60	0	g	350032014900000011	0-60						Bestimmung der Interferon-gamma-Expression bei Baypamune behandelten Hunden mittels &#x201e;Real Time PCR&#x201c;	eb.uni-giessen.de	0	0		
960	chr5	49224763	49227361	3500383646	41		49224763	49227361	8421504	2	20,21	0,2577	c,g	350038364600000008,350038364600000008,350038364600000009,350038364600000009	0-20,0-20,0-21,0-21						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
960	chr5	49224765	49224789	3500334007	24		49224765	49224789	8421504	1	24	0	c	350033400700000006	18-42						The manufacture and expression of large structural genes	Alton	1983	0		
960	chr5	49224768	49227422	3500399883	45		49224768	49227422	8421504	2	24,21	0,2633	c,g	350039988300000014,350039988300000014,350039988300000015,350039988300000015	0-24,0-24,0-21,0-21						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	bdtd.ufscar.br	0	0		
960	chr5	49224768	49227422	3500312145	46		49224768	49227422	8421504	2	24,22	0,2632	c	350031214500000008,350031214500000009	0-24,0-22						Modulation of cytokine gene expression and secretion during the periparturient period in dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis	ddr.nal.usda.gov	0	0		
960	chr5	49224768	49227422	3500164845	45		49224768	49227422	8421504	2	24,21	0,2633	c	350016484500000014,350016484500000015	0-24,0-21						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	ww.bdtd.ufscar.br	0	0		
960	chr5	49224769	49227655	3500177864	46		49224769	49227655	8421504	2	23,23	0,2863	c	350017786400000017,350017786400000018	0-23,0-23						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
960	chr5	49224769	49227655	3500136902	46		49224769	49227655	8421504	2	23,23	0,2863	c,g	350013690200000012,350013690200000012,350013690200000013	0-23,0-23,0-23						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
960	chr5	49224813	49227330	3500449915	47		49224813	49227330	8421504	3	24,13,10	0,101,2507	c,g	350044991500000022,350044991500000022,350044991500000023	0-24,0-24,0-23						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
960	chr5	49224814	49227425	3500361058	40		49224814	49227425	8421504	2	20,20	0,2591	c,g	350036105800000014,350036105800000014,350036105800000015,350036105800000015	0-20,0-20,0-20,0-20						Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade	biomedcentral.com	0	0		
960	chr5	49224895	49224918	3500457560	23		49224895	49224918	8421504	1	23	0	c	350045756000000000	0-23						Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle	aldc.nal.usda.gov	0	0		
960	chr5	49224896	49224920	3500340694	24		49224896	49224920	8421504	1	24	0	c	350034069400000000	0-24						Emprego da RT-PCR em tempo real para a quantifica&#xe7;&#xe3;o da express&#xe3;o de genes associados &#xe0; resposta imune em bezerros bovinos experimentalmente infectados por N caninum	pt.scribd.com	0	0		
960	chr5	49224918	49227363	3500083700	49		49224918	49227363	8421504	3	9,12,28	0,2402,2417	c	350008370000000051,350008370000000021,350008370000000023	0-21,0-21,0-28						COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE AGAINST MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
960	chr5	49227341	49227386	3500402758	45		49227341	49227386	8421504	1	45	0	p	350040275800015029	0-45						 <HTML> <HEAD><TITLE>a$?a3a?a1/4aaSSaa3i1/4I3a(r)ePS1/2e ae1ae3 - c1ea13i1/4i1/4i1/4i1/4i1/4i1/4i1/4	www.j-tokkyo.com	0	0		
960	chr5	49227341	49227386	3500349396	45		49227341	49227386	8421504	1	45	0	p	350034939600015030	0-45						&#x30a4;&#x30f3;&#x30bf;&#x30fc;&#x30d5;&#x30a7;&#x30ed;&#x30f3;&#xff0d;&#x03b3;&#x306e;&#x88fd;&#x9020;&#x65b9;&#x6cd5; - &#x6771;&#x30ec;&#x682a;&#x5f0f;&#x4f1a;&#x793e;	www.patentjp.com	0	0		
960	chr5	49227354	49227382	3500365742	28		49227354	49227382	8421504	1	28	0	c	350036574200000002	0-28		21039923	10.1111/j.1574-695X.2010.00739.x	1574-695X	FEMS Immunology & Medical Microbiology	Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs - Siva Reddy - 2010 - FEMS Immunology & Medical Microbiology - Wiley Online Library	Siva	2010	0		
962	chr5	49517009	49531119	3500297690	40		49517009	49531119	8421504	4	5,16,12,7	0,6,14086,14103	g	350029769000000074,350029769000000147	0-21,1-20						US Patent # 5,556,781. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
963	chr5	49577960	49577987	3500320331	23		49577960	49577987	8421504	2	6,17	0,10	g	350032033100000009	25-48						Polypeptides Having Endoglucanase Activity and Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
963	chr5	49636104	49636132	3500246878	25		49636104	49636132	8421504	2	11,14	0,14	g	350024687800000045	0-25						MOLECULAR DEATH TAGS AND METHODS OF THEIR USE - Patent application	www.faqs.org	0	0		
967	chr5	50115345	50118147	3500289527	393		50115345	50118147	8421504	3	165,170,58	0,241,2744	p	350028952700015058,350028952700015062,350028952700015061,350028952700015060,350028952700015059	63-456,0-123,0-111,0-102,63-111						101 human secreted proteins	Carter	2003	0		CAND1
967	chr5	50115345	50118147	3500288953	393		50115345	50118147	8421504	3	165,170,58	0,241,2744	p	350028895300015017	63-456						101 human secreted proteins	Carter	1999	0		CAND1
967	chr5	50115345	50118147	3500277995	393		50115345	50118147	8421504	3	165,170,58	0,241,2744	p	350027799500015017	63-456						101 human secreted proteins	Carter	2000	0		CAND1
976	chr5	51325217	51325244	3500448398	27		51325217	51325244	8421504	1	27	0	c	350044839800000004	16-43						Bifidobacteria Upregulate Expression of Toll-Like Receptor Negative Regulators Counteracting Enterotoxigenic Escherichia coli Mediated Inflammation in Bovine Intestinal Epitheliocytes	www.scirp.org	0	0		
976	chr5	51325217	51325244	3500361960	27		51325217	51325244	8421504	1	27	0	c	350036196000000027	16-43						Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation	biomedcentral.com	0	0		
981	chr5	51949464	51949494	3500443188	25		51949464	51949494	8421504	2	19,6	0,24	g	350044318800000049	21-46						Family GH-61 polypeptides - Patent # 7273738 - PatentGenius	.patentgenius.com	0	0		
987	chr5	52793499	52796850	3500034586	40		52793499	52796850	8421504	3	2,18,20	0,3257,3331	c	350003458600000013,350003458600000014	0-20,0-20						THE THAI JOURNAL OF VETERINARY MEDICINE	w.vet.chula.ac.th	0	0		
988	chr5	52844689	52844715	3500320190	24		52844689	52844715	8421504	2	15,9	0,17	c	350032019000000006	0-24						Interferon beta-like molecules	Rasmussen	2002	0		
990	chr5	53139680	53153430	3500099361	40		53139680	53153430	8421504	2	21,19	0,13731	c,g	350009936100000015,350009936100000019,350009936100000019	0-21,0-19,0-19		21189260	10.1074/jbc.M110.164632		The Journal of Biological Chemistry	TBK1-associated Protein in Endolysosomes (TAPE) Is an Innate Immune Regulator Modulating the TLR3 and TLR4 Signaling Pathways	Chun-Hung	2011	0		
990	chr5	53144939	53145887	3500341913	45		53144939	53145887	8421504	2	12,33	0,915	p	350034191300015010	0-45						Protein Kinases 	.freshpatents.com	0	0		TBK1
991	chr5	53217286	53217309	3500119640	23		53217286	53217309	8421504	1	23	0	c	350011964000000023	7-30						Identifizierung und Charakterisierung von neuen zytoplasmatischen Interaktionspartnern des IGF-1 Rezeptors	ub.uni-marburg.de	0	0		
996	chr5	53980539	53980568	3500361066	24		53980539	53980568	8421504	3	12,4,8	0,16,21	g	350036106600001307	11-35						Caev-based Vector Systems 	.freshpatents.com	0	0		
998	chr5	54244878	54244904	3500183380	26		54244878	54244904	8421504	1	26	0	c	350018338000000007,350018338000000019	12-33,8-30		16574744	10.1124/mol.105.018804	1521-0111 (Online)	Molecular Pharmacology	Soluble Mimics of the Cytoplasmic Face of the Human V1-Vascular Vasopressin Receptor Bind Arrestin2 and Calmodulin	Wu	2006	0		AVPR1A
1000	chr5	54519275	54519299	3500217750	24		54519275	54519299	8421504	1	24	0	g	350021775000000069	9-33						Method of diagnosing colon and gastric cancers	Nakamura	2006	0		PPM1H
1002	chr5	54720760	54720784	3500157945	24		54720760	54720784	8421504	1	24	0	g	350015794500000006	3-29						 Endoglucanases 	www.docstoc.com	0	0		
1003	chr5	54805246	54805270	3500217750	24		54805246	54805270	8421504	1	24	0	c	350021775000000002	0-24						Method of diagnosing colon and gastric cancers	Nakamura	2006	0		
1003	chr5	54805246	54805270	3500175867	24		54805246	54805270	8421504	1	24	0	c	350017586700000002	0-24						Method of diagnosing colon and gastric cancers	Nakamura	2009	0		
1003	chr5	54827766	54827789	3500142873	23		54827766	54827789	8421504	1	23	0	g	350014287300000146	0-23						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
1003	chr5	54858616	54858647	3500443697	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350044369700000005	1-24						Delta-5 Desaturase And Uses Thereof 	.freshpatents.com	0	0		
1003	chr5	54858616	54858647	3500250715	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350025071500000005	1-24						Desaturase genes and uses thereof	Mukerji	2011	0		
1003	chr5	54858616	54858647	3500206841	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350020684100000005	1-24						DELTA-6 DESATURASE AND USES THEREOF	Mukerji	2010	0		
1003	chr5	54858616	54858647	3500199445	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350019944500000005	1-24						Desaturase genes and uses thereof	Mukerji	2002	0		
1003	chr5	54858616	54858647	3500168859	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350016885900000005	1-24						US Patent # 7,241,619. Desaturase genes and uses thereof - Patents.com	www.patents.com	0	0		
1003	chr5	54858616	54858647	3500165037	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350016503700000005	1-24						DELTA-6 DESATURASE AND USES THEREOF - Patent application	www.faqs.org	0	0		
1003	chr5	54858616	54858647	3500029796	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350002979600000005	1-24						Desaturase genes and uses thereof - Patent application	www.faqs.org	0	0		
1003	chr5	54858616	54858647	3500012997	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350001299700000005	1-24						US Patent # 6,635,451. Desaturase genes and uses thereof - Patents.com	www.patents.com	0	0		
1003	chr5	54858616	54858647	3500010655	23		54858616	54858647	8421504	3	6,5,12	0,11,19	g	350001065500000005	1-24						Desaturase genes and uses thereof	Mukerji	2011	0		
1003	chr5	54870274	54870358	3500433622	47		54870274	54870358	8421504	2	25,22	0,62	c,g	350043362200000029,350043362200000029,350043362200000028	0-25,0-25,0-22		23200856	10.1016/j.celrep.2012.10.023	2211-1247	Cell Reports	Cell Reports - Specific miRNA Stabilization by Gld2-Catalyzed Monoadenylation	D'Ambrogio	2012	0		
1003	chr5	54870275	54870353	3500439152	44		54870275	54870353	8421504	2	22,22	0,56	c	350043915200000174,350043915200000256	0-22,0-22						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		
1003	chr5	54870279	54870353	3500059138	69		54870279	54870353	8421504	3	21,23,25	0,22,49	c,g	350005913800000087,350005913800000087,350005913800000088,350005913800000088,350005913800000086	0-21,0-21,0-23,0-23,0-25						Oligomeric compounds and compositions for use in modulation of small non-coding rnas	Baker	2005	0		
1004	chr5	54927585	54927610	3500354972	25		54927585	54927610	8421504	1	25	0	g	350035497200000002	45-70						Methods for the detection, analysis and isolation of nascent proteins	Rothschild	2003	0		
1004	chr5	54927585	54927610	3500334229	25		54927585	54927610	8421504	1	25	0	g	350033422900000002	45-70						Methods for the detection, analysis and isolation of nascent proteins	Gite	2004	0		
1005	chr5	55109337	55137061	3500334077	44		55109337	55137061	8421504	3	22,10,12	0,5369,27712	c	350033407700000009,350033407700000010	0-22,0-22		23708518	10.4161/cc.25035		Cell Cycle	The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exit	Monica	June	0		USP15
1005	chr5	55168859	55168886	3500274588	27		55168859	55168886	8421504	1	27	0	c	350027458800000004	0-27						Online Peptides Guide | papers about Peptide	m-heavy-chain.com	0	0		USP15
1010	chr5	55726855	55726880	3500104098	23		55726855	55726880	8421504	2	12,11	0,14	g	350010409800000334	0-24						METHOD OF DETECTING HUMAN PAPILLOMA VIRUS BY USING NUCLEIC ACID AMPLIFICATION METHOD AND NUCLEIC ACID CHAIN-IMMOBILIZED CARRIER - Patent application	www.faqs.org	0	0		
1020	chr5	57018100	57018133	3500157914	27		57018100	57018133	8421504	3	12,6,9	0,15,24	g	350015791400000048	15-42						Cd40 ligand fusion protein vaccine	Tang	2007	0		
1021	chr5	57148858	57148886	3500278645	24		57148858	57148886	8421504	2	8,16	0,12	g	350027864500000044	1-25						Recombinant vesiculoviruses and their uses		1997	0		
1021	chr5	57185092	57185117	3500132657	24		57185092	57185117	8421504	2	4,20	0,5	g	350013265700000024,350013265700000025	3-31,16-44						Construction of miRNA overexpression lentiviral vectors	tologylibrary.org	0	0		
1024	chr5	57569759	57569782	3500340198	23		57569759	57569782	8421504	1	23	0	g	350034019800000197	9-32						Genetically engineered vaccine strain	Cox	1993	0		
1024	chr5	57597963	57597986	3500167332	23		57597963	57597986	8421504	1	23	0	g	350016733200000008,350016733200000007	24-47,0-23		19144705	10.1128/JVI.01867-08	0022-538X	Journal of Virology	Simian Virus 40 Large T Antigen Can Specifically Unwind the Central Palindrome at the Origin of DNA Replication	Wang	2009	5		
1025	chr5	57696755	57696781	3500353938	23		57696755	57696781	8421504	2	7,16	0,10	g	350035393800000056	11-35						DNA and RNA Profiling in Human Blood	www.bjcancer.org	0	0		
1033	chr5	58735953	58735977	3500180289	23		58735953	58735977	8421504	2	10,13	0,11	g	350018028900000029	0-23						Validation of cDNA microarray as a prototype for throughput detection of GMOs	nal.sinica.edu.tw	0	0		
1037	chr5	59309623	59309648	3500383915	24		59309623	59309648	8421504	2	13,11	0,14	g	350038391500001191	0-24						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
1041	chr5	59800927	59801011	3500040785	84		59800927	59801011	8421504	1	84	0	c,g	350004078500000094,350004078500000094,350004078500000054	0-84,0-84,0-22						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		CTDSPL,MIR26A2
1041	chr5	59849620	59849645	3500177333	25		59849620	59849645	8421504	1	25	0	c	350017733300000000	22-47						Regulation of Mycobacterium-Specific Mononuclear Cell Responses by 25-Hydroxyvitamin D	aldc.nal.usda.gov	0	0		
1041	chr5	59850407	59850768	3500416999	40		59850407	59850768	8421504	3	12,8,20	0,284,341	c,g	350041699900000000,350041699900000001,350041699900000001	0-20,0-20,0-20		17911404	10.1677/JOE-07-0267	0022-0795	Journal of Endocrinology	Fibroblast growth factor-23 regulates parathyroid hormone and 1&#x03b1;-hydroxylase expression in cultured bovine parathyroid cells	Krajisnik	2007	4		CYP27B1
1041	chr5	59850407	59850768	3500005796	40		59850407	59850768	8421504	3	12,8,20	0,284,341	c,g	350000579600000000,350000579600000001,350000579600000001	0-20,0-20,0-20		17911404	10.1677/JOE-07-0267	0022-0795	Journal of Endocrinology	Fibroblast growth factor-23 regulates parathyroid hormone and 1&#x03b1;-hydroxylase expression in cultured bovine parathyroid cells	Krajisnik	2007	4		CYP27B1
1041	chr5	59850417	59850712	3500163695	23		59850417	59850712	8421504	2	2,21	0,274	c	350016369500000001	0-23		10589683		1046-6673	Journal of the American Society of Nephrology	Expression of 25-Hydroxyvitamin D3-1&#x03b1;-Hydroxylase in the Human Kidney	ZEHNDER	1999	10		CYP27B1
1041	chr5	59850417	59850712	3500025379	23		59850417	59850712	8421504	2	2,21	0,274	c	350002537900000001	0-23		11856765		1046-6673	Journal of the American Society of Nephrology	Synthesis of 1,25-Dihydroxyvitamin D3 by Human Endothelial Cells Is Regulated by Inflammatory Cytokines: A Novel Autocrine Determinant of Vascular Cell Adhesion	Zehnder	2002	10		CYP27B1
1041	chr5	59862190	59862215	3500043540	24		59862190	59862215	8421504	2	17,7	0,18	g	350004354000000469	9-33						US Patent # 6,987,212. Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use - Patents.com	www.patents.com	0	0		
1041	chr5	59862827	59863789	3500279873	50		59862827	59863789	8421504	3	25,12,13	0,796,949	c	350027987300000002,350027987300000003	0-25,0-25		19017637	10.1074/jbc.M804491200	0021-9258	Journal of Biological Chemistry	Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression	Jamin	2009	5		CDK4
1041	chr5	59862860	59862917	3500466072	57		59862860	59862917	8421504	1	57	0	p	350046607200015001	0-57						articles SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27	ology.med.nyu.edu	0	0		CDK4
1041	chr5	59862860	59862917	3500426290	57		59862860	59862917	8421504	1	57	0	p	350042629000015004	0-57						Methods to identify compounds useful for the treatment of proliferative and differentiative disorders	Pagano	2008	0		CDK4
1041	chr5	59862860	59862917	3500421333	57		59862860	59862917	8421504	1	57	0	p	350042133300015003	0-57						Novel ubiquitin ligases as therapeutic targets	Chiaur	2003	0		CDK4
1041	chr5	59862860	59862917	3500369274	57		59862860	59862917	8421504	1	57	0	p	350036927400015002	0-57						Novel ubiquitin ligases as therapeutic targets	Chiaur	2000	0		CDK4
1041	chr5	59862860	59862917	3500337316	57		59862860	59862917	8421504	1	57	0	p	350033731600015001	0-57						articles SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27	ology.med.nyu.edu	0	0		CDK4
1041	chr5	59862868	59863634	3500340274	40		59862868	59863634	8421504	2	20,20	0,746	c,g	350034027400000009,350034027400000009,350034027400000008	0-20,0-20,0-20						Doxorubicin Induces Cytotoxicity through Upregulation of pERK-Dependent ATF3. - ResearchGate	.researchgate.net	0	0		CDK4
1041	chr5	59862868	59863634	3500233103	40		59862868	59863634	8421504	2	20,20	0,746	c	350023310300000015,350023310300000014	0-20,0-20						Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells	-publications.com	0	0		CDK4
1041	chr5	59863575	59863815	3500063873	66		59863575	59863815	8421504	2	27,39	0,201	p	350006387300015023	3-105						Isolation and Characterization of cDNA Clones Encoding a Functional p34cdc2 Homologue from Zea mays	www.jstor.org	0	0		
1041	chr5	59863614	59864340	3500449946	40		59863614	59864340	8421504	3	20,7,13	0,567,713	c	350044994600000008,350044994600000009	0-20,0-20		21118196	10.1111/j.1365-2141.2010.08471.x	1365-2141	British Journal of Haematology	Proliferation and bone marrow engraftment of AML blasts is dependent on &#x03b2;-catenin signalling - Siapati - 2010 - British Journal of Haematology - Wiley Online Library	Siapati	2011	0		CDK4
1041	chr5	59863854	59864154	3500341196	38		59863854	59864154	8421504	3	19,2,17	0,30,283	c	350034119600000463,350034119600000413	0-19,0-19					Patent	siRNA targeting cyclin-dependent kinase 4 (CDK4) (Patent US:8030474)	Khvorova	2011	0		
1041	chr5	59863854	59864154	3500088299	38		59863854	59864154	8421504	3	19,2,17	0,30,283	c,g	350008829900000463,350008829900000463,350008829900000413	0-19,0-19,0-19						siRNA targeting cyclin-dependent kinase 4 (CDK4)	Khvorova	2009	0		
1041	chr5	59867317	59868165	3500375699	309		59867317	59868165	8421504	2	157,152	0,696	g	350037569900000036	0-311						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1041	chr5	59884805	59884850	3500251900	45		59884805	59884850	8421504	1	45	0	p	350025190000015005	0-45						SF 298, Report Documentation Page	www.dtic.mil	0	0		AGAP2
1042	chr5	60020318	60022199	3500140430	67		60020318	60022199	8421504	4	28,1,16,22	0,491,851,1859	c	350014043000000065,350014043000000070	6-35,0-38						DNA sequence encoding N-acetyl-galactosamine-transferase	Lowe	1994	0		
1043	chr5	60050264	60060353	3500006396	47		60050264	60060353	8421504	2	27,20	0,10069	c,g	350000639600000005,350000639600000005,350000639600000004	0-27,0-27,0-20						Localization of phosphatidylinositol phosphate kinase II &#x03b3; in kidney to a membrane trafficking compartment within specialized cells of the nephron	g.library.pcc.edu	0	0		
1043	chr5	60051765	60051798	3500227126	24		60051765	60051798	8421504	3	6,6,12	0,10,21	c	350022712600000058	2-27						Novel expressed sequence tag- simple sequence repeats (EST-SSR) markers characterized by new bioinformatic criteria reveal high genetic similarity in sugarcane ( Saccharum spp.) breeding lines	demicjournals.org	0	0		
1043	chr5	60107333	60107356	3500449690	23		60107333	60107356	8421504	1	23	0	c	350044969000000000	10-33			10.1091/mbc.E04-03-0260		Molecular Biology of the Cell	Regulation of Microtubule-dependent Recycling at the Trans-Golgi Network by Rab6A and Rab6A'	Joanne	2005	0		DCTN2
1043	chr5	60107333	60107356	3500405416	23		60107333	60107356	8421504	1	23	0	c	350040541600000000	10-33		15483056	10.1091/mbc.E04-03-0260	1059-1524	Molecular Biology of the Cell	Regulation of Microtubule-dependent Recycling at the Trans-Golgi Network by Rab6A and Rab6A'	Young	2005	5		DCTN2
1043	chr5	60107333	60107356	3500163992	23		60107333	60107356	8421504	1	23	0	c	350016399200000000	10-33						Regulation of microtubule-dependent recycling at the TGN by rab6A and rab6A&#x2019;	w.molbiolcell.org	0	0		DCTN2
1043	chr5	60130045	60130070	3500084088	25		60130045	60130070	8421504	1	25	0	g	350008408800000002,350008408800000003	3-28,5-29						gadd153/Chop10, a Potential Target Gene of the Transcriptional Repressor ATF3	mcb.asm.org	0	0		
1043	chr5	60132979	60133003	3500182022	24		60132979	60133003	8421504	1	24	0	c	350018202200000009	1-25		22570737	10.1371/journal.pone.0036682	1932-6203	PLOS ONE	PLOS ONE: Myxoid Liposarcoma-Associated EWSR1-DDIT3 Selectively Represses Osteoblastic and Chondrocytic Transcription in Multipotent Mesenchymal Cells	Suzuki	2012	4		DDIT3
1043	chr5	60133765	60133788	3500270300	23		60133765	60133788	8421504	1	23	0	c	350027030000000002	0-23						TNF&#x03b1; modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts	itis-research.com	0	0		
1043	chr5	60133796	60134296	3500086686	41		60133796	60134296	8421504	2	20,21	0,479	c,g	350008668600000004,350008668600000005,350008668600000005	0-20,0-21,0-21		15485913	10.1128/MCB.24.21.9456-9469.2004	0270-7306	Molecular and Cellular Biology	Characterization of Stanniocalcin 2, a Novel Target of the Mammalian Unfolded Protein Response with Cytoprotective Properties	Ito	2004	6		DDIT3
1043	chr5	60133993	60134018	3500440875	25		60133993	60134018	8421504	1	25	0	c	350044087500000010	0-25						Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	ecular-cancer.com	0	0		
1043	chr5	60133993	60134018	3500190261	25		60133993	60134018	8421504	1	25	0	c	350019026100000010	0-25		22913813	10.1186/1476-4598-11-59	1476-4598	Molecular Cancer	Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	Horibe	2012	4		
1043	chr5	60134275	60134299	3500300246	24		60134275	60134299	8421504	1	24	0	c,g	350030024600000005,350030024600000005	0-24,0-24		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		DDIT3
1043	chr5	60134275	60134299	3500168730	24		60134275	60134299	8421504	1	24	0	c	350016873000000005	0-24		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		DDIT3
1043	chr5	60138497	60153144	3500425104	95		60138497	60153144	8421504	6	24,1,20,23,2,25	0,8214,11986,12410,13623,14622	c	350042510400000046,350042510400000061,350042510400000128,350042510400000127	0-24,5-26,0-23,0-27						INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES - Patent application	www.faqs.org	0	0		
1044	chr5	60167316	60167341	3500218435	25		60167316	60167341	8421504	1	25	0	c	350021843500000001	0-25		16421275	10.1101/gad.1380906	0890-9369	Genes & Development	Dual degradation signals control Gli protein stability and tumor formation	Huntzicker	2006	12		
1044	chr5	60167316	60167341	3500215186	25		60167316	60167341	8421504	1	25	0	c	350021518600000001	0-25			10.1101/gad.1380906		Genes & Development	Dual degradation signals control Gli protein stability and tumor formation	Erik	2006	0		
1044	chr5	60170044	60170092	3500111672	48		60170044	60170092	8421504	1	48	0	p	350011167200015035	0-48						METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		GLIS3
1044	chr5	60170648	60170675	3500441689	26		60170648	60170675	8421504	2	4,22	0,5	c	350044168900000146	16-42						Patent Search: US Patent Number 8168602 - Compositions, kits and methods for identification, assessment, prevention and therapy of cancer	ww.archpatent.com	0	0		GLI1
1044	chr5	60170713	60171540	3500123011	81		60170713	60171540	8421504	2	63,18	0,809	p	350012301100015004	0-81						Inhibitors of viral infection	Kirkegaard	2001	0		GLI1
1044	chr5	60179759	60196059	3500142873	202		60179759	60196059	8421504	9	22,22,22,21,22,22,22,25,24	0,95,757,1337,1384,3082,5584,15506,16276	c,g	350014287300000153,350014287300000153,350014287300000015,350014287300000152,350014287300000152,350014287300000154,350014287300000156,350014287300000157,350014287300000160,350014287300000166,350014287300000022,350014287300000026,350014287300000173,350014287300000174	0-22,0-22,0-22,0-22,0-22,0-22,0-21,0-22,0-22,0-22,22-44,0-25,0-24,0-24						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
1044	chr5	60185201	60185366	3500392138	123		60185201	60185366	8421504	2	85,38	0,127	c	350039213800000430,350039213800000429,350039213800000427	0-39,0-46,6-44						Designer ligands of tgf-beta superfamily	Choe	2010	0		
1046	chr5	60436666	60437473	3500159212	84		60436666	60437473	8421504	2	45,39	0,768	p	350015921200015014	0-123						Hypusination of eukaryotic initiation factor 5A(eIF5A): a novel therapeutic target in BCR-ABL&#x2013;positive leukemias identi&#xfb01;ed by a proteomics approach	tologylibrary.org	0	0		
1046	chr5	60456004	60456035	3500215357	31		60456004	60456035	8421504	1	31	0	g	350021535700000015	8-39						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2000 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Interactions of the Low Density Lipoprotein Receptor Gene Family with Cytosolic Adaptor and Scaffold Proteins Suggest Di	www.jbc.org	0	0		
130	chr5	60548568	60565209	3500263190	16589		60548568	60565209	8421504	4	3205,80,12196,1108	0,3255,3336,15533	p,c,g	350026319000000092,350026319000000075,350026319000000084,350026319000000015,350026319000000114,350026319000000077,350026319000000095,350026319000000001,350026319000000102,350026319000000085,350026319000000069,350026319000000003,350026319000000104,350026319000000005,350026319000000106,350026319000000004,350026319000000105,350026319000000086,350026319000000071,350026319000000088,350026319000015008,350026319000015011,350026319000015013,350026319000015016,350026319000015017,350026319000015018,350026319000015019,350026319000015022,350026319000015023,350026319000015024,350026319000015028,350026319000000090,350026319000000073,350026319000015035,350026319000015036,350026319000000011,350026319000000112,350026319000000091,350026319000015038,350026319000015043,350026319000015050,350026319000015052,350026319000015055,350026319000015060,350026319000015066,350026319000015071,350026319000015076,350026319000015081,350026319000015090,350026319000015091,350026319000015096,350026319000015101,350026319000015111,350026319000015116,350026319000015119,350026319000015124,350026319000000096,350026319000000079,350026319000000097,350026319000000029,350026319000000122,350026319000015134,350026319000015138,350026319000015139,350026319000015140,350026319000015142,350026319000015143,350026319000000081,350026319000000099,350026319000000031,350026319000000123,350026319000015144,350026319000000100,350026319000000033,350026319000000125,350026319000015146,350026319000015148,350026319000015208,350026319000015150	0-150,0-275,0-16800,0-20,0-20,83-275,0-141,0-20,0-20,0-150,0-274,0-20,0-20,0-20,0-20,0-20,0-20,0-140,0-273,0-110,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-150,0-275,0-45,0-45,0-20,0-20,0-141,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-150,0-275,0-141,0-20,0-20,0-45,0-45,0-45,0-45,0-45,0-45,0-275,0-120,0-20,0-20,0-45,0-141,0-20,0-20,0-45,0-45,0-45,0-45						STAT6 EFFECTS ON LIVESTOCK ANIMAL GROWTH - Patent application	www.faqs.org	0	0		
130	chr5	60548677	60564111	3500233611	1578		60548677	60564111	8421504	10	20,80,111,273,241,31,274,274,264,10	0,3146,3227,3796,5245,5487,8757,13160,15159,15424	c,g	350023361100000015,350023361100000077,350023361100000001,350023361100000069,350023361100000003,350023361100000005,350023361100000004,350023361100000071,350023361100000073,350023361100000011,350023361100000079,350023361100000029,350023361100000081,350023361100000031,350023361100000033	0-20,83-275,0-20,0-274,0-20,0-20,0-20,0-273,0-275,0-20,0-275,0-20,0-275,0-20,0-20						STAT6 EFFECTS ON LIVESTOCK ANIMAL GROWTH	Medrano	2008	0		
130	chr5	60548677	60563992	3500202979	140		60548677	60563992	8421504	7	20,20,20,20,20,20,20	0,3317,3926,8846,13298,15235,15295	c,g	350020297900000013,350020297900000020,350020297900000002,350020297900000009,350020297900000027,350020297900000029,350020297900000031	0-20,0-20,0-20,0-20,0-20,0-20,0-20						Stat6 Effects On Livestock Animal Growth 	.freshpatents.com	0	0		
1046	chr5	60551672	60551695	3500083192	23		60551672	60551695	8421504	1	23	0	g	350008319200000004	0-23				0798-2259	Revista Cient&#xed;fica	Revista Cient&#xed;fica - Genetic diversity of limonero creole breed using Microsatellites molecular markers	Villasmil-Ontiveros	2008	0		
130	chr5	60554804	60561688	3500336858	144		60554804	60561688	8421504	5	48,6,42,10,38	0,3722,4374,6516,6846	c	350033685800000177,350033685800000030,350033685800000041	0-48,0-48,0-48						Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and Stat6c	Larochelle	2000	0		
1047	chr5	60557458	60559658	3500004083	259		60557458	60559658	8421504	6	40,48,8,67,48,48	0,229,394,737,978,2152	c	350000408300000272,350000408300000274,350000408300000277,350000408300000278,350000408300000280,350000408300000284	0-40,0-48,21-48,0-48,0-48,0-48						Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins	Hancock	2001	0		
1047	chr5	60558256	60559685	3500328322	321		60558256	60559685	8421504	4	27,123,93,78	0,153,922,1351	p	350032832200015009	0-321						Functionally active regions of signal transducer and activator of transcription	Darnell	1997	0		STAT6
1047	chr5	60558256	60559685	3500295082	321		60558256	60559685	8421504	4	27,123,93,78	0,153,922,1351	p	350029508200015012	0-321					Patent	Functionally active regions of signal transducer and activator of transcription (Patent US:5883228)	James	1999	0		STAT6
1047	chr5	60558427	60559679	3500242915	270		60558427	60559679	8421504	3	105,93,72	0,751,1180	p	350024291500015014	0-270						A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain	enesdev.cshlp.org	0	0		STAT6
1047	chr5	60559745	60561044	3500261436	49		60559745	60561044	8421504	2	27,22	0,1277	c	350026143600000103,350026143600000104	0-27,0-22						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		STAT6
1047	chr5	60561236	60561796	3500359428	96		60561236	60561796	8421504	2	48,48	0,512	p	350035942800015087,350035942800015091	0-48,0-48						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		STAT6
1047	chr5	60561236	60561796	3500322942	96		60561236	60561796	8421504	2	48,48	0,512	p	350032294200015087,350032294200015091	0-48,0-48						Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis	Dunnington	1998	0		STAT6
1047	chr5	60561236	60561796	3500075196	96		60561236	60561796	8421504	2	48,48	0,512	p	350007519600015093,350007519600015097	0-48,0-48						USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS	Dunnington	1997	0		STAT6
1047	chr5	60567929	60567957	3500344570	23		60567929	60567957	8421504	2	13,10	0,18	c	350034457000000194	22-45						Antibodies Directed to HER-3 and Uses Thereof - Patent application	www.faqs.org	0	0		
1047	chr5	60621369	60621438	3500197883	69		60621369	60621438	8421504	1	69	0	p	350019788300015045	180-249						Vol. Multiple actin-based motor genes Dictyostelium	w.molbiolcell.org	0	0		
1047	chr5	60621817	60623293	3500112034	222		60621817	60623293	8421504	6	30,90,39,9,48,6	0,491,602,749,770,1470	p	350011203400015052,350011203400015059,350011203400015060	0-120,3-51,6-60						Porcine Myosin-VI: Characterization of a New Mammalian Unconventional Myosin	jcb.rupress.org	0	0		
1047	chr5	60622344	60622413	3500389626	69		60622344	60622413	8421504	1	69	0	p	350038962600015020	81-150						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		MYO1A
1047	chr5	60622344	60622413	3500061337	69		60622344	60622413	8421504	1	69	0	p	350006133700015031,350006133700015161	18-87,0-48						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		
1047	chr5	60637252	60640889	3500446982	40		60637252	60640889	8421504	2	20,20	0,3617	c,g	350044698200000000,350044698200000001,350044698200000001	0-20,0-20,0-20		20181609	10.1523/JNEUROSCI.5848-09.2010	0270-6474	The Journal of Neuroscience	Neurokinin B and Dynorphin A in Kisspeptin Neurons of the Arcuate Nucleus Participate in Generation of Periodic Oscillation of Neural Activity Driving Pulsatile Gonadotropin-Releasing Hormone Secretion in the Goat	Wakabayashi	2010	7		
1047	chr5	60639594	60640426	3500116601	150		60639594	60640426	8421504	3	73,30,47	0,264,785	p	350011660100015003	0-150						Pesquisa de muta&#xe7;&#xf5;es na neurocinina B e no seu receptor em pacientes com dist&#xfa;rbios puberais centrais idiop&#xe1;ticos	www.teses.usp.br	0	0		
1047	chr5	60666752	60666776	3500069709	24		60666752	60666776	8421504	1	24	0	c	350006970900000011	0-24						Adrenomedullin peptides	www.devileye.net	0	0		
1050	chr5	61022917	61022948	3500383953	31		61022917	61022948	8421504	1	31	0	c	350038395300000008	0-31						NACA is a positive regulator of human erythroid-cell differentiation	cs.biologists.org	0	0		NACA
1050	chr5	61022917	61022948	3500220861	31		61022917	61022948	8421504	1	31	0	c	350022086100000008	0-31			10.1242/jcs.02295	0021-9533	Journal of Cell Science	NACA is a positive regulator of human erythroid-cell differentiation	Lopez	2005	6		TRIM61,NACA
1050	chr5	61024153	61024751	3500099845	38		61024153	61024751	8421504	2	19,19	0,579	c	350009984500000019,350009984500000020	0-19,0-19						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
1050	chr5	61057108	61057132	3500437756	24		61057108	61057132	8421504	1	24	0	c	350043775600000010	0-24			10.1046/j.1432-1033.2002.03025.x	1432-1033	European Journal of Biochemistry	Differential regulation of telomerase activity by six telomerase subunits - Chang - 2002 - European Journal of Biochemistry - Wiley Online Library	Chang	2002	0		PTGES3
1050	chr5	61059609	61059633	3500128392	24		61059609	61059633	8421504	1	24	0	c	350012839200000002	0-24		22214188	10.1186/1742-2094-9-2	1742-2094	Journal of Neuroinflammation	Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia	Oliveira	2012	4		PTGES3
1050	chr5	61059628	61061042	3500093812	29		61059628	61061042	8421504	2	7,22	0,1392	c	350009381200000003	0-29		10207098		0270-7306	Molecular and Cellular Biology	Role for Hsp90-Associated Cochaperone p23 in Estrogen Receptor Signal Transduction	Knoblauch	1999	6		PTGES3
1050	chr5	61071543	61075965	3500444783	657		61071543	61075965	8421504	14	58,5,60,2,58,40,5,57,48,3,81,57,138,45	0,300,323,473,991,1073,1358,1411,2330,2414,3032,3140,3661,4377	p	350044478300015019,350044478300015020,350044478300015024,350044478300015025,350044478300015026,350044478300015032,350044478300015034,350044478300015036,350044478300015041,350044478300015044,350044478300015045	0-63,87-147,0-60,0-45,57-114,48-96,0-84,0-57,0-84,0-54,45-90						Chaignepain Thesis ETUDE FONCTIONNELLE ET STRUCTURALE DE LA SOUS-UNITE 4 DE L' ATP SYNTHASE MITOCHONDRIALE DE LA LEVURE SACCHAROMYCES CEREVISIAE MISE EN EVIDENCE IN VITRO DE L'INTERACTION ENTRE LE DOMAINE C-TERMINAL DE LA SOUS-UNITE 4 ET L'OSCP ETUDE DE L	www.academia.edu	0	0		
1050	chr5	61071573	61071860	3500426913	45		61071573	61071860	8421504	2	28,17	0,270	p	350042691300015037	0-45						Mass Spectrometry Handbook	www.scribd.com	0	0		SNORD59A
1050	chr5	61071573	61071860	3500253203	45		61071573	61071860	8421504	2	28,17	0,270	p	350025320300015027	0-45						MorphofunctionalandBiochemicalApproachesforStudying MitochondrialChangesduringMyoblastsDifferentiation	loads.hindawi.com	0	0		SNORD59A
1050	chr5	61072930	61075986	3500352189	309		61072930	61075986	8421504	8	39,33,27,18,57,57,10,68	0,709,790,907,1729,2334,2430,2988	p	350035218900015163	0-309						Apis mellifera	lib.ugent.be	0	0		ATP5B
1050	chr5	61073083	61073633	3500418460	48		61073083	61073633	8421504	2	3,45	0,505	p	350041846000015022	3-51		18298673	10.1111/j.1365-313X.2008.03450.x	1365-313X	The Plant Journal	Silencing RNA-directed RNA polymerase 2 increases the susceptibility of Nicotiana attenuata to UV in the field and in the glasshouse - Pandey - 2008 - The Plant Journal - Wiley Online Library	Pandey	2008	0		ATP5B
1050	chr5	61074665	61074713	3500425835	48		61074665	61074713	8421504	1	48	0	p	350042583500015001	0-48		21987637	10.1083/jcb.201108059		The Journal of Cell Biology	Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential	Ying-bei	2011	0		ATP5B
1050	chr5	61074665	61074713	3500076751	48		61074665	61074713	8421504	1	48	0	p	350007675100015001	0-48						Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential	jcb.rupress.org	0	0		ATP5B
1050	chr5	61074665	61074713	3500020067	48		61074665	61074713	8421504	1	48	0	p	350002006700015002	0-48		21987637	10.1083/jcb.201108059	0021-9525	The Journal of Cell Biology	Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential	Chen	2011	10		ATP5B
1050	chr5	61075994	61076017	3500096614	23		61075994	61076017	8421504	1	23	0	c	350009661400000005	11-34			10.1128/MCB.02045-06		Molecular and Cellular Biology	Ca2+-Dependent Interaction of S100A1 with F1-ATPase Leads to an Increased ATP Content in Cardiomyocytes 	Melanie	June	0		
1051	chr5	61119689	61119714	3500446588	23		61119689	61119714	8421504	2	17,6	0,19	g	350044658800000000	7-30		19706688	10.1242/jcs.045427	0021-9533	Journal of Cell Science	A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer	Smith	2009	6		
1051	chr5	61126161	61132178	3500006584	42		61126161	61132178	8421504	3	11,11,20	0,5918,5997	c	350000658400000003,350000658400000002	0-22,0-20						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
1051	chr5	61205133	61205159	3500189823	24		61205133	61205159	8421504	3	4,6,14	0,5,12	c	350018982300000076,350018982300000086	4-27,4-28						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
1052	chr5	61214475	61214498	3500084296	23		61214475	61214498	8421504	1	23	0	c,g	350008429600000000,350008429600000000	6-29,6-29						 <HTML><HEAD><TITLE>de Peyer, Mol Vis 1999; 5:23.</TITLE></HEAD> <BODY BGCOLOR="#FFFFFF"	www.molvis.org	0	0		MIP
1052	chr5	61214477	61214582	3500430568	105		61214477	61214582	8421504	1	105	0	p	350043056800015001	0-105						Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)	Agre	1995	0		
1052	chr5	61214477	61214582	3500134080	105		61214477	61214582	8421504	1	105	0	p	350013408000015001	0-105						Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)	Agre	1995	0		
1052	chr5	61214540	61217592	3500380550	282		61214540	61217592	8421504	6	57,57,42,15,57,54	0,823,883,1327,1345,2998	p	350038055000015002,350038055000015008,350038055000015009,350038055000015010,350038055000015012	0-57,0-57,0-57,0-57,0-54						Han, Mol Vis 2004; 10:215-222. Figure 1.	www.molvis.org	0	0		
1052	chr5	61237986	61238013	3500260091	23		61237986	61238013	8421504	2	14,9	0,18	c	350026009100000010	22-46					Patent	Tapetum-specific promoters from Brassicaceae spp (Patent US:5723754)	Draper	1998	0		
1052	chr5	61279221	61288010	3500404279	124		61279221	61288010	8421504	5	26,18,29,23,28	0,5617,5781,5984,8761	c	350040427900000031,350040427900000048,350040427900000050,350040427900000065	0-26,0-47,24-47,3-31						US Patent # 5,716,622. Functionally active regions of signal transducer and activators of transcription - Patents.com	www.patents.com	0	0		
1052	chr5	61279760	61288003	3500004083	69		61279760	61288003	8421504	3	6,42,21	0,169,8222	c	350000408300000115,350000408300000146	0-48,27-48						Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins	Hancock	2001	0		
1052	chr5	61283945	61288010	3500328322	86		61283945	61288010	8421504	5	6,16,28,8,28	0,224,2433,2463,4037	c	350032832200000043,350032832200000057,350032832200000065	26-48,0-38,3-31						Functionally active regions of signal transducer and activator of transcription	Darnell	1997	0		
1052	chr5	61283945	61286416	3500295082	81		61283945	61286416	8421504	5	6,16,23,28,8	0,224,1260,2433,2463	c	350029508200000043,350029508200000050,350029508200000057	26-48,24-47,0-38					Patent	Functionally active regions of signal transducer and activator of transcription (Patent US:5883228)	James	1999	0		
1052	chr5	61286729	61288070	3500319127	40		61286729	61288070	8421504	2	20,20	0,1321	c	350031912700000012,350031912700000013	0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
1052	chr5	61289694	61289825	3500449915	43		61289694	61289825	8421504	2	21,22	0,109	c,g	350044991500000019,350044991500000019,350044991500000018	0-21,0-21,0-22						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
1052	chr5	61289761	61289821	3500377195	60		61289761	61289821	8421504	1	60	0	p	350037719500015034	0-60						Peptides and therapeutic application therefof	ZAGURY	2011	0		IL23A
1052	chr5	61289771	61289811	3500093559	40		61289771	61289811	8421504	1	40	0	c	350009355900000010	7-47						Mammalian cytokines, related reagents and methods	B*Ao Pu Man 	2002	0		
1052	chr5	61290010	61290086	3500457411	40		61290010	61290086	8421504	2	20,20	0,56	c,g	350045741100000007,350045741100000007,350045741100000006,350045741100000006	0-20,0-20,0-20,0-20		19515866	10.1128/CVI.00424-08	1556-6811	Clinical and Vaccine Immunology	T-Cell mRNA Expression in Response to Mycobacterium bovis BCG Vaccination and Mycobacterium bovis Infection of White-Tailed Deer	Thacker	2009	3		
1052	chr5	61290099	61290855	3500261631	44		61290099	61290855	8421504	2	23,21	0,735	c,g	350026163100000011,350026163100000010,350026163100000010	0-23,0-21,0-21						Innate immune markers that distinguish red deer (Cervus elaphus) selected for resistant or susceptible genotypes for Johne&#xfffd;s disease	inaryresearch.org	0	0		
1052	chr5	61311904	61311933	3500204244	25		61311904	61311933	8421504	3	13,6,6	0,14,23	g	350020424400000063	23-48						US Patent # 5,643,783. Collagen and uses therefor - Patents.com	www.patents.com	0	0		
1052	chr5	61312165	61313003	3500235760	48		61312165	61313003	8421504	2	33,15	0,823	p	350023576000015007	0-48						Proteins	Boyd	2006	0		CNPY2
1052	chr5	61327480	61327507	3500237963	24		61327480	61327507	8421504	2	18,6	0,21	g	350023796300000095	12-39						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
1052	chr5	61334596	61334966	3500337968	54		61334596	61334966	8421504	2	39,15	0,355	p	350033796800015064,350033796800015062	0-54,0-48						THE DISCOVERY AND FUNCTIONAL STUDIES OF TWO DIPHTHAMIDE BIOSYNTHETIC GENES	mmons.cornell.edu	0	0		CS
1052	chr5	61334596	61334966	3500249757	54		61334596	61334966	8421504	2	39,15	0,355	p	350024975700015047	0-54						Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase	ww.sciencemag.org	0	0		CS
1052	chr5	61334596	61334966	3500021643	54		61334596	61334966	8421504	2	39,15	0,355	p	350002164300015062,350002164300015064	0-48,0-54						THE DISCOVERY AND FUNCTIONAL STUDIES OF TWO DIPHTHAMIDE BIOSYNTHETIC GENES	brary.cornell.edu	0	0		CS
1052	chr5	61334596	61334960	3500144118	48		61334596	61334960	8421504	2	39,9	0,355	p	350014411800015005	0-48						Modulators for sirt5 and assays for screening same	Lin	2012	0		CS
1053	chr5	61358041	61359313	3500308662	49		61358041	61359313	8421504	2	25,24	0,1248	g	350030866200000021,350030866200000022	0-25,0-24						DNA	.lib.kobe-u.ac.jp	0	0		
1053	chr5	61421165	61434752	3500332803	42		61421165	61434752	8421504	2	21,21	0,13566	c,g	350033280300000075,350033280300000075,350033280300000076	0-21,0-21,0-21						COMPOSITIONS AND METHODS FOR TARGETING CANCER-SPECIFIC TRANSCRIPTION COMPLEXES	Liik	2007	0		SMARCC2
1053	chr5	61421165	61434752	3500227870	42		61421165	61434752	8421504	2	21,21	0,13566	c	350022787000000077,350022787000000078	0-21,0-21						Compositions and methods for targeting cancer-specific transcription complexes	Kazantrseva	2009	0		SMARCC2
1053	chr5	61421165	61434752	3500164461	42		61421165	61434752	8421504	2	21,21	0,13566	c	350016446100000077,350016446100000078	0-21,0-21						Compositions and methods for targeting cancer-specific transcription complexes	Kazantrseva	2008	0		SMARCC2
1053	chr5	61421165	61434752	3500143261	42		61421165	61434752	8421504	2	21,21	0,13566	c	350014326100000075,350014326100000076	0-21,0-21						Compositions and methods for targeting cancer-specific transcription complexes	Kazantseva	2008	0		SMARCC2
1053	chr5	61425710	61426803	3500013078	40		61425710	61426803	8421504	2	20,20	0,1073	c,g	350001307800000014,350001307800000014,350001307800000015,350001307800000015	0-20,0-20,0-20,0-20			10.1002/ijc.11676	1097-0215	International Journal of Cancer	Expression profile of genes associated with antimetastatic gene: nm23-Mediated metastasis inhibition in breast carcinoma cells - Zhao - 2003 - International Journal of Cancer - Wiley Online Library	Zhao	2004	0		SMARCC2
1053	chr5	61435316	61435339	3500320950	23		61435316	61435339	8421504	1	23	0	c	350032095000000002	0-23						Diversity. and specialization of mammalian SWI/SNF complexes	enesdev.cshlp.org	0	0		
1053	chr5	61443132	61443739	3500320902	318		61443132	61443739	8421504	3	74,174,70	0,165,537	p	350032090200015123,350032090200015122	0-153,0-165						Method for manufacturing a modified peptide	Bauer	2009	0		MYL6
1053	chr5	61446878	61447118	3500423725	23		61446878	61447118	8421504	3	6,9,8	0,9,232	c	350042372500000181,350042372500000327	11-34,0-22					Patent	Human chromosome 16 genes, compositions, methods of making and using same (Patent US:6030806)	Burn	2000	0		
1053	chr5	61446878	61447118	3500184607	23		61446878	61447118	8421504	3	6,9,8	0,9,232	c	350018460700000173	11-34						US Patent # 6,028,173. Human chromosome 16 genes, compositions, methods of making and using same - Patents.com	www.patents.com	0	0		MYL6B
1053	chr5	61462156	61462181	3500162229	23		61462156	61462181	8421504	3	13,4,6	0,14,19	c	350016222900000022	21-44						DESIGN FOR RAPIDLY CLONING ONE OR MORE POLYPEPTIDE CHAINS INTO AN EXPRESSION SYSTEM - Patent application	www.faqs.org	0	0		
1054	chr5	61489712	61489739	3500375740	23		61489712	61489739	8421504	2	10,13	0,14	c	350037574000000004	9-32						NormalFurDevelopmentandSebumProductionDepends onFattyAcid2-HydroxylaseExpressioninSebaceousGlands	www.jbc.org	0	0		
1054	chr5	61491829	61492343	3500217383	48		61491829	61492343	8421504	2	24,24	0,490	c	350021738300000007,350021738300000006	0-24,0-24		18802034	10.1634/stemcells.2008-0397	1549-4918	STEM CELLS	Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell-Containing Side Population - Steiniger - 2008 - STEM CELLS - Wiley Online Library	Steiniger	2008	0		LEKR1
1054	chr5	61497094	61516585	3500065454	509		61497094	61516585	8421504	16	67,44,42,41,1,42,45,13,35,39,17,12,45,21,14,31	0,469,1934,1982,2346,2668,3712,6193,6604,6693,6742,6982,10935,15984,16027,19460	c	350006545400000098,350006545400000097,350006545400000088,350006545400000075,350006545400000074,350006545400000070,350006545400000061,350006545400000053,350006545400000051,350006545400000050,350006545400000036,350006545400000003,350006545400000016	0-40,21-48,4-48,0-42,0-42,0-42,0-45,0-48,0-39,6-35,0-45,21-42,0-45						Methods and materials for characterizing and modulating interaction between heregulin and HER3 - US Patent 7314916 Description	ww.patentstorm.us	0	0		
1054	chr5	61497111	61516588	3500025494	669		61497111	61516588	8421504	21	38,44,19,13,21,48,13,35,40,42,33,20,16,31,48,48,7,16,41,62,34	0,441,808,828,1985,2651,6176,6587,6630,6676,6989,8397,8431,8622,10870,11106,13436,13446,15252,15962,19443	c	350002549400000215,350002549400000205,350002549400000201,350002549400000056,350002549400000186,350002549400000169,350002549400000168,350002549400000167,350002549400000165,350002549400000041,350002549400000155,350002549400000153,350002549400000150,350002549400000036,350002549400000137,350002549400000133,350002549400000132	0-38,0-44,0-39,0-21,0-48,0-48,0-40,0-42,15-48,20-40,0-47,0-48,0-48,3-30,7-48,0-48,0-48						ERBB3 Mutations In Cancer - Patent application	www.faqs.org	0	0		
1054	chr5	61497125	61497151	3500452946	26		61497125	61497151	8421504	1	26	0	c	350045294600000005	0-26						Trophinin-binding peptides and uses thereof	Fukuda	2008	0		ERBB3
1054	chr5	61497393	61516596	3500344570	413		61497393	61516596	8421504	15	38,20,21,48,38,39,34,4,19,22,37,1,48,2,42	0,1516,1626,2066,3095,6400,7076,7435,10891,12845,14146,14885,14934,15740,19161	c	350034457000000198,350034457000000181,350034457000000178,350034457000000169,350034457000000156,350034457000000151,350034457000000138,350034457000000129,350034457000000127,350034457000000121	0-38,0-41,0-48,0-38,9-48,0-38,0-41,0-38,0-48,4-48						Antibodies Directed to HER-3 and Uses Thereof - Patent application	www.faqs.org	0	0		
1054	chr5	61497393	61516596	3500259404	349		61497393	61516596	8421504	10	38,44,20,21,39,47,48,48,2,42	0,170,1516,1626,6400,10601,13119,14934,15740,19161	c	350025940400000198,350025940400000194,350025940400000181,350025940400000156,350025940400000142,350025940400000134,350025940400000127,350025940400000121	0-38,1-45,0-41,9-48,0-47,0-48,0-48,4-48						Material and methods for treating or preventing HER-3 associated diseases - Patent application	www.faqs.org	0	0		
1054	chr5	61497564	61497588	3500402403	24		61497564	61497588	8421504	1	24	0	c	350040240300000050	0-24						Gene Expression Markers for Response to EGFR Inhibitor Drugs	Agus	2008	0		
1054	chr5	61497823	61498022	3500276249	48		61497823	61498022	8421504	2	26,22	0,177	c,g	350027624900000007,350027624900000006,350027624900000006	0-26,0-22,0-22						0509_S1_article_02	www.jpp.krakow.pl	0	0		
1054	chr5	61499765	61500092	3500366238	75		61499765	61500092	8421504	3	42,24,9	0,45,318	p	350036623800015003	0-75						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		ERBB3
1054	chr5	61508068	61508235	3500154330	75		61508068	61508235	8421504	2	29,46	0,121	p	350015433000015006	0-75						a complete set of instruments & reagents for microgenomics	7.discountasp.net	0	0		ERBB3
1054	chr5	61511469	61512329	3500280551	48		61511469	61512329	8421504	2	24,24	0,836	c	350028055100000007,350028055100000008	0-24,0-24		12824187	10.1074/jbc.M302474200	0021-9258	Journal of Biological Chemistry	Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor Receptor	Buchanan	2003	5		ERBB3
1054	chr5	61511469	61512329	3500109042	48		61511469	61512329	8421504	2	24,24	0,836	c	350010904200000007,350010904200000008	0-24,0-24						Cell lines and animal models of HER2 expressing tumors	Crocker	2007	0		ERBB3
1054	chr5	61511469	61512329	3500103197	48		61511469	61512329	8421504	2	24,24	0,836	c	350010319700000007,350010319700000008	0-24,0-24						Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth 10.1016/S1535-6108(02)00097-1 : Cancer Cell | ScienceDirect.com	sciencedirect.com	0	0		ERBB3
1054	chr5	61560746	61560769	3500172748	23		61560746	61560769	8421504	1	23	0	c	350017274800000005	8-31						Studies on the antimicrobial defence of human hair follicle epithelium	diss.fu-berlin.de	0	0		
1054	chr5	61560747	61562600	3500050115	43		61560747	61562600	8421504	2	23,20	0,1833	c	350005011500000013,350005011500000012	0-23,0-20					American Journal of Human Genetics	Mutation of a Nuclear Respiratory Factor 2 Binding Site in the 5&#x2032; Untranslated Region of the ADSL Gene in Three Patients with Adenylosuccinate Lyase Deficiency	S.	July	0		
1054	chr5	61560747	61560770	3500274974	23		61560747	61560770	8421504	1	23	0	c	350027497400000012	0-23						Treatment of diabetes with synthetic beta cells	Alam	2005	0		RPS26,IMPA1
1054	chr5	61560783	61562580	3500240828	40		61560783	61562580	8421504	3	5,15,20	0,755,1777	c	350024082800000005,350024082800000004	0-20,0-20		14704364	10.1189/jlb.0503246	0741-5400	Journal of Leukocyte Biology	Down-regulation of Hox A7 is required for cell adhesion and migration on fibronectin during early HL-60 monocytic differentiation	Leroy	2004	5		RPS26
1054	chr5	61560783	61562580	3500213756	40		61560783	61562580	8421504	3	5,15,20	0,755,1777	c	350021375600000005,350021375600000004	0-20,0-20						Down-regulation of Hox A7 is required for cell adhesion and migration on &#xfb01;bronectin during early HL-60 monocytic differentiation	www.jleukbio.org	0	0		RPS26
1054	chr5	61561590	61561661	3500049463	48		61561590	61561661	8421504	3	7,16,25	0,8,46	c	350004946300000007,350004946300000006	0-23,0-25			10.1590/S0102-09352010000200003	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Apoptosis and expression of Bcl-2 and caspases 3 and 8 in placenta of cows at different pregnancy stages	Meca	2010	0		
1054	chr5	61561631	61562536	3500164379	129		61561631	61562536	8421504	2	38,91	0,814	p	350016437900015010	129-258						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		
1054	chr5	61572570	61582843	3500454059	1755		61572570	61582843	8421504	8	758,132,150,168,261,105,94,87	0,1439,2021,4590,5727,6972,8361,10186	p	350045405900015022,350045405900015021,350045405900015020,350045405900015019,350045405900015018,350045405900015017,350045405900015016,350045405900015015,350045405900015014,350045405900015013	0-135,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180						METHODS FOR DETECTING AND REGULATING ALOPECIA AREATA AND GENE COHORTS THEREOF	Christiano	2012	0		IKZF4
1054	chr5	61572570	61582843	3500121852	1755		61572570	61582843	8421504	8	758,132,150,168,261,105,94,87	0,1439,2021,4590,5727,6972,8361,10186	p	350012185200015021,350012185200015020,350012185200015019,350012185200015018,350012185200015017,350012185200015016,350012185200015015,350012185200015014,350012185200015013,350012185200015012	0-135,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180						METHODS FOR DETECTING AND REGULATING ALOPECIA AREATA AND GENE COHORTS THEREOF - Patent application	www.faqs.org	0	0		
1054	chr5	61574739	61577203	3500300890	45		61574739	61577203	8421504	2	2,43	0,2421	p	350030089000015013	0-45						COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE - Patent application	www.faqs.org	0	0		IKZF1
1055	chr5	61604294	61604329	3500183386	35		61604294	61604329	8421504	1	35	0	c	350018338600000005	0-35		9852039	10.1074/jbc.273.51.33901	0021-9258	Journal of Biological Chemistry	Interferon-&#x03b3; Selectively Induces Rab5a Synthesis and Processing in Mononuclear Cells	Alvarez-Dominguez	1998	5		
1055	chr5	61620091	61624300	3500362916	894		61620091	61624300	8421504	7	102,204,102,171,121,78,116	0,356,1673,2224,3044,3282,4093	p	350036291600015000	0-894						KEGG T01001: 1017	www.genome.jp	0	0		
1055	chr5	61620127	61624300	3500034953	483		61620127	61624300	8421504	8	66,24,90,90,60,31,17,105	0,320,425,2269,3035,3098,3246,4068	p	350003495300015091,350003495300015075,350003495300015062,350003495300015048,350003495300015047,350003495300015035	0-90,0-90,0-90,0-60,0-48,0-105						Proc. Nati. Acad. Sci. USA	www.pnas.org	0	0		CDK2
1055	chr5	61620447	61621009	3500067285	40		61620447	61621009	8421504	2	20,20	0,542	c,g	350006728500000030,350006728500000030,350006728500000031	0-20,0-20,0-20						Dissertation zur Erlangung des Doktorgrades der Fakult&#xe4;t f&#xfc;r Chemie und Pharmazie der Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen	b.uni-muenchen.de	0	0		
1055	chr5	61622443	61623380	3500300373	40		61622443	61623380	8421504	3	20,13,7	0,800,930	c	350030037300000017,350030037300000016	0-20,0-20			10.1128/MCB.01020-07		Molecular and Cellular Biology	Brd4 Recruits P-TEFb to Chromosomes at Late Mitosis To Promote G1 Gene Expression and Cell Cycle Progression 	Zhiyuan	2008	0		CDK2
1055	chr5	61623162	61623393	3500378011	114		61623162	61623393	8421504	2	94,20	0,211	p	350037801100015004	0-114						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	mcb.berkeley.edu	0	0		CDK2
1055	chr5	61623162	61623393	3500145445	114		61623162	61623393	8421504	2	94,20	0,211	p	350014544500015004	0-114						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	physio.ucsf.edu	0	0		CDK2
1055	chr5	61623180	61623393	3500244206	96		61623180	61623393	8421504	2	76,20	0,193	p	350024420600015029,350024420600015002,350024420600015013	0-48,0-81,0-48						High affinity protein kinase inhibitors - US Patent 6383790 Description	ww.patentstorm.us	0	0		CDK2
1055	chr5	61623180	61623393	3500109878	96		61623180	61623393	8421504	2	76,20	0,193	p	350010987800015030,350010987800015003,350010987800015014	0-48,0-81,0-48						US Patent # 6,383,790. High affinity protein kinase inhibitors - Patents.com	www.patents.com	0	0		CDK2
1055	chr5	61623195	61623393	3500300287	81		61623195	61623393	8421504	2	61,20	0,178	p	350030028700015001	0-81						Engineered Protein Kinases Which Can Utilize Modified Nucleotide Triphosphate Substrates - Patent application	www.faqs.org	0	0		CDK2
1055	chr5	61623195	61623393	3500222363	81		61623195	61623393	8421504	2	61,20	0,178	p	350022236300015001,350022236300015009	0-81,0-48						US Patent # 6,521,417. Engineered protein kinases which can utilize modified nucleotide triphosphate substrates - Patents.com	www.patents.com	0	0		CDK2
1055	chr5	61623195	61623393	3500063398	81		61623195	61623393	8421504	2	61,20	0,178	p	350006339800015001	0-81						US Patent # 7,049,116. Engineered protein kinases which can utilize modified nucleotide triphosphate substrates - Patents.com	www.patents.com	0	0		CDK2
1055	chr5	61623195	61623393	3500008336	81		61623195	61623393	8421504	2	61,20	0,178	p	350000833600015001,350000833600015008	0-81,0-45						Engineered protein kinases which can utilize modified nucleotide triphosphate substrates	Shokat	2000	0		CDK2
1055	chr5	61623213	61623375	3500335713	45		61623213	61623375	8421504	2	43,2	0,160	p	350033571300015003	0-45					Patent	High affinity protein kinase inhibitors (Patent US:6383790)	Shokat	2002	0		CDK2
1055	chr5	61623396	61623444	3500303053	48		61623396	61623444	8421504	1	48	0	p	350030305300015000	0-48			10.1046/j.1365-313X.2003.01812.x	1365-313X	The Plant Journal	Target genes for OBP3, a Dof transcription factor, include novel basic helix-loop-helix domain proteins inducible by salicylic acid - Kang - 2003 - The Plant Journal - Wiley Online Library	Kang	2003	0		CDK3
1055	chr5	61624240	61624285	3500415791	45		61624240	61624285	8421504	1	45	0	p	350041579100015004	0-45						PNA-Peptid-PNA Chim&#xe4;ren	www.roeglin.de	0	0		CDK3
1055	chr5	61624240	61624285	3500415505	45		61624240	61624285	8421504	1	45	0	p	350041550500015000	0-45		11872746		0021-9258	Journal of Biological Chemistry	Tyrosine Kinase c-Src Constitutes a Bridge between Cystic Fibrosis Transmembrane Regulator Channel Failure and MUC1 Overexpression in Cystic Fibrosis	Gonzalez-Guerrico	2002	5		CDK3
1055	chr5	61624240	61624285	3500315394	45		61624240	61624285	8421504	1	45	0	p	350031539400015004	0-45						Bicyclic pyrazolo protein kinase modulators	Bounaud	2005	0		CDK3
1055	chr5	61624240	61624285	3500173620	45		61624240	61624285	8421504	1	45	0	p	350017362000015000	0-45		18454171	10.1038/bjp.2008.136	1476-5381	British Journal of Pharmacology	Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264.7 cells - Lee - 2009 - British Journal of Pharmacology - Wiley Online Library	Lee	2008	0		CDK3
1055	chr5	61624240	61624285	3500049247	45		61624240	61624285	8421504	1	45	0	p	350004924700015000	0-45		19029294	10.1074/jbc.M807971200		The Journal of Biological Chemistry	Src Phosphorylation of &#x03bc;-Receptor Is Responsible for the Receptor Switching from an Inhibitory to a Stimulatory Signal	Lei	2009	0		CDK3
1055	chr5	61624240	61624285	3500043210	45		61624240	61624285	8421504	1	45	0	p	350004321000015004	0-45					Patent	Bicyclic pyrazolo protein kinase modulators (Patent US:7473783)	Bounaud	2009	0		CDK3
1055	chr5	61624284	61624309	3500425641	25		61624284	61624309	8421504	1	25	0	c	350042564100000002	0-25						Oligonucleotide Compositions with Enhanced Efficiency	Woolf	2010	0		
1055	chr5	61624284	61624309	3500337237	25		61624284	61624309	8421504	1	25	0	c	350033723700000001	0-25						Biomarkers of cyclin-dependent kinase modulation	Jackson	2005	0		
1055	chr5	61624284	61624309	3500157819	25		61624284	61624309	8421504	1	25	0	c	350015781900000002	0-25						Oligonucleotide Compositions with Enhanced Efficiency	Woolf	2009	0		
1055	chr5	61624284	61624309	3500105997	25		61624284	61624309	8421504	1	25	0	c	350010599700000001	0-25						Biomarkers of cyclin-dependent kinase modulation	Li	2006	0		
1055	chr5	61625906	61625935	3500206716	29		61625906	61625935	8421504	1	29	0	g	350020671600000012	0-29					The American Journal of Pathology	MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma	Jinyan	July	0		
1055	chr5	61629735	61630048	3500446845	57		61629735	61630048	8421504	2	22,35	0,278	p	350044684500015021	0-57						Mise au point d&#x2019;outils de recherche et &#xe9;tude de modifications	esups.ups-tlse.fr	0	0		PMEL
1055	chr5	61630075	61630105	3500245928	30		61630075	61630105	8421504	1	30	0	c	350024592800000008	0-30		11929831		0008-5472	Cancer Research	The Melanocyte-specific Isoform of the Microphthalmia Transcription Factor Affects the Phenotype of Human Melanoma	Selzer	2002	8		
1055	chr5	61630618	61630646	3500464861	25		61630618	61630646	8421504	3	6,15,4	0,8,24	c	350046486100000044,350046486100000043,350046486100000041,350046486100000032,350046486100000033,350046486100000030,350046486100000031,350046486100000029	3-28,3-28,3-28,3-24,3-24,3-24,3-24,3-24						BST2 INHIBITOR - ISU ABXIS CO., LTD	www.sumobrain.com	0	0		
1055	chr5	61630618	61630646	3500092269	25		61630618	61630646	8421504	3	6,15,4	0,8,24	c	350009226900000061,350009226900000060,350009226900000059,350009226900000058,350009226900000066,350009226900000067,350009226900000068,350009226900000069,350009226900000057,350009226900000056,350009226900000055,350009226900000054	3-24,3-24,3-24,3-24,3-28,3-28,3-28,3-28,3-24,3-24,3-24,3-24						Effect of Bst2 on inflammation - Patent application	www.faqs.org	0	0		
1055	chr5	61630618	61630646	3500022604	25		61630618	61630646	8421504	3	6,15,4	0,8,24	g	350002260400000063,350002260400000075,350002260400000077,350002260400000078	3-24,3-28,3-28,3-28					Patent	Treatment of inflammation using BST2 inhibitor (Patent US:8329186)	Kim	2012	0		
1055	chr5	61632000	61633318	3500441009	270		61632000	61633318	8421504	8	44,1,45,45,45,10,35,45	0,153,157,253,301,349,466,1273	p	350044100900015088,350044100900015089,350044100900015091,350044100900015092,350044100900015093,350044100900015097	0-45,0-45,0-45,0-45,0-45,0-45						Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma	Adema	1995	0		
1055	chr5	61647334	61648269	3500378421	72		61647334	61648269	8421504	3	36,3,33	0,324,902	p	350037842100015236	0-72						University of Southampton Research Repository ePrints Soton	rints.soton.ac.uk	0	0		DGKA
1055	chr5	61708774	61711851	3500013443	110		61708774	61711851	8421504	5	26,20,22,21,21	0,94,2844,3032,3056	c,g	350001344300000002,350001344300000015,350001344300000025,350001344300000027,350001344300000026	0-26,0-20,0-22,1-22,0-21						Molecular Characterization of Porcine MMP19 and MMP23B Genes and Its Association with Immune Traits	www.ijbs.com	0	0		MMP19
1055	chr5	61711824	61711872	3500455448	48		61711824	61711872	8421504	1	48	0	c	350045544800000041	0-48						 Matrix Metalloprotease 	www.docstoc.com	0	0		
1055	chr5	61727613	61727658	3500130393	45		61727613	61727658	8421504	1	45	0	p	350013039300015001	0-45		20182505	10.1038/nature08787		Nature	Orm family proteins mediate sphingolipid homeostasis	David	2010	0		ORMDL2
1056	chr5	61786024	61792622	3500241968	602		61786024	61792622	8421504	4	61,48,445,48	0,103,295,6550	g	350024196800000015,350024196800000001,350024196800000013,350024196800000009,350024196800000008,350024196800000007,350024196800000030	0-55,9-30,0-48,0-48,0-48,0-350,0-48						Bmp-11 compositions	Celeste	1994	0		
1056	chr5	61786024	61786764	3500343091	404		61786024	61786764	8421504	2	55,349	0,391	g	350034309100000012,350034309100000004	0-55,0-350						Bone morphogenetic protein -11 (BMP-11) compositions	Wozney	1995	0		
1056	chr5	61786024	61786764	3500051486	404		61786024	61786764	8421504	2	55,349	0,391	g	350005148600000011,350005148600000003	0-55,0-350					Patent	DNA molecules encoding bone morpogenetic protein-11 (Patent US:5639638)	Celeste	1997	0		
1056	chr5	61787149	61787193	3500346883	44		61787149	61787193	8421504	1	44	0	g	350034688300000017	0-44						Growth differentiation factor-11 transgenic mice	www.devileye.net	0	0		
1056	chr5	61792659	61792682	3500410253	23		61792659	61792682	8421504	1	23	0	g	350041025300000007	0-23						Somatic acquisition and signaling of TGFBR1*6A in cancer. - ResearchGate	.researchgate.net	0	0		GDF11
1056	chr5	61814046	61814247	3500176157	40		61814046	61814247	8421504	2	21,19	0,182	c,g	350017615700000034,350017615700000003,350017615700000033,350017615700000033	3-24,3-24,0-19,0-19						Assessing lipid metabolism	Barendse	1999	0		
1056	chr5	61814335	61814662	3500080915	63		61814335	61814662	8421504	2	35,28	0,299	p	350008091500015010	0-63						Potent inhibitors of human 9-cis retinol dehydrogenase	Blaner	2000	0		
1056	chr5	61816938	61817037	3500355801	99		61816938	61817037	8421504	1	99	0	p	350035580100015023	6-105						Cysteine-10 on 17&#x03b2;-hydroxysteroid dehydrogenase 1 has stabilizing interactions in the cofactor binding region and renders sensitivity to sulfhydryl modifying chemicals	loads.hindawi.com	0	0		RDH5
1056	chr5	61828514	61828542	3500307135	28		61828514	61828542	8421504	1	28	0	g	350030713500000092	7-36						NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1056	chr5	61847168	61847192	3500089923	24		61847168	61847192	8421504	1	24	0	c	350008992300000072,350008992300000155	0-24,0-24						INTEGRIN ALPHA 7 MUTATIONS IN PROSTATE CANCER, LIVER CANCER, GLIOBLASTOMA MULTIFORME, AND LEIOMYOSARCOMA - Patent application	www.faqs.org	0	0		
1062	chr5	62578390	62578419	3500013245	23		62578390	62578419	8421504	3	11,6,6	0,13,23	g	350001324500000021	7-30						Use Of Anti-tissue Factor Antibodies For Treating Thromboses 	.freshpatents.com	0	0		
1063	chr5	62760208	62760244	3500174088	28		62760208	62760244	8421504	3	8,5,15	0,11,21	g	350017408800000042,350017408800000040,350017408800000041	0-28,0-26,0-26						PDGF RECEPTOR BETA BINDING POLYPEPTIDES	Chen	2012	0		
1066	chr5	63132413	63132437	3500407097	24		63132413	63132437	8421504	1	24	0	g	350040709700000004	0-24						Detection of Germ line and Somatic Copy Number Variations in Cattle	ddr.nal.usda.gov	0	0		
1074	chr5	64102983	64103011	3500012755	23		64102983	64103011	8421504	3	8,4,11	0,12,17	g	350001275500000018	10-33						Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof	Maine	2002	0		
1075	chr5	64335222	64335245	3500383300	23		64335222	64335245	8421504	1	23	0	c	350038330000000014	0-23						Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis	enesdev.cshlp.org	0	0		NTN4
1076	chr5	64359817	64359924	3500302834	47		64359817	64359924	8421504	2	24,23	0,84	c	350030283400000002,350030283400000000	0-24,0-23						A Novel Member of the Netrin Family, -Netrin, Shares Homology with the Chain of Laminin: Identification, Expression, and Functional Characterization--&#x300a;&#x7ec6;&#x80de;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053	journal.9med.net	0	0		NTN4
1076	chr5	64475283	64475311	3500211774	25		64475283	64475311	8421504	3	5,9,11	0,7,17	g	350021177400000002	1-28						Engineering delivery and release of protein therapeutics for mammalian systems	n.library.ethz.ch	0	0		
1077	chr5	64553764	64553789	3500439514	25		64553764	64553789	8421504	1	25	0	c	350043951400000412	0-25						DIFFERENTIAL EXPRESSION OF MOLECULES ASSOCIATED WITH ACUTE STROKE - Patent application	www.faqs.org	0	0		
1077	chr5	64553787	64555303	3500102294	192		64553787	64555303	8421504	4	7,105,62,18	0,677,1433,1498	p	350010229400015012	21-213						/r;e.~~Sincerely,	an-foundation.org	0	0		
1079	chr5	64838795	64838933	3500186119	138		64838795	64838933	8421504	1	138	0	p	350018611900015108	0-138						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		ELK3
1079	chr5	64838795	64838933	3500095373	138		64838795	64838933	8421504	1	138	0	p	350009537300015108	0-138						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		ELK3
1079	chr5	64849425	64849450	3500220551	23		64849425	64849450	8421504	2	12,11	0,14	g	350022055100000069	6-30						Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same	Ye 	2009	0		
1079	chr5	64872431	64878330	3500145048	43		64872431	64878330	8421504	2	20,23	0,5876	c,g	350014504800000007,350014504800000007,350014504800000008	0-20,0-20,0-23		18065521	10.1152/ajpheart.01248.2007		American Journal of Physiology - Heart and Circulatory Physiology	SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function	Fontijn	2008	0		
1084	chr5	65448014	65448041	3500013095	25		65448014	65448041	8421504	3	5,7,13	0,6,14	g	350001309500000472	9-34						Sequenciamento do Genoma Completo e Express&#xe3;o Heter&#xf3;loga da Capa Prot&#xe9;ica do Marafivirus Associado &#xe0; Morte S&#xfa;bita dos Citros	www.bdtd.ucb.br	0	0		
1084	chr5	65488953	65494667	3500260547	180		65488953	65494667	8421504	3	51,117,12	0,3763,5702	p	350026054700015006	0-180						Analysis of the function and regulation of the centrosomal protein NEDD1 during cell division and development	y.adelaide.edu.au	0	0		
1089	chr5	66079568	66079593	3500130000	23		66079568	66079593	8421504	2	17,6	0,19	g	350013000000000089	0-23						Detection of a respiratory coronavirus from tissues archived during a pneumonia epizootic in free-ranging Pacific harbor seals Phoca vitulina richardsii. - ResearchGate	.researchgate.net	0	0		
1090	chr5	66224542	66224567	3500013455	25		66224542	66224567	8421504	1	25	0	c	350001345500000117	0-25						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		RMST
1090	chr5	66245419	66245443	3500080575	24		66245419	66245443	8421504	1	24	0	g	350008057500000008	0-24						V&#xfd;skum a ochrana cicavcov na Slovensku VIII	www.netopiere.sk	0	0		
1091	chr5	66333798	66333822	3500320331	23		66333798	66333822	8421504	2	17,6	0,18	g	350032033100000024	9-32						Polypeptides Having Endoglucanase Activity and Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
1097	chr5	67153912	67178115	3500207782	436		67153912	67178115	8421504	8	156,44,46,48,29,18,23,72	0,187,9912,15283,22266,23268,23334,24131	c	350020778200000000,350020778200000052,350020778200000001,350020778200000008,350020778200000014,350020778200000062,350020778200000070,350020778200000072,350020778200000073	1-95,0-48,19-95,0-44,0-46,0-48,1-48,0-48,0-47						Recombinant human thymopoietin proteins and uses therefor	Harris	1993	0		
1097	chr5	67213361	67219076	3500119481	261		67213361	67219076	8421504	4	157,23,24,57	0,1480,5619,5658	p	350011948100015006,350011948100015047	0-180,0-84						Redundancy in the function of mitochondrial phosphate transport in Saccharomyces cerevisiae and Arabidopsis thaliana	ci.ohio-state.edu	0	0		SLC25A3
1097	chr5	67213511	67219076	3500307245	909		67213511	67219076	8421504	9	7,125,3,162,156,14,173,111,158	0,1330,2979,2997,3917,4085,4575,5216,5407	p	350030724500015008,350030724500015021,350030724500015031,350030724500015041,350030724500015051,350030724500015061	3-138,0-162,0-156,0-105,0-153,0-198						Struktur- und Funktionsanalyse der humanen Uncoupling Proteine 1, 2 und 3 (hUCP1, hUCP2 und hUCP3)	b.uni-muenchen.de	0	0		
1098	chr5	67251719	67251749	3500192474	30		67251719	67251749	8421504	1	30	0	c,g	350019247400000009,350019247400000009	0-30,0-30		20829884	10.1038/cdd.2010.113	1350-9047	Cell Death & Differentiation	Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase	Choi	2010	9		APAF1
1098	chr5	67251719	67251742	3500397377	23		67251719	67251742	8421504	1	23	0	c	350039737700000004	20-43		19605357	10.1074/jbc.M109.034629	0021-9258	Journal of Biological Chemistry	Nuclear Degradation of Wilms Tumor 1-associating Protein and Survivin Splice Variant Switching Underlie IGF-1-mediated Survival	Small	2009	5		APAF1
1098	chr5	67251719	67251742	3500364121	23		67251719	67251742	8421504	1	23	0	c	350036412100000004	20-43		19605357	10.1074/jbc.M109.034629		The Journal of Biological Chemistry	Nuclear Degradation of Wilms Tumor 1-associating Protein and Survivin Splice Variant Switching Underlie IGF-1-mediated Survival	Theodore	2009	0		APAF1
1098	chr5	67252048	67333447	3500009029	516		67252048	67333447	8421504	14	41,3,26,48,32,57,48,48,48,42,24,3,48,48	0,130,805,879,960,19587,24333,24869,53520,66716,73210,74993,75047,81351	c	350000902900000017,350000902900000106,350000902900000108,350000902900000023,350000902900000036,350000902900000123,350000902900000045,350000902900000047,350000902900000065,350000902900000162,350000902900000075,350000902900000168,350000902900000170,350000902900000086	0-41,19-48,0-48,0-32,0-48,0-42,0-48,0-48,0-48,6-48,21-48,21-48,0-48,0-48						US Patent # 6,346,607. APAF-1 an activator of caspase-3 - Patents.com	www.patents.com	0	0		
1098	chr5	67252990	67264298	3500318543	180		67252990	67264298	8421504	2	61,119	0,11189	p	350031854300015055	0-180						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		APAF1
1100	chr5	67521814	67521839	3500426121	23		67521814	67521839	8421504	2	12,11	0,14	g	350042612100000005	0-23							biomedcentral.com	0	0		
1100	chr5	67521814	67521839	3500420824	23		67521814	67521839	8421504	2	12,11	0,14	g	350042082400000005	0-23						Wild boar tuberculosis in Iberian Atlantic Spain: a different picture from Mediterranean habitats - Springer	link.springer.com	0	0		
1100	chr5	67521814	67521839	3500301802	23		67521814	67521839	8421504	2	12,11	0,14	g	350030180200000005	0-23						Wild boar tuberculosis in Iberian Atlantic Spain: a different picture from Mediterranean habitats	biomedcentral.com	0	0		
1100	chr5	67521814	67521839	3500215781	23		67521814	67521839	8421504	2	12,11	0,14	g	350021578100000005	0-23						RESEARCH ARTICLE Open Access Wild boar tuberculosis in Iberian Atlantic Spain: a different picture from Mediterranean habitats	link.springer.com	0	0		
1100	chr5	67521814	67521839	3500007261	23		67521814	67521839	8421504	2	12,11	0,14	g	350000726100000005	0-23			10.1186/1746-6148-9-176	1746-6148	BMC Veterinary Research	Wild boar tuberculosis in Iberian Atlantic Spain: a different picture from Mediterranean habitats	MuA+-oz-Mendoza	2013	2		
1101	chr5	67704613	67704641	3500316988	23		67704613	67704641	8421504	2	10,13	0,15	g	350031698800000005,350031698800000000	1-24,1-24						ALPHA-1, 4-GALACTOSYLTRANSFERASE (CgtD) FROM CAMPYLOBACTER JEJUNI - Patent application	www.faqs.org	0	0		
1109	chr5	68747195	68747221	3500149367	23		68747195	68747221	8421504	2	15,8	0,18	c	350014936700000056	25-48						Method For Treating Ischemic Diseases 	freshpatents.com	0	0		
138	chr5	68926455	68959694	3500287061	152		68926455	68959694	8421504	9	24,15,9,19,14,7,21,21,22	0,57,7150,7177,9176,10888,19371,33099,33217	c	350028706100000044,350028706100000005,350028706100000045,350028706100000150,350028706100000050,350028706100000058,350028706100000060	0-24,20-84,0-23,0-63,21-42,21-42,0-22						Vglut-specific dsrna compounds	Bahrenberg	2005	0		
1110	chr5	68926512	68937350	3500287400	64		68926512	68937350	8421504	5	15,9,19,14,7	0,7093,7120,9119,10831	c	350028740000000005,350028740000000112	20-84,0-63						Vglut-spezifische dsrna-verbindungen	Bahrenberg	2005	0		
1110	chr5	68933626	68933674	3500155355	48		68933626	68933674	8421504	1	48	0	p	350015535500015061	0-48						US Patent # 5,985,604. Human sodium-dependent phosphate cotransporter - Patents.com	www.patents.com	0	0		SLC17A7
138	chr5	69054953	69078306	3500435779	63		69054953	69078306	8421504	2	40,23	0,23330	p	350043577900015162,350043577900015211	0-48,0-48						Novel Substitution Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System - Patent application	www.faqs.org	0	0		NR1H4
1112	chr5	69099169	69099194	3500357500	25		69099169	69099194	8421504	1	25	0	c	350035750000000007	0-25		15769750	10.1074/jbc.M414311200	0021-9258	Journal of Biological Chemistry	Developmental Changes of Bile Acid Composition and Conjugation in L- and D-Bifunctional Protein Single and Double Knockout Mice	Ferdinandusse	2005	5		
1112	chr5	69099173	69099196	3500464745	23		69099173	69099196	8421504	1	23	0	c	350046474500000001	0-23		15911693	10.1124/mol.105.012104	1521-0111 (Online)	Molecular Pharmacology	The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes	Rizzo	2005	0		NR1H4
1112	chr5	69099173	69099196	3500440409	23		69099173	69099196	8421504	1	23	0	c	350044040900000001	0-23		15911693	10.1124/mol.105.012104	1521-0111 (Online)	Molecular Pharmacology	The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes	Rizzo	2005	0		NR1H4
1112	chr5	69099173	69099196	3500223671	23		69099173	69099196	8421504	1	23	0	c	350022367100000001	0-23						&#x4e3b;&#x9898;&#xff1a;CIS | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		NR1H4
1112	chr5	69099173	69099196	3500047581	23		69099173	69099196	8421504	1	23	0	c	350004758100000001	0-23						The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive G 2006&#x5e74;&#x7b2c;68&#x5377;&#x7b2c;2&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&	www.39kf.com	0	0		NR1H4
1117	chr5	69735426	69735474	3500452460	48		69735426	69735474	8421504	1	48	0	p	350045246000015018	0-48						Methods And Compositions For Detecting Cancers 	.freshpatents.com	0	0		SLC5A12
1117	chr5	69857985	69858013	3500081807	25		69857985	69858013	8421504	3	12,7,6	0,14,22	g	350008180700000089,350008180700000192	15-40,15-40						METHOD OF DIAGNOSING COLON AND GASTRIC CANCERS - Patent application	www.faqs.org	0	0		
1118	chr5	69863479	69863504	3500020867	23		69863479	69863504	8421504	2	8,15	0,10	g	350002086700000038	7-30						US Patent # 7,192,761. Actinobacillus succinogenes shuttle vector and methods of use - Patents.com	www.patents.com	0	0		
1118	chr5	69866748	69866771	3500447745	23		69866748	69866771	8421504	1	23	0	g	350044774500000004	4-39						EHRLICHIA EWINGII PROTEINS, NUCLEIC ACIDS, AND METHODS OF THEIR USE	Rikihisa	2008	0		
1118	chr5	69901015	69903012	3500051274	90		69901015	69903012	8421504	2	80,10	0,1987	p	350005127400015002	0-90						The Arflike Gene Encodes an Essential GTP-Binding Protein in Drosophila	www.jstor.org	0	0		ARL1
1119	chr5	70074428	70074456	3500415514	24		70074428	70074456	8421504	3	5,14,5	0,8,23	c	350041551400000004	4-28		16624812	10.1074/jbc.M601388200	0021-9258	Journal of Biological Chemistry	Excess HDM2 Impacts Cell Cycle and Apoptosis and Has a Selective Effect on p53-dependent Transcription	Ohkubo	2006	5		
1119	chr5	70121333	70121361	3500381961	28		70121333	70121361	8421504	1	28	0	c	350038196100000119	0-28						INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMYL-PROLYL-TRNA SYNTHETASES - Patent application	www.faqs.org	0	0		
1120	chr5	70133390	70133414	3500454675	24		70133390	70133414	8421504	1	24	0	c	350045467500000016,350045467500000006	0-24,0-24						Cloning of human choline ethanolaminephospho transferases synthesis of phosphatidyl choline phosphatidyle thanolamine and platelet activating factor	Mcmaster	2000	0		
1120	chr5	70150665	70150690	3500246164	25		70150665	70150690	8421504	1	25	0	c	350024616400000000	0-25						Identification of a Physiologically Relevant Endogenous Ligand for PPAR&#x03b1; in Liver	iencias.uchile.cl	0	0		CHPT1
1120	chr5	70151293	70151320	3500306024	23		70151293	70151320	8421504	3	5,12,6	0,6,21	g	350030602400000010	5-30						Cyanobacterial and plant acetyl-CoA carboxylase	Haselkorn	1999	0		
1120	chr5	70200827	70211505	3500140704	720		70200827	70211505	8421504	13	1,99,86,108,3,111,18,85,110,21,48,12,18	0,3620,3969,7178,7289,7959,8073,8094,8398,8511,8535,8586,10660	p	350014070400015216	0-720						Proteins and nucleic acids encoding same	Edinger	2004	0		
1120	chr5	70204527	70232842	3500388061	207		70204527	70232842	8421504	6	19,20,63,33,12,60	0,269,292,3478,3514,28255	p	350038806100015086,350038806100015015	0-147,0-60						US Patent # 7,371,366. GlcNAc phosphotransferase of the lysosomal targeting pathway - Patents.com	www.patents.com	0	0		
1120	chr5	70232782	70232845	3500459355	63		70232782	70232845	8421504	1	63	0	p	350045935500015012	3-66					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6534300)	Canfield	2003	0		
1120	chr5	70232782	70232845	3500422793	63		70232782	70232845	8421504	1	63	0	p	350042279300015006	3-66						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
1120	chr5	70232782	70232845	3500377888	63		70232782	70232845	8421504	1	63	0	p	350037788800015012	3-66					Patent	Lysosomal targeting pathway enzymes (Patent EP:1224266)	Canfield	2007	0		
1120	chr5	70232782	70232845	3500326975	63		70232782	70232845	8421504	1	63	0	p	350032697500015025	3-66					Patent	Enzyme des auf die lysosomen gerichteten weges Enzymes of the pathway directed to the lysosomes (Patent DE:60036395)	William	2008	0		
1120	chr5	70232782	70232845	3500324905	63		70232782	70232845	8421504	1	63	0	p	350032490500015010	3-66						Lysosomal targeting pathway enzymes	Canfield	2002	0		
1120	chr5	70232782	70232845	3500285553	63		70232782	70232845	8421504	1	63	0	p	350028555300015016	3-66						LYSOSOMAL TARGETING PATHWAY ENZYMES - Canfield, William M.	www.sumobrain.com	0	0		
1120	chr5	70232782	70232845	3500280347	63		70232782	70232845	8421504	1	63	0	p	350028034700015010	3-66						Lysosomal targeting pathway enzymes	Canfield	2001	0		
1120	chr5	70232782	70232845	3500276287	63		70232782	70232845	8421504	1	63	0	p	350027628700015025	3-66					Patent	Enzyme des auf die lysosomen gerichteten weges Enzymes of the pathway directed to the lysosomes (Patent DE:60036395)	William	2008	0		
1120	chr5	70232782	70232845	3500261187	63		70232782	70232845	8421504	1	63	0	p	350026118700015013	3-66					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:7371366)	Canfield	2008	0		
1120	chr5	70232782	70232845	3500245851	63		70232782	70232845	8421504	1	63	0	p	350024585100015006	3-66						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
1120	chr5	70232782	70232845	3500227303	63		70232782	70232845	8421504	1	63	0	p	350022730300015012	3-66					Patent	Methods of treating lysosomal storage diseases (Patent US:6537785)	Canfield	2003	0		
1120	chr5	70232782	70232845	3500225243	63		70232782	70232845	8421504	1	63	0	p	350022524300015013	3-66					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6861242)	Canfield	2005	0		
1120	chr5	70232782	70232845	3500220979	63		70232782	70232845	8421504	1	63	0	p	350022097900015013	3-66					Patent	GIcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:7067127)	Canfield	2006	0		
1120	chr5	70232782	70232845	3500180443	63		70232782	70232845	8421504	1	63	0	p	350018044300015013	3-66					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
1120	chr5	70232782	70232845	3500178080	63		70232782	70232845	8421504	1	63	0	p	350017808000015013	3-66					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
1120	chr5	70232782	70232845	3500176191	63		70232782	70232845	8421504	1	63	0	p	350017619100015012	3-66					Patent	Methods for producing highly phosphorylated lysosomal hydrolases (Patent US:6534300)	Canfield	2003	0		
1120	chr5	70232782	70232845	3500161422	63		70232782	70232845	8421504	1	63	0	p	350016142200015010	3-66						Lysosomal targeting pathway enzymes	Canfield	2001	0		
1120	chr5	70232782	70232845	3500129176	63		70232782	70232845	8421504	1	63	0	p	350012917600015012	3-66					Patent	Methods of treating lysosomal storage diseases (Patent US:6537785)	Canfield	2003	0		
1120	chr5	70232782	70232845	3500053917	63		70232782	70232845	8421504	1	63	0	p	350005391700015013	3-66						Methods for producing highly phosphorylated lysosomal hydrolases	Canfield	2002	0		
1120	chr5	70232782	70232845	3500030446	63		70232782	70232845	8421504	1	63	0	p	350003044600015013	3-66					Patent	GlcNAc phosphotransferase of the lysosomal targeting pathway (Patent US:6642038)	Canfield	2003	0		
1121	chr5	70369782	70370469	3500028202	38		70369782	70370469	8421504	2	19,19	0,668	c	350002820200000003,350002820200000002	0-19,19-38		17304243	10.1038/sj.cdd.4402108	1350-9047	Cell Death & Differentiation	p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death	Crighton	2007	9		
1121	chr5	70370452	70370476	3500059706	24		70370452	70370476	8421504	1	24	0	c	350005970600000000	0-24						Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. - ResearchGate	.researchgate.net	0	0		
1124	chr5	70650840	70651178	3500380171	57		70650840	70651178	8421504	2	47,10	0,328	p	350038017100015001	0-57						Selective melanin-concentrating hormone type -1 receptor agonists	Bednarek	2003	0		PMCH
1124	chr5	70650840	70651178	3500331526	57		70650840	70651178	8421504	2	47,10	0,328	p	350033152600015095	0-57						A1 Hangzhou Sage Chemical Co., Ltd. (Page 235) @ ChemBuyersGuide.com, Inc.	embuyersguide.com	0	0		PMCH
1124	chr5	70650840	70651178	3500317074	57		70650840	70651178	8421504	2	47,10	0,328	p	350031707400015006	6-63						Melanin-concentrating hormone analogs	Bednarek	2004	0		PMCH
1124	chr5	70650840	70651178	3500293930	57		70650840	70651178	8421504	2	47,10	0,328	p	350029393000015001	0-57						Novel G protein-coupled receptors	Hiebsch	2003	0		PMCH
1124	chr5	70650840	70651178	3500232051	57		70650840	70651178	8421504	2	47,10	0,328	p	350023205100015004	0-57						G protein-coupled receptors	Lind	2006	0		PMCH
1124	chr5	70650846	70651178	3500342863	51		70650846	70651178	8421504	2	41,10	0,322	p	350034286300015073	0-51							library.wiley.com	0	0		PMCH
1124	chr5	70650846	70651178	3500324832	51		70650846	70651178	8421504	2	41,10	0,322	p	350032483200015234	0-51						G protein-coupled receptors	Lind	2001	0		PMCH
1124	chr5	70650846	70651178	3500061907	51		70650846	70651178	8421504	2	41,10	0,322	p	350006190700015234	0-51						G protein-coupled receptors	Lind	2002	0		PMCH
1125	chr5	70789788	70789812	3500429469	23		70789788	70789812	8421504	2	5,18	0,6	g	350042946900000035	1-25						REVERSE GENETICS OF NEGATIVE-STRAND RNA VIRUSES IN YEAST - Patent application	www.faqs.org	0	0		
1125	chr5	70820242	70890520	3500142873	1368		70820242	70890520	8421504	64	22,20,22,22,22,22,22,22,25,25,27,21,22,21,22,23,21,21,23,22,23,22,22,22,7,23,20,7,23,22,21,20,22,21,23,22,22,22,25,23,21,24,24,24,22,22,10,11,22,24,22,23,25,20,22,21,6,22,28,24,25,25,20,22	0,725,4912,5419,10464,12594,17653,17695,19098,19124,20473,25796,27943,28715,35647,37133,37546,41920,42450,43157,43820,44431,45289,46108,46813,46823,47515,47538,48241,48934,49598,49657,50104,50370,50843,51532,52235,52882,52933,53621,54387,55140,55811,56516,57303,58012,58749,58760,59416,60216,60931,61667,62374,63165,63835,64532,65240,65249,65960,66752,67408,68191,70153,70256	c,g	350014287300000507,350014287300000505,350014287300000492,350014287300000490,350014287300000477,350014287300000470,350014287300000456,350014287300000457,350014287300000041,350014287300000197,350014287300000043,350014287300000441,350014287300000434,350014287300000433,350014287300000412,350014287300000409,350014287300000406,350014287300000395,350014287300000122,350014287300000372,350014287300000373,350014287300000370,350014287300000369,350014287300000362,350014287300000353,350014287300000349,350014287300000335,350014287300000208,350014287300000045,350014287300000205	0-22,0-20,0-22,0-22,0-22,0-22,0-22,0-22,25-50,0-25,23-50,0-21,0-22,0-21,0-22,0-23,0-21,0-21,0-1604,0-21,0-20,0-22,0-22,0-22,0-22,0-22,0-20,0-20,18-38,0-22						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
1125	chr5	70823392	70890379	3500352979	61		70823392	70890379	8421504	4	20,20,8,13	0,135,15692,66974	c,g	350035297900000001,350035297900000003,350035297900000002	0-20,23-43,23-44						Effect of a combined trenbolone acetate and estradiol implant on steady-state IGF-I mRNA concentrations in the liver of wethers and the longissimus muscle of steers. - ResearchGate	.researchgate.net	0	0		
1125	chr5	70823554	70838927	3500202638	46		70823554	70838927	8421504	3	23,6,17	0,121,15356	c	350020263800000003,350020263800000002	0-23,0-23						EXPRESS&#xc3;O G&#xca;NICA EM FOL&#xcd;CULOS E TECIDO OVARIANO DURANTE O CICLO ESTRAL DE SU&#xcd;NOS	www.tede.ufv.br	0	0		
1125	chr5	70823554	70838927	3500021304	46		70823554	70838927	8421504	3	23,6,17	0,121,15356	c	350002130400000003,350002130400000002	0-23,0-23						EXPRESS&#xc3;O G&#xca;NICA EM FOL&#xcd;CULOS E TECIDO OVARIANO DURANTE O CICLO ESTRAL DE SU&#xcd;NOS	www.tede.ufv.br	0	0		
1125	chr5	70823582	70823606	3500274446	24		70823582	70823606	8421504	1	24	0	c	350027444600000003	23-47						Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans	jp.physoc.org	0	0		
1125	chr5	70823582	70823606	3500260984	24		70823582	70823606	8421504	1	24	0	c	350026098400000002,350026098400000000	23-47,23-46						Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans	jp.physoc.org	0	0		
1125	chr5	70823620	70823654	3500443180	34		70823620	70823654	8421504	1	34	0	g	350044318000000019,350044318000000001	8-42,8-42					Patent	Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses (Patent EP:1425305)	ANDREONI	2010	0		
1125	chr5	70823620	70823654	3500269759	34		70823620	70823654	8421504	1	34	0	c	350026975900000001	8-42						Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses	ANDREONI	2004	0		
1125	chr5	70823620	70823654	3500000854	34		70823620	70823654	8421504	1	34	0	c	350000085400000001	8-42						Igf-1 As Feline Vaccine Adjuvant, In Particular Against Feline Retroviruses 	freshpatents.com	0	0		
1125	chr5	70823624	70895061	3500100229	459		70823624	70895061	8421504	4	57,182,157,63	0,15286,66742,71374	p	350010022900015000	0-459						KEGG T01001: 3479	www.genome.jp	0	0		
1125	chr5	70823624	70895061	3500054798	459		70823624	70895061	8421504	4	57,182,157,63	0,15286,66742,71374	p	350005479800015000	0-459						KEGG T01001: 3479	www.genome.jp	0	0		IGF1
1125	chr5	70823624	70890442	3500241255	315		70823624	70890442	8421504	3	57,182,76	0,15286,66742	p	350024125500015007,350024125500015006	0-315,0-171					Patent	Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses (Patent CA:2459769)	Andreoni	2013	0		IGF1
1125	chr5	70823624	70823677	3500288740	40		70823624	70823677	8421504	2	21,19	0,34	c	350028874000000021,350028874000000023	0-21,0-19						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
1125	chr5	70823633	70895061	3500460691	450		70823633	70895061	8421504	4	48,182,157,63	0,15277,66733,71365	p	350046069100015034	0-450						Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and bph	Cotsarelis	2011	0		IGF1
1125	chr5	70823651	70838911	3500196307	31		70823651	70838911	8421504	2	30,1	0,15259	c	350019630700000017	0-31						Thalidomide Downregulates Angiogenic Genes in Bone Marrow Endothelial Cells of Patients With Active Multiple Myeloma	jco.ascopubs.org	0	0		IGF1
1125	chr5	70823651	70838911	3500121283	31		70823651	70838911	8421504	2	30,1	0,15259	c	350012128300000005	0-31						Human Chorionic Gonadotropin-Induced Ovarian Hyperstimulation Syndrome Is Associated with Up- Regulation of Vascular Endothelial Growth Factor	.endojournals.org	0	0		IGF1
1125	chr5	70823657	70838912	3500400995	26		70823657	70838912	8421504	2	24,2	0,15253	c	350040099500000010	0-26		23403580	10.1038/ncomms2484	2041-1733	Nature Communications	IGF-1 promotes the development and cytotoxic activity of human NK cells	Ni	2013	0		IGF1
1125	chr5	70823657	70838912	3500208691	26		70823657	70838912	8421504	2	24,2	0,15253	c	350020869100000010	0-26		23403580	10.1038/ncomms2484	2041-1733	Nature Communications	IGF-1 promotes the development and cytotoxic activity of human NK cells	Ni	2013	0		IGF1
1125	chr5	70823657	70838911	3500223692	25		70823657	70838911	8421504	2	24,1	0,15253	c	350022369200000004	0-25						&#x4e3b;&#x9898;&#xff1a;C-JUN | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1125	chr5	70838787	70839132	3500383720	45		70838787	70839132	8421504	2	21,24	0,321	g	350038372000000016,350038372000000015,350038372000000005	0-21,0-24,0-24						Polymorphisms in the IGF1 gene and their effect on growth traits in Mexican beef cattle	w.funpecrp.com.br	0	0		
1125	chr5	70838910	70890406	3500164591	222		70838910	70890406	8421504	2	182,40	0,51456	p	350016459100015015,350016459100015014,350016459100015007	15-69,0-54,0-168						Cours de bioinformatique M1 BBSG	logie.univ-mrs.fr	0	0		
1125	chr5	70838910	70839092	3500237315	42		70838910	70839092	8421504	2	22,20	0,162	c,g	350023731500000010,350023731500000009,350023731500000009	0-22,0-20,0-20						Molecular interplay between leptin, insulin-like growth factor-1, and &#x03b2;-amyloid in organotypic slices from rabbit hippocampus	odegeneration.com	0	0		
1125	chr5	70838958	70890442	3500424306	198		70838958	70890442	8421504	4	99,29,52,18	0,105,51408,51466	p	350042430600015012	0-198						10897 microsatellite 9668 control region 4597 Vector: pCMV-SPORT6.0 1738 Vector: pExpress1 1036 puta	www.ibio.jp	0	0		
1125	chr5	70838958	70890442	3500395097	210		70838958	70890442	8421504	2	134,76	0,51408	p	350039509700015004	3-213						Insulin-like growth factor signaling and integrin	Takada	2010	0		IGF1
1125	chr5	70838958	70890442	3500357165	210		70838958	70890442	8421504	2	134,76	0,51408	p	350035716500015038	3-213						Novel Antibodies Against Igf-ir 	.freshpatents.com	0	0		IGF1
1125	chr5	70838958	70890442	3500357165	210		70838958	70890442	8421504	2	134,76	0,51408	p	350035716500015037	3-213						Novel Antibodies Against Igf-ir 	.freshpatents.com	0	0		IGF1
1125	chr5	70838958	70890442	3500223042	210		70838958	70890442	8421504	2	134,76	0,51408	p	350022304200015035	3-213						NOVEL ANTIBODIES - GLAXO GROUP LIMITED	www.sumobrain.com	0	0		IGF1
1125	chr5	70838958	70890442	3500223042	210		70838958	70890442	8421504	2	134,76	0,51408	p	350022304200015034	3-213						NOVEL ANTIBODIES - GLAXO GROUP LIMITED	www.sumobrain.com	0	0		IGF1
1125	chr5	70838958	70890442	3500188920	210		70838958	70890442	8421504	2	134,76	0,51408	p	350018892000015022	63-273						Growth factor modified protein matrices for tissue engineering	Hubbell	2002	0		IGF1
1125	chr5	70838958	70890442	3500113632	210		70838958	70890442	8421504	2	134,76	0,51408	p	350011363200015004	3-213						Insulin-like growth factor signaling and integrin	Takada	2012	0		IGF1
1125	chr5	70838958	70890442	3500001703	210		70838958	70890442	8421504	2	134,76	0,51408	p	350000170300015004	3-213						INSULIN-LIKE GROWTH FACTOR SIGNALING AND INTEGRIN	Takada	2010	0		IGF1
1125	chr5	70838958	70890397	3500392622	165		70838958	70890397	8421504	2	134,31	0,51408	p	350039262200015016,350039262200015039,350039262200015037	0-120,0-45,0-45						Novel antler-derived bone growth factors	Arnett	1993	0		IGF1
1125	chr5	70838967	70890421	3500353092	180		70838967	70890421	8421504	2	125,55	0,51399	p	350035309200015003,350035309200015002,350035309200015001	0-60,0-60,0-60						IGF-1 LR6 | U.S. Direct PeptidesU.S. Direct Peptides	irectpeptides.com	0	0		IGF1
1125	chr5	70838976	70890391	3500380283	135		70838976	70890391	8421504	4	45,45,20,25	0,48,96,51390	p	350038028300015125,350038028300015124,350038028300015123	0-45,0-45,0-45						TARGETED THERAPEUTIC PROTEINS - Patent application	www.faqs.org	0	0		IGF1
1125	chr5	70838976	70890391	3500125607	135		70838976	70890391	8421504	4	45,45,20,25	0,48,96,51390	p	350012560700015125,350012560700015124,350012560700015123	0-45,0-45,0-45						Method for targeting lysosomal enzymes - Patent application	www.faqs.org	0	0		IGF1
1125	chr5	70838979	70890439	3500385158	186		70838979	70890439	8421504	2	113,73	0,51387	p	350038515800015048,350038515800015047	0-51,0-135						METHODS FOR LIGATION AND USES THEREOF - Patent application	www.faqs.org	0	0		IGF1
1125	chr5	70838985	70839030	3500319017	45		70838985	70839030	8421504	1	45	0	p	350031901700015001	0-45						Alignements multiples Recherche de motifs, signatures & profils	logie.univ-mrs.fr	0	0		IGF1
1125	chr5	70838985	70839010	3500141821	25		70838985	70839010	8421504	1	25	0	c	350014182100000003	0-25						The mRNA expression of the members of the IGF-system in bovine corpus luteum during induced luteolysis	quantification.de	0	0		
1125	chr5	70838985	70839010	3500036931	25		70838985	70839010	8421504	1	25	0	c	350003693100000009	0-25						Maturation medium supplements affect transcript level of apoptosis and cell survival related genes in bovine blastocysts produced in vitro	www.ufpel.edu.br	0	0		
1125	chr5	70838985	70839010	3500016815	25		70838985	70839010	8421504	1	25	0	c	350001681500000011	0-25						Standardization strategy for quantitative PCR in human seminoma and normal testis	quantification.de	0	0		
1125	chr5	70838990	70839053	3500282907	42		70838990	70839053	8421504	2	22,20	0,43	c,g	350028290700000013,350028290700000012,350028290700000012	0-22,0-20,0-20						ABSTRACT Title of Document: ENGINEERING ZONAL CARTILAGE THROUGH UTILIZATION OF A MESENCHYMAL STEM CELL POPULATION Articular	drum.lib.umd.edu	0	0		
1125	chr5	70839000	70890442	3500162126	168		70839000	70890442	8421504	2	92,76	0,51366	p	350016212600015004	0-168						Growth hormone fusion proteins	Francis	1990	0		IGF1
1125	chr5	70839024	70890391	3500043758	90		70839024	70890391	8421504	3	45,20,25	0,48,51342	p	350004375800015012,350004375800015011	0-45,0-45						Methods for Producing Proteins Using Hamster Igf-1 - Patent application	www.faqs.org	0	0		IGF1
1125	chr5	70839028	70839051	3500211107	23		70839028	70839051	8421504	1	23	0	c,g	350021110700000000,350021110700000000	0-23,0-23		14704286		0022-3166	The Journal of Nutrition	An Energy-Rich Diet Causes Rumen Papillae Proliferation Associated with More IGF Type 1 Receptors and Increased Plasma IGF-1 Concentrations in Young Goats	Shen	2004	4		IGF1
1125	chr5	70839051	70895061	3500241255	100		70839051	70895061	8421504	3	41,31,28	0,51315,55982	p,g	350024125500015004,350024125500000000,350024125500000019	0-72,11-39,11-39					Patent	Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses (Patent CA:2459769)	Andreoni	2013	0		IGF1
1125	chr5	70839051	70890376	3500207407	51		70839051	70890376	8421504	2	41,10	0,51315	p	350020740700015012	0-51						Method for manufacture of proinsulin with high export yield	Kang	1995	0		IGF1
1125	chr5	70839072	70890391	3500009634	45		70839072	70890391	8421504	2	20,25	0,51294	p	350000963400015037	0-45						CHIMERIC PEPTIDE ANTAGONIST FOR GPCR135 OR GPCR142 - Patent application	www.faqs.org	0	0		IGF1
1125	chr5	70839080	70890477	3500124900	40		70839080	70890477	8421504	3	12,9,19	0,51286,51378	c,g	350012490000000012,350012490000000011,350012490000000011	0-21,0-19,0-19						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
1125	chr5	70839087	70890409	3500435970	48		70839087	70890409	8421504	2	5,43	0,51279	c	350043597000000004	0-48						 Production Of Insulin 	www.docstoc.com	0	0		
1125	chr5	70852169	70852196	3500206977	23		70852169	70852196	8421504	2	15,8	0,19	g	350020697700000005	0-23						Journal of Biotechnology	005.pasteur.ac.ir	0	0		
1125	chr5	70854459	70854486	3500361086	23		70854459	70854486	8421504	2	6,17	0,10	g	350036108600000000,350036108600000001	9-32,0-23						Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assays	www.fasebj.org	0	0		
1125	chr5	70890373	70890442	3500210720	69		70890373	70890442	8421504	1	69	0	p	350021072000015104	0-69						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		IGF1
1125	chr5	70890385	70890442	3500065978	57		70890385	70890442	8421504	1	57	0	p	350006597800015003	0-57						MODIFIED INSULIN-LIKE GROWTH FACTORS - SYNERGEN, INC	www.sumobrain.com	0	0		IGF1
1125	chr5	70890394	70895004	3500261436	42		70890394	70895004	8421504	3	21,15,6	0,117,4604	c	350026143600000062,350026143600000061	0-21,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1125	chr5	70890396	70890510	3500315971	66		70890396	70890510	8421504	2	21,45	0,69	c	350031597100000000,350031597100000034,350031597100000035	0-21,0-45,0-27						REPRODUCTION	uction-online.org	0	0		
1125	chr5	70890470	70895793	3500383720	105		70890470	70895793	8421504	5	20,25,20,20,20	0,4575,5044,5265,5303	c,g	350038372000000014,350038372000000014,350038372000000002,350038372000000007,350038372000000008,350038372000000000	0-20,0-20,20-45,0-20,0-20,0-20						Polymorphisms in the IGF1 gene and their effect on growth traits in Mexican beef cattle	w.funpecrp.com.br	0	0		
1125	chr5	70890471	70895013	3500345859	67		70890471	70895013	8421504	4	22,22,8,15	0,23,47,4527	c	350034585900000021,350034585900000022,350034585900000020	0-22,0-22,0-23						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
1125	chr5	70890474	70890499	3500141821	25		70890474	70890499	8421504	1	25	0	c	350014182100000002	0-25						The mRNA expression of the members of the IGF-system in bovine corpus luteum during induced luteolysis	quantification.de	0	0		
1125	chr5	70890474	70890499	3500036931	25		70890474	70890499	8421504	1	25	0	c	350003693100000008	0-25						Maturation medium supplements affect transcript level of apoptosis and cell survival related genes in bovine blastocysts produced in vitro	www.ufpel.edu.br	0	0		
1125	chr5	70890474	70890499	3500016815	25		70890474	70890499	8421504	1	25	0	c,g	350001681500000010,350001681500000010	0-25,0-25						Standardization strategy for quantitative PCR in human seminoma and normal testis	quantification.de	0	0		
1125	chr5	70890487	70895077	3500315071	40		70890487	70895077	8421504	2	20,20	0,4570	c,g	350031507100000041,350031507100000041,350031507100000040	0-20,0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1125	chr5	70895001	70895193	3500352760	41		70895001	70895193	8421504	2	21,20	0,172	c,g	350035276000000053,350035276000000052,350035276000000052	0-21,0-20,0-20		21496021	10.1111/j.1471-4159.2011.07272.x	1471-4159	Journal of Neurochemistry	Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers - Garbayo - 2011 - Journal of Neurochemistry - Wiley Online Libr	Garbayo	2011	0		IGF1
1125	chr5	70895001	70895193	3500338564	41		70895001	70895193	8421504	2	21,20	0,172	c,g	350033856400000053,350033856400000052,350033856400000052	0-21,0-20,0-20						Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers. - ResearchGate	.researchgate.net	0	0		IGF1
1125	chr5	70895033	70895061	3500269759	28		70895033	70895061	8421504	1	28	0	c	350026975900000000	11-39						Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses	ANDREONI	2004	0		IGF1
1125	chr5	70895033	70895061	3500000854	28		70895033	70895061	8421504	1	28	0	c	350000085400000000	11-39						Igf-1 As Feline Vaccine Adjuvant, In Particular Against Feline Retroviruses 	freshpatents.com	0	0		IGF1
1125	chr5	70895038	70895075	3500056788	37		70895038	70895075	8421504	1	37	0	c	350005678800000000	0-37		11313458	10.1128/MCB.21.10.3325-3335.2001	0270-7306	Molecular and Cellular Biology	Transcriptional Repression by Rb-E2F and Regulation of Anchorage-Independent Survival	Yu	2001	6		IGF1
1125	chr5	70895191	70895215	3500316789	24		70895191	70895215	8421504	1	24	0	c	350031678900000009	0-24		17872375	10.1210/en.2007-0188	0013-7227	Endocrinology	Mechanism of the Divergent Effects of Estrogen on the Cell Proliferation of Human Umbilical Endothelial Versus Aortic Smooth Muscle Cells	Kawagoe	2007	4		IGF1
1125	chr5	70895191	70895215	3500057377	24		70895191	70895215	8421504	1	24	0	c	350005737700000007	0-24						Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells. - ResearchGate	.researchgate.net	0	0		IGF1
1125	chr5	70895528	70895553	3500150112	23		70895528	70895553	8421504	2	10,13	0,12	g	350015011200000001	0-23						Association of the polymorphism in the 5&#x2019; flanking region of the ovine IGF-I gene with growth traits in the Baluchi sheep | Mohammad Reza Nassiri - Academia.edu	www.academia.edu	0	0		
1125	chr5	70895528	70895553	3500039130	23		70895528	70895553	8421504	2	10,13	0,12	g	350003913000000002	0-23						Study of Polymorphisms in the 5&#xb4; Flanking Region of the Ovine IGF-I Gene in Zel Sheep	idosi.org/wasj/wa	0	0		
1125	chr5	70895543	70895793	3500399719	48		70895543	70895793	8421504	2	28,20	0,230	g	350039971900000003,350039971900000002	0-28,0-20		21635772	10.1186/1751-0147-53-35	1751-0147	Acta Veterinaria Scandinavica	Metabolic and endocrine profiles and reproductive parameters in dairy cows under grazing conditions: effect of polymorphisms in somatotropic axis genes	Ruprechter	2011	0		
1125	chr5	70895543	70895793	3500294489	250		70895543	70895793	8421504	1	250	0	g	350029448900000002,350029448900000010,350029448900000009,350029448900000007,350029448900000008,350029448900000005,350029448900000003	0-250,0-60,0-60,0-60,0-60,0-60,0-60						Genetic Characterization of Insulin Growth Factor-1 and Its Receptor Genes in Egyptian Buffalo (Bubalus bubalis	sciencedomain.org	0	0		
1125	chr5	70895543	70895793	3500218953	48		70895543	70895793	8421504	2	28,20	0,230	g	350021895300000005,350021895300000004	0-28,0-20						Genetic Characterization of Sudanese Baggara Cattle Using PCR-RFLP Technique	www.aensiweb.com	0	0		
1125	chr5	70895543	70895793	3500167786	48		70895543	70895793	8421504	2	28,20	0,230	g	350016778600000001,350016778600000000	0-28,0-20						A polymorphism in the insulin-like growth factor 1 gene is associated with postpartum resumption of ovarian cyclicity in Holstein-Friesian cows under grazing conditions	.actavetscand.com	0	0		
1125	chr5	70895543	70895793	3500078097	250		70895543	70895793	8421504	1	250	0	g	350007809700000002,350007809700000009,350007809700000010,350007809700000008,350007809700000007,350007809700000005,350007809700000003	0-250,0-60,0-60,0-60,0-60,0-60,0-60						Genetic Characterization of Insulin Growth Factor-1 and Its Receptor Genes in Egyptian Buffalo (Bubalus bubalis	sciencedomain.org	0	0		
1125	chr5	70896138	70896161	3500187087	23		70896138	70896161	8421504	1	23	0	g	350018708700000000	0-23						A new ACRS-SNP in the 5&#x2019; flanking region of the bovine insulin-like growth factor 1 (IGF1) gene (Brief report)	bn-dummerstorf.de	0	0		
1126	chr5	70982830	70983166	3500237315	40		70982830	70983166	8421504	2	20,20	0,316	g	350023731500000008,350023731500000007	0-20,0-20						Molecular interplay between leptin, insulin-like growth factor-1, and &#x03b2;-amyloid in organotypic slices from rabbit hippocampus	odegeneration.com	0	0		IGF1
1128	chr5	71247154	71251378	3500125127	45		71247154	71251378	8421504	2	21,24	0,4200	c	350012512700000007,350012512700000018	0-21,0-24						US Patent # 6,200,758. Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders - Patents.com	www.patents.com	0	0		
17	chr5	71247170	71309672	3500385158	921		71247170	71309672	8421504	10	73,134,96,57,70,136,197,68,89,1	0,4177,4830,8315,11839,13014,16788,28050,41157,62501	p	350038515800015028,350038515800015027	0-786,0-135						METHODS FOR LIGATION AND USES THEREOF - Patent application	www.faqs.org	0	0		PAH
1128	chr5	71255515	71259027	3500206832	45		71255515	71259027	8421504	2	27,18	0,3494	p	350020683200015018	0-45						Tryptophan Hydroxylase Assay 	.freshpatents.com	0	0		
1129	chr5	71326751	71326774	3500408348	23		71326751	71326774	8421504	1	23	0	c	350040834800000100	18-43						Methods and systems for producing recombinant viral antigens	Zebedee	1997	0		
1129	chr5	71364515	71364575	3500436422	60		71364515	71364575	8421504	1	60	0	g	350043642200000010	0-60						A chicken achaete-scute homolog (CASH-1) is expressed in a temporally and spatially discrete manner in the developing nervous system	ev.biologists.org	0	0		
1132	chr5	71800080	71800107	3500228127	24		71800080	71800107	8421504	2	7,17	0,10	g	350022812700000005	3-27						Hypo-immunogenic streptavidin and use thereof	Er Yu Long Yan 	2012	0		
1134	chr5	72020054	72020079	3500246549	23		72020054	72020079	8421504	2	8,15	0,10	c	350024654900000247	3-34						Haemophilus influenzae type IV pili - Patent application	www.faqs.org	0	0		
1135	chr5	72132408	72132700	3500089368	292		72132408	72132700	8421504	1	292	0	g	350008936800000017	2-294						Identification of Genetic Markers for Korean Native Cattle (Han- woo) by RAPD Analysis	www.bbe.or.kr	0	0		
1135	chr5	72138568	72138592	3500289267	23		72138568	72138592	8421504	2	4,19	0,5	g	350028926700000017	24-48						Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of cap37	Pereira	1993	0		
1136	chr5	72298545	72301327	3500138932	334		72298545	72301327	8421504	4	49,103,142,40	0,1050,1839,2742	p,c	350013893200015004,350013893200015007,350013893200015005,350013893200015008,350013893200000001	0-273,0-150,0-270,0-120,12-40						Fr&#xfc;herkennung von Vorstufen des kolorektalen Karzinoms: Identifizierung und Charakterisierung potentieller Tumorbiomarker	ie.uni-hamburg.de	0	0		HSP90B1
1136	chr5	72299690	72315563	3500293064	430		72299690	72315563	8421504	15	8,39,47,39,8,36,12,12,35,30,18,48,48,23,27	0,694,734,8163,8427,9988,11755,12047,12187,12223,12677,12743,13395,15663,15846	c	350029306400000215,350029306400000216,350029306400000229,350029306400000234,350029306400000239,350029306400000240,350029306400000242,350029306400000250,350029306400000254,350029306400000256	0-47,0-47,0-47,0-48,0-47,0-48,0-48,0-48,24-47,21-48						Methods and Compositions for Modulating Apoptosis - Patent application	www.faqs.org	0	0		
1136	chr5	72309648	72311499	3500465087	39		72309648	72311499	8421504	2	19,20	0,1831	c	350046508700000010,350046508700000011	0-19,0-20						REPRODUCTION	uction-online.org	0	0		
1136	chr5	72309648	72311499	3500145630	39		72309648	72311499	8421504	2	19,20	0,1831	c,g	350014563000000032,350014563000000032,350014563000000033,350014563000000033	0-19,0-19,0-20,0-20						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1136	chr5	72311481	72312989	3500322660	47		72311481	72312989	8421504	2	24,23	0,1485	c,g	350032266000000032,350032266000000033,350032266000000033	0-24,0-23,0-23						Caracterizaci&#xf3;n gen&#xf3;mica y prote&#xf3;mica de la expresi&#xf3;n g&#xe9;nica diferencial en jabal&#xed;es infectados de forma natural con Mycobacterium bovis Identificaci&#xf3;n de biomarcadores asociados con la infecci&#xf3;n y la respuesta inmu	digital.csic.es	0	0		
1136	chr5	72311698	72312420	3500204467	46		72311698	72312420	8421504	2	23,23	0,699	c,g	350020446700000004,350020446700000004,350020446700000005,350020446700000005	0-23,0-23,0-23,0-23			10.1111/j.1742-7843.2004.pto940305.x	1742-7843	Basic & Clinical Pharmacology & Toxicology	Cytoprotection Following Endoplasmic Reticulum Stress Protein Induction in Continuous Cell Lines - Bedard - 2004 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library	Bedard	2004	0		HSP90B1
1136	chr5	72313061	72313151	3500169957	90		72313061	72313151	8421504	1	90	0	p	350016995700015019	0-90						Targets for tumor growth inhibition - Patent #07781414	w.strutpatent.com	0	0		TGFBR3
1136	chr5	72313137	72313781	3500404944	40		72313137	72313781	8421504	3	14,6,20	0,515,624	c	350040494400000048,350040494400000049	0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
1136	chr5	72317138	72317163	3500467047	25		72317138	72317163	8421504	1	25	0	c	350046704700000007	0-25		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		
1136	chr5	72317138	72317163	3500300246	25		72317138	72317163	8421504	1	25	0	c	350030024600000007	0-25		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		
1136	chr5	72317138	72317163	3500168730	25		72317138	72317163	8421504	1	25	0	c	350016873000000007	0-25		18049481	10.1038/sj.cdd.4402276	1350-9047	Cell Death & Differentiation	A molecular chaperone inducer protects neurons from ER stress	Kudo	2007	9		
1137	chr5	72400942	72400972	3500033186	24		72400942	72400972	8421504	3	8,12,4	0,13,26	g	350003318600000007	3-27						Compositions and methods for humanization and optimization of n-glycans in plants	Cox	2008	0		
142	chr5	72468868	72483866	3500102250	71		72468868	72483866	8421504	4	21,25,18,7	0,4976,7111,14991	c	350010225000000037,350010225000000040,350010225000000036	0-21,0-25,11-36		20098743	10.1371/journal.pone.0008773		PLoS ONE	Dysbindin Regulates the Transcriptional Level of Myristoylated Alanine-Rich Protein Kinase C Substrate via the Interaction with NF-YB in Mice Brain	Hiroaki	2010	0		NFYB
1139	chr5	72660287	72660783	3500313955	46		72660287	72660783	8421504	2	22,24	0,472	c	350031395500000002,350031395500000003	0-22,0-24						Thioredoxin reductase regulates the induction of haem oxygenase-1 expression in aortic endothelial cells - Keeping the Faith	pthefaith1296.com	0	0		
1140	chr5	72855164	72855192	3500353506	25		72855164	72855192	8421504	3	7,3,15	0,8,13	g	350035350600000011	20-45						US Patent # 5,516,667. Chilling-resistant plants and their production - Patents.com	www.patents.com	0	0		
1141	chr5	73005028	73005477	3500233653	448		73005028	73005477	8421504	2	441,7	0,442	c,g	350023365300000011,350023365300000011	0-451,0-451						in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biological Engineering	dspace.mit.edu	0	0		
1143	chr5	73235773	73235796	3500415955	23		73235773	73235796	8421504	1	23	0	c	350041595500000024	0-23						Letter The Heparan and Heparin Metabolism Pathway is Involved in Regulation of Fatty Acid Composition	www.ijbs.com	0	0		
1144	chr5	73307331	73307452	3500259232	121		73307331	73307452	8421504	1	121	0	g	350025923200000014	0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
1145	chr5	73419344	73419372	3500362120	23		73419344	73419372	8421504	2	16,7	0,21	g	350036212000000021	0-23						Ryegrass CBF3 gene: identification and isolation	Bughrara	2004	0		
1145	chr5	73521796	73521820	3500258008	23		73521796	73521820	8421504	2	19,4	0,20	c	350025800800000065	14-38						BACTERIAL LEADER SEQUENCES FOR INCREASED EXPRESSION - Patent application	www.faqs.org	0	0		
1148	chr5	73914234	73914261	3500270113	24		73914234	73914261	8421504	2	9,15	0,12	g	350027011300000065	12-36						USE OF A ROCK INHIBITOR TO SUSTAIN PRIMARY HUMAN KERATINOCYTES IN A PROLIFERATIVE STATE - Patent application	www.faqs.org	0	0		
1150	chr5	74129338	74129366	3500362735	23		74129338	74129366	8421504	2	11,12	0,16	g	350036273500000461	16-39						Compositions containing nucleic acids and ligands for therapeutic treatment	Baird	1999	0		
1152	chr5	74368598	74368634	3500175757	31		74368598	74368634	8421504	2	10,21	0,15	c	350017575700000025	3-38						&#x816b;&#x760d;&#x60aa;&#x6027;&#x5316;&#x95a2;&#x9023;&#x56e0;&#x5b50; ARK5 &#x907a;&#x4f1d;&#x5b50;&#x306e; &#x816b;&#x760d;&#x7d30;&#x80de;&#x306b;&#x304a;&#x3051;&#x308b;&#x767a;&#x73fe;&#x8abf;&#x7bc0;&#x6a5f;&#x69cb;	itc.u-tokyo.ac.jp	0	0		
1153	chr5	74528529	74528555	3500436229	23		74528529	74528555	8421504	2	15,8	0,18	c	350043622900000139	14-37						cDNA encoding a BMP type II receptor	Rosenbaum	1994	0		
1155	chr5	74816362	74816387	3500383543	23		74816362	74816387	8421504	2	16,7	0,18	g	350038354300000030	5-28						Genes that encode a surface protein of p. carinii	Angus	1994	0		
1157	chr5	74974191	74982947	3500142873	85		74974191	74982947	8421504	4	21,22,22,20	0,1583,6009,8736	g	350014287300000236,350014287300000233,350014287300000227,350014287300000222	0-21,0-22,0-22,0-20						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
1157	chr5	75081790	75081853	3500394423	60		75081790	75081853	8421504	2	27,33	0,30	p	350039442300015004	3-63						NPAS2: An Analog of Clock Operative in the Mammalian Forebrain	mcknightlab.com	0	0		CRY1
1157	chr5	75081811	75081836	3500427473	25		75081811	75081836	8421504	1	25	0	c	350042747300000013	0-25		18537186	10.1002/hep.22304	1527-3350	Hepatology	The molecular mechanism regulating 24-hour rhythm of CYP2E1 expression in the mouse liver - Matsunaga - 2008 - Hepatology - Wiley Online Library	Matsunaga	2008	0		CRY1
1157	chr5	75086810	75086833	3500095488	23		75086810	75086833	8421504	1	23	0	c	350009548800000002	0-23						ABSTRACT Title of dissertation: EFFECTS OF AGING AND MODERATE CALORIE RESTRICTION ON THE REPRODUCTIVE AXIS OF THE MALE RHESUS MACAQUE (MACACA MULATTA) Brandon Dale Sitzmann, Doctor of Philosophy, 2007	drum.lib.umd.edu	0	0		CRY1
144	chr5	75092431	75174445	3500148533	44		75092431	75174445	8421504	3	23,11,10	0,18958,82004	c	350014853300000015,350014853300000014	0-23,0-21						USP2a Deubiquitinates and Stabilizes the Circadian Protein CRY1 in Response to Inflammatory Signals	www.jbc.org	0	0		CRY1
1158	chr5	75174556	75174587	3500444477	31		75174556	75174587	8421504	1	31	0	c	350044447700000007	0-31		17295926	10.1186/1740-3391-5-3	1740-3391	Journal of Circadian Rhythms	Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium	Kaladchibachi	2007	0		
1162	chr5	75657476	75657500	3500265690	23		75657476	75657500	8421504	2	15,8	0,16	c	350026569000000258	9-32						Polycystic kidney disease 12 gene and uses thereof	Harris	1998	0		
1164	chr5	75942021	75948561	3500393026	106		75942021	75948561	8421504	4	2,38,42,24	0,2187,2231,6516	c	350039302600000067,350039302600000068,350039302600000076	5-45,0-42,18-42						US Patent # 7,390,656. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
1164	chr5	75942021	75948561	3500366927	106		75942021	75948561	8421504	4	2,38,42,24	0,2187,2231,6516	c	350036692700000070,350036692700000071,350036692700000079	5-45,0-42,18-42						US Patent # 7,504,253. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof - Patents.com	www.patents.com	0	0		
1164	chr5	75942021	75948561	3500251200	106		75942021	75948561	8421504	4	2,38,42,24	0,2187,2231,6516	c	350025120000000070,350025120000000071,350025120000000079	5-45,0-42,18-42						Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof - US Patent 7504253 Description	ww.patentstorm.us	0	0		
1164	chr5	75942021	75948561	3500014025	106		75942021	75948561	8421504	4	2,38,42,24	0,2187,2231,6516	c	350001402500000067,350001402500000068,350001402500000076	5-45,0-42,18-42						US Patent # 7,087,386. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
1164	chr5	75942021	75944294	3500114953	88		75942021	75944294	8421504	2	2,86	0,2187	c	350011495300000070,350011495300000105,350011495300000071	8-48,0-47,0-48						NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
1164	chr5	75944213	75944260	3500295516	47		75944213	75944260	8421504	1	47	0	g	350029551600000102	0-47						NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
1164	chr5	75944213	75944260	3500096613	47		75944213	75944260	8421504	1	47	0	c	350009661300000102	0-47						US Patent # 6,638,734. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
1164	chr5	75944246	75944294	3500396061	48		75944246	75944294	8421504	1	48	0	c	350039606100000068	0-48						Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto	Reed	2000	0		
1164	chr5	75996820	75996846	3500454505	24		75996820	75996846	8421504	2	19,5	0,21	g	350045450500000102	13-37					Patent	Recombinant fowlpox viruses and uses thereof (Patent US:6001369)	Cochran	1999	0		
145	chr5	76232826	76288965	3500033213	600		76232826	76288965	8421504	5	121,83,112,122,162	0,45490,53604,54771,55977	p	350003321300015013,350003321300015014,350003321300015015,350003321300015016,350003321300015017	0-120,0-120,0-120,0-120,0-120						WOUND CARE COMPOSITIONS - KIMBERLY-CLARK WORLDWIDE, INC.	www.sumobrain.com	0	0		TIMP3
145	chr5	76232868	76289001	3500123766	594		76232868	76289001	8421504	5	79,83,112,122,198	0,45448,53562,54729,55935	p,c	350012376600015021,350012376600000005,350012376600015024,350012376600015023	24-165,0-567,0-417,0-138						Raav vector compositions and methods for the treatment of choroidal neovascularization	Hauswirth	2003	0		
145	chr5	76232895	76289001	3500390135	567		76232895	76289001	8421504	5	52,83,112,122,198	0,45421,53535,54702,55908	c	350039013500000024	0-567						Raav Vector Compositions And Methods For The Treatment Of Choroidal Neovascularization 	.freshpatents.com	0	0		
145	chr5	76232895	76289001	3500390135	567		76232895	76289001	8421504	5	52,83,112,122,198	0,45421,53535,54702,55908	c	350039013500000005	0-567						Raav Vector Compositions And Methods For The Treatment Of Choroidal Neovascularization 	.freshpatents.com	0	0		
1167	chr5	76286535	76287641	3500242230	51		76286535	76287641	8421504	2	7,44	0,1062	p	350024223000015015	0-51						Wound care compositions	Quirk	2005	0		TIMP3
1167	chr5	76287659	76287693	3500260320	34		76287659	76287693	8421504	1	34	0	g	350026032000000015	47-81						Increased Levels of Catalase and Cathepsin V/L2 but Decreased TIMP-1 in Keratoconus Corneas: Evidence that Oxidative Stress Plays a Role in This Disorder	www.iovs.org	0	0		TIMP3
1167	chr5	76288979	76289006	3500369994	27		76288979	76289006	8421504	1	27	0	c	350036999400000001	0-27						Adam proteins and uses thereof	Croucher	1997	0		
1167	chr5	76289464	76289488	3500462501	23		76289464	76289488	8421504	2	18,5	0,19	c	350046250100000081	15-38						FAKULT&#xc4;T F&#xdc;R CHEMIE UND HARMAZIE	b.uni-muenchen.de	0	0		
1167	chr5	76289837	76289860	3500179598	23		76289837	76289860	8421504	1	23	0	c	350017959800000001	17-40						Endothelial cells express a unique transcriptional profile under very high wall shear stress known to induce expansive arterial remodeling	g.library.pcc.edu	0	0		
1167	chr5	76320448	76320472	3500360091	23		76320448	76320472	8421504	2	4,19	0,5	g	350036009100000001,350036009100000000,350036009100000006,350036009100000005	6-31,5-30,6-31,5-30						HIV-1 Envelope Glycoprotein Oligomer and Methods of Use - Patent application	www.faqs.org	0	0		
1167	chr5	76352834	76352857	3500142873	23		76352834	76352857	8421504	1	23	0	g	350014287300000257	0-23						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
18	chr5	76529852	76562575	3500271916	1815		76529852	76562575	8421504	14	43,138,419,43,107,1,464,24,405,14,31,95,7,24	0,982,2317,7485,10487,10624,12136,27431,27457,27883,29440,29474,32634,32699	p,c	350027191600015010,350027191600015011,350027191600015012,350027191600015013,350027191600015015,350027191600015016,350027191600015017,350027191600015018,350027191600015019,350027191600000002,350027191600000003,350027191600015009,350027191600015007,350027191600015006,350027191600015005,350027191600000001,350027191600000000	0-150,0-150,0-150,0-150,0-150,0-120,0-150,0-150,0-45,0-24,8-30,9-1056,0-129,0-45,0-102,8-30,0-24						Identification of bovine hibernation-specific protein complex and evidence of its regulation in fasting and aging. - ResearchGate	.researchgate.net	0	0		
1169	chr5	76557279	76557306	3500456727	26		76557279	76557306	8421504	2	10,16	0,11	c	350045672700000055	18-44					Patent	Recombinant plant expressing non-competitively binding insecticidal crystal proteins (Patent US:5866784)	Botterman	1999	0		
1169	chr5	76557279	76557306	3500376795	26		76557279	76557306	8421504	2	10,16	0,11	c	350037679500000055	18-44						Recombinant plant expressing non-competitively binding insecticidal crystal proteins	Mellaert	1995	0		
1169	chr5	76637909	76639022	3500242436	174		76637909	76639022	8421504	4	69,15,69,21	0,1002,1020,1092	p	350024243600015133	0-174						Novel polypeptides and nucleic acids encoding same	Burgess	2002	0		
1171	chr5	76925692	76925720	3500435538	23		76925692	76925720	8421504	2	7,16	0,12	g	350043553800000001	10-33		21415150	10.1681/ASN.2010070722		Journal of the American Society of Nephrology : JASN	Circulating Bone Morphogenetic Protein 1&#x2013;3 Isoform Increases Renal Fibrosis	Lovorka	2011	0		
1172	chr5	77044277	77044301	3500186557	23		77044277	77044301	8421504	2	19,4	0,20	g	350018655700000895	4-28						Oligonucleotide for Detection of a Microorganism, Diagnostic Kits and Methods for Detection of Microorganisms Using the Oligonucleotide - Patent application	www.faqs.org	0	0		
1175	chr5	77427410	77427436	3500238590	24		77427410	77427436	8421504	3	11,8,5	0,12,21	g	350023859000000024	1-34						Modified laminin and use thereof	Nakagawa	2012	0		
1176	chr5	77555120	77555150	3500353089	26		77555120	77555150	8421504	2	11,15	0,15	g	350035308900000018	3-29						Novel truncating mutations of the CHM gene in Chinese patients with choroideremia. - ResearchGate	.researchgate.net	0	0		
1178	chr5	77742810	77742841	3500109714	27		77742810	77742841	8421504	3	5,7,15	0,7,16	g	350010971400000195	3-30						Plant fatty acid synthases	Knauf	1991	0		
1181	chr5	78242615	78242639	3500241895	23		78242615	78242639	8421504	2	8,15	0,9	g	350024189500000002	13-36						Methods, products and uses involving platelets and/or the vasculature	Boucher	2006	0		
1183	chr5	78452253	78452282	3500082764	24		78452253	78452282	8421504	2	7,17	0,12	g	350008276400000019	1-25						An enzyme with arabinanase activity	Andersen	1995	0		
1184	chr5	78541665	78541689	3500100734	23		78541665	78541689	8421504	2	11,12	0,12	g	350010073400000293	15-43						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
1184	chr5	78611524	78611547	3500142873	23		78611524	78611547	8421504	1	23	0	g	350014287300000266	0-23						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
1184	chr5	78613226	78613254	3500410205	23		78613226	78613254	8421504	2	9,14	0,14	g	350041020500000028	0-34						CONJUGATES OF NUCLEOTIDES AND METHOD FOR THE APPLICATION THEREOF	Becker	2010	0		
1184	chr5	78617549	78617573	3500306430	23		78617549	78617573	8421504	2	8,15	0,9	g	350030643000000004	11-34						Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars - Patent application	www.faqs.org	0	0		
1185	chr5	78666441	78671608	3500430548	38		78666441	78671608	8421504	4	3,16,17,2	0,1157,3910,5165	c	350043054800000000,350043054800000001	0-19,0-19						Identification and Functional Characterization of microRNAs regulated by Oxidative Stress	search.cgu.edu.tw	0	0		HMOX1
1185	chr5	78667605	78667630	3500294877	25		78667605	78667630	8421504	1	25	0	c	350029487700000000	0-25						Transcriptome analysis of human cancer reveals a functional role of Heme Oxygenase-1 in tumor cell adhesion	ecular-cancer.com	0	0		
1185	chr5	78669935	78670160	3500047878	40		78669935	78670160	8421504	2	20,20	0,205	c,g	350004787800000046,350004787800000046,350004787800000047,350004787800000047	0-20,0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1185	chr5	78670226	78670306	3500461012	67		78670226	78670306	8421504	3	20,27,20	0,21,60	c	350046101200000000,350046101200000002,350046101200000001	0-20,0-27,0-20		18854316	10.1074/jbc.M807036200		The Journal of Biological Chemistry	Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/Akt-2 Pathway	Pedro	2008	0		
1185	chr5	78670355	78671616	3500340650	23		78670355	78671616	8421504	2	13,10	0,1251	c	350034065000000000	0-23						Xyloketal B Exhibits Its Antioxidant Activity through Induction of HO-1 in Vascular Endothelial Cells and Zebrafish	www.mdpi.com	0	0		
1185	chr5	78670357	78671624	3500410139	29		78670357	78671624	8421504	2	11,18	0,1249	c	350041013900000005	0-29						Free Radical Biology and Medicine	age.myvoffice.com	0	0		
1185	chr5	78670357	78671624	3500405389	29		78670357	78671624	8421504	2	11,18	0,1249	c	350040538900000005	0-29						2009 Protandim Clinical	www.scribd.com	0	0		
1185	chr5	78670357	78671624	3500400562	29		78670357	78671624	8421504	2	11,18	0,1249	c	350040056200000005	0-29						Free Radical Biology and Medicine	liveithope.com	0	0		
1185	chr5	78670357	78671624	3500376948	29		78670357	78671624	8421504	2	11,18	0,1249	c	350037694800000005	0-29						Free Radical Biology and Medicine	thywithhealth.com	0	0		
1185	chr5	78670357	78671624	3500367608	29		78670357	78671624	8421504	2	11,18	0,1249	c	350036760800000005	0-29						Free Radical Biology and Medicine	inhealthtoday.com	0	0		
1185	chr5	78670357	78671624	3500317623	29		78670357	78671624	8421504	2	11,18	0,1249	c	350031762300000005	0-29						Free Radical Biology and Medicine	eeradicalsnow.com	0	0		
1185	chr5	78670357	78671624	3500233431	29		78670357	78671624	8421504	2	11,18	0,1249	c	350023343100000005	0-29						Free Radical Biology and Medicine	tchyourripple.com	0	0		
1185	chr5	78670357	78671624	3500183401	29		78670357	78671624	8421504	2	11,18	0,1249	c	350018340100000005	0-29						2009 FRBM Protandim Synergistic Ally Activates Nrf2	www.scribd.com	0	0		
1185	chr5	78670357	78671624	3500115784	29		78670357	78671624	8421504	2	11,18	0,1249	c	350011578400000005	0-29						Free Radical Biology and Medicine	liveitfreedom.com	0	0		
1185	chr5	78670357	78671624	3500106691	29		78670357	78671624	8421504	2	11,18	0,1249	c	350010669100000005	0-29						Glutathione Dec 2008 Paper	ww.slideshare.net	0	0		
1185	chr5	78670357	78671624	3500037115	29		78670357	78671624	8421504	2	11,18	0,1249	c	350003711500000005	0-29						Free Radical Biology and Medicine	inrelieftoday.com	0	0		
1185	chr5	78670357	78671624	3500008696	29		78670357	78671624	8421504	2	11,18	0,1249	c	350000869600000005	0-29						Free Radical Biology & Medicine	unginsidesite.com	0	0		
1185	chr5	78673031	78673234	3500274037	40		78673031	78673234	8421504	2	20,20	0,183	c	350027403700000062,350027403700000063	0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1185	chr5	78673056	78694357	3500142873	69		78673056	78694357	8421504	3	23,23,23	0,20542,21278	c,g	350014287300000274,350014287300000269,350014287300000270	0-23,0-23,0-23						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
1187	chr5	78941638	78941683	3500166310	45		78941638	78941683	8421504	1	45	0	p	350016631000015019	0-45						PROTEIN MONOMER, PROTEIN POLYMER OBTAINED FROM SAID MONOMER, AND DEVICE THAT CONTAINS THEM - Patent application	www.faqs.org	0	0		
1187	chr5	78941670	78941694	3500258361	24		78941670	78941694	8421504	1	24	0	c	350025836100000002	0-24		9722578	10.1074/jbc.273.36.23426	0021-9258	Journal of Biological Chemistry	Identification of Myoglobin in Human Smooth Muscle	Qiu	1998	5		
1187	chr5	78941680	78941704	3500257517	24		78941680	78941704	8421504	1	24	0	g	350025751700000008	0-24		16651450	10.1158/0008-5472.CAN-05-4461	0008-5472	Cancer Research	Menin Links Estrogen Receptor Activation to Histone H3K4 Trimethylation	Dreijerink	2006	8		
1187	chr5	79025296	79025326	3500204244	27		79025296	79025326	8421504	3	4,12,11	0,5,19	g	350020424400000062	8-38						US Patent # 5,643,783. Collagen and uses therefor - Patents.com	www.patents.com	0	0		
1190	chr5	79408337	79408364	3500003486	27		79408337	79408364	8421504	1	27	0	g	350000348600000210	4-36						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		
1193	chr5	79701103	79701132	3500326034	23		79701103	79701132	8421504	3	4,7,12	0,5,17	g	350032603400000232	12-35						 Selection Method 	www.docstoc.com	0	0		
1194	chr5	79844125	79875371	3500408788	75		79844125	79875371	8421504	2	30,45	0,31201	p	350040878800015003	6-81						Flightless I is a focal adhesion-associated actin-capping protein that regulates cell migration	www.fasebj.org	0	0		
1194	chr5	79852271	79852296	3500079712	24		79852271	79852296	8421504	2	6,18	0,7	c	350007971200000004	0-24						Cloning and expression of microbial phytase	Luo Bo Te *F*M*V*Ge Xiu Mu 	1991	0		
1194	chr5	79852271	79852296	3500079649	24		79852271	79852296	8421504	2	6,18	0,7	c	350007964900000004	0-24					Patent	Cloning and expression of microbial phytase (Patent CN:1053013)	Luo Bo Te *F*M*V*Ge Xiu Mu 	2000	0		
1194	chr5	79858509	79858534	3500405955	24		79858509	79858534	8421504	2	18,6	0,19	g	350040595500000046	0-24		16943360	10.1095/biolreprod.106.056499	0006-3363	Biology of Reproduction	A Restricted Role for Sperm-Borne MicroRNAs in Mammalian Fertilization	Amanai	2006	4		
1194	chr5	79859635	79897817	3500267554	540		79859635	79897817	8421504	12	45,45,45,45,45,45,45,45,45,45,45,45	0,4014,4437,7065,8933,9029,9809,9857,15694,19896,34239,38137	p	350026755400015057,350026755400015049,350026755400015047,350026755400015042,350026755400015041,350026755400015039,350026755400015037,350026755400015036,350026755400015019,350026755400015017,350026755400015013,350026755400015011	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH RENAL DISEASE - Patent application	www.faqs.org	0	0		
1194	chr5	79873517	79873542	3500384797	25		79873517	79873542	8421504	1	25	0	c	350038479700000000	21-46						Blebbistatin, a Novel Inhibitor of Myosin II ATPase Activity, Increases Aqueous Humor Out&#xfb02;ow Facility in Perfused Enucleated Porcine Eyes	www.iovs.org	0	0		MYH9
1194	chr5	79875303	79893850	3500081570	42		79875303	79893850	8421504	2	20,22	0,18525	c,g	350008157000000001,350008157000000000,350008157000000000	0-20,0-22,0-22			10.1113/jphysiol.2002.025494	0022-3751	The Journal of Physiology	Effects of thyroxine on myosin isoform expression and mechanical properties in guinea-pig smooth muscle	Lofgren	2002	5		
1195	chr5	79976403	79976431	3500327191	23		79976403	79976431	8421504	2	13,10	0,18	g	350032719100000107	5-37						N-GLYCOSYLATED HUMAN GROWTH HORMONE WITH PROLONGED CIRCULATORY HALF-LIFE - Patent application	www.faqs.org	0	0		
1195	chr5	80006933	80051884	3500142873	111		80006933	80051884	8421504	5	22,23,21,23,22	0,8964,9772,44123,44929	c,g	350014287300000278,350014287300000280,350014287300000099,350014287300000279,350014287300000282,350014287300000281	0-22,0-22,21-44,0-21,0-23,0-22						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
1195	chr5	80013695	80013720	3500303532	25		80013695	80013720	8421504	1	25	0	c	350030353200000047	0-25						DEPARTAMENT DE GENATICA ESTUDIO DE FACTORES GENATICOS DE LOS SISTEMAS RELACIONADOS CON ESTRAS OX	www.tdx.cat	0	0		
1195	chr5	80041658	80041689	3500366005	26		80041658	80041689	8421504	2	17,9	0,22	g	350036600500000000	9-35			10.1046/j.1365-3083.2001.00919.x	1365-3083	Scandinavian Journal of Immunology	In vitro Evaluation of an Enhanced Human Serum Amyloid A (SAA2) Promoter-Regulated Soluble TNF Receptor Fusion Protein for Anti-Inflammatory Gene Therapy - Rygg - 2001 - Scandinavian Journal of Immunology - Wiley Online Library	Rygg	2001	0		
1195	chr5	80048638	80049123	3500344270	45		80048638	80049123	8421504	2	11,34	0,451	p	350034427000015072	111-156						@IL23_3198:2:1:0:199/1 NCGGAACCGGGCGGAAACACCATCGTATGCCGTCTTC + &0;;;;:9:;:7;;;;;;;;;;;;;;;;;;;;;;;:8	rse.iop.kcl.ac.uk	0	0		
1195	chr5	80048638	80049123	3500057196	45		80048638	80049123	8421504	2	11,34	0,451	p	350005719600015132,350005719600015122	18-63,42-87						OSJNBa0063K04.30	p.dna.affrc.go.jp	0	0		
1195	chr5	80049135	80060238	3500187080	1587		80049135	80060238	8421504	13	238,143,130,86,131,148,133,113,73,86,137,46,123	0,500,2865,3087,4320,5076,5625,6507,7413,8047,9376,10663,10980	p	350018708000015025	0-1587						186 human secreted proteins	Bednarik	2003	0		EIF3D
1195	chr5	80049135	80060238	3500053947	1587		80049135	80060238	8421504	13	238,143,130,86,131,148,133,113,73,86,137,46,123	0,500,2865,3087,4320,5076,5625,6507,7413,8047,9376,10663,10980	p	350005394700015025	0-1587						186 human secreted proteins	Bednarik	2003	0		EIF3D
1195	chr5	80052248	80052296	3500431918	48		80052248	80052296	8421504	1	48	0	p	350043191800015013	0-48						Riboproteomics of the Hepatitis C Virus Internal Ribosomal Entry Site	gs.washington.edu	0	0		EIF3D
1196	chr5	80092940	80093234	3500177512	123		80092940	80093234	8421504	2	66,57	0,237	p	350017751200015002,350017751200015014	69-135,0-57						Untersuchungen zur Wechselwirkung von AMPA-Rezeptoren mit TARPs	uhr-uni-bochum.de	0	0		CACNG2
1196	chr5	80093153	80093207	3500453405	54		80093153	80093207	8421504	1	54	0	p	350045340500015000	0-54			10.1186/1471-2202-4-23	1471-2202	BMC Neuroscience	Human neuronal stargazin-like proteins, &#xce;&#xb3;2, &#xce;&#xb3;3 and &#xce;&#xb3;4; an investigation of their specific localization in human brain and their influence on CaV2.1 voltage-dependent calcium channels expressed in Xenopus oocytes.	Moss	2003	3		CACNG2
1196	chr5	80093153	80093207	3500386060	54		80093153	80093207	8421504	1	54	0	p	350038606000015000	0-54			10.1186/1471-2202-4-23		BMC Neuroscience	Human neuronal stargazin-like proteins, &#x03b3;2, &#x03b3;3 and &#x03b3;4; an investigation of their specific localization in human brain and their influence on CaV2.1 voltage-dependent calcium channels expressed in Xenopus oocytes.	Fraser	2003	0		CACNG2
1197	chr5	80240066	80240092	3500409632	26		80240066	80240092	8421504	1	26	0	c	350040963200000005	15-41						Heterocyclic compound	Mochizuki	2010	0		CACNG2
1197	chr5	80240066	80240092	3500299447	26		80240066	80240092	8421504	1	26	0	c	350029944700000002	15-41						Heterocyclic compound	Miura	2011	0		CACNG2
1197	chr5	80240066	80240092	3500059863	26		80240066	80240092	8421504	1	26	0	c	350005986300000002	15-41						HETEROCYCLIC COMPOUND AND USE THEREOF - TAKEDA PHARMACEUTICAL COMPANY LIMITED	www.sumobrain.com	0	0		
1197	chr5	80341180	80341240	3500269671	58		80341180	80341240	8421504	3	19,17,22	0,20,38	c	350026967100000001,350026967100000012	0-19,0-39						Microarray analysis in caudal medulla of cattle orally challenged with bovine spongiform encephalopathy	w.funpecrp.com.br	0	0		
1197	chr5	80343026	80343060	3500204204	34		80343026	80343060	8421504	1	34	0	c,g	350020420400000008,350020420400000004,350020420400000004	0-24,0-20,0-20						In Vivo Labeling of Parvalbumin-Positive Interneurons and Analysis of Electrical Coupling in Identi&#xfb01;ed Neurons	www.jneurosci.org	0	0		
1198	chr5	80415997	80416024	3500096358	23		80415997	80416024	8421504	3	6,12,5	0,8,22	g	350009635800000006	4-27					Patent	Epithelins: novel cysteine-rich growth modulating proteins (Patent US:5416192)	Plowman	1995	0		
1198	chr5	80422586	80422612	3500402411	23		80422586	80422612	8421504	2	7,16	0,10	g	350040241100000000	20-43						$i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF	Dunn	2001	0		
1198	chr5	80422586	80422612	3500243137	23		80422586	80422612	8421504	2	7,16	0,10	g	350024313700000000	20-43					Patent	Chlamydia antigene, entsprechende dna-fragmente und ihre verwendungen Chlamydia antigens, appropriate DNA fragments and their uses (Patent DE:69938059)	DUNN	2009	0		
1199	chr5	80511171	80511201	3500072483	25		80511171	80511201	8421504	2	8,17	0,13	c	350007248300000469	14-39						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
1199	chr5	80585345	80591594	3500396186	891		80585345	80591594	8421504	2	296,595	0,5654	p	350039618600015039,350039618600015038	0-810,0-81						Compositions and Methods for the Delivery of Biologically Active RNAs	Polach	2012	0		
1199	chr5	80585345	80591594	3500175950	891		80585345	80591594	8421504	2	296,595	0,5654	p	350017595000015035,350017595000015190,350017595000015189,350017595000015188,350017595000015186,350017595000015185,350017595000015184,350017595000015183,350017595000015181,350017595000015180,350017595000015179,350017595000015178,350017595000015176,350017595000015175,350017595000015174,350017595000015034	0-810,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-81						Compositions And Methods For The Delivery Of Biologically Active RNAs - Patent application	www.faqs.org	0	0		
1199	chr5	80585399	80591060	3500153192	180		80585399	80591060	8421504	4	87,21,42,30	0,96,189,5631	p	350015319200015036,350015319200015035	0-87,0-93						Biochemical and genetic characterization of mercaptopyruvate sulfurtransferase and paralogous putative sulfurtransferases of Escherichia coli	cholar.lib.vt.edu	0	0		
1200	chr5	80641457	80641481	3500441425	23		80641457	80641481	8421504	2	14,9	0,15	g	350044142500000075	9-32						IMMUNOCONJUGATES COMPRISING CD4 AND IMMUNOGLOBIN MOLECULES FOR THE TREATMENT OF HIV INFECTION - Patent application	www.faqs.org	0	0		
1201	chr5	80766574	80775967	3500142873	230		80766574	80775967	8421504	10	22,22,22,22,24,22,22,22,22,30	0,3797,3847,4487,4538,5755,6523,7499,9034,9363	g	350014287300000307,350014287300000299,350014287300000302,350014287300000297,350014287300000115,350014287300000300,350014287300000295,350014287300000296,350014287300000293,350014287300000292,350014287300000287,350014287300000110,350014287300000289	0-22,0-22,0-22,0-22,21-45,0-23,0-22,0-22,0-22,0-22,0-24,0-23,0-23						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
1201	chr5	80792132	80792180	3500441132	48		80792132	80792180	8421504	1	48	0	p	350044113200015080	0-48						US Patent # 6,277,564. Assays and reagents for identifying anti-fungal agents, and uses related thereto - Patents.com	ww.es.patents.com	0	0		RAC1
1201	chr5	80792132	80792180	3500003558	48		80792132	80792180	8421504	1	48	0	p	350000355800015080	0-48						US Patent # 6,277,564. Assays and reagents for identifying anti-fungal agents, and uses related thereto - Patents.com	www.patents.com	0	0		RAC1
1201	chr5	80792132	80792177	3500009992	45		80792132	80792177	8421504	1	45	0	p	350000999200015104	0-45						Assays and reagents for identifying anti-fungal agents, and uses related thereto	Berlin	1998	0		RAC1
1201	chr5	80795486	80807398	3500178088	86		80795486	80807398	8421504	2	66,20	0,11892	p,g	350017808800015020,350017808800000021	3-69,0-20						[tel-00148919, v1] PHYSIOPATHOLOGIE DE L'ARTHROSE : R&#xd4;LE DE LA NADPH OXYDASE NOX 4 DANS L'EXPRESSION DE LA COLLAG&#xc9;NASE, MMP-1.	hives-ouvertes.fr	0	0		RAC2
1201	chr5	80795984	80796007	3500303532	23		80795984	80796007	8421504	1	23	0	g	350030353200000071	1-24						DEPARTAMENT DE GENATICA ESTUDIO DE FACTORES GENATICOS DE LOS SISTEMAS RELACIONADOS CON ESTRAS OX	www.tdx.cat	0	0		
1201	chr5	80796793	80805184	3500466479	51		80796793	80805184	8421504	2	37,14	0,8377	c	350046647900000017,350046647900000018,350046647900000004,350046647900000003	0-51,0-51,0-28,0-28						Strukturelle Voraussetzungen der Rac2-vermittelten Aktivierung der Phospholipase C-&#x03b3;	vts.uni-ulm.de	0	0		
1201	chr5	80807374	80807402	3500251927	28		80807374	80807402	8421504	1	28	0	c	350025192700000000,350025192700000004	8-33,9-37		10961859		0006-4971	Blood	Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency	Williams	2000	10		
1201	chr5	80807374	80807399	3500235338	25		80807374	80807399	8421504	1	25	0	c	350023533800000005	8-33						EphA4 POLYPEPTIDE HAVING A NOVEL ACTIVITY AND USE THEREOF	Inoue	2008	0		
1202	chr5	80954055	80954081	3500010223	23		80954055	80954081	8421504	2	14,9	0,17	g	350001022300000000	0-24		12958309	10.1074/jbc.M305150200	0021-9258	Journal of Biological Chemistry	Oscillatory Shear Stress Stimulates Endothelial Production of from p47phox-dependent NAD(P)H Oxidases, Leading to Monocyte Adhesion	Hwang	2003	5		
1202	chr5	80966143	80967626	3500183613	69		80966143	80967626	8421504	2	25,44	0,1439	p	350018361300015055	0-69						Myosin-X associates with regions of dynamic actin	cs.biologists.org	0	0		CYTH1
1209	chr5	81876863	81876887	3500135883	23		81876863	81876887	8421504	2	11,12	0,12	g	350013588300000047	11-35						Genetic engineering of Staphylococcus gallinarum	n.library.ethz.ch	0	0		
1213	chr5	82421007	82435554	3500379064	40		82421007	82435554	8421504	2	20,20	0,14527	c,g	350037906400000002,350037906400000003,350037906400000003	0-20,0-20,0-20		20348237	10.2353/ajpath.2010.090737		The American Journal of Pathology	Desmosomal Plakophilins in the Prostate and Prostatic Adenocarcinomas : Implications for Diagnosis and Tumor Progression	Sonja	2010	0		PKP2
1214	chr5	82510985	82511117	3500273330	132		82510985	82511117	8421504	1	132	0	p	350027333000015022	39-171						43 human secreted proteins	Komatsoulis	2001	0		
1214	chr5	82515368	82515392	3500187222	24		82515368	82515392	8421504	1	24	0	c	350018722200000001	0-24						Alterations in c-Myc phenotypes resulting from dynamin-related protein 1 (Drp1)-mediated mitochondrial fission. - ResearchGate	.researchgate.net	0	0		DNM1L
1214	chr5	82526571	82574812	3500288668	405		82526571	82574812	8421504	7	16,104,79,56,57,36,57	0,3333,3461,4723,24314,48139,48184	p	350028866800015115,350028866800015104,350028866800015038	0-120,0-135,0-150						Supplemental Data A Dynamin Is Required for the Biogenesis of Secretory	download.cell.com	0	0		DNM1L
1214	chr5	82574729	82574754	3500065599	25		82574729	82574754	8421504	1	25	0	c	350006559900000007	0-25		23788031	10.1038/cddis.2013.188		Cell Death & Disease	Eleostearic acid induces RIP1-mediated atypical apoptosis in a kinase-independent manner via ERK phosphorylation, ROS generation and mitochondrial dysfunction	S	June	0		DNM1L
1214	chr5	82574729	82574754	3500025881	25		82574729	82574754	8421504	1	25	0	c	350002588100000007	0-25		23788031	10.1038/cddis.2013.188	false	Cell Death & Disease	Eleostearic acid induces RIP1-mediated atypical apoptosis in a kinase-independent manner via ERK phosphorylation, ROS generation and mitochondrial dysfunction	Obitsu	2013	0		DNM1L
1220	chr5	83243779	83243803	3500460984	23		83243779	83243803	8421504	2	13,10	0,14	g	350046098400000006	9-38					Patent	Coordinate in vivo gene expression (Patent US:6995008)	Liu	2006	0		
1222	chr5	83579000	83579031	3500028050	26		83579000	83579031	8421504	3	7,15,4	0,11,27	c	350002805000000542	22-49						Stress response and virulence in Salmonella Typhimurium: a genomics approach	edepot.wur.nl	0	0		
1223	chr5	83747624	83747652	3500207448	23		83747624	83747652	8421504	3	12,5,6	0,14,22	g	350020744800000001	2-26						THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 274, No. 19, Issue of May 7, pp. 13443&#x2013;13450, 1999 &#xa9; 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Immunosuppressant PG490 (Triptolide) Inhibits T-cell Inte	www.stanford.edu	0	0		
1225	chr5	83887180	83887207	3500159576	23		83887180	83887207	8421504	2	10,13	0,14	g	350015957600000015	14-37						Expression of tetanus toxin fragment C in yeast - Patent # 5389540 - PatentGenius	.patentgenius.com	0	0		
1225	chr5	83932475	83932499	3500256291	23		83932475	83932499	8421504	2	13,10	0,14	g	350025629100000007	0-23		17644627	10.1104/pp.107.101162	0032-0889	Plant Physiology	Enzymatic Properties and Subcellular Localization of Arabidopsis &#x03b2;-N-Acetylhexosaminidases	Strasser	2007	7		
1225	chr5	83963344	83963371	3500319022	24		83963344	83963371	8421504	3	7,3,14	0,8,13	g	350031902200000010	0-24		20398062	10.1111/j.1601-183X.2010.00588.x		Genes, brain, and behavior	Epigenetic Regulation of Serotonin Transporter Expression and Behavior in Infant Rhesus Macaques	Erin	2010	0		
1230	chr5	84634858	84634882	3500448111	23		84634858	84634882	8421504	2	10,13	0,11	g	350044811100000025	0-23						Method for tapping the immunological repertoire	Winter	1992	0		
1230	chr5	84634858	84634882	3500435564	23		84634858	84634882	8421504	2	10,13	0,11	g	350043556400000044	0-23						Heterodimeric receptor libraries using phagemids	Barbas	1994	0		
1230	chr5	84634858	84634882	3500389152	23		84634858	84634882	8421504	2	10,13	0,11	g	350038915200000058	0-23					Patent	Heterodimeric receptor libraries using phagemids (Patent US:5759817)	Barbas	1998	0		
1230	chr5	84634858	84634882	3500107724	23		84634858	84634882	8421504	2	10,13	0,11	g	350010772400000043	0-23					Patent	Heterodimeric receptor libraries using phagemids (Patent US:6468738)	Kang	2002	0		
1230	chr5	84634858	84634882	3500027157	23		84634858	84634882	8421504	2	10,13	0,11	g	350002715700000110	0-23						US Patent # 6,680,192. Method for producing polymers having a preselected activity - Patents.com	www.patents.com	0	0		
1235	chr5	85283946	85283972	3500148414	23		85283946	85283972	8421504	2	15,8	0,18	g	350014841400000682	0-23						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
1236	chr5	85404180	85404209	3500182270	24		85404180	85404209	8421504	3	11,3,10	0,12,19	g	350018227000000012	2-26						Interleukin-18 (IL-18) receptor polypeptides and their uses	Torigoe	1997	0		
1237	chr5	85575943	85575970	3500397843	23		85575943	85575970	8421504	2	17,6	0,21	g	350039784300000085	6-32					Patent	Influenza immunogen and vaccine (Patent US:8017127)	Birkett	2011	0		
1237	chr5	85575943	85575970	3500376453	23		85575943	85575970	8421504	2	17,6	0,21	g	350037645300000125	6-32						IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE	Birkett	2005	0		
1237	chr5	85575943	85575970	3500374502	23		85575943	85575970	8421504	2	17,6	0,21	g	350037450200000167	6-32						STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES	Birkett	2005	0		
1237	chr5	85575943	85575970	3500371444	23		85575943	85575970	8421504	2	17,6	0,21	g	350037144400000093	6-32						Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis	Friede	2005	0		
1237	chr5	85575943	85575970	3500292519	23		85575943	85575970	8421504	2	17,6	0,21	g	350029251900000078	6-32						Influenza immunogen and vaccine	Birkett	2006	0		
1237	chr5	85575943	85575970	3500280084	23		85575943	85575970	8421504	2	17,6	0,21	g	350028008400000093	6-32						STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS	Friede	2004	0		
1237	chr5	85575943	85575970	3500212616	23		85575943	85575970	8421504	2	17,6	0,21	g	350021261600000125	6-32						IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE	Birkett	2005	0		
1237	chr5	85575943	85575970	3500122392	23		85575943	85575970	8421504	2	17,6	0,21	g	350012239200000078	6-32						Influenza immunogen and vaccine	Birkett	2006	0		
1237	chr5	85575943	85575970	3500034954	23		85575943	85575970	8421504	2	17,6	0,21	g	350003495400000085	6-32						Influenza immunogen and vaccine	Birkett	2007	0		
1237	chr5	85575943	85575970	3500021850	23		85575943	85575970	8421504	2	17,6	0,21	g	350002185000000078	6-32					Patent	Influenza immunogen and vaccine (Patent US:7361352)	Birkett	2008	0		
1237	chr5	85575943	85575970	3500013160	23		85575943	85575970	8421504	2	17,6	0,21	g	350001316000000155	6-32						Influenza immunogen and vaccine	A*Bi Er Ke Te 	2007	0		
1248	chr5	86930248	86930293	3500065685	45		86930248	86930293	8421504	1	45	0	p	350006568500015131	0-45						Planaria EST Database	an.bio.keio.ac.jp	0	0		CCDC91
1252	chr5	87448981	87449008	3500408175	23		87448981	87449008	8421504	2	16,7	0,20	g	350040817500000052	3-27						 Poly 	www.docstoc.com	0	0		
1252	chr5	87512121	87512149	3500448967	28		87512121	87512149	8421504	1	28	0	g	350044896700000008,350044896700000002	0-28,0-27			10.1186/1476-4598-2-20	1476-4598	Molecular Cancer	Interfering with TGF&#xce;&#xb2;-induced Smad3 nuclear accumulation differentially affects TGF&#xce;&#xb2;-dependent gene expression	Lindemann	2003	4		PTHLH
1252	chr5	87519054	87519156	3500343940	102		87519054	87519156	8421504	1	102	0	p	350034394000015002	0-102						Method of inhibiting lipofibroblast to myofibroblast transdifferentiation	Torday	2003	0		PTHLH
1252	chr5	87519054	87519156	3500187271	102		87519054	87519156	8421504	1	102	0	p	350018727100015020,350018727100015236	0-102,12-57						Antibodies directed to parathyroid hormone (PTH) and uses thereof - US Patent 7288253 Description	ww.patentstorm.us	0	0		PTHLH
1252	chr5	87519096	87519147	3500205196	51		87519096	87519147	8421504	1	51	0	p	350020519600015027,350020519600015031	0-51,0-45						Nucleic acids encoding PTH functional domain conjugate peptides	Gardella	2006	0		PTHLH
1252	chr5	87519159	87519208	3500289625	49		87519159	87519208	8421504	1	49	0	c	350028962500000004,350028962500000003	0-25,0-24			10.1359/jbmr.2005.20.8.1454	1523-4681	Journal of Bone and Mineral Research	Stretch-Induced PTH-Related Protein Gene Expression in Osteoblasts - Chen - 2005 - Journal of Bone and Mineral Research - Wiley Online Library	Chen	2005	0		
1252	chr5	87519180	87519328	3500251519	39		87519180	87519328	8421504	2	20,19	0,129	c,g	350025151900000014,350025151900000014,350025151900000024,350025151900000024,350025151900000015,350025151900000015	0-20,0-20,0-19,0-19,0-19,0-19		15956356	10.1677/jme.1.01799	0952-5041	Journal of Molecular Endocrinology	Gene expression profiling of bovine endometrium during the oestrous cycle: detection of molecular pathways involved in functional changes	Bauersachs	2005	3		
1252	chr5	87519195	87519260	3500124900	42		87519195	87519260	8421504	2	19,23	0,42	c	350012490000000023,350012490000000024	0-19,0-23						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
1252	chr5	87519259	87523897	3500023562	41		87519259	87523897	8421504	2	21,20	0,4618	c	350002356200000000,350002356200000001	0-21,0-20		16322249	10.1158/0008-5472.CAN-05-2630	0008-5472	Cancer Research	Tumor-Derived Interleukin-8 Stimulates Osteolysis Independent of the Receptor Activator of Nuclear Factor-&#x03ba;B Ligand Pathway	Bendre	2005	8		PTHLH
1254	chr5	87806556	87806581	3500159935	25		87806556	87806581	8421504	1	25	0	g	350015993500000009	17-42		16455950	10.1182/blood-2005-11-4745	0006-4971	Blood	Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML	Falini	2006	10		
1255	chr5	87869970	87869994	3500252680	24		87869970	87869994	8421504	1	24	0	g	350025268000000001	9-33		11836260	10.1074/jbc.M110976200	0021-9258	Journal of Biological Chemistry	Liprin &#x03b2;1, a Member of the Family of LAR Transmembrane Tyrosine Phosphatase-interacting Proteins, Is a New Target for the Metastasis-associated Protein S100A4 (Mts1)	Kriajevska	2002	5		
1255	chr5	87923461	87923486	3500211986	23		87923461	87923486	8421504	2	7,16	0,9	g	350021198600000013	7-30		18815134	10.1074/jbc.M801011200	0021-9258	Journal of Biological Chemistry	COP1 Functions as a FoxO1 Ubiquitin E3 Ligase to Regulate FoxO1-mediated Gene Expression	Kato	2008	5		
1255	chr5	87941927	87941957	3500110101	23		87941927	87941957	8421504	3	5,6,12	0,7,18	g	350011010100000000	1-24						Recognition molecules interacting specifically with the active site or cleft of a target molecule	Muyldermans	1999	0		
1258	chr5	88241085	88241130	3500341913	45		88241085	88241130	8421504	1	45	0	p	350034191300015011	0-45						Protein Kinases 	.freshpatents.com	0	0		STK38L
1260	chr5	88590511	88590539	3500183749	25		88590511	88590539	8421504	2	8,17	0,11	g	350018374900000003	0-25						Recombinant multimeric influenza proteins	Rottier	2013	0		
1266	chr5	89313609	89313633	3500463934	23		89313609	89313633	8421504	2	10,13	0,11	g	350046393400000008	3-43						Species-specific genetic identification of Mycobacterium paratuberculosis	Ellingson	1999	0		
1268	chr5	89614111	89614143	3500242494	30		89614111	89614143	8421504	2	24,6	0,26	c	350024249400000132,350024249400000129	5-35,5-35						Taiwan Banded Krait -Bungarotoxins: Novel Isotoxins, Targeting and Gene Organization	.lib.nsysu.edu.tw	0	0		
1268	chr5	89614861	89615283	3500282217	96		89614861	89615283	8421504	2	66,30	0,392	p	350028221700015005,350028221700015006	0-48,0-48						Genetic Marker For Coronary Artery Disease 	.freshpatents.com	0	0		BHLHE41
1268	chr5	89614861	89615283	3500187127	96		89614861	89615283	8421504	2	66,30	0,392	p	350018712700015135,350018712700015136	0-48,0-48						Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof	Smith	1995	0		BHLHE41
1268	chr5	89614876	89615295	3500353322	90		89614876	89615295	8421504	3	45,3,42	0,48,377	p	350035332200015044,350035332200015046	0-45,0-45						Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor - Patent application	www.faqs.org	0	0		BHLHE41
1268	chr5	89624103	89624127	3500317142	24		89624103	89624127	8421504	1	24	0	g	350031714200000008	6-30						Methods Related To Immunostimulatory Nucleic Acid-induced Interferon 	.freshpatents.com	0	0		
1269	chr5	89729593	89729619	3500270988	24		89729593	89729619	8421504	2	15,9	0,17	g	350027098800000002	0-24						Stable expression of triple helical proteins	Galanis	1998	0		
1270	chr5	89829933	89829961	3500115843	23		89829933	89829961	8421504	2	7,16	0,12	g	350011584300000588	4-28						Methods And Compositions For Detecting Sars Virus And Other Infectious Agents 	.freshpatents.com	0	0		
1272	chr5	90059745	90059771	3500014119	24		90059745	90059771	8421504	2	6,18	0,8	g	350001411900000001	2-26		17553793	10.1074/jbc.M611422200	0021-9258	Journal of Biological Chemistry	Inflammatory Signaling Pathways Regulating ApoE Gene Expression in Macrophages	Gafencu	2007	5		
1273	chr5	90197318	90197346	3500159525	23		90197318	90197346	8421504	2	15,8	0,20	g	350015952500000075	9-36						LPS-responsive chs1/beige-like anchor gene and therapeutic applications thereof	Kerr	2002	0		
1276	chr5	90656528	90681745	3500231748	50		90656528	90681745	8421504	3	15,8,27	0,3772,25190	c	350023174800000000,350023174800000001	0-23,0-27			10.1038/sj.onc.1205577	${footerJournalISSN}		Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers		2002	0		
1276	chr5	90656541	90681753	3500421121	41		90656541	90681753	8421504	3	2,18,21	0,3759,25191	c	350042112100000002,350042112100000003	0-20,0-21						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		KRAS
1276	chr5	90656541	90681753	3500404006	61		90656541	90681753	8421504	4	2,18,20,21	0,3759,23995,25191	c,g	350040400600000002,350040400600000005,350040400600000005,350040400600000003	0-20,0-20,0-20,0-21		18687633	10.1074/mcp.M800204-MCP200	1535-9476	Molecular & Cellular Proteomics	Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer	VanMeter	2008	7		KRAS
1276	chr5	90656541	90681753	3500124832	61		90656541	90681753	8421504	4	2,18,20,21	0,3759,23995,25191	c,g	350012483200000002,350012483200000005,350012483200000005,350012483200000003	0-20,0-20,0-20,0-21		18687633	10.1074/mcp.M800204-MCP200		Molecular & Cellular Proteomics : MCP	Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer: Differential Epidermal Growth Factor Receptor (EGPR) Phosphorylation Events Associated with Mutated EGFR Compared with Wild Type*S&#x20de;	Amy	2008	0		KRAS
1276	chr5	90656541	90681753	3500020647	41		90656541	90681753	8421504	3	2,18,21	0,3759,25191	c,g	350002064700000002,350002064700000003,350002064700000003	0-20,0-21,0-21		17894888	10.1186/1477-7827-5-38	1477-7827	Reproductive Biology and Endocrinology	Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro	Dery	2007	2		KRAS
1276	chr5	90656541	90660370	3500302431	72		90656541	90660370	8421504	2	2,70	0,3759	c,g	350030243100000014,350030243100000024,350030243100000023,350030243100000022,350030243100000018,350030243100000019,350030243100000019,350030243100000017,350030243100000027,350030243100000027,350030243100000028,350030243100000025,350030243100000025,350030243100000020,350030243100000020,350030243100000029,350030243100000029	3-25,23-49,24-49,24-49,24-46,24-46,24-46,24-46,24-44,24-44,24-45,0-20,0-20,0-20,0-20,0-21,0-21						Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays	Barany	2000	0		
1276	chr5	90656541	90660321	3500264193	23		90656541	90660321	8421504	2	2,21	0,3759	c	350026419300000031	1-24						HighlyMethylatedGenesinColorectalNeoplasia: ImplicationsforScreening	.aacrjournals.org	0	0		
1276	chr5	90660291	90680611	3500331351	42		90660291	90680611	8421504	2	20,22	0,20298	c,g	350033135100000000,350033135100000005	0-20,0-22						Detection of K-ras Mutations in Lung Carcinomas: Relationship to Prognosis 1	.aacrjournals.org	0	0		KRAS
1276	chr5	90660297	90680624	3500446970	51		90660297	90680624	8421504	2	20,31	0,20296	c,g	350044697000000008,350044697000000011,350044697000000011,350044697000000023	0-20,0-19,0-19,0-21						Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing. - ResearchGate	.researchgate.net	0	0		KRAS
1276	chr5	90660300	90680623	3500006981	79		90660300	90680623	8421504	4	19,20,20,20	0,73,96,20303	c,g	350000698100000017,350000698100000018,350000698100000016,350000698100000016,350000698100000020	17-36,17-37,0-20,0-20,0-20						Estudos moleculares de tecidos normais e tumores malignos de roedores tratados com samambaia Pteridium aquilinum	cadigital.ufmg.br	0	0		
1276	chr5	90660300	90660391	3500132151	81		90660300	90660391	8421504	3	27,27,27	0,30,64	c	350013215100000040,350013215100000042,350013215100000041	0-27,0-27,0-27						Determinants of exacerbation frequency in COPD	scovery.ucl.ac.uk	0	0		KRAS
1276	chr5	90660302	90680631	3500186011	60		90660302	90680631	8421504	3	20,20,20	0,20174,20309	c,g	350018601100000012,350018601100000012,350018601100000014,350018601100000015,350018601100000015	0-20,0-20,0-20,0-20,0-20		10884918	10.1136/mp.53.1.24	1472-4154	Molecular Pathology	p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women	Servomaa	2000	0		KRAS
1276	chr5	90660310	90660385	3500266945	75		90660310	90660385	8421504	1	75	0	c,g	350026694500000006,350026694500000006,350026694500000004	0-64,0-64,1-62						BIOCHEMICAL STUDY OF ENDONUCLEASE V AND ITS APPLICATION IN MUTATION SCANNING	d.lib.clemson.edu	0	0		KRAS
1276	chr5	90660311	90694516	3500447375	53		90660311	90694516	8421504	2	25,28	0,34177	c	350044737500000000,350044737500000001	0-25,0-28						Archives_4(2009)	www.scribd.com	0	0		LYRM5,KRAS
1276	chr5	90660311	90694516	3500366237	62		90660311	90694516	8421504	2	31,31	0,34174	c	350036623700000000,350036623700000001	9-40,8-39			10.1002/ijc.23242	1097-0215	International Journal of Cancer	Differences in antitumor effects of various statins on human pancreatic cancer - Gbelcov&#xe1; - 2007 - International Journal of Cancer - Wiley Online Library	Gbelcova	2008	0		LYRM5,KRAS
1276	chr5	90660311	90694516	3500209360	53		90660311	90694516	8421504	2	25,28	0,34177	c	350020936000000000,350020936000000001	0-25,0-28						01-76 Rev onc 10-2005 1 Cris 2	www.roami.ro	0	0		
1276	chr5	90660311	90681808	3500423872	450		90660311	90681808	8421504	3	111,179,160	0,20174,21337	c	350042387200000001	0-450						Brian Golding, Dick Morton and Wilfried Haerty	ology.mcmaster.ca	0	0		KRAS
1276	chr5	90660311	90660386	3500173250	75		90660311	90660386	8421504	1	75	0	p	350017325000015084,350017325000015085,350017325000015090,350017325000015088,350017325000015092	87-162,27-102,18-93,6-81,0-63						Engineered Listeria and methods of use thereof	Dubensky	2006	0		HRAS
1276	chr5	90660311	90660371	3500395958	60		90660311	90660371	8421504	1	60	0	p	350039595800015000	0-60						Molecular differences betweenhuman and experimental pancreaticobiliarydiversion-induced	gut.bmj.com	0	0		HRAS
1276	chr5	90660311	90660371	3500062834	60		90660311	90660371	8421504	1	60	0	p	350006283400015013,350006283400015018	0-48,0-48						Modified immunoglobulin molecule incorporating an antigen in a non-CDR loop region	Bogen	1997	0		KRAS
1276	chr5	90660311	90660356	3500368564	45		90660311	90660356	8421504	1	45	0	c	350036856400000016,350036856400000018	16-38,0-24						Inhibitors of prenyl-protein transferase	Ciccarone	2000	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500333272	45		90660311	90660356	8421504	1	45	0	c	350033327200000016,350033327200000018	16-38,0-24						Inhibitors of prenyl-protein transferase	William	2000	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500331838	45		90660311	90660356	8421504	1	45	0	c	350033183800000016,350033183800000018	16-38,0-24						Inhibitors of prenyl-protein transferase	Hartman	2000	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500318323	45		90660311	90660356	8421504	1	45	0	c	350031832300000023,350031832300000010,350031832300000012,350031832300000025	16-38,16-38,0-24,0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6127390)	deSolms	2000	0		
1276	chr5	90660311	90660356	3500289096	45		90660311	90660356	8421504	1	45	0	c	350028909600000016,350028909600000018	16-38,0-24						INHIBITORS OF PRENYL-PROTEIN TRANSFERASE - MERCK & CO., INC.	www.sumobrain.com	0	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500272814	45		90660311	90660356	8421504	1	45	0	c	350027281400000015,350027281400000017	16-38,0-24						Inhibitors of prenyl-protein transferase	Hartman	2000	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500269191	45		90660311	90660356	8421504	1	45	0	c	350026919100000016,350026919100000018	16-38,0-24						Inhibitors of prenyl-protein transferase	Dinsmore	2001	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500264949	45		90660311	90660356	8421504	1	45	0	c	350026494900000016,350026494900000018	16-38,0-24						Inhibitors of prenyl-protein transferase	William	2002	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500259939	45		90660311	90660356	8421504	1	45	0	c	350025993900000016,350025993900000018	16-38,0-24						Inhibitors of prenyl-protein transferase	Anthony	2000	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500253343	45		90660311	90660356	8421504	1	45	0	c	350025334300000016,350025334300000018	16-38,0-24						Inhibitors of prenyl-protein transferase	Bell	2005	0		
1276	chr5	90660311	90660356	3500230182	45		90660311	90660356	8421504	1	45	0	c	350023018200000010,350023018200000012	16-38,0-24						Inhibitors of farnesyl-protein transferase	Ciccarone	2001	0		
1276	chr5	90660311	90660356	3500182487	45		90660311	90660356	8421504	1	45	0	c	350018248700000016,350018248700000018	16-38,0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6358956)	Hartman	2002	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500145850	45		90660311	90660356	8421504	1	45	0	c	350014585000000010,350014585000000012	13-35,0-24						Inhibitors of farnesyl-protein transferase	Halczenko	1999	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500131280	45		90660311	90660356	8421504	1	45	0	c	350013128000000016,350013128000000018	16-38,0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6410534)	Dinsmore	2002	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500092255	45		90660311	90660356	8421504	1	45	0	c	350009225500000016,350009225500000018	16-38,0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6358985)	Anthony	2002	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500090200	45		90660311	90660356	8421504	1	45	0	c	350009020000000010,350009020000000012	13-35,0-24						Inhibitors of farnesyl-protein transferase	Desolms	2000	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500034151	45		90660311	90660356	8421504	1	45	0	c	350003415100000016,350003415100000018	16-38,0-24						A METHOD OF TREATING ENDOMETRIOSIS - MERCK & CO., INC.	www.sumobrain.com	0	0		LYRM5,KRAS
1276	chr5	90660311	90660356	3500028334	45		90660311	90660356	8421504	1	45	0	c	350002833400000016,350002833400000018	16-38,0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6562823)	Dinsmore	2003	0		
1276	chr5	90660311	90660356	3500001821	45		90660311	90660356	8421504	1	45	0	c	350000182100000035,350000182100000016,350000182100000037,350000182100000018	16-38,16-38,0-24,0-24						Inhibitors of prenyl-protein transferase	Desolms	1999	0		LYRM5,KRAS
1276	chr5	90660311	90660347	3500283971	36		90660311	90660347	8421504	1	36	0	c	350028397100000010	12-48					Patent	Selection of intracellular immunoglobulins (Patent US:7569390)	Eric	2009	0		
1276	chr5	90660311	90660335	3500279095	24		90660311	90660335	8421504	1	24	0	c	350027909500000008	0-24					Patent	In-situ methods for analyzing target sequences using linear beacons (Patent US:6649349)	Gildea	2003	0		
1276	chr5	90660311	90660335	3500038466	24		90660311	90660335	8421504	1	24	0	c	350003846600000008	0-24						Methods, kits and compositions pertaining to linear beacons	Gildea	2009	0		
1276	chr5	90660313	90694400	3500373249	50		90660313	90694400	8421504	3	31,18,1	0,21477,34086	c	350037324900000022,350037324900000017	0-31,0-19						Method for amplifying specific nucleic acid sequences	Todd	1998	0		
1276	chr5	90660313	90694400	3500010249	70		90660313	90694400	8421504	4	31,20,18,1	0,34,21477,34086	c,g	350001024900000032,350001024900000026,350001024900000027	0-31,12-32,0-19						Method for amplifying specific nucleic acid sequences in the presence of a thermostable restriction endonuclease	Todd	1998	0		
1276	chr5	90660313	90680562	3500414235	52		90660313	90680562	8421504	2	31,21	0,20228	c,g	350041423500000000,350041423500000001,350041423500000001	0-31,0-21,0-21		16489012	10.1158/0008-5472.CAN-05-2521	0008-5472	Cancer Research	Multiple Oncogenic Changes (K-RASV12, p53 Knockdown, Mutant EGFRs, p16 Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells	Sato	2006	8		KRAS
1276	chr5	90660313	90680562	3500305606	52		90660313	90680562	8421504	2	31,21	0,20228	c	350030560600000000,350030560600000001	0-31,0-21		16489012	10.1158/0008-5472.CAN-05-2521	0008-5472	Cancer Research	Multiple Oncogenic Changes (K-RASV12, p53 Knockdown, Mutant EGFRs, p16 Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells	Sato	2006	8		
1276	chr5	90660313	90680562	3500224789	52		90660313	90680562	8421504	2	31,21	0,20228	c	350022478900000008,350022478900000009	0-31,0-21		21306997	10.1158/1535-7163.MCT-10-0750	1535-7163	Molecular Cancer Therapeutics	Knockdown of Oncogenic KRAS in Non&#x2013;Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy	Sunaga	2011	5		KRAS
1276	chr5	90660313	90680562	3500099530	52		90660313	90680562	8421504	2	31,21	0,20228	c,g	350009953000000000,350009953000000001,350009953000000001	0-31,0-21,0-21		16489012	10.1158/0008-5472.CAN-05-2521	0008-5472	Cancer Research	Multiple Oncogenic Changes (K-RASV12, p53 Knockdown, Mutant EGFRs, p16 Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells	Sato	2006	8		KRAS
1276	chr5	90660313	90660373	3500191877	40		90660313	90660373	8421504	2	20,20	0,40	c,g	350019187700000001,350019187700000001,350019187700000002,350019187700000002	0-20,0-20,0-20,0-20						&#x8db3;&#x7acb; &#x8ce2;	.wul.waseda.ac.jp	0	0		KRAS
1276	chr5	90660314	90680641	3500320939	76		90660314	90680641	8421504	3	30,21,25	0,20215,20302	c,g	350032093900000000,350032093900000002,350032093900000002,350032093900000005	0-30,0-21,0-21,21-46						PH.D. THESIS EFFECTS OF WOOD DUST	miljoforskning.dk	0	0		
1276	chr5	90660314	90680624	3500093128	103		90660314	90680624	8421504	4	30,26,27,20	0,35,20215,20290	c	350009312800000001,350009312800000004,350009312800000005,350009312800000007,350009312800000008,350009312800000006	0-30,0-26,0-21,0-20,0-20,0-19						Vergleichende Mutationsanalyse des k-ras-Genes in zytologischen Untersuchungsmaterialien bei nichtkleinzelligen Lungenkarzinomen	www.qucosa.de	0	0		
1276	chr5	90660314	90660377	3500252473	63		90660314	90660377	8421504	1	63	0	p	350025247300015005	0-63		17671141	10.1158/1078-0432.CCR-07-0708	1078-0432	Clinical Cancer Research	Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells	May	2007	8		KRAS
1276	chr5	90660314	90660375	3500112091	54		90660314	90660375	8421504	2	30,24	0,37	c,g	350011209100000002,350011209100000004,350011209100000004	0-30,0-24,0-24						Arrays comprising non-covalently associated nucleic acid probes and methods for making and using them	Belosludtsev	2001	0		KRAS
1276	chr5	90660314	90660344	3500442885	30		90660314	90660344	8421504	1	30	0	c	350044288500000028	0-30						Aplicatii Clinice Al Tehnicii PCR	www.scribd.com	0	0		
1276	chr5	90660314	90660344	3500439947	30		90660314	90660344	8421504	1	30	0	c	350043994700000000	0-30		14718395	10.1373/clinchem.2003.024505	0009-9147	Clinical Chemistry	Rapid Detection of K-ras Mutations in Bile by Peptide Nucleic Acid-mediated PCR Clamping and Melting Curve Analysis: Comparison with Restriction Fragment Length Polymorphism Analysis	Chen	2004	8		
1276	chr5	90660314	90660344	3500404634	30		90660314	90660344	8421504	1	30	0	c	350040463400000029	0-30						Molekulargenetische Analysen zur Etablierung eines Progressionsmodel 0&#xbb;e] w ~B -&#xd7; &#xc7;&#xf7;:1&#xe3;	uni-osnabrueck.de	0	0		
1276	chr5	90660314	90660344	3500357468	29		90660314	90660344	8421504	2	19,10	0,20	c	350035746800000011	0-29						Methods in Molecular Medicine Volume 85 - Novel Anticancer Drug Protocols	www.scribd.com	0	0		KRAS
1276	chr5	90660314	90660344	3500153816	30		90660314	90660344	8421504	1	30	0	c	350015381600000101	0-30						METHODS IN MOLECULAR BIOLOGY Clinical Applications of PCR	.researchgate.net	0	0		
1276	chr5	90660314	90660344	3500152777	30		90660314	90660344	8421504	1	30	0	c	350015277700000101	0-30						METHODS IN MOLECULAR BIOLOGY Clinical Applications of PCR	.researchgate.net	0	0		
1276	chr5	90660316	90680657	3500304770	48		90660316	90680657	8421504	2	24,24	0,20317	c	350030477000000002,350030477000000003	0-24,0-24		10362637			American Journal of Physiology - Gastrointestinal and Liver Physiology	Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury	Jones	1999	0		KRAS
1276	chr5	90660321	90660401	3500375796	43		90660321	90660401	8421504	2	23,20	0,60	c	350037579600000000,350037579600000002	7-30,0-20						The TPR-MET Oncogenic Rearrangement is Present and Expressed in Human Gastric Carcinoma and Precursor Lesions	www.jstor.org	0	0		
1276	chr5	90660323	90680615	3500100928	83		90660323	90680615	8421504	2	63,20	0,20272	c,g	350010092800000025,350010092800000025,350010092800000017,350010092800000007,350010092800000007,350010092800000026,350010092800000026	0-21,0-21,0-21,0-54,0-54,0-20,0-20						Methods and applications of molecular beacon imaging for cancer cell detection	Yang	2006	0		KRAS
1276	chr5	90660323	90680615	3500074525	83		90660323	90680615	8421504	2	63,20	0,20272	c,g	350007452500000017,350007452500000025,350007452500000025,350007452500000007,350007452500000007,350007452500000026,350007452500000026	0-21,0-21,0-21,0-54,0-54,0-20,0-20						Methods and applications of molecular beacon imaging for cancer cell detection	Yang	2006	0		KRAS
1276	chr5	90660323	90660366	3500304889	43		90660323	90660366	8421504	1	43	0	c,g	350030488900000003,350030488900000004,350030488900000005,350030488900000002,350030488900000002	24-47,24-46,24-46,0-20,0-20						Micro&#xfb02;uidic Reactor for Sequential Operation of Polymerase Chain Reaction/Ligase Detection Reaction	www.ashdin.com	0	0		
1276	chr5	90660326	90681731	3500369762	40		90660326	90681731	8421504	2	19,21	0,21384	c	350036976200000000,350036976200000001	0-19,0-21						Methods, compositions and systems for local delivery of drugs	Shemi	2011	0		KRAS
1276	chr5	90660326	90681731	3500349293	40		90660326	90681731	8421504	2	19,21	0,21384	c,g	350034929300000000,350034929300000000,350034929300000001	0-19,0-19,0-21						Methods, compositions and systems for local delivery of drugs	Shemi	2011	0		KRAS
1276	chr5	90660326	90681731	3500315837	40		90660326	90681731	8421504	2	19,21	0,21384	c,g	350031583700000000,350031583700000000,350031583700000001,350031583700000001	0-19,0-19,0-21,0-21						METHODS, COMPOSITIONS AND SYSTEMS FOR LOCAL DELIVERY OF DRUGS - SILENSEED LTD	www.sumobrain.com	0	0		KRAS
1276	chr5	90660326	90681731	3500219835	40		90660326	90681731	8421504	2	19,21	0,21384	c	350021983500000000,350021983500000001	0-19,0-21						Methods, compositions and systems for local delivery of drugs	Shemi	2011	0		KRAS
1276	chr5	90660326	90681731	3500000648	40		90660326	90681731	8421504	2	19,21	0,21384	c,g	350000064800000000,350000064800000000,350000064800000001,350000064800000001	0-19,0-19,0-21,0-21						METHODS, COMPOSITIONS AND SYSTEMS FOR LOCAL DELIVERY OF DRUGS	Shemi	2009	0		KRAS
1276	chr5	90660329	90660360	3500315372	31		90660329	90660360	8421504	1	31	0	c	350031537200000075,350031537200000012,350031537200000083,350031537200000082	0-31,0-31,0-34,0-30						RECEPTOR FAMILY PROFILING - Patent application	www.faqs.org	0	0		KRAS
1276	chr5	90660329	90660360	3500107253	31		90660329	90660360	8421504	1	31	0	c	350010725300000012	0-31						Receptor family profiling	Landsman	2010	0		KRAS
1276	chr5	90660329	90660360	3500099918	31		90660329	90660360	8421504	1	31	0	c,g	350009991800000057,350009991800000012,350009991800000064,350009991800000065,350009991800000065	0-31,0-31,0-30,0-34,0-34					Patent	Receptor family profiling (Patent EP:2064348)	Coull	2012	0		KRAS
1276	chr5	90660329	90660360	3500099437	31		90660329	90660360	8421504	1	31	0	c	350009943700000319	0-31						Receptor Family Profiling 	.freshpatents.com	0	0		KRAS
1276	chr5	90660331	90660365	3500460689	34		90660331	90660365	8421504	1	34	0	c	350046068900000003,350046068900000002	0-34,0-34		23209813	10.1371/journal.pone.0050701	1932-6203	PLOS ONE	PLOS ONE: KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells	Lin	2012	4		KRAS
1276	chr5	90660332	90660386	3500212717	54		90660332	90660386	8421504	1	54	0	c,g	350021271700000007,350021271700000007	0-54,0-54		15753390	10.1158/0008-5472.CAN-04-3196	0008-5472	Cancer Research	Real-time Detection of Gene Expression in Cancer Cells Using Molecular Beacon Imaging: New Strategies for Cancer Research	Peng	2005	8		KRAS
1276	chr5	90660332	90660386	3500159303	54		90660332	90660386	8421504	1	54	0	c,g	350015930300000007,350015930300000007	0-54,0-54						Real-time Detection of Gene Expression in Cancer Cells Using Molecular Beacon Imaging: New Strategies for Cancer Research	cular-beacons.org	0	0		KRAS
1276	chr5	90660332	90660356	3500452772	24		90660332	90660356	8421504	1	24	0	c	350045277200000018	0-24						Inhibitors of prenyl-protein transferase	Nguyen	2001	0		
1276	chr5	90660332	90660356	3500381792	24		90660332	90660356	8421504	1	24	0	c	350038179200000018	0-24						Inhibitors of prenyl-protein transferases	Stump	2002	0		
1276	chr5	90660332	90660356	3500356779	24		90660332	90660356	8421504	1	24	0	c	350035677900000012	0-24						Inhibitors of prenyl-protein transferase	Graham	1999	0		
1276	chr5	90660332	90660356	3500317274	24		90660332	90660356	8421504	1	24	0	c	350031727400000012	0-24					Patent	Inhibitors of farnesyl-protein transferase (Patent US:5977134)	Ciccarone	1999	0		
1276	chr5	90660332	90660356	3500314144	24		90660332	90660356	8421504	1	24	0	c	350031414400000018	0-24						Inhibitors of prenyl-protein transferase	Stump	2002	0		
1276	chr5	90660332	90660356	3500294312	24		90660332	90660356	8421504	1	24	0	c	350029431200000012	0-24					Patent	Inhibitors of farnesyl-protein transferase (Patent US:6015817)	Halczenko	2000	0		
1276	chr5	90660332	90660356	3500243501	24		90660332	90660356	8421504	1	24	0	c	350024350100000018	0-24						Inhibitors of prenyl-protein transferase	Desolms	2001	0		
1276	chr5	90660332	90660356	3500142333	24		90660332	90660356	8421504	1	24	0	c	350014233300000018	0-24						Inhibitors of prenyl-protein transferase	Desolms	2001	0		
1276	chr5	90660332	90660356	3500131992	24		90660332	90660356	8421504	1	24	0	c	350013199200000018	0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6316436)	deSolms	2001	0		
1276	chr5	90660332	90660356	3500114484	24		90660332	90660356	8421504	1	24	0	c	350011448400000018	0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6380228)	Stump	2002	0		
1276	chr5	90660332	90660356	3500089179	24		90660332	90660356	8421504	1	24	0	c	350008917900000018	0-24						Prenyl-protein transferase inhibitors	Dinsmore	2001	0		
1276	chr5	90660332	90660356	3500088249	24		90660332	90660356	8421504	1	24	0	c	350008824900000018	0-24						Inhibitors of prenyl-protein transferase	Bergman	2005	0		
1276	chr5	90660332	90660356	3500086303	24		90660332	90660356	8421504	1	24	0	c	350008630300000018	0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6355643)	Lumma	2002	0		
1276	chr5	90660332	90660356	3500085674	24		90660332	90660356	8421504	1	24	0	c	350008567400000018	0-24					Patent	Inhibitors of prenyl-protein transferase (Patent US:6376496)	Hartman	2002	0		
1276	chr5	90660332	90660356	3500033373	24		90660332	90660356	8421504	1	24	0	c	350003337300000012	0-24						Inhibitors of prenyl-protein transferase	Desolms	2000	0		
1276	chr5	90660332	90660356	3500031614	24		90660332	90660356	8421504	1	24	0	c	350003161400000018	0-24						A method of treating cancer	Graham	2000	0		
1276	chr5	90660332	90660356	3500018213	24		90660332	90660356	8421504	1	24	0	c	350001821300000023	0-24						Method of treating cancer	Defeo-jones	2002	0		
1276	chr5	90660334	90660365	3500370631	31		90660334	90660365	8421504	1	31	0	c	350037063100000084,350037063100000085	0-31,0-31						Polymorphism detection and separation	Kmiec	2004	0		KRAS
1276	chr5	90660350	90660373	3500432609	23		90660350	90660373	8421504	1	23	0	c,g	350043260900000000,350043260900000000	0-23,0-23			10.1002/ijc.20268	1097-0215	International Journal of Cancer	Peptide nucleic acid clamp PCR: A novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes - Taback - 2004 - International Journal of Cancer - Wiley Online Library	Taback	2004	0		KRAS
1276	chr5	90660352	90680585	3500217321	48		90660352	90680585	8421504	2	24,24	0,20209	c,g	350021732100000036,350021732100000036,350021732100000037	0-24,0-24,0-24						Nrf2 Pathway Regulates Multidrug-Resistance- Associated Protein 1 in Small Cell Lung Cancer	www.u.arizona.edu	0	0		KRAS
1276	chr5	90660358	90660383	3500262483	25		90660358	90660383	8421504	1	25	0	c,g	350026248300000001,350026248300000001	0-25,0-25						Methods and compositions for mutation analysis	Gjerde	2006	0		KRAS
1276	chr5	90660359	90680500	3500461221	78		90660359	90680500	8421504	2	63,15	0,20126	p	350046122100015003	0-78						DNA sequences for the expression of alloproteins - Patent application	www.faqs.org	0	0		KRAS
1276	chr5	90660359	90680500	3500431075	78		90660359	90680500	8421504	2	63,15	0,20126	p	350043107500015003	0-78						Method Of Expressing Protein Having Unnatural Amino Acid Integrated Thereinto 	.freshpatents.com	0	0		KRAS
1276	chr5	90660359	90680500	3500092847	78		90660359	90680500	8421504	2	63,15	0,20126	p	350009284700015003	0-78						US Patent # 7,566,555. Method of expressing proteins comprising non-naturally-occurring amino acids - Patents.com	www.patents.com	0	0		HRAS
1276	chr5	90660362	90680500	3500107572	75		90660362	90680500	8421504	2	60,15	0,20123	p	350010757200015001	0-75		9887100	10.1101/gad.13.1.64	0890-9369	Genes & Development	Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1	Bhattacharya	1999	12		HRAS
1276	chr5	90660395	90680578	3500257905	102		90660395	90680578	8421504	3	27,27,48	0,20090,20135	p	350025790500015010,350025790500015009,350025790500015001	0-54,0-45,0-48						Fayetteville State University : BSC 5936 : MidTerm.Exam	ww.coursehero.com	0	0		HRAS
1276	chr5	90680485	90680662	3500161948	177		90680485	90680662	8421504	1	177	0	p	350016194800015000	0-192						KRAS Mutation Pro&#xfb01; le in Colorectal Carcinoma and Novel Mutation &#x2013; Internal Tandem Duplication in KRAS	l.cm-uj.krakow.pl	0	0		KRAS
1276	chr5	90680527	90681738	3500276984	41		90680527	90681738	8421504	2	21,20	0,1191	c,g	350027698400000030,350027698400000030,350027698400000031,350027698400000031	0-21,0-21,0-20,0-20						Methods of transcriptionally modulating expression of oncogenes and tumor suppressor genes	Foulkes	1992	0		KRAS
1276	chr5	90680598	90680624	3500298872	26		90680598	90680624	8421504	1	26	0	c	350029887200000102,350029887200000123	0-26,0-22						EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION - Patent application	www.faqs.org	0	0		
1276	chr5	90694453	90694517	3500249208	64		90694453	90694517	8421504	1	64	0	c	350024920800000003,350024920800000002	6-68,5-69		19001095	10.1128/MCB.01144-08	0270-7306	Molecular and Cellular Biology	Identification of G Protein &#x03b1; Subunit-Palmitoylating Enzyme	Tsutsumi	2009	6		LYRM5
1276	chr5	90694458	90694516	3500293391	58		90694458	90694516	8421504	1	58	0	c	350029339100000068	3-61						Untersuchungen zum Einfluss des bei Patienten mit Lowe-Syndrom mutierten humanen OCRL-Proteins auf endozytotische Prozesse in eukaryotischen Zellen DISSERTATION	ub.uni-hamburg.de	0	0		LYRM5
1276	chr5	90694459	90694514	3500007704	55		90694459	90694514	8421504	1	55	0	c	350000770400000000,350000770400000001,350000770400000003	8-63,7-62,7-62						Copyright 2010 by The American Society for Biochemistry and Molecular Biology, Inc.	www.jbc.org	0	0		LYRM5
1276	chr5	90694459	90694504	3500308426	45		90694459	90694504	8421504	1	45	0	p	350030842600015009,350030842600015023	153-198,0-45						Conjugates of soluble peptidic compounds with membrane-binding agents	Dodd	1998	0		LYRM5
1276	chr5	90694465	90694516	3500181751	51		90694465	90694516	8421504	1	51	0	c	350018175100000003	8-59						ScienceDirect.com - Cellular Signalling - Dvl3 translocates IPMK to the cell membrane in response to Wnt	sciencedirect.com	0	0		LYRM5
1276	chr5	90694488	90694516	3500028219	28		90694488	90694516	8421504	1	28	0	c	350002821900000015	12-40						Supporting Online Material for	www.dbm.ufpb.br	0	0		LYRM5
1279	chr5	91081290	91081391	3500150857	70		91081290	91081391	8421504	3	20,23,27	0,37,74	c	350015085700000003,350015085700000005,350015085700000004	0-20,1-24,0-27		11340111		0022-3166	The Journal of Nutrition	Branched-Chain Amino Acid Aminotransferase Activity Decreases during Development in Skeletal Muscles of Sheep	Faure	2001	4		
1287	chr5	92112822	92112849	3500420476	25		92112822	92112849	8421504	2	5,20	0,7	g	350042047600000034,350042047600000035	4-30,5-31						The eukaryotic translation initiation factor 3 subunit L protein interacts with Flavivirus NS5 and may modulate yellow fever virus replication	biomedcentral.com	0	0		
1288	chr5	92261205	92261229	3500194519	24		92261205	92261229	8421504	1	24	0	g	350019451900000065	1-25						CLONING AND CHARACTERIZATION OF THE CAPSULE TRANSPORT GENE REGION FROM Haemophilus paragallinarum	etd.uovs.ac.za	0	0		
1289	chr5	92359349	92383164	3500449315	42		92359349	92383164	8421504	4	4,15,13,10	0,5,23791,23805	g	350044931500000165,350044931500000097	22-41,0-23						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
1290	chr5	92523603	92523633	3500320452	24		92523603	92523633	8421504	3	5,13,6	0,7,24	g	350032045200000030	0-24						Methods for performing direct enzymatic reactions involving nucleic acid molecules	Kim	2009	0		
1301	chr5	93937613	93937647	3500096358	25		93937613	93937647	8421504	3	7,10,8	0,12,26	g	350009635800000068	10-35					Patent	Epithelins: novel cysteine-rich growth modulating proteins (Patent US:5416192)	Plowman	1995	0		
1302	chr5	94042164	94042196	3500161043	32		94042164	94042196	8421504	1	32	0	c,g	350016104300000356,350016104300000356,350016104300000070,350016104300000070,350016104300000050,350016104300000336	20-52,20-52,20-52,20-52,0-30,0-30						PRODUCTION OF SIALYLATED N-GLYCANS IN LOWER EUKARYOTES - Patent application	www.faqs.org	0	0		
1303	chr5	94131948	94131979	3500312506	27		94131948	94131979	8421504	3	16,6,5	0,19,26	g	350031250600000000	0-27		22399788	10.1098/rsif.2011.0913		Journal of the Royal Society Interface	Osteogenic differentiation and mineralization in fibre-reinforced tubular scaffolds: theoretical study and experimental evidences	Vincenzo	2012	0		
1304	chr5	94305674	94305698	3500194347	24		94305674	94305698	8421504	1	24	0	c	350019434700000000	0-24		12826604	10.1152/ajpcell.00511.2002		American Journal of Physiology - Cell Physiology	Shear stress increases expression of a KATP channel in rat and bovine pulmonary vascular endothelial cells	Chatterjee	2003	0		
1304	chr5	94305674	94305698	3500143742	24		94305674	94305698	8421504	1	24	0	c	350014374200000000	0-24		12826604	10.1152/ajpcell.00511.2002		American Journal of Physiology - Cell Physiolog	Shear stress increases expression of a KATP channel in rat and bovine pulmonary vascular endothelial cells	Chatterjee	2003	0		
1304	chr5	94305674	94305698	3500041592	24		94305674	94305698	8421504	1	24	0	c	350004159200000000	0-24		12826604	10.1152/ajpcell.00511.2002		American Journal of Physiology - Cell Physiolog	Shear stress increases expression of a KATP channel in rat and bovine pulmonary vascular endothelial cells	Chatterjee	2003	0		
1304	chr5	94311181	94311226	3500202391	45		94311181	94311226	8421504	1	45	0	p	350020239100015007	0-45						Human potassium channel genes	Miller	2002	0		ABCC8
1304	chr5	94311181	94311226	3500128285	45		94311181	94311226	8421504	1	45	0	p	350012828500015007	0-45						Human Potassium Channel Genes	Miller	2009	0		ABCC8
1304	chr5	94311474	94311706	3500424225	42		94311474	94311706	8421504	2	21,21	0,211	c,g	350042422500000016,350042422500000017,350042422500000017	0-21,0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
1305	chr5	94389914	94389937	3500409436	23		94389914	94389937	8421504	1	23	0	g	350040943600000012	6-29		19767430	10.1128/JB.00618-09		Journal of Bacteriology	&#x03c3;X Is Involved in Controlling Bacillus subtilis Biofilm Architecture through the AbrB Homologue Abh 	Ewan	2009	0		
1305	chr5	94389914	94389937	3500064414	23		94389914	94389937	8421504	1	23	0	g	350006441400000012	6-29		19767430	10.1128/JB.00618-09	0021-9193	Journal of Bacteriology	&#x03c3;X Is Involved in Controlling Bacillus subtilis Biofilm Architecture through the AbrB Homologue Abh	Murray	2009	4		
1305	chr5	94415031	94433198	3500299530	1271		94415031	94433198	8421504	8	56,135,118,174,174,118,124,372	0,2766,10101,11684,13693,14746,16400,17795	c	350029953000000027,350029953000000028,350029953000000007	46-1319,0-20,0-20						BOVINE POLYMORPHISMS AND METHODS OF PREDICTING BOVINE TRAITS - Patent application	www.faqs.org	0	0		
1305	chr5	94417803	94432991	3500253152	1002		94417803	94432991	8421504	7	129,118,174,174,118,124,165	0,7329,8912,10921,11974,13628,15023	p	350025315200015031	0-1002						AN INTRODUCTION TO COMPUTATIONAL BIOCHEMISTRY - C Stan Tsai	www.docstoc.com	0	0		LDHB
1305	chr5	94431468	94431492	3500042521	24		94431468	94431492	8421504	1	24	0	c	350004252100000011	0-24						TUMOR ANGIOGENESIS ASSOCIATED GENES AND A METHOD FOR THEIR IDENTIFICATION - Patent application	www.faqs.org	0	0		
1305	chr5	94497483	94497753	3500196732	90		94497483	94497753	8421504	3	23,22,45	0,200,225	p	350019673200015070,350019673200015074	0-45,0-45						Variant Tlr4 Nucleic Acid And Uses Thereof 	.freshpatents.com	0	0		GYS2
1306	chr5	94518083	94522938	3500182449	90		94518083	94522938	8421504	2	45,45	0,4810	p	350018244900015128,350018244900015148	0-45,0-45						METHOD OF SCREENING COMPOUND DIRECTLY ACTIVATING GLYCOGEN SYNTHASE - Patent application	www.faqs.org	0	0		GYS1
1307	chr5	94669162	94669186	3500324592	24		94669162	94669186	8421504	1	24	0	c,g	350032459200000003,350032459200000003	0-24,0-24						METHOD OF PRODUCING AMPLIFICATION PRODUCT BY PCR AND USAGE THEREOF - Patent application	www.faqs.org	0	0		IAPP
1307	chr5	94669162	94669186	3500122085	24		94669162	94669186	8421504	1	24	0	c	350012208500000003	0-24						Method of producing amplification product by pcr and usage thereof	Izumizawa	2009	0		IAPP
1307	chr5	94669162	94669186	3500095932	24		94669162	94669186	8421504	1	24	0	c	350009593200000003	0-24						Method for production of pcr amplification product and use thereof	Izumizawa	2009	0		IAPP
1308	chr5	94849961	94874989	3500139688	100		94849961	94874989	8421504	5	26,18,8,29,19	0,10991,15271,15375,25009	c	350013968800000104,350013968800000085,350013968800000082	22-48,0-26,0-48						TRANSPORTER GENES OATP-B, C, D, AND E - Patent application	www.faqs.org	0	0		
1308	chr5	94859695	94859718	3500210980	23		94859695	94859718	8421504	1	23	0	c	350021098000000013	0-23						Clinical pharmacology & Therapeutics	005.pasteur.ac.ir	0	0		SLCO1B3
1308	chr5	94874898	94874926	3500331304	24		94874898	94874926	8421504	3	5,5,14	0,7,14	g	350033130400000055	0-24						3-Hydroxypropionic acid and other organic compounds	Gokarn	2006	0		
1310	chr5	95083915	95083959	3500463464	40		95083915	95083959	8421504	3	24,11,5	0,27,39	g	350046346400000053	2-46						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
1312	chr5	95409700	95409724	3500408348	23		95409700	95409724	8421504	2	16,7	0,17	g	350040834800000046	11-34						Methods and systems for producing recombinant viral antigens	Zebedee	1997	0		
1318	chr5	96163735	96163758	3500246296	23		96163735	96163758	8421504	1	23	0	g	350024629600000136	16-40						Methods of treating eye diseases in diabetic patients	Feinstein	2011	0		
1322	chr5	96631973	96632003	3500034609	27		96631973	96632003	8421504	2	15,12	0,18	g	350003460900000180	7-48						Small Interfering RNAs Targeting Feline Herpes Virus - Patent application	www.faqs.org	0	0		
1322	chr5	96661407	96661578	3500344270	51		96661407	96661578	8421504	2	24,27	0,144	p	350034427000015024	147-198						@IL23_3198:2:1:0:199/1 NCGGAACCGGGCGGAAACACCATCGTATGCCGTCTTC + &0;;;;:9:;:7;;;;;;;;;;;;;;;;;;;;;;;:8	rse.iop.kcl.ac.uk	0	0		
1326	chr5	97240205	97240232	3500031956	23		97240205	97240232	8421504	2	9,14	0,13	g	350003195600000546	0-23						BIOLOGICAL METHODS FOR PREPARING ADIPIC ACID	Picataggio	2011	0		
1328	chr5	97403617	97403644	3500456727	23		97403617	97403644	8421504	2	6,17	0,10	g	350045672700000018	1-24					Patent	Recombinant plant expressing non-competitively binding insecticidal crystal proteins (Patent US:5866784)	Botterman	1999	0		
1335	chr5	98304623	98304795	3500166204	172		98304623	98304795	8421504	1	172	0	c	350016620400000038	47-221						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
1335	chr5	98366224	98400846	3500449315	41		98366224	98400846	8421504	4	5,16,4,16	0,6,34601,34606	g	350044931500000371,350044931500000635	24-45,12-32						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
1338	chr5	98745087	98745114	3500309840	24		98745087	98745114	8421504	2	10,14	0,13	g	350030984000000969	1-27						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1346	chr5	99796789	99811823	3500329817	86		99796789	99811823	8421504	3	23,21,42	0,12029,14992	c,g	350032981700000007,350032981700000007,350032981700000010,350032981700000010,350032981700000000,350032981700000000,350032981700000006	0-23,0-23,0-21,0-21,10-31,10-31,0-22			10.1021/bi048016f		Biochemistry	Microsomal Glutathione S-Transferase 1 in the Retinal Pigment Epithelium: Protection against Oxidative Stress and a Potential Role in Aging	Akiko	2005	0		
1346	chr5	99796927	99796950	3500123038	23		99796927	99796950	8421504	1	23	0	c	350012303800000013	0-23						Detection of differentially expressed genes in the longissimus dorsi of Northeastern Indigenous and Large White pigs	w.funpecrp.com.br	0	0		MGST1
1350	chr5	100329199	100329227	3500354885	23		100329199	100329227	8421504	3	5,6,12	0,6,16	c	350035488500000007	3-26						Nucleic Acid Constructs And Methods For Producing Altered Seed Oil Compositions 	.freshpatents.com	0	0		
1350	chr5	100329199	100329227	3500271762	23		100329199	100329227	8421504	3	5,6,12	0,6,16	c	350027176200000007	3-26						Nucleic acid constructs and methods for producing altered seed oil compositions	Bringe	2008	0		
1350	chr5	100329199	100329227	3500229026	23		100329199	100329227	8421504	3	5,6,12	0,6,16	c	350022902600000007	3-26					Patent	Nucleic acid constructs and methods for producing altered seed oil compositions (Patent US:7566813)	Voelker	2009	0		
1350	chr5	100329199	100329227	3500176050	23		100329199	100329227	8421504	3	5,6,12	0,6,16	c	350017605000000007	3-26						Nucleic acid constructs and methods for producing altered seed oil compositions	Voelker	2009	0		
1350	chr5	100329199	100329227	3500161896	23		100329199	100329227	8421504	3	5,6,12	0,6,16	c	350016189600000007	3-26						Nucleic acid constructs and methods for producing altered seed oil compositions	Bringe	2011	0		
1350	chr5	100329199	100329227	3500092226	23		100329199	100329227	8421504	3	5,6,12	0,6,16	c	350009222600000007	3-26						Nucleic acid constructs and methods for producing altered seed oil compositions	Voelker	2006	0		
1350	chr5	100329199	100329227	3500062225	23		100329199	100329227	8421504	3	5,6,12	0,6,16	c	350006222500000007	3-26						Nucleic acid constructs and methods for producing altered seed oil compositions	Bringe	2007	0		
1350	chr5	100329199	100329227	3500018012	23		100329199	100329227	8421504	3	5,6,12	0,6,16	c	350001801200000007	3-26						Nucleic Acid Constructs And Methods For Producing Altered Seed Oil Compositions 	.freshpatents.com	0	0		
1353	chr5	100684480	100684506	3500332824	23		100684480	100684506	8421504	2	13,10	0,16	g	350033282400000009	0-23						Michael Wilhelm Schmid Doktors der Naturwissenschaften	io.tu-muenchen.de	0	0		
1357	chr5	101298584	101298616	3500201864	26		101298584	101298616	8421504	3	12,6,8	0,17,24	g	350020186400000404	2-28						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1357	chr5	101314451	101318494	3500433125	42		101314451	101318494	8421504	2	21,21	0,4022	c	350043312500000015,350043312500000014	0-21,0-21			10.1046/j.1471-4159.2001.00407.x	1471-4159	Journal of Neurochemistry	Expression and role of phosphodiesterase 6 in the chicken pineal gland - Morin - 2001 - Journal of Neurochemistry - Wiley Online Library	Morin	2001	0		PDE6H
1357	chr5	101317366	101318395	3500421678	23		101317366	101318395	8421504	2	13,10	0,1019	c	350042167800000027	0-23						Role of cGMP Phosphodiesterases in Idiopathic Pulmonary Fibrosis	eb.uni-giessen.de	0	0		
1357	chr5	101317366	101318395	3500091953	23		101317366	101318395	8421504	2	13,10	0,1019	c	350009195300000026	0-23		20979602	10.1186/1465-9921-11-146		Respiratory Research	Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis	Sevdalina	2010	0		
1358	chr5	101324685	101324713	3500110377	23		101324685	101324713	8421504	2	14,9	0,19	g	350011037700000000	0-23		11440905			American Journal of Physiology - Endocrinology and Metabolism	Differential gene expression in a murine model of cancer cachexia	Monitto	2001	0		ANTXR2
1358	chr5	101355071	101355137	3500159212	66		101355071	101355137	8421504	1	66	0	p	350015921200015008	0-66						Hypusination of eukaryotic initiation factor 5A(eIF5A): a novel therapeutic target in BCR-ABL&#x2013;positive leukemias identi&#xfb01;ed by a proteomics approach	tologylibrary.org	0	0		ARHGDIA
1358	chr5	101378522	101378546	3500081673	24		101378522	101378546	8421504	1	24	0	c	350008167300000077	11-35						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
1359	chr5	101526990	101527065	3500260805	75		101526990	101527065	8421504	1	75	0	p	350026080500015011	0-75						Innate Immune Receptor Directed Biocides	Bremel	2008	0		HIST1H2BM
1359	chr5	101526990	101527065	3500141125	75		101526990	101527065	8421504	1	75	0	p	350014112500015011	0-75						Antimicrobial Peptide Biocides	Bremel	2008	0		HIST1H2BM
1359	chr5	101526993	101527065	3500294798	72		101526993	101527065	8421504	1	72	0	p	350029479800015011	0-72						Targeted biocides	Bremel	2010	0		HIST1H2BM
1359	chr5	101529107	101529197	3500178085	90		101529107	101529197	8421504	1	90	0	p	350017808500015000	0-90						Gene regulation	www.scribd.com	0	0		HIST2H3C
1359	chr5	101529107	101529179	3500456986	72		101529107	101529179	8421504	1	72	0	p	350045698600015001	0-72						Histone deacetylase-related gene and protein	Bhatia	2002	0		HIST2H3C
1359	chr5	101529107	101529179	3500116277	72		101529107	101529179	8421504	1	72	0	p	350011627700015001	0-72						Histon-Desacetylasen der Klasse II: Entdeckung, Klonierung und funktionelle Charakterisierung der enzymatischen Aktivit&#xe4;t einer neuen Gruppe humaner HDACs	.uni-tuebingen.de	0	0		HIST2H3C
1359	chr5	101529107	101529164	3500002602	57		101529107	101529164	8421504	1	57	0	p	350000260200015000	0-57		11950950	10.1091/mbc.01-10-0482	1059-1524	Molecular Biology of the Cell	Mutations in Saccharomyces cerevisiae GeneSIR2 Can Have Differential Effects on In Vivo Silencing Phenotypes and In Vitro Histone Deacetylation Activity	Armstrong	2002	5		HIST1H4K
1359	chr5	101529107	101529161	3500397268	54		101529107	101529161	8421504	1	54	0	p	350039726800015000	0-54						acetylated histone h4: Topics by Science.gov	www.science.gov	0	0		HIST1H4K
1359	chr5	101529107	101529161	3500232415	54		101529107	101529161	8421504	1	54	0	p	350023241500015000	0-54			10.1038/sj.embor.7400391		EMBO Reports	The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3	Helen	2005	0		HIST2H3C
1359	chr5	101529107	101529152	3500077114	45		101529107	101529152	8421504	1	45	0	p	350007711400015010	0-45						Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. - ResearchGate	.researchgate.net	0	0		HIST1H4K
1359	chr5	101529107	101529152	3500039059	45		101529107	101529152	8421504	1	45	0	p	350003905900015009	0-45						Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila	roup.linkgroup.hu	0	0		HIST2H3C
1359	chr5	101529110	101529380	3500334580	270		101529110	101529380	8421504	1	270	0	p	350033458000015018,350033458000015019,350033458000015020,350033458000015021,350033458000015022	0-54,0-54,0-54,0-54,0-54						Cloning and Molecular Characterization of the Schistosoma mansoni Genes RbAp48 and Histone H4	ld.ioc.fiocruz.br	0	0		HIST2H3C
1359	chr5	101529116	101529170	3500411785	54		101529116	101529170	8421504	1	54	0	p	350041178500015017	0-54						Characterization of the Substrate Specificity and Mechanism of Protein Arginine Methyltransferase 1	alcommons.usu.edu	0	0		HIST1H4K
1359	chr5	101529146	101529389	3500448005	210		101529146	101529389	8421504	3	93,45,72	0,105,171	p	350044800500015207,350044800500015208,350044800500015209,350044800500015210,350044800500015211	0-45,0-72,0-45,0-45,0-72						Use of MVA to treat prostate cancer	Delcayre	2010	0		HIST2H3C
1359	chr5	101529179	101529377	3500382336	147		101529179	101529377	8421504	2	99,48	0,150	p	350038233600015008,350038233600015009,350038233600015011	0-48,12-63,42-90						Caract&#xe9;risation et expression des g&#xe8;nes de m&#xe9;tallothion&#xe9;ines chez deux modioles hydrothermales : Bathymodiolus thermophilus et Bathymodiolus azoricus	oc.univ-lemans.fr	0	0		HIST1H4K
1359	chr5	101529368	101529413	3500135859	45		101529368	101529413	8421504	1	45	0	p	350013585900015005	3-48						TUMOR-SPECIFIC ANTIGENS, CYTOTOXIC T LYMPHOCYTES RESPONSIVE THERETO, AND METHODS OF USING THE SAME - MEMORIAL SLOAN-KETTERING CANCER CENTER	www.sumobrain.com	0	0		HIST2H3C
1359	chr5	101529441	101529465	3500314418	24		101529441	101529465	8421504	1	24	0	c	350031441800000001	9-33			10.1093/nar/gkl666		Nucleic Acids Research	Binding of human SLBP on the 3&#x2032;-UTR of histone precursor H4-12 mRNA induces structural rearrangements that enable U7 snRNA anchoring	Sophie	2006	0		
1360	chr5	101586570	101586594	3500462415	23		101586570	101586594	8421504	2	8,15	0,9	c	350046241500000166	10-33						Antibodies to CD40	Bedian	2009	0		
1361	chr5	101757882	101757914	3500009659	26		101757882	101757914	8421504	3	9,3,14	0,12,18	c	350000965900000032	10-36						Virulencia, resistencia y elementos gen&#xe9;ticos m&#xf3;viles en serotipos no prevalentes de Salmonella enterica	www.tdx.cat	0	0		
1365	chr5	102317765	102317793	3500054946	24		102317765	102317793	8421504	2	7,17	0,11	g	350005494600000016	11-36						Antibody and chemokine constructs and their use in the treatment of infections and immunological diseases	Mack	2001	0		
1367	chr5	102547285	102547308	3500269923	23		102547285	102547308	8421504	1	23	0	c	350026992300000015	19-42						Morphine and Morphine Precursors - Patent application	www.faqs.org	0	0		
1367	chr5	102547285	102547308	3500078972	23		102547285	102547308	8421504	1	23	0	c	350007897200000015	19-42						MORPHINE AND MORPHINE PRECURSORS - Patent application	www.faqs.org	0	0		
1368	chr5	102734652	102742696	3500182064	234		102734652	102742696	8421504	3	34,17,183	0,5097,7861	p	350018206400015058,350018206400015061,350018206400015021	0-51,0-180,0-180						Assay methods for immediate diagnosis of cause of stroke	Dambinova	2006	0		GRIN2A
1368	chr5	102734652	102739766	3500437156	51		102734652	102739766	8421504	2	34,17	0,5097	p	350043715600015058	0-51						Antibody assay methods to assess risk for TIA/stroke	Dambinova	2006	0		
1368	chr5	102734652	102739766	3500353496	51		102734652	102739766	8421504	2	34,17	0,5097	p	350035349600015057	0-51						Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke	Dambinova	2001	0		
1368	chr5	102734652	102739766	3500105192	51		102734652	102739766	8421504	2	34,17	0,5097	p	350010519200015057	0-51						Antibody assay methods to assess risk for TIA/stroke	Dambinova	2006	0		
1370	chr5	102964015	102964044	3500201864	24		102964015	102964044	8421504	2	14,10	0,19	g	350020186400000848	2-26						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1373	chr5	103348210	103348239	3500396199	24		103348210	103348239	8421504	3	12,4,8	0,13,21	g	350039619900000006,350039619900000005	5-29,11-35						Upstream Stimulating Factors 1 and 2 Enhance Transcription from the Placenta-Specific Promoter 1.1 of the Bovine Cyp19 Gene	biomedcentral.com	0	0		
1373	chr5	103360120	103360183	3500359228	63		103360120	103360183	8421504	1	63	0	p	350035922800015005,350035922800015006	0-63,0-45						Identi&#xfb01;cation and characterization of an endogenous chemotactic ligand speci&#xfb01;c for FPRL2	jem.rupress.org	0	0		HTR7P1
1373	chr5	103360120	103360183	3500201077	63		103360120	103360183	8421504	1	63	0	p	350020107700015001	0-63		19307752	10.3858/emm.2009.41.5.036		Experimental & Molecular Medicine	LL-37 inhibits serum amyloid A-induced IL-8 production in human neutrophils	Ha	2009	0		HTR7P1
1373	chr5	103360120	103360183	3500047936	63		103360120	103360183	8421504	1	63	0	p	350004793600015001,350004793600015002	0-63,0-45		15623572	10.1084/jem.20041277	0022-1007	The Journal of Experimental Medicine	Identification and characterization of an endogenous chemotactic ligand specific for FPRL2	Migeotte	2005	14		HTR7P1
1373	chr5	103360120	103360183	3500019538	63		103360120	103360183	8421504	1	63	0	p	350001953800015000,350001953800015001	0-63,0-45			10.1084/jem.20041277		The Journal of Experimental Medicine	Identification and characterization of an endogenous chemotactic ligand specific for FPRL2	Isabelle	2005	0		HTR7P1
1373	chr5	103360131	103396763	3500100552	45		103360131	103396763	8421504	3	20,12,13	0,24326,36619	c	350010055200000023,350010055200000005	9-29,0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		HEBP1,HTR7P1
1374	chr5	103536907	103536934	3500236784	24		103536907	103536934	8421504	2	10,14	0,13	c	350023678400000098	0-24						Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites	Tian Gui 	2006	0		
1375	chr5	103591735	103592984	3500102834	47		103591735	103592984	8421504	2	22,25	0,1224	c,g	350010283400000003,350010283400000003,350010283400000002	9-31,9-31,9-34						miR-148a Promoted Cell Proliferation by Targeting p27 in Gastric Cancer Cells	www.ijbs.com	0	0		CDKN1B
1375	chr5	103592948	103596153	3500457001	65		103592948	103596153	8421504	3	21,23,21	0,2304,3184	c	350045700100000003,350045700100000009,350045700100000012	0-21,0-23,0-21		22372491	10.1111/j.1476-5381.2012.01921.x	1476-5381	British Journal of Pharmacology	Prodigiosin down-regulates SKP2 to induce p27KIP1 stabilization and antiproliferation in human lung adenocarcinoma cells - Hsieh - 2012 - British Journal of Pharmacology - Wiley Online Library	Hsieh	2012	0		CDKN1B
1375	chr5	103592960	103592989	3500042131	29		103592960	103592989	8421504	1	29	0	c	350004213100000009	0-29		19112177	10.1074/jbc.M804531200	0021-9258	Journal of Biological Chemistry	Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27KIP1 by Targeting ScfSKP2 Ubiquitin Ligase and Src	Cen	2009	5		
1375	chr5	103595172	103595873	3500439351	144		103595172	103595873	8421504	2	119,25	0,676	p	350043935100015002	0-144						Compositions and methods for increasing animal size growth rate	Malek	2003	0		CDKN1B
1375	chr5	103595172	103595229	3500466072	57		103595172	103595229	8421504	1	57	0	p	350046607200015000	0-57						articles SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27	ology.med.nyu.edu	0	0		CDKN1B
1375	chr5	103595172	103595229	3500426290	57		103595172	103595229	8421504	1	57	0	p	350042629000015002	0-57						Methods to identify compounds useful for the treatment of proliferative and differentiative disorders	Pagano	2008	0		CDKN1B
1375	chr5	103595172	103595229	3500421333	57		103595172	103595229	8421504	1	57	0	p	350042133300015001	0-57						Novel ubiquitin ligases as therapeutic targets	Chiaur	2003	0		CDKN1B
1375	chr5	103595172	103595229	3500369274	57		103595172	103595229	8421504	1	57	0	p	350036927400015000	0-57						Novel ubiquitin ligases as therapeutic targets	Chiaur	2000	0		CDKN1B
1375	chr5	103595172	103595229	3500337316	57		103595172	103595229	8421504	1	57	0	p	350033731600015000	0-57						articles SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27	ology.med.nyu.edu	0	0		CDKN1B
1375	chr5	103595172	103595229	3500083997	57		103595172	103595229	8421504	1	57	0	p	350008399700015004	0-57						&#x5897;&#x6b96;&#x6027;&#x304a;&#x3088;&#x3073;&#x5206;&#x5316;&#x6027;&#x75be;&#x60a3;&#x306e;&#x6cbb;&#x7642;&#x306b;&#x6709;&#x7528;&#x306a;&#x5316;&#x5408;&#x7269;&#x306e;&#x540c;&#x5b9a;&#x65b9;&#x6cd5; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 41218	astamuse.com	0	0		CDKN1B
1375	chr5	103595176	103596323	3500004435	44		103595176	103596323	8421504	2	20,24	0,1123	c,g	350000443500000003,350000443500000002,350000443500000002	15-35,10-34,10-34						Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor	Kaelin	2002	0		
1375	chr5	103595228	103596158	3500238677	40		103595228	103596158	8421504	2	20,20	0,910	c,g	350023867700000017,350023867700000016,350023867700000016	0-20,0-20,0-20		23903687	10.1590/1414-431X20132979	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - A phthalide derivative isolated from endophytic fungi Pestalotiopsis photiniae induces G1 cell cycle arrest and apoptosis in human HeLa cells	Chen	2013	1		CDKN1B
1375	chr5	103595228	103596158	3500040051	40		103595228	103596158	8421504	2	20,20	0,910	c,g	350004005100000017,350004005100000016,350004005100000016	0-20,0-20,0-20		23903687	10.1590/1414-431X20132979	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - A phthalide derivative isolated from endophytic fungi Pestalotiopsis photiniae induces G1 cell cycle arrest and apoptosis in human HeLa cells	Chen	2013	1		CDKN1B
1375	chr5	103595236	103595261	3500182513	25		103595236	103595261	8421504	1	25	0	c	350018251300000011	0-25		17185465	10.1182/blood-2006-07-035287	0006-4971	Blood	Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential	Araki	2007	10		
1375	chr5	103596133	103596190	3500456065	49		103596133	103596190	8421504	2	24,25	0,32	c	350045606500000001,350045606500000000,350045606500000005	0-24,0-24,0-20		16618721	10.1158/0008-5472.CAN-05-3250	0008-5472	Cancer Research	Suppression of Centrosome Amplification after DNA Damage Depends on p27 Accumulation	Sugihara	2006	8		CDKN1B
1375	chr5	103596133	103596190	3500160018	49		103596133	103596190	8421504	2	24,25	0,32	c,g	350016001800000001,350016001800000000,350016001800000005,350016001800000005	0-24,0-24,0-20,0-20						SuppressionofCentrosomeAmplificationafterDNADamage Dependsonp27Accumulation	.aacrjournals.org	0	0		CDKN1B
1375	chr5	103596156	103596322	3500315605	40		103596156	103596322	8421504	2	20,20	0,146	c,g	350031560500000001,350031560500000000,350031560500000000	0-20,0-20,0-20						Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells	-publications.com	0	0		CDKN1B
1375	chr5	103596171	103596325	3500030511	40		103596171	103596325	8421504	2	20,20	0,134	c,g	350003051100000012,350003051100000011,350003051100000011	0-20,0-20,0-20						Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells.	.biomedsearch.com	0	0		CDKN1B
1375	chr5	103596171	103596323	3500006015	40		103596171	103596323	8421504	2	20,20	0,132	c,g	350000601500000035,350000601500000034,350000601500000034	0-20,0-20,0-20						PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1. - ResearchGate	.researchgate.net	0	0		CDKN1B
1375	chr5	103596244	103596267	3500369407	23		103596244	103596267	8421504	1	23	0	c	350036940700000000	0-23						Assessment of transcript and protein levels contributing to cell cycle control and gap junction connections in morphologically variable groups of porcine cumulus-oocyte complexes	ulturejournals.cz	0	0		
1375	chr5	103596244	103596267	3500049548	23		103596244	103596267	8421504	1	23	0	c	350004954800000000	0-23						Assessment of transcript and protein levels contributing to cell cycle control and gap junction connections in morphologically variable groups of porcine cumulus-oocyte complexes	vri.cz/docs/vetme	0	0		
1375	chr5	103596295	103596318	3500100342	23		103596295	103596318	8421504	1	23	0	c,g	350010034200000007,350010034200000007	0-23,0-23						&#x4e2d;&#x6587;&#x6458;&#x8981;	ir.cmu.edu.tw	0	0		CDKN1B
1375	chr5	103596295	103596318	3500088690	23		103596295	103596318	8421504	1	23	0	c	350008869000000006	0-23						SURFACE MICROGROOVES OF THIRTY MICROMETERS IN WIDTH ON TITANIUM SUBSTRATA ENHANCE PROLIFERATION AND ALTER GENE EXPRESSION OF CULTURED HUMAN GINGIVAL FIBROBLASTS	journal.kap.or.kr	0	0		CDKN1B
1375	chr5	103596788	103596813	3500457432	24		103596788	103596813	8421504	2	5,19	0,6	c	350045743200000002	0-24		14729654	10.1158/0008-5472.CAN-03-2446	0008-5472	Cancer Research	Estrogen Receptor &#x03b2; Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest	Paruthiyil	2004	8		CDKN1B
1375	chr5	103596788	103596813	3500384995	24		103596788	103596813	8421504	2	5,19	0,6	c	350038499500000014	0-24						What Are &#x2018;Free Radicals&#x2019; and How Can the Body Defend Itself From Them With Supplemental Antioxidant Enzymes? Q&A	w.biotecfoods.com	0	0		CDKN1B
1375	chr5	103649398	103649424	3500434029	24		103649398	103649424	8421504	2	5,19	0,7	g	350043402900000019	3-27						Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. - ResearchGate	.researchgate.net	0	0		
1375	chr5	103649398	103649424	3500177520	24		103649398	103649424	8421504	2	5,19	0,7	g	350017752000000001	3-27						Identification of assemblage A Giardia in white-tailed deer. - ResearchGate	.researchgate.net	0	0		
1375	chr5	103649398	103649424	3500084930	24		103649398	103649424	8421504	2	5,19	0,7	g	350008493000000010	3-27		23042185	10.1128/AEM.02422-12	0099-2240	Applied and Environmental Microbiology	Prevalence, Environmental Loading, and Molecular Characterization of Cryptosporidium and Giardia Isolates from Domestic and Wild Animals along the Central California Coast	Oates	2012	4		
1375	chr5	103649398	103649424	3500000680	24		103649398	103649424	8421504	2	5,19	0,7	g	350000068000000007	3-27						INSTITUTO OSWALDO CRUZ Mestrado em Biologia Parasit&#xe1;ria	w.arca.fiocruz.br	0	0		
1378	chr5	104002038	104002062	3500066097	23		104002038	104002062	8421504	2	19,4	0,20	c	350006609700000015	5-28			10.1128/JVI.77.7.4113-4126.2003		Journal of Virology	Mapping and Functional Analysis of Interaction Sites within the Cytoplasmic Domains of the Vaccinia Virus A33R and A36R Envelope Proteins	Brian	2003	0		
1382	chr5	104513385	104513409	3500435679	23		104513385	104513409	8421504	2	9,14	0,10	g	350043567900000047	3-26					Patent	Recombinant hexose oxidase, a method of producing same and use of such enzyme (Patent US:7544795)	Stougaard	2009	0		
1382	chr5	104513385	104513409	3500201862	23		104513385	104513409	8421504	2	9,14	0,10	g	350020186200000047	3-26					Patent	Recombinant hexose oxidase, a method of producing same and use of such enzyme (Patent US:7544795)	Stougaard	2009	0		
1382	chr5	104513385	104513409	3500201569	23		104513385	104513409	8421504	2	9,14	0,10	g	350020156900000000	3-26					Patent	Rekombinante hexose oxidase, verfahren zu deren herstellung und verwendung Recombinant hexose oxidase, a method for their preparation and use (Patent DE:69623473)	HANSEN	2009	0		
1383	chr5	104603018	104603078	3500279004	60		104603018	104603078	8421504	1	60	0	p	350027900400015001	0-60		12370291	10.1128/MCB.22.21.7439-7448.2002	0270-7306	Molecular and Cellular Biology	Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element	Kuwata	2002	6		ETV6
1383	chr5	104603035	104622507	3500164733	42		104603035	104622507	8421504	2	21,21	0,19451	c	350016473300000001,350016473300000000	0-21,0-21						Prognostic Classi&#xfb01;cation of Relapsing Favorable Histology Wilms Tumor Using cDNA Microarray Expression Pro&#xfb01;ling and Support Vector Machines	ww.enm.bris.ac.uk	0	0		ETV6
1383	chr5	104606865	104608887	3500186119	141		104606865	104608887	8421504	2	3,138	0,1884	p	350018611900015112	0-141						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		ETV6
1383	chr5	104606865	104608887	3500095373	141		104606865	104608887	8421504	2	3,138	0,1884	p	350009537300015112	0-141						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		ETV6
1383	chr5	104608878	104622450	3500243271	27		104608878	104622450	8421504	2	14,13	0,13559	c	350024327100000019,350024327100000014,350024327100000020	10-30,0-27,10-33						Novel pyrazole and benzoxazole-substituted pyridine derivatives or pharmaceutically acceptable salts thereof, preparation process for same, and pharmaceutical composition for prevention and treatment of disorders involving aberrant cell proliferation cont	Koh	2009	0		
1383	chr5	104622750	104622930	3500185347	40		104622750	104622930	8421504	2	20,20	0,160	c	350018534700000003,350018534700000001	0-20,0-20						12pl3 Fusion TEL 21q22 AML1 on to on lymphoblastic	www.pnas.org	0	0		
1385	chr5	104882581	104882605	3500398238	24		104882581	104882605	8421504	1	24	0	g	350039823800000013,350039823800000058	4-28,4-28						Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus - US Patent 7132233 Description	ww.patentstorm.us	0	0		
1388	chr5	105259492	105259516	3500056872	24		105259492	105259516	8421504	1	24	0	g	350005687200000008	11-35						Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1	Feder	2004	0		
1388	chr5	105259493	105259516	3500207355	23		105259493	105259516	8421504	1	23	0	g	350020735500000007	11-34						Polynucleotides and polypeptides encoding a novel metalloprotease, Protease-40b	Chen	2004	0		
1388	chr5	105348961	105348986	3500428536	25		105348961	105348986	8421504	1	25	0	c	350042853600000023	0-25						Double-muscling in mammals	Grobet	1997	0		
1390	chr5	105627634	105627721	3500259232	87		105627634	105627721	8421504	1	87	0	g	350025923200000017	0-88						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
1391	chr5	105733152	105736539	3500326939	138		105733152	105736539	8421504	3	42,48,48	0,725,3339	c	350032693900000016,350032693900000006,350032693900000008	6-48,0-48,0-48						US Patent # 5,807,708. Conservin nucleic acid molecules and compositions - Patents.com	www.patents.com	0	0		
1391	chr5	105733877	105736539	3500290439	96		105733877	105736539	8421504	2	48,48	0,2614	c	350029043900000006,350029043900000008	0-48,0-48					Patent	Conservin compositions (Patent US:6031076)	Falb	2000	0		
1395	chr5	106174881	106175003	3500412810	25		106174881	106175003	8421504	3	1,11,13	0,94,109	c	350041281000000013	16-46						Human monocyte elastase inhibitor antibodies	Remold-o'donnell	1996	0		
1398	chr5	106631725	106645663	3500439355	747		106631725	106645663	8421504	8	103,99,152,9,109,133,125,17	0,2212,4876,9247,9257,13653,13795,13921	p,c,g	350043935500000002,350043935500000003,350043935500000004,350043935500000001,350043935500000005,350043935500000006,350043935500000006,350043935500015003,350043935500000007,350043935500000008,350043935500000000,350043935500015008,350043935500000009,350043935500000010,350043935500000011,350043935500000012	16-62,0-63,0-64,0-21,0-64,0-63,0-63,0-57,0-63,1-63,24-46,0-51,0-63,0-63,0-54,0-142						Molecular Cloning and Characterization of Dectin-1 Receptor cDNA Expression	www.scribd.com	0	0		
1399	chr5	106703848	106715154	3500444502	1831		106703848	106715154	8421504	10	104,96,170,73,20,99,116,25,72,1056	0,1921,3524,3697,8948,8989,9408,10129,10157,10250	p,c,g	350044450200000023,350044450200000023,350044450200015052,350044450200000024,350044450200015036,350044450200015053,350044450200000025,350044450200015037,350044450200015054,350044450200000026,350044450200015038,350044450200015055,350044450200015039,350044450200000042,350044450200015056,350044450200000071,350044450200000028,350044450200015040,350044450200015057,350044450200000029,350044450200015041,350044450200015058,350044450200015059,350044450200000031,350044450200015060,350044450200000033,350044450200015045,350044450200015062,350044450200000034,350044450200015046,350044450200015063,350044450200000035,350044450200015047,350044450200015064,350044450200000036,350044450200015065,350044450200000037,350044450200015049,350044450200015050,350044450200015067,350044450200000040,350044450200000040,350044450200000001,350044450200000001,350044450200000041	0-55,0-55,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-45,7-27,0-45,16-48,0-48,0-45,0-45,0-48,0-45,0-45,0-45,0-48,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-48,0-45,0-45,0-45,0-54,0-54,0-20,0-20,0-1002						USES OF HUMAN MONOCLONAL ANTIBODIES AGAINST OXIDIZED LDL RECEPTOR - Patent application	www.faqs.org	0	0		
1399	chr5	106703848	106715154	3500422293	1753		106703848	106715154	8421504	7	100,61,140,19,140,116,1177	0,1956,3524,3751,8948,9408,10129	c,g	350042229300000005,350042229300000005,350042229300000006,350042229300000027,350042229300000008,350042229300000028,350042229300000002,350042229300000002,350042229300000029,350042229300000010,350042229300000030,350042229300000011,350042229300000033,350042229300000014,350042229300000034,350042229300000015,350042229300000035,350042229300000036,350042229300000017,350042229300000037,350042229300000018,350042229300000038,350042229300000019,350042229300000039,350042229300000020,350042229300000040,350042229300000021,350042229300000041,350042229300000022,350042229300000001,350042229300000042,350042229300000023	0-52,0-52,0-48,0-48,0-48,0-48,7-27,7-27,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-46,0-47,7-28,0-1020,0-1012						Recombinant production of human and bovine receptors for modified low-density lipoprotein	Sawamura	1997	0		
1399	chr5	106703848	106715154	3500084821	1879		106703848	106715154	8421504	6	104,96,246,140,116,1177	0,1921,3524,8948,9408,10129	c,g	350008482100000018,350008482100000011,350008482100000011,350008482100000023,350008482100000023,350008482100000012,350008482100000013,350008482100000013,350008482100000025,350008482100000025,350008482100000024,350008482100000014,350008482100000014,350008482100000026,350008482100000026	0-1879,0-21,0-21,0-21,0-21,0-26,0-20,0-20,0-20,0-20,0-26,0-19,0-19,0-19,0-19						 DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE - Patent application	www.faqs.org	0	0		
1399	chr5	106703848	106715154	3500002891	1879		106703848	106715154	8421504	6	104,96,246,140,116,1177	0,1921,3524,8948,9408,10129	c,g	350000289100000011,350000289100000004,350000289100000016,350000289100000006,350000289100000006,350000289100000017,350000289100000018,350000289100000018,350000289100000005,350000289100000007,350000289100000019	0-1879,0-21,0-21,0-20,0-20,0-26,0-20,0-20,0-26,0-19,0-19						Dairy Cattle Breeding For Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
1399	chr5	106703882	106714364	3500355754	66		106703882	106714364	8421504	3	21,26,19	0,10213,10463	c,g	350035575400000011,350035575400000012,350035575400000013,350035575400000013,350035575400000014	0-21,0-26,0-20,0-20,0-19						DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE	Khatib	2007	0		
1399	chr5	106703882	106714364	3500180185	66		106703882	106714364	8421504	3	21,26,19	0,10213,10463	c,g	350018018500000011,350018018500000011,350018018500000012,350018018500000013,350018018500000013,350018018500000014	0-21,0-21,0-26,0-20,0-20,0-19						DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE	Khatib	2010	0		
1399	chr5	106703882	106714364	3500001677	66		106703882	106714364	8421504	3	21,26,19	0,10213,10463	c,g	350000167700000011,350000167700000012,350000167700000013,350000167700000013,350000167700000014,350000167700000014	0-21,0-26,0-20,0-20,0-19,0-19						Dairy Cattle Breeding For Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
1399	chr5	106705792	106707617	3500076526	318		106705792	106707617	8421504	2	73,245	0,1580	p	350007652600015070,350007652600015073	0-165,0-153						41 human secreted proteins	Komatsoulis	2001	0		
1399	chr5	106705804	106712905	3500443562	60		106705804	106712905	8421504	4	20,1,19,20	0,60,1568,7081	c,g	350044356200000000,350044356200000000,350044356200000005,350044356200000001	0-20,0-20,0-20,0-20						ScienceDirect.com - Osteoarthritis and Cartilage - Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) res	sciencedirect.com	0	0		
1399	chr5	106707376	106707614	3500095245	76		106707376	106707614	8421504	4	19,19,19,19	0,113,195,219	c,g	350009524500000002,350009524500000003,350009524500000000,350009524500000001,350009524500000001	0-19,0-19,0-19,0-19,0-19		19150883	10.1161/CIRCRESAHA.108.190116	0009-7330	Circulation Research	Mediation of Electronegative Low-Density Lipoprotein Signaling by LOX-1	Lu	2009	9		
1399	chr5	106707376	106707614	3500048146	76		106707376	106707614	8421504	4	19,19,19,19	0,113,195,219	c,g	350004814600000002,350004814600000003,350004814600000000,350004814600000000,350004814600000001,350004814600000001	0-19,0-19,0-19,0-19,0-19,0-19						Mediation of Electronegative Low-Density Lipoprotein Signaling by LOX-1	s.ahajournals.org	0	0		
1399	chr5	106714442	106714465	3500387162	23		106714442	106714465	8421504	1	23	0	c	350038716200000009	0-23						Effect of ABCG2 PPARGC1A OLR1 and gene polymorphism on estimated breeding values for functional and production traits in Polish Holstein-Friesian bulls	w.genepassport.ru	0	0		
1399	chr5	106723205	106734952	3500284525	726		106723205	106734952	8421504	6	133,122,152,147,81,91	0,747,1972,5167,9227,11656	g	350028452500000023	0-726						Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells - Patent application	www.faqs.org	0	0		
1399	chr5	106723205	106734952	3500236143	726		106723205	106734952	8421504	6	133,122,152,147,81,91	0,747,1972,5167,9227,11656	g	350023614300000023	0-726						Dendritic Cell Marker and Uses Thereof - Patent application	www.faqs.org	0	0		
1399	chr5	106740891	106740916	3500420477	24		106740891	106740916	8421504	2	5,19	0,6	g	350042047700000246	9-33						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
1399	chr5	106740891	106740916	3500032429	24		106740891	106740916	8421504	2	5,19	0,6	g	350003242900000253	9-33						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2012	0		
1399	chr5	106784954	106784980	3500379871	25		106784954	106784980	8421504	2	4,21	0,5	g	350037987100000000	6-41						Prevalence of Pathogenic Escherichia coli in a Swine Breeding Environment in Can Tho Province, Vietnam	ircas.affrc.go.jp	0	0		
1406	chr5	107701542	107702365	3500261436	42		107701542	107702365	8421504	3	7,14,21	0,727,802	c	350026143600000025,350026143600000026	0-21,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1406	chr5	107704214	107705321	3500029099	48		107704214	107705321	8421504	2	30,18	0,1089	p	350002909900015013	0-48						Compositions And Methods For Targeting A Polypeptide To The Central Nervous System 	freshpatents.com	0	0		
1406	chr5	107704217	107705321	3500074996	45		107704217	107705321	8421504	2	27,18	0,1086	p	350007499600015013	0-45						COMPOSITIONS AND METHODS FOR TARGETING A POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM - Patent application	www.faqs.org	0	0		
1406	chr5	107707413	107707770	3500240802	23		107707413	107707770	8421504	2	8,15	0,342	c	350024080200000005	10-33		17071617	10.1074/jbc.M601362200	0021-9258	Journal of Biological Chemistry	Inhibition of Bone Morphogenetic Protein 1 by Native and Altered Forms of &#x03b1;2-Macroglobulin	Zhang	2006	5		
1407	chr5	107804095	107804119	3500394182	24		107804095	107804119	8421504	1	24	0	c	350039418200000008	0-24		19855901	10.1590/S0100-879X2009001100004	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Dengue virus-induced regulation of the host cell translational machinery	Villas-Boas	2009	1		
1407	chr5	107804095	107804119	3500244884	24		107804095	107804119	8421504	1	24	0	c	350024488400000008	0-24		19855901	10.1590/S0100-879X2009001100004	0100-879X	Brazilian Journal of Medical and Biological Research	Brazilian Journal of Medical and Biological Research - Dengue virus-induced regulation of the host cell translational machinery	Villas-Boas	2009	1		DDX47
1407	chr5	107812194	107812239	3500341095	45		107812194	107812239	8421504	1	45	0	p	350034109500015001	0-45						TIP47, ein intrazellul&#xe4;res Apolipoprotein und/oder ein Sortierungsfaktor f&#xfc;r Mannose-6-Phosphat Rezeptoren?	www.uni-koeln.de	0	0		M6PR
1407	chr5	107819796	107821731	3500226397	33		107819796	107821731	8421504	2	27,6	0,1929	c	350022639700000131	0-33						Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer	Challita-Eid	2005	0		
1409	chr5	108049597	108049621	3500182431	23		108049597	108049621	8421504	2	12,11	0,13	g	350018243100000002,350018243100000000	10-48,0-38						Non-cytotoxic protein conjugates	Foster	2011	0		
1409	chr5	108058428	108062754	3500414194	593		108058428	108062754	8421504	4	152,274,116,51	0,2815,3357,4275	p,c	350041419400015015,350041419400000036,350041419400015016	4-597,4-582,4-594						Cells & vertebrates for enhanced somatic hypermutation and class switch recombination	Lee	2012	0		
1409	chr5	108120987	108121027	3500419411	40		108120987	108121027	8421504	1	40	0	g	350041941100000028	0-40						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		TENM2
1410	chr5	108164217	108165197	3500388350	82		108164217	108165197	8421504	4	21,20,21,20	0,685,866,960	c,g	350038835000000057,350038835000000053,350038835000000053,350038835000000054,350038835000000055,350038835000000055	0-21,0-20,0-20,0-21,0-20,0-20						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
1410	chr5	108164217	108165197	3500027904	82		108164217	108165197	8421504	4	21,20,21,20	0,685,866,960	c,g	350002790400000032,350002790400000032,350002790400000028,350002790400000028,350002790400000029,350002790400000029,350002790400000030,350002790400000030	0-21,0-21,0-20,0-20,0-21,0-21,0-20,0-20						 SpringerImages - primers sequences 	pringerimages.com	0	0		
1410	chr5	108165239	108169173	3500328799	40		108165239	108169173	8421504	3	6,14,20	0,3782,3914	c,g	350032879900000009,350032879900000008,350032879900000008,350032879900000022	0-20,0-20,0-20,0-20						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
1410	chr5	108240802	108243385	3500424591	109		108240802	108243385	8421504	2	52,57	0,2526	g	350042459100000020,350042459100000027,350042459100000028	0-52,0-57,0-57						Transcriptional Regulation of Human NANOG by Alternate Promoters in Embryonic Stem Cells	w.omicsonline.org	0	0		
1410	chr5	108243296	108243392	3500225215	96		108243296	108243392	8421504	1	96	0	g	350022521500000068	0-96						Method for maintaining pluripotency of stem/progenitor cells - Patent application	www.faqs.org	0	0		
1410	chr5	108243727	108246258	3500328799	40		108243727	108246258	8421504	2	20,20	0,2511	c	350032879900000000,350032879900000030,350032879900000001	0-20,0-20,0-20						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
1410	chr5	108243727	108246258	3500100652	40		108243727	108246258	8421504	2	20,20	0,2511	c,g	350010065200000002,350010065200000002,350010065200000003	0-20,0-20,0-20						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
1410	chr5	108243742	108246051	3500049864	46		108243742	108246051	8421504	3	23,4,19	0,50,2290	c,g	350004986400000002,350004986400000002,350004986400000003	0-23,0-23,0-23						Methods and Compositions To Enhance Efficiency Of Nuclear Transfer/Cloning - Patent application	www.faqs.org	0	0		
1410	chr5	108243774	108246163	3500382980	40		108243774	108246163	8421504	2	20,20	0,2369	c,g	350038298000000016,350038298000000016,350038298000000017,350038298000000017	0-20,0-20,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
1410	chr5	108243774	108246163	3500280137	40		108243774	108246163	8421504	2	20,20	0,2369	c,g	350028013700000016,350028013700000016,350028013700000017,350028013700000017	0-20,0-20,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
1410	chr5	108243782	108247491	3500179889	71		108243782	108247491	8421504	5	14,12,12,13,20	0,2250,2501,3670,3689	c	350017988900000024,350017988900000025,350017988900000008	0-26,0-25,0-20						Research Paper Characterization of Bovine Induced Pluripotent Stem Cells by Lentiviral Transduction of Reprogramming Factor Fusion Proteins	www.ijbs.com	0	0		
1410	chr5	108246041	108247836	3500219497	40		108246041	108247836	8421504	2	20,20	0,1775	c,g	350021949700000002,350021949700000002,350021949700000003,350021949700000003	0-20,0-20,0-20,0-20						Oct4 expression in in vitro-produced sheep blastocysts and embryonic-stem-like cells	w.cellbiolint.org	0	0		
1410	chr5	108246041	108247836	3500081681	40		108246041	108247836	8421504	2	20,20	0,1775	c,g	350008168100000002,350008168100000003,350008168100000003	0-20,0-20,0-20						Oct4 expression in in vitro-produced sheep blastocysts and embryonic-stem-like cells	.all-portland.net	0	0		
1410	chr5	108246044	108247463	3500432424	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c	350043242400000004,350043242400000005	0-25,0-26						In Vitro Generation of Hepatocytes from Human Embryonic Stem Cells	Mandal	2010	0		NANOG
1410	chr5	108246044	108247463	3500417024	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c	350041702400000022,350041702400000023	0-25,0-26						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - STEMPEUTICS RESEARCH PRIVATE LIMITED	www.sumobrain.com	0	0		NANOG
1410	chr5	108246044	108247463	3500401984	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c	350040198400000022,350040198400000023	0-25,0-26						XENO-FREE CULTURE CONDITIONS FOR HUMAN EMBRYONIC STEM CELLS AND METHODS THEREOF	Totey	2009	0		NANOG
1410	chr5	108246044	108247463	3500356716	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c	350035671600000004,350035671600000005	0-25,0-26						Establishment Of A Human Embryonic Stem Cell Line Using Mammalian Cells 	.freshpatents.com	0	0		NANOG
1410	chr5	108246044	108247463	3500198523	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c	350019852300000044,350019852300000004,350019852300000045,350019852300000005	0-25,0-25,0-26,0-26						Pluripotent Embryonic-like Stem Cells Derived From Corneal Limbus, Methods Of Isolation And Uses Thereof 	.freshpatents.com	0	0		NANOG
1410	chr5	108246044	108247463	3500032816	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c	350003281600000022,350003281600000062,350003281600000023,350003281600000063	0-25,0-25,0-26,0-26						XENO-FREE CULTURE CONDITIONS FOR HUMAN EMBRYONIC STEM CELLS AND METHODS THEREOF - Patent application	www.faqs.org	0	0		NANOG
1410	chr5	108246044	108247463	3500023082	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c,g	350002308200000002,350002308200000002,350002308200000016,350002308200000016,350002308200000003,350002308200000017	0-25,0-25,0-25,0-25,0-26,0-26						Human Mesenchymal stem cells and preparation thereof - Patent application	www.faqs.org	0	0		NANOG
1410	chr5	108246044	108247463	3500010184	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c,g	350001018400000004,350001018400000004,350001018400000005	0-25,0-25,0-26						Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof	Totey	2009	0		NANOG
1410	chr5	108246044	108247463	3500008009	51		108246044	108247463	8421504	3	25,15,11	0,236,1408	c	350000800900000062,350000800900000022,350000800900000063,350000800900000023	0-25,0-25,0-26,0-26						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - Patent application	www.faqs.org	0	0		NANOG
1410	chr5	108246044	108246069	3500452297	25		108246044	108246069	8421504	1	25	0	c	350045229700000002	0-25						INVITRO HUMAN EMBRYONIC MODEL AND A METHOD THEREOF	Deb	2008	0		
1410	chr5	108246044	108246069	3500264578	25		108246044	108246069	8421504	1	25	0	c	350026457800000003	0-25						Human platelet lysate permits scale-up of dental pulp stromal cells for clinical applications	eiainnovation.com	0	0		NANOG
1410	chr5	108246044	108246069	3500040267	25		108246044	108246069	8421504	1	25	0	c	350004026700000002	0-25						GOLD NANOPARTICLE, A COMPOSITION AND A METHOD TO PERPETUATE STEMNESS THEREOF - Patent application	www.faqs.org	0	0		
1410	chr5	108246229	108247479	3500015339	84		108246229	108247479	8421504	2	60,24	0,1226	p	350001533900015001	0-84						Charakterisierung der Stammzellfaktoren NANOG1 und NANOG2 auf Protein- und Genebene in embryonalen Karzinomazellen und in t(4;11)- Zellpopulationen	d-nb.info/9978043	0	0		
1410	chr5	108246275	108247457	3500240992	25		108246275	108247457	8421504	2	20,5	0,1177	c	350024099200000004,350024099200000003	0-23,0-25					Patent	Use of Activin A in human embryo stem cell trophoblast-free cell culture (Patent CN:100537752)	Lei 	2009	0		
1410	chr5	108246275	108247457	3500030451	25		108246275	108247457	8421504	2	20,5	0,1177	c	350003045100000004,350003045100000001	0-23,0-25						Use of Activin A in human embryo stem cell trophoblast-free cell culture	Xiao Lei 	2007	0		
1410	chr5	108246275	108247455	3500390060	23		108246275	108247455	8421504	2	20,3	0,1177	c	350039006000000004	0-23		19223540	10.1158/0008-5472.CAN-08-2985	0008-5472	Cancer Research	Neuronal Guidance Protein Netrin-1 Induces Differentiation in Human Embryonal Carcinoma Cells	Mancino	2009	8		
1410	chr5	108247505	108247528	3500428401	23		108247505	108247528	8421504	1	23	0	c	350042840100000008	0-23						A potential model for studying the plasticity and reprogramming of human epidermal stem cells through preimplantation blastocyst microinjection	R	2008	0		NANOG
1410	chr5	108247910	108247933	3500462545	23		108247910	108247933	8421504	1	23	0	c	350046254500000002	14-39						Full Text - Normalized embryoid cDNA library of oil palm (Elaeis guineensis)	iotechnology.info	0	0		
1410	chr5	108247910	108247933	3500265300	23		108247910	108247933	8421504	1	23	0	c	350026530000000001	8-33		22203037	10.1128/MCB.06130-11	0270-7306	Molecular and Cellular Biology	Proteins Associated with the Exon Junction Complex Also Control the Alternative Splicing of Apoptotic Regulators	Michelle	2012	6		
1410	chr5	108247910	108247933	3500183227	23		108247910	108247933	8421504	1	23	0	c	350018322700000002	14-39				0717-3458	Electronic Journal of Biotechnology	Electronic Journal of Biotechnology - Normalized embryoid cDNA library of oil palm (Elaeis guineensis)	Chan	2010	1		
1410	chr5	108247910	108247933	3500159882	23		108247910	108247933	8421504	1	23	0	c,g	350015988200000002,350015988200000002	14-39,14-39						Full Text - Normalized embryoid cDNA library of oil palm (Elaeis guineensis)	iotechnology.info	0	0		
1410	chr5	108247910	108247933	3500128451	23		108247910	108247933	8421504	1	23	0	c	350012845100000002	14-39				0717-3458	Electronic Journal of Biotechnology	Electronic Journal of Biotechnology - Normalized embryoid cDNA library of oil palm (Elaeis guineensis)	Chan	2010	1		
1410	chr5	108248027	108248242	3500270590	40		108248027	108248242	8421504	2	20,20	0,195	c,g	350027059000000002,350027059000000002,350027059000000003,350027059000000003	0-20,0-20,0-20,0-20						CELL EXTRACT-BASED REPROGRAMMING OF SOMATIC CELLS	etd.lsu.edu	0	0		
1410	chr5	108248102	108248507	3500465380	41		108248102	108248507	8421504	2	21,20	0,385	c	350046538000000008,350046538000000009	0-21,0-20						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	quantification.de	0	0		
1410	chr5	108248102	108248507	3500011924	41		108248102	108248507	8421504	2	21,20	0,385	c	350001192400000008,350001192400000009	0-21,0-20						Regulatory microRNA Network Identi&#xfb01;cation in Bovine Blastocyst Development	qpcrupdate.net	0	0		
1410	chr5	108248119	108248592	3500354445	42		108248119	108248592	8421504	2	21,21	0,452	c,g	350035444500000002,350035444500000002,350035444500000003,350035444500000003	0-21,0-21,0-21,0-21						Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)	B	2007	0		
1410	chr5	108248290	108248315	3500026625	23		108248290	108248315	8421504	2	18,5	0,20	c	350002662500000015	0-23						Monoclonal antibody to human thrombopoietin	Eaton	1995	0		
1411	chr5	108271266	108281792	3500163467	1504		108271266	108281792	8421504	11	22,210,204,102,105,188,163,241,161,93,15	0,231,1204,2004,2460,5732,6190,7002,7788,8451,10511	p,c,g	350016346700000010,350016346700000010,350016346700015004,350016346700015012,350016346700015003,350016346700015011,350016346700000009,350016346700000009,350016346700015010,350016346700015009,350016346700015008,350016346700015007,350016346700015006,350016346700015005	0-22,0-22,0-144,0-180,9-180,0-180,0-20,0-20,0-180,0-180,0-180,0-180,0-180,0-180						Entwicklungsspezifische Expression und m&#xf6;gliche funktionelle Bedeutung der Glukosetransporterisoformen in Pr&#xe4;implantationsembryonen des Rindes	ebdoc.sub.gwdg.de	0	0		
1411	chr5	108271406	108271429	3500097486	23		108271406	108271429	8421504	1	23	0	c	350009748600000019	24-47						Alterations in oxidative gene expression in equine skeletal muscle following exercise and training	cs.physiology.org	0	0		SLC2A3
1411	chr5	108273300	108273325	3500306233	25		108273300	108273325	8421504	1	25	0	c	350030623300000016	0-25						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
1411	chr5	108277532	108279760	3500119526	41		108277532	108279760	8421504	2	19,22	0,2206	c,g	350011952600000005,350011952600000005,350011952600000004	0-19,0-19,0-22						Authors: Chu Yan CHAN1,2, Jeremy A. GUGGENHEIM1, Chi Ho TO2	ll.physiology.org	0	0		
1411	chr5	108277610	108278435	3500277992	38		108277610	108278435	8421504	3	9,10,19	0,658,806	c,g	350027799200000008,350027799200000002,350027799200000002	0-19,0-19,0-19		16049004	10.1074/jbc.M507221200	0021-9258	Journal of Biological Chemistry	Glucose Uptake via Glucose Transporter 3 by Human Platelets Is Regulated by Protein Kinase B	Ferreira	2005	5		SLC2A3
1411	chr5	108279059	108279110	3500009445	51		108279059	108279110	8421504	1	51	0	p	350000944500015000	0-51						Funktionsanalyse des Saccharomyces cerevisiae Proteins Fgy1 und dessen Einfluss auf die heterologe Expression der Glukosetransporter GLUT1 und GLUT4 aus S&#xe4;ugetieren	.uni-frankfurt.de	0	0		SLC2A3
1411	chr5	108279121	108279145	3500155690	24		108279121	108279145	8421504	1	24	0	c	350015569000000021	18-42						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		
1411	chr5	108279124	108279166	3500407545	41		108279124	108279166	8421504	2	21,20	0,22	c,g	350040754500000004,350040754500000005,350040754500000005	0-21,0-20,0-20		14695907	10.1095/biolreprod.103.023853	0006-3363	Biology of Reproduction	Maternal Growth Hormone Treatment from Day 35 to 80 of Gestation Alters Nutrient Partitioning in Favor of Uteroplacental Growth in the Overnourished Adolescent Sheep	Wallace	2004	4		
1411	chr5	108279212	108279780	3500071105	43		108279212	108279780	8421504	3	3,17,23	0,505,545	c	350007110500000011,350007110500000010	0-20,0-23						REPRODUCTION	uction-online.org	0	0		
1411	chr5	108358842	108361009	3500443049	60		108358842	108361009	8421504	2	15,45	0,2122	p	350044304900015026,350044304900015013	0-60,15-63						Bestimmung der Kopienzahl von FoxN1/ FoxN4-Homologen in Lampetra fluviatilis	k.uni-freiburg.de	0	0		FOXJ2
1411	chr5	108375926	108376037	3500362403	41		108375926	108376037	8421504	2	21,20	0,91	c,g	350036240300000019,350036240300000019,350036240300000018	0-21,0-21,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
1413	chr5	108591935	108621088	3500420783	593		108591935	108621088	8421504	12	6,41,50,78,50,60,56,58,23,53,58,60	0,2868,8458,9066,21302,21647,23328,23561,27816,27847,28062,29093	c	350042078300000063,350042078300000076,350042078300000079,350042078300000013,350042078300000729,350042078300000024,350042078300000096,350042078300000345,350042078300000403,350042078300000034,350042078300000035,350042078300000105,350042078300000043	0-47,0-50,0-60,0-60,10-60,0-60,4-60,0-60,0-60,0-60,8-61,1-59,0-60						Cellular Permissivity Factor for Viruses and Uses Thereof - Patent application	www.faqs.org	0	0		
1413	chr5	108591935	108621088	3500362522	593		108591935	108621088	8421504	12	6,41,50,78,50,60,56,58,23,53,58,60	0,2868,8458,9066,21302,21647,23328,23561,27816,27847,28062,29093	c	350036252200000063,350036252200000076,350036252200000079,350036252200000013,350036252200000729,350036252200000024,350036252200000096,350036252200000403,350036252200000345,350036252200000034,350036252200000035,350036252200000105,350036252200000043	0-47,0-50,0-60,0-60,10-60,0-60,4-60,0-60,0-60,0-60,8-61,1-59,0-60						Cellular permissivity factor for viruses and uses thereof	Calvert	2011	0		
1413	chr5	108591935	108621088	3500271571	593		108591935	108621088	8421504	12	6,41,50,78,50,60,56,58,23,53,58,60	0,2868,8458,9066,21302,21647,23328,23561,27816,27847,28062,29093	c	350027157100000060,350027157100000073,350027157100000076,350027157100000012,350027157100000722,350027157100000023,350027157100000093,350027157100000338,350027157100000396,350027157100000033,350027157100000034,350027157100000102,350027157100000042	0-47,0-50,0-60,0-60,10-60,0-60,4-60,0-60,0-60,0-60,8-61,1-59,0-60						Cellular permissivity factor for viruses and uses thereof	Calvert	2005	0		
1413	chr5	108591935	108621088	3500104513	593		108591935	108621088	8421504	12	6,41,50,78,50,60,56,58,23,53,58,60	0,2868,8458,9066,21302,21647,23328,23561,27816,27847,28062,29093	c	350010451300000060,350010451300000073,350010451300000076,350010451300000012,350010451300000721,350010451300000023,350010451300000093,350010451300000395,350010451300000337,350010451300000033,350010451300000034,350010451300000102,350010451300000042	0-47,0-50,0-60,0-60,10-60,0-60,4-60,0-60,0-60,0-60,8-61,1-59,0-60						Cellular Permissivity Factor for Viruses and Uses Thereof - Patent application	www.faqs.org	0	0		
1413	chr5	108594773	108595070	3500371775	297		108594773	108595070	8421504	1	297	0	p	350037177500015028	0-297						Agents, Uses and Methods	Graversen	2010	0		
1413	chr5	108594800	108594845	3500027335	45		108594800	108594845	8421504	1	45	0	p	350002733500015062	0-45						AGENTS, USES AND METHODS - CYTOGUIDE A/S	www.sumobrain.com	0	0		
1413	chr5	108600265	108600290	3500382822	25		108600265	108600290	8421504	1	25	0	c	350038282200000002	0-25						Constitutive and regulated expression of platelet basic protein in human monocytes	www.jleukbio.org	0	0		
1413	chr5	108600468	108601067	3500306854	171		108600468	108601067	8421504	2	61,110	0,489	p	350030685400015007	0-171						Cloning and expression of porcine CD163: its use for characterization of monoclonal antibodies to porcine CD163 and development of an ELISA to measure soluble CD163 in biological fluids	www.inia.es	0	0		
1413	chr5	108600468	108601067	3500170701	171		108600468	108601067	8421504	2	61,110	0,489	p	350017070100015007	0-171						Cloning and expression of porcine CD163: its use for characterization of monoclonal antibodies to porcine CD163 and development of an ELISA to measure soluble CD163 in biological fluids	revistas.inia.es	0	0		
1415	chr5	108803879	108803903	3500319213	24		108803879	108803903	8421504	1	24	0	g	350031921300000005	0-24						BMC Genomics BioMed Central	biomedcentral.com	0	0		
1416	chr5	109021740	109021767	3500420783	27		109021740	109021767	8421504	1	27	0	g	350042078300000097	0-27						Cellular Permissivity Factor for Viruses and Uses Thereof - Patent application	www.faqs.org	0	0		
1416	chr5	109021740	109021767	3500362522	27		109021740	109021767	8421504	1	27	0	g	350036252200000097	0-27						Cellular permissivity factor for viruses and uses thereof	Calvert	2011	0		
1416	chr5	109021740	109021767	3500271571	27		109021740	109021767	8421504	1	27	0	g	350027157100000094	0-27						Cellular permissivity factor for viruses and uses thereof	Calvert	2005	0		
1416	chr5	109021740	109021767	3500104513	27		109021740	109021767	8421504	1	27	0	g	350010451300000094	0-27						Cellular Permissivity Factor for Viruses and Uses Thereof - Patent application	www.faqs.org	0	0		
177	chr5	109414640	109472375	3500319213	229		109414640	109472375	8421504	11	23,23,25,22,20,20,21,8,13,13,41	0,22035,32369,43947,44071,47766,53435,55499,55594,57411,57694	p,c	350031921300000001,350031921300000006,350031921300000012,350031921300000010,350031921300000018,350031921300000019,350031921300000020,350031921300000017,350031921300000015,350031921300015011	0-23,0-23,0-19,0-21,0-22,0-20,0-20,0-21,1-22,0-54						BMC Genomics BioMed Central	biomedcentral.com	0	0		
1419	chr5	109414640	109414663	3500060499	23		109414640	109414663	8421504	1	23	0	c	350006049900000012	0-23		23072335	10.1186/1471-2156-13-86	1471-2156	BMC Genetics	Gene number determination and genetic polymorphism of the gamma delta T cell co-receptor WC1 genes	Chen	2012	2		
1424	chr5	109994725	109994749	3500319213	24		109994725	109994749	8421504	1	24	0	g	350031921300000004	0-24						BMC Genomics BioMed Central	biomedcentral.com	0	0		
1424	chr5	110079415	110079630	3500368146	44		110079415	110079630	8421504	2	22,22	0,193	c	350036814600000003,350036814600000002	0-22,0-22						Heat Stress Elicits Different Responses in Peripheral Blood Mononuclear Cells from Brown Swiss and Holstein Cows	dspace.unitus.it	0	0		
1424	chr5	110079461	110079563	3500010617	45		110079461	110079563	8421504	2	23,22	0,80	c	350001061700000011,350001061700000010	0-23,0-22						Revista Brasileira de Zootecnia	www.scielo.br	0	0		
1424	chr5	110079483	110079836	3500288579	42		110079483	110079836	8421504	2	21,21	0,332	c,g	350028857900000013,350028857900000013,350028857900000012	0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
1424	chr5	110079585	110081241	3500451487	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350045148700000007,350045148700000006	0-20,0-20						Mixed Cell Diagnostic Systems For Detection Of Respiratory, Herpes And Enteric Viruses	Scholl	2008	0		GAPDH
1424	chr5	110079585	110081241	3500445012	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350044501200000100,350044501200000036,350044501200000035,350044501200000099	0-20,0-20,0-20,0-20						Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus 	.freshpatents.com	0	0		GAPDH
1424	chr5	110079585	110081241	3500435090	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350043509000000012,350043509000000011	0-20,0-20						Methods for detection and production of influenza viruses	Scholl	2006	0		GAPDH
1424	chr5	110079585	110081241	3500394405	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350039440500000007,350039440500000006	0-20,0-20						Systems for Detection and Production of Respiratory, Herpes and Enteric Viruses - Patent application	www.faqs.org	0	0		GAPDH
1424	chr5	110079585	110081241	3500262823	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c,g	350026282300000007,350026282300000007,350026282300000018,350026282300000018,350026282300000017,350026282300000006	0-20,0-20,0-20,0-20,0-20,0-20						Mixed Cell Diagnostic Systems For Detection Of Respiratory, Herpes And Enteric Viruses - Patent application	www.faqs.org	0	0		GAPDH
1424	chr5	110079585	110081241	3500215602	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c,g	350021560200000001,350021560200000001,350021560200000000	0-20,0-20,0-20		15243082	10.1128/JCM.42.7.3196-3206.2004	0095-1137	Journal of Clinical Microbiology	Discovery of Novel Human and Animal Cells Infected by the Severe Acute Respiratory Syndrome Coronavirus by Replication-Specific Multiplex Reverse Transcription-PCR	Gillim-Ross	2004	4		GAPDH
1424	chr5	110079585	110081241	3500168360	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350016836000000007,350016836000000006	0-20,0-20						Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses	Huang	2005	0		GAPDH
1424	chr5	110079585	110081241	3500142112	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350014211200000036,350014211200000035	0-20,0-20						Compositions and methods for detecting a non plus-stranded RNA virus	Scholl	2004	0		GAPDH
1424	chr5	110079585	110081241	3500140721	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350014072100000036,350014072100000035	0-20,0-20						COMPOSITIONS AND METHODS FOR DETECTING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS - DIAGNOSTIC HYBRIDS, INC.	www.sumobrain.com	0	0		GAPDH
1424	chr5	110079585	110081241	3500138492	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350013849200000036,350013849200000035	0-20,0-20						Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus	Scholl	2010	0		GAPDH
1424	chr5	110079585	110081241	3500019928	40		110079585	110081241	8421504	3	20,2,18	0,1518,1638	c	350001992800000023,350001992800000012,350001992800000022,350001992800000011	0-20,0-20,0-20,0-20						Methods For Detection And Production Of Influenza Viruses 	.freshpatents.com	0	0		GAPDH
1424	chr5	110079585	110080009	3500331992	40		110079585	110080009	8421504	2	20,20	0,404	c,g	350033199200000003,350033199200000003,350033199200000002,350033199200000002	0-20,0-20,0-20,0-20						&#x87fe;&#x870d;&#xf9b3;&#x53ca;&#x83ef;&#x87fe;&#xfa1d;&#x6291;&#x5236;&#x4eba;&#xf9d0;&#x524d;&#xf99c;&#x817a; &#x764c;&#x7d30;&#x80de;&#x751f;&#x9577;&#x4e4b;&#x4f5c;&#x7528;&#x6a5f;&#x8f49;	tcam.ccmp.gov.tw	0	0		GAPDH
1424	chr5	110079585	110080009	3500240855	40		110079585	110080009	8421504	2	20,20	0,404	c,g	350024085500000007,350024085500000006,350024085500000006	0-20,0-20,0-20						Potent Antiandrogen and Androgen Receptor Activities of an Angelica gigas&#x2013;Containing Herbal Formulation: Identification of Decursin as a Novel and Active Compound with Implications for Prevention and Treatment of Prostate Cancer	.aacrjournals.org	0	0		GAPDH
1424	chr5	110079585	110080009	3500151883	40		110079585	110080009	8421504	2	20,20	0,404	c	350015188300000007,350015188300000006	0-20,0-20		18253123	10.1038/sj.bjc.6604227		British Journal of Cancer	20(S)-25-methoxyl-dammarane-3&#x03b2;, 12&#x03b2;, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action	W	2008	0		GAPDH
1424	chr5	110079586	110081496	3500034609	695		110079586	110081496	8421504	17	41,28,65,30,66,1,44,93,9,36,43,5,45,15,78,21,75	0,42,172,240,355,615,702,749,845,1033,1072,1207,1260,1308,1428,1723,1835	p,c	350003460900000061,350003460900000060,350003460900015019,350003460900015018,350003460900000058,350003460900015017,350003460900000057,350003460900015014,350003460900015013,350003460900000053,350003460900015012,350003460900015011,350003460900000050,350003460900015008,350003460900015007,350003460900000047,350003460900015006,350003460900000043,350003460900000042,350003460900015002	1-42,0-48,0-45,0-45,0-47,0-45,0-44,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-45,0-48,0-45,0-48,0-48,0-45						Small Interfering RNAs Targeting Feline Herpes Virus - Patent application	www.faqs.org	0	0		
1424	chr5	110079586	110079791	3500136575	40		110079586	110079791	8421504	2	20,20	0,185	c,g	350013657500000001,350013657500000001,350013657500000000,350013657500000000	0-20,0-20,0-20,0-20						Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma	www.pedb.org	0	0		GAPDH
1424	chr5	110079586	110079785	3500053228	40		110079586	110079785	8421504	2	20,20	0,179	c,g	350005322800000001,350005322800000001,350005322800000000,350005322800000000	0-20,0-20,0-20,0-20						The human G Protein-Coupled Receptor GPR30: interaction partners and expression analysis in endothelial cells	edoc.hu-berlin.de	0	0		GAPDH
1424	chr5	110079587	110081239	3500164864	39		110079587	110081239	8421504	3	19,4,16	0,1514,1636	c	350016486400000020,350016486400000019	0-19,0-20						Novel repressor of the human FMR1 gene identi&#xfb01;cation of p56 human (GCC) -binding protein as a Kru &#xa8;ppel-like transcription factor ZF5	www.embryo.pu.ru	0	0		
1424	chr5	110079587	110079644	3500417821	40		110079587	110079644	8421504	2	20,20	0,37	c	350041782100000009,350041782100000010	20-40,20-40						HBD-1 and hBD-2 expression in HaCaT keratinocytes stimulated with nicotine	ww.sdclucknow.com	0	0		GAPDH
1424	chr5	110079590	110079613	3500123238	23		110079590	110079613	8421504	1	23	0	c	350012323800000003	0-23		15905730		1525-4135	JAIDS Journal of Acquired Immune Deficiency Syndromes	 Effects of HIV Protease Inhibitor Ritonavir on Vasomotor Fun... : JAIDS Journal of Acquired Immune Deficiency Syndromes 	Fu	2005	4		GAPDH,MCHR1
1424	chr5	110079599	110083331	3500449494	40		110079599	110083331	8421504	2	20,20	0,3712	c	350044949400000009,350044949400000008	0-20,0-20		22767581	10.1091/mbc.E12-02-0104	1059-1524	Molecular Biology of the Cell	Rab27 effector Slp2-a transports the apical signaling molecule podocalyxin to the apical surface of MDCK II cells and regulates claudin-2 expression	Yasuda	2012	5		
1424	chr5	110079599	110083331	3500428815	40		110079599	110083331	8421504	2	20,20	0,3712	c	350042881500000009,350042881500000008	0-20,0-20						Rab27 effector Slp2-a transports the apical signaling molecule podocalyxin to the apical surface of MDCK II cells and regulates claudin-2 expression	w.molbiolcell.org	0	0		
1424	chr5	110079599	110083331	3500359051	40		110079599	110083331	8421504	2	20,20	0,3712	c	350035905100000009,350035905100000008	0-20,0-20		22767581	10.1091/mbc.E12-02-0104		Molecular Biology of the Cell	Rab27 effector Slp2-a transports the apical signaling molecule podocalyxin to the apical surface of MDCK II cells and regulates claudin-2 expression	Takao	2012	0		
1424	chr5	110079599	110083331	3500274579	40		110079599	110083331	8421504	2	20,20	0,3712	c	350027457900000003,350027457900000002	0-20,0-20						Rab27 effector Slp2-a transports the apical signaling molecule podocalyxin to the apical surface of MDCK II cells and regulates claudin-2 expression. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110079601	110083327	3500052782	45		110079601	110083327	8421504	3	24,2,19	0,1918,3707	c	350005278200000003,350005278200000002	0-24,0-21						Molecular Regulation of IL-6 Activation Asbestos in Lung Epithelial Cells	www.cdc.gov	0	0		GAPDH
1424	chr5	110079601	110080427	3500133999	46		110079601	110080427	8421504	2	24,22	0,804	c	350013399900000001,350013399900000004	0-24,0-22						Physiological Role of Tumor Necrosis Factor a in Traumatic Muscle Injury	www.fasebj.org	0	0		GAPDH
1424	chr5	110079601	110080290	3500442476	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350044247600000005,350044247600000004	0-24,0-25						Tetrahydrocannabinol Inhibits Epithelial Growth Factor	www.scribd.com	0	0		
1424	chr5	110079601	110080290	3500435523	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350043552300000015,350043552300000014	0-24,0-25						Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress OCo Related Genes | Harry Williams - Academia.edu	www.academia.edu	0	0		
1424	chr5	110079601	110080290	3500406722	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350040672200000009,350040672200000008	0-24,0-25		21941370	10.1038/cdd.2011.122	1350-9047	Cell Death & Differentiation	Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis	Caffarel	2011	9		
1424	chr5	110079601	110080290	3500394352	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350039435200000005,350039435200000004	0-24,0-25		16818634	10.1158/0008-5472.CAN-05-4566	0008-5472	Cancer Research	&#x0394;9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation	Caffarel	2006	8		
1424	chr5	110079601	110080290	3500352030	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350035203000000019,350035203000000018	0-24,0-25						Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition	www.bbm1.ucm.es	0	0		
1424	chr5	110079601	110080290	3500339825	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350033982500000015,350033982500000014	0-24,0-25		16818650	10.1158/0008-5472.CAN-06-0169	0008-5472	Cancer Research	Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress&#x2013;Related Genes	Carracedo	2006	8		
1424	chr5	110079601	110080290	3500318090	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350031809000000005,350031809000000004	0-24,0-25		16818634	10.1158/0008-5472.CAN-05-4566	0008-5472	Cancer Research	&#x0394;9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation	Caffarel	2006	8		
1424	chr5	110079601	110080290	3500287007	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350028700700000005,350028700700000004	0-24,0-25		16818634	10.1158/0008-5472.CAN-05-4566	0008-5472	Cancer Research	&#x0394;9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation	Caffarel	2006	8		
1424	chr5	110079601	110080290	3500120666	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350012066600000019,350012066600000018	0-24,0-25						Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition	biomedcentral.com	0	0		
1424	chr5	110079601	110080290	3500028737	49		110079601	110080290	8421504	3	24,23,2	0,578,687	c	350002873700000015,350002873700000014	0-24,0-25						Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110079601	110079625	3500396878	24		110079601	110079625	8421504	1	24	0	c	350039687800000007	0-24						Carcinoembryonic antigen induces cytokine expression in Kuppfer cells: implications for hepatic metastasis from colorectal cancer. - ResearchGate	.researchgate.net	0	0		GAPDH
1424	chr5	110079601	110079625	3500347154	24		110079601	110079625	8421504	1	24	0	c	350034715400000003	0-24		16522738	10.1677/joe.1.06560	0022-0795	Journal of Endocrinology	Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice	Utama	2006	4		GAPDH
1424	chr5	110079601	110079625	3500259978	24		110079601	110079625	8421504	1	24	0	c	350025997800000008	24-48		16267257	10.1161/CIRCULATIONAHA.104.516898	0009-7322	Circulation	Id1 Gene Transfer Confers Angiogenic Property on Fully Differentiated Endothelial Cells and Contributes to Therapeutic Angiogenesis	Nishiyama	2005	15		GAPDH
1424	chr5	110079601	110079625	3500145122	24		110079601	110079625	8421504	1	24	0	c	350014512200000007	0-24						ScienceDirect.com - FEBS Letters - Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells	sciencedirect.com	0	0		GAPDH
1424	chr5	110079601	110079625	3500066096	24		110079601	110079625	8421504	1	24	0	c	350006609600000003	0-24						Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice	www.unmc.edu	0	0		GAPDH
1424	chr5	110079601	110079625	3500039692	24		110079601	110079625	8421504	1	24	0	c	350003969200000003	24-48						Isolation of putative progenitor endothelial cells for angiogenesis. - ResearchGate	.researchgate.net	0	0		KRBOX4,GAPDH
1424	chr5	110079601	110079625	3500025861	24		110079601	110079625	8421504	1	24	0	c	350002586100000003	0-24		16522738	10.1677/joe.1.06560	0022-0795	Journal of Endocrinology	Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice	Utama	2006	4		GAPDH
1424	chr5	110079607	110080670	3500214038	60		110079607	110080670	8421504	2	30,30	0,1033	c	350021403800000008,350021403800000007	0-30,0-30		15210819		0022-1767	The Journal of Immunology	Increase in Hepatic NKT Cells in Leukocyte Cell-Derived Chemotaxin 2-Deficient Mice Contributes to Severe Concanavalin A-Induced Hepatitis	Saito	2004	6		
1424	chr5	110079607	110080670	3500151615	60		110079607	110080670	8421504	2	30,30	0,1033	c	350015161500000009,350015161500000008	0-30,0-30		19109969	10.1016/j.yjmcc.2008.11.016		Journal of molecular and cellular cardiology	Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a	Zhongyan	2009	0		GAPDH
1424	chr5	110079607	110080670	3500052681	60		110079607	110080670	8421504	2	30,30	0,1033	c	350005268100000005,350005268100000004	0-30,0-30		18234965	10.1158/1541-7786.MCR-07-0221	1541-7786	Molecular Cancer Research	Lack of P-Glycoprotein Expression by Low-Dose Fractionated Radiation Results from Loss of Nuclear Factor-&#x03ba;B and NF-Y Activation in Oral Carcinoma Cells	Shareef	2008	4		
1424	chr5	110079607	110080670	3500044549	60		110079607	110080670	8421504	2	30,30	0,1033	c	350004454900000005,350004454900000004	0-30,0-30		18234965	10.1158/1541-7786.MCR-07-0221	1541-7786	Molecular Cancer Research	Lack of P-Glycoprotein Expression by Low-Dose Fractionated Radiation Results from Loss of Nuclear Factor-&#x03ba;B and NF-Y Activation in Oral Carcinoma Cells	Shareef	2008	4		
1424	chr5	110079608	110080008	3500199741	50		110079608	110080008	8421504	2	26,24	0,376	c	350019974100000014,350019974100000002	22-48,0-24						a1 subunit of nicotinic acetylcholine receptors in the inner ear: transcriptional regulation by ATOH1 and co-expression with the c subunit in hair cells	y.med.harvard.edu	0	0		
1424	chr5	110079610	110080296	3500368414	60		110079610	110080296	8421504	3	30,22,8	0,570,678	c	350036841400000010,350036841400000009	0-30,0-30					The American Journal of Pathology	Nitric Oxide Inhibits HIV Tat-Induced NF-&#x03ba;B Activation	Fei	July	0		
1424	chr5	110079610	110079637	3500179062	27		110079610	110079637	8421504	1	27	0	c	350017906200000001,350017906200000005	19-46,0-24					Patent	Medical device with coating that promotes endothelial cell adherence and differentiation (Patent CN:100455275)	M*A*Ku Li Ze Si Ji 	2009	0		
1424	chr5	110079611	110080425	3500434211	40		110079611	110080425	8421504	2	20,20	0,794	c	350043421100000003,350043421100000002	0-20,0-20		23892317	10.1038/srep02293	xxxx-xxxx	Scientific Reports	Capturing intercellular sugar-mediated ligand-receptor recognitions via a simple yet highly biospecific interfacial system	Li	2013	0		GAPDH
1424	chr5	110079611	110080425	3500392858	40		110079611	110080425	8421504	2	20,20	0,794	c,g	350039285800000010,350039285800000010,350039285800000009,350039285800000009	0-20,0-20,0-20,0-20		20952383	10.1074/jbc.M110.153890		The Journal of Biological Chemistry	Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways	Carola	2010	0		GAPDH
1424	chr5	110079611	110080425	3500390202	40		110079611	110080425	8421504	2	20,20	0,794	c	350039020200000006,350039020200000005	0-20,0-20						The RhoA Activator GEF-H1/Lfc Is a Transforming Growth Factor- Target Gene and Effector That Regulates -Smooth Muscle Actin Expression and Cell Migration	w.molbiolcell.org	0	0		GAPDH
1424	chr5	110079611	110080425	3500110464	40		110079611	110080425	8421504	2	20,20	0,794	c,g	350011046400000007,350011046400000007,350011046400000006,350011046400000006	0-20,0-20,0-20,0-20						Potential of glucan HBP-A in chondrocytes-alginate hydrogel constructs	demicjournals.org	0	0		GAPDH
1424	chr5	110079611	110080425	3500085193	40		110079611	110080425	8421504	2	20,20	0,794	c	350008519300000077,350008519300000076	0-20,0-20						GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF - Patent application	www.faqs.org	0	0		GAPDH
1424	chr5	110079611	110080425	3500076465	40		110079611	110080425	8421504	2	20,20	0,794	c	350007646500000001,350007646500000000	0-20,0-20		12631740	10.1091/mbc.E02-07-0375	1059-1524	Molecular Biology of the Cell	Mechanism of a Transcriptional Cross Talk between Transforming Growth Factor-&#x03b2;&#x2013;regulated Smad3 and Smad4 Proteins and Orphan Nuclear Receptor Hepatocyte Nuclear Factor-4	Chou	2003	5		GAPDH
1424	chr5	110079611	110079634	3500047825	23		110079611	110079634	8421504	1	23	0	c	350004782500000000	18-41						Development of IL-17-mediated Delayed-Type Hypersensitivity Is Not Affected by Down-Regulation of IL-25 Expression	ai.jsaweb.jp	0	0		GAPDH
1424	chr5	110079612	110080293	3500303986	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c,g	350030398600000003,350030398600000003,350030398600000002	0-23,0-23,1-24		17673547	10.1152/ajpgi.00131.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors	Hatazawa	2007	0		
1424	chr5	110079612	110080293	3500244819	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c	350024481900000007,350024481900000006	0-23,1-24		20028985	10.1074/jbc.M109.075788		The Journal of Biological Chemistry	Reduction of Raf Kinase Inhibitor Protein Expression by Bcr-Abl Contributes to Chronic Myelogenous Leukemia Proliferation	Tomonari	2010	0		
1424	chr5	110079612	110080293	3500221635	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c	350022163500000007,350022163500000006	0-23,1-24						1208_article_04	www.jpp.krakow.pl	0	0		
1424	chr5	110079612	110080293	3500149800	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c	350014980000000005,350014980000000004	0-23,1-24		18163520	10.1002/art.23174	1529-0131	Arthritis & Rheumatism	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue - Volin - 2007 - Arthritis & Rheumatism - Wiley Online Library	Volin	2008	0		
1424	chr5	110079612	110080293	3500142951	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c,g	350014295100000003,350014295100000003,350014295100000002	0-23,0-23,1-24		17673547	10.1152/ajpgi.00131.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors	Hatazawa	2007	0		
1424	chr5	110079612	110080293	3500118365	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c	350011836500000005,350011836500000004	0-23,1-24		19564843	10.1038/labinvest.2009.65	0023-6837	Laboratory Investigation	Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin	Yamaguchi	2009	4		
1424	chr5	110079612	110080293	3500089878	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c	350008987800000003,350008987800000002	0-23,1-24		17673547	10.1152/ajpgi.00131.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors	Hatazawa	2007	0		
1424	chr5	110079612	110080293	3500073155	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c	350007315500000003,350007315500000002	0-23,1-24						Cyclooxygenase-2/Prostaglandin E Accelerates the Healing of Gastric Ulcers Via EP4 Receptors	gi.physiology.org	0	0		
1424	chr5	110079612	110080293	3500041620	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c	350004162000000003,350004162000000002	0-23,1-24		17673547	10.1152/ajpgi.00131.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors	Hatazawa	2007	0		
1424	chr5	110079612	110080293	3500020350	46		110079612	110080293	8421504	3	23,18,5	0,572,676	c	350002035000000007,350002035000000006	0-23,1-24		20028985	10.1074/jbc.M109.075788	0021-9258	Journal of Biological Chemistry	Reduction of Raf Kinase Inhibitor Protein Expression by Bcr-Abl Contributes to Chronic Myelogenous Leukemia Proliferation	Takemura	2010	5		
1424	chr5	110079613	110079637	3500435667	24		110079613	110079637	8421504	1	24	0	c	350043566700000003	0-24						Medical device with coating that promotes cell adherence and differentiation	Kutryk	2003	0		GAPDH
1424	chr5	110079613	110079637	3500007698	24		110079613	110079637	8421504	1	24	0	c	350000769800000003	0-24						Medical device with coating for capturing genetically-altered cells and methods of using same	Cottone	2006	0		GAPDH
1424	chr5	110079614	110079796	3500226439	40		110079614	110079796	8421504	2	20,20	0,162	c	350022643900000003,350022643900000002	0-20,0-20		19302290	10.1111/j.1349-7006.2009.01125.x	1349-7006	Cancer Science	Core fucosylation of E-cadherin enhances cell&#x2013;cell adhesion in human colon carcinoma WiDr cells - Osumi - 2009 - Cancer Science - Wiley Online Library	Osumi	2009	0		GAPDH
1424	chr5	110079615	110081240	3500403353	62		110079615	110081240	8421504	4	21,22,2,17	0,178,1488,1608	c	350040335300000035,350040335300000007,350040335300000027	0-21,0-22,0-19						Plasminogen activator inhibitor 1: mechanisms of its synergistic regulation by growth factors	ib.dr.iastate.edu	0	0		
1424	chr5	110079615	110081079	3500412007	44		110079615	110081079	8421504	2	22,22	0,1442	c	350041200700000000,350041200700000001	17-39,19-41		22233500	10.1042/CBI20110487	1095-8355	Cell Biology International	In vitro culture and induced differentiation of sheep skeletal muscle satellite cells	H	2012	0		
1424	chr5	110079615	110080424	3500065181	49		110079615	110080424	8421504	2	25,24	0,785	c	350006518100000005,350006518100000004	0-25,0-24		23255809	10.1128/JVI.03015-12		Journal of Virology	ZAP Inhibits Murine Gammaherpesvirus 68 ORF64 Expression and Is Antagonized by RTA	Yifang	2013	0		
1424	chr5	110079615	110080424	3500027325	49		110079615	110080424	8421504	2	25,24	0,785	c,g	350002732500000005,350002732500000005,350002732500000004	0-25,0-25,0-24		23255809	10.1128/JVI.03015-12	0022-538X	Journal of Virology	ZAP Inhibits Murine Gammaherpesvirus 68 ORF64 Expression and Is Antagonized by RTA	Xuan	2013	5		GAPDH
1424	chr5	110079615	110080292	3500362436	43		110079615	110080292	8421504	3	22,17,4	0,570,673	c	350036243600000001,350036243600000000	0-22,0-21		23803658	10.3390/ijms140713266		International Journal of Molecular Sciences	CD44 Is Associated with the Aggressive Phenotype of Nasopharyngeal Carcinoma through Redox Regulation	Chien-Hung	July	0		
1424	chr5	110079615	110080292	3500222110	43		110079615	110080292	8421504	3	22,17,4	0,570,673	c	350022211000000001,350022211000000000	0-22,0-21						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
1424	chr5	110079615	110080292	3500135642	43		110079615	110080292	8421504	3	22,17,4	0,570,673	c,g	350013564200000001,350013564200000001,350013564200000000	0-22,0-22,0-21						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
1424	chr5	110079615	110079639	3500177373	24		110079615	110079639	8421504	1	24	0	c	350017737300000005	0-24						Expression and localization of hepatocyte domain-speci&#xfb01;c plasma membrane proteins in hepatoma &#xfb01;broblast hybrids and in hepatoma dedifferentiated variants	cs.biologists.org	0	0		GAPDH
1424	chr5	110079616	110080664	3500230457	42		110079616	110080664	8421504	2	21,21	0,1027	c	350023045700000009,350023045700000008	0-21,0-21						Retinal Cell Biology Vascular Endothelial Growth Factor as an Autocrine Survival Factor for Retinal Pigment Epithelial Cells under Oxidative Stress via the VEGF-R2/PI3K/Akt	www.iovs.org	0	0		GAPDH
1424	chr5	110079616	110080664	3500222477	42		110079616	110080664	8421504	2	21,21	0,1027	c	350022247700000016,350022247700000031,350022247700000015,350022247700000030	0-21,0-21,0-21,0-21						Treatment of Pulmonary Vascular Remodeling With Neprilysin - Patent application	www.faqs.org	0	0		GAPDH
1424	chr5	110079616	110080664	3500059342	42		110079616	110080664	8421504	2	21,21	0,1027	c	350005934200000019,350005934200000018	0-21,0-21		18334960			Molecular Vision	Mesenchymal cells from limbal stroma of human eye	Polisetty	2008	0		GAPDH
1424	chr5	110079616	110080662	3500443815	45		110079616	110080662	8421504	2	22,23	0,1023	c	350044381500000006,350044381500000005	0-22,0-23						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa hoc : Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines 	tailieu.vn/doc/ba	0	0		
1424	chr5	110079616	110080662	3500392912	45		110079616	110080662	8421504	2	22,23	0,1023	c	350039291200000003,350039291200000002	0-22,0-23						Differential expression of Mart-1 in human uveal melanoma cells	-publications.com	0	0		
1424	chr5	110079616	110080662	3500203662	45		110079616	110080662	8421504	2	22,23	0,1023	c	350020366200000014,350020366200000013	0-22,0-23		22984591	10.1371/journal.pone.0044946		PLoS ONE	Heparin-Binding EGF-Like Growth Factor Induces Heart Interstitial Fibrosis via an Akt/mTor/p70s6k Pathway	Hong	2012	0		
1424	chr5	110079616	110080662	3500085049	45		110079616	110080662	8421504	2	22,23	0,1023	c	350008504900000001,350008504900000000	0-22,0-23						Interleukin-11 Promotes the Progress of Gastric Carcinoma via Abnormally Expressed Versican	www.ijbs.com	0	0		GAPDH
1424	chr5	110079616	110080416	3500244164	40		110079616	110080416	8421504	2	20,20	0,780	c	350024416400000005,350024416400000004	0-20,0-20						CTGF enhances the motility of breast cancer cells via an integrin- v 3&#x2013;ERK1/2-dependent S100A4- upregulated pathway	cs.biologists.org	0	0		GAPDH
1424	chr5	110079616	110080293	3500064951	43		110079616	110080293	8421504	3	22,16,5	0,570,672	c	350006495100000005,350006495100000004	0-22,1-22						Identification of a Ras GTPase-activating protein regulated by receptor-mediated Ca2+ oscillations - Keeping the Faith	pthefaith1296.com	0	0		
1424	chr5	110079617	110081323	3500390387	41		110079617	110081323	8421504	2	20,21	0,1685	c	350039038700000020,350039038700000021	0-20,0-21					Investigative ophthalmology & visual science	Identification and Spatial Analysis of Metallothioneins Expressed by the Adult Human Lens	Brian	2001	0		
1424	chr5	110079617	110081323	3500389718	41		110079617	110081323	8421504	2	20,21	0,1685	c	350038971800000005,350038971800000004	0-20,0-21						Safety of Life and Health	fe-and-health.com	0	0		
1424	chr5	110079617	110081323	3500341303	41		110079617	110081323	8421504	2	20,21	0,1685	c	350034130300000005,350034130300000004	0-20,0-21		18480434	10.1128/JVI.00379-08	0022-538X	Journal of Virology	A Bovine Herpesvirus Type 1 Mutant Virus Specifying a Carboxyl-Terminal Truncation of Glycoprotein E Is Defective in Anterograde Neuronal Transport in Rabbits and Calves	Liu	2008	5		
1424	chr5	110079617	110081323	3500319611	41		110079617	110081323	8421504	2	20,21	0,1685	c	350031961100000001,350031961100000000	0-20,0-21						Medicine Chest - About your prescription and over-the-counter medicines, herbs and supplements - Part 6	medicinechest.com	0	0		
1424	chr5	110079617	110081323	3500304998	41		110079617	110081323	8421504	2	20,21	0,1685	c	350030499800000007,350030499800000006	0-20,0-21						PATOGENIA DA INFEC&#xc7;&#xc3;O AGUDA E LATENTE PELO HERPESV&#xcd;RUS BOVINO TIPO 5 E POR RECOMBINANTE COM DELE&#xc7;&#xc3;O NO GENE DA TIMIDINA QUINASE EM OVINOS	coralx.ufsm.br	0	0		
1424	chr5	110079617	110081323	3500292736	41		110079617	110081323	8421504	2	20,21	0,1685	c	350029273600000003,350029273600000002	0-20,0-21						UFSM Tese de Doutorado	coralx.ufsm.br	0	0		
1424	chr5	110079617	110081323	3500287186	41		110079617	110081323	8421504	2	20,21	0,1685	c	350028718600000007,350028718600000006	0-20,0-21		11448962	10.1074/jbc.M103709200	0021-9258	Journal of Biological Chemistry	Molecular Cloning and Induction of Bovine Prostaglandin E Synthase by Gonadotropins in Ovarian Follicles Prior to Ovulationin Vivo	Filion	2001	5		
1424	chr5	110079617	110081323	3500225337	41		110079617	110081323	8421504	2	20,21	0,1685	c,g	350022533700000007,350022533700000007,350022533700000006,350022533700000006	0-20,0-20,0-21,0-21						Prostaglandin F2,, Regulates Distinct Physiological Changes in Early and Mid-Cycle Bovine Corpora Lutea'	ww.biolreprod.org	0	0		
1424	chr5	110079617	110081323	3500157280	41		110079617	110081323	8421504	2	20,21	0,1685	c	350015728000000003,350015728000000002	0-20,0-21			10.1590/S0102-09352007000600023	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Profile and regulation of annexin II expression during early embryogenesis in cattle	Costa	2007	0		
1424	chr5	110079617	110081323	3500010569	41		110079617	110081323	8421504	2	20,21	0,1685	c,g	350001056900000001,350001056900000001,350001056900000000	0-20,0-20,0-21						REPRODUCTION	uction-online.org	0	0		
1424	chr5	110079617	110081297	3500304342	85		110079617	110081297	8421504	4	20,23,21,21	0,147,1023,1659	c	350030434200000019,350030434200000018,350030434200000002,350030434200000013,350030434200000012,350030434200000000,350030434200000001	0-20,0-23,0-21,2-21,0-21,0-21,2-21						BMC Biotechnology BioMed Central	biomedcentral.com	0	0		
1424	chr5	110079617	110081102	3500133203	738		110079617	110081102	8421504	8	39,98,84,79,152,82,116,88	0,141,324,506,671,1002,1176,1397	c	350013320300000188,350013320300000181,350013320300000187,350013320300000186,350013320300000183,350013320300000185,350013320300000182	0-222,0-20,0-60,0-180,0-24,23-300,0-25						[tel-00521428, v1] &#xc9;tude des voies de conduction cardiaque : identification des g&#xe8;nes sp&#xe9;cifiquement exprim&#xe9;s et impliqu&#xe9;s dans des troubles de conduction	hives-ouvertes.fr	0	0		
1424	chr5	110079617	110080813	3500307238	42		110079617	110080813	8421504	3	20,2,20	0,1082,1176	c	350030723800000003,350030723800000002	0-20,0-22						Expression Of Dc-sign By Macrophages And Methods Of Treating And Diagnosing Rheumatoid Arthritis 	freshpatents.com	0	0		
1424	chr5	110079617	110080813	3500142603	42		110079617	110080813	8421504	3	20,2,20	0,1082,1176	c,g	350014260300000003,350014260300000003,350014260300000032,350014260300000032,350014260300000002,350014260300000031	0-20,0-20,0-20,0-20,0-22,0-22						Methods of identifying and isolating cells expressing DC-sign - US Patent 7691591 Description	ww.patentstorm.us	0	0		
1424	chr5	110079617	110080668	3500456752	39		110079617	110080668	8421504	2	20,19	0,1032	c,g	350045675200000003,350045675200000002	0-20,1-20		19801523	10.4049/jimmunol.0900259		Journal of immunology (Baltimore, Md. : 1950)	Elevated Levels of Select Gangliosides In T Cells From Renal Cell Carcinoma Patients Is Associated With T-Cell Dysfunction	Soumika	2009	0		
1424	chr5	110079617	110080440	3500355031	40		110079617	110080440	8421504	2	20,20	0,803	c,g	350035503100000015,350035503100000014	0-21,0-20						OKAMATSU-OGURA, Yuko; SOLIMAN, Mohamed; ABD Citation Journal of Veterinary Medical Science, 69(5): 509-514 Issue Date 2007-05	lib.hokudai.ac.jp	0	0		
1424	chr5	110079617	110080309	3500113712	40		110079617	110080309	8421504	2	20,20	0,672	c	350011371200000010,350011371200000003	20-40,0-20						&#x4e3b;&#x9898;&#xff1a;mRNA | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		GAPDH
1424	chr5	110079617	110080170	3500414172	60		110079617	110080170	8421504	3	20,20,20	0,148,533	c	350041417200000009,350041417200000020,350041417200000008,350041417200000018,350041417200000017	19-39,0-20,20-40,0-20,0-20						Use of Compounds for Inducing Differentiation of Mesenchymal Stem Cells to Chondrocytes - Patent application	www.faqs.org	0	0		
1424	chr5	110079617	110080170	3500318522	60		110079617	110080170	8421504	3	20,20,20	0,148,533	c	350031852200000010,350031852200000009,350031852200000012,350031852200000011	19-39,20-40,0-20,0-20						Use of a compound for inducing differentiation of mesenchymal stem cells into cartilage cells	Han	2012	0		
1424	chr5	110079617	110080141	3500350389	48		110079617	110080141	8421504	3	20,10,18	0,398,506	c	350035038900000007,350035038900000000	0-20,0-28		18714012		0022-1767	The Journal of Immunology	Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp4	Fletcher	2008	6		GAPDH
1424	chr5	110079617	110080141	3500245758	44		110079617	110080141	8421504	3	21,5,18	0,403,506	c,g	350024575800000023,350024575800000023,350024575800000013	0-21,0-21,0-23						Nuclear Translocation of Components of the Neuronal Plasma Membrane Oxidoreductase after Oxidative Stress and its Effects on Induction of Apoptosis	ethesis.unifr.ch	0	0		
1424	chr5	110079617	110080007	3500364788	40		110079617	110080007	8421504	2	20,20	0,370	c	350036478800000003,350036478800000002	0-20,0-20		23685908	10.1038/aja.2013.43		Asian Journal of Andrology	Role of LM23 in cell proliferation and apoptosis and its expression during the testis development	Qing	July	0		GAPDH
1424	chr5	110079617	110080007	3500351918	40		110079617	110080007	8421504	2	20,20	0,370	c	350035191800000019,350035191800000018	0-20,0-20		18980974	10.1158/1078-0432.CCR-07-4820	1078-0432	Clinical Cancer Research	Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells via Targeting RhoC In vitro and In vivo	Wang	2008	8		GAPDH
1424	chr5	110079617	110080007	3500316245	40		110079617	110080007	8421504	2	20,20	0,370	c	350031624500000006,350031624500000005	0-20,0-20						Effective inhibition of specific gene by adeno- associated virus (AAV)-mediated expression of small interfering RNA	www.ajol.info	0	0		GAPDH
1424	chr5	110079617	110080007	3500315194	40		110079617	110080007	8421504	2	20,20	0,370	c	350031519400000007,350031519400000006	0-20,0-20		18201274	10.1111/j.1349-7006.2007.00722.x	1349-7006	Cancer Science	Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer - Yu - 2008 - Cancer Science - Wiley Online Library	Yu	2008	0		GAPDH
1424	chr5	110079617	110080007	3500303355	40		110079617	110080007	8421504	2	20,20	0,370	c	350030335500000008,350030335500000007	0-20,0-20		22696253	10.1002/stem.1154	1549-4918	STEM CELLS	microRNA-124 Regulates Cardiomyocyte Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Via Targeting STAT3 Signaling - Cai - 2012 - STEM CELLS - Wiley Online Library	Cai	2012	0		GAPDH
1424	chr5	110079617	110080007	3500291648	40		110079617	110080007	8421504	2	20,20	0,370	c	350029164800000006,350029164800000005	0-20,0-20						Yin et al. Effective inhibition of specific gene by adeno-associated virus (AAV)-mediated expression of small interfering RNA. Afr. J. Biotechnol. 2011	demicjournals.org	0	0		GAPDH
1424	chr5	110079617	110080007	3500198678	40		110079617	110080007	8421504	2	20,20	0,370	c	350019867800000005,350019867800000004	0-20,0-20			10.1124/mol.105.017483	1521-0111 (Online)	Molecular Pharmacology	Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-&#x03b2;1-Induced Extracellular Matrix Expression	Jinnin	2006	0		GAPDH
1424	chr5	110079617	110080007	3500115262	40		110079617	110080007	8421504	2	20,20	0,370	c	350011526200000019,350011526200000018	0-20,0-20		18980974	10.1158/1078-0432.CCR-07-4820	1078-0432	Clinical Cancer Research	Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells via Targeting RhoC In vitro and In vivo	Wang	2008	8		GAPDH
1424	chr5	110079617	110079640	3500083896	23		110079617	110079640	8421504	1	23	0	c	350008389600000000	23-46						The combination of pamidronate and calcitriol reverses particle- and TNF- induced altered functions of bone-marrow- derived stromal cells with osteoblastic phenotype	neandjoint.org.uk	0	0		
1424	chr5	110079618	110080293	3500466199	42		110079618	110080293	8421504	3	21,16,5	0,568,670	c	350046619900000013,350046619900000035,350046619900000012,350046619900000034,350046619900000004,350046619900000026	0-21,0-21,0-21,0-21,0-20,0-20						Methods of Screening for Atherosclerosis - Patent application	www.faqs.org	0	0		
1424	chr5	110079618	110080293	3500452479	42		110079618	110080293	8421504	3	21,16,5	0,568,670	c	350045247900000013,350045247900000012	0-21,0-21						Method for detecting IGFBP-4 protease without detecting IGFBP-4 protease/proMBP Complex	Overgaard	2000	0		
1424	chr5	110079618	110080292	3500081181	40		110079618	110080292	8421504	3	20,16,4	0,568,670	c	350008118100000015,350008118100000008	21-41,0-20						Specific physiological features of inorganic selenium compounds regarding metabolism : in vivo and in vitro investigations with type II diabetic dbdb mice and healthy rats	eb.uni-giessen.de	0	0		
1424	chr5	110079618	110079942	3500156976	40		110079618	110079942	8421504	3	20,19,1	0,219,323	c	350015697600000008,350015697600000007	0-20,0-20		21691298	10.1038/cr.2011.100	1001-0602	Cell Research	Serum inducible kinase is a positive regulator of cortical dendrite development and is required for BDNF-promoted dendritic arborization	Guo	2011	8		
1424	chr5	110079619	110080008	3500389598	40		110079619	110080008	8421504	2	20,20	0,369	c	350038959800000003,350038959800000002	0-20,0-20		18287333	10.1152/ajpcell.00411.2007		American Journal of Physiology - Cell Physiolog	A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin	Zhu	2008	0		
1424	chr5	110079619	110080003	3500092051	42		110079619	110080003	8421504	2	22,20	0,364	c	350009205100000013,350009205100000012	0-22,0-20		22205609	10.1167/iovs.11-8728	1552-5783	Investigative Ophthalmology & Visual Science	&#x03b3;-Secretase Inhibition of Murine Choroidal Neovascularization Is Associated with Reduction of Superoxide and Proinflammatory Cytokines	Qi	2012	0		
1424	chr5	110079620	110080198	3500070804	40		110079620	110080198	8421504	2	20,20	0,558	c	350007080400000012,350007080400000011	0-20,0-20		18477566	10.1074/jbc.M801307200		The Journal of Biological Chemistry	PIASy Represses CCAAT/Enhancer-binding Protein &#x03b4; (C/EBP&#x03b4;) Transcriptional Activity by Sequestering C/EBP&#x03b4; to the Nuclear Periphery	Shanggen	July	0		GAPDH
1424	chr5	110079621	110079656	3500019769	35		110079621	110079656	8421504	1	35	0	c	350001976900000011,350001976900000021	0-35,0-35						ADULT SERTOLI CELLS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1424	chr5	110079622	110080425	3500436356	45		110079622	110080425	8421504	2	24,21	0,782	c	350043635600000008,350043635600000007	0-24,0-21						Aberrant genomic imprinting in rhesus monkey embryonic stem cells. - ResearchGate	.researchgate.net	0	0		GAPDH
1424	chr5	110079622	110080013	3500140308	77		110079622	110080013	8421504	4	24,24,5,24	0,210,319,367	c	350014030800000002,350014030800000009,350014030800000006	0-24,0-29,0-24						Regulation of Metallothionein II Messenger Ribonucleic Acid Measures Exogenous Estrogen Receptor-bActivity in SAOS-2 and LNCaPLN3 Cells	.endojournals.org	0	0		
1424	chr5	110079622	110079946	3500372774	53		110079622	110079946	8421504	3	24,24,5	0,210,319	c	350037277400000002,350037277400000009	0-24,0-29						BIOASSAY FOR IDENTIFYING ESTROGEN RECEPTOR-&#x03b2;/&#x03b1; SELECTIVE MODULATORS	Bhat	2000	0		
1424	chr5	110079622	110079843	3500463188	43		110079622	110079843	8421504	2	21,22	0,199	c	350046318800000013,350046318800000012	0-21,0-22			10.1021/bi050226k		Biochemistry	Biochemical Properties of Purified Human Retinol Dehydrogenase 12 (RDH12): Catalytic Efficiency toward Retinoids and C9 Aldehydes and Effects of Cellular Retinol-Binding Protein Type I (CRBPI) and Cellular Retinaldehyde-Binding Protein (CRALBP) on the Oxi	Olga	2005	0		GAPDH
1424	chr5	110079622	110079843	3500296956	43		110079622	110079843	8421504	2	21,22	0,199	c	350029695600000013,350029695600000012	0-21,0-22						Biochemical Properties of Purified Human Retinol Dehydrogenase 12 (RDH12): Catalytic Efficiency toward Retinoids and C Aldehydes and Effects of Cellular Retinol-Binding Protein Type I (CRBPI) and Cellular Retinaldehyde-Binding Protein (CRALBP) on the Oxid	www.pedb.org	0	0		GAPDH
1424	chr5	110079622	110079843	3500191479	43		110079622	110079843	8421504	2	21,22	0,199	c	350019147900000001,350019147900000000	0-21,0-22						 <HTML> <HEAD> <TITLE> The Gene Expression Program of Prostate Fibroblast Sene	.aacrjournals.org	0	0		GAPDH
1424	chr5	110079622	110079646	3500055198	24		110079622	110079646	8421504	1	24	0	c	350005519800000011	0-24		22724005	10.1371/journal.pone.0039365		PLoS ONE	Human Umbilical Cord Blood-Derived CD34+ Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities	Reeva	2012	0		
1424	chr5	110079623	110079646	3500434264	23		110079623	110079646	8421504	1	23	0	c	350043426400000010	0-23						Regulaci&#xf3;n de la expresi&#xf3;n de versicano	www.tdx.cat	0	0		
1424	chr5	110079624	110080289	3500242795	39		110079624	110080289	8421504	3	19,19,1	0,559,664	c	350024279500000001,350024279500000000	0-19,0-20		11739556		0741-5400	Journal of Leukocyte Biology	Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection	Haas	2001	5		
1424	chr5	110079624	110080133	3500239351	42		110079624	110080133	8421504	3	21,11,10	0,390,499	c	350023935100000003,350023935100000002	0-21,0-21		19052261	10.1152/ajpcell.00254.2008		American Journal of Physiology - Cell Physiology	Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation	Jin	2009	0		
1424	chr5	110079624	110080133	3500114146	42		110079624	110080133	8421504	3	21,11,10	0,390,499	c	350011414600000003,350011414600000002	0-21,0-21		19052261	10.1152/ajpcell.00254.2008		American Journal of Physiology - Cell Physiolog	Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation	Lee	2009	0		
1424	chr5	110079624	110080133	3500000720	42		110079624	110080133	8421504	3	21,11,10	0,390,499	c	350000072000000003,350000072000000002	0-21,0-21		19052261	10.1152/ajpcell.00254.2008		American Journal of Physiology - Cell Physiology	Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation	Lee	2009	0		
1424	chr5	110079624	110079843	3500350912	44		110079624	110079843	8421504	2	22,22	0,197	c	350035091200000001,350035091200000000	0-22,0-22		18771418	10.1089/dna.2008.0766		DNA and Cell Biology	Regulation of the Mouse Treacher Collins Syndrome Homolog (Tcof1) Promoter Through Differential Repression of Constitutive Expression	Kathryn	2008	0		GAPDH
1424	chr5	110079624	110079843	3500122135	44		110079624	110079843	8421504	2	22,22	0,197	c	350012213500000019,350012213500000018	0-22,0-22					American Journal of Human Genetics	A Homozygous Mutation in a Novel Zinc-Finger Protein, ERIS, Is Responsible for Wolfram Syndrome 2	Sami 	2007	0		GAPDH
1424	chr5	110079624	110079785	3500045428	40		110079624	110079785	8421504	2	20,20	0,141	c	350004542800000064,350004542800000007,350004542800000006,350004542800000063	0-20,0-20,0-20,0-20						Intestinal folate transporter - Patent application	www.faqs.org	0	0		GAPDH
1424	chr5	110079625	110079843	3500428535	43		110079625	110079843	8421504	2	21,22	0,196	c	350042853500000043,350042853500000042	0-21,0-22						NOVEL GENE PARTICIPATING IN EPIDERMAL DIFFERENTIATION AND USE THEREOF	MATSUI	2005	0		
1424	chr5	110079625	110079793	3500366217	42		110079625	110079793	8421504	2	22,20	0,148	c,g	350036621700000013,350036621700000012,350036621700000012	0-22,0-20,0-20			10.1073/pnas.0601015103		Proceedings of the National Academy of Sciences of the United States of America	Evidence that bovine forebrain embryonic zinc finger-like gene influences immune response associated with mastitis resistance	Mayumi	2006	0		GAPDH
1424	chr5	110079626	110079942	3500285699	43		110079626	110079942	8421504	3	22,20,1	0,210,315	c	350028569900000035,350028569900000026	0-22,0-21						Dexanabinol and dexanabinol analogs regulate inflammation related genes	Avraham	2003	0		
1424	chr5	110079628	110079942	3500036240	45		110079628	110079942	8421504	3	23,21,1	0,207,313	c	350003624000000009,350003624000000010	0-23,0-22		15520175	10.1158/0008-5472.CAN-04-0715	0008-5472	Cancer Research	Epidermal Growth Factor Receptor Regulates Aberrant Expression of Insulin-Like Growth Factor-Binding Protein 3	Takaoka	2004	8		GAPDH
1424	chr5	110079628	110079651	3500367348	23		110079628	110079651	8421504	1	23	0	c	350036734800000000	25-48						Effects of chronic exposure to arsenic and estrogen on epigenetic regulatory genes expression and epigenetic code in human prostate epithelial cells. - ResearchGate	.researchgate.net	0	0		GAPDH
1424	chr5	110079628	110079651	3500139297	23		110079628	110079651	8421504	1	23	0	c	350013929700000000	22-45						Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line	odineresearch.com	0	0		GAPDH
1424	chr5	110079631	110081444	3500070510	105		110079631	110081444	8421504	7	25,2,24,25,1,5,23	0,127,1421,1449,1592,1694,1790	c	350007051000000005,350007051000000013,350007051000000014,350007051000000004	0-28,0-24,0-26,0-28						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
1424	chr5	110079631	110081444	3500068065	99		110079631	110081444	8421504	6	25,2,24,20,5,23	0,127,1421,1595,1694,1790	c	350006806500000019,350006806500000001,350006806500000000,350006806500000018	0-27,0-24,0-20,0-28						RESEARCH Open Access Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression	www.rbej.com	0	0		
1424	chr5	110079631	110081444	3500020590	79		110079631	110081444	8421504	5	25,2,24,5,23	0,127,1421,1694,1790	c	350002059000000013,350002059000000000,350002059000000012	0-27,20-44,1-29						Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110079631	110079760	3500233580	27		110079631	110079760	8421504	2	25,2	0,127	c	350023358000000009	49-76						Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle	biomedcentral.com	0	0		
1424	chr5	110079637	110080136	3500419888	41		110079637	110080136	8421504	4	19,2,7,13	0,121,381,486	c	350041988800000003,350041988800000002	0-21,0-20		18272661	10.1152/ajpregu.00787.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep	Duffield	2008	0		
1424	chr5	110079637	110080136	3500350516	41		110079637	110080136	8421504	4	19,2,7,13	0,121,381,486	c	350035051600000003,350035051600000002	0-21,0-20		19094922	10.1051/vetres:2008055	0928-4249	Veterinary Research	Neutrophils as one of the major haptoglobin sources in mastitis affected milk | Vet. Res.	Lai	2008	4		
1424	chr5	110079637	110080136	3500249124	41		110079637	110080136	8421504	4	19,2,7,13	0,121,381,486	c	350024912400000027,350024912400000026	0-21,0-20						Transcriptional Expression Profile of Toll Like Receptor 1 - 10 mRNA in Bovine Peripheral Mononuclear Cells in Response to Foot and Mouth Disease Antigens	www.scirp.org	0	0		
1424	chr5	110079637	110080136	3500148855	41		110079637	110080136	8421504	4	19,2,7,13	0,121,381,486	c	350014885500000003,350014885500000002	0-21,0-20						Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep	g.library.pcc.edu	0	0		
1424	chr5	110079644	110079770	3500408476	24		110079644	110079770	8421504	2	12,12	0,114	c	350040847600000007	0-24		22371502	10.1074/jbc.M111.224063		The Journal of Biological Chemistry	Myocilin Interacts with Syntrophins and Is Member of Dystrophin-associated Protein Complex	Myung	2012	0		GAPDH
1424	chr5	110079644	110079770	3500308887	24		110079644	110079770	8421504	2	12,12	0,114	c	350030888700000007	0-24		22258180	10.1007/s00439-012-1140-z		Human Genetics	The human lactase persistence-associated SNP &#x2212;13910*T enables in vivo functional persistence of lactase promoter-reporter transgene expression	Lin	July	0		GAPDH
1424	chr5	110079646	110079772	3500391256	24		110079646	110079772	8421504	2	10,14	0,112	c	350039125600000019	0-24					Patent	Method of identifying compounds using a transgenic pig model of cystic fibrosis (Patent US:7989675)	Engelhardt	2011	0		
1424	chr5	110079646	110079772	3500265094	24		110079646	110079772	8421504	2	10,14	0,112	c	350026509400000019	0-24						Transgenic animal models of disease	Welsh	2008	0		
1424	chr5	110079646	110079772	3500216308	24		110079646	110079772	8421504	2	10,14	0,112	c	350021630800000019	0-24					Patent	Method of identifying compounds using a transgenic pig model of cystic fibrosis (Patent US:7989675)	Engelhardt	2011	0		
1424	chr5	110079647	110081240	3500353261	40		110079647	110081240	8421504	4	9,11,3,17	0,111,1455,1576	c	350035326100000005,350035326100000004	0-20,0-20		12388300	10.1152/ajpheart.00161.2002		American Journal of Physiology - Heart and Circulatory Physiology	Regulation of the S100B gene by &#x03b1;1-adrenergic stimulation in cardiac myocytes	Tsoporis	2003	0		GAPDH
1424	chr5	110079647	110080660	3500372800	44		110079647	110080660	8421504	3	9,13,22	0,111,991	c	350037280000000009,350037280000000008	0-22,0-22		19741270	10.1074/jbc.M109.043349		The Journal of Biological Chemistry	The Kruppel-like Zinc Finger Protein ZNF224 Recruits the Arginine Methyltransferase PRMT5 on the Transcriptional Repressor Complex of the Aldolase A Gene	Elena	2009	0		GAPDH
1424	chr5	110079647	110079772	3500408020	23		110079647	110079772	8421504	2	9,14	0,111	c	350040802000000007	26-49			10.1002/art.20776	1529-0131	Arthritis & Rheumatism	Role of interleukin-1 and tumor necrosis factor &#x03b1; in matrix degradation of human osteoarthritic cartilage - Kobayashi - 2005 - Arthritis & Rheumatism - Wiley Online Library	Kobayashi	2005	0		
1424	chr5	110079648	110081236	3500461477	39		110079648	110081236	8421504	4	8,12,6,13	0,110,1451,1575	c	350046147700000056,350046147700000055	0-20,0-19		19034264	10.1038/mt.2008.253	1525-0016	Molecular Therapy	A highly Stable and Nonintegrated Human Artificial Chromosome (HAC) Containing the 2.4 Mb Entire Human Dystrophin Gene	Hoshiya	2008	7		GAPDH
1424	chr5	110079648	110081236	3500437322	39		110079648	110081236	8421504	4	8,12,6,13	0,110,1451,1575	c	350043732200000086,350043732200000085	0-20,0-19						MAMMALIAN ARTIFICIAL CHROMOSOME VECTOR COMPRISING HUMAN CYTOCHROME P450 GENE (CLUSTER) AND NON-HUMAN MAMMALIAN ANIMAL RETAINING THE SAME	Oshimura	2008	0		GAPDH
1424	chr5	110079648	110081236	3500437244	39		110079648	110081236	8421504	4	8,12,6,13	0,110,1451,1575	c	350043724400000056,350043724400000055	0-20,0-19		19034264	10.1038/mt.2008.253		Molecular Therapy: the Journal of the American Society of Gene Therapy	A highly Stable and Nonintegrated Human Artificial Chromosome (HAC) Containing the 2.4 Mb Entire Human Dystrophin Gene	Hidetoshi	2009	0		GAPDH
1424	chr5	110079648	110081236	3500179509	39		110079648	110081236	8421504	4	8,12,6,13	0,110,1451,1575	c	350017950900000019,350017950900000018	0-20,0-19		18305578	10.1038/sj.gt.3303091	0969-7128	Gene Therapy	Correction of a genetic defect in multipotent germline stem cells using a human artificial chromosome	Kazuki	2008	4		GAPDH
1424	chr5	110079648	110081236	3500019479	39		110079648	110081236	8421504	4	8,12,6,13	0,110,1451,1575	c	350001947900000027,350001947900000026	0-20,0-19		19997091	10.1038/mt.2009.274	1525-0016	Molecular Therapy	Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy	Kazuki	2009	7		GAPDH
1424	chr5	110079648	110081236	3500011021	39		110079648	110081236	8421504	4	8,12,6,13	0,110,1451,1575	c	350001102100000027,350001102100000026	0-20,0-19		19997091	10.1038/mt.2009.274	1525-0016	Molecular Therapy	Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy	Kazuki	2009	7		GAPDH
1424	chr5	110079648	110080668	3500297415	45		110079648	110080668	8421504	3	8,15,22	0,110,998	c	350029741500000001,350029741500000000	0-23,0-22		22301148	10.1128/JVI.06399-11		Journal of Virology	Characterization of the 55-Residue Protein Encoded by the 9S E1A mRNA of Species C Adenovirus	Matthew	2012	0		GAPDH
1424	chr5	110079648	110080668	3500279436	45		110079648	110080668	8421504	3	8,15,22	0,110,998	c	350027943600000007,350027943600000006	0-23,0-22						Expression and Functional Signi&#xfb01;cance of Twist1 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry	www.tijmu.edu.cn	0	0		GAPDH
1424	chr5	110079648	110080663	3500192091	40		110079648	110080663	8421504	3	8,12,20	0,110,995	c	350019209100000001,350019209100000000	0-20,0-20		19128467	10.1186/1476-4598-8-2	1476-4598	Molecular Cancer	Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy	Zabala	2009	4		GAPDH
1424	chr5	110079648	110080663	3500004966	40		110079648	110080663	8421504	3	8,12,20	0,110,995	c	350000496600000001,350000496600000000	0-20,0-20						Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy. - ResearchGate	.researchgate.net	0	0		GAPDH
1424	chr5	110079648	110079775	3500054186	25		110079648	110079775	8421504	2	8,17	0,110	c	350005418600000001	0-25		9973323		0892-6638	The FASEB Journal	Enhancement by vasoactive intestinal peptide of &#x03b3;-interferon production by antigen-stimulated type 1 helper T cells	JABRANE-FERRAT	1999	6		GAPDH
1424	chr5	110079649	110080663	3500404302	49		110079649	110080663	8421504	3	7,18,24	0,109,990	c	350040430200000005,350040430200000004	0-25,0-24						ABSTRACT Polo-Like Kinase 1 Expression is Associated with the Progression of Oral Squamous Cell Carcinomas	kaomp.org/new/fil	0	0		GAPDH
1424	chr5	110079649	110080663	3500099651	46		110079649	110080663	8421504	3	7,18,21	0,109,993	c	350009965100000007,350009965100000006	0-25,0-21						(-)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells	-publications.com	0	0		GAPDH
1424	chr5	110079651	110080670	3500121682	50		110079651	110080670	8421504	3	5,21,24	0,107,995	c	350012168200000003,350012168200000002	0-26,0-24						Collagen-IV and laminin-1 regulate estrogen receptor expression and function in mouse mammary epithelial cells	cs.biologists.org	0	0		GAPDH
1424	chr5	110079651	110080010	3500181708	47		110079651	110080010	8421504	4	5,15,5,22	0,107,330,337	c	350018170800000005,350018170800000007	0-20,15-42						Aldose reductase inhibition prevents metaplasia of airway epithelial cells. - ResearchGate	.researchgate.net	0	0		GAPDH
1424	chr5	110079651	110079801	3500021849	46		110079651	110079801	8421504	3	5,19,22	0,107,128	c	350002184900000001,350002184900000002	0-24,0-22						Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells | Sanja Dabeli&#x0107; - Academia.edu	www.academia.edu	0	0		GAPDH
1424	chr5	110079651	110079777	3500441876	24		110079651	110079777	8421504	2	5,19	0,107	c	350044187600000002	0-24			10.3858/emm.2010.42.9.061		Experimental & Molecular Medicine	TRPC3 cation channel plays an important role in proliferation and differentiation of skeletal muscle myoblasts	Jin	2010	0		GAPDH
1424	chr5	110079651	110079777	3500291151	24		110079651	110079777	8421504	2	5,19	0,107	c	350029115100000004	0-24						Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway	-publications.com	0	0		GAPDH
1424	chr5	110079651	110079777	3500279370	24		110079651	110079777	8421504	2	5,19	0,107	c	350027937000000007	0-24						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		GAPDH
1424	chr5	110079651	110079777	3500152550	24		110079651	110079777	8421504	2	5,19	0,107	c	350015255000000016	0-24						TheHistoneModificationsGoverning TFF1 Transcription MediatedbyEstrogenReceptor	www.tijmu.edu.cn	0	0		GAPDH
1424	chr5	110079653	110079788	3500281789	33		110079653	110079788	8421504	2	3,30	0,105	c	350028178900000014	0-33						Isothermal Amplification of Nucleic Acids	Hoser	2008	0		
1424	chr5	110079654	110080125	3500285020	45		110079654	110080125	8421504	4	2,18,23,2	0,104,348,469	c	350028502000000006,350028502000000005	0-20,0-25		18754879	10.1111/j.1349-7006.2008.00850.x	1349-7006	Cancer Science	Enhancement of antiproliferative activity of interferons by RNA interference-mediated silencing of SOCS gene expression in tumor cells - Takahashi - 2008 - Cancer Science - Wiley Online Library	Takahashi	2008	0		
1424	chr5	110079654	110080007	3500324103	42		110079654	110080007	8421504	3	2,19,21	0,104,332	c	350032410300000009,350032410300000008	0-21,0-21						Mol. Biol. Cell 2008 Kudlow 5238 48	www.scribd.com	0	0		GAPDH
1424	chr5	110079654	110080007	3500206548	41		110079654	110080007	8421504	4	2,4,14,21	0,104,109,332	c	350020654800000007,350020654800000006	0-20,0-21		17189323	10.1152/ajplung.00112.2006		American Journal of Physiology - Lung Cellular and Molecular Physiology	Nitric oxide production in the ventilatory muscles in response to acute resistive loading	Vassilakopoulos	2007	0		
1424	chr5	110079654	110079855	3500092300	44		110079654	110079855	8421504	3	2,21,21	0,104,180	c,g	350009230000000023,350009230000000022,350009230000000022	0-23,0-21,0-21		18403409	10.1242/dev.018572	0950-1991	Development	Wt1 negatively regulates &#x03b2;-catenin signaling during testis development	Chang	2008	7		
1424	chr5	110079654	110079779	3500286663	23		110079654	110079779	8421504	2	2,21	0,104	c	350028666300000025	0-23						Cooperativity in Mammalian RNA Silencing: A Dissertation	ship.umassmed.edu	0	0		
1424	chr5	110079655	110079943	3500127975	43		110079655	110079943	8421504	4	1,21,19,2	0,103,182,286	c	350012797500000011,350012797500000010	0-22,0-21						Sickle Cell Disease: Genetics, Cellular and Molecular Mechanisms, and Therapies	loads.hindawi.com	0	0		
1424	chr5	110079761	110081032	3500208485	59		110079761	110081032	8421504	3	30,11,18	0,1137,1253	c	350020848500000003,350020848500000007	0-30,0-29			10.1161/01.RES.0000216071.87981.16		Circulation research	Differential regulation of endothelial cell activation by complement and IL-1&#x03b1;	Gregory	2006	0		
1424	chr5	110079761	110081032	3500000045	59		110079761	110081032	8421504	3	30,11,18	0,1137,1253	c	350000004500000003,350000004500000007	0-30,0-29						&#x4e3b;&#x9898;&#xff1a;cell | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		GAPDH
1424	chr5	110079765	110080416	3500229953	62		110079765	110080416	8421504	3	20,22,20	0,554,631	c,g	350022995300000007,350022995300000007,350022995300000014,350022995300000006,350022995300000006	0-20,0-20,0-22,0-20,0-20			10.1124/jpet.105.099184	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Evaluation of Urothelial Stretch-Induced Cyclooxygenase-2 Expression in Novel Human Cell Culture and Porcine in Vivo Ureteral Obstruction Models	Jerde	2006	0		
1424	chr5	110079765	110080170	3500328966	40		110079765	110080170	8421504	2	20,20	0,385	c,g	350032896600000001,350032896600000000,350032896600000000	0-20,0-20,0-20		20073042	10.1002/stem.302	1549-4918	STEM CELLS	Reactive Oxygen Species Inhibit Adhesion of Mesenchymal Stem Cells Implanted into Ischemic Myocardium via Interference of Focal Adhesion Complex - Song - 2010 - STEM CELLS - Wiley Online Library	Song	2010	0		
1424	chr5	110079766	110080167	3500145630	48		110079766	110080167	8421504	2	24,24	0,377	c	350014563000000019,350014563000000018	0-24,0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1424	chr5	110079766	110080167	3500046604	48		110079766	110080167	8421504	2	24,24	0,377	c	350004660400000015,350004660400000014	0-24,0-24						REPRODUCTION	uction-online.org	0	0		
1424	chr5	110079766	110079789	3500237985	23		110079766	110079789	8421504	1	23	0	c	350023798500000001	0-23			10.1371/journal.ppat.0020105	1553-7374	PLOS Pathogens	PLOS Pathogens: Changes in the Expression of Human Cell Division Autoantigen-1 Influence Toxoplasma gondii Growth and Development	Radke	2006	0		GAPDH
1424	chr5	110079767	110079790	3500289717	23		110079767	110079790	8421504	1	23	0	c	350028971700000010	23-46						Identification of novel molecular mechanisms of tumor suppressor effect induced by soy isoflavones: Studies on EMP2 and ITM1 genes	u.lib.ncku.edu.tw	0	0		GAPDH
1424	chr5	110079768	110081235	3500350613	40		110079768	110081235	8421504	3	20,8,12	0,1329,1455	c	350035061300000010,350035061300000009	0-20,0-20		23392169	10.1038/cddis.2013.3	false	Cell Death & Disease	PTEN-regulated AKT&sol;FoxO3a&sol;Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells	Luo	2013	0		GAPDH
1424	chr5	110079771	110079976	3500055442	40		110079771	110079976	8421504	2	20,20	0,185	c	350005544200000003,350005544200000002	0-20,0-20						Evidence that polymorphonuclear neutrophils infiltrate into the developing corpus luteum and promote angiogenesis with interleukin-8 in the cow. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110079771	110079976	3500055362	40		110079771	110079976	8421504	2	20,20	0,185	c	350005536200000005,350005536200000004	0-20,0-20		18367512	10.1530/REP-07-0409	1470-1626	Reproduction	Expression and localization of apelin and its receptor APJ in the bovine corpus luteum during the estrous cycle and prostaglandin F2&#x03b1;-induced luteolysis	Shirasuna	2008	3		
1424	chr5	110079773	110079797	3500396701	24		110079773	110079797	8421504	1	24	0	c	350039670100000006	0-24		23977392	10.1371/journal.pone.0073709		PLoS ONE	Increased Plin2 Expression in Human Skeletal Muscle Is Associated with Sarcopenia and Muscle Weakness	Maria	2013	0		GAPDH
1424	chr5	110079774	110079943	3500235713	44		110079774	110079943	8421504	3	22,20,2	0,62,167	c	350023571300000027,350023571300000026	0-22,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
1424	chr5	110079775	110079798	3500201187	23		110079775	110079798	8421504	1	23	0	c	350020118700000005	0-23						Equine thrombospondin II (THBS2) and secreted protein acidic and cysteine-rich	cs.physiology.org	0	0		GAPDH
1424	chr5	110079776	110079834	3500077120	50		110079776	110079834	8421504	2	25,25	0,33	c	350007712000000008,350007712000000006	0-25,0-25						TRPV6 and Calbindin-D9k-expression and localization in the bovine uterus and placenta during pregnancy	www.rbej.com	0	0		GAPDH
1424	chr5	110079776	110079804	3500160984	28		110079776	110079804	8421504	1	28	0	c,g	350016098400000028,350016098400000028,350016098400000032	65-93,65-93,4-31						UNIVERSIT&#xc9; DU QU&#xc9;BEC M&#xc9;MOIRE PR&#xc9;SENT&#xc9; &#xc0; L'UNIVERSIT&#xc9; DU QU&#xc9;BEC fi.. TROIS-RIVI&#xc8;RES DE LA MA&#xce;TRISE EN BIOPHYSIQUE ET BIOLOGIE CELLULAIRES	depot-e.uqtr.ca	0	0		GAPDH
1424	chr5	110079778	110080131	3500387120	43		110079778	110080131	8421504	3	19,16,8	0,231,345	c	350038712000000011,350038712000000017	0-19,0-24		17909264	10.1677/JME-07-0048	0952-5041	Journal of Molecular Endocrinology	Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells	Ichikawa	2007	3		
1424	chr5	110079778	110080131	3500272775	43		110079778	110080131	8421504	3	19,16,8	0,231,345	c	350027277500000011,350027277500000017	0-19,0-24		17909264	10.1677/JME-07-0048	0952-5041	Journal of Molecular Endocrinology	Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells	Ichikawa	2007	3		
1424	chr5	110079784	110080411	3500275525	43		110079784	110080411	8421504	2	21,22	0,605	c	350027552500000003,350027552500000002	0-21,0-22						Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells	ng.physiology.org	0	0		GAPDH
1424	chr5	110079785	110079815	3500350759	30		110079785	110079815	8421504	1	30	0	c	350035075900000015	0-30		19164483	10.1152/ajpgi.90672.2008		American Journal of Physiology - Gastrointestinal and Liver Physiology	Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3	Govindarajan	2009	0		XPO6
1424	chr5	110079785	110079815	3500340489	30		110079785	110079815	8421504	1	30	0	c	350034048900000015	0-30		19164483	10.1152/ajpgi.90672.2008		American Journal of Physiology - Gastrointestinal and Liver Physiology	Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3	Govindarajan	2009	0		
1424	chr5	110079785	110079815	3500242421	30		110079785	110079815	8421504	1	30	0	c	350024242100000003	0-30			10.1124/dmd.107.015495		Drug metabolism and disposition: the biological fate of chemicals	Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human Intestine	Mingyan	2007	0		GAPDH
1424	chr5	110079785	110079815	3500225397	30		110079785	110079815	8421504	1	30	0	c	350022539700000007	0-30		15448143	10.1074/jbc.M407913200	0021-9258	Journal of Biological Chemistry	Identification and Characterization of a Novel Monoamine Transporter in the Human Brain	Engel	2004	5		GAPDH
1424	chr5	110079786	110080141	3500417956	40		110079786	110080141	8421504	3	20,2,18	0,237,337	c	350041795600000003,350041795600000002	0-20,0-20		19885008	10.4196/kjpp.2009.13.2.131		The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology	Janus Kinase 2 Inhibitor AG490 Inhibits the STAT3 Signaling Pathway by Suppressing Protein Translation of gp130	In	2009	0		
1424	chr5	110079786	110080141	3500250822	40		110079786	110080141	8421504	3	20,2,18	0,237,337	c	350025082200000011,350025082200000010	0-20,0-20			10.3346/jkms.2007.22.4.641		Journal of Korean Medical Science	Netrin Inhibits Regenerative Axon Growth of Adult Dorsal Root Ganglion Neurons in Vitro	Joo-In	2007	0		
1424	chr5	110079786	110080141	3500153046	40		110079786	110080141	8421504	3	20,2,18	0,237,337	c	350015304600000005,350015304600000004	0-20,0-20		19187095	10.1111/j.1471-4159.2008.05826.x	1471-4159	Journal of Neurochemistry	Interleukin-6 is required for the early induction of glial fibrillary acidic protein in Schwann cells during Wallerian degeneration - Lee - 2008 - Journal of Neurochemistry - Wiley Online Library	Lee	2009	0		
1424	chr5	110079786	110080141	3500006359	40		110079786	110080141	8421504	3	20,2,18	0,237,337	c	350000635900000005,350000635900000004	0-20,0-20			10.1111/j.1471-4159.2007.04580.x	1471-4159	Journal of Neurochemistry	Nidogen is a prosurvival and promigratory factor for adult Schwann cells - Lee - 2007 - Journal of Neurochemistry - Wiley Online Library	Lee	2007	0		
1424	chr5	110079787	110079815	3500097158	28		110079787	110079815	8421504	1	28	0	c	350009715800000015	0-28		19164483	10.1152/ajpgi.90672.2008		American Journal of Physiology Gastrointestinal and Liver Physiology	Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3	Govindarajan	2009	0		GAPDH
1424	chr5	110079795	110080902	3500316258	40		110079795	110080902	8421504	2	20,20	0,1087	c,g	350031625800000003,350031625800000002,350031625800000002	0-20,0-20,0-20		17785503	10.1152/ajpendo.00280.2007		American Journal of Physiology - Endocrinology and Metabolism	The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle	Erdmann	2007	0		
1424	chr5	110079795	110080902	3500010420	40		110079795	110080902	8421504	2	20,20	0,1087	c,g	350001042000000003,350001042000000003,350001042000000002,350001042000000002	0-20,0-20,0-20,0-20		17785503	10.1152/ajpendo.00280.2007		American Journal of Physiology - Endocrinology and Metabolism	The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle	Erdmann	2007	0		
1424	chr5	110079795	110080902	3500007142	40		110079795	110080902	8421504	2	20,20	0,1087	c,g	350000714200000003,350000714200000003,350000714200000002,350000714200000002	0-20,0-20,0-20,0-20		17785503	10.1152/ajpendo.00280.2007		American Journal of Physiology - Endocrinology and Metabolism	The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle	Erdmann	2007	0		
1424	chr5	110079801	110080295	3500317426	38		110079801	110080295	8421504	3	19,12,7	0,389,487	c	350031742600000005,350031742600000004	0-19,0-19		23302080	10.1111/j.1740-0929.2012.01038.x	1740-0929	Animal Science Journal	Fatty acid-binding protein expression in the gastrointestinal tract of calves and cows - HAYASHI - 2012 - Animal Science Journal - Wiley Online Library	HAYASHI	2013	0		
1424	chr5	110079801	110080295	3500197718	38		110079801	110080295	8421504	3	19,12,7	0,389,487	c	350019771800000010,350019771800000009	0-19,0-19						Saturated fatty acids stimulate and insulin suppresses CIDE-A expression in bovine mammary epithelial cells q - ResearchGate	.researchgate.net	0	0		
1424	chr5	110079802	110080849	3500434423	43		110079802	110080849	8421504	2	21,22	0,1025	c,g	350043442300000005,350043442300000004	0-21,0-22		23349663	10.1371/journal.pone.0049915	1932-6203	PLOS ONE	PLOS ONE: Angiotensin II Reduces Cardiac AdipoR1 Expression through AT1 Receptor/ROS/ERK1/2/c-Myc Pathway	Li	2013	4		TRIP4
1424	chr5	110079805	110079830	3500344721	25		110079805	110079830	8421504	1	25	0	c	350034472100000001	22-47						Progesterone-Regulated Changes in Endometrial Gene Expression Contribute to Advanced Conceptus Development in Cattle	ww.biolreprod.org	0	0		
1424	chr5	110079815	110080147	3500242509	44		110079815	110080147	8421504	2	23,21	0,311	c,g	350024250900000003,350024250900000002	0-23,0-21			10.1073/pnas.091577598		Proceedings of the National Academy of Sciences of the United States of America	Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola M&#xe9;rino ewes	Philippe	2001	0		
1424	chr5	110079821	110080849	3500410425	44		110079821	110080849	8421504	2	20,24	0,1004	c	350041042500000010,350041042500000007	0-20,0-24		21478903	10.1038/onc.2011.94	0950-9232	Oncogene	Oncogenic role of EAPII in lung cancer development and its activation of the MAPK&#x2013;ERK pathway	Li	2011	6		GAPDH
1424	chr5	110079821	110080849	3500402728	44		110079821	110080849	8421504	2	20,24	0,1004	c	350040272800000010,350040272800000007	0-20,0-24		21478903	10.1038/onc.2011.94	0950-9232	Oncogene	Oncogenic role of EAPII in lung cancer development and its activation of the MAPK&#x2013;ERK pathway	Li	2011	6		GAPDH
1424	chr5	110079821	110080849	3500026421	44		110079821	110080849	8421504	2	20,24	0,1004	c	350002642100000010,350002642100000007	0-20,0-24		21478903	10.1038/onc.2011.94	0950-9232	Oncogene	Oncogenic role of EAPII in lung cancer development and its activation of the MAPK&#x2013;ERK pathway	Li	2011	6		GAPDH
1424	chr5	110079824	110080133	3500203502	40		110079824	110080133	8421504	3	20,10,10	0,191,299	c	350020350200000014,350020350200000013	0-20,0-20						Blastema from rabbit ear contains progenitor cells comparable to marrow derived mesenchymal stem cells	www.urmia.ac.ir	0	0		
1424	chr5	110079829	110079853	3500450959	24		110079829	110079853	8421504	1	24	0	c	350045095900000006	0-24						NERVE ELONGATION PROMOTER AND ELONGATION INHIBITOR	Shiraki	2007	0		
1424	chr5	110079832	110079942	3500442385	25		110079832	110079942	8421504	2	24,1	0,109	c	350044238500000016	0-25						Reciprocal Transcriptional Regulation of Pou5f1 Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells	mcb.asm.org	0	0		
1424	chr5	110079832	110079942	3500371297	25		110079832	110079942	8421504	2	24,1	0,109	c	350037129700000016	0-25		15988017	10.1128/MCB.25.14.6031-6046.2005	0270-7306	Molecular and Cellular Biology	Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells	Chew	2005	6		
1424	chr5	110079832	110079942	3500364419	25		110079832	110079942	8421504	2	24,1	0,109	c	350036441900000024	0-25		23717491	10.1371/journal.pone.0063823		PLoS ONE	Hormonal Regulation of Ovarian Bursa Fluid in Mice and Involvement of Aquaporins	He	2013	0		
1424	chr5	110079832	110079942	3500315492	25		110079832	110079942	8421504	2	24,1	0,109	c	350031549200000016	0-25			10.1128/MCB.25.14.6031-6046.2005		Molecular and Cellular Biology	Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells	Joon-Lin	July	0		
1424	chr5	110079832	110079942	3500158579	25		110079832	110079942	8421504	2	24,1	0,109	c	350015857900000002	0-25						ABBS 2009,41(08): Glycerol-3-phosphate acyltransferase 4 gene is involved in mouse spermatogenesis	www.abbs.info	0	0		
1424	chr5	110079833	110081323	3500282467	48		110079833	110081323	8421504	3	23,1,24	0,108,1466	c	350028246700000002,350028246700000001	0-24,0-24		15128596	10.1095/biolreprod.104.029371	0006-3363	Biology of Reproduction	Pre-Sertoli Specific Gene Expression Profiling Reveals Differential Expression of Ppt1 and Brd3 Genes Within the Mouse Genital Ridge at the Time of Sex Determination	Boyer	2004	4		
1424	chr5	110079833	110081323	3500270141	48		110079833	110081323	8421504	3	23,1,24	0,108,1466	c	350027014100000018,350027014100000017	0-24,0-24		17108332	10.1095/biolreprod.106.057216	0006-3363	Biology of Reproduction	Low-Density Lipoprotein Receptor-Related Protein 8 (LRP8) Is Upregulated in Granulosa Cells of Bovine Dominant Follicle: Molecular Characterization and Spatio-Temporal Expression Studies	Fayad	2007	4		
1424	chr5	110079833	110081323	3500048010	48		110079833	110081323	8421504	3	23,1,24	0,108,1466	c	350004801000000007,350004801000000006	0-24,0-24		14568916	10.1095/biolreprod.103.021709	0006-3363	Biology of Reproduction	Gene Expression Profiling of Differentially Expressed Genes in Granulosa Cells of Bovine Dominant Follicles Using Suppression Subtractive Hybridization	Fayad	2004	4		
1424	chr5	110079833	110080351	3500391053	40		110079833	110080351	8421504	2	20,20	0,498	c	350039105300000003,350039105300000002	0-20,0-20		15286031	10.1095/biolreprod.104.032367	0006-3363	Biology of Reproduction	Isolation of Genes Associated with Developmentally Competent Bovine Oocytes and Quantitation of Their Levels During Development	Donnison	2004	4		
1424	chr5	110079833	110080351	3500158481	41		110079833	110080351	8421504	2	20,21	0,497	c	350015848100000005,350015848100000004	0-20,0-21		19129464	10.1152/ajpcell.00259.2007		American Journal of Physiology - Cell Physiolog	Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression	Hennebry	2009	0		
1424	chr5	110079833	110079946	3500278041	28		110079833	110079946	8421504	2	23,5	0,108	c	350027804100000005	0-28		19398648	10.1128/AAC.00114-09		Antimicrobial Agents and Chemotherapy	Alkoxyalkyl Esters of 9-(S)-(3-Hydroxy-2-Phosphonomethoxypropyl) Adenine Are Potent and Selective Inhibitors of Hepatitis B Virus (HBV) Replication In Vitro and in HBV Transgenic Mice In Vivo 	John	July	0		
1424	chr5	110079833	110079945	3500315450	27		110079833	110079945	8421504	2	23,4	0,108	c	350031545000000007	0-27			10.1046/j.1471-4159.2003.02201.x	1471-4159	Journal of Neurochemistry	Morphological and biochemical changes of neurofilaments in aged rat sciatic nerve axons - Uchida - 2004 - Journal of Neurochemistry - Wiley Online Library	Uchida	2004	0		
1424	chr5	110079833	110079942	3500463101	24		110079833	110079942	8421504	2	23,1	0,108	c	350046310100000009	0-24		16079309	10.1095/biolreprod.105.042754	0006-3363	Biology of Reproduction	Survivin Contributes to the Anti-Apoptotic Activities of Transforming Growth Factor alpha in Mouse Blastocysts Through Phosphatidylinositol 3'-Kinase Pathway	Kawamura	2005	4		
1424	chr5	110079834	110080300	3500402915	46		110079834	110080300	8421504	4	22,2,10,12	0,107,358,454	c	350040291500000015,350040291500000014	0-24,0-22		17702744	10.1074/jbc.M704798200	0021-9258	Journal of Biological Chemistry	Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function	Bernatchez	2007	5		
1424	chr5	110079834	110080128	3500182269	43		110079834	110080128	8421504	4	22,2,14,5	0,107,177,289	c	350018226900000004,350018226900000003	0-24,0-19						Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart	D	2010	0		
1424	chr5	110079834	110080128	3500055567	43		110079834	110080128	8421504	4	22,2,14,5	0,107,177,289	c	350005556700000009,350005556700000008	0-24,0-19						CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation &#x2013; transcription coupling	jcb.rupress.org	0	0		
1424	chr5	110079834	110080128	3500027715	43		110079834	110080128	8421504	4	22,2,14,5	0,107,177,289	c	350002771500000004,350002771500000003	0-24,0-19						Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart	w.cellbiolint.org	0	0		
1424	chr5	110079834	110079943	3500441936	24		110079834	110079943	8421504	2	22,2	0,107	c	350044193600000015	0-24		19047462	10.1083/jcb.200805048	0021-9525	The Journal of Cell Biology	CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation&#x2013;transcription coupling	Wheeler	2008	10		
1424	chr5	110079834	110079943	3500323075	24		110079834	110079943	8421504	2	22,2	0,107	c	350032307500000017	0-24		21280179	10.1002/iub.416	1521-6551	IUBMB Life	Activating transcription factor 3 regulates survivability and migration of vascular smooth muscle cells - Lv - 2011 - IUBMB Life - Wiley Online Library	Lv	2011	0		
1424	chr5	110079834	110079943	3500123872	24		110079834	110079943	8421504	2	22,2	0,107	c	350012387200000001	0-24		20028458	10.1111/j.1471-4159.2009.06550.x	1471-4159	Journal of Neurochemistry	Nanomolar vitamin E &#x03b1;-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection - Khanna - 2009 - Journal of Neurochemistry - Wiley Online Library	Khanna	2010	0		
1424	chr5	110079834	110079943	3500010198	24		110079834	110079943	8421504	2	22,2	0,107	c	350001019800000015	0-24		19047462	10.1083/jcb.200805048	0021-9525	The Journal of Cell Biology	CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation&#x2013;transcription coupling	Wheeler	2008	10		
1424	chr5	110079835	110080692	3500272055	42		110079835	110080692	8421504	3	21,1,20	0,106,837	c	350027205500000029,350027205500000016	0-22,0-20		15060137	10.1128/MCB.24.8.3132-3139.2004	0270-7306	Molecular and Cellular Biology	Regulation of Mammalian Epithelial Differentiation and Intestine Development by Class I Histone Deacetylases	Tou	2004	6		
1424	chr5	110079836	110080660	3500234879	39		110079836	110080660	8421504	2	19,20	0,804	c	350023487900000004,350023487900000003	0-19,0-20						Hemodynamic Regulation of Occludin and ZO-1: Effect on Barrier Function	doras.dcu.ie	0	0		
1424	chr5	110079836	110080136	3500356223	48		110079836	110080136	8421504	4	20,4,11,13	0,105,178,287	c	350035622300000013,350035622300000012	0-24,0-24		21986457	10.1159/000332040	1421-9670	American Journal of Nephrology	American Journal of Nephrology 2011, Vol. 34, No. 5 - Amelioration of Albuminuria in ROCK1 Knockout Mice with Streptozotocin-Induced Diabetic Kidney Disease - FullText - Karger Publishers	Zhou	2011	0		
1424	chr5	110079836	110080136	3500140520	44		110079836	110080136	8421504	4	20,2,9,13	0,105,180,287	c	350014052000000016,350014052000000015	0-22,0-22						Methods For Suppressing Tumor Proliferation 	.freshpatents.com	0	0		
1424	chr5	110079836	110080136	3500048156	44		110079836	110080136	8421504	4	20,2,9,13	0,105,180,287	c	350004815600000170,350004815600000016,350004815600000015,350004815600000169	0-22,0-22,0-22,0-22						Methods For Suppressing Tumor Proliferation - Patent application	www.faqs.org	0	0		
1424	chr5	110079836	110080135	3500151814	45		110079836	110080135	8421504	4	20,3,10,12	0,105,179,287	c	350015181400000007,350015181400000006	0-23,0-22			10.2353/ajpath.2006.050564		The American Journal of Pathology	Emerin-Lacking Mice Show Minimal Motor and Cardiac Dysfunctions with Nuclear-Associated Vacuoles	Ritsuko	2006	0		
1424	chr5	110079836	110079998	3500413148	40		110079836	110079998	8421504	3	20,1,19	0,105,143	c,g	350041314800000143,350041314800000142,350041314800000142	0-21,0-19,0-19						G&#xe9;n&#xe9;tique de la coloration de la robe chez les bovins : Contribution &#xe0; l&#x2019;&#xe9;tude du r&#xf4;le des g&#xe8;nes de la famille tyrosinase	cations.unilim.fr	0	0		
1424	chr5	110079836	110079946	3500018095	25		110079836	110079946	8421504	2	20,5	0,105	c	350001809500000010	0-25		12955085	10.1038/sj.onc.1206884	0950-9232	Oncogene	The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy	Johansson	2003	6		
1424	chr5	110079837	110081326	3500320730	43		110079837	110081326	8421504	2	19,24	0,1465	c,g	350032073000000002,350032073000000002,350032073000000005	0-19,0-19,0-24						Curcumin - Renal Inflammation	www.scribd.com	0	0		GAPDH
1424	chr5	110079837	110080136	3500187714	43		110079837	110080136	8421504	4	19,2,9,13	0,104,179,286	c	350018771400000011,350018771400000010	0-21,0-22		17122035	10.1523/JNEUROSCI.3032-06.2006	0270-6474	The Journal of Neuroscience	Reversible Disruption of Dynactin 1-Mediated Retrograde Axonal Transport in Polyglutamine-Induced Motor Neuron Degeneration	Katsuno	2006	7		
1424	chr5	110079847	110080416	3500206500	40		110079847	110080416	8421504	3	9,11,20	0,94,549	c	350020650000000005,350020650000000004	0-20,0-20						Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents	Royet	2011	0		
1424	chr5	110079847	110080134	3500465879	41		110079847	110080134	8421504	4	9,11,10,11	0,94,168,276	c	350046587900000005,350046587900000004	0-20,0-21						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		
1424	chr5	110079847	110080134	3500186339	41		110079847	110080134	8421504	4	9,11,10,11	0,94,168,276	c	350018633900000006,350018633900000005	0-20,0-21		20628571	10.1371/journal.pgen.1001019		PLoS Genetics	Id4, a New Candidate Gene for Senile Osteoporosis, Acts as a Molecular Switch Promoting Osteoblast Differentiation	Yoshimi	July	0		
1424	chr5	110079847	110080134	3500030942	41		110079847	110080134	8421504	4	9,11,10,11	0,94,168,276	c	350003094200000005,350003094200000004	0-20,0-21						ACVR1, a Therapeutic Target of Fibrodysplasia Ossificans Progressiva, Is Negatively Regulated by miR-148a	www.mdpi.com	0	0		
1424	chr5	110079849	110080133	3500186545	40		110079849	110080133	8421504	4	7,13,10,10	0,92,166,274	c	350018654500000008,350018654500000007	0-20,0-20		23097042	10.1242/jcs.107268	0021-9533	Journal of Cell Science	Axonal transport of neural membrane protein 35 mRNA increases axon growth	Merianda	2013	6		
1424	chr5	110079849	110080010	3500418516	41		110079849	110080010	8421504	3	7,14,20	0,92,141	c	350041851600000019,350041851600000004	0-21,0-20						ScienceDirect.com - Immunity - Indirect Inhibition of Toll-like Receptor and Type I Interferon Responses by ITAM-Coupled Receptors and Integrins	sciencedirect.com	0	0		GAPDH
1424	chr5	110079849	110079957	3500346912	23		110079849	110079957	8421504	2	7,16	0,92	c	350034691200000009	0-23		21856924	10.1152/ajpheart.00315.2011		American Journal of Physiology - Heart and Circulatory Physiology	Lactate dilates cochlear capillaries via type V fibrocyte-vessel coupling signaled by nNOS	Dai	2011	0		
1424	chr5	110079849	110079957	3500269347	23		110079849	110079957	8421504	2	7,16	0,92	c	350026934700000009	0-23		21856924	10.1152/ajpheart.00315.2011		American Journal of Physiology - Heart and Circulatory Physiology	Lactate dilates cochlear capillaries via type V fibrocyte-vessel coupling signaled by nNOS	Dai	2011	0		
1424	chr5	110079849	110079957	3500163216	23		110079849	110079957	8421504	2	7,16	0,92	c	350016321600000009	0-23						Supporting Information	www.pnas.org	0	0		
1424	chr5	110079849	110079957	3500017868	23		110079849	110079957	8421504	2	7,16	0,92	c	350001786800000001	23-46						ScienceDirect.com - Journal of Ethnopharmacology - Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression	sciencedirect.com	0	0		
1424	chr5	110079850	110080311	3500363742	40		110079850	110080311	8421504	3	6,14,20	0,91,441	c	350036374200000005,350036374200000004	0-20,0-20						Japanese Journal of Veterinary Research, 61(3): 97-107 Issue Date 2013-08	lib.hokudai.ac.jp	0	0		
1424	chr5	110079977	110080332	3500121934	171		110079977	110080332	8421504	3	48,79,44	0,146,311	p	350012193400015006,350012193400015005	0-171,0-171						Presentazione di PowerPoint	www.iscra.net	0	0		
1424	chr5	110079980	110081056	3500415643	42		110079980	110081056	8421504	2	21,21	0,1055	c	350041564300000004,350041564300000003	0-21,0-21						Systematische Analyse von Transkripten aus humaner fetaler Wachstumsfuge - Klonierung und Charakterisierung von Kandidatengenen der Zelldifferenzierung	ub.uni-hamburg.de	0	0		GAPDH
1424	chr5	110079981	110080010	3500402010	27		110079981	110080010	8421504	2	5,22	0,7	c	350040201000000005	15-42						Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by Directly Suppressing c-Myc Expression	mcb.asm.org	0	0		
1424	chr5	110079981	110080009	3500184233	26		110079981	110080009	8421504	2	5,21	0,7	c	350018423300000017	15-41						Use of miR-29 for Cell protection	Deshmukh	2011	0		
1424	chr5	110079981	110080008	3500351194	26		110079981	110080008	8421504	2	6,20	0,7	c	350035119400000003	13-39						MicroRNA-9 regulates survival of chondroblasts and cartilage integrity by targeting protogenin	.biosignaling.com	0	0		TASP1
1424	chr5	110079981	110080008	3500287455	27		110079981	110080008	8421504	1	27	0	c	350028745500000000,350028745500000004	21-48,0-24						Method of Producing Progenitor Cells from Differentiated Cells - Patent application	www.faqs.org	0	0		
1424	chr5	110079982	110080006	3500413264	24		110079982	110080006	8421504	1	24	0	c	350041326400000016	0-24		15385570	10.1074/jbc.M408554200	0021-9258	Journal of Biological Chemistry	Novel Function of Orphan Nuclear Receptor Nur77 in Stabilizing Hypoxia-inducible Factor-1&#x03b1;	Yoo	2004	5		
1424	chr5	110079982	110080006	3500409175	24		110079982	110080006	8421504	1	24	0	c	350040917500000016	0-24		15385570	10.1074/jbc.M408554200	0021-9258	Journal of Biological Chemistry	Novel Function of Orphan Nuclear Receptor Nur77 in Stabilizing Hypoxia-inducible Factor-1&#x03b1;	Yoo	2004	5		
1424	chr5	110079984	110080697	3500140696	42		110079984	110080697	8421504	2	22,20	0,693	c	350014069600000005,350014069600000004	1-23,0-20		18362887	10.1038/onc.2008.75	0950-9232	Oncogene	Epstein&#x2013;Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling	Samanta	2008	6		
1424	chr5	110079984	110080136	3500450013	50		110079984	110080136	8421504	3	20,17,13	0,24,139	c	350045001300000007,350045001300000008	0-20,0-30		20504320	10.1186/1476-4598-9-122	1476-4598	Molecular Cancer	Targeting the Transforming Growth Factor-&#xce;&#xb2; pathway inhibits human basal-like breast cancer metastasis	Ganapathy	2010	4		
1424	chr5	110079984	110080008	3500456272	24		110079984	110080008	8421504	1	24	0	c	350045627200000133,350045627200000015	0-24,0-24						Novel fetal genes - Patent application	www.faqs.org	0	0		
1424	chr5	110079984	110080008	3500436005	24		110079984	110080008	8421504	1	24	0	c	350043600500000015	0-24						Novel Fetal Genes 	.freshpatents.com	0	0		
1424	chr5	110079984	110080008	3500319535	24		110079984	110080008	8421504	1	24	0	c	350031953500000009	0-24						European Journal of Pharmacology	www.beyotime.com	0	0		
1424	chr5	110079984	110080008	3500317511	24		110079984	110080008	8421504	1	24	0	c	350031751100000003	0-24						MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer	-publications.com	0	0		
1424	chr5	110079984	110080008	3500123770	24		110079984	110080008	8421504	1	24	0	c	350012377000000009	0-24		21050894	10.1016/j.nano.2010.10.004		Nanomedicine : nanotechnology, biology, and medicine	DELIVERY OF siRNA INTO BREAST CANCER CELLS VIA PHAGE FUSION PROTEIN-TARGETED LIPOSOMES	Deepa	June	0		
1424	chr5	110079984	110080008	3500019209	24		110079984	110080008	8421504	1	24	0	c	350001920900000005	0-24						Maternal Embryonic Leucine Zipper Kinase Is a Key Regulator of the Proliferation of Malignant Brain Tumors, Including Brain Tumor Stem Cells	oncology.ucla.edu	0	0		
1424	chr5	110079985	110083336	3500130840	40		110079985	110083336	8421504	2	21,19	0,3332	c	350013084000000001,350013084000000009	0-21,0-19		19587217	10.1152/ajpcell.00213.2009		American Journal of Physiology - Cell Physiolog	GLUT1-induced cFLIP expression promotes proliferation and prevents apoptosis in vascular smooth muscle cells	Vesely	2009	0		
1424	chr5	110079985	110081298	3500460285	66		110079985	110081298	8421504	3	20,23,23	0,1072,1290	c	350046028500000001,350046028500000009,350046028500000008	0-20,0-23,0-23						Prolonged illumination up-regulates arrestin and two guanylate cyclase activating proteins: a novel mechanism for light adaptation	jp.physoc.org	0	0		
1424	chr5	110079985	110081238	3500132878	78		110079985	110081238	8421504	5	28,20,8,7,15	0,197,303,1113,1238	c	350013287800000011,350013287800000013,350013287800000003,350013287800000004	0-28,0-28,0-20,0-21						Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes	Echeverri	2011	0		
1424	chr5	110079985	110081085	3500129332	50		110079985	110081085	8421504	2	25,25	0,1075	c	350012933200000005,350012933200000004	0-25,0-25						LUCIA HELENA SIDER An&#xe1;lise da express&#xe3;o diferencial de genes do fol&#xed;culo ovariano de f&#xea;meas pr&#xe9;-p&#xfa;beres e p&#xfa;beres Bos primigenius indicus (Nelore) por meio da An&#xe1;lise Serial de Express&#xe3;o G&#xea;nica (SAGE)	www.teses.usp.br	0	0		
1424	chr5	110079985	110080416	3500394952	40		110079985	110080416	8421504	2	20,20	0,411	c	350039495200000015,350039495200000014	0-20,0-20						REPRODUCTION	www.um.es/grupo-f	0	0		GAPDH
1424	chr5	110079985	110080416	3500263272	40		110079985	110080416	8421504	2	20,20	0,411	c	350026327200000009,350026327200000008	0-20,0-20						Nitric oxide synthase (NOS) genes expression in catlle in vitro produced embryos	s.ulb.uni-bonn.de	0	0		GAPDH
1424	chr5	110079985	110080416	3500260963	40		110079985	110080416	8421504	2	20,20	0,411	c,g	350026096300000003,350026096300000002	0-20,0-20						eQTL Analysis and Association of MYF6 mRNA Expression with Meat Quality Traits in Pigs	rgi.kafkas.edu.tr	0	0		
1424	chr5	110079985	110080416	3500071382	40		110079985	110080416	8421504	2	20,20	0,411	c	350007138200000019,350007138200000018	0-20,0-20						REPRODUCTION	uction-online.org	0	0		GAPDH
1424	chr5	110079985	110080416	3500047878	40		110079985	110080416	8421504	2	20,20	0,411	c	350004787800000031,350004787800000029,350004787800000030,350004787800000028	0-19,0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		GAPDH
1424	chr5	110079985	110080416	3500031998	40		110079985	110080416	8421504	2	20,20	0,411	c,g	350003199800000014,350003199800000014,350003199800000013,350003199800000013	0-20,0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		GAPDH
1424	chr5	110079985	110080009	3500037083	24		110079985	110080009	8421504	1	24	0	c	350003708300000003	0-24		16112910	10.1016/j.ymthe.2005.07.534	1525-0016	Molecular Therapy	Herpes Simplex Virus 1 Amplicon Vector-Mediated siRNA Targeting Epidermal Growth Factor Receptor Inhibits Growth of Human Glioma Cells in Vivo	Saydam	2005	7		
1424	chr5	110079986	110081508	3500381949	177		110079986	110081508	8421504	4	39,79,26,33	0,137,302,1489	p,c	350038194900015012,350038194900015011,350038194900000003	0-72,0-72,6-39						A Human Nuclear Uracil DNA Glycosylase is the 37-kDa Subunit of Glyceraldehyde-3-Phosphate Dehydrogenase	www.jstor.org	0	0		
1424	chr5	110079986	110081240	3500347305	40		110079986	110081240	8421504	3	20,3,17	0,1116,1237	c	350034730500000003,350034730500000007	0-20,0-20		11751168	10.1152/ajpgi.00263.2001		American Journal of Physiology - Gastrointestinal and Liver Physiology	MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat	Turler	2002	0		
1424	chr5	110079986	110080698	3500433188	39		110079986	110080698	8421504	2	19,20	0,692	c	350043318800000018,350043318800000017	0-19,0-20						Analysis of Adenovirus-Host Interactions to Improve Adenoviral Vectors for Gene Therapy	b.uni-muenchen.de	0	0		KRBOX4
1424	chr5	110079986	110080698	3500422172	42		110079986	110080698	8421504	2	21,21	0,691	c	350042217200000009,350042217200000008	0-21,0-21		12719455	10.1136/jcp.56.5.352	1472-4146	Journal of Clinical Pathology	Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status	Wehkamp	2003	0		
1424	chr5	110079986	110080698	3500151028	39		110079986	110080698	8421504	2	19,20	0,692	c	350015102800000009,350015102800000008	0-19,0-20						Cell survival, DNA damage and oncogenic transformation following a transient and reversible apoptotic response	w.molbiolcell.org	0	0		GAPDH
1424	chr5	110079986	110080412	3500455340	40		110079986	110080412	8421504	2	19,21	0,405	c	350045534000000005,350045534000000003	0-19,0-21		15187159		0022-1767	The Journal of Immunology	Labile Zinc and Zinc Transporter ZnT4 in Mast Cell Granules: Role in Regulation of Caspase Activation and NF-&#x03ba;B Translocation	Ho	2004	6		GAPDH
1424	chr5	110079987	110080691	3500115693	41		110079987	110080691	8421504	2	21,20	0,684	c	350011569300000012,350011569300000011	0-21,0-20		18474598	10.1074/jbc.M801288200		The Journal of Biological Chemistry	Retinal Pigment Epithelium-Retinal G Protein Receptor-Opsin Mediates Light-dependent Translocation of All-trans-retinyl Esters for Synthesis of Visual Chromophore in Retinal Pigment Epithelial Cells	Roxana	July	0		
1424	chr5	110079987	110080664	3500342775	52		110079987	110080664	8421504	2	26,26	0,651	c	350034277500000003,350034277500000002	0-26,0-26						B-cellReceptorActivationInducesBIC/miR-155Expression throughaConservedAP-1Element	www.jbc.org	0	0		
1424	chr5	110079987	110080664	3500321731	52		110079987	110080664	8421504	2	26,26	0,651	c	350032173100000003,350032173100000002	0-26,0-26			10.1074/jbc.M708218200		The Journal of biological chemistry	B-cell Receptor Activation Induces BIC/miR-155 Expression through a Conserved AP-1 Element	Qinyan	2008	0		
1424	chr5	110079987	110080664	3500145033	52		110079987	110080664	8421504	2	26,26	0,651	c	350014503300000007,350014503300000006	0-26,0-26						Respiratory Research BioMed Central	biomedcentral.com	0	0		
1424	chr5	110079987	110080013	3500232131	26		110079987	110080013	8421504	1	26	0	c	350023213100000006	0-26						Doxycycline Inhibition of Interleukin-1 in the Corneal Epithelium	www.iovs.org	0	0		
1424	chr5	110079987	110080013	3500038743	26		110079987	110080013	8421504	1	26	0	c	350003874300000005	0-26						Respiratory Research BioMed Central	tory-research.com	0	0		
1424	chr5	110079988	110081452	3500131353	40		110079988	110081452	8421504	2	20,20	0,1444	c,g	350013135300000005,350013135300000004,350013135300000004	0-20,0-20,0-20		15576458	10.1210/en.2004-1152	0013-7227	Endocrinology	Dexamethasone Induces Apoptosis in Proliferative Chondrocytes through Activation of Caspases and Suppression of the Akt-Phosphatidylinositol 3&#x2032;-Kinase Signaling Pathway	Chrysis	2005	4		GAPDH
1424	chr5	110079988	110081242	3500454983	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350045498300000007,350045498300000006	0-20,0-20		18489712	10.1111/j.1471-4159.2008.05492.x	1471-4159	Journal of Neurochemistry	Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2 - Demeule - 2008 - Journal of Neurochemistry - Wiley Online Library	Demeule	2008	0		
1424	chr5	110079988	110081242	3500436284	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350043628400000003,350043628400000002	0-20,0-20		18199680	10.1091/mbc.E07-09-0881	1059-1524	Molecular Biology of the Cell	Phosphorylation by c-Jun NH2-terminal Kinase 1 Regulates the Stability of Transcription Factor Sp1 during Mitosis	Chuang	2008	5		
1424	chr5	110079988	110081242	3500418081	39		110079988	110081242	8421504	4	5,14,1,19	0,6,1116,1235	c	350041808100000003,350041808100000002	0-19,0-20		18194435	10.1111/j.1471-4159.2008.05226.x	1471-4159	Journal of Neurochemistry	Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074 - Chen - 2008 - Journal of Neurochemistry - Wiley Online Library	Chen	2008	0		
1424	chr5	110079988	110081242	3500354333	39		110079988	110081242	8421504	4	5,14,1,19	0,6,1116,1235	c	350035433300000013,350035433300000012	0-19,0-20						Reversibility of Caspase Activation and Its Role during Glycochenodeoxycholate-induced Hepatocyte Apoptosis--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533	journal.9med.net	0	0		
1424	chr5	110079988	110081242	3500334005	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350033400500000006,350033400500000005	0-20,0-20						Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110079988	110081242	3500331743	39		110079988	110081242	8421504	4	5,14,1,19	0,6,1116,1235	c	350033174300000009,350033174300000008	0-19,0-20		15625305	10.1152/ajpcell.00312.2004		American Journal of Physiology - Cell Physiolog	Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury	Hu	2005	0		
1424	chr5	110079988	110081242	3500310613	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350031061300000007,350031061300000003,350031061300000006,350031061300000002	0-20,0-20,0-20,0-20						Use of Nordihydroguaiaretic Acid Derivatives in the Treatment of Drug Resistant Cancer, Viral and Microbial Infection - Patent application	www.faqs.org	0	0		
1424	chr5	110079988	110081242	3500256029	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350025602900000005,350025602900000004	0-20,0-20						Phosphorylation and stabilization of c-Myc by NEMO renders cells resistant to ionizing radiation through up-regulation of &#x03b3;	-publications.com	0	0		
1424	chr5	110079988	110081242	3500131065	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350013106500000003,350013106500000002	0-20,0-20						JBC Papers in Press. Published on October 13, 2011 as Manuscript M111.310979 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M111.310979	www.jbc.org	0	0		GAPDH
1424	chr5	110079988	110081242	3500120662	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350012066200000006,350012066200000005	0-20,0-20						Function and regulation of the human bile salt export pump	tations.ub.rug.nl	0	0		
1424	chr5	110079988	110081242	3500045758	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350004575800000003,350004575800000002	0-20,0-20			10.1128/MCB.26.5.1770-1785.2006		Molecular and Cellular Biology	Sp1 Deacetylation Induced by Phorbol Ester Recruits p300 To Activate 12(S)-Lipoxygenase Gene Transcription	Jan-Jong	2006	0		
1424	chr5	110079988	110081242	3500016373	40		110079988	110081242	8421504	3	20,1,19	0,1116,1235	c	350001637300000004,350001637300000003	0-20,0-20						&#x570b;&#xf9f7;&#x6210;&#x529f;&#x5927;&#x5b78; &#x85e5;&#xf9e4;&#x5b78;&#x7814;&#x7a76;&#x6240;	u.lib.ncku.edu.tw	0	0		
1424	chr5	110079988	110081242	3500012613	39		110079988	110081242	8421504	4	5,14,1,19	0,6,1116,1235	c	350001261300000009,350001261300000008	0-19,0-20		15625305	10.1152/ajpcell.00312.2004		American Journal of Physiology - Cell Physiology	Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury	Hu	2005	0		GAPDH
1424	chr5	110079988	110081242	3500012440	39		110079988	110081242	8421504	4	5,14,1,19	0,6,1116,1235	c	350001244000000009,350001244000000008	0-19,0-20		15625305	10.1152/ajpcell.00312.2004		American Journal of Physiology - Cell Physiology	Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury	Hu	2005	0		GAPDH
1424	chr5	110079988	110081240	3500133988	40		110079988	110081240	8421504	3	20,3,17	0,1114,1235	c	350013398800000013,350013398800000012	0-20,0-20		16928828	10.1158/1535-7163.MCT-06-0044	1535-7163	Molecular Cancer Therapeutics	Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A&#x2013;mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts	Nguyen	2006	5		
1424	chr5	110079988	110080691	3500403698	40		110079988	110080691	8421504	2	20,20	0,683	c	350040369800000007,350040369800000006	0-20,0-20		9916023	10.1095/biolreprod60.2.522	0006-3363	Biology of Reproduction	Sequential Expression of Zona Pellucida Protein Genes during the Oogenesis of Domestic Cats	Jewgenow	1999	4		
1424	chr5	110079988	110080349	3500021577	41		110079988	110080349	8421504	2	21,20	0,341	c	350002157700000019,350002157700000018	0-21,0-20						O-12	www.scribd.com	0	0		
1424	chr5	110079988	110080139	3500342022	47		110079988	110080139	8421504	3	21,10,16	0,27,135	c	350034202200000001,350034202200000002	0-21,0-26		23350007	10.1371/journal.pntd.0002005		PLoS Neglected Tropical Diseases	Bispidine-Amino Acid Conjugates Act as a Novel Scaffold for the Design of Antivirals That Block Japanese Encephalitis Virus Replication	V.	2013	0		
1424	chr5	110079988	110080139	3500242776	41		110079988	110080139	8421504	3	21,4,16	0,33,135	c	350024277600000004,350024277600000005	0-21,0-20						Retinoids Induce Cytochrome P450 3A4 through RXR/VDR-mediated Pathway - Keeping the Faith	pthefaith1296.com	0	0		
1424	chr5	110079988	110080139	3500026914	48		110079988	110080139	8421504	3	22,10,16	0,27,135	c	350002691400000004,350002691400000005	0-22,0-26			10.1002/cyto.a.20418	1552-4930	Cytometry Part A	Flow sorting from organ material by intracellular markers - Moerch - 2007 - Cytometry Part A - Wiley Online Library	Moerch	2007	0		
1424	chr5	110079988	110080136	3500326849	50		110079988	110080136	8421504	2	37,13	0,135	c	350032684900000010,350032684900000009	0-21,0-29						LIVER-SPECIFIC NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USE THEREOF	Chuah	2009	0		
1424	chr5	110079988	110080012	3500419887	24		110079988	110080012	8421504	1	24	0	c	350041988700000000	0-24						Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney&#x2013;expressed Chemokine (BRAK) in Macrophage Development	jem.rupress.org	0	0		
1424	chr5	110079988	110080012	3500221310	24		110079988	110080012	8421504	1	24	0	c	350022131000000012	0-24			10.1046/j.1432-1033.2000.01769.x	1432-1033	European Journal of Biochemistry	Mechanisms of differential transferrin receptor expression in normal hematopoiesis - Sposi - 2003 - European Journal of Biochemistry - Wiley Online Library	Sposi	2000	0		
1424	chr5	110079988	110080012	3500009244	24		110079988	110080012	8421504	1	24	0	c	350000924400000010	0-24		20824710	10.1002/ijc.25647	1097-0215	International Journal of Cancer	Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells - Ferletta - 2010 - International Journal of Cancer - Wiley Online Library	Ferletta	2011	0		ELOVL4
1424	chr5	110079989	110081239	3500351302	39		110079989	110081239	8421504	3	20,3,16	0,1113,1234	c	350035130200000007,350035130200000006	0-20,0-19		10444406			American Journal of Physiology - Cell Physiology	AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells	Park	1999	0		GAPDH
1424	chr5	110079989	110081239	3500326258	39		110079989	110081239	8421504	3	20,3,16	0,1113,1234	c	350032625800000003,350032625800000002	0-20,0-19						Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery	Godbey	2004	0		GAPDH
1424	chr5	110079989	110081239	3500130214	39		110079989	110081239	8421504	3	20,3,16	0,1113,1234	c	350013021400000016,350013021400000015	0-20,0-19		21746882	10.1128/MCB.05020-11	0270-7306	Molecular and Cellular Biology	1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A	Joshi	2011	6		GAPDH
1424	chr5	110079989	110081239	3500040354	39		110079989	110081239	8421504	3	20,3,16	0,1113,1234	c,g	350004035400000007,350004035400000007,350004035400000006	0-20,0-20,0-19			10.1113/jphysiol.2004.062653		The Journal of Physiology	CaT1 knock-down strategies fail to affect CRAC channels in mucosal-type mast cells	Heike	2004	0		GAPDH
1424	chr5	110079989	110081239	3500011136	39		110079989	110081239	8421504	3	20,3,16	0,1113,1234	c	350001113600000003,350001113600000002	0-20,0-19			10.1002/jcb.21087		Journal of cellular biochemistry	Nucleo-cytoplasmic Cycling of the Vitamin D Receptor in the Enterocyte-Like Cell Line, Caco-2	Anna	2007	0		GAPDH
1424	chr5	110079989	110081239	3500009465	39		110079989	110081239	8421504	3	20,3,16	0,1113,1234	c	350000946500000003,350000946500000002	0-20,0-19		19405944	10.1186/1471-2474-10-45	1471-2474	BMC Musculoskeletal Disorders	Elevation of Bombina variegata peptide 8 in mice with collagen-induced arthritis	Kurosaka	2009	2		GAPDH
1424	chr5	110079989	110080136	3500204934	47		110079989	110080136	8421504	3	20,14,13	0,22,134	c	350020493400000004,350020493400000005	0-20,0-27		15870381	10.1152/ajprenal.00462.2004		American Journal of Physiology - Renal Physiology	AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats	Prieto-Carrasquero	2005	0		GAPDH
1424	chr5	110079989	110080136	3500186609	47		110079989	110080136	8421504	3	20,14,13	0,22,134	c	350018660900000004,350018660900000005	0-20,0-27		15870381	10.1152/ajprenal.00462.2004		American Journal of Physiology - Renal Physiology	AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats	Prieto-Carrasquero	2005	0		TASP1,GAPDH
1424	chr5	110079989	110080013	3500416298	24		110079989	110080013	8421504	1	24	0	c	350041629800000007	0-24		16116167		0022-1767	The Journal of Immunology	B Cell Maturation Antigen, the Receptor for a Proliferation-Inducing Ligand and B Cell-Activating Factor of the TNF Family, Induces Antigen Presentation in B Cells	Yang	2005	6		
1424	chr5	110079989	110080013	3500268748	24		110079989	110080013	8421504	1	24	0	c	350026874800000009	0-24						HDAC inhibitors downregulate MRP2 expression in multidrug resistant cancer cells: Implication for chemosensitization	-publications.com	0	0		
1424	chr5	110079989	110080013	3500187937	24		110079989	110080013	8421504	1	24	0	c	350018793700000015	0-24		19435809	10.1158/1541-7786.MCR-08-0296	1541-7786	Molecular Cancer Research	Histone Deacetylase Inhibitor Induction of P-Glycoprotein Transcription Requires Both Histone Deacetylase 1 Dissociation and Recruitment of CAAT/Enhancer Binding Protein &#x03b2; and pCAF to the Promoter Region	Kim	2009	4		KLHL8
1424	chr5	110079990	110080694	3500015776	45		110079990	110080694	8421504	2	23,22	0,682	c	350001577600000001,350001577600000000	0-23,0-22		11600422			American Journal of Physiology - Cell Physiology	Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays	Zhao	2001	0		
1424	chr5	110079993	110081080	3500358136	44		110079993	110081080	8421504	2	24,20	0,1067	c	350035813600000017,350035813600000020	0-24,0-20						Untersuchungen zur gef&#xe4;&#xdf;protektiven Wirkung von Iloprost an humanen Gef&#xe4;&#xdf;muskelzellen	ni-duesseldorf.de	0	0		
1424	chr5	110079993	110081080	3500110311	44		110079993	110081080	8421504	2	24,20	0,1067	c	350011031100000017,350011031100000020	0-24,0-20						Untersuchungen zur gef&#xe4;&#xdf;protektiven Wirkung von Iloprost an humanen Gef&#xe4;&#xdf;muskelzellen	ni-duesseldorf.de	0	0		GAPDH
1424	chr5	110079993	110080017	3500432784	24		110079993	110080017	8421504	1	24	0	c	350043278400000010	0-24						Targeted siRNA Delivery Methods for RNAi-Based Therapies	ir.lib.uwo.ca	0	0		
1424	chr5	110079993	110080017	3500347795	24		110079993	110080017	8421504	1	24	0	c	350034779500000002	0-24		15591227	10.1161/01.RES.0000153150.27690.f2	0009-7330	Circulation Research	Regulation of Thrombomodulin Expression in Human Vascular Smooth Muscle Cells by COX-2&#x2013;Derived Prostaglandins	Rabausch	2005	9		GAPDH
1424	chr5	110079993	110080017	3500334455	24		110079993	110080017	8421504	1	24	0	c	350033445500000012	0-24						Syndecan-4 Is Required for Thrombin-induced Migration and Proliferation in Human Vascular Smooth Muscle Cells--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x5	journal.9med.net	0	0		ATL2,GAPDH
1424	chr5	110079993	110080017	3500303720	24		110079993	110080017	8421504	1	24	0	c	350030372000000010	0-24		23867654	10.1038/emm.2013.61		Experimental & Molecular Medicine	Reactive oxygen species regulate context-dependent inhibition of NFAT5 target genes	Nam-Hoon	July	0		
1424	chr5	110079993	110080017	3500270491	24		110079993	110080017	8421504	1	24	0	c	350027049100000012	0-24						Der Einfluss vasodilatorischer Prostaglandine auf fokale Adh&#xe4;sionen und den Ph&#xe4;notyp glatter Muskelzellen der menschlichen Aorta	ni-duesseldorf.de	0	0		TRIP4,GAPDH
1424	chr5	110079993	110080017	3500267506	24		110079993	110080017	8421504	1	24	0	c	350026750600000002	0-24		22710480		1791-2997	Molecular Medicine Reports	Evaluation of Fbxw7 expression and its correlation with expression of SREBP-1 in a mouse model of NAFLD	Tu	2012	0		
1424	chr5	110079993	110080017	3500249762	24		110079993	110080017	8421504	1	24	0	c	350024976200000002	0-24						Evaluation of Fbxw7 expression and its correlation with expression of SREBP-1 in a mouse model of NAFLD	-publications.com	0	0		GAPDH
1424	chr5	110079993	110080017	3500248206	24		110079993	110080017	8421504	1	24	0	c	350024820600000006	0-24		12949248	10.1189/jlb.1102582	0741-5400	Journal of Leukocyte Biology	LF15-0195 generates tolerogenic dendritic cells by suppression of NF-&#x03ba;B signaling through inhibition of IKK activity	Yang	2003	5		GAPDH
1424	chr5	110079993	110080017	3500238103	24		110079993	110080017	8421504	1	24	0	c	350023810300000011	0-24		18772341	10.2353/ajpath.2008.080103		The American Journal of Pathology	Gene Silencing of Complement C5a Receptor Using siRNA for Preventing Ischemia/Reperfusion Injury	Xiufen	2008	0		GAPDH,KLHL8
1424	chr5	110079993	110080017	3500237935	24		110079993	110080017	8421504	1	24	0	c	350023793500000010	0-24		20686703	10.1371/journal.pone.0011875	1932-6203	PLOS ONE	PLOS ONE: Nuclear Factor-Kappa B Family Member RelB Inhibits Human Immunodeficiency Virus-1 Tat-Induced Tumor Necrosis Factor-Alpha Production	Kiebala	2010	4		GAPDH
1424	chr5	110079996	110080882	3500347624	43		110079996	110080882	8421504	2	22,21	0,865	c	350034762400000001,350034762400000000	0-22,0-21		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		
1424	chr5	110079998	110080801	3500168195	348		110079998	110080801	8421504	5	27,79,152,82,8	0,125,290,621,795	p	350016819500015055,350016819500015041,350016819500015025,350016819500015029	0-150,0-150,42-90,39-87						No Slide Title	ennedykrieger.org	0	0		
1424	chr5	110079998	110080801	3500122314	348		110079998	110080801	8421504	5	27,79,152,82,8	0,125,290,621,795	p	350012231400015026,350012231400015019,350012231400015013,350012231400015011	0-150,0-150,39-87,42-90						Bioinformatica 20-10-2011-t3-scoring matrices	ww.slideshare.net	0	0		
1424	chr5	110079998	110080661	3500359063	294		110079998	110080661	8421504	5	27,27,46,152,42	0,125,158,290,621	p	350035906300015008,350035906300015010,350035906300015222	0-147,0-90,0-150						Bioinformatics and Functional Genomics	www.scribd.com	0	0		
1424	chr5	110080001	110080290	3500131138	45		110080001	110080290	8421504	4	24,2,17,2	0,122,184,287	c	350013113800000005,350013113800000004	0-26,0-19						Cb2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same 	.freshpatents.com	0	0		
1424	chr5	110080001	110080290	3500006350	45		110080001	110080290	8421504	4	24,2,17,2	0,122,184,287	c	350000635000000005,350000635000000004	0-26,0-19						CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same	Prather	2007	0		
1424	chr5	110080001	110080124	3500358403	25		110080001	110080124	8421504	2	24,1	0,122	c	350035840300000006	0-25						POLYPEPTIDES INVOLVED IN THE NEUROREGENERATION-PROMOTING PROPERTIES OF OLFACTORY ENSHEATHING GLIA - NEDERLANDS INSTITUUT VOOR NEUROWETENSCHAPPEN	www.sumobrain.com	0	0		
1424	chr5	110080002	110080125	3500272445	25		110080002	110080125	8421504	2	23,2	0,121	c	350027244500000000	0-25						TransformingGrowthFactor 1InhibitsCysticFibrosis TransmembraneConductanceRegulator-dependent cAMP-stimulatedAlveolarEpithelialFluidTransportvia aPhosphatidylinositol3-Kinase-dependentMechanism	www.jbc.org	0	0		
1424	chr5	110080007	110080129	3500408272	24		110080007	110080129	8421504	2	18,6	0,116	c	350040827200000004	0-24		19002103	10.1038/bjp.2008.328	1476-5381	British Journal of Pharmacology	Effects of levo- and dextrosimendan on NF-&#x03ba;B-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli - Sareila - 2009 - British Journal of Pharmacology - Wiley Online Library	Sareila	2008	0		
1424	chr5	110080007	110080129	3500192794	24		110080007	110080129	8421504	2	18,6	0,116	c	350019279400000007	0-24						Compounds that increase or mimic cAMP enhance tristetraprolin degradation in LPS-treated murine J774 macrophages	aspetjournals.org	0	0		
1424	chr5	110080007	110080129	3500151269	24		110080007	110080129	8421504	2	18,6	0,116	c	350015126900000003	0-24		21911468	10.1128/IAI.05562-11	0019-9567	Infection and Immunity	Toxoplasma gondii Induces B7-2 Expression through Activation of JNK Signal Transduction	Morgado	2011	4		
1424	chr5	110080008	110080174	3500103872	66		110080008	110080174	8421504	4	17,8,22,19	0,115,124,147	c	350010387200000014,350010387200000013,350010387200000012	0-25,0-22,0-19						Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: Implication of NADPH oxidase	ww.uphs.upenn.edu	0	0		
1424	chr5	110080009	110080692	3500335870	40		110080009	110080692	8421504	3	16,4,20	0,114,663	c	350033587000000017,350033587000000016	0-20,0-20		20584329	10.1186/1471-213X-10-72		BMC Developmental Biology	Embryonic vascular endothelial cells are malleable to reprogramming via Prox1 to a lymphatic gene signature	Harold	2010	0		
1424	chr5	110080009	110080692	3500101306	40		110080009	110080692	8421504	3	16,4,20	0,114,663	c	350010130600000017,350010130600000016	0-20,0-20						RESEARCH ARTICLE Open Access	biomedcentral.com	0	0		
1424	chr5	110080009	110080136	3500204883	28		110080009	110080136	8421504	3	6,9,13	0,7,114	c	350020488300000014	0-28						PERIPHERAL AND NEURAL INFLAMMATORY CROSSTALK - Patent application	www.faqs.org	0	0		
1424	chr5	110080009	110080131	3500461351	24		110080009	110080131	8421504	2	16,8	0,114	c	350046135100000001	0-24		22156515	10.1128/JVI.05760-11	0022-538X	Journal of Virology	Identification of Adenovirus Serotype 5 Hexon Regions That Interact with Scavenger Receptors	Khare	2012	5		
1424	chr5	110080009	110080131	3500158616	24		110080009	110080131	8421504	2	16,8	0,114	c	350015861600000007	0-24		12576298	10.1152/ajplung.00225.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	DMT1 expression is increased in the lungs of hypotransferrinemic mice	Ghio	2003	0		
1424	chr5	110080009	110080131	3500072532	24		110080009	110080131	8421504	2	16,8	0,114	c	350007253200000007	0-24		12576298	10.1152/ajplung.00225.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	DMT1 expression is increased in the lungs of hypotransferrinemic mice	Ghio	2003	0		
1424	chr5	110080009	110080131	3500060902	24		110080009	110080131	8421504	2	16,8	0,114	c	350006090200000039	0-24						A stabilizing factor for mitochondrial respiratory supercomplex assembly regulates energy metabolism in muscle	ll-innovation.org	0	0		
1424	chr5	110080009	110080131	3500049795	24		110080009	110080131	8421504	2	16,8	0,114	c	350004979500000007	0-24		12576298	10.1152/ajplung.00225.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	DMT1 expression is increased in the lungs of hypotransferrinemic mice	Ghio	2003	0		
1424	chr5	110080009	110080130	3500201503	23		110080009	110080130	8421504	2	16,7	0,114	c	350020150300000003	0-23		20123989	10.1074/jbc.M109.080796	0021-9258	Journal of Biological Chemistry	Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase	Wu	2010	5		
1424	chr5	110080011	110080136	3500445698	27		110080011	110080136	8421504	2	14,13	0,112	c	350044569800000005	0-27						&#x4e3b;&#x9898;&#xff1a;AT1 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1424	chr5	110080011	110080136	3500406301	27		110080011	110080136	8421504	2	14,13	0,112	c	350040630100000011	0-27		15306544	10.1152/ajpcell.00221.2004		American Journal of Physiology - Cell Physiolog	Transforming growth factor-&#x03b2;1 signaling contributes to development of smooth muscle cells from embryonic stem cells	Sinha	2004	0		
1424	chr5	110080011	110080136	3500083062	27		110080011	110080136	8421504	2	14,13	0,112	c	350008306200000009	0-27		21498392	10.1158/1078-0432.CCR-10-3289	1078-0432	Clinical Cancer Research	Extrahepatic Cancer Suppresses Nuclear Receptor&#x2013;Regulated Drug Metabolism	Kacevska	2011	8		
1424	chr5	110080011	110080133	3500297276	24		110080011	110080133	8421504	2	14,10	0,112	c	350029727600000027	0-24						Assay For Bipolar Affective Disorder	Schofield	2004	0		
1424	chr5	110080011	110080132	3500356527	23		110080011	110080132	8421504	2	14,9	0,112	c	350035652700000000	0-23		23401705	10.1155/2013/127672		Evidence-based Complementary and Alternative Medicine : eCAM	Molecular Mechanisms Underlying the In Vitro Anti-Inflammatory Effects of a Flavonoid-Rich Ethanol Extract from Chinese Propolis (Poplar Type)	Kai	2013	0		
1424	chr5	110080011	110080132	3500112285	23		110080011	110080132	8421504	2	14,9	0,112	c	350011228500000005	0-23			10.1093/emboj/19.24.6675	ERROR! NO ISSN	The EMBO Journal	Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice	Deans	2000	0		
1424	chr5	110080013	110080159	3500346464	48		110080013	110080159	8421504	2	12,36	0,110	p	350034646400015062	0-48						Lsamp Gene Associated With Cardiovascular Disease 	.freshpatents.com	0	0		
1424	chr5	110080013	110080159	3500018228	48		110080013	110080159	8421504	2	12,36	0,110	p	350001822800015015	0-48						Assay For Identifying Biological Targets Of Polynucleotide-binding Compounds 	.freshpatents.com	0	0		
1424	chr5	110080013	110080136	3500257470	25		110080013	110080136	8421504	2	12,13	0,110	c	350025747000000056	0-25						Chimeric Non-Human Animal and Use Thereof	Kakitani	2009	0		
1424	chr5	110080013	110080136	3500227543	25		110080013	110080136	8421504	2	12,13	0,110	c	350022754300000056	0-25						Non-human chimeric animal and use thereof	KAKITANI	2007	0		
1424	chr5	110080013	110080136	3500184404	25		110080013	110080136	8421504	2	12,13	0,110	c	350018440400000057,350018440400000378	0-25,0-25						Gastrointestinal proliferative factor and uses thereof - Patent application	www.faqs.org	0	0		
1424	chr5	110080013	110080136	3500086063	25		110080013	110080136	8421504	2	12,13	0,110	c	350008606300000378,350008606300000057	0-25,0-25						Gastrointestinal proliferative foctor and uses thereof - Patent application	www.faqs.org	0	0		
1424	chr5	110080013	110080135	3500213526	24		110080013	110080135	8421504	2	12,12	0,110	c	350021352600000004	0-24		15262961	10.1074/jbc.M406866200	0021-9258	Journal of Biological Chemistry	Tobacco Smoke Control of Mucin Production in Lung Cells Requires Oxygen Radicals AP-1 and JNK	Gensch	2004	5		
1424	chr5	110080014	110080801	3500041518	42		110080014	110080801	8421504	4	11,10,13,8	0,109,674,779	c	350004151800000001,350004151800000000	0-21,0-21						Interleukin-27directlyinducesdifferentiationinhematopoieticstemcells	tologylibrary.org	0	0		
1424	chr5	110080014	110080138	3500156475	26		110080014	110080138	8421504	2	11,15	0,109	c	350015647500000023	0-26						REPRODUCTION	uction-online.org	0	0		
1424	chr5	110080014	110080136	3500246254	24		110080014	110080136	8421504	2	11,13	0,109	c	350024625400000023,350024625400000011	0-24,0-24						Calcium/Calmodulin-Dependent Protein Kinase Kinase as a Control Point for Cardiac Hypertrophy - Patent application	www.faqs.org	0	0		
1424	chr5	110080014	110080136	3500118348	24		110080014	110080136	8421504	2	11,13	0,109	c	350011834800000007	0-24		22158478	10.1038/cddis.2011.110		Cell Death & Disease	Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart	C	2011	0		
1424	chr5	110080015	110081429	3500263589	46		110080015	110081429	8421504	4	10,16,12,8	0,108,1303,1406	c	350026358900000026,350026358900000009	0-26,1-21			10.1124/jpet.107.120303	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Antiepileptic Drugs Affect Neuronal Androgen Signaling via a Cytochrome P450-Dependent Pathway	Gehlhaus	2007	0		
1424	chr5	110080015	110080141	3500380459	28		110080015	110080141	8421504	2	10,18	0,108	c	350038045900000008	0-28		17237411		0022-1767	The Journal of Immunology	Slamf1, the NKT Cell Control Gene Nkt1	Jordan	2007	6		
1424	chr5	110080015	110080141	3500199910	28		110080015	110080141	8421504	2	10,18	0,108	c	350019991000000008	0-28		17237411		0022-1767	The Journal of Immunology	Slamf1, the NKT Cell Control Gene Nkt1	Jordan	2007	6		
1424	chr5	110080015	110080139	3500205398	26		110080015	110080139	8421504	2	10,16	0,108	c	350020539800000005	0-26						The effect of 3-hydroxybutyrate methyl ester on learning and memory in mice	beyotime.com	0	0		
1424	chr5	110080015	110080136	3500458871	23		110080015	110080136	8421504	2	10,13	0,108	c	350045887100000008	0-23						Acceleration of Glutathione Efflux and Inhibition of -Glutamyltranspeptidase Sensitize Metastatic B16 Melanoma Cells to Endothelium-induced Cytotoxicity--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x	journal.9med.net	0	0		
1424	chr5	110080015	110080136	3500353630	23		110080015	110080136	8421504	2	10,13	0,108	c	350035363000000004	0-23						UNIVERSIDAD COMPLUTENSE DE MADRID	eprints.ucm.es	0	0		
1424	chr5	110080015	110080136	3500282369	23		110080015	110080136	8421504	2	10,13	0,108	c	350028236900000007	0-23						Methods of identifying and isolating stem cells and cancer stem cells	Jamieson	2007	0		
1424	chr5	110080015	110080136	3500219388	23		110080015	110080136	8421504	2	10,13	0,108	c	350021938800000021	0-23		16888011		0022-1767	The Journal of Immunology	E2A Promotes the Survival of Precursor and Mature B Lymphocytes	Lazorchak	2006	6		
1424	chr5	110080015	110080136	3500207588	23		110080015	110080136	8421504	2	10,13	0,108	c	350020758800000007	0-23						Methods of identifying and isolating stem cells and cancer stem cells	Jamieson	2003	0		
1424	chr5	110080015	110080136	3500183887	23		110080015	110080136	8421504	2	10,13	0,108	c	350018388700000004	0-23		22952941	10.1371/journal.pone.0044252	1932-6203	PLOS ONE	PLOS ONE: The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation	Scotland	2012	4		
1424	chr5	110080015	110080136	3500024500	23		110080015	110080136	8421504	2	10,13	0,108	c	350002450000000004	0-23			10.1111/j.1474-9726.2005.00151.x	1474-9726	Aging Cell	17&#x03b2;-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NF&#x03ba;B cascade - Borr&#xe1;s - 2005 - Aging Cell - Wiley Online Library	Borras	2005	0		
1424	chr5	110080016	110080138	3500170591	24		110080016	110080138	8421504	2	9,15	0,107	c	350017059100000003	0-24					Development (Cambridge, England)	An Fgf8 Mouse Mutant Phenocopies Human 22q11 Deletion Syndrome	Deborah	2002	0		
1424	chr5	110080016	110080138	3500117777	24		110080016	110080138	8421504	2	9,15	0,107	c	350011777700000018	0-24		16476726	10.1074/jbc.M601203200	0021-9258	Journal of Biological Chemistry	Prohormone Convertase 1/3 Is Essential for Processing of the Glucose-dependent Insulinotropic Polypeptide Precursor	Ugleholdt	2006	5		
1424	chr5	110080019	110080795	3500382800	255		110080019	110080795	8421504	5	6,78,87,82,2	0,104,334,600,774	p	350038280000015118	0-255						Novel proteins and nucleic acids encoding same	Anderson	2003	0		
1424	chr5	110080020	110080141	3500215312	23		110080020	110080141	8421504	2	5,18	0,103	c	350021531200000001	0-23						GAPDH nuclear translocation, oxidative stress and apoptosis	cs.biologists.org	0	0		
1424	chr5	110080021	110081305	3500360296	42		110080021	110081305	8421504	3	4,17,21	0,102,1263	c	350036029600000007,350036029600000006	0-21,0-21						&#x4e3b;&#x9898;&#xff1a;shock | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1424	chr5	110080021	110081305	3500192200	42		110080021	110081305	8421504	3	4,17,21	0,102,1263	c	350019220000000005,350019220000000004	0-21,0-21						ISOLATION, CHARACTERIZATION AND DIFFERENTIATION POTENTIAL OF RAT BONE MARROW STROMAL CELLS	a.inflibnet.ac.in	0	0		
1424	chr5	110080021	110081305	3500114446	42		110080021	110081305	8421504	3	4,17,21	0,102,1263	c	350011444600000015,350011444600000007,350011444600000006,350011444600000014	0-21,0-21,0-21,0-21						GRAFT COMPOSITION FOR NEURAL TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1424	chr5	110080021	110080144	3500421982	25		110080021	110080144	8421504	2	4,21	0,102	c	350042198200000008	0-25						Transcriptome analysis of amoeboid and ramified microglia isolated from the corpus callosum of rat brain. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080021	110080144	3500176682	25		110080021	110080144	8421504	2	4,21	0,102	c	350017668200000008	0-25						Transcriptome analysis of amoeboid and ramified microglia isolated from the corpus callosum of rat brain	biomedcentral.com	0	0		
1424	chr5	110080021	110080144	3500100932	25		110080021	110080144	8421504	2	4,21	0,102	c	350010093200000003	0-25						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Hypertonicity-induced Aquaporin-1 (AQP1) Expression Is Mediated by the Activation of MAPK Pathways and Hypertonicity-res	www.jbc.org	0	0		
1424	chr5	110080021	110080143	3500288228	24		110080021	110080143	8421504	2	4,20	0,102	c	350028822800000010	0-24						mRNA and 18S&#x2013;RNA coapplication&#x2013;reverse transcription for quantitative gene expression analysis	uantification.com	0	0		
1424	chr5	110080022	110080143	3500349446	23		110080022	110080143	8421504	2	3,20	0,101	c	350034944600000032	0-23		22615967	10.1371/journal.pone.0037286	1932-6203	PLOS ONE	PLOS ONE: Tregs Promote the Differentiation of Th17 Cells in Silica-Induced Lung Fibrosis in Mice	Song	2012	4		
1424	chr5	110080022	110080143	3500298701	23		110080022	110080143	8421504	2	3,20	0,101	c	350029870100000012	0-23					Patent	Polyconjugates for in vivo delivery of polynucleotides (Patent US:8137695)	Hagstrom	2012	0		
1424	chr5	110080022	110080143	3500265543	23		110080022	110080143	8421504	2	3,20	0,101	c	350026554300000011	0-23						Polyconjugates for in vivo delivery of polynucleotides	Blokhin	2009	0		
1424	chr5	110080022	110080143	3500223857	23		110080022	110080143	8421504	2	3,20	0,101	c	350022385700000012	0-23						Polyconjugates for In Vivo Delivery of Polynucleotides	Rozema	2008	0		
1424	chr5	110080022	110080143	3500193544	23		110080022	110080143	8421504	2	3,20	0,101	c	350019354400000012,350019354400000025	0-23,0-23						Reversibly Masked Polymers - Patent application	www.faqs.org	0	0		
1424	chr5	110080022	110080143	3500141488	23		110080022	110080143	8421504	2	3,20	0,101	c	350014148800000012	0-23						Endosomolytic Modified Poly(Alcohol) and Poly(Amine) Polymers	Monahan	2008	0		
1424	chr5	110080024	110080660	3500453904	44		110080024	110080660	8421504	3	1,21,22	0,99,614	c	350045390400000012,350045390400000011	0-22,0-22		20484637	10.1523/JNEUROSCI.4521-09.2010	0270-6474	The Journal of Neuroscience	Damage-Induced Neuronal Endopeptidase Is Critical for Presynaptic Formation of Neuromuscular Junctions	Nagata	2010	7		
1424	chr5	110080124	110081301	3500438036	45		110080124	110081301	8421504	2	22,23	0,1154	c	350043803600000007,350043803600000006	0-22,0-23						Localization of sulphonylurea receptor proteins SUR2A and SUR2B and/or SUR1 in rat kidney	www.pjps.pk	0	0		
1424	chr5	110080124	110081301	3500435197	45		110080124	110081301	8421504	2	22,23	0,1154	c,g	350043519700000011,350043519700000010,350043519700000010	0-22,0-23,0-23		10069985			American Journal of Physiology - Cell Physiolog	Splicing of a retained intron within ROMK K+ channel RNA generates a novel set of isoforms in rat kidney	Beesley	1999	0		
1424	chr5	110080124	110081301	3500179823	45		110080124	110081301	8421504	2	22,23	0,1154	c	350017982300000008,350017982300000007	0-22,0-23						&#x4e3b;&#x9898;&#xff1a;Organic | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1424	chr5	110080132	110080906	3500063812	105		110080132	110080906	8421504	2	48,57	0,717	p	350006381200015055,350006381200015051	9-57,0-57						&#x4e1d;&#x72b6;&#x771f;&#x83cc;&#x9886;&#x57df;&#x7684;&#x65b0;&#x7684;&#x8868;&#x8fbe;&#x8c03;&#x8282;&#x5e8f;&#x5217;&#x548c;&#x8868;&#x8fbe;&#x4ea7;&#x7269;	Ma Ke *A Long *Ai Ma Er Fa Er Bu 	2003	0		
1424	chr5	110080132	110080174	3500047620	41		110080132	110080174	8421504	2	22,19	0,23	c	350004762000000011,350004762000000009	0-23,0-19						Monocyte recruitment to endothelial cells in response to oscillatory shear stress	www.fasebj.org	0	0		
1424	chr5	110080135	110080428	3500412394	40		110080135	110080428	8421504	2	20,20	0,273	c	350041239400000007,350041239400000006	0-20,0-20						HYDROGELS BASED ON POLYMERS OF DEXTRAN TYRAMINE AND TYRAMINE CONJUGATES OF NATURAL POLYMERS - Patent application	www.faqs.org	0	0		
1424	chr5	110080136	110080201	3500387984	40		110080136	110080201	8421504	2	20,20	0,45	c	350038798400000005,350038798400000004	0-20,0-20		20357187	10.1152/ajpcell.00413.2009		American Journal of Physiology - Cell Physiology	An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular disease	Xiaojun	June	0		
1424	chr5	110080136	110080201	3500125773	40		110080136	110080201	8421504	2	20,20	0,45	c	350012577300000005,350012577300000004	0-20,0-20		20357187	10.1152/ajpcell.00413.2009		American Journal of Physiology - Cell Physiolog	An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular disease	Liu	2010	0		
1424	chr5	110080137	110080802	3500445257	39		110080137	110080802	8421504	3	19,11,9	0,553,656	c,g	350044525700000005,350044525700000004	0-19,0-20		18245255	10.1128/AEM.02467-07	0099-2240	Applied and Environmental Microbiology	Use of Drosophila S2 Cells as a Model for Studying Ehrlichia chaffeensis Infections	Luce-Fedrow	2008	4		
1424	chr5	110080137	110080802	3500060930	39		110080137	110080802	8421504	3	19,11,9	0,553,656	c,g	350006093000000005,350006093000000004	0-19,0-20						Use of Drosophila S2 Cells as a Model for Studying Ehrlichia chaffeensis Infections	aem.asm.org	0	0		
1424	chr5	110080152	110080416	3500395598	40		110080152	110080416	8421504	2	20,20	0,244	c	350039559800000003,350039559800000002	0-20,0-20						Consequences of physiological heat shock beginning at the zygote stage on embryonic development and expression of stress response genes in cattle	imal.ifas.ufl.edu	0	0		
1424	chr5	110080152	110080416	3500388552	40		110080152	110080416	8421504	2	20,20	0,244	c	350038855200000029,350038855200000028	0-20,0-20						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
1424	chr5	110080152	110080416	3500292483	61		110080152	110080416	8421504	4	20,14,7,20	0,36,136,244	c	350029248300000010,350029248300000011,350029248300000009	0-20,0-21,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1424	chr5	110080152	110080416	3500280109	40		110080152	110080416	8421504	2	20,20	0,244	c,g	350028010900000003,350028010900000003,350028010900000002,350028010900000002	0-20,0-20,0-20,0-20						Consequences of physiological heat shock beginning at the zygote stage on embryonic development and expression of stress response genes in cattle	imal.ifas.ufl.edu	0	0		
1424	chr5	110080152	110080416	3500143254	40		110080152	110080416	8421504	2	20,20	0,244	c	350014325400000029,350014325400000028	0-20,0-20						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
1424	chr5	110080175	110080199	3500431500	24		110080175	110080199	8421504	1	24	0	c	350043150000000005	0-24		18434363	10.1677/JOE-08-0098	0022-0795	Journal of Endocrinology	Chicken leptin receptor is functional in activating JAK&#x2013;STATpathway in vitro	Adachi	2008	4		GAPDH
1424	chr5	110080175	110080199	3500359370	24		110080175	110080199	8421504	1	24	0	c	350035937000000015	0-24		11283272	10.1128/MCB.21.8.2956-2966.2001	0270-7306	Molecular and Cellular Biology	Cyclin A Is a Mediator of p120 E4F -Dependent Cell Cycle Arrest in G1	Fajas	2001	6		GAPDH
1424	chr5	110080175	110080199	3500341760	24		110080175	110080199	8421504	1	24	0	c	350034176000000005	0-24		18434363	10.1677/JOE-08-0098	0022-0795	Journal of Endocrinology	Chicken leptin receptor is functional in activating JAK&#x2013;STATpathway in vitro	Adachi	2008	4		GAPDH
1424	chr5	110080178	110080670	3500429916	40		110080178	110080670	8421504	2	20,20	0,472	c	350042991600000004,350042991600000003	0-20,0-20						STROMAL CELL-DERIVED FACTOR-1 MEDIATES STEM CELL HOMING AND TISSUE REGENERATION IN ISCHEMIC CARDIOMYOPATHY	Penn	2003	0		GAPDH
1424	chr5	110080178	110080670	3500096738	40		110080178	110080670	8421504	2	20,20	0,472	c	350009673800000005,350009673800000004	0-20,0-20						Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy	Penn	2003	0		GAPDH
1424	chr5	110080178	110080202	3500442710	24		110080178	110080202	8421504	1	24	0	c	350044271000000002	0-24		14514640	10.2337/diabetes.52.10.2554	0012-1797	Diabetes	Inhibition of Net HepG2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation	Borradaile	2003	8		GAPDH
1424	chr5	110080178	110080202	3500367085	24		110080178	110080202	8421504	1	24	0	c	350036708500000008	0-29						OLIGOMERIC COMPOUNDS FOR THE MODULATION OF HIF-1alpha EXPRESSION	Thrue	2010	0		
1424	chr5	110080178	110080202	3500182310	24		110080178	110080202	8421504	1	24	0	c,g	350018231000000008,350018231000000008	0-29,0-29					Patent	Oligomeric compounds for the modulation of HIF-1alpha expression (Patent US:7846911)	Thrue	2010	0		
1424	chr5	110080178	110080202	3500017282	24		110080178	110080202	8421504	1	24	0	c	350001728200000005	0-29						Oligomeric compounds for the modulation of ras expression	Hansen	2004	0		
1424	chr5	110080179	110080668	3500273240	40		110080179	110080668	8421504	2	20,20	0,469	c	350027324000000005,350027324000000004	0-20,0-20		17311953		0022-3166	The Journal of Nutrition	Conjugated Eicosapentaenoic Acid Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Migration of Human Umbilical Vein Endothelial Cells	Tsuzuki	2007	4		GAPDH
1424	chr5	110080179	110080668	3500161396	40		110080179	110080668	8421504	2	20,20	0,469	c	350016139600000005,350016139600000004	0-20,0-20		17311953		0022-3166	The Journal of Nutrition	Conjugated Eicosapentaenoic Acid Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Migration of Human Umbilical Vein Endothelial Cells	Tsuzuki	2007	4		GAPDH
1424	chr5	110080179	110080668	3500059780	40		110080179	110080668	8421504	2	20,20	0,469	c	350005978000000005,350005978000000004	0-20,0-20						ScienceDirect.com - Biochemical and Biophysical Research Communications - Existence of GPR40 functioning in a human breast cancer cell line, MCF-7	sciencedirect.com	0	0		GAPDH
1424	chr5	110080179	110080668	3500002234	40		110080179	110080668	8421504	2	20,20	0,469	c	350000223400000005,350000223400000004	0-20,0-20						Conjugated Eicosapentaenoic Acid Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Migration of Human Umbilical Vein Endothelial Cells	jn.nutrition.org	0	0		GAPDH
1424	chr5	110080180	110081456	3500378011	47		110080180	110081456	8421504	3	22,1,24	0,108,1252	c	350037801100000003,350037801100000002	0-23,0-24						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	mcb.berkeley.edu	0	0		
1424	chr5	110080180	110081456	3500349759	47		110080180	110081456	8421504	3	22,1,24	0,108,1252	c	350034975900000003,350034975900000002	0-23,0-24						www.nature.com/bjp EthylcaffeatesuppressesNF-jBactivationanditsdownstream inflammatorymediators,iNOS,COX-2,andPGE in vitro orinmouseskin	web.nchu.edu.tw	0	0		
1424	chr5	110080180	110081456	3500161427	47		110080180	110081456	8421504	3	22,1,24	0,108,1252	c	350016142700000003,350016142700000002	0-23,0-24						9-Deazaguanine and Its Methyl Derivatives: Synthesis, Antitumor Activity in vitro and Effects on Purine Nucleoside Phosphorylase Gene Expression	hrcak.srce.hr	0	0		
1424	chr5	110080180	110081456	3500145445	47		110080180	110081456	8421504	3	22,1,24	0,108,1252	c	350014544500000003,350014544500000002	0-23,0-24						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	physio.ucsf.edu	0	0		
1424	chr5	110080181	110081242	3500408852	43		110080181	110081242	8421504	3	21,3,19	0,921,1042	c,g	350040885200000004,350040885200000004,350040885200000003	0-21,0-21,0-22		18393288	10.1002/hep.22215	1527-3350	Hepatology	Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways - Trujillo-Murillo - 2008 - Hepatology - Wiley Online Library	Trujillo-Murillo	2008	0		GAPDH
1424	chr5	110080182	110081238	3500458666	50		110080182	110081238	8421504	4	20,8,7,15	0,106,916,1041	c	350045866600000013,350045866600000003,350045866600000004	0-28,0-20,0-21						DELIVERY SYSTEM AND CONJUGATES FOR COMPOUND DELIVERY VIA NATURALLY OCCURRING INTRACELLULAR TRANSPORT ROUTES - CENIX BIOSCIENCE GMBH	www.sumobrain.com	0	0		GAPDH
1424	chr5	110080182	110081238	3500235911	50		110080182	110081238	8421504	4	20,8,7,15	0,106,916,1041	c	350023591100000013,350023591100000003,350023591100000004	0-28,0-20,0-21						Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes	Echeverri	2012	0		GAPDH
1424	chr5	110080182	110081238	3500085619	50		110080182	110081238	8421504	4	20,8,7,15	0,106,916,1041	c	350008561900000012,350008561900000002,350008561900000003	0-28,0-20,0-21						Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes	Echeverri	2012	0		GAPDH
1424	chr5	110080182	110080417	3500244200	40		110080182	110080417	8421504	2	20,20	0,215	c	350024420000000011,350024420000000010	0-20,0-20						Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck	-publications.com	0	0		GAPDH,LINC00602
1424	chr5	110080183	110080795	3500024983	114		110080183	110080795	8421504	4	19,47,46,2	0,105,472,610	p	350002498300015008,350002498300015005,350002498300015003	33-111,0-51,0-48						S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding	roscience.jhu.edu	0	0		
1424	chr5	110080183	110080299	3500077431	30		110080183	110080299	8421504	2	19,11	0,105	c	350007743100000009	0-30			10.1128/MCB.01811-05		Molecular and Cellular Biology	Normal Establishment of Epithelial Tight Junctions in Mice and Cultured Cells Lacking Expression of ZO-3, a Tight-Junction MAGUK Protein 	Makoto	2006	0		
1424	chr5	110080183	110080292	3500356236	23		110080183	110080292	8421504	2	19,4	0,105	c	350035623600000014	0-23		12735795	10.1186/1471-2164-4-18	1471-2164	BMC Genomics	The gene structure and expression of human ABHD1: overlapping polyadenylation signal sequence with Sec12	Edgar	2003	4		
1424	chr5	110080184	110080667	3500316357	38		110080184	110080667	8421504	3	18,1,19	0,104,464	c	350031635700000001,350031635700000000	0-19,0-19						Cornea Analysis of the Role of ZEB1 in the Pathogenesis of Posterior Polymorphous Corneal Dystrophy	www.iovs.org	0	0		
1424	chr5	110080184	110080667	3500262739	38		110080184	110080667	8421504	3	18,1,19	0,104,464	c,g	350026273900000001,350026273900000000,350026273900000000	0-19,0-19,0-19		22199242	10.1167/iovs.11-8038		Investigative Ophthalmology & Visual Science	Analysis of the Role of ZEB1 in the Pathogenesis of Posterior Polymorphous Corneal Dystrophy	Vivek	2012	0		
1424	chr5	110080184	110080293	3500206935	23		110080184	110080293	8421504	2	18,5	0,104	c	350020693500000002	1-24						Cyclooxygenase-2/prostaglandin E2 accelerates the	gi.physiology.org	0	0		
1424	chr5	110080184	110080293	3500126233	23		110080184	110080293	8421504	2	18,5	0,104	c	350012623300000004	1-24		20046424	10.3349/ymj.2009.50.6.818		Yonsei Medical Journal	Cyclooxygenase-2 Expression Is Related to the Epithelial-to-Mesenchymal Transition in Human Colon Cancers	Tae	2009	0		
1424	chr5	110080184	110080293	3500088953	23		110080184	110080293	8421504	2	18,5	0,104	c	350008895300000002	1-24		17673547	10.1152/ajpgi.00131.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors	Hatazawa	2007	0		
1424	chr5	110080184	110080293	3500037424	23		110080184	110080293	8421504	2	18,5	0,104	c	350003742400000002	1-24		17673547	10.1152/ajpgi.00131.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors	Hatazawa	2007	0		
1424	chr5	110080186	110080891	3500296987	42		110080186	110080891	8421504	3	16,4,22	0,102,683	c	350029698700000003,350029698700000002	0-20,0-22			10.1111/j.1471-4159.2004.02372.x	1471-4159	Journal of Neurochemistry	Distinct aggregation and cell death patterns among different types of primary neurons induced by mutant huntingtin protein - Tagawa - 2004 - Journal of Neurochemistry - Wiley Online Library	Tagawa	2004	0		
1424	chr5	110080186	110080425	3500427031	42		110080186	110080425	8421504	3	16,5,21	0,102,218	c	350042703100000006,350042703100000005	0-21,0-21		14602795	10.1210/jc.2003-030497	0021-972X	Journal of Clinical Endocrinology & Metabolism	Myostatin Is a Skeletal Muscle Target of Growth Hormone Anabolic Action	Liu	2003	6		
1424	chr5	110080186	110080425	3500357309	42		110080186	110080425	8421504	3	16,5,21	0,102,218	c	350035730900000009,350035730900000008	0-21,0-21		17068136	10.1210/en.2006-0736	0013-7227	Endocrinology	Hyaluronan Accumulation in Thyroid Tissue: Evidence for Contributions from Epithelial Cells and Fibroblasts	Gianoukakis	2007	4		
1424	chr5	110080186	110080425	3500348405	42		110080186	110080425	8421504	3	16,5,21	0,102,218	c	350034840500000001,350034840500000000	0-21,0-21		17210661	10.1128/IAI.01034-06	0019-9567	Infection and Immunity	Peritoneal Lavage Cells of Indonesian Thin-Tail Sheep Mediate Antibody-Dependent Superoxide Radical Cytotoxicity In Vitro against Newly Excysted Juvenile Fasciola gigantica but Not Juvenile Fasciola hepatica	Piedrafita	2007	4		
1424	chr5	110080186	110080425	3500341604	42		110080186	110080425	8421504	3	16,5,21	0,102,218	c	350034160400000003,350034160400000002	0-21,0-21			10.1111/j.1365-3024.2006.00816.x	1365-3024	Parasite Immunology	Eosinophil interactions with Haemonchus contortus larvae in the ovine gastrointestinal tract - BALIC - 2006 - Parasite Immunology - Wiley Online Library	BALIC	2006	0		
1424	chr5	110080186	110080425	3500265302	42		110080186	110080425	8421504	3	16,5,21	0,102,218	c	350026530200000006,350026530200000005	0-21,0-21						Myostatin Is a Skeletal Muscle Target of Growth Hormone Anabolic Action	.endojournals.org	0	0		
1424	chr5	110080186	110080301	3500349870	29		110080186	110080301	8421504	2	16,13	0,102	c	350034987000000009	0-29		19461998	10.1371/journal.pone.0005623	1932-6203	PLOS ONE	PLOS ONE: An Active Role of the &#x0394;N Isoform of p63 in Regulating Basal Keratin Genes K5 and K14 and Directing Epidermal Cell Fate	Romano	2009	4		
1424	chr5	110080186	110080297	3500348420	25		110080186	110080297	8421504	2	16,9	0,102	c	350034842000000003	23-48						Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080186	110080297	3500277393	25		110080186	110080297	8421504	2	16,9	0,102	c	350027739300000007	23-48						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		
1424	chr5	110080186	110080297	3500139175	25		110080186	110080297	8421504	2	16,9	0,102	c	350013917500000034	23-48						Functional characterisation of microRNA-containing Argonaute Protein complexes	b.uni-muenchen.de	0	0		
1424	chr5	110080186	110080297	3500138640	25		110080186	110080297	8421504	2	16,9	0,102	c	350013864000000001	23-48						Author's personal copy	ww.snupharm.ac.kr	0	0		
1424	chr5	110080186	110080297	3500135352	25		110080186	110080297	8421504	2	16,9	0,102	c	350013535200000016	23-48						Role of Retinoic Acid-Related Orphan Receptor- in Differentiation of Human Mesenchymal Stem Cells along with Osteoblastic Lineage	www.karger.com	0	0		
1424	chr5	110080186	110080297	3500010232	25		110080186	110080297	8421504	2	16,9	0,102	c	350001023200000017	23-48		21857646	10.1038/emboj.2011.301	ERROR! NO ISSN	The EMBO Journal	CAMTA1 is a novel tumour suppressor regulated by miR-9/9&ast; in glioblastoma stem cells	Schraivogel	2011	0		
1424	chr5	110080186	110080296	3500177639	24		110080186	110080296	8421504	2	16,8	0,102	c	350017763900000024	0-24			10.1111/j.1742-4658.2006.05135.x	1742-4658	FEBS Journal	Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells - Clement - 2006 - FEBS Journal - Wiley Online Library	Clement	2006	0		
1424	chr5	110080186	110080296	3500145039	24		110080186	110080296	8421504	2	16,8	0,102	c	350014503900000096	0-24						A novel haemopoietin receptor	Hilton	1997	0		
1424	chr5	110080186	110080296	3500091804	24		110080186	110080296	8421504	2	16,8	0,102	c	350009180400000021	0-24					Patent	Nucleic acid encoding &#x03b1; chain of human IL-11 receptor (Patent US:7476732)	Hilton	2009	0		
1424	chr5	110080186	110080296	3500047558	24		110080186	110080296	8421504	2	16,8	0,102	c	350004755800000021	0-24						Nucleic acid encoding alpha chain of human IL-11 receptor	Hilton	2006	0		
1424	chr5	110080186	110080296	3500032543	24		110080186	110080296	8421504	2	16,8	0,102	c	350003254300000021	0-24					Patent	Nucleic acid encoding &#x03b1; chain of human IL-11 receptor (Patent US:7002000)	Hilton	2006	0		
1424	chr5	110080186	110080295	3500440875	23		110080186	110080295	8421504	2	16,7	0,102	c	350044087500000019	0-23						Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	ecular-cancer.com	0	0		
1424	chr5	110080186	110080295	3500200996	23		110080186	110080295	8421504	2	16,7	0,102	c	350020099600000031	0-23					International Journal of Clinical and Experimental Pathology	Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells	Ahmad	2011	0		
1424	chr5	110080186	110080295	3500190261	23		110080186	110080295	8421504	2	16,7	0,102	c	350019026100000019	0-23		22913813	10.1186/1476-4598-11-59	1476-4598	Molecular Cancer	Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	Horibe	2012	4		
1424	chr5	110080186	110080295	3500120427	23		110080186	110080295	8421504	2	16,7	0,102	c	350012042700000003	0-23						Targeting Interleukin-4 Receptor &#x03b1; with Hybrid Peptide for Effective Cancer Therapy	.aacrjournals.org	0	0		
1424	chr5	110080186	110080295	3500108998	23		110080186	110080295	8421504	2	16,7	0,102	c	350010899800000015	0-23		12517964		0022-1767	The Journal of Immunology	A Complex Containing Polypyrimidine Tract-Binding Protein Is Involved in Regulating the Stability of CD40 Ligand (CD154) mRNA	Kosinski	2003	6		
1424	chr5	110080186	110080295	3500068922	23		110080186	110080295	8421504	2	16,7	0,102	c	350006892200000019	0-23		22913813	10.1186/1476-4598-11-59		Molecular Cancer	Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells	Tomohisa	2012	0		
1424	chr5	110080187	110081241	3500425958	40		110080187	110081241	8421504	4	15,5,2,18	0,101,916,1036	c	350042595800000029,350042595800000028	0-20,0-20						AlphaCGRP and Liver Fibrosis in Chronic Hepatitis Induced by Concanavalin A: Materials and Methods	www.medscape.com	0	0		
1424	chr5	110080187	110081241	3500371706	39		110080187	110081241	8421504	4	15,4,2,18	0,101,916,1036	c	350037170600000003,350037170600000002	0-19,0-20			10.1186/1465-9921-7-1		Respiratory Research	Upregulated Genes In Sporadic, Idiopathic Pulmonary Arterial Hypertension	Alasdair	2006	0		
1424	chr5	110080187	110081240	3500424170	47		110080187	110081240	8421504	4	15,9,6,17	0,101,912,1036	c	350042417000000007,350042417000000006	0-24,0-23		15592523	10.1038/sj.onc.1208221	0950-9232	Oncogene	Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)&sol;Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms	Huh	2004	6		
1424	chr5	110080187	110081041	3500099123	82		110080187	110081041	8421504	6	15,5,11,9,20,22	0,101,242,432,460,832	c	350009912300000033,350009912300000032,350009912300000015,350009912300000014	0-20,0-20,0-20,0-22						Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin	g.library.pcc.edu	0	0		
1424	chr5	110080187	110080425	3500461521	44		110080187	110080425	8421504	3	15,9,20	0,101,218	c	350046152100000003,350046152100000007	0-24,0-20		16585173	10.1158/0008-5472.CAN-04-2372	0008-5472	Cancer Research	Distinct Tumor Stage&#x2013;Specific Inhibitory Effects of 2-Methoxyestradiol in a Breast Cancer Mouse Model Associated with Id-1 Expression	Huh	2006	8		GAPDH
1424	chr5	110080187	110080297	3500464025	24		110080187	110080297	8421504	2	15,9	0,101	c	350046402500000001	0-24							ingtechnology.com	0	0		
1424	chr5	110080187	110080297	3500455337	24		110080187	110080297	8421504	2	15,9	0,101	c	350045533700000005	0-24		23936448	10.1371/journal.pone.0070565		PLoS ONE	Curcumin Protects Microglia and Primary Rat Cortical Neurons against HIV-1 gp120-Mediated Inflammation and Apoptosis	Luyan	2013	0		
1424	chr5	110080187	110080297	3500455273	24		110080187	110080297	8421504	2	15,9	0,101	c	350045527300000001	0-24		19439559	10.1530/REP-09-0039	1470-1626	Reproduction	Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation	Isachenko	2009	3		
1424	chr5	110080187	110080297	3500455070	24		110080187	110080297	8421504	2	15,9	0,101	c	350045507000000009	0-24			10.1111/j.1365-2443.2005.00902.x	1365-2443	Genes to Cells	Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage - Naitoh - 2005 - Genes to Cells - Wiley Online Library	Naitoh	2005	0		
1424	chr5	110080187	110080297	3500432821	24		110080187	110080297	8421504	2	15,9	0,101	c	350043282100000003	0-24						Heavy metal residues in canned fishes in Egypt - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080187	110080297	3500430498	24		110080187	110080297	8421504	2	15,9	0,101	c	350043049800000004	0-24						Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment	Carson	1994	0		
1424	chr5	110080187	110080297	3500425762	24		110080187	110080297	8421504	2	15,9	0,101	c	350042576200000012	0-24						JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression. - ResearchGat	.researchgate.net	0	0		
1424	chr5	110080187	110080297	3500422834	24		110080187	110080297	8421504	2	15,9	0,101	c	350042283400000007	0-24		23889969	10.1186/1472-6882-13-194	1472-6882	BMC Complementary and Alternative Medicine	Neutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells	Park	2013	2		
1424	chr5	110080187	110080297	3500410974	24		110080187	110080297	8421504	2	15,9	0,101	c	350041097400000010	0-24						ProgressionofProstateCancerfromaSubsetof p63-PositiveBasalEpithelialCellsinFG/Tag TransgenicMice	.aacrjournals.org	0	0		
1424	chr5	110080187	110080297	3500410886	24		110080187	110080297	8421504	2	15,9	0,101	c	350041088600000004	0-24			10.1002/ijc.21809	1097-0215	International Journal of Cancer	Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene - Suganuma - 2006 - International Journal of Cancer - Wiley Online Library	Suganuma	2006	0		
1424	chr5	110080187	110080297	3500406622	24		110080187	110080297	8421504	2	15,9	0,101	c	350040662200000007	0-24			10.1111/j.1471-4159.2007.04769.x	1471-4159	Journal of Neurochemistry	JAK-STAT signaling pathway mediates astrogliosis in brains of scrapie-infected mice - Na - 2007 - Journal of Neurochemistry - Wiley Online Library	Na	2007	0		
1424	chr5	110080187	110080297	3500392039	24		110080187	110080297	8421504	2	15,9	0,101	c	350039203900000003	0-24		11316847		1046-6673	Journal of the American Society of Nephrology	Activated Coagulation Factor X: A Novel Mitogenic Stimulus for Human Mesangial Cells	MONNO	2001	10		
1424	chr5	110080187	110080297	3500381602	24		110080187	110080297	8421504	2	15,9	0,101	c	350038160200000003	0-24						Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells	s01.rm.unicatt.it	0	0		
1424	chr5	110080187	110080297	3500377985	24		110080187	110080297	8421504	2	15,9	0,101	c	350037798500000005	0-24						Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer	Akiyama	2010	0		
1424	chr5	110080187	110080297	3500364944	24		110080187	110080297	8421504	2	15,9	0,101	c	350036494400000013	0-24						An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma	onal-medicine.com	0	0		
1424	chr5	110080187	110080297	3500362179	24		110080187	110080297	8421504	2	15,9	0,101	c	350036217900000005	0-24		12488552	10.1124/mol.63.1.192	1521-0111 (Online)	Molecular Pharmacology	Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor	Tentori	2003	0		
1424	chr5	110080187	110080297	3500351069	24		110080187	110080297	8421504	2	15,9	0,101	c	350035106900000005	0-24						Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer	Akiyama	2006	0		
1424	chr5	110080187	110080297	3500347484	24		110080187	110080297	8421504	2	15,9	0,101	c	350034748400000007	0-24		23175185	10.1038/cdd.2012.136	1350-9047	Cell Death & Differentiation	CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation	Chang	2012	9		
1424	chr5	110080187	110080297	3500332209	24		110080187	110080297	8421504	2	15,9	0,101	c	350033220900000004	0-24						Preparation of mono-nucleosomal and poly-nucleosomal DNA templates	www.nature.com	0	0		
1424	chr5	110080187	110080297	3500330744	24		110080187	110080297	8421504	2	15,9	0,101	c	350033074400000003	0-24						In&#xfb02;uence of Mycobacterium bovis Bacillus Calmette Gue&#xb4;rin on In Vitro Induction of CD1 Molecules in Human Adherent Mononuclear Cells	iai.asm.org	0	0		
1424	chr5	110080187	110080297	3500325578	24		110080187	110080297	8421504	2	15,9	0,101	c	350032557800000003	0-24		15625246	10.1210/en.2004-0972	0013-7227	Endocrinology	Stathmin Expression Modulates Migratory Properties of GN-11 Neurons in Vitro	Giampietro	2005	4		
1424	chr5	110080187	110080297	3500312267	24		110080187	110080297	8421504	2	15,9	0,101	c	350031226700000003	0-24		22955947	10.1038/cdd.2012.106	1350-9047	Cell Death & Differentiation	Suppressor of cytokine signaling 6 (SOCS6) promotes mitochondrial fission via regulating DRP1 translocation	Lin	2012	9		
1424	chr5	110080187	110080297	3500311281	24		110080187	110080297	8421504	2	15,9	0,101	c	350031128100000003	0-24		9580640		1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Role of Wild-Type p53 on the Antineoplastic Activity of Temozolomide Alone or Combined with Inhibitors of Poly(ADP-Ribose) Polymerase	Tentori	1998	0		
1424	chr5	110080187	110080297	3500295780	24		110080187	110080297	8421504	2	15,9	0,101	c	350029578000000005	0-24		20212457	10.1038/labinvest.2010.55	0023-6837	Laboratory Investigation	SERPINB3 modulates TGF-&#x03b2; expression in chronic liver disease	Turato	2010	4		
1424	chr5	110080187	110080297	3500292210	24		110080187	110080297	8421504	2	15,9	0,101	c	350029221000000005	0-24					Patent	Method for diagnosing esophageal cancer (Patent US:7932032)	Akiyama	2011	0		
1424	chr5	110080187	110080297	3500281130	24		110080187	110080297	8421504	2	15,9	0,101	c	350028113000000005	0-24						Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer	Akiyama	2009	0		
1424	chr5	110080187	110080297	3500277008	24		110080187	110080297	8421504	2	15,9	0,101	c	350027700800000005	0-24						Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer - Patent application	www.faqs.org	0	0		
1424	chr5	110080187	110080297	3500271989	24		110080187	110080297	8421504	2	15,9	0,101	c	350027198900000005	0-24		19032740	10.1186/1742-4690-5-104		Retrovirology	Physiological properties of astroglial cell lines derived from mice with high (SAMP8) and low (SAMR1, ICR) levels of endogenous retrovirus	Boe-Hyun	2008	0		
1424	chr5	110080187	110080297	3500262291	24		110080187	110080297	8421504	2	15,9	0,101	c	350026229100000003	0-24		21507968	10.1128/JVI.02627-10	0022-538X	Journal of Virology	Subversion of Cellular Autophagy Machinery by Hepatitis B Virus for Viral Envelopment	Li	2011	5		
1424	chr5	110080187	110080297	3500260184	24		110080187	110080297	8421504	2	15,9	0,101	c	350026018400000003	0-24		10207115		0270-7306	Molecular and Cellular Biology	Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a	Mitra	1999	6		
1424	chr5	110080187	110080297	3500222176	24		110080187	110080297	8421504	2	15,9	0,101	c	350022217600000003	0-24		11705921	10.1128/IAI.69.12.7461-7470.2001	0019-9567	Infection and Immunity	Influence of Mycobacterium bovisBacillus Calmette Gu&#xe9;rin on In Vitro Induction of CD1 Molecules in Human Adherent Mononuclear Cells	Giuliani	2001	4		
1424	chr5	110080187	110080297	3500220879	24		110080187	110080297	8421504	2	15,9	0,101	c	350022087900000003	0-24						Activated Coagulation Factor X: A Novel Mitogenic Stimulus for Human Mesangial Cells	n.asnjournals.org	0	0		
1424	chr5	110080187	110080297	3500216638	24		110080187	110080297	8421504	2	15,9	0,101	c	350021663800000013	0-24		21936950	10.1186/1479-5876-9-157	1479-5876	Journal of Translational Medicine	An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma	Pan	2011	3		
1424	chr5	110080187	110080297	3500213282	24		110080187	110080297	8421504	2	15,9	0,101	c	350021328200000003	0-24					Molecular and Cellular Biology	Induction of p21WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16INK4a	Jayashree	1999	0		
1424	chr5	110080187	110080297	3500208276	24		110080187	110080297	8421504	2	15,9	0,101	c	350020827600000007	0-24		23175185	10.1038/cdd.2012.136	1350-9047	Cell Death & Differentiation	CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation	Chang	2012	9		
1424	chr5	110080187	110080297	3500197259	24		110080187	110080297	8421504	2	15,9	0,101	c	350019725900000001	0-24						Nucleocytoplasmic Shuttling of the Retinoblastoma Tumor Suppressor Protein via Cdk Phosphorylation-dependent Nuclear Export--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x999	journal.9med.net	0	0		
1424	chr5	110080187	110080297	3500194486	24		110080187	110080297	8421504	2	15,9	0,101	c	350019448600000005	0-24		23936448	10.1371/journal.pone.0070565	1932-6203	PLOS ONE	PLOS ONE: Curcumin Protects Microglia and Primary Rat Cortical Neurons against HIV-1 gp120-Mediated Inflammation and Apoptosis	Guo	2013	4		
1424	chr5	110080187	110080297	3500174590	24		110080187	110080297	8421504	2	15,9	0,101	c	350017459000000003	0-24						The Clinical Significance of Aurora-A/STK15/BTAK Expression in Human Esophageal Squamous Cell Carcinoma	.aacrjournals.org	0	0		
1424	chr5	110080187	110080297	3500168700	24		110080187	110080297	8421504	2	15,9	0,101	c	350016870000000009	0-24		19795442	10.1002/ijc.24901	1097-0215	International Journal of Cancer	Snail is critical for tumor growth and metastasis of ovarian carcinoma - Jin - 2009 - International Journal of Cancer - Wiley Online Library	Jin	2010	0		
1424	chr5	110080187	110080297	3500163098	24		110080187	110080297	8421504	2	15,9	0,101	c	350016309800000003	0-24						Expression and functional activity of P-glycoprotein in JPP &#xa9; 2011 Royal passaged primary human nasal epithelial cell monolayers cultured by the air&#x2013;liquid interface method for nasal drug transport study	ww.snupharm.ac.kr	0	0		
1424	chr5	110080187	110080297	3500156199	24		110080187	110080297	8421504	2	15,9	0,101	c	350015619900000013	0-24		21936950	10.1186/1479-5876-9-157	1479-5876	Journal of Translational Medicine	An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma	Pan	2011	3		
1424	chr5	110080187	110080297	3500156110	24		110080187	110080297	8421504	2	15,9	0,101	c	350015611000000003	0-24		20565981	10.1186/1746-1596-5-41	1746-1596	Diagnostic Pathology	Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines	Ortiz	2010	2		
1424	chr5	110080187	110080297	3500153089	24		110080187	110080297	8421504	2	15,9	0,101	c	350015308900000009	0-24						Engineering bone tissue using human dental pulp stem cells and an osteogenic collagen-hydroxyapatite-poly(-lactide-co-{varepsilon}-caprolactone) scaffold. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080187	110080297	3500137948	24		110080187	110080297	8421504	2	15,9	0,101	c	350013794800000005	0-24					Patent	Method for diagnosing esophageal cancer (Patent US:8198025)	Akiyama	2012	0		
1424	chr5	110080187	110080297	3500129872	24		110080187	110080297	8421504	2	15,9	0,101	c	350012987200000005	0-24						Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer	Akiyama	2011	0		
1424	chr5	110080187	110080297	3500110117	24		110080187	110080297	8421504	2	15,9	0,101	c	350011011700000001	0-24		12193542	10.1210/en.2002-220146	0013-7227	Endocrinology	Hepatocyte Growth Factor/Scatter Factor Facilitates Migration of GN-11 Immortalized LHRH Neurons	Giacobini	2002	4		
1424	chr5	110080187	110080297	3500107612	24		110080187	110080297	8421504	2	15,9	0,101	c	350010761200000033,350010761200000001	0-24,0-24						PLURIPOTENT STEM CELLS OBTAINED FROM DENTAL PULP - Patent application	www.faqs.org	0	0		
1424	chr5	110080187	110080297	3500098776	24		110080187	110080297	8421504	2	15,9	0,101	c	350009877600000007	0-24						Neutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells	biomedcentral.com	0	0		
1424	chr5	110080187	110080297	3500095649	24		110080187	110080297	8421504	2	15,9	0,101	c	350009564900000070	0-24						Vascular/Lymphatic Endothelial Cells - Patent application	www.faqs.org	0	0		
1424	chr5	110080187	110080297	3500069047	24		110080187	110080297	8421504	2	15,9	0,101	c	350006904700000005	0-24		12810536	10.1210/en.2002-0180	0013-7227	Endocrinology	Valproic Acid Increases the Stimulatory Effect of Estrogens on Proliferation of Human Endometrial Adenocarcinoma Cells	Graziani	2003	4		
1424	chr5	110080187	110080297	3500054676	24		110080187	110080297	8421504	2	15,9	0,101	c	350005467600000004	0-24						Neuroimmune Circuits, Drugs of Abuse and Infectious Diseases - H. Friedman (Kluwer, 2001) WW	www.scribd.com	0	0		
1424	chr5	110080187	110080297	3500039700	24		110080187	110080297	8421504	2	15,9	0,101	c	350003970000000003	0-24		15756006	10.1158/1078-0432.CCR-04-1627	1078-0432	Clinical Cancer Research	The Clinical Significance of Aurora-A/STK15/BTAK Expression in Human Esophageal Squamous Cell Carcinoma	Tanaka	2005	8		
1424	chr5	110080187	110080297	3500036487	24		110080187	110080297	8421504	2	15,9	0,101	c	350003648700000005	0-24						Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer	Akiyama	2008	0		
1424	chr5	110080187	110080297	3500036228	24		110080187	110080297	8421504	2	15,9	0,101	c	350003622800000003	0-24		16951226	10.1158/1078-0432.CCR-05-2852	1078-0432	Clinical Cancer Research	The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma	Okumura	2006	8		
1424	chr5	110080187	110080297	3500016815	24		110080187	110080297	8421504	2	15,9	0,101	c	350001681500000007	0-24						Standardization strategy for quantitative PCR in human seminoma and normal testis	quantification.de	0	0		
1424	chr5	110080187	110080297	3500010540	24		110080187	110080297	8421504	2	15,9	0,101	c	350001054000000007	0-24		23175185	10.1038/cdd.2012.136	1350-9047	Cell Death & Differentiation	CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation	Chang	2012	9		
1424	chr5	110080187	110080297	3500006990	24		110080187	110080297	8421504	2	15,9	0,101	c	350000699000000003	0-24		17178870	10.1158/0008-5472.CAN-06-2322	0008-5472	Cancer Research	Collagen I Promotes Metastasis in Pancreatic Cancer by Activating c-Jun NH2-Terminal Kinase 1 and Up-regulating N-Cadherin Expression	Shintani	2006	8		
1424	chr5	110080187	110080297	3500002505	24		110080187	110080297	8421504	2	15,9	0,101	c	350000250500000007	0-24		15592523	10.1038/sj.onc.1208221	0950-9232	Oncogene	Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)&sol;Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms	Huh	2004	6		
1424	chr5	110080187	110080296	3500436461	23		110080187	110080296	8421504	2	15,8	0,101	c	350043646100000001	0-23		21263023	10.1128/IAI.00754-10	0019-9567	Infection and Immunity	NOD-Like Receptor Activation by Outer Membrane Vesicles from Vibrio cholerae Non-O1 Non-O139 Strains Is Modulated by the Quorum-Sensing Regulator HapR	Bielig	2011	4		
1424	chr5	110080187	110080296	3500434072	23		110080187	110080296	8421504	2	15,8	0,101	c	350043407200000001	0-23		19671672	10.1158/1541-7786.MCR-09-0073	1541-7786	Molecular Cancer Research	Differential Influence of Normal and Cancer-Associated Fibroblasts on the Growth of Human Epithelial Cells in an In vitro Cocultivation Model of Prostate Cancer	Paland	2009	4		
1424	chr5	110080187	110080296	3500377685	23		110080187	110080296	8421504	2	15,8	0,101	c	350037768500000008	0-23						HKU : A B : Karlas_Nature_2010	ww.coursehero.com	0	0		
1424	chr5	110080187	110080296	3500373398	23		110080187	110080296	8421504	2	15,8	0,101	c	350037339800000008	0-23						Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080187	110080296	3500365864	23		110080187	110080296	8421504	2	15,8	0,101	c	350036586400000003	0-23		19332174	10.1016/j.joca.2009.03.004		Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society	Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes	Alexander	2009	0		
1424	chr5	110080187	110080296	3500224434	23		110080187	110080296	8421504	2	15,8	0,101	c	350022443400000001	0-23		19671672	10.1158/1541-7786.MCR-09-0073	1541-7786	Molecular Cancer Research	Differential Influence of Normal and Cancer-Associated Fibroblasts on the Growth of Human Epithelial Cells in an In vitro Cocultivation Model of Prostate Cancer	Paland	2009	4		
1424	chr5	110080187	110080296	3500190945	23		110080187	110080296	8421504	2	15,8	0,101	c	350019094500000008	0-23						INFLUENZA TARGETS - MAX-PLANCK-GESELLSCHAFT ZUR F&#xd6;RDERUNG DER WISSENSCHAFTEN e.V.	www.sumobrain.com	0	0		
1424	chr5	110080187	110080296	3500187048	23		110080187	110080296	8421504	2	15,8	0,101	c	350018704800000011	0-23		20538593	10.1074/jbc.M110.109736	0021-9258	Journal of Biological Chemistry	A Role for the Human Nucleotide-binding Domain, Leucine-rich Repeat-containing Family Member NLRC5 in Antiviral Responses	Neerincx	2010	5		
1424	chr5	110080187	110080296	3500054039	23		110080187	110080296	8421504	2	15,8	0,101	c	350005403900000001	0-23		21263023	10.1128/IAI.00754-10		Infection and Immunity	NOD-Like Receptor Activation by Outer Membrane Vesicles from Vibrio cholerae Non-O1 Non-O139 Strains Is Modulated by the Quorum-Sensing Regulator HapR 	H.	2011	0		
1424	chr5	110080188	110080427	3500346956	38		110080188	110080427	8421504	3	14,5,19	0,100,220	c	350034695600000007,350034695600000006	0-19,0-19		19196452	10.1186/1479-5876-7-13	1479-5876	Journal of Translational Medicine	Drugs targeting the mitochondrial pore act as citotoxic and cytostatic agents in temozolomide-resistant glioma cells	Lena	2009	3		
1424	chr5	110080188	110080427	3500170122	38		110080188	110080427	8421504	3	14,5,19	0,100,220	c	350017012200000007,350017012200000006	0-19,0-19		19196452	10.1186/1479-5876-7-13		Journal of Translational Medicine	Drugs targeting the mitochondrial pore act as citotoxic and cytostatic agents in temozolomide-resistant glioma cells	Annalisa	2009	0		
1424	chr5	110080188	110080416	3500394704	41		110080188	110080416	8421504	3	14,7,20	0,100,208	c	350039470400000011,350039470400000009	0-21,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
1424	chr5	110080188	110080297	3500431596	23		110080188	110080297	8421504	2	14,9	0,100	c	350043159600000013	0-23						Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors	onal-medicine.com	0	0		
1424	chr5	110080188	110080297	3500157277	23		110080188	110080297	8421504	2	14,9	0,100	c	350015727700000013	0-23			10.1186/1479-5876-11-213	1479-5876	Journal of Translational Medicine	Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors	Peacock	2013	3		
1424	chr5	110080190	110080299	3500305714	23		110080190	110080299	8421504	2	12,11	0,98	c	350030571400000006	0-23		15213103	10.1182/blood-2003-12-4219	0006-4971	Blood	The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors	Hildbrand	2004	10		
1424	chr5	110080191	110080670	3500427288	44		110080191	110080670	8421504	3	11,11,22	0,97,457	c	350042728800000007,350042728800000006	0-22,0-22			10.1111/j.1474-9726.2007.00323.x	1474-9726	Aging Cell	Mitochondrial DNA deletions induce the adenosine monophosphate-activated protein kinase energy stress pathway and result in decreased secretion of some proteins - Prigione - 2007 - Aging Cell - Wiley Online Library	Prigione	2007	0		
1424	chr5	110080191	110080670	3500364320	44		110080191	110080670	8421504	3	11,11,22	0,97,457	c	350036432000000006,350036432000000005	0-22,0-22			10.1016/j.abb.2006.09.010		Archives of biochemistry and biophysics	Frataxin knockdown causes loss of cytoplasmic iron&#x2013;sulfur cluster functions, redox alterations and induction of heme transcripts	Chunye	2007	0		
1424	chr5	110080192	110080301	3500418526	23		110080192	110080301	8421504	2	10,13	0,96	c	350041852600000011	0-23			10.1111/j.1442-2042.2007.01861.x	1442-2042	International Journal of Urology	Up-regulation of urinary UPIII mRNA levels in vesicoureteral reflux patients: Potential application as a screening test for vesicoureteral reflux - Iwaki - 2007 - International Journal of Urology - Wiley Online Library	Iwaki	2007	0		
1424	chr5	110080199	110080315	3500428873	30		110080199	110080315	8421504	2	3,27	0,89	c	350042887300000003	0-30		11698241			American Journal of Physiology - Cell Physiolog	Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells	Bridges	2001	0		
1424	chr5	110080199	110080315	3500349529	30		110080199	110080315	8421504	2	3,27	0,89	c	350034952900000003	0-30		11818404		1552-5783	Investigative Ophthalmology & Visual Science	Downregulation of Reduced-Folate Transporter by Glucose in Cultured RPE Cells and in RPE of Diabetic Mice	Naggar	2002	0		
1424	chr5	110080199	110080315	3500235426	30		110080199	110080315	8421504	2	3,27	0,89	c	350023542600000007	0-30		11133847		1552-5783	Investigative Ophthalmology & Visual Science	Structure, Function, and Regulation of Human Cystine/Glutamate Transporter in Retinal Pigment Epithelial Cells	Bridges	2001	0		
1424	chr5	110080199	110080315	3500064467	30		110080199	110080315	8421504	2	3,27	0,89	c	350006446700000003	0-30		11818404		1552-5783	Investigative Ophthalmology & Visual Science	Downregulation of Reduced-Folate Transporter by Glucose in Cultured RPE Cells and in RPE of Diabetic Mice	Naggar	2002	0		
1424	chr5	110080199	110080315	3500009072	29		110080199	110080315	8421504	3	3,12,14	0,89,102	c	350000907200000003	0-29		14744916	10.1167/iovs.03-0503	1552-5783	Investigative Ophthalmology & Visual Science	Osmoregulation of Taurine Transporter Function and Expression in Retinal Pigment Epithelial, Ganglion, and M&#xfc;ller Cells	El-Sherbeny	2004	0		
1424	chr5	110080201	110080698	3500059614	41		110080201	110080698	8421504	3	1,20,20	0,87,477	c	350005961400000001,350005961400000000	0-21,0-20		20309945	10.1002/ijc.25336	1097-0215	International Journal of Cancer	Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16INK4A - Lan - 2010 - International Journal of Cancer - Wiley Online Library	Lan	2011	0		
1424	chr5	110080201	110080312	3500117256	25		110080201	110080312	8421504	2	1,24	0,87	c	350011725600000007	0-25						ScienceDirect.com - Experimental Eye Research - Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye	sciencedirect.com	0	0		
1424	chr5	110080288	110080837	3500047577	61		110080288	110080837	8421504	4	20,13,7,21	0,139,331,528	c	350004757700000015,350004757700000003,350004757700000002	0-20,0-20,0-21		20176726	10.1210/en.2009-0767	0013-7227	Endocrinology	Induction of Endothelin-2 Expression by Luteinizing Hormone and Hypoxia: Possible Role in Bovine Corpus Luteum Formation	Klipper	2010	4		
1424	chr5	110080289	110081236	3500435188	41		110080289	110081236	8421504	3	20,8,13	0,808,934	c	350043518800000011,350043518800000010	0-20,0-21		16288053	10.1158/0008-5472.CAN-05-2268	0008-5472	Cancer Research	Negative Regulation of Estrogen Receptor &#x03b1; Transactivation Functions by LIM Domain Only 4 Protein	Singh	2005	8		GAPDH
1424	chr5	110080289	110081236	3500225724	41		110080289	110081236	8421504	3	20,8,13	0,808,934	c	350022572400000011,350022572400000010	0-20,0-21						Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein. - ResearchGate	.researchgate.net	0	0		GAPDH
1424	chr5	110080289	110081038	3500075043	44		110080289	110081038	8421504	2	22,22	0,727	c	350007504300000004,350007504300000003	0-22,0-22		10473099		1078-0432	Clinical Cancer Research	Oral Administration of the Immunomodulator JBT-3002 Induces Endogenous Interleukin 15 in Intestinal Macrophages for Protection against Irinotecan-mediated Destruction of Intestinal Epithelium	Shinohara	1999	8		
1424	chr5	110080290	110080417	3500432650	45		110080290	110080417	8421504	2	23,22	0,105	c,g	350043265000000008,350043265000000007,350043265000000007	0-23,0-22,0-22		20042104	10.1186/gb-2009-10-12-r143	1465-6906	Genome Biology	Correlating measurements across samples improves accuracy of large-scale expression profile experiments	Alvarez	2009	0		
1424	chr5	110080291	110080693	3500129294	41		110080291	110080693	8421504	2	21,20	0,382	c	350012929400000013,350012929400000012	0-21,0-20						Synthetic bone substitute engineered with amniotic epithelial cells enhances bone regeneration after maxillary sinus augmentation. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080291	110080639	3500230459	41		110080291	110080639	8421504	3	20,1,20	0,148,328	c	350023045900000005,350023045900000004	2-22,0-21						ATP-binding Cassette Transporter G2 Activity in the Bovine Spermatozoa is modulated along the Epididymal Duct and at Ejaculation	ww.biolreprod.org	0	0		
1424	chr5	110080291	110080418	3500068958	60		110080291	110080418	8421504	3	20,20,20	0,24,107	c	350006895800000006,350006895800000004,350006895800000005	0-20,0-20,0-20						Erbb-3 (her3)-selective combination therapy	Liao	2010	0		GAPDH
1424	chr5	110080291	110080416	3500258614	40		110080291	110080416	8421504	2	20,20	0,105	c	350025861400000003,350025861400000004	0-20,0-20						EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression	-publications.com	0	0		
1424	chr5	110080302	110080694	3500382598	44		110080302	110080694	8421504	2	22,22	0,370	c	350038259800000005,350038259800000004	0-22,0-22			10.1111/j.1365-2567.2007.02642.x		Immunology	Prostaglandin E2 modulates dendritic cell function during chlamydial genital infection	Wei	2008	0		
1424	chr5	110080328	110081040	3500450465	40		110080328	110081040	8421504	2	20,20	0,692	c	350045046500000005,350045046500000011	0-20,0-20						The toxic effects and fate of intravenously administered zearalenone in goats	.thaiscience.info	0	0		
1424	chr5	110080330	110080422	3500271138	40		110080330	110080422	8421504	2	20,20	0,72	c	350027113800000005,350027113800000004	0-20,0-20						A novel angiogenesis model for screening anti-angiogenic compounds: The chorioallantoic membrane/feather bud assay	-publications.com	0	0		GAPDH
1424	chr5	110080330	110080416	3500221274	40		110080330	110080416	8421504	2	20,20	0,66	c,g	350022127400000003,350022127400000002,350022127400000002	0-20,0-20,0-20						Compelling evidence that a single nucleotide substitution in TYRP1 is responsible for coat-colour polymorphism in a free-living population of Soay sheep	etypublishing.org	0	0		
1424	chr5	110080373	110081034	3500184512	48		110080373	110081034	8421504	3	23,5,20	0,531,641	c	350018451200000003,350018451200000002	0-23,0-25						EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080383	110080413	3500028925	27		110080383	110080413	8421504	2	5,22	0,8	c	350002892500000003	11-38		19180480	10.1002/art.24248	1529-0131	Arthritis & Rheumatism	Altered integrin mechanotransduction in human nucleus pulposus cells derived from degenerated discs - Le Maitre - 2009 - Arthritis & Rheumatism - Wiley Online Library	Le	2009	0		
1424	chr5	110080387	110080795	3500409249	46		110080387	110080795	8421504	3	22,22,2	0,292,406	c,g	350040924900000007,350040924900000007,350040924900000006	0-22,0-22,0-24		15665816	10.1038/sj.cdd.4401567	1350-9047	Cell Death & Differentiation	Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1&sol;WAF1 expression, independent of histone deacetylase 1	Huang	2005	9		GAPDH
1424	chr5	110080387	110080795	3500017769	46		110080387	110080795	8421504	3	22,22,2	0,292,406	c	350001776900000003,350001776900000002	0-22,0-24		18382690	10.1371/journal.pone.0001921		PLoS ONE	Regulation of the High Affinity IgE Receptor (Fc&#x03b5;RI) in Human Neutrophils: Role of Seasonal Allergen Exposure and Th-2 Cytokines	Martin	2008	0		GAPDH
1424	chr5	110080390	110081241	3500460744	42		110080390	110081241	8421504	3	21,3,18	0,712,833	c,g	350046074400000002,350046074400000002,350046074400000003	0-21,0-21,0-21		17035600	10.1124/dmd.106.011759	1521-009X (Online)	Drug Metabolism and Disposition	Pregnane X Receptor-Dependent Induction of the CYP3A4 Gene by o,p&#x2032;-1,1,1,-Trichloro-2,2-Bis (p-Chlorophenyl)ethane	Medina-Diaz	2007	0		GAPDH
1424	chr5	110080390	110081241	3500318491	42		110080390	110081241	8421504	3	21,3,18	0,712,833	c	350031849100000006,350031849100000005	0-21,0-21		17071735	10.1152/ajpheart.00121.2005	0363-6135	American Journal of Physiology - Heart and Circulatory Physiology	Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase	Bivalacqua	2007	4		GAPDH
1424	chr5	110080390	110081241	3500264719	42		110080390	110081241	8421504	3	21,3,18	0,712,833	c	350026471900000030,350026471900000031	0-21,0-21						CTACK/CCL27 Accelerates Skin Regeneration via Accumulation of Bone Marrow-Derived Keratinocytes--&#x300a;&#x5e72;&#x7ec6;&#x80de;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		GAPDH
1424	chr5	110080390	110081241	3500247477	42		110080390	110081241	8421504	3	21,3,18	0,712,833	c,g	350024747700000003,350024747700000003,350024747700000002	0-22,0-22,0-21		21421555	10.1093/cvr/cvq410		Cardiovascular Research	Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity	Milena	2011	0		
1424	chr5	110080390	110081241	3500178009	42		110080390	110081241	8421504	3	21,3,18	0,712,833	c	350017800900000003,350017800900000002	0-21,0-21		20498022	10.1084/jem.20092265	0022-1007	The Journal of Experimental Medicine	IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis	Mittal	2010	14		GAPDH
1424	chr5	110080390	110081241	3500006571	42		110080390	110081241	8421504	3	21,3,18	0,712,833	c	350000657100000007,350000657100000006	0-21,0-21						Modulation of nitric oxide signaling through signaling through specific regulation by arginylation and the N-end rule pathway	Hu	2005	0		GAPDH
1424	chr5	110080390	110080664	3500365644	42		110080390	110080664	8421504	2	20,22	0,252	c	350036564400000003,350036564400000002	0-20,0-22		18818380	10.2353/ajpath.2008.071153		The American Journal of Pathology	Involvement of the Lysophosphatidic Acid-Generating Enzyme Autotaxin in Lymphocyte-Endothelial Cell Interactions	Tae	2008	0		GAPDH
1424	chr5	110080390	110080664	3500017895	42		110080390	110080664	8421504	2	20,22	0,252	c	350001789500000012,350001789500000011	0-20,0-22			10.1111/j.1365-2443.2005.00879.x	1365-2443	Genes to Cells	Inhibition of cholesterol biosynthesis by 25-hydroxycholesterol is independent of OSBP - Nishimura - 2005 - Genes to Cells - Wiley Online Library	Nishimura	2005	0		
1424	chr5	110080390	110080413	3500313240	23		110080390	110080413	8421504	1	23	0	c	350031324000000002	0-23					The American Journal of Pathology	Natural Killer T (NKT) Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis by Producing Interferon-&#x03b3;	Ji	2005	0		FRMD5,GAPDH
1424	chr5	110080390	110080413	3500159167	23		110080390	110080413	8421504	1	23	0	c	350015916700000013	0-23						&#x4e3b;&#x9898;&#xff1a;EP3 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		FRMD5,GAPDH
1424	chr5	110080390	110080413	3500041586	23		110080390	110080413	8421504	1	23	0	c	350004158600000002	0-23						NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor 1 production 2005&#x5e74;&#x7b2c;201&#x5377;&#x7b2c;1&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		GAPDH
1424	chr5	110080391	110081025	3500455481	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350045548100000003,350045548100000002	0-20,0-20						RESEARCH COMMUNICATION Inhibition of Proliferation, Viability, Migration and Invasion of Gastric Cancer Cells by Aurora-A Deletion	www.apocp.org	0	0		GAPDH
1424	chr5	110080391	110081025	3500453695	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350045369500000011,350045369500000010	0-20,0-20						CHEN, WEI-YANG, M.S. Inhibition of Cytochrome P450 by Lemongrass and the	libres.uncg.edu	0	0		GAPDH
1424	chr5	110080391	110081025	3500432455	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350043245500000009,350043245500000008	0-20,0-20						Huaier aqueous extract suppresses human breast cancer cell proliferation through inhibition of estrogen receptor signaling	ww.kaijikaryu.com	0	0		GAPDH
1424	chr5	110080391	110081025	3500431647	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c,g	350043164700000003,350043164700000003,350043164700000002	0-20,0-20,0-20		23518204	10.1186/1477-7819-11-74	1477-7819	World Journal of Surgical Oncology	Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma	Zhao	2013	1		GAPDH
1424	chr5	110080391	110081025	3500370370	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350037037000000009,350037037000000008	0-20,0-20			10.3892/ol.2013.1342		Oncology Letters	Downregulation of L-type amino acid transporter 1 expression inhibits the growth, migration and invasion of gastric cancer cells	LIANGHUI	July	0		GAPDH
1424	chr5	110080391	110081025	3500369589	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350036958900000003,350036958900000002	0-20,0-20		23967153	10.1371/journal.pone.0071071		PLoS ONE	Grape Seed Procyanidin Reversal of P-glycoprotein Associated Multi-Drug Resistance via Down-regulation of NF-&#x03ba;B and MAPK/ERK Mediated YB-1 Activity in A2780/T Cells	Bo-xin	2013	0		GAPDH
1424	chr5	110080391	110081025	3500352614	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350035261400000011,350035261400000010	0-20,0-20		21170301	10.1371/journal.pgen.1001240		PLoS Genetics	Histone Deacetylases Suppress CGG Repeat&#x2013;Induced Neurodegeneration Via Transcriptional Silencing in Models of Fragile X Tremor Ataxia Syndrome	PeK.	2010	0		GAPDH
1424	chr5	110080391	110081025	3500336761	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350033676100000003,350033676100000002	0-20,0-20						Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma	www.wjso.com	0	0		GAPDH
1424	chr5	110080391	110081025	3500310491	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350031049100000014,350031049100000015	0-20,0-20		22104393	10.1186/1756-9966-30-109	1756-9966	Journal of Experimental & Clinical Cancer Research	Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells	He	2011	2		GAPDH
1424	chr5	110080391	110081025	3500273073	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350027307300000001,350027307300000000	0-20,0-20						Antioxidant and anti-inflammatory effects of Astragalus polysaccharide on EA.hy926 cells	-publications.com	0	0		GAPDH
1424	chr5	110080391	110081025	3500272158	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350027215800000003,350027215800000002	0-20,0-20			10.3892/ol.2012.557		Oncology Letters	Establishment of the cell line, HeLa-CD14, transfected with the human CD14 gene	Bo-Tao	2012	0		GAPDH
1424	chr5	110080391	110081025	3500244852	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350024485200000003,350024485200000002	0-20,0-20						Establishment of the cell line, HeLa-CD14, transfected with the human CD14 gene	-publications.com	0	0		GAPDH
1424	chr5	110080391	110081025	3500239440	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c,g	350023944000000001,350023944000000001,350023944000000000	0-20,0-20,0-20						Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo	www.wjgnet.com	0	0		GAPDH
1424	chr5	110080391	110081025	3500232676	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350023267600000007,350023267600000006	0-20,0-20						World J Gastroenterol	www.wjgnet.com	0	0		GAPDH
1424	chr5	110080391	110081025	3500205946	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350020594600000011,350020594600000010	0-20,0-20		20137078	10.1186/1471-2407-10-33	1471-2407	BMC Cancer	Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells	Zheng	2010	3		GAPDH
1424	chr5	110080391	110081025	3500081836	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350008183600000011,350008183600000010	0-20,0-20					BMC Cancer	Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells - Scolaris	Zheng	2010	0		GAPDH
1424	chr5	110080391	110081025	3500046908	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350004690800000003,350004690800000002	0-20,0-20						Meso-tetra (carboxyphenyl) porphyrin (TCPP) nanoparticles were internalized by SW480 cells by a clathrin-mediated endocytosis pathway to induce high photocytotoxicity	.researchgate.net	0	0		GAPDH
1424	chr5	110080391	110081025	3500001478	40		110080391	110081025	8421504	3	20,9,11	0,509,623	c	350000147800000003,350000147800000002	0-20,0-20						Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma	biomedcentral.com	0	0		GAPDH
1424	chr5	110080391	110080665	3500238447	42		110080391	110080665	8421504	2	21,21	0,253	c	350023844700000003,350023844700000002	0-21,0-21		23144633	10.1371/journal.pgen.1003048		PLoS Genetics	Transcription Factor Oct1 Is a Somatic and Cancer Stem Cell Determinant	Jessica	2012	0		GAPDH
1424	chr5	110080391	110080417	3500289667	26		110080391	110080417	8421504	1	26	0	c	350028966700000007,350028966700000018	0-26,0-26						Secreted Luciferase Fluorescent Protein Conjugate Nucleic Acid Construct and Uses Thereof - Patent application	www.faqs.org	0	0		FRMD5,GAPDH
1424	chr5	110080391	110080417	3500113010	26		110080391	110080417	8421504	1	26	0	c	350011301000000003	0-26		17593970	10.1371/journal.pone.0000571	1932-6203	PLOS ONE	PLOS ONE: A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER Stress	Badr	2007	4		TASP1,GAPDH
1424	chr5	110080392	110081508	3500417024	43		110080392	110081508	8421504	2	21,22	0,1094	c	350041702400000037,350041702400000036	0-21,0-22						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - STEMPEUTICS RESEARCH PRIVATE LIMITED	www.sumobrain.com	0	0		
1424	chr5	110080392	110081508	3500401984	43		110080392	110081508	8421504	2	21,22	0,1094	c	350040198400000037,350040198400000036	0-21,0-22						XENO-FREE CULTURE CONDITIONS FOR HUMAN EMBRYONIC STEM CELLS AND METHODS THEREOF	Totey	2009	0		
1424	chr5	110080392	110081508	3500298123	43		110080392	110081508	8421504	2	21,22	0,1094	c	350029812300000015,350029812300000014	0-21,0-22		17483317	10.1158/0008-5472.CAN-06-3699	0008-5472	Cancer Research	A Transgenic Mouse Model of Plasma Cell Malignancy Shows Phenotypic, Cytogenetic, and Gene Expression Heterogeneity Similar to Human Multiple Myeloma	Boylan	2007	8		BCOR
1424	chr5	110080392	110081508	3500009124	43		110080392	110081508	8421504	2	21,22	0,1094	c	350000912400000015,350000912400000014	0-21,0-22		18390664	10.1128/JB.01965-07		Journal of Bacteriology	Functional and Phylogenetic Characterization of Vaginolysin, the Human-Specific Cytolysin from Gardnerella vaginalis 	Shari	June	0		
1424	chr5	110080392	110081508	3500008009	43		110080392	110081508	8421504	2	21,22	0,1094	c	350000800900000037,350000800900000077,350000800900000036,350000800900000076	0-21,0-21,0-22,0-22						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - Patent application	www.faqs.org	0	0		
1424	chr5	110080392	110080699	3500197527	40		110080392	110080699	8421504	2	20,20	0,287	c	350019752700000007,350019752700000006	0-20,0-20		21768309	10.1128/MCB.05746-11	0270-7306	Molecular and Cellular Biology	SCFFBXO22 Regulates Histone H3 Lysine 9 and 36 Methylation Levels by Targeting Histone Demethylase KDM4A for Ubiquitin-Mediated Proteasomal Degradation	Tan	2011	6		GAPDH
1424	chr5	110080392	110080416	3500387065	24		110080392	110080416	8421504	1	24	0	c	350038706500000034	0-24						Molecular cloning, spatial and temporal expression analysis of CatSper genes in the Chinese Meishan pigs	www.rbej.com	0	0		GAPDH
1424	chr5	110080393	110080662	3500187146	43		110080393	110080662	8421504	2	20,23	0,246	c	350018714600000021,350018714600000020	0-20,0-23						Cells	tologylibrary.org	0	0		
1424	chr5	110080393	110080639	3500317045	64		110080393	110080639	8421504	4	20,23,1,20	0,22,46,226	c	350031704500000024,350031704500000025,350031704500000023	0-20,0-23,0-21		20592089	10.1128/JVI.00642-10		Journal of Virology	Foot-and-Mouth Disease Virus Replicates Only Transiently in Well-Differentiated Porcine Nasal Epithelial Cells 	Pradyot	2010	0		
1424	chr5	110080393	110080639	3500246332	41		110080393	110080639	8421504	3	20,1,20	0,46,226	c,g	350024633200000001,350024633200000001,350024633200000000	0-20,0-20,0-21						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		
1424	chr5	110080393	110080639	3500124900	41		110080393	110080639	8421504	3	20,1,20	0,46,226	c	350012490000000008,350012490000000007	0-20,0-21						Bernier dodier et al., 2011 MSD Salud Animal Salud Lechera	ww.slideshare.net	0	0		
1424	chr5	110080393	110080631	3500366041	44		110080393	110080631	8421504	3	20,12,12	0,35,226	c	350036604100000001,350036604100000000	0-20,0-24		18245814	10.2353/ajpath.2008.070312		The American Journal of Pathology	Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells	Yoichi	2008	0		
1424	chr5	110080393	110080631	3500325952	44		110080393	110080631	8421504	3	20,12,12	0,35,226	c	350032595200000001,350032595200000000	0-20,0-24						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		
1424	chr5	110080394	110080662	3500450835	43		110080394	110080662	8421504	2	20,23	0,245	c	350045083500000009,350045083500000008	0-20,0-23		23137106	10.1186/1475-2840-11-139	1475-2840	Cardiovascular Diabetology	Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice	Shiota	2012	3		GAPDH
1424	chr5	110080394	110080662	3500423692	42		110080394	110080662	8421504	3	20,6,16	0,245,252	c	350042369200000003,350042369200000002	0-20,0-22						Supporting Information	cience.nus.edu.sg	0	0		
1424	chr5	110080394	110080662	3500376375	43		110080394	110080662	8421504	2	20,23	0,245	c	350037637500000007,350037637500000006	0-20,0-23		19912636	10.1186/1744-8069-5-64		Molecular Pain	Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain	Lin	2009	0		
1424	chr5	110080394	110080662	3500154708	43		110080394	110080662	8421504	2	20,23	0,245	c	350015470800000009,350015470800000008	0-20,0-23		23137106	10.1186/1475-2840-11-139	1475-2840	Cardiovascular Diabetology	Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice	Shiota	2012	3		
1424	chr5	110080394	110080662	3500149844	43		110080394	110080662	8421504	2	20,23	0,245	c	350014984400000013,350014984400000012	0-20,0-23		23382956	10.1371/journal.pone.0054750	1932-6203	PLOS ONE	PLOS ONE: Ethanol Alters Alveolar Fluid Balance via Nadph Oxidase (NOX) Signaling to Epithelial Sodium Channels (ENaC) in the Lung	Downs	2013	4		
1424	chr5	110080394	110080419	3500013069	25		110080394	110080419	8421504	1	25	0	c	350001306900000003	0-25						Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1	tologylibrary.org	0	0		GAPDH
1424	chr5	110080395	110080419	3500297390	24		110080395	110080419	8421504	1	24	0	c,g	350029739000000018,350029739000000018	0-24,0-24			10.1634/stemcells.22-3-385	1549-4918	STEM CELLS	Derivation of Endothelial Cells from CD34&#x2212; Umbilical Cord Blood - Murga - 2004 - STEM CELLS - Wiley Online Library	Murga	2004	0		GAPDH,KLHL8
1424	chr5	110080395	110080419	3500121282	24		110080395	110080419	8421504	1	24	0	c	350012128200000002	0-24		16219802	10.1182/blood-2005-03-1000	0006-4971	Blood	Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function	Williams	2006	10		
1424	chr5	110080396	110080885	3500186733	40		110080396	110080885	8421504	2	20,20	0,469	c	350018673300000003,350018673300000001	0-20,0-20		21357410	10.1167/iovs.10-5971	1552-5783	Investigative Ophthalmology & Visual Science	A Three-Pore Model Describes Transport Properties of Bovine Retinal Endothelial Cells in Normal and Elevated Glucose	Lopez-Quintero	2011	0		GAPDH
1424	chr5	110080396	110080885	3500072429	40		110080396	110080885	8421504	2	20,20	0,469	c	350007242900000003,350007242900000001	0-20,0-20		21357410	10.1167/iovs.10-5971		Investigative Ophthalmology & Visual Science	A Three-Pore Model Describes Transport Properties of Bovine Retinal Endothelial Cells in Normal and Elevated Glucose	Sandra	2011	0		GAPDH
1424	chr5	110080396	110080422	3500458476	26		110080396	110080422	8421504	1	26	0	c	350045847600000009	0-26			10.2353/ajpath.2007.060828		The American Journal of Pathology	Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells	Kozo	July	0		GAPDH
1424	chr5	110080396	110080422	3500445263	26		110080396	110080422	8421504	1	26	0	c	350044526300000009	0-26						&#x4e3b;&#x9898;&#xff1a;inhibit | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		GAPDH
1424	chr5	110080397	110080420	3500455512	23		110080397	110080420	8421504	1	23	0	c	350045551200000002	0-23		21508317	10.1091/mbc.E11-01-0053	1059-1524	Molecular Biology of the Cell	Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells	Gomez-Nicola	2011	5		GAPDH
1424	chr5	110080398	110080884	3500174538	40		110080398	110080884	8421504	2	20,20	0,466	c	350017453800000021,350017453800000020	0-20,0-20		17012251	10.1096/fj.05-5580com	0892-6638	The FASEB Journal	Pivotal role of integrin &#x03b1;5&#x03b2;1 in hypotonic stress-induced responses of human endothelium	Hirakawa	2006	6		
1424	chr5	110080398	110080884	3500129809	40		110080398	110080884	8421504	2	20,20	0,466	c,g	350012980900000003,350012980900000003,350012980900000002,350012980900000002	0-20,0-20,0-20,0-20		11711515	10.1161/hy1101.095993	0194-911X	Hypertension	Flow Pulsatility Is a Critical Determinant of Oxidative Stress in Endothelial Cells	Silacci	2001	6		
1424	chr5	110080399	110080426	3500447362	27		110080399	110080426	8421504	1	27	0	c	350044736200000002	0-27						Pharmaceutical uses of diterpene excavatolide B from a coral or an analogue thereof	Sheu	2012	0		
1424	chr5	110080399	110080426	3500427291	27		110080399	110080426	8421504	1	27	0	c	350042729100000006,350042729100000002	0-27,0-27						Pharmaceutical uses of diterpene excavatolide B from a coral or an analogue thereof - Patent # 8530513 - PatentGenius	.patentgenius.com	0	0		
1424	chr5	110080399	110080425	3500356257	26		110080399	110080425	8421504	1	26	0	c	350035625700000012	0-26		15769948	10.1124/mol.105.011056	1521-0111 (Online)	Molecular Pharmacology	DNA Methylation-Related Chromatin Modification in the Regulation of Mouse &#x03b4;-Opioid Receptor Gene	Wang	2005	0		
1424	chr5	110080399	110080425	3500298978	26		110080399	110080425	8421504	1	26	0	c	350029897800000023	0-26						&#x4e3b;&#x9898;&#xff1a;Modification | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1424	chr5	110080399	110080425	3500276109	26		110080399	110080425	8421504	1	26	0	c	350027610900000012	0-26						&#x4e3b;&#x9898;&#xff1a;Methylation-Related | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		GAPDH
1424	chr5	110080399	110080424	3500417735	25		110080399	110080424	8421504	1	25	0	c	350041773500000006	0-25		20123963	10.1128/MCB.00810-09	0270-7306	Molecular and Cellular Biology	Requirement of ATM for Rapid p53 Phosphorylation at Ser46 without Ser/Thr-Gln Sequences	Kodama	2010	6		
1424	chr5	110080401	110081242	3500457105	48		110080401	110081242	8421504	3	24,5,19	0,699,822	c	350045710500000013,350045710500000012	0-24,0-24		12117914	10.1128/IAI.70.8.4075-4082.2002	0019-9567	Infection and Immunity	Bacterium-Induced CXCL10 Secretion by Osteoblasts Can Be Mediated in Part through Toll-Like Receptor 4	Gasper	2002	4		GAPDH
1424	chr5	110080401	110081242	3500389571	48		110080401	110081242	8421504	3	24,5,19	0,699,822	c	350038957100000009,350038957100000008	0-24,0-24		18558011	10.1186/1471-2164-9-289	1471-2164	BMC Genomics	Venezuelan equine encephalitis virus infection causes modulation of inflammatory and immune response genes in mouse brain	Sharma	2008	4		GAPDH
1424	chr5	110080401	110081242	3500355580	48		110080401	110081242	8421504	3	24,5,19	0,699,822	c	350035558000000001,350035558000000000	0-24,0-24		12595434	10.1128/IAI.71.3.1209-1216.2003	0019-9567	Infection and Immunity	Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblasts	Schrum	2003	4		
1424	chr5	110080401	110081071	3500119305	45		110080401	110081071	8421504	2	22,23	0,647	c	350011930500000003,350011930500000002	0-22,0-23		14967823	10.1194/jlr.M400011-JLR200	0022-2275	Journal of Lipid Research	LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1	Wang	2004	6		
1424	chr5	110080401	110080426	3500453457	25		110080401	110080426	8421504	1	25	0	c	350045345700000009	0-25		20809956	10.1186/1471-2407-10-467	1471-2407	BMC Cancer	Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma	Liu	2010	3		
1424	chr5	110080401	110080426	3500341814	25		110080401	110080426	8421504	1	25	0	c	350034181400000005	0-25		20846391	10.1186/1471-2407-10-495		BMC Cancer	Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy	Guanglin	2010	0		
1424	chr5	110080401	110080426	3500170370	25		110080401	110080426	8421504	1	25	0	c	350017037000000009	0-25		20809956	10.1186/1471-2407-10-467		BMC Cancer	Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma	Wan-li	2010	0		
1424	chr5	110080401	110080426	3500072735	25		110080401	110080426	8421504	1	25	0	c,g	350007273500000005,350007273500000005	43-68,43-68						Astrocyte Elevated Gene-1is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival	.aacrjournals.org	0	0		
1424	chr5	110080401	110080426	3500049962	25		110080401	110080426	8421504	1	25	0	c	350004996200000009	0-25		18980995	10.1158/1078-0432.CCR-08-0754	1078-0432	Clinical Cancer Research	Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival	Li	2008	8		
1424	chr5	110080401	110080426	3500021039	25		110080401	110080426	8421504	1	25	0	c	350002103900000005	0-25		22385677	10.1186/1756-9966-31-18	1756-9966	Journal of Experimental & Clinical Cancer Research	Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival	Zhou	2012	2		
1424	chr5	110080401	110080425	3500411517	24		110080401	110080425	8421504	1	24	0	c	350041151700000013	0-24						The M-Ras-RA-GEF-2-Rap1 Pathway Mediates Tumor Necrosis Factor- &#x2013;dependent Regulation of Integrin Activation in Splenocytes	w.molbiolcell.org	0	0		GAPDH
1424	chr5	110080401	110080425	3500407530	24		110080401	110080425	8421504	1	24	0	c	350040753000000013	0-24		17538012	10.1091/mbc.E07-03-0250	1059-1524	Molecular Biology of the Cell	The M-Ras-RA-GEF-2-Rap1 Pathway Mediates Tumor Necrosis Factor-&#x03b1;&#x2013;dependent Regulation of Integrin Activation in Splenocytes	Yoshikawa	2007	5		GAPDH
1424	chr5	110080401	110080425	3500369226	24		110080401	110080425	8421504	1	24	0	c	350036922600000003	0-24						[CANCER RESEARCH 63, 8853&#x2013;8860, December 15, 2003] MKP-1-Induced Dephosphorylation of Extracellular Signal-Regulated Kinase Is Essential for Triggering Nitric Oxide-Induced Apoptosis in Human Breast Cancer Cell Lines: Implications in Breast Cancer	.aacrjournals.org	0	0		GAPDH
1424	chr5	110080401	110080425	3500314888	24		110080401	110080425	8421504	1	24	0	c	350031488800000003	0-24		15539456	10.1189/jlb.0804465	0741-5400	Journal of Leukocyte Biology	Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis	Elhofy	2005	5		GAPDH
1424	chr5	110080401	110080425	3500295478	24		110080401	110080425	8421504	1	24	0	c	350029547800000010	0-24					BMC Genomics	Venezuelan equine encephalitis virus infection causes modulation of inflammatory and immune response genes in mouse brain - Scolaris	Sharma	2008	0		
1424	chr5	110080401	110080425	3500277668	24		110080401	110080425	8421504	1	24	0	c	350027766800000027	0-24						320-022125 FOCUS 25	ww.invitrogen.com	0	0		
1424	chr5	110080401	110080425	3500089866	24		110080401	110080425	8421504	1	24	0	c	350008986600000003	0-24		14695202		0008-5472	Cancer Research	MKP-1-Induced Dephosphorylation of Extracellular Signal-Regulated Kinase Is Essential for Triggering Nitric Oxide-Induced Apoptosis in Human Breast Cancer Cell Lines	Pervin	2003	8		GAPDH
1424	chr5	110080401	110080425	3500071549	24		110080401	110080425	8421504	1	24	0	c	350007154900000027	0-24						320-022125 FOCUS 25	ww.invitrogen.com	0	0		
1424	chr5	110080401	110080425	3500022845	23		110080401	110080425	8421504	2	16,7	0,17	c	350002284500000001	0-23						Black Tea Polyphenols, Theaflavins, Prevent Cellular DNA Damage by Inhibiting Oxidative Stress and Suppressing Cytochrome P450 1A1 in Cell Cultures	ww.aseanfood.info	0	0		GAPDH
1424	chr5	110080402	110081319	3500179742	48		110080402	110081319	8421504	2	24,24	0,893	c	350017974200000011,350017974200000010	0-24,0-24		18471518	10.1053/j.gastro.2008.02.018		Gastroenterology	Characterization of fetal and postnatal enteric neuronal cell lines with improvement in intestinal neural function	Mallappa	2008	0		
1424	chr5	110080402	110081319	3500102527	48		110080402	110081319	8421504	2	24,24	0,893	c	350010252700000011,350010252700000010	0-24,0-24						Characterization of Fetal and Postnatal Enteric Neuronal Cell Lines With Improvement in Intestinal Neural Function	service.emory.edu	0	0		
1424	chr5	110080402	110080426	3500228224	24		110080402	110080426	8421504	1	24	0	c	350022822400000017	22-46						Bedeutung der Myosin-Leichtketten-Kinase f&#xfc;r den alpha1-adrenergen positiv inotropen Effekt im Herzmuskel	ie.uni-hamburg.de	0	0		
1424	chr5	110080403	110081427	3500339640	48		110080403	110081427	8421504	3	23,19,6	0,908,1018	c	350033964000000003,350033964000000002	0-23,0-25		19393061	10.1186/1471-2164-10-186	1471-2164	BMC Genomics	Novel transcripts discovered by mining genomic DNA from defined regions of bovine chromosome 6	Weikard	2009	4		
1424	chr5	110080403	110081297	3500199022	43		110080403	110081297	8421504	2	22,21	0,873	c	350019902200000015,350019902200000014	0-22,0-21						Original Article Reprogramming of bone marrow-derived mesenchymal stem cells into functional insulin-producing cells by chemical regimen	www.ajsc.us	0	0		
1424	chr5	110080403	110081237	3500142685	40		110080403	110081237	8421504	3	20,6,14	0,696,820	c,g	350014268500000003,350014268500000003,350014268500000002	0-20,0-20,0-20						&#x718a;&#x672c;&#x5927;&#x5b66;&#x5b66;&#x8853;&#x30ea;&#x30dd;&#x30b8;&#x30c8;&#x30ea; Kumamoto University Repository System	.kumamoto-u.ac.jp	0	0		GAPDH
1424	chr5	110080404	110081240	3500452859	42		110080404	110081240	8421504	3	21,4,17	0,697,819	c	350045285900000006,350045285900000005	0-21,0-21		20980549	10.1152/ajpcell.00142.2010		American Journal of Physiology - Cell Physiolog	Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle	Allen	2011	0		GAPDH
1424	chr5	110080404	110081240	3500360615	42		110080404	110081240	8421504	3	21,4,17	0,697,819	c	350036061500000006,350036061500000005	0-21,0-21		20980549	10.1152/ajpcell.00142.2010		American Journal of Physiology - Cell Physiolog	Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle	Allen	2011	0		
1424	chr5	110080404	110081240	3500221843	42		110080404	110081240	8421504	3	21,4,17	0,697,819	c	350022184300000003,350022184300000002	0-21,0-21		21389674	10.1159/000323654	1422-6421	Cells Tissues Organs	Cells Tissues Organs 2011, Vol. 194, No. 6 - Matrix Metalloproteinase-9 Deficiency Results in Decreased Fiber Cross-Sectional Area and Alters Fiber Type Distribution in Mouse Hindlimb Skeletal Muscle - FullText - Karger Publishers	Mehan	2011	0		
1424	chr5	110080404	110081075	3500410800	42		110080404	110081075	8421504	2	21,21	0,650	c,g	350041080000000003,350041080000000002,350041080000000002	0-21,0-21,0-21						Asociaci&#xf3;n entre receptores de leptina en test&#xed;culo, niveles de leptina y testosterona en terneros p&#xfa;beres	unicordoba.edu.co	0	0		
1424	chr5	110080404	110081075	3500309581	42		110080404	110081075	8421504	2	21,21	0,650	c,g	350030958100000007,350030958100000006,350030958100000006	0-21,0-21,0-21				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Reproducci&#xf3;n		2011	0		
1424	chr5	110080404	110081075	3500308562	42		110080404	110081075	8421504	2	21,21	0,650	c	350030856200000001,350030856200000000	0-21,0-21						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
1424	chr5	110080404	110081075	3500303705	42		110080404	110081075	8421504	2	21,21	0,650	c,g	350030370500000007,350030370500000007,350030370500000006,350030370500000006	0-21,0-21,0-21,0-21				0120-0690	Revista Colombiana de Ciencias Pecuarias	Revista Colombiana de Ciencias Pecuarias - Reproducci&#xf3;n		2011	0		
1424	chr5	110080404	110081075	3500244511	42		110080404	110081075	8421504	2	21,21	0,650	c	350024451100000003,350024451100000002	0-21,0-21						None	unicordoba.edu.co	0	0		
1424	chr5	110080404	110081075	3500092675	42		110080404	110081075	8421504	2	21,21	0,650	c	350009267500000003,350009267500000002	0-21,0-21				0122-0268	Revista MVZ C&#xf3;rdoba	Revista MVZ C&#xf3;rdoba - Asociaci&#xf3;n entre receptores de leptina en test&#xed;culo, niveles de leptina y testosterona en terneros p&#xfa;beres	Ruiz-Cortes	2010	0		
1424	chr5	110080404	110081072	3500380020	46		110080404	110081072	8421504	2	23,23	0,645	c	350038002000000003,350038002000000002	0-23,0-23						Platelet activating factor receptor expression is associated withneuronalapoptosisinan invivomodelofexcitotoxicity	137.122.232.177	0	0		
1424	chr5	110080404	110081072	3500285058	46		110080404	110081072	8421504	2	23,23	0,645	c	350028505800000006,350028505800000005	0-23,0-23		20529862	10.1074/jbc.M110.130054	0021-9258	Journal of Biological Chemistry	Pannexin 2 Is Expressed by Postnatal Hippocampal Neural Progenitors and Modulates Neuronal Commitment	Swayne	2010	5		
1424	chr5	110080404	110081072	3500267215	46		110080404	110081072	8421504	2	23,23	0,645	c	350026721500000007,350026721500000006	0-23,0-23						Reactive Oxygen Species-Induced Apoptosis in PC12 Cells and Protective Effect of Bilobalide	aspetjournals.org	0	0		
1424	chr5	110080404	110081072	3500264124	46		110080404	110081072	8421504	2	23,23	0,645	c	350026412400000007,350026412400000006	0-23,0-23				1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Reactive Oxygen Species-Induced Apoptosis in PC12 Cells and Protective Effect of Bilobalide	Zhou	2000	0		
1424	chr5	110080404	110080846	3500311877	40		110080404	110080846	8421504	2	21,19	0,423	c	350031187700000005,350031187700000004	0-21,0-19						Expression of ghrelin receptor, GHSR-1a, and its functional role in the porcine ovarian follicles	r.binoz.uj.edu.pl	0	0		
1424	chr5	110080404	110080427	3500442928	23		110080404	110080427	8421504	1	23	0	c	350044292800000006	22-45						POMC, iNOS, PGES, IL-4, IL-5 and IL-10 Gene Expression in Peripheral Blood Mononuclear Cells of Cyclic and Pregnant Mares [1]	rgi.kafkas.edu.tr	0	0		GAPDH,LINC00602
1424	chr5	110080404	110080427	3500226351	23		110080404	110080427	8421504	1	23	0	c	350022635100000001	23-46		22458943	10.1186/1749-8104-7-11	1749-8104	Neural Development	Pannexin 1 regulates postnatal neural stem and progenitor cell proliferation	Wicki-Stordeur	2012	4		GAPDH
1424	chr5	110080405	110081323	3500331365	41		110080405	110081323	8421504	2	20,21	0,897	c	350033136500000003,350033136500000002	0-20,0-21		15659710	10.1095/biolreprod.104.032953	0006-3363	Biology of Reproduction	Cooperative Expression of Monocyte Chemoattractant Protein 1 Within the Bovine Corpus Luteum: Evidence of Immune Cell-Endothelial Cell Interactions in a Coculture System	Liptak	2005	4		
1424	chr5	110080405	110081323	3500258226	41		110080405	110081323	8421504	2	20,21	0,897	c	350025822600000001,350025822600000000	0-20,0-21		20551012	10.2337/dc10-0132	0149-5992	Diabetes Care	Homocysteinethiolactone and Paraoxonase	Barathi	2010	8		
1424	chr5	110080405	110081241	3500104721	44		110080405	110081241	8421504	3	22,4,18	0,696,818	c	350010472100000005,350010472100000004	0-22,0-22					American Journal of Physiology - Heart and Circulatory Physiology	Separation of cardiomyocytes and coronary endothelial cells for cell-specific RT-PCR	Preisig-Muller	1999	0		
1424	chr5	110080405	110081238	3500233018	47		110080405	110081238	8421504	3	23,9,15	0,691,818	c	350023301800000005,350023301800000004	0-23,0-24						Chapitre 5&#xa0;: In Vivo DNase I-Mediated Footprinting Analysis Along the Human Bradykinin B1 Receptor (BDKRB1) Gene Promoter&#xa0;: Evidence for Cell Specific Regulation	theses.ulaval.ca	0	0		GAPDH
1424	chr5	110080405	110081238	3500147551	47		110080405	110081238	8421504	3	23,9,15	0,691,818	c	350014755100000004,350014755100000003	0-23,0-24						Chapitre 4&#xa0;: In Vivo Protein-DNA Interactions at the Kinin B1 Receptor Gene Promoter&#xa0;: No Modification on Interleukin-1 Beta or Lipopolysaccharide Induction	de.bibl.ulaval.ca	0	0		GAPDH
1424	chr5	110080405	110081238	3500041003	47		110080405	110081238	8421504	3	23,9,15	0,691,818	c	350004100300000004,350004100300000003	0-23,0-24						Chapitre 4&#xa0;: In Vivo Protein-DNA Interactions at the Kinin B1 Receptor Gene Promoter&#xa0;: No Modification on Interleukin-1 Beta or Lipopolysaccharide Induction	theses.ulaval.ca	0	0		GAPDH
1424	chr5	110080405	110081238	3500027425	47		110080405	110081238	8421504	3	23,9,15	0,691,818	c	350002742500000031,350002742500000030	0-23,0-24						ES FACTEURS DE TRANSCRIPTION IMPLIQU&#xc9;S DANS LA R&#xc9;GULATION DE L&#x2019;EXPRESSION DU G&#xc8;NE DU RETARD MENTAL LI&#xc9; &#xc0; L&#x2019;X FRAGILE-1 ET DU G&#xc8;NE DU R&#xc9;CEPTEUR B1 DES BRADYKININES	.theses.ulaval.ca	0	0		GAPDH
1424	chr5	110080405	110081237	3500088223	80		110080405	110081237	8421504	6	20,3,17,20,6,14	0,32,214,459,694,818	c,g	350008822300000013,350008822300000007,350008822300000006,350008822300000006,350008822300000012	0-20,0-20,0-20,0-20,0-20						NUTRITIONAL REGULATION OF SERUM INSULIN-LIKE GROWTH FACTOR-I CONCENTRATION IN CATTLE	cholar.lib.vt.edu	0	0		
1424	chr5	110080405	110080692	3500143222	40		110080405	110080692	8421504	2	20,20	0,267	c	350014322200000046,350014322200000045	0-20,0-20						Diagnosis and Treatment of Age Related Macular Degeneration	Hoh	2007	0		GAPDH
1424	chr5	110080405	110080430	3500206337	25		110080405	110080430	8421504	1	25	0	c	350020633700000009	0-25						Mammalian tumor susceptibility genes and their uses	Cohen	1998	0		
1424	chr5	110080406	110080847	3500302093	40		110080406	110080847	8421504	2	20,20	0,421	c	350030209300000005,350030209300000001,350030209300000004,350030209300000000	0-20,0-20,0-20,0-20						(+)-OPIOIDS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1424	chr5	110080406	110080847	3500213901	40		110080406	110080847	8421504	2	20,20	0,421	c	350021390100000001,350021390100000000	0-20,0-20						(+)-opioids and methods of use	Hutchinson	2009	0		
1424	chr5	110080408	110080432	3500134187	24		110080408	110080432	8421504	1	24	0	c	350013418700000017	0-24		20829348	10.1074/jbc.M110.139113		The Journal of Biological Chemistry	Cactin Targets the MHC Class III Protein I&#x03ba;B-like (I&#x03ba;BL) and Inhibits NF-&#x03ba;B and Interferon-regulatory Factor Signaling Pathways	Paola	2010	0		GAPDH
1424	chr5	110080413	110080440	3500252273	26		110080413	110080440	8421504	2	5,21	0,6	c	350025227300000000	0-26						Effect of serotonin on adipokines expression in mature bovine adipocytes	www.bu.edu.eg	0	0		
1424	chr5	110080415	110080438	3500296484	23		110080415	110080438	8421504	1	23	0	c	350029648400000006	2-25						Evaluation of cytokine expression by blood monocytes of lactating Holstein cows with or without postpartum uterine disease. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080420	110081241	3500202466	40		110080420	110081241	8421504	3	20,2,18	0,683,803	c	350020246600000040,350020246600000050	0-20,0-20						Clock gene BMAL2	Fukada	2001	0		
1424	chr5	110080423	110080848	3500423043	44		110080423	110080848	8421504	3	17,5,22	0,196,403	c	350042304300000017,350042304300000016	0-22,0-22						Activin-A reduces follicular growth stimulated by FSH in bovine preantral follicles	www.uece.br	0	0		
1424	chr5	110080423	110080848	3500331184	44		110080423	110080848	8421504	3	17,5,22	0,196,403	c	350033118400000001,350033118400000000	0-22,0-22						UNIVERSIDADE ESTADUAL DO CEAR&#xc1; PR&#xd3;-REITORIA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O E PESQUISA FACULDADE DE VETERIN&#xc1;RIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS VETERIN&#xc1;RIAS JULIANA JALES DE HOLLANDA CELESTINO EXX PPRREESSSS&#	cnptia.embrapa.br	0	0		
1424	chr5	110080423	110080848	3500263461	44		110080423	110080848	8421504	3	17,5,22	0,196,403	c	350026346100000001,350026346100000000	0-22,0-22						Isolation and culture of Preantral Follicles	www.cbra.org.br	0	0		
1424	chr5	110080423	110080848	3500111744	44		110080423	110080848	8421504	3	17,5,22	0,196,403	c	350011174400000003,350011174400000002	0-22,0-22						UNIVERSIDADE ESTADUAL DO CEAR&#xc1; PR&#xd3;-REITORIA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O E PESQUISA FACULDADE DE VETERIN&#xc1;RIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS NADJA SOARES VILA NOVA ALTERNATIVAS FITOTER&#xc1;PICAS PARA O TRATAMEN	www.uece.br	0	0		
1424	chr5	110080425	110081245	3500212126	40		110080425	110081245	8421504	3	15,5,20	0,194,800	c	350021212600000016,350021212600000015	0-20,0-20						The activin-follistatin system and in vitro early follicle development in goats	logy-journals.org	0	0		
1424	chr5	110080425	110080654	3500418753	48		110080425	110080654	8421504	3	15,11,22	0,194,207	c	350041875300000012,350041875300000010	0-26,0-22						Structural and functional analysis of the ovine laminin receptor gene (RPSA): Possible involvement of the LRP/LR protein in scrapie response. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080427	110080837	3500091455	41		110080427	110080837	8421504	3	13,7,21	0,192,389	c	350009145500000005,350009145500000004	0-20,0-21		22174022	10.1095/biolreprod.111.095067	0006-3363	Biology of Reproduction	Regulation of Angiogenesis-Related Prostaglandin F2alpha-Induced Genes in the Bovine Corpus Luteum	Zalman	2012	4		
1424	chr5	110080436	110081298	3500329313	43		110080436	110081298	8421504	3	4,18,21	0,183,841	c	350032931300000012,350032931300000011	0-22,0-21		21289118	10.1128/JVI.02546-10	0022-538X	Journal of Virology	TRIM56 Is a Virus- and Interferon-Inducible E3 Ubiquitin Ligase That Restricts Pestivirus Infection	Wang	2011	5		
1424	chr5	110080437	110081478	3500107366	40		110080437	110081478	8421504	3	3,18,19	0,182,1022	c,g	350010736600000003,350010736600000002,350010736600000002	0-21,0-19,0-19						Northern blot analysis Total cellular RNA | Online Peptides Guide	-eps15-acetyl.com	0	0		
1424	chr5	110080437	110080884	3500444204	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350044420400000007,350044420400000006	0-20,0-20						Modulation of keratocyte phenotype by collagen fibril nanoarchitecture in membranes for corneal repair	.johnshopkins.edu	0	0		
1424	chr5	110080437	110080884	3500440042	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350044004200000003,350044004200000002	0-20,0-20		20959538	10.1152/ajpendo.00498.2010		American Journal of Physiology - Endocrinology and Metabolism	Caveolin-1 is required for vascular endothelial insulin uptake	Wang	2011	0		
1424	chr5	110080437	110080884	3500407458	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350040745800000013,350040745800000012	0-20,0-20						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
1424	chr5	110080437	110080884	3500383646	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350038364600000037,350038364600000036	0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
1424	chr5	110080437	110080884	3500344523	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350034452300000003,350034452300000002	0-20,0-20		20959538	10.1152/ajpendo.00498.2010		American Journal of Physiology - Endocrinology and Metabolism	Caveolin-1 is required for vascular endothelial insulin uptake	Hong	2011	0		
1424	chr5	110080437	110080884	3500307550	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350030755000000003,350030755000000002	0-20,0-20		20406783	10.1677/JOE-10-0015	0022-0795	Journal of Endocrinology	Effect of feeding level on serum IGF1 response to GH injection	Wu	2010	4		
1424	chr5	110080437	110080884	3500188576	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350018857600000007,350018857600000006	0-20,0-20		16569760	10.1152/ajpendo.00007.2006		American Journal of Physiology - Endocrinology and Metabolism	Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+	O'Kane	2006	0		
1424	chr5	110080437	110080884	3500179955	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350017995500000003,350017995500000002	0-20,0-20		20959538	10.1152/ajpendo.00498.2010		American Journal of Physiology - Endocrinology and Metabolism	Caveolin-1 is required for vascular endothelial insulin uptake	Wang	2011	0		
1424	chr5	110080437	110080884	3500155888	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350015588800000003,350015588800000002	0-20,0-20						Weaning induces NOS-2 expression through NF-kappaB modulation in the lactating mammary gland: importance of GSH. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080437	110080884	3500144320	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350014432000000003,350014432000000002	0-20,0-20						 Variants and Gene Expression of the 	scialert.net	0	0		
1424	chr5	110080437	110080884	3500047107	40		110080437	110080884	8421504	3	3,17,20	0,182,427	c	350004710700000003,350004710700000002	0-20,0-20						Effect of feeding level on serum IGF1 response to GH injection	logy-journals.org	0	0		
1424	chr5	110080437	110080811	3500156044	40		110080437	110080811	8421504	4	3,17,2,18	0,182,262,356	c	350015604400000007,350015604400000006	0-20,0-20						The role of glucocorticoid in the regulation of prostaglandin biosynthesis in non-pregnant bovine endometrium	logy-journals.org	0	0		
1424	chr5	110080437	110080811	3500106980	40		110080437	110080811	8421504	4	3,17,2,18	0,182,262,356	c	350010698000000011,350010698000000010	0-20,0-20						Differential gene expression of bovine intramuscular and subcutaneous preadipocytes during differentiation*	www.ighz.edu.pl	0	0		
1424	chr5	110080437	110080802	3500267670	40		110080437	110080802	8421504	4	3,17,11,9	0,182,253,356	c	350026767000000003,350026767000000002	0-20,0-20		19966167	10.2527/jas.2009-2218	0021-8812	Journal of Animal Science	Effects of partial ruminal defaunation on urea-nitrogen recycling, nitrogen metabolism, and microbial nitrogen supply in growing lambs fed low or high dietary crude protein concentrations	Kiran	2010	2		
1424	chr5	110080437	110080802	3500126808	40		110080437	110080802	8421504	4	3,17,11,9	0,182,253,356	c	350012680800000001,350012680800000000	0-20,0-20						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
1424	chr5	110080439	110081080	3500414028	40		110080439	110081080	8421504	3	1,19,20	0,180,621	c	350041402800000029,350041402800000028	0-20,0-20						Ganjam virus/Nairobi sheep disease virus induces a pro-inflammatory response in infected sheep	biomedcentral.com	0	0		
1424	chr5	110080439	110081080	3500265224	40		110080439	110081080	8421504	3	1,19,20	0,180,621	c	350026522400000027,350026522400000026	0-20,0-20						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
1424	chr5	110080439	110081080	3500140454	40		110080439	110081080	8421504	3	1,19,20	0,180,621	c	350014045400000003,350014045400000002	0-20,0-20						Evaluation of reference genes for real-time PCR studies of Brazilian Somalis sheep infected by gastrointestinal nematodes	www.scielo.br	0	0		
1424	chr5	110080439	110081080	3500117703	40		110080439	110081080	8421504	3	1,19,20	0,180,621	c	350011770300000003,350011770300000002	0-20,0-20						Evaluation of reference genes for real-time PCR studies of Brazilian Somalis sheep infected by gastrointestinal nematodes. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080626	110080837	3500453465	42		110080626	110080837	8421504	2	19,23	0,188	c,g	350045346500000015,350045346500000015,350045346500000014,350045346500000014	0-19,0-19,0-23,0-23						Expression profile of genes associated with mastitis in dairy cattle	cnptia.embrapa.br	0	0		
1424	chr5	110080626	110080837	3500399883	42		110080626	110080837	8421504	2	19,23	0,188	c	350039988300000001,350039988300000000	0-19,0-23						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	bdtd.ufscar.br	0	0		
1424	chr5	110080626	110080837	3500365742	42		110080626	110080837	8421504	2	19,23	0,188	c,g	350036574200000000,350036574200000000,350036574200000001,350036574200000001	0-19,0-19,0-23,0-23		21039923	10.1111/j.1574-695X.2010.00739.x	1574-695X	FEMS Immunology & Medical Microbiology	Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs - Siva Reddy - 2010 - FEMS Immunology & Medical Microbiology - Wiley Online Library	Siva	2010	0		
1424	chr5	110080626	110080837	3500315071	42		110080626	110080837	8421504	2	19,23	0,188	c	350031507100000057,350031507100000056	0-19,0-23						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
1424	chr5	110080626	110080837	3500311390	42		110080626	110080837	8421504	2	19,23	0,188	c	350031139000000001,350031139000000000	0-19,0-23						Angiogenesis and Morphometry of Bovine Placentas in Late Gestation from Embryos Produced In Vivo or In Vitro	ww.biolreprod.org	0	0		
1424	chr5	110080626	110080837	3500248474	42		110080626	110080837	8421504	2	19,23	0,188	c	350024847400000045,350024847400000044	0-19,0-23						REPRODUCTION	uction-online.org	0	0		
1424	chr5	110080626	110080837	3500205057	42		110080626	110080837	8421504	2	19,23	0,188	c	350020505700000029,350020505700000028	0-19,0-23						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1424	chr5	110080626	110080837	3500191489	42		110080626	110080837	8421504	2	19,23	0,188	c,g	350019148900000005,350019148900000004,350019148900000004	0-19,0-23,0-23						RICARDO DE NARDI FONOFF	www.teses.usp.br	0	0		
1424	chr5	110080626	110080837	3500177864	42		110080626	110080837	8421504	2	19,23	0,188	c	350017786400000028,350017786400000027	0-19,0-23						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
1424	chr5	110080626	110080837	3500164845	42		110080626	110080837	8421504	2	19,23	0,188	c	350016484500000001,350016484500000000	0-19,0-23						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	ww.bdtd.ufscar.br	0	0		
1424	chr5	110080626	110080837	3500137197	42		110080626	110080837	8421504	2	19,23	0,188	c	350013719700000029,350013719700000028	0-19,0-23						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1424	chr5	110080626	110080837	3500136902	42		110080626	110080837	8421504	2	19,23	0,188	c,g	350013690200000023,350013690200000023,350013690200000022,350013690200000022	0-19,0-19,0-23,0-23						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
1424	chr5	110080626	110080837	3500024081	42		110080626	110080837	8421504	2	19,23	0,188	c	350002408100000039,350002408100000038	0-19,0-23						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080626	110080837	3500023326	42		110080626	110080837	8421504	2	19,23	0,188	c,g	350002332600000017,350002332600000016,350002332600000016	0-19,0-23,0-23						Title Japanese Journal of Veterinary Research, 61(3): 109-116 Issue Date 2013-08	lib.hokudai.ac.jp	0	0		
1424	chr5	110080626	110080837	3500008335	42		110080626	110080837	8421504	2	19,23	0,188	c	350000833500000003,350000833500000002	0-19,0-23						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
1424	chr5	110080626	110080836	3500056162	41		110080626	110080836	8421504	2	19,22	0,188	c,g	350005616200000017,350005616200000017,350005616200000016,350005616200000016	0-19,0-19,0-22,0-22						Universidade de S&#xe3;o Paulo Escola Superior de Agricultura &#x201c;Luiz de Queiroz&#x201d;	www.teses.usp.br	0	0		
1424	chr5	110080627	110080656	3500289121	24		110080627	110080656	8421504	2	18,6	0,23	c	350028912100000003	0-24						Methods and compositions for the treatment of cirrhosis and liver fibrosis	FORTES	2012	0		
1424	chr5	110080627	110080656	3500257142	24		110080627	110080656	8421504	2	18,6	0,23	c	350025714200000003	0-24						Methods and compositions for the treatment of cirrhosis and liver fibrosis	Alonso	2012	0		
1424	chr5	110080630	110080654	3500465911	24		110080630	110080654	8421504	1	24	0	c	350046591100000004	0-24		16166269	10.1124/jpet.105.092478	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Deltamethrin, a Pyrethroid Insecticide, Is a Potent Inducer for the Activity-Dependent Gene Expression of Brain-Derived Neurotrophic Factor in Neurons	Imamura	2006	0		GAPDH
1424	chr5	110080630	110080654	3500341653	24		110080630	110080654	8421504	1	24	0	c	350034165300000010	0-24		18848628	10.1016/j.mcn.2008.08.012		Molecular and cellular neurosciences	Expression of Disabled 1 suppresses astroglial differentiation in neural stem cells	Il-Sun	2009	0		GAPDH
1424	chr5	110080630	110080654	3500201726	24		110080630	110080654	8421504	1	24	0	c	350020172600000008	0-24						A micro&#xfb02;uidic culture platform for CNS axonal injury, regeneration and transport	group.eng.uci.edu	0	0		GAPDH
1424	chr5	110080630	110080654	3500169435	24		110080630	110080654	8421504	1	24	0	c	350016943500000000	0-24			10.1186/ar1708		Arthritis Research & Therapy	Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1	MiguOtero	2005	0		GAPDH
1424	chr5	110080630	110080654	3500047098	24		110080630	110080654	8421504	1	24	0	c	350004709800000002	0-24						Methods for diagnosing and treating huntington's disease	Abbracchio	2002	0		GAPDH
1424	chr5	110080635	110083331	3500198876	40		110080635	110083331	8421504	2	20,20	0,2676	c	350019887600000031,350019887600000030	0-20,0-20		22085910	10.1186/1471-2415-11-33	1471-2415	BMC Ophthalmology	DPOFA, a Cl-/HCO3 - exchanger antagonist, stimulates fluid absorption across basolateral surface of the retinal pigment epithelium	Iserovich	2011	1		
1424	chr5	110080635	110080659	3500318770	24		110080635	110080659	8421504	1	24	0	c	350031877000000003	1-25		18316583	10.1158/1078-0432.CCR-07-0952	1078-0432	Clinical Cancer Research	Insulin-like Growth Factor-I Receptor Signaling Pathway Induces Resistance to the Apoptotic Activities of SCH66336 (Lonafarnib) through Akt/Mammalian Target of Rapamycin&#x2013;Mediated Increases in Survivin Expression	Oh	2008	8		
1424	chr5	110080635	110080659	3500283251	24		110080635	110080659	8421504	1	24	0	c	350028325100000005	1-25						A ginseng saponin metabolite suppresses tumor necrosis factor-&#x03b1; promoted metastasis by suppressing nuclear factor- B signaling in murine colon cancer cells	-publications.com	0	0		
1424	chr5	110080635	110080659	3500177059	24		110080635	110080659	8421504	1	24	0	c	350017705900000013	1-25		17121915	10.1158/1535-7163.MCT-06-0142	1535-7163	Molecular Cancer Therapeutics	Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor&#x2013;independent urokinase-type plasminogen activator inhibition	Oh	2006	5		
1424	chr5	110080636	110080802	3500200680	39		110080636	110080802	8421504	3	19,11,9	0,54,157	c	350020068000000001,350020068000000000	0-19,0-20		23385523	10.1038/mtna.2012.61		Molecular Therapy. Nucleic Acids	Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis	Laurie	2013	0		
1424	chr5	110080636	110080659	3500025508	23		110080636	110080659	8421504	1	23	0	c	350002550800000003	2-25						IJC	ww.snupharm.ac.kr	0	0		
1424	chr5	110080637	110080697	3500079132	60		110080637	110080697	8421504	1	60	0	p	350007913200015033	0-60					Patent	Expression-regulating sequences and expression products in field of filamentous fungi chrysosporium (Patent CN:100420753)	Bi De *Yang *Peng Te 	2008	0		GAPDH
1424	chr5	110080638	110081240	3500450948	42		110080638	110081240	8421504	3	21,4,17	0,463,585	c	350045094800000001,350045094800000000	0-21,0-21						METHOD FOR FORMATION OF RENAL TUBULES	Zink	2009	0		GAPDH
1424	chr5	110080638	110080663	3500318471	25		110080638	110080663	8421504	1	25	0	c	350031847100000016	0-25						modification of the aldehyde dehydrogenase ALDH3B1 Issue Date 2013-08	lib.hokudai.ac.jp	0	0		
1424	chr5	110080638	110080662	3500246327	24		110080638	110080662	8421504	1	24	0	c	350024632700000009	0-24						Induction of adipose-derived stem cell into motoneuron-like cells using selegiline as preinducer	uploadtak.com	0	0		
1424	chr5	110080638	110080662	3500173956	24		110080638	110080662	8421504	1	24	0	c	350017395600000006	0-24						Trans-differentiation of the Adipose Tissue-Derived Stem Cells into Neuron-Like Cells Expressing Neurotrophins by Selegiline	ibj.pasteur.ac.ir	0	0		
1424	chr5	110080639	110083337	3500002182	40		110080639	110083337	8421504	2	20,20	0,2678	c	350000218200000007,350000218200000014	0-20,0-20		10720953	10.1046/j.1523-1755.2000.00928.x	0085-2538	Kidney International	Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy	Wang	2000	7		
1424	chr5	110080639	110080666	3500017030	27		110080639	110080666	8421504	1	27	0	c	350001703000000004	0-27		14612494		0008-5472	Cancer Research	Developmental Arrest of Angioblastic Lineage Initiates Tumorigenesis in von Hippel-Lindau Disease	Vortmeyer	2003	8		
1424	chr5	110080639	110080662	3500384731	23		110080639	110080662	8421504	1	23	0	c	350038473100000012	0-23						Influence of adipose tissue derived mesenchymal stem cells in combination with injectable bone substitute on osteoclastogenesis in osteoporotic rats	japsonline.com	0	0		
1424	chr5	110080639	110080662	3500220343	23		110080639	110080662	8421504	1	23	0	c	350022034300000002	0-23		23899187	10.1186/1423-0127-20-52	1423-0127	Journal of Biomedical Science	Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer	Han	2013	0		
1424	chr5	110080639	110080662	3500184546	23		110080639	110080662	8421504	1	23	0	c	350018454600000000	0-23						Research Paper Interleukin-11 Promotes the Progress of Gastric Carcinoma via Abnormally Expressed Versican	www.ijbs.com	0	0		
1424	chr5	110080639	110080662	3500155431	23		110080639	110080662	8421504	1	23	0	c	350015543100000000	0-23						Conferences, Proceedings, Journals, Open Access Journals, SCIRP	file.scirp.org	0	0		GUCY2F
1424	chr5	110080639	110080662	3500056761	23		110080639	110080662	8421504	1	23	0	c	350005676100000000	0-23						ScienceDirect.com - Vascular Pharmacology - Suppression of endothelial cell adhesion by XJP-1, a new phenolic compound derived from banana peel	sciencedirect.com	0	0		TRIP4
1424	chr5	110080641	110081242	3500442370	49		110080641	110081242	8421504	3	25,5,19	0,459,582	c	350044237000000010,350044237000000011	0-25,0-24				0022-1317	Journal of General Virology	Deletion or substitution of the aphthovirus 3&#x2032; NCR abrogates infectivity and virus replication	Saiz	2001	3		
1424	chr5	110080641	110081029	3500338377	40		110080641	110081029	8421504	3	21,4,15	0,264,373	c	350033837700000011,350033837700000010	0-21,0-19					Journal of Virology	CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection	Hassan	1998	0		
1424	chr5	110080641	110080666	3500364222	25		110080641	110080666	8421504	1	25	0	c	350036422200000007	0-25			10.1099/vir.0.18668-0	0022-1317	Journal of General Virology	Stable expression of antisense RNAs targeted to the 5&#x2032; non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection	Rosas	2003	3		
1424	chr5	110080642	110080884	3500173619	41		110080642	110080884	8421504	2	21,20	0,222	c	350017361900000009,350017361900000008	0-21,0-20						Acta Veterinaria Scandinavica BioMed Central	.actavetscand.com	0	0		
1424	chr5	110080642	110080668	3500211356	26		110080642	110080668	8421504	1	26	0	c	350021135600000002	0-26						Isoform-Specific Regulation of Adenylyl Cyclase Function by Disruption of Membrane Trafficking 2005&#x5e74;&#x7b2c;67&#x5377;&#x7b2c;2&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		BAAT
1424	chr5	110080643	110081240	3500340698	43		110080643	110081240	8421504	3	22,4,17	0,458,580	c	350034069800000074,350034069800000073	0-22,0-21						METHODS OF TREATMENT USING SIRT MODULATORS AND COMPOSITIONS CONTAINING SIRT1 MODULATORS	Farmer	2008	0		GAPDH
1424	chr5	110080643	110081240	3500099342	43		110080643	110081240	8421504	3	22,4,17	0,458,580	c	350009934200000053,350009934200000052	0-22,0-21		17954559	10.1128/MCB.00992-07	0270-7306	Molecular and Cellular Biology	Identification of a Domain within Peroxisome Proliferator-Activated Receptor &#x03b3; Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in Adipocytes	Wang	2008	6		
1424	chr5	110080643	110081078	3500365089	45		110080643	110081078	8421504	2	21,24	0,411	c	350036508900000004,350036508900000019	0-21,0-24						&#x718a;&#x672c;&#x5927;&#x5b66;&#x5b66;&#x8853;&#x30ea;&#x30dd;&#x30b8;&#x30c8;&#x30ea; Kumamoto University Repository System	.kumamoto-u.ac.jp	0	0		GAPDH
1424	chr5	110080644	110081233	3500388427	39		110080644	110081233	8421504	3	20,9,10	0,452,579	c	350038842700000009,350038842700000008	0-20,0-19						MT1G Hypermethylation Is Associated with Higher Tumor Stage in Prostate Cancer	.aacrjournals.org	0	0		GAPDH
1424	chr5	110080644	110080668	3500083049	24		110080644	110080668	8421504	1	24	0	c	350008304900000005	0-24		16551680	10.1189/jlb.0805468	0741-5400	Journal of Leukocyte Biology	Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver	Khandoga	2006	5		GAPDH
1424	chr5	110080646	110080670	3500464695	24		110080646	110080670	8421504	1	24	0	c	350046469500000007	0-24			10.1128/MCB.22.7.2099-2110.2002		Molecular and Cellular Biology	Convergence of Multiple Signaling Cascades at Glycogen Synthase Kinase 3: Edg Receptor-Mediated Phosphorylation and Inactivation by Lysophosphatidic Acid through a Protein Kinase C-Dependent Intracellular Pathway	Xianjun	2002	0		GAPDH
1424	chr5	110080646	110080670	3500308056	24		110080646	110080670	8421504	1	24	0	c	350030805600000003	0-24						Lysophosphatidic Acid as a Target for Molecular Diagnosis and Therapy of Ovarian Cancer	phd.sote.hu	0	0		FRMD5,GAPDH
1424	chr5	110080646	110080670	3500286415	24		110080646	110080670	8421504	1	24	0	c	350028641500000003	0-24		14506139		1078-0432	Clinical Cancer Research	Role of Decreased Levels of Lipid Phosphate Phosphatase-1 in Accumulation of Lysophosphatidic Acid in Ovarian Cancer	Tanyi	2003	8		GAPDH
1424	chr5	110080646	110080670	3500234191	24		110080646	110080670	8421504	1	24	0	c	350023419100000003	0-24						A lizofoszfatidil sav potenci&#xe1;lis szerepe ov&#xe1;rium tumorok molekul&#xe1;ris diagn&#xf3;zis&#xe1;ban &#xe9;s kezel&#xe9;s&#xe9;ben	phd.sote.hu	0	0		GAPDH
1424	chr5	110080646	110080670	3500147865	24		110080646	110080670	8421504	1	24	0	c	350014786500000005	0-24		12615725		0008-5472	Cancer Research	The Human Lipid Phosphate Phosphatase-3 Decreases the Growth, Survival, and Tumorigenesis of Ovarian Cancer Cells	Tanyi	2003	8		GAPDH
1424	chr5	110080646	110080670	3500104973	24		110080646	110080670	8421504	1	24	0	c	350010497300000003	25-49						 <HTML> <HEAD> <TITLE> The Human Lipid Phosphate Phosphatase-3 Decreases the G	.aacrjournals.org	0	0		FRMD5,GAPDH
1424	chr5	110080647	110081041	3500398906	42		110080647	110081041	8421504	2	20,22	0,372	c	350039890600000015,350039890600000014	0-20,0-22						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
1424	chr5	110080647	110081041	3500140406	42		110080647	110081041	8421504	2	20,22	0,372	c	350014040600000007,350014040600000006	0-20,0-22						Suppression of ovarian secretions before puberty strongly affects mammogenesis in the goat. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080647	110081041	3500040185	42		110080647	110081041	8421504	2	20,22	0,372	c	350004018500000003,350004018500000002	0-20,0-22						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
1424	chr5	110080669	110080693	3500151231	24		110080669	110080693	8421504	1	24	0	c	350015123100000010	0-24		12668131	10.1016/S1525-0016(02)00062-X	1525-0016	Molecular Therapy	Efficient BMP2 Gene Transfer and Bone Formation of Mesenchymal Stem Cells by a Fiber-Mutant Adenoviral Vector	Tsuda	2003	7		
1424	chr5	110080669	110080693	3500111781	24		110080669	110080693	8421504	1	24	0	c	350011178100000002	0-24						Method for preparing peritoneal dialysate	Miyata	2005	0		
1424	chr5	110080669	110080693	3500091637	24		110080669	110080693	8421504	1	24	0	c	350009163700000008,350009163700000002	0-24,0-24						US Patent # 6,919,326. Carbonyl-stress improving agent and peritoneal dialysate - Patents.com	www.patents.com	0	0		
1424	chr5	110080671	110080694	3500213984	23		110080671	110080694	8421504	1	23	0	c	350021398400000005	0-23					Patent	Endometriosis-specific secretory protein (Patent US:6531277)	Timms	2003	0		GAPDH
1424	chr5	110080671	110080694	3500096455	23		110080671	110080694	8421504	1	23	0	c	350009645500000005	0-23						US Patent # 6,531,277. Endometriosis-specific secretory protein - Patents.com	www.patents.com	0	0		GAPDH
1424	chr5	110080674	110080810	3500465085	42		110080674	110080810	8421504	3	22,3,17	0,24,119	c	350046508500000002,350046508500000000	0-22,0-20			10.1002/art.22300	1529-0131	Arthritis & Rheumatism	Isolation and chondroinduction of a dermis-isolated, aggrecan-sensitive subpopulation with high chondrogenic potential - Deng - 2006 - Arthritis & Rheumatism - Wiley Online Library	Deng	2007	0		
1424	chr5	110080674	110080810	3500096061	42		110080674	110080810	8421504	3	22,3,17	0,24,119	c,g	350009606100000014,350009606100000014,350009606100000002,350009606100000002,350009606100000000,350009606100000012	0-22,0-22,0-22,0-22,0-20,0-20						Dermis-Derived Cells for Tissue Engineering Applications - Patent application	www.faqs.org	0	0		
1424	chr5	110080675	110080873	3500287387	38		110080675	110080873	8421504	2	19,19	0,179	c	350028738700000003,350028738700000002	0-19,0-19		21693577	10.1242/jcs.084558	0021-9533	Journal of Cell Science	TGFB1 disrupts the angiogenic potential of microvascular endothelial cells of the corpus luteum	Maroni	2011	6		
1424	chr5	110080675	110080797	3500302916	27		110080675	110080797	8421504	3	6,17,4	0,9,118	c	350030291600000008	4-31			10.1046/j.1365-3083.2003.01212.x	1365-3083	Scandinavian Journal of Immunology	Indoleamine 2,3-Dioxygenase Expression in Patients with Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation and in Pregnant Women: Association with the Induction of Allogeneic Immune Tolerance? - Steckel - 2003 - Scandinavian Journa	Steckel	2003	0		
1424	chr5	110080675	110080797	3500025903	30		110080675	110080797	8421504	2	26,4	0,118	c	350002590300000022	4-34						Entwicklungen von PCR-Methoden zur sensitiven Quantifizierung des mit der chronisch myeloischen Leuk&#xe4;mie assoziierten BCR/ABL-Fusionstranskriptes	eb.uni-giessen.de	0	0		
1424	chr5	110080676	110080700	3500358800	24		110080676	110080700	8421504	1	24	0	c	350035880000000011	0-24						Gastroenterology World Journal of	www.wjgnet.com	0	0		
1424	chr5	110080676	110080700	3500151256	24		110080676	110080700	8421504	1	24	0	c	350015125600000011	0-24						Gastroenterology World Journal of	www.wjgnet.com	0	0		
1424	chr5	110080678	110080797	3500213609	27		110080678	110080797	8421504	2	23,4	0,115	c	350021360900000002	0-27		19437487	10.1002/hep.22862	1527-3350	Hepatology	Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model - Zhou - 2009 - Hepatology - Wiley Online Library	Zhou	2009	0		GAPDH
1424	chr5	110080680	110083329	3500443285	38		110080680	110083329	8421504	3	21,4,13	0,113,2636	c	350044328500000027	18-101						2012-The Molecular Regulation of Telomeres and Telomerase	www.scribd.com	0	0		
1424	chr5	110080680	110080796	3500432765	24		110080680	110080796	8421504	2	21,3	0,113	c	350043276500000019,350043276500000004	0-24,0-24						Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR - Patent application	www.faqs.org	0	0		
1424	chr5	110080680	110080796	3500368001	24		110080680	110080796	8421504	2	21,3	0,113	c	350036800100000024,350036800100000005	0-24,0-24						UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		
1424	chr5	110080680	110080796	3500318349	24		110080680	110080796	8421504	2	21,3	0,113	c	350031834900000005,350031834900000023	0-24,0-24						USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS - Patent application	www.faqs.org	0	0		
1424	chr5	110080680	110080796	3500299313	24		110080680	110080796	8421504	2	21,3	0,113	c	350029931300000019,350029931300000004	0-24,0-24						Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR - Patent application	www.faqs.org	0	0		
1424	chr5	110080680	110080796	3500272404	24		110080680	110080796	8421504	2	21,3	0,113	c	350027240400000005	0-24		19336521	10.1158/1078-0432.CCR-08-3172		Clinical cancer research : an official journal of the American Association for Cancer Research	Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma	Minoru	2009	0		
1424	chr5	110080680	110080796	3500246879	24		110080680	110080796	8421504	2	21,3	0,113	c	350024687900000003	0-24						 - Patent WO/2010/096734	www.sumobrain.com	0	0		GAPDH
1424	chr5	110080680	110080796	3500231590	24		110080680	110080796	8421504	2	21,3	0,113	c	350023159000000008	0-24						USE OF CCR9, CCL25/TECK, AND INTEGRIN ALPHA4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE	Hoon	2010	0		
1424	chr5	110080680	110080796	3500187827	24		110080680	110080796	8421504	2	21,3	0,113	c	350018782700000017,350018782700000008	0-24,0-24						USE OF CCR9, CCL25/TECK, AND INTEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE - Patent application	www.faqs.org	0	0		
1424	chr5	110080680	110080796	3500057728	24		110080680	110080796	8421504	2	21,3	0,113	c	350005772800000006	0-24		16278380	10.1158/1078-0432.CCR-05-0479	1078-0432	Clinical Cancer Research	X-Linked Inhibitor of Apoptosis Protein Expression Level in Colorectal Cancer Is Regulated by Hepatocyte Growth Factor/C-Met Pathway via Akt Signaling	Takeuchi	2005	8		
1424	chr5	110080680	110080796	3500048692	24		110080680	110080796	8421504	2	21,3	0,113	c	350004869200000023,350004869200000005	0-24,0-24						USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS - Patent application	www.faqs.org	0	0		
1424	chr5	110080680	110080796	3500039618	24		110080680	110080796	8421504	2	21,3	0,113	c	350003961800000004	0-24						Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr	HOON	2005	0		
1424	chr5	110080680	110080796	3500013021	24		110080680	110080796	8421504	2	21,3	0,113	c	350001302100000011,350001302100000033	0-24,0-24						UTILITY OF RET MUTANT IN DIAGNOSIS AND TREATMENT OF MELANOMA - Patent application	www.faqs.org	0	0		
1424	chr5	110080680	110080796	3500001717	24		110080680	110080796	8421504	2	21,3	0,113	c	350000171700000008	0-24						USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE	Hoon	2007	0		
1424	chr5	110080682	110080797	3500232363	23		110080682	110080797	8421504	2	19,4	0,111	c	350023236300000015	0-23		12052885	10.1128/MCB.22.13.4781-4791.2002	0270-7306	Molecular and Cellular Biology	Kinetics of a Gamma Interferon Response: Expression and Assembly of CIITA Promoter IV and Inhibition by Methylation	Morris	2002	6		
1424	chr5	110080682	110080797	3500014695	23		110080682	110080797	8421504	2	19,4	0,111	c	350001469500000015	0-23						Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080684	110083327	3500431558	40		110080684	110083327	8421504	4	17,3,1,19	0,109,836,2624	c	350043155800000003,350043155800000002	0-20,0-20						A comparative approach to somatic cell nuclear transfer in the rhesus monkey	www.ohsu.edu	0	0		GAPDH
1424	chr5	110080684	110083327	3500385423	40		110080684	110083327	8421504	4	17,3,1,19	0,109,836,2624	c	350038542300000003,350038542300000002	0-20,0-20						&#xc9c4;&#xc2e4;&#xaddc;&#xba85;&#xacfc; &#xc0ac;&#xd68c;&#xac1c;&#xd601;&#xc744; &#xc704;&#xd55c; &#xad6d;&#xbbfc;&#xbaa8;&#xc784;...&#xbbfc;&#xcd08;&#xb9ac;	minchori.org	0	0		GAPDH
1424	chr5	110080685	110080802	3500433401	25		110080685	110080802	8421504	2	16,9	0,108	c	350043340100000005	0-25		16837625	10.1124/mol.106.023796	1521-0111 (Online)	Molecular Pharmacology	In Vivo Activation of Human Pregnane X Receptor Tightens the Blood-Brain Barrier to Methadone through P-Glycoprotein Up-Regulation	Bauer	2006	0		
1424	chr5	110080685	110080802	3500216414	25		110080685	110080802	8421504	2	16,9	0,108	c	350021641400000001	0-25		17251577	10.1099/vir.0.82427-0	0022-1317	Journal of General Virology	Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3	Sawatsky	2007	3		
1424	chr5	110080685	110080802	3500010346	25		110080685	110080802	8421504	2	16,9	0,108	c	350001034600000001	0-25		17251577	10.1099/vir.0.82427-0	0022-1317	Journal of General Virology	Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3	Sawatsky	2007	3		
1424	chr5	110080690	110081266	3500355494	39		110080690	110081266	8421504	3	11,9,19	0,103,557	c,g	350035549400000003,350035549400000002,350035549400000002	0-20,0-19,0-19		11861755		0021-9533	Journal of Cell Science	Sites of Ca2+ wave initiation move with caveolae to the trailing edge of migrating cells	Isshiki	2002	6		
1424	chr5	110080697	110080812	3500454803	23		110080697	110080812	8421504	2	4,19	0,96	c	350045480300000001	0-23						RESEARCH Open Access Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF- B-dependent a by preventing RelA from binding its cognate	-inflammation.com	0	0		
1424	chr5	110080697	110080812	3500296001	23		110080697	110080812	8421504	2	4,19	0,96	c	350029600100000002	0-23						ABSTRACT	tory.lib.ncsu.edu	0	0		
1424	chr5	110080697	110080812	3500123243	23		110080697	110080812	8421504	2	4,19	0,96	c	350012324300000015	0-23		21422173	10.1128/IAI.00133-11	0019-9567	Infection and Immunity	Role of Fibronectin-Binding Proteins A and B in In Vitro Cellular Infections and In Vivo Septic Infections by Staphylococcus aureus	Shinji	2011	4		
1424	chr5	110080697	110080812	3500070459	23		110080697	110080812	8421504	2	4,19	0,96	c	350007045900000001	0-23		21138578	10.1186/1476-9255-7-59		Journal of Inflammation (London, England)	Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-&#x03ba;B-dependent transcription of TNF-&#x03b1; and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA	AkinbolaO	2010	0		
1424	chr5	110080697	110080812	3500049713	23		110080697	110080812	8421504	2	4,19	0,96	c	350004971300000015	0-23		21422173	10.1128/IAI.00133-11		Infection and Immunity	Role of Fibronectin-Binding Proteins A and B in In Vitro Cellular Infections and In Vivo Septic Infections by Staphylococcus aureus 	Hitomi	June	0		
1424	chr5	110080698	110080814	3500245941	24		110080698	110080814	8421504	2	3,21	0,95	c	350024594100000014,350024594100000006	0-24,0-24						COMPOUNDS FOR TREATMENTS OF INFLAMMATION - Patent application	www.faqs.org	0	0		
1424	chr5	110080698	110080813	3500415414	23		110080698	110080813	8421504	2	3,20	0,95	c	350041541400000000	0-23		12746297	10.1210/en.2002-0106	0013-7227	Endocrinology	Microarray and Suppression Subtractive Hybridization Analyses of Gene Expression in Pheochromocytoma Cells Reveal Pleiotropic Effects of Pituitary Adenylate Cyclase-Activating Polypeptide on Cell Proliferation, Survival, and Adhesion	Grumolato	2003	4		
1424	chr5	110080698	110080813	3500363518	23		110080698	110080813	8421504	2	3,20	0,95	c	350036351800000008	0-23						i>>?<?xml version="1.0" encoding="UTF-8" standalone="yes"?> <results> <page pageNumber="1"> <parag	www.nature.com	0	0		
1424	chr5	110080698	110080813	3500355536	23		110080698	110080813	8421504	2	3,20	0,95	c	350035553600000000	0-23						Interleukin-6 activates arginine vasopressin neurons in the supraoptic nucleus during immune challenge in rats	g.library.pcc.edu	0	0		
1424	chr5	110080698	110080813	3500353143	23		110080698	110080813	8421504	2	3,20	0,95	c	350035314300000016	0-23		21280160	10.1002/stem.554	1549-4918	STEM CELLS	Sox1 Maintains the Undifferentiated State of Cortical Neural Progenitor Cells via the Suppression of Prox1-Mediated Cell Cycle Exit and Neurogenesis - Elkouris - 2011 - STEM CELLS - Wiley Online Library	Elkouris	2011	0		
1424	chr5	110080700	110080816	3500449915	24		110080700	110080816	8421504	2	1,23	0,93	c	350044991500000029	0-24						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080814	110080837	3500124495	23		110080814	110080837	8421504	1	23	0	c	350012449500000012	1-24						The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080814	110080837	3500062286	23		110080814	110080837	8421504	1	23	0	c,g	350006228600000000,350006228600000000	0-23,0-23						Inhibin removes the inhibitory effects of activin on steroid enzyme expression and androgen production by normal ovarian thecal cells	logy-journals.org	0	0		
1424	chr5	110080815	110080839	3500454125	24		110080815	110080839	8421504	1	24	0	c	350045412500000002	0-24						Pulse Drug Nebulization Systems, Formulations Therefore, And Methods Of Use 	freshpatents.com	0	0		
1424	chr5	110080815	110080839	3500018983	24		110080815	110080839	8421504	1	24	0	c	350001898300000002	0-24						PULSE DRUG NEBULIZATION SYSTEMS, FORMULATIONS THEREFORE, AND METHODS OF USE	Kraft	2007	0		
1424	chr5	110080825	110080875	3500385614	42		110080825	110080875	8421504	2	19,23	0,27	c	350038561400000004,350038561400000005	0-19,0-23		19506300	10.1182/blood-2009-01-199166		Blood	Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells	Esther	2009	0		
1424	chr5	110080825	110080875	3500340694	42		110080825	110080875	8421504	2	19,23	0,27	c	350034069400000012,350034069400000013	17-36,0-23						Emprego da RT-PCR em tempo real para a quantifica&#xe7;&#xe3;o da express&#xe3;o de genes associados &#xe0; resposta imune em bezerros bovinos experimentalmente infectados por N caninum	pt.scribd.com	0	0		
1424	chr5	110080825	110080875	3500026318	42		110080825	110080875	8421504	2	19,23	0,27	c,g	350002631800000004,350002631800000005,350002631800000005	0-19,0-23,0-23						Expressionofvascularendothelialgrowthfactoriscoordinatelyregulatedbythe activin-likekinasereceptors1and5inendothelialcells	tologylibrary.org	0	0		
1424	chr5	110080826	110080851	3500227537	25		110080826	110080851	8421504	1	25	0	c	350022753700000005	0-25						Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-&#x03ba;B signaling pathways	www.cst-c.com.cn	0	0		
1424	chr5	110080827	110080851	3500466734	24		110080827	110080851	8421504	1	24	0	c	350046673400000007	0-24			10.1002/dvdy.1169	1097-0177	Developmental Dynamics	Localization of Lutheran, a novel laminin receptor, in normal, knockout, and transgenic mice suggests an interaction with laminin &#x03b1;5 in vivo - Moulson - 2001 - Developmental Dynamics - Wiley Online Library	Moulson	2001	0		
1424	chr5	110080828	110081303	3500285320	51		110080828	110081303	8421504	2	23,28	0,447	c	350028532000000005,350028532000000004	0-23,0-28		22508491	10.1038/mt.2012.68	1525-0016	Molecular Therapy	RNA Interference Inhibits DUX4-induced Muscle Toxicity In Vivo: Implications for a Targeted FSHD Therapy	Wallace	2012	7		
1424	chr5	110080828	110080882	3500027621	54		110080828	110080882	8421504	1	54	0	p	350002762100015021	6-60						TEREZA CRISTINA VIEIRA de REZENDE	itorio.bce.unb.br	0	0		GAPDH
1424	chr5	110080848	110081303	3500352626	42		110080848	110081303	8421504	2	19,23	0,432	c	350035262600000007,350035262600000006	0-19,0-23		15483264	10.1099/vir.0.80110-0	0022-1317	Journal of General Virology	Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection	Booth	2004	3		
1424	chr5	110080856	110081291	3500432905	40		110080856	110081291	8421504	2	20,20	0,415	c	350043290500000009,350043290500000008	0-20,0-20		23537346	10.1186/1297-9716-44-21	1297-9716	Veterinary Research	Bovine HEXIM1 inhibits bovine immunodeficiency virus replication through regulating BTat-mediated transactivation	Guo	2013	0		
1424	chr5	110080862	110081319	3500314547	40		110080862	110081319	8421504	2	20,20	0,437	c	350031454700000007,350031454700000006	0-20,0-20						Cartilage Regeneration Using a Fibrin and Autologous Cultured Chondrocytes Mixture in a Canine Model	w.omicsonline.org	0	0		
1424	chr5	110080862	110081319	3500135529	40		110080862	110081319	8421504	2	20,20	0,437	c	350013552900000007,350013552900000006	0-20,0-20						Cartilage Regeneration Using a Fibrin and Autologous Cultured Chondrocytes Mixture in a Canine Model	w.omicsonline.org	0	0		
1424	chr5	110080863	110081311	3500168277	40		110080863	110081311	8421504	2	20,20	0,428	c	350016827700000005,350016827700000004	0-20,0-20						Long-term culture of primary porcine oviduct epithelial cells: Validation of a comprehensive in vitro model for reproductive science. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110080869	110080892	3500345448	23		110080869	110080892	8421504	1	23	0	c	350034544800000001	17-40						Chondrocyte intracellular calcium, cytoskeletal organization, and gene expression responses to dynamic osmotic loading	g.library.pcc.edu	0	0		
1424	chr5	110080871	110081309	3500027848	65		110080871	110081309	8421504	4	21,15,10,19	0,23,143,419	c,g	350002784800000013,350002784800000014,350002784800000012,350002784800000012	0-21,0-25,0-19,0-19						COMPOSITIONS AND METHODS FOR TREATING PULP INFLAMMATIONS CAUSED BY INFECTION OR TRAUMA	Lu	2007	0		
1424	chr5	110080884	110080909	3500279085	25		110080884	110080909	8421504	1	25	0	c	350027908500000006	8-33						Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) negatively regulates the replication of Bamboo mosaic virus and its associated satellite RNA	jvi.asm.org	0	0		
1424	chr5	110080894	110081475	3500354445	40		110080894	110081475	8421504	3	15,5,20	0,120,561	c	350035444500000025,350035444500000024	0-20,0-20						Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)	B	2007	0		
1424	chr5	110080894	110081023	3500361357	24		110080894	110081023	8421504	2	15,9	0,120	c	350036135700000005	0-24		23846223	10.1038/cddis.2013.247	false	Cell Death & Disease	The role of thioredoxin 1 in the mycophenolic acid-induced apoptosis of insulin-producing cells	Huh	2013	0		
1424	chr5	110080900	110081239	3500399151	40		110080900	110081239	8421504	4	9,11,4,16	0,114,201,323	c	350039915100000003,350039915100000002	0-20,0-20					Translational Oncology	KGF Promotes Paracrine Activation of the SCF/c-KIT Axis from Human Keratinocytes to Melanoma Cells	Francesca	2010	0		
1424	chr5	110080901	110081030	3500266457	24		110080901	110081030	8421504	2	8,16	0,113	c	350026645700000014	0-24		20086099	10.1128/MCB.01335-09		Molecular and Cellular Biology	14-3-3&#x03c4; Regulates Ubiquitin-Independent Proteasomal Degradation of p21, a Novel Mechanism of p21 Downregulation in Breast Cancer 	Bing	2010	0		
1424	chr5	110080901	110081030	3500150343	24		110080901	110081030	8421504	2	8,16	0,113	c	350015034300000019	0-24		15075294	10.1101/gad.1180204	0890-9369	Genes & Development	TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival	Liu	2004	12		
1424	chr5	110080901	110081030	3500115594	24		110080901	110081030	8421504	2	8,16	0,113	c	350011559400000041	0-24		19289498	10.1128/MCB.01140-08		Molecular and Cellular Biology	Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer 	Kang	2009	0		
1424	chr5	110080904	110081034	3500360878	25		110080904	110081034	8421504	2	5,20	0,110	c	350036087800000015	0-25		19587222	10.1152/ajpcell.00069.2009		American Journal of Physiology - Cell Physiolog	PPAR&#x03b4;-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells	Sue	2009	0		
1424	chr5	110080904	110081034	3500310223	25		110080904	110081034	8421504	2	5,20	0,110	c	350031022300000004	0-25						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		
1424	chr5	110080904	110081034	3500218636	25		110080904	110081034	8421504	2	5,20	0,110	c	350021863600000015	0-25		19587222	10.1152/ajpcell.00069.2009		American Journal of Physiology - Cell Physiolog	PPAR&#x03b4;-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells	Sue	2009	0		
1424	chr5	110080904	110081034	3500194455	25		110080904	110081034	8421504	2	5,20	0,110	c	350019445500000015	0-25		19587222	10.1152/ajpcell.00069.2009		American Journal of Physiology - Cell Physiology	PPAR&#x03b4;-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells	Sue	2009	0		
1424	chr5	110080904	110081034	3500180540	25		110080904	110081034	8421504	2	5,20	0,110	c	350018054000000002	0-25		18230756	10.1182/blood-2007-03-080309	0006-4971	Blood	EBV LMP2A affects LMP1-mediated NF-&#x03ba;B signaling and survival of lymphoma cells by regulating TRAF2 expression	Guasparri	2008	10		
1424	chr5	110080905	110081034	3500427434	24		110080905	110081034	8421504	2	4,20	0,109	c	350042743400000003	0-24		16227238	10.1099/vir.0.81045-0	0022-1317	Journal of General Virology	Trypsin is associated with the rotavirus capsid and is activated by solubilization of outer capsid proteins	Benureau	2005	3		
1424	chr5	110080905	110081034	3500147289	24		110080905	110081034	8421504	2	4,20	0,109	c	350014728900000009	0-24		21228236	10.1128/JVI.01631-10	0022-538X	Journal of Virology	Rotavirus Replication Requires a Functional Proteasome for Effective Assembly of Viroplasms	Contin	2011	5		
1424	chr5	110081016	110081040	3500278064	24		110081016	110081040	8421504	1	24	0	c	350027806400000023	0-24		15572666	10.1128/MCB.24.24.10593-10610.2004	0270-7306	Molecular and Cellular Biology	PIAS-1 Is a Checkpoint Regulator Which Affects Exit from G1 and G2 by Sumoylation of p73	Munarriz	2004	6		PPM1H
1424	chr5	110081016	110081040	3500197210	24		110081016	110081040	8421504	1	24	0	c	350019721000000001	0-24						Human hematopoietic growth regulatory gene and uses	Sharma	2002	0		PPM1H
1424	chr5	110081016	110081040	3500017516	24		110081016	110081040	8421504	1	24	0	c	350001751600000001	0-24		11154219	10.1182/blood.V97.2.426	0006-4971	Blood	Human CD34+ stem cells express the hiwigene, a human homologue of the Drosophila genepiwi	Sharma	2001	10		
1424	chr5	110081016	110081040	3500015620	24		110081016	110081040	8421504	1	24	0	c	350001562000000003	0-24		21040551	10.1186/1756-9966-29-140	1756-9966	Journal of Experimental & Clinical Cancer Research	Estrogen receptor &#xce;&#xb1; (ER&#xce;&#xb1;) mediates 17&#xce;&#xb2;-estradiol (E2)-activated expression of HBO1	Wang	2010	2		
1424	chr5	110081017	110081041	3500064116	23		110081017	110081041	8421504	2	15,8	0,16	c	350006411600000009	0-25		17426247	10.1158/1541-7786.MCR-06-0218	1541-7786	Molecular Cancer Research	Inhibitor of DNA Binding 1 Activates Vascular Endothelial Growth Factor through Enhancing the Stability and Activity of Hypoxia-Inducible Factor-1&#x03b1;	Kim	2007	4		
1424	chr5	110081039	110081449	3500136244	68		110081039	110081449	8421504	4	22,24,1,21	0,42,184,389	c	350013624400000007,350013624400000008,350013624400000006	0-22,0-25,0-21						ScienceDirect.com - Theriogenology - Gene expression of leukemia inhibitory factor (LIF) and macrophage colony stimulating factor (M-CSF) in bovine endometrium during early pregnancy	sciencedirect.com	0	0		
1424	chr5	110081048	110081294	3500436969	43		110081048	110081294	8421504	2	23,20	0,226	c	350043696900000005,350043696900000004	0-23,0-20		21726209	10.1111/j.1476-5381.2011.01575.x	1476-5381	British Journal of Pharmacology	Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage - Chen - 2011 - British Journal of Pharmacology - Wiley Online Library	Chen	2012	0		
1424	chr5	110081048	110081071	3500249892	23		110081048	110081071	8421504	1	23	0	c	350024989200000010	0-23		20396675	10.1155/2010/326909	1110-7243	BioMed Research International	L6E9 Myoblasts Are Deficient of Myostatin and Additional TGF-<svg style="vertical-align:-3.294pt;width:12.6375px;" id="M1" height="19.200001" version="1.1" viewBox="0 0 12.6375 19.200001" width="12.6375" xmlns="http://www.w3.org/2000/svg"> <g transform="m	Rossi	2010	2		
1424	chr5	110081049	110081329	3500090022	44		110081049	110081329	8421504	2	22,22	0,258	c	350009002200000007,350009002200000006	0-22,0-22						Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Calcineurin/Nfatc3 Pathway	www.ijbs.com	0	0		
1424	chr5	110081052	110081246	3500324863	44		110081052	110081246	8421504	2	24,20	0,174	c	350032486300000005,350032486300000004	0-24,0-20		20950427	10.1186/1477-7827-8-120		Reproductive Biology and Endocrinology : RB&E	Transforming growth factor beta family expression at the bovine feto-maternal interface	Kumiko	2010	0		
1424	chr5	110081052	110081246	3500233640	70		110081052	110081246	8421504	4	24,25,1,20	0,28,171,174	c	350023364000000005,350023364000000006,350023364000000004	0-24,0-26,0-20						Gene silencing during development of in vitro-produced female bovine embryos	w.funpecrp.com.br	0	0		
1424	chr5	110081052	110081246	3500078470	44		110081052	110081246	8421504	2	24,20	0,174	c,g	350007847000000019,350007847000000018	0-24,0-20						Transforming growth factor beta family expression at the bovine feto-maternal interface	biomedcentral.com	0	0		
1424	chr5	110081052	110081246	3500074407	70		110081052	110081246	8421504	4	24,25,1,20	0,28,171,174	c	350007440700000005,350007440700000006,350007440700000004	0-24,0-26,0-20						RODRIGO DA SILVA NUNES BARRETO	www.teses.usp.br	0	0		
1424	chr5	110081052	110081246	3500063060	70		110081052	110081246	8421504	4	24,25,1,20	0,28,171,174	c	350006306000000004,350006306000000005,350006306000000003	0-24,0-26,0-20						&#x03b2;-casein gene expression by in vitro cultured bovine mammary epithelial cells derived from developing mammary glands	w.funpecrp.com.br	0	0		
1424	chr5	110081052	110081246	3500011430	44		110081052	110081246	8421504	2	24,20	0,174	c,g	350001143000000005,350001143000000004,350001143000000004	0-24,0-20,0-20		23279472	10.1111/rda.12002	1439-0531	Reproduction in Domestic Animals	Canine Fibroblasts Expressing Human Transcription Factors: What is in the Route for the Production of Canine Induced Pluripotent Stem Cells - Gon&#xe7;alves - 2012 - Reproduction in Domestic Animals - Wiley Online Library	Goncalves	2012	0		
1424	chr5	110081052	110081224	3500337725	50		110081052	110081224	8421504	3	24,25,1	0,28,171	c	350033772500000007,350033772500000008	0-24,0-26						Felipe Camargo Braga TESE	www.teses.usp.br	0	0		
1424	chr5	110081052	110081224	3500237346	50		110081052	110081224	8421504	3	24,25,1	0,28,171	c	350023734600000019,350023734600000020	0-24,0-26						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
1424	chr5	110081052	110081076	3500178239	24		110081052	110081076	8421504	1	24	0	c	350017823900000007	0-24						Fetal-Maternal Interactions in the Synepitheliochorial Placenta Using the eGFP Cloned Cattle Model. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110081053	110081078	3500365761	25		110081053	110081078	8421504	1	25	0	c	350036576100000013	0-25		19620279	10.1128/MCB.00267-09	0270-7306	Molecular and Cellular Biology	SOCS1, SOCS3, and PIAS1 Promote Myogenic Differentiation by Inhibiting the Leukemia Inhibitory Factor-Induced JAK1/STAT1/STAT3 Pathway	Diao	2009	6		
1424	chr5	110081053	110081077	3500206937	24		110081053	110081077	8421504	1	24	0	c	350020693700000026	0-24						terms and conditions of use	.era.lib.ed.ac.uk	0	0		
1424	chr5	110081053	110081076	3500246246	23		110081053	110081076	8421504	1	23	0	c	350024624600000002	0-23		18006838	10.1158/0008-5472.CAN-07-1121	0008-5472	Cancer Research	Transient Receptor Potential Melastatin 7&#x2013;like Current in Human Head and Neck Carcinoma Cells: Role in Cell Proliferation	Jiang	2007	8		
1424	chr5	110081054	110083338	3500119125	45		110081054	110083338	8421504	2	24,21	0,2263	c	350011912500000027,350011912500000022	0-24,0-21						Novel &#xfffd;-catenin target genes identified in thalamic neurons encode modulators of neuronal excitability	biomedcentral.com	0	0		
1424	chr5	110081054	110081079	3500454191	25		110081054	110081079	8421504	1	25	0	c	350045419100000005	0-25		10645910			American Journal of Physiology - Lung Cellular and Molecular Physiology	Vascular expression of the &#x03b1;v&#x03b2;3-integrin in lung and other organs	Singh	2000	0		
1424	chr5	110081054	110081079	3500443989	25		110081054	110081079	8421504	1	25	0	c	350044398900000004	0-25		12771574	10.1097/01.WCB.0000059566.39780.8D	0271-678X	Journal of Cerebral Blood Flow & Metabolism	Mild Hypothermia Inhibits Nuclear Factor-&kgr;B Translocation in Experimental Stroke	Han	2003	5		
1424	chr5	110081054	110081079	3500286550	25		110081054	110081079	8421504	1	25	0	c	350028655000000005	0-25		10645910			American Journal of Physiology - Lung Cellular and Molecular Physiology	Vascular expression of the &#x03b1;v&#x03b2;3-integrin in lung and other organs	Singh	2000	0		
1424	chr5	110081054	110081079	3500124383	25		110081054	110081079	8421504	1	25	0	c	350012438300000007	0-25		9488390		0019-9567	Infection and Immunity	Protective Role of Nitric Oxide inStaphylococcus aureus Infection in Mice	Sasaki	1998	4		
1424	chr5	110081054	110081079	3500122356	25		110081054	110081079	8421504	1	25	0	c	350012235600000013	0-25						In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110081054	110081079	3500074048	25		110081054	110081079	8421504	1	25	0	c	350007404800000003	0-25						&#xb0b4;&#xb3c5;&#xc18c;&#xb85c; &#xd65c;&#xc131;&#xd654;&#xb41c; &#xb1cc;&#xc18c;&#xad50;&#xc138;&#xd3ec;&#xc758; &#xc720;&#xc804;&#xc790; &#xbc1c;&#xd604;&#xc5d0; &#xb300;&#xd55c; &#xc720;&#xc804;&#xc790;&#xce69;&#xbd84;&#xc11d;	bbs.neuro.or.kr	0	0		
1424	chr5	110081057	110081294	3500382906	41		110081057	110081294	8421504	2	22,19	0,218	c,g	350038290600000015,350038290600000014,350038290600000014	0-22,0-19,0-19						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
1424	chr5	110081057	110081294	3500143893	41		110081057	110081294	8421504	2	22,19	0,218	c,g	350014389300000015,350014389300000014,350014389300000014	0-22,0-19,0-19						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
1424	chr5	110081057	110081294	3500060499	41		110081057	110081294	8421504	2	22,19	0,218	c	350006049900000011,350006049900000010	0-22,0-19		23072335	10.1186/1471-2156-13-86	1471-2156	BMC Genetics	Gene number determination and genetic polymorphism of the gamma delta T cell co-receptor WC1 genes	Chen	2012	2		
1424	chr5	110081057	110081081	3500440773	24		110081057	110081081	8421504	1	24	0	c	350044077300000001	0-24		21297658	10.1038/aja.2010.167		Asian Journal of Andrology	Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo	Zuo-Wen	2011	0		
1424	chr5	110081057	110081081	3500404705	24		110081057	110081081	8421504	1	24	0	c,g	350040470500000001,350040470500000001	0-24,0-24		21297658	10.1038/aja.2010.167	1008-682X	Asian Journal of Andrology	Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo	Liang	2011	2		
1424	chr5	110081057	110081081	3500298495	24		110081057	110081081	8421504	1	24	0	c	350029849500000004	0-24						Knockdown of Beclin 1 inhibits vitamin K3&#x2011;induced autophagy, but promotes apoptosis of human hepatoma SMMC&#x2011;7721 cells	-publications.com	0	0		
1424	chr5	110081057	110081081	3500000136	24		110081057	110081081	8421504	1	24	0	c	350000013600000001	0-24						Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo	www.asiaandro.com	0	0		
1424	chr5	110081060	110081296	3500275246	40		110081060	110081296	8421504	2	20,20	0,216	c	350027524600000001,350027524600000000	0-20,0-20		15297438	10.1210/en.2004-0478	0013-7227	Endocrinology	Free Fatty Acids and Cytokines Induce Pancreatic &#x03b2;-Cell Apoptosis by Different Mechanisms: Role of Nuclear Factor-&#x03ba;B and Endoplasmic Reticulum Stress	Kharroubi	2004	4		
1424	chr5	110081060	110081296	3500234315	40		110081060	110081296	8421504	2	20,20	0,216	c	350023431500000001,350023431500000000	0-20,0-20		15297438	10.1210/en.2004-0478	0013-7227	Endocrinology	Free Fatty Acids and Cytokines Induce Pancreatic &#x03b2;-Cell Apoptosis by Different Mechanisms: Role of Nuclear Factor-&#x03ba;B and Endoplasmic Reticulum Stress	Kharroubi	2004	4		
1424	chr5	110081060	110081286	3500032199	41		110081060	110081286	8421504	2	20,21	0,205	c	350003219900000003,350003219900000002	0-20,0-21		19141072	10.1111/j.1471-4159.2008.05862.x	1471-4159	Journal of Neurochemistry	Signaling mechanisms of interferon gamma induced apoptosis in chromaffin cells: involvement of nNOS, iNOS, and NF&#x03ba;B - P&#xe9;rez-Rodr&#xed;guez - 2008 - Journal of Neurochemistry - Wiley Online Library	Perez-Rodriguez	2009	0		
1424	chr5	110081064	110081089	3500016159	25		110081064	110081089	8421504	1	25	0	c	350001615900000004	0-25						Catechins inhibit angiotensin II-induced vascular smooth muscle 	www.docstoc.com	0	0		
1424	chr5	110081069	110081238	3500326785	40		110081069	110081238	8421504	3	20,5,15	0,31,154	c	350032678500000005,350032678500000004	0-20,0-20			10.1128/IAI.71.11.6411-6419.2003		Infection and Immunity	Revaccination of Neonatal Calves with Mycobacterium bovis BCG Reduces the Level of Protection against Bovine Tuberculosis Induced by a Single Vaccination 	B.	2003	0		
1424	chr5	110081069	110081238	3500197219	40		110081069	110081238	8421504	3	20,5,15	0,31,154	c	350019721900000003,350019721900000002	0-20,0-20		19553336	10.1128/JVI.00626-09	0022-538X	Journal of Virology	Bluetongue Virus Targets Conventional Dendritic Cells in Skin Lymph	Hemati	2009	5		
1424	chr5	110081069	110081238	3500173104	40		110081069	110081238	8421504	3	20,5,15	0,31,154	c	350017310400000013,350017310400000012	0-20,0-20		20479118	10.1084/jem.20100223	0022-1007	The Journal of Experimental Medicine	The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8&#x03b1;+ dendritic cells	Crozat	2010	14		
1424	chr5	110081069	110081238	3500117118	40		110081069	110081238	8421504	3	20,5,15	0,31,154	c	350011711800000003,350011711800000002	0-20,0-20		19553336	10.1128/JVI.00626-09		Journal of Virology	Bluetongue Virus Targets Conventional Dendritic Cells in Skin Lymph 	Behzad	2009	0		
1424	chr5	110081080	110081224	3500317947	26		110081080	110081224	8421504	2	25,1	0,143	c	350031794700000004	0-26						Breeding of transgenic cattle for human coagulation factor IX by a combination of lentiviral system and cloning. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110081080	110081224	3500074470	26		110081080	110081224	8421504	2	25,1	0,143	c	350007447000000001	0-26						L&#xcd;GIA GARCIA MESQUITA	www.teses.usp.br	0	0		
1424	chr5	110081096	110083336	3500036408	41		110081096	110083336	8421504	3	9,11,21	0,127,2219	c	350003640800000015,350003640800000218	0-20,0-21						Modulation of apolipoprotein C-III expression	Crooke	2010	0		GAPDH
1424	chr5	110081096	110081422	3500355407	47		110081096	110081422	8421504	4	9,11,26,1	0,127,208,325	c	350035540700000009,350035540700000008	0-20,0-27						&#x4e3b;&#x9898;&#xff1a;Receptor | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1424	chr5	110081096	110081288	3500443994	42		110081096	110081288	8421504	3	9,12,21	0,127,171	c	350044399400000007,350044399400000006	0-21,0-21						 SpringerImages - Oligonucleotide primers and probes used for real-time RT-PCR analysis 	pringerimages.com	0	0		
1424	chr5	110081096	110081288	3500030650	42		110081096	110081288	8421504	3	9,12,21	0,127,171	c	350003065000000007,350003065000000006	0-21,0-21						Relationship between quantity of IFNT estimated by IFN-stimulated gene expression in peripheral blood mononuclear cells and bovine embryonic mortality after AI or ET	www.rbej.com	0	0		
1424	chr5	110081096	110081242	3500302995	28		110081096	110081242	8421504	2	9,19	0,127	c	350030299500000001	0-28		18258846	10.2353/ajpath.2008.070473		The American Journal of Pathology	Integrin &#x03b1;1&#x03b2;1 Regulates Matrix Metalloproteinases via P38 Mitogen-Activated Protein Kinase in Mesangial Cells : Implications for Alport Syndrome	Dominic	2008	0		
1424	chr5	110081097	110081452	3500454953	40		110081097	110081452	8421504	3	8,12,20	0,126,335	c	350045495300000020,350045495300000019	0-20,0-20		23732709	10.1038/oncsis.2013.14	false	Oncogenesis	Acid ceramidase induces sphingosine kinase 1&sol;S1P receptor 2-mediated activation of oncogenic Akt signaling	Beckham	2013	0		GAPDH
1424	chr5	110081097	110081452	3500444472	40		110081097	110081452	8421504	3	8,12,20	0,126,335	c	350044447200000007,350044447200000006	0-20,0-20		19923420	10.1152/ajpcell.00032.2009		American Journal of Physiology - Cell Physiology	Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells	Israeli	2010	0		GAPDH
1424	chr5	110081097	110081452	3500440514	40		110081097	110081452	8421504	3	8,12,20	0,126,335	c	350044051400000019,350044051400000018	0-20,0-20		15735005	10.1158/0008-5472.CAN-04-4249	0008-5472	Cancer Research	A Germline DNA Polymorphism Enhances Alternative Splicing of the KLF6 Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk	Narla	2005	8		GAPDH
1424	chr5	110081097	110081452	3500437270	40		110081097	110081452	8421504	3	8,12,20	0,126,335	c	350043727000000020,350043727000000019	0-20,0-20		23732709	10.1038/oncsis.2013.14		Oncogenesis	Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling	T	June	0		
1424	chr5	110081097	110081452	3500416192	40		110081097	110081452	8421504	3	8,12,20	0,126,335	c	350041619200000007,350041619200000006	0-20,0-20		16778100	10.1158/1078-0432.CCR-06-0054	1078-0432	Clinical Cancer Research	Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination	DiFeo	2006	8		GAPDH
1424	chr5	110081097	110081452	3500234917	40		110081097	110081452	8421504	3	8,12,20	0,126,335	c	350023491700000007,350023491700000006	0-20,0-20		19923420	10.1152/ajpcell.00032.2009		American Journal of Physiology - Cell Physiolog	Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells	Israeli	2010	0		
1424	chr5	110081099	110081457	3500381412	40		110081099	110081457	8421504	3	6,13,21	0,124,337	c,g	350038141200000003,350038141200000002	0-19,0-21						Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus	www.virologyj.com	0	0		
1424	chr5	110081099	110081457	3500056610	40		110081099	110081457	8421504	3	6,13,21	0,124,337	c,g	350005661000000003,350005661000000002	0-19,0-21			10.1186/1743-422X-10-259	1743-422X	Virology Journal	Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus	Wahyuni	2013	2		
1424	chr5	110081099	110081294	3500038184	38		110081099	110081294	8421504	3	6,13,19	0,124,176	c,g	350003818400000035,350003818400000036,350003818400000036	0-19,0-19,0-19						Mechanisms Regulating Osteoblast Response to Surface Microtopography and Vitamin D	artech.gatech.edu	0	0		GAPDH
1424	chr5	110081099	110081246	3500299376	29		110081099	110081246	8421504	2	6,23	0,124	c	350029937600000014	0-29						Investigation of molecular mechanisms regulating the expression of cMyBP-C mutants in familial hypertrophic cardiomyopathy	ie.uni-hamburg.de	0	0		GAPDH
1424	chr5	110081100	110081242	3500424022	24		110081100	110081242	8421504	2	5,19	0,123	c	350042402200000001	0-24			10.1111/j.1471-4159.2007.04921.x	1471-4159	Journal of Neurochemistry	Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells - Fitzgerald - 2007 - Journal of Neurochemistry - Wiley Online Library	Fitzgerald	2007	0		
1424	chr5	110081100	110081242	3500405449	24		110081100	110081242	8421504	2	5,19	0,123	c	350040544900000005	1-25						HUMAN ADRENOMEDULLIN-SPECIFIC ANTIBODY, PHARMACEUTICAL COMPOSITION CONTAINING SAME, THERAPEUTIC USES THEREOF - Sanofi-synthelabo	www.sumobrain.com	0	0		
1424	chr5	110081100	110081242	3500126609	24		110081100	110081242	8421504	2	5,19	0,123	c	350012660900000004	0-24						Behavioral phenotyping, gene expression profiles, and cognitive aspects in a mouse model of trait anxiety	b.uni-muenchen.de	0	0		
1424	chr5	110081100	110081241	3500408192	23		110081100	110081241	8421504	2	5,18	0,123	c	350040819200000007	0-23						Regulation of Inhibitor of Apoptosis Expression by Nitric Oxide and Cytokines: Relation to Apoptosis Induction in Rat Mesangial Cells and RAW 264.7 Macrophages	n.asnjournals.org	0	0		GAPDH
1424	chr5	110081100	110081241	3500092476	23		110081100	110081241	8421504	2	5,18	0,123	c	350009247600000004	0-23						Mechanismen der Mastzellaktivierung durch gram-negative Bakterien und Bakterienprodukte aus der Darmflora	.uni-hohenheim.de	0	0		
1424	chr5	110081101	110083324	3500015872	44		110081101	110083324	8421504	4	4,18,6,16	0,122,414,2207	c	350001587200000013,350001587200000012	0-22,0-22		17873007	10.1152/ajplung.00121.2007		American Journal of Physiology - Lung Cellular and Molecular Physiology	Involvement of chloride channels in TGF-&#x03b2;1-induced apoptosis of human bronchial epithelial cells	Cheng	2007	0		
1424	chr5	110081101	110081300	3500160307	38		110081101	110081300	8421504	3	4,15,19	0,122,180	c,g	350016030700000007,350016030700000006,350016030700000006	0-19,0-19,0-19						Caffeine Regulates Neuronal Expression of the Dopamine 2 Receptor Gene	aspetjournals.org	0	0		
1424	chr5	110081101	110081300	3500142914	38		110081101	110081300	8421504	3	4,15,19	0,122,180	c,g	350014291400000007,350014291400000006,350014291400000006	0-19,0-19,0-19			10.1124/mol.64.6.1463	1521-0111 (Online)	Molecular Pharmacology	Caffeine Regulates Neuronal Expression of the Dopamine 2 Receptor Gene	Stonehouse	2003	0		
1424	chr5	110081102	110081311	3500003718	39		110081102	110081311	8421504	3	3,17,19	0,121,190	c	350000371800000001,350000371800000000	0-20,0-19		12117943	10.1128/IAI.70.8.4336-4343.2002	0019-9567	Infection and Immunity	Inflammatory Cytokines Enhance the Interaction of Mannheimia haemolytica Leukotoxin with Bovine Peripheral Blood Neutrophils In Vitro	Leite	2002	4		
1424	chr5	110081102	110081293	3500163669	39		110081102	110081293	8421504	3	3,17,19	0,121,172	c	350016366900000001,350016366900000000	0-20,0-19		19508430	10.1111/j.1471-4159.2009.06204.x	1471-4159	Journal of Neurochemistry	Degeneration of cultured cortical neurons following prolonged inactivation: molecular mechanisms - Schonfeld-Dado - 2009 - Journal of Neurochemistry - Wiley Online Library	Schonfeld-Dado	2009	0		
1424	chr5	110081103	110081457	3500305142	42		110081103	110081457	8421504	3	2,19,21	0,120,333	c	350030514200000007,350030514200000006	0-21,0-21						Cytotoxicity assay	tologylibrary.org	0	0		GAPDH
1424	chr5	110081103	110081457	3500294270	42		110081103	110081457	8421504	3	2,19,21	0,120,333	c,g	350029427000000001,350029427000000000	0-21,0-21		15955812	10.1074/jbc.M411253200	0021-9258	Journal of Biological Chemistry	Dual Roles of P2 Purinergic Receptors in Insulin-stimulated Leptin Production and Lipolysis in Differentiated Rat White Adipocytes	Lee	2005	5		
1424	chr5	110081103	110081457	3500134656	42		110081103	110081457	8421504	3	2,19,21	0,120,333	c	350013465600000003,350013465600000002	0-21,0-21		20089716	10.1677/JME-09-0161	0952-5041	Journal of Molecular Endocrinology	Melanocortins induce interleukin 6 gene expression and secretion through melanocortin receptors 2 and 5 in 3T3-L1 adipocytes	Jun	2010	3		GAPDH
1424	chr5	110081103	110081457	3500030922	42		110081103	110081457	8421504	3	2,19,21	0,120,333	c	350003092200000007,350003092200000006	0-21,0-21		21515746	10.1096/fj.10-178715	0892-6638	The FASEB Journal	Modulation of exosome-mediated mRNA turnover by interaction of GTP-binding protein 1 (GTPBP1) with its target mRNAs	Woo	2011	6		GAPDH
1424	chr5	110081103	110081246	3500262467	25		110081103	110081246	8421504	2	2,23	0,120	c	350026246700000002	0-25					American Journal of Physiology - Renal Physiology	Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity	Whyte	1999	0		GAPDH
1424	chr5	110081104	110081246	3500346441	24		110081104	110081246	8421504	2	1,23	0,119	c	350034644100000000	0-24		16835400	10.1152/ajpendo.00171.2006		American Journal of Physiology - Endocrinology and Metabolism	The PPAR&#x03b3; agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats	Zanchi	2006	0		GAPDH
1424	chr5	110081104	110081246	3500281025	24		110081104	110081246	8421504	2	1,23	0,119	c	350028102500000000	0-24		16835400	10.1152/ajpendo.00171.2006		American Journal of Physiology - Endocrinology and Metabolism	The PPAR&#x03b3; agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats	Zanchi	2006	0		GAPDH
1424	chr5	110081223	110081247	3500077678	24		110081223	110081247	8421504	1	24	0	c	350007767800000015	0-24						ABSTRACT	tory.lib.ncsu.edu	0	0		
1424	chr5	110081225	110081255	3500121932	25		110081225	110081255	8421504	2	15,10	0,20	c	350012193200000007	0-25		11907202	10.1128/JVI.76.8.3626-3636.2002	0022-538X	Journal of Virology	Feline Immunodeficiency Virus Xenoinfection: the Role of Chemokine Receptors and Envelope Diversity	Johnston	2002	5		
1424	chr5	110081226	110081253	3500165606	27		110081226	110081253	8421504	1	27	0	c	350016560600000000	28-55						Isolation and multilineage differentiation of bone marrow mesenchymal stem cells from abattoir-derived bovine fetuses	biomedcentral.com	0	0		
1424	chr5	110081228	110081500	3500181919	41		110081228	110081500	8421504	2	21,20	0,252	c	350018191900000003,350018191900000002	0-21,0-20		19116366	10.2353/ajpath.2009.080659		The American Journal of Pathology	A Defective SERCA1 Protein Is Responsible for Congenital Pseudomyotonia in Chianina Cattle	Roberta	2009	0		
1424	chr5	110081238	110081441	3500030805	44		110081238	110081441	8421504	3	21,3,20	0,89,183	c	350003080500000006,350003080500000005	0-21,0-23						Bone morphogenetic proteins (BMP) 2, 4, 6 and 7 affect ovarian follicular development through regulation of follicle-stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHR) expression in goat granulosa cells	demicjournals.org	0	0		
1424	chr5	110081262	110081286	3500338834	24		110081262	110081286	8421504	1	24	0	c	350033883400000009	20-44						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
1424	chr5	110081262	110081286	3500306609	24		110081262	110081286	8421504	1	24	0	c	350030660900000009	20-44						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
1424	chr5	110081266	110081449	3500432118	40		110081266	110081449	8421504	2	20,20	0,163	c	350043211800000001,350043211800000000	0-20,0-20						The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110081266	110081449	3500317153	40		110081266	110081449	8421504	2	20,20	0,163	c,g	350031715300000007,350031715300000007,350031715300000035,350031715300000035,350031715300000006,350031715300000006,350031715300000034,350031715300000034	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20						Markers for Viral Infections and Other Inflammatory Responses - Patent application	www.faqs.org	0	0		
1424	chr5	110081266	110081449	3500027225	40		110081266	110081449	8421504	2	20,20	0,163	c,g	350002722500000001,350002722500000001,350002722500000000,350002722500000000	0-20,0-20,0-20,0-20		22053725	10.1186/1477-7827-9-148	1477-7827	Reproductive Biology and Endocrinology	The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep	Ashley	2011	2		
1424	chr5	110081266	110081291	3500426360	25		110081266	110081291	8421504	1	25	0	c	350042636000000002	0-25						Suppressive Effects of Fruit-juice Concentrate of Prunus Mume Sieb. et Zucc. (Japanese apricot, Ume) on Helicobacter Pylori- induced Glandular Stomach Lesions in Mongolian Gerbils	apjcpcontrol.net	0	0		
1424	chr5	110081266	110081291	3500286446	25		110081266	110081291	8421504	1	25	0	c	350028644600000000	0-25		19622613	10.1158/1940-6207.CAPR-09-0082	1940-6207	Cancer Prevention Research	Pitavastatin Fails to Lower Serum Lipid Levels or Inhibit Gastric Carcinogenesis in Helicobacter pylori&#x2013;Infected Rodent Models	Toyoda	2009	5		
1424	chr5	110081266	110081291	3500216761	25		110081266	110081291	8421504	1	25	0	c	350021676100000002	0-25						Generic Peptides | Online Peptide Guide	www.myostatin.us	0	0		
1424	chr5	110081266	110081291	3500175515	25		110081266	110081291	8421504	1	25	0	c	350017551500000000	0-25		19622613	10.1158/1940-6207.CAPR-09-0082	1940-6207	Cancer Prevention Research	Pitavastatin Fails to Lower Serum Lipid Levels or Inhibit Gastric Carcinogenesis in Helicobacter pylori&#x2013;Infected Rodent Models	Toyoda	2009	5		
1424	chr5	110081266	110081291	3500047600	25		110081266	110081291	8421504	1	25	0	c	350004760000000000	0-25		19622613	10.1158/1940-6207.CAPR-09-0082	1940-6207	Cancer Prevention Research	Pitavastatin Fails to Lower Serum Lipid Levels or Inhibit Gastric Carcinogenesis in Helicobacter pylori&#x2013;Infected Rodent Models	Toyoda	2009	5		
1424	chr5	110081268	110081293	3500323836	25		110081268	110081293	8421504	1	25	0	c	350032383600000005	0-25		19727393	10.1371/journal.pone.0006885		PLoS ONE	PrP Expression, PrPSc Accumulation and Innervation of Splenic Compartments in Sheep Experimentally Infected with Scrapie	Randi	2009	0		
1424	chr5	110081277	110081423	3500317712	48		110081277	110081423	8421504	4	5,19,22,2	0,6,31,144	c,g	350031771200000005,350031771200000005,350031771200000003	0-24,0-24,0-24						Effect of ouabain on myocardial remodeling in rats	-publications.com	0	0		
1424	chr5	110081278	110081301	3500337370	23		110081278	110081301	8421504	1	23	0	c	350033737000000015	0-23						Dissertation zur Erlangung des Doktorgrades der Fakult&#xe4;t f&#xfc;r Chemie und Pharmazie der Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen	b.uni-muenchen.de	0	0		
1424	chr5	110081300	110081323	3500393042	23		110081300	110081323	8421504	1	23	0	c	350039304200000018	18-41						Varied Pathways of Stage IA Lung Adenocarcinomas Discovered by Inte- grated Gene Expression Analysis	www.ijbs.com	0	0		
1424	chr5	110081301	110081494	3500407500	43		110081301	110081494	8421504	2	22,21	0,172	c	350040750000000007,350040750000000006	0-22,0-21						1 , Rong Shao , C.V. Rao , and Ali Akoum	ww.biolreprod.org	0	0		GAPDH
1424	chr5	110081301	110081494	3500347691	43		110081301	110081494	8421504	2	22,21	0,172	c	350034769100000009,350034769100000008	0-22,0-21						Florida International University FIU Digital Commons	alcommons.fiu.edu	0	0		GAPDH
1424	chr5	110081304	110081327	3500338597	23		110081304	110081327	8421504	1	23	0	c	350033859700000008	0-23		23527309	10.1371/journal.pone.0060215		PLoS ONE	Toxoplasma gondii Triggers Phosphorylation and Nuclear Translocation of Dendritic Cell STAT1 while Simultaneously Blocking IFN&#x03b3;-Induced STAT1 Transcriptional Activity	Anne	2013	0		
1424	chr5	110081305	110081429	3500203019	33		110081305	110081429	8421504	2	25,8	0,116	c	350020301900000008	3-36		16940498	10.1128/JVI.00397-06	0022-538X	Journal of Virology	AIDS Vaccination Studies with an Ex Vivo Feline Immunodeficiency Virus Model: Analysis of the Accessory ORF-A Protein and DNA as Protective Immunogens	Pistello	2006	5		
1424	chr5	110081305	110081429	3500021720	33		110081305	110081429	8421504	2	25,8	0,116	c	350002172000000006	4-37						Tuberculosis in African lions | DANIEL AYUKO - Academia.edu	www.academia.edu	0	0		
1424	chr5	110081314	110081429	3500318133	24		110081314	110081429	8421504	2	16,8	0,107	c	350031813300000020	2-26						Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye	Hla	2009	0		
1424	chr5	110081314	110081429	3500316546	24		110081314	110081429	8421504	2	16,8	0,107	c	350031654600000020,350031654600000043	2-26,2-26						Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye - Patent application	www.faqs.org	0	0		
1424	chr5	110081315	110081430	3500452125	24		110081315	110081430	8421504	2	15,9	0,106	c	350045212500000002	1-25		15979413	10.1016/j.ymthe.2005.04.017	1525-0016	Molecular Therapy	Localized Gene Expression Following Administration of Adeno-associated Viral Vectors via Pancreatic Ducts	Loiler	2005	7		
1424	chr5	110081315	110081430	3500018927	24		110081315	110081430	8421504	2	15,9	0,106	c	350001892700000002	1-25		15979413	10.1016/j.ymthe.2005.04.017	1525-0016	Molecular Therapy	Localized Gene Expression Following Administration of Adeno-associated Viral Vectors via Pancreatic Ducts	Loiler	2005	7		
1424	chr5	110081325	110081444	3500414945	28		110081325	110081444	8421504	2	5,23	0,96	c	350041494500000000	0-28						Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: Influence of collagen type II extracellular matrix on MSC chondrogenesis	prints.ugd.edu.mk	0	0		
1424	chr5	110081325	110081444	3500221208	28		110081325	110081444	8421504	2	5,23	0,96	c	350022120800000002	0-28						Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium. - ResearchGate	.researchgate.net	0	0		
1424	chr5	110081325	110081444	3500007036	28		110081325	110081444	8421504	2	5,23	0,96	c	350000703600000004	0-28						Effects of Chronic Cadmium Poisoning on Zn, Cu, Fe, Ca, and Metallothionein in Liver and Kidney of Rats	www.boster.com.cn	0	0		
1424	chr5	110081328	110081444	3500408774	25		110081328	110081444	8421504	2	2,23	0,93	c	350040877400000004	0-25						&#x03b2;-INDUCED SYNTHESIS AND SECRETION OF PROSTAGLANDIN E IN THE PORCINE UTERUS DURING VARIOUS PERIODS OF PREGNANCY	www.jpp.krakow.pl	0	0		GAPDH
1424	chr5	110081328	110081444	3500317416	25		110081328	110081444	8421504	2	2,23	0,93	c	350031741600000002	0-25						0906_article_13	www.jpp.krakow.pl	0	0		GAPDH
1424	chr5	110081328	110081444	3500014561	25		110081328	110081444	8421504	2	2,23	0,93	c	350001456100000002	0-25						Immortalization of swine umbilical vein endothelial cells (SUVECs) with the simian virus 40 large-T antigen. - ResearchGate	.researchgate.net	0	0		GAPDH
1424	chr5	110081426	110081456	3500440574	26		110081426	110081456	8421504	2	6,20	0,10	c	350044057400000000	14-40						Cells Behave Distinctly Within Sponges and Hydrogels Due to Differences of Internal Structure	ww.coe.pku.edu.cn	0	0		
1424	chr5	110081432	110081457	3500146382	25		110081432	110081457	8421504	1	25	0	c	350014638200000006	0-25		22199253	10.1093/nar/gkr1233		Nucleic Acids Research	Human box C/D snoRNA processing conservation across multiple cell types	Michelle	2012	0		
1424	chr5	110081434	110081457	3500467357	23		110081434	110081457	8421504	1	23	0	c	350046735700000006	0-23			10.1128/MCB.00580-06		Molecular and Cellular Biology	Role of Transcription Factor NFAT in Glucose and Insulin Homeostasis 	Teddy	2006	0		GAPDH
1424	chr5	110081435	110081460	3500417535	25		110081435	110081460	8421504	1	25	0	c	350041753500000006	0-25						(TITLE OF THE THESIS)*	ibrary.queensu.ca	0	0		GAPDH
1424	chr5	110081435	110081460	3500096887	25		110081435	110081460	8421504	1	25	0	c	350009688700000003	0-25		16603524	10.1099/vir.0.81667-0	0022-1317	Journal of General Virology	Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds	Garcia	2006	3		
1424	chr5	110081436	110083652	3500441253	40		110081436	110083652	8421504	2	20,20	0,2196	c,g	350044125300000005,350044125300000005,350044125300000004,350044125300000004	0-20,0-20,0-20,0-20						1. INTRODU&#xc7;&#xc3;O	www.ufpel.tche.br	0	0		
1424	chr5	110081436	110083652	3500303663	40		110081436	110083652	8421504	2	20,20	0,2196	c,g	350030366300000001,350030366300000001,350030366300000000,350030366300000000	0-20,0-20,0-20,0-20						UNIVERSIDADE FEDERAL DE PELOTAS	www.ufpel.tche.br	0	0		
1424	chr5	110081436	110083652	3500238922	41		110081436	110083652	8421504	2	20,21	0,2195	c	350023892200000013,350023892200000012	0-20,0-21						AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS E DE ESTRESSE OXIDATIVO EM O&#xd3;CITOS E TECIDOS REPRODUTIVOS EQ&#xdc;INOS KAEFER, Cristian *; BEGNINI, Karine; LEON, Priscila Marques Moura; CAMPOS, Vinicius; COLLARES, Tha&#xed;s; AMARAL, M.G.; DES	www.ufpel.edu.br	0	0		
1424	chr5	110081436	110083652	3500003927	41		110081436	110083652	8421504	2	20,21	0,2195	c	350000392700000013,350000392700000012	0-20,0-21						AVALIA&#xc7;&#xc3;O IN VITRO DE GENES APOPT&#xd3;TICOS E DE ESTRESSE OXIDATIVO EM O&#xd3;CITOS E TECIDOS REPRODUTIVOS EQ&#xdc;INOS KAEFER, Cristian *; BEGNINI, Karine; LEON, Priscila Marques Moura; CAMPOS, Vinicius; COLLARES, Tha&#xed;s; AMARAL, M.G.; DES	www.ufpel.tche.br	0	0		
1424	chr5	110081436	110083331	3500211344	40		110081436	110083331	8421504	2	20,20	0,1875	c	350021134400000001,350021134400000000	0-20,0-20						Poly ( l -lactide-co-caprolactone) scaffolds enhanced with poly (-hydroxybutyrate-co--hydroxyvalerate) microspheres for cartilage regeneration	ww.coe.pku.edu.cn	0	0		
1424	chr5	110081445	110083332	3500421693	42		110081445	110083332	8421504	2	20,22	0,1865	c	350042169300000007,350042169300000006	0-20,0-22		24019931	10.1371/journal.pone.0073636		PLoS ONE	SGO1 Maintains Bovine Meiotic and Mitotic Centromeric Cohesions of Sister Chromatids and Directly Affects Embryo Development	Feng-Xia	2013	0		
1424	chr5	110081456	110083329	3500225423	60		110081456	110083329	8421504	3	20,20,20	0,29,1853	c,g	350022542300000001,350022542300000002,350022542300000000,350022542300000000	0-20,0-20,0-20,0-20		11093774	10.1124/mol.58.6.1357	1521-0111 (Online)	Molecular Pharmacology	Xenobiotic Transport across Isolated Brain Microvessels Studied by Confocal Microscopy	Miller	2000	0		
1424	chr5	110081464	110081494	3500427854	30		110081464	110081494	8421504	1	30	0	c	350042785400000001	0-30						Research Paper Real-time RT-PCR: considerations for efficient and sensitive assay design	uantification.com	0	0		
1424	chr5	110081482	110081507	3500100552	25		110081482	110081507	8421504	1	25	0	c	350010055200000002	0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		
1424	chr5	110081482	110081507	3500000458	25		110081482	110081507	8421504	1	25	0	c	350000045800000001	0-25						BMC Complementary and Alternative Medicine	biomedcentral.com	0	0		
1424	chr5	110081483	110081508	3500461379	25		110081483	110081508	8421504	1	25	0	c	350046137900000006	0-25			10.1111/j.1471-4159.2005.03123.x	1471-4159	Journal of Neurochemistry	Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells - Ludwig - 2005 - Journal of Neurochemistry - Wiley Online Library	Ludwig	2005	0		GAPDH
1424	chr5	110081483	110081508	3500354530	25		110081483	110081508	8421504	1	25	0	c	350035453000000000	0-25						LOW INTENSITY PULSED ULTRASOUND STIMULATES CELL PROLIFERATION	www.docstoc.com	0	0		GAPDH
1424	chr5	110081485	110081510	3500213156	25		110081485	110081510	8421504	1	25	0	c	350021315600000010	0-25		22909213	10.1186/1744-8069-8-59	1744-8069	Molecular Pain	Involvement of Tyr1472 phosphorylation of NMDA receptor NR2B subunit in postherpetic neuralgia in model mice	Unezaki	2012	4		GAPDH
1424	chr5	110081518	110083328	3500066364	23		110081518	110083328	8421504	2	3,20	0,1790	c	350006636400000009	0-23		18773076	10.1371/journal.pone.0003146		PLoS ONE	Cyclin T1-Dependent Genes in Activated CD4+ T and Macrophage Cell Lines Appear Enriched in HIV-1 Co-Factors	Wendong	2008	0		GAPDH
1424	chr5	110083308	110083332	3500254934	24		110083308	110083332	8421504	1	24	0	c	350025493400000002	0-24		18549898	10.1016/j.surg.2008.03.018	0039-6060	Surgery	Diurnal rhythmicity in glucose uptake is mediated by temporal periodicity in the expression of the sodium-glucose co-transporter (SGLT1)	A	June	3		
1424	chr5	110083314	110083339	3500185883	23		110083314	110083339	8421504	2	15,8	0,17	c	350018588300000005	6-29		16702955	10.1038/sj.onc.1209653	0950-9232	Oncogene	Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis	Chen	2006	6		
22	chr5	110083835	110232525	3500198087	26		110083835	110232525	8421504	3	13,3,10	0,14,148680	c	350019808700000142	14-48						Peptide Vaccine For Influenza Virus 	.freshpatents.com	0	0		
1425	chr5	110124532	110127604	3500410512	23		110124532	110127604	8421504	2	2,21	0,3051	c	350041051200000011	0-23		22241992	10.1371/journal.ppat.1002466	1553-7374	PLOS Pathogens	PLOS Pathogens: Molecular Determinants and Dynamics of Hepatitis C Virus Secretion	Coller	2012	0		
1425	chr5	110127665	110128031	3500046452	180		110127665	110128031	8421504	2	45,135	0,231	p	350004645200015003,350004645200015004	0-90,0-90						VAMP-1: synaptic vesicle-associated integral membrane protein	www.pnas.org	0	0		VAMP1
1425	chr5	110127902	110128055	3500028332	150		110127902	110128055	8421504	2	105,45	0,108	p	350002833200015002	0-150						 Chemical Products CAS Catalog 3A,11C-DIHYDRO-3H-BENZO[5,6]CHROMENO[4,3-C]ISOXAZOL-1(4H)-YL(3,4-DICHLOROPHENYL)METHANONE,3A,11C-DIHYDRO-3H-BENZO[5,6]CHROMENO[4,3-C]ISOXAZOLE-1(4H)-CARBOTHIOAMIDE,Ethyl 2-(acetylamino)-3-[3,5-diiodo-4-(4-methoxyphenoxy)phen	.chemicalbook.com	0	0		VAMP2
1425	chr5	110127935	110128031	3500122558	93		110127935	110128031	8421504	2	48,45	0,51	p	350012255800015260	0-93						US Patent # 7,399,607. Fluorescence polarization assays for determining clostridial toxin activity - Patents.com	www.patents.com	0	0		
1425	chr5	110130289	110130317	3500434877	25		110130289	110130317	8421504	2	15,10	0,18	c	350043487700000083	8-33						Recombinant Vectors Based On the Modified Vaccinia Ankara Virus (MVA) as Preventive and Therapeutic Vaccines Against Aids - Patent application	www.faqs.org	0	0		
1425	chr5	110219779	110219836	3500136055	45		110219779	110219836	8421504	2	20,25	0,32	c	350013605500000002,350013605500000013	0-20,0-25						Effects of Mineralocorticoid and Glucocorticoid Agonists on Gene and Protein Expression, Structural Maturation and Compliance in the Ovine Preterm Fetal Lung	ufdc.ufl.edu	0	0		
1425	chr5	110224745	110224894	3500010772	25		110224745	110224894	8421504	3	5,16,4	0,128,145	c	350001077200000018	0-25						BONE MARROW STEM CELL-MEDIATED AIRWAY EPITHELIAL REGENERATION	brary.utoronto.ca	0	0		
1425	chr5	110225507	110225534	3500006708	23		110225507	110225534	8421504	2	15,8	0,19	c	350000670800000009	8-38						Self-inactivating Retroviral Vector 	.freshpatents.com	0	0		SCNN1A
1425	chr5	110225507	110225534	3500003486	23		110225507	110225534	8421504	2	15,8	0,19	c	350000348600000381,350000348600000310	8-38,0-29						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		SCNN1A
1425	chr5	110226730	110226973	3500199933	40		110226730	110226973	8421504	2	20,20	0,223	c	350019993300000002,350019993300000003	0-20,0-20		17251323	10.1152/ajpcell.00369.2006		American Journal of Physiology - Cell Physiology	Glucocorticoids stimulate ENaC upregulation in bovine mammary epithelium	Quesnell	2007	0		
1425	chr5	110226730	110226973	3500061173	40		110226730	110226973	8421504	2	20,20	0,223	c,g	350006117300000002,350006117300000002,350006117300000003	0-20,0-20,0-20		17251323	10.1152/ajpcell.00369.2006		American Journal of Physiology - Cell Physiolog	Glucocorticoids stimulate ENaC upregulation in bovine mammary epithelium	Quesnell	2007	0		
1426	chr5	110232767	110239743	3500187505	42		110232767	110239743	8421504	2	39,3	0,6973	c	350018750500000000	0-42						TNF binding proteins	Hauptmann	2001	0		
1426	chr5	110239873	110240548	3500273954	68		110239873	110240548	8421504	3	21,1,46	0,245,629	c	350027395400000008,350027395400000087,350027395400000062,350027395400000029	16-38,16-38,2-48,0-42						Nucleic acids encoding truncated soluble tumor necrosis factor - US Patent 7732587 Description	ww.patentstorm.us	0	0		
1426	chr5	110240483	110243216	3500192148	40		110240483	110243216	8421504	3	20,13,7	0,2597,2726	c	350019214800000002,350019214800000003	0-20,0-20						Effects of leptin and tumor necrosis factor-alpha on degranulation and superoxide production of polymorphonuclear neutrophils from Holstein cows. - ResearchGate	.researchgate.net	0	0		
1426	chr5	110240506	110244472	3500233361	73		110240506	110244472	8421504	2	42,31	0,3935	c	350023336100000082,350023336100000119,350023336100000255	0-42,0-27,5-36						TNF binding proteins - US Patent 7238776 Description	ww.patentstorm.us	0	0		
1426	chr5	110245017	110245090	3500388552	46		110245017	110245090	8421504	2	21,25	0,48	c	350038855200000026,350038855200000027	0-21,0-25						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
1426	chr5	110245017	110245090	3500143254	46		110245017	110245090	8421504	2	21,25	0,48	c,g	350014325400000026,350014325400000026,350014325400000027	0-21,0-21,0-25						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
1427	chr5	110410825	110411659	3500305445	48		110410825	110411659	8421504	2	21,27	0,807	c	350030544500000009	0-48						Monoclonal antibody, polypeptides and production thereof	Ikeyama	1994	0		
1427	chr5	110441577	110441600	3500445067	23		110441577	110441600	8421504	1	23	0	c	350044506700000000	0-23		11588022	10.1182/blood.V98.8.2293	0006-4971	Blood	The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines	Hamaia	2001	10		CD81
1428	chr5	110581501	110581641	3500100123	49		110581501	110581641	8421504	2	24,25	0,115	c	350010012300000022,350010012300000026	6-30,1-26						Therapeutic domains of von willebrand factor	Ruggeri	1993	0		
1428	chr5	110581501	110581525	3500017300	24		110581501	110581525	8421504	1	24	0	c	350001730000000028	6-30						Therapeutic polypeptides based on von willebrand factor	Chang	1993	0		
1428	chr5	110581588	110581633	3500150349	45		110581588	110581633	8421504	1	45	0	p	350015034900015021	0-45						 Aptamers To Von Willebrand Factor And Their Use As Thrombotic Disease Therapeutics 	www.docstoc.com	0	0		
1428	chr5	110581616	110581641	3500372967	25		110581616	110581641	8421504	1	25	0	c	350037296700000035	1-26						Therapeutic fragments of von willebrand factor	Ruggeri	1995	0		
1428	chr5	110582518	110582545	3500400238	23		110582518	110582545	8421504	2	16,7	0,20	c	350040023800000039	0-32						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1428	chr5	110582723	110584262	3500194368	23		110582723	110584262	8421504	3	12,6,5	0,1527,1534	c	350019436800000131	8-33						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
1430	chr5	110846214	110846242	3500096253	25		110846214	110846242	8421504	2	20,5	0,23	g	350009625300000025	0-25						Revista Brasileira de Zootecnia	www.scielo.br	0	0		
1431	chr5	110912908	110912934	3500098153	23		110912908	110912934	8421504	2	13,10	0,16	g	350009815300000003	11-34						Method of synthesizing polydeoxyribonucleotides, method of synthesizing chromosomal DNA and method of producing chromosomes	Miura	1997	0		
1432	chr5	111031224	111031539	3500040499	270		111031224	111031539	8421504	2	225,45	0,270	p	350004049900015020,350004049900015019,350004049900015018,350004049900015017,350004049900015016,350004049900015014	0-45,0-45,0-45,0-45,0-45,0-45					Patent	Pantropic neurotrophic factors (Patent US:5981480)	Presta	1999	0		NTF3
1432	chr5	111031300	111031329	3500256045	29		111031300	111031329	8421504	1	29	0	c	350025604500000035,350025604500000034	49-75,46-72						Therapeutic and diagnostic methods based on neurotrophin-4 expression	Hallbook	1994	0		
1432	chr5	111031491	111031539	3500251741	48		111031491	111031539	8421504	1	48	0	p	350025174100015013,350025174100015007	0-48,3-48						Analogs of cationic proteins	Boone	1998	0		NTF3
1432	chr5	111031911	111031941	3500208590	30		111031911	111031941	8421504	1	30	0	c	350020859000000004	12-42		15585410	10.1016/j.ymthe.2004.09.020	1525-0016	Molecular Therapy	Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model	Kurozumi	2005	7		
1435	chr5	111412722	111412747	3500159578	23		111412722	111412747	8421504	3	5,14,4	0,6,21	g	350015957800000011	9-32						Proteinase inhibitor for food processing	An	1997	0		
1435	chr5	111432851	111432947	3500126050	96		111432851	111432947	8421504	1	96	0	p	350012605000015227	3-99						GOS 1116020 - Metagenes	annotathon.org	0	0		KCNA1
1435	chr5	111534894	111534921	3500171353	24		111534894	111534921	8421504	2	12,12	0,15	g	350017135300000028,350017135300000059	0-24,0-24						MODIFIED FAMILY 6 GLYCOSIDASES WITH ALTERED SUBSTRATE SPECIFICITY - Patent application	www.faqs.org	0	0		
1436	chr5	111559618	111559642	3500337649	23		111559618	111559642	8421504	2	16,7	0,17	g	350033764900000021	0-23						Phosphorylation of the Twist1-Family Basic Helix-Loop- Helix Transcription Factors Is Involved in Pathological Cardiac Remodeling	w.ebioservice.com	0	0		
1436	chr5	111657491	111657516	3500307135	24		111657491	111657516	8421504	2	6,18	0,7	c	350030713500000219	0-24						NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1437	chr5	111795829	111800533	3500224451	23		111795829	111800533	8421504	2	14,9	0,4695	c	350022445100000020	9-32						GENETIC POLYMORPHISMS ASSOCIATED WITH RHEUMATOID ARTHRITIS, METHODS OF DETECTION AND USES THEREOF	Schrodi	2010	0		
1438	chr5	111853559	111869237	3500201864	40		111853559	111869237	8421504	3	21,5,14	0,15658,15664	c,g	350020186400000210,350020186400000246	20-43,8-27						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1438	chr5	111918038	111921209	3500247198	174		111918038	111921209	8421504	2	159,15	0,3156	p	350024719800015048	0-174						50 human secreted proteins	Komatsoulis	2000	0		FGF6,RAD51AP1
1439	chr5	112060219	112060244	3500148394	24		112060219	112060244	8421504	2	9,15	0,10	c	350014839400000083	11-35						Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	.freshpatents.com	0	0		
179	chr5	112060273	112073235	3500256218	40		112060273	112073235	8421504	2	20,20	0,12942	c,g	350025621800000108,350025621800000108,350025621800000107	0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
179	chr5	112060273	112073235	3500126808	40		112060273	112073235	8421504	2	20,20	0,12942	c,g	350012680800000021,350012680800000021,350012680800000020	0-20,0-20,0-20						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
1440	chr5	112071226	112071250	3500127640	24		112071226	112071250	8421504	1	24	0	c,g	350012764000000007,350012764000000007	0-24,0-24						MiR-497 and miR-302b regulate ethanol induced neuronal cell death through BCL2 and cyclin D2 Sanjay Yadav*, Ankita Pandey, Aruna Shukla, Sarang S. Talwelkar, Ashutosh Kumar,	www.jbc.org	0	0		
1440	chr5	112071416	112073164	3500122917	23		112071416	112073164	8421504	2	11,12	0,1736	c	350012291700000004	0-23			10.1038/sj.bjp.0706987		British Journal of Pharmacology	Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-&#x03ba;B	Y-C	2007	0		
1440	chr5	112190948	112190975	3500441216	24		112190948	112190975	8421504	3	6,13,5	0,7,22	g	350044121600000019	7-32						CHLAMYDIA ANTIGENS AND PROTEIN VACCINE - Patent application	www.faqs.org	0	0		
1441	chr5	112272031	112272057	3500186204	23		112272031	112272057	8421504	2	7,16	0,10	g	350018620400000172	12-35						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
1442	chr5	112392753	112392777	3500132721	23		112392753	112392777	8421504	2	5,18	0,6	g	350013272100000065	7-30						 Hepadnavirus Receptor 	www.docstoc.com	0	0		
1442	chr5	112431481	112431506	3500395481	23		112431481	112431506	8421504	2	7,16	0,9	c	350039548100000033	22-45						Apparatus and method for detecting and identifying infectious agents - Patent # 6649356 - PatentGenius	.patentgenius.com	0	0		
1443	chr5	112521668	112521698	3500449315	24		112521668	112521698	8421504	3	14,4,6	0,15,24	g	350044931500000621	7-31						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
1444	chr5	112689610	112689638	3500309840	24		112689610	112689638	8421504	2	18,6	0,22	g	350030984000000651	23-47						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1445	chr5	112824296	112824702	3500449380	23		112824296	112824702	8421504	2	15,8	0,398	c	350044938000000080	19-43						Anti-hiv Antibody 	freshpatents.com	0	0		
1446	chr5	112855502	112855529	3500246250	23		112855502	112855529	8421504	2	14,9	0,18	g	350024625000000039	21-44					Patent	Polymer conjugates of interferon beta-1a and their uses (Patent CN:1329082)	B*Pei Bin Si Ji 	2007	0		
1446	chr5	112956276	112956301	3500451407	24		112956276	112956301	8421504	2	4,20	0,5	g	350045140700000196	10-34						Dye compositions containing purified polyporus laccases and nucleic acids encoding same	Yaver	1995	0		
1447	chr5	113112831	113112856	3500192940	23		113112831	113112856	8421504	2	6,17	0,8	g	350019294000000091	9-33						Nucleic acids encoding hedgehog proteins	Ingham	2000	0		
1448	chr5	113228998	113229025	3500136350	24		113228998	113229025	8421504	2	8,16	0,11	c	350013635000000001	1-25		16162811	10.1681/ASN.2005050509	1046-6673	Journal of the American Society of Nephrology	Glomerular Permeability Is Altered by Loss of P0, a Myelin Protein Expressed in Glomerular Epithelial Cells	Plaisier	2005	10		
1448	chr5	113232683	113236095	3500424804	195		113232683	113236095	8421504	6	51,12,30,23,31,48	0,60,844,964,1415,3364	p	350042480400015060,350042480400015033,350042480400015005	0-93,0-51,0-72						Expression characterization human FKBP52, 90-kDa protein	www.pnas.org	0	0		
1448	chr5	113233649	113234201	3500267782	43		113233649	113234201	8421504	2	21,22	0,530	c,g	350026778200000013,350026778200000013,350026778200000012,350026778200000012	0-21,0-21,0-22,0-22						The effect of progesterone replacement on gene expression in the corpus luteum during induced regression and late luteal phase in the bonnet monkey (Macaca radiata)	www.rbej.com	0	0		FKBP4
1449	chr5	113282786	113282809	3500442201	23		113282786	113282809	8421504	1	23	0	c	350044220100000101	11-34						Amylase variants	Bisgard-frantzen	1996	0		
1449	chr5	113282786	113282809	3500293769	23		113282786	113282809	8421504	1	23	0	c	350029376900000101	11-34						 Amylase Variants 	www.docstoc.com	0	0		
1449	chr5	113282786	113282809	3500151825	23		113282786	113282809	8421504	1	23	0	c	350015182500000101	11-34						 Amylase Variants 	www.docstoc.com	0	0		
1450	chr5	113493285	113493330	3500156335	45		113493285	113493330	8421504	1	45	0	p	350015633500015033	0-45						METHOD FOR PRODUCING A CELL CAPABLE OF HIGH-YIELD PRODUCTION OF HETEROPROTEINS - Patent application	www.faqs.org	0	0		SLC6A13
181	chr5	113494147	113525548	3500004807	240		113494147	113525548	8421504	6	27,33,60,24,36,60	0,352,2994,10001,11016,31341	p	350000480700015019,350000480700015014,350000480700015011,350000480700015002	0-60,0-60,0-60,0-60						Mus musculus solute carrier family 6 (neurotransmitter transporter, GABA), member 13 (Slc6a13), mRNA. , NM_144512.1 - GenScript	www.genscript.com	0	0		SLC6A13
1451	chr5	113511864	113525521	3500414427	63		113511864	113525521	8421504	2	8,55	0,13602	p	350041442700015000	0-63						 <HTML><HEAD><TITLE>Qian, Mol Vis 1998; 4:6.</TITLE></HEAD> <BODY BGCOLOR="#FFFFFF"><FON	www.molvis.org	0	0		SLC6A12
1451	chr5	113595380	113595407	3500182025	23		113595380	113595407	8421504	3	5,6,12	0,7,15	g	350018202500000013	0-23		18227172	10.1128/IAI.01519-07	0019-9567	Infection and Immunity	The Listeria monocytogenes Virulence Factor InlJ Is Specifically Expressed In Vivo and Behaves as an Adhesin	Sabet	2008	4		
1452	chr5	113640120	113640147	3500025345	24		113640120	113640147	8421504	2	7,17	0,10	c	350002534500000051	4-28						Pygopus In Diagnosis And Treatment Of Cancer 	.freshpatents.com	0	0		
1452	chr5	113757266	113757289	3500342699	23		113757266	113757289	8421504	1	23	0	g	350034269900000075	1-39						US Patent # 6,426,447. Plant seed oils - Patents.com	www.patents.com	0	0		
1453	chr5	113865792	113865817	3500296739	23		113865792	113865817	8421504	3	7,11,5	0,8,20	g	350029673900000000	9-34						Salmonella Flagellin Induces Tumor Necrosis Factor Alpha in a Human Promonocytic Cell Line - Keeping the Faith	pthefaith1296.com	0	0		
1453	chr5	113896987	113897010	3500227613	23		113896987	113897010	8421504	1	23	0	g	350022761300000174	8-31						IMMUNODOMINANT MYCOBACTERIUM TUBERCULOSIS PEPTIDES FROM CELL WALL PROTEINS FOR EARLY DIAGNOSIS AND IMMUNIZATION - Patent application	www.faqs.org	0	0		
1456	chr5	114213349	114213374	3500252917	23		114213349	114213374	8421504	2	12,11	0,14	g	350025291700000051	0-23						Glycosylated interferon alpha - Patent application	www.faqs.org	0	0		
1458	chr5	114467964	114468075	3500108640	111		114467964	114468075	8421504	1	111	0	p	350010864000015082	0-111						Proteins and nucleic acids encoding same	Alsobrook	2002	0		WNT5B
1458	chr5	114544470	114544518	3500252575	48		114544470	114544518	8421504	1	48	0	c	350025257500000100	0-48						ADIPONECTIN RECEPTOR AND GENE ENCODING THE SAME - Patent application	www.faqs.org	0	0		
1458	chr5	114544470	114544518	3500080939	48		114544470	114544518	8421504	1	48	0	c	350008093900000100	0-48						Adiponectin receptor and gene encoding the same - Patent application	www.faqs.org	0	0		
1460	chr5	114705848	114705876	3500241103	23		114705848	114705876	8421504	3	7,5,11	0,9,17	g	350024110300000128	10-33						Antibodies That Bind OV064 and Methods of Use Therefor - Patent application	www.faqs.org	0	0		
1460	chr5	114705848	114705876	3500186499	23		114705848	114705876	8421504	3	7,5,11	0,9,17	g	350018649900000247	10-33						Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity. - Patent application	www.faqs.org	0	0		
1461	chr5	114882074	114882100	3500435763	24		114882074	114882100	8421504	3	4,14,6	0,5,20	g	350043576300000090	17-41						Single chain monoclonal antibody fusion reagents that regulate transcription in vivo	Hoeffler	2000	0		
1461	chr5	114882074	114882100	3500096131	24		114882074	114882100	8421504	3	4,14,6	0,5,20	g	350009613100000090	17-41						Single chain monoclonal antibody fusion reagents that regulate transcription in vivo	Hoeffler	2000	0		
1463	chr5	115139506	115139531	3500152492	24		115139506	115139531	8421504	2	18,6	0,19	g	350015249200000015	5-29						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
1466	chr5	115507275	115508809	3500304990	24		115507275	115508809	8421504	2	16,8	0,1526	c	350030499000000007	0-24		17855492	10.1152/ajpregu.00208.2007		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Adaptive redistribution of NBCe1-A and NBCe1-B in rat kidney proximal tubule and striated ducts of salivary glands during acid-base disturbances	Brandes	2007	0		
1466	chr5	115570224	115570248	3500201852	23		115570224	115570248	8421504	2	14,9	0,15	c	350020185200000086,350020185200000044	12-35,24-47						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
1467	chr5	115630230	115630258	3500078232	26		115630230	115630258	8421504	3	13,5,8	0,14,20	g	350007823200000012	0-29						CHARACTERIZATION AND ISOLATION OF SUBSETS OF HUMAN EMBRYONIC STEM CELLS (HES) AND CELLS ASSOCIATED OR DERIVED THEREFROM - ES CELL INTERNATIONAL PTE LTD	www.sumobrain.com	0	0		
1468	chr5	115774078	115774103	3500034801	24		115774078	115774103	8421504	2	15,9	0,16	g	350003480100000109	0-25						SYSTEM FOR PROTEIN EXPRESSION AND SECRETION ESPECIALLY IN CORYNEBACTERIA - Orsan	www.sumobrain.com	0	0		
1468	chr5	115821382	115825592	3500128210	99		115821382	115825592	8421504	2	45,54	0,4156	p	350012821000015016,350012821000015017	0-45,0-54						Cell, Volume 135	download.cell.com	0	0		TUBA8
1469	chr5	115880048	115880078	3500331896	23		115880048	115880078	8421504	3	5,12,6	0,7,24	g	350033189600000012	15-38						Overexpression of a pepper basic pathogenesis-related protein 1 gene in tobacco plants enhances resistance to heavy metal and pathogen stresses	otech.korea.ac.kr	0	0		
1469	chr5	115916736	115916760	3500298532	24		115916736	115916760	8421504	1	24	0	g	350029853200000186	13-37						 Biocatalyst Inhibitors 	www.docstoc.com	0	0		
1469	chr5	115945278	115948133	3500388626	328		115945278	115948133	8421504	3	10,174,144	0,2200,2711	p	350038862600015000	0-405						KEGG T01008: 326598	www.genome.jp	0	0		
1469	chr5	115947510	115947582	3500388552	43		115947510	115947582	8421504	2	20,23	0,49	c	350038855200000012,350038855200000013	0-20,0-23						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
1469	chr5	115947510	115947582	3500143254	43		115947510	115947582	8421504	2	20,23	0,49	c	350014325400000012,350014325400000013	0-20,0-23						Effects of lactation and pregnancy on gene expression of endometrium of Holstein cows at day 17 of the estrous cycle or pregnancy	imal.ifas.ufl.edu	0	0		
1469	chr5	115947515	115947998	3500157219	41		115947515	115947998	8421504	3	20,12,9	0,125,474	c,g	350015721900000027,350015721900000027,350015721900000005	0-20,0-20,0-21		18239051	10.1530/REP-07-0415	1470-1626	Reproduction	Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle	Mitko	2008	3		
1470	chr5	116010017	116010050	3500035685	27		116010017	116010050	8421504	3	14,6,7	0,18,26	g	350003568500000070	0-28						METHOD OF PREDICTING POTENTIAL SEVERITY OF HEPATITIS E, PROBE SETS, AND PRIMER SETS - Patent application	www.faqs.org	0	0		
1470	chr5	116099298	116099322	3500086063	23		116099298	116099322	8421504	2	17,6	0,18	c	350008606300000334	10-33						Gastrointestinal proliferative foctor and uses thereof - Patent application	www.faqs.org	0	0		
1470	chr5	116099729	116099900	3500255056	171		116099729	116099900	8421504	1	171	0	p	350025505600015083	0-171						Facultad de Biociencias.	www.tdx.cat	0	0		H1F0
1471	chr5	116187630	116187657	3500186204	23		116187630	116187657	8421504	2	6,17	0,10	g	350018620400000231	15-39						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
1471	chr5	116191115	116191142	3500181936	23		116191115	116191142	8421504	2	7,16	0,11	c	350018193600000062	12-35						ESTROGEN RECEPTOR GENES AND UTILIZATION THEREOF - Patent application	www.faqs.org	0	0		
1471	chr5	116214981	116215012	3500309840	29		116214981	116215012	8421504	3	13,12,4	0,14,27	g	350030984000000412	0-29						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1471	chr5	116215205	116216666	3500185602	39		116215205	116216666	8421504	2	19,20	0,1441	c	350018560200000007,350018560200000012	0-19,0-20			10.1091/mbc.E07-06-0551		Molecular Biology of the Cell	The Interaction of JRAB/MICAL-L2 with Rab8 and Rab13 Coordinates the Assembly of Tight Junctions and Adherens Junctions	Rie	2008	0		
1471	chr5	116215205	116216666	3500092701	39		116215205	116216666	8421504	2	19,20	0,1441	c	350009270100000007,350009270100000012	0-19,0-20		18094055	10.1091/mbc.E07-06-0551	1059-1524	Molecular Biology of the Cell	The Interaction of JRAB/MICAL-L2 with Rab8 and Rab13 Coordinates the Assembly of Tight Junctions and Adherens Junctions	Yamamura	2008	5		
1471	chr5	116230718	116230746	3500007191	23		116230718	116230746	8421504	3	7,4,12	0,11,16	c	350000719100000068	8-34						Non-anaphylactogenic IgE fusion proteins	Morsey	2005	0		
1471	chr5	116240406	116240627	3500101334	40		116240406	116240627	8421504	2	20,20	0,201	c,g	350010133400000061,350010133400000061,350010133400000060	0-20,0-20,0-20						Neural crest development in a human embryonic stem cell-based model system	s.ulb.uni-bonn.de	0	0		SOX10
1471	chr5	116240457	116243536	3500109864	42		116240457	116243536	8421504	3	21,12,9	0,519,3070	c	350010986400000003,350010986400000002	0-21,0-21		19304657	10.1074/jbc.M901177200	0021-9258	Journal of Biological Chemistry	The Armadillo Repeat-containing Protein, ARMCX3, Physically and Functionally Interacts with the Developmental Regulatory Factor Sox10	Mou	2009	5		SOX10
1471	chr5	116243581	116249116	3500420461	46		116243581	116249116	8421504	2	25,21	0,5514	c,g	350042046100000029,350042046100000028,350042046100000028	0-25,0-21,0-21			10.1634/stemcells.22-6-1070	1549-4918	STEM CELLS	Adult Pancreas Generates Multipotent Stem Cells and Pancreatic and Nonpancreatic Progeny - Choi - 2004 - STEM CELLS - Wiley Online Library	Choi	2004	0		
1471	chr5	116243772	116248918	3500374887	39		116243772	116248918	8421504	2	20,19	0,5127	c	350037488700000007,350037488700000021,350037488700000006	0-20,0-19,0-19						SUBSTRATE FOR CARTILAGE CULTIVATION USING ARTIFICIAL COLLAGEN, AND METHOD FOR CARTILAGE REGENERATION TREATMENT USING THE SUBSTRATE - Patent application	www.faqs.org	0	0		
1471	chr5	116243772	116248918	3500220522	39		116243772	116248918	8421504	2	20,19	0,5127	c,g	350022052200000014,350022052200000012,350022052200000012	0-20,0-19,0-19						Culture substrate for cartilage comprising artificial collagen, and cartilage regeneration therapy method using the culture substrate	Suzuki	2010	0		
1471	chr5	116243787	116248879	3500282907	25		116243787	116248879	8421504	2	9,16	0,5076	c	350028290700000032	0-25						ABSTRACT Title of Document: ENGINEERING ZONAL CARTILAGE THROUGH UTILIZATION OF A MESENCHYMAL STEM CELL POPULATION Articular	drum.lib.umd.edu	0	0		SOX9
1471	chr5	116248868	116248949	3500329759	81		116248868	116248949	8421504	1	81	0	p	350032975900015006	0-81						TaiLieu.VN: B&#xe1;o c&#xe1;o khoa hoc:"SRY-related genes in the genome of the rice &#xfb01;eld eel (Monopterus albus)" 	tailieu.vn/doc/ba	0	0		SOX10
1471	chr5	116248928	116248979	3500254665	51		116248928	116248979	8421504	1	51	0	p	350025466500015054	0-51						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		SOX10
1471	chr5	116249050	116249079	3500192823	29		116249050	116249079	8421504	1	29	0	c	350019282300000054	0-29						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	digibug.ugr.es	0	0		
22	chr5	116388844	116419988	3500262505	84		116388844	116419988	8421504	3	22,39,23	0,6890,31121	g	350026250500000174,350026250500000074,350026250500000053	0-22,8-47,0-23						US Patent # 6,274,140. Calcium independent cytosolic phospholipase A2/B enzymes - Patents.com	www.patents.com	0	0		
1473	chr5	116457302	116457466	3500047878	40		116457302	116457466	8421504	2	20,20	0,144	c,g	350004787800000009,350004787800000009,350004787800000008	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1473	chr5	116459495	116459521	3500322564	23		116459495	116459521	8421504	2	18,5	0,21	c	350032256400000000	8-31		18680593	10.1186/1742-4690-5-72	1742-4690	Retrovirology	APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication	Li	2008	6		
1473	chr5	116459495	116459521	3500013966	23		116459495	116459521	8421504	2	18,5	0,21	c	350001396600000000	8-31		18680593	10.1186/1742-4690-5-72	1742-4690	Retrovirology	APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication	Li	2008	6		
1473	chr5	116462660	116462686	3500024576	24		116462660	116462686	8421504	2	9,15	0,11	g	350002457600000002	7-31		9862688		0022-1767	The Journal of Immunology	Loss of Original Antigenic Specificity in T Cell Hybridomas Transduced with a Chimeric Receptor Containing Single-Chain Fv of an Anti-Collagen Antibody and Fc&#x03b5;RI-Signaling &#x03b3; Subunit	Annenkov	1998	6		
1473	chr5	116515887	116515912	3500037326	24		116515887	116515912	8421504	2	20,4	0,21	g	350003732600000143	10-44						MICROORGANISM EXPRESSING XYLOSE ISOMERASE - Patent application	www.faqs.org	0	0		
1473	chr5	116517454	116517483	3500107334	24		116517454	116517483	8421504	3	12,8,4	0,16,25	g	350010733400000060	0-31						Helicobacter pylori live vaccine	Gomez-Duarte	1998	0		
1474	chr5	116542395	116542421	3500369501	26		116542395	116542421	8421504	1	26	0	c	350036950100000049	0-26						Protein kinases	Hoekstra	1994	0		
1474	chr5	116542395	116542421	3500222750	26		116542395	116542421	8421504	1	26	0	c	350022275000000049	0-26					Patent	Protein kinases (Patent US:6060296)	Hoekstra	2000	0		
1474	chr5	116542395	116542421	3500177828	26		116542395	116542421	8421504	1	26	0	c	350017782800000048	0-26					Patent	Protein kinases (Patent US:5756289)	Hoekstra	1998	0		
1474	chr5	116542395	116542421	3500090353	26		116542395	116542421	8421504	1	26	0	c	350009035300000047	0-26					Patent	Protein kinases (Patent US:5686412)	Hoekstra	1997	0		
1475	chr5	116685806	116719076	3500024623	1014		116685806	116719076	8421504	13	67,117,61,115,74,92,73,42,53,83,147,45,45	0,7253,15533,15939,16179,16636,20136,21458,23575,29525,31365,32539,33225	p	350002462300015000	12-1026						KEGG T01006: 427903	www.genome.jp	0	0		DMC1
1475	chr5	116685849	116719080	3500349429	40		116685849	116719080	8421504	2	20,20	0,33211	c	350034942900000001,350034942900000000	0-20,0-20						COMPOSITIONS COMPRISING FEMALE GERMLINE STEM CELLS AND METHODS OF USE THEREOF	Tilly	2011	0		
1475	chr5	116685849	116719080	3500199039	40		116685849	116719080	8421504	2	20,20	0,33211	c	350019903900000001,350019903900000000	0-20,0-20						Compositions comprising female germline stem cells and methods of use thereof	Tilly	2005	0		
1475	chr5	116685849	116719080	3500181030	40		116685849	116719080	8421504	2	20,20	0,33211	c	350018103000000001,350018103000000000	0-20,0-20						Application # 2006/0010508. Compositions comprising female germline stem cells and methods of use thereof - Patents.com	www.patents.com	0	0		
1476	chr5	116802626	116802658	3500398461	29		116802626	116802658	8421504	2	8,21	0,11	g	350039846100000006	6-35						Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis	Lees	2003	0		
1476	chr5	116804159	116804489	3500303839	329		116804159	116804489	8421504	2	301,28	0,302	c	350030383900000002	0-330						ASSESSMENT OF MYCOBACTERIUM INFECTION - THE UNVERSITY OF SYDNEY	www.sumobrain.com	0	0		
1478	chr5	117052159	117056169	3500354494	315		117052159	117056169	8421504	9	45,39,6,45,45,45,45,31,14	0,48,3532,3541,3637,3685,3733,3781,3996	p	350035449400015156,350035449400015157,350035449400015158,350035449400015160,350035449400015161,350035449400015162,350035449400015163	0-45,0-45,0-45,0-45,0-45,0-45,0-45						Modified cytosine deaminases - Patent application	www.faqs.org	0	0		
1479	chr5	117227384	117227417	3500414436	27		117227384	117227417	8421504	3	7,12,8	0,8,25	c	350041443600000006	4-36						High-Risk Human Papillomavirus Detection - Patent application	www.faqs.org	0	0		
1479	chr5	117228897	117229273	3500040030	24		117228897	117229273	8421504	2	15,9	0,367	c	350004003000000000	0-24		22932723	10.1038/cddis.2012.114		Cell Death & Disease	Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated Neuronal dysfunction	G	2012	0		PDGFB
1479	chr5	117229315	117248827	3500431331	51		117229315	117248827	8421504	2	32,19	0,19493	c,g	350043133100000001,350043133100000008	0-32,0-19		15175554		0160-2446	Journal of Cardiovascular Pharmacology	 Roles of NF-&#x03ba;B and SP-1 in Oxidative Stress-Mediated Inducti... : Journal of Cardiovascular Pharmacology 	Jianru	2004	2		PDGFB
1479	chr5	117229323	117247748	3500009269	180		117229323	117247748	8421504	4	48,48,42,42	0,5885,9625,18383	c,g	350000926900000069,350000926900000063,350000926900000072,350000926900000044,350000926900000056	0-48,0-48,0-34,13-48,0-48					Patent	Method for expression of heterologous proteins in yeast (Patent US:6017731)	Merryweather	2000	0		
1479	chr5	117229341	117229398	3500195492	57		117229341	117229398	8421504	1	57	0	p	350019549200015019	0-57						HEPATITIS B VIRUS-BINDING POLYPEPTIDES AND METHODS OF USE THEREOF	Zimmerman	2008	0		PDGFB
1479	chr5	117235207	117235244	3500032513	37		117235207	117235244	8421504	1	37	0	c	350003251300000012	0-37						Use of platelet-derived growth factor to improve collateral circulation	Khouri	1994	0		
1479	chr5	117235207	117235231	3500378310	24		117235207	117235231	8421504	1	24	0	c	350037831000000001	1-25						Recombinant production of PDGF A-chain polypeptides - Patent 0288307	data.epo.org	0	0		
1479	chr5	117235207	117235231	3500355189	24		117235207	117235231	8421504	1	24	0	c	350035518900000001	1-25						Recombinant PDGF A-chain homodimers and methods of use - Patent # 6939849 - PatentGenius	.patentgenius.com	0	0		
1479	chr5	117235207	117235231	3500235245	24		117235207	117235231	8421504	1	24	0	c	350023524500000001	1-25						Glycosylated pdgf	Calderon-Cacia	1991	0		
1479	chr5	117235207	117235231	3500111326	24		117235207	117235231	8421504	1	24	0	c	350011132600000001	1-25						Recombinant production of PDGF A-chain polypeptides	Bell	1988	0		
1479	chr5	117235207	117235231	3500021188	24		117235207	117235231	8421504	1	24	0	c	350002118800000001	1-25						Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors	Heldin	1990	0		PDGFB
1479	chr5	117236578	117238954	3500365673	40		117236578	117238954	8421504	3	16,4,20	0,2315,2356	c,g	350036567300000001,350036567300000000,350036567300000000	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
1479	chr5	117236578	117238954	3500262357	40		117236578	117238954	8421504	3	16,4,20	0,2315,2356	c,g	350026235700000001,350026235700000000,350026235700000000	0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
1479	chr5	117238947	117247770	3500106510	107		117238947	117247770	8421504	2	43,64	0,8759	c	350010651000000081	0-107						Multicistronic expression units and their use	Dirks	1994	0		
1479	chr5	117238948	117238982	3500241128	34		117238948	117238982	8421504	1	34	0	c	350024112800000072	0-34					Patent	Method for expression of heterologous proteins in yeast (Patent US:6083723)	Tekamp-Olson	2000	0		
1479	chr5	117308787	117308850	3500310350	63		117308787	117308850	8421504	1	63	0	p	350031035000015063	0-63						Nontoxic shiga-like toxin mutant compositions and methods	Di	2009	0		RPL3
1479	chr5	117308787	117308850	3500147593	63		117308787	117308850	8421504	1	63	0	p	350014759300015061	0-63						NONTOXIC SHIGA-LIKE TOXIN MUTANT COMPOSITIONS AND METHODS	Tumer	2008	0		RPL3
1479	chr5	117308790	117308862	3500429067	72		117308790	117308862	8421504	1	72	0	p	350042906700015000	0-72						 Tolerance Of Trichothecene Mycotoxins In Plants And Animals Through The Modification Of The Peptidyl Transferase Gene 	www.docstoc.com	0	0		RPL3
1479	chr5	117308790	117308862	3500408491	72		117308790	117308862	8421504	1	72	0	p	350040849100015003	0-72						Tolerance of trichothecene mycotoxins in plants and animals through the modification of the peptidyl transferase gene	Harris	1997	0		RPL3
184	chr5	117308795	117310502	3500375699	317		117308795	117310502	8421504	3	93,187,37	0,583,1670	c	350037569900000012	0-317						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1480	chr5	117310516	117310541	3500041857	24		117310516	117310541	8421504	2	16,8	0,17	g	350004185700000039	0-24						Proteases - Patent application	www.faqs.org	0	0		
1480	chr5	117312088	117312115	3500072483	27		117312088	117312115	8421504	1	27	0	c	350007248300000586	0-27						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
1480	chr5	117436272	117436298	3500043540	23		117436272	117436298	8421504	2	16,7	0,19	c	350004354000000430	12-35						US Patent # 6,987,212. Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use - Patents.com	www.patents.com	0	0		
1481	chr5	117472450	117472475	3500096358	23		117472450	117472475	8421504	3	14,4,5	0,15,20	g	350009635800000058	2-25					Patent	Epithelins: novel cysteine-rich growth modulating proteins (Patent US:5416192)	Plowman	1995	0		
1481	chr5	117489410	117489434	3500446522	24		117489410	117489434	8421504	1	24	0	g	350044652200000055	12-36						Production of modified glycoproteins having multiple antennary structures	Bobrowicz	2004	0		
1481	chr5	117489410	117489434	3500418932	24		117489410	117489434	8421504	1	24	0	g	350041893200000057	12-36					Patent	N-acetylglucosaminyltransferase III expression in lower eukaryotes (Patent US:7598055)	Bobrowicz	2009	0		
1481	chr5	117489527	117489550	3500146501	23		117489527	117489550	8421504	1	23	0	g	350014650100000059	0-23					Patent	GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants (Patent CN:1665934)	D*E*A*Fu Luo La Ke 	2010	0		
1481	chr5	117528120	117529260	3500430164	1044		117528120	117529260	8421504	2	220,824	0,316	p	350043016400015000	0-1044						KEGG T01008: 509107	www.genome.jp	0	0		
1481	chr5	117528858	117529102	3500348669	38		117528858	117529102	8421504	2	19,19	0,225	c,g	350034866900000004,350034866900000004,350034866900000005	0-19,0-19,0-19						Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cells. - ResearchGate	.researchgate.net	0	0		ATF4
1481	chr5	117528954	117529209	3500191222	255		117528954	117529209	8421504	1	255	0	p	350019122200015017	0-255						Basic leucine zipper transcription factor Hac1 binds DNA in two distinct modes as revealed by microfluidic analyses	alterlab.ucsf.edu	0	0		ATF4
1481	chr5	117531901	117531931	3500041857	25		117531901	117531931	8421504	3	8,5,12	0,10,18	g	350004185700000111	12-43						Proteases - Patent application	www.faqs.org	0	0		
1482	chr5	117648884	117648908	3500246343	24		117648884	117648908	8421504	1	24	0	g	350024634300000015	6-30						Interleukin-8 receptors and related molecules and methods	Navarro	1992	0		
1487	chr5	118307605	118307632	3500053431	23		118307605	118307632	8421504	2	10,13	0,14	g	350005343100000849	1-25					Patent	Binding agents which inhibit myostatin (Patent US:7928075)	Han	2011	0		
1489	chr5	118552231	118554124	3500299454	74		118552231	118554124	8421504	2	50,24	0,1869	c	350029945400000013,350029945400000002	0-50,0-24					Patent	Dog melanin-concentrating hormone receptor (Patent US:7148026)	Tan	2006	0		
1489	chr5	118553612	118553869	3500259367	96		118553612	118553869	8421504	3	26,44,26	0,108,231	c,g	350025936700000000,350025936700000002,350025936700000001,350025936700000001	0-26,0-44,0-26,0-26					Patent	DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof (Patent US:6221616)	Salon	2001	0		MCHR1
1489	chr5	118553612	118553869	3500248653	96		118553612	118553869	8421504	3	26,44,26	0,108,231	c,g	350024865300000000,350024865300000002,350024865300000002,350024865300000001,350024865300000001	0-26,0-44,0-44,0-26,0-26					Patent	DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof (Patent US:6221613)	Salon	2001	0		MCHR1
1489	chr5	118553716	118553740	3500092336	24		118553716	118553740	8421504	1	24	0	g	350009233600000003,350009233600000011	0-24,0-24						Mch Receptor Antagonists 	.freshpatents.com	0	0		
1489	chr5	118553720	118553764	3500160177	44		118553720	118553764	8421504	1	44	0	c	350016017700000002	0-44						Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof	Laz	2002	0		
1489	chr5	118553784	118554500	3500170379	64		118553784	118554500	8421504	2	19,45	0,671	p,c	350017037900000001,350017037900000002,350017037900015025	21-40,19-38,0-45						Caract&#xe9;risation des r&#xe9;cepteurs de l&#x2019;hormone de m&#xe9;lano-concentration (MCH)	eses.u-strasbg.fr	0	0		MCHR1
1489	chr5	118554100	118554124	3500042010	24		118554100	118554124	8421504	1	24	0	c	350004201000000002	0-24						Dog melanin-concentrating hormone receptor	Tan	2003	0		
1489	chr5	118554167	118554212	3500455853	45		118554167	118554212	8421504	1	45	0	p	350045585300015001	0-45		18650383	10.1073/pnas.0804536105		Proceedings of the National Academy of Sciences of the United States of America	Melanin-concentrating hormone as a mediator of intestinal inflammation	Efi	July	0		MCHR1
1489	chr5	118554167	118554212	3500044199	45		118554167	118554212	8421504	1	45	0	p	350004419900015000	0-45		18650383	10.1073/pnas.0804536105	0027-8424	Proceedings of the National Academy of Sciences	Melanin-concentrating hormone as a mediator of intestinal inflammation	Kokkotou	2008	10		MCHR1
1489	chr5	118554474	118554499	3500038376	25		118554474	118554499	8421504	1	25	0	c	350003837600000007	0-25						Melanin concentrating hormone receptors - Patent # 7078187 - PatentGenius	.patentgenius.com	0	0		
1489	chr5	118609117	118609142	3500102953	24		118609117	118609142	8421504	2	10,14	0,11	g	350010295300000045	13-40						Use of multiple recombination sites with unique specificity in recombinational cloning	Brasch	2001	0		
1492	chr5	118944949	118966102	3500400238	45		118944949	118966102	8421504	4	15,8,17,5	0,18,21130,21148	c	350040023800000087,350040023800000648	20-43,26-48						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1492	chr5	118957618	118957646	3500102512	23		118957618	118957646	8421504	2	13,10	0,18	g	350010251200000014	0-23						Double stranded linear nucleic acid probe and uses thereof	Abravaya	2005	0		
1492	chr5	118959304	118959331	3500292328	25		118959304	118959331	8421504	2	11,14	0,13	g	350029232800000048	1-26						METHOD AND COMPOSITIONS FOR ENHANCED ANTI-TUMOR EFFECTOR FUNCTIONING OF T CELLS - Patent application	www.faqs.org	0	0		
1492	chr5	118969099	118969123	3500366831	24		118969099	118969123	8421504	1	24	0	c	350036683100000005,350036683100000004	5-29,0-24		20235223	10.1002/dvdy.22263	1097-0177	Developmental Dynamics	Distinct roles for telethonin N-versus C-terminus in sarcomere assembly and maintenance - Sadikot - 2010 - Developmental Dynamics - Wiley Online Library	Sadikot	2010	0		
1492	chr5	118978655	118978681	3500396965	23		118978655	118978681	8421504	2	10,13	0,13	c	350039696500000004	0-23					Journal of immunology (Baltimore, Md. : 1950)	Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF	Weifeng	July	0		
1492	chr5	118978655	118978681	3500141673	23		118978655	118978681	8421504	2	10,13	0,13	c	350014167300000004	0-23						Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an	www.uccs.edu	0	0		
1492	chr5	118978655	118978681	3500131054	23		118978655	118978681	8421504	2	10,13	0,13	c	350013105400000000	0-23						CD40 Ligand and Appropriate Cytokines Induce Switching to IgG, IgA, and IgE and Coordinated Germinal Center and Plasmacytoid Phenotypic Differentiation in a Human	www.jimmunol.org	0	0		
1492	chr5	118978655	118978681	3500028329	23		118978655	118978681	8421504	2	10,13	0,13	c	350002832900000004	0-23		18566393		0022-1767	The Journal of Immunology	Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF	Xu	2008	6		
1493	chr5	119028354	119028379	3500169617	23		119028354	119028379	8421504	2	10,13	0,12	c	350016961700000125	0-23						Recombinant feline coronavirus S proteins	Miller	2001	0		
1493	chr5	119028354	119028379	3500102026	23		119028354	119028379	8421504	2	10,13	0,12	c	350010202600000101	0-23						Compositions and methods for vaccination against coronaviruses	Jones	1993	0		
1493	chr5	119106039	119106062	3500281825	23		119106039	119106062	8421504	1	23	0	c	350028182500000027,350028182500000025,350028182500000029	0-23,0-21,0-21						Enhancing the circulating half-life of antibody-based fusion proteins	Burger	2002	0		
1493	chr5	119106040	119106063	3500452310	23		119106040	119106063	8421504	1	23	0	c	350045231000000026	8-31						Methods and compositions for improving recombinant protein production - Patent application	www.faqs.org	0	0		
1493	chr5	119106040	119106063	3500128132	23		119106040	119106063	8421504	1	23	0	c	350012813200000100	0-23						Antibodies with glycosylated in the variable region	A*Shao Bu Ma 	2009	0		
1494	chr5	119156589	119162412	3500055765	51		119156589	119162412	8421504	2	41,10	0,5813	p	350005576500015001	0-51		19454487	10.1093/hmg/ddp239		Human Molecular Genetics	Human ISD11 is essential for both iron&#x2013;sulfur cluster assembly and maintenance of normal cellular iron homeostasis	Yanbo	2009	0		ACO2
1494	chr5	119162433	119162481	3500426913	48		119162433	119162481	8421504	1	48	0	p	350042691300015038	0-48						Mass Spectrometry Handbook	www.scribd.com	0	0		
1494	chr5	119165791	119178530	3500253203	237		119165791	119178530	8421504	6	48,39,27,33,42,48	0,8765,9667,10848,12251,12691	p	350025320300015023,350025320300015024	0-48,0-189						MorphofunctionalandBiochemicalApproachesforStudying MitochondrialChangesduringMyoblastsDifferentiation	loads.hindawi.com	0	0		
1494	chr5	119178042	119178087	3500056210	45		119178042	119178087	8421504	1	45	0	p	350005621000015022	0-45						ScienceDirect.com - Journal of Proteomics - A comparative proteome analysis links tyrosine kinase 2 (Tyk2) to the regulation of cellular glucose and lipid metabolism in response to poly(I:C)	sciencedirect.com	0	0		ACO2
1496	chr5	119421926	119423239	3500099123	40		119421926	119423239	8421504	4	13,7,7,13	0,1004,1112,1300	c	350009912300000030,350009912300000031	0-20,0-20						Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin	g.library.pcc.edu	0	0		
1496	chr5	119442370	119445026	3500261436	39		119442370	119445026	8421504	2	19,20	0,2636	c	350026143600000101,350026143600000102	0-19,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1496	chr5	119445465	119445527	3500128018	43		119445465	119445527	8421504	2	21,22	0,40	c,g	350012801800000002,350012801800000006,350012801800000003,350012801800000003	0-21,0-21,0-22,0-22						miR-33 INHIBITORS AND USES THEREOF	Fernandez-Hernando	2012	0		SREBF2
1496	chr5	119450673	119450703	3500406751	25		119450673	119450703	8421504	3	8,4,13	0,12,17	c	350040675100000021	0-25						Growth differentiation factor-11	www.devileye.net	0	0		
1496	chr5	119450673	119450703	3500038103	25		119450673	119450703	8421504	3	8,4,13	0,12,17	c	350003810300000021	0-25					Patent	Methods of detecting growth differentiation factor-11 (Patent US:5914234)	Lee	1999	0		
1497	chr5	119547488	119577176	3500355215	1347		119547488	119577176	8421504	16	89,109,142,93,111,125,237,42,101,5,58,40,58,58,58,21	0,8803,9487,9785,12739,18735,18863,19106,19151,28090,28097,29445,29487,29547,29607,29667	p,c,g	350035521500000004,350035521500000004,350035521500015025,350035521500015103,350035521500000005,350035521500015006,350035521500015007,350035521500000006,350035521500015104,350035521500000007,350035521500015008,350035521500015027,350035521500015037,350035521500015001,350035521500000008,350035521500015009,350035521500015029,350035521500000009,350035521500015039,350035521500000010,350035521500015032,350035521500015040,350035521500015013,350035521500000012,350035521500015041,350035521500015014,350035521500000013,350035521500015042,350035521500015107,350035521500015015,350035521500000014,350035521500015043,350035521500000015,350035521500015044,350035521500000016,350035521500000016,350035521500015018,350035521500000017,350035521500000018,350035521500015045,350035521500015020,350035521500000019,350035521500000019,350035521500000020,350035521500000034,350035521500000033,350035521500015022,350035521500000021,350035521500015046,350035521500015003,350035521500000022,350035521500000023,350035521500000024,350035521500000001,350035521500000001,350035521500000043,350035521500000043,350035521500000025,350035521500000026,350035521500000026	8-53,8-53,0-93,0-90,0-45,0-45,0-45,0-42,0-48,0-45,0-45,0-45,0-48,0-72,0-48,0-48,0-48,0-48,0-72,0-45,0-273,0-48,0-48,0-45,0-45,0-48,0-45,0-48,3-81,0-48,0-48,0-45,0-45,0-105,0-45,0-45,0-48,0-45,0-45,18-144,0-48,0-42,0-42,0-45,0-34,9-44,0-48,0-42,6-54,0-48,0-45,0-42,0-46,0-23,0-23,0-19,0-19,0-118,0-235,0-235						US Patent # 7,384,913. PT32 sperm protein, sperm c-Yes, oocyte cytoplasmic c-Yes, and uses thereof - Patents.com	www.patents.com	0	0		
1497	chr5	119547488	119577176	3500039855	1389		119547488	119577176	8421504	9	89,109,142,93,111,517,70,11,247	0,8803,9487,9785,12739,18735,28090,29428,29441	p,c,g	350003985500000004,350003985500000004,350003985500015026,350003985500000005,350003985500015007,350003985500015028,350003985500000006,350003985500015008,350003985500015030,350003985500000007,350003985500015009,350003985500015032,350003985500015054,350003985500015000,350003985500015010,350003985500000008,350003985500015034,350003985500015011,350003985500000009,350003985500015056,350003985500015036,350003985500015012,350003985500000010,350003985500015057,350003985500015038,350003985500015013,350003985500015058,350003985500015040,350003985500015014,350003985500000012,350003985500015059,350003985500015042,350003985500015015,350003985500000013,350003985500015060,350003985500015044,350003985500015016,350003985500015061,350003985500015046,350003985500015017,350003985500015062,350003985500015047,350003985500015018,350003985500015063,350003985500015048,350003985500015019,350003985500000017,350003985500015064,350003985500015049,350003985500015020,350003985500000018,350003985500015021,350003985500000019,350003985500015022,350003985500015065,350003985500015050,350003985500000020,350003985500015066,350003985500015023,350003985500015067,350003985500015051,350003985500015002,350003985500015024,350003985500015068,350003985500015052,350003985500015025,350003985500015069,350003985500000024,350003985500000043,350003985500000043,350003985500000001,350003985500000001,350003985500000025	8-53,8-53,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-72,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-49,0-23,0-23,0-23,0-23,0-383						Pt32 Sperm Protein, Sperm C-yes, Oocyte Cytoplasmic C-yes, And Uses Thereof 	.freshpatents.com	0	0		
1497	chr5	119556388	119566671	3500051608	143		119556388	119566671	8421504	4	12,60,48,23	0,587,10146,10260	p,c	350005160800015002,350005160800015004,350005160800000001	0-72,0-48,0-23						PT32 sperm protein, sperm c-Yes, oocyte cytoplasmic c-Yes, and uses thereof	Oko	2005	0		
1497	chr5	119592292	119592340	3500215814	48		119592292	119592340	8421504	1	48	0	c	350021581400000032	0-48						US Patent # 5,382,524. Cloning and expression of biologically active .alpha.-n-acetylgalactosaminidase - Patents.com	www.patents.com	0	0		
1497	chr5	119606628	119606652	3500105842	23		119606628	119606652	8421504	2	4,19	0,5	g	350010584200000082	8-31						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
1497	chr5	119606628	119606652	3500094640	23		119606628	119606652	8421504	2	4,19	0,5	g	350009464000000082	8-31						SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION	Natt	2010	0		
1497	chr5	119606628	119606652	3500084904	23		119606628	119606652	8421504	2	4,19	0,5	g	350008490400000082	8-31					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404832)	Natt	2013	0		
1497	chr5	119611074	119611099	3500420477	23		119611074	119611099	8421504	2	16,7	0,18	g	350042047700000367	8-40						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2008	0		
1497	chr5	119611307	119612042	3500075252	40		119611307	119612042	8421504	2	24,16	0,719	c	350007525200000077	0-40						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
1497	chr5	119643737	119657261	3500200759	47		119643737	119657261	8421504	2	24,23	0,13501	c	350020075900000002,350020075900000000	0-24,0-23			10.1046/j.1471-4159.2002.01069.x	1471-4159	Journal of Neurochemistry	Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics - Miksys - 2002 - Journal of Neurochemistry - Wiley Online Library	Miksys	2002	0		CYP2D6
1498	chr5	119711729	119711753	3500238672	24		119711729	119711753	8421504	1	24	0	c	350023867200000000,350023867200000001	0-22,0-22		15831449	10.1128/MCB.25.9.3421-3430.2005	0270-7306	Molecular and Cellular Biology	SPBP Is a Phosphoserine-Specific Repressor of Estrogen Receptor &#x03b1;	Gburcik	2005	6		
1498	chr5	119713075	119713101	3500195439	25		119713075	119713101	8421504	2	7,18	0,8	c	350019543900000084	9-37						Gene Promotors Which Can be Used in Plants - Patent application	www.faqs.org	0	0		
1498	chr5	119715989	119716016	3500241434	23		119715989	119716016	8421504	2	17,6	0,21	c,g	350024143400000558,350024143400000477,350024143400000477,350024143400000823,350024143400000823	1-25,3-27,3-27,0-24,0-24						GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME	Schellenberger	2010	0		
1498	chr5	119715989	119716016	3500132071	23		119715989	119716016	8421504	2	17,6	0,21	c	350013207100000495,350013207100000450	1-25,1-25						EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME	Schellenberger	2010	0		
1498	chr5	119799124	119799152	3500056872	24		119799124	119799152	8421504	3	8,3,13	0,10,15	g	350005687200000012	15-39						Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1	Feder	2004	0		
1500	chr5	120014339	120014366	3500454493	24		120014339	120014366	8421504	2	14,10	0,17	c	350045449300000011	13-37						Biosynthetic Polypeptide Fusion Inhibitors - Patent application	www.faqs.org	0	0		
1500	chr5	120014339	120014366	3500317336	24		120014339	120014366	8421504	2	14,10	0,17	c	350031733600000015	6-30						Bifunctional molecules for inhibiting hiv entry	Jiang	2009	0		
1500	chr5	120014339	120014366	3500020375	24		120014339	120014366	8421504	2	14,10	0,17	c	350002037500000011	13-37						Biosynthetic Polypeptide Fusion Inhibitors	Mariani	2007	0		
1500	chr5	120041080	120041103	3500314961	23		120041080	120041103	8421504	1	23	0	c	350031496100000014	0-23						Chimeric animal and method for constructing the same	Fu [?] Mo 	1998	0		
1500	chr5	120045815	120045841	3500187973	23		120045815	120045841	8421504	2	17,6	0,20	g	350018797300000063	25-48						Tomatoes Having Reduced Polygalacturonase Activity Caused by Non-Transgenic Mutations in the Polygalacturonase Gene - Patent application	www.faqs.org	0	0		
1506	chr5	120746945	120746972	3500094682	23		120746945	120746972	8421504	3	5,6,12	0,7,15	g	350009468200000015	22-46						Detergent compositions - Patent application	www.faqs.org	0	0		
1507	chr5	120917286	120917321	3500246392	28		120917286	120917321	8421504	3	7,16,5	0,11,30	g	350024639200000002	7-35		22233686	10.1186/1756-0500-5-23	1756-0500	BMC Research Notes	Cloning and expression of an endo-1,4-&#xce;&#xb2;-xylanase from the coffee berry borer, Hypothenemus hampei	Padilla-Hurtado	2012	0		
1508	chr5	121002772	121002800	3500282773	23		121002772	121002800	8421504	2	17,6	0,22	g	350028277300000272,350028277300000556,350028277300000270,350028277300000554	6-30,6-30,0-23,0-23						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT - Patent application	www.faqs.org	0	0		
1511	chr5	121427583	121427612	3500189676	24		121427583	121427612	8421504	2	14,10	0,19	g	350018967600000029	8-32						 Transgenic Plants Containing Ligninase And Cellulase Which Degrade Lignin And Cellulose To Fermentab 	www.docstoc.com	0	0		
1514	chr5	121850778	121850806	3500094617	24		121850778	121850806	8421504	3	5,6,13	0,8,15	g	350009461700000023	24-48						Organic Material-Immobiling Structure and Method for Production of the Same, and Peptide and DNA Therefor - Patent application	www.faqs.org	0	0		
1514	chr5	121895213	121895270	3500033615	57		121895213	121895270	8421504	1	57	0	p	350003361500015002	0-57			10.1083/jcb.200204102		The Journal of Cell Biology	Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly	Fang-Ming	2002	0		UPK3A
1514	chr5	121895213	121895270	3500003191	57		121895213	121895270	8421504	1	57	0	p	350000319100015003	0-57		12446744	10.1083/jcb.200204102	0021-9525	The Journal of Cell Biology	Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly	Deng	2002	10		UPK3A
1514	chr5	121895213	121895267	3500388628	54		121895213	121895267	8421504	1	54	0	p	350038862800015030,350038862800015029	69-123,6-60						123 human secreted proteins	Brewer	1999	0		
1514	chr5	121895213	121895267	3500163563	54		121895213	121895267	8421504	1	54	0	p	350016356300015030,350016356300015029	69-123,6-60						123 human secreted proteins	Brewer	2000	0		
1516	chr5	122147001	122147035	3500120874	30		122147001	122147035	8421504	2	14,16	0,18	g	350012087400000008,350012087400000009	0-35,7-42						Method for testing risk of coronary artery diseases	Kimura	2010	0		
1517	chr5	122179678	122179702	3500120768	24		122179678	122179702	8421504	1	24	0	c,g	350012076800000021,350012076800000021	18-42,18-42						RESEARCH ARTICLE Open Access	itis-research.com	0	0		
1521	chr5	122700530	122701357	3500408810	96		122700530	122701357	8421504	2	74,22	0,805	c	350040881000000013,350040881000000003,350040881000000004	0-74,0-22,0-22						Compositions And Methods For Modulation Of Pdx-1 	freshpatents.com	0	0		MIR4763
1521	chr5	122700533	122700603	3500044198	70		122700533	122700603	8421504	1	70	0	c	350004419800000000	0-70		21528451	10.1007/978-1-61779-046-1_9		Methods in molecular biology (Clifton, N.J.)	Detection of human Dicer and Argonaute 2 catalytic activity	Marjorie	2011	0		MIR4763
1521	chr5	122700552	122700581	3500122942	29		122700552	122700581	8421504	1	29	0	c	350012294200000318,350012294200000317	22-51,25-54						 Methods And Compositions For RNA Interference 	www.docstoc.com	0	0		MIR4763
1521	chr5	122700552	122700581	3500042254	29		122700552	122700581	8421504	1	29	0	c	350004225400000317,350004225400000318	25-54,26-55						Methods and compositions for RNA interference - Patent application	www.faqs.org	0	0		MIR4763
1521	chr5	122775159	122796597	3500107366	49		122775159	122796597	8421504	2	25,24	0,21414	c,g	350010736600000000,350010736600000000,350010736600000001,350010736600000001	0-25,0-25,0-24,0-24						Northern blot analysis Total cellular RNA | Online Peptides Guide	-eps15-acetyl.com	0	0		
1521	chr5	122782366	122784188	3500140729	40		122782366	122784188	8421504	2	20,20	0,1802	c,g	350014072900000000,350014072900000000,350014072900000001	0-20,0-20,0-20		23304114	10.1155/2012/891841		PPAR Research	Effect of 2,4-Thiazolidinedione on Limousin Cattle Growth and on Muscle and Adipose Tissue Metabolism	M.	2012	0		
1521	chr5	122784169	122785207	3500461947	40		122784169	122785207	8421504	2	20,20	0,1018	c,g	350046194700000004,350046194700000005,350046194700000005	0-20,0-20,0-20						Heat stress abatement during the dry period influences metabolic gene expression and improves immune status in the transition period of dairy cows	ddr.nal.usda.gov	0	0		
1521	chr5	122784169	122785207	3500367267	40		122784169	122785207	8421504	2	20,20	0,1018	c,g	350036726700000004,350036726700000005,350036726700000005	0-20,0-20,0-20						Heat stress abatement during the dry period influences metabolic gene expression and improves immune status in the transition period of dairy cows	aldc.nal.usda.gov	0	0		
1521	chr5	122784183	122785180	3500077888	43		122784183	122785180	8421504	3	15,5,23	0,931,974	c	350007788800000068,350007788800000069	0-20,0-23						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1521	chr5	122785313	122800845	3500232370	49		122785313	122800845	8421504	5	4,6,12,14,13	0,10887,10894,11321,15519	c	350023237000000014,350023237000000015	1-23,16-43						<HTML><!-- InstanceBegin template="/Templates/index.dwt" codeOutsideHTMLIsLocked="false" --> <HEAD>	ock.colostate.edu	0	0		
1521	chr5	122796621	122800940	3500281920	40		122796621	122800940	8421504	2	20,20	0,4299	c,g	350028192000000026,350028192000000026,350028192000000027	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
1521	chr5	122796641	122800850	3500227525	25		122796641	122800850	8421504	2	7,18	0,4191	c	350022752500000017	0-25						REAL-TIME RT-PCR AND PROTEOMIC ANALYSIS OF ADIPOSE TISSUE FROM OB/OB MICE TREATED WITH LEPTIN WEI ZHANG	aeum.libs.uga.edu	0	0		PPARA
1521	chr5	122801003	122801026	3500424133	23		122801003	122801026	8421504	1	23	0	c	350042413300000168	4-27						Method of identifying PAX8-PPAR gamma-nucleic acid molecules - Patent # 6723506 - PatentGenius	.patentgenius.com	0	0		
1521	chr5	122801054	122801080	3500059117	26		122801054	122801080	8421504	1	26	0	c	350005911700000005	7-33		15475571	10.1124/mol.104.005553	1521-0111 (Online)	Molecular Pharmacology	Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms	Erbe	2005	0		
1521	chr5	122801059	122801086	3500059343	27		122801059	122801086	8421504	1	27	0	c	350005934300000003	3-30						Evidence for the suppression of apoptosis by the peroxisome - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
1523	chr5	122997607	122997632	3500014852	24		122997607	122997632	8421504	2	17,7	0,18	g	350001485200000006	0-34						&#x0418;&#x0437;&#x0434;&#x0430;&#x0442;&#x0435;&#x043b;&#x044c;	labmed.kz/uploads	0	0		
190	chr5	123054139	123098079	3500110329	38		123054139	123098079	8421504	4	14,5,13,6	0,17,43920,43934	g	350011032900000835,350011032900000545	10-29,10-29						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
1524	chr5	123096277	123096300	3500407417	23		123096277	123096300	8421504	1	23	0	g	350040741700000143	22-48						Method For Producing Carotenoids Or Their Precursors Using Genetically Modified Organisms Of The Blakeslea Genus, Carotenoids Or Their Precursors Produced By Said Method And Use Thereof 	.freshpatents.com	0	0		
1525	chr5	123297082	123297109	3500145608	27		123297082	123297109	8421504	1	27	0	c	350014560800000027	7-34						Regulation of endocytosis and secretion by Rab GTPase activating proteins	b.uni-muenchen.de	0	0		TBC1D22A
1526	chr5	123408251	123408278	3500228110	25		123408251	123408278	8421504	2	20,5	0,22	g	350022811000000000	0-29						Regulation of Cyclic Adenosine 39,59-Monophosphate Response Element Binding Protein (CREB) Expression by Sp1 in the Mammalian Testis	ww.biolreprod.org	0	0		
1526	chr5	123412185	123412236	3500304427	51		123412185	123412236	8421504	1	51	0	p	350030442700015004	6-57						<HTML> <HEAD> <TITLE>MAFF_Rice cDNA C28019</TITLE> </HEAD> <BODY> <A NAME=TOP> &lt;<A HREF=/~qxrice	p.dna.affrc.go.jp	0	0		TBC1D22B
1529	chr5	123758504	123758528	3500270988	23		123758504	123758528	8421504	2	17,6	0,18	g	350027098800000008	6-29						Stable expression of triple helical proteins	Galanis	1998	0		
1534	chr5	124456285	124456311	3500088330	25		124456285	124456311	8421504	2	15,10	0,16	g	350008833000000017	7-32						Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle	Mueller	1996	0		
1534	chr5	124486225	124486250	3500287500	24		124486225	124486250	8421504	2	19,5	0,20	g	350028750000000544,350028750000000542	1-35,0-34						Reconstituted human anti-hm1.24 antibody	Xiao Ye Hao [?] Lang 	2006	0		
1535	chr5	124537834	124537859	3500354454	23		124537834	124537859	8421504	2	8,15	0,10	g	350035445400000004	0-23						Molecular Identification of Fungi	ggene.cn/uploads/	0	0		
1535	chr5	124537834	124537859	3500043729	23		124537834	124537859	8421504	2	8,15	0,10	g	350004372900000004	0-23						Molecular Identi&#xfb01;cation of Fungi	dlx.bookos.org	0	0		
192	chr5	124964358	125067503	3500225038	294		124964358	125067503	8421504	4	24,136,128,6	0,37673,78719,103139	p,g	350022503800000047,350022503800000013,350022503800015065,350022503800015063	7-31,7-31,0-264,0-267						Growth factors nsg28, nsg30, and nsg32 - Patent application	www.faqs.org	0	0		
192	chr5	125002121	125043181	3500024651	150		125002121	125043181	8421504	2	46,104	0,40956	p	350002465100015009	0-150						GUS3 NEUROPEPTIDES FOR REGULATING HYPOTHALAMIC FUNCTION	Larsen	2005	0		FAM19A5
1538	chr5	125036901	125036927	3500218344	26		125036901	125036927	8421504	1	26	0	g	350021834400000021	21-47						IgA allelic variants - Patent application	www.faqs.org	0	0		
1538	chr5	125039030	125039053	3500031496	23		125039030	125039053	8421504	1	23	0	g	350003149600000276	0-23						Kit for detection of telomerase reverse transcriptase nucleic acids - Patent application	www.faqs.org	0	0		
589	chr6	539847	539951	3500008335	42		539847	539951	8421504	2	21,21	0,83	g	350000833500000005,350000833500000004	0-21,0-21						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
589	chr6	539861	540062	3500378665	40		539861	540062	8421504	2	20,20	0,181	g	350037866500000023,350037866500000022	0-20,0-20						Specific maternal transcripts in bovine oocytes and cleavaged embryos: Identification with novel DDRT-PCR methods	www.seegene.com	0	0		
602	chr6	2229471	2230349	3500003087	176		2229471	2230349	8421504	5	53,32,48,23,20	0,108,590,741,858	c	350000308700000043,350000308700000089,350000308700000041,350000308700000077,350000308700000028,350000308700000072	0-44,9-47,0-32,0-48,0-23,0-20						Chimeric mammalian NPY Y5 receptors	Parker	1998	0		
602	chr6	2229573	2230698	3500162031	197		2229573	2230698	8421504	5	41,41,23,47,45	0,414,762,888,1080	c	350016203100000035,350016203100000056,350016203100000049,350016203100000046,350016203100000042	0-41,0-41,6-29,0-47,2-47						Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5	Gerald	1996	0		
602	chr6	2229573	2230505	3500360717	259		2229573	2230505	8421504	4	41,81,96,41	0,278,452,891	p,c	350036071700000083,350036071700015123,350036071700015111,350036071700000024,350036071700000051,350036071700000050,350036071700000042	0-41,0-48,0-48,0-47,0-48,0-48,0-41						Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)	Branchek	1996	0		
602	chr6	2229573	2229614	3500131865	41		2229573	2229614	8421504	1	41	0	c	350013186500000025	0-41					Patent	DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) (Patent US:5968819)	Branchek	1999	0		
602	chr6	2229660	2229690	3500107125	26		2229660	2229690	8421504	3	9,5,12	0,10,18	c	350010712500000004	0-26						 Predogled 	www.dlib.si	0	0		
602	chr6	2317675	2317704	3500252890	26		2317675	2317704	8421504	2	15,11	0,18	g	350025289000000235	12-39						Neisseria meningitidis antigens and compositions	Fraser	2012	0		
607	chr6	3013758	3013785	3500083127	23		3013758	3013785	8421504	2	6,17	0,10	g	350008312700000011	4-28		21571921	10.1128/EC.05012-11		Eukaryotic Cell	Ubiquitylation and Developmental Regulation of Invariant Surface Protein Expression in Trypanosomes 	Ka	July	0		
610	chr6	3358386	3358410	3500233103	24		3358386	3358410	8421504	1	24	0	c,g	350023310300000017,350023310300000017	0-24,0-24						Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells	-publications.com	0	0		CCNA2
610	chr6	3358387	3361213	3500077585	44		3358387	3361213	8421504	2	22,22	0,2804	c	350007758500000000,350007758500000001	12-34,13-35						Cell Cycle Control Mechanisms and Protocols Methods in Molecular Biology - Tim Humphrey, Gavin Br	www.scribd.com	0	0		
610	chr6	3358390	3360195	3500236229	42		3358390	3360195	8421504	2	21,21	0,1784	c,g	350023622900000006,350023622900000007,350023622900000007	0-21,0-21,0-21		10642573	10.1095/biolreprod62.2.355	0006-3363	Biology of Reproduction	Impact of Bovine Oocyte Maturation Media on Oocyte Transcript Levels, Blastocyst Development, Cell Number, and Apoptosis	Watson	2000	4		
610	chr6	3358390	3360195	3500228652	42		3358390	3360195	8421504	2	21,21	0,1784	c	350022865200000006,350022865200000007	0-21,0-21		10642573	10.1095/biolreprod62.2.355	0006-3363	Biology of Reproduction	Impact of Bovine Oocyte Maturation Media on Oocyte Transcript Levels, Blastocyst Development, Cell Number, and Apoptosis	Watson	2000	4		
610	chr6	3358393	3360102	3500328122	333		3358393	3360102	8421504	5	45,177,42,57,12	0,223,1086,1218,1697	p	350032812200015005,350032812200015010,350032812200015020,350032812200015027	0-111,0-63,0-273,0-69						Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase.	mcb.asm.org	0	0		CCNA2
610	chr6	3358781	3358835	3500381831	54		3358781	3358835	8421504	1	54	0	p	350038183100015009	0-54						Novel germinal center kinase cell cycle proteins, compositions and methods of use	Fu	2001	0		CCNA1
610	chr6	3358781	3358835	3500368830	54		3358781	3358835	8421504	1	54	0	p	350036883000015007	0-54						Methods of producing a library and methods of selecting polynucletides	Smith	2001	0		CCNA1
610	chr6	3358781	3358835	3500367243	54		3358781	3358835	8421504	1	54	0	p	350036724300015008	0-54						Histone deacetylase-8 proteins, nuclei acids, and methods for use	Buggy	2000	0		CCNA1
610	chr6	3358781	3358835	3500236661	54		3358781	3358835	8421504	1	54	0	p	350023666100015005	0-54					Patent	Multiparameter facs assays to detect alterations in cellular parameters (Patent EP:1071809)	Fisher	2003	0		CCNA1
610	chr6	3358781	3358835	3500191029	54		3358781	3358835	8421504	1	54	0	p	350019102900015011,350019102900015057	0-54,0-48						Multiparameter FACS assays to detect alterations in cell cycle regulation	Lorens	1998	0		CCNA1
610	chr6	3358781	3358835	3500184727	54		3358781	3358835	8421504	1	54	0	p	350018472700015007,350018472700015018	0-54,0-48						US Patent # 7,067,251. Methods of directly selecting cells expressing inserts of interest - Patents.com	www.patents.com	0	0		CCNA1
610	chr6	3358781	3358835	3500139777	54		3358781	3358835	8421504	1	54	0	p	350013977700015049	0-54						Methods and compositions comprising Renilla GFP	Anderson	2002	0		CCNA1
610	chr6	3358781	3358835	3500124950	54		3358781	3358835	8421504	1	54	0	p	350012495000015010,350012495000015289	0-54,0-48						US Patent # 6,887,675. Tankyrase H, compositions involved in the cell cycle and methods of use - Patents.com	www.patents.com	0	0		CCNA1
610	chr6	3358781	3358835	3500079485	54		3358781	3358835	8421504	1	54	0	p	350007948500015007	0-54					Patent	Multiparameter facs test zum ermitteln von &#xe4;nderungen in den zellularen parametern (Patent DE:69910756)	Fisher	2004	0		CCNA1
610	chr6	3358781	3358835	3500074000	54		3358781	3358835	8421504	1	54	0	p	350007400000015012	0-54					Patent	Multiparameter FACS assays to detect alterations in cellular parameters and small molecule screening (Patent CN:100334227)	J*Fei She Er 	2007	0		CCNA1
610	chr6	3358781	3358835	3500068925	54		3358781	3358835	8421504	1	54	0	p	350006892500015006	0-54					Patent	&#x68c0;&#x6d4b;&#x7ec6;&#x80de;&#x53c2;&#x6570;&#x53d8;&#x5316;&#x548c;&#x7b5b;&#x9009;&#x5c0f;&#x5206;&#x5b50;&#x6587;&#x5e93;&#x6240;&#x7528;&#x7684;&#x591a;&#x53c2;&#x6570;facs&#x5206;&#x6790; (Patent CN:100334227)	J*Fei She Er 	2007	0		CCNA1
610	chr6	3358781	3358835	3500061810	54		3358781	3358835	8421504	1	54	0	p	350006181000015011	0-54						Histone deacetylase-8 proteins, nucleic acids, and methods for use	Buggy	2004	0		CCNA1
610	chr6	3358781	3358835	3500048605	54		3358781	3358835	8421504	1	54	0	p	350004860500015007	0-54						METHODS OF PRODUCING A LIBRARY AND METHODS OF SELECTING POLYNUCLEOTIDES OF INTEREST - UNIVERSITY OF ROCHESTER	www.sumobrain.com	0	0		CCNA1
610	chr6	3358781	3358835	3500000202	54		3358781	3358835	8421504	1	54	0	p	350000020200015010	0-54						Tankyrase H, compositions involved in the cell cycle and methods of use	Luo	2001	0		CCNA1
610	chr6	3360778	3361250	3500116127	51		3360778	3361250	8421504	2	22,29	0,443	c	350011612700000009,350011612700000007,350011612700000005	0-22,0-29,0-24		20064240	10.1186/1743-422X-7-4	1743-422X	Virology Journal	Classic swine fever virus NS2 protein leads to the induction of cell cycle arrest at S-phase and endoplasmic reticulum stress	Tang	2010	2		
610	chr6	3361171	3361194	3500118294	23		3361171	3361194	8421504	1	23	0	c	350011829400000022	0-23		21930790	10.1128/MCB.05574-11	0270-7306	Molecular and Cellular Biology	TopBP1 Mediates Mutant p53 Gain of Function through NF-Y and p63/p73	Liu	2011	6		
612	chr6	3542667	3556727	3500246622	240		3542667	3556727	8421504	6	13,95,12,21,57,42	0,1621,2922,7726,8178,14018	p	350024662200015000,350024662200015002	0-120,0-120						Production of the anticoagulant protein PP4 by genetic engineering	Abel	1989	0		ANXA5
612	chr6	3544293	3561073	3500452256	234		3544293	3561073	8421504	9	48,47,3,17,45,30,2,34,8	0,1302,1407,2956,2998,15506,16720,16735,16772	c	350045225600000007,350045225600000009,350045225600000055,350045225600000021,350045225600000067,350045225600000037,350045225600000058,350045225600000048,350045225600000024	0-48,0-47,0-44,3-23,6-26,0-45,0-42,0-32,0-42						 Modified Annexin Proteins And Methods For Their Use In Organ Transplantation 	www.docstoc.com	0	0		
612	chr6	3544293	3561073	3500068107	196		3544293	3561073	8421504	8	48,3,17,48,33,2,37,8	0,1407,2956,15452,15503,16720,16732,16772	c	350006810700000006,350006810700000045,350006810700000020,350006810700000021,350006810700000047,350006810700000023,350006810700000048	0-48,3-23,6-26,0-48,0-35,0-45,0-42						Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia - Patent application	www.faqs.org	0	0		
612	chr6	3545595	3561073	3500425727	231		3545595	3561073	8421504	9	47,3,17,45,45,30,2,34,8	0,105,1654,1696,14156,14204,15418,15433,15470	c	350042572700000009,350042572700000070,350042572700000040,350042572700000061,350042572700000050,350042572700000051,350042572700000024	0-47,6-26,0-45,0-42,0-45,0-32,0-42						US Patent # 7,635,678. Modified annexin compositions and methods of using same - Patents.com	www.patents.com	0	0		
612	chr6	3545673	3557691	3500385397	231		3545673	3557691	8421504	5	30,91,20,40,50	0,1576,4661,11066,11968	p	350038539700015029,350038539700015001,350038539700015013,350038539700015010,350038539700015016,350038539700015032,350038539700015005,350038539700015041,350038539700015043,350038539700015042,350038539700015023,350038539700015024,350038539700015011	45-180,45-177,45-180,0-135,45-180,45-108,45-180,0-135,45-183,45-186,0-123,0-90,0-84						Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions	Yap	1994	0		
612	chr6	3545673	3557691	3500203495	231		3545673	3557691	8421504	5	30,91,20,40,50	0,1576,4661,11066,11968	p	350020349500015041,350020349500015043,350020349500015042,350020349500015016,350020349500015029,350020349500015001,350020349500015013,350020349500015010,350020349500015005,350020349500015032,350020349500015023,350020349500015024,350020349500015011	0-135,45-183,45-186,45-180,45-180,45-177,45-180,0-135,45-180,45-108,0-123,0-90,0-84						Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions	Yap	1995	0		
612	chr6	3545700	3559723	3500165664	42		3545700	3559723	8421504	4	3,17,5,17	0,1549,13796,14006	c	350016566400000077,350016566400000067	6-26,7-29						Cysteine-containing peptide tag for site-specific conjugation of proteins - Patent application	www.faqs.org	0	0		
612	chr6	3559712	3561064	3500164379	168		3559712	3561064	8421504	2	117,51	0,1301	p	350016437900015070	168-336						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		
612	chr6	3559793	3561015	3500016524	38		3559793	3561015	8421504	2	36,2	0,1220	c	350001652400000023,350001652400000048	0-38,0-35						Modified Annexin Proteins And Methods For Their Use In Platelet Storage And Transfusion 	.freshpatents.com	0	0		
618	chr6	4432280	4432307	3500406521	24		4432280	4432307	8421504	2	5,19	0,8	g	350040652100000074	23-47						High molecular weight major outer membrane protein of moraxella	Sasaki	1998	0		
77	chr6	4544429	4644861	3500248703	401		4544429	4644861	8421504	11	18,23,47,3,45,33,48,50,36,50,48	0,47068,47140,47188,79882,79933,82237,82294,83458,89233,100384	c	350024870300000060,350024870300000257,350024870300000062,350024870300000258,350024870300000259,350024870300000068,350024870300000319,350024870300000070,350024870300000075,350024870300000325,350024870300000077	0-41,0-47,0-41,0-48,6-39,0-48,0-48,0-47,6-48,0-47,0-48						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
624	chr6	5171548	5171574	3500014918	26		5171548	5171574	8421504	1	26	0	g	350001491800000002	5-38			10.1128/MCB.23.8.2699-2708.2003		Molecular and Cellular Biology	Fbx15 Is a Novel Target of Oct3/4 but Is Dispensable for Embryonic Stem Cell Self-Renewal and Mouse Development	Yoshimi	2003	0		
624	chr6	5187149	5187177	3500398958	24		5187149	5187177	8421504	2	12,12	0,16	g	350039895800000000	3-39						2006	.biochem.wisc.edu	0	0		
626	chr6	5469142	5469166	3500235713	24		5469142	5469166	8421504	1	24	0	c	350023571300000023	0-24						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
9	chr6	6130320	6304685	3500222901	2554		6130320	6304685	8421504	24	220,133,414,90,72,90,138,68,109,88,41,93,60,147,126,95,88,21,32,78,64,75,84,128	0,22784,22959,36133,64182,65940,68779,71072,109574,110721,122385,122468,125649,140169,145450,147329,156104,159814,159883,161627,165523,170342,172151,174237	p,c,g	350022290100000014,350022290100000014,350022290100000015,350022290100000084,350022290100000016,350022290100000017,350022290100000018,350022290100000019,350022290100000088,350022290100000021,350022290100000022,350022290100000023,350022290100000091,350022290100000024,350022290100000025,350022290100000026,350022290100000027,350022290100000028,350022290100000029,350022290100000030,350022290100000031,350022290100000032,350022290100000100,350022290100000033,350022290100000101,350022290100000034,350022290100000102,350022290100000035,350022290100000036,350022290100000104,350022290100000037,350022290100000038,350022290100015000,350022290100000039,350022290100000040,350022290100000109,350022290100000041,350022290100000042,350022290100000112,350022290100000044,350022290100000045,350022290100000046,350022290100000047,350022290100000048,350022290100000049,350022290100000117,350022290100000050,350022290100000051,350022290100000052,350022290100000053,350022290100000054,350022290100000055,350022290100000057,350022290100000125,350022290100000058,350022290100000126,350022290100000059,350022290100000127,350022290100000060,350022290100000061,350022290100000062,350022290100000063,350022290100000064,350022290100000132,350022290100000065,350022290100000066	0-113,0-113,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-60,0-117,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-117,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-29						US Patent # 5,652,131. Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods - Patents.com	www.patents.com	0	0		
9	chr6	6130320	6304685	3500127829	2053		6130320	6304685	8421504	29	60,32,65,469,72,90,24,42,90,138,68,109,88,89,39,9,6,126,12,35,88,21,32,64,36,18,45,3,83	0,75,155,22784,23301,36133,64182,64212,65940,68779,71072,109574,110721,122385,122522,125649,140310,145450,147329,147389,156104,159814,159883,161627,165551,170342,172190,174237,174282	p,c,g	350012782900000005,350012782900000005,350012782900000066,350012782900000007,350012782900000008,350012782900000009,350012782900000010,350012782900000011,350012782900000071,350012782900000012,350012782900000013,350012782900000014,350012782900000074,350012782900000015,350012782900000016,350012782900000076,350012782900000017,350012782900000019,350012782900000020,350012782900000080,350012782900000021,350012782900000081,350012782900000023,350012782900000083,350012782900000024,350012782900000084,350012782900000025,350012782900000026,350012782900000027,350012782900000087,350012782900000028,350012782900000029,350012782900015000,350012782900000030,350012782900000090,350012782900000031,350012782900000032,350012782900000092,350012782900000033,350012782900000034,350012782900000035,350012782900000037,350012782900000042,350012782900000102,350012782900000043,350012782900000044,350012782900000046,350012782900000047,350012782900000048,350012782900000050,350012782900000110,350012782900000051,350012782900000112,350012782900000053,350012782900000056,350012782900000117,350012782900000058,350012782900000059	0-97,0-97,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-60,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-29						 Antibodies To CGMP 	www.docstoc.com	0	0		
9	chr6	6130320	6304650	3500202465	1823		6130320	6304650	8421504	30	113,65,133,294,72,72,42,90,12,78,18,2,94,61,41,39,60,45,90,12,35,88,21,32,64,36,18,45,3,48	0,155,22784,22959,23301,36133,64212,65940,68779,68839,71072,71138,109574,110748,122385,122522,125649,140169,145486,147329,147389,156104,159814,159883,161627,165551,170342,172190,174237,174282	p,c,g	350020246500000011,350020246500000011,350020246500000081,350020246500000013,350020246500000014,350020246500000015,350020246500000016,350020246500000085,350020246500000018,350020246500000019,350020246500000020,350020246500000088,350020246500000021,350020246500000022,350020246500000022,350020246500000023,350020246500000023,350020246500000025,350020246500000026,350020246500000027,350020246500000029,350020246500000097,350020246500000030,350020246500000031,350020246500000033,350020246500000101,350020246500000034,350020246500000036,350020246500015000,350020246500000106,350020246500000038,350020246500000039,350020246500000042,350020246500000043,350020246500000114,350020246500000047,350020246500000048,350020246500000050,350020246500000051,350020246500000052,350020246500000054,350020246500000122,350020246500000055,350020246500000124,350020246500000057,350020246500000060,350020246500000129	0-113,0-113,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-117,0-60,0-48,0-48,0-48,0-48,0-117,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						US Patent # 5,702,936. Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods - Patents.com	www.patents.com	0	0		
78	chr6	6130535	6201431	3500041634	1023		6130535	6201431	8421504	7	5,589,90,72,90,138,39	0,22569,35918,63967,65725,68564,70857	p	350004163400015000	21-1044						&#x7121;&#x6a19;&#x984c;&#x6587;&#x4ef6;	.life.nthu.edu.tw	0	0		PDE5A
78	chr6	6153312	6241118	3500462880	50		6153312	6241118	8421504	2	21,29	0,87777	c	350046288000000031,350046288000000213	9-30,0-29						cAMP- und cGMP-bindende Tandem-GAF-Dom&#xa8;anen: Biochemische Untersuchungen mit einer cyanobakteriellen Adenylatcyclase	.uni-tuebingen.de	0	0		
78	chr6	6153645	6166486	3500036646	60		6153645	6166486	8421504	2	39,21	0,12820	p	350003664600015004	0-63						homework4	.life.nthu.edu.tw	0	0		PDE5A
632	chr6	6201458	6239952	3500045683	60		6201458	6239952	8421504	2	2,58	0,38436	p	350004568300015000	0-60						Cgmp-binding, Cgmp-specific Phosphodiesterase Materials And Methods 	.freshpatents.com	0	0		
9	chr6	6256015	6304653	3500339756	91		6256015	6304653	8421504	4	14,6,20,51	0,14474,39872,48587	p,c	350033975600000000,350033975600000001,350033975600015000	0-20,0-20,0-51		9815111			American Journal of Physiology - Lung Cellular and Molecular Physiology	Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity	Hanson	1998	0		
9	chr6	6256015	6304653	3500056974	91		6256015	6304653	8421504	4	14,6,20,51	0,14474,39872,48587	p,c,g	350005697400000000,350005697400000001,350005697400000001,350005697400015000	0-20,0-20,0-20,0-51		9815111			American Journal of Physiology - Lung Cellular and Molecular Physiology	Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity	Hanson	1998	0		
9	chr6	6270605	6300663	3500247477	40		6270605	6300663	8421504	3	20,19,1	0,25283,30057	c,g	350024747700000004,350024747700000004,350024747700000000,350024747700000001	0-19,0-19,0-20,0-20		21421555	10.1093/cvr/cvq410		Cardiovascular Research	Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity	Milena	2011	0		PDE5A
9	chr6	6277712	6304641	3500173558	102		6277712	6304641	8421504	3	32,46,24	0,8712,26905	p,c	350017355800015003,350017355800000005	0-78,15-39						CRYSTAL OF PDE5, ITS CRYSTAL STRUCTURE AND ITS USE IN DRUG DESIGN - PFIZER LIMITED	www.sumobrain.com	0	0		
635	chr6	6622029	6622089	3500407663	60		6622029	6622089	8421504	1	60	0	c	350040766300000143	0-60						Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation	AMALRIC	2005	0		MAD2L1
636	chr6	6791324	6792488	3500317426	40		6791324	6792488	8421504	3	20,16,4	0,147,1160	c	350031742600000000,350031742600000001	0-20,0-20		23302080	10.1111/j.1740-0929.2012.01038.x	1740-0929	Animal Science Journal	Fatty acid-binding protein expression in the gastrointestinal tract of calves and cows - HAYASHI - 2012 - Animal Science Journal - Wiley Online Library	HAYASHI	2013	0		
636	chr6	6791383	6791410	3500174342	27		6791383	6791410	8421504	1	27	0	c	350017434200000053	0-27						MACRONUTRIENT SENSITIVITY	Smith	2010	0		
638	chr6	7037867	7037892	3500007560	24		7037867	7037892	8421504	2	13,11	0,14	c	350000756000000056	0-24						Elizabeth Parks 2011	etd.uovs.ac.za	0	0		
640	chr6	7246683	7246706	3500221735	23		7246683	7246706	8421504	1	23	0	g	350022173500000066	1-24						Early, Rapid and Sensitive Veterinary Molecular Diagnostics - Real Time PCR Applications	quantification.de	0	0		
640	chr6	7275652	7276393	3500166204	441		7275652	7276393	8421504	14	106,85,17,21,37,8,17,12,13,6,17,13,11,78	0,109,197,279,348,389,409,434,480,494,520,629,651,663	g	350016620400000098	0-539						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
644	chr6	7853840	7853866	3500206723	23		7853840	7853866	8421504	2	11,12	0,14	g	350020672300000016	0-23						MMB 292 DNA Viruses Methods and Protocols	www.scribd.com	0	0		
645	chr6	7959430	7959454	3500415955	24		7959430	7959454	8421504	1	24	0	c	350041595500000020	0-24						Letter The Heparan and Heparin Metabolism Pathway is Involved in Regulation of Fatty Acid Composition	www.ijbs.com	0	0		
648	chr6	8269245	8269268	3500219962	23		8269245	8269268	8421504	1	23	0	g	350021996200000020	22-45						Transcriptome Analysis of the Desert Locust Central Nervous System: Production and Annotation of a Schistocerca gregariaEST Database	bio.kuleuven.be	0	0		
670	chr6	11260635	11260662	3500389139	23		11260635	11260662	8421504	3	12,5,6	0,14,21	g	350038913900000178	1-24						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		
670	chr6	11260635	11260662	3500306561	23		11260635	11260662	8421504	3	12,5,6	0,14,21	g	350030656100000177	1-24						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
670	chr6	11260635	11260662	3500257436	23		11260635	11260662	8421504	3	12,5,6	0,14,21	g	350025743600000177	1-24						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
670	chr6	11260635	11260662	3500232262	23		11260635	11260662	8421504	3	12,5,6	0,14,21	g	350023226200000177	1-24					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		
671	chr6	11317976	11318003	3500236767	25		11317976	11318003	8421504	2	8,17	0,10	g	350023676700000003	11-36					Patent	Chlamydia-antigene, entsprechende dns-fragmente und ihre verwendungen Chlamydia antigens, corresponding dns-fragments and their uses (Patent DE:60125350)	DUNN	2007	0		
671	chr6	11317976	11318002	3500155117	24		11317976	11318002	8421504	2	8,16	0,10	g	350015511700000001	0-24						Chlamydia secretory locus orf and uses thereof - Sanofi Pasteur Limited	patentsonline.com	0	0		
676	chr6	12030169	12030203	3500237468	34		12030169	12030203	8421504	1	34	0	c,g	350023746800000004,350023746800000004,350023746800000002	23-57,23-57,17-44		18417587	10.1128/JVI.02496-07	0022-538X	Journal of Virology	Sulfatide Is Required for Efficient Replication of Influenza A Virus	Takahashi	2008	5		
685	chr6	13133634	13178220	3500174123	39		13133634	13178220	8421504	2	19,20	0,44566	c,g	350017412300000040,350017412300000040,350017412300000011,350017412300000011	0-19,0-19,0-20,0-20		20696840	10.1128/MCB.00409-10	0270-7306	Molecular and Cellular Biology	Mechanism of Hypoxia-Induced NF-&#x03ba;B	Culver	2010	6		
685	chr6	13136712	13137216	3500386033	60		13136712	13137216	8421504	2	33,27	0,477	p	350038603300015000	0-60		18562610	10.1523/JNEUROSCI.0696-08.2008	0270-6474	The Journal of Neuroscience	Facilitation of P2X7 Receptor Currents and Membrane Blebbing via Constitutive and Dynamic Calmodulin Binding	Roger	2008	7		CAMK2B
685	chr6	13136721	13137225	3500213520	60		13136721	13137225	8421504	2	24,36	0,468	p	350021352000015003	0-60						Calmodulin adopts an extended conformation when interacting with L-selectin in membranes. - ResearchGate	.researchgate.net	0	0		CAMK2D
685	chr6	13136727	13137231	3500061337	60		13136727	13137231	8421504	2	18,42	0,462	p	350006133700015130,350006133700015014	0-48,0-60						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		CAMK2D
685	chr6	13149514	13149539	3500271950	25		13149514	13149539	8421504	1	25	0	c	350027195000000030	0-25						Novel human protein kinases and protein kinase-like enzymes	Clary	2001	0		CAMK2D
685	chr6	13151173	13151201	3500148414	23		13151173	13151201	8421504	2	6,17	0,11	g	350014841400000598	3-26						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
691	chr6	13929955	13929983	3500406521	23		13929955	13929983	8421504	3	12,4,7	0,13,21	g	350040652100000068	20-46						High molecular weight major outer membrane protein of moraxella	Sasaki	1998	0		
692	chr6	14073149	14073720	3500213595	45		14073149	14073720	8421504	2	25,20	0,551	c	350021359500000081,350021359500000079,350021359500000084	0-20,19-43,0-20						EXPRESSION OF MIRNAS IN PLACENTAL TISSUE - UNIVERSITY OF BREMEN	www.sumobrain.com	0	0		
692	chr6	14073150	14073174	3500177892	24		14073150	14073174	8421504	1	24	0	c	350017789200000031	22-46						Supporting Information	www.pnas.org	0	0		
692	chr6	14073151	14073891	3500031979	45		14073151	14073891	8421504	2	23,22	0,718	c	350003197900000367,350003197900000380	0-23,0-22						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		LARP7
692	chr6	14073151	14073174	3500371873	23		14073151	14073174	8421504	1	23	0	g	350037187300000104	0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		LARP7
692	chr6	14073745	14073768	3500306561	23		14073745	14073768	8421504	1	23	0	c	350030656100000066	19-42						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
692	chr6	14073745	14073768	3500257436	23		14073745	14073768	8421504	1	23	0	c	350025743600000066	21-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
693	chr6	14160164	14160202	3500030411	38		14160164	14160202	8421504	1	38	0	g	350003041100000005,350003041100000006	0-19,0-19		21259317	10.1002/jnr.22562		Journal of neuroscience research	HeyL promotes neuronal differentiation of neural progenitor cells	Ali	2011	0		NEUROG2
694	chr6	14339203	14339227	3500300716	24		14339203	14339227	8421504	1	24	0	c	350030071600000003	24-48						LASSA VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF - Patent application	www.faqs.org	0	0		
694	chr6	14339203	14339227	3500266896	24		14339203	14339227	8421504	1	24	0	c	350026689600000004	24-48						Lassa virus-like particles and methods of production thereof	Branco	2012	0		
694	chr6	14339203	14339227	3500220741	24		14339203	14339227	8421504	1	24	0	c	350022074100000003	24-48						Lassa virus-like particles and methods of production thereof	Branco	2012	0		
696	chr6	14587527	14587552	3500068063	23		14587527	14587552	8421504	2	5,18	0,7	g	350006806300000012,350006806300000179	3-26,3-26						MICROBIAL SYNTHESIS OF D-1,2,4-BUTANETRIOL - Patent application	www.faqs.org	0	0		
708	chr6	16195430	16201478	3500276685	113		16195430	16201478	8421504	3	20,48,45	0,5616,6003	c,g	350027668500000057,350027668500000127,350027668500000109,350027668500000081,350027668500000099,350027668500000117,350027668500000135	0-20,0-45,0-45,0-45,0-42,0-45,0-42						US Patent # 7,141,543. RIEG compositions and therapeutic and diagnostic uses therefor - Patents.com	www.patents.com	0	0		
708	chr6	16200044	16200073	3500215658	24		16200044	16200073	8421504	2	18,6	0,23	g	350021565800000016,350021565800000004	0-30,0-30					Patent	Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant (Patent US:6017761)	Bohnlein	2000	0		
708	chr6	16200044	16200073	3500196260	24		16200044	16200073	8421504	2	18,6	0,23	g	350019626000000004	0-30						US Patent # 5,910,434. Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant - Patents.com	www.patents.com	0	0		
708	chr6	16200044	16200073	3500069203	24		16200044	16200073	8421504	2	18,6	0,23	g	350006920300000014,350006920300000002	0-30,0-30						Method for obtaining retroviral vector supernatant having high transduction efficiency	Bohnlein	1997	0		
708	chr6	16200044	16200073	3500043500	24		16200044	16200073	8421504	2	18,6	0,23	g	350004350000000004	0-30					Patent	Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant (Patent US:5910434)	Bohnlein	1999	0		
708	chr6	16201013	16201505	3500318145	120		16201013	16201505	8421504	2	45,75	0,417	p	350031814500015006,350031814500015018	60-105,0-75						Left-right asymmetric expression of BbPtx, a Ptx-related gene, in a lancelet species and the developmental left-sidedness in deuterostomes. - ResearchGate	.researchgate.net	0	0		PITX2
712	chr6	16690940	16703017	3500301078	83		16690940	16703017	8421504	3	14,10,59	0,11989,12018	c,g	350030107800000039,350030107800000066,350030107800000066,350030107800000040	0-24,0-59,0-59,0-25						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
712	chr6	16757865	16757898	3500148381	26		16757865	16757898	8421504	3	11,8,7	0,15,26	g	350014838100000142	0-27						PRODU&#xc7;&#xc3;O DE FERRAMENTAS BIOL&#xd3;GICAS E ESTUDO DE PROTE&#xcd;NAS DERMONECR&#xd3;TICAS RECOMBINANTES DE ARANHA MARROM Loxosceles intermedia	pace.c3sl.ufpr.br	0	0		
714	chr6	16942907	16946574	3500166993	30		16942907	16946574	8421504	2	5,25	0,3642	c	350016699300000008,350016699300000049	4-27,24-47						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins	Kieliszewski	2006	0		
714	chr6	16942907	16946574	3500110349	30		16942907	16946574	8421504	2	5,25	0,3642	c	350011034900000008,350011034900000049	4-27,24-47						SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH PROTEINS - Patent application	www.faqs.org	0	0		
714	chr6	16942911	16946574	3500220997	23		16942911	16946574	8421504	3	1,4,18	0,3638,3645	c	350022099700000049	24-47					Patent	Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins (Patent US:6639050)	Kieliszewski	2003	0		
714	chr6	16985725	16986023	3500362403	38		16985725	16986023	8421504	2	19,19	0,279	c,g	350036240300000038,350036240300000038,350036240300000039,350036240300000039	0-19,0-19,0-19,0-19						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
714	chr6	16985742	16985772	3500385471	26		16985742	16985772	8421504	2	14,12	0,18	c	350038547100000004	11-37						Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain	roscience.jhu.edu	0	0		
715	chr6	17058646	17061846	3500040185	45		17058646	17061846	8421504	2	23,22	0,3178	c,g	350004018500000039,350004018500000040,350004018500000040	0-23,0-22,0-22						Investigations of extracellular matrix proteases, apoptotic and anti-apoptotic factors in the bovine corpus luteum	b.uni-muenchen.de	0	0		
722	chr6	18000949	18001094	3500112146	129		18000949	18001094	8421504	4	17,22,50,40	0,21,45,105	c	350011214600000035	17-158						Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use	Anderson	2002	0		
90	chr6	18428723	18531674	3500246022	1113		18428723	18531674	8421504	11	213,67,134,133,91,1,122,163,108,49,32	0,2574,4091,76984,83133,84838,86991,88121,97005,102202,102919	p	350024602200015000	0-1113						KEGG T01001: 51176	www.genome.jp	0	0		
90	chr6	18432946	18505728	3500176877	23		18432946	18505728	8421504	2	2,21	0,72761	c	350017687700000026	21-44						Wnt/ &#x03b2;-Catenin-Zielgene in der Maus-Entwicklung	k.uni-freiburg.de	0	0		LEF1
726	chr6	18505712	18516864	3500217565	41		18505712	18516864	8421504	3	19,2,20	0,10122,11132	c,g	350021756500000000,350021756500000000,350021756500000001	0-19,0-19,0-22						Activation of the Canonical Wingless/T-Cell Factor Signaling Pathway Promotes Invasive Differentiation of Human Trophoblast 2006&#x5e74;&#x7b2c;168&#x5377;&#x7b2c;4&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		LEF1
726	chr6	18513631	18515759	3500041755	60		18513631	18515759	8421504	2	14,46	0,2082	p	350004175500015003	0-60						BMC Cancer BioMed Central	biomedcentral.com	0	0		
726	chr6	18516857	18516881	3500334046	24		18516857	18516881	8421504	1	24	0	c	350033404600000001	0-24		19924227	10.1371/journal.pone.0007841		PLoS ONE	Integration of the &#x03b2;-Catenin-Dependent Wnt Pathway with Integrin Signaling through the Adaptor Molecule Grb2	Steve	2009	0		
726	chr6	18516887	18516913	3500313209	26		18516887	18516913	8421504	1	26	0	c	350031320900000006	0-26					Molecular and Cellular Biology	Differential Importin-&#x03b1; Recognition and Nuclear Transport by Nuclear Localization Signals within the High-Mobility-Group DNA Binding Domains of Lymphoid Enhancer Factor 1 and T-Cell Factor 1	Mary	1998	0		
726	chr6	18516920	18525770	3500332150	93		18516920	18525770	8421504	3	48,3,42	0,84,8808	p	350033215000015021,350033215000015023	0-48,0-45						DNA SUPERCOILING WITH A TWIST	etd.lsu.edu	0	0		
726	chr6	18516968	18525770	3500324960	81		18516968	18525770	8421504	2	39,42	0,8760	p	350032496000015005	81-162						Edwin Kamau- DNA Supercoiling with a Twist	www.scribd.com	0	0		LEF1
726	chr6	18516980	18531669	3500316174	57		18516980	18531669	8421504	3	27,3,27	0,13991,14662	c	350031617400000016,350031617400000000,350031617400000017	0-27,24-54,0-27						CELL MASS CAPABLE OF SERVING AS A PRIMITIVE ORGAN-LIKE STRUCTURE COMPRISED OF A PLURALITY OF CELL TYPES OF SOMATIC ORIGIN - Patent application	www.faqs.org	0	0		LEF1
726	chr6	18531679	18543871	3500296416	23		18531679	18543871	8421504	2	4,19	0,12173	c	350029641600000015	0-23		22674471	10.1002/jcp.24122	1097-4652	Journal of Cellular Physiology	Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption - Zhu - 2012 - Journal of Cellular Physiology - Wiley Online Library	Zhu	2013	0		LEF1
726	chr6	18531679	18543871	3500007183	23		18531679	18543871	8421504	2	4,19	0,12173	c	350000718300000001	0-23		22639890	10.1186/1471-230X-12-53	1471-230X	BMC Gastroenterology	The balance between two isoforms of LEF-1 regulates colon carcinoma growth	Wang	2012	2		LEF1
726	chr6	18608588	18609414	3500356848	90		18608588	18609414	8421504	2	59,31	0,795	p	350035684800015000,350035684800015001	0-90,0-48						P450rai-2 (p450 Cytochrome 26b), Encoding Nucleic Acid Molecules And Methods And Uses Thereof 	.freshpatents.com	0	0		CYP2U1
726	chr6	18608588	18609414	3500189250	90		18608588	18609414	8421504	2	59,31	0,795	p	350018925000015000	0-90						P450RAI-2 (P450 CYTOCHROME 26B), ENCODING NUCLEIC ACID MOLECULES AND METHODS AND USES THEREOF - Patent application	www.faqs.org	0	0		CYP2U1
727	chr6	18640267	18640291	3500461493	23		18640267	18640291	8421504	2	11,12	0,12	g	350046149300000008	7-35						TheE3UbiquitinLigasecIAP1BindsandUbiquitinates Caspase-3and-7viaUniqueMechanismsatDistinctStepsin TheirProcessing S	www.jbc.org	0	0		
727	chr6	18734678	18734706	3500326034	24		18734678	18734706	8421504	3	5,6,13	0,7,15	g	350032603400000797	20-44						 Selection Method 	www.docstoc.com	0	0		
11	chr6	18834839	18928948	3500048645	519		18834839	18928948	8421504	7	24,111,114,33,90,81,66	0,14606,20092,53945,56502,72645,94043	p	350004864500015099,350004864500015100,350004864500015102,350004864500015104,350004864500015106	0-138,0-114,0-126,0-81,18-84						Secreted protein HFEAF41	Brewer	2002	0		PAPSS1
728	chr6	18857837	18857872	3500019989	29		18857837	18857872	8421504	3	12,4,13	0,17,22	g	350001998900000544	0-29						Genexpressions-Profil einer dysmyelinisierenden Doppel knock out-Mausmutante (mbp-/- plp-/-) und Rescue-Versuch des normalen Ph&#xe4;notyps	www.uni-koeln.de	0	0		
729	chr6	18888913	18888940	3500162532	23		18888913	18888940	8421504	3	13,5,5	0,14,22	g	350016253200000024	5-28						STRUCTURAL VARIANTS OF ANTIBODIES FOR IMPROVED THERAPEUTIC CHARACTERISTICS - Patent application	www.faqs.org	0	0		
729	chr6	18888913	18888940	3500118920	23		18888913	18888940	8421504	3	13,5,5	0,14,22	g	350011892000000022	14-37						Expression and use of anti-CD20 antibodies - US Patent 7381560 Description	ww.patentstorm.us	0	0		
729	chr6	18888913	18888940	3500083010	23		18888913	18888940	8421504	3	13,5,5	0,14,22	g	350008301000000022	14-37						Anti-CD20 antibodies - US Patent 7422739 Description	ww.patentstorm.us	0	0		
733	chr6	19428537	19428565	3500282252	24		19428537	19428565	8421504	2	17,7	0,21	g	350028225200000226	20-44						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
734	chr6	19535489	19659948	3500302241	132		19535489	19659948	8421504	3	48,78,6	0,108,124453	c	350030224100000234,350030224100000218,350030224100000237	0-48,6-47,0-48						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
91	chr6	19535639	19664348	3500302241	92		19535639	19664348	8421504	3	36,12,44	0,124303,128665	c	350030224100000219,350030224100000230	0-48,0-44						Compositions And Methods To Prevent Cancer By Stabilizing P53 Through Non Mdm2-mediated Pathways 	.freshpatents.com	0	0		
734	chr6	19562507	19562535	3500044051	24		19562507	19562535	8421504	3	6,12,6	0,8,22	g	350004405100000076	2-26						Mutation associated with epilepsy - US Patent 7157569 Description	ww.patentstorm.us	0	0		
734	chr6	19644557	19644582	3500248072	23		19644557	19644582	8421504	2	17,6	0,19	g	350024807200000009	0-24						Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr	Hoon	2004	0		
735	chr6	19664199	19664346	3500418174	114		19664199	19664346	8421504	2	54,60	0,87	p	350041817400015020,350041817400015026,350041817400015022	0-54,0-60,0-60						An ancient Wnt-Dickkopf antagonism in Hydra	ev.biologists.org	0	0		DKK2
739	chr6	20254109	20254139	3500241583	23		20254109	20254139	8421504	3	12,5,6	0,14,24	g	350024158300000012	0-23						METHODS FOR MAKING AND USING MOLECULAR SWITCHES INVOLVING CIRCULAR PERMUTATION - Patent application	www.faqs.org	0	0		
739	chr6	20290099	20292203	3500243240	123		20290099	20292203	8421504	2	29,94	0,2010	p,c	350024324000015000,350024324000000000	0-123,8-32						Novel peptide and use thereof	Han	2008	0		AIMP1
744	chr6	20871423	20879047	3500115394	219		20871423	20879047	8421504	4	15,69,36,99	0,18,111,7525	p	350011539400015118	0-234						Method for identification of genes involved in specific diseases	Harris	2002	0		
750	chr6	21689088	21689115	3500201243	26		21689088	21689115	8421504	2	10,16	0,11	g	350020124300000052	0-26						COMPOSITIONS AND METHODS FOR TREATING COAGULATION RELATED DISORDERS - Patent application	www.faqs.org	0	0		
755	chr6	22338882	22338908	3500252315	23		22338882	22338908	8421504	3	5,5,13	0,7,13	g	350025231500000001	5-29					Patent	Modified cytokines for use in cancer therapy (Patent US:7476721)	Corti	2009	0		
756	chr6	22435022	22435207	3500166204	113		22435022	22435207	8421504	4	51,22,5,35	0,114,144,150	g	350016620400000026	0-299						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
759	chr6	22840825	22875807	3500205532	46		22840825	22875807	8421504	3	24,16,6	0,58,34976	c	350020553200000011,350020553200000010	0-24,0-22		20929541	10.1186/1465-9921-11-139	1465-9921	Respiratory Research	Expression and function of human hemokinin-1 in human and guinea pig airways	Grassin-Delyle	2010	0		
759	chr6	22925452	22925485	3500457735	33		22925452	22925485	8421504	1	33	0	c	350045773500000004	0-33			10.1038/sj.bjp.0706660		British Journal of Pharmacology	Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells	Margherita	2006	0		
759	chr6	22927313	22927412	3500116601	99		22927313	22927412	8421504	1	99	0	p	350011660100015015	0-99						Pesquisa de muta&#xe7;&#xf5;es na neurocinina B e no seu receptor em pacientes com dist&#xfa;rbios puberais centrais idiop&#xe1;ticos	www.teses.usp.br	0	0		
760	chr6	22999704	22999729	3500019915	24		22999704	22999729	8421504	2	9,15	0,10	g	350001991500000457	5-33						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
761	chr6	23153032	23153058	3500384975	23		23153032	23153058	8421504	2	10,13	0,13	g	350038497500000009	8-31						Cloning and characterization of a novel alternatively spliced transcript of the human CHD7 putative helicase	biomedcentral.com	0	0		
762	chr6	23296375	23320128	3500299541	735		23296375	23320128	8421504	9	72,79,97,109,61,114,59,93,51	0,1113,3150,5654,14370,15640,20568,21213,23702	p	350029954100015000	0-735						BMDB: Showing (R)-3-Hydroxybutyric acid (BMDB00011)	www.cowmetdb.ca	0	0		
764	chr6	23573069	23578871	3500367934	39		23573069	23578871	8421504	2	19,20	0,5782	c	350036793400000310	0-39						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
764	chr6	23578923	23579936	3500403930	48		23578923	23579936	8421504	2	6,42	0,971	c	350040393000000017	0-48						Human ubiquitin conjugating enzyme	Draetta	1994	0		UBE2D3
764	chr6	23582311	23582335	3500285188	24		23582311	23582335	8421504	1	24	0	c	350028518800000016	18-42						Mutation Research	005.pasteur.ac.ir	0	0		UBE2D3
95	chr6	23604968	23731423	3500343855	2592		23604968	23731423	8421504	19	177,95,106,171,124,176,111,152,118,87,51,75,174,42,165,145,143,258,222	0,11194,13854,15943,20892,31791,33029,54389,57399,59348,63290,63383,85218,85395,91528,109255,121121,122122,126233	p	350034385500015110,350034385500015114,350034385500015115,350034385500015119,350034385500015120,350034385500015125,350034385500015124,350034385500015130,350034385500015135,350034385500015139,350034385500015140,350034385500015150,350034385500015147,350034385500015154,350034385500015155,350034385500015162,350034385500015164,350034385500015163,350034385500015165,350034385500015170,350034385500015175,350034385500015174,350034385500015180,350034385500015185,350034385500015184,350034385500015189,350034385500015191	0-159,0-180,0-180,0-177,0-177,0-180,0-180,0-180,0-177,0-180,0-180,0-135,0-135,0-180,0-180,0-69,0-69,0-93,0-93,0-180,0-180,3-180,0-177,0-174,0-174,0-102,0-69						Abstract	tory.lib.ncsu.edu	0	0		
765	chr6	23710899	23710922	3500386203	23		23710899	23710922	8421504	1	23	0	g	350038620300000153	20-48						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
766	chr6	23755080	23757051	3500383646	40		23755080	23757051	8421504	2	20,20	0,1951	c,g	350038364600000017,350038364600000016,350038364600000016	0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
766	chr6	23755108	23755132	3500292367	24		23755108	23755132	8421504	1	24	0	c	350029236700000005	0-24						Activation of the transcription factor, nuclear factor kappa-B, during the estrous cycle and early pregnancy in the pig	www.rbej.com	0	0		NFKB1
766	chr6	23779254	23783937	3500136867	291		23779254	23783937	8421504	3	105,92,94	0,2068,4589	p	350013686700015005,350013686700015028,350013686700015001,350013686700015017	0-138,0-156,0-153,0-78						Regulation of pyruvate dehydrogenase kinase 4 (PDK4) through protein-protein interaction and its role in apoptosis	dspace.wits.ac.za	0	0		NFKB1
766	chr6	23787544	23835753	3500351378	38		23787544	23835753	8421504	3	19,2,17	0,44097,48192	c,g	350035137800000014,350035137800000014,350035137800000013	0-19,0-19,0-19						Method of identifying a chemical that alters dissociation of an NF-KB/IKB complex	Haskill	1995	0		NFKB1
766	chr6	23787544	23835753	3500328006	38		23787544	23835753	8421504	3	19,2,17	0,44097,48192	c,g	350032800600000013,350032800600000013,350032800600000012	0-19,0-19,0-19						INHIBITOR OF NF-&#x03bb;B TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF	Albert	1992	0		NFKB1
766	chr6	23831607	23844292	3500092051	45		23831607	23844292	8421504	2	22,23	0,12662	c,g	350009205100000011,350009205100000011,350009205100000010	0-22,0-22,0-23		22205609	10.1167/iovs.11-8728	1552-5783	Investigative Ophthalmology & Visual Science	&#x03b3;-Secretase Inhibition of Murine Choroidal Neovascularization Is Associated with Reduction of Superoxide and Proinflammatory Cytokines	Qi	2012	0		
766	chr6	23835750	23840224	3500030440	28		23835750	23840224	8421504	2	27,1	0,4473	c	350003044000000004,350003044000000000	29-57,18-46						Fusion polypeptides and uses thereof	Patrick	2012	0		
769	chr6	24213628	24213970	3500375699	342		24213628	24213970	8421504	1	342	0	g	350037569900000022	0-342						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
771	chr6	24465019	24465051	3500231742	27		24465019	24465051	8421504	3	10,13,4	0,14,28	g	350023174200000016	0-27		10644357	10.1128/JVI.74.4.1840-1853.2000	0022-538X	Journal of Virology	Analysis of Capsid Formation of Human Polyomavirus JC (Tokyo-1 Strain) by a Eukaryotic Expression System: Splicing of Late RNAs, Translation and Nuclear Transport of Major Capsid Protein VP1, and Capsid Assembly	Shishido-Hara	2000	5		
773	chr6	24668822	24668847	3500388386	23		24668822	24668847	8421504	3	5,5,13	0,6,12	g	350038838600000006	1-26						METHODS AND NUCLEIC ACIDS FOR ANALYSES OF CELLULAR PROLIFERATIVE DISORDERS - Patent application	www.faqs.org	0	0		
773	chr6	24668822	24668847	3500280810	23		24668822	24668847	8421504	3	5,5,13	0,6,12	g	350028081000000006	1-26						Methods and nucleic acids for analyses of cellular proliferative disorders	Lofton-Day	2010	0		
1	chr6	25015663	25338272	3500351863	1563		25015663	25338272	8421504	14	58,201,125,112,146,140,78,95,126,75,85,98,30,194	0,172394,247105,255464,258029,261235,270669,275220,292963,295695,314216,316040,319247,322415	p	350035186300015001	0-1563						KEGG T01001: 11261	www.genome.jp	0	0		
1	chr6	25015663	25338272	3500064631	1542		25015663	25338272	8421504	19	48,4,201,125,112,146,51,86,78,95,20,42,27,25,75,85,98,30,194	0,54,172394,247105,255464,258029,261235,261289,270669,275220,292963,292986,293034,293064,295695,314216,316040,319247,322415	p	350006463100015024,350006463100015018,350006463100015021,350006463100015025,350006463100015019,350006463100015027,350006463100015023	0-807,0-603,0-606,0-66,0-531,0-306,0-339						Methods of diagnosing and treating diabetes and insulin resistance	Bernard	2003	0		
1	chr6	25015663	25271142	3500064631	390		25015663	25271142	8421504	6	48,4,77,121,125,15	0,54,172394,172474,247105,255464	p	350006463100015020	0-393						Methods of diagnosing and treating diabetes and insulin resistance	Bernard	2003	0		PPP3CA
97	chr6	25273792	25338275	3500114396	112		25273792	25338275	8421504	5	26,19,20,20,27	0,34934,56129,64325,64456	c,g	350011439600000005,350011439600000008,350011439600000008,350011439600000010,350011439600000010,350011439600000012,350011439600000012,350011439600000002	5-31,0-19,0-19,0-20,0-20,0-20,0-20,6-33						Studies on Bovine Eye Retinal Calcineurin	ecommons.usask.ca	0	0		
778	chr6	25329893	25329941	3500061337	48		25329893	25329941	8421504	1	48	0	p	350006133700015135	0-48						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		PPP3CA
778	chr6	25338107	25338188	3500411148	81		25338107	25338188	8421504	1	81	0	p	350041114800015003	3-84						transcription with calcineurin Interaction NFAT1	www.pnas.org	0	0		PPP3CA
778	chr6	25338107	25338182	3500172243	75		25338107	25338182	8421504	1	75	0	p	350017224300015000	0-75						Mouse Emi2 as a distinctive regulatory hub in second meiotic metaphase	ev.biologists.org	0	0		PPP3CA
778	chr6	25338107	25338182	3500078772	75		25338107	25338182	8421504	1	75	0	p	350007877200015000	0-75		20724447	10.1242/dev.052480	0950-1991	Development	Mouse Emi2 as a distinctive regulatory hub in second meiotic metaphase	Suzuki	2010	7		PPP3CA
778	chr6	25338107	25338167	3500384310	60		25338107	25338167	8421504	1	60	0	p	350038431000015033	0-60						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		PPP3CA
778	chr6	25338186	25338246	3500184264	40		25338186	25338246	8421504	2	21,19	0,41	c,g	350018426400000000,350018426400000001,350018426400000001	0-21,0-19,0-19		19344364	10.1111/j.1538-7836.2009.03355.x	1538-7836	Journal of Thrombosis and Haemostasis	Protein phosphatase&#xa0;2B inhibition promotes the secretion of von Willebrand factor from endothelial cells - NOLASCO - 2009 - Journal of Thrombosis and Haemostasis - Wiley Online Library	NOLASCO	2009	0		PPP3CA
779	chr6	25499174	25499203	3500406732	25		25499174	25499203	8421504	2	12,13	0,16	g	350040673200000122	0-26						Control of fruit ripening and senescence in plants	Klee	1991	0		
779	chr6	25499174	25499203	3500088021	25		25499174	25499203	8421504	2	12,13	0,16	g	350008802100000122	0-26						Control of fruit ripening and senescence in plants - US Patent 5512466 Description	ww.patentstorm.us	0	0		
783	chr6	25964244	25964269	3500348013	23		25964244	25964269	8421504	3	12,7,4	0,13,21	g	350034801300000038	1-29						Modified Anti-cd52 Antibody 	.freshpatents.com	0	0		
783	chr6	25964244	25964269	3500259090	23		25964244	25964269	8421504	3	12,7,4	0,13,21	g	350025909000000038,350025909000000197	1-29,1-29						MODIFIED ANTI-CD52 ANTIBODY - Patent application	www.faqs.org	0	0		
784	chr6	26112695	26112718	3500441972	23		26112695	26112718	8421504	1	23	0	c	350044197200000004	0-23		20647331	10.1158/1541-7786.MCR-10-0174	1541-7786	Molecular Cancer Research	p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase	Zemskova	2010	4		DDIT4L
784	chr6	26149510	26149535	3500046125	23		26149510	26149535	8421504	2	17,6	0,19	g	350004612500000016	18-41						MUTANT ENZYMES - ISIS INNOVATION LIMITED	www.sumobrain.com	0	0		
784	chr6	26153115	26153143	3500280518	23		26153115	26153143	8421504	2	12,11	0,17	g	350028051800000015	19-48						Novel Hansenula Polymorpha Gene Coding for Alpha 1,6-Mannosyltransferase and Process for the Production of Recombinant Glycoproteins with Hansenula Polymorpha Mutant Strain Deficient in the Same Gene - Patent application	www.faqs.org	0	0		
785	chr6	26292422	26292451	3500308331	23		26292422	26292451	8421504	3	5,12,6	0,8,23	c	350030833100000041	4-27						Recombinant neu differentiation factors		1995	0		
785	chr6	26342590	26342620	3500358013	30		26342590	26342620	8421504	1	30	0	c	350035801300000001	0-30						yavapai county az: Topics by Science.gov	www.science.gov	0	0		H2AFZ
785	chr6	26343095	26344468	3500094913	71		26343095	26344468	8421504	2	53,18	0,1355	c	350009491300000011,350009491300000062	0-71,0-19						Gene Expression Markers For Response To Egfr Inhibitor Drugs 	.freshpatents.com	0	0		H2AFZ
785	chr6	26344486	26345299	3500232777	48		26344486	26345299	8421504	3	24,23,1	0,536,812	c,g	350023277700000000,350023277700000000,350023277700000001	0-24,0-24,0-24						1 abstract title	tory.lib.ncsu.edu	0	0		
785	chr6	26344486	26345299	3500181711	48		26344486	26345299	8421504	3	24,23,1	0,536,812	c,g	350018171100000000,350018171100000000,350018171100000001	0-24,0-24,0-24						REPRODUCTION	uction-online.org	0	0		
785	chr6	26344486	26345299	3500162809	48		26344486	26345299	8421504	3	24,23,1	0,536,812	c,g	350016280900000000,350016280900000000,350016280900000001	0-24,0-24,0-24						Epigenetic differences between male and female bovine blastocysts produced in vitro	cs.physiology.org	0	0		
785	chr6	26344486	26345299	3500133737	48		26344486	26345299	8421504	3	24,23,1	0,536,812	c,g	350013373700000000,350013373700000000,350013373700000001	0-24,0-24,0-24						REPRODUCTION	uction-online.org	0	0		
785	chr6	26344537	26345317	3500294910	40		26344537	26345317	8421504	3	20,1,19	0,507,761	c,g	350029491000000014,350029491000000014,350029491000000015	0-20,0-20,0-20						UNIVERSIDADE JOS&#xc9; DO ROS&#xc1;RIO VELLANO &#x2013; UNIFENAS TOCHIMARA APARECIDA MIYAUCHI	tede.unifenas.br	0	0		
785	chr6	26344915	26344978	3500253226	63		26344915	26344978	8421504	1	63	0	p	350025322600015001	0-63						The Human Histone H2A.Z Gene	www.jbc.org	0	0		H2AFV
785	chr6	26344921	26345330	3500414157	138		26344921	26345330	8421504	3	93,13,32	0,111,377	p	350041415700015012,350041415700015023,350041415700015034,350041415700015013,350041415700015045	0-45,0-45,0-45,0-45,0-45						Methods and Compositions for Altering Temperature Sensing in Eukaryotic Organisms - Patent application	www.faqs.org	0	0		H2AFV
785	chr6	26344970	26345371	3500263272	48		26344970	26345371	8421504	2	24,24	0,377	c,g	350026327200000002,350026327200000002,350026327200000017,350026327200000017,350026327200000003,350026327200000003	0-24,0-24,0-23,0-23,0-24,0-24						Nitric oxide synthase (NOS) genes expression in catlle in vitro produced embryos	s.ulb.uni-bonn.de	0	0		H2AFZ
785	chr6	26344995	26345046	3500361209	32		26344995	26345046	8421504	2	8,24	0,27	g	350036120900000000	24-56						Temporal Divergence in the Pattern of Messenger RNA Expression in Bovine Embryos Cultured from the Zygote to Blastocyst Stage In Vitro or In Vivo	ww.biolreprod.org	0	0		
785	chr6	26345022	26345299	3500365295	24		26345022	26345299	8421504	2	23,1	0,276	c	350036529500000000	24-48						1 BIOLOGICAL DIFFERENCES BETWEEN IN VITRO PRODUCED BOVINE 2 EMBRYOS AND PARTHENOTES	uction-online.org	0	0		
785	chr6	26345347	26345371	3500465001	24		26345347	26345371	8421504	1	24	0	c,g	350046500100000007,350046500100000007	24-48,24-48				1470-1626		Selective degradation of maternal and embryonic transcripts in in vitro produced bovine oocytes and embryos using sequence specific double-stranded RNA 	uction-online.org	0	3		UBAC2,H2AFZ
98	chr6	26345380	26345529	3500192477	60		26345380	26345529	8421504	3	20,20,20	0,31,129	c,g	350019247700000004,350019247700000000,350019247700000000,350019247700000001,350019247700000002	0-20,0-20,0-20,0-20,0-20		20299344	10.1093/nar/gkq171		Nucleic Acids Research	Identification and characterization of the two isoforms of the vertebrate H2A.Z histone variant	Ryo	July	0		
785	chr6	26345430	26345455	3500068732	25		26345430	26345455	8421504	1	25	0	c	350006873200000003	0-25		19587330	10.1095/biolreprod.109.078162	0006-3363	Biology of Reproduction	Tubulointerstitial Nephritis Antigen-Like 1 Is Expressed in Extraembryonic Tissues and Interacts with Laminin 1 in the Reichert Membrane at Postimplantation in the Mouse	Igarashi	2009	4		
786	chr6	26347313	26347336	3500402654	23		26347313	26347336	8421504	1	23	0	c	350040265400000004	1-24		15192124		1541-7786	Molecular Cancer Research	HMG-I/Y Is a c-Jun/Activator Protein-1 Target Gene and Is Necessary for c-Jun&#x2013;Induced Anchorage-Independent Growth in Rat1a Cells	Hommura	2004	4		
786	chr6	26410820	26412173	3500296271	24		26410820	26412173	8421504	3	14,2,8	0,1342,1345	c	350029627100000012	3-27						Rastreamento e estudo funcional de muta&#xe7;&#xf5;es no gene da tireoglobulina associadas a b&#xf3;cio cong&#xea;nito e hipotireoidismo	www.teses.usp.br	0	0		
786	chr6	26465607	26465655	3500358440	48		26465607	26465655	8421504	1	48	0	p	350035844000015000	0-48		21930970	10.4049/jimmunol.1003072	0022-1767	The Journal of Immunology	The Adaptor Protein Bam32 in Human Dendritic Cells Participates in the Regulation of MHC Class I-Induced CD8+ T Cell Activation	Ortner	2011	6		DAPP1
788	chr6	26614784	26663761	3500175481	2917		26614784	26663761	8421504	17	470,171,125,228,122,98,212,213,108,169,158,151,140,117,108,144,183	0,2024,5267,14373,15975,16198,17984,19870,23292,24379,32369,35280,37477,37907,40379,47284,48794	c,g	350017548100000000,350017548100000014,350017548100000013,350017548100000013,350017548100000036,350017548100000039,350017548100000005,350017548100000005,350017548100000037,350017548100000017,350017548100000017	0-2891,0-2881,25-90,25-90,0-33,0-23,9-33,9-33,0-30,0-48,0-48					Patent	Microsomal triglyceride transfer protein (Patent US:5789197)	Gregg	1998	0		
788	chr6	26614784	26663737	3500219051	2893		26614784	26663737	8421504	17	470,171,125,228,122,98,212,213,108,169,158,151,140,117,108,144,159	0,2024,5267,14373,15975,16198,17984,19870,23292,24379,32369,35280,37477,37907,40379,47284,48794	p,c,g	350021905100000000,350021905100015016,350021905100015015,350021905100015014,350021905100015013,350021905100015012,350021905100015011,350021905100000023,350021905100000023,350021905100015010,350021905100015009,350021905100015008,350021905100015007,350021905100015006,350021905100015005,350021905100000017,350021905100015004,350021905100015003,350021905100015002,350021905100015001,350021905100015000,350021905100000007	0-2881,0-150,0-150,0-150,0-150,0-150,0-150,25-90,25-90,0-150,0-150,0-150,0-150,0-150,0-150,8-31,0-150,0-150,0-150,0-150,0-150,0-36					Patent	Microsomal triglyceride transfer protein (Patent US:6492365)	John	2002	0		
788	chr6	26616882	26616905	3500059527	23		26616882	26616905	8421504	1	23	0	c	350005952700000002	0-23		17538025	10.1091/mbc.E06-09-0869	1059-1524	Molecular Biology of the Cell	Evidence that Mono-ADP-Ribosylation of CtBP1/BARS Regulates Lipid Storage	Bartz	2007	5		MTTP
788	chr6	26634669	26634692	3500351226	23		26634669	26634692	8421504	1	23	0	c	350035122600000001	20-43						A radiation hybrid map of river buffalo (Bubalus bubalis) chromosome 7 and comparative mapping to the cattle and human genomes	ticabovina.com.br	0	0		
788	chr6	26634803	26634839	3500391509	36		26634803	26634839	8421504	1	36	0	c	350039150900000170	1-37						US Patent # 6,767,739. Antisense modulation of microsomal triglyceride transfer protein expression - Patents.com	www.patents.com	0	0		
788	chr6	26639202	26639226	3500436605	24		26639202	26639226	8421504	1	24	0	c	350043660500000002	1-25		18393287	10.1002/hep.22197	1527-3350	Hepatology	Apolipoprotein B&#x2013;dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin - Nahmias - 2008 - Hepatology - Wiley Online Library	Nahmias	2008	0		
788	chr6	26663599	26663624	3500239349	25		26663599	26663624	8421504	1	25	0	c	350023934900000012	0-25						Efecte de la sobreexpressi&#xf3; de la carnitina-palmito&#xef;ltransferasa (CPT) 1A en el fetge de ratolins obesos	www.tdx.cat	0	0		
788	chr6	26663740	26670366	3500400415	48		26663740	26670366	8421504	2	26,22	0,6604	p	350040041500015000	0-48			10.1152/ajpendo.00157.2006		American Journal of Physiology - Endocrinology and Metabolism	PPAR&#x03b1; mediates the hypolipidemic action of fibrates by antagonizing FoxO1	Qu	2007	0		MTTP
788	chr6	26663740	26670366	3500245424	48		26663740	26670366	8421504	2	26,22	0,6604	p	350024542400015000	0-48			10.1152/ajpendo.00157.2006		American Journal of Physiology - Endocrinology and Metabolism	PPAR&#x03b1; mediates the hypolipidemic action of fibrates by antagonizing FoxO1	Qu	2007	0		MTTP
98	chr6	27000632	27006362	3500085562	39		27000632	27006362	8421504	2	36,3	0,5727	c	350008556200000782	0-39						Methods and compositions for assaying analytes	Yuan	1999	0		
792	chr6	27140419	27140497	3500339302	78		27140419	27140497	8421504	1	78	0	p	350033930200015062	0-78						Multiple Sequence Alignment	www.cs.uml.edu	0	0		ADH6
792	chr6	27140419	27140497	3500326081	78		27140419	27140497	8421504	1	78	0	p	350032608100015019	0-78						Overview of the Bernoulli Sampler	web.ccv.brown.edu	0	0		ADH6
792	chr6	27140419	27140497	3500036433	78		27140419	27140497	8421504	1	78	0	p	350003643300015019	0-78						Overview of the Gibbs Motif Sampler	web.ccv.brown.edu	0	0		ADH6
792	chr6	27223205	27223760	3500078731	42		27223205	27223760	8421504	2	21,21	0,534	c,g	350007873100000005,350007873100000005,350007873100000006	0-21,0-21,0-21						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		
792	chr6	27247944	27248004	3500151745	60		27247944	27248004	8421504	1	60	0	p	350015174500015005	0-60						NPG.nature.vol.410.Issue.6827.Mar	www.scribd.com	0	0		ADH5
792	chr6	27249717	27250259	3500085562	47		27249717	27250259	8421504	2	19,28	0,514	c	350008556200000745	0-47						Methods and compositions for assaying analytes	Yuan	1999	0		
792	chr6	27250266	27250314	3500384310	48		27250266	27250314	8421504	1	48	0	p	350038431000015127	6-54						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		ADH5
99	chr6	27385873	27423442	3500337744	617		27385873	27423442	8421504	7	18,107,96,64,115,80,137	0,23619,29403,32292,33034,35232,37432	p,c	350033774400015000,350033774400000004,350033774400000005,350033774400015003,350033774400000006,350033774400000007,350033774400000008,350033774400000009,350033774400000010,350033774400000011,350033774400000013,350033774400015011,350033774400000003,350033774400000014,350033774400000001	0-57,0-60,0-60,0-63,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-25,0-61,0-23						Strukturelle und funktionelle Charakterisierung essenzieller Faktoren f&#xfc;r die Initiation der Translation im Endometrium des Schweins	ok.uni-rostock.de	0	0		
99	chr6	27385873	27423401	3500112692	636		27385873	27423401	8421504	7	18,107,96,64,115,139,97	0,23619,29403,32292,33034,35232,37431	p	350011269200015031,350011269200015038,350011269200015046,350011269200015054,350011269200015055	0-105,0-171,0-180,0-180,0-180						UNIVERSITAT AUTANOMA DE BARCELONA DEPARTAMENT DE GENATICA I DE MICROBIOLOGIA INSTITUT	ddd.uab.cat	0	0		EIF4E
99	chr6	27385873	27423401	3500092157	636		27385873	27423401	8421504	7	18,107,96,64,115,139,97	0,23619,29403,32292,33034,35232,37431	p	350009215700015029,350009215700015036,350009215700015044,350009215700015053,350009215700015052	0-105,0-171,0-180,0-180,0-180						Identificaci&#xf3;n de un candidato	ww.tesisenred.net	0	0		EIF4E
99	chr6	27385873	27418922	3500051132	300		27385873	27418922	8421504	5	18,107,96,64,15	0,23619,29403,32292,33034	p	350005113200015008,350005113200015009	0-150,0-150						Bioinformatics 1 -- lecture 18 signatures motifs footprints	w.bioinfo.rpi.edu	0	0		EIF4E
794	chr6	27409493	27409519	3500380649	26		27409493	27409519	8421504	1	26	0	c	350038064900000015	0-26						Oligomeric compounds that facilitate risc loading	Allerson	2005	0		EIF4E
794	chr6	27409493	27409519	3500376816	26		27409493	27409519	8421504	1	26	0	c	350037681600000015	0-26						Oligomeric compounds that facilitate risc loading	Allerson	2007	0		EIF4E
794	chr6	27409493	27409519	3500271859	26		27409493	27409519	8421504	1	26	0	c	350027185900000013	0-26						Conjugated double strand compositions for use in gene modulation	Bhat	2009	0		EIF4E
794	chr6	27409493	27409519	3500255449	26		27409493	27409519	8421504	1	26	0	c	350025544900000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500246270	26		27409493	27409519	8421504	1	26	0	c	350024627000000017	0-26						Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation	Bhat	2008	0		EIF4E
794	chr6	27409493	27409519	3500212457	26		27409493	27409519	8421504	1	26	0	c	350021245700000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500174703	26		27409493	27409519	8421504	1	26	0	c	350017470300000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500159438	26		27409493	27409519	8421504	1	26	0	c	350015943800000015	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Allerson	2007	0		EIF4E
794	chr6	27409493	27409519	3500101200	26		27409493	27409519	8421504	1	26	0	c	350010120000000017	0-26						Oligomeric Compounds That Facilitate Risc Loading	Swayze	2005	0		EIF4E,PHB
794	chr6	27409493	27409519	3500095801	26		27409493	27409519	8421504	1	26	0	c	350009580100000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500093922	26		27409493	27409519	8421504	1	26	0	c	350009392200000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500093733	26		27409493	27409519	8421504	1	26	0	c	350009373300000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500093639	26		27409493	27409519	8421504	1	26	0	c	350009363900000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500088990	26		27409493	27409519	8421504	1	26	0	c	350008899000000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E,PHB
794	chr6	27409493	27409519	3500087644	26		27409493	27409519	8421504	1	26	0	c	350008764400000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500087056	26		27409493	27409519	8421504	1	26	0	c	350008705600000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409493	27409519	3500084723	26		27409493	27409519	8421504	1	26	0	c	350008472300000017	0-26						Double strand compositions comprising differentially modified strands for use in gene modulation	Bhat	2007	0		EIF4E
794	chr6	27409550	27418224	3500443103	48		27409550	27418224	8421504	2	24,24	0,8650	c,g	350044310300000000,350044310300000001,350044310300000001	0-24,0-24,0-24						Poster Aacr 2010 Pettersson 2	ww.slideshare.net	0	0		EIF4E
794	chr6	27418178	27421182	3500345219	43		27418178	27421182	8421504	2	22,21	0,2983	c,g	350034521900000006,350034521900000000,350034521900000000,350034521900000001	0-19,0-21,0-21,0-21		22573234	10.1016/j.celrep.2012.02.010	2211-1247	Cell Reports	Cell Reports - Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis	Lin	2012	0		EIF4E
794	chr6	27418178	27421182	3500276875	43		27418178	27421182	8421504	2	22,21	0,2983	c	350027687500000006,350027687500000000,350027687500000001	0-19,0-21,0-21		22573234	10.1016/j.celrep.2012.02.010	2211-1247	Cell Reports	Cell Reports - Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis	Lin	2012	0		
794	chr6	27418178	27421182	3500197589	43		27418178	27421182	8421504	2	22,21	0,2983	c	350019758900000006,350019758900000000,350019758900000001	0-19,0-21,0-21			10.1016/j.celrep.2012.02.010		Cell reports	Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis	Chen-Ju	2012	0		EIF4E
794	chr6	27423394	27423420	3500292853	26		27423394	27423420	8421504	1	26	0	c	350029285300000001	8-34						Negative Regulation of Protein Translation by Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 - Keeping the Faith	pthefaith1296.com	0	0		EIF4E
794	chr6	27423418	27424037	3500286864	40		27423418	27424037	8421504	2	20,20	0,599	c,g	350028686400000008,350028686400000004,350028686400000005,350028686400000003	0-20,0-20,0-19,0-20						POSITIONALLY MODIFIED siRNA CONSTRUCTS	Allerson	2005	0		EIF4E
794	chr6	27423418	27424037	3500228306	40		27423418	27424037	8421504	2	20,20	0,599	c,g	350022830600000008,350022830600000005,350022830600000005,350022830600000004,350022830600000004,350022830600000003,350022830600000003	0-20,0-19,0-19,0-20,0-20,0-20,0-20						POSITIONALLY MODIFIED siRNA CONSTRUCTS	Allerson	2007	0		
794	chr6	27424324	27424348	3500277668	24		27424324	27424348	8421504	1	24	0	c	350027766800000031	0-24						320-022125 FOCUS 25	ww.invitrogen.com	0	0		
794	chr6	27424324	27424348	3500071549	24		27424324	27424348	8421504	1	24	0	c	350007154900000031	0-24						320-022125 FOCUS 25	ww.invitrogen.com	0	0		
796	chr6	27717813	27717840	3500229213	24		27717813	27717840	8421504	2	6,18	0,9	g	350022921300000026	3-28						Npc1l1 (npc3) and methods of identifying ligands thereof	Garcia-Calvo	2008	0		
799	chr6	28065632	28065663	3500221916	27		28065632	28065663	8421504	3	18,4,5	0,19,26	g	350022191600000076	5-32						VECTORS AND YEAST STRAINS FOR PROTEIN PRODUCTION	Choi	2009	0		
801	chr6	28371510	28371533	3500083403	23		28371510	28371533	8421504	1	23	0	g	350008340300000005,350008340300000041	3-26,3-26						RECOMBINANT IL-5 ANTAGONISTS USEFUL IN TREATMENT OF IL-5 MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
806	chr6	29049754	29049779	3500308662	25		29049754	29049779	8421504	1	25	0	g	350030866200000026	0-25						DNA	.lib.kobe-u.ac.jp	0	0		
819	chr6	30718814	30718837	3500225410	23		30718814	30718837	8421504	1	23	0	g	350022541000000083	2-36						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	osdir.com/patents	0	0		
819	chr6	30718814	30718837	3500152492	23		30718814	30718837	8421504	1	23	0	g	350015249200000123	2-36						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
822	chr6	31157116	31157142	3500422177	26		31157116	31157142	8421504	1	26	0	c	350042217700000010	0-26		12604620	10.1095/biolreprod.102.008433	0006-3363	Biology of Reproduction	Molecular Characterization and Expression of Porcine Bone Morphogenetic Protein Receptor-IB in the Uterus of Cyclic and Pregnant Gilts	Kim	2003	4		
102	chr6	31157872	31207870	3500388596	138		31157872	31207870	8421504	6	21,31,23,19,22,22	0,16804,16921,26118,49933,49976	c,g	350038859600000014,350038859600000012,350038859600000008,350038859600000018,350038859600000018,350038859600000010,350038859600000000	0-21,0-31,0-23,0-19,0-19,0-22,0-22		11259271	10.1095/biolreprod64.4.1225	0006-3363	Biology of Reproduction	Highly Prolific Booroola Sheep Have a Mutation in the Intracellular Kinase Domain of Bone Morphogenetic Protein IB Receptor (ALK-6) That Is Expressed in Both Oocytes and Granulosa Cells	Wilson	2001	4		BMPR1B
102	chr6	31157872	31207777	3500301519	1039		31157872	31207777	8421504	16	21,45,83,131,25,103,137,112,32,62,96,48,69,27,28,20	0,56,108,1972,5978,6051,15500,15686,16803,16882,24585,26127,36240,36819,36894,49885	c,g	350030151900000008,350030151900000076,350030151900000042,350030151900000041,350030151900000040,350030151900000039,350030151900000038,350030151900000036,350030151900000035,350030151900000034,350030151900000033,350030151900000066,350030151900000032,350030151900000030,350030151900000029,350030151900000028,350030151900000005,350030151900000026,350030151900000026,350030151900000004,350030151900000023,350030151900000022,350030151900000020,350030151900000018,350030151900000017,350030151900000015	0-21,6-51,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-47,0-48,0-48,0-31,0-48,0-48,0-23,0-48,0-48,0-48,0-48,0-48,0-48						Mutated BMP1B receptor as regulator of ovularion rate	Te Li Sa *M*Wei Er Xun 	2003	0		
822	chr6	31157936	31157961	3500204547	25		31157936	31157961	8421504	1	25	0	c	350020454700000014	10-35						Molecular characterization of adult mouse subventricular zone progenitor cells during the onset of differentiation | Matthew Thakur - Academia.edu	www.academia.edu	0	0		
102	chr6	31157940	31207900	3500361277	1506		31157940	31207900	8421504	10	123,131,176,298,193,139,97,103,103,143	0,1904,5910,15432,16735,24487,26024,36138,36751,49817	p	350036127700015012,350036127700015008	0-1506,0-1506						BONE MORPHOGENETIC PROTEIN RECEPTOR BINDING AGENTS AND METHODS OF THEIR USE	Chartier-courtaud	2011	0		
822	chr6	31157940	31157967	3500041712	27		31157940	31157967	8421504	1	27	0	c	350004171200000007	0-27		12135884	10.1095/biolreprod67.2.473	0006-3363	Biology of Reproduction	Bone Morphogenetic Protein Receptor Type II Is a Receptor for Growth Differentiation Factor-9	Vitt	2002	4		
822	chr6	31163868	31174818	3500265208	40		31163868	31174818	8421504	2	20,20	0,10930	c,g	350026520800000003,350026520800000011,350026520800000002,350026520800000002,350026520800000010,350026520800000010	0-20,0-20,0-20,0-20,0-20,0-20						Anti-Inflammatory Bacteria - Patent application	www.faqs.org	0	0		BMPR1B
822	chr6	31163868	31174818	3500044263	40		31163868	31174818	8421504	2	20,20	0,10930	c,g	350004426300000003,350004426300000002,350004426300000002	0-20,0-20,0-20						ANTI-INFLAMMATORY BACTERIA - THE CHINESE UNIVERSITY OF HONG KONG	www.sumobrain.com	0	0		BMPR1B
822	chr6	31163887	31163998	3500099578	99		31163887	31163998	8421504	2	51,48	0,63	p	350009957800015013,350009957800015006	0-51,0-48						TransformingGrowthFactor&#xc3;&#x0178;TypeIReceptorKinaseMutantAssociatedwith MetastaticBreastCancer1	.aacrjournals.org	0	0		BMPR1B
822	chr6	31173453	31173477	3500008335	24		31173453	31173477	8421504	1	24	0	c	350000833500000030	0-24						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		BMPR1B
822	chr6	31173656	31174801	3500053265	40		31173656	31174801	8421504	3	14,6,20	0,1019,1125	c	350005326500000009,350005326500000008	0-20,0-20						Levels of mRNA for BMP-7 in goat ovarian follicles and in vitro effects of BMP-7 on secondary follicle development	www.cbra.org.br	0	0		BMPR1B
822	chr6	31173668	31174763	3500314401	90		31173668	31174763	8421504	2	2,88	0,1007	c,g	350031440100000055,350031440100000033,350031440100000033	0-90,0-54,0-54						SI appendix for	www.pnas.org	0	0		
102	chr6	31174676	31207827	3500211935	72		31174676	31207827	8421504	3	31,19,22	0,9314,33129	c,g	350021193500000012,350021193500000018,350021193500000018,350021193500000010	0-31,0-19,0-19,0-22		11259271	10.1095/biolreprod64.4.1225	0006-3363	Biology of Reproduction	Highly Prolific Booroola Sheep Have a Mutation in the Intracellular Kinase Domain of Bone Morphogenetic Protein IB Receptor (ALK-6) That Is Expressed in Both Oocytes and Granulosa Cells	Wilson	2001	4		
822	chr6	31174676	31174866	3500333068	54		31174676	31174866	8421504	2	31,23	0,167	c	350033306800000001,350033306800000000	0-31,0-23		12021074	10.1095/biolreprod66.6.1869	0006-3363	Biology of Reproduction	DNA Tests in Prolific Sheep from Eight Countries Provide New Evidence on Origin of the Booroola (FecB) Mutation	Davis	2002	4		
822	chr6	31174676	31174866	3500324551	54		31174676	31174866	8421504	2	31,23	0,167	c	350032455100000001,350032455100000000	0-31,0-23		12021074	10.1095/biolreprod66.6.1869	0006-3363	Biology of Reproduction	DNA Tests in Prolific Sheep from Eight Countries Provide New Evidence on Origin of the Booroola (FecB) Mutation	Davis	2002	4		
822	chr6	31174676	31174707	3500274934	31		31174676	31174707	8421504	1	31	0	c	350027493400000003	0-31						Mutated bmp1b receptor as regulator of ovulation rate	Wilson	2001	0		
822	chr6	31174676	31174707	3500133444	31		31174676	31174707	8421504	1	31	0	c	350013344400000003	0-31						Mutated bmp1b receptor as regulator of ovulation rate	Wilson	2003	0		
102	chr6	31174760	31207879	3500394874	212		31174760	31207879	8421504	5	96,48,8,12,48	0,7751,9293,19318,33071	c	350039487400000163,350039487400000162,350039487400000159,350039487400000156,350039487400000150	0-48,0-48,0-48,28-48,0-48						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2002	0		
822	chr6	31174760	31194090	3500031651	116		31174760	31194090	8421504	4	48,48,8,12	0,7751,9293,19318	c	350003165100000163,350003165100000159,350003165100000156	0-48,0-48,28-48						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2003	0		
822	chr6	31174769	31184029	3500280145	63		31174769	31184029	8421504	2	39,24	0,9236	c	350028014500000157,350028014500000150	0-39,0-24						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2003	0		
822	chr6	31174785	31182515	3500398643	70		31174785	31182515	8421504	3	22,22,26	0,42,7704	c	350039864300000003,350039864300000010,350039864300000009	0-22,0-22,0-26		19074578	10.1210/en.2008-0900		Endocrinology	Expression of Bone Morphogenetic Protein Receptor (BMPR) during Perinatal Ovary Development and Primordial Follicle Formation in the Hamster: Possible Regulation by FSH	Cheng	2009	0		BMPR1B
102	chr6	31184032	31207897	3500001774	375		31184032	31207897	8421504	4	29,103,103,140	0,10046,10659,23725	p	350000177400015003	0-375						Bone morphogenetic protein receptor 1B(BMPR1B)&#x7d30;&#x80de;&#x5916;&#x30c9;&#x30e1;&#x30a4;&#x30f3;&#x53c8;&#x306f;&#x305d;&#x306e;&#x5909;&#x7570;&#x4f53;&#x3092;&#x542b;&#x3080;&#x86cb;&#x767d;&#x8cea;&#x3092;&#x542b;&#x6709;&#x3059;&#x308b;&#x9aa8;&	Kakitani	2011	0		
822	chr6	31184038	31194118	3500454655	63		31184038	31194118	8421504	2	23,40	0,10040	p	350045465500015020	3-66						Characterization Cloning of	mcb.asm.org	0	0		BMPR1B
822	chr6	31194693	31194716	3500401126	23		31194693	31194716	8421504	1	23	0	c	350040112600000009	22-45						Platelet-Rich Plasma Promotes the Proliferation of Human Muscle Derived Progenitor Cells and Maintains Their Stemness	olarship.pitt.edu	0	0		BMPR1B
822	chr6	31194767	31194792	3500414182	25		31194767	31194792	8421504	1	25	0	c	350041418200000013	0-25						Bone morphonic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma	Clark	2009	0		BMPR1B
822	chr6	31194767	31194792	3500070722	25		31194767	31194792	8421504	1	25	0	c	350007072200000013,350007072200000039	0-25,0-25					Patent	Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma (Patent EP:1440159)	Clark	2006	0		BMPR1B
822	chr6	31194768	31194792	3500350634	24		31194768	31194792	8421504	1	24	0	c	350035063400000013	0-24		19366455	10.1186/1757-2215-2-4	1757-2215	Journal of Ovarian Research	BMP-2 signaling in ovarian cancer and its association with poor prognosis	Page	2009	3		BMPR1B
822	chr6	31194768	31194792	3500210430	24		31194768	31194792	8421504	1	24	0	c	350021043000000013	0-24		19366455	10.1186/1757-2215-2-4	1757-2215	Journal of Ovarian Research	BMP-2 signaling in ovarian cancer and its association with poor prognosis	Page	2009	3		BMPR1B
822	chr6	31194768	31194792	3500014877	24		31194768	31194792	8421504	1	24	0	c	350001487700000013	0-24		19366455	10.1186/1757-2215-2-4		Journal of Ovarian Research	BMP-2 signaling in ovarian cancer and its association with poor prognosis	Cecile	2009	0		BMPR1B
825	chr6	31569235	31569258	3500355249	23		31569235	31569258	8421504	1	23	0	g	350035524900000004	8-43						A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia	ev.biologists.org	0	0		
827	chr6	31743610	31743637	3500282252	23		31743610	31743637	8421504	3	4,13,6	0,5,21	g	350028225200000121	17-42						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
830	chr6	32143195	32143221	3500402697	23		32143195	32143221	8421504	2	8,15	0,11	g	350040269700000363	0-23						METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF - Patent application	www.faqs.org	0	0		
831	chr6	32372305	32372333	3500402697	23		32372305	32372333	8421504	2	17,6	0,22	g	350040269700000222	2-26						METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF - Patent application	www.faqs.org	0	0		
832	chr6	32466140	32466470	3500361470	318		32466140	32466470	8421504	5	90,45,93,45,45	0,93,141,237,285	p	350036147000015044	0-318						 Methods And Products For Biasing Cellular Development 	www.docstoc.com	0	0		
832	chr6	32466332	32466395	3500373609	63		32466332	32466395	8421504	1	63	0	p	350037360900015000	0-63						Composition and methods for the therapeutic use of an atonal-associated sequence	Bellen	2000	0		GRID2
832	chr6	32467020	32467046	3500125340	26		32467020	32467046	8421504	1	26	0	c,g	350012534000000037,350012534000000037	4-30,4-30						US Patent # 7,053,200. Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation - Patents.com	www.patents.com	0	0		
848	chr6	34591307	34591337	3500001057	28		34591307	34591337	8421504	3	18,4,6	0,19,24	g	350000105700000264	5-35					Patent	Chitinase encoding DNA molecules from cotton expressed preferentially in secondary walled cells during secondary wall deposition and a corresponding promoter (Patent CN:100564528)	C*H*Hai Ge Le 	2009	0		
850	chr6	34807177	34807201	3500059380	23		34807177	34807201	8421504	2	9,14	0,10	g	350005938000000004	0-44						A link in transcription between the native pbpB the acquired mecA gene in a strain of Staphylococcus aureus	c.sgmjournals.org	0	0		
859	chr6	35918526	35918554	3500060533	24		35918526	35918554	8421504	2	10,14	0,14	g	350006053300000073	9-45						PLANT TRANSFORMED WITH POLYNUCLEOTIDE ENCODING LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS DELTA-ENDOTOXIN - Patent application	www.faqs.org	0	0		
859	chr6	36004890	36004916	3500293908	23		36004890	36004916	8421504	2	12,11	0,15	c	350029390800000289	1-24						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	hera.ugr.es	0	0		
859	chr6	36004890	36004916	3500192823	23		36004890	36004916	8421504	2	12,11	0,15	c	350019282300000289	1-24						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	digibug.ugr.es	0	0		
862	chr6	36419254	36419281	3500322758	27		36419254	36419281	8421504	1	27	0	c	350032275800000000	10-37						Post-transcriptionalRegulationof -SynucleinExpressionby mir-7andmir-153 S	www.jbc.org	0	0		
862	chr6	36419256	36419283	3500080079	27		36419256	36419283	8421504	1	27	0	c	350008007900000000	0-27		23457458	10.1371/journal.pone.0055068		PLoS ONE	Dopamine-Mediated Oxidation of Methionine 127 in &#x03b1;-Synuclein Causes Cytotoxicity and Oligomerization of &#x03b1;-Synuclein	Kazuhiro	2013	0		SNCA
862	chr6	36419256	36419282	3500315643	26		36419256	36419282	8421504	1	26	0	c	350031564300000001	0-26		10567343	10.1074/jbc.274.48.33855	0021-9258	Journal of Biological Chemistry	Degradation of &#x03b1;-Synuclein by Proteasome	Bennett	1999	5		SNCA
862	chr6	36419256	36419282	3500306012	26		36419256	36419282	8421504	1	26	0	c	350030601200000000	0-26						-Synuclein Stimulates Differentiation of Osteosarcoma Cells--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		SNCA
862	chr6	36419361	36427317	3500168880	30		36419361	36427317	8421504	2	16,14	0,7942	c	350016888000000001	0-30		22389823	10.5402/2011/521847	2090-5505	ISRN Neurology	Familial Parkinson's Disease Mutant E46K <i>&#x03b1;</i>-Synuclein Localizes to Membranous Structures, Forms Aggregates, and Induces Toxicity in Yeast Models	Fiske	2011	0		SNCA
862	chr6	36427329	36434021	3500085554	45		36427329	36434021	8421504	2	16,29	0,6663	p	350008555400015029	0-45						METHOD FOR INTRODUCING FOREIGN GENE INTO EARLY EMBRYO OF PRIMATE ANIMAL AND METHOD FOR PRODUCING TRANSGENIC PRIMATE ANIMAL COMPRISING SUCH METHOD - Patent application	www.faqs.org	0	0		
862	chr6	36434009	36434099	3500255810	84		36434009	36434099	8421504	2	27,57	0,33	p	350025581000015001	0-87						Methods and compositions for the treatment of neurological disorders	Fink	2008	0		SNCA
863	chr6	36561671	36563926	3500342863	63		36561671	36563926	8421504	2	60,3	0,2252	p	350034286300015090,350034286300015089	0-63,0-48							library.wiley.com	0	0		SNCA
863	chr6	36561695	36563953	3500380846	66		36561695	36563953	8421504	2	36,30	0,2228	p,c	350038084600015007,350038084600015006,350038084600015005,350038084600015004,350038084600015003,350038084600015001,350038084600015008,350038084600000007,350038084600000006	0-66,0-66,0-66,0-66,0-66,0-66,0-63,0-24,0-24						Novel peptides conferring environmental stress resistance and fusion proteins including said peptides	Kim	2005	0		SNCA
863	chr6	36561695	36563933	3500409367	41		36561695	36563933	8421504	3	30,1,10	0,35,2228	c	350040936700000005,350040936700000009,350040936700000004	0-30,0-30,0-32						Molecular Determinant of &#x03b1;-Synuclein Pathotoxicity in Yeast Models	ww.lakeforest.edu	0	0		SNCA
863	chr6	36561712	36563957	3500347822	53		36561712	36563957	8421504	2	19,34	0,2211	c	350034782200000020	0-53						NOVEL PEPTIDES CONFERRING ENVIRONMENTAL STRESS RESISTANCE AND FUSION PROTEINS INCLUDING SAID PEPTIDES	Kim	2005	0		
863	chr6	36563935	36563959	3500320307	24		36563935	36563959	8421504	1	24	0	c	350032030700000003	6-30		15744056	10.1534/genetics.104.035493	0016-6731	Genetics	&#x03b1;-Synuclein Targets the Plasma Membrane via the Secretory Pathway and Induces Toxicity in Yeast	Dixon	2005	4		
865	chr6	36743371	36753763	3500115394	555		36743371	36753763	8421504	9	42,15,30,51,129,48,14,102,124	0,45,1464,1497,7104,7236,7287,7812,10268	p	350011539400015048	0-555						Method for identification of genes involved in specific diseases	Harris	2002	0		
865	chr6	36808658	36808682	3500115982	23		36808658	36808682	8421504	2	12,11	0,13	c	350011598200000396	12-35						Human telomerase catalytic subunit: diagnostic and therapeutic methods	Cech	1997	0		
867	chr6	36984062	36984086	3500335075	23		36984062	36984086	8421504	2	19,4	0,20	g	350033507500000007	12-35						US Patent # 5,990,390. Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof - Patents.com	www.patents.com	0	0		
868	chr6	37193100	37194495	3500390002	48		37193100	37194495	8421504	2	24,24	0,1371	c	350039000200000002,350039000200000003	0-24,0-24						Human protein phosphatase iic abi2	Xiao	2001	0		PPM1K
868	chr6	37199828	37199853	3500271944	23		37199828	37199853	8421504	2	15,8	0,17	c	350027194400000032	12-40						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		
868	chr6	37199828	37199853	3500237109	23		37199828	37199853	8421504	2	15,8	0,17	c	350023710900000032	12-40						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		
868	chr6	37199828	37199853	3500210939	23		37199828	37199853	8421504	2	15,8	0,17	c	350021093900000073	12-40						Starchless variety of pisum sativum having elevated levels of sucrose	Webster	2000	0		
869	chr6	37259580	37259811	3500378848	172		37259580	37259811	8421504	2	57,115	0,116	g	350037884800000021,350037884800000018	59-231,0-171						COMPOUNDS, KITS AND METHODS FOR CONFERRING CYTOPROTECTION - Patent application	www.faqs.org	0	0		
869	chr6	37286583	37286628	3500032905	45		37286583	37286628	8421504	1	45	0	p	350003290500015008	0-45						BREAST CANCER RESISTANCE PROTEIN (BCRP) AND ANTIBODIES THERETO - Patent application	www.faqs.org	0	0		
869	chr6	37293963	37298589	3500290863	41		37293963	37298589	8421504	3	19,2,20	0,889,4606	c,g	350029086300000010,350029086300000011,350029086300000011	0-21,0-20,0-20						MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells	aspetjournals.org	0	0		ABCG2
869	chr6	37293963	37298589	3500267604	41		37293963	37298589	8421504	3	19,2,20	0,889,4606	c,g	350026760400000012,350026760400000013,350026760400000013	0-21,0-20,0-20		19270061	10.1124/mol.108.054163		Molecular Pharmacology	MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells	Yu-Zhuo	June	0		ABCG2
869	chr6	37293963	37298589	3500194520	41		37293963	37298589	8421504	3	19,2,20	0,889,4606	c,g	350019452000000012,350019452000000013,350019452000000013	0-21,0-20,0-20		19270061	10.1124/mol.108.054163	1521-0111 (Online)	Molecular Pharmacology	MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells	Pan	2009	0		ABCG2
869	chr6	37293964	37298589	3500278012	40		37293964	37298589	8421504	3	18,2,20	0,888,4605	c,g	350027801200000004,350027801200000005,350027801200000005	0-20,0-20,0-20						shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells	-publications.com	0	0		ABCG2
869	chr6	37306290	37320554	3500434935	39		37306290	37320554	8421504	2	20,19	0,14245	c,g	350043493500000004,350043493500000005,350043493500000005	0-20,0-19,0-19		22071170	10.1124/dmd.111.041467		Drug Metabolism and Disposition	UDP-Glucuronosyltransferase (UGT) 1A9-Overexpressing HeLa Cells Is an Appropriate Tool to Delineate the Kinetic Interplay between Breast Cancer Resistance Protein (BRCP) and UGT and to Rapidly Identify the Glucuronide Substrates of BCRP	Wen	2012	0		ABCG2
869	chr6	37306413	37309759	3500230459	42		37306413	37309759	8421504	3	1,21,20	0,2089,3326	c,g	350023045900000000,350023045900000001,350023045900000001	0-22,0-20,0-20						ATP-binding Cassette Transporter G2 Activity in the Bovine Spermatozoa is modulated along the Epididymal Duct and at Ejaculation	ww.biolreprod.org	0	0		
869	chr6	37309772	37323533	3500053901	44		37309772	37323533	8421504	2	24,20	0,13741	c	350005390100000002,350005390100000006	21-45,20-40		17483351	10.1158/0008-5472.CAN-06-3169	0008-5472	Cancer Research	Oligomerization Domain of the Multidrug Resistance&#x2013;Associated Transporter ABCG2 and Its Dominant Inhibitory Activity	Xu	2007	8		
869	chr6	37320528	37320551	3500446393	23		37320528	37320551	8421504	1	23	0	c	350044639300000005	0-23		15961534	10.1152/ajpregu.00173.2005		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages	Mathias	2005	0		ABCG2
869	chr6	37320528	37320551	3500294219	23		37320528	37320551	8421504	1	23	0	c	350029421900000005	0-23		15961534	10.1152/ajpregu.00173.2005		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages	Mathias	2005	0		ABCG2
869	chr6	37320528	37320551	3500218103	23		37320528	37320551	8421504	1	23	0	c	350021810300000005	0-23		15961534	10.1152/ajpregu.00173.2005		American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages	Mathias	2005	0		ABCG2
869	chr6	37320531	37323531	3500265784	43		37320531	37323531	8421504	2	22,21	0,2979	c,g	350026578400000000,350026578400000000,350026578400000001	0-22,0-22,0-21						Proteomic analysis of epithelium-denuded human amniotic membrane as a limbal stem cell niche	www.molvis.org	0	0		
869	chr6	37322151	37322184	3500331403	33		37322151	37322184	8421504	1	33	0	c	350033140300000003	0-33			10.1124/dmd.105.007591	1521-009X (Online)	Drug Metabolism and Disposition	EPIDERMAL GROWTH FACTOR-MEDIATED ACTIVATION OF THE MAP KINASE CASCADE RESULTS IN ALTERED EXPRESSION AND FUNCTION OF ABCG2 (BCRP)	Schwabedissen	2006	0		ABCG2
869	chr6	37323492	37331288	3500201018	41		37323492	37331288	8421504	2	21,20	0,7776	c,g	350020101800000000,350020101800000001	0-21,0-21						Culture & characterisation of limbal epithelial cells & oral mucosal cells	www.icmr.nic.in	0	0		
869	chr6	37323513	37323536	3500279370	23		37323513	37323536	8421504	1	23	0	c	350027937000000004	0-23						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
869	chr6	37327638	37327878	3500101011	42		37327638	37327878	8421504	2	21,21	0,219	g	350010101100000000,350010101100000001	0-21,0-21						Novel SNPs of the ABCG2 Gene and Their Associations with Milk Production Traits in Iranian Holstein Bulls	als.modares.ac.ir	0	0		
869	chr6	37327727	37327837	3500263194	42		37327727	37327837	8421504	2	21,21	0,89	g	350026319400000002,350026319400000003	0-21,0-21						International Buffalo Information Centre	ibic.lib.ku.ac.th	0	0		
869	chr6	37327759	37328687	3500257699	42		37327759	37328687	8421504	2	20,22	0,906	c,g	350025769900000010,350025769900000011,350025769900000011	0-20,0-22,0-22						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
869	chr6	37328666	37328689	3500310730	23		37328666	37328689	8421504	1	23	0	c	350031073000000002	23-46						Expression of ABCB1, ABCC2 and ABCG2 in porcine tissues	ive.library.uu.nl	0	0		ABCG2
869	chr6	37341982	37342008	3500362735	24		37341982	37342008	8421504	3	5,13,6	0,6,20	c	350036273500000473	0-28						Compositions containing nucleic acids and ligands for therapeutic treatment	Baird	1999	0		
870	chr6	37399985	37400033	3500340116	48		37399985	37400033	8421504	1	48	0	p	350034011600015005	0-48						A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes. - ResearchGate	.researchgate.net	0	0		PKD2
870	chr6	37421618	37421642	3500097341	24		37421618	37421642	8421504	1	24	0	c	350009734100000001	0-24						ScienceDirect.com - Journal of Dairy Science - Proteomic analysis and immunodetection of the bovine milk osteopontin isoforms	sciencedirect.com	0	0		
870	chr6	37421788	37421813	3500351226	25		37421788	37421813	8421504	1	25	0	c	350035122600000003	27-52						A radiation hybrid map of river buffalo (Bubalus bubalis) chromosome 7 and comparative mapping to the cattle and human genomes	ticabovina.com.br	0	0		
870	chr6	37421803	37421828	3500112233	25		37421803	37421828	8421504	1	25	0	c	350011223300000012,350011223300000001	11-36,11-36						Recombinant anti-osteopontin antibody and use thereof - US Patent 7241873 Description	ww.patentstorm.us	0	0		
870	chr6	37421813	37421836	3500296074	23		37421813	37421836	8421504	1	23	0	c	350029607400000002	0-23						Osteopontin Gene Expression Determines Spontaneous Metastatic Performance of Orthotopic Human Breast Cancer Xenografts--&#x300a;&#x7f8e;&#x56fd;&#x75c5;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x	journal.9med.net	0	0		SPP1
870	chr6	37421813	37421836	3500205295	23		37421813	37421836	8421504	1	23	0	c	350020529500000002	0-23						Osteopontin Gene Expression Determines Spontaneous Metastatic Performance of Orthotopic Human Breast Cancer Xenografts 2007&#x5e74;&#x7b2c;169&#x5377;&#x7b2c;8&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		SPP1
870	chr6	37421967	37421998	3500173307	31		37421967	37421998	8421504	1	31	0	c	350017330700000007,350017330700000008	0-19,0-19						Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial &#xfb01;broblasts in hypoxic pulmonary hypertension	ng.physiology.org	0	0		
870	chr6	37422852	37424412	3500084821	1560		37422852	37424412	8421504	1	1560	0	g	350008482100000017,350008482100000009,350008482100000021	0-1560,0-22,0-22						 DAIRY CATTLE BREEDING FOR IMPROVED MILK PRODUCTION TRAITS IN CATTLE - Patent application	www.faqs.org	0	0		
870	chr6	37422852	37424412	3500002891	1560		37422852	37424412	8421504	1	1560	0	g	350000289100000010,350000289100000014,350000289100000002	0-1560,0-22,0-22						Dairy Cattle Breeding For Improved Milk Production Traits In Cattle 	.freshpatents.com	0	0		
870	chr6	37422865	37424497	3500005217	40		37422865	37424497	8421504	2	20,20	0,1612	c	350000521700000005,350000521700000004	0-20,0-20						Treatment of bony defects with osteoblast precursor cells	Frank	1999	0		SPP1
870	chr6	37422883	37422979	3500070056	96		37422883	37422979	8421504	1	96	0	p	350007005600015068,350007005600015067	0-48,0-48						Method Of Screening For Inhibitors Of Osteopontin 	.freshpatents.com	0	0		
870	chr6	37423366	37423656	3500163898	51		37423366	37423656	8421504	2	29,22	0,268	g	350016389800000004,350016389800000002	0-29,0-22						Universidade de S&#xaa;o Paulo Faculdade de Medicina de Ribeir&#xaa;o Preto Departamento de Gen&#xd8;tica	www.teses.usp.br	0	0		
870	chr6	37427153	37427177	3500178716	24		37427153	37427177	8421504	1	24	0	c	350017871600000015	0-24						Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study	www.ossatec.eu	0	0		SPP1
870	chr6	37427153	37427177	3500009628	24		37427153	37427177	8421504	1	24	0	c	350000962800000005	0-24		19224509	10.1634/stemcells.2008-0233	1549-4918	STEM CELLS	The Multipotency of Luteinizing Granulosa Cells Collected from Mature Ovarian Follicles - Kossowska-Tomaszczuk - 2009 - STEM CELLS - Wiley Online Library	Kossowska-Tomaszczuk	2009	0		SPP1
870	chr6	37427159	37427185	3500393042	26		37427159	37427185	8421504	1	26	0	c	350039304200000011	16-42						Varied Pathways of Stage IA Lung Adenocarcinomas Discovered by Inte- grated Gene Expression Analysis	www.ijbs.com	0	0		SPP1
871	chr6	37577976	37578001	3500414906	25		37577976	37578001	8421504	1	25	0	g	350041490600000002	0-25						Runx2- and Histone Deacetylase 3-mediated Repression Is Relieved in Differentiating Human Osteoblast Cells to Allow High Bone Sialoprotein Expression--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520	journal.9med.net	0	0		
871	chr6	37580557	37580581	3500135352	24		37580557	37580581	8421504	1	24	0	c	350013535200000013	0-24						Role of Retinoic Acid-Related Orphan Receptor- in Differentiation of Human Mesenchymal Stem Cells along with Osteoblastic Lineage	www.karger.com	0	0		
109	chr6	37873850	37896485	3500320608	628		37873850	37896485	8421504	9	66,60,25,24,103,80,105,45,120	0,3480,7865,14887,15766,20059,21887,22455,22515	p,c	350032060800015027,350032060800015039,350032060800000006,350032060800015076,350032060800000014,350032060800000022,350032060800015079,350032060800015078,350032060800015094,350032060800015096,350032060800015109,350032060800015108	90-336,90-330,0-25,0-114,0-25,0-19,0-60,0-60,0-105,0-45,0-96,0-120						Purification of P. c. chabaudi aminopeptidase, and antimalarial effects of the aminopeptidase inhibitor bestatin.	doras.dcu.ie	0	0		
874	chr6	37918698	37968851	3500195017	156		37918698	37968851	8421504	7	20,27,27,21,21,20,20	0,45925,46348,46716,47045,49760,50133	g	350019501700000078,350019501700000040,350019501700000007,350019501700000039,350019501700000042,350019501700000008,350019501700000041,350019501700000044,350019501700000043,350019501700000009	0-20,0-27,0-27,0-27,0-21,0-21,0-21,0-20,0-20,0-20						Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same - Patent application	www.faqs.org	0	0		
874	chr6	37965046	37965073	3500435772	27		37965046	37965073	8421504	1	27	0	g	350043577200000007	0-27						Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same	Takasuga	2009	0		
875	chr6	38031335	38140905	3500195017	3705		38031335	38140905	8421504	43	20,20,156,207,229,20,146,23,28,85,23,193,150,20,21,141,25,24,124,23,90,20,180,111,120,228,21,182,175,21,162,28,139,27,20,84,20,76,23,236,20,24,20	0,356,31373,32655,33285,35309,35466,35678,35800,35895,36030,36956,37627,41224,41895,41962,42120,42507,42666,44572,44665,44945,45070,50120,52439,58892,59146,70739,71187,73393,73509,73757,73925,74129,74322,74403,74573,76288,77117,77242,77480,109124,109550	p,c,g	350019501700000046,350019501700000010,350019501700000045,350019501700000026,350019501700015002,350019501700015003,350019501700015004,350019501700015006,350019501700015007,350019501700015008,350019501700015009,350019501700015011,350019501700015012,350019501700000047,350019501700015013,350019501700015014,350019501700000011,350019501700000048,350019501700000012,350019501700000049,350019501700015016,350019501700015017,350019501700000050,350019501700015018,350019501700015019,350019501700015021,350019501700015022,350019501700015023,350019501700015024,350019501700000034,350019501700000004,350019501700000051,350019501700015026,350019501700015027,350019501700000052,350019501700000053,350019501700015028,350019501700015029,350019501700000057,350019501700015031,350019501700000016,350019501700000058,350019501700000061,350019501700015032,350019501700015033,350019501700015034,350019501700015036,350019501700015037,350019501700015038,350019501700015039,350019501700015041,350019501700015042,350019501700015043,350019501700015044,350019501700000064,350019501700015046,350019501700015047,350019501700015048,350019501700015049,350019501700015051,350019501700015052,350019501700000065,350019501700015053,350019501700015054,350019501700000067,350019501700000020,350019501700000066,350019501700015056,350019501700015057,350019501700015058,350019501700000068,350019501700000069,350019501700015059,350019501700000070,350019501700000022,350019501700015061,350019501700015062,350019501700000071,350019501700015063,350019501700000072,350019501700000023,350019501700000074,350019501700000073,350019501700000073	0-20,0-20,0-20,1-3215,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-20,0-45,0-45,19-42,0-22,0-28,0-27,0-45,0-45,0-23,0-45,0-45,0-45,0-45,0-45,0-45,0-20,20-40,0-21,0-45,0-45,0-25,0-24,0-45,0-45,0-23,0-45,23-43,0-20,0-20,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-21,0-45,0-45,0-45,0-45,0-45,0-45,0-21,0-45,0-45,0-23,18-42,0-21,0-45,0-45,0-45,0-27,0-20,0-45,0-20,20-40,0-45,0-45,0-23,0-45,0-20,23-43,0-24,0-20,0-20						Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same - Patent application	www.faqs.org	0	0		
875	chr6	38067135	38067163	3500435772	28		38067135	38067163	8421504	1	28	0	g	350043577200000012	0-28						Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same	Takasuga	2009	0		
875	chr6	38073995	38108718	3500061252	109		38073995	38108718	8421504	7	20,23,6,17,5,16,22	0,106,31005,31265,31822,33628,34701	c,g	350006125200000000,350006125200000001,350006125200000005,350006125200000002,350006125200000003,350006125200000004	0-20,0-23,0-23,0-22,0-21,0-22		19720859	10.1534/genetics.109.106476	0016-6731	Genetics	Dissection of Genetic Factors Modulating Fetal Growth in Cattle Indicates a Substantial Role of the Non-SMC Condensin I Complex, Subunit G (NCAPG) Gene	Eberlein	2009	4		
877	chr6	38287673	38287980	3500195017	39		38287673	38287980	8421504	2	20,19	0,288	c,g	350019501700000076,350019501700000025,350019501700000025,350019501700000075,350019501700000075	0-20,0-19,0-19,0-19,0-19						Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same - Patent application	www.faqs.org	0	0		
877	chr6	38287876	38287904	3500464863	28		38287876	38287904	8421504	1	28	0	c	350046486300000053	0-28						US Patent # 5,789,195. Human notch and delta, binding domains in toporythmic proteins, and methods based thereon - Patents.com	www.patents.com	0	0		IRF2BPL
880	chr6	38699257	38699280	3500300417	23		38699257	38699280	8421504	1	23	0	g	350030041700000003	2-28						Genomic Comparison of the Closely Related Salmonella enterica Serovars Enteritidis and Dublin	enthamscience.com	0	0		
895	chr6	40706657	40706692	3500001171	26		40706657	40706692	8421504	3	8,10,8	0,13,27	g	350000117100000208	9-35						METHOD TO DETERMINE RESPONSIVENESS OF CANCER TO EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING TREATMENTS - THE GENERAL HOSPITAL CORPORATION	www.sumobrain.com	0	0		
896	chr6	40822913	40822936	3500155338	23		40822913	40822936	8421504	1	23	0	g	350015533800000016	9-40						Recent Progress in Optical Biosensors for Environmental Applications	ww.intechopen.com	0	0		
112	chr6	41120514	41159367	3500425686	79		41120514	41159367	8421504	4	20,19,20,20	0,19284,28509,38833	c,g	350042568600000004,350042568600000000,350042568600000000,350042568600000006,350042568600000006,350042568600000007	0-20,0-19,0-19,0-20,0-20,0-20		21264840	10.1002/cncr.25890	1097-0142	Cancer	A novel exon 15-deleted, splicing variant of Slit2 shows potential for growth inhibition in addition to invasion inhibition in lung cancer - Lin - 2011 - Cancer - Wiley Online Library	Lin	2011	0		
898	chr6	41149026	41153976	3500068421	45		41149026	41153976	8421504	2	26,19	0,4931	c	350006842100000002	0-45						Human Placental Expression of SLIT/ROBO Signaling Cues: Effects of Preeclampsia and Hypoxia Authors 1, 2 1,	ww.biolreprod.org	0	0		
898	chr6	41153182	41153207	3500117034	25		41153182	41153207	8421504	1	25	0	c	350011703400000000	0-25		22968430	10.4161/epi.22103		Epigenetics	miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues	Tatiana	2012	0		SLIT2
903	chr6	41719108	41719134	3500280721	23		41719108	41719134	8421504	2	11,12	0,14	g	350028072100000242	24-47						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
910	chr6	42599421	42599452	3500449217	24		42599421	42599452	8421504	3	5,13,6	0,7,25	g	350044921700000000	5-30		20819186	10.1111/j.1755-148X.2010.00760.x	1755-148X	Pigment Cell & Melanoma Research	Downregulation of SIK2 expression promotes the melanogenic program in mice - Horike - 2010 - Pigment Cell & Melanoma Research - Wiley Online Library	Horike	2010	0		
912	chr6	42870704	42870732	3500083334	24		42870704	42870732	8421504	2	9,15	0,13	g	350008333400000195	18-42					Patent	Short interfering ribonucleic acid (siRNA) with improved pharmacological properties (Patent US:8084600)	Billy	2011	0		
925	chr6	44641280	44641303	3500367490	23		44641280	44641303	8421504	1	23	0	c	350036749000000080	25-48						Growth differentiation factor-8	Lee	1998	0		
925	chr6	44641280	44641303	3500239104	23		44641280	44641303	8421504	1	23	0	c	350023910400000080	25-48						SureChem - Document - USPTO Granted - Patent No. 5994618 - "Growth differentiation factor-8 transgenic mice" - Description	www.surechem.org	0	0		
925	chr6	44641576	44660026	3500387162	79		44641576	44660026	8421504	4	21,38,3,17	0,153,18279,18433	c	350038716200000007,350038716200000006,350038716200000004	0-21,0-38,0-20						Effect of ABCG2 PPARGC1A OLR1 and gene polymorphism on estimated breeding values for functional and production traits in Polish Holstein-Friesian bulls	w.genepassport.ru	0	0		
925	chr6	44642761	44649379	3500258055	45		44642761	44649379	8421504	2	24,21	0,6597	c,g	350025805500000003,350025805500000002	0-24,1-22		19826104	10.1152/ajpendo.00505.2009		American Journal of Physiology - Endocrinology and Metabolism	Changed mitochondrial function by pre- and/or postpartum diet alterations in sheep	Jorgensen	2009	0		
925	chr6	44642761	44642785	3500345006	24		44642761	44642785	8421504	1	24	0	c	350034500600000003	0-24		19826104	10.1152/ajpendo.00505.2009		American Journal of Physiology - Endocrinology and Metabolism	Changed mitochondrial function by pre- and/or postpartum diet alterations in sheep	Jorgensen	2009	0		PPARGC1A
925	chr6	44649870	44659751	3500050879	40		44649870	44659751	8421504	3	20,6,14	0,68,9867	c,g	350005087900000001,350005087900000001,350005087900000000	0-20,0-20,0-20		23166610	10.1371/journal.pone.0049189	1932-6203	PLOS ONE	PLOS ONE: Transcutaneous Application of Carbon Dioxide (CO2) Induces Mitochondrial Apoptosis in Human Malignant Fibrous Histiocytoma In Vivo	Onishi	2012	4		PPARGC1A
925	chr6	44649929	44659748	3500203232	26		44649929	44659748	8421504	2	15,11	0,9808	c	350020323200000012	19-45						Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity. - ResearchGate	.researchgate.net	0	0		PPARGC1A
925	chr6	44660742	44660820	3500415326	46		44660742	44660820	8421504	2	22,24	0,54	c	350041532600000005,350041532600000026,350041532600000025	24-46,0-22,0-24						ESTABLISHED HUMAN BROWN ADIPOCYTE LINE AND METHOD FOR DIFFERENTIATION FROM AN HMADS CELL LINE - Patent application	www.faqs.org	0	0		
925	chr6	44660846	44661373	3500165278	117		44660846	44661373	8421504	6	20,19,19,21,19,19	0,243,313,341,372,508	c,g	350016527800000080,350016527800000180,350016527800000180,350016527800000081,350016527800000081,350016527800000179,350016527800000176,350016527800000176,350016527800000175	20-40,0-19,0-19,0-19,0-19,0-21,0-19,0-19,0-19						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
925	chr6	44661257	44661577	3500147381	46		44661257	44661577	8421504	2	24,22	0,298	c,g	350014738100000001,350014738100000001,350014738100000000,350014738100000000	0-24,0-24,0-22,0-22						Molecular differentiation of Peroxysome proliferator activated receptor coactivator-1 among different breeds of Bubalus bubalis	ioinformation.net	0	0		
925	chr6	44661545	44673303	3500343864	46		44661545	44673303	8421504	2	23,23	0,11735	c	350034386400000012,350034386400000011	0-23,0-23						NPG.nature.vol.431.Issue.7005.Sep	www.scribd.com	0	0		PPARGC1A
925	chr6	44661545	44673303	3500279365	46		44661545	44673303	8421504	2	23,23	0,11735	c	350027936500000001,350027936500000000	0-23,0-23						Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders	Rinsch	2012	0		PPARGC1A
925	chr6	44661545	44673303	3500111100	46		44661545	44673303	8421504	2	23,23	0,11735	c	350011110000000027,350011110000000026	0-23,0-23		23690838	10.1155/2013/212139		Evidence-based Complementary and Alternative Medicine : eCAM	Combined Ethanol Extract of Grape Pomace and Omija Fruit Ameliorates Adipogenesis, Hepatic Steatosis, and Inflammation in Diet-Induced Obese Mice	Su-Jung	2013	0		PPARGC1A
925	chr6	44673279	44677483	3500433096	42		44673279	44677483	8421504	2	21,21	0,4183	c,g	350043309600000001,350043309600000001,350043309600000000	0-21,0-21,0-21		16614354	10.1152/japplphysiol.01486.2005	8750-7587	Journal of Applied Physiology	ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction	Zoll	2006	4		PPARGC1A
925	chr6	44673280	44673303	3500254000	23		44673280	44673303	8421504	1	23	0	c	350025400000000024	0-23						Use of pi3k inibitors for the treatment of obesity, steatosis and ageing	Bischoff	2012	0		PPARGC1A
925	chr6	44673296	44677395	3500161716	51		44673296	44677395	8421504	3	25,22,4	0,188,4095	c	350016171600000048,350016171600000049	0-25,0-26						Universit&#xe9; catholique de Louvain Facult&#xe9; de M&#xe9;decine	.bib.ucl.ac.be:81	0	0		PPARGC1A
925	chr6	44673469	44677559	3500372009	40		44673469	44677559	8421504	2	20,20	0,4070	c	350037200900000016,350037200900000015	0-20,0-20						Differential Roles of Insulin Receptor Substrates in Brown Adipocyte Differentiation	mcb.asm.org	0	0		
925	chr6	44673469	44677559	3500348060	40		44673469	44677559	8421504	2	20,20	0,4070	c	350034806000000043,350034806000000009,350034806000000042,350034806000000008	0-20,0-20,0-20,0-20						METHODS AND COMPOSITIONS FOR INDUCING BROWN ADIPOGENESIS - Patent application	www.faqs.org	0	0		PPARGC1A
925	chr6	44673469	44677559	3500340698	40		44673469	44677559	8421504	2	20,20	0,4070	c	350034069800000026,350034069800000025	0-20,0-20						METHODS OF TREATMENT USING SIRT MODULATORS AND COMPOSITIONS CONTAINING SIRT1 MODULATORS	Farmer	2008	0		
925	chr6	44673469	44677559	3500249167	40		44673469	44677559	8421504	2	20,20	0,4070	c	350024916700000009,350024916700000008	0-20,0-20						Methods and compositions for inducing brown adipogenesis	Tseng	2011	0		PPARGC1A
925	chr6	44673469	44677559	3500229660	40		44673469	44677559	8421504	2	20,20	0,4070	c	350022966000000009,350022966000000008	0-20,0-20						Methods and compositions for inducing brown adipogenesis	Tseng	2009	0		PPARGC1A
925	chr6	44673469	44677559	3500099342	40		44673469	44677559	8421504	2	20,20	0,4070	c	350009934200000005,350009934200000004	0-20,0-20		17954559	10.1128/MCB.00992-07	0270-7306	Molecular and Cellular Biology	Identification of a Domain within Peroxisome Proliferator-Activated Receptor &#x03b3; Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in Adipocytes	Wang	2008	6		PPARGC1A
925	chr6	44673469	44677559	3500085644	40		44673469	44677559	8421504	2	20,20	0,4070	c	350008564400000016,350008564400000015	0-20,0-20		14966273	10.1128/MCB.24.5.1918-1929.2004	0270-7306	Molecular and Cellular Biology	Differential Roles of Insulin Receptor Substrates in Brown Adipocyte Differentiation	Tseng	2004	6		
925	chr6	44673473	44677482	3500139150	44		44673473	44677482	8421504	2	24,20	0,3989	c	350013915000000001,350013915000000000	0-24,0-20						Treatment of human muscle cells with popular dietary supplements increase mitochondrial function and metabolic rate	andmetabolism.com	0	0		PPARGC1A
925	chr6	44677398	44678576	3500339640	40		44677398	44678576	8421504	2	20,20	0,1158	c,g	350033964000000001,350033964000000001,350033964000000000	0-20,0-20,0-20		19393061	10.1186/1471-2164-10-186	1471-2164	BMC Genomics	Novel transcripts discovered by mining genomic DNA from defined regions of bovine chromosome 6	Weikard	2009	4		
925	chr6	44677411	44677595	3500409160	40		44677411	44677595	8421504	2	20,20	0,164	c,g	350040916000000037,350040916000000037,350040916000000036,350040916000000036	0-20,0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
925	chr6	44677449	44677550	3500261436	40		44677449	44677550	8421504	2	20,20	0,81	c,g	350026143600000084,350026143600000084,350026143600000083,350026143600000083	0-20,0-20,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
925	chr6	44678543	44680418	3500415138	57		44678543	44680418	8421504	2	36,21	0,1854	p	350041513800015002	0-57		19903832	10.1124/mol.109.060541	1521-0111 (Online)	Molecular Pharmacology	15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor &#x03b2;/&#x03b4; Agonist	Naruhn	2010	0		PPARGC1A
925	chr6	44678546	44680439	3500466835	75		44678546	44680439	8421504	2	33,42	0,1851	p	350046683500015047	0-75						Ppar Active Compounds 	.freshpatents.com	0	0		PPARGC1A
925	chr6	44678546	44680439	3500456201	75		44678546	44680439	8421504	2	33,42	0,1851	p	350045620100015000	0-75						Lxr ligand testing method - Patent application	www.faqs.org	0	0		PPARGC1A
925	chr6	44678546	44680439	3500341244	75		44678546	44680439	8421504	2	33,42	0,1851	p	350034124400015001	0-75						Lxr ligand testing method	Terasaka	2008	0		PPARGC1A
925	chr6	44678546	44680439	3500304394	75		44678546	44680439	8421504	2	33,42	0,1851	p	350030439400015047	0-75						Ppar Active Compounds 	.freshpatents.com	0	0		PPARGC1A
925	chr6	44678546	44680439	3500242820	75		44678546	44680439	8421504	2	33,42	0,1851	p	350024282000015046	0-75						PPAR active compounds	Lin	2006	0		PPARGC1A
925	chr6	44678546	44680439	3500213123	75		44678546	44680439	8421504	2	33,42	0,1851	p	350021312300015047,350021312300015158	0-75,0-45						PPAR active compounds - Patent application	www.faqs.org	0	0		PPARGC1A
925	chr6	44678546	44680439	3500188389	75		44678546	44680439	8421504	2	33,42	0,1851	p	350018838900015057	0-75						PPAR active compounds	Lin	2005	0		PPARGC1A
925	chr6	44678546	44680439	3500179198	75		44678546	44680439	8421504	2	33,42	0,1851	p	350017919800015000	0-75					Patent	LXR ligand testing method (Patent US:7989179)	Honzumi	2011	0		PPARGC1A
925	chr6	44678546	44680439	3500094851	75		44678546	44680439	8421504	2	33,42	0,1851	p	350009485100015048	0-75						PPAR active compounds	Artis	2006	0		PPARGC1A
925	chr6	44678555	44680439	3500112470	66		44678555	44680439	8421504	2	24,42	0,1842	p	350011247000015048	0-66						Indole derivatives for use as ppar active compounds	Artis	2007	0		PPARGC1A
925	chr6	44680473	44680498	3500056183	25		44680473	44680498	8421504	1	25	0	c	350005618300000000	0-25						THE J BIOLOGICAL C &#xa9; 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. in the Regulation of Hepatic Glucose and Energy Metabolism*	www.jbc.org	0	0		PPARGC1A
925	chr6	44680481	44680504	3500186873	23		44680481	44680504	8421504	1	23	0	c	350018687300000000	0-23						The microRNA miR-696 regulates PGC-1&#x03b1; in mouse skeletal muscle in response to physical activity	do.physiology.org	0	0		
925	chr6	44680481	44680504	3500120068	23		44680481	44680504	8421504	1	23	0	c	350012006800000000	0-23		20086200	10.1152/ajpendo.00448.2009		American Journal of Physiology - Endocrinology and Metabolism	The microRNA miR-696 regulates PGC-1&#x03b1; in mouse skeletal muscle in response to physical activity	Aoi	2010	0		
926	chr6	44740112	44740136	3500336416	24		44740112	44740136	8421504	1	24	0	g	350033641600000024	16-40		21391224	10.1002/hep.24290	1527-3350	Hepatology	Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in heparg cells - Anth&#xe9;rieu - 2011 - Hepatology - Wiley Online Library	Antherieu	2011	0		
926	chr6	44745630	44745654	3500329012	24		44745630	44745654	8421504	1	24	0	c,g	350032901200000004,350032901200000004	0-24,0-24		19884383	10.1210/me.2009-0302	0888-8809	Molecular Endocrinology	Peroxisome Proliferator-Activated Receptor &#x03b3; Coactivator-1&#x03b1; Interacts with the Androgen Receptor (AR) and Promotes Prostate Cancer Cell Growth by Activating the AR	Shiota	2010	5		PPARGC1A
926	chr6	44745658	44745824	3500329155	86		44745658	44745824	8421504	3	22,43,21	0,74,145	c,g	350032915500000001,350032915500000013,350032915500000002,350032915500000012	0-22,0-21,0-23,0-21						ADD1/SREBP1c activates the PGC1-alpha promoter in brown adipocytes. - ResearchGate	.researchgate.net	0	0		PPARGC1A
926	chr6	44745792	44745848	3500449958	56		44745792	44745848	8421504	1	56	0	g	350044995800000032,350044995800000033	49-105,5-61		22540007	10.1371/journal.pone.0035823		PLoS ONE	Diammonium Glycyrrhizinate Upregulates PGC-1&#x03b1; and Protects against A&#x03b2;1&#x2013;42-Induced Neurotoxicity	Xiaolei	2012	0		
929	chr6	45096436	45096463	3500333232	24		45096436	45096463	8421504	3	4,5,15	0,5,12	g	350033323200000006	3-28						 Xylose Isomerase Gene Of Thermus Aquaticus 	www.docstoc.com	0	0		
931	chr6	45391916	45391941	3500247901	25		45391916	45391941	8421504	1	25	0	c	350024790100000009	10-35		19432882	10.1111/j.1349-7006.2009.01185.x	1349-7006	Cancer Science	Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis - Lin - 2009 - Cancer Science - Wiley Online Library	Lin	2009	0		
931	chr6	45433121	45438028	3500221873	78		45433121	45438028	8421504	3	30,9,39	0,75,4868	p	350022187300015018	147-261						INVESTIGATION OF WHEAT GENES INVOLVED IN ZINC EFFICIENCY MECHANISM USING DIFFERENTIAL DISPLAY TECHNIQUE	d.lib.metu.edu.tr	0	0		DHX15
932	chr6	45553529	45553556	3500199435	25		45553529	45553556	8421504	2	6,19	0,8	g	350019943500000306	1-26					Patent	Nucleic acid that encodes a chimeric adenoviral coat protein (Patent US:6153435)	Crystal	2000	0		
933	chr6	45651037	45651079	3500165920	42		45651037	45651079	8421504	1	42	0	c,g	350016592000000009,350016592000000030,350016592000000042	160-202,165-207,159-201						A superoxide dismutase	Edlund	1987	0		
933	chr6	45651047	45651079	3500388761	32		45651047	45651079	8421504	1	32	0	c	350038876100000029,350038876100000030,350038876100000025	6-34,6-38,6-38						Transgenic non-human mammals producing EC-SOD protein in their milk	Hansson	1995	0		
933	chr6	45651047	45651079	3500379167	32		45651047	45651079	8421504	1	32	0	c	350037916700000029,350037916700000030,350037916700000025	6-34,6-38,6-38						Transgenic production of ec-sod	Hansson	1995	0		
934	chr6	45784783	45784813	3500240600	25		45784783	45784813	8421504	2	16,9	0,21	g	350024060000000029	23-48						CD30 ligand conjugates	Goodwin	1995	0		
935	chr6	45919876	45919899	3500001171	23		45919876	45919899	8421504	1	23	0	g	350000117100000383	7-30						METHOD TO DETERMINE RESPONSIVENESS OF CANCER TO EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING TREATMENTS - THE GENERAL HOSPITAL CORPORATION	www.sumobrain.com	0	0		
936	chr6	46017918	46017942	3500263142	23		46017918	46017942	8421504	2	9,14	0,10	g	350026314200000000	5-28		19411305	10.1677/JME-09-0036	0952-5041	Journal of Molecular Endocrinology	Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids	Bogdarina	2009	3		
936	chr6	46071306	46071329	3500131034	23		46071306	46071329	8421504	1	23	0	c	350013103400000000	7-30		16754673	10.1074/jbc.M602915200	0021-9258	Journal of Biological Chemistry	De-epoxidation of Violaxanthin in the Minor Antenna Proteins of Photosystem II, LHCB4, LHCB5, and LHCB6	Wehner	2006	5		
936	chr6	46122123	46122152	3500398923	26		46122123	46122152	8421504	3	5,17,4	0,7,25	g	350039892300000151	3-29						PHAGE-DISPLAYING SINGLE-CHAIN ANTIBODY CAPABLE OF RECOGNIZING NON-REDUCED MANNOSE RESIDUE - Patent application	www.faqs.org	0	0		
941	chr6	46676667	46676692	3500371040	23		46676667	46676692	8421504	2	13,10	0,15	g	350037104000000099,350037104000000253	0-23,0-23						METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS - Patent application	www.faqs.org	0	0		
941	chr6	46676667	46676692	3500335035	23		46676667	46676692	8421504	2	13,10	0,15	g	350033503500000119,350033503500000088	14-37,12-35					Patent	In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells (Patent EP:1340088)	Smith	2007	0		
941	chr6	46676667	46676692	3500280690	23		46676667	46676692	8421504	2	13,10	0,15	g	350028069000000077	0-23						Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof	Wu	2002	0		
941	chr6	46676667	46676692	3500211134	23		46676667	46676692	8421504	2	11,12	0,13	g	350021113400000004	0-23						Monoclonal antibody against platelet membrane glycoprotein VI	Takayama	2004	0		
941	chr6	46676667	46676692	3500176773	23		46676667	46676692	8421504	2	13,10	0,15	g	350017677300000094	0-23					Patent	Methods for producing members of specific binding pairs (Patent US:7723270)	McCafferty	2010	0		
941	chr6	46676667	46676692	3500176107	23		46676667	46676692	8421504	2	13,10	0,15	g	350017610700000034	0-23						Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY30	Feder	2002	0		
941	chr6	46676667	46676692	3500175652	23		46676667	46676692	8421504	2	13,10	0,15	g	350017565200000045	0-23					Patent	Vascular endothelial growth factor 2 (Patent US:8206708)	Rosen	2012	0		
941	chr6	46676667	46676692	3500058525	23		46676667	46676692	8421504	2	13,10	0,15	g	350005852500000067	0-23					Patent	BSL2v1c2 polypeptides (Patent US:7807786)	Mikesell	2010	0		
941	chr6	46676667	46676692	3500057438	23		46676667	46676692	8421504	2	13,10	0,15	g	350005743800000036	0-23						Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v	Franco	2004	0		CNTN4
941	chr6	46676667	46676692	3500019816	23		46676667	46676692	8421504	2	13,10	0,15	g	350001981600000101	0-23						Methods for producing members of specific binding pairs	McCafferty	2009	0		
941	chr6	46676667	46676692	3500009804	23		46676667	46676692	8421504	2	13,10	0,15	g	350000980400000029	0-23						Novel human G-protein coupled receptor, BMSOTR, and splice variant thereof	Ramanathan	2003	0		CNTN4
944	chr6	47109224	47114190	3500399464	90		47109224	47114190	8421504	3	42,21,27	0,4891,4939	p	350039946400015028	0-132						lag-1, a gene required for lin-12 and glp-1 signaling in Caenorhabditis elegans, is homologous to human CBF1 and DrosophilaSu(H)	ev.biologists.org	0	0		RBPJ
944	chr6	47159708	47163849	3500146462	44		47159708	47163849	8421504	2	23,21	0,4120	c	350014646200000001,350014646200000000	0-23,0-21		12065727	10.1124/jpet.302.1.274	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	C-Terminal Heptapeptide of Gastrin Inhibits Astrocytomas Motility by Interacting with a New Gastrin Binding Site	Pannequin	2002	0		CCKAR
944	chr6	47163804	47163882	3500163087	78		47163804	47163882	8421504	1	78	0	p	350016308700015011	0-78						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		CCKAR
945	chr6	47221793	47221822	3500103717	25		47221793	47221822	8421504	2	19,6	0,23	g	350010371700000008	8-36		21319793	10.1021/bi1020088		Biochemistry	Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain	Tsukasa	2011	0		
946	chr6	47381145	47381173	3500318648	24		47381145	47381173	8421504	2	8,16	0,12	g	350031864800001494	8-34						US Patent # 6,060,594. Nucleic acid segments encoding modified bacillus thuringiensis coleopteran-toxic crystal proteins - Patents.com	www.patents.com	0	0		
947	chr6	47551837	47551862	3500025039	23		47551837	47551862	8421504	3	5,14,4	0,6,21	g	350002503900000034	16-41						Recombinant swinepox virus	Cochran	1996	0		
948	chr6	47609829	47609852	3500238244	23		47609829	47609852	8421504	1	23	0	g	350023824400000012	8-33						Expression systems for making single-chain monellin analogs - US Patent 5487983 Description	ww.patentstorm.us	0	0		
948	chr6	47681009	47681033	3500200895	23		47681009	47681033	8421504	2	10,13	0,11	g	350020089500000146	16-46						 Chemoreceptors In Plant Parasitic Nematodes 	www.docstoc.com	0	0		
949	chr6	47730767	47730791	3500269694	23		47730767	47730791	8421504	2	10,13	0,11	g	350026969400000006	9-32						PKA/AKAP/VR-1 Module: A Common Link of G -Mediated Signaling to Thermal Hyperalgesia	www.jneurosci.org	0	0		
950	chr6	47928224	47928252	3500194335	23		47928224	47928252	8421504	2	8,15	0,13	g	350019433500000053	0-23						Journal of General Virology	005.pasteur.ac.ir	0	0		
964	chr6	49721811	49721839	3500201405	23		49721811	49721839	8421504	2	7,16	0,12	g	350020140500000016	15-45						Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists - Patent # 7498409 - PatentGenius	.patentgenius.com	0	0		
970	chr6	50555780	50555807	3500406765	23		50555780	50555807	8421504	2	11,12	0,15	g	350040676500000005	2-25		20181723	10.1210/me.2008-0359	0888-8809	Molecular Endocrinology	Corepressors TLE1 and TLE3 Interact with HESX1 and PROP1	Carvalho	2010	5		
979	chr6	51675206	51675310	3500259232	104		51675206	51675310	8421504	1	104	0	g	350025923200000046	0-105						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
979	chr6	51675206	51675271	3500000589	65		51675206	51675271	8421504	1	65	0	g	350000058900000075	0-66						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
994	chr6	53721277	53721312	3500218114	26		53721277	53721312	8421504	3	9,11,6	0,13,29	g	350021811400000042	14-40						US Patent # 5,498,831. Pea ADP-glucose pyrophosphorylase subunit genes and their uses - Patents.com	www.patents.com	0	0		
1011	chr6	55858550	55858582	3500197873	30		55858550	55858582	8421504	3	6,18,6	0,7,26	g	350019787300000094,350019787300000955	10-43,19-43						Nucleic acid compositions encoding modified Bacillus thuringiensis coleopteran-toxic crystal proteins	English	1999	0		
1015	chr6	56401447	56401477	3500219888	24		56401447	56401477	8421504	3	4,14,6	0,5,24	g	350021988800000321	16-42					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404831)	Natt	2013	0		
1015	chr6	56401447	56401477	3500219703	24		56401447	56401477	8421504	3	4,14,6	0,5,24	g	350021970300000321	16-42					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8344128)	Natt	2013	0		
1021	chr6	57155947	57155972	3500402771	24		57155947	57155972	8421504	2	6,18	0,7	g	350040277100000021,350040277100000022	6-30,13-37						MODULATORS OF APOPTOSIS AND THE USES THEREOF - Patent application	www.faqs.org	0	0		
1025	chr6	57791875	57791900	3500137915	23		57791875	57791900	8421504	2	17,6	0,19	g	350013791500000674	5-29						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1035	chr6	59057789	59057817	3500231688	23		59057789	59057817	8421504	2	7,16	0,12	g	350023168800000284	14-37						Method of detecting neutophil inhibitory factor mimics	Moyle	1993	0		
1037	chr6	59358042	59358924	3500225389	882		59358042	59358924	8421504	1	882	0	g	350022538900000006	0-882						Pegasoferae? - Genomewiki	nomewiki.ucsc.edu	0	0		
1038	chr6	59401011	59401043	3500339288	32		59401011	59401043	8421504	1	32	0	c	350033928800000399	0-33						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		
1039	chr6	59631733	59631761	3500294513	24		59631733	59631761	8421504	2	7,17	0,11	c	350029451300000042	2-26						NOVEL DEATH DOMAIN PROTEINS - Patent application	www.faqs.org	0	0		
1044	chr6	60254106	60289359	3500018219	132		60254106	60289359	8421504	6	22,22,22,22,22,22	0,226,17840,17994,35099,35231	c,g	350001821900000023,350001821900000022,350001821900000022,350001821900000005,350001821900000004,350001821900000015,350001821900000014	0-22,0-22,0-22,0-22,0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
1044	chr6	60254184	60289154	3500361960	71		60254184	60289154	8421504	4	5,21,24,21	0,7,16426,34949	c	350036196000000010,350036196000000001,350036196000000006	20-46,22-46,21-42						Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation	biomedcentral.com	0	0		
1044	chr6	60254343	60272302	3500249124	79		60254343	60272302	8421504	4	20,19,20,20	0,170,369,17939	c	350024912400000025,350024912400000024,350024912400000017,350024912400000006	0-20,0-19,0-20,0-20						Transcriptional Expression Profile of Toll Like Receptor 1 - 10 mRNA in Bovine Peripheral Mononuclear Cells in Response to Foot and Mouth Disease Antigens	www.scirp.org	0	0		
1044	chr6	60254343	60272302	3500225619	79		60254343	60272302	8421504	4	20,19,20,20	0,170,369,17939	c	350022561900000025,350022561900000024,350022561900000017,350022561900000006	0-20,0-19,0-20,0-20						Transcriptional Expression Profile of Toll Like Receptor 1 - 10 mRNA in Bovine Peripheral Mononuclear Cells in Response to Foot and Mouth Disease Antigens	www.scirp.org	0	0		
1044	chr6	60254510	60289550	3500444535	108		60254510	60289550	8421504	5	22,20,22,22,22	0,15721,34299,34919,35018	c,g	350044453500000020,350044453500000021,350044453500000017,350044453500000017,350044453500000015,350044453500000015,350044453500000016	0-22,0-20,0-22,0-22,0-22,0-22,0-22						2009 OPEN ACCESS diversity	dspace.unitus.it	0	0		
1044	chr6	60255840	60255864	3500312394	24		60255840	60255864	8421504	1	24	0	c	350031239400000012	18-42						Innate Immunity at the Mucosal Surface: Role of Toll-Like Receptor 3 and Toll-Like	ww.biolreprod.org	0	0		TLR10
1044	chr6	60270231	60289550	3500163561	152		60270231	60289550	8421504	7	20,22,22,22,22,22,22	0,750,17748,18493,18578,19198,19297	c,g	350016356100000021,350016356100000019,350016356100000020,350016356100000018,350016356100000017,350016356100000017,350016356100000015,350016356100000016,350016356100000016	0-20,0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-22						2009 OPEN ACCESS diversity	www.mdpi.com	0	0		
1044	chr6	60270526	60272707	3500382145	41		60270526	60272707	8421504	2	22,19	0,2162	c,g	350038214500000001,350038214500000000,350038214500000000	0-22,4-23,4-23		20167196	10.1051/vetres/2010006	0928-4249	Veterinary Research	Identification of full length bovine TLR1 and functional characterization of lipopeptide recognition by bovine TLR2/1 heterodimer | Vet. Res.	Farhat	2010	4		
1044	chr6	60270609	60270633	3500328567	24		60270609	60270633	8421504	1	24	0	c	350032856700000000	23-47						DOMAIN EXCHANGE BETWEEN HUMAN TOLL-LIKE RECEPTORS 1 AND 6 REVEALS A REGION REQUIRED FOR LIPOPEPTIDE DISCRIMINATION	www.jbc.org	0	0		
1044	chr6	60270609	60270633	3500272347	24		60270609	60270633	8421504	1	24	0	c	350027234700000000	24-48		17951129	10.1684/ejd.2007.0264	1167-1122	European Journal of Dermatology	European Journal of Dermatology 	Begon	2007	3		
1044	chr6	60272387	60288729	3500445435	44		60272387	60288729	8421504	2	20,24	0,16318	c	350044543500000111,350044543500000113	0-20,20-44						2012	prints.qut.edu.au	0	0		
1044	chr6	60288096	60289467	3500133335	123		60288096	60289467	8421504	6	20,20,21,22,20,20	0,209,571,823,1108,1351	c,g	350013333500000023,350013333500000024,350013333500000024,350013333500000021,350013333500000021,350013333500000022,350013333500000022,350013333500000019,350013333500000019,350013333500000020,350013333500000020	0-20,0-20,0-20,0-21,0-21,0-22,0-22,0-20,0-20,0-20,0-20						ScienceDirect.com - Genomics - Analysis of sequence variability and protein domain architectures for bovine peptidoglycan recognition protein 1 and Toll-like receptors 2 and 6	sciencedirect.com	0	0		
130	chr6	60645268	60701622	3500098009	376		60645268	60701622	8421504	12	48,45,39,35,12,48,33,42,6,15,27,26	0,3568,13278,14523,15506,22468,36971,37052,37174,50912,52904,56328	c	350009800900000017,350009800900000020,350009800900000033,350009800900000038,350009800900000045,350009800900000061,350009800900000063,350009800900000078,350009800900000083	0-48,0-45,9-48,1-48,0-48,15-48,0-48,6-48,12-38						PROSTATE-SPECIFIC POLYPEPTIDE PAMP AND ENCODING NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
1047	chr6	60650641	60650668	3500167341	23		60650641	60650668	8421504	3	4,5,14	0,5,13	g	350016734100000001	11-34						Antagonistic Regulation of -Globin Gene Expression by Helix-Loop-Helix Proteins USF and TFII-I	mcb.asm.org	0	0		
1048	chr6	60816875	60816905	3500155106	28		60816875	60816905	8421504	2	20,8	0,22	g	350015510600000073	9-39						NOVEL EXPRESSION VECTOR - Patent application	www.faqs.org	0	0		
1049	chr6	60872110	60872138	3500313011	25		60872110	60872138	8421504	3	16,4,5	0,17,23	c	350031301100000051	2-27						CYTOLETHAL DISTENDING TOXINS AND DETECTION OF CAMPYLOBACTER BACTERIA USING THE SAME AS A TARGET - Patent application	www.faqs.org	0	0		
1049	chr6	60882855	60882901	3500212682	44		60882855	60882901	8421504	2	20,24	0,22	c,g	350021268200000002,350021268200000002,350021268200000000	0-22,0-22,0-24		23122059	10.1186/1471-2164-13-590	1471-2164	BMC Genomics	Detection of genetic association and functional polymorphisms of UGDH affecting milk production trait in Chinese Holstein cattle	Xu	2012	4		
1049	chr6	60886795	60888775	3500459668	58		60886795	60888775	8421504	3	28,2,28	0,1911,1952	c	350045966800000007,350045966800000006	0-30,0-28		19248106	10.1002/art.24302	1529-0131	Arthritis & Rheumatism	Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt - David-Raoudi - 2009 - Arthritis & Rheumatism - Wiley Online Library	David-Raoudi	2009	0		
1049	chr6	60886795	60888775	3500286143	58		60886795	60888775	8421504	3	28,2,28	0,1911,1952	c	350028614300000007,350028614300000006	0-30,0-28						Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt	atlantisilac.com	0	0		
1049	chr6	60892146	60892206	3500314092	60		60892146	60892206	8421504	1	60	0	p	350031409200015001	198-258						Cloning of an Enzyme That Synthesizes a Key Nucleotide- Sugar Precursor of Hemicellulose Biosynthesis from Soybean: U D P-G lucose Dehyd rogenase	.plantphysiol.org	0	0		UGDH
1049	chr6	60895660	60907555	3500187783	231		60895660	60907555	8421504	2	69,162	0,11733	p	350018778300015014	0-231						Oxford_SGC_Clones_web	www.docstoc.com	0	0		UGDH
1052	chr6	61313004	61313032	3500239982	24		61313004	61313032	8421504	2	15,9	0,19	g	350023998200000014,350023998200000015	10-34,14-38						ANTIBODIES TO MAdCAM	Pullen	2009	0		
1054	chr6	61585670	61585698	3500195809	23		61585670	61585698	8421504	2	7,16	0,12	g	350019580900000023	4-30						Identification of pyrazinamide-resistant mycobacteria and methods for treating mycobacterial infections - Patent # 5846718 - PatentGenius	.patentgenius.com	0	0		
1055	chr6	61683670	61683699	3500247376	25		61683670	61683699	8421504	2	10,15	0,14	c	350024737600000027	15-40						Method for detecting analytes based on evanescent illumination and scatter-based detection of nonoparticle probe complexes	Bao	2007	0		
1059	chr6	62215217	62215241	3500134317	23		62215217	62215241	8421504	2	8,15	0,9	g	350013431700000278,350013431700000494	13-36,0-23						Perhydrolase 	.freshpatents.com	0	0		
1060	chr6	62293219	62293244	3500280721	23		62293219	62293244	8421504	2	16,7	0,18	g	350028072100000278	19-42						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1060	chr6	62342926	62342949	3500297747	23		62342926	62342949	8421504	1	23	0	g	350029774700000053	0-24					Patent	Anti-VEGF antibodies (Patent US:7060269)	Baca	2006	0		
1060	chr6	62342926	62342949	3500044476	23		62342926	62342949	8421504	1	23	0	g	350004447600000053	0-24					Patent	Anti-VEGF antibodies (Patent US:7060269)	Baca	2006	0		
1061	chr6	62461431	62462402	3500259199	75		62461431	62462402	8421504	2	67,8	0,963	p	350025919900015016	0-75						Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in Endothelial Progenitor Cells	www.mcponline.org	0	0		UCHL1
1062	chr6	62531294	62531322	3500400238	24		62531294	62531322	8421504	3	5,5,14	0,6,14	c	350040023800000244	13-37						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1062	chr6	62562236	62562323	3500309450	42		62562236	62562323	8421504	3	11,21,10	0,54,77	g	350030945000000018	32-97						Method and reagent kit for analyzing and diagnosing bladder cancer by means of uropsammus DNA methylation profile	Zhu Jing De 	2009	0		
1064	chr6	62860242	62860270	3500457633	24		62860242	62860270	8421504	2	7,17	0,11	c	350045763300000012,350045763300000095	0-24,0-24						US Patent # 7,141,718. Nucleic acid sequences to proteins involved in tocopherol synthesis - Patents.com	www.patents.com	0	0		
1064	chr6	62860242	62860270	3500357477	24		62860242	62860270	8421504	2	7,17	0,11	c	350035747700000012,350035747700000096	0-24,0-24						**Please see images for: ( Certificate of Correction ) ** | Seedbuzz	www.seedbuzz.com	0	0		
1064	chr6	62860242	62860270	3500257911	24		62860242	62860270	8421504	2	7,17	0,11	c	350025791100000012,350025791100000095	0-24,0-24						US Patent # 7,265,207. Nucleic acid sequences to proteins involved in tocopherol synthesis - Patents.com	www.patents.com	0	0		
1064	chr6	62860242	62860270	3500146976	24		62860242	62860270	8421504	2	7,17	0,11	c	350014697600000095,350014697600000012	0-24,0-24						Nucleic acid sequences to proteins involved in tocopherol synthesis - US Patent 7141718 Description	ww.patentstorm.us	0	0		
1064	chr6	62860242	62860270	3500068987	24		62860242	62860270	8421504	2	7,17	0,11	c	350006898700000012	0-24						Nucleic acid sequences to proteins involved in tocopherol synthesis	Chen	2001	0		
1064	chr6	62860242	62860270	3500067667	24		62860242	62860270	8421504	2	7,17	0,11	c	350006766700000012	0-24						Nucleic acid sequences to proteins involved in tocopherol synthesis	Lassner	2002	0		
1064	chr6	62860242	62860270	3500042982	24		62860242	62860270	8421504	2	7,17	0,11	c	350004298200000177	0-24					Patent	Nucleic acid sequences to proteins involved in tocopherol synthesis (Patent CN:1318593)	B*Sa Wei Ji 	2007	0		
1064	chr6	62860242	62860270	3500041925	24		62860242	62860270	8421504	2	7,17	0,11	c	350004192500000162	0-24						Nucleic acid sequences to proteins involved in tocopherol synthesis	B*Sa Wei Ji 	2003	0		
1067	chr6	63220259	63220622	3500375699	360		63220259	63220622	8421504	4	12,61,149,138	0,13,75,225	g	350037569900000028	0-362						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1068	chr6	63343126	63363448	3500322425	138		63343126	63363448	8421504	4	23,25,48,42	0,3574,3743,20280	c	350032242500000093,350032242500000089,350032242500000068	0-48,0-48,6-48						Genes and polypeptides relating to prostate cancers	Zhong Cun You Fu 	2007	0		
16	chr6	63934153	63965892	3500197871	99		63934153	63965892	8421504	3	53,22,24	0,31690,31715	p	350019787100015000	0-99						Supporting Online Material for	ww.sciencemag.org	0	0		ATP8A1
16	chr6	63934153	63965892	3500114832	99		63934153	63965892	8421504	3	53,22,24	0,31690,31715	p	350011483200015000	0-99						Role of C. elegans TAT-1 Protein in Maintaining Plasma Membrane Phosphatidylserine Asymmetry Monica Darland-Ransom, www.sciencemag.org (this information is current as of April 24, 2008 )	mcdb.colorado.edu	0	0		ATP8A1
1073	chr6	63986179	63986207	3500118643	23		63986179	63986207	8421504	2	12,11	0,17	g	350011864300000010	6-29						JENNIFER ANNE COGGAN	www.teses.usp.br	0	0		
1086	chr6	65795612	65795638	3500065380	23		65795612	65795638	8421504	2	5,18	0,8	g	350006538000000018	15-38					Patent	Production of L-threonine by fermentation (Patent CN:1071378)	Zuo Ye Xiao Zhi Fu 	2001	0		
1086	chr6	65795612	65795638	3500024858	23		65795612	65795638	8421504	2	5,18	0,8	g	350002485800000013	15-38					Patent	Method for the production of L-threonine by fermentation, using mutated DNA encoding aspartokinase III (Patent US:5661012)	Kojima	1997	0		
1087	chr6	65892755	65892780	3500045044	23		65892755	65892780	8421504	3	13,6,4	0,14,21	g	350004504400000017	0-29						Replication and stability of the linear plasmid pBSSB2	ository.cam.ac.uk	0	0		
1095	chr6	66974515	66974562	3500447590	47		66974515	66974562	8421504	1	47	0	c	350044759000000187	0-47						METHODS TO EVALUATE GLUCOCORTICOID RECEPTOR AGONISTS AND ANTAGONISTS FOR EFFECTS ON NEURON-LIKE CELLS - Patent application	www.faqs.org	0	0		GABRG1
1096	chr6	66999351	67024406	3500210532	26		66999351	67024406	8421504	2	17,9	0,25046	c	350021053200000009	21-47						Different Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T Lymphocytes	u.diva-portal.org	0	0		
1096	chr6	67004648	67004672	3500463419	23		67004648	67004672	8421504	2	18,5	0,19	g	350046341900000005	1-26		22378069	10.1038/cddis.2012.16	false	Cell Death & Disease	Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells	Sanges	2012	0		
1096	chr6	67077840	67077865	3500080417	23		67077840	67077865	8421504	2	12,11	0,14	g	350008041700000001	10-33						STRESS PROTEIN COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CANCER AND INFECTIOUS DISEASE - CORIXA CORPORATION	www.sumobrain.com	0	0		
1096	chr6	67077840	67077865	3500015062	23		67077840	67077865	8421504	2	12,11	0,14	g	350001506200000001	10-33						Stress protein compositions and methods for prevention and treatment of cancer and infectious disease	Subjeck	2008	0		
137	chr6	67176899	67316855	3500240668	1347		67176899	67316855	8421504	10	294,203,153,144,83,5,210,68,116,71	0,14847,55144,56309,61035,63494,63505,84603,137226,139885	p	350024066800015023,350024066800015022	0-882,0-465						Cell lines expressing gaba receptor and methods using them	Langer	2010	0		GABRA2
137	chr6	67176899	67316855	3500234175	1353		67176899	67316855	8421504	9	294,203,153,144,83,221,68,116,71	0,14847,55144,56309,61035,63494,84603,137226,139885	p	350023417500015002	0-1353						KEGG T01001: 200959	www.genome.jp	0	0		GABRA2
137	chr6	67176899	67316855	3500131639	1353		67176899	67316855	8421504	9	294,203,153,144,83,221,68,116,71	0,14847,55144,56309,61035,63494,84603,137226,139885	p	350013163900015020	0-1353						Cell lines expressing gaba receptor and methods using them	Langer	2011	0		GABRA2
137	chr6	67176899	67316855	3500061496	1353		67176899	67316855	8421504	9	294,203,153,144,83,221,68,116,71	0,14847,55144,56309,61035,63494,84603,137226,139885	p	350006149600015000	0-1353						KEGG T01001: 2555	www.genome.jp	0	0		GABRA2
1097	chr6	67176900	67177149	3500036664	43		67176900	67177149	8421504	2	22,21	0,228	c,g	350003666400000007,350003666400000007,350003666400000065,350003666400000065,350003666400000006,350003666400000006,350003666400000064,350003666400000064	0-22,0-22,0-22,0-22,0-21,0-21,0-21,0-21						Ex Vivo Progenitor and Stem Cell Expansion and Differentiation for Use in the Treatment of Disease of the Nervous System - Patent application	www.faqs.org	0	0		GABRA2
1097	chr6	67191897	67191927	3500401488	30		67191897	67191927	8421504	1	30	0	c	350040148800000000	0-30				1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Trichloroethanol Modulation of Recombinant GABAA, Glycine and GABA &#x03c1;1 Receptors	Krasowski	1998	0		GABRA2
1097	chr6	67191897	67191927	3500329099	30		67191897	67191927	8421504	1	30	0	c	350032909900000000	0-30		9495821	10.1124/mol.53.3.530	1521-0111 (Online)	Molecular Pharmacology	Propofol and Other Intravenous Anesthetics Have Sites of Action on the &#x03b3;-Aminobutyric Acid Type A Receptor Distinct from That for Isoflurane	Krasowski	1998	0		GABRA2
1103	chr6	67970964	67971069	3500370269	44		67970964	67971069	8421504	2	20,24	0,81	c	350037026900000001,350037026900000023	0-20,0-24						Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector	Farb	1997	0		GABRB1
17	chr6	67971058	68530957	3500240668	1413		67971058	68530957	8421504	10	80,92,68,221,4,70,138,153,245,342	0,247,769,207664,425854,425867,535685,535922,539124,559557	p	350024066800015029,350024066800015030	0-465,0-948						Cell lines expressing gaba receptor and methods using them	Langer	2010	0		GABRB1
1103	chr6	67971356	67971891	3500149981	105		67971356	67971891	8421504	2	41,64	0,471	c	350014998100000066,350014998100000067,350014998100000068,350014998100000069	0-54,0-54,0-52,0-51						 Neuron 	www.docstoc.com	0	0		
1103	chr6	67971356	67971891	3500026444	105		67971356	67971891	8421504	2	41,64	0,471	c	350002644400000065,350002644400000066,350002644400000068,350002644400000067	0-54,0-54,0-51,0-52						US Patent # 6,066,726. Neuron-specific transcriptional promoter - Patents.com	www.patents.com	0	0		
1104	chr6	68146440	68146467	3500162993	23		68146440	68146467	8421504	3	6,5,12	0,9,15	g	350016299300000031	1-24						Immunogenic compositions for gram positive bacteria	Galeotti	2009	0		
1109	chr6	68765066	68765091	3500414165	23		68765066	68765091	8421504	2	18,5	0,20	c,g	350041416500000065,350041416500000065,350041416500000142,350041416500000142	6-30,6-30,6-30,6-30						Assay for virulent revertants of attenuated live vaccines and kits therefor	Levenbook	1994	0		
1109	chr6	68797364	68797387	3500101116	23		68797364	68797387	8421504	1	23	0	g	350010111600000025	7-30						Novel modified corin molecules having substitute activation sequences and uses thereof	Wu	2004	0		
1112	chr6	69169606	69181260	3500037046	267		69169606	69181260	8421504	7	48,47,48,48,45,2,29	0,241,480,864,2656,3481,11625	c	350003704600000041,350003704600000036,350003704600000031,350003704600000023,350003704600000017,350003704600000011	0-48,0-47,0-48,0-48,0-47,0-29						Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification - Patent application	www.faqs.org	0	0		
1112	chr6	69170155	69170257	3500154352	102		69170155	69170257	8421504	1	102	0	p	350015435200015016	0-102						NPG.nature.vol.417.Issue.6888.May	www.scribd.com	0	0		
1112	chr6	69170245	69170311	3500452184	66		69170245	69170311	8421504	1	66	0	p	350045218400015035	129-195						potassium Drophila	www.pnas.org	0	0		CNGA3
1112	chr6	69181239	69181263	3500134077	23		69181239	69181263	8421504	2	14,9	0,15	c	350013407700000123	21-44						 Pectin Lyase Genes Of Aspergillus Niger 	www.docstoc.com	0	0		
1112	chr6	69203350	69203377	3500308897	25		69203350	69203377	8421504	3	9,12,4	0,10,23	g	350030889700000838	20-45						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
1115	chr6	69588870	69588895	3500039368	24		69588870	69588895	8421504	2	10,14	0,11	c	350003936800000013	23-47						Lineage-restricted regulation of the murine SCL/TAL-1 promoter. - ResearchGate	.researchgate.net	0	0		
1116	chr6	69717158	69722391	3500142132	297		69717158	69722391	8421504	5	57,54,48,54,84	0,147,255,5059,5149	p	350014213200015006,350014213200015012,350014213200015014,350014213200015055,350014213200015060	0-57,0-54,0-48,0-54,0-84						Cloning and expression of SLC10A4, a putative organic anion transport protein	www.wjgnet.com	0	0		
1116	chr6	69723817	69727675	3500386272	142		69723817	69727675	8421504	6	19,19,27,22,35,20	0,325,783,2531,3760,3838	c,g	350038627200000001,350038627200000007,350038627200000007,350038627200000017,350038627200000017,350038627200000002,350038627200000002,350038627200000020,350038627200000020,350038627200000016,350038627200000021	0-19,0-19,0-19,0-27,0-27,0-22,0-22,0-19,0-19,0-22,0-20						www.rbej.com - Table 	www.rbej.com	0	0		
1116	chr6	69727545	69727668	3500435447	40		69727545	69727668	8421504	2	20,20	0,103	c,g	350043544700000000,350043544700000000,350043544700000001	0-20,0-20,0-20						Effect of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate on in vitro developmental competence of bovine oocytes	health.huji.ac.il	0	0		
1120	chr6	70141888	70141915	3500459869	23		70141888	70141915	8421504	2	17,6	0,21	g	350045986900000254	5-30						 Highly Conserved Genes And Their Use To Generate Probes And Primers For Detection Of Microorganisms 	www.docstoc.com	0	0		
1120	chr6	70141888	70141915	3500427792	23		70141888	70141915	8421504	2	17,6	0,21	g	350042779200000213	5-30						Highly conserved genes and their use to generate probes and primers for detection of microorganisms	Bergeron	2005	0		
1120	chr6	70201219	70228329	3500380574	110		70201219	70228329	8421504	4	48,36,8,18	0,14612,23679,27092	c	350038057400000038,350038057400000048,350038057400000145	0-48,6-42,0-26						NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 162P1E6 USEFUL IN TREATMENT AND DETECTION OF CANCER - Patent application	www.faqs.org	0	0		
1122	chr6	70422615	70422646	3500106719	28		70422615	70422646	8421504	2	7,21	0,10	c	350010671900000140	9-37						Optimizing Expression of Active Botulinum Toxin Type E - Patent application	www.faqs.org	0	0		
1122	chr6	70448260	70448286	3500440489	25		70448260	70448286	8421504	2	19,6	0,20	c	350044048900000023	23-48						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
1123	chr6	70624654	70624680	3500368705	26		70624654	70624680	8421504	1	26	0	g	350036870500000001	0-26						Breed characteristics in Iranian native goat populations	demicjournals.org	0	0		
1127	chr6	71054920	71054946	3500104575	24		71054920	71054946	8421504	2	16,8	0,18	g	350010457500000086	6-30						Peptide inhibitors of c-jun dimerization and uses thereof - Patent application	www.faqs.org	0	0		
1127	chr6	71139819	71139846	3500322635	23		71139819	71139846	8421504	3	5,4,14	0,8,13	c	350032263500000024	20-43						Antibodies to ccr2	A*La Ji Pa Er 	2011	0		
1127	chr6	71139819	71139846	3500216860	23		71139819	71139846	8421504	3	5,4,14	0,8,13	c	350021686000000012	20-43						ANTIBODIES TO CCR2 - PFIZER INC.	www.sumobrain.com	0	0		
1127	chr6	71139819	71139846	3500135720	23		71139819	71139846	8421504	3	5,4,14	0,8,13	c	350013572000000091,350013572000000018	20-43,20-43						ANTIBODIES TO CCR2 - Patent application	www.faqs.org	0	0		
1127	chr6	71139819	71139846	3500101886	23		71139819	71139846	8421504	3	5,4,14	0,8,13	c	350010188600000012	20-43						Antibodies to ccr2	Gladue	2010	0		
1128	chr6	71191585	71191611	3500459869	25		71191585	71191611	8421504	2	15,10	0,16	c	350045986900000253	0-25						 Highly Conserved Genes And Their Use To Generate Probes And Primers For Detection Of Microorganisms 	www.docstoc.com	0	0		
1128	chr6	71191585	71191611	3500427792	25		71191585	71191611	8421504	2	15,10	0,16	c	350042779200000212	0-25						Highly conserved genes and their use to generate probes and primers for detection of microorganisms	Bergeron	2005	0		
1135	chr6	72169380	72169404	3500266002	24		72169380	72169404	8421504	1	24	0	c	350026600200000203	0-24						Treatment of Cellulosic Material and Enzymes Useful Therein - Patent application	www.faqs.org	0	0		
1136	chr6	72273317	72308316	3500054009	411		72273317	72308316	8421504	14	6,41,48,19,5,42,48,28,8,48,42,47,24,5	0,1481,1570,1780,5690,12274,18654,18714,18997,19053,20167,28108,34967,34994	c	350005400900000205,350005400900000292,350005400900000207,350005400900000288,350005400900000227,350005400900000242,350005400900000243,350005400900000245,350005400900000247,350005400900000264,350005400900000270	1-48,0-25,0-48,0-24,6-48,0-48,12-48,0-48,6-48,0-47,0-29						US Patent # 5,686,572. Domains of extracellular region of human platelet derived growth factor receptor polypeptides - Patents.com	www.patents.com	0	0		
1136	chr6	72273317	72308188	3500347340	582		72273317	72308188	8421504	19	6,41,48,28,11,34,42,27,17,48,42,25,23,40,7,48,47,8,40	0,1481,1570,1771,5690,9581,12274,15592,15829,19053,20167,20305,23177,24777,26454,26716,28108,28252,34831	c	350034734000000134,350034734000000136,350034734000000140,350034734000000153,350034734000000157,350034734000000167,350034734000000176,350034734000000178,350034734000000181,350034734000000188,350034734000000192,350034734000000195,350034734000000198	1-48,0-48,9-48,14-48,6-48,0-44,0-48,6-48,0-48,0-47,0-48,0-47,0-48						Human platelet-derived growth factor receptors	Williams	1995	0		
1136	chr6	72273319	72308226	3500025568	248		72273319	72308226	8421504	9	4,41,43,45,37,7,5,40,26	0,1479,15901,19054,24778,26452,28253,34829,34881	c	350002556800000134,350002556800000169,350002556800000176,350002556800000188,350002556800000198,350002556800000199	0-45,0-43,0-45,0-44,0-45,9-35						US Patent # 7,105,305. Human platelet-derived growth factor receptors - Patents.com	www.patents.com	0	0		
1136	chr6	72274803	72279012	3500418514	49		72274803	72279012	8421504	3	25,19,5	0,294,4204	c	350041851400000017,350041851400000013	0-25,0-24						Human platelet-derived growth factor receptor extracellular domain antibodies	Wolf	1995	0		
1136	chr6	72274845	72285660	3500048156	246		72274845	72285660	8421504	4	96,42,39,69	0,171,8053,10746	c	350004815600000124,350004815600000125,350004815600000058,350004815600000142,350004815600000073,350004815600000146,350004815600000077	0-48,0-48,6-48,8-47,0-26,0-48,0-48						Methods For Suppressing Tumor Proliferation - Patent application	www.faqs.org	0	0		
1136	chr6	72275018	72308265	3500458923	113		72275018	72308265	8421504	3	42,41,30	0,18466,33217	c	350045892300000027,350045892300000072,350045892300000097	0-42,1-42,0-30						US Patent # 6,475,782. Human platelet-derived growth factor receptor - Patents.com	www.patents.com	0	0		
1136	chr6	72275088	72308188	3500196657	364		72275088	72308188	8421504	11	28,11,42,27,17,48,48,48,47,8,40	0,3919,10503,13821,14058,16883,17282,24945,26337,26481,33060	c	350019665700000211,350019665700000228,350019665700000238,350019665700000244,350019665700000247,350019665700000263,350019665700000266,350019665700000269	9-48,6-48,0-44,0-48,0-48,0-48,0-47,0-48						Human Platelet-derived Growth Factor Receptors 	.freshpatents.com	0	0		
1136	chr6	72285612	72301472	3500045305	330		72285612	72301472	8421504	9	48,4,44,38,4,44,48,47,53	0,5950,6336,6779,8031,10882,12425,15738,15807	c	350004530500000039,350004530500000334,350004530500000338,350004530500000343,350004530500000208,350004530500000355,350004530500000427,350004530500000530	0-48,0-48,0-38,0-48,0-48,0-47,0-48,0-32						ACTIVATING MUTATIONS OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA (PDGFRA) AS DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS - Patent application	www.faqs.org	0	0		
1136	chr6	72288059	72291981	3500424182	42		72288059	72291981	8421504	2	20,22	0,3900	c	350042418200000000,350042418200000001	0-20,0-22		24023874	10.1371/journal.pone.0073426		PLoS ONE	Functional Cross Talk between CXCR4 and PDGFR on Glioblastoma Cells Is Essential for Migration	Miriam	2013	0		PDGFRA
1136	chr6	72289158	72289230	3500245398	72		72289158	72289230	8421504	1	72	0	p	350024539800015016	0-72						Factors Associated With Disease Progression in Patients With Gastrointestinal Stromal Tumors in the Pre-Imatinib Era	.ascpjournals.org	0	0		PDGFRA
1136	chr6	72289218	72289244	3500299330	25		72289218	72289244	8421504	2	20,5	0,21	c	350029933000000013	0-25						Clinical Impact of Germ Cell Tumor Cells in Apheresis Products of Patients Receiving High-Dose Chemotherapy	jco.ascopubs.org	0	0		
1136	chr6	72291974	72291997	3500186204	23		72291974	72291997	8421504	1	23	0	c	350018620400000224	0-23						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
1136	chr6	72291974	72291997	3500150372	23		72291974	72291997	8421504	1	23	0	c	350015037200000224	0-23						Hptpbeta As A Target In Treatment Of Angiogenesis Mediated Disorders 	.freshpatents.com	0	0		PDGFRA
1136	chr6	72292314	72293539	3500152171	39		72292314	72293539	8421504	2	19,20	0,1205	c	350015217100000028,350015217100000029	0-19,0-20						Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines. - ResearchGate	.researchgate.net	0	0		
1136	chr6	72297019	72297042	3500255300	23		72297019	72297042	8421504	1	23	0	c	350025530000000001,350025530000000002	0-23,17-40						ScienceDirect.com - Structure - Crystal Structures of the Mnk2 Kinase Domain Reveal an Inhibitory Conformation and a Zinc Binding Site	sciencedirect.com	0	0		PDGFRA
1136	chr6	72308236	72308260	3500128817	24		72308236	72308260	8421504	1	24	0	c	350012881700000001	0-24			10.1124/mol.54.6.1007	1521-0111 (Online)	Molecular Pharmacology	Platelet-Derived Growth Factor-BB and Thrombin Activate Phosphoinositide 3-Kinase and Protein Kinase B: Role in Mediating Airway Smooth Muscle Proliferation	Walker	1998	0		
1136	chr6	72310739	72310938	3500330005	52		72310739	72310938	8421504	2	22,30	0,169	c	350033000500000000,350033000500000005,350033000500000004,350033000500000007,350033000500000006	8-30,6-36,0-30,14-43,0-29			10.1371/journal.pone.0067581		PLoS ONE	MiR-34a/c-Dependent PDGFR-&#x03b1;/&#x03b2; Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer	Michela	2013	0		
1136	chr6	72311156	72311180	3500226180	23		72311156	72311180	8421504	2	13,10	0,14	c	350022618000000020	7-30		22238358	10.1091/mbc.E11-06-0517	1059-1524	Molecular Biology of the Cell	Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	Yoneyama	2012	5		
1136	chr6	72311156	72311180	3500207967	23		72311156	72311180	8421504	2	13,10	0,14	c	350020796700000024	7-30						Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	w.molbiolcell.org	0	0		
1139	chr6	72706234	72706262	3500424697	25		72706234	72706262	8421504	2	5,20	0,8	c	350042469700000013	5-30			10.1634/stemcells.2005-0499	1549-4918	STEM CELLS	Tal1/Scl Gene Transduction Using a Lentiviral Vector Stimulates Highly Efficient Hematopoietic Cell Differentiation from Common Marmoset (Callithrix jacchus) Embryonic Stem Cells - Kurita - 2006 - STEM CELLS - Wiley Online Library	Kurita	2006	0		
142	chr6	72706257	72791267	3500101830	2658		72706257	72791267	8421504	75	45,4,41,45,45,45,45,34,11,45,45,45,45,45,28,17,45,45,45,45,45,1,44,45,45,45,45,45,19,26,45,38,7,45,45,45,40,5,45,45,3,42,45,34,59,43,2,45,45,10,35,45,45,17,28,45,13,32,45,45,45,45,24,21,45,40,5,45,44,1,45,45,6,39,45	0,48,38297,38341,38389,38437,38485,38533,41667,41681,41729,41777,41825,41873,41921,43022,43042,43090,47369,47417,47465,47513,52052,52099,52147,52195,54380,54428,54476,70828,70857,70905,72627,72637,72685,72733,72781,74020,74028,74076,74124,74217,74262,74310,74617,74679,74806,74811,74859,74907,76248,76286,76334,76382,78333,78364,78412,78880,78915,78963,80028,80076,80124,83053,83077,83125,83278,83286,83334,83724,83728,83776,83824,84923,84965	p	350010183000015000,350010183000015001,350010183000015002,350010183000015003,350010183000015004,350010183000015005,350010183000015006,350010183000015007,350010183000015008,350010183000015009,350010183000015010,350010183000015011,350010183000015012,350010183000015013,350010183000015014,350010183000015016,350010183000015017,350010183000015018,350010183000015019,350010183000015020,350010183000015021,350010183000015022,350010183000015023,350010183000015024,350010183000015025,350010183000015026,350010183000015027,350010183000015028,350010183000015029,350010183000015030,350010183000015031,350010183000015032,350010183000015033,350010183000015034,350010183000015035,350010183000015036,350010183000015037,350010183000015038,350010183000015039,350010183000015040,350010183000015041,350010183000015042,350010183000015043,350010183000015044,350010183000015045,350010183000015046,350010183000015047,350010183000015048,350010183000015049,350010183000015050,350010183000015051,350010183000015052,350010183000015053,350010183000015054,350010183000015055,350010183000015056,350010183000015057,350010183000015058,350010183000015059	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-48,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						 <HTML> <HEAD><TITLE>a|a*c+-aeY=i1/2i1/4i1/4<<i1/2i1/2a?a3aa-e3aa<<a-3/4aaaC/aa-aa1/4aa<<ae	www.j-tokkyo.com	0	0		
1140	chr6	72747939	72748070	3500365673	40		72747939	72748070	8421504	2	20,20	0,111	c,g	350036567300000012,350036567300000012,350036567300000013	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
1140	chr6	72747939	72748070	3500262357	40		72747939	72748070	8421504	2	20,20	0,111	c,g	350026235700000012,350026235700000012,350026235700000013	0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
1140	chr6	72777414	72784266	3500138830	38		72777414	72784266	8421504	4	13,6,6,13	0,18,6829,6839	g	350013883000000132,350013883000000143	1-20,0-19						Method And Nucleic Acids For The Improved Treatment Of Breast Cell Proliferative Disorders 	.freshpatents.com	0	0		
1140	chr6	72780498	72780561	3500393400	63		72780498	72780561	8421504	1	63	0	p	350039340000015002	0-63						METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS - Patent application	www.faqs.org	0	0		KIT
1140	chr6	72780498	72780561	3500199167	63		72780498	72780561	8421504	1	63	0	p	350019916700015002	0-63			10.1172/JCI32373		The Journal of Clinical Investigation	An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic	AriFernandez	2007	0		KIT
1140	chr6	72780507	72780561	3500321498	54		72780507	72780561	8421504	1	54	0	p	350032149800015002	6-60						Methods and compositions related to wrapping of dehydrons	Bornmann	2008	0		KIT
1140	chr6	72780552	72780882	3500290061	57		72780552	72780882	8421504	2	49,8	0,322	p	350029006100015000	0-57						PCR	www.seap.es	0	0		KIT
1140	chr6	72780571	72782719	3500122685	42		72780571	72782719	8421504	2	21,21	0,2127	c,g	350012268500000001,350012268500000003	0-21,0-21		18612157	10.1200/JCO.2007.14.3420	0732-183X	Journal of Clinical Oncology	Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study	Schilder	2008	18		
1140	chr6	72780876	72780924	3500029246	48		72780876	72780924	8421504	1	48	0	p	350002924600015037	0-48						Use Of Tyrosine Inhibitors For Whitening Human Skin And Treating Melanocyted Dysfunction Associated Diseases 	.freshpatents.com	0	0		CSF1R
1140	chr6	72781101	72781152	3500182245	51		72781101	72781152	8421504	1	51	0	p	350018224500015000	0-51						University of Geneva Master&#x2019;s in Proteomics and Bioinformatics 2009	www.mpb.unige.ch	0	0		KIT
1140	chr6	72782505	72785231	3500109725	47		72782505	72785231	8421504	2	24,23	0,2703	c	350010972500000004,350010972500000005	0-24,0-23						ScienceDirect.com - European Journal of Cancer - Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone m	sciencedirect.com	0	0		
1140	chr6	72782506	72789595	3500205525	46		72782506	72789595	8421504	2	22,24	0,7065	c,g	350020552500000008,350020552500000008,350020552500000009	0-22,0-22,0-24						RUNX1regulatescorepressorinteractionsofPU	tologylibrary.org	0	0		
1140	chr6	72782513	72782558	3500449175	45		72782513	72782558	8421504	1	45	0	p	350044917500015020	3-48						Crystal Structure Of Liganded Cfms Kinase Domain 	.freshpatents.com	0	0		KIT
1140	chr6	72782525	72782551	3500351805	26		72782525	72782551	8421504	1	26	0	c	350035180500000110	9-35						Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2	Lemischka	1992	0		
1140	chr6	72782552	72785217	3500412565	111		72782552	72785217	8421504	2	60,51	0,2614	p	350041256500015005	0-135						Analysis of platelet-derived growth factor receptor domain function using a novel chimeric receptor approach. - ResearchGate	.researchgate.net	0	0		KIT
1140	chr6	72786340	72786365	3500419344	25		72786340	72786365	8421504	1	25	0	g	350041934400000002	0-25		19747364	10.1111/j.1365-2141.2009.07870.x	1365-2141	British Journal of Haematology	Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms - Grimwade - 2009 - British Journal of Haematology - Wiley Online Library	Grimwade	2009	0		KIT
1140	chr6	72789370	72789394	3500455108	24		72789370	72789394	8421504	1	24	0	c	350045510800000001	0-24		10205200	10.1136/gut.44.5.643	1468-3288	Gut	Mast cells are an important cellular source of tumour necrosis factor &#x03b1; in human intestinal tissue	Bischoff	1999	0		KIT
1140	chr6	72789418	72789579	3500037309	48		72789418	72789579	8421504	2	4,44	0,117	c	350003730900000058	0-48						Methods of identifying and treating individuals exhibiting mutant kit protein - Patent application	www.faqs.org	0	0		
1140	chr6	72789575	72791309	3500341442	50		72789575	72791309	8421504	2	23,27	0,1707	c	350034144200000020,350034144200000033	0-23,0-27						Methods for analyzing animal products	Andersson	2004	0		
1140	chr6	72789575	72791309	3500265879	50		72789575	72791309	8421504	2	23,27	0,1707	c	350026587900000032,350026587900000045	0-23,0-27						Methods for analyzing animal products	Andersson	1998	0		
1140	chr6	72789575	72789598	3500182598	23		72789575	72789598	8421504	1	23	0	c	350018259800000008	0-23		16940280	10.1530/rep.1.01018	1470-1626	Reproduction	Molecular cloning, testicular postnatal expression, and oocyte-activating potential of porcine phospholipase C&#x03b6;	Yoneda	2006	3		KIT
1140	chr6	72789587	72790007	3500257699	41		72789587	72790007	8421504	2	20,21	0,399	c,g	350025769900000006,350025769900000006,350025769900000007	0-20,0-20,0-21						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
1140	chr6	72789587	72790006	3500056050	40		72789587	72790006	8421504	2	20,20	0,399	c,g	350005605000000006,350005605000000006,350005605000000007	0-20,0-20,0-20			10.1186/scrt247	1757-6512	Stem Cell Research & Therapy	MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro	Chung	2013	3		
1142	chr6	73115507	73117883	3500366379	43		73115507	73117883	8421504	2	21,22	0,2354	c	350036637900000001,350036637900000000	1-22,0-22		15604279	10.1158/0008-5472.CAN-04-2360	0008-5472	Cancer Research	Small In-Frame Deletion in the Epidermal Growth Factor Receptor as a Target for ZD6474	Arao	2004	8		KDR
1142	chr6	73115507	73117883	3500310485	43		73115507	73117883	8421504	2	21,22	0,2354	c,g	350031048500000005,350031048500000004,350031048500000004	1-22,0-22,0-22		17505008	10.1158/1078-0432.CCR-06-2743	1078-0432	Clinical Cancer Research	AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor	Takeda	2007	8		
1142	chr6	73115507	73117883	3500239833	43		73115507	73117883	8421504	2	21,22	0,2354	c,g	350023983300000007,350023983300000006,350023983300000006	1-22,0-22,0-22						AZD2171ShowsPotentAntitumorActivityAgainstGastricCancer OveE-rxpresnsigFibrobalstGrowthFactorReceptor 2/KeratinocyteGrowthFactorReceptor	.aacrjournals.org	0	0		
142	chr6	73115604	73152674	3500348580	815		73115604	73152674	8421504	26	37,45,82,50,42,42,25,11,45,12,54,32,23,15,33,22,22,42,3,38,4,41,28,1,41,25	0,156,2800,8024,8077,8122,9406,9841,9870,10304,10468,13090,15075,15197,15797,15864,16459,18890,19361,19430,21733,25228,28287,30179,31942,37045	c	350034858000000254,350034858000000362,350034858000000359,350034858000000247,350034858000000355,350034858000000246,350034858000000245,350034858000000244,350034858000000243,350034858000000240,350034858000000348,350034858000000235,350034858000000344,350034858000000231,350034858000000230,350034858000000227,350034858000000335,350034858000000328,350034858000000216,350034858000000208,350034858000000195,350034858000000188,350034858000000175	5-42,17-42,0-45,0-42,0-42,0-44,0-42,0-42,0-42,6-42,0-45,0-42,0-45,10-42,0-23,0-48,0-44,0-45,0-42,1-42,0-29,0-41,0-25						US Patent # 7,226,755. HPTPbeta as a target in treatment of angiogenesis mediated disorders - Patents.com	www.patents.com	0	0		
1142	chr6	73115653	73115760	3500382980	40		73115653	73115760	8421504	2	20,20	0,87	c,g	350038298000000011,350038298000000011,350038298000000010,350038298000000010	0-20,0-20,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
1142	chr6	73115653	73115760	3500280137	40		73115653	73115760	8421504	2	20,20	0,87	c,g	350028013700000011,350028013700000011,350028013700000010,350028013700000010	0-20,0-20,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
142	chr6	73115760	73154773	3500150372	445		73115760	73154773	8421504	14	47,45,25,11,48,39,33,26,15,33,22,25,48,28	0,7966,9250,9685,9714,10121,10312,14919,15041,15641,15708,16303,21587,38985	c	350015037200000359,350015037200000243,350015037200000240,350015037200000348,350015037200000345,350015037200000235,350015037200000230,350015037200000227,350015037200000335,350015037200000215,350015037200000171	1-48,0-45,9-45,0-48,0-48,0-45,0-26,0-48,0-47,0-48,0-28						Hptpbeta As A Target In Treatment Of Angiogenesis Mediated Disorders 	.freshpatents.com	0	0		
1142	chr6	73115760	73137395	3500186204	435		73115760	73137395	8421504	15	47,45,48,19,24,39,9,26,15,33,22,25,19,16,48	0,7966,9714,9766,10048,10121,10312,14919,15041,15641,15708,16303,16398,17950,21587	c	350018620400000359,350018620400000243,350018620400000348,350018620400000347,350018620400000345,350018620400000230,350018620400000227,350018620400000335,350018620400000223,350018620400000215	1-48,0-45,0-48,1-44,0-48,0-26,0-48,0-47,6-41,0-48						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
142	chr6	73117862	73138708	3500292931	43		73117862	73138708	8421504	2	22,21	0,20825	c	350029293100000075,350029293100000057	0-22,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent EP:2135950)	NATT	2012	0		
142	chr6	73117862	73138708	3500219888	66		73117862	73138708	8421504	3	22,21,23	0,5885,20823	c,g	350021988800000075,350021988800000075,350021988800000067,350021988800000093,350021988800000057	0-22,0-22,0-21,21-40,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404831)	Natt	2013	0		
142	chr6	73117862	73138708	3500219703	66		73117862	73138708	8421504	3	22,21,23	0,5885,20823	c,g	350021970300000075,350021970300000075,350021970300000067,350021970300000093,350021970300000057	0-22,0-22,0-21,21-40,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8344128)	Natt	2013	0		
142	chr6	73117862	73138708	3500105842	64		73117862	73138708	8421504	3	22,21,21	0,5885,20825	c	350010584200000075,350010584200000067,350010584200000057	0-22,0-21,0-21						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
142	chr6	73117862	73138708	3500095873	64		73117862	73138708	8421504	3	22,21,21	0,5885,20825	c	350009587300000075,350009587300000067,350009587300000057	0-22,0-21,0-21						Short interfering ribonucleic acid (siRNA) for oral administration	NATT	2011	0		
142	chr6	73117862	73138708	3500085091	64		73117862	73138708	8421504	3	22,21,21	0,5885,20825	c	350008509100000075,350008509100000067,350008509100000057	0-22,0-21,0-21						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
142	chr6	73117862	73138708	3500083334	64		73117862	73138708	8421504	3	22,21,21	0,5885,20825	c	350008333400000075,350008333400000067,350008333400000057	0-22,0-21,0-21					Patent	Short interfering ribonucleic acid (siRNA) with improved pharmacological properties (Patent US:8084600)	Billy	2011	0		
1142	chr6	73118453	73123693	3500095649	40		73118453	73123693	8421504	2	20,20	0,5220	c,g	350009564900000085,350009564900000085,350009564900000084	0-20,0-20,0-20						Vascular/Lymphatic Endothelial Cells - Patent application	www.faqs.org	0	0		KDR
1142	chr6	73118482	73123654	3500006639	30		73118482	73123654	8421504	2	4,26	0,5146	c	350000663900000005	0-30						Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor	tologylibrary.org	0	0		KDR
1142	chr6	73123649	73123780	3500188044	46		73123649	73123780	8421504	2	19,27	0,104	c	350018804400000004,350018804400000000	11-30,0-27			10.1093/emboj/20.11.2768		The EMBO Journal	A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-&#x03b3; and DNA synthesis in vascular endothelial cells	Tomoko	June	0		
142	chr6	73123670	73152685	3500351805	330		73123670	73152685	8421504	13	38,24,3,29,8,32,15,27,42,42,13,31,26	0,86,1259,1336,1775,2493,4979,7053,13743,17234,17424,18247,28989	c	350035180500000205,350035180500000203,350035180500000201,350035180500000194,350035180500000190,350035180500000176,350035180500000169,350035180500000165,350035180500000137	0-38,21-48,6-43,0-47,21-48,6-48,0-42,0-44,22-48						Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2	Lemischka	1992	0		
1142	chr6	73123679	73123711	3500128914	32		73123679	73123711	8421504	1	32	0	c,g	350012891400000003,350012891400000003	0-32,0-32						Embryonic Stem-like Cells Derived from in vitro Produced Bovine Blastocysts	www.scielo.br	0	0		KDR
142	chr6	73123747	73138708	3500133622	42		73123747	73138708	8421504	2	21,21	0,14940	c	350013362200000067,350013362200000057	0-21,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404832)	Natt	2013	0		
142	chr6	73123756	73152685	3500348845	176		73123756	73152685	8421504	8	24,3,29,8,42,13,31,26	0,1173,1250,1689,13657,17338,18161,28903	c	350034884500000135,350034884500000133,350034884500000109,350034884500000098,350034884500000070	21-48,6-43,6-48,0-44,22-48						Nucleic acids encoding hencatoporetic stem cell receptor flk-2 - Patent # 5185438 - PatentGenius	.patentgenius.com	0	0		
142	chr6	73123756	73152685	3500282272	179		73123756	73152685	8421504	8	24,3,29,8,32,15,42,26	0,1173,1250,1689,2407,4893,13657,28903	c,g	350028227200000136,350028227200000134,350028227200000127,350028227200000110,350028227200000071,350028227200000071	21-48,6-43,0-47,6-48,22-48,22-48					Patent	Nucleic acids encoding hencatoporetic stem cell receptor flk-2 (Patent US:5185438)	Lemischka	1993	0		
1142	chr6	73125480	73126075	3500014561	43		73125480	73126075	8421504	3	24,16,3	0,424,592	c	350001456100000011,350001456100000010	0-24,0-19						Immortalization of swine umbilical vein endothelial cells (SUVECs) with the simian virus 40 large-T antigen. - ResearchGate	.researchgate.net	0	0		KDR
1142	chr6	73125892	73130740	3500145033	38		73125892	73130740	8421504	2	19,19	0,4829	c	350014503300000003,350014503300000002	0-19,0-19						Respiratory Research BioMed Central	biomedcentral.com	0	0		
1142	chr6	73125892	73130740	3500129322	38		73125892	73130740	8421504	2	19,19	0,4829	c,g	350012932200000006,350012932200000006,350012932200000004	0-19,0-19,0-19						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: "Participation of the PI-3K/Akt-NF-&#x03ba;B signaling pathways in hypoxia-induced mitogenic factor-stimulated Flk-1 " 	tailieu.vn/doc/ba	0	0		
1142	chr6	73126113	73128686	3500074335	48		73126113	73128686	8421504	2	24,24	0,2549	c	350007433500000020,350007433500000019	0-24,0-24						TREATMENT AND PREVENTION OF ISCHEMIC INJURY USING ACTIVATED PROTEIN C - Patent application	www.faqs.org	0	0		KDR
1142	chr6	73126135	73128691	3500257699	43		73126135	73128691	8421504	2	23,20	0,2536	c,g	350025769900000005,350025769900000005,350025769900000004,350025769900000004	0-23,0-23,0-20,0-20						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
1142	chr6	73128692	73128717	3500319331	25		73128692	73128717	8421504	1	25	0	c	350031933100000007	8-33		9716565	10.1095/biolreprod59.3.643	0006-3363	Biology of Reproduction	Vascular Endothelial Growth Factor Stimulates Proliferation but Not Migration or Invasiveness in Human Extravillous Trophoblast	Athanassiades	1998	4		KDR
1142	chr6	73128702	73128726	3500414783	24		73128702	73128726	8421504	1	24	0	c	350041478300000041	1-25						Composition And Methods Of Rnai Therapeutics For Treatment Of Cancer And Other Neovascularization Diseases 	.freshpatents.com	0	0		
1142	chr6	73128702	73128726	3500376513	24		73128702	73128726	8421504	1	24	0	c	350037651300000058	1-25						Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases	Lui	2008	0		
1142	chr6	73128702	73128726	3500139508	24		73128702	73128726	8421504	1	24	0	c	350013950800000053,350013950800000354	1-25,1-25						Composition and methods of RNAI therapeutics for treatment of cancer and other neovascularization diseases - Patent application	www.faqs.org	0	0		
1142	chr6	73128702	73128726	3500074124	24		73128702	73128726	8421504	1	24	0	c	350007412400000058,350007412400000365	1-25,1-25						Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases - Patent application	www.faqs.org	0	0		
1142	chr6	73131457	73131482	3500424039	25		73131457	73131482	8421504	1	25	0	c	350042403900000072	0-25						FLT4 (VEGFR-3) as a Target for Tumor Imaging and Anti-Tumor Therapy - Patent application	www.faqs.org	0	0		
1142	chr6	73131457	73131482	3500239599	25		73131457	73131482	8421504	1	25	0	c	350023959900000138	0-25						F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy	Qia Li *A Li Ta Luo 	2002	0		
1142	chr6	73131457	73131482	3500100457	25		73131457	73131482	8421504	1	25	0	c	350010045700000072	0-25						US Patent # 6,107,046. Antibodies to Flt4, a receptor tyrosine kinase and uses thereof - Patents.com	www.patents.com	0	0		
1142	chr6	73132176	73133733	3500347585	24		73132176	73133733	8421504	2	1,23	0,1534	c	350034758500000012	0-24		19168695	10.1215/15228517-2008-117		Neuro-Oncology	MRI assessment of hemodynamic effects of angiopoietin-2 overexpression in a brain tumor model	SamuValable	2009	0		
1142	chr6	73134513	73134536	3500271592	23		73134513	73134536	8421504	1	23	0	c	350027159200000004	0-23		12037014		1552-5783	Investigative Ophthalmology & Visual Science	Erythropoietin and VEGF Promote Neural Outgrowth from Retinal Explants in Postnatal Rats	Bocker-Meffert	2002	0		KDR
1142	chr6	73134513	73134536	3500042482	23		73134513	73134536	8421504	1	23	0	c	350004248200000000	0-23		14627725	10.1242/dev.00887	0950-1991	Development	Retinoic acid regulates endothelial cell proliferation during vasculogenesis	Lai	2003	7		KDR
142	chr6	73137347	73154773	3500073470	151		73137347	73154773	8421504	5	48,13,35,27,28	0,8587,8687,12319,17398	c	350007347000000180,350007347000000156,350007347000000142,350007347000000136	0-48,0-48,21-48,0-28						COMBINATION METHODS OF INHIBITING TUMOR GROWTH WITH A VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTAGONIST - Patent application	www.faqs.org	0	0		
1142	chr6	73137374	73137446	3500223512	72		73137374	73137446	8421504	1	72	0	p	350022351200015003	0-72						ANTIBODIES TO TUMOR ENDOTHELIAL MARKER 8 - SCOTT & WHITE HEALTHCARE	www.sumobrain.com	0	0		KDR
1143	chr6	73138674	73138699	3500428659	25		73138674	73138699	8421504	1	25	0	c	350042865900000000,350042865900000001	0-25,0-25						&#x4e3b;&#x9898;&#xff1a;Factor | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		KDR
1143	chr6	73138674	73138699	3500218498	25		73138674	73138699	8421504	1	25	0	c,g	350021849800000000,350021849800000001,350021849800000001	0-25,0-25,0-25						&#x4e3b;&#x9898;&#xff1a;factor | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		KDR
1143	chr6	73145832	73145858	3500318905	26		73145832	73145858	8421504	1	26	0	c	350031890500000001	0-26						Expression of Soluble Vascular Endothelial Growth Factor Receptor-2 and Its Effect on Proliferation of Vascular Endothelial Cells	w.cjcu.jlu.edu.cn	0	0		
1143	chr6	73145855	73145884	3500393986	24		73145855	73145884	8421504	2	17,7	0,22	c	350039398600000042	21-45						US Patent # 6,942,865. Methods and reagents to detect and characterize norwalk and related viruses - Patents.com	www.patents.com	0	0		
1143	chr6	73147600	73147638	3500333519	38		73147600	73147638	8421504	1	38	0	c	350033351900000196	0-38						Methods of treating inflammatory skin diseases	Xia	2001	0		
1143	chr6	73147600	73147638	3500307446	38		73147600	73147638	8421504	1	38	0	c	350030744600000186	0-38						Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties - Patent application	www.faqs.org	0	0		
1143	chr6	73147692	73148382	3500143718	75		73147692	73148382	8421504	3	15,21,39	0,627,651	p	350014371800015105	0-75						Molecular antigen array presenting amyloid beta	Bachmann	2003	0		KDR
1143	chr6	73147692	73148382	3500089496	75		73147692	73148382	8421504	3	15,21,39	0,627,651	p	350008949600015105	0-75						Molecular antigen array presenting amyloid beta	Renner	2002	0		KDR
1143	chr6	73149234	73158530	3500438030	603		73149234	73158530	8421504	5	107,131,197,94,74	0,375,3373,5474,9222	c	350043803000000017,350043803000000016,350043803000000003	0-605,19-39,19-45						Express&#xe3;o de fatores angiog&#xea;nicos em corpo l&#xfa;teo c&#xed;clico e superovulado de b&#xfa;falas	www.teses.usp.br	0	0		
1143	chr6	73149283	73152646	3500402915	48		73149283	73152646	8421504	2	24,24	0,3339	c,g	350040291500000013,350040291500000012,350040291500000012	0-24,0-24,0-24		17702744	10.1074/jbc.M704798200	0021-9258	Journal of Biological Chemistry	Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function	Bernatchez	2007	5		
1143	chr6	73149334	73149732	3500093770	44		73149334	73149732	8421504	4	7,15,16,6	0,275,375,392	c	350009377000000007,350009377000000006	2-24,0-22						Migration of mouse-induced pluripotent stem cells to glioma-conditioned medium is mediated by tumor-associated specific growth factors	-publications.com	0	0		
1143	chr6	73149695	73152625	3500258471	50		73149695	73152625	8421504	3	23,9,18	0,36,2912	c	350025847100000003	62-112						Virginia Tech : LIB 04212005 : Dissertation	ww.coursehero.com	0	0		
1143	chr6	73152654	73152678	3500217315	24		73152654	73152678	8421504	1	24	0	c	350021731500000064	0-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		KDR
1143	chr6	73152725	73152770	3500064591	45		73152725	73152770	8421504	1	45	0	p	350006459100015180	0-45						sVEGFR-2 AND ITS ROLE IN LYMPHANGIOGENESIS MODULATION - Patent application	www.faqs.org	0	0		
1143	chr6	73154752	73154778	3500419664	26		73154752	73154778	8421504	1	26	0	c	350041966400000006,350041966400000000	6-32,6-32						Vegf-b/receptor complex and uses thereof	Alitalo	1998	0		
1143	chr6	73154752	73154778	3500248353	26		73154752	73154778	8421504	1	26	0	c	350024835300000000	6-32					Proceedings of the National Academy of Sciences of the United States of America	Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells	Birgitta	1998	0		
1143	chr6	73154799	73158480	3500008403	27		73154799	73158480	8421504	2	3,24	0,3657	c	350000840300000138,350000840300000007,350000840300000006	0-23,0-23,4-31						HUMAN MONOCLONAL ANTIBODY NEUTRALIZING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND USE THEREOF - Patent application	www.faqs.org	0	0		
1143	chr6	73158501	73158525	3500141134	24		73158501	73158525	8421504	1	24	0	c	350014113400000051,350014113400000047	7-31,0-22						Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy 	.freshpatents.com	0	0		
1143	chr6	73158509	73158537	3500299683	28		73158509	73158537	8421504	1	28	0	c	350029968300000002	0-28						Angiogenic Inhibition Mediated by a DNAzyme That Targets Vascular Endothelial Growth Factor Receptor 2	irexlim.fm.usp.br	0	0		
1144	chr6	73390366	73390393	3500068166	23		73390366	73390393	8421504	2	10,13	0,14	g	350006816600000252	13-41						Attenuated SP12 mutants as antigen carriers - US Patent 7700104 Description	ww.patentstorm.us	0	0		
1145	chr6	73517547	73517582	3500440622	28		73517547	73517582	8421504	3	15,7,6	0,17,29	c	350044062200000024	16-45						Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor	Gefter	1995	0		
1146	chr6	73565741	73565766	3500459701	25		73565741	73565766	8421504	1	25	0	c	350045970100000006	0-25						Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias	tologylibrary.org	0	0		
1149	chr6	73950463	73950490	3500386250	25		73950463	73950490	8421504	2	9,16	0,11	c,g	350038625000000001,350038625000000001,350038625000000005	7-32,7-32,3-27			10.1105/tpc.022277		The Plant Cell	Targeting of a Nicotiana plumbaginifolia H+-ATPase to the Plasma Membrane Is Not by Default and Requires Cytosolic Structural Determinants	Benoit	July	0		
1151	chr6	74261870	74261896	3500315344	24		74261870	74261896	8421504	3	11,9,4	0,12,22	g	350031534400000011	0-25						Letter to the Editor	ww3.botany.ubc.ca	0	0		
1152	chr6	74365613	74365638	3500464960	25		74365613	74365638	8421504	1	25	0	c	350046496000000003	0-25		17510634	10.1038/sj.emboj.7601712	ERROR! NO ISSN	The EMBO Journal	Staufen1 regulates diverse classes of mammalian transcripts	Kim	2007	0		
1152	chr6	74368423	74368446	3500384749	23		74368423	74368446	8421504	1	23	0	c	350038474900000303	7-30						5' to 3' exonuclease mutations of thermostable DNA polymerases - Patent # 5795762 - PatentGenius	.patentgenius.com	0	0		
1152	chr6	74368499	74371334	3500062368	106		74368499	74371334	8421504	5	31,7,20,7,41	0,1241,1269,1393,2794	c	350006236800000499,350006236800000244,350006236800000503	0-38,0-20,0-48					Patent	Factors affecting tumor necrosis factor receptor releasing enzyme activity (Patent CN:100368547)	G*A*Ge Lan Jie 	2008	0		
1152	chr6	74385135	74385179	3500094640	36		74385135	74385179	8421504	3	23,6,7	0,28,37	c	350009464000000391	2-39						SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION	Natt	2010	0		
1155	chr6	74790222	74804620	3500082071	61		74790222	74804620	8421504	3	20,20,21	0,12674,14377	c,g	350008207100000033,350008207100000009,350008207100000009,350008207100000010	0-20,0-20,0-20,0-21		21252229	10.1074/jbc.M110.174540		The Journal of Biological Chemistry	REST Regulates DYRK1A Transcription in a Negative Feedback Loop	Mei	2011	0		REST
1155	chr6	74802943	74803138	3500085287	47		74802943	74803138	8421504	2	22,25	0,170	c	350008528700000025,350008528700000022	18-40,0-25						Methods and compositions for the diagnosis, prognosis, and treatment of cancer	Neuman	2003	0		REST
1157	chr6	74983005	74983332	3500359260	201		74983005	74983332	8421504	2	107,94	0,233	p	350035926000015005	0-201						<HTML> <HEAD> </HEAD> <BODY> <FONT FACE="Sabon"><H1><P ALIGN="CENTER"> V22.0480.002 <P ALIGN="CENTE	www.settheory.com	0	0		POLR2B
1157	chr6	74983428	75008372	3500161240	123		74983428	75008372	8421504	3	30,15,78	0,385,24866	p	350016124000015034,350016124000015042	0-45,9-87						Prokaryotic eukaryotic homologous	www.pnas.org	0	0		POLR2B
1157	chr6	74999070	74999423	3500210995	60		74999070	74999423	8421504	2	51,9	0,344	p	350021099500015015	0-60						RNA polymerase II gene (RPB2) encoding the second largest protein subunit in Phaeosphaeria nodorum	aldc.nal.usda.gov	0	0		POLR2B
1157	chr6	74999070	74999423	3500031413	60		74999070	74999423	8421504	2	51,9	0,344	p	350003141300015015	0-60						RNA polymerase II gene (RPB2) encoding the second largest protein subunit in Phaeosphaeria nodorum	crec.ifas.ufl.edu	0	0		POLR2B
1157	chr6	75014889	75014912	3500261622	23		75014889	75014912	8421504	1	23	0	c	350026162200000017	0-23						Pluripotent embryonic-like stem cells derived from teeth and uses thereof	Schierholz	2003	0		
1157	chr6	75016532	75027565	3500230510	225		75016532	75027565	8421504	6	45,45,39,6,45,45	0,1027,1075,10931,10940,10988	p	350023051000015020,350023051000015018,350023051000015017,350023051000015016,350023051000015015	0-45,0-45,0-45,0-45,0-45						INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 FOR TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		IGFBP7
1157	chr6	75017617	75017641	3500042521	24		75017617	75017641	8421504	1	24	0	c	350004252100000010	0-24						TUMOR ANGIOGENESIS ASSOCIATED GENES AND A METHOD FOR THEIR IDENTIFICATION - Patent application	www.faqs.org	0	0		
1157	chr6	75017621	75095352	3500397549	67		75017621	75095352	8421504	5	25,3,14,6,19	0,9842,9938,77528,77712	c,g	350039754900000258,350039754900000258,350039754900000256,350039754900000098,350039754900000096	0-21,0-21,0-21,0-20,0-19						Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence	Sa Mo .A Er -Mu La Ni 	2013	0		IGFBP7
1157	chr6	75017621	75095352	3500388291	67		75017621	75095352	8421504	5	25,3,14,6,19	0,9842,9938,77528,77712	c,g	350038829100000286,350038829100000286,350038829100000284,350038829100000087,350038829100000086	0-21,0-21,0-21,0-20,0-19						Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence	Sa Mo .A Er -Mu La Ni 	2012	0		IGFBP7
1157	chr6	75017621	75095352	3500385332	67		75017621	75095352	8421504	5	25,3,14,6,19	0,9842,9938,77528,77712	c,g	350038533200000144,350038533200000144,350038533200000143,350038533200000049,350038533200000048	0-21,0-21,0-21,0-20,0-19						Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer	Al-Murrani	2010	0		IGFBP7
1157	chr6	75017621	75095352	3500337516	67		75017621	75095352	8421504	5	25,3,14,6,19	0,9842,9938,77528,77712	c,g	350033751600000144,350033751600000144,350033751600000143,350033751600000049,350033751600000048	0-21,0-21,0-21,0-20,0-19						Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer	Al-Murrani	2010	0		IGFBP7
1157	chr6	75017621	75095352	3500337225	67		75017621	75095352	8421504	5	25,3,14,6,19	0,9842,9938,77528,77712	c,g	350033722500000144,350033722500000144,350033722500000143,350033722500000049,350033722500000048	0-21,0-21,0-21,0-20,0-19						Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer	Al-Murrani	2010	0		IGFBP7
1157	chr6	75017621	75095352	3500326248	67		75017621	75095352	8421504	5	25,3,14,6,19	0,9842,9938,77528,77712	c,g	350032624800000144,350032624800000144,350032624800000143,350032624800000049,350032624800000048	0-21,0-21,0-21,0-20,0-19						Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer	Al-Murrani	2010	0		IGFBP7
1157	chr6	75017621	75095352	3500259525	67		75017621	75095352	8421504	5	25,3,14,6,19	0,9842,9938,77528,77712	c,g	350025952500000144,350025952500000144,350025952500000143,350025952500000049,350025952500000048	0-21,0-21,0-21,0-20,0-19						Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence	Al-Murrani	2011	0		IGFBP7
1157	chr6	75017621	75095352	3500092120	67		75017621	75095352	8421504	5	25,3,14,6,19	0,9842,9938,77528,77712	c,g	350009212000000144,350009212000000144,350009212000000143,350009212000000049,350009212000000048	0-21,0-21,0-21,0-20,0-19					Patent	Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression (Patent US:8192935)	Al-Murrani	2012	0		IGFBP7
1157	chr6	75017621	75095155	3500267380	48		75017621	75095155	8421504	4	25,3,14,6	0,9842,9938,77528	c,g	350026738000000517,350026738000000517,350026738000000287,350026738000000287,350026738000000516,350026738000000286,350026738000000086	0-21,0-21,0-21,0-21,0-21,0-21,0-20						Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence	Sa Mo *A Er -Mu La Ni 	2007	0		IGFBP7
1157	chr6	75017621	75095155	3500168013	48		75017621	75095155	8421504	4	25,3,14,6	0,9842,9938,77528	c,g	350016801300000252,350016801300000252,350016801300000135,350016801300000135,350016801300000134,350016801300000251,350016801300000040	0-21,0-21,0-21,0-21,0-21,0-21,0-20					Patent	Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer (Patent EP:1704250)	Al-Murrani	2012	0		IGFBP7
1157	chr6	75017621	75095155	3500037919	48		75017621	75095155	8421504	4	25,3,14,6	0,9842,9938,77528	c,g	350003791900000261,350003791900000261,350003791900000144,350003791900000144,350003791900000143,350003791900000260,350003791900000049	0-21,0-21,0-21,0-21,0-21,0-21,0-20						Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer - Patent application	www.faqs.org	0	0		IGFBP7
1157	chr6	75017621	75027466	3500113901	28		75017621	75027466	8421504	2	25,3	0,9842	c,g	350011390100000144,350011390100000144,350011390100000143	0-21,0-21,0-21						Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence	Al-Murrani	2005	0		IGFBP7
1157	chr6	75017621	75027466	3500107440	28		75017621	75027466	8421504	2	25,3	0,9842	c,g	350010744000000144,350010744000000144,350010744000000143	0-21,0-21,0-21					Patent	Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer (Patent US:7700280)	Al-Murrani	2010	0		IGFBP7
1157	chr6	75027559	75095352	3500267380	39		75027559	75095352	8421504	3	14,6,19	0,67590,67774	c,g	350026738000000406,350026738000000085,350026738000000402	0-20,0-19,0-19						Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence	Sa Mo *A Er -Mu La Ni 	2007	0		IGFBP7
1157	chr6	75027559	75095352	3500168013	39		75027559	75095352	8421504	3	14,6,19	0,67590,67774	c,g	350016801300000194,350016801300000039,350016801300000192	0-20,0-19,0-19					Patent	Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer (Patent EP:1704250)	Al-Murrani	2012	0		IGFBP7
1157	chr6	75027559	75095352	3500037919	39		75027559	75095352	8421504	3	14,6,19	0,67590,67774	c,g	350003791900000203,350003791900000048,350003791900000201	0-20,0-19,0-19						Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer - Patent application	www.faqs.org	0	0		IGFBP7
1157	chr6	75027559	75095352	3500009570	39		75027559	75095352	8421504	3	14,6,19	0,67590,67774	c,g	350000957000000049,350000957000000048	0-20,0-19						Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer	Al-murrani	2010	0		IGFBP7
1160	chr6	75451461	75451493	3500300397	24		75451461	75451493	8421504	3	5,12,7	0,8,25	g	350030039700000007	5-29						Methods and compositions for polypeptide engineering	Patten	2005	0		
1160	chr6	75451461	75451493	3500137585	24		75451461	75451493	8421504	3	5,12,7	0,8,25	g	350013758500000007	5-29						Methods and compositions for polypeptide engineering	Patten	2006	0		
1163	chr6	75794752	75794776	3500310050	23		75794752	75794776	8421504	2	15,8	0,16	g	350031005000000063	4-27						Approaches for eliminating PCR inhibitors and designing PCR primers for the detection of phytopathogenic fungi	biodiversity.info	0	0		
1171	chr6	76810255	76810280	3500401872	25		76810255	76810280	8421504	1	25	0	g	350040187200000015	15-40						Methods And Compositions For Treating And Preventing Peripheral Nerve Damage 	.freshpatents.com	0	0		
1182	chr6	78342242	78342266	3500046125	23		78342242	78342266	8421504	2	16,7	0,17	g	350004612500000048	0-32						MUTANT ENZYMES - ISIS INNOVATION LIMITED	www.sumobrain.com	0	0		
1191	chr6	79508294	79508889	3500382374	595		79508294	79508889	8421504	1	595	0	g	350038237400000005	29-699						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
1191	chr6	79508294	79508889	3500221817	595		79508294	79508889	8421504	1	595	0	g	350022181700000005	29-699					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
1191	chr6	79508294	79508889	3500101798	595		79508294	79508889	8421504	1	595	0	g	350010179800000006	29-699						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
1191	chr6	79508297	79508889	3500360633	592		79508297	79508889	8421504	1	592	0	g	350036063300000003	29-696						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
149	chr6	80038808	80222294	3500033154	276		80038808	80222294	8421504	4	54,1,214,7	0,20042,90597,183479	p	350003315400015004	0-276						Gpcrs as angiogenesis targets	Leung	2008	0		
1195	chr6	80083360	80083386	3500177994	23		80083360	80083386	8421504	3	13,5,5	0,15,21	g	350017799400000065	0-23						US Patent # 7,491,398. Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections - Patents.com	www.patents.com	0	0		
1198	chr6	80444745	80467415	3500272471	56		80444745	80467415	8421504	3	27,1,28	0,28,22642	c	350027247100000011,350027247100000010	0-27,0-29						Lectomedin materials and methods	Douangpanya	2000	0		
1199	chr6	80522107	80522136	3500300648	29		80522107	80522136	8421504	1	29	0	c	350030064800000146	16-45						Methods and targets for identifying compounds for regulating angiogenesis - Patent application	www.faqs.org	0	0		
1199	chr6	80522107	80522133	3500081673	26		80522107	80522133	8421504	1	26	0	c	350008167300000350	19-45						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
1200	chr6	80613147	80613192	3500272471	45		80613147	80613192	8421504	1	45	0	p	350027247100015007	3-48						Lectomedin materials and methods	Douangpanya	2000	0		LPHN3
1200	chr6	80613147	80613192	3500240709	45		80613147	80613192	8421504	1	45	0	p	350024070900015006	3-48						Lectomedin materials and methods	Hayflick	2000	0		LPHN3
1213	chr6	82325643	82325666	3500040714	23		82325643	82325666	8421504	1	23	0	g	350004071400000003	5-28						DNA APTAMERS FOR PROMOTING REMYELINATION - MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH	www.sumobrain.com	0	0		
1215	chr6	82698589	82698615	3500281795	23		82698589	82698615	8421504	2	18,5	0,21	g	350028179500000090,350028179500000062	0-23,0-23						Methods and compositions related to fatty alcohol biosynthetic enzymes	Schirmer	2011	0		
1217	chr6	82912434	82912460	3500368576	25		82912434	82912460	8421504	2	5,20	0,6	g	350036857600000118	16-42						Alanine 2, 3 aminomutases - Patent application	www.faqs.org	0	0		
1226	chr6	84069979	84070005	3500147086	23		84069979	84070005	8421504	2	7,16	0,10	g	350014708600000013	16-39						Aus der III. Medizinischen Klinik und Poliklinik der Universit&#xe4;tsmedizin der Johannes Gutenberg-Universit&#xe4;t Mainz Evaluation von Nukleotidpolymorphismen f&#xfc;r die Analyse des h&#xe4;matopoetischen Spenderchim&#xe4;rismus auf Ebene der cDNA In	m.opus.hbz-nrw.de	0	0		
1236	chr6	85453744	85453774	3500341927	25		85453744	85453774	8421504	2	11,14	0,16	g	350034192700000022	0-25						NOVEL SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOUNDS, METHODS FOR PREPARATION AND USE THEREOF	Hampson	2009	0		
1240	chr6	85941435	85954896	3500004227	41		85941435	85954896	8421504	3	7,14,20	0,8,13441	c	350000422700000446,350000422700001058	0-21,0-20						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
1241	chr6	86045948	86049875	3500390291	231		86045948	86049875	8421504	2	186,45	0,3882	p,c	350039029100015010,350039029100000006,350039029100015008	0-186,0-20,0-45						Dog gonadotropin releasing hormone receptor	Cui	2000	0		GNRHR
1241	chr6	86049826	86049849	3500142474	23		86049826	86049849	8421504	1	23	0	c	350014247400000005	0-23		10614625	10.1210/en.141.1.72	0013-7227	Endocrinology	Role of Gonadotropin-Releasing Hormone as an Autocrine Growth Factor in Human Ovarian Surface Epithelium	Kang	2000	4		
1245	chr6	86567456	86567481	3500118118	23		86567456	86567481	8421504	2	11,12	0,13	g	350011811800000045	1-24						Method for preparing polypeptide specifically recognizing membrane protein	Tai	2010	0		
1245	chr6	86623207	86623241	3500252890	25		86623207	86623241	8421504	3	14,3,8	0,18,26	g	350025289000000207	0-25						Neisseria meningitidis antigens and compositions	Fraser	2012	0		
1246	chr6	86745293	86766034	3500306201	120		86745293	86766034	8421504	3	4,59,57	0,10769,20684	p	350030620100015010,350030620100015009	0-63,0-57						Signal dependency of Tra2-beta1 alternative splicing	b.uni-erlangen.de	0	0		YTHDC1
1246	chr6	86745293	86766034	3500144405	120		86745293	86766034	8421504	3	4,59,57	0,10769,20684	p	350014440500015010,350014440500015009	0-63,0-57						Characterisation of heterogeneous nuclear ribonucleoprotein G (hnRNP G) and its role in splice site selection.	b.uni-erlangen.de	0	0		YTHDC1
1248	chr6	86980320	86980344	3500010045	23		86980320	86980344	8421504	2	14,9	0,15	g	350001004500000000	2-30		19641000	10.1128/JVI.01200-09	0022-538X	Journal of Virology	Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation	Hurt	2009	5		
1250	chr6	87277678	87277708	3500220074	24		87277678	87277708	8421504	3	7,13,4	0,12,26	g	350022007400000437	10-41					Patent	Thermophilic DNA polymerases from Thermotoga neapolitana (Patent US:6077664)	Bolchakova	2000	0		
1251	chr6	87368143	87368308	3500293780	129		87368143	87368308	8421504	2	45,84	0,81	p	350029378000015253,350029378000015250	0-45,0-84					Patent	Nucleic acid encoding a NOVX13 polypeptide (Patent US:7122345)	Padigaru	2006	0		
1251	chr6	87403650	87405256	3500077888	49		87403650	87405256	8421504	3	25,6,18	0,48,1588	c	350007788800000035,350007788800000034	0-25,0-24						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1255	chr6	87848473	87848500	3500408735	23		87848473	87848500	8421504	2	17,6	0,21	c	350040873500000149	3-26						METHODS AND MEANS FOR REGULATING GENE EXPRESSION	Den	2004	0		
1256	chr6	87978925	87978953	3500275238	23		87978925	87978953	8421504	2	6,17	0,11	g	350027523800000000	0-24			10.1167/iovs.04-0013	1552-5783	Investigative Ophthalmology & Visual Science	Bves Is Expressed in the Epithelial Components of the Retina, Lens, and Cornea	Ripley	2004	0		
1257	chr6	88085726	88085749	3500312786	23		88085726	88085749	8421504	1	23	0	g	350031278600000078	15-38						Compositions and methods for synthesizing nucleic acids	Lee	2005	0		
1257	chr6	88126731	88130412	3500342160	72		88126731	88130412	8421504	2	46,26	0,3655	c	350034216000000032,350034216000000028	2-48,7-33						US Patent # 5,714,594. cDNA cloning and expression of human liver estrogen sulfotransferase - Patents.com	www.patents.com	0	0		
1257	chr6	88139827	88139851	3500390991	24		88139827	88139851	8421504	1	24	0	c	350039099100000002	0-24		17341680	10.1096/fj.06-7688com	0892-6638	The FASEB Journal	Low expression of COX-2, reduced cumulus expansion, and impaired ovulation in SULT1E1-deficient mice	Gershon	2007	6		
1257	chr6	88139827	88139851	3500179309	24		88139827	88139851	8421504	1	24	0	c	350017930900000002	0-24						Low expression of COX-2, reduced cumulus expansion, and impaired ovulation in SULT1E1-de&#xfb01;cient mice	www.fasebj.org	0	0		
1258	chr6	88231008	88257402	3500145236	66		88231008	88257402	8421504	3	22,23,21	0,25617,26373	c,g	350014523600000008,350014523600000010,350014523600000011	0-22,0-23,0-21		17170087	10.1677/jme.1.02131	0952-5041	Journal of Molecular Endocrinology	DNA-remethylation around a STAT5-binding enhancer in the &#x03b1;S1-casein promoter is associated with abrupt shutdown of &#x03b1;S1-casein synthesis during acute mastitis	Vanselow	2006	3		
1258	chr6	88240906	88288057	3500186308	294		88240906	88288057	8421504	2	177,117	0,47034	g	350018630800000020,350018630800000022	0-177,0-117						EFFECTS OF GROWTH HORMONE AND INSULIN-LIKE GROWTH FACTOR-I ON MILK PROTEIN GENE EXPRESSION AND NUTRIENT UPTAKE AND CELL PROLIFERATION IN CLONAL BOVINE MAMMARY EPITHELIAL CELLS	cholar.lib.vt.edu	0	0		
1258	chr6	88241083	88258531	3500345230	270		88241083	88258531	8421504	4	183,47,20,20	0,1439,16300,17428	c,g	350034523000000140,350034523000000016,350034523000000001,350034523000000145,350034523000000002,350034523000000002,350034523000000003	0-183,16-36,0-19,4-51,0-20,0-20,0-20						Transgenic bovines and milk from transgenic bovines	Deboer	1995	0		
1258	chr6	88241083	88258531	3500151266	270		88241083	88258531	8421504	4	183,47,20,20	0,1439,16300,17428	c,g	350015126600000139,350015126600000016,350015126600000001,350015126600000146,350015126600000002,350015126600000002,350015126600000003	0-183,16-36,0-19,4-51,0-20,0-20,0-20						Transgenic bovine	Deboer	1995	0		
1258	chr6	88241084	88258531	3500383943	79		88241084	88258531	8421504	4	20,19,20,20	0,163,16299,17427	c,g	350038394300000016,350038394300000001,350038394300000002,350038394300000002,350038394300000003	16-36,0-19,0-20,0-20,0-20						Production of recombinant polypeptides by bovine species and transgenic methods	Heyneker	1996	0		
1258	chr6	88241084	88258531	3500133280	79		88241084	88258531	8421504	4	20,19,20,20	0,163,16299,17427	c,g	350013328000000016,350013328000000016,350013328000000001,350013328000000002,350013328000000002,350013328000000003,350013328000000003	16-36,16-36,0-19,0-20,0-20,0-20,0-20						Production of recombinant polypeptides by bovine species and transgenic methods	Deboer	1991	0		
1258	chr6	88241091	88257405	3500046787	60		88241091	88257405	8421504	3	20,20,20	0,1130,16294	c,g	350004678700000002,350004678700000000,350004678700000001,350004678700000001	0-20,0-20,0-20,0-20						ScienceDirect.com - FEBS Letters - Human nerve growth factor beta (hNGF-&#x03b2;): mammary gland specific expression and production in transgenic rabbits	sciencedirect.com	0	0		
1258	chr6	88241094	88241125	3500102321	30		88241094	88241125	8421504	2	18,12	0,19	c	350010232100000000	10-40						Recombinant vector	Sekine	1990	0		
1258	chr6	88241247	88258531	3500427131	59		88241247	88258531	8421504	3	19,20,20	0,16136,17264	c,g	350042713100000001,350042713100000002,350042713100000002,350042713100000003	0-19,0-20,0-20,0-20						&#x0422;&#x0440;&#x0430;&#x043d;&#x0441;&#x0433;&#x0435;&#x043d; &#x0434;&#x043b;&#x044f; &#x043f;&#x043e;&#x043b;&#x0443;&#x0447;&#x0435;&#x043d;&#x0438;&#x044f; &#x0440;&#x0435;&#x043a;&#x043e;&#x043c;&#x0431;&#x0438;&#x043d;&#x0430;&#x043d;&#x0442;&#x0	www.findpatent.ru	0	0		
1258	chr6	88242526	88282046	3500398906	47		88242526	88282046	8421504	2	27,20	0,39500	c,g	350039890600000000,350039890600000000,350039890600000004	0-27,0-27,0-20						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
1258	chr6	88242542	88242911	3500380526	45		88242542	88242911	8421504	2	23,22	0,347	c,g	350038052600000002,350038052600000002,350038052600000003	0-23,0-23,0-22						Direct gene transfer into the ruminant mammary gland	Karatzas	1996	0		
1258	chr6	88242542	88242565	3500430867	23		88242542	88242565	8421504	1	23	0	c	350043086700000000	0-23						Method for the production of biologically active polypeptides in a mammal's	Hyttinen	1994	0		CSN1S1
1258	chr6	88242542	88242565	3500324682	23		88242542	88242565	8421504	1	23	0	c	350032468200000002	0-23						Direct gene transfer into the ruminant mammary gland	Karatzas	1995	0		CSN1S1
1258	chr6	88242571	88282029	3500418941	840		88242571	88282029	8421504	13	6,33,39,24,18,45,15,33,27,24,96,474,6	0,1969,2895,3374,4039,7832,9409,11335,12262,13235,14054,37657,39452	p	350041894100015018,350041894100015019,350041894100015021,350041894100015023,350041894100015024,350041894100015025,350041894100015046,350041894100015045,350041894100015044,350041894100015043,350041894100015042,350041894100015041,350041894100015040,350041894100015039	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60						TEJFEH&#xc9;RJE GENETIKAI VIZSG&#xc1;LATOK HAZAI SZARVASMARHA FAJT&#xc1;KBAN	www.szie.hu	0	0		
1258	chr6	88242571	88256760	3500376942	96		88242571	88256760	8421504	4	6,33,30,27	0,1969,2895,14162	p	350037694200015016,350037694200015003,350037694200015018,350037694200015009	0-66,0-66,0-87,0-51						Casein-derived antimicrobial peptides and lactobacillus strains that produce them	Ross	2007	0		
1258	chr6	88242574	88244561	3500219205	24		88242574	88244561	8421504	2	3,21	0,1966	c	350021920500000000	0-24						Establishment and characterization of a lactating bovine mammary epithelial cell model for the study of milk synthesis	w.cellbiolint.org	0	0		
1258	chr6	88245490	88247245	3500286152	72		88245490	88247245	8421504	4	15,24,24,9	0,455,1120,1746	p	350028615200015001,350028615200015006	0-57,0-72		20023075	10.1128/AEM.00151-09	0099-2240	Applied and Environmental Microbiology	Milk Protein Fragments Induce the Biosynthesis of Macedocin, the Lantibiotic Produced by Streptococcus macedonicus ACA-DC 198	Georgalaki	2010	4		
1258	chr6	88245490	88247245	3500164001	72		88245490	88247245	8421504	4	15,24,24,9	0,455,1120,1746	p	350016400100015001	0-72		20023075	10.1128/AEM.00151-09		Applied and Environmental Microbiology	Milk Protein Fragments Induce the Biosynthesis of Macedocin, the Lantibiotic Produced by Streptococcus macedonicus ACA-DC 198 	Marina	2010	0		
1258	chr6	88246625	88247964	3500447183	45		88246625	88247964	8421504	3	9,24,12	0,611,1327	c	350044718300000000	0-45						Isolation of exogenous recombinant proteins from the milk of transgenic mammals	Meade	1987	0		
1258	chr6	88246625	88247964	3500224542	45		88246625	88247964	8421504	3	9,24,12	0,611,1327	c	350022454200000000	0-45						Expression of proteins in milk	Lonberg	2004	0		
1258	chr6	88246625	88247964	3500212614	45		88246625	88247964	8421504	3	9,24,12	0,611,1327	c	350021261400000000	0-45					Patent	Isolation of exogenous recombinant proteins from the milk of transgenic mammals (Patent US:4873316)	Lonberg	1989	0		
1258	chr6	88246625	88247964	3500150794	45		88246625	88247964	8421504	3	9,24,12	0,611,1327	c	350015079400000000	0-45						 Isolation Of Exogenous Recombinant Proteins From The Milk Of Transgenic Mammals 	www.docstoc.com	0	0		
1258	chr6	88246625	88247964	3500093060	45		88246625	88247964	8421504	3	9,24,12	0,611,1327	c	350009306000000000	0-45						Expression of proteins in milk	Lonberg	2002	0		
1258	chr6	88246625	88247963	3500380237	44		88246625	88247963	8421504	3	9,24,11	0,611,1327	c	350038023700000000	0-44						Improved expression of polypeptides	Meade	1991	0		
1258	chr6	88247234	88247259	3500097362	25		88247234	88247259	8421504	1	25	0	g	350009736200000000	13-38					Patent	Isolation of exogenous recombinant proteins from the milk of transgenic mammals (Patent US:4873316)	Lonberg	1989	0		
1258	chr6	88249430	88263496	3500378322	574		88249430	88263496	8421504	11	21,91,21,16,5,20,60,54,185,81,20	0,60,177,2844,2861,8603,8686,8806,8861,9106,14046	c,g	350037832200000000,350037832200000011,350037832200000025,350037832200000023,350037832200000013,350037832200000004,350037832200000005,350037832200000029,350037832200000033,350037832200000008,350037832200000035,350037832200000047,350037832200000037,350037832200000010,350037832200000039,350037832200000043,350037832200000006,350037832200000003	0-21,0-60,0-27,4-52,0-60,0-21,0-20,0-60,0-54,0-21,0-60,1-38,0-60,0-21,0-60,0-60,0-21,0-20						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
1258	chr6	88250302	88279588	3500288419	46		88250302	88279588	8421504	3	2,25,19	0,92,29267	c	350028841900000006,350028841900000007	24-51,20-39						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
1258	chr6	88250430	88255830	3500404523	42		88250430	88255830	8421504	3	18,3,21	0,1550,5379	c	350040452300000003,350040452300000001	0-21,0-21						Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides - Patent # 6465432 - PatentGenius	.patentgenius.com	0	0		
1258	chr6	88250489	88280713	3500467197	41		88250489	88280713	8421504	2	20,21	0,30203	g	350046719700000003,350046719700000004	1-21,0-21						SINGLE-STRAND CONFORMATION POLYMORPHISM (SSCP) ANALYSIS OF aS -CASEIN, b-CASEIN AND -CASEIN GENES IN CHARNEQUEIRA PORTUGUESE INDIGENOUS GOAT BREED	www.uco.es/organi	0	0		
1258	chr6	88253923	88256747	3500447347	40		88253923	88256747	8421504	3	16,4,20	0,910,2804	c,g	350044734700000000,350044734700000001	0-20,0-20						Characterization of Differentiation of Bovine Mammary Epithelial Cells	commons.uconn.edu	0	0		
1258	chr6	88256625	88257402	3500417810	44		88256625	88257402	8421504	2	23,21	0,756	c	350041781000000010,350041781000000011	0-23,0-21						DNA-remethylation around a STAT5-binding enhancer in the aS1-casein promoter is associated with abrupt shutdown of aS1-casein synthesis during acute mastitis	logy-journals.org	0	0		
1258	chr6	88256647	88256980	3500261468	40		88256647	88256980	8421504	2	20,20	0,313	c,g	350026146800000000,350026146800000000,350026146800000001	0-20,0-20,0-20						Genetic analysis of milk protein composition and of its relationship with renneting properties of individual cow milk	arch.cab.unipd.it	0	0		
1258	chr6	88257386	88257479	3500262583	44		88257386	88257479	8421504	2	23,21	0,72	c,g	350026258300000002,350026258300000005	7-30,0-21						&#x0413;&#x0435;&#x043d;&#x043d;&#x043e;-&#x0438;&#x043d;&#x0436;&#x0435;&#x043d;&#x0435;&#x0440;&#x043d;&#x0430;&#x044f; &#x043a;&#x043e;&#x043d;&#x0441;&#x0442;&#x0440;&#x0443;&#x043a;&#x0446;&#x0438;&#x044f; pgoatcasgcsf, &#x043e;&#x0431;&#x0435;&#x044	www.freepatent.ru	0	0		
1258	chr6	88258291	88258383	3500150747	45		88258291	88258383	8421504	2	21,24	0,68	c,g	350015074700000004,350015074700000006	0-21,0-24						Relationship between arterial pressure and pulse wave velocity using photoplethysmography during the post-exercise recovery period | Zbignevs Marcinkevics - Academia.edu	www.academia.edu	0	0		
1258	chr6	88258291	88258383	3500105272	45		88258291	88258383	8421504	2	21,24	0,68	c,g	350010527200000000,350010527200000002	0-21,0-24						Genetic diversity in milk proteins among goats bred in Lithuania	eeb.lu.lv/EEB/200	0	0		
1258	chr6	88258359	88258383	3500013963	24		88258359	88258383	8421504	1	24	0	c	350001396300000006	0-24						753. S&#x0112;JUMS Biolo&#x0123;ija	www.lu.lv/fileadm	0	0		
1258	chr6	88278391	88287879	3500402183	7471		88278391	88287879	8421504	148	51,58,59,60,58,64,55,59,58,58,40,19,59,59,61,57,59,60,58,59,59,59,28,30,59,60,51,7,57,59,59,59,119,57,60,59,58,56,56,55,52,58,55,56,55,17,38,55,55,56,55,56,58,57,57,55,55,55,53,58,55,56,54,55,56,54,54,56,57,57,36,21,54,56,55,56,55,55,55,55,56,54,34,30,57,55,55,54,56,55,56,55,56,58,57,56,56,54,56,54,56,55,41,13,56,54,55,57,51,58,57,57,56,56,55,53,58,55,13,42,6,48,13,16,4,11,12,53,8,11,26,32,20,55,55,56,56,58,57,54,58,57,52,55,52,57,55,46	0,52,111,171,232,291,356,412,472,531,590,631,651,711,771,833,891,951,1012,1071,1131,1191,1251,1281,1312,1372,1433,1485,1494,1552,1612,1672,1732,1852,1910,1971,2031,2090,2151,2211,2271,2328,2391,2451,2511,2571,2589,2632,2692,2752,2812,2872,2931,2992,3052,3112,3172,3232,3292,3350,3412,3472,3533,3592,3652,3712,3771,3830,3891,3951,4011,4048,4072,4131,4192,4252,4312,4372,4432,4492,4552,4612,4672,6206,6240,6302,6361,6421,6480,6541,6601,6661,6721,6780,6841,6901,6960,7022,7081,7142,7201,7261,7321,7364,7383,7444,7503,7562,7624,7680,7743,7803,7863,7922,7983,8043,8101,8163,8223,8237,8284,8291,8349,8363,8380,8385,8397,8416,8477,8499,8513,8546,8579,8604,8664,8724,8784,8843,8904,8964,9023,9085,9147,9204,9264,9321,9382,9442	g	350040218300000005	3279-11379						 Retrovirus 	www.docstoc.com	0	0		
1258	chr6	88278538	88279131	3500428921	84		88278538	88279131	8421504	3	23,22,39	0,277,554	g	350042892100000005,350042892100000009,350042892100000004,350042892100000001	10-33,0-22,9-31,8-31						Knocking-in of the human thrombopoietin gene on beta-casein locus in bovine fibroblasts.	.biomedsearch.com	0	0		
1258	chr6	88278620	88287863	3500408468	330		88278620	88287863	8421504	6	64,201,6,18,12,29	0,1620,3554,6305,7248,9214	p,c	350040846800000020,350040846800015008,350040846800000008,350040846800000003	0-65,390-591,0-24,15-56						&#x5c71;&#x7f8a;&#x03b2;	www.csas.org.tw	0	0		
1258	chr6	88279597	88285868	3500092530	46		88279597	88285868	8421504	3	6,17,23	0,607,6248	c	350009253000000002,350009253000000001	0-23,0-23						dnasequence@sanger	ibic.lib.ku.ac.th	0	0		
1258	chr6	88279597	88280267	3500055642	69		88279597	88280267	8421504	2	6,63	0,607	p,c	350005564200000001,350005564200015006	0-23,3-69						2008-3buffalo bulletin	www.scribd.com	0	0		
1258	chr6	88279600	88280252	3500446569	51		88279600	88280252	8421504	2	3,48	0,604	p	350044656900015006,350044656900015016	0-51,0-60						IDENTIFICATION OF BITTER LIGANDS THAT SPECIFICALLY ACTIVATE HUMAN T2R RECEPTORS AND RELATED ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS	LI	2006	0		
1258	chr6	88279600	88280252	3500346190	51		88279600	88280252	8421504	2	3,48	0,604	p	350034619000015001	0-51		11694622		0022-3166	The Journal of Nutrition	A Peptide Derived from Bovine &#x03b2;-Casein Modulates Functional Properties of Bone Marrow-Derived Macrophages from Germfree and Human Flora-Associated Mice	Sandre	2001	4		
1258	chr6	88279600	88280252	3500297589	51		88279600	88280252	8421504	2	3,48	0,604	p	350029758900015000	0-60					Patent	Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators (Patent US:7883856)	Li	2011	0		
1258	chr6	88279600	88280252	3500291341	51		88279600	88280252	8421504	2	3,48	0,604	p	350029134100015014	0-51						UNIVERSIT&#xc0; DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1258	chr6	88279600	88280252	3500282079	51		88279600	88280252	8421504	2	3,48	0,604	p	350028207900015000,350028207900015006	0-51,0-60						Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators	Li	2011	0		
1258	chr6	88279600	88280252	3500277218	51		88279600	88280252	8421504	2	3,48	0,604	p	350027721800015003	0-60						Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators	Li	2011	0		
1258	chr6	88279600	88280252	3500060097	51		88279600	88280252	8421504	2	3,48	0,604	p	350006009700015001	0-51		11694622		0022-3166	The Journal of Nutrition	A Peptide Derived from Bovine &#x03b2;-Casein Modulates Functional Properties of Bone Marrow-Derived Macrophages from Germfree and Human Flora-Associated Mice	Sandre	2001	4		
1258	chr6	88280205	88280702	3500352598	41		88280205	88280702	8421504	2	20,21	0,476	c,g	350035259800000003,350035259800000003,350035259800000002,350035259800000002	0-20,0-20,0-21,0-21			10.1590/S1415-47572008005000002	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - &#x03b2;-casein gene polymorphism permits identification of bovine milk mixed with bubaline milk in mozzarella cheese	Otaviano	2008	1		
1258	chr6	88280220	88280685	3500109980	465		88280220	88280685	8421504	1	465	0	c,g	350010998000000004,350010998000000002,350010998000000001,350010998000000001,350010998000000003,350010998000000000	0-465,0-465,0-22,0-22,0-447,0-22						Volume 26 No. 1	ibic.lib.ku.ac.th	0	0		
1258	chr6	88280231	88280690	3500075281	159		88280231	88280690	8421504	3	63,48,48	0,297,411	p	350007528100015006,350007528100015005,350007528100015003,350007528100015004	0-51,0-48,0-48,0-48						Obtenci&#xf3;n de una nueva cepa de bifidobacterium bifidum con actividad frente a la infecci&#xf3;n por helicobacter pylori	Echevarria	2009	0		
1258	chr6	88280274	88280612	3500061712	108		88280274	88280612	8421504	4	28,23,29,28	0,163,188,310	c	350006171200000001,350006171200000003,350006171200000002,350006171200000000	0-28,0-23,0-29,0-28						Beta-casein (Alleles A and B) ARMS-PCR (Amplification Refractory Mutation System)	ience.ucdavis.edu	0	0		
1258	chr6	88280309	88280381	3500063060	70		88280309	88280381	8421504	3	22,25,23	0,23,49	c	350006306000000001,350006306000000002,350006306000000000	0-22,0-25,0-23						&#x03b2;-casein gene expression by in vitro cultured bovine mammary epithelial cells derived from developing mammary glands	w.funpecrp.com.br	0	0		
1258	chr6	88280309	88280357	3500106263	48		88280309	88280357	8421504	1	48	0	p	350010626300015068	0-48						Protein modification method	Sato	1995	0		
1258	chr6	88280332	88280357	3500317947	25		88280332	88280357	8421504	1	25	0	c	350031794700000002	0-25						Breeding of transgenic cattle for human coagulation factor IX by a combination of lentiviral system and cloning. - ResearchGate	.researchgate.net	0	0		
1258	chr6	88280384	88280681	3500415712	132		88280384	88280681	8421504	2	81,51	0,246	p	350041571200015000,350041571200015003,350041571200015002	0-45,0-48,0-51			10.1046/j.1432-1327.2000.01589.x	1432-1033	European Journal of Biochemistry	Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response - Gray - 2001 - European Journal of Biochemistry - Wiley Online Library	Gray	2000	0		
1258	chr6	88280402	88280626	3500228344	40		88280402	88280626	8421504	2	20,20	0,204	c,g	350022834400000005,350022834400000004,350022834400000004	0-20,0-20,0-20						GEN&#xd4;MICA COMPARATIVA COMO FERRAMENTA PARA O ESTUDO DE GENES RELACIONADOS COM PRODU&#xc7;&#xc3;O DE LEITE NO GENOMA DO B&#xda;FALO DE RIO COMPARATIVE GENOMICSAS A TOOL FOR STUDINGGENES RELATED WITH MILK PRODUCTION IN RIVER BUFFALO	prope.unesp.br	0	0		
1258	chr6	88280423	88280743	3500067185	299		88280423	88280743	8421504	4	39,30,179,51	0,49,89,269	c,g	350006718500000026,350006718500000008,350006718500000025,350006718500000024,350006718500000024,350006718500000022,350006718500000022,350006718500000020,350006718500000004,350006718500000015,350006718500000001,350006718500000013,350006718500000002,350006718500000009,350006718500000023	0-39,0-20,0-30,0-110,0-110,4-57,4-57,4-56,0-23,0-23,0-19,0-20,0-20,0-19,0-110						BREEDING AND MILKING COWS FOR MILK FREE OF BETA-CASEIN A1 - Patent application	www.faqs.org	0	0		
1258	chr6	88280423	88280632	3500420184	43		88280423	88280632	8421504	2	20,23	0,186	c,g	350042018400000008,350042018400000004,350042018400000001,350042018400000001,350042018400000003,350042018400000002,350042018400000009,350042018400000009	0-20,0-23,0-19,0-19,0-20,0-20,0-19,0-19						Breeding and milking cows for milk free of &#x03b2;-casein A1	Mclachlan	2003	0		
1258	chr6	88280423	88280632	3500077154	43		88280423	88280632	8421504	2	20,23	0,186	c,g	350007715400000008,350007715400000002,350007715400000003,350007715400000001,350007715400000001,350007715400000004,350007715400000009,350007715400000009	0-20,0-20,0-20,0-19,0-19,0-23,0-19,0-19						Breeding and milking cows for milk free of &#x03b2;-casein A1 	Mclachlan	2009	0		
1258	chr6	88280423	88280628	3500004240	39		88280423	88280628	8421504	2	20,19	0,186	c	350000424000000006,350000424000000007,350000424000000001	0-20,0-19,0-19						Breeding And Milking Cows For Milk Free Of Beta-casein A1 	.freshpatents.com	0	0		
1258	chr6	88280487	88280517	3500464352	30		88280487	88280517	8421504	1	30	0	c	350046435200000003,350046435200000005	10-30,0-26						 Real Science Radio: Bergman on Whale Evolution - Theology Online | Christian Forums & More	heologyonline.com	0	0		
1258	chr6	88280552	88280624	3500218298	72		88280552	88280624	8421504	1	72	0	p	350021829800015001,350021829800015005	0-72,0-48		18515474	10.1128/AEM.00393-08	0099-2240	Applied and Environmental Microbiology	Short Peptide Induces an &#x201c;Uncultivable&#x201d; Microorganism To Grow In Vitro	Nichols	2008	4		
1258	chr6	88280578	88280689	3500203412	81		88280578	88280689	8421504	3	20,24,37	0,38,74	c,g	350020341200000001,350020341200000001,350020341200000004,350020341200000002,350020341200000000	0-20,0-20,0-24,0-24,0-19						High Resolution Melt Curve Analysis for the detection of A1, A2 &#x03b2;-casein variants in Indian Cows.	searchlibrary.com	0	0		
1258	chr6	88282029	88282349	3500256354	216		88282029	88282349	8421504	3	138,54,24	0,139,296	c,g	350025635400000006,350025635400000005,350025635400000004,350025635400000000	0-30,0-57,0-110,0-24					Patent	Casein phosphopeptide, casein containing same and process for the preparation thereof (Patent US:5834427)	Han	1998	0		
1258	chr6	88282029	88282222	3500205083	193		88282029	88282222	8421504	1	193	0	c,g	350020508300000005,350020508300000004,350020508300000003,350020508300000002	0-36,0-56,0-51,0-51						Casein from Korean cattle	Han	1999	0		
1258	chr6	88282032	88282158	3500315044	91		88282032	88282158	8421504	2	89,2	0,124	c,g	350031504400000008,350031504400000004,350031504400000007	0-33,54-89,0-56					Patent	Casein phospho peptide, casein containing same and process for the preparation thereof (Patent CN:1136228)	Han Xiang Ji 	2004	0		
1258	chr6	88282032	88282158	3500030479	91		88282032	88282158	8421504	2	89,2	0,124	c,g	350003047900000008,350003047900000004,350003047900000007	0-33,54-89,0-56						Casein Phosphopeptide, casein containing same and process for the preparation thereof	Han Xiang Ji 	1998	0		
1258	chr6	88282065	88285823	3500041921	202		88282065	88285823	8421504	4	157,12,27,6	0,2875,2999,3752	p,g	350004192100000003,350004192100000002,350004192100000001,350004192100015000,350004192100015003	0-56,0-51,0-51,0-45,0-45						Casein phosphopeptide, casein containing same and process for the preparation thereof	Han	1998	0		
1258	chr6	88285809	88289613	3500149607	3765		88285809	88289613	8421504	13	461,201,46,364,554,727,4,13,63,182,809,25,316	0,466,668,723,1089,1655,2384,2389,2403,2467,2652,3462,3488	c,g	350014960700000014,350014960700000016,350014960700000015,350014960700000012,350014960700000011,350014960700000010,350014960700000008,350014960700000002	61-1056,0-4112,14-894,15-785,25-907,191-1076,8-28,8-28						Isolation, Cloning, Sequencing and Functional analysis of -casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis) - Patent application	www.faqs.org	0	0		
1258	chr6	88287877	88289603	3500465634	1722		88287877	88289603	8421504	5	833,13,46,534,296	0,834,848,895,1430	g	350046563400000010,350046563400000001	0-1723,10-31						METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION - Patent application	www.faqs.org	0	0		
1258	chr6	88287972	88288003	3500189422	31		88287972	88288003	8421504	1	31	0	g	350018942200000000	0-31		21436886	10.1371/journal.pone.0017593	1932-6203	PLOS ONE	PLOS ONE: Characterization of Bioactive Recombinant Human Lysozyme Expressed in Milk of Cloned Transgenic Cattle	Yang	2011	4		
1258	chr6	88289399	88289454	3500378204	55		88289399	88289454	8421504	1	55	0	g	350037820400000038,350037820400000018	0-55,0-52						Patent EP0555435A4 - Google Patents	T	1995	0		
1258	chr6	88289399	88289454	3500365123	55		88289399	88289454	8421504	1	55	0	g	350036512300000030	0-55						Transgenic non-human mammals comprising a bovine 5' flanking regulatory sequence - Patent # 5850000 - PatentGenius	.patentgenius.com	0	0		
1258	chr6	88289399	88289454	3500096651	55		88289399	88289454	8421504	1	55	0	g	350009665100000024	0-55					Patent	Transgenic mice producing bovine &#x03b1;-lactalbumin in their milk (Patent US:5530177)	Bleck	1996	0		
1259	chr6	88358319	88358376	3500186308	57		88358319	88358376	8421504	1	57	0	g	350018630800000021	0-57						EFFECTS OF GROWTH HORMONE AND INSULIN-LIKE GROWTH FACTOR-I ON MILK PROTEIN GENE EXPRESSION AND NUTRIENT UPTAKE AND CELL PROLIFERATION IN CLONAL BOVINE MAMMARY EPITHELIAL CELLS	cholar.lib.vt.edu	0	0		
1259	chr6	88360587	88360786	3500228344	42		88360587	88360786	8421504	2	22,20	0,179	g	350022834400000002,350022834400000003	0-22,0-20						GEN&#xd4;MICA COMPARATIVA COMO FERRAMENTA PARA O ESTUDO DE GENES RELACIONADOS COM PRODU&#xc7;&#xc3;O DE LEITE NO GENOMA DO B&#xda;FALO DE RIO COMPARATIVE GENOMICSAS A TOOL FOR STUDINGGENES RELATED WITH MILK PRODUCTION IN RIVER BUFFALO	prope.unesp.br	0	0		
1259	chr6	88363134	88371508	3500418941	402		88363134	88371508	8421504	9	36,27,27,15,18,45,114,12,108	0,425,1245,1712,2788,2902,3207,7150,8266	p	350041894100015027,350041894100015028,350041894100015029,350041894100015030,350041894100015031,350041894100015035,350041894100015036	0-60,0-45,0-57,0-60,0-60,0-60,0-60						TEJFEH&#xc9;RJE GENETIKAI VIZSG&#xc1;LATOK HAZAI SZARVASMARHA FAJT&#xc1;KBAN	www.szie.hu	0	0		
1259	chr6	88367000	88371437	3500398906	40		88367000	88371437	8421504	3	17,3,20	0,1413,4417	c,g	350039890600000002,350039890600000003,350039890600000003	0-20,0-20,0-20						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
1259	chr6	88370157	88371472	3500376942	120		88370157	88371472	8421504	3	3,45,72	0,94,1243	p	350037694200015001,350037694200015000	0-48,0-117						Casein-derived antimicrobial peptides and lactobacillus strains that produce them	Ross	2007	0		
1259	chr6	88371406	88371451	3500155826	45		88371406	88371451	8421504	1	45	0	p	350015582600015002	0-45						Feline Probiotic Bifidobacteria 	.freshpatents.com	0	0		
157	chr6	88473382	88481459	3500398906	51		88473382	88481459	8421504	2	26,25	0,8052	c,g	350039890600000006,350039890600000007,350039890600000007	0-26,1-26,1-26						Gene expression of six major milk proteins in primary bovine mammary epithelial cells isolated from milk during the first twenty weeks of lactation	ulturejournals.cz	0	0		
157	chr6	88473386	88481918	3500372563	474		88473386	88481918	8421504	4	57,33,357,27	0,5971,8017,8505	p,c,g	350037256300015052,350037256300015050,350037256300015064,350037256300015068,350037256300000000,350037256300000014,350037256300000014,350037256300015069,350037256300015080,350037256300000001,350037256300000008	0-150,0-150,0-60,0-60,28-180,0-80,0-80,0-78,0-150,0-144,0-27						GENETIC POLYMORPHISM IN GOAT	tdx.cat/bitstream	0	0		
157	chr6	88473386	88481883	3500433728	570		88473386	88481883	8421504	3	57,33,480	0,5971,8017	p	350043372800015009,350043372800015008,350043372800015010,350043372800015017,350043372800015024,350043372800015031	0-180,0-180,0-180,0-177,0-162,0-51						A NY&#xda;L KAPPA-KAZEIN G&#xc9;N JELLEMZ&#xc9;SE, &#xc9;S TERMELTET&#xc9;S&#xc9;NEK HAT`SA TRANSZG&#xc9;NIKUS `LLATOKBAN	phd.szie.hu	0	0		
1260	chr6	88479366	88482340	3500435005	961		88479366	88482340	8421504	2	24,937	0,2037	p,g	350043500500015021,350043500500015022,350043500500000014,350043500500000012,350043500500015030,350043500500015024,350043500500015025,350043500500015026,350043500500015027,350043500500000013,350043500500000004	0-57,0-60,0-874,0-20,0-417,0-60,3-60,0-60,0-45,0-20,0-20						ANKARA &#xdc;N&#x0130;VERS&#x0130;TES&#x0130; FEN B&#x0130;L&#x0130;MLER&#x0130; ENST&#x0130;T&#xdc;S&#xdc; Y&#xdc;KSEK L&#x0130;SANS TEZ&#x0130;	siv.ankara.edu.tr	0	0		
1260	chr6	88479366	88481796	3500418941	417		88479366	88481796	8421504	2	24,393	0,2037	p	350041894100015048,350041894100015049,350041894100015050,350041894100015051,350041894100015052,350041894100015053,350041894100015054	0-57,0-60,0-60,0-60,0-60,0-60,0-60						TEJFEH&#xc9;RJE GENETIKAI VIZSG&#xc1;LATOK HAZAI SZARVASMARHA FAJT&#xc1;KBAN	www.szie.hu	0	0		
1260	chr6	88481126	88481687	3500008154	68		88481126	88481687	8421504	3	22,23,23	0,430,538	c,g	350000815400000031,350000815400000030,350000815400000028	0-22,0-23,0-23						Mining the Mammalian Genome for Artiodactyl Systematics	www.jstor.org	0	0		
1260	chr6	88481365	88481918	3500267865	75		88481365	88481918	8421504	3	21,27,27	0,100,526	c,g	350026786500000017,350026786500000015,350026786500000016	0-21,0-27,0-27						DIVERSIDAD GEN&#xc9;TICA DEL GANADO HART&#xd3;N DEL VALLE Y SUS RELACIONES CON HOLSTEIN Y BRAHMAN, MEDIANTE EL USO DE MARCADORES MOLECULARES	www.uco.es/conbia	0	0		
1260	chr6	88481365	88481916	3500298819	48		88481365	88481916	8421504	2	21,27	0,524	c,g	350029881900000000,350029881900000001	0-21,0-27						High polymorphism in the k-casein (CSN3) gene from wild and domestic caprine species revealed by DNA sequencing	iotechnology.info	0	0		
1260	chr6	88481365	88481803	3500403005	87		88481365	88481803	8421504	3	21,43,23	0,301,415	c,g	350040300500000000,350040300500000010,350040300500000004,350040300500000002,350040300500000002,350040300500000016	0-21,0-23,0-28,0-28,0-28,0-23						&#x201c;Caracterizaci&#xf3;n de las variantes del gen de K-case&#xed;na en razas de ganado bovino&#x201d;	tesis.bnct.ipn.mx	0	0		
1260	chr6	88481365	88481803	3500078256	87		88481365	88481803	8421504	3	21,43,23	0,301,415	c,g	350007825600000000,350007825600000010,350007825600000004,350007825600000002,350007825600000002,350007825600000022,350007825600000016	0-21,0-23,0-28,0-28,0-28,0-23,0-23						&#x201c;Caracterizaci&#xf3;n de las variantes del gen de K-case&#xed;na en razas de ganado bovino&#x201d;	.bnct.ipn.mx:8080	0	0		
1260	chr6	88481403	88482182	3500141702	50		88481403	88482182	8421504	2	24,26	0,753	c,g	350014170200000000,350014170200000001	0-24,0-26						Journal of Animal Production (JAP) Vol. 10 (1) Januari 2008	id.scribd.com	0	0		
1260	chr6	88481439	88481970	3500461894	50		88481439	88481970	8421504	2	25,25	0,506	c,g	350046189400000013,350046189400000014	0-25,0-25						&#x0414;&#x041e;&#x041a;&#x041b;&#x0410;&#x0414;&#x042b; m k b	csl.bas-net.by	0	0		
1260	chr6	88481439	88481464	3500310383	24		88481439	88481464	8421504	2	13,11	0,14	g	350031038300000000	0-24						&#x0412;&#x0415;&#x0421;&#x0422;&#x041d;&#x0418;&#x041a; &#x2116;10 15	www.rgazu.ru	0	0		
1260	chr6	88481439	88481464	3500245680	25		88481439	88481464	8421504	1	25	0	c	350024568000000000	0-25						Redalyc.KAPPA-CASEIN AND PRL-RSA I GENOTYPIC FREQUENCIES IN TWO RUSSIAN CATTLE BREEDS	redalyc.uaemex.mx	0	0		
1260	chr6	88481465	88481918	3500055642	51		88481465	88481918	8421504	2	27,24	0,429	c,g	350005564200000002,350005564200000002,350005564200000003,350005564200000003	0-27,0-27,0-24,0-24						2008-3buffalo bulletin	www.scribd.com	0	0		
1260	chr6	88481465	88481918	3500053311	54		88481465	88481918	8421504	2	27,27	0,426	c	350005331100000000,350005331100000001	0-27,0-27						Genetic polymorphism of the kappa-casein gene in Brazilian cattle. - ResearchGate	.researchgate.net	0	0		
1260	chr6	88481465	88481492	3500150747	27		88481465	88481492	8421504	1	27	0	c	350015074700000009	0-27						Relationship between arterial pressure and pulse wave velocity using photoplethysmography during the post-exercise recovery period | Zbignevs Marcinkevics - Academia.edu	www.academia.edu	0	0		
1260	chr6	88481465	88481492	3500105272	27		88481465	88481492	8421504	1	27	0	c	350010527200000005	0-27						Genetic diversity in milk proteins among goats bred in Lithuania	eeb.lu.lv/EEB/200	0	0		
1260	chr6	88481465	88481492	3500013963	27		88481465	88481492	8421504	1	27	0	c	350001396300000009	0-27						753. S&#x0112;JUMS Biolo&#x0123;ija	www.lu.lv/fileadm	0	0		
1260	chr6	88481480	88481932	3500150463	40		88481480	88481932	8421504	2	20,20	0,432	c,g	350015046300000003,350015046300000003,350015046300000001	0-20,0-20,0-20						A single nucleotide polymorphism in the sheep kappa-casein coding region. - ResearchGate	.researchgate.net	0	0		
1260	chr6	88481662	88482040	3500458856	52		88481662	88482040	8421504	2	25,27	0,351	c,g	350045885600000006,350045885600000007	0-25,0-27						Journal of Basic & Applied Genetics. Suppl. Vol XXIII (1) 2012	www.sag.org.ar	0	0		
1260	chr6	88481662	88482040	3500374714	51		88481662	88482040	8421504	2	25,26	0,352	c,g	350037471400000003,350037471400000004	0-25,0-26						m n	demicjournals.org	0	0		
1260	chr6	88481662	88482040	3500360377	51		88481662	88482040	8421504	2	25,26	0,352	c,g	350036037700000000,350036037700000001	0-25,0-26						Kappa-casein gene polymorphism in Holstein and Iranian native cattle by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP)	www.ajol.info	0	0		
1260	chr6	88481662	88482040	3500351012	51		88481662	88482040	8421504	2	25,26	0,352	c,g	350035101200000000,350035101200000001	0-25,0-26						Doosti et al. Kappa-casein gene polymorphism in Holstein and Iranian native cattle by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Afr. J. Biotechnol. 2011	demicjournals.org	0	0		
1260	chr6	88481662	88482038	3500119122	71		88481662	88482038	8421504	3	25,22,24	0,233,352	c,g	350011912200000000,350011912200000002,350011912200000001	0-25,0-22,0-24			10.1590/S1415-47572005000200010	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Kappa-casein gene study with molecular markers in female buffaloes (Bubalus bubalis)	Otaviano	2005	1		
1260	chr6	88481662	88481687	3500460259	25		88481662	88481687	8421504	1	25	0	c	350046025900000000	0-25						DISSERTA&#xc7;&#xc3;O DE MESTRADO	pace.c3sl.ufpr.br	0	0		
1260	chr6	88481662	88481687	3500420784	25		88481662	88481687	8421504	1	25	0	c	350042078400000000	0-25						Kappa-casein gene polymorphism in Holstein and Iranian native cattle by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP)	demicjournals.org	0	0		
1260	chr6	88481662	88481687	3500352598	25		88481662	88481687	8421504	1	25	0	c	350035259800000004	0-25			10.1590/S1415-47572008005000002	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - &#x03b2;-casein gene polymorphism permits identification of bovine milk mixed with bubaline milk in mozzarella cheese	Otaviano	2008	1		
1260	chr6	88481670	88481769	3500026517	99		88481670	88481769	8421504	1	99	0	p	350002651700015018	204-303						0470085851	www.scribd.com	0	0		
1260	chr6	88481683	88481911	3500459517	47		88481683	88481911	8421504	2	23,24	0,204	c	350045951700000000,350045951700000001	0-23,0-24						Identification of Bovine Kappa-Casein Genotypes In Two Iranian Holstein Farms by PCR-RFLP | Mahyar Heydarpour - Academia.edu	www.academia.edu	0	0		
1260	chr6	88481683	88481911	3500275350	47		88481683	88481911	8421504	2	23,24	0,204	c	350027535000000000,350027535000000001	0-23,0-24						Identification of Bovine Kappa-Casein Genotypes in Two Iranian Holstein Farms by PCR-RFLP | Mahyar Heydarpour - Academia.edu	www.academia.edu	0	0		
1260	chr6	88481684	88482034	3500029392	99		88481684	88482034	8421504	4	25,24,24,26	0,98,143,324	c,g	350002939200000072,350002939200000000,350002939200000000,350002939200000002,350002939200000003,350002939200000003,350002939200000033,350002939200000033,350002939200000001	0-25,0-25,0-25,0-24,0-23,0-23,0-24,0-24,0-26						Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes	Gengler	2003	0		
1260	chr6	88481684	88481851	3500326870	73		88481684	88481851	8421504	3	25,24,24	0,98,143	c	350032687000000072,350032687000000000,350032687000000002,350032687000000003	0-25,0-25,0-24,0-24					Patent	Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes (Patent EP:1485506)	Gengler	2009	0		
1260	chr6	88481684	88481709	3500296031	25		88481684	88481709	8421504	1	25	0	c	350029603100000000	0-25			10.1590/S1415-47572005000200015	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Effects of CSN3 and LGB gene polymorphisms on production traits in beef cattle	Curi	2005	1		
1260	chr6	88481684	88481709	3500294754	25		88481684	88481709	8421504	1	25	0	c	350029475400000000	0-25			10.1590/S1415-47572005000200015	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Effects of CSN3 and LGB gene polymorphisms on production traits in beef cattle	Curi	2005	1		
1260	chr6	88481684	88481709	3500130318	25		88481684	88481709	8421504	1	25	0	c	350013031800000000	0-25						Archive of SID	www.sid.ir/fa/VEW	0	0		
1260	chr6	88481684	88481709	3500035207	25		88481684	88481709	8421504	1	25	0	c	350003520700000000	0-25			10.1590/S1415-47572005000200015	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Effects of CSN3 and LGB gene polymorphisms on production traits in beef cattle	Curi	2005	1		
1260	chr6	88481691	88481883	3500164480	153		88481691	88481883	8421504	2	90,63	0,129	p	350016448000015001,350016448000015002	0-90,0-63						MECANISMO DE ACCI&#xd3;N DEL GLUCOMACROP&#xc9;PTIDO COMO AGENTE ANTIINFLAMATORIO INTESTINAL | Natalia Prokipchuk - Academia.edu	www.academia.edu	0	0		
1260	chr6	88481727	88483898	3500082790	120		88481727	88483898	8421504	6	23,15,26,7,27,22	0,178,429,2057,2072,2149	c,g	350008279000000001,350008279000000006,350008279000000000,350008279000000002,350008279000000007	0-23,0-22,24-50,23-50,0-22						Ju et al. The polymorphisms of &#x03ba;-casein gene and their associations with milk production traits and expression analysis in Chinese Holstein cattle. Afr. J. Biotechnol. 2011	demicjournals.org	0	0		
1260	chr6	88481727	88481998	3500069214	42		88481727	88481998	8421504	2	21,21	0,250	c,g	350006921400000002,350006921400000002,350006921400000003	0-21,0-21,0-21						the bovine CSN1S1 and CSN3 genes: construction of the contig spanning the casein gene cluster*	www.ighz.edu.pl	0	0		
1260	chr6	88481751	88481916	3500052918	165		88481751	88481916	8421504	1	165	0	c,g	350005291800000006,350005291800000000,350005291800000000,350005291800000007,350005291800000008,350005291800000001,350005291800000001	0-50,0-24,0-24,0-50,0-50,0-27,0-27						UNIVERSITA' DEGLI STUDI DI PADOVA Sede Amministrativa: Universit&#xe0; degli Studi di Padova SCUOLA DI DOTTORATO DI RICERCA IN : Scienze Veterinarie CICLO XX	arch.cab.unipd.it	0	0		
1260	chr6	88481758	88482434	3500194570	76		88481758	88482434	8421504	3	25,25,26	0,121,650	g	350019457000000000,350019457000000001,350019457000000011,350019457000000003	5-30,5-30,3-29,3-29						&#x0421;&#x043f;&#x043e;&#x0441;&#x043e;&#x0431; &#x043f;&#x0440;&#x043e;&#x0432;&#x0435;&#x0434;&#x0435;&#x043d;&#x0438;&#x044f; &#x0430;&#x043b;&#x043b;&#x0435;&#x043b;&#x044c;-&#x0441;&#x043f;&#x0435;&#x0446;&#x0438;&#x0444;&#x0438;&#x0447;&#x043d;&#x0	www.findpatent.ru	0	0		
1260	chr6	88481760	88481858	3500463303	41		88481760	88481858	8421504	2	22,19	0,79	c,g	350046330300000004,350046330300000004,350046330300000006	0-22,0-22,0-19						JH zelf 24012009	w.milkgenomics.nl	0	0		
1260	chr6	88481760	88481858	3500402805	41		88481760	88481858	8421504	2	22,19	0,79	c,g	350040280500000004,350040280500000004,350040280500000006	0-22,0-22,0-19						JH zelf 24012009	edepot.wur.nl	0	0		
1260	chr6	88481891	88481918	3500467601	27		88481891	88481918	8421504	1	27	0	c	350046760100000001	0-27						Genetic polymorphism of the K-casein (CSN3) gene in goats reared in Southern Italy - ResearchGate	.researchgate.net	0	0		
1260	chr6	88482010	88482037	3500444788	26		88482010	88482037	8421504	2	13,13	0,14	g	350044478800000001	0-26						26 a 30 de maio de 2008 Jo&#xe3;o Pessoa, PB &#x2013; UFPB/ABZ	www.abz.org.br	0	0		
1262	chr6	88820702	88820731	3500203667	23		88820702	88820731	8421504	3	8,4,11	0,13,18	g	350020366700000013	9-32						US Patent # 6,340,461. Superantigen based methods and compositions for treatment of diseases - Patents.com	www.patents.com	0	0		
1262	chr6	88820702	88820731	3500108742	23		88820702	88820731	8421504	3	8,4,11	0,13,18	g	350010874200000013	9-32						Superantigen based methods and compositions for treatment of diseases - US Patent 6340461 Description	ww.patentstorm.us	0	0		
1262	chr6	88855218	88855242	3500445631	24		88855218	88855242	8421504	1	24	0	c	350044563100000078	0-24						Igm Production By Transformed Cells And Methods Of Quantifying Said Igm Production 	.freshpatents.com	0	0		
1265	chr6	89130078	89130104	3500108104	23		89130078	89130104	8421504	2	15,8	0,18	c	350010810400000010	16-39						Methods for the simultaneous identification of novel biological targets and lead structures for drug development	Gao	1999	0		
1266	chr6	89328937	89328967	3500318576	30		89328937	89328967	8421504	1	30	0	c	350031857600000002	0-30		11029313			American Journal of Physiology - Cell Physiolog	Expression and localization of Na+-HCO3 &#x2212; cotransporter in bovine corneal endothelium	Sun	2000	0		SLC4A4
1266	chr6	89328983	89329010	3500297697	27		89328983	89329010	8421504	1	27	0	c	350029769700000004	0-27						World J Gastroenterol	www.wjgnet.com	0	0		
1266	chr6	89328983	89329010	3500220992	27		89328983	89329010	8421504	1	27	0	c	350022099200000000	0-27			10.1111/j.1469-7793.2001.0375i.x	0022-3751	The Journal of Physiology	The stoichiometry of the electrogenic sodium bicarbonate cotransporter pNBC1 in mouse pancreatic duct cells is 2 HCO3&#x2212;:1 Na+	Gross	2001	5		
1266	chr6	89328983	89329010	3500203960	27		89328983	89329010	8421504	1	27	0	c	350020396000000004	0-27						Characterization of H+ and HCO3- transporters in CFPAC-1 human pancreatic duct cells. - ResearchGate	.researchgate.net	0	0		
1266	chr6	89347585	89347608	3500146554	23		89347585	89347608	8421504	1	23	0	g	350014655400000007,350014655400000006	0-19,0-23		12813087	10.1128/JB.185.13.3926-3934.2003	0021-9193	Journal of Bacteriology	Transcriptional Regulation of the Gene Encoding an Alcohol Dehydrogenase in the Archaeon Sulfolobus solfataricus Involves Multiple Factors and Control Elements	Fiorentino	2003	4		
1267	chr6	89428441	89428465	3500169879	24		89428441	89428465	8421504	1	24	0	c	350016987900000001	0-24		11274232		1046-6673	Journal of the American Society of Nephrology	Novel Nonsense Mutation in the Na+/HCO3- Cotransporter Gene (SLC4A4) in a Patient with Permanent Isolated Proximal Renal Tubular Acidosis and Bilateral Glaucoma	IGARASHI	2001	10		
1268	chr6	89571470	89571500	3500318576	30		89571470	89571500	8421504	1	30	0	c	350031857600000003	0-30		11029313			American Journal of Physiology - Cell Physiolog	Expression and localization of Na+-HCO3 &#x2212; cotransporter in bovine corneal endothelium	Sun	2000	0		SLC4A4
1268	chr6	89619976	89620012	3500461622	31		89619976	89620012	8421504	3	5,7,19	0,7,17	g	350046162200000084	14-45						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
1268	chr6	89624872	89624900	3500370435	25		89624872	89624900	8421504	2	13,12	0,16	c	350037043500000421	8-34						Neisseria meningitidis antigens and compositions	Fraser	2008	0		
1268	chr6	89624872	89624900	3500128714	25		89624872	89624900	8421504	2	13,12	0,16	c	350012871400000024	8-34						Neisseria meningitidis antigens and compositions	Fraser	2009	0		
1268	chr6	89624872	89624900	3500059115	25		89624872	89624900	8421504	2	13,12	0,16	c	350005911500000105	9-35						genomic sequences and methods of their use - US Patent 7612192 Description	ww.patentstorm.us	0	0		
158	chr6	89648735	89662975	3500237214	42		89648735	89662975	8421504	3	11,10,21	0,12,14219	c,g	350023721400000000,350023721400000000,350023721400000001,350023721400000001	0-21,0-21,0-21,0-21						Aus dem Veterin&#xe4;r-Physiologischen Institut der Veterin&#xe4;rmedizinischen Fakult&#xe4;t der Universit&#xe4;t Leipzig	www.qucosa.de	0	0		
158	chr6	89650059	89665053	3500391687	42		89650059	89665053	8421504	4	17,4,2,19	0,9592,13013,14975	c	350039168700000006,350039168700000007	0-21,0-21		11435462	10.1172/JCI11869	0021-9738	The Journal of Clinical Investigation	Molecular basis of ocular abnormalities associated with proximal renal tubular acidosis	Usui	2001	13		SLC4A4
158	chr6	89650059	89665053	3500121393	42		89650059	89665053	8421504	4	17,4,2,19	0,9592,13013,14975	c	350012139300000006,350012139300000007	0-21,0-21		11435462	10.1172/JCI11869	0021-9738	The Journal of Clinical Investigation	Molecular basis of ocular abnormalities associated with proximal renal tubular acidosis	Usui	2001	13		SLC4A4
1269	chr6	89663073	89671807	3500212949	46		89663073	89671807	8421504	3	1,24,21	0,1961,8713	c	350021294900000004,350021294900000002	0-25,0-21						Role of NH2 and COOH termini in targeting, stability, and activity of sodium bicarbonate cotransporter 1	al.physiology.org	0	0		SLC4A4
1269	chr6	89776001	89776025	3500030036	24		89776001	89776025	8421504	1	24	0	g	350003003600000001	8-32		11404244			American Journal of Physiology - Lung Cellular and Molecular Physiology	Sodium 4-phenylbutyrate downregulates HSC70 expression by facilitating mRNA degradation	Rubenstein	2001	0		HSPA8
1273	chr6	90293445	90293473	3500434928	28		90293445	90293473	8421504	1	28	0	g	350043492800000010	0-28						Compositions, methods and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals - Patent application	www.faqs.org	0	0		
1279	chr6	91056664	91056688	3500147485	23		91056664	91056688	8421504	2	12,11	0,13	g	350014748500000066	0-23						Antigen Binding Proteins Capable Of Binding Thymic Stromal Lymphopoietin 	.freshpatents.com	0	0		
1279	chr6	91085022	91085049	3500422967	23		91085022	91085049	8421504	2	9,14	0,13	g	350042296700000002	1-26		15201340	10.1091/mbc.E04-04-0341	1059-1524	Molecular Biology of the Cell	Expression of a Major Surface Protein of Trypanosoma brucei Insect Forms Is Controlled by the Activity of Mitochondrial Enzymes	Vassella	2004	5		
1280	chr6	91127060	91134886	3500199712	216		91127060	91134886	8421504	2	128,88	0,7738	p	350019971200015050,350019971200015028,350019971200015027	33-249,0-156,228-273						Identification of specific tumor antigens by means of the selection of cdna libraries with sera and the use of said antigena in the treatment of tumors	Felici	2002	0		
1280	chr6	91187062	91203718	3500275412	1080		91187062	91203718	8421504	7	186,95,234,148,148,157,112	0,2113,4937,6332,6739,11514,16544	p	350027541200015010,350027541200015007,350027541200015006,350027541200015004,350027541200015002,350027541200015009,350027541200015000	0-681,0-171,0-165,0-174,0-153,0-393,0-168						45 human secreted proteins	Komatsoulis	2000	0		ANKRD17
1280	chr6	91187062	91203718	3500051421	1080		91187062	91203718	8421504	7	186,95,234,148,148,157,112	0,2113,4937,6332,6739,11514,16544	p	350005142100015013,350005142100015008,350005142100015006,350005142100015004,350005142100015002,350005142100015012,350005142100015000,350005142100015011,350005142100015010	0-612,0-171,0-168,0-174,0-177,0-156,0-180,0-156,0-156						45 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
1282	chr6	91410169	91425969	3500454571	53		91410169	91425969	8421504	2	29,24	0,15776	c	350045457100000004,350045457100000005	11-40,18-42						Recombinant Production of Serum Albumin	Bach	2009	0		
1282	chr6	91410169	91425969	3500254683	53		91410169	91425969	8421504	2	29,24	0,15776	c	350025468300000004,350025468300000005	11-40,18-42						Recombinant production of serum albumin	Bach	2007	0		
1282	chr6	91410169	91425969	3500121788	53		91410169	91425969	8421504	2	29,24	0,15776	c	350012178800000004,350012178800000005	11-40,18-42						Recombinant Production of Serum Albumin	Christensen	2005	0		
1282	chr6	91410169	91425969	3500085280	986		91410169	91425969	8421504	19	29,31,58,7,78,111,38,58,24,72,48,86,139,15,48,48,48,6,42	0,52,791,1703,1758,3574,5985,7496,7602,8551,8671,11598,12731,13482,13545,13641,14984,15080,15758	c	350008528000000160,350008528000000004,350008528000000045,350008528000000007,350008528000000008,350008528000000010,350008528000000087,350008528000000011,350008528000000012,350008528000000051,350008528000000020,350008528000000021,350008528000000023,350008528000000024,350008528000000026,350008528000000031,350008528000000032,350008528000000033,350008528000000034,350008528000000035,350008528000000037,350008528000000039,350008528000000041,350008528000000043,350008528000000161,350008528000000005	11-40,11-40,0-42,0-48,0-48,0-48,0-26,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,18-42,18-42						Recombinant Production of Serum Albumin - Patent application	www.faqs.org	0	0		
1282	chr6	91410169	91425969	3500014235	53		91410169	91425969	8421504	2	29,24	0,15776	c	350001423500000004,350001423500000005	11-40,18-42						Recombinant production of serum albumin	Bach	2010	0		
1282	chr6	91410173	91425966	3500352796	1814		91410173	91425966	8421504	14	79,58,133,209,133,98,130,215,126,98,139,224,133,39	0,787,1699,3570,4346,5921,7492,8547,9882,11582,12727,13478,14949,15754	p	350035279600015022	0-1821						Prot&#xe9;omique Reproduction & Toxicologie	www.sftox.com	0	0		
1282	chr6	91410173	91410227	3500299744	54		91410173	91410227	8421504	1	54	0	p	350029974400015005	0-54						Method for preparing foreign protein in yeast, recombinat DNA, transformant	Hayasuke	1989	0		
1282	chr6	91410179	91425966	3500460988	64		91410179	91425966	8421504	3	22,21,21	0,9978,15766	c	350046098800000020,350046098800000023,350046098800000025	15-37,0-21,0-21					Patent	Fucosyltransferase fusion protein (Patent US:7569376)	Bayer	2009	0		
1282	chr6	91410179	91425966	3500438456	64		91410179	91425966	8421504	3	22,21,21	0,9978,15766	c,g	350043845600000020,350043845600000023,350043845600000023,350043845600000025	15-37,0-21,0-21,0-21						Recombinant glycosyltransferase fusion proteins	J	2006	0		
1282	chr6	91410179	91425966	3500379972	64		91410179	91425966	8421504	3	22,21,21	0,9978,15766	c,g	350037997200000020,350037997200000023,350037997200000023,350037997200000025	15-37,0-21,0-21,0-21						Recombinant glycosyltransferase fusion proteins	Bayer	2003	0		
1282	chr6	91410179	91425966	3500367109	64		91410179	91425966	8421504	3	22,21,21	0,9978,15766	c	350036710900000020,350036710900000023,350036710900000025	15-37,0-21,0-21						Recombinant glycosyltransferase fusion proteins	Bayer	2005	0		
1282	chr6	91410179	91425966	3500215018	64		91410179	91425966	8421504	3	22,21,21	0,9978,15766	c	350021501800000020,350021501800000023,350021501800000025	15-37,0-21,0-21						Recombinant glycosyltransferase fusion proteins	Bayer	2006	0		
1282	chr6	91410212	91410245	3500348685	33		91410212	91410245	8421504	1	33	0	c	350034868500000013	27-60						Fusion proteins comprising alpha fetoprotein	Rosen	2007	0		ALB
1282	chr6	91410212	91410245	3500306131	33		91410212	91410245	8421504	1	33	0	c	350030613100000013	27-60						Fusion proteins comprising alpha fetoprotein	Bell	2007	0		ALB
1282	chr6	91410212	91410245	3500162748	33		91410212	91410245	8421504	1	33	0	c	350016274800000013	27-60						Fusion proteins comprising alpha fetoprotein	Bell	2007	0		ALB
1282	chr6	91410221	91410971	3500464482	42		91410221	91410971	8421504	2	31,11	0,739	c	350046448200000012	0-42					Patent	Expression of human serum albumin in Pichia pastoris (Patent US:5707828)	Barr	1998	0		
1282	chr6	91410221	91410971	3500296682	42		91410221	91410971	8421504	2	31,11	0,739	c	350029668200000012	0-42						Expression of human serum albumin in Pichia pastoris	Sreekrishna	1995	0		
1282	chr6	91410227	91425969	3500288582	48		91410227	91425969	8421504	2	24,24	0,15718	c	350028858200000000,350028858200000001	15-39,16-40						rBSA from K. lactis Expression, Secretion and Purification of Recombinant Bovine Serum Albumin (rBSA) from K. lactis and uses thereof	Colussi	2010	0		
1282	chr6	91410227	91425969	3500133637	48		91410227	91425969	8421504	2	24,24	0,15718	c	350013363700000000,350013363700000001	15-39,16-40					Patent	rBSA from K. lactis expression, secretion and purification of recombinant bovine serum albumin (rBSA) from K. lactis and uses thereof (Patent US:8361750)	Colussi	2013	0		
1282	chr6	91410227	91425969	3500089744	48		91410227	91425969	8421504	2	24,24	0,15718	c	350008974400000000,350008974400000001	15-39,16-40						rBSA from K. lactis Expression, Secretion and Purification of Recombinant Bovine Serum Albumin (rBSA) from K. lactis and uses thereof	Colussi	2007	0		
1282	chr6	91410229	91410971	3500112886	34		91410229	91410971	8421504	2	23,11	0,731	c	350011288600000026	0-34						Albumin fusion proteins	Haseltine	2003	0		
1282	chr6	91410229	91410971	3500112216	34		91410229	91410971	8421504	2	23,11	0,731	c	350011221600000026	0-34						Albumin fusion proteins	Rosen	2002	0		
1282	chr6	91410229	91410971	3500063295	34		91410229	91410971	8421504	2	23,11	0,731	c	350006329500000026	0-34						Albumin fusion proteins	Haseltine	2003	0		
1282	chr6	91410245	91422951	3500304911	94		91410245	91422951	8421504	4	7,41,26,20	0,715,11543,12686	c	350030491100000054,350030491100000078,350030491100000080	0-48,0-26,0-20						Albumin Fusion Proteins - Patent application	www.faqs.org	0	0		
1282	chr6	91410245	91411001	3500002775	48		91410245	91411001	8421504	2	7,41	0,715	c	350000277500000054	0-48						Albumin fusion proteins - US Patent 6905688 Description	ww.patentstorm.us	0	0		
1282	chr6	91410249	91411001	3500334115	44		91410249	91411001	8421504	2	3,41	0,711	c	350033411500000053	1-45						US Patent # 7,507,414. Albumin fusion proteins - Patents.com	www.patents.com	0	0		
1282	chr6	91410249	91411001	3500040180	44		91410249	91411001	8421504	2	3,41	0,711	c	350004018000000087	1-45						Albumin fusion proteins - US Patent 7507413 Description	ww.patentstorm.us	0	0		
1282	chr6	91411939	91425162	3500074526	231		91411939	91425162	8421504	8	41,47,29,19,23,24,8,40	0,1882,4224,5726,8119,11880,11928,13183	c	350007452600000011,350007452600000014,350007452600000021,350007452600000029,350007452600000040,350007452600000041	0-41,0-47,0-48,0-23,0-24,0-48						Yeast strains and modified albumins	Gilbert	1995	0		
1282	chr6	91413767	91414526	3500142519	192		91413767	91414526	8421504	2	185,7	0,752	p	350014251900015070,350014251900015093,350014251900015039,350014251900015056,350014251900015020,350014251900015071,350014251900015094,350014251900015041,350014251900015057,350014251900015021,350014251900015072,350014251900015095,350014251900015022,350014251900015073	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-48,0-48						&#x53ef;&#x6eb6;&#x6027;&#x878d;&#x5408;&#x86cb;&#x767d;&#x8cea;&#x3068;&#x305d;&#x308c;&#x3092;&#x30b3;&#x30fc;&#x30c9;&#x3059;&#x308b;&#x907a;&#x4f1d;&#x5b50;&#x3001;&#x4e26;&#x3073;&#x306b;&#x305d;&#x306e;&#x878d;&#x5408;&#x86cb;&#x767d;&#x8cea;&#x306e	www.patentjp.com	0	0		
1282	chr6	91413792	91413817	3500432424	25		91413792	91413817	8421504	1	25	0	c	350043242400000057	0-25						In Vitro Generation of Hepatocytes from Human Embryonic Stem Cells	Mandal	2010	0		
1282	chr6	91413792	91413817	3500356716	25		91413792	91413817	8421504	1	25	0	c	350035671600000057	0-25						Establishment Of A Human Embryonic Stem Cell Line Using Mammalian Cells 	.freshpatents.com	0	0		
1282	chr6	91413792	91413817	3500341621	25		91413792	91413817	8421504	1	25	0	c	350034162100000007	0-25						Method of forming multicellular spheroids from the cultured cells	Yang	2005	0		
1282	chr6	91413792	91413817	3500198523	25		91413792	91413817	8421504	1	25	0	c	350019852300000020	0-25						Pluripotent Embryonic-like Stem Cells Derived From Corneal Limbus, Methods Of Isolation And Uses Thereof 	.freshpatents.com	0	0		
1282	chr6	91413792	91413817	3500192520	25		91413792	91413817	8421504	1	25	0	c	350019252000000013	0-25						Novel method of forming human embryoid bodies in a polystyrene dish surface-coated with a temperature-responsive methylcellulose hydrogel. - ResearchGate	.researchgate.net	0	0		
1282	chr6	91413809	91413854	3500043897	45		91413809	91413854	8421504	1	45	0	c	350004389700000017	0-45						SUGAR CHAIN-CONTAINING ALBUMIN, PRODUCTION METHOD THEREOF AND USE THEREOF - Patent application	www.faqs.org	0	0		
1282	chr6	91413821	91425162	3500151866	95		91413821	91425162	8421504	3	47,8,40	0,10046,11301	c	350015186600000014,350015186600000041	0-47,0-48						Yeast strains and modified albumins	Gilbert	1996	0		
1282	chr6	91413821	91423843	3500264609	103		91413821	91423843	8421504	3	47,32,24	0,9098,9998	c	350026460900000014,350026460900000034,350026460900000040	0-47,0-32,0-24					Patent	Yeast strains and modified albumins (Patent US:5965386)	Gilbert	1999	0		
1282	chr6	91413920	91414532	3500211486	45		91413920	91414532	8421504	2	32,13	0,599	p	350021148600015001	0-45		11160351		0022-1767	The Journal of Immunology	Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis	Winer	2001	6		
1282	chr6	91413941	91425186	3500214825	162		91413941	91425186	8421504	4	11,64,23,64	0,578,9911,11181	p	350021482500015027,350021482500015031	12-87,0-87						VACCINE CARRIER - BIOMAY AG	www.sumobrain.com	0	0		
1282	chr6	91414544	91414589	3500272251	45		91414544	91414589	8421504	1	45	0	p	350027225100015014	0-45						Algorithms and Hardness Results for DNA Physical Mapping, Protein Identi cation, and Related Combinatorial Problems	ww.ti.inf.ethz.ch	0	0		
1282	chr6	91416160	91417667	3500346665	34		91416160	91417667	8421504	2	32,2	0,1505	c	350034666500000067	0-34						Human serum albumin expression construct	Hurwitz	1994	0		
1282	chr6	91417668	91417692	3500141941	24		91417668	91417692	8421504	1	24	0	c	350014194100000011	0-24						Isolation and Characterization of Equine Umbilical Cord Blood Derived Stem Cells	ufdc.ufl.edu	0	0		ALB
1282	chr6	91417668	91417692	3500124981	24		91417668	91417692	8421504	1	24	0	c	350012498100000011	0-24			10.1002/jcp.21312	1097-4652	Journal of Cellular Physiology	Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types - Reed - 2007 - Journal of Cellular Physiology - Wiley Online Library	Reed	2008	0		ALB
1282	chr6	91418884	91422951	3500030482	42		91418884	91422951	8421504	2	22,20	0,4047	c,g	350003048200000071,350003048200000078,350003048200000078	23-45,0-20,0-20						Albumin Fusion Proteins - Patent application	www.faqs.org	0	0		
1282	chr6	91420055	91420081	3500090447	26		91420055	91420081	8421504	1	26	0	c	350009044700000032	9-35						 Expression Of Human Serum Albumin In Pichia Pastoris Expression of human serum albumin in 	www.docstoc.com	0	0		
1282	chr6	91421770	91422913	3500442695	72		91421770	91422913	8421504	3	30,29,13	0,54,1130	p	350044269500015001	0-72		21209152	10.1074/mcp.M110.003087		Molecular & Cellular Proteomics : MCP	An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer	Chia-Li	2011	0		
1282	chr6	91421770	91422913	3500425804	72		91421770	91422913	8421504	3	30,29,13	0,54,1130	p	350042580400015000	0-72		21209152	10.1074/mcp.M110.003087	1535-9476	Molecular & Cellular Proteomics	An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer	Han	2011	7		
1282	chr6	91421770	91422913	3500283967	72		91421770	91422913	8421504	3	30,29,13	0,54,1130	p	350028396700015000	0-72		21209152	10.1074/mcp.M110.003087	1535-9476	Molecular & Cellular Proteomics	An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer	Han	2011	7		
1282	chr6	91422905	91422931	3500028109	26		91422905	91422931	8421504	1	26	0	g	350002810900000076	19-45						US Patent # 7,482,013. Albumin fusion proteins - Patents.com	www.patents.com	0	0		
1282	chr6	91422919	91423843	3500247139	56		91422919	91423843	8421504	2	32,24	0,900	c	350024713900000034,350024713900000040	0-32,0-24					Patent	Yeast strains and modified albumins (Patent US:5965386)	Gilbert	1999	0		
1282	chr6	91422922	91422967	3500193802	45		91422922	91422967	8421504	1	45	0	p	350019380200015000	0-45						Label-free Quantitative Proteomics and N-glycoproteomics Analysis of KRAS-activated Human Bronchial Epithelial Cells	www.mcponline.org	0	0		ALB
1282	chr6	91422922	91422967	3500188433	45		91422922	91422967	8421504	1	45	0	p	350018843300015000	0-45		24151579	10.1155/2013/107238	2314-6133	BioMed Research International	Extending the Serum Half-Life of G-CSF via Fusion with the Domain III of Human Serum Albumin	Zhao	2013	0		ALB
1282	chr6	91423653	91423754	3500261436	41		91423653	91423754	8421504	2	21,20	0,81	c,g	350026143600000014,350026143600000014,350026143600000013,350026143600000013	0-21,0-21,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1282	chr6	91423717	91423762	3500242128	45		91423717	91423762	8421504	1	45	0	p	350024212800015022	6-51						Method of producing polyvalent antigens	Chou	2002	0		ALB
1282	chr6	91423717	91423762	3500206805	45		91423717	91423762	8421504	1	45	0	p	350020680500015022	6-51						Method of producing antigens	Chou	2003	0		ALB
1282	chr6	91423717	91423762	3500125913	45		91423717	91423762	8421504	1	45	0	p	350012591300015023	6-51						Method of producing transglutaminase having broad substrate activity	Chou	2002	0		ALB
1282	chr6	91423717	91423762	3500105667	45		91423717	91423762	8421504	1	45	0	p	350010566700015024	6-51						Method of producing polyvalent antigens	Chou	2002	0		ALB
1282	chr6	91423822	91423873	3500387448	51		91423822	91423873	8421504	1	51	0	p	350038744800015001	0-51						13th International Congress on Infectious Diseases	ww2.isid.org	0	0		
1282	chr6	91423822	91423873	3500184722	51		91423822	91423873	8421504	1	51	0	p	350018472200015001	0-51						13th International Congress on Infectious Diseases	test.isid.org	0	0		
1282	chr6	91423822	91423873	3500016707	51		91423822	91423873	8421504	1	51	0	p	350001670700015001	0-51						th ISE Abstracts BMV Urinary Tract Infection	www.docstoc.com	0	0		
1282	chr6	91437978	91443640	3500463546	45		91437978	91443640	8421504	2	21,24	0,5638	c,g	350046354600000005,350046354600000005,350046354600000008	1-22,1-22,0-24						HUMAN LIVER PROGENITORS	Reid	2010	0		
1282	chr6	91437978	91443640	3500447042	45		91437978	91443640	8421504	2	21,24	0,5638	c,g	350044704200000005,350044704200000005,350044704200000008	1-22,1-22,0-24						Human liver progenitors	Reid	2004	0		
1282	chr6	91442124	91457165	3500077268	74		91442124	91457165	8421504	3	18,23,33	0,19,15008	c	350007726800000020,350007726800000085	0-42,8-41						Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof - US Patent 7208576 Description	ww.patentstorm.us	0	0		
1282	chr6	91443616	91443640	3500354324	24		91443616	91443640	8421504	1	24	0	c	350035432400000008	0-24						LIVER TISSUE SOURCE	Reid	2009	0		
1282	chr6	91446738	91448574	3500461897	25		91446738	91448574	8421504	2	22,3	0,1833	c	350046189700000034,350046189700000004	0-25,0-25						CULTURE MEDIA, CELL CULTURES AND METHODS OF CULTURING PLURIPOTENT STEM CELLS IN AN UNDIFFERENTIATED STATE - Patent application	www.faqs.org	0	0		
1282	chr6	91446738	91448574	3500451172	25		91446738	91448574	8421504	2	22,3	0,1833	c	350045117200000004	0-25						Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same	Amit	2003	0		
1282	chr6	91446738	91448574	3500420699	25		91446738	91448574	8421504	2	22,3	0,1833	c	350042069900000006	0-25						Co-culturing mammalian embryonic stem cells with human foreskin fibroblasts	Amit	2013	0		
1282	chr6	91446738	91448574	3500397707	25		91446738	91448574	8421504	2	22,3	0,1833	c	350039770700000000	0-25						Primate embryonic stem cells	Thomson	1998	0		
1282	chr6	91446738	91448574	3500385578	25		91446738	91448574	8421504	2	22,3	0,1833	c	350038557800000000	0-25						Primate embryonic stem cells	Thomson	2006	0		
1282	chr6	91446738	91448574	3500378776	25		91446738	91448574	8421504	2	22,3	0,1833	c	350037877600000004	0-25						Optimizing xeno-free culture conditions for human embryonic stem cells to correspond GMP-quality standards	tutkielmat.uta.fi	0	0		
1282	chr6	91446738	91448574	3500324896	25		91446738	91448574	8421504	2	22,3	0,1833	c	350032489600000014	0-25			10.1634/stemcells.2004-0366	1549-4918	STEM CELLS	Establishment of Novel Embryonic Stem Cell Lines Derived from the Common Marmoset (Callithrix jacchus) - Sasaki - 2005 - STEM CELLS - Wiley Online Library	Sasaki	2005	0		
1282	chr6	91446738	91448574	3500297724	25		91446738	91448574	8421504	2	22,3	0,1833	c	350029772400000000	0-25						Primate embryonic stem cells	Thomson	2005	0		
1282	chr6	91446738	91448574	3500289311	25		91446738	91448574	8421504	2	22,3	0,1833	c	350028931100000000	0-25						Primate Embryonic Stem Cells	Thomson	2012	0		
1282	chr6	91446738	91448574	3500288814	25		91446738	91448574	8421504	2	22,3	0,1833	c	350028881400000034,350028881400000004	0-25,0-25						METHODS OF EXPANDING EMBRYONIC STEM CEELS IN A SUSPENSION CULTURE - Patent application	www.faqs.org	0	0		
1282	chr6	91446738	91448574	3500279940	25		91446738	91448574	8421504	2	22,3	0,1833	c	350027994000000006	0-25						Human foreskin fibroblasts for culturing ES cells	Amit	2007	0		
1282	chr6	91446738	91448574	3500253120	25		91446738	91448574	8421504	2	22,3	0,1833	c	350025312000000004	0-25					Patent	Culture of human embryonic stem cells on a matrix with TGFB1 and bFGF (Patent US:7955851)	Amit	2011	0		
1282	chr6	91446738	91448574	3500227602	25		91446738	91448574	8421504	2	22,3	0,1833	c	350022760200000000	0-25					Patent	Preparation of human embryonic stem cells (Patent US:8273569)	Thomson	2012	0		
1282	chr6	91446738	91448574	3500225559	25		91446738	91448574	8421504	2	22,3	0,1833	c	350022555900000011,350022555900000033	0-25,0-25						METHOD OF DYNAMICALLY CULTURING EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		
1282	chr6	91446738	91448574	3500222756	25		91446738	91448574	8421504	2	22,3	0,1833	c	350022275600000006	0-25						Human foreskin fibroblast conditioned media for culturing es cells	Amit	2010	0		
1282	chr6	91446738	91448574	3500218382	25		91446738	91448574	8421504	2	22,3	0,1833	c	350021838200000004	0-25					Patent	Tissue culture medium comprising transforming growth factor beta 1 and basic fibroblast growth factor (Patent US:8222034)	Amit	2012	0		
1282	chr6	91446738	91448574	3500188263	25		91446738	91448574	8421504	2	22,3	0,1833	c	350018826300000006	0-25						HUMAN FORESKIN FIBROBLAST CONDITIONED MEDIA FOR CULTURING ES CELLS	Amit	2010	0		
1282	chr6	91446738	91448574	3500186343	25		91446738	91448574	8421504	2	22,3	0,1833	c	350018634300000004	0-25						CULTURE MEDIA, CELL CULTURES AND METHODS OF CULTURING PLURIPOTENT STEM CELLS IN AN UNDIFFERENTIATED STATE	Amit	2010	0		
1282	chr6	91446738	91448574	3500185226	25		91446738	91448574	8421504	2	22,3	0,1833	c	350018522600000004	0-25						Media for culturing stem cells	Amit	2006	0		
1282	chr6	91446738	91448574	3500184637	25		91446738	91448574	8421504	2	22,3	0,1833	c	350018463700000000	0-25						Primate embryonic stem cells	Thomson	1997	0		
1282	chr6	91446738	91448574	3500179609	25		91446738	91448574	8421504	2	22,3	0,1833	c	350017960900000004	0-25					Patent	Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and cell cultures prepared using same (Patent US:7592175)	Amit	2009	0		
1282	chr6	91446738	91448574	3500160158	25		91446738	91448574	8421504	2	22,3	0,1833	c	350016015800000000	0-25						Primate embryonic stem cells	Thomson	1996	0		
1282	chr6	91446738	91448574	3500153508	25		91446738	91448574	8421504	2	22,3	0,1833	c	350015350800000000	0-25						Primate embryonic stem cells - Patent # 6200806 - PatentGenius	.patentgenius.com	0	0		
1282	chr6	91446738	91448574	3500132374	25		91446738	91448574	8421504	2	22,3	0,1833	c	350013237400000004	0-25						Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells	ww.biolreprod.org	0	0		
1282	chr6	91446738	91448574	3500125556	25		91446738	91448574	8421504	2	22,3	0,1833	c	350012555600000000	0-25						Primate embryonic stem cells	Thomson	2001	0		
1282	chr6	91446738	91448574	3500115016	25		91446738	91448574	8421504	2	22,3	0,1833	c	350011501600000000	0-25					Patent	Primate embryonic stem cells (Patent US:7029913)	Thomson	2006	0		
1282	chr6	91446738	91448574	3500108164	25		91446738	91448574	8421504	2	22,3	0,1833	c	350010816400000000	0-25					Patent	Primate embryonic stem cells (Patent US:5843780)	Thomson	1998	0		
1282	chr6	91446738	91448574	3500085206	25		91446738	91448574	8421504	2	22,3	0,1833	c	350008520600000004	0-25						Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same	Amit	2011	0		
1282	chr6	91446738	91448574	3500083571	25		91446738	91448574	8421504	2	22,3	0,1833	c	350008357100000006,350008357100000020	0-25,0-25						Human foreskin fibroblast conditioned media for culturing ES cells - Patent # 7790455 - PatentGenius	.patentgenius.com	0	0		
1282	chr6	91446738	91448574	3500033649	25		91446738	91448574	8421504	2	22,3	0,1833	c	350003364900000000	0-25						Primate embryonic stem cells | Patexia.com	www.patexia.com	0	0		
1282	chr6	91446738	91448574	3500023525	25		91446738	91448574	8421504	2	22,3	0,1833	c	350002352500000000	0-25						Primate embryonic stem cells	Thomson	2006	0		
1282	chr6	91446738	91448574	3500013769	25		91446738	91448574	8421504	2	22,3	0,1833	c	350001376900000000	0-25						US Patent # 5,843,780. Primate embryonic stem cells - Patents.com	www.patents.com	0	0		
1282	chr6	91446738	91448574	3500012127	25		91446738	91448574	8421504	2	22,3	0,1833	c	350001212700000000	0-25						Primate embryonic stem cells	Thomson	1996	0		
1282	chr6	91451068	91452055	3500382980	40		91451068	91452055	8421504	2	20,20	0,967	c,g	350038298000000000,350038298000000000,350038298000000001	0-20,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
1282	chr6	91451068	91452055	3500280137	40		91451068	91452055	8421504	2	20,20	0,967	c,g	350028013700000000,350028013700000000,350028013700000001,350028013700000001	0-20,0-20,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
1282	chr6	91457147	91457172	3500327066	25		91457147	91457172	8421504	1	25	0	c	350032706600000007	21-46						Compositions enriched in neoplastic stem cells and methods comprising same	Duntsch	2007	0		
1284	chr6	91739483	91741246	3500399193	44		91739483	91741246	8421504	3	10,13,21	0,11,1742	c	350039919300000000,350039919300000001	0-23,0-21		22235260	10.1371/journal.pone.0029054		PLoS ONE	Rapid Accumulation of Polymorphonuclear Neutrophils in the Corpus luteum during Prostaglandin F2&#x03b1;-Induced Luteolysis in the Cow	Koumei	2012	0		
1284	chr6	91739483	91741246	3500055442	44		91739483	91741246	8421504	3	10,13,21	0,11,1742	c,g	350005544200000000,350005544200000001,350005544200000001	0-23,0-21,0-21						Evidence that polymorphonuclear neutrophils infiltrate into the developing corpus luteum and promote angiogenesis with interleukin-8 in the cow. - ResearchGate	.researchgate.net	0	0		
1284	chr6	91739483	91741246	3500005411	44		91739483	91741246	8421504	3	10,13,21	0,11,1742	c	350000541100000000,350000541100000001	0-23,0-21						Rapid accumulation of polymorphonuclear neutrophils in the Corpus luteum during prostaglandin F(2&#x03b1;)-induced luteolysis in the cow. - ResearchGate	.researchgate.net	0	0		
1284	chr6	91739497	91742088	3500120546	46		91739497	91742088	8421504	3	23,1,22	0,2129,2569	c	350012054600000015,350012054600000016	0-23,0-23						Use of recombinant bovine CD14 in the treatment and prevention of coliform mastitis in dairy cows	Wang	2002	0		
1284	chr6	91739497	91742088	3500018812	46		91739497	91742088	8421504	3	23,1,22	0,2129,2569	c	350001881200000015,350001881200000016	0-23,0-23						 Use Of Recombinant Bovine CD14 In The Treatment And Prevention Of Coliform Mastitis In Dairy Cows 	www.docstoc.com	0	0		
1284	chr6	91739497	91741219	3500291860	44		91739497	91741219	8421504	2	22,22	0,1700	c	350029186000000004,350029186000000005	0-22,0-22						Die Immunantwort boviner und capriner Euterepithelzellen auf verschiedene Mastitiserreger	b.uni-muenchen.de	0	0		
1284	chr6	91739504	91739528	3500143696	24		91739504	91739528	8421504	1	24	0	c	350014369600000006	0-24		15728708	10.1152/ajpcell.00610.2004		American Journal of Physiology - Cell Physiolog	LPA2 receptor mediates mitogenic signals in human colon cancer cells	Yun	2005	0		
1284	chr6	91739504	91739528	3500091598	24		91739504	91739528	8421504	1	24	0	c	350009159800000006	0-24		15728708	10.1152/ajpcell.00610.2004		American Journal of Physiology - Cell Physiolog	LPA2 receptor mediates mitogenic signals in human colon cancer cells	Yun	2005	0		
1284	chr6	91739507	91741208	3500092051	45		91739507	91741208	8421504	2	22,23	0,1678	c	350009205100000006,350009205100000007	0-22,0-23		22205609	10.1167/iovs.11-8728	1552-5783	Investigative Ophthalmology & Visual Science	&#x03b3;-Secretase Inhibition of Murine Choroidal Neovascularization Is Associated with Reduction of Superoxide and Proinflammatory Cytokines	Qi	2012	0		
1284	chr6	91739509	91741615	3500275310	39		91739509	91741615	8421504	2	19,20	0,2086	c,g	350027531000000010,350027531000000011,350027531000000011	1-20,0-20,0-20						The Bovine Mammary Glands Cytokines at the Periparturient Period	apps.kfu.edu.sa	0	0		
1284	chr6	91739542	91741138	3500458362	23		91739542	91741138	8421504	2	19,4	0,1592	c	350045836200000002	3-26						ScienceDirect.com - Atherosclerosis - Dehydroepiandrosterone inhibits the TNF-alpha-induced inflammatory response in human umbilical vein endothelial cells	sciencedirect.com	0	0		
1284	chr6	91739542	91741138	3500148348	23		91739542	91741138	8421504	2	19,4	0,1592	c	350014834800000008	3-26						Luteolin inhibits proliferation and affects the function of stimulated rat synovial fibroblasts	Y	2009	0		
1284	chr6	91739551	91741577	3500263488	40		91739551	91741577	8421504	3	10,10,20	0,1583,2006	c	350026348800000002,350026348800000003	0-20,0-20						Cinobufocini inhibits NF-&#x03ba;B and COX-2 activation induced by TNF- &#x03b1; in lung adenocarcinoma cells	-publications.com	0	0		
1284	chr6	91739555	91741151	3500361960	23		91739555	91741151	8421504	2	6,17	0,1579	c	350036196000000023	20-43						Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation	biomedcentral.com	0	0		
1284	chr6	91741136	91742084	3500439378	39		91741136	91742084	8421504	3	20,1,18	0,490,930	c,g	350043937800000004,350043937800000004,350043937800000005	0-20,0-20,0-19		15150340	10.1099/jmm.0.45530-0	0022-2615	Journal of Medical Microbiology	Phenotypic and functional characterization of intraepithelial lymphocytes in a bovine ligated intestinal loop model of enterohaemorrhagic Escherichia coli infection	Menge	2004	3		
1284	chr6	91741136	91742084	3500408450	39		91741136	91742084	8421504	3	20,1,18	0,490,930	c	350040845000000005,350040845000000006	0-20,0-19						Phenotypic and functional characterization of intraepithelial lymphocytes in a bovine ligated intestinal loop model of enterohaemorrhagic Escherichia coliinfection	m.sgmjournals.org	0	0		
1284	chr6	91741166	91741592	3500409160	40		91741166	91741592	8421504	2	20,20	0,406	c,g	350040916000000044,350040916000000044,350040916000000045	0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
1284	chr6	91741226	91742457	3500265613	70		91741226	91742457	8421504	3	23,20,27	0,964,1204	c,g	350026561300000006,350026561300000006,350026561300000010,350026561300000011	0-24,0-24,0-20,0-27						&#x5229;&#x7528;&#x591a;&#x56e0;&#x5b50;&#x964d;&#x7ef4;&#x6cd5;&#x7814;&#x7a76;CXCR1 &#x548c;IL-8 &#x57fa;&#x56e0;&#x4ea4;&#x4e92;&#x4f5c;&#x7528;&#x4e0e;&#x4e2d;&#x56fd;&#x8377;&#x65af;&#x5766;&#x725b;&#x4e73;&#x623f;&#x708e;&#x7684;&#x5173;&#x7cfb; - &	www.docin.com	0	0		
1284	chr6	91741229	91741253	3500335255	24		91741229	91741253	8421504	1	24	0	c	350033525500000001	20-44						1. GENERAL INTRODUCTION	ecommons.usask.ca	0	0		
1284	chr6	91741240	91742088	3500399883	40		91741240	91742088	8421504	2	19,21	0,827	c,g	350039988300000008,350039988300000008,350039988300000009,350039988300000009	0-19,0-19,0-21,0-21						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	bdtd.ufscar.br	0	0		
1284	chr6	91741240	91742088	3500177864	40		91741240	91742088	8421504	2	19,21	0,827	c,g	350017786400000009,350017786400000009,350017786400000010,350017786400000010	0-19,0-19,0-21,0-21						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
1284	chr6	91741240	91742088	3500164845	40		91741240	91742088	8421504	2	19,21	0,827	c,g	350016484500000008,350016484500000008,350016484500000009,350016484500000009	0-19,0-19,0-21,0-21						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	ww.bdtd.ufscar.br	0	0		
1284	chr6	91741240	91742088	3500136902	40		91741240	91742088	8421504	2	19,21	0,827	c,g	350013690200000004,350013690200000005,350013690200000005	0-19,0-21,0-21						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
1284	chr6	91741240	91741605	3500383646	41		91741240	91741605	8421504	2	21,20	0,345	c	350038364600000006,350038364600000007	0-21,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
1284	chr6	91741546	91741605	3500199033	55		91741546	91741605	8421504	2	34,21	0,38	c	350019903300000003,350019903300000002	0-34,21-42		12704177	10.1128/IAI.71.5.2950-2955.2003	0019-9567	Infection and Immunity	Coordinated Expression of Tracheal Antimicrobial Peptide and Inflammatory-Response Elements in the Lungs of Neonatal Calves with Acute Bacterial Pneumonia	Caverly	2003	4		
1284	chr6	91741600	91741625	3500040688	25		91741600	91741625	8421504	1	25	0	c	350004068800000001	28-53						Characterization of cytoki ne expression in milk somatic cells during intramammary infections with Escherichia coli Staphylococcus aureus by real-time PCR	etres-archive.org	0	0		
1284	chr6	91741626	91742088	3500252273	23		91741626	91742088	8421504	2	1,22	0,440	c	350025227300000005	23-46						Effect of serotonin on adipokines expression in mature bovine adipocytes	www.bu.edu.eg	0	0		
1284	chr6	91741924	91741947	3500163596	23		91741924	91741947	8421504	1	23	0	g	350016359600000011	0-23						Interleukin Gene Polymorphisms in Age-Related Macular Degeneration	www.iovs.org	0	0		
1284	chr6	91742081	91742104	3500449915	23		91742081	91742104	8421504	1	23	0	c	350044991500000007	0-23						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
1284	chr6	91742185	91742414	3500435703	40		91742185	91742414	8421504	2	20,20	0,209	c	350043570300000000,350043570300000001	0-20,0-20		20956586	10.1128/AAC.01052-10	0066-4804	Antimicrobial Agents and Chemotherapy	Anti-Inflammatory Benefits of Antibiotic-Induced Neutrophil Apoptosis: Tulathromycin Induces Caspase-3-Dependent Neutrophil Programmed Cell Death and Inhibits NF-&#x03ba;B Signaling and CXCL8 Transcription	Fischer	2011	5		
1284	chr6	91742393	91742419	3500296484	26		91742393	91742419	8421504	1	26	0	c	350029648400000003	0-26						Evaluation of cytokine expression by blood monocytes of lactating Holstein cows with or without postpartum uterine disease. - ResearchGate	.researchgate.net	0	0		
1284	chr6	91742763	91742893	3500281920	47		91742763	91742893	8421504	2	24,23	0,107	c,g	350028192000000020,350028192000000020,350028192000000021,350028192000000021	0-24,0-24,0-23,0-23						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
1285	chr6	91875760	91875784	3500316409	24		91875760	91875784	8421504	1	24	0	c	350031640900000001	0-24						Clara cells impact the pulmonary innate immune response to LPS	ng.physiology.org	0	0		
1285	chr6	91875760	91875784	3500140040	24		91875760	91875784	8421504	1	24	0	c	350014004000000001	0-24		17526599	10.1152/ajplung.00024.2007		American Journal of Physiology - Lung Cellular and Molecular Physiology	Clara cells impact the pulmonary innate immune response to LPS	Elizur	2007	0		
1285	chr6	91875760	91875784	3500104617	24		91875760	91875784	8421504	1	24	0	c	350010461700000012	0-24						Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model	biomedcentral.com	0	0		
1286	chr6	91924182	91924210	3500416772	23		91924182	91924210	8421504	2	6,17	0,11	g	350041677200000036	13-36						Supplemental Data Identification of SUMO-Dependent Chromatin-Associated Transcriptional Repression Components by a Genome-wide RNA Interference Screen	mt.uni-marburg.de	0	0		
1286	chr6	92008603	92008799	3500131195	87		92008603	92008799	8421504	2	5,82	0,114	p	350013119500015007	0-87						Constitutiveoverexpression of a growth-regulated gene in transformed Chinese hamster and human cells	www.pnas.org	0	0		
1287	chr6	92020186	92020211	3500052338	25		92020186	92020211	8421504	1	25	0	c	350005233800000002	0-25		16940143	10.1128/IAI.00519-06	0019-9567	Infection and Immunity	The K1 Serotype Capsular Polysaccharide of Porphyromonas gingivalis Elicits Chemokine Production from Murine Macrophages That Facilitates Cell Migration	d'Empaire	2006	4		
1287	chr6	92020196	92020220	3500460017	24		92020196	92020220	8421504	1	24	0	c	350046001700000012	0-24						Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model - Springer	link.springer.com	0	0		
1287	chr6	92020196	92020220	3500269525	24		92020196	92020220	8421504	1	24	0	c	350026952500000001	0-24		17526599	10.1152/ajplung.00024.2007		American Journal of Physiology - Lung Cellular and Molecular Physiology	Clara cells impact the pulmonary innate immune response to LPS	Elizur	2007	0		
1287	chr6	92020196	92020220	3500073457	24		92020196	92020220	8421504	1	24	0	c	350007345700000001	0-24		17526599	10.1152/ajplung.00024.2007		American Journal of Physiology - Lung Cellular and Molecular Physiology	Clara cells impact the pulmonary innate immune response to LPS	Elizur	2007	0		
1289	chr6	92344745	92344768	3500404353	23		92344745	92344768	8421504	1	23	0	g	350040435300000001	0-23			10.1590/S0103-84782012001000026	0103-8478	Ci&#xea;ncia Rural	Ci&#xea;ncia Rural - Angiotensin-(1-7) during the initial process of ovulatory cascade in cattle	Santos	2012	0		
1289	chr6	92350500	92350529	3500276235	29		92350500	92350529	8421504	1	29	0	g	350027623500000013	0-29		18625725	10.1128/MCB.00787-08	0270-7306	Molecular and Cellular Biology	Transforming Growth Factor &#x03b2; Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab	Wang	2008	6		EREG
1290	chr6	92410245	92410293	3500272859	48		92410245	92410293	8421504	1	48	0	c	350027285900000217	0-48						Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family		1996	0		
1290	chr6	92411227	92413258	3500008335	43		92411227	92413258	8421504	2	22,21	0,2010	c,g	350000833500000006,350000833500000006,350000833500000007,350000833500000007	0-22,0-22,0-21,0-21						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
1290	chr6	92411260	92413218	3500273964	27		92411260	92413218	8421504	2	19,8	0,1950	c	350027396400000008	24-51						REPRODUCTION	uction-online.org	0	0		
1292	chr6	92736246	92736271	3500334528	23		92736246	92736271	8421504	2	13,10	0,15	c	350033452800000056	22-45					Patent	&#x5e7d;&#x95e8;&#x87ba;&#x6746;&#x83cc;&#x6d3b;&#x75ab;&#x82d7; Helicobacter pylori vaccine (Patent CN:1215167)	T*F*Mai Ye 	2005	0		
1292	chr6	92736246	92736271	3500328349	23		92736246	92736271	8421504	2	13,10	0,15	c	350032834900000032	22-45						Helicobacter pylori live vaccine	Gomez-Duarte	1999	0		
1292	chr6	92736246	92736271	3500107334	23		92736246	92736271	8421504	2	13,10	0,15	c	350010733400000032	22-45						Helicobacter pylori live vaccine	Gomez-Duarte	1998	0		
1292	chr6	92736522	92736545	3500220423	23		92736522	92736545	8421504	1	23	0	c	350022042300000004	0-23						TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES	Sliwkowski	2009	0		
1292	chr6	92736522	92736545	3500194538	23		92736522	92736545	8421504	1	23	0	c	350019453800000029	0-23						Treating Prostate Cancer With Anti-erbb2 Antibodies 	.freshpatents.com	0	0		
1292	chr6	92738431	92783711	3500401732	534		92738431	92783711	8421504	5	106,147,118,99,64	0,2111,11639,21686,45216	p	350040173200015004	0-534						Actions of betacellulin in the gastrointestinal tract: studies in transgenic mouse lines	b.uni-muenchen.de	0	0		
1292	chr6	92738522	92750187	3500145630	48		92738522	92750187	8421504	3	15,9,24	0,2020,11641	c	350014563000000013,350014563000000012	0-24,0-24						Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro	ww.biolreprod.org	0	0		
1292	chr6	92740592	92740663	3500268263	52		92740592	92740663	8421504	2	25,27	0,44	c	350026826300000001,350026826300000000	0-25,0-27		18578861	10.1186/1755-8794-1-27		BMC Medical Genomics	Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman	Scott	2008	0		
1292	chr6	92740592	92740663	3500115853	52		92740592	92740663	8421504	2	25,27	0,44	c	350011585300000001,350011585300000000	0-25,0-27						BMC Medical Genomics BioMed Central	biomedcentral.com	0	0		
1292	chr6	92740617	92750143	3500128547	42		92740617	92750143	8421504	2	20,22	0,9504	c	350012854700000019,350012854700000018	0-20,0-22		15814714		0022-1767	The Journal of Immunology	Differential Regulation of &#x03b2;-Defensin Expression in Human Skin by Microbial Stimuli	Sorensen	2005	6		BTC
1292	chr6	92740631	92740661	3500175504	30		92740631	92740661	8421504	1	30	0	c	350017550400000025	18-48						Smooth muscle mitogen and isolated DNA coding therefor	Folkman	1998	0		
1292	chr6	92740665	92750146	3500008335	40		92740665	92750146	8421504	2	20,20	0,9461	c,g	350000833500000011,350000833500000010,350000833500000010	0-20,0-20,0-20						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
161	chr6	92917071	92997187	3500141636	23		92917071	92997187	8421504	3	16,3,4	0,18,80112	c	350014163600000015	20-43						NOVEL IMMUNOPHILINS AND CORRESPONDING NUCLEIC ACIDS - The Salk, Institute For Biological Studies Bourgeois Cohn Suzanne H.	www.sumobrain.com	0	0		
1298	chr6	93542930	93542960	3500407663	30		93542930	93542960	8421504	1	30	0	c	350040766300000070	9-39						Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation	AMALRIC	2005	0		
1298	chr6	93542930	93542960	3500348009	30		93542930	93542960	8421504	1	30	0	c	350034800900000150,350034800900000045	9-39,9-39						NOVEL DEATH ASSOCIATED PROTEINS, AND THAP1 AND PAR4 PATHWAYS IN APOPTOSIS CONTROL - Patent application	www.faqs.org	0	0		
1298	chr6	93542930	93542960	3500249275	30		93542930	93542960	8421504	1	30	0	c	350024927500000052	9-39						Activity of THAP-family chemokine-binding domains	Jullien	2006	0		
1299	chr6	93657667	93657692	3500030751	25		93657667	93657692	8421504	1	25	0	c,g	350003075100000002,350003075100000002	0-25,0-25						Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2	cs.biologists.org	0	0		G3BP2
1300	chr6	93733513	93733537	3500002105	24		93733513	93733537	8421504	1	24	0	c	350000210500000002	9-33		12438416	10.1083/jcb.200208013	0021-9525	The Journal of Cell Biology	A caspase cleavage fragment of p115 induces fragmentation of the Golgi apparatus and apoptosis	Chiu	2002	10		USO1
1300	chr6	93801954	93801979	3500459021	23		93801954	93801979	8421504	2	17,6	0,19	c	350045902100000451,350045902100000523	1-24,13-36						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
1300	chr6	93813543	93813566	3500002105	23		93813543	93813566	8421504	1	23	0	c	350000210500000004	19-42		12438416	10.1083/jcb.200208013	0021-9525	The Journal of Cell Biology	A caspase cleavage fragment of p115 induces fragmentation of the Golgi apparatus and apoptosis	Chiu	2002	10		
1301	chr6	93975985	93976034	3500463464	49		93975985	93976034	8421504	1	49	0	c,g	350046346400000006,350046346400000015	19-40,19-67						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
1302	chr6	93997931	93997957	3500064530	25		93997931	93997957	8421504	2	5,20	0,6	g	350006453000000005	8-35						Diffusion and Not Active Transport Underlies and Limits ERK1/2 Synapse-to-Nucleus Signaling in Hippocampal Neurons--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d	journal.9med.net	0	0		
1302	chr6	94077881	94080228	3500413440	1061		94077881	94080228	8421504	11	27,343,269,134,56,32,10,38,45,79,28	0,32,376,651,786,1271,1351,1585,1626,2239,2319	p,c	350041344000000027,350041344000000026,350041344000015014,350041344000000025,350041344000015010,350041344000000023,350041344000015008,350041344000000022,350041344000015004,350041344000000020,350041344000000028,350041344000000000	0-773,0-51,0-48,0-48,0-48,0-48,0-45,0-45,0-48,0-107,0-20,0-20						Embryo Implantation Inhibitor 	.freshpatents.com	0	0		
1302	chr6	94079152	94079175	3500344721	23		94079152	94079175	8421504	1	23	0	c	350034472100000003	21-44						Progesterone-Regulated Changes in Endometrial Gene Expression Contribute to Advanced Conceptus Development in Cattle	ww.biolreprod.org	0	0		
1302	chr6	94079183	94079206	3500446362	23		94079183	94079206	8421504	1	23	0	c	350044636200000011	0-23						Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses	Cheng	2003	0		
1302	chr6	94079183	94079206	3500020774	23		94079183	94079206	8421504	1	23	0	c	350002077400000011	0-23						METHODS FOR STIMULATING TLR/IRF3 PATHWAYS FOR INDUCING ANTI-MICROBIAL, ANTI-INFLAMMATORY AND ANTICANCER RESPONSES - THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	www.sumobrain.com	0	0		
1302	chr6	94079183	94079206	3500006833	23		94079183	94079206	8421504	1	23	0	c	350000683300000011,350000683300000052	0-23,0-23						Methods For Stimulating Tlr Irf3 Pathways For Inducing Anti-microbial, Anti-inflammatory And Anticancer Responses 	.freshpatents.com	0	0		
1302	chr6	94079477	94080215	3500137193	40		94079477	94080215	8421504	2	20,20	0,718	c,g	350013719300000019,350013719300000019,350013719300000018,350013719300000018	0-20,0-20,0-20,0-20						Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system	biomedcentral.com	0	0		
1302	chr6	94094944	94094972	3500177982	24		94094944	94094972	8421504	2	17,7	0,21	g	350017798200000426	0-25						Titelblatt Dissertation- Logo	thes.univie.ac.at	0	0		
1302	chr6	94095563	94095611	3500320159	48		94095563	94095611	8421504	1	48	0	c	350032015900000010	0-48						 Chemokine .alpha. 	www.docstoc.com	0	0		
1302	chr6	94095596	94095619	3500231882	23		94095596	94095619	8421504	1	23	0	c	350023188200000007	0-23		23302882	10.1128/JVI.02576-12		Journal of Virology	Henipavirus Pathogenesis in Human Respiratory Epithelial Cells	Olivier	2013	0		
1303	chr6	94210044	94211850	3500176866	60		94210044	94211850	8421504	2	36,24	0,1782	p	350017686600015002	3-63		18287518	10.1091/mbc.E08-02-0110	1059-1524	Molecular Biology of the Cell	Protein Networks Supporting AP-3 Function in Targeting Lysosomal Membrane Proteins	Baust	2008	5		
1303	chr6	94220765	94220788	3500155690	23		94220765	94220788	8421504	1	23	0	c	350015569000000033	20-43						Gene expression profiling of bovine macrophages in response to Escherichia coli O157:H7 lipopolysaccharide	alcommons.unl.edu	0	0		
1306	chr6	94580615	94580641	3500080660	23		94580615	94580641	8421504	2	18,5	0,21	g	350008066000000049	13-36						VEGI, an inhibitor of angiogenesis and tumor growth	Li Lu Yuan 	2001	0		
1308	chr6	94805681	94805709	3500164917	24		94805681	94805709	8421504	3	6,14,4	0,9,24	c	350016491700000013	7-31						THE GHRELIN RECEPTOR ISOFORMS (GHS-R1a AND GHS-R1b) AND GPR39: AN INVESTIGATION INTO RECEPTOR DIMERISATION	prints.qut.edu.au	0	0		
1308	chr6	94818189	94833784	3500152492	41		94818189	94833784	8421504	3	20,6,15	0,15570,15580	c,g	350015249200000030,350015249200000007	9-32,11-32						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
1310	chr6	95074904	95074933	3500258078	27		95074904	95074933	8421504	3	6,14,7	0,7,22	c	350025807800000286	1-34						Nematode PAN and ZP Receptor-Like Sequences - Patent application	www.faqs.org	0	0		
1310	chr6	95083917	95086977	3500081248	144		95083917	95086977	8421504	3	6,75,63	0,154,2997	p	350008124800015017	0-144						NPG.nature.vol.409.Issue.6822.Feb	www.scribd.com	0	0		CCNI
1313	chr6	95420925	95420951	3500258868	23		95420925	95420951	8421504	2	10,13	0,13	g	350025886800000033	0-23						US Patent # 5,347,076. Herbicide-tolerant plants expressing carbamate hydrolase - Patents.com	www.patents.com	0	0		
1315	chr6	95733389	95733413	3500281997	23		95733389	95733413	8421504	2	16,7	0,17	g	350028199700000007	3-26						HIV-2 antigen compositions	Montagnier	2002	0		
1315	chr6	95733640	95733669	3500068155	24		95733640	95733669	8421504	2	15,9	0,20	c	350006815500000138	4-28						AMPLIFICATION DYNAMICS OF PRIMATE RETROTRANSPOSONS	etd.lsu.edu	0	0		
1318	chr6	96164938	96164964	3500152250	25		96164938	96164964	8421504	2	13,12	0,14	g	350015225000000035	22-48						Biosensors to measure InsP3 concentration in living cells - Patent application	www.faqs.org	0	0		
1318	chr6	96192557	96192583	3500204954	23		96192557	96192583	8421504	2	7,16	0,10	g	350020495400000048	8-36						Vaccines against circovirus infections	Poet	1999	0		
1322	chr6	96630459	96666946	3500052549	43		96630459	96666946	8421504	4	13,9,9,12	0,14,36465,36475	g	350005254900000335,350005254900000377	0-32,10-32						 Compositions Against SARS 	www.docstoc.com	0	0		
1322	chr6	96719984	96720013	3500152492	24		96719984	96720013	8421504	3	12,6,6	0,16,23	g	350015249200000060	0-24						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		
1324	chr6	96887697	96887721	3500360985	23		96887697	96887721	8421504	2	15,8	0,16	g	350036098500000002	0-23		21248099	10.1128/JCM.01657-10	0095-1137	Journal of Clinical Microbiology	The rtxA Toxin Gene of Kingella kingae: a Pertinent Target for Molecular Diagnosis of Osteoarticular Infections	Lehours	2011	4		
1328	chr6	97419650	97419680	3500417028	25		97419650	97419680	8421504	3	7,4,14	0,8,16	g	350041702800000031,350041702800000011	8-33,8-33						US Patent # 7,491,394. Cytotoxic factors for modulating cell death - Patents.com	www.patents.com	0	0		
1330	chr6	97671754	97671784	3500014307	27		97671754	97671784	8421504	2	22,5	0,25	g	350001430700000005	1-28						Ehrlichia Ewingii Proteins, Nucleic Acids, And Methods Of Their Use 	.freshpatents.com	0	0		
1332	chr6	97932490	97932513	3500294995	23		97932490	97932513	8421504	1	23	0	c	350029499500000025,350029499500000088	0-23,0-23						MUTATIONS IN CAPILLARY MORPHOGENESIS GENE-2 (CMG-2) AND USE THEREOF - Patent application	www.faqs.org	0	0		
1336	chr6	98440918	98440942	3500194519	23		98440918	98440942	8421504	2	11,12	0,12	g	350019451900000221	11-34						CLONING AND CHARACTERIZATION OF THE CAPSULE TRANSPORT GENE REGION FROM Haemophilus paragallinarum	etd.uovs.ac.za	0	0		
1341	chr6	99177463	99177491	3500353659	24		99177463	99177491	8421504	3	7,3,14	0,8,14	c	350035365900000003	1-25						ORIGINAL ARTICLE Mutations of the UMODgene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy	jmg.highwire.org	0	0		
1341	chr6	99177463	99177491	3500007454	24		99177463	99177491	8421504	3	7,3,14	0,8,14	c	350000745400000015	1-25						Method for diagnosing renal diseases or predispositions	Hart	2005	0		
1341	chr6	99195710	99204342	3500276152	619		99195710	99204342	8421504	3	363,108,148	0,8373,8484	p,c,g	350027615200000001,350027615200015009,350027615200000002,350027615200000002,350027615200000003,350027615200015010,350027615200015011,350027615200000004,350027615200000015,350027615200000015,350027615200000005,350027615200000016,350027615200000016,350027615200000006,350027615200000006,350027615200000007,350027615200000010,350027615200000011,350027615200000011,350027615200000012,350027615200000012,350027615200000013,350027615200000013,350027615200000014	0-41,0-54,0-54,0-54,0-54,0-54,0-54,0-39,0-48,0-48,0-54,0-50,0-50,0-54,0-54,0-52,0-57,0-51,0-51,0-54,0-54,0-54,0-54,0-40						Bone and cartilage inductive compositions	Rosen	1991	0		
1341	chr6	99195949	99204263	3500189969	123		99195949	99204263	8421504	2	69,54	0,8260	p	350018996900015003,350018996900015009	0-69,0-54						Bone and cartilage inductive proteins	Hewick	1994	0		
1341	chr6	99195991	99204278	3500037926	180		99195991	99204278	8421504	5	45,24,21,45,45	0,48,8122,8194,8242	p	350003792600015214,350003792600015215,350003792600015217,350003792600015218	0-45,0-45,0-45,0-45						Polynucleotides Encoding Growth Differentiation Factor-8 - Patent application	www.faqs.org	0	0		BMP3
1341	chr6	99196042	99204302	3500242254	210		99196042	99204302	8421504	2	21,189	0,8071	p	350024225400015022	204-414						f8 family members transforming growthfactor Identification purified	www.pnas.org	0	0		
1341	chr6	99204113	99204296	3500214099	75		99204113	99204296	8421504	2	42,33	0,150	p	350021409900015004	0-99						 &#x9aa8;&#x5f62;&#x6001;&#x53d1;&#x751f;&#x86cb;&#x767d;(Bone Morphogenetic Proteins, BMPs)&#xe004; - NoNo's &#x5fc3;&#x60c5;&#x968f;&#x7b14; - nono_bu - &#x548c;&#x8baf;&#x535a;&#x5ba2;	bu.blog.hexun.com	0	0		BMP3
1341	chr6	99204140	99204302	3500362819	162		99204140	99204302	8421504	1	162	0	p	350036281900015034	0-162						Characterization of a gonad-specific transforming growth factor-&#x03b2; superfamily member differentially expressed during the reproductive cycle of the oyster Crassostrea gigas	chimer.ifremer.fr	0	0		BMP3
1341	chr6	99204251	99204299	3500063913	48		99204251	99204299	8421504	1	48	0	p	350006391300015024	0-48						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		BMP3
1342	chr6	99221939	99221968	3500407090	26		99221939	99221968	8421504	3	12,8,6	0,14,23	g	350040709000000397	13-39						HIV envelope polypeptides and vaccine	Berman	1997	0		
167	chr6	99240471	99354356	3500378946	7500		99240471	99354356	8421504	153	37,52,54,54,54,55,54,53,59,54,54,57,57,57,57,56,38,5,54,14,54,55,40,34,53,41,55,54,36,20,53,55,10,54,56,56,54,25,53,56,55,47,54,13,55,44,166,58,53,55,52,58,56,54,34,54,55,54,54,56,56,54,55,48,56,53,59,54,54,40,54,56,56,54,33,54,22,32,56,54,56,54,55,54,8,55,44,56,56,53,57,21,10,55,54,56,56,53,56,46,59,54,56,56,54,5,20,10,58,15,50,58,54,56,56,49,54,56,56,54,53,56,54,52,32,55,51,58,55,20,20,20,53,56,54,55,54,56,57,53,60,35,36,17,43,55,54,55,54,56,57,53,60	0,42,100,160,220,280,340,400,457,520,580,981,1041,1101,1161,1221,1283,1331,1341,1501,1521,1581,1641,1721,1761,1820,1881,1941,2018,2058,2118,2177,4342,4358,4416,4476,4538,4597,15046,15105,15165,15224,15287,15346,17459,17520,17578,17759,22647,22706,22766,22824,22886,22946,47012,47052,47112,47173,47232,47292,47352,47412,47472,49685,49739,49800,49859,49922,49980,50039,52897,52955,53015,53077,53136,54752,54812,54835,54871,54931,54991,55052,55112,55173,55233,56420,56481,56539,56599,56661,56719,56782,56804,60619,60680,60738,60798,60860,60918,60980,66117,66182,66240,66300,66362,66421,66436,66466,66482,74530,74551,74607,74670,74730,74790,74920,78164,78222,78282,78344,78403,78462,78524,78584,78642,79826,79887,79942,80004,80075,80106,85403,85429,85488,85550,85610,85670,85730,85790,85851,85910,113244,113284,113321,113355,113404,113465,113525,113585,113645,113705,113766,113825	c,g	350037894600000051,350037894600000050,350037894600000049,350037894600000046,350037894600000045,350037894600000044,350037894600000043,350037894600000041,350037894600000039,350037894600000037,350037894600000003,350037894600000038,350037894600000033,350037894600000034,350037894600000035,350037894600000036,350037894600000000,350037894600000052,350037894600000032,350037894600000030,350037894600000029,350037894600000028,350037894600000026,350037894600000024,350037894600000025,350037894600000023,350037894600000018,350037894600000019,350037894600000020,350037894600000017,350037894600000015,350037894600000014,350037894600000013,350037894600000012,350037894600000011,350037894600000010,350037894600000009,350037894600000008	0-580,0-322,0-59,0-163,0-128,0-109,0-56,0-108,0-255,0-211,4-118,0-67,0-99,0-56,0-94,0-55,0-20,0-20,0-329,0-472,0-364,0-254,0-445,0-99,0-253,0-376,1-285,0-20,0-68,0-289,0-50,0-467,0-219,0-20,0-20,0-518,0-88,0-487						Genetic test for the identification of dwarfism in cattle - US Patent 7700291 Description	ww.patentstorm.us	0	0		
167	chr6	99240471	99354356	3500206581	7445		99240471	99354356	8421504	151	37,52,54,54,54,55,54,53,59,54,54,57,57,57,57,56,38,5,54,14,54,55,40,34,53,41,55,54,36,20,53,55,10,54,56,56,54,25,53,56,55,47,54,13,55,44,166,55,53,55,52,58,56,54,34,54,55,54,54,56,56,54,55,48,56,53,59,54,54,40,54,56,56,54,33,54,15,30,56,54,56,54,55,54,8,55,44,56,56,53,57,21,10,55,54,56,56,53,56,46,59,54,56,56,54,5,20,10,58,15,50,58,54,56,56,49,54,56,56,54,53,56,54,52,32,55,51,58,55,20,20,53,56,54,55,54,56,57,53,60,35,30,43,55,54,55,54,56,57,53,60	0,42,100,160,220,280,340,400,457,520,580,981,1041,1101,1161,1221,1283,1331,1341,1501,1521,1581,1641,1721,1761,1820,1881,1941,2018,2058,2118,2177,4342,4358,4416,4476,4538,4597,15046,15105,15165,15224,15287,15346,17459,17520,17578,17759,22647,22706,22766,22824,22886,22946,47012,47052,47112,47173,47232,47292,47352,47412,47472,49685,49739,49800,49859,49922,49980,50039,52897,52955,53015,53077,53136,54752,54812,54837,54871,54931,54991,55052,55112,55173,55233,56420,56481,56539,56599,56661,56719,56782,56804,60619,60680,60738,60798,60860,60918,60980,66117,66182,66240,66300,66362,66421,66436,66466,66482,74530,74551,74607,74670,74730,74790,74920,78164,78222,78282,78344,78403,78462,78524,78584,78642,79826,79887,79942,80004,80106,85403,85429,85488,85550,85610,85670,85730,85790,85851,85910,113244,113284,113355,113404,113465,113525,113585,113645,113705,113766,113825	c,g	350020658100000052,350020658100000051,350020658100000050,350020658100000047,350020658100000046,350020658100000045,350020658100000044,350020658100000042,350020658100000040,350020658100000038,350020658100000003,350020658100000039,350020658100000034,350020658100000035,350020658100000036,350020658100000037,350020658100000033,350020658100000031,350020658100000030,350020658100000029,350020658100000026,350020658100000027,350020658100000024,350020658100000025,350020658100000023,350020658100000018,350020658100000019,350020658100000020,350020658100000017,350020658100000015,350020658100000014,350020658100000013,350020658100000011,350020658100000010,350020658100000009,350020658100000008	0-580,0-322,0-59,0-163,0-128,0-109,0-56,0-108,0-255,0-211,4-118,0-67,0-99,0-56,0-94,0-55,0-329,0-472,0-364,0-254,0-69,0-367,0-99,0-253,0-376,1-285,0-20,0-68,0-289,0-50,0-467,0-219,0-20,0-518,0-65,0-487						 Genetic Test For The Identification Of Dwarfism In Cattle 	www.docstoc.com	0	0		
1342	chr6	99242629	99244959	3500335446	41		99242629	99244959	8421504	2	20,21	0,2309	c,g	350033544600000007,350033544600000007,350033544600000006	0-20,0-20,0-21		19887637	10.1073/pnas.0904513106		Proceedings of the National Academy of Sciences of the United States of America	A nonsense mutation in cGMP-dependent type II protein kinase (PRKG2) causes dwarfism in American Angus cattle	James	2009	0		
1342	chr6	99242629	99244959	3500249864	41		99242629	99244959	8421504	2	20,21	0,2309	c,g	350024986400000007,350024986400000007,350024986400000006	0-20,0-20,0-21						A nonsense mutation in cGMP-dependant type II protein kinase (PRKG2) causes dwarfism in American Angus cattle	www.pnas.org	0	0		
1342	chr6	99242629	99244959	3500136028	41		99242629	99244959	8421504	2	20,21	0,2309	c,g	350013602800000007,350013602800000007,350013602800000006	0-20,0-20,0-21						A nonsense mutation in cGMP-dependent type II protein kinase (PRKG2) causes dwarfism in American Angus cattle	www.pnas.org	0	0		
1342	chr6	99320409	99320432	3500416135	23		99320409	99320432	8421504	1	23	0	c	350041613500000029	21-47						 Aspartoacylase Gene, Protein, And Methods Of Screening For Mutations Associated With Canavan Disease 	www.docstoc.com	0	0		
1342	chr6	99320409	99320432	3500004918	23		99320409	99320432	8421504	1	23	0	c	350000491800000029	21-47						Aspartoacylase Gene, Protein, And Methods Of Screening For Mutations Associated With Canavan Disease 	.freshpatents.com	0	0		
1344	chr6	99599546	99599580	3500320656	31		99599546	99599580	8421504	2	25,6	0,28	g	350032065600000113	6-39						US Patent # 5,834,279. Methods of identifying compounds that inhibit DNA synthesis in mycobacterium tuberculosis and compositions, reagents and kits for performing the same - Patents.com	www.patents.com	0	0		
1344	chr6	99602771	99602797	3500241923	23		99602771	99602797	8421504	2	15,8	0,18	c	350024192300000026	9-32						Methods of preparing a targeting vector and uses thereof	Morrison	2003	0		
1345	chr6	99685128	99685151	3500243673	23		99685128	99685151	8421504	1	23	0	g	350024367300000026	0-23						TARGETING OF MIRNA PRECURSORS - UNIVERSITY OF DUNDEE	www.sumobrain.com	0	0		
1347	chr6	99955311	99955337	3500398569	23		99955311	99955337	8421504	2	8,15	0,11	g	350039856900000086	22-45						Purified mammalian flt3 ligands and agonists and antagonists thereof	Birnbaum	1994	0		
1349	chr6	100182417	100182442	3500198677	23		100182417	100182442	8421504	2	9,14	0,11	g	350019867700000053	3-35						NOVEL CANCER-ASSOCIATED GENES - Patent application	www.faqs.org	0	0		
1349	chr6	100186067	100186099	3500327724	27		100186067	100186099	8421504	3	8,5,14	0,11,18	g	350032772400000053	3-35					Patent	Mutated thermostable nucleic acid polymerase enzyme from thermotoga maritima (Patent US:5420029)	Gelfand	1995	0		
1349	chr6	100186067	100186099	3500321554	27		100186067	100186099	8421504	3	8,5,14	0,11,18	g	350032155400000085	3-35						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1993	0		
1351	chr6	100454019	100454043	3500175109	23		100454019	100454043	8421504	2	12,11	0,13	g	350017510900000001	1-33					Patent	Identification and engineering of antibodies with variant Fc regions and methods of using same (Patent US:8003774)	Gorlatov	2011	0		
1353	chr6	100771644	100787052	3500214701	43		100771644	100787052	8421504	2	21,22	0,15386	c,g	350021470100000005,350021470100000005,350021470100000004,350021470100000004	10-31,10-31,8-30,8-30		20716519	10.1093/nar/gkq717		Nucleic Acids Research	AUF1 p42 isoform selectively controls both steady-state and PGE2-induced FGF9 mRNA decay	Tsung-Ming	2010	0		HNRNPD
1353	chr6	100771644	100786988	3500453660	48		100771644	100786988	8421504	2	24,24	0,15320	c	350045366000000007,350045366000000006	10-34,12-36		18573886	10.1128/MCB.00431-08	0270-7306	Molecular and Cellular Biology	Chaperone Hsp27, a Novel Subunit of AUF1 Protein Complexes, Functions in AU-Rich Element-Mediated mRNA Decay	Sinsimer	2008	6		
1353	chr6	100771690	100784876	3500339288	61		100771690	100784876	8421504	4	19,20,2,20	0,1240,1379,13166	c,g	350033928800000041,350033928800000180,350033928800000179,350033928800000179	0-21,0-20,0-20,0-20						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		HNRNPD
1353	chr6	100773626	100786825	3500320902	339		100773626	100786825	8421504	5	105,66,93,1,74	0,1415,2260,11264,13125	p	350032090200015039,350032090200015038	0-171,0-168						Method for manufacturing a modified peptide	Bauer	2009	0		HNRNPD
1353	chr6	100773719	100775053	3500026266	24		100773719	100775053	8421504	2	12,12	0,1322	c	350002626600000002	0-24			10.1124/mol.64.2.308	1521-0111 (Online)	Molecular Pharmacology	c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages	Lahti	2003	0		
1353	chr6	100775868	100775893	3500040130	25		100775868	100775893	8421504	1	25	0	c,g	350004013000000004,350004013000000004	0-25,0-25		20805360	10.1128/MCB.00807-10	0270-7306	Molecular and Cellular Biology	Polyamines Regulate the Stability of JunD mRNA by Modulating the Competitive Binding of Its 3&#x2032; Untranslated Region to HuR and AUF1	Zou	2010	6		HNRNPD
1353	chr6	100784848	100786846	3500416974	138		100784848	100786846	8421504	2	43,95	0,1903	p	350041697400015004	0-138						Curriculum Vitae Beth E. Zucconi Education	hsl.umaryland.edu	0	0		
1357	chr6	101194756	101298063	3500131986	16349		101194756	101298063	8421504	6	301,121,7,50,120,15750	0,44695,44817,44825,44876,87557	c,g	350013198600000035,350013198600000035,350013198600000001,350013198600000001,350013198600000034,350013198600000034,350013198600000033,350013198600000000,350013198600000032,350013198600000032,350013198600000031,350013198600000031,350013198600000028	0-141,0-141,0-302,0-302,0-150,0-150,0-121,0-299,0-20,0-20,0-120,0-120,0-15750						SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK - Patent application	www.faqs.org	0	0		
1357	chr6	101194936	101194964	3500064240	25		101194936	101194964	8421504	2	14,11	0,17	c	350006424000000058	0-25						Ubiquitin ligases, and uses related thereto	Beach	1997	0		
1357	chr6	101263631	101263655	3500156475	24		101263631	101263655	8421504	1	24	0	c	350015647500000017	0-24						REPRODUCTION	uction-online.org	0	0		
1358	chr6	101369543	101374323	3500131986	4780		101369543	101374323	8421504	1	4780	0	g	350013198600000026	0-4780						SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK - Patent application	www.faqs.org	0	0		
1358	chr6	101427827	101427853	3500210939	23		101427827	101427853	8421504	2	9,14	0,12	g	350021093900000112	12-35						Starchless variety of pisum sativum having elevated levels of sucrose	Webster	2000	0		
1358	chr6	101441055	101441115	3500168311	60		101441055	101441115	8421504	1	60	0	p	350016831100015001	0-60		20089833	10.1091/mbc.E09-10-0914		Molecular Biology of the Cell	Vesicular Calcium Regulates Coat Retention, Fusogenicity, and Size of Pre-Golgi Intermediates	Marvin	2010	0		SEC31A
1358	chr6	101441055	101441115	3500128476	60		101441055	101441115	8421504	1	60	0	p	350012847600015000	0-60		20089833	10.1091/mbc.E09-10-0914	1059-1524	Molecular Biology of the Cell	Vesicular Calcium Regulates Coat Retention, Fusogenicity, and Size of Pre-Golgi Intermediates	Bentley	2010	5		SEC31A
1359	chr6	101501255	101501281	3500374244	23		101501255	101501281	8421504	2	11,12	0,14	g	350037424400000001,350037424400000056	5-28,5-28						 Chondroitinase ABC I And Methods Of Production 	www.docstoc.com	0	0		
1359	chr6	101501255	101501281	3500052997	23		101501255	101501281	8421504	2	11,12	0,14	g	350005299700000002	5-28						Chondroitinase ABC I polynucleotides	Prabhakar	2006	0		
1360	chr6	101693028	101695842	3500308562	44		101693028	101695842	8421504	2	22,22	0,2792	c,g	350030856200000009,350030856200000009,350030856200000008	0-22,0-22,0-22						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
21	chr6	101693029	101714284	3500424225	42		101693029	101714284	8421504	3	21,19,2	0,2834,21253	c,g	350042422500000035,350042422500000035,350042422500000034	0-21,0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
21	chr6	101695779	101714345	3500181711	42		101695779	101714345	8421504	2	21,21	0,18545	c,g	350018171100000014,350018171100000014,350018171100000013,350018171100000013	0-21,0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
21	chr6	101695779	101714345	3500133737	42		101695779	101714345	8421504	2	21,21	0,18545	c,g	350013373700000016,350013373700000016,350013373700000015,350013373700000015	0-21,0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
170	chr6	101811629	101857908	3500254858	103		101811629	101857908	8421504	5	24,22,4,20,33	0,12192,12819,13363,46246	c	350025485800000009,350025485800000016,350025485800000001,350025485800000018,350025485800000019	0-24,0-22,0-24,0-22,0-22					Patent	Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells (Patent US:6664105)	Pecker	2003	0		HPSE
1361	chr6	101811629	101837336	3500396392	148		101811629	101837336	8421504	6	24,29,45,27,6,17	0,10580,13365,13911,16541,25690	c	350039639200000157,350039639200000146,350039639200000140,350039639200000138,350039639200000132,350039639200000054	0-24,9-38,0-45,18-45,0-23,3-26						Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells	I*Pei Ke 	2000	0		
1361	chr6	101811631	101825643	3500197451	49		101811631	101825643	8421504	2	28,21	0,13991	c	350019745100000005,350019745100000021,350019745100000022	5-33,1-22,1-22						Para obtener el grado de Doctor de la Universidad de Valencia Programa de Doctorado: Biolog&#xed;a Celular (030G) del Departamento de Bioqu&#xed;mica y Biolog&#xed;a Molecular de la Facultad de Medicina CARACTERIZACI&#xd3;N ESTRUCTURAL DE HEPARANASA POR R	roderic.uv.es	0	0		
1361	chr6	101822259	101837336	3500173990	55		101822259	101837336	8421504	4	10,22,6,17	0,1557,5911,15060	c	350017399000000027,350017399000000015	10-42,3-26						 Heparanase Specific Molecular Probes And Their Use In Research And Medical Applications 	www.docstoc.com	0	0		
1361	chr6	101825535	101825558	3500438270	23		101825535	101825558	8421504	1	23	0	c	350043827000000000	0-23						Eosinophil Major Basic Protein as a natural heparanase-inhibiting protein, compositions, methods and uses thereof	Vlodavsky	2004	0		HPSE
1361	chr6	101825650	101828018	3500218793	30		101825650	101828018	8421504	2	15,15	0,2353	c	350021879300000001	19-49						HeparanaseEnhancesSyndecan-1Shedding	www.jbc.org	0	0		
1364	chr6	102196036	102196090	3500351896	54		102196036	102196090	8421504	1	54	0	c	350035189600000028,350035189600000058	6-48,0-42						Gpat3 Encodes A Mammalian, Microsomal Acyl-coa:glycerol 3- Phosphate Acyltransferase 	.freshpatents.com	0	0		
1366	chr6	102405143	102405170	3500059269	23		102405143	102405170	8421504	2	8,15	0,12	g	350005926900000036	4-27						Protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof	Yamaguchi	2000	0		
1368	chr6	102750769	102750792	3500281681	23		102750769	102750792	8421504	1	23	0	g	350028168100000053	22-47					Patent	DNA construct encoding the YAP3 signal peptide (Patent US:5726038)	Christiansen	1998	0		
1369	chr6	102828812	102828838	3500109485	23		102828812	102828838	8421504	2	15,8	0,18	g	350010948500000017	0-23						&#x9810;&#x544a;&#x8a02;&#x5b9a;&#x300c;&#x98df;&#x54c1;&#x5fae;&#x751f;&#x7269;&#x4e4b;&#x6aa2;&#x9a57;&#x65b9;&#x6cd5;&#xff0d;&#x8089;&#x6bd2;&#x687f;&#x83cc;&#x4e4b;&#x6aa2;&#x9a57;&#x300d;&#xff0c;&#x70ba;&#x98df;&#x54c1;&#x885b;&#x751f;&#x7ba1;&#x7406	anservices.com.tw	0	0		
1371	chr6	103101955	103101982	3500108622	24		103101955	103101982	8421504	2	16,8	0,19	g	350010862200000144	8-32						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
1372	chr6	103247160	103247186	3500341581	25		103247160	103247186	8421504	2	15,10	0,16	g	350034158100000003	4-33						Hedgehog Inhibitor Assay 	.freshpatents.com	0	0		
1372	chr6	103252143	103254525	3500060624	40		103252143	103254525	8421504	3	20,10,10	0,177,2372	c	350006062400000011,350006062400000010	0-20,0-20		23341441	10.5966/sctm.2012-0077	2157-6564	Stem Cells Translational Medicine	Differentiation of CD133+ Stem Cells From Amyotrophic Lateral Sclerosis Patients Into Preneuron Cells	Gonzalez-Garza	2013	0		CDS1
1372	chr6	103252322	103254530	3500438382	23		103252322	103254530	8421504	2	8,15	0,2193	c	350043838200000012	1-24						Original Article In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long- term culture running risk of malignant transformation	www.ajsc.us	0	0		
1372	chr6	103254667	103256400	3500412634	23		103254667	103256400	8421504	2	21,2	0,1731	c	350041263400000014	18-41						ScienceDirect.com - Biochemical and Biophysical Research Communications - Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets	sciencedirect.com	0	0		CDS1
1372	chr6	103254677	103256413	3500311369	26		103254677	103256413	8421504	2	11,15	0,1721	c	350031136900000004	0-26						Adult Stem Cell-derived Connective Tissue Progenitors For Tissue Engineering 	.freshpatents.com	0	0		CDS1
1372	chr6	103254677	103256413	3500210815	26		103254677	103256413	8421504	2	11,15	0,1721	c	350021081500000004	0-26						Adult Stem Cell-derived Connective Tissue Progenitors For Tissue Engineering 	.freshpatents.com	0	0		CDS1
1372	chr6	103256889	103256915	3500367838	23		103256889	103256915	8421504	3	5,4,14	0,7,12	c	350036783800000227	6-29						 <HTML> <HEAD><TITLE>Show BLAST File</TITLE></HEAD> <BODY BGCOLOR=ffffff><BR> <br> <A NAME=top> <P	rth.lab.nig.ac.jp	0	0		
1375	chr6	103634958	103634982	3500040778	23		103634958	103634982	8421504	2	6,17	0,7	g	350004077800000022	3-26		20154099	10.1104/pp.109.148742		Plant Physiology	The Catalytic and Protein-Protein Interaction Domains Are Required for APM1 Function	Fazeeda	2010	0		
1385	chr6	104892106	104906617	3500240510	53		104892106	104906617	8421504	3	20,14,19	0,172,14492	c,g	350024051000000057,350024051000000057,350024051000000174,350024051000000174,350024051000000196,350024051000000198	0-20,0-20,0-20,0-20,0-33,0-33						COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS - Patent application	www.faqs.org	0	0		
1385	chr6	104892106	104906617	3500053557	53		104892106	104906617	8421504	3	20,14,19	0,172,14492	c	350005355700000174,350005355700000057,350005355700000198,350005355700000196	0-20,0-20,0-33,0-33						COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS - Patent application	www.faqs.org	0	0		
1385	chr6	104895047	104895075	3500092809	23		104895047	104895075	8421504	2	6,17	0,11	g	350009280900000023	0-23						Therapeutic uses of inhibitors of RTP801	Feinstein	2006	0		
1386	chr6	104995428	104995542	3500414502	114		104995428	104995542	8421504	1	114	0	p	350041450200015012	0-114						Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same	Burgess	2001	0		MAPK10
1386	chr6	104995428	104995542	3500140393	114		104995428	104995542	8421504	1	114	0	p	350014039300015012	0-114						Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same	Burgess	2001	0		MAPK10
1387	chr6	105206352	105206378	3500234928	23		105206352	105206378	8421504	2	9,14	0,12	g	350023492800000006	0-23						Method and model for hair pigmentation	Zhao	2000	0		
1388	chr6	105346281	105346306	3500031829	23		105346281	105346306	8421504	2	10,13	0,12	g	350003182900000015	8-31		21062931	10.1158/1078-0432.CCR-10-1461		Clinical cancer research : an official journal of the American Association for Cancer Research	Hypoexpression and Epigenetic Regulation of Candidate Tumor Suppressor Gene CADM-2 in Human Prostate Cancer	Guimin	2010	0		
1389	chr6	105459680	105459705	3500207917	24		105459680	105459705	8421504	2	19,5	0,20	c	350020791700000041	20-48						US Patent # 7,208,310. Proteases - Patents.com	www.patents.com	0	0		
1389	chr6	105459680	105459705	3500066984	24		105459680	105459705	8421504	2	19,5	0,20	c	350006698400000024	20-48						Proteases - Patent application	www.faqs.org	0	0		
1389	chr6	105459680	105459705	3500041857	24		105459680	105459705	8421504	2	19,5	0,20	c	350004185700000024	20-48						Proteases - Patent application	www.faqs.org	0	0		
1390	chr6	105594333	105594361	3500103869	28		105594333	105594361	8421504	1	28	0	c,g	350010386900000010,350010386900000010	45-73,45-73						Methods	Alessi	2005	0		PTPN13
1391	chr6	105644851	105644899	3500191346	48		105644851	105644899	8421504	1	48	0	c	350019134600000027	68-116						Nucleotide sequences for novel protein tyrosine phosphatases	Gonez	1996	0		
1393	chr6	105973445	105973474	3500013997	25		105973445	105973474	8421504	3	13,4,8	0,14,21	g	350001399700000011	0-25			10.1093/nar/gkl476		Nucleic Acids Research	Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling	Kumar	2006	0		
1393	chr6	105975641	106016151	3500036548	41		105975641	106016151	8421504	3	20,2,19	0,175,40491	c,g	350003654800000070,350003654800000070,350003654800000025	0-20,0-20,17-38						RNAi modulation of MLL-AF4 and uses thereof	Heidenreich	2005	0		AFF1
1395	chr6	106218744	106224753	3500205057	42		106218744	106224753	8421504	3	20,21,1	0,1824,6008	c	350020505700000011,350020505700000010	0-20,0-22						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1395	chr6	106218744	106224753	3500137197	42		106218744	106224753	8421504	3	20,21,1	0,1824,6008	c	350013719700000011,350013719700000010	0-20,0-22						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
1395	chr6	106283006	106289983	3500047878	40		106283006	106289983	8421504	3	20,19,1	0,2995,6976	c,g	350004787800000041,350004787800000041,350004787800000040	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
1396	chr6	106367230	106372662	3500188994	183		106367230	106372662	8421504	5	33,32,1,30,87	0,39,3516,3583,5345	p	350018899400015016,350018899400015018	15-81,0-126						NPG.nature.vol.411.Issue.6837.May	www.scribd.com	0	0		
1396	chr6	106411145	106411172	3500305295	23		106411145	106411172	8421504	2	10,13	0,14	g	350030529500000001	0-23		19812301	10.1095/biolreprod.109.079582	0006-3363	Biology of Reproduction	SPAM1 Isoforms from Two Tissue Origins Are Differentially Localized Within Ejaculated Bull Sperm Membranes and Have Different Roles During Fertilization	Morin	2010	4		
1397	chr6	106542216	106542284	3500061042	44		106542216	106542284	8421504	2	26,18	0,50	g	350006104200000034	168-212						Porcine dentin matrix protein 1: gene structure, cDNA sequence, and expression in teeth	lue.lib.umich.edu	0	0		
1397	chr6	106545999	106546234	3500274037	40		106545999	106546234	8421504	2	20,20	0,215	c,g	350027403700000144,350027403700000145,350027403700000145	0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1397	chr6	106546224	106546271	3500296446	43		106546224	106546271	8421504	2	20,23	0,24	c	350029644600000000	19-62						PLEASE SCROLL DOWN FOR ARTICLE	bpages.uidaho.edu	0	0		
1398	chr6	106626795	106626824	3500029190	24		106626795	106626824	8421504	2	14,10	0,19	g	350002919000000014	2-27						Gene synthesis kit	Cox	2006	0		
1399	chr6	106787045	106787073	3500252985	23		106787045	106787073	8421504	3	11,7,5	0,15,23	g	350025298500000093	3-27					Patent	DNA encoding phosphoenolpyruvate carboxykinase, recombinant vector and transformed plant containing the same (Patent US:5880334)	Arai	1999	0		
1401	chr6	107035939	107035964	3500269550	24		107035939	107035964	8421504	2	5,19	0,6	g	350026955000000269	10-35						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
1404	chr6	107372019	107372042	3500280455	23		107372019	107372042	8421504	1	23	0	g	350028045500000046	11-37						TRIMERIZING POLYPEPTIDES - Patent application	www.faqs.org	0	0		
1405	chr6	107492919	107492964	3500059323	45		107492919	107492964	8421504	1	45	0	p	350005932300015003	0-45		11549731		0270-6474	The Journal of Neuroscience	Isolation and Expression Pattern of Human Unc-33-Like Phosphoprotein 6/Collapsin Response Mediator Protein 5 (Ulip6/CRMP5): Coexistence with Ulip2/CRMP2 in Sema3A- Sensitive Oligodendrocytes	Ricard	2001	7		CRMP1
1405	chr6	107573431	107573459	3500400909	25		107573431	107573459	8421504	2	5,20	0,8	g	350040090900000026	0-25						Use of bacterial polysaccharides for biofilm inhibition	Re	2009	0		
1405	chr6	107573431	107573459	3500341629	25		107573431	107573459	8421504	2	5,20	0,8	g	350034162900000026	0-25					Patent	Use of bacterial polysaccharides for biofilm inhibition (Patent EP:2046378)	Da	2010	0		
1413	chr6	108542322	108542441	3500400964	51		108542322	108542441	8421504	2	25,26	0,93	g	350040096400000037,350040096400000036	1-26,0-26						RESSOURCES G&#xc9;N&#xc9;TIQUES ANIMALES	www.fao.org	0	0		
1413	chr6	108648727	108652019	3500180458	44		108648727	108652019	8421504	2	22,22	0,3270	c,g	350018045800000004,350018045800000004,350018045800000005,350018045800000005	0-22,0-22,0-22,0-22		17030628	10.1128/MCB.00759-06	0270-7306	Molecular and Cellular Biology	Bone Morphogenetic Protein-Induced Msx1 and Msx2 Inhibit Myocardin-Dependent Smooth Muscle Gene Transcription	Hayashi	2006	6		MSX1
1413	chr6	108649128	108651832	3500266147	46		108649128	108651832	8421504	2	23,23	0,2681	c	350026614700000031,350026614700000032	24-47,1-24						Method for proliferation of pluripotent stem cell	Bao Tian Shang Xiao 	2011	0		
1413	chr6	108651684	108652471	3500031998	85		108651684	108652471	8421504	4	21,22,21,21	0,320,607,766	c	350003199800000003,350003199800000005,350003199800000004,350003199800000006,350003199800000001,350003199800000002	0-21,21-42,0-21,20-42,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
1413	chr6	108651789	108651840	3500206152	38		108651789	108651840	8421504	2	19,19	0,32	c,g	350020615200000002,350020615200000003,350020615200000003	0-19,0-19,0-19						Neonatal Exposure to Estrogen and Estrogen Receptor Agonists and Antagonists: Effects on the Adult Endometrial Proteome and Morphoregulatory Gene Expression in the Neonatal Uterus	etd.auburn.edu	0	0		
1413	chr6	108651809	108651832	3500463024	23		108651809	108651832	8421504	1	23	0	c	350046302400000184	1-24						METHOD FOR PROLIFERATION OF PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		
1413	chr6	108651809	108651832	3500449206	23		108651809	108651832	8421504	1	23	0	c,g	350044920600000054,350044920600000054	1-24,1-24						EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS - Patent application	www.faqs.org	0	0		
1413	chr6	108651809	108651832	3500119347	23		108651809	108651832	8421504	1	23	0	c	350011934700000019	1-24		21119622	10.1038/mt.2010.269	1525-0016	Molecular Therapy	Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell&#x2013;derived Induced Pluripotent Stem Cells	Kambal	2010	7		
1417	chr6	109087316	109087344	3500139966	23		109087316	109087344	8421504	2	9,14	0,14	g	350013996600000112	16-39						US Patent # 6,531,579. Fused polypeptides - Patents.com	www.patents.com	0	0		
1418	chr6	109267833	109267858	3500044535	23		109267833	109267858	8421504	2	14,9	0,16	g	350004453500000006	1-24		19656853	10.1091/mbc.E09-02-0109		Molecular Biology of the Cell	Udu Deficiency Activates DNA Damage Checkpoint	Chiaw-Hwee	2009	0		
1422	chr6	109817349	109817376	3500404231	24		109817349	109817376	8421504	3	6,7,11	0,7,16	g	350040423100000112,350040423100000057	9-33,9-33						CD23 BINDING MOLECULES AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
1423	chr6	109849141	109849172	3500220074	23		109849141	109849172	8421504	3	5,12,6	0,8,25	g	350022007400000245,350022007400000010	8-31,10-33					Patent	Thermophilic DNA polymerases from Thermotoga neapolitana (Patent US:6077664)	Bolchakova	2000	0		
178	chr6	110864627	110889771	3500110550	39		110864627	110889771	8421504	4	14,6,7,12	0,19,25122,25132	g	350011055000000489,350011055000000092	19-39,24-43						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
178	chr6	110872580	110919006	3500407417	40		110872580	110919006	8421504	3	20,15,5	0,46404,46421	g	350040741700000117,350040741700000232	5-26,12-33						Method For Producing Carotenoids Or Their Precursors Using Genetically Modified Organisms Of The Blakeslea Genus, Carotenoids Or Their Precursors Produced By Said Method And Use Thereof 	.freshpatents.com	0	0		
1432	chr6	111030507	111030536	3500200843	24		111030507	111030536	8421504	2	15,9	0,20	g	350020084300000015	8-39					Applied and Environmental Microbiology	Gene Cloning and Expression and Secretion of Listeria monocytogenes Bacteriophage-Lytic Enzymes in Lactococcus lactis	Susanne	July	0		
1438	chr6	111850185	111850208	3500137915	23		111850185	111850208	8421504	1	23	0	g	350013791500000497	11-47						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1440	chr6	112192085	112192112	3500172944	24		112192085	112192112	8421504	2	18,6	0,21	g	350017294400000164	8-32					Patent	Biofuel production (Patent US:8318473)	Yoshikuni	2012	0		
1440	chr6	112192085	112192112	3500083504	24		112192085	112192112	8421504	2	18,6	0,21	g	350008350400000164	8-32						Biofuel production	Kashiyama	2011	0		
1447	chr6	113072840	113072867	3500451169	24		113072840	113072867	8421504	3	11,9,4	0,13,23	g	350045116900000000	6-33						NUCLEIC ACID SEQUENCES FOR REGULATION OF EMBRYO-SPECIFIC EXPRESSION IN MONOCOTYLEDONEOUS PLANTS - Patent application	www.faqs.org	0	0		
1450	chr6	113382138	113382161	3500366403	23		113382138	113382161	8421504	1	23	0	g	350036640300000001	9-35						Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence	Pavlakis	1996	0		
1453	chr6	113794510	113794534	3500253026	23		113794510	113794534	8421504	2	8,15	0,9	g	350025302600000048	16-39						Processes and products with modified antibodies of human milk fat globule specificity	Do	2004	0		
1462	chr6	114981077	114981102	3500147485	24		114981077	114981102	8421504	2	20,4	0,21	g	350014748500000081,350014748500000544,350014748500000697	24-48,12-36,15-39						Antigen Binding Proteins Capable Of Binding Thymic Stromal Lymphopoietin 	.freshpatents.com	0	0		
1463	chr6	115168955	115168984	3500223473	23		115168955	115168984	8421504	3	11,7,5	0,16,24	g	350022347300000508	25-48							ww.patentlens.net	0	0		
1464	chr6	115241945	115241968	3500358203	23		115241945	115241968	8421504	1	23	0	g	350035820300000000	15-38		24066188	10.1371/journal.pone.0075888	1932-6203	PLOS ONE	PLOS ONE: Organ-Specific Splice Variants of Aquaporin Water Channel AgAQP1 in the Malaria Vector Anopheles gambiae	Tsujimoto	2013	4		
1464	chr6	115241945	115241968	3500347653	23		115241945	115241968	8421504	1	23	0	g	350034765300000003	15-38						Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use	Lewis	1999	0		
22	chr6	115340947	115343699	3500376741	198		115340947	115343699	8421504	2	149,49	0,2703	p	350037674100015008,350037674100015033	0-111,18-114					Patent	F-box genes and proteins (Patent US:6573094)	Harper	2003	0		
22	chr6	115341092	115343681	3500148841	35		115341092	115343681	8421504	2	4,31	0,2558	c	350014884100000088	0-35						F-box genes and proteins	Harper	1997	0		
1465	chr6	115469171	115469196	3500189431	23		115469171	115469196	8421504	2	18,5	0,20	g	350018943100000438	0-23						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1467	chr6	115665294	115665318	3500099048	23		115665294	115665318	8421504	2	10,13	0,11	g	350009904800000176,350009904800000526	0-23,0-23						Methods For Rapid Identification Of Pathogens In Humans And Animals - Patent application	www.faqs.org	0	0		
1470	chr6	116063979	116064002	3500128306	23		116063979	116064002	8421504	1	23	0	g	350012830600000119	6-39						Means and Methods for Controlling Flowering in Plants - Patent application	www.faqs.org	0	0		
1472	chr6	116318700	116318723	3500250523	23		116318700	116318723	8421504	1	23	0	g	350025052300000001	1-24		23526585	10.1002/jcp.24367	1097-4652	Journal of Cellular Physiology	Acetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: Reduction of oxidant levels - Schunke - 2013 - Journal of Cellular Physiology - Wiley Online Library	Schunke	2013	0		
1475	chr6	116682605	116682630	3500144935	23		116682605	116682630	8421504	2	11,12	0,13	g	350014493500000003	1-26						SARS CORONAVIRUS S PROTEINS AND USES THEREOF - AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH	www.sumobrain.com	0	0		
1476	chr6	116803276	116803306	3500108885	25		116803276	116803306	8421504	2	6,19	0,11	g	350010888500000004	2-27		18647749	10.1074/jbc.M802132200	0021-9258	Journal of Biological Chemistry	G9a-mediated Lysine Methylation Alters the Function of CCAAT/Enhancer-binding Protein-&#x03b2;	Pless	2008	5		
1478	chr6	117053448	117053474	3500087860	23		117053448	117053474	8421504	2	18,5	0,21	g	350008786000000002	0-25		18172008	10.1128/MCB.02061-07	0270-7306	Molecular and Cellular Biology	Repression of PTEN Phosphatase by Snail1 Transcriptional Factor during Gamma Radiation-Induced Apoptosis	Escriva	2008	6		
1479	chr6	117209610	117209640	3500194854	25		117209610	117209640	8421504	2	8,17	0,13	g	350019485400000033	6-31						DNA Microarrays for Virus Detection in Cases of Central Nervous System Infection	jcm.asm.org	0	0		
1479	chr6	117279977	117280001	3500416780	24		117279977	117280001	8421504	1	24	0	g	350041678000000087	0-24						Gamma-iterferon-leukotoxin gene fusions and uses thereof	Potter	1991	0		
1483	chr6	117706085	117706112	3500220335	26		117706085	117706112	8421504	2	21,5	0,22	g	350022033500000002	11-39		15479836	10.1128/JVI.78.21.11962-11971.2004	0022-538X	Journal of Virology	Identification of a Negative Regulatory Element in the Epstein-Barr Virus Zta Transactivation Domain That Is Regulated by the Cell Cycle Control Factors c-Myc and E2F1	Lin	2004	5		
1483	chr6	117811851	117811889	3500044944	30		117811851	117811889	8421504	3	15,8,7	0,20,31	g	350004494400000004	1-33						Supporting Information	www.pnas.org	0	0		
1485	chr6	118035422	118035446	3500256560	23		118035422	118035446	8421504	2	15,8	0,16	c	350025656000000003	5-28					Journal of Bacteriology	Cloning and Molecular Characterization of the Genes for Carbon Monoxide Dehydrogenase and Localization of Molybdopterin, Flavin Adenine Dinucleotide, and Iron-Sulfur Centers in the Enzyme of Hydrogenophaga pseudoflava	Beom	1999	0		GAK
1485	chr6	118035423	118035451	3500407803	24		118035423	118035451	8421504	2	15,9	0,19	c	350040780300000010	0-24						ABSTRACT Title of Dissertation / Thesis: EVALUATION OF THE ROLE OF BarA-UvrY TWO-COMPONENT SYSTEM IN ESCHERICHIA COLI	drum.lib.umd.edu	0	0		
1485	chr6	118048218	118048243	3500194734	24		118048218	118048243	8421504	2	19,5	0,20	g	350019473400000032	3-27						 Interferon Interferon beta 1a immunoglobulin fusion proteins and uses 	www.docstoc.com	0	0		
1485	chr6	118048218	118048243	3500152141	24		118048218	118048243	8421504	2	19,5	0,20	g	350015214100000037	15-39						Polymer conjugates of interferon beta-1a and uses	Pepinsky	2007	0		
1485	chr6	118048218	118048243	3500007534	24		118048218	118048243	8421504	2	19,5	0,20	g	350000753400000032	3-27						Interferon-beta fusion proteins and uses	Whitty	2004	0		
1485	chr6	118086876	118086899	3500161237	23		118086876	118086899	8421504	1	23	0	c	350016123700000185	2-27						US Patent # 6,683,165. Human gene relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
1486	chr6	118149211	118149238	3500384630	23		118149211	118149238	8421504	2	12,11	0,16	c	350038463000000036	22-47						 Human Genes Relating To Respiratory Diseases And Obesity 	www.docstoc.com	0	0		
1486	chr6	118149627	118149658	3500224483	31		118149627	118149658	8421504	1	31	0	c	350022448300000016	11-42						Fibroblast growth factor receptor-5	Young	2001	0		
1486	chr6	118151817	118151845	3500459220	24		118151817	118151845	8421504	3	13,7,4	0,16,24	c	350045922000000065	0-24						 M. Tuberculosis Antigens 	www.docstoc.com	0	0		
1486	chr6	118151817	118151845	3500447421	24		118151817	118151845	8421504	3	13,7,4	0,16,24	c	350044742100000065	0-24						M. tuberculosis antigens	Andersen	2001	0		
1486	chr6	118151817	118151845	3500265596	24		118151817	118151845	8421504	3	13,7,4	0,16,24	c	350026559600000064	0-24						NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)	Andersen	2000	0		
1487	chr6	118249404	118280687	3500153276	40		118249404	118280687	8421504	4	5,14,9,12	0,8,31261,31271	g	350015327600000332,350015327600000525	10-29,10-31						US Patent # 7,381,549. Method for zymotic production of fine chemicals (mety) containing sulphur - Patents.com	www.patents.com	0	0		
1488	chr6	118376939	118376965	3500045715	23		118376939	118376965	8421504	2	16,7	0,19	c	350004571500000347	19-42						Modulation of eIF4E-BP2 expression - US Patent 7468431 Description	ww.patentstorm.us	0	0		
1489	chr6	118577091	118586826	3500147485	39		118577091	118586826	8421504	4	7,13,14,5	0,8,9715,9730	g	350014748500000532,350014748500000025	21-41,12-31						Antigen Binding Proteins Capable Of Binding Thymic Stromal Lymphopoietin 	.freshpatents.com	0	0		
1490	chr6	118691390	118693858	3500461029	34		118691390	118693858	8421504	2	32,2	0,2466	c	350046102900000002,350046102900000001	14-48,0-30			10.1042/BSR20130074		Bioscience Reports	Replication stress-induced alternative mRNA splicing alters properties of the histone RNA-binding protein HBP/SLBP: a key factor in the control of histone gene expression	Alexander M.	2013	0		
1490	chr6	118709068	118709095	3500226462	24		118709068	118709095	8421504	2	14,10	0,17	c	350022646200000016	24-48						Orally-administered interferon-tau compositions and methods - US Patent 7214367 Description	ww.patentstorm.us	0	0		
1490	chr6	118722981	118736888	3500137915	40		118722981	118736888	8421504	4	4,15,12,9	0,5,13884,13898	g	350013791500000144,350013791500000683,350013791500000014	7-26,0-21,0-20						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1491	chr6	118759371	118772012	3500466335	2409		118759371	118772012	8421504	17	109,267,54,173,124,191,145,191,146,122,111,191,123,71,138,106,147	0,5203,5556,7112,7367,7570,9231,9840,10334,10841,11045,11374,11648,11850,12075,12305,12494	c	350046633500000007	0-2409						BOTULINUM TOXIN SCREENING ASSAYS - Patent application	www.faqs.org	0	0		
1491	chr6	118759371	118772012	3500379843	2409		118759371	118772012	8421504	17	109,267,54,173,124,191,145,191,146,122,111,191,123,71,138,106,147	0,5203,5556,7112,7367,7570,9231,9840,10334,10841,11045,11374,11648,11850,12075,12305,12494	c	350037984300000007	0-2409						BOTULINUM TOXIN SCREENING ASSAYS - Patent application	www.faqs.org	0	0		
1491	chr6	118759371	118772012	3500267088	2409		118759371	118772012	8421504	17	109,267,54,173,124,191,145,191,146,122,111,191,123,71,138,106,147	0,5203,5556,7112,7367,7570,9231,9840,10334,10841,11045,11374,11648,11850,12075,12305,12494	c	350026708800000007	0-2409						Botulinum Toxin Screening Assays 	.freshpatents.com	0	0		
1491	chr6	118764834	118772018	3500095695	2029		118764834	118772018	8421504	18	7,54,173,124,191,145,191,146,122,111,85,96,123,71,138,106,119,27	0,93,1649,1904,2107,3768,4377,4871,5378,5582,5911,6006,6185,6387,6612,6842,7031,7157	p,c,g	350009569500000015,350009569500000004,350009569500000004,350009569500000013,350009569500000013,350009569500000016,350009569500015004,350009569500015001,350009569500015008,350009569500000017,350009569500000008,350009569500000005,350009569500000014	1-1350,0-21,0-21,0-21,0-21,0-350,0-48,3-48,0-48,0-324,0-42,0-21,0-22						Screening for the molecular defect causing spider lamb syndrome in sheep	Cockett	1998	0		
1491	chr6	118764834	118772018	3500050484	2029		118764834	118772018	8421504	18	7,54,173,124,191,145,191,146,122,111,85,96,123,71,138,106,119,27	0,93,1649,1904,2107,3768,4377,4871,5378,5582,5911,6006,6185,6387,6612,6842,7031,7157	p,c,g	350005048400000015,350005048400000013,350005048400000013,350005048400000004,350005048400000004,350005048400000016,350005048400015004,350005048400015001,350005048400015008,350005048400000017,350005048400000008,350005048400000014,350005048400000005	1-1350,0-21,0-21,0-21,0-21,0-350,0-48,3-48,0-48,0-324,0-42,0-22,0-21						Screening for the molecular defect causing spider lamb syndrome in sheep - US Patent 6306591 Description	ww.patentstorm.us	0	0		
1491	chr6	118766530	118771126	3500173089	109		118766530	118771126	8421504	3	45,45,19	0,476,4577	p,c	350017308900015000,350017308900015005,350017308900000002	0-45,0-45,7-26						ANTI-FGFR3 ANTIBODIES AND METHODS USING SAME	Ashkenazi	2010	0		FGFR3
1491	chr6	118766850	118770224	3500146382	45		118766850	118770224	8421504	4	12,7,14,12	0,91,2987,3362	c	350014638200000001,350014638200000002	0-19,0-26		22199253	10.1093/nar/gkr1233		Nucleic Acids Research	Human box C/D snoRNA processing conservation across multiple cell types	Michelle	2012	0		
1491	chr6	118767102	118769216	3500129658	90		118767102	118769216	8421504	4	30,15,40,5	0,1500,1605,2109	c	350012965800000031,350012965800000034	0-45,0-45						Animal model for fibroblast growth factor receptor associated chondrodysplasia	Yayon	1999	0		
1491	chr6	118767123	118768713	3500385768	93		118767123	118768713	8421504	3	9,27,57	0,1479,1533	p	350038576800015017	0-114						#4487 HAYMAN, MICHABL J , ~M'D / Type of Application: I~ I~]Comimmfi	accodocuments.org	0	0		
1491	chr6	118769399	118770892	3500092953	64		118769399	118770892	8421504	4	3,22,19,20	0,306,1428,1473	c,g	350009295300000000,350009295300000001,350009295300000007,350009295300000007,350009295300000006	0-25,0-25,3-22,3-22,0-20						Fibroblast growth factor receptor 3 effects on proliferation and telomerase activity in sheep growth plate chondrocytes	www.jasbsci.com	0	0		
1491	chr6	118770213	118771453	3500117211	192		118770213	118771453	8421504	5	48,48,18,71,7	0,226,911,1008,1233	p	350011721100015051,350011721100015083,350011721100015054,350011721100015086,350011721100015062,350011721100015094,350011721100015063,350011721100015095	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						METHOD OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER - Patent application	www.faqs.org	0	0		
1491	chr6	118770749	118771739	3500020125	43		118770749	118771739	8421504	2	21,22	0,968	c,g	350002012500000000,350002012500000000,350002012500000001	0-21,0-21,0-22						Localization of the locus causing Spider Lamb Syndrome to the distal end of ovine Chromosome 6	.udifmv.ulg.ac.be	0	0		FGFR3
1491	chr6	118770932	118771039	3500348845	24		118770932	118771039	8421504	2	4,20	0,87	c	350034884500000126	11-35						Nucleic acids encoding hencatoporetic stem cell receptor flk-2 - Patent # 5185438 - PatentGenius	.patentgenius.com	0	0		
1493	chr6	119062391	119062417	3500380911	24		119062391	119062417	8421504	2	6,18	0,8	g	350038091100000014	0-24						Human monoclonal antibodies against CD20	Teeling	2011	0		
1493	chr6	119062391	119062417	3500280326	24		119062391	119062417	8421504	2	6,18	0,8	g	350028032600000014	0-24						Human antibodies specific for interleukin 15 (il-15)	Baadsgaard	2003	0		
1494	chr6	119175084	119175108	3500152538	23		119175084	119175108	8421504	2	4,19	0,5	g	350015253800000035	16-39						Transgenic animals	Bremel	1999	0		
1494	chr6	119175084	119175108	3500137979	23		119175084	119175108	8421504	2	4,19	0,5	g	350013797900000035	16-39					Patent	Methods for creating transgenic animals (Patent US:6080912)	Bremel	2000	0		
1494	chr6	119181131	119181154	3500137915	23		119181131	119181154	8421504	1	23	0	g	350013791500000632	4-47						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1498	chr6	119787243	119787267	3500307340	23		119787243	119787267	8421504	2	8,15	0,9	g	350030734000000001	0-29		12177055	10.1074/jbc.M203585200	0021-9258	Journal of Biological Chemistry	Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs)	Richter	2002	5		
1498	chr6	119792022	119792046	3500156000	24		119792022	119792046	8421504	1	24	0	g	350015600000000001	0-24			10.1111/j.1574-6941.1999.tb00572.x	1574-6941	FEMS Microbiology Ecology	Characterisation of symbiotically efficient alfalfa-nodulating rhizobia isolated from acid soils of Argentina and Uruguay - Segundo - 2006 - FEMS Microbiology Ecology - Wiley Online Library	Segundo	1999	0		
1499	chr6	119814118	119814141	3500257530	23		119814118	119814141	8421504	1	23	0	c	350025753000000076	18-41						HER-2/NEU FUSION PROTEINS - Patent application	www.faqs.org	0	0		
1499	chr6	119814118	119814141	3500232484	23		119814118	119814141	8421504	1	23	0	c	350023248400000063	15-38						Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated - Patent # 8524491 - PatentGenius	.patentgenius.com	0	0		
1499	chr6	119814118	119814141	3500065454	23		119814118	119814141	8421504	1	23	0	c	350006545400000200	15-38						Methods and materials for characterizing and modulating interaction between heregulin and HER3 - US Patent 7314916 Description	ww.patentstorm.us	0	0		
1500	chr6	119932727	119932754	3500101538	25		119932727	119932754	8421504	3	7,4,14	0,8,13	c	350010153800000182	0-25						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
1500	chr6	120012093	120046344	3500186470	823		120012093	120046344	8421504	10	107,20,7,77,121,60,80,139,142,70	0,201,7962,16528,23983,26871,27319,29241,33356,34181	g	350018647000000009	0-842						Treatment of neurodegenerative disease through intracranial delivery of sirna	Kaemmerer	2005	0		
1500	chr6	120012093	120046344	3500180572	823		120012093	120046344	8421504	10	107,20,7,77,121,60,80,139,142,70	0,201,7962,16528,23983,26871,27319,29241,33356,34181	g	350018057200000057,350018057200000059,350018057200000062,350018057200000060	0-842,0-21,0-21,0-21					Patent	Treatment of neurodegenerative disease through intracranial delivery of siRNA (Patent US:7829694)	Kaemmerer	2010	0		
1500	chr6	120012113	120012138	3500252138	25		120012113	120012138	8421504	1	25	0	g	350025213800000053	35-60						Reduction of off-target RNA interference toxicity	Davidson	2012	0		
1500	chr6	120012113	120012138	3500047758	25		120012113	120012138	8421504	1	25	0	g	350004775800000056	35-60						REDUCTION OF OFF-TARGET RNA INTERFERENCE TOXICITY - Patent application	www.faqs.org	0	0		
1500	chr6	120012114	120012144	3500451241	30		120012114	120012144	8421504	1	30	0	g	350045124100000000	0-30		18353560	10.1016/j.neuroscience.2008.02.004		Neuroscience	Up-regulation of GLT1 Expression Increases Glutamate Uptake and Attenuates the Huntington's Disease Phenotype in the R6/2 Mouse	Benjamin	2008	0		
1500	chr6	120012114	120012144	3500197150	30		120012114	120012144	8421504	1	30	0	g	350019715000000000	0-30						USE OF ORGANIC COMPOUNDS	Rangwala	2007	0		
1500	chr6	120012114	120012137	3500416997	23		120012114	120012137	8421504	1	23	0	g	350041699700000000	0-23		17653262	10.1371/journal.pone.0000635	1932-6203	PLOS ONE	PLOS ONE: Polyglutamine Expansion Mutation Yields a Pathological Epitope Linked to Nucleation of Protein Aggregate: Determinant of Huntington's Disease Onset	Sugaya	2007	4		
1500	chr6	120012123	120012147	3500193119	24		120012123	120012147	8421504	1	24	0	g	350019311900000157	5-29						NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF - Patent application	www.faqs.org	0	0		
1500	chr6	120050009	120050033	3500395876	23		120050009	120050033	8421504	2	17,6	0,18	g	350039587600000001	1-28						Myocardial grafts and cellular compositions	Field	2010	0		
1500	chr6	120050009	120050033	3500341278	23		120050009	120050033	8421504	2	17,6	0,18	g	350034127800000118	11-38						Method of distinguishing an IBRV-vaccinated bovine from a bovine infected with a wild type virus	Cochran	1996	0		
1500	chr6	120050009	120050033	3500136614	23		120050009	120050033	8421504	2	17,6	0,18	g	350013661400000001	1-28						Myocardial grafts and cellular compositions useful for same	Field	1995	0		
1500	chr6	120050009	120050033	3500074846	23		120050009	120050033	8421504	2	17,6	0,18	g	350007484600000001	1-28						Myocardial grafts and cellular compositions useful for same	Field	2005	0		
1500	chr6	120050009	120050033	3500042995	23		120050009	120050033	8421504	2	17,6	0,18	g	350004299500000001	1-28					Patent	Myocardial grafts and cellular compositions useful for same (Patent US:6818210)	Field	2004	0		
1501	chr6	120088885	120088909	3500355159	23		120088885	120088909	8421504	2	4,19	0,5	g	350035515900000015	9-32						GENERATION OF INNER EAR CELLS - Patent application	www.faqs.org	0	0		
1502	chr6	120241617	120241642	3500364515	25		120241617	120241642	8421504	1	25	0	c	350036451500000012	5-30						ScienceDirect.com - Biochemical and Biophysical Research Communications - Identification of hepatocyte growth factor activator (Hgfac) gene as a target of HNF1&#x03b1; in mouse &#x03b2;-cells	sciencedirect.com	0	0		
1502	chr6	120248330	120248354	3500378122	24		120248330	120248354	8421504	1	24	0	c	350037812200000005	0-24						Dna encoding the human serine protease c-e	Andrade-Gordon	2001	0		
1502	chr6	120248330	120248354	3500332780	24		120248330	120248354	8421504	1	24	0	c	350033278000000005	0-24						Dna encoding the human serine protease c-e	Andrade-Gordon	2002	0		
1502	chr6	120248372	120249279	3500432786	24		120248372	120249279	8421504	2	7,17	0,890	c	350043278600000031	5-29					Patent	Factor VII or VIIa-like molecules (Patent US:6806063)	Pedersen	2004	0		
1502	chr6	120248372	120249279	3500375861	24		120248372	120249279	8421504	2	7,17	0,890	c	350037586100000031	5-29						Factor Vii Or Viia-like Molecules 	.freshpatents.com	0	0		
1502	chr6	120248372	120249279	3500295436	24		120248372	120249279	8421504	2	7,17	0,890	c	350029543600000031	5-29					Patent	Factor VII or VIIa-like molecules (Patent US:6806063)	Pedersen	2004	0		
1502	chr6	120248372	120249279	3500281784	24		120248372	120249279	8421504	2	7,17	0,890	c	350028178400000038	5-29						Factor VII or VIIa like molecules	Jin *V*An De Sen 	2003	0		
1502	chr6	120248372	120249279	3500095675	24		120248372	120249279	8421504	2	7,17	0,890	c	350009567500000025	5-29						Factor VII or VIIa Polypeptide Variants - Patent application	www.faqs.org	0	0		
1502	chr6	120248372	120249279	3500053786	24		120248372	120249279	8421504	2	7,17	0,890	c	350005378600000031	5-29						Factor Vii Or Viia - Like Molecules 	.freshpatents.com	0	0		
1502	chr6	120248372	120249279	3500029671	24		120248372	120249279	8421504	2	7,17	0,890	c	350002967100000033	5-29						Factor VII or VIIa - Like Molecules - Patent application	www.faqs.org	0	0		
1502	chr6	120248372	120249279	3500023981	24		120248372	120249279	8421504	2	7,17	0,890	c	350002398100000031	5-29						Factor VII or VIIa - Like Molecules - Patent application	www.faqs.org	0	0		
1504	chr6	120528319	120528343	3500358160	23		120528319	120528343	8421504	2	10,13	0,11	g	350035816000000014	0-23						Method for detection of nucleic acid target sequences involving in vitro transcription from an rna promoter	Assenberg	1999	0		
1504	chr6	120529610	120529634	3500416625	23		120529610	120529634	8421504	2	18,5	0,19	g	350041662500000021	9-32						UNIVERSIDAD DE MURCIA FACULTAD DE BIOLOG&#xcd;A NUEVOS PROBI&#xd3;TICOS Y PREBI&#xd3;TICOS PARA DORADA (SPARUS AURATA L.).	digitum.um.es	0	0		
1504	chr6	120540229	120540257	3500198961	25		120540229	120540257	8421504	2	8,17	0,11	g	350019896100000005	1-39						Process for producing trypsin (trypsinogen)	Woldike	1997	0		
1505	chr6	120679375	120679404	3500026714	24		120679375	120679404	8421504	2	16,8	0,21	g	350002671400000010	0-24			10.1046/j.1365-2958.1999.01579.x	1365-2958	Molecular Microbiology	The A-factor regulatory cascade leading to streptomycin biosynthesis in Streptomyces griseus&#xa0;: identification of a target gene of the A-factor receptor - Ohnishi - 2002 - Molecular Microbiology - Wiley Online Library	Ohnishi	1999	0		
1508	chr6	121001922	121001951	3500370435	25		121001922	121001951	8421504	2	19,6	0,23	g	350037043500000730	7-32						Neisseria meningitidis antigens and compositions	Fraser	2008	0		
1508	chr6	121001922	121001951	3500252890	25		121001922	121001951	8421504	2	19,6	0,23	g	350025289000000854	7-32						Neisseria meningitidis antigens and compositions	Fraser	2012	0		
1509	chr6	121196577	121196601	3500356614	23		121196577	121196601	8421504	2	10,13	0,11	g	350035661400000005	0-23						Functional Genomic Analysis of Three Nitrogenase Isozymes in the Photosynthetic Bacterium Rhodopseudomonas palustris	ieg.ou.edu/public	0	0		
188	chr6	121241588	121241612	3500206286	23		121241588	121241612	8421504	2	8,15	0,9	g	350020628600000112	2-43						Process for preparing human coagulation factor VIII protein complex	Yonemura	1994	0		
188	chr6	121368949	121393571	3500137915	46		121368949	121393571	8421504	5	15,5,7,7,12	0,18,24,24601,24610	g	350013791500000565,350013791500000427	8-39,3-22						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
1511	chr6	121377971	121377994	3500189676	23		121377971	121377994	8421504	1	23	0	g	350018967600000131	9-32						 Transgenic Plants Containing Ligninase And Cellulase Which Degrade Lignin And Cellulose To Fermentab 	www.docstoc.com	0	0		
1512	chr6	121553780	121553803	3500360474	23		121553780	121553803	8421504	1	23	0	c	350036047400000047	25-48						Gene encoding for a transmembrane protein	Shimizu	2000	0		
1514	chr6	121869093	121869119	3500030519	23		121869093	121869119	8421504	2	13,10	0,16	g	350003051900000183	10-33						Nematode-extracted serine protease inhibitors and anticoagulant proteins - Patent application	www.faqs.org	0	0		
1515	chr6	122005822	122005848	3500172452	24		122005822	122005848	8421504	2	11,13	0,13	g	350017245200000002	0-24		10706706		0022-1767	The Journal of Immunology	The Role of High-Mobility Group I(Y) Proteins in Expression of IL-2 and T Cell Proliferation	Himes	2000	6		
586	chr7	179942	179966	3500258554	23		179942	179966	8421504	2	19,4	0,20	g	350025855400000253,350025855400000328,350025855400000003,350025855400000469,350025855400000192	5-24,0-23,5-24,3-26,0-20						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
586	chr7	179942	179966	3500254774	23		179942	179966	8421504	2	19,4	0,20	g	350025477400000803	21-44						Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies - Patent application	www.faqs.org	0	0		
586	chr7	179942	179966	3500180724	23		179942	179966	8421504	2	19,4	0,20	g	350018072400000005	5-28						Agonist Antibody To Human Thrombopoietin Receptor 	.freshpatents.com	0	0		
586	chr7	179942	179966	3500135973	23		179942	179966	8421504	2	19,4	0,20	g	350013597300000265	9-32						CARRIER IMMUNOGLOBULINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
586	chr7	179942	179966	3500083476	23		179942	179966	8421504	2	19,4	0,20	g	350008347600000010	5-28						Anti-a33 antibody	Kataoka	2007	0		
588	chr7	492802	509616	3500100457	114		492802	509616	8421504	3	26,48,40	0,15518,16774	g	350010045700000017,350010045700000082,350010045700000084	1-27,0-48,0-40						US Patent # 6,107,046. Antibodies to Flt4, a receptor tyrosine kinase and uses thereof - Patents.com	www.patents.com	0	0		
588	chr7	493963	503650	3500133622	62		493963	503650	8421504	3	20,21,21	0,9196,9666	g	350013362200000126,350013362200000142,350013362200000117	0-20,0-21,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404832)	Natt	2013	0		
588	chr7	493963	503650	3500105842	41		493963	503650	8421504	2	20,21	0,9666	g	350010584200000126,350010584200000117	0-20,0-21						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
588	chr7	503159	506498	3500083334	63		503159	506498	8421504	3	21,21,21	0,470,3318	g	350008333400000142,350008333400000117,350008333400000133	0-21,0-21,0-21					Patent	Short interfering ribonucleic acid (siRNA) with improved pharmacological properties (Patent US:8084600)	Billy	2011	0		
589	chr7	570901	570929	3500250035	23		570901	570929	8421504	2	7,16	0,12	c	350025003500000027	11-35			10.1042/BJ20041472		Biochemical Journal	Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y)	Yuwaraj	2005	0		
589	chr7	573541	573586	3500457776	45		573541	573586	8421504	1	45	0	p	350045777600015005	0-45						BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms. - ResearchGate	.researchgate.net	0	0		CNOT6
589	chr7	593998	594024	3500449906	26		593998	594024	8421504	1	26	0	c,g	350044990600000004,350044990600000004	0-26,0-26		18180299	10.1074/jbc.M706986200	0021-9258	Journal of Biological Chemistry	Components of the CCR4-NOT Complex Function as Nuclear Hormone Receptor Coactivators via Association with the NRC-interacting Factor NIF-1	Garapaty	2008	5		
591	chr7	861036	861078	3500126523	42		861036	861078	8421504	1	42	0	c	350012652300000098	3-45						PLANTS WITH INCREASED HYALURONAN PRODUCTION - Patent application	www.faqs.org	0	0		
73	chr7	917386	925185	3500452170	140		917386	925185	8421504	4	44,48,23,25	0,48,4830,7774	c	350045217000000069,350045217000000070,350045217000000072	0-44,0-48,0-48						US Patent # 6,706,509. Oncoprotein protein kinase - Patents.com	www.patents.com	0	0		
73	chr7	917434	925185	3500029292	144		917434	925185	8421504	3	60,59,25	0,4746,7726	p,c	350002929200000070,350002929200000071,350002929200015103,350002929200015105,350002929200000072	0-48,0-48,0-48,0-48,0-48						US Patent # 6,863,888. Oncoprotein protein kinase - Patents.com	www.patents.com	0	0		
592	chr7	925221	925246	3500361592	25		925221	925246	8421504	1	25	0	c	350036159200000001	0-25						 Assessing Mitochondrial Redox Status by Flow Cytometric Methods: Vascular Response to Fluid Shear Stress - Current Protocols 	rentprotocols.com	0	0		MAPK9
594	chr7	1226006	1226029	3500165883	23		1226006	1226029	8421504	1	23	0	c	350016588300000010,350016588300000009,350016588300000011	0-21,0-22,0-22		21692045	10.1002/cncr.25860	1097-0142	Cancer	miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met - Wu - 2011 - Cancer - Wiley Online Library	Wu	2011	0		RNF130
594	chr7	1226049	1226072	3500371873	23		1226049	1226072	8421504	1	23	0	c	350037187300000112	0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		RNF130
594	chr7	1226049	1226072	3500304886	23		1226049	1226072	8421504	1	23	0	c	350030488600000088	0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		RNF130
595	chr7	1321902	1321932	3500032439	26		1321902	1321932	8421504	2	17,9	0,21	g	350003243900000038	13-39						Tripeptidyl aminopeptidase	Holm	1997	0		
595	chr7	1384431	1384454	3500309807	23		1384431	1384454	8421504	1	23	0	c	350030980700000001	1-45						Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma	-publications.com	0	0		
595	chr7	1431088	1431133	3500174773	45		1431088	1431133	8421504	1	45	0	p	350017477300015000	0-45						Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection	jcb.rupress.org	0	0		SQSTM1
595	chr7	1431088	1431133	3500129513	45		1431088	1431133	8421504	1	45	0	p	350012951300015001	0-45		21041446	10.1083/jcb.201005012	0021-9525	The Journal of Cell Biology	Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection	Riley	2010	10		SQSTM1
595	chr7	1431166	1431214	3500169645	48		1431166	1431214	8421504	1	48	0	p	350016964500015008	0-48						ANovelInterleukin-12p40-RelatedProteinInducedbyLatent Epstein-BarrVirusInfectioninBLymphocytes	jvi.asm.org	0	0		SQSTM1
74	chr7	1441786	1441812	3500275436	26		1441786	1441812	8421504	1	26	0	c	350027543600000000	8-34						Autophagic Degradation of Caspase-8 Protects U87MG Cells Against H O-induced Oxidative Stress	.apocpcontrol.net	0	0		
74	chr7	1441786	1441812	3500145504	26		1441786	1441812	8421504	1	26	0	c	350014550400000000	8-34		23519119	10.1038/cddis.2013.77	false	Cell Death & Disease	Autophagy protein p62&sol;SQSTM1 is involved in HAMLET-induced cell death by modulating apotosis in U87MG cells	Zhang	2013	0		
74	chr7	1441786	1441812	3500137810	26		1441786	1441812	8421504	1	26	0	c	350013781000000000	8-34						Autophagic Degradation of Caspase-8 Protects U87MG Cells Against H O-induced Oxidative Stress	.apocpcontrol.org	0	0		
596	chr7	1513369	1513399	3500440430	25		1513369	1513399	8421504	3	5,13,7	0,8,23	c	350044043000000004	0-26						Compositions And Methods For Treating Conditions Related To Ephrin Signaling With Cupredoxins And Mutants Thereof 	.freshpatents.com	0	0		
596	chr7	1514112	1516044	3500119203	56		1514112	1516044	8421504	2	26,30	0,1902	c	350011920300000005,350011920300000010	0-30,1-48					Patent	Nucleic acids and expression vectors encoding human leukotiene C.sub.4 synthase (Patent US:5952210)	Creely	1999	0		
596	chr7	1514130	1516029	3500075617	23		1514130	1516029	8421504	2	8,15	0,1884	c	350007561700000001	0-23		10666225		0006-4971	Blood	Aberrant expression of active leukotriene C4 synthase in CD16+ neutrophils from patients with chronic myeloid leukemia	Sjolinder	2000	10		LTC4S
596	chr7	1562430	1569524	3500027167	1287		1562430	1569524	8421504	14	97,156,41,55,139,179,72,134,57,67,60,90,93,47	0,1380,1745,1834,3313,4401,4659,4787,5067,5136,5593,5745,6504,7047	p	350002716700015014,350002716700015017,350002716700015023,350002716700015026,350002716700015029,350002716700015032,350002716700015043,350002716700015033,350002716700015045,350002716700015034,350002716700015037,350002716700015040	0-150,0-144,0-108,0-150,0-150,0-150,0-147,0-48,0-78,0-60,0-150,0-147						Neela Devi Sing RAMBARUTH	search.wmin.ac.uk	0	0		
596	chr7	1563869	1563917	3500159212	48		1563869	1563917	8421504	1	48	0	p	350015921200015001	0-48						Hypusination of eukaryotic initiation factor 5A(eIF5A): a novel therapeutic target in BCR-ABL&#x2013;positive leukemias identi&#xfb01;ed by a proteomics approach	tologylibrary.org	0	0		HNRNPH1
596	chr7	1563887	1563922	3500235523	35		1563887	1563922	8421504	1	35	0	c	350023552300000315,350023552300000104,350023552300000318,350023552300000319,350023552300000317,350023552300000107,350023552300000316,350023552300000105	0-35,0-35,0-27,0-27,0-21,0-27,0-20,0-20						METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - Patent application	www.faqs.org	0	0		
596	chr7	1563889	1563922	3500312192	33		1563889	1563922	8421504	1	33	0	c,g	350031219200000144,350031219200000054,350031219200000129,350031219200000128,350031219200000127,350031219200000057,350031219200000126,350031219200000126,350031219200000055,350031219200000055	0-33,0-33,0-27,0-27,0-21,0-27,0-20,0-20,0-20,0-20						METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - Patent application	www.faqs.org	0	0		
596	chr7	1563889	1563922	3500033114	33		1563889	1563922	8421504	1	33	0	c,g	350003311400000054,350003311400000054,350003311400000057,350003311400000055	0-33,0-33,0-27,0-20						Methods and compositions for the specific inhibition of gene expression by double-stranded RNA	Rossi	2005	0		
596	chr7	1563891	1563918	3500248138	27		1563891	1563918	8421504	1	27	0	c	350024813800000107,350024813800000105	0-27,0-20						Methods and compositions for the specific inhibition of gene expression by double-stranded RNA	Rossi	2007	0		HNRNPH1
596	chr7	1565775	1566883	3500377255	159		1565775	1566883	8421504	2	107,52	0,1056	p	350037725500015068	0-159						49 human secreted proteins	Komatsoulis	2000	0		HNRNPH1
596	chr7	1567125	1567297	3500095765	40		1567125	1567297	8421504	2	20,20	0,152	c,g	350009576500000023,350009576500000023,350009576500000024	0-20,0-20,0-20						Escape from Transcriptional Shutoff during Poliovirus Infection: NF- B-Responsive Genes I Ba and A20	jvi.asm.org	0	0		HNRNPH1
74	chr7	1902913	1978317	3500302429	42		1902913	1978317	8421504	3	20,21,1	0,78,75403	c,g	350030242900000000,350030242900000000,350030242900000001	0-20,0-20,0-22						International Journal of Veterinary Science	www.ijvets.com	0	0		ADAMTS2
600	chr7	1996425	1996451	3500000540	23		1996425	1996451	8421504	3	6,13,4	0,8,22	g	350000054000000025	14-37						 DNA Encoding A Mutated Thermostable Nucleic Acid Polymerase Enzyme From Thermus Species Sps17 	www.docstoc.com	0	0		
600	chr7	2050008	2050037	3500347939	25		2050008	2050037	8421504	2	19,6	0,23	g	350034793900000052	5-30						 Cystic Fibrosis Gene Mutations 	www.docstoc.com	0	0		
600	chr7	2093188	2093211	3500327832	23		2093188	2093211	8421504	1	23	0	c	350032783200000016	0-23			10.2119/2006-00028.Paulissen		Molecular Medicine	Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma	Genevieve	2006	0		ADAMTS2
600	chr7	2093881	2093904	3500085562	23		2093881	2093904	8421504	1	23	0	c	350008556200000229	11-34						Methods and compositions for assaying analytes	Yuan	1999	0		
600	chr7	2093911	2093934	3500082184	23		2093911	2093934	8421504	1	23	0	c	350008218400000016	3-26					Patent	Vector for expression and secretion of polypeptide microorganism transformed by the vector and production of polypeptide with the same microorganism (Patent US:5545564)	Kajifusa	1996	0		
601	chr7	2113094	2113123	3500331821	29		2113094	2113123	8421504	1	29	0	c	350033182100000005	19-48						Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma	.aacrjournals.org	0	0		
601	chr7	2222044	2222125	3500272104	60		2222044	2222125	8421504	2	18,42	0,39	p	350027210400015028	3-63						Inducible adeno -associated virus vector mediated transgene ablation system	Wilson	2013	0		
603	chr7	2373895	2373923	3500090447	25		2373895	2373923	8421504	2	15,10	0,18	g	350009044700000023	7-35						 Expression Of Human Serum Albumin In Pichia Pastoris Expression of human serum albumin in 	www.docstoc.com	0	0		
603	chr7	2464161	2464272	3500430809	111		2464161	2464272	8421504	1	111	0	p	350043080900015050,350043080900015080	0-111,0-111						Patent Search: US Patent Number 8299236 - Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells	ww.archpatent.com	0	0		HIST3H2BB
603	chr7	2464161	2464272	3500188627	111		2464161	2464272	8421504	1	111	0	p	350018862700015056,350018862700015055	0-111,0-111						COMPOSITIONS AND METHODS FOR ENHANCING DELIVERY OF NUCLEIC ACIDS INTO CELLS AND FOR MODIFYING EXPRESSION OF TARGET GENES IN CELLS - Patent application	www.faqs.org	0	0		HIST3H2BB
603	chr7	2464161	2464221	3500066566	60		2464161	2464221	8421504	1	60	0	p	350006656600015000	0-60						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		HIST3H2BB
606	chr7	2771679	2771702	3500093232	23		2771679	2771702	8421504	1	23	0	g	350009323200000203	0-23					Patent	Haemophilus outer membrane protein (Patent US:6083743)	Chong	2000	0		
607	chr7	2912235	2912259	3500357889	24		2912235	2912259	8421504	1	24	0	c	350035788900000011	0-24						SureChem - Document - WO/PCT - Patent No. 1997027327 - "METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL" - Description	www.surechem.org	0	0		
607	chr7	2912235	2912259	3500340613	24		2912235	2912259	8421504	1	24	0	c	350034061300000011	0-24						Methods and compositions for enhancing sensitivity in the analysis of biological-based assays	Ness	1997	0		
607	chr7	2912235	2912259	3500212648	24		2912235	2912259	8421504	1	24	0	c,g	350021264800000011,350021264800000011	0-24,0-24						 Methods And Compositions For Enhancing Sensitivity In The Analysis Of Biological 	www.docstoc.com	0	0		
607	chr7	2912235	2912259	3500173543	24		2912235	2912259	8421504	1	24	0	c	350017354300000011,350017354300000024	0-24,0-24						 Methods And Compositions For Enhancing Sensitivity In The Analysis Of Biological 	www.docstoc.com	0	0		
607	chr7	2912235	2912259	3500135427	24		2912235	2912259	8421504	1	24	0	c	350013542700000011	0-24						US Patent # 6,027,890. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays - Patents.com	www.patents.com	0	0		
607	chr7	2913673	2913825	3500341953	48		2913673	2913825	8421504	2	32,16	0,136	c	350034195300000083	0-48						Thymidine kinase mutants	www.devileye.net	0	0		
607	chr7	2927333	2927361	3500195251	25		2927333	2927361	8421504	2	18,7	0,21	c	350019525100000006	0-25						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: "Mapping of IgE-binding regions on recombinant Cyn d 1, a major allergen from Bermuda Grass Pollen (BGP)" 	tailieu.vn/doc/ba	0	0		
607	chr7	2931532	2931580	3500287453	48		2931532	2931580	8421504	1	48	0	p	350028745300015000	0-48					Patent	Regulation of oxidative burst using LMWG-derived peptides and analogs (Patent US:6184203)	Bokoch	2001	0		ARF1
607	chr7	2931559	2931583	3500453547	24		2931559	2931583	8421504	1	24	0	c	350045354700000000	8-32		19005166	10.1095/biolreprod.108.073197	0006-3363	Biology of Reproduction	ADP-Ribosylation Factor 1 Regulates Asymmetric Cell Division in Female Meiosis in the Mouse	Wang	2009	4		
607	chr7	2946594	2946622	3500090675	23		2946594	2946622	8421504	2	13,10	0,18	g	350009067500000033	11-38						Cloning Nucleotide Sequences oflux Genes Characterization Luciferase Xenorhabdus	jb.asm.org/conten	0	0		
607	chr7	2965600	2965651	3500148394	51		2965600	2965651	8421504	1	51	0	g	350014839400000335,350014839400000096,350014839400000180	1-33,0-48,4-33						Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	.freshpatents.com	0	0		
612	chr7	3630078	3630104	3500245482	23		3630078	3630104	8421504	2	16,7	0,19	c	350024548200000213	6-37						RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS - Patent application	www.faqs.org	0	0		
612	chr7	3642777	3642805	3500316135	24		3642777	3642805	8421504	2	6,18	0,10	c	350031613500000010	16-40						Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma. - ResearchGate	.researchgate.net	0	0		
612	chr7	3650069	3650098	3500188562	29		3650069	3650098	8421504	1	29	0	c	350018856200000034	0-29						Amplified genes involved in cancer	Li	2003	0		
612	chr7	3650069	3650098	3500098455	29		3650069	3650098	8421504	1	29	0	c	350009845500000034	0-29						Amplified genes involved in cancer	Li	2004	0		
612	chr7	3650259	3651843	3500311151	40		3650259	3651843	8421504	2	20,20	0,1564	c	350031115100000002,350031115100000003	0-20,0-20		21320075	10.1042/CBI20100706	1095-8355	Cell Biology International	Lysophosphatidic acid (LPA) stimulates mouse mammary epithelial cell growth	IS	2011	0		LPAR2
612	chr7	3650507	3651701	3500179423	44		3650507	3651701	8421504	2	22,22	0,1172	c	350017942300000003,350017942300000005	0-22,0-22			10.1016/j.bbagen.2007.08.008		Biochimica et biophysica acta	Lysophospholipid Signaling: Beyond the EDGs	William	2008	0		LPAR2
612	chr7	3650516	3651869	3500193512	113		3650516	3651869	8421504	6	48,23,5,18,14,5	0,1163,1307,1313,1332,1348	c	350019351200000094,350019351200000102,350019351200000105	0-48,0-23,0-42						Methods for detecting compounds which modulate the activity of an LPA receptor	Erickson	1998	0		
613	chr7	3765466	3765499	3500446814	27		3765466	3765499	8421504	3	14,5,8	0,17,25	c	350044681400000018	10-37						Cellulosic Cultivation Of Oleaginous Microorganisms 	.freshpatents.com	0	0		
614	chr7	3918737	3918763	3500034531	24		3918737	3918763	8421504	3	7,4,13	0,8,13	c	350003453100000047	16-43						Human monoclonal antibodies to epidermal growth factor receptor - US Patent 7807798 Description	ww.patentstorm.us	0	0		SUGP1
615	chr7	4062739	4062766	3500429772	24		4062739	4062766	8421504	2	19,5	0,22	c	350042977200000043	12-36						 Tissue Plasminogen Activator 	www.docstoc.com	0	0		
616	chr7	4063754	4063781	3500231114	24		4063754	4063781	8421504	2	5,19	0,8	c	350023111400000022	0-24						Stereoselective reduction of substituted acetophenone	Chu	2002	0		
616	chr7	4063754	4063781	3500116878	24		4063754	4063781	8421504	2	5,19	0,8	c	350011687800000019	0-24						Stereoselective reduction of substituted acetophenone	Patel	2002	0		
616	chr7	4063754	4063781	3500098376	24		4063754	4063781	8421504	2	5,19	0,8	c	350009837600000019	0-24						 Stereoselective Reduction Of Substituted Acetophenone 	www.docstoc.com	0	0		
617	chr7	4211985	4212008	3500101054	23		4211985	4212008	8421504	1	23	0	g	350010105400000004	25-48						THE INFLUENCE OF LINE 1 HEREFORDS ON THE GLOBAL HEREFORD POPULATION Vicki L. Reisenauer Leesburg	etd.uovs.ac.za	0	0		
617	chr7	4247434	4247462	3500393395	23		4247434	4247462	8421504	2	10,13	0,15	g	350039339500000006	0-23						Recombinational cloning using engineered recombination sites - Patent # 6171861 - PatentGenius	.patentgenius.com	0	0		
617	chr7	4247434	4247462	3500099866	23		4247434	4247462	8421504	2	10,13	0,15	g	350009986600000006	0-23						RECOMBINATIONAL CLONING USING ENGINEERED RECOMBINATION SITES - Patent application	www.faqs.org	0	0		
617	chr7	4290561	4294848	3500171948	38		4290561	4294848	8421504	2	19,19	0,4268	g	350017194800000006,350017194800000005	0-19,0-19		20946641	10.1186/1471-2164-11-565		BMC Genomics	Expression proteomics of UPF1 knockdown in HeLa cells reveals autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting in nonsense-mediated mRNA decay	Nicholas	2010	0		UPF1
617	chr7	4294829	4297913	3500269885	38		4294829	4297913	8421504	2	19,19	0,3065	g	350026988500000006,350026988500000005	0-19,0-19						Nonsense Mutations in hERG Cause a Decrease in Mutant mRNA Transcripts by Nonsense-Mediated mRNA Decay in Human Long-QT Syndrome	c.ahajournals.org	0	0		UPF1
618	chr7	4370861	4371853	3500281548	138		4370861	4371853	8421504	3	84,52,2	0,513,990	p	350028154800015003	156-294						LETTERS	www.sdix.com	0	0		
618	chr7	4370864	4371853	3500451370	135		4370864	4371853	8421504	3	81,52,2	0,510,987	p	350045137000015000	0-135			10.1073/pnas.0501902102		Proceedings of the National Academy of Sciences of the United States of America	Cooperative interaction of Angiopoietin-like proteins 1 and 2 in zebrafish vascular development	Yoshiaki	2005	0		COMP
618	chr7	4373145	4373310	3500018658	39		4373145	4373310	8421504	2	20,19	0,146	c,g	350001865800000000,350001865800000000,350001865800000001,350001865800000001	0-20,0-20,0-19,0-19		21604381	10.1002/term.358	1932-7005	Journal of Tissue Engineering and Regenerative Medicine	Differential response of cartilage oligomeric matrix protein (COMP) to morphogens of bone morphogenetic protein/transforming growth factor-&#x03b2; family in the surface, middle and deep zones of articular cartilage - Motaung - 2011 - Journal of Tissue En	Motaung	2011	0		
618	chr7	4375543	4375810	3500463365	43		4375543	4375810	8421504	2	22,21	0,246	c	350046336500000004,350046336500000005	0-19,0-24						 SpringerImages - Primer and probe sequences of desired genes 	pringerimages.com	0	0		
618	chr7	4375543	4375810	3500202018	43		4375543	4375810	8421504	2	22,21	0,246	c	350020201800000000,350020201800000002	0-19,0-24						Gene expression of single articular chondrocytes. - ResearchGate	.researchgate.net	0	0		
618	chr7	4376356	4376630	3500153648	40		4376356	4376630	8421504	3	20,10,10	0,133,264	c,g	350015364800000022,350015364800000022,350015364800000023	0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
618	chr7	4380480	4380506	3500368006	23		4380480	4380506	8421504	2	15,8	0,18	c	350036800600000006	5-41						The Open Biotechnology Journal, 2008, 2 121-132 121 Expansion of p75NTR/Oct4-Expressing Putative Stem Cells in HPV16- Transformed Precancerous Immortal Cell Lines under the Presence of and TNF	enthamscience.com	0	0		
619	chr7	4461048	4461074	3500151875	23		4461048	4461074	8421504	2	14,9	0,17	g	350015187500000007	7-30		15618148	10.1128/IAI.73.1.135-145.2005	0019-9567	Infection and Immunity	Molecular Aspects of Biogenesis of Escherichia coli Dr Fimbriae: Characterization of DraB-DraE Complexes	Piatek	2005	4		
619	chr7	4552699	4552722	3500003004	23		4552699	4552722	8421504	1	23	0	c	350000300400000054	9-32						Compositions and methods for the modification of gene expression - Patent # 7211711 - PatentGenius	.patentgenius.com	0	0		
619	chr7	4552725	4553776	3500366688	180		4552725	4553776	8421504	6	2,43,41,4,45,45	0,593,639,951,958,1006	p	350036668800015048,350036668800015047,350036668800015046,350036668800015045	0-45,0-45,0-45,0-45						Modified Bacteriophage Vectors and Uses Thereof - Patent application	www.faqs.org	0	0		RPS27A
619	chr7	4553341	4553394	3500347910	53		4553341	4553394	8421504	1	53	0	c,g	350034791000000033,350034791000000033,350034791000000023,350034791000000037	0-23,0-23,7-44,6-48						Plant ubiquitin promoter system	Quail	1996	0		UBA52
619	chr7	4553341	4553394	3500081282	53		4553341	4553394	8421504	1	53	0	c	350008128200000032,350008128200000022,350008128200000036	0-23,7-44,6-48					Patent	Plant ubiquitin promoter system (Patent US:5614399)	Christensen	1997	0		UBA52
619	chr7	4553341	4553394	3500044851	53		4553341	4553394	8421504	1	53	0	c	350004485100000033,350004485100000023,350004485100000037	0-23,7-44,6-48					Patent	Plant ubiquitin promoter system (Patent US:6020190)	Christensen	2000	0		UBA52
619	chr7	4553341	4553381	3500044261	40		4553341	4553381	8421504	1	40	0	c	350004426100000031,350004426100000021	0-23,7-44					Patent	Plant ubiquitin promoter system (Patent US:6054574)	Christensen	2000	0		
619	chr7	4553350	4553775	3500167572	129		4553350	4553775	8421504	4	20,15,38,56	0,40,326,369	c	350016757200000008	0-145						Trimerising module - US Patent 7642044 Description	ww.patentstorm.us	0	0		
619	chr7	4553364	4553731	3500319738	96		4553364	4553731	8421504	2	41,55	0,312	p	350031973800015108,350031973800015107	0-48,0-48						Expression Systems 	.freshpatents.com	0	0		RPS27A
619	chr7	4553401	4553769	3500340765	44		4553401	4553769	8421504	3	4,16,24	0,275,344	c	350034076500000020,350034076500000021	4-24,0-24		21140382	10.1002/etc.423	1552-8618	Environmental Toxicology and Chemistry	The effects of environmental low-dose irradiation on tolerance to chemotherapeutic agents - Howell - 2011 - Environmental Toxicology and Chemistry - Wiley Online Library	Howell	2011	0		
619	chr7	4566287	4566328	3500317567	30		4566287	4566328	8421504	2	22,8	0,33	g	350031756700000173	11-42						Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies	Cong	2013	0		
619	chr7	4566287	4566328	3500068926	30		4566287	4566328	8421504	2	22,8	0,33	g	350006892600000173	11-42						Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies	Cong	2013	0		
619	chr7	4586193	4586379	3500411740	66		4586193	4586379	8421504	2	54,12	0,174	p	350041174000015049	0-66						Dissertation	thek.uni-halle.de	0	0		FKBP8
621	chr7	4772047	4772075	3500034199	25		4772047	4772075	8421504	3	7,13,5	0,9,23	c	350003419900000352	17-42						MODULATION OF APOLIPOPROTEIN (a) EXPRESSION - Patent application	www.faqs.org	0	0		
621	chr7	4839570	4839598	3500352528	24		4839570	4839598	8421504	2	10,14	0,14	c	350035252800000133,350035252800000408	11-36,0-25						Compositions And Methods Comprising Variant Microbial Proteases - Patent application	www.faqs.org	0	0		
621	chr7	4839575	4839605	3500032868	23		4839575	4839605	8421504	3	11,6,6	0,13,24	c	350003286800000107	22-45						ASSAYS AND METHODS USING BIOMARKERS - Patent application	www.faqs.org	0	0		
622	chr7	4861170	4861625	3500037915	50		4861170	4861625	8421504	2	24,26	0,429	c	350003791500000023,350003791500000033	21-48,9-35						ONCOPROTEIN PROTEIN KINASE ANTIBODY KIT - Patent application	www.faqs.org	0	0		
622	chr7	4861644	4861728	3500148060	84		4861644	4861728	8421504	1	84	0	p	350014806000015015,350014806000015142	0-84,0-45						MULTIMERIC PROTEINS AND METHODS OF MAKING AND USING SAME - Patent application	www.faqs.org	0	0		MIR3188
622	chr7	4933382	4933407	3500096356	25		4933382	4933407	8421504	1	25	0	c	350009635600000006	0-25						Growth differentiation factor-11	Lee	1998	0		
622	chr7	4933382	4933407	3500038103	25		4933382	4933407	8421504	1	25	0	c	350003810300000006	0-25					Patent	Methods of detecting growth differentiation factor-11 (Patent US:5914234)	Lee	1999	0		
622	chr7	4962850	4962876	3500096830	26		4962850	4962876	8421504	1	26	0	c	350009683000000024	12-38						Human brain phosphodiesterase	Livi	1998	0		
622	chr7	4973125	4976908	3500292472	46		4973125	4976908	8421504	2	21,25	0,3758	c	350029247200000000,350029247200000001	16-37,14-39			10.1242/jcs.03406	0021-9533	Journal of Cell Science	Differential dynamics of Rab3A and Rab27A on secretory granules	Handley	2007	6		
622	chr7	4973344	4974572	3500133767	66		4973344	4974572	8421504	2	9,57	0,1171	p	350013376700015002	0-66		21262767	10.1128/MCB.00834-10	0270-7306	Molecular and Cellular Biology	Tctex-1, a Novel Interaction Partner of Rab3D, Is Required for Osteoclastic Bone Resorption	Pavlos	2011	6		RAB3C
622	chr7	4975725	4975748	3500336054	23		4975725	4975748	8421504	1	23	0	c	350033605400000008	0-23			10.1038/nm.2886		Nature medicine	Decreased Expression of Synapse-Related Genes and Loss of Synapses in Major Depressive Disorder	H.J.	2012	0		
622	chr7	4976909	4976932	3500267062	23		4976909	4976932	8421504	1	23	0	c	350026706200000009	7-30		12665574	10.1128/MCB.23.8.2720-2732.2003	0270-7306	Molecular and Cellular Biology	A Nucleoprotein Complex Containing Sp1, C/EBP&#x03b2;, and HMGI-Y Controls Human Insulin Receptor Gene Transcription	Foti	2003	6		
623	chr7	5015370	5015395	3500294819	23		5015370	5015395	8421504	2	5,18	0,7	c	350029481900000043	15-38						Doppel Delay	www.mad-cow.org	0	0		
623	chr7	5086260	5086291	3500135750	26		5086260	5086291	8421504	3	7,6,13	0,11,18	g	350013575000000013	18-44					Journal of Virology	Characterization of the CBF2 Binding Site within the Epstein-Barr Virus Latency C Promoter and Its Role in Modulating EBNA2-Mediated Transactivation	EzequiM.	1998	0		
624	chr7	5129140	5129520	3500278326	43		5129140	5129520	8421504	2	21,22	0,358	c,g	350027832600000005,350027832600000004,350027832600000004	0-21,0-22,0-22		22190728	10.1128/JVI.06143-11	0022-538X	Journal of Virology	Cellular Transcription Factors Induced in Trigeminal Ganglia during Dexamethasone-Induced Reactivation from Latency Stimulate Bovine Herpesvirus 1 Productive Infection and Certain Viral Promoters	Workman	2012	5		
625	chr7	5279605	5281159	3500460565	735		5279605	5281159	8421504	4	193,223,306,13	0,1009,1233,1541	p,c,g	350046056500015009,350046056500015001,350046056500015002,350046056500000009,350046056500000010,350046056500000010,350046056500000006,350046056500000006,350046056500015014,350046056500015004,350046056500000012,350046056500015005,350046056500015015,350046056500015006,350046056500015007,350046056500000015,350046056500000016,350046056500000017	0-108,0-45,0-45,0-45,0-46,0-46,0-20,0-20,0-138,0-45,0-43,0-45,0-129,0-45,0-45,0-43,0-45,0-319						Relaxin-Like Factor Gene Is Highly Expressed in the Bovine Ovary of the Cycle and Pregnancy: Sequence and Messenger Ribonucleic Acid Analysis'	ww.biolreprod.org	0	0		
625	chr7	5279605	5280820	3500063878	399		5279605	5280820	8421504	2	193,206	0,1009	p,c,g	350006387800015053,350006387800000113,350006387800000045,350006387800000045,350006387800015061,350006387800000107,350006387800000107,350006387800000047,350006387800000047,350006387800015054,350006387800000114,350006387800015062,350006387800000108,350006387800015065,350006387800000121,350006387800000121,350006387800000048,350006387800000048,350006387800015055,350006387800000115,350006387800015063,350006387800000109,350006387800015066,350006387800015056,350006387800000116,350006387800000110,350006387800000110,350006387800000049,350006387800000049,350006387800000117,350006387800015064,350006387800000050,350006387800000111,350006387800015067,350006387800015059,350006387800000118,350006387800000118,350006387800000051,350006387800000051,350006387800000112,350006387800000112,350006387800000044,350006387800000066,350006387800000056,350006387800000046	0-66,0-66,0-22,0-22,0-63,0-66,0-66,0-20,0-20,0-66,0-67,0-66,0-67,0-90,31-56,31-56,0-20,0-20,0-66,0-66,0-66,0-54,0-150,0-66,0-65,0-66,0-66,0-21,0-21,0-66,0-63,0-22,0-39,0-78,0-63,0-66,0-66,0-20,0-20,0-63,0-63,0-22,0-23,0-22,0-21						Die Relaxin-Familie im Reproduktionstrakt von Mammaliern	thek.uni-halle.de	0	0		
625	chr7	5318211	5320907	3500072968	26		5318211	5320907	8421504	2	2,24	0,2672	c	350007296800000450	15-41						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
626	chr7	5399077	5399107	3500047637	25		5399077	5399107	8421504	3	5,7,13	0,8,17	c	350004763700000727	10-35						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
626	chr7	5405147	5405172	3500070088	24		5405147	5405172	8421504	2	12,12	0,13	g	350007008800000012	9-34						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
627	chr7	5573873	5573902	3500390047	29		5573873	5573902	8421504	1	29	0	c	350039004700000090	12-41						Fatty acid transport proteins	Stahl	1999	0		
627	chr7	5580446	5581352	3500301078	40		5580446	5581352	8421504	4	10,11,3,16	0,732,799,890	c	350030107800000166,350030107800000165	0-21,0-19						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
627	chr7	5581977	5606372	3500464472	210		5581977	5606372	8421504	2	43,167	0,24228	p	350046447200015028	0-210						CARACTERIZACI&#xd3;N DE GENES CANDIDATOS PARA CARACTERES LIP&#xcd;DICOS E IDENTIFICACI&#xd3;N DE COPY NUMBER VARIATION EN UNA POBLACI&#xd3;N PORCINA DUROC	www.tdx.cat	0	0		
627	chr7	5581977	5606372	3500274639	210		5581977	5606372	8421504	2	43,167	0,24228	p	350027463900015027	0-210						CARACTERIZACIAN DE GENES CANDIDATOS PARA CARACTERES LIPADICOS E IDENTIFICACIAN DE COPY NUMBER VAR	www.tdx.cat	0	0		
628	chr7	5649030	5649055	3500295556	23		5649030	5649055	8421504	2	6,17	0,8	c	350029555600000049	10-33						Seed plants exhibiting early reproductive development and methods of making same	Weigel	1997	0		
628	chr7	5649030	5649055	3500121284	23		5649030	5649055	8421504	2	6,17	0,8	c	350012128400000049	10-33						Seed plants exhibiting inducible early reproductive development and methods of making same	Yanofsky	1999	0		
628	chr7	5649030	5649055	3500002499	23		5649030	5649055	8421504	2	6,17	0,8	c	350000249900000049	10-33						Maize and cauliflower apetalai gene products and nucleic acid molecules encoding same	Yanofsky	1996	0		
628	chr7	5730668	5730693	3500179832	23		5730668	5730693	8421504	3	4,5,14	0,5,11	g	350017983200000081	1-24						Hepatitis c virus epitopes	Kim	1991	0		
628	chr7	5741200	5741225	3500321941	25		5741200	5741225	8421504	1	25	0	c	350032194100000045	1-26						Proteins and nucleic acids encoding same - Patent # 6875570 - PatentGenius	.patentgenius.com	0	0		
628	chr7	5741200	5741225	3500127794	25		5741200	5741225	8421504	1	25	0	c	350012779400000045	1-26						 Proteins And Nucleic Acids Encoding Same 	www.docstoc.com	0	0		
628	chr7	5756465	5756495	3500128500	30		5756465	5756495	8421504	1	30	0	c	350012850000000001	0-30			10.1128/MCB.22.21.7701-7711.2002		Molecular and Cellular Biology	A Human Mitochondrial GTP Binding Protein Related to tRNA Modification May Modulate Phenotypic Expression of the Deafness-Associated Mitochondrial 12S rRNA Mutation	Xiaoming	2002	0		
629	chr7	5810708	5810741	3500396915	33		5810708	5810741	8421504	1	33	0	c	350039691500000004	0-33						NOGO-A BINDING MOLECULES AND PHARMACEUTICAL USE THEREOF - Patent application	www.faqs.org	0	0		
629	chr7	5815559	5815583	3500196049	23		5815559	5815583	8421504	2	5,18	0,6	c	350019604900000000	16-40		21402876	10.1242/jcs.068965	0021-9533	Journal of Cell Science	Trp53 regulates Notch 4 signaling through Mdm2	Sun	2011	6		
629	chr7	5854722	5856680	3500417781	60		5854722	5856680	8421504	2	49,11	0,1947	p	350041778100015012	0-60						Determina&#xe7;&#xe3;o de alvos antig&#xea;nicos na doen&#xe7;a reum&#xe1;tica card&#xed;aca utilizando phage display	www.teses.usp.br	0	0		MYO9B
630	chr7	5940337	5940371	3500332194	28		5940337	5940371	8421504	3	5,12,11	0,7,23	c	350033219400000013	5-33						High level expression of human cyclooxygenase-2	Mancini	1995	0		
630	chr7	5980567	5985490	3500019912	23		5980567	5985490	8421504	3	4,7,12	0,4899,4911	c	350001991200000007	11-34						Fluorescent protein vectors for promoter analysis in lactic acid bacteria and Escherichia coli. - ResearchGate	.researchgate.net	0	0		
630	chr7	6027084	6027118	3500211391	26		6027084	6027118	8421504	3	6,14,6	0,10,28	g	350021139100000060	5-33						Cellular Rhogtpase Activation Assay 	.freshpatents.com	0	0		
635	chr7	6605092	6605119	3500133622	24		6605092	6605119	8421504	2	8,16	0,11	g	350013362200000185	18-42					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404832)	Natt	2013	0		
635	chr7	6657475	6657499	3500302387	24		6657475	6657499	8421504	1	24	0	c	350030238700000005	0-24		11408522		1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Administration of a Potent Antagonist of Protease-Activated Receptor-1 (PAR-1) Attenuates Vascular Restenosis Following Balloon Angioplasty in Rats	Andrade-Gordon	2001	0		
635	chr7	6658013	6658048	3500461247	35		6658013	6658048	8421504	1	35	0	c	350046124700000019	0-35					Patent	Protese-activated receptor PAR4 (ZCHEMR2) (Patent US:6111075)	Foster	2000	0		
635	chr7	6658231	6658285	3500338440	54		6658231	6658285	8421504	1	54	0	p	350033844000015006	0-54						&#x30e2;&#x30c1;&#x30fc;&#x30d5;&#xff1a;&#x914d;&#x5217;&#x306e;&#x7279;&#x5fb4;&#x8868;&#x73fe;	i.s.u-tokyo.ac.jp	0	0		F2RL3
636	chr7	6794353	6794379	3500109143	24		6794353	6794379	8421504	2	18,6	0,20	g	350010914300000085	0-24						Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1	Coppieters	2002	0		
638	chr7	6968753	6968787	3500190571	34		6968753	6968787	8421504	1	34	0	c	350019057100000007	9-43						Compositions and methods for the prevention and treatment of Huntington's disease	Kmiec	2002	0		DACH1
638	chr7	7045654	7045685	3500337980	26		7045654	7045685	8421504	2	6,20	0,11	g	350033798000000010	3-29						GENERATION AND CHARACTERIZATION OF ANTI-NOTCH ANTIBODIES FOR THERAPEUTIC AND DIAGNOSTIC USE - Patent application	www.faqs.org	0	0		
639	chr7	7177451	7177474	3500213543	23		7177451	7177474	8421504	1	23	0	g	350021354300000026	0-23						VACCINE AGAINST BURKHOLDERIA INFECTIONS - Patent application	www.faqs.org	0	0		
639	chr7	7187138	7187176	3500055011	38		7187138	7187176	8421504	1	38	0	g	350005501100000000	3-41						Tumor Necrosis Factor Alpha-Mediated Reduction of KLF2 Is Due to Inhibition of MEF2 by NF- B and Histone Deacetylases	mcb.asm.org	0	0		
640	chr7	7326661	7326684	3500076979	23		7326661	7326684	8421504	1	23	0	c	350007697900000001	10-33		10593899	10.1074/jbc.274.51.36153	0021-9258	Journal of Biological Chemistry	The Leucine-based Sorting Motifs in the Cytoplasmic Domain of the Invariant Chain Are Recognized by the Clathrin Adaptors AP1 and AP2 and their Medium Chains	Hofmann	1999	5		
640	chr7	7332188	7337707	3500164379	198		7332188	7337707	8421504	3	66,54,78	0,316,5441	p	350016437900015095	180-378						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		FAM32A
641	chr7	7387642	7387669	3500083196	24		7387642	7387669	8421504	2	13,11	0,16	c	350008319600000000	0-24			10.1073/pnas.0610012104		Proceedings of the National Academy of Sciences of the United States of America	Functionally important glycosyltransferase gain and loss during catarrhine primate emergence	Chihiro	2007	0		RAB8A
641	chr7	7391766	7394070	3500296582	66		7391766	7394070	8421504	2	58,8	0,2296	p	350029658200015001	0-66		21262767	10.1128/MCB.00834-10		Molecular and Cellular Biology	Tctex-1, a Novel Interaction Partner of Rab3D, Is Required for Osteoclastic Bone Resorption 	Nathan	2011	0		RAB8B
641	chr7	7399518	7399567	3500305565	49		7399518	7399567	8421504	1	49	0	c	350030556500000017	0-49						Methods For Determining The Response Of Cells To Vegf And Uses Thereof 	.freshpatents.com	0	0		
641	chr7	7404910	7428647	3500409227	852		7404910	7428647	8421504	9	80,70,63,76,71,118,134,126,114	0,4446,4602,6881,7935,8568,12396,17047,23623	p	350040922700015012	0-852						Patent for Diagnosis of Early Diagnosis of Systemic Tissue Fibrosis	www.scribd.com	0	0		
641	chr7	7404910	7428647	3500141136	852		7404910	7428647	8421504	9	80,70,63,76,71,118,134,126,114	0,4446,4602,6881,7935,8568,12396,17047,23623	p	350014113600015010	0-852						BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS	DGaldo	2011	0		
641	chr7	7409356	7412870	3500381001	234		7409356	7412870	8421504	4	70,63,76,25	0,156,2435,3489	c	350038100100000017	103-337						Identification, assessment, and therapy of cancers with innate or acquired resistance to alk inhibitors	Mano	2012	0		
641	chr7	7409356	7412870	3500320761	234		7409356	7412870	8421504	4	70,63,76,25	0,156,2435,3489	c	350032076100000017	103-337						Identification, Assessment, and Therapy of Cancers with Innate or Acquired Resistance to ALK Inhibitors	Mano	2011	0		
641	chr7	7413524	7417384	3500222279	41		7413524	7417384	8421504	2	22,19	0,3841	c	350022227900000029,350022227900000028	0-22,0-19						NCoR promotes esophageal cancer cell invasion by transcriptional repression of interferon-&#x03b3;-inducible protein 10 in a CK2-dependent manner	w.molbiolcell.org	0	0		TPM4
645	chr7	7993896	7993923	3500354494	23		7993896	7993923	8421504	3	5,5,13	0,8,14	g	350035449400000273	11-34						Modified cytosine deaminases - Patent application	www.faqs.org	0	0		
646	chr7	8029645	8029668	3500086931	23		8029645	8029668	8421504	1	23	0	g	350008693100000082,350008693100000304	13-48,4-39						Hepatitis c assay utilizing recombinant antigens to ns1	Dailey	1993	0		
648	chr7	8341435	8341462	3500013095	23		8341435	8341462	8421504	3	4,6,13	0,5,14	g	350001309500000294	0-24						Sequenciamento do Genoma Completo e Express&#xe3;o Heter&#xf3;loga da Capa Prot&#xe9;ica do Marafivirus Associado &#xe0; Morte S&#xfa;bita dos Citros	www.bdtd.ucb.br	0	0		
650	chr7	8603559	8603583	3500181907	23		8603559	8603583	8421504	2	18,5	0,19	g	350018190700000002	0-23		9675008	10.1095/biolreprod59.1.169	0006-3363	Biology of Reproduction	Adenylyl Cyclase Messenger Ribonucleic Acid in Myometrium: Splice Variant of Type IV	Emala	1998	4		
651	chr7	8774114	8774142	3500096256	23		8774114	8774142	8421504	2	6,17	0,11	g	350009625600000211	4-27						Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium	Zhao Cang Yang Zi 	2001	0		
652	chr7	8821370	8821395	3500370567	24		8821370	8821395	8421504	2	6,18	0,7	c	350037056700000031	7-31						Methods for making 3-indole-pyruvic acid from tryptophan using a tryptophan deaminase - Patent # 8518665 - PatentGenius	.patentgenius.com	0	0		
652	chr7	8821370	8821395	3500331383	24		8821370	8821395	8421504	2	6,18	0,7	c	350033138300000002,350033138300000028	7-31,7-31						PROCESS FOR PRODUCING GLUTAMATE DERIVATIVES - Patent application	www.faqs.org	0	0		
652	chr7	8821370	8821395	3500307346	24		8821370	8821395	8421504	2	6,18	0,7	c	350030734600000002	7-31						Process for producing glutamic acid derivatives	Sugiyama	2011	0		
652	chr7	8821370	8821395	3500279987	24		8821370	8821395	8421504	2	6,18	0,7	c	350027998700000028,350027998700000002	3-27,7-31						Process of producing glutamate derivatives - Patent # 7297800 - PatentGenius	.patentgenius.com	0	0		
652	chr7	8821370	8821395	3500248359	24		8821370	8821395	8421504	2	6,18	0,7	c	350024835900000002	7-31					Patent	Process for producing glutamic acid derivatives (Patent EP:1445323)	Sugiyama	2011	0		
654	chr7	9077219	9079151	3500036492	24		9077219	9079151	8421504	2	12,12	0,1920	c	350003649200000065	20-44						UNIVERSIDAD DE SALAMANCA	gredos.usal.es	0	0		
657	chr7	9538166	9542095	3500318889	495		9538166	9542095	8421504	8	169,152,40,35,36,12,27,24	0,1164,1319,3677,3718,3775,3875,3905	p	350031888900015006	0-513						Gene amplification and overexpression in cancer	Yang	2004	0		
657	chr7	9553129	9553189	3500278260	60		9553129	9553189	8421504	1	60	0	p	350027826000015014	3-63						THE JOURNAL OF Vol. No. 15, 0 Inc. Printed U.S.A. Cloning and Expression of cDNA for the Human Prostaglandin E Receptor EPI Subtype*	www.jbc.org	0	0		
657	chr7	9554915	9554940	3500163087	25		9554915	9554940	8421504	1	25	0	c	350016308700000039	0-25						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		
658	chr7	9584209	9584232	3500109143	23		9584209	9584232	8421504	1	23	0	c	350010914300000099	11-34						Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1	Coppieters	2002	0		
658	chr7	9585002	9585222	3500294910	40		9585002	9585222	8421504	2	20,20	0,200	c,g	350029491000000003,350029491000000002,350029491000000002	0-20,0-20,0-20						UNIVERSIDADE JOS&#xc9; DO ROS&#xc1;RIO VELLANO &#x2013; UNIFENAS TOCHIMARA APARECIDA MIYAUCHI	tede.unifenas.br	0	0		
658	chr7	9585828	9586026	3500057212	198		9585828	9586026	8421504	1	198	0	p	350005721200015008	0-198						DnaJ-related protein essential for placentation	ev.biologists.org	0	0		DNAJB1
658	chr7	9586236	9587612	3500386061	40		9586236	9587612	8421504	2	20,20	0,1356	c	350038606100000005,350038606100000004	0-20,0-20						Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells	-publications.com	0	0		DNAJB1
658	chr7	9586265	9586291	3500123129	26		9586265	9586291	8421504	1	26	0	g	350012312900000009	0-26					Patent	Heat shock protein-based vaccines and immunotherapies (Patent US:6663868)	Rothman	2003	0		DNAJB1
658	chr7	9587496	9587706	3500176042	210		9587496	9587706	8421504	1	210	0	p	350017604200015004	0-210						Heat shock response and virus replication	Moseley	2005	0		DNAJB1
658	chr7	9587511	9587556	3500328191	45		9587511	9587556	8421504	1	45	0	p	350032819100015006	0-45						 Expression System For Enhancing Solubility And Immunogeneicity Of Recombinant Proteins 	www.docstoc.com	0	0		DNAJB1
659	chr7	9804329	9804359	3500227613	23		9804329	9804359	8421504	3	8,4,11	0,13,19	c	350022761300000133	12-36						IMMUNODOMINANT MYCOBACTERIUM TUBERCULOSIS PEPTIDES FROM CELL WALL PROTEINS FOR EARLY DIAGNOSIS AND IMMUNIZATION - Patent application	www.faqs.org	0	0		
660	chr7	9846726	9863233	3500384329	1053		9846726	9863233	8421504	10	46,62,129,99,83,127,96,123,165,123	0,7976,8486,10875,11975,13076,13295,13491,15651,16384	p	350038432900015001	0-1053						KEGG T01001: 5566	www.genome.jp	0	0		
660	chr7	9846726	9854704	3500334751	48		9846726	9854704	8421504	2	46,2	0,7976	p	350033475100015008	0-48						Catalytic subunits of Aplysia neuronal cAMP-dependent protein kinase with two different N termini. - ResearchGate	.researchgate.net	0	0		PRKACA
660	chr7	9855227	9857667	3500185699	180		9855227	9857667	8421504	2	114,66	0,2374	p	350018569900015034,350018569900015024	0-72,0-180						Introduction to Bioinformatics	www.koshika.co.in	0	0		PRKACA
660	chr7	9855227	9855299	3500288106	72		9855227	9855299	8421504	1	72	0	p	350028810600015033	0-72						Duke : SCIENCE 111 : complete notes on Bioinformatics	ww.coursehero.com	0	0		PRKACA
660	chr7	9855227	9855299	3500204284	72		9855227	9855299	8421504	1	72	0	p	350020428400015032	0-72						17727 Complete Notes on tics	www.scribd.com	0	0		
660	chr7	9857661	9858743	3500300287	81		9857661	9858743	8421504	2	39,42	0,1040	p	350030028700015000	0-81						Engineered Protein Kinases Which Can Utilize Modified Nucleotide Triphosphate Substrates - Patent application	www.faqs.org	0	0		PRKACA
660	chr7	9857661	9858743	3500244206	81		9857661	9858743	8421504	2	39,42	0,1040	p	350024420600015011,350024420600015001	0-48,0-81						High affinity protein kinase inhibitors - US Patent 6383790 Description	ww.patentstorm.us	0	0		PRKACA
660	chr7	9857661	9858743	3500222363	81		9857661	9858743	8421504	2	39,42	0,1040	p	350022236300015000,350022236300015007	0-81,0-48						US Patent # 6,521,417. Engineered protein kinases which can utilize modified nucleotide triphosphate substrates - Patents.com	www.patents.com	0	0		PRKACA
660	chr7	9857661	9858743	3500109878	81		9857661	9858743	8421504	2	39,42	0,1040	p	350010987800015012,350010987800015002	0-48,0-81						US Patent # 6,383,790. High affinity protein kinase inhibitors - Patents.com	www.patents.com	0	0		
660	chr7	9857661	9858743	3500063398	81		9857661	9858743	8421504	2	39,42	0,1040	p	350006339800015000	0-81						US Patent # 7,049,116. Engineered protein kinases which can utilize modified nucleotide triphosphate substrates - Patents.com	www.patents.com	0	0		PRKACA
660	chr7	9857661	9858743	3500008336	81		9857661	9858743	8421504	2	39,42	0,1040	p	350000833600015000,350000833600015006	0-81,0-45						Engineered protein kinases which can utilize modified nucleotide triphosphate substrates	Shokat	2000	0		PRKACA
660	chr7	9857679	9858725	3500335713	45		9857679	9858725	8421504	2	21,24	0,1022	p	350033571300015002	0-45					Patent	High affinity protein kinase inhibitors (Patent US:6383790)	Shokat	2002	0		PRKACA
660	chr7	9862515	9862540	3500116395	25		9862515	9862540	8421504	1	25	0	c,g	350011639500000002,350011639500000002	0-25,0-25		19911008	10.1038/cdd.2009.174	1350-9047	Cell Death & Differentiation	Pim-1 controls NF-&#x03ba;B signalling by stabilizing RelA&sol;p65	Nihira	2009	9		PRKACA
661	chr7	9984095	9984121	3500435329	25		9984095	9984121	8421504	2	14,11	0,15	c	350043532900000000,350043532900000001	3-28,10-35		11106655	10.1074/jbc.M008283200	0021-9258	Journal of Biological Chemistry	Mechanisms Underlying Preferential Assembly of Heparan Sulfate on Glypican-1	Chen	2001	5		
661	chr7	10063267	10063291	3500166534	24		10063267	10063291	8421504	1	24	0	g	350016653400001515	0-24						METHODS FOR QUANTITATING SMALL RNA MOLECULES	Raymond	2007	0		MIR181A1,MIR181C
82	chr7	10063451	10106095	3500114594	65		10063451	10106095	8421504	3	22,21,22	0,42288,42622	c,g	350011459400000426,350011459400000853,350011459400000390,350011459400000391,350011459400000817,350011459400000818,350011459400000392,350011459400000819	0-22,0-22,0-21,0-21,0-21,0-21,0-22,0-22						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		
662	chr7	10104937	10105760	3500191409	42		10104937	10105760	8421504	2	20,22	0,801	c,g	350019140900000013,350019140900000002	0-20,8-30		23559009	10.1038/cddis.2013.97	false	Cell Death & Disease	Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression	Wang	2013	0		
662	chr7	10105695	10106096	3500070906	80		10105695	10106096	8421504	3	21,30,29	0,41,372	c	350007090600000036,350007090600000037,350007090600000003	0-21,0-30,1-30		15372072	10.1038/sj.emboj.7600385	ERROR! NO ISSN	The EMBO Journal	MicroRNA genes are transcribed by RNA polymerase II	Lee	2004	0		
662	chr7	10105695	10105768	3500040785	73		10105695	10105768	8421504	1	73	0	c	350004078500000089,350004078500000051,350004078500000050	0-73,0-21,0-21						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		ZSWIM4
662	chr7	10105739	10106095	3500290833	64		10105739	10106095	8421504	3	21,21,22	0,183,334	c,g	350029083300000011,350029083300000011,350029083300000012,350029083300000012,350029083300000008,350029083300000006	0-21,0-21,0-21,0-21,0-22,5-27		18353861	10.1093/nar/gkn032		Nucleic Acids Research	Transforming growth factor-&#x03b2;-regulated miR-24 promotes skeletal muscle differentiation	Qiang	2008	0		
662	chr7	10105739	10106095	3500031979	43		10105739	10106095	8421504	2	21,22	0,334	c	350003197900000305,350003197900000306,350003197900000307	0-21,0-21,0-22						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		
662	chr7	10105873	10105948	3500433622	52		10105873	10105948	8421504	2	26,26	0,49	c,g	350043362200000040,350043362200000041	0-26,2-28		23200856	10.1016/j.celrep.2012.10.023	2211-1247	Cell Reports	Cell Reports - Specific miRNA Stabilization by Gld2-Catalyzed Monoadenylation	D'Ambrogio	2012	0		
662	chr7	10105920	10105945	3500445393	25		10105920	10105945	8421504	1	25	0	c	350044539300000004,350044539300000002	0-25,0-21		22184411	10.1182/blood-2011-08-373886	0006-4971	Blood	MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A	Urbich	2012	10		ZSWIM4
662	chr7	10105922	10106095	3500379266	43		10105922	10106095	8421504	2	21,22	0,151	c	350037926600000009,350037926600000007	1-22,0-22						ScienceDirect.com - Molecular Cell - Human Argonaute2 Mediates RNA Cleavage Targeted by miRNAs and siRNAs	sciencedirect.com	0	0		
662	chr7	10105922	10106095	3500307429	43		10105922	10106095	8421504	2	21,22	0,151	c	350030742900000008,350030742900000007	0-21,0-22						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - YEDA RESEARCH AND DEVELOPMENT CO. LTD.	www.sumobrain.com	0	0		
662	chr7	10106067	10106096	3500394538	29		10106067	10106096	8421504	1	29	0	c	350039453800000009	1-30		18199619	10.2967/jnumed.107.042507	0161-5505	Journal of Nuclear Medicine	Development of a Dual-Luciferase Reporter System for In Vivo Visualization of MicroRNA Biogenesis and Posttranscriptional Regulation	Lee	2008	6		
662	chr7	10106073	10106097	3500453153	24		10106073	10106097	8421504	1	24	0	c,g	350045315300000014,350045315300000015,350045315300000015,350045315300000017,350045315300000017	22-46,24-46,24-46,0-22,0-22						MicroRNAs regulate human hepatocyte nuclear factor 4 modulating the expression of metabolic enzymes and cell cycle	www.jbc.org	0	0		
662	chr7	10106073	10106096	3500407196	23		10106073	10106096	8421504	1	23	0	c	350040719600000010,350040719600000011,350040719600000013	23-46,24-46,0-22						MicroRNAs regulate human hepatocyte nuclear factor 4&#x03b1;, modulating the expression of metabolic enzymes and cell cycle - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
662	chr7	10149578	10150946	3500081372	60		10149578	10150946	8421504	2	11,49	0,1319	p	350008137200015107	0-60						Plants having enhanced yield-related traits and a method for making the same	Sanz	2010	0		MRI1
662	chr7	10154002	10154028	3500464289	26		10154002	10154028	8421504	1	26	0	c	350046428900000323	1-27						High bone mass gene of 11q13.3	Carulli	2000	0		
665	chr7	10526648	10526672	3500219870	23		10526648	10526672	8421504	2	4,19	0,5	g	350021987000000014	9-34						Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins	Renard	2012	0		
665	chr7	10551029	10566550	3500189289	76		10551029	10566550	8421504	3	27,21,28	0,3100,15493	c	350018928900000002,350018928900000003,350018928900000009	9-36,12-33,8-36						ScienceDirect.com - Neuron - The I-II Loop of the Ca2+ Channel &#x03b1;1 Subunit Contains an Endoplasmic Reticulum Retention Signal Antagonized by the &#x03b2; Subunit	sciencedirect.com	0	0		CACNA1A
665	chr7	10592109	10592135	3500367838	23		10592109	10592135	8421504	3	5,5,13	0,7,13	c	350036783800000161	9-32						 <HTML> <HEAD><TITLE>Show BLAST File</TITLE></HEAD> <BODY BGCOLOR=ffffff><BR> <br> <A NAME=top> <P	rth.lab.nig.ac.jp	0	0		
665	chr7	10616493	10616522	3500267473	29		10616493	10616522	8421504	1	29	0	c	350026747300000003	1-30		10908603		0270-6474	The Journal of Neuroscience	Reduced Voltage Sensitivity of Activation of P/Q-Type Ca2+ Channels is Associated with the Ataxic Mouse MutationRolling Nagoya (tg rol )	Mori	2000	7		CACNA1B
666	chr7	10635057	10635256	3500392700	24		10635057	10635256	8421504	3	12,4,8	0,13,191	c	350039270000000004	8-39						Trans-membrane-antibody induced inhibition of apoptosis	Brown	2004	0		
666	chr7	10641466	10657981	3500418658	80		10641466	10657981	8421504	2	75,5	0,16510	c	350041865800000021	0-80						Human polynucleotides, polypeptides, and antibodies	Coleman	2003	0		
666	chr7	10745848	10746006	3500053180	155		10745848	10746006	8421504	4	12,126,10,7	0,13,140,151	g	350005318000000032,350005318000000031	64-126,10-106						Selection method involving acetal coenzyme a synthetase in calves	Cook	1997	0		
666	chr7	10745908	10745998	3500106592	87		10745908	10745998	8421504	3	10,67,10	0,12,80	g	350010659200000030,350010659200000031	1-58,72-125						Method and kit for detecting bovine acetyl coenzyme a synthetase nucleic acids	Cook	1996	0		
667	chr7	10801408	10801432	3500278114	23		10801408	10801432	8421504	2	9,14	0,10	g	350027811400000054	11-44					Patent	Hog cholera virus vaccine and diagnostic (Patent US:5811103)	Meyers	1998	0		
667	chr7	10873860	10873884	3500042099	23		10873860	10873884	8421504	2	16,7	0,17	c	350004209900000076	0-24						CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY - Patent application	www.faqs.org	0	0		
668	chr7	10879560	10879774	3500394704	40		10879560	10879774	8421504	2	20,20	0,194	c,g	350039470400000025,350039470400000025,350039470400000024	0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
668	chr7	10879560	10879774	3500292483	40		10879560	10879774	8421504	2	20,20	0,194	c	350029248300000025,350029248300000024	0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		
668	chr7	10884933	10888103	3500125410	45		10884933	10888103	8421504	2	21,24	0,3146	c	350012541000000001,350012541000000000	11-32,19-43						The arginylation-dependent association of calreticulin with stress granules is regulated by calcium. - ResearchGate	.researchgate.net	0	0		
668	chr7	10885271	10886716	3500263420	96		10885271	10886716	8421504	3	42,6,48	0,659,1397	c	350026342000000028,350026342000000017	0-48,0-48						Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen - Patent application	www.faqs.org	0	0		
668	chr7	10885271	10885936	3500293064	48		10885271	10885936	8421504	2	42,6	0,659	c	350029306400000102	0-48						Methods and Compositions for Modulating Apoptosis - Patent application	www.faqs.org	0	0		
668	chr7	10887553	10888101	3500327989	180		10887553	10888101	8421504	2	89,91	0,457	p	350032798900015026	0-180						Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin	Hung	2006	0		
668	chr7	10887553	10888101	3500235372	180		10887553	10888101	8421504	2	89,91	0,457	p	350023537200015040	0-180						Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin	Wu	2007	0		
668	chr7	10939062	10941121	3500368431	45		10939062	10941121	8421504	2	40,5	0,2054	p	350036843100015051	0-45						METHODS AND COMPOSITIONS RELATING TO PROMOTER REGULATION BY MUC1 AND KLF PROTEINS - Patent application	www.faqs.org	0	0		KLF13
668	chr7	10998164	10998215	3500038361	51		10998164	10998215	8421504	1	51	0	p	350003836100015103	0-51						Proteomic analysis of differentially expressed proteins in colorectal cancer	.lib.nsysu.edu.tw	0	0		PRDX2
668	chr7	10998227	10998481	3500388350	45		10998227	10998481	8421504	2	25,20	0,234	c,g	350038835000000066,350038835000000067,350038835000000067	0-25,0-20,0-20						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
668	chr7	10998227	10998481	3500027904	45		10998227	10998481	8421504	2	25,20	0,234	c,g	350002790400000041,350002790400000042,350002790400000042	0-25,0-20,0-20						 SpringerImages - primers sequences 	pringerimages.com	0	0		
668	chr7	10999388	10999433	3500448274	45		10999388	10999433	8421504	1	45	0	p	350044827400015000	0-45						#sen2geneID pmid senID geneID hgncID approvedSymbol matchString actualString startPos score flanking	ogy.med.umich.edu	0	0		PRDX2
668	chr7	10999411	10999436	3500129535	25		10999411	10999436	8421504	1	25	0	c	350012953500000025	0-25		19016754	10.1111/j.1349-7006.2008.00912.x	1349-7006	Cancer Science	Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1 - Shiota - 2008 - Cancer Science - Wiley Online Library	Shiota	2008	0		
668	chr7	11002541	11002564	3500187243	23		11002541	11002564	8421504	1	23	0	c	350018724300000000	18-41						Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells	teca.cinvestav.mx	0	0		
668	chr7	11002599	11002628	3500435248	25		11002599	11002628	8421504	3	8,11,6	0,10,23	c	350043524800000057	3-28						Identification Of Oligonucleotides For The Capture, Detection And Quantitation Of West Nile Virus 	.freshpatents.com	0	0		
668	chr7	11002599	11002628	3500398238	25		11002599	11002628	8421504	3	8,11,6	0,10,23	c	350039823800000007	3-28						Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus - US Patent 7132233 Description	ww.patentstorm.us	0	0		
668	chr7	11002809	11002833	3500190510	24		11002809	11002833	8421504	1	24	0	c	350019051000000003	7-31						Wild-type p53/junB fusion gene eukaryotic expression vector - Clinical Medicine papers - Medicine papers - Research Papers Center	eng.hi138.com	0	0		
668	chr7	11002813	11003854	3500361881	51		11002813	11003854	8421504	2	24,27	0,1014	c,g	350036188100000003,350036188100000003,350036188100000002	0-24,0-24,0-27		17204476	10.1074/jbc.M608456200	0021-9258	Journal of Biological Chemistry	JunB and JunD Regulate Human Heme Oxygenase-1 Gene Expression in Renal Epithelial Cells	Hock	2007	5		JUNB
668	chr7	11002936	11003092	3500252570	156		11002936	11003092	8421504	1	156	0	p	350025257000015001	0-156						JunB differs from c-Jun in its DNA- binding and dlmenzatlon domains, and represses c-Jun by formation of inactive heterodimers	enesdev.cshlp.org	0	0		JUNB
668	chr7	11002980	11003010	3500372015	30		11002980	11003010	8421504	1	30	0	c	350037201500000531	0-30						Method for selective oligonucleotide modification	Mitsch	2011	0		
669	chr7	11024842	11025033	3500328497	23		11024842	11025033	8421504	3	5,2,16	0,172,175	c	350032849700000007	12-35						Rekombinante blutgerinnungsproteasen	Kopetzki	1997	0		
669	chr7	11024842	11025033	3500118617	23		11024842	11025033	8421504	3	5,2,16	0,172,175	c	350011861700000014	12-35						Recombinant blood-coagulation proteases	Hopfner	1999	0		
669	chr7	11024842	11025033	3500039895	23		11024842	11025033	8421504	3	5,2,16	0,172,175	c	350003989500000007	12-35						Rekombinante blutgerinnungsproteasen	Hopfner	1999	0		
669	chr7	11025679	11025709	3500264622	24		11025679	11025709	8421504	4	5,4,13,2	0,7,14,28	c	350026462200000076	1-26						ANWENDUNG VON ANTIK&#xd6;RPERDOM&#xc4;NEN ZUR	b.uni-muenchen.de	0	0		
669	chr7	11063179	11063233	3500391126	54		11063179	11063233	8421504	1	54	0	p	350039112600015000	0-54					The Journal of Cell Biology	Transportin-mediated Nuclear Import of Heterogeneous Nuclear RNP Proteins 	Mikiko	1997	0		TNPO2
669	chr7	11063204	11063229	3500367838	25		11063204	11063229	8421504	1	25	0	c	350036783800000209	0-25						 <HTML> <HEAD><TITLE>Show BLAST File</TITLE></HEAD> <BODY BGCOLOR=ffffff><BR> <br> <A NAME=top> <P	rth.lab.nig.ac.jp	0	0		
669	chr7	11082698	11086167	3500074348	1107		11082698	11086167	8421504	9	207,165,122,97,87,106,104,126,93	0,782,1138,1347,1523,2039,2225,3166,3376	p	350007434800015000	0-1107						BMDB: Showing 1,3-Diaminopropane (BMDB00002)	www.cowmetdb.ca	0	0		
669	chr7	11083956	11085963	3500040315	117		11083956	11085963	8421504	3	2,52,63	0,89,1944	p	350004031500015193,350004031500015094,350004031500015033,350004031500015021,350004031500015057,350004031500015083	0-45,0-45,0-48,0-48,0-48,0-48					Patent	&#x7f16;&#x7801;&#x690d;&#x7269;&#x8131;&#x6c27;&#x6d77;&#x666e;&#x8d56;&#x6c28;&#x9178;&#x5408;&#x6210;&#x9176;&#x7684;dna&#xff0c;&#x690d;&#x7269;&#x771f;&#x6838;&#x8d77;&#x59cb;&#x56e0;&#x5b50;5a&#xff0c;&#x8f6c;&#x57fa;&#x56e0;&#x690d;&#x7269;&#x548c;&#	D*L*Lu 	2010	0		
669	chr7	11090709	11103461	3500447618	285		11090709	11103461	8421504	5	29,106,24,62,64	0,12017,12496,12532,12688	p	350044761800015092,350044761800015093,350044761800015094,350044761800015095	0-81,0-78,0-60,0-66					Patent	Antibodies to HASAV70 polypeptide (Patent US:7169565)	Ruben	2007	0		WDR83OS
669	chr7	11090709	11103461	3500439093	285		11090709	11103461	8421504	5	29,106,24,62,64	0,12017,12496,12532,12688	p	350043909300015091,350043909300015092,350043909300015093,350043909300015094	0-81,0-78,0-60,0-66						Secreted protein HFEAF41	Brewer	2003	0		WDR83OS
669	chr7	11090709	11103461	3500080223	285		11090709	11103461	8421504	5	29,106,24,62,64	0,12017,12496,12532,12688	p	350008022300015092,350008022300015093,350008022300015094,350008022300015095	0-81,0-78,0-60,0-66						87 Human Secreted Proteins	Young	2007	0		WDR83OS
669	chr7	11090709	11103461	3500064227	285		11090709	11103461	8421504	5	29,106,24,62,64	0,12017,12496,12532,12688	p	350006422700015090,350006422700015091,350006422700015092,350006422700015093	0-81,0-78,0-60,0-66						Secreted protein HFEAF41	Brewer	2003	0		WDR83OS
669	chr7	11090709	11103461	3500032881	270		11090709	11103461	8421504	6	29,52,39,24,62,64	0,12017,12084,12496,12532,12688	p	350003288100015091,350003288100015092,350003288100015093,350003288100015094	0-81,3-66,0-60,0-66						87 human secreted proteins	Brewer	2003	0		WDR83OS
669	chr7	11090709	11103461	3500029713	276		11090709	11103461	8421504	6	29,52,45,24,62,64	0,12017,12078,12496,12532,12688	p	350002971300015092,350002971300015093,350002971300015094,350002971300015095	0-81,0-69,0-60,0-66						87 human secreted proteins	Young	2005	0		WDR83OS
669	chr7	11090709	11103446	3500048645	204		11090709	11103446	8421504	5	29,106,18,2,49	0,12017,12496,12592,12688	p	350004864500015091,350004864500015092,350004864500015093	0-81,0-72,0-51						Secreted protein HFEAF41	Brewer	2002	0		WDR83OS
669	chr7	11104673	11120011	3500074494	9493		11104673	11120011	8421504	34	510,245,320,838,30,50,40,110,60,698,157,23,603,100,60,862,782,349,590,88,579,221,220,67,222,431,6,23,321,250,170,220,20,228	0,525,780,1110,1958,1998,2250,2300,2420,2529,3247,3411,3550,6742,6852,6922,7786,8765,9124,9724,10318,10943,12381,12611,12679,12911,13343,13350,13603,14323,14583,14773,15023,15110	p,c,g	350007449400000121,350007449400000057,350007449400000057,350007449400015053,350007449400015002,350007449400000058,350007449400015054,350007449400015003,350007449400000016,350007449400000012,350007449400015055,350007449400000060,350007449400015004,350007449400015056,350007449400000122,350007449400000123,350007449400000017,350007449400015005,350007449400015057,350007449400000018,350007449400000062,350007449400000124,350007449400000063,350007449400000019,350007449400000064,350007449400000004,350007449400000004,350007449400000066,350007449400000067,350007449400000022,350007449400015009,350007449400015060,350007449400000069,350007449400000070,350007449400000125,350007449400000126,350007449400000141,350007449400000142,350007449400000143,350007449400000145,350007449400000071,350007449400015062,350007449400015016,350007449400000024,350007449400015063,350007449400000074,350007449400015017,350007449400000146,350007449400015064,350007449400000003,350007449400000003,350007449400000015,350007449400000026,350007449400000075,350007449400015018,350007449400015065,350007449400000076,350007449400000147,350007449400000150,350007449400000005,350007449400000196,350007449400000000,350007449400015066,350007449400000077,350007449400000027,350007449400000027,350007449400000078,350007449400000029,350007449400000029,350007449400000153,350007449400000154,350007449400000155,350007449400000079,350007449400000030,350007449400000030,350007449400015022,350007449400015069,350007449400000081,350007449400015023,350007449400015070,350007449400000082,350007449400015024,350007449400015072,350007449400000084,350007449400015026,350007449400000033,350007449400000032,350007449400000086,350007449400000156,350007449400000087,350007449400015029,350007449400015076,350007449400000088,350007449400000034,350007449400000034,350007449400000035,350007449400000035,350007449400000089,350007449400000090,350007449400015031,350007449400015078,350007449400000158,350007449400000159,350007449400000036,350007449400000093,350007449400000037,350007449400000037,350007449400000094,350007449400000160,350007449400000166,350007449400015033,350007449400000096,350007449400000038,350007449400000039,350007449400000039,350007449400000098,350007449400000099,350007449400000040,350007449400000167,350007449400000175,350007449400000041,350007449400000101,350007449400000176,350007449400015086,350007449400000042,350007449400000177,350007449400000043,350007449400000043,350007449400000044,350007449400000106,350007449400000107,350007449400015041,350007449400015090,350007449400000181,350007449400000108,350007449400015042,350007449400015091,350007449400000045,350007449400000045,350007449400015043,350007449400015092,350007449400000046,350007449400000111,350007449400000112,350007449400000187,350007449400015047,350007449400015094,350007449400015048,350007449400000114,350007449400015049,350007449400015096,350007449400000115,350007449400000047,350007449400000188,350007449400000048,350007449400000048,350007449400000049,350007449400000049,350007449400015099,350007449400000189,350007449400000050,350007449400000191,350007449400000195,350007449400000195,350007449400000119,350007449400000119,350007449400000120,350007449400000120,350007449400000052,350007449400000052	0-510,0-50,0-50,0-48,0-48,0-48,0-48,0-48,0-19,0-19,0-48,0-48,0-48,0-48,5-250,0-320,0-20,0-48,0-48,0-19,0-48,0-1010,0-48,0-22,0-48,0-24,0-24,0-48,0-48,0-21,0-48,0-48,0-48,0-48,0-30,0-50,0-40,0-110,0-60,0-390,0-48,0-48,0-48,0-20,0-48,0-48,0-48,0-300,0-48,0-22,0-22,0-22,0-22,0-48,0-48,0-45,0-48,0-180,0-610,2-23,4-296,4-23,0-48,0-48,0-20,0-20,0-48,0-23,0-23,0-100,0-60,0-863,0-48,0-22,0-22,0-48,0-48,0-48,0-48,0-48,0-48,0-45,0-48,0-48,0-48,0-22,0-21,0-48,0-782,0-48,0-48,0-48,0-48,0-21,0-21,0-21,0-21,0-48,0-48,0-48,0-48,0-350,0-590,0-23,0-48,0-20,0-20,0-48,0-90,0-580,0-45,0-48,0-24,0-19,0-19,0-48,0-48,0-19,0-220,0-220,0-19,0-48,0-289,0-48,0-22,0-460,0-20,0-20,0-20,0-48,0-48,0-48,0-48,0-320,0-48,0-48,0-48,0-23,0-23,0-48,0-45,0-21,0-48,0-48,0-250,0-45,0-48,0-48,0-48,0-45,0-48,0-48,0-21,0-170,0-22,0-22,0-21,0-21,0-48,0-220,0-24,0-20,0-225,0-225,0-53,0-53,0-101,0-101,0-26,0-26						A GENETIC TEST FOR &#x03b1;-MANNOSIDOSIS	Berg	1997	0		
669	chr7	11104687	11119890	3500182550	2913		11104687	11119890	8421504	26	162,103,174,194,133,146,117,86,121,79,110,33,63,117,147,98,118,119,102,88,9,60,228,156,66,84	0,835,1115,1673,2515,2868,3804,7013,7182,7382,7635,8018,8063,8418,9348,10568,10751,12443,12642,12916,13179,13200,13682,14350,14597,15119	p	350018255000015002,350018255000015012,350018255000015022,350018255000015032,350018255000015043,350018255000015053,350018255000015063,350018255000015073,350018255000015083,350018255000015084,350018255000015099,350018255000015109,350018255000015119,350018255000015129,350018255000015139,350018255000015149,350018255000015159,350018255000015169,350018255000015190	0-165,0-180,0-180,0-180,0-177,0-180,0-171,0-171,0-54,0-78,0-132,0-144,0-168,0-177,0-162,0-171,0-159,0-180,0-84						Functional characterization of alpha- mannosidosis associated sequence variants	munin.uit.no	0	0		
669	chr7	11104774	11119993	3500203273	622		11104774	11119993	8421504	30	19,20,19,22,24,21,20,22,20,23,22,23,21,21,23,20,24,19,19,4,18,20,20,23,21,21,22,21,24,26	0,710,791,1079,1171,1659,2559,2850,3775,3806,6942,7574,7987,8016,9287,9328,10552,10707,12310,12616,12621,12880,12976,13671,13744,14415,14552,14581,14722,15193	c,g	350020327300000012,350020327300000012,350020327300000016,350020327300000016,350020327300000017,350020327300000018,350020327300000019,350020327300000004,350020327300000004,350020327300000022,350020327300000024,350020327300000003,350020327300000026,350020327300000015,350020327300000027,350020327300000027,350020327300000029,350020327300000030,350020327300000030,350020327300000033,350020327300000033,350020327300000032,350020327300000032,350020327300000034,350020327300000034,350020327300000035,350020327300000035,350020327300000036,350020327300000037,350020327300000037,350020327300000038,350020327300000038,350020327300000039,350020327300000039,350020327300000041,350020327300000042,350020327300000043,350020327300000043,350020327300000044,350020327300000045,350020327300000045,350020327300000046,350020327300000046,350020327300000047,350020327300000048,350020327300000048,350020327300000049,350020327300000049,350020327300000050,350020327300000052	0-19,0-19,0-19,0-19,0-20,0-19,0-22,0-24,0-24,0-21,0-20,0-22,0-22,0-22,0-20,0-20,0-23,0-22,0-22,0-22,0-22,0-21,0-21,0-21,0-21,0-21,0-21,0-23,0-20,0-20,0-24,0-24,0-19,0-19,0-19,0-22,0-20,0-20,0-20,0-23,0-23,0-21,0-21,0-21,0-22,0-22,0-21,0-21,0-24,0-26						Genetic test for .alpha.-mannosidosis - Patent # 6197507 - PatentGenius	.patentgenius.com	0	0		
669	chr7	11104774	11119993	3500189324	603		11104774	11119993	8421504	29	19,19,22,24,21,20,22,20,23,22,23,21,21,23,20,24,19,19,4,18,20,20,23,21,21,22,21,24,27	0,791,1079,1171,1659,2559,2850,3775,3806,6942,7574,7987,8016,9287,9328,10552,10707,12310,12616,12621,12880,12976,13671,13744,14415,14552,14581,14722,15192	c,g	350018932400000016,350018932400000012,350018932400000018,350018932400000019,350018932400000004,350018932400000022,350018932400000024,350018932400000015,350018932400000026,350018932400000003,350018932400000027,350018932400000027,350018932400000029,350018932400000030,350018932400000033,350018932400000032,350018932400000034,350018932400000034,350018932400000035,350018932400000035,350018932400000036,350018932400000037,350018932400000038,350018932400000039,350018932400000039,350018932400000041,350018932400000042,350018932400000043,350018932400000043,350018932400000044,350018932400000045,350018932400000045,350018932400000046,350018932400000047,350018932400000048,350018932400000048,350018932400000049,350018932400000050,350018932400000052	0-19,0-19,0-19,0-22,0-24,0-21,0-20,0-22,0-22,0-22,0-20,0-20,0-23,0-22,0-22,0-21,0-21,0-21,0-21,0-21,0-23,0-20,0-24,0-19,0-19,0-19,0-22,0-20,0-20,0-20,0-23,0-23,0-21,0-21,0-22,0-22,0-21,0-24,0-27						Genetic test for &#x03b1;-mannosidosis	Berg	1999	0		
669	chr7	11119260	11119289	3500093374	24		11119260	11119289	8421504	2	12,12	0,17	g	350009337400000001	0-24						ScienceDirect.com - Biochemical and Biophysical Research Communications - IQGAP1 interacts with Aurora-A and enhances its stability and its role in cancer	sciencedirect.com	0	0		
670	chr7	11195602	11195626	3500201405	23		11195602	11195626	8421504	2	14,9	0,15	g	350020140500000141	0-23						Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists - Patent # 7498409 - PatentGenius	.patentgenius.com	0	0		
674	chr7	11725094	11725125	3500114392	26		11725094	11725125	8421504	3	14,4,8	0,18,23	g	350011439200000003	1-27		15131061	10.1158/1078-0432.CCR-03-0287	1078-0432	Clinical Cancer Research	Antisense RNA Down-Regulation of bcl-2 Expression in DU145 Prostate Cancer Cells Does Not Diminish the Cytostatic Effects of G3139 (Oblimersen)	Raffo	2004	8		
675	chr7	11810442	11810471	3500251514	29		11810442	11810471	8421504	1	29	0	g	350025151400000227	31-60						Odorant receptor polypeptides and nucleic acids encoding same	Li	2002	0		
681	chr7	12643654	12643738	3500220702	84		12643654	12643738	8421504	1	84	0	p	350022070200015023,350022070200015046	0-69,0-84						Regulatory zinc finger proteins	Jin-Soo	2004	0		ZNF177
681	chr7	12643654	12643723	3500385351	69		12643654	12643723	8421504	1	69	0	p	350038535100015071,350038535100015192	21-90,0-69						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZNF177
681	chr7	12643654	12643723	3500269504	69		12643654	12643723	8421504	1	69	0	p	350026950400015068	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZNF177
681	chr7	12643654	12643723	3500229015	69		12643654	12643723	8421504	1	69	0	p	350022901500015018	0-69						Figure S1 AB	genome.cshlp.org	0	0		ZNF177
681	chr7	12643654	12643723	3500176901	69		12643654	12643723	8421504	1	69	0	p	350017690100015051	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZNF177
681	chr7	12643654	12643723	3500160097	69		12643654	12643723	8421504	1	69	0	p	350016009700015064	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZNF177
681	chr7	12643654	12643723	3500105130	69		12643654	12643723	8421504	1	69	0	p	350010513000015012	0-69						Supplemental Figure 1	genome.cshlp.org	0	0		ZNF177
681	chr7	12643654	12643723	3500075471	69		12643654	12643723	8421504	1	69	0	p	350007547100015096,350007547100015036	0-69,21-90						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZNF177
683	chr7	12870201	12870231	3500220670	30		12870201	12870231	8421504	1	30	0	c	350022067000000006	0-30						A Novel Gene Involved in the Regulation of Energy Balance: Research Design and Methods	www.medscape.com	0	0		UBL5
683	chr7	12877984	12889674	3500226249	195		12877984	12889674	8421504	5	58,2,67,29,39	0,2302,10680,11613,11651	p,c	350022624900015014,350022624900015026,350022624900015010,350022624900015044,350022624900000011,350022624900000012	0-48,0-48,0-48,0-48,0-48,9-48						Nima Interacting Proteins 	.freshpatents.com	0	0		
683	chr7	12878011	12880303	3500203162	48		12878011	12880303	8421504	2	31,17	0,2275	c	350020316200000004	0-48						US Patent # 5,952,467. NIMA interacting proteins - Patents.com	www.patents.com	0	0		
683	chr7	12878014	12880303	3500441152	45		12878014	12880303	8421504	2	28,17	0,2272	c	350044115200000004	0-45						US Patent # 7,148,003. NIMA interacting proteins - Patents.com	www.patents.com	0	0		
683	chr7	12888643	12889614	3500128488	47		12888643	12889614	8421504	3	25,5,17	0,83,954	c	350012848800000003,350012848800000004	0-25,0-22		23750710	10.1111/jcmm.12082	1582-4934	Journal of Cellular and Molecular Medicine	Essential role of Pin1 via STAT3 signalling and mitochondria-dependent pathways in restenosis in type 2 diabetes - Lv - 2013 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Lv	2013	0		
684	chr7	12978284	12978313	3500096115	23		12978284	12978313	8421504	3	12,7,4	0,17,25	g	350009611500000014	0-23					Patent	Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products (Patent US:6592876)	Briles	2003	0		
684	chr7	12980309	12980339	3500195767	30		12980309	12980339	8421504	1	30	0	c	350019576700000016,350019576700000020,350019576700000019	10-40,16-46,13-43						Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules - Patent application	www.faqs.org	0	0		
684	chr7	12980309	12980339	3500086219	30		12980309	12980339	8421504	1	30	0	c	350008621900000002,350008621900000069	10-40,14-44						Methods and vectors for display of molecules and displayed molecules and collections - Patent application	www.faqs.org	0	0		
684	chr7	12980310	12980333	3500080464	23		12980310	12980333	8421504	1	23	0	c	350008046400000030	4-27						Delta, a Drosophila neurogenic gene, is transcriptionally complex and encodes a protein related to blood coagulauon factors and epidermal growth factor of vertebrates	enesdev.cshlp.org	0	0		
685	chr7	13123386	13152864	3500047637	39		13123386	13152864	8421504	2	20,19	0,29459	c	350004763700000814,350004763700000554	23-43,10-29						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
685	chr7	13144178	13186823	3500447940	4833		13144178	13186823	8421504	40	29,91,117,164,196,178,167,142,283,129,85,193,222,174,134,205,116,148,98,184,188,152,93,119,110,81,46,35,82,35,88,35,82,35,76,76,220,108,37,80	0,426,1286,1530,2006,2892,3453,4955,5413,5856,6179,7555,8613,10524,11646,11859,12470,13580,14075,15408,15699,16161,16778,17204,20290,20475,20651,21141,23163,23733,25462,26498,28004,28477,31409,32760,33904,34318,35077,42565	p	350044794000015019	0-4833						MULTIPLE DOMAIN PROTEINS	Chalasani	2009	0		
685	chr7	13147139	13147162	3500218393	23		13147139	13147162	8421504	1	23	0	c,g	350021839300000009,350021839300000009	0-23,0-23						Nuclear Transfer Protocol Affects Messenger RNA Expression Patterns in Cloned Bovine Blastocysts	ww.biolreprod.org	0	0		
685	chr7	13147139	13147162	3500162809	23		13147139	13147162	8421504	1	23	0	c,g	350016280900000005,350016280900000005	0-23,0-23						Epigenetic differences between male and female bovine blastocysts produced in vitro	cs.physiology.org	0	0		
685	chr7	13149773	13186885	3500364984	46		13149773	13186885	8421504	2	26,20	0,37092	c,g	350036498400000017,350036498400000031,350036498400000032	0-26,0-20,0-20						&#x7814;&#x7a76;&#x751f;&#xff1a;&#x8521;&#x4f91;&#x5ead;	u.lib.ncku.edu.tw	0	0		DNMT1
685	chr7	13149773	13149799	3500173373	26		13149773	13149799	8421504	1	26	0	c	350017337300000003	0-26		20460473	10.1158/1078-0432.CCR-09-3338	1078-0432	Clinical Cancer Research	DNMT3L Is a Novel Marker and Is Essential for the Growth of Human Embryonal Carcinoma	Minami	2010	8		
685	chr7	13150037	13150064	3500445316	25		13150037	13150064	8421504	2	14,11	0,16	c	350044531600000043,350044531600000017	11-36,11-36						 A COMPOSITION COMPRISING A NOTCH LIGAND AND AN ALLERGENB OR ALLERGEN BYSTANDER ANTIGEN - Patent application	www.faqs.org	0	0		
685	chr7	13150037	13150064	3500342877	25		13150037	13150064	8421504	2	14,11	0,16	c	350034287700000016	11-36						Conjugate of notch signalling pathway modulators and their use in medical treatment	William	2004	0		
685	chr7	13150037	13150064	3500138829	25		13150037	13150064	8421504	2	14,11	0,16	c	350013882900000022	11-36						Composotion comprising inhibitors of the notch signalling pathway for the modulation of the immune system	Bodmer	2003	0		
685	chr7	13150037	13150064	3500120630	25		13150037	13150064	8421504	2	14,11	0,16	c	350012063000000043,350012063000000017	11-36,11-36						Treatment Of Allergic Diseases Using A Modulator Of The Notch Signaling Pathway 	.freshpatents.com	0	0		
685	chr7	13150037	13150064	3500089545	25		13150037	13150064	8421504	2	14,11	0,16	c	350008954500000016	11-36						Conjugate of notch signalling pathway modulators and their use in medical treatment	BODMER	2005	0		
685	chr7	13150037	13150064	3500003653	25		13150037	13150064	8421504	2	14,11	0,16	c	350000365300000018	11-36						Treatment of allergic diseases using a modulator of the Notch signaling pathway	Bodmer	2005	0		
685	chr7	13206829	13206874	3500324624	45		13206829	13206874	8421504	1	45	0	p	350032462400015010	0-45						Canis sphingosine 1-phosphate receptor isoform 2 - Patent application	www.faqs.org	0	0		S1PR2
685	chr7	13206983	13207007	3500225067	24		13206983	13207007	8421504	1	24	0	c	350022506700000002	1-25					Patent	Isolated human EDG-4 receptor and polynucletide encoding said receptor (Patent US:6482609)	Munroe	2002	0		
685	chr7	13206983	13207007	3500143918	24		13206983	13207007	8421504	1	24	0	c	350014391800000002	1-25						Identification of lysolipid receptors involved in inflammatory response	Gupta	2000	0		
685	chr7	13237089	13237114	3500219356	23		13237089	13237114	8421504	2	17,6	0,19	c	350021935600000078	10-33						US Patent # 6,512,103. Mammalian chemokine reagents - Patents.com	www.patents.com	0	0		
685	chr7	13237089	13237114	3500205829	23		13237089	13237114	8421504	2	17,6	0,19	c	350020582900000077	7-30						US Patent # 7,132,508. Mammalian chemokine reagents - Patents.com	www.patents.com	0	0		
685	chr7	13237089	13237114	3500164721	23		13237089	13237114	8421504	2	17,6	0,19	c	350016472100000079	10-33						Mammalian chemokine ccf8 and chemokine receptor cckr3	Dairaghi	1997	0		
686	chr7	13253982	13277507	3500325952	45		13253982	13277507	8421504	3	22,12,11	0,18465,23514	c,g	350032595200000003,350032595200000002	0-22,0-23						 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0//EN"> <HTML> <HEAD> <meta http-equiv="Content-Type" 	pthefaith1296.com	0	0		
686	chr7	13254197	13278186	3500428817	40		13254197	13278186	8421504	3	20,6,14	0,23602,23975	c,g	350042881700000000,350042881700000001	0-20,0-20						Curr. Issues Mol. Biol. 12: 129-134. Online journal at http://www.cimb.org SPUD qPCR Assay Confirms PREXCEL-Q Software&#x2019;s Ability to Avoid qPCR Inhibition	uantification.net	0	0		
686	chr7	13254197	13278186	3500354860	63		13254197	13278186	8421504	4	20,23,6,14	0,23576,23602,23975	c,g	350035486000000012,350035486000000014,350035486000000013	0-20,0-23,0-20						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system &#x2018;FocusField2-6GallupqPCRSet-upTool-001&#x2019; to attain consistently high fidelity qPCR reactions	uantification.com	0	0		
686	chr7	13254197	13278186	3500295231	63		13254197	13278186	8421504	4	20,23,6,14	0,23576,23602,23975	c,g	350029523100000012,350029523100000014,350029523100000013	0-20,0-23,0-20						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system &#x2018;FocusField2-6GallupqPCRSet-upTool-001&#x2019; to attain consistently high fidelity qPCR reactions	quantification.de	0	0		
686	chr7	13254197	13278186	3500132952	40		13254197	13278186	8421504	3	20,6,14	0,23602,23975	c,g	350013295200000000,350013295200000001	0-20,0-20						Curr. Issues Mol. Biol. 12: 129-134. Online journal at http://www.cimb.org SPUD qPCR Assay Confirms PREXCEL-Q Software&#x2019;s Ability to Avoid qPCR Inhibition	quantification.de	0	0		
686	chr7	13254197	13278186	3500099621	63		13254197	13278186	8421504	4	20,23,6,14	0,23576,23602,23975	c,g	350009962100000012,350009962100000014,350009962100000013	0-20,0-23,0-20						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet-upTool-001' to attain consistently high fidelity qPCR reactions.	.biomedsearch.com	0	0		
686	chr7	13272447	13277558	3500366041	45		13272447	13277558	8421504	3	12,11,22	0,5049,5089	c	350036604100000002,350036604100000003	0-23,0-22		18245814	10.2353/ajpath.2008.070312		The American Journal of Pathology	Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells	Yoichi	2008	0		
686	chr7	13277333	13277356	3500224291	23		13277333	13277356	8421504	1	23	0	g	350022429100000017	10-33						Biosynthesis of lignans in plant species of the section Linum: pinoresinol-lariciresinol reductase and justicidin B 7-hydroxylase	ni-duesseldorf.de	0	0		
686	chr7	13277712	13277738	3500047620	26		13277712	13277738	8421504	1	26	0	c	350004762000000005	0-26						Monocyte recruitment to endothelial cells in response to oscillatory shear stress	www.fasebj.org	0	0		
686	chr7	13278206	13278232	3500199033	26		13278206	13278232	8421504	1	26	0	c	350019903300000005	0-26		12704177	10.1128/IAI.71.5.2950-2955.2003	0019-9567	Infection and Immunity	Coordinated Expression of Tracheal Antimicrobial Peptide and Inflammatory-Response Elements in the Lungs of Neonatal Calves with Acute Bacterial Pneumonia	Caverly	2003	4		
686	chr7	13278567	13278967	3500298978	48		13278567	13278967	8421504	2	24,24	0,376	c	350029897800000002,350029897800000003	0-24,0-24						&#x4e3b;&#x9898;&#xff1a;Modification | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
686	chr7	13278940	13278967	3500133900	27		13278940	13278967	8421504	1	27	0	c	350013390000000035	1-28						Intercellular adhesion molecules and their binding ligands - Patent application	www.faqs.org	0	0		
686	chr7	13279296	13279319	3500237167	23		13279296	13279319	8421504	1	23	0	c	350023716700000001	21-44						Increased neutrophil adherence and adhesion molecule mRNA expression in endothelial cells during selenium de&#xfb01;ciency	www.jleukbio.org	0	0		
686	chr7	13280432	13280456	3500399193	24		13280432	13280456	8421504	1	24	0	c	350039919300000007	0-24		22235260	10.1371/journal.pone.0029054		PLoS ONE	Rapid Accumulation of Polymorphonuclear Neutrophils in the Corpus luteum during Prostaglandin F2&#x03b1;-Induced Luteolysis in the Cow	Koumei	2012	0		
686	chr7	13280432	13280456	3500005411	24		13280432	13280456	8421504	1	24	0	c	350000541100000007	0-24						Rapid accumulation of polymorphonuclear neutrophils in the Corpus luteum during prostaglandin F(2&#x03b1;)-induced luteolysis in the cow. - ResearchGate	.researchgate.net	0	0		
686	chr7	13285510	13290139	3500187384	68		13285510	13290139	8421504	2	20,48	0,4581	c	350018738400000073,350018738400000055	0-20,69-117						ICAM-4 materials and methods	www.devileye.net	0	0		
686	chr7	13355474	13355513	3500004083	39		13355474	13355513	8421504	1	39	0	c	350000408300000424	0-39						Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins	Hancock	2001	0		
687	chr7	13441203	13441229	3500057752	23		13441203	13441229	8421504	2	15,8	0,18	c	350005775200000001	0-23						ERCC1 Codon118PolymorphismIsaPredictiveFactorforthe Tumor Response to Oxaliplatin/5-Fluorouracil Combination ChemotherapyinPatientswithAdvancedColorectalCancer	.aacrjournals.org	0	0		
687	chr7	13444791	13451494	3500271050	135		13444791	13451494	8421504	6	6,33,31,33,15,17	0,2028,3008,3400,4553,6686	c	350027105000000459,350027105000000196,350027105000000470,350027105000000373,350027105000000409	9-48,1-48,0-48,0-35,0-32						Cloning by complementation and related processes	Colicelli	1991	0		
687	chr7	13449352	13449380	3500060937	23		13449352	13449380	8421504	2	7,16	0,12	g	350006093700000001	0-23		11804963	10.1095/biolreprod66.2.458	0006-3363	Biology of Reproduction	Mammalian Lipocalin-Type Prostaglandin D2 Synthase in the Fluids of the Male Genital Tract: Putative Biochemical and Physiological Functions	Fouchecourt	2002	4		
687	chr7	13475858	13476350	3500122255	108		13475858	13476350	8421504	2	54,54	0,438	p	350012225500015003,350012225500015004	0-54,0-54		21143560	10.1111/j.1365-2443.2010.01466.x	1365-2443	Genes to Cells	Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish - Tsujita - 2010 - Genes to Cells - Wiley Online Library	Tsujita	2011	0		
687	chr7	13478566	13478594	3500457081	27		13478566	13478594	8421504	2	13,14	0,14	c	350045708100000221	0-27						 Methods of treating inflammatory skin diseases Patent (Patent # 6,833,349 issued December 21, 2004) - Justia Patents Database 	atents.justia.com	0	0		
687	chr7	13478566	13478594	3500333519	27		13478566	13478594	8421504	2	13,14	0,14	c	350033351900000221	0-27						Methods of treating inflammatory skin diseases	Xia	2001	0		
688	chr7	13535747	13535807	3500391427	60		13535747	13535807	8421504	1	60	0	p	350039142700015005	0-60						Assays - Patent application	www.faqs.org	0	0		KRI1
688	chr7	13535762	13535807	3500208501	45		13535762	13535807	8421504	1	45	0	p	350020850100015007	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		KRI1
688	chr7	13535762	13535807	3500189065	45		13535762	13535807	8421504	1	45	0	p	350018906500015009	0-45						Assays	Schofield	2005	0		KRI1
688	chr7	13539323	13544571	3500138944	46		13539323	13544571	8421504	2	21,25	0,5223	c,g	350013894400000003,350013894400000003,350013894400000000	7-28,7-28,15-40					The Journal of Cell Biology	Distribution and Function of Ap-1 Clathrin Adaptor Complexes in Polarized Epithelial Cells	Heike	2001	0		AP1M2
688	chr7	13584218	13589937	3500359288	99		13584218	13589937	8421504	3	3,48,48	0,90,5671	p	350035928800015196,350035928800015152,350035928800015177	0-48,0-48,0-48						US Patent # 6,943,235. Transmembrane protein expressed in prostate cancer - Patents.com	www.patents.com	0	0		
688	chr7	13587791	13587909	3500452053	33		13587791	13587909	8421504	2	23,10	0,108	c	350045205300000082	12-45						US Patent # 7,227,008. 13-transmembrane protein expressed in prostate cancer - Patents.com	www.patents.com	0	0		
688	chr7	13592804	13592831	3500159378	25		13592804	13592831	8421504	2	13,12	0,15	c	350015937800000109	10-37						 Method Of Detection Of Herpes B Virus 	www.docstoc.com	0	0		
688	chr7	13613052	13613076	3500101001	23		13613052	13613076	8421504	2	16,7	0,17	g	350010100100000158,350010100100000146,350010100100000074	6-29,6-29,6-29						MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS - Patent application	www.faqs.org	0	0		
688	chr7	13622106	13625734	3500162809	45		13622106	13625734	8421504	2	23,22	0,3606	c,g	350016280900000012,350016280900000012,350016280900000013	0-23,0-23,0-22						Epigenetic differences between male and female bovine blastocysts produced in vitro	cs.physiology.org	0	0		
689	chr7	13663466	13711282	3500252730	135		13663466	13711282	8421504	4	45,14,31,45	0,48,30864,47771	p	350025273000015007,350025273000015009,350025273000015029	0-45,0-45,0-45						METHOD OF DETECTING CANINE EXERCISE-INDUCED COLLAPSE - Patent application	www.faqs.org	0	0		MIR638,DNM2
689	chr7	13694398	13706480	3500042046	27		13694398	13706480	8421504	2	6,21	0,12061	c	350004204600000111,350004204600000033,350004204600000110,350004204600000032	0-21,0-21,0-21,0-21						METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS INVOLVING HIGHER MOLECULAR WEIGHT HYALURONAN - Patent application	www.faqs.org	0	0		DNM2
689	chr7	13711259	13748752	3500356491	39		13711259	13748752	8421504	2	19,20	0,37473	c,g	350035649100000000,350035649100000000,350035649100000003,350035649100000003	0-19,0-19,0-20,0-20		17682044	10.1128/IAI.00534-07	0019-9567	Infection and Immunity	Mannheimia haemolytica Leukotoxin Binds to Lipid Rafts in Bovine Lymphoblastoid Cells and Is Internalized in a Dynamin-2- and Clathrin-Dependent Manner	Atapattu	2007	4		
689	chr7	13711259	13748752	3500170226	39		13711259	13748752	8421504	2	19,20	0,37473	c,g	350017022600000000,350017022600000000,350017022600000003,350017022600000003	0-19,0-19,0-20,0-20			10.1128/IAI.00534-07		Infection and Immunity	Mannheimia haemolytica Leukotoxin Binds to Lipid Rafts in Bovine Lymphoblastoid Cells and Is Internalized in a Dynamin-2- and Clathrin-Dependent Manner 	Dhammika	2007	0		
689	chr7	13737315	13737386	3500392693	71		13737315	13737386	8421504	1	71	0	c	350039269300000000,350039269300000001	6-77,12-83		22498306	10.1111/j.1742-4658.2012.08589.x	1742-4658	FEBS Journal	MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells - Cheng - 2012 - FEBS Journal - Wiley Online Library	Cheng	2012	0		MIR199A1
689	chr7	13737315	13737386	3500339770	45		13737315	13737386	8421504	2	23,22	0,49	g	350033977000000017,350033977000000016	0-23,0-22		23598416	10.1038/cddis.2013.134		Cell Death & Disease	microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress	B-H	2013	0		MIR199A1
689	chr7	13737315	13737386	3500185291	71		13737315	13737386	8421504	1	71	0	c	350018529100000055	0-71						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR199A1
689	chr7	13737319	13737381	3500131061	45		13737319	13737381	8421504	2	22,23	0,39	g	350013106100000012,350013106100000060	0-22,0-23						MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES - Patent application	www.faqs.org	0	0		MIR199A1
689	chr7	13737358	13737381	3500415206	23		13737358	13737381	8421504	1	23	0	c	350041520600000002	0-23		17875710	10.1158/0008-5472.CAN-07-1936	0008-5472	Cancer Research	MicroRNA Signatures in Human Ovarian Cancer	Iorio	2007	8		DNM3OS
689	chr7	13737358	13737381	3500327675	23		13737358	13737381	8421504	1	23	0	c	350032767500000004	0-23		18408758	10.1038/onc.2008.112	0950-9232	Oncogene	Regulation of IKK&#x03b2; by miR-199a affects NF-&#x03ba;B activity in ovarian cancer cells	Chen	2008	6		MIR199A1
689	chr7	13737358	13737381	3500287752	23		13737358	13737381	8421504	1	23	0	c	350028775200000034	0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		MIR199A1
689	chr7	13737358	13737381	3500267182	23		13737358	13737381	8421504	1	23	0	c	350026718200000004	0-23		18408758	10.1038/onc.2008.112		Oncogene	Regulation of IKK&#x03b2; by miR-199a affects NF-&#x03ba;B activity in ovarian cancer cells	R	2008	0		DNM3OS
689	chr7	13737358	13737381	3500208755	23		13737358	13737381	8421504	1	23	0	c	350020875500000011	0-23		21959934	10.1038/cdd.2011.126	1350-9047	Cell Death & Differentiation	Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA	Eto	2011	9		MIR199A1
689	chr7	13737358	13737381	3500180264	23		13737358	13737381	8421504	1	23	0	c	350018026400000002	0-23		17875710	10.1158/0008-5472.CAN-07-1936	0008-5472	Cancer Research	MicroRNA Signatures in Human Ovarian Cancer	Iorio	2007	8		MIR199A1,DNM3OS
689	chr7	13737358	13737381	3500169217	23		13737358	13737381	8421504	1	23	0	g	350016921700000011	0-23		21959934	10.1038/cdd.2011.126	1350-9047	Cell Death & Differentiation	Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA	Eto	2011	9		MIR199A1
689	chr7	13737358	13737381	3500119147	23		13737358	13737381	8421504	1	23	0	c,g	350011914700000015,350011914700000015	0-23,0-23						(COX -2) regulation in colon cancer cells	rato.cib.unibo.it	0	0		DNM3OS
689	chr7	13737358	13737381	3500031979	23		13737358	13737381	8421504	1	23	0	c	350003197900000350	0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		DNM3OS
689	chr7	13737358	13737381	3500008666	23		13737358	13737381	8421504	1	23	0	c,g	350000866600000004,350000866600000004	0-23,0-23		18408758	10.1038/onc.2008.112	0950-9232	Oncogene	Regulation of IKK&#x03b2; by miR-199a affects NF-&#x03ba;B activity in ovarian cancer cells	Chen	2008	6		DNM3OS
689	chr7	13748810	13749927	3500446448	72		13748810	13749927	8421504	2	8,64	0,1053	p	350044644800015001	0-72		11018064	10.1083/jcb.151.1.187	0021-9525	The Journal of Cell Biology	Regulated Interactions between Dynamin and the Actin-Binding Protein Cortactin Modulate Cell Shape	McNiven	2000	10		DNM2
690	chr7	13817192	13817220	3500415287	23		13817192	13817220	8421504	2	8,15	0,13	c	350041528700000004	0-27						Bacterial expression of porcine growth hormone	Aviv	1992	0		
690	chr7	13882558	13882583	3500356815	23		13882558	13882583	8421504	2	7,16	0,9	g	350035681500000017	7-34						High affinity human antibodies to tumor antigens	Marks	1996	0		
691	chr7	13906451	13906570	3500006718	27		13906451	13906570	8421504	2	24,3	0,116	c	350000671800000238	12-39						CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME - Patent application	www.faqs.org	0	0		
691	chr7	14017329	14017353	3500361940	24		14017329	14017353	8421504	1	24	0	c,g	350036194000000002,350036194000000002	1-25,1-25						&#x4e3b;&#x9898;&#xff1a;atherogenesis | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		LDLR
691	chr7	14017329	14017352	3500022437	23		14017329	14017352	8421504	1	23	0	c	350002243700000024	1-24						ONLINE MATERIALS AND METHODS	b.ahajournals.org	0	0		LDLR
691	chr7	14017699	14023347	3500321356	40		14017699	14023347	8421504	3	16,4,20	0,1872,5628	c	350032135600000000,350032135600000001	0-20,0-20		10875237	10.1210/en.141.7.2377	0013-7227	Endocrinology	Calcium Ions Positively Modulate Follicle-Stimulating Hormone- and Exogenous Cyclic 3&#x2032;,5&#x2032;-Adenosine Monophosphate-Driven Transcription of the P450scc Gene in Porcine Granulosa Cells	Jayes	2000	4		
691	chr7	14017699	14023347	3500128409	40		14017699	14023347	8421504	3	16,4,20	0,1872,5628	c	350012840900000006,350012840900000007	0-20,0-20		16303770	10.1074/jbc.M509417200	0021-9258	Journal of Biological Chemistry	A Novel Functional Interaction between the Sp1-like Protein KLF13 and SREBP-Sp1 Activation Complex Underlies Regulation of Low Density Lipoprotein Receptor Promoter Function	Natesampillai	2006	5		
692	chr7	14031277	14033580	3500270141	43		14031277	14033580	8421504	2	21,22	0,2281	c,g	350027014100000005,350027014100000005,350027014100000006	0-21,0-21,0-22		17108332	10.1095/biolreprod.106.057216	0006-3363	Biology of Reproduction	Low-Density Lipoprotein Receptor-Related Protein 8 (LRP8) Is Upregulated in Granulosa Cells of Bovine Dominant Follicle: Molecular Characterization and Spatio-Temporal Expression Studies	Fayad	2007	4		
692	chr7	14031308	14032655	3500156475	42		14031308	14032655	8421504	3	20,14,8	0,21,1339	c,g	350015647500000027,350015647500000027,350015647500000029	0-20,0-20,0-22						REPRODUCTION	uction-online.org	0	0		
692	chr7	14032676	14032736	3500311801	60		14032676	14032736	8421504	1	60	0	p	350031180100015022	0-60						Method of identifying transmembrane protein-interacting compounds	Bu Lai En *F*Ao Dang De 	2005	0		LDLR
692	chr7	14032676	14032736	3500300562	60		14032676	14032736	8421504	1	60	0	p	350030056200015031	0-60						Method of identifying transmembrane protein-interacting compounds	George	2005	0		LDLR
692	chr7	14032676	14032736	3500289629	60		14032676	14032736	8421504	1	60	0	p	350028962900015032	0-60						METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - Patent application	www.faqs.org	0	0		LDLR
692	chr7	14032676	14032736	3500127324	60		14032676	14032736	8421504	1	60	0	p	350012732400015030	0-60						Method of Identifying Transmembrane Protein-Interacting Compounds	O'Dowd	2013	0		LDLR
692	chr7	14032676	14032736	3500126126	60		14032676	14032736	8421504	1	60	0	p	350012612600015031	0-60						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2010	0		LDLR
692	chr7	14032676	14032736	3500090706	60		14032676	14032736	8421504	1	60	0	p	350009070600015024	0-60						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2011	0		LDLR
692	chr7	14032676	14032736	3500083847	60		14032676	14032736	8421504	1	60	0	p	350008384700015031	0-60						Method of identifying transmembrane protein-interacting compounds	O'Dowd	2003	0		LDLR
692	chr7	14032676	14032736	3500043017	60		14032676	14032736	8421504	1	60	0	p	350004301700015033	0-60						METHOD OF IDENTIFYING TRANSMEMBRANE PROTEIN-INTERACTING COMPOUNDS - Patent application	www.faqs.org	0	0		LDLR
692	chr7	14032795	14033498	3500263910	24		14032795	14033498	8421504	2	10,14	0,689	c	350026391000000000	23-47						Expression of LDL Receptor, VLDL Receptor, LDL Receptor&#x2013;Related Protein, and Scavenger Receptor in Rabbit Atherosclerotic Lesions	c.ahajournals.org	0	0		LDLR
692	chr7	14033517	14035242	3500182135	1662		14033517	14035242	8421504	33	14,50,285,29,100,21,60,22,21,126,59,30,26,26,200,8,5,6,6,70,83,25,166,12,49,28,5,3,34,34,41,4,14	0,15,66,352,390,491,513,575,600,622,749,809,840,867,900,1101,1110,1116,1123,1138,1210,1294,1320,1487,1500,1550,1579,1585,1589,1624,1663,1705,1711	c,g	350018213500000002,350018213500000003,350018213500000004,350018213500000014,350018213500000014,350018213500000012,350018213500000012,350018213500000005,350018213500000005	0-589,0-288,0-584,0-64,0-64,0-22,0-22,0-214,0-214						Polymorphism evolution ofAlu	www.pnas.org	0	0		
692	chr7	14062045	14064477	3500125835	48		14062045	14064477	8421504	2	42,6	0,2426	p	350012583500015063	0-48						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"> <HTML> <HEAD> <META http-equiv="Cont	www.aist.go.jp	0	0		KANK2
692	chr7	14085634	14089687	3500121800	531		14085634	14089687	8421504	6	67,104,141,90,126,3	0,721,1527,2221,2409,4050	p	350012180000015090,350012180000015085,350012180000015083	0-171,0-180,0-180						49 human secreted proteins	Komatsoulis	2000	0		DOCK6
692	chr7	14115468	14116415	3500283958	23		14115468	14116415	8421504	3	7,2,14	0,926,933	c	350028395800000009	0-23						Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel cat&#xfb01;sh (Ictalurus punctatus	ddr.nal.usda.gov	0	0		
693	chr7	14234044	14234075	3500110478	27		14234044	14234075	8421504	2	20,7	0,24	c	350011047800000035,350011047800000040	0-28,11-39						Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins	Chen	2007	0		
693	chr7	14234044	14234075	3500100808	27		14234044	14234075	8421504	2	20,7	0,24	c	350010080800000039,350010080800000043,350010080800000035,350010080800000040	0-20,19-39,0-28,11-39						Pharmacokinetic modulation and compositions for modified Fn3 polypeptides	Chen	2006	0		
694	chr7	14323525	14323550	3500329538	23		14323525	14323550	8421504	3	6,4,13	0,7,12	c	350032953800000086	0-27						US Patent # 5,460,950. Expression of PACE in host cells and methods of use thereof - Patents.com	www.patents.com	0	0		
694	chr7	14340204	14345127	3500402281	40		14340204	14345127	8421504	2	20,20	0,4903	c,g	350040228100000014,350040228100000007,350040228100000007	0-20,0-20,0-20		18805960	10.1152/ajplung.90202.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Integrin-linked kinase regulates smooth muscle differentiation marker gene expression in airway tissue	Wu	2008	0		CNN1
694	chr7	14345132	14345198	3500022437	38		14345132	14345198	8421504	2	19,19	0,47	c,g	350002243700000008,350002243700000008,350002243700000009,350002243700000009	0-19,0-19,0-19,0-19						ONLINE MATERIALS AND METHODS	b.ahajournals.org	0	0		
694	chr7	14346233	14346258	3500130586	25		14346233	14346258	8421504	1	25	0	c	350013058600000002	23-48						ScienceDirect.com - Developmental Biology - The cytoplasmic domain of TGF&#x03b2;R3 through its interaction with the scaffolding protein, GIPC, directs epicardial cell behavior	sciencedirect.com	0	0		
695	chr7	14491721	14491748	3500161237	23		14491721	14491748	8421504	3	6,4,13	0,9,14	c	350016123700000252	14-37						US Patent # 6,683,165. Human gene relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
695	chr7	14543978	14544062	3500301078	44		14543978	14544062	8421504	2	22,22	0,62	g	350030107800000140,350030107800000139	0-22,0-22						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
695	chr7	14543978	14544062	3500006584	45		14543978	14544062	8421504	2	23,22	0,62	g	350000658400000021,350000658400000020	0-23,0-22						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
695	chr7	14543978	14544030	3500463464	52		14543978	14544030	8421504	1	52	0	g	350046346400000059	6-60						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
697	chr7	14740279	14740310	3500398347	24		14740279	14740310	8421504	3	6,13,5	0,11,26	g	350039834700000004	5-29						Gallus Heat shock cognate protein 70, a novel binding partner of Apoptin	www.virologyj.com	0	0		
698	chr7	14850150	14851369	3500075252	99		14850150	14851369	8421504	4	30,21,8,40	0,303,431,1179	c	350007525200000323,350007525200000329,350007525200000343	0-30,4-33,0-40						Identifying ligands of the C-terminal domain of cardiac expressed connexin 40 and assessing its involvement in cardiac conduction disease	scholar.sun.ac.za	0	0		
698	chr7	14918409	14918437	3500174807	23		14918409	14918437	8421504	2	10,13	0,15	c	350017480700000124	21-44						Nucleic acid transfer system	www.devileye.net	0	0		
698	chr7	14918409	14918437	3500102489	23		14918409	14918437	8421504	2	10,13	0,15	c	350010248900000124	21-44						Nucleic acid transfer system	Fominaya	1996	0		
698	chr7	14920321	14920345	3500386886	23		14920321	14920345	8421504	2	19,4	0,20	g	350038688600000001	6-29					The Journal of General Physiology	Glutamine Substitution at Alanine1649 in the S4&#x2013;S5 Cytoplasmic Loop of Domain 4 Removes the Voltage Sensitivity of Fast Inactivation in the Human Heart Sodium Channel 	Lihui	1998	0		
698	chr7	14926998	14927295	3500287953	23		14926998	14927295	8421504	3	5,5,13	0,6,284	c	350028795300000198	0-23						Method For Increasing Pathogen Resistance In Transgenic Plants - Patent application	www.faqs.org	0	0		
699	chr7	14942529	14942552	3500024433	23		14942529	14942552	8421504	1	23	0	c	350002443300000001	23-46						The Munc18-1 domain 3a loop is essential for neuroexocytosis but not for syntaxin-1A transport to the plasma membrane. - ResearchGate	.researchgate.net	0	0		
699	chr7	14982987	14983011	3500003114	23		14982987	14983011	8421504	2	12,11	0,13	c	350000311400000014	1-24		14977825	10.1158/1078-0432.CCR-1154-03	1078-0432	Clinical Cancer Research	The Evaluation of Recombinant, Chimeric, Tetravalent Antihuman CD22 Antibodies	Meng	2004	8		
699	chr7	15026942	15026976	3500043540	28		15026942	15026976	8421504	3	10,5,13	0,15,21	g	350004354000000332	5-33						US Patent # 6,987,212. Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use - Patents.com	www.patents.com	0	0		
699	chr7	15042028	15044932	3500152812	83		15042028	15044932	8421504	4	20,20,3,40	0,1469,2711,2864	c	350015281200000001,350015281200000003,350015281200000002,350015281200000000	0-20,0-20,0-20,2-27		18319290	10.1189/jlb.0807523	0741-5400	Journal of Leukocyte Biology	Identification and functional characterization of a bovine orthologue to DC-SIGN	Yamakawa	2008	5		
699	chr7	15043832	15044117	3500194695	24		15043832	15044117	8421504	2	9,15	0,270	c	350019469500000010	0-24						Veterinary Research	inaryresearch.org	0	0		
700	chr7	15170046	15170075	3500445622	24		15170046	15170075	8421504	2	13,11	0,18	c	350044562200000016	0-24						Utilization of Genome-wide DNA Methylation Changes in Breast Cancer for Identification of Biomarkers for Prognosis and Mechanisms of Tumorigenesis	d-nb.info/1033029	0	0		
700	chr7	15171107	15200888	3500225367	71		15171107	15200888	8421504	3	24,19,28	0,3105,29753	c,g	350022536700000003,350022536700000004,350022536700000002,350022536700000002	10-34,5-24,12-40,12-40		21660185	10.2174/1874357901105010012		The Open Virology Journal	 In Vivo Interaction of the Hepatitis Delta Virus Small Antigen with the ELAV-Like Protein HuR	Ana	2011	0		
700	chr7	15171111	15200888	3500114457	49		15171111	15200888	8421504	2	25,24	0,29753	c,g	350011445700000002,350011445700000001,350011445700000001	0-25,0-24,0-24		10629032	10.1128/MCB.20.3.760-769.2000	0270-7306	Molecular and Cellular Biology	HuR Regulates p21 mRNA Stabilization by UV Light	Wang	2000	6		
700	chr7	15171111	15200888	3500033209	49		15171111	15200888	8421504	2	25,24	0,29753	c,g	350003320900000002,350003320900000002,350003320900000001,350003320900000001	0-25,0-25,0-24,0-24					Molecular and Cellular Biology	HuR Regulates p21 mRNA Stabilization by UV Light	Wengong	2000	0		ELAVL1
700	chr7	15171111	15174233	3500339058	41		15171111	15174233	8421504	2	20,21	0,3101	c,g	350033905800000054,350033905800000054,350033905800000055	0-20,0-20,0-21		20498276	10.1128/MCB.00169-10	0270-7306	Molecular and Cellular Biology	HuR Uses AUF1 as a Cofactor To Promote p16INK4 mRNA Decay	Chang	2010	6		ELAVL1
700	chr7	15171378	15174102	3500352871	102		15171378	15174102	8421504	2	58,44	0,2680	p	350035287100015003	0-105		15037768	10.1261/rna.5224304	1355-8382	RNA	Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR	REBANE	2004	5		ELAVL1
700	chr7	15171378	15174102	3500278989	102		15171378	15174102	8421504	2	58,44	0,2680	p	350027898900015003	0-105		15037768	10.1261/rna.5224304	1355-8382	RNA	Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR	REBANE	2004	5		ELAVL1
700	chr7	15171421	15174090	3500036127	47		15171421	15174090	8421504	2	15,32	0,2637	c	350003612700000025	0-47						Modulating levels of RNA-binding proteins for the treatment of breast cancer - Patent application	www.faqs.org	0	0		
700	chr7	15174210	15174233	3500363302	23		15174210	15174233	8421504	1	23	0	c	350036330200000004	0-23		18579691	10.1091/mbc.E07-09-0962	1059-1524	Molecular Biology of the Cell	RNA-binding Protein HuR Interacts with Thrombomodulin 5&#x2032;Untranslated Region and Represses Internal Ribosome Entry Site&#x2013;mediated Translation under IL-1&#x03b2; Treatment	Yeh	2008	5		ELAVL1
700	chr7	15174212	15200720	3500243332	43		15174212	15200720	8421504	3	22,17,4	0,8474,26504	c	350024333200000004,350024333200000003	0-22,0-21		20881234	10.1152/ajpcell.00093.2010		American Journal of Physiology - Cell Physiology	RNA-binding protein HuR regulates RGS4 mRNA stability in rabbit colonic smooth muscle cells	Fang	2010	0		
700	chr7	15200851	15200875	3500181873	24		15200851	15200875	8421504	1	24	0	c,g	350018187300000004,350018187300000004	0-24,0-24						Down-Regulation of -Actin Gene and Human Antigen R (HuR) in Human Keratoconus	www.iovs.org	0	0		ELAVL1
700	chr7	15200866	15200893	3500415565	27		15200866	15200893	8421504	1	27	0	c	350041556500000000	0-27		14729623	10.1158/0008-5472.CAN-03-1987	0008-5472	Cancer Research	Overexpression of the Embryonic-Lethal Abnormal Vision-like Protein HuR in Ovarian Carcinoma Is a Prognostic Factor and Is Associated with Increased Cyclooxygenase 2 Expression	Denkert	2004	8		ELAVL1
700	chr7	15200866	15200893	3500340900	27		15200866	15200893	8421504	1	27	0	c	350034090000000006	9-36		21391979	10.1111/j.1476-5381.2011.01312.x	1476-5381	British Journal of Pharmacology	Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases - Lin - 2011 - British Jou	Lin	2011	0		ELAVL1
700	chr7	15200866	15200893	3500125821	27		15200866	15200893	8421504	1	27	0	c	350012582100000006	9-36		21391979	10.1111/j.1476-5381.2011.01312.x		British Journal of Pharmacology	Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases	Wei-Ning	2011	0		ELAVL1
701	chr7	15261262	15261297	3500119167	26		15261262	15261297	8421504	3	15,3,8	0,19,27	g	350011916700000160	4-30						Human jagged polypeptide, encoding nucleic acids and methods of use	Li	1997	0		
702	chr7	15431528	15431555	3500246268	23		15431528	15431555	8421504	2	13,10	0,17	g	350024626800000197	1-24						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
703	chr7	15469797	15476095	3500342852	987		15469797	15476095	8421504	6	237,112,114,96,282,146	0,1141,4171,4597,4784,6152	p,c	350034285200015008,350034285200015009,350034285200015011,350034285200015012,350034285200000000,350034285200015013,350034285200000001,350034285200015014,350034285200015015	0-87,0-150,0-150,0-150,0-22,0-150,0-22,0-150,0-150						ANGIOPOIETIN-LIKE PROTEIN 4 IN BOVINE PHYSIOLOGY SHIHHUI LI A THESIS	krex.k-state.edu	0	0		
703	chr7	15474859	15476002	3500182039	57		15474859	15476002	8421504	2	4,53	0,1090	p	350018203900015033	0-57						Secreted protein HCEJQ69	Brewer	2003	0		ANGPTL4
703	chr7	15502033	15502061	3500340794	26		15502033	15502061	8421504	2	10,16	0,12	g	350034079400000022	0-26						Cell Death and Differentiation	005.pasteur.ac.ir	0	0		
703	chr7	15576828	15576858	3500020881	25		15576828	15576858	8421504	2	7,18	0,12	c	350002088100000036	0-25						Insect expression vectors - Patent # 7135337 - PatentGenius	.patentgenius.com	0	0		
704	chr7	15607643	15615467	3500148752	270		15607643	15615467	8421504	4	78,90,88,14	0,7139,7350,7810	p	350014875200015010	0-270						Beginners Problem Set 1 Answers	www.colorado.edu	0	0		MYO1F
704	chr7	15629557	15629583	3500231128	26		15629557	15629583	8421504	1	26	0	c	350023112800000004	0-26						MARKERS FOR DETECTION OF GASTRIC CANCER - PACIFIC EDGE BIOTECHNOLOGY LIMITED	www.sumobrain.com	0	0		ADAMTS10
704	chr7	15641769	15642204	3500331821	29		15641769	15642204	8421504	2	13,16	0,419	c	350033182100000021	20-49						Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma	.aacrjournals.org	0	0		
704	chr7	15724252	15724275	3500379687	23		15724252	15724275	8421504	1	23	0	c	350037968700000000	0-23						<HTML> <HEAD> <TITLE>KITZNET.COM (at InMotion)</TITLE> </HEAD> <BODY bgcolor="#000000" LEFTMAR	www.kitznet.com	0	0		ACTB
704	chr7	15724252	15724275	3500266718	23		15724252	15724275	8421504	1	23	0	c	350026671800000007	0-23		17158758	10.1677/erc.1.01257	1351-0088	Endocrine-Related Cancer	Endocrine therapy resistance can be associated with high estrogen receptor &#x03b1; (ER&#x03b1;) expression and reduced ER&#x03b1; phosphorylation in breast cancer models	Kuske	2006	4		AMY2B
704	chr7	15724252	15724275	3500266398	23		15724252	15724275	8421504	1	23	0	c	350026639800000001	0-23						Entwicklung eines gewebenahen Konstruktes aus einer Matrix mit in vitro kultivierten Fibroblasten und Keratinozyten zum Ersatz der Oralmukosa unter Einsatz von Tissue Engineering	.uni-wuerzburg.de	0	0		AMY2B
704	chr7	15724252	15724275	3500210308	23		15724252	15724275	8421504	1	23	0	c	350021030800000007	0-23						endocrine therapy resistance can be associated with high estrogen receptor (er) expression and reduced er phosphorylation in breast cancer models - &#x671f;&#x520a;&#x6742;&#x5fd7;|&#x514d;&#x8d39;&#x6742;&#x5fd7;|&#x7535;&#x5b50;&#x6742;&#x5fd7;|&#x6742;	qkzz.net/article/	0	0		AMY2B
704	chr7	15724252	15724275	3500113867	23		15724252	15724275	8421504	1	23	0	c	350011386700000000	0-23						allergic to gillette 3x armpit cyst - amy reid armpit 	www.mymihri.de	0	0		ACTB
704	chr7	15724252	15724275	3500014892	23		15724252	15724275	8421504	1	23	0	c	350001489200000003	0-23		19193763	10.1091/mbc.E08-12-1196	1059-1524	Molecular Biology of the Cell	Loss of E-Cadherin&#x2013;mediated Cell&#x2013;Cell Contacts Activates a Novel Mechanism for Up-Regulation of the Proto-Oncogene c-Jun	Knirsh	2009	5		ACTB
708	chr7	16243219	16246504	3500141481	555		16243219	16246504	8421504	7	85,86,87,69,96,100,32	0,712,897,1261,1555,2363,3253	p	350014148100015031,350014148100015024,350014148100015014	0-150,0-228,0-177						A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2	dlab.stanford.edu	0	0		VAV1
709	chr7	16265009	16265032	3500453187	23		16265009	16265032	8421504	1	23	0	g	350045318700000102,350045318700000237	24-47,24-47						Detection of nucleic acid hybrids	www.devileye.net	0	0		
709	chr7	16328093	16328117	3500227307	24		16328093	16328117	8421504	1	24	0	c	350022730700000002	0-24						In Vitro Mimicking of Estrous Cycle Stages in Porcine Oviduct Epithelium Cells: Estradiol and Progesterone Regulate Differentiation, Gene Expression, and Cellular Function	ww.biolreprod.org	0	0		
709	chr7	16342438	16351419	3500080675	900		16342438	16351419	8421504	7	151,76,160,99,157,164,93	0,743,1077,2210,5612,7417,8888	c,g	350008067500000008,350008067500000008	0-900,0-900						Veterinary immunisation vectors comprising nucleic acid sequences encoding variants of non-human c3d polypeptides	Cox	2002	0		
711	chr7	16527782	16533126	3500001029	1332		16527782	16533126	8421504	4	57,109,111,1055	0,575,793,4289	p	350000102900015000	0-1332						KEGG T01001: 10382	www.genome.jp	0	0		TUBB
711	chr7	16528595	16528640	3500137241	45		16528595	16528640	8421504	1	45	0	p	350013724100015064	0-45						Improved cancer therapeutics	Lewensohn	2009	0		TUBB8
711	chr7	16532184	16533039	3500123358	317		16532184	16533039	8421504	4	29,96,96,96	0,231,615,759	c	350012335800000075,350012335800000080,350012335800000081,350012335800000088,350012335800000089,350012335800000091,350012335800000092	9-38,0-48,0-48,0-48,0-48,0-48,0-48					Patent	53BP2 complexes (Patent US:5977311)	Nandabalan	1999	0		TUBB2A,TUBB2B
711	chr7	16532452	16532475	3500369296	23		16532452	16532475	8421504	1	23	0	g	350036929600000029	0-23						Treatment of neurological disorders with hematopoeitic growth factors	Schaebitz	2006	0		TUBB2A,TUBB3
711	chr7	16532452	16532475	3500339523	23		16532452	16532475	8421504	1	23	0	c	350033952300000029	0-23						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPEITIC GROWTH FACTORS	Schaebitz	2007	0		TUBB2A
711	chr7	16532796	16532820	3500061817	24		16532796	16532820	8421504	1	24	0	c	350006181700000016	0-24						//ejpvfs2/sites2/ccr www/ccr files/2008/06/23/00011787/01/11787 1 supp 0 k2xdck fig	.aacrjournals.org	0	0		
711	chr7	16532970	16532995	3500417024	25		16532970	16532995	8421504	1	25	0	c	350041702400000005	0-25						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - STEMPEUTICS RESEARCH PRIVATE LIMITED	www.sumobrain.com	0	0		TUBB2A
711	chr7	16532970	16532995	3500401984	25		16532970	16532995	8421504	1	25	0	c	350040198400000005	0-25						XENO-FREE CULTURE CONDITIONS FOR HUMAN EMBRYONIC STEM CELLS AND METHODS THEREOF	Totey	2009	0		TUBB2A
711	chr7	16532970	16532995	3500008009	25		16532970	16532995	8421504	1	25	0	c	350000800900000005,350000800900000045	0-25,0-25						GERM LINEAGE DERIVED FEEDER CELLS AND METHODS THEREOF - Patent application	www.faqs.org	0	0		FAM166A
711	chr7	16532979	16533020	3500168776	33		16532979	16533020	8421504	2	7,26	0,15	c	350016877600002016,350016877600002017,350016877600002015	11-44,11-44,11-44						Micrornas (mirnas) For Plant Growth And Development 	.freshpatents.com	0	0		TUBB4A
711	chr7	16591006	16591029	3500356258	23		16591006	16591029	8421504	1	23	0	g	350035625800000008	0-23		11781334	10.1083/jcb.200105133	0021-9525	The Journal of Cell Biology	A predominantly nuclear protein affecting cytoplasmic localization of &#x03b2;-actin mRNA in fibroblasts and neurons	Gu	2002	10		
711	chr7	16591006	16591029	3500315225	23		16591006	16591029	8421504	1	23	0	g	350031522500000008	0-23			10.1083/jcb.200105133		The Journal of Cell Biology	A predominantly nuclear protein affecting cytoplasmic localization of &#x03b2;-actin mRNA in fibroblasts and neurons	Wei	2002	0		
712	chr7	16695529	16695557	3500114128	25		16695529	16695557	8421504	2	19,6	0,22	g	350011412800000100	15-41						Hepatitis G virus protease	Belyaev	1996	0		
714	chr7	16955932	16955957	3500119690	23		16955932	16955957	8421504	2	18,5	0,20	g	350011969000000006	1-25			10.1111/j.1365-2249.2007.03407.x	1365-2249	Clinical & Experimental Immunology	Levels of CD40 expression on dendritic cells dictate tumour growth or regression - Murugaiyan - 2007 - Clinical & Experimental Immunology - Wiley Online Library	Murugaiyan	2007	0		
714	chr7	17034091	17034879	3500058136	510		17034091	17034879	8421504	4	63,207,178,62	0,133,474,726	p	350005813600015022	0-510						Palaemonetes_pugio-Contig_263-v1 | MarineGenomics.org	arinegenomics.org	0	0		
715	chr7	17062967	17062991	3500213871	23		17062967	17062991	8421504	2	6,17	0,7	g	350021387100000001	0-25						Organization of Escherichia coli O157 O Antigen Gene Cluster and Identi&#xfb01;cation of Its Speci&#xfb01;c Genes	www.tjbiochip.com	0	0		
715	chr7	17062967	17062991	3500011782	23		17062967	17062991	8421504	2	6,17	0,7	g	350001178200000000	0-25			10.1111/j.1365-2672.2005.02545.x	1365-2672	Journal of Applied Microbiology	Detection of Escherichia coli serogroup O103 by real-time polymerase chain reaction - Perelle - 2005 - Journal of Applied Microbiology - Wiley Online Library	Perelle	2005	0		
715	chr7	17083464	17083492	3500464901	28		17083464	17083492	8421504	1	28	0	c	350046490100000001	0-28						Modifications on glycosidic enzymes as a strategy to alter tumour cell adhesion	www.tdx.cat	0	0		
715	chr7	17086275	17086581	3500307606	306		17086275	17086581	8421504	1	306	0	p	350030760600015053,350030760600015049	54-360,51-351						In vivo gene therapy of parkinson's disease	Rosenblad	2006	0		
715	chr7	17086275	17086581	3500277985	306		17086275	17086581	8421504	1	306	0	p	350027798500015049,350027798500015053	51-351,54-360						In vivo gene therapy of parkinson's disease	Rosenblad	2005	0		
715	chr7	17086275	17086581	3500115211	306		17086275	17086581	8421504	1	306	0	p	350011521100015002,350011521100015003	0-306,0-303						Novel neurturin conjugates for pharmaceutical use	Austen	2011	0		FUT6
715	chr7	17086275	17086395	3500075698	120		17086275	17086395	8421504	1	120	0	p	350007569800015003	0-120						Treatment Of Retinopathies Using Gfra3 Agonists 	.freshpatents.com	0	0		FUT6
715	chr7	17086281	17086581	3500241222	300		17086281	17086581	8421504	1	300	0	p	350024122200015006	0-300						NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE	Austen	2013	0		FUT6
715	chr7	17086281	17086581	3500070967	300		17086281	17086581	8421504	1	300	0	p	350007096700015002	0-300						Novel Neurturin Conjugates For Pharmaceutical Use 	.freshpatents.com	0	0		FUT6
715	chr7	17086290	17089774	3500110961	442		17086290	17089774	8421504	7	45,45,22,45,45,71,169	0,72,141,192,240,336,3315	p,c	350011096100015124,350011096100015114,350011096100000010,350011096100015122,350011096100015121,350011096100015030,350011096100015059,350011096100015029,350011096100015107,350011096100015058,350011096100015118,350011096100015117,350011096100015028	0-45,0-45,18-40,0-45,0-45,0-60,0-90,0-90,0-45,0-150,0-45,0-45,0-90						NEURTURIN MOLECULES - Patent application	www.faqs.org	0	0		
715	chr7	17086344	17086395	3500344800	51		17086344	17086395	8421504	1	51	0	p	350034480000015000	0-51						14 GENOMPR OJEKT Jagten p&#xe5; generne	biotechacademy.dk	0	0		FUT6
715	chr7	17086344	17086395	3500129853	51		17086344	17086395	8421504	1	51	0	p	350012985300015000	0-51						14 GENOMPR OJEKT Jagten p&#xe5; generne	viden.jp.dk	0	0		FUT6
715	chr7	17086395	17086440	3500141084	45		17086395	17086440	8421504	1	45	0	p	350014108400015028	0-45						NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE - Patent application	www.faqs.org	0	0		
715	chr7	17086626	17089774	3500289883	240		17086626	17089774	8421504	2	71,169	0,2979	p	350028988300015051,350028988300015022,350028988300015050,350028988300015021	0-90,0-150,0-150,0-90						Improved neurturin molecules	Runeberg-Roos	2011	0		
715	chr7	17086626	17089774	3500273006	240		17086626	17089774	8421504	2	71,169	0,2979	p	350027300600015051,350027300600015022,350027300600015050,350027300600015021	0-90,0-150,0-150,0-90						Improved neurturin molecules	Runeberg-Roos	2012	0		
715	chr7	17150957	17150981	3500239390	23		17150957	17150981	8421504	2	6,17	0,7	g	350023939000000016	1-24		24010046	10.1186/2193-1801-2-392		SpringerPlus	DNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation	Maria	2013	0		
716	chr7	17174179	17174203	3500348581	24		17174179	17174203	8421504	1	24	0	c,g	350034858100000185,350034858100000185	0-48,0-48						Use of Proteins as Demulsifying Agents - Patent application	www.faqs.org	0	0		
716	chr7	17174179	17174203	3500193766	24		17174179	17174203	8421504	1	24	0	c,g	350019376600000185,350019376600000185	0-48,0-48						Use of Hydrophobin-Polypeptides and Conjugates From Hydrophobin-Polypeptides Having Active and Effect Agents and the Production Thereof and Use Thereof In the Cosmetic Industry - Patent application	www.faqs.org	0	0		
716	chr7	17175992	17176245	3500164379	180		17175992	17176245	8421504	2	66,114	0,139	p	350016437900015024	180-360						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPL36
716	chr7	17200251	17283728	3500023106	513		17200251	17283728	8421504	7	32,28,59,205,65,85,39	0,949,67140,70664,70949,80267,83438	p	350002310600015048	0-519						NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS	Tainsky	2010	0		
716	chr7	17267418	17267446	3500461622	23		17267418	17267446	8421504	2	12,11	0,17	c	350046162200000246	1-24						Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease	Williams	2001	0		
716	chr7	17267418	17267446	3500322097	23		17267418	17267446	8421504	2	12,11	0,17	c	350032209700000264	1-24						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
716	chr7	17267418	17267446	3500309840	23		17267418	17267446	8421504	2	12,11	0,17	c	350030984000000264	1-24						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
716	chr7	17267418	17267446	3500119454	23		17267418	17267446	8421504	2	12,11	0,17	c	350011945400000268	1-24						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
716	chr7	17267418	17267446	3500065112	23		17267418	17267446	8421504	2	12,11	0,17	c	350006511200000242	1-24					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
716	chr7	17267418	17267446	3500011388	23		17267418	17267446	8421504	2	12,11	0,17	c	350001138800000247	1-24						Vaccine and antitoxin for the treatment of C. difficile disease	Kink	1997	0		
716	chr7	17267418	17267446	3500004227	23		17267418	17267446	8421504	2	12,11	0,17	c	350000422700000268	1-24						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
89	chr7	17563626	17563651	3500375860	24		17563626	17563651	8421504	2	11,13	0,12	g	350037586000000052	22-46						Phytase polypeptides	Bech	1998	0		
721	chr7	17848904	17848931	3500218185	24		17848904	17848931	8421504	2	13,11	0,16	g	350021818500000137	0-26						Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
721	chr7	17891157	17892344	3500003486	44		17891157	17892344	8421504	2	8,36	0,1151	c	350000348600000256	4-48						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		
721	chr7	17928458	17928690	3500022796	40		17928458	17928690	8421504	2	20,20	0,212	c,g	350002279600000016,350002279600000017,350002279600000017	0-20,0-20,0-20						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
722	chr7	17963723	17963748	3500057372	25		17963723	17963748	8421504	1	25	0	c	350005737200000013,350005737200000000	0-25,0-23						Circular RNAs are a large class of animal RNAs with regulatory potency	www.sfu.ca/mbb/Gr	0	0		HNRNPK
722	chr7	17963723	17963746	3500439152	23		17963723	17963746	8421504	1	23	0	c	350043915200000215,350043915200000168	0-23,0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		HNRNPK
722	chr7	17963723	17963746	3500363476	23		17963723	17963746	8421504	1	23	0	c	350036347600000021,350036347600000022	0-23,0-23						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - Patent application	www.faqs.org	0	0		
722	chr7	17963723	17963746	3500357539	23		17963723	17963746	8421504	1	23	0	c	350035753900000010	0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		HNRNPK
722	chr7	17963723	17963746	3500351709	23		17963723	17963746	8421504	1	23	0	g	350035170900000000	0-23		21683814	10.1016/j.bbagrm.2011.05.015		Biochimica et biophysica acta	Drosha processing controls the specificity and efficiency of global microRNA expression	Yong	2011	0		HNRNPK
722	chr7	17963723	17963746	3500210973	23		17963723	17963746	8421504	1	23	0	c	350021097300000010	0-23						Microrna molecules	Tuschl	2002	0		MIR3529
722	chr7	17963723	17963746	3500125321	23		17963723	17963746	8421504	1	23	0	c	350012532100000113,350012532100000012,350012532100000034	0-23,0-21,0-21						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
722	chr7	17997846	17997874	3500286339	24		17997846	17997874	8421504	3	5,14,5	0,8,23	g	350028633900000043	7-31						QUANTITATIVE TRAIT LOCI MAPPING AND CANDIDATE GENE ANALYSIS	nces.missouri.edu	0	0		
722	chr7	18037972	18038001	3500425477	24		18037972	18038001	8421504	2	12,12	0,17	g	350042547700000001	5-40						PPhylogenetic analysis of bovine herpesvirus 1 isolated in Croatiahylogenetic analysis of bovine herpesvirus 1 isolated in Croatia	www.vef.unizg.hr	0	0		
722	chr7	18068255	18068303	3500335406	48		18068255	18068303	8421504	1	48	0	c	350033540600000089	0-48						HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS	Kato	1998	0		
724	chr7	18221520	18221543	3500195493	23		18221520	18221543	8421504	1	23	0	c	350019549300000002	11-34						FUNCTIONAL TOLL-LIKE RECEPTORS (TLR) ON MELANOCYTES AND MELANOMA CELLS AND USES THEREOF	Hoon	2008	0		
724	chr7	18323695	18323719	3500328810	23		18323695	18323719	8421504	2	6,17	0,7	c	350032881000000040	0-23						Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereof	Farrelly	2002	0		
725	chr7	18352189	18352234	3500079754	45		18352189	18352234	8421504	1	45	0	p	350007975400015112	0-45						Heparanase Specific Molecular Probes And Their Use In Research And Medical Applications 	.freshpatents.com	0	0		SH3GL1
725	chr7	18352919	18352944	3500318229	23		18352919	18352944	8421504	2	16,7	0,18	c	350031822900000061	0-23						METHODS OF IDENTIFYING AND CREATING RUBISCO LARGE SUBUNIT VARIANTS WITH IMPROVED RUBISCO ACTIVITY, COMPOSITIONS AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
725	chr7	18397329	18404871	3500310579	879		18397329	18404871	8421504	5	46,360,30,102,341	0,2776,6615,6738,7201	g	350031057900000011	0-879						Methods of modulating immune function	Chen	2011	0		
726	chr7	18534031	18537907	3500410534	243		18534031	18537907	8421504	3	16,121,106	0,25,3770	p,c	350041053400000141,350041053400015156,350041053400015164,350041053400015159	8-190,12-198,0-198,12-198						NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
726	chr7	18534085	18554926	3500370433	1200		18534085	18554926	8421504	11	92,211,147,78,52,125,214,65,62,46,108	0,3716,8218,13278,14009,14131,14823,16861,18071,19018,20733	p	350037043300015007	0-1200						Braf biomarkers	Hosted	2011	0		MAP2K2
726	chr7	18534085	18554926	3500259816	1188		18534085	18554926	8421504	13	92,160,45,147,78,52,125,141,67,65,62,46,108	0,3716,3882,8218,13278,14009,14131,14823,14970,16861,18071,19018,20733	p	350025981600015008	0-1194						Braf biomarkers	Hosted	2010	0		MAP2K2
726	chr7	18534085	18554857	3500386372	852		18534085	18554857	8421504	9	92,211,147,78,52,125,62,46,39	0,3716,8218,13278,14009,14131,18071,19018,20733	p	350038637200015191	0-852						Human proteins, polynucleotides encoding them and methods of using the same	Anderson	2002	0		
726	chr7	18534085	18534133	3500240655	48		18534085	18534133	8421504	1	48	0	p	350024065500015012	0-48						Gene regulatory peptides	Ni Sa Er *Ai Ha Mai De *Qia En 	2005	0		MAP2K2
726	chr7	18534085	18534133	3500229194	48		18534085	18534133	8421504	1	48	0	p	350022919400015029	0-48						Gene regulatory peptides	Ni Sa Er *Ai Ha Mai De *Qia En 	2010	0		MAP2K2
726	chr7	18534085	18534133	3500080561	48		18534085	18534133	8421504	1	48	0	p	350008056100015005	0-48						&#x57fa;&#x56e0;&#x8c03;&#x8282;&#x80bd;	Ni Sa Er *Ai Ha Mai De *Qia En 	2005	0		MAP2K2
726	chr7	18534085	18534133	3500050030	48		18534085	18534133	8421504	1	48	0	p	350005003000015016	0-48						&#x57fa;&#x56e0;&#x8c03;&#x8282;&#x80bd;	Ni Sa Er *Ai Ha Mai De *Qia En 	2010	0		MAP2K2
726	chr7	18590101	18590161	3500068372	60		18590101	18590161	8421504	1	60	0	p	350006837200015000	0-60						articles Role of the proto-oncogene Pokemon in cellular transformation and ARF repression	cer.med.umich.edu	0	0		ZBTB7A
726	chr7	18595860	18595884	3500062690	24		18595860	18595884	8421504	1	24	0	c,g	350006269000000010,350006269000000010	0-24,0-24		19723341	10.1186/1756-0500-2-175		BMC Research Notes	SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells	Xuyu	2009	0		ZBTB7C
726	chr7	18596466	18596489	3500133797	23		18596466	18596489	8421504	1	23	0	g	350013379700000132	0-23						Canine Disease Gene Identification n	works.unsw.edu.au	0	0		ZBTB7A
726	chr7	18605135	18607968	3500290590	195		18605135	18607968	8421504	3	19,161,15	0,2569,2818	p	350029059000015040	0-195						The Drosophila trithorax group gene tonalli(tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING &#xfb01;nger protein	ev.biologists.org	0	0		PIAS4
90	chr7	18607745	18622505	3500328917	106		18607745	18622505	8421504	4	42,2,33,29	0,2351,2454,14731	c	350032891700000303,350032891700000297,350032891700000286	0-42,0-35,0-29						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
727	chr7	18651632	18651661	3500439085	24		18651632	18651661	8421504	2	8,16	0,13	g	350043908500000023	13-39						Human tyrosine hydroxylase promoter and uses thereof	Iacovitti	2002	0		
727	chr7	18652686	18652737	3500342863	51		18652686	18652737	8421504	1	51	0	p	350034286300015110	0-51							library.wiley.com	0	0		EEF2
727	chr7	18654791	18654816	3500426705	23		18654791	18654816	8421504	2	7,16	0,9	c	350042670500000021	1-24						BH3 interacting domain death agonist	Korsmeyer	1997	0		
727	chr7	18654791	18654816	3500105711	23		18654791	18654816	8421504	2	7,16	0,9	c	350010571100000017	1-24						BH3 interacting domain death agonist	Korsmeyer	1996	0		
727	chr7	18656157	18656875	3500434170	40		18656157	18656875	8421504	3	19,10,11	0,82,707	c,g	350043417000000032,350043417000000032,350043417000000033	0-19,0-19,0-21						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
727	chr7	18658884	18658983	3500060654	99		18658884	18658983	8421504	1	99	0	p	350006065400015008	0-99						Structure and expression of elongation factor 2 gene during development of Dictyostelium discoideum. - ResearchGate	.researchgate.net	0	0		EEF2
727	chr7	18658893	18658938	3500123657	45		18658893	18658938	8421504	1	45	0	p	350012365700015000	0-45						Supporting Information	www.pnas.org	0	0		EEF2
727	chr7	18674910	18674933	3500074208	23		18674910	18674933	8421504	1	23	0	c	350007420800000268	12-48						Modified factor viii	Lollar	2001	0		
728	chr7	18820874	18821033	3500211925	159		18820874	18821033	8421504	1	159	0	p	350021192500015007	0-159						 Phylogeography Ppt Presentation 	.authorstream.com	0	0		MATK
728	chr7	18842784	18842817	3500339819	27		18842784	18842817	8421504	3	9,5,13	0,14,20	c	350033981900000017	0-27						 Antibodies Recognizing Tie Receptor Tyrosine Kinase And Uses Thereof 	www.docstoc.com	0	0		
729	chr7	18917890	18917935	3500137229	45		18917890	18917935	8421504	1	45	0	p	350013722900015092	0-45						METHODS OF TREATMENT - Patent application	www.faqs.org	0	0		PIP5K1C
732	chr7	19281787	19281835	3500301600	48		19281787	19281835	8421504	1	48	0	p	350030160000015000	0-48						Transmembrane Protein 147 (TMEM147) Is a Novel Component of the Nicalin-NOMO Protein Complex - Keeping the Faith	pthefaith1296.com	0	0		NCLN
732	chr7	19281787	19281835	3500044504	48		19281787	19281835	8421504	1	48	0	p	350004450400015001	0-48		20538592	10.1074/jbc.M110.132548		The Journal of Biological Chemistry	Transmembrane Protein 147 (TMEM147) Is a Novel Component of the Nicalin-NOMO Protein Complex	Ulf	2010	0		NCLN
732	chr7	19302799	19302826	3500383952	27		19302799	19302826	8421504	1	27	0	c	350038395200000025	20-47						Yeast cells expressing modified g proteins and methods of use therefor	Benegal	2000	0		
732	chr7	19302799	19302826	3500121688	27		19302799	19302826	8421504	1	27	0	c	350012168800000025	20-47						Yeast cells expressing modified G proteins and methods of use therefor	Fowlkes	1997	0		
732	chr7	19307458	19313045	3500236924	64		19307458	19313045	8421504	3	35,8,21	0,3678,5566	c	350023692400000119,350023692400000111	0-35,6-35						EPF receptor assays, compounds and therapeutic compsns.	A*Bu Yi Si Te 	2004	0		
732	chr7	19310994	19311042	3500068645	48		19310994	19311042	8421504	1	48	0	p	350006864500015010	0-48						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
732	chr7	19310994	19311039	3500243579	45		19310994	19311039	8421504	1	45	0	p	350024357900015056	0-45					Patent	&#x5229;&#x7528;EPF&#x53d7;&#x4f53;&#x9274;&#x5b9a;&#x7ed3;&#x5408;&#x6216;&#x8c03;&#x8282;hDRR&#x6d3b;&#x6027;&#x7684;&#x5316;&#x5408;&#x7269;&#x4ee5;&#x53ca;hDRR&#x7684;&#x5206;&#x79bb; Identified using receptor binding EPF or adjust hDRR active compoun	A*Bu Yi Si Te 	2008	0		
732	chr7	19310994	19311039	3500038763	45		19310994	19311039	8421504	1	45	0	p	350003876300015046	0-45					Patent	&#x5229;&#x7528;EPF&#x53d7;&#x4f53;&#x9274;&#x5b9a;&#x7ed3;&#x5408;&#x6216;&#x8c03;&#x8282;hDRR&#x6d3b;&#x6027;&#x7684;&#x5316;&#x5408;&#x7269;&#x4ee5;&#x53ca;hDRR&#x7684;&#x5206;&#x79bb; (Patent CN:100406891)	A*Bu Yi Si Te 	2008	0		
732	chr7	19319839	19319864	3500360215	23		19319839	19319864	8421504	2	6,17	0,8	g	350036021500000002	13-36					Patent	Compounds and methods for development of Ret modulators (Patent US:8067434)	Artis	2011	0		
732	chr7	19320707	19320755	3500046024	48		19320707	19320755	8421504	1	48	0	p	350004602400015087	0-48						Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor - US Patent 7235648 Description	ww.patentstorm.us	0	0		
732	chr7	19332714	19332739	3500036685	25		19332714	19332739	8421504	1	25	0	c	350003668500000003	14-39						Materials and methods relating to g-protein coupled receptor oligomers	Behan	2004	0		
732	chr7	19332718	19332775	3500167830	57		19332718	19332775	8421504	1	57	0	p	350016783000015000	0-57						Altered Levels of Gq Activity Modulate Axonal Path&#xfb01;nding in Drosophila	www.jneurosci.org	0	0		GNAQ
732	chr7	19377004	19377462	3500183507	40		19377004	19377462	8421504	3	21,13,6	0,434,452	c	350018350700000008,350018350700000009,350018350700000011,350018350700000010	9-32,15-38,20-39,5-24		19435876	10.1158/1535-7163.MCT-08-1093	1535-7163	Molecular Cancer Therapeutics	NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III1	Dexheimer	2009	5		
734	chr7	19589467	19589946	3500284936	23		19589467	19589946	8421504	3	11,6,6	0,465,473	c	350028493600000006	3-26		10805736	10.1128/MCB.20.11.3928-3941.2000	0270-7306	Molecular and Cellular Biology	Neoplastic Transformation by Notch Requires Nuclear Localization	Jeffries	2000	6		
734	chr7	19632860	19632890	3500193865	25		19632860	19632890	8421504	3	6,13,6	0,9,24	c	350019386500000045	14-40						Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis	Targan	1995	0		
735	chr7	19689844	19689869	3500222144	24		19689844	19689869	8421504	2	10,14	0,11	g	350022214400000016,350022214400000026	0-24,0-23						THE JOURNAL OF BIOLOGICAL CHEMISTRY &#xa9; 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Mechanisms of Growth Hormone (GH) Action	www.jbc.org	0	0		
736	chr7	19843643	19843673	3500246268	26		19843643	19843673	8421504	3	13,3,10	0,14,20	c	350024626800000172	9-35						Nucleoc acids and secreted polypeptides encoded thereby	Fernandes	2001	0		
736	chr7	19843806	19844295	3500256218	41		19843806	19844295	8421504	2	21,20	0,469	c,g	350025621800000110,350025621800000109,350025621800000109	0-21,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
736	chr7	19873661	19873776	3500118842	23		19873661	19873776	8421504	3	6,1,16	0,9,99	c	350011884200000004	1-26			10.1128/JB.188.1.150-159.2006		Journal of Bacteriology	The Mycobacterium tuberculosis TrcR Response Regulator Represses Transcription of the Intracellularly Expressed Rv1057 Gene, Encoding a Seven-Bladed &#x03b2;-Propeller	Shelley	2006	0		
736	chr7	19876423	19876447	3500088885	24		19876423	19876447	8421504	1	24	0	c	350008888500000003	9-33						ScienceDirect.com - FEBS Letters - Identification of a novel, highly variable amino-terminal amino acid sequence element in the nuclear intermediate filament protein lamin B2 from higher vertebrates	sciencedirect.com	0	0		
737	chr7	20010979	20011006	3500462561	24		20010979	20011006	8421504	2	11,13	0,14	g	350046256100000012	4-28						Expression of an epitope-tagged virulence protein in Rickettsia parkeri using transposon insertion. - ResearchGate	.researchgate.net	0	0		
738	chr7	20078686	20078711	3500447721	23		20078686	20078711	8421504	2	12,11	0,14	g	350044772100000327	8-40						Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications - Patent application	www.faqs.org	0	0		
738	chr7	20135292	20138248	3500213598	1906		20135292	20138248	8421504	5	554,143,109,163,937	0,1194,1557,1772,2019	p,c,g	350021359800000010,350021359800015004,350021359800015005,350021359800015006,350021359800015008,350021359800015009,350021359800015010,350021359800015011,350021359800015047,350021359800015013,350021359800015014,350021359800015015,350021359800015016,350021359800015018,350021359800015019,350021359800015020,350021359800015021,350021359800015023,350021359800015024,350021359800015025,350021359800015026,350021359800015028,350021359800015029,350021359800015030,350021359800015031,350021359800000012,350021359800000012,350021359800015033,350021359800015075,350021359800015034,350021359800015077,350021359800015070,350021359800015035,350021359800015078,350021359800015036,350021359800015081	0-1906,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-327,0-327,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						METHOD OF MODULATION OF MULLERIAN INHIBITORY SUBSTANCE (MIS) RECEPTOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - Patent application	www.faqs.org	0	0		AMH,SF3A2,JSRP1
738	chr7	20135463	20135733	3500435393	40		20135463	20135733	8421504	2	20,20	0,250	c	350043539300000040,350043539300000041	0-20,0-20						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		
738	chr7	20135487	20135513	3500444804	23		20135487	20135513	8421504	2	11,12	0,14	c	350044480400000002	17-40					Infection and Immunity	Mapping of Specific and Promiscuous HLA-DR-Restricted T-Cell Epitopes on the Plasmodium falciparum 27-Kilodalton Sexual Stage-Specific Antigen	Carmen	1998	0		
738	chr7	20135519	20135548	3500068013	29		20135519	20135548	8421504	1	29	0	c	350006801300000003	0-29						Composition comprising Mullerian inhibiting substance-like polypeptides	Cate	1992	0		
738	chr7	20137840	20138167	3500446710	279		20137840	20138167	8421504	2	192,87	0,240	c,g	350044671000000004,350044671000000004,350044671000000005,350044671000000006,350044671000000008,350044671000000009	0-118,0-118,0-48,0-48,0-48,0-39						Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression	Donahoe	1994	0		
738	chr7	20137870	20138167	3500362819	294		20137870	20138167	8421504	2	135,159	0,138	p	350036281900015026,350036281900015045	0-135,0-159						Characterization of a gonad-specific transforming growth factor-&#x03b2; superfamily member differentially expressed during the reproductive cycle of the oyster Crassostrea gigas	chimer.ifremer.fr	0	0		AMH,JSRP1
738	chr7	20137870	20138164	3500063913	276		20137870	20138164	8421504	2	138,138	0,156	p	350006391300015053,350006391300015054	0-138,0-138						Drosophila 60A Gene, Another Transforming Growth Factor &#x03b2; Family Member, is Closely Related to Human Bone Morphogenetic Proteins	www.jstor.org	0	0		AMH,JSRP1
738	chr7	20138005	20138109	3500394821	41		20138005	20138109	8421504	2	21,20	0,84	c,g	350039482100000000,350039482100000001	0-21,0-20		21076084	10.1095/biolreprod.110.088187	0006-3363	Biology of Reproduction	Regulation of Anti-M&#xfc;llerian Hormone Production in the Cow: A Multiscale Study at Endocrine, Ovarian, Follicular, and Granulosa Cell Levels	Rico	2011	4		
738	chr7	20138005	20138109	3500224504	41		20138005	20138109	8421504	2	21,20	0,84	c,g	350022450400000000,350022450400000001,350022450400000001	0-21,0-20,0-20						Title: Short title: Summary sentence: Authors	ww.biolreprod.org	0	0		
738	chr7	20139130	20139153	3500327109	23		20139130	20139153	8421504	1	23	0	c	350032710900000168	18-48						Invasive cleavage of nucleic acids	Brow	1999	0		
738	chr7	20139130	20139153	3500139533	23		20139130	20139153	8421504	1	23	0	c	350013953300000168	18-48						Invasive cleavage of nucleic acids	Brow	1997	0		
738	chr7	20168170	20168195	3500332833	23		20168170	20168195	8421504	2	17,6	0,19	c	350033283300000028,350033283300000098	19-42,10-33						Heat tolerant phytases	Loon	2000	0		AP3D1
738	chr7	20169545	20169569	3500070204	23		20169545	20169569	8421504	2	17,6	0,18	c	350007020400000125	11-34						Modified virus having an altered tropism	BOULANGER	2003	0		
738	chr7	20171666	20172003	3500324965	93		20171666	20172003	8421504	2	39,54	0,283	p	350032496500015000	0-93						Phosphatidylinositol-4-Kinase Type II Alpha Contains an AP-3&#x2013;sorting Motif and a Kinase Domain That Are Both Required for Endosome Traf&#xfb01;c	w.molbiolcell.org	0	0		AP3D1
738	chr7	20171666	20172003	3500236263	93		20171666	20172003	8421504	2	39,54	0,283	p	350023626300015001	0-93						Clathrin-dependent mechanisms modulate the subcellular distribution of class C Vps/HOPS tether subunits in polarized and nonpolarized cells	w.molbiolcell.org	0	0		AP3D1
739	chr7	20230661	20232796	3500096065	43		20230661	20232796	8421504	2	22,21	0,2114	g	350009606500000065,350009606500000067	23-45,25-46						Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM - Patent application	www.faqs.org	0	0		
740	chr7	20373644	20373673	3500314068	29		20373644	20373673	8421504	1	29	0	c	350031406800000001	0-29		22855808	10.1523/JNEUROSCI.0015-12.2012	0270-6474	The Journal of Neuroscience	Live-Cell Imaging Evidence for the Ciliary Transport of Rod Photoreceptor Opsin by Heterotrimeric Kinesin-2	Trivedi	2012	7		
740	chr7	20373644	20373673	3500071697	29		20373644	20373673	8421504	1	29	0	c	350007169700000001	0-29		22855808	10.1523/JNEUROSCI.0015-12.2012		The Journal of neuroscience : the official journal of the Society for Neuroscience	Live-cell imaging evidence for the ciliary transport of rod photoreceptor opsin by heterotrimeric kinesin-2	Deepti	2012	0		
741	chr7	20457587	20457613	3500333352	26		20457587	20457613	8421504	1	26	0	c,g	350033335200000002,350033335200000002	25-51,25-51						Molecular and biochemical evaluation of anti- proliferative effect of (Cichorium endivia, extracts on breast cancer cell line	ww.e3journals.org	0	0		IL4
741	chr7	20457598	20464833	3500023326	40		20457598	20464833	8421504	3	20,10,10	0,2462,7225	c,g	350002332600000003,350002332600000003,350002332600000002	0-20,0-20,0-20						Title Japanese Journal of Veterinary Research, 61(3): 109-116 Issue Date 2013-08	lib.hokudai.ac.jp	0	0		
741	chr7	20457609	20465266	3500347624	40		20457609	20465266	8421504	2	20,20	0,7637	c,g	350034762400000007,350034762400000007,350034762400000006,350034762400000006	0-20,0-20,0-20,0-20		15749871		0022-1767	The Journal of Immunology	&#x03b3;&#x03b4; T Cell Function Varies with the Expressed WC1 Coreceptor	Rogers	2005	6		
741	chr7	20457613	20484678	3500399883	85		20457613	20484678	8421504	4	20,20,25,20	0,7724,25675,27045	c,g	350039988300000007,350039988300000007,350039988300000006,350039988300000006,350039988300000013,350039988300000012	0-20,0-20,0-20,0-20,0-25,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	bdtd.ufscar.br	0	0		
741	chr7	20457613	20484678	3500177864	85		20457613	20484678	8421504	4	20,20,25,20	0,7724,25675,27045	c,g	350017786400000008,350017786400000008,350017786400000007,350017786400000007,350017786400000014,350017786400000013	0-20,0-20,0-20,0-20,0-25,0-20						Tese Lilian Giotto Zaros	www.teses.usp.br	0	0		
741	chr7	20457613	20484678	3500164845	85		20457613	20484678	8421504	4	20,20,25,20	0,7724,25675,27045	c,g	350016484500000007,350016484500000007,350016484500000006,350016484500000006,350016484500000013,350016484500000012	0-20,0-20,0-20,0-20,0-25,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O QUANTIFICA&#xc7;&#xc3;O DE mRNA DE GENES RELACIONADOS &#xc0; RESPOSTA IMUNE EM B	ww.bdtd.ufscar.br	0	0		
741	chr7	20457613	20484678	3500136902	85		20457613	20484678	8421504	4	20,20,25,20	0,7724,25675,27045	c,g	350013690200000003,350013690200000003,350013690200000002,350013690200000002,350013690200000009,350013690200000008	0-20,0-20,0-20,0-20,0-25,0-20						Quantification of bovine cytokine gene expression using real-time RT-PCR methodology	www.scielo.br	0	0		
741	chr7	20457623	20459955	3500326785	42		20457623	20459955	8421504	3	21,10,11	0,30,2321	c,g	350032678500000003,350032678500000003,350032678500000002	0-21,0-21,0-21			10.1128/IAI.71.11.6411-6419.2003		Infection and Immunity	Revaccination of Neonatal Calves with Mycobacterium bovis BCG Reduces the Level of Protection against Bovine Tuberculosis Induced by a Single Vaccination 	B.	2003	0		
741	chr7	20457630	20482880	3500394731	72		20457630	20482880	8421504	3	26,25,21	0,7597,25229	c,g	350039473100000003,350039473100000002,350039473100000007	0-26,0-25,0-21			10.1111/j.1365-3024.2006.00928.x	1365-3024	Parasite Immunology	Haemonchus contortus intestine: a prominent source of mucosal antigens - JASMER - 2007 - Parasite Immunology - Wiley Online Library	JASMER	2007	0		
741	chr7	20457635	20464834	3500383646	40		20457635	20464834	8421504	3	20,9,11	0,2426,7188	c,g	350038364600000005,350038364600000005,350038364600000004	0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
741	chr7	20457635	20464834	3500034602	40		20457635	20464834	8421504	3	20,9,11	0,2426,7188	c,g	350003460200000009,350003460200000009,350003460200000008	0-20,0-20,0-20						Tesis JRE final 18-01-2012	www.uclm.es	0	0		
741	chr7	20457640	20482894	3500449915	46		20457640	20482894	8421504	2	23,23	0,25231	c,g	350044991500000002,350044991500000013,350044991500000013	0-23,0-23,0-23						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
741	chr7	20457662	20460009	3500146682	64		20457662	20460009	8421504	4	1,19,24,20	0,2282,2302,2327	c,g	350014668200000001,350014668200000002,350014668200000002,350014668200000000,350014668200000000	0-20,0-24,0-24,0-20,0-20			10.1111/j.1365-2249.2006.03053.x		Clinical and Experimental Immunology	Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette&#x2013;Gu&#xe9;rin vaccination	S	2006	0		
741	chr7	20459946	20460009	3500457560	40		20459946	20460009	8421504	2	20,20	0,43	c,g	350045756000000005,350045756000000005,350045756000000004,350045756000000004	0-20,0-20,0-20,0-20						Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle	aldc.nal.usda.gov	0	0		
741	chr7	20459946	20460009	3500312145	40		20459946	20460009	8421504	2	20,20	0,43	c,g	350031214500000003,350031214500000003,350031214500000002,350031214500000002	0-20,0-20,0-20,0-20						Modulation of cytokine gene expression and secretion during the periparturient period in dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis	ddr.nal.usda.gov	0	0		
741	chr7	20459950	20483317	3500120743	42		20459950	20483317	8421504	2	21,21	0,23346	c	350012074300000002,350012074300000004	20-41,22-43						Peripheral and gastrointestinal immune systems of healthy cattle raised outdoors at pasture or indoors on a concentrate-based ration	biomedcentral.com	0	0		
741	chr7	20459982	20465180	3500365742	43		20459982	20465180	8421504	3	7,14,22	0,8,5176	c,g	350036574200000010,350036574200000011,350036574200000011	0-21,0-22,0-22		21039923	10.1111/j.1574-695X.2010.00739.x	1574-695X	FEMS Immunology & Medical Microbiology	Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs - Siva Reddy - 2010 - FEMS Immunology & Medical Microbiology - Wiley Online Library	Siva	2010	0		
741	chr7	20460031	20464867	3500453465	41		20460031	20464867	8421504	2	21,20	0,4816	c,g	350045346500000003,350045346500000003,350045346500000002,350045346500000002	0-21,0-21,0-20,0-20						Expression profile of genes associated with mastitis in dairy cattle	cnptia.embrapa.br	0	0		
741	chr7	20460039	20460064	3500328855	25		20460039	20460064	8421504	1	25	0	c	350032885500000752	0-25						Polynucleotide encoding cytokine receptor zcytor17 multimer - US Patent 7494804 Description	ww.patentstorm.us	0	0		
741	chr7	20460042	20460067	3500326748	25		20460042	20460067	8421504	1	25	0	c	350032674800000005	0-25						Human interleukin-4 muteins	Anderson	1988	0		
741	chr7	20460046	20460070	3500467254	24		20460046	20460070	8421504	1	24	0	c	350046725400000012	0-24						Gastroenterology World Journal of	www.wjgnet.com	0	0		
741	chr7	20460049	20464825	3500464215	23		20460049	20464825	8421504	2	21,2	0,4774	c	350046421500000033	0-23						Method of identifying activated T-cells	Dolganov	1996	0		
741	chr7	20460053	20464857	3500340694	48		20460053	20464857	8421504	3	17,10,21	0,4770,4783	c	350034069400000007,350034069400000006	0-27,0-21						Emprego da RT-PCR em tempo real para a quantifica&#xe7;&#xe3;o da express&#xe3;o de genes associados &#xe0; resposta imune em bezerros bovinos experimentalmente infectados por N caninum	pt.scribd.com	0	0		
741	chr7	20460142	20483665	3500124247	60		20460142	20483665	8421504	3	20,20,20	0,23103,23503	c,g	350012424700000016,350012424700000020,350012424700000018	0-20,0-20,0-20						Flavia Aline Bressani Donatoni Prospec&#xe7;&#xe3;o de SNPs por eletroforese capilar e sua identifica&#xe7;&#xe3;o em genes candidatos relacionados &#xe0; resist&#xea;ncia de caprinos a nemat&#xf3;ides gastrintestinais	www.teses.usp.br	0	0		
741	chr7	20464839	20483615	3500345578	41		20464839	20483615	8421504	2	21,20	0,18756	c	350034557800000002,350034557800000006	0-21,19-39						R&#xf4;le des &#xe9;osinophiles dans la r&#xe9;gulation des populations d'Haemonchus contortus chez le mouton	s.inp-toulouse.fr	0	0		
741	chr7	20464839	20483615	3500307224	41		20464839	20483615	8421504	2	21,20	0,18756	c	350030722400000002,350030722400000006	0-21,19-39						Haemonchus contortus (Nematoda: Trichostrongylidae) infection in lambs elicits an unequivocal Th	etres-archive.org	0	0		
741	chr7	20464839	20483615	3500043402	41		20464839	20483615	8421504	2	21,20	0,18756	c	350004340200000002,350004340200000006	0-21,19-39						Haemonchus contortus (Nematoda: Trichostrongylidae) infection in lambs elicits an unequivocal Th	www.vetres.org	0	0		
741	chr7	20483319	20483414	3500282923	40		20483319	20483414	8421504	2	20,20	0,75	c,g	350028292300000007,350028292300000006	0-20,0-20						Minisequencing on Functionalised Self-Assembled Monolayer as a Simple Approach for Single Nucleotide Polymorphism Analysis of Cattle	.znaturforsch.com	0	0		
741	chr7	20483595	20484599	3500370177	39		20483595	20484599	8421504	3	20,8,11	0,32,993	c,g	350037017700000005,350037017700000005,350037017700000004	0-20,0-20,0-19		18337375	10.1128/CVI.00034-08	1556-6811	Clinical and Vaccine Immunology	Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone	Wedlock	2008	3		
741	chr7	20483595	20484599	3500005370	39		20483595	20484599	8421504	3	20,8,11	0,32,993	c	350000537000000005,350000537000000004	0-20,0-19		18337375	10.1128/CVI.00034-08		Clinical and Vaccine Immunology : CVI	Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone 	D.	2008	0		
742	chr7	20580439	20582759	3500131600	285		20580439	20582759	8421504	4	93,27,129,36	0,338,2048,2284	p,c	350013160000015007,350013160000000011,350013160000000022,350013160000015008,350013160000000012,350013160000000024,350013160000000014,350013160000000025,350013160000000015,350013160000000026,350013160000000016,350013160000000027	3-48,12-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Immune response modulators and uses therefor	Seow	1997	0		
742	chr7	20580506	20580784	3500457560	44		20580506	20580784	8421504	3	20,11,13	0,48,265	c	350045756000000012,350045756000000013	0-20,0-24						Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle	aldc.nal.usda.gov	0	0		
742	chr7	20580509	20582553	3500274037	40		20580509	20582553	8421504	2	20,20	0,2024	c	350027403700000088,350027403700000089	0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
742	chr7	20580544	20580773	3500120743	23		20580544	20580773	8421504	2	21,2	0,227	c	350012074300000003	20-43						Peripheral and gastrointestinal immune systems of healthy cattle raised outdoors at pasture or indoors on a concentrate-based ration	biomedcentral.com	0	0		
742	chr7	20580559	20580789	3500442928	24		20580559	20580789	8421504	2	6,18	0,212	c	350044292800000002	0-24						POMC, iNOS, PGES, IL-4, IL-5 and IL-10 Gene Expression in Peripheral Blood Mononuclear Cells of Cyclic and Pregnant Mares [1]	rgi.kafkas.edu.tr	0	0		
742	chr7	20580783	20582493	3500345578	27		20580783	20582493	8421504	2	21,6	0,1704	c	350034557800000008	21-48						R&#xf4;le des &#xe9;osinophiles dans la r&#xe9;gulation des populations d'Haemonchus contortus chez le mouton	s.inp-toulouse.fr	0	0		
742	chr7	20580783	20582493	3500307224	27		20580783	20582493	8421504	2	21,6	0,1704	c	350030722400000008	21-48						Haemonchus contortus (Nematoda: Trichostrongylidae) infection in lambs elicits an unequivocal Th	etres-archive.org	0	0		
742	chr7	20580783	20582493	3500043402	27		20580783	20582493	8421504	2	21,6	0,1704	c	350004340200000008	21-48						Haemonchus contortus (Nematoda: Trichostrongylidae) infection in lambs elicits an unequivocal Th	www.vetres.org	0	0		
742	chr7	20631581	20634448	3500426301	42		20631581	20634448	8421504	2	22,20	0,2847	c,g	350042630100000000,350042630100000001,350042630100000001	0-22,0-20,0-20					Molecular and Cellular Biology	The Fanconi Anemia Protein FANCC Binds to and Facilitates the Activation of STAT1 by Gamma Interferon and Hematopoietic Growth Factors	Qishen	July	0		IRF1
742	chr7	20631586	20631611	3500149951	25		20631586	20631611	8421504	1	25	0	g	350014995100000020	1-26			10.1046/j.1432-1033.2003.03380.x	1432-1033	European Journal of Biochemistry	Genomic structure, expression and characterization of a STAT5 homologue from pufferfish (Tetraodon fluviatilis) - Sung - 2003 - European Journal of Biochemistry - Wiley Online Library	Sung	2003	0		
742	chr7	20631587	20631613	3500304329	26		20631587	20631613	8421504	1	26	0	g	350030432900000000	0-26						Opposing effects of PMLand PML/RAR on STAT3 activity	tologylibrary.org	0	0		
742	chr7	20631587	20631610	3500202437	23		20631587	20631610	8421504	1	23	0	g	350020243700000002	0-23		17105733	10.1074/jbc.M607674200	0021-9258	Journal of Biological Chemistry	A Novel c-Jun-dependent Signal Transduction Pathway Necessary for the Transcriptional Activation of Interferon &#x03b3; Response Genes	Gough	2007	5		
742	chr7	20633002	20635363	3500123461	192		20633002	20635363	8421504	4	48,73,23,48	0,1373,2242,2313	p	350012346100015024,350012346100015026,350012346100015027,350012346100015029	0-48,0-48,0-48,0-48						Identification of genes altered in multiple myeloma - Patent # 6245562 - PatentGenius	.patentgenius.com	0	0		IRF1
742	chr7	20634390	20635255	3500317619	43		20634390	20635255	8421504	3	21,11,11	0,47,854	c	350031761900000005,350031761900000006	0-21,0-22		15155784	10.1210/me.2003-0467	0888-8809	Molecular Endocrinology	Convergence of Interferon-&#x03b3; and Progesterone Signaling Pathways in Human Endometrium: Role of PIASy (Protein Inhibitor of Activated Signal Transducer and Activator of Transcription-y)	Zoumpoulidou	2004	5		IRF1
742	chr7	20634394	20635353	3500319127	40		20634394	20635353	8421504	2	20,20	0,939	c,g	350031912700000016,350031912700000016,350031912700000017,350031912700000017	0-20,0-20,0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
742	chr7	20634440	20635264	3500307283	28		20634440	20635264	8421504	2	8,20	0,804	c	350030728300000000	20-48		19502235	10.1074/jbc.M109.019505		The Journal of Biological Chemistry	Cooperative Regulation of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by Core Components of the Molecular Chaperone Machinery	Vikram	2009	0		
742	chr7	20634444	20635264	3500069502	24		20634444	20635264	8421504	2	4,20	0,800	c	350006950200000004	0-24		20435892	10.1074/jbc.M110.100818	0021-9258	Journal of Biological Chemistry	Activation of IL-27 p28 Gene Transcription by Interferon Regulatory Factor 8 in Cooperation with Interferon Regulatory Factor 1	Zhang	2010	5		IRF1
742	chr7	20634447	20635269	3500336074	26		20634447	20635269	8421504	2	1,25	0,797	c	350033607400000007	0-26		16636670	10.1038/sj.onc.1209566	0950-9232	Oncogene	Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells	Pramoonjago	2006	6		
742	chr7	20636131	20636462	3500143371	24		20636131	20636462	8421504	2	17,7	0,324	c	350014337100000012	0-24		23226549	10.1371/journal.pone.0050932		PLoS ONE	Interferon-&#x03b3; Upregulates Expression of IFP35 Gene in HeLa Cells via Interferon Regulatory Factor-1	Wei	2012	0		
742	chr7	20637409	20637826	3500157219	41		20637409	20637826	8421504	3	20,4,17	0,82,400	c	350015721900000003,350015721900000004	0-20,0-21		18239051	10.1530/REP-07-0415	1470-1626	Reproduction	Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle	Mitko	2008	3		
743	chr7	20728383	20730264	3500380098	38		20728383	20730264	8421504	2	19,19	0,1862	c,g	350038009800000025,350038009800000025,350038009800000024,350038009800000024	0-19,0-19,0-19,0-19						Genes involved in carnitine synthesis and carnitine uptake are up-regulated in the liver of sows during lactation	eb.uni-giessen.de	0	0		SLC22A5
743	chr7	20728383	20730264	3500355847	38		20728383	20730264	8421504	2	19,19	0,1862	c,g	350035584700000046,350035584700000046,350035584700000045,350035584700000045	0-19,0-19,0-19,0-19						Untersuchungen zu genomweiten Ver&#xe4;nderungen der Genexpression in der Leber von Sauen w&#xe4;hrend der Laktation	eb.uni-giessen.de	0	0		SLC22A5
743	chr7	20728383	20730264	3500086329	38		20728383	20730264	8421504	2	19,19	0,1862	c,g	350008632900000025,350008632900000025,350008632900000024,350008632900000024	0-19,0-19,0-19,0-19							.actavetscand.com	0	0		SLC22A5
743	chr7	20728503	20728527	3500157726	24		20728503	20728527	8421504	1	24	0	c	350015772600000003	0-24		15793098	10.1128/AAC.49.4.1279-1288.2005	0066-4804	Antimicrobial Agents and Chemotherapy	Accumulation and Oriented Transport of Ampicillin in Caco-2 Cells from Its Pivaloyloxymethylester Prodrug, Pivampicillin	Chanteux	2005	5		
743	chr7	20734039	20734068	3500412505	25		20734039	20734068	8421504	3	8,5,12	0,10,17	c	350041250500000020	20-45						US Patent # 5,837,479. Screening assays for inhibitors of mammalian prostaglandin H synthase-2 - Patents.com	www.patents.com	0	0		
743	chr7	20734039	20734068	3500380718	25		20734039	20734068	8421504	3	8,5,12	0,10,17	c	350038071800000021	20-45						Mammalian prostaglandin h synthase-2	O'Banion	1996	0		
743	chr7	20734039	20734068	3500258533	25		20734039	20734068	8421504	3	8,5,12	0,10,17	c	350025853300000021	20-45					Patent	Method of inhibiting prostaglandin synthesis in a human host (Patent US:6048850)	O'Banion	2000	0		
744	chr7	20906538	20909092	3500466715	48		20906538	20909092	8421504	2	25,23	0,2531	p	350046671500015012	0-48						Novel lysyl hydroxylase isoforms	herkules.oulu.fi	0	0		P4HA2
745	chr7	21090773	21092806	3500463327	47		21090773	21092806	8421504	2	23,24	0,2009	c	350046332700000047,350046332700000023,350046332700000046,350046332700000022	11-34,11-34,12-36,12-36					Patent	Vaccins adn ameliores pour herpesvirus-1 bovin (Patent EP:1248650)	Audonnet	2006	0		
745	chr7	21090773	21092806	3500367862	50		21090773	21092806	8421504	2	26,24	0,2009	c,g	350036786200000164,350036786200000159	48-74,12-36						Improved dna vaccines for production-type animals	Audonnet	2002	0		
745	chr7	21090773	21092806	3500303979	50		21090773	21092806	8421504	2	26,24	0,2009	c	350030397900000227,350030397900000121,350030397900000225,350030397900000119,350030397900000224,350030397900000118	11-37,11-37,11-34,11-34,12-36,12-36						 DNA Vaccines For Farm Animals, In Particular Bovines And Porcines 	www.docstoc.com	0	0		
745	chr7	21090773	21092806	3500276508	47		21090773	21092806	8421504	2	23,24	0,2009	c	350027650800000023,350027650800000047,350027650800000022,350027650800000046	11-34,11-34,12-36,12-36					Patent	Vaccins adn ameliores pour herpesvirus-1 bovin (Patent EP:1248650)	Audonnet	2006	0		
745	chr7	21090773	21092806	3500232418	47		21090773	21092806	8421504	2	23,24	0,2009	c	350023241800000058,350023241800000057	11-34,12-36						Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3	Audonnet	2005	0		
745	chr7	21090773	21092806	3500163096	47		21090773	21092806	8421504	2	23,24	0,2009	c	350016309600000058,350016309600000057	11-34,12-36						Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3	Audonnet	2004	0		
745	chr7	21090773	21092806	3500095783	50		21090773	21092806	8421504	2	26,24	0,2009	c	350009578300000103,350009578300000105,350009578300000102	11-34,11-37,12-36						Vaccins adn ameliores pour animaux de rente	Audonnet	2002	0		
745	chr7	21090773	21092806	3500012787	50		21090773	21092806	8421504	2	26,24	0,2009	c	350001278700000205,350001278700000209,350001278700000204	11-34,11-37,12-36						Improved DNA vaccines for production-type animals	J-C*F*Ao Duo Nai Te 	2003	0		
745	chr7	21090773	21092806	3500009333	50		21090773	21092806	8421504	2	26,24	0,2009	c	350000933300000119,350000933300000225,350000933300000121,350000933300000227,350000933300000118,350000933300000224	11-34,11-34,11-37,11-37,12-36,12-36						DNA vaccines for farm animals, in particular bovines and porcines - Patent # 6852705 - PatentGenius	.patentgenius.com	0	0		
745	chr7	21090773	21090799	3500453912	26		21090773	21090799	8421504	1	26	0	c	350045391200000108	11-37					Patent	Improved DNA vaccines for production-type animals (Patent CN:1404398)	J-C*F*Ao Duo Nai Te 	2012	0		
745	chr7	21090775	21092806	3500251331	48		21090775	21092806	8421504	2	23,25	0,2006	c	350025133100000001,350025133100000000	9-32,9-34		12244180		0022-1767	The Journal of Immunology	DNA-Encoded Fetal Liver Tyrosine Kinase 3 Ligand and Granulocyte Macrophage-Colony-Stimulating Factor Increase Dendritic Cell Recruitment to the Inoculation Site and Enhance Antigen-Specific CD4+ T Cell Responses Induced by DNA Vaccination of Outbred Anim	Mwangi	2002	6		
745	chr7	21090778	21092806	3500024776	285		21090778	21092806	8421504	7	45,12,84,39,9,48,48	0,93,885,972,1730,1884,1980	p	350002477600015082,350002477600015090,350002477600015080,350002477600015079,350002477600015086,350002477600015084,350002477600015073	0-45,3-48,0-48,0-48,0-48,0-48,0-48						Dna Immunization With Recombinase/transposase 	.freshpatents.com	0	0		
93	chr7	21090794	21105821	3500265224	40		21090794	21105821	8421504	2	20,20	0,15007	c,g	350026522400000023,350026522400000023,350026522400000005,350026522400000005	0-20,0-20,0-20,0-20						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
745	chr7	21091688	21091712	3500357889	24		21091688	21091712	8421504	1	24	0	c	350035788900000006	0-24						SureChem - Document - WO/PCT - Patent No. 1997027327 - "METHODS AND COMPOSITIONS FOR DETECTING BINDING OF LIGAND PAIR USING NON-FLUORESCENT LABEL" - Description	www.surechem.org	0	0		CSF2
745	chr7	21091688	21091712	3500340613	24		21091688	21091712	8421504	1	24	0	c	350034061300000006	0-24						Methods and compositions for enhancing sensitivity in the analysis of biological-based assays	Ness	1997	0		CSF2
745	chr7	21091688	21091712	3500212648	24		21091688	21091712	8421504	1	24	0	c	350021264800000006	0-24						 Methods And Compositions For Enhancing Sensitivity In The Analysis Of Biological 	www.docstoc.com	0	0		CSF2
745	chr7	21091688	21091712	3500173543	24		21091688	21091712	8421504	1	24	0	c	350017354300000019,350017354300000006	0-24,0-24						 Methods And Compositions For Enhancing Sensitivity In The Analysis Of Biological 	www.docstoc.com	0	0		CSF2
745	chr7	21091688	21091712	3500135427	24		21091688	21091712	8421504	1	24	0	c	350013542700000006	0-24						US Patent # 6,027,890. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays - Patents.com	www.patents.com	0	0		CSF2
745	chr7	21092670	21092806	3500277919	44		21092670	21092806	8421504	2	21,23	0,113	c	350027791900000005,350027791900000003,350027791900000006	0-21,0-21,21-44						Equine granulocyte-macrophage colony-stimulating factor (gm-csf)	Andreoni	2000	0		
745	chr7	21092782	21092806	3500378178	24		21092782	21092806	8421504	1	24	0	c	350037817800000033	12-36					Patent	Improved dna vaccines for bovine herpesvirus-1 (Patent EP:1248650)	Audonnet	2006	0		
745	chr7	21092782	21092806	3500271240	24		21092782	21092806	8421504	1	24	0	c	350027124000000033	12-36					Patent	Improved dna vaccines for bovine herpesvirus-1 (Patent EP:1248650)	Audonnet	2006	0		
745	chr7	21092783	21092806	3500069346	23		21092783	21092806	8421504	1	23	0	c	350006934600000067,350006934600000138	21-44,21-44					Patent	Dna vaccines for pets or for animals used in sports (Patent CA:2375320)	Fischer	2013	0		
746	chr7	21197636	21197663	3500013193	23		21197636	21197663	8421504	2	13,10	0,17	c	350001319300000077	9-39						VARIABLE DOMAINS OF CAMELID HEAVY-CHAIN ANTIBODIES DIRECTED AGAINST GLIAL FIBRILLARY ACIDIC PROTEINS - Patent application	www.faqs.org	0	0		
747	chr7	21341136	21341162	3500123306	25		21341136	21341162	8421504	2	10,15	0,11	g	350012330600000017	0-27						Parasite Vaccine	Snell	2010	0		
747	chr7	21341136	21341162	3500036058	25		21341136	21341162	8421504	2	10,15	0,11	g	350003605800000013	0-27		18367645	10.1101/gad.1656508		Genes & Development	The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes	Yanjie	2008	0		
750	chr7	21651847	21651874	3500418252	24		21651847	21651874	8421504	2	8,16	0,11	c	350041825200000144	7-47						US Patent # 7,157,262. Lipolytic enzymes - Patents.com	www.patents.com	0	0		
750	chr7	21653638	21653664	3500007842	23		21653638	21653664	8421504	2	8,15	0,11	c	350000784200000067,350000784200000066,350000784200000021,350000784200000020	0-23,10-33,0-23,10-33						Modified Bacillus Anthracis, Vaccine Compositions And Methods Of Use Thereof 	.freshpatents.com	0	0		
751	chr7	21881650	21881681	3500449854	24		21881650	21881681	8421504	3	11,8,5	0,16,26	g	350044985400000002	10-35		16321939	10.1128/JB.187.24.8350-8360.2005	0021-9193	Journal of Bacteriology	luxS-Dependent Gene Regulation in Escherichia coli K-12 Revealed by Genomic Expression Profiling	Wang	2005	4		
753	chr7	22109505	22109531	3500453399	24		22109505	22109531	8421504	2	12,12	0,14	g	350045339900000002	5-29		20003420	10.1186/1471-2199-10-108	1471-2199	BMC Molecular Biology	Transpositionally active episomal hAT elements	O'Brochta	2009	3		
754	chr7	22164799	22164825	3500459975	23		22164799	22164825	8421504	2	18,5	0,21	g	350045997500000000	0-23					Neoplasia (New York, N.Y.)	Oncogenic Activation of MAP Kinase by BRAF Pseudogene in Thyroid Tumors	Minjing	2009	0		
757	chr7	22614256	22614303	3500445505	43		22614256	22614303	8421504	2	7,36	0,11	c	350044550500000000	31-74						Treating degenerative joint disorders with tribonectins	Jay	2004	0		
759	chr7	22902991	22903014	3500387324	23		22902991	22903014	8421504	1	23	0	g	350038732400000011	0-33						Recombinant fowlpox vaccine for protection against Marek's disease - US Patent 5369025 Description	ww.patentstorm.us	0	0		
761	chr7	23174825	23174849	3500331821	24		23174825	23174849	8421504	1	24	0	c	350033182100000036	0-24						Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma	.aacrjournals.org	0	0		ADAMTS19
771	chr7	24486344	24486370	3500093266	23		24486344	24486370	8421504	3	12,5,6	0,14,20	g	350009326600000306	0-23						Methods and compositions for diagnosing and treating chromosome -18p related disorders	Chen	2000	0		
772	chr7	24590134	24590163	3500179690	24		24590134	24590163	8421504	2	15,9	0,20	g	350017969000000100	13-37						 Osp A And B Sequence Of Borrelia Burgdonferi Strains ACA1 And IP90 	www.docstoc.com	0	0		
774	chr7	24798715	24798883	3500313338	168		24798715	24798883	8421504	1	168	0	p	350031333800015000,350031333800015006	327-495,6-66						Activation of the thiazide-sensitive Na -Cl cotransporter by the WNK-regulated kinases SPAK and OSR1	cs.biologists.org	0	0		SLC12A2
774	chr7	24798820	24798880	3500406196	60		24798820	24798880	8421504	1	60	0	p	350040619600015003	6-66		18270262	10.1242/jcs.025312	0021-9533	Journal of Cell Science	Activation of the thiazide-sensitive Na+-Cl&#x2013; cotransporter by the WNK-regulated kinases SPAK and OSR1	Richardson	2008	6		SLC12A2
774	chr7	24798820	24798880	3500385742	60		24798820	24798880	8421504	1	60	0	p	350038574200015003	6-66		18270262	10.1242/jcs.025312	0021-9533	Journal of Cell Science	Activation of the thiazide-sensitive Na+-Cl&#x2013; cotransporter by the WNK-regulated kinases SPAK and OSR1	Richardson	2008	6		SLC12A2
774	chr7	24842802	24842832	3500276090	25		24842802	24842832	8421504	2	19,6	0,24	g	350027609000000077,350027609000000158	3-28,3-28						ANTI IgE ANTIBODIES - Patent application	www.faqs.org	0	0		
774	chr7	24842802	24842832	3500122920	25		24842802	24842832	8421504	2	19,6	0,24	g	350012292000000041	3-28						Anti-IgE antibodies - Patent application	www.faqs.org	0	0		
775	chr7	24914998	24915026	3500179654	24		24914998	24915026	8421504	2	14,10	0,18	g	350017965400000002	15-40			10.1128/AEM.67.5.2222-2229.2001		Applied and Environmental Microbiology	Mycobacterium Diversity and Pyrene Mineralization in Petroleum-Contaminated Soils	Pui-Yi	2001	0		
777	chr7	25193438	25193463	3500246276	24		25193438	25193463	8421504	2	15,9	0,16	g	350024627600000031	9-33						ATTENUATED VIRUSES, VACCINES AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
777	chr7	25257046	25257070	3500445239	24		25257046	25257070	8421504	1	24	0	c	350044523900000007	20-44						Robert W. Li, Matthew J. Meyer, Curtis. P. Van Tassell, Tad S. Sonstegard, Erin E. Connor, Michael E. Van Amburgh, Yves R. Boisclair and Anthony V. Capuco Physiol Genomics 27:42-53, 2006. First published Jun 20, 2006; This article cites 42 articles, 25 of	ddr.nal.usda.gov	0	0		
778	chr7	25342679	25342705	3500109714	25		25342679	25342705	8421504	2	16,9	0,17	g	350010971400000050	15-40						Plant fatty acid synthases	Knauf	1991	0		
779	chr7	25535465	25545929	3500226354	24		25535465	25545929	8421504	3	8,15,1	0,13,10463	c	350022635400000031,350022635400000104	8-33,8-33						Rapid Expression Cloning of Human Monoclonal Antibodies from Memory B Cells - Patent application	www.faqs.org	0	0		
780	chr7	25608123	25608151	3500224267	23		25608123	25608151	8421504	3	5,5,13	0,7,15	g	350022426700000274	0-23						Methods And Nucleic Acids For Analyses Of Colorectal Cell Proliferative Disorders 	.freshpatents.com	0	0		
780	chr7	25629597	25641032	3500088918	201		25629597	25641032	8421504	4	76,20,73,32	0,1411,1440,11403	p	350008891800015025,350008891800015024,350008891800015109	0-96,0-105,0-96						and the Immune System of Drosophila melanogaster.	edoc.hu-berlin.de	0	0		MEGF10
780	chr7	25661434	25661461	3500298477	24		25661434	25661461	8421504	2	17,7	0,20	g	350029847700000002	0-24						Functional Characterization of Mutations in Inherited Human cPLA Deficiency	ty.washington.edu	0	0		
781	chr7	25739299	25739324	3500278114	24		25739299	25739324	8421504	2	5,19	0,6	g	350027811400000106	6-44					Patent	Hog cholera virus vaccine and diagnostic (Patent US:5811103)	Meyers	1998	0		
784	chr7	26130362	26130394	3500121462	28		26130362	26130394	8421504	2	12,16	0,16	c	350012146200000238	57-85						DETECTION OF MUTATIONS IN A GENE ASSOCIATED WITH RESISTANCE TO VIRAL INFECTION, MX1 - Patent application	www.faqs.org	0	0		
784	chr7	26130363	26130392	3500390912	29		26130363	26130392	8421504	1	29	0	c	350039091200000058	22-51						UNIVERSITE DE LIMOGES	cations.unilim.fr	0	0		
12	chr7	26187669	26218228	3500020417	564		26187669	26218228	8421504	8	108,54,68,13,24,85,107,105	0,1953,2689,8688,24675,27020,28026,30454	p	350002041700015002,350002041700015040,350002041700015041,350002041700015039	0-243,0-321,0-321,0-321						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		
785	chr7	26314665	26314692	3500025178	23		26314665	26314692	8421504	2	6,17	0,10	g	350002517800000011	10-36						First inducible transgene expression in porcine large animal models	www.fasebj.org	0	0		
790	chr7	26936400	26936429	3500413818	25		26936400	26936429	8421504	3	12,6,7	0,13,22	g	350041381800000011,350041381800000016,350041381800000004,350041381800000007,350041381800000008,350041381800000018	12-42,12-42,12-42,12-42,12-42,12-42						Small interfering oligonucleotides comprising arabinose modified nucleotides	Damha	2008	0		
791	chr7	27040576	27040602	3500100734	23		27040576	27040602	8421504	2	10,13	0,13	g	350010073400000440	21-44						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
795	chr7	27525824	27525851	3500406593	24		27525824	27525851	8421504	2	10,14	0,13	g	350040659300000001	3-27						Lipid Signaling Protocols	.researchgate.net	0	0		
796	chr7	27702654	27702679	3500065296	24		27702654	27702679	8421504	2	18,6	0,19	g	350006529600000019	3-27						Gene expression profile of epithelial cells and mesenchymal cells derived from limbal explant culture	www.molvis.org	0	0		
798	chr7	28019019	28019046	3500096062	26		28019019	28019046	8421504	2	22,4	0,23	g	350009606200000034	2-28						Inhibition Of Viral Gene Expression Using Small Interfering Rna 	.freshpatents.com	0	0		
799	chr7	28099110	28131949	3500155230	40		28099110	28131949	8421504	3	8,12,20	0,9,32819	g	350015523000000122,350015523000000007	13-33,7-27						 Microbially Expresses Xylanases And Their Use As Feed Additives And Other Uses 	www.docstoc.com	0	0		
805	chr7	28845163	28929535	3500369501	424		28845163	28929535	8421504	13	32,114,24,2,48,2,34,45,3,24,48,2,46	0,33,13937,14470,33462,33513,39685,39725,39886,39946,52960,74578,84326	c	350036950100000255,350036950100000225,350036950100000224,350036950100000223,350036950100000025,350036950100000243,350036950100000210	0-172,0-48,6-42,0-48,24-48,0-48,0-48						Protein kinases	Hoekstra	1994	0		
805	chr7	28845163	28898219	3500177828	292		28845163	28898219	8421504	8	32,114,24,2,45,3,24,48	0,33,13937,14470,39725,39886,39946,53008	c	350017782800000259,350017782800000227,350017782800000025,350017782800000246	0-172,0-48,24-48,0-48					Patent	Protein kinases (Patent US:5756289)	Hoekstra	1998	0		
805	chr7	28873419	28898162	3500461058	40		28873419	28898162	8421504	2	20,20	0,24723	c	350046105800000015,350046105800000014	0-20,0-20			10.1002/ijc.11152	1097-0215	International Journal of Cancer	Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells - Masuda - 2003 - International Journal of Cancer - Wiley Online Library	Masuda	2003	0		CSNK1G3
805	chr7	28885109	28885133	3500222750	24		28885109	28885133	8421504	1	24	0	c	350022275000000025	24-48					Patent	Protein kinases (Patent US:6060296)	Hoekstra	2000	0		
807	chr7	29143673	29143702	3500057503	26		29143673	29143702	8421504	2	19,7	0,22	c	350005750300000130	1-27						Genomic Screen for Epigenetically Silenced Genes Associated With Cancer	Baylin	2009	0		
809	chr7	29371568	29371595	3500415415	24		29371568	29371595	8421504	2	9,15	0,12	c	350041541500000001	5-29		23179371	10.1007/s00401-012-1063-8		Acta Neuropathologica	Charcot&#x2013;Marie&#x2013;Tooth type 2B disease-causing RAB7A mutant proteins show altered interaction with the neuronal intermediate filament peripherin	Laura	2013	0		
809	chr7	29371936	29468582	3500248703	468		29371936	29468582	8421504	9	99,70,2,84,5,64,13,128,3	0,7224,16166,16204,16504,27505,27617,31167,96643	c,g	350024870300000196,350024870300000164,350024870300000195,350024870300000363,350024870300000163,350024870300000359,350024870300000159,350024870300000189,350024870300000157,350024870300000188,350024870300000151,350024870300000275,350024870300000273,350024870300000148,350024870300000272,350024870300000299,350024870300000299,350024870300000271	0-39,0-48,0-48,0-27,0-48,0-48,0-48,6-48,0-47,12-48,0-48,0-33,0-48,0-48,0-48,0-36,0-36,0-48						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		PRDM6
809	chr7	29388905	29388929	3500423166	23		29388905	29388929	8421504	2	14,9	0,15	g	350042316600000043	8-31						Compounds and methods for treatment and diagnosis of chlamydial infection	Bhatia	2008	0		
809	chr7	29388905	29388929	3500312638	23		29388905	29388929	8421504	2	14,9	0,15	g	350031263800000085	8-31						Compounds and methods for treatment and diagnosis of chlamydial infection	P*Pu Luo Bu Si Te 	2003	0		
809	chr7	29398644	29398674	3500145023	23		29398644	29398674	8421504	3	12,5,6	0,15,24	g	350014502300000040	4-27						METHODS FOR PRODUCING CERAMIDE USING TRANSFORMED YEAST - Patent application	www.faqs.org	0	0		
809	chr7	29403213	29478048	3500248703	256		29403213	29478048	8421504	7	18,30,6,59,38,58,47	0,65366,65400,65445,65636,74729,74788	c	350024870300000146,350024870300000270,350024870300000144,350024870300000268,350024870300000140,350024870300000139,350024870300000138	0-48,15-48,0-47,9-48,0-48,0-48,0-47						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		PRDM6
810	chr7	29542983	29546961	3500367934	124		29542983	29546961	8421504	2	92,32	0,3946	c	350036793400000215	0-124						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
814	chr7	30101180	30101206	3500446401	24		30101180	30101206	8421504	2	19,5	0,21	c	350044640100000033	21-45						Human melanocyte stimulating hormone receptor polypeptide and DNA	Wikberg	1995	0		
814	chr7	30101180	30101206	3500208026	24		30101180	30101206	8421504	2	19,5	0,21	c	350020802600000035	0-24						Probes and methods for detecting melanocortin-5 receptor	Yamada	1997	0		
814	chr7	30101180	30101206	3500189032	24		30101180	30101206	8421504	2	19,5	0,21	c	350018903200000035	0-24						Genes encoding melanocortin receptors	Yamada	1994	0		
814	chr7	30121302	30127108	3500249529	96		30121302	30127108	8421504	2	66,30	0,5776	p	350024952900015018	3-99						Compositions for treatment of cancer	Jia	2007	0		
817	chr7	30462668	30473540	3500455055	747		30462668	30473540	8421504	7	127,109,138,157,96,116,4	0,477,1657,3330,6797,7255,10868	p	350045505500015025,350045505500015024,350045505500015022	0-396,0-741,0-732						Lox and loxl2 inhibitors and uses thereof	Smith	2009	0		
817	chr7	30463252	30466018	3500412680	40		30463252	30466018	8421504	3	2,18,20	0,1073,2746	c	350041268000000008,350041268000000009	0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		
817	chr7	30463252	30466018	3500105107	40		30463252	30466018	8421504	3	2,18,20	0,1073,2746	c	350010510700000008,350010510700000009	0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		
817	chr7	30463252	30466018	3500035761	40		30463252	30466018	8421504	3	2,18,20	0,1073,2746	c	350003576100000008,350003576100000009	0-20,0-20						Enhanced transforming growth factor- signaling and &#xfb01;brogenesis in ovine fetal skeletal muscle of obese dams at late gestation	do.physiology.org	0	0		
817	chr7	30464327	30466052	3500366333	44		30464327	30466052	8421504	2	23,21	0,1704	c	350036633300000002,350036633300000003	0-23,0-21		21640519	10.1016/j.ijrobp.2011.04.027		International journal of radiation oncology, biology, physics	IMPACT OF HYPOXIA ON THE METASTATIC POTENTIAL OF HUMAN PROSTATE CANCER CELLS	YAO	2011	0		LOX
817	chr7	30464350	30469521	3500025030	40		30464350	30469521	8421504	2	20,20	0,5151	c,g	350002503000000004,350002503000000004,350002503000000005	0-20,0-20,0-20		21165333	10.4196/kjpp.2010.14.5.331		The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology	CaMKII Inhibitor KN-62 Blunts Tumor Response to Hypoxia by Inhibiting HIF-1&#x03b1; in Hepatoma Cells	Kyoung-Hwa	2010	0		LOX
817	chr7	30464350	30464373	3500349912	23		30464350	30464373	8421504	1	23	0	c,g	350034991200000024,350034991200000024	0-23,0-23						JBC Papers in Press. Published on November 26, 2012 as Manuscript M112.424366 Fetal fibronectin and amnion http://www.jbc.org/cgi/doi/10.1074/jbc.M112.424366	www.jbc.org	0	0		LOX
817	chr7	30466053	30466076	3500262698	23		30466053	30466076	8421504	1	23	0	c	350026269800000014	0-23						Three-dimensional culture promotes reconstitution of the tumor- specific hypoxic microenvironment under TGF stimulation	-publications.com	0	0		
817	chr7	30469524	30469957	3500257960	433		30469524	30469957	8421504	1	433	0	c,g	350025796000000023,350025796000000012,350025796000000012,350025796000000006,350025796000000007,350025796000000024,350025796000000013,350025796000000013	1-152,0-20,0-20,1-50,0-381,0-147,0-20,0-20						 DNA Markers For Meat Tenderness 	www.docstoc.com	0	0		
817	chr7	30470020	30473543	3500416172	26		30470020	30473543	8421504	2	19,7	0,3516	c	350041617200000003	0-26						LysylOxidaseInteractswithHormonePlacentalLactogen andSynergisticallyPromotesBreastEpithelialCell ProliferationandMigration	array.petagen.com	0	0		LOX
817	chr7	30470020	30473543	3500062671	26		30470020	30473543	8421504	2	19,7	0,3516	c	350006267100000003	0-26						LysylOxidaseInteractswithHormonePlacentalLactogen andSynergisticallyPromotesBreastEpithelialCell ProliferationandMigration	www.jbc.org	0	0		LOX
819	chr7	30691479	30691502	3500156769	23		30691479	30691502	8421504	1	23	0	g	350015676900000004	18-41						M&#xe9;moire de th&#xe8;se	esups.ups-tlse.fr	0	0		
820	chr7	30882975	30883003	3500436488	23		30882975	30883003	8421504	2	7,16	0,12	g	350043648800000067	6-29						Anti-c35 Antibodies For Treating Cancer 	.freshpatents.com	0	0		
820	chr7	30882975	30883003	3500104282	23		30882975	30883003	8421504	2	7,16	0,12	g	350010428200000067	6-29						Anti-C35 antibodies for treating cancer - Patent application	www.faqs.org	0	0		
821	chr7	31012818	31012843	3500135598	24		31012818	31012843	8421504	2	20,4	0,21	g	350013559800000001	10-36		12524448	10.1074/jbc.M205747200	0021-9258	Journal of Biological Chemistry	Homodimerization of Neuropeptide Y Receptors Investigated by Fluorescence Resonance Energy Transfer in Living Cells	Dinger	2003	5		
822	chr7	31119406	31119430	3500020410	23		31119406	31119430	8421504	2	15,8	0,16	g	350002041000000016	3-45						Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the p - Patent # 6316004 - PatentGenius	.patentgenius.com	0	0		
840	chr7	33536713	33536738	3500166513	23		33536713	33536738	8421504	3	14,5,4	0,15,21	c,g	350016651300000069,350016651300000069	2-25,2-25						Isolation and Functional Characterization of a Dioxin-Inducible CYP1A Regulatory Region From Zebrafish ( Gary T. ZeRuth A dissertation submitted in partial fulfillment	gradworks.umi.com	0	0		
843	chr7	33890392	33890419	3500182034	24		33890392	33890419	8421504	2	5,19	0,8	g	350018203400000013,350018203400000014	7-31,5-26						-Proximal Hot Spot for an Inducible Positive-to-Negative-Strand Template Switch by Coronavirus RNA-Dependent RNA Polymerase	jvi.asm.org	0	0		
853	chr7	35145310	35145336	3500105414	24		35145310	35145336	8421504	2	8,16	0,10	g	350010541400000008	0-24						Compositions And Methods Comprising Variant Microbial Proteases - Patent application	www.faqs.org	0	0		
854	chr7	35386941	35386966	3500367555	24		35386941	35386966	8421504	2	20,4	0,21	g	350036755500000062	14-38						Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies	Bander	2003	0		
859	chr7	36008375	36008402	3500013319	25		36008375	36008402	8421504	3	12,4,9	0,13,18	g	350001331900000001	0-26		12869552	10.1074/jbc.M306967200	0021-9258	Journal of Biological Chemistry	dUTPase and Nucleocapsid Polypeptides of the Mason-Pfizer Monkey Virus Form a Fusion Protein in the Virion with Homotrimeric Organization and Low Catalytic Efficiency	Barabas	2003	5		
861	chr7	36240464	36240493	3500308226	23		36240464	36240493	8421504	3	12,6,5	0,17,24	g	350030822600000010,350030822600000016	1-25,0-24		11861841	10.1128/JVI.76.6.2739-2752.2002	0022-538X	Journal of Virology	Specific Inactivation of Inhibitory Sequences in the 5&#x2032; End of the Human Papillomavirus Type 16 L1 Open Reading Frame Results in Production of High Levels of L1 Protein in Human Epithelial Cells	Collier	2002	5		
862	chr7	36348415	36348444	3500389252	27		36348415	36348444	8421504	3	11,9,7	0,12,22	g	350038925200000010	7-47						Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction	edoc.rki.de	0	0		
865	chr7	36726664	36726691	3500105743	26		36726664	36726691	8421504	2	4,22	0,5	g	350010574300000009	1-27						Interaction of the Dosage Compensation Complex with DNA	b.uni-muenchen.de	0	0		
866	chr7	36899475	36899504	3500293291	24		36899475	36899504	8421504	2	13,11	0,18	c	350029329100000003	11-35						COMMON SIGNALING ELEMENTS IN RESPONSE PATHWAYS ACTIVATED BY THE ENDOTHELIAL SURVIVAL FACTORS VEGF AND INSULIN	cholar.lib.vt.edu	0	0		
108	chr7	37216567	37257691	3500402085	738		37216567	37257691	8421504	19	45,12,33,120,21,45,5,40,45,30,45,38,7,27,45,45,45,45,45	0,48,19277,30977,32729,32753,32801,35150,35193,35259,36913,36961,37097,37107,39187,40241,40337,40983,41079	p	350040208500015075,350040208500015077,350040208500015078,350040208500015079,350040208500015080,350040208500015081,350040208500015085,350040208500015087,350040208500015088,350040208500015089,350040208500015090	0-90,0-45,0-48,0-48,0-135,0-147,0-45,0-45,0-45,0-45,0-45						Apoptosis related polynucleotides, polypeptides, and antibodies - US Patent 7078186 Description	ww.patentstorm.us	0	0		FAF2
869	chr7	37253683	37263643	3500453271	48		37253683	37263643	8421504	3	19,8,21	0,4003,9939	c,g	350045327100000000,350045327100000000,350045327100000003	0-19,0-19,0-29		22238364	10.1091/mbc.E11-11-0950		Molecular Biology of the Cell	Derlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid droplets	Michitaka	2012	0		FAF2
869	chr7	37253683	37263643	3500055114	48		37253683	37263643	8421504	3	19,8,21	0,4003,9939	c	350005511400000000,350005511400000003	0-19,0-29						Derlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid droplets	w.molbiolcell.org	0	0		FAF2
870	chr7	37371143	37379206	3500195604	52		37371143	37379206	8421504	4	22,24,5,1	0,7394,7422,8062	c	350019560400000005,350019560400000000	12-34,7-37		17652097	10.1074/jbc.M703711200	0021-9258	Journal of Biological Chemistry	Enhanced Lysosomal Pathology Caused by &#x03b2;-Synuclein Mutants Linked to Dementia with Lewy Bodies	Wei	2007	5		
870	chr7	37371144	37378568	3500011123	44		37371144	37378568	8421504	2	22,22	0,7402	c	350001112300000003,350001112300000002	9-31,9-31		11724769	10.1074/jbc.M105326200	0021-9258	Journal of Biological Chemistry	Formation and Removal of &#x03b1;-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors	Lee	2002	5		MIR4281,SNCB
870	chr7	37371574	37375342	3500185267	45		37371574	37375342	8421504	2	21,24	0,3744	p	350018526700015000	0-45		10964942		0270-6474	The Journal of Neuroscience	Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant &#x03b1;-Synuclein in Human and Transgenic Mouse Brain	Kahle	2000	7		SNCB
870	chr7	37371589	37375360	3500371015	48		37371589	37375360	8421504	2	6,42	0,3729	p	350037101500015022	0-48						Cloning of a gene mutation for parkinson's disease	Duvoisin	1999	0		
870	chr7	37398927	37398978	3500372326	51		37398927	37398978	8421504	1	51	0	p	350037232600015001	0-51						Tm4sf receptor polynucleotides, polypeptides, and antibodies	Ruben	2001	0		TSPAN17
873	chr7	37824271	37824296	3500378755	25		37824271	37824296	8421504	1	25	0	c	350037875500000002	0-25		10488071	10.1074/jbc.274.39.27399	0021-9258	Journal of Biological Chemistry	JAZ Requires the Double-stranded RNA-binding Zinc Finger Motifs for Nuclear Localization	Yang	1999	5		ZNF346
873	chr7	37857975	37865405	3500307427	2400		37857975	37865405	8421504	17	91,261,81,167,124,191,139,194,146,122,111,191,123,71,138,106,144	0,746,1094,1285,1965,2613,2930,3614,3917,4148,5467,5666,6199,6404,6686,7074,7286	p	350030742700015000	0-2400						KEGG T01008: 317696	www.genome.jp	0	0		
873	chr7	37858822	37861596	3500352177	244		37858822	37861596	8421504	7	47,4,44,48,54,40,7	0,324,438,497,1864,2182,2767	c	350035217700000480,350035217700000485,350035217700000188,350035217700000174,350035217700000528,350035217700000181,350035217700000532,350035217700000200	0-47,0-48,0-32,0-48,0-48,0-48,0-47,0-44						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
873	chr7	37859331	37862018	3500463793	870		37859331	37862018	8421504	6	96,124,191,139,194,126	0,609,1257,1574,2258,2561	p	350046379300015002	3-873						<HTML> <HEAD> <META http-equiv="content-type" content="text/html; charset=UTF-8"> <TITLE>KF0397	ry.ddbj.nig.ac.jp	0	0		
873	chr7	37860974	37864415	3500129658	50		37860974	37864415	8421504	2	23,27	0,3414	c	350012965800000033,350012965800000110	15-38,15-42						Animal model for fibroblast growth factor receptor associated chondrodysplasia	Yayon	1999	0		
873	chr7	37864437	37864464	3500032480	27		37864437	37864464	8421504	1	27	0	g	350003248000000351	15-42						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments - US Patent 7964349 Description	ww.patentstorm.us	0	0		
874	chr7	37900465	37900494	3500182135	29		37900465	37900494	8421504	1	29	0	g	350018213500000006	40-69						Polymorphism evolution ofAlu	www.pnas.org	0	0		NSD1
875	chr7	38065924	38065948	3500114536	23		38065924	38065948	8421504	2	5,18	0,6	c	350011453600000437	12-35						HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF - Patent application	www.faqs.org	0	0		
875	chr7	38065924	38065948	3500099437	23		38065924	38065948	8421504	2	5,18	0,6	c	350009943700000187	12-35						Receptor Family Profiling 	.freshpatents.com	0	0		
876	chr7	38221618	38221930	3500322291	26		38221618	38221930	8421504	2	20,6	0,306	c	350032229100000007,350032229100000005	0-21,0-21						Biased ligands and methods of identifying same	Dewire	2008	0		GRK6
876	chr7	38227871	38228621	3500445480	78		38227871	38228621	8421504	2	27,51	0,699	p	350044548000015054,350044548000015014	0-48,0-78						Shuttle vectors	Luo	1998	0		GRK6
876	chr7	38227871	38228621	3500425562	78		38227871	38228621	8421504	2	27,51	0,699	p	350042556200015081,350042556200015014	0-48,0-78						US Patent # 6,455,247. Methods for screening for transdominant effector peptides and RNA molecules - Patents.com	www.patents.com	0	0		GRK6
876	chr7	38227871	38228621	3500386086	78		38227871	38228621	8421504	2	27,51	0,699	p	350038608600015017	0-78					Patent	Methods for screening for transdominant effector peptides and RNA molecules (Patent US:6455247)	Nolan	2002	0		GRK6
876	chr7	38227871	38228621	3500316159	78		38227871	38228621	8421504	2	27,51	0,699	p	350031615900015027,350031615900015089	0-78,0-45						Methods for screening for transdominant intracellular effector peptides and RNA molecules	Nolan	2001	0		GRK6
876	chr7	38227871	38228621	3500275353	78		38227871	38228621	8421504	2	27,51	0,699	p	350027535300015054,350027535300015014	0-48,0-78						 Shuttle Vectors 	www.docstoc.com	0	0		GRK6
876	chr7	38227871	38228621	3500241961	78		38227871	38228621	8421504	2	27,51	0,699	p	350024196100015011	0-78					Patent	Methods for screening for transdominant intracellular effector peptides and RNA molecules (Patent US:6737241)	Nolan	2004	0		GRK6
876	chr7	38227871	38228621	3500236661	78		38227871	38228621	8421504	2	27,51	0,699	p	350023666100015020	0-78					Patent	Multiparameter facs assays to detect alterations in cellular parameters (Patent EP:1071809)	Fisher	2003	0		GRK6
876	chr7	38227871	38228621	3500191029	78		38227871	38228621	8421504	2	27,51	0,699	p	350019102900015077,350019102900015027	0-48,0-78						Multiparameter FACS assays to detect alterations in cell cycle regulation	Lorens	1998	0		GRK6
876	chr7	38227871	38228621	3500182891	78		38227871	38228621	8421504	2	27,51	0,699	p	350018289100015013	0-78						US Patent # 6,645,766. Shuttle vectors - Patents.com	www.patents.com	0	0		GRK6
876	chr7	38227871	38228621	3500149728	78		38227871	38228621	8421504	2	27,51	0,699	p	350014972800015009	0-78						Bi-directionally cloned random cDNA expression vector libraries, compositions and methods of use	Lorens	2002	0		GRK6
876	chr7	38227871	38228621	3500139777	78		38227871	38228621	8421504	2	27,51	0,699	p	350013977700015024	0-78						Methods and compositions comprising Renilla GFP	Anderson	2002	0		GRK6
876	chr7	38227871	38228621	3500079485	78		38227871	38228621	8421504	2	27,51	0,699	p	350007948500015017	0-78					Patent	Multiparameter facs test zum ermitteln von &#xe4;nderungen in den zellularen parametern (Patent DE:69910756)	Fisher	2004	0		GRK6
876	chr7	38227871	38228621	3500074000	78		38227871	38228621	8421504	2	27,51	0,699	p	350007400000015038	0-78					Patent	Multiparameter FACS assays to detect alterations in cellular parameters and small molecule screening (Patent CN:100334227)	J*Fei She Er 	2007	0		GRK6
876	chr7	38227871	38228621	3500071885	78		38227871	38228621	8421504	2	27,51	0,699	p	350007188500015012	0-78						METHODS FOR SCREENING FOR TRANSDOMINANT EFFECTOR PEPTIDES AND RNA MOLECULES - THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY.	www.sumobrain.com	0	0		GRK6
876	chr7	38227871	38228621	3500068925	78		38227871	38228621	8421504	2	27,51	0,699	p	350006892500015019	0-78					Patent	&#x68c0;&#x6d4b;&#x7ec6;&#x80de;&#x53c2;&#x6570;&#x53d8;&#x5316;&#x548c;&#x7b5b;&#x9009;&#x5c0f;&#x5206;&#x5b50;&#x6587;&#x5e93;&#x6240;&#x7528;&#x7684;&#x591a;&#x53c2;&#x6570;facs&#x5206;&#x6790; (Patent CN:100334227)	J*Fei She Er 	2007	0		GRK6
876	chr7	38227871	38228621	3500054111	78		38227871	38228621	8421504	2	27,51	0,699	p	350005411100015009	0-78						US Patent # 7,205,130. Bi-directionally cloned random cDNA expression vector libraries, compositions and methods of use - Patents.com	www.patents.com	0	0		GRK6
876	chr7	38227871	38228621	3500038065	78		38227871	38228621	8421504	2	27,51	0,699	p	350003806500015012	0-78						Methods for screening for transdominant effector peptides and rna molecules	Noaln	1998	0		GRK6
876	chr7	38227871	38228621	3500024333	78		38227871	38228621	8421504	2	27,51	0,699	p	350002433300015013	0-78					Patent	Methods for screening for transdominant intracellular effector peptides and RNA molecules (Patent US:6153380)	Nolan	2000	0		GRK6
876	chr7	38227871	38228621	3500010293	78		38227871	38228621	8421504	2	27,51	0,699	p	350001029300015012,350001029300015051	0-78,0-48						Bi-directionally Cloned Random Cdna Expression Vector Libraries, Compositions And Methods Of Use 	.freshpatents.com	0	0		GRK6
876	chr7	38227871	38228621	3500001979	78		38227871	38228621	8421504	2	27,51	0,699	p	350000197900015014,350000197900015053	0-78,0-48						US Patent # 6,391,582. Shuttle vectors - Patents.com	www.patents.com	0	0		GRK6
876	chr7	38234551	38234581	3500000675	26		38234551	38234581	8421504	3	11,4,11	0,12,19	g	350000067500000018	0-33						Title of Dissertation	drum.lib.umd.edu	0	0		
876	chr7	38244935	38244963	3500320404	23		38244935	38244963	8421504	2	14,9	0,19	c	350032040400000010	1-26						N-ACETYLGLUCOSAMINYLTRANSFERASE VB CODING SEQUENCES, RECOMBINANT CELLS AND METHODS - Patent application	www.faqs.org	0	0		
876	chr7	38244935	38244963	3500065628	23		38244935	38244963	8421504	2	14,9	0,19	c	350006562800000010	1-26						US Patent # 7,348,171. N-acetylglucosaminyltransferase Vb coding sequences, recombinant cells and methods - Patents.com	www.patents.com	0	0		
877	chr7	38278728	38283972	3500378345	96		38278728	38283972	8421504	3	40,8,48	0,702,5196	c	350037834500000010,350037834500000002	0-48,0-48						Human insulin receptor endocytic code binding protein - US Patent 5504192 Description	ww.patentstorm.us	0	0		
878	chr7	38410378	38410413	3500279130	25		38410378	38410413	8421504	3	8,11,6	0,13,29	c,g	350027913000000043,350027913000000043,350027913000000015,350027913000000015	11-36,11-36,11-36,11-36						MULTIPLE MUTATION VARIANTS OF SERINE PROTEASE - Patent application	www.faqs.org	0	0		
878	chr7	38410378	38410413	3500228561	25		38410378	38410413	8421504	3	8,11,6	0,13,29	c,g	350022856100000016,350022856100000016	11-36,11-36						Multiple mutation variants of serine protease	Aehle	2007	0		
109	chr7	38534033	38537567	3500267325	79		38534033	38537567	8421504	4	8,21,22,28	0,630,3273,3506	c	350026732500000002,350026732500000001,350026732500000003	0-29,0-22,8-36						Human H/ACA Small Nucleolar RNPs and Telomerase Share Evolutionarily Conserved Proteins NHP2 and NOP10	mcb.asm.org	0	0		NHP2
879	chr7	38537306	38537567	3500434101	50		38537306	38537567	8421504	2	22,28	0,233	c	350043410100000001,350043410100000003	0-22,8-36		11074001	10.1128/MCB.20.23.9028-9040.2000	0270-7306	Molecular and Cellular Biology	Human H/ACA Small Nucleolar RNPs and Telomerase Share Evolutionarily Conserved Proteins NHP2 and NOP10	Pogacic	2000	6		
879	chr7	38580630	38580657	3500017564	27		38580630	38580657	8421504	1	27	0	c,g	350001756400000036,350001756400000036	48-75,48-75						&#x201e;Immunpathologische Folgen von Infektionen des ZNS durch das lymphotrope Maus-Herpesvirus 68 als Modell f&#xfc;r Epstein-Barr Virus assoziierte ZNS-Erkrankungen des Menschen&#x201c;	th.rwth-aachen.de	0	0		HNRNPAB
880	chr7	38722216	38722245	3500426922	24		38722216	38722245	8421504	3	6,12,6	0,9,23	g	350042692200000021	16-41					Patent	Antibodies to lymphotoxin-alpha (Patent US:7923011)	Adams	2011	0		
881	chr7	38919238	38919265	3500182228	25		38919238	38919265	8421504	3	17,4,4	0,18,23	g	350018222800000004	11-36					Patent	Chlamydia antigens and protein vaccine (Patent US:7658934)	Murdin	2010	0		
881	chr7	38919238	38919265	3500179851	25		38919238	38919265	8421504	3	17,4,4	0,18,23	g	350017985100000004	11-36						Chlamydia antigens and corresponding DNA fragments and uses thereof	Dunn	2004	0		
883	chr7	39139953	39142892	3500358114	82		39139953	39142892	8421504	4	22,19,20,21	0,211,1714,2918	c,g	350035811400000000,350035811400000000,350035811400000001,350035811400000003,350035811400000005	0-22,0-22,0-19,0-20,0-21						The Prophet of PIT1 Gene Variation and its Effect on Growth Traits in Chinese Indigeous Goat	dwelljournals.com	0	0		
883	chr7	39139953	39141687	3500234583	42		39139953	39141687	8421504	2	22,20	0,1714	c,g	350023458300000000,350023458300000000,350023458300000003	0-22,0-22,0-20						Five novel single nucleotide polymorphisms (SNPs) of the prophet of PIT1 (PROP1) gene in bovine (Brief report)	bn-dummerstorf.de	0	0		
883	chr7	39149153	39149544	3500348740	39		39149153	39149544	8421504	2	20,19	0,372	g	350034874000000005,350034874000000004	0-20,0-19						BIOMEDICAL SCIENCES www.bjournal.com.br CLINICAL INVESTIGATION AND Braz J Med Biol Res, July 2011, Volume 44(7) 694-699	www.scielo.br	0	0		
884	chr7	39250045	39250073	3500447970	23		39250045	39250073	8421504	2	15,8	0,20	g	350044797000000037	10-33						R-SPONDIN COMPOSITIONS AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
884	chr7	39314332	39314681	3500245224	44		39314332	39314681	8421504	2	23,21	0,328	c	350024522400000003,350024522400000002	0-23,0-21					The Journal of Cell Biology	Mek and Cdc2 Kinase Are Sequentially Required for Golgi Disassembly in Mdck Cells by the Mitotic Xenopus Extracts	Fumi	2000	0		
884	chr7	39314586	39314679	3500321486	93		39314586	39314679	8421504	1	93	0	p	350032148600015001,350032148600015002	111-204,15-90						OF Val. 269, No. U.S.A. Medial-Golgi Retention of N-Acetylglucosaminyltransferase I	www.jbc.org	0	0		MGAT1
885	chr7	39412487	39412513	3500018529	23		39412487	39412513	8421504	2	18,5	0,21	g	350001852900000138	8-32						***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Streptococcus pneumoniae antigens and vaccines	Choi	1997	0		
886	chr7	39465260	39465288	3500121462	23		39465260	39465288	8421504	3	5,13,5	0,8,23	g	350012146200000191	14-37						DETECTION OF MUTATIONS IN A GENE ASSOCIATED WITH RESISTANCE TO VIRAL INFECTION, MX1 - Patent application	www.faqs.org	0	0		
887	chr7	39690692	39690718	3500380836	23		39690692	39690718	8421504	2	17,6	0,20	c	350038083600000445	6-29						US Patent # 7,186,541. 3-hydroxypropionic acid and other organic compounds - Patents.com	www.patents.com	0	0		
887	chr7	39690692	39690718	3500370305	23		39690692	39690718	8421504	2	17,6	0,20	c	350037030500000434	6-29						 3 	www.docstoc.com	0	0		
887	chr7	39690692	39690718	3500166501	23		39690692	39690718	8421504	2	17,6	0,20	c	350016650100000445	6-29						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
887	chr7	39690692	39690718	3500104401	23		39690692	39690718	8421504	2	17,6	0,20	c	350010440100000442	9-32						3-HYDROXYPROPIONIC ACID AND OTHER ORGANIC COMPOUNDS - Patent application	www.faqs.org	0	0		
889	chr7	39902735	39902761	3500444973	23		39902735	39902761	8421504	3	12,6,5	0,14,21	g	350044497300000007	0-24						213 (2-Pyridylazo) Resorcinol Monosodium Salt	loads.hindawi.com	0	0		
889	chr7	39933496	39933521	3500059076	23		39933496	39933521	8421504	2	6,17	0,8	g	350005907600000129	3-26						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE	Frank-Kamenetsky	2009	0		
890	chr7	39991855	39991903	3500306361	48		39991855	39991903	8421504	1	48	0	c	350030636100000342	0-48						PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use - Patent application	www.faqs.org	0	0		
890	chr7	39992080	39992260	3500273330	102		39992080	39992260	8421504	2	33,69	0,111	p	350027333000015131	0-168						43 human secreted proteins	Komatsoulis	2001	0		
891	chr7	40208371	40208398	3500179508	23		40208371	40208398	8421504	2	17,6	0,21	g	350017950800000093	10-33						Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules - Patent application	www.faqs.org	0	0		
899	chr7	41164260	41164293	3500312720	27		41164260	41164293	8421504	3	7,7,13	0,12,20	g	350031272000000014	8-35						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
899	chr7	41228469	41228492	3500094682	23		41228469	41228492	8421504	1	23	0	g	350009468200000018	1-35						Detergent compositions - Patent application	www.faqs.org	0	0		
902	chr7	41596025	41596050	3500373709	25		41596025	41596050	8421504	1	25	0	g	350037370900000004	55-80						Cdk4 (cyclin dependent kinase 4) binding proteins	Draetta	1995	0		
904	chr7	41880447	41880471	3500326034	23		41880447	41880471	8421504	2	9,14	0,10	g	350032603400000699	1-24						 Selection Method 	www.docstoc.com	0	0		
905	chr7	41978926	41979116	3500241494	48		41978926	41979116	8421504	2	46,2	0,188	p	350024149400015069	0-48						US Patent # 6,534,641. Compositions and methods for the treatment and diagnosis of cardiovascular disease - Patents.com	www.patents.com	0	0		ZNF692
906	chr7	42128710	42128736	3500043540	23		42128710	42128736	8421504	2	11,12	0,14	c	350004354000000317	0-23						US Patent # 6,987,212. Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use - Patents.com	www.patents.com	0	0		
906	chr7	42158017	42158043	3500397633	24		42158017	42158043	8421504	3	5,5,14	0,6,12	g	350039763300000051	0-24						Nucleic acid probes and methods for detecting Proteus mirabilis - US Patent 5683876 Description	ww.patentstorm.us	0	0		
906	chr7	42158017	42158043	3500357020	24		42158017	42158043	8421504	3	5,5,14	0,6,12	g	350035702000000169	0-24						Nucleic acid probes for detection and/or quantitation of non-viral organisms	Hogan	1988	0		
906	chr7	42158017	42158043	3500289201	24		42158017	42158043	8421504	3	5,5,14	0,6,12	g	350028920100000101	0-24						Nucleic acid probes and methods for detecting fungi	Hogan	1995	0		
906	chr7	42158017	42158043	3500270067	24		42158017	42158043	8421504	3	5,5,14	0,6,12	g	350027006700000046	0-24						US Patent # 5,593,841. Nucleic acid probes for detection and/or quantitation of non-viral organisms - Patents.com	www.patents.com	0	0		
906	chr7	42158017	42158043	3500250692	24		42158017	42158043	8421504	3	5,5,14	0,6,12	g	350025069200000043	0-24						US Patent # 5,714,321. Nucleic acid probes and methods for detecting salmonella - Patents.com	www.patents.com	0	0		
906	chr7	42158017	42158043	3500119734	24		42158017	42158043	8421504	3	5,5,14	0,6,12	g	350011973400000081	0-24						US Patent # 7,172,863. Nucleic acid probes and methods for detecting Neisseria gonorrhoeae - Patents.com	www.patents.com	0	0		
906	chr7	42158017	42158043	3500043708	24		42158017	42158043	8421504	3	5,5,14	0,6,12	g	350004370800000058	0-24						Nucleic acid probes and methods for detecting group I pseudomonas	Hogan	1995	0		
906	chr7	42158017	42158043	3500002784	24		42158017	42158043	8421504	3	5,5,14	0,6,12	g	350000278400000064	0-24						Nucleic acid probes for detection and/or quantitation of non-viral organisms	Hogan	1994	0		
907	chr7	42310734	42311725	3500233580	86		42310734	42311725	8421504	5	22,10,13,19,22	0,112,396,430,969	c,g	350023358000000000,350023358000000010,350023358000000011,350023358000000011,350023358000000001,350023358000000001	0-22,0-23,0-19,0-19,0-22,0-22						Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle	biomedcentral.com	0	0		
907	chr7	42335833	42335858	3500229525	25		42335833	42335858	8421504	1	25	0	g	350022952500000051,350022952500000017	0-25,0-25						Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof	Kandel	1998	0		
908	chr7	42339403	42340309	3500409160	41		42339403	42340309	8421504	2	21,20	0,886	c,g	350040916000000013,350040916000000015,350040916000000015,350040916000000012	0-21,0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
908	chr7	42341066	42341126	3500119438	60		42341066	42341126	8421504	1	60	0	c,g	350011943800000029,350011943800000002,350011943800000002	0-60,0-20,0-20						Sex Differences in Gene Expression in Dog Cortex	www.ibg.uu.se	0	0		
908	chr7	42368677	42368701	3500421379	24		42368677	42368701	8421504	1	24	0	c	350042137900000101	8-32						 Antibody (11C7) Anti Nogo A And Its Pharmaceutical Use 	www.docstoc.com	0	0		
908	chr7	42376345	42393565	3500395610	41		42376345	42393565	8421504	3	14,6,21	0,17,17199	g	350039561000000363,350039561000000159	9-29,0-22						Single-Chain Multivalent Binding Proteins with Effector Function - Patent application	www.faqs.org	0	0		
908	chr7	42416281	42416311	3500133656	24		42416281	42416311	8421504	3	6,6,12	0,10,18	g	350013365600000004	0-24			10.1124/jpet.107.123695	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Cysteine Pairs in the Third Intracellular Loop of the Muscarinic M1 Acetylcholine Receptor Play a Role in Agonist-Induced Internalization	Sawyer	2008	0		
909	chr7	42473717	42475040	3500405992	54		42473717	42475040	8421504	2	15,39	0,1284	p	350040599200015000	102-156						Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostate Denise E Abbott , Colin *Pritchard , Nigel J Clegg , Camari Ferguson Ruth Dumpit , Robert A Sikes	genomebiology.com	0	0		
909	chr7	42473717	42475040	3500254660	54		42473717	42475040	8421504	2	15,39	0,1284	p	350025466000015000	102-156						Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostate Denise E Abbott , Colin *Pritchard , Nigel J Clegg , Camari Ferguson Ruth Dumpit , Robert A Sikes	pedb.org/PUBLICAT	0	0		
909	chr7	42473759	42475022	3500062987	32		42473759	42475022	8421504	2	11,21	0,1242	c	350006298700000047	0-32						METHODS AND COMPOSITIONS FOR ADENO-ASSOCIATED VIRUS (AAV) WITH HI LOOP MUTATIONS - Patent application	www.faqs.org	0	0		
909	chr7	42553955	42553981	3500380283	23		42553955	42553981	8421504	2	7,16	0,10	c	350038028300000093	1-24						TARGETED THERAPEUTIC PROTEINS - Patent application	www.faqs.org	0	0		
909	chr7	42553955	42553981	3500265346	23		42553955	42553981	8421504	2	7,16	0,10	c	350026534600000040,350026534600000086	25-48,1-24						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
909	chr7	42553955	42553981	3500160759	23		42553955	42553981	8421504	2	7,16	0,10	c	350016075900000086	1-24						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
909	chr7	42553955	42553981	3500125607	23		42553955	42553981	8421504	2	7,16	0,10	c	350012560700000085	1-24						Method for targeting lysosomal enzymes - Patent application	www.faqs.org	0	0		
909	chr7	42554488	42554733	3500360474	23		42554488	42554733	8421504	3	4,13,6	0,225,239	c	350036047400000037	0-29						Gene encoding for a transmembrane protein	Shimizu	2000	0		
909	chr7	42554879	42555509	3500099123	40		42554879	42555509	8421504	4	6,14,6,14	0,386,512,616	c	350009912300000020,350009912300000021	0-20,0-20						Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin	g.library.pcc.edu	0	0		
909	chr7	42584643	42585048	3500373626	57		42584643	42585048	8421504	2	42,15	0,390	p	350037362600015117	6-63						Annexes	theses.ulb.ac.be	0	0		POLR2E
909	chr7	42585985	42586048	3500346604	63		42585985	42586048	8421504	1	63	0	p	350034660400015011	0-63						Subunits shared by eukaryotic nuclear RNA polymerases	enesdev.cshlp.org	0	0		POLR2E
909	chr7	42592916	42594552	3500310643	40		42592916	42594552	8421504	2	20,20	0,1616	c,g	350031064300000004,350031064300000004,350031064300000005	0-20,0-20,0-20		12606442	10.1095/biolreprod.102.007476	0006-3363	Biology of Reproduction	Antioxidant Defenses Are Modulated in the Cow Oviduct During the Estrous Cycle	Lapointe	2003	4		
909	chr7	42594129	42594225	3500192489	73		42594129	42594225	8421504	4	9,28,16,20	0,11,58,76	g	350019248900000012	5-105						Phospholipid-hydroperoxide glutathione peroxidase in sperm. - ResearchGate	.researchgate.net	0	0		
909	chr7	42594172	42594423	3500192881	44		42594172	42594423	8421504	3	25,15,4	0,93,247	c	350019288100000018,350019288100000019	0-25,0-19						&#x4e3b;&#x9898;&#xff1a;expression | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
910	chr7	42687825	42689529	3500012101	504		42687825	42689529	8421504	4	141,154,89,120	0,765,1405,1584	p	350001210100015026,350001210100015031	0-276,0-228						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		
910	chr7	42687828	42687891	3500144055	63		42687828	42687891	8421504	1	63	0	c,g	350014405500000224,350014405500000223,350014405500000223,350014405500000222,350014405500000221	0-63,0-63,0-63,0-48,0-48						GENERATION AND REPRODUCTION OF DNA SEQUENCES AND ANALYSIS OF POLYMORPHISMS AND MUTATIONS BY USING ERROR-CORRECTING CODES - Patent application	www.faqs.org	0	0		
910	chr7	42713240	42713373	3500323170	48		42713240	42713373	8421504	2	4,44	0,89	p	350032317000015013,350032317000015004	0-45,0-45						RBM3 in Colorectal Cancer Prognostics - Patent application	www.faqs.org	0	0		CIRBP
910	chr7	42713240	42713373	3500041594	48		42713240	42713373	8421504	2	4,44	0,89	p	350004159400015011,350004159400015002	0-45,0-45						RBM3 AS A MARKER FOR BREAST CANCER PROGNOSIS - Patent application	www.faqs.org	0	0		CIRBP
910	chr7	42715069	42715093	3500127308	24		42715069	42715093	8421504	1	24	0	c	350012730800000246	13-37						PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS - Patent application	www.faqs.org	0	0		
910	chr7	42727106	42727129	3500040858	23		42727106	42727129	8421504	1	23	0	c	350004085800000002	7-30		19299512	10.1074/jbc.M807598200		The Journal of Biological Chemistry	Bidirectional Signaling through EphrinA2-EphA2 Enhances Osteoclastogenesis and Suppresses Osteoblastogenesis	Naoko	2009	0		EFNA2
911	chr7	42736546	42736615	3500330320	54		42736546	42736615	8421504	2	27,27	0,42	p	350033032000015046	15-75						Structure, Function & Control of the EphA3 Receptor Tyrosine Kinase	.swinburne.edu.au	0	0		EFNA2
911	chr7	42819142	42819450	3500010322	23		42819142	42819450	8421504	3	10,8,5	0,13,303	c	350001032200000001	2-40		19801632	10.1074/jbc.M109.047118	0021-9258	Journal of Biological Chemistry	A Biosensor for Fluorescent Determination of ADP with High Time Resolution	Kunzelmann	2009	5		
911	chr7	42850155	42851329	3500279721	361		42850155	42851329	8421504	3	56,235,70	0,788,1104	c,g	350027972100000000,350027972100000002,350027972100000002	0-361,2-23,2-23			10.1251/bpo107		Biological Procedures Online	New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR	JM	2005	0		RPS15
911	chr7	42850155	42851329	3500163064	361		42850155	42851329	8421504	3	56,235,70	0,788,1104	c,g	350016306400000000,350016306400000002,350016306400000002	0-361,2-23,2-23			10.1251/bpo107		Biological Procedures Online	New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR	Jack	2005	0		RPS15
911	chr7	42851081	42851105	3500085562	24		42851081	42851105	8421504	1	24	0	c	350008556200000590	8-32						Methods and compositions for assaying analytes	Yuan	1999	0		
911	chr7	42851136	42851260	3500305779	42		42851136	42851260	8421504	3	21,20,1	0,22,123	c,g	350030577900000020,350030577900000020,350030577900000019	2-23,2-23,0-21						Differential Expression of Ovine Innate Immune Genes by Preterm and Neonatal Lung Epithelia Infected with Respiratory Syncytial Virus	ddr.nal.usda.gov	0	0		
911	chr7	42851136	42851260	3500295231	43		42851136	42851260	8421504	2	42,1	0,123	c,g	350029523100000020,350029523100000020,350029523100000027,350029523100000019	2-23,2-23,0-21,0-21						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system &#x2018;FocusField2-6GallupqPCRSet-upTool-001&#x2019; to attain consistently high fidelity qPCR reactions	quantification.de	0	0		RPS15
911	chr7	42851136	42851260	3500256733	42		42851136	42851260	8421504	3	21,20,1	0,22,123	c,g	350025673300000023,350025673300000023,350025673300000022	2-23,2-23,0-21						Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q)	www.ijbs.org	0	0		
911	chr7	42851136	42851260	3500099621	43		42851136	42851260	8421504	2	42,1	0,123	c,g	350009962100000020,350009962100000020,350009962100000027,350009962100000019	2-23,2-23,0-21,0-21						Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet-upTool-001' to attain consistently high fidelity qPCR reactions.	.biomedsearch.com	0	0		RPS15
912	chr7	42893362	42893389	3500329538	27		42893362	42893389	8421504	1	27	0	g	350032953800000079	88-115						US Patent # 5,460,950. Expression of PACE in host cells and methods of use thereof - Patents.com	www.patents.com	0	0		
912	chr7	42939992	42940672	3500369674	48		42939992	42940672	8421504	2	13,35	0,645	p	350036967400015000	0-48						Diego F. Mastroeni	ichtuniversity.nl	0	0		MBD3
912	chr7	42941108	42941159	3500299630	51		42941108	42941159	8421504	1	51	0	p	350029963000015059,350029963000015060	0-48,0-51						ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis	icine.bjmu.edu.cn	0	0		MBD3
912	chr7	42941108	42941159	3500216346	51		42941108	42941159	8421504	1	51	0	p	350021634600015060,350021634600015059	0-51,0-48						ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis	icine.bjmu.edu.cn	0	0		MBD3
912	chr7	42943920	42943944	3500299834	24		42943920	42943944	8421504	1	24	0	g	350029983400000056,350029983400000100	0-19,0-19						Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers - Patent application	www.faqs.org	0	0		
912	chr7	42982663	42982686	3500114805	23		42982663	42982686	8421504	1	23	0	c	350011480500000029	0-23						US Patent # 5,516,658. DNA encoding cytokines that bind the cell surface receptor hek - Patents.com	www.patents.com	0	0		
14	chr7	42990905	42992182	3500066024	66		42990905	42992182	8421504	2	21,45	0,1232	p	350006602400015054	0-66						Nature 01 August 2013	www.scribd.com	0	0		TCF3
915	chr7	43324052	43324077	3500117791	23		43324052	43324077	8421504	3	5,6,12	0,6,13	g	350011779100000035,350011779100000034	4-33,5-34						Characterization of the Ubiquitin/Nedd8 E3 Ligase Activity of the Mdm2/MdmX complex	www.uni-koeln.de	0	0		
918	chr7	43770519	43770544	3500368819	23		43770519	43770544	8421504	2	16,7	0,18	g	350036881900000011,350036881900000073	8-31,8-31						HUMANIZED AXL ANTIBODIES - US Patent Application 20120117670 Description	ww.patentstorm.us	0	0		
921	chr7	44070819	44073222	3500362883	63		44070819	44073222	8421504	3	20,20,23	0,137,2380	c	350036288300000003,350036288300000002,350036288300000001	0-20,0-20,0-23						REPRODUCTION	uction-online.org	0	0		
921	chr7	44070950	44073661	3500120175	206		44070950	44073661	8421504	9	22,20,30,22,22,25,22,21,22	0,185,298,384,432,594,1150,2001,2689	c,g	350012017500000007,350012017500000023,350012017500000023,350012017500000026,350012017500000022,350012017500000027,350012017500000025,350012017500000021,350012017500000006,350012017500000005,350012017500000004	0-22,0-20,0-20,0-30,0-22,0-22,0-25,0-21,0-22,0-21,0-22						Mutations in the Genes for Oocyte-Derived Growth Factors GDF9 and BMP15 Are Associated with Both Increased Ovulation Rate and Sterility in Cambridge and Belclare Sheep (Ovis aries)	ww.biolreprod.org	0	0		
921	chr7	44070950	44073586	3500328889	205		44070950	44073586	8421504	9	22,20,30,22,22,25,23,20,21	0,185,298,384,432,594,1052,1648,2615	c,g	350032888900000005,350032888900000021,350032888900000024,350032888900000020,350032888900000025,350032888900000023,350032888900000019,350032888900000019,350032888900000016,350032888900000014,350032888900000012	23-45,0-20,0-30,0-22,0-22,0-25,0-21,0-21,0-23,0-20,0-21						New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate	Davis	2003	0		
921	chr7	44070952	44073661	3500059320	63		44070952	44073661	8421504	3	20,21,22	0,1999,2687	c,g	350005932000000005,350005932000000005,350005932000000001,350005932000000000	0-20,0-20,0-21,0-22						Identificaci&#xf3;n de la deleci&#xf3;n FecXR del gen ovino BMP15 en la Raza Rasa Aragonesa: Su implicaci&#xf3;n en la mejora gen&#xe9;tica de la prolificidad y su difusi&#xf3;n en la caba&#xf1;a ganadera / Adolfo Lavi&#xf1;a G&#xf3;mez	zaguan.unizar.es	0	0		
921	chr7	44071075	44071611	3500340475	87		44071075	44071611	8421504	4	20,24,21,22	0,377,455,514	c,g	350034047500000003,350034047500000003,350034047500000002,350034047500000011,350034047500000010	0-20,0-20,0-24,0-21,0-22		21401961	10.1186/1477-7827-9-33	1477-7827	Reproductive Biology and Endocrinology	Quantitative analysis of bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) gene expression in calf and adult bovine ovaries	Hosoe	2011	2		
921	chr7	44071191	44071643	3500232292	80		44071191	44071643	8421504	3	20,39,21	0,21,431	c	350023229200000001,350023229200000000	0-59,1-22						Archive of SID	www.sid.ir/en/VEW	0	0		
921	chr7	44071286	44071311	3500130318	25		44071286	44071311	8421504	1	25	0	c	350013031800000002	0-25						Archive of SID	www.sid.ir/fa/VEW	0	0		GDF9
921	chr7	44071381	44071534	3500055148	45		44071381	44071534	8421504	2	22,23	0,130	c	350005514800000002,350005514800000001	0-22,22-45		17715428	10.1095/biolreprod.107.062752	0006-3363	Biology of Reproduction	Patterns of Expression of Messenger RNAs Encoding GDF9, BMP15, TGFBR1, BMPR1B, and BMPR2 During Follicular Development and Characterization of Ovarian Follicular Populations in Ewes Carrying the Woodlands FecX2W Mutation	Feary	2007	4		
921	chr7	44071411	44071586	3500235713	46		44071411	44071586	8421504	2	24,22	0,153	c,g	350023571300000002,350023571300000002,350023571300000003	0-24,0-24,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
921	chr7	44071457	44071480	3500055849	23		44071457	44071480	8421504	1	23	0	c	350005584900000000	21-44						Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells	s.ulb.uni-bonn.de	0	0		
921	chr7	44071739	44073506	3500028009	40		44071739	44073506	8421504	2	20,20	0,1747	c,g	350002800900000005,350002800900000005,350002800900000004	0-20,0-20,0-20						Putative imprinted gene expression in uniparental bovine embryo models	library.uq.edu.au	0	0		
921	chr7	44071968	44073238	3500160159	39		44071968	44073238	8421504	2	19,20	0,1250	c,g	350016015900000005,350016015900000004	0-19,0-20						Arq. Bras. Med. Vet. Zootec., v.62, n.6, p.1394-1400, 2010	www.scielo.br	0	0		
921	chr7	44073199	44073222	3500008335	23		44073199	44073222	8421504	1	23	0	c	350000833500000054	0-23						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
921	chr7	44073296	44073322	3500395273	24		44073296	44073322	8421504	3	4,15,5	0,5,21	c	350039527300000133,350039527300000101	18-42,18-37						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
921	chr7	44110988	44111011	3500035949	23		44110988	44111011	8421504	1	23	0	c	350003594900000003	12-35						Research Paper MCEF is localized to the nucleus by protein sequences encoded within three distinct exons, where it represses HIV-1 Tat-transactivation of LTR-directed transcription	www.ijbs.com	0	0		
923	chr7	44330074	44346956	3500407334	41		44330074	44346956	8421504	3	4,16,21	0,647,16861	c	350040733400000000,350040733400000001	0-20,0-21		9841496			American Journal of Physiology - Renal Physiology	Characterization of the Hsp110/SSE gene family response to hyperosmolality and other stresses	Santos	1998	0		HSPA4
926	chr7	44825409	44825436	3500187127	23		44825409	44825436	8421504	2	7,16	0,11	c	350018712700000053	15-47						Nucleic acids encoding CR8 polypeptides, vector and transformed cell thereof, and expression thereof	Smith	1995	0		
927	chr7	44829256	44840975	3500253203	195		44829256	44840975	8421504	6	38,55,30,4,38,30	0,964,5420,5612,11490,11689	p	350025320300015009,350025320300015011	0-63,0-195						MorphofunctionalandBiochemicalApproachesforStudying MitochondrialChangesduringMyoblastsDifferentiation	loads.hindawi.com	0	0		VDAC1
927	chr7	44831955	44842555	3500224737	630		44831955	44842555	8421504	6	127,228,53,153,50,19	0,2689,8791,8939,9993,10581	p,c,g	350022473700000015,350022473700000014,350022473700000014,350022473700000013,350022473700015012,350022473700000012,350022473700000012,350022473700000011,350022473700000011,350022473700015011,350022473700000010,350022473700000010,350022473700015010,350022473700015009,350022473700000009,350022473700015008,350022473700000008,350022473700000007,350022473700000007,350022473700015007,350022473700000006,350022473700000005,350022473700015006,350022473700000000	0-30,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-63,0-60,0-66,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-24						Lokalisation und Relevanz von Porin Subtypen im bovinen Hoden	eb.uni-giessen.de	0	0		
927	chr7	44831985	44842606	3500017305	246		44831985	44842606	8421504	6	51,54,37,23,11,70	0,2685,2850,8761,10002,10551	p	350001730500015009,350001730500015008,350001730500015007,350001730500015005	66-117,66-120,66-126,48-129						VOLTAGE DEPENDENT ANION CHANNEL (VDACl) COMPOSITIONS AND METHODS OF USE THEREOF FOR REGULATING APOPTOSIS	Shoshan-Barmatz	2006	0		
927	chr7	44832042	44834673	3500048481	69		44832042	44834673	8421504	2	40,29	0,2602	p	350004848100015006	0-69						PROTEIN IMPORT, CHOLESTEROL TRANSPORT AND	ry.georgetown.edu	0	0		
927	chr7	44841987	44842606	3500111505	81		44841987	44842606	8421504	2	11,70	0,549	p	350011150500015006	48-129						Voltage dependent anion channel (vdac1) compositions and methods of use thereof for regulating apoptosis	Shoshan-Barmatz	2011	0		
927	chr7	44851799	44851824	3500354095	25		44851799	44851824	8421504	1	25	0	g	350035409500000002	13-38						Over and under expression of endothelin 1 and TGF-beta family ligands and receptors in lung tissue of broilers with pulmonary hypertension	loads.hindawi.com	0	0		
927	chr7	44933851	44934840	3500285362	45		44933851	44934840	8421504	2	23,22	0,967	c	350028536200000032,350028536200000033	18-41,19-41						Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy	onal-medicine.com	0	0		
927	chr7	44948209	44948236	3500344831	23		44948209	44948236	8421504	3	5,5,13	0,8,14	g	350034483100000191	9-34						 Tuberculosis Nucleic Acids, Polypeptides And Immunogenic Compositions 	www.docstoc.com	0	0		
928	chr7	44960147	44961024	3500313209	46		44960147	44961024	8421504	2	22,24	0,853	c,g	350031320900000004,350031320900000005	0-22,3-27					Molecular and Cellular Biology	Differential Importin-&#x03b1; Recognition and Nuclear Transport by Nuclear Localization Signals within the High-Mobility-Group DNA Binding Domains of Lymphoid Enhancer Factor 1 and T-Cell Factor 1	Mary	1998	0		
928	chr7	44970438	44971118	3500445452	51		44970438	44971118	8421504	2	33,18	0,662	p	350044545200015003	0-51		18678709	10.1083/jcb.200802146		The Journal of Cell Biology	Ku80 removal from DNA through double strand break&#x2013;induced ubiquitylation	Lisa	2008	0		SKP1
928	chr7	44970438	44971118	3500209696	51		44970438	44971118	8421504	2	33,18	0,662	p	350020969600015004	0-51		18678709	10.1083/jcb.200802146	0021-9525	The Journal of Cell Biology	Ku80 removal from DNA through double strand break&#x2013;induced ubiquitylation	Postow	2008	10		SKP1
928	chr7	45011814	45012358	3500185372	40		45011814	45012358	8421504	2	37,3	0,541	c	350018537200000002,350018537200000003	0-40,0-40						Lenalidomide targets the T-cell co-stimulatory pathway to mediate immune modulation	arcommons.usf.edu	0	0		MIR3661
928	chr7	45011827	45012392	3500209016	43		45011827	45012392	8421504	2	21,22	0,543	c,g	350020901600000002,350020901600000003,350020901600000003	0-21,0-22,0-22			10.1128/JVI.79.24.15342-15350.2005		Journal of Virology	Upregulation of Protein Phosphatase 2Ac by Hepatitis C Virus Modulates NS3 Helicase Activity through Inhibition of Protein Arginine Methyltransferase 1	Francois	2005	0		MIR3661
928	chr7	45011827	45012392	3500087501	43		45011827	45012392	8421504	2	21,22	0,543	c,g	350008750100000006,350008750100000007,350008750100000007	0-21,0-22,0-22			10.1002/hep.21611	1527-3350	Hepatology	Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A - Christen - 2007 - Hepatology - Wiley Online Library	Christen	2007	0		MIR3661
928	chr7	45011828	45012994	3500121557	47		45011828	45012994	8421504	3	23,1,23	0,527,1143	c	350012155700000025,350012155700000024	0-24,0-23						Reduced complexity nucleic acid targets and methods of using same	Mcclelland	1999	0		MIR3661
928	chr7	45011841	45012370	3500100552	25		45011841	45012370	8421504	2	10,15	0,514	c	350010055200000016	0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		
928	chr7	45011845	45012412	3500246174	63		45011845	45012412	8421504	2	6,57	0,510	p,c	350024617400015087,350024617400015009,350024617400015025,350024617400015013,350024617400015011,350024617400015015,350024617400000007,350024617400000004,350024617400000005,350024617400000002,350024617400000003,350024617400000000,350024617400000001,350024617400015033,350024617400015064,350024617400015053,350024617400015037,350024617400015061,350024617400015041,350024617400015057,350024617400015045,350024617400015049	36-90,33-96,0-57,48-108,48-108,45-105,36-90,47-108,48-108,54-114,54-114,0-60,36-96,0-48,0-51,0-54,0-57,0-51,0-54,0-48,0-51,0-48						Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9	Decaudin	2012	0		
928	chr7	45012391	45013077	3500282713	135		45012391	45013077	8421504	4	30,21,3,81	0,33,575,605	p	350028271300015011,350028271300015005	0-54,0-81						THE BIOLOGICAL CHEMISTRY JOGRNAL 268, Vol. No. OF by U.S.A. in Expression, Purification, Crystallization, and Biochemical a Recombinant Protein Phosphatase* Characterization of	www.jbc.org	0	0		PPP2CB
928	chr7	45032916	45032976	3500322383	60		45032916	45032976	8421504	1	60	0	p	350032238300015004	0-60			10.1046/j.1432-1327.2000.01591.x	1432-1033	European Journal of Biochemistry	Biochemical characterization of recombinant subunits of type 2A protein phosphatase overexpressed in Pichia pastoris - Swiatek - 2001 - European Journal of Biochemistry - Wiley Online Library	Swiatek	2000	0		
929	chr7	45092163	45092229	3500271950	63		45092163	45092229	8421504	2	15,48	0,18	p	350027195000015014	0-63						Novel human protein kinases and protein kinase-like enzymes	Clary	2001	0		
929	chr7	45110565	45121359	3500067926	120		45110565	45121359	8421504	5	5,30,22,10,53	0,11,42,8372,10741	c	350006792600000006,350006792600000011	0-60,0-63						Structural and Functional Conservation of Two Human Homologs of the Yeast DNA Repair Gene RAD6	www.jstor.org	0	0		
929	chr7	45110638	45123042	3500403930	302		45110638	45123042	8421504	7	44,29,19,40,89,6,75	0,2196,4062,8269,10668,12275,12329	c	350040393000000182,350040393000000005,350040393000000184,350040393000000186,350040393000000187,350040393000000188,350040393000000190,350040393000000191,350040393000000006	0-44,6-30,0-48,9-48,0-48,0-48,0-48,0-26,6-30						Human ubiquitin conjugating enzyme	Draetta	1994	0		
929	chr7	45110638	45123042	3500058326	398		45110638	45123042	8421504	8	44,77,26,41,40,89,6,75	0,2148,4062,8219,8269,10668,12275,12329	c,g	350005832600000253,350005832600000005,350005832600000130,350005832600000131,350005832600000132,350005832600000133,350005832600000134,350005832600000135,350005832600000136,350005832600000138,350005832600000139,350005832600000006,350005832600000006	12-36,6-30,0-44,0-48,0-48,0-48,9-48,0-48,0-48,0-48,0-26,6-30,6-30						Ubiquitin conjugating enzymes	Rolfe	1996	0		
929	chr7	45110669	45114715	3500433778	66		45110669	45114715	8421504	5	13,7,26,5,15	0,2113,2146,2189,4031	c	350043377800000012,350043377800000013,350043377800000014	0-20,0-26,0-20		19143834	10.1111/j.1742-4658.2008.06814.x	1742-4658	FEBS Journal	Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling - Laure - 2008 - FEBS Journal - Wiley Online Library	Laure	2009	0		
930	chr7	45266072	45266096	3500179670	23		45266072	45266096	8421504	2	14,9	0,15	g	350017967000000121	15-38						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
930	chr7	45308699	45308726	3500406521	24		45308699	45308726	8421504	2	13,11	0,16	c	350040652100000094	24-48						High molecular weight major outer membrane protein of moraxella	Sasaki	1998	0		
930	chr7	45308699	45308726	3500023267	24		45308699	45308726	8421504	2	13,11	0,16	c	350002326700000094	24-48						High molecular weight major outer membrane protein of moraxella	Sasaki	1996	0		
931	chr7	45425597	45432806	3500375831	191		45425597	45432806	8421504	5	48,48,9,39,47	0,1928,3754,7027,7162	c	350037583100000004,350037583100000013,350037583100000017,350037583100000020	0-48,0-48,0-48,0-47						Cell calcium regulation and its use	Bram	1995	0		
933	chr7	45625396	45625419	3500387065	23		45625396	45625419	8421504	1	23	0	c,g	350038706500000016,350038706500000016	0-23,0-23						Molecular cloning, spatial and temporal expression analysis of CatSper genes in the Chinese Meishan pigs	www.rbej.com	0	0		
933	chr7	45650874	45651165	3500130011	40		45650874	45651165	8421504	2	20,20	0,271	c	350013001100000006,350013001100000017	0-20,0-20						NPG.Nature.vol.428.issue.6984.Apr.2004	www.scribd.com	0	0		PITX1
933	chr7	45650929	45651013	3500453822	84		45650929	45651013	8421504	1	84	0	p	350045382200015020,350045382200015019	0-75,0-84						Asymmetric expression of BbPtx in lancelets	ev.biologists.org	0	0		PITX1
936	chr7	46048273	46048333	3500442584	60		46048273	46048333	8421504	1	60	0	p	350044258400015004	0-60						Chromatin regulator genes	Jenuwein	2004	0		H2AFY
936	chr7	46048273	46048333	3500341221	60		46048273	46048333	8421504	1	60	0	p	350034122100015007	0-60						Method for identifying compounds altering higher-order chromatin-dependent chromosome stability	Jenuwein	2001	0		H2AFY
936	chr7	46048273	46048333	3500236690	60		46048273	46048333	8421504	1	60	0	p	350023669000015004	0-60						Screening-method for modulators of methyltransferase-dependent chromosome stability	Eisenhaber	2001	0		H2AFY
936	chr7	46048273	46048333	3500208696	60		46048273	46048333	8421504	1	60	0	p	350020869600015008	0-60						Method for identifying compounds altering higher-order chromatin-dependent chromosome stability	Jenuwein	2002	0		H2AFY
936	chr7	46048273	46048333	3500063417	60		46048273	46048333	8421504	1	60	0	p	350006341700015004	0-60						Chromatin regulator genes - Patent # 7252968 - PatentGenius	.patentgenius.com	0	0		H2AFY
937	chr7	46210027	46210075	3500018414	48		46210027	46210075	8421504	1	48	0	g	350001841400000096	70-118						Expression of neurogenic bHLH genes in primitive neuroectodermal tumors	Tapscott	1997	0		
937	chr7	46254814	46254862	3500139425	48		46254814	46254862	8421504	1	48	0	c	350013942500000018	0-48						Chemokine alpha 2	Ni Jian 	1999	0		
938	chr7	46383639	46383664	3500406751	23		46383639	46383664	8421504	2	5,18	0,7	g	350040675100000029	8-31						Growth differentiation factor-11	www.devileye.net	0	0		
938	chr7	46383639	46383664	3500096356	23		46383639	46383664	8421504	2	5,18	0,7	g	350009635600000029	8-31						Growth differentiation factor-11	Lee	1998	0		
940	chr7	46635707	46635730	3500426557	23		46635707	46635730	8421504	1	23	0	g	350042655700000001	0-25			10.1038/sj.onc.1204271	${footerJournalISSN}		Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism		2001	0		
941	chr7	46728799	46728827	3500362015	24		46728799	46728827	8421504	3	12,7,5	0,13,23	g	350036201500000017	9-37						BUTANOL PRODUCTION BY METABOLICALLY ENGINEERED YEAST - Patent application	www.faqs.org	0	0		
941	chr7	46728799	46728827	3500023681	24		46728799	46728827	8421504	3	12,7,5	0,13,23	g	350002368100000017	9-37						Butanol production by metabolically engineered yeast	GUNAWARDENA	2010	0		
941	chr7	46783861	46791120	3500228010	50		46783861	46791120	8421504	2	25,25	0,7234	c	350022801000000035,350022801000000036	0-25,0-25						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION	Hata	2009	0		SMAD5
941	chr7	46783861	46791120	3500125620	50		46783861	46791120	8421504	2	25,25	0,7234	c	350012562000000035,350012562000000180,350012562000000181,350012562000000036	0-25,0-25,0-25,0-25						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION - Patent application	www.faqs.org	0	0		SMAD5
941	chr7	46783862	46783907	3500455533	45		46783862	46783907	8421504	1	45	0	p	350045553300015004	0-45			10.1002/ijc.10584	1097-0215	International Journal of Cancer	Target validation for genomics using peptide-specific phage antibodies: A study of five gene products overexpressed in colorectal cancer - van Beijnum - 2002 - International Journal of Cancer - Wiley Online Library	Beijnum	2002	0		SMAD5
942	chr7	46796230	46797855	3500058474	63		46796230	46797855	8421504	2	12,51	0,1574	p	350005847400015004,350005847400015005	0-63,0-63						Genetic Characterization and Cloning of Mothers against dpp, a Gene Required for decapentuplegic Function in DrosqPhila melanogaster	www.genetics.org	0	0		SMAD5
942	chr7	46818486	46818512	3500087139	23		46818486	46818512	8421504	2	8,15	0,11	g	350008713900000467	0-23						Full text of "Protocols_molecular_biology"	01.us.archive.org	0	0		
942	chr7	46835548	46894288	3500323827	1332		46835548	46894288	8421504	13	167,76,81,222,54,72,61,197,62,124,69,14,133	0,2095,9330,10043,16105,16162,16240,32579,32782,44402,44541,44622,58607	p	350032382700015011,350032382700015010,350032382700015009	0-1122,0-69,18-165						Use of a trpc channel for the treatment of a cardiovascular disease	Struebing	2006	0		
942	chr7	46837701	46851773	3500256575	52		46837701	46851773	8421504	3	18,8,26	0,7177,14046	c,g	350025657500000039,350025657500000038,350025657500000038	0-26,0-26,0-26						Thrombin Activates Ca&#xc6cc;&#xc6b8;-permeating Nonselective Cation Channels through Protein Kinase C in Human Umbilical Vein Endothelial Cells	s-igaku.umin.jp	0	0		TRPC7
942	chr7	46868156	46868179	3500356772	23		46868156	46868179	8421504	1	23	0	c	350035677200000009	0-23						Supplement Material	s.ahajournals.org	0	0		TRPC7
943	chr7	46978455	46978480	3500292291	24		46978455	46978480	8421504	2	13,11	0,14	c	350029229100000022	0-24						Aortic Carboxypeptidase-like Polypeptide 	.freshpatents.com	0	0		
943	chr7	47031374	47031399	3500169307	23		47031374	47031399	8421504	3	12,7,4	0,13,21	g	350016930700000002	1-24						Virology Journal BioMed Central	www.virologyj.com	0	0		
945	chr7	47248359	47248383	3500135814	23		47248359	47248383	8421504	2	15,8	0,16	g	350013581400000003	7-30			10.1124/dmd.106.010991	1521-009X (Online)	Drug Metabolism and Disposition	Functional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)	Ninomiya	2006	0		
948	chr7	47590933	47591062	3500295686	69		47590933	47591062	8421504	2	36,33	0,96	p	350029568600015006	0-69						Struktur-Funktions-Beziehungen	ebdoc.sub.gwdg.de	0	0		SPOCK1
948	chr7	47591033	47591057	3500367930	24		47591033	47591057	8421504	1	24	0	c	350036793000000449,350036793000000198	0-24,0-24						Recurrent gene fusions in prostate cancer - Patent application	www.faqs.org	0	0		
948	chr7	47591033	47591057	3500017630	24		47591033	47591057	8421504	1	24	0	c	350001763000000468,350001763000000198	0-24,0-24						RECURRENT GENE FUSIONS IN PROSTATE CANCER - Patent application	www.faqs.org	0	0		
948	chr7	47662268	47662744	3500000589	104		47662268	47662744	8421504	3	7,36,61	0,355,415	g	350000058900000031,350000058900000032	0-68,0-36						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
948	chr7	47662623	47662744	3500259232	121		47662623	47662744	8421504	1	121	0	g	350025923200000015	0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
950	chr7	47846718	47846747	3500293589	25		47846718	47846747	8421504	3	6,7,12	0,7,17	g	350029358900000006	3-28					Patent	Protein expression systems (Patent US:8288127)	Schneider	2012	0		
950	chr7	47846718	47846747	3500138827	25		47846718	47846747	8421504	3	6,7,12	0,7,17	g	350013882700000006	3-28						Protein expression systems	Schneider	2009	0		
950	chr7	47846718	47846747	3500132031	25		47846718	47846747	8421504	3	6,7,12	0,7,17	g	350013203100000006	3-28						Protein expression systems	Schneider	2009	0		
950	chr7	47944859	47944893	3500407090	28		47944859	47944893	8421504	3	12,11,5	0,17,29	g	350040709000000080	10-39						HIV envelope polypeptides and vaccine	Berman	1997	0		
950	chr7	47972191	47972217	3500426250	24		47972191	47972217	8421504	3	6,4,14	0,7,12	g	350042625000000076	24-48						Toxins from the wasp Bracon hebetor	Windass	1997	0		
952	chr7	48148192	48148222	3500446736	30		48148192	48148222	8421504	1	30	0	c,g	350044673600000017,350044673600000017	0-30,0-30						Testican 2 Abrogates Inhibition of Membrane-type Matrix Metalloproteinases by Other Testican Family Proteins	.aacrjournals.org	0	0		SPOCK1
956	chr7	48674788	48675865	3500148386	48		48674788	48675865	8421504	2	3,45	0,1032	p	350014838600015173	0-48						Polycystic Xidney Disease Pkd2 Gene And Uses Thereop 	.freshpatents.com	0	0		PKD2L1
958	chr7	48951808	48951836	3500224256	23		48951808	48951836	8421504	3	5,7,11	0,6,17	g	350022425600000013	23-46					Patent	IL-13 cytokine receptor chain (Patent US:5710023)	Collins	1998	0		
958	chr7	48972621	48978024	3500407387	42		48972621	48978024	8421504	2	21,21	0,5382	c	350040738700000001,350040738700000000	0-21,0-21						Treatment of Retinopathies Using Gfra3 Agonists	Jorgensen	2006	0		
959	chr7	49116756	49116779	3500466627	23		49116756	49116779	8421504	1	23	0	g	350046662700000015	8-31						Antibodies to cytokine receptor common gamma chain like	Ruben	2002	0		
959	chr7	49116756	49116779	3500465862	23		49116756	49116779	8421504	1	23	0	g	350046586200000080,350046586200000017	8-31,8-31						 Tissue Plasminogen Activator 	www.docstoc.com	0	0		
959	chr7	49116756	49116779	3500464481	23		49116756	49116779	8421504	1	23	0	g	350046448100000008	8-31						Antibodies to HBIMF63 polypeptide - US Patent 7381800 Description	ww.patentstorm.us	0	0		
959	chr7	49116756	49116779	3500462733	23		49116756	49116779	8421504	1	23	0	g	350046273300000028	8-31						110 human secreted proteins	Carter	2000	0		EGR1
959	chr7	49116756	49116779	3500453194	23		49116756	49116779	8421504	1	23	0	g	350045319400000005	8-31						Nucleic acids, proteins, and antibodies	Barash	2002	0		
959	chr7	49116756	49116779	3500446957	23		49116756	49116779	8421504	1	23	0	g	350044695700000011	8-31						METH1 and METH2 Polynucleotides and Polypeptides	Iruela-arispe	2007	0		
959	chr7	49116756	49116779	3500446792	23		49116756	49116779	8421504	1	23	0	g	350044679200000015,350044679200000037	8-31,8-31						Galectin-11 polypeptides	Ni	2000	0		
959	chr7	49116756	49116779	3500440413	23		49116756	49116779	8421504	1	23	0	g	350044041300000002	8-31						Secreted protein HKABT24	Carter	2003	0		
959	chr7	49116756	49116779	3500436879	23		49116756	49116779	8421504	1	23	0	g	350043687900000011	8-31						70 human secreted proteins	Ruben	2002	0		
959	chr7	49116756	49116779	3500434043	23		49116756	49116779	8421504	1	23	0	g	350043404300000005	8-31						Human pancreas and pancreatic cancer associated gene sequences and polypeptides	Rosen	2000	0		
959	chr7	49116756	49116779	3500433160	23		49116756	49116779	8421504	1	23	0	g	350043316000000005	8-31						Human pancreas and pancreatic cancer associated gene sequences and polypeptides	Rosen	2000	0		
959	chr7	49116756	49116779	3500432002	23		49116756	49116779	8421504	1	23	0	g	350043200200000013	8-31						Antibodies to protein HPMBQ91	osdir.com/patents	0	0		
959	chr7	49116756	49116779	3500430220	23		49116756	49116779	8421504	1	23	0	g	350043022000000009	8-31						49 human secreted proteins	A	2000	0		
959	chr7	49116756	49116779	3500428930	23		49116756	49116779	8421504	1	23	0	g	350042893000000010	8-31						50 human secreted proteins	George	2000	0		
959	chr7	49116756	49116779	3500395807	23		49116756	49116779	8421504	1	23	0	g	350039580700000009	8-31						71 human secreted proteins	Brewer	2000	0		
959	chr7	49116756	49116779	3500391229	23		49116756	49116779	8421504	1	23	0	g	350039122900000037	8-31						Albumin fusion proteins - US Patent 6994857 Description	ww.patentstorm.us	0	0		
959	chr7	49116756	49116779	3500390777	23		49116756	49116779	8421504	1	23	0	g	350039077700000017	8-31						Human chemokine beta-10 mutant polypeptides	Adams	2001	0		
959	chr7	49116756	49116779	3500384752	23		49116756	49116779	8421504	1	23	0	g	350038475200000009	8-31						48 human secreted proteins	Komatsoulis	2002	0		
959	chr7	49116756	49116779	3500383104	23		49116756	49116779	8421504	1	23	0	g	350038310400000013	8-31						Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2	Ni	2000	0		
959	chr7	49116756	49116779	3500381398	23		49116756	49116779	8421504	1	23	0	g	350038139800000012	8-31						47 human secreted proteins	Komatsoulis	2002	0		
959	chr7	49116756	49116779	3500366312	23		49116756	49116779	8421504	1	23	0	g	350036631200000035	8-31						KERATINOCYTE DERIVED INTERFERON - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
959	chr7	49116756	49116779	3500359713	23		49116756	49116779	8421504	1	23	0	g	350035971300000006	8-31						16 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
959	chr7	49116756	49116779	3500354734	23		49116756	49116779	8421504	1	23	0	g	350035473400000031	8-31						Albumin fusion proteins	Rosen	2004	0		
959	chr7	49116756	49116779	3500341561	23		49116756	49116779	8421504	1	23	0	g	350034156100000005	8-31						Nucleic acids, proteins, and antibodies	Barash	2002	0		
959	chr7	49116756	49116779	3500340078	23		49116756	49116779	8421504	1	23	0	g	350034007800000021	8-31						TUMOR NECROSIS FACTOR RECEPTOR RELATED GENE 12 POLYPEPTIDES	NI.	1999	0		
959	chr7	49116756	49116779	3500334115	23		49116756	49116779	8421504	1	23	0	g	350033411500000107,350033411500000033	8-31,8-31						US Patent # 7,507,414. Albumin fusion proteins - Patents.com	www.patents.com	0	0		
959	chr7	49116756	49116779	3500334041	23		49116756	49116779	8421504	1	23	0	g	350033404100000017,350033404100000081	8-31,8-31						Tissue plasminogen activator-like protease - US Patent 7205139 Description	ww.patentstorm.us	0	0		
959	chr7	49116756	49116779	3500332968	23		49116756	49116779	8421504	1	23	0	g	350033296800000009	8-31						Interferon receptor HKAEF92	Ni	2003	0		
959	chr7	49116756	49116779	3500322849	23		49116756	49116779	8421504	1	23	0	g	350032284900000010	8-31						Prostate derived Ets factor	Libermann	2004	0		
959	chr7	49116756	49116779	3500322574	23		49116756	49116779	8421504	1	23	0	g	350032257400000006	8-31						50 human secreted proteins	Komatsoulis	2000	0		
959	chr7	49116756	49116779	3500319348	23		49116756	49116779	8421504	1	23	0	g	350031934800000015	8-31						Human tumor necrosis factor receptor-like proteins TR11, TR11SV1, and TR11SV2	Ni	2002	0		
959	chr7	49116756	49116779	3500314203	23		49116756	49116779	8421504	1	23	0	g	350031420300000035	8-31						Albumin fusion proteins	Haseltine	2003	0		
959	chr7	49116756	49116779	3500314165	23		49116756	49116779	8421504	1	23	0	g	350031416500000013	8-31						PGRP-L POLYNUCLEOTIDES, POLYPEPTIDES, AND ANTIBODIES - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
959	chr7	49116756	49116779	3500312980	23		49116756	49116779	8421504	1	23	0	g	350031298000000014	8-31						Transforming growth factor alpha hiii	Wei	2002	0		
959	chr7	49116756	49116779	3500308254	23		49116756	49116779	8421504	1	23	0	g	350030825400000021	8-31						Dendritic enriched secreted lymphocyte activation molecule	Ruben	2002	0		
959	chr7	49116756	49116779	3500304088	23		49116756	49116779	8421504	1	23	0	g	350030408800000008	8-31						67 human secreted proteins	Carter	1999	0		
959	chr7	49116756	49116779	3500301607	23		49116756	49116779	8421504	1	23	0	g	350030160700000013	8-31						31 human secreted proteins	Ferrie	1999	0		
959	chr7	49116756	49116779	3500294470	23		49116756	49116779	8421504	1	23	0	g	350029447000000030	8-31						Albumin fusion proteins	Rosen	2005	0		
959	chr7	49116756	49116779	3500289664	23		49116756	49116779	8421504	1	23	0	g	350028966400000007	8-31						Prostate derived ets factor	Endress	2000	0		
959	chr7	49116756	49116779	3500288953	23		49116756	49116779	8421504	1	23	0	g	350028895300000007	8-31						101 human secreted proteins	Carter	1999	0		
959	chr7	49116756	49116779	3500284360	23		49116756	49116779	8421504	1	23	0	g	350028436000000017	8-31						95 human secreted proteins	Duan	1999	0		
959	chr7	49116756	49116779	3500275412	23		49116756	49116779	8421504	1	23	0	g	350027541200000009	8-31						45 human secreted proteins	Komatsoulis	2000	0		
959	chr7	49116756	49116779	3500266999	23		49116756	49116779	8421504	1	23	0	g	350026699900000011	8-31						US Patent # 7,175,988. Human G-protein Chemokine Receptor (CCR5) HDGNR10 - Patents.com	www.patents.com	0	0		
959	chr7	49116756	49116779	3500265505	23		49116756	49116779	8421504	1	23	0	g	350026550500000005	8-31						Dendritic enriched secreted lymphocyte activation molecule	Ruben	1999	0		
959	chr7	49116756	49116779	3500262932	23		49116756	49116779	8421504	1	23	0	g	350026293200000011	8-31						Human chemokine beta-13	Li	2001	0		
959	chr7	49116756	49116779	3500261465	23		49116756	49116779	8421504	1	23	0	g	350026146500000077	8-31						Lp mammalian proteins; related reagents	Amegadzie	2002	0		
959	chr7	49116756	49116779	3500251281	23		49116756	49116779	8421504	1	23	0	g	350025128100000013	8-31						33 Human Secreted Proteins	Soppet	2009	0		
959	chr7	49116756	49116779	3500245940	23		49116756	49116779	8421504	1	23	0	g	350024594000000002	8-31						Secreted protein HCEJQ69	Brewer	2003	0		
959	chr7	49116756	49116779	3500242563	23		49116756	49116779	8421504	1	23	0	g	350024256300000005	8-31						Nucleic acids, proteins, and antibodies	Barash	2001	0		
959	chr7	49116756	49116779	3500242547	23		49116756	49116779	8421504	1	23	0	g	350024254700000005	8-31						13 human colon and colon cancer associated proteins	Birse	2001	0		
959	chr7	49116756	49116779	3500242337	23		49116756	49116779	8421504	1	23	0	g	350024233700000029	8-31						Albumin fusion proteins	Ballance	2010	0		
959	chr7	49116756	49116779	3500242239	23		49116756	49116779	8421504	1	23	0	g	350024223900000006	8-31						50 human secreted proteins	Komatsoulis	2002	0		
959	chr7	49116756	49116779	3500233615	23		49116756	49116779	8421504	1	23	0	g	350023361500000028	8-31						110 human secreted proteins	Carter	1999	0		EGR1
959	chr7	49116756	49116779	3500232554	23		49116756	49116779	8421504	1	23	0	g	350023255400000006	8-31						Human cancer associated gene sequences and polypeptides	Rosen	2001	0		
959	chr7	49116756	49116779	3500231766	23		49116756	49116779	8421504	1	23	0	g	350023176600000014	8-31						29 human secreted proteins	Birse	2001	0		
959	chr7	49116756	49116779	3500231644	23		49116756	49116779	8421504	1	23	0	g	350023164400000005	8-31						Human breast and ovarian cancer associated gene sequences and polypeptides	Rosen	2000	0		
959	chr7	49116756	49116779	3500227723	23		49116756	49116779	8421504	1	23	0	g	350022772300000037	8-31						Albumin fusion proteins	Prior	2003	0		
959	chr7	49116756	49116779	3500225159	23		49116756	49116779	8421504	1	23	0	g	350022515900000016	8-31						33 human secreted proteins	Soppet	2006	0		
959	chr7	49116756	49116779	3500220464	23		49116756	49116779	8421504	1	23	0	g	350022046400000019	8-31						Albumin Fusion Proteins	Rosen	2009	0		
959	chr7	49116756	49116779	3500219706	23		49116756	49116779	8421504	1	23	0	g	350021970600000034	8-31						Albumin fusion proteins	Ballance	2003	0		
959	chr7	49116756	49116779	3500214023	23		49116756	49116779	8421504	1	23	0	g	350021402300000032	8-31						Albumin Fusion Proteins - Patent application	www.faqs.org	0	0		
959	chr7	49116756	49116779	3500207429	23		49116756	49116779	8421504	1	23	0	g	350020742900000008	8-31						Nucleic acids, proteins, and antibodies	Rosen	2001	0		
959	chr7	49116756	49116779	3500199259	23		49116756	49116779	8421504	1	23	0	g	350019925900000019	8-31					Patent	Secreted protein HHTLF25 antibodies (Patent US:7105644)	Rosen	2006	0		
959	chr7	49116756	49116779	3500198285	23		49116756	49116779	8421504	1	23	0	g	350019828500000006	8-31						36 Human Secreted Proteins 	.freshpatents.com	0	0		
959	chr7	49116756	49116779	3500192384	23		49116756	49116779	8421504	1	23	0	g	350019238400000012	8-31						Metalloproteinase ADAM 22	Young	2005	0		
959	chr7	49116756	49116779	3500191974	23		49116756	49116779	8421504	1	23	0	g	350019197400000020	8-31						148 human secreted proteins	Feng	2002	0		
959	chr7	49116756	49116779	3500188813	23		49116756	49116779	8421504	1	23	0	g	350018881300000036	8-31						Albumin fusion proteins	Rosen	2001	0		
959	chr7	49116756	49116779	3500188757	23		49116756	49116779	8421504	1	23	0	g	350018875700000011,350018875700000043	8-31,8-31						Antibodies against fibroblast growth factor 11	Alderson	2000	0		
959	chr7	49116756	49116779	3500187327	23		49116756	49116779	8421504	1	23	0	g	350018732700000011	8-31						Connective Tissue Growth Factor-4	Young	2007	0		
959	chr7	49116756	49116779	3500187211	23		49116756	49116779	8421504	1	23	0	g	350018721100000034	8-31						Albumin fusion proteins	Ballance	2001	0		
959	chr7	49116756	49116779	3500179217	23		49116756	49116779	8421504	1	23	0	g	350017921700000036	8-31						Albumin fusion proteins	Rosen	2001	0		
959	chr7	49116756	49116779	3500174685	23		49116756	49116779	8421504	1	23	0	g	350017468500000027	8-31						Albumin fusion proteins	Ballance	2010	0		
959	chr7	49116756	49116779	3500169328	23		49116756	49116779	8421504	1	23	0	g	350016932800000042,350016932800000011	8-31,8-31						Polynucleotides encoding fibroblast growth factor 15	Greene	2000	0		
959	chr7	49116756	49116779	3500166547	23		49116756	49116779	8421504	1	23	0	g	350016654700000087,350016654700000013	8-31,8-31						Human tumor necrosis factor receptor-like proteins TR11, TR11SV1, and TR11SV2	Ni	1998	0		
959	chr7	49116756	49116779	3500163563	23		49116756	49116779	8421504	1	23	0	g	350016356300000013	8-31						123 human secreted proteins	Brewer	2000	0		
959	chr7	49116756	49116779	3500159659	23		49116756	49116779	8421504	1	23	0	g	350015965900000017	8-31						125 human secreted proteins	Carter	2000	0		
959	chr7	49116756	49116779	3500158647	23		49116756	49116779	8421504	1	23	0	g	350015864700000008	8-31						15 human secreted proteins	Duan	2002	0		
959	chr7	49116756	49116779	3500155822	23		49116756	49116779	8421504	1	23	0	g	350015582200000002	8-31						Secreted protein HKABT24	Carter	2003	0		
959	chr7	49116756	49116779	3500141193	23		49116756	49116779	8421504	1	23	0	g	350014119300000008	8-31						Zytokinrezeptor wie eine gemeinsame Gammakette - Dokument EP1982990	www.patent-de.com	0	0		
959	chr7	49116756	49116779	3500138031	23		49116756	49116779	8421504	1	23	0	g	350013803100000031	8-31						Albumin Fusion Proteins	Rosen	2010	0		
959	chr7	49116756	49116779	3500137730	23		49116756	49116779	8421504	1	23	0	g	350013773000000013	8-31						Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2	Ni	1999	0		
959	chr7	49116756	49116779	3500132593	23		49116756	49116779	8421504	1	23	0	g	350013259300000030	8-31						Albumin fusion proteins	Rosen	2005	0		
959	chr7	49116756	49116779	3500122509	23		49116756	49116779	8421504	1	23	0	g	350012250900000037	8-31						Albumin fusion proteins	Rosen	2001	0		
959	chr7	49116756	49116779	3500113257	23		49116756	49116779	8421504	1	23	0	g	350011325700000011	8-31						48 human secreted proteins	Komatsoulis	2000	0		
959	chr7	49116756	49116779	3500109392	23		49116756	49116779	8421504	1	23	0	g	350010939200000035	8-31						Albumin fusion proteins	Rosen	2001	0		
959	chr7	49116756	49116779	3500107060	23		49116756	49116779	8421504	1	23	0	g	350010706000000009	8-31						Interleukins-21 and 22	Ebner	2001	0		
959	chr7	49116756	49116779	3500106577	23		49116756	49116779	8421504	1	23	0	g	350010657700000007	8-31						21 human secreted proteins	Baker	2001	0		
959	chr7	49116756	49116779	3500102237	23		49116756	49116779	8421504	1	23	0	g	350010223700000016	8-31						33 human secreted proteins	Ebner	2001	0		
959	chr7	49116756	49116779	3500101220	23		49116756	49116779	8421504	1	23	0	g	350010122000000125,350010122000000005	8-31,8-31						36 human secreted proteins	Brewer	2000	0		
959	chr7	49116756	49116779	3500101112	23		49116756	49116779	8421504	1	23	0	g	350010111200000005	8-31						Nucleic acids, proteins, and antibodies	Barash	2001	0		
959	chr7	49116756	49116779	3500099051	23		49116756	49116779	8421504	1	23	0	g	350009905100000036	8-31						Albumin fusion proteins	Rosen	2001	0		
959	chr7	49116756	49116779	3500096469	23		49116756	49116779	8421504	1	23	0	g	350009646900000027	8-31						Albumin fusion proteins	Ballance	2007	0		
959	chr7	49116756	49116779	3500089509	23		49116756	49116779	8421504	1	23	0	g	350008950900000034	8-31						Albumin fusion proteins	Ballance	2003	0		
959	chr7	49116756	49116779	3500089118	23		49116756	49116779	8421504	1	23	0	g	350008911800000016,350008911800000006	8-31,8-31						36 human secreted proteins	LaFleur	2001	0		
959	chr7	49116756	49116779	3500082806	23		49116756	49116779	8421504	1	23	0	g	350008280600000005	8-31						20 human secreted proteins	Feng	2000	0		
959	chr7	49116756	49116779	3500071372	23		49116756	49116779	8421504	1	23	0	g	350007137200000016	8-31						ANTIBODIES TO CCR5 - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
959	chr7	49116756	49116779	3500058395	23		49116756	49116779	8421504	1	23	0	g	350005839500000018	8-31						49 HUMAN SECRETED PROTEINS - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
959	chr7	49116756	49116779	3500057189	23		49116756	49116779	8421504	1	23	0	g	350005718900000011	8-31						METH1 polynucleotides - US Patent 7220557 Description	ww.patentstorm.us	0	0		
959	chr7	49116756	49116779	3500049197	23		49116756	49116779	8421504	1	23	0	g	350004919700000006	8-31						PITUITRONE GENE AND POLYPEPTIDES - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
959	chr7	49116756	49116779	3500040180	23		49116756	49116779	8421504	1	23	0	g	350004018000000032	8-31						Albumin fusion proteins - US Patent 7507413 Description	ww.patentstorm.us	0	0		
959	chr7	49116756	49116779	3500039862	23		49116756	49116779	8421504	1	23	0	g	350003986200000033	8-31						Albumin Fusion Proteins - Patent application	www.faqs.org	0	0		
959	chr7	49116756	49116779	3500035801	23		49116756	49116779	8421504	1	23	0	g	350003580100000014	8-31						Antibodies against human protein HUVDJ43	Moore	2002	0		
959	chr7	49116756	49116779	3500034140	23		49116756	49116779	8421504	1	23	0	g	350003414000000019	8-31						TNFR RELATED GENE 12 - HUMAN GENOME SCIENCES, INC.	www.sumobrain.com	0	0		
959	chr7	49116756	49116779	3500032881	23		49116756	49116779	8421504	1	23	0	g	350003288100000005	8-31						87 human secreted proteins	Brewer	2003	0		
959	chr7	49116756	49116779	3500032801	23		49116756	49116779	8421504	1	23	0	g	350003280100000005	8-31						Nucleic acids, proteins, and antibodies	Barash	2001	0		
959	chr7	49116756	49116779	3500029713	23		49116756	49116779	8421504	1	23	0	g	350002971300000015	8-31						87 human secreted proteins	Young	2005	0		
959	chr7	49116756	49116779	3500023216	23		49116756	49116779	8421504	1	23	0	g	350002321600000026	8-31						Albumin fusion proteins	Rosen	2011	0		
959	chr7	49116756	49116779	3500022080	23		49116756	49116779	8421504	1	23	0	g	350002208000000011	8-31						Meth1 And Meth2 Polynucleotides And Polypeptides 	.freshpatents.com	0	0		
959	chr7	49116756	49116779	3500021903	23		49116756	49116779	8421504	1	23	0	g	350002190300000027	8-31						Albumin fusion proteins	Ballance	2007	0		
959	chr7	49116756	49116779	3500010467	23		49116756	49116779	8421504	1	23	0	g	350001046700000009	8-31						Connective tissue growth factor-4	Young	2003	0		
959	chr7	49116756	49116779	3500010113	23		49116756	49116779	8421504	1	23	0	g	350001011300000011	8-31						32 Human Secreted Proteins	Ruben	2007	0		
959	chr7	49116756	49116779	3500004941	23		49116756	49116779	8421504	1	23	0	g	350000494100000012	8-31						Human G-protein Chemokine receptor (CCR5) HDGNR10	Rosen	2001	0		
959	chr7	49116756	49116779	3500002775	23		49116756	49116779	8421504	1	23	0	g	350000277500000035	8-31						Albumin fusion proteins - US Patent 6905688 Description	ww.patentstorm.us	0	0		
959	chr7	49116756	49116779	3500000709	23		49116756	49116779	8421504	1	23	0	g	350000070900000010	8-31						50 human secreted proteins	Komatsoulis	2002	0		
959	chr7	49117060	49119380	3500089919	46		49117060	49119380	8421504	2	20,26	0,2294	c	350008991900000012,350008991900000013,350008991900000011	15-35,15-41,6-30						Molecular mediators of alveolarization	eb.uni-giessen.de	0	0		
959	chr7	49117060	49119380	3500036758	72		49117060	49119380	8421504	3	24,19,29	0,88,2291	c,g	350003675800000002,350003675800000001,350003675800000001,350003675800000003	0-24,0-19,0-19,0-29						Cancer Research Loss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor Activating Mutations	.aacrjournals.org	0	0		EGR1
959	chr7	49117060	49119004	3500145963	39		49117060	49119004	8421504	2	20,19	0,1925	c	350014596300000004,350014596300000000	0-20,0-19		14722058	10.1074/jbc.M312972200	0021-9258	Journal of Biological Chemistry	Microsomal Prostaglandin E Synthase-1 Is Overexpressed in Inflammatory Bowel Disease	Subbaramaiah	2004	5		EGR1
959	chr7	49117144	49117168	3500375462	24		49117144	49117168	8421504	1	24	0	c,g	350037546200000006,350037546200000006	0-24,0-24			10.1186/1477-3163-3-8	1477-3163	Journal of Carcinogenesis	Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells	Erk	2004	0		EGR1
959	chr7	49117256	49117282	3500460757	23		49117256	49117282	8421504	2	16,7	0,19	c	350046075700000008	10-33						ISSUU - Gene Therapy & Molecular Biology Volume 3 Isuue A by Niko Boulikas	issuu.com/gtmb/do	0	0		
959	chr7	49117345	49118133	3500316102	42		49117345	49118133	8421504	2	21,21	0,767	c	350031610200000058,350031610200000059	0-21,0-21		21998580	10.1371/journal.ppat.1002278		PLoS Pathogens	The Herpes Simplex Virus-1 Transactivator Infected Cell Protein-4 Drives VEGF-A Dependent Neovascularization	Todd	2011	0		EGR1
959	chr7	49118183	49118210	3500035288	25		49118183	49118210	8421504	2	20,5	0,22	c	350003528800000000	14-39		21283769	10.1371/journal.pone.0016234		PLoS ONE	Suppression of Osteosarcoma Cell Invasion by Chemotherapy Is Mediated by Urokinase Plasminogen Activator Activity via Up-Regulation of EGR1	Yukihiro	2011	0		
959	chr7	49118552	49119023	3500074121	198		49118552	49119023	8421504	2	108,90	0,381	p	350007412100015005,350007412100015001,350007412100015002	0-108,0-90,0-90						Functional characterization of Early Growth Response Transcription Factor 2 (EGR-2) DISSERTATION 	.db-thueringen.de	0	0		EGR1
959	chr7	49118561	49118984	3500264622	141		49118561	49118984	8421504	2	12,129	0,294	p	350026462200015107	9-150						ANWENDUNG VON ANTIK&#xd6;RPERDOM&#xc4;NEN ZUR	b.uni-muenchen.de	0	0		
959	chr7	49118561	49118927	3500318467	159		49118561	49118927	8421504	3	12,75,72	0,207,294	p	350031846700015050,350031846700015049,350031846700015017	0-75,0-75,0-66						ARGENT Regulated Transcription Plasmid Kit	www.ariad.com	0	0		
959	chr7	49118630	49119692	3500142159	122		49118630	49119692	8421504	3	43,44,35	0,47,1027	c	350014215900000094,350014215900000095,350014215900000157	0-43,4-48,0-35						Catalytic molecules - US Patent 7355035 Description	ww.patentstorm.us	0	0		
959	chr7	49118753	49118801	3500220702	48		49118753	49118801	8421504	1	48	0	p	350022070200015001	0-48						Regulatory zinc finger proteins	Jin-Soo	2004	0		EGR1
959	chr7	49118753	49118801	3500160097	48		49118753	49118801	8421504	1	48	0	p	350016009700015023	0-48						Phenotypic screen of chimeric proteins	JANG	2004	0		EGR1
959	chr7	49118753	49118798	3500385351	45		49118753	49118798	8421504	1	45	0	p	350038535100015008	0-45						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		EGR1
959	chr7	49118753	49118798	3500075471	45		49118753	49118798	8421504	1	45	0	p	350007547100015004	0-45						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		EGR1
959	chr7	49118792	49118849	3500453783	57		49118792	49118849	8421504	1	57	0	p	350045378300015023	39-96						Monomeric and dimeric fluorescent protein variants and methods for making same	Campbell	2004	0		EGR1
959	chr7	49118792	49118849	3500186902	57		49118792	49118849	8421504	1	57	0	p	350018690200015018	3-60						Monomeric and dimeric fluorescent protein variants and methods for making same	Campbell	2004	0		EGR1
959	chr7	49118871	49118921	3500022234	50		49118871	49118921	8421504	1	50	0	c	350002223400000126	0-50						Treatment of cancer	Khachigian	2002	0		
959	chr7	49118885	49118945	3500422420	60		49118885	49118945	8421504	1	60	0	p	350042242000015019	0-60						Clone pAT 133 Identifies a Gene that Encodes Another Human Member of a Class of Growth Factor-Induced Genes with Almost Identical Zinc-Finger Domains	www.jstor.org	0	0		EGR3
959	chr7	49118909	49118969	3500363892	60		49118909	49118969	8421504	1	60	0	p	350036389200015013,350036389200015034	0-48,0-48						METHOD FOR GENOME MODIFICATION - Patent application	www.faqs.org	0	0		EGR1
959	chr7	49118980	49119004	3500368835	24		49118980	49119004	8421504	1	24	0	c	350036883500000007	25-49						Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules	Choo	2002	0		
959	chr7	49119002	49119026	3500355108	24		49119002	49119026	8421504	1	24	0	c	350035510800000003	0-24		19608733	10.1152/ajpgi.00133.2009		American Journal of Physiology - Gastrointestinal and Liver Physiology	Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes	Miyaki	2009	0		
959	chr7	49119002	49119026	3500007442	24		49119002	49119026	8421504	1	24	0	c	350000744200000003	0-24		19608733	10.1152/ajpgi.00133.2009		American Journal of Physiology - Gastrointestinal and Liver Physiology	Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes	Miyaki	2009	0		
959	chr7	49119353	49119378	3500461420	25		49119353	49119378	8421504	1	25	0	c	350046142000000000	0-25		19374776	10.1186/gb-2009-10-4-r41	1465-6906	Genome Biology	Genome-wide investigation of in vivo EGR-1 binding sites in monocytic differentiation	Kubosaki	2009	0		
959	chr7	49119356	49119386	3500453532	30		49119356	49119386	8421504	1	30	0	c	350045353200000001	0-30						Cyclooxygenase Inhibitors Induce the Expression of the Tumor Suppressor Gene EGR-1, Which Results in the Up-Regulation of NAG-1, an Antitumorigenic Protein 2005&#x5e74;&#x7b2c;67&#x5377;&#x7b2c;2&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4	www.39kf.com	0	0		EGR1
959	chr7	49119356	49119386	3500195139	30		49119356	49119386	8421504	1	30	0	c,g	350019513900000001,350019513900000001	0-30,0-30						Cyclooxygenase Inhibitors Induce the Expression of the Tumor Suppressor Gene EGR-1, Which Results in the Up-Regulation of NAG-1, an Antitumorigenic Protein--&#x300a;&#x5206;&#x5b50;&#x836f;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;	journal.9med.net	0	0		EGR1
959	chr7	49119803	49119826	3500170386	23		49119803	49119826	8421504	1	23	0	c	350017038600000001	14-37		18556351	10.1210/en.2008-0035		Endocrinology	Transcriptional Responses to Estrogen and Progesterone in Mammary Gland Identify Networks Regulating p53 Activity	Shaolei	2008	0		EGR1
959	chr7	49120165	49120193	3500166125	23		49120165	49120193	8421504	3	6,12,5	0,9,23	g	350016612500000016	4-27						Retinal Cell Biology Regulation of Retinal Progenitor Cell Differentiation by Bone Morphogenetic Protein 4 Is Mediated by the Smad/Id Cascade	www.brain.hku.hk	0	0		
959	chr7	49145217	49145243	3500100169	24		49145217	49145243	8421504	2	6,18	0,8	g	350010016900000105	2-26						Antigenic investigation of genetically different strains of Beak and feather disease virus	etd.uovs.ac.za	0	0		
119	chr7	49149235	49176198	3500259772	42		49149235	49176198	8421504	2	21,21	0,26942	c	350025977200000001,350025977200000000	10-31,28-49		12446775	10.1128/MCB.22.24.8562-8570.2002	0270-7306	Molecular and Cellular Biology	Inhibition of Translation Termination Mediated by an Interaction of Eukaryotic Release Factor 1 with a Nascent Peptidyl-tRNA	Janzen	2002	6		
960	chr7	49152242	49155279	3500257189	153		49152242	49155279	8421504	3	71,22,60	0,353,2977	p	350025718900015072,350025718900015010,350025718900015021,350025718900015074,350025718900015027	0-93,0-84,0-63,0-57,0-60						Plants Having Enhanced Yield-Related Traits and a Method for Making the Same - Patent application	www.faqs.org	0	0		ETF1
960	chr7	49152242	49155279	3500102966	153		49152242	49155279	8421504	3	71,22,60	0,353,2977	p	350010296600015068,350010296600015003,350010296600015014,350010296600015070,350010296600015020	0-93,0-84,0-63,6-66,0-60						Plants having enhanced yield-related traits and a method for making the same	Hatzfeld	2011	0		ETF1
960	chr7	49185196	49197793	3500291921	172		49185196	49197793	8421504	10	19,31,18,7,16,22,19,4,17,19	0,44,282,2001,2874,4266,8635,9573,10488,12578	c	350029192100000279,350029192100000273,350029192100000098,350029192100000094,350029192100000075,350029192100000063,350029192100000211,350029192100000022,350029192100000177,350029192100000004	0-19,0-19,17-36,17-36,15-38,13-35,0-19,17-38,0-19,17-36						DOWN-REGULATION OF MORTALIN BY siRNA - Patent application	www.faqs.org	0	0		
960	chr7	49185265	49189594	3500298715	44		49185265	49189594	8421504	3	6,14,24	0,213,4305	c	350029871500000005,350029871500000000	12-32,0-24						CATECHOLAMINE REGULATED PROTEIN - Patent application	www.faqs.org	0	0		
960	chr7	49186264	49186309	3500343325	45		49186264	49186309	8421504	1	45	0	p	350034332500015026	0-45						Hsp70 from Arthrobacter - Patent # 7674892 - PatentGenius	.patentgenius.com	0	0		HSPA9
960	chr7	49186267	49186318	3500286885	51		49186267	49186318	8421504	1	51	0	p	350028688500015076	0-51						Dna Vaccine Enhancement With Mhc Class Ii Activators 	.freshpatents.com	0	0		HSPA9
960	chr7	49186270	49186315	3500212979	45		49186270	49186315	8421504	1	45	0	p	350021297900015013	0-45						Endogenous stress proteins as targets for anti-inflammatory T cells	ive.library.uu.nl	0	0		HSPA9
960	chr7	49187159	49188076	3500259199	51		49187159	49188076	8421504	2	45,6	0,911	p	350025919900015010	0-51						Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in Endothelial Progenitor Cells	www.mcponline.org	0	0		SNORD63
960	chr7	49188133	49188181	3500292213	48		49188133	49188181	8421504	1	48	0	p	350029221300015026	0-48						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		SNORD63
960	chr7	49193793	49193816	3500394860	23		49193793	49193816	8421504	1	23	0	c	350039486000000066	6-29						METHODS AND COMPOSITIONS FOR TREATING TULAREMIA - Patent application	www.faqs.org	0	0		
960	chr7	49193864	49193909	3500136436	45		49193864	49193909	8421504	1	45	0	p	350013643600015027	27-72						Anu Thesis corrections 11oct	search.wmin.ac.uk	0	0		HSPA9
960	chr7	49197747	49197770	3500177408	23		49197747	49197770	8421504	1	23	0	c	350017740800000000	21-44		17934217	10.1074/mcp.M700116-MCP200	1535-9476	Molecular & Cellular Proteomics	Association of Mortalin (HSPA9) with Liver Cancer Metastasis and Prediction for Early Tumor Recurrence	Yi	2008	7		PTPRM,HSPA9
960	chr7	49197747	49197770	3500065107	23		49197747	49197770	8421504	1	23	0	c,g	350006510700000000,350006510700000000	21-44,21-44		17934217	10.1074/mcp.M700116-MCP200	1535-9476	Molecular & Cellular Proteomics	Association of Mortalin (HSPA9) with Liver Cancer Metastasis and Prediction for Early Tumor Recurrence	Yi	2008	7		HSPA9
120	chr7	49391859	49559298	3500454949	2718		49391859	49559298	8421504	17	105,196,167,120,270,204,81,153,93,157,201,152,111,182,106,135,285	0,1168,32989,33666,42193,44904,117414,118665,131502,144327,157409,158350,162752,164384,164689,166118,167154	p	350045494900015000	0-2718						KEGG T01001: 1495	www.genome.jp	0	0		CTNNA1,LRRTM2
962	chr7	49434077	49434100	3500461516	23		49434077	49434100	8421504	1	23	0	c	350046151600000010	0-23		18684985	10.1152/ajpcell.90619.2007		American Journal of Physiology - Cell Physiolog	Nuclear localization of the titin Z1Z2Zr domain and role in regulating cell proliferation	Qi	2008	0		
962	chr7	49510527	49510618	3500240603	39		49510527	49510618	8421504	2	19,20	0,71	c,g	350024060300000004,350024060300000004,350024060300000005	0-19,0-19,0-20		15616222	10.1095/biolreprod.104.034801	0006-3363	Biology of Reproduction	Identification of Differentially Regulated Genes During Elongation and Early Implantation in the Ovine Trophoblast Using Complementary DNA Array Screening	Cammas	2005	4		
963	chr7	49558035	49558060	3500360669	23		49558035	49558060	8421504	2	6,17	0,8	c	350036066900000002	3-26		12517793		0008-5472	Cancer Research	Paradoxical Effects of Thiol Reagents on Jurkat Cells and a New Thiol-sensitive Mutant Form of Human Mitochondrial Superoxide Dismutase	Hernandez-Saavedra	2003	8		
963	chr7	49655635	49655663	3500224824	26		49655635	49655663	8421504	2	11,15	0,13	g	350022482400000004	0-40						June | 2013 | Epitope Tags/Tag Peptides Guide	www.gap-1-13.com	0	0		
965	chr7	49876700	49876723	3500139730	23		49876700	49876723	8421504	1	23	0	g	350013973000000052	0-23		19033365	10.1093/nar/gkn929		Nucleic Acids Research	Identification of a signature motif in target mRNAs of RNA-binding protein AUF1	Krystyna	2009	0		
965	chr7	49881421	49883198	3500191331	40		49881421	49883198	8421504	3	20,10,10	0,1521,1767	c	350019133100000021,350019133100000020	0-20,0-20						Increased adipogenesis in cultured embryonic chondrocytes and in adult bone marrow of dominant negative erg transgenic mice. - ResearchGate	.researchgate.net	0	0		MATR3
966	chr7	49994575	49994759	3500174579	23		49994575	49994759	8421504	3	7,4,12	0,10,172	c	350017457900000002	17-40		21393246	10.1074/jbc.M111.229807		The Journal of Biological Chemistry	A 4-Selenocysteine, 2-Selenocysteine Insertion Sequence (SECIS) Element Methionine Sulfoxide Reductase from Metridium senile Reveals a Non-catalytic Function of Selenocysteines	Byung	2011	0		
120	chr7	50063198	50104410	3500117791	62		50063198	50104410	8421504	3	20,21,21	0,34488,41191	c,g	350011779100000057,350011779100000057,350011779100000063,350011779100000058,350011779100000058	9-29,9-29,0-21,9-30,9-30						Characterization of the Ubiquitin/Nedd8 E3 Ligase Activity of the Mdm2/MdmX complex	www.uni-koeln.de	0	0		UBE2D2
120	chr7	50063207	50103109	3500407389	96		50063207	50103109	8421504	6	17,7,3,24,23,22	0,29851,34345,34427,34456,39880	c	350040738900000031,350040738900000044,350040738900000043,350040738900000032	0-24,0-27,0-23,0-22						Journal of Virological Methods	005.pasteur.ac.ir	0	0		UBE2D2
120	chr7	50063207	50093065	3500406924	24		50063207	50093065	8421504	2	17,7	0,29851	c	350040692400000008	0-24						aPhysikalischer Status des HPV16 Genoms und die virale Onkogenexpression a Bedeutung fA1/4r di	.db-thueringen.de	0	0		
120	chr7	50063207	50093065	3500150393	24		50063207	50093065	8421504	2	17,7	0,29851	c	350015039300000007	0-24						Validation of Housekeeping Genes for Normalizing RNA Expression In Real-Time PCR | Alimuddin Zumla - Academia.edu	www.academia.edu	0	0		
967	chr7	50093082	50097845	3500058326	74		50093082	50097845	8421504	3	40,8,26	0,4441,4737	c	350005832600000016,350005832600000029	0-48,0-26						Ubiquitin conjugating enzymes	Rolfe	1996	0		
967	chr7	50097840	50104398	3500403930	96		50097840	50104398	8421504	3	48,14,34	0,5278,6524	c	350040393000000018,350040393000000021	0-48,0-48						Human ubiquitin conjugating enzyme	Draetta	1994	0		
967	chr7	50097841	50103079	3500296753	49		50097841	50103079	8421504	2	27,22	0,5216	c	350029675300000004,350029675300000005	0-27,0-22			10.1111/j.1365-2567.2006.02383.x		Immunology	Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-&#x03b1; production by human monocytes	Cecilia	2006	0		
967	chr7	50098531	50098555	3500207549	23		50098531	50098555	8421504	2	7,16	0,8	g	350020754900000010	4-28						Pseudomonas exotoxin-myelin basic protein chimeric proteins	Lorberboum-galski	1999	0		
967	chr7	50103092	50104509	3500442599	44		50103092	50104509	8421504	2	20,24	0,1393	c,g	350044259900000002,350044259900000002,350044259900000003	0-20,0-20,8-32						TaiLieu.VN: B&#xe1;o c&#xe1;o y h&#x1ecd;c: "Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain" 	tailieu.vn/doc/ba	0	0		
967	chr7	50104600	50104645	3500002319	45		50104600	50104645	8421504	1	45	0	c	350000231900000002	0-45						Blood Group Antibody Screening 	.freshpatents.com	0	0		
967	chr7	50157335	50157383	3500445828	48		50157335	50157383	8421504	1	48	0	p	350044582800015018	0-48						METHODS FOR DETERMINING A PROGNOSIS FOR SURVIVAL FOR A PATIENT WITH LEUKAEMIA - Patent application	www.faqs.org	0	0		
968	chr7	50242082	50242110	3500088036	24		50242082	50242110	8421504	3	5,4,15	0,8,13	g	350008803600000049,350008803600000026	3-27,3-27						US Patent # 7,629,440. Lectin compositions and methods for modulating an immune response to an antigen - Patents.com	www.patents.com	0	0		
969	chr7	50337824	50337872	3500317509	48		50337824	50337872	8421504	1	48	0	g	350031750900000025	0-48						Cerebellum-derived growth factors, and uses related thereto		1997	0		
969	chr7	50340320	50340346	3500276592	23		50340320	50340346	8421504	3	11,8,4	0,13,22	g	350027659200000001	4-27						Development of New Platforms for Efficient Production and Purification of Recombinant Protein in Higher Plants	ir.lib.uwo.ca	0	0		
970	chr7	50573223	50573895	3500408263	431		50573223	50573895	8421504	6	48,48,47,48,48,192	0,96,192,240,384,480	c,g	350040826300000048,350040826300000050,350040826300000052,350040826300000053,350040826300000055,350040826300000057,350040826300000005,350040826300000005,350040826300000058,350040826300000059,350040826300000060	0-48,0-48,0-47,0-48,0-48,0-48,0-20,0-20,0-48,0-48,0-48						Methods for identifying compounds that bind to PUR protein	Johnson	1995	0		
970	chr7	50573223	50573895	3500348163	479		50573223	50573895	8421504	5	48,143,48,48,192	0,96,240,384,480	c,g	350034816300000034,350034816300000036,350034816300000037,350034816300000038,350034816300000039,350034816300000041,350034816300000043,350034816300000005,350034816300000005,350034816300000044,350034816300000045,350034816300000046	0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-20,0-20,0-48,0-48,0-48						US Patent # 5,545,551. Cloning and expression of pur protein - Patents.com	www.patents.com	0	0		
970	chr7	50573643	50573721	3500017419	78		50573643	50573721	8421504	1	78	0	p	350001741900015030	0-78						REGULATION OF GONADOTROPIN RELEASING HORMONE 1 GENE TRANSCRIPTION BY MEMBERS OF THE PURINE-RICH ELEMENT BINDING PROTEIN FAMILY	www.stanford.edu	0	0		IGIP
970	chr7	50573799	50573847	3500390012	48		50573799	50573847	8421504	1	48	0	c	350039001200000048	0-48						Cloning and expression of pur protein	Bergemann	1994	0		
970	chr7	50587744	50587843	3500020103	94		50587744	50587843	8421504	2	22,72	0,27	p,c,g	350002010300000002,350002010300015000,350002010300000003,350002010300000003,350002010300000001	0-22,0-72,0-22,0-22,0-22		12874223		0022-1767	The Journal of Immunology	Identification and Characterization of a Novel Regulatory Factor: IgA-Inducing Protein	Austin	2003	6		
971	chr7	50606639	50606675	3500269550	30		50606639	50606675	8421504	3	5,15,10	0,8,26	g	350026955000000078,350026955000000079	14-41,15-46						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
971	chr7	50712045	50712073	3500122711	23		50712045	50712073	8421504	2	8,15	0,13	g	350012271100000097	1-24						Humanized antibodies that recognize beta amyloid peptide - US Patent 7790856 Description	ww.patentstorm.us	0	0		
972	chr7	50807494	50817201	3500179621	40		50807494	50817201	8421504	3	1,19,20	0,825,9687	c,g	350017962100000005,350017962100000004,350017962100000004	0-20,0-20,0-20						Levels of Cyclooxygenase-2 Are Increased in the Oral Mucosa of Smokers: Evidence for the Role of Epidermal Growth Factor Receptor and Its Ligands	.aacrjournals.org	0	0		
972	chr7	50808428	50817221	3500325983	49		50808428	50817221	8421504	2	25,24	0,8769	c,g	350032598300000030,350032598300000005,350032598300000007,350032598300000021,350032598300000021,350032598300000004,350032598300000004	7-30,18-40,17-38,10-34,10-34,10-30,10-30						PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT	Kimura	2007	0		
972	chr7	50808428	50817221	3500145282	47		50808428	50817221	8421504	2	23,24	0,8769	c	350014528200000092,350014528200000030,350014528200000067,350014528200000005,350014528200000086,350014528200000021,350014528200000066,350014528200000004	7-29,7-30,18-40,18-40,10-34,10-34,10-30,10-30						PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT - Patent application	www.faqs.org	0	0		
972	chr7	50808429	50817221	3500305350	46		50808429	50817221	8421504	2	22,24	0,8768	c	350030535000000010,350030535000000000,350030535000000008	18-40,0-21,10-30						Pharmaceutical composition containing anti-hb-egf antibody as active ingredient	Kimura	2011	0		
972	chr7	50808429	50817221	3500276174	46		50808429	50817221	8421504	2	22,24	0,8768	c,g	350027617400000010,350027617400000004,350027617400000004,350027617400000000,350027617400000000,350027617400000008	18-40,10-34,10-34,0-21,0-21,10-30						Pharmaceutical composition containing anti-hb-egf antibody as active ingredient	Kimura	2011	0		
972	chr7	50808429	50817221	3500092516	48		50808429	50817221	8421504	2	24,24	0,8768	c	350009251600000005,350009251600000007,350009251600000000,350009251600000004	18-40,17-38,0-21,10-30						Anti-cancer agent comprising anti-hb-egf antibody as active ingredient	Kimura	2010	0		
972	chr7	50808429	50817221	3500069363	48		50808429	50817221	8421504	2	24,24	0,8768	c	350006936300000052,350006936300000005,350006936300000007,350006936300000047,350006936300000000,350006936300000002,350006936300000049,350006936300000051,350006936300000004	18-40,18-40,17-38,0-21,0-21,10-34,10-34,10-30,10-30						ANTI-CANCER AGENT COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT - Patent application	www.faqs.org	0	0		
972	chr7	50808429	50817218	3500370495	43		50808429	50817218	8421504	2	22,21	0,8768	c	350037049500000004,350037049500000000	18-40,0-21						Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient	Kimura	2009	0		HBEGF
972	chr7	50808429	50808474	3500316673	45		50808429	50808474	8421504	1	45	0	p	350031667300015163	0-45						Erbb4 receptor-specific neuregulin, related ligands and uses thereof	Godowski	1999	0		HBEGF
972	chr7	50808429	50808474	3500164837	45		50808429	50808474	8421504	1	45	0	p	350016483700015159	0-45						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		HBEGF
972	chr7	50813770	50816963	3500155898	84		50813770	50816963	8421504	2	47,37	0,3156	c	350015589800000471,350015589800000465	1-48,10-47						Heparin-binding growth factors for gene therapy and anterior eye disorders	Sosnowski	1995	0		
972	chr7	50816926	50817218	3500362735	84		50816926	50817218	8421504	3	37,1,46	0,48,246	c	350036273500000135,350036273500000134	10-47,0-47						Compositions containing nucleic acids and ligands for therapeutic treatment	Baird	1999	0		
972	chr7	50817194	50817220	3500254595	26		50817194	50817220	8421504	1	26	0	c,g	350025459500000000,350025459500000000	4-30,4-30		11888934		0008-5472	Cancer Research	Activation of the Erk Mitogen-activated Protein Kinase Pathway Stimulates Neuroendocrine Differentiation in LNCaP Cells Independently of Cell Cycle Withdrawal and STAT3 Phosphorylation	Kim	2002	8		
972	chr7	50817194	50817220	3500121531	26		50817194	50817220	8421504	1	26	0	c	350012153100000000	4-30		12446587	10.1210/en.2002-220561	0013-7227	Endocrinology	Heparin-Binding Epidermal Growth Factor-Like Growth Factor Stimulates Androgen-Independent Prostate Tumor Growth and Antagonizes Androgen Receptor Function	Adam	2002	4		
972	chr7	50817197	50817221	3500292323	24		50817197	50817221	8421504	1	24	0	c	350029232300000000,350029232300000008	0-21,10-30						Cancer therapeutic agent comprising anti-HB-EGF antibody as active ingredient	Mu Cun Zhi Ji 	2009	0		HBEGF
972	chr7	50817197	50817221	3500137198	24		50817197	50817221	8421504	1	24	0	c	350013719800000034,350013719800000008	10-34,10-30						Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient	Mu Cun Zhi Ji 	2009	0		
972	chr7	50817199	50817226	3500151017	27		50817199	50817226	8421504	1	27	0	c	350015101700000000	8-35			10.1046/j.1365-2958.2003.03550.x	1365-2958	Molecular Microbiology	Transgenic mice expressing the diphtheria toxin receptor are sensitive to the toxin - Cha - 2003 - Molecular Microbiology - Wiley Online Library	Cha	2003	0		
972	chr7	50844115	50844160	3500018173	45		50844115	50844160	8421504	1	45	0	p	350001817300015000,350001817300015001	0-45,3-48		11102437	10.1074/jbc.M004513200	0021-9258	Journal of Biological Chemistry	A New Member of the HCO Transporter Superfamily Is an Apical Anion Exchanger of &#x03b2;-Intercalated Cells in the Kidney	Tsuganezawa	2001	5		SLC4A9
974	chr7	51036599	51037812	3500018812	1021		51036599	51037812	8421504	10	28,18,54,114,114,55,413,174,48,3	0,91,112,172,292,412,473,892,1072,1210	p,c	350001881200000019,350001881200000017,350001881200015014,350001881200015012,350001881200015010,350001881200015006,350001881200015005,350001881200015003,350001881200015002,350001881200000000,350001881200000018	6-34,3-943,0-45,0-45,0-45,0-318,0-45,0-45,0-45,9-28,9-28						 Use Of Recombinant Bovine CD14 In The Treatment And Prevention Of Coliform Mastitis In Dairy Cows 	www.docstoc.com	0	0		
974	chr7	51036603	51036627	3500394801	24		51036603	51036627	8421504	1	24	0	c	350039480100000001	12-36					Proceedings of the National Academy of Sciences of the United States of America	Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation	Dominik	2001	0		
974	chr7	51036700	51037812	3500265135	1022		51036700	51037812	8421504	2	1019,3	0,1109	c	350026513500000002,350026513500000000	4-1026,12-33						ABSTRACT Title of Dissertation: THE INTERELATIONSHIP BETWEEN CD14 AND LPS DURING MASTITIS: RELEASE OF SOLUBLE CD14 AND CYTOKINES BY BOVINE PMN FOLLOWING ACTIVATION WITH LPS	drum.lib.umd.edu	0	0		
974	chr7	51036944	51036968	3500416505	24		51036944	51036968	8421504	1	24	0	c	350041650500000010	0-24						Cd93 or use of soluble fragment thereof	Park	2010	0		
974	chr7	51037351	51037529	3500153648	40		51037351	51037529	8421504	2	20,20	0,158	c,g	350015364800000005,350015364800000005,350015364800000004	0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
974	chr7	51044863	51044888	3500145728	24		51044863	51044888	8421504	2	9,15	0,10	c	350014572800000012	5-29						Methods for the treatment of cancer using anti-CD40 antibodies - US Patent 7510711 Description	ww.patentstorm.us	0	0		
974	chr7	51044863	51044887	3500445397	23		51044863	51044887	8421504	2	9,14	0,10	c	350044539700000039	7-30						Vector - Patent application	www.faqs.org	0	0		
974	chr7	51044863	51044887	3500033559	23		51044863	51044887	8421504	2	9,14	0,10	c	350003355900000032	6-29						ANTIBODIES TO TROPONIN I AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
974	chr7	51044863	51044887	3500013619	23		51044863	51044887	8421504	2	9,14	0,10	c	350001361900000029	6-29						ANTIBODIES TO TROPONIN I AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
974	chr7	51052511	51052736	3500261436	40		51052511	51052736	8421504	3	19,14,7	0,82,218	c	350026143600000072,350026143600000071	0-19,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		NDUFA2
974	chr7	51076390	51076760	3500433420	48		51076390	51076760	8421504	2	33,15	0,355	p	350043342000015080	0-48						COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES - Patent application	www.faqs.org	0	0		
976	chr7	51358017	51361395	3500164515	40		51358017	51361395	8421504	2	20,20	0,3358	c,g	350016451500000006,350016451500000006,350016451500000007	0-20,0-20,0-20						TARTU &#xdc;LIKOOL LOODUS- JA TEHNOLOOGIATEADUSKOND MOLEKULAAR- JA RAKUBIOLOOGIA INSTITUUT Liisi V&#xf5;sa	www.ebc.ee/kaitsm	0	0		PCDHA12
979	chr7	51688238	51688265	3500340691	24		51688238	51688265	8421504	3	4,11,9	0,5,18	c	350034069100000270	0-25						Transgenic non-human animals capable of producing heterologous antibodies of various isotypes	Lonberg	1993	0		
979	chr7	51688238	51688265	3500131771	24		51688238	51688265	8421504	3	4,11,9	0,5,18	c	350013177100000319	0-25					Patent	Transgenic non-human animals for producing heterologous antibodies (Patent US:5814318)	Kay	1998	0		
979	chr7	51714836	51764600	3500023334	161		51714836	51764600	8421504	5	47,21,34,35,24	0,297,49353,49435,49740	c	350002333400000423,350002333400000429,350002333400000390,350002333400000392,350002333400000398	0-47,12-33,14-48,0-35,17-41						Proteins, Polynucleotides Encoding Them And Methods Of Using The Same 	.freshpatents.com	0	0		
979	chr7	51765560	51765587	3500414565	23		51765560	51765587	8421504	2	11,12	0,15	c	350041456500000741	10-33						Analyzing Comparative Sequence Data to Understand Genome Function and Evolution	gradworks.umi.com	0	0		
981	chr7	52011267	52011419	3500258588	26		52011267	52011419	8421504	2	21,5	0,147	c	350025858800000011	0-26						ASSAY FOR IDENTIFYING AGENTS THAT MODULATE EPIGENETIC SILENCING, AND AGENTS IDENTIFIED THEREBY - Patent application	www.faqs.org	0	0		
981	chr7	52029073	52029133	3500208127	60		52029073	52029133	8421504	1	60	0	p	350020812700015020	0-60						Etude g&#xe9;notypique et ph&#xe9;notypique du Naevus Cong&#xe9;nital (de taille moyenne et large)	theses.ulb.ac.be	0	0		
983	chr7	52235197	52249862	3500080418	3135		52235197	52249862	8421504	11	594,582,129,48,51,462,159,213,720,137,40	0,612,1197,1329,1380,1437,1902,2064,5245,5971,14625	p	350008041800015090	0-3153						Methods and compositions for predicting response to eribulin	AGOULNIK	2012	0		
984	chr7	52387075	52387120	3500306083	45		52387075	52387120	8421504	1	45	0	p	350030608300015028	0-45						Nature June 2 ,2011	www.calameo.com	0	0		RNF14
986	chr7	52639554	52639582	3500290898	23		52639554	52639582	8421504	2	9,14	0,14	g	350029089800000000	5-34						Candida albicans sphingolipid C9- methyltransferase is involved in hyphal elongation	c.sgmjournals.org	0	0		
986	chr7	52656492	52656521	3500395930	24		52656492	52656521	8421504	2	18,6	0,23	g	350039593000000255	3-27						Recombinant infectious laryngotracheitis virus and uses thereof	Cochran	1995	0		
986	chr7	52656492	52656521	3500179670	24		52656492	52656521	8421504	2	18,6	0,23	g	350017967000000173	3-27						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
989	chr7	52968330	52968375	3500451139	45		52968330	52968375	8421504	1	45	0	p	350045113900015006	0-45						TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY IN VIVO GENE DELIVERY - Patent application	www.faqs.org	0	0		
989	chr7	52968381	52975248	3500465007	48		52968381	52975248	8421504	2	39,9	0,6858	c	350046500700000079	0-48						US Patent # 6,294,359. Human basic fibroblast growth factor analog - Patents.com	www.patents.com	0	0		
991	chr7	53300459	53300487	3500335393	23		53300459	53300487	8421504	2	13,10	0,18	g	350033539300000380	1-30					Patent	Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories (Patent US:	Bergeron	1999	0		
991	chr7	53300459	53300487	3500293595	23		53300459	53300487	8421504	2	13,10	0,18	g	350029359500000286	1-30					Patent	Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories (Patent US:	Bergeron	1999	0		
991	chr7	53338719	53338745	3500319915	24		53338719	53338745	8421504	2	6,18	0,8	g	350031991500000007	2-26						Chemokine alpha-4	Olsen	1998	0		
994	chr7	53688399	53708389	3500060362	54		53688399	53708389	8421504	2	35,19	0,19971	c	350006036200000367,350006036200000068,350006036200000312	0-36,1-20,1-20						ENHANCED ANTISENSE OLIGONUCLEOTIDES - Patent application	www.faqs.org	0	0		
994	chr7	53691634	53691975	3500076778	54		53691634	53691975	8421504	2	28,26	0,315	c	350007677800000001,350007677800000000	0-28,0-26		21217824	10.1371/journal.pone.0014476		PLoS ONE	Glucocorticoid-Mediated Inhibition of Angiogenic Changes in Human Endothelial Cells Is Not Caused by Reductions in Cell Proliferation or Migration	James	2010	0		NR3C1
994	chr7	53691954	53692178	3500380921	46		53691954	53692178	8421504	2	22,24	0,200	c,g	350038092100000014,350038092100000014,350038092100000006	0-22,0-22,0-24						END OF PROJECT REPORT 5230 Animal Transport: Developing optimum animal handling procedures and effective transport strategies in the food production chain to improve animal welfare and food quality.	www.teagasc.ie	0	0		NR3C1
994	chr7	53691958	53691983	3500093052	25		53691958	53691983	8421504	1	25	0	c	350009305200000001	0-25		15769988	10.1210/jc.2004-1920	0021-972X	Journal of Clinical Endocrinology & Metabolism	A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity	Charmandari	2005	6		NR3C1
994	chr7	53692051	53692077	3500313436	26		53692051	53692077	8421504	1	26	0	c	350031343600000009	0-26						ScienceDirect.com - Molecular Cell - GR and HMGB1 Interact Only within Chromatin and Influence Each Other&#x2019;s Residence Time	sciencedirect.com	0	0		
994	chr7	53692107	53692133	3500318206	26		53692107	53692133	8421504	1	26	0	c,g	350031820600000002,350031820600000000	10-36,49-75					Patent	Compounds with anti-inflammatory activity (Patent CN:100393741)	Bo Si Qia *He Wa Xi Ke 	2008	0		NR3C1
994	chr7	53692115	53707440	3500392554	441		53692115	53707440	8421504	4	150,158,131,2	0,729,11430,15323	p	350039255400015004	0-441						Biological applications of steroid binding domains	Hovens	2010	0		
994	chr7	53692172	53708267	3500356489	621		53692172	53708267	8421504	6	93,158,67,1,145,157	0,672,11373,11503,15266,15938	p	350035648900015086,350035648900015067	0-318,0-303					Patent	Polynucleotide encoding insect ecdysone receptor (Patent US:6245531)	Hogness	2001	0		NR3C1
994	chr7	53692220	53714336	3500185455	294		53692220	53714336	8421504	5	45,30,74,52,93	0,624,708,11325,22023	p	350018545500015102,350018545500015079,350018545500015118,350018545500015022	0-75,0-126,0-123,0-93						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers_ Sources	www.docstoc.com	0	0		NR3C1
994	chr7	53692238	53692265	3500115662	27		53692238	53692265	8421504	1	27	0	c	350011566200000002	0-27						High level inducible expression of heterologous genes	Israel	1988	0		NR3C1
994	chr7	53692238	53692263	3500390024	25		53692238	53692263	8421504	1	25	0	c	350039002400000009	0-25					International Journal of Molecular Sciences	Modulation of Human Serotonin Transporter Expression by 5-HTTLPR in Colon Cells - Scolaris	Prasansuklab	2011	0		NR3C1
994	chr7	53707510	53708135	3500463987	44		53707510	53708135	8421504	2	22,22	0,603	c	350046398700000021,350046398700000020	0-22,0-22						Effets d'une d&#xe9;nutrition maternelle pr&#xe9;natale sur la r&#xe9;gulation de l'hom&#xe9;ostasie &#xe9;nerg&#xe9;tique chez la descendance m&#xe2;le adulte : focus sur l'hypothalamus et le tissu adipeux	eo.univ-lille1.fr	0	0		
994	chr7	53708282	53708321	3500295556	36		53708282	53708321	8421504	2	29,7	0,32	c	350029555600000182	12-48						Seed plants exhibiting early reproductive development and methods of making same	Weigel	1997	0		
994	chr7	53708327	53714243	3500445068	78		53708327	53714243	8421504	2	62,16	0,5900	p	350044506800015004	0-78						Methods, compositions, and systems for the identification of species-specific or developmental stage-specific insecticides	Henrich	2006	0		
994	chr7	53708327	53714243	3500006486	78		53708327	53714243	8421504	2	62,16	0,5900	p	350000648600015004	0-78						Compounds that act to modulate insect growth and methods and systems for identifying such compounds	Henrich	2004	0		
994	chr7	53708334	53708360	3500301912	26		53708334	53708360	8421504	1	26	0	c	350030191200000026	8-34						METHODS AND COMPOSITIONS FOR RAPID DEVELOPMENT OF SCREENING ASSAYS NUCLEAR RECEPTORS - VERTEX PHARMACEUTICALS INCORPORATED	www.sumobrain.com	0	0		NR3C1
994	chr7	53708334	53708360	3500188792	26		53708334	53708360	8421504	1	26	0	c	350018879200000026	8-34						Methods and compositions for rapid development of screening assays	Whitney	2003	0		NR3C1
994	chr7	53708372	53714261	3500254665	51		53708372	53714261	8421504	2	17,34	0,5855	p	350025466500015060	0-51						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		NR3C1
994	chr7	53708375	53714261	3500307353	48		53708375	53714261	8421504	2	14,34	0,5852	p	350030735300015033	0-48						 Regulation Of Gene Expression Using Chromatin Remodelling Factors 	www.docstoc.com	0	0		NR3C1
994	chr7	53714276	53714321	3500001468	45		53714276	53714321	8421504	1	45	0	p	350000146800015002	0-45						P53AS protein and antibody therefor	Kulesz-martin	1996	0		NR3C1
994	chr7	53714284	53723701	3500077888	51		53714284	53723701	8421504	3	30,10,11	0,50,9406	c	350007788800000059,350007788800000058	0-30,0-21						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
994	chr7	53723703	53723751	3500259041	48		53723703	53723751	8421504	1	48	0	p	350025904100015116	0-48						Treatment Of Disease Using An Improved Regulated Expression System 	.freshpatents.com	0	0		NR3C1
995	chr7	53802729	53802861	3500383646	40		53802729	53802861	8421504	2	20,20	0,112	c,g	350038364600000021,350038364600000021,350038364600000020,350038364600000020	0-20,0-20,0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
995	chr7	53802729	53802861	3500156044	40		53802729	53802861	8421504	2	20,20	0,112	c,g	350015604400000001,350015604400000001,350015604400000000	0-20,0-20,0-20						The role of glucocorticoid in the regulation of prostaglandin biosynthesis in non-pregnant bovine endometrium	logy-journals.org	0	0		
995	chr7	53802770	53802894	3500315971	44		53802770	53802894	8421504	2	22,22	0,102	c	350031597100000027,350031597100000026	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
995	chr7	53802770	53802894	3500248474	44		53802770	53802894	8421504	2	22,22	0,102	c	350024847400000027,350024847400000026	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
995	chr7	53802770	53802894	3500024081	44		53802770	53802894	8421504	2	22,22	0,102	c,g	350002408100000031,350002408100000030,350002408100000030	0-22,0-22,0-22						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
995	chr7	53802919	53802976	3500136055	56		53802919	53802976	8421504	2	24,32	0,25	c	350013605500000003,350013605500000014	21-45,0-32						Effects of Mineralocorticoid and Glucocorticoid Agonists on Gene and Protein Expression, Structural Maturation and Compliance in the Ovine Preterm Fetal Lung	ufdc.ufl.edu	0	0		
995	chr7	53802947	53802999	3500059189	52		53802947	53802999	8421504	1	52	0	g	350005918900000000	169-221		10096574		0008-5472	Cancer Research	Glucocorticoid-induced Cell Death Requires Autoinduction of Glucocorticoid Receptor Expression in Human Leukemic T Cells	Ramdas	1999	8		
995	chr7	53803254	53803278	3500106759	24		53803254	53803278	8421504	1	24	0	c	350010675900000002	24-48						Neuroendocrine Consequences of Binge Alcohol Exposure During Peri-Puberty on Functioning of the Hypothalamo-Pituitary-Adrenal (HPA) Axis	ecommons.luc.edu	0	0		
995	chr7	53803254	53803278	3500047473	24		53803254	53803278	8421504	1	24	0	c	350004747300000003	24-48		22039522	10.1371/journal.pone.0026647		PLoS ONE	Alcohol Dysregulates Corticotropin-Releasing-Hormone (CRH) Promoter Activity by Interfering with the Negative Glucocorticoid Response Element (nGRE)	Magdalena	2011	0		
995	chr7	53803708	53803808	3500301078	44		53803708	53803808	8421504	2	22,22	0,78	c,g	350030107800000152,350030107800000152,350030107800000151	0-22,0-22,0-22						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
996	chr7	53968680	53968704	3500109617	23		53968680	53968704	8421504	2	11,12	0,12	g	350010961700000018	0-23						[tel-00855515, v1] Caract&#xe9;risation de facteurs bact&#xe9;riens essentiels &#xe0; la virulence des souches de Escherichia coli associ&#xe9;es &#xe0; la maladie de Crohn	hives-ouvertes.fr	0	0		
1000	chr7	54453084	54453112	3500000624	23		54453084	54453112	8421504	2	16,7	0,21	g	350000062400000020	3-30						Thermostable DNA polymerase from 9&#xb0;N-7 and methods for producing the same	Perler	1994	0		
1000	chr7	54471527	54471555	3500187612	24		54471527	54471555	8421504	2	7,17	0,11	g	350018761200000198	14-38						US Patent # 5,635,617. Methods and compositions comprising the agfA gene for detection of Salmonella - Patents.com	www.patents.com	0	0		
1000	chr7	54493483	54493506	3500453101	23		54493483	54493506	8421504	1	23	0	g	350045310100000150	5-28						 Nucleotide Sequences Encoding Anthonomous Toxic Polypeptides From Bacillus Thuringiensis 	www.docstoc.com	0	0		
1001	chr7	54634084	54634110	3500376074	23		54634084	54634110	8421504	2	16,7	0,19	g	350037607400000000	0-23		15654078	10.1074/jbc.M414093200	0021-9258	Journal of Biological Chemistry	Evolution of Mitochondrial Oxa Proteins from Bacterial YidC	Preuss	2005	5		
1002	chr7	54713928	54713954	3500453101	23		54713928	54713954	8421504	2	8,15	0,11	g	350045310100000143	7-30						 Nucleotide Sequences Encoding Anthonomous Toxic Polypeptides From Bacillus Thuringiensis 	www.docstoc.com	0	0		
1004	chr7	55025915	55025948	3500036437	26		55025915	55025948	8421504	3	13,8,5	0,18,28	g	350003643700000179	0-26						Antisense modulation of integrin &#x03b1;4 expression	Bennett	1999	0		
1018	chr7	56875869	56875894	3500096200	24		56875869	56875894	8421504	2	15,9	0,16	g	350009620000000007	11-35						System for producing multimeric peptides and proteins and use thereof	MARTINEZ	2009	0		
1019	chr7	56970637	56980123	3500154960	23		56970637	56980123	8421504	3	9,6,8	0,9471,9478	c	350015496000000001	0-23						Human posh-like protein 1	Shannon	2002	0		SH3RF2
15	chr7	57605832	57730905	3500116466	498		57605832	57730905	8421504	12	36,45,63,45,42,74,10,15,33,8,19,108	0,39,2953,20564,58345,58408,73283,118123,118141,118177,124925,124965	p	350011646600015088,350011646600015109,350011646600015086,350011646600015113,350011646600015130,350011646600015084,350011646600015013,350011646600015083,350011646600015129,350011646600015121,350011646600015078,350011646600015077,350011646600015127,350011646600015092,350011646600015117	6-87,0-66,0-63,0-60,12-69,0-45,0-129,6-87,0-72,6-81,6-81,0-108,0-75,0-81,0-69						Litopenaeus_vannamei-Contig_3669-v1 | MarineGenomics.org	arinegenomics.org	0	0		
1025	chr7	57734195	57734225	3500167803	30		57734195	57734225	8421504	1	30	0	c	350016780300000007,350016780300000002	0-30,0-30		15965230	10.1074/jbc.M505317200	0021-9258	Journal of Biological Chemistry	Protein Phosphatase 2A Regulates Estrogen Receptor &#x03b1; (ER) Expression through Modulation of ER mRNA Stability	Keen	2005	5		PPP2R2B
1026	chr7	57835842	57835870	3500036136	23		57835842	57835870	8421504	2	14,9	0,19	g	350003613600000003	0-24						Anti-apoptotic function of T-KTS+, T-KTS-, WT1+/+ and WT1+/- isoforms in breast cancer	gitaljournals.org	0	0		
1027	chr7	57939988	57940012	3500406732	23		57939988	57940012	8421504	2	5,18	0,6	g	350040673200000078	23-48						Control of fruit ripening and senescence in plants	Klee	1991	0		
1027	chr7	57939988	57940012	3500088021	23		57939988	57940012	8421504	2	5,18	0,6	g	350008802100000078	23-48						Control of fruit ripening and senescence in plants - US Patent 5512466 Description	ww.patentstorm.us	0	0		
1027	chr7	57939988	57940012	3500018595	23		57939988	57940012	8421504	2	5,18	0,6	g	350001859500000078	23-48						Control of fruit ripening and senescence in plants	Klee	1995	0		
1028	chr7	58080015	58080047	3500410049	26		58080015	58080047	8421504	3	14,6,6	0,19,26	c	350041004900000001	0-26		19318353	10.1074/jbc.M900075200		The Journal of Biological Chemistry	Interaction of Adipocyte Fatty Acid-binding Protein (AFABP) and JAK2: AFABP/aP2 AS A REGULATOR OF JAK2 SIGNALING*	Brian	2009	0		
1031	chr7	58527179	58527206	3500434928	23		58527179	58527206	8421504	2	11,12	0,15	c	350043492800000675	2-25						Compositions, methods and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals - Patent application	www.faqs.org	0	0		
1032	chr7	58716686	58716712	3500059076	23		58716686	58716712	8421504	2	9,14	0,12	g	350005907600000035	19-42						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE	Frank-Kamenetsky	2009	0		
1035	chr7	59031746	59036777	3500311730	60		59031746	59036777	8421504	2	59,1	0,5030	p	350031173000015063	0-60						The Lewisx glycan in mice	ie.uni-hamburg.de	0	0		DPYSL3
1035	chr7	59031749	59031803	3500187559	54		59031749	59031803	8421504	1	54	0	p	350018755900015007	0-54						Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes	Aguera	2006	0		DPYSL3
1038	chr7	59437510	59437537	3500319957	24		59437510	59437537	8421504	2	6,18	0,9	g	350031995700000002	4-31			10.1038/sj.onc.1203835	${footerJournalISSN}		Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: Similarities to retroviral RNA-protein interactions		2000	0		
1044	chr7	60200780	60200804	3500332215	24		60200780	60200804	8421504	1	24	0	c	350033221500000011	3-27						Composition and methods for therapy and diagnosis of cancer	Koslowski	2007	0		
1044	chr7	60200780	60200804	3500121135	24		60200780	60200804	8421504	1	24	0	c	350012113500000011	3-27						Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis	Sahin	2009	0		
1044	chr7	60200780	60200804	3500117470	24		60200780	60200804	8421504	1	24	0	c	350011747000000011	3-27						Compositions and methods for therapy and diagnosis of cancer	Koslowski	2007	0		
1044	chr7	60200780	60200804	3500032476	24		60200780	60200804	8421504	1	24	0	c	350003247600000011	3-27						Compositions and methods for therapy and diagnosis of cancer	Sahin	2009	0		
1045	chr7	60295005	60295032	3500048525	27		60295005	60295032	8421504	1	27	0	c	350004852500000001	14-41		18338032	10.1371/journal.pone.0001317		PLoS ONE	Modifying Ligand-Induced and Constitutive Signaling of the Human 5-HT4 Receptor	Wei	2007	0		HTR4
1045	chr7	60318569	60346738	3500381923	264		60318569	60346738	8421504	9	48,24,16,31,25,23,41,54,2	0,348,4177,4194,4246,26539,26617,26686,28167	c	350038192300000090,350038192300000045,350038192300000013,350038192300000076,350038192300000074,350038192300000008,350038192300000034	0-48,0-24,0-47,0-48,0-41,0-47,0-48						Dna encoding 5-ht4 serotonin receptors and uses thereof	Branchek	1994	0		
1045	chr7	60318866	60345169	3500185530	40		60318866	60345169	8421504	2	20,20	0,26283	c,g	350018553000000007,350018553000000007,350018553000000006	0-20,0-20,0-20		19654143	10.1677/JOE-09-0187	0022-0795	Journal of Endocrinology	The bovine mammary gland expresses multiple functional isoforms of serotonin receptors	Hernandez	2009	4		
1045	chr7	60318917	60318941	3500415448	24		60318917	60318941	8421504	1	24	0	c	350041544800000045	0-24						DNA encoding 5-HT4 serotonin receptors and uses thereof	Gerald	1995	0		
1045	chr7	60322784	60345239	3500380525	45		60322784	60345239	8421504	2	20,25	0,22430	c,g	350038052500000005,350038052500000005,350038052500000006	0-20,0-20,0-25						HTR4 gene structure and altered expression in the developing lung	tory-research.com	0	0		HTR4
1046	chr7	60428887	60428911	3500466593	24		60428887	60428911	8421504	1	24	0	c	350046659300000000	0-24		10220570		1521-0111 (Online)	Molecular Pharmacology	Novel Brain-Specific 5-HT4 Receptor Splice Variants Show Marked Constitutive Activity: Role of the C-Terminal Intracellular Domain	Claeysen	1999	0		HTR4
1047	chr7	60637431	60637454	3500245790	23		60637431	60637454	8421504	1	23	0	c	350024579000000002	0-23					Patent	Immortalized cell lines from human adipose tissue, process for preparing same and applications thereof (Patent US:6071747)	Strosberg	2000	0		ADRB2
1047	chr7	60637431	60637454	3500189549	23		60637431	60637454	8421504	1	23	0	c	350018954900000002	0-23						Immortalized cell lines from human adipose tissue, process for preparing same and applications thereof	Strosberg	1998	0		ADRB2
1047	chr7	60637431	60637454	3500125715	23		60637431	60637454	8421504	1	23	0	c	350012571500000002	0-23						Immortalized cell lines from human adipose tissue, process for preparing same and applications thereof - Patent # 6071747 - PatentGenius	.patentgenius.com	0	0		ADRB2
1047	chr7	60637431	60637454	3500017026	23		60637431	60637454	8421504	1	23	0	c	350001702600000002	0-23						Human immortalized brown adipocytes express functional &#x03b2;-adrenoceptor coupled to lipolysis	cs.biologists.org	0	0		ADRB2
1047	chr7	60637654	60637755	3500103878	42		60637654	60637755	8421504	2	21,21	0,80	c,g	350010387800000004,350010387800000004,350010387800000005	0-21,0-21,0-21						Molecular regulation of progesterone synthesis in the bovine corpus luteum	www.vri.cz/docs/v	0	0		
1047	chr7	60637664	60637704	3500102098	40		60637664	60637704	8421504	1	40	0	c	350010209800000002	0-40					Patent	Dopamine receptors and genes (Patent EP:0447483)	Bunzow	1997	0		
1047	chr7	60637664	60637704	3500059463	40		60637664	60637704	8421504	1	40	0	c	350005946300000002	0-40						US Patent # 6,342,360. Dopamine receptors and genes - Patents.com	www.patents.com	0	0		
1047	chr7	60637688	60637754	3500345859	45		60637688	60637754	8421504	2	23,22	0,44	c,g	350034585900000005,350034585900000005,350034585900000006,350034585900000006	0-23,0-23,0-22,0-22						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
1047	chr7	60637688	60637754	3500243216	45		60637688	60637754	8421504	2	23,22	0,44	c,g	350024321600000003,350024321600000003,350024321600000004,350024321600000004	0-23,0-23,0-22,0-22						EFFECT OF ZILPATEROL HYDROCHLORIDE AND STEROID IMPLANTATION ON YEARLING STEER FEEDLOT PERFORMANCE, CARCASS CHARACTERISTICS, AND SKELETAL MUSCLE GENE EXPRESSION TIMOTHY JOHN BAXA B.S., Kansas State University, 2004 A THESIS	krex.k-state.edu	0	0		
1047	chr7	60637688	60637754	3500093083	45		60637688	60637754	8421504	2	23,22	0,44	c,g	350009308300000003,350009308300000003,350009308300000004,350009308300000004	0-23,0-23,0-22,0-22						messenger ribonucleic acid abundance in finishing steers1	animalscience.org	0	0		
1047	chr7	60637821	60638014	3500067688	42		60637821	60638014	8421504	2	22,20	0,173	c	350006768800000000,350006768800000001	0-22,0-20		10342858	10.1210/en.140.6.2679	0013-7227	Endocrinology	Characterization and Localization of&#x03b2; 2-Adrenergic Receptors in the Bovine Oviduct: Indication for Progesterone-Mediated Expression	Einspanier	1999	4		
1047	chr7	60638206	60638229	3500077698	23		60638206	60638229	8421504	1	23	0	c,g	350007769800000001,350007769800000001	0-23,0-23						Physiology and Endocrinology: Endocrinology/Metabolic Physiology	www.jtmtg.org	0	0		
1047	chr7	60638226	60638262	3500312251	36		60638226	60638262	8421504	1	36	0	c	350031225100000067	13-49						Membrane to membrane delivery	Surber	2002	0		
1047	chr7	60638226	60638262	3500218365	36		60638226	60638262	8421504	1	36	0	c	350021836500000067	13-49						Forward screening with minicells	Sabbadini	2002	0		
1047	chr7	60638226	60638262	3500211148	35		60638226	60638262	8421504	2	18,17	0,19	c	350021114800000068	13-48						Minicell-based bioremediation	Segall	2002	0		
1047	chr7	60638226	60638262	3500186807	36		60638226	60638262	8421504	1	36	0	c	350018680700000067	13-49						Methods of making pharmaceutical compositions with minicells	Sabbadini	2002	0		
1047	chr7	60638226	60638262	3500183987	36		60638226	60638262	8421504	1	36	0	c	350018398700000067,350018398700000297	13-49,13-49						Eubacterial minicells and their use as vectors for nucleic acid delivery and expression - Patent # 7183105 - PatentGenius	.patentgenius.com	0	0		
1047	chr7	60638226	60638262	3500143666	36		60638226	60638262	8421504	1	36	0	c	350014366600000067	13-49						Minicell compositions and methods	Surber	2002	0		
1047	chr7	60638230	60638258	3500275757	28		60638230	60638258	8421504	1	28	0	c	350027575700000001	0-28		16227322	10.1152/ajplung.00233.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	The &#x03b2;-agonist isoproterenol attenuates EGF-stimulated wound closure in human airway epithelial cells	Schnackenberg	2006	0		ADRB2
1047	chr7	60638230	60638258	3500089226	28		60638230	60638258	8421504	1	28	0	c	350008922600000001	0-28		16227322	10.1152/ajplung.00233.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	The &#x03b2;-agonist isoproterenol attenuates EGF-stimulated wound closure in human airway epithelial cells	Schnackenberg	2006	0		ADRB2
1047	chr7	60638230	60638258	3500037657	28		60638230	60638258	8421504	1	28	0	c	350003765700000001	0-28		16227322	10.1152/ajplung.00233.2005		American Journal of Physiology - Lung Cellular and Molecular Physiology	The &#x03b2;-agonist isoproterenol attenuates EGF-stimulated wound closure in human airway epithelial cells	Schnackenberg	2006	0		ADRB2
1047	chr7	60638231	60638260	3500142497	29		60638231	60638260	8421504	1	29	0	c	350014249700000007	12-41						Detection and Quantification of b2AR Internalization in Living Cells Using FAP-Based Biosensor Technology	ectragenetics.com	0	0		ADRB2
1049	chr7	60821659	60821690	3500284394	24		60821659	60821690	8421504	3	12,6,6	0,15,25	g	350028439400000519	10-36						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2011	0		
1049	chr7	60821659	60821690	3500253796	24		60821659	60821690	8421504	3	12,6,6	0,15,25	g	350025379600000519	10-36					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
1049	chr7	60821659	60821690	3500241875	24		60821659	60821690	8421504	3	12,6,6	0,15,25	g	350024187500000519	10-36					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
1049	chr7	60821659	60821690	3500070088	24		60821659	60821690	8421504	3	12,6,6	0,15,25	g	350007008800000519	10-36						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
1049	chr7	60821659	60821690	3500068199	24		60821659	60821690	8421504	3	12,6,6	0,15,25	g	350006819900000519	10-36						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
1049	chr7	60821659	60821690	3500019915	24		60821659	60821690	8421504	3	12,6,6	0,15,25	g	350001991500000519	10-36						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
1051	chr7	61118360	61118385	3500390857	23		61118360	61118385	8421504	2	9,14	0,11	c	350039085700000012	22-45						Method of identifying antibacterial compounds	Dalrymple	2007	0		
1051	chr7	61180400	61180451	3500235216	51		61180400	61180451	8421504	1	51	0	p	350023521600015008	6-57						Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage	Haudenschild	2002	0		
1051	chr7	61180454	61181732	3500287327	33		61180454	61181732	8421504	2	22,11	0,1267	c	350028732700000017	12-45						Postpartum Cells Derived From Umbilical Cord Tissue, And Methods Of Making And Using The Same 	.freshpatents.com	0	0		
1052	chr7	61215437	61221026	3500088467	121		61215437	61221026	8421504	5	33,22,21,23,22	0,4106,4140,5529,5567	c,g	350008846700000009,350008846700000010,350008846700000011,350008846700000001,350008846700000001,350008846700000000,350008846700000002,350008846700000003,350008846700000003	1-33,0-33,0-22,0-22,0-22,0-21,0-23,0-22,0-22						Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof	Olson	2010	0		
1052	chr7	61219530	61219566	3500415858	36		61219530	61219566	8421504	1	36	0	c	350041585800000004	0-36						Methods of Modulating Smooth Muscle Cell Proliferation and Differentiation - Patent application	www.faqs.org	0	0		
1052	chr7	61219543	61221026	3500183142	88		61219543	61221026	8421504	4	22,21,23,22	0,34,1423,1461	c,g	350018314200000001,350018314200000001,350018314200000000,350018314200000000,350018314200000002,350018314200000003	0-22,0-22,0-21,0-21,0-23,0-22					Patent	Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof (Patent US:7994150)	Olson	2011	0		MIR143
1052	chr7	61219543	61219598	3500280470	55		61219543	61219598	8421504	1	55	0	c,g	350028047000000046,350028047000000046,350028047000000010,350028047000000010,350028047000000048,350028047000000045,350028047000000047,350028047000000012,350028047000000011,350028047000000009,350028047000000035	0-55,0-55,0-55,0-55,0-21,0-21,11-32,0-21,11-32,0-21,11-32						NUCLEIC ACID DETECTION AND QUANTIFICATION BY POST-HYBRIDIZATION LABELING AND UNIVERSAL ENCODING - Patent application	www.faqs.org	0	0		
1052	chr7	61219543	61219598	3500240259	55		61219543	61219598	8421504	1	55	0	c,g	350024025900000007,350024025900000007,350024025900000009,350024025900000006	0-55,0-55,0-21,0-21						NUCLEIC ACID DETECTION AND QUANTIFICATION BY POST-HYBRIDIZATION LABELING AND UNIVERSAL ENCODING	Pregibon	2012	0		MIR143
1052	chr7	61219569	61219599	3500467542	30		61219569	61219599	8421504	1	30	0	c	350046754200000000,350046754200000003,350046754200000001	0-30,0-21,0-21						ScienceDirect.com - Mechanisms of Development - Heartbeat regulates cardiogenesis by suppressing retinoic acid signaling via expression of miR-143	sciencedirect.com	0	0		
1052	chr7	61219577	61220987	3500175527	42		61219577	61220987	8421504	2	21,21	0,1389	c,g	350017552700000006,350017552700000006,350017552700000007,350017552700000007	0-21,0-21,0-21,0-21						Compositions and methods of treating neoplasia	Mendell	2011	0		MIR143
1052	chr7	61219577	61220987	3500017451	42		61219577	61220987	8421504	2	21,21	0,1389	c	350001745100000006,350001745100000007	0-21,0-21						COMPOSITIONS AND METHODS OF TREATING NEOPLASIA	Mendell	2008	0		MIR143
1052	chr7	61220951	61221039	3500465622	88		61220951	61221039	8421504	1	88	0	c,g	350046562200000022,350046562200000022	0-88,0-88						ISSN 1684 - 5315 Volume 10 Number 18 2 May, 2011	demicjournals.org	0	0		MIR143
1052	chr7	61220951	61221039	3500433622	50		61220951	61221039	8421504	2	25,25	0,63	c,g	350043362200000030,350043362200000030,350043362200000031	0-25,0-25,0-25		23200856	10.1016/j.celrep.2012.10.023	2211-1247	Cell Reports	Cell Reports - Specific miRNA Stabilization by Gld2-Catalyzed Monoadenylation	D'Ambrogio	2012	0		MIR143
1052	chr7	61220959	61220989	3500242116	30		61220959	61220989	8421504	1	30	0	c	350024211600000010	0-30						Methods of Modulating Smooth Muscle Cell Proliferation and Differentiation	Srivastava	2010	0		
1052	chr7	61220966	61220990	3500371873	24		61220966	61220990	8421504	1	24	0	c	350037187300000134	0-24						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		
1052	chr7	61220966	61220990	3500304886	24		61220966	61220990	8421504	1	24	0	c	350030488600000110	0-24						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		
1052	chr7	61220966	61220990	3500275548	24		61220966	61220990	8421504	1	24	0	c	350027554800000129	0-24						MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF - Patent application	www.faqs.org	0	0		MIR143
1052	chr7	61220966	61220990	3500260567	24		61220966	61220990	8421504	1	24	0	c	350026056700000000	0-24						Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b	journal.9med.net	0	0		
1052	chr7	61220966	61220989	3500439152	23		61220966	61220989	8421504	1	23	0	c	350043915200000265	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR143
1052	chr7	61266773	61313308	3500177828	827		61266773	61313308	8421504	14	45,31,67,107,18,9,79,56,51,99,69,13,107,76	0,7008,7054,8167,10288,10354,11306,12256,12345,18223,21530,21644,45738,46459	c	350017782800000116,350017782800000007,350017782800000163,350017782800000139,350017782800000114,350017782800000161,350017782800000113,350017782800000112,350017782800000159,350017782800000136,350017782800000134,350017782800000109,350017782800000156,350017782800000108,350017782800000172,350017782800000173,350017782800000132,350017782800000153,350017782800000130,350017782800000105,350017782800000152,350017782800000128,350017782800000104,350017782800000127,350017782800000103,350017782800000126,350017782800000150,350017782800000102,350017782800000125,350017782800000100,350017782800000123,350017782800000147,350017782800000099,350017782800000122,350017782800000146,350017782800000098,350017782800000121,350017782800000145,350017782800000097,350017782800000170	0-52,8-27,0-32,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-19,0-19,0-48,0-48,10-48,0-48,0-48,0-25,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-20					Patent	Protein kinases (Patent US:5756289)	Hoekstra	1998	0		
1052	chr7	61266773	61313304	3500090353	303		61266773	61313304	8421504	7	45,31,77,3,13,86,48	0,7008,8197,10288,21644,45738,46483	c	350009035300000115,350009035300000162,350009035300000136,350009035300000111,350009035300000158,350009035300000099,350009035300000122,350009035300000121,350009035300000096	0-52,0-32,0-47,0-48,0-48,0-48,0-48,0-48,0-48					Patent	Protein kinases (Patent US:5686412)	Hoekstra	1997	0		
1052	chr7	61266809	61313352	3500369501	136		61266809	61313352	8421504	4	9,31,48,48	0,6972,8169,46495	c	350036950100000007,350036950100000165,350036950100000115,350036950100000099	8-27,0-32,0-48,0-48						Protein kinases	Hoekstra	1994	0		
1052	chr7	61273791	61313355	3500325977	960		61273791	61313355	8421504	9	103,107,75,79,140,99,127,107,123	0,1149,3270,4288,5238,11205,14512,38720,39441	p,c,g	350032597700000015,350032597700015029,350032597700015018,350032597700000014,350032597700015028,350032597700015017,350032597700000013,350032597700000013,350032597700015016,350032597700000012,350032597700000012,350032597700000011,350032597700015014,350032597700000010,350032597700000009,350032597700015025,350032597700015012,350032597700000008,350032597700000008,350032597700015002,350032597700015011,350032597700000007,350032597700015024,350032597700015010,350032597700000006,350032597700015023,350032597700000005,350032597700015009,350032597700000004,350032597700000004,350032597700015008,350032597700000003,350032597700015007,350032597700000002,350032597700015006,350032597700000001,350032597700000001,350032597700015005,350032597700015020,350032597700000000,350032597700000000,350032597700015004	0-60,0-90,0-60,0-60,0-150,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-90,0-60,0-60,0-60,0-84,0-60,0-60,0-48,0-60,0-60,0-150,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-90,0-60,0-60,0-60						Purification of Casein Kinase I and Isolation of cDNAs Encoding Multiple Casein Kinase I-Like Enzymes	www.jstor.org	0	0		
1052	chr7	61275002	61277064	3500222750	48		61275002	61277064	8421504	2	45,3	0,2059	c	350022275000000161	0-48					Patent	Protein kinases (Patent US:6060296)	Hoekstra	2000	0		
1052	chr7	61277112	61278100	3500029063	45		61277112	61278100	8421504	2	24,21	0,967	p	350002906300015007	0-45			10.1042/BJ20050343		Biochemical Journal	Aurora-A site specificity: a study with synthetic peptide substrates	Stefano	2005	0		CSNK1A1
1054	chr7	61510133	61510160	3500184568	26		61510133	61510160	8421504	2	11,15	0,12	g	350018456800000003	8-35						Molecular Characterisation of Multiple Antibiotic Resistance in Escherichia coli Isolated from Animals and Humans in Australia	ro.uow.edu.au	0	0		
1055	chr7	61606091	61606195	3500087743	104		61606091	61606195	8421504	1	104	0	c	350008774300000046,350008774300000023,350008774300000024,350008774300000022	0-104,0-21,0-26,0-21						Molecular Biological and Immunological Techniques and Applications for Food Chemists	www.scribd.com	0	0		
1055	chr7	61606093	61606122	3500172805	29		61606093	61606122	8421504	1	29	0	c	350017280500000000	102-131						Safety Analysis of Foods of Animal Origin	www.scribd.com	0	0		
1055	chr7	61717335	61717360	3500260091	24		61717335	61717360	8421504	2	11,13	0,12	c	350026009100000023,350026009100000015	0-24,21-45					Patent	Tapetum-specific promoters from Brassicaceae spp (Patent US:5723754)	Draper	1998	0		
1055	chr7	61720564	61720593	3500308565	24		61720564	61720593	8421504	2	13,11	0,18	c	350030856500000060,350030856500000025,350030856500000055,350030856500000020	9-33,9-33,10-34,10-34						Artificial disulfide isomerases and uses thereof - US Patent 7829687 Description	ww.patentstorm.us	0	0		
1056	chr7	61802823	61802846	3500418514	23		61802823	61802846	8421504	1	23	0	c	350041851400000142	9-32						Human platelet-derived growth factor receptor extracellular domain antibodies	Wolf	1995	0		
1056	chr7	61814993	61815099	3500155689	27		61814993	61815099	8421504	3	3,10,14	0,78,92	c	350015568900000058	3-44						Antibodies Against Inducible Th2 Cell Factors 	.freshpatents.com	0	0		
1057	chr7	61895700	61905820	3500386351	62		61895700	61905820	8421504	3	20,21,21	0,8397,10099	c	350038635100000009,350038635100000014,350038635100000000	0-20,0-21,0-21					Translational Oncology	Imatinib and Dasatinib Inhibit Hemangiosarcoma and Implicate PDGFR-&#x03b2; and Src in Tumor Growth	Erin	2013	0		
1057	chr7	61895756	61912996	3500054009	226		61895756	61912996	8421504	6	25,23,69,21,40,48	0,1322,2446,15373,16334,17192	c	350005400900000197,350005400900000191,350005400900000055,350005400900000019,350005400900000014,350005400900000011	0-48,0-48,0-48,27-48,0-40,0-48						US Patent # 5,686,572. Domains of extracellular region of human platelet derived growth factor receptor polypeptides - Patents.com	www.patents.com	0	0		
1057	chr7	61895756	61912130	3500347340	402		61895756	61912130	8421504	9	25,71,48,48,48,75,41,6,40	0,1322,2446,5524,6734,7866,8334,10060,16334	c	350034734000000268,350034734000000267,350034734000000262,350034734000000250,350034734000000246,350034734000000038,350034734000000243,350034734000000241,350034734000000218	0-48,0-48,0-48,0-48,0-48,0-51,0-48,0-41,0-40						Human platelet-derived growth factor receptors	Williams	1995	0		
1057	chr7	61895756	61905822	3500025568	201		61895756	61905822	8421504	8	25,20,45,18,9,33,45,6	0,1322,1345,1537,2416,4846,7866,10060	c	350002556800000268,350002556800000267,350002556800000263,350002556800000253,350002556800000038	0-45,0-45,18-45,12-45,0-51						US Patent # 7,105,305. Human platelet-derived growth factor receptors - Patents.com	www.patents.com	0	0		
1057	chr7	61895759	61900317	3500210109	40		61895759	61900317	8421504	2	20,20	0,4538	c	350021010900000013,350021010900000012	0-20,0-20						Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. - ResearchGate	.researchgate.net	0	0		PDGFRB
1057	chr7	61898194	61901289	3500006481	70		61898194	61901289	8421504	3	23,24,23	0,699,3072	c,g	350000648100000025,350000648100000026,350000648100000024	22-45,0-24,21-44						COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF B-RAF INHIBITOR-RESISTANT MELANOMAS	Lo	2011	0		PDGFRB
1057	chr7	61898202	61905822	3500196657	147		61898202	61905822	8421504	4	48,48,45,6	0,3078,5420,7614	c	350019665700000192,350019665700000180,350019665700000038	0-48,0-48,0-51						Human Platelet-derived Growth Factor Receptors 	.freshpatents.com	0	0		
1057	chr7	61898923	61899388	3500224483	45		61898923	61899388	8421504	2	5,40	0,425	p	350022448300015074	0-45						Fibroblast growth factor receptor-5	Young	2001	0		
1057	chr7	61899454	61901355	3500389361	102		61899454	61901355	8421504	3	6,45,51	0,767,1850	p	350038936100015003,350038936100015001	0-51,0-51					Patent	Polypeptides having kinase activity, their preparation and use (Patent EP:0590126)	Dhand	2007	0		PDGFRB
1057	chr7	61899454	61901355	3500326001	102		61899454	61901355	8421504	3	6,45,51	0,767,1850	p	350032600100015003,350032600100015001	0-51,0-51						Method for determining expression of a PI3 kinase gene	Hiles	1999	0		PDGFRB
1057	chr7	61899454	61901355	3500295373	102		61899454	61901355	8421504	3	6,45,51	0,767,1850	p	350029537300015003,350029537300015001	0-51,0-51					Patent	Polypeptides having kinase activity, their preparation and use (Patent US:5824492)	Dhand	1998	0		PDGFRB
1057	chr7	61899454	61901355	3500293469	102		61899454	61901355	8421504	3	6,45,51	0,767,1850	p	350029346900015003,350029346900015001	0-51,0-51					Patent	Method for determining expression of a PI3 kinase gene (Patent US:7422849)	Hiles	2008	0		PDGFRB
1057	chr7	61899454	61901355	3500193936	102		61899454	61901355	8421504	3	6,45,51	0,767,1850	p	350019393600015003,350019393600015001	0-51,0-51						Polypeptides having kinase activity, their preparation and use	Hiles	1994	0		PDGFRB
1057	chr7	61899454	61901355	3500165774	102		61899454	61901355	8421504	3	6,45,51	0,767,1850	p	350016577400015003,350016577400015001	0-51,0-51						Polypeptides having kinase activity, their preparation and use	Dhand	1993	0		PDGFRB
1057	chr7	61900312	61900338	3500282803	26		61900312	61900338	8421504	1	26	0	c	350028280300000156	12-38						TTK AS TUMOR MARKER AND THERAPEUTIC TARGET FOR LUNG CANCER - Patent application	www.faqs.org	0	0		
1057	chr7	61900312	61900338	3500073073	26		61900312	61900338	8421504	1	26	0	c	350007307300000058	12-38						erbB-2 gene segments, probes, recombinant DNA and kits for detection	King	1995	0		
1057	chr7	61902526	61904698	3500288106	180		61902526	61904698	8421504	4	15,44,105,16	0,1129,1511,2156	p	350028810600015021,350028810600015014,350028810600015038,350028810600015029	0-180,0-180,0-84,0-72						Duke : SCIENCE 111 : complete notes on Bioinformatics	ww.coursehero.com	0	0		
1057	chr7	61902526	61904698	3500204284	180		61902526	61904698	8421504	4	15,44,105,16	0,1129,1511,2156	p	350020428400015012,350020428400015020,350020428400015037,350020428400015028	0-180,0-180,0-84,0-72						17727 Complete Notes on tics	www.scribd.com	0	0		
1057	chr7	61902526	61904698	3500185699	180		61902526	61904698	8421504	4	15,44,105,16	0,1129,1511,2156	p	350018569900015013,350018569900015040,350018569900015030	0-180,0-84,0-72						Introduction to Bioinformatics	www.koshika.co.in	0	0		
1057	chr7	61903610	61903661	3500182245	51		61903610	61903661	8421504	1	51	0	p	350018224500015005	0-51						University of Geneva Master&#x2019;s in Proteomics and Bioinformatics 2009	www.mpb.unige.ch	0	0		PDGFRB
1057	chr7	61904800	61908126	3500322655	111		61904800	61908126	8421504	3	15,95,1	0,931,3325	p	350032265500015002	108-219					Patent	Single chain, multiple antigen-binding molecule, its preparation and use (Patent EP:0952218)	Kontermann	2008	0		PDGFRB
1057	chr7	61904800	61908126	3500088200	111		61904800	61908126	8421504	3	15,95,1	0,931,3325	p	350008820000015002	108-219						Single chain, multiple antigen-binding molecule, its preparation and use	Kontermann	1999	0		PDGFRB
1057	chr7	61904800	61905824	3500405852	108		61904800	61905824	8421504	2	15,93	0,931	p	350040585200015003	0-108						Single-chain, multiple antigen forming molecule, its manufacture and use	Kontermann	2009	0		PDGFRB
1057	chr7	61904800	61905824	3500332685	102		61904800	61905824	8421504	3	15,45,42	0,931,982	p	350033268500015026	0-105						Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use	Kontermann	2009	0		PDGFRB
1057	chr7	61904800	61905824	3500328343	102		61904800	61905824	8421504	3	15,45,42	0,931,982	p	350032834300015018	0-105					Patent	Single-chain multiple antigen-binding molecule, its preparation and use (Patent US:7838637)	Kontermann	2010	0		PDGFRB
1057	chr7	61904800	61905824	3500327652	108		61904800	61905824	8421504	2	15,93	0,931	p	350032765200015003	0-108						Single-chain multiple antigen-binding molecule, its preparation and use	R*Ke Te Man 	1999	0		PDGFRB
1057	chr7	61904800	61905824	3500282033	108		61904800	61905824	8421504	2	15,93	0,931	p	350028203300015001	0-108						Einzelkettiges, mehrfach-antigenbindendes Molek&#xfc;l, dessen Herstellung und Verwendung	Kontermann	2009	0		PDGFRB
1057	chr7	61904800	61905824	3500214185	108		61904800	61905824	8421504	2	15,93	0,931	p	350021418500015001	0-108					Patent	Single-chain multiple antigen-binding molecule, its preparation and use (Patent US:6759518)	Kontermann	2004	0		PDGFRB
1057	chr7	61904800	61905824	3500118559	102		61904800	61905824	8421504	3	15,45,42	0,931,982	p	350011855900015018	0-105					Patent	Single-chain multiple antigen-binding molecule, its preparation and use (Patent US:7838637)	Kontermann	2010	0		PDGFRB
1057	chr7	61904800	61905824	3500112721	102		61904800	61905824	8421504	3	15,45,42	0,931,982	p	350011272100015024,350011272100015030	0-105,0-45						Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use - Patent application	www.faqs.org	0	0		PDGFRB
1057	chr7	61904800	61905824	3500100634	108		61904800	61905824	8421504	2	15,93	0,931	p	350010063400015003	0-108						Single-chain, multiple antigen forming molecule, its manufacture and use	Kontermann	2009	0		PDGFRB
1057	chr7	61904807	61905812	3500025648	89		61904807	61905812	8421504	2	8,81	0,924	p,c	350002564800000017,350002564800015009,350002564800015103	0-32,0-81,0-48						US Patent # 6,482,407. Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same - Patents.com	www.patents.com	0	0		PDGFRB
1057	chr7	61905731	61905812	3500199028	81		61905731	61905812	8421504	1	81	0	p	350019902800015009	0-81						Membrane-bound cytokine compositions and methods of modulating an immune response using same	Hoo	2001	0		PDGFRB
1057	chr7	61905787	61905812	3500370036	25		61905787	61905812	8421504	1	25	0	c	350037003600000140,350037003600000141	0-25,0-25						Composition And Methods Of Rnai Therapeutics For Treatment Of Cancer And Other Neovascularization Diseases 	.freshpatents.com	0	0		PDGFRB
1057	chr7	61913996	61914031	3500290459	28		61913996	61914031	8421504	3	9,7,12	0,12,23	c	350029045900000014,350029045900000013	0-28,10-38		8647842	10.1074/jbc.271.21.12387	0021-9258	Journal of Biological Chemistry	Enhanced Expression of the Eosinophil-derived Neurotoxin Ribonuclease (RNS2) Gene Requires Interaction between the Promoter and Intron	Tiffany	1996	5		
1057	chr7	61993489	61993515	3500096220	23		61993489	61993515	8421504	2	18,5	0,21	g	350009622000000005,350009622000000025	9-32,9-32						IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH - Patent application	www.faqs.org	0	0		
1058	chr7	62020057	62021608	3500389626	60		62020057	62021608	8421504	2	42,18	0,1533	p	350038962600015002	0-60						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		CAMK2A
1058	chr7	62021611	62022046	3500196926	66		62021611	62022046	8421504	2	63,3	0,432	p	350019692600015005	0-66						NPG.nature.vol.411.Issue.6839.Jun	www.scribd.com	0	0		CAMK2A
1058	chr7	62028396	62036276	3500378011	117		62028396	62036276	8421504	3	46,55,16	0,894,7864	p	350037801100015003	0-117						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	mcb.berkeley.edu	0	0		CAMK2A
1058	chr7	62028396	62036276	3500145445	117		62028396	62036276	8421504	3	46,55,16	0,894,7864	p	350014544500015003	0-117						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	physio.ucsf.edu	0	0		CAMK2A
1058	chr7	62028417	62036276	3500244206	96		62028417	62036276	8421504	3	25,55,16	0,873,7843	p	350024420600015028,350024420600015027	0-48,0-48						High affinity protein kinase inhibitors - US Patent 6383790 Description	ww.patentstorm.us	0	0		CAMK2A
1058	chr7	62028417	62036276	3500109878	96		62028417	62036276	8421504	3	25,55,16	0,873,7843	p	350010987800015028,350010987800015027	0-48,0-48						US Patent # 6,383,790. High affinity protein kinase inhibitors - Patents.com	www.patents.com	0	0		CAMK2A
1059	chr7	62167929	62170097	3500274037	40		62167929	62170097	8421504	3	20,2,18	0,489,2150	c	350027403700000019,350027403700000018	0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1059	chr7	62172350	62175109	3500259065	91		62172350	62175109	8421504	2	13,78	0,2681	p,c,g	350025906500015002,350025906500000002,350025906500000001,350025906500000000,350025906500000000	0-90,0-30,0-60,8-51,8-51		17215335	10.1128/CVI.00363-06	1556-6811	Clinical and Vaccine Immunology	DNA Vaccine Construct Incorporating Intercellular Trafficking and Intracellular Targeting Motifs Effectively Primes and Induces Memory B- and T-Cell Responses in Outbred Animals	Mwangi	2007	3		
1059	chr7	62194988	62196917	3500164379	360		62194988	62196917	8421504	3	49,162,149	0,1125,1780	p	350016437900015006	180-540						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPS14
1060	chr7	62264632	62313138	3500226818	394		62264632	62313138	8421504	11	81,15,39,40,8,48,48,48,15,14,38	0,8912,9368,12312,29569,32365,33331,38922,41326,46213,48468	c	350022681800000012,350022681800000013,350022681800000023,350022681800000025,350022681800000034,350022681800000037,350022681800000042,350022681800000047,350022681800000054	0-48,0-48,9-48,0-48,0-48,0-48,0-48,18-47,0-38						US Patent # 5,541,095. Glycosaminoglycan specific sulfotransferases - Patents.com	www.patents.com	0	0		
1061	chr7	62465265	62465291	3500284826	23		62465265	62465291	8421504	3	5,5,13	0,7,13	c	350028482600000001	22-45		23226833	10.1038/srep00935		Scientific Reports	Bone regeneration by polyhedral microcrystals from silkworm virus	Goichi	2012	0		
1061	chr7	62465265	62465291	3500093103	23		62465265	62465291	8421504	3	5,5,13	0,7,13	c	350009310300000001	22-45		23226833	10.1038/srep00935	xxxx-xxxx	Scientific Reports	Bone regeneration by polyhedral microcrystals from silkworm virus	Matsumoto	2012	0		
1063	chr7	62755025	62755048	3500269234	23		62755025	62755048	8421504	1	23	0	g	350026923400000009	0-23						University of Montana : ETD 05312007 : Gardipee,Florence	ww.coursehero.com	0	0		
1063	chr7	62767835	62767861	3500023563	23		62767835	62767861	8421504	3	6,13,4	0,8,22	g	350002356300000006	6-29		16306622	10.1128/JVI.79.24.15511-15524.2005	0022-538X	Journal of Virology	Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs	Sims	2005	5		
1064	chr7	62862789	62862990	3500281920	40		62862789	62862990	8421504	2	20,20	0,181	c,g	350028192000000002,350028192000000003,350028192000000003	0-20,0-20,0-20						Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach	cs.physiology.org	0	0		
1064	chr7	62863113	62863138	3500098032	23		62863113	62863138	8421504	2	14,9	0,16	c	350009803200000586	4-27						Compositions and methods for increasing bone mineralization	Brunkow	2000	0		
1065	chr7	62928656	62928683	3500265596	23		62928656	62928683	8421504	2	7,16	0,11	c	350026559600000248	4-27						NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)	Andersen	2000	0		
1065	chr7	62944343	62945846	3500174152	57		62944343	62945846	8421504	2	48,9	0,1494	p	350017415200015010	0-57						Regular Article	tologylibrary.org	0	0		ANXA6
1065	chr7	62958678	62959227	3500188806	54		62958678	62959227	8421504	2	45,9	0,540	p	350018880600015057,350018880600015056,350018880600015055	0-54,0-51,0-48						Journal of Immunological Methods	005.pasteur.ac.ir	0	0		ANXA6
1068	chr7	63377830	63377859	3500194424	24		63377830	63377859	8421504	2	8,16	0,13	g	350019442400000000	0-24			10.1099/jmm.0.45882-0	0022-2615	Journal of Medical Microbiology	Listeria monocytogenes in the Chinese food system: strain characterization through partial actA sequencing and tissue-culture pathogenicity assays	Zhou	2005	3		
1069	chr7	63452333	63452429	3500333943	96		63452333	63452429	8421504	1	96	0	p	350033394300015115	0-96						Novel proteins and nucleic acids encoding same and antibodies directed against these proteins	Herrmann	2002	0		
1069	chr7	63460323	63460351	3500233825	23		63460323	63460351	8421504	2	8,15	0,13	c	350023382500000008,350023382500000002	1-34,1-34						Methods for the Screening of Antibacterial Substances - Patent application	www.faqs.org	0	0		
1069	chr7	63468434	63469525	3500349986	23		63468434	63469525	8421504	3	3,4,16	0,1068,1075	c	350034998600000178	25-48						Mammalian cell surface antigens	Aversa	1995	0		
1069	chr7	63480656	63480688	3500110329	25		63480656	63480688	8421504	3	5,11,9	0,7,23	c	350011032900000547	13-38						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
1070	chr7	63582805	63582828	3500094133	23		63582805	63582828	8421504	1	23	0	c	350009413300000001	25-48						Identification and Characterization of Aortic Valve Mesenchymal Progenitor Cells with Robust Osteogenic Calcification Potential	w.mie.utoronto.ca	0	0		
1070	chr7	63583940	63594502	3500201187	46		63583940	63594502	8421504	2	22,24	0,10538	c,g	350020118700000003,350020118700000002	1-23,0-24						Equine thrombospondin II (THBS2) and secreted protein acidic and cysteine-rich	cs.physiology.org	0	0		
1070	chr7	63583943	63594502	3500409227	909		63583943	63594502	8421504	9	26,149,149,134,121,122,88,63,57	0,495,2490,3643,5494,7388,8885,9576,10502	p	350040922700015009,350040922700015008	0-159,0-750						Patent for Diagnosis of Early Diagnosis of Systemic Tissue Fibrosis	www.scribd.com	0	0		SPARC
1070	chr7	63583943	63594502	3500141136	909		63583943	63594502	8421504	9	26,149,149,134,121,122,88,63,57	0,495,2490,3643,5494,7388,8885,9576,10502	p	350014113600015008	0-909						BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS	DGaldo	2011	0		SPARC
1070	chr7	63584451	63589455	3500055198	42		63584451	63589455	8421504	3	21,3,18	0,3266,4986	c	350005519800000007,350005519800000006	0-21,0-21		22724005	10.1371/journal.pone.0039365		PLoS ONE	Human Umbilical Cord Blood-Derived CD34+ Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities	Reeva	2012	0		SPARC
1070	chr7	63584451	63589455	3500010970	42		63584451	63589455	8421504	3	21,3,18	0,3266,4986	c	350001097000000007,350001097000000006	0-21,0-21		22724005	10.1371/journal.pone.0039365	1932-6203	PLOS ONE	PLOS ONE: Human Umbilical Cord Blood-Derived CD34+ Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities	Aggarwal	2012	4		SPARC
1070	chr7	63584466	63594514	3500295686	94		63584466	63594514	8421504	4	36,19,20,19	0,102,1967,10029	p,c	350029568600015000,350029568600000011	0-75,0-19						Struktur-Funktions-Beziehungen	ebdoc.sub.gwdg.de	0	0		SPARC
1070	chr7	63584498	63586449	3500435879	40		63584498	63586449	8421504	3	21,3,16	0,86,1935	c,g	350043587900000001,350043587900000001,350043587900000000	0-21,0-21,0-19		22308039	10.1074/jbc.M111.317727	0021-9258	Journal of Biological Chemistry	Integrin &#x03b2;4 Regulates SPARC Protein to Promote Invasion	Gerson	2012	5		SPARC
1070	chr7	63584498	63586449	3500343135	40		63584498	63586449	8421504	3	21,3,16	0,86,1935	c,g	350034313500000025,350034313500000025,350034313500000024	0-21,0-21,0-19						Method for Differentiating of Human Embryonic Stem Cells Into the Osteoblastic Lineage	Cho	2010	0		SPARC
1070	chr7	63584498	63586449	3500095292	40		63584498	63586449	8421504	3	21,3,16	0,86,1935	c,g	350009529200000025,350009529200000025,350009529200000024	0-21,0-21,0-19					Patent	mTOR inhibtors and mTOR signaling pathway inhibitors induce differentiation of human embryonic stem cells into the osteoblastic lineage (Patent US:8093050)	Cho	2012	0		SPARC
1070	chr7	63586435	63586486	3500178716	48		63586435	63586486	8421504	2	24,24	0,27	c	350017871600000019,350017871600000017	0-24,0-24						Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study	www.ossatec.eu	0	0		SPARC
1070	chr7	63586462	63586485	3500454848	23		63586462	63586485	8421504	1	23	0	c	350045484800000006	0-23						Novel Use of Cryptotanshinone - Patent application	www.faqs.org	0	0		
1070	chr7	63586462	63586485	3500352344	23		63586462	63586485	8421504	1	23	0	c	350035234400000014	0-23		18163504	10.1002/art.23143	1529-0131	Arthritis & Rheumatism	A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells - De Bari - 2007 - Arthritis & Rheumatism - Wiley Online Library	Bari	2008	0		
1070	chr7	63589455	63594497	3500348506	40		63589455	63594497	8421504	2	20,20	0,5022	c	350034850600000009,350034850600000008	0-20,0-20						REPRODUCTION	uction-online.org	0	0		
1070	chr7	63589508	63592854	3500426314	39		63589508	63592854	8421504	2	20,19	0,3327	c,g	350042631400000002,350042631400000002,350042631400000001	0-20,0-20,0-19						Isolated Dna Fragment Of The Sparc Human Promoter And Its Use For Driving The Expression Of An Heterologous Gene In Tumor Cells 	.freshpatents.com	0	0		SPARC
1070	chr7	63589522	63594502	3500166512	46		63589522	63594502	8421504	2	24,22	0,4958	c,g	350016651200000023,350016651200000023,350016651200000022	0-24,0-24,0-22						Embryonic stem cell self maintenance and renewal reporter	Lemischka	2006	0		SPARC
1070	chr7	63591425	63594491	3500332575	46		63591425	63594491	8421504	2	23,23	0,3043	c	350033257500000001,350033257500000000	0-23,0-23						Effects of calcium ion incorporation on osteoblast gene expression in MC3T3-E1 cells cultured on microstructured titanium surfaces	www.megagen.lt	0	0		
1070	chr7	63592832	63594451	3500402519	153		63592832	63594451	8421504	3	84,63,6	0,687,1613	p	350040251900015002	0-153		22069448	10.1371/journal.pone.0026390	1932-6203	PLOS ONE	PLOS ONE: A Peptide of SPARC Interferes with the Interaction between Caspase8 and Bcl2 to Resensitize Chemoresistant Tumors and Enhance Their Regression In Vivo	Rahman	2011	4		SPARC
1070	chr7	63593540	63594448	3500455533	45		63593540	63594448	8421504	2	42,3	0,905	p	350045553300015000	0-45			10.1002/ijc.10584	1097-0215	International Journal of Cancer	Target validation for genomics using peptide-specific phage antibodies: A study of five gene products overexpressed in colorectal cancer - van Beijnum - 2002 - International Journal of Cancer - Wiley Online Library	Beijnum	2002	0		SPARC
1070	chr7	63594445	63594502	3500397607	57		63594445	63594502	8421504	1	57	0	p	350039760700015016,350039760700015015	0-57,0-57						None	www.jaici.or.jp	0	0		SPARC
1070	chr7	63594447	63605506	3500119324	96		63594447	63605506	8421504	2	68,28	0,11031	c	350011932400000000	6-102			10.1186/ar4022	1478-6354	Arthritis Research & Therapy	Cartilage oligomeric matrix protein specific antibodies are pathogenic	Geng	2012	4		SPARC
1070	chr7	63605482	63605507	3500379868	25		63605482	63605507	8421504	1	25	0	c	350037986800000060	9-34						Sparc Promoter Mutations Associated with Drug Resistance, and Methods, Oligonucleotides, Cells and Arrays Associated Therewith - Patent application	www.faqs.org	0	0		
1071	chr7	63704034	63704059	3500030751	25		63704034	63704059	8421504	1	25	0	c	350003075100000003	0-25						Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2	cs.biologists.org	0	0		
1071	chr7	63726235	63726264	3500374045	25		63726235	63726264	8421504	3	13,6,6	0,16,23	g	350037404500000011	0-27			10.1128/EC.3.5.1233-1240.2004	1535-9778	Eukaryotic Cell	RNA Polymerase II Localizes in Tetrahymena thermophila Meiotic Micronuclei When Micronuclear Transcription Associated with Genome Rearrangement Occurs	Mochizuki	2004	4		
1071	chr7	63726235	63726264	3500132865	25		63726235	63726264	8421504	3	13,6,6	0,16,23	g	350013286500000011	0-27			10.1128/EC.3.5.1233-1240.2004		Eukaryotic Cell	RNA Polymerase II Localizes in Tetrahymena thermophila Meiotic Micronuclei When Micronuclear Transcription Associated with Genome Rearrangement Occurs	Kazufumi	2004	0		
1071	chr7	63733303	63830134	3500174747	1347		63733303	63830134	8421504	9	288,147,215,138,83,224,68,128,56	0,6524,13824,16128,17628,20394,42537,48100,96775	p	350017474700015000	0-1347						KEGG T01001: 2741	www.genome.jp	0	0		GLRA1
1071	chr7	63733378	63739935	3500265704	345		63733378	63739935	8421504	2	237,108	0,6449	p	350026570400015003,350026570400015004,350026570400015001	0-150,0-150,0-195						Disease-related posttranscriptional modifications of glycine receptor mRNA under physiological and pathophysiological conditions	diss.fu-berlin.de	0	0		
1071	chr7	63747147	63747170	3500401488	23		63747147	63747170	8421504	1	23	0	c	350040148800000004	0-23				1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Trichloroethanol Modulation of Recombinant GABAA, Glycine and GABA &#x03c1;1 Receptors	Krasowski	1998	0		
1071	chr7	63830337	63830362	3500399325	24		63830337	63830362	8421504	2	20,4	0,21	c	350039932500000000	0-24		21105876	10.1111/j.1471-4159.2010.07122.x	1471-4159	Journal of Neurochemistry	Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington&#x2019;s disease - Soldati - 2010 - Journal of Neurochemistry - Wiley Online Library	Soldati	2011	0		
1081	chr7	65114376	65114400	3500453347	24		65114376	65114400	8421504	1	24	0	g	350045334700000008,350045334700000012	1-25,1-22						&#x4e3b;&#x9898;&#xff1a;Adenosine | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1081	chr7	65114376	65114400	3500276180	24		65114376	65114400	8421504	1	24	0	g	350027618000000006	0-24		10938127	10.1128/MCB.20.17.6508-6517.2000	0270-7306	Molecular and Cellular Biology	Phosphoenolpyruvate Carboxykinase Is Necessary for the Integration of Hepatic Energy Metabolism	She	2000	6		
1081	chr7	65116756	65116779	3500182466	23		65116756	65116779	8421504	1	23	0	g	350018246600000047,350018246600000046,350018246600000007,350018246600000006	0-24,18-42,0-24,18-42						Cd16a Binding Proteins And Use For The Treatment Of Immune Disorders 	.freshpatents.com	0	0		
1081	chr7	65129726	65129756	3500278094	26		65129726	65129756	8421504	2	16,10	0,20	g	350027809400000103,350027809400000002	0-26,0-26						Alzhimer's disease secretase	M*E*Ge Ni 	2004	0		
1084	chr7	65527165	65527192	3500409632	27		65527165	65527192	8421504	1	27	0	g	350040963200000000	15-42						Heterocyclic compound	Mochizuki	2010	0		
1087	chr7	65879391	65879415	3500201004	24		65879391	65879415	8421504	1	24	0	g	350020100400000003	24-48						Expression of glutamate receptors on cultured cerebral endothelial cells	.szbk.u-szeged.hu	0	0		
1089	chr7	66063466	66063495	3500072968	24		66063466	66063495	8421504	2	12,12	0,17	c	350007296800000405	24-48						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
1089	chr7	66112000	66112026	3500160644	23		66112000	66112026	8421504	2	6,17	0,9	c	350016064400000000	7-30						Genetics/Botany 629 (Fall 2011) Phylogenetic Trees September 7, 2011 1 / 13 September 8, 2011	www.stat.wisc.edu	0	0		
1089	chr7	66113000	66113027	3500467421	25		66113000	66113027	8421504	2	11,14	0,13	c	350046742100000023	10-35						Transgenic systems for the manufacture of poly(2-hydroxy-butyrate-co-3-hydroxyhexanoate) - Patent # 7504556 - PatentGenius	.patentgenius.com	0	0		
1092	chr7	66510676	66512455	3500425360	40		66510676	66512455	8421504	2	20,20	0,1759	c	350042536000000025,350042536000000024	0-20,0-20		21305651	10.1002/dvdy.22568	1097-0177	Developmental Dynamics	Developmental arrest of scNT-derived fetuses by disruption of the developing endometrial gland as a result of impaired trophoblast migration and invasiveness - Kim - 2011 - Developmental Dynamics - Wiley Online Library	Kim	2011	0		HAND1
1092	chr7	66512835	66512860	3500417050	25		66512835	66512860	8421504	1	25	0	c	350041705000000013	45-70						Structural and Functional Characterization of the ATP- Driven Glycolipid-Efflux Pump DevBCA-TolC and its Homologues in the Filamentous Cyanobacterium	.uni-tuebingen.de	0	0		
1094	chr7	66823363	66823408	3500457776	45		66823363	66823408	8421504	1	45	0	p	350045777600015004	0-45						BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms. - ResearchGate	.researchgate.net	0	0		CNOT8
1095	chr7	66903917	66903942	3500312535	23		66903917	66903942	8421504	2	9,14	0,11	g	350031253500000028	3-26		21697476	10.1128/JVI.00569-11		Journal of Virology	Cellular Transcription Factor Oct-1 Interacts with the Epstein-Barr Virus BRLF1 Protein To Promote Disruption of Viral Latency	Amanda	2011	0		
1095	chr7	66935992	66936017	3500000703	23		66935992	66936017	8421504	2	6,17	0,8	g	350000070300000008	13-36						NKCC1 and NHE1 are abundantly expressed in the basolateral plasma membrane of secretory coil cells in rat, mouse, and human sweat glands	ll.physiology.org	0	0		
1095	chr7	66958158	66958182	3500200393	23		66958158	66958182	8421504	2	5,18	0,6	g	350020039300000044	16-39						Doktorarbeit Nadine St&#xf6;hr	thek.uni-halle.de	0	0		
1104	chr7	68040724	68040749	3500391478	23		68040724	68040749	8421504	2	13,10	0,15	g	350039147800000422	0-37						dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION - Patent application	www.faqs.org	0	0		
138	chr7	68258831	68441663	3500020187	122		68258831	68441663	8421504	7	3,18,24,25,28,1,23	0,26221,26284,26353,26382,182734,182809	c,g	350002018700000007,350002018700000006,350002018700000005,350002018700000004,350002018700000003,350002018700000003	3-24,0-24,0-25,0-29,0-23,0-23						Identification of the Syrian hamster cardiomyopathy gene	.vincenzonigro.it	0	0		
138	chr7	68285052	68783962	3500126726	867		68285052	68783962	8421504	7	189,102,88,120,73,124,171	0,156513,240845,247428,306543,497250,498739	p	350012672600015000	3-870						KEGG T01001: 6444	www.genome.jp	0	0		
1107	chr7	68441652	68525905	3500435082	23		68441652	68525905	8421504	2	15,8	0,84245	c	350043508200000027	0-23						Biochemical and Biophysical Research Communications	teca.cinvestav.mx	0	0		SGCD
1107	chr7	68525984	68532527	3500464146	48		68525984	68532527	8421504	2	1,47	0,6496	p	350046414600015000	39-87					Proceedings of the National Academy of Sciences of the United States of America	Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, &#x03b4;-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated&#x2009;glycoprotein&#x2009;complex	Aiji	1997	0		SGCD
138	chr7	68532596	68783962	3500421044	357		68532596	68783962	8421504	5	4,73,124,57,99	0,58999,249706,251195,251267	p	350042104400015089,350042104400015058,350042104400015095,350042104400015062,350042104400015100	0-150,0-150,0-108,0-99,0-87						Positionsklonierung des Locus f&#xfc;r das Myoklonus-Dystonia-Syndrom (MDS) und Untersuchung des Epsilon-Sarkoglykan-Gens (SGCE) auf genomische Pr&#xe4;gung	b.uni-muenchen.de	0	0		SGCD
1113	chr7	69302985	69303008	3500395930	23		69302985	69303008	8421504	1	23	0	g	350039593000000280	0-29						Recombinant infectious laryngotracheitis virus and uses thereof	Cochran	1995	0		
1115	chr7	69485385	69501493	3500271852	840		69485385	69501493	8421504	7	157,37,127,41,84,339,55	0,2235,6521,8050,13789,14723,16053	p	350027185200015004,350027185200015098,350027185200015097,350027185200015095,350027185200015094,350027185200015093,350027185200015092,350027185200015090,350027185200015089,350027185200015088,350027185200015087,350027185200015085,350027185200015084,350027185200015083	0-840,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						THERAPEUTIC USES OF TIM-3 MODULATORS - Patent application	www.faqs.org	0	0		
1116	chr7	69627906	69628116	3500366238	120		69627906	69628116	8421504	2	8,112	0,98	p	350036623800015030	9-129						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		ITK
1116	chr7	69688000	69691169	3500383984	48		69688000	69691169	8421504	2	15,33	0,3136	p	350038398400015087	0-48						Inaugural-Dissertation	uni-heidelberg.de	0	0		CYFIP2
1117	chr7	69821800	69821828	3500220391	24		69821800	69821828	8421504	2	15,9	0,19	c	350022039100000000	2-26						Bispecific nanobodies as a therapeutic for alzheimer's disease	Sierks	2012	0		
1119	chr7	70027164	70027191	3500087263	27		70027164	70027191	8421504	1	27	0	c	350008726300000000	5-32						Identification of genes having a role in the presentation of diabetic nephropathy	Brady	2000	0		
1119	chr7	70096482	70102998	3500289527	360		70096482	70102998	8421504	4	63,247,29,21	0,2690,6462,6495	p	350028952700015031	0-363						101 human secreted proteins	Carter	2003	0		
1122	chr7	70501120	70501146	3500082346	24		70501120	70501146	8421504	2	15,9	0,17	g	350008234600000222	21-45						INVESTIGATION OF A POSSIBLE MULTI-ENZYME COMPLEX INVOLVED IN NICOTINE BIOSYNTHESIS IN ROOTS OF TOBACCO (Nicotiana tabacum)	cholar.lib.vt.edu	0	0		
1127	chr7	71058915	71058938	3500145475	23		71058915	71058938	8421504	1	23	0	g	350014547500000107	0-23						Selective and potent peptide inhibitors of kv1.3	Arora	2012	0		
1127	chr7	71110194	71161564	3500219388	40		71110194	71161564	8421504	3	3,17,20	0,24174,51350	c,g	350021938800000006,350021938800000005,350021938800000005	0-20,0-20,0-20		16888011		0022-1767	The Journal of Immunology	E2A Promotes the Survival of Precursor and Mature B Lymphocytes	Lazorchak	2006	6		EBF1
1127	chr7	71134497	71161477	3500181051	24		71134497	71161477	8421504	2	2,22	0,26958	c	350018105100000004	0-24						DNA Palindromes with a Modest Arm Length of 20 Base Pairs Are a Signi&#xfb01;cant Target for Recombinant Adeno-Associated Virus Vector Integration in the Liver, Muscles, and Heart in Mice	ylab.stanford.edu	0	0		EBF1
1127	chr7	71134497	71161477	3500137409	24		71134497	71161477	8421504	2	2,22	0,26958	c	350013740900000004	0-24			10.1128/JVI.00963-07		Journal of Virology	DNA Palindromes with a Modest Arm Length of &#x2273;20 Base Pairs Are a Significant Target for Recombinant Adeno-Associated Virus Vector Integration in the Liver, Muscles, and Heart in Mice 	Katsuya	2007	0		EBF1
1130	chr7	71435633	71435662	3500393957	29		71435633	71435662	8421504	1	29	0	c	350039395700000021	0-29			10.1128/MCB.22.24.8539-8551.2002		Molecular and Cellular Biology	Early B-Cell Factor, E2A, and Pax-5 Cooperate To Activate the Early B Cell-Specific mb-1 Promoter	MikaSigvardsson	2002	0		EBF1
1131	chr7	71639252	71649046	3500203975	946		71639252	71649046	8421504	12	126,158,154,54,55,53,55,54,57,93,30,57	0,1742,3299,3459,5549,5610,6255,6315,6374,6435,9706,9737	c,g	350020397500000062,350020397500000060,350020397500000061,350020397500000059,350020397500000064,350020397500000063,350020397500000007,350020397500000015,350020397500000014	0-895,9-895,9-895,3-880,81-882,81-843,0-58,0-58,0-57						US Patent # 7,115,712. Cytokine polypeptides - Patents.com	www.patents.com	0	0		
1131	chr7	71639252	71649046	3500131600	544		71639252	71649046	8421504	9	71,96,46,2,42,16,31,152,88	0,1784,3471,5547,5603,6279,6296,6375,9706	c	350013160000000075,350013160000000009,350013160000000074,350013160000000071,350013160000000070,350013160000000065,350013160000000063,350013160000000061,350013160000000059,350013160000000058,350013160000000057,350013160000000056,350013160000000055,350013160000000008	0-24,9-30,1-48,0-48,0-48,0-48,0-42,0-47,0-48,0-48,0-48,0-48,0-48,9-30						Immune response modulators and uses therefor	Seow	1997	0		
1131	chr7	71639262	71642563	3500199284	42		71639262	71642563	8421504	3	21,9,12	0,1881,3289	c	350019928400000009,350019928400000008	0-21,0-21						Anthony Luyai thesis-Final[1]	brary.okstate.edu	0	0		
1131	chr7	71639332	71642623	3500275310	40		71639332	71642623	8421504	2	20,20	0,3271	c,g	350027531000000015,350027531000000015,350027531000000014,350027531000000014	0-20,0-20,0-20,0-20						The Bovine Mammary Glands Cytokines at the Periparturient Period	apps.kfu.edu.sa	0	0		
1131	chr7	71639332	71642623	3500023326	40		71639332	71642623	8421504	2	20,20	0,3271	c,g	350002332600000009,350002332600000009,350002332600000008,350002332600000008	0-20,0-20,0-20,0-20						Title Japanese Journal of Veterinary Research, 61(3): 109-116 Issue Date 2013-08	lib.hokudai.ac.jp	0	0		
1131	chr7	71639343	71641086	3500449915	43		71639343	71641086	8421504	2	23,20	0,1723	c,g	350044991500000011,350044991500000011,350044991500000010,350044991500000010	0-23,0-23,0-20,0-20						Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model - ResearchGate	.researchgate.net	0	0		
1131	chr7	71639343	71641086	3500414028	43		71639343	71641086	8421504	2	23,20	0,1723	c,g	350041402800000017,350041402800000016,350041402800000016	0-23,0-20,0-20						Ganjam virus/Nairobi sheep disease virus induces a pro-inflammatory response in infected sheep	biomedcentral.com	0	0		
1131	chr7	71641009	71641060	3500370177	40		71641009	71641060	8421504	2	20,20	0,31	c,g	350037017700000003,350037017700000002,350037017700000002	0-20,0-20,0-20		18337375	10.1128/CVI.00034-08	1556-6811	Clinical and Vaccine Immunology	Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone	Wedlock	2008	3		
1131	chr7	71641009	71641060	3500005370	40		71641009	71641060	8421504	2	20,20	0,31	c,g	350000537000000003,350000537000000002,350000537000000002	0-20,0-20,0-20		18337375	10.1128/CVI.00034-08		Clinical and Vaccine Immunology : CVI	Enhanced Protection against Bovine Tuberculosis after Coadministration of Mycobacterium bovis BCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant Alone 	D.	2008	0		
1131	chr7	71641130	71642553	3500075145	24		71641130	71642553	8421504	2	22,2	0,1421	c	350007514500000020	0-24			10.1172/JCI18141		Journal of Clinical Investigation	Angiotensin II&#x2013;accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice	Dennis	2003	0		
1131	chr7	71642611	71645610	3500423964	40		71642611	71645610	8421504	2	20,20	0,2979	c,g	350042396400000002,350042396400000002,350042396400000003	0-20,0-20,0-20						gd T cells present antigen to CD4 ab T cells	www.jleukbio.org	0	0		
1131	chr7	71642611	71645610	3500355031	40		71642611	71645610	8421504	2	20,20	0,2979	c,g	350035503100000005,350035503100000005,350035503100000004	0-20,0-20,0-20						OKAMATSU-OGURA, Yuko; SOLIMAN, Mohamed; ABD Citation Journal of Veterinary Medical Science, 69(5): 509-514 Issue Date 2007-05	lib.hokudai.ac.jp	0	0		
1131	chr7	71642611	71645610	3500242704	40		71642611	71645610	8421504	2	20,20	0,2979	c,g	350024270400000001,350024270400000001,350024270400000000,350024270400000000	0-20,0-20,0-20,0-20		11818438		0741-5400	Journal of Leukocyte Biology	NK-like CD8+ cells in immunologically na&#xef;ve neonatal calves that respond to dendritic cells infected with Mycobacterium bovis BCG	Hope	2002	5		
1131	chr7	71644855	71645684	3500265224	40		71644855	71645684	8421504	2	20,20	0,809	c,g	350026522400000013,350026522400000012,350026522400000012	0-20,0-20,0-20						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
1131	chr7	71645507	71645639	3500101828	78		71645507	71645639	8421504	2	36,42	0,90	p	350010182800015007	0-108						Improved il-12 for expression in mammalian cells	Felber	2007	0		
1131	chr7	71645586	71645613	3500146467	27		71645586	71645613	8421504	1	27	0	g	350014646700000005	0-27			10.1182/blood-2005-06-2265		Blood	SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells	Bence	2006	0		
1131	chr7	71645621	71645660	3500201044	39		71645621	71645660	8421504	1	39	0	c	350020104400000008	0-39						Natural killer stimulatory factor	Trinchieri	1990	0		
1131	chr7	71649017	71649046	3500341090	29		71649017	71649046	8421504	1	29	0	c	350034109000000017,350034109000000007	0-29,0-29						AVIAN CYTOKINES, SUCH IL-12, COMPRISING A P40 AND/OR P35 SUBUNIT(S)	Degen	2003	0		
1131	chr7	71649017	71649046	3500086346	29		71649017	71649046	8421504	1	29	0	c	350008634600000007	0-29						Avian cytokines, such il-12, comprising a p40 and/or p35 subunit(s)	Burnside	2004	0		
1132	chr7	71739985	71740009	3500320404	23		71739985	71740009	8421504	2	12,11	0,13	g	350032040400000019	1-43						N-ACETYLGLUCOSAMINYLTRANSFERASE VB CODING SEQUENCES, RECOMBINANT CELLS AND METHODS - Patent application	www.faqs.org	0	0		
1136	chr7	72244235	72244280	3500065040	45		72244235	72244280	8421504	1	45	0	c,g	350006504000000002,350006504000000002	0-45,0-45						Alterations in responsiveness and mRNA expression of alpha-1 adrenergic receptors in neonatal ventral hippocampus lesioned rats	ry.mcgill.ca:8881	0	0		
1136	chr7	72244465	72244489	3500008577	24		72244465	72244489	8421504	1	24	0	c	350000857700000011	0-24						Human Neuropeptide Receptor 	.freshpatents.com	0	0		
1136	chr7	72244900	72245116	3500007844	216		72244900	72245116	8421504	1	216	0	p	350000784400015007	0-216						A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease	P	1998	0		ADRA1B
1136	chr7	72244996	72245044	3500345627	48		72244996	72245044	8421504	1	48	0	p	350034562700015091	0-48						Cloned human alpha1c adrenergic receptor	Bayne	1996	0		ADRA1B
1136	chr7	72304590	72304614	3500246343	24		72304590	72304614	8421504	1	24	0	g	350024634300000074	0-24						Interleukin-8 receptors and related molecules and methods	Navarro	1992	0		
1137	chr7	72367516	72367540	3500374909	23		72367516	72367540	8421504	2	8,15	0,9	g	350037490900000893	12-35						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
1138	chr7	72544404	72544427	3500288143	23		72544404	72544427	8421504	1	23	0	c	350028814300000003	5-28		17909007	10.1158/0008-5472.CAN-06-3690	0008-5472	Cancer Research	A Novel Variant of Ileal Bile Acid Binding Protein Is Up-regulated through Nuclear Factor-&#x03ba;B Activation in Colorectal Adenocarcinoma	Fang	2007	8		
1140	chr7	72787698	72793600	3500235713	44		72787698	72793600	8421504	2	22,22	0,5880	c,g	350023571300000012,350023571300000012,350023571300000013	0-22,0-22,0-22						ScienceDirect.com - Theriogenology - Effect of ovarian stimulation on oocyte gene expression in cattle	sciencedirect.com	0	0		
1140	chr7	72789555	72789578	3500392265	23		72789555	72789578	8421504	1	23	0	c	350039226500000002	0-23		15886233	10.1210/jc.2005-0523	0021-972X	Journal of Clinical Endocrinology & Metabolism	Pituitary Tumor Transforming Gene Binding Factor: A Novel Transforming Gene in Thyroid Tumorigenesis	Stratford	2005	6		
1140	chr7	72789555	72789578	3500335730	23		72789555	72789578	8421504	1	23	0	c	350033573000000002	0-23		15886233	10.1210/jc.2005-0523	0021-972X	Journal of Clinical Endocrinology & Metabolism	Pituitary Tumor Transforming Gene Binding Factor: A Novel Transforming Gene in Thyroid Tumorigenesis	Stratford	2005	6		SGK3
143	chr7	73788377	74075292	3500240668	1509		73788377	74075292	8421504	11	345,114,245,153,138,83,221,75,22,39,74	0,35375,39809,43962,45782,133401,172781,285269,285673,286645,286841	p	350024066800015031	0-1533						Cell lines expressing gaba receptor and methods using them	Langer	2010	0		
1150	chr7	74117506	74117532	3500207808	23		74117506	74117532	8421504	2	10,13	0,13	g	350020780800000032	18-42						Polypeptides Recognized by Anti-Trichinella Antibodies, and Uses Thereof - Patent application	www.faqs.org	0	0		
1151	chr7	74209952	74209975	3500367817	23		74209952	74209975	8421504	1	23	0	c	350036781700000008	1-24						Regulation of the microglial NADPH oxidase by neurotransmitters: implications for microglial &#x2013; neuronal interactions	scovery.ucl.ac.uk	0	0		
1152	chr7	74434396	74437821	3500371863	108		74434396	74437821	8421504	2	74,34	0,3391	p	350037186300015010	0-108						Novel gabab receptor dna sequences	Bonner	1999	0		
1152	chr7	74434396	74437821	3500111462	108		74434396	74437821	8421504	2	74,34	0,3391	p	350011146200015012	0-108						Novel gaba b? receptor dna sequences	Bonner	2000	0		
1153	chr7	74479041	74479069	3500086850	23		74479041	74479069	8421504	2	9,14	0,14	g	350008685000000066	23-46					Patent	Method for linking sequences of interest (Patent EP:1921144)	Andersen	2011	0		
1153	chr7	74541417	74546289	3500358741	25		74541417	74546289	8421504	2	11,14	0,4858	c	350035874100000000	0-25		22364254	10.1186/1423-0127-19-25		Journal of Biomedical Science	Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A	Jobin	2012	0		
1153	chr7	74541417	74546289	3500197222	25		74541417	74546289	8421504	2	11,14	0,4858	c	350019722200000000	0-25		22364254	10.1186/1423-0127-19-25	1423-0127	Journal of Biomedical Science	Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A	Mathew	2012	0		
1153	chr7	74541417	74546289	3500020770	25		74541417	74546289	8421504	2	11,14	0,4858	c	350002077000000000	0-25						Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A. - ResearchGate	.researchgate.net	0	0		
1153	chr7	74557298	74557324	3500367817	26		74557298	74557324	8421504	1	26	0	c	350036781700000004	0-26						Regulation of the microglial NADPH oxidase by neurotransmitters: implications for microglial &#x2013; neuronal interactions	scovery.ucl.ac.uk	0	0		
144	chr7	74631978	74758756	3500240668	1401		74631978	74758756	8421504	9	107,152,68,221,83,138,153,206,273	0,28552,30514,32753,37080,41326,116708,122868,126505	p	350024066800015037	0-1401						Cell lines expressing gaba receptor and methods using them	Langer	2010	0		GABRG2
144	chr7	74631978	74758756	3500234175	1401		74631978	74758756	8421504	9	107,152,68,221,83,138,153,206,273	0,28552,30514,32753,37080,41326,116708,122868,126505	p	350023417500015013	0-1401						KEGG T01001: 200959	www.genome.jp	0	0		GABRG2
144	chr7	74631978	74758756	3500131639	1425		74631978	74758756	8421504	10	107,152,68,221,83,138,153,206,24,273	0,28552,30514,32753,37080,41326,116708,122868,125073,126505	p	350013163900015032	0-1425						Cell lines expressing gaba receptor and methods using them	Langer	2011	0		GABRG2
144	chr7	74631978	74758756	3500131639	1401		74631978	74758756	8421504	9	107,152,68,221,83,138,153,206,273	0,28552,30514,32753,37080,41326,116708,122868,126505	p	350013163900015031	0-1401						Cell lines expressing gaba receptor and methods using them	Langer	2011	0		
144	chr7	74631978	74758753	3500240668	1422		74631978	74758753	8421504	10	107,152,68,221,83,138,153,206,24,270	0,28552,30514,32753,37080,41326,116708,122868,125073,126505	p	350024066800015038	0-1422						Cell lines expressing gaba receptor and methods using them	Langer	2010	0		
1155	chr7	74748826	74754893	3500306790	60		74748826	74754893	8421504	2	13,47	0,6020	p	350030679000015009	54-114						Annual Review of Pharmacology and Toxicology Volume 31 (1991) - IsSN 0362-1642 03621642 0066-4251 00664251	www.scribd.com	0	0		GABRG2
1155	chr7	74754992	74758684	3500162824	282		74754992	74758684	8421504	4	60,15,6,201	0,2059,2077,3491	p	350016282400015000,350016282400015001	0-75,0-207		21795628	10.1152/jn.00641.2011		Journal of Neurophysiology	Inhibition to excitation ratio regulates visual system responses and behavior in vivo	Wanhua	2011	0		GABRG2
1155	chr7	74755000	74755024	3500358741	24		74755000	74755024	8421504	1	24	0	c	350035874100000008	0-24		22364254	10.1186/1423-0127-19-25		Journal of Biomedical Science	Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A	Jobin	2012	0		GABRG2
1155	chr7	74755000	74755024	3500197222	24		74755000	74755024	8421504	1	24	0	c	350019722200000008	0-24		22364254	10.1186/1423-0127-19-25	1423-0127	Journal of Biomedical Science	Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A	Mathew	2012	0		GABRG2
1155	chr7	74755000	74755024	3500020770	24		74755000	74755024	8421504	1	24	0	c	350002077000000008	0-24						Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A. - ResearchGate	.researchgate.net	0	0		GABRG2
1155	chr7	74758390	74758417	3500459021	23		74758390	74758417	8421504	3	12,5,6	0,15,21	g	350045902100000257	11-36						Aureobasin a synthetase - Patent application	www.faqs.org	0	0		
1166	chr7	76155798	76155823	3500282983	25		76155798	76155823	8421504	1	25	0	c	350028298300000005	0-25						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		CCNG1
1166	chr7	76156049	76157969	3500454707	27		76156049	76157969	8421504	2	6,21	0,1899	c	350045470700000025	0-27						Methods and kits for investigating cancer	Munnes	2008	0		CCNG1
1166	chr7	76156049	76157969	3500400698	27		76156049	76157969	8421504	2	6,21	0,1899	c	350040069800000025	0-27						Methods and kits for investigating cancer	Munnes	2008	0		CCNG1
1166	chr7	76158790	76159239	3500228810	42		76158790	76159239	8421504	3	21,13,8	0,212,441	c	350022881000000006,350022881000000007	0-21,0-21						Expression analysis of regulatory MicroRNA in bovine cumulus oocyte complex and preimplantation embryos	s.ulb.uni-bonn.de	0	0		
1166	chr7	76175420	76175446	3500185789	26		76175420	76175446	8421504	1	26	0	c	350018578900000000	8-34						Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model	Takayuki	2007	0		
1166	chr7	76191129	76195871	3500398747	61		76191129	76195871	8421504	3	21,20,20	0,2386,4722	c,g	350039874700000005,350039874700000004,350039874700000008,350039874700000008,350039874700000009,350039874700000009	0-21,0-19,0-20,0-20,0-20,0-20						Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and &#xc1;-adducin	-publications.com	0	0		
1166	chr7	76203305	76206695	3500424225	42		76203305	76206695	8421504	2	21,21	0,3369	c	350042422500000026,350042422500000027	0-21,0-21						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
1166	chr7	76225773	76225836	3500032207	63		76225773	76225836	8421504	1	63	0	p	350003220700015000	0-63						NovelFunctionandIntracellularLocalizationofMethionine Adenosyltransferase2 SplicingVariants	www.jbc.org	0	0		MAT2B
1166	chr7	76225828	76240231	3500192102	204		76225828	76240231	8421504	5	8,17,95,42,42	0,4778,4812,8000,14361	c	350019210200000031,350019210200000075,350019210200000032,350019210200000033,350019210200000106,350019210200000050	7-32,7-32,1-48,0-48,0-42,0-42						US Patent # 6,696,279. Purified and isolated Mat II .beta. subunit nucleic acids and polypeptides and therapeutic and screening methods using same - Patents.com	www.patents.com	0	0		
1166	chr7	76225828	76233870	3500231420	67		76225828	76233870	8421504	3	8,17,42	0,4778,8000	c	350023142000000078,350023142000000034,350023142000000109	7-32,7-32,0-42						Mat II Beta Subunit RNAi and Therapeutic Methods Using Same - Patent application	www.faqs.org	0	0		
1166	chr7	76230624	76240231	3500290029	921		76230624	76240231	8421504	6	177,115,153,194,114,168	0,2782,3097,6095,7145,9439	p	350029002900015025	3-924							rcebioscience.com	0	0		MAT2B
1166	chr7	76230624	76233442	3500187783	213		76230624	76233442	8421504	2	177,36	0,2782	p	350018778300015046	3-216						Oxford_SGC_Clones_web	www.docstoc.com	0	0		MAT2B
1166	chr7	76230687	76230711	3500023342	24		76230687	76230711	8421504	1	24	0	c	350002334200000001	0-24						Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism. - ResearchGate	.researchgate.net	0	0		
1167	chr7	76329310	76329333	3500068975	23		76329310	76329333	8421504	1	23	0	g	350006897500000029	0-23						Tripeptides that Down Regulate the Activity of Plasma Membrane transporters Including Sodium-D-Glucose Cotransporter Sglt1 - Patent application	www.faqs.org	0	0		
1171	chr7	76846195	76846219	3500096045	23		76846195	76846219	8421504	2	13,10	0,14	g	350009604500000081	0-23					Patent	Oligonucleotides for the detection of salmonella (Patent US:5824795)	Fellous	1998	0		
1173	chr7	77122412	77122438	3500059076	23		77122412	77122438	8421504	2	5,18	0,8	g	350005907600000248	5-28						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE	Frank-Kamenetsky	2009	0		
1178	chr7	77729859	77729882	3500433612	23		77729859	77729882	8421504	1	23	0	g	350043361200000217	3-26						US Patent # 7,132,399. Mammalian cell surface DNA receptor - Patents.com	www.patents.com	0	0		
1181	chr7	78128625	78128653	3500354454	23		78128625	78128653	8421504	2	17,6	0,22	g	350035445400000062	0-24						Molecular Identification of Fungi	ggene.cn/uploads/	0	0		
1181	chr7	78158025	78158049	3500448570	24		78158025	78158049	8421504	1	24	0	g	350044857000000004	5-29						Compositions and methods for the diagnosis and treatment of herpes simplex virus infection	Mcgowan	2002	0		
1183	chr7	78414815	78414845	3500258709	25		78414815	78414845	8421504	2	18,7	0,23	g	350025870900000058	11-38					Patent	Fungal resistant plants, process for obtaining fungal resistant plants and recombinant polynucleotides for use therein (Patent US:5670706)	Bol	1997	0		
1201	chr7	80824929	80824952	3500114655	23		80824929	80824952	8421504	1	23	0	g	350011465500000029	18-47						&#x5e7d;&#x95e8;&#x87ba;&#x6746;&#x83cc;&#x6d3b;&#x75ab;&#x82d7; Helicobacter pylori vaccine	T*F*Mai Ye 	2000	0		
1202	chr7	80956124	80956243	3500461949	48		80956124	80956243	8421504	2	23,25	0,94	g	350046194900000047,350046194900000046	0-23,0-25						RESSOURCES G&#xc9;N&#xc9;TIQUES ANIMALES	www.fao.org	0	0		
1204	chr7	81169793	81169821	3500114630	23		81169793	81169821	8421504	2	7,16	0,12	g	350011463000000092	21-45						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
1207	chr7	81553584	81553608	3500339863	23		81553584	81553608	8421504	2	4,19	0,5	g	350033986300000005	6-29		11282603	10.1128/AEM.67.4.1542-1550.2001	0099-2240	Applied and Environmental Microbiology	Succession of Phenotypic, Genotypic, and Metabolic Community Characteristics during In Vitro Bioslurry Treatment of Polycyclic Aromatic Hydrocarbon-Contaminated Sediments	Ringelberg	2001	4		
1207	chr7	81553584	81553608	3500281525	23		81553584	81553608	8421504	2	4,19	0,5	g	350028152500000005	6-29			10.1128/AEM.67.4.1542-1550.2001		Applied and Environmental Microbiology	Succession of Phenotypic, Genotypic, and Metabolic Community Characteristics during In Vitro Bioslurry Treatment of Polycyclic Aromatic Hydrocarbon-Contaminated Sediments	David	2001	0		
1209	chr7	81904853	81904878	3500332026	24		81904853	81904878	8421504	2	10,14	0,11	g	350033202600000153,350033202600000848	1-25,1-25						Methods for Detecting Epigenetic Modifications - Patent application	www.faqs.org	0	0		
1209	chr7	81904853	81904878	3500275629	24		81904853	81904878	8421504	2	10,14	0,11	g	350027562900000153	1-25						Methods for Detecting Epigenetic Modifications	Engeland	2008	0		
1212	chr7	82282444	82282469	3500348013	23		82282444	82282469	8421504	2	9,14	0,11	c	350034801300000001	0-23						Modified Anti-cd52 Antibody 	.freshpatents.com	0	0		RARS
1212	chr7	82282444	82282469	3500259090	23		82282444	82282469	8421504	2	9,14	0,11	c	350025909000000001,350025909000000160	0-23,0-23						MODIFIED ANTI-CD52 ANTIBODY - Patent application	www.faqs.org	0	0		RARS
1214	chr7	82512830	82523706	3500359035	234		82512830	82523706	8421504	6	76,8,50,7,34,59	0,4522,4566,4617,7502,10817	p	350035903500015058,350035903500015055,350035903500015026,350035903500015043,350035903500015050	66-132,0-84,0-57,0-90,0-78						Advances in Enzymology and Related Areas of Molecular Biology	www.scribd.com	0	0		
1214	chr7	82520243	82520284	3500201554	41		82520243	82520284	8421504	1	41	0	c	350020155400000056	0-41						Gene amplification methods	Denney	1996	0		
1214	chr7	82520356	82523714	3500284436	50		82520356	82523714	8421504	3	10,14,26	0,3291,3332	c	350028443600000000,350028443600000001	0-24,0-26						Identification of a de novo thymidylate biosynthesis pathway in mammalian mitochondria	www.pnas.org	0	0		
1214	chr7	82523702	82527053	3500340259	68		82523702	82527053	8421504	4	23,24,14,7	0,3293,3326,3344	c,g	350034025900000009,350034025900000010,350034025900000008,350034025900000008	0-23,0-24,0-21,0-21						&#x4e3b;&#x9898;&#xff1a;mRNA | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		DHFR,MTRNR2L2
1219	chr7	83130903	83130926	3500296662	23		83130903	83130926	8421504	1	23	0	c	350029666200000000	3-26						Immunocompromised ungulates	Ayares	2011	0		
1219	chr7	83130903	83130926	3500125757	23		83130903	83130926	8421504	1	23	0	c	350012575700000000	3-26						Immunocompromised Ungulates	Ayares	2011	0		
1219	chr7	83130903	83130926	3500067463	23		83130903	83130926	8421504	1	23	0	c	350006746300000000	3-26						Immunocompromised Ungulates - Patent application	www.faqs.org	0	0		
1223	chr7	83631963	83631987	3500370232	23		83631963	83631987	8421504	2	6,17	0,7	g	350037023200000166	7-32						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
1226	chr7	84037393	84037468	3500164379	75		84037393	84037468	8421504	1	75	0	p	350016437900015008	75-150						SEINE AVAL 2 : L&#x2019;ANALYSE ET LA GESTION DES RISQUES	ne-aval.crihan.fr	0	0		RPS23
1230	chr7	84582511	84582538	3500275996	23		84582511	84582538	8421504	2	17,6	0,21	g	350027599600000107	11-34						 Plant Lysophosphatidic Acid Acyltransferases 	www.docstoc.com	0	0		
1232	chr7	84836542	84836569	3500123121	23		84836542	84836569	8421504	3	6,12,5	0,7,22	g	350012312100000006	7-30						renal stem cell	ww.sciencepub.net	0	0		
1234	chr7	85144464	85144491	3500439509	27		85144464	85144491	8421504	1	27	0	c	350043950900000007,350043950900000009	10-37,10-37						Human DNA ligase IV and the ligase IV/XRCC4 complex: analysis of nick ligation fidelity. - ResearchGate	.researchgate.net	0	0		
1236	chr7	85333179	85351381	3500101625	23		85333179	85351381	8421504	3	3,12,8	0,18181,18194	c	350010162500000155	7-30						Universidade de S&#xe3;o Paulo Escola Superior de Agricultura &#x201c;Luiz de Queiroz&#x201d;	www.teses.usp.br	0	0		
1236	chr7	85336417	85336447	3500060905	25		85336417	85336447	8421504	3	4,14,7	0,5,23	g	350006090500000017	7-33						Purified papillomavirus proteins	E*D*La Man 	1998	0		
1236	chr7	85351572	85380957	3500441052	42		85351572	85380957	8421504	2	20,22	0,29363	c,g	350044105200000000,350044105200000000,350044105200000001	0-20,0-20,0-22		11221884		0008-5472	Cancer Research	Versican Accumulation in Human Prostatic Fibroblast Cultures Is Enhanced by Prostate Cancer Cell-derived Transforming Growth Factor &#x03b2;1	Sakko	2000	8		VCAN
1236	chr7	85351576	85380726	3500298062	51		85351576	85380726	8421504	2	24,27	0,29123	c,g	350029806200000000,350029806200000000,350029806200000001	0-24,0-24,0-27						Kathryn Michelle Gebhardt	y.adelaide.edu.au	0	0		VCAN
1236	chr7	85392726	85392749	3500343080	23		85392726	85392749	8421504	1	23	0	g	350034308000000001	0-23		20730861	10.1002/ar.21235	1932-8494	The Anatomical Record	Versican G1 Domain and V3 Isoform Overexpression Results in Increased Chondrogenesis in the Developing Chick Limb In Ovo - Hudson - 2010 - The Anatomical Record - Wiley Online Library	Hudson	2010	0		
1236	chr7	85392793	85399308	3500423043	40		85392793	85399308	8421504	3	20,9,11	0,5310,6504	c,g	350042304300000002,350042304300000002,350042304300000003	0-20,0-20,0-20						Activin-A reduces follicular growth stimulated by FSH in bovine preantral follicles	www.uece.br	0	0		
1236	chr7	85399318	85399346	3500316174	28		85399318	85399346	8421504	1	28	0	c	350031617400000023	0-28						CELL MASS CAPABLE OF SERVING AS A PRIMITIVE ORGAN-LIKE STRUCTURE COMPRISED OF A PLURALITY OF CELL TYPES OF SOMATIC ORIGIN - Patent application	www.faqs.org	0	0		
1236	chr7	85421045	85421072	3500158245	27		85421045	85421072	8421504	1	27	0	c	350015824500000117	3-30						METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION - Patent application	www.faqs.org	0	0		
1236	chr7	85421057	85421080	3500327988	23		85421057	85421080	8421504	1	23	0	c	350032798800000002	20-43						OTO447172 568.	www.sbccp.org.br	0	0		VCAN
1237	chr7	85490806	85505456	3500030801	222		85490806	85505456	8421504	5	48,48,39,39,48	0,2821,2932,14491,14602	c	350003080100000082,350003080100000077,350003080100000028,350003080100000070,350003080100000021	0-48,0-48,9-48,9-48,0-48						NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 151P3D4 USEFUL IN TREATMENT AND DETECTION OF CANCER - Patent application	www.faqs.org	0	0		
1237	chr7	85490904	85491013	3500182158	41		85490904	85491013	8421504	2	20,21	0,88	c,g	350018215800000013,350018215800000013,350018215800000012,350018215800000012	0-20,0-20,0-21,0-21						METHODS AND USES OF HYPOXIC COMPARTMENT CELLS - Patent application	www.faqs.org	0	0		
1237	chr7	85493675	85493844	3500153648	40		85493675	85493844	8421504	2	20,20	0,149	c,g	350015364800000031,350015364800000031,350015364800000030	0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
1237	chr7	85505296	85505320	3500358404	24		85505296	85505320	8421504	1	24	0	c,g	350035840400000011,350035840400000011	0-24,0-24		22514539	10.3389/fphys.2012.00085		Frontiers in Physiology	Implications of TGF&#x03b2; on Transcriptome and Cellular Biofunctions of Palatal Mesenchyme	Xiujuan	2012	0		
1237	chr7	85567716	85567743	3500235521	23		85567716	85567743	8421504	2	11,12	0,15	c	350023552100000523	15-38						IMPROVED METHODS FOR TRANSFORMING PHAFFIA STRAINS, TRANSFORMED PHAFFIA STRAINS SO OBTAINED AND RECOMBINANT DNA IN SAID METHODS - Gist-brocades B.	www.sumobrain.com	0	0		
1241	chr7	86085850	86085876	3500110329	23		86085850	86085876	8421504	2	15,8	0,18	g	350011032900000243	21-44						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
1242	chr7	86222167	86222191	3500022970	23		86222167	86222191	8421504	2	19,4	0,20	g	350002297000000021	3-29						Structural and Functional Analysis of Adenovirus Receptor Interaction	diss.fu-berlin.de	0	0		
1243	chr7	86288499	86288532	3500085562	26		86288499	86288532	8421504	4	12,6,4,4	0,17,24,29	g	350008556200000325	11-37						Methods and compositions for assaying analytes	Yuan	1999	0		
1244	chr7	86408254	86408282	3500060851	23		86408254	86408282	8421504	2	10,13	0,15	g	350006085100000004	2-25						Entwicklung einer rekombinanten Coxiella burnetii-Vakzine und &#xdc;berpr&#xfc;fung der Wirksamkeit im Mausmodell	eb.uni-giessen.de	0	0		
1249	chr7	87049348	87049374	3500208764	24		87049348	87049374	8421504	3	14,5,5	0,15,21	g	350020876400000001	22-46						PositiveRegulationofApoptosisSignal-regulatingKinase1 SignalingbyZPR9Protein,aZincFingerProtein S	www.jbc.org	0	0		
1252	chr7	87501089	87501116	3500259309	23		87501089	87501116	8421504	2	7,16	0,11	g	350025930900000011	2-28						Tagging of Endogenous Genes in a Toxoplasma gondii Strain Lacking Ku80	ec.asm.org/conten	0	0		
1259	chr7	88359896	88359923	3500108622	25		88359896	88359923	8421504	2	5,20	0,7	g	350010862200000506	6-31						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
1262	chr7	88854211	88854237	3500395029	23		88854211	88854237	8421504	2	10,13	0,13	g	350039502900000449	5-28						 Recombinant Infectious Laryngotracheitis Virus And Uses Thereof 	www.docstoc.com	0	0		
1264	chr7	89044908	89045067	3500424306	50		89044908	89045067	8421504	2	25,25	0,134	c	350042430600000291,350042430600000292	0-25,0-25						10897 microsatellite 9668 control region 4597 Vector: pCMV-SPORT6.0 1738 Vector: pExpress1 1036 puta	www.ibio.jp	0	0		
1264	chr7	89045147	89045776	3500147394	194		89045147	89045776	8421504	5	57,2,37,50,48	0,59,63,101,581	c	350014739400000011,350014739400000018	9-159,0-48						 Gap Gene Sequences 	www.docstoc.com	0	0		
1264	chr7	89045147	89045298	3500051804	146		89045147	89045298	8421504	4	57,2,37,50	0,59,63,101	c	350005180400000011	9-159						Gap gene sequences	Wong	1994	0		
19	chr7	89103345	89152101	3500051804	1848		89103345	89152101	8421504	29	68,109,17,61,39,32,53,20,35,79,12,48,66,26,88,48,158,77,173,45,40,74,39,116,87,68,89,33,48	0,1040,1808,5495,5574,8686,11336,13542,13658,15391,23431,23491,24182,24278,28666,33049,34889,35542,36956,37524,37644,39177,39281,40800,41614,44745,46289,47694,48708	c	350005180400000021,350005180400000022,350005180400000094,350005180400000023,350005180400000095,350005180400000024,350005180400000098,350005180400000026,350005180400000100,350005180400000028,350005180400000101,350005180400000104,350005180400000033,350005180400000105,350005180400000034,350005180400000036,350005180400000038,350005180400000110,350005180400000040,350005180400000112,350005180400000041,350005180400000113,350005180400000042,350005180400000114,350005180400000003,350005180400000044,350005180400000116,350005180400000117,350005180400000082,350005180400000118,350005180400000001,350005180400000120,350005180400000002,350005180400000052,350005180400000124,350005180400000055,350005180400000127,350005180400000056,350005180400000058,350005180400000129,350005180400000059,350005180400000130,350005180400000060,350005180400000131,350005180400000061,350005180400000132,350005180400000133,350005180400000063,350005180400000134,350005180400000064,350005180400000135,350005180400000065,350005180400000136,350005180400000066,350005180400000069	0-48,0-48,0-48,0-48,0-48,0-33,0-48,0-48,0-117,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,6-28,0-48,0-48,0-48,0-351,0-48,0-26,0-48,0-25,0-48,0-48,0-48,0-116,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Gap gene sequences	Wong	1994	0		
19	chr7	89104431	89151042	3500147394	837		89104431	89151042	8421504	23	63,9,32,7,28,20,35,43,48,26,88,66,24,42,40,8,48,41,7,2,68,89,3	0,4518,7600,10250,10275,12456,12572,14305,22405,23192,27580,33803,36019,36438,36558,38091,39723,39789,40528,40613,43659,45203,46608	c	350014739400000095,350014739400000024,350014739400000028,350014739400000101,350014739400000104,350014739400000033,350014739400000036,350014739400000040,350014739400000112,350014739400000113,350014739400000044,350014739400000116,350014739400000052,350014739400000124,350014739400000055,350014739400000059,350014739400000131,350014739400000063,350014739400000064,350014739400000065,350014739400000136	0-48,0-33,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48						 Gap Gene Sequences 	www.docstoc.com	0	0		
1264	chr7	89105155	89108860	3500278545	35		89105155	89108860	8421504	2	15,20	0,3685	c	350027854500000008	0-35						Rasgap Derived Peptide For Selectively Killing Cancer Cells 	.freshpatents.com	0	0		
1264	chr7	89108889	89108919	3500055878	30		89108889	89108919	8421504	1	30	0	c	350005587800000000	0-30						RASGAP DERIVED PEPTIDE FOR SELECTIVELY KILLING CANCER CELLS	Widmann	2004	0		RASA1
19	chr7	89127533	89136396	3500194103	40		89127533	89136396	8421504	3	20,18,2	0,4548,8861	c,g	350019410300000052,350019410300000052,350019410300000053	0-20,0-20,0-20						AZ IZOM DIFFERENCI&#xc1;L&#xd3;D&#xc1;ST BEFOLY&#xc1;SOL&#xd3; G&#xc9;NEK IN VITRO VIZSG&#xc1;LATA EMBRION&#xc1;LIS EREDET&#x0170; &#x0150;S-SEJTVONALAKBAN EG&#xc9;R MODELLRENDSZERBEN	phd.szie.hu	0	0		
1267	chr7	89398790	89398818	3500151702	24		89398790	89398818	8421504	2	18,6	0,22	g	350015170200000006	0-24		20719951	10.1128/JVI.00947-10	0022-538X	Journal of Virology	Culturing the Unculturable: Human Coronavirus HKU1 Infects, Replicates, and Produces Progeny Virions in Human Ciliated Airway Epithelial Cell Cultures	Pyrc	2010	5		
1270	chr7	89811736	89811771	3500114897	29		89811736	89811771	8421504	3	13,4,12	0,16,23	g	350011489700000068	15-44						COLLAGEN PRODUCING PLANTS AND METHODS OF GENERATING AND USING SAME - Patent application	www.faqs.org	0	0		
1274	chr7	90318855	90318915	3500277393	46		90318855	90318915	8421504	2	22,24	0,36	c	350027739300000000,350027739300000010,350027739300000023,350027739300000003,350027739300000009	0-22,0-22,0-23,0-24,0-22						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		LINC00461
1274	chr7	90318855	90318914	3500460589	44		90318855	90318914	8421504	2	21,23	0,36	g	350046058900000012	43-87						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Soreq	2010	0		LINC00461
1274	chr7	90318855	90318914	3500400478	44		90318855	90318914	8421504	2	21,23	0,36	c,g	350040047800000050,350040047800000050,350040047800000162,350040047800000162,350040047800000012,350040047800000012,350040047800000071,350040047800000071	0-21,0-21,0-21,0-21,0-23,0-23,0-23,0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		LINC00461
1274	chr7	90318855	90318914	3500371873	44		90318855	90318914	8421504	2	21,23	0,36	c,g	350037187300000012,350037187300000130,350037187300000129	43-87,0-21,0-23						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		LINC00461
1274	chr7	90318855	90318914	3500357539	44		90318855	90318914	8421504	2	21,23	0,36	c	350035753900000050,350035753900000162,350035753900000012,350035753900000071	0-21,0-21,0-23,0-23					Patent	Identification of novel genes coding for small temporal RNAs (Patent US:8207326)	Tuschl	2012	0		LINC00461
1274	chr7	90318855	90318914	3500304886	44		90318855	90318914	8421504	2	21,23	0,36	c,g	350030488600000106,350030488600000106,350030488600000012,350030488600000105,350030488600000105	0-21,0-21,43-87,0-23,0-23						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		LINC00461
1274	chr7	90318855	90318914	3500256738	44		90318855	90318914	8421504	2	21,23	0,36	g	350025673800000012	43-87						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2007	0		LINC00461
1274	chr7	90318855	90318914	3500246068	44		90318855	90318914	8421504	2	21,23	0,36	g	350024606800000012	43-87						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2008	0		LINC00461
1274	chr7	90318855	90318914	3500210973	44		90318855	90318914	8421504	2	21,23	0,36	c	350021097300000050,350021097300000162,350021097300000012,350021097300000071	0-21,0-21,0-23,0-23						Microrna molecules	Tuschl	2002	0		LINC00461
1274	chr7	90318855	90318914	3500208886	44		90318855	90318914	8421504	2	21,23	0,36	g	350020888600000012	43-87						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL	Soreq	2008	0		LINC00461
1274	chr7	90318890	90318914	3500125619	24		90318890	90318914	8421504	1	24	0	c	350012561900000005,350012561900000007	18-42,0-23						Lentiviral miRNA Expression	biosettia.com	0	0		RHBG
1274	chr7	90318891	90318915	3500353647	24		90318891	90318915	8421504	1	24	0	c	350035364700000074	22-46						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		LINC00461
1274	chr7	90318891	90318915	3500351139	24		90318891	90318915	8421504	1	24	0	c	350035113900000074,350035113900000199	22-46,0-23						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
1274	chr7	90318891	90318914	3500447978	23		90318891	90318914	8421504	1	23	0	c,g	350044797800000009,350044797800000009,350044797800000008,350044797800000008	0-23,0-23,3-26,3-26						Improved Methods Controlling Gene Expression	Ren	2006	0		RHBG
1274	chr7	90318891	90318914	3500439152	23		90318891	90318914	8421504	1	23	0	c	350043915200000207	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		POLG,RHBG
1274	chr7	90318891	90318914	3500423784	23		90318891	90318914	8421504	1	23	0	c	350042378400000127	0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		POLG,LINC00461
1274	chr7	90318891	90318914	3500404240	23		90318891	90318914	8421504	1	23	0	c	350040424000000004	0-23		19702828	10.1111/j.1742-4658.2009.07237.x	1742-4658	FEBS Journal	MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-&#x03ba;B1 - Guo - 2009 - FEBS Journal - Wiley Online Library	Guo	2009	0		RHBG,LINC00461
1274	chr7	90318891	90318914	3500351194	23		90318891	90318914	8421504	1	23	0	c	350035119400000037	0-23						MicroRNA-9 regulates survival of chondroblasts and cartilage integrity by targeting protogenin	.biosignaling.com	0	0		POLG,RHBG
1274	chr7	90318891	90318914	3500322980	23		90318891	90318914	8421504	1	23	0	c,g	350032298000000002,350032298000000002	0-23,0-23						AD (Leave blank)	handle.dtic.mil	0	0		RHBG,LINC00461
1274	chr7	90318891	90318914	3500287752	23		90318891	90318914	8421504	1	23	0	c,g	350028775200000056,350028775200000056	0-23,0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		POLG,LINC00461
1274	chr7	90318891	90318914	3500244257	23		90318891	90318914	8421504	1	23	0	c	350024425700000007	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		RHBG,LINC00461
1274	chr7	90318891	90318914	3500241683	23		90318891	90318914	8421504	1	23	0	c,g	350024168300000010,350024168300000010	0-23,0-23						al Regulation of microRNA Expression in Drosophila melanogaster mediated by Hormonal Signals and Broad-Complex gene activity - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		LINC00461
1274	chr7	90318891	90318914	3500180208	23		90318891	90318914	8421504	1	23	0	c,g	350018020800001579,350018020800001579	0-23,0-23					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		RHBG,LINC00461
1274	chr7	90318891	90318914	3500166534	23		90318891	90318914	8421504	1	23	0	c	350016653400001579	0-23						METHODS FOR QUANTITATING SMALL RNA MOLECULES	Raymond	2007	0		POLG,LINC00461
1274	chr7	90318891	90318914	3500164893	23		90318891	90318914	8421504	1	23	0	c,g	350016489300001579,350016489300001579	0-23,0-23						Methods for quantitating small rna molecules	Raymond	2007	0		POLG,RHBG
1274	chr7	90318891	90318914	3500114594	23		90318891	90318914	8421504	1	23	0	c,g	350011459400000380,350011459400000380,350011459400000807,350011459400000807	0-23,0-23,0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		POLG,LINC00461
1274	chr7	90318891	90318914	3500069843	23		90318891	90318914	8421504	1	23	0	c	350006984300000022	0-23						microRNA expression profiling of pediatric acute myeloid leukemia patient samples and global identification of Argonaute protein-associated RNAs in respective cell line models	ni-duesseldorf.de	0	0		POLG,LINC00461
1274	chr7	90318891	90318914	3500065300	23		90318891	90318914	8421504	1	23	0	c	350006530000000003	0-23						Die Funktion von microRNAs bei der Entstehung und Verarbeitung von Schmerzen	.uni-frankfurt.de	0	0		RHBG,LINC00461
1274	chr7	90318891	90318914	3500031979	23		90318891	90318914	8421504	1	23	0	c,g	350003197900000295,350003197900000295	0-23,0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		RHBG
1274	chr7	90318907	90318930	3500020710	23		90318907	90318930	8421504	1	23	0	c,g	350002071000000001,350002071000000001	0-23,0-23		20624818	10.1093/nar/gkq604		Nucleic Acids Research	A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation	Pietro	2010	0		
1274	chr7	90326821	90326848	3500400238	24		90326821	90326848	8421504	2	7,17	0,10	g	350040023800000175	13-39						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1274	chr7	90374198	90374337	3500021669	40		90374198	90374337	8421504	2	20,20	0,119	c,g	350002166900000001,350002166900000000,350002166900000000	0-20,0-20,0-20		12506029	10.1182/blood-2002-05-1341	0006-4971	Blood	Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition	Chagraoui	2003	10		MEF2C
1274	chr7	90374257	90374462	3500271165	40		90374257	90374462	8421504	2	20,20	0,185	c,g	350027116500000013,350027116500000012,350027116500000012	0-20,0-20,0-20						Novel pacemaker cell	Hisatome	2012	0		
1274	chr7	90374258	90374283	3500424726	25		90374258	90374283	8421504	1	25	0	c	350042472600000015	0-25		24010014	10.7717/peerj.134	2167-8359	PeerJ	The emerin-binding transcription factor Lmo7 is regulated by association with p130Cas at focal adhesions [PeerJ]	Wozniak	2013	0		MEF2C
1274	chr7	90374258	90374283	3500350580	25		90374258	90374283	8421504	1	25	0	c	350035058000000015	0-25						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal P	peerj.com/article	0	0		MEF2C
1274	chr7	90374258	90374283	3500283136	25		90374258	90374283	8421504	1	25	0	c	350028313600000015	0-25		24010014	10.7717/peerj.134		PeerJ	The emerin-binding transcription factor Lmo7 is regulated by association with p130Cas at focal adhesions	Michele	2013	0		MEF2C
1274	chr7	90374260	90374283	3500288332	23		90374260	90374283	8421504	1	23	0	c	350028833200000002	23-46						Method for generating primate cardiovascular progenitor cells for clinical and drug cells testing use from primate embryonic stem cells or embryonic-like state cells, and their applications	Costecalde	2013	0		MEF2C
1274	chr7	90374260	90374283	3500229357	23		90374260	90374283	8421504	1	23	0	c	350022935700000002	23-46						Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications	Larghero	2009	0		MEF2C
1274	chr7	90374429	90381147	3500449206	56		90374429	90381147	8421504	2	28,28	0,6690	c,g	350044920600000021,350044920600000021,350044920600000076,350044920600000076,350044920600000075	28-54,28-54,0-28,0-28,0-28						EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS - Patent application	www.faqs.org	0	0		MEF2C
1274	chr7	90374429	90374457	3500311545	28		90374429	90374457	8421504	1	28	0	c	350031154500000044	0-28						Nuclear reprogramming factor and induced pluripotent stem cells	Yamanaka	2008	0		MEF2C
1274	chr7	90374429	90374456	3500018619	27		90374429	90374456	8421504	1	27	0	c	350001861900000047	0-27						Nuclear Reprogramming Factor And Induced Pluripotent Stem Cells 	.freshpatents.com	0	0		MEF2C
1274	chr7	90374429	90374455	3500194143	26		90374429	90374455	8421504	1	26	0	c,g	350019414300000021,350019414300000021	28-54,28-54						EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS	Huangfu	2009	0		MEF2C
1274	chr7	90381136	90382136	3500152152	40		90381136	90382136	8421504	2	20,20	0,980	c,g	350015215200000009,350015215200000008,350015215200000008	0-20,0-20,0-20						Functional effect of mir-27b on myostatin expression: a relationship in piedmontese cattle with double-muscled phenotype	biomedcentral.com	0	0		
1274	chr7	90384667	90384745	3500192620	78		90384667	90384745	8421504	1	78	0	p	350019262000015000	0-78			10.1084/jem.20021842		The Journal of Experimental Medicine	Orphan Nuclear Receptor Nur77 Is Involved in Caspase-independent Macrophage Cell Death	Sung	June	0		MEF2C
1275	chr7	90472442	90472469	3500424726	27		90472442	90472469	8421504	1	27	0	c	350042472600000014	0-27		24010014	10.7717/peerj.134	2167-8359	PeerJ	The emerin-binding transcription factor Lmo7 is regulated by association with p130Cas at focal adhesions [PeerJ]	Wozniak	2013	0		MEF2C
1275	chr7	90472442	90472469	3500350580	27		90472442	90472469	8421504	1	27	0	c	350035058000000014	0-27						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal P	peerj.com/article	0	0		MEF2C
1275	chr7	90472442	90472469	3500283136	27		90472442	90472469	8421504	1	27	0	c	350028313600000014	0-27		24010014	10.7717/peerj.134		PeerJ	The emerin-binding transcription factor Lmo7 is regulated by association with p130Cas at focal adhesions	Michele	2013	0		MEF2C
1275	chr7	90472444	90472469	3500210186	25		90472444	90472469	8421504	1	25	0	c	350021018600000010	0-25						THE J BIOLOGICAL C &#xa9; 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Overexpression of Peroxisome Proliferator-activated Receptor Coactivator-1 Down-regulates GLUT4 mRNA in Skeletal Muscles*	www.jbc.org	0	0		
1275	chr7	90472448	90472473	3500175430	25		90472448	90472473	8421504	1	25	0	c	350017543000000014	0-25			10.1111/j.1582-4934.2007.00155.x	1582-4934	Journal of Cellular and Molecular Medicine	Mef2c is an essential regulatory element required for unique expression of the cardiac-specific CARK gene - Wang - 2007 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Wang	2008	0		MEF2C
1275	chr7	90472458	90472481	3500207032	23		90472458	90472481	8421504	1	23	0	c	350020703200000008	0-23						MYOMETRIAL-DERIVED MESENCHYMAL STEM CELLS AND USES THEREOF - PROJECH SCIENCE TO TECHNOLOGY, S.L.	www.sumobrain.com	0	0		MEF2C
1276	chr7	90578529	90578554	3500325902	24		90578529	90578554	8421504	2	16,8	0,17	g	350032590200000017	9-33						Nucleotide Sequence Encoding Artemisinic Aldehyde Double Bond Reductase, Artemisinic Aldehyde Double Bond Reductase And Uses Thereof 	.freshpatents.com	0	0		
1276	chr7	90667992	90668017	3500308662	25		90667992	90668017	8421504	1	25	0	g	350030866200000030	0-25						DNA	.lib.kobe-u.ac.jp	0	0		
1282	chr7	91460434	91460463	3500149073	26		91460434	91460463	8421504	2	7,19	0,10	g	350014907300000010	0-26		23434509	10.1016/j.celrep.2013.01.032	2211-1247	Cell Reports	Cell Reports - An Ancient Protein Phosphatase, SHLP1, Is Critical to Microneme Development in Plasmodium Ookinetes and Parasite Transmission	Patzewitz	2013	0		
1282	chr7	91460434	91460463	3500078830	26		91460434	91460463	8421504	2	7,19	0,10	g	350007883000000010	0-26		23434509	10.1016/j.celrep.2013.01.032	2211-1247	Cell Reports	Cell Reports - An Ancient Protein Phosphatase, SHLP1, Is Critical to Microneme Development in Plasmodium Ookinetes and Parasite Transmission	Patzewitz	2013	0		
1284	chr7	91656525	91656548	3500291921	23		91656525	91656548	8421504	1	23	0	g	350029192100000145	3-34						DOWN-REGULATION OF MORTALIN BY siRNA - Patent application	www.faqs.org	0	0		
1284	chr7	91683396	91683426	3500400373	25		91683396	91683426	8421504	3	15,6,4	0,19,26	g	350040037300000047	9-34						Prostate-specific membrane antigen and uses thereof	Israeli	1996	0		
160	chr7	91999103	92016152	3500353341	46		91999103	92016152	8421504	3	24,4,18	0,15047,17031	c	350035334100000004,350035334100000005	0-24,0-22		20529377	10.1186/1471-2407-10-268	1471-2407	BMC Cancer	Differential expression of centrosomal proteins at different stages of human glioma	Loh	2010	3		
1287	chr7	92078646	92078675	3500242423	24		92078646	92078675	8421504	3	13,7,4	0,17,25	c	350024242300000042	9-33					Patent	A novel protein, a genes encoding therefor and a method of using the same (Patent CN:100545263)	Gao Cang You Guang 	2009	0		
1288	chr7	92179719	92179750	3500060533	28		92179719	92179750	8421504	3	12,6,10	0,14,21	g	350006053300000427	10-40						PLANT TRANSFORMED WITH POLYNUCLEOTIDE ENCODING LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS DELTA-ENDOTOXIN - Patent application	www.faqs.org	0	0		
1288	chr7	92263497	92263529	3500119672	28		92263497	92263529	8421504	2	13,15	0,17	g	350011967200000003	0-39						July | 2013 | Apoptosis Guide	w.a-endorphin.com	0	0		
1294	chr7	92942761	92942785	3500337682	23		92942761	92942785	8421504	2	6,17	0,7	c	350033768200000001	2-27						Genetic Diversity and High Proportion of Intersubtype Recombinants among HIV Type 1-Infected Pregnant Women in Kisumu, Western Kenya	ol.washington.edu	0	0		ARRDC3
1297	chr7	93438834	93438862	3500321883	25		93438834	93438862	8421504	2	17,8	0,20	g	350032188300000296	14-44						Compound and methods for immunotherapy and diagnosis of tuberculosis	S*G*Lei De 	2000	0		
1298	chr7	93543749	93543775	3500454120	23		93543749	93543775	8421504	2	8,15	0,11	g	350045412000000001	7-30		11447160	10.1128/IAI.69.8.4851-4857.2001	0019-9567	Infection and Immunity	Identification and Characterization of a Novel Secreted Immunoglobulin Binding Protein from Group A Streptococcus	Fagan	2001	4		
1304	chr7	94275911	94275936	3500186517	23		94275911	94275936	8421504	2	10,13	0,12	g	350018651700000022	0-23					Patent	Methods and compositions for secretion of heterologous polypeptides (Patent US:5747662)	Simmons	1998	0		
1308	chr7	94841665	94841691	3500395029	23		94841665	94841691	8421504	2	12,11	0,15	g	350039502900000275	12-35						 Recombinant Infectious Laryngotracheitis Virus And Uses Thereof 	www.docstoc.com	0	0		
1310	chr7	95109246	95109272	3500240114	23		95109246	95109272	8421504	2	6,17	0,9	g	350024011400000003	1-24						Latent phase viral interleukin-10-(VII-10) and uses thereof - Patent application	www.faqs.org	0	0		
163	chr7	95283054	95291985	3500126962	60		95283054	95291985	8421504	2	30,30	0,8901	c	350012696200000002,350012696200000003	0-30,0-30						Title GABP&#x03b1; regulates Oct-3/4 expression in mouse embryonic stem cells Author(s) Citation Biochemical and Biophysical Research Communications, 353(3): 686-691 Issue Date Type Journal Article Text version http://hdl.handle.net/2297/3552	.kanazawa-u.ac.jp	0	0		NR2F1
163	chr7	95283054	95291970	3500078708	1260		95283054	95291970	8421504	3	466,528,266	0,2990,8650	p	350007870800015000	0-1260						KEGG T01008: 327684	www.genome.jp	0	0		
1311	chr7	95283054	95283082	3500406284	28		95283054	95283082	8421504	1	28	0	c	350040628400000140	27-55						Isolated ApoA-I gene regulatory sequence elements	Zannis	1993	0		
163	chr7	95283411	95291949	3500111757	462		95283411	95291949	8421504	4	90,51,76,245	0,2938,3085,8293	p	350011175700015022,350011175700015047,350011175700015084,350011175700015129,350011175700015106	0-90,0-51,6-153,0-87,0-174						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers, Sources	www.scribd.com	0	0		
1315	chr7	95729816	95729841	3500195595	23		95729816	95729841	8421504	2	6,17	0,8	g	350019559500000025	1-25						Use Of Lectin Library For Distinguishing Glycoproteins Or Cells, Diagnosing Serum Or Cells, Or Fractionating Glycoproteins Or Cells 	.freshpatents.com	0	0		
1316	chr7	95845376	95845405	3500060896	24		95845376	95845405	8421504	2	18,6	0,23	g	350006089600000166	5-29						Polypeptides and polynucleotides from coagulase-negative staphylococci	Foster	1999	0		
1316	chr7	95878839	95878862	3500100755	23		95878839	95878862	8421504	1	23	0	g	350010075500000013	5-33						Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability	Mckee	1999	0		
1316	chr7	95878839	95878862	3500009393	23		95878839	95878862	8421504	1	23	0	g	350000939300000012	5-33						Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability	Mckee	1997	0		
1319	chr7	96236613	96236636	3500414165	23		96236613	96236636	8421504	1	23	0	c	350041416500000109	8-38						Assay for virulent revertants of attenuated live vaccines and kits therefor	Levenbook	1994	0		
1321	chr7	96498020	96498044	3500422541	23		96498020	96498044	8421504	2	4,19	0,5	g	350042254100000029	2-25						COMPOSITIONS AND METHODS FOR SILENCING GENES EXPRESSED IN CANCER - Patent application	www.faqs.org	0	0		
1326	chr7	97126948	97182701	3500084979	343		97126948	97182701	8421504	11	23,18,47,35,4,32,32,15,48,42,47	0,9213,9232,9288,9339,12694,12822,33863,33879,34077,55706	c	350008497900000085,350008497900000086,350008497900000087,350008497900000088,350008497900000091,350008497900000092,350008497900000096,350008497900000113	7-48,1-48,9-44,12-48,0-47,0-48,6-48,0-47						GENE THERAPY FOR SULFATASE DEFICIENCY - Patent application	www.faqs.org	0	0		
1326	chr7	97136180	97182701	3500061508	220		97136180	97182701	8421504	6	47,4,32,48,42,47	0,107,3462,24647,24845,46474	c	350006150800000086,350006150800000088,350006150800000092,350006150800000096,350006150800000113	1-48,12-48,0-48,6-48,0-47						DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIES - Patent application	www.faqs.org	0	0		
1326	chr7	97198209	97198233	3500129453	23		97198209	97198233	8421504	2	17,6	0,18	g	350012945300000206,350012945300000422	0-23,13-36					Patent	Perhydrolase (Patent EP:1689859)	Amin	2011	0		
1327	chr7	97297809	97297838	3500322494	24		97297809	97297838	8421504	2	11,13	0,16	g	350032249400000003	0-24		19566814	10.1111/j.1469-8137.2009.02900.x	1469-8137	New Phytologist	Post-translational modification of an R2R3-MYB transcription factor by a MAP Kinase during xylem development - Morse - 2009 - New Phytologist - Wiley Online Library	Morse	2009	0		
1333	chr7	98061883	98064212	3500235521	24		98061883	98064212	8421504	3	3,12,9	0,2307,2320	c	350023552100000527	0-24						IMPROVED METHODS FOR TRANSFORMING PHAFFIA STRAINS, TRANSFORMED PHAFFIA STRAINS SO OBTAINED AND RECOMBINANT DNA IN SAID METHODS - Gist-brocades B.	www.sumobrain.com	0	0		
1333	chr7	98067716	98070936	3500000158	25		98067716	98070936	8421504	2	9,16	0,3204	c	350000015800000002	0-25		17504977	10.1096/fj.06-7440com	0892-6638	The FASEB Journal	Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1&#x03b1;- and basic FGF-dependent pathway in muscle cells	Egger	2007	6		
1333	chr7	98071029	98071053	3500182814	24		98071029	98071053	8421504	1	24	0	c	350018281400000005	20-44						Aberrantly expressed Genes in HacaT Keratinocytes chronically exposed to Arsenic Trioxide	www.la-press.com	0	0		PCSK1
1334	chr7	98294275	98294302	3500366733	23		98294275	98294302	8421504	2	13,10	0,17	g	350036673300000181	9-32						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
1335	chr7	98348475	98398725	3500357772	2550		98348475	98398725	8421504	7	1406,233,17,177,347,300,70	0,1556,1810,1856,49383,49780,50180	c,g	350035777200000099,350035777200000083,350035777200000006,350035777200000050,350035777200000048,350035777200000043,350035777200000116,350035777200000058,350035777200000051,350035777200000007,350035777200000017,350035777200000117,350035777200000011,350035777200000022,350035777200000119,350035777200000005,350035777200000013,350035777200000014,350035777200000089,350035777200000090,350035777200000023,350035777200000120,350035777200000078,350035777200000015,350035777200000121,350035777200000122,350035777200000123,350035777200000124,350035777200000125,350035777200000126,350035777200000127,350035777200000128,350035777200000129,350035777200000131,350035777200000132,350035777200000133,350035777200000134,350035777200000135,350035777200000136,350035777200000140,350035777200000141,350035777200000142,350035777200000143,350035777200000144,350035777200000146,350035777200000147,350035777200000148,350035777200000148,350035777200000149,350035777200000154,350035777200000155,350035777200000156,350035777200000157,350035777200000159,350035777200000160,350035777200000161,350035777200000163,350035777200000164,350035777200000165,350035777200000166,350035777200000167,350035777200000168,350035777200000171,350035777200000172	0-1380,0-1320,0-1251,0-60,0-58,0-58,0-50,0-60,0-58,0-50,1-50,0-50,0-50,0-50,7-58,0-69,0-50,0-50,0-19,0-19,0-50,0-50,0-58,0-50,0-50,2-54,0-50,0-50,0-50,4-54,0-50,0-50,0-50,0-50,0-50,4-54,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-27,0-50,8-58,4-54,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-50,0-20						Functional Polymorphisms: Bovine Calpastatin Gene and Meat Tenderness	.nottingham.ac.uk	0	0		
1335	chr7	98349591	98389826	3500056162	67		98349591	98389826	8421504	4	10,20,10,27	0,935,17702,40208	c,g	350005616200000008,350005616200000010,350005616200000010,350005616200000009,350005616200000009,350005616200000011,350005616200000011	0-20,0-20,0-20,0-19,0-19,0-20,0-20						Universidade de S&#xe3;o Paulo Escola Superior de Agricultura &#x201c;Luiz de Queiroz&#x201d;	www.teses.usp.br	0	0		
166	chr7	98350726	98483701	3500321684	839		98350726	98483701	8421504	29	30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,18,11,30,30,30,30,30,30,30,30	0,31,10943,10974,18462,18493,48660,48691,55871,55902,69444,69475,83048,83079,90207,90238,102424,102455,108344,108375,108394,114610,114641,119395,119426,124227,124258,132914,132945	g	350032168400000020,350032168400000022,350032168400000023,350032168400000027,350032168400000028,350032168400000030,350032168400000032,350032168400000033,350032168400000034,350032168400000035,350032168400000036,350032168400000037,350032168400000038,350032168400000039	0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-59,0-60,0-60,0-60,0-60						EVALUATION OF SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH FERTILITY AND PRODUCTION TRAITS IN HOLSTEIN AND MULTI-GENERATIONAL ANGUS FEMALES	etd.lsu.edu	0	0		
1335	chr7	98356627	98356651	3500139049	24		98356627	98356651	8421504	1	24	0	g	350013904900000031	5-29					Patent	Methods for making proteins containing free cysteine residues (Patent US:6753165)	Cox	2004	0		
1335	chr7	98424570	98424595	3500072508	25		98424570	98424595	8421504	1	25	0	c	350007250800000000,350007250800000001	0-25,0-25		15180919	10.1152/ajplung.00079.2004		American Journal of Physiology - Lung Cellular and Molecular Physiology	Cigarette smoke extract inhibits angiogenesis of pulmonary artery endothelial cells: the role of calpain	Su	2004	0		CAST
1335	chr7	98433968	98434523	3500193928	554		98433968	98434523	8421504	2	97,457	0,98	c,g	350019392800000007,350019392800000008,350019392800000000	0-554,21-41,21-41						Bovine Castgene Snp And Meat Tenderness 	.freshpatents.com	0	0		
1335	chr7	98433985	98434509	3500045688	45		98433985	98434509	8421504	2	20,25	0,499	c	350004568800000000,350004568800000001	21-41,0-25						Bovine CAST gene SNP and meat tenderness	Schenkel	2005	0		
1335	chr7	98434295	98434326	3500290147	31		98434295	98434326	8421504	1	31	0	g	350029014700000009	0-31						UNIVERSIDADE DE S&#xc3;O PAULO FACULDADE DE ZOOTENIA E ENGENHARIA DE ALIMENTOS	www.teses.usp.br	0	0		
1336	chr7	98441651	98485917	3500009417	63		98441651	98485917	8421504	2	27,36	0,44230	c,g	350000941700000006,350000941700000009,350000941700000009	28-55,27-63,27-63						Doctorat ParisTech T H &#xc8; S E L Institut des Sciences et Industries (AgroParisTech)	hives-ouvertes.fr	0	0		
1336	chr7	98445797	98445821	3500338930	24		98445797	98445821	8421504	1	24	0	c	350033893000000003	0-24						Genetic Variability and population structure in Beta-lactoglobulin, Calpastain and Calpain in Iranian Kurdi sheep | Mohammad Reza Nassiri - Academia.edu	www.academia.edu	0	0		
1336	chr7	98445797	98445821	3500199465	24		98445797	98445821	8421504	1	24	0	c	350019946500000001	0-24						Study of polymorphism of Calpastatin gene in Holstein cattle and Buffalo using PCR-RFLP method | Elena Dehnavi - Academia.edu	www.academia.edu	0	0		
1336	chr7	98445797	98445821	3500193658	24		98445797	98445821	8421504	1	24	0	c	350019365800000001	0-24						disserta..o de mestrado original	cnptia.embrapa.br	0	0		
1336	chr7	98445797	98445821	3500185246	24		98445797	98445821	8421504	1	24	0	c	350018524600000001	0-24						Polymorphism investigation of calpastatin gene in Zel sheep population of Iran by PCR-RFLP method	demicjournals.org	0	0		
1336	chr7	98445797	98445821	3500160276	24		98445797	98445821	8421504	1	24	0	c	350016027600000001	0-24						disserta..o de mestrado original	torio.ufc.br:8080	0	0		
1336	chr7	98445797	98445821	3500112750	24		98445797	98445821	8421504	1	24	0	c	350011275000000001	0-24						Gharahveysi et al. Polymorphism investigation of calpastatin gene in Zel sheep population of Iran by PCR-RFLP method. Afr. J. Biotechnol.	demicjournals.org	0	0		
1336	chr7	98445797	98445821	3500107696	24		98445797	98445821	8421504	1	24	0	c	350010769600000001	0-24						&#xfee6;&#xfef4;&#xfe91; &#xfea9;&#xfead;&#xfe8d;&#xfeaa;&#xfee7;&#xfe8e;&#xfe98;&#xfeb3;&#xfe8d; &#xfee9;&#xfead;&#xfe8e;&#xfee4;&#xfeb7; &#x0661;&#x0663;&#x0668;&#x0668; &#x0661;&#x0669; &#xfeaa;&#xfee0;&#xfe9f; &#x0661; &#xfee9;&#xfead;&#xfe8e;&#xfee4;	tabrizu.ac.ir	0	0		
1336	chr7	98445797	98445821	3500090264	24		98445797	98445821	8421504	1	24	0	c	350009026400000001	0-24						Allelic Polymorphism of Makoei Sheep Calpastatin Gene Identified by Polymerase Chain Reaction and Single Strand Conformation Polymorphism	als.modares.ac.ir	0	0		
1336	chr7	98445797	98445821	3500050208	24		98445797	98445821	8421504	1	24	0	c	350005020800000001	0-24						&#x062f;&#x0627;&#xfb8b;&#xfee7;	profdoc.um.ac.ir	0	0		
1336	chr7	98445797	98445821	3500041372	24		98445797	98445821	8421504	1	24	0	c	350004137200000001	0-24						Calpastatin (CAST) Gene Polymorphism and its Association with Average Daily Weight Gain in Balkhi and Kajli Sheep and Beetal Goat Breeds	www.zsp.com.pk	0	0		
1336	chr7	98445797	98445821	3500029133	24		98445797	98445821	8421504	1	24	0	c	350002913300000001	0-24						Polymorphism of calpastatin gene in Arabic sheep using PCR- RFLP	www.ajol.info	0	0		
1336	chr7	98445797	98445821	3500024763	24		98445797	98445821	8421504	1	24	0	c	350002476300000001	0-24						ANALYSIS OF POLYMORPHISM OF CAST GENE AND CLPG GENE IN SHEEP BY PCR-RFLP METHOD ANALIYA POLIMORFISMULUI GENELOR CAST &#x015e;I CLPG LA OI PRIN METODA PCR-RFLP	www.usab-tm.ro	0	0		
1336	chr7	98455127	98457293	3500056162	40		98455127	98457293	8421504	3	20,17,3	0,1024,2163	c,g	350005616200000012,350005616200000012,350005616200000013	0-20,0-20,0-20						Universidade de S&#xe3;o Paulo Escola Superior de Agricultura &#x201c;Luiz de Queiroz&#x201d;	www.teses.usp.br	0	0		
1336	chr7	98471549	98471627	3500243216	75		98471549	98471627	8421504	3	23,23,29	0,24,49	c	350024321600000006,350024321600000008,350024321600000007	0-23,0-23,0-29						EFFECT OF ZILPATEROL HYDROCHLORIDE AND STEROID IMPLANTATION ON YEARLING STEER FEEDLOT PERFORMANCE, CARCASS CHARACTERISTICS, AND SKELETAL MUSCLE GENE EXPRESSION TIMOTHY JOHN BAXA B.S., Kansas State University, 2004 A THESIS	krex.k-state.edu	0	0		
1336	chr7	98484251	98484526	3500146366	59		98484251	98484526	8421504	2	29,30	0,245	c	350014636600000004,350014636600000005	0-29,0-30			10.1590/S1415-47572007000600006	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Association of CAPN1 and CAST gene polymorphisms with meat tenderness in Bos taurus beef cattle from Argentina	Corva	2007	1		
1336	chr7	98484433	98484602	3500257960	169		98484433	98484602	8421504	1	169	0	c,g	350025796000000021,350025796000000000,350025796000000008,350025796000000008,350025796000000020,350025796000000003,350025796000000001,350025796000000005,350025796000000009	0-162,0-49,0-22,0-22,0-157,0-121,0-121,0-121,0-25						 DNA Markers For Meat Tenderness 	www.docstoc.com	0	0		
1336	chr7	98484463	98484554	3500001009	54		98484463	98484554	8421504	2	26,28	0,63	c,g	350000100900000004,350000100900000004,350000100900000003	39-65,39-65,65-93						Genetic variants affecting meat and milk production traits appear to have effects on reproduction traits in cattle | Marina R. S. Fortes - Academia.edu	www.academia.edu	0	0		
1337	chr7	98650519	98653763	3500435659	48		98650519	98653763	8421504	2	27,21	0,3223	p	350043565900015038	0-48						 Proteins And Nucleic Acids Encoding Same 	www.docstoc.com	0	0		ERAP2
1337	chr7	98650525	98653766	3500245734	45		98650525	98653766	8421504	2	21,24	0,3217	p	350024573400015055	0-45						FILAMENTOUS FUNGI WITH INACTIVATED PROTEASE GENES FOR ALTERED PROTEIN PRODUCTION - Patent application	www.faqs.org	0	0		LNPEP
1349	chr7	100260342	100260365	3500159585	23		100260342	100260365	8421504	1	23	0	g	350015958500000007	18-41						BMC Microbiology BioMed Central	biomedcentral.com	0	0		
1350	chr7	100330039	100330063	3500167934	23		100330039	100330063	8421504	2	7,16	0,8	g	350016793400000007	4-27						Immunity, Vol. 15, 159&#x2013;172, July, 2001, Copyright 2001 by Cell Press The Basis for IL-2-Induced IL-2 Receptor Chain Gene Regulation: Importance of Two Widely Separated IL-2 Response Elements	kendallasmith.com	0	0		
1351	chr7	100433370	100433397	3500258811	24		100433370	100433397	8421504	2	16,8	0,19	g	350025881100000063	6-48						GRAIN QUALITY THROUGH ALTERED EXPRESSION OF SEED PROTEINS - Patent application	www.faqs.org	0	0		
1351	chr7	100498436	100499975	3500342848	207		100498436	100499975	8421504	3	82,116,9	0,299,1530	p	350034284800015005	1140-1347						The DNA-binding domain of the Chd1 chromatin-remodelling enzyme contains SANT and SLIDE domains. - ResearchGate	.researchgate.net	0	0		
1351	chr7	100521969	100523766	3500245677	528		100521969	100523766	8421504	4	144,100,226,58	0,355,617,1739	p	350024567700015016,350024567700015011,350024567700015006	0-168,0-180,0-180						CHD8, a Novel ATP-dependent Chromatin Remodeling Enzyme by	lue.lib.umich.edu	0	0		CHD1
1351	chr7	100524131	100527533	3500013566	258		100524131	100527533	8421504	3	139,65,54	0,2310,3348	p	350001356600015046,350001356600015197,350001356600015196,350001356600015044,350001356600015042	0-150,0-45,0-45,0-54,0-54						NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS - Patent application	www.faqs.org	0	0		CHD1
1351	chr7	100524131	100526485	3500023106	183		100524131	100526485	8421504	2	139,44	0,2310	p	350002310600015028	0-183						NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS	Tainsky	2010	0		CHD1
1352	chr7	100649389	100649416	3500194519	24		100649389	100649416	8421504	2	8,16	0,11	g	350019451900000217	0-24						CLONING AND CHARACTERIZATION OF THE CAPSULE TRANSPORT GENE REGION FROM Haemophilus paragallinarum	etd.uovs.ac.za	0	0		
1353	chr7	100733868	100733893	3500269550	24		100733868	100733893	8421504	2	13,11	0,14	g	350026955000000102,350026955000000100	1-28,1-28						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
1360	chr7	101680968	101680992	3500394860	23		101680968	101680992	8421504	2	14,9	0,15	g	350039486000000169	7-30						METHODS AND COMPOSITIONS FOR TREATING TULAREMIA - Patent application	www.faqs.org	0	0		
1374	chr7	103515763	103515805	3500119257	41		103515763	103515805	8421504	2	36,5	0,37	g	350011925700000010	3-45						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
1376	chr7	103727888	103727915	3500129361	24		103727888	103727915	8421504	3	5,14,5	0,6,22	g	350012936100000075	4-30					Patent	Recombinant poxvirus compositions and methods of inducing immune responses (Patent US:5942235)	Paoletti	1999	0		
1377	chr7	103939233	103939261	3500275614	23		103939233	103939261	8421504	2	11,12	0,16	c	350027561400000637	13-42						Toxin peptide therapeutic agents	Sullivan	2006	0		
1379	chr7	104082191	104082241	3500194768	42		104082191	104082241	8421504	2	19,23	0,27	g	350019476800000019	4-56						Origine des alt&#xe9;rations superficielles du tubercule de pomme de terre: e	es.u-bourgogne.fr	0	0		
1387	chr7	105168108	105168131	3500358064	23		105168108	105168131	8421504	1	23	0	g	350035806400000004,350035806400000006	6-29,0-23						Identification Of The Gene And Mutation Responsible For Progressive Rod-cone Degeneration In Dog And A Method For Testing Same 	.freshpatents.com	0	0		
1393	chr7	105947314	105947341	3500335804	25		105947314	105947341	8421504	2	10,15	0,12	g	350033580400000189	22-48						VACCINE AND ANTITOXIN FOR TREATMENT AND PREVENTION OF C. DIFFICILE DISEASE - OPHIDIAN PHARMACEUTICALS, INC	www.sumobrain.com	0	0		
1396	chr7	106407163	106407189	3500328808	23		106407163	106407189	8421504	2	17,6	0,20	g	350032880800000020	0-23						Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification	Carrico	2012	0		
1397	chr7	106533685	106533728	3500400388	41		106533685	106533728	8421504	2	20,21	0,22	g	350040038800000011,350040038800000009	0-20,0-21			10.1111/j.1742-4658.2007.05810.x	1742-4658	FEBS Journal	Identification of substrates for transglutaminase in Physarum polycephalum, an acellular slime mold, upon cellular mechanical damage - Wada - 2007 - FEBS Journal - Wiley Online Library	Wada	2007	0		SLC25A4
1398	chr7	106611062	106611087	3500248094	23		106611062	106611087	8421504	2	15,8	0,17	g	350024809400001080	0-23						INDUCIBLE NUCLEIC ACID TARGETS FOR DETECTION OF PATHOGENS, METHODS AND COMPOSITIONS THEREOF - Patent application	www.faqs.org	0	0		
1401	chr7	106985334	106985361	3500242028	24		106985334	106985361	8421504	2	5,19	0,8	g	350024202800000563	1-28						Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases	Silverman	2011	0		
1404	chr7	107386196	107386220	3500466414	23		107386196	107386220	8421504	2	7,16	0,8	g	350046641400000049	0-23						METHODS OF ASSESSING CROHN'S DISEASE PATIENT PHENOTYPE BY I2 SEROLOGIC RESPONSE - Patent application	www.faqs.org	0	0		
1405	chr7	107482666	107482689	3500143796	23		107482666	107482689	8421504	1	23	0	g	350014379600000145,350014379600000067	0-37,0-37						PROTEASE VARIANTS - Patent application	www.faqs.org	0	0		
1405	chr7	107567299	107567403	3500394704	40		107567299	107567403	8421504	2	20,20	0,84	c,g	350039470400000029,350039470400000029,350039470400000028,350039470400000028	0-20,0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		PPIP5K2
1405	chr7	107567299	107567403	3500292483	40		107567299	107567403	8421504	2	20,20	0,84	c,g	350029248300000029,350029248300000029,350029248300000028,350029248300000028	0-20,0-20,0-20,0-20						Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo	imal.ifas.ufl.edu	0	0		PPIP5K2
1408	chr7	107877678	107877704	3500420078	23		107877678	107877704	8421504	2	5,18	0,8	g	350042007800000013	2-25					Patent	Recombinational cloning using engineered recombination sites (Patent US:6270969)	Hartley	2001	0		
1408	chr7	107877678	107877704	3500339774	23		107877678	107877704	8421504	2	5,18	0,8	g	350033977400000013	2-25						Recombinational cloning using engineered recombination sites	Hartley	2002	0		
1408	chr7	107877678	107877704	3500286808	23		107877678	107877704	8421504	2	5,18	0,8	g	350028680800000022	14-37						Corn Plants And Seed Enhanced For Asparagine And Protein 	.freshpatents.com	0	0		
1408	chr7	107877678	107877704	3500284736	23		107877678	107877704	8421504	2	5,18	0,8	g	350028473600000057,350028473600000055	2-25,3-25						SELF-CLEAVING AFFINITY TAGS AND METHODS OF USE - THE TRUSTEES OF PRINCETON UNIVERSITY	www.sumobrain.com	0	0		
1408	chr7	107877678	107877704	3500235171	23		107877678	107877704	8421504	2	5,18	0,8	g	350023517100000013	2-25						Recombinational cloning using engineered recombination sites	Brasch	1996	0		
1408	chr7	107877678	107877704	3500225574	23		107877678	107877704	8421504	2	5,18	0,8	g	350022557400000013	2-25					Patent	Recombinational cloning using engineered recombination sites (Patent US:7223576)	Hartley	2007	0		
1408	chr7	107877678	107877704	3500219612	23		107877678	107877704	8421504	2	5,18	0,8	g	350021961200000071,350021961200000019,350021961200000017,350021961200000069	3-25,3-25,2-25,2-25						RECOMBINATIONAL CLONING USING NUCLEIC ACIDS HAVING RECOMBINATION SITES - Patent application	www.faqs.org	0	0		
1408	chr7	107877678	107877704	3500205227	23		107877678	107877704	8421504	2	5,18	0,8	g	350020522700000030,350020522700000029	2-25,3-25						Methods And Compositions For Synthesis Of Nucleic Acid Molecules Using Multiple Recognition Sites 	.freshpatents.com	0	0		
1408	chr7	107877678	107877704	3500195799	23		107877678	107877704	8421504	2	5,18	0,8	g	350019579900000010,350019579900000013	3-25,2-25						Recombinational cloning using engineered recombination sites	Hartley	2002	0		
1408	chr7	107877678	107877704	3500195666	23		107877678	107877704	8421504	2	5,18	0,8	g	350019566600000019,350019566600000017	3-25,2-25						Recombinational cloning using nucleic acids having recombination sites	Hartley	2001	0		
1408	chr7	107877678	107877704	3500167662	24		107877678	107877704	8421504	2	5,19	0,7	g	350016766200000013,350016766200000010,350016766200000007	2-25,3-25,2-21						Chromosome-based platforms	Fleming	2002	0		
1412	chr7	108399080	108399106	3500325423	23		108399080	108399106	8421504	2	6,17	0,9	g	350032542300000115	10-35						Dna vaccines for pets and sport animals	Audonnet	2002	0		
1412	chr7	108399080	108399106	3500172045	23		108399080	108399106	8421504	2	6,17	0,9	g	350017204500000063	10-35						Vaccins adn pour animaux de compagnie et de sport	Audonnet	2000	0		
1412	chr7	108513422	108513453	3500456896	27		108513422	108513453	8421504	2	18,9	0,22	g	350045689600000018	2-30						&#x7279;&#x8a31;&#x306e;&#x82f1;&#x8a9e;&#xff06;&#x7279;&#x8a31;&#x7ffb;&#x8a33;&#x306e;&#x5bfe;&#x8a33;&#xff08;&#x8272;&#x3005;&#x306a;&#x5206;&#x91ce;&#xff09;&#x3000;&#x5ef6;&#x9577;&#x3055;&#x308c;&#x305f;&#x8840;&#x6db2;&#x534a;&#x6e1b;&#x671f;&#x3092	c.blog117.fc2.com	0	0		
1412	chr7	108517374	108517400	3500327539	23		108517374	108517400	8421504	2	17,6	0,20	g	350032753900000167	15-40						Albumin-Fused Kunitz Domain Peptides - Patent application	www.faqs.org	0	0		
1414	chr7	108737975	108737999	3500022748	23		108737975	108737999	8421504	2	12,11	0,13	g	350002274800000006	0-23		12097596	10.1128/JVI.76.15.7843-7854.2002	0022-538X	Journal of Virology	Subcellular Localization of the Bovine Leukemia Virus R3 and G4 Accessory Proteins	Lefebvre	2002	5		
1418	chr7	109213489	109213514	3500315927	24		109213489	109213514	8421504	2	19,5	0,20	g	350031592700000040	13-37						Parasitic helminth PLA2 proteins and nucleic acid molecules - US Patent 6060281 Description	ww.patentstorm.us	0	0		
177	chr7	109233490	109518657	3500100654	47		109233490	109518657	8421504	3	24,3,20	0,49490,285147	c	350010065400000032,350010065400000036	21-45,0-23						Screening Method For Anti-diabetic Compounds 	.freshpatents.com	0	0		EFNA5,FBXL17
177	chr7	109234953	109518762	3500286800	684		109234953	109518762	8421504	5	119,81,66,293,125	0,5419,5911,47737,283684	p	350028680000015002	0-684						Methods for Identifying Risk of Type II Diabetes and Treatments Thereof - Patent application	www.faqs.org	0	0		EFNA5,FBXL17
177	chr7	109234965	109518711	3500286800	450		109234965	109518711	8421504	14	45,45,11,34,44,1,14,31,45,45,45,19,26,45	0,48,96,5407,5444,5899,5951,47725,47807,47855,47951,47999,283672,283701	p	350028680000015111,350028680000015110,350028680000015109,350028680000015108,350028680000015106,350028680000015104,350028680000015103,350028680000015101,350028680000015100,350028680000015099	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Methods for Identifying Risk of Type II Diabetes and Treatments Thereof - Patent application	www.faqs.org	0	0		EFNA5,FBXL17
1418	chr7	109240445	109282790	3500330320	126		109240445	109282790	8421504	4	8,64,27,27	0,419,42276,42318	p	350033032000015013,350033032000015049	0-72,15-75						Structure, Function & Control of the EphA3 Receptor Tyrosine Kinase	.swinburne.edu.au	0	0		EFNA5
177	chr7	109282937	109518651	3500356965	60		109282937	109518651	8421504	2	46,14	0,235700	p	350035696500015002	0-60						AL-1 neurotrophic factor antibodies	Caras	1995	0		EFNA5,FBXL17
1419	chr7	109335690	109335719	3500167973	24		109335690	109335719	8421504	2	12,12	0,17	g	350016797300000003	0-24		21199918	10.1128/MCB.01062-10	0270-7306	Molecular and Cellular Biology	CtBP2 Downregulation during Neural Crest Specification Induces Expression of Mitf and REST, Resulting in Melanocyte Differentiation and Sympathoadrenal Lineage Suppression	Liang	2011	6		
1419	chr7	109339192	109339216	3500115116	23		109339192	109339216	8421504	2	14,9	0,15	g	350011511600000294	21-44						Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use	J*M*Wei Er Sen 	2005	0		
1420	chr7	109518639	109518665	3500203179	26		109518639	109518665	8421504	1	26	0	c,g	350020317900000001,350020317900000001	6-32,6-32						NPG.nature.vol.408.Issue.6809.Nov	www.scribd.com	0	0		FBXL17
1420	chr7	109518657	109518702	3500111220	45		109518657	109518702	8421504	1	45	0	p	350011122000015000	0-45					Patent	Cytokine designated lerk-7 (Patent EP:0871702)	Cerretti	2005	0		FBXL17
1422	chr7	109797757	109797781	3500352177	23		109797757	109797781	8421504	2	7,16	0,8	g	350035217700000412	13-36						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
1425	chr7	110139929	110139988	3500424337	36		110139929	110139988	8421504	2	20,16	0,43	g	350042433700000000	126-162						McGraw-Hill Ryerson. High School Biology Volume 3 2001	www.scribd.com	0	0		
1426	chr7	110332937	110332960	3500367476	23		110332937	110332960	8421504	1	23	0	c	350036747600000009	0-23						Polymorphism discovery and allele frequency estimation using high-throughput DNA sequencing of target-enriched pooled DNA samples. - ResearchGate	.researchgate.net	0	0		
1430	chr7	110871649	110871694	3500178668	45		110871649	110871694	8421504	1	45	0	p	350017866800015003	0-45		18985748	10.1002/dvdy.21789	1097-0177	Developmental Dynamics	Expression of Fer testis (FerT) tyrosine kinase transcript variants and distribution sites of FerT during the development of the acrosome-acroplaxome-manchette complex in rat spermatids - Kierszenbaum - 2008 - Developmental Dynamics - Wiley Online Library	Kierszenbaum	2008	0		FER
1430	chr7	110871738	110871765	3500233391	27		110871738	110871765	8421504	1	27	0	c	350023339100000018	0-27		22238358	10.1091/mbc.E11-06-0517		Molecular Biology of the Cell	A Highlights from MBoC Selection: Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	Tohru	2012	0		
1430	chr7	110871738	110871765	3500226180	27		110871738	110871765	8421504	1	27	0	c	350022618000000018	0-27		22238358	10.1091/mbc.E11-06-0517	1059-1524	Molecular Biology of the Cell	Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	Yoneyama	2012	5		
1430	chr7	110871738	110871765	3500207967	27		110871738	110871765	8421504	1	27	0	c	350020796700000022	0-27						Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	w.molbiolcell.org	0	0		
1430	chr7	110871738	110871765	3500025891	27		110871738	110871765	8421504	1	27	0	c	350002589100000023	0-27						Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation. - ResearchGate	.researchgate.net	0	0		FER
1432	chr7	111094846	111094870	3500025891	24		111094846	111094870	8421504	1	24	0	c	350002589100000000	0-24						Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation. - ResearchGate	.researchgate.net	0	0		FER
1433	chr7	111150822	111150850	3500159829	24		111150822	111150850	8421504	2	9,15	0,13	g	350015982900000001	0-24						Use of growth hormone to enhance the immune response in immunosuppressed patients	Bofill	2012	0		
1433	chr7	111219632	111225006	3500019454	48		111219632	111225006	8421504	2	19,29	0,5345	p	350001945400015041,350001945400015045	0-48,48-96						Introduction to Computational Molecular Biology - Carlos Setubal, Joao Meidanis	www.scribd.com	0	0		FES
1433	chr7	111219646	111224997	3500233391	23		111219646	111224997	8421504	3	5,13,5	0,5331,5346	c	350023339100000015	5-28		22238358	10.1091/mbc.E11-06-0517		Molecular Biology of the Cell	A Highlights from MBoC Selection: Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	Tohru	2012	0		
1433	chr7	111219646	111224997	3500226180	23		111219646	111224997	8421504	3	5,13,5	0,5331,5346	c	350022618000000015	5-28		22238358	10.1091/mbc.E11-06-0517	1059-1524	Molecular Biology of the Cell	Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	Yoneyama	2012	5		
1433	chr7	111219646	111224997	3500207967	23		111219646	111224997	8421504	3	5,13,5	0,5331,5346	c	350020796700000018	7-30						Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation	w.molbiolcell.org	0	0		
1433	chr7	111219646	111224997	3500025891	23		111219646	111224997	8421504	3	5,13,5	0,5331,5346	c	350002589100000019	7-30						Fer kinase regulates cell migration through &#x03b1;-dystroglycan glycosylation. - ResearchGate	.researchgate.net	0	0		
1433	chr7	111225950	111237111	3500114656	39		111225950	111237111	8421504	3	20,12,7	0,11140,11154	g	350011465600000026,350011465600000017	0-22,0-19						An Invariant T Cell Receptor a Chain De&#xfb01;nes a Novel TAP-independent Major Histocompatibility Complex Class Ib&#x2013;restricted a b T Cell Subpopulation in Mammals	jem.rupress.org	0	0		
1438	chr7	111808717	111832061	3500395481	39		111808717	111832061	8421504	4	14,6,6,13	0,17,23322,23331	g	350039548100000148,350039548100000078	9-29,14-33						Apparatus and method for detecting and identifying infectious agents - Patent # 6649356 - PatentGenius	.patentgenius.com	0	0		
1439	chr7	111966754	111966787	3500346363	33		111966754	111966787	8421504	1	33	0	c	350034636300000108	11-44						Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells	Hamilton	2003	0		MAN2A1
1444	chr7	112674910	112674941	3500417171	23		112674910	112674941	8421504	3	12,5,6	0,15,25	g	350041717100000179	0-23						UNIVERSIDAD COMPLUTENSE DE MADRID	www.elfoiegras.es	0	0		
585	chr8	118951	118976	3500019347	23		118951	118976	8421504	3	4,7,12	0,5,13	g	350001934700000098	14-37						CORYNEBACTERIUM GLUTAMICUM GENES ENCODING REGULATORY PROTEINS INVOLVED IN THE PRODUCTION OF METHIONINE - Patent application	www.faqs.org	0	0		
586	chr8	220114	220145	3500008756	24		220114	220145	8421504	3	13,6,5	0,17,26	g	350000875600000607	15-39						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
590	chr8	756859	759168	3500308562	42		756859	759168	8421504	2	22,20	0,2289	g	350030856200000024,350030856200000025	0-22,0-20						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
592	chr8	933001	933882	3500393417	156		933001	933882	8421504	5	15,9,57,27,48	0,18,743,803,833	p	350039341700015006	0-156						Posh interacting proteins and related methods	Taglicht	2006	0		
594	chr8	1298166	1298192	3500227059	23		1298166	1298192	8421504	3	5,5,13	0,7,13	g	350022705900000000	9-34		19472338	10.1002/pro.131		Protein Science : A Publication of the Protein Society	Green fluorescence induced by EF-hand assembly in a split GFP system	Stina	June	0		
601	chr8	2192514	2192538	3500342066	23		2192514	2192538	8421504	2	18,5	0,19	g	350034206600000004	8-38						Multiplex PCR Assay for Detection of Streptococcus suis Species and Serotypes 2 and 1/2 in Tonsils of Live and Dead Pigs	jcm.asm.org	0	0		
616	chr8	4130763	4130789	3500165546	26		4130763	4130789	8421504	1	26	0	g	350016554600000054	45-71						GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF - Patent application	www.faqs.org	0	0		
623	chr8	5013548	5013573	3500012895	23		5013548	5013573	8421504	2	18,5	0,20	g	350001289500000067	14-38						Methods, Compositions, And Kits For Detection Of Microrna 	.freshpatents.com	0	0		
627	chr8	5521882	5521906	3500008756	23		5521882	5521906	8421504	2	4,19	0,5	g	350000875600000737	3-26						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
627	chr8	5550455	5550483	3500113379	26		5550455	5550483	8421504	3	11,5,10	0,12,18	g	350011337900000084	15-48						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
627	chr8	5550455	5550483	3500062787	26		5550455	5550483	8421504	3	11,5,10	0,12,18	g	350006278700000084	15-48						Polypeptides of Botryosphaeria Rhodina - Patent application	www.faqs.org	0	0		
627	chr8	5598351	5599810	3500421157	627		5598351	5599810	8421504	4	156,175,146,150	0,651,910,1309	p	350042115700015003,350042115700015007,350042115700015006	0-627,0-225,0-231						JP 2009-517404 A 2009.4	biosciencedbc.jp	0	0		HMGB2
627	chr8	5598351	5599810	3500156107	621		5598351	5599810	8421504	5	156,175,146,39,105	0,651,910,1309,1354	p	350015610700015004,350015610700015008,350015610700015007	0-621,0-225,0-228						HIGH AFFINITY ANTIBODIES AGAINST HMGB1 AND METHODS OF USE THEREOF - MEDIMMUNE, INC.	www.sumobrain.com	0	0		HMGB2
627	chr8	5598378	5599810	3500446558	600		5598378	5599810	8421504	4	129,175,146,150	0,624,883,1282	p	350044655800015002,350044655800015006,350044655800015005	0-600,0-225,0-231						Antagonists Of Hmgb1 And/or Rage And Methods Of Use Thereof 	.freshpatents.com	0	0		HMGB2
627	chr8	5598402	5599711	3500187738	360		5598402	5599711	8421504	10	45,45,45,45,40,5,45,42,3,45	0,48,639,687,735,859,867,963,1258,1264	p	350018773800015078,350018773800015077,350018773800015075,350018773800015074,350018773800015073,350018773800015072,350018773800015070,350018773800015069	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Immunogenic Compositions Comprising Hmgb 1 Polypeptides - Patent application	www.faqs.org	0	0		HMGB2
627	chr8	5598504	5599714	3500269428	357		5598504	5599714	8421504	5	3,175,32,93,54	0,498,757,810,1156	p	350026942800015013,350026942800015002	0-210,0-147						Use Of Hmgb Fragments As Anti-inflammatory Agents 	.freshpatents.com	0	0		HMGB2
627	chr8	5598504	5599714	3500206068	327		5598504	5599714	8421504	5	3,175,32,63,54	0,498,757,840,1156	p	350020606800015029,350020606800015028,350020606800015010	0-90,0-120,0-117						Use of HMGB fragments as anti-inflammatory agents	O'keefe	2003	0		HMGB2
627	chr8	5598504	5599714	3500180393	357		5598504	5599714	8421504	5	3,175,32,93,54	0,498,757,810,1156	p	350018039300015015,350018039300015004	0-210,0-147						HMGB1 combination therapies	Newman	2003	0		HMGB2
627	chr8	5598504	5599293	3500390608	210		5598504	5599293	8421504	3	3,175,32	0,498,757	p	350039060800015001	0-210						Use of hmgb polypetides for increasing immune responses	Tracey	2006	0		HMGB2
627	chr8	5598504	5599293	3500339917	210		5598504	5599293	8421504	3	3,175,32	0,498,757	p	350033991700015001	0-210						Use of hmgb polypetides for increasing immune responses	Tracey	2003	0		HMGB2
627	chr8	5599339	5599765	3500164515	41		5599339	5599765	8421504	2	20,21	0,405	c,g	350016451500000005,350016451500000004,350016451500000004	0-20,0-21,0-21						TARTU &#xdc;LIKOOL LOODUS- JA TEHNOLOOGIATEADUSKOND MOLEKULAAR- JA RAKUBIOLOOGIA INSTITUUT Liisi V&#xf5;sa	www.ebc.ee/kaitsm	0	0		HMGB2
628	chr8	5762188	5762216	3500127308	24		5762188	5762216	8421504	3	14,5,5	0,15,23	g	350012730800000205	19-43						PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS - Patent application	www.faqs.org	0	0		
630	chr8	5905335	5905362	3500362735	23		5905335	5905362	8421504	2	11,12	0,15	g	350036273500000474	24-47						Compositions containing nucleic acids and ligands for therapeutic treatment	Baird	1999	0		
636	chr8	6726817	6726897	3500172791	52		6726817	6726897	8421504	2	25,27	0,53	c	350017279100000025,350017279100000024	0-25,0-27		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
636	chr8	6726817	6726897	3500120290	52		6726817	6726897	8421504	2	25,27	0,53	c	350012029000000025,350012029000000024	0-25,0-27						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
636	chr8	6726817	6726897	3500048191	52		6726817	6726897	8421504	2	25,27	0,53	c	350004819100000025,350004819100000024	0-25,0-27		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
636	chr8	6728351	6763303	3500397705	46		6728351	6763303	8421504	2	24,22	0,34930	c	350039770500000001,350039770500000000	0-24,0-22						REPRODUCTION	uction-online.org	0	0		
636	chr8	6733846	6763298	3500326589	70		6733846	6763298	8421504	3	20,25,25	0,26341,29427	c	350032658900000015,350032658900000013,350032658900000004	0-20,0-25,0-25		8977409	10.1210/en.138.1.237	0013-7227	Endocrinology	Cloning of Guinea Pig Cyclooxygenase-2 and 15-Hydroxyprostaglandin Dehydrogenase Complementary Deoxyribonucleic Acids: Steroid-Modulated Gene Expression Correlates to Prostaglandin F2&#x03b1; Secretion in Cultured Endometrial Cells	Bracken	1997	4		HPGD
636	chr8	6748502	6763303	3500332885	42		6748502	6763303	8421504	2	21,21	0,14780	c,g	350033288500000001,350033288500000001,350033288500000000,350033288500000000	0-21,0-21,0-21,0-21		11058524	10.1095/biolreprod63.5.1229	0006-3363	Biology of Reproduction	Prostaglandin Metabolism in the Ovine Corpus Luteum: Catabolism of Prostaglandin F2&#x03b1; (PGF2&#x03b1;) Coincides with Resistance of the Corpus Luteum to PGF2&#x03b1;	Silva	2000	4		
636	chr8	6748502	6763303	3500130264	42		6748502	6763303	8421504	2	21,21	0,14780	c,g	350013026400000001,350013026400000001,350013026400000000,350013026400000000	0-21,0-21,0-21,0-21						Prostaglandin Metabolism in the Ovine Corpus Luteum: MATERIALS AND METHODS | Medical Help Online	l-help-online.com	0	0		
636	chr8	6762887	6763303	3500187783	147		6762887	6763303	8421504	2	54,93	0,323	p	350018778300015053	66-213						Oxford_SGC_Clones_web	www.docstoc.com	0	0		HPGD
639	chr8	7092450	7092473	3500036664	23		7092450	7092473	8421504	1	23	0	g	350003666400000024,350003666400000082	0-23,0-23						Ex Vivo Progenitor and Stem Cell Expansion and Differentiation for Use in the Treatment of Disease of the Nervous System - Patent application	www.faqs.org	0	0		GLRA3
641	chr8	7438656	7442508	3500050172	216		7438656	7442508	8421504	5	60,51,28,2,75	0,1308,3144,3769,3777	p	350005017200015021,350005017200015006,350005017200015061,350005017200015066	0-60,0-51,75-159,0-45						NAOSITE: Nagasaki University's Academic Output SITE	.nagasaki-u.ac.jp	0	0		
641	chr8	7438677	7438702	3500058609	25		7438677	7438702	8421504	1	25	0	c	350005860900000024	22-47						Supporting Information	www.pnas.org	0	0		CTSB
641	chr8	7439958	7440024	3500221496	66		7439958	7440024	8421504	1	66	0	p	350022149600015000	0-66		18959767	10.1111/j.1742-4658.2008.06674.x	1742-4658	FEBS Journal	Purification and characterization of cathepsin&#xa0;B-like cysteine protease from cotyledons of daikon radish, Raphanus&#xa0;sativus - Tsuji - 2008 - FEBS Journal - Wiley Online Library	Tsuji	2008	0		CTSB
641	chr8	7440526	7440549	3500426288	23		7440526	7440549	8421504	1	23	0	c	350042628800000021	0-23						Entwicklung muriner cDNA-Arrays zur Bestimmung der Proteinase-Expression arthritischer Fibroblasten im Modell der Antigen-induzierten Arthritis	.db-thueringen.de	0	0		
641	chr8	7456337	7460383	3500444872	25		7456337	7460383	8421504	2	14,11	0,4035	c	350044487200000002	0-25		18083912	10.1124/jpet.107.132217	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Inhibition of Geranylgeranyl Diphosphate Synthase Induces Apoptosis through Multiple Mechanisms and Displays Synergy with Inhibition of Other Isoprenoid Biosynthetic Enzymes	Dudakovic	2008	0		
641	chr8	7456337	7460383	3500401695	25		7456337	7460383	8421504	2	14,11	0,4035	c	350040169500000002	0-25						Geranylgeranyl diphosphate synthase as a novel cancer therapeutic target	ir.uiowa.edu	0	0		
642	chr8	7500541	7507388	3500354445	38		7500541	7507388	8421504	2	19,19	0,6828	c,g	350035444500000021,350035444500000021,350035444500000020,350035444500000020	0-19,0-19,4-23,4-23						Isolation and characterization of EG-like cells from Chinese swamp buffalo (Bubalus bubalis)	B	2007	0		
642	chr8	7500577	7500600	3500304799	23		7500577	7500600	8421504	1	23	0	c	350030479900000084	4-27						www.stemcell8.cn &#x2190;&#x70b9;&#x51fb;&#x8fdb;&#x5165;	www.bjcancer.org	0	0		GATA4
642	chr8	7503822	7503847	3500306730	25		7503822	7503847	8421504	1	25	0	c	350030673000000010	21-46						Method for inducing differentiation of embryonic stem cells into functioning cells	Inoue	2002	0		
642	chr8	7503822	7503847	3500220080	25		7503822	7503847	8421504	1	25	0	c	350022008000000010	21-46						Method for inducing differentiation of embryonic stem cells	Inoue	2003	0		
642	chr8	7503823	7503847	3500135205	24		7503823	7503847	8421504	1	24	0	c	350013520500000005	0-24						Universit&#xe0; degli Studi di Trieste	enstarts.units.it	0	0		
642	chr8	7503832	7546443	3500452614	42		7503832	7546443	8421504	3	20,18,4	0,3611,42607	c,g	350045261400000001,350045261400000001,350045261400000000	0-20,0-20,4-26		12668514	10.1161/01.CIR.0000064899.53876.A3	0009-7322	Circulation	Ascorbic Acid Enhances Differentiation of Embryonic Stem Cells Into Cardiac Myocytes	Takahashi	2003	15		
642	chr8	7506218	7507430	3500257451	40		7506218	7507430	8421504	2	20,20	0,1192	c	350025745100000096,350025745100000095	0-20,0-20						METHOD FOR IDENTIFYING THERAPEUTICAL TARGETS IN SECONDARY TUMORS, THE USE OF THEREOF AND MEANS FOR IDENTIFYING, LABELLING AND TARGETING SECONDARY TUMORS - Patent application	www.faqs.org	0	0		GATA4
642	chr8	7507323	7546452	3500417716	44		7507323	7546452	8421504	3	21,10,13	0,128,39116	c	350041771600000010,350041771600000009	0-21,0-23						Interaction of Wnt/ Early Stage of Cardiac Differentiation of P19CL6 Cells	icine.bjmu.edu.cn	0	0		GATA4
642	chr8	7507344	7507368	3500293877	24		7507344	7507368	8421504	1	24	0	c	350029387700000002	0-24						Hypermethylation of GATA-4 and GATA-5 Transcription Factor Genes in Cancer - Patent application	www.faqs.org	0	0		
642	chr8	7507441	7546442	3500057666	23		7507441	7546442	8421504	2	20,3	0,38998	c	350005766600000000	4-27						Cyclic adenosine 3prime,5prime-monophosphate induces differentiation of mouse embryonic stem cells into cardiomyocytes	Y	2006	0		
642	chr8	7591147	7591175	3500062826	28		7591147	7591175	8421504	1	28	0	g	350006282600000012	5-33		15987774	10.1242/dev.01913	0950-1991	Development	Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element	Rojas	2005	7		
644	chr8	7791464	7791488	3500305520	23		7791464	7791488	8421504	2	8,15	0,9	g	350030552000000017,350030552000000001,350030552000000016	2-25,0-22,0-22						Process for production of restrictocin	Fitton	1993	0		
644	chr8	7791464	7791488	3500252874	23		7791464	7791488	8421504	2	8,15	0,9	g	350025287400000006	0-23					Patent	Derivatives of human &#x03b1;.sub.1 -antitrypsin and process for their preparation (Patent US:6072029)	Courtney	2000	0		
644	chr8	7862883	7863711	3500338588	25		7862883	7863711	8421504	3	12,3,10	0,14,818	c	350033858800000027	8-33						US Patent # 6,498,024. Subtractive amplification kit useful in the diagnosis of genetic disease mutation or variation - Patents.com	www.patents.com	0	0		
644	chr8	7862883	7863711	3500208252	25		7862883	7863711	8421504	3	12,3,10	0,14,818	c	350020825200000027	8-33						Subtractive amplification kit useful in the diagnosis of genetic disease mutation or variation	Malek	1999	0		
645	chr8	7987148	7987174	3500179690	23		7987148	7987174	8421504	3	13,5,5	0,14,21	g	350017969000000152	20-43						 Osp A And B Sequence Of Borrelia Burgdonferi Strains ACA1 And IP90 	www.docstoc.com	0	0		XKR6
645	chr8	7987148	7987174	3500155608	23		7987148	7987174	8421504	3	13,5,5	0,14,21	g	350015560800000153	20-43						Borrelia burdorferi Osp A and B proteins and immunogenic peptides	Barbour	1995	0		
648	chr8	8271793	8271818	3500008756	25		8271793	8271818	8421504	1	25	0	g	350000875600000383	11-42						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		MTMR9
649	chr8	8448970	8448993	3500443593	23		8448970	8448993	8421504	1	23	0	g	350044359300000011	4-27						US Patent # 7,186,688. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2 - Patents.com	www.patents.com	0	0		
649	chr8	8448970	8448993	3500177118	23		8448970	8448993	8421504	1	23	0	g	350017711800000011	4-27						Vascular endothelial growth factor 2	Rosen	2008	0		
649	chr8	8453871	8453897	3500170547	23		8453871	8453897	8421504	2	11,12	0,14	c	350017054700000004	11-34						Methods of preventing or treating brain ischemia or brain injury - US Patent 7202211 Description	ww.patentstorm.us	0	0		
651	chr8	8665762	8665822	3500404422	60		8665762	8665822	8421504	1	60	0	g	350040442200000012	0-60						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		MSRA
652	chr8	8783644	8783667	3500156893	23		8783644	8783667	8421504	1	23	0	g	350015689300000001	19-42						Novel genes encoding protein kinase/protein phosphatase	Ota	2005	0		
652	chr8	8790615	8889982	3500404422	768		8790615	8889982	8421504	3	540,225,3	0,541,99364	p,c,g	350040442200000018,350040442200000017,350040442200000017,350040442200000004,350040442200015023	0-589,0-60,0-60,0-32,0-165						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		
652	chr8	8791219	8791258	3500315118	39		8791219	8791258	8421504	1	39	0	c,g	350031511800000001,350031511800000001	0-39,0-39		11867705	10.1073/pnas.032671199	0027-8424	Proceedings of the National Academy of Sciences	High-quality life extension by the enzyme peptide methionine sulfoxide reductase	Ruan	2002	10		
652	chr8	8791219	8791258	3500262378	39		8791219	8791258	8421504	1	39	0	c	350026237800000001	0-39			10.1073/pnas.032671199		Proceedings of the National Academy of Sciences of the United States of America	High-quality life extension by the enzyme peptide methionine sulfoxide reductase	Hongyu	2002	0		
652	chr8	8791262	8889980	3500404422	120		8791262	8889980	8421504	2	119,1	0,98717	c,g	350040442200000016,350040442200000016,350040442200000015	0-60,0-60,0-60						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		
652	chr8	8791330	8791381	3500404422	51		8791330	8791381	8421504	1	51	0	p	350040442200015015,350040442200015003	0-51,0-45						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		
81	chr8	8889980	8976031	3500404422	267		8889980	8976031	8421504	3	112,121,34	0,62830,86017	p,c,g	350040442200000014,350040442200000014,350040442200015022,350040442200015014	0-60,0-60,0-540,0-54						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		
652	chr8	8890000	8890092	3500404422	92		8890000	8890092	8421504	1	92	0	p,c	350040442200015004,350040442200015013,350040442200000013	0-48,7-57,8-60						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		
81	chr8	8952810	9181604	3500404422	209		8952810	9181604	8421504	3	121,69,19	0,23187,228775	p,c,g	350040442200015011,350040442200000011,350040442200000011,350040442200015005,350040442200015010,350040442200000010,350040442200000010,350040442200015009,350040442200000009,350040442200015008	0-29,0-30,0-30,0-60,0-57,0-60,0-60,0-45,0-60,0-60						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		
81	chr8	8976026	9181605	3500404422	60		8976026	9181605	8421504	2	40,20	0,205559	c	350040442200000008	0-60						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		
81	chr8	8976031	9181785	3500404422	235		8976031	9181785	8421504	2	35,200	0,205554	p,c	350040442200015020,350040442200015007,350040442200000007,350040442200015006,350040442200000006,350040442200015018	0-87,0-57,0-60,0-54,0-120,0-51						Cloning and Expression of a Mammalian Gene Involved in the Reduction of Methionine Sulfoxide Residues in Proteins	www.jstor.org	0	0		
656	chr8	9339706	9339733	3500182786	24		9339706	9339733	8421504	2	7,17	0,10	g	350018278600000070	1-25						Screening and Treatment Methods Using IGS5 Enzymes of the Metalloprotease Family - Patent application	www.faqs.org	0	0		
658	chr8	9594154	9594179	3500260877	23		9594154	9594179	8421504	2	17,6	0,19	g	350026087700000047	17-40					Patent	Methods of identifying inhibitors of sensor histidine kinases through rational drug design (Patent US:6162627)	Ikura	2000	0		
658	chr8	9594154	9594179	3500022529	23		9594154	9594179	8421504	2	17,6	0,19	g	350002252900000047	17-40						Methods of identifying inhibitors of sensor histidine kinases through rational drug design	Inouye	1998	0		
661	chr8	10054587	10054614	3500271876	25		10054587	10054614	8421504	2	10,15	0,12	g	350027187600000000	1-27		19801545	10.1074/jbc.M109.036087		The Journal of Biological Chemistry	A Human Germ Line Antibody Light Chain with Hydrolytic Properties Associated with Multimerization Status	Vikram	2009	0		
661	chr8	10054625	10054650	3500341622	23		10054625	10054650	8421504	2	17,6	0,19	c	350034162200000000	9-32		15998640	10.1074/jbc.M505159200	0021-9258	Journal of Biological Chemistry	The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease	Robinson	2005	5		
82	chr8	10189639	10228038	3500239118	98		10189639	10228038	8421504	3	51,25,22	0,38086,38377	p,c	350023911800015001,350023911800000001,350023911800000000	0-51,0-25,0-22		18212053	10.1128/MCB.01780-07	0270-7306	Molecular and Cellular Biology	Wnt-3a and Dickkopf-1 Stimulate Neurite Outgrowth in Ewing Tumor Cells via a Frizzled3- and c-Jun N-Terminal Kinase-Dependent Mechanism	Endo	2008	6		FZD3
663	chr8	10268184	10268209	3500249196	25		10268184	10268209	8421504	1	25	0	c	350024919600000008	0-25						Method for treating synovial sarcoma	Toyomasa	2004	0		
663	chr8	10314190	10314213	3500374909	23		10314190	10314213	8421504	1	23	0	c	350037490900000357	12-35						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
664	chr8	10418500	10418599	3500091014	99		10418500	10418599	8421504	1	99	0	p	350009101400015010	0-99						Mol. Cell. Biol. doi:10.1128/MCB.02132-06 A unique DNA binding domain converts TCFs into strong Wnt effectors ACCEPTED	mcb.asm.org	0	0		ZNF395
664	chr8	10429078	10429129	3500444747	51		10429078	10429129	8421504	1	51	0	p	350044474700015005	0-51						NON-CYTOTOXIC PROTEIN CONJUGATES	Foster	2012	0		PNOC
664	chr8	10429078	10429129	3500423613	51		10429078	10429129	8421504	1	51	0	p	350042361300015000	0-51						Non-Cytotoxic Protein Conjugates	Foster	2008	0		PNOC
664	chr8	10429078	10429129	3500416678	51		10429078	10429129	8421504	1	51	0	p	350041667800015001	0-51					Patent	Non-cytotoxic protein conjugates (Patent US:8187834)	Foster	2012	0		PNOC
664	chr8	10429078	10429129	3500414872	51		10429078	10429129	8421504	1	51	0	p	350041487200015003	0-51						Orphanin FQ receptor nucleic acids	Owyang	2002	0		PNOC
664	chr8	10429078	10429129	3500384310	51		10429078	10429129	8421504	1	51	0	p	350038431000015100	0-51						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		PNOC
664	chr8	10429078	10429129	3500376680	51		10429078	10429129	8421504	1	51	0	p	350037668000015020	0-51						Opioid receptor agonist fusion proteins	Bell	2008	0		PNOC
664	chr8	10429078	10429129	3500339885	51		10429078	10429129	8421504	1	51	0	p	350033988500015001	0-51						Non-cytotoxic Protein Conjugates 	.freshpatents.com	0	0		PNOC
664	chr8	10429078	10429129	3500326482	51		10429078	10429129	8421504	1	51	0	p	350032648200015003	0-51						Orphanin FQ receptor	Owyang	2004	0		PNOC
664	chr8	10429078	10429129	3500269711	51		10429078	10429129	8421504	1	51	0	p	350026971100015000	0-51					Patent	Opioid antagonists and methods of their use (Patent US:5821219)	Grandy	1998	0		PNOC
664	chr8	10429078	10429129	3500231353	51		10429078	10429129	8421504	1	51	0	p	350023135300015010	0-51						Non-cytotoxic protein conjugates	Foster	2011	0		PNOC
664	chr8	10429078	10429129	3500213466	51		10429078	10429129	8421504	1	51	0	p	350021346600015000	0-51					Patent	Non-cytotoxic protein conjugates (Patent US:7658933)	Foster	2010	0		PNOC
664	chr8	10429078	10429129	3500182431	51		10429078	10429129	8421504	1	51	0	p	350018243100015000	0-51						Non-cytotoxic protein conjugates	Foster	2011	0		PNOC
664	chr8	10429078	10429129	3500151424	51		10429078	10429129	8421504	1	51	0	p	350015142400015000	0-51						Opioid antagonists and methods of their use	Grandy	1995	0		PNOC
664	chr8	10429078	10429129	3500142325	51		10429078	10429129	8421504	1	51	0	p	350014232500015049	0-51						Template for Electronic Submission to ACS Journals	esups.ups-tlse.fr	0	0		PNOC
664	chr8	10429078	10429129	3500072826	51		10429078	10429129	8421504	1	51	0	p	350007282600015020	0-51						Opioid receptor agonist fusion proteins	Bell	2008	0		PNOC
664	chr8	10429078	10429129	3500028030	51		10429078	10429129	8421504	1	51	0	p	350002803000015005	0-51						Novel polypeptide and dna thereof	Hinuma	2003	0		PNOC
664	chr8	10429078	10429129	3500008524	51		10429078	10429129	8421504	1	51	0	p	350000852400015001	0-51						NON-CYTOTOXIC PROTEIN CONJUGATES - Patent application	www.faqs.org	0	0		PNOC
664	chr8	10429078	10429129	3500000057	51		10429078	10429129	8421504	1	51	0	p	350000005700015014	0-51						TREATMENT OF PAIN THROUGH EXPRESSION OF OPIOID RECEPTORS	Kyrkanides	2007	0		PNOC
664	chr8	10429081	10429183	3500214615	102		10429081	10429183	8421504	1	102	0	p	350021461500015124,350021461500015155,350021461500015159,350021461500015162,350021461500015123,350021461500015156	0-48,0-48,0-48,0-48,0-48,0-48						Secretory Or Membrane-binding Chimeric Protein 	.freshpatents.com	0	0		
666	chr8	10671685	10673730	3500004516	48		10671685	10673730	8421504	2	27,21	0,2024	p	350000451600015002	0-48		18996918	10.1093/hmg/ddn375		Human Molecular Genetics	Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration	Claire	2009	0		ELP3
667	chr8	10806891	10806916	3500302606	23		10806891	10806916	8421504	2	8,15	0,10	g	350030260600000004	14-40						Requirement for Both Shc and Phosphatidylinositol 3&#x2032; Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis - ResearchGate	.researchgate.net	0	0		
672	chr8	11430639	11430662	3500030382	23		11430639	11430662	8421504	1	23	0	g	350003038200000000	2-30						Polypeptides Having Cellobiohydrolase Activity And Polynucleotides Encoding Same	Maiyuran	2012	0		
673	chr8	11591731	11592044	3500375699	312		11591731	11592044	8421504	2	29,283	0,30	c	350037569900000031	12-324						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
674	chr8	11670922	11670947	3500133203	25		11670922	11670947	8421504	1	25	0	c	350013320300000191	0-25						[tel-00521428, v1] &#xc9;tude des voies de conduction cardiaque : identification des g&#xe8;nes sp&#xe9;cifiquement exprim&#xe9;s et impliqu&#xe9;s dans des troubles de conduction	hives-ouvertes.fr	0	0		
685	chr8	13109788	13109812	3500463282	24		13109788	13109812	8421504	1	24	0	g	350046328200000023	6-30						CUSTOM MICROARRAY ANALYSIS PIPELINE Perl scripts and file formats	theileria.org	0	0		
702	chr8	15351085	15351111	3500360661	23		15351085	15351111	8421504	2	11,12	0,14	g	350036066100000014	7-30						 Isoprenoid Biosynthesis 	www.docstoc.com	0	0		
704	chr8	15700218	15700243	3500019190	24		15700218	15700243	8421504	2	10,14	0,11	g	350001919000000042	21-45						Complexes comprising truncated CMV gH polypeptides and escort proteins	Spaete	1995	0		
705	chr8	15733125	15733153	3500059115	23		15733125	15733153	8421504	2	14,9	0,19	g	350005911500000117	0-23						genomic sequences and methods of their use - US Patent 7612192 Description	ww.patentstorm.us	0	0		
710	chr8	16496443	16496469	3500148780	23		16496443	16496469	8421504	2	14,9	0,17	g	350014878000000009	6-29						Materials and Methods Useful for Affecting Tumor Cell Growth, Migration and Invasion - Patent application	www.faqs.org	0	0		
711	chr8	16643266	16643296	3500019816	23		16643266	16643296	8421504	3	5,6,12	0,7,18	g	350001981600000059	0-23						Methods for producing members of specific binding pairs	McCafferty	2009	0		
713	chr8	16846799	16846827	3500090793	25		16846799	16846827	8421504	2	11,14	0,14	g	350009079300000007	6-31						Streptococcus pyogenes antigens and corresponding dna fragments	Martin	2013	0		
715	chr8	17110287	17110311	3500068063	23		17110287	17110311	8421504	2	4,19	0,5	g	350006806300000049	17-40						MICROBIAL SYNTHESIS OF D-1,2,4-BUTANETRIOL - Patent application	www.faqs.org	0	0		
715	chr8	17115708	17116119	3500106438	48		17115708	17116119	8421504	2	26,22	0,389	c	350010643800000028,350010643800000020	0-26,26-48						 Interferon 	www.docstoc.com	0	0		
716	chr8	17249958	17249999	3500276755	35		17249958	17249999	8421504	3	7,14,14	0,10,27	g	350027675500000069	5-41						HCV e1e2 vaccine compositions	M*Hao Dun 	2005	0		
718	chr8	17476581	17476604	3500311837	23		17476581	17476604	8421504	1	23	0	g	350031183700000036	11-34						Adjuvant compositions - Patent application	www.faqs.org	0	0		
718	chr8	17477837	17524747	3500149367	336		17477837	17524747	8421504	9	48,48,48,11,37,5,43,48,48	0,12309,26231,30943,32608,38936,40057,46766,46862	p,c	350014936700015122,350014936700000040,350014936700000031,350014936700000023,350014936700000014,350014936700000010,350014936700000008	0-48,0-48,0-48,0-48,0-48,0-48,0-48						Method For Treating Ischemic Diseases 	freshpatents.com	0	0		
718	chr8	17477838	17524675	3500348580	415		17477838	17524675	8421504	10	32,38,96,19,10,42,45,41,44,48	0,5434,5490,7374,9854,12233,19313,33412,40076,46789	c	350034858000000316,350034858000000376,350034858000000308,350034858000000367,350034858000000306,350034858000000366,350034858000000301,350034858000000292,350034858000000284,350034858000000270,350034858000000264,350034858000000260	0-20,0-32,0-38,0-45,0-45,0-48,15-44,0-42,0-45,0-41,0-44,0-48						US Patent # 7,226,755. HPTPbeta as a target in treatment of angiogenesis mediated disorders - Patents.com	www.patents.com	0	0		
718	chr8	17478536	17478612	3500365673	40		17478536	17478612	8421504	2	20,20	0,56	c,g	350036567300000025,350036567300000025,350036567300000024	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
718	chr8	17478536	17478612	3500262357	40		17478536	17478612	8421504	2	20,20	0,56	c,g	350026235700000025,350026235700000025,350026235700000024	0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
718	chr8	17480702	17524654	3500245265	230		17480702	17524654	8421504	5	68,42,29,44,47	0,7135,25554,35934,43905	c	350024526500000053,350024526500000052,350024526500000041,350024526500000024,350024526500000012,350024526500000005	0-26,6-48,6-48,0-29,0-44,0-47						US Patent # 5,466,596. Tissue specific transcriptional regulatory element - Patents.com	www.patents.com	0	0		
718	chr8	17480702	17506285	3500346733	55		17480702	17506285	8421504	2	26,29	0,25554	c	350034673300000053,350034673300000024	0-26,0-29						Tissue specific transcriptional regulatory element	Breitman	1992	0		
718	chr8	17481710	17481737	3500139063	24		17481710	17481737	8421504	2	12,12	0,15	g	350013906300000061	5-29						Expression cassettes for seed-preferential expression in plants	Duwenig	2009	0		
718	chr8	17483316	17524627	3500150372	279		17483316	17524627	8421504	6	108,19,10,47,47,48	0,1896,4376,27934,34598,41263	c	350015037200000307,350015037200000306,350015037200000366,350015037200000301,350015037200000270,350015037200000264,350015037200000261	0-48,0-48,0-48,15-44,0-47,0-47,0-48						Hptpbeta As A Target In Treatment Of Angiogenesis Mediated Disorders 	.freshpatents.com	0	0		
89	chr8	17483355	17569291	3500219888	87		17483355	17569291	8421504	4	22,22,22,21	0,13803,41173,85915	c	350021988800000185,350021988800000154,350021988800000177,350021988800000164,350021988800000183	0-22,0-21,0-22,0-22,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404831)	Natt	2013	0		
89	chr8	17483355	17569291	3500219703	87		17483355	17569291	8421504	4	22,22,22,21	0,13803,41173,85915	c	350021970300000185,350021970300000154,350021970300000177,350021970300000164,350021970300000183	0-22,0-21,0-22,0-22,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8344128)	Natt	2013	0		
89	chr8	17483355	17569291	3500094640	43		17483355	17569291	8421504	2	22,21	0,85915	c	350009464000000185,350009464000000183	0-22,0-21						SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION	Natt	2010	0		
89	chr8	17483355	17569291	3500085091	130		17483355	17569291	8421504	6	22,22,22,21,22,21	0,6822,13803,27091,41173,85915	c,g	350008509100000185,350008509100000154,350008509100000182,350008509100000177,350008509100000156,350008509100000156,350008509100000164,350008509100000164,350008509100000183	0-22,0-21,19-41,0-22,0-21,0-21,0-22,0-22,0-21						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
89	chr8	17483355	17569291	3500084904	108		17483355	17569291	8421504	5	22,22,21,22,21	0,13803,27091,41173,85915	c,g	350008490400000185,350008490400000154,350008490400000177,350008490400000156,350008490400000164,350008490400000164,350008490400000183	0-22,0-21,0-22,0-21,0-22,0-22,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404832)	Natt	2013	0		
718	chr8	17483364	17524723	3500186204	345		17483364	17524723	8421504	8	60,48,47,28,19,47,48,48	0,6806,27886,33386,34530,34550,41215,41311	c	350018620400000306,350018620400000366,350018620400000290,350018620400000270,350018620400000265,350018620400000264,350018620400000261,350018620400000259	0-48,0-48,0-48,0-47,0-47,0-47,0-48,0-48						HEPTbeta AS A TARGET IN TREATMENT OF ANGIOGENISIS MEDIATED DISORDERS - Patent application	www.faqs.org	0	0		
718	chr8	17487822	17487849	3500361105	27		17487822	17487849	8421504	1	27	0	c	350036110500000002	0-27		15548727	10.1152/ajpheart.00410.2004		American Journal of Physiology - Heart and Circulatory Physiology	Stretch induces upregulation of key tyrosine kinase receptors in microvascular endothelial cells	Zheng	2004	0		
89	chr8	17490177	17569291	3500105842	43		17490177	17569291	8421504	2	22,21	0,79093	c,g	350010584200000182,350010584200000183,350010584200000183	19-41,0-21,0-21						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
89	chr8	17490178	17569291	3500096737	63		17490178	17569291	8421504	3	21,21,21	0,20268,79092	c	350009673700000182,350009673700000156,350009673700000183	0-21,0-21,0-21						Short Interfering Ribonucleic Acid (siRNA) for Oral Administration	Billy	2012	0		
718	chr8	17494873	17497172	3500453109	41		17494873	17497172	8421504	2	20,21	0,2278	c,g	350045310900000029,350045310900000028	0-20,0-21						Expression von lokalen Regulationsfaktoren im Ovar des Schweins	b.uni-muenchen.de	0	0		
718	chr8	17504044	17524675	3500208888	239		17504044	17524675	8421504	7	48,5,28,19,39,52,48	0,6483,12706,13850,13922,20483,20583	c	350020888800000028,350020888800000009,350020888800000011,350020888800000007	0-48,0-116,0-47,0-48						Tyrosine kinase	Ziegler	1994	0		
718	chr8	17508690	17511276	3500156101	77		17508690	17511276	8421504	2	36,41	0,2545	c	350015610100000025,350015610100000020	9-45,0-41						US Patent # 5,681,714. Nucleic acid encoding tek receptor tyrosine kinase - Patents.com	www.patents.com	0	0		
89	chr8	17510446	17569291	3500133622	42		17510446	17569291	8421504	2	21,21	0,58824	c,g	350013362200000156,350013362200000183,350013362200000183	0-21,0-21,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404832)	Natt	2013	0		
89	chr8	17510446	17569291	3500083334	42		17510446	17569291	8421504	2	21,21	0,58824	c	350008333400000156,350008333400000183	0-21,0-21					Patent	Short interfering ribonucleic acid (siRNA) with improved pharmacological properties (Patent US:8084600)	Billy	2011	0		
718	chr8	17511347	17524705	3500319739	44		17511347	17524705	8421504	3	18,4,22	0,5278,13336	c,g	350031973900000003,350031973900000002,350031973900000002	0-22,0-22,0-22		12388336	10.1152/ajplung.00202.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	Characterization of CD34+ cells isolated from human fetal lung	Acarregui	2003	0		TEK
718	chr8	17511347	17524705	3500311596	44		17511347	17524705	8421504	3	18,4,22	0,5278,13336	c	350031159600000003,350031159600000002	0-22,0-22		12388336	10.1152/ajplung.00202.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	Characterization of CD34+ cells isolated from human fetal lung	Acarregui	2003	0		TEK
718	chr8	17511347	17524705	3500067080	44		17511347	17524705	8421504	3	18,4,22	0,5278,13336	c,g	350006708000000003,350006708000000002,350006708000000002	0-22,0-22,0-22		12388336	10.1152/ajplung.00202.2002		American Journal of Physiology - Lung Cellular and Molecular Physiology	Characterization of CD34+ cells isolated from human fetal lung	Acarregui	2003	0		TEK
718	chr8	17516653	17524572	3500058319	43		17516653	17524572	8421504	2	21,22	0,7897	c,g	350005831900000001,350005831900000001,350005831900000000,350005831900000000	1-22,1-22,0-22,0-22						Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins	cs.biologists.org	0	0		
89	chr8	17524528	17569291	3500292931	43		17524528	17569291	8421504	2	22,21	0,44742	c	350029293100000164,350029293100000183	0-22,0-21					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent EP:2135950)	NATT	2012	0		
718	chr8	17524570	17524595	3500308604	25		17524570	17524595	8421504	1	25	0	c	350030860400000004	0-25						Targeting tumor vasculature	edoc.unibas.ch	0	0		
719	chr8	17569215	17569239	3500424636	24		17569215	17569239	8421504	1	24	0	c	350042463600000016	0-24						KURENAI : Kyoto University Research Information Repository	lib.kyoto-u.ac.jp	0	0		TEK
719	chr8	17569215	17569239	3500263297	24		17569215	17569239	8421504	1	24	0	c	350026329700000005	0-24		18552213	10.1182/blood-2007-12-127480	0006-4971	Blood	Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression	Zhu	2008	10		TEK
719	chr8	17687687	17687756	3500273253	69		17687687	17687756	8421504	1	69	0	p	350027325300015009	0-69						Supplementary Materials for	ww.sciencemag.org	0	0		
739	chr8	20237598	20237625	3500298504	23		20237598	20237625	8421504	2	17,6	0,21	c	350029850400000326	20-43						Streptococcal heat shock proteins members of the HSP70 family	J*Ha Mei Er 	1998	0		
744	chr8	20919952	20919977	3500155900	25		20919952	20919977	8421504	1	25	0	g	350015590000000518	18-46						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
745	chr8	21093094	21093118	3500341606	24		21093094	21093118	8421504	1	24	0	g	350034160600000001	0-32						Genes from the 20Q13 amplicon and their uses	Gray	1996	0		
747	chr8	21274783	21274811	3500100378	24		21274783	21274811	8421504	2	10,14	0,14	g	350010037800000064	17-41						Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4)	Antonaccio	1998	0		
757	chr8	22601733	22601758	3500441210	23		22601733	22601758	8421504	3	4,7,12	0,5,13	c	350044121000000003	0-25						Sequence Analysis of the Direct Repeat Region in Mycobacterium bovis	jcm.asm.org	0	0		
757	chr8	22601733	22601758	3500199058	23		22601733	22601758	8421504	3	4,7,12	0,5,13	c	350019905800000021	0-25						&#x0414;&#x0438;&#x0441;&#x0441;&#x0435;&#x0440;&#x0442;&#x0430;&#x0446;&#x0438;&#x044f; &#x043d;&#x0430; &#x0442;&#x0435;&#x043c;&#x0443; &#xab;&#x0413;&#x0435;&#x043d;&#x0435;&#x0442;&#x0438;&#x0447;&#x0435;&#x0441;&#x043a;&#x043e;&#x0435; &#x0440;&#x04	Mokrousov	2009	0		
760	chr8	22980946	22983240	3500192886	48		22980946	22983240	8421504	2	6,42	0,2252	p	350019288600015186	0-48						US Patent # 6,413,943. Methods and reagents for inhibiting proliferation of smooth muscle cells - Patents.com	www.patents.com	0	0		
760	chr8	22983285	22983348	3500040223	63		22983285	22983348	8421504	1	63	0	p	350004022300015001	0-63						Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells - Patent application	www.faqs.org	0	0		CDKN2A
761	chr8	23070237	23088130	3500355789	41		23070237	23088130	8421504	2	19,22	0,17871	g	350035578900000001,350035578900000000	0-19,0-22						Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma	dspace.unav.es	0	0		MTAP
764	chr8	23578337	23578360	3500364288	23		23578337	23578360	8421504	1	23	0	c	350036428800000038	21-44						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
764	chr8	23578447	23578471	3500229051	24		23578447	23578471	8421504	1	24	0	c	350022905100000009	0-24						Reprogramming of Human Somatic Cells Using Human and Animal Oocytes	advancedcell.com	0	0		
764	chr8	23578476	23579135	3500101157	59		23578476	23579135	8421504	3	20,20,19	0,38,640	c,g	350010115700000000,350010115700000002,350010115700000002,350010115700000001	0-20,5-25,5-25,0-19		19324401	10.1016/j.theriogenology.2009.01.017		Theriogenology	Expression of bovine interferon-tau variants according to sex and age of conceptuses	Angela	July	0		
95	chr8	23578514	23603553	3500066884	40		23578514	23603553	8421504	2	20,20	0,25019	c,g	350006688400000001,350006688400000000	0-20,0-20		10642558	10.1095/biolreprod62.2.235	0006-3363	Biology of Reproduction	Bovine Blastocyst-Derived Trophectoderm and Endoderm Cell Cultures: Interferon Tau and Transferrin Expression as Respective In Vitro Markers	Talbot	2000	4		
764	chr8	23578514	23591307	3500073604	40		23578514	23591307	8421504	2	20,20	0,12773	g	350007360400000015,350007360400000014	0-20,0-20						Changes in gene expression profiles of bovine embryos produced in vitro, by natural ovulation, or hormonal superstimulation	w.funpecrp.com.br	0	0		
764	chr8	23578514	23579098	3500434788	40		23578514	23579098	8421504	2	20,20	0,564	c,g	350043478800000001,350043478800000001,350043478800000000	0-20,0-20,0-20		12493719	10.1095/biolreprod.102.007799	0006-3363	Biology of Reproduction	Bovine Embryo Culture in the Presence or Absence of Serum: Implications for Blastocyst Development, Cryotolerance, and Messenger RNA Expression	Rizos	2003	4		
764	chr8	23578514	23579098	3500360677	40		23578514	23579098	8421504	2	20,20	0,564	c,g	350036067700000001,350036067700000001,350036067700000000	0-20,0-20,0-20						Bovine Embryo Culture in the Presence or Absence of Serum: Implications for Blastocyst Development, Cryotolerance, and Messenger RNA Expression	ww.biolreprod.org	0	0		
764	chr8	23578514	23579098	3500181711	40		23578514	23579098	8421504	2	20,20	0,564	c,g	350018171100000016,350018171100000016,350018171100000015	0-20,0-20,0-20						REPRODUCTION	uction-online.org	0	0		
764	chr8	23578514	23579098	3500113600	40		23578514	23579098	8421504	2	20,20	0,564	c,g	350011360000000001,350011360000000001,350011360000000000	0-20,0-20,0-20		12493719	10.1095/biolreprod.102.007799	0006-3363	Biology of Reproduction	Bovine Embryo Culture in the Presence or Absence of Serum: Implications for Blastocyst Development, Cryotolerance, and Messenger RNA Expression	Rizos	2003	4		
764	chr8	23578514	23579098	3500028009	42		23578514	23579098	8421504	2	22,20	0,564	c	350002800900000007,350002800900000006	0-22,0-20						Putative imprinted gene expression in uniparental bovine embryo models	library.uq.edu.au	0	0		
95	chr8	23578532	23603687	3500335697	66		23578532	23603687	8421504	3	20,23,23	0,826,25132	c,g	350033569700000001,350033569700000001,350033569700000016,350033569700000017	0-20,0-20,0-23,0-23						Down-regulation of Interferon Tau Gene Transcription With a Transcription Factor, EOMES. - ResearchGate	.researchgate.net	0	0		
764	chr8	23578532	23579135	3500413440	40		23578532	23579135	8421504	2	20,20	0,583	c	350041344000000033,350041344000000005,350041344000000032,350041344000000004	0-20,0-20,0-20,0-20						Embryo Implantation Inhibitor 	.freshpatents.com	0	0		
764	chr8	23578532	23579135	3500319127	40		23578532	23579135	8421504	2	20,20	0,583	c	350031912700000023,350031912700000022	0-20,0-20						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
764	chr8	23578536	23579130	3500068065	93		23578536	23579130	8421504	4	25,23,20,25	0,436,476,569	c	350006806500000027,350006806500000009,350006806500000008,350006806500000026	0-25,0-23,0-20,0-25						RESEARCH Open Access Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression	www.rbej.com	0	0		
764	chr8	23578716	23578871	3500047878	40		23578716	23578871	8421504	2	20,20	0,135	c,g	350004787800000055,350004787800000054	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
764	chr8	23578899	23578944	3500353032	44		23578899	23578944	8421504	2	20,24	0,21	c,g	350035303200000001,350035303200000001,350035303200000002	0-20,0-20,0-24						Effects of Polyunsaturated Fatty Acids and Bovine Somatotropin on Endocrine Function, Embryo Development, and Uterine-Conceptus Interactions in Dairy Cattle	ufdc.ufl.edu	0	0		
764	chr8	23578924	23578947	3500209988	23		23578924	23578947	8421504	1	23	0	c	350020998800000013	19-42						Maruotti MRD 2012 - ResearchGate	.researchgate.net	0	0		
95	chr8	23578946	23603317	3500402065	41		23578946	23603317	8421504	3	11,8,22	0,12,24349	c,g	350040206500000006,350040206500000007,350040206500000007	0-19,0-22,0-22		23638875	10.1111/aji.12131	1600-0897	American Journal of Reproductive Immunology	Heat Shock Induces Interferon-TAU Gene Expression by In Vitro-Produced Bovine Blastocysts - Hickman - 2013 - American Journal of Reproductive Immunology - Wiley Online Library	Hickman	2013	0		
95	chr8	23578972	23603016	3500020590	49		23578972	23603016	8421504	2	23,26	0,24018	c	350002059000000006,350002059000000018	21-44,25-51						Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression. - ResearchGate	.researchgate.net	0	0		
765	chr8	23602996	23603355	3500218393	48		23602996	23603355	8421504	2	24,24	0,335	c	350021839300000013,350021839300000012	0-24,0-24						Nuclear Transfer Protocol Affects Messenger RNA Expression Patterns in Cloned Bovine Blastocysts	ww.biolreprod.org	0	0		
765	chr8	23603117	23603143	3500450485	26		23603117	23603143	8421504	1	26	0	g	350045048500000002	58-84						Viable calves produced by somatic cell nuclear transfer using meiotic-blocked oocytes. - ResearchGate	.researchgate.net	0	0		
765	chr8	23603502	23603576	3500233640	45		23603502	23603576	8421504	2	22,23	0,51	c	350023364000000011,350023364000000010	0-22,0-23						Gene silencing during development of in vitro-produced female bovine embryos	w.funpecrp.com.br	0	0		
765	chr8	23603832	23603860	3500004062	24		23603832	23603860	8421504	3	5,6,13	0,6,15	c	350000406200000003	0-24		12771139	10.1074/jbc.M303932200	0021-9258	Journal of Biological Chemistry	Hox Proteins Functionally Cooperate with the GC Box-binding Protein System through Distinct Domains	Suzuki	2003	5		
95	chr8	23782405	23931086	3500429994	397		23782405	23931086	8421504	22	20,24,6,16,6,16,26,11,8,4,17,33,16,14,36,22,13,43,14,15,19,18	0,22,55,63,194,204,233,599,612,622,627,646,28661,28679,28703,81240,81273,81288,148602,148618,148636,148663	g	350042999400000007,350042999400000003	171-305,0-345						Bovine interferon alpha genes. Structure and expression. - ResearchGate	.researchgate.net	0	0		
766	chr8	23782592	23790587	3500231257	40		23782592	23790587	8421504	2	21,19	0,7976	c,g	350023125700000000,350023125700000001	0-21,0-19						Constitutive and Trophoblast-Specific Expression of a Class of Bovine Interferon Genes	www.jstor.org	0	0		
766	chr8	23790655	23790940	3500226462	138		23790655	23790940	8421504	3	45,48,45	0,48,240	p,c	350022646200015011,350022646200015019,350022646200000019,350022646200015036,350022646200015022	3-48,12-81,0-45,0-48,0-45						Orally-administered interferon-tau compositions and methods - US Patent 7214367 Description	ww.patentstorm.us	0	0		
766	chr8	23845558	23846063	3500226462	197		23845558	23846063	8421504	5	25,41,38,45,48	0,29,176,409,457	c	350022646200000022,350022646200000021,350022646200000018,350022646200000013,350022646200000012	0-25,0-41,0-38,0-45,0-48						Orally-administered interferon-tau compositions and methods - US Patent 7214367 Description	ww.patentstorm.us	0	0		
95	chr8	23846110	23863741	3500060499	66		23846110	23863741	8421504	3	22,22,22	0,17061,17609	c,g	350006049900000006,350006049900000001,350006049900000000,350006049900000000	0-22,0-22,0-22,0-22		23072335	10.1186/1471-2156-13-86	1471-2156	BMC Genetics	Gene number determination and genetic polymorphism of the gamma delta T cell co-receptor WC1 genes	Chen	2012	2		
767	chr8	23863240	23863263	3500104370	23		23863240	23863263	8421504	1	23	0	c	350010437000000003	0-23			10.1128/CDLI.10.6.1065-1073.2003	1556-6811	Clinical and Diagnostic Laboratory Immunology	CD56+-T-Cell Responses to Bacterial Superantigens and Immune Recognition of Attenuated Vaccines	Saikh	2003	3		IFNA10
767	chr8	23863279	23863399	3500365742	39		23863279	23863399	8421504	2	20,19	0,101	c,g	350036574200000004,350036574200000005,350036574200000005	0-20,0-19,0-19		21039923	10.1111/j.1574-695X.2010.00739.x	1574-695X	FEMS Immunology & Medical Microbiology	Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs - Siva Reddy - 2010 - FEMS Immunology & Medical Microbiology - Wiley Online Library	Siva	2010	0		
767	chr8	23930587	23930610	3500425534	23		23930587	23930610	8421504	1	23	0	c	350042553400000003	0-23			10.1128/CDLI.10.6.1065-1073.2003		Clinical and Diagnostic Laboratory Immunology	CD56+-T-Cell Responses to Bacterial Superantigens and Immune Recognition of Attenuated Vaccines	KamU.	2003	0		
768	chr8	24083873	24083899	3500201852	26		24083873	24083899	8421504	1	26	0	g	350020185200000539	0-26						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
768	chr8	24090102	24090130	3500099527	23		24090102	24090130	8421504	2	8,15	0,13	g	350009952700000219	10-42						HIV envelopolype peptides	Berman	2001	0		
769	chr8	24232898	24232922	3500229051	24		24232898	24232922	8421504	1	24	0	c	350022905100000008	0-24						Reprogramming of Human Somatic Cells Using Human and Animal Oocytes	advancedcell.com	0	0		
770	chr8	24273448	24307272	3500429994	197		24273448	24307272	8421504	5	72,69,15,18,23	0,201,33747,33772,33801	p,g	350042999400015008,350042999400015009,350042999400000004	0-72,6-75,0-66						Bovine interferon alpha genes. Structure and expression. - ResearchGate	.researchgate.net	0	0		
770	chr8	24273560	24273772	3500349767	43		24273560	24273772	8421504	2	21,22	0,190	c	350034976700000018,350034976700000019	0-21,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
770	chr8	24273720	24273760	3500155830	40		24273720	24273760	8421504	1	40	0	c	350015583000000036	5-45						Human leukocyte interferon Hu-IFN-&#x03b1;001	Pestka	1994	0		
770	chr8	24273748	24273771	3500204337	23		24273748	24273771	8421504	1	23	0	c	350020433700000004	23-46		22531919	10.1002/eji.201141657	1521-4141	European Journal of Immunology	MxA expression induced by &#x03b1;-defensin in healthy human periodontal tissue - Mahanonda - 2012 - European Journal of Immunology - Wiley Online Library	Mahanonda	2012	0		IFNA22P
770	chr8	24273752	24273776	3500233036	24		24273752	24273776	8421504	1	24	0	c	350023303600000002	25-49		20382888	10.4049/jimmunol.0903559		Journal of immunology (Baltimore, Md. : 1950)	A high throughput screening for TLR3-IRF3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors	Jianzhong	2010	0		
770	chr8	24332784	24332809	3500230330	23		24332784	24332809	8421504	2	16,7	0,18	g	350023033000000431	15-38						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
770	chr8	24351728	24351754	3500201852	26		24351728	24351754	8421504	1	26	0	c	350020185200000411	0-26						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
771	chr8	24400230	24400256	3500269382	23		24400230	24400256	8421504	2	18,5	0,21	g	350026938200000003	1-24		12147493	10.1128/AEM.68.8.3932-3942.2002	0099-2240	Applied and Environmental Microbiology	The Peptidyl-Prolyl Isomerase Motif Is Lacking in PmpA, the PrsA-Like Protein Involved in the Secretion Machinery of Lactococcus lactis	Drouault	2002	4		
773	chr8	24706375	24706940	3500017422	40		24706375	24706940	8421504	2	20,20	0,545	c	350001742200000002,350001742200000003	0-20,0-20		14671095	10.1128/JVI.78.1.136-145.2004	0022-538X	Journal of Virology	Role for Bovine Viral Diarrhea Virus Erns Glycoprotein in the Control of Activation of Beta Interferon by Double-Stranded RNA	Iqbal	2004	5		
773	chr8	24706690	24706714	3500448711	24		24706690	24706714	8421504	1	24	0	c	350044871100000002	11-35						Type I interferons	Chen	1998	0		
776	chr8	25138544	25138628	3500185291	84		25138544	25138628	8421504	1	84	0	c,g	350018529100000111,350018529100000110,350018529100000110	0-84,0-22,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR491
776	chr8	25138590	25138613	3500322980	23		25138590	25138613	8421504	1	23	0	c	350032298000000006	0-23						AD (Leave blank)	handle.dtic.mil	0	0		MIR491
776	chr8	25138590	25138613	3500114594	23		25138590	25138613	8421504	1	23	0	c	350011459400000908,350011459400000481	0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR491
776	chr8	25138590	25138613	3500031979	23		25138590	25138613	8421504	1	23	0	c	350003197900000396	0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR491
777	chr8	25236184	25237763	3500221122	180		25236184	25237763	8421504	2	12,168	0,1411	p	350022112200015023	0-180						&#x0395;&#x0398;&#x039d;&#x0399;&#x039a;&#x039f; &#x039c;&#x0395;&#x03a4;&#x03a3;&#x039f;&#x0392;&#x0399;&#x039f; &#x03a0;&#x039f;&#x039b;&#x03a5;&#x03a4;&#x0395;&#x03a7;&#x039d;&#x0395;&#x0399;&#x039f;	dbnet.ece.ntua.gr	0	0		MLLT3
778	chr8	25396823	25407601	3500221122	114		25396823	25407601	8421504	5	33,24,9,33,15	0,42,10694,10721,10763	p	350022112200015024	0-120						&#x0395;&#x0398;&#x039d;&#x0399;&#x039a;&#x039f; &#x039c;&#x0395;&#x03a4;&#x03a3;&#x039f;&#x0392;&#x0399;&#x039f; &#x03a0;&#x039f;&#x039b;&#x03a5;&#x03a4;&#x0395;&#x03a7;&#x039d;&#x0395;&#x0399;&#x039f;	dbnet.ece.ntua.gr	0	0		
779	chr8	25450942	25450968	3500171455	26		25450942	25450968	8421504	1	26	0	c	350017145500000317,350017145500000320,350017145500000318,350017145500000307,350017145500000301,350017145500000302,350017145500000313,350017145500000312,350017145500000311,350017145500000310,350017145500000308,350017145500000309,350017145500000298,350017145500000299	17-43,17-43,17-43,17-43,17-43,17-43,17-43,17-43,17-43,17-43,17-43,17-43,17-43,17-43						Dna diagnostics based on mass spectrometry	Braun	1998	0		
779	chr8	25450942	25450968	3500128303	26		25450942	25450968	8421504	1	26	0	c	350012830300000292	11-37						 DNA Diagnostics Based On Mass Spectrometry 	www.docstoc.com	0	0		
779	chr8	25500278	25502140	3500391901	31		25500278	25502140	8421504	2	28,3	0,1859	c,g	350039190100000001,350039190100000001,350039190100000003	0-21,0-21,0-19						Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles	-publications.com	0	0		MLLT3
779	chr8	25510734	25510764	3500155631	30		25510734	25510764	8421504	1	30	0	c	350015563100000001	0-30		15851483	10.1074/jbc.M412237200	0021-9258	Journal of Biological Chemistry	Multiple Mixed Lineage Leukemia (MLL) Fusion Proteins Suppress p53-mediated Response to DNA Damage	Wiederschain	2005	5		MLLT3
12	chr8	26197825	26245290	3500269673	40		26197825	26245290	8421504	3	19,3,18	0,24518,47447	c	350026967300000017,350026967300000059,350026967300000060,350026967300000018	0-19,0-19,0-21,0-21						Method of Screening for Compounds That Alter Skin and/or Hair Pigmentation - Patent application	www.faqs.org	0	0		SLC24A2
12	chr8	26197825	26245290	3500077237	40		26197825	26245290	8421504	3	19,3,18	0,24518,47447	c,g	350007723700000017,350007723700000017,350007723700000018	0-19,0-19,0-21						METHOD OF SCREENING FOR COMPOUNDS THAT ALTER SKIN AND/OR HAIR PIGMENTATION - UNILEVER N.V.	www.sumobrain.com	0	0		SLC24A2
12	chr8	26197825	26245290	3500064454	40		26197825	26245290	8421504	3	19,3,18	0,24518,47447	c,g	350006445400000017,350006445400000017,350006445400000018	0-19,0-19,0-21						Method of screening for compounds that alter skin and/or hair pigmentation	Filsell	2007	0		SLC24A2
12	chr8	26197825	26245290	3500063444	61		26197825	26245290	8421504	4	19,3,21,18	0,24518,26706,47447	c,g	350006344400000017,350006344400000017,350006344400000062,350006344400000062,350006344400000018,350006344400000063,350006344400000059	0-19,0-19,0-19,0-19,0-21,0-21,3-24						SCREENING METHODS - Patent application	www.faqs.org	0	0		
785	chr8	26245336	26245362	3500326924	24		26245336	26245362	8421504	2	9,15	0,11	c,g	350032692400000227,350032692400000227	14-46,14-46						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
786	chr8	26357017	26357040	3500395599	23		26357017	26357040	8421504	1	23	0	g	350039559900000038	1-24						GENES FROM THE 20Q13 AMPLICON AND THEIR USES - Patent application	www.faqs.org	0	0		
787	chr8	26596631	26598491	3500198723	43		26596631	26598491	8421504	2	21,22	0,1838	c,g	350019872300000004,350019872300000004,350019872300000005,350019872300000005	0-21,0-21,0-22,0-22						Technical note: Determination of cell-specific gene expression in bovine skeletal muscle tissue using laser microdissection and reverse-transcription quantitative polymerase chain reaction	animalscience.org	0	0		
787	chr8	26596644	26596725	3500301078	41		26596644	26596725	8421504	2	21,20	0,61	c,g	350030107800000033,350030107800000033,350030107800000034	0-21,0-21,0-20						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
787	chr8	26599493	26603380	3500003486	173		26599493	26603380	8421504	6	36,22,29,27,21,38	0,1243,2456,2525,3801,3849	c	350000348600000357,350000348600000363,350000348600000336,350000348600000366,350000348600000339	0-36,1-23,0-29,0-48,0-38						Protein Targeting To Lipid Bodies - Patent application	www.faqs.org	0	0		
787	chr8	26599573	26603596	3500455309	40		26599573	26603596	8421504	2	20,20	0,4003	c,g	350045530900000000,350045530900000000,350045530900000001,350045530900000001	0-20,0-20,0-20,0-20		23072373	10.1186/1476-511X-11-139		Lipids in Health and Disease	Lipopolysaccharide promotes lipid accumulation in human adventitial fibroblasts via TLR4-NF-&#x03ba;B pathway	Jun	2012	0		PLIN2
787	chr8	26599573	26603596	3500174593	40		26599573	26603596	8421504	2	20,20	0,4003	c,g	350017459300000000,350017459300000001,350017459300000001	0-20,0-20,0-20		23072373	10.1186/1476-511X-11-139	1476-511X	Lipids in Health and Disease	Lipopolysaccharide promotes lipid accumulation in human adventitial fibroblasts via TLR4-NF-&#xce;&#xba;B pathway	Wang	2012	2		PLIN2
787	chr8	26602039	26603311	3500421561	23		26602039	26603311	8421504	2	6,17	0,1255	c	350042156100000002	0-23						Trans-10, cis-12 CLA increases adipocyte lipolysis and alters lipid droplet-associated proteins: role of mTOR and ERK signaling	www.jlr.org	0	0		PLIN2
787	chr8	26602039	26603311	3500115618	23		26602039	26603311	8421504	2	6,17	0,1255	c	350011561800000002	0-23						CHUNG, SOONKYU, Ph. D. Mechanisms by Which Conjugated Linoleic Acid Directed by Dr. Michael K. McIntosh. 151pp.	libres.uncg.edu	0	0		PLIN2
787	chr8	26603985	26604032	3500463464	47		26603985	26604032	8421504	1	47	0	c	350046346400000057	20-67						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
789	chr8	26765190	26765214	3500248193	23		26765190	26765214	8421504	2	18,5	0,19	g	350024819300000049,350024819300000019	11-36,11-36						ISOLATED STAPHYLOCOCCUS DNAX SUBUNIT AND USE THEREOF - Patent application	www.faqs.org	0	0		
789	chr8	26784634	26784659	3500343610	24		26784634	26784659	8421504	2	5,19	0,6	c	350034361000000013	20-44						US Patent # 7,354,726. Screening method - Patents.com	www.patents.com	0	0		
789	chr8	26785095	26785119	3500434768	23		26785095	26785119	8421504	2	6,17	0,7	c	350043476800000003	10-33		9786920	10.1074/jbc.273.44.29118	0021-9258	Journal of Biological Chemistry	Differential Regulation of Multiple Glucose Transporter Genes in Leishmania mexicana	Burchmore	1998	5		PGPEP1
789	chr8	26785095	26785119	3500355933	23		26785095	26785119	8421504	2	6,17	0,7	c	350035593300000019	12-35			10.1128/JVI.78.18.9633-9644.2004		Journal of Virology	Autographa californica Multiple Nucleopolyhedrovirus exon0 (orf141), Which Encodes a RING Finger Protein, Is Required for Efficient Production of Budded Virus	Xiaojiang	2004	0		PGPEP1
789	chr8	26785095	26785119	3500190593	23		26785095	26785119	8421504	2	6,17	0,7	c	350019059300000083	13-36						Oligonucleotide probe and primers specific to bovine or porcine male genomic DNA	Silversides	1994	0		
799	chr8	28078580	28078611	3500206703	25		28078580	28078611	8421504	3	11,5,9	0,14,22	g	350020670300000005	10-35			10.1002/ijc.20366	1097-0215	International Journal of Cancer	Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients - Osman - 2004 - International Journal of Cancer - Wiley Online Library	Osman	2004	0		
12	chr8	28149246	28467671	3500173349	48		28149246	28467671	8421504	3	24,14,10	0,17264,318415	c	350017334900000001,350017334900000000	0-24,0-24		12606338	10.1095/biolreprod.102.012427	0006-3363	Biology of Reproduction	Receptor-Mediated Chicken Oocyte Growth: Differential Expression of Endophilin Isoforms in Developing Follicles	Hirayama	2003	4		
812	chr8	29781845	29781997	3500181711	39		29781845	29781997	8421504	2	20,19	0,133	g	350018171100000024,350018171100000025	0-20,0-19						REPRODUCTION	uction-online.org	0	0		
812	chr8	29781845	29781997	3500133737	39		29781845	29781997	8421504	2	20,19	0,133	g	350013373700000011,350013373700000012	0-20,0-19						REPRODUCTION	uction-online.org	0	0		
817	chr8	30516068	30517037	3500185382	39		30516068	30517037	8421504	3	26,5,8	0,664,961	c	350018538200000020,350018538200000019	23-63,0-40						Methods of using LEDGF/p75	Goldstein	2009	0		
817	chr8	30516068	30517037	3500091850	39		30516068	30517037	8421504	3	26,5,8	0,664,961	c	350009185000000020,350009185000000019	23-63,0-40					Patent	Compositions and methods for diagnosing tumors using LEDGF/p75 (Patent US:8168393)	Goldstein	2012	0		
817	chr8	30516743	30517026	3500055242	72		30516743	30517026	8421504	2	42,30	0,253	p	350005524200015000	3-75						Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium	www.pnas.org	0	0		PSIP1
817	chr8	30519661	30519684	3500301860	23		30519661	30519684	8421504	1	23	0	c	350030186000000011	21-44						Neuroblastoma cells can be classified according to glycosphingolipid expression profiles identified by liquid chromatography-tandem mass spectrometry	-publications.com	0	0		PSIP1
817	chr8	30519696	30519721	3500449061	25		30519696	30519721	8421504	1	25	0	c	350044906100000009	8-33		19609362	10.1371/journal.ppat.1000522	1553-7374	PLOS Pathogens	PLOS Pathogens: LEDGF/p75 Proteins with Alternative Chromatin Tethers Are Functional HIV-1 Cofactors	Meehan	2009	0		PSIP1
817	chr8	30519696	30519721	3500174961	25		30519696	30519721	8421504	1	25	0	c	350017496100000009	8-33		19609362	10.1371/journal.ppat.1000522		PLoS Pathogens	LEDGF/p75 Proteins with Alternative Chromatin Tethers Are Functional HIV-1 Cofactors	Anne	July	0		PSIP1
817	chr8	30519718	30519742	3500206660	24		30519718	30519742	8421504	1	24	0	c,g	350020666000000001,350020666000000001	8-32,8-32						Screening process for atopic dermatitis	Tan	2001	0		
821	chr8	31056691	31056721	3500362735	25		31056691	31056721	8421504	3	8,6,11	0,12,19	g	350036273500000260	10-44						Compositions containing nucleic acids and ligands for therapeutic treatment	Baird	1999	0		
821	chr8	31056691	31056721	3500155898	25		31056691	31056721	8421504	3	8,6,11	0,12,19	g	350015589800000139	10-44						Heparin-binding growth factors for gene therapy and anterior eye disorders	Sosnowski	1995	0		
822	chr8	31160804	31166513	3500431060	26		31160804	31166513	8421504	3	20,1,5	0,5701,5704	c	350043106000000086	4-30						Modified cytosine deaminases	Harris	2009	0		
822	chr8	31160804	31166513	3500354494	26		31160804	31166513	8421504	3	20,1,5	0,5701,5704	c	350035449400000086,350035449400000324,350035449400000325	4-30,3-29,4-30						Modified cytosine deaminases - Patent application	www.faqs.org	0	0		
822	chr8	31180926	31180951	3500253540	23		31180926	31180951	8421504	2	9,14	0,11	g	350025354000000033	2-25						Genetic studies on the biosynthesis of the major aminoglycoside antibiotics	.uni-wuppertal.de	0	0		
824	chr8	31355398	31355427	3500037028	23		31355398	31355427	8421504	3	5,6,12	0,6,17	g	350003702800000010,350003702800000007	0-25,0-25		16251283	10.1128/AAC.49.11.4455-4464.2005	0066-4804	Antimicrobial Agents and Chemotherapy	Fitness Cost Due to Mutations in the 16S rRNA Associated with Spectinomycin Resistance in Chlamydia psittaci 6BC	Binet	2005	5		
825	chr8	31519794	31519820	3500454666	23		31519794	31519820	8421504	2	17,6	0,20	g	350045466600000019	0-23						Methods of diagnosis and treatment - Patent application	www.faqs.org	0	0		
825	chr8	31549522	31549550	3500369129	23		31549522	31549550	8421504	2	15,8	0,20	g	350036912900000004	10-36						Asthma susceptibility locus	Kere	2005	0		
826	chr8	31602902	31602925	3500352220	23		31602902	31602925	8421504	1	23	0	c	350035222000000008	0-23						&#x201c;SAPIENZA&#x201d; UNIVERSITY OF ROME &#x201c;The Role of NFI-A in Hematopoietic Lineage Specification A Thesis by Linda Marie Starnes SUBMITTED TO THE DEPARTMENT OF HISTOLOGY AND MEDICAL EMBRYOLOGY IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE 	padis.uniroma1.it	0	0		NFIB
827	chr8	31784886	31817256	3500257500	44		31784886	31817256	8421504	2	22,22	0,32348	c	350025750000000034,350025750000000035	0-22,0-22						Two Promoters Mediate Transcription from the Human Gene: Involvement of Nuclear Factor I and Specificity Protein 1	www.ars.usda.gov	0	0		NFIB
827	chr8	31814365	31848626	3500376180	246		31814365	31848626	8421504	3	46,185,15	0,2869,34246	p	350037618000015011	6-252						Lung Cancer Diagnostic Assay - Patent application	www.faqs.org	0	0		NFIB
827	chr8	31814365	31848626	3500209076	246		31814365	31848626	8421504	3	46,185,15	0,2869,34246	p	350020907600015012	6-252						Lung Cancer Diagnostic Assay	Hirschowitz	2006	0		
832	chr8	32474711	32474735	3500253850	23		32474711	32474735	8421504	2	8,15	0,9	g	350025385000000029	1-24						A collection and methods for its use	Enzelberger	2010	0		
832	chr8	32474711	32474735	3500119214	23		32474711	32474735	8421504	2	8,15	0,9	g	350011921400000040	1-24					Patent	Collection and methods for its use (Patent US:8367586)	Urlinger	2013	0		
836	chr8	32959218	32959245	3500207420	23		32959218	32959245	8421504	2	16,7	0,20	c	350020742000000061	11-35						 Protein Fragment Complementation Assays For High 	www.docstoc.com	0	0		
836	chr8	32974077	32974128	3500341764	51		32974077	32974128	8421504	1	51	0	p	350034176400015235,350034176400015121	0-48,0-48						US Patent # 6,337,192. MMSC1-an MMAC1 interacting protein - Patents.com	www.patents.com	0	0		MPDZ
838	chr8	33227391	33227418	3500304556	23		33227391	33227418	8421504	2	15,8	0,19	g	350030455600000107,350030455600000039,350030455600000059,350030455600000127	8-31,8-31,11-30,11-30						Biological system and assay for identifying modulators of tubulin ligases - Patent application	www.faqs.org	0	0		
838	chr8	33284733	33284764	3500055955	25		33284733	33284764	8421504	3	4,13,8	0,5,23	g	350005595500000111	6-37						US Patent # 7,413,888. Variants of beta-glucosidases - Patents.com	www.patents.com	0	0		
104	chr8	33419526	33435771	3500413148	1792		33419526	33435771	8421504	9	68,211,147,180,168,205,323,466,24	0,74,1140,4249,6889,10555,13636,15308,16221	p,c,g	350041314800000066,350041314800000066,350041314800000126,350041314800000127,350041314800015108,350041314800015061,350041314800000065,350041314800015060,350041314800000064,350041314800000064,350041314800000123,350041314800000063,350041314800000063,350041314800015059,350041314800000122,350041314800000139,350041314800015107,350041314800000062,350041314800015058,350041314800000138,350041314800015057,350041314800015056,350041314800000060,350041314800000060,350041314800000059,350041314800015055,350041314800015106,350041314800000058,350041314800000058,350041314800015054,350041314800000057,350041314800000057,350041314800015053,350041314800000056,350041314800000056,350041314800015052,350041314800015105,350041314800000055,350041314800015051,350041314800000054,350041314800000054,350041314800015050,350041314800015049,350041314800000053,350041314800015104,350041314800015048,350041314800000052,350041314800000052,350041314800015047,350041314800000051,350041314800000051,350041314800015046,350041314800000050,350041314800000050,350041314800015045,350041314800000049,350041314800000049,350041314800015103,350041314800015044,350041314800000048,350041314800000048,350041314800015043,350041314800000047,350041314800000047,350041314800015042,350041314800000046,350041314800000046,350041314800015102,350041314800000045,350041314800000045,350041314800015041,350041314800000044,350041314800000044,350041314800015040,350041314800015039,350041314800015101,350041314800000042,350041314800000042,350041314800015038,350041314800000041,350041314800015037,350041314800000040,350041314800000040,350041314800015036,350041314800015035,350041314800000039,350041314800000039,350041314800015100,350041314800000038,350041314800000038,350041314800000120,350041314800000120,350041314800015033,350041314800000037,350041314800000037,350041314800000036,350041314800000036,350041314800000125,350041314800000035,350041314800000124	0-99,0-99,0-31,0-27,0-171,0-54,0-54,0-54,0-54,0-54,0-30,0-55,0-55,0-54,0-30,0-25,0-180,0-54,0-54,0-20,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-56,0-56,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-57,0-57,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-180,0-54,0-54,0-30,0-30,0-54,0-54,0-54,0-61,0-61,0-29,0-72,0-30						G&#xe9;n&#xe9;tique de la coloration de la robe chez les bovins : Contribution &#xe0; l&#x2019;&#xe9;tude du r&#xf4;le des g&#xe8;nes de la famille tyrosinase	cations.unilim.fr	0	0		
104	chr8	33420811	33436345	3500240147	172		33420811	33436345	8421504	9	2,18,20,26,15,27,23,19,22	0,2964,9385,12394,12659,14023,14383,14884,15512	c,g	350024014700000011,350024014700000009,350024014700000009,350024014700000010,350024014700000010,350024014700000005,350024014700000007,350024014700000003,350024014700000004,350024014700000006,350024014700000001,350024014700000000	0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-21,0-20,0-23,0-19,0-22			10.4081/ijas.2012.e12	1828-051X	Italian Journal of Animal Science	Identification of c.483C>T polymorphism in the caprine tyrosinase-related protein 1 (TYRP1) gene	Badaoui	2012	0		
104	chr8	33420811	33435217	3500221274	145		33420811	33435217	8421504	9	2,18,20,22,20,20,15,5,23	0,2964,9270,9314,9385,12394,12659,14023,14383	c,g	350022127400000009,350022127400000014,350022127400000012,350022127400000013,350022127400000007,350022127400000007,350022127400000008,350022127400000005,350022127400000004	0-20,0-20,19-41,22-43,0-20,0-20,0-20,0-20,0-23						Compelling evidence that a single nucleotide substitution in TYRP1 is responsible for coat-colour polymorphism in a free-living population of Soay sheep	etypublishing.org	0	0		
840	chr8	33423893	33435275	3500359247	98		33423893	33435275	8421504	5	20,19,19,20,20	0,6194,6234,11178,11362	c,g	350035924700000029,350035924700000020,350035924700000020,350035924700000019,350035924700000019,350035924700000013,350035924700000011,350035924700000011	0-20,0-19,0-19,0-19,0-19,0-20,0-20,0-20						Abstract	www.pucrs.br	0	0		
840	chr8	33450019	33450045	3500173273	23		33450019	33450045	8421504	2	13,10	0,16	g	350017327300000120	4-28						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT	Murphy	2009	0		
841	chr8	33659882	33659909	3500443924	23		33659882	33659909	8421504	2	7,16	0,11	g	350044392400000032	12-35					Patent	Plasmids comprising nucleic acids from the hereditary hemochromatosis gene (Patent US:7078513)	Thomas	2006	0		
841	chr8	33659882	33659909	3500029442	23		33659882	33659909	8421504	2	7,16	0,11	g	350002944200000032	12-35						Hereditary Hemochromatosis Gene - Patent application	www.faqs.org	0	0		
843	chr8	33878667	33878690	3500346879	23		33878667	33878690	8421504	1	23	0	g	350034687900000003	0-23						BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation. - ResearchGate	.researchgate.net	0	0		
850	chr8	34754889	34754916	3500368555	23		34754889	34754916	8421504	3	6,4,13	0,9,14	g	350036855500000038	18-42						Antibodies against human respiratory syncytial virus (RSV) and methods of use - Patent application	www.faqs.org	0	0		
850	chr8	34754889	34754916	3500022547	23		34754889	34754916	8421504	3	6,4,13	0,9,14	g	350002254700000161	18-42						ANTI-HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIBODIES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
858	chr8	35794540	35794564	3500230174	23		35794540	35794564	8421504	2	11,12	0,12	g	350023017400000077	2-43						Alphaviral vector with reduced inhibition of cellular macromolecular synthesis		1998	0		
860	chr8	36091544	36091572	3500182562	24		36091544	36091572	8421504	2	15,9	0,19	g	350018256200000002	4-28		20856248	10.1038/mp.2010.99	1359-4184	Molecular Psychiatry	A functional alternative splicing mutation in human tryptophan hydroxylase-2	Zhang	2010	14		
871	chr8	37495033	37495056	3500458528	23		37495033	37495056	8421504	1	23	0	g	350045852800000008	0-23		18815134	10.1074/jbc.M801011200		The Journal of Biological Chemistry	COP1 Functions as a FoxO1 Ubiquitin E3 Ligase to Regulate FoxO1-mediated Gene Expression	Satomi	2008	0		
871	chr8	37549855	37549881	3500230179	23		37549855	37549881	8421504	2	18,5	0,21	g	350023017900000012	3-27		16140766	10.1128/JVI.79.18.11901-11913.2005	0022-538X	Journal of Virology	The Carboxy-Terminal Sequence of the Pestivirus Glycoprotein Erns Represents an Unusual Type of Membrane Anchor	Fetzer	2005	5		
874	chr8	37922393	37922422	3500442201	24		37922393	37922422	8421504	2	12,12	0,17	g	350044220100000063	0-28						Amylase variants	Bisgard-frantzen	1996	0		
874	chr8	37922393	37922422	3500151825	24		37922393	37922422	8421504	2	12,12	0,17	g	350015182500000063	0-28						 Amylase Variants 	www.docstoc.com	0	0		
875	chr8	38016599	38016628	3500218688	27		38016599	38016628	8421504	3	19,4,4	0,20,25	g	350021868800000098	1-29						US Patent # 6,388,169. Maize orthologues of bacterial RecA proteins - Patents.com	www.patents.com	0	0		
876	chr8	38227105	38227130	3500381320	24		38227105	38227130	8421504	2	6,18	0,7	g	350038132000000012	0-24						Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer	Challita-Eid	2006	0		
886	chr8	39472144	39472173	3500197351	24		39472144	39472173	8421504	3	4,13,7	0,5,22	g	350019735100000095	4-30						STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS	Birkett	2003	0		
892	chr8	40245314	40245337	3500161485	23		40245314	40245337	8421504	1	23	0	c	350016148500000091	0-23						Hepadnavirus receptor	Li	1997	0		
892	chr8	40245314	40245337	3500137655	23		40245314	40245337	8421504	1	23	0	c	350013765500000079	0-23					Patent	Hepadnavirus receptor (Patent US:5929220)	Li	1999	0		
892	chr8	40255648	40255678	3500440731	24		40255648	40255678	8421504	3	4,13,7	0,5,23	g	350044073100000009,350044073100000046	10-34,12-36						Oxidatively stable alpha-amylase	Antrim	1994	0		
892	chr8	40298981	40299004	3500336623	23		40298981	40299004	8421504	1	23	0	c	350033662300000006	0-23						TARGETING METABOLIC ENZYMES IN HUMAN CANCER - AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH	www.sumobrain.com	0	0		
892	chr8	40311399	40311424	3500309991	25		40311399	40311424	8421504	1	25	0	c	350030999100000001	0-25						admin | Online Peptides Guide	atrin-peptide.com	0	0		
892	chr8	40337861	40337891	3500449315	24		40337861	40337891	8421504	3	6,6,12	0,10,18	c	350044931500000137	18-45						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
892	chr8	40337861	40337891	3500080694	24		40337861	40337891	8421504	3	6,6,12	0,10,18	c	350008069400000114	18-45						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
896	chr8	40851726	40851750	3500432765	24		40851726	40851750	8421504	1	24	0	c	350043276500000015,350043276500000000	0-24,0-24						Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR - Patent application	www.faqs.org	0	0		MLANA
896	chr8	40851726	40851750	3500325156	24		40851726	40851750	8421504	1	24	0	c	350032515600000007,350032515600000023	0-24,0-24						B7-H3 AS A BIOMARKER FOR DIAGNOSING THE PROGRESSION AND EARLY LYMPH NODE METASTASIS OF CANCER - Patent application	www.faqs.org	0	0		MLANA
896	chr8	40851726	40851750	3500299313	24		40851726	40851750	8421504	1	24	0	c	350029931300000000,350029931300000015	0-24,0-24						Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR - Patent application	www.faqs.org	0	0		MLANA
896	chr8	40851726	40851750	3500248072	24		40851726	40851750	8421504	1	24	0	c	350024807200000000	0-24						Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr	Hoon	2004	0		MLANA
896	chr8	40851726	40851750	3500246879	24		40851726	40851750	8421504	1	24	0	c	350024687900000007	0-24						 - Patent WO/2010/096734	www.sumobrain.com	0	0		MLANA
896	chr8	40851726	40851750	3500085192	24		40851726	40851750	8421504	1	24	0	c,g	350008519200000000,350008519200000000	0-24,0-24						Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR	Hoon	2003	0		MLANA
896	chr8	40851726	40851750	3500039618	24		40851726	40851750	8421504	1	24	0	c	350003961800000000	0-24						Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr	HOON	2005	0		MLANA
896	chr8	40862771	40862794	3500309086	23		40862771	40862794	8421504	1	23	0	g	350030908600000032	0-23						ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF - CURAGEN CORPORATION	www.sumobrain.com	0	0		MLANA
897	chr8	40924160	40924186	3500161109	24		40924160	40924186	8421504	3	5,5,14	0,6,12	g	350016110900000004	20-44						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
900	chr8	41294750	41307380	3500361058	108		41294750	41307380	8421504	5	19,20,29,20,20	0,5343,5386,11184,12610	c,g	350036105800000003,350036105800000003,350036105800000005,350036105800000000,350036105800000004,350036105800000002	0-19,0-19,0-21,0-29,0-20,0-20						Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade	biomedcentral.com	0	0		
900	chr8	41358218	41358244	3500455313	23		41358218	41358244	8421504	3	5,13,5	0,7,21	g	350045531300000028	14-37						GLYPHOSATE TOLERANT 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASES - MONSANTO COMPANY.	www.sumobrain.com	0	0		
900	chr8	41365083	41365107	3500467352	23		41365083	41365107	8421504	2	13,10	0,14	c	350046735200000053	11-34					Patent	Recombinant fowlpox virus S-FPV-043 and uses thereof (Patent US:6123949)	Cochran	2000	0		
900	chr8	41365083	41365107	3500454505	23		41365083	41365107	8421504	2	13,10	0,14	c	350045450500000067	11-34					Patent	Recombinant fowlpox viruses and uses thereof (Patent US:6001369)	Cochran	1999	0		
900	chr8	41365083	41365107	3500428877	23		41365083	41365107	8421504	2	13,10	0,14	c	350042887700000055	11-34						Recombinant fowlpox viruses and uses thereof	Cochran	1994	0		
900	chr8	41365083	41365107	3500408690	23		41365083	41365107	8421504	2	13,10	0,14	c	350040869000000067	11-34						 Recombinant Fowlpox Viruses And Uses Thereof 	www.docstoc.com	0	0		
900	chr8	41365083	41365107	3500282511	23		41365083	41365107	8421504	2	13,10	0,14	c	350028251100000067	11-34						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
900	chr8	41365083	41365107	3500263349	23		41365083	41365107	8421504	2	13,10	0,14	c	350026334900000067	11-34						Recombinant fowlpox viruses and uses thereof	Cochran	1998	0		
900	chr8	41365083	41365107	3500197547	23		41365083	41365107	8421504	2	13,10	0,14	c	350019754700000055	11-34						Recombinant fowlpox virus s-fpv-043 and uses thereof		1994	0		
900	chr8	41365083	41365107	3500195146	23		41365083	41365107	8421504	2	13,10	0,14	c	350019514600000053	11-34						Recombinant fowlpox virus S-FPV-043 and uses thereof	Cochran	1995	0		
900	chr8	41365083	41365107	3500180733	23		41365083	41365107	8421504	2	13,10	0,14	c	350018073300000055	11-34						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
900	chr8	41365083	41365107	3500179670	23		41365083	41365107	8421504	2	13,10	0,14	c	350017967000000067	11-34						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
900	chr8	41365083	41365107	3500177869	23		41365083	41365107	8421504	2	13,10	0,14	c	350017786900000053	11-34						US Patent # 6,123,949. Recombinant fowlpox virus S-FPV-043 and uses thereof - Patents.com	www.patents.com	0	0		
900	chr8	41365083	41365107	3500115879	23		41365083	41365107	8421504	2	13,10	0,14	c	350011587900000055	11-34						Recombinant fowlpox virus s-fpv-043 and uses thereof	Cochran	1994	0		
901	chr8	41433149	41433180	3500175227	25		41433149	41433180	8421504	3	14,6,5	0,18,26	g	350017522700000091	8-33						Diversit&#xe9; des antig&#xe8;nes de Plasmodium falciparum, candidats potentiels &#xe0; la mise au point d'un vaccin antipalustre au Kenya	umentation.ird.fr	0	0		
901	chr8	41464823	41474289	3500213314	42		41464823	41474289	8421504	2	21,21	0,9445	g	350021331400000013,350021331400000012	0-21,0-21						Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma	tologylibrary.org	0	0		JAK2
903	chr8	41780353	41780457	3500307534	41		41780353	41780457	8421504	2	20,21	0,83	g	350030753400000056,350030753400000055	0-20,0-21						PUTATIVE TUMOR SUPPRESSOR MICRORNA-101 MODULATES THE CANCER EPIGENOME BY REPRESSING THE POLYCOMB GROUP PROTEIN EZH2 - Patent application	www.faqs.org	0	0		
904	chr8	41883838	41902810	3500052832	621		41883838	41902810	8421504	5	121,120,173,119,88	0,10626,11718,12776,18884	p	350005283200015135,350005283200015140,350005283200015192,350005283200015136,350005283200015193,350005283200015137,350005283200015194,350005283200015138,350005283200015195	12-150,12-495,12-180,0-150,0-177,0-150,0-180,0-150,0-93						NOTES ON SELECTED SOFTBERRY PRODUCTS	ux1.softberry.com	0	0		
904	chr8	41883850	41896722	3500443182	228		41883850	41896722	8421504	5	66,36,10,11,105	0,10682,10724,11706,12767	p	350044318200015059,350044318200015061,350044318200015067,350044318200015065	21-87,0-57,12-102,0-75						Bioinformatics sequence and genome analysis david w. mount	ww.slideshare.net	0	0		
904	chr8	41883850	41896722	3500425833	228		41883850	41896722	8421504	5	66,36,10,11,105	0,10682,10724,11706,12767	p	350042583300015072,350042583300015074,350042583300015070,350042583300015078	21-87,0-57,12-102,0-75						Bioinformatics Sequence and Genome Analysis - David W. Mount.pdf	www.scribd.com	0	0		
905	chr8	41950245	41950365	3500245940	111		41950245	41950365	8421504	2	33,78	0,42	p	350024594000015054	0-111						Secreted protein HCEJQ69	Brewer	2003	0		PPAPDC2
905	chr8	41950245	41950365	3500182039	120		41950245	41950365	8421504	1	120	0	p	350018203900015011	0-120						Secreted protein HCEJQ69	Brewer	2003	0		PPAPDC2
905	chr8	42016032	42016242	3500342863	210		42016032	42016242	8421504	1	210	0	p	350034286300015069	0-210							library.wiley.com	0	0		SLC1A1
905	chr8	42027419	42028612	3500424447	42		42027419	42028612	8421504	3	22,15,5	0,90,1188	c	350042444700000001,350042444700000000	0-22,0-20		21593323	10.1523/JNEUROSCI.6577-10.2011	0270-6474	The Journal of Neuroscience	Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 Expression	Escartin	2011	7		
905	chr8	42027419	42028612	3500106916	42		42027419	42028612	8421504	3	22,15,5	0,90,1188	c	350010691600000001,350010691600000000	0-22,0-20		21593323	10.1523/JNEUROSCI.6577-10.2011		The Journal of Neuroscience	Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 Expression	Carole	2011	0		
113	chr8	42303897	42343763	3500008756	42		42303897	42343763	8421504	3	8,12,22	0,12,39844	g	350000875600000927,350000875600000729	13-34,13-35						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
908	chr8	42447942	42447966	3500040930	24		42447942	42447966	8421504	1	24	0	g	350004093000000003	0-24		22820919	10.1007/s10059-012-0109-z		Molecules and cells	Glis3 regulates neurogenin 3 (Ngn3) expression in pancreatic &#x03b2;cells and interacts with its activator, Hnf6	Yong-Sik	2012	0		GLIS3
909	chr8	42568461	42568491	3500422266	27		42568461	42568491	8421504	2	22,5	0,25	g	350042226600000069	1-28						Method and materials for producing a genetically modified animal	Fahrenkrug	2013	0		
909	chr8	42568461	42568491	3500012563	27		42568461	42568491	8421504	2	22,5	0,25	g	350001256300000069	1-28						METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ANIMALS	Fahrenkrug	2009	0		
920	chr8	43931970	43934065	3500270141	45		43931970	43934065	8421504	2	23,22	0,2073	c	350027014100000008,350027014100000007	0-23,0-22		17108332	10.1095/biolreprod.106.057216	0006-3363	Biology of Reproduction	Low-Density Lipoprotein Receptor-Related Protein 8 (LRP8) Is Upregulated in Granulosa Cells of Bovine Dominant Follicle: Molecular Characterization and Spatio-Temporal Expression Studies	Fayad	2007	4		
920	chr8	43937675	43937698	3500263910	23		43937675	43937698	8421504	1	23	0	c	350026391000000001	0-23						Expression of LDL Receptor, VLDL Receptor, LDL Receptor&#x2013;Related Protein, and Scavenger Receptor in Rabbit Atherosclerotic Lesions	c.ahajournals.org	0	0		
920	chr8	43937681	43939217	3500355148	70		43937681	43939217	8421504	3	22,23,25	0,1485,1511	c,g	350035514800000007,350035514800000007,350035514800000008,350035514800000008,350035514800000006	0-22,0-22,0-23,0-23,0-25						Expression of SR-BI and LDL receptor and differential use of lipoproteins to support	.endojournals.org	0	0		VLDLR
920	chr8	43939232	43939257	3500176877	25		43939232	43939257	8421504	1	25	0	c	350017687700000054	0-25						Wnt/ &#x03b2;-Catenin-Zielgene in der Maus-Entwicklung	k.uni-freiburg.de	0	0		VLDLR
920	chr8	43941156	43941183	3500008791	27		43941156	43941183	8421504	1	27	0	c	350000879100000016	19-46						<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xs	edcentral.nih.gov	0	0		
920	chr8	43942105	43942129	3500110231	24		43942105	43942129	8421504	1	24	0	c	350011023100000005	0-24						Contributions of VLDLR and LRP8 in the establishment of retinogeniculate projections	biomedcentral.com	0	0		
922	chr8	44275848	44275876	3500025771	24		44275848	44275876	8421504	2	17,7	0,21	g	350002577100000226	10-34						US Patent # 7,244,577. Method of screening for modulator of LRP5 activity - Patents.com	www.patents.com	0	0		
922	chr8	44280025	44280063	3500060255	33		44280025	44280063	8421504	2	27,6	0,32	c,g	350006025500000011,350006025500000011	35-69,35-69			10.1111/j.1567-1364.2007.00253.x	1567-1364	FEMS Yeast Research	A functional analysis of the Candida albicans homolog of Saccharomyces cerevisiae VPS4 - Lee - 2007 - FEMS Yeast Research - Wiley Online Library	Lee	2007	0		
115	chr8	44530376	44571170	3500044539	40		44530376	44571170	8421504	2	21,19	0,40775	c	350004453900000001,350004453900000003	0-21,0-19		23349796	10.1371/journal.pone.0054110		PLoS ONE	MITF-Independent Pro-Survival Role of BRG1-Containing SWI/SNF Complex in Melanoma Cells	Lubica	2013	0		
935	chr8	45915913	45915943	3500173250	24		45915913	45915943	8421504	3	6,5,13	0,11,17	g	350017325000000387	2-28						Engineered Listeria and methods of use thereof	Dubensky	2006	0		
936	chr8	46027509	46027928	3500332546	45		46027509	46027928	8421504	2	34,11	0,408	p	350033254600015001	0-45		22412158	10.1084/jem.20111692		The Journal of Experimental Medicine	The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes	Fan	2012	0		DOCK8
936	chr8	46101729	46101756	3500366733	23		46101729	46101756	8421504	2	12,11	0,16	c	350036673300000138	21-44						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
936	chr8	46101729	46101756	3500193635	23		46101729	46101756	8421504	2	12,11	0,16	c	350019363500000136	21-44						Materials and methods for immunocontraception	Harris	1993	0		
936	chr8	46101780	46101805	3500389666	24		46101780	46101805	8421504	2	5,19	0,6	c	350038966600000379	2-26						VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS - Patent application	www.faqs.org	0	0		
936	chr8	46101781	46101805	3500396369	23		46101781	46101805	8421504	2	4,19	0,5	c	350039636900000375	0-23						 VMP 	www.docstoc.com	0	0		
937	chr8	46152297	46152320	3500217278	23		46152297	46152320	8421504	1	23	0	c	350021727800000028	16-39						US Patent # 6,331,411. TopA - Patents.com	www.patents.com	0	0		
937	chr8	46152297	46152320	3500008069	23		46152297	46152320	8421504	1	23	0	c	350000806900000028	16-39						TopA	www.devileye.net	0	0		
947	chr8	47540104	47540132	3500096515	23		47540104	47540132	8421504	2	7,16	0,12	c	350009651500000145	25-48						Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins	M*Le Na Er 	2007	0		
949	chr8	47793375	47793398	3500447411	23		47793375	47793398	8421504	1	23	0	c	350044741100000077	22-45						Osteoinductive compositions	Celeste	1990	0		
949	chr8	47793375	47793398	3500090126	23		47793375	47793398	8421504	1	23	0	c	350009012600000077	22-45						Osteoinductive compositions	Celeste	1990	0		
950	chr8	47844606	47844629	3500173250	23		47844606	47844629	8421504	1	23	0	g	350017325000000345	11-34						Engineered Listeria and methods of use thereof	Dubensky	2006	0		
954	chr8	48371204	48371228	3500453226	24		48371204	48371228	8421504	1	24	0	g	350045322600000001	0-37						Starter unit speci&#xfb01;city directs genome mining of polyketide synthase pathways in fungi	ddr.nal.usda.gov	0	0		
956	chr8	48633115	48633139	3500339022	24		48633115	48633139	8421504	1	24	0	c	350033902200000010	0-24		20554758	10.1091/mbc.E10-04-0290		Molecular Biology of the Cell	Bimodal, Reciprocal Regulation of Fibroblast Growth Factor Receptor 1 Promoter Activity by BTEB1/KLF9 during Myogenesis	Darrion	2010	0		
956	chr8	48633301	48656453	3500317082	42		48633301	48656453	8421504	3	13,7,22	0,23091,23130	c	350031708200000033,350031708200000032	0-20,0-22		18687676	10.1074/jbc.M804831200	0021-9258	Journal of Biological Chemistry	A Network of Kr&#xfc;ppel-like Factors (Klfs)	Eaton	2008	5		KLF9
956	chr8	48656565	48656799	3500128409	41		48656565	48656799	8421504	2	21,20	0,214	c,g	350012840900000011,350012840900000010,350012840900000010	0-21,0-20,0-20		16303770	10.1074/jbc.M509417200	0021-9258	Journal of Biological Chemistry	A Novel Functional Interaction between the Sp1-like Protein KLF13 and SREBP-Sp1 Activation Complex Underlies Regulation of Low Density Lipoprotein Receptor Promoter Function	Natesampillai	2006	5		KLF9
958	chr8	48965737	48965760	3500022514	23		48965737	48965760	8421504	1	23	0	g	350002251400000002	0-23						US Patent # 7,504,481. TRP channel family member, LTRPC3 polypeptides - Patents.com	www.patents.com	0	0		
959	chr8	49074835	49074903	3500420747	68		49074835	49074903	8421504	1	68	0	c,g	350042074700000006,350042074700000006,350042074700000013,350042074700000013,350042074700000001,350042074700000008,350042074700000007,350042074700000000,350042074700000003,350042074700000010	0-68,0-68,0-68,0-68,0-23,0-23,0-22,0-22,0-22,0-22						MIR 204, MIR 211, THEIR ANTI-MIRS, AND THERAPEUTIC USES OF SAME - Patent application	www.faqs.org	0	0		TRPM3
959	chr8	49074838	49074863	3500351139	25		49074838	49074863	8421504	1	25	0	c	350035113900000040	0-25						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
959	chr8	49074875	49074898	3500400478	23		49074875	49074898	8421504	1	23	0	c,g	350040047800000214,350040047800000214	0-23,0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		TRPM3
959	chr8	49111342	49111387	3500330800	45		49111342	49111387	8421504	1	45	0	p	350033080000015010	0-45						Methods and Kits for Detecting Congenital Stationary Night Blindness and Selecting Different Coat Patterns - Patent application	www.faqs.org	0	0		TRPM3
966	chr8	50001006	50001029	3500362721	23		50001006	50001029	8421504	1	23	0	g	350036272100000011	4-27						Methods for Treating Cancer Using an Immunotoxin - Patent application	www.faqs.org	0	0		
966	chr8	50050161	50050184	3500290988	23		50050161	50050184	8421504	1	23	0	c	350029098800000005	1-30			10.1128/IAI.70.1.277-285.2002		Infection and Immunity	Functional Differences among FimA Variants of Porphyromonas gingivalis and Their Effects on Adhesion to and Invasion of Human Epithelial Cells 	Ichiro	2002	0		
967	chr8	50129437	50129462	3500298532	24		50129437	50129462	8421504	2	5,19	0,6	c	350029853200000056	8-37						 Biocatalyst Inhibitors 	www.docstoc.com	0	0		
968	chr8	50234331	50234360	3500034386	25		50234331	50234360	8421504	2	8,17	0,12	c	350003438600000018	5-30			10.1111/j.1742-4658.2006.05183.x	1742-4658	FEBS Journal	Identification of ERR&#x03b1; as a specific partner of PGC-1&#x03b1; for the activation of PDK4 gene expression in muscle - Araki - 2006 - FEBS Journal - Wiley Online Library	Araki	2006	0		
969	chr8	50350512	50350535	3500433279	23		50350512	50350535	8421504	1	23	0	g	350043327900000058	10-34						Transgenic plants presenting a modified inulin producing profile	Koops	2000	0		
972	chr8	50738189	50742982	3500184286	600		50738189	50742982	8421504	5	146,126,104,98,126	0,1080,3383,4114,4667	p	350018428600015062,350018428600015059,350018428600015056,350018428600015052	0-114,0-180,0-180,0-126						[tel-00555532, v1] Etude des int&#xe9;ractions prot&#xe9;ine-prot&#xe9;ine par double hybride bact&#xe9;rien : applications en agro-alimentaire et en sant&#xe9;.	hives-ouvertes.fr	0	0		ZFAND5
972	chr8	50738189	50742982	3500138186	600		50738189	50742982	8421504	5	146,126,104,98,126	0,1080,3383,4114,4667	p	350013818600015062,350013818600015059,350013818600015056,350013818600015052	0-114,0-180,0-180,0-126						[tel-00555532, v1] Etude des int&#xe9;ractions prot&#xe9;ine-prot&#xe9;ine par double hybride bact&#xe9;rien : applications en agro-alimentaire et en sant&#xe9;.	hives-ouvertes.fr	0	0		ZFAND5
972	chr8	50739310	50741660	3500460733	40		50739310	50741660	8421504	2	20,20	0,2330	c	350046073300000009,350046073300000008	0-20,0-20			10.1210/en.2007-1470		Endocrinology	Forkhead Box Protein O1 Negatively Regulates Skeletal Myocyte Differentiation through Degradation of Mammalian Target of Rapamycin Pathway Components	Ai-Luen	2008	0		
972	chr8	50739356	50739388	3500171898	32		50739356	50739388	8421504	1	32	0	c	350017189800000002	0-32						Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer	Buck	2005	0		
975	chr8	51187360	51187388	3500186557	23		51187360	51187388	8421504	2	15,8	0,20	g	350018655700000549	0-23						Oligonucleotide for Detection of a Microorganism, Diagnostic Kits and Methods for Detection of Microorganisms Using the Oligonucleotide - Patent application	www.faqs.org	0	0		
975	chr8	51214636	51214662	3500095649	26		51214636	51214662	8421504	1	26	0	c	350009564900000165	0-26						Vascular/Lymphatic Endothelial Cells - Patent application	www.faqs.org	0	0		
975	chr8	51214798	51216594	3500394185	28		51214798	51216594	8421504	3	17,1,10	0,1784,1786	c	350039418500000011	0-28						Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development	www.ucdenver.edu	0	0		ALDH1A1
977	chr8	51474555	51474747	3500161586	72		51474555	51474747	8421504	3	27,15,30	0,51,162	p,c	350016158600000002,350016158600000000,350016158600015019	8-35,8-35,0-45						NOVEL MODIFICATION OF IMMUNOMODULATORY PROTEIN - Patent application	www.faqs.org	0	0		
977	chr8	51474558	51474618	3500363559	57		51474558	51474618	8421504	2	33,24	0,36	p	350036355900015000	0-57						Annexin1anditsbioactivepeptideinhibitneutrophil-endotheliuminteractions under&#xfb02;ow:indicationofdistinctreceptorinvolvement	tologylibrary.org	0	0		
977	chr8	51474558	51474618	3500356790	57		51474558	51474618	8421504	2	33,24	0,36	p	350035679000015000	0-57		20107188	10.4049/jimmunol.0903526	0022-1767	The Journal of Immunology	Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation	Dufton	2010	6		
977	chr8	51474558	51474618	3500289571	60		51474558	51474618	8421504	1	60	0	p	350028957100015004	0-60		19023040	10.1124/jpet.108.145821	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects	Hecht	2009	0		
977	chr8	51474558	51474618	3500126043	57		51474558	51474618	8421504	2	33,24	0,36	p	350012604300015000	0-57		17158208	10.1210/en.2006-0732	0013-7227	Endocrinology	Expression and Externalization of Annexin 1 in the Adrenal Gland: Structure and Function of the Adrenal Gland in Annexin 1-Null Mutant Mice	Davies	2007	4		
977	chr8	51474558	51474618	3500033222	57		51474558	51474618	8421504	2	33,24	0,36	p	350003322200015002	0-57			10.1124/jpet.104.080473	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	A Novel Effect for Annexin 1-Derived Peptide Ac2-26: Reduction of Allergic Inflammation in the Rat	Bandeira-Melo	2005	0		
977	chr8	51474591	51485493	3500269063	120		51474591	51485493	8421504	5	26,30,40,12,12	0,3905,7197,9854,10890	c	350026906300000003,350026906300000014,350026906300000018,350026906300000022	0-26,18-48,0-40,24-48						INHIBITORS OF NF-KB ACTIVITY - Patent application	www.faqs.org	0	0		
977	chr8	51475648	51478233	3500047878	40		51475648	51478233	8421504	3	3,17,20	0,1062,2565	c,g	350004787800000036,350004787800000037,350004787800000037	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
977	chr8	51477321	51478229	3500066284	66		51477321	51478229	8421504	2	34,32	0,876	p	350006628400015092	0-66						I. BANDAS DIFERENCIALES SELECCIONADAS	www.tdx.cat	0	0		
977	chr8	51480389	51481822	3500404944	40		51480389	51481822	8421504	3	13,7,20	0,1349,1413	c,g	350040494400000018,350040494400000019,350040494400000019	0-20,0-20,0-20						Regulation of apoptotic pathways in bovine T cells	tatic.msi.umn.edu	0	0		
979	chr8	51658314	51658338	3500342384	23		51658314	51658338	8421504	2	6,17	0,7	g	350034238400000157	17-40						Compositions and methods for inhibiting expression of a gene from the JC virus	Tan	2007	0		
980	chr8	51889609	51889638	3500008970	24		51889609	51889638	8421504	2	18,6	0,23	g	350000897000000002	1-25		14657251	10.1091/mbc.E03-06-0389	1059-1524	Molecular Biology of the Cell	Meiosis-specific Failure of Cell Cycle Progression in Fission Yeast by Mutation of a Conserved &#x03b2;-Tubulin Residue	Paluh	2004	5		
123	chr8	52716721	52919643	3500385340	1377		52716721	52919643	8421504	10	7,86,142,402,122,133,108,111,113,153	0,153866,159046,166168,182893,184376,187090,188963,192005,202769	p	350038534000015009	0-1377						METHODS FOR IN VITRO DIFFERENTIATION OF TH-17+ CELLS	Manel	2012	0		RORB
123	chr8	52716721	52919643	3500185430	1377		52716721	52919643	8421504	10	7,86,142,402,122,133,108,111,113,153	0,153866,159046,166168,182893,184376,187090,188963,192005,202769	p	350018543000015005	0-1377						METHODS FOR IN VITRO DIFFERENTIATION OF TH-17+ CELLS - Patent application	www.faqs.org	0	0		RORB
989	chr8	52980919	52980943	3500116940	23		52980919	52980943	8421504	2	15,8	0,16	g	350011694000000004	8-31						Cloning, Expression, and Pharmacological Characterization of a Novel Human Histamine Receptor	aspetjournals.org	0	0		
991	chr8	53263542	53263568	3500271964	23		53263542	53263568	8421504	2	15,8	0,18	g	350027196400000013	2-25						ftsZ Gene of Mycobacterium smegmatis is expressed Through Multiple Transcripts	enthamscience.com	0	0		
991	chr8	53307066	53318628	3500263315	165		53307066	53318628	8421504	4	39,51,64,11	0,6695,9659,11551	p	350026331500015013,350026331500015042,350026331500015044	0-165,33-198,30-192						Compositions and methods for producing bioactive fusion proteins	Walker	2008	0		OSTF1
991	chr8	53307066	53318628	3500236543	165		53307066	53318628	8421504	4	39,51,64,11	0,6695,9659,11551	p	350023654300015072,350023654300015027,350023654300015068	30-192,0-165,33-192					Patent	Compositions and methods for producing bioactive fusion proteins (Patent US:8420779)	Walker	2013	0		OSTF1
991	chr8	53307066	53318628	3500227699	165		53307066	53318628	8421504	4	39,51,64,11	0,6695,9659,11551	p	350022769900015027,350022769900015068,350022769900015072	0-165,33-192,30-192						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		OSTF1
991	chr8	53307066	53318628	3500004002	165		53307066	53318628	8421504	4	39,51,64,11	0,6695,9659,11551	p	350000400200015015,350000400200015047,350000400200015045	0-165,30-192,33-198						COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS	Walker	2013	0		OSTF1
996	chr8	53953379	53953408	3500362410	24		53953379	53953408	8421504	2	10,14	0,15	g	350036241000000007	0-24						Maltodextrin Utilization Plays a Key Role in the Ability of Group A Streptococcus To Colonize the Oropharynx	iai.asm.org	0	0		
997	chr8	54004919	54004944	3500170393	25		54004919	54004944	8421504	1	25	0	g	350017039300000007	9-34						Parentage assignment using microsatellites in	www.vliz.be	0	0		
997	chr8	54038195	54038230	3500195182	35		54038195	54038230	8421504	1	35	0	g	350019518200000065	77-112						CD4+ T-lymphocyte proteases and genes encoding said proteases	Franzusoff	1995	0		
997	chr8	54108389	54108418	3500201848	24		54108389	54108418	8421504	2	11,13	0,16	g	350020184800000000	0-24		15919920	10.1128/JVI.79.12.7673-7681.2005	0022-538X	Journal of Virology	Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3	Brzozka	2005	5		
997	chr8	54108389	54108417	3500345168	23		54108389	54108417	8421504	2	11,12	0,16	g	350034516800000004	0-23						The rabies virus phosphoprotein P: a key regulator of innate immune responses	b.uni-muenchen.de	0	0		
998	chr8	54227865	54227890	3500302946	23		54227865	54227890	8421504	2	12,11	0,14	g	350030294600000004	1-24						articles Initial sequencing and analysis of the human genome	www.ndsu.edu	0	0		
998	chr8	54227865	54227890	3500274251	23		54227865	54227890	8421504	2	12,11	0,14	g	350027425100000004	1-24						articles Initial sequencing and analysis of the human genome	ttk.pte.hu/biolog	0	0		
998	chr8	54227865	54227890	3500213927	23		54227865	54227890	8421504	2	12,11	0,14	g	350021392700000004	1-24						articles Initial sequencing and analysis of the human genome	www.biosino.org	0	0		
1002	chr8	54701731	54702775	3500034597	131		54701731	54702775	8421504	3	48,48,35	0,192,1009	c	350003459700000009,350003459700000013,350003459700000030	0-48,0-48,1-36						US Patent # 5,684,134. Antibody specific for .beta.1.fwdarw.6 N-acetylglucosamininyltransferase - Patents.com	www.patents.com	0	0		
1004	chr8	54953174	54953198	3500354220	23		54953174	54953198	8421504	2	5,18	0,6	g	350035422000000014	8-33						Molecular phylogeny, taxonomy and evolution of arbuscular mycorrhizal fungi	b.uni-muenchen.de	0	0		
1006	chr8	55205652	55205677	3500395610	23		55205652	55205677	8421504	2	6,17	0,8	g	350039561000000258	0-23						Single-Chain Multivalent Binding Proteins with Effector Function - Patent application	www.faqs.org	0	0		
1009	chr8	55665180	55666527	3500465117	54		55665180	55666527	8421504	2	31,23	0,1324	c	350046511700000015	64-118						Characterization of G-Protein |alpha Subunits in the Gq Class: Expression in Murine Tissues and in Stromal and Hematopoietic Cell Lines	www.jstor.org	0	0		
1010	chr8	55751708	55751733	3500367978	24		55751708	55751733	8421504	2	16,8	0,17	g	350036797800000001	0-24						Toxin Compounds With Enhanced Membrane Translocation Characteristics 	.freshpatents.com	0	0		
1010	chr8	55751708	55751733	3500360151	24		55751708	55751733	8421504	2	16,8	0,17	g	350036015100000001	0-24						Toxin compounds with enhanced membrane translocation characteristics	Fernandez-salas	2004	0		
1010	chr8	55751708	55751733	3500280799	24		55751708	55751733	8421504	2	16,8	0,17	g	350028079900000001	0-24						Toxin compounds with enhanced membrane translocation characteristics	Aoki	2006	0		
1011	chr8	55881368	55881403	3500300392	35		55881368	55881403	8421504	1	35	0	c	350030039200000016	0-35						Method for identifying inhibitors of g protein coupled receptor signaling	Gilchrist	2002	0		
1011	chr8	55881368	55881403	3500201598	35		55881368	55881403	8421504	1	35	0	c	350020159800000021,350020159800000009	0-35,0-24						Method for identifying inhibitors of G protein coupled receptor signaling	Gilchrist	2001	0		
126	chr8	55881370	56191684	3500360360	1077		55881370	56191684	8421504	7	188,154,130,129,155,185,136	0,6365,74436,77001,94938,204659,310178	p	350036036000015000	0-1077						KEGG T01001: 2776	www.genome.jp	0	0		GNAQ
1011	chr8	55881370	55881401	3500439611	31		55881370	55881401	8421504	1	31	0	c	350043961100000205,350043961100000203	11-42,0-29						MINICELLS EXPRESSING ANTIBODIES OR DERIVATIVES THEREOF AND COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS	Sabbadini	2007	0		GNAQ
1011	chr8	55881370	55881401	3500365768	31		55881370	55881401	8421504	1	31	0	c	350036576800000107,350036576800000105	11-42,0-29						Minicell compositions and methods	Berkley	2011	0		GNAQ
1011	chr8	55881370	55881401	3500183987	31		55881370	55881401	8421504	1	31	0	c	350018398700000171,350018398700000169	11-42,0-29						Eubacterial minicells and their use as vectors for nucleic acid delivery and expression - Patent # 7183105 - PatentGenius	.patentgenius.com	0	0		
1011	chr8	55881373	55881398	3500009933	25		55881373	55881398	8421504	1	25	0	c	350000993300000007	0-25						Mechanism Underlying the Aluminum-Induced Stimulation of Bone Nodule Formation by Rat Calvarial Osteoblasts	jhs.pharm.or.jp	0	0		
1011	chr8	55881376	55881400	3500392754	24		55881376	55881400	8421504	1	24	0	c	350039275400000006	0-24						Method for identifying modulators of g protein coupled receptor signaling	Gilchrist	2006	0		
126	chr8	55881383	56191685	3500168470	1065		55881383	56191685	8421504	7	175,154,130,129,155,185,137	0,6352,74423,76988,94925,204646,310165	c	350016847000000067	1203-2268						 FUNCTIONAL COMPLEMENTATION ASSAY FOR DEFINED GPCR OLIGOMERS - Patent application	www.faqs.org	0	0		GNAQ
1011	chr8	55881535	55887775	3500405757	63		55881535	55887775	8421504	2	23,40	0,6200	p	350040575700015038	0-63						protein a subunit specifically expressed hematopoietic cells	brary.caltech.edu	0	0		GNAQ
126	chr8	56086158	56191570	3500152838	78		56086158	56191570	8421504	2	56,22	0,105390	p	350015283800015037	111-189						US Patent # 5,876,951. Yeast cells engineered to produce pheromone system protein surrogates and uses therefor - Patents.com	www.patents.com	0	0		GNA14
126	chr8	56086213	56191571	3500383952	24		56086213	56191571	8421504	2	1,23	0,105335	c	350038395200000011	5-29						Yeast cells expressing modified g proteins and methods of use therefor	Benegal	2000	0		
126	chr8	56086213	56191571	3500049768	24		56086213	56191571	8421504	2	1,23	0,105335	c	350004976800000072	5-29						YEAST CELLS EXPRESSING MODIFIED G PROTEINS AND METHODS OF USE THEREFOR - Patent application	www.faqs.org	0	0		
126	chr8	56086213	56191571	3500049768	24		56086213	56191571	8421504	2	1,23	0,105335	c	350004976800000011	5-29						YEAST CELLS EXPRESSING MODIFIED G PROTEINS AND METHODS OF USE THEREFOR - Patent application	www.faqs.org	0	0		
1013	chr8	56191549	56191609	3500181280	60		56191549	56191609	8421504	1	60	0	p	350018128000015011	0-60						Molecular characterization of two components of the IP3 signalling pathway in the lobster olfactory organ	ufdc.ufl.edu	0	0		GNAQ
1013	chr8	56191642	56191667	3500461580	25		56191642	56191667	8421504	1	25	0	c,g	350046158000000002,350046158000000002	11-36,11-36						Use of gpr101 receptor in methods to identify modulators of hypothalamic proopiomelanocortin (pomc)-derived biologically active peptide secretion useful in the treatment of pomc-derived biologically active peptide-related disorders	Bagnol	2007	0		
1013	chr8	56191642	56191667	3500450359	25		56191642	56191667	8421504	1	25	0	c,g	350045035900000000,350045035900000000	11-36,11-36						Compositions For Treating Flushing And Lipid-Associated Disorders Comprising Niacin Receptor Partial Agonists	Behan	2005	0		GNAQ
1013	chr8	56191642	56191667	3500438127	25		56191642	56191667	8421504	1	25	0	c,g	350043812700000002,350043812700000002	11-36,11-36						HUMAN G PROTEIN-COUPLED RECEPTOR AND MODULATORS THEREOF FOR THE TREATMENT OF OBESITY AND CONDITIONS RELATED THERETO	Bagnol	2006	0		
1013	chr8	56191642	56191667	3500425083	25		56191642	56191667	8421504	1	25	0	c,g	350042508300000004,350042508300000004	11-36,11-36						Constitutively active CXCR3 G protein-coupled chemokine receptor and modulators thereof for the treatment of inflammatory disorders	Villegas	2004	0		GNAQ
1013	chr8	56191642	56191667	3500410105	25		56191642	56191667	8421504	1	25	0	c,g	350041010500000002,350041010500000002	11-36,11-36						Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure	Adams	2007	0		
1013	chr8	56191642	56191667	3500395538	25		56191642	56191667	8421504	1	25	0	c,g	350039553800000006,350039553800000006	11-36,11-36						Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders	Gatlin	2004	0		
1013	chr8	56191642	56191667	3500384696	25		56191642	56191667	8421504	1	25	0	c,g	350038469600000054,350038469600000054	11-36,11-36						Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors	Chen	2012	0		TUBA3D
1013	chr8	56191642	56191667	3500381905	25		56191642	56191667	8421504	1	25	0	c,g	350038190500000004,350038190500000004	11-36,11-36						Modulators of hematopoiesis	Bruinsma	2009	0		
1013	chr8	56191642	56191667	3500375879	25		56191642	56191667	8421504	1	25	0	c,g	350037587900000004,350037587900000004	11-36,11-36						Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders	Liaw	2004	0		GNAQ
1013	chr8	56191642	56191667	3500360205	25		56191642	56191667	8421504	1	25	0	c,g	350036020500000004,350036020500000004	11-36,11-36						Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders	Connolly	2006	0		GNAQ
1013	chr8	56191642	56191667	3500320897	25		56191642	56191667	8421504	1	25	0	c	350032089700000000	10-35						Gpr22 and methods relating thereto	Liaw	2007	0		
1013	chr8	56191642	56191667	3500293473	25		56191642	56191667	8421504	1	25	0	c,g	350029347300000031,350029347300000031,350029347300000004,350029347300000004	11-36,11-36,11-36,11-36						Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure	Yue Han *W*Ya Dang Mu Si 	2005	0		
1013	chr8	56191642	56191667	3500282869	25		56191642	56191667	8421504	1	25	0	c,g	350028286900000004,350028286900000004	11-36,11-36						Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders	Qiu	2006	0		GNAQ
1013	chr8	56191642	56191667	3500252350	25		56191642	56191667	8421504	1	25	0	c,g	350025235000000002,350025235000000002	11-36,11-36						Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure	Adams	2005	0		
1013	chr8	56191642	56191667	3500247635	25		56191642	56191667	8421504	1	25	0	c,g	350024763500000002,350024763500000002	11-36,11-36					Patent	Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure (Patent US:7611832)	Adams	2009	0		
1013	chr8	56191642	56191667	3500235435	25		56191642	56191667	8421504	1	25	0	c,g	350023543500000011,350023543500000011	11-36,11-36						Non-endogenous, Constitutively Activated Versions Of Human G Protein Coupled Receptor: Fshr 	.freshpatents.com	0	0		GNAQ
1013	chr8	56191642	56191667	3500223565	25		56191642	56191667	8421504	1	25	0	c,g	350022356500000002,350022356500000002	11-36,11-36					Patent	Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders (Patent US:8017313)	Adams	2011	0		GNAQ
1013	chr8	56191642	56191667	3500200859	25		56191642	56191667	8421504	1	25	0	c,g	350020085900000060,350020085900000060	11-36,11-36						Human G protein-coupled receptors for metabolic-related disorders	Unett	2004	0		
1013	chr8	56191642	56191667	3500192938	25		56191642	56191667	8421504	1	25	0	c,g	350019293800000019,350019293800000019,350019293800000041,350019293800000041	11-36,11-36,11-36,11-36						Method of Using GPR35 to Identify Metabolic-Stabilizing Compounds - Patent application	www.faqs.org	0	0		TUBA3D
1013	chr8	56191642	56191667	3500187489	25		56191642	56191667	8421504	1	25	0	c,g	350018748900000006,350018748900000006	11-36,11-36						5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders	Leonard	2009	0		
1013	chr8	56191642	56191667	3500160408	25		56191642	56191667	8421504	1	25	0	c,g	350016040800000002,350016040800000002	11-36,11-36						Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure	Adams	2004	0		GNAQ
1013	chr8	56191642	56191667	3500118424	25		56191642	56191667	8421504	1	25	0	c,g	350011842400000002,350011842400000002,350011842400000008,350011842400000008	11-36,11-36,11-36,11-36					Patent	Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders (Patent EP:1636583)	Adams	2011	0		
1013	chr8	56191642	56191667	3500106988	25		56191642	56191667	8421504	1	25	0	c,g	350010698800000002,350010698800000002	11-36,11-36						Human g protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto	Bagnol	2007	0		GNAQ
1013	chr8	56191642	56191667	3500092551	25		56191642	56191667	8421504	1	25	0	c,g	350009255100000019,350009255100000019	11-36,11-36						Method of Using GPR35 to Identify Metabolic-Stabilizing Compounds	Chu	2012	0		
1013	chr8	56191642	56191667	3500091873	25		56191642	56191667	8421504	1	25	0	c,g	350009187300000002,350009187300000002	11-36,11-36						Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders	Adams	2007	0		GNAQ
1013	chr8	56191642	56191667	3500086952	25		56191642	56191667	8421504	1	25	0	c,g	350008695200000019,350008695200000019	11-36,11-36					Patent	Method of using GPR35 to identify metabolic-stabilizing compounds (Patent US:8039219)	Chu	2011	0		
1013	chr8	56191642	56191667	3500085841	25		56191642	56191667	8421504	1	25	0	c,g	350008584100000039,350008584100000039,350008584100000011,350008584100000011	11-36,11-36,11-36,11-36						Non-endogenous, constitutively activated versions of human G protein coupled receptor: FSHR - Patent application	www.faqs.org	0	0		GNAQ
1013	chr8	56191642	56191667	3500063597	25		56191642	56191667	8421504	1	25	0	c,g	350006359700000008,350006359700000008,350006359700000019,350006359700000019	11-36,11-36,11-36,11-36						Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders - Patent application	www.faqs.org	0	0		GNAQ
1013	chr8	56191642	56191667	3500029244	25		56191642	56191667	8421504	1	25	0	c,g	350002924400000006,350002924400000006	11-36,11-36						Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Cell Death-Related Disorders	Villegas	2004	0		
1013	chr8	56191642	56191667	3500021461	25		56191642	56191667	8421504	1	25	0	c,g	350002146100000019,350002146100000019	11-36,11-36						MODULATORS OF GPR35 FOR THE TREATMENT OF METABOLIC-RELATED DISORDERS - ARENA PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		GNAQ
1013	chr8	56191642	56191667	3500004223	25		56191642	56191667	8421504	1	25	0	c,g	350000422300000008,350000422300000008	11-36,11-36						Human G Protein-coupled Receptor And Modulators Thereof For The Treatment Of Cell Death-related Disorders 	.freshpatents.com	0	0		
1013	chr8	56191644	56191667	3500232044	23		56191644	56191667	8421504	1	23	0	c,g	350023204400000048,350023204400000048,350023204400000198,350023204400000198	11-34,11-34,11-34,11-34						Endogenous and non-endogenous versions of human G protein-coupled receptors	Liao Wang Zhen 	2004	0		GNAQ
1013	chr8	56191644	56191667	3500138953	23		56191644	56191667	8421504	1	23	0	c	350013895300000026	11-34						Endogenous and non-endogenous versions of human g protein-coupled receptors	Chen	2003	0		GNAQ
1013	chr8	56191644	56191667	3500098355	23		56191644	56191667	8421504	1	23	0	c,g	350009835500000026,350009835500000026,350009835500000080,350009835500000080	11-34,11-34,11-34,11-34						Endogenous And Non-endogenous Version Of Human G Protein-coupled Receptors 	.freshpatents.com	0	0		GNAQ
1013	chr8	56191644	56191667	3500017442	23		56191644	56191667	8421504	1	23	0	c	350001744200000042	11-34						Endogenous and non-endogenous versions of human G protein-coupled receptors	Liaw	2002	0		GNAQ
1013	chr8	56191657	56191684	3500365756	27		56191657	56191684	8421504	1	27	0	c	350036575600000004	21-48		20958291	10.1111/j.1476-5381.2010.01082.x		British Journal of Pharmacology	Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via G&#x03b1;13 and &#x03b2;-arrestin-2	Laura	2011	0		GNAQ
1013	chr8	56191831	56191856	3500407806	23		56191831	56191856	8421504	2	8,15	0,10	c	350040780600000100	7-30						METHOD RELATING TO SWEETNESS ENHANCEMENT - Patent application	www.faqs.org	0	0		
1013	chr8	56191831	56191856	3500326993	23		56191831	56191856	8421504	2	8,15	0,10	c	350032699300000188	7-30						Nucleic Acid, Polypeptide and Its Use - Patent application	www.faqs.org	0	0		
1015	chr8	56444779	56444802	3500043778	23		56444779	56444802	8421504	1	23	0	g	350004377800000076	4-42						 Methods For Degrading Or Converting Plant Cell Wall Polysaccharides 	www.docstoc.com	0	0		
1019	chr8	56976428	56976453	3500401488	23		56976428	56976453	8421504	2	9,14	0,11	g	350040148800000002	10-34				1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Trichloroethanol Modulation of Recombinant GABAA, Glycine and GABA &#x03c1;1 Receptors	Krasowski	1998	0		
1028	chr8	58110496	58110520	3500305954	23		58110496	58110520	8421504	2	16,7	0,17	g	350030595400000027	5-37					Patent	Bovine herpesvirus vaccine and method of using same (Patent US:5462734)	Israel	1995	0		
1028	chr8	58134740	58134767	3500309374	23		58134740	58134767	8421504	2	13,10	0,17	g	350030937400000158	0-23						&#xfee6;&#xfef3;&#xfeee;&#xfee7; &#xfeda;&#xfef4;&#xfe98;&#xfee7;&#x0698;	mg.genetics.ir	0	0		
1047	chr8	60631790	60631817	3500218688	26		60631790	60631817	8421504	2	22,4	0,23	g	350021868800000119	0-29						US Patent # 6,388,169. Maize orthologues of bacterial RecA proteins - Patents.com	www.patents.com	0	0		
1050	chr8	60951362	60951387	3500052584	23		60951362	60951387	8421504	2	5,18	0,7	g	350005258400000042	10-35						Compounds and methods for development of Ret modulators	Artis	2007	0		
1053	chr8	61452989	61453014	3500466154	23		61452989	61453014	8421504	2	18,5	0,20	g	350046615400000077	0-26						Annotation, phylogenetic analysis and functional characterization of barley [Hordeum vulgare L] WRKY transcription factors in the interaction with powdery mildew fungus Blumeria graminis	eb.uni-giessen.de	0	0		
1053	chr8	61458540	61458571	3500230330	23		61458540	61458571	8421504	3	12,6,5	0,17,26	g	350023033000000494	4-27						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
1056	chr8	61772258	61772299	3500131966	41		61772258	61772299	8421504	1	41	0	c	350013196600000262,350013196600000259,350013196600000265	0-41,0-41,0-32						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
1056	chr8	61772421	61782521	3500174708	1683		61772421	61782521	8421504	29	103,2,51,9,39,66,69,48,108,69,138,15,105,21,75,45,26,49,15,36,93,117,8,85,51,147,12,33,48	0,254,268,400,1841,1931,2271,2346,2472,2776,2851,3236,3254,3449,3539,4033,4120,4529,4650,4743,6947,7717,7840,8422,8510,9648,9807,10004,10052	p	350017470800015079,350017470800015078,350017470800015072,350017470800015071,350017470800015070,350017470800015058,350017470800015057,350017470800015063,350017470800015052,350017470800015043,350017470800015040,350017470800015029,350017470800015019,350017470800015018,350017470800015008,350017470800015007,350017470800015006,350017470800015005	0-105,0-51,0-48,0-135,0-48,0-177,0-153,3-54,0-126,0-120,0-75,0-51,0-210,0-93,0-51,0-147,0-45,0-48						C. elegans MAC-1, an essential member of the AAA family of ATPases, can bind CED-4 and prevent cell death	ev.biologists.org	0	0		VCP
1056	chr8	61775341	61775663	3500166675	75		61775341	61775663	8421504	2	69,6	0,316	p	350016667500015068,350016667500015126	0-57,0-72						US Patent # 7,501,484. Methods and DNA constructs for high yield production of polypeptides - Patents.com	www.patents.com	0	0		VCP
1056	chr8	61775341	61775389	3500048033	48		61775341	61775389	8421504	1	48	0	p	350004803300015061	0-48						METHODS AND DNA CONSTRUCTS FOR HIGH YIELD PRODUCTION OF POLYPEPTIDES - Patent application	www.faqs.org	0	0		VCP
1056	chr8	61776014	61779428	3500376790	606		61776014	61779428	8421504	6	21,113,136,134,103,99	0,440,936,1150,1905,3315	p	350037679000015031	0-606						Dsrna as insect control agent	Raemaekers	2007	0		VCP
1056	chr8	61776957	61777017	3500124382	60		61776957	61777017	8421504	1	60	0	p	350012438200015085	0-60						ABSTRACT	tory.lib.ncsu.edu	0	0		VCP
1056	chr8	61777182	61779365	3500356261	255		61777182	61779365	8421504	3	116,103,36	0,737,2147	p	350035626100015008	0-255						Dsrna as Insect Control Agent	Raemaekers	2009	0		VCP
1056	chr8	61808194	61808217	3500024692	23		61808194	61808217	8421504	1	23	0	c	350002469200000042	6-29						Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species	Cochran	1998	0		
1059	chr8	62201713	62201737	3500442858	23		62201713	62201737	8421504	2	4,19	0,5	g	350044285800000015	5-33						Methods For Breeding Glyphosate Resistant Plants And Compositions Thereof 	.freshpatents.com	0	0		
1059	chr8	62232795	62232820	3500453954	23		62232795	62232820	8421504	3	13,6,4	0,14,21	g	350045395400000000	9-32		17416670	10.1128/JB.00261-07	0021-9193	Journal of Bacteriology	Functional Genomics Enables Identification of Genes of the Arginine Transaminase Pathway in Pseudomonas aeruginosa	Yang	2007	4		
1059	chr8	62247261	62247309	3500274639	48		62247261	62247309	8421504	1	48	0	p	350027463900015056	81-129						CARACTERIZACIAN DE GENES CANDIDATOS PARA CARACTERES LIPADICOS E IDENTIFICACIAN DE COPY NUMBER VAR	www.tdx.cat	0	0		
1060	chr8	62278224	62278248	3500304753	23		62278224	62278248	8421504	2	9,14	0,10	c	350030475300000188	11-34						Compositions and methods for detection of antibody binding to cells - Patent application	www.faqs.org	0	0		
1060	chr8	62289503	62320353	3500189431	40		62289503	62320353	8421504	2	20,20	0,30830	c,g	350018943100000518,350018943100000644	3-23,0-20						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1060	chr8	62308331	62314419	3500319008	720		62308331	62314419	8421504	10	68,70,63,9,37,71,42,120,126,114	0,1039,1275,1842,1881,2057,2222,2452,5399,5974	p	350031900800015075,350031900800015060,350031900800015051,350031900800015011,350031900800015036,350031900800015031,350031900800015006,350031900800015018,350031900800015017	0-90,0-120,0-150,0-180,0-150,0-90,0-111,0-150,15-165						Cell surface tropomyosin as a target of angiogenesis inhibition	Donate	2005	0		TPM2
1060	chr8	62310237	62310400	3500305674	24		62310237	62310400	8421504	2	12,12	0,151	c	350030567400000000	0-24			10.1091/mbc.E02-10-0669		Molecular Biology of the Cell	Sequential Entry of Components of Gene Expression Machinery into Daughter Nuclei	Kannanganattu	2003	0		
1060	chr8	62314395	62314421	3500169773	26		62314395	62314421	8421504	1	26	0	c	350016977300000000	7-33						Tropomyosin Dynamics in Cardiac Thin Filaments: A Multisite Fo&#xa8;rster Resonance Energy Transfer and Anisotropy Study	ysiology.wisc.edu	0	0		TPM1
1060	chr8	62328284	62328703	3500121538	40		62328284	62328703	8421504	2	20,20	0,399	c,g	350012153800000001,350012153800000001,350012153800000000	0-20,0-20,0-20		23230271	10.1128/MCB.00790-12		Molecular and Cellular Biology	Talin1 and Rap1 Are Critical for Osteoclast Function	Wei	2013	0		
1060	chr8	62332702	62332867	3500280403	48		62332702	62332867	8421504	2	9,39	0,126	p	350028040300015086	0-48						Antisense modulation of talin expression	www.devileye.net	0	0		
1060	chr8	62341009	62341247	3500430809	66		62341009	62341247	8421504	2	12,54	0,184	p	350043080900015028	0-66						Patent Search: US Patent Number 8299236 - Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells	ww.archpatent.com	0	0		TLN1
1060	chr8	62341009	62341247	3500292820	66		62341009	62341247	8421504	2	12,54	0,184	p	350029282000015081	0-66						Lipopeptides for delivery of nucleic acids	Adami	2010	0		TLN1
1060	chr8	62341009	62341247	3500208064	66		62341009	62341247	8421504	2	12,54	0,184	p	350020806400015040	0-66						COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY	Cui	2007	0		TLN1
1060	chr8	62341009	62341247	3500188627	66		62341009	62341247	8421504	2	12,54	0,184	p	350018862700015027	0-66						COMPOSITIONS AND METHODS FOR ENHANCING DELIVERY OF NUCLEIC ACIDS INTO CELLS AND FOR MODIFYING EXPRESSION OF TARGET GENES IN CELLS - Patent application	www.faqs.org	0	0		TLN1
1060	chr8	62341009	62341247	3500100022	66		62341009	62341247	8421504	2	12,54	0,184	p	350010002200015090	0-66						Peptide-dicer substrate rna conjugates as delivery vehicles for sirna	Ahmadian	2007	0		TLN1
1061	chr8	62408043	62415196	3500017050	40		62408043	62415196	8421504	2	20,20	0,7133	c,g	350001705000000020,350001705000000020,350001705000000021	0-20,0-20,0-20						Regulation der Expression des Tumorinvasionssuppressors Visinin-like Protein 1 (VILIP-1) und seine Bedeutung f&#xfc;r das Metastasierungspotential von Plattenepithelkarzinomzellen	diss.fu-berlin.de	0	0		
1061	chr8	62416376	62416633	3500040949	26		62416376	62416633	8421504	2	20,6	0,251	c	350004094900000003	0-26						Journal of Molecular and Cellular Cardiology	physiology.dal.ca	0	0		NPR2
1061	chr8	62467497	62467524	3500340574	23		62467497	62467524	8421504	2	10,13	0,14	c	350034057400000005	0-23						Supplemental Materials and Methods Real time PCR primers for mRNA expression	www.jbc.org	0	0		
1065	chr8	62922038	62922181	3500301166	141		62922038	62922181	8421504	2	117,24	0,119	p	350030116600015048,350030116600015049	0-78,0-66						26 Human secreted proteins	Ruben	2000	0		
1065	chr8	62945629	62946862	3500004770	40		62945629	62946862	8421504	2	20,20	0,1213	c	350000477000000004,350000477000000005	0-20,0-20						Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. - ResearchGate	.researchgate.net	0	0		RECK
1068	chr8	63327914	63327943	3500113069	24		63327914	63327943	8421504	2	10,14	0,15	g	350011306900000011	0-24						Development and validation of a multiplex PCR-based DNA microarray hybridisation method for detecting bacterial antibiotic resistance genes in cheese	digital.csic.es	0	0		
1068	chr8	63345794	63354075	3500141372	50		63345794	63354075	8421504	3	25,3,22	0,2905,8259	c	350014137200000000,350014137200000002	0-25,0-25						Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers	Seeley	2001	0		MELK
1068	chr8	63345794	63354075	3500000708	50		63345794	63354075	8421504	3	25,3,22	0,2905,8259	c	350000070800000000,350000070800000002	0-25,0-25						Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers	Wu	2001	0		MELK
1068	chr8	63377211	63377234	3500307492	23		63377211	63377234	8421504	1	23	0	c	350030749200000006	26-49					Patent	Cancer stem cell antigen vaccines and methods (Patent US:8129184)	Yu	2012	0		
1068	chr8	63377211	63377234	3500023932	23		63377211	63377234	8421504	1	23	0	c	350002393200000006	26-49						CANCER STEM CELL ANTIGEN VACCINES AND METHODS	Yu	2007	0		
1068	chr8	63382881	63409009	3500027904	75		63382881	63409009	8421504	3	26,25,24	0,7698,26104	c	350002790400000014,350002790400000016,350002790400000017	0-26,0-25,0-25						 SpringerImages - primers sequences 	pringerimages.com	0	0		
1068	chr8	63382881	63390604	3500388350	51		63382881	63390604	8421504	2	26,25	0,7698	c	350038835000000039,350038835000000041	0-26,0-25						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		
1069	chr8	63539789	63539813	3500051117	23		63539789	63539813	8421504	2	14,9	0,15	g	350005111700000046	1-24						Full text of "Protocols_molecular_biology"	archive.org	0	0		
1069	chr8	63539789	63539813	3500020978	23		63539789	63539813	8421504	2	14,9	0,15	g	350002097800000002	1-24						MMB 261 Protein Protein Interactions	www.scribd.com	0	0		
1070	chr8	63690774	63690891	3500399962	41		63690774	63690891	8421504	2	21,20	0,97	g	350039996200000002,350039996200000003	7-28,8-28						THE J B C &#xa9; 2002 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. The Interaction of Pax5 (BSAP) with Daxx Can Result in Transcriptional Activation in B Cells*	www.jbc.org	0	0		
1071	chr8	63743508	63743531	3500083094	23		63743508	63743531	8421504	1	23	0	g	350008309400000014	0-23		16428437	10.1128/MCB.26.3.810-821.2006	0270-7306	Molecular and Cellular Biology	E2A and IRF-4/Pip Promote Chromatin Modification and Transcription of the Immunoglobulin &#x03ba; Locus in Pre-B Cells	Lazorchak	2006	6		
1071	chr8	63749351	63749376	3500426545	25		63749351	63749376	8421504	1	25	0	g	350042654500000004	0-25					PLoS ONE	Transcription Factors E2A, FOXO1 and FOXP1 Regulate Recombination Activating Gene Expression in Cancer Cells - Scolaris	Chen	2011	0		
1071	chr8	63757574	63757598	3500019810	24		63757574	63757598	8421504	1	24	0	g	350001981000000000	0-24						NPG.nature.vol.401.Issue.6753.Oct	www.scribd.com	0	0		PAX5
1075	chr8	64229889	64229916	3500189748	23		64229889	64229916	8421504	2	14,9	0,18	c	350018974800000035	11-34						MEGSIN protein	Miyata	2004	0		
1076	chr8	64422321	64422346	3500386203	23		64422321	64422346	8421504	2	6,17	0,8	c	350038620300000103	5-29						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
1078	chr8	64694550	64694574	3500234968	24		64694550	64694574	8421504	1	24	0	c	350023496800000359	3-27						Method and product for regulating cell responsiveness to external signals - Patent application	www.faqs.org	0	0		
1079	chr8	64808782	64808811	3500188892	25		64808782	64808811	8421504	2	18,7	0,22	g	350018889200000004	22-47						METHOD FOR MODIFYING THE ATP/ADP RATIO IN CELLS - Patent application	www.faqs.org	0	0		
1081	chr8	65099775	65099803	3500201864	24		65099775	65099803	8421504	2	7,17	0,11	g	350020186400000290	14-39						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
1081	chr8	65099775	65099803	3500005314	24		65099775	65099803	8421504	2	7,17	0,11	g	350000531400000294	14-39						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
1083	chr8	65286193	65288271	3500093048	23		65286193	65288271	8421504	3	5,3,15	0,2058,2063	c	350009304800000028	7-36						Human lactoferrin	Kruzel	2001	0		
1084	chr8	65466112	65469985	3500154980	111		65466112	65469985	8421504	2	22,89	0,3784	p	350015498000015000	0-111			10.1111/j.1432-1033.2004.04251.x	1432-1033	European Journal of Biochemistry	Interaction of selenium compounds with zinc finger proteins involved in DNA repair - Blessing - 2004 - European Journal of Biochemistry - Wiley Online Library	Blessing	2004	0		XPA
1085	chr8	65651154	65651180	3500437803	23		65651154	65651180	8421504	2	12,11	0,15	g	350043780300000004	1-24		23118955	10.1371/journal.pone.0048211	1932-6203	PLOS ONE	PLOS ONE: Ppm1-Encoded Polyprenyl Monophosphomannose Synthase Activity Is Essential for Lipoglycan Synthesis and Survival in Mycobacteria	Rana	2012	4		
1087	chr8	65910640	65910667	3500121839	23		65910640	65910667	8421504	3	6,4,13	0,9,14	g	350012183900000034	1-24						DIRECTED EVOLUTION OF NOVEL BINDING PROTEINS	Ladner	2007	0		
1088	chr8	65938866	65938891	3500182929	25		65938866	65938891	8421504	1	25	0	g	350018292900000089	5-36						Free Medical Textbook | every people has explanation!!!!!!!! | Page 31	ree.wordpress.com	0	0		
1089	chr8	66124534	66124558	3500277116	23		66124534	66124558	8421504	2	4,19	0,5	g	350027711600000002	0-23					American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Ca2+ binding to cardiac troponin C: effects of temperature and pH on mammalian and salmonid isoforms	Gillis	2000	0		
1089	chr8	66124534	66124558	3500187419	23		66124534	66124558	8421504	2	4,19	0,5	g	350018741900000002	0-23					American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	Ca2+ binding to cardiac troponin C: effects of temperature and pH on mammalian and salmonid isoforms	Gillis	2000	0		
1091	chr8	66344706	66344733	3500440739	23		66344706	66344733	8421504	2	6,17	0,10	g	350044073900000155	5-28						5' to 3' exonuclease mutations of thermostable DNA polymerases	Abramson	1993	0		
1091	chr8	66344706	66344733	3500384749	23		66344706	66344733	8421504	2	6,17	0,10	g	350038474900000153	5-28						5' to 3' exonuclease mutations of thermostable DNA polymerases - Patent # 5795762 - PatentGenius	.patentgenius.com	0	0		
136	chr8	66704361	66726075	3500257458	40		66704361	66726075	8421504	3	20,19,1	0,18951,21713	c	350025745800000006,350025745800000007	0-20,0-20						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
1093	chr8	66708106	66708249	3500008335	48		66708106	66708249	8421504	2	24,24	0,119	c	350000833500000065,350000833500000066	0-24,0-24						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
136	chr8	66708312	66716777	3500354530	25		66708312	66716777	8421504	2	15,10	0,8455	c	350035453000000002	0-25						LOW INTENSITY PULSED ULTRASOUND STIMULATES CELL PROLIFERATION	www.docstoc.com	0	0		
136	chr8	66708324	66723172	3500349767	44		66708324	66723172	8421504	4	3,19,13,9	0,8443,8661,14839	c	350034976700000024,350034976700000025	0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		TGFBR1
136	chr8	66708324	66716811	3500149873	47		66708324	66716811	8421504	2	3,44	0,8443	c	350014987300000001	0-47		11251079	10.1091/mbc.12.3.675	1059-1524	Molecular Biology of the Cell	Mechanisms of Transforming Growth Factor-&#x03b2; Receptor Endocytosis and Intracellular Sorting Differ between Fibroblasts and Epithelial Cells	Jules	2001	5		TGFBR1
1094	chr8	66723288	66726225	3500167894	38		66723288	66726225	8421504	2	19,19	0,2918	c,g	350016789400000077,350016789400000078,350016789400000078	0-19,0-19,0-19						&#xc9;COLE DOCTORALE SST	lis.univ-tours.fr	0	0		
1094	chr8	66723288	66726225	3500157269	38		66723288	66726225	8421504	2	19,19	0,2918	c,g	350015726900000077,350015726900000077,350015726900000078	0-19,0-19,0-19						&#xc9;COLE DOCTORALE SST	scd.univ-tours.fr	0	0		
1094	chr8	66726221	66737558	3500370112	25		66726221	66737558	8421504	2	10,15	0,11322	c	350037011200000072,350037011200000032	0-25,0-25						Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity - Patent application	www.faqs.org	0	0		TGFBR1
1094	chr8	66737594	66743717	3500030343	54		66737594	66743717	8421504	2	27,27	0,6096	c	350003034300000000,350003034300000001	0-27,0-27		15289325	10.1158/0008-5472.CAN-04-0018	0008-5472	Cancer Research	Targeting Endogenous Transforming Growth Factor &#x03b2; Receptor Signaling in SMAD4-Deficient Human Pancreatic Carcinoma Cells Inhibits Their Invasive Phenotype 1	Subramanian	2004	8		TGFBR1
1094	chr8	66737604	66743696	3500350809	39		66737604	66743696	8421504	2	20,19	0,6073	c,g	350035080900000014,350035080900000014,350035080900000015	0-20,0-20,0-19						Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase	Zern	2002	0		TGFBR1
1094	chr8	66738764	66743641	3500406815	23		66738764	66743641	8421504	2	21,2	0,4875	c	350040681500000000	0-23		14684852	10.1210/me.2003-0393	0888-8809	Molecular Endocrinology	Growth Differentiation Factor-9 Signaling Is Mediated by the Type I Receptor, Activin Receptor-Like Kinase 5	Mazerbourg	2004	5		TGFBR1
1094	chr8	66743671	66743757	3500217315	48		66743671	66743757	8421504	2	24,24	0,62	c	350021731500000057,350021731500000058	0-24,0-24						GENE EXPRESSION IN SOWS WITH HIGH AND LOW OVULATION RATE, HIGH AND LOW BIRTH WEIGHT LITTER AND THE EFFECT OF SOW CATABOLIC STATUS ON EMBRYONIC GENE EXPRESSION	www.tede.ufv.br	0	0		
1094	chr8	66822090	66822119	3500410785	25		66822090	66822119	8421504	2	13,12	0,17	c	350041078500000003	0-25		10218980	10.1210/en.140.5.2268	0013-7227	Endocrinology	Identification of a GABP&#x03b1;/&#x03b2; Binding Site Involved in the Induction of Oxytocin Receptor Gene Expression in Human Breast Cells. Potentiation by c-Fos/c-Jun	Hoare	1999	4		
1094	chr8	66833471	66833528	3500151936	57		66833471	66833528	8421504	1	57	0	p	350015193600015009	0-57						Nature Magazine - 26 August 2010	www.scribd.com	0	0		SEC61B
1096	chr8	67102434	67102459	3500406269	23		67102434	67102459	8421504	2	10,13	0,12	c	350040626900000133	7-30					Patent	Ad6 recombinant nucleic acid (Patent CN:1880457)	A*J*Bei Te 	2010	0		
1099	chr8	67460105	67460128	3500328740	23		67460105	67460128	8421504	1	23	0	g	350032874000000004	8-31			10.1042/BJ20050967		Biochemical Journal	Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation	Andrew D.	2006	0		
1100	chr8	67589685	67599650	3500258818	136		67589685	67599650	8421504	3	45,29,62	0,148,9903	p,c	350025881800015021,350025881800000018,350025881800000195,350025881800015024,350025881800000305,350025881800000304	0-45,0-28,0-28,0-45,0-21,0-19						METHODS AND MATERIALS RELATED TO HAIR PIGMENTATION AND CANCER - Patent application	www.faqs.org	0	0		
1102	chr8	67850594	67850622	3500457089	23		67850594	67850622	8421504	2	6,17	0,11	g	350045708900000050,350045708900000141	5-28,5-28						 Treatment Of Macular Degeneration With ADP 	www.docstoc.com	0	0		
1111	chr8	69035033	69072253	3500362691	38		69035033	69072253	8421504	4	13,6,6,13	0,16,37196,37207	g	350036269100000335,350036269100000009	5-24,7-26						Highly polymorphic microsatellites 00Graphicraft Limited, Hong Kong in the lacertid Gallotia galloti	ents.plant.wur.nl	0	0		
1118	chr8	69889876	69908456	3500322795	809		69889876	69908456	8421504	11	47,6,42,35,7,41,19,104,105,263,140	0,48,6668,9846,11553,12804,12874,13916,15532,18176,18440	c	350032279500000059,350032279500000060,350032279500000067,350032279500000154,350032279500000140,350032279500000156,350032279500000157,350032279500000158,350032279500000159,350032279500000160,350032279500000161	0-47,0-48,6-41,0-48,29-48,0-48,0-48,0-48,0-48,0-55,0-365						Method of Diagnosis/Prognosis of Human Chronic Lymphocytic Leukemia Comprising the Profiling of Lpl/Adam Genes - Patent application	www.faqs.org	0	0		
1118	chr8	69889896	69896560	3500157577	43		69889896	69896560	8421504	3	21,6,16	0,28,6648	c	350015757700000005,350015757700000004	0-21,24-46						Effect of food restriction on adipose tissue in spontaneously diabetic Torii fatty rats. - ResearchGate	.researchgate.net	0	0		
1118	chr8	69889910	69896549	3500082043	25		69889910	69896549	8421504	2	20,5	0,6634	c	350008204300000003	0-25						Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis	www.jlr.org	0	0		LPL
1118	chr8	69889914	69896558	3500067382	30		69889914	69896558	8421504	2	16,14	0,6630	c	350006738200000003	0-30						 Lipoprotein lipase in highly vascularized structures of the eye 	rch.microsoft.com	0	0		LPL
1118	chr8	69889924	69908456	3500149704	850		69889924	69908456	8421504	12	6,42,29,30,35,48,7,41,104,105,263,140	0,6620,6716,9759,9798,11310,11505,12756,13868,15484,18128,18392	c	350014970400000060,350014970400000062,350014970400000035,350014970400000067,350014970400000041,350014970400000154,350014970400000156,350014970400000157,350014970400000051,350014970400000158,350014970400000159,350014970400000160,350014970400000161	0-48,6-35,18-48,6-41,0-48,0-48,0-48,0-48,0-41,0-48,0-48,0-55,0-365						METHOD OF DIAGNOSIS/PROGNOSIS OF HUMAN CHRONIC LYMPHOCYTIC LEUKEMIA COMPRISING THE PROFILING OF LPL/ADAM GENES - Patent application	www.faqs.org	0	0		
1118	chr8	69896617	69898592	3500159234	39		69896617	69898592	8421504	3	19,16,4	0,91,1971	c	350015923400000004,350015923400000005	0-19,0-20						Trabajo Fin de Master . Olaia Urrutia Vera.	ica-e.unavarra.es	0	0		
1118	chr8	69898620	69899824	3500274729	203		69898620	69899824	8421504	3	20,37,146	0,43,1058	c,g	350027472900000010,350027472900000010,350027472900000022	0-20,0-20,0-183						Ex vivo Expansion and Differentiation of Mesenchymal Stem Cells from Goat Bone Marrow	www.mums.ac.ir	0	0		
1118	chr8	69899722	69902748	3500232370	46		69899722	69902748	8421504	2	22,24	0,3002	c	350023237000000004,350023237000000005	0-22,19-43						<HTML><!-- InstanceBegin template="/Templates/index.dwt" codeOutsideHTMLIsLocked="false" --> <HEAD>	ock.colostate.edu	0	0		
1118	chr8	69899831	69899854	3500459826	23		69899831	69899854	8421504	1	23	0	c	350045982600000003	22-45						Changes in the Endometrial Transcriptome During the Bovine Estrous Cycle: Effect of Low Circulating Progesterone and Consequences for Conceptus Elongation	ww.biolreprod.org	0	0		
1118	chr8	69901256	69901281	3500354925	25		69901256	69901281	8421504	1	25	0	c	350035492500000001	0-25		21282354	10.1158/1535-7163.MCT-10-0802	1535-7163	Molecular Cancer Therapeutics	Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation	Kuemmerle	2011	5		
1118	chr8	69902795	69908060	3500407458	42		69902795	69908060	8421504	4	6,15,13,8	0,918,2705,5257	c	350040745800000006,350040745800000007	0-21,0-21						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		
1118	chr8	69903849	69905409	3500029099	48		69903849	69905409	8421504	2	47,1	0,1559	p	350002909900015035	0-48						Compositions And Methods For Targeting A Polypeptide To The Central Nervous System 	freshpatents.com	0	0		
1118	chr8	69903852	69905409	3500074996	45		69903852	69905409	8421504	2	44,1	0,1556	p	350007499600015035	0-45						COMPOSITIONS AND METHODS FOR TARGETING A POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM - Patent application	www.faqs.org	0	0		
1118	chr8	69909315	69909494	3500464199	50		69909315	69909494	8421504	2	24,26	0,153	c,g	350046419900000003,350046419900000005,350046419900000005	0-24,0-26,0-26				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		
1118	chr8	69909592	69909721	3500172791	43		69909592	69909721	8421504	2	22,21	0,108	c	350017279100000026,350017279100000027	0-22,0-21		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
1118	chr8	69909592	69909721	3500120290	43		69909592	69909721	8421504	2	22,21	0,108	c	350012029000000026,350012029000000027	0-22,0-21						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
1118	chr8	69909592	69909721	3500048191	43		69909592	69909721	8421504	2	22,21	0,108	c,g	350004819100000026,350004819100000026,350004819100000027	0-22,0-22,0-21		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
1120	chr8	70189179	70189208	3500440812	29		70189179	70189208	8421504	1	29	0	g	350044081200000079	18-47						Vesicle membrane transport proteins	Edwards	1993	0		
1120	chr8	70192022	70231200	3500409678	77		70192022	70231200	8421504	3	8,40,29	0,606,39149	c	350040967800000019,350040967800000036	0-48,0-29						Human amine transporter polypeptide fragments	Li	1998	0		
17	chr8	70246929	70269205	3500362806	393		70246929	70269205	8421504	5	60,136,83,105,9	0,18080,19625,20962,22267	p	350036280600015006,350036280600015011,350036280600015020	0-60,0-315,0-315						V-ATPASE EXPRESSION AND FUNCTION IN THE BRINE SHRIMP, ARTEMIA FRANCISCANA ROLE OF PROTON GRADIENTS IN ANOXIA-INDUCED QUIESCENCE	etd.lsu.edu	0	0		ATP6V1B2
1121	chr8	70260585	70266571	3500376790	495		70260585	70266571	8421504	7	19,78,140,6,84,151,17	0,173,696,1174,2398,4409,5969	p	350037679000015010,350037679000015017	0-495,0-192						Dsrna as insect control agent	Raemaekers	2007	0		ATP6V1B2
1121	chr8	70262235	70266556	3500456974	372		70262235	70266556	8421504	4	95,124,151,2	0,708,2759,4319	p	350045697400015019,350045697400015021,350045697400015020,350045697400015024,350045697400015022	0-210,0-210,0-210,0-162,0-162						Ion-motive ATPases and active, transbranchial NaCl uptake in the red freshwater crab, Dilocarcinus pagei (Decapoda, Trichodactylidae)	eb.biologists.org	0	0		ATP6V1B2
1121	chr8	70309669	70309692	3500023901	23		70309669	70309692	8421504	1	23	0	c	350002390100000070	0-23						US Patent # 7,141,417. Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene - Patents.com	www.patents.com	0	0		
1121	chr8	70381026	70381054	3500318229	23		70381026	70381054	8421504	2	17,6	0,22	g	350031822900000078	4-27						METHODS OF IDENTIFYING AND CREATING RUBISCO LARGE SUBUNIT VARIANTS WITH IMPROVED RUBISCO ACTIVITY, COMPOSITIONS AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
1122	chr8	70412583	70412608	3500049343	23		70412583	70412608	8421504	2	8,15	0,10	g	350004934300000009	1-24					Molecular Biology of the Cell	The Yeast Dynactin Complex Is Involved in Partitioning the Mitotic Spindle between Mother and Daughter Cells during Anaphase B	Jason	July	0		
1124	chr8	70704943	70704966	3500173543	23		70704943	70704966	8421504	1	23	0	g	350017354300000016	15-38						 Methods And Compositions For Enhancing Sensitivity In The Analysis Of Biological 	www.docstoc.com	0	0		
1124	chr8	70768057	70769898	3500453386	46		70768057	70769898	8421504	2	25,21	0,1820	g	350045338600000013,350045338600000014	53-78,4-25		14726517	10.1074/jbc.M313589200	0021-9258	Journal of Biological Chemistry	Sp2 DNA Binding Activity and trans-Activation Are Negatively Regulated in Mammalian Cells	Moorefield	2004	5		
1127	chr8	71137448	71137479	3500008519	24		71137448	71137479	8421504	3	13,6,5	0,18,26	g	350000851900000136	24-48						RefSeq: NC_000962	www.genome.jp	0	0		
1128	chr8	71177130	71177159	3500127954	26		71177130	71177159	8421504	3	7,15,4	0,9,25	g	350012795400000000	2-28						VARIANTS OF THE ALPHA 1 SUBUNIT OF HUMAN AMPK - Patent application	www.faqs.org	0	0		
1129	chr8	71395328	71395358	3500414165	27		71395328	71395358	8421504	2	19,8	0,22	g	350041416500000003	0-27						Assay for virulent revertants of attenuated live vaccines and kits therefor	Levenbook	1994	0		
1134	chr8	71998700	71998940	3500265540	96		71998700	71998940	8421504	2	48,48	0,192	c	350026554000000024,350026554000000020	0-48,0-48						RECEPTORS FOR TGF-&#x03b2;-RELATED NEUROTROPHIC FACTORS	Baloh	1998	0		
1134	chr8	71998700	71998741	3500085073	41		71998700	71998741	8421504	1	41	0	c	350008507300000045,350008507300000011	16-48,7-48						Glial Cell Line-derived Neurotrophic Factor Receptor 	freshpatents.com	0	0		
1134	chr8	72004039	72004062	3500334721	23		72004039	72004062	8421504	1	23	0	c	350033472100000003	20-43		21193547	10.1128/EC.00196-10	1535-9778	Eukaryotic Cell	Characterization of the Dictyostelium Homolog of Chromatin Binding Protein DET1 Suggests a Conserved Pathway Regulating Cell Type Specification and Developmental Plasticity	Dubin	2011	4		
1135	chr8	72114037	72114061	3500453007	23		72114037	72114061	8421504	2	10,13	0,11	g	350045300700000087	1-24						REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY - Patent application	www.faqs.org	0	0		
1135	chr8	72127580	72127603	3500142031	23		72127580	72127603	8421504	1	23	0	c	350014203100000009	0-24		21324897	10.1074/jbc.M110.176099		The Journal of Biological Chemistry	A Runx2/miR-3960/miR-2861 Regulatory Feedback Loop during Mouse Osteoblast Differentiation	Rong	2011	0		
1136	chr8	72342346	72342421	3500272021	75		72342346	72342421	8421504	1	75	0	p	350027202100015005,350027202100015002	0-75,0-66						Pulmonary hydrophobic surfactant-associated proteins	Fox	1989	0		
1136	chr8	72342346	72342421	3500043665	75		72342346	72342421	8421504	1	75	0	p	350004366500015005,350004366500015002	0-75,0-66						Pulmonary hydrophobic surfactant-associated proteins	Fox	1988	0		
1136	chr8	72343088	72344012	3500042740	321		72343088	72344012	8421504	7	45,45,3,42,57,75,54	0,48,96,337,391,792,870	p	350004274000015042,350004274000015043,350004274000015044,350004274000015093,350004274000015048,350004274000015094,350004274000015049,350004274000015050,350004274000015096	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Compound And Method For Treatment Of Alzheimer's Disease - Patent application	www.faqs.org	0	0		
1136	chr8	72343135	72343502	3500193113	41		72343135	72343502	8421504	2	21,20	0,347	c,g	350019311300000006,350019311300000007,350019311300000007	0-21,0-20,0-20		24086682	10.1371/journal.pone.0076036	1932-6203	PLOS ONE	PLOS ONE: Establishment and Evaluation of a Stable Cattle Type II Alveolar Epithelial Cell Line	Su	2013	4		
1137	chr8	72386487	72386539	3500252181	52		72386487	72386539	8421504	1	52	0	g	350025218100000001	7-59					Patent	Peptidic procollagen C-proteinase inhibitors (Patent US:6951918)	Dankwardt	2005	0		
1137	chr8	72386487	72386539	3500121514	52		72386487	72386539	8421504	1	52	0	g	350012151400000001	7-59					Patent	Peptidic procollagen C-proteinase inhibitors (Patent US:6426402)	Dankwardt	2002	0		
1137	chr8	72386487	72386539	3500061351	52		72386487	72386539	8421504	1	52	0	g	350006135100000001	7-59						Peptidic procollagen C-proteinase inhibitors	Dankwardt	2002	0		
1137	chr8	72386487	72386539	3500024548	52		72386487	72386539	8421504	1	52	0	g	350002454800000001,350002454800000006	7-59,7-59						Peptidic procollagen C-proteinase inhibitors	www.devileye.net	0	0		
1137	chr8	72404576	72404601	3500287505	23		72404576	72404601	8421504	2	13,10	0,15	c	350028750500000031	8-45						Methods for diagnosing Pseudoxanthoma elasticum	www.devileye.net	0	0		
1137	chr8	72430527	72430553	3500013455	26		72430527	72430553	8421504	1	26	0	c	350001345500000220	20-46						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		
1137	chr8	72430530	72430553	3500423784	23		72430530	72430553	8421504	1	23	0	g	350042378400000109	0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		
1137	chr8	72430530	72430553	3500131061	23		72430530	72430553	8421504	1	23	0	g	350013106100000021,350013106100000079	0-23,0-22						MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES - Patent application	www.faqs.org	0	0		
1137	chr8	72430530	72430553	3500125321	23		72430530	72430553	8421504	1	23	0	c	350012532100000158	0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
1137	chr8	72436581	72436607	3500333255	24		72436581	72436607	8421504	3	11,4,9	0,12,17	c	350033325500000008	0-24						Cacna1g polynucleotide, polypeptide and methods of use therefor	Issa	2003	0		
1137	chr8	72436581	72436607	3500313173	24		72436581	72436607	8421504	3	11,4,9	0,12,17	c	350031317300000008	0-24						Cacna1g polynucleotide, polypeptide and methods of use therefor	Issa	2002	0		
1137	chr8	72436581	72436607	3500253345	24		72436581	72436607	8421504	3	11,4,9	0,12,17	c	350025334500000008	0-24						CACNA1G polynucleotide, polypeptide and methods of use therefor	Issa	2005	0		
1137	chr8	72436581	72436607	3500251924	24		72436581	72436607	8421504	3	11,4,9	0,12,17	c	350025192400000008	0-24					Patent	CACNA1G polynucleotide, polypeptide and methods of use therefor (Patent US:6783933)	Issa	2004	0		
1137	chr8	72436581	72436607	3500250040	24		72436581	72436607	8421504	3	11,4,9	0,12,17	c	350025004000000008	0-24					Patent	PITX2 polynucleotide, polypeptide and methods of use therefor (Patent US:7427476)	Issa	2008	0		
1137	chr8	72436581	72436607	3500245504	24		72436581	72436607	8421504	3	11,4,9	0,12,17	c	350024550400000008	0-24						PITX2 Polynucleotide, Polypeptide and Methods of Use Therefor	Issa	2009	0		
1137	chr8	72436581	72436607	3500158976	24		72436581	72436607	8421504	3	11,4,9	0,12,17	c	350015897600000008	0-24						Cacna1g polynucleotide, polypeptide and methods of use therefor	Issa	2002	0		
1138	chr8	72594062	72594086	3500224793	24		72594062	72594086	8421504	1	24	0	c	350022479300000007	0-24			10.1111/j.1742-4658.2005.04580.x	1742-4658	FEBS Journal	SLC39A14, a LZT protein, is induced in adipogenesis and transports zinc - Tominaga - 2005 - FEBS Journal - Wiley Online Library	Tominaga	2005	0		
1140	chr8	72768701	72768846	3500247073	23		72768701	72768846	8421504	3	11,6,6	0,12,139	c	350024707300000114	2-25						APM1 biallelic markers and uses thereof	Bougueleret	2000	0		
1140	chr8	72827985	72828015	3500458275	25		72827985	72828015	8421504	3	6,6,13	0,10,17	c	350045827500000006	8-35		18266930	10.1111/j.1471-4159.2008.05289.x	1471-4159	Journal of Neurochemistry	Group III metabotropic glutamate receptor activation suppresses self-replication of undifferentiated neocortical progenitor cells - Nakamichi - 2008 - Journal of Neurochemistry - Wiley Online Library	Nakamichi	2008	0		
1142	chr8	73123398	73123424	3500204363	24		73123398	73123424	8421504	2	7,17	0,9	g	350020436300000015	2-26						 hep a | Search Results | The Refusers | Page 2	therefusers.com	0	0		
1143	chr8	73157395	73157422	3500332961	23		73157395	73157422	8421504	2	13,10	0,17	g	350033296100000218	0-23						 Biosynthesis Of Commodity Chemicals 	www.docstoc.com	0	0		
1145	chr8	73454218	73454253	3500198384	31		73454218	73454253	8421504	3	14,13,4	0,17,31	c	350019838400000079	2-33						Apo-2DcR	Ashkenazi	1998	0		
1145	chr8	73524642	73524666	3500274224	24		73524642	73524666	8421504	1	24	0	c	350027422400000014,350027422400000015	9-33,9-33						Rho GTPasen der RhoBTB Familie: Charakterisierung und Rolle in der Tumorentstehung	www.uni-koeln.de	0	0		
1146	chr8	73604380	73604412	3500113263	26		73604380	73604412	8421504	3	8,3,15	0,10,17	g	350011326300000006	9-35					Patent	Antik&#xf6;rper mit verbesserter produzierbarkeit Antibodies with improved reproducibility (Patent DE:69935516)	Bamberger	2008	0		
1150	chr8	74102402	74102440	3500375699	36		74102402	74102440	8421504	2	27,9	0,29	g	350037569900000027	49-85						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
143	chr8	74177992	74192394	3500065154	111		74177992	74192394	8421504	2	60,51	0,14351	p	350006515400015043,350006515400015003	0-60,0-51						Klonierung und funktionelle Charakterisierung der NTPDase3 aus der Ratte	.uni-frankfurt.de	0	0		ENTPD4
143	chr8	74178001	74194345	3500106577	585		74178001	74194345	8421504	12	93,36,11,31,70,101,47,16,33,108,31,8	0,407,446,7403,7437,8027,8131,14239,14261,15010,15121,16336	p	350010657700015028,350010657700015025,350010657700015022,350010657700015015	15-108,6-180,0-174,0-150						21 human secreted proteins	Baker	2001	0		ENTPD4
1152	chr8	74328719	74328752	3500194201	28		74328719	74328752	8421504	3	5,5,18	0,8,15	c	350019420100000045,350019420100000012,350019420100000013	4-32,9-32,9-32						 Chemical Inhibitors Of Mismatch Repair 	www.docstoc.com	0	0		
1152	chr8	74406728	74406849	3500259232	121		74406728	74406849	8421504	1	121	0	g	350025923200000013	0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
1152	chr8	74406728	74406849	3500000589	121		74406728	74406849	8421504	1	121	0	g	350000058900000029	0-122						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
1154	chr8	74595015	74595139	3500157219	40		74595015	74595139	8421504	2	19,21	0,103	c,g	350015721900000015,350015721900000016,350015721900000016	0-19,0-21,0-21		18239051	10.1530/REP-07-0415	1470-1626	Reproduction	Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle	Mitko	2008	3		STC1
1154	chr8	74595656	74603342	3500274037	60		74595656	74603342	8421504	3	20,20,20	0,7615,7666	c,g	350027403700000157,350027403700000156,350027403700000156,350027403700000154	0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1154	chr8	74595741	74606971	3500036737	40		74595741	74606971	8421504	2	20,20	0,11210	c,g	350003673700000001,350003673700000001,350003673700000000,350003673700000000	0-20,0-20,0-20,0-20		16452456	10.1095/biolreprod.106.050807	0006-3363	Biology of Reproduction	Stanniocalcin (STC) in the Endometrial Glands of the Ovine Uterus: Regulation by Progesterone and Placental Hormones	Song	2006	4		
1154	chr8	74606953	74606976	3500440561	23		74606953	74606976	8421504	1	23	0	c	350044056100000003	0-23		16505094	10.1158/1535-7163.MCT-05-0289	1535-7163	Molecular Cancer Therapeutics	Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function	Rouleau	2006	5		STC1
1154	chr8	74606953	74606976	3500333601	23		74606953	74606976	8421504	1	23	0	c	350033360100000003	0-23						Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function	.aacrjournals.org	0	0		STC1
1154	chr8	74606957	74607002	3500291837	45		74606957	74607002	8421504	1	45	0	p	350029183700015156	0-45						OVR110 ANTIBODY COMPOSITIONS AND METHODS OF USE - Patent application	www.faqs.org	0	0		STC1
1156	chr8	74918960	74918983	3500155900	23		74918960	74918983	8421504	1	23	0	g	350015590000000186	19-42						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
1163	chr8	75856134	75856292	3500446880	44		75856134	75856292	8421504	2	22,22	0,136	c,g	350044688000000037,350044688000000056,350044688000000056,350044688000000016	0-22,0-22,0-22,22-44						Compositions and Methods for Modulating Pgc-1Alpha to Treat Neurological Diseases and Disorders - Patent application	www.faqs.org	0	0		
1163	chr8	75857203	75857942	3500467535	24		75857203	75857942	8421504	2	12,12	0,727	c	350046753500000025	0-24						IsolationofaGlial-Restricted TripotentialCellLineFrom EmbryonicSpinalCordCultures	bio.drexelmed.edu	0	0		
1163	chr8	75857203	75857942	3500430105	24		75857203	75857942	8421504	2	12,12	0,727	c	350043010500000026	24-48		19912344	10.1111/j.1365-2443.2009.01356.x	1365-2443	Genes to Cells	Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells - Nagata - 2009 - Genes to Cells - Wiley Online Library	Nagata	2009	0		
1163	chr8	75859564	75859587	3500251026	23		75859564	75859587	8421504	1	23	0	c	350025102600000006	21-44						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	ository.ubn.ru.nl	0	0		
1163	chr8	75859791	75859815	3500266480	23		75859791	75859815	8421504	2	5,18	0,6	c	350026648000000057	7-31						US Patent # 6,951,720. Use of phosphorothiolate polynucleotides in ligating nucleic acids - Patents.com	www.patents.com	0	0		
1163	chr8	75861111	75861134	3500417479	23		75861111	75861134	8421504	1	23	0	c	350041747900000005	0-23						Identification of neuroendocrine-specific genes with the use of gene expression profiling	folk.ntnu.no	0	0		
1163	chr8	75863915	75863941	3500019667	24		75863915	75863941	8421504	2	19,5	0,21	g	350001966700000014	1-26						Detection of food-relevant filamentous fungi by real time PCR	opus4.kobv.de	0	0		
1165	chr8	76049411	76049443	3500320656	26		76049411	76049443	8421504	3	5,13,8	0,8,24	g	350032065600000068	5-40						US Patent # 5,834,279. Methods of identifying compounds that inhibit DNA synthesis in mycobacterium tuberculosis and compositions, reagents and kits for performing the same - Patents.com	www.patents.com	0	0		
1165	chr8	76081586	76082294	3500041679	75		76081586	76082294	8421504	3	23,28,24	0,653,684	p	350004167900015023	48-129						The Amino Acid Sequence of a Glutamic Acid-Rich Protein from Bovine Retina as Deduced from the cDNA Sequence	www.jstor.org	0	0		
1165	chr8	76082493	76085085	3500247412	349		76082493	76085085	8421504	9	32,22,38,7,48,47,96,21,38	0,80,493,1920,1989,2038,2133,2475,2554	c	350024741200000180,350024741200000178,350024741200000149,350024741200000071,350024741200000140,350024741200000139,350024741200000137,350024741200000136,350024741200000134,350024741200000132	0-32,0-48,0-48,0-60,0-48,0-47,0-48,0-47,0-21,0-38						Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS) - Patent application	www.faqs.org	0	0		
1165	chr8	76082541	76082573	3500261622	27		76082541	76082573	8421504	2	6,21	0,11	c	350026162200000005	0-27						Pluripotent embryonic-like stem cells derived from teeth and uses thereof	Schierholz	2003	0		
1165	chr8	76083020	76083045	3500313060	25		76083020	76083045	8421504	1	25	0	c	350031306000000097	17-42						Gene specific universal mammalian sequence-tagged sites	Brewer	1997	0		
1165	chr8	76084413	76084689	3500371765	60		76084413	76084689	8421504	2	7,53	0,223	c	350037176500000071	0-60						Peripherin And Neurofilament Light Protein Splice Variants In Amyotrophic Lateral Sclerosis (als) 	.freshpatents.com	0	0		
1165	chr8	76085151	76085181	3500035228	30		76085151	76085181	8421504	1	30	0	c	350003522800000002,350003522800000003,350003522800000000,350003522800000001	0-30,0-30,0-30,0-30			10.1111/j.1471-4159.2005.03095.x	1471-4159	Journal of Neurochemistry	Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport - P&#xe9;rez-Oll&#xe9; - 2005 - Journal of Neurochemistry - Wiley Online Library	Perez-Olle	2005	0		NEFL
1168	chr8	76495752	76495776	3500099666	23		76495752	76495776	8421504	2	6,17	0,7	g	350009966600000020	3-26						Circular dna vectors for synthesis of rna and dna	Kool	2000	0		
1168	chr8	76517496	76517521	3500105905	24		76517496	76517521	8421504	2	16,8	0,17	g	350010590500000016	0-33						Method for Expression and Accumulation of Peptide in Plant - Patent application	www.faqs.org	0	0		
1169	chr8	76562371	76562396	3500128306	23		76562371	76562396	8421504	3	8,11,4	0,9,21	g	350012830600000284,350012830600000040	0-24,0-24						Means and Methods for Controlling Flowering in Plants - Patent application	www.faqs.org	0	0		
1169	chr8	76568363	76568389	3500084014	23		76568363	76568389	8421504	2	14,9	0,17	g	350008401400000004	0-27		19553330	10.1128/JVI.01009-09	0022-538X	Journal of Virology	Dexamethasone Treatment of Calves Latently Infected with Bovine Herpesvirus 1 Leads to Activation of the bICP0 Early Promoter, in Part by the Cellular Transcription Factor C/EBP-Alpha	Workman	2009	5		
1169	chr8	76612393	76615045	3500453299	177		76612393	76615045	8421504	3	15,96,66	0,1521,2586	c	350045329900000002	0-177						The Estradiol-lnduced Luteinizing Hormone Surge in the Ewe Is Not Associated with Increased Gonadotropin-Releasing Hormone Messenger Ribonucleic Acid Levels'	ww.biolreprod.org	0	0		
1171	chr8	76848200	76848225	3500317725	24		76848200	76848225	8421504	2	20,4	0,21	g	350031772500000047	0-24						Transcriptional Regulation of the Nickel and Iron Metabolism in Helicobacter pylori	repub.eur.nl	0	0		
18	chr8	77536048	77612282	3500033304	1350		77536048	77612282	8421504	11	1,75,98,166,113,178,165,170,92,287,5	0,396,45671,58438,65142,66813,68908,70145,72378,75489,76229	c	350003330400000060	32-1382						Human Protooncogene and Protein Encoded By Same - Patent application	www.faqs.org	0	0		BNIP3L
1176	chr8	77539435	77539459	3500203491	23		77539435	77539459	8421504	2	9,14	0,10	g	350020349100000006	3-26						Nature Magazine - September 23rd 2010	www.scribd.com	0	0		
1178	chr8	77788354	77788387	3500197584	33		77788354	77788387	8421504	1	33	0	c	350019758400000000	7-40		20961402	10.1186/1477-5956-8-53	1477-5956	Proteome Science	Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases	Shinkai-Ouchi	2010	2		DPYSL2
1178	chr8	77788363	77831424	3500351243	113		77788363	77831424	8421504	6	33,12,29,19,18,2	0,3332,3392,5182,5349,43059	p,c	350035124300015003,350035124300000187,350035124300000249,350035124300000061	0-45,0-48,0-20,0-20						ANTISENSE INHIBITION VIA RNASE H-INDEPENDENT REDUCTION IN MRNA - Patent application	www.faqs.org	0	0		
1178	chr8	77798983	77799011	3500387104	23		77798983	77799011	8421504	2	10,13	0,15	g	350038710400000000	1-24		22649503	10.1371/journal.pone.0036941		PLoS ONE	Suppression of AP1 Transcription Factor Function in Keratinocyte Suppresses Differentiation	Bingshe	2012	0		
1178	chr8	77835807	77841844	3500309534	48		77835807	77841844	8421504	2	42,6	0,6031	p	350030953400015000	0-48			10.1111/j.1471-4159.2007.04504.x	1471-4159	Journal of Neurochemistry	Proteomic analysis of &#x03b3;-butyrolactone-treated mouse thalamus reveals dysregulated proteins upon absence seizure - Ryu - 2007 - Journal of Neurochemistry - Wiley Online Library	Ryu	2007	0		DPYSL2
1178	chr8	77835807	77841844	3500059323	48		77835807	77841844	8421504	2	42,6	0,6031	p	350005932300015002	0-48		11549731		0270-6474	The Journal of Neuroscience	Isolation and Expression Pattern of Human Unc-33-Like Phosphoprotein 6/Collapsin Response Mediator Protein 5 (Ulip6/CRMP5): Coexistence with Ulip2/CRMP2 in Sema3A- Sensitive Oligodendrocytes	Ricard	2001	7		DPYSL2
1179	chr8	77956871	77956898	3500264352	25		77956871	77956898	8421504	2	14,11	0,16	c	350026435200000001,350026435200000003	5-30,5-30						Preventives/remedies For Urinary Disturbance 	.freshpatents.com	0	0		
1179	chr8	77956871	77956898	3500204798	25		77956871	77956898	8421504	2	14,11	0,16	c	350020479800000001	5-30						Preventives/remedies for urinary disturbance	Ishichi	2006	0		
1179	chr8	77956871	77956898	3500173470	25		77956871	77956898	8421504	2	14,11	0,16	c	350017347000000003,350017347000000001	5-30,5-30						 Preventives/remedies For Urinary Disturbance 	www.docstoc.com	0	0		
1181	chr8	78168002	78168362	3500176147	360		78168002	78168362	8421504	1	360	0	p	350017614700015006,350017614700015008,350017614700015009	0-180,0-180,0-180						Bioinformatics Notes site	iomath.med.uth.gr	0	0		ADRA1A
1181	chr8	78168746	78168794	3500345627	48		78168746	78168794	8421504	1	48	0	p	350034562700015010	0-48						Cloned human alpha1c adrenergic receptor	Bayne	1996	0		
1184	chr8	78533141	78538060	3500146314	420		78533141	78538060	8421504	3	51,192,177	0,3636,4742	p	350014631400015018,350014631400015016,350014631400015014	0-60,0-180,0-180						Use of tlr3 agonists for the treatment of neurodegenerative disorders	Van	2007	0		STMN4
1184	chr8	78533141	78538060	3500108880	420		78533141	78538060	8421504	3	51,192,177	0,3636,4742	p	350010888000015018,350010888000015016,350010888000015014	0-60,0-180,0-180						Use of tlr3 agonists for the treatment of neurodegenerative disorders	Van	2008	0		STMN4
1185	chr8	78683399	78747138	3500402447	3027		78683399	78747138	8421504	30	204,179,88,80,63,55,141,75,102,118,40,47,51,98,85,101,116,101,90,205,109,66,126,147,36,25,47,138,81,213	0,28746,29435,31077,33536,34117,34603,35138,35828,36586,37258,37955,39132,39697,40516,41204,41541,44678,44957,45898,48496,50388,52635,57771,58472,58872,61069,61773,62336,63526	p	350040244700015000	0-3027						KEGG T01001: 2185	www.genome.jp	0	0		PTK2B,CHRNA2
1185	chr8	78750803	78750831	3500266153	28		78750803	78750831	8421504	1	28	0	c	350026615300000014	6-34						&#xb0ea;&#xa5df;&#xa4a4;&#xa473;&#xa46a;&#xbec7; &#xa5cd;&#xaaab;&#xc2e5;&#xbec7;&#xace3;&#xa873;&#xa9d2; &#xbad3;&#xa468;&#xbdd7;&#xa4e5;	.lib.nsysu.edu.tw	0	0		CHRNA2
1185	chr8	78755806	78760276	3500314542	27		78755806	78760276	8421504	2	6,21	0,4449	c	350031454200000002	0-27						Negative Allosteric Modulators That Target Human 4 2 Neuronal Nicotinic Receptors	.researchgate.net	0	0		
1186	chr8	78796131	78851542	3500089192	101		78796131	78851542	8421504	4	24,30,26,21	0,23141,53729,55390	c	350008919200000019,350008919200000027,350008919200000043	11-35,7-37,1-48						 Recombinant Soluble Epoxide Hydrolase 	www.docstoc.com	0	0		
1186	chr8	78819272	78851542	3500002146	77		78819272	78851542	8421504	3	30,26,21	0,30588,32249	c	350000214600000027,350000214600000043	7-37,1-48						Recombinant soluble epoxide hydrolase	Hammock	1993	0		
1186	chr8	78819272	78819302	3500429458	30		78819272	78819302	8421504	1	30	0	c	350042945800000026	7-37					Patent	Recombinant soluble epoxide hydrolase (Patent US:5445956)	Beetham	1995	0		
1187	chr8	78919922	78919948	3500124220	24		78919922	78919948	8421504	2	5,19	0,7	g	350012422000000013	1-25			10.1002/hep.20887	1527-3350	Hepatology	HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation - Sansonno - 2005 - Hepatology - Wiley Online Library	Sansonno	2005	0		
1187	chr8	78980896	78990653	3500247721	1449		78980896	78990653	8421504	9	97,142,178,105,228,115,116,101,367	0,1182,1456,3717,4512,7020,8154,8567,9390	c	350024772100000014,350024772100000015,350024772100000012,350024772100000018,350024772100000017,350024772100000008,350024772100000016,350024772100000013	0-1449,0-20,0-20,0-158,0-50,19-41,0-21,0-21						Genomic marker for tenderness meat - Patent application	www.faqs.org	0	0		
1187	chr8	78982088	78990502	3500022313	1185		78982088	78990502	8421504	9	117,9,178,105,228,115,116,101,216	0,123,264,2525,3320,5828,6962,7375,8198	p	350002231300015152,350002231300015008,350002231300015009,350002231300015015,350002231300015021,350002231300015027,350002231300015033,350002231300015039	0-420,0-117,0-96,0-201,0-237,0-237,0-201,0-78						The characterisation of trypanosomal type 1 DnaJ-like proteins | Michael Ludewig - Academia.edu	www.academia.edu	0	0		DNAJA1
1187	chr8	78989478	78990301	3500256218	55		78989478	78990301	8421504	3	27,13,15	0,73,808	c	350025621800000127,350025621800000128	0-27,0-28						REPRODUCTION	uction-online.org	0	0		
1187	chr8	78989538	78990460	3500389551	42		78989538	78990460	8421504	2	20,22	0,900	c	350038955100000012,350038955100000008,350038955100000013	0-20,19-41,0-21						Genomic marker for tenderness meat	Bernard-capel	2007	0		DNAJA1
1187	chr8	78989538	78990460	3500388699	42		78989538	78990460	8421504	2	20,22	0,900	c	350038869900000012,350038869900000008,350038869900000013	0-20,19-41,0-21					Patent	Genomic marker for tenderness meat (Patent US:8097411)	Bernard-Capel	2012	0		DNAJA1
1187	chr8	78990451	78990502	3500336946	51		78990451	78990502	8421504	1	51	0	p	350033694600015020	0-51						METHOD FOR THE DETECTION OF POST-TRANSLATIONAL MODIFICATIONS - Patent application	www.faqs.org	0	0		DNAJA1
1188	chr8	79052540	79105029	3500265310	933		79052540	79105029	8421504	6	133,105,123,188,236,148	0,597,3696,10909,23255,52341	p,c	350026531000000012,350026531000000022,350026531000000010,350026531000000020,350026531000015011	12-39,12-39,8-38,8-38,0-930						Catalytic domains of beta(1,4)-galactosyl transferase i having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use - Patent application	www.faqs.org	0	0		B4GALT1
1188	chr8	79052540	79052567	3500446445	27		79052540	79052567	8421504	1	27	0	c	350044644500000029,350044644500000025	12-36,0-27						Production of galactosylated glycoproteins in lower eukaryotes	Davidson	2005	0		B4GALT1
1188	chr8	79052540	79052567	3500239580	27		79052540	79052567	8421504	1	27	0	c	350023958000000001,350023958000000007	0-27,12-36						Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris	P*Bo Bu Luo Wei Qi 	2012	0		B4GALT1
1188	chr8	79052540	79052567	3500165815	27		79052540	79052567	8421504	1	27	0	c	350016581500000025,350016581500000029	0-27,12-36						Production of galactosylated glycoproteins in lower eukaryotes	Davidson	2005	0		B4GALT1
1188	chr8	79052540	79052567	3500025054	27		79052540	79052567	8421504	1	27	0	c	350002505400000025,350002505400000029	0-27,12-36						Production of galactosylated glycoproteins in lower eukaryotes	Davidson	2007	0		B4GALT1
1188	chr8	79052540	79052564	3500161043	24		79052540	79052564	8421504	1	24	0	c	350016104300000069,350016104300000355	12-36,12-36						PRODUCTION OF SIALYLATED N-GLYCANS IN LOWER EUKARYOTES - Patent application	www.faqs.org	0	0		B4GALT1
1188	chr8	79052543	79105026	3500368533	927		79052543	79105026	8421504	6	130,105,123,188,236,145	0,594,3693,10906,23252,52338	p	350036853300015002	0-927						Catalytic Domains Of Beta(1,4)-galactosyltransferase I Having Altered Metal Ion Specificity 	.freshpatents.com	0	0		
1188	chr8	79052543	79105026	3500084893	927		79052543	79105026	8421504	6	130,105,123,188,236,145	0,594,3693,10906,23252,52338	p	350008489300015011	0-927						Catalytic Domains Of Beta(1,4)-Galactosyltransferase I Having Altered Metal Ion Specificity - Patent application	www.faqs.org	0	0		
1188	chr8	79052546	79105305	3500265310	1053		79052546	79105305	8421504	9	45,48,88,8,48,141,15,236,424	0,48,608,3690,3746,10932,11076,23249,52335	p,c	350026531000015149,350026531000015148,350026531000015102,350026531000015147,350026531000015100,350026531000015146,350026531000015099,350026531000015145,350026531000015097,350026531000015144,350026531000015095,350026531000015143,350026531000015094,350026531000015142,350026531000015141,350026531000015092,350026531000015025,350026531000015091,350026531000015139,350026531000015090,350026531000015024,350026531000015138,350026531000015089,350026531000015137,350026531000015023,350026531000015136,350026531000015087,350026531000015018,350026531000015086,350026531000015085,350026531000015114,350026531000015017,350026531000015084,350026531000015113,350026531000015010,350026531000015112,350026531000015016,350026531000015082,350026531000015009,350026531000015111,350026531000000009,350026531000000019,350026531000015081,350026531000015008,350026531000015080	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-93,0-45,0-45,0-45,0-93,0-45,0-45,0-45,0-93,0-45,0-45,0-69,0-45,0-45,0-45,0-93,0-45,0-45,0-93,0-45,0-93,0-45,0-93,0-45,12-39,12-39,0-45,0-90,0-45						Catalytic domains of beta(1,4)-galactosyl transferase i having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use - Patent application	www.faqs.org	0	0		
1188	chr8	79052546	79105305	3500084893	1194		79052546	79105305	8421504	9	45,79,105,53,67,170,15,236,424	0,48,591,3690,3746,10903,11076,23249,52335	p	350008489300015147,350008489300015146,350008489300015100,350008489300015050,350008489300015099,350008489300015049,350008489300015145,350008489300015098,350008489300015144,350008489300015097,350008489300015126,350008489300015143,350008489300015095,350008489300015045,350008489300015070,350008489300015094,350008489300015142,350008489300015093,350008489300015141,350008489300015092,350008489300015140,350008489300015139,350008489300015090,350008489300015025,350008489300015089,350008489300015024,350008489300015137,350008489300015088,350008489300015136,350008489300015087,350008489300015135,350008489300015023,350008489300015036,350008489300015061,350008489300015134,350008489300015085,350008489300015018,350008489300015084,350008489300015083,350008489300015112,350008489300015017,350008489300015082,350008489300015010,350008489300015111,350008489300015110,350008489300015016,350008489300015080,350008489300015009,350008489300015109,350008489300015079,350008489300015028,350008489300015008,350008489300015078	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-90,0-45,0-99,0-45,0-45,0-45,0-45,0-45,0-96,0-45,0-45,0-45,0-45,0-66,0-45,0-45,0-45,0-96,0-45,0-96,0-45,0-45,0-93,0-45,0-93,0-45,0-45,0-45,0-90,0-45						Catalytic Domains Of Beta(1,4)-Galactosyltransferase I Having Altered Metal Ion Specificity - Patent application	www.faqs.org	0	0		B4GALT1
1188	chr8	79052609	79105298	3500369966	217		79052609	79105298	8421504	7	64,14,54,32,8,24,21	0,528,3674,10867,11020,23186,52668	c	350036996600000037,350036996600000088,350036996600000036,350036996600000084,350036996600000032,350036996600000082,350036996600000079,350036996600000001	0-30,0-48,0-48,0-48,0-48,9-41,0-32,16-37						Proteins having glycosyltransferase activity	Berger	1997	0		
1188	chr8	79052642	79056340	3500018703	96		79052642	79056340	8421504	3	31,17,48	0,495,3650	c	350001870300000029,350001870300000025	0-48,0-48						Method For Secretory Production Of Glycoprotein Having Human-type Sugar Chain Using Plant Cell 	.freshpatents.com	0	0		
1188	chr8	79052665	79075921	3500044092	100		79052665	79075921	8421504	3	8,23,69	0,472,23187	p,c	350004409200000012,350004409200015001	0-31,33-102						Vol. 139, No. 1, 1986 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS August 29, 1986 Pages 1 63-1 68 ISOLATION OF A cDNA CODING FOR HUMAN GALACTOSYLTRANSFERASE	lue.lib.umich.edu	0	0		
1188	chr8	79075852	79075921	3500151488	69		79075852	79075921	8421504	1	69	0	p	350015148800015005	33-102						Isolation of a cDNA coding for human galactosyltransferase. - ResearchGate	.researchgate.net	0	0		
1188	chr8	79122420	79122444	3500313213	24		79122420	79122444	8421504	1	24	0	g	350031321300000003	6-30						PAX6 expression identifies progenitor cells for corneal keratocytes	www.fasebj.org	0	0		
1189	chr8	79214387	79215018	3500175024	39		79214387	79215018	8421504	3	19,18,2	0,84,629	c,g	350017502400000003,350017502400000003,350017502400000002	0-19,0-19,0-20						Microarray analysis of gene expression in blood neutrophils of parturient cows	cs.physiology.org	0	0		
1190	chr8	79407881	79408039	3500048191	44		79407881	79408039	8421504	2	24,20	0,138	c	350004819100000013,350004819100000012	0-24,0-20		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
1190	chr8	79407881	79407905	3500172791	24		79407881	79407905	8421504	1	24	0	c	350017279100000013	0-24		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
1190	chr8	79407881	79407905	3500120290	24		79407881	79407905	8421504	1	24	0	c	350012029000000013	0-24						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
1190	chr8	79408026	79408162	3500010617	40		79408026	79408162	8421504	2	20,20	0,116	c,g	350001061700000003,350001061700000003,350001061700000002,350001061700000002	0-20,0-20,0-20,0-20						Revista Brasileira de Zootecnia	www.scielo.br	0	0		
1191	chr8	79533525	79533557	3500403858	23		79533525	79533557	8421504	3	11,6,6	0,16,26	g	350040385800000005	0-23						Differentiation of Human Embryonic Stem Cells into Cells with Corneal Keratocyte Phenotype - ResearchGate	.researchgate.net	0	0		SNAI2
1193	chr8	79754257	79754281	3500322097	24		79754257	79754281	8421504	1	24	0	g	350032209700000111	9-33						Multivalent vaccine for clostridium botulinum neurotoxin	Thalley	1998	0		
1196	chr8	80185534	80185675	3500282201	93		80185534	80185675	8421504	2	48,45	0,96	p	350028220100015022,350028220100015025	0-48,0-45						Novel Peptide Involved in Energy Homeostasis - Patent application	www.faqs.org	0	0		
1197	chr8	80272228	80272256	3500252687	23		80272228	80272256	8421504	2	15,8	0,20	c	350025268700000006	1-26						Inhibition of Angiogenesis and HIF-1aActivity by Antimycin A1	bpb.pharm.or.jp	0	0		DCTN3
1197	chr8	80295517	80295544	3500300648	24		80295517	80295544	8421504	2	5,19	0,8	c	350030064800000250	15-39						Methods and targets for identifying compounds for regulating angiogenesis - Patent application	www.faqs.org	0	0		
1197	chr8	80296081	80296108	3500022166	25		80296081	80296108	8421504	2	13,12	0,15	c	350002216600000114	13-41						Identification of polycystic kidney disease gene, diagnostics and treatment	Reeders	1995	0		
1197	chr8	80296099	80297933	3500334980	666		80296099	80297933	8421504	4	221,93,201,151	0,1124,1350,1683	p	350033498000015000	0-666						 DMC Target SPDP00152 	r2d2drug.org	0	0		
1197	chr8	80296249	80296294	3500269345	45		80296249	80296294	8421504	1	45	0	c	350026934500000038	0-45						METHOD OF DIAGNOSING A NEURODEGENERATIVE DISEASE - Patent application	www.faqs.org	0	0		
1197	chr8	80304255	80304556	3500196986	25		80304255	80304556	8421504	2	8,17	0,284	c	350019698600000004	0-25		11152465	10.1074/jbc.M009583200	0021-9258	Journal of Biological Chemistry	Relationship between Genotype, Activity, and Galactose Sensitivity in Yeast Expressing Patient Alleles of Human Galactose-1-phosphate Uridylyltransferase	Riehman	2001	5		
1197	chr8	80311144	80313185	3500201890	47		80311144	80313185	8421504	3	24,16,7	0,2017,2034	c	350020189000000000,350020189000000001	0-24,0-23		11313268	10.1182/blood.V97.9.2758	0006-4971	Blood	Interleukin-11 induces Th2 polarization of human CD4+ T cells	Curti	2001	10		
1197	chr8	80315622	80315664	3500145039	42		80315622	80315664	8421504	1	42	0	c	350014503900000043	0-42						A novel haemopoietin receptor	Hilton	1997	0		
1199	chr8	80558279	80558303	3500244987	23		80558279	80558303	8421504	2	18,5	0,19	c	350024498700000103	2-26						Modulation of cytokinin activity in plants	C*Jin Sai Er Mai Er 	2008	0		
1204	chr8	81152796	81153688	3500284840	270		81152796	81153688	8421504	6	7,12,14,10,6,221	0,8,21,640,664,671	c,g	350028484000000077,350028484000000073,350028484000000073,350028484000000072,350028484000000069,350028484000000069,350028484000000066,350028484000000065	0-43,0-75,0-75,0-69,0-76,0-76,0-41,0-35						Die Positionsklonierung als Strategie zur Isolierung und Charakterisierung retinaler Gene	.uni-wuerzburg.de	0	0		
1204	chr8	81157193	81157221	3500004577	25		81157193	81157221	8421504	2	20,5	0,23	g	350000457700000007,350000457700000008	19-44,0-25		18479457	10.1111/j.1742-4658.2008.06461.x	1742-4658	FEBS Journal	A fluorescence energy transfer-based mechanical stress sensor for specific proteins in&#xa0;situ - Meng - 2008 - FEBS Journal - Wiley Online Library	Meng	2008	0		
1206	chr8	81479991	81480014	3500353577	23		81479991	81480014	8421504	1	23	0	c,g	350035357700000008,350035357700000008	0-23,0-23						&#x4e3b;&#x9898;&#xff1a;prolyl-4 | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1206	chr8	81479991	81480014	3500187665	23		81479991	81480014	8421504	1	23	0	c	350018766500000008	0-23						&#x4e3b;&#x9898;&#xff1a;TNF- | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		HNRNPK
1206	chr8	81479991	81480014	3500132375	23		81479991	81480014	8421504	1	23	0	c	350013237500000008	0-23		17478756	10.1161/ATVBAHA.107.144881	1079-5642	Arteriosclerosis, Thrombosis, and Vascular Biology	TNF-&#x03b1; Suppresses Prolyl-4-Hydroxylase &#x03b1;1 Expression via the ASK1&#x2013;JNK&#x2013;NonO Pathway	Zhang	2007	6		
1206	chr8	81479991	81480014	3500131258	23		81479991	81480014	8421504	1	23	0	c	350013125800000008	0-23						TNF- Suppresses Prolyl-4-Hydroxylase 1 Expression via the ASK1-JNK-NonO Pathway 2007&#x5e74;&#x7b2c;27&#x5377;&#x7b2c;8&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		HNRNPK,CXCR4
1206	chr8	81480037	81480871	3500006948	55		81480037	81480871	8421504	2	24,31	0,803	c,g	350000694800000009,350000694800000008,350000694800000008	9-33,1-32,1-32		19349299	10.1128/MCB.00360-09		Molecular and Cellular Biology	Functional Association of the Microprocessor Complex with the Spliceosome 	Naoyuki	June	0		HNRNPK
1206	chr8	81480442	81480465	3500400478	23		81480442	81480465	8421504	1	23	0	c	350040047800000010	0-23					Patent	MicroRNA molecules (Patent US:7838663)	Tuschl	2010	0		MIR3529
1206	chr8	81480442	81480465	3500351709	23		81480442	81480465	8421504	1	23	0	c	350035170900000000	0-23		21683814	10.1016/j.bbagrm.2011.05.015		Biochimica et biophysica acta	Drosha processing controls the specificity and efficiency of global microRNA expression	Yong	2011	0		HNRNPK
1206	chr8	81480442	81480465	3500241683	23		81480442	81480465	8421504	1	23	0	c	350024168300000008	0-23						al Regulation of microRNA Expression in Drosophila melanogaster mediated by Hormonal Signals and Broad-Complex gene activity - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		HNRNPK
1206	chr8	81480442	81480465	3500074815	23		81480442	81480465	8421504	1	23	0	c	350007481500000032,350007481500000031	0-21,0-23						Post-transcriptional gene regulation in Drosophila: an investigation into the roles of RNA silencing and the DEAD-box helicase Belle	uni-heidelberg.de	0	0		HNRNPK
1206	chr8	81481362	81481419	3500175051	57		81481362	81481419	8421504	1	57	0	p	350017505100015001	0-57		11279198	10.1074/jbc.M101360200	0021-9258	Journal of Biological Chemistry	The Heterogeneous Nuclear Ribonucleoproteins I and K Interact with a Subset of the Ro Ribonucleoprotein-associated Y RNAs in Vitro and in Vivo	Fabini	2001	5		HNRNPK
1206	chr8	81484287	81484939	3500194466	120		81484287	81484939	8421504	2	48,72	0,580	p	350019446600015014,350019446600015007	0-69,0-51						Proteomic Analysis of Phosphorylated Nuclear Proteins Underscores Novel Roles for Rapid Actions of Retinoic Acid in the Regulation of mRNA Splicing and Translation	digital.csic.es	0	0		HNRNPK
1206	chr8	81488034	81488085	3500254665	51		81488034	81488085	8421504	1	51	0	p	350025466500015040	0-51						Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof	Elsner	2003	0		HNRNPK
1206	chr8	81490696	81490720	3500118087	24		81490696	81490720	8421504	1	24	0	c	350011808700000016	0-24						Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. - ResearchGate	.researchgate.net	0	0		RMI1
1208	chr8	81775528	81775551	3500236851	23		81775528	81775551	8421504	1	23	0	c,g	350023685100000014,350023685100000002,350023685100000000	0-23,0-23,0-23						Nucleic acid tagged immunoassay	Fields	1994	0		
1210	chr8	81921269	81921296	3500047315	23		81921269	81921296	8421504	3	4,5,14	0,5,13	g	350004731500000006	11-34						Universitat de Barcelona Facultat de Biologia Departamento de MicrobiologAa Sistema de secreciA3n 	www.tdx.cat	0	0		
1210	chr8	81958922	81958949	3500225174	23		81958922	81958949	8421504	2	9,14	0,13	g	350022517400000122	0-23						Biological methods for preparing adipic acid	Beardslee	2012	0		
1210	chr8	81958922	81958949	3500101720	23		81958922	81958949	8421504	2	9,14	0,13	g	350010172000000123	0-23						Biological methods for preparing adipic acid	Beardslee	2012	0		
1212	chr8	82298766	82298789	3500066806	23		82298766	82298789	8421504	1	23	0	c	350006680600000012	0-23						Use of gdnf for treating corneal defects	Hanke	2002	0		NTRK2
1212	chr8	82298766	82298789	3500002230	23		82298766	82298789	8421504	1	23	0	c	350000223000000012	0-23						Use of gdnf for treating corneal defects	Hanke	2001	0		NTRK2
1214	chr8	82470335	82474404	3500356057	40		82470335	82474404	8421504	2	20,20	0,4049	g	350035605700000026,350035605700000027	0-20,0-21		21350004	10.1158/1078-0432.CCR-10-1890	1078-0432	Clinical Cancer Research	Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival	Vanhecke	2011	8		NTRK2
1215	chr8	82655022	82655046	3500224701	24		82655022	82655046	8421504	1	24	0	g	350022470100000013	0-24		17584746	10.1074/jbc.M703746200	0021-9258	Journal of Biological Chemistry	The Transcription Factor Runx3 Represses the Neurotrophin Receptor TrkB during Lineage Commitment of Dorsal Root Ganglion Neurons	Inoue	2007	5		
1221	chr8	83396313	83396339	3500004918	23		83396313	83396339	8421504	2	18,5	0,21	g	350000491800000027	17-40						Aspartoacylase Gene, Protein, And Methods Of Screening For Mutations Associated With Canavan Disease 	.freshpatents.com	0	0		
1223	chr8	83706244	83706273	3500036341	24		83706244	83706273	8421504	2	17,7	0,22	c	350003634100000019	5-29						Endomannosidases in the modification of glycoproteins in eukaryotes - Patent application	www.faqs.org	0	0		
1227	chr8	84174797	84174820	3500432414	23		84174797	84174820	8421504	1	23	0	g	350043241400000053	18-41						OVINE IDENTIFICATION METHOD	Mcewan	2008	0		
1231	chr8	84747155	84756048	3500119454	43		84747155	84756048	8421504	4	5,18,14,6	0,8,8872,8887	g	350011945400000445,350011945400000575	1-25,23-43						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
154	chr8	85130192	85286579	3500130111	363		85130192	85286579	8421504	11	23,22,45,45,5,40,45,45,48,42,3	0,110839,110912,111008,111056,149682,149773,151989,152037,155007,156384	p	350013011100015038,350013011100015040,350013011100015042,350013011100015043,350013011100015045,350013011100015083	0-45,0-45,0-45,0-45,3-141,0-45						DAP-kinase related protein - Patent # 7026148 - PatentGenius	.patentgenius.com	0	0		DAPK1
1234	chr8	85194008	85194034	3500119454	25		85194008	85194034	8421504	2	8,17	0,9	g	350011945400000316	3-28						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1235	chr8	85241104	85283159	3500218806	453		85241104	85283159	8421504	13	45,45,5,40,45,45,45,82,11,35,10,14,31	0,48,144,38770,38813,38861,41077,41125,41383,41397,41518,41531,42024	p	350021880600015061,350021880600015062,350021880600015064,350021880600015065	0-45,0-45,0-45,0-318						 Crystallographic Structure Of Mnk 	www.docstoc.com	0	0		DAPK1
1235	chr8	85279881	85279926	3500058037	45		85279881	85279926	8421504	1	45	0	p	350005803700015007	3-48						&#x3010;&#x7279;&#x8a31;&#x8acb;&#x6c42;&#x306e;&#x7bc4;&#x56f2;&#x3011;	jstore.jst.go.jp	0	0		DAPK1
154	chr8	85283671	85339162	3500282054	383		85283671	85339162	8421504	10	18,30,12,84,48,31,32,48,32,48	0,1480,1558,2905,5864,11214,37100,45913,47194,55443	c	350028205400000115,350028205400000117,350028205400000118,350028205400000191,350028205400000004,350028205400000122,350028205400000135,350028205400000142,350028205400000149,350028205400000153,350028205400000180	0-48,0-48,0-48,17-36,17-36,0-48,13-44,9-41,0-48,0-32,0-48					Patent	Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins (Patent US:6160106)	Kimchi	2000	0		
1235	chr8	85285184	85286618	3500302110	99		85285184	85286618	8421504	2	57,42	0,1392	p	350030211000015001	0-99						DARPP32 - ResearchGate	.researchgate.net	0	0		DAPK1
1237	chr8	85502635	85505692	3500261436	51		85502635	85505692	8421504	2	22,29	0,3028	c,g	350026143600000042,350026143600000042,350026143600000041	0-22,0-22,0-29						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1238	chr8	85673558	85673582	3500068502	23		85673558	85673582	8421504	2	10,13	0,11	g	350006850200000068	9-33						Repressors of the trans-activating function of papillomavirus e2 proteins	Androphy	1992	0		
1241	chr8	86041128	86041921	3500040785	89		86041128	86041921	8421504	2	21,68	0,725	c,g	350004078500000051,350004078500000091,350004078500000091,350004078500000052,350004078500000052	0-21,0-68,0-68,0-22,0-22						Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Patent application	www.faqs.org	0	0		ZSWIM4,MIR3074
1241	chr8	86041128	86041918	3500210973	88		86041128	86041918	8421504	4	23,20,23,22	0,231,730,768	c,g	350021097300000094,350021097300000132,350021097300000132,350021097300000026,350021097300000137,350021097300000198,350021097300000095,350021097300000027	0-21,0-23,0-23,0-21,0-20,0-23,0-22,0-22						Microrna molecules	Tuschl	2002	0		
1241	chr8	86041128	86041918	3500131966	64		86041128	86041918	8421504	3	21,21,22	0,231,768	c	350013196600000088,350013196600000094,350013196600000093,350013196600000089	0-21,0-21,0-21,0-22						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		
1241	chr8	86041128	86041380	3500205029	42		86041128	86041380	8421504	2	21,21	0,231	c	350020502900000008,350020502900000011,350020502900000019	0-21,0-21,0-21						METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME	Khew-goodall	2007	0		MIR3074
1241	chr8	86041128	86041151	3500277975	23		86041128	86041151	8421504	1	23	0	c,g	350027797500000015,350027797500000015	0-23,0-23						MicroRNA-9ControlstheExpressionofGranuphilin/Slp4 andtheSecretoryResponseofInsulin-producingCells	www.jbc.org	0	0		
1241	chr8	86041128	86041151	3500059138	23		86041128	86041151	8421504	1	23	0	c	350005913800000044	0-23						Oligomeric compounds and compositions for use in modulation of small non-coding rnas	Baker	2005	0		
1241	chr8	86041299	86041396	3500185291	97		86041299	86041396	8421504	1	97	0	c	350018529100000083	0-97						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIR3074
1241	chr8	86041359	86041918	3500307429	43		86041359	86041918	8421504	2	21,22	0,537	g	350030742900000008,350030742900000007	0-21,0-22						METHODS AND COMPOSITIONS FOR THE TREATMENT OF INSULIN-ASSOCIATED MEDICAL CONDITIONS - YEDA RESEARCH AND DEVELOPMENT CO. LTD.	www.sumobrain.com	0	0		
1241	chr8	86041359	86041918	3500304886	43		86041359	86041918	8421504	2	21,22	0,537	c	350030488600000097,350030488600000122	0-21,0-22						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		ZSWIM4
1241	chr8	86041359	86041395	3500330723	36		86041359	86041395	8421504	1	36	0	c	350033072300000002,350033072300000010,350033072300000000,350033072300000005	0-21,5-25,0-20,0-26		16982751	10.1158/0008-5472.CAN-06-1403	0008-5472	Cancer Research	MicroRNA Regulates the Expression of Human Cytochrome P450 1B1	Tsuchiya	2006	8		
1241	chr8	86041858	86041881	3500125321	23		86041858	86041881	8421504	1	23	0	c	350012532100000093	0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIR3074
1242	chr8	86158153	86158182	3500119454	24		86158153	86158182	8421504	3	5,7,12	0,8,17	g	350011945400000716	12-36						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1243	chr8	86346913	86349178	3500264039	84		86346913	86349178	8421504	4	21,21,21,21	0,1860,2101,2244	c,g	350026403900000064,350026403900000066,350026403900000067,350026403900000009,350026403900000009	0-21,0-21,0-21,0-21,0-21						Structure and Evolution of the Y-chromosomal and Mitochondrial DNA of cattle	ive.library.uu.nl	0	0		
1243	chr8	86347078	86347406	3500185768	82		86347078	86347406	8421504	4	20,21,22,19	0,110,241,309	c,g	350018576800000000,350018576800000002,350018576800000003,350018576800000001	0-20,0-21,0-22,0-19						Sexing single bovine blastomeres using TSPY gene amplification	w.funpecrp.com.br	0	0		
1243	chr8	86347078	86347406	3500178239	82		86347078	86347406	8421504	4	20,21,22,19	0,110,241,309	c,g	350017823900000000,350017823900000000,350017823900000003,350017823900000002,350017823900000001	0-20,0-20,0-21,0-22,0-19						Fetal-Maternal Interactions in the Synepitheliochorial Placenta Using the eGFP Cloned Cattle Model. - ResearchGate	.researchgate.net	0	0		
1243	chr8	86347078	86347406	3500074407	39		86347078	86347406	8421504	2	20,19	0,309	c	350007440700000000,350007440700000001	0-20,0-19						RODRIGO DA SILVA NUNES BARRETO	www.teses.usp.br	0	0		
1243	chr8	86347078	86347341	3500419206	42		86347078	86347341	8421504	2	20,22	0,241	c	350041920600000000,350041920600000001	0-20,0-22			10.1590/S1415-47572005000100020	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Use of the TSPY gene for sexing cattle	Lemos	2005	1		
1243	chr8	86347078	86347341	3500307566	42		86347078	86347341	8421504	2	20,22	0,241	c	350030756600000000,350030756600000001	0-20,0-22			10.1590/S1415-47572005000100020	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Use of the TSPY gene for sexing cattle	Lemos	2005	1		
1245	chr8	86629722	86629750	3500063695	25		86629722	86629750	8421504	3	6,6,13	0,7,15	c	350006369500000680	0-26						G protein-coupled receptor-like receptors and modulators thereof - US Patent 7208591 Description	ww.patentstorm.us	0	0		
155	chr8	86630748	86690792	3500023932	4308		86630748	86690792	8421504	25	141,120,246,255,100,143,138,281,184,143,310,403,119,126,99,156,132,148,122,199,92,70,190,193,198	0,186,312,3606,4428,8071,10995,12563,14314,16488,21245,21976,24349,30129,30753,31523,32104,33057,34011,34422,36331,36516,39612,58020,59846	p	350002393200015045	0-4341						CANCER STEM CELL ANTIGEN VACCINES AND METHODS	Yu	2007	0		
1245	chr8	86630831	86634401	3500157762	66		86630831	86634401	8421504	3	22,23,21	0,24,3549	c	350015776200000025,350015776200000026,350015776200000020	19-41,0-23,23-44		19433502	10.1530/REP-08-0317	1470-1626	Reproduction	The hedgehog-patched signaling pathway and function in the mammalian ovary: a novel role for hedgehog proteins in stimulating proliferation and steroidogenesis of theca cells	Spicer	2009	3		
1245	chr8	86631179	86634467	3500030345	40		86631179	86634467	8421504	2	20,20	0,3268	c,g	350003034500000003,350003034500000003,350003034500000002	0-20,0-20,0-20						The Hedgehog System in Ovarian Follicles of Cattle Selected for Twin Ovulations and Births: Evidence of a Link between the IGF and Hedgehog Systems	ww.biolreprod.org	0	0		
155	chr8	86634485	86647375	3500264993	50		86634485	86647375	8421504	2	25,25	0,12865	c	350026499300000003,350026499300000002	0-25,0-25						Angiogenesis-modulating compositions and uses	Ling	2003	0		
155	chr8	86634485	86647375	3500162207	50		86634485	86647375	8421504	2	25,25	0,12865	c	350016220700000003,350016220700000002	0-25,0-25						Angiogenesis-modulating compositions and uses	Ling	2001	0		PTCH1
155	chr8	86634485	86647375	3500101088	50		86634485	86647375	8421504	2	25,25	0,12865	c	350010108800000106,350010108800000003,350010108800000105,350010108800000002	0-25,0-25,0-25,0-25						Angiogenesis-modulating compositions and uses - Patent application	www.faqs.org	0	0		PTCH1
155	chr8	86634485	86647375	3500093417	50		86634485	86647375	8421504	2	25,25	0,12865	c	350009341700000003,350009341700000002	0-25,0-25						Angiogenesis-modulating compositions and uses	Ling	2010	0		PTCH1
155	chr8	86634485	86647375	3500090396	50		86634485	86647375	8421504	2	25,25	0,12865	c	350009039600000003,350009039600000002	0-25,0-25						Angiogenesis-modulating compositions and uses	Ling	2003	0		PTCH1
1246	chr8	86641825	86647289	3500428924	46		86641825	86647289	8421504	3	6,20,20	0,11,5444	c	350042892400000007,350042892400000003	14-40,0-20		18084326	10.1038/sj.onc.1210991	0950-9232	Oncogene	The EWS&sol;FLI1 oncogenic transcription factor deregulates GLI1	Zwerner	2007	6		
1246	chr8	86641825	86647289	3500157907	46		86641825	86647289	8421504	3	6,20,20	0,11,5444	c	350015790700000007,350015790700000003	14-40,0-20		18084326	10.1038/sj.onc.1210991	0950-9232	Oncogene	The EWS&sol;FLI1 oncogenic transcription factor deregulates GLI1	Zwerner	2007	6		
1246	chr8	86662272	86690614	3500227688	44		86662272	86690614	8421504	4	24,1,5,14	0,26688,28322,28328	c	350022768800000013,350022768800000008	18-42,0-20						20060503131	www.dtic.mil	0	0		
1246	chr8	86662862	86665262	3500293908	155		86662862	86665262	8421504	5	29,36,35,20,35	0,56,1901,1951,2365	c,g	350029390800000202,350029390800000023,350029390800000023,350029390800000196,350029390800000178,350029390800000175,350029390800000163	0-29,0-20,0-20,7-35,0-35,0-20,0-35						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	hera.ugr.es	0	0		
1246	chr8	86662862	86665262	3500192823	155		86662862	86665262	8421504	5	29,36,35,20,35	0,56,1901,1951,2365	c,g	350019282300000202,350019282300000023,350019282300000023,350019282300000196,350019282300000178,350019282300000175,350019282300000163	0-29,0-20,0-20,7-35,0-35,0-20,0-35						Control Gen&#xb4;etico del desarrollo gonadal de Talpa occidentalis	digibug.ugr.es	0	0		
1246	chr8	86670501	86670528	3500094094	27		86670501	86670528	8421504	1	27	0	c,g	350009409400000012,350009409400000012	0-27,0-27						Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo	-publications.com	0	0		PTCH1
1246	chr8	86688775	86688833	3500314970	38		86688775	86688833	8421504	2	19,19	0,39	c,g	350031497000000003,350031497000000002,350031497000000002	5-24,0-19,0-19						ScienceDirect.com - Developmental Biology - Roles for Hedgehog signaling in androgen production and prostate ductal morphogenesis	sciencedirect.com	0	0		
1246	chr8	86690072	86690121	3500254252	49		86690072	86690121	8421504	1	49	0	g	350025425200000023	1-50						RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR - Patent application	www.faqs.org	0	0		
1246	chr8	86690072	86690121	3500221357	49		86690072	86690121	8421504	1	49	0	g	350022135700000026	1-50						METHODS AND COMPOSITIONS FOR TREATING INFLUENZA - Patent application	www.faqs.org	0	0		
1246	chr8	86690773	86691037	3500021429	46		86690773	86691037	8421504	2	22,24	0,240	c,g	350002142900000015,350002142900000015,350002142900000014	0-22,0-22,0-24						Hh-Gli SIGNALING PATHWAY ACTIVITY IN ORAL AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA	.researchgate.net	0	0		
1249	chr8	87043762	87043789	3500189823	25		87043762	87043789	8421504	2	14,11	0,16	g	350018982300000582	21-46						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
1251	chr8	87337227	87337253	3500426004	23		87337227	87337253	8421504	2	8,15	0,11	g	350042600400000009	2-25						Parasitic helminth PLA2 proteins	Grieve	1995	0		
1251	chr8	87364078	87364106	3500048516	23		87364078	87364106	8421504	3	13,4,6	0,14,22	c	350004851600000056	0-23						ASSEMBLY ACTIVATING PROTEIN (AAP) AND ITS USE FOR THE MANUFACTURE OF PARVOVIRUS PARTICLES ESSENTIALLY CONSISTING OF VP3 - Patent application	www.faqs.org	0	0		
1252	chr8	87455567	87455590	3500163741	23		87455567	87455590	8421504	1	23	0	c	350016374100000001	9-32		15899858	10.1128/MCB.25.11.4541-4551.2005	0270-7306	Molecular and Cellular Biology	The Dual-Specificity Phosphatase CDC14B Bundles and Stabilizes Microtubules	Cho	2005	6		CDC14B
1254	chr8	87700577	87700605	3500395029	25		87700577	87700605	8421504	2	15,10	0,18	c	350039502900000541	10-35						 Recombinant Infectious Laryngotracheitis Virus And Uses Thereof 	www.docstoc.com	0	0		
1254	chr8	87700655	87700685	3500416141	24		87700655	87700685	8421504	3	12,4,8	0,13,22	c	350041614100000005,350041614100000024	13-43,8-38						US Patent # 7,482,146. Phenylethanolamine-N-methyltransferase sequence variants - Patents.com	www.patents.com	0	0		
1254	chr8	87700655	87700685	3500157515	24		87700655	87700685	8421504	3	12,4,8	0,13,22	c	350015751500000005	13-43						US Patent # 7,371,523. Phenylethanolamine-N-methyltransferase sequence variants - Patents.com	www.patents.com	0	0		
1256	chr8	88030889	88030917	3500190959	28		88030889	88030917	8421504	1	28	0	c	350019095900000029	17-45						TELOMERASE EXPRESSION REPRESSOR PROTEINS AND METHODS OF USING THE SAME - Patent application	www.faqs.org	0	0		
1257	chr8	88181315	88181341	3500466686	23		88181315	88181341	8421504	3	4,14,5	0,5,21	g	350046668600000003	4-27					Patent	Brain derived neurotrophic factor (Patent US:5229500)	Barde	1993	0		
1257	chr8	88181315	88181341	3500427965	23		88181315	88181341	8421504	3	4,14,5	0,5,21	g	350042796500000004,350042796500000003	4-27,8-31						US Patent # 5,438,121. Brain derived neurotrophic factor - Patents.com	www.patents.com	0	0		
1257	chr8	88210818	88210845	3500119257	23		88210818	88210845	8421504	2	17,6	0,21	g	350011925700000056	0-24						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
1258	chr8	88256743	88268559	3500157797	131		88256743	88268559	8421504	4	48,48,10,25	0,3132,5106,11791	c	350015779700000143,350015779700000156,350015779700000151	0-48,0-48,0-35						 Therapeutic Polypeptides, Nucleic Acids Encoding Same, And Methods Of Use 	www.docstoc.com	0	0		
1258	chr8	88270071	88270094	3500115071	23		88270071	88270094	8421504	1	23	0	c	350011507100000187	0-23						DECEMBER 2005 PC LINICAL HARMACOLOGY HERAPEUTICS	005.pasteur.ac.ir	0	0		OGN
1258	chr8	88270188	88270224	3500286026	36		88270188	88270224	8421504	1	36	0	c,g	350028602600000014,350028602600000014	10-46,10-46						Analysis of transcriptional regulation of the small leucine rich proteoglycans	www.molvis.org	0	0		
1259	chr8	88367913	88367976	3500344270	63		88367913	88367976	8421504	1	63	0	p	350034427000015035	126-198						@IL23_3198:2:1:0:199/1 NCGGAACCGGGCGGAAACACCATCGTATGCCGTCTTC + &0;;;;:9:;:7;;;;;;;;;;;;;;;;;;;;;;;:8	rse.iop.kcl.ac.uk	0	0		
1261	chr8	88629813	88629841	3500013426	23		88629813	88629841	8421504	2	15,8	0,20	c	350001342600000000	11-34		7775459	10.1074/jbc.270.23.13973	0021-9258	Journal of Biological Chemistry	Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells	Bouaboula	1995	5		
1261	chr8	88630096	88630128	3500115995	26		88630096	88630128	8421504	3	15,4,7	0,19,25	g	350011599500000032	6-32						Effects of antagonists of luteinizing hormone- and growth hormone-releasing hormone on experimental benign prostatic hyperplasia and prostate cancer	aok.pte.hu/docs/p	0	0		
1261	chr8	88652515	88652543	3500339994	23		88652515	88652543	8421504	2	16,7	0,21	g	350033999400000017	13-36						Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells	Finer	1999	0		
1261	chr8	88656588	88656615	3500088017	24		88656588	88656615	8421504	2	9,15	0,12	g	350008801700000023	4-33						US Patent # 5,451,522. Genes encoding and method of expressing an enzyme: phthalyl amidase - Patents.com	www.patents.com	0	0		
1262	chr8	88747549	88747573	3500346255	24		88747549	88747573	8421504	1	24	0	c	350034625500000005	24-48						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		
1264	chr8	89086663	89086687	3500162629	23		89086663	89086687	8421504	2	8,15	0,9	c	350016262900000027	2-25						Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor	Li	1998	0		
1265	chr8	89151626	89151649	3500223318	23		89151626	89151649	8421504	1	23	0	g	350022331800000000	8-31						ScienceDirect.com - International Journal of Food Microbiology - Exopolysaccharide production by lactose-hydrolyzing bacteria isolated from traditionally fermented milk	sciencedirect.com	0	0		
1266	chr8	89260519	89260545	3500276427	23		89260519	89260545	8421504	2	12,11	0,15	g	350027642700000062	2-26						KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy	Arbogast	2011	0		
1269	chr8	89769664	89772310	3500408810	254		89769664	89772310	8421504	3	80,87,87	0,353,2559	c,g	350040881000000011,350040881000000011,350040881000000018,350040881000000018,350040881000000007,350040881000000016,350040881000000005,350040881000000005	0-80,0-80,0-87,0-87,0-22,0-87,0-21,0-21						Compositions And Methods For Modulation Of Pdx-1 	freshpatents.com	0	0		
1269	chr8	89769664	89772310	3500185291	167		89769664	89772310	8421504	2	80,87	0,2559	c,g	350018529100000005,350018529100000005,350018529100000009,350018529100000008	0-80,0-80,0-87,0-22						Compositions And Methods For Modulating Mtor Signaling 	.freshpatents.com	0	0		MIRLET7DHG
1269	chr8	89769664	89769744	3500467059	47		89769664	89769744	8421504	2	21,26	0,54	c	350046705900000014,350046705900000015	0-21,0-26						Sj&#xf6;gren&#x2019;s syndrome antigen B (SSB)/La promotes global microRNA expression	www.jbc.org	0	0		
1269	chr8	89769664	89769744	3500465622	80		89769664	89769744	8421504	1	80	0	c,g	350046562200000021,350046562200000021	0-80,0-80						ISSN 1684 - 5315 Volume 10 Number 18 2 May, 2011	demicjournals.org	0	0		MIRLET7DHG
1269	chr8	89769664	89769744	3500415067	80		89769664	89769744	8421504	1	80	0	c	350041506700000007,350041506700000000,350041506700000008	86-166,0-80,81-161						Burhansstipanov-Bemis GENA&#xae; obj. 14 miRNA & CBPR excerpt from obj. 29	natamcancer.org	0	0		MIRLET7DHG
1269	chr8	89769664	89769744	3500179047	80		89769664	89769744	8421504	1	80	0	c	350017904700000008,350017904700000021	8-88,8-88						BACTERIA-MEDIATED GENE MODULATION VIA microRNA MACHINERY - Patent application	www.faqs.org	0	0		
1269	chr8	89769664	89769744	3500176000	80		89769664	89769744	8421504	1	80	0	c,g	350017600000000026,350017600000000057,350017600000000001,350017600000000049	0-80,0-80,0-22,0-22						MICRO RNA (MiRNA) AND NEUROFIBROMATOSIS TYPE 1: A ROLE IN DIAGNOSIS AND THERAPY - Patent application	www.faqs.org	0	0		
1269	chr8	89769664	89769744	3500106400	79		89769664	89769744	8421504	2	40,39	0,41	c,g	350010640000000186,350010640000000097,350010640000000007,350010640000000003,350010640000000096,350010640000000096,350010640000000001,350010640000000001,350010640000000175,350010640000000180,350010640000000179	0-79,1-20,1-20,1-20,0-21,0-21,0-21,0-21,0-22,0-23,0-23						Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor - Patent application	www.faqs.org	0	0		MIRLET7DHG
1269	chr8	89769669	89770045	3500331643	46		89769669	89770045	8421504	2	24,22	0,354	g	350033164300000015,350033164300000016	5-29,7-29						Reduced Expression of the let-7MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival	.aacrjournals.org	0	0		
1269	chr8	89769669	89769739	3500410063	41		89769669	89769739	8421504	2	21,20	0,50	c	350041006300000001,350041006300000002	0-21,0-20						Ribonuclease activity and RNA binding of recombinant human Dicer	www.shutcm.com	0	0		MIRLET7DHG
1269	chr8	89769669	89769739	3500221977	41		89769669	89769739	8421504	2	21,20	0,50	c,g	350022197700000001,350022197700000001,350022197700000002	0-21,0-21,0-20		12411504	10.1093/emboj/cdf578	ERROR! NO ISSN	The EMBO Journal	Ribonuclease activity and RNA binding of recombinant human Dicer	Provost	2002	0		
1269	chr8	89769669	89769693	3500052702	24		89769669	89769693	8421504	1	24	0	c	350005270200000015	5-29		15172979	10.1158/0008-5472.CAN-04-0637	0008-5472	Cancer Research	Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival	Takamizawa	2004	8		
1269	chr8	89769682	89769707	3500101538	23		89769682	89769707	8421504	2	10,13	0,12	c	350010153800000598	14-38						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
1269	chr8	89770023	89772252	3500031979	44		89770023	89772252	8421504	2	22,22	0,2207	c	350003197900000291,350003197900000289	0-22,0-22						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		HUWE1,MIR98
1269	chr8	89770023	89772251	3500049720	43		89770023	89772251	8421504	2	22,21	0,2207	c,g	350004972000000005,350004972000000003,350004972000000003	0-22,0-21,0-21						Electronic Supplementary Information	www.rsc.org	0	0		
1269	chr8	89770023	89770123	3500245857	41		89770023	89770123	8421504	2	22,19	0,81	c,g	350024585700000016,350024585700000009	7-29,1-20		15172979	10.1158/0008-5472.CAN-04-0637	0008-5472	Cancer Research	Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival	Takamizawa	2004	8		
1269	chr8	89772223	89772299	3500168448	74		89772223	89772299	8421504	3	24,25,25	0,25,51	c	350016844800000089,350016844800000091,350016844800000090	0-24,0-25,0-25						Oligomeric compounds and compositions for use in modulation of small non-coding rnas	Baker	2005	0		
1269	chr8	89772223	89772299	3500059138	74		89772223	89772299	8421504	3	24,25,25	0,25,51	c	350005913800000089,350005913800000091,350005913800000090	0-24,0-25,0-25						Oligomeric compounds and compositions for use in modulation of small non-coding rnas	Baker	2005	0		
1272	chr8	90115981	90124986	3500405493	93		90115981	90124986	8421504	2	70,23	0,8982	p	350040549300015007	0-93						Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. - ResearchGate	.researchgate.net	0	0		SPTLC1
1272	chr8	90119959	90119983	3500380594	23		90119959	90119983	8421504	2	6,17	0,7	g	350038059400000001	1-24						NOVEL $i(BACILLUS THURINGIENSIS) ISOLATES ACTIVE AGAINST PHTHIRAPTERA PESTS	Hickle	1994	0		
1275	chr8	90440502	90449062	3500337812	675		90440502	90449062	8421504	7	103,11,258,34,176,67,26	0,3782,3796,4063,5265,5444,8534	p	350033781200015095,350033781200015092	0-372,0-303						Wnt antagonists and methods of treatment and screening	Satyal	2011	0		ROR2
1275	chr8	90440502	90449062	3500039991	675		90440502	90449062	8421504	7	103,11,258,34,176,67,26	0,3782,3796,4063,5265,5444,8534	p	350003999100015097,350003999100015094	0-372,0-303						WNT ANTAGONISTS AND METHODS OF TREATMENT AND SCREENING - ONCOMED PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		ROR2
1277	chr8	90779382	90779405	3500215207	23		90779382	90779405	8421504	1	23	0	c	350021520700000004	7-30		10627534	10.1128/JVI.74.3.1241-1251.2000	0022-538X	Journal of Virology	Identification of Multiple Transcription Factors, HLF, FTF, and E4BP4, Controlling Hepatitis B Virus Enhancer II	Ishida	2000	5		
1281	chr8	91311592	91311622	3500283971	30		91311592	91311622	8421504	1	30	0	c	350028397100000009	11-41					Patent	Selection of intracellular immunoglobulins (Patent US:7569390)	Eric	2009	0		
1281	chr8	91311592	91311622	3500037520	30		91311592	91311622	8421504	1	30	0	c,g	350003752000000021,350003752000000021,350003752000000009,350003752000000009	11-41,11-41,11-41,11-41						SELECTION OF INTRACELLULAR IMMUNOGLOBULINS - Patent application	www.faqs.org	0	0		
1281	chr8	91330841	91330867	3500092476	23		91330841	91330867	8421504	2	13,10	0,16	c	350009247600000013	10-33						Mechanismen der Mastzellaktivierung durch gram-negative Bakterien und Bakterienprodukte aus der Darmflora	.uni-hohenheim.de	0	0		
1281	chr8	91341828	91344035	3500351071	38		91341828	91344035	8421504	2	19,19	0,2188	c,g	350035107100000003,350035107100000002,350035107100000002	0-19,0-19,0-19		18981293	10.1182/blood-2008-05-158618		Blood	Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target	Ryan	2009	0		SYK
160	chr8	91347340	91366831	3500211925	324		91347340	91366831	8421504	3	82,77,165	0,16658,19326	p	350021192500015011,350021192500015012	0-159,0-165						 Phylogeography Ppt Presentation 	.authorstream.com	0	0		SYK
1289	chr8	92382251	92382275	3500253863	23		92382251	92382275	8421504	2	8,15	0,9	g	350025386300000017	3-26						Use of intrinsic reporters of cell signaling for high content drug profiling and toxicity screening	Sealfon	2002	0		
1293	chr8	92892961	92892988	3500064074	23		92892961	92892988	8421504	2	7,16	0,11	g	350006407400000004	1-24						MICROBIAL SYSTEMS FOR PRODUCING COMMODITY CHEMICALS - BIO ARCHITECTURE LAB, INC.	www.sumobrain.com	0	0		
1294	chr8	93053040	93053066	3500420657	24		93053040	93053066	8421504	2	11,13	0,13	g	350042065700000169	9-33						Collection and Methods For Its Use - Patent application	www.faqs.org	0	0		
1296	chr8	93200564	93200725	3500433790	48		93200564	93200725	8421504	2	41,7	0,154	c	350043379000000128	0-48						Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression - Patent # 6020155 - PatentGenius	.patentgenius.com	0	0		
1296	chr8	93318269	93318293	3500045997	23		93318269	93318293	8421504	2	4,19	0,5	g	350004599700000030	2-25						METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX - Patent application	www.faqs.org	0	0		
1298	chr8	93463345	93463372	3500316685	24		93463345	93463372	8421504	2	14,10	0,17	g	350031668500000072	2-26						Neoplasia-Specific Autoantibodies and Methods - Patent application	www.faqs.org	0	0		
1298	chr8	93504973	93505001	3500010458	23		93504973	93505001	8421504	3	4,6,13	0,5,15	g	350001045800000063,350001045800000187	10-34,10-34						METHODS OF TREATMENT USING TLR7 AND/OR TLR9 INHIBITORS - Patent application	www.faqs.org	0	0		
1298	chr8	93576281	93577657	3500276160	60		93576281	93577657	8421504	2	38,22	0,1354	p	350027616000015001	0-60						Supplemental Data Mutual Inhibition of Separase and Cdk1 by Two-Step Complex Formation	download.cell.com	0	0		CKS1B
1301	chr8	93921889	93921937	3500193512	48		93921889	93921937	8421504	1	48	0	c	350019351200000077	0-48						Methods for detecting compounds which modulate the activity of an LPA receptor	Erickson	1998	0		
1301	chr8	93922129	93922153	3500060001	24		93922129	93922153	8421504	1	24	0	c	350006000100000013	0-24			10.1046/j.1471-4159.2003.02106.x	1471-4159	Journal of Neurochemistry	Cyclic phosphatidic acid elicits neurotrophin-like actions in embryonic hippocampal neurons - Fujiwara - 2003 - Journal of Neurochemistry - Wiley Online Library	Fujiwara	2003	0		
1301	chr8	93922606	93922681	3500163087	75		93922606	93922681	8421504	1	75	0	p	350016308700015035	0-75						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		SHC3
1301	chr8	93942924	93942947	3500229353	23		93942924	93942947	8421504	1	23	0	g	350022935300000425	1-24						Regulating metabolism by modifying level of trehalose-6-phosphate	O*J*M*Ge Di Jin 	1999	0		
1304	chr8	94367165	94367193	3500110705	23		94367165	94367193	8421504	2	8,15	0,13	g	350011070500000126	11-44						DIAGNOSTIC MARKER FOR ALLERGY - Patent application	www.faqs.org	0	0		
1305	chr8	94388794	94388817	3500142159	23		94388794	94388817	8421504	1	23	0	c	350014215900000229	4-27						Catalytic molecules - US Patent 7355035 Description	ww.patentstorm.us	0	0		
1305	chr8	94465706	94465732	3500419411	26		94465706	94465732	8421504	1	26	0	c	350041941100000063	0-26						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		
163	chr8	94466203	94511273	3500242674	43		94466203	94511273	8421504	2	22,21	0,45049	c	350024267400000006,350024267400000005	14-36,15-36		21836164	10.1074/mcp.M110.005371	1535-9476	Molecular & Cellular Proteomics	Chromatin Affinity Purification and Quantitative Mass Spectrometry Defining the Interactome of Histone Modification Patterns	Nikolov	2011	7		SPIN1
1308	chr8	94886953	94886976	3500189209	23		94886953	94886976	8421504	1	23	0	c	350018920900000006	0-23						Novel Cdk11 molecules and uses thereof	Coats	2007	0		
1309	chr8	94988038	94988067	3500341514	24		94988038	94988067	8421504	3	4,6,14	0,5,15	g	350034151400000030	10-35					Patent	Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof (Patent US:5955364)	Brams	1999	0		
1309	chr8	94988038	94988067	3500004521	24		94988038	94988067	8421504	3	4,6,14	0,5,15	g	350000452100000159	10-35						US Patent # 6,680,209. Human antibodies as diagnostic reagents - Patents.com	www.patents.com	0	0		
1309	chr8	94988038	94988067	3500000260	24		94988038	94988067	8421504	3	4,6,14	0,5,15	g	350000026000000040,350000026000000070,350000026000000147,350000026000000133	10-35,10-35,10-35,10-35						Ligand - Patent application	www.faqs.org	0	0		
1311	chr8	95187753	95187778	3500456395	23		95187753	95187778	8421504	3	5,12,6	0,6,19	g	350045639500000002	5-34		12110581	10.1093/emboj/cdf372	ERROR! NO ISSN	The EMBO Journal	Selenoproteins and selenocysteine insertion system in the model plant cell system, Chlamydomonas reinhardtii	Novoselov	2002	0		
1312	chr8	95409097	95409124	3500042383	25		95409097	95409124	8421504	2	6,19	0,8	g	350004238300000101	14-39						NUCLEOTIDE TRANSIENT BINDING FOR SEQUENCING METHODS - Patent application	www.faqs.org	0	0		
164	chr8	95736795	95885361	3500025900	495		95736795	95885361	8421504	14	12,33,45,9,36,45,45,45,45,45,42,3,45,45	0,101698,101782,101878,117824,117863,117911,140755,140803,145394,145442,148467,148473,148521	p	350002590000015135,350002590000015140,350002590000015148,350002590000015153,350002590000015211,350002590000015206,350002590000015165,350002590000015173,350002590000015178,350002590000015183,350002590000015186	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Anti-claudin 3 Monoclonal Antibody And Treatment And Diagnosis Of Cancer Using The Same 	.freshpatents.com	0	0		BAAT
1317	chr8	95977399	95977468	3500385351	69		95977399	95977468	8421504	1	69	0	p	350038535100015153,350038535100015214	21-90,0-69						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZNF189
1317	chr8	95977399	95977468	3500269504	69		95977399	95977468	8421504	1	69	0	p	350026950400015046	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZNF189
1317	chr8	95977399	95977468	3500229015	69		95977399	95977468	8421504	1	69	0	p	350022901500015037	0-69						Figure S1 AB	genome.cshlp.org	0	0		ZNF189
1317	chr8	95977399	95977468	3500220702	69		95977399	95977468	8421504	1	69	0	p	350022070200015021	0-69						Regulatory zinc finger proteins	Jin-Soo	2004	0		ZNF189
1317	chr8	95977399	95977468	3500176901	69		95977399	95977468	8421504	1	69	0	p	350017690100015029	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZNF189
1317	chr8	95977399	95977468	3500160097	69		95977399	95977468	8421504	1	69	0	p	350016009700015117	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZNF189
1317	chr8	95977399	95977468	3500105130	69		95977399	95977468	8421504	1	69	0	p	350010513000015032	0-69						Supplemental Figure 1	genome.cshlp.org	0	0		ZNF189
1317	chr8	95977399	95977468	3500075471	69		95977399	95977468	8421504	1	69	0	p	350007547100015077,350007547100015107	21-90,0-69						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZNF189
1317	chr8	95986405	95986429	3500068502	23		95986405	95986429	8421504	2	4,19	0,5	g	350006850200000088	12-35						Repressors of the trans-activating function of papillomavirus e2 proteins	Androphy	1992	0		
1317	chr8	95999694	96000626	3500465898	84		95999694	96000626	8421504	3	15,47,22	0,21,910	p	350046589800015014	0-84						Complete acid sequencefor aldolase Bderived cDNA	www.pnas.org	0	0		
1317	chr8	96054843	96059153	3500120545	24		96054843	96059153	8421504	3	4,3,17	0,4286,4293	c	350012054500000197	0-24						DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS	St.	2007	0		
1319	chr8	96242767	96283754	3500383915	39		96242767	96283754	8421504	2	20,19	0,40968	g	350038391500000733,350038391500000397	0-21,2-21						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
1323	chr8	96754293	96765777	3500236784	41		96754293	96765777	8421504	4	5,17,4,15	0,6,11464,11469	g	350023678400000101,350023678400000132	17-39,7-26						Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites	Tian Gui 	2006	0		
1326	chr8	97203205	97203234	3500045837	23		97203205	97203234	8421504	3	12,5,6	0,13,23	g	350004583700000124,350004583700000183	20-43,26-49						Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same - US Patent 7105345 Description	ww.patentstorm.us	0	0		
1330	chr8	97726081	97726106	3500110881	23		97726081	97726106	8421504	2	7,16	0,9	g	350011088100000011	22-45					Patent	Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins (Patent EP:1732585)	Heidmann	2010	0		
1338	chr8	98818532	98818559	3500119454	23		98818532	98818559	8421504	2	9,14	0,13	g	350011945400000069	25-48						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1342	chr8	99284075	99284101	3500281851	26		99284075	99284101	8421504	1	26	0	g	350028185100000000	24-50						&#x30cb;&#x30c1;&#x30b8;&#x30f3;&#x3092;&#x6210;&#x5206;&#x3068;&#x3059;&#x308b;&#x6297;&#x764c;&#x5264;&#x3001;&#x304a;&#x3088;&#x3073;&#x8a72;&#x6297;&#x764c;&#x5264;&#x306e;&#x611f;&#x53d7;&#x6027;&#x5897;&#x5f37;&#x5264; &#xff08;&#x516c;&#x958b;&#x516	astamuse.com	0	0		ABCA1
1342	chr8	99287146	99287228	3500343890	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350034389000015000,350034389000000000	0-66,0-24						ABCA-1 Elevating compounds	Ibrahim	2002	0		ABCA1
1342	chr8	99287146	99287228	3500331795	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350033179500015006,350033179500000000	0-66,0-24						ABCA-1 elevating compounds	Campbell	2001	0		ABCA1
1342	chr8	99287146	99287228	3500326003	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350032600300015002,350032600300000000	0-66,0-24					Patent	ABCA-1 elevating compounds (Patent US:6919339)	Campbell	2005	0		ABCA1
1342	chr8	99287146	99287228	3500244961	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350024496100015000,350024496100000000	0-66,0-24						Abca-1 elevating compounds against coronary artery disease or atherosclerosis	Mai Ke Er *Kang Pu Bei Er 	2004	0		ABCA1
1342	chr8	99287146	99287228	3500224590	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350022459000015002,350022459000000000	0-66,0-24						ABCA-1 elevating compounds	Campbell	2002	0		ABCA1
1342	chr8	99287146	99287228	3500095379	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350009537900015000,350009537900000000	0-66,0-24					Patent	ABCA-1 elevating compounds (Patent US:6995285)	Ibrahim	2006	0		ABCA1
1342	chr8	99287146	99287228	3500090989	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350009098900015000,350009098900000000	0-66,0-24						Abca-1 elevating compounds	Ibrahim	2005	0		ABCA1
1342	chr8	99287146	99287228	3500079596	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350007959600015000,350007959600000000	0-66,0-24						Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis	Ibrahim	2004	0		ABCA1
1342	chr8	99287146	99287228	3500062395	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350006239500015000,350006239500000000	0-66,0-24						ABCA-1 elevating compounds	Campbell	2003	0		ABCA1
1342	chr8	99287146	99287228	3500044173	79		99287146	99287228	8421504	2	45,34	0,48	p,c	350004417300015002,350004417300000000	0-66,0-24						Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis	Campbell	2003	0		ABCA1
1342	chr8	99287204	99287228	3500401864	24		99287204	99287228	8421504	1	24	0	c	350040186400000000,350040186400000072	0-24,0-24						COMPOSITIONS AND METHODS FOR INCREASING CHOLESTEROL EFFLUX AND RAISING HDL USING ATP BINDING CASSETTE TRANSPORTER PROTEIN ABC1 - Patent application	www.faqs.org	0	0		
1342	chr8	99287204	99287228	3500231227	24		99287204	99287228	8421504	1	24	0	c	350023122700000048,350023122700000000	0-24,0-24					Patent	Regulation with binding cassette transporter protein abc1 (Patent EP:1218515)	Garvin	2009	0		
1342	chr8	99287238	99287970	3500118563	43		99287238	99287970	8421504	2	23,20	0,712	c,g	350011856300000029,350011856300000028,350011856300000028	0-23,0-20,0-20						Dietary xenosterols lead to infertility and loss of abdominal adipose tissue in sterolin-deficient mice. - ResearchGate	.researchgate.net	0	0		ABCA1
1342	chr8	99287277	99287970	3500131945	55		99287277	99287970	8421504	3	1,34,20	0,631,673	c	350013194500000005	0-78						Brain Sterol Metabolism &#x2013; Modulating Alzheimer&#x2019;s Disease	arno.unimaas.nl	0	0		
1342	chr8	99287986	99288013	3500013191	24		99287986	99288013	8421504	2	16,8	0,19	c	350001319100000016	4-28					Patent	Erythromycine und verfahren zu ihrer herstellung (Patent DE:69733416)	Cortes	2006	0		
1342	chr8	99288125	99288853	3500274051	28		99288125	99288853	8421504	2	27,1	0,727	c	350027405100000004	0-28						ScienceDirect.com - FEBS Letters - Phosphorylation of the liver X receptors	sciencedirect.com	0	0		ABCA1
1342	chr8	99288125	99288853	3500256424	28		99288125	99288853	8421504	2	27,1	0,727	c	350025642400000019	0-28						Mir-33 inhibitors and uses thereof	Fernandez-Hernando	2013	0		ABCA1
1342	chr8	99288125	99288853	3500132129	28		99288125	99288853	8421504	2	27,1	0,727	c	350013212900000000	0-28		22711909	10.1194/jlr.M024471		Journal of Lipid Research	Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages	Yu-Cheng	2012	0		ABCA1
1342	chr8	99288125	99288853	3500067515	28		99288125	99288853	8421504	2	27,1	0,727	c	350006751500000002	0-28						Interaction of Fish Oil and Conjugated Linoleic Acid in Affecting Hepatic Activity of Lipogenic Enzymes and Gene Expression in Liver and Adipose Tissue	betesjournals.org	0	0		ABCA1
1342	chr8	99288125	99288853	3500048654	28		99288125	99288853	8421504	2	27,1	0,727	c	350004865400000000	0-28		19713213	10.1074/jbc.M109.028910		The Journal of Biological Chemistry	Murine 12/15-Lipoxygenase Regulates ATP-binding Cassette Transporter G1 Protein Degradation through p38- and JNK2-dependent Pathways	Melissa	2009	0		ABCA1
1342	chr8	99299907	99300062	3500002088	69		99299907	99300062	8421504	2	52,17	0,138	p	350000208800015007	0-69						Cholesterol transport gene	Attie	2000	0		
1342	chr8	99299948	99315499	3500099123	84		99299948	99315499	8421504	6	11,9,13,7,22,22	0,97,200,2228,8125,15529	c,g	350009912300000019,350009912300000018,350009912300000001,350009912300000000,350009912300000000	0-20,0-20,0-22,0-22,0-22						Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin	g.library.pcc.edu	0	0		
1342	chr8	99309101	99322483	3500451948	38		99309101	99322483	8421504	4	8,11,5,14	0,12,13361,13368	c	350045194800000638,350045194800000236	11-30,0-19						CREATING POULTRY AND OTHER ANIMALS RESISTANT TO VIRAL DISEASE - Patent application	www.faqs.org	0	0		
1342	chr8	99313514	99313538	3500131305	24		99313514	99313538	8421504	1	24	0	c	350013130500000001	0-24		11473048	10.2337/diabetes.50.8.1851	0012-1797	Diabetes	Glucose Regulates the Transcription of Human Genes Relevant to HDL Metabolism	Tu	2001	8		ABCA1
1342	chr8	99332351	99332377	3500318388	26		99332351	99332377	8421504	1	26	0	c	350031838800000001	0-26						IMB2026791, a Xanthone, Stimulates Cholesterol Efflux by Increasing the Binding of Apolipoprotein A-I to ATP-Binding Cassette Transporter A1	www.mdpi.com	0	0		ABCA1
167	chr8	99338804	99355667	3500129435	96		99338804	99355667	8421504	3	25,49,22	0,2146,16841	c	350012943500000044,350012943500000041,350012943500000024,350012943500000018	0-25,0-27,0-22,3-25						Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes	Lagu	2006	0		
167	chr8	99340950	99355667	3500346568	71		99340950	99355667	8421504	2	49,22	0,14695	c	350034656800000041,350034656800000024,350034656800000018	0-27,0-22,3-25						HETEROCYCLIC AMIDE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES - JANSSEN PHARMACEUTICA N.V.	www.sumobrain.com	0	0		
1343	chr8	99389012	99389035	3500146945	23		99389012	99389035	8421504	1	23	0	c	350014694500000001	21-44		15197231	10.1189/jlb.0204107	0741-5400	Journal of Leukocyte Biology	Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages	Reiss	2004	5		
1343	chr8	99430783	99430811	3500307135	23		99430783	99430811	8421504	2	18,5	0,23	g	350030713500000306	7-30						NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1344	chr8	99555992	99556023	3500110550	26		99555992	99556023	8421504	2	7,19	0,12	g	350011055000000049	10-40						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY	Keith	2007	0		
1347	chr8	99935184	99935209	3500372169	23		99935184	99935209	8421504	3	13,4,6	0,14,19	g	350037216900000000	0-23						US Patent # 7,250,251. Virion-based fusion assay - Patents.com	www.patents.com	0	0		
1348	chr8	100038622	100038648	3500432292	26		100038622	100038648	8421504	1	26	0	g	350043229200000024	11-37						PLANTS WITH IMPROVED MORPHOGENESIS AND METHOD OF CONSTRUCTING THE SAME - Patent application	www.faqs.org	0	0		
1348	chr8	100081805	100081831	3500279401	23		100081805	100081831	8421504	3	5,6,12	0,7,14	g	350027940100000314	11-36						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1992	0		
1351	chr8	100480464	100480490	3500416808	24		100480464	100480490	8421504	3	15,4,5	0,16,21	g	350041680800000193	7-31					Patent	Recombinant herpesvirus of turkeys and uses thereof (Patent US:5853733)	Cochran	1998	0		
1351	chr8	100480464	100480490	3500179670	24		100480464	100480490	8421504	3	15,4,5	0,16,21	g	350017967000000083	16-40						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
1351	chr8	100480464	100480490	3500115879	24		100480464	100480490	8421504	3	15,4,5	0,16,21	g	350011587900000071	16-40						Recombinant fowlpox virus s-fpv-043 and uses thereof	Cochran	1994	0		
1359	chr8	101579285	101579310	3500379924	23		101579285	101579310	8421504	2	11,12	0,13	g	350037992400000069	1-24						ScienceDirect.com - Virology - Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon	sciencedirect.com	0	0		
1359	chr8	101579285	101579310	3500257647	23		101579285	101579310	8421504	2	11,12	0,13	g	350025764700000002	3-26					Patent	Methods for inducing mucosal immune responses (Patent US:6630455)	Mitchell	2003	0		
1359	chr8	101579285	101579310	3500043438	23		101579285	101579310	8421504	2	11,12	0,13	g	350004343800000004	3-26		22551420	10.1186/1742-4690-9-36		Retrovirology	MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency	Katrijn	2012	0		
1360	chr8	101684513	101684542	3500213165	27		101684513	101684542	8421504	3	4,5,18	0,5,11	c	350021316500000040	1-28						COMPOSITIONS AND METHODS FOR REGULATING POLYSACCHARIDES OF A PLANT CELL - Patent application	www.faqs.org	0	0		
1360	chr8	101684513	101684542	3500023490	27		101684513	101684542	8421504	3	4,5,18	0,5,11	c	350002349000000040	1-28						Polynucleotides encoding cellulose synthase from pinus radiata and methods of use for regulating polysaccharides of a plant - Patent #08110726	w.strutpatent.com	0	0		
1361	chr8	101774317	101774342	3500394860	23		101774317	101774342	8421504	2	12,11	0,14	c	350039486000000217	15-38						METHODS AND COMPOSITIONS FOR TREATING TULAREMIA - Patent application	www.faqs.org	0	0		
1363	chr8	102039185	102039212	3500385314	24		102039185	102039212	8421504	2	9,15	0,12	g	350038531400000049	5-35						2008	repositorio.ul.pt	0	0		
1364	chr8	102192479	102192503	3500035283	24		102192479	102192503	8421504	1	24	0	c	350003528300000001	0-24		14724568	10.1038/sj.onc.1207067	0950-9232	Oncogene	Identification of Kr&#xfc;ppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer	Zhao	2004	6		
1364	chr8	102192660	102192683	3500074608	23		102192660	102192683	8421504	1	23	0	c	350007460800000012,350007460800000013	0-23,25-45						miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4	.aacrjournals.org	0	0		
1364	chr8	102192741	102192906	3500278326	40		102192741	102192906	8421504	2	21,19	0,146	c,g	350027832600000009,350027832600000008	0-21,0-19		22190728	10.1128/JVI.06143-11	0022-538X	Journal of Virology	Cellular Transcription Factors Induced in Trigeminal Ganglia during Dexamethasone-Induced Reactivation from Latency Stimulate Bovine Herpesvirus 1 Productive Infection and Certain Viral Promoters	Workman	2012	5		
1364	chr8	102193086	102194757	3500179889	59		102193086	102194757	8421504	3	20,20,19	0,219,1652	c,g	350017988900000007,350017988900000007,350017988900000004,350017988900000004,350017988900000006,350017988900000006	0-20,0-20,0-20,0-20,0-19,0-19						Research Paper Characterization of Bovine Induced Pluripotent Stem Cells by Lentiviral Transduction of Reprogramming Factor Fusion Proteins	www.ijbs.com	0	0		
1364	chr8	102193123	102196415	3500078880	67		102193123	102196415	8421504	3	22,25,20	0,139,3272	c,g	350007888000000017,350007888000000035,350007888000000024,350007888000000024,350007888000000034	0-22,0-23,0-20,0-20,0-20						METHODS FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		KLF4
1364	chr8	102193188	102193212	3500268510	24		102193188	102193212	8421504	1	24	0	c	350026851000000000	8-32		21518959	10.1128/MCB.01189-10		Molecular and Cellular Biology	A KLF4&#x2013;miRNA-206 Autoregulatory Feedback Loop Can Promote or Inhibit Protein Translation Depending upon Cell Context 	Chen-Chung	June	0		
1364	chr8	102193249	102196407	3500379873	51		102193249	102196407	8421504	2	23,28	0,3130	c,g	350037987300000001,350037987300000053,350037987300000000,350037987300000052	9-32,9-32,10-38,10-38						VECTORS FOR GENERATING PLURIPOTENT STEM CELLS AND METHODS OF PRODUCING PLURIPOTENT STEM CELLS USING THE SAME - Patent application	www.faqs.org	0	0		
1364	chr8	102193249	102196407	3500150231	51		102193249	102196407	8421504	2	23,28	0,3130	c,g	350015023100000001,350015023100000000	9-32,10-38						Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same	Nakanishi	2010	0		
1364	chr8	102193249	102193272	3500357462	23		102193249	102193272	8421504	1	23	0	c	350035746200000043,350035746200000001	9-32,9-32						VECTORS FOR GENERATING PLURIPOTENT STEM CELLS AND METHODS OF PRODUCING PLURIPOTENT STEM CELLS USING THE SAME - Patent application	www.faqs.org	0	0		
1364	chr8	102193249	102193272	3500209129	23		102193249	102193272	8421504	1	23	0	c	350020912900000045	9-32						Vectors For Generating Pluripotent Stem Cells And Methods Of Producing Pluripotent Stem Cells Using The Same 	.freshpatents.com	0	0		
1364	chr8	102193249	102193272	3500173610	23		102193249	102193272	8421504	1	23	0	c	350017361000000001	9-32						VECTORS FOR GENERATING PLURIPOTENT STEM CELLS AND METHODS OF PRODUCING PLURIPOTENT STEM CELLS USING THE SAME	Nakanishi	2010	0		
1364	chr8	102193251	102196403	3500074319	76		102193251	102196403	8421504	3	25,21,30	0,2213,3122	c,g	350007431900000009,350007431900000003,350007431900000001,350007431900000012,350007431900000000	16-41,10-35,10-32,0-21,31-61						RegulationofKru&#xa8;ppel-likeFactor4bytheAnaphase PromotingComplexPathwayIsInvolvedinTGF- Signaling	www.jbc.org	0	0		
1364	chr8	102193251	102196400	3500432629	921		102193251	102196400	8421504	20	27,93,26,19,48,45,45,45,48,45,45,45,45,45,45,45,45,93,48,24	0,54,150,1128,1150,1246,1393,1441,1489,1585,1633,1681,1729,1825,1873,1921,2197,2293,3049,3125	p,c	350043262900000117,350043262900000001,350043262900000086,350043262900015134,350043262900015132,350043262900015130,350043262900000083,350043262900015128,350043262900015124,350043262900015122,350043262900015120,350043262900015118,350043262900000078,350043262900015114,350043262900015112,350043262900015110,350043262900015108,350043262900015104,350043262900015102,350043262900015100,350043262900015090,350043262900000061,350043262900000060,350043262900015084,350043262900015082,350043262900000116,350043262900000000	15-42,15-42,0-48,0-45,0-45,0-45,0-48,0-45,0-45,0-45,0-45,0-45,0-38,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-48,0-48,0-45,0-45,16-40,16-40						CANINE iPS CELLS AND METHOD OF PRODUCING SAME - Patent application	www.faqs.org	0	0		
1364	chr8	102193251	102196345	3500375899	54		102193251	102196345	8421504	2	35,19	0,3075	c,g	350037589900000001,350037589900000006,350037589900000006	0-35,0-19,0-19		18197146	10.1097/SHK.0b013e318162bef7	1073-2322	Shock	 Klf4 Promotes the Expression, Translocation, and Release of... : Shock 	Liu	2008	3		KLF4
1364	chr8	102193251	102193286	3500362258	35		102193251	102193286	8421504	1	35	0	c	350036225800000001	0-35		20401760	10.1007/s12192-010-0199-5		Cell Stress & Chaperones	KLF4 promotes hydrogen-peroxide-induced apoptosis of chronic myeloid leukemia cells involving the bcl-2/bax pathway	Zhongdong	2010	0		
1364	chr8	102193251	102193281	3500439109	30		102193251	102193281	8421504	1	30	0	c	350043910900000057,350043910900000006,350043910900000017	9-39,9-39,9-34						SINGLE LENTIVIRAL VECTOR SYSTEM FOR INDUCED PLURIPOTENT (IPS) STEM CELLS DERIVATION - Patent application	www.faqs.org	0	0		
1364	chr8	102193251	102193281	3500209110	30		102193251	102193281	8421504	1	30	0	c	350020911000000017,350020911000000006	9-34,9-39						SINGLE LENTIVIRAL VECTOR SYSTEM FOR INDUCED PLURIPOTENT (IPS) STEM CELLS DERIVATION	Mostoslavsky	2011	0		
1364	chr8	102193251	102193278	3500282811	27		102193251	102193278	8421504	1	27	0	c	350028281100000001	15-42						Canine iPS cells and method of producing same	Nakamura	2011	0		KLF4
1364	chr8	102193251	102193278	3500157275	27		102193251	102193278	8421504	1	27	0	c	350015727500000001	15-42						CANINE iPS CELLS AND METHOD OF PRODUCING SAME	Nakamura	2010	0		KLF4
1364	chr8	102193251	102193277	3500370150	26		102193251	102193277	8421504	1	26	0	c	350037015000000001	12-38		15805274	10.1158/0008-5472.CAN-04-3619	0008-5472	Cancer Research	Drastic Down-regulation of Kr&#xfc;ppel-Like Factor 4 Expression Is Critical in Human Gastric Cancer Development and Progression	Wei	2005	8		KLF4
1364	chr8	102193251	102193277	3500325029	26		102193251	102193277	8421504	1	26	0	c	350032502900000001	12-38		15805274	10.1158/0008-5472.CAN-04-3619	0008-5472	Cancer Research	Drastic Down-regulation of Kr&#xfc;ppel-Like Factor 4 Expression Is Critical in Human Gastric Cancer Development and Progression	Wei	2005	8		KLF4
1364	chr8	102193252	102196400	3500273909	50		102193252	102196400	8421504	3	5,20,25	0,6,3123	c	350027390900000035,350027390900000034	17-42,8-33						Record for a UF thesis. Title & abstract won't display until thesis is accessible after 2014-05-31.	ufdc.ufl.edu	0	0		
1364	chr8	102193254	102194968	3500385366	642		102193254	102194968	8421504	4	173,165,241,63	0,1125,1389,1651	p	350038536600015020,350038536600015021	0-642,0-264						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		
1364	chr8	102193257	102194501	3500283192	284		102193257	102194501	8421504	3	170,94,20	0,1122,1224	p,c	350028319200015020,350028319200000023	0-264,20-40						Multipotent/pluripotent cells and methods	Ishikawa	2010	0		KLF4
1364	chr8	102193261	102194489	3500277529	44		102193261	102194489	8421504	2	20,24	0,1204	c	350027752900000037,350027752900000074	18-38,0-24						CELLS AND METHODS FOR OBTAINING THEM	Liu	2010	0		
1364	chr8	102193261	102193284	3500383465	23		102193261	102193284	8421504	1	23	0	c	350038346500000002	0-23							olecularbrain.com	0	0		KLF4
1364	chr8	102193262	102193364	3500038067	48		102193262	102193364	8421504	2	24,24	0,78	c	350003806700000005,350003806700000004	0-24,0-24						A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-&#x03b2;/&#x03b4; (PPAR&#x03b2;/&#x03b4;)	www.cmtc.psu.edu	0	0		KLF4
1364	chr8	102193267	102194658	3500297313	40		102193267	102194658	8421504	3	20,5,15	0,1272,1376	c	350029731300000005,350029731300000004	0-20,0-20		21289094	10.1091/mbc.E10-11-0879		Molecular Biology of the Cell	A decisive function of transforming growth factor-&#x03b2;/Smad signaling in tissue morphogenesis and differentiation of human HaCaT keratinocytes	Susanne	2011	0		KLF4
1364	chr8	102193267	102194658	3500127650	40		102193267	102194658	8421504	3	20,5,15	0,1272,1376	c,g	350012765000000005,350012765000000005,350012765000000004	0-20,0-20,0-20						A decisive function of transforming growth factor-&#x03b2;/Smad signaling in tissue morphogenesis and differentiation of human HaCaT keratinocytes	w.molbiolcell.org	0	0		KLF4
1364	chr8	102193320	102193365	3500313691	45		102193320	102193365	8421504	1	45	0	p	350031369100015136	0-45						COMPOSITIONS AND METHODS FOR THE TREATMENT OF A NEOPLASIA - Patent application	www.faqs.org	0	0		KLF2
1364	chr8	102193341	102193416	3500385351	75		102193341	102193416	8421504	1	75	0	p	350038535100015121,350038535100015129	0-75,0-75						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		KLF2
1364	chr8	102193341	102193416	3500269504	75		102193341	102193416	8421504	1	75	0	p	350026950400015075,350026950400015079	0-75,0-75					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		KLF2
1364	chr8	102193341	102193416	3500229015	75		102193341	102193416	8421504	1	75	0	p	350022901500015028	0-75						Figure S1 AB	genome.cshlp.org	0	0		KLF4
1364	chr8	102193341	102193416	3500176901	75		102193341	102193416	8421504	1	75	0	p	350017690100015058,350017690100015062	0-75,0-75						Zinc finger domains and methods of identifying same	Hwang	2002	0		KLF2
1364	chr8	102193341	102193416	3500160097	75		102193341	102193416	8421504	1	75	0	p	350016009700015094,350016009700015098	0-75,0-75						Phenotypic screen of chimeric proteins	JANG	2004	0		KLF2
1364	chr8	102193341	102193416	3500075471	75		102193341	102193416	8421504	1	75	0	p	350007547100015065,350007547100015061	0-75,0-75						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		KLF2
1364	chr8	102193351	102196400	3500282320	63		102193351	102196400	8421504	3	20,20,23	0,1037,3026	c	350028232000000010,350028232000000040,350028232000000039,350028232000000005,350028232000000033	20-40,0-20,0-20,11-34,11-34						INDUCED PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		KLF4
1364	chr8	102193351	102194654	3500197607	40		102193351	102194654	8421504	3	20,9,11	0,1184,1292	c	350019760700000005,350019760700000004	0-20,0-20						TheFbw7/HumanCDC4TumorSuppressorTargets ProproliferativeFactorKLF5forUbiquitinationand DegradationthroughMultiplePhosphodegronMotifs	www.jbc.org	0	0		
1364	chr8	102193351	102194654	3500003042	40		102193351	102194654	8421504	3	20,9,11	0,1184,1292	c	350000304200000005,350000304200000004	0-20,0-20		20388706	10.1074/jbc.M109.099440		The Journal of Biological Chemistry	The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs	Ning	June	0		KLF4
1364	chr8	102193351	102194408	3500400461	40		102193351	102194408	8421504	2	20,20	0,1037	c	350040046100000004,350040046100000044,350040046100000043	20-40,0-20,0-20						DIFFERENTIATING INDUCED PLURIPOTENT STEM CELLS INTO GLUCOSE-RESPONSIVE, INSULIN-SECRETING PROGENY - Patent application	www.faqs.org	0	0		KLF4
1364	chr8	102193351	102194408	3500007804	41		102193351	102194408	8421504	2	20,21	0,1036	c	350000780400000007,350000780400000006	0-20,0-21						RETINAL PIGMENT EPITHELIAL STEM CELLS	Temple	2009	0		KLF4
1364	chr8	102194465	102194489	3500337582	24		102194465	102194489	8421504	1	24	0	c	350033758200000005	0-24		21706774	10.1002/term.428	1932-7005	Journal of Tissue Engineering and Regenerative Medicine	A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells - Ohnishi - 2011 - Journal of Tissue Engineering and Regenerative Medicine - Wiley Online Library	Ohnishi	2012	0		
1364	chr8	102194465	102194489	3500276182	24		102194465	102194489	8421504	1	24	0	c	350027618200000006	0-24						METHODS OF ISOLATING AND USING STEM CELLS	Huang	2009	0		
1364	chr8	102194465	102194489	3500260546	24		102194465	102194489	8421504	1	24	0	c	350026054600000002	0-24						Large-scale Propagation And Maintenance Method Of Embryoid Bodies Generated From Stem Cells 	.freshpatents.com	0	0		KLF4
1364	chr8	102194466	102194489	3500103242	23		102194466	102194489	8421504	1	23	0	c	350010324200000006	0-23						LARGE-SCALE PROPAGATION AND MAINTENANCE METHOD OF EMBRYOID BODIES GENERATED FROM STEM CELLS - Patent application	www.faqs.org	0	0		
1364	chr8	102194482	102194658	3500235579	64		102194482	102194658	8421504	4	20,22,7,15	0,28,55,161	c	350023557900000014,350023557900000012,350023557900000013	0-20,0-22,0-22						00-00 1 Human Tooth Germ Stem Cells Preserve Neuro-Protective Effects after Long-Term Cryo-Preservation	www.bioeden.es	0	0		KLF4
1364	chr8	102194827	102194919	3500382980	40		102194827	102194919	8421504	2	20,20	0,72	c,g	350038298000000013,350038298000000013,350038298000000012,350038298000000012	0-20,0-20,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
1364	chr8	102194827	102194919	3500280137	40		102194827	102194919	8421504	2	20,20	0,72	c,g	350028013700000013,350028013700000013,350028013700000012,350028013700000012	0-20,0-20,0-20,0-20						Importance of culture conditions during the morula-to-blastocyst period on capacity of inner cell-mass cells of bovine blastocysts for establishment of self-renewing pluripotent cells	imal.ifas.ufl.edu	0	0		
1364	chr8	102196375	102196399	3500429053	24		102196375	102196399	8421504	1	24	0	g	350042905300000002	0-24		17135299	10.1152/ajpcell.00360.2006		American Journal of Physiology - Cell Physiolog	Regulation of the human biotin transporter hSMVT promoter by KLF-4 and AP-2: confirmation of promoter activity in vivo	Reidling	2007	0		
1364	chr8	102196375	102196399	3500155535	24		102196375	102196399	8421504	1	24	0	c	350015553500000002	0-24		17135299	10.1152/ajpcell.00360.2006		American Journal of Physiology - Cell Physiolog	Regulation of the human biotin transporter hSMVT promoter by KLF-4 and AP-2: confirmation of promoter activity in vivo	Reidling	2007	0		KLF4
1368	chr8	102684185	102684208	3500004570	23		102684185	102684208	8421504	1	23	0	g	350000457000000022	13-36						Tesi doctoral presentada per En/Na Soraya RUIZ PAZ amb el tAtol "TrA!fico intracelular y activac	www.tdx.cat	0	0		
1371	chr8	103107688	103107712	3500319336	23		103107688	103107712	8421504	2	13,10	0,14	g	350031933600000150	23-48						Subtilases 	.freshpatents.com	0	0		
1372	chr8	103283547	103283577	3500398930	25		103283547	103283577	8421504	3	7,6,12	0,8,18	g	350039893000000001	16-48						Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use	Dan Ni Er *Shen De Le 	2009	0		
1374	chr8	103538587	103538614	3500291453	23		103538587	103538614	8421504	2	17,6	0,21	g	350029145300000027	6-30						Development of type I markers in channel cat&#xfb01;sh through intron sequencing	ddr.nal.usda.gov	0	0		
1377	chr8	103924718	103924742	3500145592	23		103924718	103924742	8421504	2	7,16	0,8	c	350014559200000011	8-42						Isolated viral protein cytokine antagonists	Goodwin	1991	0		
1380	chr8	104322136	104322163	3500119454	25		104322136	104322163	8421504	2	12,13	0,14	g	350011945400000646,350011945400000565	21-46,24-46						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1381	chr8	104367596	104367619	3500447684	23		104367596	104367619	8421504	1	23	0	g	350044768400000051	19-42						Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins	Friden	1996	0		
1382	chr8	104495230	104495257	3500448251	24		104495230	104495257	8421504	3	14,4,6	0,15,21	g	350044825100000001	2-30						Nucleoside derivatives.	Haralambidis	1990	0		
1382	chr8	104590035	104590059	3500253387	23		104590035	104590059	8421504	2	8,15	0,9	g	350025338700000011	2-25						THE ROLE OF THE NATRIURETIC PEPTIDE SYSTEM IN CARDIOVASCULAR	etd.nd.edu/ETD-db	0	0		
1383	chr8	104645236	104645290	3500111111	54		104645236	104645290	8421504	1	54	0	p	350011111100015036	0-54						Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity	Chang	2012	0		TXN
1384	chr8	104756037	104762118	3500452717	91		104756037	104762118	8421504	4	24,21,24,22	0,553,6034,6059	c,g	350045271700000001,350045271700000006,350045271700000005,350045271700000005,350045271700000004,350045271700000004	8-32,1-22,0-24,0-24,1-23,1-23						The nonclassic secretion of thioredoxin is not sensitive to redox state	ll.physiology.org	0	0		
1384	chr8	104756037	104756061	3500389429	24		104756037	104756061	8421504	1	24	0	c	350038942900000001	8-32		17823364	10.1161/ATVBAHA.107.149419	1079-5642	Arteriosclerosis, Thrombosis, and Vascular Biology	Nuclear Redox-Signaling Is Essential for Apoptosis Inhibition in Endothelial Cells&#x2014;Important Role for Nuclear Thioredoxin-1	Schroeder	2007	6		TXN
1384	chr8	104756595	104761598	3500000649	49		104756595	104761598	8421504	3	22,1,26	0,4975,4977	c	350000064900000006,350000064900000004	0-23,0-26						INFORMATION TO USERS The quality of this reproduction is dependent upon the quality of the	penrepository.com	0	0		
1384	chr8	104756609	104761586	3500091247	24		104756609	104761586	8421504	2	8,16	0,4961	c	350009124700000006	0-24			10.1016/j.exer.2007.05.001		Experimental eye research	REGULATION OF THE BIOAVAILABILITY OF THIOREDOXIN IN THE LENS BY A SPECIFIC THIOREDOXIN-BINDING PROTEIN (TBP-2)	NamP.M.	2007	0		TXN
1384	chr8	104761605	104762070	3500181711	26		104761605	104762070	8421504	2	25,1	0,464	c	350018171100000029	0-26						REPRODUCTION	uction-online.org	0	0		TXN
1384	chr8	104761605	104762070	3500133737	26		104761605	104762070	8421504	2	25,1	0,464	c	350013373700000010	0-26						REPRODUCTION	uction-online.org	0	0		
1384	chr8	104761619	104762090	3500162425	32		104761619	104762090	8421504	2	11,21	0,450	c	350016242500000005	0-32		17300148			Journal of Agricultural and Food Chemistry	Dual action of sulforaphane in the regulation of thioredoxin reductase and thioredoxin in human HepG2 and Caco-2 cells.	Bacon	2007	0		
1384	chr8	104762079	104762120	3500294385	41		104762079	104762120	8421504	1	41	0	c	350029438500000001	0-41		12816947	10.1074/jbc.M211107200	0021-9258	Journal of Biological Chemistry	Redox Potential of Human Thioredoxin 1 and Identification of a Second Dithiol/Disulfide Motif	Watson	2003	5		
1385	chr8	104917015	104917042	3500161204	23		104917015	104917042	8421504	3	4,6,13	0,5,14	g	350016120400000003	2-25						15	jeremydewaard.com	0	0		
1385	chr8	104917015	104917042	3500028390	23		104917015	104917042	8421504	3	4,6,13	0,5,14	g	350002839000000003,350002839000000007	2-25,2-25						Kerr et al	e.rockefeller.edu	0	0		
1386	chr8	105076194	105076221	3500088819	24		105076194	105076221	8421504	2	9,15	0,12	g	350008881900000002	0-24			10.1002/phy2.71	2051-817X	Physiological Reports	Regeneration of injured skeletal muscle in heat shock transcription factor 1-null mice - Nishizawa - 2013 - Physiological Reports - Wiley Online Library	Nishizawa	2013	0		
1387	chr8	105147688	105147712	3500115686	24		105147688	105147712	8421504	1	24	0	g	350011568600000030,350011568600000031	0-24,0-24						Characterization of the two PPAR target genes FIAF (Fastening-Induced Adipose Factor) and G0S2 (G0/G1 switch gene 2)	edepot.wur.nl	0	0		MUSK
1388	chr8	105316334	105378334	3500085193	168		105316334	105378334	8421504	6	35,42,22,23,25,21	0,36,110,276,61922,61979	c,g	350008519300000046,350008519300000045,350008519300000009,350008519300000063,350008519300000063,350008519300000040,350008519300000002	1-36,6-48,18-40,0-20,0-20,0-48,0-21						GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF - Patent application	www.faqs.org	0	0		
1388	chr8	105316343	105316506	3500282748	43		105316343	105316506	8421504	2	24,19	0,144	c	350028274800000019,350028274800000002,350028274800000023	0-24,23-47,5-24						Methods of regulating differentiation in stem cells	Pebay	2003	0		
1388	chr8	105316343	105316367	3500459775	24		105316343	105316367	8421504	1	24	0	c	350045977500000001,350045977500000009	0-24,0-24						THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF - Patent application	www.faqs.org	0	0		LPAR1
1388	chr8	105316343	105316367	3500441641	24		105316343	105316367	8421504	1	24	0	c	350044164100000001	0-24			10.1046/j.1471-4159.2000.0751575.x	1471-4159	Journal of Neurochemistry	Lysophosphatidic Acid Inhibits Ca2+ Signaling in Response to Epidermal Growth Factor Receptor Stimulation in Human Astrocytoma Cells by a Mechanism Involving Phospholipase C&#x03b3; and a G&#x03b1;i Protein - Hern&#xe1;ndez - 2002 - Journal of Neurochemis	Hernandez	2000	0		LPAR1
1388	chr8	105316343	105316367	3500403018	24		105316343	105316367	8421504	1	24	0	c	350040301800000001	0-24					Patent	Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof (Patent US:7307093)	Dalton	2007	0		LPAR1
1388	chr8	105316343	105316367	3500399480	24		105316343	105316367	8421504	1	24	0	c,g	350039948000000011,350039948000000050,350039948000000050	0-24,0-20,0-20						 Methods Of Regulating Differentiation In Stem Cells 	www.docstoc.com	0	0		LPAR1
1388	chr8	105316343	105316367	3500380968	24		105316343	105316367	8421504	1	24	0	c	350038096800000001	0-24						Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents	Dalton	2008	0		LPAR1
1388	chr8	105316343	105316367	3500368754	24		105316343	105316367	8421504	1	24	0	c	350036875400000005,350036875400000025	23-47,0-24						Methods of regulating differentiation in stem cells	Pebay	2003	0		LPAR1
1388	chr8	105316343	105316367	3500270540	24		105316343	105316367	8421504	1	24	0	c	350027054000000033,350027054000000009	0-24,0-24						Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same	Goetzl	1999	0		LPAR1
1388	chr8	105316343	105316367	3500248769	24		105316343	105316367	8421504	1	24	0	c	350024876900000028	0-24						Methods of regulating differentiation in stem cells	Pebay	2005	0		LPAR1
1388	chr8	105316343	105316367	3500212844	24		105316343	105316367	8421504	1	24	0	c	350021284400000011	0-24					Patent	Methods of regulating differentiation in stem cells (Patent US:7604990)	Pebay	2009	0		LPAR1
1388	chr8	105316343	105316367	3500202278	24		105316343	105316367	8421504	1	24	0	c,g	350020227800000003,350020227800000003	0-24,0-24		21901169	10.1177/1947601911419362		Genes & Cancer	Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene G&#x03b1;12 	Zachariah	2011	0		LPAR1
1388	chr8	105316343	105316367	3500191701	24		105316343	105316367	8421504	1	24	0	c	350019170100000011	0-24						Methods of regulating differentiation in stem cells	Pebay	2004	0		LPAR1
1388	chr8	105316343	105316367	3500174181	24		105316343	105316367	8421504	1	24	0	c	350017418100000005	0-24		10493533		0008-5472	Cancer Research	Dual Mechanisms for Lysophospholipid Induction of Proliferation of Human Breast Carcinoma Cells	Goetzl	1999	8		LPAR1
1388	chr8	105316343	105316367	3500172729	24		105316343	105316367	8421504	1	24	0	c	350017272900000025,350017272900000005	0-24,23-47					Patent	Methods of regulating differentiation in stem cells (Patent US:7413903)	Pebay	2008	0		LPAR1
1388	chr8	105316343	105316367	3500150912	24		105316343	105316367	8421504	1	24	0	c	350015091200000001	0-24						Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof	Miller	2004	0		LPAR1
1388	chr8	105316343	105316367	3500096195	24		105316343	105316367	8421504	1	24	0	c,g	350009619500000001,350009619500000001	0-24,0-24						Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents	Miller	2007	0		LPAR1
1388	chr8	105316343	105316367	3500019638	24		105316343	105316367	8421504	1	24	0	c	350001963800000001	0-24						Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof	Dalton	2006	0		LPAR1
1388	chr8	105316376	105316472	3500193512	84		105316376	105316472	8421504	2	36,48	0,48	c	350019351200000031,350019351200000030	12-48,0-48						Methods for detecting compounds which modulate the activity of an LPA receptor	Erickson	1998	0		
1388	chr8	105316605	105316628	3500094442	23		105316605	105316628	8421504	1	23	0	c	350009444200000005	0-23		22359668	10.1371/journal.pone.0032185	1932-6203	PLOS ONE	PLOS ONE: Targeting Lysophosphatidic Acid Signaling Retards Culture-Associated Senescence of Human Marrow Stromal Cells	Kanehira	2012	4		LPAR1
1388	chr8	105378312	105378710	3500301608	40		105378312	105378710	8421504	2	20,20	0,378	c,g	350030160800000001,350030160800000001,350030160800000000,350030160800000000	0-20,0-20,0-20,0-20						Sista versionen RAM	u.diva-portal.org	0	0		LPAR1
1388	chr8	105378346	105378422	3500404018	41		105378346	105378422	8421504	2	21,20	0,56	c,g	350040401800000003,350040401800000003,350040401800000002,350040401800000002	0-21,0-21,0-20,0-20						Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity	www.hal.inserm.fr	0	0		LPAR1
1390	chr8	105513513	105513537	3500445688	24		105513513	105513537	8421504	1	24	0	g	350044568800000098	17-42						 Herpes Simplex Virus Mutant ICP0 Protein 	www.docstoc.com	0	0		
1395	chr8	106228892	106228918	3500231688	23		106228892	106228918	8421504	2	7,16	0,10	g	350023168800000262,350023168800000018,350023168800000160	0-24,0-24,0-24						Method of detecting neutophil inhibitory factor mimics	Moyle	1993	0		
1395	chr8	106228892	106228918	3500192210	23		106228892	106228918	8421504	2	7,16	0,10	g	350019221000000017	0-24						Neutrophil inhibitors	Moyle	1995	0		
1395	chr8	106228892	106228918	3500180791	23		106228892	106228918	8421504	2	7,16	0,10	g	350018079100000018	0-24						Modified hookworm neutrophil inhibitors	Moyle	1995	0		
1395	chr8	106228892	106228918	3500034224	23		106228892	106228918	8421504	2	7,16	0,10	g	350003422400000013	0-24					Patent	Neutrophil inhibitors (Patent US:5789178)	Foster	1998	0		
1396	chr8	106381659	106391160	3500055707	135		106381659	106391160	8421504	5	24,58,5,31,17	0,27,1615,9450,9484	p,c	350005570700015007,350005570700000015	0-87,0-48						Expression cDNA	www.pnas.org	0	0		
1396	chr8	106389308	106389359	3500013219	51		106389308	106389359	8421504	1	51	0	p	350001321900015082	0-51						SOURCE (OR PART OF THE FOLLOWING SOURCE): FULL BIBLIOGRAPHIC DETAILS: Type Dissertation	dare.uva.nl	0	0		MIR4668
1399	chr8	106782023	106782049	3500447745	23		106782023	106782049	8421504	2	7,16	0,10	g	350044774500000019	20-45						EHRLICHIA EWINGII PROTEINS, NUCLEIC ACIDS, AND METHODS OF THEIR USE	Rikihisa	2008	0		
1400	chr8	106871105	106871255	3500141583	44		106871105	106871255	8421504	2	20,24	0,126	c	350014158300000086,350014158300000087	0-20,0-24						Annealing control primer system for improving specificity of PCR amplification	www.seegene.com	0	0		
1401	chr8	107076017	107076042	3500339288	24		107076017	107076042	8421504	2	6,18	0,7	g	350033928800000250	7-31						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		
1406	chr8	107718644	107721402	3500343582	104		107718644	107721402	8421504	4	19,12,9,64	0,36,1080,2694	p,c,g	350034358200000003,350034358200000003,350034358200000056,350034358200000057,350034358200000057,350034358200015004	0-19,0-19,0-21,0-19,0-19,0-54						ABSTRACT	tory.lib.ncsu.edu	0	0		
1406	chr8	107718680	107721357	3500306908	40		107718680	107721357	8421504	3	12,9,19	0,1044,2658	c	350030690800000008,350030690800000009	0-21,0-19				0021-8812		Amount and source of dietary copper affects small intestine morphology, duodenal lipid peroxidation, hepatic oxidative stress,and mRNA expression of hepatic copper regulatory proteins in weanling pigs 	animalscience.org	0	2		
1406	chr8	107722595	107722691	3500023334	71		107722595	107722691	8421504	2	29,42	0,54	c	350002333400000354,350002333400000355	0-29,6-48						Proteins, Polynucleotides Encoding Them And Methods Of Using The Same 	.freshpatents.com	0	0		
1406	chr8	107725685	107725711	3500110892	23		107725685	107725711	8421504	2	10,13	0,13	c	350011089200000199	17-42						Method of screening for the presence of a genetic defect associated with deep venous thrombosis	Bertina	2006	0		
1407	chr8	107765170	107765194	3500006524	23		107765170	107765194	8421504	2	13,10	0,14	c	350000652400000025,350000652400000024	11-34,10-33						Charakterisierung des Glyoxalasesystems des Malariaerregers Plasmodium falciparum	b.uni-muenchen.de	0	0		
1408	chr8	107978685	107978716	3500300552	23		107978685	107978716	8421504	3	5,7,11	0,8,20	g	350030055200000002	0-23						ScienceDirect.com - Vaccine - Rotavirus enterotoxin NSP4 has mucosal adjuvant properties	sciencedirect.com	0	0		
1409	chr8	108034381	108034406	3500448855	23		108034381	108034406	8421504	3	4,5,14	0,5,11	c	350044885500000068	10-33						Non-contiguous Protein Recombination	brary.caltech.edu	0	0		
1411	chr8	108357178	108357203	3500088017	23		108357178	108357203	8421504	2	16,7	0,18	g	350008801700000133	16-39						US Patent # 5,451,522. Genes encoding and method of expressing an enzyme: phthalyl amidase - Patents.com	www.patents.com	0	0		
1413	chr8	108528279	108528324	3500144116	45		108528279	108528324	8421504	1	45	0	p	350014411600015133	0-45						&#x4f7f;&#x7528;&#x5305;&#x542b;glp&#xff0d;1&#x7684;&#x8fd0;&#x94c1;&#x86cb;&#x767d;&#x878d;&#x5408;&#x86cb;&#x767d;&#x7684;&#x7ec4;&#x5408;&#x6cbb;&#x7597;	Huo Ma Yang *Sa De Ji 	2007	0		AMBP
1418	chr8	109196771	109217384	3500020947	163		109196771	109217384	8421504	6	41,41,24,5,22,30	0,294,383,431,4013,20583	c	350002094700000019,350002094700000013,350002094700000011,350002094700000010,350002094700000008	6-47,0-41,24-48,21-48,7-37						US Patent # 6,852,839. Fhm, a novel member of the TNF ligand supergene family - Patents.com	www.patents.com	0	0		
1418	chr8	109196909	109200797	3500080660	133		109196909	109200797	8421504	5	29,47,26,18,13	0,33,171,280,3875	c,g	350008066000000041,350008066000000119,350008066000000024,350008066000000095,350008066000000113	6-35,0-23,0-47,4-30,0-31						VEGI, an inhibitor of angiogenesis and tumor growth	Li Lu Yuan 	2001	0		
1418	chr8	109196920	109196986	3500209161	63		109196920	109196986	8421504	2	18,45	0,21	p	350020916100015048	0-63						US Patent # 7,498,407. Vascular endothelial cell growth inhibitor, VEGI-192a - Patents.com	www.patents.com	0	0		
1419	chr8	109315297	109329384	3500444875	148		109315297	109329384	8421504	6	4,44,23,48,16,13	0,5,121,274,1882,14074	c	350044487500000070,350044487500000117,350044487500000079,350044487500000062	0-48,25-48,0-48,0-29						Antibodies directed against CD30 ligand	www.devileye.net	0	0		
1419	chr8	109315297	109329384	3500180094	149		109315297	109329384	8421504	6	4,44,23,49,16,13	0,5,121,273,1882,14074	c	350018009400000070,350018009400000117,350018009400000114,350018009400000079,350018009400000062	0-48,25-48,0-40,0-48,0-29						Antibodies directed against CD30 ligand	Goodwin	1995	0		
1419	chr8	109315297	109315619	3500088261	120		109315297	109315619	8421504	4	4,44,23,49	0,5,121,273	c,g	350008826100000073,350008826100000120,350008826100000120,350008826100000117,350008826100000082	0-48,25-48,25-48,0-40,0-48						US Patent # 6,667,039. CD30 ligand - Patents.com	www.patents.com	0	0		
1419	chr8	109315297	109315346	3500240600	48		109315297	109315346	8421504	2	4,44	0,5	c	350024060000000074	0-48						CD30 ligand conjugates	Goodwin	1995	0		
1420	chr8	109500679	109501700	3500180889	25		109500679	109501700	8421504	2	13,12	0,1009	c	350018088900000015	0-25						Mechanoactive Tenogenic Differentiation of Human Mesenchymal Stem Cells	ncedbiomatrix.com	0	0		
1420	chr8	109509312	109511380	3500450900	41		109509312	109511380	8421504	3	3,19,19	0,1993,2049	c	350045090000000005,350045090000000004	0-22,0-19		21412429	10.1371/journal.pone.0017531		PLoS ONE	BMP-12 Treatment of Adult Mesenchymal Stem Cells In Vitro Augments Tendon-Like Tissue Formation and Defect Repair In Vivo	Jonathan	2011	0		
1420	chr8	109513602	109514805	3500018210	40		109513602	109514805	8421504	3	20,5,15	0,91,1188	c,g	350001821000000003,350001821000000003,350001821000000002	0-20,0-20,0-20		21800203	10.1007/s10439-011-0365-7		Annals of biomedical engineering	Fiber Stretch and Reorientation Modulates Mesenchymal Stem Cell Morphology and Fibrous Gene Expression on Oriented Nanofibrous Microenvironments	Su-Jin	2011	0		
1420	chr8	109549606	109562728	3500452264	63		109549606	109562728	8421504	4	21,11,10,21	0,4072,5155,13101	c	350045226400000009,350045226400000024,350045226400000000	6-27,0-21,24-45						Biological Materials and Uses Thereof	Midwood	2010	0		
1420	chr8	109550362	109550388	3500408152	24		109550362	109550388	8421504	2	11,13	0,13	g	350040815200000005	4-28		10548593		1556-6811	Clinical and Diagnostic Laboratory Immunology	Genotyping of the CCR5 Chemokine Receptor by Isothermal NASBA Amplification and Differential Probe Hybridization	Romano	1999	3		
1420	chr8	109562380	109562470	3500015308	90		109562380	109562470	8421504	1	90	0	p	350001530800015004	0-90						Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug	Pfizenmaier	2003	0		TNC
1420	chr8	109562589	109562721	3500243781	40		109562589	109562721	8421504	2	20,20	0,112	c,g	350024378100000005,350024378100000004,350024378100000004	0-20,0-20,0-20		17438134	10.1128/MCB.02404-06	0270-7306	Molecular and Cellular Biology	Constitutively Activated Stat3 Induces Tumorigenesis and Enhances Cell Motility of Prostate Epithelial Cells through Integrin &#x03b2;6	Azare	2007	6		TNC
1420	chr8	109562589	109562721	3500000667	43		109562589	109562721	8421504	2	22,21	0,111	c,g	350000066700000009,350000066700000008,350000066700000008	0-22,0-21,0-21						ORIGINAL ARTICLE Examination of Oral Cancer Biomarkers by Tissue Microarray Analysis	l.jamanetwork.com	0	0		TNC
1427	chr8	110414810	110414835	3500432081	25		110414810	110414835	8421504	1	25	0	g	350043208100000174	18-43						Biological methods for preparing adipic acid	Picataggio	2011	0		
1430	chr8	110783203	110783230	3500379475	26		110783203	110783230	8421504	2	9,17	0,10	g	350037947500000017	5-32						Protein complexes having factor viii:c activity and production thereof	Burke	1991	0		
1431	chr8	110949626	110949653	3500223393	23		110949626	110949653	8421504	2	11,12	0,15	g	350022339300000092	8-42						Microsatellites reveal genetic diversity in Rotylenchulus reniformis populations	aldc.nal.usda.gov	0	0		
1432	chr8	111076794	111076817	3500208479	23		111076794	111076817	8421504	1	23	0	g	350020847900000058	4-27						Identification Of Oligonucleotides For The Capture, Detection And Quantitation Of West Nile Virus 	.freshpatents.com	0	0		
1433	chr8	111155964	111155995	3500084279	26		111155964	111155995	8421504	2	13,13	0,18	c	350008427900000023	0-26						High throughput directed evolution by rational mutagenesis	Drittanti	2003	0		
1433	chr8	111198138	111198163	3500280216	23		111198138	111198163	8421504	2	10,13	0,12	g	350028021600000095	5-29						Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof	CEDRONE	2012	0		
1434	chr8	111323278	111323751	3500229425	473		111323278	111323751	8421504	1	473	0	g	350022942500000054	0-473						JINKEE JUNG 2012	www.naqs.go.kr	0	0		
1434	chr8	111324980	111325009	3500355886	24		111324980	111325009	8421504	3	13,6,5	0,15,24	g	350035588600000013	0-24						BMC Cancer	biomedcentral.com	0	0		
180	chr8	112326674	112336305	3500465289	66		112326674	112336305	8421504	3	20,24,22	0,9520,9609	c,g	350046528900000000,350046528900000000,350046528900000002,350046528900000003,350046528900000003	0-20,0-20,0-24,0-22,0-22						Single nucleotide polymorphisms in immunity-related genes and their association with mastitis in Chilean dairy cattle. - ResearchGate	.researchgate.net	0	0		
180	chr8	112326674	112336305	3500425625	66		112326674	112336305	8421504	3	20,24,22	0,9520,9609	c,g	350042562500000000,350042562500000000,350042562500000002,350042562500000003,350042562500000003	0-20,0-20,0-24,0-22,0-22						Single nucleotide polymorphisms in immunity-related genes and their association with mastitis in Chilean dairy cattle. - ResearchGate	.researchgate.net	0	0		
180	chr8	112327039	112331740	3500018219	44		112327039	112331740	8421504	3	11,11,22	0,4559,4679	c	350001821900000010,350001821900000011	0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
180	chr8	112327122	112334861	3500263785	67		112327122	112334861	8421504	3	22,23,22	0,4725,7717	c,g	350026378500000005,350026378500000006,350026378500000007	20-42,20-43,22-44						Exome-wide DNA capture and next generation sequencing in domestic and wild species	biomedcentral.com	0	0		
1442	chr8	112331599	112336502	3500022154	104		112331599	112336502	8421504	5	21,23,20,20,20	0,143,3424,3815,4883	c,g	350002215400000002,350002215400000003,350002215400000004,350002215400000005,350002215400000005,350002215400000006,350002215400000006	0-21,0-23,0-20,0-20,0-20,0-20,0-20			10.5402/2012/659513		ISRN Molecular Biology	Nucleotide Sequencing and SNP Detection of Toll-Like Receptor-4 Gene in Murrah Buffalo (<i>Bubalus bubalis</i>)	Mitra	2012	0		
1442	chr8	112331635	112334578	3500358194	44		112331635	112334578	8421504	2	22,22	0,2921	c,g	350035819400000004,350035819400000004,350035819400000005	0-22,0-22,0-22		17158892	10.1128/IAI.00686-06	0019-9567	Infection and Immunity	Effect of Corticosteroids and Neuropeptides on the Expression of Defensins in Bovine Tracheal Epithelial Cells	Mitchell	2007	4		
1442	chr8	112333000	112333027	3500101531	23		112333000	112333027	8421504	2	9,14	0,13	g	350010153100000010	0-23						Targeted adenovirus vectors for delivery of heterologous genes	DEDIEU	2001	0		
1442	chr8	112334424	112336833	3500163561	132		112334424	112336833	8421504	6	22,22,22,22,22,22	0,684,943,1664,1697,2387	c,g	350016356100000008,350016356100000009,350016356100000009,350016356100000010,350016356100000011,350016356100000011,350016356100000012,350016356100000012,350016356100000013	0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-22,0-22						2009 OPEN ACCESS diversity	www.mdpi.com	0	0		
1442	chr8	112334557	112335009	3500027805	46		112334557	112335009	8421504	2	24,22	0,430	c,g	350002780500000006,350002780500000006,350002780500000007,350002780500000007	0-24,0-24,0-22,0-22						Pharmacology Pharmacy and African Journal of	demicjournals.org	0	0		
1442	chr8	112334683	112336908	3500449734	142		112334683	112336908	8421504	6	26,23,21,22,22,28	0,1567,1971,2043,2075,2197	c	350044973400000004,350044973400000007,350044973400000008,350044973400000036,350044973400000000,350044973400000009	0-26,26-49,25-46,7-29,24-46,24-52						3 Materials and Methods	a.inflibnet.ac.in	0	0		
1442	chr8	112334708	112336520	3500158871	385		112334708	112336520	8421504	7	22,240,20,29,23,23,28	0,413,970,1212,1541,1569,1784	c,g	350015887100000004,350015887100000064,350015887100000047,350015887100000047,350015887100000048,350015887100000005,350015887100000005,350015887100000061,350015887100000059,350015887100000059,350015887100000060,350015887100000062,350015887100000062	0-22,0-241,0-21,0-21,0-25,0-20,0-20,0-29,0-23,0-23,0-23,0-28,0-28						ER UNTERSUCHUNG GENETISCHER URSACHEN DER HING UNTERSCHIEDLICHEN EMPF&#xc4;NGLICHKEIT F&#xdc;R DIE	eb.uni-giessen.de	0	0		
1442	chr8	112334778	112336628	3500444298	60		112334778	112336628	8421504	3	20,20,20	0,1357,1830	c,g	350044429800000003,350044429800000003,350044429800000000,350044429800000000,350044429800000001,350044429800000001	0-20,0-20,0-20,0-20,0-20,0-20						Molecular analysis of TLR4 gene and its association with intra-mammary infections in Sahiwal cattle and Murrah buffaloes	pr.niscair.res.in	0	0		
1442	chr8	112335108	112336833	3500444535	110		112335108	112336833	8421504	5	22,22,22,22,22	0,259,980,1013,1703	c,g	350044453500000009,350044453500000009,350044453500000010,350044453500000011,350044453500000012,350044453500000012,350044453500000013	0-22,0-22,0-22,0-22,0-22,0-22,0-22						2009 OPEN ACCESS diversity	dspace.unitus.it	0	0		
1442	chr8	112335119	112335445	3500274525	43		112335119	112335445	8421504	2	20,23	0,303	c,g	350027452500000008,350027452500000008,350027452500000009	0-20,0-20,0-23						DIAGNOSTIC TOOLS AND GENETIC SUSCEPTIBILITY FACTORS ASSOCIATED WITH BOVINE PARATUBERCULOSIS INFECTION	ges.uflib.ufl.edu	0	0		
1442	chr8	112335492	112335680	3500291860	44		112335492	112335680	8421504	2	22,22	0,166	c,g	350029186000000016,350029186000000017,350029186000000017	0-22,0-22,0-22						Die Immunantwort boviner und capriner Euterepithelzellen auf verschiedene Mastitiserreger	b.uni-muenchen.de	0	0		
1442	chr8	112335533	112335558	3500194446	23		112335533	112335558	8421504	2	16,7	0,18	c	350019444600000009	10-33					Patent	Human monocyte elastase inhibitor antibodies (Patent US:5827672)	Remold-O'Donnell	1998	0		
1442	chr8	112335571	112336657	3500388919	138		112335571	112336657	8421504	4	27,31,38,42	0,459,894,1044	c	350038891900000061,350038891900000071,350038891900000080,350038891900000083	21-48,0-31,0-38,6-48						Screening Method - Patent application	www.faqs.org	0	0		
1442	chr8	112335701	112336053	3500431686	40		112335701	112336053	8421504	3	21,14,5	0,332,347	c,g	350043168600000002,350043168600000001,350043168600000001	0-21,0-19,0-19						Identificaci&#xf3;n de Polimorfismos del gen tlr4 en cr&#xed;as de alpacas con cuadros de neumon&#xed;as	cybertesis.edu.pe	0	0		
1442	chr8	112335787	112336407	3500086644	107		112335787	112336407	8421504	5	20,19,27,21,20	0,310,330,363,600	c,g	350008664400000006,350008664400000013,350008664400000013,350008664400000015,350008664400000015,350008664400000014,350008664400000014,350008664400000007	0-20,0-19,0-19,0-27,0-27,0-21,0-21,0-20			10.1111/j.1365-2567.2004.01781.x	1365-2567	Immunology	Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists - Werling - 2003 - Immunology - Wiley Online Library	Werling	2004	0		
1442	chr8	112335791	112336173	3500366576	40		112335791	112336173	8421504	2	20,20	0,362	c,g	350036657600000002,350036657600000003,350036657600000003	0-20,0-20,0-20						Genetic Polymorphism of TLR4 Gene and Correlation with Mastitis in Cattle	www.chinagene.cn	0	0		
1442	chr8	112335791	112336173	3500223145	40		112335791	112336173	8421504	2	20,20	0,362	c,g	350022314500000002,350022314500000003,350022314500000003	0-20,0-20,0-20						Genetic polymorphism of TLR4 gene and correlation with mastitis in cattle. - ResearchGate	.researchgate.net	0	0		
1442	chr8	112335802	112336040	3500322039	42		112335802	112336040	8421504	2	21,21	0,217	c,g	350032203900000013,350032203900000014,350032203900000014	0-21,0-21,0-21			10.1128/CDLI.11.1.174-185.2004		Clinical and Diagnostic Laboratory Immunology	Mastitis Increases Mammary mRNA Abundance of &#x03b2;-Defensin 5, Toll-Like-Receptor 2 (TLR2), and TLR4 but Not TLR9 in Cattle	T.	2004	0		
1442	chr8	112335990	112336014	3500467548	24		112335990	112336014	8421504	1	24	0	c	350046754800000007	24-48						Effects of Lipopolysaccharide and Mannheimia haemolytica Leukotoxin on Bovine Lung Microvascular Endothelial Cells and Alveolar Epithelial Cells	cvi.asm.org	0	0		
1442	chr8	112336425	112336473	3500256733	46		112336425	112336473	8421504	2	25,21	0,27	c,g	350025673300000005,350025673300000004,350025673300000004	0-25,0-21,0-21						Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q)	www.ijbs.org	0	0		
1442	chr8	112336680	112336738	3500305779	52		112336680	112336738	8421504	2	24,28	0,30	c	350030577900000012,350030577900000014	0-24,0-28						Differential Expression of Ovine Innate Immune Genes by Preterm and Neonatal Lung Epithelia Infected with Respiratory Syncytial Virus	ddr.nal.usda.gov	0	0		
1442	chr8	112336680	112336738	3500279721	52		112336680	112336738	8421504	2	24,28	0,30	c	350027972100000003,350027972100000004	0-24,0-28			10.1251/bpo107		Biological Procedures Online	New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR	JM	2005	0		
1442	chr8	112336680	112336738	3500163064	52		112336680	112336738	8421504	2	24,28	0,30	c	350016306400000003,350016306400000004	0-24,0-28			10.1251/bpo107		Biological Procedures Online	New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR	Jack	2005	0		
1442	chr8	112336680	112336704	3500357795	24		112336680	112336704	8421504	1	24	0	c	350035779500000001	0-24						Ovine fetal thymus response to lipopolysaccharide-induced chorioamnionitis and antenatal corticosteroids. - ResearchGate	.researchgate.net	0	0		
1442	chr8	112336707	112336871	3500383646	40		112336707	112336871	8421504	2	20,20	0,144	c	350038364600000014,350038364600000015	0-20,0-20						Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress	biomedcentral.com	0	0		
1445	chr8	112755059	112755085	3500088017	25		112755059	112755085	8421504	2	13,12	0,14	g	350008801700000086	11-48						US Patent # 5,451,522. Genes encoding and method of expressing an enzyme: phthalyl amidase - Patents.com	www.patents.com	0	0		
1448	chr8	113224484	113224512	3500114257	23		113224484	113224512	8421504	2	9,14	0,14	g	350011425700000006	11-34						Multipotent mesenchymal stem cells (MSCs) from human umbilical cord: Potential differentiation of germ cells	demicjournals.org	0	0		
1454	chr8	113953727	113953753	3500155689	23		113953727	113953753	8421504	2	17,6	0,20	c	350015568900000124	24-47						Antibodies Against Inducible Th2 Cell Factors 	.freshpatents.com	0	0		
1454	chr8	114023804	114023827	3500415894	23		114023804	114023827	8421504	1	23	0	c	350041589400000001	0-23			10.1111/j.1365-2141.2006.06131.x	1365-2141	British Journal of Haematology	Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter - San Jos&#xe9;-En&#xe9;riz - 2006 - British Journal of Haematology - Wiley Online Library	San	2006	0		DBC1
1455	chr8	114093185	114093246	3500239265	61		114093185	114093246	8421504	1	61	0	c	350023926500000021	0-61						Molecular Diagnosis in Bladder Cancer	repub.eur.nl	0	0		DBC1
1455	chr8	114146898	114146922	3500291453	23		114146898	114146922	8421504	2	11,12	0,12	g	350029145300000044	6-47						Development of type I markers in channel cat&#xfb01;sh through intron sequencing	ddr.nal.usda.gov	0	0		
1458	chr8	114463956	114463990	3500137174	25		114463956	114463990	8421504	3	7,13,5	0,12,29	g	350013717400000004	0-27						The ClgR protein regulates transcription of the clpP operon in Bifidobacterium breve UCC2003. | John Kenny - Academia.edu	www.academia.edu	0	0		
1459	chr8	114599555	114599581	3500451948	25		114599555	114599581	8421504	2	21,4	0,22	g	350045194800000411	2-28						CREATING POULTRY AND OTHER ANIMALS RESISTANT TO VIRAL DISEASE - Patent application	www.faqs.org	0	0		
1459	chr8	114615264	114615289	3500236774	24		114615264	114615289	8421504	2	18,6	0,19	g	350023677400000019	18-42						Methods for making and using a thermophilic enzyme as a &#x03b2;-glycosidase - US Patent 6960454 Description	ww.patentstorm.us	0	0		
1459	chr8	114685825	114685850	3500189823	24		114685825	114685850	8421504	2	18,6	0,19	g	350018982300000194	8-32						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
1462	chr8	115012185	115012213	3500426250	23		115012185	115012213	8421504	2	13,10	0,18	g	350042625000000119	21-45						Toxins from the wasp Bracon hebetor	Windass	1997	0		
1463	chr8	115161206	115161230	3500072483	24		115161206	115161230	8421504	1	24	0	c	350007248300000634	18-42						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
1464	chr8	115237031	115237055	3500052549	23		115237031	115237055	8421504	2	10,13	0,11	c	350005254900000270	20-45						 Compositions Against SARS 	www.docstoc.com	0	0		
1464	chr8	115273412	115273435	3500442517	23		115273412	115273435	8421504	1	23	0	g	350044251700000016	12-35						and	www.tipharma.com	0	0		
1466	chr8	115588787	115588816	3500355210	23		115588787	115588816	8421504	3	6,6,11	0,10,18	g	350035521000000003	0-23		21062744	10.1074/jbc.M110.170050		The Journal of Biological Chemistry	Sall1 Regulates Embryonic Stem Cell Differentiation in Association with Nanog	Efthimia	2011	0		
1466	chr8	115589922	115591767	3500265224	39		115589922	115591767	8421504	3	19,12,8	0,166,1837	c	350026522400000025,350026522400000024	0-19,0-20						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
1466	chr8	115589929	115589955	3500437423	24		115589929	115589955	8421504	2	5,19	0,7	c	350043742300000187	21-45						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
1466	chr8	115589929	115589955	3500135973	24		115589929	115589955	8421504	2	5,19	0,7	c	350013597300000222	0-24						CARRIER IMMUNOGLOBULINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1466	chr8	115589929	115589955	3500036684	24		115589929	115589955	8421504	2	5,19	0,7	c	350003668400000283	0-24						ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
1467	chr8	115629627	115630353	3500274037	40		115629627	115630353	8421504	2	20,20	0,706	c,g	350027403700000051,350027403700000051,350027403700000050,350027403700000050	0-20,0-20,0-20,0-20						Galindo and de la Fuente, J Proteomics Bioinform 2012, 5:4 Proteomics & Bioinformatics	w.omicsonline.org	0	0		
1467	chr8	115680045	115680069	3500295856	24		115680045	115680069	8421504	1	24	0	c	350029585600000075	0-24						C5A BINDING NUCLEIC ACIDS AND THE USE THEREOF - NOXXON PHARMA AG	www.sumobrain.com	0	0		
1467	chr8	115680045	115680069	3500265563	24		115680045	115680069	8421504	1	24	0	c	350026556300000075	0-24						C5a binding nucleic acids and the use thereof	Jarosch	2010	0		
1467	chr8	115683358	115683418	3500194415	60		115683358	115683418	8421504	1	60	0	p	350019441500015014	0-60						C5a binding nucleic acids	Purschke	2008	0		
1467	chr8	115683388	115685029	3500073865	144		115683388	115685029	8421504	3	48,68,28	0,96,1613	p	350007386500015101,350007386500015099,350007386500015014,350007386500015098	0-48,0-48,0-63,0-48						Compositions and methods for the treatment of sepsis - US Patent 6866845 Description	ww.patentstorm.us	0	0		
1467	chr8	115683517	115685029	3500076583	63		115683517	115685029	8421504	2	35,28	0,1484	p	350007658300015010	0-63						Patent 6,866,845	www.pharmcast.com	0	0		
1468	chr8	115828561	115828587	3500119454	23		115828561	115828587	8421504	2	5,18	0,8	g	350011945400000188,350011945400000173	28-48,4-27						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1469	chr8	115899973	115899996	3500396915	23		115899973	115899996	8421504	1	23	0	c	350039691500000006	13-36						NOGO-A BINDING MOLECULES AND PHARMACEUTICAL USE THEREOF - Patent application	www.faqs.org	0	0		
183	chr8	115997539	116025898	3500363762	2250		115997539	116025898	8421504	17	48,205,155,162,150,90,133,89,216,134,91,171,175,125,78,61,167	0,1495,2371,8402,10482,12609,15194,15802,16055,18240,20498,21506,22306,23950,24304,27545,28192	p	350036376200015015	96-2346						Gelsolin binding agent compositions and uses of same	Shen	2007	0		
183	chr8	115997539	116025898	3500298595	2250		115997539	116025898	8421504	17	48,205,155,162,150,90,133,89,216,134,91,171,175,125,78,61,167	0,1495,2371,8402,10482,12609,15194,15802,16055,18240,20498,21506,22306,23950,24304,27545,28192	p	350029859500015002	96-2346						GELSOLIN BINDING AGENT COMPOSITIONS AND USES OF SAME - Patent application	www.faqs.org	0	0		
1470	chr8	115999041	116008092	3500222125	41		115999041	116008092	8421504	2	21,20	0,9031	c	350022212500000008,350022212500000010,350022212500000006,350022212500000001,350022212500000000	13-34,15-34,15-34,0-20,27-47		16120646	10.1091/mbc.E05-07-0648	1059-1524	Molecular Biology of the Cell	Separate Functions of Gelsolin Mediate Sequential Steps of Collagen Phagocytosis	Arora	2005	5		
1470	chr8	115999235	115999966	3500082476	60		115999235	115999966	8421504	2	4,56	0,675	p	350008247600015013	0-60						Sequence Similarity & Sequence Searching	staff.aub.edu.lb	0	0		GSN
1470	chr8	116013421	116013636	3500450851	51		116013421	116013636	8421504	2	9,42	0,173	p	350045085100015001	0-51						Compositions And Methods For Inhibiting Liver Stellate Cell Growth 	.freshpatents.com	0	0		GSN
1470	chr8	116013612	116013660	3500128180	48		116013612	116013660	8421504	1	48	0	p	350012818000015037	0-48						PEPTIDES AND PROTEINS INTERACTING WITH THE ANDROGEN RECEPTOR	repub.eur.nl	0	0		GSN
1472	chr8	116308972	116309017	3500410834	45		116308972	116309017	8421504	1	45	0	p	350041083400015000	0-45		18697920	10.1261/rna.1132008	1355-8382	RNA	The role of human ribosomal proteins in the maturation of rRNA and ribosome production	Robledo	2008	5		RPS7
1472	chr8	116308972	116309017	3500182164	45		116308972	116309017	8421504	1	45	0	p	350018216400015000	0-45		18697920	10.1261/rna.1132008	1355-8382	RNA	The role of human ribosomal proteins in the maturation of rRNA and ribosome production	Robledo	2008	5		RPS7
1472	chr8	116308972	116309017	3500103090	45		116308972	116309017	8421504	1	45	0	p	350010309000015001	0-45						The role of human ribosomal proteins in the maturation of rRNA and ribosome production	journal.cshlp.org	0	0		RPS7
1473	chr8	116396450	116402276	3500202983	537		116396450	116402276	8421504	4	120,120,180,117	0,1985,4546,5709	p	350020298300015000	0-537						KEGG T01008: 615764	www.genome.jp	0	0		
589	chr9	642950	643071	3500259232	121		642950	643071	8421504	1	121	0	g	350025923200000005	0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
589	chr9	642950	643071	3500000589	121		642950	643071	8421504	1	121	0	g	350000058900000011	0-122						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
590	chr9	693603	693724	3500259232	121		693603	693724	8421504	1	121	0	g	350025923200000006	0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
590	chr9	693641	693724	3500000589	83		693641	693724	8421504	1	83	0	g	350000058900000012	0-84						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
73	chr9	781951	808772	3500259232	242		781951	808772	8421504	2	121,121	0,26700	g	350025923200000007,350025923200000004	0-122,0-122						 20100223687 Publication | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS | PTO Direct	www.ptodirect.com	0	0		
73	chr9	781951	808716	3500000589	125		781951	808716	8421504	2	60,65	0,26700	g	350000058900000016,350000058900000009	0-60,0-65						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
598	chr9	1729030	1758073	3500266002	39		1729030	1758073	8421504	3	11,8,20	0,14,29023	g	350026600200000028,350026600200000146	18-37,0-21						Treatment of Cellulosic Material and Enzymes Useful Therein - Patent application	www.faqs.org	0	0		
598	chr9	1766471	1766499	3500465982	24		1766471	1766499	8421504	2	18,6	0,22	g	350046598200000007	5-30						Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. - ResearchGate	.researchgate.net	0	0		
599	chr9	1867295	1867322	3500194368	24		1867295	1867322	8421504	3	13,6,5	0,15,22	g	350019436800000897	5-29						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
599	chr9	1924290	1924478	3500367838	108		1924290	1924478	8421504	3	24,28,56	0,98,132	c	350036783800000139,350036783800000141,350036783800000143,350036783800000207	0-50,0-50,0-52,0-53						 <HTML> <HEAD><TITLE>Show BLAST File</TITLE></HEAD> <BODY BGCOLOR=ffffff><BR> <br> <A NAME=top> <P	rth.lab.nig.ac.jp	0	0		
599	chr9	1924391	1939226	3500168093	60		1924391	1939226	8421504	2	33,27	0,14808	p	350016809300015004	66-126						Working Group &#x201c;Integrated Control in Oilseed Crops&#x201d;	www.iobc-wprs.org	0	0		
599	chr9	1953103	1953134	3500095610	31		1953103	1953134	8421504	1	31	0	g	350009561000000437	13-44						Optimizing glycan processing in plants	D*E*A*Fu Luo La Ke 	2009	0		
602	chr9	2336689	2336715	3500459811	23		2336689	2336715	8421504	2	14,9	0,17	g	350045981100000029	9-33						VIRAL CHEMOKINE-ANTIGEN FUSION PROTEINS - Patent application	www.faqs.org	0	0		
602	chr9	2336689	2336715	3500057259	23		2336689	2336715	8421504	2	14,9	0,17	g	350005725900000029	9-33						VIRAL CHEMOKINE-ANTIGEN FUSION PROTEINS	Kwak	2013	0		
614	chr9	3832240	3832300	3500419411	60		3832240	3832300	8421504	1	60	0	g	350041941100000038	0-60						Uso de h&#xe1;bitat y estructura gen&#xe9;tica de la subespecie Ozotoceros bezoarticus uruguayensis Pautas para su conservaci&#xf3;n	.bib.fcien.edu.uy	0	0		
618	chr9	4447079	4447195	3500018861	116		4447079	4447195	8421504	1	116	0	g	350001886100000053	29-145						Primers, Probes And Reference Plasmid For Detection Of Meat Adulteration 	.freshpatents.com	0	0		
618	chr9	4447079	4447160	3500417171	81		4447079	4447160	8421504	1	81	0	g	350041717100000226,350041717100000186	0-81,0-50						UNIVERSIDAD COMPLUTENSE DE MADRID	www.elfoiegras.es	0	0		
623	chr9	5092604	5092631	3500161151	23		5092604	5092631	8421504	3	8,4,11	0,11,16	g	350016115100000100	7-32						3-hydroxypropionic acid and other organic compounds	Gokarn	2008	0		
628	chr9	5731375	5731398	3500342581	23		5731375	5731398	8421504	1	23	0	g	350034258100000009	2-32		18454192	10.1371/journal.pgen.1000005	1553-7404	PLOS Genetics	PLOS Genetics: Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic Screen	Arnoldo	2008	0		
632	chr9	6214207	6214233	3500104623	25		6214207	6214233	8421504	2	16,9	0,17	g	350010462300000018	11-37					Patent	Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion (Patent US:6054572)	Burnham	2000	0		
640	chr9	7335366	7335391	3500430989	23		7335366	7335391	8421504	2	8,15	0,10	c	350043098900000500	21-44						TOXOPLASMA GONDII NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
646	chr9	8067395	8067423	3500213852	23		8067395	8067423	8421504	2	14,9	0,19	g	350021385200000009	0-23		22022628	10.1371/journal.pntd.0001348	1935-2735	PLOS Neglected Tropical Diseases	PLOS Neglected Tropical Diseases: Genetic Manipulation of Schistosoma haematobium, the Neglected Schistosome	Rinaldi	2011	0		
659	chr9	9765791	9765816	3500323879	23		9765791	9765816	8421504	2	6,17	0,8	g	350032387900000011	2-25						Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models	om.weizmann.ac.il	0	0		
660	chr9	9861894	9861917	3500227292	23		9861894	9861917	8421504	1	23	0	c	350022729200000021	5-43						 Streptavidin Expressed Gene Fusions And Methods Of Use Thereof 	www.docstoc.com	0	0		
662	chr9	10189204	10189232	3500104979	24		10189204	10189232	8421504	3	9,3,12	0,11,16	g	350010497900000067	5-29						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
664	chr9	10359463	10359526	3500304886	44		10359463	10359526	8421504	2	22,22	0,41	c,g	350030488600000008,350030488600000008,350030488600000004	0-22,0-22,0-22						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial - Patent application	www.faqs.org	0	0		LINC00472
664	chr9	10359463	10359526	3500297315	46		10359463	10359526	8421504	2	22,24	0,39	c,g	350029731500000059,350029731500000059,350029731500000058	0-22,0-22,0-24						METHODS AND COMPOSITIONS FOR SEAMLESS CLONING OF NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		LINC00472
664	chr9	10359463	10359526	3500256738	44		10359463	10359526	8421504	2	22,22	0,41	c,g	350025673800000008,350025673800000008,350025673800000004	0-22,0-22,0-22						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2007	0		
664	chr9	10359463	10359526	3500246068	44		10359463	10359526	8421504	2	22,22	0,41	c,g	350024606800000008,350024606800000008,350024606800000004	0-22,0-22,0-22						Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial	Avni	2008	0		LINC00472
664	chr9	10359463	10359526	3500208886	44		10359463	10359526	8421504	2	22,22	0,41	c,g	350020888600000008,350020888600000008,350020888600000004	0-22,0-22,0-22						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL	Soreq	2008	0		
664	chr9	10359500	10359528	3500013455	28		10359500	10359528	8421504	1	28	0	g	350001345500000058	20-48						Compositions and methods for decreasing microrna expression for the treatment of neoplasia	Mendell	2006	0		
664	chr9	10359501	10359525	3500025704	24		10359501	10359525	8421504	1	24	0	c	350002570400000010	0-24						METHODS FOR QUANTIFYING MICRORNA PRECURSORS	Schmittigen	2006	0		LINC00472
664	chr9	10359503	10359526	3500277975	23		10359503	10359526	8421504	1	23	0	c,g	350027797500000018,350027797500000018	0-23,0-23						MicroRNA-9ControlstheExpressionofGranuphilin/Slp4 andtheSecretoryResponseofInsulin-producingCells	www.jbc.org	0	0		LINC00472
664	chr9	10447818	10447966	3500398706	43		10447818	10447966	8421504	2	22,21	0,127	g	350039870600000006,350039870600000007	0-22,0-21						DIVERSIDAD GEN&#xc9;TICA DE LA RAZA CRIOLLO LIMONERO UTILIZANDO MARCADORES DE ADN MICROSAT&#xc9;LITES	vistas.luz.edu.ve	0	0		
664	chr9	10447818	10447966	3500188581	43		10447818	10447966	8421504	2	22,21	0,127	g	350018858100000040,350018858100000041	0-22,0-21						Cross-species tests of 45 microsatellite loci isolated from different species of ungulates in the Iberian red deer Cervus elaphus hispanicus) to generate a multiplex panel	digital.csic.es	0	0		
664	chr9	10447818	10447966	3500018454	43		10447818	10447966	8421504	2	22,21	0,127	g	350001845400000012,350001845400000013	0-22,0-21						Genetic diversity and relationship of cattle populations of East India: distinguishing lesser known cattle populations and established breeds based on STR markers	.springerplus.com	0	0		
681	chr9	12649946	12649973	3500262004	24		12649946	12649973	8421504	2	5,19	0,8	g	350026200400000090	17-41					Patent	Glyphosate tolerant plants (Patent US:5463175)	Barry	1995	0		
681	chr9	12679029	12679055	3500392911	24		12679029	12679055	8421504	2	18,6	0,20	g	350039291100000169	0-26						Endonuclease-substrate complexes	Allawi	2004	0		
684	chr9	13009287	13016377	3500413129	45		13009287	13016377	8421504	2	23,22	0,7068	c,g	350041312900000002,350041312900000003,350041312900000003	0-23,0-22,0-22		10810093	10.1101/gr.10.5.703	1088-9051	Genome Research	Identification of Novel Human Genes Evolutionarily Conserved in Caenorhabditis elegans by Comparative Proteomics	Lai	2000	14		MTO1
684	chr9	13051593	13051643	3500036905	50		13051593	13051643	8421504	1	50	0	c	350003690500000002	0-50		18820646	10.1038/cdd.2008.136	1350-9047	Cell Death & Differentiation	Novel cell death by downregulation of eEF1A1 expression in tetraploids	Kobayashi	2008	9		EEF1A1
684	chr9	13051657	13053678	3500338732	1287		13051657	13053678	8421504	7	122,235,257,151,297,180,45	0,224,542,896,1125,1540,1976	p	350033873200015048,350033873200015047	0-1287,0-1287						Diagnosis and treatment of infectious diseases through indel-differentiated proteins	Reiner	2002	0		EEF1A1
684	chr9	13051657	13051765	3500192247	108		13051657	13051765	8421504	1	108	0	p	350019224700015006	366-474						Widespread and ancient distribution of a noncanonical genetic code in diplomonads. - ResearchGate	.researchgate.net	0	0		EEF1A1
684	chr9	13051684	13051707	3500025091	23		13051684	13051707	8421504	1	23	0	c	350002509100000034	15-45						Aav4 vector and uses thereof	Chiorini	1998	0		
684	chr9	13051693	13053371	3500095702	1194		13051693	13053371	8421504	8	86,235,129,125,151,297,24,147	0,188,506,638,860,1089,1504,1531	p	350009570200015106,350009570200015107,350009570200015105,350009570200015103,350009570200015102,350009570200015100,350009570200015098,350009570200015099,350009570200015097,350009570200015096,350009570200015095,350009570200015094,350009570200015093,350009570200015091,350009570200015089,350009570200015090	0-81,0-150,0-66,0-150,0-150,0-120,0-54,6-153,0-90,0-150,0-138,0-150,0-150,0-150,0-147,0-96						MODULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DOS GENES EF1A E PTI-1 NO C&#xc2;NCER DE PR&#xd3;STATA	epositorio.ufu.br	0	0		EEF1A1
684	chr9	13051698	13051724	3500260924	26		13051698	13051724	8421504	1	26	0	c	350026092400000076	0-26						Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen	Buendia	2011	0		
684	chr9	13051698	13051724	3500246117	26		13051698	13051724	8421504	1	26	0	c	350024611700000076	0-26						Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen	Buendia	2012	0		
684	chr9	13051698	13051724	3500030096	26		13051698	13051724	8421504	1	26	0	c	350003009600000076	0-26						Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen	Buendia	2009	0		
684	chr9	13051711	13051777	3500047003	66		13051711	13051777	8421504	1	66	0	p	350004700300015004	0-66						Emerald Luc -pELuc&#x30d9;&#x30af;&#x30bf;&#x30fc;&#x30b7;&#x30ea;&#x30fc;&#x30ba;-	www.toyobo.co.jp	0	0		EEF1A1
684	chr9	13051717	13052941	3500287307	127		13051717	13052941	8421504	3	42,47,38	0,1081,1186	c	350028730700000053,350028730700000038,350028730700000036	6-48,0-47,0-38					Patent	Human prostate tumor inducing gene-1 and uses thereof (Patent US:5851764)	Fisher	1998	0		
684	chr9	13051720	13053218	3500320902	813		13051720	13053218	8421504	7	59,235,15,165,21,297,21	0,161,479,527,963,1062,1477	p	350032090200015077,350032090200015076,350032090200015075,350032090200015074,350032090200015073	0-168,0-141,0-165,0-168,0-171						Method for manufacturing a modified peptide	Bauer	2009	0		EEF1A1
684	chr9	13051747	13053777	3500205889	255		13051747	13053777	8421504	3	32,88,135	0,134,1895	p	350020588900015046,350020588900015047,350020588900015021,350020588900015017,350020588900015016,350020588900015013,350020588900015113,350020588900015105,350020588900015109	0-120,0-120,0-135,0-135,0-135,0-135,0-117,0-117,3-117						A Brief Introduction to Multiple Sequence Analysis through GCG s SeqLab	bio.fsu.edu	0	0		EEF1A1
684	chr9	13051747	13051972	3500121800	123		13051747	13051972	8421504	2	32,91	0,134	p	350012180000015055	0-123						49 human secreted proteins	Komatsoulis	2000	0		EEF1A1
684	chr9	13052215	13052872	3500437093	89		13052215	13052872	8421504	5	5,27,1,25,31	0,430,488,567,626	c	350043709300000404	1-90						US Patent # 8,182,996. Compositions and methods for detecting Klebsiella pneumoniae - Patents.com	patents.com	0	0		
684	chr9	13052215	13052872	3500214186	89		13052215	13052872	8421504	5	5,27,1,25,31	0,430,488,567,626	c	350021418600000353	1-90						Highly conserved genes and their use to generate probes and primers for detection of microorganisms - Patent application	www.faqs.org	0	0		
684	chr9	13052215	13052872	3500205565	89		13052215	13052872	8421504	5	5,27,1,25,31	0,430,488,567,626	c	350020556500000361	1-90						HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE PROBES AND PRIMERS FOR DETECTION OF MICROORGANISMS - Patent application	www.faqs.org	0	0		
684	chr9	13052292	13053777	3500053560	285		13052292	13053777	8421504	7	60,44,16,21,24,60,60	0,120,261,766,905,989,1425	p	350005356000015014,350005356000015012,350005356000015005,350005356000015003,350005356000015000	0-60,15-75,0-45,0-60,6-66						A Higher Plant Extracellular Vitronectin-like Adhesion Protein 1s Related to the Translational Elongation Factor-I a	faculty.ucr.edu	0	0		EEF1A1
684	chr9	13052408	13052582	3500396095	46		13052408	13052582	8421504	2	24,22	0,152	c	350039609500000012,350039609500000011	0-24,0-22		15226416	10.1128/MCB.24.14.6117-6126.2004	0270-7306	Molecular and Cellular Biology	Transcription Regulatory Complexes Bind the Human T-Cell Leukemia Virus 5&#x2032; and 3&#x2032; Long Terminal Repeats To Control Gene Expression	Lemasson	2004	6		
684	chr9	13052410	13053317	3500099327	46		13052410	13053317	8421504	2	22,24	0,883	c	350009932700000003,350009932700000002	0-22,0-24						Follistatin-Related Gene (FLRG) Expression in Human Endometrium: Sex Steroid Hormones Regulate the Expression of FLRG in Cultured Human Endometrial Stromal Cells	.endojournals.org	0	0		EEF1A1
684	chr9	13052602	13052914	3500260510	234		13052602	13052914	8421504	2	102,132	0,180	p	350026051000015013,350026051000015017	0-234,0-234						Cheminformatics-Driven Identification of Inhibitors of Protein-Protein Interactions	chim.u-strasbg.fr	0	0		EEF1A1
684	chr9	13052652	13052676	3500181750	24		13052652	13052676	8421504	1	24	0	c	350018175000000002,350018175000000009	0-24,0-24						Bin1 as a Prognostic Marker in Cardiovascular Disease - Patent application	www.faqs.org	0	0		
684	chr9	13052668	13053248	3500436466	41		13052668	13053248	8421504	2	21,20	0,560	c,g	350043646600000003,350043646600000002,350043646600000002	0-21,0-20,0-20		16204080	10.1158/0008-5472.CAN-05-1261	0008-5472	Cancer Research	Targeted Virus Replication Plus Immunotherapy Eradicates Primary and Distant Pancreatic Tumors in Nude Mice	Sarkar	2005	8		
684	chr9	13052798	13053245	3500280434	41		13052798	13053245	8421504	2	20,21	0,426	c,g	350028043400000011,350028043400000010	0-20,0-21						COMPARATIVE OSTEOGENESIS OF EQUINE MESENCHYMAL STEM CELLS ISOLATED FROM BONE MARROW, ADIPOSE TISSUE AND SYNOVIUM BY ANTONELLA LIZA PANTALEONI ANDRIETTI THESIS	eals.illinois.edu	0	0		
684	chr9	13052841	13053249	3500068121	40		13052841	13053249	8421504	2	20,20	0,388	c	350006812100000027,350006812100000028	0-20,0-20						Analyse einzelner disseminierter Mammakarzinomzellen durch SSH: Identifizierung eines differentiell exprimierten ERV9-LTR Transkripes	b.uni-muenchen.de	0	0		EEF1A1
684	chr9	13052965	13053762	3500381115	81		13052965	13053762	8421504	2	36,45	0,752	p	350038111500015002	0-81		12533507	10.1101/gad.1040803	0890-9369	Genes & Development	Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA	Pestova	2003	12		EEF1A1
684	chr9	13052979	13053205	3500434170	39		13052979	13053205	8421504	3	20,11,8	0,89,218	c	350043417000000031,350043417000000030	0-20,0-19						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
684	chr9	13053065	13053224	3500459869	41		13053065	13053224	8421504	2	14,27	0,132	c	350045986900000266	0-41						 Highly Conserved Genes And Their Use To Generate Probes And Primers For Detection Of Microorganisms 	www.docstoc.com	0	0		
684	chr9	13053221	13053777	3500347723	300		13053221	13053777	8421504	2	156,144	0,412	p	350034772300015009	0-300						&#x6587;&#x5b57;&#x5217;&#x63a2;&#x7d22;(2)	www.hgc.jp/~tshib	0	0		EEF1A1
684	chr9	13053221	13053777	3500004201	300		13053221	13053777	8421504	2	156,144	0,412	p	350000420100015019	0-300						Suffix Trees and Arrays	phys.chuo-u.ac.jp	0	0		EEF1A1
684	chr9	13053296	13053341	3500205252	45		13053296	13053341	8421504	1	45	0	p	350020525200015000	0-45						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		EEF1A1
684	chr9	13053651	13053741	3500326339	90		13053651	13053741	8421504	1	90	0	p	350032633900015030	180-270						Lehninger Biochemistry 4th Edition	www.scribd.com	0	0		EEF1A1
684	chr9	13053651	13053741	3500302987	90		13053651	13053741	8421504	1	90	0	p	350030298700015021	180-270						Lehninger 003	www.scribd.com	0	0		EEF1A1
685	chr9	13199894	13199926	3500245650	32		13199894	13199926	8421504	1	32	0	c	350024565000000003,350024565000000001,350024565000000002,350024565000000000	0-32,0-31,0-28,2-29		11751519		1078-0432	Clinical Cancer Research	Identification of a Novel Membrane Protein, HP59, with Therapeutic Potential as a Target of Tumor Angiogenesis	Fu	2001	8		
685	chr9	13199894	13199926	3500178794	32		13199894	13199926	8421504	1	32	0	c	350017879400000003,350017879400000001,350017879400000002,350017879400000000	0-32,0-31,0-28,2-29		11751519		1078-0432	Clinical Cancer Research	Identification of a Novel Membrane Protein, HP59, with Therapeutic Potential as a Target of Tumor Angiogenesis	Fu	2001	8		
686	chr9	13279876	13279906	3500261622	24		13279876	13279906	8421504	3	7,6,11	0,8,19	g	350026162200000020	0-29						Pluripotent embryonic-like stem cells derived from teeth and uses thereof	Schierholz	2003	0		
686	chr9	13279876	13279906	3500023532	24		13279876	13279906	8421504	3	7,6,11	0,8,19	g	350002353200000009	0-29		23521530	10.1111/boc.201200064	1768-322X	Biology of the Cell	Inflammatory environment induces gingival tissue-specific mesenchymal stem cells to differentiate towards a pro-fibrotic phenotype - Li - 2013 - Biology of the Cell - Wiley Online Library	Li	2013	0		
688	chr9	13615038	13615063	3500367439	23		13615038	13615063	8421504	2	7,16	0,9	g	350036743900000196	19-42						Genetically engineered vaccine strain	The	2003	0		
689	chr9	13685828	13685853	3500460843	23		13685828	13685853	8421504	3	14,5,4	0,15,21	g	350046084300000008	1-24						DEVICES AND PROCESSES FOR NUCLEIC ACID EXTRACTION - Patent application	www.faqs.org	0	0		
689	chr9	13685828	13685853	3500245107	23		13685828	13685853	8421504	3	14,5,4	0,15,21	g	350024510700000023	1-24						Culture-independent techniques applied to food industry water surveillance &#x2014; A case study	athogencombat.com	0	0		
689	chr9	13685828	13685853	3500102280	23		13685828	13685853	8421504	3	14,5,4	0,15,21	g	350010228000000003	2-25						ScienceDirect.com - Water Research - Ability of three DNA-based assays to identify presumptive Escherichia coli colonies isolated from water by the culture-based mFC agar method	sciencedirect.com	0	0		
689	chr9	13685828	13685853	3500068432	23		13685828	13685853	8421504	3	14,5,4	0,15,21	g	350006843200000016	23-46						1. Culture-Independent Techniques Applied to Food Industry Water	www.scribd.com	0	0		
698	chr9	14876913	14887031	3500209595	42		14876913	14887031	8421504	3	22,11,9	0,5972,10109	c,g	350020959500000030,350020959500000030,350020959500000003,350020959500000029	0-20,0-20,18-40,0-20						Human dental follicle stem cells and methods for obtaining - Patent # 8192987 - PatentGenius	.patentgenius.com	0	0		COL12A1
699	chr9	14973948	14975907	3500311369	40		14973948	14975907	8421504	2	20,20	0,1939	c,g	350031136900000073,350031136900000073,350031136900000072	0-20,0-20,0-20						Adult Stem Cell-derived Connective Tissue Progenitors For Tissue Engineering 	.freshpatents.com	0	0		COL12A1
699	chr9	14973948	14975907	3500225111	40		14973948	14975907	8421504	2	20,20	0,1939	c	350022511100000029,350022511100000028	0-20,0-20						Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders 	.freshpatents.com	0	0		COL12A1
699	chr9	14973948	14975907	3500152485	40		14973948	14975907	8421504	2	20,20	0,1939	c	350015248500000029,350015248500000028	0-20,0-20						Human Embryonic Stem Cell-Derived Connective Tissue Progenitors For Tissue Engineering	Itskovitz-eldor	2007	0		COL12A1
699	chr9	15061315	15061342	3500405159	25		15061315	15061342	8421504	2	13,12	0,15	c	350040515900000137	1-35						PATHOGEN AND SUBSTANCE TRAPS - VECOY NANOMEDICINES LTD.	www.sumobrain.com	0	0		
699	chr9	15061493	15061517	3500126233	24		15061493	15061517	8421504	1	24	0	c	350012623300000005	0-24		20046424	10.3349/ymj.2009.50.6.818		Yonsei Medical Journal	Cyclooxygenase-2 Expression Is Related to the Epithelial-to-Mesenchymal Transition in Human Colon Cancers	Tae	2009	0		TMEM30A
699	chr9	15061547	15061572	3500147558	25		15061547	15061572	8421504	1	25	0	c	350014755800000003,350014755800000014	0-25,0-25						BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF - Patent application	www.faqs.org	0	0		
700	chr9	15150455	15201261	3500220259	357		15150455	15201261	8421504	3	4,179,174	0,42145,50632	p	350022025900015006,350022025900015005,350022025900015004	0-111,0-150,54-150						BMC Cancer BioMed Central	biomedcentral.com	0	0		FILIP1
701	chr9	15231309	15231337	3500350860	24		15231309	15231337	8421504	3	12,8,4	0,15,24	g	350035086000000020	0-24						ANTI-BACTERIAL VACCINE COMPOSITIONS	Lowery	2001	0		
702	chr9	15456601	15456625	3500340946	24		15456601	15456625	8421504	1	24	0	g	350034094600000001	9-33						APPROCHE ENDODARWINIENNE DE LA VARIABILITE INTERCELLULAIRE DE L'EXPRESSION GENETIQUE	hives-ouvertes.fr	0	0		
703	chr9	15525261	15525286	3500104717	24		15525261	15525286	8421504	2	8,16	0,9	g	350010471700000021	1-25						Optimierung einer Lipase aus Bacillus subtilis mit neuen Methoden der gerichteten Evolution	ni-duesseldorf.de	0	0		
705	chr9	15751348	15752126	3500399861	132		15751348	15752126	8421504	2	125,7	0,771	p	350039986100015036	39-171						COINCIDENCE DETECTION	Parker	2011	0		MYO6
706	chr9	15936206	15936234	3500054250	24		15936206	15936234	8421504	2	8,16	0,12	g	350005425000000025,350005425000000058	0-24,0-24						Small Breast Epithelial Mucin Gene Promoter - Patent application	www.faqs.org	0	0		
706	chr9	15949474	15949499	3500256535	23		15949474	15949499	8421504	2	7,16	0,9	c	350025653500000106	2-30						Glyphosate tolerant plants	Barry	1992	0		
711	chr9	16552393	16552421	3500162809	25		16552393	16552421	8421504	2	10,15	0,13	g	350016280900000025	0-26						Epigenetic differences between male and female bovine blastocysts produced in vitro	cs.physiology.org	0	0		
721	chr9	17849437	17849468	3500000260	25		17849437	17849468	8421504	3	4,14,7	0,5,24	g	350000026000000022,350000026000000009	0-32,0-32						Ligand - Patent application	www.faqs.org	0	0		
726	chr9	18591253	18591279	3500102197	23		18591253	18591279	8421504	2	7,16	0,10	g	350010219700000036	0-23					Patent	Simultaneous detection, identification and differentiation of Mycobacterium species using a hybridization assay (Patent EP:1091004)	Jannes	2009	0		
729	chr9	18887676	18887701	3500212893	24		18887676	18887701	8421504	2	13,11	0,14	g	350021289300000014	0-24						TREATMENT OF A DISEASE OR A CONDITION ASSOCIATED WITH ABERRANT GENE HYPOMETHYLATION BY A METHOD INVOLVING TAILORED EPIGENOMIC MODIFICATION - Patent application	www.faqs.org	0	0		
91	chr9	19124573	19159565	3500308562	43		19124573	19159565	8421504	2	23,20	0,34972	c,g	350030856200000015,350030856200000014,350030856200000014	0-23,0-20,0-20						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
731	chr9	19203546	19203569	3500199514	23		19203546	19203569	8421504	1	23	0	g	350019951400000160	0-23						Rapid detection of mutations in the p53 gene	Heisler	1995	0		
731	chr9	19203546	19203569	3500178969	23		19203546	19203569	8421504	1	23	0	g	350017896900000191	0-23						Cleavage of nucleic acid acid using thermostable methoanococcus jannaschii FEN-1 endonucleases	Kaiser	1996	0		
92	chr9	20037249	20074924	3500456993	49		20037249	20074924	8421504	2	27,22	0,37653	c	350045699300000028,350045699300000026	21-48,16-38						Human elongase genes and uses thereof	Winther	2001	0		ELOVL4
92	chr9	20037249	20074924	3500243728	49		20037249	20074924	8421504	2	27,22	0,37653	c	350024372800000027,350024372800000028,350024372800000026	22-49,21-48,16-38						Human elongase genes and uses thereof	Allen	2002	0		
737	chr9	20037249	20037276	3500326764	27		20037249	20037276	8421504	1	27	0	c	350032676400000082,350032676400000083,350032676400000027,350032676400000028	22-49,21-48,22-49,21-48						Human Elongase Genes, Uses Thereof, and Compounds for Modulating Same - Patent application	www.faqs.org	0	0		
738	chr9	20074149	20074176	3500227910	23		20074149	20074176	8421504	2	7,16	0,11	g	350022791000000002	0-23						anti-glypican-3 antibody having improved kinetics in plasma	Jing Chuan Zhi Zhi 	2010	0		
738	chr9	20138906	20177408	3500282803	300		20138906	20177408	8421504	9	7,41,48,41,23,44,45,3,48	0,2768,2905,3935,20804,32265,33658,35050,38454	c	350028280300000052,350028280300000055,350028280300000061,350028280300000026,350028280300000197,350028280300000079,350028280300000087,350028280300000091,350028280300000096	0-48,0-48,6-47,0-21,0-21,0-23,0-44,0-48,0-48						TTK AS TUMOR MARKER AND THERAPEUTIC TARGET FOR LUNG CANCER - Patent application	www.faqs.org	0	0		
740	chr9	20361081	20361106	3500401699	24		20361081	20361106	8421504	2	16,8	0,17	g	350040169900000011,350040169900000012	0-23,0-23						Organic compounds	Jungbauer	2009	0		
740	chr9	20361081	20361106	3500341765	24		20361081	20361106	8421504	2	16,8	0,17	g	350034176500000007,350034176500000008	0-23,0-23						Oligopeptide ligands	Hahn	2011	0		
740	chr9	20361081	20361106	3500295072	24		20361081	20361106	8421504	2	16,8	0,17	g	350029507200000007,350029507200000008	0-23,0-23						Oligopeptide ligands	Hahn	2011	0		
740	chr9	20361081	20361106	3500265952	24		20361081	20361106	8421504	2	16,8	0,17	g	350026595200000010,350026595200000011	0-23,0-23						Organic compounds	Hahn	2012	0		
740	chr9	20361081	20361106	3500151523	24		20361081	20361106	8421504	2	16,8	0,17	g	350015152300000005,350015152300000006	0-23,0-23						Organic Compounds	Achmuller	2010	0		
740	chr9	20361081	20361106	3500104764	24		20361081	20361106	8421504	2	16,8	0,17	g	350010476400000012,350010476400000013	0-23,0-23						ORGANIC COMPOUNDS	Jungbauer	2012	0		
740	chr9	20361081	20361106	3500068742	24		20361081	20361106	8421504	2	16,8	0,17	g	350006874200000002,350006874200000003	0-23,0-23						Process of production of a recombinant polypeptide by fusion with an autoprotease	Werther	2011	0		
740	chr9	20361081	20361106	3500016648	24		20361081	20361106	8421504	2	16,8	0,17	g	350001664800000005,350001664800000006	0-23,0-23						Organic Compounds	Achmuller	2010	0		
744	chr9	20862408	20862432	3500415073	23		20862408	20862432	8421504	2	13,10	0,14	g	350041507300000015,350041507300000014	0-23,9-33						Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane	www.hal.inserm.fr	0	0		
749	chr9	21621528	21621554	3500187962	23		21621528	21621554	8421504	3	4,5,14	0,5,12	g	350018796200000039	25-48						 Starchless Variety Of Pisum Sativum Having Elevated Levels Of Sucrose 	www.docstoc.com	0	0		
750	chr9	21730985	21731008	3500139650	23		21730985	21731008	8421504	1	23	0	g	350013965000000334	1-27					Patent	Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells (Patent US:6479261)	Bauer	2002	0		
756	chr9	22419270	22419298	3500439322	25		22419270	22419298	8421504	2	12,13	0,15	g	350043932200000009	0-25						Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. - ResearchGate	.researchgate.net	0	0		
757	chr9	22554353	22554377	3500111986	23		22554353	22554377	8421504	2	10,13	0,11	g	350011198600000002	0-23		16554723			Journal of microbiology Seoul Korea	Detection of Escherichia coli O157:H7, Salmonella spp., Staphylococcus aureus and Listeria monocytogenes in kimchi by multiplex polymerase chain reaction (mPCR).	Park	2006	0		
757	chr9	22562164	22562191	3500348738	23		22562164	22562191	8421504	2	7,16	0,11	g	350034873800000042	22-45						Methods for Recombinant Peptide Production - Patent application	www.faqs.org	0	0		
762	chr9	23202297	23202359	3500043603	62		23202297	23202359	8421504	1	62	0	g	350004360300000015	0-62						Mhc class ii peptide epitope of 5t4 antigen	Carroll	2003	0		
769	chr9	24133193	24133222	3500255100	25		24133193	24133222	8421504	2	14,11	0,18	g	350025510000000029	4-30						Gemini virus vectors for gene expression in plants	Mason	1999	0		
769	chr9	24239441	24241159	3500078731	40		24239441	24241159	8421504	3	20,2,18	0,58,1700	c	350007873100000016,350007873100000015	0-20,0-20						Gene expression profiling of liver and mammary tissues of lactating dairy cows.	.biomedsearch.com	0	0		
770	chr9	24300070	24300097	3500465421	23		24300070	24300097	8421504	2	17,6	0,21	g	350046542100000030	11-34						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
770	chr9	24300070	24300097	3500448775	23		24300070	24300097	8421504	2	17,6	0,21	g	350044877500000038	11-34						Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis	Schlesinger	2000	0		
770	chr9	24300070	24300097	3500376873	23		24300070	24300097	8421504	2	17,6	0,21	g	350037687300000037	11-34						Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis	Belli	1999	0		
770	chr9	24300070	24300097	3500210757	23		24300070	24300097	8421504	2	17,6	0,21	g	350021075700000025	11-34						Alphavirus vector constructs	Dubensky	1996	0		
770	chr9	24300070	24300097	3500203324	23		24300070	24300097	8421504	2	17,6	0,21	g	350020332400000025	11-34						Alphavirus structural protein expression cassettes	Dubensky	1996	0		
770	chr9	24300070	24300097	3500104593	23		24300070	24300097	8421504	2	17,6	0,21	g	350010459300000166,350010459300000025	11-34,11-34						Eukaryotic Layered Vector Initiation Systems - Patent application	www.faqs.org	0	0		
772	chr9	24554814	24570446	3500066812	24		24554814	24570446	8421504	2	16,8	0,15624	c	350006681200000007	20-44						Effects of Low Progesterone on the Endometrial Transcriptome in Cattle1	ww.biolreprod.org	0	0		
773	chr9	24718017	24722321	3500123410	51		24718017	24722321	8421504	3	10,31,10	0,863,4294	p	350012341000015000	0-51		22398720	10.1091/mbc.E11-11-0939	1059-1524	Molecular Biology of the Cell	The apoptotic engulfment protein Ced-6 participates in clathrin-mediated yolk uptake in Drosophila egg chambers	Jha	2012	5		
773	chr9	24736517	24736565	3500092272	48		24736517	24736565	8421504	1	48	0	p	350009227200015030	36-84						Compositions and methods for improving production of recombinant polypeptides	Bogin	2013	0		CHD7
773	chr9	24736517	24736565	3500066461	48		24736517	24736565	8421504	1	48	0	p	350006646100015001	36-84						&#x30d0;&#x30a4;&#x30aa;&#x3068;&#x30e1;&#x30c7;&#x30a3;&#x30ab;&#x30eb;&#x306e;&#x7279;&#x8a31;&#x7ffb;&#x8a33;&#x306e;&#x9577;&#x6587;&#x4f8b;&#xff08;&#x5bfe;&#x8a33;&#x4e2d;&#x5fc3;&#xff1a;&#x30d0;&#x30a4;&#x30aa;&#x3001;&#x533b;&#x5b66;&#x3001;&#x533b	s.blog119.fc2.com	0	0		CHD7
773	chr9	24736596	24736622	3500290891	23		24736596	24736622	8421504	3	5,13,5	0,7,21	c	350029089100000019	13-37						Genetic and non-genetic causes of Isolated Growth Hormone Deciency and Combined Pituitary Hormone Deciency: Results of the HYPOPIT study	repub.eur.nl	0	0		
775	chr9	25005329	25005355	3500466042	23		25005329	25005355	8421504	3	12,6,5	0,13,21	g	350046604200000003	10-33						Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer	www.pnas.org	0	0		
777	chr9	25243809	25243832	3500209717	23		25243809	25243832	8421504	1	23	0	c	350020971700000011	0-23						METHODS AND COMPOSITIONS FOR IMPROVED FERTILIZATION AND EMBRYONIC SURVIAL	Khatib	2009	0		
777	chr9	25243809	25243832	3500067968	23		25243809	25243832	8421504	1	23	0	c	350006796800000011	0-23						Methods and compositions for improved fertilization and embryonic survival	Khatib	2009	0		
777	chr9	25243929	25243965	3500166204	36		25243929	25243965	8421504	1	36	0	c	350016620400000033	76-112						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
779	chr9	25453298	25453331	3500445493	33		25453298	25453331	8421504	1	33	0	c	350044549300000056	15-48						Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide	Tang	2001	0		
779	chr9	25453298	25453331	3500058643	33		25453298	25453331	8421504	1	33	0	c	350005864300000046,350005864300000083	15-48,27-48						 Method Of Promoting Stem Cell Proliferation Or Survival By Contacting A Cell With A Stem Cell Factor 	www.docstoc.com	0	0		
779	chr9	25453406	25553486	3500355085	657		25453406	25553486	8421504	5	23,198,147,192,97	0,55683,61909,64016,99983	p,c	350035508500015012,350035508500000141	0-657,25-71						R-SPONDIN TRANSLOCATIONS AND METHODS USING THE SAME - Patent application	www.faqs.org	0	0		
779	chr9	25509150	25553441	3500058643	258		25509150	25553441	8421504	4	87,96,23,52	0,8288,8441,44239	c	350005864300000042,350005864300000022,350005864300000073,350005864300000016,350005864300000035,350005864300000072,350005864300000051,350005864300000013,350005864300000032	0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48						 Method Of Promoting Stem Cell Proliferation Or Survival By Contacting A Cell With A Stem Cell Factor 	www.docstoc.com	0	0		
783	chr9	25964350	25964376	3500334082	24		25964350	25964376	8421504	2	18,6	0,20	g	350033408200000001	0-24			10.1186/scrt230	1757-6512	Stem Cell Research & Therapy	Adipogenesis of adipose-derived stem cells may be regulated via the cytoskeleton at physiological oxygen levels in vitro	Schiller	2013	3		
787	chr9	26515335	26515363	3500063372	23		26515335	26515363	8421504	2	13,10	0,18	g	350006337200000003	0-23						High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm	Benvenisti	2000	0		
790	chr9	26989506	26991926	3500353322	90		26989506	26991926	8421504	3	42,3,45	0,2369,2375	p	350035332200015033,350035332200015032	0-45,0-45						Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor - Patent application	www.faqs.org	0	0		HEY2
790	chr9	26991936	26994123	3500460831	40		26991936	26994123	8421504	3	20,5,15	0,231,2172	c	350046083100000005,350046083100000004	0-20,0-20						Plasmids. Mouse Dll4-Fc (Dll4-Fc), comprising the extracellular domain of murine	tologylibrary.org	0	0		HEY2
794	chr9	27431610	27431641	3500340574	26		27431610	27431641	8421504	2	18,8	0,23	g	350034057400000014	0-26						Supplemental Materials and Methods Real time PCR primers for mRNA expression	www.jbc.org	0	0		
796	chr9	27761933	27761962	3500376849	24		27761933	27761962	8421504	3	6,12,6	0,7,23	g	350037684900000037	19-47						Methods for enhancing antibody-induced cell lysis and treating cancer	Weiner	2001	0		
796	chr9	27761933	27761962	3500237781	24		27761933	27761962	8421504	3	6,12,6	0,7,23	g	350023778100000037	19-47					Patent	Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. (Patent EP:1296714)	Hartmann	2009	0		
797	chr9	27834227	27834250	3500057184	23		27834227	27834250	8421504	1	23	0	g	350005718400000012	3-26						BMC Microbiology BioMed Central	biomedcentral.com	0	0		
797	chr9	27853124	27853152	3500102475	25		27853124	27853152	8421504	3	5,15,5	0,7,23	g	350010247500000000	0-26			10.1128/JB.184.6.1649-1660.2002		Journal of Bacteriology	RecA Protein from the Extremely Radioresistant Bacterium Deinococcus radiodurans: Expression, Purification, and Characterization	Jong-Il	2002	0		
803	chr9	28690295	28690321	3500038986	24		28690295	28690321	8421504	3	14,4,6	0,15,20	g	350003898600000019	19-45						Methods for enhancement of protective immune responses	Reed	1996	0		
806	chr9	28993485	28993511	3500158224	23		28993485	28993511	8421504	2	12,11	0,15	g	350015822400000018	4-30						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
809	chr9	29448954	29448982	3500441852	25		29448954	29448982	8421504	2	6,19	0,9	g	350044185200000010	5-30		15879595	10.1074/jbc.M501459200	0021-9258	Journal of Biological Chemistry	Calcium-dependent Activation of Interleukin-21 Gene Expression in T Cells	Kim	2005	5		
811	chr9	29623583	29623607	3500104740	23		29623583	29623607	8421504	2	15,8	0,16	g	350010474000000109	1-24						Untersuchungen zur transkriptionellen Regulation des humanen Chromogranin A Gens und seine Anwendung zum zellspezifischen therapeutischen Gentransfer in neuroendokrine Pankreastumorzellen	ub.uni-marburg.de	0	0		
814	chr9	30105743	30105768	3500296637	23		30105743	30105768	8421504	2	5,18	0,7	c	350029663700000005	24-48						Albumin variants	Andersen	2012	0		
814	chr9	30105743	30105768	3500272497	23		30105743	30105768	8421504	2	5,18	0,7	c	350027249700000005	24-48						Albumin variants	Andersen	2012	0		
814	chr9	30105925	30109291	3500072415	49		30105925	30109291	8421504	2	24,25	0,3341	c	350007241500000016,350007241500000015	14-38,13-38						Methods and compositions involving polymeric immunoglobulin fusion proteins	Arnason	2010	0		
816	chr9	30402287	30402344	3500395230	57		30402287	30402344	8421504	1	57	0	p	350039523000015002	0-57		18434628	10.1095/biolreprod.107.066241	0006-3363	Biology of Reproduction	Interaction of HSF1 and HSF2 with the Hspa1b Promoter in Mouse Epididymal Spermatozoa	Wilkerson	2008	4		HSF2
816	chr9	30402287	30402344	3500278168	57		30402287	30402344	8421504	1	57	0	p	350027816800015002	0-57		18434628	10.1095/biolreprod.107.066241		Biology of Reproduction	Interaction of HSF1 and HSF2 with the Hspa1b Promoter in Mouse Epididymal Spermatozoa	Donald	2008	0		HSF2
816	chr9	30402287	30402344	3500265761	57		30402287	30402344	8421504	1	57	0	p	350026576100015002	0-57						Interaction of HSF1 and HSF2 with the Hspa1b Promoter in Mouse Epididymal Spermatozoa	ww.biolreprod.org	0	0		HSF2
816	chr9	30402287	30402344	3500254849	57		30402287	30402344	8421504	1	57	0	p	350025484900015001	3-60		18570919	10.1016/j.yexcr.2008.04.015		Experimental cell research	PRC1 associates with the hsp70i promoter and interacts with HSF2 during mitosis	Lynea	July	0		HSF2
817	chr9	30417045	30423318	3500294910	40		30417045	30423318	8421504	2	20,20	0,6253	c	350029491000000009,350029491000000008	0-20,0-20						UNIVERSIDADE JOS&#xc9; DO ROS&#xc1;RIO VELLANO &#x2013; UNIFENAS TOCHIMARA APARECIDA MIYAUCHI	tede.unifenas.br	0	0		
820	chr9	30916954	30916980	3500175757	24		30916954	30916980	8421504	2	16,8	0,18	g	350017575700000021	4-28						&#x816b;&#x760d;&#x60aa;&#x6027;&#x5316;&#x95a2;&#x9023;&#x56e0;&#x5b50; ARK5 &#x907a;&#x4f1d;&#x5b50;&#x306e; &#x816b;&#x760d;&#x7d30;&#x80de;&#x306b;&#x304a;&#x3051;&#x308b;&#x767a;&#x73fe;&#x8abf;&#x7bc0;&#x6a5f;&#x69cb;	itc.u-tokyo.ac.jp	0	0		
821	chr9	31014754	31014783	3500255066	24		31014754	31014783	8421504	3	6,14,4	0,10,25	g	350025506600000004	0-24		23275090	10.1128/IAI.00822-12		Infection and Immunity	Disruption of Francisella tularensis Schu S4 iglI, iglJ, and pdpC Genes Results in Attenuation for Growth in Human Macrophages and In Vivo Virulence in Mice and Reveals a Unique Phenotype for pdpC	Matthew	2013	0		
822	chr9	31154426	31154454	3500330161	25		31154426	31154454	8421504	2	11,14	0,14	g	350033016100000019	20-45						US Patent # 7,291,711. Fluorescent proteins from aquatic species - Patents.com	www.patents.com	0	0		
822	chr9	31171214	31171239	3500367088	23		31171214	31171239	8421504	2	15,8	0,17	g	350036708800000003	3-26						Bap-dependent bio&#xfb01;lm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer?	c.sgmjournals.org	0	0		
822	chr9	31171214	31171239	3500209441	23		31171214	31171239	8421504	2	15,8	0,17	g	350020944100000017	3-26						Faculdade de Medicina Veterin&#xe1;ria	repository.utl.pt	0	0		
822	chr9	31171214	31171239	3500203287	23		31171214	31171239	8421504	2	15,8	0,17	g	350020328700000003	3-26		16000737	10.1099/mic.0.27865-0	1350-0872	Microbiology	Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer?	Tormo	2005	3		
825	chr9	31507205	31520216	3500115506	3091		31507205	31520216	8421504	3	619,2284,188	0,621,12823	c	350011550600000091,350011550600000013,350011550600000014,350011550600000010,350011550600000022,350011550600000024	1-3092,0-19,0-19,0-25,0-25,0-25						RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS - Patent application	www.faqs.org	0	0		
825	chr9	31507556	31507579	3500333999	23		31507556	31507579	8421504	1	23	0	c	350033399900000002	0-23		17639042	10.1677/ERC-06-0081	1351-0088	Endocrine-Related Cancer	Aroclor-1254 affects mRNA polyadenylation, translational activation, cell morphology, and DNA integrity of rat primary prostate cells	Cillo	2007	4		
825	chr9	31508852	31508883	3500387417	31		31508852	31508883	8421504	1	31	0	c	350038741700000000	28-59						Express&#xe3;o g&#xea;nica das c&#xe9;lulas do cumulus oophorus de bovinos ap&#xf3;s a vitrifica&#xe7;&#xe3;o*	www.ufrgs.br	0	0		
825	chr9	31508853	31509369	3500464145	60		31508853	31509369	8421504	2	30,30	0,486	c	350046414500000003,350046414500000002	0-30,0-30						Expression of the gap junction gene in preimplantation bovine embryos derived in vitro in	uction-online.org	0	0		
825	chr9	31508945	31509005	3500414025	60		31508945	31509005	8421504	1	60	0	p	350041402500015091,350041402500015056,350041402500015017	0-60,48-108,0-54						Compositions and methods for promoting wound healing and tissue regeneration	Ghatnekar	2011	0		GJA1
825	chr9	31509154	31510075	3500355416	63		31509154	31510075	8421504	3	19,19,25	0,465,896	c,g	350035541600000100,350035541600000101,350035541600000101,350035541600000097,350035541600000088,350035541600000088,350035541600000091	0-19,0-19,0-19,0-25,0-19,0-19,0-19						Rnai-mediated Inhibition Of Connexin 43 For Treatment Of Iop-related Conditions 	.freshpatents.com	0	0		
825	chr9	31509188	31509446	3500376693	51		31509188	31509446	8421504	2	30,21	0,237	c,g	350037669300000001,350037669300000002	0-30,0-21						Improved medical devices	Becker	2009	0		
825	chr9	31509188	31509218	3500445098	30		31509188	31509218	8421504	1	30	0	c	350044509800000001	0-30						Impaired wound healing compositions and treatments	Becker	2007	0		
825	chr9	31509188	31509218	3500411930	30		31509188	31509218	8421504	1	30	0	c	350041193000000000,350041193000000001	0-30,0-30						Overexpression of the gap junction protein Cx43 as found in diabetic foot ulcers can retard fibroblast migration	w.cellbiolint.org	0	0		
825	chr9	31509188	31509218	3500400748	30		31509188	31509218	8421504	1	30	0	c	350040074800000001,350040074800000000	0-30,0-30		22455314	10.1042/CBI20110628	1095-8355	Cell Biology International	Overexpression of the gap junction protein Cx43 as found in diabetic foot ulcers can retard fibroblast migration	A	2012	0		
825	chr9	31509188	31509218	3500392508	30		31509188	31509218	8421504	1	30	0	c,g	350039250800000041,350039250800000042,350039250800000001,350039250800000000,350039250800000035	0-30,0-30,0-30,0-30,0-21						IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS - Patent application	www.faqs.org	0	0		GJA1
825	chr9	31509188	31509218	3500346486	30		31509188	31509218	8421504	1	30	0	c	350034648600000001	0-30						Impaired Wound Healing Compositions And Treatments 	.freshpatents.com	0	0		
825	chr9	31509188	31509218	3500320590	30		31509188	31509218	8421504	1	30	0	c	350032059000000001	0-30						Anticonnexin polynucleotides as impaired wound healing compositions	Becker	2008	0		
825	chr9	31509188	31509218	3500143816	30		31509188	31509218	8421504	1	30	0	c	350014381600000001	0-30						Improved methods and compositions for wound healing	Green	2008	0		
825	chr9	31509188	31509218	3500123211	30		31509188	31509218	8421504	1	30	0	c	350012321100000001	0-30						Impaired wound healing compositions and methods	Becker	2013	0		
825	chr9	31509188	31509218	3500119721	30		31509188	31509218	8421504	1	30	0	c	350011972100000001	0-30						Impaired wound healing compositions and treatments	Becker	2012	0		
825	chr9	31509188	31509218	3500092728	30		31509188	31509218	8421504	1	30	0	c	350009272800000001,350009272800000027	0-30,0-30						MEDICAL DEVICES - Patent application	www.faqs.org	0	0		
825	chr9	31509188	31509218	3500021633	30		31509188	31509218	8421504	1	30	0	c	350002163300000029,350002163300000001,350002163300000000,350002163300000030	0-30,0-30,0-30,0-30						METHODS AND COMPOSITIONS FOR WOUND HEALING - Patent application	www.faqs.org	0	0		GJA1
825	chr9	31509188	31509218	3500015607	30		31509188	31509218	8421504	1	30	0	c	350001560700000001	0-30						METHODS AND COMPOSITIONS FOR WOUND HEALING	Green	2012	0		
825	chr9	31509467	31509533	3500455444	63		31509467	31509533	8421504	2	48,15	0,51	p	350045544400015002	0-63						A Binary Immunoliposomal System Directed to Cx43-Positive Glioma Cells	rsmu.ru/fileadmin	0	0		
825	chr9	31509703	31509955	3500151918	40		31509703	31509955	8421504	2	20,20	0,232	c,g	350015191800000001,350015191800000001,350015191800000000,350015191800000000	0-20,0-20,0-20,0-20						Melatonin Synergizes with Oxytocin to Enhance Contractility of Human Myometrial Smooth Muscle Cells	.endojournals.org	0	0		GJA1
825	chr9	31509802	31509945	3500394952	42		31509802	31509945	8421504	2	21,21	0,122	c,g	350039495200000011,350039495200000010,350039495200000010	0-21,0-21,0-21						REPRODUCTION	www.um.es/grupo-f	0	0		GJA1
825	chr9	31509802	31509945	3500181711	42		31509802	31509945	8421504	2	21,21	0,122	c,g	350018171100000031,350018171100000030,350018171100000030	0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		GJA1
825	chr9	31509803	31510093	3500212912	58		31509803	31510093	8421504	3	19,19,20	0,232,270	c,g	350021291200000010,350021291200000004,350021291200000004,350021291200000003	0-19,0-19,0-19,0-20		20089928	10.1152/ajpcell.00406.2009		American Journal of Physiology - Cell Physiolog	Regulation of gap junction coupling in bovine ciliary epithelium	Wang	2010	0		
825	chr9	31510016	31510046	3500450519	30		31510016	31510046	8421504	1	30	0	g	350045051900000000	0-30						Cloning of a gap junctional protein from vascular smooth muscle and expression in two-cell mouse embryos. - ResearchGate	.researchgate.net	0	0		
825	chr9	31510046	31510094	3500144365	48		31510046	31510094	8421504	1	48	0	p	350014436500015002	0-48						Immunoglobulin and cytokine expression in mixed lymphocyte cultures is reduced by disruption of gap junction intercellular communication	www.fasebj.org	0	0		GJA1
826	chr9	31681233	31681256	3500465548	23		31681233	31681256	8421504	1	23	0	g	350046554800000128,350046554800000092	0-23,0-23						 Method For Rapid Amplification Of DNA 	www.docstoc.com	0	0		
828	chr9	31856414	31856438	3500439977	23		31856414	31856438	8421504	2	13,10	0,14	g	350043997700000101	1-27						Ostertagia Vaccine - Patent application	www.faqs.org	0	0		
834	chr9	32690866	32690891	3500261462	23		32690866	32690891	8421504	2	9,14	0,11	g	350026146200000007	1-24		19304835	10.1128/AEM.01862-08		Applied and Environmental Microbiology	Inactivation of the SauI Type I Restriction-Modification System Is Not Sufficient To Generate Staphylococcus aureus Strains Capable of Efficiently Accepting Foreign DNA 	Helena	2009	0		
834	chr9	32763715	32763749	3500243191	31		32763715	32763749	8421504	3	17,6,8	0,19,26	g	350024319100000106	0-48						ABCG8 vectors, host cells, and method of making	Hobbs	2001	0		
105	chr9	33799820	33986675	3500462795	176		33799820	33986675	8421504	7	38,24,6,38,38,6,26	0,167,49032,87937,124640,170132,186829	c	350046279500000008,350046279500000041,350046279500000074,350046279500000084,350046279500000087,350046279500000097	6-44,6-44,24-48,0-44,0-44,0-26						Combinatorial DNA library for producing modified N-glycans in lower eukaryotes - Patent application	www.faqs.org	0	0		
105	chr9	33799820	33986675	3500161043	224		33799820	33986675	8421504	7	38,72,6,38,38,6,26	0,167,49032,87937,124640,170132,186829	c	350016104300000010,350016104300000089,350016104300000397,350016104300000398,350016104300000407,350016104300000410,350016104300000420	6-44,6-44,24-48,0-48,0-44,0-44,0-26						PRODUCTION OF SIALYLATED N-GLYCANS IN LOWER EUKARYOTES - Patent application	www.faqs.org	0	0		
842	chr9	33799820	33799858	3500446522	38		33799820	33799858	8421504	1	38	0	c	350044652200000007	6-44						Production of modified glycoproteins having multiple antennary structures	Bobrowicz	2004	0		
842	chr9	33799820	33799858	3500446146	38		33799820	33799858	8421504	1	38	0	c	350044614600000009	6-44						Production of modified glycoproteins having multiple antennary structures	Bobrowicz	2004	0		
842	chr9	33799820	33799858	3500426538	38		33799820	33799858	8421504	1	38	0	c	350042653800000009	6-44					Patent	N-acetylglucosaminyltransferase III expression in lower eukaryotes (Patent US:8445227)	Bobrowicz	2013	0		
842	chr9	33799820	33799858	3500418932	38		33799820	33799858	8421504	1	38	0	c	350041893200000009	6-44					Patent	N-acetylglucosaminyltransferase III expression in lower eukaryotes (Patent US:7598055)	Bobrowicz	2009	0		
842	chr9	33799820	33799858	3500416020	38		33799820	33799858	8421504	1	38	0	c	350041602000000007	6-44						Combinatorial DNA library for producing modified N-glycans in lower eukaryotes	Bobrowicz	2004	0		
842	chr9	33799820	33799858	3500413829	38		33799820	33799858	8421504	1	38	0	c	350041382900000008	6-44					Patent	Combinatorial DNA library for producing modified N-glycans in lower eukaryotes (Patent US:7449308)	Bobrowicz	2008	0		
842	chr9	33799820	33799858	3500346363	38		33799820	33799858	8421504	1	38	0	c	350034636300000009	6-44						Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells	Hamilton	2003	0		
842	chr9	33799820	33799858	3500345798	38		33799820	33799858	8421504	1	38	0	c	350034579800000008	6-44						Combinatorial DNA Library for Producing Modified N-Glycans In Lower Eukaryotes	Gerngross	2012	0		
842	chr9	33799820	33799858	3500326760	38		33799820	33799858	8421504	1	38	0	c	350032676000000009	6-44						N-acetylglucosamintransferase III expression in lower eukaryotes	Bobrowicz	2005	0		
842	chr9	33799820	33799858	3500326503	38		33799820	33799858	8421504	1	38	0	c	350032650300000009	6-44						N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes	Bobrowicz	2010	0		
842	chr9	33799820	33799858	3500308195	38		33799820	33799858	8421504	1	38	0	c	350030819500000007	6-44						Production of modified glycoproteins having multiple antennary structures	Bobrowicz	2004	0		
842	chr9	33799820	33799858	3500301063	38		33799820	33799858	8421504	1	38	0	c	350030106300000007	6-44						N-acetylglucosaminyltransferase iii expression in lower eukaryotes	Bobrowicz	2004	0		
842	chr9	33799820	33799858	3500227169	38		33799820	33799858	8421504	1	38	0	c	350022716900000007	6-44						Production of modified glycoproteins having multiple antennary structures	Bobrowicz	2009	0		
842	chr9	33799820	33799858	3500224642	38		33799820	33799858	8421504	1	38	0	c	350022464200000007	6-44						N -acetylglucosaminyltransferase iii expression in lower eukaryotes	Bobrowicz	2005	0		
842	chr9	33799820	33799858	3500221505	38		33799820	33799858	8421504	1	38	0	c	350022150500000007	6-44					Patent	Production of modified glycoproteins having multiple antennary structures (Patent EP:1597381)	Bobrowicz	2009	0		
842	chr9	33799820	33799858	3500189959	38		33799820	33799858	8421504	1	38	0	c	350018995900000007	6-44					Patent	Production of modified glycoproteins having multiple antennary structures (Patent EP:1597381)	Bobrowicz	2013	0		
842	chr9	33799820	33799858	3500167845	38		33799820	33799858	8421504	1	38	0	c	350016784500000071,350016784500000009	6-44,6-44						N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes - Patent application	www.faqs.org	0	0		
842	chr9	33799820	33799858	3500158679	38		33799820	33799858	8421504	1	38	0	c	350015867900000007	6-44						Production of modified glycoproteins having multiple antennary structures	Bobrowicz	2005	0		
842	chr9	33799820	33799858	3500141335	38		33799820	33799858	8421504	1	38	0	c	350014133500000009	6-44					Patent	N-acetylglucosaminyltransferase III expression in lower eukaryotes (Patent US:8445227)	Bobrowicz	2013	0		
842	chr9	33799820	33799858	3500119712	38		33799820	33799858	8421504	1	38	0	c	350011971200000009	6-44						N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes	Bobrowicz	2010	0		
842	chr9	33799820	33799858	3500057533	38		33799820	33799858	8421504	1	38	0	c	350005753300000008	6-44						Combinatorial DNA library for producing modified N-glycans in lower eukaryotes	Bobrowicz	2009	0		
844	chr9	33996361	33996394	3500247765	33		33996361	33996394	8421504	1	33	0	c	350024776500000018	1-34						Supplemental data Gene expression signature-based chemical genomic prediction identifies novel class of HSP90 pathway modulators Supplemental experimental procedures	download.cell.com	0	0		
844	chr9	34000728	34000757	3500114897	26		34000728	34000757	8421504	2	11,15	0,14	g	350011489700000116	13-39						COLLAGEN PRODUCING PLANTS AND METHODS OF GENERATING AND USING SAME - Patent application	www.faqs.org	0	0		
851	chr9	34957085	34957109	3500033923	23		34957085	34957109	8421504	2	9,14	0,10	g	350003392300000008	0-23						Molecular Phylogenetics and Evolution	www.tc.umn.edu	0	0		
854	chr9	35339360	35339391	3500114630	30		35339360	35339391	8421504	2	11,19	0,12	g	350011463000000111	0-48						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
855	chr9	35425405	35425430	3500262089	23		35425405	35425430	8421504	2	5,18	0,7	g	350026208900000032	21-44						US Patent # 6,080,912. Methods for creating transgenic animals - Patents.com	www.patents.com	0	0		
855	chr9	35493627	35493650	3500341533	23		35493627	35493650	8421504	1	23	0	c	350034153300000014	20-43						Microbial system for formaldehyde sensing and remediation	Donohue	1998	0		
855	chr9	35518922	35518946	3500309124	23		35518922	35518946	8421504	2	4,19	0,5	c	350030912400000015	3-28						Expression In Insect Cells Of Genes With Overlapping Open Reading Frames, Methods And Compositions Therefor 	.freshpatents.com	0	0		
856	chr9	35577574	35577600	3500282751	26		35577574	35577600	8421504	1	26	0	c	350028275100000018,350028275100000044	0-26,0-26						ROS Kinase in Lung Cancer - Patent application	www.faqs.org	0	0		
856	chr9	35577574	35577600	3500066249	26		35577574	35577600	8421504	1	26	0	c	350006624900000018	0-26						ROS KINASE IN LUNG CANCER - CELL SIGNALING TECHNOLOGY, INC.	www.sumobrain.com	0	0		
856	chr9	35585568	35585591	3500395517	23		35585568	35585591	8421504	1	23	0	c	350039551700000045,350039551700000014	1-24,1-24						Mutant ROS Expression In Human Cancer - Patent application	www.faqs.org	0	0		
856	chr9	35632592	35632617	3500074276	25		35632592	35632617	8421504	1	25	0	g	350007427600000027,350007427600000102	0-25,0-25						 Telomerizing Nuclear Donor Cells And Improving The Efficiency On Nuclear Transfer 	www.docstoc.com	0	0		
858	chr9	35845775	35845803	3500290270	23		35845775	35845803	8421504	2	16,7	0,21	g	350029027000000165	0-23					Patent	Recombinant poxvirus-cytomegalovirus, compositions and uses (Patent US:5997878)	Cox	1999	0		
858	chr9	35868952	35868978	3500192210	24		35868952	35868978	8421504	2	11,13	0,13	g	350019221000000190	14-38						Neutrophil inhibitors	Moyle	1995	0		
860	chr9	36108423	36108449	3500255012	23		36108423	36108449	8421504	2	6,17	0,9	g	350025501200000022,350025501200000230,350025501200000231	24-47,4-27,4-27						Omega-amino carboxylic acids, omega-amino carboxylic acid esters, or recombinant cells which produce lactams thereof	A*Qia Lao 	2009	0		
861	chr9	36220579	36220602	3500312037	23		36220579	36220602	8421504	1	23	0	g	350031203700000378	5-28						TARGETED WHOLE GENOME AMPLIFICATION METHOD FOR IDENTIFICATION OF PATHOGENS - Patent application	www.faqs.org	0	0		
862	chr9	36338497	36338521	3500115116	23		36338497	36338521	8421504	2	5,18	0,6	g	350011511600000322	5-28						Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use	J*M*Wei Er Sen 	2005	0		
862	chr9	36348560	36348583	3500382817	23		36348560	36348583	8421504	1	23	0	c	350038281700000046	3-26						Long Acting Human Interferon Analogs - Patent application	www.faqs.org	0	0		
862	chr9	36348560	36348583	3500089969	23		36348560	36348583	8421504	1	23	0	c	350008996900000046	3-26						Long acting human interferon analogs - Patent application	www.faqs.org	0	0		
862	chr9	36381973	36381998	3500308662	25		36381973	36381998	8421504	1	25	0	g	350030866200000037	0-25						DNA	.lib.kobe-u.ac.jp	0	0		
865	chr9	36716618	36720969	3500352661	41		36716618	36720969	8421504	2	20,21	0,4330	c,g	350035266100000012,350035266100000012,350035266100000013	0-20,0-20,0-21						Archive of SID	www.sid.ir/en/VEW	0	0		
865	chr9	36716618	36720969	3500274729	41		36716618	36720969	8421504	2	20,21	0,4330	c	350027472900000012,350027472900000013	0-20,0-21						Ex vivo Expansion and Differentiation of Mesenchymal Stem Cells from Goat Bone Marrow	www.mums.ac.ir	0	0		
865	chr9	36716619	36720765	3500449513	41		36716619	36720765	8421504	3	19,6,16	0,84,4130	c,g	350044951300000002,350044951300000002,350044951300000003	0-19,0-19,0-22			10.1359/jbmr.2002.17.2.275	1523-4681	Journal of Bone and Mineral Research	The Assembly and Remodeling of the Extracellular Matrix in the Growth Plate in Relationship to Mineral Deposition and Cellular Hypertrophy: An In Situ Study of Collagens II and IX and Proteoglycan - Mwale - 2002 - Journal of Bone and Mineral Research - Wi	Mwale	2002	0		
865	chr9	36720872	36721259	3500305017	41		36720872	36721259	8421504	2	20,21	0,366	c	350030501700000042,350030501700000043,350030501700000016	0-20,0-20,20-40						Mesenchymal precursor cell - Patent application	www.faqs.org	0	0		
865	chr9	36720872	36721258	3500406332	40		36720872	36721258	8421504	2	20,20	0,366	c	350040633200000024,350040633200000025	0-20,0-20						Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc)	Gronthos	2009	0		
865	chr9	36720872	36721258	3500338867	40		36720872	36721258	8421504	2	20,20	0,366	c	350033886700000024,350033886700000025	0-20,0-20						Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC)	Gronthos	2011	0		
865	chr9	36720872	36721258	3500300282	40		36720872	36721258	8421504	2	20,20	0,366	c	350030028200000026,350030028200000045,350030028200000027,350030028200000046	0-20,0-20,0-20,0-20						Mesenchymal precursor cell - US Patent 7670628 Description	ww.patentstorm.us	0	0		
865	chr9	36720872	36721258	3500276552	40		36720872	36721258	8421504	2	20,20	0,366	c	350027655200000032,350027655200000068,350027655200000033,350027655200000069	0-20,0-20,0-20,0-20						Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof - Patent application	www.faqs.org	0	0		
865	chr9	36720872	36721258	3500203643	40		36720872	36721258	8421504	2	20,20	0,366	c	350020364300000004,350020364300000005	0-20,0-20		16461546	10.1677/joe.1.06364	0022-0795	Journal of Endocrinology	Locally produced estrogen promotes fetal rat metatarsal bone growth; an effect mediated through increased chondrocyte proliferation and decreased apoptosis	Chagin	2006	4		
865	chr9	36720872	36721258	3500131353	40		36720872	36721258	8421504	2	20,20	0,366	c	350013135300000002,350013135300000003	0-20,0-20		15576458	10.1210/en.2004-1152	0013-7227	Endocrinology	Dexamethasone Induces Apoptosis in Proliferative Chondrocytes through Activation of Caspases and Suppression of the Akt-Phosphatidylinositol 3&#x2032;-Kinase Signaling Pathway	Chrysis	2005	4		COL10A1,NT5DC1
865	chr9	36720872	36721258	3500111162	40		36720872	36721258	8421504	2	20,20	0,366	c	350011116200000032,350011116200000033	0-20,0-20						Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof	Gronthos	2011	0		
865	chr9	36722215	36722238	3500338132	23		36722215	36722238	8421504	1	23	0	c	350033813200000006	0-23						Functional relationship between high mobility group A1 (HMGA1) protein and insulin-like growth factor-binding protein 3 (IGFBP-3) in human chondrocytes	itis-research.com	0	0		
865	chr9	36722467	36722493	3500117611	26		36722467	36722493	8421504	1	26	0	c	350011761100000013	0-26			10.1016/j.bone.2007.01.011		Bone	The Post-Translational Phenotype of Collagen Synthesized by Saos-2 Osteosarcoma Cells	Russell	2007	0		NT5DC1
865	chr9	36722509	36722788	3500153648	40		36722509	36722788	8421504	2	20,20	0,259	c,g	350015364800000028,350015364800000028,350015364800000029,350015364800000029	0-20,0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
865	chr9	36722574	36722598	3500020495	24		36722574	36722598	8421504	1	24	0	c	350002049500000005	0-24			10.1002/ar.a.20010	1552-4892	The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology	Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture - Charles Huang - 2004 - The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology - Wiley Online Library	Charles	2004	0		NT5DC1
865	chr9	36723195	36723356	3500335446	46		36723195	36723356	8421504	2	20,26	0,135	c,g	350033544600000004,350033544600000004,350033544600000005,350033544600000005	0-20,0-20,0-26,0-26		19887637	10.1073/pnas.0904513106		Proceedings of the National Academy of Sciences of the United States of America	A nonsense mutation in cGMP-dependent type II protein kinase (PRKG2) causes dwarfism in American Angus cattle	James	2009	0		
865	chr9	36723195	36723356	3500249864	46		36723195	36723356	8421504	2	20,26	0,135	c	350024986400000004,350024986400000005	0-20,0-26						A nonsense mutation in cGMP-dependant type II protein kinase (PRKG2) causes dwarfism in American Angus cattle	www.pnas.org	0	0		
865	chr9	36723195	36723356	3500136028	46		36723195	36723356	8421504	2	20,26	0,135	c,g	350013602800000004,350013602800000004,350013602800000005	0-20,0-20,0-26						A nonsense mutation in cGMP-dependent type II protein kinase (PRKG2) causes dwarfism in American Angus cattle	www.pnas.org	0	0		
879	chr9	38544880	38544908	3500356355	24		38544880	38544908	8421504	3	5,6,13	0,7,15	g	350035635500000187	15-39						Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy - Patent # 5863724 - PatentGenius	.patentgenius.com	0	0		
880	chr9	38715417	38715446	3500072266	29		38715417	38715446	8421504	1	29	0	c,g	350007226600000002,350007226600000002	8-37,8-37		22158273	10.1038/bjc.2011.532	0007-0920	British Journal of Cancer	Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide	Chang	2011	5		
880	chr9	38715419	38728494	3500302543	40		38715419	38728494	8421504	2	20,20	0,13055	c,g	350030254300000003,350030254300000003,350030254300000002	0-20,0-20,0-20		21248725	10.1038/mi.2010.83	1933-0219	Mucosal Immunology	Epigenetic regulation of human &#x03b2;-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria	Yin	2011	7		HDAC2
880	chr9	38728494	38746130	3500282073	477		38728494	38746130	8421504	11	45,37,8,45,45,32,34,105,36,45,45	0,1253,3474,3485,4133,4181,6718,6755,10869,16845,17591	p	350028207300015011,350028207300015020,350028207300015022,350028207300015072,350028207300015073,350028207300015030,350028207300015032,350028207300015075,350028207300015034,350028207300015076,350028207300015036,350028207300015052,350028207300015056	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						METHOD FOR TREATMENT OF PROSTATE CANCER AND SCREENING OF PATIENTS BENEFITING FROM SAID METHOD - Patent application	www.faqs.org	0	0		HDAC2
880	chr9	38732615	38732639	3500435132	24		38732615	38732639	8421504	1	24	0	c	350043513200000003	20-44						RESEARCH ARTICLE	.apocpcontrol.org	0	0		HDAC2
880	chr9	38735351	38739413	3500096354	51		38735351	38739413	8421504	3	3,23,25	0,4012,4037	c	350009635400000008,350009635400000007	0-26,0-25						Assay For Identifying Agents That Modulate Epigenetic Silencing, And Agents Identified Thereby 	.freshpatents.com	0	0		HDAC2
880	chr9	38739388	38739412	3500170505	24		38739388	38739412	8421504	1	24	0	c	350017050500000006	0-24						Mechanisms Associated with the Chemotherapeutic Effects of Zyflamend, a Multi-Herbal Extract, on Advanced Prostate Cancer	ace.tennessee.edu	0	0		HDAC2
880	chr9	38749916	38750943	3500454707	27		38749916	38750943	8421504	2	7,20	0,1007	c	350045470700000005	0-27						Methods and kits for investigating cancer	Munnes	2008	0		
880	chr9	38749916	38750943	3500400698	27		38749916	38750943	8421504	2	7,20	0,1007	c	350040069800000005	0-27						Methods and kits for investigating cancer	Munnes	2008	0		
881	chr9	38821988	38824516	3500212595	58		38821988	38824516	8421504	3	19,19,20	0,294,2508	c,g	350021259500000004,350021259500000004,350021259500000005,350021259500000011,350021259500000011	0-19,0-19,0-19,0-20,0-20		16943556	10.1523/JNEUROSCI.2828-06.2006	0270-6474	The Journal of Neuroscience	Involvement of Protein Kinase C-&#x03b5; in Activity-Dependent Potentiation of Large Dense-Core Vesicle Exocytosis in Chromaffin Cells	Park	2006	7		
881	chr9	38822263	38822332	3500298158	69		38822263	38822332	8421504	1	69	0	p	350029815800015003	0-72						INTRACELLULAR REPORTERS - Patent application	www.faqs.org	0	0		
882	chr9	38994580	38994608	3500333430	24		38994580	38994608	8421504	3	13,6,5	0,14,23	g	350033343000000018	0-24		12566309		0008-5472	Cancer Research	Genotypic and Phenotypic Characterization of a Putative Tumor Susceptibility Gene, GNMT, in Liver Cancer	Tseng	2003	8		
882	chr9	39050204	39050229	3500264928	23		39050204	39050229	8421504	2	13,10	0,15	g	350026492800000046	11-34						US Patent # 5,888,764. Human fas gene promoter region - Patents.com	www.patents.com	0	0		
885	chr9	39324853	39324878	3500194350	23		39324853	39324878	8421504	2	5,18	0,7	g	350019435000000108	2-26						Soybean peroxidase gene family and an assay for detecting soybean peroxidase activity	Vierling	1998	0		
888	chr9	39788953	39788979	3500342438	23		39788953	39788979	8421504	2	13,10	0,16	g	350034243800000004	0-23						Editorial Board	www.wjgnet.com	0	0		MBD2
893	chr9	40435280	40435306	3500171762	23		40435280	40435306	8421504	2	12,11	0,15	c	350017176200000008	0-23		18156264	10.1128/JB.01660-07	0021-9193	Journal of Bacteriology	LuxG Is a Functioning Flavin Reductase for Bacterial Luminescence	Nijvipakul	2008	4		
894	chr9	40590044	40590068	3500204757	24		40590044	40590068	8421504	1	24	0	c	350020475700000009	0-24						LAMININ CHAIN EXPRESSION AND BASEMENT MEMBRANE FORMATION BY RESPIRATORY EPITHELIAL CELLS, MLE-15 Nguyet M. Nguyen, Yushi Bai *, Katsumi Mochitate *, and Robert M. Senior	ng.physiology.org	0	0		LAMA4
894	chr9	40590641	40590672	3500326083	25		40590641	40590672	8421504	3	4,6,15	0,5,16	c	350032608300000000	17-42		12543799		0008-5472	Cancer Research	Melanoma Metastasis Suppression by Chromosome 6	Goldberg	2003	8		
897	chr9	40991529	40991580	3500109754	51		40991529	40991580	8421504	1	51	0	c	350010975400000008,350010975400000009,350010975400000022	7-58,5-56,0-51						MODIFIED DENDRITIC CELLS HAVING ENHANCED SURVIVAL AND IMMUNOGENICITY AND RELATED COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		FYN
897	chr9	40991544	40991604	3500000028	60		40991544	40991604	8421504	1	60	0	p	350000002800015000	0-60						&#x4e3b;&#x9898;&#xff1a;Model | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		FYN
897	chr9	40991563	40991655	3500040720	40		40991563	40991655	8421504	2	20,20	0,72	c,g	350004072000000006,350004072000000007,350004072000000007	0-20,0-20,0-20						None	www.nature.com	0	0		FYN
897	chr9	40991635	40993625	3500308105	40		40991635	40993625	8421504	2	20,20	0,1970	c,g	350030810500000002,350030810500000002,350030810500000003	0-20,0-20,0-20						Dasatinib and Paclitaxel in Human Ovarian Cancer: Materials and Methods	www.medscape.com	0	0		FYN
897	chr9	40991635	40993625	3500063876	40		40991635	40993625	8421504	2	20,20	0,1970	c,g	350006387600000002,350006387600000002,350006387600000003	0-20,0-20,0-20		21813412	10.1093/jnci/djr280		JNCI Journal of the National Cancer Institute	The Role of p27Kip1 in Dasatinib-Enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells	Xiao-Feng	2011	0		FYN
897	chr9	40993576	41000962	3500263315	174		40993576	41000962	8421504	2	95,79	0,7307	p	350026331500015010	0-174						Compositions and methods for producing bioactive fusion proteins	Walker	2008	0		FYN
897	chr9	40993576	41000962	3500236543	174		40993576	41000962	8421504	2	95,79	0,7307	p	350023654300015022	0-174					Patent	Compositions and methods for producing bioactive fusion proteins (Patent US:8420779)	Walker	2013	0		FYN
897	chr9	40993576	41000962	3500227699	174		40993576	41000962	8421504	2	95,79	0,7307	p	350022769900015022	0-174						Compositions and methods for producing bioactive fusion proteins	Walker	2009	0		FYN
897	chr9	40993576	41000962	3500004002	174		40993576	41000962	8421504	2	95,79	0,7307	p	350000400200015012	0-174						COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS	Walker	2013	0		FYN
897	chr9	41007441	41007489	3500335247	48		41007441	41007489	8421504	1	48	0	p	350033524700015049	0-48						Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection	Dunnington	1997	0		FYN
897	chr9	41007468	41007516	3500113627	48		41007468	41007516	8421504	1	48	0	p	350011362700015000	0-48						Leukemia - Figures and tables for article: Altered splicing in hematological malignancies reveals a tissue-specific translational block of the Src-family tyrosine kinase fyn brain isoform expression	www.nature.com	0	0		FYN
897	chr9	41010857	41010880	3500190684	23		41010857	41010880	8421504	1	23	0	c	350019068400000000	0-23		16966330	10.1074/jbc.M603928200	0021-9258	Journal of Biological Chemistry	Phosphorylation of Tyr1214 within VEGFR-2 Triggers the Recruitment of Nck and Activation of Fyn Leading to SAPK2/p38 Activation and Endothelial Cell Migration in Response to VEGF	Lamalice	2006	5		FYN
897	chr9	41010932	41013219	3500378011	114		41010932	41013219	8421504	2	79,35	0,2252	p	350037801100015001	0-114						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	mcb.berkeley.edu	0	0		FYN
897	chr9	41010932	41013219	3500145445	114		41010932	41013219	8421504	2	79,35	0,2252	p	350014544500015001	0-114						Achemical switchfor inhibitor- sensitiveallelesofanyproteinkinase	physio.ucsf.edu	0	0		FYN
897	chr9	41010932	41013201	3500244206	96		41010932	41013201	8421504	2	79,17	0,2252	p	350024420600015021,350024420600015022	0-48,0-48						High affinity protein kinase inhibitors - US Patent 6383790 Description	ww.patentstorm.us	0	0		
897	chr9	41010932	41010980	3500222363	48		41010932	41010980	8421504	1	48	0	p	350022236300015025	0-48						US Patent # 6,521,417. Engineered protein kinases which can utilize modified nucleotide triphosphate substrates - Patents.com	www.patents.com	0	0		FYN
897	chr9	41010935	41010980	3500008336	45		41010935	41010980	8421504	1	45	0	p	350000833600015024	0-45						Engineered protein kinases which can utilize modified nucleotide triphosphate substrates	Shokat	2000	0		FYN
898	chr9	41031750	41031795	3500355215	45		41031750	41031795	8421504	1	45	0	p	350035521500015129	0-45						US Patent # 7,384,913. PT32 sperm protein, sperm c-Yes, oocyte cytoplasmic c-Yes, and uses thereof - Patents.com	www.patents.com	0	0		FYN
898	chr9	41121518	41124119	3500446711	43		41121518	41124119	8421504	2	23,20	0,2581	c	350044671100000022,350044671100000023	0-23,0-20		17982039		0022-1767	The Journal of Immunology	Requirement for Both JAK-Mediated PI3K Signaling and ACT1/TRAF6/TAK1-Dependent NF-&#x03ba;B Activation by IL-17A in Enhancing Cytokine Expression in Human Airway Epithelial Cells	Huang	2007	6		TRAF3IP2
901	chr9	41430734	41430759	3500078566	25		41430734	41430759	8421504	1	25	0	c	350007856600000001	0-25						The Role of Thyroid Hormones in Placental Development and the Importance of the Thyroid Hormone Transporter MCT8	theses.bham.ac.uk	0	0		
902	chr9	41646051	41646078	3500413325	23		41646051	41646078	8421504	2	16,7	0,20	g	350041332500000223	1-30						Fusion Proteins Useful For Detecting Analytes 	.freshpatents.com	0	0		
903	chr9	41689650	41705265	3500033479	40		41689650	41705265	8421504	2	20,20	0,15595	c,g	350003347900000003,350003347900000002,350003347900000002	0-20,0-20,0-20						ISSUU - Gene Therapy & Molecular Biology Volume 11 Issue B by Niko Boulikas	issuu.com/gtmb/do	0	0		AMD1
907	chr9	42312591	42320319	3500355496	25		42312591	42320319	8421504	3	12,2,11	0,13,7717	c	350035549600000015	13-41						High resolution typing of Chlamydophila psittaci by multilocus VNTR analysis (MLVA)	tal.umaryland.edu	0	0		
908	chr9	42384160	42384186	3500082661	23		42384160	42384186	8421504	2	10,13	0,13	c	350008266100000018	21-44		9882665		0021-9193	Journal of Bacteriology	Localization of FtsI (PBP3) to the Septal Ring Requires Its Membrane Anchor, the Z Ring, FtsA, FtsQ, and FtsL	Weiss	1999	4		
908	chr9	42384168	42384194	3500055843	26		42384168	42384194	8421504	1	26	0	c	350005584300000002	19-45		10970852	10.1093/emboj/19.17.4589	ERROR! NO ISSN	The EMBO Journal	Scar/WAVE-1, a Wiskott&#x2013;Aldrich syndrome protein, assembles an actin-associated multi-kinase scaffold	Westphal	2000	0		
908	chr9	42398252	42402016	3500307330	927		42398252	42402016	8421504	5	24,33,101,180,589	0,27,63,1875,3175	p	350030733000015001	0-927						Wave1 inhibition in the medical intervention of inflammatory diseases and/or infections caused by a pathogen	Knapp	2011	0		
908	chr9	42401745	42401770	3500060061	25		42401745	42401770	8421504	1	25	0	c	350006006100000006	0-25			10.1242/jcs.03311	0021-9533	Journal of Cell Science	Rac-WAVE-mediated actin reorganization is required for organization and maintenance of cell-cell adhesion	Yamazaki	2007	6		WASF1
908	chr9	42403118	42403143	3500085783	25		42403118	42403143	8421504	1	25	0	g	350008578300000000	89-114						Arp2/3 complex is essential for actin network treadmilling as well as for targeting of capping protein and cofilin	w.molbiolcell.org	0	0		WASF1
909	chr9	42516991	42517022	3500258078	26		42516991	42517022	8421504	3	13,8,5	0,17,26	c	350025807800000266	1-43						Nematode PAN and ZP Receptor-Like Sequences - Patent application	www.faqs.org	0	0		
912	chr9	42872945	42872977	3500267789	28		42872945	42872977	8421504	2	13,15	0,17	g	350026778900000040	6-41						Human Transcriptome Subtraction by Using Short Sequence Tags To Search for Tumor Viruses in Conjunctival Carcinoma	virology.pitt.edu	0	0		
913	chr9	42992028	42992056	3500376903	23		42992028	42992056	8421504	2	9,14	0,14	g	350037690300000039	20-44						Antibody libray display by yeast cell plasma membrane	Gao	2008	0		
913	chr9	43004970	43004996	3500373336	23		43004970	43004996	8421504	2	6,17	0,9	c	350037333600000166	16-39						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins - US Patent 7378506 Description	ww.patentstorm.us	0	0		
917	chr9	43613458	43613487	3500158245	24		43613458	43613487	8421504	3	13,6,5	0,15,24	g	350015824500000112	24-48						METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION - Patent application	www.faqs.org	0	0		
114	chr9	43828411	43925916	3500183785	2007		43828411	43925916	8421504	4	63,1245,81,618	0,69,1317,96887	p	350018378500015006	0-2013						METHOD OF USING FOXO3A POLYMORPHISMS AND HAPLOTYPES TO PREDICT AND PROMOTE HEALTHY AGING AND LONGEVITY - KUAKINI MEDICAL CENTER	www.sumobrain.com	0	0		
114	chr9	43828609	43925499	3500385072	480		43828609	43925499	8421504	3	240,39,201	0,1161,96689	p	350038507200015037,350038507200015012	0-240,0-240						Analysis of FOXO transcriptional networks	ive.library.uu.nl	0	0		
919	chr9	43829721	43829746	3500129212	25		43829721	43829746	8421504	1	25	0	c	350012921200000007	0-25		22159760	10.3892/or.2011.1579		Oncology Reports	TRAIL is involved in CpG ODN-mediated anti-apoptotic signals	EUN-JUNG	2012	0		ZNF286B
920	chr9	43925305	43925350	3500031168	44		43925305	43925350	8421504	2	21,23	0,22	c	350003116800000011,350003116800000009	0-21,0-23		18349321	10.1182/blood-2007-10-117762	0006-4971	Blood	The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph&#x2212; acute lymphoblastic leukemia cells	Scuto	2008	10		ZNF286B
920	chr9	43925321	43925392	3500349798	44		43925321	43925392	8421504	2	23,21	0,50	c,g	350034979800000019,350034979800000019,350034979800000018	0-23,0-23,0-21		22438963	10.1371/journal.pone.0033609	1932-6203	PLOS ONE	PLOS ONE: TWEAK Affects Keratinocyte G2/M Growth Arrest and Induces Apoptosis through the Translocation of the AIF Protein to the Nucleus	Alaoui	2012	4		ZNF286B
920	chr9	43925327	43925350	3500261436	23		43925327	43925350	8421504	1	23	0	c,g	350026143600000045,350026143600000045	0-23,0-23						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		FOXO3,ZNF286B
920	chr9	43925329	43925352	3500375478	23		43925329	43925352	8421504	1	23	0	c	350037547800000000	0-23						Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a	biomedcentral.com	0	0		FOXO3
14	chr9	43961915	44131968	3500280869	1197		43961915	44131968	8421504	12	99,114,141,101,71,83,59,100,131,102,52,144	0,2737,6559,47860,48217,70990,103397,126561,136339,137389,149084,169909	p	350028086900015175	0-1197						Pisum_sativum_v2_Contig3651 | Cool Season Food Legume Database	www.gabcsfl.org	0	0		LACE1
920	chr9	43968511	43968539	3500247014	23		43968511	43968539	8421504	2	11,12	0,16	c	350024701400000023	8-31						ADAMTS13 GENES AND PROTEINS AND VARIANTS, AND THERAPEUTIC COMPOSITIONS AND METHODS OF UTILIZING THE SAME - Patent application	www.faqs.org	0	0		
920	chr9	44009787	44009817	3500105414	27		44009787	44009817	8421504	2	14,13	0,17	c	350010541400000071	3-33						Compositions And Methods Comprising Variant Microbial Proteases - Patent application	www.faqs.org	0	0		LACE1
922	chr9	44207585	44207614	3500130848	24		44207585	44207614	8421504	2	14,10	0,19	g	350013084800000329	3-27						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
922	chr9	44248540	44250797	3500174220	40		44248540	44250797	8421504	2	20,20	0,2237	c,g	350017422000000000,350017422000000000,350017422000000001,350017422000000001	0-20,0-20,0-20,0-20						NuclearOrphanReceptorTLXInducesOct-3/4forthe SurvivalandMaintenanceofAdultHippocampalProgenitors uponHypoxia S	www.jbc.org	0	0		NR2E1
922	chr9	44248540	44250797	3500113803	40		44248540	44250797	8421504	2	20,20	0,2237	c,g	350011380300000000,350011380300000001,350011380300000001	0-20,0-20,0-20		21135096	10.1074/jbc.M110.167445	0021-9258	Journal of Biological Chemistry	Nuclear Orphan Receptor TLX Induces Oct-3/4 for the Survival and Maintenance of Adult Hippocampal Progenitors upon Hypoxia	Chavali	2011	5		NR2E1
922	chr9	44257391	44257439	3500052842	48		44257391	44257439	8421504	1	48	0	p	350005284200015016	0-48						DMD #24695 A Phosphomimetic Mutation at Threonine-57 Abolishes Transactivation Activity and Alters Nuclear Localization Pattern of Human Pregnane X Receptor	aspetjournals.org	0	0		NR2E1
926	chr9	44796005	44796034	3500314221	23		44796005	44796034	8421504	3	4,12,7	0,5,22	g	350031422100000042	7-32						Use of ectoenzymes and secreted enzymes to monitor cellular proliferation	Zyskind	2000	0		
930	chr9	45246005	45246033	3500395273	23		45246005	45246033	8421504	2	6,17	0,11	g	350039527300000156,350039527300000189	26-48,11-34						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
930	chr9	45264162	45264190	3500297690	26		45264162	45264190	8421504	2	6,20	0,8	c	350029769000000019	19-45						US Patent # 5,556,781. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
930	chr9	45264162	45264190	3500039160	26		45264162	45264190	8421504	2	6,20	0,8	c	350003916000000019	19-45						US Patent # 5,830,715. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
931	chr9	45365377	45365411	3500156344	28		45365377	45365411	8421504	3	10,13,5	0,13,29	g	350015634400000000	11-39			10.1111/j.1471-4159.2006.03962.x	1471-4159	Journal of Neurochemistry	Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation - Ravni - 2006 - Journal of Neurochemistry - Wiley Online Library	Ravni	2006	0		
936	chr9	46112057	46112086	3500005734	25		46112057	46112086	8421504	2	14,11	0,18	c	350000573400000097	4-32						Apo-2 RECEPTOR	Adams	1998	0		
936	chr9	46112057	46112084	3500116257	23		46112057	46112084	8421504	2	14,9	0,18	c	350011625700000017	0-26						SAM-6 VARIANTS, TARGET AND METHODS OF USE - Patent application	www.faqs.org	0	0		
936	chr9	46112059	46112086	3500383088	23		46112059	46112086	8421504	2	12,11	0,16	c	350038308800000593	22-48						METHODS AND COMPOSITIONS FOR TREATING TUMOR DISEASES - Patent application	www.faqs.org	0	0		
936	chr9	46112059	46112086	3500194368	23		46112059	46112086	8421504	2	12,11	0,16	c	350019436800000118	22-48						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
937	chr9	46175833	46175857	3500436014	24		46175833	46175857	8421504	1	24	0	g	350043601400000005	11-35			10.1111/j.1742-4658.2007.05652.x	1742-4658	FEBS Journal	Molecular cloning and characterization of methylenedioxy bridge-forming enzymes involved in stylopine biosynthesis in Eschscholzia californica - Ikezawa - 2007 - FEBS Journal - Wiley Online Library	Ikezawa	2007	0		
937	chr9	46227729	46227754	3500308081	25		46227729	46227754	8421504	1	25	0	c	350030808100000002	11-36						ScienceDirect.com - Cell - GAPDH and Autophagy Preserve Survival after Apoptotic Cytochrome c Release in the Absence of Caspase Activation	sciencedirect.com	0	0		
937	chr9	46227738	46227762	3500339735	24		46227738	46227762	8421504	1	24	0	c	350033973500000000	0-24		19357194	10.1091/mbc.E08-11-1092	1059-1524	Molecular Biology of the Cell	Autophagic Elimination of Misfolded Procollagen Aggregates in the Endoplasmic Reticulum as a Means of Cell Protection	Ishida	2009	5		ATG5
937	chr9	46227738	46227762	3500136655	24		46227738	46227762	8421504	1	24	0	c	350013665500000000	0-24		19357194	10.1091/mbc.E08-11-1092		Molecular Biology of the Cell	Autophagic Elimination of Misfolded Procollagen Aggregates in the Endoplasmic Reticulum as a Means of Cell Protection	Yoshihito	June	0		ATG5
937	chr9	46241493	46241575	3500206756	44		46241493	46241575	8421504	2	24,20	0,62	c	350020675600000012,350020675600000004	0-24,0-20						Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK- dependent activation of autophagy	bisclinicians.org	0	0		ATG5
937	chr9	46241493	46241575	3500108753	44		46241493	46241575	8421504	2	24,20	0,62	c,g	350010875300000012,350010875300000004,350010875300000004	0-24,0-20,0-20		21475304	10.1038/cdd.2011.32	1350-9047	Cell Death & Differentiation	Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy	Vara	2011	9		ATG5
937	chr9	46241493	46241523	3500282174	30		46241493	46241523	8421504	1	30	0	c	350028217400000003	23-53		20705711	10.1681/ASN.2010030238	1046-6673	Journal of the American Society of Nephrology	Heme Oxygenase-1 Inhibits Renal Tubular Macroautophagy in Acute Kidney Injury	Bolisetty	2010	10		ATG5
937	chr9	46241493	46241523	3500250186	30		46241493	46241523	8421504	1	30	0	c	350025018600000003	23-53		20705711	10.1681/ASN.2010030238		Journal of the American Society of Nephrology : JASN	Heme Oxygenase-1 Inhibits Renal Tubular Macroautophagy in Acute Kidney Injury	Subhashini	2010	0		ATG5
937	chr9	46241555	46259666	3500439225	53		46241555	46259666	8421504	3	26,25,2	0,9739,18109	c	350043922500000002,350043922500000003	0-26,0-27						Sulfabenzamide promotes autophagic cell death in T-47D breast cancer cells through p53/ DRAM pathway	jcmb.halic.edu.tr	0	0		
937	chr9	46241555	46259666	3500049854	53		46241555	46259666	8421504	3	26,25,2	0,9739,18109	c	350004985400000010,350004985400000011	0-26,0-27						Journal of Cell and Molecular Biology	jcmb.halic.edu.tr	0	0		ATG5
117	chr9	46259739	46334520	3500333344	435		46259739	46334520	8421504	4	88,95,118,134	0,29610,58418,74647	p	350033334400015004	0-435						COMPOSITIONS AND METHODS FOR MODULATING AUTOPHAGY	Gottlieb	2011	0		ATG5
938	chr9	46335093	46335118	3500181589	25		46335093	46335118	8421504	1	25	0	c,g	350018158900000001,350018158900000000,350018158900000000	0-19,0-19,0-19						JBC Papers in Press. Published on June 10, 2013 as Manuscript M113.477505 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M113.477505	www.jbc.org	0	0		ATG5
938	chr9	46335095	46335118	3500344333	23		46335095	46335118	8421504	1	23	0	c	350034433300000001	3-26						Signal Transduction: Epigallocatechin Gallate (EGCG) Stimulates Autophagy in Vascular Endothelial Cells: A POTENTIAL ROLE FOR REDUCING LIPID ACCUMULATION Hae-Suk Kim, Vedrana Montana, Hyun-Ju	.si.mahidol.ac.th	0	0		ATG5
945	chr9	47293731	47311237	3500385222	705		47293731	47311237	8421504	5	86,95,132,157,235	0,1123,4436,13476,17271	p	350038522200015003,350038522200015007,350038522200015011,350038522200015015	0-174,0-180,0-171,0-180						Doktori &#xe9;rtekez&#xe9;s	www.enzim.hu	0	0		PREP
945	chr9	47311273	47311297	3500104732	24		47311273	47311297	8421504	1	24	0	c	350010473200000002	0-24		10747969	10.1074/jbc.M000942200	0021-9258	Journal of Biological Chemistry	The Noncatalytic &#x03b2;-Propeller Domain of Prolyl Oligopeptidase Enhances the Catalytic Capability of the Peptidase Domain	Szeltner	2000	5		
948	chr9	47591910	47591936	3500101538	23		47591910	47591936	8421504	3	12,6,5	0,13,21	g	350010153800001686	0-24						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
954	chr9	48390683	48390710	3500368243	23		48390683	48390710	8421504	2	7,16	0,11	g	350036824300000019	2-25						MULTI-PRIMER ASSAY FOR MYCOPLASMA DETECTION - Patent application	www.faqs.org	0	0		
969	chr9	50420617	50459783	3500338459	288		50420617	50459783	8421504	3	162,30,96	0,15865,39070	c	350033845900000193,350033845900000192,350033845900000191,350033845900000190,350033845900000183,350033845900000182	0-48,0-48,0-48,0-48,0-48,0-48						Glutamate receptor (or EAA receptor) polynucleotides and their uses	Kamboj	1996	0		
969	chr9	50420617	50420662	3500174049	45		50420617	50420662	8421504	1	45	0	p	350017404900015005	0-45						Drug Addiction	edc.fums.ac.ir	0	0		GRIK2
121	chr9	50420776	51153173	3500179259	2565		50420776	51153173	8421504	16	3,251,226,218,119,224,207,114,108,144,174,54,182,258,168,115	0,15706,38844,120646,124471,157624,210594,241986,261387,265326,381293,385447,393200,445360,449507,732282	p	350017925900015000	0-2565						KEGG T01001: 2898	www.genome.jp	0	0		GRIK2
970	chr9	50541503	50578576	3500338459	144		50541503	50578576	8421504	2	96,48	0,37025	c	350033845900000178,350033845900000177,350033845900000170	0-48,0-48,0-48						Glutamate receptor (or EAA receptor) polynucleotides and their uses	Kamboj	1996	0		
970	chr9	50545324	50545349	3500383106	25		50545324	50545349	8421504	1	25	0	c	350038310600000002	0-25						Neuron Neurotechnique	p.uni-muenchen.de	0	0		
970	chr9	50545324	50545349	3500336658	25		50545324	50545349	8421504	1	25	0	c,g	350033665800000001,350033665800000001	0-25,0-25						ScienceDirect.com - Neuron - Remote Control of Neuronal Activity with a Light-Gated Glutamate Receptor	sciencedirect.com	0	0		
121	chr9	50631466	50814087	3500338459	288		50631466	50814087	8421504	6	48,48,45,51,48,48	0,31329,54735,170603,170702,182573	c	350033845900000166,350033845900000163,350033845900000157,350033845900000156,350033845900000154,350033845900000150	0-48,0-48,0-48,0-48,0-48,0-48						Glutamate receptor (or EAA receptor) polynucleotides and their uses	Kamboj	1996	0		
972	chr9	50814030	50814055	3500106719	24		50814030	50814055	8421504	2	6,18	0,7	c	350010671900000131	0-24						Optimizing Expression of Active Botulinum Toxin Type E - Patent application	www.faqs.org	0	0		
979	chr9	51665187	51681753	3500022398	23		51665187	51681753	8421504	3	5,2,16	0,16546,16550	c	350002239800000395	21-45						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
981	chr9	52006861	52006886	3500104668	23		52006861	52006886	8421504	2	11,12	0,13	g	350010466800000002	0-23		21103216	10.1007/s11302-010-9180-0		Purinergic Signalling	Proline residues link the active site to transmembrane domain movements in human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3)	Keith	2010	0		
982	chr9	52077680	52077706	3500241536	23		52077680	52077706	8421504	2	10,13	0,13	g	350024153600000015	11-34						Luciferase biosensor	Fan	2011	0		
982	chr9	52127543	52127746	3500361666	43		52127543	52127746	8421504	2	23,20	0,183	g	350036166600000236,350036166600000047,350036166600000237	0-23,0-20,0-20						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
984	chr9	52374765	52374788	3500158476	23		52374765	52374788	8421504	1	23	0	g	350015847600000003	9-32						Animal model for protease activity and liver damage	Kalkeri	2005	0		
988	chr9	52873934	52891745	3500299877	759		52873934	52891745	8421504	12	55,85,70,52,56,36,66,20,68,80,119,52	0,863,1137,3223,8751,9542,10285,10357,11042,15051,16200,17759	p	350029987700015061,350029987700015067,350029987700015074,350029987700015075,350029987700015082,350029987700015088	0-174,0-180,0-66,0-81,0-99,0-159						Molecular cloning and characterization of an E-type CDK and its interacting cyclin from	u.lib.ncku.edu.tw	0	0		CCNC
994	chr9	53677641	53686943	3500376741	95		53677641	53686943	8421504	4	12,24,34,25	0,9204,9229,9277	c,g	350037674100000011,350037674100000010,350037674100000010,350037674100000013	0-36,0-34,0-34,13-38					Patent	F-box genes and proteins (Patent US:6573094)	Harper	2003	0		
995	chr9	53758412	53758437	3500354736	25		53758412	53758437	8421504	1	25	0	c	350035473600000000	0-25		22290434	10.1128/MCB.06257-11		Molecular and Cellular Biology	Phosphorylation of BRN2 Modulates Its Interaction with the Pax3 Promoter To Control Melanocyte Migration and Proliferation	Irina	2012	0		POU3F2
995	chr9	53758524	53758547	3500312535	23		53758524	53758547	8421504	1	23	0	c	350031253500000012,350031253500000011	0-23,21-44		21697476	10.1128/JVI.00569-11		Journal of Virology	Cellular Transcription Factor Oct-1 Interacts with the Epstein-Barr Virus BRLF1 Protein To Promote Disruption of Viral Latency	Amanda	2011	0		POU3F2
995	chr9	53758563	53758614	3500130897	40		53758563	53758614	8421504	2	20,20	0,31	c,g	350013089700000015,350013089700000015,350013089700000014	0-20,0-20,0-20						Identification of a new inhibitor of Schwann cell differentiation	ni-duesseldorf.de	0	0		
996	chr9	53945298	53945322	3500237781	23		53945298	53945322	8421504	2	6,17	0,7	g	350023778100000375	14-40					Patent	Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer. (Patent EP:1296714)	Hartmann	2009	0		
996	chr9	53945298	53945322	3500237369	23		53945298	53945322	8421504	2	6,17	0,7	g	350023736900000379	14-40						Methods for enhancing antibody-induced cell lysis and treating cancer	Weiner	2001	0		
999	chr9	54322622	54322647	3500277012	24		54322622	54322647	8421504	2	19,5	0,20	g	350027701200000108	4-28						Vectors and yeast strains for protein production	Bobrowicz	2010	0		
1009	chr9	55619260	55619291	3500158245	27		55619260	55619291	8421504	4	6,5,4,12	0,8,14,19	g	350015824500000103	4-31						METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION - Patent application	www.faqs.org	0	0		
1010	chr9	55836249	55836276	3500057401	24		55836249	55836276	8421504	2	11,13	0,14	g	350005740100000009	0-24		19244107	10.1158/0008-5472.CAN-08-3795	0008-5472	Cancer Research	A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion&#x2013;Resistant Growth	Guo	2009	8		
1013	chr9	56172025	56172052	3500150324	23		56172025	56172052	8421504	3	12,6,5	0,14,22	g	350015032400000006	0-23						DIETARY DIVALENT METAL UPTAKE AND INTERACTIONS IN FRESHWATER FISH: IMPLICATIONS FOR METAL TOXICITY A Thesis Submitted to the College of For the Degree of Doctor of Philosophy In the Toxicology Graduate Program University of Saskatchewan Saskatoon By Raymo	ecommons.usask.ca	0	0		
1022	chr9	57280229	57310582	3500036341	113		57280229	57310582	8421504	3	30,48,35	0,240,30318	c	350003634100000041,350003634100000036,350003634100000026	18-48,0-48,3-38						Endomannosidases in the modification of glycoproteins in eukaryotes - Patent application	www.faqs.org	0	0		
1038	chr9	59445940	59457332	3500282773	40		59445940	59457332	8421504	4	19,5,11,5	0,11367,11375,11387	g	350028277300000420,350028277300000135,350028277300000443,350028277300000158	4-23,4-23,6-27,6-27						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT - Patent application	www.faqs.org	0	0		
1038	chr9	59478972	59478999	3500010118	23		59478972	59478999	8421504	2	7,16	0,11	g	350001011800000020	19-42			10.1186/gb-2013-14-2-r13	1465-6906	Genome Biology	Pervasive and dynamic protein binding sites of the mRNA transcriptome in Saccharomyces cerevisiae	Freeberg	2013	0		
1038	chr9	59478972	59478999	3500003710	23		59478972	59478999	8421504	2	7,16	0,11	g	350000371000000028,350000371000000030	19-42,19-42						MicroRNAs in Development - Methods and Protocols	www.scribd.com	0	0		
1041	chr9	59822954	59884811	3500330320	291		59822954	59884811	8421504	3	153,103,35	0,471,61822	p	350033032000015026,350033032000015035	0-153,0-138						Structure, Function & Control of the EphA3 Receptor Tyrosine Kinase	.swinburne.edu.au	0	0		EPHA7
1044	chr9	60242387	60242414	3500421823	25		60242387	60242414	8421504	3	15,5,5	0,16,22	g	350042182300000029,350042182300000088	8-35,8-35						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX - Patent application	www.faqs.org	0	0		
1044	chr9	60242387	60242414	3500243302	25		60242387	60242414	8421504	3	15,5,5	0,16,22	g	350024330200000019,350024330200000043	8-35,8-35						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX - Patent application	www.faqs.org	0	0		
1044	chr9	60242387	60242414	3500022158	25		60242387	60242414	8421504	3	15,5,5	0,16,22	g	350002215800000019	8-35						SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING CDCA1-KNTC2 COMPLEX	Nakamura	2006	0		
1051	chr9	61154511	61154537	3500245637	26		61154511	61154537	8421504	1	26	0	g	350024563700000019	6-32						Dna encoding prost 07 polypeptide	Bringmann	2001	0		
1051	chr9	61154511	61154537	3500132776	26		61154511	61154537	8421504	1	26	0	g	350013277600000019	6-32						Dna encoding prost 07 polypeptide	Bringmann	2002	0		
1051	chr9	61154511	61154536	3500417794	25		61154511	61154536	8421504	1	25	0	g	350041779400000001	6-31		20398264	10.1186/1744-8069-6-20		Molecular Pain	Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation	NathaniA	2010	0		
1051	chr9	61154511	61154536	3500013895	25		61154511	61154536	8421504	1	25	0	g	350001389500000001	6-31		20398264	10.1186/1744-8069-6-20	1744-8069	Molecular Pain	Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation	Sowa	2010	4		
1054	chr9	61478281	61478311	3500038561	26		61478281	61478311	8421504	3	6,8,12	0,7,18	g	350003856100000001,350003856100000003	0-32,2-22						Engineering Fc Antibody Regions to Confer Effector Function - Patent application	www.faqs.org	0	0		
1058	chr9	62104744	62104772	3500104698	23		62104744	62104772	8421504	2	10,13	0,15	g	350010469800000033	4-28						MN Gene and Protein - Patent application	www.faqs.org	0	0		
1061	chr9	62505680	62505710	3500435354	26		62505680	62505710	8421504	2	19,7	0,23	g	350043535400000071	13-42						Novel Wheat Allergens - Patent application	www.faqs.org	0	0		
1064	chr9	62834117	62834142	3500277969	23		62834117	62834142	8421504	2	6,17	0,8	g	350027796900000004,350027796900000005	1-24,4-27						Essential Role of Interferon Regulatory Factor 3 in Direct Activation of RANTES Chemokine Transcription	mcb.asm.org	0	0		
1064	chr9	62837000	62845127	3500278664	40		62837000	62845127	8421504	2	20,20	0,8107	c	350027866400000000,350027866400000001	0-20,0-20		16498455	10.1038/sj.cdd.4401882	1350-9047	Cell Death & Differentiation	Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-&#x03ba;B transactivation by RANKL	Huang	2006	9		
1064	chr9	62842481	62845117	3500446711	40		62842481	62845117	8421504	2	20,20	0,2616	c	350044671100000012,350044671100000013	0-20,0-20		17982039		0022-1767	The Journal of Immunology	Requirement for Both JAK-Mediated PI3K Signaling and ACT1/TRAF6/TAK1-Dependent NF-&#x03ba;B Activation by IL-17A in Enhancing Cytokine Expression in Human Airway Epithelial Cells	Huang	2007	6		MAP3K7
1064	chr9	62845519	62845545	3500065320	24		62845519	62845545	8421504	2	11,13	0,13	c	350006532000000027	9-33						Studies Enabling a Faster Directed Evolution	uhr-uni-bochum.de	0	0		
1064	chr9	62846104	62846132	3500416917	24		62846104	62846132	8421504	2	9,15	0,13	c	350041691700000024	13-37		17909011	10.1158/0008-5472.CAN-07-1146	0008-5472	Cancer Research	Cisplatin Depletes TREX2 and Causes Robertsonian Translocations as Seen in TREX2 Knockout Cells	Chen	2007	8		
1064	chr9	62905875	62905898	3500330329	23		62905875	62905898	8421504	1	23	0	g	350033032900000020	0-23						Direct Control of Cell Cycle Gene Expression by Proto-Oncogene Product ACTR, and Its Autoregulation Underlies Its Transforming Activity	mcb.asm.org	0	0		
1068	chr9	63404411	63404438	3500266395	26		63404411	63404438	8421504	2	8,18	0,9	g	350026639500000002	0-26						Hypoxia-related human genes, proteins, and uses thereof	Denko	2001	0		
1070	chr9	63598778	63599558	3500246430	23		63598778	63599558	8421504	2	13,10	0,770	c	350024643000000000	0-23						CEN 551	lcs3.syr.edu	0	0		
1070	chr9	63598778	63599558	3500229769	23		63598778	63599558	8421504	2	13,10	0,770	c	350022976900000001	0-23						CEN 551: Biochemical Engineering Instructor: Dr. Christine Kelly	ww.slideshare.net	0	0		
1070	chr9	63627420	63628139	3500007194	23		63627420	63628139	8421504	4	1,12,5,5	0,694,708,714	c	350000719400000459	23-48						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1073	chr9	64043043	64043072	3500395481	25		64043043	64043072	8421504	3	5,8,12	0,7,17	c	350039548100000146	14-39						Apparatus and method for detecting and identifying infectious agents - Patent # 6649356 - PatentGenius	.patentgenius.com	0	0		
1077	chr9	64577287	64579634	3500325072	60		64577287	64579634	8421504	2	53,7	0,2340	p	350032507200015077	0-60						Subolesin/akirin orthologs from Ornithodoros spp soft ticks: cloning, RNAi gene silencing and protective effect of the recombinant proteins.	digital.csic.es	0	0		AKIRIN2
1078	chr9	64704789	64704815	3500199858	26		64704789	64704815	8421504	1	26	0	c	350019985800000001	0-26						Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP&#x2013;sialic acid transporter	tologylibrary.org	0	0		
1078	chr9	64707266	64732094	3500160351	450		64707266	64732094	8421504	12	45,45,17,28,45,45,45,30,15,45,45,45	0,48,96,601,680,728,8302,8350,8556,8574,8622,24783	p	350016035100015175,350016035100015174,350016035100015173,350016035100015171,350016035100015170,350016035100015166,350016035100015165,350016035100015164,350016035100015163,350016035100015159	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						METHOD FOR PREPARING RECOMBINANT GLYCOPROTEINS WITH HIGH SIALIC ACID CONTENT - Patent application	www.faqs.org	0	0		
1080	chr9	64900014	64900037	3500389224	23		64900014	64900037	8421504	1	23	0	g	350038922400000005	4-34						CTCF-dependent enhancer blockers at the upstream region of the chicken -globin gene domain--&#x300a;&#x6838;&#x9178;&#x7814;&#x7a76;&#x533b;&#x5b66;&#x671f;&#x520a;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66	journal.9med.net	0	0		
1080	chr9	64930522	64930575	3500067631	30		64930522	64930575	8421504	2	11,19	0,34	c	350006763100000007	21-51						Chapter 1	ology.ualberta.ca	0	0		
1080	chr9	64950117	64950140	3500137760	23		64950117	64950140	8421504	1	23	0	c	350013776000000025	5-28						A novel voltage-gated potassium channel gene	Chandy	1995	0		
1081	chr9	65093576	65093601	3500378828	25		65093576	65093601	8421504	1	25	0	c	350037882800000001	17-42						HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY	Low	2006	0		
1081	chr9	65093576	65093601	3500089804	25		65093576	65093601	8421504	1	25	0	c	350008980400000002	17-42						Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility	Low	2005	0		
1081	chr9	65093576	65093600	3500128145	24		65093576	65093600	8421504	1	24	0	c	350012814500000000	7-31						Use of human cells of myeloid leukaemia origin for expression of antibodies	filed	2012	0		CGA
1081	chr9	65093576	65093600	3500040479	24		65093576	65093600	8421504	1	24	0	c	350004047900000000	7-31						Use of human cells of myeloid leukaemia origin for expression of antibodies	Goletz	2010	0		CGA
1081	chr9	65093580	65093605	3500404264	25		65093580	65093605	8421504	1	25	0	c	350040426400000017	0-25					Patent	Gene manipulation and expression using genomic elements (Patent US:5578461)	Klapholz	1996	0		CGA
1081	chr9	65093580	65093605	3500141950	25		65093580	65093605	8421504	1	25	0	c	350014195000000017	0-25						US Patent # 5,578,461. Gene manipulation and expression using genomic elements - Patents.com	www.patents.com	0	0		CGA
1081	chr9	65093649	65095663	3500140642	292		65093649	65095663	8421504	3	29,185,78	0,1124,1936	p,c,g	350014064200000006,350014064200000006,350014064200000008,350014064200015011,350014064200000013,350014064200000013,350014064200015003,350014064200015007,350014064200015008,350014064200015004,350014064200000009,350014064200000009,350014064200000016,350014064200000016,350014064200000017,350014064200000018,350014064200000007,350014064200000007,350014064200000010,350014064200000010,350014064200015005,350014064200000019,350014064200000019,350014064200000011,350014064200015006,350014064200000022,350014064200000024,350014064200015015,350014064200015012,350014064200000012,350014064200000012,350014064200000027,350014064200000025,350014064200000025,350014064200000005,350014064200000004	5-73,5-73,8-60,0-210,0-60,0-60,9-60,66-354,0-210,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-221,0-221,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-60,0-78,0-78,0-60,0-60,0-51,0-51,0-51,12-33,14-34						SEQ&#xdc;ENCIAMENTO E AN&#xc1;LISE DOS GENES DAS SUBUNIDADES ALFA E BETA DO HORM&#xd4;NIO FOL&#xcd;CULO ESTIMULANTE DE BOVINO Bos taurus indicus	epositorio.unb.br	0	0		
1081	chr9	65093650	65095666	3500025913	51		65093650	65095666	8421504	2	27,24	0,1992	c	350002591300000000,350002591300000001	13-40,10-34			10.1046/j.1432-1327.2001.02384.x	1432-1033	European Journal of Biochemistry	Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants - Dirnberger - 2001 - European Journal of Biochemistry - Wiley Online Library	Dirnberger	2001	0		
1081	chr9	65095626	65095654	3500347400	28		65095626	65095654	8421504	1	28	0	c	350034740000000228	20-48						Single-chain forms of the glycoprotein hormone quartet	Boime	1999	0		
1081	chr9	65095626	65095653	3500152492	23		65095626	65095653	8421504	3	5,4,14	0,8,13	c	350015249200000014	0-23						Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors	Liu	2004	0		CGA
1081	chr9	65095633	65095659	3500466993	26		65095633	65095659	8421504	1	26	0	c	350046699300000016	16-42						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1082	chr9	65163476	65164039	3500334303	59		65163476	65164039	8421504	2	35,24	0,539	c	350033430300000026,350033430300000015	0-35,0-24						Dna encoding a human 5-ht1e receptor and uses thereof	Branchek	1993	0		
1082	chr9	65208919	65208943	3500442697	23		65208919	65208943	8421504	2	8,15	0,9	g	350044269700000000	0-23						Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease - Vol. 6 No. 2 - April 2000 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
1082	chr9	65208919	65208943	3500086794	23		65208919	65208943	8421504	2	8,15	0,9	g	350008679400000000	0-23						Bacteroides fragilis Enterotoxin Gene Sequences: The Study	www.medscape.com	0	0		
1086	chr9	65748907	65748934	3500114655	25		65748907	65748934	8421504	3	7,12,6	0,8,21	g	350011465500000028	8-33						&#x5e7d;&#x95e8;&#x87ba;&#x6746;&#x83cc;&#x6d3b;&#x75ab;&#x82d7; Helicobacter pylori vaccine	T*F*Mai Ye 	2000	0		
1090	chr9	66214737	66214815	3500406027	78		66214737	66214815	8421504	1	78	0	p	350040602700015049	0-78						Polypeptide producing cells	Endl	2013	0		
1090	chr9	66214737	66214815	3500025885	78		66214737	66214815	8421504	1	78	0	p	350002588500015048	0-78						Polypeptide producing cells	Endl	2009	0		
1090	chr9	66214770	66214833	3500291458	63		66214770	66214833	8421504	1	63	0	p	350029145800015000	0-63						BMC Genomics BioMed Central	biomedcentral.com	0	0		
1090	chr9	66218371	66218461	3500365673	40		66218371	66218461	8421504	2	20,20	0,70	c,g	350036567300000017,350036567300000016,350036567300000016	0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
1090	chr9	66218371	66218461	3500262357	40		66218371	66218461	8421504	2	20,20	0,70	c,g	350026235700000017,350026235700000017,350026235700000016,350026235700000016	0-20,0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
1090	chr9	66220206	66221422	3500153648	40		66220206	66221422	8421504	2	20,20	0,1196	c,g	350015364800000015,350015364800000014,350015364800000014	0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
1090	chr9	66225138	66243321	3500101498	23		66225138	66243321	8421504	2	20,3	0,18180	c	350010149800000021,350010149800000105	0-23,0-23						MESOANGIOBLAST-LIKE CELL AS WELL AS METHODS AND USES RELATING THERETO - Patent application	www.faqs.org	0	0		
1090	chr9	66248799	66248824	3500017696	25		66248799	66248824	8421504	1	25	0	c	350001769600000006	0-25						Equine Veterinary Journal ISSN 0425-1644 DOI: 10.1111/j.2042-3306.2010.00353.x Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells	library.hverf.org	0	0		
1091	chr9	66331780	66331806	3500154550	23		66331780	66331806	8421504	3	12,5,6	0,14,20	g	350015455000000045	8-32					Patent	Process for immobilizing nucleic acid probes on polystyrene surfaces (Patent US:5712383)	Chang	1998	0		
1091	chr9	66449561	66449586	3500217167	23		66449561	66449586	8421504	2	7,16	0,9	g	350021716700000051	1-24		21902733	10.1111/j.1365-2958.2011.07806.x	1365-2958	Molecular Microbiology	Dysregulation of serine biosynthesis contributes to the growth defect of a Mycobacterium tuberculosis crp mutant - Bai - 2011 - Molecular Microbiology - Wiley Online Library	Bai	2011	0		
1092	chr9	66467603	66467629	3500318788	23		66467603	66467629	8421504	3	5,12,6	0,6,20	g	350031878800000485	5-28						Nematode Control 	.freshpatents.com	0	0		
1093	chr9	66647257	66647282	3500347464	25		66647257	66647282	8421504	1	25	0	g	350034746400000016	0-26						Infectious cDNA of North American Porcine Reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof	Calvert	2009	0		
1093	chr9	66647257	66647282	3500057018	25		66647257	66647282	8421504	1	25	0	g	350005701800000015	0-26					Patent	Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof (Patent US:7232680)	Calvert	2007	0		
1095	chr9	66936837	66936865	3500042094	23		66936837	66936865	8421504	2	13,10	0,18	c	350004209400000008	19-42						Expression of Circadian Rhythm Genes in Gonadotropin- Releasing Hormone-Secreting GT1-7 Neurons	.endojournals.org	0	0		
1095	chr9	66948702	66959724	3500388628	99		66948702	66959724	8421504	3	15,65,19	0,4343,11003	p	350038862800015086,350038862800015088	0-63,0-72						123 human secreted proteins	Brewer	1999	0		
1095	chr9	66948702	66959724	3500163563	99		66948702	66959724	8421504	3	15,65,19	0,4343,11003	p	350016356300015086,350016356300015088	0-63,0-72						123 human secreted proteins	Brewer	2000	0		
1097	chr9	67187348	67187374	3500114897	23		67187348	67187374	8421504	2	16,7	0,19	g	350011489700000171	7-31						COLLAGEN PRODUCING PLANTS AND METHODS OF GENERATING AND USING SAME - Patent application	www.faqs.org	0	0		
1098	chr9	67359571	67359597	3500287953	23		67359571	67359597	8421504	2	17,6	0,20	g	350028795300000509,350028795300000603	17-40,5-28						Method For Increasing Pathogen Resistance In Transgenic Plants - Patent application	www.faqs.org	0	0		
1104	chr9	68087612	68087641	3500309840	25		68087612	68087641	8421504	3	9,12,4	0,12,25	g	350030984000000062	0-39						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		
1105	chr9	68186761	68186789	3500435926	26		68186761	68186789	8421504	2	17,9	0,19	g	350043592600000022	4-30						A Dissertation Presented to the Faculty of the Graduate School of Cornell University in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Melinda Anne Klein January 2007	mmons.cornell.edu	0	0		
1106	chr9	68410243	68410288	3500205676	45		68410243	68410288	8421504	1	45	0	p	350020567600015001	0-45						Receptor-type phosphotyrosine phosphatase-kappa antibodies	Schlessinger	2001	0		PTPRK
1107	chr9	68461628	68461654	3500465169	24		68461628	68461654	8421504	2	9,15	0,11	g	350046516900000433	21-45						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
1107	chr9	68461628	68461654	3500092685	24		68461628	68461654	8421504	2	9,15	0,11	g	350009268500000433	21-45						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
138	chr9	68620513	68993375	3500355085	1152		68620513	68993375	8421504	7	293,175,116,82,272,123,91	0,33179,54910,57536,143485,230737,372771	p	350035508500015016	9-1161						R-SPONDIN TRANSLOCATIONS AND METHODS USING THE SAME - Patent application	www.faqs.org	0	0		
1111	chr9	68960626	68960651	3500361066	25		68960626	68960651	8421504	1	25	0	g	350036106600000601	15-40						Caev-based Vector Systems 	.freshpatents.com	0	0		
1117	chr9	69784288	69784314	3500309540	24		69784288	69784314	8421504	2	13,11	0,15	g	350030954000000100	0-24						BACTERIAL MEDIATED TNF-&#x03b1; GENE SILENCING	Fruehauf	2008	0		
1118	chr9	69907193	69907216	3500114630	23		69907193	69907216	8421504	1	23	0	g	350011463000000164	12-35						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
1119	chr9	70049398	70049427	3500114630	29		70049398	70049427	8421504	1	29	0	g	350011463000000211	0-29						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
1119	chr9	70122312	70122338	3500114630	26		70122312	70122338	8421504	1	26	0	g	350011463000000266	0-26						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
1124	chr9	70727369	70727396	3500232871	23		70727369	70727396	8421504	3	12,4,7	0,13,20	g	350023287100000001	4-28						Carbonyl reductase, gene thereof and method of using the same	Kizaki	2005	0		
1126	chr9	70925348	70942735	3500462501	42		70925348	70942735	8421504	4	7,12,18,5	0,11,17361,17382	g	350046250100000120,350046250100000125	14-33,20-45						FAKULT&#xc4;T F&#xdc;R CHEMIE UND HARMAZIE	b.uni-muenchen.de	0	0		
1129	chr9	71329250	71329280	3500255296	26		71329250	71329280	8421504	3	5,15,6	0,7,24	g	350025529600000016	0-26						Universit&#xe9; Bordeaux 1	mm.u-bordeaux1.fr	0	0		
1132	chr9	71706745	71706773	3500034780	23		71706745	71706773	8421504	2	6,17	0,11	g	350003478000000000	4-27						Microsatellite-based characterization of southern African domestic pig Sus scrofa domestica) breeds	ul.netd.ac.za	0	0		
1134	chr9	72025393	72040786	3500254728	609		72025393	72040786	8421504	6	57,73,175,160,18,126	0,4640,8492,10508,11495,15267	p	350025472800015016,350025472800015021,350025472800015026,350025472800015041	0-123,0-180,0-180,0-126						PROJETO DE PESQUISA	itorio.bce.unb.br	0	0		
1134	chr9	72030072	72040245	3500079460	189		72030072	72040245	8421504	8	34,13,24,25,16,29,41,7	0,3813,5847,6886,9848,9870,9912,10166	c	350007946000000010,350007946000000007,350007946000000002,350007946000000019,350007946000000020,350007946000000021	0-47,0-24,0-24,7-48,6-35,0-48						Pharmaceutical Preparation and Method of Treatment of Human Malignancies with Arginine Deprivation - Patent application	www.faqs.org	0	0		
1134	chr9	72034052	72035996	3500261436	40		72034052	72035996	8421504	3	8,11,21	0,1849,1923	c,g	350026143600000021,350026143600000022,350026143600000022	0-19,0-21,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1134	chr9	72035919	72035943	3500459833	24		72035919	72035943	8421504	1	24	0	c	350045983300000002,350045983300000008	0-24,0-24						PHARMACEUTICAL PREPARATION AND METHOD OF TREATMENT OF HUMAN MALIGNANCIES WITH ARGININE DEPRIVATION	Cheng	2003	0		
1134	chr9	72035919	72035943	3500143544	24		72035919	72035943	8421504	1	24	0	c	350014354400000002	0-24						Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies - Patent application	www.faqs.org	0	0		
1134	chr9	72036097	72036126	3500038534	23		72036097	72036126	8421504	3	7,5,11	0,11,18	g	350003853400000005	3-26						Cab molecules	Fox	2005	0		
1134	chr9	72036931	72040870	3500098866	542		72036931	72040870	8421504	4	52,105,137,248	0,2989,3307,3691	c,g	350009886600000087,350009886600000087	1-543,1-543						Protection against herbivores - Patent application	www.faqs.org	0	0		
1134	chr9	72036931	72040870	3500089708	542		72036931	72040870	8421504	4	52,105,137,248	0,2989,3307,3691	c,g	350008970800000089,350008970800000089	1-543,1-543						Protection against herbivores	Chen	2006	0		
1134	chr9	72057262	72057286	3500018630	23		72057262	72057286	8421504	2	14,9	0,15	c	350001863000000034	1-25						Method and materials for detecting Legionella pneumophila - Patent # 5935782 - PatentGenius	.patentgenius.com	0	0		
1136	chr9	72289057	72320973	3500045770	215		72289057	72320973	8421504	7	23,48,11,37,19,29,48	0,2036,10111,10426,18519,20691,31868	c	350004577000000038,350004577000000041,350004577000000050,350004577000000063,350004577000000084	0-23,0-48,0-48,0-48,0-48						US Patent # 6,465,185. Polymorphic human PC-1 sequences associated with insulin resistance - Patents.com	www.patents.com	0	0		
1136	chr9	72301795	72303020	3500115411	28		72301795	72303020	8421504	2	9,19	0,1206	c	350011541100000035,350011541100000011,350011541100000026	0-20,0-22,0-19						Method for detecting ovarian cancer and method for suppressing the same - Patent application	www.faqs.org	0	0		ENPP1
1137	chr9	72421099	72421122	3500086827	23		72421099	72421122	8421504	1	23	0	c,g	350008682700000003,350008682700000003	0-23,0-23		23555635	10.1371/journal.pone.0059226		PLoS ONE	Cartilage&#x2013;Specific Over-Expression of CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Stimulates Insulin-Like Growth Factor Expression and Bone Growth	Nao	2013	0		CTGF
1137	chr9	72421253	72424067	3500394511	166		72421253	72424067	8421504	6	20,48,25,48,2,23	0,1083,1380,1554,2674,2791	c,g	350039451100000285,350039451100000073,350039451100000204,350039451100000342,350039451100000130,350039451100000129,350039451100000341,350039451100000202,350039451100000159	0-20,0-20,0-48,0-19,0-19,0-20,0-20,0-48,1-26						ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF - Patent application	www.faqs.org	0	0		
1137	chr9	72421681	72421910	3500344693	42		72421681	72421910	8421504	2	20,22	0,207	c,g	350034469300000003,350034469300000003,350034469300000002	0-20,0-20,0-22						Methods for inhibiting ocular processes	Hinton	2002	0		
1137	chr9	72421681	72421910	3500333202	42		72421681	72421910	8421504	2	20,22	0,207	c,g	350033320200000003,350033320200000003,350033320200000002,350033320200000002	0-20,0-20,0-22,0-22						Methods for inhibiting ocular processes	He	2003	0		
1137	chr9	72421681	72421910	3500023213	42		72421681	72421910	8421504	2	20,22	0,207	c,g	350002321300000003,350002321300000003,350002321300000002,350002321300000002	0-20,0-20,0-22,0-22		12963611	10.1001/archopht.121.9.1283	0003-9950	Archives of Ophthalmology	 JAMA Network | JAMA Ophthalmology | A Role for Connective Tissue Growth Factor in the Pathogenesis of Choroidal Neovascularization 	He	2003	4		
1137	chr9	72422133	72422812	3500275531	59		72422133	72422812	8421504	3	26,22,11	0,271,668	c	350027553100000023,350027553100000007	13-39,7-40						CCN2-interaction to CCN3 in chondrocytes	b.okayama-u.ac.jp	0	0		
1137	chr9	72422180	72422306	3500420956	77		72422180	72422306	8421504	2	48,29	0,97	c	350042095600000020,350042095600000018	0-48,18-47						Connective tissue growth factor(CTGF)	www.devileye.net	0	0		
1137	chr9	72422235	72422802	3500144261	40		72422235	72422802	8421504	3	20,19,1	0,172,566	c	350014426100000007,350014426100000006	0-20,0-20						Gene expression profiling of bovine in vitro adipogenesis using a cDNA microarray	iotechnology.info	0	0		
1137	chr9	72422277	72424067	3500010057	152		72422277	72424067	8421504	6	29,9,45,44,2,23	0,140,524,1026,1650,1767	c	350001005700000109,350001005700000106,350001005700000082,350001005700000098,350001005700000092	15-44,0-48,0-47,3-47,1-26						CYR61 COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		
1137	chr9	72422340	72422957	3500442593	40		72422340	72422957	8421504	2	20,20	0,597	c,g	350044259300000001,350044259300000001,350044259300000000	0-20,0-20,0-20						METHODS AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF RADIATION-INDUCED FIBROSIS	OH	2008	0		CTGF
1137	chr9	72422340	72422957	3500108820	40		72422340	72422957	8421504	2	20,20	0,597	c,g	350010882000000001,350010882000000001,350010882000000000	0-20,0-20,0-20						Methods And Compositions For Treatment Or Prevention Of Radiation-induced Fibrosis 	.freshpatents.com	0	0		CTGF
1137	chr9	72422340	72422957	3500023444	40		72422340	72422957	8421504	2	20,20	0,597	c,g	350002344400000009,350002344400000009,350002344400000001,350002344400000001,350002344400000000,350002344400000008	0-20,0-20,0-20,0-20,0-20,0-20						METHODS AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF RADIATION-INDUCED FIBROSIS - Patent application	www.faqs.org	0	0		CTGF
1137	chr9	72422351	72422393	3500166079	42		72422351	72422393	8421504	1	42	0	c	350016607900000025	0-42						 Connective Tissue Growth Factor 	www.docstoc.com	0	0		
1137	chr9	72422407	72422904	3500299308	45		72422407	72422904	8421504	3	19,4,22	0,394,475	c	350029930800000001,350029930800000002	0-23,0-22			10.1186/1471-2121-8-1		BMC Cell Biology	High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells	Xiaojing	2007	0		CTGF
1137	chr9	72422407	72422904	3500028141	45		72422407	72422904	8421504	3	19,4,22	0,394,475	c	350002814100000001,350002814100000002	0-23,0-22		17224075	10.1186/1471-2121-8-1	1471-2121	BMC Cell Biology	High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells	Liu	2007	3		CTGF
1137	chr9	72422880	72422904	3500437298	24		72422880	72422904	8421504	1	24	0	c	350043729800000000	0-24		23951098	10.1371/journal.pone.0071156		PLoS ONE	CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Has Anti-Aging Effects That Protect Articular Cartilage from Age-Related Degenerative Changes	Shinsuke	2013	0		CYR61
1137	chr9	72423209	72423278	3500364520	69		72423209	72423278	8421504	1	69	0	p	350036452000015001,350036452000015004	0-69,0-45						Connective tissue growth factor antibodies	Lin	2010	0		CTGF
1137	chr9	72423209	72423278	3500156203	69		72423209	72423278	8421504	1	69	0	p	350015620300015000,350015620300015003	3-72,0-45						Connective tissue growth factor antibodies	Lin	2011	0		CTGF
1137	chr9	72423212	72423257	3500151154	45		72423212	72423257	8421504	1	45	0	p	350015115400015002	0-45						Connective Tissues Growth Factor Antibodies 	.freshpatents.com	0	0		CTGF
1137	chr9	72423248	72423896	3500341867	90		72423248	72423896	8421504	2	45,45	0,603	p	350034186700015120,350034186700015118	0-45,0-45						Connective tissues growth factor antibodies - Patent application	www.faqs.org	0	0		
1137	chr9	72423248	72423896	3500137605	90		72423248	72423896	8421504	2	45,45	0,603	p	350013760500015120,350013760500015118	0-45,0-45						Connective tissue growth factor antibodies - Patent application	www.faqs.org	0	0		
1137	chr9	72424379	72424527	3500142657	44		72424379	72424527	8421504	2	24,20	0,128	g	350014265700000000,350014265700000001	0-24,0-20		21473864	10.1016/j.yexcr.2011.03.019		Experimental cell research	The Notch Ligand Delta-Like 1 Integrates Inputs from TGFBeta/Activin and Wnt Pathways	MichaBordonaro	June	0		
1140	chr9	72863300	72863326	3500150086	23		72863300	72863326	8421504	2	8,15	0,11	g	350015008600000014	9-32			10.1111/j.1574-6968.2002.tb11302.x	1574-6968	FEMS Microbiology Letters	Design and evaluation of oligonucleotide-microarray method for the detection of human intestinal bacteria in fecal samples - Wang - 2006 - FEMS Microbiology Letters - Wiley Online Library	Wang	2002	0		
1142	chr9	73091361	73091390	3500317620	28		73091361	73091390	8421504	2	16,12	0,17	c	350031762000000035	17-46						Nucleic acids encoding a biogenic amine receptor - US Patent 7381542 Description	ww.patentstorm.us	0	0		
1142	chr9	73091361	73091390	3500209051	28		73091361	73091390	8421504	2	16,12	0,17	c	350020905100000035	17-46						US Patent # 6,783,973. Mammalian catecholamine receptor genes and uses - Patents.com	www.patents.com	0	0		
1144	chr9	73363217	73363262	3500204494	45		73363217	73363262	8421504	1	45	0	p	350020449400015002	3-48					Patent	PON3 and uses thereof (Patent US:6573370)	Du	2003	0		VNN3
1145	chr9	73487030	73487243	3500049915	24		73487030	73487243	8421504	3	10,2,12	0,194,201	c	350004991500000072	13-44						Trehalose transporter gene and method of introducing trehalose into cells - Patent application	www.faqs.org	0	0		
1145	chr9	73487038	73488583	3500163889	41		73487038	73488583	8421504	4	2,20,8,11	0,186,295,1534	c	350016388900000006,350016388900000007	0-22,0-19						NeurobiologyofDisease ReelinDeficiencyandDisplacementofMatureNeurons,But NotNeurogenesis,UnderlietheFormationofGranuleCell DispersionintheEpilepticHippocampus	n.uni-freiburg.de	0	0		RPS12
1145	chr9	73487038	73488583	3500141547	41		73487038	73488583	8421504	4	2,20,8,11	0,186,295,1534	c	350014154700000006,350014154700000007	0-22,0-19		16641251	10.1523/JNEUROSCI.5516-05.2006	0270-6474	The Journal of Neuroscience	Reelin Deficiency and Displacement of Mature Neurons, But Not Neurogenesis, Underlie the Formation of Granule Cell Dispersion in the Epileptic Hippocampus	Heinrich	2006	7		
1145	chr9	73489136	73490281	3500072973	39		73489136	73490281	8421504	2	20,19	0,1126	c,g	350007297300000000,350007297300000000,350007297300000001	0-20,0-20,0-19		21371490	10.1016/j.steroids.2011.02.013		Steroids	Progesterone Inhibition of Voltage-Gated Calcium Channels is a Potential Neuroprotective Mechanism against Excitotoxicity	Jessie	2011	0		
1147	chr9	73774675	73774701	3500016169	23		73774675	73774701	8421504	2	12,11	0,15	g	350001616900000093	20-44						Novel Nucleic Acid Molecules Correlated With The Rhesus Weak D Phenotype 	.freshpatents.com	0	0		
1147	chr9	73791100	73791131	3500358458	24		73791100	73791131	8421504	3	5,13,6	0,8,25	g	350035845800000011	15-42						Research Article Open Access Modulation of the Intestinal Microbiota and Immune System of Farmed Sparus aurata by the Administration of the Yeast Debaryomyces hansenii L2 in Conjunction with Inulin	w.omicsonline.org	0	0		
1154	chr9	74637880	74637904	3500414453	24		74637880	74637904	8421504	1	24	0	c,g	350041445300000003,350041445300000003	0-24,0-24						&#x4e3b;&#x9898;&#xff1a;interstitial | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1154	chr9	74637880	74637904	3500187581	24		74637880	74637904	8421504	1	24	0	c,g	350018758100000003,350018758100000003	0-24,0-24						&#x4e3b;&#x9898;&#xff1a;Adult | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1154	chr9	74681770	74681796	3500403380	25		74681770	74681796	8421504	2	18,7	0,19	g	350040338000000012	3-28		9852042	10.1074/jbc.273.51.33915	0021-9258	Journal of Biological Chemistry	A Mutational Analysis of the Baculovirus Inhibitor of Apoptosis Op-IAP	Vucic	1998	5		
1155	chr9	74714387	74715859	3500100552	25		74714387	74715859	8421504	2	19,6	0,1466	c	350010055200000021	0-25						Methods and uses involving heme binding protein 1	Krug	2010	0		
1155	chr9	74724892	74725334	3500434170	44		74724892	74725334	8421504	2	22,22	0,420	c	350043417000000005,350043417000000007	0-22,0-22						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
1155	chr9	74793876	74793977	3500434170	41		74793876	74793977	8421504	2	22,19	0,82	c,g	350043417000000006,350043417000000006,350043417000000004,350043417000000004	0-22,0-22,0-19,0-19						Functional Analyse of GLUT1 and GLUT12 in Glucose Uptake in Goat Mammary Gland Epithelial Cells. - ResearchGate	.researchgate.net	0	0		
1155	chr9	74793888	74793911	3500439262	23		74793888	74793911	8421504	1	23	0	c,g	350043926200000000,350043926200000000	0-23,0-23						&#x4e3b;&#x9898;&#xff1a;Glucose | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
1156	chr9	74909145	74909171	3500270905	25		74909145	74909171	8421504	2	20,5	0,21	c	350027090500000009	0-25						Lu Ping Tan, Erwin Seinen, Gerben Duns, Debora de Jong, Ody C.M. Sibon, Sibrand Poppema, Bart-Jan Kroesen, Klaas Kok, Anke van den Berg. Submitted	tations.ub.rug.nl	0	0		
1156	chr9	74909246	74911146	3500399057	54		74909246	74911146	8421504	3	18,15,21	0,1422,1879	p	350039905700015007	0-54						Method for designing pdk1 modulators	ALESSI	2005	0		SGK2
1156	chr9	74911144	74911194	3500136055	49		74911144	74911194	8421504	2	25,24	0,26	c	350013605500000017,350013605500000006	0-25,0-24						Effects of Mineralocorticoid and Glucocorticoid Agonists on Gene and Protein Expression, Structural Maturation and Compliance in the Ovine Preterm Fetal Lung	ufdc.ufl.edu	0	0		
1156	chr9	74912463	74912934	3500005563	41		74912463	74912934	8421504	2	20,21	0,450	c	350000556300000037,350000556300000036	0-20,0-21						C/EBPbatthecoreoftheTGF bcytostaticresponseanditsevasionin metastatic breast cancer cells	yadda.icm.edu.pl	0	0		SGK1
1156	chr9	74912950	74913717	3500458666	180		74912950	74913717	8421504	3	28,76,76	0,470,691	p	350045866600015081,350045866600015085,350045866600015029,350045866600015042,350045866600015080,350045866600015084	0-180,0-105,0-180,0-132,0-168,0-51						DELIVERY SYSTEM AND CONJUGATES FOR COMPOUND DELIVERY VIA NATURALLY OCCURRING INTRACELLULAR TRANSPORT ROUTES - CENIX BIOSCIENCE GMBH	www.sumobrain.com	0	0		SGK1
1156	chr9	74912950	74913717	3500235911	180		74912950	74913717	8421504	3	28,76,76	0,470,691	p	350023591100015022,350023591100015035,350023591100015079,350023591100015075,350023591100015074,350023591100015078	0-180,0-132,0-105,0-180,0-168,0-51						Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes	Echeverri	2012	0		SGK1
1156	chr9	74912950	74913717	3500132878	180		74912950	74913717	8421504	3	28,76,76	0,470,691	p	350013287800015075,350013287800015079,350013287800015022,350013287800015035,350013287800015074,350013287800015078	0-180,0-105,0-180,0-132,0-168,0-51						Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes	Echeverri	2011	0		SGK1
1156	chr9	74912950	74913717	3500085619	180		74912950	74913717	8421504	3	28,76,76	0,470,691	p	350008561900015080,350008561900015041,350008561900015027,350008561900015079,350008561900015083	0-180,0-132,0-180,0-180,0-51						Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes	Echeverri	2012	0		
1160	chr9	75431432	75431456	3500401303	23		75431432	75431456	8421504	2	10,13	0,11	g	350040130300000000	9-32						Process of making human nerve growth factor	Chan	1989	0		
1161	chr9	75581362	75597871	3500448333	1140		75581362	75597871	8421504	6	450,42,111,255,129,153	0,7310,7361,9426,14600,16356	p	350044833300015000	0-1146						 PigGIS&#x2192;GeneSnapshot&#x2192;ENST00000265605&#x2192;all	g.genomics.org.cn	0	0		
1161	chr9	75588643	75605583	3500165278	127		75588643	75605583	8421504	6	21,21,20,24,20,21	0,2138,2303,7428,9090,16919	c,g	350016527800000114,350016527800000110,350016527800000109,350016527800000109,350016527800000017,350016527800000106,350016527800000012	0-21,0-21,0-20,0-20,0-24,0-20,23-44						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
1162	chr9	75634194	75635206	3500084617	103		75634194	75635206	8421504	2	52,51	0,961	c	350008461700000066,350008461700000065,350008461700000064	0-103,0-21,0-21						POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - Patent application	www.faqs.org	0	0		HBS1L
1163	chr9	75826172	75830637	3500174960	96		75826172	75830637	8421504	2	23,73	0,4392	p	350017496000015002	0-96						&#x25a1;&#x4e2d;&#x6838;&#x6a5f;&#x95a2;&#xff08;&#x25a1;&#x4ee3;&#x8868;&#x6a5f;&#x95a2;&#xff0f;&#x25a1;&#x53c2;&#x753b;&#x6a5f;&#x95a2;&#xff09;	encedb.mext.go.jp	0	0		MYB
1163	chr9	75834328	75834421	3500196738	90		75834328	75834421	8421504	2	45,45	0,48	p	350019673800015068,350019673800015066	0-45,0-45						Methods and compositions for regulating cell cycle progression	Bernstein	2001	0		MYB
1163	chr9	75834337	75836221	3500252203	42		75834337	75836221	8421504	3	21,19,2	0,178,1882	c,g	350025220300000001,350025220300000001,350025220300000007	21-42,21-42,21-42						Hematopoietic differentiation of umbilical cord blood-derived very small embryonic&sol;epiblast-like stem cells	www.floegel.info	0	0		MYB
1163	chr9	75834338	75834528	3500351628	59		75834338	75834528	8421504	3	20,19,20	0,111,170	c,g	350035162800000012,350035162800000012,350035162800000020,350035162800000013,350035162800000013	0-20,0-20,0-19,0-20,0-20		23675407	10.1371/journal.pone.0061015		PLoS ONE	Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R	Lulu	2013	0		MYB
1163	chr9	75834346	75834375	3500167605	29		75834346	75834375	8421504	1	29	0	c,g	350016760500000002,350016760500000002	0-29,0-29		20547751	10.1128/MCB.01284-09	0270-7306	Molecular and Cellular Biology	Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53	Deisenroth	2010	6		MYB
1163	chr9	75836295	75836318	3500070952	23		75836295	75836318	8421504	1	23	0	c	350007095200000006	9-32			10.1093/nar/gkh240		Nucleic Acids Research	A new &#x03b3;-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase	Jianming	2004	0		
1163	chr9	75860554	75860605	3500150245	48		75860554	75860605	8421504	3	5,36,7	0,7,44	c	350015024500000004	2-51						C-myb transfected T98G cells which produce GM-CSF and stem cell factor	Calabretta	1993	0		
1164	chr9	76009409	76009435	3500318648	24		76009409	76009435	8421504	3	4,16,4	0,5,22	g	350031864800001476	19-43						US Patent # 6,060,594. Nucleic acid segments encoding modified bacillus thuringiensis coleopteran-toxic crystal proteins - Patents.com	www.patents.com	0	0		
1166	chr9	76214991	76215016	3500039475	24		76214991	76215016	8421504	2	7,17	0,8	g	350003947500000001	1-34			10.1128/MCB.00629-06		Molecular and Cellular Biology	Pur&#x03b1; and Pur&#x03b2; Collaborate with Sp3 To Negatively Regulate &#x03b2;-Myosin Heavy Chain Gene Expression during Skeletal Muscle Inactivity 	Juan	2007	0		
1171	chr9	76930716	76930741	3500016556	25		76930716	76930741	8421504	1	25	0	c	350001655600000000	0-25		24198842	10.1155/2013/349067	1740-2522	Clinical and Developmental Immunology	Lymphoid Progenitor Cells from Childhood Acute Lymphoblastic Leukemia Are Functionally Deficient and Express High Levels of the Transcriptional Repressor Gfi-1	Purizaca	2013	2		BCLAF1
146	chr9	77232907	77464792	3500200330	4098		77232907	77464792	8421504	30	58,77,113,113,244,106,186,169,178,21,178,158,106,137,128,134,82,96,50,108,154,160,113,171,107,169,194,24,140,424	0,792,2369,3453,10717,20480,24212,30979,31238,36792,37541,40019,45741,46784,47923,52429,68735,74781,77347,83140,89355,92051,102361,130220,132964,134447,135854,141768,168222,231461	p	350020033000015000	0-4098						KEGG T01008: 537380	www.genome.jp	0	0		
1174	chr9	77270623	77272946	3500005731	23		77270623	77272946	8421504	2	3,20	0,2303	c	350000573100000081	0-23			10.1111/j.1462-5822.2004.00412.x	1462-5822	Cellular Microbiology	Transcriptome analysis and gene expression profiles of early apoptosis-related genes in Streptococcus pyogenes-infected epithelial cells - Nakagawa - 2004 - Cellular Microbiology - Wiley Online Library	Nakagawa	2004	0		
1174	chr9	77278658	77278706	3500426490	48		77278658	77278706	8421504	1	48	0	p	350042649000015108	0-48						Signal Transduction Protein Tab2 	.freshpatents.com	0	0		MAP3K5
1174	chr9	77280924	77285425	3500215413	123		77280924	77285425	8421504	2	34,89	0,4412	p	350021541300015018,350021541300015046,350021541300015017	0-57,0-120,0-60					Patent	Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK) (Patent US:7109021)	Johnson	2006	0		MAP3K5
1174	chr9	77280924	77285359	3500217607	57		77280924	77285359	8421504	2	34,23	0,4412	p	350021760700015056	0-57					Patent	Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK) (Patent US:RE40624)	Johnson	2009	0		MAP3K5
1174	chr9	77301715	77310301	3500076202	44		77301715	77310301	8421504	3	9,14,21	0,5973,8565	c,g	350007620200000020,350007620200000023,350007620200000023	7-30,0-21,0-21		18948261	10.1074/jbc.M807219200		The Journal of Biological Chemistry	Murine Protein Serine/Threonine Kinase 38 Activates Apoptosis Signal-regulating Kinase 1 via Thr838 Phosphorylation	Haiyoung	2008	0		
1177	chr9	77604938	77604963	3500455443	23		77604938	77604963	8421504	2	6,17	0,8	c	350045544300000015	2-25						Method for treating wounds using an EGF-like domain of thrombomodulin - Patent # 8293710 - PatentGenius	.patentgenius.com	0	0		
1177	chr9	77618285	77618311	3500092121	24		77618285	77618311	8421504	2	7,17	0,9	g	350009212100000049	7-31						Compositions and methods for treating intracellular diseases	Lee	1998	0		
1177	chr9	77686957	77701363	3500320376	89		77686957	77701363	8421504	3	21,40,28	0,9355,14378	c	350032037600000308,350032037600000246,350032037600000039,350032037600000138	12-33,0-45,1-48,4-48						 Immunoconjugates Of Anti 	www.docstoc.com	0	0		
1177	chr9	77696327	77696351	3500259289	24		77696327	77696351	8421504	1	24	0	c	350025928900000022	0-24						Remedy for lung cancer	Nezu	2005	0		
1178	chr9	77807516	77807553	3500325127	37		77807516	77807553	8421504	1	37	0	c	350032512700000127	0-37						Method For Detecting Gene Specifying Allergic Predisposition 	.freshpatents.com	0	0		
1180	chr9	78048267	78048293	3500366733	23		78048267	78048293	8421504	2	8,15	0,11	g	350036673300000013	11-34						DNAs encoding mammalian ZPC and uses thereof	Harris	1995	0		
1180	chr9	78058764	78058787	3500041126	23		78058764	78058787	8421504	1	23	0	g	350004112600000004	12-44						UNIVERSIDADE FEDERAL DE GOI&#xc1;S PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM MEDICINA TROPICAL E SA&#xda;DE P&#xda;BLICA ALYNE MELO PEREIRA	ensu.iptsp.ufg.br	0	0		
1181	chr9	78168766	78168790	3500376671	23		78168766	78168790	8421504	2	7,16	0,8	g	350037667100000004	2-25						DNA Methylation of the Gonadal Aromatase (cyp19a) Promoter Is Involved in Temperature-Dependent Sex Ratio Shifts in the European Sea Bass	digital.csic.es	0	0		
1182	chr9	78351353	78351376	3500198087	23		78351353	78351376	8421504	1	23	0	g	350019808700000126	17-42						Peptide Vaccine For Influenza Virus 	.freshpatents.com	0	0		
1183	chr9	78469890	78470913	3500408509	45		78469890	78470913	8421504	2	23,22	0,1001	c,g	350040850900000004,350040850900000004,350040850900000005,350040850900000005	0-23,0-23,0-22,0-22		22749770	10.1016/j.ajpath.2012.04.028		The American Journal of Pathology	Methylation-Dependent Activation of CDX1 through NF-&#x03ba;B: A Link from Inflammation to Intestinal Metaplasia in the Human Stomach	Tilman	2012	0		TNFAIP3
1183	chr9	78469890	78470909	3500066131	44		78469890	78470909	8421504	3	23,3,18	0,87,1001	c	350006613100000007,350006613100000008	0-23,0-21		12673210	10.1038/sj.onc.1206262	0950-9232	Oncogene	Identification of NF-&#x03ba;B-regulated genes induced by TNF&#x03b1; utilizing expression profiling and RNA interference	Zhou	2003	6		
1183	chr9	78469890	78469915	3500072235	25		78469890	78469915	8421504	1	25	0	c,g	350007223500000005,350007223500000005	0-25,0-25		22525270	10.1038/onc.2012.145		Oncogene	A20/TNFAIP3 inhibits NF-&#x03ba;B activation induced by the Kaposi&#x2019;s sarcoma-associated herpesvirus vFLIP oncoprotein	S	2013	0		TNFAIP3
1183	chr9	78474156	78474184	3500452892	27		78474156	78474184	8421504	2	8,19	0,9	g	350045289200000065	14-41						HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE - Patent application	www.faqs.org	0	0		
1183	chr9	78474156	78474184	3500357757	27		78474156	78474184	8421504	2	8,19	0,9	g	350035775700000061	14-41						Humanized Antibodies That Recognize Beta Amyloid Peptide 	.freshpatents.com	0	0		
1187	chr9	78935359	78935385	3500369884	24		78935359	78935385	8421504	3	15,4,5	0,16,21	c	350036988400000021	0-24						Anti-Pancreatic Cancer Antibodies - Patent application	www.faqs.org	0	0		
1189	chr9	79215530	79215558	3500020175	25		79215530	79215558	8421504	2	9,16	0,12	g	350002017500000003	0-25		22871047	10.1186/1476-4598-11-53	1476-4598	Molecular Cancer	Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma	Ho	2012	4		
1190	chr9	79401301	79403151	3500262495	192		79401301	79403151	8421504	3	127,64,1	0,1506,1849	p	350026249500015016	0-192						est_a_palmata1012 | MarineGenomics.org	arinegenomics.org	0	0		REPS1
1193	chr9	79820580	79820611	3500275548	31		79820580	79820611	8421504	1	31	0	c	350027554800000046	0-31						MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF - Patent application	www.faqs.org	0	0		
1193	chr9	79820753	79820778	3500357068	25		79820753	79820778	8421504	1	25	0	c	350035706800000009	21-46						BASES MOL&#xc9;CULAIRES DES D&#xc9;FAUTS S&#xc9;CR&#xc9;TOIRES DES CELLULES &#x03b2;	ai.u-bordeaux1.fr	0	0		CITED2
1193	chr9	79820753	79820778	3500149429	25		79820753	79820778	8421504	1	25	0	c	350014942900000009	21-46						BASES MOL&#xc9;CULAIRES DES D&#xc9;FAUTS S&#xc9;CR&#xc9;TOIRES DES CELLULES &#x03b2;	tacell-cellbio.eu	0	0		CITED2
1193	chr9	79821160	79821800	3500187874	40		79821160	79821800	8421504	2	19,21	0,619	c,g	350018787400000000,350018787400000000,350018787400000003,350018787400000003	0-19,0-19,0-21,0-21						Post-transcriptionalControlofCited2byTransforming GrowthFactor	www.jbc.org	0	0		CITED2
1193	chr9	79821180	79821276	3500081014	96		79821180	79821276	8421504	1	96	0	p	350008101400015013	0-96						Transcription activator of the cited family	Bhattacharya	2001	0		CITED2
1193	chr9	79821353	79821381	3500378640	28		79821353	79821381	8421504	1	28	0	c	350037864000000088,350037864000000089	38-66,36-64					Patent	Polyhydroxyalkanoate-containing structure and manufacturing method thereof (Patent EP:1275728)	Honma	2008	0		
1193	chr9	79821353	79821381	3500128423	28		79821353	79821381	8421504	1	28	0	c	350012842300000216,350012842300000215	36-64,38-66						Polyhydroxyalkanoate-containing structure and manufacturing method thereof - US Patent 6951745 Description	ww.patentstorm.us	0	0		
1193	chr9	79821353	79821381	3500038254	28		79821353	79821381	8421504	1	28	0	c	350003825400000088,350003825400000089	38-66,36-64						Polyhydroxyalkanoate-containing Structure And Manufacturing Method Thereof 	.freshpatents.com	0	0		
1193	chr9	79821353	79821381	3500008674	28		79821353	79821381	8421504	1	28	0	c	350000867400000215,350000867400000216	38-66,36-64						 Polyhydroxyalkanoate 	www.docstoc.com	0	0		
1193	chr9	79821354	79821377	3500285298	23		79821354	79821377	8421504	1	23	0	c	350028529800000059	0-23						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
1193	chr9	79821486	79821572	3500166895	41		79821486	79821572	8421504	2	20,21	0,65	c,g	350016689500000002,350016689500000002,350016689500000001,350016689500000001	0-20,0-20,0-21,0-21						ORIGINAL RESEARCH ARTICLE Cellular Knockdown of CITED2 Using Short-Hairpin RNA Sensitizes Cancer Cells to Cisplatin Through Stabilization of p53 and Enhancement of p53-Dependent Apoptosis	memo.cgu.edu.tw	0	0		CITED2
1193	chr9	79821656	79821799	3500409758	40		79821656	79821799	8421504	2	20,20	0,123	c,g	350040975800000016,350040975800000016,350040975800000015,350040975800000015	0-20,0-20,0-20,0-20						The Hypoxia-Inducible Factor 2 N-Terminal and C-Terminal Transactivation Domains Cooperate To Promote Renal Tumorigenesis In Vivo	mcb.asm.org	0	0		CITED2
1194	chr9	79926152	79931724	3500119454	41		79926152	79931724	8421504	4	14,5,17,5	0,17,5549,5567	g	350011945400000162,350011945400000703	9-28,7-29						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1198	chr9	80473484	80475578	3500156510	61		80473484	80475578	8421504	3	20,21,20	0,1834,2074	g	350015651000000066,350015651000000068,350015651000000069	0-20,0-21,0-20						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
1199	chr9	80595959	80595983	3500241978	23		80595959	80595983	8421504	2	9,14	0,10	g	350024197800000037	8-31						Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates	Sun	2013	0		
1201	chr9	80755128	80755156	3500292931	23		80755128	80755156	8421504	2	10,13	0,15	g	350029293100000159	8-31					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent EP:2135950)	NATT	2012	0		
1207	chr9	81542004	81542041	3500119454	31		81542004	81542041	8421504	3	13,4,14	0,14,23	g	350011945400000451	0-32						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1207	chr9	81590324	81590351	3500106719	24		81590324	81590351	8421504	3	13,5,6	0,14,21	g	350010671900000146	23-48						Optimizing Expression of Active Botulinum Toxin Type E - Patent application	www.faqs.org	0	0		
1208	chr9	81775770	81775795	3500212746	23		81775770	81775795	8421504	2	14,9	0,16	g	350021274600000780	0-23					Patent	Immunisation against chlamydia trachomatis (Patent CN:100515494)	G*La Di 	2009	0		
1219	chr9	83155440	83155468	3500241703	23		83155440	83155468	8421504	2	16,7	0,21	g	350024170300000020	0-25						Method of treating cell damage or depletion	Clark	1995	0		
1220	chr9	83233710	83233736	3500156510	23		83233710	83233736	8421504	2	5,18	0,8	g	350015651000000055	1-24						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
1221	chr9	83386939	83386966	3500128972	24		83386939	83386966	8421504	2	12,12	0,15	g	350012897200000024	10-34						MUTANT DNA POLYMERASES - Patent application	www.faqs.org	0	0		
1225	chr9	83909622	83909647	3500385809	24		83909622	83909647	8421504	2	4,20	0,5	g	350038580900000787	21-47						Novel family of pheromone receptors	Buck	1999	0		
1225	chr9	83909622	83909647	3500320858	24		83909622	83909647	8421504	2	4,20	0,5	g	350032085800000787	21-47						Novel family of pheromone receptors	Buck	2000	0		
1226	chr9	84071763	84120110	3500361666	41		84071763	84120110	8421504	2	20,21	0,48326	c,g	350036166600000083,350036166600000273,350036166600000080,350036166600000080,350036166600000270,350036166600000270	0-20,0-20,0-21,0-21,0-21,0-21						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
1226	chr9	84071763	84120110	3500156510	61		84071763	84120110	8421504	3	20,20,21	0,536,48326	c,g	350015651000000083,350015651000000083,350015651000000082,350015651000000080,350015651000000080	0-20,0-20,0-20,0-21,0-21						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
1226	chr9	84106099	84106122	3500441121	23		84106099	84106122	8421504	1	23	0	c,g	350044112100000010,350044112100000010	13-36,13-36		16980692	10.1074/jbc.M607183200	0021-9258	Journal of Biological Chemistry	The Import Competence of a Peroxisomal Membrane Protein Is Determined by Pex19p before the Docking Step	Pinto	2006	5		
1229	chr9	84516845	84516899	3500432646	54		84516845	84516899	8421504	1	54	0	p	350043264600015002	0-54		19564402	10.1083/jcb.200904048	0021-9525	The Journal of Cell Biology	Distinct cytoplasmic maturation steps of 40S ribosomal subunit precursors require hRio2	Zemp	2009	10		LTV1
1229	chr9	84516845	84516899	3500350617	54		84516845	84516899	8421504	1	54	0	p	350035061700015001	0-54		19564402	10.1083/jcb.200904048		The Journal of Cell Biology	Distinct cytoplasmic maturation steps of 40S ribosomal subunit precursors require hRio2	Ivo	June	0		LTV1
1230	chr9	84566735	84566761	3500364288	26		84566735	84566761	8421504	1	26	0	g	350036428800000024	0-26						Impact du stress de la culture in vitro sur la survie et le transcriptome embryonnaire chez le bovin. &#xab; Entre adaptation et viabilit&#xe9; &#xbb;	.theses.ulaval.ca	0	0		
1230	chr9	84567186	84568020	3500044049	121		84567186	84568020	8421504	4	14,17,48,42	0,18,615,792	c	350004404900000068,350004404900000055,350004404900000015	10-48,0-48,6-48						Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation	Journot	1998	0		
1230	chr9	84567266	84568100	3500143138	48		84567266	84568100	8421504	2	24,24	0,810	c	350014313800000007,350014313800000006	0-24,0-24						RESEARCH Open Access KCNQ1OT1 CDKN1C H19 PLAGL1 KvDMR1 and H19/IGF2 imprinting control regions	ww.jbiomedsci.com	0	0		
1234	chr9	85098806	85098832	3500310150	23		85098806	85098832	8421504	2	9,14	0,12	g	350031015000000002	0-23		19885846	10.1002/jcp.21958		Journal of cellular physiology	1&#x03b1;,25-dihydroxy vitamin D3 induces nuclear matrix association of the 1&#x03b1;,25-dihydroxy vitamin D3 receptor in osteoblasts independently of its ability to bind DNA	Gloria	2010	0		
1234	chr9	85142177	85142538	3500375699	361		85142177	85142538	8421504	1	361	0	g	350037569900000025	0-361						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
1237	chr9	85586907	85586934	3500019155	23		85586907	85586934	8421504	2	9,14	0,13	g	350001915500000004	0-23						TFF3 HYPOMETHYLATION AS A NOVEL BIOMARKER FOR PROSTATE CANCER - AARHUS UNIVERSITET	www.sumobrain.com	0	0		
1238	chr9	85635433	85635459	3500424633	23		85635433	85635459	8421504	2	13,10	0,16	g	350042463300000013	4-29		19702650	10.1111/j.1462-5822.2009.01375.x	1462-5822	Cellular Microbiology	Secretory protein with RING finger domain (SPRING) specific to Trypanosoma cruzi is directed, as a ubiquitin ligase related protein, to the nucleus of host cells - Hashimoto - 2009 - Cellular Microbiology - Wiley Online Library	Hashimoto	2010	0		
155	chr9	86767417	86932823	3500385544	48		86767417	86932823	8421504	2	8,40	0,165366	c	350038554400000183	0-48						Chimeric metabotropic glutamate receptors and uses thereof	Gupta	2005	0		
1248	chr9	86932871	87008150	3500385544	95		86932871	87008150	8421504	3	47,4,44	0,144,75235	c	350038554400000185,350038554400000188	0-47,0-48						Chimeric metabotropic glutamate receptors and uses thereof	Gupta	2005	0		
19	chr9	87008306	87042807	3500385544	109		87008306	87042807	8421504	3	32,29,48	0,34117,34453	c	350038554400000192,350038554400000203,350038554400000143	12-44,0-29,0-48						Chimeric metabotropic glutamate receptors and uses thereof	Gupta	2005	0		
1249	chr9	87042817	87074409	3500222141	40		87042817	87074409	8421504	2	20,20	0,31572	c,g	350022214100000000,350022214100000000,350022214100000001	0-20,0-20,0-20			10.1046/j.1471-4159.2002.00929.x	1471-4159	Journal of Neurochemistry	Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways - Iacovelli - 2002 - Journal of Neurochemistry - Wiley Online Library	Iacovelli	2002	0		GRM1
1249	chr9	87042817	87042843	3500458275	25		87042817	87042843	8421504	2	21,4	0,22	c	350045827500000000	0-25		18266930	10.1111/j.1471-4159.2008.05289.x	1471-4159	Journal of Neurochemistry	Group III metabotropic glutamate receptor activation suppresses self-replication of undifferentiated neocortical progenitor cells - Nakamichi - 2008 - Journal of Neurochemistry - Wiley Online Library	Nakamichi	2008	0		
1249	chr9	87043039	87043066	3500402389	27		87043039	87043066	8421504	1	27	0	c	350040238900000000	8-35		11723231	10.1124/mol.60.6.1243	1521-0111 (Online)	Molecular Pharmacology	Agonist-Stimulated and Tonic Internalization of Metabotropic Glutamate Receptor 1a in Human Embryonic Kidney 293 Cells: Agonist-Stimulated Endocytosis Is &#x03b2;-Arrestin1 Isoform-Specific	Dale	2001	0		
1249	chr9	87075237	87075297	3500342863	60		87075237	87075297	8421504	1	60	0	p	350034286300015018	45-105							library.wiley.com	0	0		GRM1
1249	chr9	87075591	87075620	3500128303	29		87075591	87075620	8421504	1	29	0	c	350012830300000383	33-62						 DNA Diagnostics Based On Mass Spectrometry 	www.docstoc.com	0	0		
1250	chr9	87237320	87237344	3500270815	24		87237320	87237344	8421504	1	24	0	c	350027081500000038	0-24						Differential Gene Expression Profiles of Scirrhous Gastric Cancer Cells with High	.aacrjournals.org	0	0		
1251	chr9	87406885	87406920	3500121405	28		87406885	87406920	8421504	3	14,9,5	0,18,30	c	350012140500000018,350012140500000017,350012140500000007,350012140500000006	8-36,0-28,8-36,0-28						Modified Dna Cleavage Enzymes And Methods For Use (as Amended By Isa) 	.freshpatents.com	0	0		
1256	chr9	87982428	87982455	3500331356	24		87982428	87982455	8421504	2	18,6	0,21	c	350033135600000003	0-24		14610179	10.1128/JVI.77.23.12562-12571.2003	0022-538X	Journal of Virology	Mutations within the P2 Domain of Norovirus Capsid Affect Binding to Human Histo-Blood Group Antigens: Evidence for a Binding Pocket	Tan	2003	5		
1256	chr9	87982428	87982455	3500045986	24		87982428	87982455	8421504	2	18,6	0,21	c	350004598600000003	0-24			10.1128/JVI.77.23.12562-12571.2003		Journal of Virology	Mutations within the P2 Domain of Norovirus Capsid Affect Binding to Human Histo-Blood Group Antigens: Evidence for a Binding Pocket	Ming	2003	0		
1256	chr9	88075999	88076024	3500437597	25		88075999	88076024	8421504	1	25	0	c	350043759700000003	31-56		21998599	10.1371/journal.pgen.1002323	1553-7404	PLOS Genetics	PLOS Genetics: Positional Cloning of a Type 2 Diabetes Quantitative Trait Locus; Tomosyn-2, a Negative Regulator of Insulin Secretion	Bhatnagar	2011	0		STXBP5
1260	chr9	88483678	88483706	3500119231	23		88483678	88483706	8421504	3	13,5,5	0,15,23	g	350011923100000004	0-24						ORIGINAL Open Access meso-diaminopimelate dehydrogenase from an Ureibacillus thermosphaericus strain A1 isolated from a Japanese compost: purification, characterization	w.amb-express.com	0	0		
1260	chr9	88488470	88488497	3500241875	23		88488470	88488497	8421504	2	11,12	0,15	g	350024187500000402	8-34					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
1264	chr9	89096293	89114455	3500156510	40		89096293	89114455	8421504	2	20,20	0,18142	g	350015651000000093,350015651000000090	2-22,0-20						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
19	chr9	90165370	90192396	3500426490	458		90165370	90192396	8421504	9	96,48,48,34,62,90,34,14,32	0,576,816,1440,21711,22087,23524,26920,26994	c	350042649000000010,350042649000000011,350042649000000022,350042649000000027,350042649000000040,350042649000000041,350042649000000044,350042649000000045,350042649000000047,350042649000000049	0-48,0-48,0-48,0-48,0-48,0-48,6-48,0-48,0-48,12-44						Signal Transduction Protein Tab2 	.freshpatents.com	0	0		
1273	chr9	90185706	90185729	3500320858	23		90185706	90185729	8421504	1	23	0	g	350032085800000505	11-36						Novel family of pheromone receptors	Buck	2000	0		
1274	chr9	90346754	90346779	3500380174	23		90346754	90346779	8421504	2	8,15	0,10	c	350038017400000432	11-34						Goodpasture Antigen Binding Protein 	.freshpatents.com	0	0		
1274	chr9	90352036	90355162	3500072968	132		90352036	90355162	8421504	4	48,40,6,38	0,1354,1447,3088	c	350007296800000406,350007296800000412,350007296800000414	0-48,0-40,0-44						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
1274	chr9	90369379	90369427	3500385499	48		90369379	90369427	8421504	1	48	0	p	350038549900015129	0-48						US Patent # 6,603,060. Method for regulating cell death - Patents.com	www.patents.com	0	0		KATNA1
1274	chr9	90425197	90425220	3500450731	23		90425197	90425220	8421504	1	23	0	c	350045073100000004	10-33		22909338	10.1186/1756-9966-31-67	1756-9966	Journal of Experimental & Clinical Cancer Research	Decreased expression of LATS1 is correlated with the progression and prognosis of glioma	Ji	2012	2		
1275	chr9	90461555	90485197	3500368349	49		90461555	90485197	8421504	2	26,23	0,23619	c,g	350036834900000003,350036834900000016	0-26,0-23						Christopher G. DeVry &#xb7; Steven Clarke Polymorphic forms of the protein L-isoaspartate (D-aspartate) O-methyltrans- ferase involved in the repair of age-damaged proteins	hemistry.ucla.edu	0	0		
1275	chr9	90477316	90487103	3500243347	81		90477316	90487103	8421504	4	18,30,27,6	0,7828,7906,9781	c	350024334700000018,350024334700000020	0-48,0-33						Production and use of human and plant methyltransferases	Clarke	1996	0		
1275	chr9	90485174	90485197	3500143330	23		90485174	90485197	8421504	1	23	0	c	350014333000000017	0-23						Structure of the Human Gene Encoding the Protein Repair L-Isoaspartyl (D-Aspartyl) O-Methyltransferase	hemistry.ucla.edu	0	0		
1275	chr9	90508064	90508139	3500395032	69		90508064	90508139	8421504	3	18,36,15	0,21,60	p	350039503200015075,350039503200015082	0-51,21-72						Lp mammalian proteins; related reagents	Bhatt	2002	0		
1276	chr9	90629062	90629094	3500184207	28		90629062	90629094	8421504	3	5,17,6	0,7,26	g	350018420700000025	6-38					Patent	Diagnostic assay for detection of HIV (Patent US:6277561)	Guertler	2001	0		
1276	chr9	90629062	90629094	3500118877	28		90629062	90629094	8421504	3	5,17,6	0,7,26	g	350011887700000025,350011887700000032	6-38,2-22					Patent	Retrovirus from the HIV group and its use (Patent US:6528626)	Guertler	2003	0		
1277	chr9	90741704	90741735	3500151266	29		90741704	90741735	8421504	3	8,6,15	0,9,16	g	350015126600000085	9-38						Transgenic bovine	Deboer	1995	0		
1278	chr9	90872243	90872269	3500426462	23		90872243	90872269	8421504	3	5,14,4	0,7,22	g	350042646200000072	5-28						Immunoglobulin chimeric monomer-dimer hybrids	Peters	2005	0		
1278	chr9	90872243	90872269	3500293109	23		90872243	90872269	8421504	3	5,14,4	0,7,22	g	350029310900000055,350029310900000112	5-28,5-28						 Immunoglobulin Chimeric Monomer 	www.docstoc.com	0	0		
1278	chr9	90872243	90872269	3500274318	23		90872243	90872269	8421504	3	5,14,4	0,7,22	g	350027431800000115	5-28						Immunoglobulin chimeric monomer - dimer heterozygote	A*J*Bi Tong Di 	2011	0		
1278	chr9	90872243	90872269	3500119178	23		90872243	90872269	8421504	3	5,14,4	0,7,22	g	350011917800000055	5-28						Immunoglobulin Chimeric Monomer-Dimer Hybrids	Peters	2012	0		
1278	chr9	90944516	90944542	3500328497	25		90944516	90944542	8421504	2	7,18	0,8	g	350032849700000023	3-30						Rekombinante blutgerinnungsproteasen	Kopetzki	1997	0		
1280	chr9	91102990	91103024	3500460452	25		91102990	91103024	8421504	3	6,13,6	0,10,28	g	350046045200000079	0-28						Nucleic Acid - Patent application	www.faqs.org	0	0		
1280	chr9	91141935	91141959	3500285693	23		91141935	91141959	8421504	2	9,14	0,10	g	350028569300000084,350028569300000020	0-23,0-23						Infectious cDNA Clone of North American Porcine Reproductive and Respiratory Syndrome (PPRS) Virus and Uses Thereof - Patent application	www.faqs.org	0	0		
160	chr9	91729770	91765197	3500035109	160		91729770	91765197	8421504	5	26,18,29,39,48	0,1480,1592,9149,35379	c	350003510900000145,350003510900000147,350003510900000090,350003510900000099	0-26,0-47,9-48,0-48						METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE - Patent application	www.faqs.org	0	0		
1285	chr9	91823410	91830046	3500342699	41		91823410	91830046	8421504	3	7,13,21	0,8,6615	g	350034269900000292,350034269900000288	28-48,26-48						US Patent # 6,426,447. Plant seed oils - Patents.com	www.patents.com	0	0		
1285	chr9	91850983	91851017	3500035109	34		91850983	91851017	8421504	1	34	0	c	350003510900000130	7-41						METHODS AND MATERIALS FOR IDENTIFYING POLYMORPHIC VARIANTS, DIAGNOSING SUSCEPTIBILITIES, AND TREATING DISEASE - Patent application	www.faqs.org	0	0		
1286	chr9	91892610	91892637	3500408375	23		91892610	91892637	8421504	2	9,14	0,13	g	350040837500000007	10-36					Patent	Self-assembling recombinant papillomavirus capsid proteins (Patent US:5437951)	Kirnbauer	1995	0		
1288	chr9	92235960	92235989	3500269550	23		92235960	92235989	8421504	3	13,4,6	0,14,23	g	350026955000000383	2-25						MARCADORES MOLECULARES PARA IDENTIFICA&#xc7;&#xc3;O DE CARRAPATOS VETORES DE AGENTES RICKETTSIAIS	www.tede.ufv.br	0	0		
1288	chr9	92248289	92248316	3500287953	24		92248289	92248316	8421504	2	7,17	0,10	c	350028795300000704	0-24						Method For Increasing Pathogen Resistance In Transgenic Plants - Patent application	www.faqs.org	0	0		
1289	chr9	92404607	92404635	3500320858	24		92404607	92404635	8421504	3	14,5,5	0,16,23	g	350032085800000798	13-38						Novel family of pheromone receptors	Buck	2000	0		
1291	chr9	92547974	92548222	3500257009	248		92547974	92548222	8421504	1	248	0	g	350025700900000037,350025700900000028,350025700900000029,350025700900000031,350025700900000032,350025700900000033,350025700900000034	0-248,0-249,0-60,0-60,0-60,0-57,0-60						JABS (2013) 7(2), 94-101 - ResearchGate	.researchgate.net	0	0		
161	chr9	92550805	92688403	3500370623	312		92550805	92688403	8421504	7	99,33,66,28,29,49,8	0,132,41396,41492,73594,73662,137590	p,c,g	350037062300015018,350037062300015000,350037062300000003,350037062300000005,350037062300000005,350037062300015055,350037062300000007,350037062300015029,350037062300000008,350037062300015057,350037062300000010,350037062300015031,350037062300015059,350037062300015033	0-48,0-99,0-33,0-33,0-33,0-48,0-33,0-48,0-33,0-48,0-32,0-48,0-48,0-48						ESTROGEN RECEPTORS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
1291	chr9	92550805	92550868	3500404891	63		92550805	92550868	8421504	1	63	0	p	350040489100015001	0-63						Estrogen Receptor ( and &#x03b2; Expression in the Excurrenit Ducts of the Adult Male Rat Reproductive Tract	tmed.illinois.edu	0	0		ESR1
1291	chr9	92550806	92550829	3500415944	23		92550806	92550829	8421504	1	23	0	c	350041594400000000	0-23		17684116	10.1124/jpet.107.126748	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Influence of Estrogen and Xenoestrogens on Basolateral Uptake of Tetraethylammonium by Opossum Kidney Cells in Culture	Pelis	2007	0		ESR1
1291	chr9	92550806	92550829	3500397252	23		92550806	92550829	8421504	1	23	0	c	350039725200000000	0-23		17684116	10.1124/jpet.107.126748	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Influence of Estrogen and Xenoestrogens on Basolateral Uptake of Tetraethylammonium by Opossum Kidney Cells in Culture	Pelis	2007	0		ESR1
1291	chr9	92550815	92592227	3500161096	52		92550815	92592227	8421504	2	24,28	0,41384	c	350016109600000015,350016109600000014	0-24,1-29						Estradiol Stabilizes Estrogen Receptor Messenger Ribonucleic Acid in Sheep Endometrium via Discrete Sequence Elements in Its -Untranslated Region	.endojournals.org	0	0		
161	chr9	92592163	92688644	3500420672	514		92592163	92688644	8421504	6	162,117,193,15,6,21	0,32236,96232,96426,96442,96460	c,g	350042067200000004,350042067200000003,350042067200000003	6-499,0-21,0-21						Vagina und Zervix beim Rind post partum unter Ber&#xfc;cksichtigung der	d-nb.info/9719394	0	0		
1291	chr9	92592210	92592236	3500316773	25		92592210	92592236	8421504	2	21,4	0,22	c	350031677300000002	0-25						journal.pone.0015594[1] - ResearchGate	.researchgate.net	0	0		
1291	chr9	92592210	92592236	3500014939	25		92592210	92592236	8421504	2	21,4	0,22	c	350001493900000002	0-25						Fatty acids derived from royal jelly are modulators of estrogen receptor functions. - ResearchGate	.researchgate.net	0	0		
1291	chr9	92592222	92624476	3500031850	174		92592222	92624476	8421504	3	84,13,77	0,90,32177	p	350003185000015005,350003185000015006	0-84,0-90					Patent	Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains (Patent US:6444438)	Chambon	2002	0		
1291	chr9	92592225	92592250	3500340139	25		92592225	92592250	8421504	1	25	0	c	350034013900000024	0-25						Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with HER-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes	Pastorek	2007	0		
1291	chr9	92592228	92624455	3500397140	48		92592228	92624455	8421504	2	24,24	0,32203	c	350039714000000003,350039714000000002	0-24,0-24						Rapid Estrogen Receptor Signaling Is Essential for the Protective Effects of Estrogen Against Vascular Injury	c.ahajournals.org	0	0		ESR1
1291	chr9	92592241	92624464	3500421972	39		92592241	92624464	8421504	2	20,19	0,32204	c	350042197200000000,350042197200000001	0-20,0-19						Nutrition and Cancer	jn.nutrition.org	0	0		ESR1
1291	chr9	92592241	92624464	3500373435	39		92592241	92624464	8421504	2	20,19	0,32204	c	350037343500000000,350037343500000001	0-20,0-19		14988466		0022-3166	The Journal of Nutrition	Conjugated Linoleic Acid Blocks Estrogen Signaling in Human Breast Cancer Cells	Tanmahasamut	2004	4		ESR1
1291	chr9	92592258	92624452	3500315971	44		92592258	92624452	8421504	2	22,22	0,32172	c,g	350031597100000028,350031597100000028,350031597100000029,350031597100000029	0-22,0-22,0-22,0-22						REPRODUCTION	uction-online.org	0	0		
1291	chr9	92592258	92624452	3500248474	44		92592258	92624452	8421504	2	22,22	0,32172	c,g	350024847400000028,350024847400000028,350024847400000029,350024847400000029	0-22,0-22,0-22,0-22						REPRODUCTION	uction-online.org	0	0		
1291	chr9	92592258	92624452	3500024081	44		92592258	92624452	8421504	2	22,22	0,32172	c,g	350002408100000032,350002408100000032,350002408100000033,350002408100000033	0-22,0-22,0-22,0-22						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
1291	chr9	92592288	92592314	3500181936	26		92592288	92592314	8421504	1	26	0	c	350018193600000101,350018193600000046	27-48,9-32						ESTROGEN RECEPTOR GENES AND UTILIZATION THEREOF - Patent application	www.faqs.org	0	0		
161	chr9	92592297	92688421	3500284322	96		92592297	92688421	8421504	4	28,17,25,26	0,32102,32194,96098	p	350028432200015008,350028432200015009	0-45,0-51						28	jpkc.gmu.cn	0	0		ESR1
1291	chr9	92624401	92624506	3500265228	105		92624401	92624506	8421504	1	105	0	p	350026522800015018	0-105						NUCLEBTIDE SEQUENCE OF A crf-1,	summit.sfu.ca	0	0		ESR2
1291	chr9	92624407	92624500	3500185455	93		92624407	92624500	8421504	1	93	0	p	350018545500015020	0-93						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers_ Sources	www.docstoc.com	0	0		ESR1
1291	chr9	92624407	92624500	3500111757	93		92624407	92624500	8421504	1	93	0	p	350011175700015028	0-93						A Rumor Has Surfaced that Morgellons are a Patented Weapon G&#xc7;&#xf4; Here are the Patent Numbers, Sources	www.scribd.com	0	0		ESR2
1291	chr9	92624423	92624469	3500441760	41		92624423	92624469	8421504	2	20,21	0,25	c	350044176000000002,350044176000000012	0-20,0-21						Endocrine therapy resistance can be associated with high estrogen receptor a (ERa) expression and reduced ERa phosphorylation in breast cancer models	logy-journals.org	0	0		ESR1
1291	chr9	92624423	92624469	3500266718	41		92624423	92624469	8421504	2	20,21	0,25	c	350026671800000002,350026671800000012	0-20,0-21		17158758	10.1677/erc.1.01257	1351-0088	Endocrine-Related Cancer	Endocrine therapy resistance can be associated with high estrogen receptor &#x03b1; (ER&#x03b1;) expression and reduced ER&#x03b1; phosphorylation in breast cancer models	Kuske	2006	4		ESR1
1291	chr9	92624423	92624469	3500210308	41		92624423	92624469	8421504	2	20,21	0,25	c	350021030800000002,350021030800000012	0-20,0-21						endocrine therapy resistance can be associated with high estrogen receptor (er) expression and reduced er phosphorylation in breast cancer models - &#x671f;&#x520a;&#x6742;&#x5fd7;|&#x514d;&#x8d39;&#x6742;&#x5fd7;|&#x7535;&#x5b50;&#x6742;&#x5fd7;|&#x6742;	qkzz.net/article/	0	0		ESR1
161	chr9	92624476	92688406	3500077888	40		92624476	92688406	8421504	3	20,9,11	0,31,63919	c,g	350007788800000060,350007788800000060,350007788800000061	0-20,0-20,0-20						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
1292	chr9	92688403	92688426	3500038249	23		92688403	92688426	8421504	1	23	0	c	350003824900000001	1-24						Not all estrogen receptors are created equally - WeeksMD | WeeksMD	weeksmd.com	0	0		
1292	chr9	92688413	92688436	3500438307	23		92688413	92688436	8421504	1	23	0	c	350043830700000001	0-23		18275596	10.1186/bcr1862	1465-5411	Breast Cancer Research	1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE) disrupts the estrogen-androgen balance regulating the growth of hormone-dependent breast cancer cells	AubA(c)	2008	0		ESR1
1292	chr9	92688413	92688436	3500388222	23		92688413	92688436	8421504	1	23	0	c	350038822200000001	21-44						ESTROGEN SIGNALING IN NOCICEPTIVE	diss.fu-berlin.de	0	0		
1292	chr9	92688413	92688436	3500373601	23		92688413	92688436	8421504	1	23	0	c	350037360100000001	0-23		16216908	10.1677/jme.1.01783	0952-5041	Journal of Molecular Endocrinology	The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor &#x03b1; in human breast cancer cells	Maggiolini	2005	3		ESR1
1292	chr9	92688413	92688436	3500336935	23		92688413	92688436	8421504	1	23	0	c	350033693500000002	0-23		14684617	10.1210/en.2003-0752	0013-7227	Endocrinology	Estradiol Represses Prolactin-Induced Expression of Na+/Taurocholate Cotransporting Polypeptide in Liver Cells through Estrogen Receptor-&#x03b1; and Signal Transducers and Activators of Transcription 5a	Cao	2004	4		ESR1
1292	chr9	92688413	92688436	3500324858	23		92688413	92688436	8421504	1	23	0	c,g	350032485800000005,350032485800000005	0-23,0-23		17329597	10.1095/biolreprod.106.057687	0006-3363	Biology of Reproduction	The Aryl Hydrocarbon Receptor Affects Mouse Ovarian Follicle Growth via Mechanisms Involving Estradiol Regulation and Responsiveness	Barnett	2007	4		ESR1
1292	chr9	92688413	92688436	3500318615	23		92688413	92688436	8421504	1	23	0	c	350031861500000001	0-23						&#xc9;tude des effets endocriniens produits par les organochlor&#xe9;s en lien avec la carcinogen&#xe8;se mammaire	de.bibl.ulaval.ca	0	0		ESR1
1292	chr9	92688413	92688436	3500306737	23		92688413	92688436	8421504	1	23	0	c	350030673700000001	0-23						The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor in human breast cancer cells	logy-journals.org	0	0		ESR1
1292	chr9	92688413	92688436	3500298626	23		92688413	92688436	8421504	1	23	0	c	350029862600000001	0-23						&#xc9;tude des effets endocriniens produits par les organochlor&#xe9;s en lien avec la carcinogen&#xe8;se mammaire	de.bibl.ulaval.ca	0	0		ESR1
1292	chr9	92688413	92688436	3500281449	23		92688413	92688436	8421504	1	23	0	c	350028144900000003	0-23						The Novel Estrogen Receptor, G Protein-Coupled Receptor 30, Mediates the Proliferative Effects Induced by 17 -Estradiol on Mouse Spermatogonial GC-1	.endojournals.org	0	0		ESR1
1292	chr9	92688413	92688436	3500259875	23		92688413	92688436	8421504	1	23	0	c	350025987500000022	0-23						REGULATING MECHANISMS OF GONADAL AND PITUITARY TUMORIGENESIS IN MICE PRODUCING HUMAN CHORIONIC GONADOTROPIN	www.doria.fi	0	0		ESR1
1292	chr9	92688413	92688436	3500228862	23		92688413	92688436	8421504	1	23	0	c	350022886200000001	0-23						Protein Tyrosine Kinase and Estrogen Receptor-dependent Pathways Regulate the Synthesis and Distribution of Glycosaminoglycans/Proteoglycans Produced by Two Human Colon Cancer Cell Lines	.iiarjournals.org	0	0		ESR1
1292	chr9	92688413	92688436	3500133512	23		92688413	92688436	8421504	1	23	0	c,g	350013351200000001,350013351200000001	0-23,0-23		21042288	10.1038/aps.2010.178	1671-4083	Acta Pharmacologica Sinica	Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro	Ye	2010	2		ESR1
1292	chr9	92688413	92688436	3500121896	23		92688413	92688436	8421504	1	23	0	c,g	350012189600000003,350012189600000003	0-23,0-23		11252157	10.1186/1471-2202-2-3	1471-2202	BMC Neuroscience	Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine	Turchan	2001	3		ESR1
1292	chr9	92688413	92688436	3500100555	23		92688413	92688436	8421504	1	23	0	c	350010055500000001	0-23		16216908	10.1677/jme.1.01783	0952-5041	Journal of Molecular Endocrinology	The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor &#x03b1; in human breast cancer cells	Maggiolini	2005	3		ESR1
1292	chr9	92688413	92688436	3500054702	23		92688413	92688436	8421504	1	23	0	c	350005470200000001	0-23		11861533	10.1210/en.143.3.1058	0013-7227	Endocrinology	17&#x03b2;-Estradiol Affords Protection against 4-Vinylcyclohexene Diepoxide-Induced Ovarian Follicle Loss in Fischer-344 Rats	Thompson	2002	4		ESR1
1292	chr9	92688627	92688650	3500319127	23		92688627	92688650	8421504	1	23	0	c	350031912700000000	0-23						Sakurai et al., Supplemental Table S1. Primers for RT-PCR analyses.	ww.biolreprod.org	0	0		
1292	chr9	92688701	92688727	3500415944	26		92688701	92688727	8421504	1	26	0	c	350041594400000002	0-26		17684116	10.1124/jpet.107.126748	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Influence of Estrogen and Xenoestrogens on Basolateral Uptake of Tetraethylammonium by Opossum Kidney Cells in Culture	Pelis	2007	0		
1292	chr9	92688701	92688727	3500397252	26		92688701	92688727	8421504	1	26	0	c	350039725200000002	0-26		17684116	10.1124/jpet.107.126748	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Influence of Estrogen and Xenoestrogens on Basolateral Uptake of Tetraethylammonium by Opossum Kidney Cells in Culture	Pelis	2007	0		
1293	chr9	92829940	92829965	3500121690	25		92829940	92829965	8421504	1	25	0	c,g	350012169000000009,350012169000000009	0-25,0-25						Aromatase Promoter I.f is Regulated by Estrogen Receptor Alpha (ESR1) in Mouse Hypothalamic Neuronal Cell Lines	ww.biolreprod.org	0	0		
1293	chr9	92829940	92829965	3500016976	25		92829940	92829965	8421504	1	25	0	c	350001697600000009	0-25		19605792	10.1095/biolreprod.109.077206	0006-3363	Biology of Reproduction	Aromatase Promoter I.f is Regulated by Estrogen Receptor Alpha (ESR1) in Mouse Hypothalamic Neuronal Cell Lines	Yilmaz	2009	4		
1293	chr9	92829970	92859226	3500093095	147		92829970	92859226	8421504	4	18,42,16,71	0,21,66,29185	p	350009309500015126	0-147						Method for identifying antagonist compounds of the estrogen-related receptor 3 (ERR3) by using the x-ray structural coordinates of the ligand binding domain - Patent # 7279325 - PatentGenius	.patentgenius.com	0	0		
1293	chr9	92830045	92859250	3500436745	99		92830045	92859250	8421504	3	7,14,78	0,29110,29127	p	350043674500015009	0-99						Target activated nucleic acid biosensor and methods of using same	Stanton	2002	0		
1293	chr9	92830045	92859250	3500376308	99		92830045	92859250	8421504	3	7,14,78	0,29110,29127	p	350037630800015009	0-99						Target activated nucleic acid biosensor and methods of using same	Stanton	2002	0		
1293	chr9	92859190	92859216	3500238777	26		92859190	92859216	8421504	1	26	0	c	350023877700000001	0-26		12819297	10.1210/me.2003-0040	0888-8809	Molecular Endocrinology	Regulation of Cyclic Adenosine 3&#x2032;,5&#x2032;-Monophosphate Signaling and Pulsatile Neurosecretion by Gi-coupled Plasma Membrane Estrogen Receptors in Immortalized Gonadotropin-Releasing Hormone Neurons	Navarro	2003	5		
1293	chr9	92859334	92864285	3500181936	71		92859334	92864285	8421504	3	5,43,23	0,4867,4928	c	350018193600000027,350018193600000066,350018193600000122	0-48,0-45,0-23						ESTROGEN RECEPTOR GENES AND UTILIZATION THEREOF - Patent application	www.faqs.org	0	0		
1293	chr9	92864215	92864241	3500435393	26		92864215	92864241	8421504	1	26	0	c	350043539300000033	0-26						Variation in the Ovarian Reserve Is Linked to Alterations in Intrafollicular Estradiol Production and Ovarian Biomarkers of Follicular Differentiation and Oocyte Quality in Cattle	ww.biolreprod.org	0	0		ESR1
1293	chr9	92864224	92864248	3500186832	24		92864224	92864248	8421504	1	24	0	c	350018683200000002	0-24		18310301	10.1677/erc.1.01255	1351-0088	Endocrine-Related Cancer	Roles of estrogen receptor &#x03b1; and &#x03b2; in modulating urothelial cell proliferation	Teng	2008	4		
1293	chr9	92864224	92864248	3500154276	24		92864224	92864248	8421504	1	24	0	c	350015427600000002	0-24		18310301	10.1677/erc.1.01255		Endocrine-related cancer	Roles of estrogen receptor &#x03b1; and &#x03b2; in modulating urothelial cell proliferation	Jian	2008	0		ESR1
1293	chr9	92864264	92864342	3500156510	40		92864264	92864342	8421504	2	19,21	0,57	c,g	350015651000000100,350015651000000101,350015651000000101	0-19,0-21,0-21						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
1293	chr9	92865697	92865727	3500073117	30		92865697	92865727	8421504	1	30	0	g	350007311700000026	0-30						The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor- (ER ) and Messenger RNA and Protein Expression in Breast Cancer Cell Lines	cell.uchc.edu	0	0		
1297	chr9	93407244	93407273	3500441209	27		93407244	93407273	8421504	3	8,5,14	0,9,15	g	350044120900000419	4-31						Antibodies Against Lesion Tissue 	.freshpatents.com	0	0		
1299	chr9	93655487	93656379	3500198196	132		93655487	93656379	8421504	5	27,54,4,27,20	0,36,91,843,872	c,g	350019819600000000,350019819600000001,350019819600000002,350019819600000004,350019819600000003,350019819600000003	0-27,0-36,0-23,0-31,0-20,0-20		12097482		0270-6474	The Journal of Neuroscience	Coincident Elevation of cAMP and Calcium Influx by PACAP-27 Synergistically Regulates Vasoactive Intestinal Polypeptide Gene Transcription through a Novel PKA-Independent Signaling Pathway	Hamelink	2002	7		
1299	chr9	93655554	93656379	3500055430	43		93655554	93656379	8421504	2	23,20	0,805	c,g	350005543000000002,350005543000000003,350005543000000003	0-23,0-20,0-20		15087472	10.1210/me.2003-0129	0888-8809	Molecular Endocrinology	The Proinflammatory Cytokines Tumor Necrosis Factor-&#x03b1; and Interleukin-1 Stimulate Neuropeptide Gene Transcription and Secretion in Adrenochromaffin Cells via Activation of Extracellularly Regulated Kinase 1/2 and p38 Protein Kinases, and Activator 	Ait-Ali	2004	5		
1299	chr9	93656367	93656454	3500242076	87		93656367	93656454	8421504	1	87	0	p	350024207600015007	3-90						TARGETED FUSION PROTEINS FOR CANCER THERAPY - Patent application	www.faqs.org	0	0		
1299	chr9	93656367	93656451	3500389626	84		93656367	93656451	8421504	1	84	0	p	350038962600015026	0-84						&#xff26;&#xff32;&#xff25;&#xff34;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cd;&#x5149;&#x6307;&#x793a;&#x85ac; &#xff08;&#x767b;&#x9332;&#x516c;&#x5831; 4214206&#xff09;&#xff5c;&#x30a2;&#x30b9;&#x30bf;&#x30df;&#x30e5;&#x30fc;&#x30bc; - astamuse	astamuse.com	0	0		VIP
1299	chr9	93656367	93656451	3500061337	84		93656367	93656451	8421504	1	84	0	p	350006133700015038,350006133700015170	0-84,0-48						 Fluorescent Protein Indicators 	www.docstoc.com	0	0		VIP
1299	chr9	93656367	93656427	3500384310	60		93656367	93656427	8421504	1	60	0	p	350038431000015141	0-60						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		VIP
1299	chr9	93659347	93659374	3500401653	23		93659347	93659374	8421504	2	17,6	0,21	c	350040165300000196	0-26					Patent	Amplification of target nucleic acids using gap filling ligase chain reaction (Patent US:5427930)	Birkenmeyer	1995	0		
1299	chr9	93659347	93659374	3500338832	23		93659347	93659374	8421504	2	17,6	0,21	c	350033883200000195	0-26						 Amplification Of Target Nucleic Acids Using Gap Filling Ligase Chain Reaction 	www.docstoc.com	0	0		
162	chr9	93839351	93849642	3500393026	132		93839351	93849642	8421504	5	29,33,2,48,20	0,1820,3702,3902,10271	c	350039302600000165,350039302600000157,350039302600000152,350039302600000141	1-30,0-35,0-48,28-48						US Patent # 7,390,656. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
1300	chr9	93839351	93843301	3500251200	112		93839351	93843301	8421504	4	29,33,2,48	0,1820,3702,3902	c	350025120000000169,350025120000000161,350025120000000156	1-30,0-35,0-48						Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof - US Patent 7504253 Description	ww.patentstorm.us	0	0		
162	chr9	93843253	93849642	3500295516	68		93843253	93849642	8421504	2	48,20	0,6369	c	350029551600000152,350029551600000141	0-48,28-48						NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
162	chr9	93843253	93849642	3500114953	68		93843253	93849642	8421504	2	48,20	0,6369	c	350011495300000155,350011495300000144	0-48,28-48						NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO - Patent application	www.faqs.org	0	0		
1300	chr9	93843253	93843301	3500396061	48		93843253	93843301	8421504	1	48	0	c	350039606100000152	0-48						Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto	Reed	2000	0		
1300	chr9	93843253	93843301	3500366927	48		93843253	93843301	8421504	1	48	0	c	350036692700000156	0-48						US Patent # 7,504,253. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof - Patents.com	www.patents.com	0	0		
1300	chr9	93843253	93843301	3500347497	48		93843253	93843301	8421504	1	48	0	c	350034749700000152	0-48						Nucleic Acid Encoding Proteins Involved In Protein Degradation, Products And Methods Related Thereto 	.freshpatents.com	0	0		
1300	chr9	93843253	93843301	3500096613	48		93843253	93843301	8421504	1	48	0	c	350009661300000152	0-48						US Patent # 6,638,734. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
1303	chr9	94121010	94121034	3500153655	23		94121010	94121034	8421504	2	19,4	0,20	g	350015365500000318	19-42						Nuclear factors and binding assay	Hoey	1995	0		
1306	chr9	94537281	94537306	3500427408	24		94537281	94537306	8421504	2	4,20	0,5	g	350042740800000000	9-33		15994812	10.1128/JVI.79.14.9180-9191.2005	0022-538X	Journal of Virology	Regulation of Human Immunodeficiency Virus Type 1 Gene Expression by Clade-Specific Tat Proteins	Desfosses	2005	5		
1308	chr9	94834483	94889859	3500406106	1413		94834483	94889859	8421504	5	447,353,521,83,9	0,37099,38318,55283,55367	c	350040610600000034	0-1414						TREATMENT OF PAIN THROUGH EXPRESSION OF OPIOID RECEPTORS - Patent application	www.faqs.org	0	0		
1308	chr9	94834483	94889859	3500204883	1413		94834483	94889859	8421504	5	447,353,521,83,9	0,37099,38318,55283,55367	c	350020488300000116	0-1414						PERIPHERAL AND NEURAL INFLAMMATORY CROSSTALK - Patent application	www.faqs.org	0	0		
1308	chr9	94871619	94871699	3500305452	80		94871619	94871699	8421504	1	80	0	p,c	350030545200015081,350030545200000018	0-48,7-44						Human mu opioid receptor	Yu	1995	0		OPRM1
1308	chr9	94872840	94873281	3500209681	60		94872840	94873281	8421504	2	30,30	0,411	c	350020968100000000,350020968100000001	0-30,0-30		10861070		0022-1767	The Journal of Immunology	Ascaris suum, an Intestinal Parasite, Produces Morphine	Goumon	2000	6		OPRM1
1308	chr9	94872840	94873281	3500118399	40		94872840	94873281	8421504	2	20,20	0,421	c,g	350011839900000000,350011839900000000,350011839900000001,350011839900000001	0-20,0-20,0-20,0-20		15615897	10.1530/rep.1.00284	1470-1626	Reproduction	Expression and subcellular localization of the &#x03bc;-opioid receptor in equine spermatozoa: evidence for its functional role	Albrizio	2005	3		OPRM1
1308	chr9	94872931	94872979	3500116533	45		94872931	94872979	8421504	2	23,22	0,26	c	350011653300000001,350011653300000000	0-23,23-45		17553897	10.1128/JVI.00155-07	0022-538X	Journal of Virology	Expression of the Mu Opioid Receptor in the Human Immunodeficiency Virus Type 1 Transgenic Rat Model	Chang	2007	5		OPRM1
1312	chr9	95331491	95331517	3500043540	23		95331491	95331517	8421504	2	15,8	0,18	g	350004354000000091,350004354000000032,350004354000000367	4-27,1-24,7-30						US Patent # 6,987,212. Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use - Patents.com	www.patents.com	0	0		
1312	chr9	95353770	95353796	3500241875	24		95353770	95353796	8421504	3	13,4,7	0,14,19	g	350024187500000080,350024187500000702	0-37,0-32					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
1314	chr9	95560059	95560089	3500328917	27		95560059	95560089	8421504	2	8,19	0,11	g	350032891700000147	0-33						Human cDNAs and proteins and uses thereof - US Patent 7285631 Description	ww.patentstorm.us	0	0		
1316	chr9	95822110	95936425	3500042549	5121		95822110	95936425	8421504	27	1176,436,173,225,29,67,93,147,72,162,105,79,93,264,104,180,51,144,109,180,119,109,59,106,88,155,596	0,7504,11100,12532,15117,16454,19534,26570,32172,42744,44281,44585,47325,47996,68035,97593,100355,101327,102541,106435,108457,109523,110229,110857,111871,112323,113719	g	350004254900000063	0-5121						ISOLATION OF THE T-COMPLEX DISTORTERS AND APPLICATIONS THEREOF - Patent application	www.faqs.org	0	0		
1316	chr9	95926267	95926292	3500450040	24		95926267	95926292	8421504	2	5,19	0,6	g	350045004000000020	2-28						Plants with Increased Yield (NUE)	Schon	2011	0		
1317	chr9	96060364	96060389	3500419007	23		96060364	96060389	8421504	2	18,5	0,20	g	350041900700000004	11-34			10.1128/JVI.79.4.2393-2403.2005		Journal of Virology	Norovirus Proteinase-Polymerase and Polymerase Are Both Active Forms of RNA-Dependent RNA Polymerase	Gael	2005	0		
1327	chr9	97257148	97257294	3500156510	41		97257148	97257294	8421504	2	21,20	0,126	g	350015651000000104,350015651000000105	0-21,0-20						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
1330	chr9	97707939	97707964	3500253256	23		97707939	97707964	8421504	2	6,17	0,8	g	350025325600002467	14-37						 Methods Of Using Conjugated Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
1332	chr9	97924216	97932263	3500119454	39		97924216	97932263	8421504	4	7,13,5,14	0,8,8026,8033	g	350011945400000441,350011945400000267	23-43,24-43						 Soluble Recombinant Botulinum Toxin Proteins 	www.docstoc.com	0	0		
1335	chr9	98381150	98381176	3500420390	25		98381150	98381176	8421504	2	21,4	0,22	g	350042039000000136	3-28						SEQUENCE DIVERSITY GENERATION IN IMMUNOGLOBULINS AND OTHER PROTEINS - Patent application	www.faqs.org	0	0		
1337	chr9	98630442	98630466	3500463357	24		98630442	98630466	8421504	1	24	0	g	350046335700000066	0-24						Genes And Polypeptides Relating To Hepatocellular Or Colorectal Carcinoma 	.freshpatents.com	0	0		
1338	chr9	98823375	98823400	3500210328	24		98823375	98823400	8421504	2	12,12	0,13	c	350021032800000006	18-42						Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability--&#x300a;&#x6838;&#x9178;&#x7814;&#x7a76;&#x533b;&#x5b66;&#x671f;&	journal.9med.net	0	0		
1339	chr9	98863257	98863282	3500376145	24		98863257	98863282	8421504	2	10,14	0,11	c	350037614500000034	4-28						1 TITLE The Lactobacillus casei MaeKR two component system is required for L-malic acid	digital.csic.es	0	0		
1341	chr9	99185732	99193253	3500180480	722		99185732	99193253	8421504	7	165,135,129,78,124,42,49	0,166,307,722,1162,4710,7472	p,c	350018048000000012,350018048000000027,350018048000000026,350018048000000029,350018048000000001,350018048000000000,350018048000000003,350018048000000028,350018048000000002,350018048000015000,350018048000015006,350018048000015002,350018048000015001,350018048000015005,350018048000015007,350018048000015003	7-735,0-342,0-342,0-342,0-342,0-342,0-342,0-341,0-341,0-339,0-339,0-339,0-339,0-48,0-45,0-240						STIMULATING NEURITE OUTGROWTH USING TCTEX-1-RELATED POLYPEPTIDES - Patent application	www.faqs.org	0	0		
1341	chr9	99186097	99193231	3500446162	342		99186097	99193231	8421504	5	71,78,124,42,27	0,357,797,4345,7107	p,c	350044616200000001,350044616200000000,350044616200000003,350044616200000002,350044616200015007,350044616200015003,350044616200015002,350044616200015001,350044616200015006,350044616200015004	0-342,0-342,0-342,0-341,0-339,0-339,0-339,0-339,0-48,0-240						Stimulating neurite outgrowth using Tctex-1-related polypeptides	Sung	2008	0		
1341	chr9	99186097	99193231	3500348017	342		99186097	99193231	8421504	5	71,78,124,42,27	0,357,797,4345,7107	p,c	350034801700000003,350034801700000001,350034801700000000,350034801700000002,350034801700015006,350034801700015001,350034801700015002,350034801700015007,350034801700015003,350034801700015004	0-342,0-342,0-342,0-341,0-48,0-330,0-330,0-327,0-327,0-240						Tctex-1-related polypeptides	Sung	2006	0		
1342	chr9	99287353	99287382	3500266085	23		99287353	99287382	8421504	3	13,4,6	0,14,23	g	350026608500000009,350026608500000008	19-42,0-23		14747546	10.1128/JVI.78.4.1817-1830.2004	0022-538X	Journal of Virology	Small Internal Deletions in the Human Cytomegalovirus IE2 Gene Result in Nonviable Recombinant Viruses with Differential Defects in Viral Gene Expression	White	2004	5		
1342	chr9	99294824	99294848	3500312747	23		99294824	99294848	8421504	2	6,17	0,7	c	350031274700000007	2-25						HIV-1 Envelope Polypeptides for HIV Vaccine - Patent application	www.faqs.org	0	0		
1342	chr9	99295126	99295155	3500046122	29		99295126	99295155	8421504	1	29	0	c	350004612200000001,350004612200000000	0-29,0-29		16873375	10.1074/jbc.M602237200	0021-9258	Journal of Biological Chemistry	Androgen Induction of Prostate Cancer Cell Invasion Is Mediated by Ezrin	Chuan	2006	5		
1342	chr9	99295498	99295526	3500313229	23		99295498	99295526	8421504	2	12,11	0,17	g	350031322900000031,350031322900000030	0-23,4-27		23741432	10.1371/journal.pone.0064950		PLoS ONE	Identification of Diverse Lipid Droplet Targeting Motifs in the PNPLA Family of Triglyceride Lipases	Sricharan	2013	0		
1342	chr9	99298421	99298444	3500318051	23		99298421	99298444	8421504	1	23	0	c	350031805100000003	5-31						Controlling the Fibroblastic Differentiation of Mesenchymal Stem Cells Via the Combination of Fibrous Scaffolds and Connective Tissue Growth Factor	dspace.mit.edu	0	0		
1342	chr9	99312312	99312341	3500146501	26		99312312	99312341	8421504	2	18,8	0,21	c	350014650100000079	0-26					Patent	GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants (Patent CN:1665934)	D*E*A*Fu Luo La Ke 	2010	0		
1343	chr9	99481729	99481755	3500196016	26		99481729	99481755	8421504	1	26	0	g	350019601600000035,350019601600000031,350019601600000028,350019601600000022	1-22,1-24,1-24,1-24						Development of recombinant antibody-mediated resistance against Tomato yellow leaf curl virus	th.rwth-aachen.de	0	0		
1349	chr9	100182549	100185212	3500326548	46		100182549	100185212	8421504	2	24,22	0,2641	c,g	350032654800000001,350032654800000007	0-24,0-22		12040026	10.1210/me.16.6.1417	0888-8809	Molecular Endocrinology	Identification of Two Novel ACTH-Responsive Genes Encoding Manganese-Dependent Superoxide Dismutase (SOD2) and the Zinc Finger Protein TIS11b [Tetradecanoyl Phorbol Acetate (TPA)-Inducible Sequence 11b]	Chinn	2002	5		
1349	chr9	100184578	100184885	3500449159	47		100184578	100184885	8421504	2	24,23	0,284	c,g	350044915900000003,350044915900000003,350044915900000002	0-24,0-24,0-23						Evaluation of developmental changes in bovine in vitro produced embryos following exposure to bovine Herpesvirus type 5	www.rbej.com	0	0		
1349	chr9	100184578	100184885	3500202868	47		100184578	100184885	8421504	2	24,23	0,284	c,g	350020286800000003,350020286800000003,350020286800000002	0-24,0-24,0-23			10.1186/1477-7827-10-53		Reproductive Biology and Endocrinology : RB&E	Evaluation of developmental changes in bovine in vitro produced embryos following exposure to bovine Herpesvirus type 5	Mariana	2012	0		
1349	chr9	100184578	100184885	3500073604	47		100184578	100184885	8421504	2	24,23	0,284	c	350007360400000009,350007360400000008	0-24,0-23						Changes in gene expression profiles of bovine embryos produced in vitro, by natural ovulation, or hormonal superstimulation	w.funpecrp.com.br	0	0		
1349	chr9	100184578	100184885	3500017852	47		100184578	100184885	8421504	2	24,23	0,284	c,g	350001785200000003,350001785200000003,350001785200000002	0-24,0-24,0-23			10.1186/1477-7827-10-53		Reproductive Biology and Endocrinology : RB&E	Evaluation of developmental changes in bovine in vitro produced embryos following exposure to bovine Herpesvirus type 5	Mariana	2012	0		
1349	chr9	100184858	100184885	3500081911	27		100184858	100184885	8421504	1	27	0	c	350008191100000004	0-27						UNIVERSIDADE DE BRAS&#xcd;LIA FACULDADE DE AGRONOMIA E MEDICINA VETERIN&#xc1;RIA	itorio.bce.unb.br	0	0		
1349	chr9	100189193	100193834	3500455327	39		100189193	100193834	8421504	3	12,8,19	0,4603,4622	c,g	350045532700000004,350045532700000003,350045532700000003	0-20,0-19,0-19						Influence of Growth Factors on Bovine Embryo Development	cholar.lib.vt.edu	0	0		
1349	chr9	100193908	100193955	3500253779	47		100193908	100193955	8421504	1	47	0	c	350025377900000033	1-48						Mice having a mutant SOD-1-encoding transgene	Brown	1994	0		
1349	chr9	100193914	100193962	3500195183	48		100193914	100193962	8421504	1	48	0	c	350019518300000011	0-48						Human manganese superoxide dismutase proteins	Nick	1998	0		
1349	chr9	100222603	100222632	3500384746	24		100222603	100222632	8421504	2	15,9	0,20	g	350038474600000034	11-37						Albumin Fusion Proteins 	.freshpatents.com	0	0		
1349	chr9	100256946	100257047	3500261436	40		100256946	100257047	8421504	2	20,20	0,81	c,g	350026143600000004,350026143600000004,350026143600000005	0-20,0-20,0-20						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
1350	chr9	100272015	100272039	3500457732	23		100272015	100272039	8421504	2	18,5	0,19	c	350045773200000006	7-30						Method and device for optimizing a nucelotide sequence for the purpose of expression in a protein	Raab	2013	0		
1351	chr9	100444175	100444220	3500458997	45		100444175	100444220	8421504	1	45	0	p	350045899700015011	0-45						<Html><Title> Complet list of 1h18 hssp file</Title><body bgcolor="FF FF CC"><Title> Complet list of	cnptia.embrapa.br	0	0		ZIC2
1351	chr9	100473978	100474004	3500087648	26		100473978	100474004	8421504	1	26	0	c	350008764800000023	18-44						MOLECULAR CLONING AND SEQUENCING OF FISH MPR 300	d.inflibnet.ac.in	0	0		
1351	chr9	100485982	100486006	3500036931	24		100485982	100486006	8421504	1	24	0	c	350003693100000014	0-24						Maturation medium supplements affect transcript level of apoptosis and cell survival related genes in bovine blastocysts produced in vitro	www.ufpel.edu.br	0	0		
1351	chr9	100497490	100500183	3500308562	45		100497490	100500183	8421504	3	6,17,22	0,1021,2671	c,g	350030856200000006,350030856200000007,350030856200000007	0-23,0-22,0-22						 SpringerImages - Primers used for Real time PCR validation 	pringerimages.com	0	0		
1351	chr9	100500224	100500978	3500127481	43		100500224	100500978	8421504	2	20,23	0,731	c,g	350012748100000005,350012748100000005,350012748100000004,350012748100000004	0-20,0-20,24-47,24-47						Insulin-Like Growth Factor (IGF) 2 Stimulates Steroidogenesis and Mitosis of Bovine Granulosa Cells Through the IGF1 Receptor: Role of Follicle-Stimulating Hormone and IGF2 Receptor	ww.biolreprod.org	0	0		
1351	chr9	100500957	100501500	3500315971	43		100500957	100501500	8421504	3	22,8,13	0,90,530	c,g	350031597100000006,350031597100000006,350031597100000007	0-22,0-22,0-21						REPRODUCTION	uction-online.org	0	0		
1351	chr9	100500957	100501500	3500248474	43		100500957	100501500	8421504	3	22,8,13	0,90,530	c,g	350024847400000020,350024847400000020,350024847400000021	0-22,0-22,0-21						REPRODUCTION	uction-online.org	0	0		
1351	chr9	100500957	100501500	3500024081	43		100500957	100501500	8421504	3	22,8,13	0,90,530	c,g	350002408100000006,350002408100000006,350002408100000007	0-22,0-22,0-21						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
1351	chr9	100524313	100524885	3500218393	50		100524313	100524885	8421504	2	25,25	0,547	c,g	350021839300000016,350021839300000017	0-25,0-25						Nuclear Transfer Protocol Affects Messenger RNA Expression Patterns in Cloned Bovine Blastocysts	ww.biolreprod.org	0	0		
1351	chr9	100524313	100524885	3500073604	50		100524313	100524885	8421504	2	25,25	0,547	c,g	350007360400000002,350007360400000003,350007360400000003	0-26,0-25,0-25						Changes in gene expression profiles of bovine embryos produced in vitro, by natural ovulation, or hormonal superstimulation	w.funpecrp.com.br	0	0		
1351	chr9	100524772	100525263	3500361666	47		100524772	100525263	8421504	2	24,23	0,468	c	350036166600000301,350036166600000111,350036166600000112,350036166600000302	0-24,0-24,0-23,0-23						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
1351	chr9	100524772	100525263	3500156510	47		100524772	100525263	8421504	2	24,23	0,468	c,g	350015651000000112,350015651000000113,350015651000000113	0-24,0-23,0-23						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
1352	chr9	100538300	100538324	3500456445	23		100538300	100538324	8421504	2	8,15	0,9	c	350045644500000005	10-33						Production of polyketides	Arslanian	2005	0		
1352	chr9	100538300	100538324	3500241887	23		100538300	100538324	8421504	2	8,15	0,9	c	350024188700000005	10-33						Heterologous production of polyketides	Arslanian	2003	0		
1352	chr9	100546051	100546166	3500348778	40		100546051	100546166	8421504	2	20,20	0,95	c,g	350034877800000010,350034877800000011,350034877800000011	0-20,0-20,0-20						Analysis of imprinted gene expression in normal fertilized and uniparental preimplantation porcine embryos. - ResearchGate	.researchgate.net	0	0		
1352	chr9	100555078	100555105	3500162943	23		100555078	100555105	8421504	2	8,15	0,12	g	350016294300000002	0-24					Patent	Prohormone convertase transformed cells (Patent EP:0616645)	Gorman	2001	0		
1354	chr9	100823449	100824885	3500361666	47		100823449	100824885	8421504	3	27,17,3	0,391,1433	c	350036166600000110,350036166600000300,350036166600000109,350036166600000299	0-27,0-27,0-20,0-20						Qtls for Mastitis Resistance in Cattle - Patent application	www.faqs.org	0	0		
1354	chr9	100823449	100824885	3500156510	47		100823449	100824885	8421504	3	27,17,3	0,391,1433	c	350015651000000111,350015651000000110	0-27,0-20						Qtls For Mastitis Resistance In Cattle 	.freshpatents.com	0	0		
1354	chr9	100823520	100823546	3500377715	23		100823520	100823546	8421504	2	9,14	0,12	c	350037771500000007	8-31						Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2	Creasey	1996	0		
1354	chr9	100823520	100823546	3500370584	23		100823520	100823546	8421504	2	9,14	0,12	c	350037058400000196,350037058400000279	19-42,19-42						Protease inhibition - Patent application	www.faqs.org	0	0		
1354	chr9	100823520	100823546	3500248879	23		100823520	100823546	8421504	2	9,14	0,12	c	350024887900000192	19-42						Protease Inhibition 	.freshpatents.com	0	0		
1354	chr9	100823734	100825005	3500108068	246		100823734	100825005	8421504	2	123,123	0,1148	p	350010806800015098,350010806800015094,350010806800015096	0-66,0-63,0-180						Protein amf-1 to amf-10 and nucleic acids encoding the same	Burgess	2001	0		
1354	chr9	100825018	100857933	3500395462	62		100825018	100857933	8421504	3	10,16,36	0,2743,32879	c	350039546200000072,350039546200000037	0-26,5-41					Patent	Activatable fibrinolytic and anti-thrombotic proteins (Patent US:5637492)	Dawson	1997	0		
1354	chr9	100827820	100827846	3500463784	26		100827820	100827846	8421504	1	26	0	c	350046378400000014	12-38					Patent	Modified plasmin precursors with resistance to inhibitors of plasmin (Patent US:5932213)	Dawson	1999	0		
1354	chr9	100827820	100827846	3500212251	26		100827820	100827846	8421504	1	26	0	c	350021225100000014	12-38					Patent	Inhibitor resistant serine proteases (Patent US:5645833)	Dawson	1997	0		
1354	chr9	100830435	100845188	3500115158	103		100830435	100845188	8421504	5	30,8,24,21,20	0,10321,14619,14654,14733	c	350011515800000351,350011515800000231,350011515800000174,350011515800000230,350011515800000287,350011515800000150	9-39,5-37,8-40,24-45,24-45,24-44						 Modulation Of Apolipoprotein (a) Expression 	www.docstoc.com	0	0		
1354	chr9	100830435	100845188	3500034199	101		100830435	100845188	8421504	5	30,20,7,24,20	0,2812,10322,14619,14733	c	350003419900000354,350003419900000350,350003419900000127,350003419900000096	15-45,28-48,17-48,27-47						MODULATION OF APOLIPOPROTEIN (a) EXPRESSION - Patent application	www.faqs.org	0	0		
1354	chr9	100830438	100830465	3500248450	27		100830438	100830465	8421504	1	27	0	c	350024845000000067	21-48						Activatable fibrinolytic and anti-thrombotic proteins - US Patent 5637492 Description	ww.patentstorm.us	0	0		
1354	chr9	100837472	100845189	3500455371	250		100837472	100845189	8421504	6	45,48,90,2,46,19	0,884,938,1031,3119,7698	p,c	350045537100015075,350045537100015074,350045537100015073,350045537100015078,350045537100015072,350045537100000001,350045537100000035	0-48,0-45,0-45,0-48,0-93,26-45,26-45						 Antiangiogenic Peptides, Polypeptides Encoding Same And Methods For Inhibiting Angiogenesis 	www.docstoc.com	0	0		
1354	chr9	100838416	100865894	3500313787	55		100838416	100865894	8421504	3	24,26,5	0,25908,27473	c	350031378700000001,350031378700000000	0-24,0-31						Methods and compositions for diagnosing and treating disorders involving angiogenesis	Sheppard	2002	0		
1354	chr9	100840721	100860060	3500236891	474		100840721	100860060	8421504	12	43,53,11,37,13,35,45,48,32,13,124,20	0,4333,4482,10409,10543,11229,11312,13265,15086,17099,17115,19319	p	350023689100015080,350023689100015125,350023689100015124,350023689100015107,350023689100015122,350023689100015103,350023689100015118,350023689100015117,350023689100015116,350023689100015115	0-48,0-48,0-48,0-48,0-45,0-48,0-45,0-48,0-48,0-48						Angiostatin fragments and method of use	Folkman	2000	0		
1354	chr9	100857897	100857932	3500388237	35		100857897	100857932	8421504	1	35	0	c	350038823700000014	0-35						ANTI-ANGIOGENIC PROTEIN, COMPOSITION AND USE THEREOF - Patent application	www.faqs.org	0	0		
169	chr9	101045133	101117677	3500028471	125		101045133	101117677	8421504	5	26,22,37,31,9	0,3761,3832,19907,72535	c	350002847100000118,350002847100000116,350002847100000108	0-48,10-47,7-47						Method of screening compounds that inhibit lysophosphatidic acid acyltransferase	Leung	2001	0		
1356	chr9	101111732	101111756	3500441209	23		101111732	101111756	8421504	2	17,6	0,18	g	350044120900000342	19-44						Antibodies Against Lesion Tissue 	.freshpatents.com	0	0		
1358	chr9	101377001	101377027	3500405663	23		101377001	101377027	8421504	3	5,5,13	0,6,13	g	350040566300000035	15-39						US Patent # 6,512,097. High affinity human antibodies to tumor antigens - Patents.com	www.patents.com	0	0		
1359	chr9	101488888	101488915	3500467212	27		101488888	101488915	8421504	1	27	0	c	350046721200000004	0-27		20089136	10.1111/j.1471-4159.2010.06605.x	1471-4159	Journal of Neurochemistry	Identification and characterization of a novel endogenous murine parkin mutation - Ramsey - 2010 - Journal of Neurochemistry - Wiley Online Library	Ramsey	2010	0		
1360	chr9	101622447	101622478	3500031312	23		101622447	101622478	8421504	3	5,12,6	0,8,25	g	350003131200000006	5-28					Patent	Polyhydroxyalkanoate synthesis in plants (Patent US:6103956)	Eschenlauer	2000	0		
1361	chr9	101768599	101768627	3500089211	24		101768599	101768627	8421504	3	12,7,5	0,15,23	g	350008921100000008	10-35						PLANTS HAVING IMPROVED TOLERANCE TO VARIOUS TYPES OF ENVIRONMENTAL STRESS, THEIR PRODUCTION, AND POLYAMINE METABOLISM-RELATED ENZYME GENES - Patent application	www.faqs.org	0	0		
1363	chr9	102025621	102025645	3500339491	23		102025621	102025645	8421504	2	19,4	0,20	g	350033949100000066	5-29						Vaccine For Preventing And Treating Porcine Progressive Atrophic Rhinitis 	.freshpatents.com	0	0		
1379	chr9	104162297	104162322	3500369366	23		104162297	104162322	8421504	2	16,7	0,18	g	350036936600000154	10-34						Focused libraries of genetic packages	Ladner	2011	0		
1383	chr9	104597484	104597512	3500280721	23		104597484	104597512	8421504	2	17,6	0,22	g	350028072100000364	7-30						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
1388	chr9	105340877	105342206	3500403175	114		105340877	105342206	8421504	3	25,62,27	0,141,1302	p	350040317500015012	0-114						Mesoderm formation in the rabbit gastrula	ev.biologists.org	0	0		
1388	chr9	105343387	105344247	3500430178	42		105343387	105344247	8421504	2	21,21	0,839	c,g	350043017800000014,350043017800000014,350043017800000013,350043017800000013	0-21,0-21,0-21,0-21						A novel signaling pathway in mouse embryonic stem cells	ibg.uu.se/digital	0	0		T
1389	chr9	105403750	105403778	3500181669	23		105403750	105403778	8421504	2	11,12	0,16	g	350018166900000008	0-23						Ubiquitin fusion-based vaccine system	Kenten	2003	0		
1389	chr9	105403750	105403778	3500167829	23		105403750	105403778	8421504	2	11,12	0,16	g	350016782900000008	0-23						Heat shock fusion-based vaccine system	Kenten	2001	0		
1389	chr9	105403750	105403778	3500166394	23		105403750	105403778	8421504	2	11,12	0,16	g	350016639400000031	0-23						Ubiquitin fusion-based vaccine system	Kenten	2001	0		
1389	chr9	105403750	105403778	3500073094	23		105403750	105403778	8421504	2	11,12	0,16	g	350007309400000008	0-23						Heat shock fusion-based vaccine system	Kenten	1999	0		
1389	chr9	105501905	105501932	3500149045	23		105501905	105501932	8421504	2	10,13	0,14	c	350014904500000000	0-23						Genes and proteins associated with angiogenesis and uses thereof	Schiemann	2006	0		
173	chr9	105580466	105734981	3500295452	2016		105580466	105734981	8421504	20	123,138,118,77,162,159,90,75,102,65,89,71,143,38,107,80,81,82,117,99	0,1696,4034,5464,9546,11180,12086,24766,33350,40870,48707,50679,53910,56091,58800,65757,66918,79381,87906,154416	p	350029545200015025,350029545200015024	0-942,0-1074						Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer	Fritz	2011	0		
1390	chr9	105590540	105590565	3500135136	23		105590540	105590565	8421504	2	12,11	0,14	g	350013513600000121,350013513600000122	0-26,0-26						AGENT FOR PREVENTING/TREATING CANCER - Patent application	www.faqs.org	0	0		
1390	chr9	105590540	105590565	3500116024	23		105590540	105590565	8421504	2	12,11	0,14	g	350011602400000122,350011602400000121	0-26,0-26						Preventive/Remedy for Cancer - Patent application	www.faqs.org	0	0		
1391	chr9	105734957	105734981	3500072600	24		105734957	105734981	8421504	1	24	0	c	350007260000000011	21-45						CriticalroleforRsk2inT-lymphocyteactivation	tologylibrary.org	0	0		
1391	chr9	105759154	105759178	3500406455	23		105759154	105759178	8421504	2	14,9	0,15	g	350040645500000071	10-33						&#x9ad8;&#x3044;&#x30a8;&#x30cd;&#x30eb;&#x30ae;&#x30fc;&#x79fb;&#x52d5;&#x52b9;&#x7387;&#x3092;&#x6709;&#x3059;&#x308b;&#xff22;&#xff32;&#xff25;&#xff34;&#x767a;&#x73fe;&#x7cfb; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; 2008283959&#xff09;&#xff5c;&#x30a2;&#x	astamuse.com	0	0		
1392	chr9	105879233	105879261	3500193314	28		105879233	105879261	8421504	1	28	0	g	350019331400000001	23-51						Origins of Central Siberian Populations Mitochondrial DNA Evidence	www.scribd.com	0	0		
1392	chr9	105892172	105892198	3500243976	23		105892172	105892198	8421504	2	9,14	0,12	g	350024397600000013	7-30						Procine Circovirus Type 2 Vaccines 	.freshpatents.com	0	0		
1394	chr9	106085685	106086576	3500212895	23		106085685	106086576	8421504	2	6,17	0,874	c	350021289500000051	0-23						Prognostic markers and therapeutic targets for lung cancer	Nakamura	2010	0		
1395	chr9	106226382	106226411	3500127909	25		106226382	106226411	8421504	2	10,15	0,14	g	350012790900000226	10-36						Protease inhibition	Ladner	2008	0		
1398	chr9	106588490	106588517	3500405823	23		106588490	106588517	8421504	2	12,11	0,16	g	350040582300000109	3-29						Parathyroid hormone receptor	www.devileye.net	0	0		
1399	chr9	106714217	106714242	3500219868	24		106714217	106714242	8421504	2	16,8	0,17	g	350021986800000000	8-33		19843526	10.1074/jbc.M109.028852		The Journal of Biological Chemistry	MODY7 Gene, KLF11, Is a Novel p300-dependent Regulator of Pdx-1 (MODY4) Transcription in Pancreatic Islet &#x03b2; Cells	Martin	2009	0		
1399	chr9	106714217	106714242	3500219618	24		106714217	106714242	8421504	2	16,8	0,17	g	350021961800000000	8-33		19843526	10.1074/jbc.M109.028852	0021-9258	Journal of Biological Chemistry	MODY7 Gene, KLF11, Is a Novel p300-dependent Regulator of Pdx-1 (MODY4) Transcription in Pancreatic Islet &#x03b2; Cells	Fernandez-Zapico	2009	5		
1401	chr9	107073334	107073357	3500151042	23		107073334	107073357	8421504	1	23	0	g	350015104200000010	6-31						Kappa casein gen (CSN3) in horse: genetic variability in exon 1 and 4 - ResearchGate	.researchgate.net	0	0		
1402	chr9	107177343	107177372	3500408175	23		107177343	107177372	8421504	3	6,5,12	0,11,17	g	350040817500000061	0-23						 Poly 	www.docstoc.com	0	0		
175	chr9	107477424	107503613	3500201187	3504		107477424	107503613	8421504	22	5,140,98,272,228,235,119,160,108,219,153,128,174,177,165,1,90,141,197,85,557,52	0,1764,3058,4467,5130,6650,7516,9052,10538,11277,11820,12052,12665,13008,13355,14576,14583,15360,17572,20814,22145,26137	p,c	350020118700015060,350020118700015057,350020118700015059,350020118700015054,350020118700015056,350020118700015051,350020118700015049,350020118700015046,350020118700015042,350020118700000000,350020118700015039,350020118700015041,350020118700015040,350020118700015036,350020118700015037,350020118700015038,350020118700015034,350020118700015030,350020118700015031,350020118700015028,350020118700015025,350020118700015024,350020118700015021,350020118700015022,350020118700015019,350020118700015016,350020118700015013,350020118700015010,350020118700015007,350020118700015004	0-54,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-22,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,0-180,12-180,0-168,0-180,0-180,0-180,0-180,0-180,0-222						Equine thrombospondin II (THBS2) and secreted protein acidic and cysteine-rich	cs.physiology.org	0	0		
1405	chr9	107499795	107500012	3500091455	39		107499795	107500012	8421504	2	19,20	0,197	c,g	350009145500000015,350009145500000015,350009145500000014,350009145500000014	0-19,0-19,0-20,0-20		22174022	10.1095/biolreprod.111.095067	0006-3363	Biology of Reproduction	Regulation of Angiogenesis-Related Prostaglandin F2alpha-Induced Genes in the Bovine Corpus Luteum	Zalman	2012	4		
1407	chr9	107796794	107796822	3500116045	23		107796794	107796822	8421504	2	8,15	0,13	g	350011604500000039	22-45						Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease	Progulske-fox	1994	0		
1408	chr9	107951514	107951541	3500440776	23		107951514	107951541	8421504	3	13,5,5	0,14,22	g	350044077600000002	2-25		9949156		0006-4971	Blood	Coreceptor/Chemokine Receptor Expression on Human Hematopoietic Cells: Biological Implications for Human Immunodeficiency Virus&#x2013;Type 1 Infection	Lee	1999	10		
1409	chr9	108033695	108033722	3500079533	23		108033695	108033722	8421504	2	8,15	0,12	g	350007953300000295	0-26					Patent	Live vaccine and method of manufacture (Patent CN:1582333)	A*Ai Ge Luo Fu 	2010	0		
1411	chr9	108334679	108334703	3500090345	23		108334679	108334703	8421504	2	10,13	0,11	g	350009034500000048	0-23						Anti-cd14 antibody fusion protein	Furusako	2012	0		
1412	chr9	108428840	108428867	3500181389	23		108428840	108428867	8421504	2	14,9	0,18	g	350018138900000017	0-26						Interaction of Moraxella Catarrhalis with Epithelial Cells, Extracellular Matrix Proteins and the Complement System - Patent application	www.faqs.org	0	0		
585	chrM	0	420	3500361967	420		0	420	8421504	1	420	0	g	350036196700000004	558-978						AN&#xc1;LISIS DE LA VARIABILIDAD GEN&#xc9;TICA EN LA RAZA BOVINA DE LIDIA UTILIZANDO INFORMACI&#xd3;N MOLECULAR	emigracion.ucm.es	0	0		
585	chrM	0	27	3500269870	27		0	27	8421504	1	27	0	g	350026987000000047	23-50						Evolution of the Mammalian Mitochondrial Control Region-Comparisons of Control Region Sequences Between Monotreme and Therian Mammals	brary.arizona.edu	0	0		
585	chrM	0	16264	3500447716	697		0	16264	8421504	6	171,158,159,153,20,36	0,180,15822,16028,16207,16228	g	350044771600000020,350044771600000032,350044771600000042,350044771600000010,350044771600000021,350044771600000037,350044771600000018,350044771600000039,350044771600000040,350044771600000019,350044771600000008,350044771600000035,350044771600000028,350044771600000023,350044771600000009,350044771600000036	91-262,0-120,0-158,0-20,0-157,0-20,0-159,0-159,0-153,0-150,0-20,0-20,0-20,1-24,0-20,0-20						Method for detecting the presence of biological matters of bovine origin, and oligonucleotides for its implementation	Hanni	2000	0		
585	chrM	134	15923	3500446935	63		134	15923	8421504	3	22,21,20	0,15473,15769	g	350044693500000001,350044693500000000,350044693500000002	0-22,0-21,0-20						Szent Istv&#xe1;n Egyetem &#xc1;llatorvos-tudom&#xe1;nyi Doktori Iskola	huveta.hu/bitstre	0	0		
585	chrM	332	16233	3500147470	40		332	16233	8421504	2	20,20	0,15881	g	350014747000000008,350014747000000007	0-20,0-20						Impacts of genetic drift and restricted gene flow in indigenous cattle breeds: evidence from the Jutland breed | Eline Lorenzen - Academia.edu	www.academia.edu	0	0		
585	chrM	381	407	3500183022	26		381	407	8421504	1	26	0	g	350018302200000001	0-26						Pan-African Genetic Structure in the African Buffalo (Syncerus caffer): Investigating Intraspecific Divergence. - ResearchGate	.researchgate.net	0	0		
585	chrM	381	1058	3500012318	48		381	1058	8421504	2	26,22	0,655	g	350001231800000000,350001231800000002	0-26,0-22						Molecular and Morphological Phylogenies of Ruminantia and the Alternative Position of the Moschidae | Alexandre Hassanin - Academia.edu	www.academia.edu	0	0		
585	chrM	384	2799	3500134059	60		384	2799	8421504	3	20,20,20	0,1995,2395	g	350013405900000000,350013405900000011,350013405900000012	0-20,0-20,0-20						Biological Identifications Through DNA Barcodes	dn.intechopen.com	0	0		
585	chrM	384	16284	3500302718	85		384	16284	8421504	5	20,23,15,6,21	0,14077,14955,14971,15879	g	350030271800000005,350030271800000000,350030271800000002,350030271800000003	0-20,0-23,0-21,0-21						REPRODUCTION AND GENETIC DIVERSITY OF THE SWAMP BUFFALO Voortplanting en genetische diversiteit van de karbouw	ive.library.uu.nl	0	0		
585	chrM	400	14675	3500254924	162		400	14675	8421504	8	20,20,20,22,20,20,20,20	0,393,1173,2266,3079,9283,10962,14255	g	350025492400000001,350025492400000002,350025492400000026,350025492400000005,350025492400000003,350025492400000013,350025492400000021,350025492400000022	0-20,0-20,0-20,0-22,0-20,0-20,0-20,0-20						OPEN ACCESS International Journal of Molecular Sciences	www.mdpi.com	0	0		
585	chrM	469	493	3500169405	24		469	493	8421504	1	24	0	g	350016940500000001	0-24						REPRODUCTION	uction-online.org	0	0		
585	chrM	663	2893	3500185639	157		663	2893	8421504	7	19,21,20,22,30,20,25	0,306,598,1075,1699,1941,2205	g	350018563900000002,350018563900000004,350018563900000006,350018563900000009,350018563900000013,350018563900000015,350018563900000018	0-19,0-21,8-28,0-22,0-30,0-20,0-25						Further Evidence for Inclusion of the New Zealand Short-Tailed Bat (Mystacina tuberculata) within Noctilionoidea	www.jstor.org	0	0		
585	chrM	809	14770	3500409160	120		809	14770	8421504	6	20,20,20,20,20,20	0,186,6950,7599,13749,13941	g	350040916000000002,350040916000000003,350040916000000004,350040916000000008,350040916000000006,350040916000000007	0-20,0-20,0-20,0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
585	chrM	826	850	3500361355	24		826	850	8421504	1	24	0	g	350036135500000000	0-24						Suppression of human tumor cell proliferation through mitochondrial targeting	www.fasebj.org	0	0		RGS18
585	chrM	845	8311	3500447295	195		845	8311	8421504	2	19,176	0,7290	g	350044729500000008,350044729500000005,350044729500000003	20-39,0-176,0-20						ANNALS OF ANIMAL SCIENCE	ww.izoo.krakow.pl	0	0		
585	chrM	858	882	3500270088	24		858	882	8421504	1	24	0	g	350027008800000029,350027008800000033	0-23,0-24						BMC Medical Genetics BioMed Central	biomedcentral.com	0	0		
585	chrM	908	9754	3500375699	996		908	9754	8421504	7	6,142,7,328,9,471,33	0,7,160,7581,8331,8341,8813	g	350037569900000020,350037569900000010,350037569900000004	14-175,9-337,0-513						Diagnosis of bovine viral diarrhea virus	Austin	2004	0		
585	chrM	941	1367	3500417171	417		941	1367	8421504	2	267,150	0,276	g	350041717100000220,350041717100000187,350041717100000185,350041717100000197,350041717100000222,350041717100000201,350041717100000208,350041717100000224,350041717100000190,350041717100000194,350041717100000228,350041717100000202,350041717100000206	0-88,0-49,0-50,0-47,0-90,0-50,0-50,0-89,0-50,0-50,5-70,0-50,14-50						UNIVERSIDAD COMPLUTENSE DE MADRID	www.elfoiegras.es	0	0		
585	chrM	969	1192	3500229051	44		969	1192	8421504	2	20,24	0,199	g	350022905100000006,350022905100000007	0-20,0-24						Reprogramming of Human Somatic Cells Using Human and Animal Oocytes	advancedcell.com	0	0		
585	chrM	970	15727	3500308662	44		970	15727	8421504	2	22,22	0,14735	g	350030866200000001,350030866200000000	0-22,0-22						DNA	.lib.kobe-u.ac.jp	0	0		
585	chrM	1036	4245	3500023035	67		1036	4245	8421504	3	22,24,21	0,1730,3188	g	350002303500000013,350002303500000056,350002303500000004	0-22,0-24,7-28						Mitochondrial Mutations And Rearrangements As A Diagnostic Tool For The Detection Of Sun Exposure, Prostate Cancer And Other Cancers 	.freshpatents.com	0	0		MAP9
585	chrM	1036	13288	3500080185	136		1036	13288	8421504	6	22,24,24,21,22,23	0,1730,1835,3188,4473,12229	g	350008018500000013,350008018500000056,350008018500000057,350008018500000004,350008018500000010,350008018500000044	0-22,0-24,0-24,7-28,3-25,0-23						Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers	Parr	2011	0		
585	chrM	1255	16187	3500258270	127		1255	16187	8421504	5	22,22,44,17,22	0,1122,14717,14767,14910	g	350025827000000001,350025827000000004,350025827000000013,350025827000000000	0-22,0-22,0-66,0-22						Evolution of the Mitochondrial Genome In Mammals Living at High Altitude: New Insights From a Study of the Tribe Caprini (Bovidae, Antilopinae) | Alexandre Hassanin - Academia.edu	www.academia.edu	0	0		
585	chrM	1693	2441	3500158927	43		1693	2441	8421504	2	21,22	0,726	g	350015892700000000,350015892700000001	0-21,0-22						Cytogenetic and molecular analysis of the Pantaneiro cattle breed	www.scielo.br	0	0		
585	chrM	1693	11788	3500123610	41		1693	11788	8421504	2	21,20	0,10075	g	350012361000000004,350012361000000000	0-21,0-20			10.1590/S1415-47571999000400013	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Is the American Zebu really Bos indicus?	Meirelles	1999	1		
585	chrM	2257	14938	3500041125	42		2257	14938	8421504	2	20,22	0,12659	g	350004112500000001,350004112500000003	0-20,8-30		23082748	10.1186/1743-422X-9-240		Virology Journal	Molecular detection of a novel paramyxovirus in fruit bats from Indonesia	Michihito	2012	0		
585	chrM	2286	2530	3500077572	44		2286	2530	8421504	2	22,22	0,222	g	350007757200000009,350007757200000010	0-22,0-22						Complete genome sequence of an astrovirus identified in a domestic rabbit (Oryctolagus cuniculus) with gastroenteritis	ace.tennessee.edu	0	0		
585	chrM	2365	2874	3500392769	44		2365	2874	8421504	3	16,6,22	0,19,487	g	350039276900000001,350039276900000002	0-23,0-22						Antarctic marine benthic invertebrates: chemical ecology, bioactivity and biodiversity	www.tdx.cat	0	0		
585	chrM	2374	2795	3500329517	39		2374	2795	8421504	2	19,20	0,401	g	350032951700000015,350032951700000018	0-19,0-20						ScienceDirect.com - Current Biology - Nuclear Gene Sequences from a Late Pleistocene Sloth Coprolite	sciencedirect.com	0	0		MTRNR2L1
585	chrM	2376	2399	3500168523	23		2376	2399	8421504	1	23	0	g	350016852300000002,350016852300000009	0-23,1-24						Expression of a novel non-coding mitochondrial RNA in human proliferating cells--&#x300a;&#x6838;&#x9178;&#x7814;&#x7a76;&#x533b;&#x5b66;&#x671f;&#x520a;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		
585	chrM	2508	2627	3500169687	41		2508	2627	8421504	2	21,20	0,99	g	350016968700000002,350016968700000004	0-21,0-20		8552600			Proceedings of the National Academy of Sciences of the United States of America	Molecular phylogeny of the extinct ground sloth Mylodon darwinii.	Hoss	1996	0		PRSS1,MTRNR2L8
585	chrM	2508	2535	3500249036	25		2508	2535	8421504	3	16,4,5	0,17,22	g	350024903600000002	0-25						&#x4ee5;&#x53e4;&#x4ee3;&#x51fa;&#x6c34;&#x8150;&#x8089;&#x4e3a;&#x4f8b;&#x521d;&#x6b65;&#x63a2;&#x8ba8;&#x53e4;DNA	www.casb.org.cn	0	0		SLC47A1
585	chrM	2508	15538	3500441147	82		2508	15538	8421504	6	15,5,9,13,20,20	0,16,265,275,12469,13010	g	350044114700000003,350044114700000004,350044114700000001,350044114700000002	0-20,0-22,0-20,0-20		23050856	10.1186/1756-3305-5-230		Parasites & Vectors	Reconsideration of Anopheles rivulorum as a vector of Plasmodium falciparum in western Kenya: some evidence from biting time, blood preference, sporozoite positive rate, and pyrethroid resistance	Hitoshi	2012	0		
585	chrM	2718	2742	3500194202	24		2718	2742	8421504	1	24	0	g	350019420200000000	0-24						Method of test for animal-derived ingredients in foods	Shih	2005	0		PRSS1,RAE1
585	chrM	2725	2748	3500115675	23		2725	2748	8421504	1	23	0	g	350011567500000000	0-23						Anti-Aging Animals Links	rch.homestead.com	0	0		PRSS1
585	chrM	2769	2874	3500116836	39		2769	2874	8421504	2	19,20	0,85	g	350011683600000002,350011683600000003	0-19,0-20						Genetically modi&#xfb01;ed soya bean in rabbit feeding: detection of DNA fragments and evaluation of metabolic effects by enzymatic analysis	www.stopogm.net	0	0		
585	chrM	2769	16224	3500003113	101		2769	16224	8421504	5	19,20,20,21,21	0,236,381,13391,13434	g	350000311300000000,350000311300000004,350000311300000001,350000311300000010,350000311300000012	0-19,0-20,0-20,0-21,0-21						Pronounced Segregation of Donor Mitochondria Introduced by Bovine Ooplasmic Transfer to the Female Germ-Line	ww.biolreprod.org	0	0		
585	chrM	2773	14997	3500184012	42		2773	14997	8421504	3	9,13,20	0,10,12204	g	350018401200000004,350018401200000001	0-22,0-20		23050856	10.1186/1756-3305-5-230	1756-3305	Parasites & Vectors	Reconsideration of Anopheles rivulorum as a vector of Plasmodium falciparum in western Kenya: some evidence from biting time, blood preference, sporozoite positive rate, and pyrethroid resistance	Kawada	2012	3		
585	chrM	2779	4614	3500389994	43		2779	4614	8421504	2	21,22	0,1813	g	350038999400000036,350038999400000006	0-21,0-22						TABLE OF CONTENTS	www.cstl.nist.gov	0	0		PRSS1
585	chrM	2835	2858	3500361710	23		2835	2858	8421504	1	23	0	g	350036171000000003	0-23						A multiplex allele-specific primer extension assay for forensically informative SNPs distributed throughout the mitochondrial genome	www.cstl.nist.gov	0	0		
585	chrM	2835	2858	3500131415	23		2835	2858	8421504	1	23	0	g	350013141500000003	0-23						A multiplex allele-specific primer extension assay for forensically informative SNPs distributed throughout the mitochondrial genome	.bioforensics.com	0	0		
585	chrM	2850	2874	3500050206	24		2850	2874	8421504	1	24	0	g	350005020600000000	0-24			10.1590/S1415-47572005000100009	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Molecular phylogeny of the genus Saguinus (Platyrrhini, Primates) based on the ND1 mitochondrial gene and implications for conservation	Tagliaro	2005	1		PRSS1
585	chrM	3184	3243	3500137334	59		3184	3243	8421504	1	59	0	g	350013733400000042	0-59						ISOLATION OF ANTIGENIC PEPTIDES OF COWDRIA RUMINANTIUM AND THEIR ENCODING GENES USING A GENOME-DERIVED PHAGE DISPLAY LIBRARY	eprints.ru.ac.za	0	0		
585	chrM	4196	4265	3500166849	68		4196	4265	8421504	2	51,17	0,52	g	350016684900000002	0-68						Compositions and Methods for Regulating Cytochrome c-Mediated Apoptosis by tRNA	Yang	2010	0		
585	chrM	5508	12110	3500191741	46		5508	12110	8421504	2	20,26	0,6576	g	350019174100000025,350019174100000005	0-20,0-26						Papel de las mutaciones	www.tdx.cat	0	0		
585	chrM	5721	6207	3500389839	486		5721	6207	8421504	1	486	0	g	350038983900000000	0-486						Biotechnology in the restoration of extinct animal BioTechnologia	www.docstoc.com	0	0		
585	chrM	5721	6207	3500211605	486		5721	6207	8421504	1	486	0	g	350021160500000000	0-486						Biotechnology in the restoration of extinct animal species. An analysis of genomic and mitochondrial DNA of aurochs	logia-journal.net	0	0		
585	chrM	5721	6207	3500084309	486		5721	6207	8421504	1	486	0	g	350008430900000000	0-486						Biotechnology in the restoration of extinct animal species. An analysis of genomic and mitochondrial DNA of aurochs	ologia-journal.pl	0	0		
585	chrM	7453	16272	3500264039	1584		7453	16272	8421504	5	480,20,244,600,240	0,7111,7186,7431,8579	g	350026403900000030,350026403900000031,350026403900000032,350026403900000033,350026403900000014,350026403900000022,350026403900000023,350026403900000024,350026403900000025,350026403900000026,350026403900000027,350026403900000028,350026403900000059,350026403900000039,350026403900000060	0-120,0-120,0-120,0-120,0-62,0-120,0-119,0-120,0-120,0-120,0-120,0-120,0-120,0-119,0-120						Structure and Evolution of the Y-chromosomal and Mitochondrial DNA of cattle	ive.library.uu.nl	0	0		
585	chrM	8073	8128	3500112085	55		8073	8128	8421504	1	55	0	g	350011208500000006	2-57		12456664	10.1093/emboj/cdf656	ERROR! NO ISSN	The EMBO Journal	Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases	Suzuki	2002	0		
585	chrM	8106	8377	3500095134	44		8106	8377	8421504	2	23,21	0,250	g	350009513400000006,350009513400000007	0-23,0-21						Malaria Journal BioMed Central	biomedcentral.com	0	0		
585	chrM	9686	12097	3500135730	1580		9686	12097	8421504	15	151,45,6,66,114,174,88,69,70,60,309,123,177,68,60	0,172,219,283,439,573,1073,1163,1238,1373,1436,1751,1889,2195,2351	g	350013573000000001,350013573000000002,350013573000000003,350013573000000005,350013573000000007,350013573000000008,350013573000000021,350013573000000022,350013573000000023,350013573000000029,350013573000000030,350013573000000031,350013573000000032,350013573000000034,350013573000000035,350013573000000036,350013573000000037,350013573000000038,350013573000000039,350013573000000040,350013573000000041,350013573000000042,350013573000000043,350013573000000044,350013573000000047,350013573000000051	0-68,0-83,49-101,0-66,0-45,0-69,0-48,0-63,0-63,0-49,0-247,0-58,0-61,0-160,0-64,0-65,0-65,0-64,0-57,0-63,0-60,0-54,0-63,0-63,0-68,0-60						(PHRYNOSOMATIDAE) IN CENTRAL MEXICO	www.jstor.org	0	0		
585	chrM	11768	12523	3500363871	40		11768	12523	8421504	2	20,20	0,735	g	350036387100000000,350036387100000001	0-20,0-20						 Caracteriza&#xe7;&#xe3;o de um rebanho Gir Leiteiro quanto &#xe0; origem do DNA Mitocondrial (mtDNA) - Engormix 	pt.engormix.com	0	0		
585	chrM	11768	12523	3500256281	40		11768	12523	8421504	2	20,20	0,735	g	350025628100000000,350025628100000001	0-20,0-20						Increase in mitochondrial DNA quantity and impairment of oxidative phosphorylation in bovine fibroblast cells treated with ethidium bromide for 15 passages in culture	w.funpecrp.com.br	0	0		
585	chrM	11768	12523	3500040382	40		11768	12523	8421504	2	20,20	0,735	g	350004038200000000,350004038200000001	0-20,0-20			10.1590/S0100-204X2007000800019	0100-204X	Pesquisa Agropecu&#xe1;ria Brasileira	Pesquisa Agropecu&#xe1;ria Brasileira - Mitochondrial DNA of Nellore and European x Nellore crossing cattle of high performance	Curi	2007	1		
585	chrM	12054	14779	3500246318	108		12054	14779	8421504	5	20,20,20,20,28	0,775,1169,1973,2697	g	350024631800000002,350024631800000004,350024631800000006,350024631800000010,350024631800000013	0-20,0-20,0-20,0-20,0-28						Identification of mitochondrial DNA substitutions related to meat quality in Japanese Black cattle	nimal-science.org	0	0		
585	chrM	12400	12711	3500418301	305		12400	12711	8421504	6	84,77,27,18,85,14	0,85,164,192,211,297	g	350041830100000006,350041830100000022,350041830100000023,350041830100000021	0-305,0-20,0-20,0-20					Patent	Sexing method of bovine embyros (Patent US:5461145)	Itagaki	1995	0		
585	chrM	12400	12711	3500160638	305		12400	12711	8421504	6	84,77,27,18,85,14	0,85,164,192,211,297	g	350016063800000006,350016063800000023,350016063800000021	0-305,0-20,0-20						Sexing method of bovine embyros	Kudo	1992	0		
585	chrM	12604	12661	3500062201	47		12604	12661	8421504	2	21,26	0,31	g	350006220100000003,350006220100000005	0-21,0-26						Mitochondrial Multiplex Real-Time PCR as a Source Tracking Method in Fecal-Contaminated Effluents	www.emc.ncsu.edu	0	0		
585	chrM	14471	15540	3500229133	112		14471	15540	8421504	5	20,24,22,21,25	0,463,540,900,1044	g	350022913300000001,350022913300000011,350022913300000005,350022913300000014,350022913300000015	0-20,0-24,0-22,0-21,0-25						Phylogenetic Study of Complete Cytochrome b Genes in Musk Deer (Genus &#xe1; E&#xa7;^&#xc8;I&#xa1;2 JkX&#xbe;&#xac;5 &#xec;&#xeb;&#xbe;&#xdb; &#xf6;&#xdc;O	www.cgrb.org	0	0		
585	chrM	14523	16337	3500028165	1265		14523	16337	8421504	3	420,26,819	0,688,995	g	350002816500000000,350002816500000001,350002816500000014,350002816500000002,350002816500000009,350002816500000011	70-850,0-20,0-24,0-26,0-819,0-26						Entwicklung und Anwendung molekularbiologischer Verfahren zum Nachweis von Kuhmilch in Ziegenmilch und -k&#xe4;se	eb.uni-giessen.de	0	0		
585	chrM	14655	14938	3500154131	40		14655	14938	8421504	2	20,20	0,263	g	350015413100000001,350015413100000006	0-20,0-20						The 'Evolutionary Signal'of Homoplasy In Proteincoding Gene Sequences and Its Consequences for a Priori Weighting In Phylogeny | Alexandre Hassanin - Academia.edu	www.academia.edu	0	0		
585	chrM	14674	15513	3500032838	99		14674	15513	8421504	4	24,24,29,22	0,210,306,817	g	350003283800000001,350003283800000000,350003283800000004,350003283800000005	0-24,0-24,0-29,0-22						PH&#xc2;N BI&#x1ec6;T TH&#x1eca;T TR&#xc2;U V&#xc0; TH&#x1eca;T B&#xd2; B&#x1eb0;NG K&#x1ef8; THU&#x1eac;T PCR	www.lhu.edu.vn	0	0		
585	chrM	14701	14730	3500323032	29		14701	14730	8421504	1	29	0	g	350032303200000002	0-29						Application of mitochondrial DNA analysis for microbial source tracking purposes in shell&#xfb01;sh harvesting waters	ww.iwaponline.com	0	0		
585	chrM	14815	14901	3500201986	49		14815	14901	8421504	2	29,20	0,66	g	350020198600000000	66-160						&#x7528;PCR&#x6280;&#x672f;&#x5feb;&#x901f;&#x9274;&#x522b;&#x8089;&#x8d28;&#x54c1; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
585	chrM	14910	15382	3500113924	51		14910	15382	8421504	2	25,26	0,446	g	350011392400000000,350011392400000001	0-25,0-26						DNA species surveillance: Monitoring bushmeat poaching and trading in Kenya using partial cytochrome b gene	demicjournals.org	0	0		
585	chrM	14911	14938	3500426531	27		14911	14938	8421504	1	27	0	g	350042653100000002	50-77						14146935 PCR Protocol for Fish and Seafood Authentication MSc Thesis	www.scribd.com	0	0		
585	chrM	14915	14940	3500420509	24		14915	14940	8421504	2	18,6	0,19	g	350042050900000001	0-24		23452350	10.1186/2041-2223-4-6		Investigative Genetics	Where is the game? Wild meat products authentication in South Africa: a case study	Maria	2013	0		
585	chrM	14915	14938	3500154075	23		14915	14938	8421504	1	23	0	g	350015407500000421,350015407500000759	11-34,11-34						US Patent # 6,730,479. Detection of nucleic acid hybrids - Patents.com	www.patents.com	0	0		
585	chrM	14915	14938	3500016205	23		14915	14938	8421504	1	23	0	g	350001620500000002	0-23					Iranian Journal of Arthropod-borne Diseases	Blood Meal Identification in Field-Captured Sand flies: Comparison of PCR-RFLP and ELISA Assays	N	2009	0		
585	chrM	14916	14944	3500126740	28		14916	14944	8421504	1	28	0	g	350012674000000001	0-28						Mitochondrial DNA phylogeography reveals marked population structure in the common vampire bat, Desmodus rotundus (Phyllostomidae) | Felipe Martins - Academia.edu	www.academia.edu	0	0		
585	chrM	14919	15216	3500232616	39		14919	15216	8421504	2	19,20	0,277	g	350023261600000000,350023261600000005	0-19,0-20						Differentiation of animal species in food by oligonucleotide microarray hybridization	.researchgate.net	0	0		
585	chrM	15023	15263	3500066194	240		15023	15263	8421504	1	240	0	g	350006619400000029,350006619400000031,350006619400000046,350006619400000033,350006619400000035	0-60,0-60,0-49,0-60,0-60						The application of a PCR based species identification method to African wildlife	upetd.up.ac.za	0	0		
585	chrM	15063	15535	3500325906	47		15063	15535	8421504	2	24,23	0,449	g	350032590600000003,350032590600000000	0-24,0-23						Molecular traceability of the species origin of meats using multiplex PCR	demicjournals.org	0	0		
585	chrM	15063	15535	3500072891	47		15063	15535	8421504	2	24,23	0,449	g	350007289100000003,350007289100000000	0-24,0-23						Zarringhabaie et al. Molecular traceability of the species origin of meats using multiplex PCR. Afr. J. Biotechnol.	demicjournals.org	0	0		
585	chrM	15461	15870	3500208517	40		15461	15870	8421504	2	20,20	0,389	g	350020851700000000,350020851700000002	0-20,0-20						Predominant African-Derived mtDNA in Caribbean and Brazilian Creole Cattle is also Found in Spanish Cattle (Bos taurus	w.corpoica.org.co	0	0		
585	chrM	15512	15535	3500107696	23		15512	15535	8421504	1	23	0	g	350010769600000002	0-23						&#xfee6;&#xfef4;&#xfe91; &#xfea9;&#xfead;&#xfe8d;&#xfeaa;&#xfee7;&#xfe8e;&#xfe98;&#xfeb3;&#xfe8d; &#xfee9;&#xfead;&#xfe8e;&#xfee4;&#xfeb7; &#x0661;&#x0663;&#x0668;&#x0668; &#x0661;&#x0669; &#xfeaa;&#xfee0;&#xfe9f; &#x0661; &#xfee9;&#xfead;&#xfe8e;&#xfee4;	tabrizu.ac.ir	0	0		
585	chrM	15694	15718	3500099617	24		15694	15718	8421504	1	24	0	g	350009961700000002	0-24						THE UTILIZATION OF GENETIC MARKERS TO RESOLVE MODERN MANAGEMENT ISSUES IN HISTORIC BISON POPULATIONS: IMPLICATIONS FOR SPECIES CONSERVATION	fieldcampaign.org	0	0		
585	chrM	15741	15770	3500390788	29		15741	15770	8421504	1	29	0	g	350039078800000000	0-29						&#xff1c;&#x8cc7;&#x6599;&#xff1e; &#x4e00;&#x672c;&#x9396;&#x9ad8;&#x6b21;&#x69cb;&#x9020;&#x591a;&#x578b;&#x6cd5;&#x306b;&#x3088;&#x308b;&#x725b;&#x30df;&#x30c8;&#x30b3;&#x30f3;&#x30c9;&#x30ea;&#x30a2;DNA&#x306e;&#x89e3;&#x6790;	w.pref.okayama.jp	0	0		
585	chrM	16007	16295	3500277122	86		16007	16295	8421504	4	23,23,20,20	0,129,240,268	g	350027712200000000,350027712200000002,350027712200000004,350027712200000003	0-23,0-23,0-20,0-20		20346116	10.1186/1471-2148-10-83		BMC Evolutionary Biology	Population dynamic of the extinct European aurochs: genetic evidence of a north-south differentiation pattern and no evidence of post-glacial expansion	Stefano	2010	0		
585	chrM	16143	16192	3500419696	49		16143	16192	8421504	1	49	0	g	350041969600000017	40-89						The occurrence of mtDNA heteroplasmy in multiple cetacean species | Nicole Vollmer - Academia.edu	www.academia.edu	0	0		
585	chrM	16143	16182	3500323925	39		16143	16182	8421504	1	39	0	g	350032392500000019	31-70						galov doktorat 2007	www.scribd.com	0	0		
585	chrM	16143	16182	3500279982	39		16143	16182	8421504	1	39	0	g	350027998200000027	31-70						Sveu&#x010d;ili&#x0161;te u Zagrebu	www.vef.unizg.hr	0	0		
585	chrM	16155	16179	3500128576	24		16155	16179	8421504	1	24	0	g	350012857600000003,350012857600000000	0-20,0-20						Supporting Information 	www.pnas.org	0	0		
585	chrUn_AAFC02005712	4930	4954	3500299832	23		4930	4954	8421504	2	13,10	0,14	g	350029983200000004	10-33						Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby	Hall	2004	0		
585	chrUn_AAFC02005861	810	837	3500377507	25		810	837	8421504	3	11,4,10	0,12,17	g	350037750700000006	3-28					Patent	Nucleic acid probes for detection and/or quantitation of non-viral organisms (Patent EP:0272009)	Hogan	1998	0		
585	chrUn_AAFC02006001	1625	1652	3500231746	24		1625	1652	8421504	3	11,6,7	0,13,20	g	350023174600000004	0-24			10.1093/emboj/20.20.5556		The EMBO Journal	Calcium-dependent protein kinases play an essential role in a plant defence response	Tina	2001	0		
585	chrUn_AAFC02006001	1625	1652	3500053218	24		1625	1652	8421504	3	11,6,7	0,13,20	g	350005321800000004	0-24						Calcium-dependent protein kinases play an essential role in a plant defence response	www.tsl.ac.uk	0	0		
585	chrUn_AAFC02008162	23876	23903	3500460467	25		23876	23903	8421504	2	12,13	0,14	g	350046046700000191,350046046700000281	14-39,26-48						 Neutrophil Inhibitors 	www.docstoc.com	0	0		
585	chrUn_AAFC02008162	23876	23903	3500017068	25		23876	23903	8421504	2	12,13	0,14	g	350001706800000191	14-39						Neutrophil inhibitors	Moyle	1995	0		
585	chrUn_AAFC02008162	24026	24053	3500211386	23		24026	24053	8421504	3	4,6,13	0,5,14	g	350021138600000001,350021138600000000	10-33,0-23		20054000	10.1074/jbc.M109.074872	0021-9258	Journal of Biological Chemistry	Akt Cys-310-targeted Inhibition by Hydroxylated Benzene Derivatives Is Tightly Linked to Their Immunosuppressive Effects	Lee	2010	5		
585	chrUn_AAFC02009200	39777	39801	3500142873	24		39777	39801	8421504	1	24	0	g	350014287300000286,350014287300000108	0-22,20-44						COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02011278	7229	7262	3500372491	30		7229	7262	8421504	2	12,18	0,15	g	350037249100000012	6-40						Genes and polypeptides relating to human pancreatic cancers	Nakamura	2010	0		
585	chrUn_AAFC02011278	7229	7262	3500247076	30		7229	7262	8421504	2	12,18	0,15	g	350024707600000012	6-40						Genes and polypeptides relating to human pancreatic cancers	Katagiri	2005	0		
585	chrUn_AAFC02014299	20803	20831	3500314371	25		20803	20831	8421504	3	5,5,15	0,7,13	g	350031437100000029	8-33						ITI-D1 Kunitz domain mutants as HNE inhibitors - Patent # 7078383 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_AAFC02017818	2548	2572	3500449585	23		2548	2572	8421504	2	13,10	0,14	g	350044958500000027	7-30		17105994	10.1261/rna.174307	1355-8382	RNA	Identification of novel snRNA-specific Sm proteins that bind selectively to U2 and U4 snRNAs in Trypanosoma brucei	Tkacz	2007	5		
585	chrUn_AAFC02018327	28466	28499	3500011388	25		28466	28499	8421504	3	7,13,5	0,12,28	g	350001138800000114	8-33						Vaccine and antitoxin for the treatment of C. difficile disease	Kink	1997	0		
585	chrUn_AAFC02025633	13115	13139	3500036492	23		13115	13139	8421504	2	13,10	0,14	g	350003649200000101	9-32						UNIVERSIDAD DE SALAMANCA	gredos.usal.es	0	0		
585	chrUn_AAFC02026457	32497	32524	3500282252	24		32497	32524	8421504	2	19,5	0,22	g	350028225200000371	4-28						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
585	chrUn_AAFC02027289	1493	1521	3500378640	23		1493	1521	8421504	2	17,6	0,22	g	350037864000000175,350037864000000058	11-34,11-34					Patent	Polyhydroxyalkanoate-containing structure and manufacturing method thereof (Patent EP:1275728)	Honma	2008	0		
585	chrUn_AAFC02027289	1493	1521	3500128423	23		1493	1521	8421504	2	17,6	0,22	g	350012842300000060,350012842300000183	11-34,11-34						Polyhydroxyalkanoate-containing structure and manufacturing method thereof - US Patent 6951745 Description	ww.patentstorm.us	0	0		
585	chrUn_AAFC02029045	47854	47881	3500008756	25		47854	47881	8421504	3	13,5,7	0,14,20	g	350000875600000666	11-38						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02031955	236	259	3500164274	23		236	259	8421504	1	23	0	g	350016427400000007	0-23						RBI th on the Conservation of Animal Genetic Resources Tekirdag, TURKIYE 4 8 October 2011)	nf2011.nku.edu.tr	0	0		
585	chrUn_AAFC02033459	2572	4150	3500414143	255		2572	4150	8421504	3	31,143,81	0,177,1497	p,c	350041414300000018,350041414300015026,350041414300000014,350041414300015015,350041414300015020,350041414300015027,350041414300015023	0-251,0-150,0-250,0-66,0-114,0-105,0-72						Deletion der Untereinheit VIa der Cytochrom c Oxidase in Hefe und heterologe Expression des entsprechenden Rindergens sowie Charakterisierung der Mutanten	ub.uni-marburg.de	0	0		
585	chrUn_AAFC02033459	2758	4126	3500409160	40		2758	4126	8421504	2	20,20	0,1348	c,g	350040916000000018,350040916000000018,350040916000000019,350040916000000019	0-20,0-20,0-20,0-20			10.1111/j.1742-4658.2007.05809.x	1742-4658	FEBS Journal	Lithium increases PGC-1&#x03b1; expression and mitochondrial biogenesis in primary bovine aortic endothelial cells - Struewing - 2007 - FEBS Journal - Wiley Online Library	Struewing	2007	0		
585	chrUn_AAFC02034154	11764	11793	3500440276	25		11764	11793	8421504	3	13,7,5	0,14,24	g	350044027600000190,350044027600000250	10-35,10-35					Patent	Kunitz domain peptides (Patent US:6989369)	Ladner	2006	0		
585	chrUn_AAFC02036063	9922	9947	3500378510	23		9922	9947	8421504	2	9,14	0,11	g	350037851000000085	0-23						P2x receptors (purinoceptor family)	Buell	1995	0		
585	chrUn_AAFC02036063	25110	25139	3500102098	23		25110	25139	8421504	3	11,4,8	0,13,21	g	350010209800000001	0-24					Patent	Dopamine receptors and genes (Patent EP:0447483)	Bunzow	1997	0		
585	chrUn_AAFC02037755	11994	12023	3500302764	25		11994	12023	8421504	2	18,7	0,22	c	350030276400000002	14-39						Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 - US Patent 7256267 Description	ww.patentstorm.us	0	0		
585	chrUn_AAFC02039858	337	2522	3500315971	87		337	2522	8421504	4	45,21,7,14	0,940,1046,2171	c	350031597100000041,350031597100000040,350031597100000009,350031597100000008	0-45,0-27,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
585	chrUn_AAFC02039858	1277	2522	3500141821	42		1277	2522	8421504	3	21,7,14	0,106,1231	c,g	350014182100000011,350014182100000011,350014182100000010	0-21,0-21,0-21						The mRNA expression of the members of the IGF-system in bovine corpus luteum during induced luteolysis	quantification.de	0	0		
585	chrUn_AAFC02039858	1277	2522	3500024081	42		1277	2522	8421504	3	21,7,14	0,106,1231	c	350002408100000009,350002408100000008	0-21,0-21						Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. - ResearchGate	.researchgate.net	0	0		
585	chrUn_AAFC02039878	6003	6029	3500365497	24		6003	6029	8421504	2	14,10	0,16	g	350036549700000071	7-36					Patent	Recombinant antibodies for human therapy (Patent US:5750105)	Hanna	1998	0		
585	chrUn_AAFC02043845	19818	19841	3500132071	23		19818	19841	8421504	1	23	0	c	350013207100000526	5-28						EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME	Schellenberger	2010	0		
585	chrUn_AAFC02043845	23421	23450	3500311219	29		23421	23450	8421504	1	29	0	c	350031121900000171	0-29						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
585	chrUn_AAFC02043845	29401	30596	3500227937	23		29401	30596	8421504	3	2,10,11	0,1172,1184	c	350022793700000082	7-30						POLYMORPHISMS IN GENES AFFECTING CNS DISORDERS AND USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02043845	34367	34512	3500423799	40		34367	34512	8421504	2	20,20	0,125	c,g	350042379900000004,350042379900000004,350042379900000005	0-20,0-20,0-20			10.1042/BJ20061118		Biochemical Journal	Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers	Motohiro	2007	0		ST6GALNAC6
585	chrUn_AAFC02045218	6416	6464	3500177828	48		6416	6464	8421504	1	48	0	g	350017782800000106	0-48					Patent	Protein kinases (Patent US:5756289)	Hoekstra	1998	0		
585	chrUn_AAFC02048881	9906	9929	3500334794	23		9906	9929	8421504	1	23	0	g	350033479400000019	0-26		10708364		1350-0872	Microbiology	Regulation of the transport system for C4-dicarboxylic acids in Bacillus subtilis	Asai	2000	3		
585	chrUn_AAFC02049706	5779	6930	3500210802	40		5779	6930	8421504	2	20,20	0,1131	g	350021080200000020,350021080200000021	0-20,0-20			10.1002/ejlt.201100343	1438-9312	European Journal of Lipid Science and Technology	Fish-meal diet enriched with omega-3 PUFA and treatment of canine chronic enteropathies - Ontsouka - 2012 - European Journal of Lipid Science and Technology - Wiley Online Library	Ontsouka	2012	0		
585	chrUn_AAFC02050481	15750	15774	3500411987	23		15750	15774	8421504	2	4,19	0,5	g	350041198700000404	1-25					Patent	Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories (Patent US:	Bergeron	1999	0		
585	chrUn_AAFC02050481	15750	15774	3500293595	23		15750	15774	8421504	2	4,19	0,5	g	350029359500000310	1-25					Patent	Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories (Patent US:	Bergeron	1999	0		
585	chrUn_AAFC02052522	14998	15026	3500332442	23		14998	15026	8421504	3	5,6,12	0,7,16	g	350033244200000048	6-29						Unique dendritic cell-associated c-type lectins, dectin-1 and dectin-2; compositions and uses thereof	Ariizumi	1998	0		
585	chrUn_AAFC02052747	27149	27177	3500019915	23		27149	27177	8421504	2	16,7	0,21	g	350001991500000505	16-40						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
585	chrUn_AAFC02054843	608	636	3500301866	24		608	636	8421504	2	16,8	0,20	g	350030186600000009	0-24						Lisa A. Barroso Master of Science in Biology Approved	cholar.lib.vt.edu	0	0		
585	chrUn_AAFC02056303	10719	10744	3500086931	25		10719	10744	8421504	1	25	0	g	350008693100000440	3-33						Hepatitis c assay utilizing recombinant antigens to ns1	Dailey	1993	0		
585	chrUn_AAFC02058610	24272	24301	3500223662	25		24272	24301	8421504	3	8,5,12	0,9,17	g	350022366200000005	6-32		23935497	10.1371/journal.ppat.1003513		PLoS Pathogens	Rab18 Binds to Hepatitis C Virus NS5A and Promotes Interaction between Sites of Viral Replication and Lipid Droplets	Shadi	2013	0		
585	chrUn_AAFC02063839	19702	19728	3500111047	23		19702	19728	8421504	2	15,8	0,18	g	350011104700000008	9-34						THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES	Fung	1996	0		
585	chrUn_AAFC02065408	228	351	3500315071	40		228	351	8421504	2	20,20	0,103	c	350031507100000023,350031507100000022	0-20,0-20						Expression of genes involved in energy homeostasis in the duodenum and liver of 2 Holstein-Friesian and Jersey cows and their F hybrid 3	cs.physiology.org	0	0		
585	chrUn_AAFC02065408	2380	2443	3500163087	63		2380	2443	8421504	1	63	0	p,c	350016308700015008,350016308700000005	0-63,0-36						Discovery and validation of potential drug targets based on the phylogenetic evolution of GPCRs	www.scirp.org	0	0		
585	chrUn_AAFC02065408	2397	2442	3500247970	45		2397	2442	8421504	1	45	0	c	350024797000000000	0-45					Patent	DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof (Patent US:5516653)	Bard	1996	0		
585	chrUn_AAFC02065408	2397	2442	3500219194	45		2397	2442	8421504	1	45	0	c	350021919400000000	0-45						DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof	Bard	1997	0		
585	chrUn_AAFC02065408	2397	2442	3500107423	45		2397	2442	8421504	1	45	0	c	350010742300000000	0-45					Patent	Method of obtaining compositions comprising Y4 specific compounds (Patent US:6913892)	Bard	2005	0		
585	chrUn_AAFC02065946	11959	11986	3500374909	23		11959	11986	8421504	2	15,8	0,19	g	350037490900001092	8-38						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02070048	1555	1578	3500419773	23		1555	1578	8421504	1	23	0	c	350041977300000032	9-32						USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, AND NK2 RECEPTORS - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02070048	1683	1709	3500141378	23		1683	1709	8421504	2	16,7	0,19	c	350014137800000030	3-28						Expression in plants of antibodies against enterotoxigenic escherichia coli	Brown	2004	0		
585	chrUn_AAFC02070621	1810	1837	3500180915	25		1810	1837	8421504	3	12,9,4	0,13,23	g	350018091500000004	4-29						METHODS AND COMPOUNDS FOR THE DIAGNOSIS AND TREATMENT OF CANCER	Coverley	2011	0		
585	chrUn_AAFC02070621	35397	35424	3500414499	25		35397	35424	8421504	3	4,17,4	0,5,23	g	350041449900000299	15-40						Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02074050	11855	11878	3500280721	23		11855	11878	8421504	1	23	0	g	350028072100000351	12-35						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
585	chrUn_AAFC02074096	8520	8548	3500100734	25		8520	8548	8421504	3	12,9,4	0,14,24	g	350010073400000243	0-25						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
585	chrUn_AAFC02076944	11414	11440	3500007191	23		11414	11440	8421504	2	17,6	0,20	g	350000719100000035	10-33						Non-anaphylactogenic IgE fusion proteins	Morsey	2005	0		
585	chrUn_AAFC02079876	18626	18650	3500444466	23		18626	18650	8421504	2	15,8	0,16	g	350044446600000017	11-34						Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas	Peters	1998	0		
585	chrUn_AAFC02081734	14485	14510	3500120720	25		14485	14510	8421504	1	25	0	g	350012072000000000	0-25						Muscular Dystrophy	www.scribd.com	0	0		
585	chrUn_AAFC02082608	1607	1630	3500366131	23		1607	1630	8421504	1	23	0	g	350036613100000002	2-25						Fmoc-Pro-OH | Protease Inhibitors Guide	www.peplogs.com	0	0		
585	chrUn_AAFC02084553	11193	11217	3500148414	23		11193	11217	8421504	2	17,6	0,18	c	350014841400000142	5-28						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
585	chrUn_AAFC02088802	5940	7893	3500329934	1503		5940	7893	8421504	16	41,13,101,36,9,16,118,16,11,35,126,202,41,48,613,77	0,62,264,371,410,425,442,645,663,684,722,950,1163,1205,1262,1876	g	350032993400000036,350032993400000031,350032993400000029,350032993400000027,350032993400000024,350032993400000022,350032993400000018,350032993400000017,350032993400000016,350032993400000014,350032993400000012,350032993400000010,350032993400000008,350032993400000006,350032993400000004,350032993400000002,350032993400000003,350032993400000001,350032993400000000	28-89,0-101,0-91,0-98,0-96,0-101,0-101,0-101,6-98,0-89,0-97,0-99,0-101,0-100,0-101,0-100,0-101,0-98,0-99						Seminalplasmin: Recentevolution of anothermemberof the neuropeptide Ygene family	www.pnas.org	0	0		
585	chrUn_AAFC02089501	4722	4749	3500193235	24		4722	4749	8421504	2	17,7	0,20	g	350019323500000067	8-32						US Patent # 7,374,896. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC02090522	363	393	3500290417	30		363	393	8421504	1	30	0	g	350029041700000028,350029041700000046	26-56,7-36						HUMANIZED ANTI-LT-beta-R ANTIBODIES	Garber	2009	0		
585	chrUn_AAFC02090522	363	393	3500187018	30		363	393	8421504	1	30	0	g	350018701800000028	26-56						HUMANIZED ANTI-LT-beta-R ANTIBODIES - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02090522	363	393	3500068023	30		363	393	8421504	1	30	0	g	350006802300000056	26-56						Humanized anti-LT-beta-R antibodies	Ai Lun *Jia Bo 	2004	0		
585	chrUn_AAFC02090522	363	393	3500047848	30		363	393	8421504	1	30	0	g	350004784800000028	26-56						Humanized anti-lt-beta-r antibodies	Garber	2003	0		
585	chrUn_AAFC02090522	363	393	3500003854	30		363	393	8421504	1	30	0	g	350000385400000037	26-56						Humanized Anti-lt-beta-r Antibodies 	.freshpatents.com	0	0		
585	chrUn_AAFC02091292	13754	13779	3500050819	23		13754	13779	8421504	3	5,13,5	0,6,20	g	350005081900000003	6-31						FGF21 MUTANTS AND USES THEREOF	Walker	2009	0		
585	chrUn_AAFC02091856	11623	11650	3500445203	23		11623	11650	8421504	2	8,15	0,12	g	350044520300000047	18-48						Detecting foot-and-mouth disease virus	Engelhard	2005	0		
585	chrUn_AAFC02093223	12025	12050	3500305977	25		12025	12050	8421504	1	25	0	g	350030597700000049,350030597700000051,350030597700000053,350030597700000022,350030597700000011,350030597700000012,350030597700000013,350030597700000153,350030597700000054	21-40,20-39,19-38,18-37,10-29,10-29,17-37,9-28,27-46						Method for Quantification of Small RNA Species	Busk	2012	0		
585	chrUn_AAFC02093233	18634	18663	3500129486	23		18634	18663	8421504	3	4,6,13	0,5,16	g	350012948600000025	6-30						US Patent # 5,850,016. Alteration of amino acid compositions in seeds - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC02097594	7257	7282	3500135058	24		7257	7282	8421504	2	7,17	0,8	g	350013505800000047	0-24						Recombinant hexose oxidase, a method of producing same and use of such enzyme	Stougaard	2009	0		
585	chrUn_AAFC02098201	1660	1686	3500239135	24		1660	1686	8421504	2	12,12	0,14	g	350023913500000046	0-24						Synthesis of branched nucleic acids	Gryaznov	1995	0		
585	chrUn_AAFC02114258	4193	4218	3500333430	23		4193	4218	8421504	2	7,16	0,9	g	350033343000000002	0-23		12566309		0008-5472	Cancer Research	Genotypic and Phenotypic Characterization of a Putative Tumor Susceptibility Gene, GNMT, in Liver Cancer	Tseng	2003	8		
585	chrUn_AAFC02117289	6185	6211	3500205426	23		6185	6211	8421504	2	16,7	0,19	g	350020542600000311	0-30						Methods and products related to genotyping and DNA analysis	Landers	2003	0		
585	chrUn_AAFC02119551	2760	2790	3500363440	25		2760	2790	8421504	2	12,13	0,17	g	350036344000000006	4-29		22171261	10.1128/JVI.06166-11	0022-538X	Journal of Virology	The Vaccinia Virus O1 Protein Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase 1/2 and Promotes Viral Virulence	Schweneker	2012	5		
585	chrUn_AAFC02141769	10676	10700	3500392535	23		10676	10700	8421504	2	4,19	0,5	g	350039253500000002	5-28						Agonistic antibody directed against human thrombopoietin receptor	HAGIWARA	2008	0		
585	chrUn_AAFC02141769	10676	10700	3500388508	23		10676	10700	8421504	2	4,19	0,5	g	350038850800000002,350038850800000033	5-28,5-28						HUMAN MONOCLONAL ANTIBODIES TO INFLUENZA M2 PROTEIN AND METHODS OF MAKING AND USING SAME - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02141769	10676	10700	3500340000	23		10676	10700	8421504	2	4,19	0,5	g	350034000000000010	5-28						Anti-A33 antibody	Kataoka	2005	0		
585	chrUn_AAFC02141769	10676	10700	3500304335	23		10676	10700	8421504	2	4,19	0,5	g	350030433500000438,350030433500000526	0-20,0-23						Diagnosis and Treatment of Cancer Using Anti-EREG Antibody - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02141769	10676	10700	3500208662	23		10676	10700	8421504	2	4,19	0,5	g	350020866200000073,350020866200000115	1-24,0-23					Patent	Methods for producing members of specific binding pairs (Patent US:7635666)	McCafferty	2009	0		
585	chrUn_AAFC02141769	10676	10700	3500185890	23		10676	10700	8421504	2	4,19	0,5	g	350018589000000003	1-24						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof	Kruif	2009	0		
585	chrUn_AAFC02141769	10676	10700	3500107370	23		10676	10700	8421504	2	4,19	0,5	g	350010737000000003	1-24						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2008	0		
585	chrUn_AAFC02141769	10676	10700	3500100833	23		10676	10700	8421504	2	4,19	0,5	g	350010083300000003	1-24						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2010	0		
585	chrUn_AAFC02141769	10676	10700	3500085058	23		10676	10700	8421504	2	4,19	0,5	g	350008505800000003	1-24						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2007	0		
585	chrUn_AAFC02141769	10676	10700	3500068951	23		10676	10700	8421504	2	4,19	0,5	g	350006895100000003,350006895100000175	1-24,1-24						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02141769	10676	10700	3500017108	23		10676	10700	8421504	2	4,19	0,5	g	350001710800000005	1-24						Host cell specific binding molecules capable of neutralizing viruses and uses thereof	Throsby	2011	0		
585	chrUn_AAFC02141769	10676	10700	3500013299	23		10676	10700	8421504	2	4,19	0,5	g	350001329900000289	21-44						Human Antibodies As Detection Reagents 	.freshpatents.com	0	0		
585	chrUn_AAFC02144827	104	133	3500374909	25		104	133	8421504	2	11,14	0,15	g	350037490900000505	14-39						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02156743	888	914	3500264609	23		888	914	8421504	3	4,5,14	0,5,12	g	350026460900000017	11-34					Patent	Yeast strains and modified albumins (Patent US:5965386)	Gilbert	1999	0		
585	chrUn_AAFC02165706	2039	2065	3500439692	24		2039	2065	8421504	3	5,13,6	0,6,20	g	350043969200000003,350043969200000053	16-39,0-24						HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof	Hasel	1993	0		
585	chrUn_AAFC02180055	8	37	3500308897	24		8	37	8421504	2	16,8	0,21	g	350030889700001227	4-31						HCV/GBV-B CHIMERIC VIRUS - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02191251	0	155	3500137460	58		0	155	8421504	3	17,33,8	0,63,147	g	350013746000000057,350013746000000073	15-74,15-74						Production Of Ssdna In Vivo 	.freshpatents.com	0	0		
585	chrUn_AAFC02191251	0	100	3500424543	54		0	100	8421504	2	17,37	0,63	g	350042454300000021	22-77						Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes	Hadlaczky	2006	0		
585	chrUn_AAFC02191251	0	100	3500305956	54		0	100	8421504	2	17,37	0,63	g	350030595600000022	22-77					Patent	Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes (Patent US:8288610)	Hadlaczky	2012	0		
585	chrUn_AAFC02191251	0	100	3500103754	54		0	100	8421504	2	17,37	0,63	g	350010375400000022	22-77						Application # 2006/0150271. Artificial chromosomes, uses thereof and method for preparing artificial chromosomes - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC02191251	0	100	3500027983	54		0	100	8421504	2	17,37	0,63	g	350002798300000105,350002798300000022	22-77,22-77						Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02199284	1007	1030	3500407417	23		1007	1030	8421504	1	23	0	g	350040741700000090	1-48						Method For Producing Carotenoids Or Their Precursors Using Genetically Modified Organisms Of The Blakeslea Genus, Carotenoids Or Their Precursors Produced By Said Method And Use Thereof 	.freshpatents.com	0	0		
585	chrUn_AAFC02199846	590	618	3500242097	28		590	618	8421504	1	28	0	g	350024209700000066	0-28						Secreted and transmembrane polypeptides and nucleic acids encoding the same	Ashkenazi	2004	0		
585	chrUn_AAFC02199846	590	618	3500205880	28		590	618	8421504	1	28	0	g	350020588000000055	0-28						Secreted and transmembrane polypeptides and nucleic acids encoding the same	Baker	2001	0		
585	chrUn_AAFC02199846	590	618	3500119940	28		590	618	8421504	1	28	0	g	350011994000000013	0-28						Method of preventing the death of retinal neurons and treating ocular diseases	Ferrara	2000	0		
585	chrUn_AAFC02199846	590	618	3500062631	28		590	618	8421504	1	28	0	g	350006263100000057	0-28						Novel polypeptides and nucleic acids encoding the same	Baker	1999	0		
585	chrUn_AAFC02199846	4246	4270	3500171141	24		4246	4270	8421504	1	24	0	c	350017114100000000,350017114100000002	12-36,9-32						Target specific screening andits use for identifying target binders	Blume	2003	0		
585	chrUn_AAFC02203380	324	356	3500070288	25		324	356	8421504	3	12,4,9	0,17,23	g	350007028800000451	13-38						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
585	chrUn_AAFC02209530	574	598	3500190095	24		574	598	8421504	1	24	0	c	350019009500000084	0-24						Affinity proteins for controlled application of cosmetic substances	Houtzager	2006	0		
585	chrUn_AAFC02209530	574	598	3500181117	24		574	598	8421504	1	24	0	c	350018111700000084	0-24						Affinity proteins for controlled application of cosmetic substances	Houtzager	2006	0		
585	chrUn_AAFC02209530	574	598	3500165317	24		574	598	8421504	1	24	0	c	350016531700000021,350016531700000094	0-24,0-24						Structure For Presenting Desired Peptide Sequences 	.freshpatents.com	0	0		
585	chrUn_AAFC02209530	574	598	3500119182	24		574	598	8421504	1	24	0	c	350011918200000087	0-24						Structure for presenting desired peptide sequences	Houtzager	2003	0		
585	chrUn_AAFC02209530	719	745	3500089910	26		719	745	8421504	1	26	0	c	350008991000000073	0-26						US Patent # 6,342,369. Apo-2-receptor - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC02209530	728	755	3500351594	27		728	755	8421504	1	27	0	c	350035159400000004	8-35						Monoclonal antibody against LPS core	Gram	1996	0		
585	chrUn_AAFC02209530	728	755	3500320257	27		728	755	8421504	1	27	0	c	350032025700000004	8-35						Monoclonal antibody against LPS core	www.devileye.net	0	0		
585	chrUn_AAFC02209530	729	755	3500380971	26		729	755	8421504	1	26	0	c	350038097100000201,350038097100000207,350038097100000030,350038097100000005	0-25,0-23,1-26,0-26						Selection of Human TNFAlpha Specific Antibodies	Smith	2008	0		
585	chrUn_AAFC02209530	729	755	3500313823	26		729	755	8421504	1	26	0	c	350031382300000005,350031382300000207,350031382300000030	0-26,0-23,1-26						Selection of Human TNFAlpha Specific Antibodies - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02209530	729	755	3500000260	26		729	755	8421504	1	26	0	c	350000026000000190,350000026000000205,350000026000000049,350000026000000268,350000026000000236,350000026000000198,350000026000000229,350000026000000213,350000026000000221,350000026000000244,350000026000000252,350000026000000284,350000026000000034,350000026000000026	9-34,9-34,9-34,9-34,9-34,9-34,9-34,9-34,9-34,9-34,9-34,9-34,9-34,8-34						Ligand - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02209530	731	754	3500443364	23		731	754	8421504	1	23	0	c	350044336400000026	0-23						US Patent # 6,838,254. Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC02209530	793	856	3500374196	63		793	856	8421504	1	63	0	p	350037419600015006	3-66						Anti-c35 antibodies for treating cancer	Evans	2009	0		
585	chrUn_AAFC02209530	793	856	3500188277	63		793	856	8421504	1	63	0	p	350018827700015026	3-66						Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof	Anderson	2001	0		
585	chrUn_AAFC02209530	793	856	3500144387	63		793	856	8421504	1	63	0	p	350014438700015018	3-66					Patent	&#x901a;&#x8fc7;&#x9776;&#x5b9a;&#x66b4;&#x9732;&#x5728;&#x7ec6;&#x80de;&#x51cb;&#x4ea1;&#x80bf;&#x7624;&#x7ec6;&#x80de;&#x4e0a;&#x7684;&#x5185;&#x90e8;&#x6297;&#x539f;&#x6740;&#x6b7b;&#x80bf;&#x7624;&#x7ec6;&#x80de;&#x7684;&#x65b9;&#x6cd5; Through target	D*M*Sa Ha Si La Bu He 	2012	0		
585	chrUn_AAFC02209530	793	856	3500135501	63		793	856	8421504	1	63	0	p	350013550100015027	3-66					Patent	Humanized antibodies to human gp39, compositions containing thereof (Patent US:6001358)	Black	1999	0		
585	chrUn_AAFC02209530	793	856	3500068981	63		793	856	8421504	1	63	0	p	350006898100015010	3-66						Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells	Evans	2005	0		
585	chrUn_AAFC02209530	793	856	3500028929	63		793	856	8421504	1	63	0	p	350002892900015010	3-66						ANTIBODIES THAT SPECIFICALLY BIND IRTA AND METHODS OF USE - THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES	www.sumobrain.com	0	0		
585	chrUn_AAFC02209530	793	856	3500021841	63		793	856	8421504	1	63	0	p	350002184100015016	3-66						Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells	Evans	2004	0		
585	chrUn_AAFC02209530	796	844	3500287091	48		796	844	8421504	1	48	0	p	350028709100015198	0-48						&#x4e00;&#x79cd;&#x86cb;&#x767d;&#x8d28;	Jin Cun Gang Shi 	2010	0		
585	chrUn_AAFC02209530	796	844	3500107042	48		796	844	8421504	1	48	0	p	350010704200015224	0-48						Gold-binding Protein And Use Thereof 	.freshpatents.com	0	0		
585	chrUn_AAFC02209530	796	844	3500080412	48		796	844	8421504	1	48	0	p	350008041200015198	0-48						&#x4e00;&#x79cd;&#x9776;&#x7269;&#x8d28;&#x4fd8;&#x83b7;&#x4f53;	Jin Cun Gang Shi 	2010	0		
585	chrUn_AAFC02209530	796	841	3500104119	45		796	841	8421504	1	45	0	p	350010411900015214	0-45						GOLD-BINDING PROTEIN AND USE THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02209530	799	1029	3500166869	69		799	1029	8421504	2	60,9	0,221	c	350016686900000163,350016686900000168	0-50,0-59						Rapid Isolation of Monoclonal Antibodies from Animals - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02209530	833	859	3500462415	26		833	859	8421504	1	26	0	c	350046241500000132,350046241500000065	0-26,0-26						Antibodies to CD40	Bedian	2009	0		
585	chrUn_AAFC02209530	833	859	3500440689	26		833	859	8421504	1	26	0	c	350044068900000091,350044068900000074,350044068900000147,350044068900000132	0-26,0-26,0-26,0-26						Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses	Bedian	2007	0		
585	chrUn_AAFC02209530	833	859	3500398534	26		833	859	8421504	1	26	0	c	350039853400000079	0-26						US Patent # 7,338,660. Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC02209530	833	859	3500383088	26		833	859	8421504	1	26	0	c	350038308800000722	0-26						METHODS AND COMPOSITIONS FOR TREATING TUMOR DISEASES - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02209530	833	859	3500346929	26		833	859	8421504	1	26	0	c	350034692900000069	0-26						Antibodies to cd40	Bedian	2010	0		
585	chrUn_AAFC02209530	833	859	3500277772	26		833	859	8421504	1	26	0	c	350027777200000094	0-26					Patent	Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses (Patent US:8388971)	Bedian	2013	0		
585	chrUn_AAFC02209530	833	859	3500276092	26		833	859	8421504	1	26	0	c	350027609200000147,350027609200000131,350027609200000073,350027609200000090	0-26,0-26,0-26,0-26						Antibodies to CD40	Bedian	2009	0		
585	chrUn_AAFC02209530	833	859	3500115302	26		833	859	8421504	1	26	0	c	350011530200000074	0-26						Antibodies To Cd40 	.freshpatents.com	0	0		
585	chrUn_AAFC02209530	833	859	3500043924	26		833	859	8421504	1	26	0	c	350004392400000094,350004392400000164	0-26,0-26						ANTIBODIES TO CD40 - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02209530	836	862	3500152106	26		836	862	8421504	1	26	0	c	350015210600000021	0-26						In Vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells	Zauderer	2007	0		
585	chrUn_AAFC02209530	836	862	3500058442	26		836	862	8421504	1	26	0	c	350005844200000021	0-26						In Vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells	Smith	2008	0		
585	chrUn_AAFC02209530	836	861	3500310375	25		836	861	8421504	1	25	0	c	350031037500000426	7-32						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02209530	841	959	3500405736	36		841	959	8421504	2	29,7	0,111	c	350040573600000031,350040573600000023	17-38,0-27						Collection and Methods For Its Use	Urlinger	2012	0		
585	chrUn_AAFC02209530	847	954	3500017218	25		847	954	8421504	2	23,2	0,105	c	350001721800000003,350001721800000002	0-25,1-26						Chimeric anti-ricin antibody	Thullier	2010	0		
585	chrUn_AAFC02209530	850	959	3500306172	27		850	959	8421504	2	20,7	0,102	c	350030617200000055,350030617200000012	0-27,0-27						Collection and Methods for its Use - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02209530	850	959	3500136131	27		850	959	8421504	2	20,7	0,102	c	350013613100000012	0-27						Collection and Methods for its Use	Enzelberger	2012	0		
585	chrUn_AAFC02209530	850	959	3500022547	27		850	959	8421504	2	20,7	0,102	c	350002254700000196,350002254700000094	0-27,0-27						ANTI-HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIBODIES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02241660	2581	2608	3500183939	27		2581	2608	8421504	1	27	0	g	350018393900000000	0-27						&#x0e01;&#x0e32;&#x0e23;&#x0e41;&#x0e22;&#x0e01;&#x0e40;&#x0e1e;&#x0e28;&#x0e2d;&#x0e2a;&#x0e38;&#x0e08;&#x0e34;&#x0e42;&#x0e04;&#x0e14;&#x0e49;&#x0e27;&#x0e22;&#x0e42;&#x0e21;&#x0e42;&#x0e19;&#x0e42;&#x0e04;&#x0e25;&#x0e19;&#x0e31;&#x0e25;&#x0e41;&#x0e2d	ir.sut.ac.th:8080	0	0		
585	chrUn_AAFC02248261	0	196	3500248249	172		0	196	8421504	4	16,7,135,14	0,21,31,182	g	350024824900000014	516-719						Methods For Delivering Nucleic Acid Molecules Into Cells And Assessment Thereof 	.freshpatents.com	0	0		
585	chrUn_AAFC02248261	0	196	3500057796	172		0	196	8421504	4	16,7,135,14	0,21,31,182	g	350005779600000071	516-719						CHROMOSOME-BASED PLATFORMS - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02248261	0	196	3500027983	172		0	196	8421504	4	16,7,135,14	0,21,31,182	g	350002798300000099	516-719						Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC02248261	0	166	3500103754	147		0	166	8421504	4	16,42,59,30	0,31,75,136	g	350010375400000101	501-669						Application # 2006/0150271. Artificial chromosomes, uses thereof and method for preparing artificial chromosomes - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC02319173	381	612	3500282246	230		381	612	8421504	2	140,90	0,141	g	350028224600000002	44-274					Patent	Expression vector systems and method of use (Patent US:5756264)	DeMayo	1998	0		
585	chrUn_AAFC02319173	631	657	3500196141	25		631	657	8421504	2	16,9	0,17	g	350019614100000012	0-25		11158314	10.1128/MCB.21.4.1285-1296.2001	0270-7306	Molecular and Cellular Biology	The CELF Family of RNA Binding Proteins Is Implicated in Cell-Specific and Developmentally Regulated Alternative Splicing	Ladd	2001	6		
585	chrUn_AAFC03005556	1990	2016	3500304827	24		1990	2016	8421504	2	7,17	0,9	g	350030482700000019	14-38						Anti-Interferon Alpha Monoclonal Antibodies and Methods For Use - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03006917	2582	2755	3500408096	42		2582	2755	8421504	2	22,20	0,153	g	350040809600000001,350040809600000000	0-22,0-20						Biopsy by PCR embryos	uction-online.org	0	0		
585	chrUn_AAFC03010481	3974	4002	3500119662	23		3974	4002	8421504	2	10,13	0,15	g	350011966200000002	19-42						Journal of Inflammation BioMed Central	biomedcentral.com	0	0		IDO2
585	chrUn_AAFC03013645	3079	3104	3500408830	25		3079	3104	8421504	1	25	0	g	350040883000000007	4-29						Prenatal bovine sex determination using male-specific oligonucleotides	Gingeras	1990	0		
585	chrUn_AAFC03014731	8040	8069	3500221031	23		8040	8069	8421504	3	4,13,6	0,5,23	g	350022103100000002	7-30						NEW USE OF SIXTH IMMUNOGLOBULIN-LIKE DOMAIN OF VCAM-1 - SNU R&DB FOUNDATION	www.sumobrain.com	0	0		
585	chrUn_AAFC03019875	485	2062	3500264004	576		485	2062	8421504	3	107,276,193	0,222,1384	c,g	350026400400000135,350026400400000129,350026400400000128,350026400400000136,350026400400000127,350026400400000126,350026400400000130	426-1002,426-1002,426-1002,426-1002,417-993,400-976,426-1002						Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03019875	492	712	3500362403	40		492	712	8421504	3	20,15,5	0,85,215	c	350036240300000005,350036240300000004	0-20,0-20						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
585	chrUn_AAFC03019875	752	776	3500109701	24		752	776	8421504	1	24	0	c	350010970100000007	15-39						Methods of suppressing immune response by gene therapy	Barber	1995	0		
585	chrUn_AAFC03019875	848	872	3500227786	24		848	872	8421504	1	24	0	c	350022778600000003	0-24						IDENTIFICATION OF A NUCLEIC ACID MOLECULE	Sayer	2007	0		HCG17
585	chrUn_AAFC03019875	2013	2044	3500297977	30		2013	2044	8421504	2	15,15	0,16	c	350029797700000001,350029797700000000	0-30,0-30		15814900	10.1095/biolreprod.104.037986	0006-3363	Biology of Reproduction	HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms	Discorde	2005	4		HCG27
585	chrUn_AAFC03020007	13395	13418	3500394337	23		13395	13418	8421504	1	23	0	g	350039433700000003	10-33						Use of proteins as demulsifying agents	Baus	2006	0		
585	chrUn_AAFC03020123	42982	43008	3500008403	23		42982	43008	8421504	2	7,16	0,10	g	350000840300000018,350000840300000146	0-23,0-23						HUMAN MONOCLONAL ANTIBODY NEUTRALIZING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND USE THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03027903	508	544	3500104740	36		508	544	8421504	1	36	0	g	350010474000000082	16-52						Untersuchungen zur transkriptionellen Regulation des humanen Chromogranin A Gens und seine Anwendung zum zellspezifischen therapeutischen Gentransfer in neuroendokrine Pankreastumorzellen	ub.uni-marburg.de	0	0		
585	chrUn_AAFC03027903	525	550	3500402055	25		525	550	8421504	1	25	0	g	350040205500000099,350040205500000364,350040205500000154,350040205500000419	0-23,0-23,0-22,0-22						Methods And Kits For Detecting Mutations 	.freshpatents.com	0	0		KATNAL1
585	chrUn_AAFC03029468	1651	1677	3500445405	24		1651	1677	8421504	2	6,18	0,8	g	350044540500000196	3-27						Haemophilus outer membrane protein	Chong	1998	0		
585	chrUn_AAFC03029468	1651	1677	3500093232	24		1651	1677	8421504	2	6,18	0,8	g	350009323200000196	3-27					Patent	Haemophilus outer membrane protein (Patent US:6083743)	Chong	2000	0		
585	chrUn_AAFC03035264	8466	8491	3500158245	24		8466	8491	8421504	2	9,15	0,10	g	350015824500000052	0-24						METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03037054	4092	4119	3500445383	23		4092	4119	8421504	3	5,12,6	0,7,21	g	350044538300000004	11-35						Yellow fever virus infection in golden Syrian hamsters: relationship between cytokine expression and pathologic changes	www.ijcep.com	0	0		
585	chrUn_AAFC03039266	2542	2568	3500299365	24		2542	2568	8421504	3	5,5,14	0,6,12	g	350029936500000004	9-33						Construction of mammalian cell expression vector for pAcGFP-bFLIP(L) fusion protein and its expression in follicular granulosa cells.	.biomedsearch.com	0	0		
585	chrUn_AAFC03039540	28500	28530	3500409058	24		28500	28530	8421504	3	13,5,6	0,16,24	g	350040905800000000	16-40						Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carc	www.gtmb.org	0	0		
585	chrUn_AAFC03039702	21	55	3500050535	28		21	55	8421504	3	8,14,6	0,9,28	g	350005053500000054	16-48						DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor	Gearing	1993	0		
585	chrUn_AAFC03042789	4885	4913	3500319733	26		4885	4913	8421504	3	14,6,6	0,15,22	g	350031973300000190	0-26						ISOLEMENT ET NOUVEAU L'INFECTION CHEZ	tionscanada.gc.ca	0	0		
585	chrUn_AAFC03045509	5395	5423	3500304843	24		5395	5423	8421504	3	11,4,9	0,12,19	g	350030484300000044	11-36						Vaccine and antitoxin for treatment and prevention of c. difficile disease	Firca	1997	0		
585	chrUn_AAFC03046655	33107	33135	3500295532	23		33107	33135	8421504	2	14,9	0,19	g	350029553200000000	20-43						Transcription factor Islet-Brain 1 (IB1)	Waeber	1997	0		
585	chrUn_AAFC03050748	6947	6977	3500211749	27		6947	6977	8421504	2	15,12	0,18	g	350021174900000016	11-38					Patent	Bacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic form (Patent US:5977065)	Anlezark	1999	0		
585	chrUn_AAFC03050751	3472	3499	3500231857	27		3472	3499	8421504	1	27	0	g	350023185700000061	6-33						Toxicology and Applied Pharmacology	www.usask.ca	0	0		
585	chrUn_AAFC03051174	25355	25386	3500395463	25		25355	25386	8421504	3	4,7,14	0,5,17	g	350039546300000035	12-44						Methods for enhancement of protective immune responses	Reed	1999	0		
585	chrUn_AAFC03053747	12934	12960	3500405094	25		12934	12960	8421504	2	13,12	0,14	g	350040509400000001	0-25						ScienceDirect.com - Developmental & Comparative Immunology - Oligoclonal Peyer's patch follicles in the terminal small intestine of cattle	sciencedirect.com	0	0		
585	chrUn_AAFC03053752	298	347	3500420553	43		298	347	8421504	2	22,21	0,28	g	350042055300000003,350042055300000005,350042055300000002,350042055300000004	0-21,0-22,0-21,0-19						&#x767a;&#xff08;&#x30d7;&#x30ed;&#x30b8;&#x30a7;&#x30af;&#x30c8;&#x7814;&#x7a76;&#x6210;&#x679c;&#x30b7;&#x30ea;&#x30fc;&#x30ba;411&#xff09; &#x7e41;&#x6b96;&#x6280;&#x8853;&#x306e;&#x9ad8;&#x5ea6;&#x5316;&#x306b;&#x57fa;&#x3065;&#x304f;&#x65b0;&#x4e73;&#x	ledge.affrc.go.jp	0	0		
585	chrUn_AAFC03053752	298	347	3500388822	49		298	347	8421504	1	49	0	g	350038882200000000	0-49						Specific dna molecular probes for bos-type male genome	Bishop	1989	0		
585	chrUn_AAFC03054350	1042	1074	3500447590	27		1042	1074	8421504	2	15,12	0,20	g	350044759000000248	9-36						METHODS TO EVALUATE GLUCOCORTICOID RECEPTOR AGONISTS AND ANTAGONISTS FOR EFFECTS ON NEURON-LIKE CELLS - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03054669	82	106	3500462347	23		82	106	8421504	2	5,18	0,6	g	350046234700000016	1-26						Discrimination of Streptococcus pneumoniae from Viridans Group Streptococci by Genomic Subtractive Hybridization	jcm.asm.org	0	0		
585	chrUn_AAFC03054881	2578	2604	3500212921	25		2578	2604	8421504	2	20,5	0,21	g	350021292100000001	9-37		17545541	10.1158/1078-0432.CCR-06-3037	1078-0432	Clinical Cancer Research	Overexpression of Clostridium perfringens Enterotoxin Receptors Claudin-3 and Claudin-4 in Uterine Carcinosarcomas	Santin	2007	8		
585	chrUn_AAFC03055148	356	384	3500324876	24		356	384	8421504	2	7,17	0,11	g	350032487600000000	9-33						Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor	Diamond	1996	0		
585	chrUn_AAFC03064331	8300	8330	3500427034	30		8300	8330	8421504	1	30	0	g	350042703400000001	43-73		19864464	10.1091/mbc.E09-01-0036	1059-1524	Molecular Biology of the Cell	Phosphatidylinositol 3,4,5-trisphosphate Localization in Recycling Endosomes Is Necessary for AP-1B&#x2013;dependent Sorting in Polarized Epithelial Cells	Fields	2010	5		KLLN
585	chrUn_AAFC03064331	8306	8331	3500246113	25		8306	8331	8421504	1	25	0	g	350024611300000007	7-32					Patent	A tumor suppressor designated ts10q23.3 (Patent EP:1012338)	Jasser	2005	0		
585	chrUn_AAFC03065813	2704	2730	3500148959	23		2704	2730	8421504	3	12,6,5	0,14,21	g	350014895900000069	5-28						INTEIN-MODIFIED ENZYMES, THEIR PRODUCTION AND INDUSTRIAL APPLICATION - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03066688	10959	10984	3500436518	24		10959	10984	8421504	2	5,19	0,6	g	350043651800000026	20-47						Pasteurella neuraminidase coding sequences and diagnostic methods	Lee	1999	0		
585	chrUn_AAFC03067885	830	856	3500312386	25		830	856	8421504	2	9,16	0,10	g	350031238600000172	23-48						ALANINE 2, 3-AMINOMUTASE - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03069706	2268	2509	3500056107	46		2268	2509	8421504	2	22,24	0,217	g	350005610700000000,350005610700000001	1-23,0-24						None	venio.lib.auth.gr	0	0		
585	chrUn_AAFC03074921	763	880	3500008503	117		763	880	8421504	1	117	0	p,c	350000850300000000,350000850300000056,350000850300015000,350000850300015102	0-117,0-117,0-117,0-45						F-box proteins and genes	Elledge	1999	0		FBXW2
585	chrUn_AAFC03077498	739	763	3500318568	24		739	763	8421504	1	24	0	g	350031856800000000	1-25						Differential gene expression in a murine model of cancer cachexia	do.physiology.org	0	0		
585	chrUn_AAFC03077669	4970	4996	3500395217	23		4970	4996	8421504	2	14,9	0,17	g	350039521700000041	0-23						Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti	Brodin	2003	0		
585	chrUn_AAFC03077669	4970	4996	3500106334	23		4970	4996	8421504	2	14,9	0,17	g	350010633400000041	0-23						Identification of virulence associated regions rd1 and rd5 enabling the development of imrpoved vaccines of m. bovis bcg and m. microti	Brodin	2005	0		
585	chrUn_AAFC03079854	5138	5162	3500114536	24		5138	5162	8421504	1	24	0	g	350011453600000476	17-41						HtSNPs FOR DETERMINING A GENOTYPE OF CYTOCHROME P450 1A2, 2A6 AND 2D6, PXR AND UDP-GLUCURONOSYLTRANSFERASE 1A GENE AND MULTIPLEX GENOTYPING METHODS USING THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03081720	1634	1663	3500270665	27		1634	1663	8421504	3	8,15,4	0,9,25	g	350027066500000025,350027066500000006	8-35,8-35						USE OF ANTI-INTEGRIN ANTIBODIES FOR REDUCING SCAR TISSUE FORMATION - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03081913	3027	3050	3500390342	23		3027	3050	8421504	1	23	0	g	350039034200000000	0-23			10.1590/S0102-09352011000400030	0102-0935	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia	Arquivo Brasileiro de Medicina Veterin&#xe1;ria e Zootecnia - Sensitivity of PCR to amplify sex-specific bovine DNA in diluted samples	Cruz	2011	0		
585	chrUn_AAFC03083314	3350	3376	3500056166	24		3350	3376	8421504	2	7,17	0,9	g	350005616600000143	10-34						US Patent # 6,579,526. Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC03087416	1943	1971	3500357160	28		1943	1971	8421504	1	28	0	c	350035716000000000	0-28		23094017	10.1371/journal.pone.0045488		PLoS ONE	No Evidence for a Second Evolutionary Stratum during the Early Evolution of Mammalian Sex Chromosomes	Yukako	2012	0		
585	chrUn_AAFC03088262	666	691	3500436578	25		666	691	8421504	1	25	0	g	350043657800000022	0-25			10.1111/j.1365-2672.2006.02805.x	1365-2672	Journal of Applied Microbiology	Total bacterial and species-specific 16S rDNA micro-array quantification of complex samples - Treimo - 2006 - Journal of Applied Microbiology - Wiley Online Library	Treimo	2006	0		
585	chrUn_AAFC03088262	667	692	3500360884	25		667	692	8421504	1	25	0	g	350036088400000013	1-26						THE JOURNAL OF BIOLOGICAL C Vol. 279, No. 25, Issue of June 18, pp. 26462&#x2013;26468, 2004 &#xa9; 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Rapid Evolution of -Glucuronidase Specificity by Saturation Mut	biochem.emory.edu	0	0		
585	chrUn_AAFC03088262	667	691	3500263756	24		667	691	8421504	1	24	0	g	350026375600000041	0-24						GAMMA SATELLITE INSULATOR SEQUENCES AND THEIR USE IN PREVENTING GENE SILENCING - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088262	668	692	3500324616	24		668	692	8421504	1	24	0	g	350032461600000001	0-24		22152050	10.1186/1754-6834-4-58	1754-6834	Biotechnology for Biofuels	High level expression of Acidothermus cellulolyticus &#xce;&#xb2;-1, 4-endoglucanase in transgenic rice enhances the hydrolysis of its straw by cultured cow gastric fluid	Chou	2011	6		
585	chrUn_AAFC03088262	668	692	3500062865	24		668	692	8421504	1	24	0	g	350006286500000003	0-24						Igf-1r binding polypeptides and their use	Bergman	2010	0		
585	chrUn_AAFC03088262	668	692	3500061742	24		668	692	8421504	1	24	0	g	350006174200000000	0-24						Her3 binding polypeptides	Frejd	2011	0		
585	chrUn_AAFC03088262	668	692	3500058967	24		668	692	8421504	1	24	0	g	350005896700000000	0-24						COMPOSITIONS, METHODS AND USES - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088262	804	998	3500241654	65		804	998	8421504	2	24,41	0,153	g	350024165400000154,350024165400000236	1-25,9-50					Patent	Molecular antigen arrays using a virus like particle derived from the AP205 coat protein (Patent CN:1668637)	A*Di Suo 	2010	0		
585	chrUn_AAFC03088262	971	995	3500277321	24		971	995	8421504	1	24	0	g	350027732100000000	22-46						Novel flavivirus antigens - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088262	971	1014	3500413719	42		971	1014	8421504	2	36,6	0,37	g	350041371900000002	3-45						Encyclopedia of Medical Devices and Instrumentation [Vol 3]	www.scribd.com	0	0		
585	chrUn_AAFC03088262	971	1014	3500277837	43		971	1014	8421504	1	43	0	g	350027783700000033	4-47						Tear lipocalin in muteins binding Il-4 R alpha	A*Huo Er Bao Mu 	2013	0		
585	chrUn_AAFC03088262	971	1014	3500240937	43		971	1014	8421504	1	43	0	g	350024093700000047	214-257						&#x65b9;&#x6cd5; Method	A*J*Jin Si Man 	2007	0		
585	chrUn_AAFC03088262	971	1014	3500193213	43		971	1014	8421504	1	43	0	g	350019321300000147	0-43						Vectors and methods for immunization or therapeutic protocols	Krieg	1998	0		
585	chrUn_AAFC03088262	971	1014	3500157423	43		971	1014	8421504	1	43	0	g	350015742300000146	0-43						Vectors and methods for immunization or therapeutic protocols - Patent # 6339068 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_AAFC03088262	971	1014	3500122872	43		971	1014	8421504	1	43	0	g	350012287200000135	0-43						Vectors and methods for immunization or therapeutic protocols	Krieg	2001	0		
585	chrUn_AAFC03088262	971	1014	3500021772	43		971	1014	8421504	1	43	0	g	350002177200000011,350002177200000013,350002177200000015	235-278,229-272,161-204						Adeno-associated virus vectors - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088262	971	1013	3500247387	42		971	1013	8421504	1	42	0	g	350024738700000406	18-60						Antigen delivery platforms	Franti	2012	0		
585	chrUn_AAFC03088421	5551	5745	3500085146	164		5551	5745	8421504	8	11,34,8,14,5,15,16,61	0,32,67,78,94,100,116,133	g	350008514600000063,350008514600000042,350008514600000071	59-256,54-208,59-216						US Patent # 7,238,356. Core-glycosylated HCV envelope proteins - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC03088421	5583	5745	3500465421	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350046542100000192	147-307						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
585	chrUn_AAFC03088421	5583	5745	3500463399	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350046339900000027	23-183						RT-PCR assays for the detection of SARS &#x2013; Urbani Coronavirus	ww.tib-molbiol.de	0	0		
585	chrUn_AAFC03088421	5583	5745	3500446762	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350044676200000038	531-691						Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods	Franklin	2012	0		
585	chrUn_AAFC03088421	5583	5745	3500435564	156		5583	5745	8421504	6	34,25,5,12,19,61	0,35,62,68,81,101	g	350043556400000208	21-181						Heterodimeric receptor libraries using phagemids	Barbas	1994	0		
585	chrUn_AAFC03088421	5583	5745	3500434687	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350043468700000002	114-274						Uspa1 And Uspa2 Antigens Of Moraxella Catarrhalis 	.freshpatents.com	0	0		
585	chrUn_AAFC03088421	5583	5745	3500396839	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350039683900000101	531-691						Food compositions comprising tailored oils	Franklin	2011	0		
585	chrUn_AAFC03088421	5583	5745	3500395935	156		5583	5745	8421504	6	34,25,5,12,19,61	0,35,62,68,81,101	g	350039593500000008	136-296						Viral vector	Limited	2005	0		
585	chrUn_AAFC03088421	5583	5745	3500369568	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350036956800000042,350036956800000050	490-650,380-532						Methods and compositions for seamless cloning of nucleic acid molecules	Chesnut	2009	0		
585	chrUn_AAFC03088421	5583	5745	3500355785	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350035578500000002	451-611						Use Of Histone Chaperone Activity Of Agrobacterium 6b Protein 	.freshpatents.com	0	0		
585	chrUn_AAFC03088421	5583	5745	3500338837	154		5583	5745	8421504	8	34,25,5,12,19,29,22,8	0,35,62,68,81,101,131,154	g	350033883700000060	137-296						Isolated stealth viruses and related vaccines	Martin	1995	0		
585	chrUn_AAFC03088421	5583	5745	3500312272	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350031227200000010	160-320						Producer cell for the production of retroviral vectors	Kingsman	2001	0		
585	chrUn_AAFC03088421	5583	5745	3500285660	157		5583	5745	8421504	5	34,25,5,32,61	0,35,62,68,101	g	350028566000000064,350028566000000052,350028566000000071,350028566000000048,350028566000000053	586-712,609-763,674-834,672-832,155-307						Chromosome walking at the fertility restorer locus Rf1 in sunflower	ok.uni-rostock.de	0	0		
585	chrUn_AAFC03088421	5583	5745	3500250826	156		5583	5745	8421504	6	34,25,5,12,19,61	0,35,62,68,81,101	g	350025082600000002	18-178		22025674	10.1128/MCB.06242-11		Molecular and Cellular Biology	Architecture of the Yeast RNA Polymerase II Open Complex and Regulation of Activity by TFIIF	James	2012	0		
585	chrUn_AAFC03088421	5583	5745	3500242634	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350024263400000027	27-187						UNIVERSITE D'ORLEANS THESE	hives-ouvertes.fr	0	0		
585	chrUn_AAFC03088421	5583	5745	3500215746	146		5583	5745	8421504	7	34,8,14,5,15,16,54	0,35,46,62,68,84,108	g	350021574600000074,350021574600000041	59-213,59-213						US Patent # 7,314,925. Constructs and methods for expression of recombinant HCV envelope proteins - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC03088421	5583	5745	3500210375	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350021037500000038	531-691						MICROBIAL OILS WITH LOWERED POUR POINTS, DIELECTRIC FLUIDS PRODUCED THEREFROM, AND RELATED METHODS - SOLAZYME, INC.	www.sumobrain.com	0	0		
585	chrUn_AAFC03088421	5583	5745	3500183987	150		5583	5745	8421504	8	19,13,25,5,12,17,41,18	0,21,35,62,68,83,101,144	g	350018398700000349	136-290						Eubacterial minicells and their use as vectors for nucleic acid delivery and expression - Patent # 7183105 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_AAFC03088421	5583	5745	3500147176	158		5583	5745	8421504	4	60,5,32,61	0,62,68,101	g	350014717600000015,350014717600000016,350014717600000011	117-278,132-292,118-278						&#xc81c; &#xcd9c; &#xbb38;	webbook.me.go.kr	0	0		
585	chrUn_AAFC03088421	5583	5745	3500139007	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350013900700000075,350013900700000064	65-225,65-119						Immortalized avian cell lines for virus production	V*Sang Di Xi 	2007	0		
585	chrUn_AAFC03088421	5583	5745	3500083227	156		5583	5745	8421504	6	34,25,5,15,16,61	0,35,62,68,84,101	g	350008322700000005	623-783						The protective role of Oryzacystatin-I under abiotic stress	upetd.up.ac.za	0	0		
585	chrUn_AAFC03088421	5583	5745	3500068995	157		5583	5745	8421504	5	34,25,5,32,61	0,35,62,68,101	g	350006899500000097,350006899500000389,350006899500000018,350006899500000423	152-341,0-69,132-183,130-185						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
585	chrUn_AAFC03088421	5583	5745	3500044348	146		5583	5745	8421504	7	34,8,14,5,15,16,54	0,35,46,62,68,84,108	g	350004434800000065,350004434800000040	59-213,59-213						 Constructs And Methods For Expression Of Recombinant HCV Envelope Proteins 	www.docstoc.com	0	0		
585	chrUn_AAFC03088421	5583	5745	3500031406	156		5583	5745	8421504	6	34,25,5,12,19,61	0,35,62,68,81,101	g	350003140600000015	64-224						METHOD OF SYNTHESIZING NUCLEIC ACID - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088421	5583	5745	3500019495	156		5583	5745	8421504	6	34,25,5,12,19,61	0,35,62,68,81,101	g	350001949500000032,350001949500000008	136-296,136-296						TRANSGENIC ORGANISM - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088421	5583	5745	3500018804	157		5583	5745	8421504	5	34,25,5,32,61	0,35,62,68,101	g	350001880400000012,350001880400000010	50-210,0-93						Incorporation Of Modified Nucleotides By Archaeon Dna Polymerases And Related Methods 	.freshpatents.com	0	0		
585	chrUn_AAFC03088421	5583	5743	3500321569	140		5583	5743	8421504	8	7,4,10,9,22,30,50,8	0,9,14,25,35,70,101,152	g	350032156900000099,350032156900000085	62-212,31-195						Protease-resistant thrombomodulin analogs	Andrews	1995	0		
585	chrUn_AAFC03088421	5583	5722	3500259213	133		5583	5722	8421504	6	34,25,5,15,16,38	0,35,62,68,84,101	g	350025921300000123	398-535					Patent	Purified coprinus laccases and nucleic acids encoding the same (Patent US:6008029)	Brown	1999	0		
585	chrUn_AAFC03088421	5583	5717	3500066495	128		5583	5717	8421504	6	34,25,5,15,16,33	0,35,62,68,84,101	g	350006649500000009,350006649500000005,350006649500000000	0-92,0-111,2-100						Public data TCell Lymphoma Project	tagc.univ-mrs.fr	0	0		
585	chrUn_AAFC03088421	5583	5715	3500370584	126		5583	5715	8421504	6	34,25,5,15,16,31	0,35,62,68,84,101	g	350037058400000145	0-130						Protease inhibition - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088421	5583	5715	3500248879	126		5583	5715	8421504	6	34,25,5,15,16,31	0,35,62,68,84,101	g	350024887900000141	0-130						Protease Inhibition 	.freshpatents.com	0	0		
585	chrUn_AAFC03088421	5583	5711	3500369366	123		5583	5711	8421504	5	34,25,18,19,27	0,35,62,81,101	g	350036936600000044,350036936600000185,350036936600000184,350036936600000043	0-66,0-66,0-60,0-60						Focused libraries of genetic packages	Ladner	2011	0		
585	chrUn_AAFC03088421	5583	5705	3500138386	116		5583	5705	8421504	6	34,25,5,12,19,21	0,35,62,68,81,101	g	350013838600000005	143-264						Method for detection and treatment of breast cancer	Holt	1998	0		
585	chrUn_AAFC03088421	5583	5698	3500240936	109		5583	5698	8421504	6	34,25,5,15,16,14	0,35,62,68,84,101	g	350024093600000012	157-270						COMPOSITIONS AND METHOD FOR MANIPULATING PIM-1 ACTIVITY IN CIRCULATORY SYSTEM CELLS - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088421	5583	5673	3500407574	85		5583	5673	8421504	5	34,25,5,15,6	0,35,62,68,84	g	350040757400000012	0-89					Patent	Adenovirus vectors (Patent US:6057158)	Chamberlain	2000	0		
585	chrUn_AAFC03088421	5583	5673	3500206654	85		5583	5673	8421504	5	34,25,5,15,6	0,35,62,68,84	g	350020665400000012	0-89						Adenovirus vectors	Chamberlain	1999	0		
585	chrUn_AAFC03088421	5583	5650	3500122900	65		5583	5650	8421504	2	60,5	0,62	g	350012290000001065,350012290000001089,350012290000001097,350012290000000953,350012290000000132,350012290000001192,350012290000000737,350012290000000136,350012290000000128,350012290000000614,350012290000000658	1-67,7-73,8-74,6-71,6-72,4-70,8-73,6-72,5-71,5-65,15-77						Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library. application to the detection of mycobacteria - Patent #07842781	w.strutpatent.com	0	0		
585	chrUn_AAFC03088421	5583	5650	3500010909	65		5583	5650	8421504	2	60,5	0,62	g	350001090900000489,350001090900000611,350001090900000363,350001090900000074	6-71,4-70,6-72,5-71						Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria	Cole	1998	0		
585	chrUn_AAFC03088421	5583	5643	3500329421	59		5583	5643	8421504	2	34,25	0,35	g	350032942100000029	5-65						<HTML> <HEAD> <BASE TARGET="_top"> <TITLE>United States Patent: 6,054,564</TITLE></HEAD> <BODY B	l.med.cornell.edu	0	0		
585	chrUn_AAFC03088421	5583	5643	3500129761	59		5583	5643	8421504	2	34,25	0,35	g	350012976100000025	5-65						US Patent # 6,054,564. Thermostable ligase mediated DNA amplification system for the detection of genetic diseases - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC03088421	5585	5627	3500066131	41		5585	5627	8421504	2	32,9	0,33	g	350006613100000004,350006613100000002	0-21,0-33		12673210	10.1038/sj.onc.1206262	0950-9232	Oncogene	Identification of NF-&#x03ba;B-regulated genes induced by TNF&#x03b1; utilizing expression profiling and RNA interference	Zhou	2003	6		
585	chrUn_AAFC03088421	5585	5608	3500158353	23		5585	5608	8421504	1	23	0	g	350015835300000022	10-33		18945934	10.1104/pp.108.130419	0032-0889	Plant Physiology	The Arabidopsis Calcium Sensor Calcineurin B-Like 3 Inhibits the 5&#x2032;-Methylthioadenosine Nucleosidase in a Calcium-Dependent Manner	Oh	2008	7		
585	chrUn_AAFC03088421	5591	5745	3500431485	95		5591	5745	8421504	4	21,14,52,8	0,78,93,146	g	350043148500000000,350043148500000009,350043148500000008	13-84,0-60,64-134						Nucleic acid encoding a fragment of bovine luteinizing hormone/chorionic gonadotropin receptor	Saxena	1993	0		
585	chrUn_AAFC03088421	5591	5745	3500194396	95		5591	5745	8421504	4	21,14,52,8	0,78,93,146	g	350019439600000000,350019439600000009,350019439600000008	13-84,0-60,64-134						hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine	Saxena	2003	0		
585	chrUn_AAFC03088421	5593	5624	3500198699	30		5593	5624	8421504	2	24,6	0,25	g	350019869900000051	0-30						Production Of Very Long Chain Polyunsaturated Fatty Acids In Oil Seed Plants 	.freshpatents.com	0	0		
585	chrUn_AAFC03088421	5594	5690	3500332472	90		5594	5690	8421504	6	23,25,5,12,19,6	0,24,51,57,70,90	g	350033247200000003	289-383						Improved alphavirus replicons and helper constructs	Smith	2004	0		
585	chrUn_AAFC03088421	5598	5739	3500221320	50		5598	5739	8421504	3	19,9,22	0,20,119	g	350022132000000007,350022132000000029	0-28,0-22					Patent	Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin (Patent US:5665869)	Ernst	1997	0		
585	chrUn_AAFC03088421	5599	5625	3500450703	25		5599	5625	8421504	2	18,7	0,19	g	350045070300000028	0-25						Nucleic acids from rice conferring resistance to bacterial blight disease caused by Xanthomonas spp	Yin	2003	0		
585	chrUn_AAFC03088421	5599	5624	3500450708	24		5599	5624	8421504	2	18,6	0,19	g	350045070800000001	0-24						Compositions and methods relating to transdominant Tat mutants	Gaynor	1994	0		
585	chrUn_AAFC03088421	5599	5624	3500221108	24		5599	5624	8421504	2	18,6	0,19	g	350022110800000032	0-24						Methods and compositions for DNA manipulation	Jurate	2012	0		
585	chrUn_AAFC03088421	5599	5624	3500197820	24		5599	5624	8421504	2	18,6	0,19	g	350019782000000001	0-24						US Patent # 5,830,711. Thermostable ligase mediated DNA amplification system for the detection of genetic diseases - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC03088421	5599	5624	3500065584	24		5599	5624	8421504	2	18,6	0,19	g	350006558400000007	0-24		9515907		0021-9193	Journal of Bacteriology	The LysR-Type Transcriptional Regulator CbbR Controlling Autotrophic CO2 Fixation by Xanthobacter flavus Is an NADPH Sensor	Keulen	1998	4		
585	chrUn_AAFC03088421	5600	5640	3500433897	39		5600	5640	8421504	2	17,22	0,18	g	350043389700000000	0-40						Ligand interactions with lactose repressor protein and the repressor-operator complex: the effects of ionization and oligomerization on binding. - ResearchGate	.researchgate.net	0	0		
585	chrUn_AAFC03088421	5600	5640	3500114788	39		5600	5640	8421504	2	17,22	0,18	g	350011478800000000	0-40		20804152	10.1021/bi101106x		Biochemistry	Positions 94&#x2013;98 of the lactose repressor N-subdomain monomer&#x2022;monomer interface are critical for allosteric communication	Hongli	2010	0		
585	chrUn_AAFC03088421	5600	5627	3500356197	26		5600	5627	8421504	2	17,9	0,18	g	350035619700000012	16-42						F&#xdc;R DIE HIV-GENTHERAPIE	ub.uni-hamburg.de	0	0		
585	chrUn_AAFC03088421	5600	5625	3500211402	24		5600	5625	8421504	2	17,7	0,18	g	350021140200000006	0-24		15184124	10.1128/AEM.70.6.3298-3304.2004	0099-2240	Applied and Environmental Microbiology	Cloning, Nucleotide Sequence, and Overexpression of the l-Rhamnose Isomerase Gene from Pseudomonas stutzeri in Escherichia coli	Leang	2004	4		
585	chrUn_AAFC03088421	5600	5624	3500366784	23		5600	5624	8421504	2	17,6	0,18	g	350036678400000011	0-23						Polymorphic kinase anchor proteins and nucleic acids encoding the same	Braun	2001	0		
585	chrUn_AAFC03088421	5600	5624	3500135351	23		5600	5624	8421504	2	17,6	0,18	g	350013535100000001	0-23						BBRC	load.bioon.com.cn	0	0		
585	chrUn_AAFC03088421	5604	5715	3500259295	105		5604	5715	8421504	6	13,25,5,12,19,31	0,14,41,47,60,80	g	350025929500000083	0-109						Novel Phage Display Technologies - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088421	5618	5706	3500361569	84		5618	5706	8421504	4	25,18,19,22	0,27,46,66	g	350036156900000041	12-98						Method of using P35 antigen of toxoplasma gondii in distinguishing acute from chronic toxoplasmosis	Maine	1999	0		
585	chrUn_AAFC03088421	5618	5706	3500086931	84		5618	5706	8421504	4	25,21,16,22	0,27,49,66	g	350008693100000000	12-98						Hepatitis c assay utilizing recombinant antigens to ns1	Dailey	1993	0		
585	chrUn_AAFC03088421	5632	5728	3500257293	91		5632	5728	8421504	5	11,5,15,16,44	0,13,19,35,52	g	350025729300000000	6-100						SPECIFIC BINDING PROTEINS AND USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088421	5632	5728	3500185396	91		5632	5728	8421504	5	11,5,15,16,44	0,13,19,35,52	g	350018539600000000	6-100					Patent	Specific binding proteins and uses thereof (Patent US:7589180)	Old	2009	0		
585	chrUn_AAFC03088421	5632	5728	3500104768	91		5632	5728	8421504	5	11,5,15,16,44	0,13,19,35,52	g	350010476800000000	6-100						US Patent # 7,589,180. Specific binding proteins and uses thereof - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC03088421	5643	5724	3500202460	61		5643	5724	8421504	5	7,14,16,4,20	0,8,24,41,61	g	350020246000000017,350020246000000016,350020246000000013,350020246000000012,350020246000000018,350020246000000025,350020246000000032	22-65,21-64,40-83,41-84,22-63,0-20,0-20						METHOD FOR AMPLIFICATION OF NUCLEOTIDE SEQUENCE - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088421	5643	5675	3500039132	30		5643	5675	8421504	3	7,15,8	0,8,24	g	350003913200000019	0-32						Funktionelle Charakterisierung zweier Levamisolrezeptor-assoziierter Proteine in C. elegans &#x2013; NRA-2 und NRA-4	.uni-frankfurt.de	0	0		
585	chrUn_AAFC03088421	5645	5683	3500410766	36		5645	5683	8421504	3	5,12,19	0,6,19	g	350041076600000000	4-42						Positive-selection vector for direct protein expression. - ResearchGate	.researchgate.net	0	0		
585	chrUn_AAFC03088421	5645	5683	3500006882	36		5645	5683	8421504	3	5,12,19	0,6,19	g	350000688200000000	4-42						Positive-Selection Vector for Direct Protein Expression | Andreas Haag - Academia.edu	www.academia.edu	0	0		
585	chrUn_AAFC03088421	5645	5673	3500360481	26		5645	5673	8421504	3	5,15,6	0,6,22	g	350036048100000030	0-28						US Patent # 5,837,500. Directed evolution of novel binding proteins - Patents.com	ww.es.patents.com	0	0		
585	chrUn_AAFC03088421	5645	5673	3500185554	26		5645	5673	8421504	3	5,15,6	0,6,22	g	350018555400000026	0-28						 Directed Evolution Of Novel Binding Proteins 	www.docstoc.com	0	0		
585	chrUn_AAFC03088421	5645	5673	3500054568	26		5645	5673	8421504	3	5,15,6	0,6,22	g	350005456800000037,350005456800000031	3-25,0-28						Directed evolution of novel binding proteins - US Patent 5837500 Description	ww.patentstorm.us	0	0		
585	chrUn_AAFC03088421	5645	5673	3500012277	26		5645	5673	8421504	3	5,15,6	0,6,22	g	350001227700000062,350001227700000141	0-28,3-25						 Directed Evolution Of Novel Binding Proteins 	www.docstoc.com	0	0		
585	chrUn_AAFC03088421	5651	5745	3500193213	92		5651	5745	8421504	3	12,19,61	0,13,33	g	350019321300000137,350019321300000138,350019321300000139	17-60,17-60,0-49						Vectors and methods for immunization or therapeutic protocols	Krieg	1998	0		
585	chrUn_AAFC03088421	5651	5745	3500157423	92		5651	5745	8421504	3	12,19,61	0,13,33	g	350015742300000136,350015742300000137,350015742300000138	17-60,17-60,0-49						Vectors and methods for immunization or therapeutic protocols - Patent # 6339068 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_AAFC03088421	5651	5745	3500122872	92		5651	5745	8421504	3	12,19,61	0,13,33	g	350012287200000125,350012287200000126,350012287200000127	17-60,17-60,0-49						Vectors and methods for immunization or therapeutic protocols	Krieg	2001	0		
585	chrUn_AAFC03088421	5651	5675	3500269628	23		5651	5675	8421504	2	15,8	0,16	g	350026962800000001	0-23						Identification of p54 otein HS1 as TNF- Pr and the 14-3-3 -Inducible Genes Related to Cell Cycle Co l and Apoptosis in Human o ntr elial Cells Arterial Endoth	www.jbmb.or.kr	0	0		
585	chrUn_AAFC03088421	5653	5706	3500105958	51		5653	5706	8421504	3	13,16,22	0,14,31	g	350010595800000000	12-63						Hepatitis c assay utilizing recombinant antigens from ns5 region	Dailey	1994	0		
585	chrUn_AAFC03088421	5658	5683	3500460185	24		5658	5683	8421504	2	5,19	0,6	g	350046018500000004	0-24						nucleic acid molecule for encoding xylose isomerase and xylose isomerase encoded by the nucleic acid molecule	Bao	2012	0		
585	chrUn_AAFC03088421	5658	5683	3500441958	24		5658	5683	8421504	2	5,19	0,6	g	350044195800000004	0-24						NUCLEIC ACID MOLECULE FOR ENCODING XYLOSE ISOMERASE AND XYLOSE ISOMERASE ENCODED BY THE NUCLEIC ACID MOLECULE	Bao	2011	0		
585	chrUn_AAFC03088421	5658	5683	3500168588	24		5658	5683	8421504	2	5,19	0,6	g	350016858800000008	0-24						Nucleic acid molecule encoding xylose isomerase and xylose isomerase encoded thereof	Bao	2012	0		
585	chrUn_AAFC03088421	5658	5682	3500326400	23		5658	5682	8421504	2	5,18	0,6	g	350032640000000014	0-23						PCR-based expression analysis and	libpubmedia.co.uk	0	0		
585	chrUn_AAFC03088421	5691	5745	3500240181	54		5691	5745	8421504	1	54	0	g	350024018100000056	19-73						Strains for production of RcoMBx-1 proteins and assay of in vivo activity.	www.addgene.org	0	0		
585	chrUn_AAFC03088421	5694	5743	3500082958	48		5694	5743	8421504	2	8,40	0,9	g	350008295800000018	0-50						Steroid receptor antagonist co-modulator and methods for using same	Horwitz	1997	0		
585	chrUn_AAFC03088421	5695	5735	3500038264	40		5695	5735	8421504	1	40	0	g	350003826400000036	0-40						Production of branched chain fatty acids and derivatives thereof in recombinant microbial cells	Hu	2011	0		
585	chrUn_AAFC03088421	5695	5720	3500201714	25		5695	5720	8421504	1	25	0	g	350020171400000001	0-25						Abstracts of Oak Ridge Posters	www.clinchem.org	0	0		
585	chrUn_AAFC03088421	5696	5745	3500023618	49		5696	5745	8421504	1	49	0	g	350002361800000096	0-49						METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03088421	5699	5723	3500315104	24		5699	5723	8421504	1	24	0	g	350031510400000003	0-24			10.1091/mbc.E03-07-0474		Molecular Biology of the Cell	Tetrahymena Telomerase Is Active as a Monomer	Tracy	2003	0		
585	chrUn_AAFC03088421	5699	5723	3500180149	24		5699	5723	8421504	1	24	0	g	350018014900000003	0-24		13679509	10.1091/mbc.E03-07-0474	1059-1524	Molecular Biology of the Cell	Tetrahymena Telomerase Is Active as a Monomer	Bryan	2003	5		
585	chrUn_AAFC03088421	5705	5740	3500146501	35		5705	5740	8421504	1	35	0	g	350014650100000469,350014650100000470,350014650100000674,350014650100000673	0-31,0-35,0-29,0-29					Patent	GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants (Patent CN:1665934)	D*E*A*Fu Luo La Ke 	2010	0		
585	chrUn_AAFC03088421	5706	5736	3500284980	30		5706	5736	8421504	1	30	0	g	350028498000000125	12-42					Patent	Transgenic transchromosomal rodents for making human antibodies (Patent CN:1487996)	E*Ha Er Ke 	2010	0		
585	chrUn_AAFC03088421	5715	5739	3500196015	24		5715	5739	8421504	1	24	0	g	350019601500000009	6-30						REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY	Curtiss	2009	0		
585	chrUn_AAFC03088421	5716	5739	3500384745	23		5716	5739	8421504	1	23	0	g	350038474500000019	9-32						Purification of hemoglobin	Ernst	1996	0		
585	chrUn_AAFC03088421	5716	5739	3500175122	23		5716	5739	8421504	1	23	0	g	350017512200000019	9-32						 Purification Of Hemoglobin 	www.docstoc.com	0	0		
585	chrUn_AAFC03088421	5716	5739	3500116965	23		5716	5739	8421504	1	23	0	g	350011696500000018	9-32					Patent	Purification of hemoglobin (Patent US:5840851)	Durfee	1998	0		
585	chrUn_AAFC03088421	5716	5739	3500027695	23		5716	5739	8421504	1	23	0	g	350002769500000019	9-32						Purification of hemoglobin	Plomer	1995	0		
585	chrUn_AAFC03088421	5717	5743	3500312902	26		5717	5743	8421504	1	26	0	g	350031290200000024	0-26						Role of Transcription in Plasmid Maintenance in the hpr1 Mutant of Saccharomyces cerevisiae	mcb.asm.org	0	0		
585	chrUn_AAFC03088421	5717	5741	3500296965	23		5717	5741	8421504	2	19,4	0,20	g	350029696500000018	9-32						MICROORGANISMS FOR n-PROPANOL PRODUCTION - NOVOZYMES A/S	www.sumobrain.com	0	0		
585	chrUn_AAFC03088421	5719	5745	3500221470	26		5719	5745	8421504	1	26	0	g	350022147000000001	9-35		17959663	10.1128/JVI.01441-07	0022-538X	Journal of Virology	Rous Sarcoma Virus (RSV) Integration In Vivo: a CA Dinucleotide Is Not Required in U3, and RSV Linear DNA Does Not Autointegrate	Oh	2008	5		
585	chrUn_AAFC03088421	5721	5744	3500315114	23		5721	5744	8421504	1	23	0	g	350031511400000005	0-23					Infection and Immunity	IS1414, an Escherichia coli Insertion Sequence with a Heat-Stable Enterotoxin Gene Embedded in a Transposase-Like Gene	Annette	2000	0		
585	chrUn_AAFC03091019	173	282	3500069206	42		173	282	8421504	2	24,18	0,91	g	350006920600000003	1-112						 Oligonucleotide Probes Specific For The Human Alpha Satellite Locus 	www.docstoc.com	0	0		
585	chrUn_AAFC03091019	173	1219	3500365999	68		173	1219	8421504	3	24,18,26	0,91,1020	g	350036599900000003,350036599900000001	1-112,5-31						US Patent # 5,464,945. Oligonucleotide probes specific for the human alpha satellite locus - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC03091019	576	624	3500159039	48		576	624	8421504	1	48	0	g	350015903900000066	0-48						CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03091019	576	624	3500097250	48		576	624	8421504	1	48	0	g	350009725000000059	0-48						Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV) - US Patent 7544467 Description	ww.patentstorm.us	0	0		
585	chrUn_AAFC03091019	869	1140	3500406057	71		869	1140	8421504	3	21,21,29	0,42,242	g	350040605700000000	79-178		16183641	10.1074/jbc.M509666200	0021-9258	Journal of Biological Chemistry	Human Centromere Protein B Induces Translational Positioning of Nucleosomes on &#x03b1;-Satellite Sequences	Tanaka	2005	5		
585	chrUn_AAFC03091024	712	736	3500311347	24		712	736	8421504	1	24	0	g	350031134700000065	0-24						METHODS FOR IDENTIFYING CANCER RISK	Feinberg	2009	0		COL4A5
585	chrUn_AAFC03091066	338	390	3500263756	40		338	390	8421504	2	13,27	0,25	g	350026375600000157	16-67						GAMMA SATELLITE INSULATOR SEQUENCES AND THEIR USE IN PREVENTING GENE SILENCING - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03094992	4196	4222	3500017994	24		4196	4222	8421504	2	6,18	0,8	g	350001799400000069	0-24						THE UL36-ENCODED UBIQUITIN-SPECIFIC PROTEASE IN MAREK&#x2019;S DISEASE VIRUS REPLICATION AND TUMOURIGENESIS	diss.fu-berlin.de	0	0		
585	chrUn_AAFC03096657	7620	7751	3500074407	41		7620	7751	8421504	2	20,21	0,110	g	350007440700000000,350007440700000003	0-20,0-21						RODRIGO DA SILVA NUNES BARRETO	www.teses.usp.br	0	0		
585	chrUn_AAFC03097774	2909	2937	3500205215	24		2909	2937	8421504	2	12,12	0,16	g	350020521500000104	0-24						Control of ostrinia	www.devileye.net	0	0		
585	chrUn_AAFC03098077	1344	15201	3500418301	8098		1344	15201	8421504	40	1048,22,1028,398,36,81,410,52,259,162,8,29,68,98,32,13,30,25,10,158,86,18,54,21,95,20,18,12,44,330,376,404,456,5,94,8,418,268,221,1183	0,1049,1072,4133,4532,4569,4651,5062,5115,5392,5558,5567,5597,5666,5765,5798,5812,5847,5890,5901,6060,6151,6170,6225,6247,6343,6364,6383,6396,6442,6773,7150,7555,8013,8019,8114,8124,8543,12452,12674	g	350041830100000005,350041830100000003,350041830100000004,350041830100000002,350041830100000001	0-2104,0-1722,0-1328,0-1655,0-1404					Patent	Sexing method of bovine embyros (Patent US:5461145)	Itagaki	1995	0		
585	chrUn_AAFC03098077	1344	15201	3500160638	8098		1344	15201	8421504	40	1048,22,1028,398,36,81,410,52,259,162,8,29,68,98,32,13,30,25,10,158,86,18,54,21,95,20,18,12,44,330,376,404,456,5,94,8,418,268,221,1183	0,1049,1072,4133,4532,4569,4651,5062,5115,5392,5558,5567,5597,5666,5765,5798,5812,5847,5890,5901,6060,6151,6170,6225,6247,6343,6364,6383,6396,6442,6773,7150,7555,8013,8019,8114,8124,8543,12452,12674	g	350016063800000005,350016063800000003,350016063800000004,350016063800000002,350016063800000001	0-2104,0-1722,0-1328,0-1655,0-1404						Sexing method of bovine embyros	Kudo	1992	0		
585	chrUn_AAFC03100583	28592	29705	3500155689	93		28592	29705	8421504	3	15,30,48	0,418,1065	p	350015568900015193,350015568900015220	3-48,0-48						Antibodies Against Inducible Th2 Cell Factors 	.freshpatents.com	0	0		
585	chrUn_AAFC03103641	9540	9563	3500369053	23		9540	9563	8421504	1	23	0	g	350036905300000104	0-23						 BGS 4 	www.docstoc.com	0	0		
585	chrUn_AAFC03103641	9540	9563	3500245605	23		9540	9563	8421504	1	23	0	g	350024560500000012	0-23						Human binding molecules having killing activity against staphylococci and uses thereof	Kruif	2012	0		ZNF280B
585	chrUn_AAFC03103641	9540	9563	3500216886	23		9540	9563	8421504	1	23	0	g	350021688600000011,350021688600000039	0-21,18-41						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2010	0		
585	chrUn_AAFC03103641	9540	9563	3500210431	23		9540	9563	8421504	1	23	0	g	350021043100000066	0-23						Binding molecules capable of neutralizing West Nile virus and uses thereof - Patent #07244430	w.strutpatent.com	0	0		
585	chrUn_AAFC03103641	9540	9563	3500108690	23		9540	9563	8421504	1	23	0	g	350010869000000049	0-23					Patent	Vascular endothelial growth factor 2 (Patent US:7850963)	Rosen	2010	0		
585	chrUn_AAFC03103834	10054	10078	3500312037	23		10054	10078	8421504	2	17,6	0,18	g	350031203700000052	20-44						TARGETED WHOLE GENOME AMPLIFICATION METHOD FOR IDENTIFICATION OF PATHOGENS - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03104160	2416	2440	3500229051	24		2416	2440	8421504	1	24	0	g	350022905100000008	0-24						Reprogramming of Human Somatic Cells Using Human and Animal Oocytes	advancedcell.com	0	0		
585	chrUn_AAFC03105622	2027	2056	3500050546	23		2027	2056	8421504	3	7,12,4	0,12,25	g	350005054600000007	12-36		19372237	10.1210/me.2009-0011	0888-8809	Molecular Endocrinology	Nucleocytoplasmic Shuttling of the Adapter Protein SH2B1&#x03b2; (SH2-B&#x03b2;) Is Required for Nerve Growth Factor (NGF)-Dependent Neurite Outgrowth and Enhancement of Expression of a Subset of NGF-Responsive Genes	Maures	2009	5		
585	chrUn_AAFC03107696	21287	21311	3500025902	23		21287	21311	8421504	2	16,7	0,17	g	350002590200000031	0-23						INFLAMMATORY BOWEL DISEASE PROGNOSTICS - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03109231	2955	2987	3500112957	26		2955	2987	8421504	3	11,9,6	0,15,26	g	350011295700000004	0-30						Process for eliminating N-terminal methionine	Nishimura	2001	0		
585	chrUn_AAFC03110000	3124	3147	3500381159	23		3124	3147	8421504	1	23	0	g	350038115900000015,350038115900000053	8-31,8-31						Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS) - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03110932	3234	3259	3500262089	24		3234	3259	8421504	2	7,17	0,8	g	350026208900000025	5-29						US Patent # 6,080,912. Methods for creating transgenic animals - Patents.com	www.patents.com	0	0		
585	chrUn_AAFC03114197	9774	9801	3500253256	23		9774	9801	8421504	3	6,6,11	0,9,16	g	350025325600002469	15-41						 Methods Of Using Conjugated Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
585	chrUn_AAFC03114197	48035	48062	3500394411	24		48035	48062	8421504	2	6,18	0,9	g	350039441100002463	14-40						OSK1 peptide analogs and pharmaceutical compositions - Patent application	www.faqs.org	0	0		
585	chrUn_AAFC03119919	30223	37087	3500440537	40		30223	37087	8421504	2	20,20	0,6844	c,g	350044053700000022,350044053700000022,350044053700000023,350044053700000023	0-20,0-20,0-20,0-20						EMX2 IN CANCER DIAGNOSIS AND PROGNOSIS - Patent application	www.faqs.org	0	0		WNT16
585	chrUn_AAFC03119919	32785	32809	3500155900	23		32785	32809	8421504	2	15,8	0,16	g	350015590000000476	7-38						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
585	chrUn_AAFC03120861	15841	15871	3500018955	25		15841	15871	8421504	3	5,14,6	0,8,24	g	350001895500000020	6-31						Prostate-specific membrane antigen and uses thereof	Heston	2003	0		
585	chrUn_AAFC03120861	91102	91127	3500337280	23		91102	91127	8421504	2	10,13	0,12	g	350033728000000024	15-38					Patent	Temporal seed promoters for expressing genes in plants (Patent CN:1728937)	Pa Te Li Si *Du Bo Yi Si 	2011	0		
585	chrUn_AAFC03124059	7196	7223	3500041331	24		7196	7223	8421504	2	6,18	0,9	g	350004133100000012	15-40						Juvenile Parkinson disease caused by parkin mutations: large deletions and pathogenic mechanisms	run.unl.pt/bitstr	0	0		
585	chrUn_AAFC03130478	3299	3328	3500396857	24		3299	3328	8421504	3	13,6,5	0,16,24	g	350039685700000002	8-32					Patent	Human T1R2 nucleic acid sequences and polypeptides (Patent US:8138322)	Zozulya	2012	0		
585	chrUn_AAFC03130478	3299	3328	3500059357	24		3299	3328	8421504	3	13,6,5	0,16,24	g	350005935700000002	8-32						US Patent # 7,435,552. Binding assays that use human T1R2 to identify potential taste modulators - Patents.com	www.patents.com	0	0		
585	chrUn_JH121286	68981	69006	3500043721	24		68981	69006	8421504	2	15,9	0,16	g	350004372100000199	24-48						NUCLEIC ACIDS CODING FOR ADHESION FACTOR OF GROUP B STREPTOCOCCUS, ADHESION FACTORS OF GROUP B STREPTOCOCCUS AND FURTHER USES THEREOF - Patent application	www.faqs.org	0	0		
587	chrUn_JH121286	293655	293683	3500442582	24		293655	293683	8421504	3	13,7,4	0,16,24	g	350044258200000015	1-27						The Prevalence of Parasites and Pathogens in Asian Honeybees Apis cerana in China. - ResearchGate	.researchgate.net	0	0		
592	chrUn_JH121286	941631	956961	3500400966	948		941631	956961	8421504	6	380,40,66,95,174,193	0,2003,2052,4863,6172,15137	p	350040096600015032,350040096600015031,350040096600015030,350040096600015021,350040096600015016,350040096600015017,350040096600015027	0-60,0-186,0-180,0-177,0-180,0-180,0-180						GEN&#xc9;TICA DE LA ENFERMEDAD DE CHARCOT-MARIE- TOOTH AUTOS&#xd3;MICA RECESIVA	digital.csic.es	0	0		GDAP1
592	chrUn_JH121286	943683	957677	3500171702	570		943683	957677	8421504	5	66,95,174,193,42	0,2811,4120,13085,13952	p	350017170200015015,350017170200015018	0-1254,138-360						DEPARTAMENT GENATICA I MEDICINA MOLECULAR GENATICA DE LA ENFERMEDAD DE CHARCOT-MARIETOOTH AUTOSA	www.tdx.cat	0	0		GDAP1
593	chrUn_JH121286	1080432	1080458	3500175973	25		1080432	1080458	8421504	2	10,15	0,11	c,g	350017597300000055,350017597300000055	8-48,8-48					Patent	DNA encoding the Canine coronavirus spike protein (Patent US:5661006)	Brown	1997	0		
595	chrUn_JH121286	1311101	1312194	3500022796	53		1311101	1312194	8421504	2	27,26	0,1067	c	350002279600000013,350002279600000012	0-27,0-26						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
595	chrUn_JH121286	1312160	1328180	3500349767	44		1312160	1328180	8421504	2	22,22	0,15998	c,g	350034976700000005,350034976700000005,350034976700000004,350034976700000004	0-22,0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
595	chrUn_JH121286	1322500	1322524	3500392970	24		1322500	1322524	8421504	1	24	0	c	350039297000000025	0-24						Probiotic Bacteria Enhance the Antibacterial Barrier of Enterocytes: Insights into Their Mechanism of Action	.uni-hohenheim.de	0	0		LY96
595	chrUn_JH121286	1377992	1384187	3500069201	147		1377992	1384187	8421504	3	19,41,87	0,6010,6108	p	350006920100015003,350006920100015005	0-60,0-87						RNA polymerase II transcription factor	Bradsher	1995	0		TCEB1
74	chrUn_JH121286	1418300	1478755	3500242804	450		1418300	1478755	8421504	7	15,92,103,129,24,76,11	0,30473,36198,48635,48767,52379,60444	p	350024280400015002,350024280400015003	0-339,0-111						27960, a novel ubiquitin conjugating enzyme family member and uses therefor	Meyers	2001	0		
596	chrUn_JH121286	1561524	1561554	3500199448	27		1561524	1561554	8421504	2	14,13	0,17	c	350019944800000241	9-43						Chromosome 13-linked breast cancer susceptibility gene	Tavtigian	1996	0		
598	chrUn_JH121286	1747590	1747615	3500371020	24		1747590	1747615	8421504	2	20,4	0,21	g	350037102000000034	24-48						Substance Specific to Human PD-1 - Patent application	www.faqs.org	0	0		
599	chrUn_JH121286	1928131	1928176	3500052486	45		1928131	1928176	8421504	1	45	0	p	350005248600015000	0-45		19458327	10.1167/iovs.09-3797	1552-5783	Investigative Ophthalmology & Visual Science	The 11-cis-Retinol Dehydrogenase Activity of RDH10 and Its Interaction with Visual Cycle Proteins	Farjo	2009	0		RDH10
599	chrUn_JH121286	1956282	1956574	3500286422	24		1956282	1956574	8421504	2	1,23	0,269	c	350028642200000005	7-31		19264703	10.1095/biolreprod.108.072314	0006-3363	Biology of Reproduction	Distinct Transcriptional Mechanisms Direct Expression of the Rat Dmrt1 Promoter in Sertoli Cells and Germ Cells of Transgenic Mice	Lei	2009	4		RPL7
599	chrUn_JH121286	1956611	1956637	3500321220	26		1956611	1956637	8421504	1	26	0	c	350032122000000015	0-26		17082775	10.1038/sj.emboj.7601399	ERROR! NO ISSN	The EMBO Journal	Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming	Chen	2006	0		RPL7
600	chrUn_JH121286	1983793	1983819	3500430558	23		1983793	1983819	8421504	2	16,7	0,19	g	350043055800000093	6-29						Domain II Mutants Of Anthrax Lethal Factor	Duesbery	2005	0		
602	chrUn_JH121286	2248589	2248739	3500154352	150		2248589	2248739	8421504	1	150	0	p	350015435200015009	0-150						NPG.nature.vol.417.Issue.6888.May	www.scribd.com	0	0		ZFAS1
602	chrUn_JH121286	2248688	2248751	3500370024	63		2248688	2248751	8421504	1	63	0	p	350037002400015003	0-63						Human leukocyte calcium activated potassium channel polypeptide	Aiyar	1999	0		ZFAS1
602	chrUn_JH121286	2249087	2249267	3500126050	180		2249087	2249267	8421504	1	180	0	p	350012605000015213	0-180						GOS 1116020 - Metagenes	annotathon.org	0	0		
604	chrUn_JH121286	2571545	2571575	3500125026	26		2571545	2571575	8421504	3	14,7,5	0,16,25	g	350012502600000000	0-36		17108326	10.1091/mbc.E06-06-0535	1059-1524	Molecular Biology of the Cell	A Conserved Dileucine Motif Mediates Clathrin and AP-2&#x2013;dependent Endocytosis of the HIV-1 Envelope Protein	Byland	2007	5		
606	chrUn_JH121286	2823240	2823266	3500190793	23		2823240	2823266	8421504	2	11,12	0,14	g	350019079300000008	10-33						US Patent # 6,730,499. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1 - Patents.com	www.patents.com	0	0		
607	chrUn_JH121286	2975186	2975213	3500025077	23		2975186	2975213	8421504	2	7,16	0,11	g	350002507700000013	7-33						Mutation detection by competitive oligonucleotide priming	Caskey	1998	0		
607	chrUn_JH121286	2978370	2978397	3500225808	25		2978370	2978397	8421504	3	11,5,9	0,12,18	g	350022580800000072,350022580800000073	0-25,10-35						MUTANT RECEPTORS AND THEIR USE IN A NUCLEAR RECEPTOR-BASED INDUCIBLE GENE EXPRESSION SYSTEM - Patent application	www.faqs.org	0	0		
608	chrUn_JH121286	3045165	3045190	3500314385	24		3045165	3045190	8421504	2	7,17	0,8	g	350031438500000001	11-35						Nucleic acid encoding DR5 antibodies and uses thereof - US Patent 8030023 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121287	15194	52930	3500051787	1440		15194	52930	8421504	3	811,372,257	0,33396,37479	p	350005178700015001	0-1440						KEGG T01001: 11072	www.genome.jp	0	0		
585	chrUn_JH121287	15194	15218	3500197574	24		15194	15218	8421504	1	24	0	c	350019757400000085	8-32						Identification, Function and clinical Relevance of mouse myeloid leukemia Genes	repub.eur.nl	0	0		
587	chrUn_JH121287	331294	331320	3500248138	23		331294	331320	8421504	2	5,18	0,8	g	350024813800000038	0-23						Methods and compositions for the specific inhibition of gene expression by double-stranded RNA	Rossi	2007	0		
588	chrUn_JH121287	487536	487559	3500077120	23		487536	487559	8421504	1	23	0	g	350007712000000002	0-23						TRPV6 and Calbindin-D9k-expression and localization in the bovine uterus and placenta during pregnancy	www.rbej.com	0	0		
592	chrUn_JH121287	972434	972462	3500200299	24		972434	972462	8421504	2	14,10	0,18	g	350020029900000012	3-27		19079576	10.1371/journal.ppat.1000241	1553-7374	PLOS Pathogens	PLOS Pathogens: Resistance to Mucosal Lysozyme Compensates for the Fitness Deficit of Peptidoglycan Modifications by Streptococcus pneumoniae	Davis	2008	0		
595	chrUn_JH121287	1373322	1373922	3500382374	599		1373322	1373922	8421504	2	34,565	0,35	g	350038237400000006	29-698						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
595	chrUn_JH121287	1373322	1373922	3500221817	599		1373322	1373922	8421504	2	34,565	0,35	g	350022181700000006	29-698					Patent	Compositions, methods and systems for inferring bovine breed (Patent US:7511127)	DeNise	2009	0		
595	chrUn_JH121287	1373332	1373922	3500360633	589		1373332	1373922	8421504	2	24,565	0,25	g	350036063300000004	29-688						Compositions, Methods And Systems For Inferring Bovine Breed 	.freshpatents.com	0	0		
595	chrUn_JH121287	1373350	1373922	3500101798	571		1373350	1373922	8421504	2	4,567	0,5	g	350010179800000007	29-670						Compositions, methods and systems for inferring bovine breed - Patent application	www.faqs.org	0	0		
598	chrUn_JH121287	1769321	1769344	3500451303	23		1769321	1769344	8421504	1	23	0	c	350045130300000044	17-40						US Patent # 5,856,177. Promoters derived from the maize phosphoenolpyruvate carboxylase gene involved in C.sub.4 photosynthesis - Patents.com	www.patents.com	0	0		
598	chrUn_JH121287	1796088	1796406	3500389139	44		1796088	1796406	8421504	2	22,22	0,296	c	350038913900000030,350038913900000051	22-44,22-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		ATG2A
598	chrUn_JH121287	1796088	1796406	3500232262	44		1796088	1796406	8421504	2	22,22	0,296	c	350023226200000030,350023226200000051	22-44,22-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		IARS2
598	chrUn_JH121287	1796088	1796405	3500125321	43		1796088	1796405	8421504	2	22,21	0,296	c,g	350012532100000021,350012532100000085,350012532100000085,350012532100000101	0-22,0-19,0-19,0-20						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		
599	chrUn_JH121287	1874426	1923841	3500381961	72		1874426	1923841	8421504	3	25,26,21	0,33911,49394	c	350038196100000025,350038196100000051,350038196100000074	0-25,0-26,0-21						INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMYL-PROLYL-TRNA SYNTHETASES - Patent application	www.faqs.org	0	0		EPRS
600	chrUn_JH121287	2086462	2086492	3500008756	26		2086462	2086492	8421504	3	14,3,9	0,15,21	g	350000875600000413	2-28						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
601	chrUn_JH121287	2182590	2182615	3500276244	25		2182590	2182615	8421504	1	25	0	g	350027624400000042	0-30						NOVEL flt-3 RECEPTOR AGONISTS	Feng	1998	0		
601	chrUn_JH121287	2182590	2182615	3500250080	25		2182590	2182615	8421504	1	25	0	g	350025008000000044	0-30						Circular permuteins of flt3 ligand	Mcwherter	1997	0		
590	chrUn_JH121288	741102	741125	3500092188	23		741102	741125	8421504	1	23	0	g	350009218800000002	6-29		20505761	10.1371/journal.pone.0010755	1932-6203	PLOS ONE	PLOS ONE: Eef1a2 Promotes Cell Growth, Inhibits Apoptosis and Activates JAK/STAT and AKT Signaling in Mouse Plasmacytomas	Li	2010	4		
595	chrUn_JH121288	1393458	1393484	3500286747	24		1393458	1393484	8421504	2	19,5	0,21	g	350028674700000040	3-27						Proteases and variants thereof	Norregaard-Madsen	2000	0		
597	chrUn_JH121288	1651643	1651672	3500284394	27		1651643	1651672	8421504	2	16,11	0,18	g	350028439400000124	6-34						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2011	0		
597	chrUn_JH121288	1651643	1651672	3500070088	24		1651643	1651672	8421504	2	11,13	0,16	g	350007008800000015	8-32						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
586	chrUn_JH121289	167149	167178	3500087097	24		167149	167178	8421504	3	12,8,4	0,16,25	g	350008709700000003	0-31					Patent	Peptide and protein fusions to thioredoxin and thioredoxin-like molecules (Patent US:5292646)	LaVallie	1994	0		
587	chrUn_JH121289	270934	311855	3500383915	41		270934	311855	8421504	4	5,14,7,15	0,6,40894,40906	g	350038391500001147,350038391500001148,350038391500000942,350038391500000943	4-23,4-23,5-27,5-25						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
588	chrUn_JH121289	492906	492931	3500041945	24		492906	492931	8421504	2	18,6	0,19	g	350004194500000078	7-31						SOLUBLE IL-17RA/RC FUSION PROTEINS AND RELATED METHODS - Patent application	www.faqs.org	0	0		
590	chrUn_JH121289	683572	683595	3500442201	23		683572	683595	8421504	1	23	0	g	350044220100000096	0-40						Amylase variants	Bisgard-frantzen	1996	0		
597	chrUn_JH121289	1631759	1631782	3500261711	23		1631759	1631782	8421504	1	23	0	g	350026171100000016	1-24						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
585	chrUn_JH121290	7638	7663	3500214780	24		7638	7663	8421504	2	20,4	0,21	g	350021478000000001	1-26						US Patent # 5,827,651. Nucleic acid probes and methods for detecting fungi - Patents.com	www.patents.com	0	0		
590	chrUn_JH121291	681685	681708	3500337656	23		681685	681708	8421504	1	23	0	g	350033765600000002	3-36					Patent	Interaction trap system for isolating novel proteins (Patent US:5580736)	Brent	1996	0		
590	chrUn_JH121291	781842	781869	3500066002	27		781842	781869	8421504	1	27	0	g	350006600200000072	22-49						Method for producing derivational pluripotent stem cell with meninges cell and uses thereof	He Wen Zhi 	2009	0		
592	chrUn_JH121291	1044578	1044604	3500430558	24		1044578	1044604	8421504	2	16,8	0,18	c	350043055800000046	9-33						Domain II Mutants Of Anthrax Lethal Factor	Duesbery	2005	0		
593	chrUn_JH121292	1063619	1063646	3500099437	24		1063619	1063646	8421504	2	17,7	0,20	g	350009943700000193	2-26						Receptor Family Profiling 	.freshpatents.com	0	0		
593	chrUn_JH121292	1125143	1125168	3500229425	25		1125143	1125168	8421504	1	25	0	g	350022942500000023	0-25						JINKEE JUNG 2012	www.naqs.go.kr	0	0		
585	chrUn_JH121295	76420	76447	3500088021	23		76420	76447	8421504	2	17,6	0,21	g	350008802100000039	0-23						Control of fruit ripening and senescence in plants - US Patent 5512466 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121295	84700	84731	3500012452	24		84700	84731	8421504	3	6,12,6	0,9,25	g	350001245200000189	17-41						Rabies Virus Vector Systems and Compositions and Methods Thereof - Patent application	www.faqs.org	0	0		
586	chrUn_JH121295	234481	234513	3500369175	26		234481	234513	8421504	3	6,15,5	0,11,27	g	350036917500000181,350036917500000109	1-29,19-47						TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6 - Patent application	www.faqs.org	0	0		
587	chrUn_JH121295	287669	287694	3500358422	25		287669	287694	8421504	1	25	0	g	350035842200000000	0-25						M E T H O D S I N M O L E C U L A R M E D I C I N E Muscular Dystrophy	thankinh.edu.vn	0	0		
590	chrUn_JH121295	706619	706648	3500265203	24		706619	706648	8421504	2	10,14	0,15	g	350026520300000002	2-26						Multivalent antigen-binding proteins	King	1991	0		
592	chrUn_JH121295	960599	960627	3500138822	26		960599	960627	8421504	3	18,4,4	0,19,24	g	350013882200000057	10-38						Selective control of lignin biosynthesis in transgenic plants	Yanofsky	2001	0		
593	chrUn_JH121295	1060187	1118000	3500306828	180		1060187	1118000	8421504	4	20,62,75,23	0,6053,43741,57790	p	350030682800015005	0-180						INSTITUTO POLIT&#xc9;CNICO NACIONAL	.bnct.ipn.mx:8080	0	0		
593	chrUn_JH121295	1143546	1145678	3500231561	87		1143546	1145678	8421504	2	35,52	0,2080	p	350023156100015000	0-87						Alignment Lab	ublic.iastate.edu	0	0		DMD
593	chrUn_JH121295	1156490	1156513	3500358422	23		1156490	1156513	8421504	1	23	0	g	350035842200000085	0-23						M E T H O D S I N M O L E C U L A R M E D I C I N E Muscular Dystrophy	thankinh.edu.vn	0	0		
588	chrUn_JH121296	436269	436297	3500436922	24		436269	436297	8421504	3	7,5,12	0,10,16	g	350043692200000031	9-33						Effects of sex steroids on indices of protein turnover in rainbow trout (Oncorhynchus mykiss) white muscle	aldc.nal.usda.gov	0	0		
589	chrUn_JH121297	609267	612414	3500289217	2822		609267	612414	8421504	3	648,1826,348	0,972,2799	g	350028921700000035,350028921700000028	0-2984,229-3224						JY-1 Regulation Of Granulosa Cell Function And Early Embryonic Development In Cattle - Patent application	www.faqs.org	0	0		
590	chrUn_JH121297	774510	774680	3500449734	43		774510	774680	8421504	2	22,21	0,149	c	350044973400000030,350044973400000029	23-45,2-23						3 Materials and Methods	a.inflibnet.ac.in	0	0		
587	chrUn_JH121298	307788	307811	3500079947	23		307788	307811	8421504	1	23	0	g	350007994700000066	1-28						Genomanalyse verschiedener Isolate des Bovinen Leukosevirus unter besonderer Ber&#xfc;cksichtigung des serologischen Status und der geographischen Herkunft des Rindes	diss.fu-berlin.de	0	0		
587	chrUn_JH121298	310820	310844	3500440554	24		310820	310844	8421504	1	24	0	c	350044055400000002	0-24						Molecular Evidence for a Glycine-gated Chloride Channel in Macrophages and Leukocytes	gi.physiology.org	0	0		GLRA2
587	chrUn_JH121298	310847	310876	3500423257	24		310847	310876	8421504	2	8,16	0,13	c	350042325700000737	15-45						Vaccines Against Japanese Encephalitis Virus and West Nile Virus - Patent application	www.faqs.org	0	0		
585	chrUn_JH121299	24857	24882	3500127797	24		24857	24882	8421504	2	10,14	0,11	g	350012779700000004	7-33						Dynamics of RASSF1A/MOAP-1 Association with Death Receptors &#x2020;	mcb.asm.org	0	0		
587	chrUn_JH121299	315449	315475	3500438648	26		315449	315475	8421504	1	26	0	c	350043864800000013	0-26						Human erythroid p55 nucleic acids	www.devileye.net	0	0		
587	chrUn_JH121299	350154	350178	3500212948	23		350154	350178	8421504	2	14,9	0,15	g	350021294800000038	25-48						TACI-IMMUNOGLOBULIN FUSION PROTEINS - Patent application	www.faqs.org	0	0		
73	chrUn_JH121299	362046	459289	3500228069	508		362046	459289	8421504	17	29,20,39,44,26,35,6,17,23,48,23,47,12,78,14,6,41	0,8356,8416,9628,21522,24159,29382,30112,30131,30265,51696,61353,68383,72558,94259,94770,97202	c	350022806900000392,350022806900000154,350022806900000390,350022806900000383,350022806900000143,350022806900000140,350022806900000364,350022806900000123,350022806900000062,350022806900000053,350022806900000340,350022806900000046,350022806900000339,350022806900000037,350022806900000330,350022806900000321	0-41,7-48,9-48,4-48,0-26,0-35,0-48,0-48,7-30,0-47,0-48,0-48,6-48,8-28,29-48,0-41						Production of recombinant blood clotting factors in human cell lines	C*Hao Ze Er 	2003	0		
73	chrUn_JH121299	362054	412803	3500206286	184		362054	412803	8421504	8	21,20,26,5,38,48,22,4	0,8348,21514,30116,30123,30257,50722,50745	c	350020628600000149,350020628600000138,350020628600000121,350020628600000118,350020628600000078	7-48,0-26,0-43,0-48,0-27						Process for preparing human coagulation factor VIII protein complex	Yonemura	1994	0		
587	chrUn_JH121299	362064	370418	3500048828	27		362064	370418	8421504	2	11,16	0,8338	c	350004882800000015	0-27						NON-IMMUNOGENIC PRODRUGS AND SELECTABLE MARKERS FOR USE IN GENE THERAPY	Jolly	1998	0		F8
587	chrUn_JH121299	383572	383600	3500293502	28		383572	383600	8421504	1	28	0	c	350029350200000048,350029350200000046,350029350200000049	0-28,0-27,0-27						Modified factor viii	Jones	2003	0		
73	chrUn_JH121299	390990	466441	3500074208	111		390990	466441	8421504	6	26,21,40,4,16,4	0,215,43789,47634,71706,75447	c	350007420800000259,350007420800000168,350007420800000227,350007420800000209	1-48,4-48,0-44,0-20						Modified factor viii	Lollar	2001	0		
587	chrUn_JH121299	391296	391341	3500368481	45		391296	391341	8421504	1	45	0	p	350036848100015106	9-54						Novel procoagulant proteins	Toole	1986	0		
588	chrUn_JH121299	413115	413144	3500247350	29		413115	413144	8421504	1	29	0	c	350024735000000125	19-48						Modified factor VIII	J*S*Luo La 	2003	0		
588	chrUn_JH121299	413868	459196	3500080734	92		413868	459196	8421504	4	20,21,36,15	0,39,45274,45313	p,c	350008073400000009,350008073400000007,350008073400015005	0-20,0-21,0-51						Factor viii polypeptide	Bang	2004	0		
588	chrUn_JH121299	423367	423391	3500229153	24		423367	423391	8421504	1	24	0	c	350022915300000004	0-24					Patent	Modifizierter faktor viii (Patent DE:60133541)	Lollar	2009	0		
588	chrUn_JH121299	456204	456228	3500427169	24		456204	456228	8421504	1	24	0	c	350042716900000004	0-24						Blood coagulation fviii analogues	Bolt	2006	0		
588	chrUn_JH121299	456204	456228	3500316684	24		456204	456228	8421504	1	24	0	c	350031668400000004	0-24						Blood coagulation fviii analogues	Bolt	2006	0		
588	chrUn_JH121299	459191	459214	3500108036	23		459191	459214	8421504	1	23	0	c	350010803600000011	0-23						Mini-adenoviral vector	Alemany	1999	0		F8
588	chrUn_JH121299	499505	499529	3500200369	24		499505	499529	8421504	1	24	0	c	350020036900000042,350020036900000210	15-39,15-39						High level expression of proteins	Seed	1996	0		FUNDC2
588	chrUn_JH121299	499548	499576	3500121820	28		499548	499576	8421504	1	28	0	c	350012182000000004	0-28						Real time quantitative PCR.	fou02.bioforsk.no	0	0		
73	chrUn_JH121299	506980	525412	3500283144	96		506980	525412	8421504	4	47,1,15,33	0,10895,15816,18399	p,c	350028314400000019,350028314400015049	0-48,0-48						Bak binding protein, DNA encoding the protein, and methods of use thereof - Patent # 6441135 - PatentGenius	.patentgenius.com	0	0		
589	chrUn_JH121299	525827	525855	3500290366	23		525827	525855	8421504	3	13,5,5	0,16,23	c	350029036600000290	20-43						FUNGUS RESISTANT PLANTS AND THEIR USES - Patent application	www.faqs.org	0	0		
589	chrUn_JH121299	560959	560982	3500346879	23		560959	560982	8421504	1	23	0	c	350034687900000003	0-23						BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation. - ResearchGate	.researchgate.net	0	0		
589	chrUn_JH121299	626515	627029	3500185361	23		626515	627029	8421504	2	9,14	0,500	c	350018536100000024	0-23						Compositions and methods for the detection of human T cell receptor variable family gene expression	Brewer	2003	0		BRCC3
590	chrUn_JH121299	745394	747994	3500434049	41		745394	747994	8421504	2	21,20	0,2580	c,g	350043404900000027,350043404900000026,350043404900000026	0-21,0-20,0-20						The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b	journal.9med.net	0	0		RAB39B
586	chrUn_JH121300	254044	254069	3500378306	25		254044	254069	8421504	1	25	0	c	350037830600000006	22-47						Respiratory Research BioMed Central	tory-research.com	0	0		
590	chrUn_JH121300	707764	707793	3500407090	26		707764	707793	8421504	3	5,6,15	0,7,14	g	350040709000000329	12-39						HIV envelope polypeptides and vaccine	Berman	1997	0		
591	chrUn_JH121300	822944	823252	3500060001	46		822944	823252	8421504	2	24,22	0,286	c,g	350006000100000006,350006000100000006,350006000100000007,350006000100000007	0-24,0-24,0-22,0-22			10.1046/j.1471-4159.2003.02106.x	1471-4159	Journal of Neurochemistry	Cyclic phosphatidic acid elicits neurotrophin-like actions in embryonic hippocampal neurons - Fujiwara - 2003 - Journal of Neurochemistry - Wiley Online Library	Fujiwara	2003	0		LPAR4
591	chrUn_JH121300	823231	823338	3500199490	42		823231	823338	8421504	2	22,20	0,87	c	350019949000000006,350019949000000007	0-22,0-20		18925509	10.1080/09537100802220468		Platelets	Lysophosphatidic Acid-Induced Platelet Shape Change Revealed Through LPA1&#x2013;5 Receptor-selective Probes and Albumin	A.L.	2008	0		LPAR4
586	chrUn_JH121301	259940	259967	3500259074	23		259940	259967	8421504	2	17,6	0,21	g	350025907400000190	5-29						A SINE-based dichotomous key for primate identification	www.as.wvu.edu	0	0		
587	chrUn_JH121302	338757	338782	3500120445	24		338757	338782	8421504	2	9,15	0,10	g	350012044500000013	4-36					Patent	Heterologous signal sequences for secretion of insect controlling proteins (Patent US:5547871)	Black	1996	0		
589	chrUn_JH121302	574903	575114	3500284840	125		574903	575114	8421504	9	16,10,21,14,11,27,4,14,8	0,17,28,50,65,154,182,188,203	c,g	350028484000000068,350028484000000075,350028484000000075	0-72,0-53,0-53						Die Positionsklonierung als Strategie zur Isolierung und Charakterisierung retinaler Gene	.uni-wuerzburg.de	0	0		
591	chrUn_JH121302	787734	787762	3500094960	24		787734	787762	8421504	3	12,6,6	0,14,22	g	350009496000000007	11-36						Somatotropin analogs	Harbour	1995	0		
586	chrUn_JH121304	201613	201662	3500119257	49		201613	201662	8421504	1	49	0	g	350011925700000009,350011925700000035	42-95,42-95						Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof - Patent application	www.faqs.org	0	0		
586	chrUn_JH121304	212102	212125	3500338834	23		212102	212125	8421504	1	23	0	c	350033883400000007	22-45						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
586	chrUn_JH121304	212102	212125	3500306609	23		212102	212125	8421504	1	23	0	c	350030660900000007	22-45						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
586	chrUn_JH121304	217024	217099	3500456201	75		217024	217099	8421504	1	75	0	p	350045620100015007	0-75						Lxr ligand testing method - Patent application	www.faqs.org	0	0		NR0B1
586	chrUn_JH121304	217024	217099	3500341244	75		217024	217099	8421504	1	75	0	p	350034124400015008	0-75						Lxr ligand testing method	Terasaka	2008	0		NR0B1
586	chrUn_JH121304	217024	217099	3500179198	75		217024	217099	8421504	1	75	0	p	350017919800015007	0-75					Patent	LXR ligand testing method (Patent US:7989179)	Honzumi	2011	0		NR0B1
586	chrUn_JH121304	217024	217099	3500137367	75		217024	217099	8421504	1	75	0	p	350013736700015003	0-75						ANovelPrincipleforPartialAgonismofLiverX ReceptorLigands	www.dkfz.de	0	0		NR0B1
586	chrUn_JH121304	217455	217495	3500273721	40		217455	217495	8421504	1	40	0	c	350027372100000018	0-40						The Wilms&#x2019; Tumor Suppressor Gene (wt1) Product Regulates Dax-1 Gene Expression during Gonadal Differentiation	mcb.asm.org	0	0		NR0B1
589	chrUn_JH121304	601929	601956	3500229865	23		601929	601956	8421504	3	5,12,6	0,6,21	g	350022986500000174	16-39						GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA - Patent application	www.faqs.org	0	0		
589	chrUn_JH121304	607496	614373	3500235139	42		607496	614373	8421504	3	3,18,21	0,6128,6856	c	350023513900000006,350023513900000007	0-21,0-21						USE HEDGEHOG KINASE ANTAGONISTS TO INHIBIT HEDGEHOG SIGNALING AND TO TREAT CANCER - GENENTECH, INC.	www.sumobrain.com	0	0		
585	chrUn_JH121305	87275	99586	3500161627	45		87275	99586	8421504	2	1,44	0,12267	p	350016162700015000	0-45					Proceedings of the National Academy of Sciences of the United States of America	Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase&#x2009;II	Zhenyu	1997	0		RNGTT
585	chrUn_JH121306	12395	12424	3500371591	24		12395	12424	8421504	2	16,8	0,21	g	350037159100000039	1-25						Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites - US Patent 7198924 Description	ww.patentstorm.us	0	0		
588	chrUn_JH121306	429309	429337	3500261697	24		429309	429337	8421504	2	9,15	0,13	g	350026169700000144	2-42						Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease	Potts	2001	0		
588	chrUn_JH121306	460788	460816	3500435776	24		460788	460816	8421504	2	10,14	0,14	g	350043577600000030	3-36						Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof	Reinscheid	2003	0		
588	chrUn_JH121307	402766	402791	3500391778	24		402766	402791	8421504	2	11,13	0,12	g	350039177800000218	19-44						Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof	Halbur	1996	0		
589	chrUn_JH121307	580761	580792	3500004227	25		580761	580792	8421504	3	6,6,13	0,10,18	g	350000422700000338	20-48						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
585	chrUn_JH121308	25805	25833	3500279987	23		25805	25833	8421504	2	6,17	0,11	g	350027998700000044	21-45						Process of producing glutamate derivatives - Patent # 7297800 - PatentGenius	.patentgenius.com	0	0		
587	chrUn_JH121308	287965	287990	3500001947	24		287965	287990	8421504	2	5,19	0,6	g	350000194700000001	0-26						THE J BIOLOGICAL C Printed in U.S.A. The SufE Protein and the SufBCD Complex Enhance SufS Cysteine Desulfurase Activity as Part of a Sulfur Transfer Pathway for Fe-S Cluster Assembly in Escherichia coli	www.jbc.org	0	0		
590	chrUn_JH121308	662111	662143	3500089194	27		662111	662143	8421504	3	9,13,5	0,12,27	g	350008919400000045	14-42						Antibodies That Bind M. Tuberculosis Polypeptides 	.freshpatents.com	0	0		
590	chrUn_JH121308	682524	682551	3500085535	25		682524	682551	8421504	2	11,14	0,13	g	350008553500000010	0-33						&#x901a;&#x7528;&#x57fa;&#x56e0;&#x82af;&#x7247;&#x68c0;&#x6d4b;&#x5976;&#x725b;&#x4e73;&#x623f;&#x708e;&#x4e3b;&#x8981;&#x81f4;&#x75c5;&#x83cc;&#x7684;&#x65b9;&#x6cd5;&#x7814;&#x7a76; - &#x8c46;&#x4e01;&#x7f51;	www.docin.com	0	0		
586	chrUn_JH121309	197202	197226	3500454302	23		197202	197226	8421504	2	11,12	0,12	g	350045430200000017	0-23						Carbon dioxide fixation by Calvin-Cycle enzymes improves ethanol yield in yeast	gyforbiofuels.com	0	0		
586	chrUn_JH121309	197202	197226	3500027111	23		197202	197226	8421504	2	11,12	0,12	g	350002711100000017	0-23						Carbon dioxide fixation by Calvin-Cycle enzymes improves ethanol yield in yeast	sitory.tudelft.nl	0	0		
587	chrUn_JH121309	279554	329475	3500400978	99		279554	329475	8421504	3	31,32,36	0,34007,49885	g	350040097800000003,350040097800000004,350040097800000002	0-31,0-32,198-234						The Pattern of Mammalian Evolution and the Relative Rate of Molecular Evolution	www.genetics.org	0	0		
587	chrUn_JH121309	338375	338400	3500461897	25		338375	338400	8421504	1	25	0	g	350046189700000023,350046189700000053	0-25,0-25						CULTURE MEDIA, CELL CULTURES AND METHODS OF CULTURING PLURIPOTENT STEM CELLS IN AN UNDIFFERENTIATED STATE - Patent application	www.faqs.org	0	0		
587	chrUn_JH121309	360669	361086	3500121349	339		360669	361086	8421504	5	10,29,15,125,160	0,61,92,116,257	g	350012134900000017	0-343						GLOBIN LENTIVIRAL VECTORS FOR TREATMENT OF DISEASE - Patent application	www.faqs.org	0	0		
73	chrUn_JH121309	367965	398455	3500302686	40		367965	398455	8421504	2	20,20	0,30470	g	350030268600000024,350030268600000004	28-48,4-24					Patent	Human beta-globin gene and recombinant adenovirus related virus vector thereof (Patent CN:101348786)	Tan Meng Qun 	2011	0		
589	chrUn_JH121310	562673	562698	3500435622	25		562673	562698	8421504	1	25	0	g	350043562200000068	22-47						DNA encoding ATP-sensitive potassium channel genes	Adelman	1995	0		
586	chrUn_JH121311	145706	145732	3500413907	23		145706	145732	8421504	2	6,17	0,9	g	350041390700000270	10-33						 Alvac Canarypox Virus Recombinants Comprising Heterlogous Inserts 	www.docstoc.com	0	0		
586	chrUn_JH121311	145706	145732	3500259466	23		145706	145732	8421504	2	6,17	0,9	g	350025946600000076	10-33						Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products	Paoletti	1994	0		
589	chrUn_JH121315	590727	590750	3500137915	23		590727	590750	8421504	1	23	0	g	350013791500000347	3-26						Hcv rna having novel sequence - Patent application	www.faqs.org	0	0		
587	chrUn_JH121316	337465	338649	3500282794	40		337465	338649	8421504	2	19,21	0,1163	c	350028279400000018	7-47						CYTOKINE RECEPTOR CHAIN - Patent application	www.faqs.org	0	0		
587	chrUn_JH121316	337466	338698	3500284441	60		337466	338698	8421504	3	18,22,20	0,1162,1212	c	350028444100000045,350028444100000044	0-40,0-20						US Patent # 6,248,714. Methods of inhibiting binding and treating Ig-mediated responses with IL-13 receptor - Patents.com	www.patents.com	0	0		
587	chrUn_JH121316	338710	352428	3500395273	198		338710	352428	8421504	7	48,45,17,20,15,11,42	0,5568,5619,10122,13596,13624,13676	c,g	350039527300000354,350039527300000372,350039527300000396,350039527300000395,350039527300000314	0-48,3-48,6-48,11-48,17-140						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
586	chrUn_JH121318	174726	174757	3500370269	25		174726	174757	8421504	3	5,7,13	0,6,18	g	350037026900000029	10-35						Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector	Farb	1997	0		
586	chrUn_JH121318	174726	174757	3500026444	25		174726	174757	8421504	3	5,7,13	0,6,18	g	350002644400000032	10-35						US Patent # 6,066,726. Neuron-specific transcriptional promoter - Patents.com	www.patents.com	0	0		
585	chrUn_JH121319	81170	81202	3500328336	26		81170	81202	8421504	3	11,6,9	0,12,23	g	350032833600000272	15-48						US Patent # 5,854,220. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
587	chrUn_JH121319	369181	369207	3500005314	23		369181	369207	8421504	2	15,8	0,18	g	350000531400000746	9-43						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
587	chrUn_JH121321	378123	378148	3500189823	23		378123	378148	8421504	3	14,4,5	0,15,20	g	350018982300000127	20-43						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
588	chrUn_JH121321	520622	520649	3500007191	23		520622	520649	8421504	3	5,4,14	0,8,13	g	350000719100000108	14-37						Non-anaphylactogenic IgE fusion proteins	Morsey	2005	0		
588	chrUn_JH121322	443399	443427	3500276092	25		443399	443427	8421504	3	5,12,8	0,6,20	g	350027609200000109	3-28						Antibodies to CD40	Bedian	2009	0		
588	chrUn_JH121322	443399	443427	3500197658	25		443399	443427	8421504	3	5,12,8	0,6,20	g	350019765800000120	3-28						Methods of treating cancer and enhancing immune responses with antibodies that bind CD40	Bedian	2005	0		
588	chrUn_JH121322	443399	443427	3500115302	25		443399	443427	8421504	3	5,12,8	0,6,20	g	350011530200000105	3-28						Antibodies To Cd40 	.freshpatents.com	0	0		
586	chrUn_JH121323	250571	250596	3500047604	23		250571	250596	8421504	2	18,5	0,20	c	350004760400000005,350004760400000006,350004760400000035,350004760400000036	10-33,8-31,10-33,8-31						VARIANTS OF PLASMINOGEN AND PLASMIN - Patent application	www.faqs.org	0	0		
586	chrUn_JH121323	254652	254775	3500033059	123		254652	254775	8421504	1	123	0	p	350003305900015000	0-123						Method For Regulating Neurite Growth 	.freshpatents.com	0	0		TENM1
586	chrUn_JH121323	254757	254784	3500003849	27		254757	254784	8421504	1	27	0	c	350000384900000003	0-27						Teneurin c-terminal associated peptides (TCAP) and uses thereof	Lovejoy	2003	0		TENM1
587	chrUn_JH121323	265977	284476	3500332384	297		265977	284476	8421504	4	48,51,64,134	0,60,4768,18365	p	350033238400015129,350033238400015128	0-48,24-273						Polypeptide ligands containing linkers	Ni	2006	0		SH2D1A
587	chrUn_JH121323	265977	284476	3500080380	309		265977	284476	8421504	3	111,64,134	0,4768,18365	p	350008038000015186,350008038000015178,350008038000015185	0-48,0-306,24-273						SureChem - Document - USPTO Granted - Patent No. 8063018 - "Bivalent thrombin binding molecules comprising linkers" - Description	www.surechem.org	0	0		SH2D1A
73	chrUn_JH121323	517898	525709	3500323558	126		517898	525709	8421504	3	54,6,66	0,1004,7745	p	350032355800015002,350032355800015001	0-60,0-66		20818333	10.1038/emboj.2010.217	ERROR! NO ISSN	The EMBO Journal	The hsSsu72 phosphatase is a cohesin-binding protein that regulates the resolution of sister chromatid arm cohesion	Kim	2010	0		STAG2
73	chrUn_JH121323	517898	525709	3500136783	126		517898	525709	8421504	3	54,6,66	0,1004,7745	p	350013678300015002,350013678300015001	0-60,0-66		20818333	10.1038/emboj.2010.217		The EMBO Journal	The hsSsu72 phosphatase is a cohesin-binding protein that regulates the resolution of sister chromatid arm cohesion	Hyun-Soo	2010	0		STAG2
589	chrUn_JH121323	531246	531269	3500199255	23		531246	531269	8421504	1	23	0	c	350019925500000073	25-48						Recombinant pneumocystis carinii aminoacyl tRNA synthetase genes, tester strains and assays	Whoriskey	1995	0		
590	chrUn_JH121323	698668	700197	3500126808	48		698668	700197	8421504	3	7,18,23	0,1447,1506	c	350012680800000019,350012680800000018	0-25,0-23						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
590	chrUn_JH121323	700296	700987	3500210527	40		700296	700987	8421504	2	20,20	0,671	c	350021052700000007,350021052700000006	0-20,0-20						Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells. - ResearchGate	.researchgate.net	0	0		XIAP
590	chrUn_JH121323	700296	700987	3500205693	40		700296	700987	8421504	2	20,20	0,671	c	350020569300000007,350020569300000006	0-20,0-20		16618750	10.1158/0008-5472.CAN-05-3248	0008-5472	Cancer Research	Altered Expression of c-IAP1, Survivin, and Smac Contributes to Chemotherapy Resistance in Thyroid Cancer Cells	Tirro	2006	8		XIAP
590	chrUn_JH121323	700347	700775	3500189832	59		700347	700775	8421504	3	19,21,19	0,70,409	c,g	350018983200000053,350018983200000052,350018983200000052,350018983200000042	20-39,0-21,0-21,20-39						Methods and reagents for the treatment of proliferative diseases	Lacasse	2004	0		
590	chrUn_JH121323	700417	701009	3500180511	40		700417	701009	8421504	2	21,19	0,573	c,g	350018051100000040,350018051100000113	0-21,0-19						Antisense Iap Nucleobase Oligomers And Uses Thereof 	.freshpatents.com	0	0		
590	chrUn_JH121323	700417	700775	3500430382	40		700417	700775	8421504	2	21,19	0,339	c	350043038200000029,350043038200000019	0-21,20-39						US Patent # 6,673,917. Antisense IAP nucleic acids and uses thereof - Patents.com	www.patents.com	0	0		
590	chrUn_JH121323	700417	700775	3500159065	40		700417	700775	8421504	2	21,19	0,339	c,g	350015906500000040,350015906500000087	0-21,0-19						Antisense Iap Nucleobase Oligomers And Uses Thereof 	.freshpatents.com	0	0		
590	chrUn_JH121323	700417	700775	3500080025	40		700417	700775	8421504	2	21,19	0,339	c,g	350008002500000029,350008002500000029,350008002500000019	0-21,0-21,20-39						Antisense IAP oligonucleotides and uses thereof	Korneluk	2006	0		
590	chrUn_JH121323	700710	700908	3500463762	198		700710	700908	8421504	1	198	0	p	350046376200015009	0-198						Combination therapies with mitochondrial-targeted anti-tumor agents	Altieri	2011	0		XIAP
590	chrUn_JH121323	700710	700908	3500453589	198		700710	700908	8421504	1	198	0	p	350045358900015010	0-198						Mitochondria-targeted anti-tumor agents	Altieri	2009	0		XIAP
590	chrUn_JH121323	700710	700908	3500392106	186		700710	700908	8421504	3	51,48,87	0,57,111	p	350039210600015017	0-186						Mitochondria-targeted anti-tumor agents	Jiang Bing Xian 	2010	0		XIAP
590	chrUn_JH121323	700710	700908	3500281646	186		700710	700908	8421504	3	51,48,87	0,57,111	p	350028164600015009	0-186					Patent	&#x9776;&#x5411;&#x7ebf;&#x7c92;&#x4f53;&#x7684;&#x6297;&#x80bf;&#x7624;&#x5242; (Patent CN:101854955)	Jiang Bing Xian 	2012	0		XIAP
590	chrUn_JH121323	700710	700908	3500278948	186		700710	700908	8421504	3	51,48,87	0,57,111	p	350027894800015017	0-186					Patent	Mitochondria-targeted anti-tumor agents (Patent CN:101854955)	Jiang Bing Xian 	2012	0		XIAP
590	chrUn_JH121323	700710	700908	3500079348	186		700710	700908	8421504	3	51,48,87	0,57,111	p	350007934800015009	0-186						&#x9776;&#x5411;&#x7ebf;&#x7c92;&#x4f53;&#x7684;&#x6297;&#x80bf;&#x7624;&#x5242;	Jiang Bing Xian 	2010	0		XIAP
590	chrUn_JH121323	700710	700908	3500030768	198		700710	700908	8421504	1	198	0	p	350003076800015010	0-198					Patent	Mitochondria-targeted anti-tumor agents (Patent US:8466140)	Altieri	2013	0		XIAP
590	chrUn_JH121323	700755	701000	3500001300	38		700755	701000	8421504	2	19,19	0,226	c,g	350000130000000003,350000130000000003,350000130000000002	0-19,0-19,0-19		21411500	10.1158/1940-6207.CAPR-10-0323		Cancer prevention research (Philadelphia, Pa.)	Garlic Constituent Diallyl Trisulfide Suppresses X-Linked Inhibitor of Apoptosis Protein in Prostate Cancer Cells in Culture and In Vivo	Su-Hyeong	June	0		
590	chrUn_JH121323	700857	700881	3500307492	24		700857	700881	8421504	1	24	0	c	350030749200000021	0-24					Patent	Cancer stem cell antigen vaccines and methods (Patent US:8129184)	Yu	2012	0		
590	chrUn_JH121323	700857	700881	3500108695	24		700857	700881	8421504	1	24	0	c	350010869500000021	0-24						CANCER STEM CELL ANTIGEN VACCINES AND METHODS - Patent application	www.faqs.org	0	0		
590	chrUn_JH121323	700857	700881	3500023932	24		700857	700881	8421504	1	24	0	c	350002393200000021	0-24						CANCER STEM CELL ANTIGEN VACCINES AND METHODS	Yu	2007	0		
590	chrUn_JH121323	700859	700884	3500081361	25		700859	700884	8421504	1	25	0	c	350008136100000001,350008136100000000	0-25,0-25						Oxytocin Increases Invasive Properties of Endometrial Cancer Cells Through Phosphatidylinositol 3-Kinase/AKT-Dependent Up-Regulation of Cyclooxygenase-1, -2, and X-Linked Inhibitor of Apoptosis Protein	ww.biolreprod.org	0	0		XIAP
590	chrUn_JH121323	700905	700930	3500258078	25		700905	700930	8421504	1	25	0	c	350025807800000175	11-36						Nematode PAN and ZP Receptor-Like Sequences - Patent application	www.faqs.org	0	0		XIAP
590	chrUn_JH121323	700978	701004	3500174123	26		700978	701004	8421504	1	26	0	c	350017412300000006	0-26		20696840	10.1128/MCB.00409-10	0270-7306	Molecular and Cellular Biology	Mechanism of Hypoxia-Induced NF-&#x03ba;B	Culver	2010	6		XIAP
588	chrUn_JH121324	462660	462687	3500070165	23		462660	462687	8421504	2	17,6	0,21	g	350007016500000118	0-23						US Patent # 7,309,597. Alanine 2,3-Aminomutase - Patents.com	www.patents.com	0	0		
586	chrUn_JH121327	137890	137915	3500046519	23		137890	137915	8421504	2	17,6	0,19	g	350004651900000002	4-27		23269416	10.1128/CVI.00649-12		Clinical and Vaccine Immunology : CVI	Serodiagnostic Potential of Mycobacterium avium MAV2054 and MAV5183 Proteins	A-Rum	2013	0		
586	chrUn_JH121327	225327	225356	3500105905	24		225327	225356	8421504	2	18,6	0,23	g	350010590500000021	15-40						Method for Expression and Accumulation of Peptide in Plant - Patent application	www.faqs.org	0	0		
73	chrUn_JH121327	367858	399784	3500352676	49		367858	399784	8421504	2	27,22	0,31904	c	350035267600000001,350035267600000014,350035267600000013	10-37,16-43,9-31		19439498	10.1124/mol.109.055442	1521-0111 (Online)	Molecular Pharmacology	Cytosolic Aryl Sulfotransferase 4A1 Interacts with the Peptidyl Prolyl Cis-Trans Isomerase Pin1	Mitchell	2009	0		
585	chrUn_JH121329	69656	69682	3500249641	23		69656	69682	8421504	2	9,14	0,12	g	350024964100000001	0-23		19357175	10.1128/JVI.00379-09		Journal of Virology	Human Metapneumovirus Establishes Persistent Infection in the Lungs of Mice and Is Reactivated by Glucocorticoid Treatment 	Yuru	July	0		
586	chrUn_JH121329	142625	142655	3500277476	26		142625	142655	8421504	3	8,13,5	0,10,25	g	350027747600000017	17-43						Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer	www.mdpi.com	0	0		
586	chrUn_JH121329	211396	211422	3500240316	23		211396	211422	8421504	3	5,14,4	0,7,22	g	350024031600000012	0-24						Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome	tologylibrary.org	0	0		
585	chrUn_JH121331	9257	9285	3500143796	23		9257	9285	8421504	2	8,15	0,13	g	350014379600000106	13-44						PROTEASE VARIANTS - Patent application	www.faqs.org	0	0		
586	chrUn_JH121331	171852	171881	3500308235	26		171852	171881	8421504	2	9,17	0,12	g	350030823500000170	15-48					Patent	Recombinant infectious bovine rhinotracheitis virus (Patent US:5874279)	Cochran	1999	0		
586	chrUn_JH121331	171852	171881	3500069576	26		171852	171881	8421504	2	9,17	0,12	g	350006957600000180	15-48						Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof	Cochran	1995	0		
587	chrUn_JH121331	271705	271729	3500452460	23		271705	271729	8421504	2	12,11	0,13	g	350045246000000054	0-28						Methods And Compositions For Detecting Cancers 	.freshpatents.com	0	0		
588	chrUn_JH121331	481778	481806	3500412866	23		481778	481806	8421504	2	14,9	0,19	g	350041286600000005	11-34						Impaired Repression at a Vasopressin Promoter Polymorphism Underlies Overexpression of Vasopressin in a Rat Model of Trait Anxiety | Chris Murgatroyd - Academia.edu	www.academia.edu	0	0		
586	chrUn_JH121332	228350	228374	3500209368	23		228350	228374	8421504	2	19,4	0,20	g	350020936800000003	2-26		19605563	10.1091/mbc.E08-10-1029	1059-1524	Molecular Biology of the Cell	The Rho-Guanine Nucleotide Exchange Factor Domain of Obscurin Activates RhoA Signaling in Skeletal Muscle	Ford-Speelman	2009	5		
585	chrUn_JH121333	18160	50804	3500341139	86		18160	50804	8421504	2	38,48	0,32596	c	350034113900000011,350034113900000009	0-38,0-48						Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 - Patent application	www.faqs.org	0	0		
586	chrUn_JH121333	197679	198412	3500306561	66		197679	198412	8421504	3	22,22,22	0,312,711	c,g	350030656100000080,350030656100000128,350030656100000085,350030656100000003	20-42,0-21,22-44,22-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		MIR17HG
586	chrUn_JH121333	197679	198412	3500257436	66		197679	198412	8421504	3	22,22,22	0,312,711	c,g	350025743600000080,350025743600000254,350025743600000085,350025743600000003	0-22,1-20,22-44,22-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
586	chrUn_JH121333	197679	198412	3500232262	66		197679	198412	8421504	3	22,22,22	0,312,711	c,g	350023226200000080,350023226200000128,350023226200000254,350023226200000254,350023226200000085,350023226200000003	22-44,23-44,24-43,1-20,22-44,22-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		MIR92A2,MIR106A,MIR20B
586	chrUn_JH121333	197681	198252	3500355416	41		197681	198252	8421504	2	20,21	0,550	c,g	350035541600000025,350035541600000026,350035541600000020,350035541600000020,350035541600000021,350035541600000021	0-20,0-19,0-21,0-21,0-19,0-19						Rnai-mediated Inhibition Of Connexin 43 For Treatment Of Iop-related Conditions 	.freshpatents.com	0	0		MIR92A2,MIR106A,MIR20B
586	chrUn_JH121333	197828	197852	3500347866	24		197828	197852	8421504	1	24	0	c	350034786600000029,350034786600000028	0-23,0-23						Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells.	.biomedsearch.com	0	0		MIR17HG
586	chrUn_JH121333	197829	198412	3500131061	46		197829	198412	8421504	2	23,23	0,560	c,g	350013106100000009,350013106100000046,350013106100000046	0-23,0-23,0-23						MICRORNA-BASED DIAGNOSTIC TESTING AND THERAPIES FOR INFLAMMATORY BOWEL DISEASE AND RELATED DISEASES - Patent application	www.faqs.org	0	0		MIR17HG
586	chrUn_JH121333	197829	197852	3500336067	23		197829	197852	8421504	1	23	0	c	350033606700000007,350033606700000006,350033606700000005,350033606700000004	0-23,0-23,0-23,0-23						Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides	ELMEN	2010	0		MIR17HG
586	chrUn_JH121333	197829	197852	3500095645	23		197829	197852	8421504	1	23	0	c	350009564500000007,350009564500000006,350009564500000005,350009564500000004	0-23,0-23,0-23,0-23						Pharmaceutical Composition	Elmen	2010	0		MIR17HG
586	chrUn_JH121333	197829	197852	3500089055	23		197829	197852	8421504	1	23	0	g	350008905500000007,350008905500000006,350008905500000005,350008905500000004,350008905500000041	0-23,0-23,0-23,0-23,0-23						Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides	ELMEN	2010	0		MIR17HG
586	chrUn_JH121333	197990	198412	3500114594	46		197990	198412	8421504	2	23,23	0,399	c,g	350011459400000389,350011459400000816,350011459400000406,350011459400000833	0-23,0-23,0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		
586	chrUn_JH121333	197990	198013	3500271171	23		197990	198013	8421504	1	23	0	c	350027117100000034,350027117100000016	0-23,0-23						Method for Categorizing Samples Containing Spermatozoa by Molecular Profiling - Patent application	www.faqs.org	0	0		
586	chrUn_JH121333	198229	198252	3500428956	23		198229	198252	8421504	1	23	0	c	350042895600000067	0-23						Role and regulatory mechanisms of heat shock factor 2	www.doria.fi	0	0		MIR106A
586	chrUn_JH121333	198388	198412	3500423784	24		198388	198412	8421504	1	24	0	c	350042378400000023	0-24						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR106A
586	chrUn_JH121333	198388	198412	3500377404	24		198388	198412	8421504	1	24	0	c	350037740400000018	0-24						METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME - Patent application	www.faqs.org	0	0		
586	chrUn_JH121333	198388	198412	3500371873	24		198388	198412	8421504	1	24	0	c	350037187300000108	0-24						AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - Patent application	www.faqs.org	0	0		
586	chrUn_JH121333	198388	198412	3500244257	24		198388	198412	8421504	1	24	0	c	350024425700000010	0-24						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		
586	chrUn_JH121333	198388	198412	3500131966	24		198388	198412	8421504	1	24	0	g	350013196600000010	0-24						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR106A
586	chrUn_JH121333	198388	198412	3500013249	24		198388	198412	8421504	1	24	0	c	350001324900000009	0-24		18429962	10.1111/j.1349-7006.2008.00800.x	1349-7006	Cancer Science	Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells - Takakura - 2008 - Cancer Science - Wiley Online Library	Takakura	2008	0		MIR106A
586	chrUn_JH121333	198389	198412	3500254286	23		198389	198412	8421504	1	23	0	c	350025428600000016	0-23						Mirnas dysregulated in triple-negative breast cancer	Richer	2011	0		
586	chrUn_JH121333	198389	198412	3500171540	23		198389	198412	8421504	1	23	0	c,g	350017154000000016,350017154000000016	0-23,0-23						MiRNAs dysregulated in triple-negative breast cancer	Richer	2010	0		MIR106A
586	chrUn_JH121333	198389	198412	3500031979	23		198389	198412	8421504	1	23	0	c	350003197900000321	0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR106A
586	chrUn_JH121333	198389	198412	3500003566	23		198389	198412	8421504	1	23	0	c	350000356600000016	0-23						MIRNAS DYSREGULATED IN TRIPLE-NEGATIVE BREAST CANCER	Richer	2010	0		
586	chrUn_JH121333	222107	222130	3500017708	23		222107	222130	8421504	1	23	0	g	350001770800000010	22-46						ABC transporter	Warren	1998	0		
586	chrUn_JH121333	250128	250152	3500165039	23		250128	250152	8421504	2	13,10	0,14	c	350016503900000005,350016503900000001	6-29,6-29						Thermostabillization of Dna Polymerase by Protein Folding Pathway from a Hyperthermophile Archaeon, Pyrococcus Furiosus - Patent application	www.faqs.org	0	0		
588	chrUn_JH121333	398766	428247	3500211102	44		398766	428247	8421504	3	8,14,22	0,8948,29459	c	350021110200000008,350021110200000009	0-22,0-22		20636325	10.1111/j.1469-7580.2010.01267.x	1469-7580	Journal of Anatomy	Expression of Ten-m/Odz3 in the fibrous layer of mandibular condylar cartilage during postnatal growth in mice - Murakami - 2010 - Journal of Anatomy - Wiley Online Library	Murakami	2010	0		
588	chrUn_JH121333	398766	407730	3500359355	24		398766	407730	8421504	2	8,16	0,8948	c	350035935500000007	0-24						JBC Papers in Press. Published on March 16, 2012 as Manuscript M112.339580 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M112.339580 14-3-3 -STAR interaction in steroidogenesis	www.jbc.org	0	0		
588	chrUn_JH121333	398771	407734	3500303138	23		398771	407734	8421504	2	3,20	0,8943	c	350030313800000004	19-42						The influence of cerebrospinal fluid on epidermal neural crest stem cells may pave the path for cell-based therapy	stemcellres.com	0	0		HPRT1
588	chrUn_JH121333	398772	409376	3500125137	40		398772	409376	8421504	3	2,19,19	0,8942,10585	c,g	350012513700000024,350012513700000025,350012513700000025	0-21,0-19,0-19						<?xml version="1.0"?> <ART xmlns="http://highwire.org/sgml/arthw" VERSION="4.2.39HW" DOI="10.1074/jb	ke.sciencemag.org	0	0		
588	chrUn_JH121333	398773	407737	3500301314	24		398773	407737	8421504	2	1,23	0,8941	c	350030131400000003	20-44		20870902	10.1182/blood-2010-03-271940		Blood	Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease	Yi	2011	0		HPRT1
588	chrUn_JH121333	398773	407737	3500047653	24		398773	407737	8421504	2	1,23	0,8941	c	350004765300000003	20-44		20870902	10.1182/blood-2010-03-271940	0006-4971	Blood	Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease	Zhang	2011	10		HPRT1
588	chrUn_JH121333	407717	418128	3500425929	40		407717	418128	8421504	2	20,20	0,10391	c	350042592900000089,350042592900000029,350042592900000088,350042592900000028	0-20,0-20,0-20,0-20						Osf2/Cbfa1 nucleic acids and methods of use therefor	Ducy	1998	0		
588	chrUn_JH121333	407717	418128	3500126178	40		407717	418128	8421504	2	20,20	0,10391	c	350012617800000028,350012617800000027	0-20,0-20						REPORT DATE: July	handle.dtic.mil	0	0		
588	chrUn_JH121333	407717	418128	3500015966	40		407717	418128	8421504	2	20,20	0,10391	c,g	350001596600000003,350001596600000003,350001596600000002,350001596600000002	0-20,0-20,0-20,0-20						Hepp, a novel gene with a role in hematopoietic and neural development	Jurecic	2002	0		
588	chrUn_JH121333	407717	418128	3500014068	40		407717	418128	8421504	2	20,20	0,10391	c,g	350001406800000013,350001406800000013,350001406800000012,350001406800000012	0-20,0-20,0-20,0-20		11230154	10.1101/gad.845101	0890-9369	Genes & Development	Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice	Takeda	2001	12		
588	chrUn_JH121333	407717	418128	3500001575	40		407717	418128	8421504	2	20,20	0,10391	c	350000157500000013,350000157500000012	0-20,0-20		11230154	10.1101/gad.845101	0890-9369	Genes & Development	Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice	Takeda	2001	12		
588	chrUn_JH121333	407718	407742	3500026606	24		407718	407742	8421504	1	24	0	c	350002660600000006	0-24						Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A). - ResearchGate	.researchgate.net	0	0		HPRT1
588	chrUn_JH121333	407720	407784	3500048835	47		407720	407784	8421504	2	22,25	0,39	c	350004883500000010,350004883500000011	0-22,0-25						ScienceDirect.com - Virology - Phenotypic effects of HPV-16 E2 protein expression in human keratinocytes	sciencedirect.com	0	0		HPRT1
588	chrUn_JH121333	407762	409356	3500084617	47		407762	409356	8421504	2	25,22	0,1572	c	350008461700000055,350008461700000056	0-25,0-22						POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - Patent application	www.faqs.org	0	0		
588	chrUn_JH121333	407769	428263	3500387050	59		407769	428263	8421504	3	16,13,30	0,17,20464	c	350038705000000002,350038705000000003	0-30,0-30						Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors	www.pnas.org	0	0		
588	chrUn_JH121333	407769	409355	3500462886	40		407769	409355	8421504	3	16,4,20	0,17,1566	c	350046288600000008,350046288600000009	0-20,0-20		19773446	10.1158/0008-5472.CAN-08-4783	0008-5472	Cancer Research	Epidermal Growth Factor Receptor Variant III&#x2013;Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate Overexpression	Micallef	2009	8		HPRT1
588	chrUn_JH121333	407787	409356	3500364272	48		407787	409356	8421504	2	26,22	0,1547	c	350036427200000000,350036427200000001	0-26,0-22		15377675	10.1189/jlb.0704414	0741-5400	Journal of Leukocyte Biology	Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages	Skwor	2004	5		
588	chrUn_JH121333	407787	409356	3500235240	48		407787	409356	8421504	2	26,22	0,1547	c	350023524000000000,350023524000000001	0-26,0-22						Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages	www.jleukbio.org	0	0		
588	chrUn_JH121333	407792	409356	3500447030	46		407792	409356	8421504	2	26,20	0,1544	c	350044703000000012,350044703000000013	0-26,0-20						Evaluation of Internal Reference Genes for Quantitative Expression Analysis by Real-Time PCR in Ovine Whole Blood	www.mdpi.com	0	0		HPRT1
588	chrUn_JH121333	407799	409414	3500442940	49		407799	409414	8421504	3	22,3,24	0,1515,1591	c	350044294000000012,350044294000000013	0-25,0-24		23468969	10.1371/journal.pone.0057313		PLoS ONE	Effect of NDP-&#x03b1;-MSH on PPAR-&#x03b3; and &#x2013;&#x03b2; Expression and Anti-Inflammatory Cytokine Release in Rat Astrocytes and Microglia	Lila	2013	0		
588	chrUn_JH121333	409327	409405	3500202892	46		409327	409405	8421504	2	23,23	0,55	c	350020289200000006,350020289200000007	0-23,0-23		18570214	10.1002/hep.22404	1527-3350	Hepatology	Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes - Cl&#xe9;ment - 2008 - Hepatology - Wiley Online Library	Clement	2008	0		
588	chrUn_JH121333	409330	409353	3500362678	23		409330	409353	8421504	1	23	0	c	350036267800000001	0-23						Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth	www.molvis.org	0	0		
588	chrUn_JH121333	409331	428003	3500433630	41		409331	428003	8421504	3	21,13,7	0,15175,18665	c	350043363000000005,350043363000000006	0-21,0-20						Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation	Chang	2006	0		
588	chrUn_JH121333	409363	409387	3500457143	24		409363	409387	8421504	1	24	0	c	350045714300000005	0-24			10.1046/j.1365-2141.2000.01985.x	1365-2141	British Journal of Haematology	Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma - Matsuo - 2008 - British Journal of Haematology - Wiley Online Library	Matsuo	2000	0		
588	chrUn_JH121333	409382	409405	3500411406	23		409382	409405	8421504	1	23	0	c	350041140600000005	0-23		14638678	10.1074/jbc.M312062200	0021-9258	Journal of Biological Chemistry	Fatty Aldehyde Dehydrogenase	Demozay	2004	5		HPRT1
588	chrUn_JH121333	409382	409405	3500360367	23		409382	409405	8421504	1	23	0	c	350036036700000003	0-23		15561930	10.2337/diabetes.53.suppl_3.S97	0012-1797	Diabetes	The Potential Role of SOCS-3 in the Interleukin-1&#x03b2;-Induced Desensitization of Insulin Signaling in Pancreatic Beta-Cells	Emanuelli	2004	8		HPRT1
588	chrUn_JH121333	409391	409416	3500121208	25		409391	409416	8421504	1	25	0	c	350012120800000008	0-25						Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy	Lorenz	2004	0		
588	chrUn_JH121333	409408	409434	3500318231	26		409408	409434	8421504	1	26	0	c	350031823100000004	0-26		20822529	10.1186/1742-2094-7-51		Journal of Neuroinflammation	Hemin inhibits NO production by IL-1&#x03b2;-stimulated human astrocytes through induction of heme oxygenase-1 and reduction of p38 MAPK activation	Wen	2010	0		
588	chrUn_JH121333	409408	409434	3500285826	26		409408	409434	8421504	1	26	0	c	350028582600000004	0-26						Hemin inhibits NO production by IL-1&#x03b2;-stimulated human astrocytes through induction of heme oxygenase-1 and reduction of p38 MAPK activation.	.biomedsearch.com	0	0		
588	chrUn_JH121333	409410	409435	3500122115	25		409410	409435	8421504	1	25	0	c	350012211500000002	0-25		15078922	10.1128/JVI.78.9.4408-4420.2004	0022-538X	Journal of Virology	Human Immunodeficiency Virus (HIV) Type 1 Vpu Induces the Expression of CD40 in Endothelial Cells and Regulates HIV-Induced Adhesion of B-Lymphoma Cells	Henderson	2004	5		
588	chrUn_JH121333	409474	409498	3500111605	24		409474	409498	8421504	1	24	0	c,g	350011160500000004,350011160500000004	0-46,0-46						UNIVERSIT&#xc1; DEGLI STUDI DI TRIESTE	enstarts.units.it	0	0		
588	chrUn_JH121333	418078	428027	3500069896	42		418078	428027	8421504	2	20,22	0,9927	c	350006989600000012,350006989600000013	0-20,0-22		20232416	10.1002/humu.21244		Human mutation	Role of SFRS13A in Low Density Lipoprotein Receptor Splicing	I-Fang	June	0		HPRT1
588	chrUn_JH121333	418085	424511	3500019573	48		418085	424511	8421504	2	28,20	0,6406	c	350001957300000000,350001957300000002	0-28,0-20			10.1093/nar/gnh023		Nucleic Acids Research	Nuclear localization signal and cell synchrony enhance gene targeting efficiency in primary fetal fibroblasts	Bashir	2004	0		
588	chrUn_JH121333	418086	418111	3500248246	25		418086	418111	8421504	1	25	0	g	350024824600000001	23-48						Altered Placental Lactogen and Leptin Expression in Placentomes from Bovine Nuclear Transfer Pregnancies	ww.biolreprod.org	0	0		
588	chrUn_JH121333	418105	418128	3500437400	23		418105	418128	8421504	1	23	0	c,g	350043740000000004,350043740000000004	0-23,0-23						Running Title: SMN Differential Splicing	eeves.mmg.uci.edu	0	0		
588	chrUn_JH121333	418111	428254	3500018812	51		418111	428254	8421504	2	26,25	0,10118	c	350001881200000011,350001881200000025,350001881200000026,350001881200000012	0-26,0-21,0-20,0-25						 Use Of Recombinant Bovine CD14 In The Treatment And Prevention Of Coliform Mastitis In Dairy Cows 	www.docstoc.com	0	0		
588	chrUn_JH121333	418116	418139	3500256799	23		418116	418139	8421504	1	23	0	c	350025679900000005	0-23		16705184	10.1128/MCB.01743-05	0270-7306	Molecular and Cellular Biology	E Proteins and Id2 Converge on p57Kip2 To Regulate Cell Cycle in Neural Cells	Rothschild	2006	6		HPRT1
588	chrUn_JH121333	418122	421684	3500357145	27		418122	421684	8421504	2	19,8	0,3554	c	350035714500000001	0-27		19246491	10.1096/fj.08-121608	0892-6638	The FASEB Journal	Signaling mechanism of extracellular RNA in endothelial cells	Fischer	2009	6		HPRT1
588	chrUn_JH121333	428001	428028	3500328230	27		428001	428028	8421504	1	27	0	c	350032823000000036	0-27						Genes asociados con la deposiciA3n y composiciA3n de grasas en porcino: estudios de expresiA3n gA(c)ni	www.tdx.cat	0	0		HPRT1
588	chrUn_JH121333	428008	428032	3500246994	24		428008	428032	8421504	1	24	0	c	350024699400000002	0-24		19384293	10.1038/mt.2009.85		Molecular Therapy: the Journal of the American Society of Gene Therapy	Injection of Bone Marrow Cell Extract Into Infarcted Hearts Results in Functional Improvement Comparable to Intact Cell Therapy	Yerem	June	0		
588	chrUn_JH121333	428018	428042	3500400505	24		428018	428042	8421504	1	24	0	c	350040050500000007	0-24						Selection of reference genes for quantitative RT-PCR studies in striped dolphin (Stenella coeruleoalba) skin biopsies.	.biomedsearch.com	0	0		
588	chrUn_JH121333	428033	428214	3500394833	27		428033	428214	8421504	2	10,17	0,164	c	350039483300000049	0-27						Compositions And Methods For Diagnosis And Treatment Of Tumors 	.freshpatents.com	0	0		
588	chrUn_JH121333	428034	428214	3500417436	26		428034	428214	8421504	2	9,17	0,163	c	350041743600000176	0-26						Modifications for Antisense Compounds - Patent application	www.faqs.org	0	0		
588	chrUn_JH121333	428036	428214	3500354374	24		428036	428214	8421504	2	7,17	0,161	c	350035437400000070	1-25						Modifications for antisense compounds	Behlke	2012	0		
588	chrUn_JH121333	428036	428214	3500248992	24		428036	428214	8421504	2	7,17	0,161	c	350024899200000047	1-25						Modifications for Antisense Compounds	Behlke	2012	0		
588	chrUn_JH121333	428197	428247	3500437997	48		428197	428247	8421504	2	23,25	0,25	c	350043799700000003,350043799700000001	0-23,0-25						Differential gene expression in pre-implantation embryos from mouse oocytes injected with round spermatids or spermatozoa	www.sbri.fr	0	0		
588	chrUn_JH121333	428202	428227	3500096277	25		428202	428227	8421504	1	25	0	c	350009627700000000	0-25		19720741	10.1128/MCB.00270-09	0270-7306	Molecular and Cellular Biology	Overlapping Functions of Nuclear Envelope Proteins NET25 (Lem2) and Emerin in Regulation of Extracellular Signal-Regulated Kinase Signaling in Myoblast Differentiation	Huber	2009	6		HPRT1
588	chrUn_JH121333	428203	428227	3500452325	24		428203	428227	8421504	1	24	0	c	350045232500000005	0-24						Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model. - ResearchGate	.researchgate.net	0	0		HPRT1
588	chrUn_JH121333	428221	428245	3500433263	24		428221	428245	8421504	1	24	0	c	350043326300000001	0-24		22570383	10.1113/jphysiol.2011.226423		The Journal of Physiology	Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor	Kay	2012	0		
588	chrUn_JH121333	428222	428247	3500439783	25		428222	428247	8421504	1	25	0	c	350043978300000003	0-25						 <HTML> <HEAD> <TITLE> Expression of E6 and E7 Papillomavirus Oncogenes in the	.aacrjournals.org	0	0		HPRT1
588	chrUn_JH121333	428222	428247	3500350086	25		428222	428247	8421504	1	25	0	c	350035008600000003	0-25		19448672	10.1038/onc.2009.116		Oncogene	Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma	Tricia	July	0		
588	chrUn_JH121333	428222	428247	3500137628	25		428222	428247	8421504	1	25	0	c	350013762800000007,350013762800000006	0-25,0-25		19164486	10.1152/ajpgi.90363.2008		American Journal of Physiology - Gastrointestinal and Liver Physiology	UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms	Bassil	2009	0		
588	chrUn_JH121333	428222	428247	3500000442	25		428222	428247	8421504	1	25	0	c	350000044200000003	0-25						Compounds and methods for modulating nonclassical cadherin-mediated functions	Blaschuk	1999	0		
588	chrUn_JH121333	428222	428246	3500357068	24		428222	428246	8421504	1	24	0	c	350035706800000046	25-49						BASES MOL&#xc9;CULAIRES DES D&#xc9;FAUTS S&#xc9;CR&#xc9;TOIRES DES CELLULES &#x03b2;	ai.u-bordeaux1.fr	0	0		
588	chrUn_JH121333	428222	428246	3500149429	24		428222	428246	8421504	1	24	0	c	350014942900000046	25-49						BASES MOL&#xc9;CULAIRES DES D&#xc9;FAUTS S&#xc9;CR&#xc9;TOIRES DES CELLULES &#x03b2;	tacell-cellbio.eu	0	0		HPRT1
588	chrUn_JH121333	428224	428249	3500207340	25		428224	428249	8421504	1	25	0	c	350020734000000097,350020734000000038	0-25,0-25						NUCLEIC ACID HAVING AN ANTI-METABOLIC SYNDROME EFFECT - Patent application	www.faqs.org	0	0		HPRT1
588	chrUn_JH121333	428226	428839	3500233640	51		428226	428839	8421504	2	24,27	0,586	c	350023364000000016,350023364000000017	0-24,0-27						Gene silencing during development of in vitro-produced female bovine embryos	w.funpecrp.com.br	0	0		
588	chrUn_JH121333	428237	428263	3500092140	26		428237	428263	8421504	1	26	0	c	350009214000000003	0-26		20605974	10.1128/IAI.00204-10	0019-9567	Infection and Immunity	Conidia but Not Yeast Cells of the Fungal Pathogen Histoplasma capsulatum Trigger a Type I Interferon Innate Immune Response in Murine Macrophages	Inglis	2010	4		HPRT1
588	chrUn_JH121333	428240	428264	3500098608	24		428240	428264	8421504	1	24	0	c	350009860800000006	24-48						Effects of Culture Conditions on Proliferation and Self-renewal of Murine Embryonic Stem Cells: Growth Factors and 3D Substrates ILANA MOSCATELLI	art.torvergata.it	0	0		HPRT1
588	chrUn_JH121333	428907	428932	3500150128	25		428907	428932	8421504	1	25	0	c	350015012800000009	6-31						BMC Biotechnology BioMed Central	biomedcentral.com	0	0		
588	chrUn_JH121333	429013	429037	3500005060	24		429013	429037	8421504	1	24	0	c	350000506000000003	23-47						Evaluation of Serotonin as a Feedback Inhibitor of Lactation in the Bovine	alcommons.unl.edu	0	0		
588	chrUn_JH121333	429282	429360	3500232249	51		429282	429360	8421504	2	21,30	0,48	c,g	350023224900000002,350023224900000002,350023224900000003,350023224900000003	0-21,0-21,0-30,0-30		17311849	10.1242/jcs.002949	0021-9533	Journal of Cell Science	BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis	Scharpfenecker	2007	6		
588	chrUn_JH121333	429282	429360	3500214885	51		429282	429360	8421504	2	21,30	0,48	c,g	350021488500000002,350021488500000003,350021488500000003	0-21,0-30,0-30						BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis	cs.biologists.org	0	0		
588	chrUn_JH121333	463556	463580	3500320312	24		463556	463580	8421504	1	24	0	c,g	350032031200000036,350032031200000036,350032031200000017,350032031200000017,350032031200000021,350032031200000021,350032031200000001,350032031200000001	0-24,0-24,0-24,0-24,0-20,0-20,0-20,0-20						MUC1 and Galectin-3 - Patent application	www.faqs.org	0	0		MIR503
585	chrUn_JH121336	77682	77709	3500384138	24		77682	77709	8421504	2	8,16	0,11	c	350038413800000068	3-27						Modified FRT Recombination Site Libraries and Methods of Use - Patent application	www.faqs.org	0	0		
585	chrUn_JH121336	77682	77709	3500266422	24		77682	77709	8421504	2	8,16	0,11	c	350026642200000068	3-27						Novel Frt Recombination Sites And Methods Of Use 	.freshpatents.com	0	0		
585	chrUn_JH121336	77682	77709	3500062108	24		77682	77709	8421504	2	8,16	0,11	c	350006210800000068	3-27						Modified Frt Recombination Site Libraries And Methods Of Use 	.freshpatents.com	0	0		
586	chrUn_JH121336	133684	133710	3500173273	23		133684	133710	8421504	2	7,16	0,10	g	350017327300000223	5-28						METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT	Murphy	2009	0		
586	chrUn_JH121336	187800	187824	3500052661	23		187800	187824	8421504	2	14,9	0,15	c	350005266100000181	0-30						Novel Haemopoietin Receptor And Genetic Sequences Encoding Same 	.freshpatents.com	0	0		
586	chrUn_JH121336	213360	213390	3500326993	25		213360	213390	8421504	2	7,18	0,12	c	350032699300000200	17-42						Nucleic Acid, Polypeptide and Its Use - Patent application	www.faqs.org	0	0		
73	chrUn_JH121336	239289	268913	3500072483	41		239289	268913	8421504	4	15,5,13,8	0,18,29599,29616	c,g	350007248300000593,350007248300000507	20-40,14-36						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
586	chrUn_JH121336	252359	252386	3500133900	23		252359	252386	8421504	2	7,16	0,11	g	350013390000000019	14-39						Intercellular adhesion molecules and their binding ligands - Patent application	www.faqs.org	0	0		
586	chrUn_JH121336	261763	261791	3500246972	28		261763	261791	8421504	1	28	0	c	350024697200000012	0-28						Drug binding protein	Adams	1995	0		
586	chrUn_JH121336	261763	261791	3500192041	28		261763	261791	8421504	1	28	0	c	350019204100000011	0-28						Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins	Lee	1997	0		
586	chrUn_JH121336	261763	261791	3500094823	28		261763	261791	8421504	1	28	0	c	350009482300000017	0-28						Drug binding protein	J*C*L*Li 	1996	0		
586	chrUn_JH121336	261763	261791	3500060915	28		261763	261791	8421504	1	28	0	c	350006091500000011	0-28					Patent	Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins (Patent US:5955366)	Adams	1999	0		
586	chrUn_JH121336	261763	261791	3500050029	28		261763	261791	8421504	1	28	0	c	350005002900000014	0-28					Patent	Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins (Patent US:5871934)	Adams	1999	0		
586	chrUn_JH121336	261763	261791	3500037646	28		261763	261791	8421504	1	28	0	c	350003764600000014	0-28					Patent	Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein (Patent US:5777097)	Adams	1998	0		
588	chrUn_JH121336	430227	430252	3500114630	24		430227	430252	8421504	2	12,12	0,13	g	350011463000000003	23-47						Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell - Patent application	www.faqs.org	0	0		
589	chrUn_JH121336	556328	556369	3500372728	41		556328	556369	8421504	1	41	0	c	350037272800000009	0-41						Intermedin and its uses - Patent # 6965013 - PatentGenius	.patentgenius.com	0	0		
589	chrUn_JH121336	618059	618088	3500143583	24		618059	618088	8421504	2	11,13	0,16	g	350014358300000012	0-41						BTL-II NUCLEIC ACIDS - Patent application	www.faqs.org	0	0		
590	chrUn_JH121336	656301	656520	3500133054	42		656301	656520	8421504	2	21,21	0,198	c,g	350013305400000001,350013305400000001,350013305400000000	0-21,0-21,0-21						Method For Increasing Performance of Offspring - Patent application	www.faqs.org	0	0		
590	chrUn_JH121336	657422	657543	3500127617	45		657422	657543	8421504	2	24,21	0,100	c,g	350012761700000005,350012761700000004,350012761700000004	0-24,0-21,0-21						LYVERS PEFFER, PASHA A. Unraveling the pathway of lipid oxidation in the young pig: Assessment of hepatic &#x03b2;-oxidation and characterization of carnitine palmitoyltransferase I (CPT I). (Under the direction of Jack Odle).	tory.lib.ncsu.edu	0	0		
590	chrUn_JH121336	664530	710807	3500249506	40		664530	710807	8421504	4	15,6,13,6	0,17,46255,46271	c,g	350024950600000028,350024950600000028,350024950600000134	1-23,1-23,17-36					Patent	Optimizing glycan processing in plants (Patent CN:100532558)	D*E*A*Fu Luo La Ke 	2009	0		
590	chrUn_JH121336	685386	685410	3500086226	23		685386	685410	8421504	2	14,9	0,15	c	350008622600000005	25-48						Cross-linking oligonucleotides	Gall	1996	0		ANP32E
590	chrUn_JH121336	685508	685697	3500272037	63		685508	685697	8421504	2	57,6	0,183	p	350027203700015003	0-63						Cell-permeable peptide inhibitors of the jnk signal transduction pathway	Bonny	2003	0		MAPK8IP2
590	chrUn_JH121336	710257	710507	3500158699	63		710257	710507	8421504	2	22,41	0,209	p	350015869900015014	3-66						Descripci&#xf3;n y reivindicaciones de la patente: diagn&#xf3;stico y tratamiento de deficiencia m&#xfa;ltiple de sulfatasas y otras usando una enzima generadora de formilglicina(fge) (21 de marzo de 2012).	patentados.com	0	0		ARSA
590	chrUn_JH121336	710257	710507	3500127891	63		710257	710507	8421504	2	22,41	0,209	p	350012789100015016	3-66						GENE THERAPY FOR SULFATASE DEFICIENCY	Figura	2012	0		ARSA
590	chrUn_JH121336	710257	710507	3500083518	63		710257	710507	8421504	2	22,41	0,209	p	350008351800015005	3-66						ScienceDirect.com - Cell - Multiple Sulfatase Deficiency Is Caused by Mutations in the Gene Encoding the Human C&#x03b1;-Formylglycine Generating Enzyme	sciencedirect.com	0	0		ARSA
590	chrUn_JH121336	710257	710507	3500045549	63		710257	710507	8421504	2	22,41	0,209	p	350004554900015012	3-66						Invenes	invenes.oepm.es	0	0		ARSA
590	chrUn_JH121336	783260	783286	3500456272	24		783260	783286	8421504	2	13,11	0,15	g	350045627200000121,350045627200000002	10-38,10-38						Novel fetal genes - Patent application	www.faqs.org	0	0		
590	chrUn_JH121336	783260	783286	3500271099	24		783260	783286	8421504	2	13,11	0,15	g	350027109900000001	6-34						Expression of the apolipoprotein C-II gene during myelomonocytic differentiation of human leukemic cells	www.jleukbio.org	0	0		
590	chrUn_JH121336	783260	783286	3500248713	24		783260	783286	8421504	2	13,11	0,15	g	350024871300000037	10-38						POLYPEPTIDES AND NUCLEIC ACIDS ENCODING SAME - Patent application	www.faqs.org	0	0		
590	chrUn_JH121336	783260	783286	3500046039	24		783260	783286	8421504	2	13,11	0,15	g	350004603900000001	6-34		11310852		0741-5400	Journal of Leukocyte Biology	Expression of the apolipoprotein C-II gene during myelomonocytic differentiation of human leukemic cells	Chun	2001	5		
591	chrUn_JH121336	845893	845923	3500427186	25		845893	845923	8421504	3	4,16,5	0,5,25	g	350042718600000129	17-42						PREDICTOR SETS FOR TYROSINE KINASE PATHWAYS - BRISTOL-MYERS SQUIBB COMPANY	www.sumobrain.com	0	0		
585	chrUn_JH121337	39737	39767	3500004392	24		39737	39767	8421504	3	5,13,6	0,6,24	g	350000439200000343	4-29						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
586	chrUn_JH121338	178519	178543	3500346255	24		178519	178543	8421504	1	24	0	c	350034625500000000	24-48						Use of a bovine genome array to identify new biological pathways for beef marbling in Hanwoo (Korean Cattle)	biomedcentral.com	0	0		
586	chrUn_JH121338	244330	244365	3500227868	35		244330	244365	8421504	1	35	0	c	350022786800000038,350022786800000039,350022786800000037,350022786800000035,350022786800000042,350022786800000031	0-27,0-23,0-35,0-25,0-20,0-20						Modulation of LMW-PTPase Expression	Pandey	2012	0		ACP1
588	chrUn_JH121338	395183	430361	3500321554	43		395183	430361	8421504	3	15,5,23	0,16,35155	g	350032155400000342,350032155400000017	8-28,5-28						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1993	0		
588	chrUn_JH121338	424240	424265	3500114661	23		424240	424265	8421504	2	12,11	0,14	g	350011466100000002	2-33						Dynamic and Functional Assembly of the AAA Peroxins, Pex1p and Pex6p, and Their Membrane Receptor Pex26p--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&	journal.9med.net	0	0		
586	chrUn_JH121339	229429	229457	3500244036	23		229429	229457	8421504	2	16,7	0,21	g	350024403600000008	10-33						Method of testing for salmonella	Thorns	1993	0		
586	chrUn_JH121340	210956	210989	3500044350	28		210956	210989	8421504	2	13,15	0,18	g	350004435000000001	9-44						La Macroestafa Del Sida	es.scribd.com	0	0		
585	chrUn_JH121342	77420	77447	3500346929	26		77420	77447	8421504	2	5,21	0,6	g	350034692900000200	8-34						Antibodies to cd40	Bedian	2010	0		
587	chrUn_JH121343	293512	293539	3500225683	25		293512	293539	8421504	2	11,14	0,13	g	350022568300000084	13-38						NOVEL SCAVENGER RECEPTOR - Patent application	www.faqs.org	0	0		
585	chrUn_JH121344	38819	38864	3500441917	45		38819	38864	8421504	1	45	0	p	350044191700015043	0-45						US Patent # 7,256,274. Apoptin-associating protein - Patents.com	www.patents.com	0	0		SUV420H2
587	chrUn_JH121344	299492	299520	3500034780	23		299492	299520	8421504	2	17,6	0,22	g	350003478000000008	15-38						Microsatellite-based characterization of southern African domestic pig Sus scrofa domestica) breeds	ul.netd.ac.za	0	0		
587	chrUn_JH121344	306103	306128	3500431462	24		306103	306128	8421504	2	14,10	0,15	g	350043146200000045	0-34						US Patent # 7,205,146. Nucleotide and amino acid sequences relating to respiratory diseases and obesity - Patents.com	www.patents.com	0	0		
585	chrUn_JH121345	46752	62648	3500342863	51		46752	62648	8421504	3	10,32,9	0,11366,15887	p	350034286300015104	0-51							library.wiley.com	0	0		DMD
587	chrUn_JH121347	285817	285843	3500229453	23		285817	285843	8421504	2	8,15	0,11	g	350022945300000007	0-23		20817642	10.1099/mic.0.043422-0	1350-0872	Microbiology	Role of GacA in virulence of Vibrio vulnificus	Gauthier	2010	3		
587	chrUn_JH121347	301616	301643	3500362838	25		301616	301643	8421504	2	12,13	0,14	g	350036283800000032	9-35						Evidence of a Louse-Borne Outbreak Involving Typhus in Douai, 1710-1712 during the War of Spanish Succession	fectiopolesud.com	0	0		
586	chrUn_JH121349	221684	221713	3500415209	25		221684	221713	8421504	2	18,7	0,22	g	350041520900000004	0-27						Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR	biomedcentral.com	0	0		
586	chrUn_JH121349	221684	221713	3500114278	25		221684	221713	8421504	2	18,7	0,22	g	350011427800000002	0-27						USE OF DIHYDRODEHYDRODIISOEUGENOL AND PREPARATIONS COMPRISING DIHYDRODEHYDRODIISOEUGENOL - Patent application	www.faqs.org	0	0		
586	chrUn_JH121349	221684	221713	3500064034	25		221684	221713	8421504	2	18,7	0,22	g	350006403400000007	0-27						SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt	www.jhoonline.org	0	0		
585	chrUn_JH121350	110030	110057	3500172045	26		110030	110057	8421504	2	9,17	0,10	g	350017204500000015	10-36						Vaccins adn pour animaux de compagnie et de sport	Audonnet	2000	0		
587	chrUn_JH121351	320967	320995	3500188969	26		320967	320995	8421504	3	15,4,7	0,16,21	g	350018896900000152	11-42						Lipolytic enzymes	Fuglsang	1998	0		
585	chrUn_JH121352	37131	37159	3500230031	23		37131	37159	8421504	2	17,6	0,22	g	350023003100000217	5-29						METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCER - Patent application	www.faqs.org	0	0		
585	chrUn_JH121352	115856	123393	3500061714	135		115856	123393	8421504	4	45,23,22,45	0,48,7467,7492	p	350006171400015016,350006171400015015,350006171400015014	0-45,0-45,0-45						Loop-Variant Pdz Domains as Biotherapeutics, Diagnostics and Research Reagents - Patent application	www.faqs.org	0	0		CASK
586	chrUn_JH121352	172759	172804	3500093608	45		172759	172804	8421504	1	45	0	p	350009360800015000	3-48					The Journal of Cell Biology	Direct Interaction of CASK/LIN-2 and Syndecan Heparan Sulfate Proteoglycan and Their Overlapping Distribution in Neuronal Synapses 	Yi-Ping	July	0		CASK
585	chrUn_JH121353	57936	57962	3500361066	25		57936	57962	8421504	2	7,18	0,8	g	350036106600000679	10-35						Caev-based Vector Systems 	.freshpatents.com	0	0		
586	chrUn_JH121353	209770	209798	3500412261	23		209770	209798	8421504	2	8,15	0,13	g	350041226100000000	22-45						US Patent # 6,004,555. Methods for the specific coagulation of vasculature - Patents.com	www.patents.com	0	0		
587	chrUn_JH121353	351098	351121	3500312272	23		351098	351121	8421504	1	23	0	g	350031227200000021	17-40						Producer cell for the production of retroviral vectors	Kingsman	2001	0		
588	chrUn_JH121353	413830	413855	3500101793	23		413830	413855	8421504	3	12,4,7	0,13,18	g	350010179300000151	8-37						Maize orthologues of bacterial RecA proteins	Mahajan	1999	0		
586	chrUn_JH121355	198368	198392	3500024634	23		198368	198392	8421504	2	16,7	0,17	g	350002463400000013	0-33						Brucella abortus RB51 Vaccine: Testing its Spectrum of Protective and Curative Characteristics	cholar.lib.vt.edu	0	0		
73	chrUn_JH121356	129770	163401	3500395273	133		129770	163401	8421504	6	18,30,34,13,31,7	0,5750,20316,23406,29864,33624	c	350039527300000287,350039527300000296,350039527300000303	0-48,0-47,0-38						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
586	chrUn_JH121356	253658	253683	3500018216	23		253658	253683	8421504	2	17,6	0,19	g	350001821600000002,350001821600000003	3-27,8-32		10348846		0021-9193	Journal of Bacteriology	Maltose Metabolism in the Hyperthermophilic Archaeon Thermococcus litoralis: Purification and Characterization of Key Enzymes	Xavier	1999	4		
586	chrUn_JH121357	175001	178317	3500077120	68		175001	178317	8421504	3	21,27,20	0,3233,3296	c,g	350007712000000003,350007712000000005,350007712000000005,350007712000000004,350007712000000004	0-21,0-27,0-27,0-20,0-20						TRPV6 and Calbindin-D9k-expression and localization in the bovine uterus and placenta during pregnancy	www.rbej.com	0	0		
586	chrUn_JH121357	251669	251699	3500173591	25		251669	251699	8421504	3	13,7,5	0,17,25	g	350017359100000044	0-35						 Methods Of Using The OB Receptor Antibodies To Treat Bodyweight Disorders 	www.docstoc.com	0	0		
587	chrUn_JH121357	359323	359347	3500170557	24		359323	359347	8421504	1	24	0	c	350017055700000001	10-34					Neoplasia (New York, N.Y.)	Ras-Related Tumorigenesis Is Suppressed by BNIP3-Mediated Autophagy through Inhibition of Cell Proliferation	Shan-Ying	2011	0		
588	chrUn_JH121357	413672	413696	3500293692	23		413672	413696	8421504	2	8,15	0,9	g	350029369200000143	0-23						Novel polypeptides and nucleic acids encoding same	Li	2001	0		
585	chrUn_JH121359	72323	79630	3500366940	38		72323	79630	8421504	2	19,19	0,7288	c,g	350036694000000009,350036694000000009,350036694000000010,350036694000000010	0-19,0-19,0-19,0-19		22933270	10.1128/JVI.00432-12	0022-538X	Journal of Virology	Identification of RNA-Protein Interaction Networks Involved in the Norovirus Life Cycle	Vashist	2012	5		DDX3X
585	chrUn_JH121359	72838	72904	3500258368	66		72838	72904	8421504	1	66	0	p	350025836800015006	0-66						Treating Basal-Like Genotype Cancers	Buchsbaum	2010	0		
585	chrUn_JH121359	76232	76261	3500040563	24		76232	76261	8421504	2	7,17	0,12	c	350004056300000010	6-30						ESTUDIO DE LA PRODUCCI&#xd3;N HETER&#xd3;LOGA	tdx.cat/bitstream	0	0		
586	chrUn_JH121360	254312	254336	3500141100	23		254312	254336	8421504	2	4,19	0,5	g	350014110000000023	1-24						Recombinant microorganisms expressing an oligosaccharide receptor mimic	Paton	2000	0		
585	chrUn_JH121361	126981	127005	3500270871	24		126981	127005	8421504	1	24	0	g	350027087100000000	1-25						Methods for detecting a mycobacterium tuberculosis infection	Lewinsohn	2009	0		
587	chrUn_JH121361	385120	385149	3500363276	26		385120	385149	8421504	3	11,11,4	0,13,25	g	350036327600000022	7-33						Methods For Immunotherapy Of Cancer 	.freshpatents.com	0	0		
585	chrUn_JH121365	13544	13568	3500319336	23		13544	13568	8421504	2	13,10	0,14	c	350031933600000156	5-32						Subtilases 	.freshpatents.com	0	0		
585	chrUn_JH121365	15749	15778	3500144536	25		15749	15778	8421504	3	4,5,16	0,5,13	c	350014453600000006	22-47					Patent	Signal amplification with lollipop probes (Patent US:6686157)	Ward	2004	0		
585	chrUn_JH121365	23045	44955	3500464105	42		23045	44955	8421504	2	21,21	0,21889	c,g	350046410500000001,350046410500000000,350046410500000000	10-31,7-28,7-28		19825988	10.1158/1541-7786.MCR-09-0072	1541-7786	Molecular Cancer Research	Expression of PGK1 by Prostate Cancer Cells Induces Bone Formation	Jung	2009	4		PGK1
585	chrUn_JH121365	23045	44955	3500270964	42		23045	44955	8421504	2	21,21	0,21889	c	350027096400000001,350027096400000000	10-31,7-28						letters to nature Phosphoglyceratekinaseacts in tumour angiogenesis as a disulphidereductase	.erin.utoronto.ca	0	0		PGK1
585	chrUn_JH121365	23045	44955	3500163306	42		23045	44955	8421504	2	21,21	0,21889	c,g	350016330600000008,350016330600000007,350016330600000007	10-31,7-28,7-28						NPG.nature.vol.408.Issue.6814.Dec	www.scribd.com	0	0		PGK1
585	chrUn_JH121365	25434	25457	3500007278	23		25434	25457	8421504	1	23	0	c	350000727800000012	0-23						Stony Brook University	yconnect.suny.edu	0	0		OPHN1
585	chrUn_JH121365	31400	31425	3500455612	25		31400	31425	8421504	1	25	0	c	350045561200000014	20-45						Cardiac hypertrophy is a complex organ response of the heart to several biological stresses induced by many primary cardiovascu	e.ahajournals.org	0	0		
585	chrUn_JH121365	35528	35598	3500149660	44		35528	35598	8421504	2	23,21	0,49	c	350014966000000024,350014966000000010,350014966000000023,350014966000000009	0-23,0-23,0-21,0-21						POLYMERASE COMPOSITIONS AND USES - Patent application	www.faqs.org	0	0		PGK1
585	chrUn_JH121365	35528	35598	3500080371	44		35528	35598	8421504	2	23,21	0,49	c	350008037100000010,350008037100000009	0-23,0-21						Polymerase compositions and uses	Janulaitis	2011	0		
585	chrUn_JH121365	35603	35814	3500447030	42		35603	35814	8421504	2	22,20	0,191	c	350044703000000011,350044703000000010	0-22,0-20						Evaluation of Internal Reference Genes for Quantitative Expression Analysis by Real-Time PCR in Ovine Whole Blood	www.mdpi.com	0	0		
585	chrUn_JH121365	35795	35885	3500169433	40		35795	35885	8421504	2	20,20	0,70	c,g	350016943300000001,350016943300000001,350016943300000000	0-20,0-20,0-20		21084656	10.3945/jn.110.128652	0022-3166	The Journal of Nutrition	Intestinal Glucose Absorption but Not Endogenous Glucose Production Differs between Colostrum- and Formula-Fed Neonatal Calves	Steinhoff-Wagner	2011	4		
585	chrUn_JH121365	35908	44931	3500134803	40		35908	44931	8421504	3	16,4,20	0,2629,9003	c	350013480300000039,350013480300000038	0-20,0-20						Estrogen effects on cartilage and bone changes in models for osteoarthritis	repub.eur.nl	0	0		
586	chrUn_JH121365	180876	180899	3500396097	23		180876	180899	8421504	1	23	0	g	350039609700000051	0-34						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins	Kieliszewski	2012	0		
586	chrUn_JH121365	180876	180899	3500375467	23		180876	180899	8421504	1	23	0	g	350037546700000052,350037546700000054	0-34,0-34						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins	Kieliszewski	2008	0		
586	chrUn_JH121365	248630	248699	3500112591	69		248630	248699	8421504	1	69	0	p	350011259100015018	0-69						Heavy metal ATPases from archaeabacteria to plants	www.wpi.edu	0	0		
587	chrUn_JH121365	293212	293235	3500306908	23		293212	293235	8421504	1	23	0	c	350030690800000014	0-23				0021-8812		Amount and source of dietary copper affects small intestine morphology, duodenal lipid peroxidation, hepatic oxidative stress,and mRNA expression of hepatic copper regulatory proteins in weanling pigs 	animalscience.org	0	2		
587	chrUn_JH121365	298984	299697	3500343582	43		298984	299697	8421504	2	20,23	0,690	c	350034358200000009,350034358200000008	0-20,0-23						ABSTRACT	tory.lib.ncsu.edu	0	0		
586	chrUn_JH121368	190046	190072	3500115346	24		190046	190072	8421504	2	10,14	0,12	g	350011534600000000	4-28		21278289	10.1128/JB.01343-10	0021-9193	Journal of Bacteriology	Identification of Genes Essential for Prey-Independent Growth of Bdellovibrio bacteriovorus HD100	Roschanski	2011	4		
585	chrUn_JH121369	6007	6034	3500355395	27		6007	6034	8421504	1	27	0	c	350035539500000003	0-27						Use Of Natriuretic Peptides For The Treatment Of Stature Disorders Related To The Shox Gene 	.freshpatents.com	0	0		
585	chrUn_JH121369	6007	6034	3500207481	27		6007	6034	8421504	1	27	0	c	350020748100000003	0-27						Use of natriuretic peptides for the treatment of stature disorders related to the shox gene	Rappold-hoerbrand	2004	0		
586	chrUn_JH121370	245397	245421	3500422167	23		245397	245421	8421504	2	11,12	0,12	g	350042216700000062	20-43					Patent	Osteogenic proteins (Patent US:5266683)	Kuberasampath	1993	0		
585	chrUn_JH121371	114614	114639	3500407090	25		114614	114639	8421504	1	25	0	g	350040709000000923	8-38						HIV envelope polypeptides and vaccine	Berman	1997	0		
586	chrUn_JH121371	143827	143852	3500064229	24		143827	143852	8421504	2	10,14	0,11	g	350006422900000165	12-36						Novel scavenger receptors	Ruo Gong Shen Long 	2005	0		
585	chrUn_JH121373	105865	109736	3500383915	39		105865	109736	8421504	3	6,13,20	0,9,3851	g	350038391500000659,350038391500000660,350038391500001499	8-27,8-27,0-20						Haplotype markers for diagnosing susceptibility to immunological conditions	Murray	2005	0		
586	chrUn_JH121373	142524	142552	3500416162	25		142524	142552	8421504	2	13,12	0,16	g	350041616200000011	4-44						US Patent # 5,464,745. Protein ligand binding region mapping system - Patents.com	www.patents.com	0	0		
586	chrUn_JH121373	184018	184048	3500068995	26		184018	184048	8421504	2	18,8	0,22	g	350006899500000121	3-30						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
586	chrUn_JH121373	186456	186480	3500419884	23		186456	186480	8421504	2	17,6	0,18	c	350041988400000078	2-25						Trehalose Metabolismus in (Hyper-) thermophilen Archaea	duisburg-essen.de	0	0		
587	chrUn_JH121373	302005	302036	3500407865	27		302005	302036	8421504	3	12,11,4	0,15,27	g	350040786500000029	9-36						Methods for making proteins containing free cysteine residues	Cox	2000	0		
587	chrUn_JH121373	302005	302036	3500340450	27		302005	302036	8421504	3	12,11,4	0,15,27	g	350034045000000029	9-36						METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES	Cox	2009	0		
587	chrUn_JH121373	302005	302036	3500175158	27		302005	302036	8421504	3	12,11,4	0,15,27	g	350017515800000045	9-36					Patent	Methods for making proteins containing free cysteine residues (Patent US:7629314)	George	2009	0		
587	chrUn_JH121373	302005	302031	3500230111	23		302005	302031	8421504	2	11,12	0,14	g	350023011100000029	0-23						Mono-and dual chemokine/cytokine constructs	Mack	2003	0		
586	chrUn_JH121374	214105	214130	3500355785	24		214105	214130	8421504	2	13,11	0,14	g	350035578500000067	0-42						Use Of Histone Chaperone Activity Of Agrobacterium 6b Protein 	.freshpatents.com	0	0		
585	chrUn_JH121375	4796	4826	3500195039	28		4796	4826	8421504	2	5,23	0,7	g	350019503900000055	11-39						Methods for insertion of nucleic acids into circular vectors	Romantchikov	1998	0		
586	chrUn_JH121375	213195	239505	3500342384	42		213195	239505	8421504	3	5,14,23	0,7,26287	g	350034238400000042,350034238400000416	17-36,6-29						Compositions and methods for inhibiting expression of a gene from the JC virus	Tan	2007	0		
585	chrUn_JH121376	31446	31472	3500436229	23		31446	31472	8421504	2	6,17	0,9	g	350043622900000258	21-44						cDNA encoding a BMP type II receptor	Rosenbaum	1994	0		
586	chrUn_JH121376	181933	181978	3500165074	45		181933	181978	8421504	1	45	0	p	350016507400015065	0-45						Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use - Patent application	www.faqs.org	0	0		
587	chrUn_JH121376	301319	301460	3500165074	135		301319	301460	8421504	3	45,45,45	0,48,96	p	350016507400015064,350016507400015063,350016507400015061	0-45,0-45,0-45						Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use - Patent application	www.faqs.org	0	0		
586	chrUn_JH121377	207707	207732	3500236383	24		207707	207732	8421504	2	12,12	0,13	g	350023638300000000	0-33						Metal ion mediated receptor binding of polypeptide hormones	Bass	1993	0		
587	chrUn_JH121377	356151	356176	3500319336	25		356151	356176	8421504	1	25	0	g	350031933600000025	23-48						Subtilases 	.freshpatents.com	0	0		
586	chrUn_JH121378	152110	152136	3500346929	25		152110	152136	8421504	2	4,21	0,5	g	350034692900000017	0-25						Antibodies to cd40	Bedian	2010	0		
586	chrUn_JH121379	189459	189491	3500395700	26		189459	189491	8421504	3	14,5,7	0,17,25	g	350039570000000038	0-26						Compositions And Methods For Restoring Sensitivity Of Tumor Cells To Antitumor Therapy And Inducing Apoptosis 	.freshpatents.com	0	0		
587	chrUn_JH121379	285372	285398	3500068407	23		285372	285398	8421504	2	16,7	0,19	g	350006840700000003,350006840700000002	4-27,8-31						CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype	gut.bmj.com	0	0		
585	chrUn_JH121380	68160	68185	3500112644	23		68160	68185	8421504	2	6,17	0,8	g	350011264400000083	21-44					Patent	Nucleic acids encoding a chloride channel protein (Patent US:6716603)	Holroyd	2004	0		
585	chrUn_JH121381	26857	26884	3500067927	23		26857	26884	8421504	3	5,4,14	0,8,13	g	350006792700000006	6-29		18362165	10.1128/MCB.02272-07		Molecular and Cellular Biology	Functions of Saccharomyces cerevisiae TFIIF during Transcription Start Site Utilization 	Denys	June	0		
585	chrUn_JH121382	74537	74565	3500195767	25		74537	74565	8421504	2	14,11	0,17	c	350019576700000378,350019576700000381	6-26,12-37						Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules - Patent application	www.faqs.org	0	0		
586	chrUn_JH121382	177934	216034	3500236344	33792		177934	216034	8421504	15	899,7873,94,108,671,4723,101,8418,454,1829,44,68,327,6,8177	0,5191,13065,13160,13269,13941,18665,18767,27186,27641,29471,29516,29585,29913,29923	g	350023634400000070	92-33885						Double-muscling in mammals	Georges	2006	0		
586	chrUn_JH121382	245830	245857	3500463203	23		245830	245857	8421504	2	6,17	0,10	g	350046320300000001	7-30		18192507	10.1182/blood-2007-10-116194	0006-4971	Blood	Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders	Kunishima	2008	10		
585	chrUn_JH121384	29838	29863	3500462129	25		29838	29863	8421504	1	25	0	g	350046212900000003	0-25						Protrudin serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation	w.molbiolcell.org	0	0		RAB11A
585	chrUn_JH121384	54340	54365	3500109336	23		54340	54365	8421504	2	17,6	0,19	g	350010933600000043	25-48						Gene therapy for effector cell regulation	Dow	1996	0		
73	chrUn_JH121384	112157	145421	3500407090	41		112157	145421	8421504	3	8,13,20	0,13,33244	g	350040709000001009,350040709000000164	23-44,17-38						HIV envelope polypeptides and vaccine	Berman	1997	0		
585	chrUn_JH121385	108587	108628	3500004405	41		108587	108628	8421504	1	41	0	g	350000440500000056,350000440500000157,350000440500000143,350000440500000070,350000440500000166,350000440500000079	0-23,0-26,0-23,0-24,0-27,0-24						US Patent # 5,760,012. Methods and compounds for curing diseases caused by mutations - Patents.com	www.patents.com	0	0		
585	chrUn_JH121386	2028	2052	3500224317	23		2028	2052	8421504	2	10,13	0,11	g	350022431700000070	2-25					Patent	Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration (Patent US:7767786)	Sieg	2010	0		
585	chrUn_JH121386	4595	4623	3500443939	23		4595	4623	8421504	2	10,13	0,15	g	350044393900000005	20-43		18829984	10.1104/pp.108.126516		Plant Physiology	Decreased Expression of Cytosolic Pyruvate Kinase in Potato Tubers Leads to a Decline in Pyruvate Resulting in an in Vivo Repression of the Alternative Oxidase	Sandra	2008	0		
585	chrUn_JH121386	4595	4623	3500292721	23		4595	4623	8421504	2	10,13	0,15	g	350029272100000005	20-43						Decreased Expression of Cytosolic Pyruvate Kinase in Potato Tubers Leads to a Decline in Pyruvate Resulting in an in Vivo Repression of the Alternative Oxidase	www.jstor.org	0	0		
587	chrUn_JH121386	304357	304380	3500462088	23		304357	304380	8421504	1	23	0	c	350046208800000036	2-25						Insulin-like growth factor binding protein	Ling	1992	0		
585	chrUn_JH121387	30710	30736	3500409492	23		30710	30736	8421504	2	17,6	0,20	g	350040949200000064	0-23						Detection methods for cryptosporidium	Morgan	1998	0		
585	chrUn_JH121388	12587	12707	3500404999	120		12587	12707	8421504	1	120	0	p	350040499900015026	0-120						COMBINATORIAL LIBRARIES BASED ON C-TYPE LECTIN DOMAIN - ANPHORE, INC	www.sumobrain.com	0	0		IKBKG
585	chrUn_JH121388	12587	12707	3500256587	120		12587	12707	8421504	1	120	0	p	350025658700015036	0-120						Polypeptides that bind Trail-R1 and Trail-R2	Bowdish	2010	0		IKBKG
73	chrUn_JH121389	237656	265918	3500414499	41		237656	265918	8421504	4	6,13,16,6	0,8,28235,28256	g	350041449900000696,350041449900000149	3-22,19-41						Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies - Patent application	www.faqs.org	0	0		
587	chrUn_JH121389	313147	313175	3500216021	25		313147	313175	8421504	3	15,5,5	0,17,23	g	350021602100000006	1-27						PPrevalence of aerobactin and adhesin genes in revalence of aerobactin and adhesin genes in EEscherichia colischerichia coli iisolates from blood of bacteremic severely ill neonatal calvessolates from blood of bacteremic severely ill neonatal calves	www.vef.unizg.hr	0	0		
585	chrUn_JH121391	18783	18916	3500142141	133		18783	18916	8421504	1	133	0	g	350014214100000019,350014214100000020	7-71,0-70						O GENE DA MIOGENINA: SEQUENCIAMENTO EM SU&#xcd;NOS E AN&#xc1;LISE FILOGEN&#xc9;TICA	www.tede.ufv.br	0	0		
585	chrUn_JH121391	18783	18916	3500093714	133		18783	18916	8421504	1	133	0	g	350009371400000019,350009371400000020	7-71,0-70						O GENE DA MIOGENINA: SEQUENCIAMENTO EM SU&#xcd;NOS E AN&#xc1;LISE FILOGEN&#xc9;TICA	www.tede.ufv.br	0	0		
585	chrUn_JH121391	19199	19396	3500247541	40		19199	19396	8421504	2	20,20	0,177	c,g	350024754100000004,350024754100000004,350024754100000005,350024754100000005	0-20,0-20,0-20,0-20						Effect of sex steroid hormones on bovine myogenic satellite cell proliferation, differentiation and lipid accumulation in myotube.	.biomedsearch.com	0	0		
586	chrUn_JH121391	218291	218315	3500093232	24		218291	218315	8421504	1	24	0	g	350009323200000215	1-48					Patent	Haemophilus outer membrane protein (Patent US:6083743)	Chong	2000	0		
587	chrUn_JH121392	264971	264995	3500113379	24		264971	264995	8421504	1	24	0	g	350011337900000201	0-25						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
587	chrUn_JH121392	274525	275364	3500408683	534		274525	275364	8421504	5	367,19,87,45,16	0,369,389,535,823	g	350040868300000026	882-1581						Ungulates with genetically modified immune systems	Wells	2006	0		
585	chrUn_JH121393	50732	58413	3500306430	38		50732	58413	8421504	2	19,19	0,7662	g	350030643000000161,350030643000000058	9-28,9-28						Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars - Patent application	www.faqs.org	0	0		
585	chrUn_JH121393	51484	51510	3500314221	24		51484	51510	8421504	2	19,5	0,21	g	350031422100000049	24-48						Use of ectoenzymes and secreted enzymes to monitor cellular proliferation	Zyskind	2000	0		
586	chrUn_JH121393	258287	258318	3500318543	26		258287	258318	8421504	3	6,14,6	0,7,25	c	350031854300000007	16-42						All rights reserved INFORMATION TO ALL USERS	gradworks.umi.com	0	0		
587	chrUn_JH121393	304879	304906	3500238271	25		304879	304906	8421504	3	5,14,6	0,6,21	g	350023827100000052	8-37						Cdr-grafted anti-tissue factor antibodies and methods of use thereof	Joliffe	1998	0		
587	chrUn_JH121393	314342	314599	3500450959	40		314342	314599	8421504	2	20,20	0,237	c,g	350045095900000008,350045095900000007,350045095900000007	0-20,0-20,0-20						NERVE ELONGATION PROMOTER AND ELONGATION INHIBITOR	Shiraki	2007	0		
587	chrUn_JH121393	314342	314599	3500271226	40		314342	314599	8421504	2	20,20	0,237	c,g	350027122600000001,350027122600000000,350027122600000000	0-20,0-20,0-20		19923188	10.1128/JVI.02061-09	0022-538X	Journal of Virology	Antibody to Varicella-Zoster Virus Immediate-Early Protein 62 Augments Allodynia in Zoster via Brain-Derived Neurotrophic Factor	Hama	2010	5		
587	chrUn_JH121393	314669	314694	3500208763	25		314669	314694	8421504	1	25	0	c	350020876300000026	23-48		18305102	10.1091/mbc.E07-09-0914		Molecular Biology of the Cell	Multiplexed Dendritic Targeting of &#x03b1; Calcium Calmodulin-dependent Protein Kinase II, Neurogranin, and Activity-regulated Cytoskeleton-associated Protein RNAs by the A2 Pathway	Yuanzheng	2008	0		ARC
585	chrUn_JH121394	14107	14132	3500426222	23		14107	14132	8421504	2	17,6	0,19	g	350042622200000026	14-37						Treponema hyodysenteriae vaccine	Muir	1992	0		
586	chrUn_JH121394	256310	256338	3500253256	23		256310	256338	8421504	3	12,5,6	0,14,22	g	350025325600001939	0-24						 Methods Of Using Conjugated Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
586	chrUn_JH121394	256310	256338	3500196508	23		256310	256338	8421504	3	12,5,6	0,14,22	g	350019650800001948	0-24						 Conjugated Toxin Peptide Therapeutic Agents 	www.docstoc.com	0	0		
585	chrUn_JH121398	52696	52722	3500326597	24		52696	52722	8421504	3	6,4,14	0,7,12	g	350032659700000002	13-39			10.1128/JVI.79.11.6620-6630.2005		Journal of Virology	Selective Replication of Coronavirus Genomes That Express Nucleocapsid Protein	Barbara	June	0		
585	chrUn_JH121398	105885	105911	3500311484	24		105885	105911	8421504	2	6,18	0,8	g	350031148400000116	16-45						Anticancer Combination Therapies - Patent application	www.faqs.org	0	0		
585	chrUn_JH121399	31084	31108	3500247642	23		31084	31108	8421504	2	9,14	0,10	g	350024764200000022	1-24						Distinct Diversity of the cag Pathogenicity Island among pylori Strains in Japan	jcm.asm.org	0	0		
585	chrUn_JH121400	76650	76678	3500335768	23		76650	76678	8421504	2	11,12	0,16	g	350033576800000014	1-24						Identification of cyclic-AMP-responsive elementwithinthe rat somatostatin gene	www.pnas.org	0	0		
587	chrUn_JH121403	287074	287099	3500420245	23		287074	287099	8421504	2	15,8	0,17	g	350042024500000001	7-30						PRODUCTION OF FATTY ACIDS & DERIVATIVES THEREOF - Patent application	www.faqs.org	0	0		SMARCA1
587	chrUn_JH121403	287074	287099	3500332828	23		287074	287099	8421504	2	15,8	0,17	g	350033282800000031,350033282800000001	7-30,7-30						ENHANCED PRODUCTION OF FATTY ACID DERIVATIVES - Patent application	www.faqs.org	0	0		SMARCA1
587	chrUn_JH121403	287074	287099	3500290410	23		287074	287099	8421504	2	15,8	0,17	g	350029041000000005	7-30						METHODS AND COMPOSITIONS RELATED TO THIOESTERASE ENZYMES - LS9, INC.	www.sumobrain.com	0	0		
587	chrUn_JH121403	287074	287099	3500230908	23		287074	287099	8421504	2	15,8	0,17	g	350023090800000001	9-32		12502715	10.1074/jbc.M210533200	0021-9258	Journal of Biological Chemistry	A Novel Bifunctional Wax Ester Synthase/Acyl-CoA:Diacylglycerol Acyltransferase Mediates Wax Ester and Triacylglycerol Biosynthesis inAcinetobacter calcoaceticus ADP1	Kalscheuer	2003	5		
587	chrUn_JH121403	287074	287099	3500132350	23		287074	287099	8421504	2	15,8	0,17	g	350013235000000001	7-30						Production of fatty acids and derivatives thereof	Keasling	2010	0		
585	chrUn_JH121404	2756	2783	3500361851	27		2756	2783	8421504	1	27	0	g	350036185100000049	21-48						Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates - Patent application	www.faqs.org	0	0		
585	chrUn_JH121404	55402	91433	3500190358	46		55402	91433	8421504	4	8,15,15,8	0,10,36006,36023	g	350019035800000020,350019035800000018	0-23,21-44					Patent	Chimeric alphavirus replicon particles (Patent US:7531180)	Polo	2009	0		
585	chrUn_JH121404	55402	91433	3500016898	46		55402	91433	8421504	4	8,15,15,8	0,10,36006,36023	g	350001689800000020,350001689800000018	0-23,21-44						CHIMERIC ALPHAVIRUS REPLICON PARTICLES	Polo	2009	0		
585	chrUn_JH121404	91408	91433	3500213214	23		91408	91433	8421504	2	15,8	0,17	g	350021321400000013	21-44						Chimeric alphavirus replicon particles	Polo	2011	0		
585	chrUn_JH121404	121135	121161	3500343421	23		121135	121161	8421504	2	13,10	0,16	g	350034342100000185	3-38						NOVEL NUCLEIC ACID SEQUENCES AND THEIR USE IN METHODS FOR ACHIEVING PATHOGEN RESISTANCE IN PLANTS - Patent application	www.faqs.org	0	0		
587	chrUn_JH121405	267866	267889	3500049456	23		267866	267889	8421504	1	23	0	g	350004945600000007	5-28						Identification of a gene encoding Lon protease from Brevibacillus thermoruber WR-249 and biochemical characterization of its thermostable recombinant enzyme	ur.lib.ntu.edu.tw	0	0		
586	chrUn_JH121406	235101	235124	3500316254	23		235101	235124	8421504	1	23	0	g	350031625400000093,350031625400000233	5-40,5-40						Gene Synthesis Kit 	.freshpatents.com	0	0		
586	chrUn_JH121412	256314	256337	3500395209	23		256314	256337	8421504	1	23	0	g	350039520900000245	18-41						Cytokinin Oxidase Sequences and Methods of Use - Patent application	www.faqs.org	0	0		
586	chrUn_JH121412	257186	257211	3500406083	23		257186	257211	8421504	2	6,17	0,8	g	350040608300000010	9-32					Patent	Method for fluorescence based detection assay (Patent EP:0915173)	Little	2007	0		
586	chrUn_JH121412	257186	257211	3500347180	23		257186	257211	8421504	2	6,17	0,8	g	350034718000000007	9-32						Detection of Neisseria gonorrhoeae by amplification and detection of its nucleic acid	Durmowicz	1997	0		
586	chrUn_JH121412	257186	257211	3500005003	23		257186	257211	8421504	2	6,17	0,8	g	350000500300000022	9-32					Patent	Verfahren f&#xfc;r Fluoreszenzerkennungstest Method for fluorescence detection test (Patent DE:69836888)	Little	2007	0		
587	chrUn_JH121412	277435	279645	3500086447	1335		277435	279645	8421504	4	1058,111,109,57	0,1588,1776,2153	p	350008644700015021	0-1335						T3DB: Showing Arsenic (T3D0001)	classic.t3db.org	0	0		
587	chrUn_JH121412	277540	279645	3500276476	468		277540	279645	8421504	8	60,48,48,60,86,97,12,57	0,291,411,606,867,1483,1768,2048	p	350027647600015021,350027647600015016,350027647600015014,350027647600015010,350027647600015005,350027647600015026,350027647600015024	0-60,0-48,0-48,0-60,0-60,0-174,0-69						Genetic and Molecular Analysis of a Caenorhabditis elegans / -Tubulin That Conveys Benzimidazole Sensitivity	jcb.rupress.org	0	0		
587	chrUn_JH121412	277569	277594	3500032816	25		277569	277594	8421504	1	25	0	c	350003281600000005,350003281600000045	0-25,0-25						XENO-FREE CULTURE CONDITIONS FOR HUMAN EMBRYONIC STEM CELLS AND METHODS THEREOF - Patent application	www.faqs.org	0	0		FAM166A
587	chrUn_JH121412	277786	277809	3500118856	23		277786	277809	8421504	1	23	0	c	350011885600000007	0-23			10.1093/emboj/18.2.420	ERROR! NO ISSN	The EMBO Journal	Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation	Li	1999	0		TUBB4B
587	chrUn_JH121412	278089	278112	3500369296	23		278089	278112	8421504	1	23	0	c	350036929600000029	0-23						Treatment of neurological disorders with hematopoeitic growth factors	Schaebitz	2006	0		TUBB2A,TUBB3
587	chrUn_JH121412	278089	278112	3500148684	23		278089	278112	8421504	1	23	0	c	350014868400000027	0-23						Treatment of neurological disorders with haematopoietic growth factors	Schneider	2011	0		THOC2,TUBB3
587	chrUn_JH121412	279069	279114	3500128210	45		279069	279114	8421504	1	45	0	p	350012821000015019	0-45						Cell, Volume 135	download.cell.com	0	0		TUBBP5
585	chrUn_JH121416	2922	6179	3500026368	61		2922	6179	8421504	3	21,20,20	0,3059,3237	c,g	350002636800000001,350002636800000005,350002636800000004,350002636800000004	1-22,0-20,0-20,0-20			10.1111/j.0019-2805.2003.01808.x		Immunology	Cloning and characterization of an immunoglobulin A Fc receptor from cattle	H	2004	0		
586	chrUn_JH121416	175495	175523	3500240738	23		175495	175523	8421504	2	15,8	0,20	g	350024073800000040	2-37						Antibodies Against Protective Antigen - Patent application	www.faqs.org	0	0		
586	chrUn_JH121417	257486	257514	3500154222	23		257486	257514	8421504	2	8,15	0,13	g	350015422200000157	4-36						Molekularbiologische Untersuchungen der Ebola-Viren Zaire und Reston mit Hilfe reverser Genetik	ub.uni-marburg.de	0	0		
586	chrUn_JH121419	215789	215818	3500304120	25		215789	215818	8421504	2	17,8	0,21	g	350030412000000032	11-36						 Cotton Promoter 	www.docstoc.com	0	0		
73	chrUn_JH121419	221059	267001	3500425242	40		221059	267001	8421504	2	20,20	0,45922	g	350042524200000001,350042524200000008	0-20,0-20						Multiple paternal origins of domestic cattle revealed by Y-specific interspersed multilocus microsatellites	emigracion.ucm.es	0	0		
585	chrUn_JH121421	51489	51514	3500018529	24		51489	51514	8421504	2	4,20	0,5	g	350001852900000494	0-24						***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Streptococcus pneumoniae antigens and vaccines	Choi	1997	0		
585	chrUn_JH121422	86151	86182	3500352177	26		86151	86182	8421504	3	6,13,7	0,8,24	g	350035217700000047	16-42						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121423	57491	57713	3500042215	80		57491	57713	8421504	2	6,74	0,148	c	350004221500000030	0-80						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	dare.ubn.kun.nl	0	0		
586	chrUn_JH121423	143962	192822	3500042215	159		143962	192822	8421504	4	11,67,63,18	0,855,42389,48842	p	350004221500015021,350004221500015013	0-78,0-81						PDF hosted at the Radboud Repository of the Radboud University Nijmegen	dare.ubn.kun.nl	0	0		
586	chrUn_JH121425	255044	255067	3500454061	23		255044	255067	8421504	1	23	0	g	350045406100000058	13-40						PIROPLASMID VACCINE - Patent application	www.faqs.org	0	0		
585	chrUn_JH121430	38302	38326	3500214603	23		38302	38326	8421504	2	11,12	0,12	g	350021460300000008	0-23						Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH121432	33462	33491	3500336939	24		33462	33491	8421504	2	10,14	0,15	g	350033693900000001	13-37						Studies on Indoor Fungi | James Scott - Academia.edu	www.academia.edu	0	0		
586	chrUn_JH121433	213069	213097	3500396309	24		213069	213097	8421504	2	8,16	0,12	g	350039630900000009	3-27						Functional Phosphoproteomic Analysis Reveals That a Serine-62-Phosphorylated Isoform of Ethylene Response Factor110 Is Involved in Arabidopsis Bolting	.plantphysiol.org	0	0		
586	chrUn_JH121434	228744	228772	3500464999	23		228744	228772	8421504	2	16,7	0,21	g	350046499900000041	6-30						INTEIN-MODIFIED ENZYMES, THEIR PRODUCTION AND INDUSTRIAL APPLICATIONS - AGRIVIDA, INC.	www.sumobrain.com	0	0		
585	chrUn_JH121435	68141	68171	3500452256	24		68141	68171	8421504	3	5,14,5	0,8,25	c	350045225600000083,350045225600000148	24-43,15-39						 Modified Annexin Proteins And Methods For Their Use In Organ Transplantation 	www.docstoc.com	0	0		
585	chrUn_JH121435	68141	68171	3500425727	24		68141	68171	8421504	3	5,14,5	0,8,25	c	350042572700000152	15-39						US Patent # 7,635,678. Modified annexin compositions and methods of using same - Patents.com	www.patents.com	0	0		
585	chrUn_JH121435	68141	68171	3500068107	24		68141	68171	8421504	3	5,14,5	0,8,25	c	350006810700000147	21-45						Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia - Patent application	www.faqs.org	0	0		
585	chrUn_JH121435	78183	82171	3500022796	60		78183	82171	8421504	3	20,20,20	0,779,3968	c,g	350002279600000022,350002279600000023,350002279600000023,350002279600000006	0-20,0-20,0-20,19-39						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
586	chrUn_JH121437	165802	166146	3500079912	40		165802	166146	8421504	2	20,20	0,324	c,g	350007991200000004,350007991200000004,350007991200000003	1-21,1-21,0-20						Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations	Beeler	2002	0		
586	chrUn_JH121440	191252	191278	3500111719	23		191252	191278	8421504	2	15,8	0,18	g	350011171900000020	0-23						Identi&#xfb01;cation of Clinically Relevant Viridans Streptococci by an Oligonucleotide Array	jcm.asm.org	0	0		
586	chrUn_JH121441	196375	196401	3500286519	23		196375	196401	8421504	2	14,9	0,17	g	350028651900000008	8-32						Development of a novel Plasmodium falciparum Topoisomerase I specific biosensor for diagnosis of malaria	boa.unimib.it	0	0		
585	chrUn_JH121442	26185	26213	3500301801	26		26185	26213	8421504	3	11,5,10	0,12,18	g	350030180100000010	0-26						Chimeric Carrier Molecules for the Production of Mucosal Vaccines - Patent application	www.faqs.org	0	0		
585	chrUn_JH121443	4421	4446	3500188956	25		4421	4446	8421504	1	25	0	g	350018895600000009	17-42						Mucin biosynthesis in the bovine goblet cell induced by Cooperia oncophora infection. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH121443	22670	22694	3500016368	24		22670	22694	8421504	1	24	0	c,g	350001636800000000,350001636800000000,350001636800000001,350001636800000001	0-23,0-23,1-22,1-22		18971266	10.1128/JVI.01864-08	0022-538X	Journal of Virology	Host Cell Factors and Functions Involved in Vesicular Stomatitis Virus Entry	Johannsdottir	2009	5		AP2A2
585	chrUn_JH121443	22670	22694	3500005715	24		22670	22694	8421504	1	24	0	c	350000571500000000,350000571500000001	0-23,1-22						Host Cell Factors and Functions Involved in Vesicular Stomatitis Virus Entry	jvi.asm.org	0	0		AP2A1
585	chrUn_JH121443	94947	100178	3500081673	39		94947	100178	8421504	2	10,29	0,5202	c	350008167300000114	6-45						Polynucleotides and membrane-bound polypeptide encoded thereby	Fernandes	2000	0		
585	chrUn_JH121443	116835	116858	3500002117	23		116835	116858	8421504	1	23	0	g	350000211700000004	2-30						BIOMARKER FOR DIAGNOSIS OF CANINE CANCER - Patent application	www.faqs.org	0	0		
586	chrUn_JH121443	132970	152024	3500005314	39		132970	152024	8421504	4	6,13,14,6	0,10,19029,19048	g	350000531400000179,350000531400000566	18-37,9-29						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
586	chrUn_JH121443	137355	141742	3500331673	82		137355	141742	8421504	4	20,21,21,20	0,975,1187,4367	c,g	350033167300000007,350033167300000007,350033167300000004,350033167300000001,350033167300000006,350033167300000006	0-20,0-20,0-21,0-21,0-20,0-20						ISSN 1684 - 5315	demicjournals.org	0	0		
586	chrUn_JH121443	137355	141742	3500138247	82		137355	141742	8421504	4	20,21,21,20	0,975,1187,4367	c,g	350013824700000007,350013824700000007,350013824700000004,350013824700000004,350013824700000001,350013824700000001,350013824700000006,350013824700000006	0-20,0-20,0-21,0-21,0-21,0-21,0-20,0-20						African Journal of Biotechnology	demicjournals.org	0	0		
586	chrUn_JH121443	137355	141742	3500029633	61		137355	141742	8421504	3	20,21,20	0,1187,4367	c	350002963300000007,350002963300000001,350002963300000006	0-20,0-21,0-20						Two novel missense mutations in bovine gene and their association with economic traits in Qinchuan cattle	www.ajol.info	0	0		
586	chrUn_JH121443	137779	139160	3500377093	66		137779	139160	8421504	2	34,32	0,1349	c,g	350037709300000040,350037709300000027	13-47,6-38						IDENTIFICATION, CLONING, EXPRESSION, AND A PURIFICATION OF THREE NOVEL HUMAN CALCIUM-INDEPENDENT PHOSPHOLIPASE A2 FAMILY MEMBERS POSSESSING TRIACYLGLYCEROL LIPASE AND ACYLGLYCEROL TRANSACYLASE ACTIVITIES - Patent application	www.faqs.org	0	0		
586	chrUn_JH121443	138641	139068	3500463464	56		138641	139068	8421504	6	5,29,2,5,9,6	0,152,182,405,411,421	c	350046346400000056,350046346400000030	14-70,21-43						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
586	chrUn_JH121443	138793	139116	3500301078	43		138793	139116	8421504	2	22,21	0,302	c	350030107800000158,350030107800000157	0-22,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
586	chrUn_JH121443	139098	139223	3500464199	43		139098	139223	8421504	2	21,22	0,103	c,g	350046419900000017,350046419900000017,350046419900000016	0-21,0-21,0-22				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		
586	chrUn_JH121443	145529	145577	3500105384	48		145529	145577	8421504	1	48	0	p	350010538400015085,350010538400015088	0-48,0-48						Activatable toxin complexes comprising a cleavable inhibitory peptide	Benhar	2012	0		RPLP1
586	chrUn_JH121443	145790	147371	3500409605	42		145790	147371	8421504	3	17,4,21	0,595,1560	c,g	350040960500000003,350040960500000002,350040960500000002	9-30,9-30,9-30						Le r&#xf4;le des r&#xe9;cepteurs &#xe0; VEGF dans la r&#xe9;gulation de l'angiogen&#xe8;se	doc.rero.ch	0	0		
586	chrUn_JH121443	145790	147371	3500079611	42		145790	147371	8421504	3	17,4,21	0,595,1560	c,g	350007961100000003,350007961100000002,350007961100000002	9-30,9-30,9-30		11714897		1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro	Tille	2001	0		
586	chrUn_JH121443	145790	147371	3500060313	42		145790	147371	8421504	3	17,4,21	0,595,1560	c,g	350006031300000003,350006031300000002,350006031300000002	9-30,9-30,9-30		11714897		1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in Vivo and in Vitro	Tille	2001	0		
586	chrUn_JH121443	154425	154534	3500242028	27		154425	154534	8421504	3	6,10,11	0,11,98	c	350024202800000687	2-29						Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases	Silverman	2011	0		
586	chrUn_JH121443	221818	221848	3500106615	24		221818	221848	8421504	3	13,7,4	0,18,26	g	350010661500000036	21-45						GASP1: A FOLLISTATIN DOMAIN CONTAINING PROTEIN - Patent application	www.faqs.org	0	0		
586	chrUn_JH121443	248255	248280	3500025091	24		248255	248280	8421504	2	17,7	0,18	g	350002509100000010	3-39						Aav4 vector and uses thereof	Chiorini	1998	0		
586	chrUn_JH121445	221162	221186	3500295082	23		221162	221186	8421504	2	14,9	0,15	g	350029508200000245	19-43					Patent	Functionally active regions of signal transducer and activator of transcription (Patent US:5883228)	James	1999	0		
586	chrUn_JH121448	148877	148906	3500084793	25		148877	148906	8421504	3	6,6,13	0,7,16	g	350008479300000082	6-33						Cab molecules	Fox	2008	0		
586	chrUn_JH121448	172740	172764	3500241875	23		172740	172764	8421504	2	11,12	0,12	g	350024187500000114	8-31					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
586	chrUn_JH121448	172740	172764	3500070088	23		172740	172764	8421504	2	11,12	0,12	g	350007008800000114	8-31						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
585	chrUn_JH121449	71399	71426	3500294115	23		71399	71426	8421504	2	15,8	0,19	g	350029411500000010	0-26						ANTI-HDLK-1 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO - Patent application	www.faqs.org	0	0		
586	chrUn_JH121449	222501	222606	3500301078	40		222501	222606	8421504	3	21,4,15	0,83,90	c	350030107800000108,350030107800000107	0-21,0-19						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
586	chrUn_JH121449	222508	239009	3500167223	785		222508	239009	8421504	11	22,77,103,88,92,21,45,148,112,55,22	0,142,590,1471,1868,2514,4106,4485,4711,6834,16479	p,c,g	350016722300000001,350016722300000001,350016722300015011,350016722300015010,350016722300015009,350016722300000006,350016722300015003,350016722300015002,350016722300015001,350016722300000000,350016722300000000	0-22,0-22,6-126,0-126,6-126,0-21,6-126,6-126,6-126,0-22,0-22						Molecular characterization of the encoding regions and tissue expression analyses for three novel buffalo AKT genes AKT1 AKT2 and AKT3	ls.tubitak.gov.tr	0	0		
586	chrUn_JH121449	222650	222710	3500032244	60		222650	222710	8421504	1	60	0	p	350003224400015000	0-60						ScienceDirect.com - FEBS Letters - Akt2 regulates expression of the actin-bundling protein palladin	sciencedirect.com	0	0		AKT1
586	chrUn_JH121449	222658	222690	3500307841	32		222658	222690	8421504	1	32	0	c	350030784100000003,350030784100000002	2-34,0-32						For submission to JBC Inhibition of Protein Synthesis Alters Protein Degradation through Activation of Protein Kinase B (AKT)	www.jbc.org	0	0		
586	chrUn_JH121449	222659	222689	3500220548	30		222659	222689	8421504	1	30	0	c	350022054800000003,350022054800000002	0-30,0-30		17635998	10.1242/jcs.03476	0021-9533	Journal of Cell Science	Mechanical force modulates global gene expression and &#x03b2;-catenin signaling in colon cancer cells	Avvisato	2007	6		AKT2
586	chrUn_JH121449	222665	227329	3500318073	236		222665	227329	8421504	6	45,20,27,48,48,48	0,516,1314,1842,3916,4616	c	350031807300000036,350031807300000033,350031807300000028,350031807300000017,350031807300000011	3-48,0-47,0-48,0-48,0-48						RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK - Patent application	www.faqs.org	0	0		
586	chrUn_JH121449	222665	227329	3500037315	181		222665	227329	8421504	4	45,40,48,48	0,3868,3916,4616	c	350003731500000036,350003731500000018,350003731500000017,350003731500000011	3-48,8-48,0-48,0-48						ACTIVATION OF MUTATED RAC-PK - Patent application	www.faqs.org	0	0		
586	chrUn_JH121449	223136	223159	3500068430	23		223136	223159	8421504	1	23	0	c	350006843000000010	0-23						The Role Of Intracellular Signalling Pathways In Conferring Resistance To Endocrine Therapies In Breast Cancer	.era.lib.ed.ac.uk	0	0		
586	chrUn_JH121449	223190	224562	3500376217	65		223190	224562	8421504	4	11,12,20,22	0,789,836,1350	c,g	350037621700000041,350037621700000003,350037621700000014	0-23,0-20,0-22						Use of antisense oligonucleotides to inhibit the expression of akt-1	Yoon	2004	0		
586	chrUn_JH121449	223190	224046	3500261943	43		223190	224046	8421504	3	11,12,20	0,789,836	c,g	350026194300000001,350026194300000005,350026194300000005,350026194300000004,350026194300000004	0-23,0-20,0-20,0-20,0-20						RTICLE Journal of	tsouthwestern.edu	0	0		AKT1
586	chrUn_JH121449	223190	223991	3500177735	23		223190	223991	8421504	2	11,12	0,789	c	350017773500000052	0-23					Patent	Use of antisense oligonucleotides to inhibit the expression of Akt-1 (Patent CN:100558740)	An Chang Hao 	2009	0		
586	chrUn_JH121449	224026	224562	3500279796	42		224026	224562	8421504	2	20,22	0,514	c,g	350027979600000002,350027979600000008,350027979600000001	0-20,0-22,0-20					Patent	Use of antisense oligonucleotides to inhibit the expression of human Akt-1 (Patent US:7122527)	Ahn	2006	0		
586	chrUn_JH121449	224026	224562	3500207206	42		224026	224562	8421504	2	20,22	0,514	c,g	350020720600000003,350020720600000002,350020720600000008	0-20,0-20,0-22						Use of antisense oligonucleotides to inhibit the expression of human Akt-1	Yoon	2003	0		
586	chrUn_JH121449	224478	224501	3500444033	23		224478	224501	8421504	1	23	0	c	350044403300000010	0-23						OpposingRolesforAkt1andAkt2inRac/PakSignalingand CellMigration	www.jbc.org	0	0		
586	chrUn_JH121449	224541	226576	3500232374	47		224541	226576	8421504	2	28,19	0,2016	c,g	350023237400000051,350023237400000053	0-28,0-19						METHODS FOR CREATING AND IDENTIFYING FUNCTIONAL RNA INTERFERENCE ELEMENTS - Patent application	www.faqs.org	0	0		
586	chrUn_JH121449	227266	227326	3500315591	60		227266	227326	8421504	1	60	0	c	350031559100000000,350031559100000001	0-60,0-57						Investigating The Cardiac Functions Of Protein Kinase B Biology Essay	www.ukessays.com	0	0		AKT1
586	chrUn_JH121449	229399	229423	3500339288	24		229399	229423	8421504	1	24	0	c	350033928800000191	0-24						Document Title: The Determination Of The Physical Characteristics Of An Individual From Biological Stains	www.ncjrs.gov	0	0		
585	chrUn_JH121452	36345	36371	3500218638	26		36345	36371	8421504	1	26	0	g	350021863800000006	9-35		10022906		0270-7306	Molecular and Cellular Biology	Hsp60 Is Targeted to a Cryptic Mitochondrion-Derived Organelle (&#x201c;Crypton&#x201d;) in the Microaerophilic Protozoan Parasite Entamoeba histolytica	Mai	1999	6		
585	chrUn_JH121452	36345	36371	3500024528	26		36345	36371	8421504	1	26	0	g	350002452800000009	11-37		15879516	10.1124/mol.105.012567	1521-0111 (Online)	Molecular Pharmacology	A Major Species of Mouse &#x03bc;-opioid Receptor mRNA and Its Promoter-Dependent Functional Polyadenylation Signal	Wu	2005	0		
585	chrUn_JH121453	23694	46471	3500301622	47		23694	46471	8421504	2	25,22	0,22755	c,g	350030162200000005,350030162200000004	15-40,22-44						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
585	chrUn_JH121453	23694	23719	3500186272	25		23694	23719	8421504	1	25	0	c	350018627200000005	15-40						Medical device	Lahtinen	2003	0		
585	chrUn_JH121453	36582	36607	3500391930	25		36582	36607	8421504	1	25	0	c	350039193000000028	0-25						Hepatoblast-Like Progenitor Cells Derived From Embryonic Stem Cells Can Repopulate Livers of Mice	library.ibp.ac.cn	0	0		FGF5
585	chrUn_JH121453	46174	46197	3500284166	23		46174	46197	8421504	1	23	0	c	350028416600000004	0-23			10.1038/nature05972		Nature	New cell lines from mouse epiblast share defining features with human embryonic stem cells	Tesar	2007	0		FGF5
586	chrUn_JH121453	136675	136702	3500024322	23		136675	136702	8421504	3	5,6,12	0,6,15	g	350002432200000153	10-34						US Patent # 7,132,257. Production or aromatic carotenoids in gram negative bacteria - Patents.com	www.patents.com	0	0		
586	chrUn_JH121453	138703	140690	3500248703	129		138703	140690	8421504	2	33,96	0,1891	c	350024870300000304,350024870300000236,350024870300000237	0-33,0-48,0-48						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
585	chrUn_JH121455	62668	62696	3500004227	24		62668	62696	8421504	2	11,13	0,15	g	350000422700000477	0-26						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
586	chrUn_JH121457	188864	188891	3500084267	23		188864	188891	8421504	2	15,8	0,19	g	350008426700000228	0-34						Methods for Producing Hybrid Seed	Allen	2009	0		
585	chrUn_JH121458	40407	40547	3500307212	41		40407	40547	8421504	2	20,21	0,119	c,g	350030721200000000,350030721200000004,350030721200000004	0-20,0-21,0-21		10393042		1552-5783	Investigative Ophthalmology & Visual Science	A Transgenic Animal Model of Osmotic Cataract. Part 1: Over-expression of Bovine Na+/Myo-inositol Cotransporter in Lens Fibers	Cammarata	1999	0		
585	chrUn_JH121458	40751	81598	3500152160	47		40751	81598	8421504	3	22,5,20	0,25,40827	c	350015216000000118,350015216000000119	15-42,0-20						Short Communication A 4 Mb high resolution BAC contig on bovine chromosome 1q12 and comparative analysis with human chromosome 21q22	loads.hindawi.com	0	0		
585	chrUn_JH121458	41901	41925	3500421349	23		41901	41925	8421504	2	7,16	0,8	c,g	350042134900000004,350042134900000004	0-23,0-23						Forensics, phylogeography and population genetics: a case study using the Australasian snake-necked turtle, Chelodina rugosa	g.canberra.edu.au	0	0		
585	chrUn_JH121459	60906	60932	3500400189	23		60906	60932	8421504	2	16,7	0,19	g	350040018900000000	1-24						Recombinant animal interferon polypeptides	www.devileye.net	0	0		
585	chrUn_JH121459	64728	64762	3500365031	28		64728	64762	8421504	3	5,17,6	0,8,28	c	350036503100000459	15-43						PURIFIED SR-p70 PROTEIN	Caput	1997	0		
586	chrUn_JH121460	232329	232352	3500026430	23		232329	232352	8421504	1	23	0	g	350002643000000153	6-32						Compositions and Methods Comprising Protease Variants	Basler	2010	0		
585	chrUn_JH121463	16621	16646	3500309840	23		16621	16646	8421504	2	17,6	0,19	c	350030984000000844	23-47						MULTIVALENT VACCINE FOR $i(CLOSTRIDIUM BOTULINUM) NEUROTOXIN - OPHIDIAN PHARMACEUTICALS, INC.	www.sumobrain.com	0	0		SLC6A14
585	chrUn_JH121463	16621	16646	3500106719	23		16621	16646	8421504	2	17,6	0,19	c	350010671900000093	23-47						Optimizing Expression of Active Botulinum Toxin Type E - Patent application	www.faqs.org	0	0		SLC6A14
586	chrUn_JH121466	232297	234565	3500002829	2259		232297	234565	8421504	4	32,1267,940,20	0,35,1306,2248	g	350000282900000010	8922-11188						Sex- specific selection of sperm from transgenic animals	Forsberg	2002	0		
585	chrUn_JH121473	2583	2613	3500010909	25		2583	2613	8421504	3	6,15,4	0,10,26	g	350001090900000005	0-26						Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria	Cole	1998	0		
586	chrUn_JH121473	164435	164461	3500394874	24		164435	164461	8421504	3	6,5,13	0,7,13	g	350039487400000114	24-48						Bone morphogenetic protein-2 in the treatment and diagnosis of cancer	Langenfeld	2002	0		
586	chrUn_JH121475	156285	156309	3500237667	24		156285	156309	8421504	1	24	0	g	350023766700000026,350023766700000029	17-41,9-33						Method for making complementary oligonucleotide tag sets	Dubridge	2000	0		
585	chrUn_JH121476	4712	7606	3500402065	51		4712	7606	8421504	2	21,30	0,2864	g	350040206500000013,350040206500000012	0-21,0-30		23638875	10.1111/aji.12131	1600-0897	American Journal of Reproductive Immunology	Heat Shock Induces Interferon-TAU Gene Expression by In Vitro-Produced Bovine Blastocysts - Hickman - 2013 - American Journal of Reproductive Immunology - Wiley Online Library	Hickman	2013	0		
585	chrUn_JH121476	7576	7606	3500306233	30		7576	7606	8421504	1	30	0	g	350030623300000023	0-30						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
585	chrUn_JH121476	9980	10060	3500408830	60		9980	10060	8421504	2	30,30	0,50	g	350040883000000008,350040883000000000	0-30,23-53						Prenatal bovine sex determination using male-specific oligonucleotides	Gingeras	1990	0		
585	chrUn_JH121479	69848	69877	3500093232	23		69848	69877	8421504	3	5,6,12	0,6,17	g	350009323200000242	10-33					Patent	Haemophilus outer membrane protein (Patent US:6083743)	Chong	2000	0		
585	chrUn_JH121481	90735	90765	3500405329	25		90735	90765	8421504	3	13,7,5	0,16,25	g	350040532900000007	8-33						Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 &#x03b2;-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells 10.1016/j.febslet.2007.02.070 : FEBS Lette	sciencedirect.com	0	0		
586	chrUn_JH121481	131865	131892	3500150070	24		131865	131892	8421504	2	14,10	0,17	g	350015007000000001	7-32		11748198	10.1128/IAI.70.1.323-334.2002	0019-9567	Infection and Immunity	Novel 45-Kilodalton Leptospiral Protein That Is Processed to a 31-Kilodalton Growth-Phase-Regulated Peripheral Membrane Protein	Matsunaga	2002	4		
585	chrUn_JH121482	4225	4252	3500004336	23		4225	4252	8421504	3	11,7,5	0,13,22	g	350000433600000000	7-31			10.1111/j.1349-7006.2005.00085.x	1349-7006	Cancer Science	Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesis - Painter - 2005 - Cancer Science - Wiley Online Library	Painter	2005	0		
586	chrUn_JH121484	203158	203184	3500445486	24		203158	203184	8421504	2	9,15	0,11	g	350044548600000240	0-24						Novel methods for production of di-chain botulinum toxin	Li	2004	0		
585	chrUn_JH121487	21234	106853	3500004246	269		21234	106853	8421504	12	14,34,27,8,11,25,23,48,8,40,23,8	0,2262,2619,15650,15660,55497,58140,68414,69993,70726,84446,85611	c	350000424600000195,350000424600000199,350000424600000222,350000424600000332,350000424600000338,350000424600000257	0-48,0-48,0-48,0-48,0-48,0-31						Assays for agonists and antagonists of recombinant human calcium channels	Harpold	1991	0		
73	chrUn_JH121487	91119	133652	3500328440	2817		91119	133652	8421504	32	27,83,202,84,36,27,6,63,45,18,63,117,66,92,145,102,23,80,14,94,56,25,113,125,118,117,48,85,35,186,477,45	0,33,841,1263,1350,1392,1422,1758,1824,2214,2235,14000,14518,15726,17850,22354,22459,27863,30732,30749,35120,35203,35672,36633,39437,39714,40968,41091,41408,41473,42005,42488	p	350032844000015007	0-2985						Methods for identifying ion channel modulators	Friden	2004	0		
585	chrUn_JH121487	104593	104625	3500319939	26		104593	104625	8421504	3	13,8,5	0,16,27	g	350031993900000015	7-33						Resonance energy transfer assay system for multi-component detection	Eidne	2005	0		
585	chrUn_JH121488	48051	48077	3500345827	23		48051	48077	8421504	2	10,13	0,13	g	350034582700000041	23-46						ABO genotyping	Yamamoto	1991	0		
586	chrUn_JH121490	142332	142360	3500344887	23		142332	142360	8421504	2	7,16	0,12	g	350034488700000011	11-36						Fermentative carotenoid production	Pasamontes	2003	0		
585	chrUn_JH121491	74419	74442	3500189676	23		74419	74442	8421504	1	23	0	g	350018967600000099	10-38						 Transgenic Plants Containing Ligninase And Cellulase Which Degrade Lignin And Cellulose To Fermentab 	www.docstoc.com	0	0		
585	chrUn_JH121491	107251	107275	3500424353	23		107251	107275	8421504	2	4,19	0,5	c	350042435300000002	5-28		12538513	10.1242/dev.00312	0950-1991	Development	CRM1-mediated nuclear export and regulated activity of the Receptor Tyrosine Kinase antagonist YAN require specific interactions with MAE	Tootle	2003	7		
585	chrUn_JH121491	107251	107275	3500145528	23		107251	107275	8421504	2	4,19	0,5	c,g	350014552800000003,350014552800000002,350014552800000002	15-38,5-28,5-28		12538513	10.1242/dev.00312	0950-1991	Development	CRM1-mediated nuclear export and regulated activity of the Receptor Tyrosine Kinase antagonist YAN require specific interactions with MAE	Tootle	2003	7		
585	chrUn_JH121494	95284	95320	3500101538	27		95284	95320	8421504	3	12,9,6	0,16,30	g	350010153800000627	18-45						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
585	chrUn_JH121500	6987	7011	3500263213	23		6987	7011	8421504	2	15,8	0,16	g	350026321300000037	1-24		20400938	10.1038/emboj.2010.75	ERROR! NO ISSN	The EMBO Journal	Rice early flowering1, a CKI, phosphorylates DELLA protein SLR1 to negatively regulate gibberellin signalling	Dai	2010	0		
586	chrUn_JH121502	147679	147705	3500248703	26		147679	147705	8421504	1	26	0	c	350024870300000376	0-26						PR-domain containing nucleic acids, polypeptides, antibodies and methods	Huang	1999	0		
585	chrUn_JH121505	8420	8443	3500028061	23		8420	8443	8421504	1	23	0	g	350002806100000284	14-37						Surface proteins of leptospira	www.devileye.net	0	0		
586	chrUn_JH121505	218954	218999	3500252626	45		218954	218999	8421504	1	45	0	p	350025262600015002	0-45						Mouse lacking heart-muscle adenine nucleotide translocator protein and methods	Wallace	1997	0		SLC25A5
586	chrUn_JH121505	218954	218984	3500127847	30		218954	218984	8421504	1	30	0	c	350012784700000003	0-30						Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor	Anderson	2005	0		
587	chrUn_JH121505	298415	306953	3500067926	56		298415	306953	8421504	4	2,26,10,18	0,363,8509,8520	c	350006792600000012	63-119						Structural and Functional Conservation of Two Human Homologs of the Yeast DNA Repair Gene RAD6	www.jstor.org	0	0		
587	chrUn_JH121505	307005	308017	3500128992	23		307005	308017	8421504	2	9,14	0,998	c	350012899200000276	7-30						Multiplexed assay and probes for identification of HPV types	Pourmand	2007	0		UBE2A
585	chrUn_JH121507	47678	91543	3500331487	45		47678	91543	8421504	2	25,20	0,43845	c	350033148700000000,350033148700000007	15-40,8-28		21677149	10.1152/ajprenal.00062.2011		American Journal of Physiology - Renal Physiology	Activity of the Ste20-like kinase, SLK, is enhanced by homodimerization	Delarosa	2011	0		
585	chrUn_JH121507	74648	80196	3500321033	63		74648	80196	8421504	3	33,10,20	0,51,5528	p	350032103300015048	6-84						Tese Simone - 02-03-09	pt.scribd.com	0	0		
585	chrUn_JH121507	110444	110469	3500428744	23		110444	110469	8421504	2	12,11	0,14	c	350042874400000009	0-23						Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells	ngr.colostate.edu	0	0		
585	chrUn_JH121507	110444	110469	3500168814	23		110444	110469	8421504	2	12,11	0,14	c	350016881400000005	0-23						Laminin-5 Induces Osteogenic Gene Expression in Human Mesenchymal Stem Cells through an ERK-dependent Pathway	w.molbiolcell.org	0	0		
585	chrUn_JH121507	130402	130438	3500254250	36		130402	130438	8421504	1	36	0	c	350025425000000002	32-68						SERIES EDITORS Laura Huilaja MEDICA A	herkules.oulu.fi	0	0		
585	chrUn_JH121508	20672	52178	3500191464	46		20672	52178	8421504	2	25,21	0,31485	c	350019146400000062,350019146400000061	10-35,0-21						Expression Vectors With Improved Safety 	.freshpatents.com	0	0		
585	chrUn_JH121508	20672	52178	3500136718	46		20672	52178	8421504	2	25,21	0,31485	c	350013671800000062,350013671800000061	10-35,0-21						Expression vectors with improved safety	Kim	2010	0		CYBB
585	chrUn_JH121508	20677	28418	3500178088	48		20677	28418	8421504	2	28,20	0,7721	c	350017808800000004,350017808800000003	12-40,0-20						[tel-00148919, v1] PHYSIOPATHOLOGIE DE L'ARTHROSE : R&#xd4;LE DE LA NADPH OXYDASE NOX 4 DANS L'EXPRESSION DE LA COLLAG&#xc9;NASE, MMP-1.	hives-ouvertes.fr	0	0		CYBB
585	chrUn_JH121508	28386	28411	3500025489	25		28386	28411	8421504	1	25	0	c	350002548900000002	0-25						NAD(P)HOxidasesRegulateHIF-2 ProteinExpression	www.jbc.org	0	0		CYBB
585	chrUn_JH121508	28386	28411	3500019411	25		28386	28411	8421504	1	25	0	c	350001941100000005	0-25		16532036	10.1038/sj.onc.1209406	0950-9232	Oncogene	Inhibition of NADPH oxidase 4 activates apoptosis via the AKT&sol;apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells	Mochizuki	2006	6		CYBB
585	chrUn_JH121508	28620	40539	3500199651	40		28620	40539	8421504	3	15,5,20	0,2684,11899	c	350019965100000003,350019965100000002	0-20,0-20		21975039	10.1186/1742-2094-8-129	1742-2094	Journal of Neuroinflammation	Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade	Zawada	2011	4		
585	chrUn_JH121508	34051	34080	3500416691	26		34051	34080	8421504	2	21,5	0,24	g	350041669100000007,350041669100000002	0-21,19-45						US Patent # 6,335,424. ribG - Patents.com	www.patents.com	0	0		
585	chrUn_JH121508	40491	40514	3500427693	23		40491	40514	8421504	1	23	0	c	350042769300000002	0-23		11880305	10.1152/ajplung.00206.2001		American Journal of Physiology - Lung Cellular and Molecular Physiology	NADPH oxidase promotes NF-&#x03ba;B activation and proliferation in human airway smooth muscle	Brar	2002	0		
585	chrUn_JH121508	40491	40514	3500411809	23		40491	40514	8421504	1	23	0	c	350041180900000002	0-23						NADPH oxidase promotes NF- B activation and proliferation in human airway smooth muscle	ng.physiology.org	0	0		
585	chrUn_JH121508	49936	49959	3500303532	23		49936	49959	8421504	1	23	0	c	350030353200000006	0-23						DEPARTAMENT DE GENATICA ESTUDIO DE FACTORES GENATICOS DE LOS SISTEMAS RELACIONADOS CON ESTRAS OX	www.tdx.cat	0	0		
585	chrUn_JH121508	52153	52178	3500368940	25		52153	52178	8421504	1	25	0	c	350036894000000000	0-25		16505175	10.1161/CIRCULATIONAHA.105.581397	0009-7322	Circulation	Glycated Proteins Stimulate Reactive Oxygen Species Production in Cardiac Myocytes	Zhang	2006	15		CYBB
586	chrUn_JH121508	240247	240276	3500443877	23		240247	240276	8421504	3	7,4,12	0,8,17	g	350044387700000010	0-24		19395484	10.1128/JB.00205-09		Journal of Bacteriology	Decarboxylating and Nondecarboxylating Glutaryl-Coenzyme A Dehydrogenases in the Aromatic Metabolism of Obligately Anaerobic Bacteria 	Simon	July	0		
585	chrUn_JH121510	18140	18172	3500312701	24		18140	18172	8421504	3	9,2,13	0,14,19	g	350031270100000145	11-35						Novel peptides	Han Chuan Xian Zhi 	2002	0		
585	chrUn_JH121512	6894	6920	3500183368	25		6894	6920	8421504	2	12,13	0,13	g	350018336800000124	0-44						Recombinant antibodies specific for a growth factor receptor	Wels	1994	0		
586	chrUn_JH121515	153673	153697	3500074983	24		153673	153697	8421504	1	24	0	g	350007498300000111	21-45						Alpha-amylase mutants with altered properties - US Patent 7713723 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121517	112810	112839	3500135243	23		112810	112839	8421504	3	12,7,4	0,17,25	g	350013524300000135	15-38						Electrical Conductors and Devices from Prion-Like Proteins - Patent application	www.faqs.org	0	0		
585	chrUn_JH121518	38680	38704	3500073739	23		38680	38704	8421504	2	13,10	0,14	g	350007373900000295	3-29						ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION - Patent application	www.faqs.org	0	0		
585	chrUn_JH121518	66164	66200	3500184837	26		66164	66200	8421504	3	6,13,7	0,11,29	g	350018483700000016	5-34						ALBUMIN VARIANTS - NOVOZYMES BIOPHARMA DK A/S	www.sumobrain.com	0	0		
585	chrUn_JH121518	92708	92736	3500107865	24		92708	92736	8421504	3	7,13,4	0,10,24	c	350010786500000563,350010786500000026	2-26,2-26						Anti-Cd14 Antibody Fusion Protein - Patent application	www.faqs.org	0	0		
73	chrUn_JH121518	110257	146924	3500245468	1580		110257	146924	8421504	26	75,18,92,4,97,65,60,109,71,89,7,20,128,80,12,9,54,47,162,30,102,11,37,102,42,57	0,1612,1678,5359,5381,6724,7741,7849,9589,9672,10601,10656,13331,16191,17912,17958,20316,21022,22599,26633,28899,29004,33242,35151,36529,36610	c	350024546800000349,350024546800000348,350024546800000346,350024546800000442,350024546800000345,350024546800000301,350024546800000215,350024546800000171,350024546800000343,350024546800000440,350024546800000342,350024546800000439,350024546800000341,350024546800000396,350024546800000340,350024546800000338,350024546800000434,350024546800000337,350024546800000336,350024546800000119,350024546800000163,350024546800000334,350024546800000072,350024546800000333,350024546800000331,350024546800000158,350024546800000330,350024546800000384,350024546800000426,350024546800000329,350024546800000067,350024546800000112,350024546800000022,350024546800000425,350024546800000328,350024546800000327,350024546800000197,350024546800000325,350024546800000421,350024546800000324,350024546800000322,350024546800000377,350024546800000321,350024546800000013,350024546800000320,350024546800000417,350024546800000374,350024546800000319,350024546800000372,350024546800000317,350024546800000414,350024546800000143,350024546800000371,350024546800000053,350024546800000008,350024546800000315,350024546800000412,350024546800000313,350024546800000049,350024546800000004,350024546800000003,350024546800000311,350024546800000408,350024546800000364,350024546800000406,350024546800000309	0-45,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,9-47,0-48,1-29,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,1-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,1-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,11-36,0-48,15-36,0-48,18-47,0-48,0-48,0-48,0-48,0-47,0-47,0-48,0-48,0-48,0-48,1-48,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48						Inhibition Of Cancer Metastasis 	.freshpatents.com	0	0		
585	chrUn_JH121518	115623	116989	3500366238	120		115623	116989	8421504	2	112,8	0,1358	p	350036623800015018	6-126						Atyrosine kinase profile of prostate carcinoma	www.pnas.org	0	0		BMX
585	chrUn_JH121521	1842	41807	3500431809	38		1842	41807	8421504	3	19,12,7	0,39943,39958	g	350043180900000038,350043180900000005	1-20,0-19						Isolated nucleotide sequences associated with Multiple sclerosis	Perron	1996	0		
585	chrUn_JH121522	27885	27911	3500278645	25		27885	27911	8421504	2	20,5	0,21	g	350027864500000209	23-48						Recombinant vesiculoviruses and their uses		1997	0		
585	chrUn_JH121523	128934	128962	3500236195	24		128934	128962	8421504	2	15,9	0,19	g	350023619500000023	0-24						Methods for rapidly detecting methicillin resistant staphylococci	Bekkaoui	1998	0		
585	chrUn_JH121527	13600	13627	3500320272	23		13600	13627	8421504	3	12,5,6	0,15,21	g	350032027200000035,350032027200000034	12-35,0-23					Patent	Polynucleotide constructs and uses thereof (Patent EP:1115877)	Binley	2009	0		
585	chrUn_JH121530	56115	56139	3500118856	24		56115	56139	8421504	1	24	0	g	350011885600000008	0-24			10.1093/emboj/18.2.420	ERROR! NO ISSN	The EMBO Journal	Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation	Li	1999	0		TUBB4A
73	chrUn_JH121530	129586	165062	3500113066	870		129586	165062	8421504	6	16,105,115,131,128,375	0,454,3668,10170,31362,35101	p	350011306600015000	0-870						KEGG T01001: 7257	www.genome.jp	0	0		
585	chrUn_JH121532	45422	45450	3500464482	23		45422	45450	8421504	2	16,7	0,21	g	350046448200000014	10-36					Patent	Expression of human serum albumin in Pichia pastoris (Patent US:5707828)	Barr	1998	0		
585	chrUn_JH121537	18325	18350	3500285675	24		18325	18350	8421504	2	6,18	0,7	g	350028567500000054	10-34					Patent	Mutated thermostable nucleic acid polymerase enzyme from Thermus species Z05 (Patent US:5455170)	Abramson	1995	0		
585	chrUn_JH121537	100171	100194	3500395280	23		100171	100194	8421504	1	23	0	g	350039528000000087	2-28						Method of providing a hybrid polypeptide exhibiting an activity of interest - Patent # 6270968 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH121537	116887	117152	3500181711	44		116887	117152	8421504	2	22,22	0,243	c	350018171100000018,350018171100000017	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
585	chrUn_JH121537	116887	117152	3500133737	44		116887	117152	8421504	2	22,22	0,243	c	350013373700000024,350013373700000023	0-22,0-22						REPRODUCTION	uction-online.org	0	0		
585	chrUn_JH121537	120154	124212	3500033775	40		120154	124212	8421504	2	20,20	0,4038	c,g	350003377500000005,350003377500000005,350003377500000004,350003377500000004	0-20,0-20,0-20,0-20		19747959	10.1016/j.mce.2009.09.004		Molecular and cellular endocrinology	Progesterone Regulation of Primordial Follicle Assembly In Bovine Fetal Ovaries	Eric	2009	0		
585	chrUn_JH121537	120226	124140	3500067199	45		120226	124140	8421504	2	41,4	0,3910	p	350006719900015007	0-45						DRUG CLASS FOR THE TREATMENT OF CANCER - Patent application	www.faqs.org	0	0		PGRMC1
585	chrUn_JH121537	124192	124355	3500047878	40		124192	124355	8421504	2	20,20	0,143	c,g	350004787800000061,350004787800000061,350004787800000060	0-20,0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
585	chrUn_JH121541	79424	79543	3500362403	41		79424	79543	8421504	2	22,19	0,100	c	350036240300000043,350036240300000042	0-22,0-19						TECHNISCHE UNIVERSIT&#xc4;T M&#xdc;NCHEN Lehrstuhl f&#xfc;r Physiologie Differential gene expression during pre-implantation pregnancy in bos taurus Andr&#xe9;a Hammerle-Fickinger Erlangung des akademischen Grades eines	d-nb.info/1024567	0	0		
585	chrUn_JH121543	36966	37116	3500323930	150		36966	37116	8421504	1	150	0	p	350032393000015016	0-150						METHOD FOR IDENTIFICATION OF GENES INVOLVED IN SPECIFIC DISEASES - OXFORD BIOMEDICA (UK) LIMITED	www.sumobrain.com	0	0		EGLN1
585	chrUn_JH121543	36981	37026	3500354336	45		36981	37026	8421504	1	45	0	p	350035433600015001	0-45		22946054	10.1242/jcs.109041	0021-9533	Journal of Cell Science	Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling	Pientka	2012	6		EGLN1
585	chrUn_JH121543	37476	97152	3500109773	720		37476	97152	8421504	5	363,120,137,68,32	0,49828,55859,58561,59644	p	350010977300015009,350010977300015011,350010977300015013,350010977300015015	0-180,0-180,0-180,0-180						Selective Inhibition and Mechanistic Studies of the Human O2 Sensor, Prolyl Hydroxylase Domain 2 (PHD2)	arworks.umass.edu	0	0		EGLN1
585	chrUn_JH121543	37831	93373	3500164505	45		37831	93373	8421504	3	8,17,20	0,49473,55522	c	350016450500000003,350016450500000002,350016450500000006,350016450500000007	0-25,0-25,0-20,0-20						Oxygen-dependentATF-4 stability is mediated by the PHD3 oxygen sensor	tologylibrary.org	0	0		EGLN1
585	chrUn_JH121543	37835	93400	3500013303	40		37835	93400	8421504	3	4,16,20	0,49469,55545	c,g	350001330300000002,350001330300000003,350001330300000003	0-20,0-20,0-20			10.1128/MCB.01867-06		Molecular and Cellular Biology	The Ternary Complex Factor Net Is Downregulated by Hypoxia and Regulates Hypoxia-Responsive Genes 	Christian	June	0		EGLN1
585	chrUn_JH121543	37835	93373	3500329531	40		37835	93373	8421504	3	4,16,20	0,49469,55518	c	350032953100000013,350032953100000014	0-20,0-20		17353276	10.1128/MCB.01324-06	0270-7306	Molecular and Cellular Biology	The Peptidyl Prolyl cis/trans Isomerase FKBP38 Determines Hypoxia-Inducible Transcription Factor Prolyl-4-Hydroxylase PHD2 Protein Stability	Barth	2007	6		EGLN1
585	chrUn_JH121543	37835	93373	3500008780	40		37835	93373	8421504	3	4,16,20	0,49469,55518	c,g	350000878000000013,350000878000000014,350000878000000014	0-20,0-20,0-20		17353276	10.1128/MCB.01324-06	0270-7306	Molecular and Cellular Biology	The Peptidyl Prolyl cis/trans Isomerase FKBP38 Determines Hypoxia-Inducible Transcription Factor Prolyl-4-Hydroxylase PHD2 Protein Stability	Barth	2007	6		EGLN1
585	chrUn_JH121543	37835	93372	3500406298	39		37835	93372	8421504	3	4,16,19	0,49469,55518	c,g	350040629800000013,350040629800000014,350040629800000014	0-20,0-19,0-19						The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. - ResearchGate	.researchgate.net	0	0		EGLN1
585	chrUn_JH121543	93439	96072	3500151579	48		93439	96072	8421504	2	23,25	0,2608	c	350015157900000006,350015157900000007	0-23,0-25		23145312	10.1038/srep00788	xxxx-xxxx	Scientific Reports	Autocrine stimulation of clear-cell renal carcinoma cell migration in hypoxia via HIF-independent suppression of thrombospondin-1	Bienes-Martinez	2012	0		EGLN1
586	chrUn_JH121543	148595	150417	3500450117	24		148595	150417	8421504	2	5,19	0,1803	c	350045011700000017	0-24		18291369	10.1016/j.expneurol.2007.12.011		Experimental neurology	Lipopolysaccharide-induced Peroxisomal Dysfunction Exacerbates Cerebral White Matter Injury: Attenuation by N-Acetyl Cysteine	Manjeet	2008	0		GNPAT
585	chrUn_JH121546	28169	28195	3500338588	24		28169	28195	8421504	2	13,11	0,15	g	350033858800000020	4-29						US Patent # 6,498,024. Subtractive amplification kit useful in the diagnosis of genetic disease mutation or variation - Patents.com	www.patents.com	0	0		
585	chrUn_JH121546	83731	83754	3500338834	23		83731	83754	8421504	1	23	0	g	350033883400000003	23-46						LONG TERM HYPOXIA REPRESSES THE EXPRESSION OF KEY GENES REGULATING CORTISOL BIOSYNTHESIS IN THE NEAR TERM OVINE FETUS	gu.physiology.org	0	0		
585	chrUn_JH121546	85197	85462	3500405697	44		85197	85462	8421504	2	22,22	0,243	g	350040569700000006,350040569700000007	0-22,0-22						Intrafollicular Steroids and Anti-Mu&#xa8;llerian Hormone During Normal and Cystic Ovarian Follicular Development in the Cow	ww.biolreprod.org	0	0		
585	chrUn_JH121547	13606	13632	3500465169	23		13606	13632	8421504	2	6,17	0,9	g	350046516900000435	13-36						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
586	chrUn_JH121548	133687	133718	3500446230	25		133687	133718	8421504	3	6,4,15	0,11,16	g	350044623000000013	12-37						Zinc finger binding domains for cnn	Carlos	2008	0		
585	chrUn_JH121551	126309	126335	3500019915	24		126309	126335	8421504	2	17,7	0,19	g	350001991500000526	7-31						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
586	chrUn_JH121551	157481	157511	3500407090	25		157481	157511	8421504	2	10,15	0,15	g	350040709000000560	0-25						HIV envelope polypeptides and vaccine	Berman	1997	0		
585	chrUn_JH121553	58159	58185	3500439546	23		58159	58185	8421504	2	6,17	0,9	g	350043954600000009	11-36						Monoclonal antibodies to prostate cells	www.devileye.net	0	0		
585	chrUn_JH121554	49657	50149	3500332335	42		49657	50149	8421504	2	39,3	0,489	c	350033233500000020,350033233500000065,350033233500000015	0-27,0-27,0-27						US Patent # 6,610,504. Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase - Patents.com	www.patents.com	0	0		
585	chrUn_JH121554	49672	50149	3500085562	27		49672	50149	8421504	2	24,3	0,474	c	350008556200000818	0-27						Methods and compositions for assaying analytes	Yuan	1999	0		
585	chrUn_JH121555	114977	115005	3500415764	26		114977	115005	8421504	2	21,5	0,23	g	350041576400000400,350041576400000094	19-45,19-45						US Patent # 6,538,109. Polynucleotide compositions encoding broad spectrum delta-endotoxins - Patents.com	www.patents.com	0	0		
585	chrUn_JH121555	114977	115005	3500164088	26		114977	115005	8421504	2	21,5	0,23	g	350016408800000124	19-45						Broad-spectrum delta-endotoxins	Gilmer	1998	0		
586	chrUn_JH121556	176691	176719	3500317486	23		176691	176719	8421504	2	17,6	0,22	g	350031748600000014	7-30						COMPOSITIONS, COMBINATIONS, AND METHODS FOR TREATING CARDIOVASCULAR CONDITIONS AND OTHER ASSOCIATED CONDITIONS - PHARMACIA CORPORATION	www.sumobrain.com	0	0		
585	chrUn_JH121557	78139	78169	3500461946	25		78139	78169	8421504	3	11,10,4	0,15,26	g	350046194600000093	2-27						TRANSGENIC COVER PLANTS CONTAINING HEMICELLULASE AND CELLULASE WHICH DEGRADE LIGNIN AND CELLULOSE TO FERMENTABLE SUGARS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121557	78139	78169	3500306430	25		78139	78169	8421504	3	11,10,4	0,15,26	g	350030643000000093	2-27						Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars - Patent application	www.faqs.org	0	0		
585	chrUn_JH121557	78514	78541	3500047637	23		78514	78541	8421504	2	16,7	0,20	g	350004763700000693	3-26						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
585	chrUn_JH121560	32288	32314	3500080084	26		32288	32314	8421504	1	26	0	g	350008008400000000	0-26						GATA Transcription Factors Inhibit Cytokine-dependent Growth and Survival of a Hematopoietic Cell Line through the Inhibition of STAT3 Activity--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9	journal.9med.net	0	0		
586	chrUn_JH121560	140033	140061	3500114689	24		140033	140061	8421504	2	17,7	0,21	g	350011468900000019	21-48					Patent	FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor (Patent US:5654182)	O'Gorman	1997	0		
586	chrUn_JH121560	144763	156763	3500347049	262		144763	156763	8421504	5	114,6,121,15,6	0,408,5286,5423,11994	c	350034704900000052,350034704900000062	0-120,0-142						Human RAD50 gene and methods of use thereof	Dolganov	1996	0		
585	chrUn_JH121561	21373	21404	3500109714	24		21373	21404	8421504	3	6,13,5	0,10,26	g	350010971400000164	19-43						Plant fatty acid synthases	Knauf	1991	0		
585	chrUn_JH121563	40171	87170	3500057001	44		40171	87170	8421504	4	5,15,14,10	0,7,46973,46989	g	350005700100000252,350005700100000357,350005700100000170,350005700100000058,350005700100000096	21-41,6-30,7-30,6-30,6-30						Surface antigen	www.devileye.net	0	0		
585	chrUn_JH121563	87144	87169	3500101289	23		87144	87169	8421504	2	14,9	0,16	g	350010128900000170	7-30						NOVEL SURFACE ANTIGEN - Patent application	www.faqs.org	0	0		
585	chrUn_JH121566	73621	73650	3500369129	23		73621	73650	8421504	3	6,12,5	0,9,24	g	350036912900000121	4-27						Asthma susceptibility locus	Kere	2005	0		
585	chrUn_JH121568	79395	79419	3500152160	24		79395	79419	8421504	1	24	0	c	350015216000000052	19-43						Short Communication A 4 Mb high resolution BAC contig on bovine chromosome 1q12 and comparative analysis with human chromosome 21q22	loads.hindawi.com	0	0		
585	chrUn_JH121568	82976	128505	3500404333	1051		82976	128505	8421504	10	156,144,163,89,72,69,90,63,143,62	0,6917,12877,20345,20841,22653,28177,30429,38728,45467	p,c	350040433300015075,350040433300015081,350040433300015093,350040433300015090,350040433300015025,350040433300015023,350040433300015078,350040433300015088,350040433300015074,350040433300015086,350040433300015022,350040433300015021,350040433300015094,350040433300015079,350040433300015096,350040433300000026,350040433300015092,350040433300015024,350040433300015098,350040433300000030	0-90,0-552,0-783,0-300,0-318,0-396,0-1032,0-537,0-954,0-459,0-276,0-339,0-432,0-495,0-45,0-26,0-201,0-45,0-54,1-23						POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS	Levine	2009	0		
585	chrUn_JH121568	82976	128501	3500086722	1047		82976	128501	8421504	10	156,144,163,89,72,69,90,63,143,58	0,6917,12877,20345,20841,22653,28177,30429,38728,45467	p,c	350008672200015024,350008672200015022,350008672200015078,350008672200015096,350008672200015084,350008672200015093,350008672200015091,350008672200015081,350008672200015077,350008672200015089,350008672200015021,350008672200015020,350008672200015097,350008672200015082,350008672200015099,350008672200000018,350008672200015095,350008672200015023,350008672200015101	0-318,0-396,0-90,0-783,0-552,0-300,0-537,0-1032,0-954,0-459,0-276,0-339,0-432,0-495,0-45,0-26,0-201,0-45,0-54						Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics	Levine	2010	0		
585	chrUn_JH121568	120045	120072	3500013212	23		120045	120072	8421504	2	7,16	0,11	g	350001321200000152	16-42						Compositions and methods for preventing and treating allograft rejection	Bennett	1994	0		
585	chrUn_JH121569	64663	64687	3500055374	23		64663	64687	8421504	2	14,9	0,15	g	350005537400000010	11-34						NOTE TO USERS	www.nlc-bnc.ca	0	0		
585	chrUn_JH121572	27892	27926	3500259903	28		27892	27926	8421504	3	7,10,11	0,10,23	g	350025990300000149	5-33						Vertebrate embryonic pattern-inducing hedgehog-like proteins	Ingham	1995	0		
585	chrUn_JH121572	27892	27926	3500192940	28		27892	27926	8421504	3	7,10,11	0,10,23	g	350019294000000154	5-33						Nucleic acids encoding hedgehog proteins	Ingham	2000	0		
585	chrUn_JH121572	65130	65159	3500013193	25		65130	65159	8421504	3	13,3,9	0,15,20	g	350001319300000084,350001319300000085,350001319300000012,350001319300000013	7-32,0-25,7-32,0-25						VARIABLE DOMAINS OF CAMELID HEAVY-CHAIN ANTIBODIES DIRECTED AGAINST GLIAL FIBRILLARY ACIDIC PROTEINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121576	47400	47514	3500266706	114		47400	47514	8421504	1	114	0	g	350026670600000020	9-123						Novel tracheal antimicrobial peptides	Bevins	1994	0		
585	chrUn_JH121578	29435	50317	3500108622	38		29435	50317	8421504	4	7,12,7,12	0,9,20861,20870	g	350010862200000098,350010862200000215	4-23,15-34						The Impact of Codon Optimization in H5N1 vaccine	.lib.umanitoba.ca	0	0		
585	chrUn_JH121578	37134	37160	3500017463	25		37134	37160	8421504	2	4,21	0,5	g	350001746300000071	20-46						DbpA compositions and methods of use	Guo	2000	0		
585	chrUn_JH121579	76340	76367	3500359256	23		76340	76367	8421504	3	12,6,5	0,13,22	g	350035925600000016	0-26						Identification and molecular characterization of a cyclic-di-GMP effector protein, PlzA (BB0733): additional evidence for the existence of a functional cyclic-di-GMP regulatory network in the Lyme disease spirochete, Borrelia burgdorferi. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH121580	88144	88174	3500217378	27		88144	88174	8421504	2	18,9	0,21	g	350021737800000001	20-47						[27] Engineering Antibody Affinity by Yeast Surface Display	openwetware.org	0	0		
585	chrUn_JH121581	91645	91674	3500206716	28		91645	91674	8421504	2	15,13	0,16	g	350020671600000020	0-28					The American Journal of Pathology	MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma	Jinyan	July	0		
586	chrUn_JH121585	134064	134089	3500052885	25		134064	134089	8421504	1	25	0	c	350005288500000000	0-25						Down-Regulation of Oxytocin-Induced Cyclooxygenase: MATERIALS AND METHODS(5) | Government programs in medicine	acutelogic.com	0	0		
585	chrUn_JH121586	44531	44935	3500084259	100		44531	44935	8421504	2	60,40	0,364	c,g	350008425900000052,350008425900000029,350008425900000008	0-50,5-31,0-40						Human A2B adenosine receptor assay	www.devileye.net	0	0		ADORA1
585	chrUn_JH121586	44531	44727	3500180587	42		44531	44727	8421504	2	21,21	0,175	c	350018058700000015,350018058700000016	0-21,0-21						&#x4e3b;&#x9898;&#xff1a;mice | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		ADORA1
585	chrUn_JH121586	44757	44783	3500021616	26		44757	44783	8421504	1	26	0	c	350002161600000009	0-26						THE ROLE OF A2B ADENOSINE RECEPTOR SIGNALING IN ADENOSINE DEPENDENT LUNG DISEASE	s.library.tmc.edu	0	0		ADORA1
585	chrUn_JH121586	58442	59460	3500309281	40		58442	59460	8421504	2	20,20	0,998	c	350030928100000001,350030928100000000	0-20,0-20		22028429	10.1152/physiolgenomics.00027.2011	1094-8341	Physiological Genomics	Acute milk yield response to frequent milking during early lactation is mediated by genes transiently regulated by milk removal	Wall	2012	3		
585	chrUn_JH121586	58472	67946	3500144585	1077		58472	67946	8421504	11	84,117,183,124,122,6,127,57,202,30,25	0,257,876,1621,4534,6597,6621,7517,8092,9195,9449	p	350014458500015072,350014458500015077,350014458500015075	0-636,0-441,0-441						Palaemonetes_pugio-Contig_381-v1 | MarineGenomics.org	arinegenomics.org	0	0		
585	chrUn_JH121586	63115	66021	3500058276	40		63115	66021	8421504	3	13,7,20	0,1954,2886	c	350005827600000007,350005827600000006	0-20,0-20		15642136	10.1186/ar1471	1478-6354	Arthritis Research & Therapy	Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading	Lorenz	2004	4		
586	chrUn_JH121587	147406	147431	3500326034	23		147406	147431	8421504	2	6,17	0,8	g	350032603400000742	12-38						 Selection Method 	www.docstoc.com	0	0		
585	chrUn_JH121588	67593	67621	3500358757	23		67593	67621	8421504	3	6,6,11	0,8,17	g	350035875700000003,350035875700000002	9-33,4-28		19188258	10.1093/nar/gkp035		Nucleic Acids Research	Human DNA polymerase &#x03b8; possesses 5&#x2032;-dRP lyase activity and functions in single-nucleotide base excision repair in vitro	Rajendra	2009	0		
585	chrUn_JH121592	16199	16228	3500460984	25		16199	16228	8421504	2	18,7	0,22	g	350046098400000069	0-25					Patent	Coordinate in vivo gene expression (Patent US:6995008)	Liu	2006	0		
585	chrUn_JH121592	16199	16228	3500212513	25		16199	16228	8421504	2	18,7	0,22	g	350021251300000069	0-25						Coordinate in vivo gene expression	Liu	1999	0		
585	chrUn_JH121592	16199	16228	3500100644	25		16199	16228	8421504	2	18,7	0,22	g	350010064400000160,350010064400000031	9-34,0-25						Coordinate in vivo gene expression	Liu	1995	0		
585	chrUn_JH121592	108074	108101	3500389666	25		108074	108101	8421504	3	6,4,15	0,7,12	g	350038966600000401	16-43						VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121594	121157	121182	3500323345	23		121157	121182	8421504	2	5,18	0,7	g	350032334500000007	1-25						Gene expression in bovine rumen epithelium during weaning identifies molecular regulators of rumen development and growth	aldc.nal.usda.gov	0	0		
585	chrUn_JH121598	63600	63628	3500253114	24		63600	63628	8421504	2	11,13	0,15	g	350025311400000034	9-34		20028839	10.1105/tpc.109.071282	1040-4651	The Plant Cell Online	The Small Subunit of Snapdragon Geranyl Diphosphate Synthase Modifies the Chain Length Specificity of Tobacco Geranylgeranyl Diphosphate Synthase in Planta	Orlova	2009	9		
585	chrUn_JH121599	64338	64365	3500275614	24		64338	64365	8421504	2	18,6	0,21	g	350027561400000603	9-35						Toxin peptide therapeutic agents	Sullivan	2006	0		
585	chrUn_JH121600	123112	123140	3500222801	27		123112	123140	8421504	2	23,4	0,24	g	350022280100000023	26-53						Preliminary comparative RH mapping between river buffalo chromosome 6 (BBU6) and bovine chromosome 3 (BTA3) - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH121600	123112	123140	3500070560	27		123112	123140	8421504	2	23,4	0,24	g	350007056000000023	26-53						Preliminary radiation hybrid map for river buffalo chromosome 6 and comparison to bovine chromosome 3	ticabovina.com.br	0	0		
585	chrUn_JH121605	102692	102719	3500368140	24		102692	102719	8421504	2	18,6	0,21	g	350036814000000007	5-31						None	aem.asm.org	0	0		
585	chrUn_JH121606	52030	52055	3500118061	25		52030	52055	8421504	1	25	0	g	350011806100000055,350011806100000081	50-75,61-86						Population genetics of dugongs around Australia	prints.jcu.edu.au	0	0		
585	chrUn_JH121610	44542	46733	3500003568	90		44542	46733	8421504	5	19,26,1,20,24	0,1042,1199,1913,2167	c,g	350000356800000004,350000356800000004,350000356800000010,350000356800000013,350000356800000014	3-22,3-22,0-26,0-21,0-24		16585584		0022-1767	The Journal of Immunology	The Bovine CD1 Family Contains Group 1 CD1 Proteins, but No Functional CD1d	Rhijn	2006	6		
585	chrUn_JH121610	46476	46500	3500344377	24		46476	46500	8421504	1	24	0	c	350034437700000002	0-24						Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH121610	97732	100690	3500003568	107		97732	100690	8421504	4	30,22,24,31	0,2009,2264,2927	c	350000356800000000,350000356800000015,350000356800000016,350000356800000001	0-30,0-22,0-24,0-31		16585584		0022-1767	The Journal of Immunology	The Bovine CD1 Family Contains Group 1 CD1 Proteins, but No Functional CD1d	Rhijn	2006	6		
585	chrUn_JH121613	94174	94200	3500160249	23		94174	94200	8421504	2	16,7	0,19	g	350016024900000068	19-43						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THERERIN - Patent application	www.faqs.org	0	0		
585	chrUn_JH121619	97493	97519	3500213088	24		97493	97519	8421504	3	13,5,6	0,14,20	g	350021308800000132	21-45						Canine coronavirus S gene and uses therefor	Miller	2001	0		
585	chrUn_JH121619	115780	115808	3500198087	23		115780	115808	8421504	2	16,7	0,21	g	350019808700000109	10-33						Peptide Vaccine For Influenza Virus 	.freshpatents.com	0	0		
585	chrUn_JH121619	115780	115808	3500022779	23		115780	115808	8421504	2	16,7	0,21	g	350002277900000109	10-33						Attenuated Viruses Useful For Vaccines 	.freshpatents.com	0	0		
585	chrUn_JH121621	73598	73623	3500277171	24		73598	73623	8421504	2	4,20	0,5	g	350027717100000421,350027717100000155,350027717100000371	0-19,0-19,0-22						Therapeutic compositions and methods - Patent application	www.faqs.org	0	0		
585	chrUn_JH121623	61277	61304	3500345538	23		61277	61304	8421504	2	16,7	0,20	g	350034553800000030	0-24						Macromolecular Compositions that Cross the Blood-Brain Barrier and Methods of Use Thereof	Pardridge	2007	0		
585	chrUn_JH121624	62979	63003	3500146501	23		62979	63003	8421504	2	14,9	0,15	g	350014650100000441	0-23					Patent	GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants (Patent CN:1665934)	D*E*A*Fu Luo La Ke 	2010	0		
585	chrUn_JH121625	127635	127658	3500128562	23		127635	127658	8421504	1	23	0	g	350012856200000005	7-30		19240692	10.1038/mt.2009.22		Molecular Therapy: the Journal of the American Society of Gene Therapy	High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma Treatment	Poonam	2009	0		
585	chrUn_JH121628	54619	54653	3500104818	28		54619	54653	8421504	3	8,4,16	0,11,18	g	350010481800000127	17-45						COMPOSITIONS AND METHODS FOR PROTECTION AGAINST CARDIAC AND/OR CENTRAL NERVOUS SYSTEM TISSUE INJURY BY INHIBITING SPHINGOSINE-1-PHOSPHATE LYASE - Patent application	www.faqs.org	0	0		
585	chrUn_JH121628	64985	65048	3500159625	63		64985	65048	8421504	1	63	0	p	350015962500015163	0-63						Methods and compositions to promote bone homeostasis	Tomme	2007	0		SLC2A9
585	chrUn_JH121628	65622	65768	3500194647	95		65622	65768	8421504	2	47,48	0,98	c	350019464700000010,350019464700000008	0-47,0-48						US Patent # 5,427,942. Human D5 dopamine recepltor gene and uses - Patents.com	www.patents.com	0	0		
585	chrUn_JH121633	33287	33315	3500130848	23		33287	33315	8421504	2	6,17	0,11	g	350013084800000817	21-46						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
585	chrUn_JH121641	110498	110527	3500351805	24		110498	110527	8421504	2	8,16	0,13	g	350035180500000005	14-38						Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2	Lemischka	1992	0		
585	chrUn_JH121647	46556	46582	3500130848	23		46556	46582	8421504	2	15,8	0,18	g	350013084800000411	19-43						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
585	chrUn_JH121650	2429	2457	3500328336	24		2429	2457	8421504	3	12,6,6	0,13,22	g	350032833600000229	11-37						US Patent # 5,854,220. Glial mitogenic factors, their preparation and use - Patents.com	www.patents.com	0	0		
585	chrUn_JH121650	99797	102756	3500063033	168		99797	102756	8421504	4	72,6,72,18	0,1553,1571,2941	p	350006303300015019,350006303300015020	0-78,0-90						UNIVERSIDAD COMPLUTENSE DE MADRID	eprints.ucm.es	0	0		
585	chrUn_JH121652	110203	110231	3500164895	23		110203	110231	8421504	2	9,14	0,14	g	350016489500000093	1-35						Kit For Detection Of Telomerase Reverse Transcriptase Nucleic Acids 	.freshpatents.com	0	0		
585	chrUn_JH121654	67724	67751	3500371407	24		67724	67751	8421504	2	13,11	0,16	c	350037140700000027	0-24						170-linked breast and ovarian cancer susceptibility gene	Skolnick	1996	0		
585	chrUn_JH121654	67724	67751	3500048446	24		67724	67751	8421504	2	13,11	0,16	c	350004844600000051	0-24					Patent	Linked breast and ovarian cancer susceptibility gene (Patent US:5709999)	Durocher	1998	0		
585	chrUn_JH121654	67724	67751	3500031485	24		67724	67751	8421504	2	13,11	0,16	c	350003148500000050	0-24					Patent	17q-linked breast and ovarian cancer susceptibility gene (Patent US:5710001)	Futreal	1998	0		
585	chrUn_JH121654	67724	67751	3500006742	24		67724	67751	8421504	2	13,11	0,16	c	350000674200000027	0-24						17q-linked breast and ovarian cancer susceptibility gene	Skolnick	1995	0		
585	chrUn_JH121660	10859	10883	3500147032	24		10859	10883	8421504	1	24	0	g	350014703200000003	0-24		19445670	10.1186/1476-4598-8-28		Molecular Cancer	siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells	Dae	2009	0		
585	chrUn_JH121660	11925	16721	3500260804	40		11925	16721	8421504	2	20,20	0,4776	g	350026080400000001,350026080400000000	0-20,0-20		21104926	10.1002/bdd.731		Biopharmaceutics & drug disposition	Tumor Necrosis Factor Alpha Increases P-glycoprotein Expression in a BME-UV In Vitro Model of Mammary Epithelial Cells	Mohammad		0		
585	chrUn_JH121660	24750	71331	3500286310	53		24750	71331	8421504	2	29,24	0,46557	g	350028631000000008,350028631000000000	0-29,0-24					Patent	P-glycoproteins and uses thereof (Patent EP:1220911)	Crespi	2006	0		
585	chrUn_JH121661	72167	72271	3500400238	43		72167	72271	8421504	5	6,12,6,8,11	0,7,24,80,93	g	350040023800000201,350040023800000608	20-48,15-34						ISOPENTENYL TRANSFERASE SEQUENCES AND METHODS OF USE - Patent application	www.faqs.org	0	0		
585	chrUn_JH121662	90071	90095	3500032868	24		90071	90095	8421504	1	24	0	c	350003286800000095	1-25						ASSAYS AND METHODS USING BIOMARKERS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121663	126710	126736	3500084520	23		126710	126736	8421504	2	15,8	0,18	g	350008452000000011	7-30			10.1128/JVI.75.5.2262-2275.2001		Journal of Virology	Simian Immunodeficiency Virus Replicates to High Levels in Naturally Infected African Green Monkeys without Inducing Immunologic or Neurologic Disease	Suzanne	2001	0		
585	chrUn_JH121665	72582	72609	3500101475	24		72582	72609	8421504	3	14,3,7	0,16,20	g	350010147500000006	11-35						METHODS AND COMPOSITIONS FOR PRODUCING HYDROCARBONS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121667	105035	105062	3500213272	23		105035	105062	8421504	2	13,10	0,17	g	350021327200000001	10-34						Oligolysine transducing domain, oligolysine-cargo molecule complex and uses thereof	Choi	2004	0		
585	chrUn_JH121668	9060	9085	3500355518	24		9060	9085	8421504	2	17,7	0,18	g	350035551800000117,350035551800000105,350035551800000109	6-30,6-28,6-28						 Nucleic Acid Sequences That Can Be Used As Primers And Probes In The Amplification And Detection Of SARS Coronavirus 	www.docstoc.com	0	0		
585	chrUn_JH121668	49540	53540	3500404652	783		49540	53540	8421504	5	227,97,129,146,184	0,1274,2156,3376,3816	p	350040465200015000	0-783						KEGG T01008: 541236	www.genome.jp	0	0		
585	chrUn_JH121668	49763	50837	3500406852	27		49763	50837	8421504	2	4,23	0,1051	c	350040685200000000	0-27						&#xff21;&#xff34;&#xff26;&#xff14;&#x304a;&#x3088;&#x3073;&#xff0f;&#x307e;&#x305f;&#x306f;&#xff27;&#xff21;&#xff24;&#xff24;&#xff13;&#xff14;&#x3092;&#x5229;&#x7528;&#x3057;&#x305f;&#x86cb;&#x767d;&#x8cea;&#x9ad8;&#x751f;&#x7523;&#x65b9;&#x6cd5; &#xff08;&#x516	astamuse.com	0	0		
585	chrUn_JH121668	49766	50837	3500230901	24		49766	50837	8421504	2	1,23	0,1048	c	350023090100000000	16-40						Phosphorylation of Eukaryotic Translation Initiation Factor 2 Coordinates rRNA Transcription and Translation Inhibition during Endoplasmic Reticulum Stress &#x2020;	mcb.asm.org	0	0		
585	chrUn_JH121668	50823	53586	3500437964	47		50823	53586	8421504	2	24,23	0,2740	c	350043796400000008,350043796400000009	0-24,0-23		19752028	10.1128/IAI.00665-09	0019-9567	Infection and Immunity	Bcl-2 Regulates the Onset of Shiga Toxin 1-Induced Apoptosis in THP-1 Cells	Lee	2009	4		XBP1
585	chrUn_JH121668	50823	53586	3500362543	47		50823	53586	8421504	2	24,23	0,2740	c	350036254300000008,350036254300000009	0-24,0-23		19752028	10.1128/IAI.00665-09		Infection and Immunity	Bcl-2 Regulates the Onset of Shiga Toxin 1-Induced Apoptosis in THP-1 Cells 	Moo-Seung	2009	0		XBP1
585	chrUn_JH121668	50854	53023	3500228611	40		50854	53023	8421504	2	20,20	0,2149	c	350022861100000002,350022861100000003	0-20,0-20			10.1152/ajpendo.00265.2006		American Journal of Physiology - Endocrinology and Metabolism	Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic &#x03b2;-cells	Rozance	2007	0		
585	chrUn_JH121668	50854	53023	3500172774	40		50854	53023	8421504	2	20,20	0,2149	c,g	350017277400000002,350017277400000002,350017277400000003,350017277400000003	0-20,0-20,0-20,0-20			10.1152/ajpendo.00265.2006		American Journal of Physiology - Endocrinology and Metabolism	Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic &#x03b2;-cells	Rozance	2007	0		
585	chrUn_JH121668	50854	53023	3500058040	40		50854	53023	8421504	2	20,20	0,2149	c	350005804000000002,350005804000000003	0-20,0-20			10.1152/ajpendo.00265.2006		American Journal of Physiology - Endocrinology and Metabolism	Chronic fetal hypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic &#x03b2;-cells	Rozance	2007	0		
585	chrUn_JH121668	51712	51738	3500444151	26		51712	51738	8421504	1	26	0	c	350044415100000012	0-26		21753146	10.4049/jimmunol.1100297	0022-1767	The Journal of Immunology	Galectin-1 and Galectin-8 Have Redundant Roles in Promoting Plasma Cell Formation	Tsai	2011	6		XBP1
585	chrUn_JH121668	51712	51738	3500219282	26		51712	51738	8421504	1	26	0	c	350021928200000012	0-26						Galectin-1 and Galectin-8 Have Redundant Roles in Promoting Plasma Cell Formation	www.jimmunol.org	0	0		
585	chrUn_JH121668	51712	51738	3500059090	26		51712	51738	8421504	1	26	0	c	350005909000000012	0-26		21753146	10.4049/jimmunol.1100297	0022-1767	The Journal of Immunology	Galectin-1 and Galectin-8 Have Redundant Roles in Promoting Plasma Cell Formation	Tsai	2011	6		
585	chrUn_JH121668	51745	53535	3500261354	40		51745	53535	8421504	2	20,20	0,1770	c	350026135400000000,350026135400000001	0-20,0-20						&#x718a;&#x672c;&#x5927;&#x5b66;&#x5b66;&#x8853;&#x30ea;&#x30dd;&#x30b8;&#x30c8;&#x30ea; Kumamoto University Repository System	.kumamoto-u.ac.jp	0	0		XBP1
585	chrUn_JH121668	52935	53036	3500120607	46		52935	53036	8421504	2	21,25	0,76	c	350012060700000017,350012060700000011,350012060700000018,350012060700000012	0-21,0-21,18-42,21-42						Methods For Treating Endoplasmic Reticulum (ER) Stress Disorders	Urano	2009	0		
585	chrUn_JH121668	52956	53003	3500308939	47		52956	53003	8421504	1	47	0	c	350030893900000004	0-47					Patent	Inhibitors of the unfolded protein response and methods for their use (Patent US:8372861)	Koong	2013	0		
585	chrUn_JH121668	52956	53003	3500283099	47		52956	53003	8421504	1	47	0	c	350028309900000010,350028309900000004	0-47,0-47						INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE AND METHODS FOR THEIR USE - Patent application	www.faqs.org	0	0		
585	chrUn_JH121668	52956	53003	3500246381	47		52956	53003	8421504	1	47	0	c	350024638100000004	0-47						INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE AND METHODS FOR THEIR USE - Patent application	www.faqs.org	0	0		
585	chrUn_JH121668	53060	53378	3500118540	24		53060	53378	8421504	2	2,22	0,296	c	350011854000000003	0-24		21113143	10.1038/cdd.2010.149	1350-9047	Cell Death & Differentiation	HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs	Muller	2010	9		XBP1
585	chrUn_JH121672	22311	22334	3500294542	23		22311	22334	8421504	1	23	0	c	350029454200000046,350029454200000076	19-42,25-48						Alpha-Amylase Variants - Patent application	www.faqs.org	0	0		
585	chrUn_JH121672	22311	22334	3500151740	23		22311	22334	8421504	1	23	0	c	350015174000000076	25-48						Alpha-Amylase Variants - Patent application	www.faqs.org	0	0		
585	chrUn_JH121672	22311	22334	3500074983	23		22311	22334	8421504	1	23	0	c	350007498300000116	19-42						Alpha-amylase mutants with altered properties - US Patent 7713723 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121672	22311	22334	3500004130	23		22311	22334	8421504	1	23	0	c	350000413000000042,350000413000000072	19-42,25-48						Alpha-Amylase Variants - Patent application	www.faqs.org	0	0		
585	chrUn_JH121673	104030	104056	3500004227	23		104030	104056	8421504	3	4,12,7	0,5,19	g	350000422700000105	16-40						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
585	chrUn_JH121676	14832	14856	3500109894	23		14832	14856	8421504	2	4,19	0,5	g	350010989400000001	0-23					Patent	Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus (Patent EP:0314569)	Drillien	1994	0		
585	chrUn_JH121682	87242	87269	3500307426	23		87242	87269	8421504	2	15,8	0,19	g	350030742600000006	1-24						A homologue of the defender against the apoptotic death gene (dad1) in Chlamydomonas cells is downregulated with the onset of programmed cell death	www.ias.ac.in	0	0		
585	chrUn_JH121694	35344	35372	3500083608	23		35344	35372	8421504	2	12,11	0,17	g	350008360800000014	13-36						Interferon-igg fusion	Kishnani	2008	0		
585	chrUn_JH121697	68394	68423	3500215986	24		68394	68423	8421504	2	12,12	0,17	g	350021598600000000	1-25						Electrocardiography repolarization abnormalities are characteristic signs of acute chagasic cardiomyopathy.	vistas.luz.edu.ve	0	0		
585	chrUn_JH121697	68394	68423	3500185917	24		68394	68423	8421504	2	12,12	0,17	g	350018591700000000	1-25		20967289	10.1371/journal.pntd.0000846	1935-2735	PLOS Neglected Tropical Diseases	PLOS Neglected Tropical Diseases: Coinfection with Different Trypanosoma cruzi Strains Interferes with the Host Immune Response to Infection	Rodrigues	2010	0		
585	chrUn_JH121697	68394	68423	3500048737	24		68394	68423	8421504	2	12,12	0,17	g	350004873700000050	1-25						International Journal for Parasitology	005.pasteur.ac.ir	0	0		
585	chrUn_JH121697	68394	68423	3500032241	24		68394	68423	8421504	2	12,12	0,17	g	350003224100000000	1-25		20967289	10.1371/journal.pntd.0000846		PLoS Neglected Tropical Diseases	Coinfection with Different Trypanosoma cruzi Strains Interferes with the Host Immune Response to Infection	Claudiney	2010	0		
585	chrUn_JH121698	20598	24686	3500063369	50		20598	24686	8421504	2	19,31	0,4057	c	350006336900000011,350006336900000001,350006336900000000	0-19,9-29,0-20		10819764	10.1095/biolreprod62.6.1624	0006-3363	Biology of Reproduction	Pregnancy-Associated Bovine and Ovine Glycoproteins Exhibit Spatially and Temporally Distinct Expression Patterns During Pregnancy	Green	2000	4		
585	chrUn_JH121698	20598	24675	3500155081	40		20598	24675	8421504	2	20,20	0,4057	c	350015508100000031,350015508100000008,350015508100000003,350015508100000026	0-20,0-20,9-29,9-29						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
585	chrUn_JH121698	96137	104956	3500191478	1143		96137	104956	8421504	9	150,99,142,117,194,119,118,151,53	0,1852,2038,3861,4898,6256,6473,7550,8766	c	350019147800000038	11-1154						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
585	chrUn_JH121698	96137	104956	3500155081	1143		96137	104956	8421504	9	150,99,142,117,194,119,118,151,53	0,1852,2038,3861,4898,6256,6473,7550,8766	c	350015508100000038	11-1154						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
585	chrUn_JH121698	96137	104956	3500121131	1143		96137	104956	8421504	9	150,99,142,117,194,119,118,151,53	0,1852,2038,3861,4898,6256,6473,7550,8766	c	350012113100000038	11-1154						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121699	43043	43076	3500137897	27		43043	43076	8421504	3	14,5,8	0,15,25	g	350013789700000032,350013789700000054	5-24,12-48						INHIBITORS OF EXTRACELLULAR HSP90 - Patent application	www.faqs.org	0	0		
585	chrUn_JH121705	60569	60596	3500194647	23		60569	60596	8421504	2	14,9	0,18	g	350019464700000016	15-39						US Patent # 5,427,942. Human D5 dopamine recepltor gene and uses - Patents.com	www.patents.com	0	0		
585	chrUn_JH121710	37488	37522	3500230330	26		37488	37522	8421504	3	7,14,5	0,11,29	c	350023033000000305	0-28						Method for obtaining the pathogenic resistance in plants	K-H*Ke Ge Er 	2005	0		
585	chrUn_JH121710	42722	42751	3500236217	25		42722	42751	8421504	3	8,5,12	0,11,17	g	350023621700000236,350023621700000126	19-44,19-44						Anti-A33 antibody	Pian Gang Zhi Lang 	2007	0		
585	chrUn_JH121711	75143	76298	3500139419	32		75143	76298	8421504	2	30,2	0,1153	c	350013941900000000	0-32		7759549	10.1074/jbc.270.21.12899	0021-9258	Journal of Biological Chemistry	Substrate Specificity and Cell Cycle Regulation of the Nek2 Protein Kinase, a Potential Human Homolog of the Mitotic Regulator NIMA of Aspergillus nidulans	Fry	1995	5		NEK2
585	chrUn_JH121713	7710	46434	3500191478	1368		7710	46434	8421504	12	20,20,22,278,99,142,117,194,119,115,151,91	0,6312,7963,29737,31706,31892,33688,34711,36092,36309,37404,38633	c,g	350019147800000029,350019147800000006,350019147800000008,350019147800000031,350019147800000009,350019147800000032,350019147800000007,350019147800000030,350019147800000019,350019147800000035,350019147800000010,350019147800000033	9-29,9-29,0-20,0-20,0-22,0-22,0-21,0-21,2-1311,0-1151,0-23,0-23						US Patent # 6,869,770. Compositions and methods for early pregnancy diagnosis - Patents.com	www.patents.com	0	0		
585	chrUn_JH121713	15673	46434	3500155081	1328		15673	46434	8421504	10	22,278,99,142,117,194,119,115,151,91	0,21774,23743,23929,25725,26748,28129,28346,29441,30670	c,g	350015508100000032,350015508100000009,350015508100000030,350015508100000007,350015508100000019,350015508100000035,350015508100000010,350015508100000033	0-22,0-22,0-21,0-21,2-1311,0-1151,0-23,0-23						Compositions And Methods For Early Pregnancy Diagnosis 	.freshpatents.com	0	0		
585	chrUn_JH121713	37447	46434	3500121131	1306		37447	46434	8421504	9	278,99,142,117,194,119,115,151,91	0,1969,2155,3951,4974,6355,6572,7667,8896	c	350012113100000019,350012113100000035	2-1311,0-1151						COMPOSITIONS AND METHODS FOR EARLY PREGNANCY DIAGNOSIS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121713	37575	44124	3500063369	56		37575	44124	8421504	2	35,21	0,6528	c,g	350006336900000007,350006336900000006,350006336900000010	20-55,9-29,0-21		10819764	10.1095/biolreprod62.6.1624	0006-3363	Biology of Reproduction	Pregnancy-Associated Bovine and Ovine Glycoproteins Exhibit Spatially and Temporally Distinct Expression Patterns During Pregnancy	Green	2000	4		
585	chrUn_JH121714	27379	27405	3500352177	23		27379	27405	8421504	3	5,5,13	0,7,13	c	350035217700000071	15-38						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121714	62095	62651	3500166204	363		62095	62651	8421504	2	20,343	0,213	g	350016620400000091,350016620400000090,350016620400000088	0-20,0-20,1-324						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
585	chrUn_JH121720	43937	43968	3500179421	27		43937	43968	8421504	3	6,13,8	0,8,23	g	350017942100000135,350017942100000147,350017942100000133	18-37,7-43,18-37						SYNTHETIC BIOLOGY TOOLS	Lou	2012	0		
585	chrUn_JH121722	80105	80131	3500209275	24		80105	80131	8421504	2	7,17	0,9	g	350020927500000001	0-24						Autodisplay komplexer Enzyme f&#xfc;r biokatalytische Anwendungen	ni-duesseldorf.de	0	0		
585	chrUn_JH121723	19335	19364	3500450739	25		19335	19364	8421504	2	19,6	0,23	g	350045073900000006	0-27		15604237	10.1158/0008-5472.CAN-04-3620	0008-5472	Cancer Research	Down-Regulation of Regulatory Subunit Type 1A of Protein Kinase A Leads to Endocrine and Other Tumors	Griffin	2004	8		
585	chrUn_JH121723	64889	64913	3500103321	23		64889	64913	8421504	2	9,14	0,10	g	350010332100000062	22-45						Influenza virus vaccine composition and method of use	Evans	2005	0		
585	chrUn_JH121725	4873	4898	3500307751	25		4873	4898	8421504	1	25	0	g	350030775100000010	49-74		18404683	10.1002/ijc.23480	1097-0215	International Journal of Cancer	Estrogen-mediated downregulation of CD24 in breast cancer cells - Kaipparettu - 2008 - International Journal of Cancer - Wiley Online Library	Kaipparettu	2008	0		
585	chrUn_JH121725	8163	8191	3500370232	25		8163	8191	8421504	2	6,19	0,9	g	350037023200000155	4-29						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
585	chrUn_JH121728	24590	30904	3500265346	185		24590	30904	8421504	7	47,27,23,20,12,36,20	0,1806,2367,3502,3618,3845,6294	c	350026534600000044,350026534600000048,350026534600000052,350026534600000061,350026534600000064,350026534600000071	0-47,0-27,24-47,28-48,0-48,28-48						Targeted Therapeutic Proteins - Patent application	www.faqs.org	0	0		
585	chrUn_JH121728	24590	28471	3500380283	145		24590	28471	8421504	5	47,27,23,12,36	0,1806,2367,3618,3845	c	350038028300000051,350038028300000055,350038028300000059,350038028300000071	0-47,0-27,24-47,0-48						TARGETED THERAPEUTIC PROTEINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121728	26399	28474	3500411767	72		26399	28474	8421504	3	24,9,39	0,1812,2036	c	350041176700000014,350041176700000030	0-24,0-48						Recombinant adeno-associated virus virions for the treatment of lysosomal disorders	Podsakoff	2000	0		
585	chrUn_JH121728	30893	30943	3500344439	43		30893	30943	8421504	2	21,22	0,28	c,g	350034443900000015,350034443900000015,350034443900000014,350034443900000014	0-21,0-21,0-22,0-22						Mucopolysaccharidosis type IIIB and GalNAc Transferase double knockout mice and additional studies in gene therapy and animal models to assess pathogenesis and therapy	ib.dr.iastate.edu	0	0		
585	chrUn_JH121729	21504	21534	3500205227	24		21504	21534	8421504	3	12,4,8	0,13,22	g	350020522700000054,350020522700000053	0-24,3-27						Methods And Compositions For Synthesis Of Nucleic Acid Molecules Using Multiple Recognition Sites 	.freshpatents.com	0	0		
585	chrUn_JH121731	35554	35582	3500357729	23		35554	35582	8421504	2	14,9	0,19	g	350035772900000015	0-23			10.1186/1743-422X-2-73	1743-422X	Virology Journal	The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization	Chakraborti	2005	2		
585	chrUn_JH121731	91595	91622	3500113379	24		91595	91622	8421504	2	17,7	0,20	g	350011337900000048	3-27						POLYPEPTIDES OF BOTRYOSPHAERIA RHODINA - Patent application	www.faqs.org	0	0		
585	chrUn_JH121733	93440	93794	3500343411	39		93440	93794	8421504	2	20,19	0,335	g	350034341100000002,350034341100000003	0-20,1-20						Identification of single nucleotide polymorphisms in the agouti signaling protein (ASIP) gene in some goat breeds in tropical and temperate climates. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH121733	93581	93668	3500413148	57		93581	93668	8421504	3	8,22,27	0,9,60	g	350041314800000003	121-179						G&#xe9;n&#xe9;tique de la coloration de la robe chez les bovins : Contribution &#xe0; l&#x2019;&#xe9;tude du r&#xf4;le des g&#xe8;nes de la famille tyrosinase	cations.unilim.fr	0	0		
585	chrUn_JH121735	7546	7572	3500216364	23		7546	7572	8421504	2	6,17	0,9	g	350021636400000048	0-23						US Patent # 5,543,501. Ri T-DNA promoters - Patents.com	www.patents.com	0	0		
585	chrUn_JH121736	71655	71682	3500001368	23		71655	71682	8421504	2	11,12	0,15	g	350000136800000008,350000136800000009	0-23,4-27						Synthesis of polyhydroxyalkanoates in the cytosol of yeast	Zhang	2005	0		
585	chrUn_JH121741	52829	54740	3500070288	42		52829	54740	8421504	3	5,16,21	0,6,1890	g	350007028800000766,350007028800001062	21-42,21-42						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121741	55222	55246	3500446792	24		55222	55246	8421504	1	24	0	c	350044679200000078	22-46						Galectin-11 polypeptides	Ni	2000	0		
585	chrUn_JH121745	40376	40404	3500450703	23		40376	40404	8421504	2	9,14	0,14	g	350045070300000032	2-25						Nucleic acids from rice conferring resistance to bacterial blight disease caused by Xanthomonas spp	Yin	2003	0		
585	chrUn_JH121755	118941	118967	3500096358	24		118941	118967	8421504	2	7,17	0,9	g	350009635800000108	14-38					Patent	Epithelins: novel cysteine-rich growth modulating proteins (Patent US:5416192)	Plowman	1995	0		
585	chrUn_JH121757	29269	29292	3500278114	23		29269	29292	8421504	1	23	0	g	350027811400000079	22-45					Patent	Hog cholera virus vaccine and diagnostic (Patent US:5811103)	Meyers	1998	0		
585	chrUn_JH121759	52951	52976	3500306233	25		52951	52976	8421504	1	25	0	g	350030623300000016	0-25						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		
585	chrUn_JH121759	54409	68479	3500352177	39		54409	68479	8421504	4	15,5,14,5	0,18,14048,14065	g	350035217700000434,350035217700000457	10-30,11-30						FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121762	72034	72062	3500236163	23		72034	72062	8421504	2	12,11	0,17	g	350023616300000018	0-23						Capture probe design for efficient hybridisation	PEYTAVI	2007	0		
585	chrUn_JH121762	72034	72062	3500043431	23		72034	72062	8421504	2	12,11	0,17	g	350004343100000018	0-23						Capture probe design for efficient hybridisation	Peytavi	2006	0		
586	chrUn_JH121765	139349	139373	3500048116	23		139349	139373	8421504	2	17,6	0,18	g	350004811600000453	12-35						 Antibodies Against Gene Products Related To Werner's Syndrome 	www.docstoc.com	0	0		
586	chrUn_JH121765	218220	218244	3500110208	23		218220	218244	8421504	2	9,14	0,10	g	350011020800000015	0-23		21106881	10.1210/me.2010-0353	0888-8809	Molecular Endocrinology	HER2/ErbB2 Receptor Signaling in Rat and Human Prolactinoma Cells: Strategy for Targeted Prolactinoma Therapy	Fukuoka	2011	5		
587	chrUn_JH121765	265041	265067	3500318787	24		265041	265067	8421504	2	5,19	0,7	g	350031878700000059	11-36						Use of bacterial polysaccharides for biofilm inhibition	Da	2009	0		
587	chrUn_JH121765	265041	265067	3500300315	24		265041	265067	8421504	2	5,19	0,7	g	350030031500000059	11-36						USE OF BACTERIAL POLYSACCHARIDES FOR BIOFILM INHIBITION - Patent application	www.faqs.org	0	0		
585	chrUn_JH121766	68160	68189	3500179593	23		68160	68189	8421504	3	11,8,4	0,16,25	g	350017959300000012	0-26						Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants	Song	2009	0		BSN
585	chrUn_JH121767	65629	65658	3500140843	24		65629	65658	8421504	2	16,8	0,21	g	350014084300000000	3-28			10.1091/mbc.E05-10-0990		Molecular Biology of the Cell	Inhibition of Transforming Growth Factor-&#x03b2;1&#x2013;induced Signaling and Epithelial-to-Mesenchymal Transition by the Smad-binding Peptide Aptamer Trx-SARA	Bryan	2006	0		
585	chrUn_JH121772	74881	87189	3500099386	1425		74881	87189	8421504	12	132,249,99,123,80,139,117,152,104,45,136,49	0,2290,2635,2895,3115,5967,6241,7452,7698,8043,8569,12259	p	350009938600015074,350009938600015007,350009938600015037,350009938600015009	0-1425,0-48,0-45,0-51						Assay for Monitoring Activity of Jmjd6	Schofield	2009	0		U2AF2,EPN1
585	chrUn_JH121772	77893	87156	3500335119	204		77893	87156	8421504	5	6,42,4,136,16	0,103,5072,5557,9247	p	350033511900015015,350033511900015009,350033511900015000	0-48,0-132,0-45						A. (2009) Science, 325 (5936), pp. 90-93.	penrepository.com	0	0		U2AF2
585	chrUn_JH121780	20478	20896	3500263194	40		20478	20896	8421504	2	20,20	0,398	c,g	350026319400000000,350026319400000000,350026319400000001	0-20,0-20,0-20						International Buffalo Information Centre	ibic.lib.ku.ac.th	0	0		
585	chrUn_JH121783	28435	28461	3500434928	23		28435	28461	8421504	2	11,12	0,14	g	350043492800000543	3-26						Compositions, methods and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals - Patent application	www.faqs.org	0	0		
585	chrUn_JH121784	11316	11341	3500432783	25		11316	11341	8421504	1	25	0	g	350043278300000018	0-26						AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS	Beirnaert	2009	0		
585	chrUn_JH121785	79900	79925	3500062192	24		79900	79925	8421504	2	8,16	0,9	g	350006219200000115,350006219200000116	7-31,0-24						Methods for assaying homocysteine - US Patent 7192729 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121794	1310	1339	3500286432	24		1310	1339	8421504	2	18,6	0,23	g	350028643200000010	3-32						Effect of Accessory Proteins P19 and P20 on Cytolytic Activity Bacillus thuringiensis Escherichia coli	www.bgu.ac.il	0	0		
585	chrUn_JH121794	40223	43792	3500322234	44		40223	43792	8421504	2	22,22	0,3547	c,g	350032223400000012,350032223400000012,350032223400000013	0-22,0-22,0-22		15534108	10.1158/1078-0432.CCR-04-0485	1078-0432	Clinical Cancer Research	High Expression of PRL-3 Promotes Cancer Cell Motility and Liver Metastasis in Human Colorectal Cancer	Kato	2004	8		PTP4A1
585	chrUn_JH121794	40223	43789	3500227435	339		40223	43789	8421504	4	105,75,44,115	0,1303,2685,3451	p	350022743500015004,350022743500015012	0-180,0-159						The Role of the Protein Tyrosine Phosphatase PRL-3 in Regulating Cell Signaling in Cancerous and Non-Cancerous Cell Lines by DARRELL CHRISTOPHER BESSETTE B.Sc., Simon Fraser University, 1999 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FO	mussenbindery.com	0	0		PTP4A1
585	chrUn_JH121794	40223	43789	3500099141	339		40223	43789	8421504	4	105,75,44,115	0,1303,2685,3451	p	350009914100015004,350009914100015012	0-180,0-159						The Role of the Protein Tyrosine Phosphatase PRL-3 in Regulating Cell Signaling in Cancerous and Non-Cancerous Cell Lines by DARRELL CHRISTOPHER BESSETTE B.Sc., Simon Fraser University, 1999 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FO	mussenbindery.com	0	0		PTP4A1
585	chrUn_JH121794	42010	43711	3500035371	90		42010	43711	8421504	4	29,16,8,37	0,867,934,1664	p	350003537100015119,350003537100015121	0-45,0-45						QUANTITATIVE TEST TO DETECT DISEASE PROGRESSION MARKERS OF EPITHELIAL OVARIAN CANCER PATIENTS - Patent application	www.faqs.org	0	0		PTP4A1
585	chrUn_JH121796	28841	28901	3500348988	60		28841	28901	8421504	1	60	0	p	350034898800015012	0-60			10.1046/j.1432-1033.2002.03191.x	1432-1033	European Journal of Biochemistry	A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo - Henriksson - 2002 - European Journal of Biochemistry - Wiley Online Library	Henriksson	2002	0		WBP5
585	chrUn_JH121797	78780	82238	3500442934	1002		78780	82238	8421504	7	97,118,166,225,147,123,126	0,829,1499,2343,2676,2926,3332	p	350044293400015014	0-1002						Biomolecular sequence alignment and sequence databank search by using publicly available Web tools	me.deib.polimi.it	0	0		
585	chrUn_JH121797	81803	81826	3500078099	23		81803	81826	8421504	1	23	0	c	350007809900000005	0-23			10.1111/j.1365-2249.2006.03188.x	1365-2249	Clinical & Experimental Immunology	Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo - Menzel - 2006 - Clinical & Experimental Immunology - Wiley Online Library	Menzel	2006	0		CTSL1P2
585	chrUn_JH121797	81821	82131	3500196470	23		81821	82131	8421504	3	8,9,6	0,291,304	c	350019647000000064	0-23						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
585	chrUn_JH121798	67850	67879	3500126483	24		67850	67879	8421504	3	12,6,6	0,16,23	g	350012648300001783	0-27						MODULAR NUCLEIC ACID-BASED CIRCUITS FOR COUNTERS, BINARY OPERATIONS, MEMORY, AND LOGIC - Patent application	www.faqs.org	0	0		
585	chrUn_JH121800	24181	32413	3500005314	40		24181	32413	8421504	4	8,13,15,4	0,9,8212,8228	g	350000531400000781,350000531400000315	26-47,18-37						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
585	chrUn_JH121801	16675	16703	3500282252	26		16675	16703	8421504	2	20,6	0,22	g	350028225200000200	3-30						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
585	chrUn_JH121804	33474	33504	3500187973	24		33474	33504	8421504	3	4,12,8	0,5,22	g	350018797300000078	8-33						Tomatoes Having Reduced Polygalacturonase Activity Caused by Non-Transgenic Mutations in the Polygalacturonase Gene - Patent application	www.faqs.org	0	0		
585	chrUn_JH121808	54219	54244	3500465943	24		54219	54244	8421504	2	15,9	0,16	g	350046594300000007	0-24		18593903	10.1158/0008-5472.CAN-07-6655	0008-5472	Cancer Research	Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis	Datta	2008	8		
585	chrUn_JH121810	1420	1445	3500428753	24		1420	1445	8421504	2	13,11	0,14	g	350042875300000030	4-34						 Cloning, Expression, And Uses Of Human Lactoferrin 	www.docstoc.com	0	0		
585	chrUn_JH121810	1420	1445	3500093048	24		1420	1445	8421504	2	13,11	0,14	g	350009304800000029	4-34						Human lactoferrin	Kruzel	2001	0		
585	chrUn_JH121810	65153	65182	3500408649	24		65153	65182	8421504	3	6,10,8	0,7,21	g	350040864900000746	5-29						HBM variants that modulate bone mass and lipid levels	Allen	2008	0		
585	chrUn_JH121810	78553	78580	3500236087	24		78553	78580	8421504	2	13,11	0,16	g	350023608700000027	12-38						Melanocortin receptor polypeptides MC-3, MC-4, and MC-5	Yamada	1996	0		
585	chrUn_JH121811	50	17178	3500269117	59		50	17178	8421504	3	19,20,20	0,15675,17108	c,g	350026911700000009,350026911700000001,350026911700000001,350026911700000000,350026911700000000	0-19,0-20,0-20,0-20,0-20						Inhibition of CYP17 expression by adrenal androgens and transforming growth factor in adrenocortical cells	www.actabp.pl	0	0		
585	chrUn_JH121811	89	15103	3500335613	80		89	15103	8421504	5	20,20,12,8,20	0,81,13954,14501,14994	c,g	350033561300000009,350033561300000008,350033561300000003,350033561300000002	0-20,0-20,0-20,0-20						ScienceDirect.com - Molecular and Cellular Endocrinology - Luteinizing hormone (LH) regulates production of androstenedione and progesterone via control of histone acetylation of StAR and CYP17 promoters in ovarian theca cells	sciencedirect.com	0	0		
585	chrUn_JH121811	13340	13413	3500156475	62		13340	13413	8421504	3	20,21,21	0,29,52	c	350015647500000007,350015647500000008,350015647500000006	0-20,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
585	chrUn_JH121811	13393	13417	3500400144	24		13393	13417	8421504	1	24	0	c	350040014400000001	24-48						Endocrine Characterization of the Reproductive Axis in Highly Prolific Lacaune	ww.biolreprod.org	0	0		
585	chrUn_JH121811	13974	14660	3500375528	42		13974	14660	8421504	2	21,21	0,665	c	350037552800000003,350037552800000002	0-21,0-21						LH-induced ERK Activation Differently Modulates Progesterone and Androstenedione Production in Bovine Theca Cells.	.endojournals.org	0	0		
585	chrUn_JH121811	13974	14660	3500075026	42		13974	14660	8421504	2	21,21	0,665	c,g	350007502600000001,350007502600000001,350007502600000000	0-21,0-21,0-21		19917087	10.1186/1757-2215-2-17		Journal of Ovarian Research	Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells	Shin	2009	0		
585	chrUn_JH121811	14048	14663	3500126808	42		14048	14663	8421504	3	7,13,22	0,542,593	c	350012680800000005,350012680800000004	0-20,0-22						1 FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle	uction-online.org	0	0		
585	chrUn_JH121811	14694	16757	3500269115	44		14694	16757	8421504	3	17,5,22	0,18,2041	c,g	350026911500000031,350026911500000032,350026911500000032	0-22,0-22,0-22					Patent	Souches de levures produisant des steroides de facon autonome (Patent EP:1385980)	Achstetter	2010	0		
585	chrUn_JH121811	15091	15754	3500170319	73		15091	15754	8421504	3	24,23,26	0,47,637	c	350017031900000000,350017031900000002,350017031900000004,350017031900000001,350017031900000003	0-24,0-23,0-22,0-26,0-25						ScienceDirect.com - General and Comparative Endocrinology - The bovine genome contains three differentially methylated paralogous copies of the P450c17 encoding gene (CYP17A1)	sciencedirect.com	0	0		
585	chrUn_JH121811	16716	16762	3500156793	45		16716	16762	8421504	2	26,19	0,27	c	350015679300000002,350015679300000000	0-26,0-19		18616460	10.1111/j.1742-4658.2008.06539.x	1742-4658	FEBS Journal	Two CYP17 genes in the South African Angora goat (Capra hircus) &#x2013; the identification of three genotypes that differ in copy number and steroidogenic output - Storbeck - 2008 - FEBS Journal - Wiley Online Library	Storbeck	2008	0		
585	chrUn_JH121811	16845	17160	3500196808	39		16845	17160	8421504	2	20,19	0,296	c	350019680800000003,350019680800000002	0-20,0-19		16731777	10.1677/joe.1.06278	0022-0795	Journal of Endocrinology	Effect of copper and thiomolybdates on bovine theca cell differentiation in vitro	Kendall	2006	4		
585	chrUn_JH121811	16847	17160	3500055961	40		16847	17160	8421504	2	20,20	0,293	c	350005596100000001,350005596100000000	0-20,0-20		20699380	10.1530/REP-10-0214	1470-1626	Reproduction	Evidence that high variation in antral follicle count during follicular waves is linked to alterations in ovarian androgen production in cattle	Mossa	2010	3		
585	chrUn_JH121811	17261	19197	3500438452	111		17261	19197	8421504	4	6,24,36,45	0,1608,1812,1891	c	350043845200000012,350043845200000013,350043845200000073,350043845200000071	0-30,0-36,0-31,0-43						Process for oxidation of steroids and genetically engineered cells used therein	Slijkhuis	1998	0		
585	chrUn_JH121811	18983	19008	3500202290	25		18983	19008	8421504	1	25	0	c	350020229000000003	0-25		12915688	10.1210/jc.2003-030154	0021-972X	Journal of Clinical Endocrinology & Metabolism	Isolation of Definitive Zone and Chromaffin Cells Based upon Expression of CD56 (Neural Cell Adhesion Molecule) in the Human Fetal Adrenal Gland	Muench	2003	6		
585	chrUn_JH121815	42854	42878	3500286508	23		42854	42878	8421504	2	12,11	0,13	g	350028650800000101	9-32						METHODS AND COMPOSITIONS RELATED TO FATTY ALCOHOL BIOSYNTHETIC ENZYMES	Schirmer	2011	0		
585	chrUn_JH121819	50028	50052	3500298705	24		50028	50052	8421504	1	24	0	g	350029870500000022	0-24		14699072	10.1091/mbc.E03-06-0360	1059-1524	Molecular Biology of the Cell	Estradiol and Selective Estrogen Receptor Modulators Differentially Regulate Target Genes with Estrogen Receptors &#x03b1; and &#x03b2;	Tee	2004	5		KRT17
585	chrUn_JH121830	32663	32693	3500235183	27		32663	32693	8421504	2	22,5	0,25	g	350023518300000275	15-44						The high bone mass gene of 11q13.3	J*P*Qia Lu Li 	2003	0		
585	chrUn_JH121831	60232	60258	3500376795	25		60232	60258	8421504	2	18,7	0,19	g	350037679500000018	16-41						Recombinant plant expressing non-competitively binding insecticidal crystal proteins	Mellaert	1995	0		
585	chrUn_JH121833	56472	56618	3500001762	62		56472	56618	8421504	3	36,7,19	0,50,127	g	350000176200000148,350000176200000058	116-244,0-20						DNA profiling of captive Roseate Spoonbill (Ajaia ajaja) populations as a mechanism of determining lineage in colonial nesting birds.	l.library.unt.edu	0	0		
585	chrUn_JH121833	73813	73840	3500318678	24		73813	73840	8421504	3	5,12,7	0,7,20	g	350031867800000063,350031867800000062,350031867800000025,350031867800000024	5-33,9-37,5-33,9-37						MUTANT FORMS OF STREPTOLYSIN O - Patent application	www.faqs.org	0	0		
585	chrUn_JH121835	5035	5059	3500155900	23		5035	5059	8421504	2	14,9	0,15	g	350015590000000093	14-37						Method For The Production By Fermentation Of Sulphur-containing Fine Chemicals (metf) 	.freshpatents.com	0	0		
585	chrUn_JH121835	91590	91617	3500413058	23		91590	91617	8421504	3	13,5,5	0,14,22	g	350041305800000001	3-26						Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom	Kufe	2002	0		
585	chrUn_JH121835	91590	91617	3500319582	23		91590	91617	8421504	3	13,5,5	0,14,22	g	350031958200000001	3-26						MUC1 EXTRACELLULAR DOMAIN AND CANCER TREATMENT COMPOSITIONS AND METHODS DERIVED THEREFROM - Patent application	www.faqs.org	0	0		
585	chrUn_JH121835	91590	91617	3500294399	23		91590	91617	8421504	3	13,5,5	0,14,22	g	350029439900000001	3-26						Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom	Kufe	2002	0		
585	chrUn_JH121835	91590	91617	3500036217	23		91590	91617	8421504	3	13,5,5	0,14,22	g	350003621700000057	3-26						MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom	Kufe	2004	0		
585	chrUn_JH121835	91590	91617	3500007071	23		91590	91617	8421504	3	13,5,5	0,14,22	g	350000707100000001	3-26						Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom	Kufe	2003	0		
585	chrUn_JH121835	91590	91617	3500001280	23		91590	91617	8421504	3	13,5,5	0,14,22	g	350000128000000057	3-26						MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom	Kufe	2005	0		
586	chrUn_JH121836	153290	153316	3500282252	23		153290	153316	8421504	2	10,13	0,13	g	350028225200000667	2-29						Group B streptococcus antigens	B*R*Bu Luo Duo Yi Er 	2007	0		
586	chrUn_JH121836	190888	190911	3500458771	23		190888	190911	8421504	1	23	0	c	350045877100000001	0-23		17047096	10.1124/mol.106.027250	1521-0111 (Online)	Molecular Pharmacology	Characterization of the Tritium-Labeled Analog of L-threo-&#x03b2;-Benzyloxyaspartate Binding to Glutamate Transporters	Shimamoto	2007	0		SLC1A6
586	chrUn_JH121836	190901	197479	3500438816	543		190901	197479	8421504	5	180,1,135,195,32	0,183,2425,5099,6546	p	350043881600015223,350043881600015212,350043881600015199	0-180,0-186,0-177						Caracterizaci&#xf3;n de transportadores de amino&#xe1;cidos en Echinococcus granulosus	al.bl.fcen.uba.ar	0	0		SLC1A6
586	chrUn_JH121836	216406	216429	3500171513	23		216406	216429	8421504	1	23	0	c	350017151300000038	0-23						Compositions and Methods of Use of Mitogen-Activated Protein Kinase Kinase Kinase - Patent application	www.faqs.org	0	0		
586	chrUn_JH121836	237681	237711	3500157593	26		237681	237711	8421504	2	19,7	0,23	c	350015759300000025	5-32						Modified Vitamin K Dependent Polypeptides	Weimer	2009	0		
585	chrUn_JH121847	24410	24436	3500329012	23		24410	24436	8421504	3	7,12,4	0,9,22	g	350032901200000009,350032901200000008	2-25,0-23		19884383	10.1210/me.2009-0302	0888-8809	Molecular Endocrinology	Peroxisome Proliferator-Activated Receptor &#x03b3; Coactivator-1&#x03b1; Interacts with the Androgen Receptor (AR) and Promotes Prostate Cancer Cell Growth by Activating the AR	Shiota	2010	5		
586	chrUn_JH121850	138700	138723	3500004227	23		138700	138723	8421504	1	23	0	g	350000422700001045	0-36						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
585	chrUn_JH121851	57608	57635	3500151970	24		57608	57635	8421504	3	13,6,5	0,14,22	g	350015197000000016	0-24			10.1371/journal.pbio.0030315	1545-7885	PLOS Biology	PLOS Biology: Lack of Support for the Association between GAD2 Polymorphisms and Severe Human Obesity	Swarbrick	2005	0		
585	chrUn_JH121853	10932	10957	3500251828	23		10932	10957	8421504	2	6,17	0,8	g	350025182800000368	5-31						Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis - Patent application	www.faqs.org	0	0		
585	chrUn_JH121857	6264	6293	3500089192	29		6264	6293	8421504	1	29	0	g	350008919200000030	0-29						 Recombinant Soluble Epoxide Hydrolase 	www.docstoc.com	0	0		
585	chrUn_JH121858	20152	51247	3500300591	39		20152	51247	8421504	3	19,13,7	0,31072,31088	g	350030059100000597,350030059100000647	3-22,28-48						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
585	chrUn_JH121865	15070	15097	3500371981	23		15070	15097	8421504	2	8,15	0,12	g	350037198100000006	12-35		11349076	10.1128/IAI.69.6.4055-4064.2001	0019-9567	Infection and Immunity	Coiled-Coil Domain of Enteropathogenic Escherichia coli Type III Secreted Protein EspD Is Involved in EspA Filament-Mediated Cell Attachment and Hemolysis	Daniell	2001	4		
585	chrUn_JH121868	26240	26268	3500456297	23		26240	26268	8421504	2	10,13	0,15	c	350045629700000003	10-33			10.1093/nar/gkl624		Nucleic Acids Research	Inducible microRNA expression by an all-in-one episomal vector system	Alexey	2006	0		
585	chrUn_JH121868	26240	26268	3500292857	23		26240	26268	8421504	2	10,13	0,15	c	350029285700000003	10-33						Inducible microRNA expression by an all-in-one episomal vector system.	.biomedsearch.com	0	0		
585	chrUn_JH121868	26240	26268	3500054707	23		26240	26268	8421504	2	10,13	0,15	c	350005470700000006	10-33						Analysis of c-MYC-induced chromosomal instability	b.uni-muenchen.de	0	0		
586	chrUn_JH121868	144773	144821	3500384310	48		144773	144821	8421504	1	48	0	p	350038431000015043	0-48						Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions	Koster	2011	0		CBLN1
585	chrUn_JH121869	57540	57567	3500043447	24		57540	57567	8421504	3	7,5,12	0,8,15	g	350004344700000000	10-34		16537600	10.1128/JVI.80.7.3332-3340.2006	0022-538X	Journal of Virology	Effect of Hepatitis C Virus (HCV) NS5B-Nucleolin Interaction on HCV Replication with HCV Subgenomic Replicon	Shimakami	2006	5		
585	chrUn_JH121871	62107	62136	3500096613	24		62107	62136	8421504	2	14,10	0,19	g	350009661300000098	19-44						US Patent # 6,638,734. Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto - Patents.com	www.patents.com	0	0		
585	chrUn_JH121872	62899	62926	3500116463	23		62899	62926	8421504	3	6,4,13	0,9,14	g	350011646300000006	7-30						A simple protocol for the extraction and sequence analysis of DNA from study skin of museum collections	www.scielo.br	0	0		
585	chrUn_JH121876	74727	74757	3500362522	28		74727	74757	8421504	2	5,23	0,7	g	350036252200000053	9-38						Cellular permissivity factor for viruses and uses thereof	Calvert	2011	0		
585	chrUn_JH121876	74730	75098	3500455991	366		74730	75098	8421504	2	351,15	0,353	g	350045599100000021	159-527						Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays - Patent application	www.faqs.org	0	0		
585	chrUn_JH121876	74733	75098	3500245052	363		74733	75098	8421504	2	348,15	0,350	g	350024505200000000	31-397						Gene therapy for treatment of cancer	Lu	2000	0		
585	chrUn_JH121876	74735	75098	3500394735	361		74735	75098	8421504	2	346,15	0,348	g	350039473500000014	131-499						Cellular immunogens useful as cancer vaccines	England	1999	0		
585	chrUn_JH121876	74735	75098	3500063762	361		74735	75098	8421504	2	346,15	0,348	g	350006376200000014	131-499						Cellular immunogens useful as cancer vaccines	England	1997	0		
585	chrUn_JH121876	74735	75081	3500305536	188		74735	75081	8421504	2	105,83	0,263	g	350030553600000010,350030553600000004	294-483,286-475						Glycosylation in avians - Patent application	www.faqs.org	0	0		
585	chrUn_JH121876	74735	75081	3500305328	188		74735	75081	8421504	2	105,83	0,263	g	350030532800000006,350030532800000010	655-844,650-839						AVIAN DERIVED FUSION PROTEINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121876	74739	74764	3500258315	25		74739	74764	8421504	1	25	0	g	350025831500000007	0-25					Patent	Nucleic acid and amino acid sequences for mammalian sulfonylurea receptor (Patent US:6054313)	Bryan	2000	0		
585	chrUn_JH121876	74759	74789	3500021958	30		74759	74789	8421504	1	30	0	g	350002195800000011	0-30						FLUORESCENT GFP VARIANT DISPLAYING HIGHLY INCREASED FLUORESCENCE INTENSITY WITHOUT A SPECTRAL SHIFT	Buerstedde	2008	0		
585	chrUn_JH121876	74759	74789	3500003209	30		74759	74789	8421504	1	30	0	g	350000320900000011,350000320900000029	0-30,0-30						FLUORESCENT GFP VARIANT DISPLAYING HIGHLY INCREASED FLUORESCENCE INTENSITY WITHOUT A SPECTRAL SHIFT - Patent application	www.faqs.org	0	0		
585	chrUn_JH121876	74768	74999	3500068995	221		74768	74999	8421504	3	6,143,72	0,7,159	g	350006899500000098,350006899500000000	68-423,97-423						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
585	chrUn_JH121876	74769	74793	3500210268	24		74769	74793	8421504	1	24	0	g	350021026800000000	7-31		22334016	10.1038/mt.2011.309	1525-0016	Molecular Therapy	Alpharetroviral Self-inactivating Vectors: Long-term Transgene Expression in Murine Hematopoietic Cells and Low Genotoxicity	Suerth	2012	7		
585	chrUn_JH121876	74770	74998	3500149537	41		74770	74998	8421504	2	20,21	0,207	g	350014953700000006,350014953700000005	0-20,11-32		18787211	10.1634/stemcells.2008-0258	1549-4918	STEM CELLS	Combinatorial Incorporation of Enhancer-Blocking Components of the Chicken &#x03b2;-Globin 5&#x2032;HS4 and Human T-Cell Receptor &#x03b1;/&#x03b4; BEAD-1 Insulators in Self-Inactivating Retroviral Vectors Reduces Their Genotoxic Potential - Ramezani - 20	Ramezani	2008	0		
585	chrUn_JH121876	74878	74901	3500381985	23		74878	74901	8421504	1	23	0	g	350038198500000002	0-23						Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography	Chiorini	2002	0		
585	chrUn_JH121876	74878	74901	3500352263	23		74878	74901	8421504	1	23	0	g	350035226300000001	0-23		11435568	10.1128/JVI.75.15.6884-6893.2001	0022-538X	Journal of Virology	Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity	Kaludov	2001	5		
585	chrUn_JH121876	74878	74901	3500343022	23		74878	74901	8421504	1	23	0	g	350034302200000002	0-23						US Patent # 7,419,817. Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography - Patents.com	www.patents.com	0	0		
585	chrUn_JH121876	74973	74998	3500054603	25		74973	74998	8421504	1	25	0	g	350005460300000003,350005460300000018	6-31,6-31						Plasmid vector comprising a retroviral integrase gene and an integrase recognition region - US Patent 6936465 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121876	74995	75081	3500396186	86		74995	75081	8421504	1	86	0	g	350039618600000046	20-106						Compositions and Methods for the Delivery of Biologically Active RNAs	Polach	2012	0		
585	chrUn_JH121877	49497	49522	3500298532	23		49497	49522	8421504	2	8,15	0,10	c	350029853200000036	10-33						 Biocatalyst Inhibitors 	www.docstoc.com	0	0		
585	chrUn_JH121881	21025	21052	3500200895	25		21025	21052	8421504	2	19,6	0,21	g	350020089500000153	1-26						 Chemoreceptors In Plant Parasitic Nematodes 	www.docstoc.com	0	0		
585	chrUn_JH121894	42831	42856	3500411827	24		42831	42856	8421504	2	5,19	0,6	g	350041182700000042	21-45						Protein targeting to glycogen	Brady	1999	0		
585	chrUn_JH121895	11486	11517	3500304804	30		11486	11517	8421504	2	7,23	0,8	g	350030480400000017	38-74						Antibody specificity transfer using minimal essential binding determinants	Flynn	2007	0		
585	chrUn_JH121895	11486	11517	3500029370	30		11486	11517	8421504	2	7,23	0,8	g	350002937000000017	38-74						Antibody specificity transfer using minimal essential binding determinants	Flynn	2005	0		
585	chrUn_JH121895	11494	11517	3500179612	23		11494	11517	8421504	1	23	0	g	350017961200000011,350017961200000039	0-21,18-41						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2010	0		
585	chrUn_JH121895	11494	11517	3500086937	23		11494	11517	8421504	1	23	0	g	350008693700000011	0-23					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent US:7740852)	Bakker	2010	0		
585	chrUn_JH121895	28870	29064	3500321807	51		28870	29064	8421504	3	32,9,10	0,33,184	g	350032180700000213	0-194						GENERATION, CHARACTERIZATION AND USES THEREOF OF ANTI-NOTCH3 ANTIBODIES - MERCK SHARP & DOHME CORP.	www.sumobrain.com	0	0		
585	chrUn_JH121895	28870	28893	3500360747	23		28870	28893	8421504	1	23	0	g	350036074700000071	0-23						B-7 related nucleic acids and polypeptides useful for immunomodulation	Mikesell	2011	0		
585	chrUn_JH121895	28870	28893	3500252049	23		28870	28893	8421504	1	23	0	g	350025204900000258,350025204900000104	0-23,0-23						METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS - Patent application	www.faqs.org	0	0		
585	chrUn_JH121895	28870	28893	3500079998	23		28870	28893	8421504	1	23	0	g	350007999800000023	0-23						Antibodies that immunospecifically bind to trail receptors	Albert	2005	0		
585	chrUn_JH121895	73118	73141	3500155813	23		73118	73141	8421504	1	23	0	g	350015581300000058	0-23						POLY-N-ACETYL GLUCOSAMINE (PNAG/DPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH121899	68895	68918	3500337543	23		68895	68918	8421504	1	23	0	g	350033754300000071,350033754300000075	18-41,18-41						Process for allele discrimination utilizing primer extension	Abarzua	2001	0		
585	chrUn_JH121903	20586	20615	3500196470	25		20586	20615	8421504	3	5,5,15	0,8,14	g	350019647000000033	10-37						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
585	chrUn_JH121903	24115	24140	3500064129	23		24115	24140	8421504	3	4,4,15	0,5,10	g	350006412900000653	16-39						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"> <HTML> <HEAD> <META http-equiv="Cont	e.dna.affrc.go.jp	0	0		
585	chrUn_JH121903	65640	65676	3500061438	28		65640	65676	8421504	3	8,5,15	0,11,21	g	350006143800000019	15-43						Method for detection of metastatic prostate cancer	Klee	1998	0		
585	chrUn_JH121906	19507	24877	3500141481	285		19507	24877	8421504	6	78,60,24,80,31,12	0,479,548,744,4821,5358	p	350014148100015030,350014148100015040	0-138,0-147						A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2	dlab.stanford.edu	0	0		FGD1
585	chrUn_JH121906	28917	28940	3500393986	23		28917	28940	8421504	1	23	0	c	350039398600000111	19-42						US Patent # 6,942,865. Methods and reagents to detect and characterize norwalk and related viruses - Patents.com	www.patents.com	0	0		
585	chrUn_JH121916	61843	61874	3500028061	26		61843	61874	8421504	3	13,7,6	0,16,25	g	350002806100000191	17-48						Surface proteins of leptospira	www.devileye.net	0	0		
585	chrUn_JH121923	36523	36548	3500408830	25		36523	36548	8421504	1	25	0	g	350040883000000004	0-25						Prenatal bovine sex determination using male-specific oligonucleotides	Gingeras	1990	0		
585	chrUn_JH121931	6160	6184	3500196109	23		6160	6184	8421504	2	16,7	0,17	g	350019610900000010	0-23		23861783	10.1371/journal.pone.0067693	1932-6203	PLOS ONE	PLOS ONE: Lipocalin-2 Expressed in Innate Immune Cells Is an Endogenous Inhibitor of Inflammation in Murine Nephrotoxic Serum Nephritis	Eller	2013	4		
585	chrUn_JH121934	46168	46194	3500288483	24		46168	46194	8421504	3	13,5,6	0,14,20	g	350028848300000026	0-24		20181750	10.1104/pp.110.153569		Plant Physiology	AtNUDX6, an ADP-Ribose/NADH Pyrophosphohydrolase in Arabidopsis, Positively Regulates NPR1-Dependent Salicylic Acid Signaling	Kazuya	2010	0		
585	chrUn_JH121934	46168	46194	3500092363	24		46168	46194	8421504	3	13,5,6	0,14,20	g	350009236300000026	0-24		20181750	10.1104/pp.110.153569	0032-0889	Plant Physiology	AtNUDX6, an ADP-Ribose/NADH Pyrophosphohydrolase in Arabidopsis, Positively Regulates NPR1-Dependent Salicylic Acid Signaling	Ishikawa	2010	7		
585	chrUn_JH121940	17914	17937	3500291921	23		17914	17937	8421504	1	23	0	g	350029192100000088	0-23						DOWN-REGULATION OF MORTALIN BY siRNA - Patent application	www.faqs.org	0	0		
585	chrUn_JH121941	39177	39206	3500017032	23		39177	39206	8421504	3	6,4,13	0,11,16	g	350001703200000004	0-24						Glucanosyl transferase-1 protein useful for immunization against Coccidioides spp.	Cole	2003	0		
585	chrUn_JH121943	63063	63090	3500344773	23		63063	63090	8421504	2	15,8	0,19	g	350034477300000003	0-23						TARGETING OF TRIACYLCLYCEROL SYNTHASE GENE FOR TUBERCULOSIS TREATMENT - Patent application	www.faqs.org	0	0		
585	chrUn_JH121945	54957	54983	3500139377	23		54957	54983	8421504	2	10,13	0,13	g	350013937700000001	0-23						Recombinant avian paramyxovirus vaccine and method for making and using thereof	Bublot	2011	0		
585	chrUn_JH121948	32150	32177	3500366346	23		32150	32177	8421504	2	10,13	0,14	g	350036634600000005	1-24		20167130	10.1186/1476-4598-9-39	1476-4598	Molecular Cancer	Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks	Tabu	2010	4		
585	chrUn_JH121955	30811	31014	3500140018	81		30811	31014	8421504	3	14,45,22	0,33,181	g	350014001800000270	7-215						Method for linking sequences of interest	M*B*Ao Lie Ke Xi Wei Qi 	2006	0		
585	chrUn_JH121955	30813	30901	3500321366	71		30813	30901	8421504	2	17,54	0,34	g	350032136600000007,350032136600000001,350032136600000000,350032136600000002,350032136600000009,350032136600000008	0-89,0-89,0-89,0-89,0-89,0-89						Antibodies	ELLIS	2005	0		
585	chrUn_JH121955	30813	30901	3500129978	71		30813	30901	8421504	2	17,54	0,34	g	350012997800000006	0-89						Humanised Anti-MAG Antibody or Functional Fragment Thereof	Ellis	2009	0		
585	chrUn_JH121955	30813	30901	3500031118	71		30813	30901	8421504	2	17,54	0,34	g	350003111800000020,350003111800000006,350003111800000007,350003111800000008,350003111800000019,350003111800000018	0-89,0-89,0-89,0-89,0-89,0-89						Humanised Anti-MAG Antibody or Functional Fragment Thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH121955	30847	30901	3500447499	54		30847	30901	8421504	1	54	0	g	350044749900000003	13-67						Humanized Anti-HLA-DR Antibodies	Goldenberg	2010	0		
585	chrUn_JH121955	30847	30901	3500185250	54		30847	30901	8421504	1	54	0	g	350018525000000003,350018525000000013	13-67,13-67						Humanized Anti-HLA-DR Antibodies - Patent application	www.faqs.org	0	0		
585	chrUn_JH121955	30847	30901	3500181965	54		30847	30901	8421504	1	54	0	g	350018196500000000	13-67						Humanized L243 antibodies	Goldenberg	2006	0		
585	chrUn_JH121955	30847	30901	3500043083	54		30847	30901	8421504	1	54	0	g	350004308300000000,350004308300000040	13-67,13-67						Humanized L243 Antibodies - Patent application	www.faqs.org	0	0		
585	chrUn_JH121955	30851	30889	3500423248	38		30851	30889	8421504	1	38	0	g	350042324800000043	7-45						Method for producing polymers having a preselected activity	Lerner	2000	0		
585	chrUn_JH121955	30851	30889	3500260552	38		30851	30889	8421504	1	38	0	g	350026055200000082	7-45						US Patent # 6,969,586. Method for tapping the immunological repertoire - Patents.com	www.patents.com	0	0		
585	chrUn_JH121955	30851	30889	3500027157	38		30851	30889	8421504	1	38	0	g	350002715700000043	7-45						US Patent # 6,680,192. Method for producing polymers having a preselected activity - Patents.com	www.patents.com	0	0		
585	chrUn_JH121955	30852	30889	3500236616	37		30852	30889	8421504	1	37	0	g	350023661600000223	0-37					Patent	Multispecific deimmunized CD3-binders (Patent CN:100453556)	A*A*Han Mi Er Dun 	2009	0		
585	chrUn_JH121955	30857	30889	3500118920	32		30857	30889	8421504	1	32	0	g	350011892000000020	0-32						Expression and use of anti-CD20 antibodies - US Patent 7381560 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121955	30863	31015	3500164738	66		30863	31015	8421504	3	27,11,28	0,58,124	g	350016473800000026	42-198						AGENTS FOR HCV TREATMENT - Patent application	www.faqs.org	0	0		
585	chrUn_JH121955	30863	31015	3500144057	89		30863	31015	8421504	3	27,19,43	0,50,109	g	350014405700000082,350014405700000078	42-198,92-195						HCV neutralizing epitopes - Patent application	www.faqs.org	0	0		
585	chrUn_JH121955	30863	30889	3500058960	26		30863	30889	8421504	1	26	0	g	350005896000000035	0-26						Humanized anti-CD19 antibodies - US Patent 7109304 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121955	30991	31014	3500034531	23		30991	31014	8421504	1	23	0	g	350003453100000045	0-23						Human monoclonal antibodies to epidermal growth factor receptor - US Patent 7807798 Description	ww.patentstorm.us	0	0		
585	chrUn_JH121955	31055	31097	3500404342	35		31055	31097	8421504	2	13,22	0,20	g	350040434200000051	10-51						US Patent # 7,279,160. Combinations of DR5 antibodies and other therapeutic agents - Patents.com	www.patents.com	0	0		
585	chrUn_JH121959	20276	20300	3500373949	24		20276	20300	8421504	1	24	0	g	350037394900000032	8-33						Cellulases	Abad	1998	0		
585	chrUn_JH121959	24074	24100	3500099271	23		24074	24100	8421504	2	12,11	0,15	g	350009927100000006	0-23						Generation of single-strand circular dna from linear self-annealing segments	Abarz	2002	0		
585	chrUn_JH121971	7360	7383	3500202750	23		7360	7383	8421504	1	23	0	g	350020275000000024	0-23						Granuphilin is activated by SREBP-1c and involved in impaired insulin secretion in diabetic mice	.researchgate.net	0	0		
585	chrUn_JH121980	14609	14637	3500399264	24		14609	14637	8421504	2	13,11	0,17	g	350039926400000005	9-33						Elevation of oil levels in brassica plants	Savage	2005	0		
585	chrUn_JH121989	19746	19772	3500187007	23		19746	19772	8421504	2	10,13	0,13	g	350018700700000003,350018700700000002	1-24,8-31		23907458	10.1038/cddis.2013.252	false	Cell Death & Disease	Wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to &#x03b3;-radiation	Song	2013	0		
585	chrUn_JH121990	10775	10798	3500266119	23		10775	10798	8421504	1	23	0	g	350026611900000002	0-23						Discovery and pro&#xfb01;ling of bovine microRNAs from immune-related and embryonic tissues	cs.physiology.org	0	0		SETD4
585	chrUn_JH121990	10776	10799	3500198578	23		10776	10799	8421504	1	23	0	g	350019857800000004	0-23		20558762	10.1152/ajpgi.00120.2010		American Journal of Physiology - Gastrointestinal and Liver Physiology	miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells	Sansom	2010	0		SETD4
586	chrUn_JH121998	218151	218174	3500234734	23		218151	218174	8421504	1	23	0	g	350023473400000038	1-24						A conserved human T cell population targets mycobacterial antigens presented by CD1b. - ResearchGate	.researchgate.net	0	0		
586	chrUn_JH121998	218151	218174	3500062329	23		218151	218174	8421504	1	23	0	g	350006232900000221	3-26						ISOLATION OF UNKNOWN REARRANGED T-CELL RECEPTORS FROM SINGLE CELLS - Patent application	www.faqs.org	0	0		
585	chrUn_JH122000	25665	26336	3500272162	48		25665	26336	8421504	2	44,4	0,667	c	350027216200000055	0-48						Isociatrate dehydrogenase and uses therof - Patent application	www.faqs.org	0	0		
585	chrUn_JH122000	37233	37259	3500063338	25		37233	37259	8421504	2	4,21	0,5	g	350006333800000061	10-35						Methods for producing polypeptides in protease-deficient mutants of trichoderma	A.Zhan 	2012	0		
585	chrUn_JH122004	47766	49665	3500284706	38		47766	49665	8421504	2	19,19	0,1880	c,g	350028470600000060,350028470600000060,350028470600000062	0-19,0-19,0-19						The Embo Journal	005.pasteur.ac.ir	0	0		NOVA1
585	chrUn_JH122017	40703	40728	3500063738	24		40703	40728	8421504	2	20,4	0,21	g	350006373800000004	5-29						NOVEL MutS PROTEIN AND METHOD OF USING SAME TO DETERMINE MUTATIONS	Hayashizaki	2011	0		
585	chrUn_JH122019	25436	25462	3500466773	23		25436	25462	8421504	2	10,13	0,13	g	350046677300000080	1-25						PROTEASES AND VARIANTS THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH122022	43299	43325	3500448596	26		43299	43325	8421504	1	26	0	c	350044859600000009	0-26						METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES	Brys	2011	0		
585	chrUn_JH122022	45903	51203	3500228810	39		45903	51203	8421504	2	20,19	0,5281	c	350022881000000008,350022881000000009	0-20,0-19						Expression analysis of regulatory MicroRNA in bovine cumulus oocyte complex and preimplantation embryos	s.ulb.uni-bonn.de	0	0		TRAF6
585	chrUn_JH122022	49849	51195	3500302345	24		49849	51195	8421504	2	9,15	0,1331	c	350030234500000041	0-24						Irak-related interventions and diagnosis	Holvoet	2012	0		
585	chrUn_JH122022	51278	52218	3500022796	61		51278	52218	8421504	3	20,20,21	0,192,919	c,g	350002279600000024,350002279600000025,350002279600000025,350002279600000007	0-20,0-20,0-20,22-43						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
585	chrUn_JH122022	51339	52050	3500300265	42		51339	52050	8421504	2	21,21	0,690	c	350030026500000004,350030026500000005	9-30,12-33		22447928	10.1074/jbc.M111.310102	0021-9258	Journal of Biological Chemistry	TRAF6 Protein Couples Toll-like Receptor 4 Signaling to Src Family Kinase Activation and Opening of Paracellular Pathway in Human Lung Microvascular Endothelia	Liu	2012	5		
585	chrUn_JH122022	51405	51486	3500156102	78		51405	51486	8421504	2	48,30	0,51	p	350015610200015021	0-78						TNF-.alpha. variants - Patent # 7056695 - PatentGenius	.patentgenius.com	0	0		TRAF6
585	chrUn_JH122027	35258	35285	3500214416	23		35258	35285	8421504	2	15,8	0,19	g	350021441600002918	0-32						MOLECULAR CHARACTERIZATION OF THEILERIA spp. USING RIBOSOMAL RNA	pository.tamu.edu	0	0		
585	chrUn_JH122037	14467	14491	3500085416	24		14467	14491	8421504	1	24	0	g	350008541600000022	11-35						Retroviral vector particles produced in a baculovirus expression system	Jones	1998	0		
585	chrUn_JH122038	34515	35713	3500408865	38		34515	35713	8421504	2	33,5	0,1193	c	350040886500000014	0-38						MONOCLONAL ANTIBODIES SPECIFIC FOR THE PUTATIVE CANCER SIGNALING PROTEIN, UEV1A	ecommons.usask.ca	0	0		
585	chrUn_JH122042	10602	10629	3500318993	27		10602	10629	8421504	1	27	0	g	350031899300000003	0-27						&#x4e3b;&#x9898;&#xff1a;cML | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
585	chrUn_JH122043	8895	8921	3500467352	24		8895	8921	8421504	2	7,17	0,9	g	350046735200000089	21-45					Patent	Recombinant fowlpox virus S-FPV-043 and uses thereof (Patent US:6123949)	Cochran	2000	0		
585	chrUn_JH122043	8895	8921	3500179670	24		8895	8921	8421504	2	7,17	0,9	g	350017967000000104	21-45						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
585	chrUn_JH122051	5774	5801	3500136628	24		5774	5801	8421504	2	5,19	0,8	g	350013662800000000	8-32					Infection and Immunity	Isolates of Chlamydia trachomatis That Occupy Nonfusogenic Inclusions Lack IncA, a Protein Localized to the Inclusion Membrane	Robert	2000	0		
585	chrUn_JH122056	12519	12544	3500128385	23		12519	12544	8421504	2	16,7	0,18	g	350012838500000034	11-34						Elicitin-mediated plant resistance - US Patent 5981843 Description	ww.patentstorm.us	0	0		
585	chrUn_JH122065	15744	15772	3500363021	28		15744	15772	8421504	1	28	0	c	350036302100000001	12-40						FSTL-1 as a biomaker of inflammation	Hirsch	2009	0		
585	chrUn_JH122065	15744	15772	3500084315	28		15744	15772	8421504	1	28	0	c,g	350008431500000013,350008431500000013,350008431500000001,350008431500000001	12-40,12-40,12-40,12-40						FSTL-1 AS A BIOMAKER OF INFLAMMATION - Patent application	www.faqs.org	0	0		
585	chrUn_JH122065	15744	15772	3500056554	28		15744	15772	8421504	1	28	0	c	350005655400000013,350005655400000001	12-40,12-40						FSTL-1 as a biomaker of inflammation - Patent # 8211652 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH122065	28718	28759	3500120476	41		28718	28759	8421504	1	41	0	g	350012047600000008	0-41						Letter	biologia.uniba.it	0	0		
585	chrUn_JH122066	25623	25651	3500242028	23		25623	25651	8421504	2	8,15	0,13	g	350024202800000287,350024202800000568	2-25,2-25						Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases	Silverman	2011	0		
585	chrUn_JH122067	40299	47377	3500262826	156		40299	47377	8421504	3	13,49,94	0,3659,6984	p	350026282600015054	0-156						Untersuchungen zur Charakterisierung der Zusammensetzung, Biogenese und des Mechanismus der Proteintranslokase der mitochondrialen Au&#xdf;enmembran von Neurospora crassa	b.uni-muenchen.de	0	0		TOMM7
585	chrUn_JH122069	40099	40128	3500022398	25		40099	40128	8421504	2	9,16	0,13	c	350002239800000169	0-27						COMPOSITIONS AND METHODS RELATED TO STAPHYLOCOCCAL BACTERIUM PROTEINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH122070	20918	20948	3500084495	25		20918	20948	8421504	2	15,10	0,20	g	350008449500000025	9-34						Recombinant plant viral nucleic acids	Dawson	1994	0		
585	chrUn_JH122091	3123	9223	3500018282	24		3123	9223	8421504	2	22,2	0,6098	c	350001828200000004	0-24					Patent	Thiophene analogues for the treatment or prevention of flavivirus infections (Patent US:8003685)	Kong	2011	0		
585	chrUn_JH122091	23924	35361	3500214646	40		23924	35361	8421504	2	20,20	0,11417	c	350021464600000005,350021464600000007	0-20,0-20		16760227	10.1124/dmd.106.009837	1521-009X (Online)	Drug Metabolism and Disposition	Small Interfering RNA-Mediated Silencing of Cytochrome P450 3A4 Gene	Chen	2006	0		CYP3A4
585	chrUn_JH122091	35416	35450	3500431427	34		35416	35450	8421504	1	34	0	c	350043142700000002	1-35		17438109	10.1158/1078-0432.CCR-06-1592	1078-0432	Clinical Cancer Research	Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its Analogs	Wang	2007	8		
585	chrUn_JH122091	35416	35450	3500329671	34		35416	35450	8421504	1	34	0	c	350032967100000014	1-35						1209788x1	www.docstoc.com	0	0		
585	chrUn_JH122091	45234	45259	3500077888	25		45234	45259	8421504	1	25	0	c,g	350007788800000029,350007788800000029	0-25,0-25						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		
585	chrUn_JH122091	45258	45306	3500185020	48		45258	45306	8421504	1	48	0	p	350018502000015136	0-48						US Patent # 6,306,624. Retinoid metabolizing protein - Patents.com	www.patents.com	0	0		
585	chrUn_JH122092	18416	19481	3500120125	36		18416	19481	8421504	2	20,16	0,1049	c	350012012500000035	12-48						Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents - Patent application	www.faqs.org	0	0		
585	chrUn_JH122092	18416	19481	3500000852	36		18416	19481	8421504	2	20,16	0,1049	c	350000085200000035	12-48						Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents	Brenner	2000	0		
585	chrUn_JH122096	20715	20909	3500144443	177		20715	20909	8421504	2	31,146	0,48	g	350014444300000000	0-187						 Tophat can't find Bowtie index files - Page 2 - SEQanswers	seqanswers.com	0	0		
585	chrUn_JH122100	19463	19489	3500371526	23		19463	19489	8421504	2	6,17	0,9	g	350037152600000001	12-35						Article	rotein.bio.msu.ru	0	0		
585	chrUn_JH122103	53773	53804	3500203133	26		53773	53804	8421504	3	13,5,8	0,16,23	g	350020313300000142	0-26						Method of preparing human stem cell factor polypeptide	Zsebo	2000	0		
585	chrUn_JH122114	4581	4607	3500028061	23		4581	4607	8421504	2	7,16	0,10	g	350002806100000293	23-46						Surface proteins of leptospira	www.devileye.net	0	0		
585	chrUn_JH122118	24218	24242	3500204927	23		24218	24242	8421504	2	13,10	0,14	g	350020492700000002	11-34						Methods for treating conditions associated with MASP-2 dependent complement activation	Schwaeble	2005	0		
585	chrUn_JH122126	15994	16017	3500293692	23		15994	16017	8421504	1	23	0	g	350029369200000100	2-25						Novel polypeptides and nucleic acids encoding same	Li	2001	0		OR1L4
585	chrUn_JH122129	39533	39647	3500449392	114		39533	39647	8421504	1	114	0	g	350044939200000021	9-123						US Patent # 5,432,270. DNA encoding tracheal antimicrobial peptides - Patents.com	www.patents.com	0	0		
585	chrUn_JH122131	46721	46746	3500239314	23		46721	46746	8421504	2	17,6	0,19	g	350023931400000053	0-23						Characterization of the Hox patterning genes in acoel flatworms	www.tdx.cat	0	0		
585	chrUn_JH122137	45957	45980	3500354906	23		45957	45980	8421504	1	23	0	g	350035490600000001	0-23						Real-Time PCR Can Rapidly Detect Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureusDirectly From Positive Blood Culture Bottles	.ascpjournals.org	0	0		
585	chrUn_JH122138	28137	34262	3500030285	155		28137	34262	8421504	8	9,22,30,23,28,15,4,24	0,10,1055,2256,2708,4703,4719,6101	g	350003028500000097,350003028500000096,350003028500000101,350003028500000103,350003028500000117,350003028500000118,350003028500000102	0-31,0-30,0-23,0-20,0-28,0-19,0-24					Patent	Transgenic ungulates having reduced prion protein activity and uses thereof (Patent CN:100526460)	I*Yi Shi Da 	2009	0		
585	chrUn_JH122138	28177	36703	3500435035	3473		28177	36703	8421504	14	4,364,124,910,76,20,20,117,548,17,114,58,194,907	0,5,372,497,1408,5358,5619,5976,6094,7197,7219,7356,7424,7619	g	350043503500000042,350043503500000064,350043503500000008,350043503500000043,350043503500000045	0-1479,0-20,0-20,0-665,0-1290						Tissue Specific Expression Of Exogenous Proteins In Transgenic Chickens 	.freshpatents.com	0	0		
585	chrUn_JH122138	28177	36703	3500297579	3453		28177	36703	8421504	13	4,364,124,910,76,20,117,548,17,114,58,194,907	0,5,372,497,1408,5619,5976,6094,7197,7219,7356,7424,7619	g	350029757900000099,350029757900000011,350029757900000100,350029757900000102	0-1479,0-20,0-665,0-1290						Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates - Patent application	www.faqs.org	0	0		
585	chrUn_JH122138	29557	39521	3500123062	4540		29557	39521	8421504	8	39,289,50,146,648,479,2869,20	0,110,406,457,604,1253,1733,9944	g	350012306200000154,350012306200000147,350012306200000148,350012306200000007,350012306200000080,350012306200000029,350012306200000102,350012306200000074,350012306200000001,350012306200000075,350012306200000002,350012306200000028,350012306200000101,350012306200000073,350012306200000000,350012306200000035,350012306200000108	0-39,0-4452,0-4485,0-26,0-26,0-20,0-20,0-21,0-21,0-25,0-25,0-20,0-20,0-20,0-20,0-20,0-20						TRANSGENIC ANIMALS AND USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH122138	29667	39521	3500451179	4502		29667	39521	8421504	6	289,50,146,648,3349,20	0,296,347,494,1143,9834	g	350045117900000135,350045117900000134,350045117900000031,350045117900000096,350045117900000029,350045117900000098,350045117900000095,350045117900000028,350045117900000000,350045117900000093,350045117900000136,350045117900000100,350045117900000035	0-4199,0-4166,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-60,0-20,0-20						 Transgenic Animals And Uses Thereof 	www.docstoc.com	0	0		
585	chrUn_JH122138	29892	33294	3500276642	114		29892	33294	8421504	3	30,29,55	0,1954,3347	g	350027664200000072,350027664200000088,350027664200000023,350027664200000022	0-30,0-29,0-55,3-58						HUMAN ARTIFICIAL CHROMOSOME VECTOR - Patent application	www.faqs.org	0	0		
585	chrUn_JH122138	30055	30084	3500340691	29		30055	30084	8421504	1	29	0	g	350034069100000020	13-42						Transgenic non-human animals capable of producing heterologous antibodies of various isotypes	Lonberg	1993	0		
585	chrUn_JH122138	30393	34262	3500426402	49		30393	34262	8421504	2	23,26	0,3843	g	350042640200000075,350042640200000076	0-23,0-26					Patent	Transgenic bovines having reduced prion protein production (Patent US:7429690)	Ishida	2008	0		
585	chrUn_JH122138	30393	30416	3500401473	23		30393	30416	8421504	1	23	0	g	350040147300000048	0-23						Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin	Robl	2001	0		
585	chrUn_JH122138	30393	30416	3500302030	23		30393	30416	8421504	1	23	0	g	350030203000000048	0-23						Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates	Ferguson	2002	0		
585	chrUn_JH122138	32095	32138	3500228494	43		32095	32138	8421504	1	43	0	g	350022849400000041	5-48						IgM Production by Transformed Cell and Method of Quantifying the Same - Patent application	www.faqs.org	0	0		
585	chrUn_JH122138	32820	39521	3500319187	60		32820	39521	8421504	3	20,20,20	0,715,6681	g	350031918700000029,350031918700000000,350031918700000035	0-20,0-20,0-20						Transgenic animals and uses thereof	Robl	2005	0		
585	chrUn_JH122138	33535	34819	3500111880	705		33535	34819	8421504	4	20,20,117,548	0,261,618,736	g	350011188000000151,350011188000000018,350011188000000130	0-20,0-20,0-665						Transgenic ungulates having reduced prion protein activity and uses thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH122138	38066	38100	3500341514	28		38066	38100	8421504	3	16,4,8	0,21,26	g	350034151400000042,350034151400000111	8-42,17-48					Patent	Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof (Patent US:5955364)	Brams	1999	0		
585	chrUn_JH122150	19803	19832	3500065454	25		19803	19832	8421504	2	14,11	0,18	g	350006545400000090	1-26						Methods and materials for characterizing and modulating interaction between heregulin and HER3 - US Patent 7314916 Description	ww.patentstorm.us	0	0		
585	chrUn_JH122150	44615	44642	3500275614	23		44615	44642	8421504	3	11,6,6	0,12,21	g	350027561400000601	22-48						Toxin peptide therapeutic agents	Sullivan	2006	0		
585	chrUn_JH122152	49631	50649	3500309281	40		49631	50649	8421504	2	20,20	0,998	g	350030928100000000,350030928100000001	0-20,0-20		22028429	10.1152/physiolgenomics.00027.2011	1094-8341	Physiological Genomics	Acute milk yield response to frequent milking during early lactation is mediated by genes transiently regulated by milk removal	Wall	2012	3		
585	chrUn_JH122155	3550	3578	3500205714	25		3550	3578	8421504	3	4,12,9	0,5,19	g	350020571400000373	18-44						Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants - Patent application	www.faqs.org	0	0		
585	chrUn_JH122157	34519	42631	3500027258	89		34519	42631	8421504	3	42,30,17	0,5257,8095	c	350002725800000088,350002725800000053	6-48,0-47						Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1) - Patent # 6759192 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH122157	34519	34561	3500344980	42		34519	34561	8421504	1	42	0	c	350034498000000089	6-48						 Polymorphic Markers Of Prostate Carcinoma Tumor Antigen 	www.docstoc.com	0	0		
585	chrUn_JH122157	39662	42631	3500408971	92		39662	42631	8421504	3	45,30,17	0,114,2952	c	350040897100000026,350040897100000053	0-45,0-47						Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1)	Blumenfeld	1999	0		
585	chrUn_JH122157	39692	42625	3500185422	125		39692	42625	8421504	2	114,11	0,2922	c,g	350018542200000059,350018542200000017,350018542200000037,350018542200000018,350018542200000038	0-48,6-48,0-48,0-48,0-47						Novel Modified Galectin 8 Proteins And Use Thereof 	.freshpatents.com	0	0		
585	chrUn_JH122157	48229	48254	3500364337	24		48229	48254	8421504	2	16,8	0,17	g	350036433700000002	0-28						Methods and kits for performing nucleic acid hybridization assays	Stabinsky	1985	0		
585	chrUn_JH122163	27400	27425	3500107506	24		27400	27425	8421504	2	4,20	0,5	g	350010750600000216,350010750600000012	1-25,1-25						METHOD FOR PRODUCING L-BETA-LYSINE - Patent application	www.faqs.org	0	0		
585	chrUn_JH122168	21318	21343	3500390012	23		21318	21343	8421504	2	12,11	0,14	g	350039001200000061	1-24						Cloning and expression of pur protein	Bergemann	1994	0		
585	chrUn_JH122171	17340	17480	3500024096	41		17340	17480	8421504	2	21,20	0,120	g	350002409600000004,350002409600000005	0-21,0-21						Polimeraz Zincir Reaksiyonu (PZR) ile S&#x0131;&#x011f;&#x0131;rlardaki Freemartinismus Sendromunun Tan&#x0131;s&#x0131;	rgi.kafkas.edu.tr	0	0		
585	chrUn_JH122176	6871	6899	3500177854	23		6871	6899	8421504	2	8,15	0,13	g	350017785400000007	0-23			10.1128/JVI.01691-07		Journal of Virology	Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses 	Yun	2008	0		
585	chrUn_JH122181	29881	29909	3500004392	23		29881	29909	8421504	2	9,14	0,14	g	350000439200000308	1-24						UNIVERSIT&#xc9; D&#x2019;EVRY VAL D&#x2019;ESSONNE	hives-ouvertes.fr	0	0		
585	chrUn_JH122185	12841	15879	3500377502	40		12841	15879	8421504	2	20,20	0,3018	g	350037750200000005,350037750200000004	0-20,0-20		9802988	10.1084/jem.188.9.1763	0022-1007	The Journal of Experimental Medicine	Two New p73 Splice Variants, &#x03b3; and &#x03b4;, with Different Transcriptional Activity	Laurenzi	1998	14		TP73
585	chrUn_JH122185	12841	15879	3500198669	40		12841	15879	8421504	2	20,20	0,3018	g	350019866900000004,350019866900000003	0-20,0-20			10.1038/sj.onc.1205750	${footerJournalISSN}		pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation		2002	0		TP73
585	chrUn_JH122187	13475	13503	3500394873	24		13475	13503	8421504	2	7,17	0,11	g	350039487300000530	11-36						Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitica	Bergeron	2001	0		EYA1
585	chrUn_JH122187	22444	22471	3500306361	23		22444	22471	8421504	2	10,13	0,14	g	350030636100000230	19-43						PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use - Patent application	www.faqs.org	0	0		
585	chrUn_JH122188	80247	80270	3500286433	23		80247	80270	8421504	1	23	0	g	350028643300000020	7-30					Patent	Manufacture and expression of large structural genes (Patent US:6936694)	Alton	2005	0		
585	chrUn_JH122188	80247	80270	3500286319	23		80247	80270	8421504	1	23	0	g	350028631900000008	7-30					Patent	Recombinant production of consensus human leukocyte interferon (Patent US:5661009)	Stabinsky	1997	0		
585	chrUn_JH122188	80247	80270	3500138099	23		80247	80270	8421504	1	23	0	g	350013809900000028	7-30						RECOMBINANT SUPER-COMPOUND INTERFERON AND USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH122188	80247	80270	3500041968	23		80247	80270	8421504	1	23	0	g	350004196800000028	7-30						USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE - Patent application	www.faqs.org	0	0		
585	chrUn_JH122190	12784	12812	3500028061	24		12784	12812	8421504	2	11,13	0,15	g	350002806100000408	3-28						Surface proteins of leptospira	www.devileye.net	0	0		
585	chrUn_JH122200	26139	26166	3500108605	23		26139	26166	8421504	2	7,16	0,11	g	350010860500000201	10-34						Production of apomictic seed	De	1999	0		
585	chrUn_JH122205	51233	51266	3500390715	30		51233	51266	8421504	3	14,11,5	0,15,28	c	350039071500000010	14-49						Non-invasive tumor imaging by tumor-targeted bacteria	Bermudes	2001	0		
585	chrUn_JH122209	9500	9524	3500189431	23		9500	9524	8421504	2	19,4	0,20	g	350018943100000578	0-24						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
585	chrUn_JH122211	16254	16342	3500464215	74		16254	16342	8421504	3	24,19,31	0,26,57	g	350046421500000148	172-265						Method of identifying activated T-cells	Dolganov	1996	0		
585	chrUn_JH122211	16254	16342	3500017468	74		16254	16342	8421504	3	24,19,31	0,26,57	g	350001746800000197	172-265						Transcripts encoding immunomodulatory polypeptides	www.devileye.net	0	0		
585	chrUn_JH122215	27517	27541	3500022494	23		27517	27541	8421504	2	7,16	0,8	g	350002249400000130	3-27						Development Of Mammalian Genome Modification Technique Using Retrotransposon 	.freshpatents.com	0	0		
585	chrUn_JH122224	24114	24146	3500129023	32		24114	24146	8421504	1	32	0	g	350012902300000007	13-50						INSTITUTO POLITECNICO NACIONAL	.bnct.ipn.mx:8080	0	0		
585	chrUn_JH122232	30094	30121	3500005511	27		30094	30121	8421504	1	27	0	c	350000551100000010	16-43		23622267	10.1186/1742-4690-10-47	1742-4690	Retrovirology	Group I p21-activated kinases facilitate Tax-mediated transcriptional activation of the human T-cell leukemia virus type 1 long terminal repeats	Chan	2013	6		CXADRP2
585	chrUn_JH122232	30109	50006	3500271950	481		30109	50006	8421504	11	25,53,28,60,45,25,101,46,35,20,43	0,10052,12347,12384,14513,14603,16077,16677,18399,18443,19854	p,c	350027195000000068,350027195000015012,350027195000015011,350027195000015010,350027195000015009,350027195000015008	0-25,0-81,0-60,18-63,0-126,21-165						Novel human protein kinases and protein kinase-like enzymes	Clary	2001	0		
585	chrUn_JH122232	30659	46278	3500410081	498		30659	46278	8421504	13	45,66,27,45,45,23,22,45,45,45,1,44,45	0,48,9358,9436,9484,9532,11797,11822,13981,14029,14077,15527,15574	p	350041008100015022,350041008100015021,350041008100015051,350041008100015018,350041008100015013,350041008100015010,350041008100015009,350041008100015008,350041008100015005,350041008100015004,350041008100015003,350041008100015002	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Method to determine inhibition of PAK3 activation of Raf-1	Marshall	1998	0		PAK3
585	chrUn_JH122236	68846	68874	3500436899	27		68846	68874	8421504	2	17,10	0,18	g	350043689900000012,350043689900000006	1-25,4-25						[tel-00203404, v1] Caract&#xe9;risation d une prot&#xe9;ine de fonction inconnue, YdiB de Bacillus subtilis, membre d une nouvelle famille d ATPases exclusivement bact&#xe9;riennes	hives-ouvertes.fr	0	0		
585	chrUn_JH122239	17042	17082	3500261567	35		17042	17082	8421504	3	7,7,21	0,8,19	g	350026156700000157	0-41						Asthma Susceptibility Locus	Kere	2008	0		
585	chrUn_JH122242	33668	33691	3500361851	23		33668	33691	8421504	1	23	0	g	350036185100000021,350036185100000102	13-36,13-36						Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates - Patent application	www.faqs.org	0	0		
585	chrUn_JH122243	8780	8820	3500406258	31		8780	8820	8421504	3	14,3,14	0,19,26	g	350040625800000094	1-32						Diagnosis of Hereditary Spastic Paraplegias (HSP) by Identification of a Mutation in the ZFVYE26 Gene or Protein	Stevanin	2012	0		
585	chrUn_JH122244	11847	11882	3500378502	34		11847	11882	8421504	2	4,30	0,5	g	350037850200000213	4-39						Vectors for expression of hml-2 polypeptides	John	2003	0		
585	chrUn_JH122244	11847	11882	3500332883	34		11847	11882	8421504	2	4,30	0,5	g	350033288300000213	4-39						Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV	Hardy	2003	0		
585	chrUn_JH122244	32805	32835	3500141134	25		32805	32835	8421504	3	14,6,5	0,16,25	g	350014113400000027	3-29						Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy 	.freshpatents.com	0	0		
585	chrUn_JH122252	34340	34367	3500187522	24		34340	34367	8421504	2	7,17	0,10	c	350018752200000003	11-35						Thrombolytic proteins	Larsen	1997	0		
585	chrUn_JH122257	6909	14746	3500269609	45		6909	14746	8421504	3	17,7,21	0,7783,7816	c,g	350026960900000003,350026960900000002,350026960900000000,350026960900000000	0-24,0-20,0-21,0-21		10318933	10.1073/pnas.96.10.5616	0027-8424	Proceedings of the National Academy of Sciences	An imprinted, mammalian bicistronic transcript encodes two independent proteins	Gray	1999	10		SNRPN,SNURF
585	chrUn_JH122257	14695	24074	3500009140	44		14695	24074	8421504	2	24,20	0,9359	c,g	350000914000000005,350000914000000004,350000914000000004	0-24,0-20,0-20		19200381	10.1186/1471-213X-9-9		BMC Developmental Biology	In vitro culture and somatic cell nuclear transfer affect imprinting of SNRPN gene in pre- and post-implantation stages of development in cattle	Joao	2009	0		
585	chrUn_JH122261	31062	31086	3500175966	23		31062	31086	8421504	2	19,4	0,20	g	350017596600000006	5-28						Methods For Diagnosing Pancreatic Cancer Using Reg4 Protein 	.freshpatents.com	0	0		
585	chrUn_JH122262	20744	20773	3500325959	25		20744	20773	8421504	3	13,4,8	0,16,21	g	350032595900000010	5-31		15066836	10.1128/AEM.70.4.2391-2397.2004	0099-2240	Applied and Environmental Microbiology	Genome Shuffling Improves Degradation of the Anthropogenic Pesticide Pentachlorophenol by Sphingobium chlorophenolicum ATCC 39723	Dai	2004	4		
585	chrUn_JH122268	14266	14293	3500353923	24		14266	14293	8421504	2	10,14	0,13	g	350035392300000012	9-33						Expression and Characterization of Ligand Binding by the Ectodomain of Toll-like Receptor 9	ecommons.usask.ca	0	0		
585	chrUn_JH122268	44498	44523	3500104979	23		44498	44523	8421504	2	8,15	0,10	g	350010497900000167	1-24						TREATMENT OF CELLULOSIC MATERIAL AND ENZYMES USEFUL THEREIN - Patent application	www.faqs.org	0	0		
585	chrUn_JH122270	22845	61809	3500237346	50		22845	61809	8421504	3	15,7,28	0,38925,38936	c	350023734600000010,350023734600000011	0-22,0-28						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
585	chrUn_JH122271	66593	66620	3500358056	24		66593	66620	8421504	2	16,8	0,19	g	350035805600000031	3-27						BACTERIAL REPLICATION SYSTEMS AND METHODS	Jarvis	2005	0		
585	chrUn_JH122271	69972	70156	3500218835	43		69972	70156	8421504	2	21,22	0,162	c,g	350021883500000001,350021883500000001,350021883500000002,350021883500000002	0-21,0-21,5-27,5-27		18388187	10.1152/ajpgi.00578.2007		American Journal of Physiology - Gastrointestinal and Liver Physiology	Functional characterization, localization, and molecular identification of rabbit intestinal N-amino acid transporter	Talukder	2008	0		
585	chrUn_JH122271	71043	71066	3500174358	23		71043	71066	8421504	1	23	0	c	350017435800000015	3-26						Sirna Based Methods For Treating Alzheimer's Disease 	.freshpatents.com	0	0		SLC38A5
585	chrUn_JH122277	24944	24969	3500282069	23		24944	24969	8421504	2	12,11	0,14	g	350028206900000010	0-23		21345962	10.1128/JVI.02557-10	0022-538X	Journal of Virology	Insights into Polyomaviridae MicroRNA Function Derived from Study of the Bandicoot Papillomatosis Carcinomatosis Viruses	Chen	2011	5		
585	chrUn_JH122277	24944	24969	3500265696	23		24944	24969	8421504	2	12,11	0,14	g	350026569600000010	0-23		21345962	10.1128/JVI.02557-10	0022-538X	Journal of Virology	Insights into Polyomaviridae MicroRNA Function Derived from Study of the Bandicoot Papillomatosis Carcinomatosis Viruses	Chen	2011	5		
585	chrUn_JH122282	20488	20516	3500371228	23		20488	20516	8421504	2	11,12	0,16	g	350037122800000019	1-24						Novel proteins and nucleic acids encoding same	Burgess	2001	0		
585	chrUn_JH122282	20488	20516	3500203940	23		20488	20516	8421504	2	11,12	0,16	g	350020394000000034	1-24						NOVEL PROTEINS AND NUCLEIC ACIDS ENCODING SAME - CURAGEN CORPORATION	www.sumobrain.com	0	0		
585	chrUn_JH122287	6727	46297	3500287505	410		6727	46297	8421504	14	32,24,24,48,35,40,32,21,33,32,26,29,28,6	0,3098,6838,6910,12188,12272,20101,20735,27809,34923,34964,35060,37628,39564	c	350028750500000042,350028750500000047,350028750500000049,350028750500000054,350028750500000056,350028750500000070,350028750500000074,350028750500000182,350028750500000088,350028750500000089,350028750500000091,350028750500000096	16-48,0-48,0-48,13-48,1-41,9-41,0-21,15-48,13-45,9-35,15-44,4-38						Methods for diagnosing Pseudoxanthoma elasticum	www.devileye.net	0	0		
585	chrUn_JH122288	44567	45023	3500219514	38		44567	45023	8421504	2	19,19	0,437	g	350021951400000055,350021951400000056	0-19,0-19						Supplemental Materials and Methods	ymphochip.nih.gov	0	0		POU2F2
585	chrUn_JH122288	59667	59692	3500111047	24		59667	59692	8421504	2	16,8	0,17	c	350011104700000020	11-36						THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES	Fung	1996	0		ZNF574
585	chrUn_JH122288	59711	59741	3500350011	24		59711	59741	8421504	3	12,6,6	0,15,24	c	350035001100000042	4-28						Wirkungen einer PPAR&#x03b1;-Aktivierung auf Parameter des Stoffwechsels von Lipiden, Schilddr&#xfc;senhormonen und Carnitin bei Schwein und Ratte als Modelltieren Dissertation	thek.uni-halle.de	0	0		
585	chrUn_JH122288	59711	59741	3500256209	24		59711	59741	8421504	3	12,6,6	0,15,24	c	350025620900000041	4-28						Clo&#xfb01;brate causes an upregulation of PPAR- target genes but does not alter AQ:1 expression of S REBP target genes in liver and adipose tissue of pigs	thek.uni-halle.de	0	0		
585	chrUn_JH122288	59711	59741	3500138517	24		59711	59741	8421504	3	12,6,6	0,15,24	c	350013851700000004	4-28						BMC Pharmacology BioMed Central	biomedcentral.com	0	0		
585	chrUn_JH122293	2902	2926	3500115116	23		2902	2926	8421504	2	8,15	0,9	g	350011511600000644	0-23						Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use	J*M*Wei Er Sen 	2005	0		
585	chrUn_JH122294	31240	31555	3500196808	39		31240	31555	8421504	2	20,19	0,296	g	350019680800000003,350019680800000002	0-20,0-19		16731777	10.1677/joe.1.06278	0022-0795	Journal of Endocrinology	Effect of copper and thiomolybdates on bovine theca cell differentiation in vitro	Kendall	2006	4		
585	chrUn_JH122294	33536	33560	3500449900	24		33536	33560	8421504	1	24	0	g	350044990000000015	0-24						US Patent # 5,420,027. Methods and compositions for the expression of biologically active fusion proteins comprising a eukaryotic cytochrome P450 fused to a reductase in bacteria - Patents.com	www.patents.com	0	0		
585	chrUn_JH122295	16470	24780	3500100951	41		16470	24780	8421504	2	21,20	0,8290	c	350010095100000000,350010095100000001	0-21,0-20						Ovine progressive pneumonia provirus levels associate with breed and Ovar-DRB1	ddr.nal.usda.gov	0	0		
585	chrUn_JH122295	25678	25712	3500201554	34		25678	25712	8421504	1	34	0	c	350020155400000108	14-48						Gene amplification methods	Denney	1996	0		
585	chrUn_JH122295	26729	26752	3500135551	23		26729	26752	8421504	1	23	0	c	350013555100000001	0-23		22481880	10.1590/S1415-47572012005000013	1415-4757	Genetics and Molecular Biology	Genetics and Molecular Biology - Molecular characterization of MHC-DRB cDNA in water buffalo (Bubalus bubalis)	Naskar	2012	1		
585	chrUn_JH122309	19839	19864	3500033256	25		19839	19864	8421504	1	25	0	g	350003325600000000	5-30						Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH122312	514	10958	3500200287	40		514	10958	8421504	2	20,20	0,10424	g	350020028700000005,350020028700000004	0-20,0-20						SequentialSynthesisandMethylationof PhosphatidylethanolaminePromoteLipidDroplet BiosynthesisandStabilityinTissueCultureand inVivo	www.jbc.org	0	0		
585	chrUn_JH122312	59124	59150	3500112083	24		59124	59150	8421504	3	14,4,6	0,15,20	g	350011208300000138	20-46						 Mycobacterial Sulfation Pathway Proteins And Methods Of Use Thereof 	www.docstoc.com	0	0		
586	chrUn_JH122312	138362	138385	3500359475	23		138362	138385	8421504	1	23	0	c	350035947500000019	0-23		12192045	10.1128/MCB.22.18.6471-6479.2002	0270-7306	Molecular and Cellular Biology	Maximal Induction of a Subset of Interferon Target Genes Requires the Chromatin-Remodeling Activity of the BAF Complex	Liu	2002	6		
586	chrUn_JH122312	138474	142397	3500121860	39		138474	142397	8421504	3	19,19,1	0,3321,3922	c	350012186000000009,350012186000000010	0-19,0-20		16207835	10.1095/biolreprod.105.046748	0006-3363	Biology of Reproduction	Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	Klein	2006	4		
586	chrUn_JH122312	138474	139046	3500049790	39		138474	139046	8421504	3	19,1,19	0,75,553	c	350004979000000009,350004979000000010	0-19,0-20						Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period	ww.biolreprod.org	0	0		
586	chrUn_JH122312	158145	158169	3500050641	23		158145	158169	8421504	2	17,6	0,18	g	350005064100000009	0-25						Hmeljarski bilten Hop Bulletin	bib.irb.hr/datote	0	0		
587	chrUn_JH122312	313798	313821	3500007717	23		313798	313821	8421504	1	23	0	c	350000771700000001	6-34						Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland	.aacrjournals.org	0	0		
587	chrUn_JH122312	314899	314924	3500094682	23		314899	314924	8421504	2	18,5	0,20	g	350009468200000016	0-25						Detergent compositions - Patent application	www.faqs.org	0	0		
587	chrUn_JH122312	324604	324628	3500318719	24		324604	324628	8421504	1	24	0	c	350031871900000018	0-24		17901070	10.1095/biolreprod.107.064667	0006-3363	Biology of Reproduction	Flow-Cytometric Isolation of Testicular Germ Cells from Rainbow Trout (Oncorhynchus mykiss) Carrying the Green Fluorescent Protein Gene Driven by Trout vasa Regulatory Regions	Yano	2008	4		
585	chrUn_JH122315	38475	38498	3500256972	23		38475	38498	8421504	1	23	0	g	350025697200000003	5-31						Occurrence of toxigenic Escherichia coli in raw milk cheese in Brazil	www.scielo.br	0	0		
585	chrUn_JH122319	51418	51442	3500437093	23		51418	51442	8421504	2	17,6	0,18	g	350043709300000437	19-43						US Patent # 8,182,996. Compositions and methods for detecting Klebsiella pneumoniae - Patents.com	patents.com	0	0		
585	chrUn_JH122320	21823	21851	3500385051	23		21823	21851	8421504	2	6,17	0,11	g	350038505100000045	4-28					Patent	Method of improving dough and bread quality (Patent CN:100591212)	C*H*Pu Er Sen 	2010	0		
585	chrUn_JH122326	24394	24421	3500142699	25		24394	24421	8421504	3	4,11,10	0,5,17	g	350014269900000001	6-31						Papillomavirus Li major	www.pnas.org	0	0		
585	chrUn_JH122327	31813	31838	3500245791	23		31813	31838	8421504	3	6,12,5	0,7,20	g	350024579100000066	5-33					Patent	G-csf&#x7c7b;&#x4f3c;&#x7269;&#x7ec4;&#x5408;&#x7269;&#x53ca;&#x5176;&#x5236;&#x5907;&#x65b9;&#x6cd5; G-csf analogs composition and its preparation method (Patent CN:1970571)	T*D*Ao Si Long De 	2013	0		
585	chrUn_JH122329	9072	9096	3500036492	23		9072	9096	8421504	2	19,4	0,20	g	350003649200000136	18-41						UNIVERSIDAD DE SALAMANCA	gredos.usal.es	0	0		
585	chrUn_JH122337	27388	27420	3500078880	26		27388	27420	8421504	3	13,4,9	0,14,23	g	350007888000000007	0-30						METHODS FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS - Patent application	www.faqs.org	0	0		
585	chrUn_JH122337	31358	31389	3500275629	27		31358	31389	8421504	2	6,21	0,10	g	350027562900000728	4-35						Methods for Detecting Epigenetic Modifications	Engeland	2008	0		
585	chrUn_JH122344	4564	4591	3500017656	23		4564	4591	8421504	2	16,7	0,20	g	350001765600000003	0-23						Nucleic Acid For Use In Algae And Use Thereof 	.freshpatents.com	0	0		
585	chrUn_JH122357	11332	11356	3500068521	23		11332	11356	8421504	2	14,9	0,15	g	350006852100000404	20-43						About ICRISAT	www.icrisat.org	0	0		
585	chrUn_JH122358	2089	16275	3500013789	82		2089	16275	8421504	3	20,15,47	0,14121,14139	g	350001378900000200,350001378900000161	0-20,252-329						Methods for using canine immunoglobulin variable domains and caninized antibodies	Krah	2002	0		
585	chrUn_JH122358	2234	33945	3500194368	39		2234	33945	8421504	2	20,19	0,31692	g	350019436800000048,350019436800000509	28-48,28-47						Antibodies That Specifically Bind to Reg IV - Patent application	www.faqs.org	0	0		
585	chrUn_JH122358	16210	16275	3500092462	62		16210	16275	8421504	2	15,47	0,18	g	350009246200000161	252-329					Patent	Methods for using canine immunoglobulin variable domains and caninized antibodies (Patent US:7261890)	Eugene	2007	0		
585	chrUn_JH122358	25332	25355	3500441209	23		25332	25355	8421504	1	23	0	g	350044120900000053,350044120900000484,350044120900000078,350044120900000507	0-21,0-21,0-19,0-19						Antibodies Against Lesion Tissue 	.freshpatents.com	0	0		
585	chrUn_JH122358	25332	25355	3500285046	23		25332	25355	8421504	1	23	0	g	350028504600000067	0-23					Patent	Binding molecules capable of neutralizing rabies virus and uses thereof (Patent CA:2568162)	Bakker	2013	0		
585	chrUn_JH122358	25332	25355	3500107370	23		25332	25355	8421504	1	23	0	g	350010737000000011,350010737000000039	0-23,18-41						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2008	0		
585	chrUn_JH122358	25332	25355	3500091064	23		25332	25355	8421504	1	23	0	g	350009106400000039	18-41						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2008	0		
585	chrUn_JH122358	41748	41771	3500441564	23		41748	41771	8421504	1	23	0	g	350044156400000058	0-23						ALBUMIN FUSION PROTEINS	Rosen	2010	0		
585	chrUn_JH122358	41748	41771	3500391229	23		41748	41771	8421504	1	23	0	g	350039122900000126	0-23						Albumin fusion proteins - US Patent 6994857 Description	ww.patentstorm.us	0	0		
585	chrUn_JH122372	41527	41551	3500143098	23		41527	41551	8421504	2	11,12	0,12	g	350014309800000403	0-23						RECOMBINANT VACCINE AGAINST WEST NILE VIRUS - Patent application	www.faqs.org	0	0		
585	chrUn_JH122375	11430	11456	3500045026	23		11430	11456	8421504	2	6,17	0,9	g	350004502600000195	0-24						Modified HIV-1 Envelope Proteins - Patent application	www.faqs.org	0	0		
585	chrUn_JH122376	41884	41912	3500077080	28		41884	41912	8421504	1	28	0	c	350007708000000092	7-35						Method of using cells expressing galanin receptor 3 (GALR3) - Patent # 7022489 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH122394	14612	14642	3500143796	25		14612	14642	8421504	2	14,11	0,19	g	350014379600000022	12-37						PROTEASE VARIANTS - Patent application	www.faqs.org	0	0		
585	chrUn_JH122399	11410	11438	3500044715	23		11410	11438	8421504	3	12,7,4	0,16,24	g	350004471500000078	25-49						Antibody immunoreactive with a 5-enolpyruvylshikimate-3-phosphate synthase - US Patent 7183110 Description	ww.patentstorm.us	0	0		
585	chrUn_JH122411	26507	26530	3500068065	23		26507	26530	8421504	1	23	0	c	350006806500000022	0-23						RESEARCH Open Access Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression	www.rbej.com	0	0		
585	chrUn_JH122418	20052	20080	3500220074	26		20052	20080	8421504	2	15,11	0,17	g	350022007400000430	0-39					Patent	Thermophilic DNA polymerases from Thermotoga neapolitana (Patent US:6077664)	Bolchakova	2000	0		
585	chrUn_JH122419	41833	41919	3500349640	65		41833	41919	8421504	3	38,5,22	0,58,64	g	350034964000000145	15-101						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
585	chrUn_JH122419	41845	41991	3500264039	136		41845	41991	8421504	2	34,102	0,44	g	350026403900000040,350026403900000041	84-118,10-112						Structure and Evolution of the Y-chromosomal and Mitochondrial DNA of cattle	ive.library.uu.nl	0	0		
585	chrUn_JH122419	41894	42392	3500147470	41		41894	42392	8421504	2	21,20	0,478	g	350014747000000006,350014747000000004	0-21,0-20						Impacts of genetic drift and restricted gene flow in indigenous cattle breeds: evidence from the Jutland breed | Eline Lorenzen - Academia.edu	www.academia.edu	0	0		
585	chrUn_JH122419	42582	42715	3500338938	133		42582	42715	8421504	1	133	0	g	350033893800000009	0-133						Sequences Used	biology.uindy.edu	0	0		
585	chrUn_JH122419	42586	42611	3500169687	25		42586	42611	8421504	1	25	0	g	350016968700000007	0-25		8552600			Proceedings of the National Academy of Sciences of the United States of America	Molecular phylogeny of the extinct ground sloth Mylodon darwinii.	Hoss	1996	0		MTRNR2L2
585	chrUn_JH122430	22190	31074	3500180480	351		22190	31074	8421504	5	77,78,124,42,30	0,593,1287,5857,8854	p,c	350018048000000022,350018048000015075,350018048000015071,350018048000015069	0-351,0-45,0-45,0-45						STIMULATING NEURITE OUTGROWTH USING TCTEX-1-RELATED POLYPEPTIDES - Patent application	www.faqs.org	0	0		
585	chrUn_JH122453	1946	1972	3500201864	23		1946	1972	8421504	2	15,8	0,18	g	350020186400000742	9-43						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
585	chrUn_JH122456	25269	25365	3500365673	40		25269	25365	8421504	2	20,20	0,76	c,g	350036567300000029,350036567300000029,350036567300000028,350036567300000028	0-20,0-20,0-20,0-20						Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH122456	25269	25365	3500262357	40		25269	25365	8421504	2	20,20	0,76	c,g	350026235700000029,350026235700000029,350026235700000028,350026235700000028	0-20,0-20,0-20,0-20		19767409	10.1152/ajplung.90611.2008		American Journal of Physiology - Lung Cellular and Molecular Physiology	Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall	Maria	2009	0		
585	chrUn_JH122456	28158	28185	3500034980	25		28158	28185	8421504	2	13,12	0,15	c	350003498000000263	4-29						Keratinocyte growth factor-2 - US Patent 6916786 Description	ww.patentstorm.us	0	0		
585	chrUn_JH122467	36328	36355	3500265170	24		36328	36355	8421504	3	6,13,5	0,7,22	g	350026517000000059	13-39					Patent	Purified thermostable nucleic acid polymerase enzyme from thermosipho africanus (Patent US:5968799)	Gelfand	1999	0		
585	chrUn_JH122476	9344	9373	3500068957	24		9344	9373	8421504	2	6,18	0,11	g	350006895700000034	2-26						Genetic method for expression of polyproteins in plants	W*F*Bu Lei Kai Te 	2001	0		
585	chrUn_JH122478	22837	22863	3500334789	23		22837	22863	8421504	3	5,13,5	0,6,21	g	350033478900000160	15-38						Recombinant bone morphogenetic protein heterodimers, compositions and methods of use	Israel	1994	0		
585	chrUn_JH122479	26917	32191	3500374909	40		26917	32191	8421504	4	20,4,4,12	0,5252,5257,5262	g	350037490900000079,350037490900000894,350037490900001163	6-26,6-26,24-44						Methods of Inhibiting Poxvirus Growth - Patent application	www.faqs.org	0	0		
585	chrUn_JH122487	9119	9147	3500289735	25		9119	9147	8421504	3	6,14,5	0,8,23	g	350028973500000052	14-39					Patent	Human IL-2 receptor &#x03b3;-chain molecule antibody (Patent US:5889160)	Asao	1999	0		
585	chrUn_JH122487	16875	16900	3500304843	24		16875	16900	8421504	2	16,8	0,17	g	350030484300000052	11-45						Vaccine and antitoxin for treatment and prevention of c. difficile disease	Firca	1997	0		
585	chrUn_JH122506	31399	31426	3500221916	23		31399	31426	8421504	3	4,7,12	0,5,15	g	350022191600000128	11-34						VECTORS AND YEAST STRAINS FOR PROTEIN PRODUCTION	Choi	2009	0		
585	chrUn_JH122518	30355	30382	3500068951	24		30355	30382	8421504	2	16,8	0,19	g	350006895100000441	11-42						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH122520	4994	5024	3500275770	25		4994	5024	8421504	3	15,6,4	0,19,26	g	350027577000000000	7-33					Patent	Verfahren zum identifizieren von prostaglandin d2 rezeptor modulatoren A method for identifying of prostaglandin d2 receptor modulators (Patent DE:60025368)	HIRAI	2006	0		
585	chrUn_JH122529	40440	40465	3500014007	23		40440	40465	8421504	2	17,6	0,19	g	350001400700000237,350001400700000251	6-29,3-26						Protease inhibitor peptides	White	1997	0		
585	chrUn_JH122530	26528	26551	3500032480	23		26528	26551	8421504	1	23	0	g	350003248000000252	0-23						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments - US Patent 7964349 Description	ww.patentstorm.us	0	0		
585	chrUn_JH122530	26528	26551	3500017979	23		26528	26551	8421504	1	23	0	g	350001797900000248	0-23						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
585	chrUn_JH122533	31752	31806	3500339190	54		31752	31806	8421504	1	54	0	p	350033919000015006	0-54						PREDICTED: Mus musculus similar to olfactory receptor Olfr288 (LOC545131), mRNA. , XM_619354.1 - GenScript	iologyproject.net	0	0		
585	chrUn_JH122535	4239	4332	3500036341	86		4239	4332	8421504	2	38,48	0,45	c	350003634100000016,350003634100000015	7-45,0-48						Endomannosidases in the modification of glycoproteins in eukaryotes - Patent application	www.faqs.org	0	0		
585	chrUn_JH122539	6002	6606	3500189969	40		6002	6606	8421504	2	20,20	0,584	g	350018996900000024,350018996900000021	0-20,0-20						Bone and cartilage inductive proteins	Hewick	1994	0		
585	chrUn_JH122548	35982	36009	3500070162	24		35982	36009	8421504	3	6,14,4	0,8,23	g	350007016200000261	7-31					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6124104)	Couch	2000	0		
585	chrUn_JH122548	35982	36009	3500049566	24		35982	36009	8421504	3	6,14,4	0,8,23	g	350004956600000261	7-31					Patent	Chromosome 13-linked breast cancer susceptibility gene (Patent US:6033857)	Couch	2000	0		
585	chrUn_JH122551	28671	28697	3500189823	23		28671	28697	8421504	2	8,15	0,11	g	350018982300000730,350018982300000607,350018982300000361,350018982300000099	3-26,0-23,21-44,12-35						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
585	chrUn_JH122552	17643	17747	3500166204	103		17643	17747	8421504	2	62,41	0,63	g	350016620400000012	143-246						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
585	chrUn_JH122559	32142	32166	3500046945	24		32142	32166	8421504	1	24	0	g	350004694500000002	23-47						Online Peptides Guide | papers about Peptide	ein-precrusor.com	0	0		
585	chrUn_JH122571	35625	35654	3500375146	24		35625	35654	8421504	2	9,15	0,14	g	350037514600000067	10-34						A radiation hybrid map of river buffalo (Bubalus bubalis) chromosome 1 (BBU1)	ticabovina.com.br	0	0		
585	chrUn_JH122578	48652	48676	3500270031	23		48652	48676	8421504	2	12,11	0,13	g	350027003100000100	15-38						Method and product for regulating cell responsiveness to external signals	Johnson	1996	0		
585	chrUn_JH122595	31274	31301	3500407417	23		31274	31301	8421504	2	14,9	0,18	g	350040741700000244	16-39						Method For Producing Carotenoids Or Their Precursors Using Genetically Modified Organisms Of The Blakeslea Genus, Carotenoids Or Their Precursors Produced By Said Method And Use Thereof 	.freshpatents.com	0	0		ZNF503
585	chrUn_JH122595	33405	33436	3500269841	26		33405	33436	8421504	3	11,10,5	0,14,26	g	350026984100000124	0-26						Therapeutic compositions and methods - Patent application	www.faqs.org	0	0		
585	chrUn_JH122598	16431	16461	3500399321	25		16431	16461	8421504	2	13,12	0,18	g	350039932100000007	4-48						Microorganism expressing aldose-1-epimerase	Sibbesen	2010	0		
585	chrUn_JH122598	16431	16461	3500017156	25		16431	16461	8421504	2	13,12	0,18	g	350001715600000007	4-48						Microorganism expressing aldose-1-epimerase	Sibbesen	2011	0		
585	chrUn_JH122600	26389	26420	3500189823	28		26389	26420	8421504	2	6,22	0,9	g	350018982300000646	5-33						 NANBV Diagnostics And Vaccines 	www.docstoc.com	0	0		
585	chrUn_JH122604	17235	17267	3500322650	32		17235	17267	8421504	1	32	0	g	350032265000000007	52-84						A note on the organization and expression of &#x03b2;-defensin genes in Polish goats. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH122606	26704	26731	3500226315	23		26704	26731	8421504	3	7,4,12	0,8,15	g	350022631500000005	4-27						Sequence-specificinhibitionofmicroRNA- andsiRNA-inducedRNAsilencing	journal.cshlp.org	0	0		
585	chrUn_JH122613	25824	25849	3500130848	23		25824	25849	8421504	2	15,8	0,17	g	350013084800000121	0-23						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
585	chrUn_JH122639	51173	70491	3500299530	1550		51173	70491	8421504	9	451,163,227,161,67,128,149,89,115	0,2201,4551,7181,12885,13981,17388,18854,19203	g	350029953000000033	320-1870						BOVINE POLYMORPHISMS AND METHODS OF PREDICTING BOVINE TRAITS - Patent application	www.faqs.org	0	0		
585	chrUn_JH122639	51619	53410	3500027754	41		51619	53410	8421504	2	5,36	0,1755	c	350002775400000009	0-41		11714865		1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Identification of Variants of CYP3A4 and Characterization of Their Abilities to Metabolize Testosterone and Chlorpyrifos	Dai	2001	0		
585	chrUn_JH122639	58460	68621	3500112685	42		58460	68621	8421504	2	22,20	0,10141	c,g	350011268500000015,350011268500000015,350011268500000014,350011268500000014	0-22,0-22,0-20,0-20						Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle	web1.sssup.it	0	0		
585	chrUn_JH122645	27920	29327	3500146047	39		27920	29327	8421504	3	1,19,19	0,1157,1388	c	350014604700000015,350014604700000014	0-20,0-19						PASTURE-FEEDING OF CHAROLAIS STEERS INFLUENCES SKELETAL MUSCLE METABOLISM AND GENE EXPRESSION	www.jpp.krakow.pl	0	0		
585	chrUn_JH122645	27920	29327	3500053255	39		27920	29327	8421504	3	1,19,19	0,1157,1388	c,g	350005325500000015,350005325500000014,350005325500000014	0-20,0-19,0-19						1009_S3_article_10	www.jpp.krakow.pl	0	0		
585	chrUn_JH122645	27920	29327	3500020580	39		27920	29327	8421504	3	1,19,19	0,1157,1388	c	350002058000000001,350002058000000000	0-20,0-19						UNIVERSIDADE ESTADUAL DO CEAR&#xc1; PR&#xd3;-REITORIA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O E PESQUISA FACULDADE DE VETERIN&#xc1;RIA PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM CI&#xca;NCIAS VETERIN&#xc1;RIAS KARLA LEYLANNE SOUSA G&#xd3;ES	www.uece.br	0	0		
585	chrUn_JH122647	33069	33095	3500361684	26		33069	33095	8421504	1	26	0	g	350036168400000005	0-26						IDENTIFICA&#xc7;&#xc3;O DE ESP&#xc9;CIES ANIMAIS USANDO SEQ&#xdc;&#xca;NCIAS DE GENES MITOCONDRIAIS NO COMBATE AOS CRIMES CONTRA A FAUNA	www.bdtd.ucb.br	0	0		
585	chrUn_JH122647	33395	33418	3500307874	23		33395	33418	8421504	1	23	0	g	350030787400000003	0-23						Phylogenetic Relationships of the Five Extant Rhinoceros Species (RhinJ5&#xcd;&#xe1;&#xca;C (;cY&#xb9; &#xef;&#xa6;(&#xca;&#xbd;&#xb3;&#xd0;&#xd7;&#xf0;{IB &#xea;&#xdc;&#xf5; &#xd2;&#xef;t~i+sC&#xcc;&#xdb;' &#xb2;(&#xf5;y?2&#xb7;.ahL&#xae; &#xcc;;&#xe1; &	ibiologia.unam.mx	0	0		NLGN4X
585	chrUn_JH122660	9865	10488	3500380194	23		9865	10488	8421504	2	14,9	0,614	c	350038019400000191	2-25						PRODUCTION OF 3-HYDROXYPROPIONIC ACID USING BETA-ALANINE/PYRUVATE AMINOTRANSFERASE - Patent application	www.faqs.org	0	0		
585	chrUn_JH122660	9865	10488	3500169143	23		9865	10488	8421504	2	14,9	0,614	c	350016914300000191	2-25						PRODUCTION OF 3-HYDROXYPROPIONIC ACID USING BETA-ALANINE/PYRUVATE AMINOTRANSFERASE - Patent application	www.faqs.org	0	0		
585	chrUn_JH122662	29210	29239	3500305954	24		29210	29239	8421504	3	5,14,5	0,7,24	g	350030595400000008	21-46					Patent	Bovine herpesvirus vaccine and method of using same (Patent US:5462734)	Israel	1995	0		
585	chrUn_JH122676	2549	2690	3500024826	46		2549	2690	8421504	2	23,23	0,118	g	350002482600000174,350002482600000173	0-23,0-23						Udder Health Characteristics 	.freshpatents.com	0	0		
585	chrUn_JH122679	13077	13102	3500393280	23		13077	13102	8421504	2	8,15	0,10	g	350039328000000089	7-35						DNA encoding &#x0b32-1,3-glucanases - US Patent 5847258 Description	ww.patentstorm.us	0	0		
585	chrUn_JH122679	13077	13102	3500156643	23		13077	13102	8421504	2	8,15	0,10	g	350015664300000087	7-35					Patent	DNA encoding plant chitinases (Patent US:5880328)	Frederich	1999	0		
585	chrUn_JH122689	27560	27602	3500311241	42		27560	27602	8421504	1	42	0	g	350031124100000088,350031124100000089,350031124100000086,350031124100000052,350031124100000091	7-32,7-32,9-34,3-25,10-33					Patent	Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof (Patent CN:100482276)	A*F*Luo Bu Ge Li Ao 	2009	0		
585	chrUn_JH122689	27561	27588	3500248313	27		27561	27588	8421504	1	27	0	g	350024831300000013	9-36						Non-aggregating human vh domains	Arbabi-Ghahroudi	2011	0		
585	chrUn_JH122689	27574	27602	3500343833	28		27574	27602	8421504	1	28	0	g	350034383300000005	49-77						US Patent # 5,849,877. Antigen-binding sites of antibody molecules specific for cancer antigens - Patents.com	www.patents.com	0	0		
585	chrUn_JH122689	27574	27602	3500204781	28		27574	27602	8421504	1	28	0	g	350020478100000005	49-77						Antigen-binding sites of antibody molecules specific for cancer antigens	Ring	1995	0		
585	chrUn_JH122689	27642	27669	3500409060	27		27642	27669	8421504	1	27	0	g	350040906000000011,350040906000000045	0-27,0-27						Human antibodies interacting with hiv gp41	Bianchi	2007	0		
585	chrUn_JH122689	27642	27669	3500131771	27		27642	27669	8421504	1	27	0	g	350013177100000067	15-42					Patent	Transgenic non-human animals for producing heterologous antibodies (Patent US:5814318)	Kay	1998	0		
585	chrUn_JH122689	27643	27806	3500037714	76		27643	27806	8421504	2	25,51	0,112	g	350003771400000043	0-167					Patent	Anti-TRAIL-R antibodies (Patent CN:100475848)	Sen Ying Zhi 	2009	0		
585	chrUn_JH122689	27756	27844	3500290266	71		27756	27844	8421504	2	54,17	0,71	g	350029026600000008	0-89					Patent	Humanised anti-MAG antibody or functional fragment thereof (Patent US:8071731)	Ellis	2011	0		
585	chrUn_JH122689	27756	27844	3500145935	71		27756	27844	8421504	2	54,17	0,71	g	350014593500000008,350014593500000007	0-89,0-89					Patent	Humanised anti-mag antibody or functional fragment thereof (Patent US:7612183)	Ellis	2009	0		
585	chrUn_JH122689	27756	27844	3500129978	71		27756	27844	8421504	2	54,17	0,71	g	350012997800000008,350012997800000007	0-89,0-89						Humanised Anti-MAG Antibody or Functional Fragment Thereof	Ellis	2009	0		
585	chrUn_JH122689	27756	27810	3500453393	54		27756	27810	8421504	1	54	0	g	350045339300000004	13-67						Internalizing Anti-CD74 Antibodies and Methods of Use	Hansen	2010	0		
585	chrUn_JH122689	27756	27810	3500173236	54		27756	27810	8421504	1	54	0	g	350017323600000004	13-67						Internalizing Anti-cd74 Antibodies And Methods Of Use 	.freshpatents.com	0	0		
585	chrUn_JH122689	27756	27810	3500076607	54		27756	27810	8421504	1	54	0	g	350007660700000004,350007660700000060	13-67,13-67						Internalizing Anti-CD74 Antibodies and Methods of Use - Patent application	www.faqs.org	0	0		
585	chrUn_JH122689	27756	27810	3500044827	54		27756	27810	8421504	1	54	0	g	350004482700000004	13-67					Patent	Internalizing anti-CD74 antibodies and methods of use (Patent US:7919087)	Hansen	2011	0		
585	chrUn_JH122689	27762	27816	3500333852	54		27762	27816	8421504	1	54	0	g	350033385200000037	24-83						ANTI-CD33 ANTIBODIES AND METHOD FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME - Patent application	www.faqs.org	0	0		
585	chrUn_JH122689	27762	27816	3500281163	54		27762	27816	8421504	1	54	0	g	350028116300000037	24-83						ANTI-CD33 ANTIBODIES AND METHODS FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME - Patent application	www.faqs.org	0	0		
585	chrUn_JH122689	27762	27816	3500052232	54		27762	27816	8421504	1	54	0	g	350005223200000037	24-83						ANTI-CD33 ANTIBODIES AND METHODS FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME - Patent application	www.faqs.org	0	0		
585	chrUn_JH122689	27762	27809	3500260552	45		27762	27809	8421504	2	35,10	0,37	g	350026055200000083	23-69						US Patent # 6,969,586. Method for tapping the immunological repertoire - Patents.com	www.patents.com	0	0		
585	chrUn_JH122689	27776	27844	3500399840	59		27776	27844	8421504	2	40,19	0,49	g	350039984000000073,350039984000000062	0-69,0-68						ANTI-CD20 THERAPEUTIC COMPOSITIONS AND METHODS	Damle	2008	0		
585	chrUn_JH122689	27776	27844	3500377781	59		27776	27844	8421504	2	40,19	0,49	g	350037778100000065,350037778100000062	0-69,0-68						Anti-cd20 Therapeutic Compositions And Methods 	.freshpatents.com	0	0		
585	chrUn_JH122698	366	393	3500186547	25		366	393	8421504	2	8,17	0,10	g	350018654700000199	20-45						Polycystic kidney disease gene and protein	Klinger	1996	0		
585	chrUn_JH122711	8075	8102	3500362691	23		8075	8102	8421504	3	11,7,5	0,14,22	g	350036269100000233	1-24						Highly polymorphic microsatellites 00Graphicraft Limited, Hong Kong in the lacertid Gallotia galloti	ents.plant.wur.nl	0	0		
585	chrUn_JH122713	13084	13112	3500314426	25		13084	13112	8421504	2	6,19	0,9	g	350031442600000125	9-34						TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER - Patent application	www.faqs.org	0	0		
585	chrUn_JH122729	7591	10138	3500412680	40		7591	10138	8421504	2	20,20	0,2527	c,g	350041268000000011,350041268000000010,350041268000000010	0-20,0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		
585	chrUn_JH122729	7591	10138	3500105107	40		7591	10138	8421504	2	20,20	0,2527	c,g	350010510700000011,350010510700000010,350010510700000010	0-20,0-20,0-20		20371734	10.1152/ajpendo.00015.2010		American Journal of Physiology - Endocrinology and Metabolism	Enhanced transforming growth factor-&#x03b2; signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation	Huang	2010	0		
585	chrUn_JH122729	7591	10138	3500035761	40		7591	10138	8421504	2	20,20	0,2527	c,g	350003576100000011,350003576100000010,350003576100000010	0-20,0-20,0-20						Enhanced transforming growth factor- signaling and &#xfb01;brogenesis in ovine fetal skeletal muscle of obese dams at late gestation	do.physiology.org	0	0		
585	chrUn_JH122729	10232	10273	3500369719	41		10232	10273	8421504	1	41	0	c	350036971900000025	0-41						Expression system for producing collagen - Patent application	www.faqs.org	0	0		
585	chrUn_JH122741	24701	24727	3500321841	23		24701	24727	8421504	2	7,16	0,10	g	350032184100000001	12-36		12502837	10.1128/JVI.77.2.1204-1210.2003	0022-538X	Journal of Virology	Glycosaminoglycan Binding Properties of Natural Venezuelan Equine Encephalitis Virus Isolates	Wang	2003	5		
585	chrUn_JH122743	21279	21304	3500282511	25		21279	21304	8421504	1	25	0	g	350028251100000022	3-34						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
585	chrUn_JH122744	22681	22712	3500335341	25		22681	22712	8421504	3	6,13,6	0,7,25	g	350033534100000017,350033534100000015	9-39,9-28					Patent	Polymer conjugates of interferon beta-1A and uses (Patent US:7446173)	Pepinsky	2008	0		
585	chrUn_JH122746	18730	18764	3500391478	26		18730	18764	8421504	3	11,6,9	0,16,25	g	350039147800000608	0-30						dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION - Patent application	www.faqs.org	0	0		
585	chrUn_JH122753	27884	27907	3500202543	23		27884	27907	8421504	1	23	0	g	350020254300000005	1-24						Colombia M&#xe9;dica Vol. 41 N&#xba; 4, 2010 (Octubre-Diciembre)	s3.amazonaws.com	0	0		
585	chrUn_JH122755	2804	2830	3500429169	23		2804	2830	8421504	3	13,4,6	0,14,20	g	350042916900000005	0-23		9826378		0019-9567	Infection and Immunity	Filarial Nematode Parasites Secrete a Homologue of the Human Cytokine Macrophage Migration Inhibitory Factor	Pastrana	1998	4		
585	chrUn_JH122766	786	812	3500101538	23		786	812	8421504	3	5,6,12	0,7,14	g	350010153800001266	1-24						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
586	chrUn_JH122778	159261	159287	3500465169	24		159261	159287	8421504	2	5,19	0,7	g	350046516900000357	12-43						US Patent # 5,801,042. Unique associated Kaposi's sarcoma virus sequences and uses thereof - Patents.com	www.patents.com	0	0		
586	chrUn_JH122778	159261	159287	3500092685	24		159261	159287	8421504	2	5,19	0,7	g	350009268500000357	12-43						<script type="text/javascript"> if (typeof($) == 'undefined') window.location.pathname = "/p	ww.patentlens.net	0	0		
585	chrUn_JH122779	7586	7611	3500412161	25		7586	7611	8421504	1	25	0	g	350041216100000001	14-39		22025682	10.1128/MCB.05770-11	0270-7306	Molecular and Cellular Biology	Eukaryotic Translation Initiation Factor 3, Subunit a, Regulates the Extracellular Signal-Regulated Kinase Pathway	Xu	2012	6		
585	chrUn_JH122780	9007	9033	3500274318	23		9007	9033	8421504	3	5,5,13	0,6,13	g	350027431800000083	14-37						Immunoglobulin chimeric monomer - dimer heterozygote	A*J*Bi Tong Di 	2011	0		
585	chrUn_JH122795	2087	2115	3500368692	23		2087	2115	8421504	2	15,8	0,20	g	350036869200000015	0-26						SIMIAN ADENOVIRUSES SADV-36, -42.1, -42.2, AND -44 AND USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH122795	2087	2115	3500187312	23		2087	2115	8421504	2	15,8	0,20	g	350018731200000000,350018731200000014	10-36,10-36						 System For Generating Recombinant Viruses 	www.docstoc.com	0	0		DST
585	chrUn_JH122795	3778	3806	3500106137	25		3778	3806	8421504	2	19,6	0,22	g	350010613700000019	0-25						THE JOURNAL OF Vol. 260, No. of 15, 0 1985 by The of Biological in U. S. A. A Single Cardiac Troponin T Gene Generates Embryonic and Adult Isoforms via Developmentally Regulated Alternate Splicing*	www.jbc.org	0	0		
585	chrUn_JH122795	14323	14348	3500411344	25		14323	14348	8421504	1	25	0	c	350041134400000000	0-25					The Journal of Biological Chemistry	RB1CC1 Protein Positively Regulates Transforming Growth Factor-&#x03b2; Signaling through the Modulation of Arkadia E3 Ubiquitin Ligase Activity* - Scolaris	Koinuma	2011	0		RNF111
585	chrUn_JH122803	12485	12512	3500345238	24		12485	12512	8421504	3	8,12,4	0,10,23	g	350034523800000006	0-25					Patent	Synthetic antigen the detection of aids-related disease (Patent US:6214539)	Cosand	2001	0		
585	chrUn_JH122804	18359	18389	3500236871	25		18359	18389	8421504	2	11,14	0,16	g	350023687100000117	10-35						Methods and compositions involving endopeptidases PepO2 and PepO3 - US Patent 7741438 Description	ww.patentstorm.us	0	0		
585	chrUn_JH122824	10452	10475	3500400996	23		10452	10475	8421504	1	23	0	g	350040099600000060	0-23						Rhynchosporium secalis: DNA sequences, gene composition and phylogenetic analysis	on.ethbib.ethz.ch	0	0		
585	chrUn_JH122837	21138	21163	3500429467	23		21138	21163	8421504	2	7,16	0,9	g	350042946700000004	1-24		15845460	10.1128/IAI.73.5.2586-2594.2005	0019-9567	Infection and Immunity	Modulation of Host Cytoskeleton Function by the Enteropathogenic Escherichia coli and Citrobacter rodentium Effector Protein EspG	Hardwidge	2005	4		
585	chrUn_JH122839	16326	25714	3500327449	42		16326	25714	8421504	2	20,22	0,9366	g	350032744900000041,350032744900000014,350032744900000013	0-20,0-22,0-22						Methods and Compositions for Improved Fertilization and Embryonic Survival	Khatib	2008	0		
585	chrUn_JH122839	18334	18364	3500172175	25		18334	18364	8421504	2	16,9	0,21	g	350017217500000009	10-35						ScienceDirect.com - FEBS Letters - FSH acts on the proliferation of type A spermatogonia via Nur77 that increases GDNF expression in the Sertoli cells	sciencedirect.com	0	0		
585	chrUn_JH122853	2964	2988	3500165943	24		2964	2988	8421504	1	24	0	c	350016594300000037	10-34						Dimer and multimer forms of single chain polypeptides	Mezes	1992	0		
585	chrUn_JH122853	2964	2988	3500135281	24		2964	2988	8421504	1	24	0	c	350013528100000036	10-34					Patent	Dimer and multimer forms of single chain polypeptides (Patent US:6329507)	Mezes	2001	0		
585	chrUn_JH122858	20477	20988	3500367934	88		20477	20988	8421504	4	44,15,19,10	0,59,76,501	g	350036793400000486	4-123						Method for enhancing the quality of life of a senior animal	Frantz	2010	0		
585	chrUn_JH122868	14819	14912	3500174217	75		14819	14912	8421504	2	54,21	0,72	c	350017421700000003,350017421700000002,350017421700000006,350017421700000000	0-28,26-46,0-27,0-21						The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha. - ResearchGate	.researchgate.net	0	0		PNRC1
585	chrUn_JH122868	15153	17452	3500027958	29		15153	17452	8421504	4	6,7,9,7	0,8,17,2292	c	350002795800000028	9-39						Incorporation on Non-Naturally Encoded Amino Acids Into Proteins	Cho	2008	0		
585	chrUn_JH122877	16902	16927	3500327881	23		16902	16927	8421504	3	14,4,5	0,15,20	g	350032788100000000	0-25			10.1111/j.1365-2958.2007.06047.x	1365-2958	Molecular Microbiology	Acquisition of a bacterial RumA-type tRNA(uracil-54, C5)-methyltransferase by Archaea through an ancient horizontal gene transfer - Urbonavi&#x010d;ius - 2007 - Molecular Microbiology - Wiley Online Library	Urbonavicius	2008	0		
585	chrUn_JH122882	995	1023	3500465109	23		995	1023	8421504	2	13,10	0,18	g	350046510900000009	9-32						REPRODUCTION	uction-online.org	0	0		
585	chrUn_JH122884	5913	5948	3500373969	28		5913	5948	8421504	3	5,8,15	0,7,20	g	350037396900000076	0-28						Transgenic non-human animals capable of producing heterologous antibodies		1998	0		
585	chrUn_JH122889	6616	6643	3500351243	23		6616	6643	8421504	2	15,8	0,19	g	350035124300000217	10-35						ANTISENSE INHIBITION VIA RNASE H-INDEPENDENT REDUCTION IN MRNA - Patent application	www.faqs.org	0	0		
585	chrUn_JH122906	26058	26088	3500096515	24		26058	26088	8421504	3	14,4,6	0,15,24	g	350009651500000245	4-28						Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins	M*Le Na Er 	2007	0		
585	chrUn_JH122937	21106	21133	3500263908	25		21106	21133	8421504	2	11,14	0,13	g	350026390800000345	1-31						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
585	chrUn_JH122954	77041	77070	3500091279	24		77041	77070	8421504	3	5,14,5	0,8,24	g	350009127900000021	7-32					Patent	Antibodies to cortistatin: neuropeptides, compositions and methods (Patent US:6814967)	Sutcliffe	2004	0		
585	chrUn_JH122954	79407	79431	3500233276	23		79407	79431	8421504	2	16,7	0,17	g	350023327600000056	0-23						LA FAMILIA DE GENES DE LA QUERATINA 6: CARACTERIZACION Y REGULACION	emigracion.ucm.es	0	0		
585	chrUn_JH122954	98445	98480	3500072483	30		98445	98480	8421504	3	14,8,8	0,18,27	g	350007248300000153	5-38						Method of Producing Transgenic Graminaceous Cells and Plants - Patent application	www.faqs.org	0	0		
586	chrUn_JH122954	155214	163369	3500343582	70		155214	163369	8421504	4	22,23,13,12	0,1855,6630,8143	c,g	350034358200000028,350034358200000029,350034358200000052	0-22,0-23,0-25						ABSTRACT	tory.lib.ncsu.edu	0	0		
586	chrUn_JH122954	157160	157193	3500103255	33		157160	157193	8421504	1	33	0	c	350010325500000001	0-33						&#x03b1;-Enolase binds to RNA	teca.cinvestav.mx	0	0		MEF2A
586	chrUn_JH122954	157161	157186	3500034141	25		157161	157186	8421504	1	25	0	c	350003414100000014	0-25						COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY - Patent application	www.faqs.org	0	0		LDLRAD4
586	chrUn_JH122954	157348	157373	3500453252	25		157348	157373	8421504	1	25	0	c	350045325200000014	6-31		22530004	10.1371/journal.pone.0035302		PLoS ONE	Role of the CCAAT-Binding Protein NFY in SCA17 Pathogenesis	Li-Ching	2012	0		TBP
586	chrUn_JH122954	157404	159479	3500077888	27		157404	159479	8421504	2	4,23	0,2052	c	350007788800000047	0-27						UNIVERSITA'DEGLI STUDI DI PADOVA	arch.cab.unipd.it	0	0		TBP
586	chrUn_JH122954	159467	159490	3500155425	23		159467	159490	8421504	1	23	0	c,g	350015542500000001,350015542500000001	0-23,0-23						Monitoring human mesenchymal stromal cell differentiation by electrochemical impedance sensing. - ResearchGate	.researchgate.net	0	0		TBP
586	chrUn_JH122954	159481	159506	3500029380	25		159481	159506	8421504	1	25	0	c	350002938000000011	20-45						The role of Akt2 and SGK1 in dendritic cells	.uni-tuebingen.de	0	0		
586	chrUn_JH122954	159488	159514	3500467582	26		159488	159514	8421504	1	26	0	c	350046758200000021	21-47						Gene array identification of Ipf1/Pdx1-/- regulated genes in pancreatic progenitor cells. - ResearchGate	.researchgate.net	0	0		TBP
586	chrUn_JH122954	159488	159514	3500408717	26		159488	159514	8421504	1	26	0	c	350040871700000021	21-47						BMC Developmental Biology BioMed Central	biomedcentral.com	0	0		TBP
586	chrUn_JH122954	159495	161694	3500464199	41		159495	161694	8421504	3	21,15,5	0,1503,2194	c,g	350046419900000026,350046419900000026,350046419900000027	0-21,0-21,0-20				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		TBP
586	chrUn_JH122954	159529	161808	3500312136	42		159529	161808	8421504	3	15,7,20	0,1392,2259	c	350031213600000008,350031213600000026,350031213600000009,350031213600000027	0-22,0-22,0-20,0-20						DOWN-REGULATION OF COLD SHOCK PROTEINS FOR CANCER TREATMENT - Patent application	www.faqs.org	0	0		TBP
586	chrUn_JH122954	159529	161808	3500167785	42		159529	161808	8421504	3	15,7,20	0,1392,2259	c	350016778500000003,350016778500000004	0-22,0-20		21357425	10.1074/jbc.M110.210765	0021-9258	Journal of Biological Chemistry	The Cancer/Testis Antigen Prostate-associated Gene 4 (PAGE4) Is a Highly Intrinsically Disordered Protein	Zeng	2011	5		TBP
586	chrUn_JH122954	159529	161808	3500167205	42		159529	161808	8421504	3	15,7,20	0,1392,2259	c,g	350016720500000003,350016720500000004,350016720500000004	0-22,0-20,0-20		21357425	10.1074/jbc.M110.210765		The Journal of Biological Chemistry	The Cancer/Testis Antigen Prostate-associated Gene 4 (PAGE4) Is a Highly Intrinsically Disordered Protein	Yu	2011	0		TBP
586	chrUn_JH122954	159532	163442	3500356850	267		159532	163442	8421504	5	12,92,73,5,85	0,1389,2157,2320,3825	p	350035685000015006,350035685000015007,350035685000015009	0-87,0-90,0-90						Lycoming : BIO 43701 : htbpseq	ww.coursehero.com	0	0		TBPL2
586	chrUn_JH122954	160991	161806	3500434784	40		160991	161806	8421504	2	20,20	0,795	c	350043478400000015,350043478400000016	0-20,0-20		23915343	10.1186/1478-811X-11-55	1478-811X	Cell Communication and Signaling	Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling	Jaafar	2013	6		TBP
586	chrUn_JH122954	160991	161806	3500330806	40		160991	161806	8421504	2	20,20	0,795	c	350033080600000010,350033080600000011	0-20,0-20		22094473	10.1152/ajpendo.00314.2011		American Journal of Physiology - Endocrinology and Metabolism	Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice	Laugerette	2012	0		TBP
586	chrUn_JH122954	160991	161806	3500316609	40		160991	161806	8421504	2	20,20	0,795	c	350031660900000015,350031660900000016	0-20,0-20		23915343	10.1186/1478-811X-11-55		Cell Communication and Signaling : CCS	Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling	Rami	2013	0		TBP
586	chrUn_JH122954	160991	161806	3500198030	40		160991	161806	8421504	2	20,20	0,795	c,g	350019803000000010,350019803000000010,350019803000000011,350019803000000011	0-20,0-20,0-20,0-20		22094473	10.1152/ajpendo.00314.2011		American Journal of Physiology - Endocrinology and Metabolism	Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice	Laugerette	2012	0		TBP
586	chrUn_JH122954	160991	161806	3500061264	40		160991	161806	8421504	2	20,20	0,795	c,g	350006126400000015,350006126400000016,350006126400000016	0-20,0-20,0-20						Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling	.biosignaling.com	0	0		TBP
586	chrUn_JH122954	160997	161800	3500406924	40		160997	161800	8421504	3	16,4,20	0,692,783	c	350040692400000014,350040692400000015	0-20,0-20						aPhysikalischer Status des HPV16 Genoms und die virale Onkogenexpression a Bedeutung fA1/4r di	.db-thueringen.de	0	0		
586	chrUn_JH122954	160997	161800	3500343706	40		160997	161800	8421504	3	16,4,20	0,692,783	c	350034370600000010,350034370600000011	0-20,0-20						Accumulation of lactosylceramide and overexpression of a PSC833-resistant P-glycoprotein in multidrug-resistant human sarcoma cells. - ResearchGate	.researchgate.net	0	0		
586	chrUn_JH122954	160997	161800	3500066497	40		160997	161800	8421504	3	16,4,20	0,692,783	c,g	350006649700000010,350006649700000011,350006649700000011	0-20,0-20,0-20						Accumulation of lactosylceramide and overexpression of a PSC833-resistant P-glycoprotein in multidrug-resistant human sarcoma cells	-publications.com	0	0		
586	chrUn_JH122954	161002	161836	3500182123	40		161002	161836	8421504	3	11,9,20	0,687,814	c	350018212300000004,350018212300000005	0-20,0-20						EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth. - ResearchGate	.researchgate.net	0	0		TBP
586	chrUn_JH122954	161011	163381	3500139310	42		161011	163381	8421504	3	2,18,22	0,678,2348	c	350013931000000002,350013931000000003	0-20,0-22						N-Cadherin and Ly6 E: Targets for Cancer Diagnosis and Therapy - Patent application	www.faqs.org	0	0		
586	chrUn_JH122954	161788	163381	3500416653	41		161788	163381	8421504	2	20,21	0,1572	c,g	350041665300000004,350041665300000004,350041665300000005	0-20,0-20,0-21		20628393	10.1038/sj.bjc.6605763		British Journal of Cancer	A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk	E	July	0		TBP
586	chrUn_JH122954	161788	163381	3500241908	41		161788	163381	8421504	2	20,21	0,1572	c	350024190800000004,350024190800000005	0-20,0-21						A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk.	.biomedsearch.com	0	0		TBP
586	chrUn_JH122954	161788	163381	3500111241	41		161788	163381	8421504	2	20,21	0,1572	c,g	350011124100000004,350011124100000004,350011124100000005	0-20,0-20,0-21		20628393	10.1038/sj.bjc.6605763	0007-0920	British Journal of Cancer	A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk	Katz	2010	5		TBP
586	chrUn_JH122954	161788	163381	3500080762	41		161788	163381	8421504	2	20,21	0,1572	c,g	350008076200000004,350008076200000004,350008076200000005	0-20,0-20,0-21		20628393	10.1038/sj.bjc.6605763	0007-0920	British Journal of Cancer	A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk	Katz	2010	5		TBP
586	chrUn_JH122954	161790	163383	3500084572	77		161790	163383	8421504	3	27,24,26	0,34,1567	c	350008457200000017,350008457200000031,350008457200000035,350008457200000021,350008457200000018,350008457200000032	0-27,0-27,0-24,0-24,0-26,0-26						Hunk, a snfi-related kinase essential for mammary tumor metastasis - Patent application	www.faqs.org	0	0		
586	chrUn_JH122954	161790	163381	3500056305	49		161790	163381	8421504	3	24,1,24	0,66,1567	c	350005630500000006,350005630500000007	0-24,0-25		21763902	10.1016/j.joen.2011.05.009		Journal of endodontics	Biomimetic Calcium-Silicate Cements Support Differentiation Of Human Orofacial Mesenchymal Stem Cells	Maria	2011	0		
586	chrUn_JH122954	161790	163381	3500017715	49		161790	163381	8421504	3	24,1,24	0,66,1567	c	350001771500000006,350001771500000007	0-24,0-25		19555657	10.1016/j.bbrc.2009.06.106		Biochemical and biophysical research communications	Dynamic Hydrostatic Pressure Promotes Differentiation of Human Dental Pulp Stem Cells	V	2009	0		
586	chrUn_JH122954	161831	163409	3500165278	45		161831	163409	8421504	2	21,24	0,1554	c,g	350016527800000207,350016527800000207,350016527800000208	0-21,0-21,0-24						Genomic approach to understanding variation in bovine fat colour	y.adelaide.edu.au	0	0		
586	chrUn_JH122954	161844	163369	3500306908	25		161844	163369	8421504	2	13,12	0,1513	c	350030690800000004	0-25				0021-8812		Amount and source of dietary copper affects small intestine morphology, duodenal lipid peroxidation, hepatic oxidative stress,and mRNA expression of hepatic copper regulatory proteins in weanling pigs 	animalscience.org	0	2		
586	chrUn_JH122954	161844	163369	3500206635	25		161844	163369	8421504	2	13,12	0,1513	c	350020663500000006	0-25						COMPOSITION FOR MANUFACTURING A SCAFFOLD FOR TISSUE ENGINEERING, AND A METHOD OF MAKING IT - NANYANG TECHNOLOGICAL UNIVERSITY	www.sumobrain.com	0	0		
586	chrUn_JH122954	161844	163369	3500193250	25		161844	163369	8421504	2	13,12	0,1513	c	350019325000000007	0-25						BMC Molecular Biology BioMed Central	curis.ku.dk	0	0		
586	chrUn_JH122954	161844	163369	3500167894	25		161844	163369	8421504	2	13,12	0,1513	c	350016789400000073	0-25						&#xc9;COLE DOCTORALE SST	lis.univ-tours.fr	0	0		
586	chrUn_JH122954	161844	163369	3500157269	25		161844	163369	8421504	2	13,12	0,1513	c	350015726900000073	0-25						&#xc9;COLE DOCTORALE SST	scd.univ-tours.fr	0	0		
586	chrUn_JH122954	172292	172323	3500290366	25		172292	172323	8421504	3	5,9,11	0,9,20	c	350029036600000111	23-48						FUNGUS RESISTANT PLANTS AND THEIR USES - Patent application	www.faqs.org	0	0		
585	chrUn_JH122968	6662	6702	3500190573	40		6662	6702	8421504	1	40	0	c	350019057300000036	0-40						Use of the CYP46A1 Gene for the Treatment of Alzheimer's Disease - Patent application	www.faqs.org	0	0		
585	chrUn_JH122972	13207	13231	3500203324	23		13207	13231	8421504	2	19,4	0,20	g	350020332400000144	10-34						Alphavirus structural protein expression cassettes	Dubensky	1996	0		
585	chrUn_JH122976	2255	2279	3500266119	24		2255	2279	8421504	1	24	0	g	350026611900000009	0-24						Discovery and pro&#xfb01;ling of bovine microRNAs from immune-related and embryonic tissues	cs.physiology.org	0	0		
585	chrUn_JH122981	91626	91649	3500153724	23		91626	91649	8421504	1	23	0	c	350015372400000019	0-23						Cellular Adaptation of Macrophages to Anthrax Lethal Toxin-Induced Pyroptosis via Epigenetic Mechanisms	ir.lib.uwo.ca	0	0		HDAC8
586	chrUn_JH122981	231504	261653	3500460440	23		231504	261653	8421504	2	7,16	0,30133	c	350046044000000009,350046044000000058	0-23,0-23						Methods of Treating Smooth Muscle Cell Disorders - Patent application	www.faqs.org	0	0		
586	chrUn_JH122981	231510	261659	3500404071	23		231510	261659	8421504	2	1,22	0,30127	c	350040407100000001	18-41		20816742	10.1016/j.ab.2010.08.040		Analytical biochemistry	Coumarin-SAHA as a Fluorescent Probe for Determining Binding Affinities and Off-Rates of Histone Deacetylase Inhibitors	Raushan	2011	0		HDAC8
585	chrUn_JH122983	15717	15740	3500298504	23		15717	15740	8421504	1	23	0	g	350029850400000138	3-34						Streptococcal heat shock proteins members of the HSP70 family	J*Ha Mei Er 	1998	0		
585	chrUn_JH122987	6418	6539	3500000589	121		6418	6539	8421504	1	121	0	g	350000058900000030	0-122						COMPOSITIONS AND METHODS FOR DIAGNOSIS OF GENETIC SUSCEPTIBILITY, RESISTANCE, OR TOLERANCE TO INFECTION BY MYCOBACTERIA AND BOVINE PARATUBERCULOSIS - Patent application	www.faqs.org	0	0		
585	chrUn_JH122988	13222	13253	3500347811	25		13222	13253	8421504	3	7,13,5	0,12,26	g	350034781100000000	6-31		21795357	10.1128/JVI.00301-11	0022-538X	Journal of Virology	Galectin-1 Binds to Influenza Virus and Ameliorates Influenza Virus Pathogenesis	Yang	2011	5		
585	chrUn_JH122989	18319	18345	3500043984	24		18319	18345	8421504	2	9,15	0,11	g	350004398400000095,350004398400000038	0-24,0-24						Compositions And Methods Comprising Alpha-Amylase Variants With Altered Properties - Patent application	www.faqs.org	0	0		
585	chrUn_JH122991	1150	1335	3500204873	48		1150	1335	8421504	3	9,23,16	0,11,169	g	350020487300000014,350020487300000036	4-58,4-58						US Patent # 7,056,672. Method of identifying an open reading frame using a nucleic acid molecule encoding multiple start codons and histidine tags - Patents.com	www.patents.com	0	0		
585	chrUn_JH122991	1150	1335	3500199599	48		1150	1335	8421504	3	9,23,16	0,11,169	g	350019959900000014	4-58						Method of identifying an open reading frame using a nucleic acid molecule encoding multiple start codons and histidine tags	Schnable	2004	0		
585	chrUn_JH122992	8586	8717	3500029854	42		8586	8717	8421504	2	21,21	0,110	g	350002985400000000,350002985400000001	0-21,0-21						Suitability Of Bovine Sexing Primers For Sex Determination Of Caprine Cells	w.biology.ewu.edu	0	0		
585	chrUn_JH122993	14313	14336	3500008756	23		14313	14336	8421504	1	23	0	g	350000875600000853	20-43						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
585	chrUn_JH123001	7386	7632	3500349767	40		7386	7632	8421504	2	20,20	0,226	g	350034976700000026,350034976700000027	0-20,0-20						Reproductive Biology and Endocrinology BioMed Central	www.rbej.com	0	0		
585	chrUn_JH123042	2464	2493	3500201852	24		2464	2493	8421504	2	11,13	0,16	g	350020185200000439	0-24						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
585	chrUn_JH123049	23153	23933	3500035733	26		23153	23933	8421504	2	22,4	0,776	c	350003573300000002	9-35			10.1128/JVI.78.14.7299-7310.2004		Journal of Virology	Accumulation of Heterochromatin Components on the Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus Mediated by the Latency-Associated Nuclear Antigen	Shuhei	July	0		
585	chrUn_JH123068	18278	18304	3500008756	24		18278	18304	8421504	3	6,4,14	0,7,12	g	350000875600000452	16-45						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
585	chrUn_JH123076	1043	1074	3500057287	27		1043	1074	8421504	3	8,5,14	0,11,17	g	350005728700000200	13-44						METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH123078	0	5586	3500236344	5533		0	5586	8421504	12	1965,48,169,748,2208,48,20,75,78,18,115,41	0,1966,2015,2185,2934,5143,5197,5219,5299,5394,5419,5545	g	350023634400000068	8916-14506						Double-muscling in mammals	Georges	2006	0		
585	chrUn_JH123078	10037	10061	3500254627	23		10037	10061	8421504	2	9,14	0,10	g	350025462700000005	12-35						4-Hydroxyacetophenone monooxygenase from Pseudomonas fluorescens ACB	tations.ub.rug.nl	0	0		
585	chrUn_JH123090	5142	5169	3500134317	23		5142	5169	8421504	2	8,15	0,12	g	350013431700000625	4-39						Perhydrolase 	.freshpatents.com	0	0		
585	chrUn_JH123097	6209	6232	3500204495	23		6209	6232	8421504	1	23	0	g	350020449500000051	4-40						Novel Tannase Gene And Protein Thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH123101	16213	16242	3500448578	24		16213	16242	8421504	3	6,6,12	0,10,17	g	350044857800000044	2-29						Thermostable cellulase	Wicher	2001	0		
585	chrUn_JH123142	60142	60176	3500150332	28		60142	60176	8421504	4	5,13,5,5	0,7,21,29	g	350015033200000011	6-34						Nucleotide Primer Set And Nucleotide Probe For Detecting Genotype Of Methylene Tetrahydrofolate Reductase (mthfr) 	.freshpatents.com	0	0		
585	chrUn_JH123154	7949	7974	3500386452	23		7949	7974	8421504	2	18,5	0,20	g	350038645200000138	3-28						NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES	Anderson	2011	0		
585	chrUn_JH123169	1007	13412	3500100319	350		1007	13412	8421504	5	21,43,132,134,20	0,9568,10790,11577,12385	p,c,g	350010031900000002,350010031900000234,350010031900015064,350010031900000235,350010031900000236,350010031900000237,350010031900000237,350010031900000238,350010031900015071,350010031900000239,350010031900000241,350010031900000242,350010031900015078,350010031900000243,350010031900000243,350010031900000003,350010031900000003	0-21,0-30,0-96,0-30,0-30,0-30,0-30,0-30,0-120,0-30,0-31,0-30,0-66,0-30,0-30,0-20,0-20						Aus dem Institut f&#xfc;r Reproduktionsmedizin der Tier&#xe4;rztlichen Hochschule Hannover	ierarzt-schupp.de	0	0		
585	chrUn_JH123173	13086	13111	3500166513	23		13086	13111	8421504	2	17,6	0,19	g	350016651300000035	0-24						Isolation and Functional Characterization of a Dioxin-Inducible CYP1A Regulatory Region From Zebrafish ( Gary T. ZeRuth A dissertation submitted in partial fulfillment	gradworks.umi.com	0	0		
585	chrUn_JH123233	2310	2336	3500255929	24		2310	2336	8421504	2	5,19	0,7	g	350025592900000016	0-24						Human elastase i	Dunlop	2000	0		
585	chrUn_JH123239	14600	14632	3500457588	27		14600	14632	8421504	2	13,14	0,18	g	350045758800000017	0-27		12414957	10.1128/JVI.76.23.12173-12184.2002	0022-538X	Journal of Virology	Direct Binding of Human Immunodeficiency Virus Type 1 Nef to the Major Histocompatibility Complex Class I (MHC-I) Cytoplasmic Tail Disrupts MHC-I Trafficking	Williams	2002	5		
585	chrUn_JH123243	18686	18721	3500244410	35		18686	18721	8421504	1	35	0	c	350024441000000031	0-35			10.1128/MCB.21.1.209-223.2001		Molecular and Cellular Biology	Identification and Characterization of Human Orthologues to Saccharomyces cerevisiae Upf2 Protein and Upf3 Protein (Caenorhabditis elegans SMG-4)	Guillaume	2001	0		
585	chrUn_JH123243	25165	25669	3500237753	23		25165	25669	8421504	3	8,11,4	0,11,500	c	350023775300000004	1-24						Histonedeacetylaseinhibitorsinducegrowtharrest, apoptosis,anddifferentiationinclearcell sarcomamodels	.aacrjournals.org	0	0		
585	chrUn_JH123243	109049	109077	3500258675	24		109049	109077	8421504	2	18,6	0,22	g	350025867500000071	6-30					Patent	Probes targeted to rRNA spacer regions, methods and kits for using said probes, for the detection of respiratory tract pathogens (Patent US:6025132)	Jannes	2000	0		
585	chrUn_JH123243	109049	109077	3500200766	24		109049	109077	8421504	2	18,6	0,22	g	350020076600000707	1-25						US Patent # 7,390,623. Detection and identification of staphylococcus aureus and epidermidis using the 16S-23S rRNA spacer - Patents.com	www.patents.com	0	0		
585	chrUn_JH123243	109049	109077	3500108046	24		109049	109077	8421504	2	18,6	0,22	g	350010804600000060	6-30						Simultaneous detection, identification and differentiation of eubacterial taxa using a hybridization assay	Jannes	1997	0		
585	chrUn_JH123243	109049	109077	3500102197	24		109049	109077	8421504	2	18,6	0,22	g	350010219700000071	6-30					Patent	Simultaneous detection, identification and differentiation of Mycobacterium species using a hybridization assay (Patent EP:1091004)	Jannes	2009	0		
585	chrUn_JH123248	15081	15112	3500463073	31		15081	15112	8421504	1	31	0	g	350046307300000001	29-60						 BMP 	www.docstoc.com	0	0		
585	chrUn_JH123248	17042	17143	3500447411	101		17042	17143	8421504	1	101	0	g	350044741100000003,350044741100000004	0-60,0-41						Osteoinductive compositions	Celeste	1990	0		
585	chrUn_JH123248	17042	17143	3500323542	101		17042	17143	8421504	1	101	0	g	350032354200000003,350032354200000004	0-60,0-41						Bmp-5 derivatives	Celeste	1992	0		
585	chrUn_JH123268	15379	15407	3500127308	24		15379	15407	8421504	2	9,15	0,13	g	350012730800000605	23-47						PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS - Patent application	www.faqs.org	0	0		
585	chrUn_JH123269	3490	3514	3500200020	24		3490	3514	8421504	1	24	0	c	350020002000000000	0-24					Cancer biology & therapy	Thymosin Beta 4 is Overexpressed in Human Pancreatic Cancer Cells and Stimulates Proinflammatory Cytokine Secretion and JNK Activation	Yuqing	2008	0		TMSB4X
585	chrUn_JH123275	8022	8046	3500023736	23		8022	8046	8421504	2	5,18	0,6	g	350002373600000009	1-25						Virulence And Antibiotic Resistance Array And Uses Thereof 	.freshpatents.com	0	0		
585	chrUn_JH123287	19319	19346	3500148414	23		19319	19346	8421504	3	6,4,13	0,9,14	g	350014841400000184	8-31						Development of novel anti-microbial agents based on bacteriophage genomics	Pelletier	1999	0		
585	chrUn_JH123301	23212	23237	3500277495	23		23212	23237	8421504	3	4,15,4	0,5,21	g	350027749500000002	5-28						THE JOURNAL OF BIOLOGICAL C Vol. 279, No. 19, Issue of May 7, pp. 20392&#x2013;20400, 2004 &#xa9; 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Role of Src-induced Dynamin-2 Phosphorylation in Caveolae-mediate	www.jbc.org	0	0		
585	chrUn_JH123308	8158	8182	3500130528	23		8158	8182	8421504	2	5,18	0,6	g	350013052800000031	0-23			10.1111/j.1365-2672.2005.02790.x	1365-2672	Journal of Applied Microbiology	Sequence, organization, transcription and regulation of lactose and galactose operons in Lactobacillus rhamnosus TCELL-1 - Tsai - 2006 - Journal of Applied Microbiology - Wiley Online Library	Tsai	2006	0		
585	chrUn_JH123311	16569	16597	3500009980	24		16569	16597	8421504	3	12,4,8	0,13,20	g	350000998000000023	22-46						METHOD FOR TREATING AN AUTOIMMUNE DISEASE USING A SOLUBLE CTLA4 MOLECULE AND A DMARD OR NSAID - Patent application	www.faqs.org	0	0		
585	chrUn_JH123326	5460	5488	3500194519	23		5460	5488	8421504	2	17,6	0,22	g	350019451900000246	10-33						CLONING AND CHARACTERIZATION OF THE CAPSULE TRANSPORT GENE REGION FROM Haemophilus paragallinarum	etd.uovs.ac.za	0	0		
585	chrUn_JH123326	12598	12624	3500108665	24		12598	12624	8421504	2	15,9	0,17	g	350010866500000066	0-25						US Patent # 5,516,683. Human D4 dopamine receptor and its uses - Patents.com	www.patents.com	0	0		
585	chrUn_JH123346	2584	2609	3500070288	23		2584	2609	8421504	3	4,5,14	0,5,11	g	350007028800000580	13-36						Methods for the detection of encysted parasites - US Patent 6514694 Description	ww.patentstorm.us	0	0		
585	chrUn_JH123363	10089	10116	3500237109	24		10089	10116	8421504	2	6,18	0,9	g	350023710900000040	0-31						A starchless variety of pisum sativum having elevated levels of sucrose	Burgess	1999	0		
585	chrUn_JH123387	3715	3741	3500034199	23		3715	3741	8421504	2	11,12	0,14	g	350003419900000107	4-27						MODULATION OF APOLIPOPROTEIN (a) EXPRESSION - Patent application	www.faqs.org	0	0		
585	chrUn_JH123426	8311	8341	3500031022	25		8311	8341	8421504	2	7,18	0,12	g	350003102200000150	1-26						NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY - Patent application	www.faqs.org	0	0		
585	chrUn_JH123506	14058	14083	3500343977	24		14058	14083	8421504	2	19,5	0,20	g	350034397700000040	8-32						Methods for the Diagnosis of Fetal Abnormalities	Kapur	2007	0		
585	chrUn_JH123555	9859	9883	3500424306	24		9859	9883	8421504	1	24	0	g	350042430600000064	0-24						10897 microsatellite 9668 control region 4597 Vector: pCMV-SPORT6.0 1738 Vector: pExpress1 1036 puta	www.ibio.jp	0	0		
585	chrUn_JH123566	9918	10110	3500114924	185		9918	10110	8421504	2	29,156	0,36	g	350011492400000000	0-187						 Tophat can't find Bowtie index files - Page 2 - SEQanswers	seqanswers.com	0	0		
585	chrUn_JH123567	23731	23759	3500253486	23		23731	23759	8421504	2	8,15	0,13	g	350025348600000013	1-24					Patent	Methods for producing probes capable of distinguishing DNA from related sources (Patent US:6159713)	Lisitsyn	2000	0		
585	chrUn_JH123567	23731	23759	3500252754	23		23731	23759	8421504	2	8,15	0,13	g	350025275400000014	1-24					Patent	Methods for producing probes capable of distinguishing DNA from related sources (Patent US:5501964)	Lisitsyn	1996	0		
585	chrUn_JH123567	23731	23759	3500163394	23		23731	23759	8421504	2	8,15	0,13	g	350016339400000014	1-24						Methods for producing probes capable of distinguishing DNA from related sources	Wigler	1993	0		
585	chrUn_JH123573	4440	4500	3500262611	60		4440	4500	8421504	1	60	0	c	350026261100000023,350026261100000022	0-23,11-48						ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO - Patent application	www.faqs.org	0	0		
585	chrUn_JH123573	4440	4463	3500294115	23		4440	4463	8421504	1	23	0	c	350029411500000053	0-23						ANTI-HDLK-1 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO - Patent application	www.faqs.org	0	0		
585	chrUn_JH123579	2565	2591	3500089910	26		2565	2591	8421504	1	26	0	g	350008991000000109	0-26						US Patent # 6,342,369. Apo-2-receptor - Patents.com	www.patents.com	0	0		
585	chrUn_JH123579	4305	4611	3500316103	44		4305	4611	8421504	3	10,4,30	0,142,276	g	350031610300000463	160-204						SureChem - Document - USPTO Granted - Patent No. 7485297 - "Method of inhibition of vascular development using an antibody" - Description	www.surechem.org	0	0		
585	chrUn_JH123579	4581	4611	3500199754	30		4581	4611	8421504	1	30	0	g	350019975400000256,350019975400000241	8-38,13-38						Tie1-binding Ligands 	.freshpatents.com	0	0		
585	chrUn_JH123579	4582	4612	3500395273	30		4582	4612	8421504	1	30	0	g	350039527300000172	0-30						CANINE IgG NUCLEIC ACID MOLECULES - Patent application	www.faqs.org	0	0		
585	chrUn_JH123579	4582	4611	3500258554	29		4582	4611	8421504	1	29	0	g	350025855400001232,350025855400001330,350025855400000212,350025855400001412	0-29,0-29,0-29,0-29						Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH123579	4588	4613	3500356815	25		4588	4613	8421504	1	25	0	g	350035681500000047	3-28						High affinity human antibodies to tumor antigens	Marks	1996	0		
585	chrUn_JH123579	11374	11401	3500114897	24		11374	11401	8421504	3	13,5,6	0,15,21	g	350011489700000157	13-40						COLLAGEN PRODUCING PLANTS AND METHODS OF GENERATING AND USING SAME - Patent application	www.faqs.org	0	0		
585	chrUn_JH123581	9994	10022	3500466133	23		9994	10022	8421504	3	5,5,13	0,8,15	g	350046613300000020	0-23						HUMAN PROTEIN SCAFFOLD WITH CONTROLLED SERUM PHARMACOKINETICS - Patent application	www.faqs.org	0	0		
585	chrUn_JH123640	15168	15195	3500203887	23		15168	15195	8421504	2	13,10	0,17	g	350020388700000061	0-23					Patent	G-CSF analog compositions and methods (Patent US:6632426)	Osslund	2003	0		
586	chrUn_JH123667	137332	137362	3500289406	27		137332	137362	8421504	2	14,13	0,17	g	350028940600000002	11-47						The role of genetics in understanding the pathophysiology of multiple sclerosis	real-d.mtak.hu	0	0		
585	chrUn_JH123724	14168	14194	3500389693	24		14168	14194	8421504	2	13,11	0,15	g	350038969300000348	6-30						Influenza Therapeutic - Patent application	www.faqs.org	0	0		
585	chrUn_JH123847	14210	14236	3500433279	23		14210	14236	8421504	3	11,7,5	0,12,21	g	350043327900000004	0-24						Transgenic plants presenting a modified inulin producing profile	Koops	2000	0		
585	chrUn_JH123867	14377	14401	3500398923	24		14377	14401	8421504	1	24	0	g	350039892300000123	3-27						PHAGE-DISPLAYING SINGLE-CHAIN ANTIBODY CAPABLE OF RECOGNIZING NON-REDUCED MANNOSE RESIDUE - Patent application	www.faqs.org	0	0		
585	chrUn_JH123876	894	923	3500145728	23		894	923	8421504	3	13,6,4	0,18,25	g	350014572800000007	9-32						Methods for the treatment of cancer using anti-CD40 antibodies - US Patent 7510711 Description	ww.patentstorm.us	0	0		
586	chrUn_JH123948	143486	143514	3500432568	23		143486	143514	8421504	3	6,12,5	0,9,23	g	350043256800000031	15-39						 VMP 	www.docstoc.com	0	0		
586	chrUn_JH123948	143486	143514	3500396369	23		143486	143514	8421504	3	6,12,5	0,9,23	g	350039636900000043	15-39						 VMP 	www.docstoc.com	0	0		
588	chrUn_JH123948	445774	445801	3500008756	23		445774	445801	8421504	2	16,7	0,20	g	350000875600000486	10-33						METHOD OF HEAT-STABILIZING alpha-GLUCAN PHOSPHORYLASE (GP) - Patent application	www.faqs.org	0	0		
590	chrUn_JH123948	706717	706740	3500266002	23		706717	706740	8421504	1	23	0	g	350026600200000397	11-39						Treatment of Cellulosic Material and Enzymes Useful Therein - Patent application	www.faqs.org	0	0		
591	chrUn_JH123948	827016	827042	3500351016	23		827016	827042	8421504	2	10,13	0,13	g	350035101600000122	10-33						Nematode-extracted anticoagulant protein	www.devileye.net	0	0		
594	chrUn_JH123948	1247720	1260319	3500072968	172		1247720	1260319	8421504	6	48,42,6,42,6,28	0,1777,6500,6554,6750,12571	c	350007296800000154,350007296800000157,350007296800000159,350007296800000173	0-48,0-48,0-48,0-28						Human proteins having transmembrane domains and dnas encoding these proteins	Kato	1999	0		
585	chrUn_JH123961	10293	10317	3500252038	24		10293	10317	8421504	1	24	0	g	350025203800000100	7-42					Patent	Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium (Patent CN:1170938)	Zhao Cang Yang Zi 	2004	0		
585	chrUn_JH123979	2131	2158	3500306201	24		2131	2158	8421504	2	10,14	0,13	g	350030620100000081,350030620100000074,350030620100000064,350030620100000066,350030620100000070,350030620100000085	5-32,5-24,5-24,5-24,5-24,5-24						Signal dependency of Tra2-beta1 alternative splicing	b.uni-erlangen.de	0	0		
585	chrUn_JH123991	19	47	3500333213	23		19	47	8421504	2	11,12	0,16	g	350033321300000016	7-30						CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF	Bukh	2000	0		
585	chrUn_JH123995	9615	9641	3500295916	24		9615	9641	8421504	2	16,8	0,18	g	350029591600000019	1-28			10.1128/MCB.24.10.4174-4183.2004		Molecular and Cellular Biology	Polypyrimidine Tract Binding Protein Modulates Efficiency of Polyadenylation	Pedro	2004	0		
585	chrUn_JH124002	8030	8059	3500460141	24		8030	8059	8421504	2	11,13	0,16	g	350046014100000011	0-24						Author's personal copy	www.dsa.unipd.it	0	0		
585	chrUn_JH124002	8030	8059	3500336592	24		8030	8059	8421504	2	11,13	0,16	g	350033659200000031	0-24						DIVERSIDADE GEN&#xc9;TICA, ANCESTRALIDADE INDIVIDUAL E MISCIGENA&#xc7;&#xc3;O NAS RA&#xc7;AS BOVINAS NO BRASIL COM BASE EM MICROSSAT&#xc9;LITES E HAPL&#xd3;TIPOS DE DNA MITOCONDRIAL: SUBS&#xcd;DIOS PARA A CONSERVA&#xc7;&#xc3;O	epositorio.unb.br	0	0		
585	chrUn_JH124030	5833	5859	3500289264	24		5833	5859	8421504	2	19,5	0,21	g	350028926400000031	24-48						US Patent # 6,346,382. Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto - Patents.com	www.patents.com	0	0		
585	chrUn_JH124041	10590	10620	3500060271	24		10590	10620	8421504	3	13,6,5	0,16,25	g	350006027100000038	0-24						IL-17 receptor like molecules and uses thereof - US Patent 7094566 Description	ww.patentstorm.us	0	0		
585	chrUn_JH124051	9192	9221	3500406455	29		9192	9221	8421504	1	29	0	c	350040645500000079	13-42						&#x9ad8;&#x3044;&#x30a8;&#x30cd;&#x30eb;&#x30ae;&#x30fc;&#x79fb;&#x52d5;&#x52b9;&#x7387;&#x3092;&#x6709;&#x3059;&#x308b;&#xff22;&#xff32;&#xff25;&#xff34;&#x767a;&#x73fe;&#x7cfb; &#xff08;&#x516c;&#x958b;&#x516c;&#x5831; 2008283959&#xff09;&#xff5c;&#x30a2;&#x	astamuse.com	0	0		
585	chrUn_JH124074	12700	12763	3500427057	63		12700	12763	8421504	1	63	0	g	350042705700000008	19-82						Tracheal antimicrobial peptides, DNA sequences and methods for the production and use thereof	Zasloff	1990	0		
585	chrUn_JH124083	2995	3027	3500084119	26		2995	3027	8421504	3	7,13,6	0,11,26	g	350008411900000078	5-31						HUMANIZED ANTIBODIES SPECIFIC FOR AMINO ACID SEQUENCE RGD OF AN EXTRACELLULAR MATRIX PROTEIN AND THE USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH124093	10818	10843	3500105965	25		10818	10843	8421504	1	25	0	g	350010596500000034,350010596500000002	1-26,1-26						Method of genetically altering and producing allergy free cats - Patent application	www.faqs.org	0	0		
585	chrUn_JH124093	19778	19807	3500440622	29		19778	19807	8421504	1	29	0	g	350044062200000057,350044062200000049	43-73,51-81						Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor	Gefter	1995	0		
585	chrUn_JH124169	2766	2898	3500365974	42		2766	2898	8421504	2	21,21	0,111	g	350036597400000000,350036597400000001	0-21,0-21			10.1071/RDv20n1Ab270	1448-5990	Reproduction, Fertility and Development	 270 STILL GLOWING AFTER ALL THESE YEARS: STORAGE LIFE OFA COMPLETE BOVINE SEXING PCR MIX		2007	0		
585	chrUn_JH124242	1819	1843	3500446110	23		1819	1843	8421504	2	10,13	0,11	g	350044611000000030	2-36						ANTIBODIES TO LYMPHOTOXIN-ALPHA	Adams	2012	0		
585	chrUn_JH124255	4176	4201	3500073664	23		4176	4201	8421504	2	5,18	0,7	g	350007366400000089	15-39						Lepidopteran-active bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use - Patent application	www.faqs.org	0	0		
585	chrUn_JH124356	57388	57413	3500100734	25		57388	57413	8421504	1	25	0	g	350010073400000058	0-44						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
585	chrUn_JH124356	57628	57656	3500218185	24		57628	57656	8421504	2	7,17	0,11	c	350021818500000052	17-42						Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
585	chrUn_JH124393	1366	1396	3500348340	23		1366	1396	8421504	3	5,8,10	0,7,20	g	350034834000000048	21-44						US Patent # 5,605,690. Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor - Patents.com	www.patents.com	0	0		
585	chrUn_JH124451	5961	5986	3500459406	23		5961	5986	8421504	2	7,16	0,9	g	350045940600000138	8-31						BIOSENSORS FOR DETECTING MACROMOLECULES AND OTHER ANALYTES - Patent application	www.faqs.org	0	0		
585	chrUn_JH124493	9991	10018	3500370305	23		9991	10018	8421504	2	6,17	0,10	g	350037030500000121	0-23						 3 	www.docstoc.com	0	0		
585	chrUn_JH124493	9991	10018	3500312386	23		9991	10018	8421504	2	6,17	0,10	g	350031238600000118	3-26						ALANINE 2, 3-AMINOMUTASE - Patent application	www.faqs.org	0	0		
585	chrUn_JH124493	9991	10018	3500166501	23		9991	10018	8421504	2	6,17	0,10	g	350016650100000127	0-23						3-hydroxypropionic acid and other organic compounds - US Patent 7186541 Description	ww.patentstorm.us	0	0		
585	chrUn_JH124493	9991	10018	3500104401	23		9991	10018	8421504	2	6,17	0,10	g	350010440100000127	3-26						3-HYDROXYPROPIONIC ACID AND OTHER ORGANIC COMPOUNDS - Patent application	www.faqs.org	0	0		
585	chrUn_JH124493	9991	10018	3500031391	23		9991	10018	8421504	2	6,17	0,10	g	350003139100000053	3-26						METHOD FOR PRODUCTION OF POLYLACTATE USING RECOMBINANT MICROORGANISM - Patent application	www.faqs.org	0	0		
585	chrUn_JH124515	5528	5553	3500253428	23		5528	5553	8421504	2	8,15	0,10	g	350025342800000004	9-35						Structures of Carbohydrate, Cysteine and Cystine Binding Receptors of ATP-Binding Cassette (ABC) Transporters	diss.fu-berlin.de	0	0		
585	chrUn_JH124550	6409	6435	3500031312	24		6409	6435	8421504	2	7,17	0,9	g	350003131200000002	14-38					Patent	Polyhydroxyalkanoate synthesis in plants (Patent US:6103956)	Eschenlauer	2000	0		
585	chrUn_JH124575	1911	1937	3500328045	24		1911	1937	8421504	3	8,12,4	0,9,22	g	350032804500000008	16-40						Global Transcription Pro&#xfb01;ling Reveals Comprehensive	.plantphysiol.org	0	0		
585	chrUn_JH124631	285	313	3500383088	23		285	313	8421504	2	8,15	0,13	g	350038308800000623,350038308800000592	1-27,1-27						METHODS AND COMPOSITIONS FOR TREATING TUMOR DISEASES - Patent application	www.faqs.org	0	0		
585	chrUn_JH124650	11609	11640	3500117501	25		11609	11640	8421504	3	12,8,5	0,17,26	g	350011750100000006	5-31						Up-regulationofLoricrinExpressionbyCellAdhesion MoleculeNectin-1throughRap1-ERKSignaling inKeratinocytes	www.jbc.org	0	0		
585	chrUn_JH124686	7128	7156	3500317364	26		7128	7156	8421504	2	8,18	0,10	g	350031736400000037	1-27						Flax seed specific promoters - US Patent 7642346 Description	ww.patentstorm.us	0	0		
585	chrUn_JH124748	2828	2877	3500074547	49		2828	2877	8421504	1	49	0	g	350007454700000000	0-49						Sondes moleculaires d'adn specifique du genome male du genre bos	Bishop	1989	0		
585	chrUn_JH124840	3575	3602	3500258818	23		3575	3602	8421504	3	4,14,5	0,5,22	g	350025881800000045	11-34						METHODS AND MATERIALS RELATED TO HAIR PIGMENTATION AND CANCER - Patent application	www.faqs.org	0	0		
585	chrUn_JH124844	2368	2394	3500052253	24		2368	2394	8421504	3	13,4,7	0,14,19	g	350005225300000050	9-36						Uncoupling cis-Acting RNA Elements from Coding Sequences Revealed a Requirement of the N-Terminal Region of Dengue Virus Capsid Protein in Virus Particle Formation	jvi.asm.org	0	0		
585	chrUn_JH124870	6948	6975	3500362320	24		6948	6975	8421504	2	18,6	0,21	g	350036232000000007	2-26						First report of a tetracycline-inducible gene expression system for mollicutes	c.sgmjournals.org	0	0		
585	chrUn_JH124909	3365	3395	3500116637	25		3365	3395	8421504	3	12,3,10	0,15,20	g	350011663700000002	21-46		18055784	10.1167/iovs.07-0673	1552-5783	Investigative Ophthalmology & Visual Science	Somatic Ablation of the Lrat Gene in the Mouse Retinal Pigment Epithelium Drastically Reduces Its Retinoid Storage	Ruiz	2007	0		
585	chrUn_JH124939	7035	7061	3500291399	23		7035	7061	8421504	3	11,4,8	0,12,18	g	350029139900000010	0-23						Down-regulation of MTUS1 in human colon tumors	-publications.com	0	0		
585	chrUn_JH124979	3757	3782	3500193489	23		3757	3782	8421504	2	5,18	0,7	g	350019348900000015	5-28						Lipocalin Protein	Yorke-smith	2006	0		
585	chrUn_JH124979	39395	39420	3500196141	23		39395	39420	8421504	3	12,4,7	0,13,18	g	350019614100000009	10-33		11158314	10.1128/MCB.21.4.1285-1296.2001	0270-7306	Molecular and Cellular Biology	The CELF Family of RNA Binding Proteins Is Implicated in Cell-Specific and Developmentally Regulated Alternative Splicing	Ladd	2001	6		
586	chrUn_JH124979	183261	183292	3500268929	26		183261	183292	8421504	3	8,10,8	0,9,23	g	350026892900000013	3-36		22491449	10.1128/JVI.06872-11	0022-538X	Journal of Virology	CD44 Participates in IP-10 Induction in Cells in Which Hepatitis C Virus RNA Is Replicating, through an Interaction with Toll-Like Receptor 2 and Hyaluronan	Abe	2012	5		
585	chrUn_JH124985	19233	19256	3500405408	23		19233	19256	8421504	1	23	0	g	350040540800000004	0-23		21542908	10.1186/1749-8104-6-22	1749-8104	Neural Development	Rostral growth of commissural axons requires the cell adhesion molecule MDGA2	Joset	2011	4		MIR548Y
585	chrUn_JH124985	19233	19256	3500264339	23		19233	19256	8421504	1	23	0	g	350026433900000004	0-23						Rostral growth of commissural axons requires the cell adhesion molecule MDGA2	aldevelopment.com	0	0		MIR548Y
585	chrUn_JH125020	3664	3692	3500387706	23		3664	3692	8421504	2	8,15	0,13	g	350038770600000012	6-32						Miscellaneous Pesticides Articles and Studies July August 2013	www.maine.gov	0	0		
585	chrUn_JH125020	3664	3692	3500176154	23		3664	3692	8421504	2	8,15	0,13	g	350017615400000012	6-32						Miscellaneous Pesticides Articles and Studies July August 2013	www.state.me.us	0	0		
585	chrUn_JH125086	41756	41854	3500344377	48		41756	41854	8421504	2	20,28	0,70	g	350034437700000015,350034437700000020	0-20,0-28						Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants. - ResearchGate	.researchgate.net	0	0		
587	chrUn_JH125086	324419	324443	3500062329	24		324419	324443	8421504	1	24	0	g	350006232900000884	17-41						ISOLATION OF UNKNOWN REARRANGED T-CELL RECEPTORS FROM SINGLE CELLS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125144	58130	58157	3500100734	23		58130	58157	8421504	2	13,10	0,17	g	350010073400000438	13-36						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
585	chrUn_JH125173	1589	1616	3500294115	23		1589	1616	8421504	2	10,13	0,14	g	350029411500000101	15-39						ANTI-HDLK-1 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO - Patent application	www.faqs.org	0	0		
585	chrUn_JH125176	18161	18218	3500208721	57		18161	18218	8421504	1	57	0	p	350020872100015000	0-57		19717468	10.1073/pnas.0908332106		Proceedings of the National Academy of Sciences of the United States of America	Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development	Hao	2009	0		MAGT1
585	chrUn_JH125176	58246	61967	3500047878	40		58246	61967	8421504	3	11,9,20	0,2429,3701	c	350004787800000010,350004787800000011	0-20,0-20						Transcriptome profiling of bovine blastocysts developed under alternative culture conditions during specific stages of development	s.ulb.uni-bonn.de	0	0		
585	chrUn_JH125316	1444	13087	3500446771	537		1444	13087	8421504	13	52,2,54,54,54,42,12,54,42,12,54,54,51	0,6736,6804,6864,8790,8850,10650,10668,10788,11454,11472,11532,11592	p	350044677100015000,350044677100015002,350044677100015003,350044677100015004,350044677100015005,350044677100015006,350044677100015008,350044677100015009,350044677100015010,350044677100015011	0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-54,0-51						1 41 CCAACAGAGAGTCCTCACCCTGCGATCATTCCTCAATCCCC	www.docstoc.com	0	0		
585	chrUn_JH125328	1469	3199	3500354244	211		1469	3199	8421504	5	51,29,63,45,23	0,103,1011,1637,1707	p,c	350035424400015058,350035424400015045,350035424400000036,350035424400015056,350035424400015043,350035424400015035,350035424400000025	0-48,0-48,0-44,0-48,0-48,0-45,0-23						Inhibition Of Complement Activation 	.freshpatents.com	0	0		
585	chrUn_JH125328	1469	3199	3500207520	211		1469	3199	8421504	5	51,29,63,45,23	0,103,1011,1637,1707	p,c	350020752000015058,350020752000015045,350020752000000036,350020752000015056,350020752000015043,350020752000015035,350020752000000025	0-48,0-48,0-44,0-48,0-48,0-45,0-23						Inhibitors of complement activation	www.devileye.net	0	0		
585	chrUn_JH125328	1469	2537	3500084451	90		1469	2537	8421504	2	45,45	0,1023	p	350008445100015028,350008445100015027	0-45,0-45						Inhibitors Of Complement Activation - Patent application	www.faqs.org	0	0		
585	chrUn_JH125330	7056	7087	3500117604	25		7056	7087	8421504	3	12,7,6	0,13,25	g	350011760400000011	0-35			10.1111/j.1462-5822.2007.01026.x	1462-5822	Cellular Microbiology	Membrane cell fusion activity of the vaccinia virus A17&#x2013;A27 protein complex - Kochan - 2007 - Cellular Microbiology - Wiley Online Library	Kochan	2008	0		
585	chrUn_JH125341	25339	25363	3500445135	23		25339	25363	8421504	2	13,10	0,14	g	350044513500000135	25-48						DNA molecules encoding bacterial lysine 2,3-aminomutase	Frey	1999	0		
585	chrUn_JH125347	353	377	3500009967	24		353	377	8421504	1	24	0	g	350000996700000000	0-24						Cloning of transgenic unglulates comprising artificial chromosomes	Forsberg	2002	0		
585	chrUn_JH125363	7180	7208	3500029696	24		7180	7208	8421504	3	12,4,8	0,13,20	g	350002969600000023	22-46						Methods for treating cardiovascular disease using a soluble CTLA4 molecule - Patent application	www.faqs.org	0	0		
585	chrUn_JH125364	66665	66692	3500399485	24		66665	66692	8421504	2	7,17	0,10	g	350039948500000001	8-32		16439535	10.1128/JVI.80.4.1787-1797.2006	0022-538X	Journal of Virology	Regulation of Human Papillomavirus Type 16 E7 Activity through Direct Protein Interaction with the E2 Transcriptional Activator	Gammoh	2006	5		
585	chrUn_JH125366	4638	5668	3500380796	40		4638	5668	8421504	2	19,21	0,1009	c,g	350038079600000003,350038079600000003,350038079600000002,350038079600000002	0-19,0-19,0-21,0-21						Tissue engineered construct for supplementing or replacing a damaged organ	Atala	2006	0		
585	chrUn_JH125366	4638	5668	3500368395	38		4638	5668	8421504	2	19,19	0,1011	c,g	350036839500000004,350036839500000004,350036839500000003	0-19,0-19,0-19						Methods and compositions for cell therapy - Patent application	www.faqs.org	0	0		
585	chrUn_JH125366	4638	5668	3500278279	40		4638	5668	8421504	2	19,21	0,1009	c,g	350027827900000004,350027827900000004,350027827900000003,350027827900000003	0-19,0-19,0-21,0-21						Methods And Compositions For Cell Therapy 	.freshpatents.com	0	0		
585	chrUn_JH125366	4638	5668	3500229454	40		4638	5668	8421504	2	19,21	0,1009	c,g	350022945400000004,350022945400000004,350022945400000003,350022945400000003	0-19,0-19,0-21,0-21						Methods and compositions for cell therapy	Cibelli	2002	0		
585	chrUn_JH125366	4638	5668	3500207328	40		4638	5668	8421504	2	19,21	0,1009	c,g	350020732800000003,350020732800000003,350020732800000002,350020732800000002	0-19,0-19,0-21,0-21						Tissue engineered construct for supplementing or replacing a damaged organ	Atala	2003	0		
585	chrUn_JH125366	48407	48441	3500373014	27		48407	48441	8421504	3	7,3,17	0,11,17	g	350037301400000039	21-48						Process and materials for production of glucosamine - Patent # 6372457 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH125367	22882	22976	3500321807	84		22882	22976	8421504	2	15,69	0,25	g	350032180700000062	1-96						GENERATION, CHARACTERIZATION AND USES THEREOF OF ANTI-NOTCH3 ANTIBODIES - MERCK SHARP & DOHME CORP.	www.sumobrain.com	0	0		
585	chrUn_JH125367	22948	22976	3500440689	28		22948	22976	8421504	1	28	0	g	350044068900000109	0-28						Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses	Bedian	2007	0		
585	chrUn_JH125367	23137	23163	3500441484	26		23137	23163	8421504	1	26	0	g	350044148400000018,350044148400000019	0-26,0-26						NON-AGGREGATING HUMAN VH DOMAINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125368	18325	18357	3500278580	32		18325	18357	8421504	1	32	0	g	350027858000000084	0-32						Nouveau anticorps anti-GF-IR et leurs applications	Corvaia	2007	0		
585	chrUn_JH125368	20242	20361	3500199393	40		20242	20361	8421504	2	21,19	0,100	g	350019939300000079,350019939300000142,350019939300000063,350019939300000128,350019939300000093,350019939300000055,350019939300000070	6-27,10-29,4-23,7-26,4-23,4-23,4-23						Multivalent antigen-binding proteins	Frenken	2000	0		
585	chrUn_JH125382	45	18894	3500443285	643		45	18894	8421504	24	20,30,32,33,40,26,28,6,38,37,36,35,37,35,7,35,4,31,8,6,27,39,30,23	0,78,159,239,318,413,502,532,581,668,743,1364,1706,9808,9900,9982,12449,18047,18413,18427,18583,18649,18745,18826	g	350044328500000012	52-1186						2012-The Molecular Regulation of Telomeres and Telomerase	www.scribd.com	0	0		
585	chrUn_JH125387	3729	3753	3500016075	24		3729	3753	8421504	1	24	0	g	350001607500000217	0-24						Nine polymorphic microsatellite loci in the rabbit, Oryctolagus cuniculus	enomics.liv.ac.uk	0	0		
585	chrUn_JH125408	43842	44916	3500196890	57		43842	44916	8421504	2	43,14	0,1060	p	350019689000015024	0-57						50 human secreted proteins	George	2000	0		
585	chrUn_JH125417	7241	7264	3500068951	23		7241	7264	8421504	1	23	0	g	350006895100000377	14-37						Binding molecules capable of neutralizing rabies virus and uses thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	3153	3299	3500319187	42		3153	3299	8421504	2	20,22	0,124	g	350031918700000030,350031918700000067	0-20,1-23						Transgenic animals and uses thereof	Robl	2005	0		
585	chrUn_JH125433	3277	3344	3500463563	65		3277	3344	8421504	3	22,5,38	0,23,29	g	350046356300000047	1-68						Recombinant Polyclonal Antibody For Treatment Of Respiratory Syncytial Virus Infections 	.freshpatents.com	0	0		
585	chrUn_JH125433	3277	3344	3500293449	65		3277	3344	8421504	3	22,5,38	0,23,29	g	350029344900000047	1-68						Recombinant antibodies for treatment of respiratory syncytial virus infections	Lantto	2011	0		
585	chrUn_JH125433	3277	14207	3500036476	47		3277	14207	8421504	2	22,25	0,10905	g	350003647600000007,350003647600000046	19-41,0-25					Patent	Method of intracellular binding of target molecules (Patent US:6072036)	Haseltine	2000	0		
585	chrUn_JH125433	3376	3551	3500104807	60		3376	3551	8421504	2	46,14	0,161	g	350010480700000015	154-326						Antibodies to tnf alpha and use thereof	Garcia-Martinez	2008	0		
585	chrUn_JH125433	3376	3551	3500083996	60		3376	3551	8421504	2	46,14	0,161	g	350008399600000118,350008399600000039	154-326,154-326						Antibodies to TNF alpha and use thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	3380	3551	3500371222	62		3380	3551	8421504	4	33,9,6,14	0,49,61,157	g	350037122200000041	158-326						Antibodies to il-6 and use thereof	Dutzar	2008	0		
585	chrUn_JH125433	3380	3551	3500280154	62		3380	3551	8421504	4	33,9,6,14	0,49,61,157	g	350028015400000051	158-326						Antibodies to IL-6 and use thereof	Dutzar	2009	0		
585	chrUn_JH125433	3380	3551	3500245486	62		3380	3551	8421504	4	33,9,6,14	0,49,61,157	g	350024548600000252	158-326						Antagonists of IL-6 to raise Albumin and/or lower CRP - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	3380	3551	3500202704	62		3380	3551	8421504	4	33,9,6,14	0,49,61,157	g	350020270400000051	158-326					Patent	Antibodies to IL-6 and use thereof (Patent US:7935340)	Dutzar	2011	0		
585	chrUn_JH125433	3380	3551	3500156580	62		3380	3551	8421504	4	33,9,6,14	0,49,61,157	g	350015658000000047	158-326						Methods of reducing CRP and/or increasing serum albumin in patients in need using IL-6 antibodies of defined epitopic specificity	Smith	2011	0		
585	chrUn_JH125433	3380	3551	3500132543	62		3380	3551	8421504	4	33,9,6,14	0,49,61,157	g	350013254300000053	158-326						Antibodies to IL-6 and use thereof	Carvalho	2010	0		
585	chrUn_JH125433	3380	3551	3500037866	62		3380	3551	8421504	4	33,9,6,14	0,49,61,157	g	350003786600000090	158-326						ANTIBODIES TO IL-6 AND USE THEREOF	Garcia-martinez	2010	0		
585	chrUn_JH125433	3380	15989	3500254774	68		3380	15989	8421504	2	37,31	0,12578	g	350025477400000701,350025477400000654,350025477400000403	8-34,8-45,10-41						Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	14184	14325	3500451133	71		14184	14325	8421504	3	23,9,39	0,25,102	g	350045113300000075	0-141						THERAPEUTIC COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	14184	14325	3500337289	82		14184	14325	8421504	4	23,9,11,39	0,25,69,102	g	350033728900000020	0-141						Specific Binding Members For Ngf 	.freshpatents.com	0	0		
585	chrUn_JH125433	14184	14325	3500277171	71		14184	14325	8421504	3	23,9,39	0,25,102	g	350027717100000080	0-141						Therapeutic compositions and methods - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	14184	14325	3500269841	71		14184	14325	8421504	3	23,9,39	0,25,102	g	350026984100000208,350026984100000076	0-141,0-141						Therapeutic compositions and methods - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	14184	14325	3500096608	71		14184	14325	8421504	3	23,9,39	0,25,102	g	350009660800000079	0-141						Erbb2 binding proteins and use thereof	Algate	2008	0		
585	chrUn_JH125433	14184	14207	3500325504	23		14184	14207	8421504	1	23	0	g	350032550400000003	0-23						Antibodies That Specifically Bind To Chemokine Beta-4 	.freshpatents.com	0	0		
585	chrUn_JH125433	14184	14207	3500219850	23		14184	14207	8421504	1	23	0	g	350021985000000024	0-23					Patent	Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors (Patent US:7306907)	Winter	2007	0		LINC00226
585	chrUn_JH125433	14184	14207	3500022136	23		14184	14207	8421504	1	23	0	g	350002213600000024	0-23						Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors	Winter	2002	0		LINC00226
585	chrUn_JH125433	14287	14314	3500437895	27		14287	14314	8421504	1	27	0	g	350043789500000338	38-65						CROSS-SPECIES-SPECIFIC SINGLE DOMAIN BISPECIFIC SINGLE CHAIN ANTIBODY - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	16225	16254	3500195767	24		16225	16254	8421504	3	11,5,8	0,13,21	g	350019576700000093	0-24						Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	28870	28950	3500140018	62		28870	28950	8421504	2	20,42	0,38	g	350014001800000262	5-86						Method for linking sequences of interest	M*B*Ao Lie Ke Xi Wei Qi 	2006	0		
585	chrUn_JH125433	28874	28962	3500403856	68		28874	28962	8421504	2	15,53	0,35	g	350040385600000019,350040385600000033,350040385600000009	0-89,0-89,0-89						Therapeutic Binding Molecules - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	28874	28962	3500370985	70		28874	28962	8421504	2	16,54	0,34	g	350037098500000319	0-89						Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	28874	28962	3500290266	70		28874	28962	8421504	2	16,54	0,34	g	350029026600000007,350029026600000006	0-89,0-89					Patent	Humanised anti-MAG antibody or functional fragment thereof (Patent US:8071731)	Ellis	2011	0		
585	chrUn_JH125433	28874	28962	3500120834	68		28874	28962	8421504	2	15,53	0,35	g	350012083400000010	0-89						Therapeutic binding molecules	Aversa	2004	0		
585	chrUn_JH125433	28874	28962	3500070457	70		28874	28962	8421504	2	16,54	0,34	g	350007045700000005,350007045700000004,350007045700000000,350007045700000003,350007045700000002	0-89,0-89,0-89,0-89,0-89						Anti-myelin associated glycoprotein (MAG) antibodies	J*H*Ai Li Si 	2005	0		
585	chrUn_JH125433	28874	28962	3500026489	74		28874	28962	8421504	2	12,62	0,26	g	350002648900000043	6-95						Epha2, Epha4 And Lmw-ptp And Methods Of Treatment Of Hyperproliferative Cell Disorders 	.freshpatents.com	0	0		
585	chrUn_JH125433	28875	28959	3500349434	74		28875	28959	8421504	2	15,59	0,25	g	350034943400000040	1-86						Antibodies to west nile virus polypeptides - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	28908	29117	3500180112	66		28908	29117	8421504	2	42,24	0,185	g	350018011200000062,350018011200000061	35-248,35-248						HUMANIZED ANTIBODIES TARGETING THE EC1 DOMAIN OF CADHERIN-11 AND RELATED COMPOSITIONS AND METHODS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	28908	28962	3500462841	54		28908	28962	8421504	1	54	0	g	350046284100000004	13-67					Patent	Internalizing anti-CD74 antibodies and methods of use (Patent US:7919087)	Hansen	2011	0		
585	chrUn_JH125433	28908	28962	3500333628	54		28908	28962	8421504	1	54	0	g	350033362800000030,350033362800000004	13-67,13-67						Anthracycline-Antibody Conjugates for Cancer Therapy - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	28908	28962	3500118036	54		28908	28962	8421504	1	54	0	g	350011803600000004	13-67						Internalizing Anti-CD74 Antibodies and Methods of Use	Hansen	2011	0		
585	chrUn_JH125433	28908	28953	3500422651	45		28908	28953	8421504	1	45	0	g	350042265100000092	35-80						Sclerostin epitopes	Henry	2008	0		
585	chrUn_JH125433	28908	28953	3500299305	45		28908	28953	8421504	1	45	0	g	350029930500000092	35-80						Sclerostin epitopes	Henry	2006	0		
585	chrUn_JH125433	28933	28962	3500107912	29		28933	28962	8421504	1	29	0	g	350010791200000178	5-34						US Patent # 6,641,999. Probing method for identifying antibodies specific for selected antigens - Patents.com	www.patents.com	0	0		
585	chrUn_JH125433	28939	28962	3500367928	23		28939	28962	8421504	1	23	0	g	350036792800000023,350036792800000022,350036792800000166,350036792800000167	10-33,0-23,0-23,10-33						CD44 ANTIBODIES - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	28941	28969	3500398534	28		28941	28969	8421504	1	28	0	g	350039853400000116	0-28						US Patent # 7,338,660. Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 - Patents.com	www.patents.com	0	0		
585	chrUn_JH125433	29049	29075	3500194498	26		29049	29075	8421504	1	26	0	g	350019449800000044,350019449800000011	0-26,0-26						Human antibodies interacting with HIV gp41	Shiver	2005	0		IGH
585	chrUn_JH125433	29050	29076	3500165508	26		29050	29076	8421504	1	26	0	g	350016550800000069	30-56						Binding Domain Fusion Protein 	.freshpatents.com	0	0		
585	chrUn_JH125433	29133	29158	3500438753	25		29133	29158	8421504	1	25	0	g	350043875300000010	7-32						Humanized antibody specific for tumor necrosis factor-alpha - Patent # 7645450 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH125433	56221	56301	3500104807	65		56221	56301	8421504	3	26,6,33	0,35,47	g	350010480700000045	111-191						Antibodies to tnf alpha and use thereof	Garcia-Martinez	2008	0		
585	chrUn_JH125433	56221	56301	3500083996	65		56221	56301	8421504	3	26,6,33	0,35,47	g	350008399600000223,350008399600000069	111-191,111-191						Antibodies to TNF alpha and use thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH125433	56268	56293	3500194430	25		56268	56293	8421504	1	25	0	g	350019443000000039	18-43						Antibodies	Cicortas	2010	0		
585	chrUn_JH125436	372	399	3500364744	27		372	399	8421504	1	27	0	g	350036474400000022	0-28		15064750	10.1038/sj.onc.1207579	0950-9232	Oncogene	EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes	Squatrito	2004	6		
585	chrUn_JH125438	1776	1804	3500024692	26		1776	1804	8421504	2	21,5	0,23	g	350002469200000015	10-37						Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species	Cochran	1998	0		
585	chrUn_JH125460	33922	33949	3500212893	23		33922	33949	8421504	2	9,14	0,13	g	350021289300000040	0-23						TREATMENT OF A DISEASE OR A CONDITION ASSOCIATED WITH ABERRANT GENE HYPOMETHYLATION BY A METHOD INVOLVING TAILORED EPIGENOMIC MODIFICATION - Patent application	www.faqs.org	0	0		
585	chrUn_JH125481	7863	7889	3500306361	23		7863	7889	8421504	2	14,9	0,17	g	350030636100000533	21-44						PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use - Patent application	www.faqs.org	0	0		
585	chrUn_JH125483	13574	13599	3500259506	25		13574	13599	8421504	1	25	0	g	350025950600000020	0-25						PARTE I &#x2013; REVIS&#xc3;O BIBLIOGR&#xc1;FICA 1 &#x2013; INTRODU&#xc7;&#xc3;O	ecadigital.ipb.pt	0	0		
585	chrUn_JH125489	14714	14743	3500223478	24		14714	14743	8421504	2	16,8	0,21	g	350022347800000061	0-24						Elements for improved expression of bovine somatotropin - Patent application	www.faqs.org	0	0		
585	chrUn_JH125489	25826	25855	3500021514	26		25826	25855	8421504	2	20,6	0,23	g	350002151400000027	1-28						Production of oligosaccharides in transgenic plants	Smeekens	1998	0		
585	chrUn_JH125490	1188	15536	3500429819	68		1188	15536	8421504	3	19,29,20	0,663,14328	c	350042981900000278,350042981900000267	0-48,27-47						Expression vectors for stimulating an immune response and methods of using the same	Fikes	1999	0		
585	chrUn_JH125495	14213	14242	3500201155	26		14213	14242	8421504	3	5,14,7	0,7,22	g	350020115500000078	8-34						Broad-spectrum .delta.-endotoxins	www.devileye.net	0	0		
585	chrUn_JH125514	25125	25154	3500224887	25		25125	25154	8421504	3	6,6,13	0,8,16	c	350022488700000031	4-30						US Patent # 5,741,772. Neurotrophic factor NNT-1 - Patents.com	www.patents.com	0	0		
585	chrUn_JH125514	25214	27888	3500395422	44		25214	27888	8421504	3	24,8,12	0,1226,2662	c	350039542200000025,350039542200000024	0-24,0-20						Methods and compositions for culturing cardiomyocyte-like cells	Shim	2005	0		TNNC1
585	chrUn_JH125514	25215	27900	3500200471	483		25215	27900	8421504	6	29,137,115,147,31,24	0,110,472,838,1202,2661	p,c	350020047100015008,350020047100015013,350020047100015007,350020047100015006,350020047100015011,350020047100015003,350020047100015009,350020047100000002,350020047100015002,350020047100015000	0-48,0-126,0-48,0-51,0-180,0-51,0-177,0-54,0-51,0-48						Cardiac Troponin C methods - The structure and conformational 	www.docstoc.com	0	0		
585	chrUn_JH125514	25215	27900	3500104940	483		25215	27900	8421504	6	29,137,115,147,31,24	0,110,472,838,1202,2661	p	350010494000015003,350010494000015002,350010494000015001,350010494000015005,350010494000015000	0-108,0-120,0-102,0-108,0-147						Effect of Environmental Temperature on Troponin C	tionscanada.gc.ca	0	0		TNNC1
585	chrUn_JH125514	46751	46780	3500379983	24		46751	46780	8421504	3	6,12,6	0,8,23	g	350037998300000007	16-41						SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION - Patent application	www.faqs.org	0	0		
585	chrUn_JH125518	939	965	3500375473	23		939	965	8421504	2	8,15	0,11	g	350037547300000169	0-23						Molecular Identification of Fungi	dlx.bookos.org	0	0		
585	chrUn_JH125518	939	965	3500354454	23		939	965	8421504	2	8,15	0,11	g	350035445400000169	0-23						Molecular Identification of Fungi	ggene.cn/uploads/	0	0		
585	chrUn_JH125518	939	965	3500043729	23		939	965	8421504	2	8,15	0,11	g	350004372900000169	0-23						Molecular Identi&#xfb01;cation of Fungi	dlx.bookos.org	0	0		
585	chrUn_JH125518	24427	24453	3500202468	23		24427	24453	8421504	2	14,9	0,17	g	350020246800000180	12-45						Production Of Beta-glucosidase, Hemicellulase And Ligninase In E1 And Flc-cellulase-transgenic Plants 	.freshpatents.com	0	0		
585	chrUn_JH125518	35118	35141	3500038986	23		35118	35141	8421504	1	23	0	g	350003898600000016,350003898600000043	5-28,9-31						Methods for enhancement of protective immune responses	Reed	1996	0		
585	chrUn_JH125518	40799	40844	3500061028	45		40799	40844	8421504	1	45	0	p	350006102800015054	0-45						COMPOSITIONS AND METHODS FOR DETECTING CANCER METASTASIS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125518	42356	44584	3500427251	67		42356	44584	8421504	5	7,12,9,15,24	0,313,424,812,2204	c	350042725100000000,350042725100000003,350042725100000002	25-44,0-24,0-24		20805357	10.1128/MCB.00396-10	0270-7306	Molecular and Cellular Biology	The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression	Yu	2010	6		
585	chrUn_JH125518	42356	44584	3500322815	67		42356	44584	8421504	5	7,12,9,15,24	0,313,424,812,2204	c	350032281500000000,350032281500000003,350032281500000002	25-44,0-24,0-24		20805357	10.1128/MCB.00396-10	0270-7306	Molecular and Cellular Biology	The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression	Yu	2010	6		
585	chrUn_JH125519	3097	3132	3500102363	35		3097	3132	8421504	1	35	0	g	350010236300000127	12-47						Ion channel	Akopian	1997	0		
585	chrUn_JH125519	27101	27130	3500081807	27		27101	27130	8421504	3	5,5,17	0,6,12	g	350008180700000029,350008180700000148	0-27,0-27						METHOD OF DIAGNOSING COLON AND GASTRIC CANCERS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125520	5212	5254	3500055494	42		5212	5254	8421504	1	42	0	g	350005549400000003	0-42					Patent	Mammalian cytokine complexes (Patent US:6800460)	Oppmann	2004	0		
585	chrUn_JH125537	6868	6893	3500284394	24		6868	6893	8421504	2	4,20	0,5	g	350028439400000486	11-35						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2011	0		
585	chrUn_JH125537	6868	6893	3500253796	24		6868	6893	8421504	2	4,20	0,5	g	350025379600000486	11-35					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
585	chrUn_JH125537	6868	6893	3500241875	24		6868	6893	8421504	2	4,20	0,5	g	350024187500000486	11-35					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
585	chrUn_JH125537	6868	6893	3500070088	24		6868	6893	8421504	2	4,20	0,5	g	350007008800000486	11-35						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
585	chrUn_JH125537	6868	6893	3500068199	24		6868	6893	8421504	2	4,20	0,5	g	350006819900000486	11-35						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
585	chrUn_JH125537	6868	6893	3500019915	24		6868	6893	8421504	2	4,20	0,5	g	350001991500000486	11-35						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
585	chrUn_JH125541	35415	35443	3500371455	23		35415	35443	8421504	2	14,9	0,19	g	350037145500000000	6-35		9096368		0027-8424	Proceedings of the National Academy of Sciences	In differentiated CD4+ T Cells, interleukin 4 production is cytokine-autonomous, whereas interferon &#x03b3; production is&#x2009;cytokine-dependent	Hu-Li	1997	10		
585	chrUn_JH125551	853	881	3500022171	24		853	881	8421504	3	5,13,6	0,6,22	g	350002217100000021	15-39						LUCIFERASE BIOSENSOR	Fan	2012	0		
585	chrUn_JH125556	8383	8437	3500297298	54		8383	8437	8421504	1	54	0	p	350029729800015000	0-54						LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1	w.path.queensu.ca	0	0		LIMK1
585	chrUn_JH125556	9152	9177	3500351142	23		9152	9177	8421504	2	15,8	0,17	c,g	350035114200000290,350035114200000067,350035114200000288,350035114200000289,350035114200000285,350035114200000079,350035114200000287,350035114200000009,350035114200000009,350035114200000265,350035114200000233,350035114200000233,350035114200000135,350035114200000069,350035114200000294,350035114200000266,350035114200000065,350035114200000041,350035114200000286,350035114200000007,350035114200000330,350035114200000128,350035114200000231	0-23,7-29,0-22,7-30,7-27,28-48,7-29,0-20,0-20,7-27,0-20,0-20,28-48,7-30,13-33,0-20,7-27,7-27,1-21,0-21,0-22,0-22,0-21						METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - Patent application	www.faqs.org	0	0		
585	chrUn_JH125556	9152	9177	3500312192	23		9152	9177	8421504	2	15,8	0,17	c,g	350031219200000113,350031219200000103,350031219200000116,350031219200000104,350031219200000114,350031219200000115,350031219200000044,350031219200000118,350031219200000040,350031219200000064,350031219200000064,350031219200000132,350031219200000132,350031219200000030,350031219200000042,350031219200000001,350031219200000142,350031219200000117,350031219200000062,350031219200000130	7-27,7-27,0-22,0-20,1-21,7-29,7-30,0-23,7-27,0-20,0-20,0-20,0-20,7-27,7-29,9-29,9-29,7-30,0-21,0-21						METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - Patent application	www.faqs.org	0	0		
585	chrUn_JH125556	9152	9177	3500248138	23		9152	9177	8421504	2	15,8	0,17	c,g	350024813800000001,350024813800000138,350024813800000009,350024813800000009,350024813800000115,350024813800000070,350024813800000072,350024813800000041,350024813800000142,350024813800000078,350024813800000068,350024813800000082,350024813800000074,350024813800000007,350024813800000131	9-29,28-48,0-20,0-20,28-48,7-29,7-30,7-27,28-48,7-27,7-27,28-48,7-27,0-21,0-22						Methods and compositions for the specific inhibition of gene expression by double-stranded RNA	Rossi	2007	0		
585	chrUn_JH125556	9152	9177	3500235523	23		9152	9177	8421504	2	15,8	0,17	c,g	350023552300000042,350023552300000236,350023552300000236,350023552300000080,350023552300000297,350023552300000291,350023552300000290,350023552300000293,350023552300000292,350023552300000002,350023552300000066,350023552300000229,350023552300000068,350023552300000138,350023552300000288,350023552300000289,350023552300000268,350023552300000269,350023552300000010,350023552300000010,350023552300000070,350023552300000333,350023552300000131,350023552300000234,350023552300000008	7-27,0-20,0-20,28-48,13-33,0-22,7-29,0-23,7-30,9-29,7-27,9-29,7-29,28-48,7-27,1-21,7-27,0-20,0-20,0-20,7-30,0-22,0-22,0-21,0-21						METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - Patent application	www.faqs.org	0	0		
585	chrUn_JH125556	9152	9177	3500132197	23		9152	9177	8421504	2	15,8	0,17	c,g	350013219700000067,350013219700000065,350013219700000069,350013219700000009,350013219700000009,350013219700000079,350013219700000041,350013219700000001,350013219700000135,350013219700000007,350013219700000128	7-29,7-27,7-30,0-20,0-20,28-48,7-27,9-29,28-48,0-21,0-22						Methods and compositions for the specific inhibition of gene expression by double-stranded rna	Rossi	2010	0		
585	chrUn_JH125556	9152	9177	3500033114	23		9152	9177	8421504	2	15,8	0,17	c,g	350003311400000042,350003311400000040,350003311400000044,350003311400000064,350003311400000064,350003311400000001,350003311400000030,350003311400000062	7-29,7-27,7-30,0-20,0-20,9-29,7-27,0-21						Methods and compositions for the specific inhibition of gene expression by double-stranded RNA	Rossi	2005	0		
585	chrUn_JH125559	23962	23991	3500332148	25		23962	23991	8421504	3	5,5,15	0,8,14	c	350033214800000047,350033214800000045	9-33,0-25						Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases	Ma Ding *Ba He Man 	2004	0		
585	chrUn_JH125559	23962	23991	3500270030	25		23962	23991	8421504	3	5,5,15	0,8,14	c	350027003000000124,350027003000000065,350027003000000120,350027003000000063	9-33,9-33,0-24,0-25						Vaccine compositions containing amyloid beta1-6 antigen arrays	M*F*Ba He Man 	2005	0		
585	chrUn_JH125559	23962	23991	3500250540	25		23962	23991	8421504	3	5,5,15	0,8,14	c	350025054000000124,350025054000000053,350025054000000051,350025054000000128	0-24,9-33,0-25,9-33						GHRELIN-carrier conjugates	Ma Ding *F*Ba Ke Man 	2005	0		
585	chrUn_JH125559	23962	23991	3500081377	25		23962	23991	8421504	3	5,5,15	0,8,14	c	350008137700000045,350008137700000047	0-25,9-33					Patent	Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases (Patent CN:1321695)	Ma Ding *Ba He Man 	2007	0		
585	chrUn_JH125559	23962	23990	3500466244	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350046624400000019,350046624400000021	0-24,9-33						Novel Attenuated Poliovirus 	.freshpatents.com	0	0		
585	chrUn_JH125559	23962	23990	3500437989	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350043798900000084,350043798900000086	0-24,9-33						US Patent # 7,320,793. Molecular antigen array - Patents.com	www.patents.com	0	0		
585	chrUn_JH125559	23962	23990	3500415445	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350041544500000219,350041544500000078,350041544500000080	9-33,0-24,9-33						Molecular antigen array - US Patent 7264810 Description	ww.patentstorm.us	0	0		
585	chrUn_JH125559	23962	23990	3500392478	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350039247800000068,350039247800000064	9-33,0-24					Patent	Vaccine compositions containing amyloid beta1-6 antigen arrays (Patent CN:1674934)	M*F*Ba He Man 	2013	0		
585	chrUn_JH125559	23962	23990	3500392437	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350039243700000064,350039243700000068	0-24,9-33						vaccine compositions containing amyloid beta1-6 antigen arrays	A*Di Suo 	2010	0		
585	chrUn_JH125559	23962	23990	3500391670	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350039167000000028,350039167000000029,350039167000000053,350039167000000051	0-24,9-33,9-33,0-24					Patent	Vaccine compositions containing amyloid beta1-6 antigen arrays (Patent EP:1524994)	Bachmann	2011	0		
585	chrUn_JH125559	23962	23990	3500390877	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350039087700000032,350039087700000034	0-24,9-33						Vaccine compositions containing amyloid beta1-6 antigen arrays	Bachmann	2005	0		
585	chrUn_JH125559	23962	23990	3500384838	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350038483800000027,350038483800000029,350038483800000071,350038483800000070	0-24,9-33,9-33,0-24						Antigen Arrays for Treatment of Allergic Eosinophilic Diseases - Patent application	www.faqs.org	0	0		
585	chrUn_JH125559	23962	23990	3500383796	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350038379600000085,350038379600000087	0-24,9-33						Molecular Antigen Array	Renner	2011	0		
585	chrUn_JH125559	23962	23990	3500376945	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350037694500000027,350037694500000029	0-24,9-33						Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases	Bachmann	2003	0		
585	chrUn_JH125559	23962	23990	3500374502	23		23962	23990	8421504	2	7,16	0,12	c	350037450200000181	2-26						STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES	Birkett	2005	0		
585	chrUn_JH125559	23962	23990	3500374171	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350037417100000062,350037417100000060	9-33,0-24						Molecular antigen array	Renner	2011	0		
585	chrUn_JH125559	23962	23990	3500372580	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350037258000000029,350037258000000027	9-33,0-24						Antigen arrays for treatment of bone disease	Bachmann	2006	0		
585	chrUn_JH125559	23962	23990	3500371527	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350037152700000028,350037152700000030	0-24,9-33						Prion protein carrier-conjugates	Bachmann	2003	0		
585	chrUn_JH125559	23962	23990	3500370493	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350037049300000079,350037049300000081	0-24,9-33						Molecular antigen array	Renner	2002	0		
585	chrUn_JH125559	23962	23990	3500367774	23		23962	23990	8421504	2	7,16	0,12	c	350036777400000104	2-26					Patent	STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES (Patent EP:1572234)	Birkett	2012	0		
585	chrUn_JH125559	23962	23990	3500364899	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350036489900000060,350036489900000034,350036489900000062,350036489900000032	0-24,9-33,9-33,0-24					Patent	Vaccine compositions containing amyloid beta1-6 antigen arrays (Patent CA:2492930)	Bachmann	2013	0		
585	chrUn_JH125559	23962	23990	3500292547	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350029254700000033,350029254700000035	0-24,9-33					Patent	Amyloid &#x03b2;1-6 antigen arrays (Patent US:7279165)	Bachmann	2007	0		
585	chrUn_JH125559	23962	23990	3500287603	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350028760300000084,350028760300000086	0-24,9-33					Patent	Molecular antigen array (Patent US:7320793)	Renner	2008	0		
585	chrUn_JH125559	23962	23990	3500279893	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350027989300000116,350027989300000114,350027989300000044,350027989300000045	9-33,0-24,0-24,9-33					Patent	Molecular antigen array presenting amyloid beta (Patent EP:1353691)	Renner	2009	0		
585	chrUn_JH125559	23962	23990	3500260645	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350026064500000083,350026064500000085	0-24,9-33						Molecular antigen arrary	Renner	2008	0		
585	chrUn_JH125559	23962	23990	3500259268	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350025926800000086,350025926800000084	9-33,0-24						Molecular antigen array	Bachmann	2003	0		
585	chrUn_JH125559	23962	23990	3500231336	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350023133600000022,350023133600000023	0-24,9-33					Patent	Antigen arrays comprising rankl for treatment of bone disease (Patent EP:1441764)	Bachmann	2008	0		
585	chrUn_JH125559	23962	23990	3500230907	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350023090700000025,350023090700000023	9-33,0-24						GHRELIN-CARRIER CONJUGATES - CYTOS BIOTECHNOLOGY AG	www.sumobrain.com	0	0		
585	chrUn_JH125559	23962	23990	3500208243	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350020824300000063,350020824300000032,350020824300000034,350020824300000061	9-33,0-24,9-33,0-24						US Patent # 7,279,165. Amyloid .beta.1-6 antigen arrays - Patents.com	www.patents.com	0	0		
585	chrUn_JH125559	23962	23990	3500143718	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350014371800000085,350014371800000083	9-33,0-24						Molecular antigen array presenting amyloid beta	Bachmann	2003	0		
585	chrUn_JH125559	23962	23990	3500123395	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350012339500000029,350012339500000027	9-33,0-24						Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases	Bachmann	2004	0		
585	chrUn_JH125559	23962	23990	3500111705	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350011170500000034,350011170500000032	9-33,0-24						Vaccine compositions containing amyloid beta1-6 antigen arrays	Bachmann	2004	0		
585	chrUn_JH125559	23962	23990	3500097925	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350009792500000032,350009792500000034	0-24,9-33						Amyloid beta1-6 antigen arrays	Bachmann	2009	0		
585	chrUn_JH125559	23962	23990	3500095833	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350009583300000081,350009583300000079	9-33,0-24					Patent	Molecular antigen array (Patent US:7264810)	Renner	2007	0		
585	chrUn_JH125559	23962	23990	3500089496	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350008949600000085,350008949600000083	9-33,0-24						Molecular antigen array presenting amyloid beta	Renner	2002	0		
585	chrUn_JH125559	23962	23990	3500089480	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350008948000000028,350008948000000030	0-24,9-33						Antigen Arrays for Treatment of Allergic Eosinophilic Diseases	Bachmann	2008	0		
585	chrUn_JH125559	23962	23990	3500020039	24		23962	23990	8421504	3	5,5,14	0,8,14	c	350002003900000083,350002003900000085	0-24,9-33						Molecular antigen array	Renner	2002	0		
585	chrUn_JH125559	24158	51390	3500276479	405		24158	51390	8421504	14	31,14,45,16,29,32,13,10,35,45,45,14,31,45	0,4767,4784,4832,15992,19176,19367,19479,20769,20855,21330,25683,27057,27187	p	350027647900015039,350027647900015040,350027647900015041,350027647900015042,350027647900015043,350027647900015044,350027647900015046,350027647900015048,350027647900015050	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						MODULATION OF SRPX2-MEDIATED ANGIOGENESIS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125573	17770	17795	3500205714	24		17770	17795	8421504	2	19,5	0,20	g	350020571400000353	3-28						Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants - Patent application	www.faqs.org	0	0		
585	chrUn_JH125601	37429	37455	3500201864	23		37429	37455	8421504	2	13,10	0,16	c	350020186400000154	23-46						US Patent # 7,125,977. Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria - Patents.com	www.patents.com	0	0		
585	chrUn_JH125614	10640	10663	3500306233	23		10640	10663	8421504	1	23	0	c,g	350030623300000005,350030623300000005	0-23,0-23						Gene expression and apoptosis in bovine embryos during in vitro culture and in vivo development	ive.library.uu.nl	0	0		PKP1
585	chrUn_JH125616	32102	32126	3500462501	23		32102	32126	8421504	2	17,6	0,18	g	350046250100000098	20-43						FAKULT&#xc4;T F&#xdc;R CHEMIE UND HARMAZIE	b.uni-muenchen.de	0	0		
585	chrUn_JH125640	51704	51731	3500402697	23		51704	51731	8421504	2	12,11	0,16	g	350040269700000246	0-28						METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH125640	95098	95121	3500335804	23		95098	95121	8421504	1	23	0	g	350033580400000071	11-36						VACCINE AND ANTITOXIN FOR TREATMENT AND PREVENTION OF C. DIFFICILE DISEASE - OPHIDIAN PHARMACEUTICALS, INC	www.sumobrain.com	0	0		
585	chrUn_JH125642	39755	39784	3500233641	23		39755	39784	8421504	3	11,4,8	0,16,21	g	350023364100000109,350023364100000110	0-26,3-29						University of Alberta	brary.ualberta.ca	0	0		
585	chrUn_JH125643	47765	47791	3500111750	25		47765	47791	8421504	2	4,21	0,5	g	350011175000000000	16-41		11136720	10.1074/jbc.M005973200	0021-9258	Journal of Biological Chemistry	An ERG Channel Inhibitor from the Scorpion Buthus eupeus	Korolkova	2001	5		
585	chrUn_JH125643	109449	109476	3500233674	23		109449	109476	8421504	2	11,12	0,15	g	350023367400000001	0-23		12839804	10.1128/AEM.69.7.4227-4235.2003	0099-2240	Applied and Environmental Microbiology	Single-Cell Protein Profiling of Wastewater Enterobacterial Communities Predicts Disinfection Efficiency	Ponniah	2003	4		
585	chrUn_JH125643	109449	109476	3500065345	23		109449	109476	8421504	2	11,12	0,15	g	350006534500000001	0-23			10.1128/AEM.69.7.4227-4235.2003		Applied and Environmental Microbiology	Single-Cell Protein Profiling of Wastewater Enterobacterial Communities Predicts Disinfection Efficiency	Gomathinayagam	July	0		
585	chrUn_JH125654	8959	8986	3500288335	24		8959	8986	8421504	3	12,5,7	0,13,20	g	350028833500000114	13-37						Nematode Fatty Acid Desaturase-Like Sequences - Patent application	www.faqs.org	0	0		
585	chrUn_JH125656	29034	29057	3500070560	23		29034	29057	8421504	1	23	0	c	350007056000000019	22-45						Preliminary radiation hybrid map for river buffalo chromosome 6 and comparison to bovine chromosome 3	ticabovina.com.br	0	0		
585	chrUn_JH125660	1935	1963	3500408649	24		1935	1963	8421504	2	10,14	0,14	g	350040864900000786,350040864900000787	18-42,0-24						HBM variants that modulate bone mass and lipid levels	Allen	2008	0		
585	chrUn_JH125661	8318	8343	3500338170	24		8318	8343	8421504	2	14,10	0,15	g	350033817000000020	0-24						&#xb5d8;&#xa448;&#xa5d2;&#xb0f2;&#xa4fe;&#xa447;&#xbbc4;&#xa6e5;&#xaf67; MMAA MMAB&#xb0f2;&#xa65d;&#xa4a7; &#xa4c0;&#xa46c;&#xbff2;&#xb6c7;&#xbec7;&#xace3;&#xa873;	www.tfrd.org.tw	0	0		
585	chrUn_JH125661	49455	49480	3500062329	23		49455	49480	8421504	3	12,7,4	0,13,21	g	350006232900000649,350006232900000101	12-35,12-35						ISOLATION OF UNKNOWN REARRANGED T-CELL RECEPTORS FROM SINGLE CELLS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125662	11691	12901	3500284887	1210		11691	12901	8421504	1	1210	0	g	350028488700000004	2-1212						VIOLIN: Vaccine Investigation and Online Information Network	www.violinet.org	0	0		
585	chrUn_JH125662	12439	12463	3500190095	24		12439	12463	8421504	1	24	0	g	350019009500000084	0-24						Affinity proteins for controlled application of cosmetic substances	Houtzager	2006	0		
585	chrUn_JH125662	12594	12619	3500369696	25		12594	12619	8421504	1	25	0	g	350036969600000054	9-34						Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria	Fischer	1998	0		
585	chrUn_JH125662	12596	18066	3500276092	52		12596	18066	8421504	2	24,28	0,5442	g	350027609200000027,350027609200000108	8-32,0-28						Antibodies to CD40	Bedian	2009	0		
585	chrUn_JH125662	12598	12621	3500144006	23		12598	12621	8421504	1	23	0	g	350014400600000392,350014400600000241,350014400600000394,350014400600000254,350014400600000430,350014400600000293	7-30,7-30,7-29,5-26,0-20,0-20						MULTIDOMAIN BIOTAGS FOR CANCER DETECTION, DIAGNOSIS AND THERAPY AND METHODS OF THEIR USE - Patent application	www.faqs.org	0	0		
585	chrUn_JH125662	12712	12735	3500398534	23		12712	12735	8421504	1	23	0	g	350039853400000074	11-34						US Patent # 7,338,660. Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 - Patents.com	www.patents.com	0	0		
585	chrUn_JH125662	17867	17898	3500032041	31		17867	17898	8421504	1	31	0	g	350003204100000071	0-31						Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof - Patent application	www.faqs.org	0	0		ADAM6
585	chrUn_JH125662	17931	18099	3500337289	61		17931	18099	8421504	2	18,43	0,125	g	350033728900000074	35-207						Specific Binding Members For Ngf 	.freshpatents.com	0	0		
585	chrUn_JH125662	18014	18132	3500321807	106		18014	18132	8421504	2	91,15	0,103	g	350032180700000012,350032180700000094,350032180700000036	1-123,60-123,2-96						GENERATION, CHARACTERIZATION AND USES THEREOF OF ANTI-NOTCH3 ANTIBODIES - MERCK SHARP & DOHME CORP.	www.sumobrain.com	0	0		
585	chrUn_JH125662	18027	18095	3500241653	58		18027	18095	8421504	2	11,47	0,21	g	350024165300000052,350024165300000142	39-110,39-110						Multispecific deimmunized CD3-binders	R*Huo Fu Mei Si Tai 	2006	0		
585	chrUn_JH125662	18027	18095	3500236616	58		18027	18095	8421504	2	11,47	0,21	g	350023661600000112,350023661600000086,350023661600000143,350023661600000222	99-168,9-54,0-20,0-20					Patent	Multispecific deimmunized CD3-binders (Patent CN:100453556)	A*A*Han Mi Er Dun 	2009	0		
585	chrUn_JH125662	18040	18105	3500172719	65		18040	18105	8421504	1	65	0	g	350017271900000030	24-94						HUMAN ANTI-CANCER ANTIBODIES	Hammond	2010	0		
585	chrUn_JH125662	18045	18099	3500459689	54		18045	18099	8421504	1	54	0	g	350045968900000004	13-67					Patent	Anthracycline-Antibody Conjugates for Cancer Therapy (Patent US:8361464)	Griffiths	2013	0		
585	chrUn_JH125662	18045	18099	3500397405	54		18045	18099	8421504	1	54	0	g	350039740500000008	53-107						Internalizing anti-cd74 antibodies and methods of use	D*M*Ge Deng Bo Ge 	2011	0		
585	chrUn_JH125662	18045	18099	3500274948	54		18045	18099	8421504	1	54	0	g	350027494800000008	53-107					Patent	Internalizing anti-CD74 antibodies and methods of use (Patent CN:1649902)	D*M*Ge Deng Bo Ge 	2011	0		
585	chrUn_JH125662	18045	18099	3500168750	54		18045	18099	8421504	1	54	0	g	350016875000000004	13-67						Internalizing anti-cd74 antibodies and methods of use	Hansen	2008	0		
585	chrUn_JH125662	18045	18099	3500078339	54		18045	18099	8421504	1	54	0	g	350007833900000004	13-67					Patent	Internalizing anti-CD74 antibodies and methods of use (Patent US:7931903)	Hansen	2011	0		
585	chrUn_JH125662	18045	18099	3500032067	54		18045	18099	8421504	1	54	0	g	350003206700000004	13-67						Internalizing Anti-CD74 Antibodies and Methods of Use	Hansen	2011	0		
585	chrUn_JH125662	18045	18086	3500333628	41		18045	18086	8421504	1	41	0	g	350033362800000013	0-41						Anthracycline-Antibody Conjugates for Cancer Therapy - Patent application	www.faqs.org	0	0		
585	chrUn_JH125665	16139	16166	3500343319	23		16139	16166	8421504	2	13,10	0,17	g	350034331900000061	9-38						US Patent # 5,298,400. Polynucleotide constructs for secreted glycosylated plasminogen activator inhibitor-2 (PAI-2) - Patents.com	www.patents.com	0	0		
585	chrUn_JH125681	25280	25309	3500369525	24		25280	25309	8421504	3	13,5,6	0,15,23	g	350036952500000005	14-38						Mcl-1 Quadruplex Nucleic Acids And Uses Thereof 	.freshpatents.com	0	0		
585	chrUn_JH125717	16676	16704	3500332742	23		16676	16704	8421504	2	14,9	0,19	c	350033274200000080	11-34						Method of treating cell damage or depletion	Williams	1994	0		
585	chrUn_JH125717	18552	18578	3500411666	23		18552	18578	8421504	3	14,5,4	0,16,22	g	350041166600000002	10-34		21920448	10.1016/j.micinf.2011.08.013		Microbes and infection / Institut Pasteur	Analysis of the Glycoproteome of Toxoplasma gondii using Lectin Affinity Chromatography and Tandem Mass Spectrometry	Qilie	2011	0		
585	chrUn_JH125717	24807	24837	3500068524	24		24807	24837	8421504	3	5,13,6	0,8,24	g	350006852400000001	18-43		21690299	10.1128/MCB.01426-10	0270-7306	Molecular and Cellular Biology	The Lysyl Oxidase Propeptide Interacts with the Receptor-Type Protein Tyrosine Phosphatase Kappa and Inhibits &#x03b2;-Catenin Transcriptional Activity in Lung Cancer Cells	Sanchez-Morgan	2011	6		
585	chrUn_JH125717	27869	27894	3500048680	23		27869	27894	8421504	2	17,6	0,19	c	350004868000000060	23-46						Novel Stra6 Polypeptides - Patent application	www.faqs.org	0	0		
585	chrUn_JH125717	27869	27894	3500001775	23		27869	27894	8421504	2	17,6	0,19	c	350000177500000060	23-46						Novel Stra6 Polypeptides 	.freshpatents.com	0	0		
585	chrUn_JH125717	55216	55265	3500108665	48		55216	55265	8421504	2	35,13	0,36	g	350010866500000054	91-139						US Patent # 5,516,683. Human D4 dopamine receptor and its uses - Patents.com	www.patents.com	0	0		
585	chrUn_JH125721	3803	3832	3500160528	24		3803	3832	8421504	2	9,15	0,14	g	350016052800000146	12-36						Anthrax toxin fusion proteins and uses thereof	Arora	1994	0		
585	chrUn_JH125725	813	846	3500440739	25		813	846	8421504	3	6,6,13	0,9,20	g	350044073900000204	0-25						5' to 3' exonuclease mutations of thermostable DNA polymerases	Abramson	1993	0		
585	chrUn_JH125727	41249	41273	3500275936	23		41249	41273	8421504	2	17,6	0,18	g	350027593600000000	6-30			10.1128/AEM.68.2.846-851.2002		Applied and Environmental Microbiology	Calnexin Overexpression Increases Manganese Peroxidase Production in Aspergillus niger	Ana	2002	0		
585	chrUn_JH125727	41249	41273	3500047612	23		41249	41273	8421504	2	17,6	0,18	g	350004761200000000	6-30		11823227	10.1128/AEM.68.2.846-851.2002	0099-2240	Applied and Environmental Microbiology	Calnexin Overexpression Increases Manganese Peroxidase Production in Aspergillus niger	Conesa	2002	4		
585	chrUn_JH125728	24026	24051	3500021081	23		24026	24051	8421504	2	5,18	0,7	g	350002108100000653	6-29						US Patent # 6,312,903. Simulataneous detection, identification and differentiation of eubacterial taxa using a hybridization assay - Patents.com	www.patents.com	0	0		
585	chrUn_JH125736	8367	8433	3500011002	66		8367	8433	8421504	1	66	0	p	350001100200015002	0-66		10777614	10.1074/jbc.275.17.13089	0021-9258	Journal of Biological Chemistry	Functional Relationship between Calreticulin, Calnexin, and the Endoplasmic Reticulum Luminal Domain of Calnexin	Danilczyk	2000	5		CANX
585	chrUn_JH125739	7260	7284	3500314401	23		7260	7284	8421504	2	4,19	0,5	g	350031440100000038	13-36						SI appendix for	www.pnas.org	0	0		
585	chrUn_JH125745	2896	2919	3500405377	23		2896	2919	8421504	1	23	0	g	350040537700000110	11-34						US Patent # 6,472,191. DNA FRAGMENT CARRYING TOLUENE MONOOXYGENASE GENE, RECOMBINANT PLASMID, TRANSFORMED MICROORGANISM, METHOD FOR DEGRADING CHLORINATED ALIPHATIC HYDROCARBON COMPOUNDS AND AROMATIC COMPOUNDS, AND METHOD FOR ENVIRONMENTAL REMEDIATION - Pa	www.patents.com	0	0		
585	chrUn_JH125747	46478	46506	3500060896	24		46478	46506	8421504	2	6,18	0,10	c	350006089600000040	2-26						Polypeptides and polynucleotides from coagulase-negative staphylococci	Foster	1999	0		
585	chrUn_JH125747	46478	46506	3500028179	24		46478	46506	8421504	2	6,18	0,10	c	350002817900000046	2-26						Polypeptides And Polynucleotides From Coagulase-negative Staphylococci 	.freshpatents.com	0	0		
585	chrUn_JH125753	37348	37373	3500005571	23		37348	37373	8421504	2	17,6	0,19	g	350000557100000146	4-28						Phytase polypeptides - Patent # 6569659 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH125760	22718	22920	3500045929	48		22718	22920	8421504	2	44,4	0,198	p	350004592900015041	0-48						US Patent # 7,166,704. Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer - Patents.com	www.patents.com	0	0		PRKAR1B
585	chrUn_JH125760	39274	39334	3500006787	60		39274	39334	8421504	1	60	0	p	350000678700015008	0-60						Protein kinase A and carney complex	Stratakis	2001	0		PRKAR1B
585	chrUn_JH125760	115087	115113	3500228180	24		115087	115113	8421504	2	6,18	0,8	g	350022818000000010	6-30						Polypeptides and nucleic acids encoding same	Fernandes	2001	0		
586	chrUn_JH125760	151399	151423	3500059779	23		151399	151423	8421504	2	14,9	0,15	g	350005977900000066	22-45						CE7-specific chimeric T cell receptor - Patent # 7265209 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH125765	16811	16835	3500370232	24		16811	16835	8421504	1	24	0	c	350037023200000137	0-27						Enzyme capable of degrading cellullose or hemicellulose	Woldike	1994	0		
585	chrUn_JH125765	16811	16835	3500187760	24		16811	16835	8421504	1	24	0	c	350018776000000119	0-27					Patent	Enzyme capable of degrading cellulose or hemicellulose (Patent US:5686593)	Hagen	1997	0		
585	chrUn_JH125765	25723	45651	3500189016	50		25723	45651	8421504	4	5,24,20,1	0,4465,19488,19927	c	350018901600000106,350018901600000516	6-35,26-47						Methods of inhibiting locomotor damage following spinal cord injury with &#x03b1; D-specific antibodies	Gallatin	2000	0		
585	chrUn_JH125765	30231	45651	3500247922	53		30231	45651	8421504	3	32,20,1	0,14980,15419	c	350024792200000557,350024792200000514	0-32,26-47						Human B2 integrin alpha subunit antibodies	Gallatin	1996	0		
585	chrUn_JH125767	4000	4027	3500217469	23		4000	4027	8421504	3	4,7,12	0,5,15	g	350021746900000011	0-23						AN ELECTRON PARAMAGNETIC RESONANCE STUDY OF HIV-1 PROTEASE AND THE DEVELOPMENT OF A SOLUBLE EXPRESSION SYSTEM FOR PRORENIN	ges.uflib.ufl.edu	0	0		
585	chrUn_JH125769	12935	12961	3500090457	23		12935	12961	8421504	2	13,10	0,16	g	350009045700000105	0-23						Compositions and Methods Relating to STOP-1	Ackerly	2011	0		
585	chrUn_JH125772	25112	25160	3500431648	48		25112	25160	8421504	1	48	0	p	350043164800015064	0-48						111111 1111111111111111111111111111111111111111111111111111111111111	invent.ucsd.edu	0	0		
585	chrUn_JH125772	25112	25157	3500240665	45		25112	25157	8421504	1	45	0	p	350024066500015057	0-45						Inhibition of cancer metastasis - Patent application	www.faqs.org	0	0		
585	chrUn_JH125773	44235	44263	3500147485	23		44235	44263	8421504	2	10,13	0,15	g	350014748500000450	13-44						Antigen Binding Proteins Capable Of Binding Thymic Stromal Lymphopoietin 	.freshpatents.com	0	0		
585	chrUn_JH125777	36219	36242	3500110329	23		36219	36242	8421504	1	23	0	g	350011032900000084	19-42						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
585	chrUn_JH125777	51128	51158	3500008258	25		51128	51158	8421504	3	12,5,8	0,14,22	c	350000825800000128	0-30						Polypeptides having L-asparaginase activity	Ario	1997	0		
585	chrUn_JH125777	66322	70377	3500118455	102		66322	70377	8421504	3	30,48,24	0,49,4031	p,c,g	350011845500000051,350011845500000037,350011845500000037,350011845500000038,350011845500000038,350011845500000009,350011845500000009,350011845500000010,350011845500000010,350011845500015048,350011845500000034	10-40,0-21,0-21,24-45,24-45,0-21,0-21,24-45,24-45,0-48,20-44						Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor	Anderson	2001	0		
585	chrUn_JH125777	66323	66352	3500264785	29		66323	66352	8421504	1	29	0	c,g	350026478500000005,350026478500000005	13-42,13-42						Adenine nucleotide translocator (ant) fusion proteins and uses thereof	Anderson	2000	0		
585	chrUn_JH125777	66323	66352	3500264300	29		66323	66352	8421504	1	29	0	c	350026430000000005	13-42						Adenine nucleotide translocator (ant) fusion proteins and uses thereof	Anderson	2000	0		
585	chrUn_JH125800	14607	14649	3500124616	42		14607	14649	8421504	1	42	0	g	350012461600000045	0-42						METHODS FOR MODULATING AND IDENTIFYING CELLULAR SENESCENCE - GERON CORPORATION	www.sumobrain.com	0	0		
585	chrUn_JH125802	2441	2469	3500219097	24		2441	2469	8421504	2	15,9	0,19	g	350021909700000166	12-38						Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques - Patent application	www.faqs.org	0	0		
585	chrUn_JH125803	17992	18017	3500278101	23		17992	18017	8421504	2	6,17	0,8	g	350027810100000083	0-23						Neurturin and related growth factors	Eugene	1997	0		
585	chrUn_JH125805	31969	35383	3500139284	90		31969	35383	8421504	3	45,38,7	0,48,3407	p	350013928400015135,350013928400015134	0-45,0-45						Genetic variations associated with psychiatric disorders - Patent application	www.faqs.org	0	0		
585	chrUn_JH125832	4925	4950	3500241032	25		4925	4950	8421504	1	25	0	g	350024103200000012	10-35						Eukaryotic cells stably expressing genes from multiple transfected episomes	Damaj	1999	0		
585	chrUn_JH125832	4925	4950	3500201616	25		4925	4950	8421504	1	25	0	g	350020161600000048,350020161600000012	10-35,10-35						Eukaryotic cells stably expressing genes from multiple transfected episomes	Horlick	1998	0		
585	chrUn_JH125833	4290	4413	3500024078	44		4290	4413	8421504	2	21,23	0,100	c	350002407800000001,350002407800000000	0-21,0-23		15548600	10.1091/mbc.E04-06-0479	1059-1524	Molecular Biology of the Cell	Identification and Characterization of Regulator of G Protein Signaling 4 (RGS4) as a Novel Inhibitor of Tubulogenesis: RGS4 Inhibits Mitogen-activated Protein Kinases and Vascular Endothelial Growth Factor Signaling	Albig	2005	5		
585	chrUn_JH125833	4382	4415	3500447590	33		4382	4415	8421504	1	33	0	c	350044759000000058	15-48						METHODS TO EVALUATE GLUCOCORTICOID RECEPTOR AGONISTS AND ANTAGONISTS FOR EFFECTS ON NEURON-LIKE CELLS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125835	2268	2292	3500338686	24		2268	2292	8421504	1	24	0	c	350033868600000002	0-24		10966929			American Journal of Physiology - Renal Physiology	Vasopressin-dependent upregulation of aquaporin-2 gene expression in glucocorticoid-deficient rats	Saito	2000	0		AVPR2
585	chrUn_JH125835	2414	2438	3500367409	24		2414	2438	8421504	1	24	0	c	350036740900000003	0-24						Recent developments in canine Cushing&#x2019;s syndrome	ive.library.uu.nl	0	0		
585	chrUn_JH125836	14439	14483	3500335406	44		14439	14483	8421504	1	44	0	c	350033540600000073	0-44						HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND DNAs ENCODING THESE PROTEINS	Kato	1998	0		
585	chrUn_JH125836	14617	14641	3500445631	23		14617	14641	8421504	2	4,19	0,5	c	350044563100000032	11-34						Igm Production By Transformed Cells And Methods Of Quantifying Said Igm Production 	.freshpatents.com	0	0		
585	chrUn_JH125836	14617	14641	3500316685	23		14617	14641	8421504	2	4,19	0,5	c	350031668500000055	0-23						Neoplasia-Specific Autoantibodies and Methods - Patent application	www.faqs.org	0	0		
585	chrUn_JH125836	14617	14641	3500228494	23		14617	14641	8421504	2	4,19	0,5	c	350022849400000031	11-34						IgM Production by Transformed Cell and Method of Quantifying the Same - Patent application	www.faqs.org	0	0		
585	chrUn_JH125843	32228	32252	3500450747	23		32228	32252	8421504	2	9,14	0,10	g	350045074700000009	21-45						Methods for expressing and recovering human monoclonal antibodies to CTLA-4	Hanson	2003	0		
585	chrUn_JH125843	32228	32252	3500440689	23		32228	32252	8421504	2	9,14	0,10	g	350044068900000017	21-45						Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses	Bedian	2007	0		
585	chrUn_JH125843	32228	32252	3500346929	23		32228	32252	8421504	2	9,14	0,10	g	350034692900000016	21-45						Antibodies to cd40	Bedian	2010	0		
585	chrUn_JH125843	32228	32252	3500272920	23		32228	32252	8421504	2	9,14	0,10	g	350027292000000256,350027292000000016	21-45,21-45						Antibodies to CD40 - Patent application	www.faqs.org	0	0		
585	chrUn_JH125843	32228	32252	3500127455	23		32228	32252	8421504	2	9,14	0,10	g	350012745500000008	21-45						Human monoclonal antibodies to CTLA-4	Hanson	2003	0		
585	chrUn_JH125846	7190	7215	3500465662	23		7190	7215	8421504	2	11,12	0,13	g	350046566200000011	0-23						Untersuchung zur Funktion des Accumulation associated proteins (Aap) bei der Staphylococcus epidermidis (Evans 1916) Biofilmbildung	ub.uni-hamburg.de	0	0		
585	chrUn_JH125848	37232	37260	3500084279	24		37232	37260	8421504	2	6,18	0,10	g	350008427900000011	1-25						High throughput directed evolution by rational mutagenesis	Drittanti	2003	0		
585	chrUn_JH125848	49290	49316	3500289310	23		49290	49316	8421504	3	4,7,12	0,5,14	g	350028931000000021	13-36						The Regulation of Peptide Mimotope/Epitope Recognition by Monoclonal Antg &#xff;&#xba;omO2	.nottingham.ac.uk	0	0		
585	chrUn_JH125852	2804	2829	3500136785	23		2804	2829	8421504	2	8,15	0,10	g	350013678500000012	2-25						Cloning, sequence, and expression ofbovineinterleukin 2	www.pnas.org	0	0		
585	chrUn_JH125852	78734	78763	3500211554	24		78734	78763	8421504	2	14,10	0,19	g	350021155400000002	0-24		12114439		1078-0432	Clinical Cancer Research	Novel Anti-CD30 Recombinant Immunotoxins Containing Disulfide-stabilized Fv Fragments	Nagata	2002	8		
585	chrUn_JH125853	0	554	3500430234	553		0	554	8421504	2	511,42	0,512	g	350043023400000006	278-831						 Method For Making Recombinant Proteins 	www.docstoc.com	0	0		
585	chrUn_JH125865	20685	20711	3500215600	23		20685	20711	8421504	2	12,11	0,15	g	350021560000000002	9-42						Vaccine against foot-and-mouth disease	Audonnet	2002	0		
585	chrUn_JH125867	11210	11237	3500083709	23		11210	11237	8421504	2	14,9	0,18	g	350008370900000000	0-23						Molecular epidemiology of eastern equine encephalitis virus, New York.	.biomedsearch.com	0	0		
585	chrUn_JH125867	11210	11237	3500082455	23		11210	11237	8421504	2	14,9	0,18	g	350008245500000000	0-23						Molecular Epidemiology of Eastern Equine Encephalitis Virus, New York - Vol. 14 No. 3 - March 2008 - Emerging Infectious Disease journal - CDC	wwwnc.cdc.gov	0	0		
585	chrUn_JH125871	120923	122217	3500281577	25		120923	122217	8421504	2	24,1	0,1293	c	350028157700000142	0-26						Lead binding polypeptides and nucleotides coding therefor	Lopez	1996	0		
585	chrUn_JH125871	120923	122217	3500084119	25		120923	122217	8421504	2	24,1	0,1293	c	350008411900000033	0-26						HUMANIZED ANTIBODIES SPECIFIC FOR AMINO ACID SEQUENCE RGD OF AN EXTRACELLULAR MATRIX PROTEIN AND THE USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH125871	120941	122236	3500360354	23		120941	122236	8421504	3	6,4,13	0,1275,1282	c	350036035400000008	0-23						Conserved regulatory motifs at phenylethanolamine | Juan Flores - Academia.edu	www.academia.edu	0	0		
585	chrUn_JH125875	6180	6205	3500159378	24		6180	6205	8421504	2	4,20	0,5	g	350015937800000104,350015937800000053	5-30,14-39						 Method Of Detection Of Herpes B Virus 	www.docstoc.com	0	0		
585	chrUn_JH125875	14950	14973	3500312057	23		14950	14973	8421504	1	23	0	g	350031205700000006,350031205700000016	0-23,0-23						Antibodies to OPGL - Patent application	www.faqs.org	0	0		
585	chrUn_JH125875	15624	15665	3500467086	34		15624	15665	8421504	3	15,9,10	0,20,31	g	350046708600000014,350046708600000013	0-41,4-45						Methods Of Preventing And Treating Rsv Infections And Related Conditions 	.freshpatents.com	0	0		
585	chrUn_JH125875	17523	17546	3500385760	23		17523	17546	8421504	1	23	0	g	350038576000000002	0-23						Compositions for seed treatment	Verheesen	2012	0		
585	chrUn_JH125875	17523	17546	3500377050	23		17523	17546	8421504	1	23	0	g	350037705000000002	0-23						COMPOSITIONS FOR SEED TREATMENT - Patent application	www.faqs.org	0	0		
585	chrUn_JH125875	17523	17546	3500312195	23		17523	17546	8421504	1	23	0	g	350031219500000003	0-23						Peptides capable of binding to serum proteins - Patent application	www.faqs.org	0	0		
585	chrUn_JH125875	17523	17546	3500247425	23		17523	17546	8421504	1	23	0	g	350024742500000002	0-23						Cxcr2 binding polypeptides	Bradley	2012	0		
585	chrUn_JH125875	17523	17546	3500239609	23		17523	17546	8421504	1	23	0	g	350023960900000002	0-23						Compositions for seed treatment	De	2012	0		ELK2AP
585	chrUn_JH125875	17523	17546	3500180754	23		17523	17546	8421504	1	23	0	g	350018075400000002,350018075400000074	0-23,0-23						CHEMOKINE RECEPTOR BINDING POLYPEPTIDES - Patent application	www.faqs.org	0	0		
585	chrUn_JH125875	18026	18050	3500293750	24		18026	18050	8421504	1	24	0	g	350029375000000785	0-24						Chimeric clotting factors	Salas	2012	0		
585	chrUn_JH125875	18026	18050	3500289762	24		18026	18050	8421504	1	24	0	g	350028976200000425	0-24						TACI-immunoglobulin fusion proteins	J*A*Ge Luo Si 	2010	0		
585	chrUn_JH125875	18040	18065	3500232921	25		18040	18065	8421504	1	25	0	g	350023292100000003	0-25						ScienceDirect.com - Comparative Immunology, Microbiology and Infectious Diseases - Histological studies on the ontogeny of bovine palatine and pharyngeal tonsil: Germinal center formation, IgG, and IgA mRNA expression	sciencedirect.com	0	0		
585	chrUn_JH125875	18046	46226	3500408714	1018		18046	46226	8421504	5	28,292,39,330,329	0,26651,27274,27439,27851	g	350040871400000011,350040871400000029,350040871400000032,350040871400000031,350040871400000030	10-38,10-38,420-1410,420-1413,0-990						ANTI-FMD VACCINE COMPOSITION AND PREPARATION AND USE THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH125875	19136	47853	3500396619	2345		19136	47853	8421504	13	92,8,176,57,20,17,34,154,13,43,12,12,1707	0,121,138,323,381,404,436,471,626,640,699,723,27010	g	350039661900000043,350039661900000037,350039661900000039,350039661900000038	1139-1844,0-1714,0-1689,0-1704						Production of humanized antibodies in transgenic animals	Wen Mu [?] Fan *Si Ku Tan 	2004	0		
585	chrUn_JH125875	45644	45767	3500205057	40		45644	45767	8421504	2	20,20	0,103	g	350020505700000012,350020505700000013	0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
585	chrUn_JH125875	45644	45767	3500137197	40		45644	45767	8421504	2	20,20	0,103	g	350013719700000012,350013719700000013	0-20,0-20						UNIVERSIDADE FEDERAL DE S&#xc3;O CARLOS CENTRO DE CI&#xca;NCIAS BIOL&#xd3;GICAS E DA SA&#xda;DE PROGRAMA DE P&#xd3;S-GRADUA&#xc7;&#xc3;O EM GEN&#xc9;TICA E EVOLU&#xc7;&#xc3;O AVALIA&#xc7;&#xc3;O DA RESPOSTA DE BOVINOS NELORE E CRUZADOS, SENEPOL X NELORE E	ww.bdtd.ufscar.br	0	0		
585	chrUn_JH125882	2970	3018	3500165635	46		2970	3018	8421504	2	14,32	0,16	g	350016563500000035,350016563500000008	25-62,76-120						Method For Diagnosing Intertility 	.freshpatents.com	0	0		
585	chrUn_JH125882	39785	39809	3500052099	23		39785	39809	8421504	2	17,6	0,18	g	350005209900000400	12-37						Card Domain Containing Polypeptides, Encoding Nucleic Acids, And Methods Of Use 	.freshpatents.com	0	0		
585	chrUn_JH125890	61135	61161	3500132186	23		61135	61161	8421504	2	10,13	0,13	c	350013218600000066	0-23						Humanized anti-alpha 9 integrin antibodies and the uses thereof	Kon	2010	0		
585	chrUn_JH125892	4658	5567	3500166204	311		4658	5567	8421504	11	94,24,14,7,10,14,15,21,15,71,26	0,105,130,147,159,222,253,269,295,391,883	g	350016620400000072	0-329						Detection Of Dna Sequence Motifs In Ruminants 	.freshpatents.com	0	0		
585	chrUn_JH125917	4597	4622	3500066857	23		4597	4622	8421504	2	9,14	0,11	g	350006685700000028	16-39						Anti-IGF-I receptor antibody	R*Xin Ge 	2005	0		
585	chrUn_JH125929	1358	1382	3500060499	24		1358	1382	8421504	1	24	0	g	350006049900000007	0-24		23072335	10.1186/1471-2156-13-86	1471-2156	BMC Genetics	Gene number determination and genetic polymorphism of the gamma delta T cell co-receptor WC1 genes	Chen	2012	2		
585	chrUn_JH125932	16289	16315	3500373149	26		16289	16315	8421504	1	26	0	g	350037314900000003	60-86						Monoclonal antibodies against claudin-18 for treatment of cancer	Sahin	2008	0		
585	chrUn_JH125932	16289	16315	3500318159	26		16289	16315	8421504	1	26	0	g	350031815900000094	27-53						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
585	chrUn_JH125932	16289	16315	3500199754	26		16289	16315	8421504	1	26	0	g	350019975400000365	2-28						Tie1-binding Ligands 	.freshpatents.com	0	0		
585	chrUn_JH125932	16289	16315	3500076234	26		16289	16315	8421504	1	26	0	g	350007623400000087	15-41						PLASMA KALLIKREIN BINDING PROTEINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125932	16289	16315	3500070440	26		16289	16315	8421504	1	26	0	g	350007044000000008	60-86						Monoclonal antibodies for treatment of cancer	Sahin	2011	0		
585	chrUn_JH125932	16289	16315	3500038220	26		16289	16315	8421504	1	26	0	g	350003822000000008	60-86						Monoclonal antibodies for treatment of cancer	Sahin	2010	0		
585	chrUn_JH125932	16292	16315	3500140018	23		16292	16315	8421504	1	23	0	g	350014001800000098	0-23						Method for linking sequences of interest	M*B*Ao Lie Ke Xi Wei Qi 	2006	0		
585	chrUn_JH125932	16292	16315	3500095670	23		16292	16315	8421504	1	23	0	g	350009567000000027	0-23					Patent	Method for linking sequences of interest (Patent US:7749697)	Andersen	2010	0		
585	chrUn_JH125932	16294	16317	3500259588	23		16294	16317	8421504	1	23	0	g	350025958800000006	0-23						Method and composition for altering a b cell mediated pathology	Gold	2002	0		
585	chrUn_JH125932	32012	32816	3500232921	50		32012	32816	8421504	2	25,25	0,779	c	350023292100000004,350023292100000005	0-25,0-25						ScienceDirect.com - Comparative Immunology, Microbiology and Infectious Diseases - Histological studies on the ontogeny of bovine palatine and pharyngeal tonsil: Germinal center formation, IgG, and IgA mRNA expression	sciencedirect.com	0	0		
585	chrUn_JH125932	32456	32777	3500104282	129		32456	32777	8421504	2	48,81	0,240	p	350010428200015147,350010428200015152,350010428200015175	0-48,0-48,0-48						Anti-C35 antibodies for treating cancer - Patent application	www.faqs.org	0	0		
585	chrUn_JH125932	32459	32777	3500047574	123		32459	32777	8421504	2	45,78	0,240	p	350004757400015125,350004757400015130,350004757400015153	0-45,0-45,0-45						Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells - Patent application	www.faqs.org	0	0		
585	chrUn_JH125932	32693	32738	3500145019	45		32693	32738	8421504	1	45	0	p	350014501900015183	0-45						BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS - Patent application	www.faqs.org	0	0		
585	chrUn_JH125932	102545	102569	3500103667	23		102545	102569	8421504	2	9,14	0,10	g	350010366700000000	0-23			10.1046/j.1365-2567.1999.00668.x		Immunology	Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier	SK	1999	0		
585	chrUn_JH125932	105531	105557	3500376889	26		105531	105557	8421504	1	26	0	c	350037688900000004	9-35						ScienceDirect.com - Cancer Cell - Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma	sciencedirect.com	0	0		
585	chrUn_JH125932	105531	105557	3500282389	26		105531	105557	8421504	1	26	0	c	350028238900000004	9-35						Genomic screen for epigenetically silenced tumor suppressor genes	Sidransky	2004	0		
585	chrUn_JH125932	105531	105557	3500182666	26		105531	105557	8421504	1	26	0	c	350018266600000004	9-35					Patent	Genomic screen for epigenetically silenced tumor suppressor genes (Patent US:7781161)	Sidransky	2010	0		
585	chrUn_JH125932	124153	124176	3500116686	23		124153	124176	8421504	1	23	0	g	350011668600000009	0-23		21595884	10.1186/1756-9966-30-60	1756-9966	Journal of Experimental & Clinical Cancer Research	ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro	Jiang	2011	2		
585	chrUn_JH125932	124153	124176	3500102815	23		124153	124176	8421504	1	23	0	g	350010281500000009	0-23						ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro	www.jeccr.com	0	0		
585	chrUn_JH125944	3448	3473	3500399667	25		3448	3473	8421504	1	25	0	c	350039966700000044,350039966700000005	18-43,0-20						ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES	Clausen	2007	0		
585	chrUn_JH125944	3448	3473	3500265908	25		3448	3473	8421504	1	25	0	c	350026590800000044,350026590800000130,350026590800000092,350026590800000005	18-43,18-43,7-28,0-20						Isolated Lectin Polypeptides Consisting Of Truncated Mammalian Udp-galnac:polypeptide N- Acetylgalactosaminyltransferases 	.freshpatents.com	0	0		
585	chrUn_JH125944	3757	3785	3500028061	24		3757	3785	8421504	2	7,17	0,11	c	350002806100000170	9-33						Surface proteins of leptospira	www.devileye.net	0	0		
585	chrUn_JH125944	4164	4976	3500270142	40		4164	4976	8421504	2	20,20	0,792	c	350027014200000004,350027014200000001	0-20,0-20		11221889		0008-5472	Cancer Research	High Density O-Glycosylation of the MUC2 Tandem Repeat Unit by N-Acetylgalactosaminyltransferase-3 in Colonic Adenocarcinoma Extracts	Inoue	2001	8		
585	chrUn_JH125944	4712	4757	3500121736	45		4712	4757	8421504	1	45	0	p	350012173600015012	0-45						Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism - Patent application	www.faqs.org	0	0		GALNT1
585	chrUn_JH125945	2152	2176	3500239159	23		2152	2176	8421504	2	9,14	0,10	g	350023915900000010	4-27		18922866	10.1128/JVI.01404-08	0022-538X	Journal of Virology	Optimization of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins with V1/V2 Deleted, Using Virus Evolution	Bontjer	2009	5		
585	chrUn_JH125945	2262	2285	3500356355	23		2262	2285	8421504	1	23	0	g	350035635500000207	2-25						Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy - Patent # 5863724 - PatentGenius	.patentgenius.com	0	0		
585	chrUn_JH125955	17603	17631	3500276244	23		17603	17631	8421504	2	12,11	0,17	c	350027624400000059	9-32						NOVEL flt-3 RECEPTOR AGONISTS	Feng	1998	0		
585	chrUn_JH125955	17603	17631	3500250080	23		17603	17631	8421504	2	12,11	0,17	c	350025008000000061	9-32						Circular permuteins of flt3 ligand	Mcwherter	1997	0		
585	chrUn_JH125955	21379	21533	3500028150	66		21379	21533	8421504	2	64,2	0,152	p	350002815000015012	0-66						A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine	Cheong	2013	0		
585	chrUn_JH125955	21388	21569	3500390460	90		21388	21569	8421504	3	45,7,38	0,48,143	p	350039046000015066,350039046000015067	0-45,0-45						Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE Proteins - Patent application	www.faqs.org	0	0		MAGED4
585	chrUn_JH125955	21388	21569	3500159336	90		21388	21569	8421504	3	45,7,38	0,48,143	p	350015933600015066,350015933600015067	0-45,0-45						SUBSTANCE FOR RESTORING NORMAL CO-EXPRESSION AND INTERACTION BETWEEN THE LOX AND NRAGE PROTEINS - Patent application	www.faqs.org	0	0		MAGED4
585	chrUn_JH125955	24110	24135	3500206738	23		24110	24135	8421504	2	6,17	0,8	c	350020673800000001	11-34		9688635			American Journal of Physiology - Endocrinology and Metabolism	Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3	Campbell	1998	0		
585	chrUn_JH125960	46134	46159	3500171075	23		46134	46159	8421504	2	6,17	0,8	g	350017107500000365	10-33						$i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES	Choi	1999	0		
585	chrUn_JH125965	70666	70690	3500021221	23		70666	70690	8421504	2	9,14	0,10	g	350002122100000057	0-33						US Patent # 5,880,334. DNA encoding phosphoenolpyruvate carboxykinase, recombinant vector and transformed plant containing the same - Patents.com	www.patents.com	0	0		
585	chrUn_JH125971	25848	25872	3500421207	24		25848	25872	8421504	1	24	0	g	350042120700000047	0-24						Immunostimulatory oligonucleotides and uses thereof	Lopez	2005	0		NXPH2
585	chrUn_JH125976	4717	4743	3500340684	26		4717	4743	8421504	1	26	0	g	350034068400000148,350034068400000169,350034068400000049	72-98,72-98,72-98						Endogenous Retrovirus Polypeptides Linked To Oncogenic Transformation 	.freshpatents.com	0	0		
585	chrUn_JH125985	49461	49486	3500253347	23		49461	49486	8421504	2	7,16	0,9	g	350025334700000038	2-31						US Patent # 6,136,310. Recombinant anti-CD4 antibodies for human therapy - Patents.com	www.patents.com	0	0		
585	chrUn_JH126002	22207	22237	3500402697	26		22207	22237	8421504	2	5,21	0,9	g	350040269700000179	3-30						METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH126004	32057	32082	3500155117	23		32057	32082	8421504	2	8,15	0,10	g	350015511700000018	5-34						Chlamydia secretory locus orf and uses thereof - Sanofi Pasteur Limited	patentsonline.com	0	0		
585	chrUn_JH126014	35094	35403	3500229770	51		35094	35403	8421504	2	26,25	0,284	c	350022977000000005,350022977000000004	0-26,0-25		17545311	10.1124/jpet.107.121566	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Opposing Control of Cannabinoid Receptor Stimulation on Amyloid-&#x03b2;-Induced Reactive Gliosis: In Vitro and in Vivo Evidence	Esposito	2007	0		
585	chrUn_JH126014	35095	35403	3500068529	50		35095	35403	8421504	2	25,25	0,283	c	350006852900000003,350006852900000002	0-25,0-25						The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism S	aspetjournals.org	0	0		CNR1
585	chrUn_JH126014	35095	35401	3500462615	48		35095	35401	8421504	2	25,23	0,283	c	350046261500000001,350046261500000000	0-25,1-24		19887554	10.1158/1535-7163.MCT-09-0448	1535-7163	Molecular Cancer Therapeutics	Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer	Qamri	2009	5		CNR1
585	chrUn_JH126014	35095	35401	3500317145	48		35095	35401	8421504	2	25,23	0,283	c	350031714500000001,350031714500000000	0-25,1-24		19887554	10.1158/1535-7163.MCT-09-0448	1535-7163	Molecular Cancer Therapeutics	Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer	Qamri	2009	5		CNR1
585	chrUn_JH126014	35096	35403	3500382464	49		35096	35403	8421504	2	24,25	0,282	c	350038246400000001,350038246400000000	0-24,0-25		18566465	10.1167/iovs.07-1319	1552-5783	Investigative Ophthalmology & Visual Science	Cannabinoid Receptors in Conjunctival Epithelium: Identification and Functional Properties	Iribarne	2008	0		CNR1
585	chrUn_JH126014	35096	35403	3500135477	49		35096	35403	8421504	2	24,25	0,282	c	350013547700000006,350013547700000005	0-24,0-25			10.1046/j.1432-1033.2002.03078.x	1432-1033	European Journal of Biochemistry	Presence and regulation of the endocannabinoid system in human dendritic cells - Matias - 2002 - European Journal of Biochemistry - Wiley Online Library	Matias	2002	0		
585	chrUn_JH126014	35247	36498	3500135854	1248		35247	36498	8421504	2	768,480	0,771	p	350013585400015002,350013585400015001	0-768,0-480						CB-1 MODULATING COMPOUNDS AND THEIR USE - ACADIA PHARMACEUTICALS INC.	www.sumobrain.com	0	0		CNR1
585	chrUn_JH126014	35265	36498	3500346931	1233		35265	36498	8421504	1	1233	0	p	350034693100015000	0-1233						Cb-1 Modulating Compounds And Their Use 	.freshpatents.com	0	0		
585	chrUn_JH126014	35625	35676	3500174049	51		35625	35676	8421504	1	51	0	p	350017404900015000	0-51						Drug Addiction	edc.fums.ac.ir	0	0		CNR1
585	chrUn_JH126014	35834	35857	3500047311	23		35834	35857	8421504	1	23	0	c	350004731100000011	18-41						Saleta Sierra &#xc1;vila Granada, 2006	hera.ugr.es	0	0		CNR1
585	chrUn_JH126014	35834	35857	3500012973	23		35834	35857	8421504	1	23	0	c	350001297300000012	18-41						TESIS DOCTORAL CAMO ENGRASAR CORRECTAMENTE EL ORGANISMO: ?EFECTO DE LA GRASA SOBRE LA RESPUESTA	ww.digibug.ugr.es	0	0		CNR1
585	chrUn_JH126014	36063	36120	3500463464	53		36063	36120	8421504	3	17,16,20	0,19,37	c	350046346400000009	43-96						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
585	chrUn_JH126014	36288	36498	3500187641	210		36288	36498	8421504	1	210	0	p	350018764100015048	0-210						Full text of "The Biological bulletin"	www.archive.org	0	0		
585	chrUn_JH126034	64112	74991	3500371922	61		64112	74991	8421504	2	25,36	0,10843	c	350037192200000075,350037192200000035	0-25,12-48						BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE - Patent application	www.faqs.org	0	0		
585	chrUn_JH126044	26607	26630	3500110329	23		26607	26630	8421504	1	23	0	g	350011032900000069	5-36						Preparation of organisms with faster growth and/or higher yield - Patent application	www.faqs.org	0	0		
585	chrUn_JH126044	68800	68827	3500234313	24		68800	68827	8421504	4	4,11,5,4	0,5,17,23	g	350023431300000001	3-27						DMD 40:198&#x2013;204, 2012 Phenotype of the Most Common &#x201c;Slow Acetylator&#x201d; Arylamine -Acetyltransferase 1 Genetic Variant ( )Is Substrate-Dependent	aspetjournals.org	0	0		
585	chrUn_JH126047	25889	25912	3500343526	23		25889	25912	8421504	1	23	0	c	350034352600000002	14-37		23349732	10.1371/journal.pone.0053706	1932-6203	PLOS ONE	PLOS ONE: Structural Basis of the &#x03b3;-Lactone-Ring Formation in Ascorbic Acid Biosynthesis by the Senescence Marker Protein-30/Gluconolactonase	Aizawa	2013	4		
585	chrUn_JH126047	25889	25912	3500216421	23		25889	25912	8421504	1	23	0	c	350021642100000002	14-37						Structural Basis of the &#x03b3;-Lactone-Ring Formation in Ascorbic Acid Biosynthesis by the Senescence Marker Protein-30/Gluconolactonase. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH126053	3604	3634	3500386802	25		3604	3634	8421504	2	12,13	0,17	c	350038680200000147	22-47					Patent	Recombinant antibodies specific for a growth factor receptor (Patent US:5571894)	Groner	1996	0		
585	chrUn_JH126053	3604	3634	3500183368	25		3604	3634	8421504	2	12,13	0,17	c	350018336800000147	22-47						Recombinant antibodies specific for a growth factor receptor	Wels	1994	0		
585	chrUn_JH126053	5181	5212	3500311219	31		5181	5212	8421504	1	31	0	c	350031121900000136	12-43						Complementary DNA's encoding proteins with signal peptides	Edwards	2000	0		
585	chrUn_JH126065	12207	12233	3500380012	24		12207	12233	8421504	2	6,18	0,8	g	350038001200000004	3-27						Antiviral drug resistance of herpes simplex virus	ive.library.uu.nl	0	0		
585	chrUn_JH126077	34425	34449	3500023144	23		34425	34449	8421504	2	18,5	0,19	g	350002314400000002	0-26						Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors	Li	2005	0		
585	chrUn_JH126088	8080	8107	3500254382	23		8080	8107	8421504	3	6,4,13	0,9,14	g	350025438200000016	9-32		18567802	10.1158/1541-7786.MCR-07-2217	1541-7786	Molecular Cancer Research	The RNA Exosome Component hRrp6 Is a Target for 5-Fluorouracil in Human Cells	Kammler	2008	4		
585	chrUn_JH126091	9366	9394	3500221738	23		9366	9394	8421504	2	16,7	0,21	g	350022173800000009	10-34						Single chain trimers and uses therefor	Linette	2006	0		
585	chrUn_JH126091	44222	44246	3500101538	23		44222	44246	8421504	2	17,6	0,18	g	350010153800000329	5-28						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
585	chrUn_JH126092	24416	24442	3500410107	23		24416	24442	8421504	2	6,17	0,9	g	350041010700000006	14-38						Anaerobic Biodegradation of Long Chain Fatty Acids	um.sdum.uminho.pt	0	0		
585	chrUn_JH126096	16041	16347	3500362819	303		16041	16347	8421504	2	159,144	0,162	p	350036281900015033,350036281900015016	0-159,0-144						Characterization of a gonad-specific transforming growth factor-&#x03b2; superfamily member differentially expressed during the reproductive cycle of the oyster Crassostrea gigas	chimer.ifremer.fr	0	0		
585	chrUn_JH126096	16042	16501	3500263194	69		16042	16501	8421504	3	22,24,23	0,198,436	c	350026319400000007,350026319400000006,350026319400000004	0-22,0-24,0-23						International Buffalo Information Centre	ibic.lib.ku.ac.th	0	0		
585	chrUn_JH126096	16059	16622	3500328889	194		16059	16622	8421504	6	22,35,63,33,21,20	0,62,294,445,515,543	p,c,g	350032888900000011,350032888900000011,350032888900000030,350032888900015003,350032888900000029,350032888900000028,350032888900000007,350032888900000008	0-22,0-22,0-35,0-45,0-20,0-33,0-21,0-20						New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate	Davis	2003	0		
585	chrUn_JH126096	16059	16622	3500120175	151		16059	16622	8421504	6	22,35,20,33,21,20	0,62,337,445,515,543	c,g	350012017500000013,350012017500000013,350012017500000032,350012017500000031,350012017500000030,350012017500000009,350012017500000010	0-22,0-22,0-35,0-20,0-33,0-21,0-20						Mutations in the Genes for Oocyte-Derived Growth Factors GDF9 and BMP15 Are Associated with Both Increased Ovulation Rate and Sterility in Cambridge and Belclare Sheep (Ovis aries)	ww.biolreprod.org	0	0		
585	chrUn_JH126096	16059	16410	3500333068	115		16059	16410	8421504	5	22,22,22,26,23	0,146,179,253,328	c,g	350033306800000010,350033306800000010,350033306800000003,350033306800000005,350033306800000006,350033306800000002	0-22,0-22,0-22,0-22,0-26,0-23		12021074	10.1095/biolreprod66.6.1869	0006-3363	Biology of Reproduction	DNA Tests in Prolific Sheep from Eight Countries Provide New Evidence on Origin of the Booroola (FecB) Mutation	Davis	2002	4		
585	chrUn_JH126096	16059	16410	3500324551	115		16059	16410	8421504	5	22,22,22,26,23	0,146,179,253,328	c,g	350032455100000010,350032455100000010,350032455100000003,350032455100000003,350032455100000005,350032455100000005,350032455100000006,350032455100000002	0-22,0-22,0-22,0-22,0-22,0-22,0-26,0-23		12021074	10.1095/biolreprod66.6.1869	0006-3363	Biology of Reproduction	DNA Tests in Prolific Sheep from Eight Countries Provide New Evidence on Origin of the Booroola (FecB) Mutation	Davis	2002	4		
585	chrUn_JH126096	16121	16537	3500360449	88		16121	16537	8421504	3	35,20,33	0,275,383	c,g	350036044900000000,350036044900000003,350036044900000003,350036044900000002	0-35,0-20,0-20,0-33						Study of BMP-15 gene polymorphism in Iranian goats	demicjournals.org	0	0		
585	chrUn_JH126096	16125	16537	3500280603	61		16125	16537	8421504	2	31,30	0,382	c,g	350028060300000002,350028060300000002,350028060300000001,350028060300000001	0-31,0-31,0-30,0-30						Study on candidate gene for fecundity traits in Xingjiang Cele black sheep	demicjournals.org	0	0		
585	chrUn_JH126096	16125	16537	3500067287	61		16125	16537	8421504	2	31,30	0,382	c,g	350006728700000002,350006728700000002,350006728700000001,350006728700000001	0-31,0-31,0-30,0-30						Study on candidate gene for fecundity traits in Xingjiang Cele black sheep	l.trc.gov.om:4000	0	0		
585	chrUn_JH126096	16138	16416	3500340475	66		16138	16416	8421504	3	21,21,24	0,52,254	c,g	350034047500000009,350034047500000008,350034047500000008,350034047500000000	0-21,0-21,0-21,0-24		21401961	10.1186/1477-7827-9-33	1477-7827	Reproductive Biology and Endocrinology	Quantitative analysis of bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) gene expression in calf and adult bovine ovaries	Hosoe	2011	2		
585	chrUn_JH126096	16205	16505	3500383896	42		16205	16505	8421504	2	22,20	0,280	c	350038389600000001,350038389600000000	0-22,0-20		17715428	10.1095/biolreprod.107.062752	0006-3363	Biology of Reproduction	Patterns of Expression of Messenger RNAs Encoding GDF9, BMP15, TGFBR1, BMPR1B, and BMPR2 During Follicular Development and Characterization of Ovarian Follicular Populations in Ewes Carrying the Woodlands FecX2W Mutation	Feary	2007	4		
585	chrUn_JH126096	16238	16598	3500008335	42		16238	16598	8421504	2	21,21	0,339	c,g	350000833500000037,350000833500000037,350000833500000036,350000833500000036	0-21,0-21,0-21,0-21						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
585	chrUn_JH126096	16401	16478	3500207174	40		16401	16478	8421504	2	19,21	0,56	c,g	350020717400000009,350020717400000010	0-19,0-21						DEVELOPMENT OF BUFFALO EMBRYONIC STEM CELL CLONES IN HANGING DROP USING DIFFERENT CULTURE MEDIUM	www.vetpract.com	0	0		
585	chrUn_JH126096	16595	22431	3500071382	42		16595	22431	8421504	2	21,21	0,5815	c,g	350007138200000001,350007138200000001,350007138200000000,350007138200000000	0-21,0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
585	chrUn_JH126096	16595	22431	3500031998	42		16595	22431	8421504	2	21,21	0,5815	c,g	350003199800000010,350003199800000010,350003199800000009	0-21,0-21,0-21						REPRODUCTION	uction-online.org	0	0		
585	chrUn_JH126096	16646	22569	3500068270	40		16646	22569	8421504	2	20,20	0,5903	c,g	350006827000000003,350006827000000003,350006827000000002,350006827000000002	0-20,0-20,0-20,0-20						Follicular Growth In Vitro: Detection of Growth Differentiation Factor 9 (GDF9) and Bone Morphogenetic Protein 15 (BMP15) During In Vitro Culture of Ovine Cortical Slices	www.sbri.fr	0	0		
585	chrUn_JH126096	16821	22532	3500212126	40		16821	22532	8421504	3	20,5,15	0,5688,5696	c,g	350021212600000010,350021212600000010,350021212600000009	0-20,0-20,0-20						The activin-follistatin system and in vitro early follicle development in goats	logy-journals.org	0	0		
585	chrUn_JH126096	16845	22249	3500059320	40		16845	22249	8421504	2	20,20	0,5384	c,g	350005932000000010,350005932000000010,350005932000000007	0-20,0-20,0-20						Identificaci&#xf3;n de la deleci&#xf3;n FecXR del gen ovino BMP15 en la Raza Rasa Aragonesa: Su implicaci&#xf3;n en la mejora gen&#xe9;tica de la prolificidad y su difusi&#xf3;n en la caba&#xf1;a ganadera / Adolfo Lavi&#xf1;a G&#xf3;mez	zaguan.unizar.es	0	0		
585	chrUn_JH126109	32579	32604	3500326034	24		32579	32604	8421504	2	7,17	0,8	c	350032603400000253	19-43						 Selection Method 	www.docstoc.com	0	0		
585	chrUn_JH126110	36484	36508	3500159378	24		36484	36508	8421504	1	24	0	g	350015937800000121,350015937800000072	11-35,13-36						 Method Of Detection Of Herpes B Virus 	www.docstoc.com	0	0		
585	chrUn_JH126111	24060	24086	3500410278	23		24060	24086	8421504	3	12,6,5	0,14,21	g	350041027800000049	14-37					Patent	Multifunctional M-CSF proteins and genes encoding therefor (Patent US:6022953)	Larrick	2000	0		
585	chrUn_JH126115	15532	15610	3500022709	32		15532	15610	8421504	3	12,9,11	0,14,67	g	350002270900000008	2-34						Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIP	biomedcentral.com	0	0		
585	chrUn_JH126115	52125	56397	3500400474	41		52125	56397	8421504	2	19,22	0,4250	c	350040047400000001,350040047400000002	0-19,3-25		21345198	10.1186/1297-9716-42-37		Veterinary Research	NKp46 defines ovine cells that have characteristics corresponding to NK cells	Timothy	2011	0		
585	chrUn_JH126124	15242	15615	3500212373	95		15242	15615	8421504	3	47,18,30	0,48,343	c	350021237300000038,350021237300000039	0-47,0-48						HUMAN MONOCLONAL ANTIBODY - Patent application	www.faqs.org	0	0		
585	chrUn_JH126124	15595	16756	3500081129	43		15595	16756	8421504	3	21,9,13	0,991,1148	c	350008112900000000,350008112900000001	0-21,0-22						Virus infectable stem cells	NEVENS	2013	0		CD81
585	chrUn_JH126124	15595	16756	3500046581	43		15595	16756	8421504	3	21,9,13	0,991,1148	c	350004658100000000,350004658100000001	0-21,0-22						VIRUS INFECTABLE STEM CELLS - KATHOLIEKE UNIVERSITEIT LEUVEN	www.sumobrain.com	0	0		CD81
585	chrUn_JH126124	16788	22845	3500037451	90		16788	22845	8421504	4	20,22,24,24	0,420,5141,6033	c,g	350003745100000000,350003745100000000,350003745100000001,350003745100000001,350003745100000004,350003745100000004,350003745100000005	0-20,0-20,0-22,0-22,0-24,0-24,0-24						Comparative genomic imprinting a	www.docstoc.com	0	0		
585	chrUn_JH126124	17226	17249	3500009186	23		17226	17249	8421504	1	23	0	c	350000918600000006	20-43						BMC Genomics BioMed Central	biomedcentral.com	0	0		
585	chrUn_JH126134	13932	13957	3500282511	23		13932	13957	8421504	2	15,8	0,17	g	350028251100000064	7-30						Recombinant fowlpox viruses and uses thereof	Cochran	1996	0		
585	chrUn_JH126136	36284	36313	3500106510	24		36284	36313	8421504	2	17,7	0,22	g	350010651000000167	22-48						Multicistronic expression units and their use	Dirks	1994	0		
585	chrUn_JH126140	25351	25377	3500196423	25		25351	25377	8421504	2	7,18	0,8	g	350019642300000038	2-27					Patent	Methods of lowering active TNF-&#x03b1; levels in mammals using tumor necrosis factor receptor (Patent US:5605690)	Jacobs	1997	0		
585	chrUn_JH126142	29619	29642	3500133749	23		29619	29642	8421504	1	23	0	c	350013374900000001	0-23		18032416	10.1095/biolreprod.107.064774	0006-3363	Biology of Reproduction	Pre-Messenger RNA Cleavage Factor I (CFIm): Potential Role in Alternative Polyadenylation During Spermatogenesis	Sartini	2008	4		
585	chrUn_JH126147	42650	42701	3500178142	51		42650	42701	8421504	1	51	0	p	350017814200015025	0-51						TaiLieu.VN: b&#xe1;o c&#xe1;o khoa h&#x1ecd;c: "Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells" 	tailieu.vn/doc/ba	0	0		SDHA
585	chrUn_JH126147	44742	45014	3500447030	45		44742	45014	8421504	2	21,24	0,248	c,g	350044703000000016,350044703000000017	0-21,0-24						Evaluation of Internal Reference Genes for Quantitative Expression Analysis by Real-Time PCR in Ovine Whole Blood	www.mdpi.com	0	0		
585	chrUn_JH126147	44990	45014	3500376799	24		44990	45014	8421504	1	24	0	c,g	350037679900000005,350037679900000005	21-45,21-45						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
585	chrUn_JH126147	53920	55533	3500382906	39		53920	55533	8421504	2	20,19	0,1594	c,g	350038290600000016,350038290600000017,350038290600000017	0-20,0-19,0-19						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
585	chrUn_JH126147	53920	55533	3500143893	39		53920	55533	8421504	2	20,19	0,1594	c,g	350014389300000016,350014389300000017,350014389300000017	0-20,0-19,0-19						Canonical WNT signaling regulates development of bovine embryos to the blastocyst stage	imal.ifas.ufl.edu	0	0		
585	chrUn_JH126147	53920	55533	3500046604	39		53920	55533	8421504	2	20,19	0,1594	c,g	350004660400000018,350004660400000019,350004660400000019	0-20,0-19,0-19						REPRODUCTION	uction-online.org	0	0		
585	chrUn_JH126147	53925	55479	3500265224	41		53925	55479	8421504	2	21,20	0,1534	c,g	350026522400000028,350026522400000028,350026522400000029	0-21,0-21,0-20						BMC Veterinary Research BioMed Central	biomedcentral.com	0	0		
585	chrUn_JH126147	53925	55479	3500117703	41		53925	55479	8421504	2	21,20	0,1534	c,g	350011770300000004,350011770300000004,350011770300000005,350011770300000005	0-21,0-21,0-20,0-20						Evaluation of reference genes for real-time PCR studies of Brazilian Somalis sheep infected by gastrointestinal nematodes. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH126147	55512	56331	3500146047	40		55512	56331	8421504	2	20,20	0,799	c,g	350014604700000012,350014604700000012,350014604700000013	0-20,0-20,0-20						PASTURE-FEEDING OF CHAROLAIS STEERS INFLUENCES SKELETAL MUSCLE METABOLISM AND GENE EXPRESSION	www.jpp.krakow.pl	0	0		
585	chrUn_JH126147	55512	56331	3500053255	40		55512	56331	8421504	2	20,20	0,799	c,g	350005325500000012,350005325500000012,350005325500000013,350005325500000013	0-20,0-20,0-20,0-20						1009_S3_article_10	www.jpp.krakow.pl	0	0		
585	chrUn_JH126147	80725	80755	3500271222	25		80725	80755	8421504	3	11,9,5	0,14,25	g	350027122200000004	1-27						Oligonucleotides complementary to mycobacterial nucleic acids	Liu	1993	0		
585	chrUn_JH126149	23659	23684	3500184228	23		23659	23684	8421504	2	15,8	0,17	g	350018422800000257	9-32						IDENTIFICATION OF A MUTATION IN COL4A5 CAUSATIVE FOR X- LINKED ALPORT SYNDROME IN THE DOMESTIC DOG AND ANALYSIS OF GENE EXPRESSION IN THE KIDNEYS OF AFFECTED AND NONAFFECTED SIBLINGS	pository.tamu.edu	0	0		
585	chrUn_JH126164	14729	14753	3500003440	23		14729	14753	8421504	2	13,10	0,14	g	350000344000000035	21-44						Ornithobacterium Rhinotracheale Subunit Vaccines 	.freshpatents.com	0	0		
585	chrUn_JH126178	22613	22653	3500099137	40		22613	22653	8421504	1	40	0	g	350009913700000021,350009913700000022,350009913700000005,350009913700000004	15-55,1-41,1-41,15-55						NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH126179	8526	8554	3500110319	23		8526	8554	8421504	2	8,15	0,13	g	350011031900000088	0-23						Regulation der Phosphatmangelgene von Corynebacterium glutamicum durch das Zweikomponenten-System PhoRS	ni-duesseldorf.de	0	0		
585	chrUn_JH126183	53216	53242	3500305030	23		53216	53242	8421504	2	7,16	0,10	g	350030503000000228	3-26						Biological methods for preparing a fatty dicarboxylic acid	Beardslee	2013	0		
585	chrUn_JH126185	45419	45442	3500466559	23		45419	45442	8421504	1	23	0	g	350046655900000015	13-36						ROLE OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS NON-STRUCTURAL PROTEIN 1 IN VIRAL REPLICATION AND PATHOGENESIS	alcommons.unl.edu	0	0		
585	chrUn_JH126186	3625	3648	3500241434	23		3625	3648	8421504	1	23	0	g	350024143400000229,350024143400000619	3-25,6-25						GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME	Schellenberger	2010	0		
585	chrUn_JH126186	3625	3648	3500132071	23		3625	3648	8421504	1	23	0	g	350013207100000197,350013207100000236,350013207100000303,350013207100000173	4-26,3-25,5-24,4-23						EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME	Schellenberger	2010	0		
585	chrUn_JH126186	5109	6476	3500065154	54		5109	6476	8421504	2	48,6	0,1361	p	350006515400015026,350006515400015023	0-54,0-51						Klonierung und funktionelle Charakterisierung der NTPDase3 aus der Ratte	.uni-frankfurt.de	0	0		ENTPD2
585	chrUn_JH126190	7055	45569	3500199787	255		7055	45569	8421504	8	32,35,17,28,48,48,16,31	0,76,3408,23322,30961,36405,36502,38483	c	350019978700000049,350019978700000053,350019978700000047,350019978700000043,350019978700000037,350019978700000035,350019978700000033	0-32,0-22,0-48,0-28,0-48,0-48,0-47						Recombinant proteins derived from HGF and MSP	Medico	2000	0		
585	chrUn_JH126190	10508	38011	3500001066	41		10508	38011	8421504	2	20,21	0,27482	c	350000106600000005,350000106600000004	0-20,0-21		18823569	10.1186/1479-5876-6-54	1479-5876	Journal of Translational Medicine	Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice	Oyamada	2008	3		HGF
585	chrUn_JH126190	30381	38076	3500458356	44		30381	38076	8421504	3	23,6,15	0,7673,7680	c	350045835600000007,350045835600000006	0-23,0-21						Sema4D induces angiogenesis through Met recruitment by Plexin B1	tologylibrary.org	0	0		HGF
585	chrUn_JH126190	30467	43462	3500423401	64		30467	43462	8421504	3	22,38,4	0,7620,12991	c	350042340100000003,350042340100000002	0-22,0-42						Thecal Cell-Granulosa Cell Interactions Involve a Positive Feedback Loop among Keratinocyte Growth Factor, Hepatocyte Growth Factor, and Kit Ligand during Ovarian Follicular Development*	.endojournals.org	0	0		HGF
585	chrUn_JH126190	30467	43462	3500369279	44		30467	43462	8421504	3	22,18,4	0,7640,12991	c	350036927900000000,350036927900000001	0-22,0-22		10342884	10.1210/en.140.6.2908	0013-7227	Endocrinology	Hepatocyte Growth Factor Induces Rat Ovarian Surface Epithelial Cell Mitosis or Apoptosis Depending on the Presence or Absence of an Extracellular Matrix	Hess	1999	4		HGF
585	chrUn_JH126190	31903	31926	3500307883	23		31903	31926	8421504	1	23	0	c	350030788300000056	21-44						Methods and materials relating to PAQR polypeptides and polynucleotides - Patent application	www.faqs.org	0	0		
585	chrUn_JH126190	31950	38019	3500347916	42		31950	38019	8421504	2	19,23	0,6046	c,g	350034791600000013,350034791600000013,350034791600000012	0-19,0-19,0-23						Method For Predicting Responsiveness To Drugs 	.freshpatents.com	0	0		HGF
585	chrUn_JH126190	31950	38019	3500263558	42		31950	38019	8421504	2	19,23	0,6046	c,g	350026355800000084,350026355800000084,350026355800000013,350026355800000013,350026355800000012,350026355800000083	0-19,0-19,0-19,0-19,0-23,0-23						Method for Predicting Responsiveness to Drugs - Patent application	www.faqs.org	0	0		HGF
585	chrUn_JH126190	31958	38046	3500304250	45		31958	38046	8421504	3	15,9,21	0,6024,6067	c	350030425000000005,350030425000000004	0-24,0-21						Progesterone Regulates FGF10, MET, IGFBP1, and IGFBP3 in the Endometrium of the Ovine Uterus	ww.biolreprod.org	0	0		HGF
585	chrUn_JH126190	31970	38004	3500273754	25		31970	38004	8421504	2	3,22	0,6012	c	350027375400000006,350027375400000016	0-25,0-25						Treatment of liver diseases through transplantation of human umbilical mesenchymal stem cells - Patent application	www.faqs.org	0	0		HGF
585	chrUn_JH126190	37992	38016	3500466805	24		37992	38016	8421504	1	24	0	c	350046680500000003	0-24		10688652	10.1128/MCB.20.6.2055-2065.2000	0270-7306	Molecular and Cellular Biology	Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis	Otsuka	2000	6		HGF
585	chrUn_JH126190	38002	38025	3500366020	23		38002	38025	8421504	1	23	0	c,g	350036602000000010,350036602000000010	0-23,0-23			10.1634/stemcells.2006-0170	1549-4918	STEM CELLS	Bone Marrow Transplantation Attenuates the Myopathic Phenotype of a Muscular Mouse Model of Spinal Muscular Atrophy - Salah-Mohellibi - 2006 - STEM CELLS - Wiley Online Library	Salah-Mohellibi	2006	0		HGF
585	chrUn_JH126190	43493	45611	3500247939	153		43493	45611	8421504	2	80,73	0,2045	p	350024793900015020	9-162						Deducedprimary mRNAin	www.pnas.org	0	0		HGF
585	chrUn_JH126194	23407	23436	3500171621	23		23407	23436	8421504	3	7,5,11	0,11,18	g	350017162100000027	4-28						Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries	Buechler	2003	0		
585	chrUn_JH126194	23407	23436	3500041674	23		23407	23436	8421504	3	7,5,11	0,11,18	g	350004167400000021,350004167400000067	4-28,4-28						Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries - Patent application	www.faqs.org	0	0		
585	chrUn_JH126198	5255	5281	3500342251	23		5255	5281	8421504	2	14,9	0,17	g	350034225100000060	0-27						US Patent # 6,066,491. Process for obtaining fungal resistant plants with recombinant polynucleotides encoding .beta.-1,3-glucanase modified for apoplast targeting - Patents.com	patents.com	0	0		
585	chrUn_JH126209	4338	4365	3500278645	23		4338	4365	8421504	2	14,9	0,18	g	350027864500000140	10-40						Recombinant vesiculoviruses and their uses		1997	0		
585	chrUn_JH126210	15617	15646	3500464027	25		15617	15646	8421504	2	14,11	0,18	g	350046402700000001	0-25			10.1111/j.1365-2958.2007.05860.x	1365-2958	Molecular Microbiology	Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle - Caimano - 2007 - Molecular Microbiology - Wiley Online Library	Caimano	2007	0		
585	chrUn_JH126224	34665	34691	3500301316	25		34665	34691	8421504	2	4,21	0,5	g	350030131600000055	22-47						Protective helicobacter antigens	Doidge	1996	0		
585	chrUn_JH126224	34665	34691	3500115313	25		34665	34691	8421504	2	4,21	0,5	g	350011531300000056	22-47						Protective helicobacter antigens	Doidge	1997	0		
585	chrUn_JH126224	62349	62374	3500453641	23		62349	62374	8421504	2	6,17	0,8	g	350045364100000002	2-25		15746352	10.1128/AEM.71.3.1495-1500.2005	0099-2240	Applied and Environmental Microbiology	Quantitative-PCR Assessment of Cryptosporidium parvum Cell Culture Infection	Giovanni	2005	4		
585	chrUn_JH126224	62349	62374	3500170153	23		62349	62374	8421504	2	6,17	0,8	g	350017015300000002	2-25						Evaluation of TaqMan real-time PCR for the detection of viable Cryptosporidium parvum oocysts in environmental water samples	arcommons.usf.edu	0	0		
585	chrUn_JH126225	60436	60925	3500269671	54		60436	60925	8421504	4	18,13,15,8	0,21,41,481	c,g	350026967100000006,350026967100000006,350026967100000007	0-31,0-31,0-23						Microarray analysis in caudal medulla of cattle orally challenged with bovine spongiform encephalopathy	w.funpecrp.com.br	0	0		
585	chrUn_JH126225	60444	62328	3500069542	80		60444	62328	8421504	4	20,19,19,22	0,1473,1522,1862	c,g	350006954200000002,350006954200000004,350006954200000004,350006954200000003,350006954200000003,350006954200000001,350006954200000001	0-20,0-19,0-19,0-19,0-19,0-22,0-22						Evidence that Cocaine- and Amphetamine-Regulated Transcript Is a Novel Intraovarian Regulator of Follicular Atresia	.endojournals.org	0	0		
585	chrUn_JH126225	60962	61968	3500342863	144		60962	61968	8421504	2	39,105	0,901	p	350034286300015070	0-144							library.wiley.com	0	0		
585	chrUn_JH126225	60983	61974	3500377178	111		60983	61974	8421504	3	18,30,63	0,880,928	p	350037717800015039,350037717800015040	0-111,27-105						Polypeptide with appetite regulating activity	Christiansen	2000	0		
585	chrUn_JH126232	26290	26315	3500359247	24		26290	26315	8421504	2	13,11	0,14	g	350035924700000004	20-44						Abstract	www.pucrs.br	0	0		
585	chrUn_JH126233	40145	40171	3500063056	24		40145	40171	8421504	2	7,17	0,9	g	350006305600000049	5-29						Vaccine and antitoxin for treatment and prevention of c. difficile disease	Firca	1999	0		
585	chrUn_JH126242	13242	13271	3500043721	25		13242	13271	8421504	2	18,7	0,22	g	350004372100000225	12-37						NUCLEIC ACIDS CODING FOR ADHESION FACTOR OF GROUP B STREPTOCOCCUS, ADHESION FACTORS OF GROUP B STREPTOCOCCUS AND FURTHER USES THEREOF - Patent application	www.faqs.org	0	0		
585	chrUn_JH126247	3048	3072	3500190095	24		3048	3072	8421504	1	24	0	g	350019009500000085,350019009500000086	0-24,0-21						Affinity proteins for controlled application of cosmetic substances	Houtzager	2006	0		
585	chrUn_JH126247	3068	4008	3500276090	42		3068	4008	8421504	2	23,19	0,921	g	350027609000000022,350027609000000228,350027609000000224,350027609000000013	0-23,0-23,4-23,4-23						ANTI IgE ANTIBODIES - Patent application	www.faqs.org	0	0		
585	chrUn_JH126247	3068	3092	3500173478	24		3068	3092	8421504	1	24	0	g	350017347800000021	0-24						Pharmaceutical Antibody Compositions With Resistance To Soluble Cea 	.freshpatents.com	0	0		
585	chrUn_JH126247	3068	3092	3500162532	24		3068	3092	8421504	1	24	0	g	350016253200000050	11-35						STRUCTURAL VARIANTS OF ANTIBODIES FOR IMPROVED THERAPEUTIC CHARACTERISTICS - Patent application	www.faqs.org	0	0		
585	chrUn_JH126247	3068	3091	3500122920	23		3068	3091	8421504	1	23	0	g	350012292000000021	0-23						Anti-IgE antibodies - Patent application	www.faqs.org	0	0		
585	chrUn_JH126247	5113	11619	3500111880	1399		5113	11619	8421504	15	568,25,69,297,90,106,52,22,12,14,41,7,20,54,22	0,590,2665,2741,3345,3436,3544,3700,5063,5192,5225,5267,5307,5360,6484	g	350011188000000129,350011188000000132	0-255,0-1290						Transgenic ungulates having reduced prion protein activity and uses thereof - Patent application	www.faqs.org	0	0		
585	chrUn_JH126259	5495	5532	3500109336	30		5495	5532	8421504	3	12,12,6	0,17,31	g	350010933600000046	6-48						Gene therapy for effector cell regulation	Dow	1996	0		
585	chrUn_JH126273	20142	61594	3500004227	44		20142	61594	8421504	5	6,17,4,11,6	0,9,41428,41433,41446	g	350000422700000257,350000422700000253	3-26,18-39						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
585	chrUn_JH126273	40094	40118	3500003356	24		40094	40118	8421504	1	24	0	g	350000335600000032	25-49						Population genetic structure and demographical history of South African abalone, Haliotis midae, in	scholar.sun.ac.za	0	0		
585	chrUn_JH126274	49080	49107	3500442509	23		49080	49107	8421504	2	8,15	0,12	g	350044250900000014,350044250900000003	0-23,0-23						HSP DNA vaccines	Wu	2000	0		
585	chrUn_JH126275	828	3394	3500178626	102		828	3394	8421504	4	22,28,23,29	0,29,2513,2537	g	350017862600000000	209-354						cDNA microarray analysis of bovine embryo gene expression profiles during the pre-implantation period. - ResearchGate	.researchgate.net	0	0		
585	chrUn_JH126281	101856	101891	3500440306	35		101856	101891	8421504	1	35	0	g	350044030600000006	0-35						Role of the PI3-kinase/mTor pathway in the regulation of the stearoyl CoA desaturase (SCD1) gene expression by insulin in liver. - ResearchGate	.researchgate.net	0	0		SCD
585	chrUn_JH126281	102206	114187	3500372563	1715		102206	114187	8421504	12	21,35,135,210,60,81,159,46,73,100,146,649	0,43,79,730,943,4887,6431,6591,8206,8339,11127,11332	p,c,g	350037256300000018,350037256300000022,350037256300015013,350037256300000023,350037256300015017,350037256300000024,350037256300000024,350037256300015019,350037256300015021,350037256300000026,350037256300000028,350037256300015025,350037256300000029,350037256300015027,350037256300015029,350037256300000030,350037256300000031,350037256300000032,350037256300015035,350037256300015039,350037256300015041,350037256300000036,350037256300000017,350037256300015043,350037256300000037,350037256300015045,350037256300000038,350037256300000040	0-21,18-232,0-60,0-62,0-60,0-60,0-60,0-57,0-60,0-60,0-59,0-63,0-60,3-60,0-60,0-60,0-60,1-60,0-60,0-60,0-60,0-60,0-20,0-60,0-60,0-66,0-60,5-654						GENETIC POLYMORPHISM IN GOAT	tdx.cat/bitstream	0	0		
585	chrUn_JH126281	102291	113479	3500090002	158		102291	113479	8421504	5	28,28,24,51,27	0,8135,8211,8281,11161	c,g	350009000200000008,350009000200000002,350009000200000002,350009000200000004,350009000200000000,350009000200000003,350009000200000003,350009000200000007	0-28,0-28,0-28,0-24,0-24,0-28,0-28,0-27						Method for evaluating quality of beef such as taste and texture on the basis of genotype of stearoyl-coa desaturase	Tsuji	2004	0		
585	chrUn_JH126281	102936	110620	3500234934	65		102936	110620	8421504	3	24,20,21	0,5769,7663	c,g	350023493400000004,350023493400000001,350023493400000002,350023493400000002	0-24,0-20,0-21,0-21			10.4081/ijas.2012.e79	1828-051X	Italian Journal of Animal Science	Effect of dietary polyunsaturated fatty acids on Stearoyl CoA-Desaturase gene expression in intramuscular lipids of lamb	Conte	2012	0		
585	chrUn_JH126281	102936	103215	3500420133	50		102936	103215	8421504	2	24,26	0,253	c	350042013300000001,350042013300000000	0-24,0-26						ENHANCING BEEF CONJUGATED LINOLEIC ACID CONTENT THROUGH OIL SUPPLEMENTATION TO GRAZING STEERS ENRIQUE PAVAN ABSTRACT	aeum.libs.uga.edu	0	0		
585	chrUn_JH126281	102951	108670	3500331201	321		102951	108670	8421504	4	90,90,108,33	0,135,4115,5686	p	350033120100015013,350033120100015035,350033120100015060	0-90,0-90,9-150						Synthetic fatty acid desaturase gene for expression in plants	Martin	2001	0		
585	chrUn_JH126281	107095	113477	3500073473	41		107095	113477	8421504	2	19,22	0,6360	c,g	350007347300000000,350007347300000000,350007347300000001	0-19,0-19,0-22		17235023	10.2527/jas.2006-087	0021-8812	Journal of Animal Science	Lipogenesis and stearoyl-CoA desaturase gene expression and enzyme activity in adipose tissue of short- and long-fed Angus and Wagyu steers fed corn- or hay-based diets	Chung	2007	2		
585	chrUn_JH126281	108669	108749	3500345859	59		108669	108749	8421504	3	20,19,20	0,29,60	c,g	350034585900000045,350034585900000045,350034585900000047,350034585900000047,350034585900000046,350034585900000046	0-20,0-20,0-19,0-19,0-20,0-20						THE EFFECTS OF ZILPATEROL HYDROCHLORIDE AND CHROMIUM PROPIONATE ON BOVINE MUSCLE SATELLITE CELLS AND PREADIPOCYTES	ositories.tdl.org	0	0		
585	chrUn_JH126281	108711	110617	3500232370	46		108711	110617	8421504	2	23,23	0,1883	c	350023237000000010,350023237000000011	0-23,19-42						<HTML><!-- InstanceBegin template="/Templates/index.dwt" codeOutsideHTMLIsLocked="false" --> <HEAD>	ock.colostate.edu	0	0		
585	chrUn_JH126281	108767	108819	3500246332	51		108767	108819	8421504	2	28,23	0,29	c,g	350024633200000008,350024633200000007,350024633200000007	0-28,0-23,0-23						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		
585	chrUn_JH126281	108826	110450	3500428289	54		108826	110450	8421504	3	17,9,28	0,1586,1596	c,g	350042828900000083,350042828900000002,350042828900000085,350042828900000085,350042828900000004,350042828900000004	0-26,0-26,0-28,0-28,0-28,0-28						Method Of Determining Gene Relating To Favorable Beef Taste And Texture 	.freshpatents.com	0	0		
585	chrUn_JH126281	108831	110423	3500000755	23		108831	110423	8421504	2	12,11	0,1581	c	350000075500000017	0-23						METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE	Park	2007	0		SCD
585	chrUn_JH126281	108834	110426	3500407458	23		108834	110426	8421504	2	9,14	0,1578	c	350040745800000010	0-23						<!Doctype HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><Html> <head> <style id=mainCSS>TD 	hefreelibrary.com	0	0		SCD
585	chrUn_JH126281	108834	110426	3500258117	23		108834	110426	8421504	2	9,14	0,1578	c	350025811700000002	0-23				0021-8812		Gene expression patterns during intramuscular fat development in cattle 	animalscience.org	0	2		SCD
585	chrUn_JH126281	110426	110716	3500430083	131		110426	110716	8421504	4	28,24,51,28	0,76,146,262	c,g	350043008300000000,350043008300000002,350043008300000004,350043008300000004,350043008300000001,350043008300000005	0-28,0-24,0-24,0-24,0-28,0-28						Genotype of stearoyl-CoA desaturase is associated with fatty acid composition in Japanese Black cattle	.researchgate.net	0	0		
585	chrUn_JH126281	110429	110530	3500301078	42		110429	110530	8421504	2	21,21	0,80	c,g	350030107800000057,350030107800000057,350030107800000058,350030107800000058	0-21,0-21,0-21,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
585	chrUn_JH126281	110429	110530	3500261436	42		110429	110530	8421504	2	21,21	0,80	c,g	350026143600000089,350026143600000089,350026143600000090,350026143600000090	0-21,0-21,0-21,0-21						SUPPLEMENTAL MATERIALS AND METHODS Clustering of sequences for microarray construction. A total of 38,732 high quality	cs.physiology.org	0	0		
585	chrUn_JH126281	110465	110530	3500463464	65		110465	110530	8421504	1	65	0	c,g	350046346400000048,350046346400000048,350046346400000022	8-67,8-67,21-42						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
585	chrUn_JH126281	110545	110715	3500066484	44		110545	110715	8421504	2	21,23	0,147	c,g	350006648400000000,350006648400000001	0-21,0-23						Composici&#x0160;n&#x02da;&#x02da; de&#x02da;&#x02da; &#xe7;cidos&#x02da;&#x02da; Grasos&#x02da;&#x02da; (MUFA&#x02da;&#x02da; y&#x02da;&#x02da; CLA)&#x02da;&#x02da; en Tejido&#x02da;&#x02da; Muscular&#x02da;&#x02da; de&#x02da;&#x02da; Bovino&#x02da;&#x02	www.scielo.cl	0	0		
585	chrUn_JH126281	113340	113364	3500291056	24		113340	113364	8421504	1	24	0	c	350029105600000011	0-24		21454638	10.1074/jbc.M110.206904	0021-9258	Journal of Biological Chemistry	Peptidyl-prolyl Cis/Trans Isomerase NIMA-interacting 1 Associates with Insulin Receptor Substrate-1 and Enhances Insulin Actions and Adipogenesis	Nakatsu	2011	5		SCD
585	chrUn_JH126281	113389	113475	3500124075	41		113389	113475	8421504	2	20,21	0,65	c,g	350012407500000000,350012407500000000,350012407500000001	0-20,0-20,0-21		18032389	10.1074/jbc.M703583200	0021-9258	Journal of Biological Chemistry	Quercetin 3-Glucoside Protects Neuroblastoma (SH-SY5Y) Cells in Vitro against Oxidative Damage by Inducing Sterol Regulatory Element-binding Protein-2-mediated Cholesterol Biosynthesis	Soundararajan	2008	5		SCD
585	chrUn_JH126281	113598	113622	3500445961	24		113598	113622	8421504	1	24	0	c,g	350044596100000007,350044596100000007	0-24,0-24						The Korean Society of Food Science and Technology Fermented Ginseng Attenuates Hepatic Lipid Accumulation and Hyperglycemia through AMPK Activation	ginst15.net	0	0		SCD
585	chrUn_JH126281	113598	113622	3500331539	24		113598	113622	8421504	1	24	0	c	350033153900000007	0-24						The Korean Society of Food Science and Technology Fermented Ginseng Attenuates Hepatic Lipid Accumulation and Hyperglycemia through AMPK Activation	gs15-4.net/Fermen	0	0		SCD,GUSBP1
585	chrUn_JH126281	113598	113622	3500159482	24		113598	113622	8421504	1	24	0	c	350015948200000009	0-24						Do Yeon Kim, Hai Dan Yuan, In Kyung Chung, and Sung Hyun Chung Additional resources and features associated with this article are available within the HTML version: Lipid Accumulation via AMPK Activation in Human Hepatoma Cells Compound K, Intestinal Meta	gs15-4.net/Compou	0	0		SCD
585	chrUn_JH126282	18454	27733	3500375842	24		18454	27733	8421504	2	9,15	0,9264	c	350037584200000003	5-29						MOLECULAR MICROBIOLOGY LABORATORY	www.stu.edu.vn	0	0		
585	chrUn_JH126284	26982	27006	3500234382	24		26982	27006	8421504	1	24	0	g	350023438200000003	7-32						A stable yeast strain efficiently producing cholesterol instead of ergosterol is functional for tryptophan uptake, but not weak organic acid resistance	cms.unige.ch	0	0		
585	chrUn_JH126287	2927	3213	3500047637	286		2927	3213	8421504	1	286	0	g	350004763700000786	0-286						DOPAMINERGIC NEURON PROGENITOR CELL MARKER 187A5 - Patent application	www.faqs.org	0	0		
585	chrUn_JH126304	114965	114992	3500317022	23		114965	114992	8421504	2	13,10	0,17	g	350031702200000017	0-23						Martin-Luther-Universit&#xe4;t Halle-Wittenberg	d-nb.info/1024873	0	0		
586	chrUn_JH126304	138766	138790	3500426142	23		138766	138790	8421504	2	6,17	0,7	g	350042614200000000	0-23						Variable antibodies	Jacquemin	2011	0		
585	chrUn_JH126313	10672	10722	3500189969	50		10672	10722	8421504	1	50	0	g	350018996900000017	0-50						Bone and cartilage inductive proteins	Hewick	1994	0		
585	chrUn_JH126321	28490	28514	3500459899	24		28490	28514	8421504	1	24	0	g	350045989900000036	0-25						REASSESSMENT OF GENETIC DIVERSITY IN NATIVE TURKISH SHEEP BREEDS WITH LARGE NUMBERS OF MICROSATELLITE MARKERS AND MITOCHONDRIAL DNA (MTDNA) A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF NATURAL AND APPLIED SCIENCES OF MIDDLE EAST TECHNICAL UNIVERSITY BY FO	d.lib.metu.edu.tr	0	0		
585	chrUn_JH126336	28520	28544	3500394794	24		28520	28544	8421504	1	24	0	c	350039479400000010	8-32						Genes and polypeptides relating to human colon cancers	Furukawa	2005	0		IGSF11
585	chrUn_JH126336	28520	28544	3500212214	24		28520	28544	8421504	1	24	0	c	350021221400000010	8-32						Genes and polypeptides relating to human colon cancers	Furukawa	2003	0		IGSF11
585	chrUn_JH126336	28520	28544	3500211755	24		28520	28544	8421504	1	24	0	c	350021175500000010	8-32						Genes and polypeptides relating to human colon cancers	Nakamura	2010	0		IGSF11
585	chrUn_JH126336	28520	28544	3500058493	24		28520	28544	8421504	1	24	0	c	350005849300000010	8-32						Genes and polypeptides relating to human colon cancers	Nakamura	2009	0		IGSF11
585	chrUn_JH126336	28520	28544	3500026288	24		28520	28544	8421504	1	24	0	c	350002628800000010	8-32						CXADRL1 polypeptides relating to human cancers	Nakamura	2008	0		IGSF11
585	chrUn_JH126336	28927	48686	3500062793	367		28927	48686	8421504	6	23,14,96,44,100,90	0,26,1527,2764,14693,19669	c	350006279300000083,350006279300000081,350006279300000080,350006279300000077,350006279300000076,350006279300000075,350006279300000068,350006279300000067	0-37,0-48,0-48,0-48,0-48,0-48,0-48,6-48						GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS - Patent application	www.faqs.org	0	0		
585	chrUn_JH126336	46366	46392	3500397154	23		46366	46392	8421504	2	16,7	0,19	g	350039715400000001,350039715400000000	0-21,0-21			10.1128/JVI.00154-07		Journal of Virology	X-Box-Binding Protein 1 Activates Lytic Epstein-Barr Virus Gene Expression in Combination with Protein Kinase D 	Prasanna	July	0		
585	chrUn_JH126338	6991	7014	3500323389	23		6991	7014	8421504	1	23	0	g	350032338900000026	9-32						CHARACTERIZATION OF G10H PROMOTER AND ISOLATION OF WRKY TRANSCRIPTION FACTORS INVOLVED IN CATHARANTHUS TERPENOID INDOLE ALKALOID BIOSYNTHESIS PATHWAY	knowledge.uky.edu	0	0		
585	chrUn_JH126339	1225	1252	3500369652	24		1225	1252	8421504	2	8,16	0,11	g	350036965200000098	15-39						<HTML> <HEAD> <TITLE>U.S. Patent: 5635617 - Methods and compositions comprising the agfA gene for	w.everypatent.com	0	0		
585	chrUn_JH126348	8637	8662	3500348723	23		8637	8662	8421504	2	5,18	0,7	g	350034872300000237	9-32						IMMUNIZATION AGAINST CHLAMYDIA PNEUMONIAE - Patent application	www.faqs.org	0	0		
585	chrUn_JH126352	9122	9328	3500328994	69		9122	9328	8421504	2	16,53	0,153	p	350032899400015001	0-69						Exon repression by polypyrimidine tract binding protein	www.mimg.ucla.edu	0	0		
585	chrUn_JH126352	9122	9328	3500085230	69		9122	9328	8421504	2	16,53	0,153	p	350008523000015000	0-69			10.1261/rna.2250405		RNA	Exon repression by polypyrimidine tract binding protein	BATOUL	2005	0		
585	chrUn_JH126352	9137	9334	3500083587	60		9137	9334	8421504	2	1,59	0,138	p	350008358700015026	0-60						PREDICTED: Mus musculus similar to Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) (57 kDa RNA-binding protein PPTB-1) (LOC385310), mRNA. , XM_358182.3 - GenScript	www.genscript.com	0	0		PTBP3
585	chrUn_JH126357	31941	31966	3500253413	23		31941	31966	8421504	2	10,13	0,12	g	350025341300000016	0-23						Determination of Kaposi&#x2019;s Sarcoma-Associated Herpesvirus C-Terminal Latency-Associated Nuclear Antigen Residues Mediating Chromosome Association and DNA Binding	jvi.asm.org	0	0		
585	chrUn_JH126368	41420	41447	3500236132	23		41420	41447	8421504	2	9,14	0,13	g	350023613200000026	3-26						Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India	nn-clinmicrob.com	0	0		
585	chrUn_JH126371	6591	6625	3500299319	34		6591	6625	8421504	1	34	0	c	350029931900000000	8-42						Intraspecies Regulation of Ribonucleolytic Activity	.biochem.wisc.edu	0	0		
585	chrUn_JH126371	37848	39203	3500309656	567		37848	39203	8421504	4	117,160,179,111	0,626,886,1244	p	350030965600015047,350030965600015042,350030965600015045	0-567,6-573,0-51						Alineamiento de secuencias. B&#xfa;squeda de parecidos.Alineamientos m&#xfa;ltiples. Parte te&#xf3;rica	www.wiphala.net	0	0		HRAS
585	chrUn_JH126371	37875	38564	3500063399	180		37875	38564	8421504	2	90,90	0,599	p	350006339900015022	0-180						Patr&#xed;cia Ribeiro Biomarcadores moleculares em peixes expostos a Nogueira compostos xenobi&#xf3;ticos Molecular biomarkers in fish exposed to xenobiotics	ria.ua.pt/bitstre	0	0		HRAS
585	chrUn_JH126371	37917	39203	3500222829	498		37917	39203	8421504	4	48,160,179,111	0,557,817,1175	p	350022282900015001,350022282900015000	0-99,0-399						&#x6838;&#x9178;&#xff08;&#xff24;&#xff2e;&#xff21;&#xff09;&#x306e;&#x7acb;&#x4f53;&#x69cb;&#x9020; &#x30bf;&#x30f3;&#x30d1;&#x30af;&#x8cea;&#x306e;&#x7acb;&#x4f53;&#x69cb;&#x9020;	isw3.naist.jp	0	0		HRAS
585	chrUn_JH126371	39134	39200	3500026017	63		39134	39200	8421504	2	18,45	0,21	p	350002601700015041	0-63						US Patent # 7,329,649. Combinatorial methods for inducing cancer cell death - Patents.com	www.patents.com	0	0		HRAS
585	chrUn_JH126371	68039	68460	3500152016	225		68039	68460	8421504	6	45,45,4,41,45,45	0,48,96,284,328,376	p	350015201600015018,350015201600015019,350015201600015020,350015201600015021,350015201600015022	0-45,0-45,0-45,0-45,0-45						Human tumor-associated gene	Hoon	1999	0		RASSF7
585	chrUn_JH126371	69694	69722	3500447184	24		69694	69722	8421504	2	9,15	0,13	c	350044718400000012	10-35						Antibodies to monocyte-colony inhibitory factor (M-CIF)	Gentz	2003	0		
585	chrUn_JH126371	70275	70306	3500414284	23		70275	70306	8421504	3	12,6,5	0,17,26	g	350041428400000009	8-31						/CD8 macrophagesin&#xfb01;ltratingatin&#xfb02;ammatorysites:apopulationof monocytes/macrophageswithacytotoxicphenotype	tologylibrary.org	0	0		
585	chrUn_JH126371	72906	72930	3500389139	24		72906	72930	8421504	1	24	0	c	350038913900000046	20-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		MIR210
585	chrUn_JH126371	72906	72930	3500306561	24		72906	72930	8421504	1	24	0	c	350030656100000046	20-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
585	chrUn_JH126371	72906	72930	3500257436	24		72906	72930	8421504	1	24	0	g	350025743600000046	0-24						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		
585	chrUn_JH126371	72907	72931	3500280470	24		72907	72931	8421504	1	24	0	c,g	350028047000000038,350028047000000038	10-34,10-34						NUCLEIC ACID DETECTION AND QUANTIFICATION BY POST-HYBRIDIZATION LABELING AND UNIVERSAL ENCODING - Patent application	www.faqs.org	0	0		
585	chrUn_JH126371	72908	72931	3500339098	23		72908	72931	8421504	1	23	0	c	350033909800000004,350033909800000008,350033909800000005	0-22,0-22,0-21		20964835	10.1186/1741-7015-8-64	1741-7015	BMC Medicine	The VHL-dependent regulation of microRNAs in renal cancer	Neal	2010	6		MIR210
585	chrUn_JH126372	46710	46743	3500068995	27		46710	46743	8421504	3	7,13,7	0,11,26	g	350006899500000515,350006899500000516	3-31,3-31						Methods for production and uses of multipotent cell populations	Ke Li Si Duo Fo *B*Li De 	2010	0		
585	chrUn_JH126374	245	271	3500365961	23		245	271	8421504	2	7,16	0,10	g	350036596100000010	0-23			10.1128/JVI.02443-06		Journal of Virology	Inhibition of Transcription of the Beta Interferon Gene by the Human Herpesvirus 6 Immediate-Early 1 Protein 	Joanna	June	0		
585	chrUn_JH126374	245	271	3500087683	23		245	271	8421504	2	7,16	0,10	g	350008768300000010	0-23		17376932	10.1128/JVI.02443-06	0022-538X	Journal of Virology	Inhibition of Transcription of the Beta Interferon Gene by the Human Herpesvirus 6 Immediate-Early 1 Protein	Jaworska	2007	5		
585	chrUn_JH126379	14410	14441	3500386203	26		14410	14441	8421504	2	18,8	0,23	g	350038620300000076	16-44						Anthrax toxin fusion proteins and uses thereof	Arora	1995	0		
585	chrUn_JH126387	53271	53301	3500175973	23		53271	53301	8421504	3	6,12,5	0,11,25	c	350017597300000165	22-45					Patent	DNA encoding the Canine coronavirus spike protein (Patent US:5661006)	Brown	1997	0		
585	chrUn_JH126387	53317	53386	3500385351	69		53317	53386	8421504	1	69	0	p	350038535100015093	0-69						Phenotypic screen of chimeric proteins	Jin Jin Xiu 	2005	0		ZNF182
585	chrUn_JH126387	53317	53386	3500269504	69		53317	53386	8421504	1	69	0	p	350026950400015058	0-69					Patent	Zinc finger domain libraries (Patent EP:1417344)	BAE	2011	0		ZNF182
585	chrUn_JH126387	53317	53386	3500176901	69		53317	53386	8421504	1	69	0	p	350017690100015041	0-69						Zinc finger domains and methods of identifying same	Hwang	2002	0		ZNF182
585	chrUn_JH126387	53317	53386	3500160097	69		53317	53386	8421504	1	69	0	p	350016009700015078	0-69						Phenotypic screen of chimeric proteins	JANG	2004	0		ZNF182
585	chrUn_JH126387	53317	53386	3500075471	69		53317	53386	8421504	1	69	0	p	350007547100015047	0-69						&#x5d4c;&#x5408;&#x86cb;&#x767d;&#x8d28;&#x7684;&#x8868;&#x578b;&#x7b5b;&#x9009;	Jin Jin Xiu 	2005	0		ZNF182
585	chrUn_JH126387	53791	53851	3500220702	60		53791	53851	8421504	1	60	0	p	350022070200015081	54-114						Regulatory zinc finger proteins	Jin-Soo	2004	0		ZNF182
585	chrUn_JH126395	41827	41850	3500189431	23		41827	41850	8421504	1	23	0	c	350018943100000199	0-23						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
585	chrUn_JH126395	44242	45581	3500021819	90		44242	45581	8421504	2	45,45	0,1294	p	350002181900015155,350002181900015154	0-45,0-45						Fibroblast growth factor homologous factor-4	Nathans	2000	0		
585	chrUn_JH126395	44305	45551	3500401657	48		44305	45551	8421504	2	2,46	0,1200	c	350040165700000027	0-48						 Polynucleotides Encoding Fibroblast Growth Factor 15 	www.docstoc.com	0	0		
585	chrUn_JH126395	44305	45551	3500169328	48		44305	45551	8421504	2	2,46	0,1200	c	350016932800000027	0-48						Polynucleotides encoding fibroblast growth factor 15	Greene	2000	0		
585	chrUn_JH126396	16756	16818	3500277393	46		16756	16818	8421504	2	22,24	0,38	g	350027739300000000,350027739300000010,350027739300000023,350027739300000003,350027739300000009	0-22,0-22,0-23,0-24,0-22						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		LINC00461
585	chrUn_JH126396	16756	16818	3500010232	46		16756	16818	8421504	2	22,24	0,38	g	350001023200000013,350001023200000001,350001023200000023,350001023200000012,350001023200000004,350001023200000022	0-22,0-22,0-21,0-23,0-24,0-22		21857646	10.1038/emboj.2011.301	ERROR! NO ISSN	The EMBO Journal	CAMTA1 is a novel tumour suppressor regulated by miR-9/9&ast; in glioblastoma stem cells	Schraivogel	2011	0		LINC00461
585	chrUn_JH126396	16756	16817	3500125321	44		16756	16817	8421504	2	21,23	0,38	g	350012532100000061,350012532100000077	0-21,0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		LINC00461
585	chrUn_JH126396	16793	16817	3500125619	24		16793	16817	8421504	1	24	0	g	350012561900000005,350012561900000007	18-42,0-23						Lentiviral miRNA Expression	biosettia.com	0	0		RHBG
585	chrUn_JH126396	16794	16817	3500439152	23		16794	16817	8421504	1	23	0	g	350043915200000207	0-23						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		POLG,RHBG
585	chrUn_JH126396	16794	16817	3500423784	23		16794	16817	8421504	1	23	0	g	350042378400000127	0-23						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		POLG,LINC00461
585	chrUn_JH126396	16794	16817	3500244257	23		16794	16817	8421504	1	23	0	g	350024425700000007	0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		RHBG,LINC00461
585	chrUn_JH126396	16794	16817	3500166534	23		16794	16817	8421504	1	23	0	g	350016653400001579	0-23						METHODS FOR QUANTITATING SMALL RNA MOLECULES	Raymond	2007	0		POLG,LINC00461
585	chrUn_JH126396	16794	16817	3500065300	23		16794	16817	8421504	1	23	0	g	350006530000000003	0-23						Die Funktion von microRNAs bei der Entstehung und Verarbeitung von Schmerzen	.uni-frankfurt.de	0	0		RHBG,LINC00461
585	chrUn_JH126396	16794	16817	3500043993	23		16794	16817	8421504	1	23	0	g	350004399300000019,350004399300000109	0-23,0-23						Invertebrate MicroRNAs - Patent application	www.faqs.org	0	0		RHBG,LINC00461
586	chrX	210676	210701	3500287505	23		210676	210701	8421504	2	6,17	0,8	g	350028750500000095	2-25						Methods for diagnosing Pseudoxanthoma elasticum	www.devileye.net	0	0		
588	chrX	416607	416712	3500386086	105		416607	416712	8421504	1	105	0	p	350038608600015022	0-105					Patent	Methods for screening for transdominant effector peptides and RNA molecules (Patent US:6455247)	Nolan	2002	0		LAMP2
588	chrX	416607	416712	3500241961	105		416607	416712	8421504	1	105	0	p	350024196100015016	0-105					Patent	Methods for screening for transdominant intracellular effector peptides and RNA molecules (Patent US:6737241)	Nolan	2004	0		LAMP2
588	chrX	416607	416712	3500236661	105		416607	416712	8421504	1	105	0	p	350023666100015025	0-105					Patent	Multiparameter facs assays to detect alterations in cellular parameters (Patent EP:1071809)	Fisher	2003	0		LAMP2
588	chrX	416607	416712	3500182891	105		416607	416712	8421504	1	105	0	p	350018289100015017	0-105						US Patent # 6,645,766. Shuttle vectors - Patents.com	www.patents.com	0	0		LAMP2
588	chrX	416607	416712	3500149728	105		416607	416712	8421504	1	105	0	p	350014972800015014	0-105						Bi-directionally cloned random cDNA expression vector libraries, compositions and methods of use	Lorens	2002	0		LAMP2
588	chrX	416607	416712	3500139777	105		416607	416712	8421504	1	105	0	p	350013977700015029	0-105						Methods and compositions comprising Renilla GFP	Anderson	2002	0		LAMP2
588	chrX	416607	416712	3500079485	105		416607	416712	8421504	1	105	0	p	350007948500015022	0-105					Patent	Multiparameter facs test zum ermitteln von &#xe4;nderungen in den zellularen parametern (Patent DE:69910756)	Fisher	2004	0		LAMP2
588	chrX	416607	416712	3500074000	99		416607	416712	8421504	2	54,45	0,60	p	350007400000015048	0-99					Patent	Multiparameter FACS assays to detect alterations in cellular parameters and small molecule screening (Patent CN:100334227)	J*Fei She Er 	2007	0		LAMP2
588	chrX	416607	416712	3500068925	99		416607	416712	8421504	2	54,45	0,60	p	350006892500015024	0-99					Patent	&#x68c0;&#x6d4b;&#x7ec6;&#x80de;&#x53c2;&#x6570;&#x53d8;&#x5316;&#x548c;&#x7b5b;&#x9009;&#x5c0f;&#x5206;&#x5b50;&#x6587;&#x5e93;&#x6240;&#x7528;&#x7684;&#x591a;&#x53c2;&#x6570;facs&#x5206;&#x6790; (Patent CN:100334227)	J*Fei She Er 	2007	0		LAMP2
588	chrX	416607	416712	3500054111	105		416607	416712	8421504	1	105	0	p	350005411100015014	0-105						US Patent # 7,205,130. Bi-directionally cloned random cDNA expression vector libraries, compositions and methods of use - Patents.com	www.patents.com	0	0		LAMP2
588	chrX	416607	416712	3500024333	105		416607	416712	8421504	1	105	0	p	350002433300015018	0-105					Patent	Methods for screening for transdominant intracellular effector peptides and RNA molecules (Patent US:6153380)	Nolan	2000	0		LAMP2
588	chrX	422888	422915	3500215797	27		422888	422915	8421504	1	27	0	c	350021579700000001	30-57						Effects of ceramide-1-phosphate on cultured cells: dependence on dodecane in the vehicle	www.jlr.org	0	0		LAMP2
589	chrX	542019	542046	3500262404	25		542019	542046	8421504	2	14,11	0,16	g	350026240400000013	8-38						Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides	-publications.com	0	0		
589	chrX	577510	584897	3500344713	48		577510	584897	8421504	3	12,10,26	0,1204,7361	c,g	350034471300000000,350034471300000001,350034471300000001	3-25,0-26,0-26		16322206	10.1158/0008-5472.CAN-05-0845	0008-5472	Cancer Research	MCT-1 Oncogene Contributes to Increased In vivo Tumorigenicity of MCF7 Cells by Promotion of Angiogenesis and Inhibition of Apoptosis	Levenson	2005	8		
589	chrX	577510	584897	3500234396	48		577510	584897	8421504	3	12,10,26	0,1204,7361	c	350023439600000000,350023439600000001	3-25,0-26						MCT-1 Oncogene Contributes to Increased In vivo Tumorigenicity of MCF7 Cells by Promotion of Angiogenesis and Inhibition of Apoptosis	.aacrjournals.org	0	0		MCTS1
589	chrX	578802	581228	3500027343	156		578802	581228	8421504	5	65,1,19,26,45	0,600,679,2352,2381	p	350002734300015011,350002734300015018,350002734300015013,350002734300015010	0-45,0-45,0-45,0-45						MCT-1, a human oncogene - US Patent 7811561 Description	ww.patentstorm.us	0	0		
589	chrX	598671	598830	3500386742	40		598671	598830	8421504	2	20,20	0,139	c	350038674200000003,350038674200000002	0-20,0-20		23424651	10.1371/journal.pone.0056211		PLoS ONE	COSMC Is Overexpressed in Proliferating Infantile Hemangioma and Enhances Endothelial Cell Growth via VEGFR2	Jian-Jr	2013	0		C1GALT1C1
590	chrX	732914	732941	3500041331	23		732914	732941	8421504	2	8,15	0,12	g	350004133100000177	13-36						Juvenile Parkinson disease caused by parkin mutations: large deletions and pathogenic mechanisms	run.unl.pt/bitstr	0	0		
591	chrX	812188	812214	3500041752	25		812188	812214	8421504	2	6,19	0,7	g	350004175200000014,350004175200000121,350004175200000122,350004175200000123	7-35,1-29,0-28,0-27						PRIMER SET FOR AMPLIFYING OBESITY GENE, REAGENT FOR AMPLIFYING OBESITY GENE CONTAINING THE SAME, AND THE USES THEREOF - Patent application	www.faqs.org	0	0		
591	chrX	812188	812212	3500236659	23		812188	812212	8421504	2	6,17	0,7	g	350023665900000042	0-26						Primer set for amplification of obesity gene, reagent for amplification of obesity gene comprising the primer set, and use of the primer set	Hirai	2009	0		
596	chrX	1517059	1517084	3500407090	23		1517059	1517084	8421504	2	5,18	0,7	g	350040709000000112,350040709000001003,350040709000000813	0-23,21-41,12-32						HIV envelope polypeptides and vaccine	Berman	1997	0		
602	chrX	2315071	2315099	3500289926	25		2315071	2315099	8421504	3	5,6,14	0,7,14	c	350028992600000055,350028992600000036,350028992600000022,350028992600000030	0-25,0-20,0-20,0-20					Patent	Nucleic acid sequence detection by triple helix formation at primer site in amplification reactions (Patent US:5800984)	Vary	1998	0		
75	chrX	2315265	2615861	3500354805	2682		2315265	2615861	8421504	15	109,159,240,188,54,162,168,105,108,207,377,199,248,115,243	0,1278,78003,152490,186750,205914,210146,215069,216288,217760,229619,241100,282797,297625,300353	p	350035480500015000	0-2682						KEGG T01001: 2892	www.genome.jp	0	0		GRIA3
602	chrX	2321588	2321613	3500382910	23		2321588	2321613	8421504	2	13,10	0,15	g	350038291000000221	10-35					Patent	DNA expression systems based on alphaviruses (Patent US:5739026)	Garoff	1998	0		
603	chrX	2483160	2483187	3500127362	23		2483160	2483187	8421504	2	8,15	0,12	g	350012736200000006	0-23					Patent	Human LXR&#x03b1; variants (Patent US:7341850)	Liu	2008	0		
603	chrX	2483160	2483187	3500115063	23		2483160	2483187	8421504	2	8,15	0,12	g	350011506300000005	0-23						Novel human LXRalpha variants	Liu	2007	0		
604	chrX	2524749	2524894	3500353564	41		2524749	2524894	8421504	2	21,20	0,125	g	350035356400000108,350035356400000467	0-21,0-20						Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof	Begovich	2004	0		GRIA3
604	chrX	2598218	2598275	3500342863	57		2598218	2598275	8421504	1	57	0	p	350034286300015106	0-57							library.wiley.com	0	0		GRIA3
604	chrX	2615711	2615861	3500109192	150		2615711	2615861	8421504	1	150	0	p	350010919200015004	0-150						Molecular Characterization of Native and Recombinant Ionotropic Glutamate Receptors Expressed in Neurons and Heterologous Systems	person.au.dk	0	0		GRIA3
604	chrX	2615796	2615836	3500207640	40		2615796	2615836	8421504	1	40	0	c	350020764000000000	0-40						AMPA-binding human GluR3 receptors	Kamboj	2002	0		GRIA3
611	chrX	3527332	3527356	3500156394	23		3527332	3527356	8421504	2	10,13	0,11	g	350015639400000002	0-23		21829166	10.1038/emboj.2011.271	ERROR! NO ISSN	The EMBO Journal	The structure of a transcription activation subcomplex reveals how &#x03c3;70 is recruited to PhoB promoters	Blanco	2011	0		
615	chrX	4043015	4043043	3500297690	24		4043015	4043043	8421504	2	13,11	0,17	g	350029769000000038	24-48						US Patent # 5,556,781. DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses - Patents.com	www.patents.com	0	0		
617	chrX	4302564	4302590	3500351984	25		4302564	4302590	8421504	2	15,10	0,16	c	350035198400000014	0-25						Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase	Kishore	1988	0		
617	chrX	4302564	4302590	3500281782	25		4302564	4302590	8421504	2	15,10	0,16	c	350028178200000019	0-25					Patent	Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases (Patent US:5310667)	Eichholtz	1994	0		
617	chrX	4302564	4302590	3500276013	25		4302564	4302590	8421504	2	15,10	0,16	c	350027601300000013	0-25						Glyphosate tolerant 5-enolpyruvyl-3-phosphoshikimate synthase	Kishore	1988	0		
617	chrX	4302564	4302590	3500199340	25		4302564	4302590	8421504	2	15,10	0,16	c	350019934000000020	0-25						Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases	Eichholtz	1989	0		
617	chrX	4302564	4302590	3500161354	25		4302564	4302590	8421504	2	15,10	0,16	c	350016135400000013	0-25					Patent	Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase (Patent US:5312910)	Kishore	1994	0		
617	chrX	4302564	4302590	3500120931	25		4302564	4302590	8421504	2	15,10	0,16	c	350012093100000013	0-25					Patent	Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases (Patent US:5866775)	Eichholtz	1999	0		
617	chrX	4302564	4302590	3500040241	25		4302564	4302590	8421504	2	15,10	0,16	c	350004024100000013	0-25					Patent	Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases (Patent US:5866775)	Eichholtz	1999	0		
618	chrX	4434184	4434210	3500133622	23		4434184	4434210	8421504	2	5,18	0,8	g	350013362200000306	16-39					Patent	Short interfering ribonucleic acid (siRNA) for oral administration (Patent US:8404832)	Natt	2013	0		
625	chrX	5373528	5373563	3500407090	25		5373528	5373563	8421504	3	13,6,6	0,18,29	g	350040709000000935	1-27						HIV envelope polypeptides and vaccine	Berman	1997	0		
628	chrX	5693550	5693573	3500350877	23		5693550	5693573	8421504	1	23	0	g	350035087700000001	6-29						Compositions and methods of using CRMP-1 and its fragments for treating cancer	Terng	2008	0		
631	chrX	6086864	6086933	3500439161	69		6086864	6086933	8421504	1	69	0	p,c	350043916100015006,350043916100000004	9-78,0-30						BMC Medical Genetics BioMed Central	biomedcentral.com	0	0		SMARCA1
631	chrX	6086902	6086932	3500419580	30		6086902	6086932	8421504	1	30	0	c	350041958000000004	0-30		18302774	10.1186/1471-2350-9-11	1471-2350	BMC Medical Genetics	Characterization of novel isoforms and evaluation of SNF2L/SMARCA1 as a candidate gene for X-linked mental retardation in 12 families linked to Xq25-26	Lazzaro	2008	2		
631	chrX	6153718	6153797	3500439161	75		6153718	6153797	8421504	2	51,24	0,55	p	350043916100015004	30-111						BMC Medical Genetics BioMed Central	biomedcentral.com	0	0		
632	chrX	6232463	6248217	3500293391	68		6232463	6248217	8421504	3	24,19,25	0,1475,15729	c,g	350029339100000085,350029339100000015,350029339100000108	0-24,2-21,0-25						Untersuchungen zum Einfluss des bei Patienten mit Lowe-Syndrom mutierten humanen OCRL-Proteins auf endozytotische Prozesse in eukaryotischen Zellen DISSERTATION	ub.uni-hamburg.de	0	0		
633	chrX	6321837	6328270	3500344705	258		6321837	6328270	8421504	3	24,167,67	0,624,6366	p,c,g	350034470500000092,350034470500000031,350034470500000110,350034470500015009,350034470500015010,350034470500015106,350034470500000109,350034470500015008,350034470500015024,350034470500015104,350034470500000108,350034470500015102,350034470500000089,350034470500000028,350034470500000026,350034470500000087,350034470500015100,350034470500000106	0-24,0-24,0-42,0-105,0-90,0-45,0-48,0-51,0-45,0-45,0-48,0-45,0-24,0-24,0-23,0-24,0-45,0-48						APJ ligand polypeptides	Hinuma	1999	0		
633	chrX	6322464	6328241	3500381835	156		6322464	6328241	8421504	4	108,11,13,24	0,153,5739,5753	p,c	350038183500015004,350038183500015005,350038183500015003,350038183500000028,350038183500000026	0-105,0-108,0-51,0-24,0-24						Polypeptide, their production and use	Fujii	1999	0		
633	chrX	6322464	6322572	3500433542	108		6322464	6322572	8421504	1	108	0	p	350043354200015000	0-108			10.1046/j.1471-4159.2003.01587.x	1471-4159	Journal of Neurochemistry	Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin - Medhurst - 2003 - Journal of Neurochemistry - Wiley Online Library	Medhurst	2003	0		
633	chrX	6322464	6322572	3500080941	108		6322464	6322572	8421504	1	108	0	p	350008094100015005,350008094100015006	0-105,0-108						&#x65b0;&#x898f;&#x751f;&#x7406;&#x6d3b;&#x6027;&#x7269;&#x8cea;&#x3001;&#x305d;&#x306e;&#x88fd;&#x9020;&#x6cd5;&#x304a;&#x3088;&#x3073;&#x7528;&#x9014; - &#x6b66;&#x7530;&#x85ac;&#x54c1;&#x5de5;&#x696d;&#x682a;&#x5f0f;&#x4f1a;&#x793e;	www.patentjp.com	0	0		
633	chrX	6322464	6322572	3500005317	108		6322464	6322572	8421504	1	108	0	p	350000531700015008,350000531700015009,350000531700015007	0-105,0-108,0-51						POLYPEPTIDE, DEREN HERSTELLUNG UND VERWENDUNG - Dokument DE69838986T2	www.patent-de.com	0	0		
633	chrX	6322471	6322589	3500428263	39		6322471	6322589	8421504	2	19,20	0,98	c,g	350042826300000001,350042826300000001,350042826300000000,350042826300000000	0-19,0-19,0-20,0-20						THE EXPRESSION OF APELIN AND ITS RECEPTOR APJ DURING DIFFERENT PHYSIOLOGICAL STAGES IN THE BOVINE OVARY	www.ijbs.com	0	0		
633	chrX	6322471	6322589	3500055362	39		6322471	6322589	8421504	2	19,20	0,98	c,g	350005536200000001,350005536200000001,350005536200000000,350005536200000000	0-19,0-19,0-20,0-20		18367512	10.1530/REP-07-0409	1470-1626	Reproduction	Expression and localization of apelin and its receptor APJ in the bovine corpus luteum during the estrous cycle and prostaglandin F2&#x03b1;-induced luteolysis	Shirasuna	2008	3		
633	chrX	6326843	6326866	3500454249	23		6326843	6326866	8421504	1	23	0	g	350045424900000141	24-47					Patent	Prosthetic devices having enhanced osteogenic properties (Patent US:5344654)	Kuberasampath	1994	0		
634	chrX	6433125	6433148	3500057287	23		6433125	6433148	8421504	1	23	0	c	350005728700000229	4-33						METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS - Patent application	www.faqs.org	0	0		
634	chrX	6442799	6442828	3500066984	24		6442799	6442828	8421504	3	6,4,14	0,10,15	c	350006698400000114	0-24						Proteases - Patent application	www.faqs.org	0	0		
634	chrX	6442799	6442828	3500041857	24		6442799	6442828	8421504	3	6,4,14	0,10,15	c,g	350004185700000114,350004185700000114	0-24,0-24						Proteases - Patent application	www.faqs.org	0	0		
634	chrX	6467445	6493900	3500395807	1089		6467445	6493900	8421504	9	111,97,104,103,49,138,159,161,167	0,3156,3648,4932,5790,6741,11675,15763,26288	p	350039580700015043,350039580700015044	0-1086,0-540						71 human secreted proteins	Brewer	2000	0		ZDHHC9
634	chrX	6467445	6493900	3500348941	1089		6467445	6493900	8421504	9	111,97,104,103,49,138,159,161,167	0,3156,3648,4932,5790,6741,11675,15763,26288	p	350034894100015035,350034894100015036	0-1089,0-552						 Secreted Protein HT5GJ57 	www.docstoc.com	0	0		ZDHHC9
635	chrX	6556068	6556096	3500433728	27		6556068	6556096	8421504	2	17,10	0,18	c	350043372800000030,350043372800000031	7-34,7-33						A NY&#xda;L KAPPA-KAZEIN G&#xc9;N JELLEMZ&#xc9;SE, &#xc9;S TERMELTET&#xc9;S&#xc9;NEK HAT`SA TRANSZG&#xc9;NIKUS `LLATOKBAN	phd.szie.hu	0	0		
636	chrX	6739884	6739911	3500095449	23		6739884	6739911	8421504	2	17,6	0,21	g	350009544900002113	0-24						Expression Cassettes for Embryo-Specific Expression in Plants - Patent application	www.faqs.org	0	0		
636	chrX	6748243	6748266	3500129285	23		6748243	6748266	8421504	1	23	0	c,g	350012928500000000,350012928500000001,350012928500000001	0-21,0-21,0-21		22839996	10.1186/1476-4598-11-48	1476-4598	Molecular Cancer	Silencing of Apoptosis-Inducing factor and poly(ADP-ribose) glycohydrolase reveals novel roles in breast cancer cell death after chemotherapy	Feng	2012	4		AIFM1
637	chrX	6885560	6885584	3500166288	24		6885560	6885584	8421504	1	24	0	c,g	350016628800000000,350016628800000000	0-24,0-24						UCP5	Adams	2008	0		
638	chrX	7017858	7017888	3500100734	27		7017858	7017888	8421504	3	6,5,16	0,8,14	g	350010073400000333	21-48						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
639	chrX	7129407	7129435	3500250562	23		7129407	7129435	8421504	2	16,7	0,21	g	350025056200000012	11-34						UNIVERSITAT DE BARCELONA FACULTAT DE FARM&#xc0;CIA DEPARTAMENT DE BIOQU&#xcd;MICA I BIOLOGIA MOLECUAR PROGRAMA DE DOCTORAT EN BIOTECNOLOGIA (bienni 2003-2005)	tdx.cat/bitstream	0	0		
641	chrX	7343232	7343259	3500237642	24		7343232	7343259	8421504	2	8,16	0,11	g	350023764200000087	2-26						METHOD FOR IDENTIFICATION OF T-LYMPHOCYTE ANTIGENS - Patent application	www.faqs.org	0	0		
642	chrX	7510669	7510697	3500449570	24		7510669	7510697	8421504	2	18,6	0,22	g	350044957000000004	1-25						Keratinocyte growth factor-2	osdir.com/patents	0	0		
644	chrX	7742717	7742762	3500441703	45		7742717	7742762	8421504	1	45	0	p	350044170300015022	0-45						STE20-RELATED PROTEIN KINASES	Plowman	1999	0		STK24
644	chrX	7742717	7742762	3500028732	45		7742717	7742762	8421504	1	45	0	p	350002873200015020	0-45					Patent	Polypeptide fragments of human PAK5 protein kinase (Patent US:6656716)	Plowman	2003	0		STK25
644	chrX	7809934	7809962	3500121586	24		7809934	7809962	8421504	2	14,10	0,18	g	350012158600000028	4-36						Nucleic acids encoding endotheliases, endotheliases and uses thereof - US Patent 7276364 Description	ww.patentstorm.us	0	0		
644	chrX	7856538	7859129	3500147772	42		7856538	7859129	8421504	3	22,17,3	0,98,2588	c	350014777200000005,350014777200000004	0-22,0-20						Rap1 and rap2 antagonistically control endothelial barrier resistance. - ResearchGate	.researchgate.net	0	0		RAP2C
644	chrX	7856538	7859129	3500077908	42		7856538	7859129	8421504	3	22,17,3	0,98,2588	c	350007790800000005,350007790800000004	0-22,0-20		23469100	10.1371/journal.pone.0057903		PLoS ONE	Rap1 and Rap2 Antagonistically Control Endothelial Barrier Resistance	Willem-Jan	2013	0		RAP2C
645	chrX	7980541	7980568	3500325127	23		7980541	7980568	8421504	2	8,15	0,12	c	350032512700000062	17-46						Method For Detecting Gene Specifying Allergic Predisposition 	.freshpatents.com	0	0		
80	chrX	7988232	8039570	3500348971	252		7988232	8039570	8421504	5	60,66,42,18,66	0,102,19083,51218,51272	p	350034897100015041,350034897100015043,350034897100015040,350034897100015046,350034897100015048,350034897100015036	0-60,0-60,0-66,0-60,0-60,0-66						Variation of the male specific wing pigment in the natural populations of Drosophila rajasekari.	www.ou.edu/journa	0	0		MBNL3
646	chrX	8007264	8007309	3500034141	45		8007264	8007309	8421504	1	45	0	p	350003414100015008	0-45						COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY - Patent application	www.faqs.org	0	0		MBNL3
646	chrX	8031109	8031133	3500094164	23		8031109	8031133	8421504	2	7,16	0,8	g	350009416400000016	3-26					Patent	Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors (Patent US:8455629)	Boyle	2013	0		
646	chrX	8101895	8101921	3500237912	25		8101895	8101921	8421504	2	20,5	0,21	g	350023791200000004	14-40					Patent	Cellulose binding domain fusion proteins (Patent US:5719044)	Doi	1998	0		
647	chrX	8215606	8215630	3500213088	23		8215606	8215630	8421504	2	5,18	0,6	g	350021308800000141,350021308800000019	28-48,25-48						Canine coronavirus S gene and uses therefor	Miller	2001	0		
648	chrX	8282976	8283002	3500243910	26		8282976	8283002	8421504	1	26	0	c	350024391000000005	10-36		19940142	10.1074/jbc.M109.021576		The Journal of Biological Chemistry	Plasmodium falciparum BAEBL Binds to Heparan Sulfate Proteoglycans on the Human Erythrocyte Surface	Kyousuke	2010	0		
650	chrX	8563644	8563740	3500341139	92		8563644	8563740	8421504	2	48,44	0,52	c	350034113900000038,350034113900000037	0-48,0-44						Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 - Patent application	www.faqs.org	0	0		
650	chrX	8563646	8563671	3500279119	25		8563646	8563671	8421504	1	25	0	c	350027911900000001,350027911900000000	0-25,0-25						Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican&#x2011;3&#x2011;derived peptide	-publications.com	0	0		GPC3
651	chrX	8651977	8652025	3500341139	48		8651977	8652025	8421504	1	48	0	c	350034113900000032	0-48						Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 - Patent application	www.faqs.org	0	0		
651	chrX	8689162	8689187	3500100734	25		8689162	8689187	8421504	1	25	0	g	350010073400000453	6-37						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
651	chrX	8721762	8722001	3500341139	143		8721762	8722001	8421504	3	47,48,48	0,95,191	c	350034113900000021,350034113900000019,350034113900000017	0-47,0-48,0-48						Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 - Patent application	www.faqs.org	0	0		
651	chrX	8721952	8721977	3500279119	25		8721952	8721977	8421504	1	25	0	c	350027911900000002	0-25						Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican&#x2011;3&#x2011;derived peptide	-publications.com	0	0		GPC3
651	chrX	8722095	8722121	3500359179	23		8722095	8722121	8421504	2	13,10	0,16	c	350035917900000001	2-25		18316472	10.1677/JME-07-0161	0952-5041	Journal of Molecular Endocrinology	Purification and characterization of an insulin-related peptide in the desert locust, Schistocerca gregaria: immunolocalization, cDNA cloning, transcript profiling and interaction with neuroparsin	Badisco	2008	3		GPC3
651	chrX	8738735	8738763	3500305090	23		8738735	8738763	8421504	2	14,9	0,19	g	350030509000000077	5-28						TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY - Patent application	www.faqs.org	0	0		
653	chrX	8916407	8916434	3500436525	25		8916407	8916434	8421504	3	7,3,15	0,8,12	g	350043652500000005	0-25						Molecular Genetic Analysis of Ceruloplasmin in Oesophageal Cancer	scholar.sun.ac.za	0	0		
653	chrX	8985083	8985107	3500301423	23		8985083	8985107	8421504	2	8,15	0,9	c	350030142300000018	9-32						Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same	Clark	2003	0		
653	chrX	8985083	8985107	3500098899	23		8985083	8985107	8421504	2	8,15	0,9	c	350009889900000018,350009889900000049	9-32,9-32						Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same	Clark	2001	0		
653	chrX	8985700	8985724	3500406991	23		8985700	8985724	8421504	2	16,7	0,17	c	350040699100000124	1-34						 Amylase Variants 	www.docstoc.com	0	0		FAM122B
653	chrX	8985700	8985724	3500151740	23		8985700	8985724	8421504	2	16,7	0,17	c	350015174000000085	4-37						Alpha-Amylase Variants - Patent application	www.faqs.org	0	0		
653	chrX	8985700	8985724	3500074983	23		8985700	8985724	8421504	2	16,7	0,17	c	350007498300000125	1-34						Alpha-amylase mutants with altered properties - US Patent 7713723 Description	ww.patentstorm.us	0	0		FAM122B
659	chrX	9756146	9756176	3500045447	25		9756146	9756176	8421504	2	12,13	0,17	c	350004544700000003	9-34		19233850	10.1074/jbc.M809013200		The Journal of Biological Chemistry	The Catalytic Flexibility of tRNAIle-lysidine Synthetase Can Generate Alternative tRNA Substrates for Isoleucyl-tRNA Synthetase	Scott	2009	0		SLC9A6
659	chrX	9796839	9796863	3500262471	23		9796839	9796863	8421504	2	16,7	0,17	g	350026247100000083,350026247100000059	10-33,12-32						<HTML><HEAD><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1"><LINK REL="SHORT	.economie.fgov.be	0	0		
661	chrX	9962550	9965478	3500260030	42		9962550	9965478	8421504	3	3,18,21	0,158,2907	c,g	350026003000000000,350026003000000001,350026003000000001	0-21,0-21,0-21		19840196	10.1111/j.1582-4934.2009.00938.x	1582-4934	Journal of Cellular and Molecular Medicine	FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth - Ding - 2009 - Journal of Cellular and Molecular Medicine - Wiley Online Library	Ding	2011	0		FHL1
662	chrX	10101836	10101859	3500407203	23		10101836	10101859	8421504	1	23	0	g	350040720300000138	0-23						G Protein Coupled Receptors And Uses Thereof 	.freshpatents.com	0	0		
663	chrX	10230121	10230349	3500050415	75		10230121	10230349	8421504	6	12,10,5,27,6,15	0,13,24,71,206,213	c	350005041500000013,350005041500000014,350005041500000012	0-27,0-27,18-39						Developmental expression and biological activity of gastrin-releasing peptide (GRP) and GRP receptors in the kidney	al.physiology.org	0	0		BRS3
663	chrX	10230192	10230359	3500304979	50		10230192	10230359	8421504	2	27,23	0,144	c	350030497900000007	0-50						Developmental expression and biological activity of gastrin-releasing peptide and its receptors in the kidney	g.library.pcc.edu	0	0		
664	chrX	10364433	10364466	3500287328	29		10364433	10364466	8421504	3	13,4,12	0,14,21	g	350028732800000248	9-38						Concatameric immunoadhesion molecule - US Patent 7670602 Description	ww.patentstorm.us	0	0		
664	chrX	10364433	10364464	3500265652	27		10364433	10364464	8421504	3	13,4,10	0,14,21	g	350026565200000167	21-48						ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15 - Patent application	www.faqs.org	0	0		
664	chrX	10393032	10404855	3500370126	864		10393032	10404855	8421504	5	170,132,58,63,441	0,2412,6702,8647,11382	c	350037012600000011	0-864						Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease	Cantwell	1999	0		
664	chrX	10393032	10404855	3500227609	864		10393032	10404855	8421504	5	170,132,58,63,441	0,2412,6702,8647,11382	c	350022760900000015	0-864						Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease	Tuo Ma Si *J*Ji Pu Si 	2000	0		
664	chrX	10393032	10404855	3500150471	864		10393032	10404855	8421504	5	170,132,58,63,441	0,2412,6702,8647,11382	c	350015047100000011	0-864						Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease		1998	0		
664	chrX	10393046	10404788	3500162427	771		10393046	10404788	8421504	9	156,132,24,31,50,10,128,105,135	0,2398,6688,6715,8633,8686,11368,11499,11607	p	350016242700015021	0-771						COMBINATION OF AN AGONISTIC ANTI-CD40 MONOCLONAL ANTIBODY OR A CD40 LIGAND AND INACTIVATED OR ATTENUATED BACTERIA FOR USE IN THE TREATMENT AND/OR PREVENTION OF MASTITIS - UNIVERSITE DE LIEGE	www.sumobrain.com	0	0		
664	chrX	10393046	10404788	3500046401	783		10393046	10404788	8421504	5	156,132,58,63,374	0,2398,6688,8633,11368	p	350004640100015006,350004640100015005,350004640100015011,350004640100015016,350004640100015021	0-240,0-240,0-240,0-240,0-63						A NOVEL IMMUNOMODULATORY SUBUNIT VACCINE TO COMBAT THE INVOLVEMENT OF BOVINE RESPIRATORY CORONAVIRUS INFECTIONS IN SHIPPING FEVER	etd.lsu.edu	0	0		
664	chrX	10393071	10404443	3500201852	128		10393071	10404443	8421504	4	47,48,4,29	0,2373,8667,11343	c	350020185200000281,350020185200000249,350020185200000306	1-48,0-48,15-48						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
664	chrX	10393133	10393181	3500186499	48		10393133	10393181	8421504	1	48	0	c	350018649900000022	0-48						Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity. - Patent application	www.faqs.org	0	0		
664	chrX	10393151	10404794	3500326914	138		10393151	10404794	8421504	5	35,3,45,32,23	0,48,2293,11415,11620	c	350032691400000037,350032691400000038,350032691400000078,350032691400000010	0-35,0-48,0-32,12-35						Methods of inhibiting CD40L binding to CD40 with soluble monomeric CD40L	Armitage	1996	0		
664	chrX	10393151	10404794	3500190461	106		10393151	10404794	8421504	4	35,3,45,23	0,48,2293,11620	c	350019046100000035,350019046100000036,350019046100000010	0-35,0-48,12-35						CD40 ligand polypeptide	Armitage	1998	0		
664	chrX	10393193	10404598	3500067216	115		10393193	10404598	8421504	3	9,62,44	0,2251,11361	c	350006721600000102,350006721600000224,350006721600000056,350006721600000103,350006721600000196,350006721600000111	18-48,18-48,12-48,0-41,0-44,0-32						DNA Vaccines Encoding Antigen Linked to a Domain That Binds CD40 - Patent application	www.faqs.org	0	0		
664	chrX	10398589	10398614	3500384027	23		10398589	10398614	8421504	2	17,6	0,19	g	350038402700000004	10-33						Multicentric breast cancer: clonality and prognostic studies	are.imbb.forth.gr	0	0		
664	chrX	10404522	10404548	3500348298	26		10404522	10404548	8421504	1	26	0	c	350034829800000037	22-48						Nucleic Acids Encoding Multimeric Fusion Proteins of TNF Superfamily Ligands - Patent application	www.faqs.org	0	0		
664	chrX	10404771	10404794	3500321782	23		10404771	10404794	8421504	1	23	0	c,g	350032178200000009,350032178200000009	12-35,12-35						CD40-LIGAND LACKING NATIVE-PATTERN GLYCOSYLATION - IMMUNEX CORPORATION	www.sumobrain.com	0	0		
664	chrX	10424246	10440485	3500180900	41		10424246	10440485	8421504	2	19,22	0,16217	c	350018090000000066,350018090000000035	0-19,0-22						SIGNALLING AND FUNCTION OF THE SMALL	theses.bham.ac.uk	0	0		ARHGEF6
665	chrX	10499447	10501651	3500187146	23		10499447	10501651	8421504	2	6,17	0,2187	c	350018714600000015	0-23						Cells	tologylibrary.org	0	0		
665	chrX	10597108	10597503	3500150954	364		10597108	10597503	8421504	9	19,8,46,57,58,55,56,54,11	0,24,33,82,142,205,264,325,384	g	350015095400000008	37-401						Nucleic acid preparation from whole blood for use in diagnosis of transmissible spongiform encephalopathy - US Patent 7569367 Description	ww.patentstorm.us	0	0		
665	chrX	10600175	10603436	3500123358	244		10600175	10603436	8421504	7	5,29,67,48,15,33,47	0,6,37,1118,2722,3180,3214	c	350012335800000153,350012335800000152,350012335800000143,350012335800000130,350012335800000129	0-54,0-48,0-48,0-48,0-47					Patent	53BP2 complexes (Patent US:5977311)	Nandabalan	1999	0		
665	chrX	10600454	10603379	3500298520	236		10600454	10603379	8421504	8	48,8,83,1,25,23,24,24	0,192,829,1012,1113,1232,2434,2901	p,c	350029852000000055,350029852000000051,350029852000015088,350029852000000050,350029852000015080,350029852000000047,350029852000015062	0-48,0-48,0-48,4-48,0-48,0-47,0-48						Cis-element Regulating Transcription, Transcriptional Regulatory Factor Binding Specifically Thereto And Use Of The Same 	.freshpatents.com	0	0		
665	chrX	10602767	10602793	3500184404	23		10602767	10602793	8421504	3	6,5,12	0,8,14	c	350018440400000424	0-23						Gastrointestinal proliferative factor and uses thereof - Patent application	www.faqs.org	0	0		
665	chrX	10602767	10602793	3500086063	23		10602767	10602793	8421504	3	6,5,12	0,8,14	c	350008606300000424	0-23						Gastrointestinal proliferative foctor and uses thereof - Patent application	www.faqs.org	0	0		
666	chrX	10688467	10688492	3500441540	23		10688467	10688492	8421504	2	11,12	0,13	g	350044154000000018,350044154000000017	0-23,13-36						Proteases with modified pro regions	Ferrari	2010	0		
666	chrX	10691313	10691412	3500041679	99		10691313	10691412	8421504	1	99	0	c	350004167900000020	0-99						The Amino Acid Sequence of a Glutamic Acid-Rich Protein from Bovine Retina as Deduced from the cDNA Sequence	www.jstor.org	0	0		
666	chrX	10724087	10724112	3500061907	25		10724087	10724112	8421504	1	25	0	g	350006190700000090,350006190700000091	0-25,0-25						G protein-coupled receptors	Lind	2002	0		
666	chrX	10724634	10724666	3500372535	32		10724634	10724666	8421504	1	32	0	g	350037253500000004	8-40						REGULATION OF HUMAN &#x03b1;1&#x0391; ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR	Ramakrishnan	2001	0		
666	chrX	10724636	10724666	3500010114	29		10724636	10724666	8421504	2	25,4	0,26	g	350001011400000029	9-38						Novel human G-protein coupled receptor, HGPRBMY8, expressed highly in brain	Battaglino	2003	0		
671	chrX	11317411	11320767	3500112610	44		11317411	11320767	8421504	2	19,25	0,3331	c,g	350011261000000001,350011261000000001,350011261000000002,350011261000000002	13-32,13-32,12-37,12-37		20872845	10.1002/stem.527	1549-4918	STEM CELLS	The Pluripotency Regulator Zic3 Is a Direct Activator of the Nanog Promoter in ESCs - Lim - 2010 - STEM CELLS - Wiley Online Library	Lim	2010	0		
671	chrX	11317668	11317694	3500417050	26		11317668	11317694	8421504	1	26	0	c	350041705000000037,350041705000000010,350041705000000018	24-50,45-70,46-71						Structural and Functional Characterization of the ATP- Driven Glycolipid-Efflux Pump DevBCA-TolC and its Homologues in the Filamentous Cyanobacterium	.uni-tuebingen.de	0	0		
675	chrX	11828843	11828870	3500414011	24		11828843	11828870	8421504	2	19,5	0,22	g	350041401100000056	0-29						Novel Insulin/igf/relaxin Family Polypeptides And Dnas Thereof 	.freshpatents.com	0	0		
675	chrX	11828843	11828870	3500244934	24		11828843	11828870	8421504	2	19,5	0,22	g	350024493400000113	0-29						Novel insulin/IGF/relaxin family polypeptides and dnas thereof	Yi Teng Kang Ming 	2005	0		
675	chrX	11874301	11874326	3500302529	23		11874301	11874326	8421504	2	10,13	0,12	g	350030252900000007	1-24						CANCER ANTIGEN-SPECIFIC T-CELL RECEPTOR GENE, PEPTIDE ENCODED BY THE GENE, AND USE OF THEM - Patent application	www.faqs.org	0	0		
678	chrX	12245322	12245415	3500105061	69		12245322	12245415	8421504	2	24,45	0,48	p,c	350010506100000004,350010506100000002,350010506100000006,350010506100015005	9-30,9-30,0-21,0-45						Fibroblast growth factor 11	Hu	1996	0		
678	chrX	12245367	12246866	3500445910	192		12245367	12246866	8421504	2	92,100	0,1399	p	350044591000015099,350044591000015098,350044591000015097,350044591000015096	0-48,0-48,0-48,0-48						Human Fgf-23 Gene And Gene Expression Products 	.freshpatents.com	0	0		FGF13
678	chrX	12245388	12318879	3500021819	495		12245388	12318879	8421504	15	45,23,22,45,45,30,15,45,38,7,45,5,40,45,45	0,48,1378,1403,1451,1547,65885,65903,65951,71361,71371,71467,73355,73398,73446	p	350002181900015055,350002181900015053,350002181900015051,350002181900015049,350002181900015142,350002181900015045,350002181900015043,350002181900015041,350002181900015037,350002181900015035,350002181900015033	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Fibroblast growth factor homologous factor-4	Nathans	2000	0		
678	chrX	12245448	12246929	3500142509	165		12245448	12246929	8421504	5	11,19,45,45,45	0,1318,1340,1388,1436	p	350014250900015047,350014250900015046	0-120,0-45						Fibroblast growth factor (FGF23) polypeptides - US Patent 7745406 Description	ww.patentstorm.us	0	0		FGF13
678	chrX	12246800	12318774	3500154938	75		12246800	12318774	8421504	3	39,5,31	0,70055,71943	p	350015493800015003	3-81						&#x5e79;&#x7d30;&#x80de;&#x306e;&#x6a19;&#x8b58;&#x65b9;&#x6cd5;&#x3001;&#x5206;&#x96e2;&#x65b9;&#x6cd5;&#x3001;&#x6d3b;&#x6027;&#x5236;&#x5fa1;&#x65b9;&#x6cd5;&#x4e26;&#x3073;&#x306b;&#x76ae;&#x819a;&#x7d44;&#x7e54;&#x306e;&#x4f5c;&#x88fd;&#x65b9;&#x6cd5	astamuse.com	0	0		FGF13
678	chrX	12246800	12318774	3500154938	75		12246800	12318774	8421504	3	39,5,31	0,70055,71943	p	350015493800015000	0-75						&#x5e79;&#x7d30;&#x80de;&#x306e;&#x6a19;&#x8b58;&#x65b9;&#x6cd5;&#x3001;&#x5206;&#x96e2;&#x65b9;&#x6cd5;&#x3001;&#x6d3b;&#x6027;&#x5236;&#x5fa1;&#x65b9;&#x6cd5;&#x4e26;&#x3073;&#x306b;&#x76ae;&#x819a;&#x7d44;&#x7e54;&#x306e;&#x4f5c;&#x88fd;&#x65b9;&#x6cd5	astamuse.com	0	0		FGF13
678	chrX	12246822	12246869	3500188757	47		12246822	12246869	8421504	1	47	0	c	350018875700000027	0-47						Antibodies against fibroblast growth factor 11	Alderson	2000	0		
678	chrX	12271217	12271243	3500342210	24		12271217	12271243	8421504	2	11,13	0,13	g	350034221000000100	11-35						Muscular Dystrophy Application of Molecular Methodologies in Muscular Dystrophies.	www.scribd.com	0	0		
678	chrX	12306620	12306647	3500467352	25		12306620	12306647	8421504	3	9,12,4	0,10,23	g	350046735200000079	3-48					Patent	Recombinant fowlpox virus S-FPV-043 and uses thereof (Patent US:6123949)	Cochran	2000	0		
678	chrX	12306620	12306647	3500428877	25		12306620	12306647	8421504	3	9,12,4	0,10,23	g	350042887700000082	3-48						Recombinant fowlpox viruses and uses thereof	Cochran	1994	0		
678	chrX	12306620	12306647	3500408690	25		12306620	12306647	8421504	3	9,12,4	0,10,23	g	350040869000000094	3-48						 Recombinant Fowlpox Viruses And Uses Thereof 	www.docstoc.com	0	0		
678	chrX	12306620	12306647	3500179670	25		12306620	12306647	8421504	3	9,12,4	0,10,23	g	350017967000000094	3-48						Recombinant fowlpox viruses and uses thereof	Cochran	1995	0		
678	chrX	12306620	12306647	3500177869	25		12306620	12306647	8421504	3	9,12,4	0,10,23	g	350017786900000079	3-48						US Patent # 6,123,949. Recombinant fowlpox virus S-FPV-043 and uses thereof - Patents.com	www.patents.com	0	0		
678	chrX	12311321	12318745	3500188757	121		12311321	12318745	8421504	4	56,40,23,2	0,5428,5516,7422	c	350018875700000023,350018875700000022,350018875700000020	0-48,0-48,23-48						Antibodies against fibroblast growth factor 11	Alderson	2000	0		FGF13
678	chrX	12316756	12316801	3500213723	45		12316756	12316801	8421504	1	45	0	p	350021372300015055	0-45						Methods of Diagnosing Hypophosphatemic Disorders - Patent application	www.faqs.org	0	0		FGF13
678	chrX	12318930	12318957	3500280943	24		12318930	12318957	8421504	2	8,16	0,11	c	350028094300000038	3-27						Compositions of Aminoacyl-tRNA Synthetase and Uses Thereof	Cho	2010	0		
686	chrX	13239501	13239546	3500146194	45		13239501	13239546	8421504	1	45	0	c	350014619400000005	0-45						Liver-specific gene expression cassettes, and methods of use - US Patent 7351813 Description	ww.patentstorm.us	0	0		
686	chrX	13258152	13262578	3500285264	45		13258152	13262578	8421504	3	12,25,8	0,209,4418	p	350028526400015059	0-45						Glycopegylation methods and proteins/peptides produced by the methods - US Patent 7265084 Description	ww.patentstorm.us	0	0		
686	chrX	13258152	13262578	3500210654	45		13258152	13262578	8421504	3	12,25,8	0,209,4418	p	350021065400015059	0-45						Interferon beta: remodeling and glycoconjugation of interferon beta - Patent # 7226903 - PatentGenius	.patentgenius.com	0	0		
686	chrX	13269866	13269895	3500220417	28		13269866	13269895	8421504	2	19,9	0,20	c	350022041700000001	1-30		9883840	10.1038/4743	ERROR! NO ISSN	Nature Medicine	Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector	Herzog	1999	0		
686	chrX	13269866	13269895	3500170695	28		13269866	13269895	8421504	2	19,9	0,20	c	350017069500000001	1-30		9883840	10.1038/4743	ERROR! NO ISSN	Nature Medicine	Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector	Herzog	1999	0		
686	chrX	13269913	13272312	3500326849	27		13269913	13272312	8421504	2	18,9	0,2390	c	350032684900000003	0-27						LIVER-SPECIFIC NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USE THEREOF	Chuah	2009	0		
686	chrX	13281312	13281335	3500136795	23		13281312	13281335	8421504	1	23	0	c	350013679500000001	0-23						In vivo therapy: Complete IX deficiency hemophilia dogs	www.pnas.org	0	0		
686	chrX	13281312	13281335	3500129137	23		13281312	13281335	8421504	1	23	0	c	350012913700000001	0-23						In vivo therapy: Complete IX deficiency hemophilia dogs	ylab.stanford.edu	0	0		
686	chrX	13283869	13284050	3500293750	101		13283869	13284050	8421504	8	9,9,27,4,4,14,11,23	0,11,22,121,126,131,146,158	c	350029375000000354,350029375000001606	0-46,4-60						Chimeric clotting factors	Salas	2012	0		
686	chrX	13284024	13284051	3500126007	27		13284024	13284051	8421504	1	27	0	c	350012600700000064,350012600700000018	15-42,15-42						PC5 as a Factor IX Propeptide Processing Enzyme - Patent application	www.faqs.org	0	0		
686	chrX	13284026	13284051	3500398124	25		13284026	13284051	8421504	1	25	0	c	350039812400000010	14-39					Patent	Production of recombinant blood clotting factors in human cell lines (Patent CN:1454257)	C*Hao Ze Er 	2013	0		
686	chrX	13284026	13284051	3500228069	25		13284026	13284051	8421504	1	25	0	c	350022806900000009,350022806900000869	14-39,14-39						Production of recombinant blood clotting factors in human cell lines	C*Hao Ze Er 	2003	0		
688	chrX	13523604	13523627	3500180208	23		13523604	13523627	8421504	1	23	0	c	350018020800001552,350018020800001551	0-22,0-22					Patent	Methods for quantitating small RNA molecules (Patent US:8071306)	Raymond	2011	0		ATP11C
688	chrX	13523604	13523627	3500166534	23		13523604	13523627	8421504	1	23	0	c	350016653400001552,350016653400001551	0-22,0-22						METHODS FOR QUANTITATING SMALL RNA MOLECULES	Raymond	2007	0		ATP11C
688	chrX	13523604	13523627	3500164893	23		13523604	13523627	8421504	1	23	0	c	350016489300001552,350016489300001551	0-22,0-22						Methods for quantitating small rna molecules	Raymond	2007	0		ATP11C
690	chrX	13856104	13856129	3500130848	23		13856104	13856129	8421504	2	12,11	0,14	g	350013084800000330	21-44						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
691	chrX	13921913	13921940	3500236604	23		13921913	13921940	8421504	2	15,8	0,19	g	350023660400000223	7-37						Fatty acid desaturases and mutant sequences thereof	Debonte	1998	0		
693	chrX	14192154	14192178	3500011388	23		14192154	14192178	8421504	2	15,8	0,16	g	350001138800000198	0-23						Vaccine and antitoxin for the treatment of C. difficile disease	Kink	1997	0		
698	chrX	14861598	14861626	3500121074	23		14861598	14861626	8421504	2	13,10	0,18	g	350012107400000006	0-23						Root-specific phosphate transporter promoters	Harrison	2006	0		
701	chrX	15289108	15289138	3500179612	24		15289108	15289138	8421504	3	8,10,6	0,13,24	g	350017961200000041	6-36						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2010	0		
701	chrX	15289108	15289138	3500107370	24		15289108	15289138	8421504	3	8,10,6	0,13,24	g	350010737000000041	6-36						Binding molecules capable of neutralizing rabies virus and uses thereof	Bakker	2008	0		
702	chrX	15460024	15460053	3500196470	26		15460024	15460053	8421504	3	12,9,5	0,13,24	g	350019647000000119	0-26						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
718	chrX	17511290	17511315	3500454061	23		17511290	17511315	8421504	3	12,7,4	0,13,21	g	350045406100000185	22-47						PIROPLASMID VACCINE - Patent application	www.faqs.org	0	0		
727	chrX	18738677	18738928	3500227060	54		18738677	18738928	8421504	2	28,26	0,225	c,g	350022706000000000,350022706000000001,350022706000000001	0-28,0-26,0-26						ScienceDirect.com - The Journal of Molecular Diagnostics - A Novel Assay for Evaluating Fragile X Locus Repeats	sciencedirect.com	0	0		FMR1
727	chrX	18738683	18738916	3500273056	60		18738683	18738916	8421504	2	30,30	0,203	c	350027305600000000,350027305600000001	0-30,0-30		20001115	10.1037/a0017616		Behavioral neuroscience	Progressive Spatial Processing Deficits in a Mouse Model of the Fragile X Premutation	MichaR.	2009	0		FMR1
727	chrX	18738683	18738916	3500126986	60		18738683	18738916	8421504	2	30,30	0,203	c	350012698600000001,350012698600000000	0-30,0-30						Methods for Detecting The Presence of Expanded CGG Repeats in the FMR1 Gene 5' Untranslated Region	Hagerman	2007	0		FMR1
727	chrX	18738886	18738916	3500208917	30		18738886	18738916	8421504	1	30	0	c	350020891700000084,350020891700000033	0-30,0-30					Patent	Nucleic acid size detection method (Patent EP:2082055)	Huang	2011	0		
728	chrX	18755638	18764734	3500252280	45		18755638	18764734	8421504	2	21,24	0,9072	c,g	350025228000000002,350025228000000002,350025228000000003	0-21,0-21,0-24						&#xc9;tudes de l'expression des prot&#xe9;ines fragile X related 1 (FXR1P) durant le d&#xe9;veloppement des vert&#xe9;br&#xe9;s	de.bibl.ulaval.ca	0	0		FMR1
728	chrX	18755638	18764734	3500178476	45		18755638	18764734	8421504	2	21,24	0,9072	c	350017847600000002,350017847600000003	0-21,0-24						&#xc9;tudes de l'expression des prot&#xe9;ines fragile X related 1 (FXR1P) durant le d&#xe9;veloppement des vert&#xe9;br&#xe9;s	theses.ulaval.ca	0	0		FMR1
728	chrX	18760400	18771274	3500353823	43		18760400	18771274	8421504	2	20,23	0,10851	c,g	350035382300000000,350035382300000000,350035382300000001,350035382300000001	0-20,0-20,0-23,0-23					American Journal of Human Genetics	Histone Modifications Depict an Aberrantly Heterochromatinized FMR1 Gene in Fragile X Syndrome	Bradford	2002	0		FMR1
728	chrX	18760400	18771274	3500308334	43		18760400	18771274	8421504	2	20,23	0,10851	c	350030833400000000,350030833400000001	0-20,0-23						ScienceDirect.com - The American Journal of Human Genetics - Histone Modifications Depict an Aberrantly Heterochromatinized FMR1 Gene in Fragile X Syndrome	sciencedirect.com	0	0		FMR1
728	chrX	18773825	18773876	3500283223	51		18773825	18773876	8421504	1	51	0	p	350028322300015001	0-51						System and Method for Quantifying Fragile X Mental Retardiation 1 Protein in Tissue and Blood Samples	Lafauci	2012	0		FMR1
728	chrX	18773836	18776585	3500352614	42		18773836	18776585	8421504	2	21,21	0,2728	c,g	350035261400000002,350035261400000002,350035261400000003	0-21,0-21,0-21		21170301	10.1371/journal.pgen.1001240		PLoS Genetics	Histone Deacetylases Suppress CGG Repeat&#x2013;Induced Neurodegeneration Via Transcriptional Silencing in Models of Fragile X Tremor Ataxia Syndrome	PeK.	2010	0		
728	chrX	18777864	18777887	3500268759	23		18777864	18777887	8421504	1	23	0	c	350026875900000005	1-24						MicroRNA-124a and microRNA-34b/c are frequently methylated in all histological types of colorectal cancer and polyps, and in the adjacent normal mucosa	-publications.com	0	0		
728	chrX	18777864	18777887	3500080648	23		18777864	18777887	8421504	1	23	0	c	350008064800000005	1-24			10.3892/ol.2010.222		Oncology Letters	MicroRNA-124a and microRNA-34b/c are frequently methylated in all histological types of colorectal cancer and polyps, and in the adjacent normal mucosa	GUOREN	2011	0		
728	chrX	18777878	18777904	3500201044	26		18777878	18777904	8421504	1	26	0	c	350020104400000052	0-26						Natural killer stimulatory factor	Trinchieri	1990	0		
728	chrX	18778817	18779306	3500433550	40		18778817	18779306	8421504	2	20,20	0,469	g	350043355000000000,350043355000000001	0-20,0-20		21314987	10.1186/1423-0127-18-17		Journal of Biomedical Science	Cellular stress-induced up-regulation of FMRP promotes cell survival by modulating PI3K-Akt phosphorylation cascades	Se	2011	0		FMR1
728	chrX	18782149	18782175	3500326034	25		18782149	18782175	8421504	2	5,20	0,6	g	350032603400000624	15-40						 Selection Method 	www.docstoc.com	0	0		
729	chrX	18989953	18989977	3500407090	23		18989953	18989977	8421504	2	18,5	0,19	g	350040709000001002	10-34						HIV envelope polypeptides and vaccine	Berman	1997	0		
730	chrX	19026220	19026246	3500196007	25		19026220	19026246	8421504	2	15,10	0,16	g	350019600700000004	0-32			10.1128/EC.00329-06	1535-9778	Eukaryotic Cell	Role of SP65 in Assembly of the Dictyostelium discoideum Spore Coat	Metcalf	2007	4		
734	chrX	19643524	19643551	3500262089	23		19643524	19643551	8421504	3	6,5,12	0,8,15	g	350026208900000034	20-44						US Patent # 6,080,912. Methods for creating transgenic animals - Patents.com	www.patents.com	0	0		
735	chrX	19733179	19763473	3500130848	42		19733179	19763473	8421504	4	18,5,6,13	0,19,30273,30281	g	350013084800000620,350013084800000903	3-28,16-35						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
737	chrX	19956123	19956153	3500107562	24		19956123	19956153	8421504	3	13,6,5	0,17,25	g	350010756200000159	21-45						Chimeric genes and methods for increasing the lysine content of the seeds of plants	Epelbaum	2000	0		
739	chrX	20226771	20226795	3500159039	23		20226771	20226795	8421504	2	10,13	0,11	c	350015903900000071	16-39						CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF - Patent application	www.faqs.org	0	0		
739	chrX	20226771	20226795	3500097250	23		20226771	20226795	8421504	2	10,13	0,11	c	350009725000000064	16-39						Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV) - US Patent 7544467 Description	ww.patentstorm.us	0	0		
740	chrX	20389306	20389332	3500246658	23		20389306	20389332	8421504	2	8,15	0,11	g	350024665800000149	1-24						PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS - Patent application	www.faqs.org	0	0		
742	chrX	20707017	20707045	3500025873	23		20707017	20707045	8421504	2	6,17	0,11	g	350002587300000289	0-23						US Patent # 6,593,293. Lepidopteran-active Bacillus thuringiensis .delta.-endotoxin compositions and methods of use - Patents.com	www.patents.com	0	0		
744	chrX	20878173	20878196	3500407090	23		20878173	20878196	8421504	1	23	0	g	350040709000000616	10-33						HIV envelope polypeptides and vaccine	Berman	1997	0		
744	chrX	20878173	20878196	3500346361	23		20878173	20878196	8421504	1	23	0	g	350034636100000000	0-23						 A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey 	rch.microsoft.com	0	0		
746	chrX	21138881	21138908	3500328355	27		21138881	21138908	8421504	1	27	0	c	350032835500000003	0-27						Compositions and methods for the therapy and diagnosis of lung cancer	Bangur	2002	0		
746	chrX	21138881	21138908	3500022835	27		21138881	21138908	8421504	1	27	0	c	350002283500000003	0-27						COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER - Patent application	www.faqs.org	0	0		
746	chrX	21138971	21139400	3500272389	150		21138971	21139400	8421504	2	57,93	0,336	p	350027238900015009	0-150						Use of hmgb and hmgb fragments to decrease specific immune response	Tracey	2005	0		HMGB3
746	chrX	21138971	21139400	3500269428	150		21138971	21139400	8421504	2	57,93	0,336	p	350026942800015003	0-150						Use Of Hmgb Fragments As Anti-inflammatory Agents 	.freshpatents.com	0	0		HMGB3
746	chrX	21138971	21139400	3500208810	150		21138971	21139400	8421504	2	57,93	0,336	p	350020881000015003,350020881000015130,350020881000015132	0-150,0-48,0-48						US Patent # 7,304,034. Use of HMGB fragments as anti-inflammatory agents - Patents.com	www.patents.com	0	0		
746	chrX	21138971	21139400	3500180393	150		21138971	21139400	8421504	2	57,93	0,336	p	350018039300015005	0-150						HMGB1 combination therapies	Newman	2003	0		HMGB3
746	chrX	21138971	21139400	3500091901	150		21138971	21139400	8421504	2	57,93	0,336	p	350009190100015158,350009190100015003,350009190100015160	0-48,0-150,0-48						Use of HMGB fragments as anti-inflammatory agents - Patent application	www.faqs.org	0	0		
746	chrX	21138971	21139370	3500206068	120		21138971	21139370	8421504	2	57,63	0,336	p	350020606800015012	0-120						Use of HMGB fragments as anti-inflammatory agents	O'keefe	2003	0		HMGB3
746	chrX	21140591	21140648	3500360158	57		21140591	21140648	8421504	1	57	0	p	350036015800015014	102-159						Bioinformatics	theory.bio.uu.nl	0	0		MYT1L
746	chrX	21211509	21211537	3500071178	23		21211509	21211537	8421504	2	10,13	0,15	g	350007117800000000	11-34		18693278	10.1002/dvg.20418		Genesis (New York, N.Y. : 2000)	Generation of a conditional mutant allele for Tab1 in mouse	Maiko	2008	0		
746	chrX	21219920	21219947	3500449854	23		21219920	21219947	8421504	2	8,15	0,12	g	350044985400000003	0-24		16321939	10.1128/JB.187.24.8350-8360.2005	0021-9193	Journal of Bacteriology	luxS-Dependent Gene Regulation in Escherichia coli K-12 Revealed by Genomic Expression Profiling	Wang	2005	4		
747	chrX	21243696	21243720	3500323036	23		21243696	21243720	8421504	2	8,15	0,9	g	350032303600000108	6-29						COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF A GENE FROM THE JC VIRUS - Patent application	www.faqs.org	0	0		
747	chrX	21340370	21340396	3500106719	24		21340370	21340396	8421504	2	16,8	0,18	g	350010671900000206	13-37						Optimizing Expression of Active Botulinum Toxin Type E - Patent application	www.faqs.org	0	0		
748	chrX	21412245	21412275	3500350900	24		21412245	21412275	8421504	3	4,13,7	0,5,23	g	350035090000000000	4-29						 Topoisomerase I 	www.docstoc.com	0	0		
748	chrX	21488421	21494758	3500336681	303		21488421	21494758	8421504	3	53,110,140	0,5507,6197	p	350033668100015032	0-303						FULL-LENGTH HUMAN CDNAS ENCODING POTENTIALLY SECRETED PROTEINS - GENSET S.A.	www.sumobrain.com	0	0		VMA21
748	chrX	21488421	21494758	3500115779	303		21488421	21494758	8421504	3	53,110,140	0,5507,6197	p	350011577900015035	0-303						Full-length human cdnas encoding potentially secreted proteins	Bejanin	2001	0		VMA21
750	chrX	21708856	21708879	3500100734	23		21708856	21708879	8421504	1	23	0	g	350010073400000088	2-47						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
751	chrX	21813338	21818619	3500336687	1914		21813338	21818619	8421504	32	110,34,56,171,58,47,107,83,92,93,45,45,45,45,45,45,45,45,45,45,47,45,45,45,93,45,45,45,93,46,45,19	0,343,380,994,2206,2267,3426,3880,3967,4062,4158,4206,4254,4302,4350,4398,4446,4494,4542,4590,4636,4686,4734,4782,4830,4926,4974,5022,5070,5166,5214,5262	p,c,g	350033668700000048,350033668700015206,350033668700000006,350033668700015096,350033668700015191,350033668700000007,350033668700015174,350033668700015097,350033668700015004,350033668700000009,350033668700015007,350033668700015101,350033668700000010,350033668700015013,350033668700000011,350033668700015018,350033668700015102,350033668700015208,350033668700015176,350033668700015021,350033668700000013,350033668700015103,350033668700015177,350033668700015194,350033668700000014,350033668700000015,350033668700015028,350033668700000016,350033668700015029,350033668700015104,350033668700000017,350033668700015178,350033668700015209,350033668700015032,350033668700000018,350033668700015158,350033668700000019,350033668700000062,350033668700000020,350033668700015197,350033668700000021,350033668700015109,350033668700000022,350033668700015043,350033668700000024,350033668700015113,350033668700000025,350033668700015162,350033668700000027,350033668700015199,350033668700000028,350033668700015049,350033668700015054,350033668700000030,350033668700015055,350033668700000031,350033668700015058,350033668700000116,350033668700000032,350033668700015166,350033668700000033,350033668700000076,350033668700015062,350033668700000034,350033668700015200,350033668700000035,350033668700000035,350033668700015068,350033668700000036,350033668700015071,350033668700000037,350033668700000038,350033668700000081,350033668700000039,350033668700015077,350033668700015171,350033668700000040,350033668700015079,350033668700000041,350033668700015188,350033668700015083,350033668700000043,350033668700000044,350033668700015086,350033668700015090,350033668700000045,350033668700015093,350033668700000046,350033668700000047,350033668700000047	0-48,0-93,0-42,0-75,0-48,0-45,6-51,0-48,0-45,0-45,0-45,0-48,0-48,0-48,0-48,0-48,0-45,0-228,0-45,0-48,0-45,0-147,3-147,0-48,0-45,0-45,0-48,0-48,0-48,24-114,0-45,0-90,0-81,0-48,0-45,0-48,0-45,0-44,0-42,0-48,0-42,0-45,0-45,0-48,0-45,0-45,0-45,0-45,0-45,0-45,0-42,0-45,0-45,0-42,0-45,0-45,0-45,0-42,0-45,0-45,0-42,0-47,0-45,0-45,0-45,0-42,0-42,0-45,0-42,0-45,0-45,0-45,0-48,0-48,0-45,0-45,0-42,0-45,0-42,0-45,0-45,0-42,0-48,0-45,0-45,0-43,0-45,0-42,0-19,0-19						US Patent # 7,417,117. Genetically modified cyclic-nucleotide controlled ion channels and the use thereof - Patents.com	www.patents.com	0	0		
751	chrX	21818264	21818345	3500173556	81		21818264	21818345	8421504	1	81	0	p	350017355600015030	0-81						EpacisaRap1guanine- nucleotide-exchangefactor directlyactivatedby cyclicAMP	mcr.umcutrecht.nl	0	0		CNGA2
753	chrX	22073063	22073091	3500383796	25		22073063	22073091	8421504	2	14,11	0,17	g	350038379600000094	9-34						Molecular Antigen Array	Renner	2011	0		
94	chrX	22200899	22343551	3500240668	1476		22200899	22343551	8421504	9	333,212,153,144,83,221,68,122,140	0,13661,18354,40000,53320,76710,96288,126055,142512	p	350024066800015024	0-1476						Cell lines expressing gaba receptor and methods using them	Langer	2010	0		GABRA3
94	chrX	22200899	22343551	3500234175	1476		22200899	22343551	8421504	9	333,212,153,144,83,221,68,122,140	0,13661,18354,40000,53320,76710,96288,126055,142512	p	350023417500015003	0-1476						KEGG T01001: 200959	www.genome.jp	0	0		GABRA3
94	chrX	22200899	22343551	3500212177	1476		22200899	22343551	8421504	9	333,212,153,144,83,221,68,122,140	0,13661,18354,40000,53320,76710,96288,126055,142512	p	350021217700015000	0-1476						KEGG T01001: 2556	www.genome.jp	0	0		GABRA3
94	chrX	22200899	22343551	3500131639	1476		22200899	22343551	8421504	9	333,212,153,144,83,221,68,122,140	0,13661,18354,40000,53320,76710,96288,126055,142512	p	350013163900015021	0-1476						Cell lines expressing gaba receptor and methods using them	Langer	2011	0		GABRA3
755	chrX	22304777	22304802	3500154222	23		22304777	22304802	8421504	2	7,16	0,9	g	350015422200000085	0-23						Molekularbiologische Untersuchungen der Ebola-Viren Zaire und Reston mit Hilfe reverser Genetik	ub.uni-marburg.de	0	0		
755	chrX	22366433	22368967	3500228010	97		22366433	22368967	8421504	3	55,21,21	0,60,2513	c,g	350022801000000065,350022801000000113,350022801000000113,350022801000000112,350022801000000112	0-76,0-21,0-21,0-21,0-21						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION	Hata	2009	0		MIR767
755	chrX	22366433	22368967	3500125620	102		22366433	22368967	8421504	2	81,21	0,2513	c,g	350012562000000201,350012562000000226,350012562000000226,350012562000000065,350012562000000113,350012562000000113,350012562000000283,350012562000000211,350012562000000225,350012562000000225,350012562000000112,350012562000000112	0-81,0-21,0-21,0-76,0-21,0-21,0-75,0-23,0-21,0-21,0-21,0-21						SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION - Patent application	www.faqs.org	0	0		MIR767
755	chrX	22366479	22366502	3500351709	23		22366479	22366502	8421504	1	23	0	c,g	350035170900000001,350035170900000001	0-23,0-23		21683814	10.1016/j.bbagrm.2011.05.015		Biochimica et biophysica acta	Drosha processing controls the specificity and efficiency of global microRNA expression	Yong	2011	0		MIR767
755	chrX	22366479	22366502	3500322980	23		22366479	22366502	8421504	1	23	0	c	350032298000000005	0-23						AD (Leave blank)	handle.dtic.mil	0	0		MIR767
755	chrX	22366479	22366502	3500114594	23		22366479	22366502	8421504	1	23	0	c,g	350011459400000832,350011459400000832,350011459400000405,350011459400000405	0-23,0-23,0-23,0-23						MicroRNAs for Modulating Herpes Virus Gene Expression - Patent application	www.faqs.org	0	0		MIR767
755	chrX	22366479	22366502	3500031979	23		22366479	22366502	8421504	1	23	0	c,g	350003197900000320,350003197900000320	0-23,0-23						Aimp2-dx2 Gene And Sirna Targeting Aimp2-dx2 	.freshpatents.com	0	0		MIR767
755	chrX	22367975	22367998	3500437914	23		22367975	22367998	8421504	1	23	0	c	350043791400000006	0-23						Human SP-A1 (SFTPA1) variant-speci&#xfb01;c 3 UTRs and poly(A) tail differentially affect the in vitro translation of a reporter gene	ng.physiology.org	0	0		MIR767
757	chrX	22642918	22643405	3500210532	23		22642918	22643405	8421504	2	17,6	0,481	c	350021053200000053	0-23						Different Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T Lymphocytes	u.diva-portal.org	0	0		
758	chrX	22716520	22720086	3500390472	516		22716520	22720086	8421504	5	87,138,129,159,3	0,505,2101,2489,3563	p	350039047200015173,350039047200015169,350039047200015143	0-273,0-273,0-243						Characterizing components of the Dictyostelium centrosome	b.uni-muenchen.de	0	0		CETN2
758	chrX	22716565	22717061	3500360412	78		22716565	22717061	8421504	2	42,36	0,460	p	350036041200015000	0-78		11279143	10.1074/jbc.M100855200	0021-9258	Journal of Biological Chemistry	Centrosome Protein Centrin 2/Caltractin 1 Is Part of the Xeroderma Pigmentosum Group C Complex That Initiates Global Genome Nucleotide Excision Repair	Araki	2001	5		
762	chrX	23229390	23229413	3500240802	23		23229390	23229413	8421504	1	23	0	c	350024080200000010	7-30		17071617	10.1074/jbc.M601362200	0021-9258	Journal of Biological Chemistry	Inhibition of Bone Morphogenetic Protein 1 by Native and Altered Forms of &#x03b1;2-Macroglobulin	Zhang	2006	5		
762	chrX	23229874	23229897	3500207027	23		23229874	23229897	8421504	1	23	0	c	350020702700000006	0-23						Keratocyte behavior in three-dimensional photopolymerizable poly(ethylene glycol) hydrogels	pkinsmedicine.org	0	0		
762	chrX	23230914	23231437	3500301077	23		23230914	23231437	8421504	2	16,7	0,516	c	350030107700000012	0-23						Trabajo Fin de M&#xe1;ster	zaguan.unizar.es	0	0		BGN
762	chrX	23231528	23232101	3500302816	216		23231528	23232101	8421504	3	13,94,109	0,268,464	p	350030281600015027	654-870						Universit&#xe9; de Reims-Champagne Ardenne 2009 N&#xb0; THESE DIPLOME DE DOCTORAT DE L'UNIVERSITE DE REIMS-CHAMPAGNE ARDENNE	ses.univ-reims.fr	0	0		
762	chrX	23231796	23232082	3500444204	40		23231796	23232082	8421504	2	20,20	0,266	c,g	350044420400000002,350044420400000003,350044420400000003	0-20,0-20,0-20						Modulation of keratocyte phenotype by collagen fibril nanoarchitecture in membranes for corneal repair	.johnshopkins.edu	0	0		
762	chrX	23231796	23232082	3500153648	40		23231796	23232082	8421504	2	20,20	0,266	c,g	350015364800000020,350015364800000021,350015364800000021	0-20,0-20,0-20						&#x201c;Desarrollo de un Implante de CMM Modificadas Gen&#xe9;ticamente para Reemplazo de Cart&#xed;lago&#x201d;	eprints.uanl.mx	0	0		
762	chrX	23232129	23233542	3500436718	24		23232129	23233542	8421504	3	2,5,17	0,1390,1396	c	350043671800000002	17-41		16908595	10.1158/1541-7786.MCR-05-0240	1541-7786	Molecular Cancer Research	Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress	Kokkinakis	2006	4		
762	chrX	23232129	23233542	3500190548	24		23232129	23233542	8421504	3	2,5,17	0,1390,1396	c	350019054800000002	17-41		16908595	10.1158/1541-7786.MCR-05-0240	1541-7786	Molecular Cancer Research	Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress	Kokkinakis	2006	4		
763	chrX	23366680	23367094	3500064535	45		23366680	23367094	8421504	2	23,22	0,392	c	350006453500000009,350006453500000015	0-23,0-22						Notch Signaling Suppresses p38 MAPK Activity via Induction of MKP-1 in Myogenesis--&#x300a;&#x751f;&#x7269;&#x7269;&#x7406;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;--&#x9996;&#x5e2d;&#x533b;&#x5b66;&#x7f51;	journal.9med.net	0	0		DUSP4,DUSP7
763	chrX	23401300	23427794	3500005314	40		23401300	23427794	8421504	4	5,15,8,12	0,6,26473,26482	c	350000531400000648,350000531400000454	22-42,2-22						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
763	chrX	23424458	23428895	3500347225	98		23424458	23428895	8421504	4	35,21,21,21	0,3642,4319,4416	c,g	350034722500000001,350034722500000000,350034722500000006,350034722500000008,350034722500000007,350034722500000007	0-35,0-35,0-21,0-21,0-21,0-21		11598117	10.1074/jbc.M107137200	0021-9258	Journal of Biological Chemistry	Cysteine 144 in the Third Transmembrane Domain of the Creatine Transporter Is Located Close to a Substrate-binding Site	Dodd	2001	5		
763	chrX	23424459	23424483	3500414419	24		23424459	23424483	8421504	1	24	0	c	350041441900000001	0-24		11171559			American Journal of Physiology - Cell Physiolog	Creatine transporter protein content, localization, and gene expression in rat skeletal muscle	Murphy	2001	0		SLC6A10P
763	chrX	23424459	23424483	3500058092	24		23424459	23424483	8421504	1	24	0	c	350005809200000001	0-24		11171559			American Journal of Physiology - Cell Physiolog	Creatine transporter protein content, localization, and gene expression in rat skeletal muscle	Murphy	2001	0		SLC6A8
763	chrX	23427201	23427356	3500156769	30		23427201	23427356	8421504	2	26,4	0,151	c	350015676900000001	19-49						M&#xe9;moire de th&#xe8;se	esups.ups-tlse.fr	0	0		SLC6A8
763	chrX	23452264	23454024	3500222901	1760		23452264	23454024	8421504	1	1760	0	g	350022290100000068,350022290100000067	0-1721,9-48						US Patent # 5,652,131. Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods - Patents.com	www.patents.com	0	0		
763	chrX	23452264	23453985	3500202465	1721		23452264	23453985	8421504	1	1721	0	g	350020246500000065	0-1721						US Patent # 5,702,936. Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods - Patents.com	www.patents.com	0	0		
763	chrX	23452264	23453985	3500127829	1705		23452264	23453985	8421504	2	25,1680	0,41	g	350012782900000061	0-1705						 Antibodies To CGMP 	www.docstoc.com	0	0		
764	chrX	23584805	23585406	3500062902	102		23584805	23585406	8421504	4	58,12,11,21	0,450,566,580	p	350006290200015013	3-105						neuer Funktionen der	ub.uni-hamburg.de	0	0		
765	chrX	23594474	23597656	3500278963	24		23594474	23597656	8421504	3	2,15,7	0,529,3175	c	350027896300000002	13-37		18701456	10.1074/jbc.M804991200		The Journal of Biological Chemistry	Kinetic Analysis of L1 Homophilic Interaction: ROLE OF THE FIRST FOUR IMMUNOGLOBULIN DOMAINS AND IMPLICATIONS ON BINDING MECHANISM*	Ricardo	2008	0		
765	chrX	23682401	23688758	3500022796	60		23682401	23688758	8421504	3	20,20,20	0,415,6337	c,g	350002279600000011,350002279600000010,350002279600000010,350002279600000000,350002279600000000	0-20,0-20,0-20,0-20,0-20						Cloning and radiation hybrid mapping of bovine toll-like receptor-4 (TLR-4) signaling molecules	ddr.nal.usda.gov	0	0		
765	chrX	23687576	23687976	3500228810	38		23687576	23687976	8421504	3	1,18,19	0,248,381	c	350022881000000011,350022881000000010	0-19,0-19						Expression analysis of regulatory MicroRNA in bovine cumulus oocyte complex and preimplantation embryos	s.ulb.uni-bonn.de	0	0		
765	chrX	23688527	23688750	3500379004	40		23688527	23688750	8421504	3	11,9,20	0,134,203	c,g	350037900400000013,350037900400000012,350037900400000012	0-20,0-20,0-20						Adaptation to High Grain Diets Proceeds Through Minimal Immune System Stimulation and Differences in Extracellular Matrix Protein Expression in A Model of Subacute Ruminal Acidosis in Non-lactating Dairy Cows	thescipub.com	0	0		
765	chrX	23688527	23688750	3500249098	40		23688527	23688750	8421504	3	11,9,20	0,134,203	c,g	350024909800000011,350024909800000010,350024909800000010	0-20,0-20,0-20						A CHARACTERIZATION OF INFLAMMATORY AND STRUCTURAL MARKERS WITHIN THE RUMEN EPITHELIUM DURING GRAIN-INDUCED RUMINAL ACIDOSIS IN	thescipub.com	0	0		
765	chrX	23691396	23697738	3500447534	94		23691396	23697738	8421504	4	21,26,20,27	0,143,6180,6315	c,g	350044753400000025,350044753400000025,350044753400000024,350044753400000015,350044753400000015,350044753400000014,350044753400000014	0-21,0-21,0-26,0-20,0-20,0-27,0-27						METHOD OF INHIBITING FIBROGENESIS AND TREATING FIBROTIC DISEASE	Mann	2010	0		
765	chrX	23691414	23691437	3500237963	23		23691414	23691437	8421504	1	23	0	c,g	350023796300000019,350023796300000019	13-39,13-39						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
765	chrX	23699770	23699827	3500372906	57		23699770	23699827	8421504	1	57	0	p	350037290600015000	0-57						Homologous pairing of 15q11&#x2013;13 imprinted domains in brain is developmentally regulated but de&#xfb01;cient in Rett and autism samples	lelab.ucdavis.edu	0	0		MECP2
765	chrX	23699770	23699827	3500071490	57		23699770	23699827	8421504	1	57	0	p	350007149000015003	0-57						Human Molecular Genetics	005.pasteur.ac.ir	0	0		MECP2
765	chrX	23700250	23701973	3500396971	240		23700250	23701973	8421504	5	60,60,60,19,41	0,63,519,582,1682	p	350039697100015015,350039697100015014,350039697100015013,350039697100015012	0-60,0-60,0-60,0-60						Bioinformatyka	amu.edu.pl/~ewas/	0	0		MECP2
765	chrX	23700250	23701973	3500279470	240		23700250	23701973	8421504	5	60,60,60,19,41	0,63,519,582,1682	p	350027947000015015,350027947000015014,350027947000015013,350027947000015012	0-60,0-60,0-60,0-60						Bioinformatyka	.staff.amu.edu.pl	0	0		MECP2
765	chrX	23700301	23700331	3500175562	30		23700301	23700331	8421504	1	30	0	c	350017556200000001	11-41						Generation and characterization of rat and mouse monoclonal antibodies specific for MeCP2 and their use in X-inactivation studies. - ResearchGate	.researchgate.net	0	0		MECP2
95	chrX	23700529	23751883	3500455006	306		23700529	23751883	8421504	5	180,28,35,1,62	0,1726,46137,46260,51292	p	350045500600015015,350045500600015002	0-180,0-144						&#x0e01;&#x0e32;&#x0e23;&#x0e15;&#x0e23;&#x0e27;&#x0e08;&#x0e01;&#x0e23;&#x0e2d;&#x0e07;&#x0e01;&#x0e32;&#x0e23;&#x0e01;&#x0e25;&#x0e32;&#x0e22;&#x0e1e;&#x0e31;&#x0e19;&#x0e18;&#x0e38;&#xf70e;&#x0e02;&#x0e2d;&#x0e07;&#x0e22;&#x0e35;&#x0e19; MECP2gene in T	c2.clib.psu.ac.th	0	0		
95	chrX	23700675	23746692	3500454732	52		23700675	23746692	8421504	2	26,26	0,45991	c	350045473200000007,350045473200000006	0-26,0-26		11689684	10.1128/MCB.21.23.7913-7922.2001	0270-7306	Molecular and Cellular Biology	Methylation-Mediated Proviral Silencing Is Associated with MeCP2 Recruitment and Localized Histone H3 Deacetylation	Lorincz	2001	6		
765	chrX	23700691	23701963	3500204964	41		23700691	23701963	8421504	2	21,20	0,1252	c	350020496400000010,350020496400000009	0-21,0-20						CHARACTERIZATION OF PORCINE ADIPOSE TISSUE-DERIVED STEM CELLS	etd.lsu.edu	0	0		
95	chrX	23702280	23751839	3500386132	41		23702280	23751839	8421504	4	3,19,1,18	0,44386,44509,49541	c	350038613200000000,350038613200000002	0-22,0-19		19333917	10.1002/art.24360		Arthritis and rheumatism	Variants within MECP2, a key transcriptional regulator, are associated with increased susceptibility to lupus and differential gene expression in lupus patients	Ryan	2009	0		MECP2,OPN1LW
766	chrX	23796335	23797716	3500150999	30		23796335	23797716	8421504	2	15,15	0,1366	c	350015099900000023,350015099900000022	0-30,0-30						Variations in Opsin Coding Sequences Cause X-Linked Cone Dysfunction Syndrome with Myopia and Dichromacy	www.iovs.org	0	0		
767	chrX	23881233	23881558	3500087133	42		23881233	23881558	8421504	2	21,21	0,304	c,g	350008713300000006,350008713300000006,350008713300000007	0-21,0-21,0-21		19755153	10.1016/j.cellsig.2009.09.002		Cellular signalling	PHOSPHOTYROSINE PROTEIN DYNAMICS IN CELL MEMBRANE RAFTS OF SPHINGOSINE-1-PHOSPHATE-STIMULATED HUMAN ENDOTHELIUM: ROLE IN BARRIER ENHANCEMENT	Jing	2009	0		FLNA
767	chrX	23893344	23894096	3500221165	147		23893344	23894096	8421504	2	123,24	0,728	p	350022116500015037,350022116500015018,350022116500015019	0-147,0-60,0-57						A high molecular mass protein isolated from chicken gizzard: its localization at the dense plaques and dense bodies of smooth muscle and the Z-disks of skeletal muscle	cs.biologists.org	0	0		FLNA
767	chrX	23900046	23900115	3500018435	69		23900046	23900115	8421504	1	69	0	p	350001843500015001	0-69						Differential Protein Expression Profiling by iTRAQ-Two-dimensional LC-MS/MS of Human Bladder Cancer EJ138 Cells Transfected with the Metastasis Suppressor KiSS-1	www.mcponline.org	0	0		FLNA
767	chrX	23967950	23969530	3500332178	101		23967950	23969530	8421504	6	11,20,16,15,19,20	0,14,532,551,1538,1560	c,g	350033217800000000,350033217800000001,350033217800000002,350033217800000003,350033217800000004,350033217800000004,350033217800000005,350033217800000005	0-31,0-31,0-31,0-31,0-39,0-39,0-39,0-39						ScienceDirect.com - Molecular Cell - The Stress-Induced MAP Kinase p38 Regulates Endocytic Trafficking via the GDI:Rab5 Complex	sciencedirect.com	0	0		
767	chrX	23973383	23973411	3500236647	23		23973383	23973411	8421504	2	15,8	0,20	c	350023664700000113	0-34					Patent	Polyhydroxyalkanoate-containing structure and manufacturing method thereof (Patent US:6951745)	Honma	2005	0		
767	chrX	23973383	23973411	3500128423	23		23973383	23973411	8421504	2	15,8	0,20	c	350012842300000113	0-34						Polyhydroxyalkanoate-containing structure and manufacturing method thereof - US Patent 6951745 Description	ww.patentstorm.us	0	0		
767	chrX	23973383	23973411	3500008674	23		23973383	23973411	8421504	2	15,8	0,20	c	350000867400000113	0-34						 Polyhydroxyalkanoate 	www.docstoc.com	0	0		
768	chrX	24029745	24029773	3500137185	23		24029745	24029773	8421504	2	14,9	0,19	g	350013718500000004	26-49						2004 ANIMAL GENETIC RESOURCES INFORMATION	tr.ilri.cgiar.org	0	0		
768	chrX	24040113	24040545	3500414028	42		24040113	24040545	8421504	2	22,20	0,412	c,g	350041402800000033,350041402800000032	0-22,0-20						Ganjam virus/Nairobi sheep disease virus induces a pro-inflammatory response in infected sheep	biomedcentral.com	0	0		
768	chrX	24040305	24040471	3500418753	42		24040305	24040471	8421504	2	20,22	0,144	c,g	350041875300000009,350041875300000008	0-20,0-22						Structural and functional analysis of the ovine laminin receptor gene (RPSA): Possible involvement of the LRP/LR protein in scrapie response. - ResearchGate	.researchgate.net	0	0		
768	chrX	24040493	24040619	3500270805	126		24040493	24040619	8421504	1	126	0	p	350027080500015004	0-126						mutants	www.pnas.org	0	0		G6PD
768	chrX	24040625	24040783	3500131417	60		24040625	24040783	8421504	2	59,1	0,157	p	350013141700015014	24-84						Evidence G6pd in the Drosophila melanogaster and Drosophila	docente.unife.it	0	0		G6PD
768	chrX	24040669	24040792	3500361209	25		24040669	24040792	8421504	2	15,10	0,113	c	350036120900000002	87-112						Temporal Divergence in the Pattern of Messenger RNA Expression in Bovine Embryos Cultured from the Zygote to Blastocyst Stage In Vitro or In Vivo	ww.biolreprod.org	0	0		
768	chrX	24040793	24040816	3500233640	23		24040793	24040816	8421504	1	23	0	c	350023364000000013	0-23						Gene silencing during development of in vitro-produced female bovine embryos	w.funpecrp.com.br	0	0		
768	chrX	24040800	24040824	3500365295	24		24040800	24040824	8421504	1	24	0	g	350036529500000011	0-24						1 BIOLOGICAL DIFFERENCES BETWEEN IN VITRO PRODUCED BOVINE 2 EMBRYOS AND PARTHENOTES	uction-online.org	0	0		
768	chrX	24041383	24041408	3500214533	25		24041383	24041408	8421504	1	25	0	c	350021453300000003	0-25						First-Generation Linkage Map of the Gray, Short-Tailed Opossum, Monodelphis domestica, Reveals Genome-Wide Reduction in Female Recombination Rates--&#x300a;&#x9057;&#x4f20;&#x5b66;&#x6742;&#x5fd7;&#x300b;--&#x533b;&#x5b66;&#x671f;&#x520a;&#x9891;&#x9053;-	journal.9med.net	0	0		
768	chrX	24041946	24042046	3500301078	42		24041946	24042046	8421504	2	21,21	0,79	c,g	350030107800000128,350030107800000128,350030107800000127	0-21,0-21,0-21						TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN RESPONSE TO ENERGY OVERFEEDING PENG JI	eals.illinois.edu	0	0		
768	chrX	24042091	24047378	3500006584	85		24042091	24047378	8421504	3	9,57,19	0,5187,5268	c	350000658400000034,350000658400000018	11-77,0-19						Regulation of Milk Fat Synthesis in Bovine Mammary Gland 	www.docstoc.com	0	0		
768	chrX	24047977	24048022	3500252912	45		24047977	24048022	8421504	1	45	0	p	350025291200015003	0-45						Molecular cloning and characterization of cDNA encoding Camelus dromedarius putative glucose 6- phosphate dehydrogenase	demicjournals.org	0	0		
768	chrX	24102568	24102596	3500011388	23		24102568	24102596	8421504	2	16,7	0,21	g	350001138800000096	8-34						Vaccine and antitoxin for the treatment of C. difficile disease	Kink	1997	0		
771	chrX	24407786	24407812	3500221585	26		24407786	24407812	8421504	1	26	0	c	350022158500000010,350022158500000012	0-25,13-33		21151919	10.1371/journal.pone.0014238	1932-6203	PLOS ONE	PLOS ONE: Fusogenic Pairings of Vesicle-Associated Membrane Proteins (VAMPs) and Plasma Membrane t-SNAREs &#x2013; VAMP5 as the Exception	Hasan	2010	4		
96	chrX	24414419	24570371	3500391891	480		24414419	24570371	8421504	7	24,138,91,68,75,18,66	0,5317,17334,140249,152728,152804,155886	p	350039189100015013,350039189100015014	0-180,873-1890						Crosstalk and Integration of Membrane Trafficking Pathways	www.scribd.com	0	0		
96	chrX	24431843	24567174	3500122558	93		24431843	24567174	8421504	4	1,47,18,27	0,122825,122875,135304	p	350012255800015258	0-93						US Patent # 7,399,607. Fluorescence polarization assays for determining clostridial toxin activity - Patents.com	www.patents.com	0	0		VAMP7
772	chrX	24567216	24567241	3500329268	24		24567216	24567241	8421504	2	6,18	0,7	c	350032926800000022	12-36						 HOPM1 Mediated Disease Resistance To Pseudomonas Syringae In Arabidopsis 	www.docstoc.com	0	0		
772	chrX	24570348	24570374	3500221585	26		24570348	24570374	8421504	1	26	0	c	350022158500000013,350022158500000011	10-36,0-26		21151919	10.1371/journal.pone.0014238	1932-6203	PLOS ONE	PLOS ONE: Fusogenic Pairings of Vesicle-Associated Membrane Proteins (VAMPs) and Plasma Membrane t-SNAREs &#x2013; VAMP5 as the Exception	Hasan	2010	4		
779	chrX	25529153	25529179	3500196340	23		25529153	25529179	8421504	2	13,10	0,16	g	350019634000000182	5-28						US Patent # 7,189,841. Method for tapping the immunological repertoire - Patents.com	www.patents.com	0	0		
795	chrX	27633854	27633882	3500300591	24		27633854	27633882	8421504	2	6,18	0,10	g	350030059100000271	13-40						Novel Plant Acyltransferases Specific For Long-Chained, Multiply Unsaturated Fatty Acids - Patent application	www.faqs.org	0	0		
796	chrX	27722351	27722378	3500011328	25		27722351	27722378	8421504	2	7,18	0,9	g	350001132800000217	13-40						US Patent # 7,119,183. Rapid immunoselection cloning method - Patents.com	www.patents.com	0	0		
797	chrX	27878064	27878091	3500114509	25		27878064	27878091	8421504	2	17,8	0,19	g	350011450900000030	0-25						&#x4e3b;&#x9898;&#xff1a;Exon | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		
797	chrX	27890599	27890622	3500237963	23		27890599	27890622	8421504	1	23	0	g	350023796300000018,350023796300000242	3-26,3-26						Proteins and polypeptides from coagulaslase-negative staphylococci - US Patent 7473762 Description	ww.patentstorm.us	0	0		
797	chrX	27890599	27890622	3500091510	23		27890599	27890622	8421504	1	23	0	g	350009151000000017,350009151000000033	3-26,3-26					Patent	Polypeptides and polynucleotides from coagulase-negative staphylococci (Patent EP:1117772)	Davis	2012	0		
811	chrX	29707522	29707546	3500300648	24		29707522	29707546	8421504	1	24	0	g	350030064800000059	17-42						Methods and targets for identifying compounds for regulating angiogenesis - Patent application	www.faqs.org	0	0		
813	chrX	29924012	29924036	3500257800	23		29924012	29924036	8421504	2	14,9	0,15	g	350025780000000000	11-34						Bidirectional transcription stimulates expansion and contraction of expanded (CTG) (CAG) repeats	cepearsonlab.com	0	0		
814	chrX	30048320	30048978	3500401207	40		30048320	30048978	8421504	2	20,20	0,638	c,g	350040120700000004,350040120700000004,350040120700000003	0-20,0-20,0-20		16532036	10.1038/sj.onc.1209406	0950-9232	Oncogene	Inhibition of NADPH oxidase 4 activates apoptosis via the AKT&sol;apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells	Mochizuki	2006	6		NOX1
814	chrX	30048320	30048978	3500019411	40		30048320	30048978	8421504	2	20,20	0,638	c,g	350001941100000004,350001941100000004,350001941100000003	0-20,0-20,0-20		16532036	10.1038/sj.onc.1209406	0950-9232	Oncogene	Inhibition of NADPH oxidase 4 activates apoptosis via the AKT&sol;apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells	Mochizuki	2006	6		NOX1
814	chrX	30048370	30048393	3500385398	23		30048370	30048393	8421504	1	23	0	c	350038539800000009	0-23		15150115	10.1158/0008-5472.CAN-03-3909	0008-5472	Cancer Research	The Superoxide-Generating Oxidase Nox1 Is Functionally Required for Ras Oncogene Transformation	Mitsushita	2004	8		
817	chrX	30503543	30504972	3500270054	47		30503543	30504972	8421504	2	24,23	0,1406	c	350027005400000031,350027005400000032	0-24,0-23						EXTRACELLULAR MATRIX SYNTHESIS AND	scovery.ucl.ac.uk	0	0		
817	chrX	30504949	30504972	3500161109	23		30504949	30504972	8421504	1	23	0	c	350016110900000011	24-47						BMC Musculoskeletal Disorders BioMed Central	biomedcentral.com	0	0		
817	chrX	30504998	30505041	3500120768	42		30504998	30505041	8421504	2	23,19	0,24	c	350012076800000015,350012076800000035	0-23,0-19						RESEARCH ARTICLE Open Access	itis-research.com	0	0		
817	chrX	30505628	30505653	3500356284	25		30505628	30505653	8421504	1	25	0	c	350035628400000003	21-46						Effect of Electrospun Mesh Diameter, Mesh Alignment, and Mechanical Stretch on Bone Marrow Stromal Cells for Ligament Tissue Engineering	cholar.lib.vt.edu	0	0		TNMD
818	chrX	30613629	30624728	3500407090	41		30613629	30624728	8421504	4	16,6,14,5	0,20,11078,11094	g	350040709000000809,350040709000000189	10-32,11-30						HIV envelope polypeptides and vaccine	Berman	1997	0		
820	chrX	30818813	30818841	3500144421	28		30818813	30818841	8421504	1	28	0	c	350014442100000001	12-40		21080425	10.1002/pro.546	1469-896X	Protein Science	Highly efficient purification of protein complexes from mammalian cells using a novel streptavidin-binding peptide and hexahistidine tandem tag system: Application to Bruton's tyrosine kinase - Li - 2010 - Protein Science - Wiley Online Library	Li	2011	0		BTK
820	chrX	30818814	30822837	3500376029	360		30818814	30822837	8421504	8	36,30,66,89,7,99,7,26	0,39,2606,2675,3285,3295,3397,3997	p	350037602900015008	12-372						Method of identifying osteoregenerative agents using differential gene expression	Horesovsky	2003	0		BTK
820	chrX	30829824	30830198	3500137122	57		30829824	30830198	8421504	2	41,16	0,358	p	350013712200015000	0-57						The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils	changlab.ucsd.edu	0	0		BTK
820	chrX	30829840	30839370	3500439691	40		30829840	30839370	8421504	2	20,20	0,9510	c	350043969100000001,350043969100000000	0-20,0-20						Method to Identify CD40-Sensitive Cells Using Gene Expression	Hollmann	2007	0		BTK
820	chrX	30829840	30839370	3500398631	40		30829840	30839370	8421504	2	20,20	0,9510	c	350039863100000001,350039863100000000	0-20,0-20						Method to identify cd40-sensitive cells	Hollmann	2008	0		BTK
820	chrX	30829840	30839370	3500374015	40		30829840	30839370	8421504	2	20,20	0,9510	c,g	350037401500000001,350037401500000001,350037401500000013,350037401500000000	0-20,0-20,0-20,0-20						Method to Identify CD40-Sensitive Cells Using Gene Expression - Patent application	www.faqs.org	0	0		BTK
820	chrX	30829840	30839370	3500070232	40		30829840	30839370	8421504	2	20,20	0,9510	c,g	350007023200000001,350007023200000001,350007023200000000	0-20,0-20,0-20						Method to identify cd40-sensitive cells using gene expression	Hollmann	2007	0		BTK
820	chrX	30843406	30843490	3500183613	84		30843406	30843490	8421504	1	84	0	p	350018361300015054	0-84						Myosin-X associates with regions of dynamic actin	cs.biologists.org	0	0		BTK
820	chrX	30856750	30859500	3500241621	300		30856750	30859500	8421504	4	3,106,68,123	0,414,726,2627	p	350024162100015000,350024162100015001,350024162100015002,350024162100015003,350024162100015004	0-60,0-60,0-60,0-60,0-60						Homo sapiens ribosomal protein L36a-like (RPL36AL), mRNA. , NM_001001.3 - GenScript	www.genscript.com	0	0		GLA,BTK
820	chrX	30868599	30870514	3500167679	184		30868599	30870514	8421504	5	28,12,48,48,48	0,586,605,701,1867	c	350016767900000015,350016767900000014,350016767900000012,350016767900000009	7-47,0-48,0-48,0-48					Patent	Cloning and expression of biologically active human &#x03b1;-galactosidase A (Patent US:5356804)	Bishop	1994	0		
820	chrX	30869204	30870514	3500270555	144		30869204	30870514	8421504	3	48,48,48	0,96,1262	c	350027055500000019,350027055500000017,350027055500000014	0-48,0-48,0-48					Patent	Cloning and expression of biologically active &#x03b1;-galactosidase A as a fusion protein (Patent US:5580757)	Bishop	1996	0		
820	chrX	30869204	30870514	3500152881	179		30869204	30870514	8421504	4	48,48,35,48	0,96,1220,1262	c	350015288100000019,350015288100000017,350015288100000015,350015288100000014	0-48,0-48,7-42,0-48						Cloning and expression of biologically active .alpha.-galactosidase A as a fusion protein - Patent # 5580757 - PatentGenius	.patentgenius.com	0	0		
820	chrX	30869204	30869348	3500332242	96		30869204	30869348	8421504	2	48,48	0,96	c	350033224200000015,350033224200000013	0-48,0-48						Cloning and expression of biologically active alpha-galactosidase a	Bishop	1994	0		
820	chrX	30869204	30869348	3500206857	96		30869204	30869348	8421504	2	48,48	0,96	c	350020685700000014,350020685700000012	0-48,0-48						US Patent # 5,356,804. Cloning and expression of biologically active human .alpha.-galactosidase A - Patents.com	www.patents.com	0	0		
822	chrX	31083163	31083832	3500109864	46		31083163	31083832	8421504	2	23,23	0,646	c	350010986400000000,350010986400000001	0-23,0-23		19304657	10.1074/jbc.M901177200	0021-9258	Journal of Biological Chemistry	The Armadillo Repeat-containing Protein, ARMCX3, Physically and Functionally Interacts with the Developmental Regulatory Factor Sox10	Mou	2009	5		ARMCX3
822	chrX	31107046	31107070	3500454707	24		31107046	31107070	8421504	1	24	0	c	350045470700000047	0-24						Methods and kits for investigating cancer	Munnes	2008	0		ARMCX2
822	chrX	31107046	31107070	3500400698	24		31107046	31107070	8421504	1	24	0	c	350040069800000047	0-24						Methods and kits for investigating cancer	Munnes	2008	0		ARMCX2
822	chrX	31110294	31110319	3500142579	25		31110294	31110319	8421504	1	25	0	g	350014257900000003	19-45			10.1128/JVI.01788-07		Journal of Virology	Crystal Structure of the NS3 Protease-Helicase from Dengue Virus 	Dahai	2008	0		
825	chrX	31530802	31530828	3500154217	23		31530802	31530828	8421504	2	10,13	0,13	g	350015421700000013	7-30						POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH	Krasnoperov	2010	0		
827	chrX	31741200	31741225	3500421413	25		31741200	31741225	8421504	1	25	0	c	350042141300000013	8-33						Charakterisierung von Tight Junction-Proteinen mit Hilfe eukaryontischer und prokaryontischer Expressionssysteme	diss.fu-berlin.de	0	0		
829	chrX	31995418	31995445	3500416780	24		31995418	31995445	8421504	3	13,5,6	0,15,21	g	350041678000000094	4-30						Gamma-iterferon-leukotoxin gene fusions and uses thereof	Potter	1991	0		
832	chrX	32391034	32391062	3500095165	25		32391034	32391062	8421504	2	20,5	0,23	g	350009516500000104	8-39						Chromosome 13-linked breast cancer susceptibility gene		1997	0		
842	chrX	33754847	33754871	3500089194	23		33754847	33754871	8421504	2	19,4	0,20	c	350008919400000086	17-40						Antibodies That Bind M. Tuberculosis Polypeptides 	.freshpatents.com	0	0		
842	chrX	33765994	33766018	3500010197	23		33765994	33766018	8421504	2	19,4	0,20	g	350001019700000112	6-29						Epiligrin, an epithelial ligand for integrins	Carter	1996	0		
845	chrX	34129144	34129167	3500343421	23		34129144	34129167	8421504	1	23	0	c	350034342100000197	25-48						NOVEL NUCLEIC ACID SEQUENCES AND THEIR USE IN METHODS FOR ACHIEVING PATHOGEN RESISTANCE IN PLANTS - Patent application	www.faqs.org	0	0		RAB9B
845	chrX	34169378	34172250	3500378680	38		34169378	34172250	8421504	2	19,19	0,2853	c,g	350037868000000001,350037868000000001,350037868000000000,350037868000000000	0-19,0-19,0-19,0-19		11333359	10.1097/00004647-200105000-00003	0271-678X	Journal of Cerebral Blood Flow & Metabolism	Insulin-like Growth Factor-1 Reduces Postischemic White Matter Injury in Fetal Sheep	Guan	2001	5		PLP1
845	chrX	34169378	34172250	3500366882	38		34169378	34172250	8421504	2	19,19	0,2853	c,g	350036688200000001,350036688200000001,350036688200000000,350036688200000000	0-19,0-19,0-19,0-19						Compositions and methods for the rescue of white matter	Guan	2001	0		PLP1
845	chrX	34169378	34172250	3500213618	38		34169378	34172250	8421504	2	19,19	0,2853	c,g	350021361800000001,350021361800000001,350021361800000000,350021361800000000	0-19,0-19,0-19,0-19						Compositions and methods for the rescue of white matter	Bennet	2003	0		PLP1
845	chrX	34169426	34173355	3500180950	151		34169426	34173355	8421504	5	25,15,63,27,21	0,1394,2157,2809,3908	c	350018095000000016,350018095000000105,350018095000000122,350018095000000130,350018095000000117,350018095000000097	0-25,0-19,0-48,0-48,0-48,0-48						BIOACTIVE PEPTIDES AND UNIQUE IRES ELEMENTS FROM MYELIN PROTEOLIPID PROTEIN PLP/DM20 - Patent application	www.faqs.org	0	0		
845	chrX	34169430	34183962	3500105503	831		34169430	34183962	8421504	7	69,66,74,169,262,187,4	0,1339,2153,2663,3904,5704,14528	p	350010550300015019	0-831						Medical treatment	Champion	2005	0		PLP1
845	chrX	34169430	34169455	3500165512	25		34169430	34169455	8421504	1	25	0	c	350016551200000067	9-34						Bioactive Peptides And Unique Ires Elements From Myelin Proteolipid Protein Plp/dm20 	.freshpatents.com	0	0		
845	chrX	34169456	34173392	3500442906	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350044290600000032,350044290600000031,350044290600000031	0-24,0-21,0-21						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS	Schaebitz	2007	0		PLP1
845	chrX	34169456	34173392	3500436669	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350043666900000033,350043666900000032,350043666900000032	0-24,0-21,0-21						Methods of treating neurological conditions with hematopoietic growth factors	Schaebitz	2004	0		PLP1
845	chrX	34169456	34173392	3500395763	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350039576300000030,350039576300000029,350039576300000029	0-24,0-21,0-21						Treatment of neurological disorders with haematopoietic growth factors	Schneider	2011	0		PLP1
845	chrX	34169456	34173392	3500390379	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350039037900000032,350039037900000031,350039037900000031	0-24,0-21,0-21						Methods of treating neurological conditions with hematopoeitic growth factors	Gassler	2005	0		PLP1
845	chrX	34169456	34173392	3500369296	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350036929600000032,350036929600000031,350036929600000031	0-24,0-21,0-21						Treatment of neurological disorders with hematopoeitic growth factors	Schaebitz	2006	0		PLP1
845	chrX	34169456	34173392	3500339523	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350033952300000032,350033952300000031,350033952300000031	0-24,0-21,0-21						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPEITIC GROWTH FACTORS	Schaebitz	2007	0		PLP1
845	chrX	34169456	34173392	3500330835	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350033083500000030,350033083500000077,350033083500000076,350033083500000076,350033083500000029,350033083500000029	0-24,0-24,0-21,0-21,0-21,0-21					Patent	Treatment of neurological disorders with haematopoietic growth factors (Patent EP:1765381)	Gassler	2010	0		PLP1
845	chrX	34169456	34173392	3500310797	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350031079700000032,350031079700000082,350031079700000031,350031079700000031,350031079700000081,350031079700000081	0-24,0-24,0-21,0-21,0-21,0-21						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS - Patent application	www.faqs.org	0	0		PLP1
845	chrX	34169456	34173392	3500241756	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350024175600000030,350024175600000029,350024175600000029	0-24,0-21,0-21						GCSF for use in treating a neurological disease with pathophysiological mechanisms involving ischemia or hypoxia	Schneider	2011	0		PLP1
845	chrX	34169456	34173392	3500175311	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350017531100000032,350017531100000031,350017531100000031	0-24,0-21,0-21						Methods Of Treating Neurological Conditions With Hematopoeitic Growth Factors 	.freshpatents.com	0	0		PLP1
845	chrX	34169456	34173392	3500148684	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350014868400000030,350014868400000029,350014868400000029	0-24,0-21,0-21						Treatment of neurological disorders with haematopoietic growth factors	Schneider	2011	0		PLP1
845	chrX	34169456	34173392	3500139277	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350013927700000032,350013927700000031,350013927700000031	0-24,0-21,0-21						Methods Of Treating Neurological Conditions With Hematopoeitic Growth Factors 	.freshpatents.com	0	0		PLP1
845	chrX	34169456	34173392	3500044055	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350004405500000032,350004405500000082,350004405500000031,350004405500000031,350004405500000081,350004405500000081	0-24,0-24,0-21,0-21,0-21,0-21						METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS - Patent application	www.faqs.org	0	0		PLP1
845	chrX	34169456	34173392	3500003314	45		34169456	34173392	8421504	2	24,21	0,3915	c,g	350000331400000032,350000331400000031,350000331400000031	0-24,0-21,0-21						Treatment of neurological disorders with haematopoietic growth factors	Schaebitz	2007	0		PLP1
845	chrX	34169483	34175205	3500212659	123		34169483	34175205	8421504	4	22,48,5,48	0,2094,2345,5674	c,g	350021265900000034,350021265900000031,350021265900000020	9-31,0-53,8-56						A point mutation in the proteoiipid protein gene of the 'shaking pup' interrupts oiigodendrocyte development	ev.biologists.org	0	0		
845	chrX	34171584	34171615	3500390858	31		34171584	34171615	8421504	1	31	0	c	350039085800000009	0-31						Transgenic animals lacking proteolipid protein and method of making such animals	Boison	1995	0		
845	chrX	34171584	34171615	3500384433	31		34171584	34171615	8421504	1	31	0	c	350038443300000011	0-31						Transgenic animals lacking proteolipid protein and method of making such animals	Boison	1995	0		
845	chrX	34171635	34172174	3500155527	40		34171635	34172174	8421504	2	20,20	0,519	c	350015552700000007,350015552700000006	0-20,0-20						&#x4e3b;&#x9898;&#xff1a;Cell | &#x533b;&#x6e90;&#x4e16;&#x754c;	www.39kf.com	0	0		PLP1
845	chrX	34171655	34173381	3500443928	48		34171655	34173381	8421504	3	2,22,24	0,438,1702	c	350044392800000021,350044392800000020	0-24,0-24		21957254	10.1523/JNEUROSCI.3343-11.2011		The Journal of neuroscience : the official journal of the Society for Neuroscience	Sox17 regulates the Wnt/beta-catenin signaling pathway in oligodendrocyte progenitor cells	Li-Jin	2011	0		PLP1
845	chrX	34171656	34173480	3500099979	40		34171656	34173480	8421504	3	1,19,20	0,437,1804	c,g	350009997900000037,350009997900000036,350009997900000036	0-20,0-20,0-20		14734521	10.1084/jem.20031677	0022-1007	The Journal of Experimental Medicine	Medullary Epithelial Cells of the Human Thymus Express a Highly Diverse Selection of Tissue-specific Genes Colocalized in Chromosomal Clusters	Gotter	2004	14		PLP1
845	chrX	34171656	34173480	3500099954	40		34171656	34173480	8421504	3	1,19,20	0,437,1804	c,g	350009995400000038,350009995400000037,350009995400000037	0-20,0-20,0-20						Medullary Epithelial Cells of the Human Thymus Express a Highly Diverse Selection of Tissue-speci&#xfb01;c Genes Colocalized in Chromosomal Clusters	jem.rupress.org	0	0		PLP1
845	chrX	34172167	34173593	3500382699	47		34172167	34173593	8421504	2	25,22	0,1404	c	350038269900000025,350038269900000047,350038269900000024,350038269900000046	0-25,0-25,0-22,0-22						EMBRYONIC STEM CELLS AND NEURAL PROGENITOR CELLS DERIVED THEREFROM - Patent application	www.faqs.org	0	0		PLP1
845	chrX	34172167	34173593	3500367987	47		34172167	34173593	8421504	2	25,22	0,1404	c	350036798700000035,350036798700000067,350036798700000066,350036798700000034	0-25,0-25,0-22,0-22						Neural progenitor cells derived from embryonic stem cells - Patent application	www.faqs.org	0	0		PLP1
845	chrX	34172167	34173593	3500287553	47		34172167	34173593	8421504	2	25,22	0,1404	c	350028755300000035,350028755300000034	0-25,0-22						Neural progenitor cells derived from embryonic stem cells	Reubinoff	2012	0		PLP1
845	chrX	34172167	34173593	3500286294	47		34172167	34173593	8421504	2	25,22	0,1404	c	350028629400000025,350028629400000024	0-25,0-22						Embryonic stem cells and neural progenitor cells derived therefrom	Reubinoff	2005	0		PLP1
845	chrX	34172167	34173593	3500281216	47		34172167	34173593	8421504	2	25,22	0,1404	c	350028121600000035,350028121600000034	0-25,0-22					Patent	Neural progenitor cells derived from embryonic stem cells (Patent US:8137969)	Ben-Hur	2012	0		
845	chrX	34172167	34173593	3500271220	47		34172167	34173593	8421504	2	25,22	0,1404	c	350027122000000067,350027122000000035,350027122000000066,350027122000000034	0-25,0-25,0-22,0-22						NEURAL PROGENITOR CELLS DERIVED FROM EMBRYONIC STEM CELLS - Patent application	www.faqs.org	0	0		PLP1
845	chrX	34172167	34173593	3500267076	47		34172167	34173593	8421504	2	25,22	0,1404	c	350026707600000035,350026707600000034	0-25,0-22						Implanting neural progenitor cells derived for human embryonic stem cells - US Patent 7011828 Description	ww.patentstorm.us	0	0		PLP1
845	chrX	34172167	34173593	3500265059	47		34172167	34173593	8421504	2	25,22	0,1404	c	350026505900000075,350026505900000017,350026505900000074,350026505900000016	0-25,0-25,0-22,0-22						CELL CULTURE - Patent application	www.faqs.org	0	0		PLP1
845	chrX	34172167	34173593	3500250771	47		34172167	34173593	8421504	2	25,22	0,1404	c	350025077100000007,350025077100000006	0-25,0-22						Embryonic stem cells and neural progenitor cells derived therefrom	Ben-Hur	2002	0		PLP1
845	chrX	34172167	34173593	3500232870	47		34172167	34173593	8421504	2	25,22	0,1404	c	350023287000000025,350023287000000024	0-25,0-22						Neural progenitor cells derived from embryonic stem cells	Pera	2012	0		PLP1
845	chrX	34172167	34173593	3500229416	47		34172167	34173593	8421504	2	25,22	0,1404	c	350022941600000035,350022941600000034	0-25,0-22					Patent	Neural progenitor cells derived from embryonic stem cells (Patent US:8460931)	Reubinoff	2013	0		PLP1
845	chrX	34172167	34173593	3500218814	47		34172167	34173593	8421504	2	25,22	0,1404	c	350021881400000035,350021881400000034	0-25,0-22					Patent	Implanting neural progenitor cells derived for human embryonic stem cells (Patent US:7011828)	Reubinoff	2006	0		PLP1
845	chrX	34172167	34173593	3500204585	47		34172167	34173593	8421504	2	25,22	0,1404	c	350020458500000025,350020458500000024	0-25,0-22					Patent	Embryonic stem cells and neural progenitor cells derived therefrom (Patent US:7947498)	Reubinoff	2011	0		PLP1
845	chrX	34172167	34173593	3500144853	47		34172167	34173593	8421504	2	25,22	0,1404	c	350014485300000025,350014485300000024	0-25,0-22						Embryonic stem cells and neural progenitor cells derived therefrom	Reubinoff	2012	0		PLP1
845	chrX	34172167	34173593	3500137855	47		34172167	34173593	8421504	2	25,22	0,1404	c	350013785500000025,350013785500000024	0-25,0-22					Patent	Embryonic stem cells and neural progenitor cells derived therefrom (Patent US:7504257)	Reubinoff	2009	0		
845	chrX	34172167	34173593	3500133298	47		34172167	34173593	8421504	2	25,22	0,1404	c	350013329800000035,350013329800000034	0-25,0-22						Neural progenitor cells derived from embryonic stem cells	Reubinoff	2009	0		PLP1
845	chrX	34172167	34173593	3500056801	47		34172167	34173593	8421504	2	25,22	0,1404	c	350005680100000035,350005680100000034	0-25,0-22						Implanting neural progenitor cells derived for human embryonic stem cells	Reubinoff	2001	0		PLP1
845	chrX	34172258	34173370	3500276219	40		34172258	34173370	8421504	2	4,36	0,1076	c	350027621900000063,350027621900000062,350027621900000064,350027621900000100,350027621900000099	6-46,6-46,0-31,51-91,6-46						Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins - Patent application	www.faqs.org	0	0		PLP1
845	chrX	34172258	34173370	3500189667	40		34172258	34173370	8421504	2	4,36	0,1076	c	350018966700000063,350018966700000062,350018966700000064	6-46,6-46,0-31						Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins	Arnason	2008	0		PLP1
845	chrX	34172259	34173370	3500450114	39		34172259	34173370	8421504	2	3,36	0,1075	c	350045011400000012	12-51						Polynucleotide therapy	Fontoura	2002	0		PLP1
845	chrX	34172259	34173370	3500198327	39		34172259	34173370	8421504	2	3,36	0,1075	c	350019832700000012	12-51						Polynucleotide therapy	Fontoura	2002	0		PLP1
845	chrX	34173338	34173370	3500049914	32		34173338	34173370	8421504	1	32	0	c	350004991400000059	12-44						Use of statins and other immunomodulatory agents in the treatment of autoimmune disease	Steinman	2003	0		PLP1
845	chrX	34173339	34173407	3500202769	67		34173339	34173407	8421504	2	45,22	0,46	c	350020276900000020,350020276900000021,350020276900000019	0-21,0-24,0-22						Materials and methods relating to treatment of injury and disease to the central nervous system	Xiao	2007	0		PLP1
845	chrX	34173339	34173407	3500138375	67		34173339	34173407	8421504	2	45,22	0,46	c	350013837500000020,350013837500000042,350013837500000021,350013837500000043,350013837500000019,350013837500000041	0-21,0-21,0-24,0-24,0-22,0-22						Materials and methods relating to treatment of injury and disease to the central nervous system - Patent application	www.faqs.org	0	0		PLP1
845	chrX	34173342	34173367	3500313060	24		34173342	34173367	8421504	2	4,20	0,5	c	350031306000000084	16-40						Gene specific universal mammalian sequence-tagged sites	Brewer	1997	0		
845	chrX	34173398	34175281	3500462417	40		34173398	34175281	8421504	2	20,20	0,1863	c,g	350046241700000007,350046241700000007,350046241700000006	0-20,0-20,0-20					Journal of Clinical & Cellular Immunology	OMICS Publishing Group | Full-text | Regulation of Encephalitogenicity of Neuroantigen-Primed T Cells by Nitric Oxide: Implications for Multiple Sclerosis	Kalipada	2012	0		PLP1
845	chrX	34173398	34175281	3500216646	40		34173398	34175281	8421504	2	20,20	0,1863	c,g	350021664600000033,350021664600000033,350021664600000032	0-20,0-20,0-20		17579047		0022-1767	The Journal of Immunology	Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Modifies T Cells at Multiple Steps and Inhibits Adoptive Transfer of Experimental Allergic Encephalomyelitis	Brahmachari	2007	6		PLP1
845	chrX	34173398	34175281	3500183508	40		34173398	34175281	8421504	2	20,20	0,1863	c,g	350018350800000007,350018350800000007,350018350800000006	0-20,0-20,0-20					Journal of Clinical & Cellular Immunology	OMICS Publishing Group | Full-text | Regulation of Encephalitogenicity of Neuroantigen-Primed T Cells by Nitric Oxide: Implications for Multiple Sclerosis	Kalipada	2012	0		PLP1
845	chrX	34173398	34175281	3500153081	40		34173398	34175281	8421504	2	20,20	0,1863	c,g	350015308100000007,350015308100000007,350015308100000006	0-20,0-20,0-20						Clinical & Cellular Mondal et al., Immunology	w.omicsonline.org	0	0		PLP1
845	chrX	34173398	34175281	3500109657	40		34173398	34175281	8421504	2	20,20	0,1863	c,g	350010965700000007,350010965700000007,350010965700000006	0-20,0-20,0-20						Clinical & Cellular Mondal et al., Immunology	w.omicsonline.org	0	0		PLP1
845	chrX	34173398	34175281	3500018489	40		34173398	34175281	8421504	2	20,20	0,1863	c,g	350001848900000015,350001848900000015,350001848900000014	0-20,0-20,0-20		19342681	10.4049/jimmunol.0801734	0022-1767	The Journal of Immunology	Functional Blocking Monoclonal Antibodies against IL-12p40 Homodimer Inhibit Adoptive Transfer of Experimental Allergic Encephalomyelitis	Mondal	2009	6		PLP1
845	chrX	34173400	34173445	3500104165	45		34173400	34173445	8421504	1	45	0	p	350010416500015245	0-45						The detection and role of human endogenous retroviruses in multiple sclerosis and other neurological diseases	penrepository.com	0	0		PLP1
845	chrX	34173436	34173502	3500316994	66		34173436	34173502	8421504	1	66	0	p	350031699400015021	0-66						Methods and compositions to generate and control the effector profile of t cells	Bot	2007	0		
845	chrX	34173436	34173502	3500062604	66		34173436	34173502	8421504	1	66	0	p	350006260400015021	0-66						Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells	Bot	2008	0		
845	chrX	34175142	34175205	3500466395	63		34175142	34175205	8421504	1	63	0	p	350046639500015025	0-63						Methods of generating antigen-specific CD4+CD25+ regulatory T cells, compositions and methods of use	Buckner	2005	0		PLP1
845	chrX	34183958	34184039	3500398470	43		34183958	34184039	8421504	2	21,22	0,59	c,g	350039847000000002,350039847000000002,350039847000000000,350039847000000000	0-21,0-21,0-22,0-22						ScienceDirect.com - Neuron - Proteolipid Protein Is Necessary in Peripheral as Well as Central Myelin	sciencedirect.com	0	0		PLP1
846	chrX	34255650	34255675	3500349145	23		34255650	34255675	8421504	2	11,12	0,13	g	350034914500000281	3-26						Novel Human Beta-2 Integrin Alpha Subunit 	.freshpatents.com	0	0		
846	chrX	34258744	34261680	3500023851	23		34258744	34261680	8421504	3	5,11,7	0,6,2929	c	350002385100000013	14-37						Antimicrobial Compositions And Related Methods Of Use 	.freshpatents.com	0	0		GLRA4
846	chrX	34261816	34261873	3500306790	57		34261816	34261873	8421504	1	57	0	p	350030679000015008	0-57						Annual Review of Pharmacology and Toxicology Volume 31 (1991) - IsSN 0362-1642 03621642 0066-4251 00664251	www.scribd.com	0	0		GLRA4
13	chrX	34597778	34604796	3500091359	164		34597778	34604796	8421504	3	96,48,20	0,99,6998	c	350009135900000016,350009135900000015,350009135900000029,350009135900000028,350009135900000001,350009135900000048	0-33,0-48,3-48,0-48,0-20,0-20						GANKYRIN - Patent application	www.faqs.org	0	0		
848	chrX	34601103	34601163	3500391427	60		34601103	34601163	8421504	1	60	0	p	350039142700015009	0-60						Assays - Patent application	www.faqs.org	0	0		PSMD10
848	chrX	34601118	34601163	3500289333	45		34601118	34601163	8421504	1	45	0	p	350028933300015003	6-51						Assays 	.freshpatents.com	0	0		PSMD10
848	chrX	34601118	34601163	3500208501	45		34601118	34601163	8421504	1	45	0	p	350020850100015011	0-45						Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same	Schofield	2005	0		PSMD10
848	chrX	34601118	34601163	3500189065	45		34601118	34601163	8421504	1	45	0	p	350018906500015013	0-45						Assays	Schofield	2005	0		PSMD10
849	chrX	34654914	34682310	3500447453	108		34654914	34682310	8421504	3	7,41,60	0,3030,27336	p	350044745300015001,350044745300015002	0-48,0-60		15140988	10.1128/JVI.78.11.5900-5912.2004	0022-538X	Journal of Virology	Processing of a Pestivirus Protein by a Cellular Protease Specific for Light Chain 3 of Microtubule-Associated Proteins	Fricke	2004	5		
106	chrX	35137364	35262092	3500193621	608		35137364	35262092	8421504	16	52,25,4,24,58,32,55,70,91,49,57,34,36,10,7,4	0,29105,29131,40073,40193,40546,42228,62343,92853,110131,123496,123685,124652,124697,124716,124724	g	350019362100000022,350019362100000025,350019362100000030,350019362100000031,350019362100000040,350019362100000056,350019362100000059,350019362100000065,350019362100000067	0-52,0-29,0-82,4-91,0-70,0-91,31-80,0-91,6-63						TYPE IV COLLAGEN IN DEVELOPMENT AND DISEASE: TOWARDS GENE THERAPY FOR X-LINKED ALPORT SYNDROME By	scottharvey.info	0	0		
854	chrX	35260896	35260928	3500184228	30		35260896	35260928	8421504	2	23,7	0,25	g	350018422800000247	0-30						IDENTIFICATION OF A MUTATION IN COL4A5 CAUSATIVE FOR X- LINKED ALPORT SYNDROME IN THE DOMESTIC DOG AND ANALYSIS OF GENE EXPRESSION IN THE KIDNEYS OF AFFECTED AND NONAFFECTED SIBLINGS	pository.tamu.edu	0	0		
858	chrX	35898677	35898791	3500308071	114		35898677	35898791	8421504	1	114	0	p	350030807100015071	0-114						IDENTIFICACIA DE NOUS GENS A LA REGIA CROMOSAMICA 21q22. CARACTERITZACIA MOLECULAR DE KCNE2 I KC	www.tdx.cat	0	0		ACSL4
859	chrX	35918675	35949882	3500095434	47		35918675	35949882	8421504	3	9,13,25	0,12,31182	g	350009543400000019,350009543400000018	0-22,0-25						BMC Genetics BioMed Central	biomedcentral.com	0	0		
862	chrX	36396651	36424525	3500407090	40		36396651	36424525	8421504	4	15,5,4,16	0,17,27853,27858	g	350040709000000091,350040709000000910	1-21,12-32						HIV envelope polypeptides and vaccine	Berman	1997	0		
863	chrX	36491132	36491158	3500307736	23		36491132	36491158	8421504	2	9,14	0,12	g	350030773600000089	15-38						 Cysteine 	www.docstoc.com	0	0		
869	chrX	37254740	37266642	3500196470	41		37254740	37266642	8421504	4	9,13,6,13	0,13,11878,11889	g	350019647000000172,350019647000000094	15-44,0-19						Gene encoding transglutaminase derived from fish	Yasueda	1996	0		
108	chrX	37460214	37555759	3500015903	1674		37460214	37555759	8421504	16	175,101,45,154,38,132,39,124,64,49,113,118,100,197,138,87	0,23977,28459,29640,31285,35716,38048,38090,46520,73222,73584,75328,76890,77878,91798,95458	p	350001590300015002	0-1674						KEGG T01006: 416734	www.genome.jp	0	0		
108	chrX	37460214	37555747	3500088950	1620		37460214	37555747	8421504	14	175,101,154,38,132,166,64,49,113,118,100,197,138,75	0,23977,29640,31285,35716,38048,46520,73222,73584,75328,76890,77878,91798,95458	p	350008895000015003	0-1620						KEGG T01001: 10298	www.genome.jp	0	0		PAK3
870	chrX	37484191	37484238	3500192623	47		37484191	37484238	8421504	1	47	0	c	350019262300000014,350019262300000015,350019262300000024	0-43,0-43,12-37						RESEARCH Open Access Group I p21-activated kinases facilitate Tax-mediated transcriptional activation of the human T-cell leukemia virus type 1 long terminal repeats	retrovirology.com	0	0		
870	chrX	37484191	37484238	3500005511	47		37484191	37484238	8421504	1	47	0	c	350000551100000013,350000551100000014,350000551100000026	0-43,0-43,12-37		23622267	10.1186/1742-4690-10-47	1742-4690	Retrovirology	Group I p21-activated kinases facilitate Tax-mediated transcriptional activation of the human T-cell leukemia virus type 1 long terminal repeats	Chan	2013	6		
871	chrX	37487009	37555759	3500076722	492		37487009	37555759	8421504	8	61,20,91,38,36,93,66,87	0,2853,2908,4490,8921,8960,11253,68663	p,c	350007672200000005,350007672200015004,350007672200000001,350007672200015021,350007672200015029,350007672200015081	0-21,3-60,0-20,0-165,0-159,0-87						THESE DOCTEUR DE L UNIVERSIT&#xc9; PARIS XI Patricia KREIS Titre	hives-ouvertes.fr	0	0		PAK3
871	chrX	37535654	37537122	3500246273	24		37535654	37537122	8421504	2	6,18	0,1450	c	350024627300000081	24-48						Methods and compositions for treatment of diabetes and related disorders	Newgard	2007	0		
871	chrX	37538121	37538166	3500166321	45		37538121	37538166	8421504	1	45	0	c	350016632100000002,350016632100000003	0-42,0-42		12464619	10.1074/jbc.M207251200	0021-9258	Journal of Biological Chemistry	A New Constitutively Active Brain PAK3 Isoform Displays Modified Specificities toward Rac and Cdc42 GTPases	Rousseau	2003	5		
872	chrX	37685305	37685353	3500342863	48		37685305	37685353	8421504	1	48	0	p	350034286300015027	0-48							library.wiley.com	0	0		DCX
875	chrX	38123439	38123527	3500450003	40		38123439	38123527	8421504	2	19,21	0,67	c	350045000300000007,350045000300000006	0-19,0-21		20668213	10.1152/ajpcell.00036.2010		American Journal of Physiology - Cell Physiology	Somatic ATP release from guinea pig sympathetic neurons does not require calcium-induced calcium release from internal stores	Laura	2010	0		TRPC5
875	chrX	38123439	38123527	3500002946	40		38123439	38123527	8421504	2	19,21	0,67	c	350000294600000007,350000294600000006	0-19,0-21		20668213	10.1152/ajpcell.00036.2010		American Journal of Physiology - Cell Physiology	Somatic ATP release from guinea pig sympathetic neurons does not require calcium-induced calcium release from internal stores	Merriam	2010	0		TRPC5
109	chrX	38127047	38169952	3500208110	72		38127047	38169952	8421504	3	51,7,14	0,31245,42891	p,c	350020811000015004,350020811000000000	0-51,0-21						Nitric oxide activates TRP channels by cysteine S-nitrosylation. - ResearchGate	.researchgate.net	0	0		
876	chrX	38170028	38170054	3500107470	24		38170028	38170054	8421504	3	6,14,4	0,7,22	c	350010747000000648	7-31						Transmembrane protein amigo and uses thereof - Patent application	www.faqs.org	0	0		
876	chrX	38170127	38170150	3500356772	23		38170127	38170150	8421504	1	23	0	c	350035677200000007	23-46						Supplement Material	s.ahajournals.org	0	0		TRPC5
876	chrX	38170153	38175476	3500011489	44		38170153	38175476	8421504	2	22,22	0,5301	c,g	350001148900000007,350001148900000006	0-22,0-22						STORE OPERATED CHANNELS IN THE PULMONARY CIRCULATION OF HIGH AND LOW ALTITUDE NEONATAL LAMBS. - ResearchGate	.researchgate.net	0	0		TRPC5
877	chrX	38287941	38288242	3500243526	41		38287941	38288242	8421504	2	21,20	0,281	c,g	350024352600000001,350024352600000000,350024352600000000	0-21,0-20,0-20						<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 	www.mdpi.com	0	0		TRPC5
877	chrX	38287941	38288242	3500083138	41		38287941	38288242	8421504	2	21,20	0,281	c	350008313800000001,350008313800000000	0-21,0-20						OPEN ACCESS pharmaceuticals	www.mdpi.com	0	0		TRPC5
882	chrX	38932723	38932748	3500322273	23		38932723	38932748	8421504	2	16,7	0,18	g	350032227300000006	13-36						Virus like particle compositions and methods of use	Nabel	2010	0		
882	chrX	38932723	38932748	3500084943	23		38932723	38932748	8421504	2	16,7	0,18	g	350008494300000007	12-35						VACCINE FOR CHIKUNGUNYA VIRUS INFECTION - Patent application	www.faqs.org	0	0		
882	chrX	38932723	38932748	3500024838	23		38932723	38932748	8421504	2	16,7	0,18	g	350002483800000007	12-35						VACCINE FOR CHIKUNGUNYA VIRUS INFECTION	Ella	2007	0		
884	chrX	39223682	39223706	3500005314	23		39223682	39223706	8421504	2	13,10	0,14	c	350000531400000580	0-23						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
888	chrX	39748260	39748287	3500354079	23		39748260	39748287	8421504	2	10,13	0,14	g	350035407900000037	0-23						E1-MINUS ADENOVIRUSES AND USE THEREOF - Patent application	www.faqs.org	0	0		
888	chrX	39748260	39748287	3500191522	23		39748260	39748287	8421504	2	10,13	0,14	g	350019152200000012	0-23						Humanized Antibodies Which Bind To Ab (1-42) Globulomer And Uses Thereof 	.freshpatents.com	0	0		
888	chrX	39787224	39787249	3500091919	23		39787224	39787249	8421504	3	13,5,5	0,14,20	g	350009191900000012	23-48						Manipulation of tocopherol levels in transgenic plants by transformation with a synechocystis 2-methyl-6-phytylplastoquinol/2-methyl-6-solanylplastoquinol-9 methyltransferase	Dellapenna	1999	0		
890	chrX	40022364	40022520	3500389774	39		40022364	40022520	8421504	2	20,19	0,137	g	350038977400000004,350038977400000005	0-20,0-19						mRNA and microRNA quality control for RT-qPCR analysis	uantification.com	0	0		
890	chrX	40022364	40022520	3500107315	39		40022364	40022520	8421504	2	20,19	0,137	g	350010731500000004,350010731500000005	0-20,0-19						mRNA and microRNA quality control for RT-qPCR analysis	uantification.net	0	0		
893	chrX	40414661	40414687	3500091510	23		40414661	40414687	8421504	3	4,6,13	0,5,13	g	350009151000000029	4-27					Patent	Polypeptides and polynucleotides from coagulase-negative staphylococci (Patent EP:1117772)	Davis	2012	0		
895	chrX	40686239	40686263	3500212020	24		40686239	40686263	8421504	1	24	0	g	350021202000000001	0-24						Inverse Agonist and Neutral Antagonist Actions of Antidepressants at Recombinant and Native 5-Hydroxytryptamine2C Receptors: Differential Modulation of Cell S 2008&#x5e74;&#x7b2c;70&#x5377;&#x7b2c;3&#x671f; | 39&#x5eb7;&#x590d;&#x7f51; | &#x533b;&#x6e90;&	www.39kf.com	0	0		HTR2C
895	chrX	40686239	40686263	3500006161	24		40686239	40686263	8421504	1	24	0	g	350000616100000001	0-24			10.1124/mol.107.041574	1521-0111 (Online)	Molecular Pharmacology	Inverse Agonist and Neutral Antagonist Actions of Antidepressants at Recombinant and Native 5-Hydroxytryptamine2C Receptors: Differential Modulation of Cell Surface Expression and Signal Transduction	Chanrion	2008	0		HTR2C
896	chrX	40848794	40848842	3500267137	48		40848794	40848842	8421504	1	48	0	p	350026713700015004	0-48					Patent	Method of diagnosis of cancer based on gene expression profiles in cells (Patent US:7640114)	Kari	2009	0		PLS3
896	chrX	40848794	40848842	3500252227	48		40848794	40848842	8421504	1	48	0	p	350025222700015004	0-48						Method of diagnosis of cancer based on gene expression profiles in cells	Showe	2004	0		PLS3
897	chrX	41010127	41010153	3500321898	23		41010127	41010153	8421504	2	17,6	0,20	g	350032189800000049,350032189800000083	6-30,6-30						CYSTIC FIBROSIS GENE MUTATIONS - Patent application	www.faqs.org	0	0		
900	chrX	41352785	41352816	3500154043	24		41352785	41352816	8421504	3	5,8,11	0,7,20	g	350015404300000052	4-31						INTERACTION BETWEEN TRICHODERMA	library.brocku.ca	0	0		
901	chrX	41477205	41477228	3500203273	23		41477205	41477228	8421504	1	23	0	g	350020327300000002	11-34						Genetic test for .alpha.-mannosidosis - Patent # 6197507 - PatentGenius	.patentgenius.com	0	0		
901	chrX	41534575	41534600	3500213088	23		41534575	41534600	8421504	2	7,16	0,9	g	350021308800000158	15-39						Canine coronavirus S gene and uses therefor	Miller	2001	0		
909	chrX	42547358	42547381	3500349938	23		42547358	42547381	8421504	1	23	0	c	350034993800000002	15-40						Recombinant Vaccine Displaying the Loop-Neutralizing Determinant from Protective Antigen Completely Protects Rabbits from Experimental Inhalation Anthrax	cvi.asm.org	0	0		CHM
919	chrX	43785939	43785964	3500328451	25		43785939	43785964	8421504	1	25	0	g	350032845100000067	4-29						Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host	Della-Cioppa	1999	0		
926	chrX	44815140	44815164	3500407654	24		44815140	44815164	8421504	1	24	0	g	350040765400000019	4-28		19200309	10.1111/j.1365-2672.2008.04043.x	1365-2672	Journal of Applied Microbiology	Multiplex real-time PCR for exhaustive detection of diarrhoeagenic Escherichia coli - Hidaka - 2009 - Journal of Applied Microbiology - Wiley Online Library	Hidaka	2009	0		
928	chrX	45015448	45023378	3500321720	621		45015448	45023378	8421504	3	243,104,274	0,1601,7656	p	350032172000015021	0-621						KEGG T01001: 2246	www.genome.jp	0	0		
928	chrX	45015466	45015645	3500008335	48		45015466	45015645	8421504	2	24,24	0,155	c	350000833500000062,350000833500000061	0-24,0-24						UNESP - UNIVERSIDADE ESTADUAL PAULISTA Instituto de Bioci&#xea;ncias Campus de Botucatu REGULA&#xc7;&#xc3;O DA EXPRESS&#xc3;O DE FATORES SECRETADOS PELO O&#xd3;CITO (FSOs) E SEUS RECEPTORES DURANTE A MATURA&#xc7;&#xc3;O (MIV) BOVINA E A&#xc7;&#xd5;ES NO C	www.ibb.unesp.br	0	0		
928	chrX	45015469	45023378	3500199473	489		45015469	45023378	8421504	5	222,6,44,145,72	0,1580,1640,7635,7837	p	350019947300015047,350019947300015037,350019947300015022,350019947300015012,350019947300015011	0-144,0-84,0-129,0-60,0-72						FUNCTIONAL CHARACTERIZATION OF A BACULOVIRUS FIBROBLAST GROWTH FACTOR by CHANITCHOTE DETVISITSAKUN B.S., King Mongkut&#x2019;s Institute of Technology Ladkrabang, Thailand, 1997 AN ABSTRACT OF A DISSERTATION	krex.k-state.edu	0	0		
928	chrX	45015481	45015595	3500142509	108		45015481	45015595	8421504	3	36,45,27	0,39,87	p	350014250900015062	0-108						Fibroblast growth factor (FGF23) polypeptides - US Patent 7745406 Description	ww.patentstorm.us	0	0		FGF16
928	chrX	45015520	45023162	3500213723	225		45015520	45023162	8421504	6	45,45,45,35,10,45	0,48,1550,1598,7584,7597	p	350021372300015080,350021372300015079,350021372300015075,350021372300015074,350021372300015073	0-45,0-45,0-45,0-45,0-45						Methods of Diagnosing Hypophosphatemic Disorders - Patent application	www.faqs.org	0	0		FGF9
930	chrX	45253649	45253673	3500207334	24		45253649	45253673	8421504	1	24	0	g	350020733400000000	0-24						Detection of mitochondrial DNA from domestic cattle in bison on Santa Catalina Island. - ResearchGate	.researchgate.net	0	0		
930	chrX	45254191	45254390	3500421980	60		45254191	45254390	8421504	3	20,20,20	0,42,179	g	350042198000000011,350042198000000023,350042198000000026	0-20,0-20,0-20						Rise and fall of the Beringian Steppe bison	ww.sciencemag.org	0	0		
930	chrX	45254225	45254255	3500447716	30		45254225	45254255	8421504	1	30	0	g	350044771600000029	0-30						Method for detecting the presence of biological matters of bovine origin, and oligonucleotides for its implementation	Hanni	2000	0		
930	chrX	45275480	45275504	3500321554	23		45275480	45275504	8421504	2	14,9	0,15	g	350032155400000108	10-33						5' to 3' exonuclease mutations of thermostable dna polymerases	Abramson	1993	0		
934	chrX	45822459	45822489	3500441632	23		45822459	45822489	8421504	3	12,6,5	0,16,25	g	350044163200000233	6-30						 Intramuscular Delivery Of Recombinant AAV 	www.docstoc.com	0	0		
935	chrX	45974558	45974584	3500100734	24		45974558	45974584	8421504	2	9,15	0,11	g	350010073400000427	24-48						Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis	Rikihisa	1999	0		
935	chrX	45979393	45979419	3500407780	25		45979393	45979419	8421504	2	21,4	0,22	g	350040778000000026	0-25						REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY	Curtiss	2013	0		
935	chrX	45979393	45979419	3500196015	25		45979393	45979419	8421504	2	21,4	0,22	g	350019601500000026	0-25						REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY	Curtiss	2009	0		
935	chrX	45993554	45993580	3500132448	24		45993554	45993580	8421504	2	12,12	0,14	g	350013244800000193,350013244800000036	3-27,3-27						METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS - Patent application	www.faqs.org	0	0		
940	chrX	46582189	46582220	3500270031	25		46582189	46582220	8421504	3	4,14,7	0,5,24	c	350027003100000313	18-47						Method and product for regulating cell responsiveness to external signals	Johnson	1996	0		RLIM
940	chrX	46634572	46634597	3500365460	25		46634572	46634597	8421504	1	25	0	c	350036546000000001	0-25		18187543	10.1210/en.2007-1475		Endocrinology	Genotype-Phenotype Relationship in Patients with Mutations in Thyroid Hormone Transporter MCT8	Jurgen	2008	0		SLC16A2
943	chrX	46957202	46957225	3500360910	23		46957202	46957225	8421504	1	23	0	c	350036091000000026	7-30						US Patent # 5,831,064. Kaposi's sarcoma-associated herpes virus (KSHV) interferon consensus sequence binding protein (ICSBP) and uses thereof - Patents.com	www.patents.com	0	0		
943	chrX	46957202	46957225	3500116787	23		46957202	46957225	8421504	1	23	0	c	350011678700000026	7-30						Kaposi's sarcoma-associated herpes virus (KSHV) interferon consensus sequence binding protein (ICSBP) and uses thereof	Chang	1996	0		MIR374A
943	chrX	46957204	46957230	3500353647	26		46957204	46957230	8421504	1	26	0	c	350035364700000037	10-36						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS	Kelley	2008	0		
943	chrX	46957204	46957230	3500351139	26		46957204	46957230	8421504	1	26	0	c	350035113900000037,350035113900000154	10-36,10-36						MICRO-RNA SCAFFOLDS AND NON-NATURALLY OCCURRING MICRO-RNAS - Patent application	www.faqs.org	0	0		
944	chrX	47162223	47162252	3500155028	24		47162223	47162252	8421504	2	18,6	0,23	g	350015502800000061	1-28						Stereoselective reduction process for the preparation of pyrrolotriazine compounds	Patel	2006	0		
945	chrX	47265889	47267274	3500062421	62		47265889	47267274	8421504	3	20,20,22	0,1061,1363	c,g	350006242100000005,350006242100000006,350006242100000006,350006242100000007	0-20,0-20,0-20,0-22		15044262	10.1095/biolreprod.103.025775	0006-3363	Biology of Reproduction	Epigenetic and Genomic Imprinting Analysis in Nuclear Transfer Derived Bos gaurus/Bos taurus Hybrid Fetuses	Dindot	2004	4		
945	chrX	47266765	47267231	3500028009	40		47266765	47267231	8421504	2	20,20	0,446	c,g	350002800900000038,350002800900000038,350002800900000039,350002800900000039	0-20,0-20,0-20,0-20						Putative imprinted gene expression in uniparental bovine embryo models	library.uq.edu.au	0	0		
945	chrX	47268193	47268219	3500043928	24		47268193	47268219	8421504	2	12,12	0,14	c	350004392800000057	24-48						HUMAN E3ALPHA UBIQUITIN LIGASE FAMILY - Patent application	www.faqs.org	0	0		
945	chrX	47299499	47299598	3500233640	77		47299499	47299598	8421504	3	31,21,25	0,50,74	c,g	350023364000000007,350023364000000009,350023364000000009,350023364000000008	0-31,0-21,0-21,0-25						Gene silencing during development of in vitro-produced female bovine embryos	w.funpecrp.com.br	0	0		
950	chrX	47944840	47944917	3500248074	77		47944840	47944917	8421504	1	77	0	c,g	350024807400000024,350024807400000024	0-77,0-77						BMC Biology BioMed Central	biomedcentral.com	0	0		
951	chrX	48024878	48026712	3500462968	143		48024878	48026712	8421504	5	45,5,43,45,5	0,133,1608,1726,1829	c	350046296800000028,350046296800000086,350046296800000239	0-50,0-43,0-50						Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer	Challita-Eid	2004	0		
951	chrX	48024878	48026712	3500390406	143		48024878	48026712	8421504	5	45,5,43,45,5	0,133,1608,1726,1829	c	350039040600000028,350039040600000086,350039040600000239,350039040600000330	0-50,0-43,0-50,0-44						Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer	Challita-Eid	2005	0		
951	chrX	48024878	48026712	3500072746	100		48024878	48026712	8421504	4	45,5,45,5	0,133,1726,1829	c	350007274600000028,350007274600000239	0-50,0-50						Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer	Challita-Eid	2007	0		
951	chrX	48026140	48026164	3500195076	24		48026140	48026164	8421504	1	24	0	c	350019507600000001,350019507600000002	9-33,0-24		24069141	10.1371/journal.pone.0072131		PLoS ONE	Inhibition of HIV-1 Reverse Transcriptase-Catalyzed Synthesis by Intercalated DNA Benzo[a]Pyrene 7,8-Dihydrodiol-9,10-Epoxide Adducts	Parvathi	2013	0		
951	chrX	48037299	48037394	3500248074	95		48037299	48037394	8421504	1	95	0	p,g	350024807400000012,350024807400015013	0-95,21-90						BMC Biology BioMed Central	biomedcentral.com	0	0		
951	chrX	48037302	48037401	3500275818	99		48037302	48037401	8421504	1	99	0	p,g	350027581800000001,350027581800015001	0-99,30-96						BMC Molecular Biology BioMed Central	biomedcentral.com	0	0		
953	chrX	48328934	48328962	3500196360	23		48328934	48328962	8421504	2	11,12	0,16	g	350019636000000080	1-24						DETERMINING CODON DISTRIBUTION AND/OR BASE PAIR DISTANCE BETWEEN CODONS IN A NUCLEIC ACID	Nayudu	2010	0		
954	chrX	48383467	48383492	3500005314	23		48383467	48383492	8421504	2	8,15	0,10	g	350000531400000382	4-37						US Patent # 6,995,250. Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium - Patents.com	www.patents.com	0	0		
958	chrX	48958838	48958867	3500103381	24		48958838	48958867	8421504	2	8,16	0,13	g	350010338100000000	8-34		18593709	10.1074/jbc.M803674200		The Journal of Biological Chemistry	Physiological and Biochemical Defects in Carboxyl-terminal Mutants of Mitochondrial DNA Helicase	Yuichi	2008	0		
960	chrX	49156452	49156512	3500053923	60		49156452	49156512	8421504	1	60	0	g	350005392300000010	0-60						TESI DI DOTTORATO	archivia.unict.it	0	0		NDUFB6
960	chrX	49265003	49271965	3500122927	537		49265003	49271965	8421504	7	132,110,40,103,85,43,24	0,825,1160,1715,2245,2674,6938	p,c	350012292700000011,350012292700015030,350012292700015027,350012292700015024,350012292700015021,350012292700000010	0-24,0-60,0-150,0-150,0-150,0-24						LM-ANTIBODIES, FUNCTIONAL FRAGMENTS, LM-1 TARGET ANTIGEN, AND METHODS FOR MAKING AND USING SAME - PATRYS LIMITED	www.sumobrain.com	0	0		NONO
960	chrX	49267301	49267326	3500449086	24		49267301	49267326	8421504	2	18,6	0,19	c	350044908600000037	10-35						CD	itc.u-tokyo.ac.jp	0	0		NONO
960	chrX	49269008	49269033	3500125180	25		49269008	49269033	8421504	1	25	0	c	350012518000000000	0-25		22941645	10.1093/nar/gks798		Nucleic Acids Research	PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks	Jana	2012	0		NONO
961	chrX	49291680	49291707	3500312616	23		49291680	49291707	8421504	2	18,5	0,22	c	350031261600000069	0-23						METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Patent application	www.faqs.org	0	0		
961	chrX	49317355	49324386	3500064129	941		49317355	49324386	8421504	10	94,30,136,282,5,54,60,108,57,115	0,95,581,727,1033,1074,1187,1306,1422,6916	c,g	350006412900000781,350006412900000776,350006412900000747,350006412900000747,350006412900000726,350006412900000721,350006412900000718,350006412900000713,350006412900000716,350006412900000714,350006412900000706,350006412900000642,350006412900000658,350006412900000652,350006412900000681,350006412900000675,350006412900000684,350006412900000684,350006412900000646,350006412900000589,350006412900000588,350006412900000621,350006412900000592,350006412900000631,350006412900000628,350006412900000618,350006412900000614,350006412900000594,350006412900000635,350006412900000549,350006412900000557,350006412900000580,350006412900000495,350006412900000491,350006412900000372,350006412900000383,350006412900000421,350006412900000420,350006412900000404,350006412900000264,350006412900000279,350006412900000302,350006412900000298,350006412900000174,350006412900000158,350006412900000073,350006412900000027,350006412900000024,350006412900000055,350006412900000055,350006412900000010,350006412900000006	0-117,52-121,0-29,0-29,1-93,0-53,0-29,0-53,0-53,2-53,0-47,0-56,0-55,0-54,0-47,0-45,0-43,0-43,0-43,0-60,0-59,0-60,0-59,0-58,0-56,0-56,0-50,0-49,0-33,0-60,0-46,0-36,0-60,0-60,0-59,0-59,0-59,0-53,0-51,0-60,0-50,0-50,0-50,0-57,0-51,0-60,0-30,0-31,0-60,0-60,0-42,0-53						<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"> <HTML> <HEAD> <META http-equiv="Cont	e.dna.affrc.go.jp	0	0		
961	chrX	49318242	49318704	3500371641	240		49318242	49318704	8421504	2	129,111	0,351	p	350037164100015076,350037164100015062,350037164100015048,350037164100015029,350037164100015038	0-129,0-117,0-105,0-105,0-51						Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions	Duft	2009	0		GJB1
961	chrX	49318242	49318704	3500369797	240		49318242	49318704	8421504	2	129,111	0,351	p	350036979700015076,350036979700015062,350036979700015047,350036979700015028,350036979700015037	0-129,0-117,0-105,0-105,0-51						Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions	Becker	2009	0		GJB1
961	chrX	49318242	49318704	3500346472	240		49318242	49318704	8421504	2	129,111	0,351	p	350034647200015115,350034647200015100,350034647200015086,350034647200015066,350034647200015075	0-129,0-117,0-105,0-105,0-51						WOUND HEALING COMPOSITIONS AND TREATMENTS	Mori	2009	0		GJB1
961	chrX	49318242	49318704	3500074141	240		49318242	49318704	8421504	2	129,111	0,351	p	350007414100015075,350007414100015060,350007414100015046,350007414100015028,350007414100015036	0-129,0-117,0-105,0-105,0-51						Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions	Duft	2009	0		GJB1
961	chrX	49318242	49318704	3500023472	240		49318242	49318704	8421504	2	129,111	0,351	p	350002347200015115,350002347200015100,350002347200015086,350002347200015066,350002347200015076	0-129,0-117,0-105,0-75,0-51						TREATMENT OF SURGICAL ADHESIONS	Duft	2008	0		GJB1
961	chrX	49318242	49318704	3500015607	240		49318242	49318704	8421504	2	129,111	0,351	p	350001560700015112,350001560700015097,350001560700015083,350001560700015063,350001560700015073	0-129,0-117,0-105,0-75,0-51						METHODS AND COMPOSITIONS FOR WOUND HEALING	Green	2012	0		GJB1
961	chrX	49318242	49318698	3500143816	234		49318242	49318698	8421504	2	129,105	0,351	p	350014381600015074,350014381600015060,350014381600015046,350014381600015036	0-129,0-117,0-105,0-51						Improved methods and compositions for wound healing	Green	2008	0		GJB1
961	chrX	49319405	49319461	3500449656	42		49319405	49319461	8421504	2	21,21	0,35	g	350044965600000008,350044965600000009	0-21,0-21		17325040	10.1128/MCB.01689-06	0270-7306	Molecular and Cellular Biology	Neuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10	LeBlanc	2007	6		
961	chrX	49387842	49387866	3500041159	23		49387842	49387866	8421504	2	9,14	0,10	g	350004115900000030	7-30						Diversity and Abundance of Sulfur-Oxidizing Bacteria in Wadden Sea Sediments Revealed by DsrAB Phylogeny and dsrAB-Targeted Real-Time PCR	www.marmic.mpg.de	0	0		
961	chrX	49406714	49407325	3500440630	42		49406714	49407325	8421504	3	21,4,17	0,129,594	c,g	350044063000000009,350044063000000009,350044063000000008	0-21,0-21,0-21		22913342	10.1186/1756-8935-5-13		Epigenetics & Chromatin	Cohesin is required for expression of the estrogen receptor-alpha (ESR1) gene	Tanja	2012	0		MED12
962	chrX	49417673	49420386	3500260785	41		49417673	49420386	8421504	3	21,2,18	0,2383,2695	c	350026078500000049,350026078500000021	0-21,0-20						Cytokines and their use in treatment and/or prophylaxis of breast cancer	Begley	1998	0		IL2RG
962	chrX	49418007	49419691	3500218014	117		49418007	49419691	8421504	5	29,28,26,14,20	0,77,121,346,1664	c	350021801400000058,350021801400000060,350021801400000013,350021801400000045	19-48,0-28,8-48,13-33					Patent	Human IL-2 receptor &#x03b3;-chain molecule antibody (Patent US:5889160)	Asao	1999	0		
962	chrX	49418007	49418367	3500289735	69		49418007	49418367	8421504	3	29,26,14	0,121,346	c	350028973500000058,350028973500000013	19-48,8-48					Patent	Human IL-2 receptor &#x03b3;-chain molecule antibody (Patent US:5889160)	Asao	1999	0		
962	chrX	49418007	49418367	3500132265	69		49418007	49418367	8421504	3	29,26,14	0,121,346	c	350013226500000058,350013226500000013	19-48,8-48					Patent	Human IL-2 receptor &#x03b3; chain molecule (Patent US:5705608)	Asao	1998	0		
962	chrX	49425886	49425910	3500329839	24		49425886	49425910	8421504	1	24	0	c	350032983900000008	0-24		24040102	10.1371/journal.pone.0073875	1932-6203	PLOS ONE	PLOS ONE: Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress	Hori	2013	4		
962	chrX	49426246	49435807	3500133181	39		49426246	49435807	8421504	2	19,20	0,9541	c,g	350013318100000005,350013318100000005,350013318100000004,350013318100000004	0-19,0-19,0-20,0-20						FOXO1 Controls Thyroid Cell Proliferation in Response to TSH and IGF-I and Is Involved in Thyroid Tumorigenesis	.endojournals.org	0	0		FOXO4
962	chrX	49464096	49464126	3500459207	27		49464096	49464126	8421504	2	20,7	0,23	c	350045920700000401,350045920700000358	4-24,0-38						Phylogenetische Charakterisierung von Mikroorganismen aus dem Intestinaltrakt von Insekten	imed.uni-mainz.de	0	0		SNX12
963	chrX	49617518	49618887	3500050883	40		49617518	49618887	8421504	3	6,14,20	0,433,1349	c	350005088300000004,350005088300000005	0-20,0-20						Select Nutrients in the Ovine Uterine Lumen. III. Cationic Amino Acid Transporters in the Ovine Uterus and Peri-Implantation Conceptuses	ww.biolreprod.org	0	0		
965	chrX	49861157	49861202	3500171471	45		49861157	49861202	8421504	1	45	0	p	350017147100015058	0-45						Sfrp Expression Enhancing Agent - Patent application	www.faqs.org	0	0		DLG2
965	chrX	49861157	49861202	3500113419	45		49861157	49861202	8421504	1	45	0	p	350011341900015051	0-45						 SFRP Expression Enhancing Agent 	www.docstoc.com	0	0		DLG2
967	chrX	50079682	50085078	3500421432	39		50079682	50085078	8421504	2	20,19	0,5377	c,g	350042143200000001,350042143200000001,350042143200000002,350042143200000002	0-20,0-20,0-19,0-19						Isolation and Culture of a High Purity Population of Cone Photoreceptor Cells by Tissue Dissociation and Pna-Panning, and Biological Applications Thereof	Balse	2005	0		
967	chrX	50096877	50096900	3500178867	23		50096877	50096900	8421504	1	23	0	c	350017886700000013	0-23		15280443	10.1124/mol.104.002642	1521-0111 (Online)	Molecular Pharmacology	Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y2 Receptor in Coronary Artery Smooth Muscle Cells	Shen	2004	0		
967	chrX	50096877	50096900	3500035223	23		50096877	50096900	8421504	1	23	0	c	350003522300000013	0-23						Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y Receptor in Coronary Artery Smooth Muscle Cells	aspetjournals.org	0	0		
967	chrX	50115083	50115106	3500263908	23		50115083	50115106	8421504	1	23	0	c	350026390800000188	0-23						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
967	chrX	50115083	50115106	3500037971	23		50115083	50115106	8421504	1	23	0	c	350003797100000188	0-23						Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor - Patent application	www.faqs.org	0	0		
967	chrX	50119866	50119893	3500291333	23		50119866	50119893	8421504	2	14,9	0,18	g	350029133300000259	0-23						Method for amplifying nucleic acid sequence - Patent # 6951722 - PatentGenius	.patentgenius.com	0	0		
967	chrX	50172149	50182059	3500263908	53		50172149	50182059	8421504	4	30,13,6,4	0,9884,9899,9906	c,g	350026390800000255,350026390800000121	18-48,4-27						HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - Patent application	www.faqs.org	0	0		
967	chrX	50172149	50182059	3500037971	181		50172149	50182059	8421504	9	30,17,25,45,4,37,13,6,4	0,150,1578,1654,2220,2751,9884,9899,9906	c,g	350003797100000255,350003797100000252,350003797100000250,350003797100000246,350003797100000121	18-48,0-42,0-45,0-41,4-27						Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor - Patent application	www.faqs.org	0	0		
968	chrX	50254674	50254699	3500200478	23		50254674	50254699	8421504	2	9,14	0,11	g	350020047800000004	17-40						Method of using solid state NMR to measure distances between nuclei in compounds attached to a surface	Went	1996	0		
969	chrX	50407310	50407341	3500321523	25		50407310	50407341	8421504	3	11,9,5	0,15,26	g	350032152300000031,350032152300000113	0-25,24-44						Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma	Chatterjee	1999	0		
970	chrX	50556459	50556484	3500326034	23		50556459	50556484	8421504	2	18,5	0,20	g	350032603400000369	14-37						 Selection Method 	www.docstoc.com	0	0		
972	chrX	50778572	50778653	3500423185	81		50778572	50778653	8421504	1	81	0	c	350042318500000021,350042318500000020	0-33,0-48						US Patent # 5,512,457. Cytokine designated elk ligand - Patents.com	www.patents.com	0	0		
972	chrX	50778674	50778737	3500094121	63		50778674	50778737	8421504	1	63	0	p	350009412100015000	42-105						Nm23-H1 regulates contact inhibition of locomotion which is affected by ephrin-B1	cs.biologists.org	0	0		EFNB1
973	chrX	50891692	50891723	3500257671	24		50891692	50891723	8421504	3	5,14,5	0,8,26	g	350025767100000034	3-27					Patent	Interferon-beta fusion proteins and uses (Patent CN:100480266)	A*Hui Di 	2009	0		
974	chrX	51064576	51064603	3500286093	23		51064576	51064603	8421504	2	6,17	0,10	g	350028609300000060	12-35						Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies	M*A*Qie Fu 	2005	0		
975	chrX	51233293	51233321	3500161545	23		51233293	51233321	8421504	2	12,11	0,17	g	350016154500000000	6-41					Journal of Virology	The Versatility of Paramyxovirus RNA Polymerase Stuttering	Stephane	July	0		
979	chrX	51757580	51765133	3500384063	43		51757580	51765133	8421504	2	21,22	0,7531	c,g	350038406300000011,350038406300000010,350038406300000010	0-21,0-22,0-22		17975021	10.1210/me.2007-0332	0888-8809	Molecular Endocrinology	Interplay of Nuclear Factor-&#x03ba;B and B-myb in the Negative Regulation of Androgen Receptor Expression by Tumor Necrosis Factor &#x03b1;	Ko	2008	5		AR
979	chrX	51757614	51758420	3500173063	40		51757614	51758420	8421504	2	20,20	0,786	c,g	350017306300000003,350017306300000003,350017306300000002	0-20,0-20,0-20		21755295	10.1007/s11033-010-0442-2	0301-4851	Molecular Biology Reports	Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells	M	2011	3		AR
979	chrX	51757674	51758450	3500456201	75		51757674	51758450	8421504	2	9,66	0,710	p	350045620100015008	0-75						Lxr ligand testing method - Patent application	www.faqs.org	0	0		AR
979	chrX	51757674	51758450	3500341244	75		51757674	51758450	8421504	2	9,66	0,710	p	350034124400015009	0-75						Lxr ligand testing method	Terasaka	2008	0		AR
979	chrX	51757674	51758450	3500179198	75		51757674	51758450	8421504	2	9,66	0,710	p	350017919800015008	0-75					Patent	LXR ligand testing method (Patent US:7989179)	Honzumi	2011	0		AR
979	chrX	51758423	51758483	3500030895	60		51758423	51758483	8421504	1	60	0	p	350003089500015018	0-60						ANDROGEN RECEPTOR EXPRESSION IN HUMAN PROSTATE CANCER	repub.eur.nl	0	0		AR
979	chrX	51758527	51765083	3500402243	39		51758527	51765083	8421504	4	15,5,13,6	0,853,971,6550	c	350040224300000013,350040224300000012	0-20,0-19		17003774	10.1038/sj.pcan.4500912	1365-7852	Prostate Cancer and Prostatic Diseases	Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells	Cai	2006	2		AR
979	chrX	51758527	51765083	3500101570	39		51758527	51765083	8421504	4	15,5,13,6	0,853,971,6550	c	350010157000000007,350010157000000006	0-20,0-19						ETV1 Is a Novel Androgen Receptor-Regulated Gene that Mediates Prostate Cancer Cell Invasion	.endojournals.org	0	0		AR
979	chrX	51759465	51765078	3500074250	44		51759465	51765078	8421504	3	20,23,1	0,23,5612	c	350007425000000010,350007425000000011	20-40,0-24		16140968	10.1158/0008-5472.CAN-04-3541	0008-5472	Cancer Research	Role of SRC-1 in the Promotion of Prostate Cancer Cell Growth and Tumor Progression	Agoulnik	2005	8		AR
979	chrX	51759476	51765115	3500406236	40		51759476	51765115	8421504	2	20,20	0,5619	c,g	350040623600000001,350040623600000001,350040623600000000	0-20,0-20,0-20		16540674	10.1158/0008-5472.CAN-05-0087	0008-5472	Cancer Research	Capsaicin, a Component of Red Peppers, Inhibits the Growth of Androgen-Independent, p53 Mutant Prostate Cancer Cells	Mori	2006	8		AR
979	chrX	51759476	51765115	3500175439	40		51759476	51765115	8421504	2	20,20	0,5619	c,g	350017543900000001,350017543900000001,350017543900000000	0-20,0-20,0-20						Capsaicin, a Component of Red Peppers, Inhibits the Growth of Androgen-Independent, p53 Mutant Prostate Cancer Cells	rbeofficinali.org	0	0		AR
979	chrX	51759488	51765078	3500201313	24		51759488	51765078	8421504	2	23,1	0,5589	c	350020131300000011	0-24		16140968	10.1158/0008-5472.CAN-04-3541	0008-5472	Cancer Research	Role of SRC-1 in the Promotion of Prostate Cancer Cell Growth and Tumor Progression	Agoulnik	2005	8		AR
979	chrX	51759489	51765118	3500374201	43		51759489	51765118	8421504	2	20,23	0,5606	c,g	350037420100000005,350037420100000005,350037420100000004	0-20,0-20,0-23						Original Article Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR- DIM treatment	www.ajtr.org	0	0		AR
979	chrX	51759491	51765141	3500402090	48		51759491	51765141	8421504	3	20,4,24	0,5586,5626	c	350040209000000007,350040209000000006	0-24,0-24						The ability of the aryl hydrocarbon receptor to regulate ovarian follicle growth and estradiol biosynthesis in mice depends on stage of sexual maturity	ww.biolreprod.org	0	0		
979	chrX	51759496	51765156	3500048199	58		51759496	51765156	8421504	3	15,5,38	0,5581,5622	c,g	350004819900000006,350004819900000024,350004819900000023	0-20,0-19,0-38		19010817	10.1158/1541-7786.MCR-08-0273	1541-7786	Molecular Cancer Research	Profiling Human Androgen Receptor Mutations Reveals Treatment Effects in a Mouse Model of Prostate Cancer	O'Mahony	2008	4		
979	chrX	51765150	51772197	3500124495	40		51765150	51772197	8421504	2	20,20	0,7027	c,g	350012449500000001,350012449500000001,350012449500000000	0-20,0-20,0-20						The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. - ResearchGate	.researchgate.net	0	0		
979	chrX	51765168	51765193	3500312269	25		51765168	51765193	8421504	1	25	0	c	350031226900000001	0-25		11804942	10.1095/biolreprod66.2.297	0006-3363	Biology of Reproduction	Elevated Endometrial Androgen Receptor Expression in Women with Polycystic Ovarian Syndrome	Apparao	2002	4		AR
979	chrX	51765168	51765193	3500282212	25		51765168	51765193	8421504	1	25	0	c	350028221200000001	0-25		10645914	10.1161/01.CIR.101.3.224	0009-7322	Circulation	Androgen Receptor Expression Is Greater in Macrophages From Male Than From Female Donors	McCrohon	2000	15		AR
979	chrX	51765168	51765193	3500129925	25		51765168	51765193	8421504	1	25	0	c	350012992500000001	0-25						REPRODUCTION	uction-online.org	0	0		AR
979	chrX	51765168	51765193	3500009703	25		51765168	51765193	8421504	1	25	0	c	350000970300000001	0-25		10645914	10.1161/01.CIR.101.3.224	0009-7322	Circulation	Androgen Receptor Expression Is Greater in Macrophages From Male Than From Female Donors	McCrohon	2000	15		AR
979	chrX	51772166	51772193	3500401544	27		51772166	51772193	8421504	1	27	0	c	350040154400000002,350040154400000003	0-27,0-27		12637588	10.1210/me.2003-0032	0888-8809	Molecular Endocrinology	Selective Modulation of Genomic and Nongenomic Androgen Responses by Androgen Receptor Ligands	Lutz	2003	5		
122	chrX	51772310	51795754	3500307353	48		51772310	51795754	8421504	2	14,34	0,23410	p	350030735300015036	0-48						 Regulation Of Gene Expression Using Chromatin Remodelling Factors 	www.docstoc.com	0	0		AR
980	chrX	51795721	51795744	3500454086	23		51795721	51795744	8421504	1	23	0	c,g	350045408600000003,350045408600000003	0-23,0-23		19258514	10.1158/0008-5472.CAN-08-2308	0008-5472	Cancer Research	Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation	Mukhopadhyay	2009	8		AR
980	chrX	51795721	51795744	3500381602	23		51795721	51795744	8421504	1	23	0	c	350038160200000001	0-23						Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells	s01.rm.unicatt.it	0	0		AR
980	chrX	51795733	51837800	3500048764	192		51795733	51837800	8421504	2	104,88	0,41979	p	350004876400015173,350004876400015108,350004876400015171,350004876400015106,350004876400015169,350004876400015104,350004876400015167,350004876400015102	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						HUMAN ANDROGEN RECEPTOR ALTERNATIVE SPLICE VARIANTS - Patent application	www.faqs.org	0	0		AR
980	chrX	51837801	51837828	3500146205	27		51837801	51837828	8421504	1	27	0	c	350014620500000003	9-36		11751884	10.1074/jbc.M108255200	0021-9258	Journal of Biological Chemistry	Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways	Ueda	2002	5		
980	chrX	51837808	51837832	3500132080	24		51837808	51837832	8421504	1	24	0	c,g	350013208000000007,350013208000000007	0-24,0-24		12746291	10.1210/en.2002-0129	0013-7227	Endocrinology	Cytochrome P450 Genes Are Differentially Expressed in Female and Male Hepatocyte Retinoid X Receptor &#x03b1;-Deficient Mice	Cai	2003	4		AR
980	chrX	51837808	51837832	3500006303	24		51837808	51837832	8421504	1	24	0	c	350000630300000007	0-24		12746291	10.1210/en.2002-0129	0013-7227	Endocrinology	Cytochrome P450 Genes Are Differentially Expressed in Female and Male Hepatocyte Retinoid X Receptor &#x03b1;-Deficient Mice	Cai	2003	4		AR
980	chrX	51837812	51837835	3500215215	23		51837812	51837835	8421504	1	23	0	c	350021521500000178,350021521500000396	0-23,0-22						Arrays and Methods for Reverse Genetic Functional Analysis - Patent application	www.faqs.org	0	0		AR
981	chrX	51954282	51963315	3500454685	297		51954282	51963315	8421504	3	60,59,178	0,8216,8855	g	350045468500000053,350045468500000065,350045468500000081,350045468500000077,350045468500000073	0-60,0-59,0-58,0-60,0-60						':24'55+5+(70%+5&'.4'%'2614 &#0&47)'05+&'.'55'8'570+6#65&' 64#05%4+2%+5#.6'40#6+8'5'0'. %0%'4&'24756#6#+'0.#&+#$'6+5	ddd.uab.cat	0	0		
981	chrX	51963860	51963884	3500381602	24		51963860	51963884	8421504	1	24	0	c	350038160200000000	0-24						Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells	s01.rm.unicatt.it	0	0		AR
981	chrX	51964188	51964212	3500454466	24		51964188	51964212	8421504	1	24	0	c	350045446600000003	22-46		12517791		0008-5472	Cancer Research	Novel Mutations of Androgen Receptor	Hara	2003	8		
981	chrX	51964897	51964926	3500454678	24		51964897	51964926	8421504	3	4,14,6	0,5,23	c	350045467800000203	0-24						Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Cargill	2004	0		
981	chrX	51966551	51966581	3500320671	29		51966551	51966581	8421504	2	25,4	0,26	g	350032067100000205,350032067100000204	1-30,27-56						PROMOTERS FOR REGULATED GENE EXPRESSION - GENELABS TECHNOLOGIES, INC.	www.sumobrain.com	0	0		
981	chrX	51966551	51966581	3500199661	29		51966551	51966581	8421504	2	25,4	0,26	g	350019966100000215,350019966100000214	1-30,27-56						Promoters for regulated gene expression	Kim	2001	0		
989	chrX	53027059	53027085	3500166350	25		53027059	53027085	8421504	2	4,21	0,5	g	350016635000000252	21-46						Glial mitogenic factors, their preparation and use - Patent application	www.faqs.org	0	0		
990	chrX	53122017	53122509	3500291450	312		53122017	53122509	8421504	2	132,180	0,312	p	350029145000015025,350029145000015015,350029145000015013,350029145000015000	0-132,0-180,0-180,0-177						BMC Biochemistry BioMed Central	biomedcentral.com	0	0		
992	chrX	53361518	53361543	3500445203	24		53361518	53361543	8421504	2	10,14	0,11	c	350044520300000167	10-35						Detecting foot-and-mouth disease virus	Engelhard	2005	0		
992	chrX	53362181	53362212	3500080694	25		53362181	53362212	8421504	3	6,13,6	0,11,25	c	350008069400000681	14-40						MIXING AND MATCHING TC PROTEINS FOR PEST CONTROL - Patent application	www.faqs.org	0	0		
1002	chrX	54658876	54675081	3500223266	41		54658876	54675081	8421504	2	22,19	0,16186	c	350022326600000001,350022326600000002	0-22,0-19						REPRODUCTION	uction-online.org	0	0		AKAP4
1002	chrX	54674748	54674773	3500106528	24		54674748	54674773	8421504	2	4,20	0,5	g	350010652800000018	1-25						UNIVERSITE MONTPELLIER II SCIENCES ET TECHNIQUES DU LANGUEDOC THESE	umentation.ird.fr	0	0		
1002	chrX	54675333	54675358	3500209653	23		54675333	54675358	8421504	2	6,17	0,8	c	350020965300000309	16-39					Patent	Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof (Patent US:6045997)	Ashworth	2000	0		
1003	chrX	54855236	54855260	3500439152	24		54855236	54855260	8421504	1	24	0	c,g	350043915200000278,350043915200000278	0-24,0-24						EMBRYONIC STEM CELL SPECIFIC MICRORNAS PROMOTE INDUCED PLURIPOTENCY	Blelloch	2010	0		MIR362
1003	chrX	54855238	54866865	3500389139	66		54855238	54866865	8421504	3	22,22,22	0,11566,11605	c	350038913900000140,350038913900000022,350038913900000023	22-44,22-44,22-44						Anti-microrna oligonucleotide molecules	Tuschl	2006	0		MIR362,MIR188
1003	chrX	54855238	54866865	3500306561	66		54855238	54866865	8421504	3	22,22,22	0,11566,11605	c	350030656100000139,350030656100000022,350030656100000023	22-44,22-44,22-44						Anti-microRNA oligonucleotide molecules	Landthaler	2011	0		
1003	chrX	54855238	54866865	3500257436	66		54855238	54866865	8421504	3	22,22,22	0,11566,11605	c	350025743600000139,350025743600000022,350025743600000023	22-44,22-44,22-44						Anti-MicroRna Oligonucleotide Molecules	Tuschl	2007	0		MIR362,MIR188
1003	chrX	54855238	54866865	3500232262	66		54855238	54866865	8421504	3	22,22,22	0,11566,11605	c	350023226200000139,350023226200000022,350023226200000023	22-44,22-44,22-44					Patent	Anti-microRNA oligonucleotide molecules (Patent US:7772389)	Tuschl	2010	0		MIR362,MIR188
1003	chrX	54866839	54866870	3500060531	31		54866839	54866870	8421504	1	31	0	c,g	350006053100000003,350006053100000000,350006053100000000	0-31,0-21,0-21		22514329	10.1523/JNEUROSCI.6471-11.2012	0270-6474	The Journal of Neuroscience	An Activity-Regulated microRNA, miR-188, Controls Dendritic Plasticity and Synaptic Transmission by Downregulating Neuropilin-2	Lee	2012	7		
125	chrX	55311646	55318004	3500239605	1419		55311646	55318004	8421504	12	210,105,139,88,105,88,81,20,151,77,102,253	0,729,923,1443,1601,2589,2857,3674,3714,4541,5809,6105	c,g	350023960500000150,350023960500000232,350023960500000062	0-1399,0-20,0-20						Materials And Methods For FOXP3 Tumor Suppression - Patent application	www.faqs.org	0	0		
1007	chrX	55315493	55316200	3500338565	31		55315493	55316200	8421504	2	18,13	0,694	c	350033856500000000,350033856500000004	0-23,0-25		17189402	10.1158/1078-0432.CCR-06-1727	1078-0432	Clinical Cancer Research	Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers	Learn	2006	8		
1007	chrX	55315493	55316192	3500447702	23		55315493	55316192	8421504	2	18,5	0,694	c	350044770200000002	0-23		21389316	10.1182/blood-2010-12-324038	0006-4971	Blood	The impact of inflammatory licensing on heme oxygenase-1&#x2013;mediated induction of regulatory T cells by human mesenchymal stem cells	Mougiakakos	2011	10		FOXP3
1007	chrX	55315493	55316192	3500374823	23		55315493	55316192	8421504	2	18,5	0,694	c	350037482300000014	0-23						Methods and compositions for modulating immune tolerance	Bataar	2008	0		
1007	chrX	55315493	55316192	3500372243	23		55315493	55316192	8421504	2	18,5	0,694	c	350037224300000017	0-23						Conjugates for modulating the immune tolerance	Bataar	2007	0		
1007	chrX	55315493	55316192	3500369529	23		55315493	55316192	8421504	2	18,5	0,694	c	350036952900000006,350036952900000002	0-23,0-23						Complete human monoclonal IgG4lambda specific for CTLA-4 and uses thereof for detection of soluble CTLA-4 and isolation of regulatory cells - Patent application	www.faqs.org	0	0		FOXP3
1007	chrX	55315493	55316192	3500111950	23		55315493	55316192	8421504	2	18,5	0,694	c	350011195000000000	0-23		21368320	10.1194/jlr.M010876	0022-2275	Journal of Lipid Research	Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis	Tang	2011	6		FOXP3
1007	chrX	55316256	55317471	3500308246	24		55316256	55317471	8421504	2	8,16	0,1199	c	350030824600000018	0-24						Vaccines & Vaccination	w.omicsonline.org	0	0		FOXP3
1007	chrX	55317503	55318010	3500341027	43		55317503	55318010	8421504	2	22,21	0,486	c,g	350034102700000000,350034102700000002	0-22,0-21			10.1128/IAI.01358-06		Infection and Immunity	Long-Term Staphylococcal Enterotoxin C1 Exposure Induces Soluble Factor-Mediated Immunosuppression by Bovine CD4+ and CD8+ T Cells 	Keun	2007	0		
1007	chrX	55317553	55317771	3500404048	24		55317553	55317771	8421504	2	4,20	0,198	c	350040404800000001	0-24						World Journal of Gastroenterology-Baishideng Publishing	www.wjgnet.com	0	0		FOXM1
1007	chrX	55317553	55317771	3500210551	24		55317553	55317771	8421504	2	4,20	0,198	c	350021055100000001	0-24						World J Gastroenterol	www.wjgnet.com	0	0		FOXM1
1007	chrX	55317856	55317898	3500374367	42		55317856	55317898	8421504	1	42	0	c	350037436700000143	0-42						Compositions and Methods for Regulating T-Cell Activity - Patent application	www.faqs.org	0	0		
1007	chrX	55319024	55319048	3500370223	24		55319024	55319048	8421504	1	24	0	c	350037022300000001	0-24		16204628	10.1189/jlb.0605299	0741-5400	Journal of Leukocyte Biology	Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo	Delgado	2005	5		
1007	chrX	55319024	55319048	3500233973	24		55319024	55319048	8421504	1	24	0	c	350023397300000001	0-24						Vasoactive intestinal peptide generates CD4 CD25 regulatory T cells in vivo	www.jleukbio.org	0	0		
1007	chrX	55337270	55344781	3500321892	61		55337270	55344781	8421504	4	20,20,15,6	0,921,7486,7505	c,g	350032189200000067,350032189200000044,350032189200000044,350032189200000050,350032189200000050	0-20,0-20,0-20,0-21,0-21						Retinal calcium channel (alpha)1F-subunit gene - US Patent 6670465 Description	ww.patentstorm.us	0	0		
1007	chrX	55341587	55341615	3500284394	23		55341587	55341615	8421504	3	6,12,5	0,8,23	g	350028439400000148	3-26						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2011	0		
1007	chrX	55341587	55341615	3500253796	23		55341587	55341615	8421504	3	6,12,5	0,8,23	g	350025379600000148	3-26					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
1007	chrX	55341587	55341615	3500241875	23		55341587	55341615	8421504	3	6,12,5	0,8,23	g	350024187500000148	3-26					Patent	Enhancement of influenza gene expression (Patent US:8227188)	Fougerolles	2012	0		
1007	chrX	55341587	55341615	3500070088	23		55341587	55341615	8421504	3	6,12,5	0,8,23	g	350007008800000148	3-26						RNAI INHIBITION OF INFLUENZA VIRUS REPLICATION	Fougerolles	2006	0		
1007	chrX	55341587	55341615	3500068199	23		55341587	55341615	8421504	3	6,12,5	0,8,23	g	350006819900000148	3-26						RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION - Patent application	www.faqs.org	0	0		
1007	chrX	55341587	55341615	3500019915	23		55341587	55341615	8421504	3	6,12,5	0,8,23	g	350001991500000148	3-26						Rnai Inhibition Of Influenza Virus Replication 	.freshpatents.com	0	0		
1007	chrX	55349131	55349263	3500225003	50		55349131	55349263	8421504	2	40,10	0,122	c	350022500300000059	0-50						Molekulargenetische Untersuchung bei inkompletter station&#xe4;rer Nachtblind heit (CSNB2)	b.uni-muenchen.de	0	0		
1007	chrX	55354762	55354846	3500449648	84		55354762	55354846	8421504	1	84	0	p	350044964800015007	0-84		9405708		0027-8424	Proceedings of the National Academy of Sciences	Predominance of the &#x03b1;1D subunit in L-type voltage-gated Ca2+ channels of hair cells in the chicken&#x2019;s&#x2009;cochlea	Kollmar	1997	10		
1007	chrX	55354762	55354846	3500067895	84		55354762	55354846	8421504	1	84	0	p	350006789500015007	0-84						Novel calcium channels and uses thereof	Kinet	2006	0		
1007	chrX	55368754	55372596	3500341572	50		55368754	55372596	8421504	3	6,14,30	0,2856,3812	c	350034157200000035,350034157200000037	0-20,0-30						 Stem Cells Of The Islets Of Langerhans And Their Use In Treating Diabetes Mellitus 	www.docstoc.com	0	0		SYP
1007	chrX	55368754	55372596	3500247779	50		55368754	55372596	8421504	3	6,14,30	0,2856,3812	c	350024777900000033,350024777900000035	0-20,0-30						Pancreatic stem cells and their use in transplantation	Abraham	2001	0		SYP
1007	chrX	55368754	55372596	3500018451	50		55368754	55372596	8421504	3	6,14,30	0,2856,3812	c	350001845100000033,350001845100000035	0-20,0-30						Stem Cells Of The Islets Of Langerhans And Their Use In Treating Diabetes Mellitus 	.freshpatents.com	0	0		SYP
1007	chrX	55371776	55371799	3500223486	23		55371776	55371799	8421504	1	23	0	c	350022348600000027	0-23						Differentiation of human osteosarcoma 3AB-OS stem-like cells in derivatives of the three primary germ layers as a useful in vitro model to develop several purposes	www.scirp.org	0	0		SYP
1007	chrX	55388307	55388331	3500285298	24		55388307	55388331	8421504	1	24	0	c	350028529800000053	0-24						Research Commons at the University of Waikato Copyright Statement	ons.waikato.ac.nz	0	0		
1008	chrX	55456773	55456796	3500100292	23		55456773	55456796	8421504	1	23	0	c	350010029200000038	7-30						METHOD FOR PRODUCING GLYCOPROTEIN HAVING MANNOSE RESIDUE AS NON-REDUCING END OF SUGAR CHAIN - Patent application	www.faqs.org	0	0		
1008	chrX	55492364	55494903	3500002606	312		55492364	55494903	8421504	5	1,57,76,148,30	0,371,598,1645,2509	p	350000260600015002,350000260600015005	0-159,0-153						Untersuchung der Regulation und Interaktionen der Aktivierungsinduzierten Cytidindeaminase (AID) in humanen B-Lymphozyten	b.uni-muenchen.de	0	0		TFE3
1008	chrX	55492746	55494909	3500336590	306		55492746	55494909	8421504	4	46,76,148,36	0,216,1263,2127	p	350033659000015018	306-612						Supporting Information	www.pnas.org	0	0		TFE3
1009	chrX	55576935	55576959	3500169844	24		55576935	55576959	8421504	1	24	0	c,g	350016984400000028,350016984400000028	0-24,0-24						SURGICAL ATTENUATION OF CONGENITAL PORTOSYSTEMIC SHUNTS IN DOGS	ive.library.uu.nl	0	0		PIM2
1009	chrX	55580843	55587928	3500329910	1161		55580843	55587928	8421504	10	91,38,75,58,152,189,198,33,302,25	0,1489,1533,1614,3931,5054,5249,5453,5489,7060	p	350032991000015014,350032991000015013	0-1149,0-1164						Compositions and methods for engineering probiotic yeast	Mccoy	2011	0		PQBP1,SLC35A2
1009	chrX	55580843	55587928	3500219960	1188		55580843	55587928	8421504	5	91,183,152,737,25	0,1489,3931,5054,7060	p	350021996000015010,350021996000015011	0-1179,0-1164						Compositions and Methods For Engineering Probiotic Yeast	McCoy	2010	0		
1009	chrX	55580843	55587928	3500122734	1161		55580843	55587928	8421504	10	91,38,75,58,152,189,198,33,302,25	0,1489,1533,1614,3931,5054,5249,5453,5489,7060	p	350012273400015013,350012273400015014	0-1164,0-1149						COMPOSITIONS AND METHODS FOR ENGINEERING PROBIOTIC YEAST - GLYCOSYN, INC.	www.sumobrain.com	0	0		PQBP1,SLC35A2
1009	chrX	55586559	55586585	3500067216	23		55586559	55586585	8421504	2	8,15	0,11	c	350006721600000205	1-24						DNA Vaccines Encoding Antigen Linked to a Domain That Binds CD40 - Patent application	www.faqs.org	0	0		
1009	chrX	55587903	55587931	3500446445	28		55587903	55587931	8421504	1	28	0	c	350044644500000021	16-44						Production of galactosylated glycoproteins in lower eukaryotes	Davidson	2005	0		
1009	chrX	55587903	55587931	3500025054	28		55587903	55587931	8421504	1	28	0	c	350002505400000021	16-44						Production of galactosylated glycoproteins in lower eukaryotes	Davidson	2007	0		
1009	chrX	55667618	55672430	3500192099	43		55667618	55672430	8421504	4	15,7,6,15	0,16,4790,4797	g	350019209900000004,350019209900000005	0-22,7-28						QUINOBENZOXAZINE ANALOGS AND METHODS OF USING THEREOF	Whitten	2008	0		
1010	chrX	55713117	55715443	3500240316	46		55713117	55715443	8421504	2	27,19	0,2307	c	350024031600000014,350024031600000001	0-27,5-24						Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome	tologylibrary.org	0	0		
1010	chrX	55713145	55713730	3500094055	156		55713145	55713730	8421504	2	57,99	0,486	p	350009405500015003	0-156						Mutationof GATA3 inhumanbreasttumors	genome.unc.edu	0	0		GATA1
1010	chrX	55713178	55713685	3500312130	69		55713178	55713685	8421504	3	24,9,36	0,453,471	p	350031213000015036	0-69						C. elegans epidermal seam development	ev.biologists.org	0	0		GATA1
1010	chrX	55713701	55713726	3500084765	23		55713701	55713726	8421504	2	15,8	0,17	c	350008476500000029	12-35						Endoglucanases	www.devileye.net	0	0		
1010	chrX	55714395	55714418	3500070544	23		55714395	55714418	8421504	1	23	0	c	350007054400000012	0-23						Design and Molecular Characterization of C-Kit Transgene Construct during Spermatogenesis in Mice	w.omicsonline.org	0	0		
1011	chrX	55904450	55904473	3500288816	23		55904450	55904473	8421504	1	23	0	c	350028881600000001	4-27						Porcupine-mediated lipid-modification regulates the activity and distribution of Wnt proteins in the chick neural tube	ev.biologists.org	0	0		PORCN
1011	chrX	55947206	55947419	3500149607	210		55947206	55947419	8421504	3	7,193,10	0,9,203	c	350014960700000013	22-233						Isolation, Cloning, Sequencing and Functional analysis of -casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis) - Patent application	www.faqs.org	0	0		
1011	chrX	55947399	55947439	3500217581	33		55947399	55947439	8421504	3	10,17,6	0,11,34	c	350021758100000164	3-36					Patent	Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods (Patent US:5604116)	Abrams	1997	0		
1013	chrX	56163980	56164003	3500369501	23		56163980	56164003	8421504	1	23	0	c	350036950100000162	5-28						Protein kinases	Hoekstra	1994	0		
1013	chrX	56163980	56164003	3500090353	23		56163980	56164003	8421504	1	23	0	c	350009035300000159	5-28					Patent	Protein kinases (Patent US:5686412)	Hoekstra	1997	0		
1013	chrX	56194017	56194043	3500130848	24		56194017	56194043	8421504	2	5,19	0,7	g	350013084800000889	11-35						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
1014	chrX	56253547	56253571	3500446607	24		56253547	56253571	8421504	1	24	0	c	350044660700000003	11-35						Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases	Garabedian	2006	0		UXT
1014	chrX	56253547	56253571	3500429153	24		56253547	56253571	8421504	1	24	0	c	350042915300000003	11-35						METHOD FOR SCREENING TRANSCRIPTIONAL COREGULATORY PROTEINS OF TRANSCRIPTION FACTORS, AND ANDROGEN RECEPTOR TRANSCRIPTIONAL COREGULATORY PROTEINS AS TARGETS FOR ANDROGEN RECEPTOR-DEPENDENT DISEASES	Garabedian	2007	0		UXT
1014	chrX	56253547	56253571	3500304942	24		56253547	56253571	8421504	1	24	0	c	350030494200000003	11-35		11854421	10.1091/mbc.01-10-0513	1059-1524	Molecular Biology of the Cell	Identification and Characterization of ART-27, a Novel Coactivator for the Androgen Receptor N Terminus	Markus	2002	5		UXT
1014	chrX	56253568	56254094	3500464199	43		56253568	56254094	8421504	3	21,13,9	0,238,517	c,g	350046419900000028,350046419900000028,350046419900000029	0-21,0-21,0-22				0021-8812		Adipocyte metabolism and cellularity are related to differences in adipose tissue maturity between Holstein and Charolais or Blond d&#x2019;Aquitaine fetuses 	animalscience.org	0	2		UXT
1014	chrX	56254151	56258284	3500463464	58		56254151	56258284	8421504	3	7,34,17	0,8,4116	c	350046346400000017,350046346400000008	13-71,20-40						TRANSITION COWS: HEPATIC ENDOCANNABINOID SYSTEM GENE EXPRESSION IN RESPONSE TO PREPARTAL PLANE OF NUTRITION AND THE EFFECTS OF GENETIC MERIT ON GENES OF LIPID METABOLISM IN ADIPOSE TISSUE MUHAMMAD JAWAD KHAN	eals.illinois.edu	0	0		
1014	chrX	56265490	56265516	3500300648	23		56265490	56265516	8421504	2	10,13	0,13	g	350030064800000301	22-45						Methods and targets for identifying compounds for regulating angiogenesis - Patent application	www.faqs.org	0	0		
1014	chrX	56268849	56268990	3500186119	141		56268849	56268990	8421504	1	141	0	p	350018611900015107	0-141						Introduction to Bioinformatics - oxford	www.koshika.co.in	0	0		ELK1
1014	chrX	56268849	56268990	3500095373	141		56268849	56268990	8421504	1	141	0	p	350009537300015107	0-141						Introduction to Bioinformatics - oxford	www.bio-nica.info	0	0		ELK1
1014	chrX	56272822	56272891	3500309106	69		56272822	56272891	8421504	1	69	0	p	350030910600015000	0-69			10.1038/sj.onc.1203197	${footerJournalISSN}		Molecular characterization of a zebrafish TCF ETS-domain transcription factor		2000	0		ELK1
1014	chrX	56273263	56273291	3500171455	23		56273263	56273291	8421504	2	14,9	0,19	g	350017145500000367	22-45						Dna diagnostics based on mass spectrometry	Braun	1998	0		
1014	chrX	56273732	56273879	3500256442	63		56273732	56273879	8421504	2	30,33	0,114	p	350025644200015002	30-93		21976515	10.1523/JNEUROSCI.2890-11.2011	0270-6474	The Journal of Neuroscience	Alterations of Molecular and Behavioral Responses to Cocaine by Selective Inhibition of Elk-1 Phosphorylation	Besnard	2011	7		ELK1
1014	chrX	56273956	56273983	3500315569	27		56273956	56273983	8421504	1	27	0	c	350031556900000001,350031556900000000	8-35,2-29		14712312	10.1038/sj.cgt.7700652	0929-1903	Cancer Gene Therapy	Antiproliferative activity of G-quartet-containing oligonucleotides generated by a novel single-stranded DNA expression system	McMicken	2003	3		
1014	chrX	56273956	56273983	3500194289	27		56273956	56273983	8421504	1	27	0	c	350019428900000006	2-29						NUCLEIC ACID-MEDIATED SHAPE CONTROL OF NANOPARTICLES - Patent application	www.faqs.org	0	0		
1014	chrX	56273957	56273983	3500234863	26		56273957	56273983	8421504	1	26	0	c	350023486300000293	3-29						GUANOSINE-RICH OLIGONUCLEOTIDES AS AGENTS FOR INDUCING CELL DEATH IN EUKARYOTIC CELLS - Patent application	www.faqs.org	0	0		
1014	chrX	56273957	56273983	3500205257	26		56273957	56273983	8421504	1	26	0	c	350020525700000000	0-26		18381443	10.1158/0008-5472.CAN-07-5723	0008-5472	Cancer Research	The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells	Soundararajan	2008	8		
1014	chrX	56273958	56273983	3500090162	25		56273958	56273983	8421504	1	25	0	c	350009016200000004	17-42						Anti-idiotypic Antibodies against an Antibody to the Platelet Glycoprotein (GP) IIb-IIIa Complex Mimic GP IIb-IIIa by Recognizing Fibrinogen*	www.jbc.org	0	0		
1014	chrX	56273959	56273983	3500098622	24		56273959	56273983	8421504	1	24	0	c	350009862200000000	7-31						Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same - Patent application	www.faqs.org	0	0		
1014	chrX	56289645	56289708	3500211555	63		56289645	56289708	8421504	1	63	0	p	350021155500015011	0-63						INVESTIGATION INTO THE FUNCTIONS OF THE POLLEN SPECIFIC	ertations.wsu.edu	0	0		CFP
1014	chrX	56308030	56308056	3500402871	26		56308030	56308056	8421504	1	26	0	c	350040287100000003	0-26						Fernando G&#xf3;mez-Pinilla, Zhe Ying, Roland R. Roy, Raffaella Molteni and V. Reggie Edgerton J Neurophysiol 88:2187-2195, 2002. &#x20ac;doi:10.1152/jn.00152	people.usd.edu	0	0		
1014	chrX	56308030	56308056	3500199679	26		56308030	56308056	8421504	1	26	0	c	350019967900000006	0-26						Afferent Input Modulates Neurotrophins and Synaptic Plasticity in the Spinal Cord	www.societyns.org	0	0		
1014	chrX	56308030	56308056	3500081379	26		56308030	56308056	8421504	1	26	0	c	350008137900000006	0-26						Afferent Input Modulates Neurotrophins and Synaptic Plasticity in the Spinal Cord	jn.physiology.org	0	0		
1014	chrX	56340425	56343108	3500257787	405		56340425	56343108	8421504	11	45,45,45,45,8,37,45,45,23,22,45	0,48,1112,1160,1208,1470,1510,1788,1836,2613,2638	p	350025778700015050,350025778700015049,350025778700015047,350025778700015046,350025778700015045,350025778700015044,350025778700015042,350025778700015041,350025778700015040	0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45,0-45						Human Antibodies Derived From Immunized Xenomice 	.freshpatents.com	0	0		
1014	chrX	56340484	56343138	3500302580	40		56340484	56343138	8421504	2	20,20	0,2634	c,g	350030258000000018,350030258000000018,350030258000000017,350030258000000017	0-20,0-20,0-20,0-20			10.1002/art.20596	1529-0131	Arthritis & Rheumatism	Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes - Martin - 2004 - Arthritis & Rheumatism - Wiley Online Library	Martin	2004	0		
1014	chrX	56340505	56341592	3500182158	40		56340505	56341592	8421504	2	19,21	0,1066	c,g	350018215800000007,350018215800000007,350018215800000006	0-19,0-19,0-21						METHODS AND USES OF HYPOXIC COMPARTMENT CELLS - Patent application	www.faqs.org	0	0		
1014	chrX	56341923	56341946	3500426620	23		56341923	56341946	8421504	1	23	0	c	350042662000000002	17-40					Neoplasia (New York, N.Y.)	SEL1L Affects Human Pancreatic Cancer Cell Cycle and Invasiveness through Modulation of PTEN and Genes Related to Cell&#x2013;Matrix Interactions	Monica	2005	0		
1014	chrX	56341937	56342235	3500175186	47		56341937	56342235	8421504	2	23,24	0,274	c,g	350017518600000011,350017518600000010,350017518600000010	0-23,0-24,0-24			10.1124/jpet.105.087569	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Collagen and Aggrecan Degradation Is Blocked in Interleukin-1-Treated Cartilage Explants by an Inhibitor of I&#x03ba;B Kinase through Suppression of Metalloproteinase Expression	Pattoli	2005	0		TIMP1
1014	chrX	56341937	56342235	3500053132	47		56341937	56342235	8421504	2	23,24	0,274	c,g	350005313200000011,350005313200000010,350005313200000010	0-23,0-24,0-24						Collagen and Aggrecan Degradation is Blocked in Interleukin-1- Treated Cartilage Explants by an Inhibitor of I&#x03ba;B Kinase through Suppression of Metalloproteinase Expression.	aspetjournals.org	0	0		TIMP1
1014	chrX	56341965	56343067	3500355126	43		56341965	56343067	8421504	2	22,21	0,1081	c	350035512600000041,350035512600000040	0-22,0-21						Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis	biomedcentral.com	0	0		TIMP1
1014	chrX	56341965	56342222	3500202018	68		56341965	56342222	8421504	3	19,31,18	0,26,239	c,g	350020201800000007,350020201800000007,350020201800000008,350020201800000006	0-19,0-19,0-23,0-26						Gene expression of single articular chondrocytes. - ResearchGate	.researchgate.net	0	0		
1014	chrX	56342208	56342232	3500343115	24		56342208	56342232	8421504	1	24	0	c	350034311500000003	24-48						Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension	j.ersjournals.com	0	0		
1014	chrX	56342208	56342232	3500327832	24		56342208	56342232	8421504	1	24	0	c,g	350032783200000029,350032783200000029	0-24,0-24			10.2119/2006-00028.Paulissen		Molecular Medicine	Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma	Genevieve	2006	0		TIMP1
1014	chrX	56342208	56342232	3500212801	24		56342208	56342232	8421504	1	24	0	g	350021280100000006	24-48						Effects of 3,5,3 -Triiodothyronine on the Invasive Potential and the Expression of Integrins and Matrix Metalloproteinases in Cultured Early Placental Extravillous Trophoblasts	.endojournals.org	0	0		
1014	chrX	56342208	56342231	3500023532	23		56342208	56342231	8421504	1	23	0	c	350002353200000002	0-23		23521530	10.1111/boc.201200064	1768-322X	Biology of the Cell	Inflammatory environment induces gingival tissue-specific mesenchymal stem cells to differentiate towards a pro-fibrotic phenotype - Li - 2013 - Biology of the Cell - Wiley Online Library	Li	2013	0		
1014	chrX	56342209	56343067	3500440561	46		56342209	56343067	8421504	2	25,21	0,837	c,g	350044056100000006,350044056100000006,350044056100000005	0-25,0-25,0-21		16505094	10.1158/1535-7163.MCT-05-0289	1535-7163	Molecular Cancer Therapeutics	Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function	Rouleau	2006	5		TIMP1
1014	chrX	56342209	56343067	3500333601	46		56342209	56343067	8421504	2	25,21	0,837	c,g	350033360100000006,350033360100000006,350033360100000005	0-25,0-25,0-21						Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function	.aacrjournals.org	0	0		TIMP1
1014	chrX	56349528	56351251	3500409802	40		56349528	56351251	8421504	2	20,20	0,1703	c,g	350040980200000006,350040980200000006,350040980200000007	0-20,0-20,0-20		16247481	10.1038/sj.onc.1209068	0950-9232	Oncogene	SWI&sol;SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines	Watanabe	2005	6		SYN1
1014	chrX	56349528	56351251	3500040165	40		56349528	56351251	8421504	2	20,20	0,1703	c,g	350004016500000006,350004016500000006,350004016500000007	0-20,0-20,0-20		16247481	10.1038/sj.onc.1209068	0950-9232	Oncogene	SWI&sol;SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines	Watanabe	2005	6		SYN1
1015	chrX	56447859	56447885	3500300526	23		56447859	56447885	8421504	2	13,10	0,16	g	350030052600000014	7-30					Patent	Method for reducing 1,2-diglyceride content of an edible oil (Patent US:8440435)	Wassell	2013	0		
1015	chrX	56447859	56447885	3500267013	23		56447859	56447885	8421504	2	13,10	0,16	g	350026701300000006	7-30						Method	Kreij	2007	0		
1017	chrX	56659106	56659273	3500337609	25		56659106	56659273	8421504	2	10,15	0,152	c	350033760900000007	8-33		15314155	10.1128/MCB.24.17.7444-7455.2004	0270-7306	Molecular and Cellular Biology	BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage	Schoenfeld	2004	6		
1017	chrX	56659106	56659273	3500216497	25		56659106	56659273	8421504	2	10,15	0,152	c	350021649700000007	8-33			10.1128/MCB.24.17.7444-7455.2004		Molecular and Cellular Biology	BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage	Alan	2004	0		
1017	chrX	56660297	56660693	3500379669	23		56660297	56660693	8421504	3	7,4,12	0,10,384	c	350037966900000004	0-23						EXPRESSION OF CATALASE IN TRICHODERMA - DANISCO US INC., GENENCOR DIVISION	www.sumobrain.com	0	0		
1017	chrX	56660297	56660693	3500102840	23		56660297	56660693	8421504	3	7,4,12	0,10,384	c	350010284000000004	0-23						Expression of Catalase in Trichoderma - Patent application	www.faqs.org	0	0		
1017	chrX	56675325	56676323	3500187783	237		56675325	56676323	8421504	3	89,115,33	0,753,965	p	350018778300015039	3-240						Oxford_SGC_Clones_web	www.docstoc.com	0	0		CDK16
1017	chrX	56676079	56677586	3500023385	54		56676079	56677586	8421504	2	21,33	0,1474	p	350002338500015012	0-54		21898343	10.1002/art.30637	1529-0131	Arthritis & Rheumatism	Origin and functional activity of the membrane-bound glucocorticoid receptor - Strehl - 2011 - Arthritis & Rheumatism - Wiley Online Library	Strehl	2011	0		CDK16
1017	chrX	56687140	56688156	3500122978	76		56687140	56688156	8421504	4	24,27,10,15	0,48,76,1001	c	350012297800000012,350012297800000013,350012297800000011	0-24,0-27,0-25		11140696	10.1038/labinvest.3780194	0023-6837	Laboratory Investigation	Variability in Gene Expression Patterns of Ewing Tumor Cell Lines Differing in EWS-FLI1 Fusion Type	Aryee	2000	4		UBA1
1017	chrX	56687184	56700615	3500403930	238		56687184	56700615	8421504	8	42,6,38,9,47,37,11,48	0,957,1332,1658,10459,11300,11597,13383	c	350040393000000175,350040393000000169,350040393000000133,350040393000000128,350040393000000116	0-48,0-47,0-47,0-48,0-48						Human ubiquitin conjugating enzyme	Draetta	1994	0		
1017	chrX	56688467	56698888	3500000128	144		56688467	56698888	8421504	3	48,48,48	0,1670,10373	p	350000012800015059,350000012800015054,350000012800015015	0-48,0-48,0-48						Ubiquitin Ligase Assay 	.freshpatents.com	0	0		
1017	chrX	56698840	56698885	3500342938	45		56698840	56698885	8421504	1	45	0	p	350034293800015015	0-45						Assays For Identifying Ubiquitin Agents And For Identifying Agents That Modify The Activity Of Ubiquitin Agents 	.freshpatents.com	0	0		
1017	chrX	56699865	56699904	3500058326	39		56699865	56699904	8421504	1	39	0	c	350005832600000072	9-48						Ubiquitin conjugating enzymes	Rolfe	1996	0		
1017	chrX	56719028	56719053	3500283738	24		56719028	56719053	8421504	2	4,20	0,5	c	350028373800000020	3-27						Discovery and Characterization of a Novel Microtubule Associated Protein Involved in Cellulose Biosynthesis	w.diva-portal.org	0	0		RBM10
1018	chrX	56797374	56797400	3500428732	23		56797374	56797400	8421504	3	5,11,7	0,6,19	g	350042873200000007	25-49						OLIGONUCLEOTIDE BASED ANALYTE DETECTION METHOD	Kojic	2011	0		
1019	chrX	56940066	56940092	3500071524	23		56940066	56940092	8421504	2	12,11	0,15	c	350007152400000223	4-28					Patent	Interleukin-18 (IL-18) receptor polypeptides and their uses (Patent US:6087116)	Kurimoto	2000	0		
1019	chrX	56941460	56941484	3500116250	23		56941460	56941484	8421504	2	19,4	0,20	c	350011625000000003	8-34				0021-8812		Identification of differentially expressed transcripts in bovine rumen and abomasum using a differential display method 	animalscience.org	0	2		
1019	chrX	56941896	57012527	3500383894	1731		56941896	57012527	8421504	13	162,225,93,161,131,164,97,147,84,275,96,84,12	0,752,1322,2596,3017,5564,7421,8940,9805,11200,12815,22369,70619	p	350038389400015005	0-1731						MOESIN, CAVEOLIN 1 AND YES ASSOCIATED PROTEIN 1 AS PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN BREAST CANCERS - Patent application	www.faqs.org	0	0		MSN
1019	chrX	56941896	57012527	3500369558	1302		56941896	57012527	8421504	11	162,225,93,161,131,104,84,150,96,84,12	0,752,1322,2596,3017,5564,11238,11325,12815,22369,70619	p	350036955800015004,350036955800015003	0-876,0-426						Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers	Finn	2007	0		MSN
1019	chrX	56941899	57012527	3500059758	1728		56941899	57012527	8421504	13	159,225,93,161,131,164,97,147,84,275,96,84,12	0,749,1319,2593,3014,5561,7418,8937,9802,11197,12812,22366,70616	p	350005975800015000	0-1728						miRNA and Autism by Robin Kaai on Prezi	prezi.com/uyi4msy	0	0		MSN
1019	chrX	56964289	56964337	3500018435	48		56964289	56964337	8421504	1	48	0	p	350001843500015000	0-48						Differential Protein Expression Profiling by iTRAQ-Two-dimensional LC-MS/MS of Human Bladder Cancer EJ138 Cells Transfected with the Metastasis Suppressor KiSS-1	www.mcponline.org	0	0		RDX
1021	chrX	57227366	57227395	3500201852	25		57227366	57227395	8421504	2	18,7	0,22	g	350020185200000507	12-40						Feline Interferon-alpha Proteins 	.freshpatents.com	0	0		
1032	chrX	58710417	58710465	3500449359	48		58710417	58710465	8421504	1	48	0	p	350044935900015112,350044935900015045	0-45,0-45						Gene Encoding a Guanine Nucleotide Exchange Factor and Its Gene Product - Patent application	www.faqs.org	0	0		ARHGEF9
1033	chrX	58799952	58811631	3500064240	850		58799952	58811631	8421504	21	48,48,77,19,51,45,48,48,13,29,10,86,48,95,2,46,3,45,35,13,41	0,727,1254,1627,1694,2356,2662,2758,2854,3845,3976,4795,5193,5290,5972,7778,7872,9046,9139,9767,11638	c	350006424000000203,350006424000000200,350006424000000195,350006424000000194,350006424000000192,350006424000000191,350006424000000187,350006424000000185,350006424000000183,350006424000000180,350006424000000179,350006424000000177,350006424000000175,350006424000000174,350006424000000169,350006424000000167,350006424000000165,350006424000000156	0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,6-48,0-48,0-48,0-48,0-47,0-48,0-48,0-48,0-48,7-48						Ubiquitin ligases, and uses related thereto	Beach	1997	0		
1033	chrX	58802585	58802695	3500317153	39		58802585	58802695	8421504	3	20,5,14	0,90,96	c,g	350031715300000029,350031715300000029,350031715300000001,350031715300000001,350031715300000028,350031715300000000	0-20,0-20,0-20,0-20,0-19,0-19						Markers for Viral Infections and Other Inflammatory Responses - Patent application	www.faqs.org	0	0		
1033	chrX	58819144	58819169	3500225183	25		58819144	58819169	8421504	1	25	0	c	350022518300000003	16-41						Bioinformatically detectable group of novel regulatory genes and uses thereof	Bentwich	2002	0		
1033	chrX	58819144	58819169	3500189043	25		58819144	58819169	8421504	1	25	0	c	350018904300000003	16-41						BIOINFORMATICALLY DETECTABLE GROUP OF NOVEL HIV REGULATORY GENES AND USES THEREOF	Bentwich	2003	0		
1033	chrX	58819203	58820107	3500125321	44		58819203	58820107	8421504	2	22,22	0,882	c	350012532100000102,350012532100000000	0-22,0-22						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		HUWE1,MIR98
1033	chrX	58820031	58820114	3500408810	83		58820031	58820114	8421504	1	83	0	c,g	350040881000000019,350040881000000019	0-83,0-83						Compositions And Methods For Modulation Of Pdx-1 	freshpatents.com	0	0		HUWE1
1033	chrX	58820083	58820107	3500406992	24		58820083	58820107	8421504	1	24	0	c,g	350040699200000017,350040699200000016	5-29,7-31		15172979	10.1158/0008-5472.CAN-04-0637	0008-5472	Cancer Research	Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival	Takamizawa	2004	8		
1033	chrX	58820083	58820107	3500331643	24		58820083	58820107	8421504	1	24	0	c	350033164300000017	5-29						Reduced Expression of the let-7MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival	.aacrjournals.org	0	0		
1033	chrX	58820083	58820107	3500052702	24		58820083	58820107	8421504	1	24	0	c	350005270200000017	5-29		15172979	10.1158/0008-5472.CAN-04-0637	0008-5472	Cancer Research	Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival	Takamizawa	2004	8		
1037	chrX	59357762	59358033	3500085562	96		59357762	59358033	8421504	2	48,48	0,223	c	350008556200000705,350008556200000708	0-48,0-48						Methods and compositions for assaying analytes	Yuan	1999	0		
1037	chrX	59372521	59372548	3500340821	23		59372521	59372548	8421504	2	8,15	0,12	c	350034082100000070	18-41						Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation	Makarov	2005	0		
1038	chrX	59381067	59382347	3500065685	627		59381067	59382347	8421504	3	150,239,238	0,243,1042	p	350006568500015140,350006568500015074,350006568500015081,350006568500015052,350006568500015060,350006568500015125,350006568500015139,350006568500015066	0-171,0-171,0-174,0-180,0-144,0-147,0-144,0-48						Planaria EST Database	an.bio.keio.ac.jp	0	0		SMC1A
1039	chrX	59553464	59584131	3500396017	5658		59553464	59584131	8421504	28	251,78,123,171,135,124,182,159,120,159,182,163,120,195,182,213,148,106,359,139,180,138,600,70,200,185,606,370	0,4076,6421,6834,7361,8233,8463,9682,11550,11797,12582,12850,18845,19076,23559,23830,24082,24836,25879,26829,27451,27770,28091,28973,29186,29494,29680,30297	p,c,g	350039601700000021,350039601700015012,350039601700015014,350039601700015048,350039601700015015,350039601700015049,350039601700015016,350039601700015018,350039601700015050,350039601700015019,350039601700015051,350039601700015020,350039601700015022,350039601700015024,350039601700015011,350039601700000020,350039601700015026,350039601700015077,350039601700015053,350039601700015027,350039601700015054,350039601700015028,350039601700000003,350039601700015079,350039601700000008,350039601700015055,350039601700015056,350039601700015030,350039601700015081,350039601700015057,350039601700015031,350039601700015082,350039601700015058,350039601700015032,350039601700000001,350039601700015059,350039601700015033,350039601700015060,350039601700015034,350039601700015061,350039601700015035,350039601700015062,350039601700015036,350039601700015063,350039601700015037,350039601700000006,350039601700015064,350039601700015038,350039601700015065,350039601700015039,350039601700015040,350039601700015067,350039601700015041,350039601700015068,350039601700015042,350039601700015069,350039601700015043,350039601700015044,350039601700015045,350039601700000010,350039601700015046,350039601700015047,350039601700000022	0-5209,0-150,0-150,0-150,0-150,0-150,0-150,0-150,3-150,0-150,0-150,0-150,0-150,0-150,0-1140,0-1226,0-150,0-150,0-150,0-150,0-150,0-150,0-20,0-150,0-27,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-20,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-21,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-150,0-21,0-150,3-81,0-370						&#xb0ea;&#xa5df;&#xa6a8;&#xa55c;&#xa46a;&#xbec7; &#xa5cd;&#xaaab;&#xacec;&#xa7de;&#xace3;&#xa873;&#xa9d2; &#xbad3;&#xa468;&#xbdd7;&#xa4e5; &#xa548;&#xa5cd;&#xaaab;&#xb8ea;&#xb054;&#xa4ce;&#xa4c0;&#xa46c;&#xa5cd;&#xaaab;&#xaa6b;&#xbfef;&#xb4de;&#xa8c5;&#xa	u.lib.ncku.edu.tw	0	0		
1039	chrX	59566181	59566226	3500164528	45		59566181	59566226	8421504	1	45	0	p	350016452800015036	0-45						JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS - Patent application	www.faqs.org	0	0		KDM5A
1040	chrX	59657118	59657146	3500060793	23		59657118	59657146	8421504	2	9,14	0,14	g	350006079300000054	21-44						Salicylic acid binding protein	Chen	1995	0		
1040	chrX	59667783	59667807	3500222744	23		59667783	59667807	8421504	2	9,14	0,10	g	350022274400000028	14-37						CLONING AND CHARACTERIZATION OF 5' FLANKING REGIONS OF A HUMAN AGGRECANASE-1 GENE	Kumar	2009	0		
1040	chrX	59672849	59673897	3500292615	740		59672849	59673897	8421504	7	21,144,48,48,48,48,383	0,40,280,376,472,568,665	c	350029261500000005,350029261500000089,350029261500000082,350029261500000165,350029261500000164,350029261500000080,350029261500000161,350029261500000077,350029261500000159,350029261500000073,350029261500000157,350029261500000071,350029261500000069,350029261500000152,350029261500000067,350029261500000066,350029261500000150,350029261500000065,350029261500000064,350029261500000147,350029261500000063,350029261500000062	10-31,10-31,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-47,0-48,0-47,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48,0-48					Patent	Polynucleotides encoding SREB3 receptor (Patent US:6808899)	Matsumoto	2004	0		
1041	chrX	59884040	59891160	3500277309	34		59884040	59891160	8421504	2	21,13	0,7107	c	350027730900000005	10-44						Novel nucleolar gtpases and method for controlling proliferation of cells	Balasundaram	2007	0		
130	chrX	59895547	59901648	3500316278	522		59895547	59901648	8421504	9	51,138,1,17,68,37,78,54,78	0,2620,2764,5183,5203,5767,5807,5888,6023	p	350031627800015020	0-525						Methods for controlling proliferation of cells	Mckay	2005	0		
130	chrX	59895547	59901648	3500279850	522		59895547	59901648	8421504	9	51,138,1,17,68,37,78,54,78	0,2620,2764,5183,5203,5767,5807,5888,6023	p	350027985000015020	0-525						Methods for controlling proliferation of cells	Mckay	2004	0		
1044	chrX	60235827	60241517	3500256061	28		60235827	60241517	8421504	2	23,5	0,5685	c	350025606100000094	45-73						Tesi doctoral: ESTUDI DEL PAPER DE LA FRUCTOSA-2,6-BISFOSFAT I LaENZIM FOSFOFRUCTO-2-QUINASA/FRUC	www.tdx.cat	0	0		
1045	chrX	60322754	60322777	3500307798	23		60322754	60322777	8421504	1	23	0	c	350030779800000002	12-35		15087475	10.1124/jpet.104.065532	1521-0103 (Online)	Journal of Pharmacology and Experimental Therapeutics	Unique Properties of a Renal Sulfotransferase, St1d1, in Dopamine Metabolism	Shimada	2004	0		
1047	chrX	60587552	60587578	3500348845	23		60587552	60587578	8421504	3	4,5,14	0,5,12	c	350034884500000065	21-44						Nucleic acids encoding hencatoporetic stem cell receptor flk-2 - Patent # 5185438 - PatentGenius	.patentgenius.com	0	0		
1047	chrX	60587552	60587578	3500282272	23		60587552	60587578	8421504	3	4,5,14	0,5,12	c	350028227200000066	21-44					Patent	Nucleic acids encoding hencatoporetic stem cell receptor flk-2 (Patent US:5185438)	Lemischka	1993	0		
1047	chrX	60588095	60588125	3500156792	25		60588095	60588125	8421504	2	8,17	0,13	c	350015679200000004	0-25			10.1186/1479-5876-1-5	1479-5876	Journal of Translational Medicine	rIFN-&#xce;&#xb3;-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition	Melichar	2003	3		
1047	chrX	60588095	60588125	3500146055	25		60588095	60588125	8421504	2	8,17	0,13	c	350014605500000000,350014605500000003	0-25,0-25						Arginase II - Patent # 6316199 - PatentGenius	.patentgenius.com	0	0		
1047	chrX	60588095	60588125	3500063737	25		60588095	60588125	8421504	2	8,17	0,13	c	350006373700000000	0-25						Arginase II	www.devileye.net	0	0		
131	chrX	61472634	61473437	3500390562	76		61472634	61473437	8421504	3	29,23,24	0,87,779	c	350039056200000017,350039056200000018,350039056200000014	11-40,13-36,14-38						Construction of HCC-targeting artificial miRNAs using natural miRNA precursors	-publications.com	0	0		
131	chrX	61472702	61473415	3500435547	47		61472702	61473415	8421504	2	24,23	0,690	c	350043554700000001,350043554700000000	0-24,0-23		18246122	10.1038/onc.2008.6	0950-9232	Oncogene	MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer	Garofalo	2008	6		MIR222
131	chrX	61472702	61473415	3500433700	47		61472702	61473415	8421504	2	24,23	0,690	c,g	350043370000000001,350043370000000001,350043370000000005,350043370000000005,350043370000000000,350043370000000004	0-21,0-21,0-24,0-24,0-23,0-23						RESEARCH Open Access High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma	onal-medicine.com	0	0		MIR222
131	chrX	61472702	61473415	3500423784	47		61472702	61473415	8421504	2	24,23	0,690	c	350042378400000210,350042378400000091,350042378400000090,350042378400000209	0-23,0-24,0-23,0-22						Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same - Patent application	www.faqs.org	0	0		MIR222
131	chrX	61472702	61473415	3500391290	47		61472702	61473415	8421504	2	24,23	0,690	c	350039129000000006,350039129000000005	0-24,0-23						glioma cell growth by targeting p27kip1 in vitro and in vivo	-publications.com	0	0		MIR222
131	chrX	61472702	61473415	3500287752	46		61472702	61473415	8421504	2	23,23	0,690	c,g	350028775200000047,350028775200000046,350028775200000046	0-23,0-23,0-23						TREATING CANCER WITH VIRAL NUCLEIC ACID	Russell	2008	0		MIR222
131	chrX	61472702	61473415	3500280470	44		61472702	61473415	8421504	2	21,23	0,690	c	350028047000000040,350028047000000039	11-32,11-34						NUCLEIC ACID DETECTION AND QUANTIFICATION BY POST-HYBRIDIZATION LABELING AND UNIVERSAL ENCODING - Patent application	www.faqs.org	0	0		MIR222
131	chrX	61472702	61473415	3500277393	44		61472702	61473415	8421504	2	21,23	0,690	c	350027739300000037,350027739300000036	0-21,0-23						Compositions and methods for micro-RNA expression profiling of cancer stem cells	Meister	2008	0		MIR222
131	chrX	61472702	61473415	3500254286	44		61472702	61473415	8421504	2	21,23	0,690	c	350025428600000008,350025428600000007	0-21,0-23						Mirnas dysregulated in triple-negative breast cancer	Richer	2011	0		MIR222
131	chrX	61472702	61473415	3500244257	47		61472702	61473415	8421504	2	24,23	0,690	c	350024425700000085,350024425700000084	0-24,0-23						Microrna-198 as a tumor suppressor in pancreatic cancer	Yao	2013	0		MIR222
131	chrX	61472702	61473415	3500234875	44		61472702	61473415	8421504	2	21,23	0,690	c	350023487500000015,350023487500000001,350023487500000014,350023487500000000	0-21,0-21,0-23,0-23						MicroRNA-221/222NegativelyRegulatesEstrogenReceptor andIsAssociatedwithTamoxifenResistancein BreastCancer	www.jbc.org	0	0		MIR222
131	chrX	61472702	61473415	3500171540	44		61472702	61473415	8421504	2	21,23	0,690	c,g	350017154000000008,350017154000000008,350017154000000007	0-21,0-21,0-23						MiRNAs dysregulated in triple-negative breast cancer	Richer	2010	0		MIR222
131	chrX	61472702	61473415	3500143616	47		61472702	61473415	8421504	2	24,23	0,690	c,g	350014361600000004,350014361600000001,350014361600000001,350014361600000003,350014361600000000	0-24,0-21,0-21,0-23,0-23		20618998	10.1186/1471-2407-10-367	1471-2407	BMC Cancer	MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN	Chun-zhi	2010	3		MIR222
131	chrX	61472702	61473415	3500131966	47		61472702	61473415	8421504	2	24,23	0,690	c	350013196600000085,350013196600000084	0-24,0-23						MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER - Patent application	www.faqs.org	0	0		MIR222
131	chrX	61472702	61473415	3500125321	47		61472702	61473415	8421504	2	24,23	0,690	c	350012532100000005,350012532100000055	0-24,0-23						NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs	Naguibneva	2008	0		MIR222
131	chrX	61472702	61473415	3500003566	44		61472702	61473415	8421504	2	21,23	0,690	c	350000356600000008,350000356600000007	0-21,0-23						MIRNAS DYSREGULATED IN TRIPLE-NEGATIVE BREAST CANCER	Richer	2010	0		MIR222
131	chrX	61472702	61473415	3500000997	44		61472702	61473415	8421504	2	21,23	0,690	c	350000099700000015,350000099700000001,350000099700000014,350000099700000000	0-21,0-21,0-23,0-23		18790736	10.1074/jbc.M806041200	0021-9258	Journal of Biological Chemistry	MicroRNA-221/222 Negatively Regulates Estrogen Receptor&#x03b1; and Is Associated with Tamoxifen Resistance in Breast Cancer	Zhao	2008	5		MIR222
1053	chrX	61472702	61472727	3500218293	25		61472702	61472727	8421504	1	25	0	c	350021829300000002,350021829300000001,350021829300000008,350021829300000006	1-25,0-24,1-26,0-20						Nucleic acid purification with a binding matrix	Bitner	2012	0		MIR222
1053	chrX	61472702	61472727	3500206818	25		61472702	61472727	8421504	1	25	0	c	350020681800000044,350020681800000036,350020681800000052,350020681800000043	0-24,0-24,0-24,0-25						Method For Producing Novel Hipsc By Means Of Sirna Introduction	Miura	2011	0		MIR222
1053	chrX	61472702	61472726	3500442647	24		61472702	61472726	8421504	1	24	0	c	350044264700000001,350044264700000002,350044264700000006	0-24,1-25,0-20						Nucleic acid purification with a binding matrix	Bitner	2006	0		MIR222
1053	chrX	61472702	61472726	3500415206	24		61472702	61472726	8421504	1	24	0	c	350041520600000005	0-24		17875710	10.1158/0008-5472.CAN-07-1936	0008-5472	Cancer Research	MicroRNA Signatures in Human Ovarian Cancer	Iorio	2007	8		MIR222
1053	chrX	61472702	61472726	3500322980	24		61472702	61472726	8421504	1	24	0	c	350032298000000031	0-24						AD (Leave blank)	handle.dtic.mil	0	0		MIR222
1053	chrX	61472702	61472726	3500270080	24		61472702	61472726	8421504	1	24	0	c,g	350027008000000002,350027008000000002,350027008000000001,350027008000000001,350027008000000006,350027008000000006	1-25,1-25,0-24,0-24,0-20,0-20						Nucleic acid purification with a binding matrix	Bitner	2008	0		MIR222
1053	chrX	61472702	61472726	3500266504	24		61472702	61472726	8421504	1	24	0	c	350026650400000001,350026650400000002	0-24,1-25						Small RNA purification	Bitner	2007	0		MIR222
1053	chrX	61472702	61472726	3500209871	24		61472702	61472726	8421504	1	24	0	c	350020987100000002,350020987100000001	1-25,0-24						Small RNA purification	Bitner	2007	0		MIR222
1053	chrX	61472702	61472726	3500180264	24		61472702	61472726	8421504	1	24	0	c	350018026400000005	0-24		17875710	10.1158/0008-5472.CAN-07-1936	0008-5472	Cancer Research	MicroRNA Signatures in Human Ovarian Cancer	Iorio	2007	8		MIR222
1053	chrX	61472702	61472726	3500175748	24		61472702	61472726	8421504	1	24	0	c	350017574800000002,350017574800000001,350017574800000006	1-25,0-24,0-20					Patent	Nucleic acid purification with a binding matrix (Patent US:8030034)	Bitner	2011	0		MIR222
1053	chrX	61472702	61472726	3500170677	24		61472702	61472726	8421504	1	24	0	c	350017067700000025	0-24		21559294	10.1371/journal.pone.0019524		PLoS ONE	Expression Patterns and miRNA Regulation of DNA Methyltransferases in Chicken Primordial Germ Cells	Rengaraj	2011	0		MIR222
1053	chrX	61472702	61472726	3500119147	24		61472702	61472726	8421504	1	24	0	c	350011914700000020	0-24						(COX -2) regulation in colon cancer cells	rato.cib.unibo.it	0	0		MIR222
1053	chrX	61472702	61472726	3500093593	24		61472702	61472726	8421504	1	24	0	c	350009359300000002,350009359300000001,350009359300000006	1-25,0-24,0-20						Nucleic acid purification with a binding matrix	Bitner	2007	0		MIR222
1054	chrX	61473392	61473416	3500441909	24		61473392	61473416	8421504	1	24	0	c	350044190900000001,350044190900000000	0-23,0-24		23372675	10.1371/journal.pone.0053906	1932-6203	PLOS ONE	PLOS ONE: MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma	Zhao	2013	4		MIR222
1054	chrX	61473392	61473415	3500243960	23		61473392	61473415	8421504	1	23	0	c	350024396000000018	0-23		22984580	10.1371/journal.pone.0044873		PLoS ONE	Systematic Analysis of Small RNAs Associated with Human Mitochondria by Deep Sequencing: Detailed Analysis of Mitochondrial Associated miRNA	Lakshmi	2012	0		MIR222
1054	chrX	61473392	61473415	3500139708	23		61473392	61473415	8421504	1	23	0	c	350013970800000051,350013970800000023	0-23,0-23						METHODS AND COMPOSITIONS FOR THE TREATMENT OF ERYTHROCYTE DISEASES - Patent application	www.faqs.org	0	0		MIR222
1054	chrX	61473392	61473415	3500072342	23		61473392	61473415	8421504	1	23	0	c	350007234200000003	14-37		21385827	10.1093/nar/gkr086		Nucleic Acids Research	Activation of a microRNA response in trans reveals a new role for poly(A) in translational repression	Emiliano	July	0		MIR222
1057	chrX	61984240	61984268	3500230031	23		61984240	61984268	8421504	2	9,14	0,14	c	350023003100000178	25-48						METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCER - Patent application	www.faqs.org	0	0		
1057	chrX	61984240	61984268	3500061628	23		61984240	61984268	8421504	2	9,14	0,14	c	350006162800000177	25-48						Method For Diagnosing Non-small Cell Lung Cancer 	.freshpatents.com	0	0		KDM6A
1058	chrX	62012349	62012372	3500456257	23		62012349	62012372	8421504	1	23	0	c	350045625700000151	0-23						 Diagnosis of Copper Transport Disorders - Current Protocols 	rentprotocols.com	0	0		
1061	chrX	62410093	62410118	3500148959	24		62410093	62410118	8421504	2	20,4	0,21	g	350014895900000090	22-46						INTEIN-MODIFIED ENZYMES, THEIR PRODUCTION AND INDUSTRIAL APPLICATION - Patent application	www.faqs.org	0	0		
1061	chrX	62437105	62437131	3500106839	23		62437105	62437131	8421504	2	12,11	0,15	g	350010683900000076	10-33						Plant having improved tolerance to various environmental stresses, method of constructing the same and polyamine metabolism-relating enzyme gene - US Patent 7238861 Description	ww.patentstorm.us	0	0		
1064	chrX	62879831	62889830	3500145104	285		62879831	62889830	8421504	2	60,225	0,9774	p	350014510400015000	0-285						Multi-functional norrin is a ligand for the LGR4 receptor	cs.biologists.org	0	0		NDP
1065	chrX	62976062	63025241	3500335859	150		62976062	63025241	8421504	3	46,95,9	0,46076,49170	p	350033585900015001	0-150						Monoamine oxidase-A is highly expressed by the human corpus luteum of pregnancy 3 4 Yumi Takao	uction-online.org	0	0		MAOB
1065	chrX	62976076	63025254	3500354850	103		62976076	63025254	8421504	5	28,6,26,21,22	0,46100,46107,46136,49156	c	350035485000000008,350035485000000004,350035485000000014	0-28,0-32,0-43						Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase	Abell	1995	0		MAOB
133	chrX	62976098	63146523	3500266732	480		62976098	63146523	8421504	15	10,34,48,48,47,48,41,41,43,36,12,5,43,7,17	0,46040,46078,98290,99914,101004,115384,118939,121180,146374,147612,158883,159765,166919,170408	c	350026673200000074,350026673200000075,350026673200000084,350026673200000088,350026673200000090,350026673200000097,350026673200000100,350026673200000104,350026673200000063,350026673200000058,350026673200000049	0-44,0-48,0-48,1-48,0-48,0-41,0-41,5-48,0-48,0-48,6-30						DETECTION, ISOLATION AND USES OF RENALASE (MONOAMINE OXIDASE C) - Patent application	www.faqs.org	0	0		
1066	chrX	63091494	63091517	3500424022	23		63091494	63091517	8421504	1	23	0	c	350042402200000000	23-46			10.1111/j.1471-4159.2007.04921.x	1471-4159	Journal of Neurochemistry	Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells - Fitzgerald - 2007 - Journal of Neurochemistry - Wiley Online Library	Fitzgerald	2007	0		
1067	chrX	63242319	63242344	3500203287	23		63242319	63242344	8421504	2	9,14	0,11	g	350020328700000004	4-28		16000737	10.1099/mic.0.27865-0	1350-0872	Microbiology	Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer?	Tormo	2005	3		
1068	chrX	63343740	63343765	3500322270	25		63343740	63343765	8421504	1	25	0	g	350032227000000048,350032227000000045	24-49,34-59						Novel human proteins, polynucleotides encoding them and methods of using the same	Spytek	2002	0		
1075	chrX	64246129	64253798	3500166438	38		64246129	64253798	8421504	4	5,14,14,5	0,8,7648,7664	g	350016643800000237,350016643800000117	5-24,1-20						Antibodies to IL-6 and use thereof - Patent application	www.faqs.org	0	0		
1075	chrX	64285159	64285183	3500130848	24		64285159	64285183	8421504	1	24	0	g	350013084800000946	19-48						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
1076	chrX	64386540	64386563	3500130848	23		64386540	64386563	8421504	1	23	0	g	350013084800000585	9-32						Method Of Heat-stabilizing A-glucan Phosphorylase(gp) 	.freshpatents.com	0	0		
1079	chrX	64873911	64873938	3500235183	23		64873911	64873938	8421504	3	5,5,13	0,6,14	g	350023518300000167	11-34						The high bone mass gene of 11q13.3	J*P*Qia Lu Li 	2003	0		
1082	chrX	65191607	65191632	3500257654	24		65191607	65191632	8421504	2	20,4	0,21	g	350025765400000045	0-25						Black Aspergillus species: implications for ochratoxin A in Australian grapes and wine	s.adelaide.edu.au	0	0		
1084	chrX	65437701	65498257	3500447740	981		65437701	65498257	8421504	9	57,138,150,54,123,154,88,82,135	0,8899,12993,13223,22218,24344,46926,58257,60421	p	350044774000015010	3-984						PIG MODEL FOR BREAST CANCER, MITOCHONDRIA RELATED PROTEIN FOLDING DISORDERS AND/OR EPIDERMOLYSIS BULLOSA SIMPLEX - Patent application	www.faqs.org	0	0		OTC
1084	chrX	65437701	65498257	3500258331	981		65437701	65498257	8421504	9	57,138,150,54,123,154,88,82,135	0,8899,12993,13223,22218,24344,46926,58257,60421	p	350025833100015005,350025833100015003	3-984,0-255						PIG MODEL FOR BREAST CANCER, MITOCHONDRIA RELATED PROTEIN FOLDING DISORDERS AND/OR EPIDERMOLYSIS BULLOSA SIMPLEX	Kragh	2008	0		OTC
1084	chrX	65446608	65446713	3500185023	47		65446608	65446713	8421504	2	24,23	0,82	c,g	350018502300000007,350018502300000006,350018502300000006	0-24,0-23,0-23		23967260	10.1371/journal.pone.0071897	1932-6203	PLOS ONE	PLOS ONE: Survival of Primary Human Hepatocytes and Death of Induced Pluripotent Stem Cells in Media Lacking Glucose and Arginine	Tomizawa	2013	4		
1085	chrX	65630499	65630526	3500425929	24		65630499	65630526	8421504	2	17,7	0,20	c	350042592900000172	19-43						Osf2/Cbfa1 nucleic acids and methods of use therefor	Ducy	1998	0		
1089	chrX	66117035	66117064	3500030042	25		66117035	66117064	8421504	3	11,7,7	0,14,22	g	350003004200000062	11-36						Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease	Damschroder	2007	0		
1097	chrX	67184376	67184402	3500011388	23		67184376	67184402	8421504	2	6,17	0,9	g	350001138800000212	16-42						Vaccine and antitoxin for the treatment of C. difficile disease	Kink	1997	0		
1106	chrX	68346441	68346467	3500251092	26		68346441	68346467	8421504	1	26	0	g	350025109200000003	34-60						TH&#xc9;RAPIE G&#xc9;NIQUE DE LA DYSTROPHIE MUSCULAIRE DE DUCHENNE Utilisation de transg&#xe8;nes de la dystrophine chez le mod&#xe8;le canin	.theses.ulaval.ca	0	0		
1106	chrX	68402904	68402931	3500140502	23		68402904	68402931	8421504	2	13,10	0,17	g	350014050200000035	10-33			10.1128/JVI.00892-07		Journal of Virology	7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G 	Tao	2007	0		
1108	chrX	68618471	68618498	3500011388	23		68618471	68618498	8421504	2	16,7	0,20	g	350001138800000311	3-26						Vaccine and antitoxin for the treatment of C. difficile disease	Kink	1997	0		
1110	chrX	68880117	68880140	3500326034	23		68880117	68880140	8421504	1	23	0	g	350032603400000694	22-45						 Selection Method 	www.docstoc.com	0	0		
1110	chrX	68942995	68943019	3500071244	24		68942995	68943019	8421504	1	24	0	g	350007124400000023	0-24						ScienceDirect.com - Neuromuscular Disorders - Molecular cloning and protein expression of Duchenne muscular dystrophy gene products in porcine retina	sciencedirect.com	0	0		DMD
1111	chrX	68994723	68994748	3500140741	24		68994723	68994748	8421504	2	18,6	0,19	g	350014074100000013	2-26						Anti-glypican-3 antibody	G*A*La Zha Er 	2013	0		
1111	chrX	68994723	68994748	3500010160	24		68994723	68994748	8421504	2	18,6	0,19	g	350001016000000019,350001016000000029	13-37,13-37						Expression vector for secreting antibody fragment using signal sequence and method for mass-producing antibody fragment - US Patent 7718399 Description	ww.patentstorm.us	0	0		
1113	chrX	69276600	69276623	3500342210	23		69276600	69276623	8421504	1	23	0	g	350034221000000011	4-27						Muscular Dystrophy Application of Molecular Methodologies in Muscular Dystrophies.	www.scribd.com	0	0		
1113	chrX	69289258	69289283	3500246549	25		69289258	69289283	8421504	1	25	0	g	350024654900000208,350024654900000253	21-48,21-48						Haemophilus influenzae type IV pili - Patent application	www.faqs.org	0	0		
1115	chrX	69475357	69475384	3500093009	23		69475357	69475384	8421504	2	6,17	0,10	g	350009300900000037	0-23						Mechanisms and enzymes involved in SARS coronavirus genome expression	r.sgmjournals.org	0	0		
1115	chrX	69500034	69500060	3500065112	23		69500034	69500060	8421504	2	13,10	0,16	g	350006511200000252	10-33					Patent	Vaccine for clostridium botulinum neurotoxin (Patent US:5919665)	Williams	1999	0		
1115	chrX	69500034	69500060	3500011388	23		69500034	69500060	8421504	2	13,10	0,16	g	350001138800000257	10-33						Vaccine and antitoxin for the treatment of C. difficile disease	Kink	1997	0		
1120	chrX	70192626	70192653	3500428782	25		70192626	70192653	8421504	2	20,5	0,22	g	350042878200000121	4-29						Identification of new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation	Gottesman	2003	0		
1133	chrX	71879808	71879833	3500235157	23		71879808	71879833	8421504	3	4,15,4	0,5,21	g	350023515700000097	25-48						METHODS AND COMPOSITIONS FOR TREATING P. ACNES - Patent application	www.faqs.org	0	0		
1136	chrX	72254867	72254890	3500043721	23		72254867	72254890	8421504	1	23	0	g	350004372100000480	14-40						NUCLEIC ACIDS CODING FOR ADHESION FACTOR OF GROUP B STREPTOCOCCUS, ADHESION FACTORS OF GROUP B STREPTOCOCCUS AND FURTHER USES THEREOF - Patent application	www.faqs.org	0	0		
1136	chrX	72330393	72330419	3500173520	23		72330393	72330419	8421504	2	7,16	0,10	g	350017352000000020	25-48						DNA encoding horseshoe crab amebocyte lysate factor G subunit A	Iwanaga	1999	0		
1137	chrX	72368109	72368142	3500130973	24		72368109	72368142	8421504	3	12,6,6	0,17,27	g	350013097300000169,350013097300000025	7-31,7-31						METHODS FOR IDENTIFYING CANCER RISK - Patent application	www.faqs.org	0	0		
1138	chrX	72534398	72534470	3500328177	72		72534398	72534470	8421504	1	72	0	p	350032817700015011	0-72						Intervening Archaea DNA gene	www.pnas.org	0	0		POLA1
1138	chrX	72534438	72534464	3500035935	25		72534438	72534464	8421504	2	4,21	0,5	c	350003593500000010,350003593500000027	0-25,0-25						Method For Preparing Active Nanoarchaeum Equitans Dna Polymerase And The Active Dna Polymerase Prepared By The Method 	.freshpatents.com	0	0		POLA1
1138	chrX	72598116	72598161	3500155190	45		72598116	72598161	8421504	1	45	0	p	350015519000015018	0-45						Incorporation of modified nucleotides by archaeon dna polymerases and related methods	Buzby	2002	0		POLA1
1138	chrX	72598116	72598161	3500018804	45		72598116	72598161	8421504	1	45	0	p	350001880400015018	0-45						Incorporation Of Modified Nucleotides By Archaeon Dna Polymerases And Related Methods 	.freshpatents.com	0	0		POLA1
1138	chrX	72603307	72613766	3500328177	246		72603307	72613766	8421504	4	86,34,45,81	0,1334,6763,10378	p	350032817700015007,350032817700015004	0-120,6-132						Intervening Archaea DNA gene	www.pnas.org	0	0		POLA1
1138	chrX	72613691	72613766	3500315788	75		72613691	72613766	8421504	1	75	0	p	350031578800015024	0-75						Eukaryotic DNA Polymerase Amino Acid Sequence Required for 3' &#x2192; 5' Exonuclease Activity	www.jstor.org	0	0		POLA1
1140	chrX	72803326	72803349	3500409586	23		72803326	72803349	8421504	1	23	0	c	350040958600000002	16-39						Influence of external resistance on electrogenesis, methanogenesis, and anode prokaryotic communities in microbial fuel cells. - ResearchGate	.researchgate.net	0	0		
1140	chrX	72803326	72803349	3500395269	23		72803326	72803349	8421504	1	23	0	c	350039526900000002	16-39						Akpinar et al. Antimicrobial activity and antibiotic resistance of Lactobacillus delbrueckii ssp. bulgaricus and Streptococcus thermophilus strains isolated from Turkish homemade yoghurts. Afr. J. Microbiol. Res. 2011	demicjournals.org	0	0		
1140	chrX	72803326	72803349	3500389620	23		72803326	72803349	8421504	1	23	0	c	350038962000000002	16-39						Mycobacterium Diversity and Pyrene Mineralization in Petroleum-Contaminated Soils	aem.asm.org	0	0		
1140	chrX	72803326	72803349	3500379436	23		72803326	72803349	8421504	1	23	0	c	350037943600000045	13-36						Journal of Microbiological Methods	005.pasteur.ac.ir	0	0		
1140	chrX	72803326	72803349	3500358723	23		72803326	72803349	8421504	1	23	0	c	350035872300000000	16-39			10.1128/AEM.67.1.22-32.2001		Applied and Environmental Microbiology	Molecular Ecology of Tetracycline Resistance: Development and Validation of Primers for Detection of Tetracycline Resistance Genes Encoding Ribosomal Protection Proteins	R.	2001	0		
1140	chrX	72803326	72803349	3500250413	23		72803326	72803349	8421504	1	23	0	c	350025041300000012	16-39						A Survey of Culturable Methanogens in Contrasting Marine Sediments, their Substrates and Physiological Characteristics	orca.cf.ac.uk	0	0		
1140	chrX	72803326	72803349	3500222632	23		72803326	72803349	8421504	1	23	0	g	350022263200000015	16-39						Alexandra Sofia Diversidade molecular e transfer&#xea;ncia de integr&#xf5;es Trindade Rodrigues de &#xe1;guas residuais Silva Moura Molecular diversity and transferability of integrons from wastewaters	ria.ua.pt/bitstre	0	0		
1140	chrX	72803326	72803349	3500194553	23		72803326	72803349	8421504	1	23	0	c	350019455300000002	16-39		21075886	10.1128/AEM.01392-10	0099-2240	Applied and Environmental Microbiology	Influence of External Resistance on Electrogenesis, Methanogenesis, and Anode Prokaryotic Communities in Microbial Fuel Cells	Jung	2011	4		
1140	chrX	72803326	72803349	3500169614	23		72803326	72803349	8421504	1	23	0	c	350016961400000002	16-39		21075886	10.1128/AEM.01392-10		Applied and Environmental Microbiology	Influence of External Resistance on Electrogenesis, Methanogenesis, and Anode Prokaryotic Communities in Microbial Fuel Cells 	Sokhee	2011	0		
1140	chrX	72846107	72872316	3500136867	354		72846107	72872316	8421504	5	54,77,78,90,55	0,1345,9775,23556,26154	p	350013686700015025,350013686700015024,350013686700015014,350013686700015013	0-180,0-180,0-174,0-174						Regulation of pyruvate dehydrogenase kinase 4 (PDK4) through protein-protein interaction and its role in apoptosis	dspace.wits.ac.za	0	0		PDK3
1141	chrX	72880755	72880778	3500051637	23		72880755	72880778	8421504	1	23	0	g	350005163700000019	0-23						Genetic Diversity among Bacillus anthracis Soil Isolates at Fine Geographic Scales	aem.asm.org	0	0		
1141	chrX	72908298	72908326	3500228465	23		72908298	72908326	8421504	2	13,10	0,18	g	350022846500000022	0-30						NOVEL ANTIBODY AND USE IN DIAGNOSIS AND THERAPY OF ARTHROPATHIES - Patent application	www.faqs.org	0	0		
1142	chrX	73120065	73120088	3500179508	23		73120065	73120088	8421504	1	23	0	c	350017950800000040	6-29						Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules - Patent application	www.faqs.org	0	0		
1142	chrX	73120806	73120898	3500060967	64		73120806	73120898	8421504	3	23,20,21	0,47,71	c,g	350006096700000057,350006096700000058,350006096700000056,350006096700000056	0-23,0-20,0-21,0-21						METHODS IN MOLECULAR BIOLOGY Pyrosequencing Protocols	ahmonged.webs.com	0	0		
1142	chrX	73120925	73121358	3500182474	433		73120925	73121358	8421504	1	433	0	c	350018247400000011	9-442						Procedure for the sex determination of embryos in mammals especially applied to bovine embryos	Fr	1995	0		
1142	chrX	73120925	73121341	3500207430	416		73120925	73121341	8421504	1	416	0	c	350020743000000001,350020743000000008,350020743000000004,350020743000000002	5-25,0-396,0-22,0-22						Method for determining the sex of an embryo	Kirkpatrick	1994	0		
1142	chrX	73120928	73123782	3500144157	42		73120928	73123782	8421504	2	23,19	0,2835	c,g	350014415700000001,350014415700000004,350014415700000004	0-23,0-19,0-19						The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251	www.jeccr.com	0	0		ZFX
1142	chrX	73120942	73121341	3500424573	399		73120942	73121341	8421504	1	399	0	c	350042457300000002,350042457300000001	0-204,0-208						determination applicable bovine embryos derived from IVM and IVF	uction-online.org	0	0		
1142	chrX	73120945	73121341	3500239038	396		73120945	73121341	8421504	1	396	0	c	350023903800000008,350023903800000004,350023903800000002	0-396,0-22,0-22						Method for determining the sex of an embryo - US Patent 5759772 Description	ww.patentstorm.us	0	0		
1142	chrX	73120954	73121201	3500463542	44		73120954	73121201	8421504	2	22,22	0,225	c	350046354200000003,350046354200000002	0-22,0-22						METHOD FOR SEX BIASING SPERMATOZOA - VICAM, L.P.	www.sumobrain.com	0	0		
1142	chrX	73120954	73121201	3500237331	44		73120954	73121201	8421504	2	22,22	0,225	c	350023733100000009,350023733100000008	0-22,0-22						Identifica&#xe7;&#xe3;o do sexo em caprinos e ovinos Dissertacao-cp048392	pt.scribd.com	0	0		
1142	chrX	73120954	73121201	3500068100	44		73120954	73121201	8421504	2	22,22	0,225	c	350006810000000003,350006810000000002	0-22,0-22						Method for sex biasing spermatozoa	Cohen	2007	0		
1142	chrX	73121074	73121128	3500282923	42		73121074	73121128	8421504	2	20,22	0,32	c	350028292300000017,350028292300000016	0-20,0-22						Minisequencing on Functionalised Self-Assembled Monolayer as a Simple Approach for Single Nucleotide Polymorphism Analysis of Cattle	.znaturforsch.com	0	0		
1142	chrX	73121162	73121185	3500436395	23		73121162	73121185	8421504	1	23	0	c	350043639500000000	0-23						CENTER for BIOLOGICAL DIVERSITY	lic.energy.ca.gov	0	0		
1142	chrX	73121379	73121524	3500210493	77		73121379	73121524	8421504	3	28,26,23	0,79,122	c,g	350021049300000003,350021049300000003,350021049300000002,350021049300000000	0-28,0-28,0-26,0-23						Interfamilial characterization of a region of the ZFX and ZFY genes facilitates sex determination in cetaceans and other mammals	swfsc.noaa.gov	0	0		ZFX
1142	chrX	73121379	73121524	3500123015	105		73121379	73121524	8421504	4	28,28,26,23	0,41,79,122	c	350012301500000003,350012301500000004,350012301500000002,350012301500000000	0-28,0-28,0-26,0-23						Interfamilial characterization of a region of the ZFX and ZFY genes facilitates sex determination in cetaceans and other mammals	.researchgate.net	0	0		
1142	chrX	73121525	73122413	3500171216	42		73121525	73122413	8421504	2	21,21	0,867	c,g	350017121600000001,350017121600000001,350017121600000000,350017121600000000	0-21,0-21,0-21,0-21						PRIMATE TOTIPOTENT AND PLURIPOTENT STEM CELLS PRODUCED BY SOMATIC CELL NUCLEAR TRANSFER	Mitalipov	2011	0		ZFX
1142	chrX	73121525	73122413	3500018123	42		73121525	73122413	8421504	2	21,21	0,867	c,g	350001812300000001,350001812300000001,350001812300000000	0-21,0-21,0-21						Primate Totipotent And Pluripotent Stem Cells Produced By Somatic Cell Nuclear Transfer 	.freshpatents.com	0	0		ZFX
1142	chrX	73122489	73135861	3500034426	471		73122489	73135861	8421504	6	44,10,9,98,150,160	0,573,586,1223,1539,13212	p	350003442600015009,350003442600015005	0-63,213-621						Comparison ofhuman ZFYandZFX transcripts	www.pnas.org	0	0		
1143	chrX	73226429	73226456	3500407226	26		73226429	73226456	8421504	2	16,10	0,17	g	350040722600000006	1-27		18281481	10.1158/0008-5472.CAN-07-5892		Cancer research	Use of a Cryptic Splice Site for the Expression of Huntingtin Interacting Protein 1 in Select Normal and Neoplastic Tissues	Chiron	2008	0		
1145	chrX	73415855	73415882	3500355181	25		73415855	73415882	8421504	2	17,8	0,19	g	350035518100000006	6-31						Method for maintaining pluripotency of stem/progenitor cells	Ng	2007	0		
1145	chrX	73472459	73472519	3500158030	60		73472459	73472519	8421504	1	60	0	p	350015803000015017	0-60						Virginia Tech : ETD 06042005 : TMLPeterson_ETD	ww.coursehero.com	0	0		PRDX4
1146	chrX	73557715	73557738	3500131497	23		73557715	73557738	8421504	1	23	0	c	350013149700000020	21-44						SIGNALING FROM MATRIX ELASTICITY AND TGF- 1 TO CELLS OF THE CARDIAC VALVE	gradworks.umi.com	0	0		
1146	chrX	73651830	73651858	3500321849	25		73651830	73651858	8421504	2	14,11	0,17	g	350032184900000016	9-34					Patent	Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes (Patent US:6500931)	Tempest	2002	0		
1152	chrX	74357055	74357080	3500045731	24		74357055	74357080	8421504	2	9,15	0,10	g	350004573100000024	2-26						Supporting Information	www.pnas.org	0	0		
1153	chrX	74452015	74465332	3500370730	23		74452015	74465332	8421504	2	19,4	0,13313	c	350037073000000000	0-23		20835608	10.1590/S0074-02762010000500005	0074-0276	Mem&#xf3;rias do Instituto Oswaldo Cruz	Mem&#xf3;rias do Instituto Oswaldo Cruz - Mycobacterium leprae downregulates the expression of PHEX in Schwann cells and osteoblasts	Silva	2010	2		PHEX
1153	chrX	74452015	74465332	3500296551	23		74452015	74465332	8421504	2	19,4	0,13313	c	350029655100000000	0-23		20835608	10.1590/S0074-02762010000500005	0074-0276	Mem&#xf3;rias do Instituto Oswaldo Cruz	Mem&#xf3;rias do Instituto Oswaldo Cruz - Mycobacterium leprae downregulates the expression of PHEX in Schwann cells and osteoblasts	Silva	2010	2		PHEX
1153	chrX	74551924	74556076	3500411929	40		74551924	74556076	8421504	3	8,12,20	0,1206,4132	c	350041192900000013,350041192900000012	0-20,0-20						Journal of Dental Research	oedencolombia.com	0	0		PHEX
1156	chrX	74968905	74968929	3500431874	23		74968905	74968929	8421504	2	17,6	0,18	c	350043187400000000	13-36		18559508	10.1158/0008-5472.CAN-07-5953	0008-5472	Cancer Research	Kr&#xfc;ppel-like Factor 4 Induces p27Kip1 Expression in and Suppresses the Growth and Metastasis of Human Pancreatic Cancer Cells	Wei	2008	8		
144	chrX	75353704	75459669	3500331596	2220		75353704	75459669	8421504	22	69,57,117,82,81,80,107,38,143,71,89,65,103,125,126,90,159,162,77,118,141,120	0,29387,52627,59393,76090,76892,77571,80394,80663,80982,88179,88453,88598,91153,93228,95348,97605,99539,102281,102879,105342,105845	p	350033159600015002	0-2220						bioinfo-btg10-grupo06 - Practica 2.2	06.wikispaces.com	0	0		RPS6KA3
144	chrX	75353704	75459669	3500295452	1851		75353704	75459669	8421504	20	69,57,117,82,81,80,107,38,143,71,46,28,125,30,159,162,77,118,141,120	0,29387,52627,59393,76090,76892,77571,80394,80663,80982,88179,88673,91153,93228,97605,99539,102281,102879,105342,105845	p	350029545200015026,350029545200015027,350029545200015028	0-891,0-183,0-777						Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer	Fritz	2011	0		RPS6KA3
144	chrX	75353704	75459669	3500245427	2220		75353704	75459669	8421504	22	69,57,117,82,81,80,107,38,143,71,89,65,103,125,126,90,159,162,77,118,141,120	0,29387,52627,59393,76090,76892,77571,80394,80663,80982,88179,88453,88598,91153,93228,95348,97605,99539,102281,102879,105342,105845	p	350024542700015003	0-2220						KEGG T01001: 27330	www.genome.jp	0	0		RPS6KA3
144	chrX	75353746	75459669	3500331596	2178		75353746	75459669	8421504	22	27,57,117,82,81,80,107,38,143,71,89,65,103,125,126,90,159,162,77,118,141,120	0,29345,52585,59351,76048,76850,77529,80352,80621,80940,88137,88411,88556,91111,93186,95306,97563,99497,102239,102837,105300,105803	p	350033159600015001	0-2178						bioinfo-btg10-grupo06 - Practica 2.2	06.wikispaces.com	0	0		RPS6KA3
1160	chrX	75413165	75459627	3500259393	64		75413165	75459627	8421504	3	14,5,45	0,16629,46417	p,c	350025939300000005,350025939300015002	0-19,0-45			10.1128/MCB.24.7.3025-3035.2004		Molecular and Cellular Biology	Ribosomal S6 Kinase (RSK) Regulates Phosphorylation of Filamin A on an Important Regulatory Site	Michele	2004	0		RPS6KA3
1160	chrX	75413165	75459627	3500004075	64		75413165	75459627	8421504	3	14,5,45	0,16629,46417	p,c	350000407500000005,350000407500015002	0-19,0-45		15024089	10.1128/MCB.24.7.3025-3035.2004	0270-7306	Molecular and Cellular Biology	Ribosomal S6 Kinase (RSK) Regulates Phosphorylation of Filamin A on an Important Regulatory Site	Woo	2004	6		RPS6KA3
1160	chrX	75446958	75447004	3500271050	46		75446958	75447004	8421504	1	46	0	c	350027105000000250	0-46						Cloning by complementation and related processes	Colicelli	1991	0		
1160	chrX	75456696	75459180	3500373289	46		75456696	75459180	8421504	3	5,18,23	0,2350,2461	c	350037328900000002,350037328900000003	0-23,0-23						ScienceDirect.com - FEBS Letters - Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray	sciencedirect.com	0	0		RPS6KA3
1160	chrX	75459582	75459651	3500392848	69		75459582	75459651	8421504	1	69	0	p	350039284800015003	0-69		10706690		0022-1767	The Journal of Immunology	Role of Mitogen-Activated Protein Kinase Cascades in Mediating Lipopolysaccharide-Stimulated Induction of Cyclooxygenase-2 and IL-1&#x03b2; in RAW264 Macrophages	Caivano	2000	6		RPS6KA3
1160	chrX	75459582	75459651	3500329831	69		75459582	75459651	8421504	1	69	0	p	350032983100015015	0-69					Patent	Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof (Patent EP:1109918)	Alessi	2006	0		RPS6KA3
1160	chrX	75459582	75459651	3500321034	69		75459582	75459651	8421504	1	69	0	p	350032103400015018	0-69					Patent	Mitogen- und stress-aktivierte proteinkinasen, die zwei kinase dom&#xe4;nen enthalten, und deren verwendungen Uses of mitogen-and stress-activated protein kinases that contain two kinase domains, and their (Patent DE:69933460)	Alessi	2007	0		RPS6KA3
1160	chrX	75459582	75459651	3500287967	69		75459582	75459651	8421504	1	69	0	p	350028796700015004	0-69						In vivo role of the phosphate groove of PDK1 de&#xfb01;ned by knockin mutation	cs.biologists.org	0	0		RPS6KA3
1160	chrX	75459582	75459651	3500257178	69		75459582	75459651	8421504	1	69	0	p	350025717800015062	0-69						Polypeptides, polynucleotides and uses thereof	Alessi	2001	0		RPS6KA3
1160	chrX	75459582	75459651	3500247142	69		75459582	75459651	8421504	1	69	0	p	350024714200015032	0-69					Patent	Polypeptides, polynucleotides and uses thereof (Patent US:7122360)	Alessi	2006	0		RPS6KA3
1162	chrX	75675178	75675203	3500340595	25		75675178	75675203	8421504	1	25	0	c	350034059500000131	4-29						ID H37Rv; SV 1; circular; unassigned DNA; STD; UNC; 4411538 BP. XX FH Key Location	genome.cshlp.org	0	0		
1164	chrX	75909815	75909843	3500203171	24		75909815	75909843	8421504	2	12,12	0,16	g	350020317100000000	0-24						Detection of collagen triple helix repeat containing-1 and nuclear factor (erythroid-derived 2)-like 3 in colorectal cancer. - ResearchGate	.researchgate.net	0	0		
1170	chrX	76786655	76786679	3500107392	23		76786655	76786679	8421504	2	4,19	0,5	g	350010739200000001	0-23						Virus du fowlpox recombinant, vecteurs d'expression de prot&#xe9;ines h&#xe9;terologues et vaccins pour la volaille d&#xe9;riv&#xe9;s de ce virus	Drillien	1989	0		
1171	chrX	76895814	76895843	3500155450	25		76895814	76895843	8421504	2	19,6	0,23	g	350015545000000009	14-39						Insight into molecular pathways of retinal metabolism, associated with vitellogenesis in zebrafish	do.physiology.org	0	0		
1174	chrX	77316402	77316431	3500448710	24		77316402	77316431	8421504	2	12,12	0,17	g	350044871000000003	0-24						p62/SQSTM1 IsaTargetGeneforTranscriptionFactorNRF2 andCreatesaPositiveFeedbackLoopbyInducing AntioxidantResponseElement-drivenGeneTranscription	www.jbc.org	0	0		
1174	chrX	77317638	77317689	3500002332	51		77317638	77317689	8421504	1	51	0	p	350000233200015168,350000233200015176	0-45,0-45						Antisense modulation of phosphorylase kinase Alpha 2 expression	Wyatt	2000	0		PHKA1
1178	chrX	77849799	77849827	3500384054	23		77849799	77849827	8421504	2	17,6	0,22	g	350038405400000007	0-23						APPROACHES TO MEASURING THE FREQUENCY OF ACHONDROPLASIA AND HYPOCHONDROPLASIA CAUSING FGFR-3 MUTATIONS IN HUMAN SPERM	etd.lsu.edu	0	0		
1180	chrX	78034474	78034498	3500114487	23		78034474	78034498	8421504	2	18,5	0,19	g	350011448700000000	4-29						The pydA pydB fusion gene produces an active dioxygenase hydrolase that degrades 3-hydroxy-4-pyridone, an intermediate of mimosine metabolism	.ctahr.hawaii.edu	0	0		
1183	chrX	78474114	78474138	3500010197	23		78474114	78474138	8421504	2	7,16	0,8	g	350001019700000037	15-40						Epiligrin, an epithelial ligand for integrins	Carter	1996	0		
1185	chrX	78686322	78686348	3500463958	23		78686322	78686348	8421504	2	10,13	0,13	g	350046395800000006	0-23						N-terminally chemically modified protein compositions and methods - Patent # 8258262 - PatentGenius	.patentgenius.com	0	0		
148	chrX	79533796	79568189	3500050415	113		79533796	79568189	8421504	6	21,25,14,8,21,24	0,79,137,34199,34303,34369	c	350005041500000010,350005041500000008,350005041500000006,350005041500000011,350005041500000009	20-41,25-50,0-22,0-21,0-24						Developmental expression and biological activity of gastrin-releasing peptide (GRP) and GRP receptors in the kidney	al.physiology.org	0	0		
1195	chrX	79969504	79969529	3500045939	25		79969504	79969529	8421504	1	25	0	g	350004593900000001	0-25			10.1371/journal.pone.0000414		PLoS ONE	The Role for HNF-1&#x03b2;-Targeted Collectrin in Maintenance of Primary Cilia and Cell Polarity in Collecting Duct Cells	Yanling	2007	0		
1195	chrX	80039323	80039368	3500083809	45		80039323	80039368	8421504	1	45	0	c	350008380900000055,350008380900000024	0-45,0-45						Novel Gene Disruptions, Compositions and Methods Relating Thereto - Patent application	www.faqs.org	0	0		
1195	chrX	80066852	80071211	3500062616	48		80066852	80071211	8421504	2	19,29	0,4330	c	350006261600000107	0-48						ANGIOTENSIN CONVERTING ENZYME HOMOLOG AND USES THEREFOR - Patent application	www.faqs.org	0	0		
1195	chrX	80074786	80074814	3500090345	24		80074786	80074814	8421504	3	7,13,4	0,10,24	c	350009034500000027	2-26						Anti-cd14 antibody fusion protein	Furusako	2012	0		
1196	chrX	80096178	80096205	3500192187	23		80096178	80096205	8421504	2	16,7	0,20	g	350019218700000002	7-30		21670171	10.1128/IAI.00135-11	0019-9567	Infection and Immunity	A Francisella tularensis Locus Required for Spermine Responsiveness Is Necessary for Virulence	Russo	2011	4		
1196	chrX	80146005	80146031	3500464585	23		80146005	80146031	8421504	2	16,7	0,19	g	350046458500000167	11-34						Caracteriza&#xe7;&#xe3;o de Metaloproteinases PIII a partir do DNA gen&#xf4;mico de Bothrops jararaca	www.teses.usp.br	0	0		
1196	chrX	80172733	80181494	3500172791	48		80172733	80181494	8421504	3	3,21,24	0,8688,8737	c,g	350017279100000020,350017279100000021,350017279100000021	0-24,0-24,0-24		20184744	10.1186/1471-2164-11-138	1471-2164	BMC Genomics	 Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Mitterhuemer	2010	4		
1196	chrX	80172733	80181494	3500120290	48		80172733	80181494	8421504	3	3,21,24	0,8688,8737	c	350012029000000020,350012029000000021	0-24,0-24						Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	biomedcentral.com	0	0		
1196	chrX	80172733	80181494	3500048191	48		80172733	80181494	8421504	3	3,21,24	0,8688,8737	c	350004819100000020,350004819100000021	0-24,0-24		20184744	10.1186/1471-2164-11-138		BMC Genomics	Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland	Simone	2010	0		
1196	chrX	80191980	80197862	3500424225	41		80191980	80197862	8421504	2	21,20	0,5862	c,g	350042422500000024,350042422500000025,350042422500000025	0-21,0-20,0-20						Incidence of apoptosis and transcript abundance in bovine follicular cells is associated with the quality of the enclosed oocyte. - ResearchGate	.researchgate.net	0	0		
1198	chrX	80408268	80408295	3500091681	23		80408268	80408295	8421504	2	14,9	0,18	g	350009168100000043	11-34						OBG3 globular head and uses thereof for decreasing body mass	Fruebis	2001	0		
1198	chrX	80439867	80473005	3500101538	41		80439867	80473005	8421504	3	21,5,15	0,33115,33123	g	350010153800000528,350010153800000631	6-29,16-36						SureChem - Document - WO/PCT - Patent No. 2001016312 - "NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION" - Description	www.surechem.org	0	0		
1202	chrX	80943016	80943040	3500342251	24		80943016	80943040	8421504	1	24	0	g	350034225100000057	1-25						US Patent # 6,066,491. Process for obtaining fungal resistant plants with recombinant polynucleotides encoding .beta.-1,3-glucanase modified for apoplast targeting - Patents.com	patents.com	0	0		KCNK10
1202	chrX	80996047	80996081	3500172572	29		80996047	80996081	8421504	4	5,7,13,4	0,7,16,30	g	350017257200000012	10-43						US Patent # 7,425,669. Transgenic plants expressing puroindolines and methods for producing such plants - Patents.com	www.patents.com	0	0		
1204	chrX	81145578	81145607	3500027825	25		81145578	81145607	8421504	3	8,12,5	0,11,24	g	350002782500000002	1-28						Opiate, cannabinoid, and estrogen receptors	Fimiani	1999	0		
1204	chrX	81220380	81220406	3500199170	23		81220380	81220406	8421504	2	8,15	0,11	g	350019917000000381	18-41							biomedcentral.com	0	0		
1205	chrX	81312560	81312588	3500238590	24		81312560	81312588	8421504	2	8,16	0,12	g	350023859000000000	2-26						Modified laminin and use thereof	Nakagawa	2012	0		
1209	chrX	81853437	81853462	3500449380	25		81853437	81853462	8421504	1	25	0	g	350044938000000248	8-43						Anti-hiv Antibody 	freshpatents.com	0	0		
1209	chrX	81862959	81862989	3500194519	25		81862959	81862989	8421504	2	8,17	0,13	g	350019451900000255	16-43						CLONING AND CHARACTERIZATION OF THE CAPSULE TRANSPORT GENE REGION FROM Haemophilus paragallinarum	etd.uovs.ac.za	0	0		
1210	chrX	81995710	81995734	3500442130	23		81995710	81995734	8421504	2	7,16	0,8	g	350044213000000011	1-30						US Patent # 6,783,756. Methods for regulating gene expression - Patents.com	www.patents.com	0	0		
1210	chrX	81995710	81995734	3500232815	23		81995710	81995734	8421504	2	7,16	0,8	g	350023281500000035	1-30						Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals.	Byrne	1995	0		
1210	chrX	81995710	81995734	3500195784	23		81995710	81995734	8421504	2	7,16	0,8	g	350019578400000011	1-30						Transgenic organisms having tetracycline-regulated transcriptional regulatory systems	Bujard	1998	0		
1210	chrX	81995710	81995734	3500079786	23		81995710	81995734	8421504	2	7,16	0,8	g	350007978600000034	1-30						Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals		1994	0		
1210	chrX	81995710	81995734	3500038343	23		81995710	81995734	8421504	2	7,16	0,8	g	350003834300000011	1-30					Patent	Methods for producing tetracycline-regulated transgenic mice (Patent US:5922927)	Bujard	1999	0		
1210	chrX	81995710	81995734	3500000835	23		81995710	81995734	8421504	2	7,16	0,8	g	350000083500000035	1-30						Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic mice	Byrne	1995	0		
1211	chrX	82100334	82103436	3500303934	3053		82100334	82103436	8421504	3	1053,1042,958	0,1075,2144	p,c	350030393400000001,350030393400015049,350030393400015047,350030393400015046,350030393400015045,350030393400015037,350030393400015036,350030393400000000,350030393400015025,350030393400015022,350030393400015021,350030393400015019,350030393400015018,350030393400015015,350030393400015014,350030393400015010,350030393400015009,350030393400015008,350030393400015007,350030393400015005,350030393400015004,350030393400015003,350030393400015002,350030393400015001	0-871,0-78,0-51,0-93,0-81,0-63,15-96,562-2793,0-96,0-108,0-45,0-111,0-72,0-45,0-60,0-144,0-123,0-123,0-93,0-69,0-60,0-48,0-84,0-81						bovine TLR8 / CD288	www.invivogen.com	0	0		
1211	chrX	82100361	82103412	3500449734	106		82100361	82103412	8421504	4	34,26,22,24	0,1446,1772,3027	c	350044973400000038,350044973400000021,350044973400000024,350044973400000025,350044973400000028	9-31,0-24,0-26,0-22,22-46						3 Materials and Methods	a.inflibnet.ac.in	0	0		
1211	chrX	82100690	82100841	3500249124	44		82100690	82100841	8421504	2	21,23	0,128	c	350024912400000021,350024912400000020	0-21,0-23						Transcriptional Expression Profile of Toll Like Receptor 1 - 10 mRNA in Bovine Peripheral Mononuclear Cells in Response to Foot and Mouth Disease Antigens	www.scirp.org	0	0		
1211	chrX	82100690	82100841	3500225619	44		82100690	82100841	8421504	2	21,23	0,128	c	350022561900000021,350022561900000020	0-21,0-23						Transcriptional Expression Profile of Toll Like Receptor 1 - 10 mRNA in Bovine Peripheral Mononuclear Cells in Response to Foot and Mouth Disease Antigens	www.scirp.org	0	0		
1211	chrX	82100805	82101456	3500201405	72		82100805	82101456	8421504	2	45,27	0,624	c	350020140500000138,350020140500000125	0-45,18-45						Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists - Patent # 7498409 - PatentGenius	.patentgenius.com	0	0		
1211	chrX	82101282	82101514	3500018219	44		82101282	82101514	8421504	2	22,22	0,210	c,g	350001821900000019,350001821900000019,350001821900000018	0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
1211	chrX	82101429	82101456	3500081767	27		82101429	82101456	8421504	1	27	0	c	350008176700000125	18-45						Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists - US Patent 7498409 Description	ww.patentstorm.us	0	0		
1211	chrX	82102138	82102163	3500395630	24		82102138	82102163	8421504	2	7,17	0,8	c	350039563000000020	0-24						A quantitative real time PCR method to analyze T cell receptor V&#x03b2; subgroup expansion by staphylococcal superantigens	onal-medicine.com	0	0		
1212	chrX	82205307	82205487	3500249124	40		82205307	82205487	8421504	2	20,20	0,160	c	350024912400000018,350024912400000011	0-20,0-20						Transcriptional Expression Profile of Toll Like Receptor 1 - 10 mRNA in Bovine Peripheral Mononuclear Cells in Response to Foot and Mouth Disease Antigens	www.scirp.org	0	0		
1212	chrX	82205307	82205487	3500225619	40		82205307	82205487	8421504	2	20,20	0,160	c,g	350022561900000018,350022561900000018,350022561900000011,350022561900000011	0-20,0-20,0-20,0-20						Transcriptional Expression Profile of Toll Like Receptor 1 - 10 mRNA in Bovine Peripheral Mononuclear Cells in Response to Foot and Mouth Disease Antigens	www.scirp.org	0	0		
1212	chrX	82205337	82205360	3500251984	23		82205337	82205360	8421504	1	23	0	c	350025198400000006	17-40						Systematische Analyse von Rezeptoren und Effektormechanismen der pulmonalen angeborenen Immunit&#xe4;t	ub.uni-marburg.de	0	0		
1212	chrX	82205577	82207978	3500449734	151		82205577	82207978	8421504	6	27,21,24,24,29,26	0,1065,1657,1896,2073,2375	c,g	350044973400000012,350044973400000012,350044973400000014,350044973400000015,350044973400000018,350044973400000016,350044973400000016,350044973400000017,350044973400000017	28-55,28-55,19-40,20-44,0-24,22-51,22-51,24-50,24-50						3 Materials and Methods	a.inflibnet.ac.in	0	0		
1212	chrX	82206430	82206807	3500201405	113		82206430	82206807	8421504	3	45,33,35	0,93,342	c	350020140500000037,350020140500000039,350020140500000044	0-45,0-33,6-41						Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists - Patent # 7498409 - PatentGenius	.patentgenius.com	0	0		
1212	chrX	82208020	82208196	3500081767	66		82208020	82208196	8421504	2	34,32	0,144	c	350008176700000070,350008176700000073	0-34,0-32						Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists - US Patent 7498409 Description	ww.patentstorm.us	0	0		
1212	chrX	82208022	82208227	3500018219	44		82208022	82208227	8421504	2	22,22	0,183	c,g	350001821900000016,350001821900000016,350001821900000017,350001821900000017	0-22,0-22,0-22,0-22						Reproductive Biology and Endocrinology BioMed Central	biomedcentral.com	0	0		
1212	chrX	82208049	82208130	3500256733	78		82208049	82208130	8421504	3	22,32,24	0,23,57	c,g	350025673300000012,350025673300000012,350025673300000014,350025673300000013,350025673300000013	0-22,0-22,0-32,0-24,0-24						Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q)	www.ijbs.org	0	0		
1212	chrX	82256902	82256928	3500017979	23		82256902	82256928	8421504	2	6,17	0,9	g	350001797900000228	6-30						Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments	Bell	2007	0		
1215	chrX	82670563	82670588	3500435564	23		82670563	82670588	8421504	2	6,17	0,8	g	350043556400000056	3-26						Heterodimeric receptor libraries using phagemids	Barbas	1994	0		
1215	chrX	82670563	82670588	3500305542	23		82670563	82670588	8421504	2	6,17	0,8	g	350030554200000056	3-26					Patent	Heterodimeric receptor libraries using phagemids (Patent US:7118866)	Kang	2006	0		
1215	chrX	82670563	82670588	3500139466	23		82670563	82670588	8421504	2	6,17	0,8	g	350013946600000043	0-23						Method of identifying binding site domains that retain the capacity of binding to an epitope	Kufer	1998	0		
1215	chrX	82670563	82670588	3500107724	23		82670563	82670588	8421504	2	6,17	0,8	g	350010772400000055	3-26					Patent	Heterodimeric receptor libraries using phagemids (Patent US:6468738)	Kang	2002	0		
1219	chrX	83158670	83158697	3500306946	23		83158670	83158697	8421504	2	16,7	0,20	g	350030694600000034	6-29						Methods for treating cardiovascular disease using a soluble CTLA4 Molecule - Patent application	www.faqs.org	0	0		
1219	chrX	83158670	83158697	3500029696	23		83158670	83158697	8421504	2	16,7	0,20	g	350002969600000034	6-29						Methods for treating cardiovascular disease using a soluble CTLA4 molecule - Patent application	www.faqs.org	0	0		
1219	chrX	83213817	83213845	3500042419	23		83213817	83213845	8421504	2	7,16	0,12	g	350004241900000028	11-34						Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms	Hogan	2000	0		
1221	chrX	83474532	83474559	3500004227	24		83474532	83474559	8421504	2	7,17	0,10	g	350000422700001021	15-39						US Patent # 6,967,088. Soluble recombinant botulinum toxin proteins - Patents.com	www.patents.com	0	0		
1222	chrX	83601115	83608905	3500231489	61		83601115	83608905	8421504	3	20,19,22	0,1734,7768	c,g	350023148900000003,350023148900000002,350023148900000002,350023148900000000	0-20,0-19,0-19,0-22						Dimorphic Goat Amelogenin Alleles on Sex Chromosomes for Gender Determination of Preimplantation Embryos	www.ijbbb.org	0	0		
1222	chrX	83601115	83607552	3500425992	1779		83601115	83607552	8421504	8	20,456,1056,168,19,20,20,20	0,39,497,1554,1734,2493,3901,6417	c,g	350042599200000013,350042599200000036,350042599200000000,350042599200000012,350042599200000012,350042599200000009,350042599200000009,350042599200000010,350042599200000010,350042599200000008,350042599200000008,350042599200000007,350042599200000007,350042599200000006,350042599200000005	0-20,0-1684,0-20,0-19,0-19,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-20,0-19						Process for sexing cow embryos	Cheng	1997	0		
1222	chrX	83602844	83603125	3500328844	199		83602844	83603125	8421504	2	127,72	0,209	c	350032884400000004,350032884400000002,350032884400000003,350032884400000001	4-131,0-21,0-90,0-21						Genotyping of Pseudohermaphrodite Polar Bears in Nunavut and Advances in DNA Sexing Techniques	www.jstor.org	0	0		
1222	chrX	83602845	83603125	3500432720	234		83602845	83603125	8421504	5	123,42,14,36,19	0,131,182,205,261	c	350043272000000003,350043272000000001,350043272000000007,350043272000000006,350043272000000005,350043272000000004,350043272000000002	0-22,0-20,0-31,0-50,0-42,0-50,0-19						Sex identi&#xfb01;cation of northern ungulates using low quality and quantity DNA	cury2.iab.uaf.edu	0	0		
1222	chrX	83602845	83603125	3500421377	41		83602845	83603125	8421504	2	22,19	0,261	c,g	350042137700000001,350042137700000001,350042137700000000,350042137700000000	0-22,0-22,0-19,0-19			10.1155/2011/897065	2090-7001	Case Reports in Veterinary Medicine	Congenital Absence of a Teat in a Japanese Black Heifer	Ghanem	2011	0		
1222	chrX	83602845	83603125	3500414598	41		83602845	83603125	8421504	2	22,19	0,261	c	350041459800000001,350041459800000000	0-22,0-19						Case Report CongenitalAbsenceofaTeatinaJapaneseBlackHeifer	loads.hindawi.com	0	0		
1222	chrX	83602845	83603125	3500155664	41		83602845	83603125	8421504	2	22,19	0,261	c	350015566400000001,350015566400000000	0-22,0-19			10.1186/1471-2156-6-16	1471-2156	BMC Genetics	X- and Y-chromosome specific variants of the amelogenin gene allow sex determination in sheep (Ovis aries) and European red deer (Cervus elaphus)	Pfeiffer	2005	2		
1222	chrX	83602845	83603125	3500088957	41		83602845	83603125	8421504	2	22,19	0,261	c,g	350008895700000003,350008895700000003,350008895700000002	0-22,0-22,0-19						The ambiguity of freemartinism diagnosis in ca&#xfffd;le revealed by cytogenetic and molecular techniques	ulturejournals.cz	0	0		
1222	chrX	83602845	83603125	3500019043	42		83602845	83603125	8421504	2	22,20	0,260	c,g	350001904300000005,350001904300000004,350001904300000004	0-22,0-20,0-20						A system for sex determination from degraded DNA: a useful tool for palaeogenetics and conservation genetics of ursids	.bearproject.info	0	0		
1222	chrX	83602845	83603125	3500006849	41		83602845	83603125	8421504	2	22,19	0,261	c	350000684900000001,350000684900000000	0-22,0-19			10.1186/1471-2156-6-16		BMC Genetics	X- and Y-chromosome specific variants of the amelogenin gene allow sex determination in sheep (Ovis aries) and European red deer (Cervus elaphus)	I	2005	0		
1222	chrX	83602846	83603213	3500354899	67		83602846	83603213	8421504	3	26,22,19	0,314,348	c,g	350035489900000001,350035489900000001,350035489900000003,350035489900000003,350035489900000002,350035489900000002,350035489900000000	0-21,0-21,0-19,0-19,0-22,0-22,0-19						Malik et al. Verification of X- and Y-spermatozoa separation by nested polymerase chain reaction (PCR), motility and membrane integrity in bovine. Afr. J. Biotechnol.	demicjournals.org	0	0		
1222	chrX	83602846	83603213	3500047953	67		83602846	83603213	8421504	3	26,22,19	0,314,348	c	350004795300000001,350004795300000003,350004795300000002,350004795300000000	0-21,0-19,0-22,0-19						ISSN 1684 - 5315 Volume10 Number 85 28 December, 2011	demicjournals.org	0	0		
1222	chrX	83602846	83603182	3500396151	48		83602846	83603182	8421504	2	26,22	0,314	c	350039615100000001,350039615100000003,350039615100000002	0-21,0-19,0-22						Verification of X- and Y-spermatozoa separation by nested polymerase chain reaction (PCR), motility and membrane integrity in bovine	demicjournals.org	0	0		
1222	chrX	83602926	83602949	3500049296	23		83602926	83602949	8421504	1	23	0	c	350004929600000009	23-46						Verifying parentage and gender of domestic dog conceptuses using microsatellites Daniela Steckler Master of Science	upetd.up.ac.za	0	0		
1222	chrX	83602977	83603037	3500153075	60		83602977	83603037	8421504	1	60	0	p	350015307500015004	24-84						Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa. - ResearchGate	.researchgate.net	0	0		
1222	chrX	83603617	83603640	3500043134	23		83603617	83603640	8421504	1	23	0	c	350004313400000049	0-23						A 26plex Autosomal STR Assay to Aid Human Identity Testing	hartnell.cc.ca.us	0	0		AMELX
1222	chrX	83604934	83604958	3500273384	24		83604934	83604958	8421504	1	24	0	g	350027338400000000	0-24						Canary islands aborigin sex determination based on mandible parameters contrasted by amelogenin analysis - ResearchGate	.researchgate.net	0	0		
1222	chrX	83604934	83604958	3500204604	24		83604934	83604958	8421504	1	24	0	g	350020460400000000	0-24						Canary islands aborigin sex determination based on mandible parameters contrasted by amelogenin analysis | Rosa Fregel - Academia.edu	www.academia.edu	0	0		
1222	chrX	83605014	83605037	3500351399	23		83605014	83605037	8421504	1	23	0	c	350035139900000034	0-23						A Low Cost Microfluidic Microarray System for Typing Y Chromosome SNPs	www.ncjrs.gov	0	0		AMELX
1222	chrX	83607114	83607564	3500461407	340		83607114	83607564	8421504	13	26,8,37,45,9,28,12,14,6,53,36,5,61	0,31,50,92,139,152,218,233,253,262,324,381,389	c,g	350046140700000047,350046140700000026,350046140700000016,350046140700000032,350046140700000052	0-421,0-54,0-43,0-43,0-49						Compositions and methods for determining canine gender - Patent # 7300752 - PatentGenius	.patentgenius.com	0	0		
1222	chrX	83607516	83607539	3500122007	23		83607516	83607539	8421504	1	23	0	c	350012200700000021	18-41					Patent	Human amyloid protein precursor homolog and Kunitz-type inhibitor (Patent US:5436153)	Foster	1995	0		
1222	chrX	83607516	83607539	3500032641	23		83607516	83607539	8421504	1	23	0	c	350003264100000021	18-41						US Patent # 5,441,931. Human amyloid protein precursor homologue and Kunitz-type inhibitors - Patents.com	www.patents.com	0	0		
1223	chrX	83635279	83635302	3500210659	23		83635279	83635302	8421504	1	23	0	g	350021065900000032	0-25						 METHODS OF PRODUCING GABA Patent Application (Application #20120030842 issued February 2, 2012) - Justia Patents Database 	atents.justia.com	0	0		
1224	chrX	83858390	83858418	3500051668	24		83858390	83858418	8421504	2	7,17	0,11	g	350005166800000007	0-24					Patent	Yeast processing system (Patent US:5514585)	slashed.rn	1996	0		
1230	chrX	84625930	84625956	3500449315	23		84625930	84625956	8421504	2	6,17	0,9	g	350044931500000472	11-34						US Patent # 7,491,698. Mixing and matching TC proteins for pest control - Patents.com	www.patents.com	0	0		
1232	chrX	84851183	84851211	3500461162	23		84851183	84851211	8421504	2	10,13	0,15	g	350046116200000042	2-25						US Patent # 6,270,974. Exogenous nucleic acid detection - Patents.com	www.patents.com	0	0		
1233	chrX	85002540	85002567	3500154995	23		85002540	85002567	8421504	2	14,9	0,18	g	350015499500000039	8-31						US Patent # 5,192,659. Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes - Patents.com	www.patents.com	0	0		
1237	chrX	85573820	85573847	3500264208	23		85573820	85573847	8421504	2	15,8	0,19	g	350026420800000081	7-31						INFORMATION TO USERS	library.mcgill.ca	0	0		
154	chrX	85580876	85601555	3500199255	40		85580876	85601555	8421504	3	13,6,21	0,18,20658	g	350019925500000132,350019925500000124	6-25,27-48						Recombinant pneumocystis carinii aminoacyl tRNA synthetase genes, tester strains and assays	Whoriskey	1995	0		
1238	chrX	85604920	85604948	3500382431	23		85604920	85604948	8421504	2	10,13	0,15	g	350038243100000011,350038243100000002	0-23,17-40						THE TUMOR METASTASIS SUPPRESSOR, nm23-&#x03b2;, INHIBITS GELATINASE A TRANSCRIPTION BY INTERFERENCE WITH TRANSACTIVATOR YB-1	www.biochemj.org	0	0		
1247	chrX	86837403	86837426	3500306427	23		86837403	86837426	8421504	1	23	0	g	350030642700000010	0-23						Modified nucleic acids	Brown	2008	0		
1248	chrX	86909309	86909507	3500250412	190		86909309	86909507	8421504	3	17,22,151	0,23,47	g	350025041200000000	0-192						 Tophat can't find Bowtie index files - Page 2 - SEQanswers	seqanswers.com	0	0		
1248	chrX	86927293	86927322	3500342384	24		86927293	86927322	8421504	3	7,5,12	0,8,17	g	350034238400000363,350034238400000362,350034238400000361,350034238400000360	9-33,9-33,9-33,9-33						Compositions and methods for inhibiting expression of a gene from the JC virus	Tan	2007	0		
1251	chrX	87302392	87302425	3500371986	26		87302392	87302425	8421504	3	8,3,15	0,12,18	g	350037198600000032	19-45						Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins	Kieliszewski	2006	0		
1253	chrX	87620151	87620176	3500003517	24		87620151	87620176	8421504	2	12,12	0,13	g	350000351700000310	2-26						 Neisseria Meningitidis Antigens And Compositions 	www.docstoc.com	0	0		
1255	chrX	87818966	87818994	3500381702	23		87818966	87818994	8421504	2	9,14	0,14	g	350038170200000002	0-23		19948736	10.1074/jbc.M109.030643		The Journal of Biological Chemistry	Phosphorylation of p22phox on Threonine 147 Enhances NADPH Oxidase Activity by Promoting p47phox Binding	Eric	2010	0		
1255	chrX	87944767	87944794	3500389719	23		87944767	87944794	8421504	2	9,14	0,13	g	350038971900000033	11-42					Patent	Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications (Patent EP:0951552)	Achtman	2011	0		
1260	chrX	88483974	88483998	3500024002	23		88483974	88483998	8421504	2	4,19	0,5	g	350002400200000010	0-23			10.1111/j.1365-2141.2004.05029.x	1365-2141	British Journal of Haematology	Molecular basis of Japanese variants of pyrimidine 5&#x2032;-nucleotidase deficiency - Kanno - 2004 - British Journal of Haematology - Wiley Online Library	Kanno	2004	0		
605	chrY	2658521	2658551	3500265438	26		2658521	2658551	8421504	3	7,6,13	0,9,17	g	350026543800000039,350026543800000018	12-38,24-48						Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof	Frank	1998	0		
605	chrY	2666531	2666556	3500382274	25		2666531	2666556	8421504	1	25	0	c	350038227400000031	0-34						Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof	Dubensky	2004	0		
605	chrY	2666531	2666556	3500213425	25		2666531	2666556	8421504	1	25	0	c	350021342500000041	0-34						Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof	Cook	2005	0		
605	chrY	2719763	2719786	3500351399	23		2719763	2719786	8421504	1	23	0	g	350035139900000034	0-23						A Low Cost Microfluidic Microarray System for Typing Y Chromosome SNPs	www.ncjrs.gov	0	0		AMELX
605	chrY	2722517	2724148	3500425992	1522		2722517	2724148	8421504	8	420,128,731,5,25,8,183,22	0,421,550,1283,1318,1346,1355,1609	g	350042599200000037,350042599200000015	0-1539,0-22						Process for sexing cow embryos	Cheng	1997	0		
611	chrY	3458559	3458586	3500347567	27		3458559	3458586	8421504	1	27	0	c	350034756700000004	9-36						Evidence that a consensus element found in naturally intronless mRNAs promotes mRNA export The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.	dash.harvard.edu	0	0		DDX3X
611	chrY	3464807	3466407	3500080205	54		3464807	3466407	8421504	2	41,13	0,1587	p	350008020500015047	96-150						DDX3Yencodes a class I MHC&#x2013;restricted H-Yantigen that is expressed in leukemic stem cells	tologylibrary.org	0	0		DDX3X
612	chrY	3653324	3653353	3500218185	25		3653324	3653353	8421504	2	9,16	0,13	g	350021818500000142	9-47						Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same - Patent application	www.faqs.org	0	0		
613	chrY	3728284	3728726	3500182474	442		3728284	3728726	8421504	1	442	0	c	350018247400000010	0-442						Procedure for the sex determination of embryos in mammals especially applied to bovine embryos	Fr	1995	0		
613	chrY	3728304	3728701	3500239038	397		3728304	3728701	8421504	1	397	0	c,g	350023903800000009,350023903800000009	0-397,0-397						Method for determining the sex of an embryo - US Patent 5759772 Description	ww.patentstorm.us	0	0		
613	chrY	3728304	3728701	3500207430	397		3728304	3728701	8421504	1	397	0	c,g	350020743000000009,350020743000000009	0-397,0-397						Method for determining the sex of an embryo	Kirkpatrick	1994	0		
613	chrY	3728433	3728487	3500282923	42		3728433	3728487	8421504	2	20,22	0,32	g	350028292300000017,350028292300000016	0-20,0-22						Minisequencing on Functionalised Self-Assembled Monolayer as a Simple Approach for Single Nucleotide Polymorphism Analysis of Cattle	.znaturforsch.com	0	0		
613	chrY	3728636	3728662	3500418200	26		3728636	3728662	8421504	1	26	0	c	350041820000000002	0-26						ScienceDirect.com - Theriogenology - Integrated morphophysiological assessment of two methods for sperm selection in bovine embryo production in vitro	sciencedirect.com	0	0		
613	chrY	3729221	3729658	3500264039	437		3729221	3729658	8421504	1	437	0	g	350026403900000058,350026403900000057,350026403900000056,350026403900000055	0-77,0-120,0-120,0-120						Structure and Evolution of the Y-chromosomal and Mitochondrial DNA of cattle	ive.library.uu.nl	0	0		
617	chrY	4199259	4199283	3500208917	23		4199259	4199283	8421504	2	13,10	0,14	g	350020891700000092	1-30					Patent	Nucleic acid size detection method (Patent EP:2082055)	Huang	2011	0		
617	chrY	4304246	4304300	3500411413	54		4304246	4304300	8421504	1	54	0	g	350041141300000001	0-54						SPERM CELL SEPARATION METHODS AND COMPOSITIONS CONTAINING SPERM CELL TARGETING LIGANDS FOR USE THEREIN - BIOCERN, INC.	www.sumobrain.com	0	0		
618	chrY	4334777	4334818	3500306794	41		4334777	4334818	8421504	1	41	0	g	350030679400000003	36-77						January - April 2003 Volume 37 Number 1	tjournal.ku.ac.th	0	0		
618	chrY	4334959	4334982	3500225465	23		4334959	4334982	8421504	1	23	0	g	350022546500000000	2-25						Towards writing the encyclopaedia of life: an introduction to DNA barcoding	api.ning.com	0	0		
629	chrY	5856244	5856269	3500452256	23		5856244	5856269	8421504	2	16,7	0,18	c	350045225600000096	8-31						 Modified Annexin Proteins And Methods For Their Use In Organ Transplantation 	www.docstoc.com	0	0		
629	chrY	5858816	5858848	3500440489	32		5858816	5858848	8421504	1	32	0	c	350044048900000114	16-48						Methods Of Diagnosis And Prognosis Of Ovarian Cancer Ii 	.freshpatents.com	0	0		
630	chrY	5997273	6011532	3500418301	40		5997273	6011532	8421504	2	20,20	0,14239	g	350041830100000015,350041830100000017	0-20,0-20					Patent	Sexing method of bovine embyros (Patent US:5461145)	Itagaki	1995	0		
632	chrY	6208370	6209953	3500418301	40		6208370	6209953	8421504	2	20,20	0,1563	g	350041830100000016,350041830100000020	0-20,0-20					Patent	Sexing method of bovine embyros (Patent US:5461145)	Itagaki	1995	0		
632	chrY	6208370	6209953	3500160638	40		6208370	6209953	8421504	2	20,20	0,1563	g	350016063800000016,350016063800000020	0-20,0-20						Sexing method of bovine embyros	Kudo	1992	0		
635	chrY	6652062	6652085	3500111538	23		6652062	6652085	8421504	1	23	0	g	350011153800000020	13-37						Antifungal proteins, dna coding therefor, and hosts incorporating same	Bres-Vloemans	1996	0		
640	chrY	7332190	7332214	3500324863	24		7332190	7332214	8421504	1	24	0	g	350032486300000000	0-24		20950427	10.1186/1477-7827-8-120		Reproductive Biology and Endocrinology : RB&E	Transforming growth factor beta family expression at the bovine feto-maternal interface	Kumiko	2010	0		
658	chrY	9631630	9631803	3500408096	42		9631630	9631803	8421504	2	20,22	0,151	c	350040809600000000,350040809600000001	0-20,0-22						Biopsy by PCR embryos	uction-online.org	0	0		
658	chrY	9631630	9631803	3500394777	42		9631630	9631803	8421504	2	20,22	0,151	c	350039477700000000,350039477700000001	0-20,0-22						Determination of genetic sex in ruminants using y-chromosome-specific polynucleotides	Beaton	1989	0		
658	chrY	9631630	9631803	3500198895	42		9631630	9631803	8421504	2	20,22	0,151	c	350019889500000000,350019889500000001	0-20,0-22						Determination of genetic sex in ruminants using Y-chromosome specific polynucleotides	Reed	1993	0		
658	chrY	9631630	9631803	3500074375	42		9631630	9631803	8421504	2	20,22	0,151	c	350007437500000000,350007437500000001	0-20,0-22						Determination of genetic sex in ruminants using y-chromosome-specific polynucleotides	Beaton	1989	0		
858	chrY	35783238	35783266	3500017866	23		35783238	35783266	8421504	2	7,16	0,12	g	350001786600000046	3-26						Molecular Characterization of an Aldehyde/Alcohol Dehydrogenase Gene Clostridium ATCC	w.papoutsakis.org	0	0		
907	chrY	42216474	42223095	3500002829	6583		42216474	42223095	8421504	33	1674,306,147,158,482,8,44,50,425,8,577,6,23,8,50,13,580,10,5,7,8,40,35,160,476,8,33,30,207,409,25,35,536	0,1675,1984,2132,2291,2774,2783,2828,2879,3305,3314,3894,3901,3925,3934,3985,3999,4580,4591,4597,4605,4615,4656,4692,4853,5330,5340,5374,5405,5613,6023,6049,6085	g	350000282900000011	0-6620						Sex- specific selection of sperm from transgenic animals	Forsberg	2002	0		
907	chrY	42224772	42226212	3500264039	1440		42224772	42226212	8421504	1	1440	0	c,g	350026403900000053,350026403900000052,350026403900000051,350026403900000050,350026403900000007,350026403900000049,350026403900000049,350026403900000048,350026403900000048,350026403900000047,350026403900000047,350026403900000046,350026403900000046,350026403900000045,350026403900000045,350026403900000006,350026403900000044,350026403900000043,350026403900000004,350026403900000042	0-120,0-120,0-120,0-120,0-21,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-120,0-19,0-119,0-120,0-21,0-120						Structure and Evolution of the Y-chromosomal and Mitochondrial DNA of cattle	ive.library.uu.nl	0	0		
907	chrY	42225166	42226819	3500190593	1644		42225166	42226819	8421504	4	1199,274,49,122	0,1200,1475,1531	c,g	350019059300000085,350019059300000006,350019059300000041,350019059300000004,350019059300000005,350019059300000009,350019059300000010,350019059300000010,350019059300000003,350019059300000002,350019059300000013	0-1644,0-23,0-20,0-26,0-24,0-20,0-19,0-19,0-25,0-25,0-20						Oligonucleotide probe and primers specific to bovine or porcine male genomic DNA	Silversides	1994	0		
907	chrY	42225166	42226819	3500069863	1644		42225166	42226819	8421504	4	1199,274,49,122	0,1200,1475,1531	c,g	350006986300000085,350006986300000006,350006986300000041,350006986300000004,350006986300000005,350006986300000009,350006986300000010,350006986300000010,350006986300000003,350006986300000002,350006986300000013	0-1644,0-23,0-20,0-26,0-24,0-20,0-19,0-19,0-25,0-25,0-20						 Oligonucleotide Probe And Primers Specific To Bovine Or Porcine Male Genomic DNA 	www.docstoc.com	0	0		
907	chrY	42225209	42225899	3500411413	690		42225209	42225899	8421504	1	690	0	c,g	350041141300000002,350041141300000002	0-690,0-690						SPERM CELL SEPARATION METHODS AND COMPOSITIONS CONTAINING SPERM CELL TARGETING LIGANDS FOR USE THEREIN - BIOCERN, INC.	www.sumobrain.com	0	0		
907	chrY	42225337	42225777	3500088957	48		42225337	42225777	8421504	2	24,24	0,416	c	350008895700000001,350008895700000000	0-24,0-24						The ambiguity of freemartinism diagnosis in ca&#xfffd;le revealed by cytogenetic and molecular techniques	ulturejournals.cz	0	0		
907	chrY	42225542	42225724	3500319637	44		42225542	42225724	8421504	2	20,24	0,158	c,g	350031963700000009,350031963700000009,350031963700000008,350031963700000008,350031963700000006,350031963700000006	0-20,0-20,0-20,0-20,0-20,0-20						Blood chimerism confounds genetic relative susceptibility testing for classical scrapie in sheep	alcommons.unl.edu	0	0		
907	chrY	42225542	42225720	3500195201	40		42225542	42225720	8421504	2	20,20	0,158	c,g	350019520100000001,350019520100000001,350019520100000000,350019520100000000	0-20,0-20,0-20,0-20						Sex Determination of Red Deer Using Polymerase Chain Reaction of DNA from Feces	www.jstor.org	0	0		
907	chrY	42225542	42225720	3500112961	40		42225542	42225720	8421504	2	20,20	0,158	c,g	350011296100000001,350011296100000001,350011296100000000,350011296100000000	0-20,0-20,0-20,0-20						Sex Determination of Red Deer Using Polymerase Chain Reaction of DNA from Feces	www.jstor.org	0	0		
907	chrY	42225564	42225727	3500463177	44		42225564	42225727	8421504	2	22,22	0,141	c	350046317700000001,350046317700000000	0-22,0-22						&#x201c;Manipulation of signalling to promote reprogramming of pig cells into a na&#xef;ve pluripotent state&#x201d;	ive.library.uu.nl	0	0		
907	chrY	42225703	42225727	3500380723	24		42225703	42225727	8421504	1	24	0	c	350038072300000000	0-24						Detection of transcriptional difference of porcine imprinted genes using different microarray platforms.	.biomedsearch.com	0	0		
907	chrY	42225703	42225727	3500018004	24		42225703	42225727	8421504	1	24	0	c	350001800400000000	0-24			10.1186/1471-2164-7-328		BMC Genomics	Detection of transcriptional difference of porcine imprinted genes using different microarray platforms	Shengdar	2006	0		
907	chrY	42226248	42226499	3500324674	68		42226248	42226499	8421504	3	23,22,23	0,183,228	g	350032467400000001,350032467400000003,350032467400000000	0-23,0-22,0-23						Establishing and optimizing the system for sex determination of bovine preimplantation embryos	iotechnology.info	0	0		
907	chrY	42231090	42233781	3500199071	64		42231090	42233781	8421504	3	20,23,21	0,1280,2670	g	350019907100000003,350019907100000002,350019907100000001	0-20,0-23,0-21		18851760	10.1186/1471-2199-9-85	1471-2199	BMC Molecular Biology	New insights into SRY regulation through identification of 5' conserved sequences	Ross	2008	3